Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353492	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1493	"liver: 1224.7"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 1548.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	51000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.1	1224.7	0.1	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	2.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.9	0.3	0.8	0.0	0.1	0.1	0.7	1.3	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.4	0.0	0.6	0.2	0.0	0.0	0.9	0.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	10.2	12.8	14.1	0.7	50.2	8.8	2.2	16.2	12.0	3.4	52.0	64.3	0.7	27.1	10.6	22.0	2.1	1.0	71.2	0.0	7.9	0.9	0.6	5.0	52.6	10.9	1.2	56.2	2.2	9.2	15.6	20.3	5.1	2.1	17.7	10.8	43.2	1548.5	25.1	8.4	1.7	0.1	20.3	110.9	66.0	2.1	1.2	49.4	115.6	0.0	60.8	3.1	15.5	0.0	8.7	5.4	0.0	1.2	94.4	11.1	0.0	2.0	15.0	5.5	26.3	29.2	43.8	4.1	7.9	1.5	3.7	1.9	52.6	0.7	0.2	0.6
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264129-218270178	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	66.5	66.4	65.0	46.2	66.1	27.5	65.2	67.1	80.1	62.6	63.2	76.3	62.8	61.7	43.8	75.1	60.8	56.1	65.4	65.7	67.2	60.2	77.5	46.6	47.8	69.2	66.6	79.8	70.7	72.7	62.1	54.9	66.4	58.0	58.0	38.4	66.9	58.7	90.4	76.6	61.7	50.7	67.5	53.0	86.9	53.8	67.1	54.0	66.6	62.0	52.6	70.0	57.4	70.3	126.1	104.6	75.1	102.2	111.9	75.7	146.0	89.6	136.3	167.1	124.5	226.2	100.1	64.6	121.8	112.6	158.8	94.3	150.7	133.4	129.3	103.5	200.9	147.4	108.2	237.4	158.9	139.3	92.4	97.8	152.7	172.2	149.7	99.7	97.6	124.3	202.6	82.4	108.9	198.0	112.4	234.9	121.0	182.4	75.4	90.6	97.5	105.8	100.3	160.5	96.2	92.9	59.4	128.7	134.7	119.1	99.1	104.6	84.7	110.2	82.3	81.2	106.8	105.7	198.1	108.4	111.0	88.6	77.4	75.9	166.2	60.3	101.1	209.2	105.1	100.3	90.1	94.9	191.4	105.7	111.1	100.7	26.2	114.9	210.6	114.1	109.3	179.4	65.0	66.1	67.1	80.1	65.7	67.2	69.2	66.6	66.4	67.5	67.1	70.3	57.8	41.7	35.2	11.4	50.4	90.5	86.1	122.9	66.0	47.7	50.7	45.2	35.5	41.5	74.0	42.3	12.5	160.0	42.2	74.3	103.7	95.7	3.5	33.5	46.4	50.6	75.5	34.0	11.5	95.4	130.3	63.4	80.5	38.2	34.8	57.6	42.5	46.2	91.9	63.9	12.9	89.9	93.6	37.0	65.3	8.8	83.3	38.5	62.2	5.6	64.8	80.2	41.2	8.0	10.5	86.6	72.0	74.9	51.2	116.0	99.5	85.3	47.4	37.1	65.7	38.4	86.5	72.0	53.3	70.2	97.3	202.6	44.4	62.5	103.5	119.9
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781006-104928155	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 13.1;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 34.1;U-87 MG: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	24.7	36.5	12.0	11.0	29.1	20.7	13.3	14.4	12.5	7.4	4.1	16.3	4.5	5.6	8.2	4.9	8.0	15.0	4.6	10.4	13.7	7.2	38.7	12.3	8.9	19.5	26.2	8.9	4.0	1.8	2.5	22.7	19.0	4.1	9.9	3.7	5.7	5.0	10.9	13.4	8.1	7.6	16.4	7.1	6.7	3.6	27.3	11.0	5.1	3.4	5.4	19.7	7.6	20.7	0.0	5.6	4.6	0.0	13.1	4.9	4.1	5.9	22.6	1.9	2.1	0.8	0.8	8.2	6.4	5.9	21.7	0.0	2.5	0.3	1.7	0.0	0.0	0.9	1.9	20.3	23.5	0.0	13.8	34.1	1.5	22.7	0.4	21.6	2.2	0.7	0.0	20.2	0.5	0.8	5.2	11.1	6.5	1.2	1.7	0.1	0.0	0.4	3.7	3.9	0.7	0.2	6.2	1.0	1.2	8.7	0.1	4.1	2.1	6.0	0.4	8.0	6.5	7.9	4.0	4.8	79.0	0.0	0.1	2.4	0.8	13.1	0.1	1.0	0.2	1.2	0.3	0.0	0.2	1.5	0.6	0.0	10.6	0.1	1.7	0.1	0.1	0.2	12.0	29.1	14.4	12.5	10.4	13.7	19.5	26.2	19.0	16.4	27.3	20.7	35.8	105.8	9.3	71.5	21.1	29.7	5.9	6.3	61.5	18.4	4.6	7.0	8.9	22.8	11.7	11.0	47.9	31.1	2.4	8.4	0.0	4.5	1.9	17.1	76.0	18.7	9.1	1.3	8.1	1.5	6.9	44.0	14.3	29.4	46.9	3.6	31.4	175.5	75.0	0.0	22.5	2.2	8.2	169.1	109.5	2.5	31.1	74.8	26.6	38.4	6.4	0.5	0.0	57.8	7.7	4.9	5.0	28.2	2.2	2.6	0.1	18.0	8.4	6.7	46.0	24.3	23.4	1.0	1.8	17.1	19.5	8.9	6.5	39.5	3.2	13.3
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"brain: 543.0"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.0	6.0	90.2	4.2	269.7	6.7	6.3	194.3	189.0	5.9	0.0	7.9	3.0	4.3	4.5	3.3	6.2	5.9	9.1	92.4	101.3	7.1	7.4	6.2	4.6	284.9	211.4	3.2	9.3	13.4	23.4	3.1	255.1	7.1	2.2	2.7	8.4	4.7	7.3	6.6	6.5	2.4	135.7	9.5	11.6	2.9	204.9	2.9	15.2	3.5	1.8	5.6	5.3	543.0	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	90.2	269.7	194.3	189.0	92.4	101.3	284.9	211.4	255.1	135.7	204.9	543.0	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992834-94121148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"choroid plexus: 144.6;retina: 461.0"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	6	"hippocampal formation: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.5	0.0	0.4	0.1	0.3	0.0	0.8	1.1	0.7	0.5	144.6	0.2	2.5	0.1	8.4	0.2	0.4	0.1	0.2	9.3	0.1	8.7	0.9	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.1	0.6	0.2	0.2	0.1	461.0	0.0	1.4	0.1	2.1	2.9	0.0	0.1	0.1	0.1	1.0	1.4	0.3	0.4	0.0	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	6.8	0.3	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.3	0.7	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.9	0.5	0.0	1.2	0.0	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	3.0	0.1	3.1	0.3	0.0	0.1	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.7	9.3	0.1	0.4	0.5	0.2	0.1	1.4	0.4	1.2	0.0	1.1	1.3	0.0	0.1	0.2	1.7	0.0	27.9	0.5	1.3	1.1	0.0	1.8	7.3	450.4	0.3	0.0	0.0	0.0	0.0	8.8	0.3	0.1	3.1	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.9	0.0	0.2	1.4	0.3	0.1	10.1	0.6	16.2	0.0	0.3	0.0	21.9	0.0	0.0	0.0	19.7	0.0	37.3	0.0	0.5	0.0	0.0	0.0	0.4	0.0	2.6	1.3	0.4	2.3	482.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.7
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558707	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HL-60: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	8.9	6.0	4.7	8.9	4.8	60.1	7.9	6.6	6.4	6.8	5.0	11.1	17.2	6.9	4.6	8.3	7.9	6.7	7.9	4.4	4.5	9.8	19.0	8.8	11.0	4.8	4.7	5.5	7.3	9.4	3.4	11.3	4.6	8.4	11.3	6.4	6.7	7.3	12.9	8.1	13.9	9.2	4.3	8.6	10.1	3.8	5.2	8.2	7.5	10.9	9.6	8.5	6.3	5.7	25.1	14.6	11.9	9.8	19.9	17.1	51.6	22.5	16.8	20.0	18.1	15.1	18.7	27.3	20.1	20.7	8.2	21.1	25.8	18.6	20.1	18.7	32.5	30.0	12.2	19.3	14.2	101.9	16.1	11.8	15.7	12.2	14.1	12.1	21.9	47.9	65.2	61.0	20.8	7.9	26.1	57.9	15.9	28.8	12.3	23.4	23.5	29.0	16.2	15.9	8.8	13.3	17.6	19.4	28.6	7.3	15.0	35.0	17.0	21.5	13.5	13.5	31.2	14.9	11.9	23.7	11.3	17.5	13.8	0.5	0.6	0.8	0.7	0.8	1.0	0.5	0.9	1.1	0.8	0.6	0.8	1.0	0.1	0.4	0.6	0.9	0.8	0.3	4.7	4.8	6.6	6.4	4.4	4.5	4.8	4.7	4.6	4.3	5.2	5.7	6.9	9.6	2.0	16.0	3.8	3.2	2.7	4.3	3.4	6.8	6.4	4.2	11.5	5.7	5.5	0.0	12.5	6.5	7.9	13.5	1.9	4.6	0.2	6.3	8.7	6.5	10.2	170.0	21.9	5.3	10.4	5.0	6.1	6.0	5.7	3.5	8.6	19.2	9.1	10.1	27.3	10.6	2.0	13.3	6.6	0.5	5.0	8.3	8.8	10.3	16.8	3.6	4.1	31.2	30.3	4.7	8.8	4.5	5.5	8.4	13.5	4.9	12.1	4.8	6.6	5.4	6.8	4.2	4.5	8.3	5.1	3.6	5.9	2.8	11.5	3.7
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051048-75156732	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	12.6	13.5	5.0	7.7	5.9	11.1	11.8	8.2	7.6	11.4	9.8	13.8	16.0	10.9	5.0	11.6	11.2	7.4	22.0	5.5	6.1	10.1	14.8	9.8	12.0	6.4	6.0	12.3	9.6	11.0	8.6	7.5	6.2	8.5	9.6	9.8	10.0	6.9	31.4	12.9	11.8	8.8	6.1	10.9	12.3	4.1	5.4	14.0	9.5	22.2	11.1	10.5	10.9	6.8	17.0	16.2	12.2	20.9	14.1	25.5	7.0	8.9	14.6	12.3	22.4	18.5	24.5	25.8	22.8	9.2	21.2	18.8	25.6	18.5	12.0	26.0	33.2	16.8	29.2	17.3	8.2	24.7	13.7	15.9	16.3	12.8	16.7	21.3	23.1	26.2	18.9	31.1	9.8	10.5	24.4	26.1	26.8	26.3	30.5	21.4	26.9	30.5	12.7	13.2	17.7	14.1	27.4	23.5	17.8	20.0	10.2	22.9	10.3	11.3	22.9	23.2	12.4	10.1	27.5	21.2	10.1	35.8	9.4	9.6	26.9	10.0	15.7	25.6	16.6	24.7	16.7	16.7	29.0	28.2	28.7	21.1	2.4	17.5	20.4	18.2	27.2	19.2	5.0	5.9	8.2	7.6	5.5	6.1	6.4	6.0	6.2	6.1	5.4	6.8	12.0	9.6	10.4	48.0	26.6	15.8	14.5	16.0	19.9	10.9	10.9	9.9	46.8	14.3	14.2	11.0	6.2	23.0	19.0	8.2	11.7	17.5	0.4	8.4	12.8	11.9	13.8	26.9	37.9	13.5	11.6	13.9	9.7	10.1	22.2	20.6	9.3	11.8	20.1	25.2	39.0	10.5	8.2	26.1	16.7	0.8	14.6	19.2	10.6	45.0	22.9	12.4	6.2	43.7	46.6	11.6	7.9	13.2	14.3	10.6	15.9	19.9	10.7	7.9	32.9	19.6	13.8	5.5	10.9	16.1	16.1	22.3	14.5	19.2	17.9	11.9
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	10.4	11.6	0.3	4.0	0.2	3.6	8.6	0.3	0.7	10.4	4.1	16.1	1.1	11.0	0.1	22.8	7.0	3.1	11.2	0.3	0.5	8.0	2.3	15.5	4.4	1.1	0.8	8.9	8.9	3.6	7.2	2.0	0.7	15.2	0.7	0.4	9.2	0.9	21.2	9.7	12.4	6.3	0.5	15.7	15.0	13.1	0.6	4.3	21.0	0.1	1.1	15.4	12.8	0.9	4.3	43.7	0.3	11.7	3.2	4.5	0.5	15.4	19.0	13.1	13.8	6.7	34.8	7.0	79.6	29.6	11.0	12.1	3.4	12.4	4.6	22.2	4.4	16.4	22.0	16.3	25.1	5.9	39.5	15.0	9.0	1.1	2.3	3.8	10.2	28.6	17.8	6.8	0.5	5.4	12.0	0.9	3.5	1.8	8.2	41.9	7.8	5.3	0.7	15.2	6.4	11.8	18.9	17.8	3.6	11.9	6.2	0.8	3.5	0.4	2.0	11.4	11.9	13.5	7.4	3.3	6.6	0.6	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.5	1.1	0.8	0.7	0.5	0.6	0.9	8.6	25.6	5.6	10.7	13.1	8.8	8.5	18.2	9.6	3.1	4.4	3.7	6.0	4.3	14.4	5.5	22.9	0.9	9.8	2.7	3.9	9.1	11.0	15.7	12.9	8.6	18.6	16.0	26.6	6.2	3.2	12.3	49.5	17.8	22.1	16.8	8.6	0.4	8.5	5.0	38.5	6.6	14.2	21.4	9.1	14.3	7.5	12.2	3.6	11.2	10.5	1.2	5.2	12.1	15.9	11.2	4.5	6.8	15.7	18.7	0.5	1.1	9.9	8.8	0.0	6.4	5.1	4.9	6.6	18.1	5.1	0.5	17.4	37.1	3.7	11.6
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285269-74303055	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	6.6	4.7	3.0	3.9	3.4	4.6	6.4	4.0	5.4	5.8	2.9	5.4	8.8	4.9	2.1	4.8	8.5	7.7	6.0	3.0	3.3	5.4	7.7	5.8	6.6	4.2	3.4	6.9	6.0	3.8	3.9	7.4	3.7	3.6	4.0	3.3	4.0	3.5	3.9	4.1	8.7	5.2	2.8	6.2	4.5	3.4	3.6	5.5	7.2	2.0	3.8	4.5	4.3	4.5	2.6	3.1	7.9	6.2	6.4	4.3	9.8	3.9	5.6	5.8	6.0	6.5	13.7	4.3	7.4	5.9	3.2	9.2	6.0	5.4	3.0	3.9	3.8	2.3	5.1	5.2	2.1	2.9	4.4	10.4	2.4	4.1	2.8	3.0	9.9	5.4	4.3	1.9	4.5	4.3	7.1	5.6	3.0	5.0	5.9	9.7	11.4	6.3	8.6	8.5	3.7	7.3	5.4	5.3	5.5	3.7	12.3	1.7	9.7	3.6	7.0	3.2	2.5	4.4	4.5	3.3	5.1	4.3	4.5	6.0	1.3	1.8	2.6	1.2	1.7	1.9	2.2	2.9	2.1	1.8	1.2	1.8	1.1	2.6	1.0	4.0	5.2	1.4	3.0	3.4	4.0	5.4	3.0	3.3	4.2	3.4	3.7	2.8	3.6	4.5	50.0	28.9	18.6	32.3	16.7	15.6	14.8	23.0	12.0	46.5	21.4	14.2	9.7	34.3	21.2	20.2	64.6	51.6	28.9	31.4	9.8	25.3	10.3	27.9	23.5	50.2	12.0	9.9	29.6	11.3	19.9	23.0	13.7	20.1	20.3	43.2	44.6	23.3	51.1	32.0	34.7	15.7	18.3	24.8	27.1	7.7	40.4	19.5	21.4	20.6	22.8	36.4	32.0	23.6	38.1	17.9	19.4	25.2	13.3	12.6	60.1	23.9	19.5	55.5	32.9	23.3	19.1	35.8	27.2	10.6	10.7	28.5	23.4	27.9	22.9	16.7
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 313.2;Proximal tubular cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 190.8"	"Low region specificity"	"Detected in all"							"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2100000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	69.2	81.9	21.3	26.1	22.3	37.4	66.0	21.4	25.3	49.7	29.9	60.0	81.5	39.3	44.7	46.1	58.3	35.2	31.0	20.2	21.4	97.3	155.6	37.8	48.3	22.2	22.2	51.2	65.2	51.3	36.5	15.4	22.7	48.5	55.3	40.4	64.8	36.6	25.1	42.7	74.8	26.9	22.4	47.1	51.0	9.6	22.9	39.0	57.1	22.6	43.1	47.9	42.9	22.3	37.6	32.9	2.7	37.3	100.6	91.3	9.2	14.5	18.4	27.2	32.5	25.3	72.6	41.7	11.4	54.2	12.6	18.5	23.5	22.2	21.0	57.6	27.2	66.6	30.6	106.6	55.3	37.8	64.9	115.1	74.4	27.8	36.9	41.9	34.0	64.2	39.1	66.8	55.8	40.5	16.8	29.9	3.5	43.6	88.5	42.1	5.2	190.8	51.8	16.7	15.2	16.6	37.3	68.0	121.8	5.7	97.7	25.8	31.5	13.8	64.8	32.3	8.7	82.1	41.6	17.4	30.4	118.9	24.8	41.7	24.3	10.9	42.2	19.9	63.3	58.3	53.0	52.0	38.1	42.9	52.4	49.2	1.9	24.5	12.9	28.4	42.4	37.5	21.3	22.3	21.4	25.3	20.2	21.4	22.2	22.2	22.7	22.4	22.9	22.3	40.4	6.4	26.2	7.8	69.4	30.2	62.4	68.5	38.1	12.7	88.1	81.0	4.7	72.9	28.7	69.9	14.6	16.7	50.7	79.6	146.8	34.8	1.4	19.6	22.4	36.8	75.9	41.2	10.1	46.8	19.0	43.4	35.2	20.9	50.8	14.8	39.7	122.1	55.4	8.4	10.8	97.1	42.7	60.7	36.3	2.4	65.0	39.0	55.2	14.0	37.7	14.8	50.4	4.5	9.4	30.0	74.5	46.6	37.4	39.6	313.2	265.3	25.2	39.9	39.5	34.7	35.6	0.4	3.9	57.1	30.4	11.8	63.9	47.7	127.9	64.4
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.9"	"Group enriched"	"Detected in some"	77	"Early spermatids: 131.8;Late spermatids: 270.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.0;PC-3: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059272, HPA075886"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA059272: AB_2683963, HPA075886: "																		2.1	1.5	2.2	2.5	1.6	1.0	0.1	1.7	3.0	0.2	0.8	0.8	1.8	1.0	0.0	0.4	0.2	0.4	1.0	1.7	2.1	1.0	0.3	1.0	1.7	2.0	2.2	0.9	2.1	0.0	0.1	0.6	2.3	1.3	0.0	0.3	1.6	0.0	1.6	1.1	1.6	0.0	1.3	3.6	2.3	15.9	4.6	0.0	0.4	0.0	0.0	0.1	0.2	2.1	4.9	3.2	0.6	1.2	0.0	0.0	7.2	5.7	0.0	0.1	0.0	16.0	6.3	4.5	4.6	0.0	1.4	12.6	0.0	0.0	0.0	3.1	3.8	2.9	6.7	11.8	0.0	1.7	7.9	0.0	0.0	0.0	0.0	0.3	0.0	3.4	5.6	5.2	0.0	8.5	2.7	4.8	1.3	0.6	18.8	5.8	0.7	1.7	0.0	3.3	2.2	1.9	5.4	3.1	0.8	0.2	6.3	0.8	1.9	3.3	5.8	1.7	2.4	4.2	2.6	2.9	2.4	1.8	2.4	0.1	0.7	2.7	0.7	0.4	0.4	0.3	0.2	0.5	0.6	0.6	0.5	0.4	0.2	0.2	0.3	0.6	0.8	0.8	2.2	1.6	1.7	3.0	1.7	2.1	2.0	2.2	2.3	1.3	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	270.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
ABITRAM	"C9orf6, CG-8, FAM206A, FLJ20457, Simiate"	ENSG00000119328	"Actin binding transcription modulator"	Q9NX38	9	108934400-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035917, HPA035918"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	14.2	11.9	17.2	10.0	18.7	15.6	17.2	16.8	21.9	12.5	18.7	14.9	14.4	13.6	25.1	16.4	21.5	10.9	15.8	17.7	17.3	13.6	14.6	12.7	9.0	16.8	17.1	13.5	13.3	23.2	13.9	12.5	17.2	12.1	16.2	24.7	15.3	14.2	13.2	24.5	13.1	12.5	17.5	8.5	14.5	20.2	17.5	11.9	19.0	11.8	12.0	11.9	11.4	18.3	18.5	19.8	19.5	23.4	36.2	44.6	28.1	17.1	20.0	17.0	13.9	29.5	9.7	17.0	9.8	16.6	22.3	41.3	17.2	18.3	16.0	10.4	17.6	10.5	25.8	27.0	30.7	40.4	13.3	25.3	33.6	20.7	47.6	20.9	23.7	26.1	39.7	16.6	20.3	53.0	28.9	16.3	22.6	55.9	28.7	13.9	33.9	18.9	22.5	19.2	26.7	13.7	27.0	23.3	30.1	20.0	31.6	21.4	14.9	9.2	16.9	39.3	21.7	14.7	38.5	12.6	30.1	15.6	13.4	38.8	31.2	31.0	14.8	33.4	22.6	16.5	23.1	19.6	35.5	10.8	22.9	17.6	37.4	21.1	34.6	37.0	21.1	20.1	17.2	18.7	16.8	21.9	17.7	17.3	16.8	17.1	17.2	17.5	17.5	18.3	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	6.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
AC012254.7		ENSG00000288631	"Elongin A3"	Q8NG57	18	47028202-47029842	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"brain: 3.9;choroid plexus: 4.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086, HPA053158"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA							Nucleoplasm	"Nucleoli, Cytosol"	"HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: "																		0.0	0.0	2.0	0.0	2.8	0.0	0.0	1.5	1.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	3.9	3.8	0.0	0.0	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.8	1.5	1.8	1.6	1.9	3.9	3.8	2.7	1.1	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 212.6;liver: 659.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 224.0;SK-BR-3: 342.9"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	42.8	54.1	47.5	24.0	54.4	44.7	41.2	54.3	49.5	28.3	42.3	56.9	101.0	20.8	44.6	56.7	19.4	29.8	84.8	44.6	48.7	212.6	659.3	34.9	26.1	54.2	50.4	20.9	59.3	47.9	24.8	17.2	53.0	55.1	51.2	4.9	38.9	25.3	48.2	30.7	89.5	18.7	50.9	41.3	42.1	15.5	53.6	28.0	32.1	53.8	30.0	43.7	33.5	54.9	35.5	39.8	13.0	40.7	55.6	32.2	44.6	32.2	47.0	36.3	34.5	52.8	38.8	21.1	22.6	52.0	17.4	24.5	34.9	54.0	20.0	31.0	37.2	27.0	35.4	155.5	35.3	63.3	59.8	59.0	39.3	31.2	22.5	23.9	49.9	49.7	26.2	24.2	41.3	49.2	60.3	45.3	13.3	224.0	47.0	13.9	25.0	34.3	103.4	110.4	10.9	16.5	31.7	342.9	23.7	18.0	35.1	48.9	36.8	21.9	21.1	43.2	44.2	31.9	21.7	16.1	34.8	54.4	34.7	79.9	114.4	130.4	48.8	159.1	41.2	33.9	45.7	47.4	178.1	36.0	45.2	42.5	76.3	71.9	187.7	104.5	77.2	82.1	47.5	54.4	54.3	49.5	44.6	48.7	54.2	50.4	53.0	50.9	53.6	54.9	30.7	41.7	38.7	50.6	45.6	33.3	56.5	57.6	40.9	36.9	48.7	37.1	3.2	98.7	44.3	66.2	14.6	91.6	61.7	356.8	166.3	98.0	4.5	40.7	38.6	25.4	55.1	40.4	25.6	78.4	64.5	34.4	76.5	39.1	19.0	32.5	37.1	686.0	81.7	8.4	24.7	73.1	48.8	93.5	86.8	9.6	35.8	83.2	58.7	14.0	89.5	43.1	53.5	12.5	30.9	100.9	270.6	33.1	44.5	60.6	441.1	721.8	26.3	16.7	32.9	28.5	27.4	19.8	11.7	48.1	35.5	99.3	44.4	186.7	84.3	87.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 183.3;skeletal muscle: 173.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.7;Astrocytes: 136.8;Hepatocytes: 216.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.5"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 222.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006554	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	183.3	19.8	19.6	3.3	21.7	3.6	100.5	7.6	11.4	12.9	26.9	37.2	8.4	12.0	3.5	10.6	12.1	10.9	35.4	10.1	11.2	12.6	54.3	6.7	3.8	12.7	19.4	14.3	19.2	17.9	11.2	2.5	11.6	11.8	8.2	1.7	12.5	11.7	173.2	9.5	15.5	9.4	6.7	7.8	18.6	4.9	19.1	4.5	18.1	61.5	3.0	23.0	11.5	13.2	0.9	5.7	3.6	6.9	222.6	1.7	2.6	0.9	1.5	1.0	0.6	4.1	1.1	2.9	1.6	1.2	2.4	4.8	3.0	1.5	0.6	3.8	5.3	6.6	6.2	4.3	1.0	5.7	1.6	2.6	1.5	2.3	0.6	1.7	0.5	4.9	0.7	0.3	0.7	1.7	4.1	5.3	3.9	0.4	12.4	2.2	4.8	1.5	1.8	2.0	2.3	5.4	5.9	2.8	3.4	1.5	2.6	5.9	0.4	2.2	1.3	2.5	1.9	8.8	5.3	4.0	5.3	4.5	1.7	4.6	0.4	17.5	1.1	0.1	0.6	2.2	1.0	0.3	0.2	3.0	1.8	0.9	0.7	0.1	0.2	0.3	0.6	0.1	19.6	21.7	7.6	11.4	10.1	11.2	12.7	19.4	11.6	6.7	19.1	13.2	128.7	6.4	1.1	136.8	3.7	2.3	2.6	1.0	3.4	3.1	32.5	5.0	35.3	25.8	1.7	23.9	0.0	0.6	2.4	13.9	1.9	2.1	34.3	3.3	3.4	26.0	10.2	25.7	5.1	4.0	0.5	16.0	18.3	1.3	1.3	20.0	41.4	216.5	1.7	23.5	6.4	9.6	0.0	12.6	2.4	36.4	29.2	3.7	5.4	28.1	1.2	5.2	2.1	29.7	25.8	2.7	7.3	50.4	2.5	0.9	17.9	6.5	2.3	4.1	6.6	29.3	12.0	2.3	3.0	2.5	1.6	0.1	3.5	21.8	11.8	1.1
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725774-120740008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 245.5;skeletal muscle: 158.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 303.1;Hepatocytes: 203.3;Paneth cells: 185.7;Proximal enterocytes: 435.0;Undifferentiated cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	50.3	52.7	13.3	11.1	15.4	14.3	40.9	13.6	16.6	11.2	13.7	74.0	84.8	10.2	0.9	14.1	10.2	8.5	90.5	12.3	13.8	51.9	245.5	13.4	6.4	14.6	14.2	8.6	33.1	4.7	9.2	7.5	13.1	13.9	21.3	0.9	19.2	7.2	158.2	13.7	73.2	5.8	14.0	31.6	34.5	20.3	16.0	6.6	21.9	79.7	3.4	18.0	12.7	14.8	3.2	11.4	0.6	9.7	12.9	5.1	11.1	4.7	4.6	6.0	4.5	8.9	8.0	0.3	11.9	3.9	2.7	5.2	6.6	2.1	0.8	16.7	8.2	8.2	3.6	19.3	9.3	0.7	36.0	15.4	3.1	2.6	0.2	1.8	6.1	20.6	6.9	0.1	2.7	6.8	11.7	19.2	2.0	10.6	4.6	8.6	4.2	2.2	11.3	18.2	1.1	6.0	9.7	0.0	15.8	0.9	7.7	13.1	6.9	0.2	4.7	4.5	0.9	15.3	9.3	4.1	10.2	7.0	4.1	8.3	15.3	7.5	13.7	16.3	9.3	6.3	12.2	14.2	13.2	8.9	15.3	14.4	1.4	19.9	10.2	11.0	14.7	12.8	13.3	15.4	13.6	16.6	12.3	13.8	14.6	14.2	13.1	14.0	16.0	14.8	18.8	12.8	13.7	10.1	6.7	6.6	9.5	21.1	4.0	1.0	25.0	14.9	44.0	27.1	13.0	18.4	0.0	78.8	9.8	303.1	50.9	35.2	23.5	12.8	8.2	13.4	45.6	38.5	2.3	32.6	31.3	18.1	28.5	10.8	19.1	12.8	19.2	203.3	55.1	1.7	2.8	105.3	20.3	21.0	8.9	36.5	21.5	15.3	17.8	0.0	26.1	13.6	18.6	3.0	3.6	26.7	185.7	18.0	7.9	8.3	435.0	94.8	7.3	0.6	6.6	13.2	12.7	41.5	8.1	9.4	4.5	75.5	11.9	140.6	185.9	12.7
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 3430.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	5.6	1.1	0.4	18.9	0.5	41.0	2.1	0.5	0.8	2.3	0.5	7.4	4.1	1.5	0.3	4.2	4.0	3.6	2.1	0.3	0.4	4.6	5.2	16.1	39.5	0.6	0.5	0.9	1.2	0.1	1.3	0.5	0.6	3.8	2.1	0.2	3.6	0.4	0.9	2.5	43.3	0.9	0.5	96.0	5.0	0.8	0.8	25.8	5.2	0.8	22.6	4.3	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	23.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	8.8	0.1	0.0	0.1	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	29.4	0.0	0.0	14.5	37.9	0.4	0.0	0.0	15.1	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.1	0.0	0.0	9.1	8.2	10.9	0.1	24.9	0.0	28.8	7.9	30.8	29.6	2.4	33.3	20.2	31.5	32.1	13.7	21.3	26.7	27.5	22.6	32.5	0.4	17.3	39.0	22.3	0.4	0.5	0.5	0.8	0.3	0.4	0.6	0.5	0.6	0.5	0.8	0.6	3.8	9.6	5.5	1.6	150.9	8.3	7.6	25.1	2.8	15.8	7.0	8.1	32.9	7.2	12.3	5.5	18.8	3.9	160.7	2.0	7.9	3.9	498.1	8.3	5.4	5.0	3.6	22.9	0.3	3.7	3.2	8.0	5.6	3.4	40.5	1.8	7.1	5.3	7.5	0.0	1.9	2.7	8.2	26.2	39.5	3430.7	20.2	27.9	24.9	2.8	38.3	11.7	332.7	0.5	1.0	5.5	0.0	15.4	68.0	4.6	1.3	3.8	44.6	20.4	19.7	7.5	8.1	15.6	10.5	1.5	7.4	4.4	268.3	0.9	1.6	3.5
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274745-195443044	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 215.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	15.9	10.2	10.7	22.2	10.3	39.6	13.5	21.4	14.5	14.3	1.8	17.0	14.0	14.4	10.9	21.7	12.2	14.2	8.3	14.1	6.4	10.3	11.8	15.7	26.9	2.5	4.2	19.0	9.0	13.2	8.5	15.5	6.1	10.7	17.3	29.4	9.5	10.4	5.3	15.5	15.3	14.5	3.3	23.6	14.0	15.1	5.0	21.0	21.7	9.7	27.9	13.5	11.5	7.7	34.6	13.5	21.5	21.1	34.3	41.9	31.6	28.0	37.2	20.5	21.4	18.5	19.8	38.7	65.7	25.8	20.0	21.6	16.5	14.0	29.4	43.4	9.7	38.5	14.2	7.6	33.5	52.5	26.7	32.3	24.0	20.4	46.1	17.6	22.7	21.4	19.1	37.0	30.3	20.3	33.7	19.1	13.0	19.8	18.1	39.7	24.8	27.8	14.1	32.2	23.8	11.5	30.7	27.4	32.9	18.2	51.7	30.6	40.3	25.9	14.7	34.6	32.7	21.8	50.2	84.0	19.1	56.2	27.5	62.8	55.2	55.3	27.5	49.0	21.2	39.3	26.1	21.3	32.9	45.6	22.0	22.4	215.8	17.6	59.0	34.4	26.2	25.4	10.7	10.3	21.4	14.5	14.1	6.4	2.5	4.2	6.1	3.3	5.0	7.7	110.7	44.8	40.9	103.8	103.1	44.5	28.8	45.1	88.2	58.7	43.1	50.3	17.9	22.8	43.4	31.3	77.2	20.2	101.9	75.8	19.6	24.1	11.1	49.7	60.4	74.1	51.6	50.1	141.2	24.3	22.2	62.2	44.4	49.7	39.9	33.5	57.5	32.5	65.4	121.1	143.1	44.4	22.4	115.7	67.5	9.7	46.6	110.8	35.6	143.4	122.3	29.1	68.0	132.7	130.1	31.7	70.7	37.6	67.6	41.5	39.3	28.6	45.1	92.6	59.2	43.8	61.4	39.6	26.7	143.7	51.7	29.0	85.1	43.0	37.6	38.6
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186741	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Approved		Supported	"Golgi apparatus"		NA	NA		29000	"Cluster 37: B-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	21.6	16.9	11.6	20.4	12.4	25.9	24.4	13.1	13.0	27.6	16.6	23.2	17.5	22.8	20.6	30.8	17.8	23.5	21.4	10.9	13.7	20.2	24.3	22.4	21.3	12.6	13.9	23.2	22.7	28.0	14.6	31.7	12.9	22.8	25.4	16.1	24.1	16.4	21.5	19.3	17.5	21.7	13.1	17.8	31.7	18.8	13.1	18.0	28.8	20.3	25.7	26.9	20.2	13.5	43.7	29.3	24.3	15.1	73.6	65.4	47.2	53.7	55.7	31.5	40.3	38.0	53.2	46.3	48.0	69.7	28.5	33.5	34.6	35.2	43.9	19.4	40.4	22.5	30.3	34.8	47.2	36.5	26.7	48.7	46.0	39.1	51.1	44.7	36.6	22.2	42.6	32.0	51.3	22.1	27.2	28.5	36.1	72.5	38.0	25.0	53.3	47.1	29.4	39.2	27.6	39.8	47.8	52.7	53.0	34.0	54.2	41.5	46.2	31.4	22.0	76.7	51.5	60.4	67.4	57.3	37.3	24.2	52.8	2.1	1.4	1.4	0.9	1.8	1.6	5.0	1.3	0.9	1.0	4.4	1.4	1.3	1.5	1.0	1.5	1.4	1.7	0.7	11.6	12.4	13.1	13.0	10.9	13.7	12.6	13.9	12.9	13.1	13.1	13.5	53.5	67.3	41.5	14.0	50.4	52.0	63.4	17.9	38.7	35.1	50.6	37.2	35.7	27.1	37.9	35.0	56.3	45.3	44.2	46.1	15.6	25.0	24.0	56.6	84.0	47.6	43.5	10.7	29.8	34.7	60.7	55.8	50.4	85.8	24.6	29.8	28.2	52.0	37.9	26.9	31.3	71.9	28.5	25.1	51.0	7.3	40.7	39.4	49.8	20.6	18.0	52.1	18.6	27.6	29.2	39.0	28.4	32.7	87.3	61.7	26.7	32.1	26.9	39.4	32.9	46.6	51.4	72.1	55.8	46.7	77.7	62.4	34.0	33.1	35.6	98.3
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 265.1;testis: 101.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC TERT1: 63.3;HUVEC TERT2: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	13.4	4.9	1.7	4.8	8.1	0.1	8.1	0.2	2.5	18.1	0.5	11.2	176.4	8.1	3.5	4.1	6.3	8.2	10.4	1.3	1.0	10.8	1.9	49.0	4.9	1.3	0.9	1.9	6.2	18.7	9.2	11.6	1.3	8.9	6.1	0.4	7.6	23.8	16.1	3.8	265.1	9.6	0.8	2.8	8.3	101.9	2.0	0.8	19.2	10.0	2.1	5.5	3.8	1.1	0.0	0.0	0.0	0.0	2.6	63.3	0.6	2.4	4.7	0.0	0.0	0.9	5.1	1.3	1.8	11.4	0.1	0.0	3.1	0.0	0.0	0.0	1.4	6.6	0.0	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	1.2	33.8	0.0	5.8	0.0	0.1	1.1	0.0	1.4	0.4	11.7	0.7	0.1	0.5	0.9	0.0	0.0	8.2	5.6	0.0	0.0	0.0	1.3	2.9	0.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	8.1	0.2	2.5	1.3	1.0	1.3	0.9	1.3	0.8	2.0	1.1	50.0	0.0	3.3	0.0	0.5	1.5	2.6	0.1	1.2	4.0	3.6	1.9	2.1	1.5	0.7	0.0	0.0	0.1	0.3	11.9	0.0	5.9	543.6	10.8	8.0	34.7	18.0	0.0	4.7	0.4	0.1	11.5	2.0	36.3	7.0	24.1	3.6	0.8	4.2	0.0	1.8	39.8	0.0	33.7	3.5	1322.9	4.4	13.6	3.6	4.7	0.0	1.8	0.0	1.0	0.2	0.7	40.9	2.6	0.1	4.2	1172.8	21.7	0.0	1.1	0.0	2.0	4.2	13.5	6.4	0.2	0.1	0.1	2.2	0.3	26.2	2.1
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857405	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	8.3	31.7	27.8	8.6	29.8	18.1	7.6	28.2	35.2	9.3	24.3	18.5	21.1	8.5	11.0	17.5	10.7	9.2	28.1	29.8	28.6	21.3	26.0	11.0	12.6	27.0	28.5	8.0	15.6	15.1	15.4	7.1	28.7	12.7	12.8	9.2	12.8	5.9	28.7	17.0	20.5	6.4	26.0	12.3	21.3	20.2	28.7	13.1	11.4	17.8	9.7	11.0	10.4	28.1	16.8	20.2	6.8	13.4	18.3	11.0	11.7	11.1	9.5	15.1	13.7	29.2	22.7	20.8	48.2	16.3	35.4	32.3	13.0	27.8	6.6	15.5	22.3	21.2	25.1	28.5	16.9	19.9	19.3	12.9	21.3	15.1	10.9	22.6	9.4	23.6	18.8	24.2	11.0	47.4	28.7	27.0	11.8	32.4	52.2	14.0	12.2	37.6	16.5	19.1	23.1	10.8	24.9	61.7	39.5	10.6	34.4	48.8	11.6	37.9	8.5	19.5	18.9	20.7	33.8	14.0	46.3	21.2	20.8	34.3	34.3	43.6	24.8	34.6	21.8	27.5	23.2	21.9	36.7	27.9	20.0	21.6	25.0	16.3	34.2	23.3	31.9	26.7	27.8	29.8	28.2	35.2	29.8	28.6	27.0	28.5	28.7	26.0	28.7	28.1	8.2	35.3	14.1	5.9	17.9	6.1	12.3	21.9	8.6	19.2	9.8	10.9	9.3	11.5	17.7	12.9	16.7	34.2	11.8	104.2	64.6	21.6	38.5	14.2	10.4	10.9	19.2	17.0	12.3	21.0	20.9	11.4	19.9	14.0	14.0	27.6	11.4	25.5	27.8	8.4	12.0	37.3	10.2	18.6	7.1	90.3	9.9	17.5	10.6	3.7	27.5	17.8	34.0	5.0	9.6	21.6	68.4	8.6	21.3	11.3	105.4	81.5	27.1	22.8	13.1	5.8	12.8	27.0	10.2	16.1	8.0	19.4	13.9	37.6	30.3	16.0
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368298	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3643.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.7"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	480000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	3.1	5.4	0.9	7.3	1.3	17.5	3.4	0.9	0.9	6.3	1.2	3.6	3.1	1.4	17.2	47.7	2.2	1.5	0.6	1.2	1.5	28.9	1.4	4.5	1.9	1.5	1.3	1.1	2.7	3.9	0.5	10.8	1.5	3643.7	6.5	0.4	10.6	0.8	0.2	27.0	3.4	1.8	1.0	1.8	3.2	2.4	1.0	1.0	2.4	0.2	6.5	1.8	12.1	1.7	0.5	0.1	0.0	0.0	0.2	0.9	11.7	0.3	17.7	0.1	0.0	0.4	0.4	10.6	0.8	0.0	0.1	4.8	0.0	0.1	0.0	0.1	0.5	2.0	0.4	0.2	0.2	7.3	0.1	1.1	1.6	0.1	0.0	0.2	0.0	0.0	0.1	2.7	0.2	0.1	0.0	13.5	0.7	22.3	2.1	0.1	0.0	58.0	5.0	6.5	0.0	4.1	0.1	2.0	0.6	1.7	0.3	6.5	0.0	0.1	0.1	2.5	0.1	0.8	0.4	17.2	14.9	12.7	0.2	0.1	30.2	139.7	0.2	26.9	0.2	0.7	0.0	0.0	35.3	0.0	0.0	0.0	26.4	2.6	25.8	2.4	0.0	10.1	0.9	1.3	0.9	0.9	1.2	1.5	1.5	1.3	1.5	1.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 770.4;liver: 1319.0;skeletal muscle: 731.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 355.8;Hepatocytes: 1170.0;Late spermatids: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"neutrophil: 475.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 475.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1124.0;ASC TERT1: 275.2;HSkMC: 609.5;RPTEC TERT1: 358.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011317, HPA011964"	Enhanced		Uncertain	Vesicles		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA011316: AB_1844536, HPA011317: , HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	770.4	43.3	32.5	94.8	43.9	337.9	316.7	45.2	70.2	62.1	60.7	34.0	32.4	41.6	78.2	66.0	50.6	36.2	172.7	34.4	39.1	218.7	1319.0	173.7	20.7	63.2	44.4	15.5	49.3	57.0	39.6	30.0	56.2	91.3	16.3	28.4	84.2	30.1	731.8	173.0	34.5	42.8	45.2	132.8	54.2	41.9	63.2	12.2	51.3	442.0	24.7	73.2	57.7	70.8	51.6	15.9	9.7	24.6	1124.0	275.2	8.3	29.1	13.8	16.1	11.2	3.9	14.0	22.2	3.0	32.8	38.4	29.7	43.1	17.8	13.3	107.1	17.7	16.6	13.1	40.5	183.4	41.9	37.2	609.5	140.7	13.6	67.1	27.6	21.1	3.6	7.5	59.4	77.0	26.9	3.1	55.1	2.0	32.5	23.3	8.0	8.6	27.0	358.4	135.9	36.3	35.1	25.4	70.8	86.5	3.9	26.9	39.8	25.1	13.8	16.8	34.5	8.7	24.5	13.5	8.9	45.6	56.3	22.4	16.5	54.7	17.7	3.3	30.9	2.8	3.3	2.3	1.5	13.1	3.4	2.5	2.2	475.2	4.4	23.0	2.4	4.9	20.8	32.5	43.9	45.2	70.2	34.4	39.1	63.2	44.4	56.2	45.2	63.2	70.8	7.5	25.6	121.0	6.5	15.7	21.0	16.0	14.0	5.2	6.6	49.7	10.3	119.1	25.8	33.5	31.3	18.8	10.2	7.1	4.3	93.9	4.6	355.8	9.8	25.0	9.8	0.0	34.1	15.2	12.8	2.2	19.4	36.2	24.6	24.1	1.5	18.2	1170.0	41.8	3.3	22.8	4.7	85.5	140.7	14.6	456.6	19.3	170.1	32.0	6.5	40.5	3.1	1.0	8.5	89.8	8.6	1.6	16.6	8.6	51.3	1.5	111.1	26.8	11.4	13.1	11.1	12.4	10.5	16.7	26.4	41.1	3.4	10.6	1.8	3.2	23.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		16000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	44.2	40.6	11.9	38.8	14.1	16.2	19.8	13.2	14.8	48.2	5.6	12.7	15.4	19.2	17.7	15.8	13.4	29.2	29.4	16.5	23.7	46.4	13.9	39.0	24.6	17.6	20.8	14.9	11.9	19.8	9.2	21.4	21.3	13.4	13.6	24.7	10.6	15.2	42.6	9.9	13.4	22.0	13.7	22.2	19.3	26.8	14.6	20.3	18.6	16.9	18.5	68.0	10.6	18.9	67.3	21.3	24.2	28.3	97.8	61.6	20.3	94.0	107.6	91.0	97.4	21.1	45.0	46.2	35.4	71.7	100.9	19.4	22.4	92.0	143.0	15.7	23.3	181.4	26.6	223.3	44.8	44.8	360.0	51.4	36.7	103.6	74.0	50.2	71.8	25.5	5.6	54.2	100.7	4.7	40.7	60.7	31.6	15.2	37.2	26.4	45.4	39.6	136.3	20.9	15.2	12.3	109.3	0.4	63.2	49.0	1.9	45.8	128.5	81.1	22.6	129.3	85.9	28.1	31.7	41.2	139.7	97.8	52.2	32.5	10.9	35.0	4.2	15.5	3.2	3.3	3.9	3.5	10.6	3.1	3.0	3.8	29.6	4.0	19.4	4.0	6.7	6.5	11.9	14.1	13.2	14.8	16.5	23.7	17.6	20.8	21.3	13.7	14.6	18.9	27.9	76.9	184.3	29.0	19.5	22.3	25.7	20.0	81.4	44.2	7.3	8.1	37.2	15.7	40.1	73.5	2.1	7.3	18.3	0.8	50.9	27.7	1.4	79.5	27.0	29.8	7.7	26.1	76.7	25.4	36.9	46.0	7.1	208.8	633.8	151.6	18.2	44.2	23.9	6.7	78.3	5.7	2.0	64.9	59.1	4.9	5.6	67.8	16.0	57.1	70.4	10.9	8.2	71.4	116.4	32.3	3.0	10.1	36.1	19.4	0.7	12.4	12.2	16.7	0.0	20.0	27.9	3.7	5.3	10.1	8.1	31.6	25.2	34.9	2.7	18.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 133409.0"	"Group enriched"	"Detected in some"	36	"Cardiomyocytes: 1901.9;Skeletal myocytes: 1541.2"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	22	"BEWO: 469.2"	"Low region specificity"	"Detected in all"							"CAB000045, HPA041264, HPA041271"	Enhanced					NA	NA		2800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	15.3	3.8	1.2	1.6	1.2	0.3	19.8	1.8	2.8	1.2	0.4	8.8	0.3	3.0	0.0	604.6	0.6	1.6	6656.6	1.2	3.5	2.6	7.3	7.6	2.2	0.9	1.1	4.6	7.3	0.0	4.7	1.2	0.8	164.8	0.0	0.1	591.0	0.7	133409.0	36.0	5.3	66.3	0.7	3.0	5.1	2.5	1.4	3.1	14.5	20867.7	0.9	3.0	5.4	1.0	0.2	0.2	0.1	0.4	0.0	0.1	469.2	0.0	0.0	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.4	0.2	0.5	21.5	0.0	0.5	0.7	20.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.2	4.3	0.1	0.0	0.3	0.4	0.6	0.3	0.2	0.5	0.5	0.6	1.0	0.3	0.3	0.6	0.3	18.3	16.5	34.2	11.5	25.4	8.4	6.7	9.4	11.2	23.6	6.4	7.2	11.5	18.8	8.2	24.1	7.5	15.7	45.4	1.2	1.2	1.8	2.8	1.2	3.5	0.9	1.1	0.8	0.7	1.4	1.0	0.2	0.0	0.0	0.3	0.1	0.5	0.4	0.8	0.0	0.8	0.3	2.2	1901.9	0.0	0.1	0.0	4.2	1.7	0.0	0.0	0.0	1.9	0.4	0.1	0.4	38.1	0.0	0.0	0.6	0.0	3.3	43.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	2.1	0.3	0.0	9.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1541.2	46.6	1.1	0.2	0.7	0.4	0.3	8.2	0.1	0.1	0.2
ACTA2	ACTSA	ENSG00000107796	"Actin alpha 2, smooth muscle"	P62736	10	88935074-88991339	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 101.0"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	1035.2	241.6	54.0	728.1	61.4	3.9	838.4	52.7	121.1	2000.3	61.4	2755.1	248.9	6678.8	1360.1	1509.9	3104.3	906.1	1069.2	53.4	54.6	312.2	161.8	732.8	173.7	59.0	55.9	798.0	91.4	80.6	60.8	771.3	55.3	2642.8	866.4	8.2	414.7	5920.3	202.1	355.7	701.6	8099.9	54.1	452.1	1427.1	263.9	56.1	56.5	312.0	214.0	48.4	3002.5	1367.0	52.9	3.9	19.0	49.3	102.7	198.1	390.6	9.5	109.8	136.8	11.9	45.4	0.0	8.8	7.2	11.5	641.1	8.6	1.4	1.8	25.4	11.3	60.6	11.3	0.4	5.6	119.3	625.8	0.8	3.2	345.1	44.9	73.9	28.5	743.4	11.3	3.0	0.0	7.1	128.8	10.8	1.0	28.3	2.5	0.2	1.2	1.4	0.2	4.6	27.1	5.0	0.7	7.6	10.2	7.9	1.0	296.8	32.4	1.0	27.9	24.0	4.0	30.2	9.3	21.1	1.6	0.6	29.6	10.2	26.1	28.1	12.3	17.5	17.6	8.7	13.8	6.0	14.1	19.8	10.8	1.8	1.5	10.7	11.1	4.0	14.2	0.4	58.7	10.7	54.0	61.4	52.7	121.1	53.4	54.6	59.0	55.9	55.3	54.1	56.1	52.9	65.4	9.6	6.1	5.5	4.4	43.2	23.4	16.5	22.8	1.1	22.7	1007.7	25.1	2.8	5.2	0.0	6.2	16.3	7.3	1.9	1.9	1.8	11.1	11.1	225.4	41.1	0.0	4.0	3.6	0.9	16.8	316.3	10.7	8.2	5.7	448.9	474.0	4.6	37.7	0.0	1.1	2.7	4.1	5.4	67.6	48.8	141.4	12.6	55.2	61.8	4.2	13.4	4.1	1.0	0.3	2.0	3.0	5290.7	3.7	17.5	3.4	9.5	10.9	1.4	3030.6	72.0	2394.6	4.0	13.8	11.1	40.5	23.7	16.5	36.0	5.7	10.4
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5526409-5563902	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 22882.9;Pancreatic endocrine cells: 14370.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA		5800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	2558.1	1235.8	2143.2	4250.8	2321.0	3598.4	2009.8	2400.1	2776.1	2274.6	2183.3	6581.2	1659.0	5033.9	1630.3	2928.9	2943.6	1772.1	817.6	2355.6	2315.8	1313.6	1759.9	2876.0	4394.2	2654.8	2338.9	1711.5	761.9	838.5	731.4	1817.2	2569.2	2027.1	2338.4	488.2	1470.2	2943.2	465.1	1541.7	2825.9	5736.8	2457.9	3009.5	2869.7	558.3	2483.4	3278.4	1317.9	524.0	4602.3	3720.8	2223.5	3045.4	7791.1	5198.8	5604.1	4658.2	2321.1	3120.3	6654.3	6049.6	4853.2	6209.7	4619.4	8249.5	4361.9	4522.7	4557.0	9445.4	4904.8	4820.3	3279.5	9453.9	4507.4	5324.6	1668.7	3974.3	4579.6	4520.6	3538.8	4733.2	9853.8	4098.5	2786.7	6863.0	1738.0	4128.6	5073.2	3561.3	2189.7	3513.0	6603.4	7531.9	4055.1	13162.1	6813.7	2468.5	3490.8	5658.6	3351.4	3419.7	5904.6	3175.8	1633.1	2746.9	5754.7	5822.1	2400.3	5088.3	5859.7	5314.8	7975.3	10437.4	7019.9	7000.1	8802.8	1902.3	2442.5	5082.1	5772.0	6622.6	12412.7	14674.1	18104.2	29636.6	10647.1	19648.6	8327.7	5139.6	7639.4	9512.9	19292.5	4844.1	5592.0	7894.3	18040.6	6233.1	22870.8	7122.2	11463.2	37406.8	2143.2	2321.0	2400.1	2776.1	2355.6	2315.8	2654.8	2338.9	2569.2	2457.9	2483.4	3045.4	2775.4	1150.6	680.4	142.4	4118.9	5737.0	9776.6	5792.0	3110.2	146.7	1564.0	2047.2	145.3	1080.9	2763.3	2144.5	85.5	3647.7	3989.3	3419.3	2277.4	6508.8	101.3	1422.1	2344.0	2768.4	1451.5	3170.9	129.3	6365.4	12480.2	2958.5	3136.1	2041.6	1539.9	2372.0	2163.5	2590.6	13977.7	269.2	101.3	2006.7	3694.5	7392.0	11420.0	199.7	1766.7	8486.4	2995.4	259.5	22882.9	1654.4	5237.9	116.1	302.2	14370.0	2899.8	2680.3	3040.4	4764.9	4968.2	2149.2	1453.8	146.7	3287.0	1398.2	5423.9	133.8	381.9	4376.1	4722.2	3257.7	5961.7	1688.9	1966.6	6941.4
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin beta like 2"	Q562R1	5	57480018-57482811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.1;Club cells: 1.0;Ductal cells: 1.7;Early spermatids: 2.4;Exocrine glandular cells: 1.1;Pancreatic endocrine cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.3;RPTEC TERT1: 1.6;SiHa: 2.9;U-2 OS: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain					NA	NA		830000000			"Cluster 38: EFO-21 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	1.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	2.4	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin alpha cardiac muscle 1"	P68032	15	34790230-34795549	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"heart muscle: 11410.0"	"Cell type enriched"	"Detected in some"	30	"Cardiomyocytes: 9746.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037330, HPA041264, HPA041271"	Enhanced					NA	NA		2400000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (9.32e-4)"	51.1	1.8	1.9	24.7	1.7	0.0	11.9	2.1	2.6	8.6	1.3	4.0	0.8	6.9	1.1	22.8	1.6	11.8	11410.0	1.9	2.8	1.5	0.6	3.9	2.6	2.7	2.8	3.2	12.9	1.0	2.2	8.9	3.0	73.0	3.6	31.6	11.5	538.1	135.2	4.6	0.6	8.8	1.4	1.3	9.3	0.5	4.0	11.3	2.4	195.0	0.2	439.6	16.1	1.5	0.0	0.2	0.1	0.0	0.2	3.3	0.2	2.2	0.7	5.2	1.3	0.0	0.0	0.0	1.3	1131.8	0.2	0.0	0.4	0.0	1.3	0.0	0.0	0.1	23.9	0.0	0.1	1.4	0.0	457.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	4544.5	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2053.3	0.0	0.0	0.0	0.1	0.1	4.0	0.0	0.0	31.2	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	2.1	2.6	1.9	2.8	2.7	2.8	3.0	1.4	4.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	11.9	0.1	0.0	9746.1	0.0	0.0	0.0	20.9	0.1	0.0	0.0	1.9	0.0	5.0	0.0	0.1	69.2	0.0	0.0	0.2	0.2	4.3	315.2	0.0	0.0	0.0	0.1	0.4	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	63.4	86.5	1.0	0.7	0.0	0.4	0.3	0.1	0.1	0.0	0.0
ACTG1	"ACTG, DFNA20, DFNA26"	ENSG00000184009	"Actin gamma 1"	P63261	17	81509413-81523847	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 9107.1;Exocrine glandular cells: 8305.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041264, HPA041271"	Approved					NA	NA		4900000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (3.95e-2)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-3)"	1548.5	950.4	523.3	1325.4	549.3	1130.2	1158.2	582.8	628.6	1634.2	506.2	1258.5	994.5	1629.9	558.1	2422.2	1315.8	1179.5	666.3	548.5	677.3	905.8	762.8	1516.1	1696.9	652.8	592.5	2046.6	1693.4	608.2	824.5	922.4	629.8	723.8	662.3	293.9	1291.3	643.0	358.4	1455.8	1026.3	739.2	589.8	1034.8	1385.5	438.5	611.8	1347.8	1252.2	270.9	1292.7	1540.3	1571.3	709.7	3652.9	4010.4	4601.5	2275.7	813.0	2758.2	1601.3	4193.6	3154.7	3546.5	2675.5	3699.5	1690.3	2114.0	2566.1	4263.6	2867.3	2049.5	1722.7	3395.6	1727.7	3745.8	2549.8	1724.3	1784.6	3515.1	2165.8	1909.2	2003.4	3599.7	1366.0	3586.4	938.0	4516.4	5237.2	1343.4	331.2	2723.2	3288.0	2677.4	6305.5	2235.8	1970.8	2272.7	2122.3	3520.6	1537.3	1716.3	3385.4	2838.3	1234.4	1284.1	4804.4	969.0	5127.0	1530.7	2192.3	1908.9	5402.3	4755.5	1993.3	2802.6	7012.2	908.3	791.7	1505.4	3808.4	1910.5	2940.1	4240.1	1897.3	3013.3	2108.9	2333.9	2026.4	1297.8	1892.2	2024.3	3012.5	939.2	1391.8	1827.7	1532.7	1355.2	2939.2	1616.5	2980.5	5301.8	523.3	549.3	582.8	628.6	548.5	677.3	652.8	592.5	629.8	589.8	611.8	709.7	1602.0	974.4	558.2	107.1	1285.4	5276.1	9107.1	3827.4	2541.1	493.3	1477.5	1943.4	233.6	825.0	1924.3	1140.3	244.0	2002.6	1886.0	2460.0	1058.5	4368.6	293.0	1028.0	1501.0	1664.2	1914.5	567.0	59.0	8305.0	4361.7	1595.3	2440.4	1433.3	588.7	3067.7	1031.6	517.1	3219.5	267.5	65.7	2206.9	1957.2	1426.0	1807.7	258.5	1718.6	1840.3	1398.1	70.3	4004.3	3402.9	1971.2	78.4	111.9	7194.7	2426.5	1363.9	1369.6	3987.9	1673.2	566.6	950.0	571.1	1360.8	873.0	2277.1	756.5	995.7	3085.9	5371.9	2827.2	1823.7	2394.4	2187.5	6279.2
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 524.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 364.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		210000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	117.4	40.7	27.3	149.5	55.8	149.3	103.5	0.1	32.0	118.4	20.1	449.8	49.8	313.1	60.3	154.4	152.1	143.9	121.4	29.7	14.7	46.7	61.8	100.0	47.5	24.5	11.0	61.8	46.8	9.1	27.3	96.1	7.3	174.3	109.0	28.2	116.4	295.1	21.7	59.3	106.9	524.5	4.2	55.9	171.7	21.2	32.9	32.6	35.0	13.3	50.7	305.9	83.3	28.8	871.9	262.3	158.6	121.4	275.2	180.5	592.4	749.3	712.0	770.0	571.1	211.8	196.6	0.7	256.5	744.7	310.4	370.9	126.8	790.3	965.2	4.6	38.5	118.2	133.5	179.0	494.0	85.4	14.3	231.7	152.1	479.8	540.3	551.6	428.6	48.2	56.9	1.4	612.0	246.9	10.1	181.1	124.7	217.9	198.1	59.3	294.1	32.6	292.0	225.6	57.0	68.7	649.9	96.8	177.1	474.8	146.0	170.9	546.0	1085.2	432.8	126.9	662.5	113.8	47.8	3.9	314.4	115.7	584.4	64.6	67.5	137.1	5.7	28.8	7.1	0.1	22.7	12.4	45.5	0.2	103.9	92.2	364.2	4.5	8.9	2.0	9.6	89.2	27.3	55.8	0.1	32.0	29.7	14.7	24.5	11.0	7.3	4.2	32.9	28.8	44.7	38.5	25.1	19.6	4.0	119.3	154.9	137.4	82.0	74.7	88.6	157.6	60.3	51.5	36.0	42.3	246.0	155.3	3.0	17.2	3.9	186.8	34.0	65.8	112.8	135.5	38.5	21.9	102.7	144.9	351.8	88.9	34.1	90.2	7.6	15.9	129.5	96.6	79.5	18.5	29.7	57.3	59.0	100.9	82.1	10.7	35.8	96.4	30.2	34.7	105.1	6.0	4.1	9.0	4.3	203.7	28.0	245.6	0.6	132.6	2.4	15.3	47.8	80.8	177.5	30.0	270.6	19.4	18.4	51.8	59.8	66.9	22.7	20.9	47.0	67.1
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ACTN3		ENSG00000248746	"Actinin alpha 3"	Q08043	11	66546395-66563334	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	72	"skeletal muscle: 1670.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HDLM-2: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA006035	Uncertain		Uncertain	"Actin filaments"		NA	NA		11000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.2	0.0	0.2	0.0	0.1	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.1	1670.4	0.1	0.1	0.0	0.0	0.1	0.1	4.0	0.0	0.0	0.3	23.3	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.2	1.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731589	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 626.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 947.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		71000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	176.5	160.8	22.9	63.9	42.0	74.2	151.4	42.9	42.2	165.2	58.5	168.5	128.7	269.4	11.8	232.8	163.2	46.8	89.0	19.5	27.8	166.7	85.0	174.7	37.5	45.9	42.4	102.5	90.6	42.2	80.0	85.7	44.8	115.6	42.2	26.0	148.1	59.0	52.2	183.4	150.3	73.1	30.2	118.1	120.9	23.6	38.1	18.5	105.4	18.8	24.2	150.2	181.3	63.4	364.6	947.0	92.9	48.6	37.7	50.6	237.2	198.7	162.5	178.8	143.9	335.9	265.1	99.0	409.1	260.6	117.4	185.1	57.4	203.8	38.3	238.3	69.5	139.7	356.1	240.4	103.4	101.7	145.2	95.3	63.4	157.5	79.6	146.9	116.4	26.3	165.0	71.8	127.5	221.2	27.2	44.1	78.4	197.8	177.3	89.5	109.4	43.8	174.6	396.3	83.0	49.8	366.3	210.5	94.7	64.0	94.5	78.8	309.7	249.3	138.7	135.3	476.1	44.1	84.5	67.8	231.7	90.6	476.7	7.6	8.1	17.8	13.2	7.7	9.8	3.2	5.7	13.2	7.0	3.0	0.9	4.4	16.9	24.8	6.7	10.8	9.5	10.6	22.9	42.0	42.9	42.2	19.5	27.8	45.9	42.4	44.8	30.2	38.1	63.4	315.2	179.5	120.0	21.5	45.8	234.8	266.4	155.1	153.7	25.6	134.0	148.1	9.2	143.0	119.4	152.6	14.6	123.7	150.7	626.1	19.6	413.5	2.5	272.0	145.7	206.2	162.0	59.3	46.0	419.3	256.7	77.3	219.7	346.4	73.5	75.9	130.6	108.5	72.6	23.5	22.6	365.5	73.2	65.9	103.7	4.5	41.3	75.4	46.2	48.7	162.2	122.4	120.5	35.2	83.6	532.3	425.2	71.5	91.2	322.1	315.5	104.0	122.1	32.3	190.7	97.2	251.0	36.2	23.7	189.3	202.7	168.0	119.4	115.3	280.6	284.7
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"Actin related protein 1A"	P61163	10	102461881-102502712	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules		NA	NA		560000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules		"CAB037193: AB_258253, HPA047443: AB_2680049"	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	59.4	58.8	98.3	39.4	100.6	36.8	51.5	101.9	108.4	50.9	78.4	90.0	37.8	61.8	37.5	61.6	47.4	36.1	93.0	101.9	108.0	49.0	40.4	58.5	33.7	116.3	105.9	36.9	41.9	56.5	54.7	45.3	116.9	53.0	41.7	41.9	46.4	51.9	174.3	65.1	49.1	69.0	97.4	48.7	56.2	40.4	104.0	56.8	41.2	127.0	42.2	74.8	51.2	104.4	80.5	95.8	113.5	117.1	138.0	109.2	45.5	100.3	177.3	154.4	142.4	52.7	63.3	54.4	75.2	149.5	76.2	78.3	109.9	123.7	106.5	70.7	75.8	72.9	53.4	77.9	99.6	56.9	65.0	112.4	89.6	141.2	100.7	155.7	201.6	88.7	60.5	53.5	154.6	67.1	103.5	97.9	45.4	62.5	86.2	78.5	146.0	35.0	125.2	43.9	40.5	88.8	60.1	35.4	75.1	98.3	130.0	38.9	147.0	74.7	71.5	83.6	102.1	54.0	58.8	63.3	78.7	98.3	45.9	32.2	40.7	44.3	31.1	51.8	25.5	18.8	22.0	30.4	40.6	17.6	18.0	20.7	31.2	23.9	57.0	20.8	33.6	39.2	98.3	100.6	101.9	108.4	101.9	108.0	116.3	105.9	116.9	97.4	104.0	104.4	40.0	57.7	41.0	10.1	23.4	33.8	24.0	42.3	13.1	26.6	22.1	17.1	51.6	14.3	34.8	27.6	16.7	54.9	23.8	52.4	54.8	75.5	53.0	15.3	21.0	45.2	39.6	45.9	14.9	77.5	63.3	36.9	23.4	19.3	32.3	27.3	34.6	24.1	73.9	26.9	15.5	24.4	46.8	37.6	38.2	53.9	33.2	44.5	51.6	5.6	70.3	31.5	38.1	10.1	15.3	92.0	36.8	36.1	30.0	26.7	40.9	45.6	26.5	24.5	46.0	17.1	48.5	61.9	14.0	27.3	32.4	104.7	28.2	32.9	24.2	26.6
ACTR1B	"Arp1B, CTRN2"	ENSG00000115073	"Actin related protein 1B"	P42025	2	97655939-97664044	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047443			Approved	Microtubules		NA	NA		49000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules		"HPA047443: AB_2680049"	"unprognostic (5.26e-2)"	"unprognostic (8.91e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.21e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (4.69e-4)"	38.5	68.3	60.0	24.9	61.0	38.8	41.9	54.1	66.4	41.1	59.3	52.1	36.1	48.1	21.5	37.5	43.4	26.0	68.6	60.6	57.0	47.0	54.3	36.7	30.9	57.3	55.2	47.1	72.9	51.1	41.4	20.6	58.4	43.6	22.1	22.0	45.4	37.3	86.9	39.3	43.2	26.5	56.6	57.8	52.1	20.8	58.2	33.2	45.8	68.8	24.8	44.0	36.4	57.7	52.8	28.5	27.1	35.8	49.1	39.8	78.1	49.2	74.2	34.6	28.9	22.5	28.1	38.0	45.3	50.5	37.1	28.4	21.9	56.5	14.6	76.6	36.8	28.2	28.3	62.1	38.3	22.8	43.1	39.7	41.5	22.0	67.7	51.8	39.0	46.8	20.1	44.8	52.1	58.5	44.2	28.6	27.5	40.1	38.1	24.7	39.6	63.2	55.0	41.1	31.7	23.8	23.7	48.1	36.2	34.8	38.1	35.9	41.1	23.0	35.6	24.7	20.8	57.7	27.0	13.7	68.8	32.5	21.1	11.7	15.0	19.2	19.1	13.5	14.6	14.6	20.9	19.2	21.1	14.7	17.2	18.8	5.7	14.9	20.5	8.5	29.7	16.4	60.0	61.0	54.1	66.4	60.6	57.0	57.3	55.2	58.4	56.6	58.2	57.7	43.8	19.2	18.2	15.0	30.4	13.6	30.9	28.4	16.5	38.5	24.9	20.8	32.8	22.8	22.2	22.0	12.5	29.0	26.1	26.5	35.2	69.2	13.2	16.2	16.4	30.9	25.8	24.6	33.4	58.0	57.7	24.3	23.4	13.1	29.9	20.4	28.2	18.7	29.1	55.5	26.4	31.7	36.7	18.5	20.0	10.0	24.2	17.4	23.2	12.2	57.3	29.5	43.3	17.1	26.1	42.8	32.8	26.7	21.9	55.5	59.9	40.5	22.2	30.0	39.5	25.3	28.5	13.1	31.7	29.9	16.3	16.3	31.4	47.7	36.4	39.8
ACTR2	ARP2	ENSG00000138071	"Actin related protein 2"	P61160	2	65227788-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol		NA	NA		35000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	113.0	70.7	39.9	216.2	48.3	160.5	77.0	42.2	54.7	81.4	38.3	142.4	104.8	70.1	64.5	111.0	53.7	90.9	64.9	51.4	47.2	85.6	108.9	115.9	246.4	43.6	41.4	43.9	61.7	61.9	25.0	109.6	42.9	71.7	139.1	70.2	64.9	64.1	60.4	69.4	118.2	104.4	48.0	172.0	107.3	46.2	45.5	182.2	73.1	64.9	256.3	128.6	46.0	61.1	267.3	221.2	205.5	224.5	218.8	296.1	213.2	367.3	284.1	280.0	193.6	249.3	214.2	590.6	181.8	406.9	174.3	196.8	179.8	258.3	459.4	337.2	150.8	652.1	147.6	235.9	248.0	619.8	731.6	256.5	201.6	312.2	297.7	228.6	356.6	202.0	282.1	209.2	480.0	198.2	325.4	330.6	173.2	245.7	157.5	347.9	266.0	248.6	328.7	341.7	105.2	171.6	239.0	273.5	262.0	186.9	167.6	417.4	467.9	306.5	184.8	202.8	408.9	158.0	155.2	824.1	264.4	598.7	353.9	325.4	182.4	220.6	104.3	241.4	111.8	97.1	91.1	98.6	213.1	80.4	70.3	99.2	258.2	104.1	273.3	79.3	113.9	344.5	39.9	48.3	42.2	54.7	51.4	47.2	43.6	41.4	42.9	48.0	45.5	61.1	187.1	86.6	112.7	32.3	202.4	74.7	88.0	93.0	70.0	81.8	75.8	57.1	76.3	51.5	93.2	97.5	66.7	81.8	257.9	280.5	50.9	100.5	37.5	114.5	131.4	131.0	110.8	89.8	152.6	129.0	138.6	96.0	105.0	163.2	191.1	77.8	113.6	102.9	277.7	104.3	106.0	166.5	85.5	450.1	311.8	92.5	65.3	352.0	88.9	97.4	378.9	87.9	207.0	38.7	68.9	164.4	195.3	74.4	119.7	114.9	131.1	89.0	127.7	82.4	124.9	63.3	122.8	31.4	41.8	102.5	90.6	124.4	203.2	74.2	172.8	181.7
ACTR3	ARP3	ENSG00000115091	"Actin related protein 3"	P61158	2	113890063-113962596	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005085, HPA047016, HPA051683"	Approved					NA	NA		25000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB005085: AB_2289106, HPA047016: AB_2679903, HPA051683: AB_2681573"	"unprognostic (7.28e-2)"	"prognostic unfavorable (6.52e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.44e-1)"	97.5	125.3	29.9	229.7	36.4	216.5	64.5	37.6	41.0	62.7	52.4	129.3	107.4	78.1	47.2	167.1	58.1	84.4	71.7	48.0	41.9	79.4	89.9	97.9	291.2	46.4	38.2	46.4	64.3	54.7	23.1	101.4	41.7	71.3	125.1	31.7	64.3	83.6	47.8	77.7	119.0	137.0	36.2	155.8	113.1	84.8	39.0	185.8	67.3	49.8	331.3	153.6	67.1	46.7	377.8	179.1	249.4	170.6	178.0	251.7	259.9	518.7	395.0	369.7	349.1	379.9	233.6	538.7	590.6	487.9	497.1	200.0	262.3	286.5	486.7	806.2	135.6	502.7	210.2	296.2	314.8	474.0	879.1	227.1	220.8	484.9	316.5	216.1	348.6	207.1	273.9	393.8	493.1	153.2	429.7	204.5	187.2	254.8	297.5	328.8	246.8	273.4	381.0	348.9	124.0	124.1	263.0	269.7	330.6	188.7	112.7	387.7	514.6	440.9	288.3	205.6	451.5	208.5	446.5	635.4	385.5	304.2	417.7	753.0	478.9	1048.4	464.4	728.1	381.6	455.9	424.6	460.6	634.4	385.0	371.4	437.9	777.1	479.9	887.7	191.4	587.0	1265.4	29.9	36.4	37.6	41.0	48.0	41.9	46.4	38.2	41.7	36.2	39.0	46.7	113.7	89.8	64.1	26.4	254.0	331.9	369.7	139.1	93.9	32.0	57.5	48.9	68.5	57.2	125.4	68.0	8.4	144.6	196.5	164.4	129.1	220.8	113.6	109.2	100.8	138.9	85.3	154.8	40.1	154.8	316.6	101.4	122.9	171.0	267.5	88.4	81.0	72.9	339.2	38.7	40.4	120.2	105.8	201.4	413.7	108.3	45.4	288.1	112.1	69.3	316.5	46.7	286.3	58.3	67.6	177.0	168.1	73.0	158.7	181.7	103.3	132.4	117.7	19.5	65.7	58.5	194.1	207.1	74.7	173.4	353.8	205.6	264.4	242.2	120.3	314.1
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 507.2;lymphoid tissue: 259.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5"	"Group enriched"	"Detected in many"	5	"JURKAT: 570.9;MOLT-4: 1915.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	16.6	6.3	6.9	18.5	8.2	20.2	10.9	6.8	9.4	7.3	5.6	5.7	507.2	3.8	1.7	9.0	5.6	9.2	17.8	6.9	7.0	3.3	4.4	6.2	33.4	7.2	8.2	2.1	5.3	1.5	1.3	4.6	7.2	4.3	3.6	0.3	4.7	2.8	5.3	6.0	17.9	5.7	6.1	17.5	46.0	2.4	8.7	259.0	5.8	6.4	26.4	9.3	5.4	8.8	14.0	37.7	19.2	13.2	35.6	48.7	30.5	13.7	7.8	13.2	9.3	17.5	14.8	38.4	15.8	17.9	24.7	2.2	13.2	55.1	7.3	2.9	17.2	7.8	6.6	13.5	15.0	6.3	20.3	234.3	23.2	5.1	9.0	12.6	50.3	570.9	20.4	30.7	6.0	33.1	1915.5	28.9	5.2	17.2	13.5	102.3	25.8	95.0	2.3	0.0	0.7	9.3	20.2	4.4	24.2	24.0	4.5	19.1	16.9	10.1	18.6	20.5	2.8	40.1	27.3	82.3	3.5	32.5	9.0	0.5	9.8	1.2	43.3	168.5	27.8	7.5	35.5	51.0	35.2	7.6	27.3	38.6	2.5	94.5	362.8	218.6	29.8	57.4	6.9	8.2	6.8	9.4	6.9	7.0	7.2	8.2	7.2	6.1	8.7	8.8	18.2	0.0	1.9	2.9	13.5	12.9	3.4	10.0	13.6	0.0	2.7	3.2	2.1	0.0	4.8	1.8	0.0	2.9	76.4	0.8	0.0	3.7	0.4	0.7	9.1	17.0	0.0	10.7	0.2	19.7	128.2	19.7	14.8	0.8	0.0	3.5	7.1	3.6	28.5	0.0	0.2	1.5	10.2	20.8	25.5	1.8	42.3	27.6	8.8	3.7	37.4	3.8	56.7	0.5	9.4	10.7	0.3	2.6	31.4	6.0	0.7	3.0	2.4	0.0	13.1	1.9	14.1	0.3	6.2	12.9	13.9	3.7	30.9	6.8	4.9	2.7
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17258235	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 106.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	14.0	11.3	8.3	39.4	9.9	22.8	17.6	10.6	7.9	22.0	20.5	28.3	18.1	19.9	2.7	12.0	51.5	32.1	39.6	7.8	10.9	14.5	21.1	54.9	47.3	16.3	11.4	12.1	13.9	5.4	22.5	15.2	14.7	15.4	34.3	11.0	15.6	17.1	3.4	4.7	26.1	23.4	13.7	106.3	19.6	18.4	12.9	53.7	16.9	4.3	60.7	34.7	6.5	21.1	0.0	0.0	6.4	0.0	0.2	0.8	0.3	2.3	0.1	0.0	0.0	0.0	23.7	6.0	21.4	7.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.0	0.3	0.3	11.3	0.1	0.0	0.1	0.1	24.0	9.0	0.1	44.9	0.9	0.0	38.9	1.1	17.8	0.0	0.1	1.2	0.0	6.5	0.0	9.3	10.9	0.1	0.1	0.0	0.0	19.1	0.2	9.7	3.0	0.1	0.2	0.0	0.0	23.8	2.3	1.7	0.0	39.6	0.0	17.5	212.9	11.3	34.6	204.9	26.8	25.8	27.4	34.1	139.1	19.7	31.6	32.4	10.5	44.9	176.1	57.4	17.2	170.7	8.3	9.9	10.6	7.9	7.8	10.9	16.3	11.4	14.7	13.7	12.9	21.1	8.7	0.0	16.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	11.2	5.5	0.0	0.4	13.7	0.0	7.9	1.7	0.0	27.6	6.6	2.2	0.0	0.0	0.0	5.2	0.9	2.1	0.0	22.0	5.1	12.6	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	12.4	0.0	0.0	3.1	15.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	8.2	3.1	0.0	0.0
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM19	MLTNB	ENSG00000135074	"ADAM metallopeptidase domain 19"	Q9H013	5	157395534-157575775	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 56.7;Cone photoreceptor cells: 62.6;Extravillous trophoblasts: 81.8;Langerhans cells: 49.3;monocytes: 83.5;Plasma cells: 53.8;Rod photoreceptor cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 128.3;eosinophil: 139.9;memory B-cell: 50.8;naive B-cell: 53.5;neutrophil: 70.5;plasmacytoid DC: 66.8"	"Group enriched"	"Detected in many"	5	"B-cells: 53.5;dendritic cells: 66.8;granulocytes: 139.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.7;U-251 MG: 206.5"					"Low region specificity"	"Detected in all"			HPA055537			Approved	Vesicles		NA	NA		17000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles		"HPA055537: AB_2797253"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.90e-12)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-2)"	4.9	3.6	2.6	24.0	3.3	7.7	2.7	5.3	4.6	4.9	0.4	22.8	5.8	8.0	2.6	5.1	7.4	8.9	24.7	3.1	3.8	2.1	9.6	13.2	29.0	5.1	4.5	3.5	0.9	0.1	1.8	13.1	4.7	7.6	6.7	22.6	1.9	6.3	6.5	1.4	18.7	16.3	3.1	22.6	9.6	1.6	4.5	7.4	4.2	2.8	30.2	18.8	5.2	3.9	38.8	6.0	11.5	0.1	0.8	0.7	73.7	45.0	16.0	27.5	20.5	19.9	30.7	19.9	2.4	23.4	5.7	32.4	1.8	2.9	24.9	109.7	1.1	0.1	3.3	2.7	6.5	0.1	0.0	5.2	0.1	21.5	4.3	32.7	31.5	0.0	5.7	2.8	59.4	0.0	0.0	0.1	12.3	0.0	19.3	0.6	65.9	16.8	2.9	0.6	5.2	3.5	0.0	15.9	2.3	45.3	0.2	0.6	48.7	29.6	31.7	6.8	206.5	11.8	0.4	69.6	6.7	0.1	13.5	128.3	13.1	139.9	1.5	1.2	3.5	50.8	14.4	3.3	4.2	53.5	0.4	0.4	70.5	0.4	0.1	66.8	16.6	9.2	2.6	3.3	5.3	4.6	3.1	3.8	5.1	4.5	4.7	3.1	4.5	3.9	1.5	6.4	0.6	2.0	56.7	2.2	0.1	1.2	0.0	37.7	0.5	0.4	5.6	0.0	0.7	3.7	62.6	1.1	22.0	0.1	0.0	0.5	4.1	0.5	6.8	5.6	0.0	1.7	24.2	1.5	81.8	6.5	0.5	0.2	0.0	0.3	4.2	7.5	1.7	15.2	21.2	0.1	0.0	9.0	49.3	1.3	5.6	12.4	1.8	10.3	83.5	2.4	1.0	13.0	28.7	2.2	0.1	7.9	53.8	0.2	0.0	0.1	0.1	43.9	6.6	12.3	13.3	0.0	1.1	2.5	1.4	8.3	24.0	1.7	0.3	0.2
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAM30	svph4	ENSG00000134249	"ADAM metallopeptidase domain 30"	Q9UKF2	1	119893533-119896515	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	259	"testis: 25.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 77.4;Spermatocytes: 60.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026080	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA026080: AB_1844581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.8	0.0	60.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	237	"epididymis: 3726.4"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 128.3"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"BEWO: 2.4;NB-4: 6.1;RPMI-8226: 1.7;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008879	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3726.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.8	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	16.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.6;lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 54.7;Extravillous trophoblasts: 96.4;Langerhans cells: 124.9;monocytes: 81.3;NK-cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 21.2"	"Group enriched"	"Detected in many"	5	"basophil: 107.4;eosinophil: 259.0;neutrophil: 139.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.0"	"Cell line enhanced"	"Detected in many"		"A-431: 60.0;BEWO: 81.8;CAPAN-2: 70.4;HaCaT: 69.8;HDLM-2: 45.9;U-87 MG: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	5.6	2.4	2.1	22.1	2.3	68.6	2.7	1.4	21.2	4.2	1.7	3.6	5.8	2.2	2.1	3.5	6.0	5.1	2.5	1.8	1.8	4.7	8.4	21.5	11.6	3.2	1.9	3.0	4.3	0.3	3.6	3.1	4.4	4.5	1.6	1.5	4.2	1.1	1.2	3.2	11.3	2.1	1.6	48.5	11.5	2.6	5.9	4.0	3.8	1.7	8.2	11.9	3.2	3.4	60.0	1.7	0.5	0.9	0.4	0.1	81.8	0.7	1.4	0.3	0.4	4.6	70.4	1.0	1.7	0.1	0.5	69.8	0.2	11.9	0.1	45.9	1.0	0.8	0.5	0.0	0.7	3.6	15.9	0.2	1.1	0.6	1.0	3.7	0.1	0.5	3.2	2.4	0.0	4.8	0.2	20.2	0.3	7.1	1.7	0.4	0.7	6.6	0.8	1.4	0.1	0.8	0.4	0.2	1.0	1.1	1.0	2.0	1.7	0.0	1.5	0.6	1.0	3.4	2.2	0.6	34.5	2.0	0.2	107.4	24.8	259.0	22.2	9.2	15.9	10.2	14.8	21.4	37.2	5.6	5.6	8.2	139.4	24.7	9.4	0.7	16.9	25.2	2.1	2.3	1.4	21.2	1.8	1.8	3.2	1.9	4.4	1.6	5.9	3.4	1.3	3.2	10.5	3.3	23.2	7.8	6.6	14.3	0.0	4.3	2.2	1.8	2.4	2.8	9.5	0.0	8.4	7.7	54.7	0.3	1.9	3.1	1.0	1.5	0.9	1.7	0.0	5.7	3.5	2.7	96.4	2.4	6.1	2.1	12.6	1.1	2.5	2.4	23.3	0.0	3.0	0.6	2.0	8.8	124.9	0.4	0.9	33.9	7.2	0.0	81.3	0.2	82.4	2.0	2.9	39.1	0.1	0.0	20.7	11.0	0.3	0.5	10.0	5.1	0.0	0.8	1.0	1.5	0.8	0.6	6.5	20.0	39.4	0.2	0.5	42.5
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996754-39105445	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 179.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		740000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	34.2	28.0	7.1	28.8	8.2	2.1	21.5	8.5	8.3	34.8	11.4	32.9	24.5	29.7	15.2	29.7	19.3	47.1	32.1	6.0	8.4	34.9	13.5	51.4	9.7	10.2	7.5	16.8	12.7	52.5	7.8	47.4	9.0	34.9	41.7	18.5	54.9	34.8	24.1	16.1	23.0	51.6	9.4	24.0	44.2	11.1	10.6	5.9	39.9	25.0	13.2	56.1	24.3	11.5	188.3	163.6	63.5	32.6	117.2	374.0	67.0	259.6	382.4	191.7	177.9	82.7	147.1	10.1	86.1	247.2	156.7	79.5	30.8	249.7	373.2	6.9	21.5	12.1	102.8	73.0	226.4	8.9	19.1	287.5	139.2	193.3	212.7	341.0	268.9	15.2	21.5	53.2	406.2	25.0	7.2	4.4	8.3	175.2	46.7	3.8	106.3	27.6	299.3	62.4	6.4	11.5	78.4	90.9	57.8	72.9	67.3	12.0	374.2	109.9	97.9	213.9	124.1	12.9	29.5	7.7	175.8	12.0	72.1	0.3	4.0	0.5	0.1	1.3	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	0.5	0.8	0.6	0.3	0.1	0.9	7.1	8.2	8.5	8.3	6.0	8.4	10.2	7.5	9.0	9.4	10.6	11.5	14.4	48.1	37.0	16.0	3.8	35.9	66.6	78.3	26.7	19.3	23.4	9.8	49.7	24.3	82.1	35.0	20.9	24.1	8.9	44.4	3.9	90.2	14.4	42.1	35.3	20.5	10.7	2.5	47.5	115.4	85.1	42.0	80.5	82.1	5.1	26.4	25.0	7.5	125.9	5.0	38.0	32.2	44.7	60.2	44.8	7.8	28.6	54.7	21.4	33.7	21.8	17.5	1.0	30.7	26.7	179.4	30.6	24.8	5.2	108.7	24.9	41.1	51.9	25.1	13.1	31.3	31.9	4.3	2.5	20.2	21.5	34.3	5.6	11.2	32.7	103.8
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 424.9"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 14.8;Kupffer cells: 12.9;Macrophages: 25.5;monocytes: 5.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"U-266/70: 10.7;U-266/84: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		28000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.5	0.0	52.1	0.0	0.3	0.6	0.0	0.8	0.4	0.0	215.4	189.4	0.9	0.2	0.9	0.1	3.2	0.4	0.1	0.0	0.2	0.1	1.6	73.3	0.3	0.0	0.1	0.2	0.0	0.0	7.8	0.3	0.8	311.5	0.0	0.7	0.4	0.0	0.4	424.9	11.6	0.0	5.8	5.9	0.3	0.4	5.7	0.3	0.0	27.2	20.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	10.7	2.7	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.8	0.0	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.1	0.0	0.0	12.9	2.0	0.0	0.0	25.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892019	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	9.0	5.2	0.9	1.6	0.7	0.0	7.8	0.5	0.4	2.7	1.7	2.5	0.5	3.8	0.5	0.9	3.2	4.0	1.6	0.2	0.4	1.3	1.4	5.6	0.9	1.2	0.9	2.7	0.6	0.5	0.6	3.9	1.0	1.3	1.0	0.7	0.9	1.4	0.8	1.5	1.1	6.5	1.5	0.5	1.2	2.0	1.3	0.3	1.9	0.7	0.6	2.2	2.0	3.3	28.7	0.9	25.5	0.0	35.9	17.2	0.0	13.3	33.1	16.8	19.5	0.0	0.0	0.0	0.0	9.0	29.1	0.8	0.7	16.7	24.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	13.8	0.0	47.4	12.2	88.0	0.0	0.0	0.0	0.1	26.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	29.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	28.0	36.2	0.3	7.9	4.4	3.5	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	0.4	0.2	0.4	1.2	0.9	1.0	1.5	1.3	3.3	6.4	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.0	0.1	1.5	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.9	1.2	25.2	2.1	0.0	0.0	3.0	0.2	0.4	22.9	0.0	0.6	0.0	3.3	11.4	0.2	0.6	0.0	6.2	0.0	0.0	0.3	2.1	3.0	22.1	0.2	7.2	73.1	0.0	5.3	0.0	0.5	7.8	0.1	0.0	17.7	0.0	0.1	0.0	2.4	0.7	0.2	52.6	1.7	19.1	0.4	4.7	0.1	0.9	0.8	0.3	55.4	0.0	0.1
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	120000000	"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	2.5	2.8	6.9	0.5	7.3	0.6	2.8	7.6	10.0	5.0	5.3	4.3	3.2	4.2	2.9	2.4	5.7	1.2	6.0	7.1	6.2	9.6	63.8	2.8	0.9	7.0	6.7	6.7	6.2	1.5	12.5	0.8	7.1	6.4	0.9	1.1	2.5	1.4	4.3	2.6	4.4	0.6	6.3	2.6	9.8	13.5	7.2	0.8	6.1	1.4	0.5	4.4	3.1	7.1	0.0	0.8	1.9	2.6	1.5	1.3	0.8	0.7	0.5	0.2	0.3	0.3	2.1	0.2	0.9	0.4	0.6	0.3	0.1	0.4	0.1	1.2	1.7	0.2	0.9	0.4	1.1	0.0	0.7	3.6	0.9	0.2	0.7	1.2	0.1	1.3	0.0	0.8	0.3	3.3	0.0	0.9	2.0	1.1	1.1	0.2	0.2	0.9	0.8	0.8	1.3	4.0	1.4	0.6	1.2	3.9	3.7	0.4	0.5	1.5	0.8	0.9	0.0	1.7	0.3	0.3	1.1	0.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.3	7.6	10.0	7.1	6.2	7.0	6.7	7.1	6.3	7.2	7.1	0.9	0.0	2.0	16.0	1.2	0.3	0.3	0.9	0.0	1.7	1.4	1.9	4.2	4.3	2.4	0.0	0.0	0.2	0.2	1.0	1.9	0.6	19.3	3.6	1.6	0.9	1.2	0.0	12.4	0.4	0.3	1.5	4.6	3.3	0.0	3.0	5.0	1.6	0.2	3.3	12.4	1.3	0.0	0.6	0.0	13.6	0.9	0.3	0.0	7.5	0.0	1.7	0.0	2.0	5.5	0.3	3.0	1.5	0.4	0.4	1.5	0.9	0.7	1.8	0.0	0.4	0.7	6.0	3.9	0.3	0.4	0.1	0.5	1.7	0.9	0.3
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672506-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.9;gallbladder: 6.7;placenta: 7.6"	"Group enriched"	"Detected in some"	5	"Oligodendrocytes: 44.8;Paneth cells: 14.6;Theca cells: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;K-562: 10.4;RH-30: 5.4;U-138 MG: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	0.8	0.2	2.6	3.2	5.9	0.6	0.3	2.0	5.4	1.0	0.4	2.7	2.3	0.7	0.4	1.0	0.5	6.7	0.7	2.9	3.7	0.5	0.3	1.7	1.1	3.2	4.3	0.2	0.2	0.0	0.1	7.6	3.2	0.6	1.8	0.0	0.8	0.1	0.1	1.3	3.2	2.2	1.4	0.4	1.4	0.5	10.9	0.4	0.2	0.3	0.7	2.5	0.4	9.9	0.0	0.0	0.1	0.3	0.2	4.0	0.0	1.0	3.2	0.3	1.7	0.0	9.1	0.0	0.7	1.7	0.4	0.7	0.0	0.0	0.1	3.6	0.0	0.3	0.0	0.2	0.0	0.0	2.4	0.3	0.1	0.8	0.2	1.0	0.0	0.0	10.4	0.0	1.3	0.0	0.0	0.9	0.3	0.1	0.0	0.0	5.4	0.2	0.0	0.0	3.4	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	8.9	0.1	0.7	0.5	0.8	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.9	2.0	5.4	2.9	3.7	3.2	4.3	3.2	1.4	10.9	9.9	0.1	0.0	0.0	0.3	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.5	0.1	0.3	0.0	2.1	0.3	0.0	0.1	2.1	0.0	0.2	4.5	0.1	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.8	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	2.0	44.8	0.1	14.6	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.0	1.8	1.1	0.0	0.0	0.2	0.1	0.4	0.0	17.9	0.5	0.1
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110853-179345461	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2000000		"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	36.9	10.9	0.8	2.4	4.2	0.3	22.7	0.9	3.5	20.6	0.9	10.5	1.4	21.7	0.5	5.5	15.5	6.1	22.3	0.5	0.9	7.5	15.8	29.6	1.8	4.5	3.3	12.1	5.8	0.4	15.1	9.7	4.2	9.0	1.4	0.2	5.3	1.8	2.9	9.4	11.6	9.1	0.2	38.4	9.3	3.9	2.5	0.4	6.8	0.8	0.6	15.0	16.7	2.2	0.0	0.0	0.1	0.7	36.0	35.8	0.0	31.4	5.4	11.5	12.4	0.1	0.0	0.0	0.2	39.3	0.7	0.1	1.8	0.0	5.1	0.0	1.5	0.0	0.1	2.3	115.5	0.0	0.0	94.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.9	1.2	0.1	0.0	0.4	1.9	0.0	10.7	0.0	19.1	3.0	24.5	0.0	0.3	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.8	4.2	0.9	3.5	0.5	0.9	4.5	3.3	4.2	0.2	2.5	2.2	3.3	0.0	1.1	1.6	0.1	2.2	0.4	0.0	2.2	0.3	0.2	5.2	1.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.9	32.2	1.4	0.0	0.0	17.9	0.0	0.3	30.7	0.0	0.8	1.3	6.5	17.2	0.5	5.1	0.0	8.5	0.0	0.0	71.4	4.4	3.4	5.0	10.4	0.0	4.7	0.3	0.1	0.0	3.0	2.4	0.5	0.0	12.8	0.1	0.4	0.0	0.2	0.0	0.0	26.3	4.7	20.4	2.1	4.8	0.2	2.7	0.0	0.4	0.6	0.0	0.1
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 30.6"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.6	5.3	0.5	1.8	0.4	0.1	3.8	0.3	0.5	6.0	0.6	4.2	1.1	7.2	0.1	0.9	2.2	2.3	30.6	0.4	0.5	2.2	1.1	6.3	0.9	0.5	0.5	6.1	0.5	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.4	1.1	1.8	2.6	1.4	0.2	5.2	2.2	4.1	0.7	0.1	2.1	0.5	0.2	3.0	2.5	0.6	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.5	0.4	0.5	0.5	0.5	0.4	0.2	0.7	0.6	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404923-130428609	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066349	Approved				"Secreted to extracellular matrix"	NA	NA		3600000		"Cluster 19: Lung - Lung function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	1.8	0.1	1.5	10.1	2.7	0.0	0.7	0.0	3.7	2.0	0.0	7.0	1.1	3.0	1.0	3.0	2.1	1.6	2.3	3.5	0.0	0.5	0.0	27.6	0.1	0.7	0.1	0.4	0.7	0.0	0.2	2.6	0.2	2.7	0.5	0.0	0.5	4.9	0.5	0.3	2.1	4.2	0.1	0.4	5.3	0.3	1.0	0.0	0.2	0.5	0.0	4.2	0.9	1.8	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	0.0	3.7	3.5	0.0	0.7	0.1	0.2	0.1	1.0	1.8	1.3	0.0	0.6	1.0	0.0	0.4	0.4	0.1	0.0	2.4	2.3	3.9	9.1	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	14.5	30.9	0.6	0.0	0.0	7.4	0.0	0.0	6.6	0.0	37.7	1.3	1.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.7	0.5	0.0	0.1	1.8	2.8	0.0	0.1	1.0	0.5	5.9	0.0	0.0	1.5	0.0	0.5	0.0	0.1	2.6	0.2	0.0	26.9	5.7	0.1	0.3	0.1	0.1	0.0	0.6	0.1	0.0	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.2;liver: 35.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		170000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.7	28.5	6.8	1.0	7.3	0.1	1.5	12.0	10.1	2.3	1.4	2.7	1.4	3.1	3.1	1.8	3.1	2.5	73.2	5.8	7.9	25.9	35.8	23.2	3.4	19.3	11.1	4.9	7.1	1.2	15.9	1.5	20.8	8.4	0.3	0.3	3.4	2.2	4.3	0.8	3.2	0.9	8.5	6.4	2.3	3.1	9.3	0.6	12.1	0.5	0.6	5.3	1.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.5	0.0	1.1	0.7	10.1	0.0	0.0	1.4	30.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.3	12.0	10.1	5.8	7.9	19.3	11.1	20.8	8.5	9.3	7.6	1.4	0.0	0.5	4.9	0.1	0.1	0.1	0.0	0.0	4.2	0.0	0.1	2.3	0.0	0.0	1.8	0.0	0.1	0.0	1.4	5.9	0.2	0.1	0.1	0.1	5.7	5.3	0.0	5.0	0.0	0.1	8.5	0.0	0.0	0.0	0.1	4.6	0.9	0.3	0.0	3.8	0.4	0.0	0.3	0.8	1.1	4.7	0.6	0.0	12.2	0.0	0.4	0.0	2.5	4.0	0.2	0.5	3.0	0.0	0.2	0.0	0.7	0.0	0.2	6.6	1.1	1.6	0.1	0.8	0.4	0.3	0.0	0.6	0.7	1.1	0.2
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24920237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	94.4	17.3	43.5	17.3	55.1	17.7	74.6	36.7	50.1	66.7	28.4	27.5	10.9	56.4	20.5	30.4	62.1	23.0	36.6	43.3	43.4	25.9	6.6	42.5	18.9	41.6	43.8	71.9	15.7	17.0	41.7	83.6	41.1	40.6	15.8	4.2	21.6	33.0	15.2	38.4	34.4	35.3	36.9	30.4	25.0	9.8	50.6	11.4	36.8	20.4	18.1	36.4	48.9	44.9	76.5	40.4	17.2	28.3	84.5	75.4	29.6	32.3	65.9	37.1	37.8	38.6	25.1	26.0	6.2	53.2	51.0	54.5	43.1	54.5	24.0	58.4	55.8	43.0	40.0	1.7	64.0	24.0	24.6	55.7	47.5	36.6	50.8	23.6	33.8	27.9	15.5	49.2	19.3	43.6	17.9	2.1	14.9	39.9	24.4	38.8	75.3	59.5	15.5	38.7	31.6	19.1	45.8	54.2	30.2	13.0	13.5	22.5	33.5	59.7	34.2	39.1	54.1	42.4	101.6	113.6	18.7	39.2	31.4	2.6	1.5	0.0	0.4	1.6	0.3	5.5	0.9	0.5	9.5	6.0	0.7	0.5	0.0	1.2	0.4	9.0	3.4	1.0	43.5	55.1	36.7	50.1	43.3	43.4	41.6	43.8	41.1	36.9	50.6	44.9	14.6	0.0	1.8	17.0	8.2	11.0	4.2	4.1	5.2	3.0	18.6	8.0	2.8	0.0	1.3	1.8	0.0	1.0	5.2	5.0	0.0	0.9	0.3	1.9	42.2	10.6	1.2	5.2	40.1	0.0	2.1	25.5	2.0	2.2	18.4	3.7	5.0	0.3	12.6	0.0	36.8	6.0	2.0	5.4	6.9	3.9	58.4	10.1	7.2	21.5	4.0	1.6	0.0	15.1	33.2	1.0	5.8	29.3	4.9	11.2	8.3	0.2	1.1	2.2	111.7	6.5	62.8	0.4	2.4	4.4	11.8	1.2	7.2	92.9	12.1	3.9
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADGRB1	BAI1	ENSG00000181790	"Adhesion G protein-coupled receptor B1"	O14514	8	142449430-142545009	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 58.8;Excitatory neurons: 47.5;Horizontal cells: 126.2;Inhibitory neurons: 38.0;Oligodendrocyte precursor cells: 70.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.1;MCF7: 4.6;NB-4: 6.1;RPMI-8226: 17.5;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (9.57e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.50e-3)"	"unprognostic (9.98e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.30e-11)"	"unprognostic (6.27e-2)"	"unprognostic (7.42e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.29e-2)"	0.6	1.8	21.7	0.3	17.7	0.1	0.6	0.8	37.3	2.9	0.0	0.8	0.3	1.2	0.7	0.7	0.8	0.1	0.5	18.6	13.7	0.7	0.2	0.8	0.4	12.9	9.4	1.3	0.4	1.6	6.4	0.9	13.1	1.5	0.0	1.6	0.9	0.5	0.1	5.0	1.1	0.1	1.2	2.5	0.8	1.9	24.0	0.2	0.6	0.1	0.1	0.4	1.3	5.4	0.0	0.1	0.1	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	6.1	1.9	0.2	0.0	0.1	0.0	17.5	0.0	0.0	3.2	3.2	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	17.7	0.8	37.3	18.6	13.7	12.9	9.4	13.1	1.2	24.0	5.4	0.1	0.0	0.0	58.8	0.3	0.0	0.6	0.0	1.8	18.5	1.3	0.8	5.7	1.5	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.3	0.2	0.0	0.1	0.4	0.0	0.0	47.5	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.0	0.1	126.2	38.0	0.1	0.0	0.3	0.0	1.0	0.3	0.3	0.0	9.4	0.8	3.9	0.0	70.9	2.6	0.1	0.1	13.5	0.0	0.2	0.0	0.2	0.0	0.9	6.6	0.4	0.4	0.0	0.8	0.1	0.0	0.0	0.3	0.3	0.1	0.2
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635282-69389506	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.6;pituitary gland: 23.7"	"Group enriched"	"Detected in some"	10	"Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.8;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8600		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	0.8	3.9	21.1	0.8	25.5	0.0	0.6	49.6	29.7	1.3	0.0	4.3	0.4	2.2	0.9	0.7	0.9	0.9	1.9	31.1	12.1	1.0	0.5	1.7	0.0	0.0	0.6	1.6	0.3	0.1	23.7	0.1	1.1	1.0	1.3	7.1	1.2	1.4	0.3	0.4	1.4	3.3	0.0	0.6	1.3	1.9	18.2	0.1	0.8	1.4	0.0	2.6	1.4	19.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	8.8	19.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.1	25.5	49.6	29.7	31.1	12.1	0.0	0.6	1.1	0.0	18.2	19.1	3.1	0.0	0.0	1795.3	0.3	0.0	0.1	0.0	0.0	47.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	4.8	0.6	0.0	0.0	3843.1	0.0	0.0	2.1	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	2738.1	0.0	0.0	0.6	0.0	3.1	5.0	1.3	0.0	216.4	1.0	0.8	0.0	2036.3	1210.5	0.1	0.0	8.6	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	7.4	11.8	3.2	0.2	0.0	0.0	0.0	0.5	0.0	0.1
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852522-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 104.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 428.1;Alveolar cells type 1: 291.7;Alveolar cells type 2: 539.9;Endothelial cells: 222.6;Hepatic stellate cells: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 25.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		55000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	69.8	22.8	15.1	6.9	15.0	0.0	46.0	15.0	18.0	10.4	8.6	9.9	5.7	16.0	7.7	7.0	15.0	16.9	51.6	12.8	15.1	58.9	13.0	104.5	8.5	16.6	15.6	6.5	6.4	13.2	6.7	50.6	18.2	8.9	5.7	1.8	5.9	9.2	30.4	7.7	8.5	21.8	13.8	40.5	8.4	3.1	21.6	3.7	32.2	70.2	3.2	11.4	10.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	74.1	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	15.0	18.0	12.8	15.1	16.6	15.6	18.2	13.8	21.6	15.3	428.1	291.7	539.9	2.0	2.9	0.0	0.2	0.0	2.2	0.0	1.5	2.9	16.2	8.6	89.7	1.8	0.0	0.2	1.1	0.6	11.7	0.2	10.6	0.8	1.2	222.6	0.0	0.0	8.4	0.0	1.1	9.0	2.6	0.4	12.6	0.0	251.3	4.0	0.2	0.0	1.0	0.5	0.0	13.7	0.0	4.8	3.1	2.7	0.0	104.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.6	0.5	0.2	48.1	0.7	98.6	9.6	80.1	0.2	0.9	0.6	0.0	0.3	1.8	15.5	0.1	0.8
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668277-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 147.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.4;dendritic cells: 2.9;Endothelial cells: 2.8;Erythroid cells: 5.3;T-cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 10.6"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 142.3;neutrophil: 169.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 169.8"	"Group enriched"	"Detected in some"	6	"NB-4: 5.0;SK-MEL-30: 2.1;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040469	Uncertain					NA	NA		1200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA040469: AB_10794032"	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	8.5	0.3	0.1	14.6	0.2	147.0	1.7	0.1	10.6	1.1	0.3	1.6	2.2	1.0	0.0	1.0	4.3	2.3	1.2	0.1	0.1	0.8	2.3	12.0	0.3	0.2	0.2	0.4	0.7	0.0	0.2	1.7	2.0	0.6	1.4	0.0	0.4	0.1	0.3	0.7	3.4	2.6	0.1	29.4	1.3	0.3	0.4	0.6	3.2	2.8	0.4	3.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	75.5	0.0	142.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	36.4	0.1	0.0	0.0	0.9	0.1	0.2	0.1	10.6	0.1	0.1	0.2	0.2	2.0	0.1	0.4	0.1	1.0	9.6	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	1.8	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.6	0.5	0.2	2.8	0.0	5.3	0.1	0.0	0.1	0.9	0.0	0.4	2.5	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.2	1.5	0.0	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.1	4.2	0.0	0.0	0.1
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416890	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.0;intestine: 2.5;retina: 1.2"	"Group enriched"	"Detected in some"	10	"Horizontal cells: 42.1;Paneth cells: 47.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA035324	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 62: Horizontal cells - Visual perception"			"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.2	0.3	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.1	0.1	2.9	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 898.8;breast: 248.9"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			898.8	8.9	0.1	2.4	0.1	0.2	248.9	0.2	0.1	0.0	0.0	7.7	0.1	0.1	0.0	1.2	0.1	7.6	6.5	0.0	0.0	0.8	0.1	0.1	1.3	0.1	0.0	0.0	6.2	0.1	0.1	0.0	0.1	0.3	6.1	0.1	18.8	0.0	2.3	6.6	8.5	1.2	0.0	0.0	3.9	0.1	0.1	2.2	2.9	20.2	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1238.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1238.9	58.8	253.4	50.9	238.3	1.0	246.1	221.8	380.1	201.9	226.1	114.2	476.9	114.1	49.1	114.2	235.9	46.7	90.6	251.6	278.5	147.2	82.5	209.5	15.5	259.4	237.0	252.6	73.2	26.9	55.1	28.4	241.8	312.5	48.1	29.0	296.8	233.8	87.5	115.6	491.6	75.8	239.8	73.6	75.2	27.2	242.7	25.8	116.6	131.9	44.7	242.9	171.1	247.4	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	253.4	238.3	221.8	380.1	251.6	278.5	259.4	237.0	241.8	239.8	242.7	247.4	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADM	AM	ENSG00000148926	Adrenomedullin	P35318	11	10305073-10307397	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 340.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 590.8;Extravillous trophoblasts: 1217.1;Syncytiotrophoblasts: 1084.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"neutrophil: 242.2"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 242.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 684.6;fHDF/TERT166: 357.4;HSkMC: 410.9;U-138 MG: 390.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016075, HPA068955"	Approved				"Secreted to blood"	NA	NA	31000	340000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB016075: AB_628693, HPA068955: "	"unprognostic (1.67e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (9.70e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.62e-2)"	340.2	29.9	12.9	32.2	18.3	43.9	195.9	28.1	15.2	162.1	17.9	60.6	8.0	20.3	3.1	84.6	71.0	30.0	153.3	10.6	15.5	123.8	90.5	157.6	17.1	19.7	18.0	33.1	24.6	23.5	43.3	102.8	16.5	26.8	11.4	16.7	52.7	1.6	79.3	169.8	49.5	7.6	16.8	34.5	55.5	4.9	21.6	4.1	52.7	14.3	3.5	85.1	224.3	18.6	35.4	29.2	33.8	9.8	684.6	306.7	51.8	263.6	263.9	260.5	175.7	142.4	43.9	0.1	11.7	357.4	136.9	51.0	9.5	40.6	191.9	0.7	13.9	1.1	16.1	18.0	88.0	1.6	1.1	410.9	34.7	30.8	44.6	89.9	60.4	0.5	0.4	0.7	64.3	1.2	0.2	10.6	65.7	8.4	13.6	1.0	1.1	54.5	16.7	48.6	1.1	3.2	101.0	23.7	0.6	36.4	31.4	0.3	17.9	390.0	5.5	233.2	37.9	2.7	29.5	10.5	112.0	0.2	117.0	0.0	7.0	0.0	0.0	7.7	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.1	242.2	0.0	13.6	0.0	0.3	1.9	12.9	18.3	28.1	15.2	10.6	15.5	19.7	18.0	16.5	16.8	21.6	18.6	347.7	9.6	12.3	17.0	14.2	192.1	590.8	194.4	182.1	2.7	28.0	46.9	104.6	18.6	136.2	3.7	8.4	134.6	9.1	266.7	15.6	135.7	0.5	80.8	58.1	99.1	67.5	4.0	0.4	30.5	1217.1	202.8	55.0	210.9	9.5	30.1	95.7	18.6	71.4	3.3	3.0	127.6	181.0	69.6	57.7	2.6	132.7	107.9	40.9	6.5	8.1	4.9	1.0	1.5	0.1	61.7	298.3	19.2	20.0	218.9	14.0	60.1	38.7	15.3	0.0	73.3	76.5	5.1	4.9	182.3	125.6	1084.8	14.7	8.1	55.5	224.5
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159973012	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 36.9;liver: 11.4;lymphoid tissue: 11.6"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 41.5;Inhibitory neurons: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 36.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.9;HaCaT: 5.8;TIME: 9.8;U-2 OS: 7.9;U-251 MG: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.00e-5)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (1.59e-2)"	4.2	1.8	3.4	0.3	16.1	0.0	1.9	0.0	7.9	0.4	0.0	0.7	0.4	0.9	1.4	0.3	3.0	0.5	2.0	6.0	3.4	3.9	11.4	4.0	1.2	0.0	36.9	2.9	0.4	0.5	0.6	0.3	6.3	0.6	0.3	0.5	0.3	0.7	0.7	0.9	1.4	0.4	0.0	11.6	0.7	0.2	4.5	0.1	1.5	0.7	0.3	0.4	0.6	5.2	0.4	4.5	0.3	0.0	1.9	0.8	0.1	0.5	0.1	0.5	0.2	0.0	3.8	0.0	11.9	3.4	4.4	5.8	0.0	0.5	0.3	0.0	0.2	0.0	1.7	0.0	4.1	0.0	0.0	2.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	3.8	0.0	0.4	0.0	0.0	0.3	0.3	1.7	0.1	0.0	9.8	0.1	7.9	0.0	6.6	0.0	0.0	0.0	2.9	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	16.1	0.0	7.9	6.0	3.4	0.0	36.9	6.3	0.0	4.5	5.2	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220630-4249287	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.6;cervix: 7.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 1.2;Excitatory neurons: 2.1;Inhibitory neurons: 2.4;Oligodendrocyte precursor cells: 1.0;Smooth muscle cells: 2.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 7.5;CAPAN-2: 3.3;fHDF/TERT166: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038789	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA038789: AB_10673475"	"unprognostic (5.37e-2)"	"unprognostic (4.65e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.75e-11)"	"unprognostic (7.83e-3)"	"unprognostic (1.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.82e-4)"	"unprognostic (4.41e-3)"	"unprognostic (8.37e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.71e-7)"	"unprognostic (5.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.32e-5)"	1.2	0.4	5.0	0.0	0.6	0.0	0.8	0.3	4.8	7.2	0.0	2.0	0.0	3.5	0.3	0.2	2.0	0.2	0.3	7.5	4.2	0.3	0.1	2.3	0.0	2.7	4.9	0.6	0.3	0.2	0.0	0.1	2.4	3.4	0.1	0.0	0.2	1.7	0.5	0.4	0.2	0.3	1.3	1.4	1.6	0.7	9.6	0.0	0.8	0.4	0.0	2.4	2.9	1.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	7.5	1.3	0.4	0.1	0.3	3.3	0.0	0.0	4.4	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.6	0.3	4.8	7.5	4.2	2.7	4.9	2.4	1.3	9.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1
ADSS1	"ADSSL1, FLJ38602"	ENSG00000185100	"Adenylosuccinate synthase 1"	Q8N142	14	104724229-104747325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 1273.1;tongue: 609.8"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052621	Enhanced					NA	NA		290000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052621: "	"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	8.1	5.1	3.8	1.0	6.8	0.9	4.4	6.6	5.6	4.1	7.6	3.0	2.7	3.3	4.5	18.5	6.5	5.7	100.2	3.7	6.7	14.8	28.8	3.1	1.1	6.0	6.0	2.7	7.9	7.3	10.0	7.3	6.1	7.6	1.4	10.1	10.7	4.0	1273.1	5.5	2.8	2.3	5.2	2.0	6.5	18.5	5.5	1.0	7.4	609.8	0.8	6.5	5.4	7.7	0.1	3.2	2.4	7.1	1.7	1.1	0.8	0.9	1.3	0.2	0.7	0.2	2.5	0.0	15.2	0.8	0.5	1.3	0.2	0.5	0.6	1.0	0.5	0.1	7.9	1.1	1.8	0.0	6.0	3.2	2.3	0.0	2.6	2.7	0.4	0.3	2.9	0.1	1.2	14.2	0.0	0.7	2.1	23.2	1.3	0.2	0.3	0.9	0.5	1.7	2.0	4.2	23.1	1.0	3.3	1.8	7.1	2.1	0.8	0.1	0.6	1.6	0.1	4.4	3.5	0.0	2.2	1.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.8	6.8	6.6	5.6	3.7	6.7	6.0	6.0	6.1	5.2	5.5	7.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0
ADSS2	ADSS	ENSG00000035687	"Adenylosuccinate synthase 2"	P30520	1	244408494-244451909	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.4;Cytotrophoblasts: 49.3;dendritic cells: 59.6;Extravillous trophoblasts: 97.2;Hofbauer cells: 35.8;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		690000	"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.8	20.5	17.8	28.1	22.0	43.9	34.6	21.7	26.7	25.9	17.0	28.7	28.7	23.4	29.8	32.6	23.9	21.0	8.9	19.2	21.1	32.9	24.3	25.3	31.9	21.9	19.6	21.7	19.8	27.6	14.5	28.6	23.1	25.3	29.8	11.4	22.8	25.6	10.8	33.2	27.1	25.2	19.6	23.7	35.0	70.3	20.9	33.8	34.9	8.4	34.9	36.2	21.5	28.7	89.9	48.6	41.6	36.9	47.6	67.8	76.2	88.5	74.4	62.3	47.0	64.6	84.5	79.7	57.1	68.9	26.6	66.1	45.9	58.0	69.5	59.6	81.0	53.1	47.8	49.3	57.1	127.1	65.6	46.8	68.5	58.1	58.3	72.1	225.6	43.3	94.0	57.7	62.7	21.6	82.3	85.0	110.5	85.0	53.1	74.9	39.4	86.5	103.8	55.2	56.2	49.2	75.2	69.0	91.4	43.9	48.0	66.7	99.4	57.1	31.3	67.0	93.7	69.1	97.2	60.0	47.2	146.8	86.3	48.3	22.8	20.0	20.4	29.9	22.0	15.3	18.6	17.8	20.1	12.3	15.6	17.9	17.5	23.6	33.6	7.9	22.3	18.8	17.8	22.0	21.7	26.7	19.2	21.1	21.9	19.6	23.1	19.6	20.9	28.7	26.4	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	49.3	59.6	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	97.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	54.0	11.0	0.0	0.0	0.0
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500617-149000663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.0;brain: 24.6;epididymis: 11.9;placenta: 14.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 22.9;Excitatory neurons: 29.7;Granulosa cells: 24.6;Inhibitory neurons: 140.2;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 1.0;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 74.2;HL-60: 31.7;U-698: 106.4;U-937: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	0.9	0.2	7.3	1.6	8.4	12.0	0.5	18.7	19.0	3.5	0.0	0.2	0.0	0.5	11.9	0.2	0.1	2.2	0.6	24.6	10.2	0.2	0.1	2.0	5.4	4.1	4.2	0.9	0.1	0.0	3.5	14.7	5.4	0.6	0.1	8.2	0.3	1.5	0.0	0.6	0.1	0.1	5.4	0.4	0.1	2.1	9.6	5.3	0.4	0.0	6.2	0.3	0.2	1.8	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	74.2	0.1	4.3	0.0	0.0	9.9	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	31.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.0	2.2	0.0	4.2	9.6	2.7	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	1.3	4.1	0.0	0.9	0.0	3.4	0.4	0.3	106.4	0.0	22.9	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.4	18.7	19.0	24.6	10.2	4.1	4.2	5.4	5.4	9.6	1.8	0.2	0.0	0.0	2.3	0.1	0.4	0.0	0.1	0.0	4.7	0.0	0.3	1.5	0.0	0.0	0.0	22.9	0.2	0.0	0.0	0.0	0.5	8.9	1.8	0.3	0.1	0.0	2.5	29.7	0.0	0.2	1.0	0.0	3.4	5.7	24.6	0.0	0.0	0.1	1.7	140.2	0.0	0.0	0.0	0.8	6.4	7.8	0.3	0.0	4.7	0.8	1.3	0.0	38.2	3.3	0.0	0.0	17.7	0.6	0.2	0.0	0.6	0.0	15.3	6.6	0.1	1.4	0.3	0.2	0.0	0.0	0.3	0.2	2.0	0.0	0.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377227	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favorable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	26.1	25.9	16.4	21.9	17.0	32.4	29.2	18.2	19.0	24.1	30.8	60.8	79.9	22.1	17.5	41.5	23.8	18.3	88.0	17.0	18.7	62.7	51.0	21.8	23.7	17.7	16.6	24.1	41.1	76.0	18.6	23.5	18.8	24.6	54.1	20.3	30.8	24.4	145.4	29.8	58.7	25.4	15.8	18.5	39.1	18.5	19.0	24.3	39.2	155.8	31.0	30.9	19.6	17.6	56.5	56.6	39.7	44.8	45.2	48.6	52.7	61.9	61.1	86.6	63.1	88.1	34.1	161.3	66.3	56.6	76.8	55.6	101.4	71.3	70.3	38.1	43.5	48.5	59.3	83.5	61.1	185.0	69.8	54.3	76.3	82.1	107.7	47.8	64.0	57.0	111.3	92.8	43.6	89.0	66.7	58.5	55.3	277.4	41.9	74.0	125.1	135.2	74.9	123.6	73.7	51.3	97.0	103.8	90.0	50.5	47.8	84.5	49.0	102.4	88.6	98.7	81.7	64.7	80.7	104.1	56.2	71.4	48.0	3.8	16.5	12.4	11.6	17.6	13.9	14.0	13.8	17.9	21.8	10.3	17.2	20.2	1.1	28.4	16.2	11.5	9.5	13.4	16.4	17.0	18.2	19.0	17.0	18.7	17.7	16.6	18.8	15.8	19.0	17.6	24.3	41.7	49.2	23.2	36.6	22.2	45.3	21.5	42.7	50.2	36.5	36.2	74.9	50.1	28.1	35.0	50.1	58.5	29.1	85.2	72.4	39.5	5.5	37.8	52.3	27.7	39.1	61.0	21.1	37.4	37.9	31.2	53.5	46.1	14.5	41.3	21.8	85.6	37.0	30.3	26.8	82.6	18.3	32.6	14.4	5.5	32.9	34.2	23.2	12.2	27.6	26.9	40.2	14.1	17.7	47.8	43.1	30.1	38.8	43.1	88.7	100.0	22.1	58.3	26.3	53.6	26.9	50.9	65.0	75.8	31.3	92.8	28.4	60.8	94.9	38.2
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 961.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	79.7	961.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430774-177442437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 77.5;Karpas-707: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		36000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	9.4	13.3	8.1	9.1	10.4	15.4	21.1	9.8	12.0	9.2	16.2	13.1	9.6	8.6	30.2	15.9	8.4	13.1	7.5	8.4	9.9	15.3	18.7	11.6	12.2	11.4	9.1	10.2	15.1	17.1	6.1	8.4	11.4	11.8	13.1	6.6	14.9	9.8	9.0	20.6	12.4	9.5	9.5	10.3	16.2	13.2	8.6	11.1	15.8	5.8	15.6	10.9	8.2	13.7	5.4	11.9	13.3	18.8	14.9	13.2	9.0	39.5	77.5	20.1	24.8	6.2	26.2	26.9	7.2	30.0	9.7	6.5	11.3	13.0	39.4	17.3	7.5	11.2	11.9	17.3	10.0	19.6	7.4	9.6	22.5	14.7	6.5	18.0	18.7	11.4	10.3	111.6	8.0	14.6	15.9	12.0	5.2	10.5	12.2	5.0	5.4	4.0	20.5	12.9	7.3	16.4	11.9	10.3	32.2	9.9	23.3	39.8	6.1	13.9	12.3	6.6	15.2	21.2	17.4	14.0	22.3	22.0	16.0	26.4	15.3	23.9	15.6	27.5	17.9	13.9	16.6	18.8	14.8	12.9	14.8	21.3	3.3	12.7	35.8	15.8	17.8	15.1	8.1	10.4	9.8	12.0	8.4	9.9	11.4	9.1	11.4	9.5	8.6	13.7	12.6	12.8	13.5	2.6	20.5	24.0	17.4	26.9	12.5	3.9	19.8	16.9	7.5	15.7	21.7	14.7	2.1	26.3	17.6	8.4	5.9	28.2	13.6	8.9	8.5	10.9	5.4	7.8	3.7	31.3	32.0	16.0	13.7	12.5	14.0	13.9	8.2	23.5	23.1	6.7	2.3	18.2	14.2	15.4	23.3	9.2	11.1	15.9	39.2	2.8	23.8	19.1	11.3	3.5	19.3	21.4	9.1	9.8	48.8	13.4	15.1	22.1	10.5	4.8	0.0	8.4	14.1	35.8	36.6	23.7	27.3	22.7	22.5	14.1	13.6	17.7
AGAP1	"CENTG2, GGAP1, KIAA1099"	ENSG00000157985	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1"	Q9UPQ3	2	235494043-236131800	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.9;retina: 54.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 304.0;Cone photoreceptor cells: 329.4;Excitatory neurons: 289.3;Oligodendrocyte precursor cells: 1438.1;Oligodendrocytes: 997.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (1.69e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.36e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (6.52e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.32e-2)"	5.3	4.7	30.7	3.4	34.4	1.9	8.3	7.6	29.6	5.7	0.0	12.5	7.0	5.2	8.9	6.6	6.7	5.6	5.9	34.0	33.0	7.7	2.6	5.6	1.7	44.6	24.1	5.5	6.5	8.9	7.1	6.9	48.2	4.8	11.2	54.7	4.2	5.0	8.4	3.7	8.6	10.5	10.9	1.9	6.7	6.6	30.5	1.5	9.1	9.2	1.9	6.2	3.4	53.9	17.3	13.6	20.9	9.8	15.1	9.7	13.1	8.6	9.1	9.9	7.5	14.0	31.3	0.1	3.6	14.9	37.2	4.3	15.8	20.4	12.3	0.3	8.1	26.4	12.5	10.5	6.0	0.1	17.5	14.1	19.3	20.4	15.9	7.1	6.8	6.1	13.8	1.0	12.6	22.2	0.5	3.0	9.1	14.9	6.2	3.6	10.6	16.8	10.8	20.4	78.9	19.9	7.3	17.1	9.5	11.4	9.8	4.1	6.8	11.8	12.0	9.8	11.7	5.4	0.1	0.8	18.4	0.2	12.7	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	30.7	34.4	7.6	29.6	34.0	33.0	44.6	24.1	48.2	10.9	30.5	53.9	16.0	6.4	15.5	100.6	0.2	4.1	3.7	6.2	5.2	304.0	19.4	11.7	22.9	2.8	8.7	11.0	329.4	9.7	5.5	23.3	3.9	21.4	9.4	24.0	12.0	13.3	16.3	0.4	289.3	15.0	1.5	19.5	4.6	15.8	20.8	12.7	7.9	6.3	1.4	119.5	219.0	17.8	12.2	0.6	3.8	2.9	5.0	2.1	1.8	139.6	1.6	33.3	9.2	1438.1	997.9	19.1	20.7	13.5	0.8	4.9	21.1	14.0	14.4	142.0	26.3	20.4	22.5	4.8	20.7	7.1	4.3	6.6	3.0	7.0	21.8	4.9
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute RISC catalytic component 2"	Q9UKV8	8	140520156-140635633	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		65000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	7.8	4.1	6.9	6.2	11.5	11.3	5.9	12.4	9.2	6.9	2.4	8.6	3.2	7.7	5.9	6.3	8.3	5.1	7.3	5.7	11.4	5.9	3.8	9.1	6.1	14.0	10.1	9.5	5.0	7.0	8.0	5.8	11.3	5.8	4.0	6.8	4.8	4.6	17.5	8.5	6.2	5.2	5.9	5.2	6.6	3.3	10.8	7.6	6.3	9.1	5.4	6.6	6.7	19.2	18.9	15.2	15.3	17.6	9.9	11.5	12.9	11.6	8.4	5.1	6.3	17.0	5.5	21.5	14.1	11.3	5.5	12.4	26.2	12.5	11.3	12.2	13.7	25.2	28.7	11.0	8.9	10.5	8.2	7.9	11.0	14.1	14.6	7.0	12.0	13.4	26.9	13.2	16.8	28.5	18.2	8.3	11.4	12.9	26.3	18.5	12.9	9.7	6.5	19.3	18.0	13.0	18.1	6.1	12.8	15.7	15.7	15.1	16.9	8.8	24.5	14.0	18.9	11.5	4.0	14.7	6.5	18.7	13.2	0.7	0.8	0.2	0.8	0.7	0.9	0.4	0.8	0.7	0.7	0.7	0.8	0.8	2.2	0.8	0.8	0.5	0.7	0.6	6.9	11.5	12.4	9.2	5.7	11.4	14.0	10.1	11.3	5.9	10.8	19.2	30.8	22.4	25.1	50.3	40.7	21.9	74.8	5.7	17.6	26.5	34.5	24.5	22.2	8.6	22.6	14.7	43.8	46.5	63.1	14.8	7.9	25.6	21.2	73.1	54.3	37.8	24.2	122.9	32.6	18.2	21.5	44.3	28.5	129.4	17.1	31.6	27.5	14.6	14.9	42.1	36.4	19.1	2.0	26.0	48.5	14.9	37.3	53.0	5.4	32.8	36.0	26.1	32.0	51.3	83.2	37.9	18.6	46.3	46.6	115.0	12.7	9.4	15.4	29.7	32.9	65.9	44.5	3.1	4.0	31.8	23.9	79.1	49.1	12.0	19.3	100.1
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392746-177567024	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease variant, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		69000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	14.3	9.2	4.4	15.6	6.9	19.6	13.9	7.1	6.9	14.3	4.6	20.1	11.1	14.6	6.5	12.7	9.8	11.3	10.4	4.7	6.6	18.1	19.3	13.7	11.9	8.9	7.0	7.8	11.4	18.5	3.4	13.2	8.2	7.0	21.9	6.4	8.3	8.8	11.7	4.5	13.1	21.1	7.8	8.7	9.9	16.3	6.3	16.1	12.6	12.6	12.8	14.6	5.2	11.9	43.1	36.3	23.3	19.0	32.2	33.2	33.3	29.6	21.9	34.5	34.8	70.6	34.0	58.5	59.5	45.0	46.3	47.5	64.4	45.1	47.8	51.4	16.7	77.6	56.5	75.8	31.9	82.3	63.5	28.6	28.7	58.6	44.6	33.3	75.3	42.1	44.9	26.3	45.7	0.1	59.9	22.4	33.3	42.7	30.9	47.0	65.1	32.7	60.0	65.0	22.0	31.3	66.2	5.8	43.0	58.1	0.4	35.4	70.0	29.4	61.9	26.8	64.2	28.7	59.0	23.6	29.4	43.1	11.8	2.6	3.3	5.8	1.9	4.0	2.9	1.7	3.0	2.4	3.6	1.1	2.7	1.6	1.5	2.8	3.6	0.1	4.3	2.2	4.4	6.9	7.1	6.9	4.7	6.6	8.9	7.0	8.2	7.8	6.3	11.9	20.2	16.0	13.1	29.4	10.7	10.8	6.5	15.5	12.0	11.5	19.2	6.7	20.0	20.0	13.0	14.7	2.1	14.1	15.5	25.6	13.7	20.9	262.2	25.2	17.2	14.0	19.8	20.8	53.0	23.2	20.6	23.0	18.8	25.4	64.1	16.6	11.7	31.0	31.8	15.2	61.7	30.4	16.2	30.0	31.8	41.4	14.6	28.7	14.2	56.2	36.0	12.0	21.6	45.8	83.8	23.9	17.4	13.9	14.1	3.8	15.3	46.5	21.6	7.6	6.6	16.8	16.4	41.7	22.2	16.2	9.8	7.0	19.0	22.7	26.0	6.1
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483547	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 122.5;epididymis: 37.1"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 3.9;Hofbauer cells: 8.8;Leydig cells: 3.1;Macrophages: 4.5;Peritubular cells: 2.6;Theca cells: 5.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	60	"hypothalamus: 122.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.2"	"Region enriched"	"Detected in single"	16	"hypothalamus: 16.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	HPA041017	Enhanced	Supported			"Secreted in brain"	NA	NA	255000		"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.0	12.4	1.2	0.2	1.0	0.2	0.0	0.8	2.0	0.0	1.6	0.1	0.0	0.0	37.1	0.0	0.0	0.0	0.1	1.0	122.5	1.0	0.1	3.7	0.4	1.7	1.1	0.1	0.0	0.2	0.7	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.3	0.0	0.3	0.5	0.3	0.4	2.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.1	0.1	0.0	1.6	0.5	0.9	1.1	0.3	0.7	0.2	0.3	0.7	0.4	0.6	0.6	0.2	0.0	0.4	0.5	0.3	0.4	1.2	1.0	0.8	2.0	1.0	122.5	1.7	1.1	1.0	0.3	2.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.6	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.6	0.0	0.4	3.1	4.5	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	5.0	0.0	0.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1603.7"	"Group enriched"	"Detected in many"	9	"Cholangiocytes: 985.1;Hepatocytes: 2244.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 646.2;THP-1: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	11.7	14.6	252.9	2.6	259.8	0.4	4.4	267.5	243.6	9.7	138.2	5.6	2.5	3.2	1.9	2.6	6.0	92.7	154.7	236.0	242.1	52.5	1603.7	5.1	1.0	352.4	314.4	3.5	7.9	6.0	25.8	0.7	304.9	16.3	3.6	26.4	4.9	2.2	43.6	2.0	9.7	5.8	340.5	1.3	4.9	4.1	273.5	1.7	13.2	25.8	0.1	7.0	4.5	322.4	0.2	0.4	0.2	0.2	15.6	0.0	0.9	0.6	0.2	0.0	0.0	80.6	0.1	0.3	0.7	0.2	0.7	0.7	0.0	0.0	0.0	11.4	0.2	0.2	0.3	646.2	1.9	1.0	0.5	26.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	5.5	0.7	0.0	0.2	0.6	0.6	0.1	0.2	0.3	2.4	0.1	0.1	0.3	0.9	0.6	0.4	0.1	5.5	0.1	0.0	243.6	0.1	0.4	1.3	0.4	1.2	3.5	47.0	0.4	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.9	259.8	267.5	243.6	236.0	242.1	352.4	314.4	304.9	340.5	273.5	322.4	0.8	0.0	1.7	140.0	11.3	0.6	1.1	0.0	0.0	4.7	0.8	0.3	60.0	985.1	0.6	3.7	35.5	0.1	0.0	0.0	25.4	169.8	62.2	0.3	0.4	5.5	0.0	50.8	0.3	10.0	0.2	27.2	0.5	0.1	0.0	0.0	39.3	2244.9	2.1	3.3	1.5	1.1	0.0	56.9	0.4	48.5	4.1	0.9	8.8	5.6	0.6	75.1	0.0	3.5	6.8	13.7	1.2	3.4	0.0	26.2	24.2	146.9	0.1	49.8	13.1	7.2	94.1	0.4	0.4	0.0	0.0	0.7	3.9	0.0	0.4	1.9
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 395.4"	"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		10000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	243.1	27.9	62.6	43.4	50.2	44.1	190.3	33.7	45.4	183.3	61.0	276.2	49.0	183.3	51.7	248.2	145.5	74.8	115.1	65.0	98.0	59.7	60.1	144.1	36.7	76.2	48.3	125.8	30.3	26.3	16.9	97.3	62.9	88.5	96.6	10.1	127.5	105.7	188.5	334.7	136.6	113.1	60.8	59.5	133.5	18.0	49.0	27.9	64.9	172.2	63.7	142.0	213.3	78.4	188.2	107.9	9.8	44.1	421.8	561.4	70.3	166.0	201.4	103.0	57.4	93.7	64.9	0.2	61.7	554.5	79.8	244.1	41.2	203.7	130.7	154.2	7.3	22.6	173.4	27.9	80.8	31.5	142.2	204.2	233.0	202.4	183.6	131.5	215.4	2.7	21.8	138.8	211.7	72.1	0.4	60.7	3.0	59.6	171.7	0.4	45.1	113.9	227.1	120.2	0.3	9.2	167.5	69.3	69.0	198.8	133.7	28.4	582.1	182.4	119.8	229.8	74.4	25.0	5.4	0.6	138.2	10.1	60.9	44.1	75.6	0.3	38.7	45.0	25.8	20.0	24.8	31.7	73.8	16.1	3.2	17.3	1.1	31.5	37.8	20.2	21.5	36.8	62.6	50.2	33.7	45.4	65.0	98.0	76.2	48.3	62.9	60.8	49.0	78.4	413.1	439.1	106.3	49.3	171.4	479.4	133.8	285.0	253.2	1.4	173.0	226.8	199.9	195.9	224.1	193.1	0.0	110.8	194.3	400.8	13.7	99.6	10.6	188.5	195.0	282.5	47.6	43.7	0.9	64.1	145.6	312.9	538.2	351.2	238.9	4.3	201.4	88.5	79.4	1.7	0.8	164.8	138.4	329.8	458.3	33.2	451.4	292.3	318.4	43.1	284.8	30.7	138.0	0.5	0.4	262.5	195.5	466.0	329.0	202.4	262.3	6.8	149.3	1.2	177.5	349.5	244.4	3.1	8.1	596.4	610.3	102.2	256.5	3.0	101.8	198.0
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469472	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 345.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	70.9	99.1	134.7	51.8	136.1	51.0	55.4	142.0	345.7	63.9	135.3	82.4	44.8	80.1	72.3	72.6	120.9	39.4	116.7	134.9	139.1	73.2	71.8	60.8	71.6	141.8	139.3	69.8	50.3	65.5	66.7	76.5	144.0	64.4	71.8	39.1	56.7	70.3	140.2	59.8	54.9	85.0	139.4	55.7	61.9	99.4	142.5	65.2	47.1	118.3	91.4	76.9	61.1	156.2	185.0	356.7	103.1	131.9	159.1	110.3	175.1	131.2	111.6	223.0	165.3	277.0	163.4	361.3	103.0	145.1	258.4	204.7	386.2	186.5	231.8	131.8	207.5	156.1	181.6	343.3	113.7	102.6	230.8	98.3	244.9	150.7	72.2	133.1	209.9	225.3	205.5	115.6	138.5	522.6	278.6	207.8	170.6	347.7	372.9	210.2	110.3	178.1	178.2	187.1	155.0	161.4	119.2	302.9	115.8	154.4	174.4	152.6	100.3	115.3	162.1	126.2	198.7	103.7	241.6	273.8	169.1	211.3	131.1	82.7	51.5	67.9	66.4	74.0	76.9	81.0	59.8	68.0	67.2	63.7	69.0	70.6	39.8	88.7	92.5	66.4	77.2	52.2	134.7	136.1	142.0	345.7	134.9	139.1	141.8	139.3	144.0	139.4	142.5	156.2	46.6	35.3	21.6	10.1	59.4	156.0	208.2	82.8	74.0	36.0	49.9	46.6	92.2	42.9	57.0	27.6	85.5	153.4	66.8	60.0	74.3	74.2	40.6	112.6	60.8	54.9	78.3	55.8	14.6	48.8	113.3	68.3	25.5	59.6	76.2	55.2	28.9	41.0	93.5	18.5	14.7	70.5	65.1	26.7	117.5	34.2	67.7	52.6	90.7	12.2	58.5	46.6	61.8	10.1	23.6	67.8	65.6	66.5	54.1	145.4	56.4	87.0	132.2	54.1	98.6	46.9	135.0	92.0	57.3	67.7	140.1	136.7	92.3	86.0	85.2	120.1
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5817.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
AHSP	"EDRF, ERAF"	ENSG00000169877	"Alpha hemoglobin stabilizing protein"	Q9NZD4	16	31527900-31528803	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	62	"bone marrow: 1669.9"	"Cell type enriched"	"Detected in some"	296	"Erythroid cells: 8721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 3.0;K-562: 1.5"					"Low region specificity"	"Detected in some"			HPA040940	Enhanced					NA	NA		5300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA040940: AB_10796231"		"unprognostic (3.00e-1)"			"unprognostic (2.01e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.53e-1)"		"unprognostic (3.10e-1)"	"unprognostic (2.16e-1)"		"unprognostic (3.70e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-2)"		1.3	0.1	0.6	0.2	0.6	1669.9	0.4	0.6	2.6	0.4	0.6	0.1	0.0	0.1	0.0	0.2	0.2	0.0	1.5	0.6	0.5	1.9	4.7	4.5	0.2	0.7	0.7	0.2	0.3	0.1	1.4	27.1	0.7	0.1	0.3	0.0	0.5	0.0	0.2	1.4	0.1	0.0	0.6	23.7	0.2	4.1	0.6	2.9	0.7	8.9	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.6	0.6	0.6	2.6	0.6	0.5	0.7	0.7	0.7	0.6	0.6	0.8	0.1	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.6	0.0	8721.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	2.9	4.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	29.4	0.3	2.8	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.1
AIFM1	"AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130124666-130165879	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.4;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	21.0	65.2	10.5	17.6	11.2	11.8	17.8	11.9	12.8	15.7	24.7	34.3	52.9	15.3	8.9	20.8	22.1	10.1	107.7	10.9	11.6	97.3	110.6	13.9	16.2	11.3	11.0	11.9	27.8	29.7	16.2	10.3	11.4	14.8	15.9	8.5	18.6	7.6	68.9	15.2	29.9	10.1	11.2	20.3	41.2	30.3	12.1	18.5	14.7	25.2	11.0	18.4	13.4	11.6	52.8	95.4	22.6	85.2	24.1	14.6	50.0	28.6	19.0	33.5	25.2	55.8	36.4	105.0	113.3	17.5	39.3	47.2	61.3	33.3	12.7	48.2	73.4	61.6	59.1	68.9	34.0	51.5	63.5	26.1	21.7	34.5	22.0	12.1	27.2	83.4	62.6	50.7	13.1	96.7	57.6	74.5	24.4	53.6	65.1	55.6	31.7	132.7	60.8	36.6	46.0	28.2	35.5	68.0	67.5	13.2	46.0	40.8	31.7	20.5	20.4	63.9	58.7	24.2	45.0	47.5	25.3	86.4	33.4	4.1	21.0	14.1	11.8	26.6	13.1	14.6	12.8	14.6	31.7	10.3	12.7	12.6	2.4	20.7	24.8	14.7	17.9	12.4	10.5	11.2	11.9	12.8	10.9	11.6	11.3	11.0	11.4	11.2	12.1	11.6	12.6	16.0	20.1	17.0	17.1	8.7	8.2	25.0	9.1	19.3	13.0	8.3	165.4	22.8	21.2	40.5	22.9	58.0	14.2	31.6	92.0	24.9	1.8	36.7	17.3	11.5	9.6	26.3	10.8	20.5	29.0	16.4	27.0	50.4	10.8	33.1	14.3	92.3	38.0	15.2	12.1	24.0	34.6	14.4	7.4	4.9	17.4	16.8	10.6	8.4	16.6	17.2	20.6	8.0	19.6	18.0	18.9	17.3	19.2	7.9	45.6	326.1	21.3	48.1	6.6	11.3	39.3	10.2	32.0	17.1	6.8	39.7	15.8	45.9	37.2	9.8
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.9;tongue: 102.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	19.2	21.0	13.6	14.3	15.1	12.4	17.3	15.6	17.0	11.0	12.8	25.8	47.7	16.7	16.7	22.0	14.4	8.8	45.3	15.4	14.6	25.7	33.8	12.6	14.3	14.9	14.5	7.4	17.0	28.7	7.8	13.4	14.7	11.9	24.4	11.9	16.4	15.2	154.9	21.6	27.8	19.3	15.2	13.0	14.6	44.1	15.1	15.4	25.8	102.5	19.5	17.0	13.7	16.2	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.6	15.1	15.6	17.0	15.4	14.6	14.9	14.5	14.7	15.2	15.1	16.2	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
AIP	"ARA9, FKBP16, FKBP37, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483026-67491103	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055"	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	62.9	58.1	72.5	47.4	77.6	40.4	58.5	74.7	82.4	84.5	66.7	78.4	33.7	71.0	32.4	38.9	66.9	39.4	72.1	70.3	74.3	68.0	51.6	62.3	89.5	75.9	72.7	77.9	48.8	35.4	51.1	33.5	74.6	60.8	20.1	22.9	40.6	36.0	46.4	39.5	64.7	28.8	71.8	85.1	57.0	29.7	73.1	78.7	63.6	45.8	49.1	73.1	62.6	80.4	80.8	91.1	51.6	49.9	64.8	64.2	39.3	49.7	61.2	83.6	60.9	143.7	77.9	142.2	118.1	55.3	63.5	63.9	59.2	51.9	32.1	209.3	63.5	86.5	98.7	87.0	67.1	87.5	145.1	77.8	48.3	74.6	48.4	81.4	43.0	138.6	50.0	83.6	55.5	153.7	187.7	214.6	49.0	122.0	115.7	82.2	78.5	126.5	59.5	47.2	81.4	81.3	64.4	45.5	204.3	19.9	60.9	87.2	71.5	73.4	71.1	108.9	46.3	67.4	99.8	112.7	100.4	67.4	57.7	192.5	117.9	135.6	194.3	144.6	212.0	241.6	227.4	227.6	179.8	221.5	203.4	194.7	78.2	165.3	175.0	207.9	352.4	182.4	72.5	77.6	74.7	82.4	70.3	74.3	75.9	72.7	74.6	71.8	73.1	80.4	57.2	32.1	25.6	6.8	69.4	30.3	35.8	54.2	31.9	36.8	24.6	33.1	23.1	30.0	33.7	49.7	4.2	56.4	61.9	50.1	82.2	46.8	25.3	12.7	31.0	54.0	31.8	22.5	4.0	42.2	63.5	51.0	23.4	18.0	77.3	51.7	45.7	23.3	66.7	37.0	4.9	34.7	48.8	65.0	54.6	14.2	53.1	56.1	56.9	5.6	72.5	49.6	76.2	5.0	10.5	41.2	53.5	35.3	50.2	42.7	86.1	98.3	17.4	29.4	39.5	36.4	86.5	21.7	28.4	19.4	21.2	59.5	90.6	42.0	25.4	52.2
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866486-127877675	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1346.2;tongue: 783.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.3;Late spermatids: 1031.8;Muller glia cells: 287.6;Peritubular cells: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		24000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	28.5	34.5	81.3	11.5	79.2	28.4	17.0	87.9	95.1	37.5	145.8	33.8	17.9	14.3	28.5	32.0	342.2	22.5	270.0	79.5	88.5	31.4	26.5	74.6	5.0	97.4	99.8	45.0	14.9	47.0	33.8	7.6	99.0	17.1	39.5	29.0	33.1	35.9	1346.2	14.2	12.1	21.9	105.0	20.8	23.9	63.1	89.4	3.9	34.8	783.3	12.6	19.7	19.4	97.2	56.7	23.6	30.1	40.4	71.2	142.9	27.4	38.3	38.2	66.7	40.4	18.0	34.9	1.5	40.8	79.4	44.1	79.2	0.3	43.1	26.6	9.0	26.1	8.3	65.2	31.6	40.1	0.0	1.0	110.9	81.8	49.9	35.5	36.8	90.3	0.8	33.7	2.3	76.7	53.5	0.1	1.1	10.6	139.7	74.2	1.3	30.0	12.6	44.8	4.1	48.3	30.4	101.0	57.4	29.8	15.3	45.8	33.3	75.9	45.9	18.8	163.8	37.3	3.5	0.6	0.2	57.7	0.3	32.4	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.2	0.1	0.9	0.0	0.3	81.3	79.2	87.9	95.1	79.5	88.5	97.4	99.8	99.0	105.0	89.4	97.2	12.8	41.7	148.1	25.8	2.6	26.4	17.2	84.5	6.2	54.6	11.5	7.9	49.7	28.6	79.4	7.3	16.7	7.5	5.7	210.1	17.6	116.7	281.3	7.3	8.0	39.8	106.3	97.0	11.1	60.9	46.8	37.3	46.4	4.8	1.3	2.7	49.2	77.3	59.3	48.8	12.0	62.7	120.1	3.7	22.3	1031.8	226.5	7.9	83.6	2.8	2.3	287.6	10.3	4.5	9.7	57.2	132.7	386.3	4.2	14.4	22.8	8.2	186.5	69.5	26.3	107.2	56.4	20.2	16.7	33.6	28.4	13.5	7.1	83.4	65.5	25.3
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 440.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	85.3	88.6	39.9	76.9	45.0	74.3	80.4	44.1	49.0	79.6	49.8	117.2	140.0	58.6	52.1	108.5	65.3	49.0	114.1	38.8	43.8	181.6	172.9	59.3	73.3	48.5	42.8	59.9	78.9	123.6	49.4	68.4	50.4	63.2	114.0	51.0	81.1	55.5	154.2	74.4	139.4	68.1	44.0	57.2	92.7	54.8	44.3	85.9	86.6	122.9	113.4	84.2	76.9	49.3	339.1	153.4	131.6	149.7	94.9	116.6	132.8	185.0	143.5	267.7	280.2	283.2	311.9	602.1	218.4	139.8	204.2	235.4	312.5	327.0	276.6	261.6	229.3	396.2	270.0	219.9	218.2	712.5	222.2	118.1	238.2	232.7	471.2	163.3	190.2	245.7	436.9	230.4	165.0	174.2	273.0	392.8	181.2	337.4	222.4	314.7	222.2	415.6	286.2	205.1	190.8	114.8	205.4	235.0	584.8	151.4	194.5	517.2	138.9	165.5	194.3	259.4	357.5	238.0	324.7	565.7	232.4	664.6	195.5	49.2	158.8	198.0	77.1	145.5	81.8	122.3	72.7	74.0	195.8	105.8	72.9	67.9	42.1	115.3	130.4	154.2	96.8	188.1	39.9	45.0	44.1	49.0	38.8	43.8	48.5	42.8	50.4	44.0	44.3	49.3	60.5	51.3	79.0	19.6	44.0	125.2	101.4	228.1	63.7	21.1	66.5	72.6	106.9	71.4	142.8	112.2	83.4	158.0	37.0	109.6	256.3	120.2	108.3	50.0	42.1	70.7	50.4	50.9	16.2	123.7	164.6	58.0	66.3	47.0	40.0	38.8	41.4	135.5	96.1	8.4	19.7	84.7	89.5	44.8	60.1	42.8	46.9	48.4	87.2	12.2	67.3	22.1	48.4	14.1	22.0	110.5	67.2	44.0	55.7	109.0	236.9	440.0	67.0	41.8	52.6	34.1	108.4	91.0	31.6	88.6	122.7	216.6	40.7	72.2	122.6	120.5
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709556-4742043	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 242.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 485.4;HEL: 273.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063324	Enhanced		Supported	Mitochondria		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	75.5	62.9	30.1	23.7	36.9	20.1	39.7	33.5	34.9	41.0	56.2	67.4	68.3	41.9	31.2	61.2	34.4	35.9	100.6	27.0	40.6	101.4	199.9	34.9	29.6	32.8	38.1	47.8	38.9	66.8	22.2	35.1	33.7	49.2	59.6	16.8	38.7	42.6	242.8	47.4	62.5	41.7	33.5	33.0	69.5	11.2	37.9	35.1	49.9	159.6	34.4	48.7	39.7	36.5	44.1	30.7	55.5	22.6	75.3	55.5	4.9	60.4	116.1	30.4	45.5	5.7	43.6	39.5	20.4	63.5	16.6	29.3	40.8	48.0	51.2	485.4	37.1	273.3	56.1	91.3	58.5	28.7	14.1	87.9	41.4	26.4	36.0	70.4	91.2	38.2	22.1	49.6	91.8	22.5	27.5	65.6	53.3	77.1	15.4	38.2	21.1	19.2	82.1	55.7	98.3	63.6	65.7	18.5	35.1	53.7	26.5	53.2	65.9	25.7	28.8	70.1	43.6	15.5	10.5	50.3	46.9	19.9	18.9	13.3	10.2	32.2	27.6	8.1	25.5	12.1	21.6	25.7	19.6	12.3	28.4	29.2	2.8	27.4	6.5	26.3	31.8	21.1	30.1	36.9	33.5	34.9	27.0	40.6	32.8	38.1	33.7	33.5	37.9	36.5	58.3	57.7	80.3	78.0	34.0	74.2	76.4	87.4	84.2	10.7	58.8	28.3	182.9	68.6	71.0	66.2	22.9	95.5	34.6	129.9	258.2	84.8	3.7	40.7	30.6	65.7	109.6	68.1	23.4	69.6	17.0	83.4	87.1	37.8	46.2	75.8	79.2	305.6	47.5	15.2	55.8	104.2	73.2	46.9	41.4	4.5	108.7	34.7	74.7	22.5	40.9	28.2	33.0	44.7	87.0	67.3	78.7	149.7	62.8	166.7	111.8	183.5	52.8	11.0	105.2	76.0	60.8	6.4	14.1	152.5	104.4	214.0	36.4	68.5	145.5	151.6
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	11.4	13.3	10.5	12.3	12.4	10.6	12.3	11.4	13.6	11.5	15.1	11.4	9.5	12.4	8.8	10.6	10.4	10.7	7.4	11.3	11.6	13.1	8.1	11.0	16.0	9.9	10.7	13.5	8.4	15.1	7.5	12.2	10.6	10.9	11.6	15.3	9.8	11.7	7.2	9.5	10.1	13.3	10.4	14.9	11.1	14.2	13.8	14.1	15.1	9.4	12.5	11.3	10.2	14.7	18.1	21.3	13.9	9.7	18.0	22.5	25.7	20.6	21.9	22.4	26.7	23.2	10.6	15.4	13.6	16.4	19.4	18.8	18.1	17.2	30.4	12.8	15.4	13.2	20.2	11.4	17.0	9.7	20.7	19.1	21.1	20.5	25.1	25.0	18.3	18.5	8.6	7.5	23.6	13.1	18.1	14.3	9.1	25.1	7.2	11.8	45.5	8.1	18.7	11.3	4.7	14.1	23.6	11.0	19.7	84.8	26.7	10.7	16.1	17.2	14.2	14.8	19.3	9.3	10.7	18.8	22.8	11.5	17.0	4.9	9.7	12.6	8.6	14.4	8.0	8.4	8.4	9.4	8.5	9.2	10.0	8.9	33.8	7.6	13.9	6.3	7.1	4.3	10.5	12.4	11.4	13.6	11.3	11.6	9.9	10.7	10.6	10.4	13.8	14.7	13.4	3.2	12.3	71.2	24.4	7.0	9.7	8.9	10.2	24.6	11.1	9.0	8.4	21.5	11.9	5.5	16.7	14.9	16.8	15.8	1.9	9.9	12.8	11.0	14.8	12.6	7.2	15.2	55.1	7.2	11.1	11.7	14.8	10.8	10.1	18.0	16.8	13.6	16.5	33.7	54.6	9.9	12.2	35.1	10.5	13.9	15.2	21.4	5.4	61.8	32.3	11.7	25.7	51.8	78.5	7.9	15.2	13.9	11.2	15.6	14.6	5.7	15.3	23.2	19.7	10.5	11.2	23.1	23.6	11.0	7.7	14.0	19.0	15.6	11.8	12.1
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272152-42323261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane, Cytosol"		"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	12.6	13.9	14.2	11.5	27.3	3.7	11.6	10.9	19.9	16.6	0.0	10.0	7.5	13.5	15.4	10.6	10.4	10.2	11.6	22.7	12.7	13.3	10.7	10.9	15.8	8.7	15.3	14.7	6.9	11.7	9.3	7.7	8.5	11.3	10.5	32.5	8.0	12.3	5.6	9.9	8.4	12.2	11.5	13.3	10.4	20.6	16.4	13.2	14.0	10.9	13.8	10.4	8.6	18.9	15.2	15.3	18.4	11.0	23.6	28.7	8.0	20.2	16.7	11.9	11.1	16.9	12.4	31.2	7.6	22.7	12.5	17.7	16.1	16.9	22.7	33.4	7.5	8.8	10.6	8.4	18.5	22.2	20.8	21.2	17.0	24.4	21.2	17.5	17.8	15.5	29.5	12.3	24.3	11.4	13.0	7.2	10.9	22.3	7.1	10.7	12.9	15.1	11.9	11.1	7.8	11.3	15.5	10.1	7.1	8.5	8.7	11.8	24.8	20.1	10.4	30.7	15.4	4.7	6.3	15.8	25.7	11.1	14.4	1.7	0.3	0.4	0.5	0.3	0.7	0.9	0.8	0.5	0.3	1.1	0.6	0.6	0.1	1.6	0.5	0.5	1.0	0.2	14.2	27.3	10.9	19.9	22.7	12.7	8.7	15.3	8.5	11.5	16.4	18.9	41.9	25.6	30.5	58.8	42.8	12.2	13.7	15.4	14.8	67.3	20.4	14.6	44.9	12.8	32.6	29.5	37.5	4.4	21.2	12.9	1.9	12.7	14.0	24.3	33.1	25.5	21.0	16.6	105.4	9.5	3.8	27.5	24.5	25.7	34.2	25.9	29.3	22.6	12.5	42.1	105.4	14.9	20.3	24.8	21.6	14.6	21.8	25.0	8.8	46.9	21.6	69.8	16.5	69.9	91.3	12.7	15.4	33.4	27.0	12.2	9.4	20.5	33.1	38.3	19.7	33.9	27.1	49.2	32.8	20.6	16.9	2.5	25.4	28.3	12.3	13.4
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	105.6	16.0	13.8	17.1	16.6	2.2	59.7	99.7	57.5	19.8	4.5	60.1	8.6	31.1	9.3	18.6	31.2	31.5	51.8	14.7	66.8	35.8	30.6	44.3	6.9	67.0	35.3	87.8	10.8	1.6	23.3	38.3	74.7	23.1	13.2	109.4	6.5	20.8	11.9	9.4	24.9	42.9	10.9	14.3	25.6	100.0	39.4	5.9	22.1	14.5	3.4	33.0	21.2	24.3	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.6	99.7	57.5	14.7	66.8	67.0	35.3	74.7	10.9	39.4	24.3	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 161.8"	"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol		NA	NA		14000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	37.7	18.9	10.0	38.7	9.2	56.1	32.1	1.7	9.3	28.5	66.1	25.9	16.7	83.0	20.7	25.6	22.7	44.6	66.6	11.0	17.7	14.4	22.2	54.1	47.6	16.7	17.6	26.7	54.5	11.8	18.5	26.0	13.9	20.3	21.3	8.3	23.9	23.5	83.9	24.7	32.5	40.3	9.7	38.3	34.4	20.0	15.0	46.3	32.7	60.3	46.5	32.9	26.7	16.3	13.2	29.0	20.8	7.8	31.3	34.6	11.2	10.6	23.5	9.4	9.0	11.3	11.0	62.0	14.6	19.2	23.8	26.5	23.9	9.9	9.0	45.2	11.0	83.8	20.0	8.6	17.3	17.2	161.8	25.6	25.5	11.6	39.8	10.6	25.2	22.4	5.5	29.6	14.7	6.3	24.7	12.8	13.5	22.8	11.5	16.7	20.6	23.5	15.3	27.0	13.1	23.4	27.9	8.3	14.5	22.7	6.0	14.3	30.2	11.4	7.8	6.7	10.7	46.1	30.1	48.9	6.8	55.2	9.0	282.9	66.0	181.4	122.2	54.9	68.3	74.9	81.6	93.3	38.8	68.8	68.2	75.5	104.3	108.2	77.5	100.6	73.2	48.0	10.0	9.2	1.7	9.3	11.0	17.7	16.7	17.6	13.9	9.7	15.0	16.3	110.5	125.0	431.2	88.2	186.8	75.7	105.2	29.1	57.5	18.6	50.2	39.9	215.2	91.5	71.6	40.5	41.7	36.7	336.8	143.3	5.9	83.4	258.9	155.6	327.0	121.5	63.5	37.0	51.2	69.6	27.6	119.6	170.2	323.6	279.5	65.6	75.7	53.7	79.2	13.5	13.0	57.8	36.7	147.1	276.3	166.3	77.6	257.9	99.6	290.4	197.3	45.8	252.4	123.6	13.2	101.2	118.7	63.6	205.8	77.0	68.6	10.5	60.1	17.9	85.5	139.6	117.4	23.3	37.2	77.6	79.0	23.4	269.7	30.5	61.7	179.6
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;intestine: 3.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7"	"Immune cell enriched"	"Detected in single"	8	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9"	"Group enriched"	"Detected in all"	5	"amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8"	"Group enriched"	"Detected in all"	5	"amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.3	0.3	5.3	1.4	13.5	0.6	0.5	0.0	8.5	0.4	0.0	3.7	0.5	1.3	0.1	0.5	0.5	0.9	0.2	7.7	0.0	1.3	0.8	1.8	1.9	0.0	0.1	0.4	0.2	0.4	1.0	1.1	0.0	0.4	3.8	0.6	0.3	0.4	0.2	0.5	1.4	1.3	0.0	1.2	0.5	0.3	0.0	0.9	0.5	0.0	1.6	0.6	0.3	0.3	1.3	1.0	1.3	0.8	0.4	0.1	4.2	0.9	0.4	1.2	1.5	10.9	3.3	1.0	2.0	0.7	0.1	0.4	2.8	0.2	1.1	2.0	2.4	3.3	2.0	0.9	0.1	0.4	0.4	0.4	0.1	0.8	0.0	2.1	0.4	2.4	0.4	0.7	0.7	0.8	2.7	0.2	1.0	0.1	0.5	3.3	0.5	0.2	1.9	1.2	3.3	1.4	1.1	0.1	0.2	3.8	1.0	0.2	0.6	1.4	4.2	0.1	1.7	2.2	2.6	2.4	0.9	0.4	0.2	3.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	5.3	13.5	0.0	8.5	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	6.4	2.4	1.6	2.8	0.9	1.3	0.5	1.2	7.4	1.8	1.4	1.6	1.5	0.2	0.0	8.4	0.6	15.6	5.1	0.0	0.6	2.6	0.5	1.4	1.9	0.0	2.7	17.2	0.2	1.9	2.1	0.5	1.0	67.6	0.9	0.4	0.7	0.5	8.4	5.5	28.7	0.0	0.3	2.9	0.9	0.0	1.2	1.8	0.0	0.3	0.9	16.5	3.0	1.6	0.8	2.2	0.0	6.4	1.2	0.8	1.4	0.2	7.7	0.0	2.2	0.8	0.5	4.9	0.1	0.9	0.7	12.4	0.3	6.2	0.9
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135467-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	9.0	56.6	15.8	6.4	16.3	10.9	6.7	17.7	20.7	8.1	11.5	19.1	29.8	6.4	5.7	4.2	6.8	9.9	6.7	16.0	16.7	8.1	24.4	6.6	11.2	15.3	16.2	9.8	42.0	4.0	4.3	4.0	15.3	14.0	18.9	7.6	4.6	6.4	15.9	2.8	16.5	5.9	16.7	9.6	5.3	8.8	17.0	11.9	5.9	14.4	7.6	8.7	5.6	15.8	1.2	2.1	7.8	3.8	4.4	9.0	5.4	3.3	5.3	5.5	7.3	2.8	2.2	0.1	6.1	5.7	4.1	0.1	2.3	3.6	4.0	0.0	3.3	8.0	2.7	12.2	6.1	0.4	2.5	7.8	2.4	3.6	4.6	5.1	5.8	4.6	1.4	11.7	5.3	2.1	3.6	2.1	27.2	0.8	2.9	7.3	5.1	0.1	23.5	27.2	0.1	2.7	4.5	0.4	11.1	4.5	1.8	17.1	2.1	2.5	3.5	7.5	8.3	10.5	0.1	2.0	6.3	8.1	5.9	15.2	1.9	0.3	8.1	3.8	12.8	3.7	11.1	11.0	2.4	5.5	17.6	11.0	0.5	4.4	4.7	0.1	4.3	6.0	15.8	16.3	17.7	20.7	16.0	16.7	15.3	16.2	15.3	16.7	17.0	15.8	11.7	19.2	9.1	88.8	16.4	6.2	6.5	0.8	6.8	22.3	10.1	13.2	10.4	177.3	1.6	5.5	16.7	8.2	18.0	22.1	19.6	35.7	8.2	31.6	13.4	6.5	1.2	63.8	44.7	4.2	10.2	7.4	6.1	35.6	10.8	22.9	9.7	39.9	8.6	8.4	79.1	14.8	10.2	20.8	9.9	2.7	8.4	12.9	1.8	68.4	9.8	38.2	25.7	123.6	62.7	2.2	33.2	5.7	3.4	8.2	13.6	26.5	1.4	13.2	0.0	12.6	6.9	4.6	10.0	7.0	4.1	4.7	23.9	26.0	22.0	4.9
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379815	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	13.6	10.4	0.1	1.5	0.1	3.1	12.3	0.2	1.0	10.2	0.1	11.7	5.4	12.3	0.0	11.6	11.0	0.0	10.0	0.1	0.1	8.8	12.5	10.3	0.3	0.1	0.1	10.9	10.5	1.5	7.5	0.4	0.1	9.5	0.1	0.3	11.2	1.1	23.0	14.6	12.8	0.4	0.0	13.3	10.7	7.4	0.1	1.8	10.1	2.5	0.2	10.7	10.2	0.1	18.2	12.2	8.4	5.6	2.6	2.3	12.2	10.1	7.1	7.2	7.2	19.4	10.6	19.9	10.2	8.9	6.8	8.5	5.1	12.3	0.4	17.9	12.8	21.1	11.7	18.8	4.3	28.0	8.0	4.5	2.7	7.8	0.0	0.6	7.3	11.5	15.1	6.4	2.3	23.7	15.1	5.7	17.8	9.7	15.8	12.1	12.3	16.8	0.0	22.5	10.5	11.4	13.0	9.9	8.9	1.5	4.3	2.2	18.8	12.4	10.1	7.0	21.0	12.9	12.8	21.0	9.8	10.4	11.5	0.0	4.4	0.9	4.4	4.6	4.7	3.8	4.0	4.8	6.5	4.2	2.9	3.6	0.3	4.1	6.3	4.4	5.6	3.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	25.6	12.8	28.1	17.0	24.6	19.2	21.0	14.5	19.9	14.7	16.0	14.7	18.0	10.0	22.3	12.9	27.1	30.0	25.9	26.0	5.9	18.9	3.6	22.8	24.1	20.9	10.8	28.2	14.4	21.6	23.9	17.6	20.9	39.9	30.4	14.3	10.4	13.8	13.1	21.9	14.0	21.9	2.0	13.5	16.1	2.7	19.0	19.8	12.4	10.3	21.3	16.5	12.3	12.1	15.3	18.6	13.1	13.9	25.6	16.7	14.8	9.7	22.1	19.5	6.6	26.3	22.5	19.6	23.2	21.3	16.1	40.2	25.6	15.4	22.6	20.9
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940840-92110673	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	7.1	8.3	8.6	6.2	9.0	8.6	11.0	15.3	14.1	6.5	15.5	16.0	16.5	6.4	3.9	7.9	8.4	10.4	6.5	8.6	11.0	13.2	16.2	7.8	5.8	8.8	9.6	11.9	9.5	12.7	8.6	5.4	9.0	7.5	14.6	31.4	9.6	3.8	16.2	6.8	18.6	4.0	7.7	5.0	9.4	4.1	11.9	9.3	9.3	10.0	5.3	5.5	7.2	9.7	11.7	8.1	9.6	5.8	11.6	11.3	6.2	8.7	6.3	4.9	5.9	10.3	8.0	9.2	12.5	7.3	7.5	8.3	10.5	5.6	9.2	9.8	8.2	10.9	11.6	7.3	4.0	18.5	9.6	6.2	6.2	9.1	8.8	7.7	10.3	10.6	19.3	13.0	7.4	14.1	10.4	7.0	8.3	6.5	8.4	7.6	18.2	6.2	4.9	11.5	13.3	11.0	19.0	16.9	10.1	11.1	5.1	9.8	17.5	9.5	11.2	14.5	12.6	7.3	13.0	13.6	6.2	7.8	9.4	1.1	0.6	0.9	1.3	0.6	0.9	1.9	1.1	1.1	0.4	1.6	1.2	1.0	0.7	1.2	0.6	3.2	1.0	0.2	8.6	9.0	15.3	14.1	8.6	11.0	8.8	9.6	9.0	7.7	11.9	9.7	123.3	525.6	357.0	141.3	143.3	103.5	126.5	112.6	170.8	273.5	165.4	150.9	253.2	297.4	208.4	176.6	2230.9	141.4	201.5	293.4	101.8	131.0	22.5	392.3	157.7	115.9	185.1	129.4	142.6	92.6	81.9	123.5	152.9	185.0	136.6	386.1	98.2	153.5	57.2	360.1	182.6	350.8	136.3	78.3	88.4	17.5	173.4	101.6	58.7	115.2	121.5	155.7	119.4	169.9	187.1	102.4	218.9	135.8	193.5	91.4	298.5	47.2	506.3	1279.6	138.1	206.1	116.1	83.0	129.0	87.3	111.8	333.8	145.7	135.8	171.4	97.6
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 3039.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 649.2;Cytotrophoblasts: 1105.1;Extravillous trophoblasts: 1284.9;Ionocytes: 697.8;Syncytiotrophoblasts: 2022.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 1667.3;BJ hTERT+: 3096.2;RPTEC TERT1: 1447.8;U-87 MG: 1343.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	65.1	3039.1	83.1	38.4	89.3	21.9	52.3	91.8	97.4	41.4	80.9	40.1	20.5	42.4	44.0	28.2	38.7	40.2	208.2	84.1	92.5	218.0	19.3	55.0	74.6	101.6	96.9	60.5	34.4	111.2	76.5	203.7	104.9	34.4	30.9	36.5	41.9	332.7	330.0	26.6	50.8	39.6	91.4	62.8	51.4	44.9	88.7	54.9	44.3	396.9	62.5	67.3	35.0	101.4	184.2	1667.3	186.5	261.4	785.9	212.3	494.6	177.2	3096.2	259.3	335.0	75.8	170.6	0.0	79.2	301.5	1143.3	78.6	204.0	175.3	206.6	65.2	168.2	93.4	225.0	230.1	1117.9	0.1	0.8	196.9	133.4	367.6	98.3	252.8	370.3	181.1	0.1	62.4	292.4	3.5	283.3	131.0	309.2	13.9	1.8	292.9	116.5	138.8	1447.8	915.5	137.1	301.6	1261.5	1.5	134.3	121.3	0.6	140.6	289.6	254.5	116.0	22.7	195.6	168.2	196.9	470.0	1343.5	0.7	153.0	125.7	106.4	5.6	147.6	72.3	135.2	133.0	124.7	144.5	145.3	121.7	162.9	156.7	8.5	119.7	39.2	20.4	94.9	230.2	83.1	89.3	91.8	97.4	84.1	92.5	101.6	96.9	104.9	91.4	88.7	101.4	34.1	12.8	19.4	9.1	50.3	20.6	55.3	66.1	20.5	36.2	11.7	27.9	202.4	25.8	26.4	649.2	8.4	1105.1	35.1	2.3	164.4	112.7	5.0	6.1	20.9	50.9	31.0	20.2	10.5	41.5	1284.9	100.3	20.4	5.9	53.8	59.8	82.1	2.6	394.1	72.3	18.7	15.1	697.8	172.8	53.9	14.5	79.2	127.7	30.2	14.0	76.3	49.3	66.9	5.5	12.4	51.0	4.5	77.5	72.6	25.6	0.3	60.2	24.9	24.1	59.2	98.9	54.5	22.6	100.2	10.5	11.6	2022.4	49.9	70.5	6.7	54.2
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 711.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		950000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	33.3	67.9	45.3	17.5	48.0	25.0	33.8	47.4	44.2	57.2	66.2	46.4	81.1	34.7	22.4	47.8	48.4	29.1	39.1	45.9	46.1	76.7	62.7	24.6	25.3	48.8	49.4	45.7	47.9	32.7	32.6	19.0	44.9	31.6	27.5	16.0	31.4	27.7	55.4	37.1	56.8	22.6	49.2	28.3	42.7	33.1	48.2	31.3	28.6	39.6	20.5	29.6	38.5	54.1	65.3	40.2	43.3	40.2	67.0	64.7	28.8	47.6	57.6	65.0	58.2	51.5	53.6	46.8	49.6	64.2	36.6	50.8	48.7	71.5	30.5	37.5	77.4	29.4	37.5	83.3	51.9	32.9	22.9	64.8	55.5	50.0	30.6	61.5	55.8	60.2	43.6	42.6	67.7	64.9	64.2	31.9	12.4	90.8	50.1	66.7	54.0	83.2	64.2	28.3	80.9	30.2	51.8	46.1	84.6	24.6	91.9	112.7	44.2	40.6	42.7	44.0	36.2	51.4	34.8	57.9	87.6	74.4	58.5	0.7	82.2	40.6	61.4	69.7	71.7	63.8	54.4	54.2	113.5	57.6	61.7	54.1	9.5	69.4	54.1	98.8	78.9	73.7	45.3	48.0	47.4	44.2	45.9	46.1	48.8	49.4	44.9	49.2	48.2	54.1	47.6	16.0	22.3	15.3	42.6	24.3	73.2	56.4	37.5	33.1	94.6	98.8	27.7	98.7	31.7	77.3	6.2	167.5	52.8	95.0	254.3	64.0	94.6	85.8	35.8	35.3	99.7	33.4	8.6	36.2	99.8	67.9	44.9	33.4	10.2	62.5	43.2	90.6	104.6	21.9	7.5	97.9	46.8	58.4	34.2	57.6	77.3	47.6	53.4	5.6	64.6	128.7	63.8	5.5	9.2	39.4	131.5	67.7	36.3	39.3	273.8	711.5	61.0	30.1	46.0	57.8	54.4	56.3	24.9	76.0	34.1	102.6	40.4	88.4	136.4	62.3
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 457.4;Excitatory neurons: 756.1;Inhibitory neurons: 514.5;Microglial cells: 414.1;Oligodendrocyte precursor cells: 633.3;Oligodendrocytes: 475.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (9.27e-4)"	19.3	9.7	13.4	6.0	17.0	3.8	15.5	59.9	36.6	20.0	0.0	24.5	2.6	22.7	8.6	5.9	20.3	8.2	11.8	22.8	5.6	11.2	4.7	15.3	5.9	1.2	3.9	26.4	4.5	7.4	13.9	13.1	7.4	15.8	4.9	17.0	5.1	15.6	5.9	6.3	11.8	15.7	0.8	8.1	10.2	9.7	20.3	7.0	14.4	11.5	4.6	18.8	14.8	31.1	30.8	7.2	31.0	0.4	16.9	20.6	13.9	20.8	22.5	11.8	12.9	1.1	13.9	0.5	3.0	28.9	12.1	1.2	16.3	8.5	18.9	9.0	15.3	1.0	1.0	0.3	11.7	0.6	6.5	11.3	0.3	15.5	16.9	30.3	30.2	7.2	0.5	1.1	9.0	0.9	7.6	3.3	14.4	0.3	5.1	4.2	19.7	0.6	4.8	4.1	31.4	41.9	1.3	0.5	40.1	19.1	1.9	21.5	25.6	22.7	17.7	1.1	19.5	4.6	4.6	7.1	19.4	5.2	25.3	1.3	0.8	0.1	0.6	0.1	1.1	0.6	0.6	0.6	0.3	0.8	0.6	0.7	0.7	1.4	0.3	0.5	0.1	0.3	13.4	17.0	59.9	36.6	22.8	5.6	1.2	3.9	7.4	0.8	20.3	31.1	65.4	3.2	2.2	457.4	22.2	2.4	15.0	1.3	17.1	43.6	6.1	5.1	5.4	4.3	2.7	27.6	33.3	11.0	24.4	0.0	0.0	11.6	82.8	1.7	35.5	43.7	0.0	5.0	756.1	1.7	8.0	27.9	2.6	1.1	5.1	29.7	48.2	0.6	2.9	42.1	514.5	0.0	2.0	10.5	12.5	72.8	27.4	9.5	7.2	414.1	8.6	20.1	19.6	633.3	475.9	0.7	0.0	35.3	14.4	27.0	0.0	6.9	0.3	35.0	19.7	40.1	35.6	15.0	14.6	1.7	1.7	12.4	27.8	8.3	0.0	12.2
AKTIP	"FLJ13258, FTS"	ENSG00000166971	"AKT interacting protein"	Q9H8T0	16	53491040-53504411	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 168.3;Late spermatids: 325.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041794, HPA046300"	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041794: AB_2677677, HPA046300: AB_2679619"	"unprognostic (2.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"prognostic favorable (1.18e-14)"	"unprognostic (2.39e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.31e-1)"	29.3	20.5	46.9	15.7	48.9	32.1	24.7	47.8	55.7	24.5	42.0	30.2	15.5	22.3	31.6	33.2	21.4	17.4	55.3	50.9	47.2	37.1	31.8	24.4	22.5	51.5	46.9	30.4	17.3	44.9	29.0	30.2	52.8	24.7	17.8	76.9	20.5	31.0	134.9	26.9	20.0	25.7	47.6	15.5	21.2	44.0	47.5	13.2	31.7	81.4	24.2	25.1	26.1	48.9	40.2	25.7	17.2	22.7	22.8	17.2	50.5	24.7	18.6	21.5	5.3	35.0	20.6	6.6	14.9	25.4	16.2	34.0	14.9	20.0	28.8	9.7	23.6	1.9	13.6	28.1	29.6	9.2	17.1	14.6	55.1	21.4	18.4	31.2	37.1	13.4	3.6	14.1	19.2	31.2	8.0	13.7	11.9	19.2	24.6	9.6	28.5	30.3	28.4	33.2	13.5	16.8	14.9	52.4	22.4	22.9	46.7	5.7	35.2	23.1	25.1	15.2	24.4	20.6	19.6	13.5	24.9	8.1	15.0	22.3	4.5	11.0	32.4	3.4	19.5	9.1	31.1	33.9	2.0	13.7	47.7	39.3	29.3	27.1	3.4	3.0	46.4	19.1	46.9	48.9	47.8	55.7	50.9	47.2	51.5	46.9	52.8	47.6	47.5	48.9	41.9	25.6	15.4	11.8	9.3	7.0	15.1	29.0	5.7	28.4	17.9	11.9	32.2	17.2	25.4	23.9	16.7	80.3	13.6	15.0	82.2	29.8	168.3	11.2	7.1	22.2	6.0	3.6	19.4	20.5	44.3	16.4	8.2	12.9	3.8	9.6	26.0	26.3	13.3	21.9	20.2	6.5	44.7	7.0	5.6	325.9	14.0	6.2	23.2	7.5	8.0	58.8	28.8	8.5	21.5	20.6	6.0	38.4	12.2	15.0	36.2	38.2	22.0	27.3	6.6	22.1	22.2	16.1	40.4	11.2	12.8	77.3	28.7	8.4	11.5	19.0
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386312-113401290	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 209.8"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 147.8;Granulosa cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced		Approved	Cytosol		NA	NA		44000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	54.7	153.9	73.5	16.8	82.7	82.2	23.2	75.2	84.7	18.4	53.6	25.7	29.5	16.3	26.6	35.0	15.6	27.4	51.9	66.0	74.5	73.2	209.8	20.6	15.6	85.4	83.5	28.9	46.5	73.2	15.9	24.9	84.5	34.1	24.5	19.0	98.6	24.2	28.8	38.9	26.6	17.6	80.1	13.6	50.4	13.1	81.1	20.3	25.9	23.9	18.7	18.4	19.3	83.7	8.1	14.8	11.0	15.7	71.2	48.4	67.8	21.9	35.4	13.7	17.2	19.2	16.7	11.7	12.7	30.3	11.0	29.1	8.1	14.6	8.3	29.5	10.2	22.0	18.2	26.2	16.4	21.2	19.0	41.2	10.8	12.7	5.5	53.9	27.1	18.6	8.9	16.5	23.7	61.8	23.8	21.2	5.4	57.9	27.4	19.5	18.7	19.8	21.4	16.6	10.2	9.4	27.2	32.5	20.1	19.2	34.1	23.7	30.7	12.5	9.3	25.1	12.4	23.8	26.0	9.8	34.1	18.9	13.6	10.2	13.7	23.6	11.3	15.5	6.0	6.8	9.3	6.0	14.6	10.2	8.7	9.9	6.2	6.9	17.4	6.0	10.8	9.7	73.5	82.7	75.2	84.7	66.0	74.5	85.4	83.5	84.5	80.1	81.1	83.7	7.2	16.0	15.6	18.6	10.4	7.0	8.9	7.1	8.0	12.9	16.7	11.6	50.3	25.8	12.0	14.7	27.1	48.2	7.4	27.7	13.7	20.3	5.4	17.7	9.2	11.5	9.1	147.8	10.0	26.3	23.2	10.2	15.3	27.7	14.5	86.5	11.0	70.0	17.0	5.0	10.7	12.5	10.2	15.1	6.4	10.8	11.8	12.4	12.4	9.4	12.4	6.4	8.2	7.1	20.0	15.0	35.3	14.7	11.0	7.6	32.6	59.0	10.6	15.7	6.6	8.9	24.6	6.8	9.5	22.6	9.1	11.4	8.8	11.7	16.7	9.2
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 720.5;liver: 548.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 233.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 233.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	34.5	720.5	24.8	23.9	25.1	176.7	28.7	37.9	82.5	20.5	35.7	43.6	44.9	19.0	28.1	36.4	15.3	32.7	116.2	26.6	28.1	45.7	548.8	47.8	22.9	27.2	25.4	17.1	19.6	60.3	15.7	36.8	33.2	23.1	41.6	20.6	42.8	27.2	110.9	24.3	39.3	23.9	24.9	19.5	45.9	18.6	31.8	23.5	22.1	106.6	28.2	73.8	23.5	28.3	36.2	55.0	38.0	35.4	57.9	43.1	103.1	51.8	47.7	67.6	65.3	73.6	66.2	33.6	12.7	36.4	137.0	20.9	55.1	42.6	54.7	65.9	21.6	43.2	41.2	56.4	81.8	70.8	83.0	54.0	39.1	107.7	35.7	25.0	62.8	57.7	25.8	27.0	62.4	29.5	33.9	107.3	33.0	41.1	93.4	20.0	23.9	53.3	59.8	213.9	20.2	13.3	83.9	40.9	47.2	30.5	23.5	99.9	45.7	37.6	37.1	78.5	76.2	39.5	73.8	50.5	42.1	75.5	61.1	233.9	33.4	103.2	22.9	42.9	37.4	23.1	23.9	26.0	29.8	21.5	21.1	23.3	49.6	30.9	39.0	17.1	35.7	25.1	24.8	25.1	37.9	82.5	26.6	28.1	27.2	25.4	33.2	24.9	31.8	28.3	28.4	35.3	60.3	5.2	14.9	17.3	17.2	36.1	15.9	16.6	28.6	19.6	107.5	25.8	37.7	23.9	4.2	81.9	25.1	68.5	56.7	35.5	10.2	20.2	9.3	27.6	34.6	11.2	6.2	31.3	28.2	19.6	42.3	25.3	95.4	13.1	18.5	243.1	69.1	11.8	6.2	24.3	34.6	13.0	20.8	4.1	13.4	36.4	5.4	8.4	49.1	9.7	11.3	4.0	8.4	42.3	28.1	16.6	14.0	16.0	35.6	36.1	40.6	9.2	13.1	9.1	27.5	25.5	22.3	21.4	16.2	309.2	25.1	187.2	24.3	26.4
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453225-49471050	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved					NA	NA		600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	18.5	14.1	3.0	9.7	3.4	10.0	14.5	3.5	3.8	17.7	3.6	13.9	13.9	15.9	0.8	15.5	12.9	3.5	8.5	2.9	3.3	14.1	17.1	11.7	10.4	4.5	3.8	11.3	18.6	3.8	7.5	5.0	3.6	10.3	2.3	1.0	10.8	4.9	7.0	16.2	19.1	3.2	3.9	28.3	14.1	5.2	4.2	4.9	12.4	1.8	4.9	12.9	13.8	4.0	24.6	32.7	7.8	18.4	3.5	2.3	26.3	15.5	4.9	11.8	12.1	17.1	9.3	36.8	24.9	2.1	2.8	16.7	3.1	8.9	1.5	23.3	19.0	28.7	13.1	24.6	5.1	17.6	61.3	4.3	5.0	5.7	4.6	2.4	7.7	12.5	20.7	37.3	3.1	24.8	12.8	51.9	17.1	10.6	0.0	21.8	11.1	28.1	5.7	28.7	14.1	16.1	13.9	15.4	13.4	1.9	14.0	20.3	17.4	17.4	11.3	8.0	17.4	31.4	38.2	10.7	4.3	24.9	12.6	11.2	10.9	18.6	9.3	26.0	9.8	17.1	9.1	10.1	16.4	17.1	8.4	8.8	1.8	8.6	29.8	17.4	7.9	8.1	3.0	3.4	3.5	3.8	2.9	3.3	4.5	3.8	3.6	3.9	4.2	4.0	22.3	6.4	11.5	1.0	27.2	9.9	28.6	19.2	21.1	9.2	10.8	8.6	4.0	12.8	15.5	11.0	8.4	33.7	19.5	27.6	5.9	22.0	1.5	6.3	6.3	16.9	13.1	20.0	1.3	24.5	28.7	16.3	21.4	8.0	17.2	12.9	15.4	17.4	46.2	1.7	1.2	16.6	20.3	29.9	14.7	2.9	28.0	20.2	16.0	3.7	31.4	6.4	15.5	1.5	4.2	14.0	26.0	8.2	17.6	9.1	43.8	22.9	24.3	7.0	19.7	7.2	15.8	3.6	13.1	19.7	10.5	40.4	13.8	27.6	23.7	28.3
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 857.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.0;myeloid DC: 213.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.2;monocytes: 212.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved					NA	NA		2200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	303.8	102.4	139.7	39.8	146.1	29.2	77.2	136.5	163.5	25.0	123.3	73.3	73.7	30.1	21.3	73.6	32.3	37.4	111.3	132.2	139.7	177.7	857.7	111.6	18.7	140.7	144.9	42.0	23.3	2.6	23.3	7.0	141.1	34.6	72.3	29.2	32.4	29.5	130.8	127.9	74.8	30.2	143.0	20.6	101.5	13.0	151.8	27.1	30.8	165.7	52.9	50.0	29.0	144.5	8.8	13.1	18.7	31.9	86.8	13.0	60.9	9.3	16.8	4.3	3.1	23.5	12.1	0.5	45.3	20.8	11.9	16.2	0.1	4.6	2.7	0.6	6.1	0.7	8.4	64.7	97.0	0.9	0.9	23.9	22.6	14.8	0.3	17.7	26.9	0.9	17.9	3.0	4.1	0.5	1.0	23.4	24.8	152.2	2.1	0.6	0.4	1.9	31.4	0.6	7.5	23.1	22.8	201.0	0.2	33.7	20.3	92.1	1.1	0.4	16.5	0.6	0.4	5.5	3.0	25.7	22.0	0.8	0.4	6.5	212.0	51.1	0.7	93.0	0.9	6.2	0.3	0.7	213.2	5.2	0.7	0.5	10.7	3.4	25.4	70.6	0.5	123.5	139.7	146.1	136.5	163.5	132.2	139.7	140.7	144.9	141.1	143.0	151.8	144.5	27.7	147.4	242.7	51.2	22.6	60.0	205.2	311.1	80.8	78.7	35.0	23.7	378.9	165.8	243.1	66.2	18.8	62.4	48.6	260.3	399.2	127.5	4.3	27.8	24.5	66.2	55.2	42.1	11.7	218.0	127.5	103.1	200.3	47.7	30.9	29.0	139.6	857.0	129.2	35.3	18.2	231.0	101.7	278.5	124.1	10.6	79.9	189.3	35.6	26.2	940.8	130.2	8.2	14.1	6.8	130.2	366.5	149.0	12.5	84.4	384.3	882.0	89.4	42.6	46.0	46.0	67.6	3.0	3.9	105.1	124.7	42.1	13.1	81.0	272.6	150.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 311.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	119.2	105.5	49.6	29.8	51.0	24.8	76.8	49.3	60.3	51.5	62.5	45.7	54.8	38.6	93.4	105.6	50.2	32.0	48.2	47.4	57.5	142.4	206.5	38.5	40.3	50.5	52.1	53.6	44.0	81.9	39.9	38.0	51.4	65.3	50.6	46.4	104.1	45.6	93.6	54.7	48.6	42.0	50.7	37.9	39.5	63.4	49.3	39.0	123.0	56.4	60.1	39.4	43.9	55.6	55.7	53.5	48.7	44.1	152.1	132.8	40.7	71.9	101.5	70.8	61.0	33.4	40.7	0.1	67.1	64.8	34.9	42.8	40.0	70.3	83.0	25.9	50.6	35.3	34.7	36.5	78.2	56.0	36.1	86.0	34.8	75.2	62.5	97.8	62.2	45.9	56.9	48.4	111.7	33.4	37.6	57.6	71.3	145.1	64.7	31.7	62.0	74.3	92.5	52.0	57.7	39.8	51.4	57.1	67.4	65.6	108.8	84.0	61.9	42.5	41.5	52.4	37.1	44.7	62.5	54.8	47.9	52.6	41.7	61.8	35.2	50.9	45.5	37.7	48.8	49.9	43.8	49.6	34.5	46.8	43.8	50.4	51.3	43.0	45.3	21.6	69.8	45.6	49.6	51.0	49.3	60.3	47.4	57.5	50.5	52.1	51.4	50.7	49.3	55.6	56.2	16.0	47.6	12.7	43.3	32.6	43.3	43.8	68.3	25.0	83.0	54.6	46.5	55.8	36.8	51.5	22.9	48.5	39.3	43.9	97.8	42.9	45.4	27.7	39.1	49.4	55.8	28.2	5.6	37.0	76.4	60.6	36.2	20.4	38.0	60.9	59.3	158.8	61.9	13.5	8.3	56.9	32.6	59.1	24.9	39.8	95.4	43.8	56.9	6.5	34.6	311.5	39.1	12.1	12.2	32.2	33.1	115.5	34.8	39.6	80.3	204.4	59.4	28.9	26.3	32.5	40.1	85.6	49.9	123.8	51.9	38.2	43.7	148.4	63.6	28.3
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 26754.8;tongue: 9180.4"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 3267.9;Extravillous trophoblasts: 2322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004177, CAB006252"	Supported		Approved	Cytosol		NA	NA		640000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	569.3	696.4	616.8	443.1	697.4	732.5	512.6	617.3	719.7	566.0	617.0	774.1	517.9	533.7	201.0	1302.0	449.7	420.5	2286.1	731.9	652.0	709.0	217.1	425.6	358.2	762.3	654.0	510.4	390.5	943.1	525.1	351.4	763.9	457.7	400.1	465.2	904.9	597.6	26754.8	643.4	488.3	465.2	545.5	417.5	595.0	138.7	657.8	280.9	454.5	9180.4	478.3	761.8	740.3	558.7	2206.1	1620.4	477.9	1542.8	714.6	808.5	1520.8	1297.9	1336.2	1291.6	1603.0	1158.1	1643.6	1487.6	2072.2	1318.6	708.6	1632.6	966.8	2829.1	939.3	658.5	1272.9	1219.3	1202.7	2591.1	1112.5	1793.8	1251.3	1115.7	979.6	1455.4	968.9	2119.7	965.4	686.9	1070.0	951.1	1393.4	3136.7	1100.2	1477.0	1192.8	848.1	1346.6	1613.9	765.2	3353.2	1629.4	1230.5	950.7	668.5	808.6	3368.5	1213.9	591.2	1433.0	1194.7	1162.5	1892.3	750.3	1046.7	1430.0	1861.5	1387.3	1369.3	3524.5	1715.9	1532.9	2050.6	2694.7	2081.7	1008.7	2466.5	1138.1	908.5	1091.7	1047.0	2182.7	877.9	1027.4	996.9	2531.7	819.9	2780.2	824.0	1476.3	4372.2	616.8	697.4	617.3	719.7	731.9	652.0	762.3	654.0	763.9	545.5	657.8	558.7	17.0	12.8	32.4	83.2	281.2	792.0	716.4	3267.9	784.8	387.4	34.4	21.6	1968.4	273.1	1385.1	42.3	118.9	1194.1	107.9	1834.8	111.6	120.9	258.8	15.8	11.8	261.1	323.9	215.8	66.2	76.2	2322.1	329.7	513.3	16.1	196.5	18.7	289.5	102.0	1181.9	733.6	70.0	755.1	1265.4	632.2	715.4	1152.4	380.8	388.8	924.9	50.6	417.7	662.1	328.5	40.2	60.8	126.2	1497.1	405.1	409.4	676.9	1755.7	75.8	700.9	298.9	486.4	680.9	572.9	25.8	123.6	1174.6	684.5	1361.3	294.3	15.2	937.7	1146.2
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5736.6;kidney: 7181.0;liver: 11160.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.3	1.4	0.4	17.0	0.7	0.0	0.7	1.0	2.3	0.2	0.0	30.1	4073.8	2.8	1.0	0.7	0.4	176.9	1.0	2.4	0.0	7181.0	11160.8	0.5	4.9	0.0	0.0	0.5	292.7	0.0	5.6	0.4	0.0	2.1	5.6	0.3	0.3	0.0	0.4	0.5	5736.6	7.0	0.0	2.0	34.3	1.1	0.0	0.7	0.3	0.0	0.8	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.4	0.0	0.1	0.7	2.8	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	3.9	0.0	0.0	0.1	0.0	4.4	6.8	0.0	0.0	0.0	1.3	0.0	10.9	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.9	0.0	0.1	1.2	2.7	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.7	2.8	1.5	3.9	4.4	6.8	10.9	2.9	2.7	2.1	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708023	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: AB_2678803, HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	2.7	2.7	2.8	1.8	3.2	1.2	3.5	3.9	3.5	3.4	2.7	2.8	2.5	2.3	2.1	2.6	2.9	2.2	4.1	3.0	3.5	3.0	3.6	2.2	3.5	2.8	3.2	2.9	2.6	3.3	1.5	3.9	2.9	3.1	3.4	2.9	2.1	3.1	5.7	2.6	2.1	2.9	3.0	2.3	2.5	3.0	3.2	4.4	3.1	7.4	4.1	3.1	2.2	3.3	5.2	7.5	6.0	4.1	6.3	6.8	7.4	5.3	6.8	11.3	12.7	7.7	3.1	7.9	2.9	4.8	5.3	4.5	13.2	5.7	13.2	5.4	5.1	4.2	4.0	6.4	8.9	4.5	2.6	5.8	9.2	6.6	10.5	5.0	9.4	6.1	6.6	4.4	6.1	8.1	6.0	5.7	6.6	7.7	9.6	6.0	6.0	5.3	6.4	4.5	7.6	5.7	4.3	4.5	5.7	4.9	10.9	4.5	4.3	4.7	4.7	5.2	4.3	5.4	9.4	7.6	3.2	6.3	4.7	10.7	3.0	1.4	2.9	3.5	2.4	3.4	2.7	2.8	3.0	2.7	2.8	2.2	0.8	3.6	2.4	1.6	3.3	2.2	2.8	3.2	3.9	3.5	3.0	3.5	2.8	3.2	2.9	3.0	3.2	3.3	6.5	0.0	3.9	13.1	7.3	8.4	5.7	6.2	6.8	4.1	5.4	4.4	7.5	1.5	4.5	1.8	2.1	9.9	3.5	4.2	9.8	6.2	4.8	4.4	4.5	5.7	2.4	4.2	15.9	7.0	8.8	5.5	2.6	3.8	9.5	6.1	2.2	3.9	7.6	0.0	15.8	4.9	6.1	5.2	5.0	4.2	6.5	7.7	5.4	5.6	6.6	7.8	4.1	16.1	19.4	6.8	1.5	5.3	4.9	4.5	7.0	6.5	5.5	5.3	6.6	4.2	5.6	21.1	15.9	4.4	5.4	12.2	5.6	5.1	4.8	3.7
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALPP	"PALP, PLAP"	ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378724-232382889	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 17.8;placenta: 34.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 381.0;SiHa: 103.6"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	42.9	0.0	0.1	0.0	0.1	381.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	103.6	35.3	0.0	3.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	6.7	0.1	0.2	0.0	0.0
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 10947.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.7	0.2	0.1	0.0	0.1	0.0	6.4	0.3	0.4	0.2	0.3	0.3	2.3	0.1	0.4	0.3	0.4	160.4	0.5	0.1	0.1	11.0	10947.9	0.3	0.0	0.1	0.1	0.2	125.3	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.3	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
AMY2B	AMY2	ENSG00000240038	"Amylase alpha 2B"	P19961	1	103553815-103579534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	122	"pancreas: 31246.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 61.2;Exocrine glandular cells: 148.0;Inhibitory neurons: 48.4;Oligodendrocytes: 41.8"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.8;EFO-21: 10.3"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		77000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	35.4	24.8	29.5	11.2	34.8	13.4	34.9	39.9	38.6	40.8	19.7	33.0	16.5	22.7	20.2	13.1	50.3	14.1	40.9	27.9	29.5	59.4	39.0	30.2	20.0	27.7	29.1	40.0	31246.7	14.9	36.8	6.9	27.1	35.3	11.9	69.8	256.2	14.6	63.7	42.6	31.7	9.8	26.3	34.8	18.1	5.2	30.6	12.6	63.5	25.2	13.8	29.3	25.8	30.0	0.0	0.5	1.1	0.0	5.6	9.8	1.1	0.8	0.8	0.6	1.5	0.0	0.2	1.0	10.3	0.3	0.0	1.2	0.1	1.3	1.4	1.3	1.6	1.9	4.5	0.8	0.8	2.5	2.6	6.7	6.7	0.8	1.2	1.8	0.2	3.0	0.0	3.2	0.9	0.0	1.9	0.5	0.1	0.1	1.4	0.5	0.0	4.7	5.7	2.0	2.8	0.6	2.4	1.1	0.8	1.8	0.1	1.4	0.8	0.3	0.9	0.5	0.7	3.5	0.1	0.3	1.9	1.8	0.2	0.0	5.0	1.0	0.4	2.5	0.3	1.0	0.1	0.2	1.6	0.9	0.6	0.2	1.2	0.1	2.2	0.5	0.2	1.2	29.5	34.8	39.9	38.6	27.9	29.5	27.7	29.1	27.1	26.3	30.6	30.0	2.8	12.8	20.1	56.2	3.2	4.7	4.2	1.4	0.6	11.7	2.9	2.7	7.2	2.8	11.2	1.8	33.3	0.4	2.4	3.6	0.0	1.3	7.3	1.1	0.6	2.7	4.9	1.3	61.2	148.0	0.4	3.2	2.0	0.7	3.8	0.5	2.2	6.5	1.6	10.1	48.4	2.5	0.0	9.4	3.5	2.7	2.5	3.4	5.4	11.2	4.0	3.1	2.1	22.1	41.8	1.3	2.7	1.9	1.4	1.5	4.3	0.8	14.6	15.4	0.0	1.0	2.5	1.5	0.9	0.4	3.0	0.3	1.7	0.4	2.2	1.6
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	14.4	19.0	11.8	14.0	14.3	12.6	15.7	12.7	16.1	20.1	11.8	18.8	10.6	21.4	16.7	36.2	18.0	11.4	22.7	13.0	12.9	18.6	13.3	13.7	18.0	12.3	11.7	16.7	14.1	24.9	14.7	8.5	12.4	18.5	16.2	13.2	20.5	17.5	33.8	18.0	14.5	21.1	12.4	16.6	15.7	30.1	12.1	24.0	20.2	24.9	20.7	19.0	24.8	12.8	49.7	66.8	47.8	40.9	48.8	24.6	27.4	33.9	30.6	61.1	42.2	68.5	30.8	78.6	33.5	45.8	35.2	49.1	71.8	46.5	61.8	42.0	57.8	69.3	46.0	57.3	35.5	62.5	31.6	27.0	32.7	53.0	35.0	43.6	60.1	55.2	110.7	16.4	48.7	53.0	95.6	46.7	42.0	48.1	57.6	72.8	47.2	93.1	41.4	62.5	61.8	35.4	53.2	41.2	57.3	41.9	87.1	56.0	38.2	36.3	34.1	32.6	40.6	27.4	59.5	105.6	40.5	52.6	42.9	20.2	12.1	20.5	18.2	17.2	21.7	14.3	19.6	17.7	20.1	18.7	16.1	17.5	9.3	24.3	15.9	10.9	26.1	14.4	11.8	14.3	12.7	16.1	13.0	12.9	12.3	11.7	12.4	12.4	12.1	12.8	13.1	16.0	18.4	17.6	12.9	10.1	19.6	16.5	13.1	18.5	12.8	11.6	17.5	10.0	22.6	12.9	20.9	12.4	10.7	9.2	11.7	16.9	7.6	22.8	18.6	15.7	10.8	33.6	28.1	15.2	10.1	16.9	16.3	15.3	15.8	42.5	11.7	13.4	22.4	21.9	22.6	10.8	32.6	17.9	6.6	12.7	18.3	12.5	17.8	13.1	14.7	16.1	11.3	22.6	29.3	16.2	8.9	21.8	11.4	20.0	7.3	15.0	18.4	22.9	13.1	15.9	16.2	74.1	42.2	38.3	13.4	7.3	14.0	32.4	14.9	17.5
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015867	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	7.5	6.6	13.1	6.9	14.9	6.4	10.4	11.1	14.7	7.9	9.2	6.6	5.2	8.6	8.1	5.9	7.4	6.1	5.8	12.8	11.1	7.7	8.0	6.6	10.5	10.6	10.8	10.8	6.7	7.8	6.2	6.5	10.1	8.2	6.4	9.2	6.0	6.2	7.3	9.1	7.2	7.1	10.1	9.8	6.3	5.5	13.1	10.2	8.1	7.1	9.2	7.1	6.3	11.6	12.2	9.6	15.2	13.2	11.5	16.8	13.6	9.8	16.3	15.4	15.3	6.3	8.9	11.8	8.8	9.7	8.5	9.4	17.8	9.4	15.5	22.3	10.6	11.9	7.4	6.3	12.5	11.8	13.6	10.4	11.9	12.1	12.2	13.1	13.2	10.4	13.9	11.8	18.0	4.0	13.6	7.9	36.4	6.6	6.8	6.9	27.4	12.4	12.1	8.2	7.5	21.7	11.9	15.7	18.3	16.2	12.2	8.6	9.8	12.7	6.7	15.7	15.1	8.6	8.9	7.9	14.2	8.7	11.9	6.6	4.4	5.9	5.1	4.3	6.5	5.7	6.4	5.4	5.5	3.5	6.7	5.7	2.7	10.9	3.5	3.3	8.9	5.2	13.1	14.9	11.1	14.7	12.8	11.1	10.6	10.8	10.1	10.1	13.1	11.6	23.1	48.1	9.8	26.8	23.8	6.9	8.5	11.7	12.5	21.2	14.6	10.2	15.2	17.2	14.5	12.9	10.4	14.8	26.2	7.6	11.7	10.3	1.5	11.3	19.8	15.9	6.7	18.1	33.2	10.5	15.0	18.0	14.3	11.7	17.1	28.8	16.1	12.5	11.8	28.6	26.3	8.4	14.2	20.4	10.5	2.6	15.5	17.1	3.6	30.0	17.3	11.6	16.5	30.2	49.3	10.2	6.4	13.9	24.2	10.8	10.7	16.9	22.5	17.8	19.7	21.7	16.1	9.5	16.6	12.7	7.0	10.9	25.8	17.9	8.0	7.4
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 33.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 5.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	NA	NA	32000000	110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	25.1	5.6	3.2	2.6	4.5	0.7	4.6	4.5	2.2	5.8	2.5	3.4	2.3	3.5	4.8	3.5	3.0	13.2	4.8	4.5	6.1	11.1	2.1	21.7	1.4	8.0	3.5	9.5	1.6	1.2	5.8	20.5	4.8	17.7	3.3	0.6	12.0	33.5	23.4	1.2	2.6	3.3	4.8	11.0	4.0	2.3	2.1	2.1	3.5	7.0	1.0	3.9	3.7	11.9	0.0	2.4	9.3	5.3	87.9	30.2	6.6	30.0	25.8	8.1	11.9	6.2	0.1	0.0	0.1	16.0	0.0	0.0	4.2	0.1	10.5	0.0	1.4	53.1	0.6	0.0	24.5	0.7	0.0	145.5	0.0	4.9	0.6	7.5	0.6	0.0	28.2	5.1	10.9	0.0	1.1	7.9	9.6	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.1	4.2	1.1	0.6	0.0	11.6	2.2	0.0	0.3	70.5	0.9	2.5	0.7	0.2	3.2	0.0	9.7	1.1	47.5	0.1	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.6	3.2	4.5	4.5	2.2	4.5	6.1	8.0	3.5	4.8	4.8	2.1	11.9	9.0	0.0	2.3	60.4	0.0	0.6	10.1	0.4	5.2	0.9	0.5	2.8	3.3	0.0	2.2	7.3	0.0	5.2	0.0	0.0	1.9	0.3	8.1	0.7	9.1	5.6	0.0	10.1	6.5	0.0	7.6	20.4	1.5	1.9	0.0	0.0	3.3	0.1	0.5	0.0	37.6	0.0	2.0	0.3	1.0	2.4	2.5	2.9	0.0	6.5	1.5	0.5	0.0	3.0	0.6	0.0	0.0	3.8	1.1	1.2	0.0	2.8	0.8	0.0	6.6	3.5	48.6	1.6	5.4	4.0	0.1	2.7	0.8	1.7	0.1	1.2
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 12.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	110000	"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.7	0.5	5.6	3.8	5.0	0.4	9.9	6.3	9.0	6.2	2.6	2.9	1.2	4.3	1.1	2.2	4.2	4.9	7.3	4.9	6.3	5.4	2.7	4.6	6.8	12.3	5.8	2.5	0.8	2.3	0.8	11.3	12.3	3.3	1.8	1.6	2.5	2.7	4.0	3.1	2.5	6.8	7.7	0.5	1.8	0.9	7.6	6.4	8.2	2.0	2.8	10.6	3.2	7.5	0.1	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	4.7	0.4	0.1	0.9	0.0	17.9	39.9	0.0	0.0	0.0	0.1	62.6	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.8	0.0	0.0	0.1	0.3	0.1	0.1	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	22.7	1.7	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.1	5.6	5.0	6.3	9.0	4.9	6.3	12.3	5.8	12.3	7.7	7.6	7.5	81.7	9.6	0.0	5.2	7.8	8.2	2.7	2.5	1.8	9.3	1.5	1.4	2.8	2.8	1.6	0.0	29.2	1.8	3.6	0.6	0.0	1.3	3.2	4.2	5.4	182.2	13.8	1.3	17.0	0.5	1.5	6.3	1.5	5.9	4.5	2.0	30.4	0.9	0.6	38.7	16.1	1.7	0.0	2.5	10.9	5.0	43.5	2.7	16.0	26.2	2.4	2.9	7.2	24.6	11.3	1.3	1.2	3.8	0.9	9.9	2.6	1.0	1.4	12.5	0.0	8.1	79.8	1.6	1.6	0.3	8.0	30.6	5.5	2.9	1.3	4.7
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 675.7"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 567.6;Proximal tubular cells: 272.5"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	120000000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	53.0	675.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	11.5	0.0	5.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.1	0.1	0.7	0.0	16.0	0.1	0.2	0.1	0.0	2.6	0.3	0.0	0.0	9.7	567.6	0.1	0.0	0.1	0.0	0.0	16.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374370	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 195.8;breast: 165.0;liver: 183.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 318.9;Hepatocytes: 148.4;Pancreatic endocrine cells: 230.4;Proximal enterocytes: 146.3;Skeletal myocytes: 198.3"	"Cancer enriched"	"Detected in all"	4	"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.6;HBEC3-KT: 226.5;LHCN-M2: 60.9;TIME: 114.6;U-138 MG: 65.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	7750000	3100000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	195.8	23.0	25.2	15.4	31.8	1.4	165.0	26.2	32.6	18.8	14.0	25.6	11.5	6.8	0.1	41.2	7.9	9.4	45.4	27.7	27.0	51.9	183.7	46.6	2.0	30.1	37.6	9.1	70.8	1.0	16.1	18.3	27.2	30.4	0.9	3.2	19.1	2.6	24.8	30.2	28.0	6.0	27.3	13.1	21.7	6.7	33.8	0.7	34.1	6.2	2.8	26.6	32.1	33.7	0.1	2.2	1.2	3.3	54.6	12.0	0.7	4.4	0.5	0.7	0.2	0.0	20.9	0.2	30.6	8.8	4.5	3.0	0.0	226.5	0.4	1.9	0.4	0.3	0.9	0.9	1.2	0.1	0.2	5.6	1.0	34.0	0.7	6.2	17.4	0.6	1.1	0.5	60.9	1.8	0.2	2.1	0.3	0.0	1.8	1.3	0.1	1.0	11.1	4.0	0.2	0.5	26.2	2.7	4.3	1.5	6.8	0.4	114.6	65.1	0.3	33.3	0.0	0.3	0.1	0.2	44.9	0.0	12.4	3.3	0.1	0.4	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.3	0.0	0.1	0.2	0.1	25.2	31.8	26.2	32.6	27.7	27.0	30.1	37.6	27.2	27.3	33.8	33.7	53.5	38.5	5.8	128.0	1.2	14.0	39.8	318.9	17.1	0.2	71.8	49.0	5.3	1.5	85.7	14.7	0.0	7.4	2.5	17.1	0.0	107.1	0.7	4.2	6.9	28.9	0.0	0.0	0.4	18.0	111.2	89.1	46.9	13.8	2.5	1.5	17.9	148.4	8.3	0.0	0.6	14.2	16.2	1.6	10.3	2.2	88.0	5.0	8.8	2.8	2.0	2.7	0.0	1.0	4.5	230.4	8.4	131.7	1.0	38.3	146.3	4.5	19.0	0.1	32.9	198.3	121.5	0.0	3.1	21.8	11.5	40.1	2.3	20.7	6.7	77.7
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 30.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.1;Hepatic stellate cells: 5.7;Hepatocytes: 8.2;Smooth muscle cells: 15.8;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	450000	23000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.8	2.1	0.7	2.8	0.3	0.8	1.1	0.2	0.4	0.6	0.7	0.1	0.2	0.3	0.7	0.4	0.2	0.7	0.8	0.5	30.2	0.5	3.3	1.7	1.1	0.3	1.1	0.1	0.4	2.2	1.3	0.2	0.4	0.1	0.2	0.0	0.0	0.3	3.5	0.2	1.2	3.4	1.6	1.6	1.0	0.8	0.3	0.0	3.3	0.5	0.2	1.7	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	2.0	0.2	0.2	0.0	0.5	58.9	0.0	0.2	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.0	0.0	1.3	4.7	0.2	0.4	1.1	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.0	5.1	1.4	2.9	0.2	0.7	0.7	0.0	0.3	0.0	0.6	0.4	0.4	0.7	0.4	0.4	0.1	0.9	0.2	0.4	0.0	0.4	0.2	0.1	0.5	0.2	0.8	0.7	0.8	1.1	0.7	0.8	1.7	1.1	1.3	1.2	1.0	1.7	0.3	0.0	0.0	0.0	4.1	0.3	0.1	0.4	0.0	0.1	0.4	0.3	0.4	2.8	0.3	0.0	0.0	0.2	1.7	0.1	1.9	0.3	0.3	0.0	0.3	0.2	0.0	0.4	0.9	0.0	0.2	2.5	0.5	0.1	0.0	0.1	5.7	8.2	2.3	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	2.1	0.0	0.2	0.5	0.2	0.2	0.0	0.1	15.8	0.5	6.3	0.0	0.0	0.3	1.0	0.9	0.1	0.1
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 409.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	35.7	0.8	1.1	0.2	1.0	0.1	22.5	0.1	1.7	1.2	0.0	1.4	0.4	0.9	1.6	0.3	0.8	0.4	1.8	0.9	0.6	4.0	409.8	0.4	0.1	0.7	0.6	1.1	0.9	0.0	0.3	0.1	0.5	0.8	0.0	0.1	1.3	0.1	0.8	0.9	1.2	0.1	0.3	0.4	0.7	0.5	1.1	0.0	1.0	0.0	0.0	1.1	1.0	0.9	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.7	0.9	0.6	0.7	0.6	0.5	0.3	1.1	0.9	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 50.3;SK-BR-3: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	6.3	6.7	45.5	6.5	86.5	2.1	21.5	144.9	82.3	12.0	0.0	26.0	39.3	23.0	125.2	16.9	19.1	21.5	81.1	60.8	86.1	95.4	16.6	24.6	6.1	82.7	61.3	11.6	11.2	131.8	14.5	15.6	97.0	20.0	20.9	123.2	42.6	40.5	80.5	39.9	27.2	13.2	21.2	10.8	15.5	8.0	87.3	9.1	41.6	94.1	7.4	10.8	14.1	114.4	8.7	4.9	30.3	0.4	0.0	1.8	23.3	0.6	0.4	0.1	0.6	22.2	16.6	0.5	9.8	0.6	0.9	12.1	16.4	14.9	0.5	0.5	11.0	0.2	9.7	0.1	6.2	0.1	0.4	14.6	9.3	7.8	0.4	26.1	3.6	0.0	4.3	20.6	6.9	29.0	0.2	1.0	13.8	23.3	26.6	0.1	21.7	4.3	5.4	50.3	15.6	2.8	0.6	49.4	0.0	33.6	28.7	0.1	10.0	0.9	2.9	13.3	1.5	0.9	0.2	0.2	5.5	0.2	18.9	1.6	0.2	0.5	2.7	0.2	2.4	4.1	4.6	1.5	0.1	1.1	5.0	1.2	0.7	1.5	0.3	2.5	0.8	1.0	45.5	86.5	144.9	82.3	60.8	86.1	82.7	61.3	97.0	21.2	87.3	114.4	0.9	44.8	174.3	20.2	14.5	19.1	21.9	17.8	38.7	490.2	26.8	20.6	189.3	12.8	42.5	53.3	225.2	38.8	3.4	62.9	19.6	10.6	28.3	139.8	26.2	3.9	30.6	0.0	859.2	8.6	9.9	13.2	15.8	153.3	12.6	66.9	7.9	0.5	4.7	43.7	881.3	12.1	14.2	4.8	1.4	11.5	28.0	3.3	8.8	23.4	4.4	41.4	0.0	592.6	1579.5	4.8	41.8	5.7	3.4	12.2	62.5	51.3	66.7	216.6	0.0	30.2	11.7	1.1	2.3	35.9	18.2	25.0	18.5	4.5	17.8	18.4
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163821-4263995	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567"	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	13.8	16.1	18.9	13.5	25.4	16.4	12.5	23.4	19.0	15.2	15.1	25.8	11.4	18.0	10.6	13.6	15.1	11.9	11.4	17.8	23.9	11.3	13.9	15.3	14.0	27.5	23.6	19.9	9.6	19.0	12.3	14.2	25.4	12.1	13.9	13.1	13.7	12.2	14.1	19.8	13.7	14.8	25.8	15.0	13.0	5.9	22.9	20.3	14.4	11.4	12.8	14.6	13.9	28.1	20.6	47.2	31.5	21.3	41.7	31.6	20.5	22.5	23.4	35.5	35.2	21.0	13.7	17.8	18.0	34.1	19.0	32.0	29.3	24.0	31.2	9.7	29.7	17.6	34.0	19.6	23.2	10.6	20.4	33.3	24.8	25.5	18.7	19.0	21.3	17.2	17.3	16.7	24.5	16.0	15.9	11.3	13.3	16.0	16.4	23.9	21.0	9.9	18.5	27.7	10.5	16.4	31.9	15.1	20.2	24.3	17.5	13.7	27.3	22.5	11.7	31.0	30.3	5.5	4.6	5.9	27.5	21.1	27.5	1.0	3.9	1.7	2.7	6.4	2.5	0.9	1.8	1.9	2.7	0.9	1.8	1.7	1.6	1.0	7.3	1.1	1.7	2.2	18.9	25.4	23.4	19.0	17.8	23.9	27.5	23.6	25.4	25.8	22.9	28.1	14.5	28.9	24.6	43.1	8.7	12.4	8.9	12.7	13.1	24.1	12.2	13.2	4.6	8.6	13.6	18.4	29.2	11.2	15.1	13.8	1.9	9.8	4.3	13.9	20.0	15.1	12.1	6.3	59.9	9.7	9.8	15.2	18.8	12.5	3.8	21.1	24.7	19.7	20.2	26.9	60.5	10.9	6.1	24.4	7.6	3.8	14.6	19.1	17.8	39.4	18.8	9.8	19.6	36.7	46.4	13.2	6.4	19.2	7.4	15.4	11.4	7.6	22.4	30.2	6.6	25.5	11.9	12.9	12.8	17.2	11.6	6.2	15.5	16.6	12.5	14.5
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 337.8;Inhibitory neurons: 315.8;Oligodendrocyte precursor cells: 275.0;Oligodendrocytes: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: AB_2685106"	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	13.7	13.5	15.6	13.6	16.7	9.2	20.0	23.1	20.4	16.8	16.8	15.8	14.8	14.7	18.5	14.5	18.2	12.4	14.5	16.2	21.1	19.6	20.6	14.2	15.1	15.7	15.9	17.8	18.0	24.5	14.4	19.0	16.0	15.1	19.0	36.0	16.7	13.7	23.2	17.2	15.2	16.4	12.3	15.1	15.7	11.1	18.5	27.2	17.9	26.1	17.7	17.7	12.8	20.1	25.6	27.7	43.1	34.2	47.4	41.5	23.5	36.9	43.1	32.5	31.1	33.9	32.8	69.2	29.9	38.0	17.1	20.9	54.4	32.6	44.6	27.1	23.1	47.1	29.5	49.4	25.4	62.2	27.9	35.2	34.8	46.6	36.9	33.6	43.8	27.9	67.2	24.8	39.4	23.7	51.3	22.1	28.0	33.0	27.6	40.5	47.3	28.8	34.5	38.1	41.6	28.2	35.7	39.7	18.9	33.5	21.3	24.3	53.2	34.0	32.6	30.8	29.3	20.5	11.1	51.5	27.6	26.8	35.6	1.6	1.7	1.8	3.0	1.1	1.5	1.8	1.8	2.0	1.4	2.6	1.7	2.0	1.9	5.6	1.3	4.4	1.2	1.1	15.6	16.7	23.1	20.4	16.2	21.1	15.7	15.9	16.0	12.3	18.5	20.1	42.9	48.1	52.9	194.9	30.9	76.1	36.9	33.9	67.2	57.2	38.6	31.2	82.2	35.8	45.5	40.5	123.0	31.8	40.0	52.8	7.9	30.9	12.7	46.0	57.9	52.2	45.1	36.1	337.8	28.9	24.6	44.8	51.5	60.8	31.6	53.4	43.9	49.7	27.3	69.0	315.8	45.6	26.4	31.2	34.7	5.5	35.1	35.0	28.4	181.8	34.8	30.5	50.4	275.0	296.5	30.2	25.7	37.6	44.2	52.8	39.4	25.4	30.5	84.1	19.7	58.5	48.5	28.1	30.8	64.9	81.3	33.8	32.4	47.6	48.3	48.4
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983341-98015943	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		570000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	144.0	77.1	134.8	124.0	155.9	365.7	138.6	134.0	187.6	161.6	112.0	145.5	95.1	116.2	104.7	140.9	127.2	60.4	92.3	113.7	150.0	100.2	103.5	122.4	222.6	171.4	149.8	168.5	156.4	68.7	68.1	110.5	158.5	98.6	118.7	46.2	110.6	71.4	109.6	148.0	127.3	78.0	155.6	123.8	131.9	59.6	142.6	271.5	96.9	50.6	248.4	132.5	146.6	173.4	659.7	347.4	378.6	318.4	208.1	365.2	344.4	332.6	292.4	349.2	291.9	438.3	313.1	798.2	194.2	224.6	266.3	423.9	516.1	375.2	397.1	523.0	290.9	692.4	289.1	478.4	266.9	1201.9	386.8	278.7	268.8	280.9	574.0	283.2	307.9	701.5	1359.2	548.8	272.6	875.7	913.5	1062.0	148.2	638.8	341.2	537.8	589.5	381.7	228.8	269.9	304.2	265.8	390.4	376.2	364.5	185.3	213.2	444.0	377.0	226.5	367.3	288.3	355.5	493.2	601.3	469.1	209.7	472.7	432.1	91.3	83.6	118.8	65.2	95.5	89.3	106.1	122.5	92.8	100.5	93.0	143.8	112.1	34.2	74.1	149.7	96.4	162.5	85.3	134.8	155.9	134.0	187.6	113.7	150.0	171.4	149.8	158.5	155.6	142.6	173.4	127.9	86.6	101.8	7.8	227.7	180.7	201.3	180.0	208.9	61.1	100.4	126.0	85.8	112.9	120.7	75.4	25.0	345.5	159.5	159.1	97.8	144.9	114.9	73.8	176.3	146.9	149.9	709.4	5.8	171.6	537.9	121.9	123.3	117.5	119.7	247.9	159.5	96.6	284.7	119.5	6.2	242.2	75.3	310.6	152.0	95.2	146.3	222.5	128.1	14.0	263.5	68.9	149.3	8.0	18.8	137.1	151.1	145.2	266.5	260.6	177.7	101.9	56.3	42.1	151.2	113.4	189.4	204.3	339.0	243.0	154.1	333.1	217.6	188.9	302.7	234.1
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"ANTXR cell adhesion molecule 1"	Q9H6X2	2	69013176-69249327	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.6;Endometrial stromal cells: 78.1;Oligodendrocyte precursor cells: 141.8;Skeletal myocytes: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 367.9;TIME: 240.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		11000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.09e-2)"	38.7	63.1	25.7	20.3	24.1	0.2	32.7	26.6	16.1	77.8	70.2	32.7	12.9	81.4	25.2	33.9	44.1	114.6	39.9	27.9	69.2	11.0	8.2	44.8	12.1	42.5	49.5	107.2	6.7	35.4	14.6	78.8	45.6	47.9	21.4	9.5	28.6	55.4	11.3	39.3	20.2	62.1	36.5	28.3	14.5	11.7	38.3	10.5	43.3	24.0	13.0	52.3	42.4	36.6	36.8	39.5	36.4	33.9	162.7	78.8	0.6	57.1	115.6	63.2	51.5	0.4	3.0	0.0	31.6	147.4	41.7	31.7	30.7	33.8	59.9	0.1	24.4	9.5	90.5	11.9	71.1	7.6	5.1	129.7	13.4	55.5	36.4	140.9	17.3	19.4	6.7	0.1	367.9	15.2	22.1	0.5	35.8	0.0	26.5	0.1	186.3	0.6	13.8	27.9	21.1	91.0	104.3	0.5	37.5	23.7	11.0	2.3	240.4	71.3	61.6	72.1	59.6	0.2	0.1	0.2	37.3	6.7	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	24.1	26.6	16.1	27.9	69.2	42.5	49.5	45.6	36.5	38.3	36.6	4.7	6.4	20.0	130.6	0.0	49.5	21.1	15.4	17.6	1.7	7.9	13.8	6.8	0.0	8.3	0.0	0.0	0.7	0.1	0.0	0.0	1.5	37.9	5.5	78.1	4.3	0.0	0.0	61.9	2.6	1.9	68.2	0.0	11.7	1.3	22.1	3.3	0.1	4.0	0.0	64.3	0.0	4.1	0.8	19.8	33.9	42.6	2.9	24.9	40.3	0.6	13.6	0.0	141.8	1.3	1.1	0.0	67.7	1.2	10.1	0.0	0.1	9.9	0.8	19.7	111.7	59.6	5.2	2.7	4.6	23.4	1.4	1.7	26.4	0.0	8.9
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"ANTXR cell adhesion molecule 2"	P58335	4	79901146-80125454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.4;HHSteC: 197.9;LHCN-M2: 221.0;U-2197: 176.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		13000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	60.9	30.0	4.1	35.4	4.1	18.7	18.7	3.6	6.4	52.2	5.0	39.9	23.0	95.4	21.9	24.5	31.2	54.9	31.8	3.6	5.0	17.1	34.4	24.7	16.2	4.7	5.0	75.0	4.6	27.8	1.6	90.0	4.2	110.2	42.7	1.6	10.1	90.3	6.1	6.1	29.6	108.3	5.5	18.3	23.2	8.4	4.0	10.7	4.9	21.7	16.1	53.1	12.0	4.4	15.5	1.9	34.6	6.6	215.4	118.0	3.1	48.3	124.6	17.5	19.9	0.6	11.8	0.0	0.8	76.8	11.4	4.5	4.4	49.7	66.9	2.2	4.2	12.2	1.3	4.8	197.9	51.6	29.5	145.3	15.2	132.7	68.3	150.2	52.6	1.6	27.1	35.8	221.0	0.0	1.1	57.1	5.7	21.7	70.3	2.4	19.8	9.0	12.0	14.4	30.6	41.2	4.9	0.6	8.2	16.3	0.7	11.0	69.8	155.7	9.7	176.7	103.4	3.1	0.0	0.1	78.6	39.4	49.0	72.7	17.5	61.6	12.8	9.5	13.8	23.5	21.4	13.1	32.2	9.4	11.3	5.9	54.4	4.3	18.0	32.2	40.4	14.0	4.1	4.1	3.6	6.4	3.6	5.0	4.7	5.0	4.2	5.5	4.0	4.4	6.4	12.8	10.0	23.5	25.7	7.0	15.5	6.5	4.0	6.9	4.0	2.2	24.9	4.3	10.2	0.0	29.2	18.3	24.9	42.4	3.9	4.2	2.3	7.7	69.3	15.5	18.6	6.3	25.4	6.7	29.0	58.7	4.1	6.1	60.1	8.9	15.0	24.9	17.7	0.0	2.1	15.1	4.1	13.4	28.9	5.3	39.1	28.3	1.8	45.9	53.7	6.9	4.1	19.1	0.8	45.5	28.9	63.9	14.1	13.9	16.9	2.5	4.9	21.4	39.5	32.5	28.5	0.6	2.1	0.9	4.3	6.6	24.4	18.3	13.3	1.6
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 144.3;intestine: 293.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.0	1.1	1.6	2.6	0.0	0.4	2.6	2.2	0.4	1.1	21.6	293.6	1.5	2.2	0.2	58.4	144.3	0.1	1.1	1.5	7.0	20.2	0.2	0.2	4.1	2.9	0.4	0.4	0.0	0.0	0.0	3.3	0.5	36.1	4.3	0.1	24.3	0.0	0.1	219.5	2.9	3.3	0.0	0.8	4.2	2.1	0.1	0.0	0.0	0.0	0.5	0.1	5.3	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	2.6	2.2	1.1	1.5	4.1	2.9	3.3	3.3	2.1	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 337.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 322.7;Alveolar cells type 1: 589.7;Ductal cells: 434.5;Exocrine glandular cells: 305.3;Pancreatic endocrine cells: 754.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	320	"neutrophil: 207.7"	"Lineage enriched"	"Detected in single"	327	"granulocytes: 207.7"	"Cell line enhanced"	"Detected in many"		"A-431: 419.5;CACO-2: 403.5;CAPAN-2: 563.7;EFO-21: 334.7;hTERT-HME1: 566.3;OE19: 502.1;RPTEC TERT1: 477.8"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"		NA	NA		6400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	52.9	3.1	16.5	22.7	17.3	337.7	43.8	14.5	28.2	19.6	11.7	27.7	15.8	12.5	3.7	55.2	16.8	17.3	51.2	14.2	21.6	24.9	3.9	144.4	2.4	19.9	16.1	2.5	32.7	34.0	5.9	81.5	20.8	68.0	26.7	1.6	119.5	12.9	28.3	10.0	13.3	20.1	14.6	21.6	90.5	1.9	19.9	7.1	83.7	36.7	12.7	10.2	15.6	14.7	419.5	77.7	1.3	0.9	1.0	0.9	0.6	4.9	0.4	11.0	10.9	403.5	563.7	0.1	334.7	14.4	0.4	161.6	0.1	300.0	16.0	1.4	3.3	36.4	142.0	23.9	45.9	5.9	0.2	2.4	262.6	4.1	566.3	60.1	118.9	9.0	0.7	0.3	1.9	15.9	1.7	0.2	13.0	502.1	55.4	0.0	0.8	0.0	477.8	45.2	0.3	0.3	235.5	58.2	16.6	186.1	9.9	4.3	153.2	0.6	52.6	0.2	93.0	3.1	5.1	2.2	0.0	0.4	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	207.7	0.1	0.6	0.1	0.0	2.9	16.5	17.3	14.5	28.2	14.2	21.6	19.9	16.1	20.8	14.6	19.9	14.7	322.7	589.7	47.3	0.0	1.1	24.9	81.8	144.9	1.8	0.2	27.6	85.9	8.6	55.8	175.2	38.6	0.0	212.6	1.0	35.4	17.6	434.5	1.1	33.7	4.4	84.6	5.4	3.2	0.9	305.3	106.2	16.9	99.9	58.1	5.1	0.1	23.2	0.6	18.9	0.0	0.3	33.4	122.1	0.3	0.3	0.3	3.1	6.9	5.4	42.2	21.0	1.2	0.0	1.0	0.6	754.2	61.6	0.4	0.6	158.6	11.5	5.5	89.6	0.4	0.0	7.6	18.7	1.1	0.6	21.9	6.7	62.8	2.3	1.3	29.7	46.7
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		5000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	490.6	286.5	111.7	241.7	126.3	96.2	314.0	136.9	144.7	429.1	137.7	181.9	96.5	288.7	162.6	135.1	225.0	273.1	213.9	106.4	134.7	216.2	149.5	299.0	136.2	151.2	129.6	224.7	162.9	133.7	176.7	466.0	150.4	211.7	155.5	78.1	273.8	250.5	85.2	132.5	130.9	370.3	134.3	175.7	186.0	110.4	154.3	63.3	182.9	114.8	135.2	298.1	178.6	157.3	463.5	339.6	438.0	256.1	2094.3	1645.5	503.4	1582.7	1464.9	841.3	744.8	246.2	200.6	35.7	282.9	2224.8	581.7	165.4	287.3	727.6	762.2	335.1	171.2	105.0	281.6	647.4	1213.9	221.1	178.3	945.5	344.7	705.1	665.9	927.4	1120.9	25.2	106.0	271.8	2133.5	306.7	225.5	75.1	231.9	417.7	718.5	8.2	1014.5	72.6	1368.9	66.3	117.1	141.4	579.7	227.6	1515.2	872.3	201.5	261.2	830.6	1322.1	632.1	955.2	478.0	240.8	308.6	76.0	847.8	123.5	1586.2	122.2	725.8	359.9	104.8	830.5	136.0	127.3	158.8	131.9	745.6	89.5	51.3	74.6	157.9	48.4	798.0	91.2	289.9	773.3	111.7	126.3	136.9	144.7	106.4	134.7	151.2	129.6	150.4	134.3	154.3	157.3	286.5	243.6	233.9	13.7	85.0	199.3	266.4	395.9	76.2	6.8	101.6	107.4	88.3	265.9	257.2	132.4	25.0	1156.8	53.2	15.6	297.4	703.5	16.2	239.7	318.1	287.7	48.6	29.0	15.4	338.2	1125.1	564.7	91.3	312.6	148.7	177.5	186.4	54.8	753.2	13.5	7.1	110.9	187.2	446.5	705.1	41.4	379.9	544.0	352.2	45.0	412.5	161.4	13.4	23.1	26.8	501.1	31.2	366.3	203.1	473.8	15.3	194.3	268.9	30.0	295.9	443.1	377.2	15.9	28.6	101.1	140.8	1140.8	122.0	185.7	43.2	188.2
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AOPEP	"AP-O, APO, C90RF3, C9orf3, FLJ14675"	ENSG00000148120	"Aminopeptidase O (putative)"	Q8N6M6	9	94726604-95087159	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 148.2;Cytotrophoblasts: 65.9;Extravillous trophoblasts: 43.7;Syncytiotrophoblasts: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	5.6	6.6	11.8	4.9	20.4	2.2	7.0	16.9	16.3	8.1	23.8	6.9	4.3	18.5	8.3	16.9	10.3	12.1	29.4	15.9	15.5	7.2	7.6	10.4	2.2	23.0	15.7	8.1	11.2	16.3	5.7	24.3	20.7	14.3	5.8	4.7	12.2	15.2	30.5	38.6	5.0	15.8	11.1	5.0	5.7	6.0	15.4	2.6	11.2	15.3	5.6	7.7	6.8	40.5	6.8	27.6	3.3	5.3	3.4	3.8	12.4	6.4	3.0	6.3	4.1	6.3	8.7	2.1	5.3	9.8	8.7	24.8	5.7	6.1	3.4	13.2	4.9	2.0	30.1	5.8	6.1	1.8	1.4	4.4	23.7	5.5	4.1	17.7	3.5	3.3	3.4	3.0	11.4	10.1	2.8	2.3	4.4	7.8	10.7	4.2	9.4	2.7	11.0	6.4	6.6	9.7	11.2	9.4	2.5	8.5	10.8	1.5	2.7	2.9	2.8	10.8	3.4	2.5	3.6	1.0	9.8	1.7	4.8	0.0	1.4	0.9	1.4	1.0	0.8	0.9	1.1	1.2	2.2	2.2	0.8	1.0	0.5	1.4	0.7	2.1	0.8	0.7	11.8	20.4	16.9	16.3	15.9	15.5	23.0	15.7	20.7	11.1	15.4	40.5	20.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.2	0.0	0.0	0.0	0.0	65.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	43.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	88.2	0.2	0.0	0.0	0.0
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1M1	"AP47, CLAPM2"	ENSG00000072958	"Adaptor related protein complex 1 subunit mu 1"	Q9BXS5	19	16197854-16245906	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045256	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA045256: AB_10960697"	"unprognostic (5.10e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.56e-1)"	49.5	47.2	30.1	30.7	31.0	58.5	37.9	22.3	36.3	32.2	22.0	37.7	32.1	38.8	9.2	29.6	29.8	21.4	39.9	33.0	31.0	39.6	81.0	31.9	36.9	26.6	30.0	31.7	18.8	20.1	24.0	27.5	33.5	25.3	12.6	17.3	21.6	24.8	44.4	30.8	31.0	35.4	23.1	37.6	27.3	60.8	25.0	37.8	23.7	29.0	28.2	38.3	29.1	25.9	63.3	70.2	69.3	65.3	82.7	80.9	39.1	69.6	74.1	99.5	103.3	83.9	48.6	49.8	78.7	76.6	64.4	35.1	54.2	56.9	111.3	85.5	122.3	80.9	63.4	114.6	67.1	91.5	96.9	83.5	42.2	89.2	59.8	65.4	95.6	69.8	40.3	98.0	109.5	75.8	131.2	55.4	56.9	22.3	162.7	87.9	56.7	67.3	54.9	45.2	44.4	99.4	56.8	34.4	64.0	36.9	41.0	73.1	83.1	111.8	45.6	151.7	134.3	104.6	141.6	54.9	125.5	112.8	88.7	89.4	142.3	243.9	104.8	180.7	105.6	99.8	103.4	111.2	121.6	92.3	115.1	147.0	101.8	133.1	235.7	131.2	161.8	174.3	30.1	31.0	22.3	36.3	33.0	31.0	26.6	30.0	33.5	23.1	25.0	25.9	17.4	41.7	31.2	12.7	30.6	4.6	7.4	13.2	11.4	35.4	11.3	10.9	17.9	14.3	15.2	12.9	20.9	32.1	30.5	8.3	15.6	21.1	32.5	10.6	27.2	22.7	19.8	21.7	11.8	18.2	40.4	28.1	8.6	14.8	27.1	19.0	21.8	41.9	42.6	42.1	11.7	7.3	6.1	36.0	13.3	92.1	23.0	30.2	10.6	5.6	34.9	18.3	38.1	4.5	12.8	31.2	5.9	19.9	24.5	6.2	25.1	23.6	13.9	40.2	0.0	26.1	22.8	61.9	23.3	12.6	7.1	17.5	32.9	17.7	9.0	4.6
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 subunit alpha 2"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		10000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	20.1	18.0	3.5	1.3	5.1	4.5	16.6	10.8	9.9	20.3	1.4	23.0	5.4	17.9	1.5	12.7	18.1	2.0	19.1	5.5	3.5	34.4	29.9	18.9	3.2	0.9	2.1	17.5	25.3	3.7	25.6	5.2	3.0	20.3	4.9	5.8	14.6	4.0	14.1	14.5	19.6	5.6	0.0	57.6	20.6	15.5	3.3	3.8	13.9	1.6	2.5	19.0	15.7	1.4	7.5	2.9	3.7	10.7	13.8	14.2	9.1	10.2	3.3	6.0	4.9	1.3	7.3	7.4	8.7	12.3	5.7	8.9	8.9	5.6	3.9	5.5	23.2	2.1	10.4	3.9	5.3	2.8	4.9	16.8	6.1	3.1	6.1	14.8	8.5	5.0	5.9	4.7	6.3	0.4	2.6	3.2	2.0	9.1	17.9	4.2	2.6	8.1	9.2	6.2	12.3	10.0	11.4	9.2	1.7	6.3	5.4	0.8	13.3	1.9	2.3	2.8	5.2	4.3	3.9	5.3	4.0	3.7	3.1	1.5	1.7	1.5	1.1	1.7	0.5	0.5	1.1	0.6	1.4	1.0	1.1	1.2	2.1	1.1	1.4	1.3	2.1	0.6	3.5	5.1	10.8	9.9	5.5	3.5	0.9	2.1	3.0	0.0	3.3	1.4	38.1	38.5	21.8	29.4	14.3	14.3	12.4	13.3	7.4	50.9	27.2	23.0	12.9	21.5	15.9	62.5	60.5	42.1	17.3	45.3	39.2	37.5	46.7	64.0	44.6	36.6	35.2	27.1	37.2	18.0	45.2	28.7	16.3	86.7	27.3	31.0	80.3	59.8	82.8	101.0	36.4	32.3	18.3	104.7	26.9	28.3	34.5	51.8	8.8	41.2	31.2	30.4	39.1	23.1	21.9	25.8	24.2	27.8	13.6	16.9	43.5	70.4	23.5	69.2	26.3	20.7	22.6	72.7	28.0	11.2	11.4	28.5	19.7	30.5	37.0	11.5
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 subunit mu 1"	Q96CW1	3	184174689-184184091	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		7500	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	191.8	364.2	233.5	164.7	250.3	231.3	164.6	211.3	257.3	222.8	196.3	232.4	167.5	216.4	104.2	218.1	178.6	166.5	366.2	261.1	249.0	196.0	140.9	180.0	148.2	234.8	211.1	198.6	106.4	224.8	224.9	243.3	248.9	183.2	141.1	230.4	167.2	231.8	181.2	157.2	156.2	243.7	200.9	162.5	156.3	106.4	235.4	158.4	148.0	194.0	157.6	223.7	192.4	225.6	436.3	327.5	275.7	311.8	432.1	450.8	284.3	714.3	412.5	788.5	550.5	355.1	309.9	198.2	851.3	1076.1	516.1	480.0	376.3	482.9	647.1	409.8	470.4	512.2	365.8	317.9	508.9	254.8	311.5	577.0	269.4	501.1	318.5	711.0	595.3	258.3	250.0	377.1	750.1	993.6	330.1	151.2	674.1	388.1	484.7	302.7	351.5	393.7	489.7	389.3	292.0	212.6	561.3	696.4	335.1	427.5	934.4	305.7	645.0	497.1	400.1	492.4	960.2	336.9	318.7	441.6	937.1	369.9	331.7	194.4	294.8	244.9	137.5	238.8	136.2	114.3	127.6	134.0	268.7	112.7	107.7	111.8	127.7	170.2	206.8	134.1	185.4	441.0	233.5	250.3	211.3	257.3	261.1	249.0	234.8	211.1	248.9	200.9	235.4	225.6	146.8	54.5	50.7	41.4	84.8	124.9	177.2	275.1	97.9	174.2	108.0	98.2	195.9	112.9	133.5	114.0	70.9	400.9	117.3	155.9	375.6	243.7	326.6	69.3	131.2	172.2	140.8	277.8	62.0	161.3	327.1	161.5	71.4	78.5	149.1	173.6	182.4	78.0	576.9	277.6	63.4	119.0	201.4	137.1	162.9	347.8	164.7	185.1	199.3	34.7	369.4	199.4	130.7	26.2	46.1	232.1	153.1	214.8	100.2	138.8	253.8	290.7	58.3	125.9	197.2	106.9	278.0	83.3	101.7	128.5	126.6	513.6	102.6	278.1	154.1	185.1
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 subunit delta 1"	O14617	19	2100988-2164468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074408			Approved	Cytosol		No	No		28000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA074408: AB_2686686"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	30.0	40.7	39.0	36.3	39.0	27.6	28.8	29.4	55.1	29.5	39.4	36.2	35.8	35.1	16.6	38.2	32.5	28.0	43.7	45.0	39.8	35.8	40.9	31.1	37.2	39.4	43.3	29.8	63.9	40.0	56.4	33.4	48.0	31.3	22.5	29.6	48.0	34.0	61.1	30.0	35.4	32.8	26.0	34.8	37.7	44.9	38.9	33.2	43.9	40.3	27.6	34.3	25.5	34.5	114.8	117.5	68.5	105.0	85.7	71.8	83.9	90.3	87.9	94.2	85.2	134.8	61.8	61.7	51.0	134.1	115.7	76.4	99.2	109.7	61.1	89.9	94.6	80.5	74.7	106.3	149.9	88.4	102.5	89.5	72.3	98.1	141.6	79.7	92.6	44.2	84.2	210.9	84.1	84.4	85.6	46.8	102.8	78.2	74.2	90.3	75.0	83.4	70.7	162.7	97.4	81.1	82.3	85.7	154.2	62.5	83.2	101.0	121.7	89.7	37.7	123.4	106.7	176.5	184.6	78.6	122.5	57.4	91.5	0.2	3.3	2.9	3.5	3.6	5.6	2.4	3.4	4.1	3.9	2.9	2.7	3.4	3.4	5.5	3.0	7.5	2.1	2.2	39.0	39.0	29.4	55.1	45.0	39.8	39.4	43.3	48.0	26.0	38.9	34.5	29.5	60.9	61.7	41.4	35.5	20.3	41.3	20.3	36.5	66.6	39.5	26.5	77.7	44.3	34.1	40.5	35.5	55.3	32.5	79.5	21.5	53.3	70.7	34.4	36.9	37.1	47.8	42.9	24.1	74.2	71.9	38.2	69.8	48.9	17.1	38.9	29.6	49.2	66.9	48.8	30.2	68.8	18.3	38.4	30.2	68.6	37.9	43.4	39.2	18.7	31.7	55.5	29.9	21.1	28.3	67.7	54.0	38.0	67.6	65.5	52.6	36.0	30.3	43.9	19.7	37.8	33.6	105.3	129.5	38.0	23.3	78.0	36.9	39.6	56.8	59.4
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 85.6"	"Lineage enriched"	"Detected in all"	5	"T-cells: 85.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	18.1	23.8	101.7	11.9	119.4	2.7	18.0	116.6	121.1	39.5	65.1	43.3	7.0	43.5	4.3	14.9	38.3	11.4	42.0	123.3	105.3	21.5	3.8	22.5	13.9	123.9	106.0	39.2	16.3	21.4	61.3	8.6	135.0	23.7	4.7	23.3	13.4	25.9	42.3	12.2	19.2	33.2	109.4	13.8	19.4	12.7	112.1	28.9	19.1	54.0	11.1	31.2	23.5	152.9	0.0	14.9	50.6	22.8	26.7	27.4	0.2	24.6	41.7	41.2	51.4	26.4	10.3	0.0	3.6	44.3	36.9	0.5	44.4	7.5	19.4	27.8	33.7	0.3	9.3	0.9	19.3	0.2	9.9	24.8	1.9	19.4	2.9	35.3	51.7	1.2	1.1	0.7	15.3	0.5	0.5	0.1	18.3	0.8	15.5	0.2	2.0	0.2	1.7	0.2	68.1	37.6	3.6	3.0	15.9	15.2	2.1	3.4	22.8	4.2	24.8	27.5	5.0	13.8	6.8	2.0	21.1	0.0	14.3	8.4	1.7	0.3	23.2	1.5	25.2	6.7	32.5	30.2	1.7	16.2	85.6	51.7	1.6	16.5	0.6	0.3	48.7	29.9	101.7	119.4	116.6	121.1	123.3	105.3	123.9	106.0	135.0	109.4	112.1	152.9	9.6	19.2	5.4	22.9	7.5	5.0	12.1	3.6	12.0	45.8	6.6	5.7	50.5	11.5	5.4	5.5	22.9	0.4	4.6	1.1	25.4	18.2	5.6	7.6	9.5	13.9	19.3	4.0	47.1	4.2	0.7	15.2	4.6	2.3	1.3	10.8	15.7	3.3	1.2	40.4	44.8	1.2	0.0	1.9	4.0	13.1	9.6	1.8	8.8	7.5	3.2	24.7	9.2	49.3	102.3	8.0	1.7	19.2	1.4	8.3	0.4	21.6	17.3	20.1	6.6	10.0	17.3	6.9	13.7	3.2	2.8	0.8	20.1	7.0	1.3	5.4
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC regulator of WNT signaling pathway"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013349, HPA013362"	Supported		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA013349: AB_1844913, HPA013362: "	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	6.9	4.6	28.4	6.2	26.0	9.1	5.7	23.1	31.0	5.7	0.1	6.7	6.2	5.6	3.3	7.7	4.3	4.9	7.2	52.8	27.4	6.2	5.7	6.2	5.6	32.1	30.7	6.6	4.1	8.5	3.9	5.1	39.0	5.2	6.2	20.0	3.8	4.1	8.5	5.7	8.5	7.5	16.0	6.1	5.0	5.1	37.9	8.5	5.9	11.8	5.9	5.4	3.6	20.9	11.3	10.1	16.8	12.2	13.4	11.3	6.7	17.9	8.5	9.7	11.5	8.2	8.9	22.0	17.0	23.1	15.5	9.0	17.4	14.6	15.9	13.2	12.2	16.8	14.9	6.2	6.6	8.4	8.6	9.3	9.8	16.6	10.8	6.8	13.6	10.2	20.9	7.2	14.3	7.8	9.6	4.2	6.0	6.1	3.6	8.1	20.8	10.7	8.9	14.1	17.0	10.1	16.9	6.5	7.1	6.8	9.1	6.7	22.8	19.6	9.5	19.5	13.6	5.6	9.5	8.2	10.8	15.3	11.2	11.8	2.5	4.9	2.9	1.3	2.4	2.8	1.5	1.9	2.1	3.1	2.4	2.4	11.4	2.9	2.4	2.7	1.5	1.0	28.4	26.0	23.1	31.0	52.8	27.4	32.1	30.7	39.0	16.0	37.9	20.9	40.6	51.3	23.6	536.4	21.9	11.2	8.9	10.1	19.9	196.9	13.1	14.9	56.6	18.6	20.1	0.0	66.7	5.4	28.9	28.6	0.0	18.7	10.5	20.1	27.6	31.2	27.5	17.4	165.8	19.5	6.5	25.9	19.4	29.7	19.0	28.7	26.7	13.9	16.3	79.1	236.4	17.2	2.0	18.9	12.4	5.5	17.7	27.8	17.8	85.3	30.7	23.4	23.7	196.6	150.8	20.3	34.7	19.5	22.9	10.4	37.2	5.1	18.0	41.5	39.5	44.1	34.0	19.2	30.4	26.5	11.6	2.9	22.4	27.1	16.0	8.9
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3629.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	47.7	0.2	0.0	0.0	1.3	3629.2	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm		Yes	No		330000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: AB_2666158, HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	83.9	103.6	56.9	82.8	58.1	154.9	103.2	60.0	67.5	80.4	57.9	89.1	107.5	97.2	66.5	80.5	99.1	79.7	76.6	57.5	60.3	82.8	104.6	61.0	112.4	58.9	58.3	146.3	92.2	88.3	39.3	57.3	59.5	69.3	92.7	52.9	66.0	80.2	102.9	83.4	73.0	95.7	59.5	68.9	85.4	21.5	60.1	125.0	93.2	71.9	121.2	103.8	65.8	62.6	249.3	296.8	267.8	247.2	180.9	259.3	226.5	227.3	245.7	333.3	287.4	216.9	240.7	477.9	198.4	176.4	178.1	262.5	317.5	242.1	304.8	214.7	135.9	195.5	162.8	368.9	189.5	623.1	193.2	270.6	261.6	217.6	212.6	267.2	282.3	193.9	228.4	153.6	270.7	240.0	404.7	264.7	260.3	282.4	269.5	441.5	297.7	200.8	281.7	327.1	315.2	201.8	248.5	305.2	253.1	185.0	186.4	276.7	186.0	175.0	292.8	177.9	216.6	203.1	375.8	327.7	77.8	390.7	224.7	0.9	106.7	7.5	79.6	93.4	108.4	154.8	98.9	95.4	208.6	140.5	133.1	117.7	6.8	97.6	60.1	235.6	65.8	200.3	56.9	58.1	60.0	67.5	57.5	60.3	58.9	58.3	59.5	59.5	60.1	62.6	63.8	64.1	57.6	11.8	120.3	106.4	101.1	192.9	136.1	57.5	131.3	136.8	50.1	111.5	117.1	68.0	41.7	200.1	114.1	32.4	150.6	152.7	19.9	65.0	161.1	75.6	120.0	135.6	20.6	104.5	212.6	88.7	72.9	82.0	81.6	165.5	42.1	70.8	175.6	28.6	19.5	85.4	138.4	96.7	89.4	5.8	80.5	95.2	64.0	11.2	121.9	77.4	75.2	22.6	19.4	78.2	73.1	64.3	71.1	60.4	66.2	170.1	64.6	51.6	52.6	87.5	174.2	8.5	43.0	106.4	97.0	101.5	75.1	198.4	157.6	76.8
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APLP2	"APPH, APPL2"	ENSG00000084234	"Amyloid beta precursor like protein 2"	Q06481	11	130068147-130144811	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 249.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039319	Approved		Approved	Vesicles		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA039319: AB_10673141"	"unprognostic (2.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.33e-9)"	"unprognostic (3.20e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.42e-2)"	217.2	130.2	125.6	144.0	126.0	196.5	192.3	164.7	157.9	170.4	252.6	209.9	272.4	176.6	138.6	134.2	167.6	201.8	271.6	131.0	153.2	359.9	334.8	391.4	77.5	130.9	137.5	180.8	136.0	291.5	87.1	324.8	133.1	287.7	176.7	540.8	135.3	291.0	65.9	113.3	226.6	211.5	135.4	95.7	149.7	54.9	157.9	81.5	607.8	85.2	56.8	199.1	129.6	152.8	216.7	170.3	307.1	281.2	1259.7	847.8	393.7	598.6	741.1	294.2	251.8	1300.5	1541.3	107.9	1515.3	1422.2	322.4	540.4	229.1	567.6	168.0	165.6	206.4	180.9	116.7	502.9	191.9	556.7	363.8	566.4	367.8	244.5	469.5	1520.2	912.7	34.1	180.7	228.9	495.2	205.7	26.9	245.3	182.8	256.8	301.1	70.0	69.8	105.5	758.9	589.6	109.9	239.0	706.9	368.0	92.0	535.8	582.2	489.5	1567.6	314.1	211.7	496.8	281.9	33.8	50.6	245.5	347.0	487.7	221.0	55.1	249.3	65.3	17.9	122.2	13.5	16.3	12.7	17.0	110.1	44.8	9.4	12.6	160.8	15.6	94.6	10.5	20.0	149.5	125.6	126.0	164.7	157.9	131.0	153.2	130.9	137.5	133.1	135.4	157.9	152.8	239.6	942.3	550.3	37.9	74.4	106.7	175.4	497.0	78.6	967.9	252.9	183.1	262.0	254.5	460.6	404.6	706.8	798.1	72.0	354.2	52.8	305.5	13.6	211.0	191.3	220.3	92.8	156.3	99.0	107.1	130.3	253.5	86.6	432.8	103.5	109.6	127.1	498.2	652.4	240.6	133.5	159.8	463.9	287.6	214.3	13.8	167.4	405.5	96.0	54.4	293.1	396.1	56.7	45.8	31.6	276.5	220.7	214.4	45.5	190.1	352.0	244.9	258.3	729.0	190.7	148.9	207.7	182.8	240.4	81.6	109.4	927.3	58.8	165.9	161.5	215.4
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992751	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 314.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 325.4;Hepatocytes: 251.1;Syncytiotrophoblasts: 751.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 680.7;NK-cells: 343.8;T-cells: 367.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Approved		Approved	"Plasma membrane"		NA	NA		130000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: AB_2685328"	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	168.0	44.6	59.2	47.2	60.1	187.4	84.6	76.0	65.4	41.8	62.2	46.5	32.7	46.8	106.3	26.7	46.0	43.1	37.5	64.1	72.6	50.5	314.0	53.2	44.0	61.4	62.8	40.8	45.2	83.4	78.7	80.2	68.6	44.2	42.9	32.0	40.1	47.9	39.5	55.8	34.7	49.2	60.5	66.6	38.5	54.2	69.7	42.4	209.1	24.4	34.1	51.8	29.5	68.8	110.6	191.3	90.0	139.5	175.3	97.5	94.4	141.8	153.4	133.3	137.4	113.7	189.3	45.9	161.1	170.6	232.1	198.1	85.0	165.1	149.1	62.3	69.7	51.2	66.0	226.9	140.9	99.5	115.4	134.3	226.9	154.9	107.0	173.8	192.5	73.4	61.5	195.8	128.6	168.1	68.9	108.2	59.3	166.6	172.1	56.3	312.8	96.3	140.2	98.9	150.6	59.4	146.9	240.5	157.1	92.0	87.6	78.8	173.7	156.9	140.6	134.7	209.5	113.0	134.3	50.9	83.1	148.0	151.9	61.8	99.3	198.9	367.9	98.6	228.8	36.4	100.8	268.2	102.1	37.4	78.6	202.2	680.7	343.8	71.3	50.7	75.0	363.3	59.2	60.1	76.0	65.4	64.1	72.6	61.4	62.8	68.6	60.5	69.7	68.8	28.5	19.2	32.7	25.8	22.2	24.3	46.7	77.6	17.1	51.4	48.1	32.1	17.5	34.3	39.7	49.7	10.4	325.4	163.2	18.9	17.6	72.0	22.9	18.0	26.3	42.4	18.0	33.6	24.0	45.4	50.6	40.6	15.3	23.8	36.1	68.6	41.4	251.1	95.9	16.8	25.4	19.4	85.5	50.0	94.8	32.5	65.0	59.5	46.2	42.2	105.1	35.0	222.5	19.6	15.9	40.8	25.4	82.0	54.9	34.1	20.8	13.2	24.5	22.5	39.5	36.9	33.2	97.1	90.1	16.7	20.0	751.1	96.7	38.3	28.0	28.1
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19248.5"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	3.2	1.4	1.2	3.6	1.2	0.0	2.1	1.1	1.4	0.8	0.8	7.4	1709.3	3.5	0.4	1.1	6.1	1.7	67.2	1.0	1.1	3.7	19248.5	2.7	3.2	1.1	1.1	23.1	2.5	0.0	4.2	1.6	1.1	1.1	0.2	0.1	0.7	1.0	0.8	1.0	4053.7	2.1	1.1	9.0	14.6	384.5	1.2	0.9	3.7	0.2	0.1	0.5	1.5	1.2	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.2	1.2	1.1	1.4	1.0	1.1	1.1	1.1	1.1	1.1	1.2	1.2	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1388	"liver: 36012.6"	"Cell type enriched"	"Detected in some"	75	"Hepatocytes: 50065.8"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 16822.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	92000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	3.8	1.1	0.7	0.7	0.6	25.9	1.8	0.5	1.4	0.9	1.0	0.7	0.0	0.7	0.1	1.0	1.9	0.0	2.0	0.6	0.8	9.5	36012.6	2.1	0.3	1.1	0.8	0.7	2.0	0.0	1.2	1.3	1.1	0.6	0.5	0.0	0.6	0.0	0.6	0.9	0.9	0.0	0.8	7.7	1.9	1.2	0.7	0.4	0.8	0.0	0.3	0.4	0.8	1.0	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1814.4	0.0	3.6	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	5.8	10.0	16822.4	0.0	19.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.7	0.7	1.5	0.0	1.1	1.3	14.6	0.3	0.0	11.3	0.8	0.0	7.8	0.0	0.2	5.2	0.1	0.0	4.1	0.0	0.1	0.0	0.0	3.8	0.0	5.2	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.6	0.5	1.4	0.6	0.8	1.1	0.8	1.1	0.8	0.7	1.0	0.0	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	480.4	0.0	0.0	0.0	0.8	0.0	0.1	1.9	0.0	1.7	0.0	0.0	22.5	0.0	323.6	0.0	0.6	6.4	0.2	0.0	0.0	0.0	0.0	425.9	50065.8	4.7	0.0	0.0	0.2	0.0	665.8	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	5.6	26.0	0.0	0.0	0.0
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823304	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 3112.4"	"Cell type enriched"	"Detected in some"	44	"Proximal enterocytes: 10311.5"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	74000000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.3	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.9	2204.9	1.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	257.2	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3112.4	3.0	0.0	0.1	4.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	77.5	0.0	0.0	0.0	234.3	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.5	0.0	0.0	0.0	10311.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	87.7	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	216	"liver: 582.1"	"Cell type enriched"	"Detected in some"	88	"Hepatocytes: 1249.5"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"Hep G2: 35.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	114000000	21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	582.1	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	35.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	1249.5	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16232.1"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	59.2	1998.1	90.3	28.1	133.0	52.2	87.1	83.3	338.1	29.0	73.6	29.1	13.1	11.0	42.0	5.9	21.2	31.0	10.9	75.3	109.8	14.6	16232.1	289.9	140.1	133.2	152.8	56.4	21.4	16.3	23.6	41.7	121.9	14.4	16.7	15.1	35.5	2.2	22.2	73.1	49.1	4.0	92.7	254.9	22.7	18.7	139.2	37.4	36.3	6.1	33.9	23.5	11.3	169.4	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	90.3	133.0	83.3	338.1	75.3	109.8	133.2	152.8	121.9	92.7	139.2	169.4	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"liver: 9641.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.2	5.4	49.5	1.7	55.2	1.1	5.3	55.1	116.2	4.5	44.7	4.3	41.4	1.2	4.8	2.4	4.3	3.7	0.8	50.7	69.2	16.3	9641.4	34.9	15.8	65.3	64.9	0.4	2.2	6.6	3.0	2.9	74.3	1.3	4.4	2.8	2.4	2.1	1.9	4.3	65.6	0.7	63.3	3.9	2.7	1.1	59.9	3.2	0.9	0.7	9.9	2.2	0.8	75.0	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	49.5	55.2	55.1	116.2	50.7	69.2	65.3	64.9	74.3	63.3	59.9	75.0	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942237-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"liver: 629.1"	"Cell type enriched"	"Detected in single"	37	"Hepatocytes: 3.8"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Region enhanced"	"Detected in single"		"white matter: 3.0"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.4;TIME: 1.2"	"Not detected"	"Not detected"							HPA062671	Approved				"Secreted to blood"	NA	NA	1000000000	980000000	"Cluster 6: Non-specific - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.2	0.3	0.4	0.0	0.8	0.5	0.2	0.5	0.9	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.3	0.2	0.2	0.5	0.0	629.1	0.2	0.1	0.5	0.4	0.3	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.1	1.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.1	0.5	0.3	2.4	0.0	0.3	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.0	0.1	0.1	0.4	0.0	0.0	0.4	0.8	0.5	0.9	0.2	0.5	0.5	0.4	0.4	0.3	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568705-195584033	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 5037.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 4485.3;Leydig cells: 2077.4;Melanocytes: 1028.1;Peritubular cells: 994.5"	"Cancer enriched"	"Detected in all"	4	"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"memory B-cell: 5.0"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.0"	"Group enriched"	"Detected in many"	6	"ASC diff: 3507.4;ASC TERT1: 1918.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	90000000000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	2071.8	84.8	949.6	13.9	1157.3	0.9	5037.8	1174.9	1364.1	620.2	1370.1	144.7	56.0	496.7	155.7	160.0	750.6	213.3	1007.8	952.8	1010.4	49.7	7.1	183.5	24.6	1148.3	1040.5	131.2	212.4	61.9	192.2	350.5	1122.0	419.8	57.2	0.8	1272.3	183.8	1154.9	970.1	88.4	96.2	1027.5	8.2	402.6	75.7	1070.2	113.5	828.8	625.3	20.8	434.4	591.7	1347.6	0.0	2.2	0.5	0.7	3507.4	1918.1	6.1	31.3	7.6	0.1	0.2	222.4	0.4	0.4	0.9	1.8	0.0	0.9	0.4	10.5	0.3	0.3	2.4	0.3	0.2	0.1	12.5	0.3	0.5	91.4	21.0	0.2	17.0	0.3	4.3	0.2	0.2	0.9	5.3	1.3	0.1	0.7	0.5	38.9	0.5	0.1	0.0	0.6	0.0	2.8	0.7	0.5	0.0	34.8	31.8	1.3	67.2	0.1	0.4	0.5	1.4	0.4	0.1	0.2	0.3	9.2	1.0	0.4	420.3	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	949.6	1157.3	1174.9	1364.1	952.8	1010.4	1148.3	1040.5	1122.0	1027.5	1070.2	1347.6	543.2	0.0	11.0	2.9	7.5	145.0	16.0	25.4	46.7	0.0	121.6	138.7	26.9	1.5	81.8	5.5	0.0	5.4	15.9	1.4	0.0	0.4	9.7	16.3	393.7	114.1	46.3	0.0	3.3	0.0	4.2	4485.3	7.7	7.0	0.0	0.0	21.4	0.0	13.3	0.0	2.1	0.7	10.2	0.3	193.2	51.0	2077.4	31.8	1028.1	279.2	1.0	0.0	0.0	300.6	221.5	2.3	0.3	994.5	19.2	25.7	0.0	0.2	128.9	0.0	19.7	100.3	210.7	10.5	4.0	24.1	102.6	5.9	23.5	7.0	0.6	47.3
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905791-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 3453.9;liver: 6592.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 9363.4;Hofbauer cells: 6072.6;Muller glia cells: 9454.8;Peritubular cells: 4958.2;Proximal tubular cells: 8155.9;Theca cells: 7201.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1867.0;CACO-2: 466.1;Hep G2: 935.3;HSkMC: 1374.2;SK-MEL-30: 1956.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	29000000000		"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	522.1	3453.9	813.4	92.8	1164.2	66.5	325.1	775.0	943.2	271.2	329.2	130.9	40.3	81.5	20.0	37.2	72.2	100.2	176.3	606.1	841.6	1066.0	6592.5	258.8	352.2	1016.0	1037.0	508.2	41.9	34.5	110.9	102.2	1106.9	45.4	22.9	87.6	80.5	10.8	31.1	381.2	165.9	12.6	823.2	620.3	83.3	140.5	962.6	57.8	146.4	10.4	46.1	93.4	135.5	964.4	3.2	5.2	9.5	2.6	1867.0	76.3	69.4	1.5	4.3	8.4	1.4	466.1	2.8	2.0	9.9	0.3	9.1	6.4	12.6	2.1	0.7	1.7	4.0	3.3	1.7	935.3	192.4	6.8	2.3	1374.2	2.5	14.8	1.3	15.6	1.0	0.7	124.9	2.8	1.2	3.3	1.9	2.5	243.2	3.0	1.3	2.6	8.0	1.8	2.8	0.9	5.6	2.4	4.5	1.4	1956.0	131.6	165.3	52.8	3.3	13.2	3.1	1.4	1.6	5.9	8.6	3.8	5.9	4.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	813.4	1164.2	775.0	943.2	606.1	841.6	1016.0	1037.0	1106.9	823.2	962.6	964.4	136.7	0.0	8.2	444.0	66.1	935.2	12.3	18.3	67.7	81.7	86.7	565.8	2.2	450.4	5.2	228.1	41.7	46.3	6.0	2.2	682.9	1.8	73.6	33.8	936.6	140.2	0.0	331.6	1.1	0.7	43.8	860.7	3.6	22.9	174.4	103.6	208.9	9363.4	6072.6	38.7	2.1	0.6	4.1	718.0	292.6	355.3	2629.4	940.6	2481.3	60.9	70.3	9454.8	0.0	12.1	2.2	0.6	0.3	4958.2	7.2	15.0	0.2	8155.9	1.0	311.4	223.5	2958.4	345.5	14.8	12.8	15.1	1684.9	74.3	60.6	7201.0	1.7	4.7
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360568-56362857	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	344	"liver: 416.7"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 341.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	18000000000	2200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.3	0.1	0.2	0.2	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	416.7	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.4	4.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.7	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.3	8.6	0.0	0.0	2.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	16.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	5.0	341.9	0.0	0.0	0.0	0.1	0.0	10.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
APOL2	APOL-II	ENSG00000128335	"Apolipoprotein L2"	Q9BQE5	22	36226209-36239954	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 80.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001078, CAB026695"	Supported					NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"CAB026695: , HPA001078: AB_10602432"	"unprognostic (4.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.26e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (5.06e-6)"	42.0	23.4	36.5	43.6	38.3	13.0	37.4	37.0	49.7	36.8	34.9	28.8	41.8	33.1	17.8	18.4	30.2	42.1	40.0	38.6	43.2	52.6	65.4	44.8	42.5	52.0	41.6	19.5	15.3	19.7	47.3	22.3	52.3	34.2	26.5	12.2	25.0	28.3	28.0	16.2	32.3	35.8	42.1	46.6	38.3	6.8	38.2	29.6	19.4	18.3	30.4	59.5	26.1	38.2	24.0	18.7	17.0	12.7	63.6	49.1	31.7	32.1	73.4	84.1	113.3	7.1	19.2	29.3	52.4	57.2	52.0	11.1	18.3	25.4	41.6	98.0	21.3	13.4	39.9	33.5	107.3	29.0	25.2	62.4	17.0	59.2	15.5	35.2	55.8	16.4	24.8	79.1	53.2	9.4	29.8	13.2	6.3	8.6	16.4	30.3	21.6	17.3	85.6	63.3	30.2	8.5	21.8	40.7	18.4	11.5	12.8	4.1	54.8	50.6	25.1	10.6	17.9	47.6	25.8	9.1	43.7	15.0	19.6	31.1	22.8	16.8	39.7	46.6	36.3	16.3	28.6	33.2	16.5	10.3	16.2	27.1	116.5	28.4	34.0	10.2	29.2	14.3	36.5	38.3	37.0	49.7	38.6	43.2	52.0	41.6	52.3	42.1	38.2	38.2	14.8	35.3	16.8	8.5	12.5	6.0	8.0	21.4	0.6	5.0	7.5	5.0	24.3	21.5	20.1	12.9	0.0	16.6	17.1	31.8	17.6	42.6	0.2	53.0	21.1	21.2	4.8	8.6	18.1	62.9	10.7	19.5	21.4	80.2	2.5	8.3	18.9	65.4	24.2	6.7	9.3	12.0	22.4	20.9	13.0	1.9	16.8	15.0	8.8	7.5	26.6	9.3	25.7	12.1	4.8	68.1	14.5	20.7	17.9	28.4	33.1	25.6	15.6	5.1	0.0	23.9	12.4	0.4	0.2	2.8	6.7	15.2	19.1	10.4	8.0	19.4
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 32.7;Enteroendocrine cells: 14.9;Glandular and luminal cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.6;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.7;HDLM-2: 109.9;HSkMC: 16.1;K-562: 23.7;SCLC-21H: 47.9"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA049797: AB_2680887, HPA055435: AB_2682816"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favorable (2.40e-6)"	13.5	1.0	0.8	6.0	0.8	1.5	14.7	0.9	2.2	4.6	0.5	3.3	4.8	3.9	1.6	4.3	5.9	6.3	5.3	0.9	1.6	8.1	2.0	12.8	4.7	2.5	1.3	3.9	1.0	0.3	9.4	3.3	1.9	14.7	3.4	0.1	5.8	3.4	1.1	4.1	3.8	2.4	1.0	3.2	4.9	0.7	1.1	2.9	3.2	1.3	1.8	12.1	3.6	0.8	0.0	0.0	0.0	0.0	0.2	2.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	109.9	0.0	5.7	0.0	0.0	0.1	0.0	0.2	16.1	0.0	0.0	0.0	0.0	0.8	0.0	23.7	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	47.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.8	0.8	0.9	2.2	0.9	1.6	2.5	1.3	1.9	1.0	1.1	0.8	7.0	0.0	6.7	0.3	0.2	1.3	0.7	1.5	0.0	0.3	4.6	2.2	1.1	1.5	3.4	0.0	0.0	0.5	0.1	0.0	3.9	0.2	0.0	32.7	12.4	6.6	14.9	4.2	0.0	0.7	1.0	10.4	0.0	52.6	2.5	0.0	2.5	0.4	2.3	1.7	0.1	0.8	0.0	6.2	6.5	0.0	2.8	8.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	1.2	0.2	0.3	4.2	0.0	0.0	9.0	1.9	0.0	0.0	0.0	1.1	6.2	1.3	0.5	0.4	1.9
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.4;tongue: 2.0"	"Cell type enhanced"	"Detected in single"		"Early spermatids: 1.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"U-698: 1.7"															NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 390.7"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.9	5.3	0.6	0.1	0.6	2.5	5.2	1.0	0.9	3.7	0.5	3.8	0.6	3.9	1.0	4.1	4.1	0.5	3.5	0.6	0.7	93.7	390.7	2.6	0.6	0.7	0.7	6.2	6.0	0.7	4.7	0.1	0.7	3.8	0.4	0.4	3.5	0.5	7.2	6.4	9.0	0.4	0.7	4.1	5.3	16.0	0.6	1.2	5.5	0.6	1.1	3.3	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.6	0.6	1.0	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 870.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 38.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		26000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	249.9	498.0	413.0	157.4	457.6	134.4	447.5	413.1	572.4	264.2	396.8	357.2	226.4	281.1	293.3	178.6	308.1	350.8	389.0	456.2	405.3	532.5	298.2	279.4	78.9	425.0	481.9	306.2	323.5	278.6	155.4	451.9	448.7	260.6	328.5	209.3	270.7	343.6	107.5	218.6	200.3	379.9	419.7	154.4	213.5	165.6	426.4	159.2	469.9	176.0	78.2	304.9	151.7	523.5	388.7	489.9	538.4	448.5	707.7	869.8	559.8	757.1	1029.2	386.6	449.3	286.4	941.0	0.9	848.3	614.8	505.1	255.6	326.4	921.6	324.4	14.7	253.1	0.8	275.6	204.1	688.0	372.0	19.6	790.4	990.7	456.8	823.0	1584.3	1750.7	158.6	0.8	39.0	614.5	433.1	6.5	4.0	416.2	644.9	418.6	241.2	505.2	325.3	1283.3	270.1	267.3	385.6	824.0	549.0	393.4	720.0	482.4	400.1	1837.1	850.8	350.2	310.4	371.6	232.3	3.1	4.8	690.4	1.6	836.3	1.1	7.5	0.0	0.2	2.2	0.3	0.8	2.2	0.7	5.6	2.2	2.3	0.6	1.5	0.5	1.6	38.1	0.6	3.3	413.0	457.6	413.1	572.4	456.2	405.3	425.0	481.9	448.7	419.7	426.4	523.5	330.2	109.0	39.6	70.5	47.6	181.6	215.6	449.0	306.7	45.2	280.3	199.6	143.2	296.0	214.0	502.1	29.2	472.6	180.7	395.2	56.7	398.7	46.1	78.8	162.2	416.0	162.6	29.2	481.6	180.4	141.2	309.5	164.7	110.7	8.2	100.3	539.7	125.7	76.3	84.1	525.5	303.1	256.3	61.6	79.9	61.8	242.6	69.9	161.9	189.3	89.9	329.9	4.1	423.2	870.8	205.4	223.1	296.8	24.0	187.5	95.2	165.8	164.7	24.5	118.3	336.5	198.5	38.3	86.9	85.9	106.1	552.1	27.0	111.4	283.5	133.6
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811937	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	118.5	161.2	30.1	73.6	30.1	103.1	112.3	32.0	39.5	109.6	39.3	121.0	72.2	81.2	25.5	231.1	87.6	31.4	70.2	29.9	32.0	128.7	190.4	85.8	83.8	32.9	31.3	73.3	169.4	66.1	64.9	37.0	32.1	113.6	40.2	5.1	119.8	44.6	62.7	240.1	106.8	29.8	33.7	128.6	131.8	35.2	35.1	77.2	96.9	23.8	64.5	95.7	153.7	35.7	157.9	228.3	44.9	200.4	54.2	106.0	232.2	117.1	105.0	136.0	52.6	237.6	189.0	145.5	221.9	68.4	65.0	165.3	74.8	195.4	27.5	102.9	417.7	124.3	106.5	253.0	168.1	87.4	97.7	113.1	207.6	109.0	139.4	63.7	172.6	244.6	266.6	107.9	71.4	586.0	242.1	254.7	169.4	169.5	288.8	259.2	69.2	351.5	156.3	107.0	218.2	132.4	223.5	130.7	131.2	41.9	427.9	171.1	111.4	122.5	104.9	99.5	118.0	205.9	186.5	408.8	179.9	228.4	110.5	77.7	544.5	202.8	474.5	473.5	631.7	501.1	612.0	510.3	562.4	517.3	557.8	475.3	31.8	501.8	322.1	731.6	551.8	998.0	30.1	30.1	32.0	39.5	29.9	32.0	32.9	31.3	32.1	33.7	35.1	35.7	146.5	115.4	147.4	5.9	247.0	319.0	320.0	375.7	207.7	19.9	346.2	479.7	46.9	230.2	206.8	92.0	6.2	265.0	262.3	273.1	406.9	404.3	11.8	124.6	180.3	163.1	210.8	150.6	5.1	442.6	401.5	170.3	192.7	148.4	131.9	154.9	147.8	309.6	348.0	15.2	4.4	386.4	160.7	253.9	336.1	35.4	239.9	214.6	297.1	3.7	449.4	78.7	355.3	2.5	7.2	392.3	228.3	135.4	171.6	404.3	349.2	647.9	125.5	20.4	39.5	135.6	186.5	18.4	126.9	358.8	494.7	172.7	285.7	339.5	426.7	385.2
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1526.1;skin 1: 581.9;urinary bladder: 688.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 5.3;medulla oblongata: 16.0;pons: 21.0"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	10.9	2.1	1.5	16.8	0.4	19.7	36.6	2.4	3.4	173.3	1.4	10.3	73.4	10.9	2.9	1526.1	25.4	9.4	31.5	5.3	0.4	131.7	118.6	114.0	16.1	16.0	1.6	12.1	43.1	2.0	2.8	6.0	21.0	85.6	10.1	1.7	399.7	36.8	5.3	581.9	100.5	3.2	0.2	110.1	35.9	2.8	0.8	233.9	2.3	26.7	172.5	688.6	529.9	0.9	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.5	0.4	2.4	3.4	5.3	0.4	16.0	1.6	21.0	0.2	0.8	0.9	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544021-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 93.7;Granulosa cells: 104.8;Hepatocytes: 269.2;Leydig cells: 77.9;Peritubular cells: 86.5;Skeletal myocytes: 75.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.6;prostate cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;BJ hTERT+: 10.3;HAP1: 14.9;LHCN-M2: 16.1;RH-30: 23.6;T-47d: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000001, HPA004733, CAB065764"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	6.7	1.0	1.1	0.5	1.3	0.0	8.7	1.7	1.1	23.6	0.2	2.0	0.2	18.6	16.1	1.2	20.7	2.0	5.8	1.0	3.5	3.6	38.2	1.5	0.3	3.5	2.6	14.6	0.8	0.1	1.9	0.1	2.7	16.5	0.6	0.2	1.4	18.2	13.9	5.2	0.9	9.5	2.1	1.3	1.5	3.9	4.8	2.7	2.1	6.1	0.5	3.5	12.9	2.0	0.0	4.8	13.3	0.0	0.0	0.0	0.0	7.3	10.3	0.3	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	14.9	0.0	0.0	0.0	2.4	0.0	1.5	0.0	0.8	0.0	0.0	5.5	0.0	1.8	0.0	0.0	3.9	0.1	4.6	2.2	16.1	1.5	0.0	0.0	5.4	0.0	0.0	0.0	23.6	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	10.9	7.6	0.3	0.3	2.2	0.0	3.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.7	1.1	1.0	3.5	3.5	2.6	2.7	2.1	4.8	2.0	3.1	0.0	5.0	28.4	0.4	9.7	17.8	0.2	15.9	0.7	93.7	33.7	37.4	14.3	10.7	3.7	0.0	3.5	14.0	0.0	1.9	11.3	1.1	2.9	49.1	10.5	0.0	5.3	7.7	0.0	0.2	39.4	0.0	5.8	1.3	104.8	36.0	269.2	0.8	0.0	17.8	0.3	0.0	2.2	4.2	4.4	77.9	3.3	10.6	1.0	1.7	0.2	0.0	26.7	0.2	0.6	0.0	86.5	0.0	36.5	0.6	27.7	3.6	0.3	65.7	75.0	20.8	0.8	3.3	12.7	16.1	1.0	1.7	37.8	0.2	22.0
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561205-47571908	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066326	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	37.7	41.7	17.8	36.9	20.8	102.3	36.2	19.2	21.1	34.8	22.6	40.9	37.8	36.6	21.2	32.2	35.0	32.5	50.8	17.1	18.0	44.6	55.7	39.4	40.4	22.8	20.5	39.5	59.1	51.8	27.7	31.3	20.1	40.9	33.3	15.4	45.1	34.6	136.3	36.0	39.7	31.3	18.8	46.1	46.7	12.0	21.0	38.0	39.4	85.6	31.5	36.1	30.8	20.4	49.1	69.5	29.2	46.9	43.5	34.2	39.0	40.3	42.3	58.6	54.1	57.2	58.6	29.0	32.4	54.6	49.2	67.3	51.8	56.3	34.3	53.5	61.9	29.4	74.4	30.6	61.4	58.3	85.1	45.0	56.0	56.2	49.6	39.2	45.9	36.0	55.2	55.7	40.5	83.3	42.6	64.0	41.8	41.2	77.8	39.2	38.0	65.5	34.4	46.7	32.8	25.0	43.7	39.7	24.5	47.0	74.9	43.3	44.2	38.0	42.5	76.2	41.4	71.1	49.2	22.5	50.8	65.3	31.1	48.3	47.8	61.3	44.1	57.8	40.3	32.6	38.4	40.9	55.2	37.3	33.5	40.5	37.8	38.7	67.9	40.4	41.6	50.8	17.8	20.8	19.2	21.1	17.1	18.0	22.8	20.5	20.1	18.8	21.0	20.4	13.3	16.0	29.2	7.5	25.8	15.7	25.0	29.0	18.2	5.3	15.0	9.8	25.1	34.3	22.0	18.4	10.4	33.0	26.3	43.8	23.5	29.3	1.3	11.4	10.8	17.5	31.8	22.3	5.0	34.3	30.4	16.9	39.3	15.6	16.5	13.6	24.3	42.6	28.0	13.5	5.5	35.9	40.7	26.4	21.6	4.3	17.4	25.8	33.8	4.7	43.7	18.4	32.0	8.5	8.9	26.2	41.5	17.7	27.9	20.3	44.6	27.1	11.5	9.0	19.7	15.9	18.0	8.2	10.5	17.7	16.2	44.6	26.5	12.5	32.3	24.6
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		140000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	75.4	67.7	47.5	53.8	51.0	30.4	67.5	52.0	60.5	78.0	61.2	65.0	59.2	69.2	111.1	72.5	60.5	51.6	75.6	46.8	50.9	58.3	91.6	62.6	53.2	51.2	51.3	65.5	119.7	61.9	88.7	54.7	51.1	68.8	67.1	39.2	79.6	64.5	51.1	60.9	64.9	71.0	50.0	57.9	71.8	46.2	50.5	58.8	65.2	55.0	62.2	66.4	60.9	57.2	90.9	72.6	135.3	98.9	174.0	172.7	66.6	244.8	208.5	102.4	120.7	239.4	116.6	96.4	199.7	275.7	148.0	123.7	160.5	139.5	151.5	128.0	66.3	211.6	56.7	151.4	197.1	140.4	121.8	157.8	117.6	175.0	168.7	149.3	162.2	95.0	106.8	139.2	201.3	157.0	123.2	130.8	85.3	207.7	92.4	107.9	134.2	147.4	137.3	107.0	88.3	86.6	130.2	129.0	70.1	132.5	155.9	111.4	144.0	129.4	65.1	118.4	109.5	79.9	78.5	147.6	74.3	122.6	161.4	118.1	49.8	50.7	52.7	59.8	69.0	39.5	51.7	51.3	54.0	35.4	48.0	44.7	41.5	64.5	64.5	44.9	53.9	55.8	47.5	51.0	52.0	60.5	46.8	50.9	51.2	51.3	51.1	50.0	50.5	57.2	43.6	35.3	47.9	12.4	32.2	31.6	38.5	31.5	23.9	22.4	39.4	27.9	46.5	24.3	41.9	31.3	4.2	17.2	45.6	68.4	9.8	34.3	11.1	38.4	72.2	43.1	40.2	14.9	15.4	37.8	36.1	44.9	39.3	50.4	39.3	31.9	31.4	55.7	30.3	18.5	17.7	80.2	22.4	36.0	37.6	8.5	48.1	35.3	23.2	11.2	49.0	17.3	26.8	17.1	20.2	46.9	35.8	41.3	68.3	51.5	56.2	30.5	46.2	13.6	19.7	52.7	45.7	44.8	47.6	30.4	34.7	30.2	38.4	43.9	42.6	51.6
ARF3		ENSG00000134287	"ADP ribosylation factor 3"	P61204	12	48935723-48957487	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.99e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	63.1	73.4	113.5	79.9	151.8	66.7	53.1	53.9	154.2	66.9	31.4	98.0	57.7	59.8	71.0	79.5	59.2	46.6	45.2	167.5	102.3	85.6	45.9	71.0	50.6	70.1	77.1	47.3	46.3	138.1	75.2	58.6	71.7	55.2	89.0	78.0	55.1	59.2	16.9	68.2	65.4	72.0	70.2	60.7	55.3	48.9	128.4	73.3	69.5	16.7	69.8	64.8	51.0	100.4	212.1	305.2	131.0	116.7	106.5	77.4	124.8	137.8	173.0	158.5	136.4	407.0	272.1	168.6	201.4	151.2	124.4	171.7	182.9	186.8	142.4	206.8	94.2	274.5	243.0	118.3	66.5	212.1	213.5	87.4	145.2	172.8	102.3	172.1	170.9	111.8	170.4	89.0	137.1	256.7	158.1	116.7	185.4	338.5	162.4	150.4	75.0	111.6	173.3	265.7	134.7	122.7	148.6	171.2	129.7	144.4	290.1	167.1	238.8	117.3	187.1	74.2	87.3	86.0	210.4	123.0	154.7	162.0	68.4	5.7	39.0	27.7	13.5	25.2	10.6	13.1	15.6	16.8	52.1	12.7	8.4	9.8	54.8	18.7	17.1	40.2	14.0	21.3	113.5	151.8	53.9	154.2	167.5	102.3	70.1	77.1	71.7	70.2	128.4	100.4	35.8	25.6	33.2	19.6	31.4	60.3	41.5	92.2	61.5	34.5	60.2	40.6	10.1	54.3	47.4	99.3	10.4	56.4	54.4	228.4	66.5	114.8	49.9	41.3	31.8	55.0	70.8	26.5	44.3	90.7	119.8	42.7	34.1	48.9	27.9	59.5	57.5	48.7	132.8	43.7	36.8	71.5	75.3	86.9	81.2	101.9	40.7	79.9	44.4	18.7	128.1	57.4	50.4	14.6	20.6	103.2	176.3	37.2	37.6	60.5	78.9	143.3	45.8	24.1	32.9	24.0	52.3	52.6	63.8	61.6	65.8	69.0	31.3	43.2	67.3	56.7
ARF4	ARF2	ENSG00000168374	"ADP ribosylation factor 4"	P18085	3	57571363-57598220	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		3100000	"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.29e-7)"	"unprognostic (4.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (4.98e-3)"	128.5	162.7	53.5	107.4	56.5	72.6	138.4	56.5	73.3	208.7	75.3	158.9	123.5	121.7	226.7	108.9	96.1	154.8	116.5	56.8	64.5	114.4	172.6	126.3	73.9	57.4	62.3	113.5	151.2	101.5	105.8	181.8	59.6	138.5	197.2	54.0	182.1	132.8	64.8	67.3	109.2	169.2	61.6	66.5	130.9	100.8	58.6	74.9	143.9	69.5	97.3	203.6	91.4	63.6	251.8	90.4	218.5	182.1	516.7	533.3	212.8	617.9	585.5	382.0	483.4	264.4	235.0	89.2	110.3	774.3	334.8	95.4	234.0	353.1	491.3	111.7	76.9	183.4	196.6	351.3	647.1	115.7	127.8	517.3	308.8	355.4	423.8	482.6	480.1	86.8	134.5	173.8	672.8	123.1	69.7	146.8	263.8	333.5	306.5	40.7	173.3	170.5	459.6	175.8	67.5	164.1	252.9	240.1	325.0	298.5	167.9	193.4	369.8	299.8	174.9	447.9	360.6	126.3	116.3	124.0	331.4	220.8	378.3	249.4	85.3	95.4	41.1	72.8	72.2	53.2	58.3	53.5	72.3	48.1	71.4	55.5	102.8	58.2	65.9	109.2	59.9	90.8	53.5	56.5	56.5	73.3	56.8	64.5	57.4	62.3	59.6	61.6	58.6	63.6	172.5	76.9	90.8	18.3	150.2	350.1	505.9	429.6	195.8	32.2	249.8	204.7	48.4	91.5	259.6	97.5	6.2	322.3	146.7	226.5	191.7	287.1	179.1	195.5	197.2	146.5	164.5	232.4	25.2	232.6	448.2	298.4	200.3	301.4	101.7	121.8	101.7	161.0	197.2	18.5	26.9	403.7	248.2	90.1	264.9	72.6	177.0	139.4	241.9	15.9	112.8	156.2	35.0	30.2	30.2	396.8	238.1	185.8	346.8	399.6	180.8	178.5	201.2	27.2	78.9	115.1	345.5	132.4	80.7	188.2	321.9	698.2	133.0	230.4	272.3	599.7
ARF5		ENSG00000004059	"ADP ribosylation factor 5"	P84085	7	127588386-127591700	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		3900000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (6.72e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.81e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.46e-2)"	100.2	93.7	139.3	72.6	147.7	143.0	99.8	128.4	200.6	100.7	124.4	108.3	92.3	104.8	114.1	227.5	97.5	81.7	118.6	152.0	137.2	125.8	139.0	90.8	102.7	133.8	132.0	72.1	168.1	104.0	100.2	69.3	135.1	98.7	61.3	22.9	103.1	71.1	131.9	199.8	98.5	66.3	131.9	105.8	117.8	82.9	135.2	95.8	80.5	101.4	74.6	92.5	122.1	133.4	157.4	148.9	120.1	386.5	101.6	159.1	163.3	43.9	129.6	118.7	135.8	232.0	211.4	114.7	64.4	132.6	135.9	117.5	92.4	198.0	38.4	104.9	222.8	44.9	137.5	160.2	150.1	69.7	100.1	163.1	196.2	77.7	75.8	94.5	173.2	164.1	105.1	124.1	116.9	531.2	249.0	303.7	179.9	157.1	191.7	148.3	73.9	245.6	198.2	158.7	349.1	226.2	142.8	461.8	116.1	77.6	123.9	108.0	103.7	177.3	75.3	128.0	101.9	115.2	77.5	153.9	181.1	142.0	154.6	289.0	321.4	279.7	144.3	270.3	146.7	129.5	151.1	148.4	409.6	117.2	112.0	122.2	447.5	156.5	216.2	259.6	181.8	381.8	139.3	147.7	128.4	200.6	152.0	137.2	133.8	132.0	135.1	131.9	135.2	133.4	110.3	3.2	12.1	28.4	81.3	105.7	72.9	217.1	130.9	14.8	111.8	180.7	2.0	91.5	83.0	112.2	0.0	151.6	89.7	89.4	201.5	107.8	39.3	90.3	95.7	73.9	119.9	102.2	46.5	90.7	125.0	82.2	135.5	88.2	21.0	91.1	75.7	51.6	102.7	20.2	42.5	108.8	140.4	129.6	221.9	40.7	93.2	123.9	149.4	28.1	118.6	27.6	82.4	27.2	36.2	86.4	134.0	94.8	75.1	57.2	147.5	160.0	58.4	11.9	72.3	58.7	85.4	99.2	116.7	248.3	153.4	146.3	100.2	69.1	125.4	93.4
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289790	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	Cytosol	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.9	16.7	13.1	15.5	14.3	12.1	13.0	13.1	20.6	19.1	8.4	19.1	13.1	20.8	8.6	15.8	16.1	16.8	14.1	14.4	11.0	15.9	17.8	16.1	16.1	14.1	12.0	17.7	28.3	11.8	63.9	15.4	14.2	20.1	9.5	11.7	18.4	13.4	14.1	19.1	18.1	12.5	9.1	20.5	18.5	24.2	12.5	14.2	17.9	7.5	11.3	16.5	14.9	15.9	32.6	60.2	25.6	30.6	30.3	32.5	51.2	46.4	36.5	90.7	45.5	145.2	35.2	24.5	41.7	55.4	41.5	43.2	23.5	73.8	28.5	15.8	26.7	19.4	64.7	128.4	46.2	28.8	38.4	28.5	46.9	44.0	24.9	30.5	32.9	25.5	34.9	27.8	25.1	53.2	52.9	28.0	34.5	34.3	51.9	29.7	36.8	23.6	22.3	38.8	27.3	29.9	55.1	58.7	59.2	20.7	42.8	36.4	42.8	56.0	77.3	35.0	37.6	28.4	20.2	26.5	56.9	20.0	35.3	4.8	5.7	6.4	5.6	7.1	6.4	3.0	3.1	5.3	5.7	4.2	3.0	3.0	2.4	4.7	9.5	4.2	4.1	6.0	13.1	14.3	13.1	20.6	14.4	11.0	14.1	12.0	14.2	9.1	12.5	15.9	12.6	22.4	30.7	34.9	11.2	10.1	6.0	8.6	4.0	26.6	17.6	14.4	12.4	11.5	14.4	12.9	33.3	12.5	15.4	37.6	9.8	12.2	15.9	11.0	17.1	14.2	24.5	9.5	14.5	15.4	24.9	16.3	50.4	14.9	15.9	30.6	13.6	23.3	14.9	21.9	14.9	40.4	2.0	14.4	11.5	23.3	12.5	13.5	12.4	5.6	12.3	11.8	15.5	18.6	24.8	28.2	18.3	9.8	17.8	11.6	17.4	11.5	18.8	20.1	6.6	11.1	14.9	21.3	7.4	6.7	8.5	15.2	10.3	16.8	24.0	9.2
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700619	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Approved	Vesicles		NA	NA		11000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	84.5	49.2	40.9	38.0	48.3	33.4	61.8	33.4	46.1	71.3	31.2	62.8	25.7	93.7	21.5	75.0	68.4	50.7	112.3	39.1	41.0	41.5	46.2	38.4	30.7	45.7	43.2	46.4	36.5	24.7	36.8	39.0	39.0	64.9	32.6	9.6	46.1	62.6	30.0	65.3	46.7	80.6	38.0	58.4	49.0	15.8	49.8	23.2	44.6	20.5	34.6	107.9	63.4	57.4	23.0	56.7	27.9	39.8	135.4	99.6	32.9	50.3	50.7	45.3	41.2	34.2	29.5	33.1	26.7	102.3	40.7	55.8	22.4	76.0	33.5	23.3	24.6	36.8	27.7	40.4	44.5	31.3	52.3	131.9	46.7	34.5	42.9	46.8	39.1	27.1	24.3	30.3	55.9	82.6	21.2	30.9	72.1	78.5	29.4	25.0	39.9	49.3	42.3	85.2	10.0	31.6	45.8	69.8	19.1	40.1	88.0	35.4	49.1	82.1	25.5	98.7	51.0	32.0	38.2	24.8	77.4	52.0	39.3	27.6	33.0	33.1	26.7	56.9	19.3	14.3	20.8	22.8	32.3	14.7	17.9	20.8	37.3	23.7	72.0	34.1	27.4	24.9	40.9	48.3	33.4	46.1	39.1	41.0	45.7	43.2	39.0	38.0	49.8	57.4	25.2	19.2	18.7	16.6	18.3	8.5	13.4	24.6	10.8	11.9	22.3	24.6	50.2	10.0	18.1	29.5	27.1	25.1	35.2	35.2	3.9	22.2	0.4	17.9	26.9	19.6	19.4	15.3	13.0	27.9	31.0	29.2	31.6	27.6	19.6	21.3	25.7	32.1	30.4	16.8	15.3	36.0	14.2	30.7	8.4	1.7	23.6	19.1	8.8	11.2	28.2	11.0	36.0	23.1	92.3	27.3	19.2	35.3	10.1	11.4	22.4	13.3	10.9	14.2	59.2	28.0	55.9	3.1	3.5	24.7	13.1	16.6	19.9	9.4	21.5	18.7
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.7;granulocytes: 210.8;Microglial cells: 88.1;NK-cells: 103.0;T-cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 66.7;HMC-1: 256.1;NB-4: 47.3;U-266/70: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	11.1	5.2	5.2	38.8	5.4	37.4	8.0	5.6	7.9	6.0	5.1	7.2	6.2	6.7	22.7	4.3	4.7	11.7	6.7	5.2	5.6	7.1	10.1	21.3	71.4	7.6	6.0	16.7	2.1	2.3	3.5	10.7	6.7	5.0	9.6	0.6	5.1	3.8	3.2	6.2	23.3	8.3	7.1	72.8	8.8	2.5	7.0	27.3	5.1	8.4	67.3	11.9	4.7	8.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	20.8	0.5	0.0	0.1	2.5	0.0	20.5	0.0	2.3	0.0	66.7	0.0	0.0	1.0	14.8	256.1	0.2	2.4	0.4	8.1	0.0	0.0	22.2	0.4	23.6	0.0	0.0	17.2	47.3	1.2	0.2	0.0	18.7	4.3	0.8	0.0	5.4	4.1	0.6	0.2	0.0	1.4	1.4	0.0	12.3	3.5	0.1	0.9	0.1	0.5	50.8	29.0	16.8	0.2	33.3	0.3	234.8	60.8	528.7	171.3	75.9	107.0	156.4	76.2	150.0	37.4	100.8	54.2	95.2	657.3	170.6	94.8	52.3	102.0	132.0	5.2	5.4	5.6	7.9	5.2	5.6	7.6	6.0	6.7	7.1	7.0	8.4	14.1	3.2	15.0	0.3	88.7	5.6	12.4	2.9	5.7	0.8	0.7	6.1	1.4	1.5	2.0	0.0	0.0	0.5	35.1	0.1	1.9	0.1	1.8	0.7	0.6	16.6	3.0	11.6	15.5	0.2	0.4	3.5	2.0	0.4	210.8	0.1	15.4	1.0	48.6	0.0	0.9	0.5	2.0	27.3	12.8	3.6	1.5	22.6	1.8	88.1	40.9	0.5	103.0	0.5	0.9	0.0	0.1	2.6	34.7	1.2	0.0	0.2	5.2	0.2	6.6	0.8	2.1	0.6	1.3	2.5	1.4	0.3	53.7	1.8	0.2	2.5
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	11.2	5.5	3.6	43.1	3.4	68.3	5.5	4.4	7.5	4.2	5.1	12.4	7.2	3.5	0.5	5.5	6.7	5.0	4.4	3.3	4.4	7.8	7.4	39.5	58.4	9.1	5.4	2.0	2.7	0.8	4.5	6.0	6.9	5.9	2.6	8.7	6.4	1.5	2.1	3.9	53.2	2.2	7.6	106.1	10.9	3.5	8.1	32.9	9.0	0.8	18.6	6.6	5.5	11.4	11.2	2.1	0.1	12.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	29.2	13.9	73.7	3.0	0.0	0.4	9.6	2.1	0.6	0.0	54.7	1.0	10.1	22.6	3.5	0.4	48.6	56.2	0.0	2.9	0.1	0.0	0.0	0.1	46.8	6.8	100.4	0.0	0.6	54.5	43.4	7.6	1.9	5.4	52.0	0.3	74.7	0.0	0.2	0.6	0.2	16.8	0.0	4.5	0.7	3.5	92.3	4.8	0.2	1.9	0.2	0.3	130.8	60.2	58.8	0.3	72.1	5.4	6.7	24.4	25.3	45.7	21.2	38.8	15.9	52.2	54.1	22.5	18.3	68.9	53.6	37.0	28.0	20.9	13.3	43.5	59.8	3.6	3.4	4.4	7.5	3.3	4.4	9.1	5.4	6.9	7.6	8.1	11.4	2.0	48.1	8.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	15.2	11.0	0.0	0.0	1.8	11.0	0.0	40.1	62.7	0.0	0.0	2.6	0.0	4.5	0.7	1.6	0.0	0.0	0.0	3.8	56.6	1.3	0.0	3.5	3.8	0.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	72.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	15.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	75.5	30.2	0.1	0.0	0.0
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 381.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Cytosol"		"HPA046993: AB_2679895, HPA056507: AB_2683158"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	23.7	27.3	54.3	19.8	55.5	10.9	27.3	66.4	53.6	26.2	12.1	29.5	35.3	28.0	24.7	66.5	23.2	32.7	62.8	47.5	52.7	43.0	31.8	28.0	14.6	42.9	52.0	47.3	29.7	48.1	10.0	37.1	43.2	30.5	26.3	57.8	59.8	29.3	14.0	30.8	38.9	23.4	45.6	42.9	29.4	46.5	50.6	18.3	68.5	24.7	18.5	32.8	15.7	80.4	61.0	48.5	47.3	69.8	60.7	42.4	27.3	37.1	45.6	22.1	32.9	62.2	58.0	17.9	32.1	47.0	37.2	63.3	46.0	39.9	42.7	18.0	26.6	26.9	30.1	91.2	41.5	16.5	15.5	47.5	78.8	20.7	77.1	54.3	27.4	33.3	24.3	51.8	36.3	31.9	36.4	0.8	23.7	67.1	57.7	38.9	58.2	3.5	48.4	159.5	73.2	28.6	99.6	52.7	74.6	52.5	54.8	1.1	44.6	40.8	60.6	33.9	27.6	19.7	41.5	2.8	20.5	17.5	113.1	2.2	1.4	0.0	3.1	0.7	3.8	6.1	5.5	3.0	5.3	5.3	5.7	3.5	0.5	5.9	1.2	7.6	5.0	2.0	54.3	55.5	66.4	53.6	47.5	52.7	42.9	52.0	43.2	45.6	50.6	80.4	50.9	192.3	71.9	381.9	40.7	94.2	144.2	52.1	130.9	97.2	52.8	53.3	301.2	58.6	70.2	58.8	114.7	27.5	27.0	85.0	54.8	50.2	42.0	92.1	77.9	42.9	61.8	28.6	81.7	46.1	14.5	65.1	59.7	136.3	5.1	30.0	37.5	51.1	19.0	65.6	140.7	56.8	46.8	19.0	45.4	66.8	104.4	44.2	67.6	65.6	18.6	103.3	14.4	139.7	205.6	75.0	93.5	100.4	35.7	104.2	89.6	60.1	78.4	92.7	59.2	103.1	65.9	128.5	75.6	94.0	70.3	13.4	29.2	77.3	51.1	180.9
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11117651-11665920	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 44.3;Microglial cells: 127.4;Oligodendrocyte precursor cells: 60.3;Prostatic glandular cells: 54.4;Sertoli cells: 46.0;Skeletal myocytes: 62.3;Smooth muscle cells: 44.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;ASC TERT1: 34.2;HEL: 36.4;HMC-1: 24.7;HSkMC: 33.8;K-562: 26.5;RT4: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		350000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	10.8	1.1	9.0	1.7	5.1	0.7	5.6	2.0	4.2	7.6	3.2	13.9	2.1	10.5	8.2	3.8	8.4	4.2	4.0	5.0	5.8	6.5	0.9	9.6	1.2	3.2	4.0	16.4	1.9	1.2	3.2	7.0	3.2	27.6	3.9	1.0	2.6	30.9	9.6	2.5	4.7	12.9	2.6	5.9	4.1	1.9	6.1	1.0	25.4	8.1	0.8	10.4	5.7	3.8	0.0	0.0	2.4	0.0	26.2	34.2	0.6	0.4	0.6	1.4	0.9	0.4	0.0	0.0	0.0	5.0	0.0	0.1	0.9	0.0	1.2	0.6	0.5	36.4	0.4	0.0	9.7	0.1	24.7	33.8	0.0	2.5	0.1	3.1	0.7	0.1	26.5	12.3	1.5	0.0	0.0	0.2	0.7	0.2	0.4	0.1	11.6	15.7	8.3	20.3	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.4	0.3	1.6	0.7	7.1	0.2	0.7	0.0	0.0	0.5	0.2	4.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	9.0	5.1	2.0	4.2	5.0	5.8	3.2	4.0	3.2	2.6	6.1	3.8	9.6	0.0	1.7	10.4	5.3	2.0	16.9	0.3	2.8	4.3	2.3	3.3	4.7	0.0	2.6	33.1	0.0	0.6	0.4	0.0	25.4	0.0	0.1	0.1	5.1	9.2	1.2	2.1	5.5	1.1	0.7	29.1	3.6	0.2	40.0	3.0	8.2	0.0	4.9	0.0	44.3	0.4	0.0	2.2	18.9	0.9	16.1	29.1	5.4	127.4	3.4	7.2	0.0	60.3	3.5	0.7	0.0	10.1	4.9	54.4	0.0	7.4	5.6	0.7	46.0	62.3	44.4	0.2	0.4	4.5	1.7	0.0	1.2	2.1	0.0	22.3
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol		NA	NA		21000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	274.5	196.2	116.6	154.7	122.9	219.4	227.6	92.6	173.4	215.5	64.6	215.7	177.7	222.0	23.8	265.1	191.2	64.3	181.1	122.2	141.1	236.2	220.7	266.1	116.9	136.3	148.9	174.8	195.2	69.6	187.3	101.9	158.2	206.0	52.9	14.6	180.0	78.7	131.9	198.6	225.6	72.4	105.0	243.9	194.3	92.0	131.4	83.4	173.4	32.8	66.9	203.4	212.2	112.9	472.6	455.1	146.6	233.1	131.8	162.9	167.2	396.0	251.3	292.1	216.0	229.0	173.7	249.4	164.9	299.8	254.9	252.3	160.3	302.6	120.7	192.3	422.2	266.3	267.7	303.0	270.6	418.3	367.4	211.1	137.0	213.5	180.5	147.7	450.1	204.1	221.5	334.8	235.8	285.4	611.3	432.9	173.0	159.8	405.3	274.2	185.4	200.6	193.7	289.5	193.0	568.8	208.5	522.2	386.9	105.3	247.5	335.7	499.7	575.1	494.2	539.3	681.4	292.8	164.9	256.5	497.7	249.9	399.8	39.5	47.9	87.5	64.3	72.5	60.8	35.8	53.6	62.5	47.9	27.4	34.5	42.1	30.2	45.2	101.9	55.3	55.4	60.4	116.6	122.9	92.6	173.4	122.2	141.1	136.3	148.9	158.2	105.0	131.4	112.9	146.0	38.5	59.1	14.0	152.2	127.2	201.5	173.0	63.2	18.3	78.8	65.4	2.9	62.9	86.7	79.1	10.4	130.1	164.6	289.7	135.0	234.2	8.3	66.4	97.5	134.6	134.6	34.9	13.9	265.0	263.4	98.2	120.8	124.1	118.6	76.4	112.1	82.7	243.2	52.2	10.4	173.7	101.7	167.1	157.8	19.5	86.6	167.4	193.9	15.0	243.9	82.6	187.4	9.5	17.5	424.5	286.3	74.1	171.3	183.5	300.7	157.5	46.0	11.9	118.3	70.6	121.4	38.9	44.1	88.5	116.1	221.9	169.3	78.6	156.2	222.2
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942031-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 1579.9;lymphoid tissue: 1075.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	188.8	74.1	48.7	521.0	51.2	1579.9	170.4	56.0	77.6	85.4	57.9	112.9	79.6	68.0	48.4	82.9	85.3	165.9	110.7	49.4	56.4	95.9	139.0	280.3	905.3	68.5	65.4	27.6	32.2	54.1	35.4	143.8	68.4	68.8	142.4	5.3	122.3	66.3	56.3	74.2	201.6	144.3	61.8	592.6	108.1	19.5	65.6	1075.8	110.6	79.0	1036.8	290.4	67.4	79.6	147.8	5.5	5.8	327.3	23.7	17.6	2.1	6.0	1.8	2.3	1.6	19.3	156.9	1210.9	74.3	28.0	1.9	171.1	0.0	270.8	17.9	2.3	0.0	1636.5	3.5	0.7	5.2	1927.3	2070.0	2.5	37.5	0.8	24.2	5.6	929.0	1421.7	8.7	454.5	28.8	0.8	2313.6	1382.4	7.1	3.3	1.7	1912.5	21.3	540.3	52.7	845.5	1.3	1.4	1.8	205.7	2.5	14.1	10.9	1385.1	1171.8	4.6	11.5	2.2	36.2	74.5	13.0	1750.9	5.3	1339.7	2.4	5890.8	2659.3	6464.2	2731.2	3085.1	2695.1	2676.3	3099.3	3090.3	2210.1	2532.9	2986.0	3120.5	5422.5	2408.4	3802.9	955.6	5589.7	9860.2	48.7	51.2	56.0	77.6	49.4	56.4	68.5	65.4	68.4	61.8	65.6	79.6	189.6	60.9	143.0	0.7	575.2	68.2	51.9	11.1	5.7	0.6	99.7	64.5	14.0	11.5	79.5	58.8	0.0	89.6	703.8	5.3	17.6	21.9	1.5	3.2	6.1	175.6	1.2	182.1	0.7	342.7	667.6	47.3	42.3	3.6	700.2	0.4	342.3	11.1	915.2	0.0	0.2	2.2	8.2	742.6	487.7	4.1	53.4	672.9	90.7	26.2	451.3	3.3	999.0	0.5	0.1	53.5	16.3	58.6	292.5	6.9	0.2	9.2	39.0	1.2	243.3	10.3	187.9	1.2	2.3	5.5	56.1	68.0	895.2	14.9	6.7	94.7
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883173-41930150	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	50.2	20.9	17.1	79.1	21.8	113.5	39.9	19.1	21.9	37.2	17.8	37.5	26.8	33.4	3.6	34.1	36.4	23.5	26.2	16.1	18.2	31.9	30.0	67.7	127.5	24.1	20.2	32.9	27.4	12.6	25.9	18.3	22.0	32.1	10.4	5.6	28.8	11.8	15.4	37.6	87.1	13.4	19.0	168.4	34.9	10.9	21.4	96.5	36.7	8.9	48.9	33.9	33.2	27.9	58.8	69.9	15.8	19.9	21.9	22.9	18.4	30.1	45.7	37.4	32.8	21.5	49.2	77.9	54.6	27.8	19.8	33.8	20.3	46.9	11.8	74.1	23.6	63.1	30.6	28.4	31.9	68.4	100.8	27.8	30.5	36.3	23.5	19.9	36.2	68.2	25.5	46.7	21.8	40.4	48.0	52.9	17.9	46.4	54.0	71.8	29.7	46.3	23.2	31.8	10.3	43.8	42.3	18.7	36.0	8.1	21.9	114.4	49.6	49.7	33.2	26.8	47.7	63.0	43.2	68.4	40.5	107.6	80.2	10.4	20.5	29.2	47.0	39.5	37.2	20.1	35.6	49.4	21.5	19.5	36.1	39.4	27.4	32.1	57.5	11.3	38.7	36.4	17.1	21.8	19.1	21.9	16.1	18.2	24.1	20.2	22.0	19.0	21.4	27.9	46.6	6.4	22.0	35.3	97.3	14.5	13.9	15.0	20.5	18.7	13.1	12.4	4.2	8.6	8.8	7.3	27.1	13.3	156.2	21.7	3.9	23.6	1.4	12.2	16.7	29.0	21.7	23.8	8.0	24.9	22.8	17.7	56.6	16.8	31.7	19.3	26.7	9.3	38.2	11.8	7.9	29.2	16.2	52.5	31.9	1.8	19.3	58.9	19.6	18.7	39.0	8.8	187.4	13.6	27.6	55.9	22.7	16.6	66.4	15.7	10.1	7.3	6.3	19.1	26.3	17.6	17.3	7.3	10.1	17.3	14.8	10.1	159.0	20.4	26.4	11.1
ARHGEF2	"GEF-H1, GEFH1, KIAA0651, Lfc, LFP40, P40"	ENSG00000116584	"Rho/Rac guanine nucleotide exchange factor 2"	Q92974	1	155946851-156007070	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Mitosis, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043437	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 3: Monocytes - Immune response regulation"			"HPA043437: AB_2678481"	"unprognostic (2.27e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.20e-6)"	"unprognostic (5.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.85e-3)"	"unprognostic (7.98e-2)"	48.9	12.3	52.6	39.2	80.8	64.0	40.8	69.0	77.8	38.8	18.7	47.3	18.8	37.0	15.2	25.8	42.1	31.1	42.8	55.5	56.2	35.7	13.2	89.9	48.4	85.9	75.9	28.1	15.1	18.5	16.8	32.1	84.1	27.3	28.8	11.1	25.0	15.1	17.8	17.9	45.4	29.9	60.9	69.9	39.9	33.9	77.2	38.6	46.7	16.8	32.6	37.8	31.4	130.6	32.0	25.7	44.0	30.3	41.4	51.9	45.3	69.9	89.4	67.2	71.5	23.3	23.6	79.4	41.9	53.8	35.4	45.7	26.7	22.2	50.9	32.5	22.9	105.1	40.9	14.0	162.4	138.6	87.8	61.1	90.4	100.2	122.1	50.7	55.7	60.5	59.2	94.2	96.2	17.7	70.2	187.2	48.8	53.4	17.0	75.5	61.3	135.9	28.3	19.0	72.1	33.1	30.1	43.6	246.1	43.6	45.0	188.7	73.6	57.7	32.7	50.9	89.8	155.7	171.1	55.6	82.4	68.7	144.6	15.1	20.6	17.1	15.7	18.1	10.8	14.6	9.9	11.3	18.2	13.1	9.6	11.0	31.7	11.0	21.9	8.7	9.9	28.2	52.6	80.8	69.0	77.8	55.5	56.2	85.9	75.9	84.1	60.9	77.2	130.6	26.4	38.5	73.4	2.9	43.9	15.2	28.1	12.6	10.8	54.1	15.7	12.3	6.2	10.0	12.0	16.5	2.1	3.5	32.1	21.1	7.9	15.5	52.9	6.6	10.2	32.3	30.5	48.6	30.8	5.3	22.8	24.8	59.1	13.3	27.9	8.9	23.2	1.0	29.7	1.7	17.0	20.9	16.2	49.0	67.8	16.1	11.5	46.0	24.9	20.6	82.9	12.9	48.4	22.1	105.5	16.5	22.5	10.1	20.0	16.7	9.8	2.2	13.0	3.3	59.2	32.9	30.8	3.1	4.1	11.7	13.8	3.4	29.7	2.1	14.2	40.2
ARHGEF4	"ASEF, KIAA1112, STM6"	ENSG00000136002	"Rho guanine nucleotide exchange factor 4"	Q9NR80	2	130836914-131047263	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.3;skin 1: 39.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 333.3;Excitatory neurons: 83.0;Inhibitory neurons: 83.5;Oligodendrocyte precursor cells: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.0;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 39.9;hTCEpi: 78.9;REH: 20.3;SCLC-21H: 52.9"									HPA018267	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018267: AB_1845006"	"unprognostic (2.30e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (3.93e-3)"	"unprognostic (9.71e-3)"	5.6	5.0	53.1	1.0	56.8	0.0	2.1	32.5	67.3	11.2	27.3	7.0	0.2	2.9	1.6	34.0	8.4	2.9	1.4	63.1	38.1	0.4	0.9	3.1	0.3	44.4	39.7	7.8	17.9	2.5	15.4	0.2	39.9	5.2	0.8	10.2	5.7	9.3	9.0	39.8	1.3	4.1	41.5	0.2	3.1	5.2	44.6	1.8	6.1	2.6	2.5	4.5	19.9	46.0	4.8	2.0	0.9	16.6	0.1	0.0	0.4	5.3	0.3	0.3	0.2	0.9	1.5	0.0	0.5	2.1	3.6	39.9	2.4	10.5	0.0	0.0	2.2	0.0	7.0	0.0	0.6	0.0	0.1	0.0	78.9	1.2	5.8	0.1	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	5.8	0.7	7.2	20.3	0.2	0.8	3.2	0.1	52.9	7.0	0.8	8.3	0.6	1.6	0.5	0.5	0.0	0.0	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.5	0.0	0.0	0.5	1.4	0.0	0.0	0.0	1.0	0.5	0.1	53.1	56.8	32.5	67.3	63.1	38.1	44.4	39.7	39.9	41.5	44.6	46.0	0.1	25.6	0.0	333.3	0.0	17.3	1.2	4.8	15.4	18.8	0.9	5.5	3.2	1.5	2.9	0.0	37.5	1.0	2.9	0.3	0.0	0.8	10.9	7.5	1.0	0.5	0.0	2.7	83.0	0.0	0.3	3.5	2.6	5.4	0.0	3.1	0.7	0.4	0.4	28.6	83.5	0.9	0.0	0.6	2.4	8.2	5.0	0.3	5.4	11.2	0.7	3.7	0.0	143.7	28.3	1.5	0.0	10.9	0.0	1.2	0.3	0.9	6.6	13.9	0.0	3.1	1.1	1.1	4.2	17.4	19.9	0.3	0.8	0.4	0.4	0.8
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325898-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		760000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	74.4	82.9	61.6	39.7	63.3	40.4	63.2	60.1	71.9	69.8	71.9	80.7	92.8	60.1	80.9	124.6	75.5	53.3	121.7	78.7	73.9	65.9	77.4	62.2	41.9	64.6	67.7	81.5	63.8	65.4	62.1	54.3	71.7	56.9	78.2	33.0	66.6	55.5	48.0	84.5	84.9	57.2	60.8	52.7	99.1	42.4	68.4	39.2	78.8	47.1	44.9	61.6	74.9	62.9	265.3	144.3	155.1	73.6	144.2	242.4	133.5	185.5	216.1	185.5	184.4	164.4	301.7	92.3	270.5	226.7	273.8	110.6	208.0	270.8	221.5	46.7	186.4	49.7	99.9	137.1	156.1	59.2	63.7	227.6	149.1	237.8	252.0	220.0	310.8	75.9	125.9	105.6	289.8	398.6	99.4	78.5	150.5	295.3	326.1	58.1	107.8	113.9	142.0	162.7	161.7	138.3	180.9	260.2	255.9	264.2	130.2	88.4	239.3	239.0	211.0	424.7	302.1	39.6	80.0	130.7	206.6	130.1	320.2	111.7	49.9	88.8	24.2	80.8	19.3	30.8	23.1	31.5	43.0	28.8	30.0	22.6	63.7	30.7	86.1	31.9	33.5	26.9	61.6	63.3	60.1	71.9	78.7	73.9	64.6	67.7	71.7	60.8	68.4	62.9	124.3	51.3	55.5	20.9	45.2	41.4	139.5	249.1	54.7	38.0	107.2	131.6	46.7	95.8	130.1	58.8	18.8	189.6	27.3	196.2	135.0	213.6	32.1	55.0	43.7	96.4	74.2	68.8	31.6	276.9	345.8	70.6	140.2	57.4	13.3	141.4	135.0	75.8	84.6	33.7	28.0	209.4	132.2	77.5	26.1	24.6	66.8	56.0	80.0	26.2	68.6	79.8	42.2	19.1	28.4	442.5	191.6	67.4	52.4	151.5	295.7	155.5	102.2	40.1	184.1	59.1	188.4	171.6	130.0	88.9	47.9	129.7	29.8	87.7	166.3	280.7
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394816	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 317.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 899.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Enhanced		Supported	Vesicles,Cytosol		NA	NA		13000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	132.2	71.6	19.6	173.3	20.4	209.8	99.1	20.5	25.9	71.7	23.9	104.4	106.6	71.0	14.2	51.6	73.9	48.9	70.1	18.2	21.7	84.4	81.7	169.5	202.1	28.9	23.5	30.1	51.4	14.3	52.4	66.4	26.8	67.4	32.5	1.1	72.4	30.1	18.6	43.2	160.2	39.4	27.3	317.3	66.2	20.4	33.3	62.2	90.1	19.5	95.5	85.1	57.5	28.4	124.3	219.3	16.1	47.5	62.9	225.0	167.9	165.8	170.5	68.7	60.5	146.3	477.8	215.4	308.2	188.5	146.9	93.1	22.4	152.5	27.5	175.5	59.9	157.0	61.6	98.4	179.7	159.5	515.8	125.7	77.3	96.2	94.3	134.6	181.5	113.3	177.9	508.0	100.2	574.5	158.8	332.5	59.6	148.9	435.5	139.5	14.6	536.2	141.2	59.7	13.2	42.1	116.4	506.3	899.5	54.4	119.7	322.4	262.0	190.1	155.8	339.0	216.6	91.4	190.1	263.5	189.9	411.0	350.4	1026.1	2400.1	1973.2	770.3	2458.8	723.9	786.7	883.0	857.2	2054.4	699.1	510.2	680.0	1963.4	633.5	2382.6	1172.9	1315.9	4198.2	19.6	20.4	20.5	25.9	18.2	21.7	28.9	23.5	26.8	27.3	33.3	28.4	182.2	41.7	86.6	1.0	279.2	60.5	141.3	587.9	58.1	9.6	50.8	34.3	9.1	107.2	260.2	130.6	8.4	588.4	416.3	264.9	25.4	407.1	3.2	37.7	37.2	265.5	112.7	84.9	3.2	414.5	948.7	99.7	62.7	41.3	192.2	31.0	226.3	54.5	1088.1	1.7	2.3	97.6	203.4	1035.5	422.8	8.4	37.3	789.1	179.7	28.1	1029.7	21.4	498.5	0.5	1.6	405.1	268.7	18.0	154.0	132.4	516.0	110.9	214.0	14.7	92.1	29.5	238.5	2.7	15.5	26.3	37.1	303.2	324.4	20.4	161.1	187.6
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217141-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352, HPA052703"	Approved		Supported	Nucleoplasm		NA	NA		6600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"CAB001994: , HPA008352: AB_1854887, HPA052703: "	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	205.4	121.8	114.0	361.4	125.6	544.1	163.5	109.4	130.8	163.1	117.4	252.8	200.3	153.3	161.8	460.5	146.3	211.3	167.3	135.2	123.1	155.0	152.8	259.7	505.2	115.1	114.7	121.3	122.1	115.4	94.7	295.0	116.4	132.1	274.8	77.4	163.6	176.0	385.3	293.4	226.5	291.2	117.8	294.6	251.5	149.7	118.2	298.3	115.3	250.8	626.0	402.0	231.7	125.4	438.3	188.3	264.1	198.0	346.6	463.6	489.4	680.5	640.7	551.2	549.5	588.6	452.0	358.6	347.6	764.7	396.8	492.3	362.6	985.4	645.4	284.2	296.5	362.1	279.0	325.8	386.8	764.2	968.9	310.2	784.1	552.0	454.6	515.1	731.3	294.1	179.5	681.4	858.6	304.3	416.8	888.6	310.8	500.8	201.1	307.2	235.0	488.7	556.8	787.8	156.3	278.8	246.7	265.8	590.0	544.4	192.7	689.2	642.1	709.5	268.1	321.9	507.8	359.8	418.8	624.7	515.1	472.9	548.2	1728.0	1318.5	1975.5	930.7	1773.7	626.1	785.9	720.7	913.6	1330.1	658.5	505.7	750.0	2200.3	698.9	2060.4	734.3	1039.0	2503.2	114.0	125.6	109.4	130.8	135.2	123.1	115.1	114.7	116.4	117.8	118.2	125.4	334.8	285.2	326.6	21.2	506.7	928.5	691.0	1140.2	425.2	89.8	150.3	189.7	145.3	200.1	465.4	172.9	56.3	944.5	902.3	595.0	342.4	585.8	604.0	220.6	288.5	363.5	319.7	144.9	48.5	658.7	1509.4	301.7	242.6	222.4	414.5	600.6	281.3	98.4	1094.0	58.9	33.1	329.4	364.2	779.9	1321.0	759.3	214.0	896.1	414.4	53.4	1721.9	175.3	1336.7	30.7	33.7	919.8	604.5	326.5	529.9	762.7	510.9	342.8	249.6	95.3	302.4	131.6	571.2	324.4	227.9	645.2	970.6	1045.8	694.1	285.6	337.6	1126.5
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434823-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm		NA	NA		3800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	196.5	205.3	160.2	365.7	167.7	774.3	213.5	160.2	228.2	205.5	165.9	324.0	259.5	151.6	298.3	367.1	162.2	253.1	153.0	167.3	171.5	241.6	262.4	264.7	578.8	172.9	166.9	107.2	171.6	174.8	163.6	276.6	170.8	166.9	344.1	60.4	205.0	152.1	106.7	156.5	258.2	206.6	169.4	366.3	263.3	106.9	165.1	343.3	184.2	102.5	573.7	355.8	206.5	180.5	452.0	360.8	307.0	196.4	318.3	600.2	411.5	476.0	550.1	594.6	578.6	392.9	350.1	654.7	359.3	559.7	354.4	340.1	343.9	520.7	647.7	377.7	415.6	562.1	146.6	385.1	519.7	565.6	842.4	422.6	555.3	375.3	347.8	736.2	756.3	434.5	366.2	170.3	746.3	365.6	661.6	1390.3	302.7	525.8	428.6	510.9	181.5	559.4	1050.5	581.0	346.6	342.2	334.0	464.7	427.1	453.8	757.8	933.8	630.0	350.5	195.7	312.9	349.9	332.7	507.0	914.8	458.0	568.1	425.1	1313.6	1022.6	1660.3	352.4	1182.3	322.2	692.3	361.1	398.7	987.2	604.5	267.0	349.5	1607.5	418.3	1417.4	632.7	619.8	1547.5	160.2	167.7	160.2	228.2	167.3	171.5	172.9	166.9	170.8	169.4	165.1	180.5	316.2	189.1	239.5	16.6	619.4	159.5	315.8	810.1	145.1	36.1	222.3	252.2	52.2	208.8	555.8	268.5	12.5	538.2	582.4	473.2	579.2	636.3	131.2	373.6	241.1	269.0	274.1	244.0	32.4	535.1	824.0	199.0	190.6	459.6	491.8	245.8	227.7	165.5	1432.0	53.8	25.1	538.9	537.1	918.9	781.2	45.3	172.4	935.9	240.1	45.9	1221.8	184.1	545.8	23.6	41.6	630.2	665.2	157.6	352.5	313.5	422.2	777.0	407.3	35.6	249.8	108.4	329.6	209.8	200.1	365.5	171.9	721.6	462.6	323.3	401.1	629.3
ARPC4	"ARC20, p20-Arc"	ENSG00000241553	"Actin related protein 2/3 complex subunit 4"	P59998	3	9792495-9807101	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		5900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (2.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.79e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.34e-4)"	100.8	97.8	136.1	135.3	136.2	148.5	84.2	128.9	146.3	86.3	121.5	126.1	98.7	93.2	66.7	139.0	82.6	68.8	71.3	150.5	138.1	118.7	81.7	91.7	171.5	136.1	137.2	69.9	58.4	76.9	54.3	77.5	138.3	69.9	117.7	18.2	69.7	70.9	91.8	101.0	98.0	113.0	136.7	143.3	83.5	38.0	144.9	132.6	69.6	61.2	205.1	121.7	84.9	138.4	151.7	168.9	150.2	95.5	189.9	157.8	402.2	225.1	238.2	204.5	177.6	106.8	199.3	106.2	126.6	326.5	201.1	95.8	102.9	182.7	183.6	202.2	67.2	315.6	156.0	120.7	209.9	291.8	410.6	173.7	166.9	245.6	149.4	171.5	239.0	59.1	165.5	92.2	327.0	302.3	244.2	261.1	278.5	201.9	200.2	209.9	105.9	160.8	248.6	198.0	62.9	209.9	137.1	155.9	161.5	128.3	189.5	450.6	243.8	188.8	87.8	194.2	329.4	60.8	197.1	293.0	272.7	224.2	286.4	300.2	377.6	431.4	279.8	469.0	230.7	210.3	232.4	230.4	314.4	194.9	161.7	218.0	639.5	218.0	457.8	432.2	274.6	480.6	136.1	136.2	128.9	146.3	150.5	138.1	136.1	137.2	138.3	136.7	144.9	138.4	91.1	16.0	42.0	0.0	104.0	68.2	79.5	37.7	17.6	12.9	56.2	38.4	24.3	44.3	32.2	58.8	8.4	117.4	228.5	213.3	72.4	136.0	9.8	42.8	70.9	79.5	112.9	56.8	0.0	126.1	240.3	59.7	44.9	62.1	104.1	69.4	81.4	54.7	340.3	23.5	0.0	151.8	30.5	237.1	155.8	7.4	49.4	210.3	78.2	0.0	468.8	40.7	300.7	0.0	0.0	171.2	182.6	66.2	31.7	75.3	118.8	136.2	29.1	13.3	39.5	43.8	82.4	12.9	32.0	33.9	65.8	169.1	132.1	103.1	154.4	87.9
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635783	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	86.1	49.2	17.4	148.2	22.5	69.1	48.8	23.7	23.8	46.5	13.0	104.7	99.5	69.5	15.7	77.8	52.0	52.9	35.7	20.0	22.3	39.0	64.3	103.1	158.9	35.2	22.8	30.6	51.7	29.9	19.7	108.2	29.7	46.0	68.9	8.0	45.9	35.9	18.7	42.6	117.4	78.9	24.0	120.8	88.6	38.4	24.1	130.5	46.0	22.5	131.3	75.9	51.8	37.8	313.4	167.7	141.0	98.1	114.0	161.5	338.7	419.7	317.9	176.3	143.0	150.9	215.9	284.9	463.9	241.7	114.6	211.2	101.1	141.6	93.9	413.6	87.1	172.9	212.6	132.6	185.2	254.8	325.0	197.6	148.2	215.7	170.3	201.2	213.7	196.1	133.3	229.1	233.9	125.6	238.5	67.9	133.7	238.5	63.0	219.2	126.3	278.6	97.3	158.7	61.1	164.7	435.8	186.1	167.3	147.1	185.2	222.5	480.9	259.0	134.5	293.8	410.1	270.1	321.8	196.2	204.5	179.6	204.6	1221.0	987.7	1563.7	395.7	1110.1	315.7	338.3	382.3	407.1	838.9	339.7	409.4	415.4	1852.1	392.6	1267.7	394.3	512.4	1913.3	17.4	22.5	23.7	23.8	20.0	22.3	35.2	22.8	29.7	24.0	24.1	37.8	148.7	375.0	188.9	8.1	163.3	249.1	178.3	275.9	91.0	34.2	79.9	118.9	30.2	150.2	197.6	82.8	14.6	475.1	227.4	283.5	166.3	344.3	35.5	78.8	211.4	186.7	202.0	90.0	21.6	280.2	734.2	166.2	87.1	119.8	258.8	147.7	181.7	87.4	608.5	38.7	13.8	146.6	238.0	556.3	740.8	24.2	125.9	558.5	254.3	20.6	635.1	56.7	423.3	7.5	51.5	381.6	234.5	183.6	132.1	182.6	213.6	152.0	95.2	25.4	243.3	83.9	286.8	151.9	137.3	161.5	244.9	199.5	234.4	144.4	155.4	234.6
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 25.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	6.9	4.5	3.9	8.1	3.9	8.1	2.6	3.1	4.6	5.3	4.2	5.5	3.1	6.4	3.5	4.8	2.9	7.3	8.3	4.7	3.6	21.3	7.6	7.0	5.4	4.6	5.3	2.2	4.6	6.6	2.5	11.5	4.0	5.0	8.2	6.7	3.1	6.6	3.8	2.1	3.6	14.1	4.3	5.2	3.9	2.6	5.2	2.6	4.2	4.3	4.8	8.0	2.3	5.0	5.0	11.3	18.6	6.3	41.9	16.4	16.7	29.2	23.0	18.9	23.0	9.9	8.4	6.5	31.5	25.5	29.0	3.9	7.0	7.4	18.5	55.6	6.2	9.2	11.2	40.1	9.7	10.5	10.4	19.4	2.4	19.7	6.5	15.6	22.4	3.9	2.0	12.9	19.6	9.2	5.8	19.3	5.6	1.1	6.7	7.7	10.9	5.9	12.0	6.2	6.8	15.9	20.3	6.2	12.1	12.7	6.9	26.2	16.2	17.5	10.4	7.6	26.4	14.8	28.0	7.2	21.6	21.4	40.3	19.0	8.3	25.6	1.0	6.7	0.6	2.0	0.4	0.4	7.8	1.3	0.3	0.5	4.6	0.2	5.6	5.7	0.7	2.7	3.9	3.9	3.1	4.6	4.7	3.6	4.6	5.3	4.0	4.3	5.2	5.0	3.9	0.0	2.0	40.8	5.1	0.8	1.4	1.3	0.6	3.7	1.6	1.0	7.2	1.5	0.7	3.7	6.2	2.2	5.5	1.4	3.9	3.7	0.5	1.9	7.2	4.5	1.2	16.2	37.4	9.2	5.1	6.6	2.6	9.0	0.0	6.3	13.6	3.8	16.7	6.7	42.5	6.0	0.0	25.2	14.3	0.5	4.4	15.9	14.2	40.3	16.1	3.6	2.1	71.4	56.2	4.0	3.0	3.8	8.1	2.2	0.5	18.8	2.5	2.7	6.6	5.0	4.4	2.2	3.1	0.7	1.3	2.6	3.4	1.6	2.2	1.3
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555101-95605102	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 19.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	3.0	3.7	2.1	2.2	2.3	2.3	3.3	2.8	3.0	3.8	2.1	2.7	2.2	3.6	4.2	2.9	3.2	3.1	2.6	2.4	2.1	5.4	3.7	2.9	2.7	1.9	1.9	5.8	4.9	19.1	2.6	5.5	2.3	4.9	2.5	3.6	2.8	4.9	2.3	3.3	2.2	3.0	1.7	2.4	4.2	1.6	2.6	3.7	5.0	2.7	2.0	3.2	3.3	2.2	5.1	3.2	6.6	6.6	32.4	16.8	9.5	15.9	9.2	6.1	12.4	3.9	7.8	6.9	8.1	5.5	10.9	4.6	5.8	10.1	13.3	7.4	8.5	5.5	7.7	6.7	9.4	3.1	4.4	12.4	8.9	9.2	5.9	12.8	10.0	9.3	5.6	7.4	13.7	2.5	8.5	5.9	8.6	1.6	15.3	5.2	10.6	11.0	14.1	1.2	4.7	4.8	9.7	3.1	10.0	9.1	8.9	3.2	18.1	9.6	7.8	15.0	9.9	6.2	11.2	8.4	9.6	8.0	36.5	12.9	1.1	2.1	4.0	1.2	4.7	4.9	4.7	5.4	0.6	5.0	7.0	5.2	0.9	3.3	0.7	2.2	3.9	1.8	2.1	2.3	2.8	3.0	2.4	2.1	1.9	1.9	2.3	1.7	2.6	2.2	6.8	3.2	2.2	9.1	6.6	4.5	6.8	7.4	5.7	7.3	4.4	7.2	4.6	1.5	3.7	7.3	12.5	11.8	6.6	1.9	3.9	4.1	9.2	7.1	10.3	6.2	3.0	10.1	11.0	2.5	47.4	13.6	2.0	5.7	22.9	8.1	6.8	16.5	4.6	10.1	9.7	2.0	10.2	3.2	5.4	2.9	10.8	4.9	5.4	7.5	5.1	12.7	14.4	7.1	10.0	2.6	3.2	11.7	7.1	3.9	3.2	4.8	6.8	10.4	0.0	10.2	10.9	7.4	8.6	5.1	7.0	5.1	9.8	11.8	3.4	2.1
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.4;ovary: 78.7;skeletal muscle: 26.7"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 83.7;Inhibitory neurons: 53.2;Leydig cells: 131.7;Peritubular cells: 70.0;Theca cells: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;PC-3: 3.9;THP-1: 1.7;U-266/70: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.0	0.1	7.6	0.0	10.1	0.0	0.3	0.0	17.4	0.0	0.0	0.9	3.5	0.0	0.1	0.1	1.1	0.0	0.0	10.1	6.0	0.1	0.0	0.4	0.0	0.0	0.0	78.7	1.4	1.8	0.3	0.0	0.1	0.7	0.9	0.0	0.2	0.0	26.7	0.0	0.7	0.0	0.0	0.2	5.5	7.2	0.4	0.0	0.2	1.9	0.4	0.0	0.2	8.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	3.9	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.1	0.0	0.0	8.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	10.1	0.0	17.4	10.1	6.0	0.0	0.0	0.1	0.0	0.4	8.0	0.0	0.0	0.0	14.0	0.3	0.0	2.5	0.5	0.0	0.0	0.3	0.0	0.5	0.0	2.2	0.0	0.0	0.2	0.1	1.9	0.0	0.0	1.2	0.0	0.0	0.1	83.7	0.0	0.2	0.0	2.4	4.7	4.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	53.2	3.6	4.1	0.0	0.0	3.6	131.7	0.2	0.0	3.7	0.0	0.0	0.0	3.5	0.6	0.3	0.8	70.0	0.9	1.3	0.1	0.1	11.3	0.0	0.0	1.5	0.3	0.5	0.3	0.0	0.0	0.1	0.3	66.8	1.9	1.6
ASB17		ENSG00000154007	"Ankyrin repeat and SOCS box containing 17"	Q8WXJ9	1	75918873-75932404	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	192	"testis: 49.9"	"Group enriched"	"Detected in some"	69	"Early spermatids: 1043.0;Late spermatids: 301.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"																"unprognostic (7.27e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1043.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	301.3	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	9.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3, p50"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	19.0	24.9	18.3	13.9	23.5	7.3	16.4	22.4	24.5	16.1	18.8	14.4	9.0	17.1	16.4	14.3	15.3	13.7	24.8	17.2	20.7	15.2	21.6	13.5	18.5	23.4	20.6	17.9	22.7	14.2	11.9	13.0	23.6	11.9	9.9	15.7	12.8	14.5	29.7	17.1	14.6	12.4	21.7	17.1	14.4	18.4	20.4	22.3	13.4	17.3	16.8	15.7	13.6	30.4	29.3	40.3	25.8	58.1	34.0	37.9	21.1	18.0	33.5	26.5	30.7	31.4	105.3	37.0	35.6	26.3	17.9	38.4	21.1	30.6	26.5	27.2	20.1	24.1	29.1	36.4	32.7	25.2	24.1	33.3	68.9	26.7	45.0	38.1	36.4	40.4	34.8	51.8	35.0	25.7	34.2	36.1	15.7	18.8	8.8	20.1	21.1	27.4	49.8	21.0	27.1	16.9	26.1	65.7	49.4	23.9	21.7	18.5	32.0	15.2	27.1	11.6	19.4	28.4	40.4	45.5	24.6	55.9	10.8	20.4	19.0	35.0	16.5	20.3	17.0	31.4	19.4	17.7	21.0	32.5	27.2	25.8	12.5	26.6	15.4	28.9	29.2	19.0	18.3	23.5	22.4	24.5	17.2	20.7	23.4	20.6	23.6	21.7	20.4	30.4	16.7	9.6	5.8	25.5	20.5	6.2	14.0	22.8	9.6	12.9	9.0	6.3	23.6	10.0	13.4	12.9	14.6	17.7	18.6	4.7	23.5	20.4	27.5	12.1	13.8	13.9	3.6	11.1	33.1	20.0	19.5	16.5	6.6	12.1	12.7	12.6	10.4	22.0	18.2	25.2	42.9	5.2	16.2	24.1	8.7	14.2	20.5	12.7	19.6	27.2	21.4	19.9	16.5	35.7	52.8	14.7	8.4	20.7	14.5	8.0	9.5	11.4	9.8	14.3	13.1	10.8	15.9	27.8	28.2	10.9	7.0	15.2	17.9	18.9	6.5	9.2
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.5	0.3	0.8	7.9	1.0	7.0	0.5	0.9	1.3	0.4	1.3	0.5	0.3	0.3	0.1	0.5	0.6	17.6	0.5	0.8	1.0	1.2	840.7	2.5	0.9	1.0	1.1	0.2	0.5	0.1	0.2	0.5	1.2	0.4	0.4	0.0	0.5	0.2	0.2	5.2	0.6	1.3	1.0	6.8	0.5	0.5	1.4	0.5	0.3	0.1	1.0	2.0	0.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	1.0	0.9	1.3	0.8	1.0	1.0	1.1	1.2	1.0	1.4	1.2	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.0;cervix: 3.4;endometrium 1: 3.4;retina: 4.6"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 1786.2;Inhibitory neurons: 666.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;RPTEC TERT1: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.0	0.6	13.0	0.0	11.4	0.0	0.1	4.4	10.3	3.4	0.0	0.1	0.4	3.4	0.0	0.0	0.6	0.0	0.0	12.4	6.0	1.1	0.0	0.0	0.0	6.2	6.0	0.0	0.0	0.0	0.5	0.0	3.3	0.1	0.1	4.6	0.0	0.5	0.0	0.1	0.3	1.4	5.8	0.0	0.0	0.3	6.2	0.0	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	11.4	4.4	10.3	12.4	6.0	6.2	6.0	3.3	5.8	6.2	8.2	0.0	0.0	0.0	17.0	0.0	0.3	0.0	0.0	0.0	25.7	0.0	0.0	1.3	0.0	0.0	9.2	2.1	0.0	0.0	0.1	0.0	0.1	16.3	0.1	0.8	0.1	6.0	0.0	1786.2	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	10.1	666.4	1.3	0.0	0.0	0.0	47.1	0.3	0.1	1.8	26.2	0.0	0.5	0.0	144.3	22.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 396.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	21.7	16.1	5.9	16.7	6.0	23.9	22.0	6.6	8.5	18.2	8.7	53.8	60.7	17.0	6.7	28.7	18.1	27.7	16.9	5.9	8.0	61.2	396.4	27.4	10.3	7.4	7.1	19.7	37.1	15.1	19.8	9.1	9.8	19.5	35.7	2.4	18.3	9.8	8.7	15.1	45.6	10.1	6.2	30.5	43.9	4.5	7.6	5.3	24.9	6.9	8.8	19.3	19.8	6.7	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.9	6.0	6.6	8.5	5.9	8.0	7.4	7.1	9.8	6.2	7.6	6.7	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Assembly factor for spindle microtubules"	Q8IZT6	1	197084121-197146694	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 10.1;lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.2	0.1	0.0	3.0	0.0	10.1	0.4	0.0	0.1	0.2	0.0	1.6	2.1	0.3	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	5.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	1.9	0.0	0.2	0.0	0.0	2.7	1.9	0.7	0.0	0.9	1.1	3.2	0.1	17.0	0.1	0.0	5.1	0.6	0.4	0.2	44.6	22.9	39.1	23.2	1.9	5.5	14.7	35.1	23.2	32.6	25.6	16.7	31.1	45.4	12.5	27.5	13.8	40.2	33.6	12.1	39.1	41.8	25.4	33.1	56.1	12.8	0.4	51.9	20.5	0.6	1.0	26.1	15.2	7.3	31.5	32.9	41.8	50.7	29.0	16.0	40.6	10.3	17.8	24.8	6.4	30.2	55.5	31.7	7.4	11.4	20.4	29.5	50.6	20.6	9.5	20.8	26.9	12.7	28.9	20.9	20.0	34.9	61.2	13.9	21.6	26.8	14.9	11.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	1.3	5.8	6.1	1.5	4.0	2.2	0.1	2.4	2.4	1.1	0.0	1.3	1.8	0.0	20.0	7.8	7.7	0.0	0.3	3.9	2.9	6.2	4.3	0.0	99.5	2.0	0.0	14.8	9.8	13.3	8.1	1.3	121.1	6.4	2.2	11.6	0.0	4.8	6.8	4.1	6.4	2.4	4.5	0.6	6.4	0.0	0.0	0.9	0.7	4.1	0.0	1.0	0.5	0.2	1.5	44.8	2.0	0.4	0.4	0.8	0.3	0.0	0.6	7.0	43.8	44.7	27.1	3.4	3.7	9.1	5.7	16.9	2.1
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 95.3;smooth muscle: 110.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.6	7.6	1.2	5.7	1.7	0.1	11.8	2.3	2.0	40.9	0.9	25.5	9.6	69.6	9.7	10.1	16.9	65.9	95.3	1.2	1.2	11.2	41.1	14.3	3.0	1.3	1.2	7.1	13.4	3.8	2.5	4.3	1.6	4.7	11.3	0.2	3.2	11.7	7.8	12.1	17.6	110.5	1.0	2.3	12.0	1.2	1.8	2.5	11.1	19.8	5.5	13.4	5.0	1.7	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.7	2.3	2.0	1.2	1.2	1.3	1.2	1.6	1.0	1.8	1.7	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Human disease related genes, Plasma proteins, Predicted membrane proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"skin 1: 424.0"	"Cell type enhanced"	"Detected in some"		"NK-cells: 3.1;Oligodendrocytes: 4.2;Spermatogonia: 3.3;Suprabasal keratinocytes: 10.7"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 8.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.9;REH: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced		Approved	Cytosol		NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	2.6	2.1	5.8	0.9	7.3	0.9	17.1	6.1	6.6	3.1	3.0	1.7	1.6	2.5	2.6	0.9	2.3	1.1	1.8	5.3	6.0	2.2	1.9	1.7	1.0	7.2	6.7	4.8	0.7	0.2	4.0	0.9	6.5	2.2	0.6	1.5	1.3	1.3	4.4	424.0	1.7	1.2	6.0	3.9	1.2	3.6	6.5	2.1	1.3	2.1	1.0	1.5	4.5	9.3	0.0	0.3	0.9	1.9	1.2	0.4	0.2	0.2	0.4	0.2	0.1	0.6	0.0	0.7	0.1	0.2	0.2	0.2	0.8	0.1	0.2	1.3	2.5	1.5	0.2	0.6	0.4	1.3	1.0	0.5	0.4	0.2	0.4	0.3	0.2	1.6	0.5	1.9	0.2	0.3	1.1	2.9	1.0	0.2	0.2	4.9	0.5	0.3	0.0	0.0	1.0	0.2	0.1	0.7	0.8	0.2	0.0	0.5	0.1	0.0	0.9	0.0	0.2	2.0	1.3	1.4	0.1	0.9	1.0	0.0	0.1	1.5	0.5	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.1	0.4	8.7	0.3	0.0	0.8	0.7	0.4	5.8	7.3	6.1	6.6	5.3	6.0	7.2	6.7	6.5	6.0	6.5	9.3	1.1	0.0	0.0	1.3	0.0	0.4	0.1	0.2	0.0	1.1	0.5	0.9	2.6	0.0	0.1	1.8	0.0	0.3	0.1	0.5	0.0	0.1	0.1	0.4	0.5	0.8	0.0	0.0	1.0	0.2	0.0	0.7	0.0	0.4	0.0	1.1	1.4	0.1	0.2	0.0	1.5	0.9	0.0	0.3	0.6	0.5	0.9	0.3	0.0	1.0	0.2	1.2	3.1	1.5	4.2	0.3	0.0	0.7	0.1	0.2	1.1	0.9	0.2	1.6	0.0	0.7	1.1	1.4	3.3	0.0	10.7	0.4	0.2	0.5	0.2	0.1
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.9;brain: 29.8;retina: 14.0"	"Group enriched"	"Detected in some"	6	"Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	0.8	14.9	22.9	0.4	27.1	0.0	0.7	3.0	29.8	0.4	0.0	0.5	0.3	0.9	3.3	0.0	1.6	0.6	0.5	28.5	23.3	0.1	0.2	0.2	0.1	6.1	10.7	5.7	0.5	0.1	9.0	0.3	7.5	1.0	0.3	14.0	0.9	1.6	0.1	0.1	0.3	0.9	11.5	2.2	0.3	0.7	22.7	0.0	0.0	0.3	0.3	0.0	0.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	27.1	3.0	29.8	28.5	23.3	6.1	10.7	7.5	11.5	22.7	11.5	0.0	0.0	0.0	191.3	0.0	0.1	0.0	0.0	0.0	7.9	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.3	0.2	0.0	0.0	218.7	0.0	0.1	0.7	0.0	0.2	0.0	4.0	5.0	0.0	0.5	23.5	275.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	25.3	0.0	0.8	0.0	280.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.7	4.4	1.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family AAA domain containing 2B"	Q9ULI0	2	23748664-23927123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	4.8	3.1	4.9	5.9	6.1	9.8	4.5	8.1	5.5	5.9	11.0	4.2	5.1	4.9	2.6	6.0	4.6	3.5	3.7	4.0	6.1	3.7	4.1	4.8	7.3	6.5	5.7	5.8	4.3	3.3	4.1	4.0	5.7	4.3	4.3	9.4	4.8	2.3	4.4	8.3	5.2	2.8	4.8	5.1	3.9	4.3	5.9	10.3	5.2	2.8	6.5	4.0	6.6	7.7	4.1	3.4	11.0	5.0	3.1	3.4	8.5	2.7	2.2	3.5	2.4	5.5	2.0	13.4	2.4	2.5	1.6	5.3	8.6	3.0	2.9	8.8	4.1	11.3	4.5	6.6	3.4	10.2	8.1	2.7	5.2	2.1	3.4	2.9	4.8	7.4	12.2	5.8	2.7	7.0	9.5	11.9	6.5	6.8	1.9	10.8	11.8	3.1	3.8	9.1	5.1	8.4	7.4	9.0	4.2	6.0	4.4	10.0	4.6	3.5	4.0	3.0	3.2	6.0	2.9	10.0	1.9	11.5	3.3	15.8	7.9	5.1	3.9	4.7	4.4	8.5	3.6	3.5	7.6	6.4	5.2	4.2	12.0	6.0	6.2	11.0	3.4	1.8	4.9	6.1	8.1	5.5	4.0	6.1	6.5	5.7	5.7	4.8	5.9	7.7	18.4	3.2	16.0	93.0	26.1	10.7	7.7	6.4	13.1	27.6	9.5	7.1	11.3	10.0	12.2	9.2	47.9	8.4	33.8	15.2	0.0	7.7	60.2	10.1	20.1	14.6	15.6	11.1	60.3	12.2	7.4	14.7	19.9	17.0	13.3	21.2	11.7	10.7	8.2	10.1	95.5	11.0	10.2	14.4	17.6	36.1	12.5	23.8	3.6	85.3	30.9	13.0	22.6	143.7	125.3	8.9	18.6	10.9	14.0	10.8	17.2	2.4	8.5	45.4	6.6	19.1	13.5	23.5	16.8	20.0	17.5	10.9	22.6	13.1	11.3	16.5
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766298-161977574	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved					NA	NA		46000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA005935: AB_2667472"	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	13.6	10.1	7.2	13.9	8.4	12.6	11.5	8.3	7.5	8.4	13.6	9.9	9.9	10.6	18.9	11.0	8.9	11.3	9.4	7.2	9.9	14.6	22.0	11.4	10.6	10.2	9.4	9.0	34.4	18.9	7.1	18.0	10.5	10.7	11.2	16.7	13.3	10.3	8.9	11.2	9.4	12.8	10.0	11.3	11.2	10.1	8.0	8.4	15.1	9.5	11.1	13.7	7.9	11.9	23.3	17.9	15.1	22.4	18.6	17.7	26.7	27.8	25.3	17.7	19.2	11.6	38.2	16.9	39.6	34.6	19.9	34.0	15.1	18.6	17.6	23.2	12.9	15.9	22.6	12.7	40.3	29.7	40.6	18.3	29.0	18.2	53.3	23.8	40.3	22.7	37.9	19.2	19.3	23.0	15.9	17.3	12.2	24.5	23.1	13.7	21.4	39.2	19.3	11.1	9.1	13.8	33.3	19.8	41.0	32.9	24.5	39.2	54.4	23.2	21.9	8.7	31.5	28.0	29.2	20.4	28.2	5.1	29.0	9.7	17.8	12.0	9.2	18.3	9.0	8.7	8.3	7.7	12.8	9.5	9.5	9.7	33.2	7.4	24.4	5.7	9.6	10.6	7.2	8.4	8.3	7.5	7.2	9.9	10.2	9.4	10.5	10.0	8.0	11.9	40.5	102.5	85.1	41.8	31.4	34.8	45.4	28.4	18.2	38.6	38.0	25.4	21.6	25.8	67.0	51.5	50.1	49.2	23.2	30.5	7.9	45.9	13.0	27.1	25.3	49.8	37.1	17.9	79.9	37.6	43.1	46.2	23.9	40.2	54.3	24.0	37.5	53.5	50.3	26.9	69.7	28.2	30.5	59.5	59.4	10.8	23.0	66.6	26.6	103.0	62.0	34.1	21.6	60.3	105.8	35.9	15.6	24.5	53.9	43.3	22.3	18.8	61.7	29.9	6.6	61.3	31.8	43.1	30.5	22.7	47.7	103.0	29.0	22.1	22.9	44.1
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		46000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	35.0	40.8	7.3	7.4	7.4	29.4	40.3	6.6	9.9	50.2	3.9	46.3	11.9	46.0	16.7	56.6	45.6	11.5	31.2	7.9	9.1	36.7	35.1	35.6	14.2	7.7	7.7	57.1	43.4	14.1	43.0	8.8	7.6	43.7	14.0	8.1	44.9	6.3	22.4	53.3	46.9	8.9	7.1	60.0	45.4	29.3	7.4	16.7	51.1	5.0	17.0	44.3	47.0	7.1	2.5	6.3	18.1	29.7	17.8	18.9	11.5	9.8	13.3	13.7	20.8	25.2	20.9	30.4	26.8	60.1	14.5	17.0	23.5	37.2	8.1	18.3	34.5	11.2	36.1	24.7	28.9	2.9	40.0	17.2	16.1	5.4	31.4	25.5	44.0	47.9	38.0	32.9	39.9	18.3	25.5	17.4	5.1	20.8	5.4	7.5	7.6	20.7	17.5	6.3	1.8	6.4	35.2	13.9	40.5	5.0	39.5	12.5	17.1	3.6	13.0	13.7	15.6	33.8	20.4	17.0	15.5	18.5	21.9	4.2	1.1	0.7	1.9	1.7	1.5	1.6	1.0	0.9	2.3	1.1	0.6	1.4	0.9	2.5	1.5	1.4	1.7	2.2	7.3	7.4	6.6	9.9	7.9	9.1	7.7	7.7	7.6	7.1	7.4	7.1	39.1	12.8	15.2	31.6	72.7	24.9	37.6	83.0	33.6	89.3	31.8	26.0	2.0	50.1	53.1	55.2	95.9	88.4	64.9	52.9	5.9	48.1	3.3	22.0	24.5	40.3	53.5	39.8	29.5	42.8	50.2	29.8	39.8	27.8	16.5	148.5	43.5	18.5	52.8	43.7	29.9	53.9	79.3	55.4	40.5	8.9	70.8	42.0	32.0	28.1	65.4	35.0	124.6	21.6	24.1	37.2	58.6	51.9	40.3	30.6	64.3	14.6	43.5	98.0	59.2	30.5	29.8	64.3	58.6	36.1	25.3	89.2	58.6	49.5	55.7	39.8
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222832-108369102	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	6.2	7.4	8.2	17.5	15.0	16.2	8.5	17.0	12.3	8.7	16.1	6.7	5.2	10.0	9.9	4.0	7.5	8.2	7.0	7.3	11.3	5.8	7.8	7.6	33.7	15.8	13.1	15.8	14.8	9.3	12.1	8.0	17.0	6.3	7.0	20.6	11.4	6.1	4.4	7.5	12.6	6.9	10.3	22.2	8.6	5.2	12.7	18.2	8.8	6.0	25.9	7.1	6.9	28.8	4.3	6.8	14.8	7.6	20.2	29.1	3.1	10.9	13.5	6.4	11.3	7.1	10.3	18.3	14.0	10.2	9.6	7.7	11.6	10.8	9.0	12.3	5.7	15.2	8.7	10.2	10.5	16.4	17.0	18.3	6.3	10.0	21.2	15.2	14.1	16.5	12.4	9.9	14.3	3.4	10.6	18.5	9.8	8.6	7.4	9.7	9.7	24.9	8.1	7.5	9.0	10.5	11.1	4.7	20.6	13.2	9.3	10.1	23.7	15.8	8.4	7.3	9.0	6.2	7.0	78.3	7.0	19.0	18.8	21.3	5.5	4.0	16.5	5.7	11.1	11.6	11.7	12.5	2.6	13.0	21.1	20.4	9.9	9.7	13.3	6.2	6.1	5.3	8.2	15.0	17.0	12.3	7.3	11.3	15.8	13.1	17.0	10.3	12.7	28.8	23.7	38.5	20.8	62.7	146.4	12.6	17.5	21.1	28.5	111.0	19.6	14.2	39.9	12.8	19.5	22.0	210.6	16.9	140.2	4.2	5.9	9.9	19.2	14.4	52.1	25.9	20.4	39.1	70.2	12.3	13.2	39.0	12.8	20.9	13.3	45.9	32.9	23.3	29.1	60.6	82.8	14.9	26.4	96.4	34.0	5.1	39.4	69.2	26.6	178.9	63.2	27.3	339.8	85.5	217.6	7.6	7.6	27.8	96.5	9.1	8.9	11.1	16.0	200.1	26.3	41.4	29.2	31.5	37.4	15.8	12.4	4.2	147.7	52.3	11.5	10.2
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	125.2	148.3	71.7	33.7	60.1	6.9	120.6	94.2	120.0	143.8	14.5	155.4	36.3	146.4	25.5	71.9	148.9	43.2	94.2	66.8	75.7	95.5	42.7	109.0	20.4	81.3	70.6	234.6	79.6	56.7	188.9	43.8	60.0	117.6	21.1	58.8	89.8	59.5	81.9	79.2	82.0	49.4	41.2	74.2	100.4	33.3	71.5	16.3	189.0	34.4	14.0	122.2	108.8	67.4	56.4	72.1	75.9	154.7	69.6	61.7	126.3	65.5	55.4	65.1	45.8	73.6	65.6	15.2	20.4	80.8	54.1	36.8	46.2	63.8	33.3	178.0	46.3	70.6	71.7	35.6	108.3	14.6	103.8	101.8	46.1	82.4	63.6	112.5	64.4	22.4	61.1	29.9	58.2	81.2	31.9	13.5	156.0	26.2	30.1	65.9	40.6	11.2	48.3	78.3	23.4	75.3	66.5	77.2	47.1	73.6	29.5	40.3	85.2	76.7	97.9	61.1	102.2	22.7	8.1	10.7	60.1	18.7	82.3	0.5	0.1	0.7	0.6	0.0	0.5	0.7	0.2	0.3	0.1	0.5	0.3	0.4	0.0	0.1	0.0	0.5	0.3	0.2	71.7	60.1	94.2	120.0	66.8	75.7	81.3	70.6	60.0	41.2	71.5	67.4	66.3	16.0	17.2	76.4	9.1	30.2	13.5	22.9	30.1	26.6	51.5	57.4	16.4	24.3	20.4	29.5	18.8	27.4	11.4	37.4	15.6	20.5	2.3	39.9	61.2	40.7	21.7	4.8	23.8	30.3	15.3	30.9	34.7	51.7	10.1	37.1	39.7	8.0	11.9	25.2	29.7	23.0	8.2	10.9	21.0	3.5	63.6	13.7	21.4	23.4	4.8	17.3	3.1	17.6	18.2	29.9	25.3	52.6	9.5	17.4	24.2	12.1	15.4	23.9	19.7	29.4	39.5	9.7	7.7	22.1	24.9	37.1	10.9	26.2	20.4	17.9
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.0"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	13.4	7.4	3.5	9.0	4.2	6.1	10.4	3.6	4.6	11.8	10.3	10.0	5.6	11.9	9.3	5.1	10.7	8.4	5.4	3.1	4.5	11.8	49.8	7.2	14.8	4.9	4.7	12.7	4.9	5.7	3.7	5.3	5.2	9.8	7.1	2.8	6.0	14.6	3.5	6.0	8.6	10.6	3.9	12.2	7.6	9.7	4.8	11.1	6.1	4.3	8.8	13.6	9.3	4.5	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.5	4.2	3.6	4.6	3.1	4.5	4.9	4.7	5.2	3.9	4.8	4.5	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP12A	"ATP1AL1, H-K-ATPase, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680408-24712472	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 75.6;Club cells: 49.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SuSa: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Actin filaments"	Cytosol	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.6	0.0	5.6	0.0	0.2	2.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	14.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.0	0.0	0.0	0.0	75.6	0.0	0.0	0.2	0.3	0.4	0.0	49.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	8.2	0.0	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.1	1.2	0.0	0.0	0.2	0.0	0.1	13.6	0.0	0.0	0.0	1.8	1.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	1.3
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	12.9	17.0	7.3	21.8	6.5	16.1	13.9	5.4	8.6	17.1	12.3	15.6	18.6	16.2	8.0	15.6	15.0	14.0	9.7	7.4	7.9	12.8	12.9	14.0	21.4	7.9	6.5	20.8	21.1	23.4	18.1	12.9	6.9	15.1	13.0	8.8	17.7	12.6	12.8	16.2	22.2	11.6	6.1	26.4	16.7	15.8	7.6	15.9	20.2	5.8	17.5	13.9	14.4	9.0	32.8	45.2	24.3	52.8	38.2	25.3	66.1	28.9	40.1	24.5	24.9	43.5	54.3	44.9	48.6	34.4	14.0	17.8	37.2	37.0	13.4	16.5	77.6	24.6	48.7	34.5	39.3	46.8	70.1	36.7	34.2	26.5	31.8	27.1	17.9	32.1	43.0	97.5	24.7	53.9	31.8	33.7	44.5	40.6	54.7	25.0	17.4	100.9	25.8	44.7	33.4	56.7	26.8	42.6	30.0	11.4	26.9	50.6	28.7	51.5	7.7	59.2	35.3	78.8	50.6	26.8	36.0	59.6	39.5	0.0	3.5	3.5	2.8	5.6	3.1	2.2	3.3	3.1	6.5	1.9	2.1	2.7	0.1	1.4	8.6	5.0	2.9	2.4	7.3	6.5	5.4	8.6	7.4	7.9	7.9	6.5	6.9	6.1	7.6	9.0	11.3	9.6	5.8	12.1	22.7	5.9	7.4	8.2	9.6	12.0	13.0	8.5	5.5	11.5	9.0	14.7	18.8	20.3	12.5	28.5	1.9	19.1	10.3	11.5	9.8	9.0	18.6	11.1	11.2	18.4	18.2	10.2	31.6	13.6	5.7	16.2	10.8	13.2	20.0	5.0	11.0	22.9	12.2	12.2	9.5	5.1	14.0	18.3	7.2	7.5	13.6	12.6	8.2	9.0	11.0	15.6	22.4	9.8	50.4	11.9	28.6	6.6	12.8	10.8	6.6	9.2	11.4	14.7	14.6	12.6	6.1	15.3	13.9	20.2	22.2	6.4
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase cation transporting 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	15.3	18.6	49.7	20.2	45.8	11.6	14.3	30.3	81.2	10.6	3.3	15.9	12.7	12.1	6.6	23.6	9.5	9.3	11.6	46.7	66.0	16.6	6.2	17.9	17.7	112.4	60.8	8.7	55.7	12.9	57.0	12.6	110.8	14.3	9.8	22.8	27.4	7.9	17.2	16.5	16.7	8.6	32.0	26.0	19.3	10.3	64.1	9.5	16.7	5.3	10.3	12.9	12.1	44.3	28.3	27.4	14.7	60.8	13.8	12.2	40.8	15.8	15.4	17.1	16.6	48.9	31.4	12.5	65.9	26.9	14.6	43.1	32.1	59.5	6.2	17.2	58.5	43.7	28.0	27.2	17.5	15.6	19.6	10.0	31.6	47.1	36.6	55.0	32.3	32.2	28.2	22.6	70.2	22.2	18.4	8.8	23.2	66.3	20.0	20.0	60.1	50.7	19.0	42.8	40.9	27.4	73.8	87.7	60.2	18.8	29.9	19.6	34.4	18.0	34.5	30.8	33.1	4.8	6.1	14.0	34.6	85.2	30.3	0.0	1.6	0.3	2.6	3.7	2.9	1.3	2.1	2.2	0.4	3.1	1.0	1.5	0.5	2.7	3.6	20.6	1.8	1.4	49.7	45.8	30.3	81.2	46.7	66.0	112.4	60.8	110.8	32.0	64.1	44.3	18.9	0.0	2.2	14.4	8.3	6.5	6.9	5.7	6.2	35.9	16.9	11.3	3.6	7.2	6.8	7.3	35.5	5.8	33.4	44.6	5.9	15.1	1.4	6.7	3.8	14.4	7.7	4.2	53.1	25.1	33.6	6.0	18.8	19.0	8.9	20.5	6.1	3.7	10.4	47.1	61.8	15.0	0.0	17.3	2.8	1.7	5.3	10.1	5.4	11.2	6.1	34.0	8.2	20.1	18.1	57.0	49.0	6.4	5.4	12.3	18.2	5.3	4.3	38.4	0.0	4.6	5.7	13.6	16.4	11.6	5.3	9.3	11.1	4.8	21.7	12.8
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1482.3"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1879.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 2979.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		420000	"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	150.9	206.6	115.5	144.1	135.7	104.3	220.2	176.4	264.7	137.6	209.2	580.5	785.5	92.3	304.6	255.9	143.6	361.3	233.1	176.0	133.9	1127.5	132.5	255.7	89.7	140.8	103.5	137.7	661.3	1482.3	160.6	120.0	196.3	176.4	542.6	301.2	721.9	294.1	147.3	316.6	813.9	146.1	117.4	78.1	201.5	140.0	104.1	92.8	744.4	117.7	132.4	149.7	187.4	142.2	399.8	144.8	147.2	74.5	288.8	277.5	750.8	232.9	462.9	281.6	396.6	583.9	278.5	314.2	321.3	279.0	284.4	505.1	293.8	493.7	406.2	116.1	324.2	183.5	249.2	498.4	220.1	465.2	246.1	311.6	808.0	328.4	429.0	395.5	350.8	187.4	306.9	294.2	253.0	793.7	189.6	167.7	346.0	630.5	285.6	179.7	343.4	278.6	1023.2	405.1	143.8	126.7	363.0	679.6	2979.2	358.2	179.1	265.9	311.9	159.4	221.4	415.4	479.5	140.7	118.1	238.0	488.2	263.1	956.1	19.2	36.6	17.2	59.7	56.6	62.8	26.4	66.9	64.2	59.6	15.2	76.5	55.5	4.5	30.8	86.0	30.4	57.6	53.6	115.5	135.7	176.4	264.7	176.0	133.9	140.8	103.5	196.3	117.4	104.1	142.2	199.2	275.7	295.3	26.8	84.6	276.8	336.8	220.5	390.9	101.0	189.2	145.2	74.1	579.0	238.4	770.6	398.2	83.7	89.1	789.9	373.7	625.6	31.2	205.4	54.3	201.6	176.4	89.2	130.5	315.6	160.6	141.6	134.6	372.1	43.8	212.6	144.2	71.2	129.8	102.6	123.9	353.4	463.9	98.8	254.2	19.3	117.8	145.5	208.1	36.5	56.9	556.8	64.9	77.9	60.9	187.6	307.8	100.8	73.2	271.6	1879.9	308.2	171.6	147.7	32.9	109.8	147.4	20.2	35.8	320.7	268.9	67.6	133.3	58.3	498.6	280.6
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904466	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	85	"skeletal muscle: 8241.7;tongue: 3199.6"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 65.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.0"	"Region enriched"	"Detected in some"	8	"thalamus: 13.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2"	"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		2800000	"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	1.5	1.1	0.7	1.6	0.8	1.9	1.8	0.9	2.6	1.0	0.1	1.4	1.6	1.5	0.4	27.7	1.4	0.5	1.2	0.6	0.8	1.3	3.1	1.2	2.9	1.1	0.7	1.6	1.0	0.5	3.2	0.7	1.5	9.5	0.4	7.9	67.2	3.5	8241.7	2.4	2.2	0.4	0.7	1.5	1.1	10.7	1.1	1.5	2.2	3199.6	0.4	1.2	1.2	1.4	7.7	8.0	14.4	8.7	0.7	2.3	13.3	3.5	2.0	0.6	0.6	4.5	6.7	11.9	4.1	0.6	4.8	7.9	3.6	0.2	1.0	5.9	30.0	4.2	19.0	14.4	0.3	1.8	3.8	5.9	1.6	0.9	0.7	7.3	0.4	21.8	8.2	9.8	0.4	15.2	17.3	9.5	14.4	2.8	11.2	26.4	10.2	9.1	0.1	0.9	9.2	7.3	5.0	6.8	5.2	5.2	5.1	4.2	3.1	4.5	9.4	8.5	4.5	14.2	9.5	12.0	8.7	23.4	4.4	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.0	1.6	0.0	1.0	0.5	0.2	0.7	0.8	0.9	2.6	0.6	0.8	1.1	0.7	1.5	0.7	1.1	1.4	0.3	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.6	2.1	0.5	0.5	0.5	0.0	0.2	0.0	14.6	0.4	0.0	0.6	0.0	0.1	1.3	0.4	0.4	0.3	0.0	0.0	2.3	0.2	0.2	0.5	1.5	0.7	0.0	0.7	0.0	0.6	0.1	0.0	2.3	0.3	0.0	0.6	0.0	3.9	0.3	0.3	0.0	1.0	0.0	0.3	0.0	0.5	2.3	0.2	1.2	0.0	0.1	0.2	0.7	0.1	0.4	4.7	0.0	65.2	0.6	5.7	3.4	0.3	0.1	0.7	0.4	0.7	0.6	0.1
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	60.4	49.6	26.2	57.8	34.6	46.0	34.1	36.0	28.0	43.4	23.2	64.2	47.5	46.6	39.0	181.2	67.0	60.5	1005.8	39.0	28.8	34.4	54.7	49.0	36.0	32.5	46.3	42.0	38.1	56.1	24.5	55.4	29.8	93.4	69.0	19.1	92.2	70.0	2856.8	46.5	56.4	74.4	29.8	30.5	47.2	74.1	57.6	36.2	73.3	2768.8	48.1	90.9	57.9	36.1	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	26.2	34.6	36.0	28.0	39.0	28.8	32.5	46.3	29.8	29.8	57.6	36.1	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.5;Distal enterocytes: 120.7;Enteroendocrine cells: 97.8;Gastric mucus-secreting cells: 153.4;Intestinal goblet cells: 128.4;Plasma cells: 96.0;Undifferentiated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 186.8;HMC-1: 266.1;JURKAT: 152.1;MOLT-4: 253.2;SK-BR-3: 195.2"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	6.8	13.7	6.8	62.2	8.7	98.3	7.7	20.0	6.1	6.0	15.3	55.0	30.7	9.1	1.6	9.7	6.1	13.7	8.0	3.0	4.5	11.4	4.6	22.4	101.5	2.3	12.8	3.1	64.0	2.1	2.5	2.8	3.9	20.3	33.0	0.2	185.3	19.6	3.3	28.2	75.3	6.3	2.0	98.2	92.8	2.1	11.6	97.5	11.7	3.3	58.7	17.0	7.2	2.3	0.3	7.6	0.3	6.8	0.0	0.0	0.3	0.4	0.9	0.2	0.6	2.5	1.7	186.8	11.0	0.6	0.1	0.8	3.1	0.0	0.0	23.5	2.1	98.0	6.0	0.1	1.7	108.0	266.1	0.2	0.0	0.7	0.0	0.1	0.3	152.1	20.1	117.1	0.1	116.8	253.2	115.5	1.2	53.1	1.6	27.5	0.2	43.3	0.0	3.3	11.5	3.4	1.5	195.2	0.2	1.1	12.2	26.3	0.5	0.0	2.1	0.4	0.1	43.4	14.2	66.0	2.5	75.6	0.1	16.0	1.4	33.7	10.8	0.9	8.3	9.8	6.7	10.3	1.6	11.4	4.8	6.0	13.1	3.8	0.5	15.8	6.4	6.7	6.8	8.7	20.0	6.1	3.0	4.5	2.3	12.8	3.9	2.0	11.6	2.3	7.1	0.0	1.9	0.7	82.5	0.9	0.4	0.7	1.2	0.0	4.7	1.7	3.8	2.8	2.7	23.9	0.0	0.2	59.2	120.7	0.0	1.3	0.1	0.3	0.4	7.8	97.8	22.5	0.5	12.1	0.3	1.9	153.4	0.3	33.0	0.2	8.9	1.0	2.8	0.0	0.6	128.4	36.7	3.1	2.5	0.2	0.0	17.8	12.4	5.6	5.0	0.2	28.8	0.0	0.3	25.2	50.3	0.7	96.0	4.2	14.0	0.4	2.7	0.2	0.0	1.0	3.4	0.0	1.5	0.4	0.3	0.0	38.4	0.4	65.6	4.6
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 106.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 781.6;Langerhans cells: 435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 314.6;LHCN-M2: 501.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	18.5	11.2	33.0	25.6	92.0	106.8	19.6	14.0	59.1	18.8	0.0	33.1	40.8	18.2	12.1	14.7	18.6	25.2	11.0	52.7	4.9	16.4	22.7	21.3	29.2	0.0	14.4	13.1	17.1	21.5	11.0	27.3	0.0	13.9	32.3	71.2	11.5	14.9	24.4	26.0	30.1	19.7	0.0	30.7	29.0	23.0	10.9	18.4	14.4	24.1	28.8	37.0	10.6	34.9	24.0	117.8	45.5	22.1	64.5	102.2	20.9	71.2	232.6	67.5	106.8	47.7	21.6	46.8	4.9	99.3	77.6	21.0	40.3	19.7	187.5	16.2	46.9	16.6	39.8	41.9	209.6	70.7	26.6	85.0	36.9	210.8	314.6	78.9	17.5	17.6	27.9	16.6	501.1	37.6	22.1	30.1	35.6	32.9	55.6	31.1	146.4	19.7	64.4	108.5	42.9	23.4	82.6	22.9	20.2	91.7	33.9	7.8	12.5	181.8	29.4	67.6	78.9	12.7	21.2	49.1	82.6	19.6	41.0	9.4	39.4	22.3	20.9	42.5	26.4	84.5	36.3	26.8	51.3	84.4	13.2	16.8	127.1	27.0	86.1	9.0	53.7	21.8	33.0	92.0	14.0	59.1	52.7	4.9	0.0	14.4	0.0	0.0	10.9	34.9	46.0	44.8	46.0	90.8	226.4	201.6	71.0	29.3	76.2	370.9	30.9	109.7	20.3	45.8	30.0	53.3	154.3	176.8	139.8	181.5	1.9	27.6	2.3	29.3	61.0	63.6	91.6	31.5	781.6	28.5	42.1	91.6	44.9	59.4	31.6	45.5	49.6	39.5	193.5	302.9	279.1	30.7	16.2	116.0	435.1	9.6	29.2	285.4	55.2	126.5	157.1	96.4	50.4	193.5	91.9	25.5	80.6	32.0	133.9	54.7	75.0	22.1	20.6	113.3	32.9	97.0	69.5	44.5	130.7	30.4	204.7	228.8	125.1	76.0	65.9	90.2
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 104.0;choroid plexus: 43.0;salivary gland: 33.2;skeletal muscle: 37.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 104.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	0.0	0.6	3.4	0.0	15.8	0.0	0.1	38.6	104.0	2.0	43.0	0.1	0.0	2.2	0.2	0.1	3.7	0.0	0.1	10.4	0.2	0.2	20.3	0.0	0.0	1.6	9.8	0.0	0.2	2.0	3.5	0.0	2.7	0.0	0.0	13.5	33.2	0.0	37.4	0.4	0.1	1.4	0.0	0.1	0.1	0.6	16.1	0.5	0.0	4.9	0.1	0.0	0.1	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	15.8	38.6	104.0	10.4	0.2	1.6	9.8	2.7	0.0	16.1	30.3	0.1	0.0	0.0	117.5	0.1	0.5	0.0	0.0	0.0	87.7	3.6	0.3	12.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.7	0.8	0.7	0.0	0.0	323.2	0.0	0.0	0.5	0.0	14.1	2.5	0.1	0.4	27.1	0.0	104.3	230.5	0.0	0.0	0.8	0.7	7.5	0.0	0.1	3.6	14.0	0.0	16.4	0.0	58.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.2	0.0	2.3	0.5	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 187.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.1;Endometrial ciliated cells: 6.5;Excitatory neurons: 23.7;Extravillous trophoblasts: 10.7;Inhibitory neurons: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.9;SH-SY5Y: 2.9;THP-1: 2.5;U-937: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported				NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 10: Non-specific - Unknown function"			"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.0	9.7	6.0	0.0	7.5	0.0	0.0	3.4	33.7	0.0	187.9	0.3	0.0	0.0	0.9	0.0	1.2	0.0	0.0	25.7	1.3	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.5	4.8	0.0	0.0	2.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.9	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.5	3.4	33.7	25.7	1.3	5.5	0.0	4.8	0.0	2.7	12.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	1.3	0.1	0.0	0.0	23.7	0.0	10.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	30.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.4	0.0	3.5	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.6	4.5	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting subunit alpha"	P20648	19	35550031-35563658	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"stomach 1: 841.9"	"Group enriched"	"Detected in some"	6	"Gastric mucus-secreting cells: 66.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039154, HPA076684"	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	1.1	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	841.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.0	0.6	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1760.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 784.3;Distal tubular cells: 1173.9;Extravillous trophoblasts: 463.0;Proximal tubular cells: 939.6;Syncytiotrophoblasts: 578.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria		NA	NA		8800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	251.3	453.6	198.6	177.7	209.2	210.5	260.4	233.0	251.4	195.5	401.9	414.0	438.9	192.6	225.6	362.6	227.2	146.3	1498.3	207.7	246.0	730.4	441.6	175.1	223.7	234.6	237.8	211.1	299.9	868.5	277.4	201.7	226.0	211.4	419.8	465.4	307.4	265.9	1602.0	290.3	335.0	233.0	205.4	226.8	419.1	167.6	226.7	277.3	261.4	1760.3	337.6	244.9	224.7	209.6	355.2	353.0	459.6	434.3	546.0	601.8	508.6	399.5	562.4	601.0	522.8	532.7	271.9	833.2	238.9	487.4	322.3	641.7	801.1	614.1	556.4	373.0	450.3	551.7	413.3	667.2	357.1	1182.7	501.6	559.2	422.3	434.6	448.2	481.3	630.4	442.5	454.0	477.2	521.8	367.6	612.8	579.7	432.3	344.5	367.6	596.5	533.8	1131.4	816.2	849.7	465.7	434.7	293.3	361.5	506.9	428.6	466.3	679.3	370.4	328.7	282.7	174.9	354.9	542.5	501.5	533.0	328.1	698.0	358.7	119.1	573.9	162.7	353.6	511.8	455.9	492.3	422.7	388.4	959.5	392.9	503.3	421.7	55.9	414.5	485.1	468.3	527.4	1339.1	198.6	209.2	233.0	251.4	207.7	246.0	234.6	237.8	226.0	205.4	226.7	209.6	79.2	169.9	167.8	0.0	49.9	0.0	0.0	0.0	0.0	0.0	205.7	169.8	0.0	0.0	100.3	171.0	0.0	784.3	86.3	0.0	1173.9	358.3	0.0	125.3	163.3	73.0	0.0	0.0	0.0	269.7	463.0	97.8	0.0	119.3	89.6	198.7	0.0	0.0	409.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	179.9	0.0	0.0	0.0	0.0	199.1	0.0	0.0	24.0	0.0	0.0	939.6	95.5	0.0	0.0	0.0	87.1	0.0	0.0	0.0	0.0	578.2	54.6	319.2	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56645984	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2590.4;tongue: 3205.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		19000000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	432.7	555.5	217.6	300.5	231.4	465.8	301.5	281.6	303.8	241.8	443.3	741.6	689.5	235.4	223.4	527.6	277.9	225.7	2011.6	233.0	307.1	945.9	609.3	253.4	294.6	264.2	242.9	200.2	301.7	1311.6	252.6	301.4	280.4	280.9	767.6	484.2	407.7	356.4	2590.4	398.6	575.5	332.5	230.9	272.5	494.9	236.0	277.5	390.9	342.8	3205.3	458.3	404.1	311.2	244.7	693.6	834.9	632.3	1003.6	578.3	596.7	1159.8	683.2	645.6	1179.1	663.9	1375.7	755.6	1236.3	723.0	863.5	482.9	906.1	1378.1	851.5	1039.4	579.9	987.5	1333.1	726.4	872.5	716.6	1509.7	912.9	755.1	843.3	918.0	1171.2	870.2	985.8	901.7	1246.3	1363.1	992.2	671.5	1134.4	941.3	1085.9	905.6	1637.6	1079.3	711.0	1603.5	1315.6	1196.7	737.5	658.2	1042.3	1481.3	1214.0	663.4	1404.1	1151.8	657.6	454.8	507.9	671.9	751.0	659.5	865.7	1254.8	684.7	1007.8	718.4	403.5	549.4	281.8	293.5	643.6	326.3	303.2	275.4	313.6	713.4	248.4	221.0	266.8	137.1	296.9	750.6	360.9	372.9	1077.1	217.6	231.4	281.6	303.8	233.0	307.1	264.2	242.9	280.4	230.9	277.5	244.7	172.3	134.6	173.2	0.0	48.6	0.0	0.0	0.0	0.0	0.0	176.8	149.1	0.0	0.0	81.1	277.7	0.0	821.1	141.5	0.0	1238.5	517.7	0.0	194.1	169.2	115.7	0.0	0.0	0.0	367.9	592.7	115.0	0.0	163.3	145.1	267.6	0.0	0.0	608.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	281.2	0.0	0.0	0.0	0.0	333.3	0.0	0.0	26.8	0.0	0.0	951.7	102.7	0.0	0.0	0.0	151.1	0.0	0.0	0.0	0.0	1138.6	77.4	518.4	0.0	0.0
ATP5F1C	"ATP5C, ATP5C1, ATP5CL1"	ENSG00000165629	"ATP synthase F1 subunit gamma"	P36542	10	7788147-7807815	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 895.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 517.1;Distal tubular cells: 890.2;Ductal cells: 453.9;Extravillous trophoblasts: 428.5;Hofbauer cells: 423.4;Proximal tubular cells: 938.6;Theca cells: 413.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060949	Approved					NA	NA		70000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA060949: AB_2684395"	"unprognostic (1.81e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.12e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.08e-2)"	123.7	265.0	82.8	103.2	82.4	149.0	164.8	111.3	111.0	122.5	102.6	240.9	254.7	100.9	150.1	145.9	114.7	112.6	710.9	81.5	94.3	399.9	368.6	93.5	133.0	85.4	83.2	86.8	182.2	411.4	76.7	147.5	86.4	117.5	274.7	161.6	168.3	136.2	537.8	110.7	205.7	146.1	88.8	96.4	174.3	71.1	89.1	192.5	161.7	895.1	175.3	163.8	91.0	90.9	301.2	266.8	255.2	219.3	212.5	276.7	241.2	211.1	176.1	365.7	351.6	511.4	293.8	323.8	163.3	248.0	95.3	337.9	318.3	342.8	325.5	222.3	381.6	351.7	169.3	479.8	172.2	193.6	249.6	222.9	234.1	224.7	134.5	315.7	426.7	321.8	283.4	230.1	352.6	419.0	451.9	217.7	173.3	623.4	201.8	301.9	179.1	460.6	637.5	301.0	141.3	168.2	186.0	417.5	417.1	287.3	437.9	315.9	202.7	151.7	205.3	349.2	229.8	159.2	194.7	265.5	224.7	286.2	127.3	373.0	273.8	241.9	158.5	363.1	185.3	199.2	180.7	174.5	370.4	158.6	146.4	159.6	88.5	226.9	428.2	237.8	261.4	349.3	82.8	82.4	111.3	111.0	81.5	94.3	85.4	83.2	86.4	88.8	89.1	90.9	196.2	118.6	95.4	0.0	30.4	0.0	0.0	0.0	0.0	0.0	156.2	239.3	0.0	0.0	60.7	215.2	0.0	517.1	85.3	0.0	890.2	453.9	0.0	160.9	125.4	76.7	0.0	0.0	0.0	381.8	428.5	89.5	0.0	170.4	97.1	163.2	0.0	0.0	423.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.6	0.0	0.0	140.6	0.0	0.0	0.0	0.0	304.4	0.0	0.0	12.0	0.0	0.0	938.6	64.8	0.0	0.0	0.0	102.0	0.0	0.0	0.0	0.0	371.9	49.1	413.9	0.0	0.0
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1595.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031069	Supported		Supported	Mitochondria		NA	NA		820000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	274.6	276.3	291.2	136.4	295.4	175.1	205.5	302.5	424.4	156.3	316.1	333.5	276.4	128.8	368.1	258.1	129.9	129.7	1052.1	295.2	306.2	489.5	756.3	110.8	166.4	299.3	297.8	127.2	188.2	458.8	140.4	171.5	295.7	160.1	314.4	249.5	214.6	228.5	1161.7	113.6	250.6	189.8	298.7	111.2	226.9	131.5	299.4	217.5	166.0	1595.8	210.9	194.9	138.4	299.6	355.9	260.0	314.5	351.4	344.8	313.5	389.4	305.8	373.0	305.8	300.8	607.6	274.4	439.3	194.2	312.9	467.8	191.5	441.3	379.2	339.2	373.1	441.1	910.6	520.6	618.4	386.8	673.2	284.5	303.1	471.2	284.0	258.6	399.9	363.0	412.2	582.2	522.9	458.2	416.3	468.6	683.2	562.3	824.0	460.7	358.0	606.5	840.0	669.8	504.6	360.2	394.1	516.5	521.7	493.0	449.4	376.5	590.5	260.6	219.6	266.6	209.3	265.9	501.7	954.7	568.2	341.5	707.8	283.1	444.8	447.0	443.7	293.3	487.1	316.1	475.1	385.5	368.6	531.9	399.7	377.4	370.7	292.3	389.9	505.7	504.0	520.3	661.3	291.2	295.4	302.5	424.4	295.2	306.2	299.3	297.8	295.7	298.7	299.4	299.6	532.1	169.9	179.3	0.0	56.0	0.0	0.0	0.0	0.0	0.0	346.3	468.4	0.0	0.0	105.9	419.3	0.0	652.7	116.4	0.0	2375.2	447.0	0.0	299.2	257.6	150.6	0.0	0.0	0.0	472.5	522.8	135.6	0.0	308.5	109.7	341.2	0.0	0.0	522.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.2	0.0	0.0	226.4	0.0	0.0	0.0	0.0	427.1	0.0	0.0	21.4	0.0	0.0	1906.2	142.1	0.0	0.0	0.0	161.4	0.0	0.0	0.0	0.0	708.2	79.2	387.8	0.0	0.0
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915814	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1601.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 610.3;Distal tubular cells: 1794.2;Extravillous trophoblasts: 623.2;Hofbauer cells: 627.0;Proximal tubular cells: 1236.8;Syncytiotrophoblasts: 542.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016209, HPA041394"	Enhanced		Approved	Mitochondria		NA	NA		150000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB016209: AB_631361, HPA041394: AB_2677450"	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	213.0	181.0	282.7	147.9	289.4	310.6	280.4	306.0	417.7	204.8	325.2	351.9	357.2	169.2	251.1	288.3	216.7	157.9	1114.5	291.2	317.4	458.0	401.8	148.9	243.3	298.2	290.8	273.1	196.7	432.9	108.0	192.2	296.5	158.0	391.9	219.4	236.3	202.0	1063.7	188.4	293.8	217.4	290.9	143.4	304.2	150.3	291.4	281.7	224.4	1601.7	292.9	242.3	161.6	292.4	398.4	187.3	491.1	486.6	340.0	435.1	554.6	218.5	394.4	371.4	361.9	553.5	372.7	531.5	187.2	345.1	355.2	217.5	549.0	764.7	440.6	400.0	544.0	790.3	260.4	513.5	389.7	603.7	260.9	445.8	467.9	358.4	581.9	407.0	522.8	421.2	656.3	665.9	488.5	402.5	461.6	593.0	561.3	992.2	540.1	471.6	490.1	1007.5	1032.8	337.0	404.4	232.1	380.2	559.7	525.7	425.6	562.9	660.5	291.0	236.8	280.6	423.0	252.6	429.1	524.2	559.7	438.2	1046.2	349.3	329.7	561.5	407.8	335.9	596.2	400.9	575.4	439.5	404.8	753.0	487.3	540.9	459.4	136.2	412.6	539.8	445.4	585.3	1077.9	282.7	289.4	306.0	417.7	291.2	317.4	298.2	290.8	296.5	290.9	291.4	292.4	195.8	243.6	191.1	0.0	82.1	0.0	0.0	0.0	0.0	0.0	282.6	476.1	0.0	0.0	121.3	222.5	0.0	610.3	81.3	0.0	1794.2	394.5	0.0	133.0	140.9	87.3	0.0	0.0	0.0	420.2	623.2	109.7	0.0	114.8	114.8	198.9	0.0	0.0	627.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.2	0.0	0.0	218.1	0.0	0.0	0.0	0.0	331.9	0.0	0.0	17.8	0.0	0.0	1236.8	102.0	0.0	0.0	0.0	119.0	0.0	0.0	0.0	0.0	542.1	67.4	208.9	0.0	0.0
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428633-154436516	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	56.3	93.5	108.3	43.1	109.2	59.1	56.7	99.6	118.0	59.6	123.6	61.5	48.4	54.2	145.1	85.2	60.0	46.0	92.7	116.2	115.4	104.3	51.4	96.8	46.9	114.0	96.8	63.3	86.6	176.0	110.4	77.9	121.6	85.1	57.0	74.0	87.4	54.8	53.8	83.6	57.4	49.0	104.6	94.7	70.4	47.5	104.2	40.9	81.9	54.4	42.5	63.7	60.9	121.6	110.1	101.6	88.2	146.2	145.7	77.4	162.2	78.5	116.6	122.5	176.1	93.4	135.1	64.7	337.8	177.1	216.5	112.3	133.8	71.9	76.6	58.6	135.1	37.5	113.7	100.0	170.6	60.9	260.2	98.1	126.7	112.4	68.2	139.5	177.0	47.8	45.6	176.4	84.7	158.1	43.6	96.8	32.1	171.0	100.8	66.6	59.1	170.7	139.9	87.3	84.6	89.7	72.6	289.7	159.3	87.3	123.1	157.8	135.5	87.4	79.0	151.1	135.6	256.3	311.8	77.0	104.4	132.8	90.2	246.6	295.1	363.9	147.3	313.8	148.6	91.7	118.4	127.8	376.7	113.6	107.1	117.8	326.9	140.3	255.6	215.9	155.2	216.9	108.3	109.2	99.6	118.0	116.2	115.4	114.0	96.8	121.6	104.6	104.2	121.6	39.4	38.5	57.5	17.0	32.3	30.2	42.7	122.4	25.6	105.8	58.5	42.2	37.7	54.3	102.1	97.5	47.9	145.1	40.1	84.3	19.6	65.4	3.1	52.5	33.7	50.1	89.0	35.8	17.0	52.5	104.5	48.8	36.7	57.4	77.3	51.8	54.3	46.6	246.3	129.5	24.2	59.0	160.7	143.6	88.2	5.5	41.3	130.3	72.9	15.0	79.9	68.4	27.8	22.1	26.4	42.4	67.5	42.5	61.7	34.1	63.7	49.1	112.5	69.2	65.7	35.7	45.5	64.4	10.7	31.6	32.8	196.5	36.3	74.1	54.6	47.2
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712353-123761755	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	6.6	4.4	5.6	7.0	6.2	10.4	5.7	7.4	6.5	4.7	6.9	5.5	8.7	6.0	3.9	4.3	4.8	3.8	4.7	6.0	6.0	3.8	4.2	6.3	8.3	6.6	5.8	4.1	5.7	3.7	4.9	3.7	6.5	4.7	5.8	6.7	7.6	4.0	6.5	9.4	7.0	5.1	5.6	6.6	8.8	4.9	6.2	7.5	4.8	3.5	8.2	5.3	4.5	7.9	4.8	10.3	12.0	17.8	9.2	7.0	6.7	6.2	6.2	5.4	5.8	6.9	2.7	18.0	4.2	7.6	5.5	9.0	16.1	6.2	4.5	11.4	10.2	27.9	9.2	5.4	10.2	16.8	51.0	6.7	4.4	5.9	7.4	9.0	5.0	15.0	14.5	3.4	8.1	8.4	15.4	24.8	11.5	6.6	6.5	15.7	9.9	6.4	8.3	10.4	7.2	13.6	9.3	6.9	9.4	6.6	5.9	14.4	8.3	8.0	3.1	10.8	9.1	10.8	12.8	14.9	9.4	12.1	6.5	6.3	0.7	13.7	1.7	0.9	1.0	0.9	1.7	1.5	0.8	3.7	1.6	1.8	2.0	1.7	1.5	2.8	1.0	0.8	5.6	6.2	7.4	6.5	6.0	6.0	6.6	5.8	6.5	5.6	6.2	7.9	13.0	6.4	11.0	3.9	20.4	10.1	10.8	4.6	11.4	20.5	7.9	5.3	8.8	12.8	8.3	9.2	12.5	5.2	27.9	17.9	0.0	8.1	10.2	11.0	11.9	10.6	13.2	50.3	21.2	10.9	5.7	11.3	18.3	12.3	75.3	8.7	18.2	11.4	8.4	11.8	19.3	9.8	2.0	9.4	17.2	4.5	8.7	11.3	1.8	7.5	13.2	9.0	25.7	10.6	17.1	9.2	9.0	9.4	19.7	15.7	11.1	4.0	13.5	28.8	6.6	12.4	10.9	23.6	12.6	9.6	14.2	6.8	21.8	5.7	11.4	11.4
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513952-2520218	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 115.3;Basal squamous epithelial cells: 363.7;Gastric mucus-secreting cells: 128.0;Macrophages: 152.4;Plasma cells: 235.0;Squamous epithelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065100			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA065100: AB_2685421"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favorable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	203.2	247.2	150.2	95.4	176.0	182.7	165.2	82.8	252.8	178.7	66.7	172.0	95.0	154.8	32.9	337.0	147.8	23.2	211.8	204.1	196.7	414.4	207.1	230.5	50.8	136.5	139.7	154.3	140.5	103.9	327.2	62.1	141.6	144.2	29.7	110.5	214.2	48.3	301.0	281.2	164.4	30.0	72.4	222.0	175.7	143.9	147.5	44.9	166.8	54.0	31.0	134.4	207.4	135.7	154.4	174.5	84.6	125.9	105.3	54.3	203.5	234.4	72.1	98.2	90.4	163.9	206.4	81.8	209.3	106.0	154.2	193.4	90.7	137.6	45.1	207.1	295.5	95.2	128.1	201.7	152.6	139.9	274.3	98.2	104.4	118.6	59.6	90.8	68.5	88.2	214.5	143.0	80.0	323.5	141.3	363.3	176.3	99.4	211.4	240.8	73.5	251.1	163.8	97.4	277.6	224.4	201.3	215.5	204.4	74.8	222.5	175.9	171.4	154.3	184.6	229.6	160.1	280.9	351.5	146.5	137.1	105.3	161.4	89.4	123.2	203.4	51.4	139.4	53.3	58.5	46.8	56.5	76.6	55.0	52.1	47.0	165.8	52.7	171.7	105.1	50.8	78.8	150.2	176.0	82.8	252.8	204.1	196.7	136.5	139.7	141.6	72.4	147.5	135.7	1.8	25.6	49.2	38.2	115.3	1.0	0.2	0.4	363.7	0.5	1.1	0.6	0.1	0.0	18.3	1.8	0.0	0.5	3.4	3.4	0.0	0.8	0.0	4.3	2.6	12.7	0.0	73.4	72.7	0.2	1.0	48.8	128.0	3.6	17.7	0.6	1.4	0.7	1.0	0.0	107.3	0.7	0.0	1.3	0.8	0.2	0.6	152.4	0.0	39.4	0.3	0.4	0.0	36.7	53.0	0.6	0.2	0.0	235.0	0.2	2.4	1.1	25.1	0.8	0.0	0.7	17.0	0.8	1.1	385.2	1.0	1.2	72.7	0.4	2.3	0.2
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481181	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 380.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	51.3	112.9	103.1	66.9	107.1	82.3	50.3	84.1	118.4	65.2	82.4	89.8	69.0	69.2	56.6	88.6	57.8	55.9	71.5	119.9	145.1	86.2	73.0	78.7	66.9	112.6	107.4	35.1	59.2	116.3	107.7	55.8	136.0	60.5	72.7	41.4	62.8	55.0	127.6	85.9	79.9	79.6	82.6	96.1	69.4	69.5	99.4	64.7	75.1	84.7	64.0	66.8	62.2	98.5	78.9	111.6	67.3	87.5	167.2	91.2	64.3	92.7	149.1	187.0	224.3	116.5	82.6	33.0	74.2	134.7	125.3	91.9	99.0	117.7	108.8	40.3	90.5	60.5	58.4	97.6	159.4	60.5	243.3	139.8	115.1	187.4	44.5	68.2	117.9	38.0	69.7	41.9	151.9	193.7	45.7	134.9	65.2	70.6	77.9	80.2	78.5	92.1	113.3	129.3	130.4	60.4	244.0	65.8	103.1	52.3	104.8	91.1	114.4	93.4	38.6	113.9	49.8	69.5	106.8	94.9	130.1	63.8	56.3	312.7	732.5	542.4	130.1	511.7	89.9	189.4	96.3	120.3	469.2	174.5	73.1	91.3	936.5	155.5	485.5	168.4	128.0	742.7	103.1	107.1	84.1	118.4	119.9	145.1	112.6	107.4	136.0	82.6	99.4	98.5	46.0	16.0	47.2	11.1	80.1	73.8	61.5	138.2	45.5	73.3	65.7	50.5	38.8	54.3	78.0	68.0	73.0	112.1	74.7	258.8	181.9	127.7	109.6	93.3	46.4	42.6	121.9	68.8	22.7	111.0	73.1	61.5	68.3	74.5	50.1	44.2	42.5	50.2	380.4	82.4	25.7	160.2	154.6	149.4	186.7	50.1	58.7	183.1	124.5	7.5	260.9	70.6	77.2	13.6	23.1	102.0	179.5	53.0	57.0	38.8	203.1	173.6	92.7	52.9	118.3	26.6	53.2	125.7	64.0	55.0	87.5	283.6	54.7	91.3	101.6	63.2
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628749	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		34000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	119.5	165.0	209.8	68.3	220.9	90.4	109.5	214.3	287.3	101.7	200.4	128.9	56.6	112.2	135.8	117.2	96.0	84.7	224.9	231.8	226.9	230.5	85.6	110.3	88.6	220.3	202.3	81.9	59.5	239.9	117.1	113.8	230.8	95.0	99.7	128.4	83.7	126.4	232.8	120.3	83.1	121.0	215.9	99.0	101.8	67.3	218.1	108.2	100.8	178.6	109.5	114.5	97.6	245.6	121.8	108.6	96.4	94.3	314.4	169.6	106.0	159.3	212.0	198.7	228.0	137.3	97.5	76.1	132.8	215.0	251.8	187.9	152.8	140.2	174.9	145.9	173.3	137.1	97.5	182.7	459.9	159.8	226.5	212.9	267.7	192.4	138.7	220.9	170.2	95.0	174.8	150.3	341.9	127.4	136.5	114.5	71.0	269.6	152.6	80.3	140.7	45.7	331.6	189.0	70.3	122.7	146.0	101.0	358.9	187.0	98.6	180.4	146.3	137.5	72.6	174.0	119.2	145.7	275.5	96.3	221.2	76.7	189.3	178.1	106.3	184.7	64.0	100.9	63.0	78.7	64.7	61.5	83.6	59.8	60.8	63.7	137.6	76.0	120.5	81.2	97.7	112.8	209.8	220.9	214.3	287.3	231.8	226.9	220.3	202.3	230.8	215.9	218.1	245.6	66.5	76.9	83.4	13.4	47.1	41.9	77.6	121.8	19.9	54.6	33.9	34.8	126.8	74.4	83.9	138.0	27.1	235.1	63.8	105.2	461.8	143.8	7.6	74.3	56.9	69.3	41.9	49.4	24.9	119.7	143.9	60.8	40.8	79.2	90.5	41.6	72.5	46.8	186.8	53.8	24.4	54.0	116.0	75.1	52.1	17.9	94.1	91.9	80.0	15.0	144.1	94.1	85.5	13.0	31.9	154.7	104.7	97.8	38.3	60.1	65.4	411.3	78.8	50.4	59.2	39.0	74.5	71.7	74.7	34.3	51.6	479.1	54.6	57.6	40.1	93.1
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.1"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.3	2.5	2.4	78.1	0.7	3.5	6.5	1.5	3.0	1.1	0.7	6.4	4.2	0.5	3.1	2.2	0.4	4.5	2.9	1.2	1.6	1.1	1.0	2.5	2.6	0.4	0.5	0.2	0.3	3.5	2.8	0.6	1.7	0.1	0.5	0.8	0.1	0.3	1.3	3.1	3.1	2.6	0.6	0.4	2.4	0.5	0.1	0.1	1.0	1.4	0.4	4.9	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.3	2.4	3.5	6.5	4.5	2.9	2.5	2.6	2.8	3.1	2.4	4.9	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471018-3651118	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 101.6;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 89.5;Oligodendrocytes: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		27000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.8	19.1	10.5	10.3	12.2	8.6	17.2	9.3	13.2	16.5	8.9	11.8	55.8	11.8	15.6	10.4	11.7	13.9	19.1	13.4	12.2	23.9	62.8	14.4	7.5	8.0	8.7	14.0	20.2	40.1	8.7	22.6	9.0	12.8	12.3	24.2	13.9	13.2	11.6	14.9	33.4	14.9	11.3	13.8	24.0	16.6	10.8	7.8	32.3	14.2	9.6	15.7	9.1	15.8	40.8	37.6	21.9	18.4	37.9	61.5	28.1	26.6	37.5	27.4	23.1	16.3	27.1	0.0	17.5	37.4	33.8	55.6	15.0	58.1	36.4	4.5	12.8	12.7	10.0	35.1	22.8	27.2	8.3	33.1	46.0	29.0	27.8	34.3	36.0	8.7	20.2	19.2	27.0	11.7	11.1	10.4	14.7	13.2	22.3	9.2	50.9	30.8	24.8	28.5	12.9	20.2	26.7	48.9	36.3	21.3	26.2	25.5	44.7	29.0	17.0	30.8	26.6	13.4	20.1	0.1	17.9	17.9	29.6	3.6	3.2	2.0	2.3	2.8	1.0	1.4	1.2	1.4	2.8	1.7	2.0	1.7	0.0	1.5	3.1	2.6	1.8	1.0	10.5	12.2	9.3	13.2	13.4	12.2	8.0	8.7	9.0	11.3	10.8	15.8	11.1	16.0	10.4	70.2	5.8	6.4	4.3	14.1	6.8	22.5	9.9	8.8	12.6	20.0	10.3	11.0	37.5	7.4	8.0	6.5	1.9	8.2	7.1	9.9	15.1	11.1	9.6	7.4	101.6	14.6	8.4	12.7	20.4	11.8	7.0	39.3	17.9	50.9	10.4	37.0	101.1	10.7	4.1	14.2	6.7	5.4	12.5	11.5	7.2	64.6	10.1	11.8	5.2	89.5	85.7	10.0	14.3	7.9	11.4	7.0	34.6	7.3	10.2	20.1	32.9	14.3	10.9	21.3	21.1	8.5	7.2	5.1	5.8	21.0	12.6	5.2
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478"	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	67.8	78.2	80.2	51.6	86.2	82.9	65.3	89.9	116.8	83.3	72.7	75.6	43.8	71.3	20.9	81.9	77.8	29.2	68.8	82.2	82.2	85.7	96.1	85.9	62.7	83.2	80.4	81.3	96.8	33.7	116.4	39.0	83.4	80.6	27.0	56.5	70.1	27.9	63.8	76.9	86.3	33.4	75.5	117.0	82.6	178.9	83.5	52.5	83.0	23.7	46.9	75.5	77.7	86.0	77.8	97.6	99.0	112.1	59.9	61.5	116.1	76.3	73.7	82.1	91.3	124.1	90.1	178.6	95.4	54.4	128.6	110.2	93.9	76.9	90.5	140.9	83.3	119.5	124.3	127.4	107.5	135.9	161.2	78.8	90.1	116.4	166.1	72.4	73.2	174.4	158.9	219.9	68.4	109.9	166.1	228.0	100.6	46.9	67.2	216.4	68.5	125.6	48.9	79.6	102.8	81.9	44.6	83.5	95.8	62.3	91.3	141.0	88.2	101.2	83.6	65.8	106.2	311.9	238.1	159.4	76.3	128.1	119.6	0.4	2.1	1.4	1.6	1.9	1.6	4.3	1.9	2.0	1.6	2.9	1.8	2.3	2.4	1.9	1.6	5.6	1.7	1.1	80.2	86.2	89.9	116.8	82.2	82.2	83.2	80.4	83.4	75.5	83.5	86.0	30.2	28.9	33.3	26.1	48.2	36.6	25.1	20.2	66.0	31.6	29.8	26.3	2.1	21.5	19.8	20.2	45.9	23.0	39.1	19.8	1.9	17.8	71.7	37.7	34.9	27.8	24.6	23.1	37.3	20.2	21.9	20.8	31.6	53.1	25.9	23.4	27.1	14.7	24.8	26.9	37.5	23.4	14.2	29.3	33.3	25.7	21.5	36.5	8.8	24.4	26.4	10.0	33.0	18.6	31.5	32.2	19.4	19.9	65.1	33.0	19.7	4.8	18.8	48.9	13.1	28.9	22.1	83.9	28.3	46.3	31.1	34.3	48.4	24.5	23.4	27.4
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
ATXN7	"ADCAII, OPCA3, SCA7, SGF73"	ENSG00000163635	"Ataxin 7"	O15265	3	63863155-64003462	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	7.5	6.3	4.5	11.4	4.1	24.4	7.1	4.9	4.4	7.4	0.2	6.9	8.0	8.6	4.7	8.7	6.3	9.6	5.8	3.1	3.7	7.1	8.4	9.0	12.7	3.4	3.3	8.0	21.0	10.9	2.3	8.3	2.7	6.7	8.8	16.3	7.8	5.2	7.1	9.3	9.2	7.9	0.7	10.6	8.4	15.0	3.1	16.5	7.5	8.7	11.7	7.4	4.4	3.2	8.4	5.7	8.1	7.2	8.5	11.3	9.5	6.5	9.0	11.1	10.5	8.9	8.7	12.5	3.1	9.0	12.5	6.5	9.6	9.1	11.9	22.8	4.9	16.1	10.7	4.2	6.4	8.5	17.7	7.9	9.0	15.7	17.7	9.0	8.4	13.3	6.3	26.2	7.7	25.8	12.7	6.8	5.5	5.7	3.0	9.1	7.1	10.1	6.1	11.0	3.1	5.6	13.2	9.4	10.8	6.4	5.1	12.2	11.9	11.4	12.0	12.7	12.9	12.9	13.2	10.3	10.3	11.6	9.4	15.8	1.1	2.1	3.7	1.0	3.3	1.0	6.2	4.0	0.8	2.4	6.2	4.1	4.5	3.5	0.7	1.5	6.2	1.3	4.5	4.1	4.9	4.4	3.1	3.7	3.4	3.3	2.7	0.7	3.1	3.2	2.4	9.6	9.1	34.6	17.0	43.6	24.9	17.6	29.6	73.2	3.4	1.7	10.5	35.8	17.9	5.5	102.2	14.1	21.5	38.3	0.0	2.8	17.1	3.3	1.5	16.1	26.4	29.5	81.2	4.2	13.6	16.6	18.8	3.5	14.7	1.2	26.7	22.8	14.2	25.2	67.0	19.7	24.4	34.6	30.3	9.5	12.8	20.1	12.4	64.6	33.5	24.5	54.6	60.3	46.7	2.5	28.5	13.2	14.8	26.1	28.1	0.7	27.4	70.8	0.0	39.2	15.6	14.8	15.6	25.6	46.2	61.2	41.5	1.6	20.1	38.6
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105604772-105876599	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.7;Early spermatids: 93.4;Excitatory neurons: 107.3;Inhibitory neurons: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	5.0	4.3	2.8	4.4	3.0	4.3	4.5	5.0	4.3	6.6	0.6	5.3	4.1	4.7	4.5	4.1	5.8	4.3	2.6	2.8	1.3	7.3	6.3	4.0	6.4	1.6	1.7	6.5	3.2	4.9	3.3	5.7	1.5	4.7	5.9	2.0	5.8	3.8	2.3	5.9	5.0	4.1	0.1	5.7	4.8	10.2	1.8	10.1	5.0	3.1	5.9	4.5	5.2	2.7	3.2	4.3	9.0	4.2	5.5	6.5	2.8	5.7	5.6	5.0	4.6	4.2	6.1	1.3	4.3	6.1	4.4	3.0	5.1	5.9	3.7	18.0	3.3	4.3	3.2	4.1	3.3	7.1	13.9	4.5	4.7	3.3	3.3	3.7	4.6	3.0	5.2	2.8	4.2	7.7	3.9	4.3	16.7	9.0	4.3	3.8	3.0	1.0	3.8	3.2	5.6	3.7	4.0	8.0	7.9	8.9	4.1	7.2	11.5	7.8	3.5	6.5	2.2	0.6	0.0	0.1	4.8	10.9	8.0	2.3	3.8	4.2	2.4	4.4	1.8	3.5	6.5	5.6	2.9	3.5	6.9	3.9	1.3	4.4	2.8	1.9	14.3	3.3	2.8	3.0	5.0	4.3	2.8	1.3	1.6	1.7	1.5	0.1	1.8	2.7	8.3	0.0	3.9	60.7	8.0	5.1	5.4	4.9	6.2	7.8	5.2	3.9	2.4	4.3	3.6	5.5	2.1	6.3	16.8	11.3	5.9	3.9	93.4	13.1	6.4	5.2	5.4	9.4	107.3	2.6	3.6	5.9	11.2	7.9	5.1	7.9	6.4	17.0	7.5	8.4	96.3	8.5	2.0	11.6	6.1	56.6	6.5	9.3	8.8	55.3	10.8	2.0	19.6	46.8	51.3	4.2	11.0	4.5	7.4	4.6	43.7	42.6	14.9	1.0	6.6	7.5	6.4	20.9	2.5	7.0	4.0	5.3	13.3	7.7	9.4	3.7
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361918	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 191.7;Inhibitory neurons: 137.0;Oligodendrocytes: 137.5;Proximal tubular cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	17.2	41.9	11.8	6.3	12.3	4.8	15.9	16.0	15.3	13.6	17.9	17.2	23.8	10.2	14.2	8.6	12.4	10.7	38.9	12.1	14.3	62.9	26.4	10.3	7.6	14.8	13.6	13.4	25.5	45.4	10.4	16.1	15.2	28.2	17.2	21.4	26.1	14.8	24.2	8.7	20.1	8.6	12.2	8.0	22.7	5.5	14.1	9.0	21.0	29.2	7.7	9.1	9.8	15.0	9.1	8.7	12.0	6.2	14.5	15.5	18.5	8.0	10.0	6.1	7.0	5.0	11.4	10.6	8.1	8.5	18.2	13.0	18.1	10.1	8.7	82.6	15.4	7.3	9.7	29.6	11.1	10.6	7.3	13.1	12.5	4.9	16.8	14.3	7.6	10.7	10.3	15.5	7.2	8.8	14.6	23.8	15.0	22.2	12.5	8.5	9.6	18.6	26.6	4.8	12.2	8.8	11.9	28.3	15.6	27.1	5.2	6.9	7.8	6.1	7.6	9.0	7.8	17.7	16.1	3.6	9.6	8.5	4.2	17.9	5.2	18.2	7.2	3.6	8.1	8.4	7.8	10.4	4.6	11.8	9.6	9.1	7.4	10.8	2.5	6.3	10.8	6.5	11.8	12.3	16.0	15.3	12.1	14.3	14.8	13.6	15.2	12.2	14.1	15.0	9.6	0.0	7.7	75.1	11.2	5.2	24.5	27.7	12.5	18.7	15.8	13.5	37.2	27.1	19.1	27.6	25.0	44.6	11.5	27.0	191.7	29.6	3.1	11.5	11.1	11.1	22.9	28.8	101.2	16.1	28.9	14.2	19.4	16.0	1.3	14.5	11.0	18.3	13.4	13.5	137.0	17.3	38.7	8.9	4.7	1.1	14.3	8.9	12.4	67.5	29.1	9.5	18.6	100.5	137.5	12.5	23.5	11.3	18.4	36.8	59.4	120.0	15.8	34.4	13.1	11.9	11.5	8.7	10.5	16.1	4.1	36.4	12.9	11.6	25.0	24.2
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"Activator of transcription and developmental regulator AUTS2"	Q8WXX7	7	69598296-70793506	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 598.7;Excitatory neurons: 871.5;Inhibitory neurons: 1405.7;Microglial cells: 583.7;Oligodendrocytes: 1231.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 8.1;naive B-cell: 9.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 82.8;REH: 84.1;SCLC-21H: 112.5;T-47d: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	8.7	5.2	50.4	9.1	41.1	8.5	17.2	10.6	19.0	7.9	0.0	11.3	6.8	7.4	6.2	11.5	7.0	13.3	5.5	21.8	32.0	13.9	20.2	10.8	4.8	40.6	25.9	14.6	5.7	11.3	9.7	4.1	23.0	11.3	10.0	11.0	48.2	5.7	15.2	20.5	15.6	7.5	14.0	6.5	10.5	7.9	37.3	10.7	5.8	5.2	6.3	10.5	10.5	8.7	0.3	7.5	82.8	4.3	5.4	3.2	0.9	5.2	0.0	0.4	0.5	29.1	0.3	13.0	1.9	5.0	0.5	27.1	10.0	11.5	2.3	60.5	22.4	6.2	7.8	0.3	2.4	0.1	0.4	8.6	15.2	12.5	3.1	3.0	0.0	13.5	0.6	6.5	7.2	4.8	1.2	2.4	59.0	18.9	0.1	84.1	40.0	39.8	0.0	12.5	112.5	61.3	5.3	9.2	0.2	35.4	80.0	0.1	0.0	0.3	27.1	8.8	52.6	0.2	0.2	43.1	0.1	0.2	0.2	1.0	0.2	0.1	1.4	0.1	1.9	8.1	0.9	1.4	0.6	9.4	0.1	0.8	0.4	1.5	0.1	2.8	0.2	0.6	50.4	41.1	10.6	19.0	21.8	32.0	40.6	25.9	23.0	14.0	37.3	8.7	13.7	19.2	38.2	598.7	19.9	28.6	21.1	25.0	34.7	37.2	72.9	41.5	20.8	11.5	22.2	9.2	16.7	1.2	103.2	23.5	5.9	13.1	31.8	11.5	36.0	15.9	28.9	5.2	871.5	1.3	0.1	19.3	4.1	11.0	0.0	44.4	12.1	28.8	0.8	63.9	1405.7	23.4	38.7	2.6	17.1	27.7	15.8	5.5	17.8	583.7	0.8	11.2	25.7	292.0	1231.2	3.9	15.3	14.7	37.7	32.6	15.3	12.4	20.3	20.7	26.3	13.7	17.2	10.1	16.9	20.3	16.1	1.4	35.5	10.4	25.3	26.6
AVIL	"ADVIL, DOC6, FLJ12386, p92"	ENSG00000135407	Advillin	O75366	12	57797376-57818704	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 28.3;Gastric mucus-secreting cells: 23.9"	"Cancer enriched"	"Detected in all"	5	"glioma: 9.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.6;RH-30: 8.5;U-266/84: 3.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA058864	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058864: AB_2683838"	"unprognostic (3.86e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.79e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-4)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.71e-4)"	1.3	3.5	2.0	1.5	3.6	0.7	1.3	7.6	2.5	1.3	2.6	2.8	3.0	1.0	3.2	0.6	1.3	1.9	1.5	2.2	1.7	1.6	1.7	1.5	0.7	2.2	1.8	1.6	3.8	0.3	1.8	1.4	2.0	1.5	1.6	4.9	1.7	1.2	9.3	5.6	3.4	1.2	1.0	1.3	1.1	0.8	2.3	1.0	2.9	1.5	0.8	1.2	1.0	1.4	0.3	0.4	2.9	2.0	0.7	1.3	0.2	0.2	0.1	0.0	0.2	0.0	1.0	4.6	0.4	0.4	0.0	1.6	0.1	0.0	0.3	0.0	1.4	0.5	1.3	0.9	0.3	1.9	0.0	0.9	0.7	0.1	0.4	0.1	0.4	0.4	0.3	1.9	0.0	0.4	0.0	2.0	0.2	0.0	1.0	0.1	8.5	0.3	0.2	0.9	0.6	0.0	0.4	0.3	1.0	0.6	0.6	0.0	0.2	1.2	0.1	0.9	0.0	0.9	3.5	0.5	0.5	0.3	0.3	0.2	0.8	1.4	0.6	0.4	0.7	0.6	1.1	0.5	0.3	1.1	1.0	0.8	5.0	0.4	0.5	0.8	0.3	0.0	2.0	3.6	7.6	2.5	2.2	1.7	2.2	1.8	2.0	1.0	2.3	1.4	5.3	3.2	7.7	15.0	3.4	2.9	3.7	3.6	4.0	28.3	8.8	7.4	1.2	5.7	4.6	3.7	18.8	1.3	1.3	11.9	0.0	4.7	6.0	6.1	5.4	5.0	7.7	2.7	13.4	6.0	1.0	5.4	23.9	11.1	1.3	2.0	12.8	2.8	2.2	8.4	8.5	3.4	10.2	3.3	3.1	2.8	4.1	2.6	3.6	5.6	3.4	11.3	5.2	5.5	7.0	4.5	3.7	0.7	1.3	4.9	2.9	1.1	3.2	21.6	6.6	8.8	4.1	1.4	2.7	2.5	4.1	2.9	2.7	5.8	4.1	2.7
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63151201	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 24.1;Hepatocytes: 62.7;Sertoli cells: 78.9;Smooth muscle cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"ASC diff: 5.6;Karpas-707: 13.1;U-266/84: 9.8"	"Group enriched"	"Detected in some"	5	"basal ganglia: 7.0;hypothalamus: 3.8"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.90e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.58e-6)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.66e-4)"	17.2	56.6	0.4	1.4	0.2	0.0	9.0	0.0	0.3	9.1	1.4	1.7	0.7	10.9	1.1	3.0	4.8	6.1	2.0	0.3	0.5	4.6	20.9	0.5	1.2	0.5	0.2	1.3	2.3	2.2	0.5	0.3	0.2	2.3	1.2	1.4	1.1	4.2	2.0	1.8	0.9	12.2	0.1	0.8	1.7	0.6	0.8	1.4	10.4	3.5	0.6	2.5	2.6	0.2	0.1	0.2	0.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.3	0.5	0.5	0.2	0.2	0.1	0.8	0.2	14.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.6	0.3	0.2	0.3	3.4	1.5	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	3.1	24.1	4.5	0.0	2.7	0.1	0.0	0.5	2.7	0.5	1.6	0.0	0.2	0.7	62.7	0.2	0.0	1.0	0.0	0.0	1.3	0.3	0.0	2.8	1.4	0.0	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	78.9	2.9	100.9	0.2	0.2	0.0	0.3	0.1	0.6	2.1	0.0	0.3
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352723	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	11.9	9.3	10.5	9.2	10.8	23.0	11.5	14.8	12.5	12.9	9.1	17.1	12.3	13.2	3.1	16.3	11.8	6.2	11.6	10.0	9.2	11.6	11.2	13.7	10.5	10.2	10.2	13.8	13.0	7.2	12.6	5.8	9.8	12.9	6.9	2.6	11.5	6.0	21.1	20.1	15.0	5.4	9.2	15.0	12.9	11.8	10.1	12.5	11.9	7.0	6.6	14.5	13.1	11.9	18.1	25.6	13.4	23.7	9.8	9.0	28.0	11.9	10.8	16.1	13.8	37.9	20.4	27.7	18.0	12.3	19.4	25.4	21.1	18.5	7.2	27.5	34.6	18.0	21.9	27.6	16.6	20.9	19.3	9.0	31.7	16.6	20.3	14.1	10.7	19.8	45.6	14.8	7.4	48.1	22.7	14.5	30.6	21.6	15.4	42.4	12.2	38.8	12.2	10.5	30.4	18.6	22.6	24.9	38.3	10.0	16.5	26.1	12.4	15.9	17.0	18.5	17.5	17.3	18.1	34.2	7.5	13.7	15.9	1.2	0.9	5.0	8.3	0.8	7.6	1.5	2.4	5.8	0.7	1.2	2.4	3.4	2.7	3.5	0.6	1.2	2.6	2.3	10.5	10.8	14.8	12.5	10.0	9.2	10.2	10.2	9.8	9.2	10.1	11.9	7.9	3.2	8.6	4.9	5.7	18.4	7.6	8.5	5.7	4.3	11.2	9.5	4.9	5.7	7.2	3.7	0.0	3.5	30.1	27.4	0.0	7.2	1.4	10.2	7.0	6.3	10.8	8.6	18.5	6.9	27.5	6.7	15.3	14.4	10.8	10.5	5.7	5.1	7.5	5.0	12.7	15.1	6.1	6.2	9.0	2.1	5.3	6.7	10.6	1.0	5.7	4.5	28.8	8.5	8.9	11.0	12.2	4.9	7.0	13.4	11.1	2.4	7.7	5.7	13.1	8.7	7.6	5.5	8.8	7.2	15.2	3.7	12.4	5.0	15.7	10.5
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.7;Extravillous trophoblasts: 102.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	8.7	10.9	6.8	5.4	6.9	0.9	5.3	7.9	7.9	17.2	5.5	12.3	7.1	23.9	5.9	5.9	19.8	6.6	8.0	9.4	6.2	3.7	2.7	17.0	3.5	8.5	7.9	15.0	4.2	4.2	6.2	18.4	5.3	14.0	14.6	3.4	5.2	8.9	14.6	14.9	7.4	17.3	7.3	7.4	13.6	6.7	11.0	17.3	12.3	7.8	2.7	11.4	8.0	5.6	0.0	13.9	27.2	0.5	9.6	4.1	12.0	0.4	1.3	0.9	1.7	52.3	5.0	1.0	1.7	8.0	1.0	0.4	5.7	0.1	1.9	2.4	3.1	0.0	2.4	78.8	1.0	0.1	0.1	2.4	2.1	2.2	0.6	1.6	2.4	5.1	0.2	1.2	1.4	0.3	13.9	0.1	5.3	86.9	0.6	9.9	1.6	0.1	2.6	0.3	8.4	5.5	0.5	0.3	4.8	20.0	1.0	0.3	6.3	5.3	9.6	7.6	1.7	0.1	3.0	3.8	2.5	0.6	2.6	3.2	0.0	0.0	0.1	0.0	0.4	0.5	1.1	0.2	0.0	1.8	2.3	0.4	0.0	1.0	0.0	0.0	0.0	0.3	6.8	6.9	7.9	7.9	9.4	6.2	8.5	7.9	5.3	7.3	11.0	5.6	2.4	0.0	9.0	9.8	1.0	11.2	2.2	1.0	11.4	3.7	5.2	8.1	8.7	1.5	8.1	0.0	4.2	18.1	0.7	15.2	0.0	1.4	33.7	7.8	15.1	5.3	5.4	0.0	8.4	0.9	102.6	10.3	5.6	16.5	0.0	3.1	1.1	2.0	3.8	1.7	8.7	17.4	0.0	0.0	7.5	17.5	6.5	0.6	17.8	9.4	1.0	3.3	0.0	8.0	2.0	0.8	18.9	10.9	0.9	2.9	1.9	0.9	1.3	2.5	13.1	1.6	10.6	6.2	12.9	3.3	5.5	14.2	4.6	3.6	19.8	1.3
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 147.2;Kupffer cells: 187.5;Langerhans cells: 185.5;Prostatic glandular cells: 123.4;Sertoli cells: 210.4;Smooth muscle cells: 171.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.1;plasmacytoid DC: 25.7"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.7;NK-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 501.2;U-251 MG: 540.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	72000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	43.6	18.8	17.5	15.5	22.6	1.7	26.6	19.7	17.7	36.1	12.4	42.5	11.7	34.4	8.7	17.6	25.4	22.4	26.7	16.6	18.8	9.8	15.0	25.9	6.2	26.8	20.6	24.7	6.3	10.7	7.3	34.2	22.1	19.2	12.6	5.8	10.6	24.6	9.4	20.0	19.0	37.1	20.9	37.7	21.4	18.6	24.0	7.2	16.6	11.3	5.0	32.5	25.2	21.9	408.0	160.0	9.7	1.3	34.6	34.7	0.5	314.5	280.2	450.9	278.2	8.5	185.5	0.2	124.7	501.2	235.3	33.3	0.4	211.8	384.8	0.7	0.3	0.0	100.4	6.3	125.0	0.3	0.3	26.4	3.8	266.7	409.5	254.8	169.8	0.1	15.8	0.5	284.6	0.5	0.2	0.4	4.1	1.0	76.3	0.2	165.3	0.3	202.3	0.2	0.1	0.1	81.5	0.6	1.8	57.4	0.9	7.2	351.8	317.8	214.6	307.7	540.8	0.5	0.9	1.0	211.5	0.5	241.8	1.5	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.1	6.0	0.1	0.3	0.3	0.3	11.1	0.2	25.7	0.4	0.3	17.5	22.6	19.7	17.7	16.6	18.8	26.8	20.6	22.1	20.9	24.0	21.9	13.5	9.6	3.6	35.9	1.9	41.7	88.3	10.3	3.4	0.5	2.3	14.2	8.6	1.5	4.4	5.5	0.0	4.2	0.8	0.1	0.0	6.9	8.7	6.0	45.8	17.7	0.0	0.0	0.8	0.2	2.1	147.2	1.5	5.4	0.0	17.3	11.0	1.2	28.8	1.7	1.1	0.1	2.0	187.5	185.5	5.5	61.5	61.4	26.6	30.9	3.1	26.8	0.0	11.1	0.5	14.5	0.1	79.7	0.8	123.4	0.3	0.1	2.8	1.2	210.4	38.1	171.1	1.9	2.0	1.2	29.1	11.5	3.6	2.5	0.1	28.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"bone marrow: 1578.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in some"	15	"THP-1: 659.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		320000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.8	0.2	0.4	0.0	0.4	1578.1	1.5	0.2	0.9	0.2	0.2	0.2	0.0	0.5	0.0	0.1	1.4	0.0	2.0	0.4	0.3	0.4	2.8	15.9	0.6	0.3	0.3	0.2	0.2	0.0	0.9	0.9	0.4	0.4	0.0	0.0	2.6	0.0	0.5	0.6	0.2	0.0	0.2	33.1	0.2	2.4	0.4	3.1	0.5	0.0	0.0	0.3	0.2	0.3	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.6	659.5	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.6	0.0	34.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.2	0.9	0.4	0.3	0.3	0.3	0.4	0.2	0.4	0.3	3.5	0.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.0	4.5	4.6	0.7	0.0	0.5	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	8.9	1.2	1.0	0.0	8.8	0.8	0.0	0.3	0.8	0.0	2.3	0.0	0.1	0.0	0.4	3.2	0.0	1.4	0.4	0.0	3.7	0.4	0.7	0.0	3.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.0	4.5	0.0	0.0	5.7	1.2	0.1	6.4	0.9	0.1	0.0	1.0	0.0	0.6	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105411	"Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cardiomyocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 8.8;NK-cell: 22.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.8;NK-cells: 22.1"	"Cell line enhanced"	"Detected in many"		"RT4: 128.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041204			Approved	Vesicles		NA	NA		400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	5.3	7.2	20.7	3.9	21.5	4.8	9.8	14.7	19.6	20.1	8.0	2.7	1.9	9.9	8.5	6.8	14.2	9.9	53.3	21.7	26.7	19.4	1.2	14.6	4.9	12.8	21.7	18.8	11.1	8.6	9.8	13.9	18.0	11.6	2.4	26.6	22.3	8.5	1.4	2.5	2.4	9.9	14.1	6.2	10.7	8.4	25.7	2.8	27.0	3.2	5.4	12.3	5.4	13.0	17.3	0.3	7.5	0.1	1.0	2.8	0.1	9.3	8.7	22.3	7.3	11.3	13.2	0.0	35.7	8.0	12.7	3.9	0.0	16.9	7.5	0.0	0.0	9.0	5.7	0.0	11.2	0.2	0.0	23.3	5.4	6.1	1.4	15.6	31.6	0.0	0.0	0.0	8.3	29.4	0.1	0.0	17.4	0.2	38.9	0.1	0.0	0.2	9.3	128.3	15.1	0.1	23.7	8.8	6.3	3.0	35.6	13.3	0.0	0.2	15.5	0.5	0.2	3.6	0.1	0.2	14.7	0.0	0.0	8.8	0.2	0.0	0.4	0.2	0.4	2.3	0.2	0.4	1.7	0.2	0.4	0.9	0.4	22.1	0.1	1.1	0.0	0.7	20.7	21.5	14.7	19.6	21.7	26.7	12.8	21.7	18.0	14.1	25.7	13.0	5.0	19.2	2.2	10.1	2.1	5.0	5.2	5.7	6.2	56.3	7.5	6.2	56.9	0.0	8.0	14.7	12.5	21.2	1.2	0.1	11.7	3.5	0.7	4.9	5.8	7.7	1.8	17.0	22.3	8.5	13.0	13.3	4.6	8.7	10.2	13.0	6.1	0.2	9.8	6.7	27.5	0.1	6.1	2.1	6.8	2.2	7.2	3.4	10.6	9.4	4.3	12.6	1.0	14.6	3.2	9.8	0.1	5.3	0.2	6.2	0.1	15.8	3.1	8.4	0.0	5.3	13.2	6.5	20.7	8.4	2.6	5.1	1.2	4.6	0.7	4.5
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196115-62224731	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 115.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		99000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	17.3	20.8	6.6	13.3	13.6	72.7	26.1	5.9	9.8	25.9	9.0	19.4	27.7	24.6	6.2	25.1	12.7	27.4	19.0	6.8	8.6	33.4	21.8	34.2	24.1	6.9	8.3	5.9	39.7	7.6	13.2	30.6	9.7	10.8	24.3	5.2	15.5	8.2	3.2	11.0	14.4	24.1	6.1	14.9	18.2	7.6	8.5	25.5	19.5	9.0	18.3	20.1	12.8	6.7	20.7	14.0	20.9	9.3	22.5	10.0	60.0	19.8	21.8	15.4	20.5	29.2	32.5	22.3	17.8	18.5	21.6	19.4	13.3	16.6	26.5	46.8	10.8	55.1	6.4	17.2	16.8	33.2	23.8	12.3	30.7	29.6	10.5	11.0	23.4	15.3	30.4	13.7	18.9	15.7	63.7	49.6	20.0	37.4	5.8	115.0	14.4	12.3	29.2	20.1	20.1	14.9	14.1	29.9	23.5	33.4	8.6	38.7	26.7	18.6	16.4	31.7	19.9	38.2	14.4	96.2	14.6	56.5	18.4	14.9	9.0	56.2	20.0	8.6	28.0	14.8	14.7	34.6	10.6	16.6	17.3	26.0	21.3	41.0	11.7	13.3	26.2	17.6	6.6	13.6	5.9	9.8	6.8	8.6	6.9	8.3	9.7	6.1	8.5	6.7	40.3	64.1	9.8	2.0	31.4	71.5	30.9	20.8	92.2	15.6	40.0	20.7	9.2	18.6	21.9	18.4	0.0	40.9	43.8	42.7	23.5	24.0	0.1	51.1	30.3	31.8	9.5	61.6	11.2	57.2	38.3	19.5	36.7	97.3	3.8	9.7	37.5	21.3	60.4	0.0	3.4	22.7	87.5	20.5	58.5	0.7	2.5	34.4	35.6	14.0	19.7	8.6	18.6	2.5	7.2	36.3	24.8	2.2	25.8	25.5	14.2	19.0	19.1	2.1	65.7	8.1	68.2	0.3	1.6	77.4	64.8	65.3	45.9	10.6	13.9	41.1
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
B4GAT1	"B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT"	ENSG00000174684	"Beta-1,4-glucuronyltransferase 1"	O43505	11	66345374-66347629	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.3;Horizontal cells: 158.2;Muller glia cells: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015484	Uncertain				"Intracellular and membrane"	NA	NA		57000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA015484: AB_1845235"	"unprognostic (1.80e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.43e-3)"	"prognostic favorable (3.55e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.76e-3)"	16.6	41.4	120.6	6.1	124.9	1.3	16.0	71.0	125.2	23.1	68.7	30.1	16.2	28.5	15.2	8.3	23.4	9.9	44.6	115.3	220.2	25.3	18.8	17.3	6.7	85.9	97.3	34.3	25.5	22.6	62.3	22.5	101.0	17.3	7.7	46.0	15.8	22.4	27.7	12.1	14.6	14.0	91.9	10.2	25.8	8.2	150.4	6.5	21.0	19.2	4.3	20.2	16.3	83.9	10.8	26.7	29.7	36.5	32.6	29.3	39.4	18.4	42.5	28.1	22.9	20.1	14.9	8.9	76.1	16.9	24.1	16.8	32.0	20.6	13.5	17.6	58.2	1.3	20.4	77.6	19.3	7.0	2.7	28.6	15.6	17.5	7.4	92.8	33.5	14.8	8.6	13.7	13.6	18.1	16.7	19.1	20.2	10.6	28.0	24.0	23.2	15.9	29.6	2.7	17.8	33.7	15.8	10.4	74.8	18.4	42.6	6.8	19.7	21.8	15.9	28.0	9.6	26.1	19.2	5.3	36.8	5.8	26.0	0.0	1.2	0.0	7.1	0.4	9.9	5.7	7.8	7.6	3.0	3.2	9.0	8.3	0.4	4.6	0.3	7.4	5.7	4.4	120.6	124.9	71.0	125.2	115.3	220.2	85.9	97.3	101.0	91.9	150.4	83.9	13.5	22.4	10.8	25.8	2.9	0.0	1.6	0.0	14.2	72.3	6.2	12.7	45.9	25.8	1.8	20.2	58.4	57.8	8.6	8.0	5.9	7.4	0.5	3.9	9.7	17.1	4.9	0.8	22.1	6.0	22.6	23.4	6.6	2.6	1.3	22.5	30.4	24.4	12.7	158.2	35.0	8.0	0.0	2.4	0.0	2.4	32.6	2.6	0.0	10.3	1.3	70.1	2.1	22.6	14.2	4.3	4.9	40.6	6.1	2.0	13.3	17.5	2.9	47.4	26.3	21.2	11.8	1.4	2.8	5.8	0.0	18.1	2.6	28.0	7.2	0.3
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BAG3		ENSG00000151929	"BAG cochaperone 3"	O95817	10	119651380-119677819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 349.1;skeletal muscle: 514.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Supported	Cytosol		NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	73.5	40.3	81.6	16.1	80.6	5.1	40.5	96.9	349.1	41.7	61.3	72.4	12.3	45.2	20.4	86.0	37.7	35.1	153.3	82.1	124.3	42.2	38.4	77.9	8.2	127.2	100.2	33.3	20.5	53.6	36.6	36.0	101.3	39.1	12.6	12.6	50.1	24.5	514.4	61.9	25.9	43.3	106.3	15.9	72.4	23.1	84.1	5.7	31.1	187.8	17.3	60.4	55.3	95.5	100.1	111.2	30.5	39.6	77.2	53.9	56.9	89.1	74.7	66.6	56.8	47.5	47.6	3.8	41.4	76.9	86.6	145.2	31.5	157.2	45.7	49.1	51.8	5.4	28.6	60.1	65.2	0.3	22.1	54.6	89.0	48.6	76.2	70.5	75.5	17.1	43.3	24.0	67.2	142.7	5.5	22.3	12.0	33.1	125.8	0.3	43.2	17.2	50.7	22.3	5.6	5.1	35.4	61.9	47.2	32.9	38.8	13.4	94.8	35.0	30.1	47.8	129.5	22.1	14.0	2.4	65.2	1.5	27.1	0.0	0.6	0.0	0.6	0.7	1.1	0.1	2.4	0.8	0.4	0.0	4.1	1.4	0.2	0.1	0.3	0.1	1.7	0.6	81.6	80.6	96.9	349.1	82.1	124.3	127.2	100.2	101.3	106.3	84.1	95.5	77.8	22.4	43.2	34.9	10.9	79.4	882.2	51.0	414.9	6.1	48.3	62.9	196.0	18.6	48.1	7.3	18.8	41.4	4.9	61.7	27.4	19.4	29.3	56.7	60.0	107.0	38.5	0.8	1.3	25.3	57.0	142.7	51.5	89.1	23.6	7.3	22.5	15.3	33.7	1.7	2.5	87.0	46.8	8.7	95.4	32.8	22.4	146.9	55.2	10.3	4.7	32.6	3.1	1.0	1.2	37.3	69.2	24.0	29.5	225.1	8.3	42.8	39.4	1.7	19.7	141.6	134.3	21.8	18.7	370.2	76.1	73.5	85.6	10.0	53.9	488.1
BAIAP2	"BAP2, IRSp53, WAML"	ENSG00000175866	"BAR/IMD domain containing adaptor protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 19.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (7.58e-6)"	23.9	18.2	129.1	7.4	140.0	2.6	27.1	95.7	176.1	49.9	104.6	44.0	6.7	30.9	46.5	132.9	37.6	29.3	24.2	163.7	103.1	38.0	85.7	49.1	6.9	68.0	81.0	13.7	13.4	19.9	56.3	31.8	68.3	61.3	12.1	16.2	57.5	27.6	13.1	132.4	14.7	19.3	70.5	11.8	62.3	26.3	119.9	11.8	27.1	9.8	25.3	23.3	73.2	121.9	99.9	45.1	28.1	36.6	22.2	29.0	32.8	40.2	26.1	35.7	15.8	60.9	49.1	0.5	28.3	35.8	73.5	93.6	26.1	46.1	13.7	0.4	32.8	20.2	41.3	46.4	20.7	0.0	28.2	12.5	53.0	29.5	15.4	32.7	19.5	1.1	26.4	0.6	20.6	51.2	4.0	22.3	11.8	65.6	38.1	6.0	6.6	81.3	108.5	34.5	36.8	39.9	64.2	91.3	110.1	23.1	80.4	22.6	23.8	81.6	78.4	13.8	43.4	1.4	0.3	1.4	72.0	3.3	18.3	0.0	7.9	0.5	3.2	9.4	1.0	0.1	1.2	1.0	10.3	0.1	1.3	1.8	5.4	1.9	9.2	19.5	0.5	3.2	129.1	140.0	95.7	176.1	163.7	103.1	68.0	81.0	68.3	70.5	119.9	121.9	74.1	76.9	39.0	13.4	6.2	63.7	138.4	42.3	94.4	37.1	49.4	37.1	22.5	25.8	47.2	22.0	79.2	77.1	16.6	18.8	7.9	9.8	10.5	80.8	10.4	35.7	49.3	0.8	65.3	5.1	9.2	28.0	88.2	79.7	13.4	3.1	45.0	78.6	43.2	11.8	13.6	29.1	24.4	18.3	58.2	29.4	6.8	31.2	40.9	13.1	18.6	18.5	0.0	4.5	5.9	14.8	8.0	3.8	3.1	77.0	3.7	25.4	110.8	19.1	0.0	10.4	13.3	7.6	33.0	103.6	75.3	101.0	13.9	8.2	14.7	185.1
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677510-28682932	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 81.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 174.7;Breast myoepithelial cells: 163.2;Granulosa cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 166.7;SK-MEL-30: 199.0;SuSa: 357.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	4.4	44.1	13.8	2.3	16.3	6.0	23.7	18.4	17.6	5.7	20.7	3.8	1.6	17.9	2.9	2.1	6.3	5.4	43.5	13.6	15.9	19.9	23.9	12.0	2.0	19.9	16.9	81.6	6.9	8.2	8.5	39.3	21.1	7.4	4.7	13.4	6.4	16.7	1.8	5.4	2.1	12.2	16.6	18.0	3.8	8.7	14.8	0.4	1.2	1.9	1.4	30.0	5.4	22.7	1.0	41.0	4.2	2.2	4.8	0.1	24.5	9.7	3.5	15.4	10.0	166.7	17.3	0.5	5.7	7.4	8.8	12.2	10.2	1.6	7.2	10.1	21.0	39.5	6.2	63.7	5.9	2.4	51.5	3.7	2.3	10.4	1.6	96.7	2.4	2.1	22.1	18.7	3.1	70.1	0.2	3.3	71.6	34.5	9.9	0.3	7.8	3.6	12.9	40.4	6.8	5.2	13.2	78.5	199.0	357.8	23.2	3.0	0.3	10.4	7.3	17.0	4.7	0.5	15.0	0.0	1.0	8.9	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.3	18.4	17.6	13.6	15.9	19.9	16.9	21.1	16.6	14.8	22.7	6.6	9.6	5.9	15.0	5.7	4.0	7.6	0.6	13.1	14.3	174.7	163.2	34.9	58.6	3.5	11.0	4.2	12.0	9.3	33.8	1.9	20.8	0.1	14.3	15.3	7.3	26.8	0.0	0.5	0.2	22.2	46.1	58.6	21.1	1.3	334.8	14.6	16.0	6.7	6.7	0.2	3.8	0.0	1.6	4.2	1.2	3.4	5.4	16.0	15.9	0.7	50.2	0.0	46.3	21.2	12.1	34.6	2.2	4.3	10.8	1.1	16.1	1.4	5.9	0.0	4.2	42.7	1.9	15.5	13.5	1.3	8.5	7.8	6.2	3.8	14.1
BANF1	BAF	ENSG00000175334	"BAF nuclear assembly factor 1"	O75531	11	66002228-66004149	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: AB_2676409"	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	116.4	149.0	252.8	144.8	256.8	127.2	151.4	261.0	312.9	135.4	248.4	153.7	107.2	168.0	248.5	136.0	279.6	100.9	272.2	249.9	259.6	115.6	174.0	111.3	178.5	258.4	254.4	207.6	132.5	148.8	69.0	120.8	261.1	139.2	155.9	98.7	148.2	169.7	582.1	121.0	105.0	190.0	258.5	116.0	92.7	111.1	254.8	220.7	164.6	394.8	211.9	140.6	82.4	274.5	665.5	712.0	452.8	427.9	237.7	306.5	220.5	364.7	349.4	715.9	447.0	415.3	496.1	606.5	651.8	503.3	544.0	433.5	641.7	600.1	559.1	476.4	411.5	699.5	431.3	537.0	296.0	503.4	480.4	292.5	404.6	453.8	418.1	404.6	494.6	526.5	552.5	459.6	687.5	1196.3	607.7	1023.8	494.7	410.4	525.6	507.0	447.1	1297.4	647.9	361.7	362.9	458.0	399.1	636.4	469.4	352.9	698.8	378.6	350.4	535.8	574.2	601.8	515.8	313.6	680.4	771.1	442.7	420.2	485.5	112.7	231.7	82.2	165.2	239.1	159.1	243.7	139.0	160.5	252.9	234.6	166.0	174.4	28.7	219.7	266.2	238.2	125.5	324.0	252.8	256.8	261.0	312.9	249.9	259.6	258.4	254.4	261.1	258.5	254.8	274.5	135.8	54.5	41.9	11.4	112.7	126.8	154.6	301.2	142.9	52.8	164.8	230.0	32.1	102.9	153.6	196.8	25.0	296.5	101.4	70.7	326.8	196.8	17.1	164.8	147.2	126.5	142.8	144.5	12.3	177.3	346.6	126.6	86.6	116.2	140.2	199.7	79.9	130.8	324.5	50.5	13.4	171.4	223.8	80.6	169.8	41.9	142.0	124.7	186.7	8.4	155.9	123.8	186.4	9.0	22.2	170.3	107.1	123.8	110.8	126.8	77.4	251.5	187.7	57.8	72.3	123.9	145.5	250.2	325.1	227.0	118.1	174.7	104.9	172.6	196.2	148.9
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809683	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 68.6;Basal prostatic cells: 62.2;Suprabasal keratinocytes: 74.4;Urothelial cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119"	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	1.8	0.6	3.0	2.7	4.6	11.4	2.9	2.2	2.7	3.1	0.2	2.9	2.3	3.3	2.6	5.1	1.9	2.0	1.5	2.3	4.1	0.8	1.0	2.5	5.5	3.8	3.2	2.3	1.6	2.3	1.2	2.3	3.9	2.9	3.6	2.0	1.9	3.6	4.2	8.8	2.1	3.9	3.9	2.6	1.9	6.6	4.1	7.0	1.4	2.3	6.6	2.1	3.8	4.2	12.3	8.8	20.2	9.3	2.7	4.0	12.0	17.3	10.6	17.8	21.8	12.0	12.2	12.6	7.6	8.5	9.5	12.7	16.5	10.5	22.7	11.5	6.4	12.5	13.8	8.7	0.9	13.9	12.7	4.7	1.1	15.0	8.1	4.5	6.1	14.7	7.9	36.0	13.7	10.7	27.9	12.5	14.3	7.9	3.7	24.7	19.8	11.2	3.9	14.0	5.8	8.8	15.0	14.7	5.3	10.9	16.3	13.4	4.7	18.0	14.0	11.7	13.6	10.2	12.6	28.0	7.6	11.3	13.4	3.9	2.0	5.8	4.6	4.0	3.2	9.7	5.4	5.5	3.6	8.2	2.4	4.0	0.3	7.3	3.8	6.9	17.1	2.3	3.0	4.6	2.2	2.7	2.3	4.1	3.8	3.2	3.9	3.9	4.1	4.2	12.3	6.4	2.2	14.7	13.0	68.6	62.2	13.0	14.2	3.3	9.9	14.1	17.4	17.2	12.7	9.2	0.0	18.2	11.3	8.2	3.9	8.0	9.2	13.3	11.9	9.6	1.2	34.5	5.5	6.9	16.0	10.0	10.2	18.0	15.2	28.2	10.0	4.2	12.5	1.7	15.4	13.1	8.2	10.1	12.2	5.7	6.2	11.2	3.6	15.9	16.6	4.4	9.2	19.6	31.7	6.5	6.5	10.1	22.0	22.9	3.2	0.7	12.3	6.8	19.7	15.4	16.9	27.6	43.4	28.6	74.4	5.1	13.4	10.5	14.7	67.2
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440406-73522293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA058068"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB037081: AB_477637, CAB037158: AB_477636, HPA058068: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	22.6	19.4	24.1	22.1	28.3	24.7	16.7	28.6	25.2	22.5	21.5	23.0	16.0	24.4	17.7	18.0	19.3	16.0	19.6	21.9	26.9	16.8	24.1	20.3	27.9	25.1	26.5	30.8	21.0	27.6	19.2	22.7	24.7	22.6	20.5	28.3	17.1	25.4	28.0	14.2	18.2	24.7	23.8	23.4	18.9	17.3	25.5	40.6	23.8	30.7	29.6	21.9	17.5	29.1	75.6	76.1	102.5	115.3	52.0	55.1	34.1	71.7	54.7	67.4	70.5	62.4	55.6	141.6	16.3	64.1	102.6	51.7	126.1	47.7	100.9	80.3	63.8	84.4	89.3	54.3	57.9	128.8	68.5	39.6	45.5	83.2	101.6	50.4	54.5	75.9	149.9	86.4	76.7	71.7	132.8	59.1	66.7	57.6	56.2	133.1	89.9	94.5	38.5	58.2	102.4	87.2	102.1	112.4	59.8	87.1	69.1	63.6	64.4	116.1	66.5	70.6	123.2	49.7	84.7	235.7	65.9	119.1	107.7	4.0	1.5	1.0	3.0	1.1	2.6	1.2	2.3	2.2	1.1	2.5	1.7	1.9	1.1	2.8	0.8	3.1	2.5	0.9	24.1	28.3	28.6	25.2	21.9	26.9	25.1	26.5	24.7	23.8	25.5	29.1	46.3	76.9	129.8	28.7	52.8	29.8	34.5	16.7	38.1	69.9	28.1	24.6	81.7	27.1	59.0	20.2	43.8	57.3	50.4	33.1	7.9	35.5	8.4	47.4	72.2	53.5	34.7	89.8	35.0	23.1	59.6	58.7	34.7	52.6	51.8	59.5	34.6	59.1	33.0	60.6	35.3	34.6	22.4	33.4	24.8	12.5	61.2	38.7	12.4	34.7	47.3	54.4	61.8	28.6	43.9	26.5	13.6	76.3	65.3	40.5	25.2	12.9	49.2	53.8	32.9	67.1	57.5	75.7	127.0	47.0	25.3	34.6	56.5	46.1	43.3	35.2
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	29.1	23.9	10.3	30.8	13.3	65.9	27.2	22.9	18.7	29.3	19.1	27.0	25.5	25.4	22.9	30.9	24.9	20.9	21.1	10.3	20.0	19.8	21.7	35.9	33.4	17.2	13.0	36.3	30.8	33.4	27.7	35.4	14.6	23.3	26.6	48.8	25.7	21.0	28.2	29.9	31.1	23.1	5.5	35.3	26.2	47.4	19.0	50.6	27.3	32.0	30.6	24.8	30.6	19.8	50.3	45.6	61.9	52.5	35.3	35.4	66.5	32.6	44.2	46.9	34.1	56.2	59.3	69.2	49.2	38.6	44.3	41.5	70.6	46.3	40.6	48.1	37.1	80.8	35.5	28.8	38.5	47.1	60.2	31.0	43.8	40.2	55.7	50.8	46.3	28.4	87.7	94.1	26.3	30.7	40.2	30.9	54.9	32.7	34.6	33.9	45.0	48.3	32.6	48.8	41.0	33.8	54.8	57.0	30.0	66.0	65.6	41.7	65.2	24.3	49.1	30.0	23.0	46.0	48.4	65.1	22.5	33.4	34.6	12.1	7.6	5.6	4.8	6.2	4.2	6.8	3.8	3.7	3.0	6.0	3.1	2.7	28.6	17.2	15.5	11.7	3.6	3.0	10.3	13.3	22.9	18.7	10.3	20.0	17.2	13.0	14.6	5.5	19.0	19.8	47.6	67.3	61.3	29.4	74.7	50.9	43.2	35.3	60.3	70.5	43.3	26.7	26.4	30.0	36.9	25.8	137.6	48.0	62.8	71.6	7.9	32.0	66.8	29.4	33.7	50.1	44.8	53.4	29.3	28.7	37.2	35.6	34.1	41.7	43.6	34.8	53.9	32.5	24.3	32.0	27.4	39.6	26.4	62.1	65.6	73.7	60.6	38.5	39.2	40.3	80.1	24.4	116.4	25.6	33.2	34.8	39.4	57.6	78.0	65.1	44.7	12.6	34.4	67.3	85.5	44.9	44.0	134.1	131.2	59.5	61.8	95.6	58.0	41.6	34.8	67.6
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.4;Basal squamous epithelial cells: 111.5;Prostatic glandular cells: 132.9;Suprabasal keratinocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 4.5;neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 28.4;NB-4: 34.9"									"CAB007752, HPA070403"	Approved		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (2.62e-5)"	3.1	4.4	3.1	2.1	2.8	4.8	4.0	4.3	4.7	3.2	1.8	6.4	2.4	3.4	0.6	1.9	3.6	2.0	3.9	3.3	2.4	5.1	5.6	7.7	2.7	2.8	3.7	3.2	7.7	2.0	2.1	1.9	2.9	4.1	1.8	0.2	7.5	1.2	10.4	8.2	5.0	0.7	2.3	6.1	5.0	2.6	2.8	4.0	3.1	1.1	0.8	4.9	3.4	2.5	3.8	8.3	9.0	1.9	2.1	4.1	22.1	5.9	7.9	1.4	3.5	2.5	6.3	14.7	2.5	1.5	2.5	1.2	1.3	5.3	0.2	9.3	15.9	4.2	2.8	16.4	28.4	0.7	13.4	9.8	8.4	3.0	2.8	3.7	10.3	4.4	10.9	9.0	1.0	8.6	1.6	34.9	5.6	6.5	1.1	4.1	1.3	17.7	0.4	1.3	1.5	13.5	2.7	5.6	18.7	7.1	1.9	11.7	6.9	1.7	11.1	0.2	1.9	14.4	3.4	9.5	2.6	2.2	6.2	4.5	0.4	0.2	0.4	0.5	0.4	0.1	0.1	0.3	0.2	0.0	0.5	0.3	3.4	0.6	0.4	0.1	0.3	0.2	3.1	2.8	4.3	4.7	3.3	2.4	2.8	3.7	2.9	2.3	2.8	2.5	16.2	9.6	7.4	1.6	21.7	117.4	78.8	40.3	111.5	6.5	46.4	29.1	5.6	10.0	21.8	7.3	0.0	4.7	28.3	51.9	0.0	52.4	14.6	65.2	14.0	15.8	21.4	16.8	3.2	39.8	5.5	12.1	23.4	66.2	12.7	8.4	3.9	3.5	7.1	0.0	3.9	40.6	30.5	10.3	31.9	3.3	6.2	17.1	64.0	2.8	15.7	3.7	32.0	1.0	0.5	55.2	49.3	4.1	19.3	132.9	16.2	4.1	22.9	4.4	6.6	12.4	34.9	0.5	1.7	59.4	143.3	20.5	28.5	10.2	27.4	66.2
BBS7	"BBS2L1, FLJ10715"	ENSG00000138686	"Bardet-Biedl syndrome 7"	Q8IWZ6	4	121824329-121870487	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 56.6"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 65.1;Inhibitory neurons: 58.6;Rod photoreceptor cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044592	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA044592: AB_10795882"	"unprognostic (6.36e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.15e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.33e-1)"	6.9	6.4	7.3	5.3	7.7	2.1	6.1	9.8	12.4	7.9	2.6	6.3	5.0	10.5	4.9	6.2	7.9	5.9	4.7	7.7	6.4	6.7	2.4	5.3	5.0	8.9	7.8	12.4	3.7	9.1	9.1	4.7	8.7	6.8	6.3	56.6	4.8	6.6	3.8	6.8	5.3	10.3	5.1	4.6	4.8	9.1	8.4	6.4	5.5	5.5	4.8	5.8	6.9	8.9	13.7	6.6	14.9	10.9	18.8	27.2	5.4	18.3	14.6	15.5	14.2	5.2	7.4	15.0	5.1	21.7	11.6	7.1	15.5	14.8	17.6	14.4	12.1	8.9	10.0	6.2	16.7	12.7	8.0	14.0	10.6	17.7	13.3	20.2	16.8	10.0	6.0	14.8	22.1	4.3	21.3	6.1	7.9	8.3	8.2	9.7	19.3	4.6	15.7	4.8	16.4	7.0	17.5	7.7	14.0	19.7	6.5	4.7	16.9	11.6	12.5	16.2	11.8	13.9	10.3	13.1	13.4	10.0	11.6	0.6	1.0	1.7	1.9	1.1	1.5	0.9	1.5	1.8	1.2	0.9	1.2	1.6	0.2	2.0	1.2	1.2	1.6	1.0	7.3	7.7	9.8	12.4	7.7	6.4	8.9	7.8	8.7	5.1	8.4	8.9	15.7	6.4	8.4	12.7	6.9	8.7	10.8	13.7	5.7	16.6	6.0	9.3	8.4	4.3	13.0	11.0	47.9	8.5	6.6	6.4	13.7	14.6	22.2	14.4	19.9	11.2	6.1	9.5	65.1	9.8	21.5	14.4	6.1	10.6	15.2	9.2	8.6	5.0	11.4	16.8	58.6	8.2	16.2	6.3	6.1	12.9	13.1	7.7	8.8	16.9	6.3	12.6	5.2	30.7	26.4	15.6	5.1	11.3	5.6	9.3	6.0	15.1	16.5	68.9	19.7	12.2	15.2	39.6	22.4	10.9	8.5	5.7	10.7	11.4	8.4	8.6
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		18000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	105.0	23.3	24.0	9.9	23.3	3.8	125.6	23.7	39.6	87.7	38.2	32.2	13.5	78.1	21.3	29.1	115.1	15.8	118.3	21.3	24.6	316.8	38.4	89.0	9.8	26.7	27.4	50.2	51.5	20.0	38.3	44.1	26.7	130.1	5.3	3.1	65.6	49.2	44.7	54.1	31.2	19.6	24.0	36.4	39.3	20.6	28.2	13.8	215.7	30.8	7.1	52.8	72.0	21.6	34.7	44.3	1.2	120.8	0.6	0.8	142.7	13.3	6.3	10.7	7.1	66.8	83.5	0.0	65.7	1.6	0.6	298.4	10.4	74.5	3.2	0.1	7.3	0.2	8.8	93.9	23.6	0.0	15.9	11.6	28.6	3.7	4.4	34.2	6.6	0.0	7.3	0.5	1.6	17.7	0.4	1.2	13.5	10.0	15.1	0.5	14.2	3.6	90.4	21.9	0.4	0.5	54.0	276.8	3.4	13.1	157.2	5.1	17.4	2.7	130.2	3.4	6.5	0.6	1.4	0.1	1.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	23.3	23.7	39.6	21.3	24.6	26.7	27.4	26.7	24.0	28.2	21.6	374.9	6.4	12.3	5.5	4.4	40.7	118.0	454.1	80.2	2.5	109.5	185.4	12.8	52.9	48.5	548.1	0.0	705.4	3.2	8.6	82.2	34.0	1.3	62.9	8.2	214.0	52.0	4.8	0.5	4.0	36.9	21.7	15.8	45.3	0.0	14.3	73.2	31.0	44.7	0.0	1.2	5.6	40.7	8.0	21.3	2.1	29.5	3.5	16.0	9.4	0.1	23.6	0.0	1.0	0.3	14.3	21.4	15.1	2.5	80.4	4.9	149.6	20.7	1.1	157.8	14.1	240.6	3.2	18.3	8.9	24.6	433.3	3.5	6.4	13.0	40.7
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 164.7"	"Group enriched"	"Detected in some"	8	"Astrocytes: 136.1;Horizontal cells: 109.4;Melanocytes: 186.7;Oligodendrocyte precursor cells: 288.0"	"Cancer enriched"	"Detected in many"	5	"glioma: 348.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.7;K-562: 108.3;U-266/70: 63.3;U-266/84: 133.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"	NA	NA		120000	"Cluster 34: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	0.2	8.4	155.0	0.6	119.5	0.0	0.2	108.3	164.7	2.7	38.3	2.2	7.0	5.9	15.4	0.6	4.0	3.4	0.5	133.1	104.8	0.2	0.1	0.4	0.3	107.5	100.0	0.2	0.1	1.7	2.8	0.7	103.4	0.2	0.0	4.1	1.6	1.8	0.6	15.6	7.8	2.0	94.3	0.5	2.2	1.2	113.7	0.1	0.2	0.0	0.0	0.9	0.9	116.3	44.2	28.4	0.2	8.1	0.0	0.0	11.9	0.4	0.0	0.0	0.0	1.1	21.0	0.1	45.8	0.0	1.0	30.9	0.3	0.0	0.0	76.7	2.9	8.0	20.9	25.6	0.0	3.0	7.3	0.0	0.0	0.0	0.0	1.0	0.0	3.8	108.3	21.0	0.0	12.6	0.1	0.1	2.2	22.2	4.2	0.1	46.7	0.1	0.0	5.4	0.2	0.8	0.1	0.0	43.8	2.2	0.2	2.8	8.8	0.1	24.7	8.7	11.8	63.3	133.2	0.2	8.5	20.4	3.4	7.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.0	119.5	108.3	164.7	133.1	104.8	107.5	100.0	103.4	94.3	113.7	116.3	0.2	0.0	0.0	136.1	0.0	6.9	0.0	0.0	0.0	6.0	0.2	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	2.9	0.1	1.8	0.7	1.8	0.0	16.8	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.5	109.4	20.2	0.1	0.0	0.0	1.9	6.9	0.3	0.1	186.7	9.4	0.0	2.1	1.0	288.0	3.5	0.8	0.1	0.0	0.0	0.3	0.1	0.4	0.0	3.2	0.0	0.2	1.7	5.4	6.5	0.0	1.7	0.0	0.2	0.0	0.0	0.0
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1 scaffold protein, Cas family member"	P56945	16	75228181-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	34.7	22.3	3.5	4.2	5.8	0.0	27.9	16.9	6.6	37.7	6.3	34.4	15.8	39.2	2.6	22.5	25.3	9.4	47.1	2.3	7.9	47.3	34.2	38.8	2.1	3.9	1.9	19.7	32.4	5.9	29.5	14.1	2.3	25.6	3.5	1.3	25.5	5.7	93.8	18.2	33.1	3.8	0.0	33.7	44.6	34.3	4.2	0.9	26.8	6.8	1.1	24.9	26.2	15.8	21.8	36.8	17.5	6.0	6.7	6.3	34.1	29.5	17.1	20.9	16.4	46.5	32.1	1.9	38.2	33.3	23.6	18.2	6.1	34.0	6.0	0.1	20.0	0.0	23.7	37.2	16.7	0.1	15.1	19.1	16.3	25.3	12.5	12.3	57.9	0.0	20.0	1.0	12.6	48.9	0.1	1.3	23.4	16.1	24.0	0.8	7.9	8.2	19.1	27.9	21.4	31.5	28.7	6.6	11.2	8.4	15.0	5.4	53.6	34.4	29.5	8.8	44.2	8.0	4.7	0.7	22.2	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	16.9	6.6	2.3	7.9	3.9	1.9	2.3	0.0	4.2	15.8	30.1	22.4	6.9	9.4	1.2	28.0	59.7	36.8	12.0	26.5	20.3	14.4	22.9	31.5	21.8	22.0	6.2	46.8	0.7	75.7	27.4	51.9	19.0	13.7	27.9	49.2	34.8	0.0	13.1	61.8	25.7	21.1	71.9	22.5	8.9	15.0	46.8	21.0	6.0	13.5	11.7	42.1	12.2	1.4	6.3	26.8	16.4	2.1	32.0	10.3	0.6	12.9	0.0	19.1	31.2	68.5	59.6	33.4	1.4	58.4	57.4	38.9	13.1	6.8	19.7	8.5	38.5	20.6	17.1	12.5	17.6	36.1	2.2	10.9	33.7	62.7
BCAS3	FLJ20128	ENSG00000141376	"BCAS3 microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Astrocytes: 241.9;Excitatory neurons: 298.7;Inhibitory neurons: 299.2;Late spermatids: 282.3;Microglial cells: 244.5;Oligodendrocyte precursor cells: 285.0;Oligodendrocytes: 552.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 88.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	9.7	11.6	12.7	4.5	14.2	6.4	9.0	13.8	15.8	9.4	12.0	10.0	4.8	9.3	12.1	9.5	13.9	7.6	9.1	13.6	12.2	11.1	12.4	11.1	6.0	14.3	12.1	7.4	9.3	14.4	6.9	10.0	15.2	11.1	6.1	18.0	9.3	9.2	17.3	14.2	6.8	9.0	10.2	7.4	9.7	14.3	12.1	10.6	8.8	9.8	6.7	10.9	9.6	24.0	5.7	14.5	7.8	28.1	17.2	14.2	9.8	6.6	9.9	7.3	9.3	10.0	13.8	2.5	9.7	12.2	7.6	4.9	4.5	6.1	9.5	6.1	19.4	5.6	7.3	9.5	9.4	2.7	5.6	14.5	6.3	6.2	11.1	14.2	8.3	8.8	5.1	12.9	6.5	88.7	10.0	2.2	7.3	29.1	18.2	11.4	11.2	12.4	6.0	24.4	11.6	10.2	12.1	3.3	10.3	20.9	13.5	5.1	8.1	9.5	7.7	4.2	2.8	29.1	23.6	11.7	11.2	2.3	7.6	27.2	10.1	16.5	15.0	9.3	12.3	11.4	10.2	11.2	8.8	11.2	10.7	9.1	34.5	15.6	10.9	6.8	18.0	9.0	12.7	14.2	13.8	15.8	13.6	12.2	14.3	12.1	15.2	10.2	12.1	24.0	10.1	6.4	12.5	241.9	8.6	5.1	9.9	4.7	12.5	22.6	4.4	4.1	11.4	7.2	9.3	16.5	10.4	6.8	9.3	4.1	9.8	4.7	44.2	20.4	26.1	8.6	7.2	13.2	298.7	3.5	5.5	7.8	5.6	9.1	15.9	11.1	11.7	10.8	4.3	3.3	299.2	4.9	6.1	10.0	2.5	282.3	7.5	5.3	1.8	244.5	8.2	33.3	5.2	285.0	552.6	3.6	5.2	21.1	11.1	2.9	6.0	25.2	35.6	14.2	13.1	7.1	21.2	16.3	6.6	6.8	5.5	7.5	11.4	6.7	3.8	6.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 525.1"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	30.4	11.6	9.3	2.7	7.4	0.0	4.7	7.5	12.0	22.0	5.0	36.1	4.7	41.0	24.3	25.8	36.2	6.0	9.7	7.9	7.3	4.9	525.1	10.9	0.2	7.9	9.4	3.7	2.3	0.1	1.8	0.0	7.8	12.5	16.1	8.8	1.9	32.3	2.7	8.7	10.6	29.7	7.4	5.9	3.5	1.3	12.2	2.9	1.3	5.1	0.1	11.3	5.1	9.4	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.4	7.5	12.0	7.9	7.3	7.9	9.4	7.8	7.4	12.2	9.4	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1 subunit alpha"	P12694	19	41397808-41425002	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA		7700	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	33.8	78.4	32.0	19.3	35.5	32.4	25.2	37.0	39.3	24.6	37.0	20.9	19.9	17.9	14.1	65.1	28.8	15.4	90.4	32.5	35.1	44.3	110.0	22.4	24.5	34.4	33.8	25.4	46.1	56.3	24.0	19.0	36.2	23.8	15.0	21.7	40.9	23.1	110.0	31.8	18.7	12.7	33.9	24.4	52.5	27.1	35.7	27.0	41.7	122.0	21.2	21.7	31.9	40.0	42.7	75.1	14.2	44.1	22.2	12.8	17.1	11.9	25.3	24.4	29.9	18.2	36.0	34.6	23.7	15.1	11.0	17.1	15.0	25.9	12.1	36.0	41.0	27.1	35.2	21.3	51.5	25.5	17.7	27.6	37.6	16.9	38.2	36.0	45.0	50.9	25.9	68.9	17.6	41.5	28.0	20.0	12.8	61.1	21.1	27.1	22.8	89.6	29.8	19.8	32.5	38.6	39.6	84.7	34.1	12.1	45.4	81.0	29.3	22.2	23.0	12.0	22.0	131.9	55.1	34.1	81.8	56.6	24.6	61.4	149.4	59.7	49.5	123.9	56.7	46.0	47.0	49.1	154.6	49.5	43.2	44.9	46.4	82.4	95.5	62.6	63.9	125.6	32.0	35.5	37.0	39.3	32.5	35.1	34.4	33.8	36.2	33.9	35.7	40.0	0.6	0.0	13.1	4.9	10.0	0.3	0.1	2.6	26.2	0.2	1.5	0.4	0.1	1.5	5.3	5.5	0.0	1.9	0.9	3.8	3.9	14.7	0.7	0.5	0.6	2.4	6.1	15.5	5.8	11.8	1.7	3.7	23.4	0.7	5.1	0.4	2.5	2.4	2.7	0.0	6.2	7.6	8.2	2.2	0.8	0.9	0.6	6.6	3.6	3.7	12.4	0.4	5.2	4.0	5.7	8.4	3.8	0.4	25.0	0.2	6.7	2.3	1.2	1.2	0.0	0.2	3.6	1.8	0.9	27.2	0.9	2.1	6.3	0.3	7.3	0.1
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"BAF chromatin remodeling complex subunit BCL11A"	Q9H165	2	60450520-60554467	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.8;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0"	"Group enriched"	"Detected in all"	15	"B-cells: 415.7;dendritic cells: 899.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7"	"CAB014891, HPA029003, HPA075941"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: AB_2672863, HPA075941: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	0.7	2.1	31.4	11.3	34.7	25.3	7.1	10.5	47.8	5.2	9.7	18.4	9.7	2.1	1.4	18.4	5.7	2.5	8.0	38.7	15.5	1.0	0.5	2.1	29.2	31.6	15.3	0.6	10.8	1.7	3.0	0.9	31.0	7.8	6.1	1.7	13.8	1.9	1.7	33.2	13.9	3.4	15.9	19.6	4.8	2.0	15.9	33.9	2.3	0.2	40.9	3.3	11.5	38.7	0.6	0.0	4.2	0.1	0.8	0.8	0.3	1.5	0.0	0.1	0.0	0.0	0.2	51.1	0.2	0.2	0.0	10.5	15.4	7.4	0.2	0.9	15.2	0.1	0.6	0.2	0.0	18.7	0.1	1.7	4.1	0.0	2.5	4.0	2.6	17.1	0.8	0.3	0.1	0.1	49.0	19.9	28.6	7.7	0.2	48.3	1.3	19.7	0.0	0.9	20.1	4.8	0.3	0.4	0.3	8.0	0.3	9.1	1.0	0.3	11.6	0.3	0.1	0.8	0.2	106.7	0.1	34.0	1.6	4.5	23.8	5.1	0.5	44.1	1.1	312.7	0.5	0.5	89.9	415.7	1.3	1.1	11.0	8.4	33.7	899.0	1.1	11.4	31.4	34.7	10.5	47.8	38.7	15.5	31.6	15.3	31.0	15.9	15.9	38.7	0.6	0.0	7.4	3.6	149.0	46.3	16.0	34.0	118.4	2.5	31.6	28.6	18.2	4.3	11.7	1.8	0.0	0.6	140.3	7.5	5.9	9.5	12.0	3.9	2.0	1.4	19.8	69.6	180.8	6.4	0.5	3.6	5.1	4.8	10.1	67.4	0.7	0.1	43.2	52.2	153.2	13.6	6.1	7.0	86.1	5.0	0.3	20.5	16.0	11.2	16.0	0.3	0.0	3.5	4.6	4.7	12.5	0.0	6.0	11.7	16.2	0.5	5.5	0.3	0.0	0.2	2.0	2.9	6.9	120.3	69.9	0.8	4.6	1.0	28.9	5.8
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA		100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	13.4	13.3	8.7	5.7	11.6	10.8	11.5	8.4	12.8	7.7	1.4	10.0	6.0	7.9	8.8	12.3	7.4	6.8	19.7	9.4	9.9	14.0	16.4	8.4	7.6	11.6	13.7	7.5	11.8	14.8	7.8	9.2	12.1	8.2	10.3	43.8	10.0	6.8	59.6	14.1	7.8	7.6	9.2	6.4	9.5	10.7	9.7	9.2	9.6	40.5	8.7	10.3	8.7	9.4	16.2	6.1	10.6	11.1	19.6	18.8	17.2	11.4	21.3	17.1	19.8	8.3	11.7	14.6	7.5	15.4	13.9	21.3	12.6	18.4	20.9	12.2	12.3	14.5	7.5	6.1	22.3	21.3	10.0	14.5	21.1	14.0	40.1	24.2	14.7	11.3	34.5	15.2	18.9	11.6	11.7	8.9	10.7	26.8	9.7	10.9	20.7	5.3	20.1	12.4	15.6	11.5	16.4	15.6	31.0	38.0	11.9	18.0	17.2	9.9	5.0	15.3	10.5	11.9	10.5	14.7	14.9	16.1	16.4	5.1	9.5	2.3	2.3	8.0	2.8	3.1	3.1	2.7	5.4	3.2	2.8	2.3	3.6	6.5	6.4	2.9	4.5	4.7	8.7	11.6	8.4	12.8	9.4	9.9	11.6	13.7	12.1	9.2	9.7	9.4	18.7	22.4	16.7	32.3	21.5	24.6	33.6	22.7	30.1	180.5	21.8	22.4	42.7	12.8	25.3	18.4	12.5	48.5	19.7	31.7	52.8	29.1	34.8	17.7	16.0	17.5	23.4	19.8	41.9	31.6	35.0	20.0	13.3	23.5	8.8	19.7	15.7	36.0	26.0	48.8	38.1	25.4	18.3	30.8	19.8	15.5	14.0	26.3	16.0	27.2	54.7	57.9	12.3	27.6	45.4	36.4	17.8	15.4	15.4	40.3	32.6	44.4	19.6	35.2	0.0	21.3	15.6	33.1	22.6	32.1	27.1	95.9	19.3	22.9	24.0	43.1
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 38.5;Bipolar cells: 13.8;Cardiomyocytes: 9.1;Excitatory neurons: 22.3;Smooth muscle cells: 25.8;Theca cells: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 36.6;BJ hTERT+ SV40 Large T+: 28.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;HBF TERT88: 26.5;U-138 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	NA	Yes	16000000	24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038"	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.4	0.5	1.9	0.2	2.4	0.2	0.2	3.3	5.3	0.6	0.1	0.4	0.3	0.2	3.3	0.6	0.1	0.7	3.6	8.2	1.9	0.6	0.1	2.0	0.1	3.3	2.1	0.5	0.4	0.0	1.2	1.6	2.5	2.0	0.1	0.7	0.3	1.8	0.4	0.9	0.1	0.1	0.4	0.1	0.3	0.6	1.6	0.3	1.0	0.0	0.1	2.1	0.6	0.8	2.9	12.2	0.3	0.0	3.7	2.2	0.0	36.6	7.9	28.0	20.9	0.1	4.0	0.0	3.7	11.8	0.5	1.4	0.1	0.2	26.5	0.2	0.1	0.0	3.5	0.0	17.4	0.2	0.2	9.2	4.2	6.8	3.7	18.1	1.3	0.1	0.0	0.1	4.8	0.0	0.0	0.0	4.0	0.1	2.9	0.0	2.0	0.0	4.5	0.0	0.2	1.1	7.8	0.1	0.1	1.7	0.2	0.0	11.0	37.6	6.9	14.4	9.2	0.5	0.1	0.0	14.1	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.4	3.3	5.3	8.2	1.9	3.3	2.1	2.5	0.4	1.6	0.8	0.2	38.5	0.5	1.6	0.0	0.6	0.4	0.5	1.8	13.8	0.5	0.9	9.1	0.0	0.4	1.8	4.2	0.4	0.0	0.1	0.0	0.8	1.8	0.3	0.3	0.2	0.0	0.0	22.3	0.0	0.5	6.1	0.0	0.1	1.3	1.9	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.4	1.5	0.3	0.9	1.8	0.0	0.0	0.2	0.0	2.0	2.2	0.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	1.8	0.0	1.8	25.8	3.7	0.8	2.3	0.0	0.7	0.0	9.3	0.1	0.1
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BIN3		ENSG00000147439	"Bridging integrator 3"	Q9NQY0	8	22620418-22669148	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Septation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023769	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA023769: AB_1845361"	"unprognostic (4.93e-3)"	"unprognostic (4.42e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	18.6	28.4	13.4	8.5	14.1	40.3	17.6	13.2	16.3	12.4	14.4	11.4	6.8	9.6	9.4	15.8	15.1	9.5	11.5	14.0	13.6	21.0	14.0	11.6	10.4	14.1	13.2	10.4	9.7	12.5	12.6	8.4	13.8	15.5	9.9	7.7	11.6	9.4	9.2	13.9	11.1	8.0	12.8	13.3	12.6	10.4	13.5	13.3	13.2	4.4	10.9	13.5	12.9	13.7	20.6	17.5	7.7	16.6	19.9	18.4	8.6	18.2	31.0	28.4	23.2	7.2	7.9	16.6	8.0	20.0	19.9	22.7	14.9	19.0	19.4	12.6	10.1	13.8	9.0	13.6	16.7	14.3	14.8	19.0	22.2	20.9	11.1	18.0	18.4	9.7	27.5	10.2	14.8	10.0	22.8	31.7	14.6	26.9	7.6	11.4	8.2	8.1	28.4	16.2	4.0	8.8	8.7	6.4	94.2	10.3	6.2	12.7	17.7	8.8	10.8	18.1	13.7	6.8	6.1	15.1	25.1	10.3	58.5	56.3	34.2	78.3	29.0	33.9	30.0	25.8	29.5	21.9	27.5	29.1	28.9	23.5	94.9	36.4	26.1	24.9	41.0	36.9	13.4	14.1	13.2	16.3	14.0	13.6	14.1	13.2	13.8	12.8	13.5	13.7	31.7	9.6	13.0	9.1	16.5	9.8	30.9	32.9	5.2	14.0	11.5	10.0	1.1	18.6	17.2	14.7	41.7	42.8	14.7	24.0	15.6	25.1	28.5	26.7	15.3	21.0	19.8	14.3	13.3	27.6	22.5	14.0	21.4	28.4	31.7	13.6	17.2	6.1	20.2	25.2	9.8	22.1	34.6	9.6	8.7	4.9	18.3	13.0	19.6	8.4	18.6	69.3	32.0	4.0	7.2	41.7	26.1	12.0	8.5	23.4	16.7	13.9	34.1	33.8	13.1	25.4	14.6	18.0	14.0	5.4	11.5	79.4	15.0	24.4	18.2	41.2
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.0;lymphoid tissue: 141.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 209.0;naive B-cell: 159.9"	"Group enriched"	"Detected in all"	13	"B-cells: 209.0;T-cells: 83.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8"	"Low region specificity"	"Detected in all"							HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	9.0	14.7	2.7	104.8	2.9	26.3	18.4	1.6	3.4	19.1	3.4	24.9	26.6	10.5	3.7	16.0	8.5	51.0	7.7	2.8	3.5	12.6	26.3	24.6	141.5	2.6	2.7	6.6	12.0	4.3	3.6	5.3	2.3	10.6	24.7	0.6	12.7	11.4	2.7	8.1	89.0	10.7	2.5	73.2	54.3	8.2	2.7	59.2	3.9	4.3	134.4	46.9	4.8	3.6	26.4	24.5	0.2	0.4	0.7	3.9	2.4	2.5	17.5	3.3	3.7	4.6	146.5	140.7	74.3	1.4	22.8	13.0	0.1	4.6	7.8	140.1	0.3	0.5	7.3	1.4	30.7	2.4	3.7	3.5	18.1	8.4	140.2	4.9	0.4	10.2	0.5	0.0	3.0	0.1	8.3	1.3	0.3	14.2	1.0	0.1	0.8	6.8	34.3	12.9	0.1	0.3	2.1	2.1	1.8	0.5	6.4	1.8	7.5	25.6	3.4	1.4	28.3	89.2	85.8	48.8	4.0	7.4	3.0	8.6	3.9	2.2	5.8	10.1	9.8	209.0	41.7	14.1	3.6	159.9	28.4	8.3	2.6	9.9	11.0	1.7	83.6	11.9	2.7	2.9	1.6	3.4	2.8	3.5	2.6	2.7	2.3	2.5	2.7	3.6	41.2	144.2	70.8	0.0	420.1	101.2	324.9	267.2	51.2	0.3	26.6	22.9	12.5	134.4	146.9	40.5	0.0	2.0	71.2	142.4	7.9	230.3	1.8	231.3	16.8	101.4	15.0	23.6	1.1	179.7	0.5	63.4	184.5	289.4	554.8	1.8	6.4	4.4	11.7	0.0	3.2	38.0	75.3	25.4	1400.9	2.1	5.0	170.0	192.1	2.8	1117.0	0.5	14.4	0.0	0.4	207.4	281.1	2.2	288.4	455.1	817.3	19.5	88.1	0.0	0.0	60.8	90.9	0.7	0.5	31.8	84.5	0.5	278.0	0.7	49.4	193.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716174-6717664	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	8.6	11.7	8.0	7.9	8.2	9.8	8.9	8.3	8.7	9.4	9.1	8.9	9.2	9.9	7.1	11.1	9.3	6.5	8.0	8.3	7.7	10.0	11.3	6.3	12.1	8.1	8.2	12.0	7.9	5.6	7.2	7.7	8.3	9.4	5.7	4.3	8.2	6.4	10.8	8.6	11.4	5.1	8.4	13.1	8.8	6.3	8.3	8.9	7.6	5.7	8.6	9.6	8.6	8.6	15.3	10.3	15.2	15.6	11.7	15.0	30.5	12.0	13.2	11.0	9.7	9.2	16.0	14.4	12.6	10.9	15.5	10.1	8.6	14.0	8.4	11.7	14.1	22.0	10.3	23.2	14.3	10.8	19.7	14.2	13.6	8.7	7.5	10.8	10.3	12.3	29.3	12.6	11.6	15.1	17.6	37.5	19.7	11.2	20.0	17.9	16.8	13.0	15.3	13.3	13.1	17.5	9.9	7.1	22.7	11.6	22.4	20.8	11.6	10.0	8.9	11.8	15.4	18.8	19.8	19.4	11.2	19.6	16.3	2.5	2.7	14.0	4.4	4.6	4.5	6.3	5.4	4.8	3.6	5.2	8.4	4.5	1.4	2.5	3.1	3.4	5.1	1.7	8.0	8.2	8.3	8.7	8.3	7.7	8.1	8.2	8.3	8.4	8.3	8.6	18.7	6.4	5.9	3.9	40.8	23.6	35.2	4.9	26.7	29.1	25.2	27.8	5.3	21.5	5.7	23.9	6.2	65.1	49.5	21.7	25.4	9.7	2.5	28.6	28.0	20.2	11.4	26.5	6.8	7.0	93.1	27.8	21.9	25.3	3.8	18.7	32.5	23.6	35.8	30.3	6.6	22.8	4.1	24.0	22.2	1.6	32.3	16.6	30.2	5.6	18.1	38.4	60.8	4.5	8.3	9.9	33.9	22.6	19.7	40.3	33.9	51.3	4.6	24.7	6.6	26.6	20.0	16.0	14.3	23.1	24.9	63.3	47.7	39.1	24.2	34.8
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064396	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	6.8	7.0	3.6	6.3	4.2	3.9	10.5	3.9	4.7	8.1	3.0	6.4	4.2	7.0	6.9	6.6	6.4	6.1	6.0	3.3	4.7	15.7	11.4	5.9	9.9	4.4	4.2	9.9	4.7	9.6	3.1	6.8	4.5	6.5	5.8	5.2	4.7	9.2	6.5	6.4	5.0	6.6	4.0	7.4	6.0	3.7	3.9	15.6	10.1	8.6	10.6	6.2	5.3	4.6	6.1	7.0	14.7	18.9	15.7	18.8	9.6	6.7	9.4	9.5	9.4	13.6	5.8	21.8	43.9	8.6	10.8	5.4	10.8	5.4	13.6	20.6	11.5	13.1	4.8	25.8	13.4	23.2	14.8	8.4	13.4	9.6	14.4	14.5	17.3	17.3	27.7	3.9	13.6	6.7	26.6	15.1	7.9	14.3	9.4	21.5	17.0	33.8	17.6	5.4	13.5	7.2	6.8	10.3	21.3	26.4	12.9	11.8	7.2	15.1	10.7	8.9	5.9	16.5	37.3	19.7	6.2	17.9	15.9	16.2	9.4	18.3	11.8	12.3	15.7	18.9	15.3	15.2	16.6	17.7	15.2	15.9	2.3	19.6	6.7	7.2	15.2	11.8	3.6	4.2	3.9	4.7	3.3	4.7	4.4	4.2	4.5	4.0	3.9	4.6	18.1	12.8	6.9	0.0	14.6	6.0	8.3	6.8	8.6	7.0	7.1	9.9	7.3	0.0	7.9	25.8	2.1	12.5	15.6	5.9	35.2	9.9	7.5	11.5	12.4	10.7	1.8	7.2	0.0	8.7	9.2	10.6	7.7	19.5	16.5	14.5	0.0	0.0	7.8	6.7	0.0	6.9	2.0	0.0	6.1	7.8	9.6	11.0	3.6	0.0	10.7	13.2	12.3	0.0	0.0	10.1	3.9	12.4	7.3	8.4	6.7	41.8	7.7	8.4	0.0	12.4	9.3	5.8	14.4	8.9	7.5	8.2	12.7	22.5	6.6	7.5
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 625.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 3131.8;Hofbauer cells: 1099.2;Proximal enterocytes: 864.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 465.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.3;monocytes: 465.2"	"Cell line enhanced"	"Detected in many"		"A549: 506.6;K-562: 506.8;OE19: 451.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	115.7	76.8	46.6	48.2	46.9	625.2	93.8	49.4	61.0	86.2	52.1	78.5	75.1	59.0	20.5	188.8	69.3	50.9	125.6	44.5	48.0	103.1	266.2	102.8	58.9	56.0	48.6	66.7	73.2	46.1	25.2	52.1	58.5	74.3	30.3	5.5	89.4	42.2	210.4	83.9	72.2	31.7	49.8	166.7	138.4	10.2	52.3	27.5	64.5	94.1	25.3	81.0	96.5	53.4	227.9	506.6	7.3	77.7	73.7	70.2	57.3	28.0	88.7	39.3	75.4	103.4	203.8	74.3	212.3	56.3	126.8	73.1	30.4	64.6	10.5	123.8	20.0	114.9	73.4	62.4	169.8	1.6	32.2	69.2	119.4	52.4	34.2	40.1	41.8	27.4	506.8	137.0	51.0	359.2	6.1	7.2	1.9	451.4	133.8	54.0	23.4	120.3	50.9	146.5	0.4	10.5	84.5	224.5	84.4	13.2	221.5	17.6	39.2	99.4	103.9	156.4	15.9	71.7	92.1	28.5	259.1	46.2	39.0	45.5	465.2	18.0	29.2	220.9	27.0	58.2	24.3	24.5	343.3	37.5	24.7	19.3	58.4	27.4	117.7	75.8	37.3	259.4	46.6	46.9	49.4	61.0	44.5	48.0	56.0	48.6	58.5	49.8	52.3	53.4	74.6	221.2	164.5	9.4	34.4	129.4	348.5	337.9	103.6	11.2	93.8	143.0	130.5	164.5	184.2	97.5	6.2	84.9	39.5	343.6	266.1	234.2	10.0	56.5	46.3	51.1	44.9	3131.8	5.2	267.3	94.7	112.5	280.3	83.1	43.1	31.0	57.1	680.8	1099.2	10.1	5.1	223.5	158.7	627.7	165.4	23.6	124.2	286.7	144.1	13.1	219.8	88.0	32.0	2.0	5.6	260.4	464.0	94.0	25.7	229.7	864.3	488.3	139.1	13.5	32.9	65.4	146.0	2.6	4.0	160.3	130.4	74.7	34.5	34.7	191.0	260.5
BMP1	"BMP-1, PCOLC"	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22165140-22212326	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 69.3;Endometrial stromal cells: 52.8;Smooth muscle cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	11.7	17.4	3.8	6.3	4.6	1.4	9.0	4.7	4.4	15.6	4.9	8.1	4.8	12.7	3.9	7.0	11.8	9.8	5.9	4.3	3.9	7.7	14.7	8.3	1.7	5.0	4.1	5.9	4.4	3.4	3.4	27.3	4.1	9.6	5.3	0.6	3.7	6.1	3.4	6.2	5.9	14.4	4.3	5.0	4.3	2.4	4.2	1.5	10.0	3.1	1.8	10.4	10.3	4.4	15.2	20.4	7.4	30.2	47.8	41.8	23.2	54.1	50.1	33.8	27.6	5.1	27.4	3.7	32.0	56.9	18.9	51.2	5.1	27.8	6.5	3.6	6.9	6.7	24.5	7.9	31.7	2.9	14.3	49.8	26.5	25.2	11.4	78.3	31.4	5.2	7.1	10.6	19.6	4.6	1.4	3.0	4.7	17.0	8.3	6.4	8.2	15.2	26.7	4.1	2.8	10.6	52.5	3.1	13.4	20.4	5.0	8.3	41.4	17.0	18.4	32.3	23.9	4.0	2.2	0.6	23.8	10.1	28.0	0.0	0.4	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	3.8	4.6	4.7	4.4	4.3	3.9	5.0	4.1	4.1	4.3	4.2	4.4	12.5	6.4	69.3	5.5	0.8	6.2	5.2	22.6	4.0	2.6	5.0	6.1	4.9	2.8	6.7	5.5	0.0	3.3	3.2	31.9	0.0	25.1	0.7	3.1	52.8	14.1	3.0	0.8	3.5	8.2	9.5	28.7	1.1	5.7	15.2	13.9	14.6	20.1	4.3	1.7	2.7	6.2	0.0	3.4	6.1	1.1	10.2	5.4	10.6	4.7	1.0	2.2	3.1	6.6	6.7	15.3	18.6	10.9	2.8	4.7	13.2	4.1	2.2	1.1	26.3	6.4	43.7	1.5	4.0	6.5	5.3	24.4	3.3	34.2	10.7	8.0
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030708-81057627	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.3;lung: 5.5;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 32.2;Distal enterocytes: 68.9;Granulosa cells: 104.0;Paneth cells: 32.8;Proximal enterocytes: 25.2"	"Group enriched"	"Detected in some"	4	"lung cancer: 4.2;urothelial cancer: 7.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 16.3;RT4: 13.5;SK-BR-3: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	1.5	0.4	0.3	0.3	0.2	0.8	1.2	0.2	0.3	0.4	0.1	9.3	3.2	0.0	0.1	0.0	0.9	2.0	0.0	0.1	0.6	0.1	0.0	5.5	0.3	0.7	0.7	2.5	0.0	0.0	0.0	0.0	0.5	0.2	6.8	0.5	1.3	0.0	0.0	0.3	7.2	0.5	0.6	0.0	1.1	0.1	1.4	0.0	0.0	0.6	1.5	9.5	0.2	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.5	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.1	0.6	0.7	0.7	0.5	0.6	1.4	0.0	0.0	3.2	32.2	0.0	0.2	0.1	0.5	0.7	0.0	2.2	0.1	0.0	1.3	0.0	15.1	0.0	0.0	0.0	0.0	68.9	0.0	0.0	0.0	0.9	0.1	0.3	0.0	0.0	1.6	0.0	0.0	2.1	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	5.6	5.0	6.1	0.0	1.2	0.0	0.9	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.2	32.8	0.0	0.0	0.5	25.2	0.1	9.4	0.1	0.0	0.3	1.2	0.2	0.3	0.0	0.4	0.0	0.0	0.1	14.1	3.8
BMPER	"CRIM3, Cv2"	ENSG00000164619	"BMP binding endothelial regulator"	Q8N8U9	7	33904308-34156427	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Excitatory neurons: 286.9;Hepatic stellate cells: 117.8;Inhibitory neurons: 90.1;Oligodendrocyte precursor cells: 105.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.5;fHDF/TERT166: 17.0;HBF TERT88: 17.2;HSkMC: 15.5;hTEC/SVTERT24-B: 14.9;U-138 MG: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (4.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.96e-4)"	"unprognostic (5.34e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-5)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.47e-3)"	3.1	0.5	0.7	3.9	0.9	0.0	1.8	1.4	1.5	3.8	0.0	1.2	0.6	1.6	2.2	0.6	1.3	0.8	1.5	0.9	0.3	0.2	5.1	5.1	0.5	0.6	0.4	2.1	0.1	0.1	1.7	5.5	0.9	3.5	0.8	0.3	0.8	0.2	1.8	0.2	2.3	1.0	0.5	0.2	4.0	0.4	0.3	0.3	0.4	3.7	0.0	1.5	1.4	0.8	0.0	0.6	0.0	0.0	14.5	7.9	0.0	10.8	4.1	8.1	6.9	0.0	0.0	0.0	0.0	17.0	4.1	6.3	0.0	0.0	17.2	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	15.5	0.0	14.9	0.1	0.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	2.1	0.8	0.0	0.0	22.5	1.1	9.2	0.0	0.7	0.0	0.0	8.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.4	1.5	0.9	0.3	0.6	0.4	0.9	0.5	0.3	0.8	1.1	0.0	0.0	29.0	0.2	0.0	0.6	0.3	0.0	0.4	0.2	0.0	4.6	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.1	1.9	0.2	3.2	1.3	4.2	2.7	286.9	0.0	0.5	14.3	0.0	0.4	0.0	1.5	117.8	0.3	0.1	0.0	90.1	0.1	0.0	2.8	0.0	1.0	0.0	0.3	0.0	18.7	0.0	0.2	0.0	105.1	9.8	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.5	0.0	5.0	2.1	1.3	5.8	0.1	0.1	0.1	0.2	0.3	0.1	0.3
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.0;esophagus: 12.5;testis: 30.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	15.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	3.1	0.0	0.1	0.0	0.0	8.1	12.5	0.9	0.1	1.4	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.7	0.0	1.0	0.0	1.8	0.0	0.2	0.0	0.1	2.0	0.2	0.0	9.3	0.0	0.0	0.0	0.0	0.1	30.8	0.3	4.2	0.1	0.3	2.1	0.3	6.5	0.4	25.9	0.1	0.0	0.0	4.2	6.4	0.0	2.0	0.3	21.9	30.3	0.0	0.5	0.0	1.0	13.8	0.0	51.1	2.7	116.6	39.3	0.0	0.2	0.0	0.0	0.0	32.6	0.0	0.0	5.6	128.1	19.6	123.8	4.5	21.7	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	11.6	0.0	0.0	14.2	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	88.6	14.8	15.5	14.8	0.0	0.0	0.1	0.4	1.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.5	103.4	0.6	0.1	8.8	1.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.0	1.2	0.0	0.1	1.7	0.0	0.0	2.7	0.6	22.2	6.5	21.7	58.4	0.0	0.0	0.0	0.0	4.8
BOK	"BCL2L9, BOKL, MGC4631"	ENSG00000176720	"BCL2 family apoptosis regulator BOK"	Q9UMX3	2	241551424-241574131	"Plasma proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 218.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 100.8;Oligodendrocytes: 47.0;Proximal tubular cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"TIME: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (6.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.30e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.09e-9)"	"unprognostic (9.48e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"	90.6	7.1	88.4	6.2	138.6	0.4	37.7	110.4	110.3	15.6	51.0	38.0	8.1	34.2	16.3	29.5	18.1	22.7	6.3	77.0	87.8	20.5	97.0	20.1	3.7	146.6	120.6	9.9	16.3	3.8	4.7	5.7	127.1	28.5	5.0	1.2	11.8	25.5	2.6	20.0	9.4	20.4	98.5	6.5	21.5	7.7	115.4	1.1	11.0	3.2	3.4	34.9	18.6	218.8	36.0	8.8	15.7	36.2	26.3	15.6	4.4	28.6	11.3	36.9	37.9	16.2	14.6	0.1	9.7	51.0	9.0	32.9	1.7	28.9	13.8	0.1	0.3	0.1	9.3	42.2	21.8	0.2	1.3	15.9	29.2	15.5	4.4	27.8	44.6	2.4	6.4	0.1	36.7	46.0	0.2	0.2	9.9	40.0	26.8	0.4	25.9	0.2	24.2	0.9	14.0	5.4	13.2	8.5	23.3	18.3	24.4	1.3	65.0	0.1	52.8	0.7	3.2	0.1	0.1	0.1	0.1	0.0	2.1	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.7	1.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.6	88.4	138.6	110.4	110.3	77.0	87.8	146.6	120.6	127.1	98.5	115.4	218.8	22.5	6.4	32.1	0.3	0.5	7.1	11.5	8.6	5.2	0.2	19.4	10.5	10.2	32.9	6.3	11.0	0.0	2.0	2.5	5.8	15.6	23.2	0.2	6.6	17.6	15.6	11.4	5.3	0.8	11.1	10.5	10.9	5.6	14.4	0.0	2.6	12.5	100.8	0.7	0.0	1.5	3.7	2.0	4.7	1.2	1.5	6.2	0.7	1.8	4.7	0.0	3.9	6.2	7.5	47.0	27.7	2.8	10.5	0.9	26.3	7.1	41.9	1.5	1.3	0.0	11.7	11.2	0.3	8.2	19.8	12.8	6.2	1.6	3.4	6.1	15.1
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646811-134679816	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.3"	"Group enriched"	"Detected in all"	4	"Distal tubular cells: 129.1;Erythroid cells: 456.6;Syncytiotrophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 118.2;RT4: 186.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		81000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	11.4	12.6	16.3	9.1	17.1	87.3	12.4	17.9	20.5	12.5	15.8	12.9	8.4	9.6	18.5	26.9	8.5	12.9	13.5	16.5	19.0	35.1	13.1	14.0	11.1	17.9	17.8	7.1	8.4	35.3	18.1	47.0	18.2	13.5	10.0	19.9	17.8	17.9	37.8	10.7	8.0	12.1	19.6	12.5	11.9	14.7	17.7	16.3	11.9	27.0	26.2	39.0	17.2	18.5	14.0	16.3	21.7	29.6	24.3	14.4	21.9	41.3	49.9	15.7	23.2	6.5	18.5	17.1	12.0	23.2	30.9	11.2	23.3	22.7	27.6	118.2	19.9	9.8	15.4	7.8	16.7	18.8	12.4	14.2	20.0	29.7	16.0	24.0	58.0	20.8	28.8	20.9	37.8	6.6	30.7	26.0	22.7	27.7	15.3	23.2	15.5	12.4	36.1	186.8	18.7	31.1	19.3	23.1	21.7	23.1	15.1	11.8	44.7	25.1	6.0	33.7	33.9	33.9	41.2	21.5	43.3	17.7	43.7	61.1	16.4	48.9	23.3	22.2	16.7	19.3	15.0	20.7	17.5	18.9	20.7	21.1	30.2	18.5	23.0	11.4	21.1	23.6	16.3	17.1	17.9	20.5	16.5	19.0	17.9	17.8	18.2	19.6	17.7	18.5	17.6	9.6	25.5	6.5	15.7	39.0	18.5	60.6	10.8	19.2	15.9	18.7	25.0	18.6	52.3	27.6	2.1	44.5	43.0	5.0	129.1	45.9	3.4	10.0	7.0	18.8	13.1	456.6	8.0	18.2	32.7	17.0	4.1	8.5	24.7	6.6	10.0	4.7	15.1	20.2	9.3	4.6	36.7	11.7	10.5	7.2	10.2	11.8	23.2	5.6	15.7	25.6	47.4	7.5	11.6	49.0	4.6	12.0	14.2	26.0	5.5	68.8	50.5	13.5	6.6	12.0	22.1	33.9	21.8	13.5	13.2	368.9	25.0	7.8	4.8	19.2
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 6.2;lung: 18.3;pituitary gland: 12.1"	"Cell type enriched"	"Detected in some"	6	"Club cells: 1205.8"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 2.0"	"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	NA	NA		1200000		"Cluster 19: Lung - Lung function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	129.5	0.0	0.0	0.0	0.0	0.0	0.0	1205.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	126.1	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.0	80.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309871	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 566.8;salivary gland: 271.3;stomach 1: 512.5"	"Cell type enriched"	"Detected in many"	5	"Club cells: 5748.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 4.8"	"Low region specificity"	"Detected in many"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		2700000		"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.0	0.1	566.8	0.0	0.5	25.6	0.0	0.0	47.1	0.1	3.4	0.0	0.4	0.0	0.0	0.1	112.5	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	1.2	0.0	0.0	271.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	512.5	3.5	0.0	0.2	0.0	0.0	1.2	8.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	3.8	0.0	0.4	0.0	0.1	0.0	2.2	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	22.7	0.0	0.0	1.3	1.4	614.0	0.0	0.0	2.0	1.3	0.4	2.8	5748.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	63.6	0.4	0.1	1.1	0.0	0.0	0.2	0.2	0.1	3.0	31.1	0.6	3.8	0.0	0.4	0.1	0.2	0.0	0.1	0.0	1021.3	0.0	1.9	82.9	0.3	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.0	2.0	0.0	0.0	1027.4	0.0	0.0	0.4	305.5	5.8	0.8	11.6	0.4	0.1	1.0	0.0	0.0	95.9
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007704-33023703	"Plasma proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"salivary gland: 2294.3"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 6.1;Breast myoepithelial cells: 9.1;Early spermatids: 4.8;Late spermatids: 9.3;Prostatic glandular cells: 7.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	582	"Hep G2: 232.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		36000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.4	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	99.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	1.8	0.0	0.0	2294.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	9.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Late spermatids: 1.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"HEL: 3.7;HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Secreted in other tissues"	NA	NA					"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825503-67984378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	25.5	23.7	24.1	25.4	29.5	32.0	25.5	88.1	26.3	30.3	10.9	27.9	15.7	27.9	28.7	26.6	29.6	19.1	20.7	21.0	38.2	27.9	20.7	22.6	43.7	26.4	21.9	38.1	22.9	27.4	34.6	22.2	24.3	25.2	22.2	44.0	25.2	16.7	25.9	37.5	28.5	19.6	17.6	31.4	23.6	32.1	22.6	52.9	27.4	22.3	39.2	24.4	27.7	34.3	42.2	52.8	76.3	38.7	41.6	39.0	42.2	32.0	29.4	37.1	31.8	49.6	29.0	167.7	22.4	35.4	28.5	32.2	74.4	34.5	60.0	24.2	72.5	64.9	50.4	68.8	19.8	97.3	49.9	28.6	37.3	36.9	27.6	34.0	70.2	52.9	75.1	46.1	32.3	64.0	99.1	47.3	58.9	37.9	47.8	70.3	91.0	33.6	32.5	50.6	56.5	65.6	42.8	117.4	46.4	91.4	49.1	53.7	49.6	56.2	43.7	20.7	39.7	39.3	42.0	97.9	26.9	45.1	22.0	20.3	4.2	8.5	7.2	2.4	5.7	6.2	5.9	5.7	3.0	11.8	6.1	6.3	9.2	10.7	5.7	10.9	4.5	1.6	24.1	29.5	88.1	26.3	21.0	38.2	26.4	21.9	24.3	17.6	22.6	34.3	118.7	115.4	148.2	192.3	130.9	75.2	55.3	37.8	87.0	216.8	76.2	78.5	136.0	61.5	92.0	58.8	143.9	39.4	170.3	64.1	7.9	63.8	26.6	147.7	174.5	108.1	126.1	114.6	124.4	63.1	30.8	94.8	88.2	165.9	121.4	124.9	71.0	46.4	42.2	198.5	136.4	68.9	48.8	56.3	54.4	25.7	108.7	84.7	64.0	109.6	88.0	129.3	146.2	231.8	262.7	65.4	64.5	111.3	129.2	62.1	37.7	17.4	80.8	202.6	65.7	167.3	92.3	144.9	101.3	82.6	75.6	38.7	128.8	126.6	85.8	60.7
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1 DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611"	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	3.1	1.8	4.2	7.5	7.2	13.0	3.6	4.7	5.2	2.7	2.7	6.8	3.2	3.1	2.2	4.0	3.7	1.9	3.0	3.6	4.1	2.0	5.6	3.2	10.3	5.6	5.0	2.8	2.8	5.9	2.8	3.8	6.0	2.4	7.4	8.2	3.2	1.6	4.2	6.0	5.1	3.9	3.7	3.9	3.6	13.0	5.5	14.5	7.8	3.7	11.2	2.8	2.4	10.8	44.1	69.1	37.8	30.1	6.0	13.4	36.6	50.6	21.5	41.9	39.3	42.3	33.4	100.8	9.1	19.0	49.0	49.5	51.9	28.3	69.5	46.9	38.0	48.1	54.0	37.1	1.3	86.0	39.9	3.8	4.5	63.1	20.0	10.6	22.3	46.6	73.7	42.2	39.7	30.0	72.0	27.8	20.5	29.1	18.7	49.0	79.8	40.8	15.4	42.1	25.8	27.4	38.8	12.5	19.4	25.5	33.9	39.6	13.8	37.2	29.6	49.0	53.2	20.1	51.2	75.5	29.6	49.6	39.4	6.8	14.7	2.2	1.5	4.7	1.5	1.2	1.5	1.2	10.9	2.1	1.3	1.5	11.3	1.5	2.0	1.7	0.5	17.5	4.2	7.2	4.7	5.2	3.6	4.1	5.6	5.0	6.0	3.7	5.5	10.8	5.0	0.0	2.8	9.4	5.8	2.9	4.5	1.9	1.2	10.3	4.4	5.2	10.1	5.7	3.5	1.8	22.9	12.8	8.1	6.2	0.0	3.0	11.9	14.0	6.3	4.7	0.0	42.5	3.0	1.1	18.2	7.4	6.1	4.2	8.2	38.2	5.3	18.3	10.1	11.8	4.4	7.5	0.0	3.9	2.8	8.0	2.5	6.4	0.0	4.7	4.9	2.4	5.2	3.0	18.7	1.7	2.4	1.5	16.6	2.3	1.1	1.0	10.0	22.8	6.6	13.7	5.5	105.8	73.5	8.2	2.3	4.0	4.7	9.7	12.7	3.4
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"Biogenesis of ribosomes BRX1"	Q8TDN6	5	34915677-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.6	17.1	13.3	17.6	13.8	37.1	24.7	15.2	18.7	15.1	12.8	15.6	12.9	17.4	17.8	17.7	16.1	12.2	14.7	13.2	14.1	15.1	18.5	13.0	26.4	13.7	13.6	18.5	13.7	18.2	9.5	25.7	13.8	15.7	17.1	11.6	12.9	14.5	10.4	14.6	12.8	16.1	13.9	14.3	13.1	13.9	13.5	20.7	15.8	12.2	25.8	30.1	12.3	15.2	66.1	57.0	64.2	87.1	26.0	37.8	121.6	74.9	52.7	100.0	63.5	74.5	81.0	138.8	38.7	45.5	113.5	52.1	108.5	79.8	117.3	75.1	101.3	93.9	125.7	71.9	67.4	150.8	63.8	44.4	49.8	93.3	85.9	31.0	48.5	72.9	158.4	43.8	66.2	63.6	108.3	163.9	101.0	75.2	86.8	94.6	112.5	60.5	59.3	70.7	75.1	68.8	157.6	109.7	76.1	50.0	66.4	92.7	28.4	78.7	87.5	58.1	151.0	39.3	87.7	177.6	66.3	171.3	100.3	15.0	21.4	10.0	34.5	21.0	50.1	63.7	43.2	44.3	27.8	49.9	53.3	46.6	1.2	43.7	30.6	37.5	43.5	44.6	13.3	13.8	15.2	18.7	13.2	14.1	13.7	13.6	13.8	13.9	13.5	15.2	35.5	28.9	30.7	8.5	40.0	108.7	114.3	110.2	55.2	20.8	27.3	41.3	23.2	25.8	63.0	23.9	12.5	127.1	37.0	13.5	49.0	52.5	24.8	29.9	45.1	40.6	21.0	45.2	11.9	42.7	100.6	44.4	19.4	31.6	20.2	30.0	20.0	11.9	42.7	21.9	13.4	19.0	63.1	10.7	20.1	8.4	39.4	18.4	32.0	4.7	31.1	22.3	21.6	10.6	13.6	44.7	13.1	29.0	21.4	70.9	9.9	37.9	45.8	37.2	6.6	54.3	55.7	59.9	77.6	46.0	95.8	126.1	37.1	31.7	31.9	85.1
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 82.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	8.0	7.1	4.7	6.9	6.9	23.5	7.7	9.9	7.4	8.2	3.8	8.3	4.8	9.5	4.4	8.6	8.8	5.5	7.3	6.7	3.8	6.2	5.5	7.9	8.9	4.7	4.2	9.3	7.3	7.7	6.7	6.5	4.3	7.5	4.0	4.0	9.1	5.0	9.5	10.9	8.3	5.4	3.1	10.5	7.5	14.4	5.2	11.9	9.0	6.8	7.6	7.9	7.8	5.5	9.9	17.2	12.5	8.2	8.9	8.6	82.4	12.6	7.5	14.3	10.2	12.1	8.3	18.6	6.0	11.6	13.5	8.2	15.3	12.0	9.0	20.1	17.9	21.4	33.8	9.8	11.4	30.6	20.0	8.5	9.8	19.8	13.1	7.2	10.8	17.5	25.2	15.9	8.3	24.3	19.8	25.7	20.6	6.7	15.9	28.7	10.6	12.3	6.7	14.5	8.9	15.2	12.7	9.0	10.1	8.2	9.8	31.4	14.1	15.9	13.6	14.5	24.0	13.4	18.1	31.5	13.1	25.9	15.1	1.0	0.9	1.4	1.3	0.8	2.0	0.6	0.9	1.2	0.8	0.5	1.1	1.3	0.8	4.2	0.7	1.9	0.7	0.8	4.7	6.9	9.9	7.4	6.7	3.8	4.7	4.2	4.3	3.1	5.2	5.5	7.9	16.0	10.0	2.6	6.8	14.1	5.1	3.9	8.0	4.6	9.2	7.0	3.7	2.8	6.2	7.3	6.2	4.2	13.0	9.4	0.0	4.1	3.9	4.2	6.9	9.7	10.2	9.7	3.4	5.5	5.5	5.8	7.7	7.0	8.8	7.3	11.0	3.5	6.4	8.4	2.4	5.0	2.0	5.6	9.2	1.2	6.5	6.9	1.8	2.8	6.3	5.2	5.2	4.0	2.9	6.1	3.1	6.0	7.9	5.1	4.9	2.1	4.3	5.1	6.6	11.3	7.7	16.6	13.9	9.9	18.5	3.7	10.8	5.6	6.1	6.8
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
BRS3	"BB3, BB3R, BBR3"	ENSG00000102239	"Bombesin receptor subtype 3"	P32247	X	136487947-136493780	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"epididymis: 25.7"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hypothalamus: 6.1"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 1: Pancreatic cells - Digestion"					"unprognostic (1.49e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"		"unprognostic (3.73e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"		"unprognostic (5.59e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.8	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554477-49671549	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 33.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 33.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	0.1	1.4	8.2	0.1	17.6	0.0	0.1	0.1	33.6	0.2	0.0	0.2	0.1	0.3	3.0	0.0	0.1	0.0	0.2	17.2	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.3	5.3	0.1	0.0	0.2	0.0	3.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	3.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	4.9	0.1	0.2	1.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.4	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.0	0.2	0.0	0.4	0.2	0.1	0.8	0.1	0.5	0.0	0.1	0.2	0.0	0.2	4.4	2.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	17.6	0.1	33.6	17.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	15.0	0.2	0.5	2.5	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.0	7.8	0.4	0.3	0.5	0.0	0.0	76.6	0.5	0.1	0.3	0.0	0.3	0.0	0.6	0.7	0.4	0.1	25.2	50.1	0.1	0.0	0.3	0.0	11.7	1.2	0.1	1.8	9.4	0.0	3.9	2.1	22.6	6.3	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	8.8	0.0	1.0	1.3	6.7	8.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 139.8;intestine: 48.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 257.7;neutrophil: 292.7"	"Group enriched"	"Detected in many"	95	"dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		190000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	21.2	2.7	1.9	13.7	2.1	139.8	9.4	2.1	4.7	11.0	1.6	8.3	48.6	6.3	2.9	4.6	7.9	18.2	19.1	2.1	2.0	17.0	8.5	12.7	7.1	1.9	1.4	9.3	3.1	1.7	1.3	13.7	2.2	3.7	9.7	1.0	3.9	4.6	2.7	5.0	29.3	9.7	0.8	18.6	3.2	2.7	3.0	3.9	4.9	6.8	3.5	16.8	7.4	3.3	0.6	10.5	1.2	1.0	28.8	7.0	1.6	21.0	2.1	20.4	22.2	0.3	12.1	0.8	1.9	12.2	0.6	0.3	3.3	0.5	17.2	0.8	0.7	5.6	0.8	0.6	6.7	7.2	15.1	5.7	1.5	12.9	1.0	0.9	3.0	5.0	0.7	0.5	12.5	0.3	2.3	4.3	2.7	0.9	2.2	0.8	1.8	0.5	0.5	0.6	1.4	4.3	0.4	0.7	14.2	1.2	0.5	76.0	40.4	0.6	1.0	7.9	1.1	0.6	0.2	0.7	2.7	52.5	44.8	41.8	257.7	20.8	1.1	97.4	1.7	2.2	0.9	0.8	78.9	0.9	1.1	0.7	292.7	0.4	73.9	26.6	1.0	109.8	1.9	2.1	2.1	4.7	2.1	2.0	1.9	1.4	2.2	0.8	3.0	3.3	5.4	3.2	3.7	1.3	0.3	4.6	0.8	0.1	1.8	0.6	1.2	2.0	1.5	2.8	1.0	1.8	0.0	16.0	5.5	3.7	1.9	4.4	4.4	8.0	9.9	3.8	1.2	2.5	0.7	2.5	24.0	22.5	0.0	16.2	15.9	20.6	6.4	2.1	40.8	0.0	0.7	8.1	0.0	26.3	11.5	1.2	3.1	33.3	14.2	3.7	80.1	0.6	3.1	0.5	3.6	1.1	11.9	2.2	0.4	0.6	79.0	9.6	3.0	0.2	6.6	3.9	15.5	2.5	1.4	1.7	3.0	7.1	1.8	1.4	23.2	3.3
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923770-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"HPA070682: AB_2686294"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	20.4	13.2	5.2	20.1	7.3	32.1	19.2	8.5	8.6	18.4	5.9	20.4	16.2	20.7	21.1	17.2	23.4	15.2	14.4	6.1	5.5	11.8	15.4	19.1	32.0	6.1	5.3	25.4	18.1	14.7	13.3	13.7	6.0	16.8	15.9	34.3	19.2	12.7	14.8	50.4	22.0	14.0	5.9	22.0	18.4	17.9	5.8	21.7	17.3	9.2	25.5	20.1	19.9	10.4	28.9	13.8	31.7	38.7	16.5	25.8	15.8	16.5	19.6	16.0	23.7	19.1	17.2	30.8	10.3	16.3	9.9	30.4	21.5	14.6	23.8	21.2	23.2	21.9	35.7	20.0	16.8	33.3	22.0	18.4	18.5	24.3	35.1	34.3	15.6	25.9	18.2	34.5	16.6	12.6	25.8	21.0	14.4	8.3	10.8	20.6	19.7	14.5	14.9	17.5	12.2	14.3	15.8	8.0	20.3	20.8	16.2	21.9	16.9	14.3	11.4	19.5	23.7	39.7	19.6	24.9	22.4	30.1	3.8	4.4	2.7	1.5	2.5	1.9	2.2	2.5	1.9	1.8	2.1	3.1	2.3	1.8	1.9	2.2	3.6	4.9	1.6	1.4	5.2	7.3	8.5	8.6	6.1	5.5	6.1	5.3	6.0	5.9	5.8	10.4	18.3	19.2	31.5	58.4	29.5	21.7	12.1	7.3	21.6	26.7	16.2	11.9	13.6	7.2	14.6	20.2	45.9	6.6	34.8	7.9	1.9	6.8	12.9	33.3	28.0	15.6	16.2	13.9	78.5	6.6	9.8	17.3	35.2	46.6	24.1	22.4	8.9	8.7	7.1	18.5	66.4	7.1	6.1	9.7	19.8	5.1	11.8	27.1	5.4	67.5	16.4	13.9	14.4	68.3	91.5	6.7	6.3	11.7	52.1	15.7	9.6	3.3	24.9	35.5	6.6	25.7	22.8	24.7	12.2	20.4	29.8	14.6	24.7	11.4	9.3	16.4
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15722311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2800000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	25.3	16.7	10.7	8.0	12.7	13.1	16.4	20.2	12.6	13.7	11.0	15.9	46.1	13.2	62.4	9.9	18.3	19.9	10.2	11.5	10.3	37.6	95.9	15.9	9.6	12.0	10.0	25.3	44.1	27.7	5.9	17.0	12.6	19.5	17.0	35.2	16.0	21.1	7.8	9.5	30.7	14.1	10.3	11.3	24.4	18.2	9.9	10.6	26.8	11.4	10.4	14.3	7.5	19.1	9.2	22.0	7.8	7.3	51.7	15.3	39.6	15.4	18.4	16.2	28.3	10.1	21.5	4.1	16.3	31.6	7.1	9.7	5.3	16.7	18.7	7.6	11.7	12.9	28.8	24.8	12.7	8.8	14.7	18.3	16.9	42.9	5.1	39.7	30.5	5.9	8.7	32.3	44.7	11.1	4.5	8.2	8.5	16.9	13.0	5.9	18.4	27.9	16.5	17.7	5.3	11.8	17.9	5.2	24.4	15.1	19.9	11.3	24.3	20.5	13.6	19.1	10.1	8.9	11.4	4.1	21.4	7.7	14.4	74.1	20.7	44.9	22.9	19.6	21.0	14.7	23.3	19.2	21.4	13.1	19.7	15.4	19.8	15.0	15.8	24.9	28.8	16.5	10.7	12.7	20.2	12.6	11.5	10.3	12.0	10.0	12.6	10.3	9.9	19.1	14.9	6.4	11.0	11.8	11.7	5.9	12.4	25.0	6.2	13.5	9.1	7.9	6.0	45.8	16.7	18.4	18.8	25.3	19.7	9.9	5.9	21.1	31.0	9.5	6.0	9.1	7.2	4.0	6.6	28.5	22.4	14.5	9.7	5.7	5.1	8.9	20.3	63.3	14.9	5.0	12.2	8.5	16.2	8.2	5.9	17.9	32.3	9.2	10.6	5.6	8.7	19.2	6.2	27.2	23.9	12.0	17.9	18.0	16.6	6.3	52.1	32.0	19.8	54.1	13.1	8.5	8.6	45.3	7.5	7.7	5.5	23.1	13.6	17.4	8.9	9.5
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013007, HPA056420"	Approved		Supported	Cytosol		NA	Yes		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB013007: , HPA056420: AB_2683125"	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	633.3	440.1	241.0	373.7	251.2	861.1	763.0	250.7	307.9	658.2	234.9	593.6	460.9	547.0	422.0	735.8	584.3	376.6	477.8	230.9	261.7	469.8	522.5	416.4	644.4	256.5	247.8	1180.8	609.6	401.9	288.1	429.5	259.1	441.1	540.1	183.9	509.2	390.8	880.0	782.4	446.7	459.1	256.5	393.7	534.8	181.7	242.0	629.3	440.1	600.1	758.9	624.2	626.6	272.0	1148.3	747.2	798.7	1145.9	779.6	1301.4	1246.4	781.1	1084.9	1327.8	1267.4	972.1	1267.3	1719.2	1203.2	816.0	963.9	787.9	1176.6	2011.7	1517.2	716.2	1502.5	976.3	652.7	1280.2	1132.7	934.0	754.5	1139.7	1597.0	857.6	1572.3	1512.0	1227.4	975.3	924.1	1087.8	1134.7	1037.8	1410.0	1735.0	1017.4	423.0	742.0	1061.5	944.4	2147.0	1414.6	1126.0	930.6	1239.4	767.0	861.7	1650.4	744.4	1108.4	1884.6	894.7	569.6	780.5	690.2	2142.1	1020.7	1114.3	1607.2	757.0	1405.3	862.8	261.1	883.1	221.9	535.6	684.0	907.0	957.3	906.7	754.3	1140.2	788.4	986.3	892.7	116.0	878.6	556.1	637.6	1146.0	2128.9	241.0	251.2	250.7	307.9	230.9	261.7	256.5	247.8	259.1	256.5	242.0	272.0	753.2	246.8	324.7	17.0	889.7	1962.5	2039.6	2425.9	1664.7	138.9	1675.6	2355.4	357.8	566.2	908.0	323.7	43.8	1370.6	740.7	648.3	909.8	971.1	718.0	502.1	809.7	864.3	592.8	968.4	25.2	1219.7	2062.4	753.8	465.3	646.9	417.7	935.1	742.8	439.4	1066.3	85.8	29.3	1169.4	787.3	968.7	1357.2	464.2	1248.3	803.3	791.5	29.0	1487.9	376.5	726.1	20.6	49.6	1221.7	998.2	846.3	540.1	1626.5	1308.9	1229.5	432.9	137.6	644.2	1023.8	1051.0	333.7	238.2	1582.0	1953.2	1712.1	868.7	1029.7	1337.1	2269.9
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.6;lymphoid tissue: 78.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 557.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 557.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	6.3	2.9	2.3	30.7	2.6	32.6	4.4	2.8	3.4	3.9	3.1	6.6	4.8	2.5	1.5	3.6	1.9	7.6	1.6	2.3	3.1	1.3	5.4	19.6	55.5	4.7	3.6	0.8	1.2	0.9	0.9	7.0	4.7	1.9	9.1	0.3	2.8	2.3	0.6	2.9	14.7	7.1	3.8	38.4	7.0	1.4	3.9	9.3	1.3	2.0	78.0	9.3	1.5	6.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	206.7	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.3	287.4	0.0	0.0	0.0	116.7	990.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	61.9	2.3	0.0	0.0	0.6	81.5	1.6	0.0	0.0	87.2	0.1	13.2	0.0	0.0	0.2	0.0	0.3	0.1	0.5	1.0	0.0	68.5	0.4	0.0	0.3	0.2	0.1	2.6	1.4	98.3	0.5	149.8	0.3	557.5	62.2	110.5	0.2	99.9	0.2	72.4	0.2	0.1	72.7	73.0	0.4	0.1	24.7	0.2	123.9	33.1	0.1	38.4	2.3	2.6	2.8	3.4	2.3	3.1	4.7	3.6	4.7	3.8	3.9	6.5	1.5	3.2	8.9	0.3	84.7	1.0	0.2	0.0	0.6	0.0	0.9	1.4	0.6	0.0	0.6	0.0	0.0	1.4	30.1	0.1	0.0	0.0	0.2	1.3	0.3	0.8	0.0	27.1	0.5	0.0	0.5	0.9	1.1	2.3	211.4	0.0	0.7	0.3	56.6	0.0	0.3	0.3	0.0	63.5	31.0	0.1	0.3	61.1	3.6	10.3	71.1	0.0	2.1	0.0	0.1	0.1	0.5	0.0	43.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.7	1.7	0.5	0.3	1.9	5.7	0.2	0.1	0.1
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	16	"hypothalamus: 2.9;thalamus: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No				"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.3	1.8	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.5	4.8	0.0	0.0	1.1	0.0	2.7	4.6	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.8	2.4	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.9	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	8.1	15.9	10.9	10.4	11.4	7.5	13.2	12.1	13.5	8.9	12.3	11.7	13.3	12.4	18.7	8.7	15.0	7.0	19.4	10.8	11.7	21.3	14.5	8.7	12.9	11.2	10.9	16.1	13.2	27.8	13.4	10.4	11.8	11.6	12.6	26.1	12.2	10.6	17.5	7.2	10.8	10.4	10.5	9.5	12.9	26.3	11.1	16.0	14.1	14.3	13.2	9.6	8.2	11.2	39.2	33.4	51.0	15.5	13.3	14.5	27.9	25.5	22.4	34.3	29.1	18.2	14.9	23.5	28.6	18.2	52.6	42.5	32.8	27.6	46.6	18.0	37.9	18.7	39.8	39.5	26.6	26.3	14.1	13.4	33.0	25.2	17.4	28.6	25.3	43.6	38.9	31.8	22.8	29.2	76.5	26.9	37.7	23.9	14.7	50.1	31.5	44.0	21.4	18.2	50.4	44.3	21.1	19.1	62.7	37.2	50.4	16.8	19.8	18.8	35.4	9.3	42.4	42.5	51.0	82.9	15.3	23.0	5.7	34.6	12.4	16.4	17.6	12.0	20.1	18.2	16.9	18.3	16.1	19.9	18.2	17.0	3.2	19.0	17.1	12.8	19.6	15.4	10.9	11.4	12.1	13.5	10.8	11.7	11.2	10.9	11.8	10.5	11.1	11.2	12.6	12.8	30.7	7.2	13.8	5.9	13.4	27.8	12.5	25.0	11.3	13.5	25.8	8.6	19.3	14.7	8.4	31.8	10.7	3.8	43.0	16.2	10.0	17.2	8.8	10.5	12.6	13.5	11.1	13.8	18.0	9.8	9.7	10.5	11.4	18.3	6.4	11.0	9.7	32.0	15.0	8.0	28.5	7.5	3.7	6.3	7.5	7.8	5.4	2.8	6.7	17.5	11.3	10.1	8.7	11.8	3.2	8.2	14.0	6.4	6.9	29.9	29.9	23.0	39.5	9.7	13.1	88.0	31.8	12.0	6.1	16.3	15.1	10.5	8.4	8.2
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636628-22639678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1092.6"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 1663.2;Kupffer cells: 5007.4;Macrophages: 1874.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"intermediate monocyte: 226.1;non-classical monocyte: 181.7"	"Lineage enriched"	"Detected in many"	60	"monocytes: 226.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;NB-4: 1.4;RPMI-8226: 7.1;SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		2700000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	375.1	235.6	86.6	134.0	85.6	53.9	95.9	85.8	135.3	75.8	120.0	142.8	172.3	43.1	26.0	58.3	75.6	172.4	74.8	82.9	93.7	56.2	208.8	404.3	532.3	126.7	110.1	37.5	34.3	26.2	46.3	256.3	110.3	47.1	120.2	4.1	48.1	54.6	14.8	21.8	190.1	195.0	107.5	1092.6	90.8	38.2	109.4	100.3	36.5	49.3	68.0	257.5	30.4	131.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.5	0.2	7.1	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.4	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	5.2	0.1	0.1	226.1	0.0	0.0	0.1	0.1	3.7	0.0	0.0	0.0	0.5	0.3	181.7	0.0	0.0	9.7	86.6	85.6	85.8	135.3	82.9	93.7	126.7	110.1	110.3	107.5	109.4	131.6	17.4	35.3	55.8	0.0	19.0	18.4	2.3	0.0	2.2	0.4	5.1	24.6	8.9	37.1	18.0	0.0	0.0	8.7	2.7	0.5	0.0	0.0	4.5	0.2	0.5	46.0	1.8	41.0	0.0	0.2	11.3	9.6	0.0	0.2	21.5	0.2	76.1	26.2	1663.2	0.0	0.0	0.1	0.0	5007.4	291.4	9.9	13.1	1874.2	26.6	20.6	16.7	0.3	0.0	0.0	0.1	0.0	0.1	0.4	2.8	1.3	0.1	1.1	15.3	0.8	78.9	7.4	4.6	0.7	2.1	4.2	16.8	18.2	11.8	0.0	0.2	1.3
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643633-22648110	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 950.7"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 1356.5;Kupffer cells: 2134.6;Macrophages: 1040.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"intermediate monocyte: 57.2"	"Lineage enriched"	"Detected in single"	541	"monocytes: 57.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 2.6;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	2100000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	285.2	196.0	60.1	159.7	58.6	43.5	70.5	64.8	97.1	51.9	90.6	133.2	179.9	36.3	13.5	55.3	67.4	155.4	58.6	54.9	75.5	41.2	169.6	290.8	370.2	124.7	105.4	32.1	37.5	22.1	39.6	204.9	105.0	37.8	91.3	3.9	51.6	44.5	12.9	18.3	195.7	164.7	100.4	950.7	94.8	33.9	106.0	75.7	29.2	31.8	50.7	191.8	24.6	159.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.2	0.0	0.0	0.6	0.2	2.6	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	1.2	60.1	58.6	64.8	97.1	54.9	75.5	124.7	105.4	105.0	100.4	106.0	159.3	13.4	6.4	5.2	0.3	13.7	8.9	1.1	0.0	2.8	0.6	4.9	24.5	1.6	15.7	3.1	0.0	0.0	5.8	2.3	0.4	0.0	0.0	3.2	0.0	0.1	34.5	0.0	27.2	0.0	0.2	9.5	4.4	0.0	0.1	5.1	0.1	25.4	6.6	1356.5	0.0	0.1	0.1	0.0	2134.6	202.4	3.6	6.2	1040.7	7.2	29.0	23.6	0.4	0.0	0.0	0.0	0.0	1.1	1.2	0.9	0.4	0.0	0.4	0.7	0.6	46.0	2.5	1.8	0.4	0.8	3.3	6.5	9.9	3.5	0.0	0.0	0.7
C1QL1	"C1QRF, C1QTNF14, CRF, CTRP14"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968303	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 134.0"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 673.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 34.8;SH-SY5Y: 24.8;U-2 OS: 89.0;U-251 MG: 28.1;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	7.7	0.7	18.5	0.4	17.2	0.0	0.9	26.6	32.1	3.0	16.2	4.9	2.0	13.0	0.3	1.8	4.4	0.3	4.1	15.5	21.4	21.0	0.7	0.2	0.0	134.0	41.9	0.7	4.6	0.0	2.1	0.0	24.9	7.3	0.3	8.1	0.7	0.0	0.1	0.5	6.2	0.6	32.4	0.1	3.9	0.8	21.6	0.1	0.3	0.2	0.0	6.4	1.2	24.3	4.6	5.1	1.1	17.8	0.3	0.0	0.3	0.8	0.7	0.5	1.6	0.7	0.6	0.2	3.0	0.4	5.3	0.6	2.8	0.2	0.2	12.7	7.5	0.0	7.9	0.1	2.1	0.0	2.2	0.4	0.0	0.7	0.2	6.2	0.0	3.1	0.1	0.2	0.5	1.1	4.0	0.1	3.1	0.5	10.7	6.7	0.2	0.3	0.1	0.4	34.8	24.8	15.6	1.3	1.3	0.9	4.1	0.2	0.1	1.4	89.0	0.9	28.1	1.0	0.0	0.1	27.8	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	17.2	26.6	32.1	15.5	21.4	134.0	41.9	24.9	32.4	21.6	24.3	0.1	0.0	0.0	4.2	0.0	0.3	0.2	1.0	0.0	22.3	0.4	3.2	1.1	5.7	0.0	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.4	5.3	0.0	0.5	0.0	0.1	1.9	0.0	0.5	0.0	0.3	1.1	0.1	0.0	673.0	11.7	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.0	0.0	17.6	0.0	84.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.7	0.2	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34017858-34043213	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.4;salivary gland: 52.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	211	"U-266/84: 810.2"									"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	44100000	24000000		"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA064996: AB_2685399, HPA066011: AB_2685597"	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	7.3	0.5	4.1	1.7	5.0	0.6	6.8	6.8	4.0	3.6	2.6	11.2	3.5	2.7	1.0	33.4	3.0	5.9	0.9	3.9	7.0	4.8	1.1	4.1	0.8	5.3	4.3	1.4	1.7	0.3	1.3	0.6	4.5	2.2	10.0	23.7	52.0	4.9	2.2	2.3	8.9	23.3	5.8	0.7	10.7	11.4	4.2	1.0	1.6	9.9	0.4	13.2	3.6	5.1	0.7	0.1	0.2	0.3	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.7	0.8	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.8	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.2	1.6	0.0	0.1	0.6	0.1	0.0	3.8	0.6	0.1	1.0	0.0	1.0	0.9	810.2	1.3	0.0	0.8	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	5.0	6.8	4.0	3.9	7.0	5.3	4.3	4.5	5.8	4.2	5.1	2.3	3.2	2.0	0.0	2.0	5.7	0.6	0.4	1.8	5.1	3.0	2.3	1.0	8.6	0.8	3.7	0.0	0.9	1.5	0.7	1.9	1.2	161.6	2.6	1.0	7.2	1.8	1.3	0.0	1.4	0.5	61.5	1.5	2.6	0.0	1.8	0.4	1.3	1.3	8.4	0.0	1.4	2.0	0.6	9.6	387.6	1.8	1.1	7.2	0.0	0.3	227.2	1.0	0.0	0.0	0.5	1.5	2.6	0.2	0.8	0.8	2.1	1.2	11.9	0.0	77.5	4.5	6.2	2.0	1.1	5.8	0.4	1.3	1.0	2.0	0.5
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446167	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Fibroblasts: 32.3;Leydig cells: 22.7;Peritubular cells: 31.6;Skeletal myocytes: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 4.2;ASC TERT1: 2.8;HSkMC: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	7.8	1.4	1.2	1.6	1.2	0.0	4.7	1.2	2.6	23.1	0.0	8.6	1.2	16.5	10.2	6.0	6.3	14.0	7.0	0.8	1.8	5.5	1.2	10.8	1.2	1.1	1.8	20.9	0.8	0.1	1.1	7.2	0.9	9.5	4.2	0.1	2.5	3.2	0.6	3.2	3.8	12.0	0.6	9.7	9.0	1.7	1.8	0.4	3.8	6.6	0.5	10.3	10.3	1.3	0.0	0.0	0.0	0.0	4.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.6	0.8	1.8	1.1	1.8	0.9	0.6	1.8	1.3	1.2	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	15.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.1	0.2	6.5	0.5	0.0	0.0	1.0	0.0	0.3	32.3	0.0	0.6	0.0	2.0	0.0	0.0	0.1	1.7	4.4	0.0	0.0	0.0	3.2	0.5	22.7	0.3	5.4	6.5	0.0	0.3	0.0	2.5	0.7	0.0	0.0	31.6	0.2	0.1	0.0	2.8	0.0	1.2	6.6	15.2	9.9	0.0	0.1	0.6	3.0	0.0	0.7	5.7	0.0	0.1
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109238	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 54.2;Hepatocytes: 140.0;Leydig cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.2;HSkMC: 43.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	15000000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	38.3	72.5	3.4	12.2	3.3	8.2	36.5	2.6	3.1	38.6	7.1	28.8	7.6	30.2	6.3	17.5	40.8	11.7	18.4	2.7	4.0	20.1	141.9	33.1	9.5	7.4	5.0	49.4	36.7	8.0	17.5	5.1	4.4	29.3	8.7	1.5	33.7	6.9	11.0	18.1	26.3	13.7	3.7	32.3	27.5	6.1	3.9	6.9	21.7	6.0	7.7	38.1	27.5	3.3	3.0	7.7	0.7	7.9	22.4	38.2	5.4	4.9	22.7	5.0	14.8	4.9	13.4	1.3	4.1	4.1	5.0	6.4	2.1	8.1	1.9	12.0	0.4	4.8	8.5	11.4	18.7	1.0	21.9	43.1	15.7	3.0	9.3	23.3	5.3	2.8	3.6	3.1	3.1	0.1	0.7	0.9	1.4	0.6	0.2	2.7	0.0	1.0	13.1	13.2	0.6	1.7	16.7	2.0	2.8	1.3	1.9	4.1	5.0	4.3	7.7	4.9	0.9	2.3	1.0	0.2	8.1	3.4	2.0	3.8	0.7	4.0	0.6	1.1	0.3	1.2	0.6	0.5	0.8	0.5	0.4	0.4	5.4	0.3	1.3	0.4	0.4	0.4	3.4	3.3	2.6	3.1	2.7	4.0	7.4	5.0	4.4	3.7	3.9	3.3	11.0	16.0	38.6	7.5	8.4	3.8	15.4	16.4	25.6	0.5	15.6	14.5	2.6	30.0	24.6	5.5	2.1	0.2	7.3	8.3	1.9	36.3	0.1	7.9	22.6	14.6	4.2	7.8	10.2	54.2	0.4	29.0	27.5	10.4	3.8	13.8	25.0	140.0	3.6	0.0	1.3	7.7	10.2	10.0	4.9	3.0	55.6	10.2	3.6	14.0	13.3	4.0	21.6	2.0	0.4	25.8	9.7	20.3	8.0	10.2	9.3	8.2	15.9	1.1	0.0	11.8	10.1	0.6	0.9	8.5	3.1	0.1	9.7	13.6	9.5	8.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 4761.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	585.2	286.5	46.0	194.3	53.7	1.5	213.9	47.8	46.0	237.5	31.5	128.9	22.9	82.9	41.1	76.4	350.3	354.9	221.6	36.5	81.8	51.4	4761.3	176.0	68.2	143.3	99.2	228.1	182.7	17.9	21.8	17.7	116.4	35.4	76.5	11.7	155.6	57.4	36.6	51.4	156.4	123.0	89.9	7.1	107.9	41.1	103.4	34.1	92.4	52.0	126.4	363.3	101.3	121.9	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	46.0	53.7	47.8	46.0	36.5	81.8	143.3	99.2	116.4	89.9	103.4	121.9	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 115.8;liver: 336.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	27.9	115.8	0.2	10.6	1.6	0.4	15.7	0.3	2.2	12.6	0.2	31.3	7.5	16.9	11.8	2.6	29.9	2.3	21.8	0.5	1.2	43.1	336.8	14.9	4.5	5.8	1.9	57.5	23.0	0.6	20.6	0.5	2.3	11.1	3.7	5.5	14.2	0.0	1.7	1.7	17.0	0.0	0.5	15.3	11.7	4.1	1.7	4.2	44.5	0.0	2.9	23.1	4.1	1.4	0.0	0.3	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.7	0.2	0.1	0.1	0.4	0.0	58.5	0.5	0.0	0.3	1.0	0.0	0.0	0.0	72.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	17.1	33.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.3	2.2	0.5	1.2	5.8	1.9	2.3	0.5	1.7	1.4	0.0	9.6	46.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	8.3	2.8	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	4.4	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 221.5;liver: 385.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 103.9;Cardiomyocytes: 71.8;Club cells: 22.9;Fibroblasts: 53.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 129.8"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	29.7	221.5	4.0	0.4	2.5	0.6	15.9	2.5	2.3	10.3	2.4	27.3	2.0	16.6	0.0	2.2	24.0	5.9	22.7	3.2	13.3	39.8	385.2	13.6	2.7	7.1	12.4	56.5	25.1	1.1	20.1	1.6	7.7	10.2	6.0	2.5	21.0	1.2	1.3	1.1	16.6	9.7	9.9	16.3	10.3	3.1	11.8	7.5	49.1	0.2	4.3	18.5	3.7	11.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	21.0	7.8	0.5	0.0	26.2	0.1	0.0	0.0	2.6	0.0	0.0	0.0	129.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	2.5	2.3	3.2	13.3	7.1	12.4	7.7	9.9	11.8	11.6	0.0	3.2	103.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	71.8	1.5	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.2	0.0	53.9	0.0	0.0	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.5	8.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 1918.6"	"Group enriched"	"Detected in many"	14	"Alveolar cells type 1: 493.6;Alveolar cells type 2: 660.8;Hepatocytes: 1020.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.5"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 37.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	28000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	1.4	0.7	0.4	2.5	0.2	0.1	4.5	0.7	0.2	6.3	0.0	1.7	0.0	4.5	0.0	0.1	1.0	3.2	0.2	0.1	0.7	0.6	1918.6	173.3	0.3	0.4	0.2	1.5	9.6	0.2	0.1	0.7	0.5	0.1	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.1	0.1	1.2	0.4	0.3	0.3	0.0	0.1	0.0	1.1	0.1	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	37.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.7	0.2	0.1	0.7	0.4	0.2	0.5	0.1	0.3	0.4	0.0	493.6	660.8	0.0	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.4	0.2	41.5	22.5	0.0	0.0	0.0	0.0	3.2	0.0	11.2	0.3	18.0	7.6	1.9	0.0	21.5	0.7	18.7	0.0	1.1	0.0	48.8	3.8	0.0	22.1	1020.8	0.2	0.0	1.4	0.3	0.0	39.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.6	32.0	0.0	0.0	0.3	0.1	0.1	3.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	3.9	16.7	0.2	1.4
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 471.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 597.6"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	NA	NA	265000000000	1100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA000925: , HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	3.0	0.1	0.0	3.4	0.0	0.0	1.8	0.0	0.1	2.8	0.0	3.6	3.8	0.1	0.0	0.2	0.5	3.1	0.1	0.0	0.0	0.4	471.3	1.5	0.4	0.0	0.0	44.2	9.1	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.5	0.0	0.1	0.2	4.4	0.6	0.0	0.4	8.4	0.7	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	5.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	46.2	151.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	12.8	2.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	7.3	2.2	0.5	54.3	3.2	0.0	0.0	1.0	0.2	10.2	1.9	11.4	4.1	0.7	0.1	0.8	1.8	8.0	0.1	88.8	0.3	3.4	5.6	0.8	0.0	0.3	9.7	597.6	2.1	0.0	0.2	5.6	0.0	13.1	0.3	2.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	69.2	15.9	0.0	0.1	0.2	4.3	0.0	2.2	0.0	0.0	1.1	0.4	0.1	0.4	0.0	0.0	0.1	1.1	143.8	4.8	0.1
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 433.7"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	2.9	1.7	2.5	1.1	3.4	2.2	2.5	2.4	2.6	3.0	3.5	2.8	3.9	2.7	2.7	1.6	3.0	1.5	1.3	2.2	2.6	4.8	433.7	7.0	2.1	2.9	2.9	3.3	14.9	2.6	3.1	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	3.9	1.9	2.8	1.5	5.8	1.6	2.8	1.2	2.0	1.2	1.7	2.6	2.1	4.5	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.4	2.6	2.2	2.6	2.9	2.9	3.2	2.8	2.8	4.5	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 665.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	12.8	1.1	0.2	0.0	0.2	0.0	5.4	0.2	0.1	0.8	1.6	0.8	0.9	0.4	0.9	0.3	43.9	12.0	57.1	0.2	0.6	4.4	665.9	3.2	0.4	0.0	1.7	6.2	42.7	0.1	0.7	2.8	0.2	0.9	0.6	0.0	0.9	0.6	0.6	0.6	1.4	0.9	0.1	0.3	2.2	4.2	0.8	0.6	2.0	0.7	0.5	0.9	0.6	0.6	0.0	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.6	0.0	1.7	0.2	0.1	0.8	0.6	0.8	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.9	127.2	7.5	0.0	0.0	0.0	0.1	0.3	0.0	9.3	11.3	37.5	0.8	0.9	0.0	8.0	1.4	0.4	0.0	6.7	0.0	0.7	0.0	0.1	5.0	376.9	0.0	0.0	2.7	1.0	0.0	9.7	0.3	54.8	120.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.5	1.3	0.4	0.0	0.0	11.6	0.8	58.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.4	0.5	0.6	0.0
C7		ENSG00000112936	"Complement C7"	P10643	5	40909497-40984643	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 735.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1"	"Cancer enriched"	"Detected in all"	4	"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 13.7"	HPA001465	Approved				"Secreted to blood"	NA	NA		48000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	470.9	607.7	2.6	21.7	3.5	0.2	46.4	2.6	9.6	118.5	13.6	165.3	19.3	124.6	163.6	52.9	377.3	211.7	558.7	2.8	2.5	298.1	110.6	206.7	99.2	4.4	2.7	735.4	149.8	15.0	23.1	359.2	3.0	101.6	32.5	1.5	18.0	105.7	4.3	12.6	139.8	256.3	4.3	138.2	120.2	28.0	3.0	32.2	105.1	1.6	22.5	122.1	118.3	3.0	0.0	0.0	0.0	0.0	116.5	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	155.1	0.0	0.0	212.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	146.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.5	2.6	9.6	2.8	2.5	4.4	2.7	3.0	4.3	3.0	3.0	7.9	6.4	4.1	0.0	1.4	0.6	0.5	0.0	1.8	2.1	1.2	0.3	56.7	7.2	2.5	0.0	0.0	0.2	0.1	0.4	0.0	0.2	4.7	0.5	7.9	127.6	54.8	26.7	0.1	1.3	0.1	578.4	0.0	0.2	1.3	2.7	662.5	8.3	0.5	43.7	0.3	1.3	0.0	14.5	4.2	29.8	1058.5	1.5	0.0	58.1	0.6	3.7	0.0	0.0	0.0	0.9	0.9	18.0	1.0	1.3	0.2	0.1	0.0	0.9	309.0	2.2	23.7	2.6	2.5	6.5	0.6	0.3	1.2	503.1	3.0	0.8
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	195	"liver: 635.7"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	635.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 840.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 295.1"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	840.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	1.0	0.0	0.1	0.0	5.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	7.1	295.1	0.1	0.0	0.1	0.0	0.0	7.6	0.0	11.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 564.4"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1134.7"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HMC-1: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.3	1.5	0.1	0.0	0.1	0.0	0.3	0.1	0.3	0.3	0.0	1.2	31.2	0.4	0.9	0.5	0.4	2.5	1.3	0.1	0.1	2.3	564.4	0.3	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.4	0.3	0.0	0.4	0.1	3.1	0.3	17.8	0.0	0.1	2.1	1.3	2.3	0.1	0.2	0.7	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	41.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.0	0.0	0.3	2.3	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.7	28.6	0.3	0.0	2.1	0.4	1.1	25.0	0.0	0.2	0.9	0.1	0.1	0.7	1.8	8.0	0.2	0.8	1.0	0.1	0.0	0.3	8.9	1.2	17.5	1134.7	0.3	0.0	0.2	5.0	0.0	25.3	0.2	1.5	0.0	0.2	0.0	0.0	0.0	1.1	4.1	0.5	0.1	0.5	4.7	0.7	0.0	0.4	122.3	6.7	0.1	0.5	0.0	0.3	0.3	0.7	0.6	0.5	0.4	3.4	1.8	0.2	2.0	0.2
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39424868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	288	"liver: 1397.0"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 1962.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"JURKAT: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	64000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1397.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.8	2.0	0.0	18.7	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.5	1962.3	1.2	0.0	0.1	0.2	0.0	52.6	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.1	3.7	1.7	0.0	0.0	0.3	3.0	0.0	0.0	0.1
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1798.9;intestine: 2109.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	2.0	0.4	0.4	0.5	0.3	1798.9	2.1	1.0	1.5	0.3	0.0	1023.3	0.2	1.6	0.1	0.7	2.2	0.3	1.6	0.2	0.2	2.0	6.7	5.9	0.2	0.3	0.3	0.4	0.3	0.1	1.9	20.7	0.3	0.4	2109.9	0.4	1.1	1.8	1.0	1.4	1.8	30.7	0.1	35.4	2.3	0.2	0.5	0.5	0.9	3.4	0.1	0.4	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.4	0.3	1.0	1.5	0.2	0.2	0.3	0.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463968-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 687.4;stomach 1: 1108.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1773.2;Erythroid cells: 2448.1;Gastric mucus-secreting cells: 1380.7;Muller glia cells: 1536.4;Paneth cells: 781.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 263.8;HEK 293: 1097.8;THP-1: 461.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001550, CAB010102"	Enhanced					NA	Yes		570000000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	7.4	10.1	95.9	36.8	127.5	246.8	37.9	122.1	143.8	5.0	444.0	687.4	285.2	2.9	10.6	19.8	2.7	112.7	15.9	105.2	107.8	331.2	273.5	43.1	6.6	115.5	112.0	0.4	55.1	10.1	6.1	19.6	114.2	1.9	643.6	390.4	74.7	68.4	42.7	81.0	31.3	32.3	98.2	8.4	1108.7	21.2	115.6	5.1	15.9	62.8	4.3	2.9	5.2	145.5	3.7	2.8	12.2	0.0	0.1	0.0	31.2	0.0	0.0	0.0	0.0	15.1	0.9	0.0	9.5	0.0	0.1	263.8	37.4	13.2	0.0	0.0	1097.8	35.8	17.0	0.5	0.0	23.7	5.1	0.0	63.9	0.0	3.7	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.4	41.4	3.7	86.5	0.0	21.2	1.3	0.5	3.7	8.8	0.2	0.3	5.0	0.0	0.1	9.6	0.0	461.5	0.0	0.0	6.6	0.0	0.4	0.4	1.0	0.1	1.8	0.1	0.0	51.2	5.3	8.6	0.2	15.0	7.4	1.3	0.1	0.8	15.4	3.0	0.0	0.0	12.6	0.1	13.4	1.4	0.0	33.3	95.9	127.5	122.1	143.8	105.2	107.8	115.5	112.0	114.2	98.2	115.6	145.5	19.4	16.0	79.9	34.0	19.6	90.6	1.3	152.5	17.6	23.1	56.9	18.4	19.8	430.4	22.4	161.8	64.6	15.2	2.4	1773.2	348.3	60.1	65.9	3.3	1.3	26.7	30.5	2448.1	1.4	11.3	403.1	6.4	1380.7	8.3	15.9	0.4	4.2	135.6	35.4	13.5	22.3	116.0	10.2	11.0	216.5	232.1	3.4	51.8	74.7	6.5	6.6	1536.4	1.0	3.0	226.4	16.1	781.9	2.2	10.3	3.5	0.3	468.2	3.9	66.1	0.0	12.1	8.2	3.1	2.8	31.2	111.7	17.1	11.7	0.7	390.8	0.5
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 5273.7"	"Group enriched"	"Detected in many"	8	"Erythroid cells: 221.3;Skeletal myocytes: 304.0"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 47.3;RH-30: 78.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced					NA	NA		53000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favorable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	43.4	3.8	2.4	0.3	2.3	9.9	6.4	2.7	3.7	5.1	1.4	1.7	1.8	8.3	2.1	64.8	9.8	2.2	19.5	2.3	2.8	3.7	2.4	24.6	0.4	2.9	2.3	1.4	1.3	1.0	3.8	0.3	2.0	89.5	1.1	5.5	15.4	2.7	5273.7	5.2	4.4	19.1	2.5	0.8	4.1	2.9	2.5	1.4	3.0	1018.8	0.6	1.5	5.5	2.8	2.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.5	0.2	47.3	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	78.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.4	2.3	2.7	3.7	2.3	2.8	2.9	2.3	2.0	2.5	2.5	2.8	0.3	3.2	4.2	2.3	0.1	0.5	1.7	0.6	1.2	0.0	14.5	0.6	1.0	5.7	0.6	0.0	6.2	1.1	0.4	0.4	0.0	0.6	24.1	0.4	0.2	2.2	0.0	221.3	2.2	0.2	0.2	9.1	0.0	0.7	0.0	0.2	2.5	0.3	0.4	0.0	2.5	0.4	0.0	0.3	0.4	7.0	0.3	2.5	0.0	0.0	0.0	29.6	0.0	1.5	0.7	0.2	1.7	0.0	0.0	0.5	8.5	0.6	1.0	1.6	0.0	304.0	5.1	0.6	1.3	0.2	1.0	1.6	1.4	0.3	0.9	0.3
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712842-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 188.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	Nucleoli,Cytosol		NA	NA		100000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	43.7	31.0	30.1	55.2	32.9	50.9	29.6	31.5	40.6	26.5	29.3	53.7	48.0	30.7	35.0	55.8	30.0	41.3	55.6	34.3	33.9	54.1	38.6	40.0	58.0	36.5	34.5	29.2	33.1	42.5	17.1	35.5	36.4	39.9	56.0	45.6	34.4	31.2	188.5	34.3	51.2	40.4	34.0	38.0	46.2	41.3	33.6	45.1	37.3	127.8	59.1	49.4	30.5	39.5	131.6	30.0	39.8	34.0	48.2	59.8	45.3	73.7	91.8	45.4	47.2	36.6	140.0	33.8	56.5	64.5	76.5	59.1	44.8	138.5	91.9	142.1	35.1	90.5	36.9	39.5	40.9	126.6	100.8	42.5	79.1	58.5	128.4	51.8	57.1	46.1	153.9	30.3	43.8	45.6	59.1	77.9	39.8	53.4	52.0	67.8	59.3	33.5	84.6	104.9	43.2	26.4	55.2	68.2	59.9	44.7	16.9	72.4	73.1	63.9	24.3	68.2	61.0	39.0	31.8	53.8	45.4	72.4	53.4	4.0	3.6	6.0	4.7	4.4	4.8	3.0	5.8	6.1	3.0	2.4	4.7	6.5	10.3	9.3	4.3	2.2	6.2	2.4	30.1	32.9	31.5	40.6	34.3	33.9	36.5	34.5	36.4	34.0	33.6	39.5	41.6	64.1	37.5	42.1	29.6	97.8	44.2	23.0	23.3	14.4	28.3	18.9	69.1	17.2	30.5	51.5	33.3	20.8	32.3	162.5	29.4	26.0	12.0	41.4	25.2	29.6	20.4	32.0	85.1	32.7	18.7	24.1	28.5	39.5	20.3	16.6	28.2	29.3	56.8	28.6	69.3	48.5	24.4	81.2	72.4	13.5	17.4	66.2	30.2	93.7	49.6	39.6	29.9	58.8	64.3	72.3	62.4	32.0	37.0	84.4	54.6	39.8	55.6	40.5	13.1	27.5	27.3	30.8	29.5	31.2	85.1	23.1	52.0	18.9	34.8	88.6
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444064	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 200.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 41.8;RT4: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954, HPA076632"	Approved		Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favorable (7.91e-4)"	"prognostic favorable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	23.7	37.4	25.0	4.4	26.4	2.2	37.3	21.0	20.7	14.5	68.2	57.7	6.0	15.3	16.3	31.2	18.3	16.5	22.0	24.6	38.7	14.0	5.3	19.5	4.2	24.6	35.0	21.5	12.0	29.2	8.4	12.4	25.1	41.4	11.6	14.8	16.9	22.5	7.5	16.1	12.5	11.5	27.4	4.0	27.1	33.4	31.4	9.4	9.7	13.0	5.2	26.5	17.3	28.4	1.6	1.7	9.8	2.8	9.3	8.7	14.8	9.3	17.9	5.9	4.1	41.8	6.0	14.2	1.2	6.5	6.5	3.4	5.4	6.2	10.2	4.7	4.5	3.7	2.0	2.6	5.2	3.3	1.6	6.4	4.8	4.4	6.8	7.3	8.0	2.2	0.7	3.2	8.1	2.8	3.2	2.4	7.6	5.4	2.7	2.8	1.3	2.3	8.3	43.4	1.2	3.7	5.1	11.8	12.1	11.8	18.4	4.9	7.6	2.5	2.7	5.3	7.6	2.5	2.3	16.3	2.8	2.5	5.7	6.7	2.6	5.4	2.6	2.4	2.0	2.7	3.2	3.4	2.6	1.6	2.3	2.3	5.6	1.9	2.1	0.4	3.6	2.3	25.0	26.4	21.0	20.7	24.6	38.7	24.6	35.0	25.1	27.4	31.4	28.4	6.9	16.0	11.9	52.2	2.4	3.1	12.6	6.6	7.4	6.4	27.1	14.4	14.5	4.3	13.4	11.0	6.2	26.4	3.1	3.9	11.7	10.1	200.0	8.3	9.2	5.4	2.4	1.7	45.0	10.6	14.0	42.5	5.6	3.7	4.5	4.2	3.9	1.9	6.4	1.7	32.4	2.4	16.2	3.5	4.7	32.1	15.5	5.0	12.4	24.4	5.6	14.9	7.2	50.3	43.3	10.3	2.0	11.7	4.6	16.7	0.8	5.0	17.7	5.2	6.6	9.4	16.8	46.0	5.0	16.0	4.4	29.0	3.6	3.9	2.3	21.7
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	27.2	28.7	28.9	15.5	29.1	30.9	24.3	33.3	40.9	33.3	32.6	37.0	13.6	32.4	8.7	23.4	35.9	10.1	30.9	28.8	25.6	36.0	28.2	28.5	19.6	28.0	27.5	27.3	28.1	15.6	46.2	8.2	28.1	34.0	8.4	13.3	22.1	14.1	17.4	24.7	33.1	11.0	23.1	37.2	31.9	34.4	29.2	19.5	50.3	7.0	10.0	29.7	27.1	28.9	24.7	17.7	23.6	20.8	20.9	24.1	33.3	20.4	17.5	16.0	18.1	22.0	11.9	28.6	11.0	20.5	20.8	23.1	28.4	18.5	14.2	48.3	27.8	24.6	21.1	46.8	9.9	57.1	25.6	20.5	11.6	19.6	14.7	19.2	27.1	25.1	52.1	15.2	9.2	32.0	27.1	62.1	14.7	34.5	12.6	26.3	17.3	36.0	14.6	24.8	30.2	25.9	25.2	17.4	26.1	21.3	15.6	25.6	22.3	37.0	28.6	14.3	14.9	26.5	17.1	16.9	17.3	27.3	15.8	7.2	3.9	15.5	5.7	2.7	6.3	2.5	4.3	7.5	2.6	4.1	5.2	4.8	17.4	5.4	1.9	3.0	3.7	2.5	28.9	29.1	33.3	40.9	28.8	25.6	28.0	27.5	28.1	23.1	29.2	28.9	14.5	22.4	37.5	37.5	22.7	8.3	8.9	11.0	13.1	33.3	14.2	10.8	18.5	4.3	9.1	9.2	89.6	17.4	24.6	19.9	7.9	11.6	16.6	43.6	19.6	15.1	14.8	18.3	54.2	9.7	6.9	16.4	29.6	26.8	17.7	21.1	13.2	9.4	21.7	33.7	39.4	13.0	20.3	12.6	16.2	16.0	21.5	16.1	10.6	20.6	19.2	14.5	44.3	21.1	35.9	10.8	6.6	19.9	24.4	7.1	8.8	7.9	24.4	50.1	19.7	14.6	32.6	60.7	41.6	13.6	9.5	22.4	36.5	18.4	13.8	7.3
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 154.3;U-266/70: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	17.1	3.3	63.9	2.1	67.9	2.6	13.8	36.8	54.8	6.9	17.1	5.2	7.5	9.4	3.2	6.9	10.9	5.2	4.6	44.9	53.5	13.1	9.9	21.5	2.8	39.6	59.0	3.7	3.0	21.9	4.0	10.4	40.8	3.7	5.1	8.0	22.3	4.5	1.5	17.2	6.7	6.6	31.2	3.7	14.5	3.5	70.2	4.9	15.0	1.8	2.3	5.4	7.8	33.3	13.1	14.4	11.8	0.9	7.1	0.3	20.4	3.1	17.3	4.2	2.5	9.5	23.0	0.7	13.3	14.9	42.3	11.4	9.0	2.3	3.2	0.3	19.4	1.0	38.7	37.1	6.2	2.5	1.0	4.2	2.1	5.3	6.1	26.8	47.1	2.3	0.5	16.2	11.7	30.2	0.1	8.8	7.5	64.5	46.6	3.1	42.2	50.6	21.2	31.5	11.2	8.2	26.1	32.5	154.3	8.3	52.4	7.2	79.3	47.9	0.5	1.6	3.8	216.0	88.9	27.4	0.2	19.2	16.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	63.9	67.9	36.8	54.8	44.9	53.5	39.6	59.0	40.8	31.2	70.2	33.3	2.9	22.4	27.4	258.2	3.8	5.1	2.0	1.4	5.2	4.1	9.2	6.7	1.4	7.2	2.3	3.7	29.2	0.9	1.3	8.5	1.9	1.1	2.0	11.6	4.4	6.0	3.5	1.3	19.2	2.3	1.1	4.1	10.2	54.3	0.0	14.8	25.0	9.3	16.6	0.0	22.2	4.6	0.0	3.5	3.1	3.5	0.0	4.7	28.4	41.2	0.0	1.4	0.0	163.3	1.4	2.4	5.2	6.0	3.6	0.6	6.7	14.3	1.8	18.7	0.0	5.0	2.1	0.2	3.2	1.6	6.7	0.3	1.4	0.5	2.1	2.2
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 99.3"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 101.4;Enteroendocrine cells: 214.1;Excitatory neurons: 318.3;Horizontal cells: 249.0;Inhibitory neurons: 372.1;Oligodendrocyte precursor cells: 271.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	4	"cerebellum: 99.3;cerebral cortex: 30.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 45.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in all"							"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	1.0	2.3	15.4	0.3	15.8	0.1	0.9	99.3	30.4	0.6	0.0	0.7	1.2	0.8	1.1	0.2	3.2	0.1	0.6	15.1	6.8	0.5	0.2	0.2	0.4	7.2	11.2	0.9	2.6	0.1	4.2	0.0	10.6	0.4	0.4	7.1	0.2	0.1	0.5	0.3	1.7	0.2	9.4	0.6	2.7	2.3	11.3	0.1	0.7	0.1	0.2	0.3	0.7	15.2	0.0	0.1	0.1	6.0	0.2	0.2	0.0	2.2	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.2	5.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	2.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.1	0.2	1.4	0.1	0.3	0.6	0.0	0.1	0.0	0.1	45.1	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.1	0.9	0.2	0.1	0.0	0.0	0.0	23.9	0.1	0.6	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	15.4	15.8	99.3	30.4	15.1	6.8	7.2	11.2	10.6	9.4	11.3	15.2	7.7	6.4	3.2	31.3	9.6	0.6	3.4	0.0	0.0	101.4	3.1	7.4	2.8	0.0	1.3	1.8	16.7	0.0	2.9	0.6	0.0	0.5	27.1	1.2	6.3	6.5	214.1	0.4	318.3	0.4	0.2	4.7	10.7	2.6	1.3	5.2	1.8	1.2	0.5	249.0	372.1	5.0	4.1	1.9	1.4	28.0	1.2	2.1	0.0	28.1	1.2	3.0	4.1	271.9	11.5	1.5	0.1	0.4	0.5	0.8	0.2	2.0	3.7	7.0	0.0	5.1	17.6	4.3	7.1	0.4	0.1	0.3	2.0	2.5	1.0	0.9
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;pituitary gland: 6.8;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 388.8;Inhibitory neurons: 330.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 5.9;basal ganglia: 7.8;cerebral cortex: 10.2;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.0	2.8	5.9	0.1	7.8	0.0	0.0	0.8	10.2	0.3	0.0	0.4	0.0	0.0	0.6	0.0	3.1	0.4	0.3	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.8	0.0	0.0	0.5	0.1	3.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.3	5.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	3.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.8	0.8	10.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	43.4	0.0	0.0	0.1	0.0	0.0	11.7	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.2	0.1	0.0	0.0	388.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.7	330.9	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	17.8	0.6	1.7	0.0	16.1	10.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	8.2	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.1	6.6	7.0	0.2	4.3	0.7	1.8	2.3	10.4	6.0	0.0	1.5	1.7	3.7	7.3	0.5	7.7	2.0	0.6	3.6	0.8	2.2	1.0	3.7	0.1	0.0	1.2	0.5	2.8	1.2	3.5	0.6	0.4	3.0	1.5	4.3	0.5	1.8	0.2	0.7	2.4	0.7	3.5	1.8	0.8	1.6	6.1	0.2	2.9	0.2	0.1	0.6	0.1	6.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.1	0.1	0.0	0.4	0.9	0.0	0.0	0.2	55.5	0.5	3.6	4.7	2.1	0.3	10.1	1.1	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	4.3	2.3	10.4	3.6	0.8	0.0	1.2	0.4	3.5	6.1	6.0	0.6	3.2	36.2	7.8	0.6	0.9	0.8	4.6	2.2	33.3	7.2	1.8	2.3	10.0	9.1	1.8	35.5	0.9	0.5	3.0	0.0	7.2	4.9	4.3	40.1	2.4	59.4	2.7	251.2	2.3	0.2	3.4	5.1	3.3	12.6	1.7	0.0	3.4	0.2	8.4	354.1	3.8	2.0	0.8	4.0	8.3	4.4	2.1	5.4	126.5	0.5	4.0	0.0	197.5	29.9	3.8	5.6	27.1	0.1	1.7	9.5	2.7	9.5	12.9	0.0	0.2	8.6	1.0	3.7	0.5	1.0	0.3	1.7	9.6	7.6	0.9
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"retina: 125.3"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 66.5;Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 97.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA068379	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.2	0.4	0.7	0.4	0.7	1.9	0.7	2.3	1.4	0.2	0.8	0.6	0.8	0.2	1.0	0.2	0.5	0.2	0.2	0.8	0.4	0.3	0.0	0.6	1.3	0.4	0.1	0.3	0.6	0.0	0.1	0.0	0.5	0.1	0.7	125.3	0.6	0.4	0.0	1.0	1.6	0.2	0.0	0.8	0.6	0.2	0.4	0.8	0.4	0.0	0.5	0.2	0.1	0.8	0.1	0.7	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.8	0.4	0.5	0.4	0.5	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.1	0.3	1.3	0.1	0.0	0.7	0.7	2.3	1.4	0.8	0.4	0.4	0.1	0.5	0.0	0.4	0.8	0.2	0.0	0.5	0.0	1.1	0.0	0.1	0.1	0.0	66.5	1.1	0.9	1.9	0.0	0.0	1.8	133.5	0.1	2.8	0.2	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.4	0.9	0.2	0.2	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.2	6.7	0.4	2.3	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	7.4	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.4	0.1	0.1	97.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.3	0.1
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.5;cervix: 9.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 176.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6;testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.2;GAMG: 3.2;HeLa: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"			"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	1.6	0.2	7.1	0.2	5.3	0.3	1.0	19.3	9.9	9.9	0.0	0.4	0.2	2.8	0.1	0.4	3.4	0.2	3.6	2.6	10.3	0.0	0.0	0.3	0.3	4.1	19.4	5.4	0.1	0.0	0.2	0.4	1.4	1.1	0.1	8.8	0.3	0.4	0.1	1.4	0.1	0.6	12.8	0.1	0.2	0.6	37.5	0.1	0.3	0.1	0.2	0.1	3.7	6.2	0.0	9.2	2.1	2.4	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.8	0.2	0.0	0.6	0.1	3.2	0.3	1.1	0.0	0.2	1.1	0.4	0.6	3.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.7	0.5	0.4	1.0	0.8	0.0	0.0	0.1	2.7	1.1	1.8	0.1	0.0	1.5	0.0	0.1	0.2	0.8	2.5	0.3	0.1	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	5.3	19.3	9.9	2.6	10.3	4.1	19.4	1.4	12.8	37.5	6.2	0.2	0.0	0.0	0.3	0.0	1.9	0.2	0.0	0.6	176.7	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.6	11.2	0.6	0.0	0.0	16.0	0.0	0.6	4.5	0.0	0.6	0.0	0.1	0.0	0.0	0.4	5.0	21.5	0.0	0.0	0.0	5.7	0.2	0.0	0.9	3.6	1.0	0.0	2.3	0.0	22.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.0	0.3	3.7	0.7	0.9	0.8	2.8	0.1	0.3	0.0	0.1	0.1
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689735	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;thyroid gland: 5.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.9;Excitatory neurons: 16.8;Inhibitory neurons: 12.3"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 1.9;T-47d: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066992			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Cell Junctions"	"HPA066992: "	"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.2	3.3	5.0	0.8	5.6	0.6	0.1	1.5	9.7	0.1	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.1	0.0	8.7	1.3	0.1	0.0	0.5	1.9	7.6	1.4	0.0	0.1	0.0	0.3	0.0	7.9	0.1	0.0	2.6	0.1	0.0	0.0	0.2	3.3	0.0	0.7	1.5	0.6	0.8	2.2	0.2	5.3	0.0	0.5	0.4	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.0	5.6	1.5	9.7	8.7	1.3	7.6	1.4	7.9	0.7	2.2	4.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.4	16.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	3.3	12.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	1.0	2.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.1
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443777	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.7;tongue: 98.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		390000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	11.6	14.5	9.8	4.3	11.9	0.0	4.1	1.2	15.4	5.3	0.0	13.0	5.1	7.4	2.4	5.3	3.9	6.4	31.3	18.8	13.3	8.4	1.3	3.4	1.9	4.6	26.0	7.9	1.5	1.2	6.3	4.2	9.5	13.7	5.1	8.3	2.6	6.4	78.7	4.7	3.4	12.2	8.1	4.4	5.6	3.7	34.2	3.9	18.9	98.5	3.1	7.1	3.4	12.8	0.0	12.7	10.6	0.0	18.2	22.9	0.0	23.4	15.0	11.4	11.1	0.0	3.5	0.0	0.0	20.4	14.1	0.0	11.2	0.0	14.8	0.0	15.0	0.7	14.4	0.0	11.9	5.3	0.0	13.6	0.1	39.6	0.1	127.4	54.9	0.0	0.0	0.2	25.7	0.1	0.0	0.0	12.6	0.0	5.0	2.3	2.1	0.0	0.9	0.9	21.1	62.3	4.6	0.1	0.0	11.1	0.1	0.0	39.6	20.1	15.0	20.1	0.0	0.1	0.0	0.0	16.9	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.9	1.2	15.4	18.8	13.3	4.6	26.0	9.5	8.1	34.2	12.8	6.3	0.0	1.7	137.1	0.0	5.7	4.5	0.1	8.0	47.7	6.6	3.9	88.0	0.0	1.3	7.3	18.8	0.1	0.1	0.0	0.0	0.0	64.2	0.5	20.7	6.8	38.8	0.0	543.1	0.0	0.0	20.6	14.3	0.4	25.3	29.9	1.4	0.4	0.2	25.2	383.3	2.6	16.2	0.0	2.9	42.4	10.2	0.4	1.8	87.1	0.6	5.6	0.0	357.9	662.8	0.8	0.0	6.0	0.2	11.2	0.0	9.5	0.7	6.1	6.6	17.6	21.5	1.5	1.9	1.9	6.5	0.1	0.4	32.7	0.2	1.4
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175012027	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 191.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	26.5	22.6	60.7	25.5	63.4	33.8	20.6	66.8	191.9	21.8	48.5	25.6	15.9	19.1	24.4	23.8	17.4	14.7	26.8	66.3	65.6	27.2	25.7	23.7	32.7	60.8	61.8	34.8	15.9	20.5	26.9	22.8	66.8	15.3	20.7	52.5	17.5	18.5	37.7	17.4	19.1	16.4	57.8	24.1	20.3	30.5	58.7	27.9	14.9	27.4	28.9	28.0	20.4	71.9	127.7	85.6	124.0	53.1	40.2	44.8	79.5	94.7	55.6	119.8	86.8	88.9	76.9	132.8	96.0	67.5	85.8	67.3	155.0	69.4	122.7	70.6	92.4	99.6	80.8	96.3	30.1	135.4	59.9	30.3	42.2	98.7	58.8	62.0	85.5	117.0	203.7	72.2	87.0	47.4	208.2	121.5	118.0	189.1	39.4	93.6	87.9	152.5	85.4	99.8	84.9	81.4	64.7	111.0	106.3	165.7	86.8	116.6	44.9	67.9	73.3	96.0	153.8	68.6	211.5	301.8	57.1	117.1	80.6	34.0	25.5	27.9	29.4	41.7	35.4	43.0	42.0	36.2	32.3	33.7	44.6	39.9	14.6	43.7	54.9	28.3	48.7	46.1	60.7	63.4	66.8	191.9	66.3	65.6	60.8	61.8	66.8	57.8	58.7	71.9	70.6	86.6	41.9	13.1	82.1	117.0	183.6	102.2	63.7	57.7	61.8	79.0	108.1	40.0	62.7	35.0	62.6	238.8	68.7	66.2	152.6	96.8	102.2	124.5	67.6	80.0	119.6	113.0	22.4	95.0	304.1	92.8	36.7	167.3	92.0	52.8	44.3	39.4	196.3	30.3	24.1	101.6	67.1	56.0	188.2	30.6	86.0	110.9	108.5	13.1	231.0	77.8	60.8	8.5	28.0	106.9	58.4	73.7	90.7	115.4	80.7	171.4	78.0	84.0	32.9	57.6	108.4	186.7	139.9	88.7	85.7	143.5	188.0	76.5	139.1	106.9
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 287.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.0;myeloid DC: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.1;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 294.7;WM-115: 187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		220000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	7.1	29.9	46.9	6.1	59.2	0.4	17.0	78.7	53.0	21.3	6.1	11.7	7.8	17.4	103.7	12.6	22.6	12.1	25.7	47.6	57.4	29.1	65.3	72.0	14.1	41.1	40.1	12.3	16.0	56.6	26.0	37.9	44.6	15.2	8.1	287.7	38.0	28.0	7.2	10.9	8.8	8.6	30.3	8.0	12.5	50.5	55.8	8.6	69.7	8.1	14.6	13.1	4.8	38.0	0.4	23.3	25.6	0.1	0.0	0.0	0.1	24.1	41.1	3.1	0.3	294.7	26.1	0.0	75.9	36.5	25.2	4.8	4.8	27.4	2.0	1.0	38.3	0.0	7.8	114.5	0.3	0.1	56.5	0.0	38.6	0.0	63.8	16.5	1.1	17.3	0.0	2.7	4.3	19.3	20.0	0.6	24.0	0.3	0.0	0.1	0.4	61.6	44.8	0.9	50.2	107.1	0.0	25.4	21.7	102.4	92.4	1.3	0.0	2.3	44.9	23.3	13.0	64.9	98.9	18.7	36.3	0.2	187.5	0.2	0.0	0.0	8.0	0.0	3.4	1.5	2.9	2.1	8.1	0.3	0.1	1.8	0.0	0.5	0.1	0.0	4.7	1.9	46.9	59.2	78.7	53.0	47.6	57.4	41.1	40.1	44.6	30.3	55.8	38.0	14.0	464.8	195.3	980.7	6.5	20.6	26.7	2.8	19.4	566.6	22.1	22.5	61.7	34.3	27.5	36.8	350.3	71.6	6.8	1.5	11.7	39.2	189.1	88.5	6.0	10.6	7.8	5.3	301.7	2.0	5.0	13.2	3.6	126.9	24.1	36.8	2.9	45.9	36.8	30.3	310.9	2.1	4.1	8.5	20.9	224.0	5.9	14.2	44.4	60.0	13.3	489.9	2.1	676.5	622.8	9.3	0.5	4.1	88.9	38.5	0.3	8.2	8.7	759.5	0.0	13.3	11.7	55.2	23.0	9.2	23.4	32.2	8.1	5.2	4.3	13.5
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875416	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.6;retina: 184.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 772.6;Cone photoreceptor cells: 627.6;Excitatory neurons: 830.8;Inhibitory neurons: 1152.7;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 11.5;SCLC-21H: 19.7;SK-MEL-30: 9.0;U-698: 13.2;U-87 MG: 20.5"									HPA059328	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059328: AB_2683982"	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	0.4	16.4	32.2	2.0	47.7	0.1	0.7	18.7	84.6	2.8	0.0	2.8	3.2	0.6	2.5	0.2	0.4	2.4	16.7	32.1	26.0	0.2	0.2	0.8	0.5	83.2	39.7	1.9	13.5	0.2	39.6	0.2	84.5	3.6	2.4	184.3	1.4	2.8	0.1	1.4	3.3	0.8	4.1	0.6	3.0	3.2	33.0	0.6	0.2	0.0	0.7	0.4	1.4	61.7	0.0	0.0	0.8	0.0	4.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	11.5	0.0	0.1	0.0	0.0	0.0	0.0	19.7	1.5	0.0	0.0	9.0	0.4	0.0	0.0	0.1	1.6	0.1	3.3	0.9	0.0	1.7	13.2	20.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	47.7	18.7	84.6	32.1	26.0	83.2	39.7	84.5	4.1	33.0	61.7	0.0	0.0	1.9	93.0	0.1	1.3	0.2	0.0	0.0	772.6	0.5	2.8	25.6	7.2	0.0	0.0	627.6	0.1	0.0	0.4	0.0	4.1	1.1	0.2	1.1	0.9	95.9	0.0	830.8	0.4	0.0	3.2	0.0	0.1	42.5	0.2	0.0	0.0	0.0	47.1	1152.7	5.0	0.0	0.0	1.6	2.1	15.2	0.0	8.8	30.0	0.0	21.3	0.0	266.9	27.0	0.9	1.3	2.6	0.0	0.3	0.7	0.1	0.0	64.7	0.0	3.2	1.2	0.2	0.7	0.0	0.1	0.0	0.4	36.9	1.8	0.2
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.9;thyroid gland: 20.7"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Group enriched"	"Detected in many"	4	"hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.5	0.6	0.2	0.1	1.4	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.3	6.8	1.0	0.8	0.1	0.1	8.9	11.6	0.1	1.5	0.3	2.2	0.1	18.9	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.3	0.1	0.1	0.3	1.0	0.0	20.7	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.6	0.3	6.8	8.9	11.6	18.9	2.3	1.0	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 70.7;lung: 76.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 173.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	70.7	6.3	3.4	12.3	4.0	0.4	15.8	6.1	4.4	27.8	3.4	6.9	6.0	21.5	4.6	8.6	11.4	24.4	20.4	3.9	3.8	14.0	12.6	76.8	7.9	11.1	6.2	15.7	4.3	13.0	3.6	11.7	10.8	7.3	9.5	0.9	7.1	7.7	6.2	3.9	6.3	27.1	15.5	8.6	7.1	2.7	3.9	4.6	28.3	20.2	9.1	14.1	4.7	15.2	0.2	0.0	8.8	0.0	6.2	1.6	0.0	0.8	1.3	0.1	1.0	0.0	1.0	0.0	2.3	0.7	0.2	0.0	0.0	0.6	0.2	1.5	0.5	1.5	0.0	0.2	4.9	0.2	0.0	4.6	0.2	0.3	2.1	0.5	173.6	0.1	0.0	2.5	1.2	0.0	0.8	0.1	0.5	0.0	0.0	0.0	3.1	0.5	40.5	0.0	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.2	25.3	0.7	0.1	0.1	0.4	6.2	0.1	0.7	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	9.2	0.0	0.8	0.1	0.1	1.0	1.0	2.6	0.0	0.9	3.4	4.0	6.1	4.4	3.9	3.8	11.1	6.2	10.8	15.5	3.9	15.2	138.3	0.0	11.9	19.6	1.2	9.3	2.3	1.7	21.6	0.2	0.8	1.8	12.3	2.8	3.6	0.0	0.0	0.4	2.4	0.0	3.9	0.3	0.8	3.1	92.7	248.7	0.0	4.8	15.4	0.4	0.2	56.5	1.1	1.7	5.1	12.3	259.2	1.8	0.9	0.0	2.1	0.0	2.0	10.3	29.7	1.0	7.8	15.4	10.6	47.8	16.1	0.0	1.0	293.0	1.0	0.1	0.0	2.6	4.9	1.9	0.0	13.2	2.8	0.1	6.6	4.1	21.5	1.3	0.7	18.2	6.8	0.3	3.0	6.0	0.0	1.8
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524961-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 507.1;skin 1: 179.0;vagina: 200.8"	"Cell type enriched"	"Detected in some"	8	"Squamous epithelial cells: 1257.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 150.9;head and neck cancer: 196.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0"	"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					NA	NA		1200000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.5	0.1	0.2	0.0	0.2	0.0	5.4	1.5	0.1	107.9	0.0	0.1	0.0	0.1	0.1	507.1	1.2	0.0	0.1	0.0	0.3	17.3	1.6	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.3	0.0	0.2	2.9	0.0	0.0	121.0	0.1	1.0	179.0	0.2	0.0	0.0	0.1	0.3	1.7	0.7	79.5	0.1	0.0	39.8	0.2	200.8	0.0	21.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.3	0.5	0.3	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	28.4	29.8	6.3	157.1	2.2	13.3	22.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	4.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	28.5	0.0	1.4	8.3	0.3	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	59.6	0.7	0.3	0.0	0.0	0.9	6.7	0.1	1257.1	55.0	0.0	0.7	0.0	0.2	30.6
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 3060.6"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	3.9	0.5	0.0	0.0	0.0	0.1	41.2	0.0	0.0	94.0	0.0	0.8	0.0	0.3	0.7	67.5	0.1	0.0	1.3	0.0	0.0	0.3	1.7	0.8	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	554.0	0.0	11.7	3060.6	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.2	0.6	0.0	13.4	0.1	306.6	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		210000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	295.5	257.6	201.7	352.9	213.4	554.9	218.9	238.0	213.5	256.3	324.0	304.6	287.3	275.8	647.7	338.2	266.7	164.1	303.2	203.5	239.7	296.9	782.3	308.9	230.0	260.4	230.1	272.2	319.7	292.2	284.5	403.3	254.5	277.9	336.7	96.2	299.3	247.2	119.8	189.3	277.2	349.7	237.7	277.3	300.6	165.2	267.3	245.3	702.9	104.7	319.4	252.2	236.6	274.2	1681.4	673.6	832.5	1984.9	1110.8	861.5	724.6	2075.3	1160.8	839.6	1280.4	1044.2	1353.5	1087.2	1960.0	2528.4	1064.5	672.1	906.1	1476.5	800.7	730.0	588.1	894.3	689.0	1619.6	2667.5	3638.5	1171.8	946.8	638.7	1222.3	957.7	1472.5	1507.8	743.1	814.5	536.3	911.7	1222.3	1040.0	2511.9	808.7	952.0	970.1	777.0	770.8	1329.9	1138.3	846.9	312.4	668.4	1438.7	769.8	472.6	789.9	1014.4	1558.9	1460.6	1113.2	666.2	1533.6	938.3	644.3	569.7	985.8	1567.6	1616.3	1258.1	67.5	72.8	39.7	172.8	147.8	119.3	90.0	99.7	130.0	76.3	77.5	73.0	134.4	23.8	103.1	122.7	215.6	83.4	75.8	201.7	213.4	238.0	213.5	203.5	239.7	260.4	230.1	254.5	237.7	267.3	274.2	385.2	147.4	160.7	34.6	385.7	261.7	336.3	217.3	221.4	76.8	214.9	140.8	43.7	163.0	175.4	222.5	127.2	652.9	515.5	524.4	64.6	582.7	27.8	206.3	364.2	305.6	353.6	266.1	14.2	285.5	1717.5	422.5	289.5	348.2	207.4	341.6	312.7	612.4	789.3	35.3	23.8	595.1	93.6	208.8	433.2	30.6	318.7	378.4	213.5	31.9	229.9	316.5	360.5	28.6	31.1	410.2	462.8	311.1	1059.6	426.1	377.8	182.8	147.5	167.7	203.8	224.2	328.9	276.1	306.6	245.5	213.5	964.4	345.8	399.4	471.4	329.6
CALR3	"CRT2, CT93, FLJ25355, MGC26577"	ENSG00000269058	"Calreticulin 3"	Q96L12	19	16479061-16496167	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Chaperone	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"testis: 64.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 51.0;Late spermatids: 13.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025749, HPA043355, HPA048460"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403"	"unprognostic (1.19e-1)"	"unprognostic (3.84e-1)"		"unprognostic (7.17e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.18e-2)"	"unprognostic (6.69e-7)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	13.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128773400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 504.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 2467.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	115.8	56.6	20.6	137.9	22.7	22.8	66.2	22.8	28.5	133.5	54.7	97.5	37.6	113.6	61.1	60.4	57.1	92.7	236.9	24.5	23.5	45.1	74.2	68.5	38.8	24.1	22.2	54.8	52.6	85.0	28.8	211.8	24.2	113.0	81.3	19.6	67.7	150.1	82.1	29.9	40.0	328.4	22.3	47.5	62.5	39.8	33.2	31.0	77.1	117.1	45.2	160.1	48.2	26.6	257.8	207.4	486.6	152.7	1348.5	1229.5	270.9	1821.7	1378.1	577.5	770.7	238.6	388.3	100.0	351.5	2467.8	850.4	144.9	258.2	318.2	826.5	80.6	138.2	136.6	283.7	295.0	657.1	187.2	254.3	930.5	223.6	868.3	370.6	904.4	537.3	116.4	237.9	172.8	1131.8	141.0	130.2	95.5	305.2	247.0	197.3	122.9	333.3	164.5	243.5	132.7	44.3	238.2	595.4	481.5	753.1	932.2	106.2	145.6	799.8	1706.6	234.2	1350.8	754.6	306.8	385.7	224.8	1478.6	223.6	1857.2	21.7	38.8	23.5	28.3	41.4	27.9	23.7	19.5	22.0	33.4	16.6	17.1	20.0	4.5	26.2	35.7	32.9	23.4	31.2	20.6	22.7	22.8	28.5	24.5	23.5	24.1	22.2	24.2	22.3	33.2	26.6	67.3	22.4	38.5	25.5	29.9	81.3	68.1	82.0	31.3	28.2	51.7	42.7	247.0	25.8	62.7	25.8	18.8	116.8	25.0	14.4	17.6	69.5	11.4	37.5	186.3	104.0	19.7	42.3	37.7	60.5	504.7	198.8	37.2	72.8	59.6	62.6	113.2	54.2	136.9	28.6	47.0	55.9	22.4	58.9	70.7	9.3	100.3	44.6	120.9	27.2	26.3	32.4	21.6	31.2	32.2	71.5	11.4	118.8	140.9	110.6	12.6	17.7	57.2	12.8	59.2	64.9	162.8	27.1	41.9	30.9	76.9	243.0	30.9	69.7	26.1	90.5
CAMK1	"CaMKI, CaMKI-alpha"	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757347-9769992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 280.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 280.5"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 403.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		110000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	52.4	99.7	50.1	17.2	48.9	5.1	37.2	39.9	61.0	27.0	31.8	33.6	9.2	31.8	13.7	8.0	37.0	11.1	20.5	61.2	46.3	24.9	36.4	23.9	11.1	37.8	41.7	41.2	8.4	14.4	21.6	6.7	38.8	31.1	10.6	5.9	9.8	19.7	7.1	7.9	16.5	26.0	36.8	16.7	21.7	29.8	46.9	4.3	19.5	7.8	15.0	28.4	18.3	46.1	0.5	16.4	12.6	0.0	64.7	24.3	32.6	38.4	21.1	43.1	40.4	24.1	3.0	1.1	9.0	26.0	6.2	2.7	0.0	5.0	27.0	0.4	95.4	53.5	32.1	34.1	35.9	4.5	403.3	25.3	4.1	60.6	6.7	35.4	36.8	0.9	7.2	1.2	16.3	10.3	0.3	38.8	9.0	0.4	25.7	0.3	0.4	1.1	25.9	2.8	4.2	16.7	6.6	0.7	4.0	5.3	4.1	67.2	19.6	19.8	24.4	28.0	48.7	0.4	0.3	1.0	41.5	14.7	3.0	17.8	21.3	280.5	0.3	42.2	0.1	0.1	0.4	0.2	14.1	0.2	0.3	0.1	1.0	3.6	43.0	0.4	2.0	4.7	50.1	48.9	39.9	61.0	61.2	46.3	37.8	41.7	38.8	36.8	46.9	46.1	58.3	0.0	3.1	17.9	2.8	5.0	19.2	3.4	5.7	9.9	5.2	4.6	0.1	12.8	2.1	11.0	2.1	0.4	3.0	2.6	9.8	14.4	1.8	1.8	14.9	22.8	6.0	4.8	25.6	4.0	1.2	23.3	5.6	3.1	30.5	16.7	30.4	23.5	76.2	0.0	14.5	2.3	0.0	46.4	40.2	7.2	36.1	71.2	5.4	8.4	36.7	39.4	3.1	6.6	2.7	5.5	2.9	45.1	0.2	17.5	3.6	47.4	1.3	7.7	59.2	12.2	42.7	1.5	3.7	1.5	3.8	0.8	7.1	6.6	7.6	11.0
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349547-12835545	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 57.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 167.4;Cone photoreceptor cells: 392.0;Excitatory neurons: 416.9;Inhibitory neurons: 233.6;Microglial cells: 168.6;Rod photoreceptor cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 14.9;basal ganglia: 16.7;cerebral cortex: 35.6;hippocampal formation: 29.6;white matter: 14.5"	"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 75.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 113.8;U-266/70: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	6.6	4.8	14.9	8.4	16.7	6.8	4.3	4.5	35.6	7.4	1.1	11.4	3.5	3.2	2.8	8.6	3.8	5.9	14.6	29.6	0.6	2.6	8.2	7.5	9.6	3.7	0.1	2.7	16.9	0.9	2.8	2.9	0.0	4.7	12.4	57.9	4.3	7.0	1.5	18.5	6.3	5.2	0.7	10.9	3.1	6.1	1.3	23.5	13.0	2.3	12.6	7.1	9.2	14.5	0.3	6.1	6.8	0.3	4.0	1.4	0.4	0.9	2.2	1.4	2.0	8.6	4.8	3.4	0.7	0.6	3.4	3.2	8.4	1.2	1.1	113.8	4.1	13.6	19.4	0.4	1.1	0.3	11.8	0.2	5.2	2.7	0.2	14.6	0.8	7.2	0.4	0.4	1.7	7.2	26.9	5.6	4.6	0.0	2.7	20.2	3.7	6.4	0.2	6.5	10.4	4.8	13.2	4.9	0.0	0.9	3.4	3.3	0.3	5.6	8.1	18.1	4.0	50.3	16.8	11.3	8.2	8.8	0.1	19.5	4.9	75.1	3.8	7.1	3.9	12.1	3.3	4.8	9.3	14.7	3.8	2.6	29.8	3.1	8.7	2.8	1.1	3.4	14.9	16.7	4.5	35.6	29.6	0.6	3.7	0.1	0.0	0.7	1.3	14.5	12.5	3.2	25.2	130.6	68.0	22.9	8.6	26.3	13.1	167.4	3.4	1.7	17.1	12.8	36.6	1.8	392.0	0.2	22.1	36.7	0.0	9.0	20.4	3.6	4.0	13.7	16.1	7.6	416.9	22.0	0.9	30.4	2.0	2.0	23.4	2.0	15.0	13.7	16.0	45.4	233.6	27.4	10.2	50.1	61.2	9.2	23.6	36.2	3.6	168.6	34.8	24.2	30.9	111.6	7.2	10.5	42.8	60.9	23.9	4.9	2.0	1.2	27.5	214.2	26.3	7.2	10.2	4.8	11.0	24.6	41.2	0.3	21.6	8.7	33.2	20.9
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583714-209613939	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 40.5;kidney: 11.1;ovary: 21.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 20.0;Inhibitory neurons: 15.5;Peritubular cells: 6.8;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.7;hTERT-RPE1: 4.1;SK-MEL-30: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.2	2.3	22.6	0.3	27.2	0.4	0.1	0.7	40.5	0.4	0.6	0.5	0.2	1.0	4.3	0.0	0.5	0.7	0.3	23.0	17.3	11.1	0.3	0.7	0.2	6.6	6.1	21.5	0.6	0.0	3.9	1.8	13.8	3.6	0.1	0.5	0.0	5.3	0.3	0.3	0.2	1.3	3.5	5.6	0.1	0.8	26.3	0.1	0.1	0.1	0.2	0.4	0.6	21.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.9	0.0	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	27.2	0.7	40.5	23.0	17.3	6.6	6.1	13.8	3.5	26.3	21.1	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.0	0.0	20.0	0.2	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	15.5	0.0	0.0	0.0	0.3	0.1	1.2	0.5	0.0	1.9	0.0	0.3	0.0	0.0	1.2	0.1	0.0	6.8	0.0	0.0	0.0	0.2	0.0	0.1	6.6	0.2	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"	P49913	3	48223347-48225491	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 2914.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 84.4;neutrophil: 335.4"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 335.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5"	"Not detected"	"Not detected"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000	28000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"			"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.8	0.1	0.1	1.6	0.1	2914.5	0.5	0.1	0.5	0.6	0.1	0.3	0.0	0.6	339.9	0.4	0.1	0.3	1.4	0.1	0.1	0.4	3.9	7.4	6.8	0.2	0.1	0.2	0.1	0.1	0.5	2.4	0.2	0.5	0.1	0.0	15.2	0.6	0.2	3.7	1.7	0.1	0.1	23.2	0.4	1.9	0.1	10.7	5.7	0.2	2.9	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	19.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	1.0	1.4	0.1	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.5	0.0	3.4	0.1	37.9	5.5	84.4	0.0	9.8	0.0	2.3	0.0	0.0	7.7	2.4	0.0	0.0	335.4	2.6	28.1	4.7	0.0	86.9	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.9	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.3	0.9	0.3	0.2	0.0	2.1	0.0	0.2	0.0	6.9	0.5	1.4	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	1.3	1.1	17.4	0.9	3.6	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	9.4	0.0	0.1	0.7	0.0	0.0	0.0	0.1	5.0	7.2	0.0	0.0	0.0	1.0	0.0	0.4	0.6
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595863-7618304	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.4	3.3	3.2	0.8	4.4	0.0	5.3	2.5	9.0	7.7	0.1	10.3	14.9	0.5	2.3	24.8	3.1	1.6	0.4	4.2	0.7	12.0	24.3	4.6	0.2	2.5	0.0	0.5	20.6	2.7	8.2	0.4	0.4	10.2	2.4	3.2	18.1	4.5	0.2	62.7	11.5	0.1	0.0	0.6	15.5	13.0	0.2	0.5	11.1	0.0	1.1	3.6	13.4	2.4	11.2	1.8	0.3	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	26.7	5.8	3.1	4.5	0.0	1.2	9.7	4.3	2.8	0.0	2.0	10.1	0.0	0.5	15.6	0.0	0.0	4.4	0.0	5.5	0.0	0.4	0.4	0.0	4.5	0.9	0.0	0.0	13.0	0.2	0.2	6.6	8.4	4.7	0.7	0.0	3.7	1.9	6.0	8.2	8.7	1.3	12.5	0.0	1.6	10.4	1.7	0.0	0.0	2.0	0.0	0.4	5.0	1.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	2.5	9.0	4.2	0.7	2.5	0.0	0.4	0.0	0.2	2.4	0.2	9.6	19.2	3.3	1.1	9.8	2.7	2.4	3.4	22.7	19.3	12.1	1.5	20.0	5.3	9.2	0.0	0.5	0.2	40.0	3.9	5.7	4.4	9.6	1.4	1.5	13.1	0.0	9.1	11.8	0.7	0.2	38.7	13.5	5.7	8.6	0.4	24.8	0.2	10.1	10.1	22.4	0.0	1.9	1.2	2.9	1.5	1.0	0.0	1.9	0.0	1.5	0.0	4.5	0.6	13.1	28.4	0.0	0.6	6.2	29.2	15.6	2.9	13.4	0.0	0.0	1.1	0.4	2.8	9.8	18.9	0.5	0.9	1.5	18.4	8.0
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269358-67319953	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		5900000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	18.4	23.1	19.6	19.9	21.4	22.6	25.9	25.3	21.8	21.4	15.9	19.8	19.5	21.2	27.8	22.5	19.2	18.3	12.6	20.9	21.7	24.3	27.4	16.8	27.5	18.8	19.0	25.0	18.7	28.3	19.3	23.2	21.2	22.4	20.6	37.5	16.5	20.0	9.9	29.3	18.5	21.6	19.5	19.1	18.2	27.8	19.5	38.8	26.0	11.4	30.8	23.3	19.3	19.5	62.1	62.6	93.1	66.6	69.7	54.3	62.4	60.2	51.6	62.0	54.2	58.4	34.5	132.9	51.0	60.6	38.9	57.8	101.1	68.3	70.6	50.8	60.5	75.1	46.5	55.7	45.7	89.5	40.9	51.5	51.0	56.8	51.9	75.8	58.7	63.9	60.4	72.3	67.7	61.0	81.6	60.3	98.8	47.4	43.1	78.4	79.8	56.3	57.3	103.9	95.2	47.3	74.9	68.0	49.9	77.8	73.2	40.7	50.3	49.0	31.5	34.1	46.1	23.5	31.1	111.5	58.3	52.2	51.4	9.3	6.4	7.4	14.0	7.4	17.0	10.9	16.8	15.3	10.0	14.7	17.7	14.9	2.7	19.0	14.0	8.6	19.3	5.7	19.6	21.4	25.3	21.8	20.9	21.7	18.8	19.0	21.2	19.5	19.5	19.5	37.6	60.9	36.3	38.5	61.2	58.1	50.2	51.6	57.5	92.4	51.4	40.6	17.0	42.9	42.0	44.1	116.7	37.4	61.5	47.3	13.7	30.7	3.9	45.2	53.9	44.6	45.4	34.9	48.8	28.6	42.7	47.7	41.3	51.1	7.6	71.0	40.4	49.8	31.3	87.5	61.7	50.4	34.6	42.4	52.4	11.0	69.0	35.9	33.8	32.8	54.6	53.8	48.4	49.8	63.5	35.2	28.6	60.9	55.1	56.6	59.8	32.3	55.3	115.3	26.3	52.1	50.7	82.5	47.7	47.1	63.9	44.6	59.3	66.4	46.5	64.2
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179731641	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 817.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 528.3;SK-MEL-30: 790.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	128.3	112.8	15.0	36.3	17.6	76.0	110.6	18.8	31.1	121.4	25.1	108.7	45.0	137.7	171.7	106.7	109.8	6.2	137.5	13.8	24.1	121.4	193.2	112.7	18.4	24.7	24.1	129.6	209.7	9.6	96.5	75.0	20.2	96.0	62.6	68.0	123.3	17.8	111.6	83.5	97.4	85.0	19.2	73.2	115.2	75.0	17.9	9.0	159.2	53.6	16.6	112.0	95.6	22.6	13.0	91.5	89.5	53.0	295.4	229.3	37.9	261.4	342.8	341.2	298.2	148.2	49.6	309.3	351.0	127.8	121.4	18.7	120.2	121.1	405.9	64.6	6.3	63.0	247.8	22.9	399.9	82.9	50.0	39.1	313.5	118.6	528.3	56.1	93.9	23.9	43.2	99.9	39.9	51.2	40.9	15.1	9.4	11.7	6.4	43.2	71.3	24.9	252.1	82.8	24.4	8.0	62.7	16.7	790.3	182.7	267.3	16.3	234.7	49.9	56.5	36.1	200.2	19.7	87.2	46.1	53.3	50.4	46.5	51.8	61.8	17.4	29.9	38.9	34.4	14.4	21.2	25.0	47.6	10.0	15.3	15.6	9.6	32.1	30.1	38.7	16.4	74.1	15.0	17.6	18.8	31.1	13.8	24.1	24.7	24.1	20.2	19.2	17.9	22.6	187.0	198.7	296.6	53.5	109.4	148.5	115.4	181.3	152.0	117.4	245.8	153.5	537.0	185.8	247.0	182.1	158.4	162.5	148.6	174.3	49.0	173.6	225.5	160.9	253.9	204.0	178.0	133.3	45.5	153.5	245.8	202.8	156.5	255.5	197.9	137.7	157.5	438.7	227.7	159.9	77.0	250.0	134.3	206.4	215.6	817.5	159.1	218.3	176.1	44.0	181.1	213.8	84.5	63.3	79.4	153.1	125.1	191.1	327.3	249.5	188.2	196.4	294.3	160.9	92.1	114.6	211.2	158.4	72.7	182.3	161.8	244.8	105.8	183.1	251.0	157.8
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 832.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 1954.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Approved	Cytosol		NA	NA		73000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	175.2	96.8	78.6	275.0	92.3	314.9	137.5	87.6	95.3	131.2	77.8	223.7	143.7	207.2	100.4	196.2	134.2	135.3	82.3	82.6	85.3	130.7	124.4	181.7	266.8	98.0	87.6	87.7	67.8	115.1	62.8	184.2	94.4	105.0	210.4	63.4	117.4	140.1	48.1	120.2	165.0	236.6	89.7	206.1	147.8	75.0	91.5	186.8	106.8	56.0	326.4	231.2	130.4	107.9	435.9	185.1	216.4	134.8	310.6	290.5	338.9	749.8	437.7	398.9	399.9	272.5	440.1	339.5	295.7	598.7	275.7	267.1	265.8	535.7	548.1	461.6	164.9	520.2	188.7	216.8	286.4	326.9	1417.9	297.5	280.6	612.5	345.4	456.5	346.4	185.7	201.6	215.0	621.7	129.2	265.4	194.9	367.7	312.1	207.9	197.0	297.6	198.6	451.3	452.0	107.5	222.9	308.7	366.4	523.8	443.1	170.0	1954.7	628.9	347.3	317.9	188.0	641.4	178.9	381.8	301.0	451.5	353.8	466.9	1371.5	776.8	2592.7	665.8	1097.6	526.2	328.0	473.4	643.9	868.3	325.6	397.1	537.9	1560.4	479.8	1402.6	333.8	701.5	1838.4	78.6	92.3	87.6	95.3	82.6	85.3	98.0	87.6	94.4	89.7	91.5	107.9	132.5	121.8	90.9	17.6	179.0	112.3	149.0	236.2	48.9	40.8	81.8	89.9	15.7	80.1	161.8	114.0	27.1	212.9	206.9	372.1	111.6	364.1	411.3	94.5	109.8	163.2	76.1	73.4	22.3	272.3	439.6	107.9	74.5	182.9	229.1	70.9	167.0	77.0	426.0	42.1	16.7	180.2	142.4	411.6	333.3	480.3	88.0	390.8	99.6	25.3	606.5	160.9	315.1	13.0	30.4	832.7	202.0	176.8	117.1	130.7	159.7	142.1	105.6	49.5	164.3	68.9	207.1	118.0	67.9	97.2	132.8	237.8	238.0	74.8	151.5	221.4
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 858.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		2800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	118.8	93.9	40.2	64.9	50.0	40.9	92.4	45.3	39.6	110.4	29.4	140.1	46.2	67.7	58.0	134.3	120.5	119.7	71.8	36.9	42.7	115.2	31.2	182.5	35.5	51.9	46.1	83.2	55.1	136.3	28.0	68.3	46.6	47.5	131.4	19.2	151.2	91.2	82.2	41.6	58.5	87.3	43.4	42.5	130.4	26.3	49.1	27.0	80.9	81.6	54.3	85.6	89.3	49.3	419.9	263.7	79.2	54.9	257.6	356.6	79.4	383.9	541.3	267.2	151.1	209.2	323.6	0.4	125.0	417.1	209.1	255.1	86.3	593.1	243.4	109.8	95.2	7.8	124.9	25.6	232.3	21.5	13.9	193.3	187.3	416.6	217.8	472.3	537.1	0.1	123.2	106.8	789.3	8.6	1.0	19.4	45.5	49.7	346.3	35.4	262.4	7.3	454.9	24.3	17.7	94.7	198.1	524.2	122.8	189.7	80.9	98.7	858.1	252.7	212.0	220.6	498.4	32.5	66.8	1.4	625.3	46.2	284.7	7.9	118.6	7.2	106.8	77.9	89.8	34.4	72.6	103.2	163.9	16.6	22.9	62.2	6.1	24.5	73.7	7.4	81.7	136.6	40.2	50.0	45.3	39.6	36.9	42.7	51.9	46.1	46.6	43.4	49.1	49.3	240.0	394.2	134.9	82.9	42.3	47.3	136.6	197.5	38.7	12.0	35.7	32.8	38.4	115.8	264.4	53.3	33.3	24.4	72.4	356.0	181.9	271.4	94.5	70.0	52.7	125.3	24.6	6.9	13.3	195.9	92.0	105.0	103.5	93.3	27.8	47.8	35.7	9.7	38.9	13.5	23.1	104.4	242.1	50.0	239.3	232.8	77.3	86.4	112.1	22.5	66.0	22.6	78.2	48.7	21.6	373.0	191.5	68.8	83.3	237.7	104.1	23.6	288.8	18.0	39.5	85.0	107.9	3.4	3.3	67.5	27.6	8.2	83.5	63.5	98.2	268.2
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139953-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006872	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		9000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	425.4	357.9	363.0	171.4	374.4	235.7	371.7	359.4	507.1	368.1	353.9	371.4	263.2	303.5	193.8	761.7	306.6	197.8	692.5	379.8	411.1	488.5	273.5	396.7	167.4	401.0	392.3	267.6	250.9	330.9	317.9	147.3	401.0	357.0	287.6	136.2	374.9	281.4	491.3	211.9	341.4	290.0	356.5	363.6	311.1	273.6	400.3	200.8	329.9	373.4	275.1	354.8	402.5	384.1	395.2	977.6	240.0	342.7	566.3	683.0	48.2	315.8	673.4	631.3	488.1	223.3	572.2	141.9	463.7	1067.5	225.6	207.0	291.3	780.8	514.7	592.4	142.9	166.0	259.7	373.0	655.0	166.7	393.9	740.8	477.9	411.1	577.5	767.3	699.8	173.5	204.4	554.4	978.6	522.7	295.4	301.4	137.9	754.6	490.6	156.5	194.7	262.3	1208.8	368.7	159.1	199.4	385.1	532.0	155.5	279.4	308.6	261.4	460.6	555.5	424.3	188.1	318.7	198.4	277.6	126.8	630.4	225.9	480.8	24.8	50.1	22.6	44.4	75.6	28.5	29.4	30.9	36.4	46.1	32.3	18.7	25.2	25.2	24.6	83.4	58.7	34.7	21.1	363.0	374.4	359.4	507.1	379.8	411.1	401.0	392.3	401.0	356.5	400.3	384.1	172.7	125.0	98.6	10.4	49.3	30.7	76.2	69.1	29.6	21.1	91.7	75.1	149.5	130.1	85.9	163.7	0.0	74.9	107.1	250.1	62.6	226.3	102.9	168.5	118.3	136.6	107.8	47.3	13.4	251.3	87.8	83.3	66.8	234.4	63.4	84.7	157.1	78.4	155.1	16.8	11.9	220.3	52.9	244.6	86.9	230.2	93.2	130.5	39.2	15.9	208.4	78.2	109.2	6.6	21.9	254.2	187.5	76.0	50.2	98.0	243.5	135.3	74.6	33.1	46.0	64.3	92.9	120.1	6.5	109.1	28.8	70.1	62.8	132.2	165.6	112.4
CAPZA1		ENSG00000116489	"Capping actin protein of muscle Z-line subunit alpha 1"	P52907	1	112619805-112671616	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB045963	Approved					NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB045963: AB_11126023"	"unprognostic (7.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (1.17e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.59e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-1)"	73.7	49.1	42.5	115.3	43.6	156.4	55.7	46.4	51.7	48.3	45.7	86.1	67.9	43.1	61.5	96.3	42.9	59.1	27.9	40.5	49.7	41.1	73.1	65.4	154.0	51.6	49.3	30.6	35.5	39.6	21.4	85.4	51.2	42.4	95.0	37.2	38.5	37.4	25.4	92.4	70.8	63.9	49.1	105.2	70.9	71.1	50.6	118.2	48.1	22.1	187.7	97.3	52.8	57.5	308.0	88.9	148.4	120.7	180.6	207.9	186.5	237.7	245.3	236.7	210.9	120.7	126.9	319.6	174.8	277.6	108.0	142.6	199.9	251.3	293.4	245.5	100.2	279.0	141.8	148.7	212.8	507.3	376.5	224.6	186.5	230.7	219.2	140.5	268.1	143.2	287.3	191.6	335.6	177.2	262.8	222.6	146.3	179.7	180.3	192.5	292.0	158.8	207.9	221.3	102.2	109.6	274.3	246.9	192.6	118.2	127.8	441.6	305.8	192.8	191.6	317.7	292.2	135.0	134.2	359.8	331.4	381.5	450.4	396.9	254.5	319.7	172.1	385.9	194.5	198.3	188.8	209.1	207.9	145.0	105.4	171.0	524.7	145.9	434.0	164.6	252.5	369.9	42.5	43.6	46.4	51.7	40.5	49.7	51.6	49.3	51.2	49.1	50.6	57.5	59.5	28.9	49.0	59.4	186.0	180.9	73.7	87.4	63.2	31.2	73.3	35.3	22.0	54.3	69.0	101.2	25.0	138.8	194.9	152.4	92.0	94.9	380.4	62.1	95.4	78.0	61.1	104.5	48.3	111.9	206.8	72.1	59.1	86.0	92.0	48.8	83.2	74.5	233.1	43.7	47.8	101.5	52.9	320.0	361.0	210.2	57.2	211.9	122.7	54.4	236.5	33.5	125.7	55.8	73.7	168.9	135.7	55.3	137.2	105.7	89.0	88.8	71.4	31.2	65.7	42.8	79.6	166.3	67.7	110.2	237.8	184.0	196.7	73.9	110.3	147.0
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line subunit alpha 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007470, HPA007643"	Uncertain		Approved	Cytosol		No	No		4500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	26.3	20.1	17.0	20.0	17.3	43.3	21.8	22.5	25.8	18.0	16.9	24.4	20.4	19.7	19.0	20.8	14.2	20.7	45.7	21.3	17.5	37.3	33.9	23.8	20.1	17.0	17.1	12.6	13.4	19.4	7.5	24.9	20.5	20.3	23.9	13.4	14.6	20.5	64.3	12.3	23.4	28.1	14.5	22.3	20.0	8.7	19.6	16.4	22.8	53.1	17.3	28.1	11.3	18.3	30.0	19.5	19.8	25.2	35.9	37.8	9.8	28.7	41.3	28.8	32.7	14.5	38.1	20.8	46.5	41.3	36.1	18.2	20.4	24.1	45.4	22.7	14.9	31.3	18.0	24.6	22.2	21.2	40.9	30.2	26.9	22.9	21.9	34.8	63.2	12.9	20.8	35.2	57.9	13.0	28.3	35.6	29.5	31.3	16.8	19.7	26.2	42.1	69.3	24.6	20.6	23.5	27.7	104.1	29.7	25.0	14.5	25.0	23.0	47.0	14.6	37.5	28.5	27.7	21.0	39.6	28.0	29.6	34.0	57.3	34.8	45.6	11.1	45.6	13.2	14.4	13.5	11.9	33.2	12.6	12.9	13.1	69.4	15.9	54.9	18.1	18.1	45.3	17.0	17.3	22.5	25.8	21.3	17.5	17.0	17.1	20.5	14.5	19.6	18.3	177.9	73.7	67.4	44.4	109.4	243.1	219.8	224.3	94.4	106.6	85.1	67.3	219.4	71.4	146.5	171.0	27.1	151.7	96.2	147.4	516.5	193.1	9.6	139.4	113.7	189.5	121.2	263.9	59.2	160.3	204.0	124.8	103.5	340.1	126.2	48.8	262.3	110.6	314.1	107.7	48.0	102.6	286.8	238.5	274.9	16.2	74.6	262.9	181.5	64.6	222.4	164.5	72.1	49.8	47.1	193.1	147.5	110.9	83.0	140.9	182.6	519.7	99.7	95.9	92.1	122.8	188.9	43.1	47.0	94.1	218.8	144.1	108.6	78.7	109.9	207.0
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.5;U-2197: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	10.0	8.4	3.7	5.0	3.3	0.1	10.5	2.9	4.0	6.5	2.8	13.3	34.1	6.0	1.3	8.4	7.5	7.8	10.7	3.1	3.0	14.9	12.4	6.1	2.1	4.7	3.3	3.1	9.2	2.7	2.1	4.7	5.0	5.4	8.8	0.3	19.0	4.2	8.0	9.7	35.9	4.2	3.3	4.1	9.9	15.0	4.2	0.8	6.8	8.2	1.0	6.1	5.8	2.9	31.3	23.1	4.1	3.0	0.1	8.7	19.6	2.8	6.5	12.8	10.0	14.2	21.8	0.0	10.8	5.4	12.4	43.0	4.9	56.5	3.9	0.1	11.8	0.7	15.6	22.1	5.4	0.5	1.9	2.9	11.5	24.5	31.2	10.2	26.1	0.0	3.3	0.0	9.9	11.0	0.1	2.0	7.2	17.0	13.2	0.0	38.9	3.0	19.1	5.4	1.5	2.4	21.0	9.5	2.1	5.0	10.1	1.7	35.0	9.5	26.9	82.8	16.4	0.1	0.0	0.0	30.2	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.3	2.9	4.0	3.1	3.0	4.7	3.3	5.0	3.3	4.2	2.9	22.6	0.0	2.0	0.0	0.2	8.5	6.8	3.4	2.2	1.2	3.9	4.3	3.7	10.0	1.6	3.7	0.0	0.4	0.2	35.5	1.9	25.4	7.8	3.3	0.4	24.8	7.7	0.0	0.1	19.6	1.6	1.9	15.8	6.2	0.0	0.4	17.9	4.8	0.1	0.0	0.6	19.8	4.1	0.0	1.2	8.6	0.0	0.4	5.4	3.7	0.0	0.0	0.0	0.0	0.1	39.4	27.6	0.7	0.2	8.6	35.5	12.4	1.2	0.2	0.0	6.2	1.1	0.4	3.4	2.5	3.8	0.0	0.6	1.0	11.3	9.7
CARD6	CINCIN1	ENSG00000132357	"Caspase recruitment domain family member 6"	Q9BX69	5	40841308-40860175	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.8;Gastric mucus-secreting cells: 26.5;Pancreatic endocrine cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 27.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.7;granulocytes: 27.4;monocytes: 13.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.5;HUVEC TERT2: 34.0;TIME: 36.9"	"Low region specificity"	"Detected in many"							HPA036438	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036438: AB_10670105"	"unprognostic (8.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.88e-3)"	9.0	12.0	1.7	5.5	1.9	3.1	5.8	1.9	1.9	4.8	3.3	2.6	7.8	3.5	1.5	10.6	4.5	11.4	4.4	1.8	2.2	4.8	4.0	9.7	4.8	2.8	2.1	1.8	3.1	2.2	1.7	6.9	2.5	1.9	2.8	0.7	7.5	2.8	2.1	2.4	5.3	4.9	2.5	12.9	12.1	1.3	2.8	2.4	5.3	5.4	4.5	8.4	4.1	2.4	3.4	5.8	0.8	0.1	13.0	20.5	0.1	1.7	3.1	0.2	0.7	0.6	1.2	6.4	10.8	4.0	6.9	2.1	0.3	8.4	0.7	0.6	1.4	7.7	10.8	0.6	4.1	6.3	14.4	13.2	6.7	7.6	1.7	9.5	34.0	0.1	7.9	1.1	3.0	0.1	0.0	6.1	0.1	3.3	1.7	0.1	0.2	6.6	12.6	7.2	0.0	0.0	9.6	2.8	1.5	0.1	0.3	11.5	36.9	1.6	1.4	0.4	2.4	0.3	0.1	0.8	3.0	13.3	5.9	27.4	11.2	4.1	1.2	11.3	1.0	1.0	1.7	1.1	7.7	2.0	1.6	1.2	10.7	1.8	13.9	3.0	3.6	4.5	1.7	1.9	1.9	1.9	1.8	2.2	2.8	2.1	2.5	2.5	2.8	2.4	23.8	0.0	17.5	0.0	3.1	1.7	1.5	6.6	5.2	0.0	2.9	2.0	1.4	11.5	6.4	1.8	0.0	0.7	1.8	0.2	0.0	15.9	0.6	5.7	9.6	20.1	0.0	4.8	0.1	14.0	0.8	10.2	26.5	10.3	13.3	0.4	15.4	3.1	9.2	0.0	0.1	0.4	4.1	16.6	1.8	1.0	3.1	14.1	0.0	4.7	11.2	0.7	2.1	0.5	0.1	21.7	1.2	1.2	0.9	0.4	3.2	0.9	4.4	0.0	0.0	1.1	2.7	0.6	0.2	11.3	2.3	0.5	3.0	8.5	1.2	9.1
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196605	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 45.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Bipolar cells: 22.9;Excitatory neurons: 20.8;Horizontal cells: 42.1;Inhibitory neurons: 26.4;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 28.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.8;HDLM-2: 14.7;HEK 293: 3.2;SCLC-21H: 6.4;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, HPA076882, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"CAB079050: , HPA055990: AB_2682997, HPA076882: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	0.1	0.2	15.1	0.0	16.6	0.0	0.4	0.4	45.8	0.6	0.0	0.4	0.0	0.4	0.0	0.1	0.3	0.0	3.0	22.5	6.4	0.2	0.0	0.0	0.0	23.9	8.0	0.5	0.5	0.9	3.9	0.0	14.9	0.5	0.0	2.1	0.6	0.1	0.1	1.0	0.1	0.0	0.2	0.0	0.1	1.2	19.3	0.0	0.7	0.0	0.0	0.0	0.3	11.0	0.0	0.4	1.6	3.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.3	0.0	14.7	3.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.9	0.1	0.0	1.1	0.0	0.8	0.6	0.0	0.0	0.8	0.0	0.3	0.1	0.0	6.4	3.1	0.1	0.2	0.2	0.1	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	16.6	0.4	45.8	22.5	6.4	23.9	8.0	14.9	0.2	19.3	11.0	0.0	0.0	0.0	39.5	0.1	0.4	0.2	0.6	1.2	22.9	1.2	1.3	3.5	0.0	0.1	0.0	8.4	0.0	0.2	0.4	0.0	0.1	0.0	0.6	1.1	0.3	0.0	0.0	20.8	0.2	0.2	0.3	0.0	0.9	0.0	0.4	0.0	0.0	0.1	42.1	26.4	0.1	0.0	0.0	0.3	0.1	0.3	0.1	0.0	4.7	0.0	20.2	0.0	28.6	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	6.4	0.0	0.1	0.1	0.4	1.6	0.4	0.4	0.1	0.1	0.1	0.0	0.1
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 486.0"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.6	0.0	0.1	0.0	0.4	0.4	7.8	0.4	0.2	3.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.2	1.4	486.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.0	0.0	0.0	19.9	1.0	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.3	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.3	6.6	6.0	13.9	6.7	40.2	10.5	7.8	6.7	11.8	6.7	11.1	10.7	10.2	9.6	15.3	10.3	7.0	8.4	5.9	6.2	9.1	6.4	10.4	22.0	7.2	6.4	9.3	8.4	11.1	5.3	12.4	7.7	7.6	12.7	7.7	11.9	6.3	3.9	17.4	15.4	9.4	5.9	19.0	9.6	9.1	6.9	27.5	8.8	5.0	27.1	7.5	11.2	10.0	27.5	25.4	28.8	51.0	15.1	17.5	15.4	27.7	13.0	25.4	27.8	26.0	31.3	52.0	25.9	18.4	19.4	27.3	29.4	22.6	34.0	45.8	22.5	31.2	40.4	18.3	8.4	60.7	37.4	13.0	18.1	31.0	11.0	11.3	22.0	41.3	26.3	32.6	27.5	27.5	109.1	64.4	36.5	27.4	26.3	79.1	14.6	32.6	15.1	23.3	31.5	34.2	54.8	24.3	17.3	19.6	26.3	23.4	24.1	22.5	15.5	40.7	28.1	27.0	28.5	59.4	24.9	72.6	41.1	69.2	17.9	17.2	24.5	21.7	24.2	25.7	33.3	25.3	17.3	28.8	24.3	28.3	21.7	24.2	34.1	21.1	38.9	15.3	6.0	6.7	7.8	6.7	5.9	6.2	7.2	6.4	7.7	5.9	6.9	10.0	14.1	9.6	8.3	4.2	17.4	15.2	7.0	9.4	6.2	4.8	19.0	13.5	6.2	17.2	7.0	7.3	8.4	20.0	19.3	8.7	3.9	8.1	36.6	10.8	17.9	16.4	10.7	9.7	11.2	7.7	14.6	9.3	8.2	20.1	10.1	22.7	18.2	7.2	10.1	6.7	8.8	11.5	0.0	16.9	23.3	51.0	11.8	12.2	21.4	4.7	20.8	4.4	13.4	4.5	22.4	9.4	5.9	8.2	13.0	5.8	9.1	4.2	4.9	15.4	0.0	8.3	10.9	13.7	25.9	16.1	13.8	5.7	16.7	9.3	15.5	7.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 571.0;eosinophil: 408.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 571.0"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		94000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	16.3	12.1	11.3	26.6	10.9	32.8	16.3	18.6	11.4	12.7	10.0	34.2	54.1	12.7	12.9	27.7	9.2	19.9	14.7	10.8	12.2	8.5	22.0	12.8	43.4	10.8	11.5	8.9	13.4	9.0	8.8	26.1	11.4	11.3	33.9	12.7	13.2	10.6	13.9	16.1	41.8	15.3	11.6	23.0	31.2	9.3	11.3	39.0	10.6	14.1	41.9	24.4	12.0	13.0	31.0	16.7	65.3	31.6	39.4	52.2	37.6	90.2	67.7	61.9	35.4	30.7	25.2	42.4	13.9	44.1	29.2	25.5	52.1	32.1	69.7	109.9	28.7	68.2	12.9	71.4	47.3	55.9	62.3	71.7	38.3	39.3	31.4	44.4	77.6	43.1	57.2	259.8	64.5	13.2	89.1	51.8	65.1	33.7	20.9	63.6	30.8	41.2	52.9	49.3	37.1	40.5	39.1	35.1	52.1	64.3	19.2	35.9	54.1	28.2	25.9	21.1	42.4	118.9	121.6	29.2	34.2	38.5	40.9	571.0	26.1	408.6	32.1	43.3	34.4	26.0	29.5	46.3	33.3	18.6	22.2	32.8	35.6	62.0	71.0	26.5	64.1	47.5	11.3	10.9	18.6	11.4	10.8	12.2	10.8	11.5	11.4	11.6	11.3	13.0	28.6	19.2	15.8	26.4	32.3	48.7	22.2	34.1	35.9	18.6	21.7	17.0	17.5	5.7	36.3	12.9	0.0	46.9	54.8	37.4	13.7	18.4	9.6	24.9	17.1	26.6	18.0	62.3	9.6	23.7	33.6	19.5	24.5	24.9	17.7	24.8	21.0	15.3	23.9	13.5	12.6	37.6	44.7	27.0	17.4	4.0	7.5	33.3	30.2	13.1	41.5	15.4	37.0	11.1	18.4	25.0	18.8	7.5	118.6	20.1	26.6	8.4	30.4	11.3	13.1	19.0	20.8	7.9	16.4	34.6	28.6	51.4	43.8	23.1	24.4	36.7
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.0;intestine: 16.8;lymphoid tissue: 14.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.4;Paneth cells: 18.7;Proximal enterocytes: 17.2;Undifferentiated cells: 7.3"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 5.0"	"Group enriched"	"Detected in some"	13	"intermediate monocyte: 18.1;neutrophil: 13.0;non-classical monocyte: 41.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 13.0;monocytes: 41.2"	"Cell line enriched"	"Detected in single"	6	"HHSteC: 3.7"															NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.7	0.1	0.5	14.6	0.6	0.2	0.1	0.5	5.0	0.2	0.6	15.6	10.0	0.1	0.2	0.1	0.2	0.4	0.1	0.5	0.5	0.2	0.2	1.6	0.9	0.7	0.8	0.1	0.0	0.0	0.1	0.9	1.5	0.1	12.9	0.0	0.1	0.1	0.0	0.0	16.8	1.8	0.6	2.7	0.1	0.3	0.8	0.1	0.1	0.4	0.3	2.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	18.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.1	13.0	0.0	41.2	0.5	0.0	1.4	0.5	0.6	0.5	5.0	0.5	0.5	0.7	0.8	1.5	0.6	0.8	0.9	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	2.3	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.3	0.0	4.7	0.4	0.7	0.0	4.8	0.0	1.9	2.4	0.0	0.0	0.0	0.1	0.1	18.7	0.0	0.0	0.0	17.2	0.0	0.8	0.0	0.0	0.2	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.0	7.3	0.1
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffold protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.2;lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 14.0;Kupffer cells: 8.2;Langerhans cells: 7.1;Macrophages: 12.1;Microglial cells: 29.0;T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 23.1;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.5;HEL: 13.7;HMC-1: 38.9;K-562: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB034217	Approved					NA	NA		680000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	1.7	0.9	1.9	9.6	1.9	2.8	0.9	1.6	1.9	1.0	1.7	1.0	1.4	0.5	0.2	0.9	0.6	2.3	0.6	1.6	2.0	0.7	1.7	12.2	3.9	2.6	1.9	1.4	0.4	0.4	0.3	4.5	2.0	0.5	1.0	0.4	0.6	0.4	0.3	0.7	2.1	1.3	1.7	5.6	1.0	0.3	2.0	1.9	0.3	0.5	2.4	2.0	0.4	1.8	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.7	0.2	0.1	0.3	0.2	2.5	0.2	0.1	7.5	0.2	0.2	0.1	0.0	0.5	0.2	0.2	13.7	0.1	0.9	0.2	0.5	38.9	0.8	0.3	0.2	0.0	0.4	0.0	0.2	16.1	0.2	0.5	0.2	0.3	5.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	1.7	0.3	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.1	1.5	0.2	0.7	4.0	23.1	1.3	0.9	2.0	0.1	2.2	2.4	6.9	0.1	4.2	3.8	68.9	2.8	0.1	2.4	1.4	2.6	1.9	1.9	1.6	1.9	1.6	2.0	2.6	1.9	2.0	1.7	2.0	1.8	0.4	0.0	1.1	1.6	0.9	0.1	0.0	0.0	0.6	0.0	0.3	0.3	0.5	0.0	1.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	1.8	1.5	0.0	14.0	0.0	0.4	1.1	2.2	0.0	1.4	0.0	0.0	8.2	7.1	0.1	0.0	12.1	0.0	29.0	6.5	0.0	5.2	1.5	1.0	0.0	0.0	0.0	4.3	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.3	13.1	0.1	0.0	0.0
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 858.4;Early spermatids: 979.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	144.4	68.4	32.3	86.1	36.3	119.1	104.1	35.0	40.8	147.2	55.5	160.1	120.5	83.8	49.0	342.8	79.7	78.7	303.7	30.7	42.2	82.0	116.8	112.1	52.9	46.7	43.2	83.1	56.1	111.7	51.2	116.1	44.4	100.2	148.2	17.1	130.0	78.7	317.3	157.4	137.2	92.2	38.3	64.1	100.5	98.8	39.1	43.1	97.9	166.4	104.3	129.4	216.4	41.7	300.3	239.7	42.6	112.1	240.1	390.1	145.4	220.9	288.8	169.1	215.8	60.4	189.6	44.1	189.8	286.1	263.1	465.6	81.3	283.5	202.8	292.4	78.5	65.9	251.0	71.1	172.9	38.9	100.1	201.8	254.8	239.6	375.0	222.9	194.8	33.5	51.7	144.5	196.4	98.0	17.9	2.0	35.4	85.0	89.9	18.2	141.9	78.3	327.1	114.1	179.6	45.0	222.6	118.2	142.5	94.0	77.4	39.5	263.9	239.0	94.6	154.9	211.4	51.2	140.4	22.1	264.7	21.8	67.5	10.5	156.6	24.1	75.6	85.3	74.1	79.4	68.2	76.9	107.5	79.1	34.8	45.7	38.2	61.6	109.8	28.8	79.2	108.1	32.3	36.3	35.0	40.8	30.7	42.2	46.7	43.2	44.4	38.3	39.1	41.7	251.6	403.8	221.4	58.1	153.8	239.6	439.8	223.6	169.0	39.4	133.6	84.5	858.4	163.0	277.0	108.5	18.8	181.2	227.1	484.0	133.1	263.6	979.7	348.0	213.4	188.5	142.1	229.3	60.2	249.7	96.2	259.0	153.4	327.8	177.1	71.8	138.8	169.3	113.7	13.5	53.0	253.9	103.7	209.4	259.1	414.4	172.1	243.8	131.6	63.7	354.4	36.9	293.6	33.2	70.2	325.1	346.8	146.3	126.3	314.7	302.9	152.3	379.0	19.5	92.1	267.8	175.0	23.6	17.9	348.9	251.7	140.8	207.7	69.8	221.2	548.5
CAT		ENSG00000121691	Catalase	P04040	11	34438934-34472060	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1217.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	13	"eosinophil: 4736.8"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 4736.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 391.4;THP-1: 321.2;U-937: 265.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		760000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	281.3	115.1	27.1	52.1	29.6	407.7	123.6	27.9	35.5	82.0	39.4	82.6	145.1	53.1	34.8	40.1	86.8	59.8	58.1	26.6	29.4	296.6	1217.3	163.2	58.4	35.2	29.4	46.7	86.3	43.2	13.6	78.0	34.3	66.8	71.3	9.8	83.7	64.0	103.8	70.6	136.3	59.4	29.6	78.6	74.1	11.4	29.5	74.9	122.6	136.6	56.7	105.8	39.9	40.8	31.7	34.3	24.5	38.9	233.2	100.6	52.3	39.3	49.8	43.3	47.1	19.7	30.9	78.3	37.5	79.2	63.9	73.9	42.3	42.9	47.3	68.8	38.8	65.6	34.0	113.7	27.6	391.4	31.1	54.5	29.3	13.2	5.1	59.9	53.2	46.2	139.3	31.3	55.1	30.2	81.1	77.4	0.1	148.7	82.6	56.5	117.9	64.9	120.2	117.2	13.1	19.8	44.5	70.6	60.0	0.0	101.4	321.2	38.3	25.9	24.9	65.4	23.8	25.0	15.2	16.8	51.3	265.6	19.3	256.5	324.7	4736.8	54.4	265.1	64.6	133.9	63.7	61.0	353.5	124.1	61.7	66.7	290.2	105.7	298.5	235.8	92.7	397.9	27.1	29.6	27.9	35.5	26.6	29.4	35.2	29.4	34.3	29.6	29.5	40.8	196.9	227.6	275.9	41.1	53.8	28.9	93.7	44.9	27.9	13.5	42.6	36.1	44.9	82.9	66.9	73.5	27.1	96.8	92.0	59.4	225.0	36.0	2.7	72.2	41.4	43.8	48.0	722.4	12.6	26.2	30.0	53.1	54.6	29.3	24.0	38.7	57.1	443.4	138.5	0.0	1.2	56.9	91.6	125.5	95.8	6.2	78.3	93.9	26.6	16.9	253.4	19.5	28.8	22.6	45.6	15.3	44.8	77.5	25.4	37.0	151.6	333.2	96.9	19.4	78.9	46.6	68.0	6.3	11.3	24.4	27.1	40.5	37.7	57.7	95.6	97.5
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;retina: 22.8;testis: 15.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 254.4;Early spermatids: 73.6;Rod photoreceptor cells: 221.8;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.2	1.4	2.0	0.8	2.2	4.2	1.8	14.6	4.0	1.3	0.1	2.3	3.3	1.4	5.4	2.4	1.4	0.7	0.9	2.2	0.7	1.4	1.5	1.2	2.0	1.4	0.6	1.6	1.2	4.0	3.2	0.8	1.7	1.6	2.3	22.8	1.6	2.2	1.2	5.4	3.8	0.6	0.1	1.5	1.8	15.5	0.9	0.9	1.9	1.5	1.5	1.7	1.3	3.1	2.0	2.8	1.2	4.4	0.0	0.0	2.0	0.7	1.7	1.2	2.9	0.7	1.1	2.4	1.0	0.5	1.4	4.4	1.1	3.9	1.2	2.0	5.4	7.0	11.2	1.0	1.8	1.6	2.2	0.2	3.0	1.7	4.3	3.2	1.5	4.3	2.8	2.4	0.4	0.5	1.3	2.8	0.4	2.7	1.2	1.9	1.4	1.1	2.4	3.2	2.6	0.9	1.1	1.6	0.1	1.6	3.2	1.5	0.4	3.0	1.3	0.0	1.8	0.4	0.3	5.1	2.1	4.9	1.1	0.1	0.3	0.1	0.3	0.1	0.4	1.1	0.2	0.4	0.2	0.3	0.3	0.7	0.5	0.5	0.3	0.4	0.1	0.0	2.0	2.2	14.6	4.0	2.2	0.7	1.4	0.6	1.7	0.1	0.9	3.1	4.8	0.0	4.5	0.0	4.9	7.0	8.2	8.3	1.8	56.7	6.9	6.9	4.2	5.7	8.0	7.3	254.4	6.0	6.0	3.9	3.9	3.2	73.6	5.2	2.5	6.0	21.5	2.7	0.0	2.7	2.1	3.2	6.1	4.2	9.5	29.7	8.6	3.9	4.3	38.7	0.0	4.6	4.1	5.0	6.5	37.4	6.2	4.5	1.8	0.0	4.5	13.4	7.2	0.0	0.0	2.0	3.3	7.2	1.1	6.7	11.1	4.1	10.8	221.8	0.0	9.3	5.1	117.4	17.1	2.7	8.0	3.0	4.6	5.8	8.5	8.4
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402449-42423256	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		440000	"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	397.8	65.3	42.6	69.1	47.2	3.7	295.3	55.8	40.9	239.9	50.6	314.0	30.8	344.3	56.8	101.0	207.5	78.1	220.9	35.4	49.7	66.4	21.0	202.8	30.0	68.8	55.0	162.5	28.4	26.5	34.8	151.3	60.1	181.5	50.7	3.6	84.2	215.4	144.8	161.9	104.1	242.3	53.5	109.0	132.8	22.6	47.2	16.6	112.4	92.7	24.0	255.4	192.3	58.0	315.9	264.8	5.5	69.8	342.3	409.6	6.9	1105.9	477.8	432.2	340.5	134.6	20.1	0.5	216.3	796.6	177.4	509.7	46.8	331.6	351.0	1.1	9.5	137.5	154.8	66.1	215.8	0.3	1.2	283.0	120.5	340.8	115.8	230.2	592.3	0.4	95.5	1.3	187.9	5.0	7.4	1.6	25.8	48.1	1.8	0.6	173.3	0.6	186.1	1.6	0.4	2.0	371.9	6.4	91.7	145.2	29.8	2.0	920.9	912.0	429.5	330.9	407.9	0.8	0.9	1.6	270.7	0.5	104.8	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	42.6	47.2	55.8	40.9	35.4	49.7	68.8	55.0	60.1	53.5	47.2	58.0	575.1	429.5	117.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	55.4	154.9	0.0	0.0	50.8	23.9	0.0	159.8	3.4	0.0	3.9	45.6	0.0	11.7	130.4	217.4	0.0	0.0	0.0	4.4	11.3	114.2	0.0	16.9	63.1	116.3	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.5	0.0	0.0	1.1	3.6	0.0	0.0	0.0	211.7	0.0	0.0	0.0	0.0	77.2	4.5	6.6	0.0	0.0
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997357-56005519	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.8;brain: 19.3;epididymis: 8.8"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 8.9;Excitatory neurons: 26.9;Inhibitory neurons: 31.6;Peritubular cells: 38.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"	NA	NA		10000000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.6	17.8	14.6	0.1	3.4	0.0	1.4	0.0	9.4	1.9	0.0	0.0	0.0	0.7	8.8	0.1	3.8	0.5	0.0	14.4	5.8	0.6	0.9	0.7	0.0	0.7	19.3	2.0	0.7	0.3	0.1	0.2	2.4	0.1	0.0	0.3	0.1	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.3	2.0	12.2	0.1	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	3.4	0.0	9.4	14.4	5.8	0.7	19.3	2.4	0.0	12.2	0.2	0.1	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.2	8.9	0.0	26.9	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	1.3	0.1	1.7	31.6	0.0	0.0	0.0	0.0	1.0	2.1	0.2	0.0	1.9	0.0	0.2	0.0	1.0	2.0	0.0	0.0	38.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 583.9"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 524.2;Distal tubular cells: 757.2;Proximal enterocytes: 1270.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 45: Intestine - Brush border"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	32.4	95.3	150.0	25.6	200.0	10.1	29.5	186.1	174.1	52.7	207.0	68.6	583.9	41.3	50.5	189.5	34.6	47.1	29.5	154.6	166.7	125.6	252.8	41.1	28.3	173.1	175.1	28.8	36.1	38.6	35.3	27.6	175.6	48.7	50.9	10.2	101.8	42.2	33.6	111.8	345.9	34.4	166.2	39.9	133.5	18.1	180.3	22.7	46.4	23.3	36.7	51.0	85.3	266.6	114.4	180.4	22.6	55.9	115.0	115.3	1.2	123.6	97.0	72.4	86.4	68.9	67.8	28.2	78.7	128.1	137.3	84.6	46.3	132.3	55.7	133.8	95.3	82.5	105.1	48.1	65.7	49.1	77.5	56.1	165.6	70.7	30.8	83.0	78.4	0.0	0.0	21.3	67.6	121.2	24.7	50.7	0.4	0.0	123.3	0.4	0.4	80.5	195.7	60.9	60.5	52.1	121.3	186.3	157.3	17.6	86.1	69.4	71.1	78.8	30.8	202.9	96.1	131.8	268.9	0.7	144.0	48.6	115.6	7.1	134.0	68.6	64.4	198.5	54.6	67.2	79.7	60.8	109.6	61.2	102.6	75.4	9.2	77.3	156.9	39.6	89.0	162.1	150.0	200.0	186.1	174.1	154.6	166.7	173.1	175.1	175.6	166.2	180.3	266.6	26.4	121.8	69.3	17.9	22.5	128.2	63.1	295.2	524.2	11.6	27.7	98.8	20.9	77.2	117.1	95.6	2.1	116.6	15.7	91.2	757.2	93.7	8.9	31.7	45.5	23.1	38.6	32.0	6.5	70.0	80.4	65.7	127.4	45.1	34.9	30.8	41.7	277.2	85.1	3.3	6.8	94.4	396.7	66.6	27.5	4.3	122.7	49.5	90.7	4.7	79.2	69.8	23.7	16.6	128.2	91.8	146.6	132.4	41.3	66.4	1270.3	326.0	121.2	8.3	26.3	51.3	90.7	5.8	17.4	403.5	123.6	89.2	30.7	55.6	145.8	55.0
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4"	"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	6.6	2.8	42.5	1.0	39.5	0.2	3.4	58.5	55.3	12.3	29.3	4.8	3.0	4.5	0.0	2.0	5.8	1.2	7.7	41.4	40.3	3.8	174.9	10.2	2.7	42.5	44.6	30.3	99.0	2.5	8.8	1.2	42.7	12.7	0.9	2.5	19.9	1.1	1.1	2.3	7.0	2.3	38.4	1.7	16.5	2.0	48.1	0.7	17.4	1.2	1.4	11.6	6.2	45.4	30.0	17.0	31.3	113.4	48.9	31.5	177.5	39.5	10.0	15.6	15.4	53.7	1.5	0.1	19.2	67.2	0.3	1.5	172.8	13.2	3.1	0.0	20.5	12.3	73.1	63.8	224.1	7.9	19.1	21.7	1.4	16.0	16.4	13.2	38.6	85.6	138.7	118.1	11.1	197.7	16.1	0.1	20.3	65.7	29.4	0.0	0.2	197.4	0.5	15.5	57.8	85.1	78.5	5.4	44.4	18.4	27.0	91.2	5.4	0.8	42.5	0.3	4.8	34.8	30.2	41.2	19.0	11.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	42.5	39.5	58.5	55.3	41.4	40.3	42.5	44.6	42.7	38.4	48.1	45.4	0.2	0.0	0.5	0.7	0.0	0.4	0.0	2.3	0.0	0.2	0.5	0.1	4.9	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.2	0.8	1.2	0.0	0.1	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.9	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.2	1.7	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.6	0.0	1.0	0.1	0.1	0.0	0.2	0.1
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213607	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		180000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	76.2	93.0	55.5	99.2	57.8	168.8	98.5	58.8	74.1	65.0	56.6	75.3	105.8	76.7	79.7	63.9	62.9	58.5	64.2	54.2	63.2	87.6	84.9	62.1	145.7	60.2	61.0	79.5	56.3	51.5	40.5	88.8	60.7	56.6	87.2	122.7	61.3	59.8	87.2	54.7	99.0	65.9	60.2	82.0	61.7	99.6	58.2	190.4	55.3	68.6	140.4	84.1	55.7	63.6	365.4	156.3	330.0	332.2	115.0	205.8	257.8	275.9	209.1	205.2	207.2	185.8	296.8	544.1	218.7	183.9	440.6	283.0	275.7	231.2	332.1	151.8	209.1	312.8	201.0	208.5	126.1	508.3	294.7	153.9	197.5	163.2	231.2	253.9	281.7	343.2	506.1	263.9	351.7	207.5	489.4	625.9	424.4	311.3	225.1	313.6	303.9	452.3	303.8	201.4	401.1	448.2	230.5	482.6	274.9	345.3	412.4	455.1	212.0	186.0	340.5	222.1	376.8	394.6	596.5	929.3	163.2	422.3	864.3	135.7	85.9	137.7	77.3	116.3	96.9	86.8	114.4	96.1	89.1	77.7	118.4	119.6	92.6	99.2	123.2	72.4	148.3	87.2	55.5	57.8	58.8	74.1	54.2	63.2	60.2	61.0	60.7	60.2	58.2	63.6	139.1	109.0	98.4	16.3	158.5	143.6	93.3	128.0	105.3	101.8	223.8	181.0	124.1	133.0	119.7	64.4	77.2	176.3	138.7	111.2	140.8	167.6	162.2	132.4	215.4	142.6	110.2	306.6	27.4	141.4	362.1	123.6	81.1	129.0	222.0	166.2	145.3	289.2	143.1	50.5	26.8	156.6	107.8	254.9	200.0	41.9	136.4	157.6	104.9	15.0	183.3	155.9	166.9	23.1	35.8	166.3	103.8	98.2	129.1	135.1	112.6	187.4	107.3	132.1	78.9	60.0	110.1	274.5	388.6	112.5	107.8	270.8	155.2	133.1	205.9	110.9
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430939-59697662	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 33.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.1;Rod photoreceptor cells: 38.2;Theca cells: 78.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"BJ: 101.2;BJ hTERT+: 103.2;BJ hTERT+ SV40 Large T+ RasG12V: 96.4;HBF TERT88: 113.3;hTERT-HME1: 153.2;LHCN-M2: 176.9;TIME: 93.3"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 2.7;hippocampal formation: 8.7"	"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	4.1	10.2	2.7	1.2	3.4	0.5	1.8	2.2	3.0	10.5	0.7	16.7	1.1	6.9	0.5	2.8	8.3	1.3	2.1	6.5	1.1	3.3	5.7	9.9	1.3	0.2	1.9	33.5	1.1	2.9	0.4	0.5	0.3	2.4	2.8	1.1	0.6	4.0	15.3	3.0	2.5	3.2	0.2	0.5	1.6	0.6	3.7	1.2	0.9	0.9	0.7	0.8	1.3	1.5	20.6	1.9	0.0	0.2	15.1	47.2	30.7	101.2	103.2	73.5	96.4	0.3	0.3	0.4	0.2	40.6	16.7	2.3	0.2	65.5	113.3	0.4	0.3	0.2	0.4	0.3	35.1	0.3	0.2	32.0	2.9	57.0	153.2	31.2	3.6	0.3	0.2	0.5	176.9	0.6	0.1	0.2	0.3	0.0	0.6	0.1	0.2	0.2	3.9	2.0	0.4	0.7	0.3	0.2	0.9	7.2	0.3	0.5	93.3	0.2	10.0	15.3	0.3	0.3	0.3	0.2	5.0	0.3	2.4	9.2	0.2	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.5	0.4	0.1	0.2	0.1	0.1	2.7	3.4	2.2	3.0	6.5	1.1	0.2	1.9	0.3	0.2	3.7	1.5	1.5	3.2	1.3	3.9	0.2	4.6	2.0	1.0	2.2	6.4	0.8	0.4	1.6	2.8	1.9	0.0	8.4	1.0	0.2	0.2	0.0	0.2	0.8	8.8	5.1	2.2	0.0	0.0	56.1	0.2	1.3	14.5	0.0	0.6	1.3	6.8	9.7	0.2	0.4	15.2	15.1	0.0	0.0	1.0	8.9	1.1	9.6	0.5	7.2	1.0	0.2	2.4	0.0	0.5	0.7	0.3	0.0	0.4	0.1	1.5	0.1	0.1	0.9	38.2	0.0	1.6	5.9	0.4	0.9	0.2	4.3	0.8	1.2	78.0	0.1	0.9
CCDC33	"CT61, FLJ32855"	ENSG00000140481	"Coiled-coil domain containing 33"	Q8N5R6	15	74202705-74336472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 23.6;testis: 20.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.4;ovarian cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 7.4"							NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (2.16e-1)"		"unprognostic (3.16e-3)"		"unprognostic (3.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.05e-2)"		"unprognostic (4.46e-1)"	"unprognostic (4.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.37e-2)"	0.0	0.2	0.6	0.0	0.4	0.0	0.0	0.2	0.0	2.0	0.5	0.0	0.0	0.3	0.1	0.0	23.6	0.0	0.1	0.5	0.6	0.0	0.0	2.6	0.0	2.1	3.4	0.1	0.0	0.0	0.4	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	20.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	0.6	2.1	3.4	1.6	2.3	0.4	0.6	0.2	0.0	1.5	0.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	54.2	70.1	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.5	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.1	0.0	0.0	54.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.4	56.7	0.0	0.0	0.0	1.1	0.6	0.2	0.0	0.0	1.8	0.1	0.2	0.0	0.1
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.6;Late spermatids: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NB-4: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA045624: AB_10961402, HPA072007: AB_2686482"	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	22.7	21.1	11.7	16.1	12.2	40.7	22.2	10.5	16.1	27.8	17.3	24.8	13.7	24.7	8.8	18.1	24.8	10.3	21.8	12.7	10.0	25.9	22.7	26.6	10.6	15.9	12.0	30.7	49.0	14.0	16.6	13.6	11.3	25.8	8.5	12.6	20.0	12.3	26.2	34.9	18.9	9.8	9.5	23.1	24.8	35.8	12.6	9.3	23.0	11.7	7.7	23.8	23.9	12.3	27.5	27.7	21.2	23.7	6.6	17.9	24.1	37.2	16.4	22.4	24.5	29.5	21.1	12.5	10.0	24.8	18.6	25.5	19.7	16.0	12.1	33.3	12.3	32.3	27.3	22.7	21.1	13.2	31.9	19.2	23.0	21.4	20.0	19.0	15.1	15.6	45.0	61.8	15.0	32.8	15.4	116.9	23.7	45.3	10.8	26.9	20.2	14.4	10.2	19.7	8.3	21.1	50.5	36.4	20.3	17.3	30.2	26.7	20.9	25.8	23.0	15.6	32.2	20.5	38.5	19.0	24.2	17.8	20.3	0.4	1.1	2.0	1.3	1.4	0.7	0.6	1.0	1.0	0.9	0.9	1.0	0.7	3.6	1.1	0.8	1.4	1.9	0.4	11.7	12.2	10.5	16.1	12.7	10.0	15.9	12.0	11.3	9.5	12.6	12.3	13.6	6.4	1.7	1.3	16.4	14.0	15.7	1.8	12.0	3.1	8.9	5.2	3.0	2.8	1.9	1.8	4.2	5.4	9.3	13.1	5.9	7.5	50.6	13.0	10.3	9.7	3.6	8.2	1.4	11.2	9.1	7.6	14.3	16.8	8.2	4.3	3.3	3.6	5.8	0.0	1.0	12.0	2.0	7.8	14.4	79.3	4.4	9.8	7.2	1.9	10.4	1.8	7.2	0.5	0.9	11.1	11.5	3.8	15.2	8.9	7.8	6.7	2.1	7.6	6.6	8.7	10.5	2.8	7.5	12.7	17.8	15.3	12.2	5.3	8.4	13.5
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7043001	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 65.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.7;Endometrial ciliated cells: 59.7;Late spermatids: 93.4;Respiratory ciliated cells: 53.4;Spermatocytes: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 5.3"									HPA047546	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	2.0	2.0	0.5	2.4	1.3	1.2	2.4	2.1	1.1	6.0	0.8	0.9	0.8	0.7	1.3	10.7	0.8	0.6	2.5	2.1	1.4	0.5	1.7	0.8	3.4	3.7	0.7	1.3	1.0	3.3	0.5	3.0	1.0	0.6	1.8	1.0	1.1	1.1	1.7	0.8	0.6	2.7	0.8	1.1	65.4	2.6	0.7	1.5	0.7	0.6	0.7	0.9	1.9	1.0	2.7	1.4	1.1	1.8	1.2	0.3	2.7	1.6	3.0	1.8	0.9	2.4	0.6	0.7	1.5	3.9	1.2	0.5	1.2	0.9	0.1	0.4	0.6	1.1	0.7	0.9	0.8	1.5	1.1	1.3	1.8	0.2	0.3	1.2	1.9	0.4	0.2	1.9	2.4	1.6	1.0	0.5	0.9	1.6	0.6	0.9	0.1	5.3	1.0	3.8	0.8	2.2	1.0	0.5	1.3	1.0	1.5	1.3	2.5	0.7	1.5	2.1	0.0	0.1	0.5	1.9	0.0	0.8	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.1	2.0	2.4	2.4	2.1	2.5	2.1	3.4	3.7	3.0	2.7	2.6	1.9	3.1	0.0	4.8	0.0	1.0	0.6	0.8	2.8	0.6	4.0	3.7	3.2	0.9	0.0	6.9	3.7	12.5	0.6	0.7	2.5	1.9	2.2	76.7	59.7	4.0	2.3	5.4	0.0	0.0	1.1	0.6	1.5	0.5	2.4	0.0	0.6	2.9	0.9	1.2	0.0	0.0	1.9	4.1	2.2	0.9	93.4	3.1	1.7	1.8	0.0	1.1	6.9	0.0	0.0	0.0	1.7	2.7	4.1	0.1	1.2	0.2	4.5	53.4	19.6	0.0	4.6	2.3	30.6	3.6	1.2	1.0	0.5	0.8	2.7	0.8	0.9
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266185	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 317.9;choroid plexus: 89.5;intestine: 115.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 236.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 74.4"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA	43700000			"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.2	0.9	134.4	0.5	202.6	0.0	0.2	85.8	317.9	0.0	89.5	4.4	115.7	0.0	0.0	0.3	0.5	0.0	0.1	160.1	96.9	1.2	0.4	3.4	0.0	99.9	103.4	0.1	0.4	0.0	18.4	1.1	94.5	19.5	0.1	4.4	0.2	0.2	0.2	0.4	17.0	0.2	93.9	0.0	2.1	2.3	123.9	0.2	0.1	0.0	0.0	0.1	0.1	143.7	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	236.5	0.1	0.0	0.0	1.1	25.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.4	202.6	85.8	317.9	160.1	96.9	99.9	103.4	94.5	93.9	123.9	143.7	0.4	0.0	0.0	40.1	0.2	5.7	1.3	0.3	0.6	6.8	1.3	1.9	0.3	0.0	0.2	5.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	2.5	0.0	0.0	154.8	0.4	0.1	42.5	5.1	0.4	0.0	0.0	1.4	0.0	0.1	0.0	157.7	11.4	2.0	0.3	3.0	0.3	0.0	0.6	40.9	34.7	0.0	36.7	0.0	34.7	40.9	0.7	0.0	0.0	0.0	63.8	0.6	0.1	0.0	3.5	0.0	0.8	6.4	0.1	1.7	0.0	1.3	10.5	0.0	0.0	0.5	8.7
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983288-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 632.7"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 1156.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"HUVEC TERT2: 92.1"					"Low region specificity"	"Detected in all"			"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	NA	NA	5200000	37000000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	411.9	102.7	0.4	6.4	0.3	3.3	400.7	0.2	1.7	192.0	2.8	66.6	2.9	198.0	59.3	62.0	233.5	69.3	98.6	0.3	0.3	69.2	82.6	66.4	49.0	0.5	0.3	44.1	22.6	12.4	39.5	0.9	0.7	97.4	9.8	0.0	61.9	49.5	55.9	93.3	50.5	94.3	0.4	632.7	67.5	16.0	0.4	34.4	123.9	24.5	28.2	116.8	177.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.7	0.3	0.3	0.5	0.3	0.7	0.4	0.4	0.3	136.5	0.0	8.2	0.0	2.2	1.9	0.1	0.0	3.4	0.0	0.6	1.1	0.2	18.6	0.6	0.0	0.0	0.0	0.1	2.0	0.0	0.0	24.2	0.4	0.3	203.8	0.0	26.7	0.0	0.0	0.0	9.4	0.0	0.2	1.3	0.0	1156.5	11.0	0.3	0.0	0.0	1.0	0.0	58.8	3.1	63.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	2.3	1.1	2.6	0.0	0.0	0.3	2.3	0.0	0.0	2.0	1.4	0.0	1.8	0.1	0.6	0.2
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"liver: 120.3"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 262.0"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 10.1"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	2780000	23000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.2	0.5	0.2	0.2	0.0	0.0	0.3	120.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	262.0	0.0	0.0	0.0	0.2	0.0	4.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064272-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lung: 48.7"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 189.1;Langerhans cells: 104.3;Macrophages: 153.1"	"Cancer enhanced"	"Detected in all"		"lung cancer: 76.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	NA	NA	55500000	6400000		"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	9.7	0.3	0.0	2.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	2.0	3.9	0.1	0.0	0.9	0.4	0.0	1.6	0.0	0.0	0.2	0.3	48.7	7.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	2.5	0.0	0.0	0.9	9.2	1.5	0.0	4.0	0.2	0.5	0.1	6.1	1.1	0.0	5.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	25.4	0.0	1.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	13.6	0.0	0.0	0.5	4.2	0.0	0.0	0.0	24.5	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.1	0.0	0.4	0.7	189.1	0.0	0.0	0.0	0.0	4.2	104.3	5.3	0.0	153.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.4	0.9	0.0	0.1	0.1	3.4	1.6	2.9	0.0	0.0	0.0
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 756.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 7.5;eosinophil: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.0;monocytes: 7.5"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 1902.2;HMC-1: 2427.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 9.9;spinal cord: 39.4"	"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	390.9	129.8	15.6	167.2	15.1	96.5	76.8	14.7	26.8	20.4	24.4	169.5	41.2	30.2	15.0	47.1	85.6	256.5	305.8	16.0	21.1	229.5	161.1	405.1	78.4	32.7	16.5	19.3	141.6	34.6	70.5	39.1	21.9	153.1	103.5	11.5	47.0	45.4	19.6	40.3	80.3	150.7	21.4	73.2	121.2	12.1	43.3	142.7	84.4	47.0	16.6	756.1	36.3	25.3	0.1	15.3	40.4	0.0	110.7	94.5	0.3	116.6	1902.2	243.3	516.8	7.1	0.2	0.3	90.4	27.6	3.8	64.0	4.3	0.1	122.9	0.6	0.9	0.2	13.5	0.0	3.5	0.4	2427.9	105.9	0.0	50.6	2.9	162.6	112.4	0.0	6.5	20.2	0.0	0.0	0.7	19.6	5.8	0.0	0.4	0.6	3.3	20.9	354.7	0.0	0.1	8.1	0.3	6.0	3.3	108.4	4.6	2.5	6.4	129.0	5.7	3.6	0.7	1.2	0.5	0.1	75.7	37.6	84.3	0.0	7.5	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	15.6	15.1	14.7	26.8	16.0	21.1	32.7	16.5	21.9	21.4	43.3	25.3	218.3	182.7	126.5	2.0	3.6	568.6	866.2	595.3	1152.5	0.1	23.5	50.9	29.5	92.9	120.7	138.0	0.0	2.7	2.2	0.0	0.0	3382.2	0.0	8.4	37.8	577.2	0.0	0.0	0.7	919.2	3.6	840.5	5.6	11.4	353.0	0.1	50.3	0.4	439.1	0.0	0.1	0.0	6.1	8.9	408.5	0.4	12.2	593.1	213.5	8.4	37.8	13.8	0.0	0.0	0.1	781.2	0.0	1.5	2.9	889.0	0.0	67.7	27.7	0.7	131.5	994.7	1507.0	0.4	0.3	13.0	222.8	4.5	44.3	1.7	0.1	40.6
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710136	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 2726.3"	"Cell type enriched"	"Detected in many"	8	"Endothelial cells: 1213.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;K-562: 1.2"					"Low region specificity"	"Detected in some"			HPA051210	Enhanced				"Secreted to blood"	NA	NA	198000	920000		"Cluster 16: Immune cells - Immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	173.7	46.9	0.0	269.5	0.1	0.0	180.7	0.1	0.3	154.7	0.6	111.7	46.3	75.6	34.1	128.2	253.3	80.8	41.7	0.1	0.1	75.1	66.0	196.4	2726.3	0.4	0.0	33.9	15.3	0.8	2.5	1.7	0.2	38.2	135.7	0.0	21.5	19.0	6.8	46.4	498.8	69.0	0.0	336.8	60.9	10.3	0.1	28.8	519.4	30.6	998.8	74.1	50.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.7	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.2	58.4	22.4	53.3	0.0	1.9	145.3	2.4	3.8	1.8	0.0	13.5	4.3	10.1	0.0	13.0	1.8	0.0	0.2	1.4	0.2	0.0	10.0	5.7	0.1	0.3	1213.6	0.0	2.7	0.0	3.6	0.2	22.9	0.0	0.2	11.4	0.0	107.1	0.5	0.6	0.0	0.0	2.1	0.0	1.8	148.8	11.0	0.6	6.5	144.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	29.6	1.5	0.0	0.0	10.2	0.0	0.0	3.4	120.0	0.2	0.3	11.5	137.7	0.3	9.2	0.0	0.0	0.4
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017972	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Hepatic stellate cells: 243.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	163	"eosinophil: 183.7"	"Lineage enriched"	"Detected in many"	163	"granulocytes: 183.7"	"Group enriched"	"Detected in some"	4	"HEL: 17.6;THP-1: 37.4"									HPA042015	Uncertain				"Secreted to blood"	NA	NA	937000	130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	7.9	6.7	0.0	7.0	0.0	3.7	7.3	0.0	0.2	18.5	0.1	4.3	0.2	14.8	1.6	4.7	11.9	3.3	0.7	0.0	0.0	12.0	7.5	21.4	1.6	0.0	0.0	2.9	1.0	0.0	0.3	0.3	0.0	8.6	8.7	0.0	3.5	0.3	0.5	3.6	9.3	10.8	0.0	14.1	3.3	0.6	0.1	0.8	3.1	0.1	1.3	5.5	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	1.0	0.7	183.7	0.1	0.7	0.0	1.0	0.0	0.4	0.7	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.5	3.2	2.3	0.0	0.9	1.7	0.4	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.6	0.0	0.0	0.0	0.7	1.6	0.0	0.0	1.6	0.0	0.2	44.6	0.0	5.7	0.0	0.0	0.0	0.7	0.0	0.0	10.1	0.0	243.8	2.6	7.0	0.0	0.0	0.5	0.0	14.7	2.7	0.1	0.0	3.7	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21.4	0.0	0.1	0.1	0.5	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.1	2.7	0.3	0.6	0.0	4.2	0.2
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 122.1;lymphoid tissue: 135.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 6788.6;memory CD8 T-cell: 7164.3"	"Group enriched"	"Detected in all"	7	"NK-cells: 2041.1;T-cells: 7164.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1"									CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	2900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	17.2	17.1	3.9	36.3	4.0	122.1	19.5	3.8	6.5	15.5	5.4	27.7	48.7	15.7	14.4	15.8	14.0	42.9	8.9	3.9	3.7	7.5	28.4	57.4	135.2	7.3	4.3	16.9	7.0	3.0	3.8	6.3	6.4	10.4	25.6	0.3	33.5	7.9	4.8	4.0	84.5	10.5	5.8	123.9	47.9	4.6	4.7	29.5	11.5	2.7	33.4	31.4	9.5	6.1	0.7	0.5	0.2	0.0	0.5	0.4	0.8	0.3	4.0	17.8	20.8	0.4	1.7	0.3	1.6	0.9	1.3	0.9	0.0	0.0	2.3	6.5	0.3	0.0	1.5	0.6	0.5	94.1	0.8	0.1	0.2	5.5	0.3	0.0	0.2	0.1	0.1	12.5	0.2	0.6	0.1	539.9	0.5	0.0	0.0	0.6	0.2	14.0	0.2	0.5	0.1	0.5	0.2	1.2	13.4	0.5	0.2	139.9	0.3	0.6	0.3	0.6	0.4	14.2	6.6	0.8	0.4	120.1	1.3	657.8	30.0	35.8	6788.6	21.3	4221.0	61.3	1394.5	7164.3	49.8	41.6	332.4	4032.4	189.9	2041.1	26.1	46.5	25.9	6664.4	3.9	4.0	3.8	6.5	3.9	3.7	7.3	4.3	6.4	5.8	4.7	6.1	22.4	99.3	244.4	0.3	55.2	7.4	1.3	6.0	4.6	1.3	19.9	18.2	5.4	21.5	41.7	1.8	0.0	1.8	2049.9	3.1	1.9	6.3	1.2	5.5	5.4	24.2	1.8	106.3	0.5	0.2	7.1	26.0	46.9	6.7	80.8	0.2	45.0	7.0	33.8	0.0	0.3	3.5	0.0	48.0	25.0	0.1	0.3	256.3	12.4	2.8	38.5	0.4	2344.0	0.0	0.4	1.6	6.9	0.4	179.5	1.7	2.4	6.7	29.2	1.1	0.0	6.5	28.2	1.1	1.2	5.5	6.3	16.0	1947.0	0.1	3.5	1.9
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 141.6"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.9	5.4	7.2	1.6	7.3	0.0	15.0	9.5	6.8	8.7	4.2	4.6	1.3	8.9	0.6	3.7	7.7	2.5	23.2	6.1	5.8	13.3	2.2	11.8	1.5	6.8	6.4	3.6	2.6	1.4	4.1	7.8	7.0	5.8	1.1	0.4	3.4	1.8	4.8	3.9	5.4	3.3	6.1	141.6	4.2	1.6	7.3	0.8	10.2	4.8	0.9	6.4	6.3	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	7.3	9.5	6.8	6.1	5.8	6.8	6.4	7.0	6.1	7.3	5.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CCN2	"CTGF, IGFBP8"	ENSG00000118523	"Cellular communication network factor 2"	P29279	6	131948176-131951372	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	81	"B-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	265.9	107.5	18.9	168.0	18.8	2.0	206.4	16.3	34.0	531.0	31.5	148.8	43.7	418.5	34.4	271.9	243.8	441.4	371.8	25.8	14.2	235.7	82.9	226.3	73.6	18.8	32.1	77.0	194.0	43.0	44.8	198.2	20.2	364.6	136.1	2.4	138.2	154.3	51.8	155.1	151.2	576.3	14.2	569.1	182.6	24.7	20.8	49.5	464.7	61.9	14.9	324.0	102.5	18.2	4.6	7.5	126.8	3.7	279.9	158.5	1.8	373.1	178.2	226.8	119.4	0.2	12.2	0.6	1605.0	482.7	185.0	6.2	4.2	26.4	211.3	2.5	3.5	0.2	55.7	137.3	109.6	0.3	0.5	232.2	5.9	163.9	40.2	340.7	1377.0	0.0	0.4	0.3	650.8	2.5	0.5	1.2	61.8	41.3	21.7	32.6	6.0	0.7	81.9	0.4	0.5	0.8	38.3	62.2	18.3	308.5	6.1	3.1	2874.4	311.6	242.4	397.8	694.0	11.5	1.7	4.1	42.5	0.7	399.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.9	18.8	16.3	34.0	25.8	14.2	18.8	32.1	20.2	14.2	20.8	18.2	101.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	47.1	261.8	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCN5	"CT58, CTGF-L, WISP-2, WISP2"	ENSG00000064205	"Cellular communication network factor 5"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 394.6;cervix: 355.7"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 165.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 42.6;ASC TERT1: 113.8;HeLa: 62.7;HSkMC: 46.5;U-2197: 375.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB019273	Approved				"Secreted to extracellular matrix"	NA	NA		1200000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	394.6	41.5	1.8	0.7	2.0	0.2	116.5	0.9	2.9	355.7	0.7	23.6	0.7	35.3	0.7	25.4	39.0	7.7	161.1	1.6	1.3	0.7	5.6	136.4	1.9	1.4	1.4	147.1	4.4	0.6	0.8	1.4	1.4	37.0	1.6	0.1	30.7	25.5	39.2	197.1	11.5	6.5	1.0	4.0	11.4	33.1	1.4	1.3	14.2	5.1	0.4	36.7	111.6	1.5	0.0	3.7	0.1	0.0	42.6	113.8	0.0	0.2	1.2	0.1	0.2	0.0	0.0	0.1	0.5	0.7	3.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	62.7	0.0	0.1	0.1	0.1	46.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	1.1	0.3	0.0	1.9	0.2	0.0	0.1	0.2	375.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.9	2.9	1.6	1.3	1.4	1.4	1.4	1.0	1.4	1.5	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	51.2	48.8	21.0	30.4	23.0	38.3	67.2	22.9	25.8	63.4	27.8	68.0	137.2	50.5	73.4	47.8	61.8	56.7	50.4	19.1	23.4	123.5	129.6	33.4	49.0	24.7	21.6	112.0	74.4	39.7	14.6	54.0	25.0	71.4	87.0	21.3	56.3	55.7	163.6	23.5	109.1	52.3	23.5	35.5	57.3	20.7	21.7	50.3	62.4	120.6	47.0	59.7	33.8	28.6	54.9	59.8	246.6	138.8	207.9	397.3	258.2	74.1	181.2	73.8	165.2	130.4	109.4	134.1	73.7	100.1	121.7	22.2	137.2	185.0	107.9	63.7	171.9	106.6	71.7	230.0	226.4	49.9	68.9	433.8	105.6	73.3	75.1	221.5	241.1	88.3	92.3	92.8	253.4	33.8	89.6	66.5	113.3	40.1	52.7	74.6	120.7	75.2	179.5	209.4	57.6	65.6	0.4	30.5	154.0	155.2	115.5	155.8	140.5	47.6	101.0	40.8	66.2	81.5	34.2	87.7	84.3	81.4	80.6	44.5	25.6	31.0	35.8	36.1	53.9	55.4	63.2	49.3	59.6	33.9	84.5	72.0	10.9	40.7	36.7	22.6	80.9	63.9	21.0	23.0	22.9	25.8	19.1	23.4	24.7	21.6	25.0	23.5	21.7	28.6	20.8	25.6	20.0	7.5	67.3	57.2	94.7	64.7	103.0	12.4	64.4	33.0	52.9	77.2	39.7	36.8	0.0	138.7	49.8	48.2	162.4	73.0	8.1	30.6	27.5	43.5	71.0	96.3	8.4	119.0	107.7	57.1	110.6	46.1	43.7	108.8	61.1	51.7	60.0	15.2	8.8	113.2	44.7	74.8	70.5	6.1	75.8	60.8	37.4	15.0	52.0	29.9	54.6	4.5	12.7	91.1	80.2	72.2	63.5	107.2	223.4	265.9	11.2	10.8	39.5	42.4	73.4	8.8	12.1	61.5	44.2	97.3	76.4	81.5	182.7	104.3
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233608	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation"	Cyclin	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.3;pancreas: 10.1;testis: 13.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 39.3;Club cells: 51.4;Collecting duct cells: 33.1;Endometrial ciliated cells: 38.1;Ionocytes: 61.1;Respiratory ciliated cells: 97.2;Spermatocytes: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 5.2;T-47d: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA050090	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA050090: AB_2681011"	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favorable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.1	0.4	1.3	0.0	2.8	0.0	0.5	1.1	2.3	1.0	12.3	0.3	0.3	0.2	0.3	1.0	2.1	0.1	0.1	2.2	1.8	1.9	0.2	1.3	0.0	1.7	1.9	0.8	10.1	1.1	5.3	0.1	1.1	2.0	0.0	0.1	1.8	1.2	0.0	1.8	0.5	0.0	1.2	0.0	5.6	13.2	2.0	0.0	5.5	0.0	0.0	1.8	0.4	1.3	2.8	3.2	0.0	1.6	0.2	0.0	5.2	0.0	0.0	0.4	0.5	0.0	3.1	0.0	2.0	0.0	1.0	2.6	0.1	0.0	0.0	0.0	4.1	0.1	3.5	0.3	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.4	0.0	1.3	0.1	0.0	0.0	2.7	0.0	0.1	0.2	0.4	4.4	1.5	0.3	0.0	1.2	1.0	1.9	0.0	3.5	0.8	1.1	0.0	7.5	0.5	0.2	0.0	2.2	2.8	1.2	2.6	1.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	1.1	2.3	2.2	1.8	1.7	1.9	1.1	1.2	2.0	1.3	0.2	0.0	1.5	0.7	0.0	1.0	3.7	39.3	5.7	11.9	9.2	5.0	0.5	2.8	51.4	33.1	6.2	0.7	0.3	2.7	0.0	4.2	12.5	38.1	0.5	0.3	0.0	0.0	2.8	28.5	1.9	0.6	13.3	5.4	0.0	0.1	0.0	0.0	0.1	1.7	0.3	3.4	61.1	0.0	0.7	4.4	1.2	0.2	1.8	0.0	0.0	0.1	0.0	0.5	0.1	11.1	2.7	0.4	0.0	7.9	5.7	1.0	97.2	0.5	0.0	0.3	5.1	53.9	21.5	3.3	2.4	0.3	0.2	0.0	4.2	5.9
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	9.4	9.6	5.3	9.6	5.5	29.4	9.9	7.3	6.4	7.1	7.8	7.7	6.7	9.2	8.2	7.8	8.2	7.1	6.8	4.7	8.6	8.9	8.4	8.3	11.7	5.7	5.8	10.8	8.8	11.5	6.7	7.9	5.7	7.6	8.3	12.2	6.3	7.0	10.2	9.6	7.8	7.9	6.1	10.5	7.3	11.5	6.3	13.0	11.7	9.9	11.3	7.5	6.9	7.5	15.1	21.8	20.6	19.8	14.9	18.2	23.8	20.0	16.6	15.3	11.8	26.0	17.3	40.4	25.6	13.4	10.4	19.3	35.6	13.7	22.6	24.0	20.5	43.9	34.2	11.2	18.4	45.1	20.0	14.1	19.6	21.4	25.3	21.0	11.9	23.5	44.7	18.1	18.9	9.9	24.6	20.9	20.7	8.7	16.1	21.8	33.4	17.0	14.0	26.2	23.0	24.0	32.0	15.5	23.5	14.9	21.3	25.8	12.5	16.1	17.0	11.7	17.1	25.8	37.0	35.3	19.1	64.9	9.4	9.0	2.6	7.7	3.3	1.7	4.5	4.3	2.7	3.2	1.6	5.3	3.9	3.6	13.6	3.5	2.0	4.4	1.8	0.9	5.3	5.5	7.3	6.4	4.7	8.6	5.7	5.8	5.7	6.1	6.3	7.5	41.4	16.0	18.9	16.0	38.0	38.5	19.4	11.8	48.9	23.5	21.9	19.0	14.4	12.8	16.1	12.9	22.9	13.8	58.7	13.1	3.9	8.2	131.4	18.9	23.7	26.4	12.0	24.0	18.9	6.9	16.7	23.9	29.0	26.1	29.8	27.3	27.8	15.2	10.2	38.7	18.5	15.8	14.2	17.5	33.0	27.9	16.8	29.9	21.4	19.7	12.1	16.2	18.6	18.6	22.6	8.1	9.2	14.7	37.8	26.2	13.3	9.8	25.1	16.3	6.6	23.3	28.5	18.3	14.4	32.1	44.9	17.4	45.0	27.3	13.7	33.3
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.44e-4)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (3.28e-4)"	13.4	12.1	10.1	12.2	10.2	29.0	15.6	13.7	12.4	16.4	10.6	13.0	13.4	13.5	14.8	12.8	14.0	9.4	11.7	9.9	10.8	10.9	18.3	14.9	15.5	10.4	10.0	17.4	19.8	15.0	15.1	12.0	10.8	13.5	12.1	19.0	13.0	10.7	10.3	15.4	14.4	8.5	11.1	15.6	14.8	12.3	10.5	14.4	14.5	9.7	14.1	15.0	16.3	14.4	9.0	4.4	28.0	10.5	13.6	13.7	21.3	12.2	9.9	11.2	13.9	11.9	10.1	14.6	8.9	10.0	5.4	11.4	17.0	9.1	16.3	7.9	11.5	15.8	11.9	16.9	13.3	14.3	13.4	12.6	17.6	11.1	13.5	14.4	16.8	10.8	13.4	14.6	13.2	6.1	16.0	21.2	22.8	7.4	9.0	15.2	10.0	11.7	17.4	24.4	19.1	15.8	8.9	10.3	14.2	20.3	10.8	17.3	15.3	14.4	15.9	6.2	9.0	10.2	6.7	15.1	9.0	11.2	12.5	3.8	1.6	2.0	1.7	2.0	2.1	1.6	1.9	2.1	2.1	1.2	3.3	2.6	2.1	2.8	1.0	1.9	2.6	1.3	10.1	10.2	13.7	12.4	9.9	10.8	10.4	10.0	10.8	11.1	10.5	14.4	27.1	25.6	26.0	49.6	38.0	15.0	28.8	17.9	26.7	34.7	21.6	15.4	23.5	14.3	21.8	14.7	33.3	11.9	35.3	22.4	7.9	16.2	5.5	20.2	30.2	21.5	18.5	20.0	73.6	14.9	9.6	23.7	46.9	33.1	11.4	31.1	18.9	20.9	10.1	42.1	70.1	16.4	6.1	15.7	22.1	14.6	14.0	25.2	8.8	52.5	23.6	12.9	19.6	76.9	81.8	14.2	19.0	22.2	26.5	35.4	19.1	7.0	12.4	34.5	19.7	17.7	24.2	17.7	23.6	25.3	18.2	13.7	29.0	25.2	17.1	50.5
CCP110	"CP110, KIAA0419"	ENSG00000103540	"Centriolar coiled-coil protein 110"	O43303	16	19523811-19553408	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 210.2;Respiratory ciliated cells: 118.8;Spermatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039402	Approved		Approved	"Centriolar satellite"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Centriolar satellite"		"HPA039402: AB_10671041"	"unprognostic (2.83e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.37e-1)"	5.6	5.9	23.6	6.6	41.3	15.7	9.2	22.7	34.5	7.3	11.4	5.5	3.9	9.2	7.3	6.6	13.3	5.9	4.7	22.6	25.1	4.5	3.6	8.6	8.2	27.4	30.2	10.5	4.0	11.5	11.8	4.9	25.2	7.3	5.6	13.8	5.2	6.9	5.0	5.9	4.9	7.9	18.6	6.4	6.4	35.8	30.7	16.5	7.1	5.8	7.7	6.2	5.2	48.1	22.4	10.2	24.7	24.1	12.1	10.7	12.7	23.4	13.5	20.4	22.9	8.3	11.7	32.8	14.5	11.6	15.5	15.4	25.6	7.4	34.2	15.1	11.6	16.4	14.5	14.3	6.0	42.6	20.2	5.3	10.0	23.0	14.0	12.6	15.9	33.1	17.5	16.0	24.1	17.3	43.8	16.5	19.0	10.7	7.6	55.1	46.1	11.5	9.3	9.3	48.5	24.5	25.4	11.9	7.6	16.4	21.9	25.6	9.5	23.7	15.6	16.0	19.5	17.6	17.7	23.5	15.2	18.0	14.1	14.5	2.8	5.2	3.8	2.7	2.4	2.5	3.4	3.7	3.0	3.2	3.8	2.2	5.5	1.7	4.3	2.0	2.9	2.0	23.6	41.3	22.7	34.5	22.6	25.1	27.4	30.2	25.2	18.6	30.7	48.1	9.3	32.1	34.6	19.9	12.7	13.5	9.2	10.8	14.8	18.1	16.4	11.2	14.7	8.6	27.6	23.9	33.3	11.4	19.4	6.9	5.9	9.2	5.1	75.1	19.5	10.7	1.2	46.3	30.6	4.7	7.0	15.7	10.2	13.5	30.3	12.5	12.1	7.5	7.0	30.3	30.9	9.9	6.1	18.2	12.8	9.0	21.1	10.7	10.6	13.1	11.6	14.5	12.3	21.1	210.2	9.0	6.0	16.6	12.7	9.2	8.0	5.3	118.8	66.0	19.7	22.5	12.5	169.2	38.6	13.3	14.6	24.5	14.4	9.5	6.1	6.9
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.1;Bipolar cells: 12.8;Plasma cells: 62.7;Sertoli cells: 19.7;Smooth muscle cells: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"plasmacytoid DC: 24.7;T-reg: 72.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.7;T-cells: 72.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.4;RPMI-8226: 6.5;U-266/70: 17.1;U-266/84: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	4.5	2.1	1.1	0.7	1.1	0.2	5.2	3.1	2.7	6.6	0.0	4.8	1.8	8.5	0.3	0.8	8.5	0.2	4.4	0.7	6.5	2.8	0.8	4.1	0.3	3.9	4.6	6.2	2.3	0.0	20.2	0.7	6.6	3.8	0.2	0.7	2.2	0.6	4.7	1.5	3.1	0.5	1.0	3.2	2.6	4.0	4.0	0.2	2.8	0.4	0.0	2.4	3.2	1.2	0.5	0.8	0.8	4.7	0.3	0.7	1.1	1.7	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	1.6	0.8	0.0	0.1	0.1	2.0	1.2	0.0	3.2	0.4	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.5	0.1	0.3	2.6	8.4	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.1	6.5	1.1	0.0	0.7	1.0	0.4	0.0	0.2	0.3	0.8	0.9	1.9	2.1	0.5	0.7	0.2	17.1	8.4	2.5	1.3	0.6	0.9	0.0	0.6	0.2	0.4	0.1	0.3	5.3	10.9	5.4	0.4	5.9	1.3	1.8	0.2	0.2	0.4	24.7	72.4	1.5	1.1	1.1	3.1	2.7	0.7	6.5	3.9	4.6	6.6	1.0	4.0	1.2	7.3	0.0	0.0	0.7	14.1	0.8	0.3	0.4	0.6	12.8	1.0	1.3	2.1	0.0	0.1	0.0	0.0	0.2	0.6	0.0	3.9	0.3	0.5	1.6	2.9	2.9	1.8	0.0	5.1	0.5	0.3	5.4	1.5	0.9	0.0	0.6	2.2	0.2	1.9	1.7	4.6	0.6	2.0	2.5	3.7	2.5	5.6	1.2	5.4	0.0	3.8	2.5	2.1	1.0	1.3	0.3	0.1	2.6	62.7	0.3	0.2	0.7	1.0	3.2	19.7	2.3	16.7	1.6	2.1	0.3	0.3	0.0	2.9	1.9	0.7	0.1
CCS		ENSG00000173992	"Copper chaperone for superoxide dismutase"	O14618	11	66593153-66606019	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008672, HPA040026, HPA044090"	Approved					NA	NA		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805"	"unprognostic (1.19e-1)"	"unprognostic (8.46e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-3)"	21.1	26.6	29.6	18.5	30.5	34.4	14.1	33.4	40.5	18.5	30.7	21.9	27.9	19.8	18.3	16.5	17.7	21.1	21.4	30.7	31.1	21.3	56.2	15.6	23.8	32.4	30.9	23.6	31.1	22.6	17.3	17.9	30.4	22.6	14.7	24.9	36.8	20.0	19.1	21.9	30.1	17.2	30.3	21.8	23.3	16.9	31.3	15.9	17.3	14.2	17.3	17.7	14.7	35.0	24.6	34.1	24.4	26.9	22.0	21.4	29.9	22.4	18.7	15.9	10.7	38.8	26.5	14.4	31.3	19.9	23.8	24.6	7.2	25.8	5.3	26.8	10.9	23.3	30.5	51.1	42.3	6.0	18.3	35.8	18.9	16.9	11.1	33.6	26.0	16.5	12.3	19.2	16.5	55.0	9.5	30.1	22.7	40.2	23.9	17.4	23.3	29.8	25.0	25.6	19.9	12.9	37.2	25.4	49.7	14.4	38.9	17.4	23.6	10.8	17.7	24.4	10.8	32.1	19.2	7.6	29.7	9.2	26.5	23.6	26.4	60.0	19.7	21.0	17.0	32.5	16.9	16.0	31.1	25.3	17.7	17.9	17.8	19.1	13.0	83.7	18.4	17.3	29.6	30.5	33.4	40.5	30.7	31.1	32.4	30.9	30.4	30.3	31.3	35.0	37.8	19.2	33.7	58.8	56.1	24.2	52.9	44.7	31.3	42.4	33.6	37.5	29.9	45.8	30.4	36.8	25.0	55.2	59.3	49.7	82.2	34.1	25.4	16.5	38.0	28.7	73.0	204.4	20.2	59.8	43.8	60.4	44.4	27.2	21.5	63.9	39.3	163.5	64.9	11.8	19.1	41.1	26.4	35.8	32.3	12.6	71.4	43.8	44.4	23.4	38.5	65.4	44.3	15.1	20.6	40.5	44.9	57.2	50.6	31.2	90.4	132.9	19.7	104.2	19.7	31.8	67.1	46.7	31.4	30.1	20.3	51.6	41.0	191.3	46.7	37.2
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585426-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1471.3;Spermatocytes: 625.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol		NA	NA		3500000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (8.38e-4)"	"prognostic unfavorable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	64.0	69.9	56.8	77.7	61.3	140.5	85.5	62.4	70.6	51.9	68.4	70.6	53.2	66.9	43.7	69.4	69.5	54.7	68.6	60.6	64.4	92.9	72.2	46.6	94.9	62.4	59.5	65.2	53.3	71.6	37.8	70.2	62.5	57.9	85.9	57.5	45.4	52.5	103.9	55.9	51.5	83.3	62.2	51.5	52.0	216.0	59.8	100.7	56.1	73.2	108.8	106.6	49.6	63.8	266.1	388.1	343.8	330.7	154.2	174.5	392.3	280.4	203.8	448.0	276.1	529.7	121.7	572.6	266.2	222.9	281.8	250.2	538.2	313.0	536.6	319.1	398.6	418.7	313.5	331.8	171.8	520.1	255.5	152.7	195.3	425.9	248.1	308.7	296.4	311.4	519.2	165.0	410.2	378.9	496.0	446.7	482.4	273.2	403.7	389.3	375.9	373.1	369.4	476.9	334.1	281.3	291.0	314.2	289.2	284.3	411.4	371.6	196.0	231.4	292.2	275.0	427.3	203.5	409.6	614.6	201.9	354.8	290.8	36.6	41.0	12.5	47.3	66.0	72.7	74.2	54.0	61.5	72.9	60.7	62.2	68.5	3.7	65.3	62.1	66.9	63.7	70.0	56.8	61.3	62.4	70.6	60.6	64.4	62.4	59.5	62.5	62.2	59.8	63.8	80.4	35.3	47.4	17.3	97.2	136.6	233.9	173.8	126.3	51.1	70.1	89.7	81.5	57.2	110.8	80.9	79.2	189.1	93.3	48.1	92.0	198.8	1471.3	150.9	126.5	95.3	106.2	226.4	21.5	128.4	209.1	102.1	60.6	107.1	105.4	112.3	52.5	46.2	127.1	42.1	31.3	94.4	109.9	44.3	74.9	430.3	76.7	70.5	46.2	11.2	87.7	67.9	57.7	21.6	20.6	150.7	50.8	66.5	100.7	165.8	34.4	127.4	127.5	56.6	85.5	128.4	178.3	625.4	391.5	112.1	117.3	153.4	93.9	154.1	154.8	161.9
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	85.3	122.3	121.4	103.0	125.8	79.5	119.4	132.2	176.7	77.1	139.0	95.3	87.2	93.6	77.1	106.9	119.9	67.4	100.8	125.3	135.5	114.5	108.3	60.1	123.9	129.4	126.1	113.5	82.3	120.4	65.3	93.3	129.5	86.6	112.9	135.7	74.9	89.8	134.8	93.8	83.3	137.3	132.4	67.1	80.7	120.3	130.2	129.1	87.6	120.8	148.5	136.7	70.6	143.8	432.3	562.3	324.3	311.9	352.5	261.2	419.7	388.8	315.9	617.9	378.0	611.1	396.3	689.5	442.3	337.9	392.5	395.5	1045.2	519.9	519.1	384.3	660.6	437.6	438.6	579.2	261.9	547.7	357.2	333.7	312.4	556.6	514.7	303.3	531.6	425.3	795.2	250.1	375.5	603.5	688.2	372.1	656.4	859.5	702.1	587.3	314.5	771.1	496.9	349.9	434.9	448.1	347.0	635.0	388.7	531.0	560.2	707.3	366.1	249.0	373.0	263.3	717.1	457.5	808.2	975.7	288.1	349.1	408.1	75.1	107.1	49.0	129.0	137.0	171.2	142.1	144.3	138.8	171.7	156.8	177.0	156.7	14.9	145.8	146.8	120.8	164.3	222.3	121.4	125.8	132.2	176.7	125.3	135.5	129.4	126.1	129.5	132.4	130.2	143.8	82.8	54.5	62.5	18.3	104.8	144.9	241.1	247.4	119.5	124.5	133.2	118.5	121.1	98.7	132.3	90.1	106.3	226.7	100.5	71.7	113.5	208.6	111.9	118.4	137.4	122.4	125.3	134.0	29.7	183.2	217.8	113.9	70.8	86.6	73.0	180.1	74.6	88.4	162.6	74.0	34.6	93.8	193.3	83.0	96.5	226.7	83.6	78.1	112.1	22.5	153.6	158.1	105.0	37.2	41.9	199.1	78.8	88.0	95.8	169.0	115.9	212.3	137.6	244.3	118.3	110.3	145.4	410.0	232.4	123.1	159.8	184.6	112.1	347.9	149.8	157.9
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868085-61888671	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1700000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	66.4	67.0	60.4	59.9	62.6	64.9	90.2	67.1	114.9	68.4	66.7	65.1	45.8	68.7	50.8	75.6	74.4	43.1	67.0	62.3	65.7	73.5	63.7	48.7	81.4	63.9	62.6	109.3	95.3	62.8	45.9	65.8	66.1	57.8	58.9	56.8	53.7	57.5	96.7	66.4	48.5	72.0	70.4	55.3	64.5	77.6	66.0	83.3	65.3	74.0	92.0	68.4	61.2	80.0	274.5	313.6	203.1	190.1	166.2	251.5	342.5	244.6	174.3	345.6	230.4	550.5	193.2	437.9	239.7	176.5	354.6	192.4	405.8	313.9	362.3	216.0	398.9	280.4	149.4	347.7	149.3	347.8	179.1	215.0	214.4	278.8	287.2	259.5	293.3	220.0	406.5	137.2	297.5	246.4	299.6	451.2	365.3	364.2	276.0	336.9	319.2	297.4	237.5	186.2	177.6	148.8	177.2	221.9	324.5	235.7	161.9	245.6	185.2	190.6	275.5	143.3	400.1	205.3	297.3	739.8	188.9	391.7	255.7	58.2	60.7	25.0	83.2	88.9	106.9	93.6	87.1	100.8	100.4	88.6	112.9	112.2	8.4	107.5	103.3	64.3	100.7	125.2	60.4	62.6	67.1	114.9	62.3	65.7	63.9	62.6	66.1	70.4	66.0	80.0	111.8	73.7	54.3	20.9	125.4	152.6	350.8	206.6	136.1	52.9	131.3	136.4	47.7	82.9	116.7	73.5	14.6	256.5	106.5	52.8	135.0	156.0	250.0	111.9	117.2	118.0	140.6	156.9	28.0	130.6	284.9	114.9	67.8	92.8	95.8	148.2	95.3	79.4	163.5	32.0	31.3	105.9	175.0	105.0	112.4	72.1	88.3	110.2	94.3	30.0	125.8	64.9	71.1	26.7	40.8	143.9	61.4	97.8	111.9	200.3	67.9	165.2	143.1	63.3	92.1	117.2	297.8	338.8	153.2	151.2	151.3	180.6	146.6	173.7	138.2	203.8
CCT5	KIAA0098	ENSG00000150753	"Chaperonin containing TCP1 subunit 5"	P48643	5	10249929-10266389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002238, HPA005958, CAB006271"	Enhanced					NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"			"CAB006271: AB_425898, HPA002238: AB_1078427, HPA005958: AB_1846209"	"unprognostic (7.02e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (6.57e-11)"	"unprognostic (6.40e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-2)"	85.3	79.5	68.6	95.3	70.4	82.0	74.7	73.2	112.4	58.2	79.2	85.7	67.5	66.8	53.3	100.8	77.4	48.1	74.8	72.7	82.4	76.0	74.1	58.7	96.3	71.5	74.7	50.8	58.4	175.6	46.1	85.8	78.7	52.3	97.2	48.9	60.3	52.9	128.2	60.5	62.2	89.5	74.5	62.3	62.6	104.3	76.0	106.6	63.2	90.8	118.4	105.8	63.7	83.8	350.5	489.8	405.1	463.7	250.9	188.5	568.4	454.1	288.6	704.0	492.6	657.8	372.2	537.6	490.4	326.4	615.9	332.8	770.4	492.7	774.2	504.5	527.9	440.2	1063.7	510.7	293.8	667.6	303.7	221.3	300.3	556.8	368.9	191.4	422.7	343.6	597.5	188.2	453.3	494.0	481.4	659.7	432.6	348.3	579.4	437.9	304.4	275.8	447.3	359.1	304.8	335.3	953.5	424.6	335.6	316.9	327.2	490.9	285.2	576.4	517.7	214.1	687.9	192.2	322.7	570.1	323.7	955.4	470.8	125.6	181.5	139.3	117.5	248.8	155.7	151.6	131.3	130.7	188.9	125.6	121.8	123.7	101.4	147.3	286.1	69.5	150.3	255.3	68.6	70.4	73.2	112.4	72.7	82.4	71.5	74.7	78.7	74.5	76.0	83.8	81.7	67.3	41.3	12.1	71.5	88.2	172.1	206.6	60.3	46.7	50.7	54.6	23.6	51.5	116.7	49.7	18.8	214.2	60.7	81.4	49.0	217.4	235.1	127.0	107.5	92.8	70.9	98.2	16.8	162.8	271.8	81.8	62.7	101.1	48.8	100.7	40.0	52.5	175.7	35.3	19.3	89.9	116.0	69.2	64.7	93.1	83.0	84.0	40.9	13.1	92.1	56.6	72.1	19.1	22.9	199.0	81.8	75.6	59.6	128.5	61.0	99.2	131.7	60.8	72.3	81.0	272.5	282.3	184.4	93.1	74.6	155.4	66.5	170.2	126.9	126.1
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051685-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 1612.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	58.5	58.8	48.3	66.6	50.5	67.0	59.7	52.6	71.1	43.5	55.9	52.6	53.2	52.0	38.2	68.1	50.9	39.8	56.7	50.2	56.4	72.5	53.3	41.1	69.6	52.5	52.9	42.1	60.8	69.4	39.1	56.4	53.9	44.9	60.1	46.5	45.5	49.4	124.3	58.0	51.8	61.4	53.2	46.1	52.2	49.5	53.5	61.3	49.7	85.5	81.1	72.1	47.6	55.3	1612.6	357.8	211.6	322.5	145.7	181.6	243.2	293.0	165.4	284.4	227.7	407.0	196.7	487.8	222.9	192.1	511.6	333.2	438.2	339.2	390.0	276.8	328.1	306.1	337.0	363.8	157.3	444.1	240.5	157.1	191.1	287.8	284.4	224.8	283.7	221.2	682.0	121.2	325.5	199.2	346.4	392.7	449.3	356.6	466.8	315.1	213.9	284.8	321.6	302.3	280.3	282.0	259.2	440.7	272.6	321.8	324.6	341.6	238.6	194.1	372.4	651.4	617.1	146.7	321.5	596.7	194.4	389.0	658.4	21.0	69.9	34.0	57.8	87.7	77.3	65.9	59.7	63.3	96.5	50.4	59.8	64.8	8.4	77.7	103.0	54.0	68.3	81.2	48.3	50.5	52.6	71.1	50.2	56.4	52.5	52.9	53.9	53.2	53.5	55.3	94.6	89.8	106.4	13.1	83.3	108.8	201.4	175.3	91.6	60.2	77.4	83.2	114.0	65.8	187.7	47.8	27.1	199.6	93.4	56.6	88.0	263.1	22.5	209.6	121.0	129.4	102.1	163.4	19.3	274.2	264.8	97.0	88.2	133.8	131.7	123.4	71.0	66.7	148.2	38.7	23.7	94.2	124.1	83.5	79.2	19.5	70.5	104.0	58.7	19.7	206.9	80.7	80.3	18.1	22.7	245.6	66.7	90.7	106.4	184.8	65.2	146.4	190.3	60.8	59.2	99.1	136.3	115.0	219.8	160.9	109.7	199.9	91.8	189.7	138.6	145.9
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 393.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol		NA	NA		1900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	113.3	150.8	104.5	108.6	109.7	93.4	111.4	114.6	110.9	109.6	118.1	113.6	84.8	123.0	117.1	119.7	133.3	69.0	162.9	109.1	114.5	111.9	114.0	83.4	126.5	109.7	109.4	140.4	114.2	134.7	97.0	101.4	114.0	115.2	123.2	83.7	92.1	110.7	252.4	103.9	88.3	147.5	112.7	98.7	106.8	162.9	110.7	153.0	87.4	241.2	158.5	120.0	101.1	120.7	396.3	641.9	361.8	393.0	259.1	211.7	460.7	348.6	311.8	573.6	359.0	1054.5	272.1	760.3	219.0	365.9	529.3	328.2	816.6	533.8	635.9	420.7	722.9	516.2	403.2	755.3	287.5	614.9	367.5	328.9	297.7	565.9	683.3	301.4	521.0	444.7	650.2	265.8	488.7	613.6	686.5	776.1	519.1	540.6	455.8	614.8	927.2	535.0	411.6	374.7	512.4	315.9	302.6	411.0	406.7	333.6	235.2	331.4	339.7	390.9	464.3	245.7	679.7	298.1	341.1	709.2	319.4	686.1	435.6	157.7	131.4	78.1	190.8	178.8	211.3	216.6	193.5	191.4	202.0	208.8	208.9	195.3	39.5	192.1	209.8	203.7	186.0	299.3	104.5	109.7	114.6	110.9	109.1	114.5	109.7	109.4	114.0	112.7	110.7	120.7	77.7	57.7	45.6	12.4	87.5	69.1	149.7	161.5	55.8	81.1	63.8	77.1	99.2	68.6	96.7	58.8	18.8	190.2	74.3	54.8	109.5	148.2	393.0	99.8	96.4	91.6	75.3	77.8	10.8	139.0	213.2	94.8	57.1	58.1	73.6	108.2	61.8	69.3	133.6	82.4	13.3	102.2	118.0	58.8	58.1	246.3	104.7	57.3	74.7	10.3	98.9	125.5	74.2	12.1	15.0	134.1	60.3	107.2	112.3	156.0	67.3	133.2	108.2	88.6	72.3	91.8	126.7	288.9	127.8	71.1	73.6	166.5	77.2	190.6	127.6	112.5
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 240.5"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	171.8	85.6	6.1	152.5	7.0	17.6	50.8	5.2	18.4	25.6	21.5	48.7	12.4	27.3	3.6	16.4	68.1	43.5	52.7	4.9	7.9	27.3	89.7	131.7	54.4	15.8	10.9	23.1	21.4	8.8	11.4	109.4	18.0	15.5	21.6	4.3	25.9	7.2	11.4	15.3	52.9	130.4	7.2	240.5	35.6	9.7	55.9	18.7	17.2	17.6	7.2	68.5	16.3	10.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	6.1	7.0	5.2	18.4	4.9	7.9	15.8	10.9	18.0	7.2	55.9	10.3	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 141.3;lymphoid tissue: 230.2;ovary: 132.8"	"Group enriched"	"Detected in many"	7	"B-cells: 143.6;granulocytes: 95.8;Granulosa cells: 51.3;Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.6;naive B-cell: 120.3"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 280.6;REH: 83.8;U-698: 219.9;WM-115: 50.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002418, HPA024353, HPA066523"	Enhanced					NA	NA		13000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.7	5.5	39.2	75.3	66.8	13.6	1.7	42.8	58.4	2.7	17.8	4.9	2.3	3.7	2.5	2.2	30.9	4.1	1.3	42.7	53.2	2.1	1.5	7.4	219.2	63.3	53.8	132.8	0.6	0.7	2.1	1.8	60.3	2.9	6.4	0.0	3.5	1.1	0.2	0.3	53.4	2.1	37.8	161.6	7.0	3.8	55.8	11.4	6.3	0.4	230.2	5.7	1.6	141.3	0.9	1.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.4	0.0	5.1	280.6	5.6	0.3	15.0	0.5	0.0	0.0	0.1	1.5	0.0	0.0	0.2	2.2	0.1	0.3	12.4	0.0	0.0	0.2	4.1	0.1	0.0	0.0	1.5	0.1	2.6	0.5	0.1	0.0	0.1	0.4	0.4	83.8	0.3	0.2	0.0	0.0	0.0	0.0	0.3	1.4	6.6	0.2	0.5	0.1	0.3	2.6	1.5	0.0	0.0	0.0	0.1	219.9	2.2	0.9	50.1	0.1	0.1	0.1	0.0	1.1	0.0	97.6	0.0	0.0	4.6	120.3	0.0	0.0	1.0	0.2	0.7	3.8	0.0	4.9	39.2	66.8	42.8	58.4	42.7	53.2	63.3	53.8	60.3	37.8	55.8	141.3	1.7	3.2	3.0	0.0	143.6	0.3	0.4	0.0	0.0	0.0	1.0	3.3	0.7	0.0	0.6	0.0	0.0	0.2	4.1	0.1	0.0	0.0	0.6	0.2	0.4	2.1	0.0	2.7	0.3	0.2	1.3	2.8	0.5	0.5	95.8	51.3	3.3	0.2	6.8	0.0	0.3	0.0	0.0	5.6	2.0	0.2	3.7	6.9	1.8	0.0	0.9	0.0	1.0	0.0	91.5	0.2	0.1	0.7	2.3	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.4	1.1	0.0	0.4	0.1	4.1	12.2	0.0	0.1
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cell line enhanced"	"Detected in some"		"HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.1	0.4	0.3	3.7	0.4	10.0	0.4	0.3	0.5	0.3	0.3	1.1	3.0	0.3	0.3	0.4	0.5	1.0	0.6	0.4	0.3	0.3	4.2	3.3	3.4	0.4	0.3	1.0	0.1	0.1	0.1	0.4	0.3	0.4	1.4	0.0	1.1	0.4	0.3	0.3	2.8	1.1	0.3	16.8	1.0	2.7	0.3	2.8	0.2	0.2	2.0	1.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.4	6.8	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	2.1	14.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	28.7	0.0	472.1	43.3	107.9	71.3	59.1	35.2	0.3	3.7	39.7	41.0	0.2	5.3	36.0	3.1	78.5	73.6	2.4	0.2	70.7	0.3	0.4	0.3	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.1	3.2	6.1	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	5.2	0.0	0.1	0.2	0.0	2.1	0.7	1.7	0.0	0.3	0.5	0.1	3.8	0.0	0.7	0.2	0.6	0.0	0.1	0.0	0.0	17.7	3.1	2.4	1.8	8.3	0.0	0.0	8.5	0.0	66.9	0.0	0.2	0.0	0.0	2.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.0	0.1	0.0	21.9	0.5	0.0	0.0
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444955-6451718	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 147.8"	"Group enriched"	"Detected in many"	11	"B-cells: 119.4;Melanocytes: 97.8;Plasma cells: 352.1;T-cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in all"		"T-reg: 640.4"	"Group enriched"	"Detected in all"	7	"B-cells: 293.4;T-cells: 640.4"	"Group enriched"	"Detected in some"	107	"Daudi: 238.2;U-698: 141.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002420, HPA038936"	Enhanced					NA	NA		100000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB002420: AB_563539, HPA038936: AB_2676278"	"unprognostic (2.75e-3)"	"prognostic favorable (3.77e-5)"	"unprognostic (8.87e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.65e-7)"	"unprognostic (3.56e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.31e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.35e-2)"	2.1	2.6	0.3	59.0	0.5	10.6	4.3	0.0	0.5	2.4	0.1	18.0	22.5	1.7	1.0	10.2	1.9	11.0	3.9	0.1	0.1	1.3	2.0	8.2	147.8	0.5	0.2	3.0	1.4	0.0	0.3	0.4	0.8	2.5	11.6	0.4	12.3	1.4	0.6	1.9	34.5	1.6	0.2	73.8	16.6	0.9	0.4	44.7	6.5	0.7	106.3	19.0	1.4	1.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	238.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.8	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.5	0.1	0.0	0.0	0.0	141.7	0.3	0.1	0.0	6.2	1.6	1.4	117.2	1.3	201.2	293.4	283.5	262.6	1.0	114.8	382.8	281.1	6.2	65.0	1.6	2.4	640.4	182.4	0.3	0.5	0.0	0.5	0.1	0.1	0.5	0.2	0.8	0.2	0.4	1.0	1.1	0.0	4.9	0.3	119.4	2.3	0.1	0.0	0.6	1.1	1.1	1.3	0.1	0.0	0.6	0.0	0.0	0.1	7.0	0.3	0.0	0.2	0.0	0.2	0.3	0.9	1.2	8.4	0.2	0.0	0.0	1.5	3.1	0.3	1.3	0.0	2.5	1.5	0.3	0.0	0.3	0.1	0.0	3.2	4.4	0.3	0.3	3.0	97.8	0.0	5.7	0.4	14.4	1.0	1.0	0.0	0.1	0.4	352.1	0.2	0.0	0.9	0.8	1.4	0.0	0.7	1.3	0.1	0.1	0.6	3.1	0.3	109.5	0.0	2.4	0.0
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	10.6	7.5	6.7	31.1	7.1	24.4	4.6	7.1	31.1	2.8	7.5	9.2	11.3	3.5	1.8	3.5	3.1	14.2	4.7	6.9	7.8	3.5	14.6	18.1	27.0	11.4	8.6	1.5	3.2	1.4	3.6	13.9	13.2	4.0	8.6	1.0	4.0	2.5	1.6	4.5	13.5	11.7	9.2	95.2	4.9	1.2	12.1	14.1	2.3	2.7	11.7	9.5	2.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	5.5	104.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.5	45.9	0.0	0.0	0.0	0.2	0.0	88.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	17.1	0.0	845.6	170.3	481.9	226.4	374.2	48.3	18.9	45.5	67.5	159.2	6.4	16.7	52.5	560.5	456.5	387.6	149.7	3.1	197.0	6.7	7.1	7.1	31.1	6.9	7.8	11.4	8.6	13.2	9.2	12.1	12.5	1.0	0.0	7.4	0.3	7.8	0.9	0.1	0.2	0.0	0.0	0.6	1.8	0.6	1.5	0.7	0.0	0.0	0.7	103.5	0.1	0.0	0.1	0.0	0.6	0.2	2.5	0.0	5.7	0.1	0.0	1.2	0.8	0.5	0.7	59.5	0.0	2.2	1.3	114.0	0.0	0.3	0.2	0.0	97.6	24.0	0.4	0.0	90.9	3.6	5.6	36.6	0.0	225.6	1.0	0.0	0.0	0.1	0.0	14.5	0.1	0.0	0.4	0.6	0.1	6.6	0.6	0.5	0.0	0.4	0.2	0.6	1.5	33.2	0.0	0.2	0.2
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752054-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 296.7;eosinophil: 382.4;neutrophil: 401.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 401.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"		NA	NA		1000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavorable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	98.6	237.4	30.0	64.0	35.0	80.5	128.4	33.5	39.5	74.0	61.4	103.1	124.6	62.1	77.1	102.2	110.0	73.8	64.9	30.2	34.4	173.2	133.9	129.1	58.2	37.4	33.6	61.2	112.5	310.6	41.8	221.5	38.1	167.4	103.2	72.6	166.9	107.4	47.4	47.7	98.6	67.1	34.8	79.6	117.4	40.5	36.3	44.4	86.8	58.1	66.6	97.2	68.2	41.5	130.0	71.7	66.1	30.8	202.9	199.2	99.9	95.0	137.3	61.3	82.5	71.3	335.4	19.8	94.3	95.3	84.5	170.7	50.0	130.5	93.0	99.9	70.9	42.9	73.8	128.6	128.8	94.8	142.8	172.9	189.6	92.9	72.5	144.4	174.2	76.8	91.8	83.4	95.7	61.3	45.4	82.8	75.6	76.9	70.9	30.2	104.7	123.0	251.4	252.6	66.5	45.4	120.5	266.8	160.1	130.8	210.2	79.8	150.9	65.6	57.7	139.2	109.9	111.2	144.3	60.1	95.8	61.2	63.0	296.7	79.8	382.4	50.1	82.4	68.9	43.5	63.3	55.8	47.3	34.1	71.1	60.5	401.8	46.9	87.5	24.9	60.5	102.4	30.0	35.0	33.5	39.5	30.2	34.4	37.4	33.6	38.1	34.8	36.3	41.5	186.0	201.9	241.1	59.7	60.3	52.9	89.3	87.2	108.1	63.0	144.3	85.7	61.4	75.8	177.8	145.3	66.7	247.3	94.0	105.2	15.6	77.4	227.7	206.1	67.0	106.7	72.8	46.9	61.0	79.9	76.2	70.5	97.9	231.3	114.5	78.1	77.8	120.9	59.9	40.4	73.6	91.1	87.5	78.9	63.1	36.9	47.2	91.6	62.2	82.4	88.7	25.3	39.1	112.1	153.9	72.8	117.7	44.0	76.0	144.5	92.6	54.4	208.8	87.3	52.6	69.7	89.3	17.1	20.2	104.5	45.9	343.7	89.9	99.4	115.9	165.7
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	11.8	5.9	1.4	115.3	1.5	148.4	18.8	1.5	4.7	10.2	2.3	24.9	20.5	6.7	5.0	8.4	5.7	26.6	4.3	1.3	1.7	4.4	19.9	31.0	283.9	2.6	1.8	3.1	2.0	1.6	1.6	5.8	2.7	8.1	32.5	0.1	14.0	4.4	2.9	3.5	48.3	12.5	2.1	160.0	32.5	2.9	3.2	138.9	5.2	3.4	256.8	41.8	4.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	220.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	6.0	0.0	2.1	0.0	0.0	0.0	27.1	236.9	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.4	78.6	0.0	0.0	78.9	38.4	0.1	0.0	0.0	4.7	0.1	34.3	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.3	0.2	0.4	501.4	360.3	89.9	0.2	66.7	0.1	218.1	327.1	230.8	242.8	470.2	335.8	206.2	275.2	283.4	329.7	161.2	277.9	301.6	82.1	160.7	487.4	57.0	229.9	603.5	1.4	1.5	1.5	4.7	1.3	1.7	2.6	1.8	2.7	2.1	3.2	4.1	3.7	0.0	9.6	0.7	336.1	5.5	0.8	0.0	1.8	0.0	2.0	1.7	1.1	2.8	1.3	3.7	0.0	0.6	251.2	0.1	1.9	0.2	0.1	0.7	0.5	2.8	1.2	21.5	0.1	0.2	0.8	2.4	6.6	0.6	90.7	0.1	7.1	2.0	86.4	0.0	0.1	0.1	0.0	245.8	106.5	0.5	1.8	218.3	39.2	1.0	366.6	0.0	454.2	0.5	0.0	0.1	0.0	0.4	127.4	0.4	0.0	4.9	2.2	0.0	0.0	1.7	2.1	0.5	0.3	0.7	3.0	0.4	376.2	0.0	1.2	0.5
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321532-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 2227.6;Syncytiotrophoblasts: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 662.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 472.3;HMC-1: 665.7;PC-3: 395.0;U-2197: 405.3"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	360000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	64.9	161.5	13.8	99.6	23.3	134.0	59.0	15.8	28.3	103.3	19.0	47.7	47.7	58.3	17.3	58.3	28.0	49.4	48.4	15.7	29.4	20.5	28.0	224.1	26.7	21.1	20.0	67.7	24.5	28.9	26.3	92.5	26.2	16.1	42.9	9.2	126.1	18.1	108.9	85.9	50.7	46.6	15.2	43.1	44.0	36.0	20.8	15.8	47.6	59.5	41.3	183.2	41.8	34.4	33.2	43.6	0.1	14.6	54.2	55.1	220.7	62.5	100.1	31.3	33.1	139.5	44.3	60.8	50.3	35.8	123.3	17.4	65.2	12.9	29.1	29.0	26.4	79.9	472.3	23.3	162.3	50.5	665.7	25.9	150.5	40.8	171.8	133.8	169.7	9.6	89.6	29.3	19.4	35.6	5.3	37.8	43.2	78.9	395.0	7.4	42.3	50.7	54.3	30.7	17.7	0.4	321.2	64.3	53.9	95.1	54.4	41.5	80.4	17.6	33.2	405.3	23.8	24.7	31.4	42.7	44.8	19.6	78.9	317.7	181.2	247.6	35.0	174.4	51.8	108.2	46.0	36.4	121.7	115.2	102.6	101.9	662.2	134.5	223.7	64.8	34.6	159.3	13.8	23.3	15.8	28.3	15.7	29.4	21.1	20.0	26.2	15.2	20.8	34.4	95.9	2227.6	405.3	2.3	529.8	705.1	214.1	143.6	59.2	3.1	69.9	53.8	72.7	7.2	542.6	23.9	0.0	217.5	201.7	196.1	3.9	98.6	324.6	345.6	101.9	143.4	17.3	79.8	7.6	180.2	411.7	244.7	387.9	709.3	146.9	88.9	46.8	9.1	70.0	1.7	10.7	155.7	77.3	177.5	449.2	66.3	32.6	377.3	160.1	7.5	122.6	4.8	69.0	6.0	54.3	388.9	241.2	9.1	305.4	334.9	138.4	3.2	259.5	3.3	6.6	56.1	98.0	8.9	13.7	273.4	765.9	847.7	215.4	281.5	145.1	578.6
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 3747.5;U-2197: 3049.9"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		58000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	517.4	248.3	284.5	209.6	310.8	198.8	555.9	329.0	365.1	305.5	542.2	255.1	120.7	290.7	971.7	478.9	368.1	475.3	608.3	288.2	359.7	577.4	339.8	553.5	148.8	327.9	340.2	228.5	353.6	706.1	250.3	485.6	340.9	256.8	271.4	130.7	693.6	443.2	529.3	282.8	167.9	380.0	330.5	131.8	422.7	127.7	337.0	167.7	308.1	915.0	288.6	550.5	325.5	315.6	297.2	278.4	77.6	212.0	1697.1	1314.9	46.8	1765.7	1778.5	408.9	451.9	129.7	822.1	23.9	291.5	1802.5	475.5	314.0	141.0	1589.9	561.1	475.5	218.2	31.3	846.7	193.1	483.2	183.4	94.8	631.8	387.2	343.3	1550.6	1104.9	2475.5	109.3	207.9	585.9	2575.4	282.7	79.9	70.3	43.5	541.8	1421.8	30.1	232.1	227.8	1304.4	510.0	54.3	79.5	576.2	243.7	298.2	218.0	187.5	18.1	3747.5	838.6	235.5	3049.9	595.9	273.8	558.8	30.4	734.2	1.3	1556.9	164.9	22.3	209.6	50.9	7.9	64.8	63.9	104.9	56.6	95.4	59.6	68.2	41.4	134.3	92.5	4.8	49.9	298.2	53.5	284.5	310.8	329.0	365.1	288.2	359.7	327.9	340.2	340.9	330.5	337.0	315.6	728.0	272.4	247.2	32.3	39.1	286.0	1103.2	951.4	82.0	51.3	434.9	270.0	315.5	444.7	569.7	242.8	33.3	553.5	29.2	344.6	164.4	1445.2	129.4	94.3	91.6	792.6	166.6	206.0	25.1	618.3	407.2	303.5	109.6	115.6	139.4	88.2	585.0	185.7	486.7	47.1	29.9	112.8	722.2	139.4	374.2	61.6	237.3	88.2	1270.0	54.4	161.7	198.3	26.8	32.6	22.2	1195.7	392.2	204.7	149.7	1678.0	41.7	208.2	1042.5	56.2	276.1	159.1	410.7	130.6	31.2	83.7	284.4	836.6	52.4	139.5	104.9	1531.0
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830911-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 572.9"	"Group enriched"	"Detected in some"	36	"Hofbauer cells: 279.0;Kupffer cells: 567.0"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	NA	NA	4030000000	4300000000		"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		1.4	0.0	0.0	1.5	0.0	17.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	104.7	1.6	9.2	0.2	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	572.9	0.5	0.1	0.1	6.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	6.1	6.1	279.0	0.0	0.0	0.0	0.0	567.0	0.0	1.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.3	0.0	0.0	0.0
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1857.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 4897.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	954.0	882.1	509.4	457.9	526.5	747.2	769.6	532.6	717.1	715.6	611.8	809.3	394.5	854.6	1492.1	396.1	647.3	607.0	1152.2	508.5	565.7	625.3	565.1	882.2	325.0	564.7	539.9	645.9	830.1	524.7	486.6	588.0	544.3	520.0	736.0	269.1	871.6	547.4	919.3	410.0	559.3	744.5	534.9	597.7	790.8	224.3	583.6	193.3	657.7	587.4	284.9	835.3	539.7	561.7	481.0	669.0	432.6	430.8	4897.7	2932.4	577.5	1914.8	3104.6	979.2	1048.9	750.3	939.2	120.5	581.2	2608.7	787.7	436.3	301.7	732.6	1197.9	372.5	248.7	760.9	542.8	443.3	2006.7	338.5	1699.0	2315.1	639.7	1164.8	979.2	2305.1	1052.2	64.6	386.8	936.3	3062.5	626.3	64.1	439.5	395.7	1062.7	880.7	146.0	949.3	345.7	1699.3	1433.6	170.1	425.8	528.3	392.5	3348.6	630.4	546.4	1089.6	948.0	710.1	514.8	984.9	649.8	377.3	239.3	92.5	2023.9	208.1	1326.3	1279.9	610.3	1857.5	323.2	458.8	235.2	111.0	126.9	260.0	473.0	73.9	55.9	186.0	656.0	733.0	320.4	309.8	121.6	850.4	509.4	526.5	532.6	717.1	508.5	565.7	564.7	539.9	544.3	534.9	583.6	561.7	798.7	512.8	689.0	28.1	147.6	567.2	1382.5	3135.4	155.4	190.3	606.5	601.1	820.9	836.4	1789.7	875.4	152.2	608.3	322.0	1083.4	232.8	2621.2	16.7	446.7	766.7	916.3	581.1	97.0	8.8	3429.0	2756.5	1538.0	371.1	727.3	1030.0	531.6	739.6	423.9	3372.5	33.7	9.3	1251.6	1715.1	854.6	1698.3	65.5	1727.3	1146.7	1993.9	11.2	575.7	893.8	487.1	21.1	26.5	3437.4	1394.0	1157.0	326.9	2039.2	878.1	794.2	1012.6	258.8	1255.6	1845.2	1278.7	43.8	68.9	137.1	400.5	2708.1	310.4	645.8	761.6	1868.9
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 358.0;lymphoid tissue: 370.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1378.6;monocytes: 3740.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 472.0;U-87 MG: 751.0"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	139.6	78.3	10.4	236.1	9.8	266.2	72.6	11.2	33.4	77.8	14.6	88.8	279.5	26.7	9.0	126.4	43.1	161.1	38.9	8.2	26.7	50.6	156.7	358.0	217.3	45.5	31.2	19.4	22.1	14.2	8.9	173.1	36.0	13.1	91.9	4.8	52.6	19.8	23.0	24.8	240.2	79.0	16.1	370.7	87.5	15.2	58.5	44.2	22.7	21.3	84.2	149.3	50.6	31.6	243.4	48.6	3.2	3.5	472.0	177.6	2.1	75.6	203.9	97.8	113.4	10.1	71.3	2.9	84.2	220.8	174.6	10.6	1.2	47.6	65.9	2.2	9.0	38.8	13.2	59.0	42.0	19.2	207.8	57.1	9.8	205.4	150.4	162.6	26.3	4.3	15.7	24.2	95.5	2.2	1.7	17.2	2.8	63.1	36.0	3.3	4.5	144.4	20.9	10.9	1.6	3.0	63.2	31.3	72.1	2.2	1.6	146.1	82.4	123.7	8.0	125.7	100.1	1.4	2.1	1.9	751.0	46.4	64.0	243.5	3255.5	21.4	9.1	3655.9	11.1	80.2	4.1	6.2	817.3	59.0	5.8	5.1	219.4	18.7	3740.6	1378.6	6.5	3324.3	10.4	9.8	11.2	33.4	8.2	26.7	45.5	31.2	36.0	16.1	58.5	31.6	10.4	0.0	19.7	1.3	20.5	15.7	39.0	58.8	3.4	0.2	7.2	9.8	0.0	12.8	53.2	5.5	0.0	8.9	110.3	22.5	5.9	82.1	0.8	8.3	11.3	15.9	4.9	6.6	0.3	156.8	58.1	45.6	29.6	18.7	43.6	0.9	16.4	23.9	1820.4	0.0	0.4	15.8	16.2	701.2	341.5	2.1	6.5	791.2	39.2	5.6	179.2	0.3	7.2	0.0	0.1	121.0	86.1	1.9	8.5	33.3	335.3	50.2	20.6	1.0	26.3	8.7	11.7	0.5	1.2	12.4	14.3	33.4	10.8	0.5	28.9	99.9
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620358	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 280.3;Proximal enterocytes: 220.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 536.4"	"Group enriched"	"Detected in all"	6	"B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 463.8;U-87 MG: 323.3"	"Region enhanced"	"Detected in all"		"white matter: 210.9"	"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	39.2	9.1	47.7	57.3	80.5	140.9	36.6	45.2	48.8	38.8	48.5	24.7	74.1	9.1	31.9	130.9	54.0	39.6	25.6	41.9	51.7	26.1	36.9	87.3	68.5	58.5	74.3	14.9	31.3	7.8	7.5	41.0	49.8	27.5	17.2	4.2	81.1	72.1	23.1	84.2	81.6	16.6	39.6	47.3	62.8	4.5	79.0	45.0	22.4	20.0	82.6	47.6	66.1	67.2	30.0	5.2	35.1	7.2	24.0	98.4	1.2	16.9	132.9	29.4	78.5	2.0	19.6	30.9	20.8	8.1	61.1	118.8	4.6	88.4	59.6	145.4	2.7	220.9	9.3	0.6	21.3	58.8	463.8	142.1	99.2	128.3	62.1	68.4	49.7	26.9	1.6	9.4	247.3	25.0	46.7	97.7	1.1	103.2	2.4	1.5	190.0	43.9	16.8	36.1	1.2	2.0	13.0	162.6	23.0	4.2	161.2	51.3	33.9	94.4	12.5	1.8	179.0	3.6	0.4	0.9	323.3	32.5	56.0	369.9	59.3	110.7	29.9	33.0	51.4	310.1	150.7	70.3	14.9	211.9	51.1	23.1	536.4	50.1	25.0	44.5	173.1	65.9	47.7	80.5	45.2	48.8	41.9	51.7	58.5	74.3	49.8	39.6	79.0	67.2	43.6	48.1	38.8	9.4	112.8	55.1	108.1	149.0	107.6	2.4	68.1	54.7	7.7	58.6	143.8	158.2	2.1	1.3	14.9	17.4	11.7	79.7	2.0	23.1	5.0	41.0	13.2	92.9	0.3	66.7	1.1	29.1	58.6	25.2	280.3	0.7	59.6	32.5	64.3	1.7	0.6	36.8	63.1	26.6	18.2	2.0	40.4	52.3	64.0	3.7	11.0	35.7	0.0	54.3	22.4	86.7	50.3	8.2	16.0	59.1	220.6	2.5	73.0	2.7	13.1	109.0	46.0	2.1	5.9	161.3	67.2	1.4	46.3	0.6	43.1	142.8
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691187-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 1614.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"		NA	NA		62000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	476.3	143.3	132.0	119.2	142.1	105.4	327.7	148.8	135.4	367.4	126.5	353.2	148.5	305.5	132.4	208.8	249.4	264.5	343.7	128.8	247.5	112.7	227.7	256.5	146.6	210.9	178.1	303.0	234.6	46.8	132.9	194.8	216.8	270.3	152.9	15.1	184.2	258.4	163.7	284.7	210.0	226.1	224.4	186.0	209.1	199.6	139.4	562.1	152.6	168.3	129.2	296.3	314.6	227.6	259.4	276.5	308.5	424.8	1217.7	939.2	195.0	681.6	1050.1	419.2	604.8	412.3	179.1	18.3	130.0	929.4	217.5	99.4	124.1	168.4	337.5	350.8	321.2	53.1	179.5	353.4	390.1	81.7	375.0	580.1	204.9	223.7	155.6	271.8	766.4	256.3	66.4	0.9	391.9	191.2	672.3	266.8	107.5	28.6	310.0	118.7	273.2	513.5	240.7	165.4	1.0	141.2	168.7	138.2	432.6	744.9	129.6	229.4	750.2	509.7	86.1	487.1	230.2	1.0	0.8	116.1	338.1	203.1	323.8	23.6	526.0	18.3	1089.2	131.2	620.5	340.1	730.3	961.1	496.5	231.8	267.4	549.7	45.1	377.3	32.3	682.1	833.7	1421.2	132.0	142.1	148.8	135.4	128.8	247.5	210.9	178.1	216.8	224.4	139.4	227.6	297.7	64.1	68.3	20.5	172.0	250.6	207.4	274.4	138.9	5.1	66.9	48.3	86.6	112.9	88.4	71.7	0.0	223.6	507.7	68.4	13.7	145.3	8.8	180.2	279.7	387.7	80.8	136.5	0.9	138.4	189.7	604.7	116.7	188.8	230.4	1614.3	512.9	123.0	799.8	0.0	1.1	150.8	54.9	187.4	579.9	26.4	645.2	342.4	691.9	37.5	175.9	52.0	632.4	1.0	0.9	139.9	158.2	511.2	300.2	385.8	230.9	63.3	117.5	3.2	341.8	231.1	351.9	16.4	56.9	147.9	222.9	123.0	468.9	403.2	262.3	307.0
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20589086-20618903	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 193.5;esophagus: 87.1;liver: 86.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1234.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1234.7"	"Cell line enhanced"	"Detected in many"		"A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	7.1	3.0	8.0	9.6	8.1	193.5	3.7	8.3	10.6	19.7	7.4	23.7	6.4	5.3	5.5	87.1	6.4	4.3	6.7	7.9	8.3	14.0	86.7	7.1	1.5	9.0	8.2	1.5	0.8	3.2	1.2	10.8	9.5	4.3	27.8	0.5	15.0	3.1	1.7	17.1	16.3	11.3	8.3	23.4	2.1	1.0	8.9	2.0	4.5	6.4	4.4	5.5	38.5	8.7	200.3	21.4	0.0	0.0	0.2	5.5	0.0	16.7	4.3	4.1	16.2	1.0	141.9	0.0	8.1	30.8	8.7	63.9	4.5	46.8	10.7	0.1	3.9	0.0	207.1	34.4	1.4	0.0	0.0	8.8	8.9	31.4	0.0	0.5	2.7	0.0	0.0	0.0	1.6	0.2	0.0	1.0	0.1	24.7	107.0	0.0	0.1	3.4	1.5	0.0	0.1	0.0	249.9	0.0	0.3	2.2	0.0	4.3	3.4	0.2	8.3	18.5	1.2	0.0	0.1	0.0	2.4	96.9	0.0	216.2	207.2	471.1	0.5	124.7	0.8	0.1	0.4	0.9	12.7	0.2	0.3	0.4	1234.7	0.4	110.8	3.1	0.7	86.8	8.0	8.1	8.3	10.6	7.9	8.3	9.0	8.2	9.5	8.3	8.9	8.7	9.9	3.2	1.1	0.3	1.2	1.5	0.1	2.4	0.0	0.2	0.2	0.3	2.6	1.5	2.7	5.5	0.0	1.1	0.0	364.9	43.0	7.5	0.8	2.1	2.6	42.7	0.0	6.1	0.2	1.5	6.4	9.1	0.0	20.3	0.0	0.0	47.2	107.8	5.9	0.0	0.3	23.1	85.5	60.7	0.9	1.0	0.3	36.6	0.0	5.6	61.5	0.1	0.0	0.5	0.0	120.2	400.5	0.0	3.0	2.1	137.6	0.6	0.4	0.1	0.0	1.3	1.3	0.0	1.2	6.3	1.1	2.5	1.7	0.0	19.8	0.8
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	4.0	5.0	2.1	3.6	2.2	8.1	4.3	4.3	3.1	7.7	3.2	4.5	2.8	5.9	4.4	4.1	6.1	2.5	2.9	2.1	0.9	3.2	4.0	3.5	4.2	3.0	1.5	11.3	4.8	3.5	5.1	3.2	2.7	6.9	2.5	2.6	5.4	3.5	4.2	4.9	4.2	2.8	0.7	4.6	4.5	6.3	1.4	5.2	5.1	2.8	3.4	5.8	5.6	2.6	8.1	5.4	7.2	10.4	6.3	5.4	8.6	10.4	4.3	9.9	7.2	13.6	4.2	3.9	11.2	5.8	9.7	15.5	7.7	4.7	2.9	9.9	7.2	14.5	10.3	5.3	4.7	10.8	13.2	7.4	5.2	6.3	4.5	6.1	7.6	13.0	18.9	5.7	8.2	4.5	8.4	14.2	3.6	7.7	8.5	11.9	9.0	3.4	3.1	7.9	5.9	6.8	8.2	11.3	1.7	4.6	8.6	15.9	5.6	10.4	9.2	8.6	12.1	11.2	12.7	8.7	5.4	15.8	8.6	1.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2.1	2.2	4.3	3.1	2.1	0.9	3.0	1.5	2.7	0.7	1.4	2.6	2.0	0.0	3.7	4.6	2.4	1.9	2.0	1.5	1.8	3.3	3.2	1.8	2.2	2.8	1.5	7.3	4.2	3.0	2.6	1.9	0.0	1.5	0.4	2.0	2.8	2.3	4.8	1.7	7.6	1.8	1.6	2.9	3.6	2.0	1.3	9.0	3.9	3.6	2.1	1.7	6.3	1.6	4.1	2.5	0.9	1.2	4.4	1.6	0.0	4.7	1.5	4.5	2.1	5.5	3.8	1.6	0.5	4.9	2.5	2.3	2.2	1.3	1.9	4.7	19.7	3.4	2.4	5.4	2.1	2.8	1.3	2.2	2.5	4.6	2.6	1.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 149.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	23.0	15.2	9.3	20.1	12.0	27.6	18.1	18.3	15.2	18.0	5.6	15.2	14.6	20.7	13.1	16.6	15.1	18.4	23.3	11.6	12.0	15.2	22.4	18.1	23.4	10.6	10.8	17.0	14.5	24.4	10.6	25.5	11.5	15.1	17.7	13.7	12.2	15.4	22.4	12.1	13.8	24.5	10.5	19.1	15.9	25.0	11.3	25.0	42.4	28.8	24.0	19.8	11.2	11.3	80.7	84.1	69.1	56.1	45.5	72.0	41.0	110.9	99.0	103.3	105.1	54.2	41.4	107.4	72.7	93.5	66.0	37.5	75.2	62.6	141.2	155.5	77.2	125.0	92.9	48.6	49.2	74.4	54.6	52.4	30.2	93.5	73.1	49.7	108.6	61.6	101.6	58.0	85.2	68.3	91.8	33.5	32.8	45.2	67.8	48.9	177.3	47.8	62.0	50.0	45.8	55.9	55.4	19.4	61.2	58.6	58.6	51.7	116.9	107.1	91.9	68.6	82.9	58.8	110.2	95.8	59.4	43.6	76.0	9.3	3.2	4.9	5.3	7.1	5.2	4.0	4.2	5.5	4.2	6.3	4.2	5.0	4.0	8.7	5.3	5.2	8.3	3.5	9.3	12.0	18.3	15.2	11.6	12.0	10.6	10.8	11.5	10.5	11.3	11.3	63.7	9.6	26.3	61.0	28.7	26.0	17.8	25.9	38.1	22.1	21.3	17.5	39.8	21.5	27.1	20.2	16.7	31.4	22.5	11.5	15.6	28.1	28.9	20.8	33.9	50.7	13.8	149.8	124.5	26.5	35.6	41.4	21.4	22.1	26.6	24.8	38.9	27.1	27.2	35.3	104.4	12.8	8.2	28.5	22.1	33.6	28.3	30.6	7.2	83.4	31.5	19.4	35.0	89.0	96.1	30.1	9.5	29.7	39.0	18.7	13.5	23.6	16.2	14.9	19.7	41.6	40.8	97.3	38.6	32.6	26.9	11.5	27.8	34.2	16.2	17.1
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560480-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 245.6;Exocrine glandular cells: 226.0;Pancreatic endocrine cells: 266.2;Urothelial cells: 161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 7.3;intermediate monocyte: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	76.3	91.2	55.7	16.7	107.5	1.6	58.0	89.9	73.3	68.2	17.6	43.7	31.1	70.7	4.1	93.1	61.0	40.8	53.8	55.9	67.3	50.2	133.1	65.2	11.3	102.8	104.5	60.9	161.6	16.5	18.8	31.8	97.4	41.5	14.4	2.6	102.7	23.9	13.1	71.2	32.7	19.6	70.2	26.2	155.9	23.6	87.5	2.7	33.7	11.1	10.4	38.4	69.6	151.5	125.2	35.4	15.1	67.9	23.7	40.2	73.3	69.9	41.0	78.9	54.3	87.8	15.9	0.2	24.2	81.4	25.4	95.0	17.8	35.1	26.0	15.5	60.7	0.5	33.9	53.6	167.7	0.3	0.6	74.9	52.1	65.0	61.5	63.1	59.2	0.1	78.9	0.7	33.0	42.6	0.3	0.5	13.6	96.5	79.6	0.4	27.5	2.4	27.9	1.9	0.4	2.6	51.2	112.3	112.4	20.6	50.3	11.0	91.6	163.9	98.2	80.0	98.6	0.2	0.8	0.3	65.3	0.7	135.6	0.4	7.3	0.0	0.1	1.9	0.1	0.0	0.1	0.1	2.4	0.3	0.0	0.2	0.2	0.4	0.1	0.3	0.0	3.4	55.7	107.5	89.9	73.3	55.9	67.3	102.8	104.5	97.4	70.2	87.5	151.5	62.4	6.4	19.5	2.3	1.8	46.9	87.2	51.4	21.1	0.1	59.2	31.8	3.5	134.4	41.1	12.9	0.0	98.2	2.0	41.6	1.9	245.6	3.7	4.3	20.0	54.7	11.5	0.0	0.1	226.0	110.3	32.1	133.0	9.0	2.5	1.7	69.7	35.6	13.2	1.7	0.2	66.6	30.5	5.9	29.3	1.7	39.4	5.3	21.4	4.7	8.9	12.8	0.0	2.0	42.7	266.2	45.8	35.3	0.6	122.4	17.5	11.4	14.7	0.3	39.5	22.8	49.5	2.0	0.6	55.9	52.0	112.2	2.2	7.0	61.1	161.3
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853344	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6;retina: 11.6"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 859.5;Inhibitory neurons: 887.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 6.6;cerebral cortex: 3.8;hippocampal formation: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 2.2;SCLC-21H: 3.1;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA029325: AB_2672998"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.0	2.0	0.8	0.0	6.6	0.0	0.5	0.2	3.8	3.0	2.1	0.0	0.0	0.3	0.2	0.0	2.2	0.0	0.0	2.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.1	0.8	0.0	0.1	11.6	1.4	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.2	3.8	2.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.4	0.0	0.0	41.4	0.0	0.1	0.0	0.0	0.0	25.1	0.4	0.6	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	2.1	0.0	0.0	859.5	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	20.2	887.7	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	15.9	0.0	2.2	0.0	31.2	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.2	0.0	2.6	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626965-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.1;skeletal muscle: 68.6;tongue: 57.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 328.8;Inhibitory neurons: 867.0;Oligodendrocyte precursor cells: 335.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 222.2;U-138 MG: 279.2;U-87 MG: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		240000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	20.3	2.8	18.7	3.8	21.5	0.6	10.0	0.0	14.3	42.5	0.0	5.0	1.5	47.2	3.3	9.5	7.6	5.0	57.1	10.5	3.3	5.0	1.8	16.1	1.4	1.5	6.5	3.1	0.6	2.4	0.5	6.0	0.6	3.5	6.2	1.5	4.9	7.2	68.6	21.1	2.3	29.9	6.3	2.1	1.7	1.8	22.9	1.8	5.8	57.7	1.9	7.1	19.4	3.2	10.2	0.0	3.6	0.5	63.2	60.6	0.1	47.1	51.9	53.6	23.1	0.1	0.4	0.1	8.5	138.5	26.0	89.1	1.0	70.7	79.8	0.0	0.2	0.1	31.4	0.1	36.4	0.0	0.4	7.9	59.9	107.8	130.4	83.9	26.7	0.0	0.2	0.5	222.2	0.5	0.1	0.2	10.6	0.0	19.4	0.0	57.7	0.0	46.2	0.4	0.1	0.1	84.4	0.3	0.1	103.5	0.8	0.1	43.1	279.2	22.7	1.6	43.0	0.2	0.1	0.2	244.0	0.2	70.1	2.2	0.5	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.5	0.5	0.0	0.0	1.1	0.0	4.3	0.3	0.0	0.2	18.7	21.5	0.0	14.3	10.5	3.3	1.5	6.5	0.6	6.3	22.9	3.2	125.4	0.0	0.5	11.1	0.3	70.7	28.7	32.3	25.0	3.0	1.0	5.8	86.9	0.0	2.6	3.7	0.0	0.1	0.9	2.1	7.9	0.4	44.5	1.0	27.1	49.2	1.8	0.0	328.8	0.0	0.2	9.7	0.0	0.7	0.0	0.0	29.6	0.3	0.6	5.0	867.0	1.6	0.0	1.9	13.3	43.3	0.3	1.4	8.8	17.8	0.0	0.4	0.0	335.8	65.0	0.1	1.4	0.0	0.0	36.7	0.0	1.3	0.8	0.4	0.0	51.0	22.7	2.9	0.6	3.3	18.8	0.1	1.2	0.7	0.1	6.4
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27932879-28177946	"CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 196.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9"	"Cancer enhanced"	"Detected in all"		"glioma: 39.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.7;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Cluster 10: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	66.5	27.4	2.6	29.0	0.2	0.3	20.6	31.6	6.6	7.9	4.8	0.8	6.2	1.1	0.4	10.5	3.1	196.0	30.0	31.6	18.1	57.2	1.0	1.9	21.7	26.3	6.7	0.9	29.8	8.1	0.4	20.1	2.4	1.1	60.3	0.4	10.8	0.4	0.3	1.4	6.8	24.1	13.5	5.9	44.4	33.3	3.8	6.2	2.2	1.6	1.1	2.7	22.7	0.3	25.8	278.2	0.3	48.1	7.8	0.2	230.7	72.0	94.9	80.8	0.1	0.4	0.0	128.3	459.1	46.0	36.7	50.0	0.2	130.4	0.4	35.8	0.0	66.8	86.7	48.0	0.0	0.1	4.6	0.4	198.6	37.4	212.9	84.0	15.4	0.0	0.1	77.8	0.0	59.4	0.1	43.8	0.1	30.5	0.2	37.1	45.6	0.1	9.9	83.4	144.4	0.1	0.2	26.8	116.8	0.3	0.5	11.6	206.6	63.6	2.9	181.6	0.2	0.3	0.3	40.6	0.2	163.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	27.4	29.0	20.6	31.6	30.0	31.6	21.7	26.3	20.1	24.1	33.3	22.7	0.8	0.0	0.6	217.7	1.2	0.3	0.0	3.4	0.0	38.7	1.6	0.4	368.8	67.2	1.2	11.0	150.1	0.1	0.0	0.0	0.0	12.9	53.2	1.4	15.2	9.8	0.0	6.1	311.2	0.4	0.0	16.7	0.0	2.6	0.0	312.5	12.5	125.3	0.3	3.3	198.2	0.0	2.0	2.2	0.4	17.7	2.1	1.2	3.6	106.8	0.1	157.9	0.0	267.9	138.6	19.2	0.0	12.8	0.0	0.1	0.0	47.5	1.7	99.9	6.6	0.4	45.8	4.8	24.1	0.0	0.0	0.3	0.6	1.6	0.0	0.1
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958423-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 36.4"	"Low region specificity"	"Detected in some"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.9	0.4	1.0	0.3	1.5	1.0	0.8	1.2	2.0	2.0	0.3	0.7	0.4	0.6	0.4	3.4	2.0	0.4	0.7	0.9	1.8	0.5	0.3	2.1	0.4	1.6	1.7	0.3	0.5	0.3	1.7	0.4	1.5	8.0	0.3	0.4	2.0	0.5	1.0	0.6	0.8	0.4	0.6	0.8	1.2	0.7	1.9	0.9	0.6	0.3	3.0	2.7	1.3	2.6	0.0	0.7	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.1	0.0	0.8	0.8	0.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.1	7.9	0.1	0.1	0.0	0.3	0.3	0.1	1.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.7	0.1	36.4	0.8	0.1	0.4	0.2	0.1	0.4	0.2	0.4	0.2	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	1.2	2.0	0.9	1.8	1.6	1.7	1.5	0.6	1.9	2.6	4.3	6.4	6.1	17.9	0.1	0.1	1.2	6.6	0.0	0.5	1.6	0.5	0.7	0.0	18.7	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.2	2.1	0.4	2.1	0.0	2.5	9.3	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.7	0.1	0.6	0.0	8.4	0.0	6.1	1.3	0.4	1.7	0.0	1.4	0.0	7.5	0.6	0.2	1.0	7.1	14.9	0.0	0.0	0.0	0.4	10.9	0.2	0.1	39.6	0.0	0.0	0.5	2.4	0.9	0.2	0.2	0.0	14.9	0.2	0.1	0.2	7.4
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193686-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 14.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 477.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		9600000		"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	5.0	1.1	3.2	1.4	9.3	0.2	2.6	2.2	3.7	4.3	0.5	1.3	1.3	2.3	1.8	2.4	6.8	9.2	2.0	2.2	7.4	14.8	0.7	4.5	0.6	4.9	9.5	0.7	0.7	1.1	1.0	3.6	6.0	1.1	0.9	1.5	0.7	1.8	1.2	1.0	1.2	2.6	3.2	0.8	1.0	0.3	9.8	0.4	2.3	1.6	0.7	2.3	1.9	3.9	0.1	1.9	62.2	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.2	0.0	0.1	477.1	0.3	0.0	0.0	49.6	0.1	0.0	0.6	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	17.5	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	9.4	0.0	0.2	0.0	10.9	0.1	14.0	0.0	1.8	0.0	0.0	0.1	0.2	19.3	0.1	0.2	0.0	0.1	1.8	5.9	1.5	0.1	0.4	1.1	0.1	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	9.3	2.2	3.7	2.2	7.4	4.9	9.5	6.0	3.2	9.8	3.9	5.7	0.0	0.5	7.2	2.4	0.9	0.1	36.5	0.0	10.8	0.1	0.4	3.1	48.6	7.0	11.0	0.0	0.0	0.0	0.0	27.4	37.2	0.2	2.9	0.6	5.3	0.0	0.0	67.1	3.0	0.0	2.9	0.0	2.9	0.0	4.1	0.0	0.1	0.1	0.0	33.6	0.0	0.0	0.0	2.5	0.1	0.3	1.3	0.0	39.4	1.0	0.3	0.0	60.8	5.5	63.8	0.0	0.4	0.0	1.2	0.0	171.1	1.1	0.8	46.0	0.6	69.5	0.0	0.4	0.1	1.0	0.0	1.8	0.2	0.0	0.1
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 275.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	0.8	4.5	0.4	0.2	0.0	0.1	0.7	0.0	0.0	23.2	275.8	0.1	0.0	0.1	0.6	5.0	0.0	1.2	0.4	10.1	30.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.1	238.3	1.1	0.0	0.1	12.4	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	0.7	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 296.8;liver: 129.8"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.6	0.1	0.4	0.5	0.4	0.1	2.2	102.2	241.2	0.2	0.0	0.3	0.3	3.9	0.0	0.2	0.0	44.9	129.8	0.2	0.2	0.2	0.1	0.2	1.8	0.0	0.6	0.0	0.3	0.1	51.9	0.1	0.0	0.1	0.1	0.1	296.8	2.7	0.0	0.1	4.3	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981781	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favorable (7.31e-5)"	45.8	48.2	83.8	42.0	85.7	52.3	48.7	83.7	111.3	58.1	100.4	53.0	54.5	42.4	91.9	52.8	54.2	46.1	39.2	85.5	85.5	60.2	80.6	44.6	51.7	86.4	84.7	69.5	133.6	53.6	93.0	34.3	85.7	62.6	53.8	34.1	77.0	48.5	29.6	43.5	68.5	33.8	83.1	81.4	81.8	83.5	86.6	44.2	73.2	28.1	54.8	48.1	48.3	86.7	72.7	116.5	60.8	114.6	52.6	53.3	112.7	51.4	63.9	52.3	51.0	92.5	72.3	88.7	107.8	55.5	35.2	72.8	41.6	61.4	59.3	127.0	58.1	43.4	157.9	123.8	58.7	50.0	47.5	60.7	51.5	45.9	91.8	64.2	52.8	169.1	49.6	80.8	52.9	140.3	128.3	79.2	38.5	87.4	55.0	74.6	101.4	101.7	52.8	91.3	43.0	104.1	38.3	37.1	51.7	65.3	84.5	65.4	38.9	43.6	38.2	53.1	66.8	106.8	102.9	54.2	54.3	69.1	53.5	20.8	62.6	54.8	33.8	63.8	36.8	40.9	31.4	30.6	50.1	44.7	28.0	31.4	30.5	45.3	67.4	46.0	32.9	41.3	83.8	85.7	83.7	111.3	85.5	85.5	86.4	84.7	85.7	83.1	86.6	86.7	31.3	25.6	62.6	60.7	61.8	33.6	63.3	89.3	50.7	52.0	52.8	40.4	28.4	44.3	84.1	40.5	31.3	68.8	44.9	56.5	50.9	56.8	53.0	35.7	32.9	32.1	61.6	22.9	31.1	67.7	57.4	44.7	147.8	42.5	69.6	68.3	27.5	55.6	61.7	57.2	27.9	70.8	71.2	33.6	40.7	36.3	40.7	44.1	46.2	25.3	47.6	45.1	33.0	25.6	50.6	37.1	60.9	29.7	87.2	49.0	77.2	45.1	85.2	52.6	32.9	34.3	33.2	132.8	45.7	31.0	25.9	61.6	53.0	38.6	56.8	56.6
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 169.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453, CAB079975"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	13.4	19.8	9.4	9.5	10.2	29.1	14.8	10.9	12.9	17.5	11.5	13.7	13.3	12.1	12.9	37.3	12.5	6.4	12.4	9.5	10.5	18.4	13.6	12.7	4.8	9.7	9.7	11.7	14.1	3.2	18.2	16.2	9.8	13.7	7.4	12.8	18.9	4.8	26.8	25.3	12.2	7.7	9.8	12.6	13.5	30.6	10.0	9.3	13.2	15.0	13.3	16.1	19.9	9.4	42.8	5.9	19.4	30.6	6.4	24.4	169.5	30.9	37.5	46.2	42.9	62.2	64.5	3.7	36.4	36.8	34.2	65.3	10.8	31.3	40.6	9.0	3.1	8.6	21.4	25.9	32.8	17.9	33.8	7.1	61.3	1.8	46.0	24.5	32.5	22.3	16.3	16.1	13.3	33.3	9.4	51.7	20.7	2.8	25.4	12.3	0.7	27.1	42.6	25.4	8.6	17.5	11.6	50.4	42.4	28.1	44.9	39.3	7.4	17.1	27.4	33.1	18.2	14.4	30.4	16.5	31.4	10.2	15.5	27.9	7.9	16.2	5.3	8.9	7.9	10.6	7.8	10.6	7.3	14.5	5.9	6.4	8.2	8.6	4.7	8.9	10.5	6.1	9.4	10.2	10.9	12.9	9.5	10.5	9.7	9.7	9.8	9.8	10.0	9.4	12.2	16.0	13.2	10.7	7.8	57.7	21.4	32.9	15.4	6.4	12.3	14.7	11.3	10.0	20.2	5.5	12.5	121.0	11.7	10.2	15.6	27.8	26.8	33.1	10.7	11.6	3.0	9.9	17.6	21.6	343.6	13.0	9.7	27.2	15.8	7.4	7.1	6.7	24.0	1.7	13.7	12.3	20.3	8.5	6.0	7.9	7.5	8.5	7.2	11.2	11.6	10.4	15.5	8.0	11.9	29.3	16.2	7.2	5.8	28.2	12.3	29.3	42.4	8.7	26.3	10.0	12.5	70.1	18.6	15.9	41.9	64.6	11.4	6.8	13.2	29.8
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.7;Inhibitory neurons: 175.4;Late spermatids: 100.4;Oligodendrocyte precursor cells: 149.3;Oligodendrocytes: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044721: AB_2679059"	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	4.4	2.9	2.2	3.5	2.5	3.2	3.0	7.6	3.0	2.9	1.2	10.5	7.7	4.0	3.2	5.1	2.5	3.9	4.1	3.0	2.7	5.1	5.7	2.9	3.1	2.7	3.0	2.5	7.1	5.1	2.1	5.9	2.4	3.5	6.0	8.5	4.6	6.9	5.0	3.1	7.5	6.6	2.1	2.5	5.0	9.7	2.6	5.9	3.4	5.2	4.1	6.2	2.5	2.1	10.1	8.4	16.5	16.4	8.3	10.2	10.3	19.6	13.2	13.8	10.0	23.8	13.6	10.7	8.3	9.8	11.6	12.2	18.7	12.9	17.2	25.8	10.3	20.5	6.4	8.2	5.8	32.3	11.4	7.5	12.2	10.7	17.3	7.8	10.2	18.1	32.1	0.0	12.5	10.7	25.2	15.1	13.2	15.5	9.9	15.4	15.9	7.6	8.2	9.2	13.6	8.6	8.1	15.1	13.9	12.7	5.5	14.6	10.5	8.8	11.3	16.1	10.4	7.8	15.2	19.3	5.5	13.2	10.7	0.1	0.2	1.0	0.2	0.4	0.4	0.2	0.3	0.4	0.4	0.4	0.4	0.3	0.0	0.2	0.3	0.2	0.2	0.2	2.2	2.5	7.6	3.0	3.0	2.7	2.7	3.0	2.4	2.1	2.6	2.1	6.5	9.6	4.4	63.6	11.2	19.8	7.7	5.9	8.6	20.5	6.4	5.0	5.9	10.0	6.8	1.8	25.0	8.2	9.5	11.7	9.8	8.9	66.4	7.8	7.7	6.6	8.4	9.9	118.7	8.2	9.7	9.4	14.3	7.4	0.0	8.9	6.8	8.0	8.0	18.5	175.4	7.6	10.2	9.1	11.3	100.4	7.8	7.9	8.8	58.1	8.4	7.7	6.2	149.3	91.9	11.5	10.9	8.2	14.4	14.9	18.0	15.3	5.3	17.3	6.6	67.6	10.9	32.9	18.3	12.8	23.9	9.7	10.8	11.2	11.7	16.2
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790792	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	44.6	60.8	44.3	23.7	43.7	47.0	40.3	40.8	53.8	55.5	35.4	49.3	19.7	49.3	21.1	35.4	65.6	23.7	40.4	50.8	42.0	44.5	65.1	47.2	35.1	44.7	44.1	88.5	44.4	19.2	67.0	18.7	41.1	44.1	12.2	11.1	29.7	23.3	28.3	38.7	40.9	19.1	42.7	65.6	37.4	44.3	42.1	31.9	42.1	17.1	20.9	38.9	40.5	44.4	22.5	40.5	24.9	27.6	27.6	21.4	32.1	22.9	33.3	23.4	20.9	30.3	25.0	39.5	25.7	26.0	32.1	44.2	16.5	37.3	8.9	34.8	19.0	37.1	45.2	25.3	40.2	36.3	56.5	37.9	44.5	24.8	27.7	30.0	48.5	34.8	32.6	51.7	21.2	60.1	39.5	54.5	55.0	34.3	41.9	112.2	21.2	57.0	34.2	24.9	24.5	29.2	34.5	35.8	20.9	19.3	45.0	33.9	56.4	27.8	30.9	24.1	22.3	92.5	76.4	34.7	26.1	24.4	25.9	4.1	3.7	5.8	10.3	5.1	10.1	3.6	5.7	8.3	4.8	6.6	6.3	7.9	5.4	22.4	7.5	9.9	4.4	3.6	44.3	43.7	40.8	53.8	50.8	42.0	44.7	44.1	41.1	42.7	42.1	44.4	43.1	12.8	12.4	39.8	27.1	24.1	27.6	15.8	18.8	13.9	17.9	10.9	14.1	20.0	10.8	11.0	2.1	22.5	28.5	17.1	15.6	31.3	4.4	26.4	22.7	35.6	19.2	15.4	18.1	37.2	22.3	23.0	24.5	25.3	25.3	18.1	33.5	26.4	23.3	25.2	17.0	12.7	8.2	18.8	23.4	6.2	19.6	24.2	16.0	22.5	44.7	17.5	33.0	12.5	16.8	32.9	13.7	31.2	22.2	28.9	14.5	16.7	20.4	7.9	0.0	21.6	22.1	8.9	22.9	19.9	22.0	51.3	24.7	54.5	13.7	31.4
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A549: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	2.0	1.6	4.9	1.1	6.7	2.5	2.5	0.0	11.7	3.9	0.0	1.9	0.9	2.6	1.9	3.5	1.7	1.8	3.8	6.8	0.0	3.5	1.2	4.6	0.8	0.0	2.5	3.8	2.4	2.4	1.7	3.2	0.0	3.6	1.2	12.2	2.2	2.3	1.7	2.2	0.9	2.5	0.0	1.2	2.4	7.1	5.7	1.7	3.0	2.0	1.1	2.7	3.4	5.4	1.1	10.0	2.6	2.2	2.4	3.6	1.7	1.7	3.0	2.0	2.5	3.3	1.5	1.5	0.3	1.0	4.5	0.5	3.2	1.8	4.3	0.4	1.7	0.1	5.5	2.1	1.1	0.2	0.7	1.7	1.9	5.4	4.9	1.3	1.0	1.6	0.2	1.5	2.7	1.0	0.6	0.8	5.2	0.9	2.3	0.6	3.0	0.1	1.8	7.1	0.5	3.2	2.7	0.9	1.5	4.4	1.3	0.4	6.2	2.5	1.7	5.5	1.3	0.3	0.1	0.3	1.4	0.4	3.0	5.7	0.5	1.1	0.3	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	2.0	0.2	0.3	0.5	0.1	0.1	4.9	6.7	0.0	11.7	6.8	0.0	0.0	2.5	0.0	0.0	5.7	5.4	9.4	25.6	24.8	37.5	2.8	0.9	10.7	0.7	4.6	19.0	7.9	6.3	12.9	5.7	5.3	7.3	33.3	27.4	3.8	1.3	7.9	7.7	34.3	6.5	8.4	6.3	2.4	2.7	216.6	9.6	3.1	7.4	7.7	7.9	1.3	3.9	6.1	3.4	4.2	80.8	116.1	1.6	2.0	4.4	0.5	55.3	5.9	4.9	0.0	34.7	4.6	23.5	0.0	41.7	79.7	8.2	0.8	5.3	4.3	16.2	0.6	8.9	4.0	20.4	32.9	7.2	8.4	5.8	10.1	4.2	1.3	47.3	2.3	5.7	1.8	22.9
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974634	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 98.4;lymphoid tissue: 96.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 73.5;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 273.1;U-937: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	98.4	23.2	21.6	9.1	23.6	36.0	30.6	22.6	31.4	17.5	20.3	19.3	13.4	20.4	11.8	11.1	15.2	15.5	24.2	21.6	23.0	10.4	7.2	9.9	22.5	23.0	22.4	47.6	17.4	19.9	7.8	7.3	24.0	9.9	12.6	7.8	8.8	24.9	20.5	18.9	14.2	22.2	21.2	11.1	7.4	5.2	22.2	96.2	9.7	8.6	23.4	13.1	16.3	30.3	67.6	32.9	5.9	99.6	108.0	16.4	1.5	61.8	76.2	121.8	107.8	1.8	25.7	140.3	58.5	63.5	41.6	8.2	71.4	9.8	63.4	78.4	90.7	102.5	254.6	21.5	5.5	74.0	42.8	5.6	1.9	32.8	14.6	45.6	32.7	115.0	45.0	0.0	76.2	22.0	91.1	40.4	0.1	31.6	71.3	108.6	86.8	0.4	42.9	34.1	49.6	114.3	88.1	67.5	23.6	0.6	31.3	273.1	21.6	130.8	44.1	76.3	0.9	128.1	131.9	113.2	0.0	284.5	118.3	22.4	3.7	17.9	7.3	2.2	8.4	4.9	10.8	9.7	9.3	4.3	6.0	5.8	0.4	10.5	0.9	11.5	22.0	5.6	21.6	23.6	22.6	31.4	21.6	23.0	23.0	22.4	24.0	21.2	22.2	30.3	9.5	0.0	3.9	2.0	5.6	10.1	2.6	8.1	23.9	8.2	3.8	29.5	14.3	5.7	6.1	3.7	16.7	4.9	11.3	2.8	17.6	6.3	4.9	1.1	18.2	8.1	8.4	73.5	0.6	3.4	12.1	31.0	3.1	1.2	16.5	12.6	20.3	8.8	28.3	5.0	0.6	10.2	14.2	20.5	16.0	7.1	39.4	11.0	7.2	1.9	17.1	26.9	17.5	2.0	3.3	3.1	10.2	47.8	14.0	1.8	24.6	40.8	3.2	9.9	85.5	38.9	26.7	32.0	15.0	22.0	11.2	1.9	18.2	28.6	9.1	1.2
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126879-5197887	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.3	13.8	30.0	9.1	32.4	13.0	10.6	22.9	28.6	10.5	2.1	13.0	5.2	11.5	8.2	9.2	10.7	8.9	24.8	30.3	34.6	14.6	12.8	13.4	8.8	27.2	36.1	9.3	6.5	17.3	14.4	9.9	37.4	13.4	10.7	31.5	7.6	16.7	9.7	5.9	10.1	18.0	18.8	9.4	10.6	11.7	42.5	13.3	12.5	12.7	12.6	10.8	7.7	21.7	25.4	27.4	28.1	13.7	16.4	14.9	11.7	13.9	28.5	22.7	32.2	17.8	23.8	19.8	6.8	26.4	41.1	36.5	23.1	29.5	23.9	18.4	6.8	23.5	7.9	27.0	15.3	13.9	8.1	12.8	16.1	29.8	11.5	20.3	30.7	26.5	11.6	23.9	21.4	4.6	30.1	5.7	12.1	12.4	7.6	25.0	22.5	9.4	14.5	25.0	11.4	15.5	15.3	26.2	34.6	33.8	16.4	6.7	25.4	15.6	11.6	14.1	14.0	20.8	160.2	15.9	7.4	11.7	8.1	55.3	17.3	21.2	15.2	14.7	16.6	12.1	15.6	17.3	13.8	11.4	12.0	11.8	49.7	12.0	13.4	10.9	19.5	23.7	30.0	32.4	22.9	28.6	30.3	34.6	27.2	36.1	37.4	18.8	42.5	21.7	43.3	19.2	15.7	36.9	36.2	17.6	30.3	33.0	14.2	60.1	17.7	14.4	55.2	18.6	19.6	33.1	95.9	22.2	29.6	15.3	5.9	33.1	71.6	20.1	14.0	42.3	10.7	14.9	39.3	22.7	40.0	17.9	15.3	21.5	21.0	20.5	27.8	21.7	60.8	43.7	52.0	12.4	12.2	36.6	26.1	33.3	16.1	31.5	32.0	21.5	38.7	21.9	28.8	28.6	56.1	31.7	20.3	24.8	48.9	23.1	15.7	13.2	23.5	65.5	19.7	19.7	52.1	26.8	34.7	14.8	15.3	16.3	36.7	13.0	13.1	29.1
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573686-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 559.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1100000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	117.0	68.6	39.1	113.7	42.0	161.3	73.0	40.6	42.9	59.3	48.3	80.0	57.5	60.6	54.9	78.7	51.6	76.4	74.5	37.0	47.1	64.4	112.9	83.6	159.3	46.0	41.8	57.9	84.3	85.8	43.0	108.5	46.0	43.2	70.8	49.2	52.7	47.7	250.9	55.0	65.5	75.7	44.6	121.6	89.0	95.9	45.8	194.5	97.4	155.9	165.6	104.3	49.3	47.8	376.2	85.5	147.6	98.0	166.7	203.6	174.5	201.6	261.1	197.6	194.7	213.4	147.0	473.9	298.0	227.4	229.2	158.2	213.5	202.0	366.4	306.1	80.1	282.3	93.2	130.9	258.2	318.7	173.4	194.7	206.7	178.2	473.4	139.6	254.5	137.9	205.7	309.9	289.5	107.1	260.9	180.9	148.9	161.6	108.2	156.8	197.6	382.2	206.9	150.7	116.5	87.8	192.0	140.4	246.0	210.0	456.3	190.8	316.4	209.4	198.5	168.5	202.7	446.9	363.2	1103.9	117.0	187.8	124.7	14.3	10.5	17.6	13.0	12.3	13.5	11.1	12.2	13.2	9.7	7.0	9.7	15.2	9.7	6.4	13.7	15.9	24.0	5.7	39.1	42.0	40.6	42.9	37.0	47.1	46.0	41.8	46.0	44.6	45.8	47.8	116.3	57.7	69.8	7.2	114.9	145.9	217.3	19.5	63.7	22.6	97.6	77.2	86.2	74.4	34.4	84.6	10.4	51.6	169.7	158.0	37.2	42.1	324.7	174.0	160.5	99.5	47.2	59.5	13.2	87.6	82.0	93.7	88.7	314.4	45.0	63.0	91.1	97.2	118.5	23.5	12.3	102.4	10.2	146.8	117.7	559.5	34.2	145.0	55.2	17.8	100.4	109.5	90.6	8.0	14.5	88.1	101.2	35.7	239.4	320.2	26.9	74.4	27.4	29.9	26.3	120.9	92.5	21.2	30.9	94.0	128.3	35.2	126.5	124.4	90.1	219.5
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 246.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"eosinophil: 43.6;neutrophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 43.6"	"Group enriched"	"Detected in many"	5	"CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	11.9	10.6	1.3	31.1	0.8	74.5	13.3	3.2	1.8	16.4	0.0	246.3	53.3	11.1	3.9	64.9	6.0	7.4	4.0	1.9	0.0	31.9	60.5	6.8	4.3	0.4	0.1	1.1	2.4	1.7	3.8	33.1	0.5	20.2	141.2	0.6	58.9	10.3	2.7	3.3	51.0	13.1	0.0	7.9	19.9	3.7	0.2	2.3	3.1	3.1	21.5	37.0	29.2	0.0	0.6	5.6	0.3	0.3	0.0	0.0	14.4	0.0	0.2	1.0	0.5	2.3	30.6	1.7	12.2	0.0	3.2	0.8	0.0	7.9	0.4	0.1	0.5	0.3	0.2	101.0	1.7	0.2	13.3	0.0	0.1	0.1	0.1	0.0	0.7	1.4	0.0	5.0	0.0	3.2	0.3	0.2	0.9	80.9	1.7	2.6	0.0	1.3	0.6	59.2	0.5	0.2	0.0	0.2	67.4	7.3	0.3	0.0	2.1	0.3	1.2	1.4	0.5	1.8	0.0	3.7	0.2	0.4	1.0	0.8	0.0	43.6	0.1	1.7	0.3	3.3	0.9	0.4	0.2	0.8	0.6	0.2	26.3	0.1	3.3	0.1	2.7	0.6	1.3	0.8	3.2	1.8	1.9	0.0	0.4	0.1	0.5	0.0	0.2	0.0	16.7	6.4	8.2	1.0	6.0	1.3	335.2	10.4	2.8	6.0	16.3	12.7	1.8	7.2	14.7	0.0	4.2	2.0	0.7	731.7	0.0	21.3	3.5	5.0	5.2	22.3	17.3	0.4	1.7	16.1	9.4	2.9	12.8	28.7	8.9	4.6	41.4	37.7	1.4	5.0	1.4	46.1	4.1	5.9	3.1	0.2	0.0	2.6	7.2	0.0	0.9	1.3	2.1	0.5	0.6	58.7	585.4	0.7	0.2	244.9	97.5	11.1	3.9	6.4	0.0	2.7	3.1	4.3	3.9	9.2	1.0	0.7	5.5	2.2	33.2	618.9
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"CEA cell adhesion molecule 8"	P31997	19	42580243-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 217.6"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 1.6;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.6;monocytes: 1.2"	"Not detected"	"Not detected"											CAB033676	Approved				"Intracellular and membrane"	NA	NA		9200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB033676: AB_1125678"		"unprognostic (2.01e-1)"	"unprognostic (4.52e-2)"		"unprognostic (3.31e-1)"			"unprognostic (6.30e-2)"		"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"		"unprognostic (1.71e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.62e-2)"		0.2	0.0	0.3	0.2	0.2	217.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.4	0.0	0.1	0.5	0.1	0.0	0.0	6.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	1.6	0.2	1.2	0.0	0.0	2.7	0.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	27.3	32.2	36.5	31.9	44.8	46.0	25.8	59.0	37.3	29.7	35.4	34.5	22.4	31.7	23.9	32.0	28.4	24.4	30.1	34.7	31.5	26.9	56.1	32.1	39.4	24.1	26.0	26.0	28.0	48.0	23.4	27.6	20.7	23.6	25.8	29.2	26.1	22.6	74.3	30.7	30.6	29.0	20.2	34.6	26.6	29.8	30.3	28.9	28.8	58.0	38.5	29.4	29.4	24.9	48.6	84.4	68.8	71.0	52.9	55.8	58.5	51.0	52.5	62.9	65.4	72.3	56.0	127.6	34.6	55.2	75.6	70.6	107.5	72.3	104.9	53.5	46.9	39.2	117.3	52.2	51.3	62.2	41.4	43.0	43.7	68.5	82.5	44.4	58.0	54.2	75.0	50.5	40.6	64.8	64.5	49.3	96.5	60.0	49.3	65.5	54.8	49.9	54.3	85.4	64.3	54.3	67.9	62.0	41.1	70.0	87.8	40.5	67.0	71.3	69.7	69.1	70.0	42.9	42.2	99.7	57.6	29.2	59.3	13.9	11.6	22.8	12.5	10.2	15.8	14.4	13.3	14.6	13.1	15.0	14.0	11.9	14.9	7.9	17.7	8.0	10.1	9.5	36.5	44.8	59.0	37.3	34.7	31.5	24.1	26.0	20.7	20.2	30.3	24.9	56.2	54.5	41.9	90.8	74.6	107.7	78.0	82.1	79.6	82.4	78.8	59.3	51.1	72.9	56.2	79.1	95.9	52.6	84.1	51.6	21.5	57.3	16.3	76.5	68.4	73.2	85.6	81.0	134.4	56.1	48.8	48.8	57.1	94.4	21.5	92.6	92.4	233.5	72.4	127.9	108.5	62.3	52.9	123.2	98.2	12.4	52.8	81.3	42.7	91.8	106.2	52.2	98.9	76.4	65.8	86.5	53.7	55.3	55.3	103.5	46.2	43.5	106.1	42.9	52.6	52.3	72.0	50.1	69.7	70.2	109.1	36.0	68.8	50.2	70.0	101.1
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636463-48662886	"G-protein coupled receptors, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.3;pituitary gland: 7.3;retina: 3.8;testis: 2.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Cone photoreceptor cells: 16.7;Enteroendocrine cells: 9.0;Excitatory neurons: 10.1;Horizontal cells: 30.3;Inhibitory neurons: 10.8;Rod photoreceptor cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.9;HeLa: 16.2;SH-SY5Y: 18.4;SiHa: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.2	1.2	2.4	0.3	2.9	0.6	0.2	7.3	5.6	0.2	0.0	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.4	0.0	0.0	0.2	0.8	0.2	7.3	0.2	0.0	0.2	0.3	3.8	0.1	0.2	0.1	0.4	0.4	0.2	0.0	0.3	0.6	2.2	0.0	0.1	0.2	0.0	0.2	0.1	0.2	1.1	5.0	3.7	6.0	3.6	0.7	1.1	1.6	0.3	0.7	0.8	1.1	7.0	3.7	1.1	0.9	0.2	3.1	0.6	1.9	0.3	0.4	16.9	1.0	1.7	16.2	2.5	1.1	1.6	2.6	0.5	4.7	0.4	8.5	0.2	0.1	3.5	0.6	5.0	1.2	5.4	0.1	0.1	3.4	1.8	1.6	0.4	0.8	5.2	0.0	3.4	13.5	18.4	16.6	0.3	0.6	0.8	8.1	3.2	0.1	5.9	5.6	7.8	2.9	0.4	9.5	4.4	4.2	1.2	9.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	2.9	7.3	5.6	2.8	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.5	0.7	0.7	0.4	0.1	0.3	1.2	16.9	1.8	2.0	2.7	0.0	0.1	0.0	16.7	0.2	0.8	1.0	0.0	0.2	3.5	0.7	0.9	0.8	9.0	2.1	10.1	0.0	0.3	0.3	0.5	2.5	1.3	0.5	0.4	0.6	0.2	30.3	10.8	1.9	0.0	0.0	0.3	2.3	0.3	0.3	0.0	0.0	0.1	1.0	0.0	1.5	3.6	0.2	0.1	0.0	0.9	0.2	0.2	0.1	0.2	10.9	0.0	0.3	0.7	5.7	3.9	0.6	0.4	0.1	0.6	0.5	0.5	0.1
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronidase 1"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 25.3;endometrium 1: 31.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 62.5;Inhibitory neurons: 40.0;Microglial cells: 101.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 204.1;BJ hTERT+: 321.8;fHDF/TERT166: 258.7;HSkMC: 169.3;hTERT-RPE1: 187.6;U-138 MG: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		1700000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.65e-4)"	5.7	1.7	1.6	11.2	8.8	1.5	0.8	5.5	11.1	13.3	25.3	1.3	0.8	31.9	6.9	6.4	6.2	2.1	1.9	2.4	3.5	0.9	0.8	15.0	9.5	3.0	1.7	4.7	1.0	1.5	8.0	2.6	2.4	2.0	1.8	4.1	1.9	1.6	0.4	5.9	1.6	0.6	5.1	1.8	0.9	2.9	4.4	0.3	3.9	0.0	4.7	14.0	2.6	3.1	0.7	7.7	1.5	1.1	0.5	2.8	0.9	204.1	321.8	5.4	4.1	2.4	1.0	1.0	0.6	258.7	0.9	4.9	0.0	0.7	1.1	0.6	1.9	0.7	1.3	17.1	1.9	0.5	1.0	169.3	0.2	39.6	0.2	187.6	0.0	1.0	1.0	0.8	4.8	4.7	0.7	0.5	1.0	68.9	9.2	1.2	0.3	0.9	0.0	3.5	12.7	0.4	3.5	0.5	17.7	2.7	1.0	0.4	1.0	90.6	0.9	6.8	3.5	0.8	0.7	1.2	9.6	1.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.6	8.8	5.5	11.1	2.4	3.5	3.0	1.7	2.4	5.1	4.4	3.1	0.1	0.0	1.5	2.9	0.1	0.0	0.3	0.0	11.4	2.9	0.0	0.1	1.2	0.0	4.3	0.0	6.2	0.2	0.0	1.1	0.0	0.1	1.0	0.7	4.3	1.6	4.8	0.0	62.5	0.4	0.2	4.3	0.0	7.0	1.3	0.1	0.4	0.0	0.4	3.3	40.0	0.5	0.0	0.0	0.0	0.6	0.3	0.9	0.0	101.2	0.0	0.4	0.0	6.6	8.2	0.7	0.1	0.0	0.1	2.7	0.0	0.1	0.0	3.0	0.0	0.4	0.8	0.2	0.7	1.0	0.0	0.3	0.1	0.1	0.8	0.9
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812086-3857396	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Cone photoreceptor cells: 458.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	9.0	9.1	7.0	6.6	11.6	3.1	6.4	9.3	7.7	6.9	12.0	8.1	5.2	7.1	4.3	7.6	7.9	6.2	7.6	5.4	7.9	11.3	8.7	7.5	7.1	10.1	11.4	7.5	8.8	14.0	8.1	6.6	10.2	7.7	6.6	9.0	7.8	8.6	9.5	7.1	7.1	9.3	7.7	6.6	7.6	9.6	10.1	8.4	9.9	6.9	8.7	8.1	6.7	9.1	13.4	10.8	8.8	11.8	20.9	15.9	6.8	14.0	11.2	19.5	12.8	8.0	11.4	15.7	17.6	14.8	14.0	12.8	20.3	13.1	23.1	22.1	15.5	15.8	12.7	10.2	13.5	15.5	13.3	8.0	13.0	17.9	28.0	13.6	16.6	17.3	19.6	15.7	18.3	6.2	22.8	6.3	6.3	18.9	20.2	14.1	12.3	17.1	12.7	7.8	22.1	8.8	21.7	23.8	15.0	10.8	10.2	8.0	19.1	14.0	6.5	23.6	11.4	13.0	20.6	22.5	7.9	17.4	5.6	0.3	0.1	1.5	0.6	0.2	0.5	0.2	0.4	0.6	0.3	0.7	0.7	0.1	0.2	0.7	0.4	0.9	0.2	0.1	7.0	11.6	9.3	7.7	5.4	7.9	10.1	11.4	10.2	7.7	10.1	9.1	13.7	25.6	25.9	15.7	14.7	15.9	14.2	9.2	12.0	24.8	12.8	9.1	14.1	12.8	13.9	25.8	458.7	16.3	18.6	16.2	7.9	26.0	74.9	34.3	14.4	15.4	11.3	10.7	23.7	19.6	24.4	12.9	12.2	18.9	10.8	12.6	8.9	18.4	13.2	58.9	24.6	13.5	4.1	14.6	7.8	91.7	12.5	14.3	19.6	12.2	21.0	13.8	22.6	12.1	34.1	24.3	11.7	20.7	23.2	19.2	16.6	18.5	28.7	55.2	19.7	19.8	16.1	63.7	23.5	15.0	20.0	11.4	17.2	18.2	12.7	13.7
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Microtubules	"Cytokinetic bridge, Centriolar satellite"	"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	9.1	8.6	6.7	5.2	6.4	10.2	10.3	7.8	10.0	14.7	7.5	9.8	4.6	11.4	0.9	9.1	11.5	2.0	16.8	6.5	5.8	11.7	6.8	10.7	7.9	6.8	6.2	12.8	10.1	2.2	15.4	4.1	6.2	12.0	0.8	1.8	9.3	2.1	11.1	10.5	10.3	1.6	5.7	19.0	9.9	28.2	6.7	3.5	10.3	2.0	2.2	10.4	10.7	6.8	21.1	20.0	10.6	19.4	1.7	2.7	33.6	14.4	2.5	10.3	7.9	23.8	10.5	14.8	8.0	3.5	6.3	14.9	3.1	7.0	2.5	6.2	26.8	14.3	32.7	41.3	2.9	12.5	30.6	2.3	4.6	7.5	2.1	3.3	7.3	15.6	10.6	8.5	2.7	23.5	29.0	24.3	9.5	6.1	17.7	29.0	12.1	6.1	3.9	18.4	24.2	27.2	18.5	11.4	18.0	3.9	17.2	12.3	10.0	18.6	32.1	16.7	19.2	22.0	4.0	11.3	9.6	10.7	13.5	2.1	0.8	0.5	1.2	2.3	0.3	2.9	0.7	1.1	1.8	1.7	1.1	0.8	1.3	1.0	4.6	2.0	0.1	0.8	6.7	6.4	7.8	10.0	6.5	5.8	6.8	6.2	6.2	5.7	6.7	6.8	6.5	0.0	4.4	5.5	6.6	0.0	3.4	0.0	3.4	5.8	3.3	4.4	13.4	2.8	1.3	3.7	6.2	8.7	4.8	5.6	0.0	4.5	14.0	8.4	3.5	6.0	6.7	5.7	2.1	3.7	7.2	6.9	6.6	2.8	15.9	9.3	2.5	1.7	5.2	5.0	2.9	5.1	0.0	1.9	0.0	17.9	9.6	3.6	0.0	1.0	1.3	6.0	7.2	2.5	2.8	5.2	0.8	3.0	4.4	1.2	1.8	1.4	3.6	6.9	0.0	4.3	5.7	14.7	20.5	3.7	0.0	6.0	3.5	8.4	7.9	2.7
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033361	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.3;monocytes: 64.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (6.11e-5)"	2.6	1.6	1.0	7.2	1.3	10.1	2.8	2.1	1.6	3.5	1.9	2.4	3.1	7.6	2.1	2.0	3.3	3.1	1.4	1.2	1.3	4.0	1.3	3.2	10.2	1.7	1.5	5.0	1.7	2.0	1.2	5.9	1.7	2.3	3.2	3.7	1.5	1.6	0.8	3.9	3.3	5.0	1.0	5.7	2.2	6.4	2.0	9.5	2.6	1.3	7.6	2.9	2.2	1.9	8.9	4.8	13.0	12.3	2.6	5.0	5.5	8.6	6.1	7.7	9.0	5.2	9.0	23.7	6.4	3.8	6.0	4.0	13.8	5.2	14.6	6.5	8.4	8.3	7.6	4.9	2.9	15.2	12.6	3.9	4.1	9.9	7.0	3.4	6.5	11.9	15.4	11.0	8.1	5.2	21.3	9.5	8.3	4.4	4.9	15.4	6.1	4.8	5.6	6.4	9.3	9.6	7.7	5.2	6.4	7.8	6.9	9.7	6.5	10.4	17.0	12.5	15.1	5.9	4.4	15.7	5.2	11.8	13.1	9.9	2.1	2.9	3.0	2.8	2.8	3.0	3.9	2.9	1.5	5.6	5.0	3.1	4.3	4.7	3.2	5.6	2.7	1.4	1.0	1.3	2.1	1.6	1.2	1.3	1.7	1.5	1.7	1.0	2.0	1.9	16.3	6.4	12.4	7.8	30.2	9.1	8.2	6.3	7.4	12.6	5.6	6.6	8.5	2.8	9.4	7.3	10.4	20.0	27.3	5.2	3.9	9.4	92.3	23.1	14.6	18.2	5.4	28.2	10.0	5.4	16.3	11.5	3.1	13.0	14.5	38.2	12.5	1.7	10.4	26.9	10.4	5.5	6.1	12.9	11.3	19.4	5.9	19.2	5.4	19.7	64.5	4.3	32.0	8.0	13.9	15.6	6.7	8.2	16.7	5.2	3.0	10.0	17.4	24.5	6.6	16.2	11.2	57.3	38.7	6.8	6.7	9.6	20.0	34.6	5.7	6.3
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039408	Approved		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome	Nucleoplasm	"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	2.2	1.3	1.2	3.5	1.4	16.3	1.9	2.0	1.9	1.9	2.6	2.3	2.9	1.4	0.9	2.6	1.9	1.8	2.1	1.0	0.9	2.2	1.0	2.2	4.3	1.2	1.2	2.5	2.9	1.3	0.9	4.7	1.4	1.7	3.1	1.9	2.4	0.9	1.0	3.0	2.9	1.9	0.7	2.4	2.3	9.8	1.8	5.6	2.9	0.6	3.7	1.4	2.3	1.8	8.0	6.1	12.2	15.0	2.1	3.9	7.9	13.9	5.6	10.0	12.3	13.2	6.8	18.6	5.9	4.0	14.1	18.6	13.6	5.0	14.5	16.5	8.3	30.1	34.6	7.2	1.4	25.6	13.4	1.4	3.9	11.1	6.6	3.9	7.5	19.2	18.4	21.6	8.6	4.5	18.6	23.8	7.7	9.5	6.1	22.7	16.4	22.9	3.6	7.5	14.6	9.8	10.7	8.9	4.2	13.3	6.7	12.3	6.2	24.4	12.9	18.9	15.6	9.2	10.8	21.4	7.8	36.2	17.6	2.1	1.0	1.9	0.8	1.4	0.7	0.9	0.9	0.9	0.8	1.7	1.0	1.0	1.8	1.2	1.5	1.5	1.0	0.5	1.2	1.4	2.0	1.9	1.0	0.9	1.2	1.2	1.4	0.7	1.8	1.8	3.9	6.4	2.8	22.2	9.3	3.8	4.1	2.8	4.0	1.5	2.9	3.6	3.9	4.3	1.8	3.7	2.1	31.5	6.8	7.8	0.0	4.7	192.5	6.4	5.3	6.7	3.6	29.9	14.7	6.7	8.5	9.0	7.1	5.0	8.2	20.9	6.1	3.3	7.6	0.0	8.4	8.2	4.1	7.2	6.4	49.5	23.9	8.6	1.8	16.9	6.9	2.9	10.3	6.0	7.0	7.9	3.5	27.1	15.9	3.2	9.1	1.7	8.4	3.6	6.6	6.5	5.4	24.4	10.3	7.0	3.4	46.9	9.9	3.4	10.1	4.1
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA064875: AB_2685379"	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.4	12.8	13.5	12.8	22.6	6.4	12.7	11.9	11.3	11.3	10.6	6.9	10.5	8.9	10.4	11.8	7.5	6.8	11.6	13.4	6.2	6.7	7.1	23.3	11.6	12.5	14.2	7.3	12.7	12.2	6.5	11.1	12.2	8.3	15.7	10.1	8.7	9.4	13.3	11.2	9.7	9.8	20.2	8.3	18.8	14.9	16.3	8.7	6.9	14.3	9.8	10.4	11.6	33.9	38.2	18.5	34.6	27.6	24.8	27.4	16.5	18.4	25.8	20.3	51.2	27.0	36.4	21.5	23.7	80.4	36.6	20.0	50.7	28.7	6.9	8.2	68.1	31.0	49.0	16.7	33.7	36.6	17.7	30.0	43.7	61.9	29.3	27.0	38.3	23.7	33.8	44.2	17.4	41.5	34.0	12.4	18.0	43.1	23.6	53.6	10.1	24.7	38.4	24.9	27.7	45.6	30.3	21.5	14.9	21.3	29.3	43.7	113.5	29.3	42.4	23.8	11.7	13.6	33.9	63.1	22.4	19.9	20.2	2.0	5.2	10.5	2.5	6.5	5.7	4.4	8.5	4.1	6.7	5.3	6.0	0.8	7.4	1.7	14.1	5.1	4.6	12.8	12.8	12.7	11.9	11.6	13.4	11.6	12.5	11.1	9.8	14.9	11.6	3.4	6.4	7.2	7.5	14.6	1.7	6.2	3.6	8.6	21.7	4.5	5.3	13.0	5.7	12.7	9.2	12.5	11.6	15.7	7.0	5.9	5.5	11.7	16.2	8.0	4.8	3.0	19.5	13.6	2.0	6.4	7.6	11.7	9.7	5.1	11.8	7.1	3.8	9.1	16.8	17.6	5.4	2.0	9.0	2.7	20.0	4.4	7.7	1.8	5.6	4.2	8.3	20.6	5.0	5.1	5.1	3.6	3.8	18.7	5.2	5.1	2.2	19.5	28.7	0.0	9.9	6.7	24.1	14.8	10.6	2.7	3.0	15.9	5.5	6.6	3.8
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954773-180114875	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 835.2;Late spermatids: 824.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633"	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	10.9	7.0	10.7	11.5	22.1	24.6	11.4	20.8	13.4	9.1	6.0	11.2	9.3	8.6	7.5	9.3	8.3	8.7	7.8	7.7	14.0	8.9	10.4	7.9	15.5	16.7	16.7	14.0	10.6	16.9	7.5	10.0	17.0	7.7	11.1	20.9	7.5	9.2	31.4	11.8	11.6	8.4	11.4	11.7	11.0	24.9	15.6	24.0	11.3	36.9	14.0	10.5	8.6	25.5	23.8	16.4	21.2	7.5	17.6	16.2	20.0	15.8	21.0	13.2	14.5	18.7	13.8	26.0	16.8	14.2	11.4	28.8	16.1	9.0	17.2	25.9	11.4	18.6	20.6	11.9	19.2	37.1	16.7	16.3	13.7	17.3	22.5	9.7	16.4	24.4	36.9	19.5	14.3	17.2	21.9	10.4	19.8	23.0	4.3	18.9	23.4	20.3	9.3	48.2	14.8	15.9	26.2	17.3	29.7	14.9	19.0	32.8	16.8	18.7	13.0	16.7	16.9	33.5	46.2	49.9	8.7	15.9	28.6	1.4	2.1	5.0	2.9	1.9	3.3	2.3	2.1	1.8	1.7	3.7	2.2	1.9	3.8	1.9	1.7	3.4	3.4	0.8	10.7	22.1	20.8	13.4	7.7	14.0	16.7	16.7	17.0	11.4	15.6	25.5	63.6	118.6	67.4	138.4	75.9	38.0	28.4	23.9	45.5	56.8	34.3	27.4	84.3	37.1	42.2	12.9	85.5	19.7	76.4	35.3	5.9	23.3	835.2	61.0	59.5	49.4	46.2	81.4	108.3	38.9	23.9	47.5	47.9	53.6	29.7	42.9	74.6	28.4	29.4	62.2	121.3	29.3	22.4	72.3	60.9	824.3	53.7	79.0	19.6	89.0	101.0	36.2	70.0	121.2	172.9	37.2	22.4	42.2	100.1	37.5	52.0	11.8	57.3	56.4	26.3	74.0	51.3	233.9	45.0	48.5	46.7	26.3	75.2	40.7	29.5	40.0
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 462.9;Late spermatids: 372.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA018315	Approved		Approved	Microtubules,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.6	14.0	10.6	19.2	11.4	29.0	21.6	15.0	13.3	19.0	12.6	17.7	32.4	21.8	19.8	15.0	17.7	27.3	15.6	10.4	11.2	15.7	44.6	16.9	30.1	12.2	11.2	31.2	22.8	12.2	14.9	16.1	10.8	16.2	18.6	25.9	14.1	17.3	12.8	17.8	21.9	15.5	10.9	20.5	17.8	27.9	11.7	34.2	22.7	14.3	30.6	14.0	15.1	12.4	26.7	13.1	42.0	32.7	19.4	38.6	34.4	29.8	48.6	41.4	46.1	47.5	55.1	47.1	39.6	22.4	24.2	43.8	34.7	29.5	43.8	38.1	21.8	66.4	36.9	38.4	33.9	67.0	37.2	25.9	42.5	43.2	80.4	39.3	33.4	49.6	43.8	25.3	33.8	13.1	74.7	89.1	23.3	30.2	29.2	43.8	53.2	40.7	34.8	27.8	21.5	28.9	36.1	34.4	38.3	29.7	35.1	44.0	17.2	35.2	28.3	52.0	28.2	16.9	38.1	51.7	14.6	74.4	31.0	19.0	11.8	24.3	19.5	14.4	25.9	23.6	25.7	22.7	15.6	21.7	24.8	23.5	11.6	26.0	13.2	21.1	33.7	17.5	10.6	11.4	15.0	13.3	10.4	11.2	12.2	11.2	10.8	10.9	11.7	12.4	43.7	54.5	51.1	35.9	58.5	36.3	30.6	35.7	51.2	72.3	30.6	42.7	41.3	85.8	41.7	29.5	35.5	44.1	42.8	16.2	54.8	34.2	462.9	52.2	33.0	38.2	28.8	88.1	68.0	25.7	50.8	41.1	18.3	33.0	27.3	58.4	30.7	71.5	33.1	57.2	78.3	34.0	16.2	35.0	37.3	372.7	33.8	33.2	17.8	27.2	37.6	29.6	44.3	57.8	60.9	26.2	23.9	35.7	57.8	28.8	45.2	40.2	52.6	59.0	65.7	34.4	37.8	75.8	46.1	42.0	32.0	38.4	59.1	53.0	47.2	27.6
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3"	"Group enriched"	"Detected in many"	10	"B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	7.5	12.0	20.1	6.3	20.9	5.9	13.3	24.1	22.3	30.6	16.2	17.6	56.2	20.9	21.6	12.0	30.6	13.1	15.8	18.1	25.4	21.4	29.4	14.7	5.5	22.1	21.8	18.5	24.1	21.8	15.6	3.9	21.8	21.0	18.1	35.8	8.7	21.7	18.0	6.8	19.0	11.7	20.5	6.1	13.1	69.0	23.9	42.4	39.2	20.8	6.9	12.1	11.7	22.7	53.7	11.1	25.3	30.8	15.2	16.9	23.5	10.4	19.4	14.0	20.5	15.5	27.9	12.5	24.0	19.2	53.1	23.0	23.2	20.6	31.1	22.2	15.3	35.7	26.0	20.1	24.2	1.6	12.5	92.3	11.7	10.6	26.2	37.0	20.5	40.1	26.6	40.5	23.1	20.1	38.4	2.1	15.0	13.9	24.6	41.7	32.9	32.3	26.9	23.8	30.7	19.8	54.5	12.7	60.8	28.4	64.3	17.7	12.1	10.3	19.0	21.3	12.9	37.2	22.1	42.6	22.9	3.3	35.7	0.2	0.0	0.1	2.8	0.1	3.3	1.7	2.1	2.3	0.0	1.4	4.1	4.0	0.2	2.3	0.0	0.1	1.3	1.2	20.1	20.9	24.1	22.3	18.1	25.4	22.1	21.8	21.8	20.5	23.9	22.7	7.0	32.1	69.3	44.1	4.8	9.7	46.3	14.0	22.2	15.8	11.8	9.8	34.3	22.8	27.4	20.2	35.5	8.1	4.6	10.5	72.4	24.9	222.5	114.0	14.9	7.7	15.6	13.7	51.8	17.6	4.4	11.8	16.3	52.6	20.8	21.9	6.1	14.7	2.4	21.9	48.5	11.1	8.2	0.3	3.0	299.3	9.9	2.3	10.6	19.7	0.6	26.4	2.1	60.8	30.5	12.7	8.1	12.8	9.2	29.5	3.3	21.1	34.5	31.1	6.6	17.5	12.4	163.6	9.5	18.6	8.1	9.6	8.9	9.5	23.9	28.6
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961923-56983845	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 33.5;liver: 43.0;lymphoid tissue: 59.6;placenta: 36.2"	"Group enriched"	"Detected in some"	6	"Adipocytes: 48.6;Hepatic stellate cells: 75.0;Kupffer cells: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.3;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;HUVEC TERT2: 4.7;TIME: 2.8"														"Secreted to blood"	NA	NA	2470000000	360000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	33.5	2.0	0.7	3.8	0.7	5.7	6.6	0.7	1.4	0.3	0.7	0.6	0.9	0.7	0.0	0.3	0.3	4.0	0.7	0.6	0.8	3.7	43.0	2.8	43.3	1.1	0.8	0.3	0.5	1.8	3.1	36.2	0.9	0.3	0.5	0.0	0.7	0.5	0.3	0.4	1.9	0.8	0.8	59.6	0.4	0.3	0.9	2.3	5.2	0.3	7.6	1.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1.8	2.3	3.2	0.0	1.2	0.7	0.7	0.7	1.4	0.6	0.8	1.1	0.8	0.9	0.8	0.9	0.8	48.6	0.0	1.8	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	13.4	0.0	5.3	0.1	0.9	0.4	0.2	0.0	0.1	0.0	0.0	75.0	1.3	3.1	0.0	0.1	0.2	0.0	142.0	1.2	0.7	0.0	2.1	0.0	0.0	1.4	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.6	0.0	0.4	0.0	0.4	1.3	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859664-863641	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1496.7;breast: 993.2"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 9365.5;Leydig cells: 5032.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 297.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.6"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.4;THP-1: 342.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	732000000	4400000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	1496.7	33.3	1.5	9.6	1.6	10.7	993.2	1.2	2.4	597.4	3.7	324.8	23.5	58.4	2.4	212.8	258.0	9.6	854.2	1.7	2.3	18.1	8.7	363.3	2.1	3.3	2.3	74.3	41.4	1.7	9.0	14.5	3.6	277.8	10.9	0.6	247.3	6.3	197.0	488.6	248.4	4.0	2.6	28.6	263.8	51.8	2.9	3.6	332.3	26.9	0.8	848.3	729.8	5.8	3.9	5.2	0.6	2.2	197.4	26.2	9.5	0.8	0.0	0.0	0.0	0.8	0.4	0.2	5.7	0.0	0.5	3.0	1.8	0.5	0.0	5.7	14.5	0.5	12.3	3.8	3.6	2.5	4.9	8.7	0.2	0.1	0.0	0.8	0.0	4.5	11.9	0.9	0.0	2.6	0.6	49.2	1.0	4.5	16.1	1.3	0.5	5.2	0.3	1.2	1.8	1.8	5.5	1.9	0.5	0.6	7.5	342.2	0.4	0.2	5.1	2.9	0.6	7.8	4.7	0.4	0.2	20.8	0.2	297.6	41.2	127.8	8.4	55.5	13.2	5.7	4.2	10.2	14.5	1.4	9.7	9.7	112.0	1.3	57.3	1.8	4.7	37.8	1.5	1.6	1.2	2.4	1.7	2.3	3.3	2.3	3.6	2.6	2.9	5.8	857.8	9.6	23.3	0.0	19.2	785.5	49.0	10.1	17.1	2.9	107.3	120.1	55.5	21.5	30.9	18.4	2.1	36.6	40.0	33.1	11.7	7.7	27.1	23.1	593.3	114.8	4.2	8.2	0.2	0.0	32.9	9365.5	113.6	15.9	17.1	0.9	30.4	2.6	272.4	1.7	0.4	8.7	0.0	424.7	1145.2	89.6	5032.4	442.5	642.1	4.7	303.6	1.3	21.6	0.0	0.1	2.9	64.8	283.2	41.0	19.7	4.3	3.4	28.4	6.5	0.0	414.3	530.2	11.4	21.3	28.6	735.9	34.3	82.8	1.2	21.0	233.2
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196652043-196747504	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 1676.3"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 448.0;Hepatocytes: 1114.8;Leydig cells: 283.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 18.7"	"Lineage enriched"	"Detected in single"	26	"T-cells: 18.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 123.1;HSkMC: 119.5;hTERT-RPE1: 374.9;RT4: 227.0"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	100000000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	125.3	42.1	18.1	32.7	21.5	1.3	66.9	20.0	29.6	76.8	43.0	51.0	30.5	12.8	15.9	63.8	24.2	133.6	301.5	18.1	18.6	25.5	1676.3	70.8	27.4	19.3	19.0	165.1	14.0	6.4	16.0	26.1	19.9	23.0	80.2	4.3	126.7	24.0	21.1	74.5	52.1	32.5	19.5	13.9	46.9	14.3	21.6	12.1	102.5	84.0	25.9	149.9	27.0	21.1	0.0	64.9	0.0	0.0	96.5	54.7	0.1	25.8	63.1	3.5	13.5	0.1	11.9	0.3	9.6	0.1	0.2	2.2	0.0	23.6	2.6	1.3	0.0	20.0	74.7	0.0	123.1	0.9	0.3	119.5	0.3	18.4	7.9	374.9	79.2	0.0	74.4	2.7	89.4	0.1	0.5	0.1	0.4	0.0	0.1	0.2	89.8	21.0	0.0	227.0	0.0	0.1	0.4	0.0	0.1	0.6	0.1	0.0	5.6	73.6	0.9	0.8	0.8	0.8	0.0	0.3	13.1	0.2	5.8	0.0	0.1	0.0	2.0	0.0	18.7	0.0	6.6	4.0	0.2	0.0	0.4	1.5	0.7	0.0	0.0	0.0	0.0	1.1	18.1	21.5	20.0	29.6	18.1	18.6	19.3	19.0	19.9	19.5	21.6	21.1	73.9	9.6	17.6	0.7	4.2	44.2	63.6	140.6	14.2	2.4	1.3	3.4	10.9	35.8	141.1	5.5	0.0	0.0	3.1	0.1	0.0	6.2	2.6	2.3	3.8	49.8	0.0	52.6	0.6	0.8	0.0	448.0	8.6	1.9	3.8	6.9	47.8	1114.8	1.1	0.0	1.0	0.0	14.2	43.8	62.1	7.4	283.9	5.7	44.4	38.4	0.3	0.3	0.0	0.0	0.2	5.3	0.0	138.8	2.6	13.0	0.0	0.5	115.6	1.4	6.6	94.2	59.6	1.4	1.0	10.9	38.2	0.1	13.2	26.3	0.0	61.5
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196832189	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	272	"liver: 2081.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 320.0"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	1.5	0.6	0.1	1.8	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	7.6	2081.3	0.1	6.7	0.1	0.8	0.3	0.3	0.0	0.1	0.1	0.4	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.7	0.2	0.1	6.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.3	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.0	2.4	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.8	0.4	0.1	0.2	0.1	0.5	3.2	0.0	0.0	2.2	0.4	0.1	0.0	0.0	1.2	0.0	0.1	1.8	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.7	0.0	0.0	0.0	9.9	0.0	0.0	0.0	6.0	15.0	320.0	5.6	0.0	0.4	0.0	0.0	16.9	0.4	0.2	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	41.0	2.1	0.3	1.5	0.0	0.0	0.3	1.4	5.6	0.1	0.1
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943738-196959622	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2752	"liver: 1311.8"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 38.5"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		4800000000	"Cluster 6: Non-specific - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1311.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	38.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774813-196795407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	582	"liver: 505.7"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 205.5"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;SuSa: 1.5;T-47d: 3.6;U-266/70: 6.4"														"Secreted to blood"	NA	NA	582000000	3100000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.8	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.4	505.7	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.4	0.1	0.6	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.4	0.0	0.9	0.0	0.0	0.0	0.3	0.0	1.5	3.6	0.0	0.0	0.1	0.2	0.3	0.0	6.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.8	16.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	7.1	205.5	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196888014-196918713	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	432	"liver: 123.9"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 62.6"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		170000000		"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	123.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.2	62.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1675	"liver: 167.5"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 102.7"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1900000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	102.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CFL1	CFL	ENSG00000172757	"Cofilin 1"	P23528	11	65823022-65862026	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013086, CAB033687, CAB037077, HPA053761"	Approved		Supported	Cytosol		NA	NA		290000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251"	"unprognostic (1.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	609.5	435.4	578.8	932.7	598.8	1322.1	514.5	590.1	661.2	451.5	475.3	1145.1	1169.2	713.1	343.2	706.0	481.5	413.6	501.9	637.3	599.8	612.5	471.0	683.4	987.6	626.4	571.5	344.7	264.6	301.8	340.6	479.2	622.1	440.6	990.3	208.9	453.1	457.6	261.9	503.1	1120.7	847.3	608.3	775.2	633.8	267.4	632.2	939.6	370.9	230.6	1100.5	682.9	471.2	695.4	2284.3	1783.6	1908.5	1529.8	1142.6	1157.0	1031.6	2309.7	1942.4	2457.5	1460.7	1012.4	1815.2	1700.8	1755.3	2925.7	1780.5	1623.2	1389.2	2103.8	1824.9	1869.0	718.2	2185.8	1271.2	1162.1	1222.6	1890.2	2854.6	1339.3	1412.4	2166.7	1108.0	1494.0	2663.1	1099.4	1037.6	1648.5	2635.7	2133.0	2739.4	2965.4	2095.8	1985.4	1432.7	2050.3	941.1	2181.9	1847.8	1468.6	952.7	2106.6	1250.6	1733.6	1682.2	1053.4	2104.1	1427.8	2330.5	2087.3	1603.5	2672.6	2194.0	1193.1	2065.2	2251.0	2146.2	1161.7	2004.4	1690.2	2720.0	2973.1	2534.0	2955.4	1964.6	1561.4	1992.5	2296.2	3343.8	1527.0	1459.3	1905.2	2946.2	1961.1	3255.3	2558.6	2696.1	6842.2	578.8	598.8	590.1	661.2	637.3	599.8	626.4	571.5	622.1	608.3	632.2	695.4	805.5	246.8	223.0	24.5	890.8	1349.3	1253.3	1197.1	598.8	198.5	655.2	646.0	74.8	459.0	595.7	520.5	58.4	1239.8	1439.8	2052.9	892.1	2114.0	459.4	376.6	648.1	918.4	779.0	557.7	38.8	1965.0	2470.6	579.0	642.8	603.3	598.2	527.4	698.2	436.3	2911.0	203.6	30.3	1448.8	891.1	1185.5	1706.6	373.2	352.2	1474.2	985.4	38.4	2903.8	478.3	2075.2	22.6	62.0	3082.4	1894.7	502.9	639.1	991.2	2279.4	1246.5	295.5	118.0	420.7	448.2	1184.3	177.4	412.8	703.8	1267.4	1732.4	1276.2	621.7	1315.3	1383.3
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 83.9;lymphoid tissue: 58.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	8	"classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9"	"Group enriched"	"Detected in all"	46	"dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		6200000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	6.0	1.9	0.3	20.5	0.3	83.9	2.1	0.3	0.6	0.6	0.2	2.1	1.2	0.9	0.2	1.6	3.4	2.1	2.6	0.4	0.1	0.8	12.0	9.3	11.7	0.1	0.0	0.7	0.8	0.1	0.8	0.9	0.0	0.7	0.9	0.2	1.0	0.2	1.0	1.5	3.7	5.2	0.0	58.4	1.5	0.6	0.0	5.1	0.9	0.7	4.4	4.9	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	20.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	5.0	0.2	0.0	0.1	1.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.0	10.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	1.0	0.0	0.1	0.5	0.1	0.4	0.4	0.1	0.1	7.2	0.0	131.5	1167.5	39.9	3.0	1273.6	2.3	6.7	15.1	1.8	994.5	2.6	21.8	8.1	730.3	12.3	868.9	30.9	14.1	1071.9	0.3	0.3	0.3	0.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.1	1.0	5.8	4.0	0.1	0.3	1.2	3.4	0.7	0.4	0.9	1.5	2.8	0.0	0.0	0.3	1.7	0.3	0.0	0.2	0.2	0.4	0.4	7.4	0.0	2.5	1.4	0.7	0.5	2.0	1.1	0.6	1.3	4.0	108.1	2.0	17.3	1.7	1.1	0.0	0.0	356.7	164.1	0.3	0.9	177.3	5.4	0.0	473.7	0.3	4.1	2.0	0.3	0.3	0.1	1.2	1.2	0.3	0.1	0.5	7.5	1.9	0.0	1.5	1.2	0.0	0.2	0.5	3.0	0.4	4.8	3.1	0.6	0.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"CF transmembrane conductance regulator"	P13569	7	117287120-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.6;intestine: 42.7;pancreas: 210.7"	"Group enriched"	"Detected in many"	4	"Ductal cells: 485.4;Ionocytes: 252.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.0	0.5	4.7	2.0	0.0	0.4	0.7	1.3	8.5	0.0	42.7	36.2	1.1	1.1	0.8	2.2	54.6	0.1	0.3	0.7	2.1	1.6	8.2	0.0	1.1	0.7	0.0	210.7	0.2	0.1	0.6	0.7	2.2	40.7	0.0	21.5	0.5	0.0	1.9	19.9	2.0	1.7	0.0	3.1	1.7	1.0	0.1	0.1	0.0	0.3	0.7	0.0	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	98.9	0.1	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.7	1.3	0.3	0.7	1.1	0.7	0.7	1.7	1.0	2.9	0.0	6.4	65.6	0.0	0.5	0.0	2.0	2.6	0.0	0.5	0.5	0.0	2.4	55.8	17.8	0.0	0.0	0.0	0.0	45.8	0.0	485.4	3.2	9.6	1.2	0.4	7.2	0.0	2.2	4.5	0.0	0.3	4.1	19.8	1.3	0.1	0.0	0.4	0.0	0.0	1.1	13.9	252.3	0.0	0.0	2.6	0.3	0.1	0.0	1.0	6.7	0.5	0.0	0.5	23.8	14.8	86.4	0.0	0.0	4.0	8.6	0.0	5.6	0.0	0.0	0.0	1.6	2.2	0.5	0.0	0.0	0.0	0.3	0.1	87.3	5.8
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4389.4"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.8	4.1	0.2	0.1	0.4	1.9	0.1	0.7	0.7	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.5	0.3	0.3	2.7	2.0	0.7	0.3	2.1	1.6	0.5	1.3	18.9	4389.4	725.8	0.9	2.7	0.3	0.3	0.5	1.1	3.3	2.1	0.3	3.4	0.1	1.1	38.1	0.5	1.0	0.8	0.5	0.0	0.3	0.4	0.2	1.5	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.4	0.7	0.7	0.3	0.3	2.1	1.6	0.9	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0"	"Low region specificity"	"Detected in many"							"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	5.8	1.1	1.9	6.0	3.3	0.4	9.0	8.5	3.3	4.9	6.5	37.2	52.7	1.4	1.5	8.6	13.2	13.6	0.6	2.0	3.7	12.2	32.1	27.3	0.4	5.5	3.0	2.0	24.2	32.1	3.7	1.6	5.6	10.1	25.1	3.7	21.1	7.0	0.2	17.9	56.4	1.5	1.7	0.4	30.4	6.6	3.4	0.7	4.9	0.1	2.3	8.3	6.2	6.7	28.9	3.2	2.7	4.6	0.0	0.0	35.4	0.1	0.1	0.8	0.9	91.4	59.1	1.3	9.4	0.0	4.9	27.0	8.6	5.0	0.6	17.3	6.0	2.4	1.3	1.8	0.0	0.4	3.6	0.0	1.0	1.3	0.7	0.0	0.3	7.8	1.2	8.1	0.0	26.8	5.0	0.6	22.9	58.6	2.5	5.4	2.8	4.3	17.9	44.0	8.9	4.4	1.8	27.1	1.0	10.3	33.5	0.3	0.5	0.3	8.3	0.5	1.2	7.7	8.4	5.2	0.3	3.3	2.4	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	1.9	3.3	8.5	3.3	2.0	3.7	5.5	3.0	5.6	1.7	3.4	6.7	0.1	118.6	33.3	2.3	0.2	0.3	3.3	5.9	0.6	4.3	14.9	9.1	0.7	24.3	22.4	3.7	0.0	3.5	0.5	173.2	0.0	21.5	0.3	13.8	2.1	0.6	10.3	2.7	0.8	25.4	0.3	2.3	54.6	27.3	0.0	0.5	0.0	29.6	0.3	0.0	10.4	32.7	8.2	0.0	0.4	1.2	0.6	0.5	3.6	0.0	2.1	13.5	0.0	3.5	11.7	49.5	108.7	0.7	0.5	11.9	88.7	3.0	46.8	1.5	0.0	0.1	1.0	1.5	6.9	4.2	1.8	0.4	0.6	1.8	27.2	18.3
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119128	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;salivary gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 40.1;SK-BR-3: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA		700000		"Cluster 65: Brain - Ion transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	4.2	2.3	20.4	1.0	21.7	1.9	6.3	17.1	28.3	3.5	2.1	2.6	3.9	11.6	1.4	3.5	12.4	3.9	4.9	27.0	18.1	3.8	14.9	1.1	0.5	12.8	12.1	13.9	2.1	0.2	3.3	0.3	12.8	4.2	3.8	3.7	25.3	0.9	6.5	2.3	5.6	5.4	10.2	0.6	11.4	3.8	17.2	0.2	1.8	6.9	0.4	3.7	1.5	16.4	7.6	6.3	0.3	8.1	18.3	6.8	0.7	9.1	0.0	0.8	0.4	1.7	6.2	0.1	2.4	18.2	2.2	0.4	1.4	2.1	0.5	0.7	3.7	0.1	10.4	16.4	16.9	5.3	0.6	4.7	18.1	2.6	2.1	11.6	0.7	1.3	0.2	0.4	1.2	24.0	4.0	6.8	2.1	40.1	16.8	0.3	0.0	0.6	0.1	0.3	17.8	26.6	17.7	78.7	9.4	0.2	25.3	13.3	0.0	0.0	6.9	0.0	0.7	2.3	0.8	0.7	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	21.7	17.1	28.3	27.0	18.1	12.8	12.1	12.8	10.2	17.2	16.4	0.1	0.0	0.0	2.6	0.4	0.6	0.2	0.0	1.8	9.2	9.2	12.6	1.4	0.0	0.0	0.0	4.2	0.0	0.1	0.2	0.0	0.1	1.1	0.3	3.0	0.4	0.0	5.5	16.6	1.5	0.2	3.8	4.6	0.1	0.0	0.4	3.6	5.0	0.4	0.0	15.9	6.8	0.0	0.6	0.7	3.1	4.4	0.2	0.0	1.9	0.0	0.5	0.0	12.5	0.8	2.1	0.0	8.6	1.1	1.8	3.4	4.4	0.0	2.2	0.0	1.7	0.7	3.2	16.2	2.2	0.4	0.1	0.1	3.2	0.9	0.1
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468906	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2;pancreas: 32.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 23.7;liver cancer: 10.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"memory B-cell: 21.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in single"	76	"B-cells: 21.5"	"Cell line enhanced"	"Detected in some"		"RT4: 4.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		22000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	2.1	14.1	6.2	0.7	7.9	0.3	9.6	17.4	7.3	21.8	3.9	6.7	7.6	0.5	0.1	1.8	0.8	1.5	1.7	5.5	6.3	2.4	36.2	1.6	0.6	5.6	4.9	3.1	32.6	0.0	1.3	0.5	5.7	1.9	4.0	0.5	21.3	0.2	14.5	8.5	10.3	0.1	5.1	1.1	10.8	1.2	5.8	0.2	4.2	0.9	0.2	1.2	1.6	5.4	1.0	0.8	0.7	0.6	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.6	0.7	1.2	0.7	1.5	0.0	0.4	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.1	0.7	0.9	0.1	1.5	0.0	4.0	8.5	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.9	2.1	0.4	0.1	0.0	1.4	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	6.2	7.9	17.4	7.3	5.5	6.3	5.6	4.9	5.7	5.1	5.8	5.4	0.0	0.0	0.0	1.3	1.0	0.3	0.2	0.3	0.0	0.0	4.6	2.4	0.2	1.5	0.2	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.2	4.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.5	0.1	0.0	2.5	0.0	1.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.4
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385392-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favorable (5.44e-5)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	1.3	0.6	1.5	2.4	1.2	6.9	2.6	2.2	1.5	1.3	0.3	1.9	1.6	1.7	1.5	2.5	1.3	0.9	0.6	1.6	0.7	1.3	0.7	1.0	3.0	0.6	0.4	1.4	3.3	1.6	1.0	1.1	0.7	1.6	2.1	1.7	3.0	0.9	15.6	2.7	1.9	1.5	0.1	1.3	1.2	4.2	0.8	4.1	0.9	1.8	3.5	1.0	1.5	1.0	25.5	15.0	25.3	14.4	1.9	5.0	13.8	17.6	10.1	21.4	22.2	17.1	13.3	19.9	7.6	9.2	21.7	8.2	26.3	11.7	17.2	20.2	20.5	30.9	15.5	12.2	1.3	19.8	14.4	3.1	2.8	20.0	8.6	4.1	10.2	24.1	27.3	18.0	11.0	17.7	31.0	11.5	17.6	23.0	10.8	45.0	13.6	11.4	7.5	12.4	15.2	12.6	27.0	20.3	9.8	10.1	15.9	13.4	6.3	17.2	8.5	15.4	20.8	13.1	26.0	23.1	11.0	21.5	22.3	1.5	0.2	0.3	1.4	0.1	1.2	1.0	1.0	1.0	0.3	1.1	0.6	1.0	1.2	1.7	0.2	0.4	2.2	0.7	1.5	1.2	2.2	1.5	1.6	0.7	0.6	0.4	0.7	0.1	0.8	1.0	1.3	0.0	2.7	2.0	1.8	2.8	6.2	3.7	5.2	1.6	2.8	3.4	1.3	2.8	3.4	3.7	0.0	7.6	2.5	1.7	0.0	7.3	9.1	2.5	1.2	2.5	0.0	10.7	4.4	2.2	9.7	2.6	4.1	2.4	2.5	9.4	1.4	0.5	4.5	1.7	3.1	2.3	10.2	0.9	1.6	6.7	0.6	1.2	5.4	1.9	1.5	1.5	5.2	1.0	2.5	2.2	0.2	0.0	4.4	4.6	0.4	0.3	3.1	2.6	6.6	3.4	2.5	14.4	11.8	7.4	2.4	2.5	2.4	0.5	4.7	3.4
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402083-41618384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	7.2	7.7	10.2	6.9	11.4	13.5	12.4	17.5	13.0	9.5	6.0	7.1	4.0	12.7	12.4	6.1	10.0	7.2	8.0	8.5	13.1	7.2	6.8	7.5	8.4	11.7	10.9	16.2	8.1	16.2	7.9	8.4	14.2	12.2	6.1	15.7	8.4	9.3	5.5	8.7	6.1	8.9	7.3	8.2	7.4	7.1	11.0	17.2	13.6	7.8	8.2	8.1	8.8	12.9	8.4	9.8	20.6	9.2	11.5	11.7	13.3	7.2	14.8	12.6	15.2	13.5	6.7	10.0	12.7	12.4	14.2	12.2	12.9	12.4	14.3	3.2	6.3	13.7	9.1	13.2	6.5	10.9	6.6	11.8	11.3	9.2	10.1	13.5	11.0	13.7	11.0	10.4	9.9	23.3	17.3	11.8	6.8	5.2	16.5	13.2	24.2	7.1	7.9	19.3	18.6	12.8	22.1	5.8	14.2	14.9	9.9	8.1	12.7	19.8	9.6	10.0	6.3	9.9	8.6	12.8	8.7	5.2	6.2	20.2	6.0	7.5	8.1	6.1	8.2	8.5	7.0	6.9	5.2	10.6	9.4	8.0	0.9	10.2	10.0	11.4	6.0	2.4	10.2	11.4	17.5	13.0	8.5	13.1	11.7	10.9	14.2	7.3	11.0	12.9	42.2	48.1	30.8	148.2	42.8	18.1	38.6	30.3	37.0	140.4	39.5	34.7	56.6	30.0	34.4	22.0	93.8	34.2	53.3	14.5	21.5	24.4	14.5	50.3	65.3	36.5	60.6	19.6	143.2	15.8	28.2	33.8	19.9	76.0	21.5	65.1	34.2	21.1	16.5	151.4	179.0	35.9	42.7	27.7	44.7	20.3	49.7	27.5	17.8	87.1	40.8	62.2	39.1	182.9	160.6	15.4	16.0	45.5	32.3	30.3	4.1	13.9	35.6	133.8	19.7	71.0	44.4	20.6	61.9	21.8	17.2	32.7	45.5	40.4	24.5	32.9
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625665-125676255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 6.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	1.6	1.3	0.7	8.2	1.0	25.7	2.6	0.6	1.3	1.7	0.5	7.9	6.8	1.7	6.7	4.1	1.1	1.7	0.9	0.7	0.9	2.2	2.1	1.3	14.9	0.7	0.8	1.8	2.0	13.2	1.7	4.8	0.8	1.6	8.7	0.7	1.5	29.8	0.6	3.6	7.3	3.4	0.6	2.2	2.6	8.9	1.2	20.7	1.0	1.3	13.9	3.3	2.1	0.8	48.5	37.0	81.1	47.4	13.5	28.9	35.7	61.1	28.7	41.6	40.1	88.0	100.3	120.7	63.5	24.9	53.7	52.6	54.2	33.2	50.1	81.4	24.8	224.2	27.2	44.7	4.3	121.1	39.6	15.7	6.0	47.6	36.0	19.9	44.7	84.1	117.3	102.7	51.4	23.8	181.3	65.0	86.1	77.1	33.2	104.7	74.4	67.2	37.9	63.2	50.5	53.6	45.2	35.4	15.2	57.3	93.9	40.6	28.4	51.0	47.3	29.6	60.8	21.9	45.4	187.5	20.5	86.6	67.6	1.7	0.2	0.0	0.4	0.1	0.2	0.7	1.6	0.4	0.6	0.3	0.4	0.3	1.1	0.3	0.1	0.7	6.2	0.4	0.7	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.8	0.6	1.2	0.8	1.1	3.2	0.5	1.6	5.5	6.2	3.9	5.8	5.2	1.7	3.9	6.0	4.6	32.9	4.1	7.3	0.0	17.3	6.0	4.5	3.9	3.4	7.8	5.5	8.0	3.5	1.8	34.5	3.3	1.1	35.6	5.3	6.1	9.9	0.0	21.1	3.6	1.2	11.1	0.0	2.5	9.2	2.0	0.0	5.2	3.1	1.5	3.2	0.0	2.8	3.2	2.8	3.1	1.5	1.6	2.9	3.9	1.2	17.7	3.1	8.0	9.4	2.5	1.7	0.0	3.1	7.8	48.9	49.8	9.5	4.8	7.8	5.1	4.8	16.7	3.0
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: AB_2732242"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	9.8	8.1	7.8	15.6	7.9	22.0	9.1	7.1	9.1	9.8	6.0	12.4	15.9	10.7	3.3	15.6	8.7	9.9	10.7	6.9	7.0	8.6	9.0	12.2	20.9	7.9	7.3	6.2	11.9	7.6	9.4	17.7	7.9	9.9	8.5	6.3	9.4	9.6	8.0	12.3	15.0	12.6	6.0	17.5	12.9	15.4	8.6	25.2	9.1	9.2	13.8	14.4	10.8	9.1	11.0	24.1	19.3	1.6	16.8	21.3	41.0	23.4	17.9	23.7	22.7	20.6	8.7	0.2	21.6	25.3	16.7	18.6	2.1	21.5	12.2	1.3	21.0	36.5	16.7	24.4	42.0	1.2	67.5	32.4	20.0	19.6	13.5	15.5	30.1	2.8	15.9	0.0	16.7	40.4	24.5	25.3	27.4	20.9	19.8	2.9	2.5	11.4	15.3	49.4	20.8	28.2	18.2	20.0	17.8	22.5	34.4	36.2	33.3	1.2	4.7	11.8	7.7	37.0	0.1	4.2	0.0	6.8	21.7	38.3	25.5	35.5	16.7	29.6	15.8	10.5	13.2	17.8	20.7	6.4	12.0	13.3	34.8	23.2	31.5	10.6	21.5	19.3	7.8	7.9	7.1	9.1	6.9	7.0	7.9	7.3	7.9	6.0	8.6	9.1	11.2	12.8	19.5	20.5	17.2	6.1	7.9	6.0	4.6	22.1	8.2	5.7	9.9	4.3	15.3	7.3	93.8	12.3	29.4	17.9	9.8	10.2	53.0	11.1	14.3	13.1	21.1	13.0	33.4	13.8	15.7	10.8	28.1	12.2	66.4	14.4	11.4	7.7	19.4	21.9	32.0	10.2	14.2	21.7	9.3	89.1	7.5	22.0	10.6	24.4	29.4	8.8	40.2	18.1	31.3	16.9	11.4	8.6	24.2	11.2	11.7	4.4	10.8	117.9	19.7	9.2	10.7	19.0	24.6	11.1	9.7	23.7	24.2	16.1	8.6	13.8
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6568.4"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	16	"cerebral cortex: 326.0;white matter: 124.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.5	1248.5	8.6	9.4	11.4	0.2	0.3	0.0	326.0	8.3	0.0	92.0	242.7	0.4	0.3	1.0	1.1	0.2	0.2	4.4	1.7	1.0	0.4	1.6	0.1	14.4	0.0	0.2	102.5	6568.4	446.2	0.0	4.1	12.2	105.2	11.0	0.2	0.3	0.1	0.6	179.9	0.9	0.0	0.1	364.5	77.7	4.3	0.6	24.6	0.0	0.0	1.3	1.2	124.4	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	11.4	0.0	326.0	4.4	1.7	14.4	0.0	4.1	0.0	4.3	124.4	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CHI3L1	"GP39, YK-40, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186704	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 232.4;brain: 239.4;liver: 447.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	495	"neutrophil: 470.4"	"Lineage enriched"	"Detected in single"	495	"granulocytes: 470.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"olfactory bulb: 16.0"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	180000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	79.8	2.0	58.9	138.9	75.9	232.4	62.8	55.3	94.7	30.5	56.8	6.5	0.4	19.5	1.0	14.4	23.4	3.0	9.8	47.4	129.6	60.9	447.8	38.4	32.4	239.4	112.8	6.6	13.8	0.2	134.5	10.1	135.6	13.7	2.0	50.9	99.4	0.9	21.0	75.6	16.8	6.8	70.0	13.9	9.7	1.0	156.4	12.4	15.0	1.0	36.9	97.8	9.1	70.8	0.8	0.0	0.0	0.3	322.9	712.9	0.0	0.0	0.2	0.0	0.0	75.3	0.2	0.1	1.2	0.4	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	8.3	0.3	0.3	637.0	0.0	1.9	0.3	30.8	0.0	0.0	0.0	1.0	0.2	0.3	0.0	5.8	2.7	0.0	0.0	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.2	0.0	1068.4	0.0	303.5	1.6	0.0	0.4	2.3	41.9	0.3	303.7	1.2	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.4	0.0	0.9	0.0	0.0	1.3	58.9	75.9	55.3	94.7	47.4	129.6	239.4	112.8	135.6	70.0	156.4	70.8	0.7	6.4	42.8	20.5	0.1	4.2	47.1	88.7	0.0	0.1	29.8	21.5	1.0	2.8	17.3	27.6	0.0	1.3	0.6	0.0	0.0	88.9	0.0	4.8	2.2	2.1	0.0	0.4	1.1	0.0	1.1	18.6	0.0	7.2	0.0	0.0	0.0	61.8	317.5	0.0	0.1	0.0	6.1	0.8	0.4	0.0	0.9	23.7	14.2	0.0	1.0	45.1	0.0	0.0	0.1	2.0	0.0	0.0	1.4	4.2	0.0	0.2	3.4	2.8	0.0	1.0	2.3	0.0	0.0	1.5	1.1	0.8	0.9	0.0	0.0	2.2
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 200.6;salivary gland: 142.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 118.1;B-cells: 76.4;Breast glandular cells: 32.2;Breast myoepithelial cells: 30.4;Leydig cells: 74.9"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 91.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"JURKAT: 634.6;MOLT-4: 346.8"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"	NA	NA		420000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (9.10e-5)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	22.1	3.0	12.4	112.7	12.0	2.4	44.6	9.2	41.6	1.0	10.9	3.2	1.2	1.7	0.2	5.1	2.2	11.8	23.0	12.3	13.6	3.1	0.9	66.1	59.8	63.7	34.7	2.1	0.8	36.6	4.5	13.7	27.1	7.4	2.6	1.7	142.1	0.7	2.0	11.3	10.0	3.7	18.6	21.5	5.9	11.7	34.5	200.6	11.8	7.5	119.0	53.5	4.5	26.4	0.3	0.0	0.4	0.5	100.3	19.1	0.2	0.1	1.3	0.2	0.2	0.0	0.3	0.8	0.2	0.1	8.8	0.6	3.5	0.2	0.1	29.0	0.1	0.2	0.5	1.6	1.5	0.2	1.7	27.9	0.3	0.4	0.5	5.5	0.0	634.6	0.2	1.2	0.3	0.2	346.8	0.5	0.0	0.1	0.1	1.8	0.9	0.6	0.0	0.7	0.1	0.3	0.4	0.9	0.3	2.1	0.3	0.3	0.5	7.5	1.4	0.2	0.7	5.2	0.6	76.8	23.4	0.5	2.3	1.0	3.6	0.2	22.4	0.8	5.5	45.0	16.0	37.5	0.8	43.2	91.6	34.4	2.2	17.2	0.3	1.4	10.8	27.3	12.4	12.0	9.2	41.6	12.3	13.6	63.7	34.7	27.1	18.6	34.5	26.4	0.5	9.6	118.1	1.0	76.4	2.3	1.6	8.3	0.0	0.1	32.2	30.4	0.5	0.0	3.1	0.0	0.0	0.2	7.8	0.1	0.0	20.1	3.8	0.3	7.0	0.9	1.2	0.0	0.2	0.4	0.9	10.8	0.0	0.7	2.5	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	2.2	0.7	12.0	74.9	2.2	16.0	0.0	0.8	0.0	23.7	0.0	0.3	0.9	0.0	1.5	2.6	3.5	0.0	0.5	0.2	0.0	0.0	1.8	0.7	0.5	0.6	0.3	1.3	3.1	12.8	1.5	0.0	1.3
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.8;lung: 36.4;lymphoid tissue: 21.7"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	6	"cerebral cortex: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 4: Macrophages - Innate immune response"			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	13.6	0.3	0.2	0.4	0.2	49.8	8.3	0.0	12.4	8.1	0.0	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.7	36.4	21.7	0.4	0.2	0.5	2.1	0.0	0.0	0.7	1.3	1.0	1.0	0.0	0.4	0.0	0.2	0.4	0.8	0.0	0.4	5.7	0.5	0.0	0.3	3.4	1.3	0.0	1.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	12.4	0.2	0.0	0.4	0.2	1.3	0.4	0.3	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578959-50601455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.1;RPMI-8226: 19.8"									HPA018797	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.0	10.3	0.7	10.3	12.1	13.4	10.5	16.8	10.6	12.2	10.5	3.3	9.5	12.0	11.1	12.0	1.5	11.5	10.1	10.8	13.2	9.4	13.3	4.3	10.5	11.0	8.6	7.7	17.7	14.3	7.2	10.6	12.0	4.8	1.6	11.9	7.2	8.3	11.6	10.7	5.3	10.7	18.1	11.6	14.5	11.0	9.2	12.6	11.7	9.8	11.7	11.1	10.8	4.2	1.3	0.5	1.6	6.7	5.9	10.8	7.3	16.7	4.7	3.1	1.4	2.1	2.1	4.2	3.8	2.4	0.0	1.5	2.0	1.0	0.3	5.4	3.1	2.2	2.3	19.1	2.5	4.8	2.0	6.5	0.6	8.1	4.5	17.1	5.5	1.8	0.3	12.4	5.3	2.0	8.6	0.7	7.0	1.9	3.5	1.8	19.8	11.5	2.0	2.0	3.2	3.0	7.3	5.9	0.2	1.1	2.8	6.9	0.0	1.7	0.0	2.2	7.4	0.0	3.0	2.3	0.4	3.4	12.0	39.5	27.0	26.4	38.4	25.7	24.0	24.2	27.6	35.7	23.6	22.6	20.8	9.6	37.0	26.1	34.1	33.4	32.6	10.3	10.3	10.5	16.8	10.1	10.8	10.5	11.0	10.6	10.7	11.0	10.8	16.7	6.4	28.2	0.0	13.6	4.8	2.3	6.9	8.6	4.8	10.0	7.4	7.7	20.0	12.7	7.3	4.2	8.8	14.0	18.4	3.9	30.6	11.6	3.9	3.4	8.0	15.7	9.0	0.0	23.8	14.1	8.6	19.9	3.3	19.0	2.5	10.4	5.4	14.6	8.4	0.0	19.3	12.2	16.6	9.2	30.5	2.5	10.0	3.6	0.0	48.4	3.3	14.4	0.0	0.0	23.5	24.2	3.0	14.6	2.1	29.3	5.5	11.2	6.0	6.6	2.4	6.8	12.6	10.0	14.5	6.3	8.5	11.2	2.8	17.3	2.2
CHL1	"CALL, FLJ44930, L1CAM2, MGC132578"	ENSG00000134121	"Cell adhesion molecule L1 like"	O00533	3	196763-409417	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.6;Excitatory neurons: 423.8;Inhibitory neurons: 320.7;Oligodendrocyte precursor cells: 918.4"	"Cancer enhanced"	"Detected in many"		"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.7;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 91.8;WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003345, CAB026120"	Enhanced				"Secreted in brain"	NA	NA		5800000000	"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB026120: , HPA003345: AB_1078516"	"unprognostic (5.54e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	13.6	4.1	18.6	8.6	33.9	0.3	8.5	2.3	35.5	3.3	0.0	14.7	4.4	3.4	1.6	8.9	2.6	4.8	11.5	35.8	26.7	17.8	0.8	5.1	6.2	12.5	5.3	16.3	1.7	0.5	2.6	0.0	5.7	3.7	7.9	15.9	6.9	6.3	0.3	12.9	6.2	5.4	10.0	3.0	4.0	1.5	10.6	0.7	0.9	1.4	2.9	3.1	5.3	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	33.9	2.3	35.5	35.8	26.7	12.5	5.3	5.7	10.0	10.6	5.0	4.1	0.0	0.0	223.6	8.8	22.9	0.6	2.8	56.9	1.2	0.6	13.6	18.0	1.5	15.8	11.0	0.0	0.0	0.1	0.0	11.7	0.0	2.0	2.9	0.1	2.3	0.0	0.0	423.8	0.0	0.0	33.5	0.0	1.9	1.3	106.2	1.4	1.3	0.0	1.7	320.7	0.0	0.0	0.3	4.4	1.4	2.8	0.6	3.6	22.5	0.0	58.7	0.0	918.4	11.6	0.2	0.0	0.0	1.4	6.2	0.0	19.7	17.8	2.7	0.0	2.7	11.2	3.0	1.3	15.6	12.1	0.0	1.1	12.4	0.0	0.8
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174798809-175005381	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 772.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 195.2;Excitatory neurons: 596.4;Inhibitory neurons: 111.7;Microglial cells: 97.4;Oligodendrocyte precursor cells: 149.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 6.5;memory CD8 T-cell: 2.1;T-reg: 8.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 186.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036111			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	11.8	13.3	368.6	7.3	445.9	0.8	10.5	194.0	772.6	9.2	170.6	10.2	3.3	7.9	38.3	6.9	6.5	11.1	15.1	492.6	241.5	4.7	2.1	19.6	21.5	210.2	225.4	5.8	4.2	43.4	36.3	38.6	210.5	17.0	5.1	39.5	3.2	9.6	2.7	3.8	7.5	13.1	192.4	5.5	7.1	21.3	239.1	3.1	10.2	3.7	18.7	8.7	6.7	422.8	0.4	17.4	57.6	16.3	14.7	67.4	0.4	45.6	186.7	65.1	97.0	0.3	5.4	0.5	1.6	71.8	39.9	2.0	68.0	1.9	30.3	1.3	32.9	11.1	20.1	3.8	34.4	6.4	1.7	53.6	1.9	31.6	11.1	16.1	33.6	30.0	0.7	1.9	57.2	11.8	29.3	2.5	71.7	2.6	23.7	8.2	70.3	0.8	0.9	0.6	71.3	76.3	41.3	0.5	7.3	36.0	3.2	2.2	10.1	26.8	3.9	9.8	20.6	6.4	33.7	0.7	6.7	0.4	6.6	0.4	0.1	0.1	0.3	0.1	0.8	0.2	6.5	2.1	0.0	0.1	1.3	0.4	0.4	0.2	0.2	0.3	8.0	1.0	368.6	445.9	194.0	772.6	492.6	241.5	210.2	225.4	210.5	192.4	239.1	422.8	15.4	3.2	1.9	195.2	1.6	4.5	0.3	0.0	0.0	85.1	7.3	1.4	6.2	1.5	2.6	3.7	27.1	1.2	0.5	0.1	0.0	0.3	24.1	5.3	5.6	17.9	2.4	0.0	596.4	0.6	1.1	28.4	2.0	3.6	0.0	5.1	10.4	0.5	2.7	77.4	111.7	0.0	0.0	0.0	4.0	23.2	3.1	0.9	7.2	97.4	0.0	59.1	0.0	149.8	88.1	0.6	0.0	5.3	1.3	0.6	0.0	0.3	1.0	14.1	13.1	23.8	27.3	17.8	23.6	0.1	3.7	2.1	12.5	5.1	0.2	0.3
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.0;intestine: 70.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.4;HMC-1: 68.3"									"HPA018989, HPA019026"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA018989: AB_1846681, HPA019026: "	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	4.6	6.3	19.0	5.3	33.0	2.2	3.4	101.0	37.5	10.2	12.4	8.5	70.1	4.1	2.3	2.6	8.0	7.0	11.7	22.2	27.1	13.1	37.9	5.6	3.1	30.4	26.5	20.2	25.1	0.5	3.4	10.8	33.2	8.0	9.8	51.5	2.7	4.1	4.7	1.9	57.9	4.3	24.2	8.2	6.6	2.5	25.4	3.8	7.8	1.4	2.5	6.3	3.2	59.6	0.3	0.8	3.0	0.0	0.0	0.0	19.0	0.0	0.0	0.7	0.0	10.4	2.9	0.9	6.0	0.2	1.2	5.2	10.1	0.1	0.0	18.1	3.8	37.4	1.7	18.4	0.2	0.0	68.3	0.0	6.4	0.0	0.7	0.0	3.5	5.9	1.5	0.5	0.0	0.4	11.2	0.4	1.2	6.8	3.4	0.8	0.0	2.0	18.2	12.0	18.3	1.4	3.9	5.8	10.2	10.7	0.7	2.0	0.4	1.0	0.3	0.1	0.4	3.6	15.2	0.0	0.3	2.2	1.2	4.4	11.6	0.1	2.8	12.7	1.9	0.3	0.4	2.1	10.1	0.1	0.4	1.1	0.5	9.6	7.3	1.1	0.0	3.6	19.0	33.0	101.0	37.5	22.2	27.1	30.4	26.5	33.2	24.2	25.4	59.6	3.3	6.4	3.6	5.5	2.0	2.7	0.8	0.2	0.6	307.9	0.3	0.3	14.1	5.7	2.0	3.7	43.8	24.6	6.1	15.3	0.0	0.5	130.6	8.8	0.3	8.5	39.4	9.5	139.5	2.1	33.5	3.8	12.2	2.7	23.5	2.2	3.9	84.4	18.5	6.7	28.8	24.0	2.0	29.0	33.1	118.1	5.0	20.5	17.8	145.2	29.3	11.7	22.6	10.1	496.8	0.2	14.3	4.9	1.3	1.0	107.8	2.3	7.6	15.9	0.0	5.4	1.1	2.6	6.2	0.2	0.6	16.4	14.4	0.7	23.6	1.1
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281887	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	66.9	55.3	22.1	28.0	24.4	58.4	32.8	26.0	26.5	34.0	24.7	113.8	85.4	21.8	34.1	74.5	20.8	48.1	53.2	30.3	32.9	76.1	185.1	52.7	18.6	32.9	31.0	19.1	42.2	54.1	21.6	26.3	35.8	34.3	81.9	20.5	49.9	27.5	81.0	45.5	70.0	27.6	26.9	20.2	112.7	10.7	33.3	20.1	49.8	86.5	41.1	44.8	41.3	28.4	72.4	72.7	28.3	109.0	120.4	113.8	41.0	56.2	69.1	44.8	48.0	66.6	140.4	12.6	59.8	77.7	47.7	89.0	56.0	83.9	51.5	44.8	20.0	50.8	58.1	103.6	93.5	66.5	73.7	116.7	98.8	51.9	53.3	68.0	82.1	37.9	81.2	79.5	52.5	43.5	27.7	72.5	29.0	118.4	35.9	35.9	46.2	34.0	92.5	144.1	17.4	44.3	96.4	178.2	48.7	49.9	101.0	66.3	108.3	47.5	50.3	76.9	36.7	45.0	131.6	59.4	84.9	42.2	44.1	255.5	227.6	274.8	49.5	204.4	51.5	40.2	46.2	50.0	152.1	33.0	29.1	41.4	173.3	56.5	207.4	95.1	60.7	116.5	22.1	24.4	26.0	26.5	30.3	32.9	32.9	31.0	35.8	26.9	33.3	28.4	28.3	44.8	117.3	20.9	26.8	72.3	62.4	48.1	20.5	11.0	101.6	39.2	80.5	243.1	50.7	103.0	10.4	33.3	38.3	434.4	389.4	96.7	52.5	68.0	48.8	39.5	55.6	58.5	24.8	150.6	62.4	38.2	112.7	114.4	37.4	18.9	78.1	353.6	68.5	11.8	21.0	136.2	34.6	170.1	134.8	122.6	29.5	77.1	129.9	19.7	113.4	32.7	36.0	9.5	23.6	173.9	206.4	29.3	24.0	80.1	425.0	231.1	33.7	10.3	26.3	46.6	41.4	13.7	19.3	50.6	108.5	66.9	32.9	65.7	161.4	130.8
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 130.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		350000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	11.1	12.2	13.9	2.1	13.9	0.0	9.9	19.0	21.2	40.0	9.1	7.6	1.6	32.9	3.2	3.3	15.0	2.5	11.2	15.1	9.4	18.8	130.0	7.2	1.5	10.1	9.9	16.3	17.1	1.1	6.0	2.4	10.2	9.7	0.8	0.0	3.8	5.2	4.4	5.4	6.0	4.6	10.3	9.7	7.8	1.1	9.7	0.2	7.7	2.7	0.3	7.2	15.4	13.6	0.0	0.0	0.3	1.1	0.1	0.1	1.4	0.3	0.0	0.2	0.1	2.8	0.0	0.0	1.1	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	11.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	4.0	1.4	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	13.9	19.0	21.2	15.1	9.4	10.1	9.9	10.2	10.3	9.7	13.6	2.6	0.0	0.0	11.8	0.4	2.7	0.0	0.0	0.6	2.9	2.1	1.8	3.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	31.2	2.6	0.0	0.0	28.2	3.1	0.0	16.4	1.1	4.5	0.0	0.9	3.3	36.4	0.7	0.0	37.5	0.2	0.0	3.2	3.1	0.0	3.7	0.4	1.8	4.7	0.0	0.0	0.0	7.1	2.5	1.1	0.0	2.2	0.0	0.1	0.0	4.0	0.0	0.5	6.6	19.1	16.4	0.3	0.3	0.3	1.1	0.1	0.7	0.1	0.0	0.3
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	42.4	44.8	48.1	36.5	54.1	62.5	44.2	54.7	56.0	52.5	48.3	44.2	30.3	45.2	36.2	50.3	47.5	21.9	63.3	47.8	51.1	66.5	54.8	39.3	46.6	51.9	50.7	55.2	63.4	35.9	48.7	33.4	52.2	48.4	32.7	59.9	44.4	29.6	124.4	52.6	46.8	30.5	50.0	65.4	47.9	37.6	49.6	65.7	55.8	68.4	44.4	45.1	47.9	63.5	74.3	63.9	106.2	65.0	45.2	33.1	84.3	51.2	47.0	71.3	61.2	71.6	72.9	83.5	75.6	48.0	46.6	66.8	103.4	74.7	46.9	97.8	95.7	65.5	102.2	60.0	56.1	101.8	78.8	38.5	84.8	69.0	97.5	59.2	57.7	89.4	82.1	62.2	54.1	94.3	109.8	102.6	123.6	106.9	79.1	67.5	65.0	92.5	69.8	100.5	64.3	74.5	54.6	77.8	91.6	69.9	83.7	138.6	50.0	47.7	70.4	60.7	83.8	86.2	77.8	95.5	50.1	81.9	56.8	84.9	42.9	40.9	46.0	44.8	46.2	46.2	45.3	45.3	54.4	43.3	45.2	41.0	30.8	35.1	43.0	41.7	51.9	46.4	48.1	54.1	54.7	56.0	47.8	51.1	51.9	50.7	52.2	50.0	49.6	63.5	46.4	32.1	37.3	32.3	50.1	63.0	103.6	59.7	37.5	40.8	45.6	33.5	74.1	57.2	43.5	53.3	33.3	91.7	47.7	49.2	50.9	69.5	34.9	50.6	42.6	54.2	60.3	81.9	16.1	64.8	121.9	47.1	42.3	63.4	46.3	59.7	43.9	41.2	69.7	43.7	17.6	56.4	42.7	48.9	38.2	18.0	44.7	40.9	35.6	14.0	69.3	44.0	52.5	16.6	40.1	61.3	58.1	42.2	48.2	101.8	48.4	49.0	33.2	57.5	19.7	34.9	59.7	125.2	115.2	46.5	61.7	128.6	45.7	57.9	52.3	110.2
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060537			Supported	Nucleoplasm		NA	NA		240000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA060537: AB_2684314"	"unprognostic (2.77e-3)"	"prognostic favorable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	356.6	367.9	176.0	205.7	176.2	377.9	409.6	177.9	277.1	443.1	147.3	400.6	196.5	471.8	429.7	219.6	496.9	279.3	368.6	162.7	181.6	296.3	200.9	300.9	350.4	167.5	166.0	853.0	614.8	490.8	496.2	230.8	164.4	377.1	227.1	383.9	367.5	418.1	485.7	402.7	304.0	313.3	169.2	332.7	405.2	183.8	193.3	327.9	420.1	304.3	383.8	344.7	307.8	186.5	285.8	60.4	434.3	220.1	188.0	209.3	112.3	307.3	428.7	235.1	209.9	112.7	108.1	570.7	162.3	318.6	27.9	133.5	182.5	277.5	181.2	255.4	52.3	340.6	68.2	145.9	684.8	532.0	237.9	518.9	244.6	152.3	659.7	324.3	215.0	282.6	228.3	445.6	247.2	202.9	274.7	144.4	172.3	162.4	100.2	337.3	347.2	280.3	267.5	237.3	204.1	369.3	323.9	145.6	251.3	140.9	304.6	148.3	264.6	174.5	105.3	415.1	271.0	581.3	689.3	463.7	148.9	216.4	229.7	208.5	88.3	205.5	212.3	153.5	217.7	248.7	190.0	193.5	97.0	268.0	213.2	205.0	147.4	229.4	237.0	272.5	244.6	196.3	176.0	176.2	177.9	277.1	162.7	181.6	167.5	166.0	164.4	169.2	193.3	186.5	341.8	205.1	384.3	169.8	541.8	586.6	641.5	585.8	541.8	758.0	682.4	586.5	258.0	427.5	304.2	298.0	329.4	601.9	504.0	175.5	972.4	386.0	78.8	243.9	292.1	388.3	434.2	244.4	51.8	484.2	271.0	493.6	236.0	241.0	404.2	400.6	436.2	149.6	314.4	684.8	69.2	315.5	514.7	372.1	559.7	199.3	649.9	301.0	734.6	60.9	490.2	1307.9	563.4	90.0	157.2	348.7	281.7	499.5	477.5	434.5	399.6	635.6	295.8	712.7	374.7	956.8	488.0	228.5	504.5	327.6	556.8	737.4	482.5	586.9	270.5	378.6
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	57.7	38.9	36.1	28.5	37.1	55.3	48.3	36.5	46.4	60.1	19.7	68.4	34.5	53.5	24.4	46.3	47.6	33.9	46.0	36.4	33.8	31.8	21.4	38.0	35.1	35.9	31.4	69.9	70.7	35.0	33.8	28.0	34.2	40.8	26.7	26.9	44.6	33.6	90.4	65.8	41.9	36.9	26.8	35.5	51.3	56.4	36.4	35.3	37.0	42.5	29.5	57.8	50.0	40.9	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.1	37.1	36.5	46.4	36.4	33.8	35.9	31.4	34.2	26.8	36.4	40.9	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519667-103522833	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 694.7;intestine: 653.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 2767.4;Distal enterocytes: 4691.8;Distal tubular cells: 2281.3;Horizontal cells: 5042.4;Muller glia cells: 3639.8;Rod photoreceptor cells: 3789.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"non-classical monocyte: 290.8"	"Lineage enriched"	"Detected in many"	18	"monocytes: 290.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 455.8;HEK 293: 1399.8;SCLC-21H: 792.2;SH-SY5Y: 352.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol		No	No		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	90.7	60.0	471.6	25.8	627.0	3.2	47.2	641.1	694.7	105.2	192.7	653.4	36.0	222.6	16.0	54.5	197.9	17.9	269.8	428.7	482.3	161.0	9.0	60.3	4.0	427.5	440.4	58.8	27.7	108.2	74.0	4.7	345.1	301.8	151.9	471.3	37.9	208.3	80.0	76.5	120.8	113.8	434.5	6.8	479.9	97.6	596.2	2.8	87.9	47.1	5.1	298.4	101.6	383.6	2.4	54.5	321.1	14.7	4.4	2.3	6.3	37.5	0.3	2.4	1.4	455.8	7.3	0.4	36.9	29.1	9.9	70.2	109.9	1.5	0.2	9.6	1399.8	111.0	242.1	165.4	16.6	0.7	87.9	14.7	0.6	3.9	0.8	3.3	0.0	5.1	198.7	3.7	4.8	20.0	2.3	3.9	109.1	48.3	213.6	13.9	6.8	275.9	65.9	2.5	792.2	352.2	65.3	10.6	25.2	21.6	21.1	40.9	2.2	1.5	56.3	4.7	147.3	21.1	2.7	7.2	6.4	2.1	14.1	2.4	0.5	14.6	0.3	28.5	0.4	0.0	0.2	0.1	16.4	0.2	0.1	0.5	1.0	0.2	290.8	0.0	0.7	6.0	471.6	627.0	641.1	694.7	428.7	482.3	427.5	440.4	345.1	434.5	596.2	383.6	14.8	195.5	103.5	515.8	13.5	153.7	296.2	257.6	56.3	2767.4	41.5	48.9	553.5	145.8	117.9	114.0	1909.9	4.4	3.4	4691.8	2281.3	127.6	445.8	773.2	205.7	60.8	467.1	9.9	178.0	42.5	11.7	96.6	359.4	408.5	28.6	476.1	74.6	9.2	8.2	5042.4	147.0	726.0	187.2	2.8	44.9	147.4	304.1	39.8	181.5	88.1	74.2	3639.8	0.0	93.5	161.2	131.4	1996.9	1089.3	6.6	279.8	9.5	118.0	456.1	3789.9	59.2	15.4	222.6	127.3	97.4	22.1	175.2	41.6	19.1	12.2	755.6	220.1
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306413-45322875	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 73556.4;tongue: 26058.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 5353.0"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 64.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 68.8"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 1.5"	"Low region specificity"	"Detected in many"			HPA047859	Enhanced					NA	NA		170000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	8.5	2.7	0.1	0.0	0.3	0.7	12.4	0.2	0.3	0.9	0.0	6.6	0.1	1.8	0.0	512.5	0.4	0.2	4618.8	0.0	0.0	2.1	5.2	8.7	0.4	0.1	0.0	2.8	5.3	0.0	2.1	0.3	0.2	134.8	0.1	0.2	340.9	2.1	73556.4	23.4	4.3	2.4	0.0	2.5	23.5	9.9	0.0	2.5	8.5	26058.9	0.4	1.5	3.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	5.8	0.0	0.3	16.3	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.0	6.3	0.2	0.2	0.0	0.0	68.8	0.0	0.0	0.1	0.1	0.0	0.1	16.3	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5353.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.7	0.1	15.3	0.8	0.9	51.2	0.0	0.0	0.4	0.0	0.7	141.8	0.0	0.1	1.3	0.4	0.4	0.0	6.6	0.0	0.5	0.0	0.0	0.9	0.3	53.2	1.5	3.2	0.0	0.0	0.9	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.0	639.9	47.3	16.5	1.6	0.0	0.1	0.3	2.6	3.6	0.0	0.1
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	49	"heart muscle: 1240.1;skeletal muscle: 1430.8;tongue: 2324.4"	"Cell type enriched"	"Detected in many"	20	"Cardiomyocytes: 814.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 3.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	18.2	33.6	12.3	0.8	15.0	0.1	4.6	17.3	12.3	8.1	24.4	3.2	1.1	6.4	11.4	20.2	6.9	8.1	1240.1	11.2	15.0	14.7	1.0	2.5	1.3	16.3	16.8	10.2	7.7	15.7	4.5	0.7	14.9	13.1	0.7	1.6	26.3	13.1	1430.8	4.7	2.8	8.8	12.0	1.8	17.9	3.6	16.1	0.8	4.9	2324.4	0.4	4.1	4.1	17.7	0.3	0.7	0.8	1.3	1.9	0.4	3.5	0.1	0.0	0.0	0.0	2.4	0.2	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	1.5	2.4	0.1	1.0	3.2	2.6	0.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	2.1	0.3	0.5	0.0	2.2	1.2	0.2	1.0	0.0	0.7	0.6	1.0	0.1	0.0	0.0	1.4	1.0	1.2	0.3	1.4	1.5	6.3	0.3	0.7	0.4	1.2	0.7	0.2	0.2	0.1	1.3	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	12.3	15.0	17.3	12.3	11.2	15.0	16.3	16.8	14.9	12.0	16.1	17.7	1.8	0.0	0.5	40.1	0.0	0.1	0.4	0.0	1.2	0.9	0.9	0.8	814.1	7.2	0.6	12.9	0.0	0.1	0.0	0.1	37.2	1.7	25.1	13.6	3.5	9.8	0.0	0.0	11.4	0.6	0.4	16.2	6.6	27.8	0.0	0.8	0.0	0.0	0.1	0.0	18.1	0.3	0.0	0.0	0.0	2.2	7.2	0.3	3.6	23.4	0.0	1.4	0.0	4.5	9.1	0.4	0.0	15.1	0.0	0.3	0.3	0.6	0.7	1.0	0.0	11.6	15.0	1.0	0.4	0.1	0.1	0.3	0.8	23.7	2.5	0.2
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361650	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.4	5.1	2.2	1.8	3.1	1.0	1.6	3.1	3.0	3.0	1.6	16.2	9.2	3.6	3.8	1.7	2.4	7.5	1.2	2.0	2.4	3.0	1.7	1.2	0.7	3.4	3.0	4.0	4.5	3.4	2.8	1.0	2.7	2.3	10.8	0.6	2.8	2.9	0.9	1.6	8.4	1.6	2.9	1.5	2.2	10.6	3.3	1.3	2.7	0.5	0.9	2.1	2.0	4.3	8.9	3.2	2.5	6.9	2.2	1.8	5.8	2.9	1.7	3.1	2.0	16.8	3.0	3.0	8.2	1.6	8.0	15.1	3.6	3.5	0.9	2.8	4.2	2.7	7.0	7.7	1.3	1.2	2.6	3.6	2.7	2.6	3.0	1.5	2.9	3.3	1.0	1.6	1.1	5.9	0.8	1.6	3.7	7.6	4.4	5.4	2.3	10.7	3.8	6.9	4.0	2.4	3.3	11.4	5.2	1.6	9.4	1.2	1.4	1.5	4.5	7.7	7.7	3.6	5.5	2.1	2.7	5.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	3.1	3.0	2.0	2.4	3.4	3.0	2.7	2.9	3.3	4.3	2.2	3.2	4.1	16.6	0.4	1.0	0.9	0.8	1.2	2.1	2.5	2.8	1.2	14.3	1.1	0.0	0.0	1.0	1.9	81.7	0.0	3.7	2.3	2.5	4.5	1.9	3.0	0.8	4.1	2.0	0.6	2.6	2.6	4.4	1.3	11.3	2.5	0.6	0.7	1.7	8.1	3.7	0.0	1.0	0.3	2.7	5.3	1.1	0.0	1.9	0.6	1.7	0.0	6.0	15.1	2.2	16.0	4.9	0.8	0.6	27.4	2.3	2.6	2.5	0.0	0.9	2.1	3.3	1.7	1.1	0.4	1.5	1.2	62.5	9.0	0.5
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.7;kidney: 46.2;liver: 16.9"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.1	2.5	1.7	1.7	1.9	1.5	1.6	3.8	1.6	1.8	2.5	2.4	4.9	4.0	23.7	2.4	3.0	3.9	1.3	1.5	2.9	46.2	16.9	2.8	1.3	3.2	3.2	7.0	2.1	1.4	2.3	5.8	3.7	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.8	2.9	2.5	1.8	2.9	2.1	2.7	1.1	2.2	2.8	1.2	1.4	2.0	2.3	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	1.7	1.9	3.8	1.6	1.5	2.9	3.2	3.2	3.7	2.5	2.7	2.3	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11848079	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	13.6	14.8	19.1	7.5	19.1	7.7	11.9	17.3	21.3	14.8	8.2	13.7	6.3	12.6	8.7	7.4	12.6	4.9	13.2	18.0	23.5	11.8	13.7	13.8	7.4	29.6	29.5	18.6	9.2	6.0	20.2	6.4	32.1	12.5	4.8	15.2	7.8	5.5	11.6	9.8	13.0	7.3	15.4	12.0	10.5	17.1	22.5	5.3	14.4	8.1	6.1	11.5	11.1	19.4	5.1	6.4	13.9	11.1	15.2	15.4	3.8	4.1	11.1	7.1	11.7	8.6	15.9	7.9	4.4	5.5	19.3	8.8	9.0	8.8	6.7	3.6	4.5	9.4	13.8	12.1	20.1	3.9	7.6	10.1	6.2	12.7	7.7	9.4	6.9	9.6	10.6	11.7	7.8	3.1	5.7	13.4	5.7	3.3	4.5	7.0	7.4	8.6	9.7	4.4	5.7	9.6	3.9	5.1	13.0	9.5	5.0	10.6	7.4	6.5	7.0	10.1	3.3	7.2	4.0	17.6	8.5	10.2	5.3	0.0	0.8	0.0	0.4	0.6	0.3	0.6	0.2	0.3	0.6	0.9	0.2	0.3	0.0	0.1	1.6	0.6	0.0	0.4	19.1	19.1	17.3	21.3	18.0	23.5	29.6	29.5	32.1	15.4	22.5	19.4	6.4	19.2	23.6	6.8	12.5	3.4	3.7	5.1	6.2	21.7	5.6	4.7	23.5	8.6	7.0	3.7	14.6	3.7	2.5	5.8	0.0	4.5	15.0	7.7	6.6	6.5	6.6	8.2	9.0	4.6	2.9	8.5	12.2	9.8	2.5	12.6	7.1	7.9	7.5	26.9	9.4	2.9	4.1	10.8	7.8	9.0	7.5	10.2	1.8	9.4	7.4	7.7	3.1	9.0	8.8	5.6	4.4	7.2	3.9	4.7	6.3	3.9	8.9	17.0	0.0	8.9	6.4	9.3	9.8	4.8	3.1	4.1	3.8	8.0	3.2	4.5
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 420.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 76.3;Endothelial cells: 27.9;Fibroblasts: 126.4;Hepatic stellate cells: 57.5;Leydig cells: 30.1;Microglial cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 297.9;ASC TERT1: 591.9;U-2197: 120.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	NA	NA	6540000000	25000000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.53e-4)"	"prognostic favorable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	420.3	51.0	44.4	9.3	46.4	1.7	214.8	45.5	66.6	89.4	50.9	83.9	31.6	60.4	17.1	49.9	41.1	35.6	259.9	43.0	42.9	131.4	29.0	201.2	33.1	51.3	56.1	26.0	14.6	14.3	27.7	142.8	48.0	33.5	37.4	0.7	49.8	19.1	74.8	149.7	78.2	25.5	44.8	264.5	43.5	113.2	50.7	10.1	88.4	68.0	8.2	100.9	74.9	43.0	0.0	0.0	0.1	0.2	297.9	591.9	0.0	40.1	62.9	1.2	6.2	0.0	0.0	0.1	0.1	3.1	0.0	0.1	0.0	0.1	0.1	0.3	0.9	0.6	0.1	0.1	0.5	0.1	0.7	47.5	0.1	0.3	0.1	0.4	0.5	0.3	0.0	1.7	0.5	0.2	0.0	2.2	0.0	0.0	0.6	0.0	0.1	2.2	0.0	0.0	0.3	1.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	4.5	0.2	120.6	0.1	1.0	1.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	46.4	45.5	66.6	43.0	42.9	51.3	56.1	48.0	44.8	50.7	43.0	76.3	0.0	0.0	1.6	0.3	3.4	0.0	0.0	1.8	0.0	0.7	0.3	0.8	1.5	0.0	0.0	0.0	0.0	0.5	0.0	3.9	0.0	4.0	0.3	16.9	27.9	0.0	2.7	0.8	0.2	0.0	126.4	3.1	0.3	0.0	0.0	57.5	0.3	0.9	0.0	0.6	0.0	0.0	1.2	9.5	19.5	30.1	2.2	3.6	69.3	0.7	0.4	0.0	1.5	0.7	0.1	0.0	6.4	0.5	0.0	0.0	0.0	0.0	0.3	0.0	1.0	12.3	0.0	0.0	0.7	3.8	0.1	0.7	0.4	0.0	0.0
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	8.6	0.6	0.9	1.3	1.0	4.0	2.6	1.3	1.6	75.0	1.4	1.3	0.3	1.8	4.6	317.0	1.7	0.8	8.6	0.7	1.0	1.0	1.0	38.6	4.1	1.3	0.9	0.6	0.6	0.2	2.4	41.6	1.0	3.0	0.2	0.0	37.7	1.1	1.0	122.0	1.7	0.3	0.8	6.9	7.5	0.7	1.0	7.6	109.6	1.2	20.5	2.1	132.2	1.2	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	1.0	1.3	1.6	0.7	1.0	1.3	0.9	1.0	0.8	1.0	1.2	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422669	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 169.1"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 479.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"		NA	NA		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	29.6	36.7	22.5	27.8	23.5	18.0	23.2	63.0	24.4	22.8	18.3	34.1	16.9	26.2	18.0	70.8	17.0	22.3	43.1	24.4	24.0	29.7	46.2	28.1	18.4	19.0	22.5	13.1	26.8	90.1	16.4	38.9	17.7	32.5	20.6	26.9	25.2	44.4	165.4	41.3	19.7	42.4	15.7	17.3	19.6	24.8	23.3	13.9	69.5	169.1	25.2	48.3	29.8	24.3	54.2	63.5	46.0	39.1	34.8	51.7	79.4	76.3	69.2	49.2	30.0	31.7	24.4	24.2	49.8	95.7	66.9	65.6	29.7	31.2	57.9	95.0	17.0	7.7	40.2	36.3	68.6	27.8	41.5	32.1	103.3	57.0	87.6	70.3	49.2	20.2	29.4	15.0	47.7	34.6	17.4	8.7	16.7	25.7	53.2	14.7	31.5	11.6	45.5	61.9	16.1	10.7	162.9	39.5	64.0	44.9	31.4	15.9	98.2	36.8	40.1	84.3	49.3	17.0	14.4	14.1	63.0	14.0	25.6	3.3	6.5	4.0	6.6	10.6	5.1	4.9	6.1	5.9	5.6	3.0	4.5	3.2	17.1	4.7	9.4	3.2	6.3	4.1	22.5	23.5	63.0	24.4	24.4	24.0	19.0	22.5	17.7	15.7	23.3	24.3	50.2	134.6	129.9	116.2	32.4	67.2	162.6	42.4	23.9	69.6	50.0	30.1	142.2	50.1	106.5	44.1	43.8	129.7	34.5	38.0	7.9	69.0	156.9	101.2	53.1	57.3	13.9	11.3	115.3	65.5	32.9	69.1	26.0	115.0	72.7	41.3	46.4	48.3	38.3	132.9	107.7	22.3	42.7	41.8	48.5	82.9	35.8	57.0	55.2	45.0	54.2	34.8	46.4	45.2	40.7	95.6	28.5	62.1	33.0	134.4	26.4	13.2	146.5	41.8	72.3	114.6	68.4	22.0	27.4	40.3	143.3	479.4	48.5	39.6	23.0	223.9
CLIP2	"CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4"	ENSG00000106665	"CAP-Gly domain containing linker protein 2"	Q9UDT6	7	74289407-74405935	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9;Excitatory neurons: 63.9;Oligodendrocyte precursor cells: 84.4;Oligodendrocytes: 111.2"	"Cancer enhanced"	"Detected in all"		"glioma: 43.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 70.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020430, CAB020767"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB020767: , HPA020430: AB_1846958"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.96e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.38e-1)"	7.8	9.4	66.9	10.6	80.7	4.1	5.9	71.3	65.7	13.5	24.8	18.5	11.3	11.3	2.1	6.7	7.7	10.9	7.0	65.0	68.1	15.5	3.0	10.9	5.5	87.2	79.8	16.9	17.7	5.0	11.7	8.8	80.8	9.7	10.0	4.7	4.1	9.2	2.4	10.2	13.6	8.1	71.2	6.6	15.0	3.2	69.4	5.0	3.6	3.1	7.3	11.7	11.0	88.8	7.0	24.1	19.5	21.2	22.5	25.1	0.2	17.2	36.5	10.5	11.5	5.6	33.0	1.3	3.4	33.2	70.3	26.8	3.6	20.3	4.6	46.1	1.8	5.6	3.3	14.4	21.9	1.1	6.8	28.3	9.1	31.9	26.4	27.5	15.5	0.7	1.5	0.4	20.4	2.4	0.8	38.8	8.9	33.5	24.5	37.8	7.2	1.7	13.5	24.1	3.9	21.7	9.8	3.0	35.9	14.8	2.2	4.5	18.3	27.6	16.4	37.1	10.9	1.0	0.4	0.1	32.7	10.4	24.4	0.8	0.3	0.0	0.0	0.6	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	66.9	80.7	71.3	65.7	65.0	68.1	87.2	79.8	80.8	71.2	69.4	88.8	5.8	0.0	0.0	19.9	3.5	30.2	6.2	3.3	31.3	10.2	1.9	3.0	2.3	5.7	1.3	3.7	0.0	0.3	3.3	48.9	0.0	10.3	0.2	5.7	8.1	6.6	10.3	3.0	63.9	6.2	0.4	8.2	42.3	13.3	1.3	3.4	3.9	1.4	6.0	18.5	45.2	16.9	0.0	4.6	33.0	0.6	2.8	8.3	12.4	32.8	7.5	4.2	2.1	84.4	111.2	8.2	17.8	7.9	0.9	4.2	16.3	0.3	1.4	4.3	13.1	5.6	11.2	0.1	3.4	4.4	6.8	1.0	4.1	3.6	12.1	1.6
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319908	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	11.1	1.1	16.6	4.2	38.9	1.1	10.9	11.4	28.1	7.5	6.9	11.5	3.0	4.9	7.4	2.9	9.2	5.8	5.3	15.5	12.2	13.3	14.1	4.9	1.3	21.5	25.7	2.9	17.3	1.7	2.9	2.3	23.3	6.9	12.8	9.8	9.2	5.0	3.8	3.2	6.7	2.8	7.3	3.0	7.2	32.8	42.9	1.0	5.9	5.5	1.6	4.7	6.9	67.0	6.3	8.4	1.3	0.2	4.9	2.2	0.5	0.1	0.0	0.4	0.3	0.7	10.5	0.0	0.9	0.0	13.8	5.5	0.6	3.7	0.0	4.3	1.5	0.2	0.3	5.0	0.5	0.0	0.1	2.4	3.6	1.6	5.8	1.9	4.2	2.3	0.0	1.2	3.0	5.6	0.3	0.5	0.5	7.7	2.0	4.8	4.4	2.8	3.9	10.3	1.7	1.6	2.1	16.0	8.2	1.2	13.5	0.4	1.2	0.1	3.6	0.0	0.3	1.6	0.1	5.8	2.9	2.5	15.5	7.3	6.9	0.6	0.0	2.4	0.0	3.0	0.0	0.0	1.4	1.5	0.0	0.1	5.7	0.0	1.5	2.4	0.0	2.1	16.6	38.9	11.4	28.1	15.5	12.2	21.5	25.7	23.3	7.3	42.9	67.0	12.9	16.0	3.4	21.9	18.0	6.2	39.2	11.7	37.0	61.8	39.0	22.2	58.6	42.9	17.3	58.8	14.6	2.5	3.5	93.1	27.4	53.1	161.8	76.7	16.9	11.4	23.4	0.4	9.3	47.5	1.8	12.2	33.6	37.3	4.5	0.4	2.2	81.9	7.3	38.7	11.5	72.5	8.2	11.9	7.2	313.5	22.4	15.6	3.6	1.0	17.1	3.5	0.0	5.0	418.6	40.1	44.1	10.9	21.9	62.3	15.9	21.0	115.6	28.2	105.2	4.8	100.6	4.2	15.3	7.1	2.6	2.9	2.8	0.2	50.2	51.5
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"Caseinolytic mitochondrial matrix peptidase chaperone subunit B"	Q9H078	11	72285495-72434680	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 144.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 5136.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 25.5;granulocytes: 7.7;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	6.0	7.2	3.2	6.6	4.2	11.7	3.5	6.3	7.7	2.9	0.4	3.7	3.9	3.4	2.0	4.0	3.2	3.0	6.2	3.9	6.2	9.0	11.2	3.5	3.7	7.6	5.0	2.9	5.9	9.3	2.2	6.1	8.6	2.3	3.4	6.7	5.9	3.8	8.8	2.4	2.6	6.4	5.0	3.9	3.8	144.6	6.6	4.0	5.7	7.2	3.3	3.8	2.6	5.2	12.7	39.4	9.5	20.5	12.2	9.8	28.8	12.9	8.9	21.8	15.5	55.5	19.1	28.6	30.5	13.0	35.0	26.5	30.6	31.0	23.0	26.3	24.0	23.5	38.3	28.4	10.1	28.0	45.3	14.6	7.7	37.7	33.2	6.4	23.3	26.9	39.7	20.3	12.7	33.0	26.7	23.3	10.5	40.4	35.4	22.2	16.6	14.3	9.9	22.6	27.7	16.9	16.8	39.9	30.8	11.5	22.4	22.0	16.9	29.0	18.0	27.4	25.9	9.9	16.6	18.4	14.6	22.2	19.5	7.7	15.7	0.8	3.0	13.5	3.1	1.9	1.6	2.8	25.5	1.8	2.1	1.8	1.1	2.6	7.8	4.3	1.1	7.8	3.2	4.2	6.3	7.7	3.9	6.2	7.6	5.0	8.6	5.0	6.6	5.2	9.0	16.0	9.7	4.6	6.1	0.4	5.3	5.9	2.2	4.1	7.7	5.0	3.7	2.8	8.6	9.2	4.2	13.0	3.2	3.9	5.9	13.7	1135.5	7.2	13.4	8.0	0.0	11.4	9.8	16.3	17.1	5.5	7.1	9.7	3.8	9.2	1.4	10.7	21.6	3.3	9.8	1.8	10.2	5.9	4.2	5136.8	25.1	13.2	1.8	14.0	8.8	1.9	2.1	11.1	10.4	10.4	1.4	18.4	14.2	6.3	4.3	24.3	5.3	5.5	13.1	3.5	8.1	40.9	22.9	6.0	1.1	33.1	3.6	16.7	2.6	6.6
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1696	"pancreas: 262086.0"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 23175.0"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1600000	"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			30.4	6.1	0.9	5.8	1.8	9.0	17.8	0.1	0.7	13.4	0.2	6.8	40.2	6.0	5.6	9.9	3.8	0.0	46.3	1.2	0.1	5.5	17.7	4.1	10.5	0.2	0.2	154.4	262086.0	0.0	6.3	11.9	0.3	7.9	0.0	0.0	41.7	0.0	5.8	8.1	24.0	0.0	0.1	7.9	27.7	4.0	0.6	0.0	3.8	0.0	0.0	3.3	5.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.9	1.8	0.1	0.7	1.2	0.1	0.2	0.2	0.3	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.0	0.0	1.1	11.9	0.0	0.0	23175.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	130.8	0.0	0.0	0.0	0.0	1331.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLSTN1	"CDHR12, CSTN1, KIAA0911"	ENSG00000171603	"Calsyntenin 1"	O94985	1	9728926-9823984	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 437.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012412, HPA077705"	Enhanced					NA	NA		86000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA012412: AB_1846981, HPA077705: "	"unprognostic (4.63e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.10e-7)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.72e-2)"	28.1	27.4	49.7	23.1	65.8	10.8	31.7	29.5	137.5	61.2	80.6	59.5	29.2	85.4	21.4	51.4	69.8	48.1	35.9	79.6	15.5	41.3	6.1	29.6	33.5	24.7	18.4	60.2	65.7	36.2	48.4	35.7	32.8	61.8	38.2	110.8	79.0	45.7	23.1	83.5	41.1	49.4	7.0	28.3	31.0	15.0	23.5	35.0	40.0	28.9	27.1	38.0	59.9	45.9	120.9	55.4	52.5	64.8	71.1	50.1	35.0	80.5	71.4	82.0	70.2	32.1	235.0	90.5	203.1	95.2	52.6	157.7	41.2	245.6	32.1	114.2	74.6	27.3	53.0	39.6	116.1	46.3	41.4	58.0	156.5	105.9	50.0	78.6	113.9	52.7	13.1	52.6	35.8	47.2	53.2	26.6	37.9	53.1	59.7	80.6	21.4	42.9	73.1	20.9	91.4	53.7	94.8	160.1	79.1	22.1	34.7	73.9	155.0	89.3	80.5	56.6	109.9	75.6	75.4	124.3	72.2	79.6	95.7	6.2	0.6	2.3	3.0	0.8	1.5	0.8	1.9	2.3	1.4	1.0	1.3	1.2	0.2	0.4	0.9	0.8	1.6	1.5	49.7	65.8	29.5	137.5	79.6	15.5	24.7	18.4	32.8	7.0	23.5	45.9	40.2	28.9	15.7	63.6	23.7	43.8	61.0	73.7	84.2	205.1	53.3	47.0	14.7	55.8	44.6	51.5	437.9	34.1	35.0	221.1	1.9	29.2	4.5	44.6	47.0	36.0	30.7	17.9	150.9	38.8	14.3	40.6	29.6	52.2	11.4	54.0	35.3	2.2	28.8	180.0	138.1	96.5	14.2	24.2	13.3	5.6	46.3	21.3	32.0	46.9	21.0	160.9	28.8	90.0	56.0	59.7	66.9	50.4	31.2	42.4	54.9	27.9	68.3	165.6	85.5	39.5	31.4	24.6	37.5	44.5	26.1	19.2	33.8	47.2	59.6	42.7
CLSTN3	"CDHR14, CSTN3, KIAA0726"	ENSG00000139182	"Calsyntenin 3"	Q9BQT9	12	7129698-7158945	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 161.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 79.4;Inhibitory neurons: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		1700000	"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"				"prognostic favorable (5.08e-4)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.73e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (2.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.07e-4)"	12.9	14.5	23.1	13.6	20.8	12.4	13.3	18.6	42.7	13.4	0.0	8.3	6.8	11.0	2.7	6.8	11.7	10.1	7.0	21.1	33.9	21.2	29.2	12.7	14.3	13.5	7.7	25.4	10.4	11.2	30.3	3.7	24.8	9.6	3.9	20.2	11.0	4.4	2.5	10.5	14.2	7.3	0.7	20.7	7.5	4.3	22.3	10.2	12.4	1.6	9.0	9.9	9.6	14.0	6.7	11.2	4.3	10.3	4.7	5.2	30.1	3.9	9.4	7.1	12.1	18.3	10.1	12.1	2.9	6.0	9.1	8.4	6.7	8.0	3.5	10.9	7.5	19.2	19.9	18.6	5.9	2.7	34.6	15.2	5.9	8.5	7.4	30.6	9.1	11.2	19.0	6.6	1.3	2.4	8.3	2.8	12.6	0.6	0.7	5.3	0.1	3.5	10.7	13.8	5.6	9.2	8.4	9.5	1.7	10.4	5.4	7.0	4.6	3.9	13.6	8.6	2.4	8.7	2.2	1.6	7.6	3.2	2.8	1.5	0.0	0.0	3.3	0.0	1.9	0.1	1.5	2.9	0.1	0.1	0.5	1.2	0.2	6.9	0.0	0.0	2.0	1.0	23.1	20.8	18.6	42.7	21.1	33.9	13.5	7.7	24.8	0.7	22.3	14.0	6.0	0.0	3.9	5.2	2.8	4.1	2.3	4.9	7.4	161.2	15.7	7.5	2.3	4.3	3.3	14.7	62.6	5.4	14.1	2.9	0.0	9.2	1.2	3.3	18.0	15.3	29.3	1.3	79.4	7.5	9.3	12.0	7.7	6.3	5.7	8.6	5.7	26.6	1.2	26.9	60.2	4.0	16.2	2.0	7.3	1.9	12.8	3.6	5.4	4.7	1.1	9.5	13.4	10.6	3.1	7.2	3.2	6.4	12.7	1.9	1.3	23.3	3.0	40.3	6.6	5.1	6.8	0.7	1.1	2.7	5.7	3.3	16.6	6.8	3.6	1.8
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	172.8	174.2	131.6	80.8	139.1	67.2	165.6	144.7	165.1	170.9	137.5	163.3	107.9	165.6	100.7	207.1	158.9	64.4	98.1	133.3	143.8	236.0	146.8	146.2	84.1	145.1	138.5	205.6	164.3	104.3	139.3	124.4	151.4	145.0	108.6	84.8	162.8	71.2	87.7	163.2	136.0	84.9	141.6	153.0	161.4	108.5	141.7	85.2	160.1	51.5	93.4	150.9	158.4	151.5	326.3	257.2	188.4	146.3	270.0	269.8	302.6	328.5	248.2	258.1	301.5	194.2	143.9	243.8	177.0	220.9	460.7	136.2	238.8	228.2	238.4	166.0	193.1	187.5	255.0	199.8	359.4	201.0	166.5	297.3	250.5	297.4	234.3	241.0	329.6	129.3	166.0	126.4	399.0	113.3	182.2	254.8	301.8	218.8	360.3	173.3	124.8	142.1	353.7	229.1	146.1	245.3	137.3	160.0	289.4	220.2	146.9	244.2	418.4	209.4	234.0	240.3	347.9	83.0	208.9	259.5	256.9	278.0	188.9	142.2	221.7	115.4	97.1	239.6	101.9	121.0	104.9	100.2	222.6	119.6	92.9	82.0	86.7	96.2	191.8	192.2	162.9	209.4	131.6	139.1	144.7	165.1	133.3	143.8	145.1	138.5	151.4	141.6	141.7	151.5	291.5	128.2	143.9	14.4	105.9	197.3	274.3	374.3	169.0	139.4	274.0	315.0	51.5	217.3	247.4	180.3	60.5	958.0	140.1	349.3	463.7	480.5	51.9	241.5	174.3	244.0	183.8	154.8	28.5	335.6	469.1	187.5	142.2	182.7	73.5	198.4	312.7	170.6	903.7	92.5	30.4	350.5	248.2	391.7	172.0	97.6	262.9	249.3	195.7	20.6	343.5	282.8	117.4	16.1	49.0	465.2	426.4	215.5	97.7	320.5	411.5	651.7	304.7	127.3	177.5	170.0	310.4	288.0	216.8	210.9	193.2	1299.5	103.7	281.6	380.0	360.4
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291719	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 187.4;testis: 47.2;tongue: 61.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;neutrophil: 5.2"	"Group enriched"	"Detected in many"	20	"granulocytes: 5.2;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.8;K-562: 31.8"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA		2300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	6.8	16.0	5.4	0.8	6.1	15.6	4.8	6.2	6.5	5.0	5.0	2.4	0.5	3.1	1.6	3.6	3.8	1.2	14.8	5.2	7.8	3.2	6.5	3.0	0.7	7.4	8.6	3.6	2.5	2.1	13.4	1.5	8.5	5.2	1.0	2.0	3.9	0.8	187.4	4.1	1.8	1.7	5.7	3.5	2.8	47.2	9.1	3.9	8.0	61.3	0.5	2.8	3.7	6.9	4.5	4.6	3.0	4.9	10.8	5.9	1.4	3.1	3.3	4.2	6.3	1.7	1.4	1.9	0.4	7.0	3.3	1.5	4.7	8.5	3.5	0.3	4.6	0.2	4.4	5.3	5.5	6.5	64.8	25.0	7.0	7.8	10.9	12.5	2.7	2.4	31.8	1.7	10.0	3.6	0.6	22.4	3.8	18.1	2.8	2.4	24.2	0.1	3.4	1.8	6.9	1.2	6.6	4.1	0.4	3.6	8.9	27.1	0.8	7.6	15.5	4.2	5.2	3.1	8.4	0.8	4.5	17.4	1.6	0.0	2.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.4	5.4	6.1	6.2	6.5	5.2	7.8	7.4	8.6	8.5	5.7	9.1	6.9	1.4	3.2	0.5	9.4	0.1	0.6	0.5	1.0	1.2	2.4	0.7	0.3	11.3	1.5	1.8	0.0	14.6	0.4	0.2	1.2	0.0	0.8	19.3	1.2	1.9	0.9	0.0	0.8	4.5	0.0	0.2	1.4	1.5	1.4	0.0	3.5	1.1	2.4	0.3	0.0	8.9	1.3	6.1	1.0	0.7	17.0	2.5	0.5	0.0	4.7	1.3	1.5	0.0	12.5	12.5	1.2	0.8	4.1	0.1	1.3	0.2	1.3	1.0	2.0	0.0	2.6	4.5	14.5	4.7	1.0	0.9	1.1	0.1	6.2	0.9	0.0
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27614700	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 10230.8;liver: 9779.1"	"Group enriched"	"Detected in all"	4	"Cholangiocytes: 2586.5;Collecting duct cells: 3525.7;Hepatocytes: 4230.2;Muller glia cells: 8522.6"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 767.1"	"Lineage enriched"	"Detected in all"	33	"granulocytes: 767.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3644.3;SK-BR-3: 3500.4;T-47d: 2562.4;U-2 OS: 2225.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253, HPA075983"	Enhanced		Supported	Cytosol	"Secreted to blood"	NA	NA	169000000000	29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"CAB016253: AB_673562, HPA000572: AB_1078539, HPA075983: "	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.66e-5)"	"unprognostic (5.29e-2)"	1438.7	3809.7	6730.2	897.0	6536.5	53.2	1423.8	6992.3	8050.5	1389.4	6057.7	1407.9	323.9	1152.5	9148.8	768.6	3543.7	2863.5	617.7	6660.5	8149.9	1170.5	9779.1	827.8	2309.4	10230.8	8450.9	756.7	2246.3	1689.2	827.2	131.2	8001.8	986.4	276.1	3274.6	1453.0	5466.4	114.1	281.9	662.7	1439.9	8813.6	295.4	1081.6	2709.4	7385.0	388.1	2406.8	267.7	2343.1	1777.4	741.0	9752.3	13.0	1673.1	73.2	86.4	401.4	546.1	230.7	297.8	584.8	77.3	40.1	323.4	265.5	6.6	1159.9	267.1	926.6	561.2	318.4	48.1	50.3	1268.7	306.4	741.8	3644.3	403.7	348.8	19.2	1891.2	923.4	189.1	334.0	95.5	719.5	1028.1	10.6	10.1	842.2	27.5	288.4	5.7	56.5	603.3	505.3	197.6	6.5	276.1	236.3	763.0	1220.2	66.7	41.7	412.3	3500.4	18.1	349.1	2562.4	10.3	153.2	24.0	2225.3	131.8	101.9	108.1	419.0	16.1	1808.8	122.4	10.3	767.1	18.4	8.9	19.8	6.2	7.4	0.7	23.1	21.3	6.2	1.6	2.8	7.0	79.8	9.3	1.1	11.8	6.5	1073.6	6730.2	6536.5	6992.3	8050.5	6660.5	8149.9	10230.8	8450.9	8001.8	8813.6	7385.0	9752.3	255.3	32.1	91.8	720.5	16.1	81.3	944.6	134.1	118.9	74.3	475.3	480.4	86.1	2586.5	514.0	3525.7	77.2	116.3	15.2	23.6	41.1	488.3	311.3	196.9	31.1	442.0	9.5	92.4	73.4	620.7	22.7	614.8	226.8	185.6	803.0	31.4	1037.7	4230.2	12.6	30.3	81.0	30.9	28.5	180.5	88.9	789.3	114.3	244.6	206.3	69.3	25.1	8522.6	11.3	61.3	54.3	174.8	15.0	57.2	11.6	200.5	9.9	459.2	709.1	221.4	13.1	334.4	157.7	189.8	20.3	58.8	55.3	85.6	58.7	288.9	49.3	353.7
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046218-22065674	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 532.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	19.7	57.0	46.6	23.2	51.1	47.9	32.9	40.3	57.8	29.2	35.8	77.8	66.2	23.5	69.0	71.6	21.8	24.4	42.6	51.2	57.3	28.9	72.2	18.1	24.2	43.8	57.1	25.3	42.5	79.4	30.0	34.0	57.1	36.7	71.9	24.8	32.6	26.7	44.0	29.3	63.6	27.7	41.8	20.1	29.7	69.9	49.0	19.8	23.8	41.1	26.1	24.2	40.3	44.0	63.4	50.2	59.5	29.3	47.0	57.5	88.8	43.2	46.2	45.0	47.2	114.1	72.0	56.5	41.3	37.3	83.9	50.9	35.8	60.1	60.7	75.0	45.4	169.1	38.8	57.2	43.2	45.4	85.5	38.5	56.4	58.1	86.3	61.5	61.3	58.7	108.8	28.1	80.9	83.8	52.0	105.3	147.5	69.4	69.5	36.2	63.6	53.7	56.0	67.8	23.8	42.0	34.2	59.6	51.9	120.2	82.3	62.0	45.5	51.2	42.4	46.2	81.1	19.4	26.0	74.9	83.6	34.6	54.3	22.7	27.3	32.1	20.4	29.7	26.1	19.0	26.9	27.0	31.5	18.2	24.2	24.6	2.8	36.9	27.4	20.2	33.8	25.5	46.6	51.1	40.3	57.8	51.2	57.3	43.8	57.1	57.1	41.8	49.0	44.0	21.5	12.8	17.5	12.4	19.2	29.2	76.8	117.2	14.8	38.3	31.9	21.2	72.7	41.5	102.3	23.9	4.2	175.2	17.8	158.1	76.3	56.6	12.4	17.2	19.6	36.8	41.6	153.9	38.7	83.6	141.3	41.7	21.9	20.0	22.8	28.2	34.2	63.6	66.2	35.3	29.2	118.2	93.6	29.8	22.0	19.0	25.4	32.5	44.4	8.4	45.3	33.4	26.8	16.6	25.5	79.7	156.2	27.8	16.7	112.3	133.6	87.0	82.5	20.4	19.7	30.4	42.3	112.2	97.1	52.3	44.5	532.6	24.6	63.0	90.8	190.6
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		1400000	"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	88.2	45.2	47.0	64.2	50.6	53.1	102.2	51.9	73.1	74.8	49.8	134.1	163.9	44.2	42.2	108.2	35.2	88.5	63.3	44.5	56.9	78.7	217.2	63.8	71.8	52.6	52.4	38.1	90.9	57.7	32.9	48.8	54.2	95.0	141.0	29.2	157.4	50.7	71.1	65.1	152.5	56.0	52.6	58.0	109.0	17.5	52.3	61.7	92.0	73.9	87.9	80.6	63.8	55.3	124.9	68.4	86.6	77.9	154.6	179.3	122.5	216.4	129.8	128.6	129.9	61.3	84.1	183.4	108.6	147.9	120.5	82.7	64.8	112.1	174.9	279.5	52.7	142.9	91.0	106.7	100.8	206.2	100.2	101.2	132.7	107.5	119.7	121.1	135.2	67.4	137.3	143.5	169.8	45.9	168.2	96.8	55.1	162.9	93.6	103.4	149.8	138.5	126.5	134.9	78.3	41.3	155.0	177.7	128.9	113.7	44.2	121.0	127.7	159.6	92.7	154.5	180.8	103.8	154.3	124.4	126.3	125.3	111.7	43.3	12.8	24.2	16.1	14.0	20.7	13.6	18.0	20.0	13.5	14.3	16.9	16.4	5.3	19.4	17.0	11.4	20.9	15.6	47.0	50.6	51.9	73.1	44.5	56.9	52.6	52.4	54.2	52.6	52.3	55.3	101.7	70.5	54.4	14.4	148.1	175.5	125.3	88.9	102.4	34.2	167.8	67.7	48.9	147.3	87.0	75.4	16.7	82.3	117.9	280.0	174.1	186.8	1.6	56.2	63.3	83.8	117.5	126.0	28.5	181.6	133.0	91.2	125.4	98.2	94.0	39.7	88.5	235.9	75.9	43.7	30.2	326.6	91.6	122.0	265.0	5.0	59.4	107.1	254.3	31.9	100.5	66.9	124.6	20.6	25.0	146.8	168.6	70.0	119.8	203.5	234.6	254.5	112.3	31.1	85.5	75.9	95.8	14.0	29.8	167.0	195.1	118.3	160.5	49.0	240.2	250.8
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129167827-129183922	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	292.7	308.2	175.2	181.1	184.0	254.1	274.6	198.6	211.3	295.9	175.7	314.1	198.5	285.8	197.6	264.6	275.7	195.1	487.2	170.6	184.3	231.6	433.7	258.3	251.0	182.7	175.1	385.8	307.4	277.9	169.5	214.3	187.1	256.6	219.0	231.8	250.8	282.4	1207.6	288.0	199.2	234.9	195.6	200.7	262.1	131.2	181.9	254.2	261.8	797.9	250.7	317.5	269.2	211.7	452.7	266.4	369.9	294.6	355.2	303.9	294.9	344.2	535.7	362.2	412.4	389.2	305.7	589.8	292.2	318.1	269.6	328.3	484.3	396.4	484.6	404.5	357.9	569.2	251.7	420.2	355.7	622.4	314.5	295.5	449.2	254.8	897.8	247.6	324.1	328.1	437.6	391.9	384.0	538.9	578.6	454.1	452.7	399.7	439.1	502.4	343.4	707.7	379.1	425.4	501.2	402.8	271.5	263.0	766.3	214.4	305.6	421.3	347.9	268.4	266.2	374.1	353.7	367.3	365.4	932.3	277.3	419.2	362.4	1077.7	810.5	930.9	551.8	596.8	699.0	691.0	658.8	595.3	552.8	603.8	700.3	610.5	1102.3	601.1	485.5	320.4	704.3	2029.8	175.2	184.0	198.6	211.3	170.6	184.3	182.7	175.1	187.1	195.6	181.9	211.7	253.7	259.6	263.9	27.1	292.8	524.7	417.0	262.9	259.6	153.7	177.5	272.5	608.0	141.5	235.1	79.1	33.3	252.3	188.1	143.9	373.7	226.9	36.0	141.4	195.1	267.5	171.3	246.5	28.2	290.7	396.6	309.4	142.8	172.8	314.5	173.0	167.0	138.5	246.5	92.5	33.7	178.6	140.4	194.4	463.0	42.9	316.0	232.4	318.4	35.6	392.7	350.3	236.9	32.6	42.8	230.1	158.0	319.7	311.7	405.1	196.5	237.4	164.8	153.8	263.0	343.6	571.0	305.2	271.5	286.5	586.7	291.7	304.2	277.7	213.6	376.2
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534500-74587212	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 85.6"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 361.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	38	"U-266/84: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008933, HPA073283"	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	0.0	0.0	27.4	0.0	74.2	0.1	0.0	80.4	39.0	0.0	6.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	30.5	51.3	0.5	12.9	0.0	0.0	85.6	76.9	0.0	0.0	0.0	0.2	0.0	74.3	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.2	0.0	39.7	0.0	0.0	0.3	74.9	0.0	0.2	0.0	0.0	0.0	0.0	80.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	27.4	74.2	80.4	39.0	30.5	51.3	85.6	76.9	74.3	39.7	74.9	80.7	0.2	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.6	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	8.6	0.5	0.2	0.2	0.0	2.7	1.2	0.2	0.0	0.3	0.0	1.5	0.0	0.2	0.7	35.1	0.1	0.0	1.5	0.7	0.0	1.2	1.1	3.1	0.0	0.2	0.0	1.0	0.0	0.5	0.0	3.0	361.7	0.2	0.1	0.0	0.0	0.4	0.4	24.5	0.0	1.0	0.0	0.6	0.2	1.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739820	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;retina: 8.4;salivary gland: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	35	"NTERA-2: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010510	Uncertain				"Secreted to extracellular matrix"	NA	NA		9500		"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"			"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.0	0.0	1.8	0.0	4.9	0.0	0.0	2.3	2.6	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	2.0	0.0	0.0	1.6	0.0	2.4	2.3	0.0	0.3	0.0	1.0	0.1	2.2	0.5	0.0	8.4	6.7	0.0	0.1	0.0	0.1	0.0	2.7	0.3	0.0	1.8	2.4	0.1	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	4.9	2.3	2.6	1.8	2.0	2.4	2.3	2.2	2.7	2.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927223	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 315.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 10.5;naive CD4 T-cell: 11.6"	"Group enriched"	"Detected in many"	12	"B-cells: 10.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		660000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	163.9	255.6	152.7	78.9	153.7	2.1	160.0	148.6	186.3	164.8	147.7	142.4	135.9	214.0	71.0	149.7	147.1	152.3	127.6	151.7	189.9	245.1	143.7	209.0	51.4	197.4	170.9	153.1	83.3	53.1	101.7	256.0	173.1	126.2	82.8	125.0	125.5	133.7	26.3	62.5	100.0	196.0	180.8	94.1	111.8	50.2	164.5	55.1	125.0	52.6	44.3	156.5	166.2	174.0	416.6	77.9	429.0	380.1	286.0	264.2	191.7	197.2	381.3	319.4	511.2	348.7	35.6	0.1	436.6	243.4	315.7	116.2	307.2	169.9	428.1	1.6	113.0	18.8	47.5	256.2	545.0	0.2	0.8	246.2	25.5	394.1	89.4	539.6	282.8	26.7	4.1	35.3	798.9	0.2	19.8	0.9	333.6	0.3	43.3	0.6	524.2	1.8	392.9	156.6	26.3	264.2	163.0	65.0	272.8	301.7	124.8	38.5	182.4	212.2	364.9	80.2	647.0	43.9	27.2	1.5	46.0	0.6	327.1	0.2	0.0	0.0	2.2	0.1	3.4	4.6	2.1	1.2	0.1	10.5	11.6	8.3	0.4	0.9	0.1	0.0	0.0	2.6	152.7	153.7	148.6	186.3	151.7	189.9	197.4	170.9	173.1	180.8	164.5	174.0	183.5	150.6	80.7	82.9	18.1	78.3	435.7	232.3	48.9	11.9	122.2	64.1	42.2	88.6	156.2	126.9	20.9	236.1	3.2	36.0	436.3	275.1	156.1	77.4	151.1	278.3	72.4	20.0	12.9	240.7	40.9	287.8	33.1	104.9	14.0	164.4	373.0	152.1	22.6	1.7	16.9	58.7	429.3	20.1	56.3	150.7	274.6	9.3	197.5	29.0	4.7	394.6	0.0	62.4	22.7	130.8	53.2	382.1	2.6	319.1	117.9	518.5	95.1	14.4	263.0	399.8	374.9	10.8	34.7	91.4	77.7	205.8	14.9	214.5	131.0	327.4
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629885	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"	"Autism spectrum disorder, Disease variant, Holoprosencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046577: AB_2679706, HPA049664: AB_2680844"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	29.8	35.2	8.4	46.9	10.7	45.6	36.3	17.4	11.5	34.7	33.5	60.1	55.0	31.8	27.6	73.1	38.9	28.3	26.3	8.6	9.4	39.8	36.0	33.3	58.1	11.5	10.5	39.2	41.1	59.7	21.2	35.1	11.3	31.2	57.3	32.4	38.8	30.6	52.4	43.1	52.3	33.7	8.9	42.9	42.1	108.2	10.6	76.4	42.4	44.1	69.5	49.1	38.6	15.2	128.8	148.2	110.0	88.1	52.1	66.2	127.6	99.6	85.8	111.4	82.0	167.6	75.3	194.0	47.4	75.8	65.5	122.3	177.9	101.0	149.2	72.5	98.8	150.4	121.8	193.7	70.8	235.8	162.4	64.0	67.5	129.7	151.5	66.9	87.7	107.2	181.0	55.3	76.4	52.0	182.6	61.2	114.4	84.9	127.2	229.0	189.5	122.7	62.4	180.0	90.9	58.6	336.0	113.5	56.0	100.5	67.9	121.3	100.9	81.3	80.0	62.2	88.7	124.7	138.2	390.3	85.5	99.4	76.9	18.3	12.1	13.4	13.8	15.6	18.2	14.7	12.9	14.0	14.6	13.8	12.1	12.6	18.6	15.4	22.5	7.3	15.4	11.5	8.4	10.7	17.4	11.5	8.6	9.4	11.5	10.5	11.3	8.9	10.6	15.2	44.4	16.0	42.9	33.0	57.8	47.4	32.6	42.9	25.6	28.2	33.9	27.9	23.8	37.1	45.2	23.9	29.2	33.7	86.3	64.5	9.8	29.8	107.7	57.6	48.0	31.3	36.1	45.0	31.7	47.0	29.9	30.7	35.2	78.2	32.2	45.9	23.9	42.3	35.7	40.4	35.6	54.2	24.4	51.5	39.5	38.6	24.8	46.4	19.6	42.2	50.0	20.0	34.0	42.3	54.9	42.5	34.9	32.4	59.8	43.6	60.1	22.9	51.6	24.3	32.9	38.7	30.4	136.6	64.3	56.0	47.0	37.9	52.1	27.9	64.5	61.2
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876792	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA051398: AB_2681468"	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.41e-4)"	62.3	39.9	35.5	38.4	36.5	118.3	46.5	37.0	43.3	42.0	47.4	41.2	33.5	33.8	36.9	26.6	29.5	29.9	26.1	34.5	35.1	28.9	29.2	49.3	58.7	37.7	36.5	30.2	22.8	40.0	18.3	42.2	38.4	28.8	46.6	25.0	35.1	28.1	21.7	41.7	37.0	32.0	38.8	49.8	30.8	39.0	39.4	69.7	35.6	26.0	53.1	35.9	29.8	40.6	33.4	36.6	64.3	71.2	60.6	55.1	49.1	51.4	55.9	54.8	83.9	47.7	73.5	58.9	61.8	43.6	43.2	36.2	45.2	62.3	61.8	29.3	47.4	49.8	55.7	42.9	38.5	114.3	86.5	37.5	54.5	49.0	42.2	57.0	68.5	81.5	44.6	43.1	58.4	39.4	100.3	118.5	35.6	39.4	21.4	85.7	55.2	61.6	43.7	44.5	50.9	74.4	68.0	54.2	64.9	35.7	50.4	92.7	52.9	57.1	35.3	32.2	34.0	41.4	56.8	91.0	40.1	89.5	36.1	277.6	127.3	269.5	72.3	91.6	79.8	79.9	87.4	86.9	133.2	81.5	115.5	84.6	126.2	91.7	74.6	70.5	107.8	169.6	35.5	36.5	37.0	43.3	34.5	35.1	37.7	36.5	38.4	38.8	39.4	40.6	29.1	19.2	39.7	14.7	39.8	31.9	16.5	37.4	23.9	12.1	23.4	17.5	12.8	12.8	31.5	16.5	0.0	32.5	37.5	17.8	17.6	25.1	124.5	21.5	36.7	35.1	27.6	37.0	15.2	20.2	44.6	28.8	18.8	23.0	17.7	33.2	28.2	13.8	27.1	18.5	11.4	32.1	26.4	49.1	47.1	54.6	45.4	32.5	28.4	26.2	51.2	12.1	23.7	15.1	23.3	31.5	18.7	38.0	21.3	24.2	22.6	13.0	19.9	8.0	6.6	19.6	25.7	29.6	23.1	21.1	41.8	22.8	38.1	29.8	27.7	27.2
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966763-41977740	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1395.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 555.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 149.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"white matter: 1789.4"	"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		46000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	34.4	33.5	493.1	31.2	889.6	23.4	29.6	715.5	681.5	41.7	193.5	56.9	21.4	33.5	36.7	63.4	28.9	32.6	25.3	505.1	577.0	58.1	44.8	21.7	35.7	839.4	761.8	32.2	27.8	23.7	28.1	23.5	793.8	41.5	18.4	20.5	47.2	37.2	26.3	34.3	31.4	30.3	644.6	25.8	29.8	16.7	791.1	31.2	24.7	22.2	35.1	37.3	40.5	1395.7	56.9	92.4	85.8	106.6	71.7	67.2	38.5	70.1	102.5	171.1	191.5	73.0	49.6	59.0	54.3	88.5	88.1	95.0	58.3	44.6	59.0	59.7	76.8	56.7	59.3	127.7	76.9	56.7	49.6	111.0	31.5	94.1	22.8	61.9	79.4	58.0	42.4	46.4	60.6	35.1	148.5	50.9	20.7	29.8	66.5	91.4	126.7	58.7	45.7	55.7	50.9	69.5	85.7	127.0	155.5	41.6	57.2	82.3	80.2	66.6	73.7	92.3	81.9	53.4	66.6	47.5	66.1	42.9	266.4	18.7	38.2	23.4	21.5	40.7	17.2	28.0	18.8	17.4	33.8	19.2	16.6	19.6	7.7	23.5	34.0	149.4	22.4	33.0	493.1	889.6	715.5	681.5	505.1	577.0	839.4	761.8	793.8	644.6	791.1	1395.7	26.6	16.0	12.7	14.4	19.0	16.7	17.5	10.4	16.5	22.0	29.5	24.0	13.0	20.0	19.5	35.0	6.2	30.6	53.2	39.9	125.2	46.3	1.3	19.1	27.1	24.8	19.7	25.2	6.8	41.7	50.2	27.7	17.9	21.3	9.5	20.2	20.3	32.3	39.8	50.5	9.5	16.2	18.3	17.0	14.5	4.0	38.8	20.3	55.2	14.0	25.0	84.7	23.7	45.2	555.6	35.5	19.0	36.1	27.8	21.7	19.0	80.5	12.8	25.4	32.9	36.6	29.4	5.1	16.0	30.9	18.9	13.0	16.9	33.3	20.6	17.4
CNPY2	"HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316119	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	36.7	52.5	28.4	25.8	30.3	24.7	41.8	30.0	30.7	43.3	38.1	36.6	30.9	35.6	74.4	34.1	38.1	25.4	28.4	27.7	31.8	37.8	75.7	30.5	22.0	31.1	29.0	42.7	58.9	47.3	66.8	40.8	28.9	35.3	38.5	18.8	53.1	36.4	21.2	23.5	34.6	24.9	30.5	35.1	42.1	20.0	29.8	27.0	44.7	18.6	26.6	32.9	31.1	32.2	50.6	75.5	76.0	62.8	186.0	64.0	120.7	51.0	117.4	108.7	76.5	116.0	87.9	51.2	95.0	132.4	53.2	72.4	92.3	62.8	68.7	51.3	57.5	49.9	106.1	121.8	83.6	94.9	60.4	76.5	80.5	89.9	106.6	165.5	91.1	59.0	73.8	113.5	81.3	76.2	58.2	105.3	72.6	107.5	109.5	65.1	58.3	84.9	90.1	47.6	67.9	41.7	85.1	86.8	93.6	92.7	78.0	176.8	41.2	42.7	33.6	52.2	74.7	58.4	88.2	41.5	90.2	88.2	70.9	56.8	66.5	36.8	65.8	56.9	77.8	73.2	70.7	71.7	69.5	66.2	70.4	67.0	9.8	70.9	34.6	71.3	68.4	76.4	28.4	30.3	30.0	30.7	27.7	31.8	31.1	29.0	28.9	30.5	29.8	32.2	76.2	48.1	93.7	17.3	79.2	54.8	75.2	129.9	17.1	80.5	178.6	191.6	9.8	140.2	95.2	101.2	64.6	248.3	74.0	80.2	52.8	191.8	40.2	54.7	59.9	72.6	141.9	34.3	31.8	168.7	475.0	77.5	31.1	53.1	91.3	60.7	98.9	185.8	147.4	58.9	32.4	187.2	103.7	59.2	55.8	17.7	103.8	47.8	122.7	13.1	99.7	88.6	125.7	40.2	45.6	162.4	114.1	100.1	68.2	107.4	176.6	145.5	74.1	92.2	26.3	59.1	82.8	72.4	44.0	20.0	53.8	236.4	60.5	78.2	177.8	71.0
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622665-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.9;brain: 7.7"	"Cell type enhanced"	"Detected in single"		"Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 7.9"	"Low region specificity"	"Detected in all"							HPA019654	Approved		Approved	Vesicles		NA	NA	69200			"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	0.9	0.5	1.2	0.6	3.0	6.9	0.7	2.9	2.4	0.2	1.2	0.6	0.9	0.2	0.9	0.6	4.7	0.5	1.6	1.1	2.0	0.6	0.8	0.6	0.5	5.8	3.6	0.2	0.5	0.4	0.4	0.4	3.9	0.3	0.8	0.8	1.1	0.3	3.2	0.9	0.7	0.4	3.4	0.4	0.4	0.6	2.2	0.7	0.6	1.8	0.4	0.4	0.3	7.7	1.3	0.5	2.1	2.2	0.6	0.2	1.1	0.9	1.4	1.0	0.7	1.9	1.8	2.8	0.7	1.4	1.1	2.4	2.3	2.5	2.0	1.9	1.3	1.4	3.1	1.0	0.3	2.2	2.5	0.6	0.8	3.2	1.0	0.4	1.0	1.9	2.2	0.6	1.3	0.5	2.1	2.1	1.3	1.0	1.0	1.3	1.4	2.0	1.2	1.6	0.9	2.6	1.4	1.5	3.7	1.5	1.8	1.6	0.7	1.5	1.1	7.9	2.6	1.4	3.3	2.3	4.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	2.9	2.4	1.1	2.0	5.8	3.6	3.9	3.4	2.2	7.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 94.1;skeletal muscle: 129.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Fibroblasts: 22.4;Muller glia cells: 83.6;Paneth cells: 30.6"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 109.3;SH-SY5Y: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					NA	NA		55000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	60.0	10.3	67.2	1.3	91.9	0.0	49.7	81.5	69.0	29.7	16.3	7.6	3.3	2.8	2.6	3.9	13.0	6.3	39.0	54.3	58.5	2.9	12.4	3.8	1.0	57.0	82.8	5.2	2.2	0.2	9.7	5.2	62.2	11.0	2.2	13.9	11.3	7.7	129.7	11.5	8.7	0.7	49.8	30.6	7.0	7.2	94.1	5.1	13.7	35.1	0.4	5.6	17.1	47.4	0.0	0.0	109.3	0.0	13.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	52.1	0.1	0.1	0.0	1.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	91.9	81.5	69.0	54.3	58.5	57.0	82.8	62.2	49.8	94.1	47.4	0.9	0.0	0.0	57.1	0.0	3.6	1.1	0.0	1.2	19.3	11.9	1.5	1.3	8.6	0.0	0.0	6.2	0.9	0.1	6.5	1.9	0.1	4.3	0.1	2.4	0.3	0.0	0.0	4.1	0.0	0.6	22.4	0.0	0.1	0.0	0.0	2.5	1.4	1.4	3.3	9.3	0.5	0.0	0.0	2.7	1.9	9.9	0.1	3.6	2.8	0.0	83.6	0.0	15.1	0.5	0.0	30.6	2.2	0.3	0.2	14.1	0.1	0.0	3.2	0.0	1.2	1.9	5.5	19.8	0.3	2.4	2.3	0.2	0.0	0.5	0.3
CNTN1	"F3, GP135"	ENSG00000018236	"Contactin 1"	Q12860	12	40692439-41072415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 158.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025200, HPA070467"	Enhanced	Approved			"Intracellular and membrane"	NA	NA		450000000	"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025200: , HPA070467: AB_2732156"	"unprognostic (3.18e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-4)"	"unprognostic (6.98e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (3.75e-4)"	3.9	33.2	64.0	2.5	75.3	0.2	8.8	119.4	84.2	14.1	0.0	3.1	1.7	11.5	2.6	9.1	2.2	11.7	0.8	93.6	59.8	12.4	1.2	4.4	4.5	72.6	94.7	49.2	6.0	1.4	10.4	0.3	70.0	27.8	3.8	26.8	5.4	27.7	0.8	12.8	3.0	10.6	129.0	8.2	5.0	9.4	79.2	1.0	1.2	1.6	3.9	21.5	6.6	158.2	0.1	224.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.1	0.1	0.0	0.0	40.3	6.0	11.2	0.0	0.2	2.4	0.0	0.7	0.0	0.0	0.0	0.7	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	1.5	0.2	0.1	0.0	1.0	0.3	0.0	0.0	68.5	40.3	0.1	2.5	2.7	1.0	0.1	0.6	0.0	0.1	4.3	0.1	10.0	2.8	0.1	0.0	0.3	0.0	0.9	2.6	0.5	0.7	0.3	0.2	0.3	0.4	0.2	0.2	0.1	0.4	0.4	0.2	1.2	0.7	0.4	0.9	0.2	0.0	64.0	75.3	119.4	84.2	93.6	59.8	72.6	94.7	70.0	129.0	79.2	158.2	0.3	0.0	5.9	763.9	0.1	5.2	1.1	1.6	4.0	32.1	0.4	1.8	0.7	0.0	4.5	5.5	29.2	0.0	0.0	0.0	1.9	0.0	34.9	4.3	7.1	0.7	0.0	0.0	844.8	0.0	0.0	13.3	0.0	0.3	0.0	5.0	0.0	0.0	0.1	11.8	699.0	0.0	2.0	0.0	4.0	149.5	62.7	0.1	10.6	54.4	0.0	34.6	0.0	1021.4	23.9	0.7	0.0	60.2	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.5	3.6	0.6	0.8	2.1	13.5	0.0	0.5	0.3	0.0	0.2
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 248.9"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000		"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	82.6	0.4	145.4	0.0	0.1	125.7	112.4	0.6	32.4	2.1	0.1	0.0	0.0	0.2	0.1	0.1	0.7	85.2	96.6	0.1	0.0	0.0	0.0	161.6	128.1	0.0	0.1	0.0	8.0	0.0	139.8	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	110.1	0.1	0.5	6.1	125.7	0.1	0.1	0.0	0.3	0.2	0.7	248.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.6	145.4	125.7	112.4	85.2	96.6	161.6	128.1	139.8	110.1	125.7	248.9	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
CNTN3	"BIG-1, PANG"	ENSG00000113805	"Contactin 3"	Q9P232	3	74262568-74521140	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.1"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 274.0;Inhibitory neurons: 195.1;Oligodendrocyte precursor cells: 228.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BJ: 7.1;fHDF/TERT166: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003341	Approved				"Intracellular and membrane"	NA	NA		130000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA003341: AB_1078556"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.94e-5)"	"unprognostic (4.25e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.30e-7)"	"unprognostic (4.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	2.7	3.0	5.0	0.4	6.4	0.0	1.4	0.0	10.1	2.4	0.7	3.2	0.4	0.9	1.7	0.4	7.6	2.0	2.1	6.2	0.7	3.7	3.1	0.8	0.1	1.3	3.0	1.3	2.0	0.2	4.0	0.1	1.9	5.8	2.8	1.3	0.8	4.2	0.2	0.8	0.5	0.4	0.0	1.8	1.4	0.7	1.3	0.9	1.6	0.2	0.5	4.3	0.5	1.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	7.1	0.0	1.1	0.3	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.4	0.0	1.4	0.0	0.1	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	6.4	0.0	10.1	6.2	0.7	1.3	3.0	1.9	0.0	1.3	1.0	0.2	3.2	1.7	21.9	0.0	0.6	0.8	0.3	0.0	6.2	2.2	1.3	3.5	10.0	4.2	9.2	0.0	0.0	0.0	3.3	1.9	1.9	2.9	32.7	1.8	0.7	1.2	0.0	274.0	0.5	0.0	4.5	0.0	10.8	0.0	0.4	5.7	6.6	0.1	21.9	195.1	6.4	0.0	0.0	2.1	1.8	0.0	0.1	0.0	3.7	0.0	0.2	0.0	228.7	9.8	0.9	3.9	0.0	0.0	4.0	0.6	7.4	4.8	0.9	0.0	2.3	0.9	0.1	1.1	0.0	0.3	0.0	0.5	0.1	7.1	1.9
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057959	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		170000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.4	0.5	2.2	1.1	6.4	0.0	2.5	13.5	12.3	8.7	0.0	4.6	1.8	8.3	1.9	3.1	4.2	5.1	2.5	1.8	2.7	4.2	2.9	2.4	1.1	0.5	5.4	1.0	1.6	22.6	1.9	7.9	1.2	4.3	3.3	19.8	0.9	5.6	0.7	0.7	4.1	4.5	4.2	1.0	3.6	13.4	7.7	2.2	10.3	4.0	2.6	3.6	1.7	4.0	0.0	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	16.5	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	6.4	13.5	12.3	1.8	2.7	0.5	5.4	1.2	4.2	7.7	4.0	0.4	9.6	3.6	26.8	0.1	0.8	1.3	0.0	1.8	96.5	2.0	1.8	1.4	7.2	5.6	0.0	0.0	0.1	0.0	1.8	0.0	4.4	411.7	0.3	9.1	1.9	7.8	0.0	960.7	0.0	0.1	18.1	0.0	0.3	0.0	6.9	0.7	0.4	0.3	101.0	1048.5	2.0	0.0	0.3	0.7	156.3	5.0	0.4	1.8	31.9	0.0	27.5	0.0	248.3	14.7	0.0	1.6	5.3	0.4	0.4	3.7	3.7	0.0	5.9	6.6	0.5	8.3	4.5	4.9	0.9	0.0	0.3	0.1	0.1	3.5	0.2
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020949-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 968.9;Inhibitory neurons: 2295.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	NA	NA		480000		"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	4.7	1.1	0.3	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.2	0.5	2.6	0.5	0.0	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	4.1	4.7	1.1	0.0	1.3	0.5	0.0	2.9	0.1	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	3.5	0.1	0.0	0.0	0.0	968.9	0.0	0.2	1.1	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	2295.2	0.0	2.0	0.0	0.0	0.4	0.9	0.0	0.0	42.2	0.0	0.1	0.0	112.1	23.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	12.5	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;retina: 14.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3383.0;Inhibitory neurons: 6845.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;CACO-2: 6.7;NTERA-2: 12.0;SCLC-21H: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.2	0.8	10.0	0.2	13.8	0.0	0.6	1.4	20.7	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.6	0.0	0.2	5.6	5.7	0.1	1.9	0.0	0.4	5.7	0.5	1.1	0.2	0.3	3.8	0.5	3.8	4.1	0.4	14.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.2	0.5	1.8	3.7	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.2	0.0	2.0	1.7	0.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.0	1.4	0.0	0.0	0.0	2.2	0.0	0.0	21.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	13.8	1.4	20.7	5.6	5.7	5.7	0.5	3.8	0.0	1.8	0.0	0.1	0.0	0.0	65.6	9.3	0.1	0.3	15.5	1.8	33.9	0.3	0.0	1.2	7.2	4.1	0.0	2.1	40.8	0.0	1.8	0.0	1.4	7.2	0.6	0.0	0.6	2.4	0.0	3383.0	0.7	6.8	1.1	0.5	0.7	0.0	0.2	0.0	8.9	3.3	1031.4	6845.7	3.9	0.0	0.6	2.0	2.7	1.2	0.4	0.0	180.8	0.2	8.2	1.0	429.3	914.7	4.1	2.1	0.0	0.3	7.4	4.7	0.5	0.9	16.7	0.0	0.0	0.9	2.4	12.0	9.1	0.0	6.3	0.0	1.2	6.8	0.2
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.0;testis: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	2.5	13.8	3.6	28.0	5.0	4.0	3.2	4.4	6.9	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	2.1	3.3	2.8	4.1	6.7	23.3	5.4	5.5	7.5	3.9	2.8	3.1	6.3	4.1	4.5	5.6	7.5	3.6	3.8	1.1	4.9	5.2	4.9	3.7	12.6	7.8	35.3	3.4	23.9	4.8	1.8	21.7	6.5	2.8	5.3	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	2.5	3.6	4.0	3.2	2.1	3.3	5.4	5.5	4.1	3.7	3.4	5.3	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642481-230693982	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 71.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA076994: AB_2686823"	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	10.1	22.0	10.7	11.0	11.8	9.1	12.9	14.7	13.1	13.1	13.5	19.0	13.5	10.0	13.8	8.9	14.2	10.9	17.2	10.0	10.9	16.6	9.9	10.0	16.3	11.0	11.2	10.0	14.1	71.2	8.5	8.9	10.9	12.1	22.7	10.9	12.8	10.9	20.1	11.8	13.3	11.7	11.1	15.1	14.4	10.9	11.5	16.6	15.0	19.9	16.2	11.1	9.1	12.4	15.6	18.0	21.1	20.4	20.6	16.0	30.7	13.2	20.4	21.4	18.6	24.2	23.2	47.6	20.2	18.1	13.8	22.8	20.1	23.6	20.3	38.8	39.8	16.8	17.0	24.9	25.4	43.6	25.1	21.7	25.6	13.6	19.5	13.7	18.0	29.1	29.5	25.8	17.4	12.5	39.7	21.2	30.5	47.1	33.1	33.8	33.8	56.7	22.1	22.8	21.7	29.7	15.5	27.9	30.5	9.4	33.6	41.9	15.3	10.3	9.5	12.8	25.9	31.7	28.3	37.7	17.2	17.7	22.1	18.7	15.7	20.5	16.0	19.4	18.5	13.9	15.1	15.5	18.1	15.2	21.6	19.0	0.8	22.9	29.4	9.1	13.5	18.2	10.7	11.8	14.7	13.1	10.0	10.9	11.0	11.2	10.9	11.1	11.5	12.4	12.5	22.4	19.5	22.9	21.0	5.2	6.1	7.8	8.6	16.1	12.3	10.8	25.9	20.0	15.1	12.9	29.2	13.1	19.6	19.8	27.4	18.7	19.3	17.6	15.2	10.7	18.6	14.9	22.3	23.3	11.8	10.8	15.8	10.7	23.4	14.2	11.0	14.1	14.0	25.2	20.5	37.1	12.2	20.1	6.0	6.4	11.5	12.3	7.2	17.8	19.0	20.5	21.6	23.1	22.6	18.0	12.8	14.7	13.0	9.0	15.2	20.3	28.9	42.9	13.1	13.9	13.3	23.3	25.2	10.0	4.8	9.2	18.4	21.0	21.6	6.0
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"	Q96MW5	16	69320140-69339583	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA041406: AB_2677459, HPA049429: AB_2680763"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	9.9	14.5	19.7	8.5	23.2	6.5	11.1	23.2	24.4	9.8	24.0	10.5	10.5	10.8	14.1	9.9	13.9	7.7	11.2	19.4	19.7	13.4	15.0	10.2	11.3	21.1	20.6	13.7	14.2	19.9	12.0	7.9	21.2	10.3	9.9	7.7	13.8	10.6	18.1	16.3	10.0	10.5	20.3	10.9	11.2	20.3	20.9	12.2	13.0	15.8	11.3	9.4	7.7	28.1	13.2	28.5	18.2	26.7	30.1	21.0	19.4	16.9	18.6	23.0	18.7	26.2	19.8	23.7	18.1	23.0	12.4	24.9	29.5	24.3	19.8	11.9	26.4	17.0	19.9	35.0	21.3	21.1	14.8	25.2	23.5	25.2	14.7	22.2	22.6	20.4	35.4	5.7	16.7	38.3	19.4	31.3	32.2	17.8	20.5	35.6	12.6	33.3	23.6	11.1	26.0	31.1	37.5	15.0	17.5	18.4	35.4	17.8	20.5	16.8	14.4	15.8	14.1	31.3	27.1	36.8	17.3	18.8	19.2	41.4	19.6	20.6	17.8	19.0	19.6	13.3	19.2	18.2	18.6	19.0	17.4	16.7	15.6	22.2	17.6	10.7	19.6	16.8	19.7	23.2	23.2	24.4	19.4	19.7	21.1	20.6	21.2	20.3	20.9	28.1	3.2	9.6	9.7	1.3	9.4	4.2	10.4	5.8	5.2	18.9	7.3	6.7	0.0	24.3	10.6	11.0	18.8	15.0	5.0	12.6	1.9	7.6	17.4	6.1	6.4	7.2	12.7	5.5	1.9	8.0	9.1	7.4	7.1	4.6	7.0	9.0	15.7	28.5	9.5	11.8	2.0	11.7	20.3	7.9	3.3	4.8	12.8	3.1	5.4	1.0	8.4	12.1	10.3	2.0	2.6	5.4	9.5	15.8	9.0	9.6	19.3	15.3	10.2	19.9	13.1	15.5	6.2	9.9	13.6	7.2	4.1	9.2	8.3	5.4	16.7	7.2
COL11A1	"CO11A1, COLL6, DFNA37, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 20.1;retina: 9.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 83.9;Excitatory neurons: 99.5;Oligodendrocyte precursor cells: 557.4;Theca cells: 139.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 116.9;BJ: 43.2;BJ hTERT+ SV40 Large T+ RasG12V: 85.3;HBF TERT88: 48.7;HSkMC: 142.5;SuSa: 60.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		640000		"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	0.6	0.6	4.3	0.3	3.1	0.0	0.4	1.6	4.6	0.9	2.8	0.4	0.1	0.5	0.1	0.0	0.0	3.1	0.0	2.4	2.5	0.1	0.0	0.3	0.1	2.5	3.7	0.6	0.7	0.2	3.3	20.1	2.2	0.2	0.3	9.6	1.5	0.8	0.1	1.4	0.1	0.3	1.0	0.5	0.1	1.4	2.2	0.0	0.1	0.1	0.0	0.2	0.1	2.1	0.0	0.8	116.9	0.0	4.6	5.9	0.0	43.2	16.1	23.3	85.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	142.5	0.0	1.1	0.0	17.7	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	8.1	0.0	0.1	0.0	7.4	0.0	15.2	0.0	0.1	0.0	0.0	0.1	0.0	60.5	0.0	0.1	0.0	0.6	27.0	0.0	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.1	1.6	4.6	2.4	2.5	2.5	3.7	2.2	1.0	2.2	2.1	0.0	0.0	2.2	83.9	0.0	1.8	0.0	0.0	0.0	9.4	0.1	4.2	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	21.0	0.1	0.9	2.2	0.0	0.0	99.5	0.0	0.8	18.7	0.0	0.0	2.5	8.3	0.0	0.0	0.3	0.0	32.9	0.0	0.0	0.0	1.3	4.0	1.2	0.2	10.6	29.0	0.0	29.8	0.0	557.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	2.6	0.5	0.8	0.0	1.1	0.3	0.2	139.6	0.0	0.0
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pituitary gland: 23.5;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Early spermatids: 10.8;Muller glia cells: 5.2;Oligodendrocytes: 6.7"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.0	0.3	0.3	0.0	0.6	0.0	0.9	0.5	0.6	1.6	0.0	0.7	0.2	1.2	0.2	0.5	0.9	0.1	1.8	0.3	0.3	1.3	0.8	1.0	0.0	0.5	0.4	1.1	0.6	0.1	23.5	0.0	0.5	1.3	0.0	0.1	0.8	0.1	1.3	0.6	0.7	0.1	0.5	1.2	0.7	8.1	0.5	0.3	3.5	0.7	0.0	0.6	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	0.3	0.3	0.5	0.4	0.5	0.5	0.5	0.8	2.6	0.0	0.0	8.5	0.1	1.5	0.2	0.1	1.8	2.8	1.2	1.8	2.3	0.0	0.1	0.0	4.2	0.0	0.6	0.3	0.0	0.1	10.8	0.2	0.6	1.5	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.5	0.0	0.6	4.6	0.2	0.2	0.0	3.7	0.1	0.0	0.6	0.4	1.9	0.0	0.3	1.8	1.0	0.0	5.2	0.0	3.5	6.7	0.1	0.6	0.4	0.8	0.2	0.0	0.1	0.0	1.1	0.0	0.7	1.8	0.9	2.1	0.7	1.1	0.0	0.4	0.2	0.5	0.1
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206267	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"fHDF/TERT166: 1432.1;SiHa: 846.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 29.1"	"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		9100000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	105.1	15.7	2.2	16.0	1.9	0.0	65.4	0.8	2.7	112.8	0.4	74.9	8.7	124.5	5.5	36.2	42.2	20.9	25.5	1.0	1.2	25.9	3.5	24.6	7.2	1.8	4.8	123.2	5.9	5.0	4.8	1.8	0.6	20.8	17.2	0.4	16.1	42.4	14.4	48.9	40.6	72.1	0.6	11.4	18.1	4.6	2.0	5.5	19.3	12.5	4.2	26.3	45.8	0.8	0.2	2.2	11.5	0.2	270.2	162.0	28.3	275.4	229.3	186.2	257.3	27.5	0.7	0.0	27.7	1432.1	3.9	59.2	0.5	28.7	174.6	0.2	1.4	0.2	101.1	0.1	97.9	0.3	0.2	234.9	5.0	42.2	50.6	173.6	32.0	0.1	0.0	0.0	29.4	0.2	0.1	0.2	6.4	0.0	15.3	0.1	23.1	0.2	8.9	14.4	0.0	0.0	846.1	21.2	0.3	15.5	131.8	0.5	0.2	78.5	97.0	41.5	91.4	0.1	0.1	0.4	26.4	0.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.8	2.7	1.0	1.2	1.8	4.8	0.6	0.6	2.0	0.8	14.2	76.9	5.1	2.3	0.0	20.6	0.6	12.7	5.2	0.4	4.7	7.1	4.1	0.0	4.7	3.7	0.0	0.6	0.0	0.0	0.0	1.4	24.1	6.3	44.3	11.0	0.0	0.0	52.9	4.6	1.3	99.7	2.6	14.1	1.3	0.1	3.3	0.0	0.8	0.0	32.4	0.0	0.0	0.3	18.4	14.7	60.3	1.8	21.4	38.4	0.0	0.0	0.0	19.6	1.2	6.7	0.0	13.2	0.1	1.7	0.0	0.9	1.7	0.0	46.0	20.0	48.6	0.3	0.6	0.6	13.1	0.7	2.5	1.4	0.1	0.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405165-45513720	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0"	"Region enriched"	"Detected in all"	6	"cerebellum: 22.1"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		290000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	136.4	87.6	14.5	33.9	22.3	15.9	97.1	26.4	21.8	229.4	34.4	91.2	30.4	135.6	35.4	50.1	118.3	28.9	122.2	15.7	18.1	218.2	561.9	83.2	19.8	43.7	28.6	257.3	102.3	7.9	106.5	40.7	39.1	91.0	5.5	5.4	35.8	46.8	26.5	77.8	65.7	28.5	26.6	86.8	44.5	30.0	27.0	9.0	101.1	7.4	7.2	109.8	112.2	45.4	10.5	84.0	20.6	18.0	38.6	31.9	3.3	82.0	139.0	39.1	10.5	48.8	28.9	1.5	309.4	82.8	21.6	37.9	4.6	5.0	7.4	0.7	20.0	47.9	1.4	69.6	37.3	0.7	4.4	37.6	3.3	3.8	4.5	8.5	121.3	0.5	49.6	0.3	14.4	16.7	0.8	3.2	170.6	3.2	30.7	0.7	12.6	4.0	131.6	1.3	22.8	16.3	7.6	7.8	26.6	73.0	7.5	9.9	186.0	0.5	11.4	0.4	17.7	0.4	0.8	1.5	0.1	1.7	32.7	0.8	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.0	0.1	0.0	0.1	14.5	22.3	26.4	21.8	15.7	18.1	43.7	28.6	39.1	26.6	27.0	45.4	156.9	0.0	4.1	6.5	3.9	67.7	15.5	19.0	67.7	13.5	9.3	32.1	15.7	61.5	5.0	112.2	4.2	1.9	3.4	0.1	9.8	117.5	1.5	58.3	99.5	91.2	0.0	33.0	4.9	5.8	1.1	101.1	3.6	144.2	57.8	6.6	75.0	479.6	2.4	0.0	15.8	0.1	4.1	12.1	32.5	6.7	79.9	6.5	49.8	82.4	3.2	141.9	7.2	4.0	28.0	9.9	0.0	126.0	4.6	14.0	0.0	72.9	0.7	6.3	223.5	138.2	268.6	4.1	6.0	7.9	28.6	2.5	15.3	47.5	0.4	2.6
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866556-70212468	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;Excitatory neurons: 66.6;Inhibitory neurons: 164.2;Oligodendrocyte precursor cells: 39.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 9.1"	"Group enriched"	"Detected in some"	218	"memory B-cell: 14.6;naive B-cell: 31.9"	"Lineage enriched"	"Detected in single"	299	"B-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;RH-30: 11.4;SCLC-21H: 3.7;SH-SY5Y: 2.9;SK-MEL-30: 9.6;WM-115: 9.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	0.0	0.1	1.2	1.5	1.6	0.3	0.0	9.1	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.7	2.3	0.1	1.4	0.1	0.0	2.6	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.3	0.7	0.7	0.6	0.1	0.0	0.7	0.0	0.7	0.0	0.0	1.6	1.1	0.4	0.0	1.1	0.0	0.2	3.2	2.2	0.2	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.7	2.9	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	31.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	1.6	9.1	1.9	2.3	0.1	0.2	0.2	0.3	0.0	0.0	2.1	0.0	0.0	0.0	11.1	33.5	0.1	0.2	0.0	0.0	4.4	0.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	66.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.7	0.1	0.0	0.0	164.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	8.4	0.3	0.1	1.0	39.7	10.6	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.7	0.1	0.0	11.2	0.4	1.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974373-189012746	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 2369.0;gallbladder: 2092.8;placenta: 1981.7;smooth muscle: 2140.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2812.0;Fibroblasts: 1764.2;Smooth muscle cells: 643.0;Theca cells: 466.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 15.0;thalamus: 10.9;white matter: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 1362.4;ASC diff: 2465.0;ASC TERT1: 4252.6;fHDF/TERT166: 1815.7;HHSteC: 1690.0;HSkMC: 3189.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 61.1"	"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		32000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	763.6	48.9	1.1	575.5	2.3	1.1	340.0	1.4	15.0	2369.0	11.5	275.9	84.5	768.9	60.9	298.5	177.6	2092.8	234.6	1.3	1.4	42.9	97.4	187.0	119.0	1.8	2.0	146.9	45.2	37.0	13.6	1981.7	2.2	147.5	334.7	0.0	65.6	276.9	67.1	329.8	152.5	2140.7	1.9	134.7	156.9	63.5	10.9	40.9	71.8	71.8	73.1	1097.6	273.8	4.6	0.0	0.2	1362.4	53.0	2465.0	4252.6	0.9	558.6	495.3	239.4	212.8	8.1	0.0	0.6	0.3	1815.7	0.1	0.8	1.1	1.0	26.4	0.0	0.9	0.7	228.9	0.2	1690.0	2.0	0.6	3189.5	0.0	291.5	46.9	1.0	12.5	0.0	0.4	0.0	146.4	0.0	0.2	1.4	2.6	0.1	1.7	0.3	38.5	0.5	0.0	7.2	1.3	21.1	14.5	0.4	0.0	954.8	0.1	0.0	0.7	2.3	28.0	117.3	0.5	2.8	1.3	0.4	0.5	1.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	1.4	15.0	1.3	1.4	1.8	2.0	2.2	1.9	10.9	4.6	111.8	3.2	13.7	0.0	0.6	171.6	0.4	1.9	3.4	0.0	7.7	9.9	11.1	0.0	1.3	0.0	0.0	57.9	1.6	0.0	0.0	2.4	29.0	75.4	2812.0	68.4	6.0	0.0	0.0	0.0	58.1	1764.2	4.1	60.7	6.3	9.7	235.2	0.9	91.1	0.0	0.2	0.0	0.0	0.6	275.3	20.8	323.1	17.5	172.5	20.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	235.9	1.5	0.6	0.0	0.2	1.6	0.0	453.6	224.3	643.0	0.9	1.5	2.2	155.7	126.3	29.1	466.8	0.0	0.4
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513209	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 474.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1041.3;WM-115: 428.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		2700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	240.5	51.2	15.1	103.5	2.3	0.6	153.5	1.7	5.9	111.6	3.4	282.0	29.5	219.4	10.4	51.8	122.9	84.2	113.0	19.3	1.8	71.7	19.1	181.7	22.8	4.3	7.8	51.9	32.6	25.6	17.5	474.0	6.0	121.3	18.9	2.8	35.0	95.8	44.7	45.2	84.1	226.8	2.6	121.5	96.4	15.7	11.5	7.9	74.9	21.5	7.1	186.2	74.4	2.9	88.9	45.7	218.7	0.6	213.7	99.0	312.8	307.9	97.4	167.3	76.1	2.5	0.7	0.6	1041.3	60.0	75.0	85.4	0.1	82.4	27.3	28.1	46.3	0.2	76.6	0.7	150.5	0.5	1.0	42.8	4.5	114.8	71.2	193.5	158.5	0.0	1.3	0.9	25.4	0.3	0.3	12.1	34.2	0.8	11.7	0.6	87.8	0.4	125.6	0.0	6.4	35.4	0.3	0.9	81.2	84.7	0.6	6.7	327.7	94.9	237.9	2.3	161.9	0.6	3.0	7.4	5.8	0.4	428.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	2.3	1.7	5.9	19.3	1.8	4.3	7.8	6.0	2.6	11.5	2.9	313.6	83.3	5.8	17.9	2.9	9.6	8.0	16.3	1.8	2.4	7.0	56.8	31.8	20.0	1.8	53.3	0.0	77.4	0.1	10.0	1.9	39.0	1.7	19.4	308.3	278.2	0.0	8.0	17.7	4.4	512.9	159.1	5.6	50.1	1.3	223.8	102.1	1.8	30.9	0.0	44.0	7.0	2.0	3.3	13.3	3.4	60.6	3.8	39.2	46.9	2.0	7.3	0.0	5.5	1.1	2.8	1.4	176.0	1.5	12.3	23.9	32.7	2.1	0.3	374.7	64.7	338.9	0.9	8.5	0.7	7.0	67.2	3.6	49.4	5.4	2.4
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164624-227314792	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 169.9;Bipolar cells: 62.1;Cone photoreceptor cells: 398.2;Muller glia cells: 143.1;Oligodendrocyte precursor cells: 84.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 18.8;hTERT-RPE1: 14.5;Karpas-707: 9.9;RPTEC TERT1: 11.0;U-266/70: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.6	11.5	1.9	2.1	1.8	0.3	1.0	1.5	1.7	0.4	21.5	0.8	0.7	1.2	16.3	1.0	2.1	3.2	8.9	1.4	2.0	30.5	0.6	15.0	2.9	3.3	3.1	3.9	5.0	0.2	16.2	0.2	2.7	6.0	1.0	52.9	1.2	9.9	22.2	0.5	6.7	0.8	1.6	7.2	1.8	1.7	6.3	0.4	20.5	15.2	5.6	1.4	1.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.3	1.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	1.2	0.0	9.9	0.0	0.4	0.0	0.1	1.4	0.0	0.0	0.1	0.0	3.2	11.0	2.3	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	9.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	1.5	1.7	1.4	2.0	3.3	3.1	2.7	1.6	6.3	2.2	0.5	169.9	31.7	3.9	14.0	0.1	0.1	0.1	0.6	62.1	0.1	0.9	2.6	1.5	9.3	42.3	398.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	2.4	0.0	0.0	5.5	1.0	0.0	4.6	0.5	0.3	1.3	22.8	0.4	0.2	0.0	1.7	14.1	0.0	0.0	0.0	0.3	0.3	8.4	0.3	1.8	13.1	0.0	143.1	0.0	84.9	3.6	1.0	0.0	12.0	8.0	0.1	0.0	1.9	0.1	11.9	13.1	11.7	3.6	0.4	0.0	0.3	0.3	0.0	1.2	0.1	0.0	0.0
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002714-227164453	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Collecting duct cells: 46.0;Cone photoreceptor cells: 56.3;Granulosa cells: 62.6;Muller glia cells: 78.6;Oligodendrocyte precursor cells: 55.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 4.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 34.3;hTERT-RPE1: 27.2;Karpas-707: 8.9;RPTEC TERT1: 14.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.0	6.9	1.3	2.1	1.1	0.1	0.7	0.9	0.9	0.5	14.2	0.9	0.9	2.0	7.2	1.1	2.1	4.4	9.2	1.0	1.3	14.0	1.6	8.3	2.8	3.1	2.2	2.0	5.5	0.6	10.2	0.3	2.6	4.5	0.8	8.4	0.7	8.3	6.9	0.3	2.4	1.6	1.5	1.9	1.2	1.3	4.4	0.9	9.9	5.7	4.5	2.9	0.9	1.3	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.1	0.6	0.0	0.7	0.0	1.7	0.0	0.7	0.1	3.1	1.1	0.2	0.0	3.4	0.0	34.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	27.2	0.0	1.1	0.0	8.9	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	14.5	5.6	0.8	0.0	2.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	2.7	0.0	0.3	6.7	5.3	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	1.1	0.9	0.9	1.0	1.3	3.1	2.2	2.6	1.5	4.4	1.3	2.0	73.7	24.1	3.6	11.1	0.5	0.4	0.2	0.0	29.1	0.5	1.3	3.5	8.6	6.2	46.0	56.3	0.0	1.4	0.1	1.9	0.3	0.8	0.3	1.8	5.2	1.2	0.0	2.5	3.8	0.0	8.1	1.5	0.9	0.0	62.6	2.5	0.7	0.1	0.0	10.4	0.1	2.0	0.3	1.5	4.3	25.1	0.8	0.0	12.2	0.0	78.6	0.0	55.3	3.4	4.1	0.1	27.1	14.9	0.2	0.0	3.6	0.0	8.5	0.0	16.8	8.6	0.1	0.6	0.2	0.0	0.0	1.4	0.9	0.3	0.1
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL5A2		ENSG00000204262	"Collagen type V alpha 2 chain"	P05997	2	189031898-189225312	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 186.0;Excitatory neurons: 185.2;Fibroblasts: 145.7;Skeletal myocytes: 76.4;Smooth muscle cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 447.8;BJ hTERT+ SV40 Large T+ RasG12V: 382.4;fHDF/TERT166: 430.3;HSkMC: 340.2;SuSa: 373.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		820000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (7.45e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.53e-10)"	"unprognostic (4.57e-3)"	"unprognostic (3.76e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.58e-4)"	61.0	4.8	2.3	42.5	5.7	0.2	25.7	0.0	15.6	83.4	3.1	48.7	10.0	43.4	32.7	23.6	21.2	81.9	19.5	17.6	0.8	6.3	12.4	26.1	9.3	2.0	17.4	25.2	7.1	7.5	7.3	111.5	3.8	14.8	25.4	1.6	7.4	12.8	7.8	12.9	22.8	98.3	1.9	10.0	21.5	6.8	1.0	4.7	9.8	26.8	10.3	57.3	29.7	2.5	0.4	93.5	143.9	67.5	212.0	285.3	0.8	213.7	242.3	447.8	382.4	63.2	0.7	0.2	2.2	430.3	23.2	1.6	4.1	2.3	153.3	0.9	1.3	1.0	2.1	0.6	282.6	0.6	0.4	340.2	7.8	129.8	45.3	92.2	108.5	0.9	0.5	0.4	109.1	2.4	0.3	0.3	20.9	0.9	124.3	0.5	33.9	0.4	0.5	24.9	2.0	1.4	5.2	2.5	5.2	373.0	2.1	0.2	91.6	212.8	22.9	52.6	44.6	0.8	0.4	0.6	32.2	0.1	235.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.7	0.0	15.6	17.6	0.8	2.0	17.4	3.8	1.9	1.0	2.5	36.7	0.0	1.5	29.7	0.3	26.1	0.2	7.2	6.2	1.3	1.6	3.7	2.8	0.0	0.7	1.8	0.0	4.6	0.2	0.5	1.9	0.6	0.7	22.4	186.0	9.1	38.7	0.0	185.2	0.7	3.9	145.7	0.5	5.1	0.0	4.2	25.7	7.4	6.6	0.0	23.8	0.2	4.1	0.3	27.4	1.7	48.7	1.4	21.4	25.3	0.6	0.7	0.0	21.6	10.9	1.1	0.1	19.5	0.4	0.3	0.1	1.0	1.9	0.8	46.0	76.4	116.0	3.9	1.8	2.0	18.8	6.2	2.8	27.4	0.0	0.4
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414207	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 391.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Region enriched"	"Detected in many"	4	"spinal cord: 12.0"	"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	150.8	8.3	0.1	126.5	1.0	0.4	74.5	0.2	3.0	212.6	5.2	94.8	22.9	156.3	10.2	44.1	91.8	236.4	61.2	2.4	0.1	5.7	10.3	65.8	30.7	0.6	0.1	123.8	21.1	17.3	2.8	132.9	0.7	47.7	51.7	0.0	45.2	55.4	32.5	35.7	46.6	391.3	0.8	19.0	41.5	15.6	1.8	24.8	38.1	62.3	16.1	188.4	62.7	0.9	0.2	0.5	0.6	0.0	3311.7	4227.5	60.9	815.6	1279.6	167.0	188.2	0.0	0.1	4.5	0.1	818.7	67.4	0.6	0.7	0.9	98.8	2.0	0.1	0.0	0.0	0.0	669.9	0.0	0.4	2705.3	0.0	596.3	1.8	7.8	0.2	0.0	0.1	0.6	6.2	0.0	0.1	0.2	0.5	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	17.3	0.0	0.4	2.9	19.0	45.1	27.6	142.4	1.0	0.0	0.1	859.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	3.0	2.4	0.1	0.6	0.1	0.7	0.8	1.8	0.9	48.2	0.0	10.5	0.3	0.6	61.1	0.5	0.5	1.8	1.0	2.5	2.9	10.6	1.5	3.8	0.0	0.0	4.5	1.2	0.0	0.0	0.9	5.4	11.0	355.2	17.6	0.0	0.0	0.8	0.0	6.2	567.9	6.6	8.7	1.3	1.8	25.4	1.8	8.1	0.0	0.4	0.0	0.0	1.3	85.4	9.6	315.1	5.5	72.9	29.0	2.2	1.1	1.0	0.0	0.3	2.4	0.0	103.4	2.0	0.9	0.0	0.2	1.0	2.3	32.9	19.2	197.7	1.5	1.3	3.3	61.5	5.7	9.3	48.7	0.0	1.0
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 34.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	33.0	7.0	1.7	5.8	2.9	0.0	5.7	1.8	2.6	3.8	4.4	12.4	1.0	5.2	2.7	11.1	9.1	10.8	39.1	1.3	3.0	5.9	0.9	32.8	0.9	3.1	3.9	9.2	1.2	17.9	11.3	4.2	3.4	12.7	6.9	0.5	7.0	12.0	2.3	3.2	3.7	31.5	2.7	1.0	5.3	0.5	2.6	0.4	27.5	7.8	0.5	25.0	5.4	2.5	0.1	0.4	3.0	0.3	142.2	236.4	0.2	68.5	45.7	69.6	138.6	0.0	0.3	0.1	5.9	1098.3	1.9	0.1	0.4	88.2	157.8	0.1	0.2	0.1	7.9	0.0	26.8	0.0	0.1	142.8	3.2	52.6	82.9	431.9	129.4	0.0	0.1	0.2	313.0	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	144.3	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.1	0.2	471.5	31.0	24.1	1.6	34.2	0.1	0.0	0.1	58.4	0.0	241.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.9	1.8	2.6	1.3	3.0	3.1	3.9	3.4	2.7	2.6	2.5	4.4	246.8	22.1	0.0	0.4	0.8	0.5	2.8	14.8	0.4	1.8	5.2	4.9	4.3	3.9	9.2	0.0	0.1	0.9	0.0	0.0	0.1	1.3	0.2	2.6	14.1	0.0	0.0	1.9	0.0	0.3	53.3	2.0	0.3	5.1	0.2	102.8	0.8	0.1	0.0	0.7	0.0	0.0	1.9	2.3	1.0	2.1	0.8	1.8	4.7	0.2	0.7	2.1	9.0	0.6	0.1	0.0	9.4	0.5	0.2	0.0	1.6	1.0	0.6	0.0	1.9	51.6	0.3	0.3	1.0	0.6	0.4	0.9	0.1	0.0	0.5
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300489-40317813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.2;pituitary gland: 108.1"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 295.4;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 128.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 3.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 3.2"	"Group enriched"	"Detected in many"	4	"HDLM-2: 98.6;Hep G2: 27.6;HMC-1: 90.3;THP-1: 105.0"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	Nucleoplasm	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	2.2	3.4	42.6	3.7	71.5	10.9	5.9	58.9	51.1	12.1	21.6	6.5	5.8	5.0	1.7	1.6	11.4	8.5	2.2	38.2	49.7	24.6	0.9	4.3	5.9	65.9	74.1	1.3	2.3	21.0	108.1	1.1	66.2	13.7	3.1	23.1	16.3	24.2	0.2	4.6	10.4	1.4	52.0	9.8	16.5	2.6	58.6	1.8	12.2	0.3	3.1	12.1	2.0	86.2	12.0	0.3	1.8	0.8	2.6	1.3	7.8	0.0	0.0	0.6	1.3	0.4	6.8	3.4	10.0	0.3	0.0	2.0	0.1	0.0	0.3	98.6	1.4	2.0	0.8	27.6	1.5	0.9	90.3	4.8	0.0	0.1	0.0	0.7	0.0	1.5	0.1	19.8	0.0	2.7	1.2	2.1	2.2	0.0	1.2	2.3	0.0	6.9	0.0	14.3	1.4	2.3	0.1	11.8	1.3	6.6	15.0	105.0	0.1	0.0	11.6	0.2	0.4	1.4	0.2	3.4	1.0	12.3	0.6	0.0	0.1	3.2	0.0	0.2	0.0	0.2	0.1	0.0	1.2	0.2	0.0	0.0	0.5	0.2	0.3	0.1	0.1	0.0	42.6	71.5	58.9	51.1	38.2	49.7	65.9	74.1	66.2	52.0	58.6	86.2	0.5	0.0	3.3	26.1	10.8	1.0	3.0	8.5	0.0	2.0	7.1	9.7	1.0	7.2	10.0	25.8	0.0	3.2	2.5	7.2	0.0	11.7	0.2	13.6	0.9	0.6	12.7	0.4	0.3	0.8	0.6	2.1	26.0	20.0	26.1	1.6	1.1	0.0	3.4	0.0	0.3	6.6	2.0	0.3	22.4	0.9	2.1	6.4	1.8	3.7	22.1	295.4	1.0	62.4	128.1	4.9	9.6	0.0	4.0	6.1	5.0	0.3	12.9	10.9	0.0	1.3	1.8	3.4	6.2	0.2	0.6	1.4	2.7	1.8	13.4	13.4
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119108455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 65.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.9;Hepatic stellate cells: 10.4;Inhibitory neurons: 5.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 3.4;SK-BR-3: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		30000000		"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.6	0.1	0.4	0.4	65.7	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	10.9	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	10.4	0.4	0.3	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.8	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.2;liver: 143.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 37.4;Hepatic stellate cells: 89.3;Peritubular cells: 52.3;Proximal tubular cells: 127.1;Sertoli cells: 72.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 135.7;SH-SY5Y: 111.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA035241	Uncertain				"Secreted to blood"	NA	NA		130000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	13.8	40.6	1.0	0.9	1.0	1.9	3.3	4.8	1.9	1.8	6.9	2.8	3.5	1.2	0.4	1.6	4.4	54.2	46.6	1.4	0.9	24.8	143.1	2.4	1.9	1.3	0.5	46.4	13.8	1.2	5.8	2.4	1.3	3.3	0.6	0.5	0.6	1.1	0.6	1.4	3.8	1.1	0.4	3.8	3.1	7.4	1.1	4.0	17.0	0.8	0.2	7.1	1.0	1.3	0.2	1.4	0.7	2.5	0.0	0.0	11.7	0.7	0.0	0.3	0.2	0.7	0.2	0.3	4.0	0.1	0.4	0.4	0.1	0.4	0.3	0.2	0.8	0.6	1.4	5.0	135.7	0.2	1.0	1.6	0.1	0.2	0.0	0.4	0.1	0.8	11.1	0.8	0.0	0.1	0.0	0.8	0.6	0.2	0.9	0.0	0.0	0.5	0.0	0.3	2.1	111.7	1.6	1.1	0.8	0.3	0.5	1.0	0.0	0.0	0.7	0.6	0.5	3.2	26.2	1.5	0.3	1.3	0.6	0.7	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.9	0.3	0.1	0.2	0.1	0.0	1.0	1.0	4.8	1.9	1.4	0.9	1.3	0.5	1.3	0.4	1.1	1.3	7.3	0.0	0.0	0.7	0.6	1.0	0.0	0.0	2.8	0.5	0.1	0.3	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	17.6	0.0	0.3	1.1	22.0	4.2	0.0	0.0	2.2	0.0	1.4	37.4	0.0	0.6	0.0	1.3	89.3	7.9	2.5	0.0	0.9	0.1	0.0	1.9	0.3	0.5	7.5	0.8	3.6	1.0	0.0	1.4	0.0	0.5	0.2	0.1	0.0	52.3	0.0	0.2	0.0	127.1	0.0	0.1	72.3	0.3	18.0	1.3	11.6	0.6	0.9	1.2	0.7	27.0	0.0	0.1
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 77.6;heart muscle: 65.3;skin 1: 80.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 859.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (9.08e-5)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (6.95e-4)"	77.6	0.2	0.0	1.1	0.2	0.0	11.0	1.3	0.2	7.5	0.0	2.3	0.0	4.6	7.6	9.5	1.2	16.1	65.3	0.0	0.0	5.2	0.3	8.0	3.6	0.3	0.1	0.4	2.8	2.2	0.4	8.2	0.1	10.2	0.0	0.0	14.1	6.7	18.0	80.6	0.9	12.1	0.3	0.3	2.5	14.9	0.0	0.1	10.3	0.6	0.3	6.5	22.7	0.1	0.0	0.0	0.0	0.0	178.4	0.4	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	859.6	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.3	0.0	0.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.2	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.1	3.2	0.5	0.0	0.0	11.5	0.6	19.3	0.0	1.4	0.3	0.3	0.8	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	37.0	2.8	3.7	1.0	0.0	0.0	0.1	0.2	0.2	32.0	0.0	32.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	1.3	0.0	0.0	10.7	75.3	0.9	0.7	10.6	0.0	0.1	1.6	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.7	0.4	6.6	2.4	4.2	16.8	1.6	0.0	7.1	0.5	1.0	0.0	0.2	0.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
COPA	HEP-COP	ENSG00000122218	"COPI coat complex subunit alpha"	P53621	1	160288594-160343273	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		150000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	47.7	43.1	46.6	38.5	48.9	30.0	42.0	57.2	57.1	52.9	67.4	42.3	53.7	46.7	55.1	38.3	41.2	38.6	55.1	48.6	53.7	48.6	55.0	47.0	36.1	57.9	51.0	46.9	49.9	51.8	59.8	48.3	60.0	43.5	47.9	26.2	57.6	39.4	59.1	40.0	49.0	50.0	53.9	42.7	43.5	24.4	51.1	37.6	60.1	38.2	38.9	41.3	37.9	66.4	91.0	68.5	70.1	66.9	164.9	154.7	78.6	116.5	144.3	103.1	138.7	72.0	60.5	64.4	73.3	194.0	57.7	86.0	92.0	81.3	126.5	68.6	64.3	76.8	95.2	79.0	115.1	94.1	74.5	134.8	49.1	140.0	128.9	126.3	126.4	64.4	71.9	69.7	124.4	43.6	49.3	53.3	80.1	97.3	79.0	49.2	89.2	118.9	94.3	94.7	62.1	84.3	157.3	109.2	148.0	115.0	140.4	133.9	162.8	84.3	54.1	108.2	80.2	106.8	76.3	106.6	104.2	51.3	122.8	48.1	39.0	25.4	18.6	36.7	25.5	17.8	16.7	21.3	40.4	14.2	14.3	17.9	10.9	26.7	36.2	17.8	22.9	35.5	46.6	48.9	57.2	57.1	48.6	53.7	57.9	51.0	60.0	53.9	51.1	66.4	53.6	76.9	54.7	44.7	66.4	28.2	35.5	41.6	29.6	52.4	53.0	41.3	51.8	42.9	49.7	40.5	81.3	41.0	83.2	66.8	13.7	49.9	14.7	50.7	68.1	50.4	55.3	37.0	77.6	49.6	63.3	66.2	65.2	64.3	45.6	63.0	52.8	71.1	51.2	45.4	73.8	83.8	30.5	93.7	58.0	6.4	71.1	84.3	26.6	67.5	75.0	41.0	38.1	65.9	178.9	55.5	48.1	56.8	115.9	52.9	98.9	41.4	66.2	53.7	39.5	57.6	52.4	37.6	25.7	35.8	31.8	69.2	58.3	58.1	66.6	61.2
COPB1	COPB	ENSG00000129083	"COPI coat complex subunit beta 1"	P53618	11	14443440-14500027	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	48.1	47.1	19.9	55.0	21.8	79.8	62.6	26.2	25.3	64.9	44.7	59.8	57.7	52.6	69.3	46.7	49.2	54.9	43.7	20.1	23.6	65.3	73.6	49.9	59.1	24.2	21.8	49.1	59.2	67.6	48.4	69.2	23.7	66.9	67.1	39.3	67.5	53.8	33.1	36.6	58.8	61.1	23.5	46.3	59.7	46.8	23.0	68.1	81.0	38.1	64.5	60.4	40.0	27.6	134.9	113.6	118.6	89.4	193.1	221.3	95.9	199.2	206.5	173.1	202.0	89.1	203.5	130.1	87.1	252.9	164.6	144.7	134.6	133.3	212.1	122.7	114.0	138.3	74.3	135.8	171.3	128.9	134.4	156.3	172.4	116.0	217.8	158.9	183.7	71.6	104.5	103.8	221.1	101.6	117.2	78.7	61.7	163.3	123.1	94.9	163.1	89.0	156.1	123.3	75.6	81.2	154.2	123.2	104.8	135.5	112.3	110.1	189.5	166.2	85.4	181.3	110.1	55.2	100.5	143.8	125.1	79.2	158.6	52.8	38.7	43.5	45.7	47.8	55.7	38.4	38.1	47.6	52.3	32.0	37.8	39.8	31.2	44.6	49.8	31.1	44.8	43.2	19.9	21.8	26.2	25.3	20.1	23.6	24.2	21.8	23.7	23.5	23.0	27.6	55.6	109.0	63.2	29.0	64.3	38.9	59.7	82.6	52.3	28.4	43.0	27.9	31.3	35.8	107.8	44.1	27.1	65.4	71.2	55.9	41.1	77.1	17.2	72.6	81.4	55.5	43.8	50.9	36.9	81.7	69.6	70.5	63.2	72.5	65.2	50.7	51.4	58.1	60.9	18.5	39.1	87.5	61.1	50.7	43.5	10.7	51.0	61.5	21.4	35.6	70.1	34.0	44.3	32.6	49.6	93.6	37.5	55.3	107.4	54.3	60.6	57.3	131.9	29.5	52.6	60.8	78.7	87.5	64.3	48.7	35.8	117.0	77.0	49.3	51.5	60.7
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"COPI coat complex subunit beta 2"	P35606	3	139353946-139389736	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		63000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	46.7	58.2	17.9	50.5	19.7	22.3	60.4	20.4	21.0	76.5	35.9	62.5	57.4	48.5	62.5	55.0	47.5	48.4	47.9	17.4	21.8	52.9	71.1	44.3	44.8	20.5	18.9	38.9	89.7	68.2	60.0	68.9	20.4	72.2	71.7	37.0	71.1	57.0	33.5	37.4	53.4	63.5	20.8	42.8	60.7	35.0	20.2	54.4	64.3	31.2	61.5	56.2	42.2	25.0	192.1	84.0	111.2	99.0	247.2	214.9	96.8	223.9	235.9	158.2	204.7	143.4	83.5	90.2	203.0	287.1	145.1	110.9	136.2	141.0	210.6	139.0	85.2	138.2	114.9	152.3	152.7	121.9	139.7	160.1	114.7	132.2	138.5	178.6	161.6	76.5	86.7	105.7	199.4	138.6	59.4	59.7	102.2	215.0	99.5	75.8	93.6	149.5	141.2	133.4	85.2	61.7	254.6	212.0	147.2	168.6	193.2	123.2	185.1	90.3	66.4	122.8	83.7	148.0	80.8	129.7	115.2	61.0	138.0	74.4	49.8	52.0	36.0	56.3	35.8	35.3	31.0	37.6	57.7	23.8	24.2	31.1	45.0	44.1	57.2	30.2	38.1	44.2	17.9	19.7	20.4	21.0	17.4	21.8	20.5	18.9	20.4	20.8	20.2	25.0	36.6	57.7	46.6	18.3	45.8	19.6	39.5	61.2	29.6	38.0	41.3	29.3	58.5	32.9	74.5	20.2	31.3	83.3	34.9	52.4	41.1	83.4	40.8	64.9	62.9	45.2	63.9	51.1	25.1	82.1	76.1	66.6	75.4	54.8	45.0	50.4	36.4	48.5	52.7	42.1	25.5	86.7	46.8	34.6	21.3	8.6	54.7	42.8	21.4	13.1	60.1	62.0	29.9	20.1	30.8	79.7	34.8	50.0	118.6	46.6	46.9	42.4	108.6	51.1	19.7	47.3	69.6	83.1	45.6	36.5	14.9	133.1	37.5	74.4	44.7	52.9
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COPG2	2-COP	ENSG00000158623	"COPI coat complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 50.6;Oligodendrocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045712: AB_2679428"	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.1	21.3	17.0	9.3	16.2	12.4	20.3	3.2	14.1	13.2	2.6	12.2	9.3	16.5	17.0	14.6	19.1	12.7	15.8	15.5	30.9	12.3	9.1	9.8	9.3	9.7	16.2	39.3	9.6	25.8	13.9	15.8	11.5	11.9	13.8	28.1	9.5	14.3	17.3	20.8	8.7	13.9	6.3	9.8	9.7	24.5	33.5	15.6	18.3	14.4	15.2	12.7	12.1	8.8	44.2	24.8	44.7	22.5	19.3	34.2	11.6	20.2	30.5	33.2	32.2	15.4	23.8	30.4	16.6	26.3	36.7	21.9	15.0	38.0	43.3	33.2	31.1	31.0	12.1	22.2	30.6	40.9	27.6	27.5	18.9	27.0	41.1	32.2	31.7	30.5	50.3	8.8	42.6	44.2	39.6	31.9	56.4	29.2	19.9	37.9	58.6	18.2	40.2	57.9	34.3	49.4	42.1	38.9	32.7	37.3	25.3	13.2	28.1	29.8	15.4	25.0	30.2	19.4	25.4	35.2	33.2	33.3	26.3	1.2	1.5	2.6	0.7	1.4	0.6	1.6	0.7	0.5	1.8	0.8	0.7	0.6	0.4	0.8	2.0	0.7	0.7	0.7	17.0	16.2	3.2	14.1	15.5	30.9	9.7	16.2	11.5	6.3	33.5	8.8	4.9	0.0	2.0	23.2	6.5	9.1	7.7	9.4	7.4	13.8	8.8	6.3	5.1	5.7	8.3	14.7	14.6	18.5	4.5	4.1	11.7	9.5	3.5	7.6	6.4	5.5	2.4	5.0	42.9	24.1	13.4	6.5	7.1	4.8	1.3	11.6	11.7	5.0	9.0	5.0	50.6	7.0	6.1	10.7	7.5	2.3	5.9	7.8	8.8	22.5	9.9	9.3	2.1	39.7	52.0	9.2	2.2	6.8	6.8	3.5	2.8	8.1	9.2	13.1	13.1	9.9	7.5	18.6	26.5	11.0	10.1	22.4	6.0	9.6	7.1	6.8
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 301.4;Paneth cells: 324.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 221.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		960000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	54.4	56.4	20.2	29.7	23.8	20.3	53.4	23.4	27.0	55.7	21.1	70.2	62.9	72.8	14.6	80.2	54.2	44.1	26.1	19.4	22.7	48.2	47.2	53.7	41.9	28.0	23.6	42.7	52.5	24.6	35.1	31.2	25.1	71.0	34.5	6.6	73.2	39.6	13.0	42.4	62.3	36.7	24.2	66.0	77.1	13.9	25.1	21.1	55.8	9.9	18.4	58.3	53.5	26.3	80.9	81.4	37.5	76.0	94.1	81.3	56.6	58.5	118.0	94.2	70.8	134.1	116.0	6.4	111.3	80.8	95.8	67.9	41.9	74.9	16.8	19.4	40.7	54.9	47.3	57.9	148.1	2.3	120.8	110.6	66.3	80.1	37.2	59.7	120.7	49.4	42.7	9.2	54.2	238.4	14.4	11.2	47.7	198.2	73.4	11.2	41.0	14.9	62.6	104.3	40.7	50.8	52.4	139.6	181.6	26.0	178.5	63.0	92.2	63.4	47.4	87.4	35.2	1.6	3.3	14.6	103.4	8.2	66.4	57.3	102.8	8.0	10.9	212.9	8.3	20.0	37.6	14.6	79.0	11.0	21.2	11.4	47.8	11.9	221.8	60.8	55.2	57.8	20.2	23.8	23.4	27.0	19.4	22.7	28.0	23.6	25.1	24.2	25.1	26.3	58.7	3.2	2.2	4.6	53.4	27.9	60.1	90.8	40.9	13.0	53.8	39.0	1.6	50.1	66.4	47.8	8.4	87.8	39.2	301.4	60.7	111.4	8.9	43.6	32.9	52.0	99.0	19.8	1.8	105.0	229.8	35.8	111.1	64.8	28.0	46.7	47.8	22.4	251.8	15.2	2.4	188.6	81.4	138.6	66.4	5.0	39.4	96.3	71.2	10.3	195.3	30.0	41.2	4.5	6.8	136.9	324.9	34.6	64.3	55.6	263.5	84.0	41.2	14.6	52.6	22.1	55.1	8.1	6.6	47.6	31.0	150.5	100.3	54.8	128.0	74.5
CORO1C	"coronin-3, HCRNN4"	ENSG00000110880	"Coronin 1C"	Q9ULV4	12	108645109-108731526	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041737	Approved					NA	NA		13000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA041737: AB_10804115"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.90e-3)"	68.5	30.6	36.1	49.7	36.1	52.5	36.6	28.1	36.8	49.9	22.1	116.6	28.9	96.1	24.1	67.7	55.9	54.4	33.7	41.3	39.1	25.8	49.1	76.4	31.6	43.9	37.1	30.4	13.0	36.4	22.0	48.2	39.0	35.8	53.3	10.5	24.6	67.3	30.0	52.1	42.9	142.9	38.3	26.1	45.0	22.5	40.8	47.4	14.2	23.6	33.6	71.5	44.7	53.4	188.2	207.2	274.3	140.8	137.3	186.5	117.3	347.8	372.0	443.2	353.6	245.8	81.5	10.6	88.8	547.9	173.2	85.4	153.3	255.1	558.1	82.8	71.4	313.8	95.3	192.7	123.8	76.6	154.1	173.7	120.3	501.0	376.9	262.3	234.1	51.8	157.0	101.0	473.6	68.4	34.7	90.5	70.5	68.7	197.9	53.3	158.6	121.9	176.0	122.5	75.0	66.3	115.6	16.0	156.6	173.0	83.0	58.0	263.7	316.1	165.1	297.7	296.8	99.4	245.7	232.8	246.3	64.0	215.5	42.3	70.7	32.0	7.4	78.1	3.5	24.6	2.9	4.5	75.7	19.1	1.0	3.3	81.9	12.6	75.2	75.9	7.5	44.7	36.1	36.1	28.1	36.8	41.3	39.1	43.9	37.1	39.0	38.3	40.8	53.4	24.5	54.5	20.7	18.3	27.8	138.0	168.2	47.7	66.0	7.1	18.2	14.1	19.0	18.6	34.6	12.9	2.1	28.4	39.1	41.3	3.9	59.7	58.9	33.6	47.2	51.9	30.9	25.5	32.8	22.7	125.3	38.4	20.4	39.1	41.8	43.3	17.2	49.8	122.2	15.2	39.7	23.4	16.2	71.0	181.4	56.4	22.4	108.8	90.7	37.5	81.7	6.7	8.2	46.3	42.6	76.9	29.8	58.6	31.6	92.8	19.0	30.1	10.5	5.3	13.1	42.8	53.2	26.8	22.9	60.6	167.8	46.8	12.0	9.9	30.7	93.2
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565596-84618078	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.2;lymphoid tissue: 374.3"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1402.6;Hofbauer cells: 595.3;Kupffer cells: 1015.5;Langerhans cells: 1146.3;Macrophages: 1046.2;monocytes: 949.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 2441.1;eosinophil: 3418.8;intermediate monocyte: 4072.1;myeloid DC: 2395.7;neutrophil: 1758.0;non-classical monocyte: 4579.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2395.7;granulocytes: 3418.8;monocytes: 4579.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 1271.3"	"Low region specificity"	"Detected in all"							"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	87.8	36.8	65.8	296.0	82.1	273.2	54.2	80.6	67.4	31.7	57.7	68.7	90.4	46.7	12.1	32.4	49.5	75.2	25.1	68.8	82.8	140.5	44.6	110.6	374.3	87.5	80.5	24.1	30.3	32.4	47.4	78.0	86.6	44.5	66.0	44.4	24.9	28.5	10.9	20.4	104.8	66.6	78.0	330.5	126.5	20.5	101.5	88.6	38.0	12.2	263.5	118.4	28.3	86.4	546.3	445.0	994.2	1058.1	111.5	305.0	299.5	462.0	295.8	355.8	136.6	609.1	818.7	149.6	137.6	349.7	211.7	266.8	61.3	364.1	355.1	1.1	77.9	281.9	87.7	162.7	314.0	320.1	1069.3	245.6	57.6	344.2	305.0	222.2	172.2	326.4	26.5	60.5	215.3	88.3	99.1	191.7	123.1	178.5	448.8	10.4	33.7	9.3	529.2	227.5	156.7	7.9	430.7	101.9	238.8	116.9	77.1	256.7	445.9	509.0	290.2	165.8	341.4	11.5	58.1	123.7	397.7	154.1	1271.3	740.1	2441.1	3418.8	69.9	4072.1	92.5	546.6	441.0	417.2	2395.7	279.2	192.6	229.6	1758.0	667.2	4579.3	123.7	685.2	2954.6	65.8	82.1	80.6	67.4	68.8	82.8	87.5	80.5	86.6	78.0	101.5	86.4	44.0	3.2	12.2	20.5	331.8	63.5	116.5	7.5	27.3	10.4	22.2	32.9	5.1	17.2	6.2	77.3	244.0	136.4	104.5	47.0	39.2	73.0	6.8	17.6	74.5	94.4	145.6	78.4	6.8	34.5	1402.6	59.9	181.0	29.8	141.8	126.0	189.2	6.6	595.3	25.2	14.1	77.8	2.0	1015.5	1146.3	10.8	8.1	1046.2	96.0	39.4	949.1	31.5	74.2	27.6	2.1	108.2	19.8	16.1	130.1	165.3	52.8	305.3	4.5	43.2	6.6	15.4	75.7	5.1	39.5	9.2	38.2	172.8	354.9	11.9	140.2	179.6
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938083	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		530000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	175.6	176.7	187.1	105.1	189.5	148.5	150.8	231.1	258.1	109.8	201.3	454.2	326.9	98.2	110.7	293.0	89.3	67.8	1749.5	193.1	229.3	373.5	349.6	133.0	125.6	216.1	207.5	71.1	259.3	385.3	141.1	88.0	208.8	118.4	398.2	194.1	211.2	99.2	1609.7	169.0	269.6	95.0	194.8	150.8	306.8	217.8	220.4	150.7	141.5	1735.8	197.9	141.2	146.3	193.8	300.4	309.1	376.8	331.1	227.2	260.2	443.1	262.7	222.3	317.7	294.8	346.0	352.1	700.0	322.0	219.5	387.8	567.7	898.3	368.4	263.7	401.0	906.2	566.6	299.7	436.0	283.9	642.7	335.0	266.6	389.9	198.3	445.1	217.4	377.7	450.0	522.2	429.9	321.2	222.4	558.8	494.6	408.7	575.8	540.1	499.0	369.7	778.4	469.8	472.4	570.5	250.1	396.6	569.2	871.3	407.6	286.3	507.6	274.3	241.4	238.7	303.9	421.1	508.4	1000.3	759.0	258.2	836.1	224.5	332.4	361.5	210.2	198.1	465.6	238.6	296.4	242.4	235.7	452.9	227.3	171.6	198.0	87.4	354.9	432.7	365.2	372.6	426.4	187.1	189.5	231.1	258.1	193.1	229.3	216.1	207.5	208.8	194.8	220.4	193.8	120.7	99.3	119.6	20.5	166.6	158.2	235.3	623.6	151.4	113.4	202.6	313.4	1645.3	221.6	324.0	171.0	39.6	502.8	162.7	987.6	1475.2	407.5	1046.3	199.4	124.3	163.8	461.4	227.3	18.9	436.7	528.2	156.3	247.2	192.8	104.0	143.3	117.8	471.8	571.5	92.5	25.1	890.5	496.4	286.0	209.1	819.6	100.3	238.6	250.8	17.8	413.7	159.9	162.7	15.6	20.2	412.1	817.3	85.7	350.7	319.3	1276.3	921.7	242.7	176.8	92.1	139.6	590.9	523.0	253.6	371.3	159.0	511.0	144.2	216.5	1045.6	393.3
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648323-35658782	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 2453.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004192	Supported		Supported	Mitochondria		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	322.3	211.6	733.9	206.6	741.0	465.2	371.1	780.8	935.9	291.0	758.1	598.9	427.0	197.2	633.9	410.0	329.7	245.8	1284.7	749.3	761.3	519.5	582.3	201.7	316.0	768.3	740.1	241.1	292.4	850.2	169.9	222.3	757.0	249.2	690.0	276.5	356.6	328.6	1467.0	264.7	351.3	342.8	735.4	193.3	336.8	107.0	759.7	426.3	270.5	2453.4	510.5	402.2	205.1	747.2	480.3	1219.5	479.2	649.4	665.5	701.3	455.3	383.4	641.0	684.8	686.4	1018.3	478.0	555.8	663.1	656.6	413.4	341.7	836.5	700.6	683.5	632.0	570.1	929.4	626.6	1014.1	521.1	835.0	454.9	800.2	906.5	619.5	361.1	606.3	690.4	577.8	616.9	783.0	714.9	1019.4	589.2	626.8	357.0	2445.6	811.5	502.1	525.9	930.4	1567.1	1035.9	434.4	484.5	615.9	1049.3	393.4	568.5	419.6	892.9	365.9	363.8	398.0	382.3	605.6	450.5	683.3	776.7	470.9	695.0	472.7	1138.1	1099.7	998.5	628.9	1228.5	607.0	1150.2	854.9	732.8	1140.2	956.3	839.9	744.3	1115.9	672.8	1178.4	1176.1	1138.3	2058.8	733.9	741.0	780.8	935.9	749.3	761.3	768.3	740.1	757.0	735.4	759.7	747.2	324.6	243.6	227.3	27.4	409.4	427.1	436.6	1071.1	373.3	143.5	498.4	615.2	2710.8	664.8	529.6	698.9	64.6	623.0	361.5	1496.0	2985.6	711.7	328.0	427.4	293.2	312.6	625.7	436.5	21.2	808.9	735.5	360.9	484.2	397.2	280.8	277.9	338.8	1270.7	1041.1	89.2	27.9	1277.1	736.5	800.2	705.9	942.4	327.7	582.7	748.8	18.7	807.7	351.1	435.6	16.1	31.6	863.0	1445.3	273.1	523.2	548.7	2291.0	2228.5	445.5	193.3	263.0	293.8	454.2	175.7	186.6	784.8	565.6	670.7	373.1	229.1	1277.5	717.0
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	13.0	2.3	17.9	2.2	18.1	0.9	20.8	18.7	29.8	70.2	129.2	13.0	9.8	14.8	0.0	5.6	8.3	1.1	39.2	17.5	33.0	9.5	1871.4	13.4	18.9	28.1	20.3	0.8	6.5	3.9	28.6	3.4	24.9	7.9	16.4	246.5	39.9	0.9	2.6	13.0	20.8	2.4	19.2	23.1	3.0	1.5	20.1	0.5	16.1	8.3	20.0	23.9	2.3	29.0	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.1	18.7	29.8	17.5	33.0	28.1	20.3	24.9	19.2	20.1	29.0	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.6;skin 1: 57.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		390000		"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	5.0	4.4	0.4	0.4	0.4	0.1	3.5	0.5	1.7	15.3	0.5	0.0	0.0	0.2	0.3	21.6	0.4	0.1	1.1	0.6	2.1	0.6	0.1	0.4	0.2	1.1	0.7	0.1	12.7	0.0	0.5	2.0	1.1	0.2	0.0	0.2	6.7	0.0	0.3	57.1	0.2	0.8	0.6	3.3	0.4	0.3	1.2	0.8	0.0	0.0	0.9	0.0	12.6	1.1	95.3	5.0	0.3	0.3	0.7	1.5	0.1	74.6	140.1	74.9	18.5	0.7	8.1	0.1	14.3	31.9	75.2	5.5	0.0	41.3	76.7	0.4	0.3	0.0	33.3	2.1	1.8	0.3	0.2	1.0	65.2	6.7	9.4	261.0	0.3	0.1	0.0	0.2	284.2	0.2	0.0	0.0	0.8	0.4	11.1	0.3	75.4	0.1	34.5	4.0	0.2	0.0	49.9	23.3	0.5	28.0	0.5	0.4	57.3	18.1	151.0	6.2	7.4	0.2	0.2	0.1	272.7	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.5	1.7	0.6	2.1	1.1	0.7	1.1	0.6	1.2	1.1	0.0	3.2	0.5	0.0	0.0	17.7	0.5	23.7	0.6	0.0	4.2	2.8	0.3	0.0	8.5	0.0	0.0	5.6	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.3	0.0	0.0	0.4	54.1	1.2	11.5	0.0	2.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.3	3.6	1.0	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	0.9	0.0	0.1	2.9	0.0	0.0	1.3	0.4	0.1	0.7	10.0	31.0	9.4	0.1	0.0	0.0	1.6
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1970	"pancreas: 226925.8"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 7306.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		88000000	"Cluster 17: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	15.7	83.0	0.4	5.1	1.7	2.5	78.3	0.6	1.4	6.0	0.1	2.6	31.2	4.7	0.3	3.5	1.8	0.1	40.8	0.6	0.8	2.0	7.1	1.7	8.1	1.0	1.2	115.1	226925.8	0.0	2.1	13.7	1.1	4.7	4.5	0.0	36.3	0.0	2.2	2.8	17.2	0.0	0.4	19.2	28.3	2.9	1.2	0.1	1.6	0.0	0.0	1.4	2.0	3.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	4.0	0.3	0.5	1.3	0.4	0.9	0.4	0.5	1.1	0.1	0.7	0.3	1.4	1.9	1.4	0.5	0.5	0.3	0.4	0.4	1.7	0.6	1.4	0.6	0.8	1.0	1.2	1.1	0.4	1.2	3.3	2.2	0.0	0.0	1.0	0.0	0.6	0.5	0.0	0.0	0.0	8.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.6	11.2	0.0	0.1	1.1	164.9	1.3	0.3	7306.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	1.0	2.5	0.6	1.5	0.0	0.0	18.1	0.0	0.0	0.0	29.8	590.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	4.2	2.5	0.0	1.1	0.1	0.3	0.3	0.3	1.1	0.2	0.2
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1484.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.5	0.1	3.1	0.7	0.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	4.8	0.0	0.5	1.4	0.4	1484.1	17.6	0.1	1.7	2.0	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.6	1.8	0.5	1.4	1.7	2.0	2.5	0.3	2.2	5.1	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 156.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 16.6;monocytes: 21.0"	"Group enriched"	"Detected in many"	4	"ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		7100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	156.1	11.5	6.4	14.4	13.3	3.5	40.2	10.1	10.5	14.4	3.8	33.5	4.4	23.9	0.9	10.1	16.2	16.1	4.6	7.6	10.2	41.3	26.5	59.3	16.1	19.3	11.5	18.0	13.0	12.0	1.0	70.1	11.9	14.7	26.6	6.7	4.1	2.8	5.8	21.7	5.9	6.4	7.5	19.4	15.3	5.4	28.0	4.3	7.5	9.7	10.5	9.3	5.7	23.5	0.1	4.0	0.1	0.0	71.1	50.0	0.7	9.8	1.1	1.7	2.3	3.2	4.1	0.5	9.6	1.4	4.1	0.0	1.4	2.7	4.1	0.1	2.7	0.0	15.1	0.3	0.4	1.2	1.9	91.2	0.6	1.0	2.0	8.6	0.0	0.3	0.0	0.1	7.3	1.7	0.0	0.7	1.7	0.0	5.2	3.1	0.6	0.0	7.2	5.9	0.4	0.2	68.9	10.7	7.9	5.5	1.2	26.5	0.2	1.2	7.5	0.5	0.2	0.4	0.5	13.1	4.3	13.1	5.9	0.6	21.0	0.1	0.2	14.5	0.0	1.8	1.5	0.1	16.6	3.5	0.9	0.2	1.6	0.5	7.4	1.1	1.9	7.3	6.4	13.3	10.1	10.5	7.6	10.2	19.3	11.5	11.9	7.5	28.0	23.5	83.3	359.0	362.2	34.6	4.9	12.4	3.5	6.1	0.6	3.3	7.8	8.9	2.6	135.8	70.1	51.5	0.0	32.3	1.1	97.5	29.4	57.9	16.6	100.9	8.3	29.0	10.8	3.6	1.2	212.5	59.9	14.1	4.6	237.1	112.5	6.7	73.9	36.6	134.6	0.0	1.3	28.7	0.0	368.5	36.3	17.5	105.0	202.2	10.6	19.7	23.3	68.9	1.0	23.1	161.8	68.0	65.9	79.0	2.4	38.7	1.9	63.7	16.4	5.7	762.6	7.2	126.9	0.6	3.9	2.4	9.9	172.4	14.5	46.3	32.7	2.8
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 81.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 141.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 15: Hepatocytes - Hemostasis"						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.6	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 218.6"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.0	0.7	0.4	0.6	1.5	0.2	0.6	1.1	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.7	0.8	14.7	218.6	0.2	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.4	0.2	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.7	0.8	0.2	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514435-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		71000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	35.4	29.3	14.6	22.4	17.4	76.6	42.3	23.0	15.0	40.7	24.3	35.0	32.1	33.2	21.4	73.6	32.0	30.1	52.4	15.5	19.2	51.5	46.2	33.8	39.5	15.3	17.6	39.2	29.7	52.1	11.8	25.5	17.3	41.2	34.2	18.2	37.1	29.9	17.5	36.3	30.8	31.7	16.4	28.4	30.1	8.3	16.2	38.5	60.9	26.4	46.5	34.9	25.5	21.8	135.1	46.8	30.9	40.9	116.9	92.1	24.6	63.3	93.3	51.9	58.2	30.4	44.5	36.7	40.6	77.6	31.6	101.2	68.7	67.5	92.5	39.5	52.1	6.0	27.2	34.7	41.0	2.3	1.5	63.0	71.2	57.6	76.0	83.1	64.6	17.6	33.2	68.4	65.0	51.6	65.9	1.8	10.5	110.6	64.4	30.7	28.9	174.4	67.4	92.2	66.2	51.5	55.4	249.3	39.6	35.7	95.0	10.3	69.3	44.5	44.1	61.3	49.4	47.0	63.3	9.9	66.0	12.6	42.9	28.6	32.6	54.3	33.2	38.1	26.2	26.4	27.5	23.8	63.1	26.9	23.8	26.1	46.5	27.6	52.5	62.2	20.9	32.0	14.6	17.4	23.0	15.0	15.5	19.2	15.3	17.6	17.3	16.4	16.2	21.8	84.1	137.8	103.9	23.2	52.0	81.8	110.6	111.8	96.2	16.2	80.2	73.9	120.2	75.8	89.3	69.9	14.6	73.0	85.4	49.4	99.7	77.9	1.6	66.9	73.5	66.3	50.2	28.4	37.0	83.7	55.1	92.6	48.9	83.5	8.2	44.7	66.4	103.9	50.4	45.4	39.9	55.3	81.4	71.0	93.8	4.5	85.7	64.0	53.4	13.1	75.0	75.6	36.0	58.3	24.5	59.3	51.7	87.6	49.4	112.5	53.3	126.1	78.8	17.4	59.2	102.1	77.4	3.2	8.8	183.2	91.1	78.0	55.2	71.4	75.1	91.8
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36839444	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4;heart muscle: 92.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6"	"Cancer enhanced"	"Detected in all"		"glioma: 11.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 62.4"	"Group enriched"	"Detected in some"	80	"memory B-cell: 51.6;naive B-cell: 26.8"	"Lineage enriched"	"Detected in single"	105	"B-cells: 51.6"	"Group enriched"	"Detected in some"	5	"Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 135.5"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	6.4	0.9	16.6	10.7	62.4	1.4	2.3	0.0	29.5	3.9	0.0	6.2	5.6	5.8	1.0	2.4	19.9	2.0	92.7	23.0	2.7	4.5	0.8	2.6	23.6	0.0	4.6	6.6	1.0	0.4	11.0	1.4	0.0	5.8	5.0	2.8	3.5	2.5	0.5	1.8	8.6	4.7	1.1	20.0	5.1	25.3	0.8	2.3	3.3	0.2	28.1	4.9	5.7	13.3	0.9	0.0	0.5	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.5	0.0	0.2	59.4	0.5	0.8	2.7	0.4	0.1	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.7	0.0	4.1	25.7	0.2	0.2	1.7	0.5	0.0	0.0	0.4	0.1	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.5	0.1	0.0	0.0	5.3	0.3	0.0	0.8	5.9	0.4	0.7	0.0	2.1	19.7	17.1	28.1	0.3	6.5	0.1	0.0	0.1	0.0	0.0	0.2	0.2	51.6	0.2	0.0	0.1	26.8	0.0	0.0	0.4	0.0	0.2	0.3	0.0	4.5	16.6	62.4	0.0	29.5	23.0	2.7	0.0	4.6	0.0	1.1	0.8	13.3	2.8	0.0	3.6	1.3	50.6	0.6	0.2	0.2	0.0	13.4	0.3	0.5	30.0	0.0	0.0	0.0	0.0	0.0	1.5	15.1	1.9	0.0	3.3	0.4	0.8	7.4	4.2	0.0	35.1	0.2	0.0	2.8	1.5	1.4	12.6	0.3	5.0	1.0	0.4	0.0	8.6	1.8	0.0	1.9	0.6	4.8	0.0	6.2	3.6	2.8	0.2	1.3	2.1	36.7	0.8	0.5	12.5	0.4	89.6	0.2	2.3	0.1	0.0	1.6	0.0	2.3	1.0	0.8	1.5	1.1	0.1	0.0	2.0	0.2	1.7	0.4
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.3;retina: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031636, HPA076665"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"			"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	0.2	0.2	42.1	0.2	37.7	0.2	0.0	20.0	41.1	0.2	12.2	1.5	2.5	0.2	0.3	1.7	0.3	0.0	0.2	54.3	24.9	7.0	2.1	0.1	0.0	31.4	23.2	0.1	0.0	0.0	8.0	0.0	32.7	2.8	0.5	16.4	0.0	12.3	0.1	0.4	3.4	0.3	20.8	0.0	0.4	0.5	31.3	0.1	0.2	0.1	0.0	0.7	0.4	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	37.7	20.0	41.1	54.3	24.9	31.4	23.2	32.7	20.8	31.3	26.0	0.0	0.0	0.0	15.3	0.0	0.1	0.0	0.0	0.0	26.3	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	6.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.4	0.2	0.0	0.0	0.0	18.1	0.6	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.3	6.5	2.4	0.0	3.8	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645242-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 225.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 150.2;Oligodendrocytes: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 250.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	46.2	35.9	22.6	25.4	33.9	31.8	34.7	28.0	26.7	75.1	20.6	39.6	29.3	46.0	36.2	25.9	39.8	57.8	51.8	21.6	27.0	80.5	70.0	32.3	22.8	32.6	27.5	87.4	46.7	60.7	25.6	39.2	33.2	40.2	33.1	16.8	32.8	54.2	13.3	20.6	35.0	64.7	25.9	31.3	32.1	13.9	30.3	8.2	225.9	33.2	17.0	46.3	38.6	38.6	0.6	2.1	2.1	0.1	116.1	131.4	0.5	35.3	55.6	12.8	26.5	2.0	0.9	0.4	27.2	59.0	15.7	1.0	2.4	2.8	12.0	31.4	4.4	28.4	1.5	17.7	25.6	4.9	37.0	69.6	6.5	15.0	3.7	108.2	6.0	0.1	27.1	97.0	29.4	1.2	0.5	14.1	2.5	0.2	5.2	4.3	0.0	0.6	26.7	13.2	2.4	0.3	10.2	0.4	28.2	25.8	12.3	28.6	21.3	51.9	4.9	0.8	11.5	7.9	0.9	0.3	32.2	21.6	33.5	32.0	71.3	45.1	27.3	49.6	27.6	5.4	20.3	24.0	51.8	7.4	17.6	24.6	250.5	25.9	47.5	14.8	22.2	40.6	22.6	33.9	28.0	26.7	21.6	27.0	32.6	27.5	33.2	25.9	30.3	38.6	46.6	12.8	12.5	150.2	11.7	19.4	25.7	21.3	9.6	12.7	12.1	27.9	27.2	42.9	13.9	47.8	29.2	12.1	40.8	9.3	17.6	22.7	5.0	6.6	43.3	27.1	13.8	7.2	24.0	10.7	1.8	123.8	10.7	8.6	38.0	43.1	51.0	48.3	54.0	10.1	31.3	7.9	24.4	56.0	44.9	9.0	72.4	39.4	78.2	131.2	33.7	43.4	39.1	44.7	299.6	11.7	9.5	73.0	11.9	12.4	42.4	56.0	9.7	16.3	52.6	71.1	67.8	5.6	3.4	2.8	13.1	6.0	23.8	38.6	12.2	13.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1063.2"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000		"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.5	0.4	1.0	0.4	10.0	0.1	1.5	4.9	1.7	0.9	0.1	0.8	211.8	1.6	2.8	1.5	0.9	1.6	1.2	0.7	2.3	1.9	1063.2	1.0	0.3	6.9	8.7	2.9	0.8	0.1	0.9	2.5	6.0	0.8	0.4	0.3	0.5	0.8	0.6	1.4	123.4	2.1	3.4	1.2	0.6	6.0	5.8	0.3	1.7	0.5	0.2	0.6	0.7	6.3	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.0	4.9	1.7	0.7	2.3	6.9	8.7	6.0	3.4	5.8	6.3	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409335	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA065167: AB_2685426, HPA068906: AB_2686055"	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	39.1	52.0	16.2	11.0	16.6	20.4	45.5	15.9	23.3	53.5	16.2	54.8	27.4	48.8	3.8	49.2	49.1	9.0	44.9	15.9	14.9	52.2	76.3	43.3	12.3	16.8	14.9	56.6	88.6	6.1	78.0	6.8	17.1	61.7	4.2	5.2	49.6	7.6	41.0	55.3	68.1	5.7	14.6	70.5	68.9	132.0	15.6	15.0	52.9	5.2	6.8	41.2	44.0	16.2	21.4	29.4	26.3	27.7	13.8	11.0	25.7	19.6	12.4	15.8	16.3	29.8	27.0	24.6	18.7	14.8	10.7	19.1	14.9	16.7	4.4	22.2	43.0	48.3	37.4	48.6	11.7	18.6	28.8	12.1	6.9	14.5	8.5	9.5	21.2	40.1	41.1	20.4	8.0	90.7	48.8	38.6	15.9	17.9	41.0	34.7	10.6	19.9	17.0	31.1	21.3	21.1	25.4	15.7	14.8	7.4	27.9	20.5	18.4	10.8	41.3	23.9	22.3	12.1	10.2	23.3	14.6	31.0	13.1	3.8	5.1	3.3	4.8	6.1	5.1	4.0	5.2	5.1	5.7	4.8	4.5	4.3	0.9	4.0	6.2	2.6	6.7	4.2	16.2	16.6	15.9	23.3	15.9	14.9	16.8	14.9	17.1	14.6	15.6	16.2	10.1	16.0	22.5	10.1	9.5	10.1	4.0	6.6	6.2	9.6	15.1	16.9	8.3	20.0	10.7	9.2	12.5	10.1	14.5	26.4	1.9	9.5	19.5	9.6	7.8	11.7	13.1	15.8	9.4	11.5	11.5	10.7	21.9	11.8	14.0	20.7	8.9	8.1	15.1	8.4	6.9	28.6	8.2	12.4	12.4	40.4	14.0	11.7	14.2	3.7	11.9	5.0	10.3	5.5	6.5	10.5	8.8	16.1	17.9	4.1	24.0	6.2	11.7	14.4	6.6	7.7	9.0	36.5	23.1	12.2	12.4	7.3	11.5	7.6	30.3	4.3
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121969-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	14.8	14.5	7.3	24.9	9.7	11.5	11.8	9.3	10.1	13.7	13.0	16.1	14.7	15.0	15.0	18.3	11.7	15.0	13.1	6.8	8.9	13.6	19.7	14.7	21.0	9.5	9.2	12.6	14.9	18.2	10.7	16.7	10.6	15.6	16.8	13.9	13.6	14.1	27.1	11.1	14.4	17.8	8.5	18.6	17.4	26.0	8.5	27.3	18.3	25.6	24.8	16.6	12.3	12.2	48.1	46.9	47.0	48.6	23.9	21.1	69.5	60.7	59.0	55.1	54.3	41.4	64.9	51.3	38.9	65.1	37.2	69.2	65.2	55.2	79.2	83.3	22.4	75.4	46.1	39.5	70.5	76.3	60.6	34.7	46.2	52.5	93.8	36.5	52.2	54.5	68.8	62.9	62.1	69.6	88.3	26.8	53.3	76.8	42.3	86.0	72.7	45.9	37.5	67.1	51.7	34.7	71.7	39.9	51.1	41.9	82.9	47.4	56.3	43.9	27.7	33.4	52.4	37.6	66.2	103.0	53.0	58.9	69.7	16.6	12.9	9.3	7.8	11.7	10.4	7.6	6.9	8.4	11.3	4.0	6.1	8.6	4.4	11.1	9.8	7.3	12.1	9.5	7.3	9.7	9.3	10.1	6.8	8.9	9.5	9.2	10.6	8.5	8.5	12.2	14.2	28.9	31.8	23.2	22.9	10.3	15.2	15.1	15.9	12.7	13.4	9.5	27.1	10.0	25.5	7.3	29.2	24.0	19.8	14.6	13.7	18.0	28.2	24.3	30.0	22.9	13.8	33.0	13.6	24.0	22.7	20.0	17.3	16.8	30.4	26.2	20.7	27.2	24.8	11.8	17.5	17.3	12.2	32.9	8.8	11.2	19.0	31.1	3.6	19.7	41.2	16.9	27.8	18.6	27.9	23.8	14.0	23.0	35.4	29.9	12.5	16.3	34.1	22.7	32.9	19.6	23.2	61.7	41.3	27.2	12.8	25.3	22.8	26.6	18.2	20.2
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 110.0;Hepatocytes: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		45000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	24.3	27.7	16.0	22.3	18.4	38.9	22.7	20.2	17.3	20.4	32.0	67.4	70.7	25.1	7.3	22.0	25.4	27.7	25.4	14.7	17.7	38.4	67.9	25.3	15.9	20.6	22.0	18.3	23.6	27.6	14.3	18.4	19.3	20.3	44.6	22.6	26.0	21.9	9.9	17.0	71.3	34.9	15.9	27.4	35.6	13.5	22.1	14.0	15.4	14.3	12.3	18.7	18.0	13.9	29.4	50.9	7.3	48.6	31.2	28.0	2.1	22.9	18.8	17.7	3.6	2.0	96.0	0.1	82.2	60.4	62.2	93.5	63.9	13.6	5.3	46.8	6.3	71.5	52.3	24.0	46.4	41.9	82.6	29.2	6.6	35.5	21.4	24.1	63.5	28.2	7.6	56.8	16.5	83.6	34.4	73.7	0.8	149.7	53.2	94.7	1.2	127.1	41.7	71.7	1.0	31.8	63.0	119.9	20.2	4.8	107.4	40.0	64.5	38.3	0.9	77.7	33.5	43.9	60.1	29.2	40.3	30.3	42.8	8.2	6.6	9.5	7.3	7.7	4.2	1.9	4.4	4.4	4.4	2.0	2.7	5.5	3.2	4.9	6.7	10.4	2.8	2.7	16.0	18.4	20.2	17.3	14.7	17.7	20.6	22.0	19.3	15.9	22.1	13.9	44.4	38.5	28.8	35.6	13.5	9.4	11.0	9.0	28.5	4.8	9.6	7.6	25.5	22.8	18.0	23.9	64.6	15.9	39.3	110.0	19.6	13.8	14.7	33.2	22.6	30.4	16.2	30.9	5.6	9.5	3.9	16.6	31.1	56.7	29.7	23.0	40.7	108.3	15.7	1.7	5.7	48.9	10.2	39.1	11.5	43.9	9.6	24.6	0.0	28.1	31.4	12.7	23.7	7.1	1.7	8.5	43.4	32.0	28.6	9.6	83.4	11.8	23.8	43.0	39.5	18.3	21.1	14.5	10.0	14.8	7.7	7.8	24.0	17.3	67.4	9.2
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 174.0"	"Group enriched"	"Detected in some"	17	"B-cells: 54.9;Plasma cells: 14.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.1;stomach cancer: 5.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.0;JURKAT: 4.0;MOLT-4: 13.4;RPMI-8226: 4.7"	"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced					NA	NA		220000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favorable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	2.0	0.0	0.1	53.1	0.1	0.8	0.6	0.0	0.2	0.0	0.0	5.1	0.9	0.4	0.0	0.7	0.1	2.0	0.1	0.2	0.0	6.2	0.4	1.1	174.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.1	1.1	4.0	0.0	4.3	0.0	0.2	0.0	16.7	0.4	0.0	73.2	6.9	0.5	0.1	15.2	0.8	0.0	171.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	13.4	0.0	2.1	0.0	0.3	0.0	0.2	4.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	17.5	1.0	0.6	0.0	20.3	2.4	2.2	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 544.1;thyroid gland: 173.2"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.9	1.7	14.2	2.5	24.8	0.2	56.1	25.6	26.4	1.3	28.5	6.9	0.8	2.3	2.0	0.6	0.3	1.6	0.4	9.6	39.6	15.5	0.0	0.7	0.2	61.7	62.6	0.4	0.7	0.0	27.6	15.0	58.4	2.6	1.7	544.1	1.1	47.4	0.2	26.7	5.0	1.8	23.8	75.2	7.1	0.5	86.2	1.7	173.2	0.2	1.2	0.6	2.5	13.7	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	24.8	25.6	26.4	9.6	39.6	61.7	62.6	58.4	23.8	86.2	13.7	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs cell polarity complex component 1"	P82279	1	197268204-197478455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.3;retina: 74.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 7.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	8	"HeLa: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Secreted in brain"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	0.1	0.1	15.7	0.0	17.6	0.4	0.1	19.8	20.5	0.0	9.6	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.2	15.8	14.2	0.1	0.0	0.1	0.1	18.7	18.4	0.7	0.4	0.0	2.2	0.0	17.5	0.0	0.0	74.7	0.0	0.0	0.7	0.0	0.0	0.0	18.9	0.0	0.2	2.9	16.1	0.0	0.2	0.5	0.0	0.0	0.0	21.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.7	17.6	19.8	20.5	15.8	14.2	18.7	18.4	17.5	18.9	16.1	21.3	0.0	0.0	0.0	469.5	0.0	0.3	0.2	0.3	0.0	15.0	0.2	0.1	1.1	0.0	0.2	0.0	164.7	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.7	0.0	11.6	53.2	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.7	130.1	0.0	2.0	0.0	0.5	1.6	1.8	0.0	0.0	24.4	0.0	79.7	0.0	280.0	105.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	149.3	0.0	0.2	0.1	1.8	0.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880713	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	17.4	10.6	5.8	17.1	5.2	52.9	16.8	25.4	11.5	20.9	3.7	18.8	12.5	26.5	12.4	16.5	22.4	16.6	14.4	5.9	3.1	12.0	14.3	15.9	17.6	8.9	6.8	37.3	29.7	18.5	11.3	16.9	2.9	16.1	14.1	13.8	17.2	16.2	29.6	21.0	16.4	19.6	0.4	21.0	16.3	33.2	7.9	29.1	23.3	28.9	20.7	16.6	16.5	6.4	12.3	31.0	39.3	17.4	23.5	23.1	20.4	17.4	28.9	29.2	28.2	28.2	22.4	33.7	20.1	33.3	18.7	23.2	45.7	14.2	32.9	57.5	18.5	26.6	29.2	17.9	26.0	26.9	36.5	20.7	14.2	32.5	38.9	18.0	22.3	17.0	30.9	44.8	16.0	42.0	17.9	13.0	32.3	11.7	12.7	83.4	31.1	26.1	11.2	16.2	32.6	21.5	29.5	28.7	16.8	25.3	25.6	25.9	34.7	35.5	35.2	18.4	16.0	20.8	24.3	63.7	7.2	15.8	25.6	1.9	1.1	0.9	1.7	1.5	0.8	3.7	0.8	1.3	0.7	2.1	0.8	1.1	6.7	1.4	2.9	1.5	0.8	0.9	5.8	5.2	25.4	11.5	5.9	3.1	8.9	6.8	2.9	0.4	7.9	6.4	48.1	44.8	51.6	91.1	38.3	56.2	31.0	16.0	27.3	34.2	34.4	25.7	41.2	40.0	28.0	11.0	25.0	17.4	50.1	31.2	5.9	20.9	43.0	37.2	56.4	35.7	15.0	33.4	88.7	20.3	11.3	39.5	32.1	63.5	30.4	53.1	32.5	29.5	20.9	28.6	89.8	25.3	18.3	44.0	42.8	80.2	56.5	49.0	17.8	87.1	52.5	34.5	43.3	111.6	101.2	27.5	19.5	51.1	35.6	39.8	25.2	10.9	28.2	17.6	46.0	75.8	44.9	35.1	42.2	34.6	58.8	30.8	44.2	36.2	24.6	44.2
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176376-66178464	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 137.2"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 160.6"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enriched"	"Detected in many"	6	"medulla oblongata: 137.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons: 25.1"						"Secreted to blood"	NA	NA	10000			"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"								"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	1.5	0.2	5.6	0.0	2.2	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	9.6	0.0	0.0	0.0	0.0	137.2	9.8	0.0	1.6	0.7	0.2	6.6	16.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	23.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.2	0.0	5.4	1.3	9.6	137.2	9.8	16.9	0.2	23.0	1.5	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	31.5	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	160.6	0.0	0.0	0.0	0.1
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76953045-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 166.5"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 480.8;Hepatic stellate cells: 1319.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		69000000		"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	22.2	13.7	4.1	0.7	5.6	3.2	6.2	3.2	7.5	3.7	2.2	0.4	0.6	2.6	0.9	0.2	1.8	0.8	7.4	5.8	15.8	36.5	166.5	0.5	0.9	7.0	9.1	1.3	0.1	0.6	0.1	10.2	11.9	1.1	0.4	0.1	1.1	4.1	0.9	0.5	0.7	1.5	3.7	37.2	0.3	0.8	20.1	0.5	4.1	1.3	0.6	0.9	0.8	7.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	4.4	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	7.6	4.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.1	5.6	3.2	7.5	5.8	15.8	7.0	9.1	11.9	3.7	20.1	7.0	134.9	0.0	0.0	1.3	8.8	0.4	0.0	0.0	0.0	0.0	0.4	1.1	0.7	17.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	45.9	0.0	39.4	0.8	0.2	0.2	0.3	0.0	0.0	0.0	480.8	1319.7	9.9	1.8	0.0	32.4	0.0	0.0	75.0	2.1	1.0	0.3	3.8	0.0	4.7	0.3	0.0	0.0	0.5	11.1	0.0	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.0	0.1	2.3	0.5	1.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 980.8;Endometrial ciliated cells: 1761.1;Proximal enterocytes: 2548.8;Respiratory ciliated cells: 1702.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 699.8;CAPAN-2: 415.5;HaCaT: 464.1;HDLM-2: 329.5;OE19: 1305.8;T-47d: 586.0"									HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"		NA	NA		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	265.2	21.7	19.2	61.1	19.7	29.4	180.8	20.0	36.4	147.4	20.3	133.9	121.7	108.0	206.6	118.7	118.2	28.1	262.6	18.5	20.3	109.7	17.8	254.6	83.9	26.9	29.1	49.8	18.3	21.2	41.5	28.3	24.6	49.6	55.4	0.2	135.7	87.9	44.7	301.1	312.5	42.4	24.7	94.5	94.2	14.3	21.0	79.6	182.1	50.2	135.7	113.7	98.9	20.3	0.0	699.8	4.8	0.6	12.1	8.3	66.8	1.3	0.4	9.0	0.1	21.0	415.5	228.0	2.4	191.0	2.6	464.1	0.1	0.0	0.0	329.5	0.0	17.7	294.7	116.3	1.8	0.1	0.2	3.8	0.0	23.1	0.0	0.9	0.5	64.6	0.5	0.9	0.0	3.7	8.1	1.6	7.4	1305.8	36.4	181.3	0.0	45.5	0.0	0.0	18.5	1.3	2.6	1.2	0.0	0.5	586.0	106.4	1.5	0.4	0.4	5.5	0.0	0.3	0.2	17.9	0.0	0.0	0.6	121.8	218.6	313.1	209.2	214.4	135.1	697.0	442.0	222.1	442.9	384.2	85.4	100.2	13.9	323.5	283.9	291.3	694.8	465.6	19.2	19.7	20.0	36.4	18.5	20.3	26.9	29.1	24.6	24.7	21.0	20.3	50.2	980.8	256.2	0.3	350.7	186.5	1.2	79.5	67.2	0.0	88.1	18.3	1.0	2.8	501.3	51.5	0.0	2.1	287.8	360.4	1.9	20.5	3.6	1761.1	124.5	86.4	76.5	27.3	0.0	3.1	4.3	313.3	210.0	491.9	521.5	0.1	24.7	1.3	52.2	0.0	0.0	243.1	30.5	168.0	577.3	26.2	25.1	523.7	370.0	1.9	461.4	0.2	83.4	0.0	0.1	34.2	659.2	9.4	584.3	0.7	2548.8	2.5	1702.1	0.0	223.5	8.2	448.0	1.0	11.4	29.4	251.6	1.5	524.7	0.1	190.7	3.0
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727376-49744437	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 1203.8;salivary gland: 2310.0"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"neutrophil: 2.5;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	19	"granulocytes: 2.5;monocytes: 1.2"	"Group enriched"	"Detected in some"	20	"HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		420000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.3	0.6	0.0	0.0	0.0	381.8	3.9	0.0	0.0	61.0	0.0	0.1	0.4	1.7	0.1	266.8	1203.8	23.1	0.8	0.0	0.0	0.1	0.9	1.3	0.0	0.0	0.0	0.5	5.5	0.0	0.5	0.6	0.0	2.9	0.0	0.0	2310.0	111.9	0.3	3.9	0.2	0.0	0.0	2.5	0.3	0.2	0.0	0.3	0.2	0.0	4.0	4.7	140.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	9.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	2.1	5.6	0.0	21.5	13.1	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	182.2	47.2	0.8	0.0	0.4	0.0	3.7	0.0	0.2	0.0	551.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	26.8
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984505-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 29.4"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA		8200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	2.7	1.3	3.9	2.5	4.0	1.5	29.4	3.4	3.1	6.3	3.4	2.7	0.7	8.6	4.9	5.0	7.4	10.0	8.8	4.3	8.0	2.1	2.1	2.3	2.8	5.8	10.4	5.7	2.4	19.3	1.2	7.8	8.3	24.6	1.6	3.1	19.3	2.6	0.5	2.3	1.2	7.0	6.3	2.0	0.9	3.8	4.1	9.4	15.1	1.2	1.1	2.5	1.1	10.7	0.0	1.7	134.4	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.9	0.8	0.0	0.0	19.0	0.0	2.2	0.1	11.3	0.1	0.0	0.1	5.2	0.2	5.1	0.0	3.0	0.0	1.0	7.2	0.3	0.1	1.0	16.6	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.2	13.9	0.0	5.0	0.0	18.5	0.2	0.0	0.0	0.8	72.0	0.0	0.1	8.0	27.5	10.4	6.4	0.0	3.8	19.6	0.2	0.5	2.4	0.9	0.0	4.6	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.9	4.0	3.4	3.1	4.3	8.0	5.8	10.4	8.3	6.3	4.1	10.7	1.0	3.2	0.0	12.7	0.0	0.8	6.1	1.4	17.6	1.6	10.3	36.1	0.4	0.0	5.4	1.8	0.0	22.7	0.3	0.0	0.0	0.0	15.3	62.2	4.9	3.2	0.0	3.0	15.7	0.0	3.8	9.2	0.0	22.4	3.8	1.8	23.6	0.1	2.0	0.0	11.1	0.0	0.0	0.9	0.0	1.5	4.1	0.4	7.2	1.9	0.0	8.8	0.0	81.4	0.9	0.0	0.0	1.5	0.0	9.4	0.0	0.2	22.5	0.9	0.0	0.4	1.5	1.3	6.0	2.5	1.0	12.0	0.4	6.3	0.0	2.3
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917407-20953747	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 344.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.7	14.8	34.5	18.4	34.9	53.7	16.3	34.6	35.7	17.5	26.0	18.4	22.0	19.4	13.0	26.6	20.4	14.3	25.1	33.7	33.5	17.1	27.3	20.7	25.5	36.8	37.0	27.4	23.5	19.1	16.1	25.9	34.0	16.5	19.6	22.4	14.8	19.0	54.3	24.9	19.7	19.5	38.8	22.4	14.7	13.3	38.9	33.3	14.8	43.0	27.6	18.9	18.4	36.0	43.9	25.8	56.7	44.8	37.5	23.9	61.0	29.0	35.5	43.7	49.1	42.8	19.2	56.1	22.9	30.8	30.0	54.8	67.2	46.3	51.7	47.7	65.5	77.7	28.6	47.3	37.4	83.5	38.0	24.3	60.3	38.1	64.6	35.7	39.1	44.3	344.9	44.8	35.7	41.2	49.0	39.0	44.8	45.5	27.7	62.7	89.9	13.5	29.2	37.8	36.5	46.9	48.6	42.4	36.4	67.7	36.4	45.9	31.9	69.0	77.8	26.2	37.2	42.7	44.4	64.1	51.1	34.8	43.3	16.2	15.0	22.1	18.5	13.9	19.3	12.1	16.2	18.4	16.5	11.4	19.7	18.9	15.9	12.9	26.1	8.3	14.4	21.2	34.5	34.9	34.6	35.7	33.7	33.5	36.8	37.0	34.0	38.8	38.9	36.0	11.8	9.6	17.8	17.3	18.6	54.2	13.5	15.2	29.6	17.8	19.7	14.2	23.1	7.2	12.2	5.5	14.6	19.6	26.4	19.6	1.9	7.7	30.4	19.3	15.3	15.0	20.4	28.6	23.9	8.6	42.4	16.5	10.2	18.4	1.3	15.8	20.7	25.0	17.5	18.5	18.6	19.9	8.2	19.5	20.8	52.5	15.2	15.2	24.9	9.4	19.0	17.5	21.6	16.6	25.0	11.2	11.8	15.4	14.1	19.0	18.5	10.7	14.8	13.2	13.1	15.7	12.1	12.7	11.0	40.2	60.4	27.2	17.8	12.7	18.5	18.6
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	7.5	4.9	3.5	21.5	3.2	20.6	7.0	10.5	4.4	7.6	0.2	7.8	6.1	5.3	2.8	12.8	4.9	7.5	4.3	4.5	2.7	4.2	5.4	9.1	35.5	1.8	1.9	4.3	4.4	7.9	4.7	12.6	2.4	4.7	7.9	9.5	5.9	3.8	3.8	11.1	9.7	6.5	1.3	23.4	6.6	10.3	3.7	33.4	4.3	4.4	32.7	11.0	8.0	3.0	11.3	12.2	7.5	15.6	13.4	10.3	11.1	10.4	10.1	19.8	20.6	13.5	7.4	36.8	15.2	13.0	19.3	19.2	12.8	8.6	23.6	17.6	23.3	15.7	9.9	10.3	7.4	21.0	11.2	6.1	11.8	16.0	13.4	7.4	19.4	32.9	40.1	37.6	12.6	6.8	46.6	21.8	14.9	18.7	7.4	20.0	24.2	22.2	13.1	9.4	5.3	12.5	10.6	16.1	11.6	15.6	12.5	10.3	10.4	11.4	13.9	18.5	25.8	15.7	14.2	24.9	10.9	16.6	12.9	53.7	57.9	139.9	37.0	59.5	39.3	46.7	52.2	42.4	43.0	46.8	99.9	75.6	117.3	40.3	72.1	22.0	63.7	84.5	3.5	3.2	10.5	4.4	4.5	2.7	1.8	1.9	2.4	1.3	3.7	3.0	10.4	0.0	12.5	17.6	50.9	22.6	8.0	5.4	16.5	17.9	7.0	4.3	4.5	2.8	4.6	7.3	14.6	18.7	36.2	9.2	5.9	5.1	13.5	6.1	8.4	10.6	3.6	46.9	54.8	5.3	17.6	7.7	13.3	9.1	22.8	5.5	8.9	4.2	16.8	6.7	56.5	3.9	8.2	26.1	25.0	21.3	6.5	26.7	5.4	42.2	39.9	4.7	47.4	38.7	38.0	9.1	3.4	4.1	25.7	8.4	2.6	5.3	8.9	25.2	13.1	9.2	7.5	27.5	27.3	11.4	27.8	45.8	47.1	5.3	4.2	7.8
CRNKL1	"CLF, Clf1, CRN, SYF3"	ENSG00000101343	"Crooked neck pre-mRNA splicing factor 1"	Q9BZJ0	20	20034368-20056046	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"				"unprognostic (5.43e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-2)"	8.5	8.3	7.3	9.7	9.2	23.7	16.2	12.1	8.1	11.2	6.8	10.2	10.2	13.0	10.3	10.1	9.8	8.1	9.7	7.0	7.9	11.9	11.2	7.8	12.2	7.6	7.7	14.7	6.7	14.9	5.8	11.5	8.2	14.0	11.3	9.8	8.2	10.6	16.6	9.0	9.9	11.2	8.2	10.5	10.1	11.3	7.6	13.9	12.9	15.3	12.2	9.7	7.1	12.1	21.2	26.0	20.1	24.2	18.7	19.5	26.9	18.9	18.2	23.9	22.9	17.5	19.6	20.7	14.0	20.0	31.4	29.1	24.1	25.3	29.0	10.5	12.2	20.5	8.0	37.1	15.2	24.6	46.5	15.8	14.5	25.9	15.7	16.9	18.8	23.1	22.0	24.9	22.9	32.5	28.2	18.8	18.4	34.3	26.2	23.8	49.8	28.4	14.2	14.7	30.0	22.0	25.8	42.2	27.2	19.2	35.6	18.5	17.0	18.8	15.1	18.3	21.0	33.7	35.4	22.2	9.4	13.6	16.7	37.2	13.8	32.0	13.8	15.3	16.6	14.8	15.9	15.2	10.8	14.4	14.8	13.2	37.7	22.4	23.7	9.8	17.5	11.7	7.3	9.2	12.1	8.1	7.0	7.9	7.6	7.7	8.2	8.2	7.6	12.1	20.1	22.4	15.1	6.2	23.3	9.3	8.9	11.7	12.5	11.9	19.6	12.7	19.2	18.6	20.5	14.7	12.5	19.8	32.3	17.0	9.8	22.8	11.7	39.7	37.9	16.9	20.4	24.4	8.1	18.5	17.1	18.3	23.0	40.5	35.5	26.5	15.0	19.6	19.4	16.8	7.7	30.2	12.2	18.4	7.6	5.7	20.2	18.3	3.6	5.6	23.3	17.2	19.6	8.0	10.0	19.7	12.7	18.8	30.3	8.3	17.7	18.3	24.8	16.3	26.3	21.7	20.8	62.5	36.9	18.0	8.9	20.1	25.4	22.0	14.9	13.0
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9388.5"	"Group enriched"	"Detected in some"	16	"Ductal cells: 1087.7;Hepatocytes: 4142.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	3.4	0.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	3.1	0.0	0.5	0.4	111.7	0.7	0.0	0.0	0.7	9388.5	0.5	0.1	0.0	0.0	0.4	118.5	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.6	0.5	0.0	0.0	6.1	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.8	0.0	11.7	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1087.7	1.4	0.0	0.1	6.3	0.0	163.2	0.0	63.2	0.0	0.0	0.0	0.2	0.0	0.0	89.6	4142.7	0.1	0.0	0.0	0.0	0.0	98.8	0.3	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.6;fallopian tube: 38.2;lung: 50.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008175	Enhanced				"Secreted to extracellular matrix"	NA	NA		550000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favorable (1.51e-4)"	4.4	0.8	8.7	1.1	23.7	0.0	2.4	10.9	20.1	6.4	0.9	11.5	0.5	1.3	3.8	8.3	38.2	0.3	10.6	9.1	8.1	4.3	0.4	50.0	0.4	45.1	10.2	0.7	1.3	0.8	5.3	0.0	45.6	2.3	0.4	11.3	3.4	33.6	1.1	4.1	2.3	0.8	12.6	0.1	1.8	3.9	18.5	0.2	4.7	1.5	0.3	30.2	4.9	15.5	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	3.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.7	1.1	0.5	0.0	7.7	0.3	0.0	0.0	9.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	23.7	10.9	20.1	9.1	8.1	45.1	10.2	45.6	12.6	18.5	15.5	1.9	22.4	119.5	2.9	0.0	1.5	2.7	1.3	5.7	10.1	2.6	2.8	7.1	1.5	36.4	9.2	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.5	0.1	8.8	1.8	0.0	22.9	0.7	0.0	2.3	0.0	0.6	5.1	0.0	5.7	0.1	0.0	0.0	63.6	0.0	0.0	0.6	0.9	0.6	0.0	0.2	8.8	2.8	0.0	14.1	0.0	54.8	6.2	0.6	0.0	0.4	1.2	1.3	0.0	0.0	0.9	5.3	0.0	3.5	0.3	1.5	1.9	13.1	0.4	0.0	0.4	0.0	0.0	1.7
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246859-29254494	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 2.1"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 1.1;Syncytiotrophoblasts: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 3.2;BEWO: 4.1;SuSa: 1.0"	"Group enriched"	"Detected in some"	7	"hippocampal formation: 2.7;hypothalamus: 1.2;thalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA022016	Supported					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	0.1	0.7	0.1	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.4	0.6	0.2	0.3	0.9	0.4	0.9	0.3	0.8	2.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.1	0.0	0.0	0.0
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618027	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 9.6"	"Cell type enriched"	"Detected in some"	21	"Hofbauer cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 10.3;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 10.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 43.3;RPMI-8226: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003448, CAB010058"	Supported					NA	NA		89000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB010058: AB_668166, HPA003448: AB_2732396"	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	1.3	1.6	1.5	0.9	1.6	0.6	0.6	1.6	2.4	0.6	1.3	0.5	0.4	0.3	9.6	0.4	0.4	1.2	0.4	1.6	1.6	0.2	0.4	0.5	1.2	1.9	1.8	0.2	0.2	0.3	0.5	3.3	2.3	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.4	0.9	1.9	1.6	0.3	0.3	2.2	0.4	0.2	0.2	0.5	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.3	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	0.0	82.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.2	0.5	0.0	0.0	0.7	0.2	1.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	10.3	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.5	7.5	0.0	0.0	0.6	1.5	1.6	1.6	2.4	1.6	1.6	1.9	1.8	2.3	1.9	2.2	2.1	0.1	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.1	1.3	0.0	0.0	0.2	82.6	0.0	0.2	0.0	0.0	3.5	0.8	0.6	0.0	2.8	1.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.2	0.0	0.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 331.0;liver: 282.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 160.0;Distal tubular cells: 226.9;Hepatocytes: 200.6;Proximal tubular cells: 526.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	19.8	34.2	19.2	12.9	19.8	2.2	39.0	19.3	36.0	54.6	54.2	21.4	51.2	40.8	120.6	29.0	50.0	68.9	45.6	21.6	23.3	331.0	282.9	32.4	24.4	21.3	24.9	31.6	64.6	52.9	17.0	16.8	24.4	38.8	22.0	15.3	25.0	56.9	25.1	22.2	44.0	40.1	21.1	19.4	25.1	9.2	24.5	33.9	44.5	23.0	23.8	40.8	21.7	24.9	12.1	112.2	57.6	16.3	64.4	70.2	38.6	36.5	57.1	51.8	57.4	88.9	46.1	64.9	62.0	71.3	92.2	31.0	47.2	46.0	83.6	75.2	19.2	27.0	32.2	179.0	33.8	23.1	52.6	33.1	40.0	82.8	15.1	49.1	43.7	35.9	85.9	22.8	109.2	27.0	42.3	38.6	43.1	93.6	72.6	26.8	53.6	23.7	439.4	36.0	15.9	27.9	8.5	60.1	41.2	64.3	54.0	7.7	21.9	12.3	30.7	38.8	55.7	16.2	33.3	32.1	99.4	9.0	35.6	13.1	9.4	1.9	32.1	15.1	26.2	32.8	31.6	30.3	17.1	26.5	27.4	29.5	1.5	30.3	17.9	14.4	42.3	18.8	19.2	19.8	19.3	36.0	21.6	23.3	21.3	24.9	24.4	21.1	24.5	24.9	6.9	28.9	22.6	4.9	20.4	17.8	28.0	32.4	24.5	4.0	16.8	16.8	32.3	84.4	15.7	160.0	2.1	13.5	8.6	6.6	226.9	53.8	0.2	54.8	7.8	8.0	6.7	8.4	4.5	32.4	18.1	20.7	20.9	27.0	14.5	7.8	12.8	200.6	18.5	0.0	4.4	12.0	8.2	15.7	13.7	2.1	20.8	11.4	10.6	4.7	7.1	7.7	11.3	7.1	9.1	31.2	14.5	20.7	20.5	10.2	79.1	526.6	17.3	2.9	0.0	10.6	16.2	1.7	7.4	19.7	21.2	7.3	16.9	13.8	16.2	17.0
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300391	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 550.1;tongue: 600.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		670000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	154.2	93.6	29.2	61.7	30.0	111.0	66.3	33.7	49.9	55.4	40.5	110.1	97.7	56.4	32.2	95.6	58.3	42.4	319.3	30.9	34.6	86.6	39.0	58.0	67.2	39.4	32.0	56.0	61.5	127.6	28.9	45.7	39.4	59.0	124.1	128.9	73.7	60.5	550.1	70.5	81.2	77.5	22.5	49.0	66.5	24.4	41.0	69.4	53.0	600.7	106.1	70.2	58.2	31.6	168.9	176.8	141.6	198.2	188.4	173.8	93.3	136.9	132.0	231.1	160.6	271.2	158.2	322.9	128.2	172.6	99.3	182.1	396.8	200.8	234.9	109.3	200.2	222.9	136.1	261.4	107.3	288.4	166.6	188.2	201.6	182.4	232.0	202.2	268.6	163.7	233.2	193.7	214.7	160.8	229.8	121.9	117.5	128.0	247.8	222.3	167.1	247.6	166.2	194.6	189.3	125.2	175.2	251.7	157.7	137.5	297.6	174.3	178.3	127.1	165.3	167.4	147.4	124.5	200.4	206.2	120.4	206.4	119.5	59.6	73.3	205.7	47.0	93.0	61.9	60.6	56.5	45.1	119.3	51.8	59.2	47.9	31.3	51.6	94.0	65.6	63.4	71.2	29.2	30.0	33.7	49.9	30.9	34.6	39.4	32.0	39.4	22.5	41.0	31.6	14.5	16.0	39.5	32.3	31.6	39.0	23.5	26.9	46.7	22.8	38.3	29.7	239.9	15.7	21.5	12.9	62.6	18.5	24.1	66.9	35.2	32.5	6.6	25.1	31.5	27.2	16.9	36.0	21.5	45.1	31.3	25.8	42.3	53.5	27.9	21.3	18.9	29.7	34.3	10.1	24.6	43.9	20.3	39.4	35.0	4.8	20.2	34.6	10.6	9.4	44.8	16.7	16.5	18.6	18.8	44.6	35.7	19.9	46.7	33.1	50.4	22.0	14.9	38.3	13.1	27.8	38.2	29.7	25.8	74.8	52.1	16.8	25.8	32.0	71.3	34.5
CSAD	"CSD, PCAP"	ENSG00000139631	"Cysteine sulfinic acid decarboxylase"	Q9Y600	12	53157663-53180925	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in all"		"ASC diff: 84.5;T-47d: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039487	Approved				"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA039487: AB_10672776"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (1.57e-1)"	"unprognostic (7.99e-2)"	"prognostic favorable (6.33e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.46e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (4.59e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.81e-6)"	68.0	28.3	24.3	15.9	25.4	39.1	62.4	25.2	25.7	54.9	33.8	34.3	17.3	31.2	52.3	29.3	41.5	19.2	25.2	24.0	24.5	39.2	101.7	30.8	19.1	26.1	23.0	54.0	35.9	14.9	40.9	13.0	24.8	50.3	16.0	16.8	34.7	19.8	19.6	59.6	28.5	19.6	20.2	37.5	31.9	27.7	24.7	14.2	36.0	7.7	14.1	25.8	37.6	36.7	3.7	6.8	16.0	6.8	84.5	34.4	5.7	14.5	3.2	6.0	5.0	4.1	8.8	4.9	10.6	7.7	2.0	12.6	7.1	11.2	3.5	6.6	8.6	7.8	19.4	8.8	7.6	3.3	4.9	42.6	13.8	9.0	11.2	30.8	5.6	10.4	8.4	42.8	5.7	30.8	1.8	9.2	3.1	1.9	6.3	6.6	1.0	11.4	8.0	9.6	8.0	6.3	14.3	19.9	5.7	9.9	52.7	6.5	12.6	17.5	3.4	5.2	4.2	12.2	3.4	2.6	14.7	8.3	7.1	3.7	2.0	2.5	1.3	1.1	0.8	1.1	1.8	0.8	1.0	1.8	2.4	1.4	16.3	1.6	1.3	2.3	3.4	0.5	24.3	25.4	25.2	25.7	24.0	24.5	26.1	23.0	24.8	20.2	24.7	36.7	23.5	3.2	22.0	40.1	15.6	16.6	28.3	18.3	4.0	29.0	27.9	43.4	8.9	20.0	17.4	23.9	16.7	12.2	18.5	19.3	3.9	12.6	0.7	11.6	20.4	22.5	14.4	0.4	47.0	9.1	6.9	23.0	19.4	14.3	9.5	22.0	21.4	38.2	8.4	26.9	51.1	21.3	14.2	11.9	12.8	3.5	27.1	11.1	14.2	30.0	15.6	18.3	20.6	34.2	62.4	10.0	25.5	30.9	6.9	28.8	22.5	5.1	15.4	30.0	39.5	22.5	27.9	48.0	64.4	5.5	18.3	8.9	13.0	17.9	15.4	24.2
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2403.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	412.5	166.8	149.0	170.9	168.8	276.4	241.9	160.5	170.8	193.8	163.5	300.1	187.3	226.7	196.2	247.2	162.9	172.0	414.8	137.6	169.8	228.2	233.6	182.8	172.4	166.4	169.5	258.8	216.2	273.8	85.8	182.4	172.6	229.8	199.6	177.6	230.0	245.6	1408.6	201.6	196.1	236.4	172.2	176.5	201.7	257.4	164.7	218.8	262.6	1039.4	208.2	238.4	137.0	187.3	658.8	226.6	395.5	396.1	440.7	561.4	550.1	566.7	420.5	373.0	301.1	334.0	193.7	514.9	465.6	543.1	217.0	272.3	442.4	439.6	539.2	632.1	302.8	506.1	390.3	299.9	388.2	380.7	288.7	414.7	468.2	447.0	583.2	502.2	433.5	426.5	523.3	327.3	458.9	2403.4	513.8	242.0	755.0	274.0	302.5	378.4	1221.9	244.0	295.4	508.4	485.6	320.7	553.9	455.8	433.3	411.9	234.5	599.4	526.9	437.8	597.3	579.6	629.1	495.7	587.9	567.7	564.9	422.2	1365.1	217.2	241.4	230.8	146.4	233.1	199.7	161.6	186.5	180.7	226.8	130.4	219.3	189.1	155.2	191.0	270.8	87.2	222.2	389.4	149.0	168.8	160.5	170.8	137.6	169.8	166.4	169.5	172.6	172.2	164.7	187.3	193.2	198.7	194.2	41.8	198.3	216.2	219.7	149.0	235.6	134.0	218.2	161.5	572.0	160.2	181.1	128.8	58.4	172.4	155.2	160.8	226.9	198.2	405.5	130.4	178.8	191.3	219.9	232.8	70.8	202.9	208.2	181.7	143.2	174.3	219.1	234.7	156.4	189.1	156.8	99.3	73.7	220.3	120.1	277.9	202.0	639.7	161.8	216.8	220.5	55.3	241.8	195.5	117.4	54.3	86.5	213.8	150.6	225.7	283.6	269.0	240.1	235.5	143.2	121.3	164.3	232.4	274.2	263.3	189.8	247.2	234.0	272.9	193.3	208.2	210.5	283.8
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 58.9;granulocytes: 113.5;Hepatic stellate cells: 53.2;Sertoli cells: 59.2;Skeletal myocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 13.2;eosinophil: 22.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 22.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.0;BJ hTERT+: 149.5;GAMG: 142.1;HHSteC: 338.7;HSkMC: 216.4;hTERT-RPE1: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	67.4	37.5	27.5	24.5	32.9	18.4	46.4	36.9	25.8	25.0	32.9	26.8	13.3	21.1	5.2	15.6	28.5	31.9	29.0	24.5	30.9	17.3	16.4	47.6	28.2	42.3	32.6	22.1	17.5	10.5	8.7	41.2	36.1	21.4	16.2	1.5	18.9	16.6	11.4	19.4	26.7	17.6	36.0	48.0	22.0	3.7	32.2	13.5	22.2	11.3	12.2	42.0	29.6	46.5	9.3	29.3	14.7	5.7	220.0	138.3	5.7	36.0	149.5	25.9	23.9	1.3	4.5	0.2	47.0	80.1	142.1	6.8	5.7	11.0	9.4	99.5	5.3	10.9	17.3	10.3	338.7	0.0	13.7	216.4	3.2	57.5	33.0	153.1	5.4	2.8	2.9	5.5	31.2	0.5	0.3	1.8	5.3	2.4	3.1	1.0	8.4	0.9	10.9	7.9	0.5	1.6	9.7	2.6	12.6	16.7	2.3	1.0	19.2	27.8	10.5	123.7	22.1	2.8	1.1	0.3	70.7	0.1	106.6	13.2	0.0	22.3	0.3	0.0	0.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.2	27.5	32.9	36.9	25.8	24.5	30.9	42.3	32.6	36.1	36.0	32.2	46.5	30.6	9.6	35.5	11.8	2.3	7.4	5.1	7.9	13.1	0.3	10.0	9.3	3.2	14.3	5.3	3.7	0.0	0.8	2.0	0.6	0.0	40.4	0.4	20.6	9.3	21.6	7.8	11.1	0.3	2.3	0.5	58.9	4.6	24.8	113.5	0.3	53.2	3.0	9.2	0.0	1.0	0.8	0.0	3.5	13.1	0.3	25.1	8.2	10.6	28.1	1.6	1.8	0.0	3.0	17.5	9.3	1.6	8.6	1.9	8.0	1.2	0.9	1.1	0.2	59.2	94.4	37.1	0.6	0.7	5.6	5.5	0.8	20.9	0.7	1.0	2.6
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor subunit beta"	P32927	22	36913628-36940439	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.5;lymphoid tissue: 65.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basophil: 238.1;neutrophil: 76.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 238.1"	"Group enriched"	"Detected in some"	5	"HEL: 107.3;HMC-1: 321.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078677			Approved	"Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	10.1	2.0	1.0	65.5	1.1	54.5	5.4	1.2	5.2	2.5	1.3	9.9	10.3	2.0	0.7	6.6	2.6	9.8	2.3	0.9	1.6	1.8	2.6	15.1	40.1	2.6	2.1	0.5	2.1	0.9	0.7	31.3	3.1	1.6	8.5	0.0	4.9	1.5	1.0	5.4	11.0	7.0	2.3	22.8	9.3	2.1	3.0	9.8	2.7	4.0	62.5	18.3	2.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	16.1	0.0	107.3	0.0	0.0	0.1	1.7	321.1	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.1	12.6	0.0	0.0	0.1	11.2	0.0	0.0	0.0	10.7	0.0	40.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.1	9.6	0.3	1.0	0.1	0.3	0.0	1.6	1.1	6.8	0.2	15.6	0.1	238.1	9.1	23.5	0.0	7.7	0.0	1.6	0.2	0.0	4.8	1.1	0.0	0.0	76.0	0.0	7.0	14.4	2.3	10.3	1.0	1.1	1.2	5.2	0.9	1.6	2.6	2.1	3.1	2.3	3.0	2.9	4.3	0.0	9.1	1.6	9.1	7.1	0.0	0.0	0.0	0.0	0.2	0.3	1.2	2.8	1.8	0.0	0.0	3.4	44.8	0.0	0.0	0.0	13.4	0.0	0.2	22.0	0.0	32.0	0.1	0.2	37.9	2.8	0.0	0.0	91.2	0.0	4.6	0.0	20.1	0.0	0.1	0.0	0.0	31.9	68.3	41.2	0.0	34.7	12.4	5.6	42.3	0.0	2.1	0.0	0.0	0.0	0.0	0.4	49.5	0.1	0.0	0.1	2.9	0.0	0.0	0.3	0.5	0.0	0.0	0.1	6.3	16.6	2.9	0.1	0.0	0.2
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 123.0;urinary bladder: 57.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.0;Alveolar cells type 2: 121.2;Basal respiratory cells: 155.9;Club cells: 85.8;Endothelial cells: 192.1;Fibroblasts: 101.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 74.8;U-87 MG: 286.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	6170			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	41.7	5.9	1.3	14.2	1.2	3.5	7.3	0.9	1.5	25.2	0.7	8.5	0.0	4.1	0.0	6.2	7.2	2.3	16.5	1.1	1.0	3.1	0.5	123.0	0.3	2.0	1.2	1.9	3.8	0.3	10.2	2.5	1.6	16.1	0.5	0.3	3.0	0.1	21.7	1.8	4.3	1.6	2.0	0.9	8.0	1.3	1.3	0.3	3.9	10.5	0.4	57.5	5.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	2.8	0.2	0.0	0.0	1.0	0.0	3.2	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	36.0	11.6	0.0	9.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	286.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.9	1.5	1.1	1.0	2.0	1.2	1.6	2.0	1.3	1.1	57.0	22.4	121.2	0.0	0.0	34.5	5.3	155.9	0.0	0.0	0.1	0.1	0.1	0.0	85.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	11.4	0.8	192.1	0.0	0.0	0.0	0.2	0.0	101.5	5.6	23.6	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	18.3	0.0	36.5	0.0	0.0	2.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	14.0	0.0	0.0	34.9	0.0	0.0	37.3	6.4	0.2	0.9	0.9	33.5	0.0	3.2	0.0	0.8	17.3
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CSMD1	"KIAA1890, PPP1R24"	ENSG00000183117	"CUB and Sushi multiple domains 1"	Q96PZ7	8	2935353-4994972	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 10.7"	"Group enriched"	"Detected in some"	20	"Excitatory neurons: 4868.4;Inhibitory neurons: 3913.1;Oligodendrocyte precursor cells: 4521.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 4.9;U-2 OS: 2.2;U-266/70: 2.2;U-266/84: 2.1;U-698: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074707			Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA074707: AB_2686707"	"unprognostic (6.32e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.67e-3)"	"unprognostic (5.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.11e-1)"	0.1	0.0	3.5	0.0	5.8	0.0	0.2	0.0	10.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	5.8	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	1.6	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	0.0	2.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.2	0.0	0.0	2.2	2.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	0.0	10.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.0	0.5	108.4	0.0	0.3	0.0	0.0	2.2	15.0	1.0	0.9	2.2	0.0	0.6	1.8	0.0	3.4	0.0	0.1	0.0	0.0	52.5	1.5	0.3	2.2	0.0	0.0	4868.4	0.0	1.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	3913.1	0.1	0.0	0.0	0.7	15.0	0.3	0.2	0.0	220.2	0.7	0.5	0.0	4521.8	135.2	0.0	0.1	0.4	0.0	0.0	0.0	1.2	9.7	0.6	0.0	0.2	0.5	10.2	5.3	1.0	0.1	3.6	0.1	2.8	0.0	0.1
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 9.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.0;Inhibitory neurons: 148.9;Oligodendrocyte precursor cells: 314.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 6.8;HEL: 10.5;NTERA-2: 8.1;PC-3: 8.4;U-87 MG: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	0.2	0.5	5.3	0.2	3.2	0.0	0.1	0.7	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.2	7.1	5.5	0.1	0.0	0.1	0.2	2.3	2.7	0.0	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.1	0.3	1.0	0.2	0.1	0.5	9.3	0.0	0.1	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.2	0.7	4.8	7.1	5.5	2.3	2.7	1.8	1.0	9.3	2.5	1.4	6.4	3.0	2.6	0.0	0.3	0.6	0.0	0.0	11.2	0.1	0.0	5.5	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	4.3	3.2	0.2	2.3	1.2	0.0	0.0	159.0	2.9	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	148.9	0.0	0.0	0.0	0.3	6.0	1.5	0.4	0.0	12.2	0.3	0.1	0.0	314.7	52.5	1.4	0.0	3.8	0.0	0.9	0.0	0.1	0.0	1.9	0.0	1.4	0.7	0.3	2.1	0.0	0.4	0.0	0.2	0.2	0.0	0.3
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492982-149551471	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	77.0	67.6	49.0	67.3	53.9	210.8	97.8	60.0	52.7	67.9	61.5	83.2	56.6	73.7	60.2	142.4	56.6	79.7	87.6	48.6	55.9	50.3	68.2	69.6	60.0	61.3	56.4	53.2	55.0	99.4	48.8	71.7	56.6	88.3	68.2	57.6	71.3	69.2	104.1	121.4	63.1	82.9	57.9	60.7	73.5	45.6	57.8	81.0	76.9	59.5	81.8	94.8	82.3	66.3	154.4	106.4	151.0	144.1	143.6	191.4	185.0	189.7	176.8	146.0	153.5	194.1	187.0	71.6	221.3	183.3	140.7	153.9	101.2	292.5	184.1	124.6	78.0	96.9	96.6	87.8	143.1	163.9	148.4	158.5	313.4	148.1	269.0	163.9	184.7	137.2	102.2	116.0	140.7	104.4	152.2	66.6	71.4	167.6	247.3	129.0	96.1	98.9	112.3	248.3	123.5	110.5	151.1	193.3	200.8	135.6	194.1	134.4	164.6	168.6	83.6	118.2	197.1	117.0	149.2	100.6	169.2	95.6	216.9	106.0	72.6	66.6	47.5	68.9	51.6	50.2	58.1	49.7	80.0	39.9	61.4	55.2	61.1	63.7	67.8	47.4	76.7	94.7	49.0	53.9	60.0	52.7	48.6	55.9	61.3	56.4	56.6	57.9	57.8	66.3	169.7	147.4	176.7	137.1	101.8	684.5	583.1	270.0	187.8	135.8	257.0	158.4	63.5	90.1	298.1	115.8	64.6	171.2	135.6	126.8	92.0	167.1	95.7	195.8	193.5	191.1	129.9	146.7	108.4	184.1	223.7	159.8	124.4	285.2	117.6	114.0	216.4	108.9	136.1	151.4	115.4	141.9	154.6	167.8	311.5	87.5	104.1	183.8	152.9	119.0	156.6	156.9	108.1	168.4	198.1	197.2	113.9	111.7	105.4	368.6	120.4	102.8	276.7	109.6	157.8	190.2	216.1	181.9	88.9	272.4	847.7	350.9	133.5	177.0	115.7	485.2
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 312.5;Late spermatids: 775.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	46.7	57.0	36.9	28.9	36.9	25.9	42.3	34.4	37.9	45.3	30.3	57.1	35.1	56.6	26.7	50.8	45.3	24.8	42.4	39.0	40.2	45.5	40.9	45.3	30.8	37.2	37.6	43.1	47.5	43.1	54.2	30.2	36.3	51.8	20.0	15.1	48.6	36.8	88.9	36.4	50.9	29.0	36.3	56.3	49.3	60.7	42.6	34.0	44.7	38.7	22.8	49.0	37.0	32.9	60.3	70.9	39.5	54.7	50.8	53.9	77.7	85.1	54.4	61.0	56.8	58.6	49.4	55.0	66.3	62.5	64.8	57.1	37.4	88.3	48.9	47.0	90.5	68.5	53.4	63.7	146.9	56.9	50.4	81.9	61.5	41.6	61.3	76.0	90.0	39.5	78.5	28.4	58.5	70.6	73.7	59.3	42.2	71.3	108.6	62.6	48.7	49.7	64.8	93.4	48.5	87.4	100.4	85.5	97.7	54.3	61.5	73.0	95.6	86.9	77.3	76.2	67.0	61.0	32.1	58.4	69.5	48.1	64.7	8.8	20.8	27.4	12.3	21.3	11.8	11.1	9.6	12.1	20.1	9.0	8.1	8.7	50.4	15.3	20.3	9.6	9.2	15.4	36.9	36.9	34.4	37.9	39.0	40.2	37.2	37.6	36.3	36.3	42.6	32.9	65.8	48.1	54.3	36.6	81.1	56.6	116.0	58.3	52.9	46.5	59.8	51.2	19.7	31.5	65.7	42.3	27.1	61.8	101.0	105.2	33.2	71.6	312.5	69.6	54.0	54.2	46.2	32.4	24.4	69.6	95.2	42.8	87.1	93.2	60.1	45.3	42.5	33.6	65.3	95.9	21.2	62.8	67.1	51.5	83.8	775.6	30.1	75.7	28.4	24.4	65.8	28.7	79.3	24.6	21.2	87.7	83.2	40.3	80.9	90.8	94.3	43.8	66.6	54.4	39.5	78.6	57.5	55.1	29.6	44.2	48.3	126.6	87.6	46.7	56.7	118.6
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665227-31670343	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved					NA	NA		83000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	155.8	157.4	15.8	31.9	24.6	62.2	150.2	17.6	54.1	147.9	16.8	142.2	27.8	126.7	183.7	166.6	130.1	33.1	178.9	15.9	16.4	172.1	163.7	133.0	72.5	16.3	17.5	161.2	142.3	69.3	130.0	68.2	17.8	120.3	50.4	41.4	131.9	57.6	232.0	294.2	126.5	66.3	15.4	146.0	146.7	257.9	17.1	56.5	132.4	94.8	30.1	126.2	139.8	17.4	0.9	95.5	2.5	164.9	97.4	158.0	120.8	200.9	350.2	407.6	377.9	0.2	129.3	302.5	127.9	196.8	146.0	0.1	1.0	374.5	409.4	153.1	322.6	4.3	0.6	1.1	260.0	341.5	0.9	257.8	1.5	0.8	0.2	0.2	4.7	208.3	1.7	1.7	0.8	2.9	237.1	2.2	102.0	240.0	0.0	221.1	2.3	247.7	222.3	136.5	1.2	243.0	1.8	0.9	175.8	101.0	7.4	1.3	118.8	210.3	203.9	198.0	1.3	167.3	285.9	267.6	122.3	1.6	196.1	87.3	114.8	121.8	80.1	125.9	80.5	113.7	81.7	85.1	111.0	99.1	71.4	61.9	95.2	90.8	83.2	131.7	113.4	95.0	15.8	24.6	17.6	54.1	15.9	16.4	16.3	17.5	17.8	15.4	17.1	17.4	114.3	51.3	67.0	11.1	124.4	186.1	125.1	196.1	138.9	56.8	135.5	196.3	91.3	105.8	116.5	101.2	12.5	211.8	106.4	185.6	270.1	184.7	452.7	75.1	71.7	122.7	125.7	103.5	14.1	175.2	252.7	118.3	93.3	68.2	129.5	102.3	125.7	126.6	296.2	48.8	14.3	175.4	138.4	204.4	218.5	270.7	153.7	146.2	152.9	8.4	181.1	168.3	121.5	14.6	19.1	182.9	248.1	125.3	152.1	154.3	283.1	397.5	91.3	47.8	138.1	107.9	152.2	485.6	186.5	142.7	186.3	282.1	111.5	116.8	184.3	150.6
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 2743.3;seminal vesicle: 2571.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		11000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	344.5	127.2	713.6	224.5	871.4	41.0	321.8	742.5	717.3	542.4	467.6	2743.3	180.6	1904.4	308.4	884.1	1025.6	152.7	194.2	647.3	735.1	192.5	114.7	386.0	64.9	840.1	837.4	319.0	114.6	188.0	117.0	118.3	719.0	947.2	432.0	24.2	250.1	2571.3	64.0	219.8	503.6	2009.6	713.5	165.6	748.3	44.2	848.5	48.0	186.4	53.8	65.7	1494.5	469.1	766.6	83.0	195.3	52.0	116.4	83.2	107.7	273.6	605.7	514.3	455.3	360.9	211.1	57.7	78.7	36.1	325.0	96.7	144.7	32.7	120.3	321.2	169.5	29.3	90.7	220.1	30.7	387.4	72.1	10.2	99.3	105.3	373.0	163.1	253.1	508.1	34.9	4.5	71.9	302.1	232.9	46.6	11.8	0.8	99.0	73.2	18.3	304.9	266.8	212.6	129.7	27.1	22.5	238.0	503.8	163.9	25.6	87.0	74.3	610.6	303.7	195.7	206.6	250.6	40.5	82.6	30.6	303.5	137.6	202.6	75.5	49.8	65.6	37.4	49.3	36.9	25.0	35.8	34.9	65.0	18.1	20.5	25.2	5.0	34.3	54.2	5.2	54.1	46.5	713.6	871.4	742.5	717.3	647.3	735.1	840.1	837.4	719.0	713.5	848.5	766.6	151.8	38.5	47.8	86.5	21.8	49.2	341.2	24.6	207.7	3.4	123.7	737.5	24.8	21.5	36.9	47.8	0.0	88.8	23.3	96.6	49.0	165.1	21.5	30.1	73.6	86.9	57.9	19.1	2.4	171.7	388.5	86.7	36.7	38.9	27.9	13.9	91.1	28.3	66.0	0.0	2.1	80.0	14.2	29.1	55.8	44.9	41.0	37.0	126.3	10.3	73.5	137.4	15.5	6.6	114.8	140.5	71.4	292.3	61.5	113.8	97.2	28.4	25.2	3.1	144.7	37.7	419.9	2.4	3.2	75.3	34.9	160.9	31.2	30.4	69.7	103.6
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000		"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.3	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.0	39.6	0.0	0.5	2613.3	0.1	0.2	0.2	0.2	1.2	1.2	0.2	0.1	0.5	2.6	0.0	0.1	0.1	0.2	32.8	0.0	0.0	24.8	0.0	1649.3	0.4	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.7	579.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747562-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	119	"salivary gland: 28401.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 14.3;Collecting duct cells: 79.1;Glandular and luminal cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 1142.2"									"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"	NA	NA		6300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080"	"prognostic favorable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.3	0.1	1.1	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.0	3.7	0.4	0.1	0.2	238.8	8.0	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.7	7.1	37.3	0.0	0.1	4.1	1.4	13.0	0.2	0.0	28401.8	0.6	0.0	3.2	0.0	0.0	0.4	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.7	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	172.6	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.4	0.0	0.1	0.0	0.1	0.0	51.2	0.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	45.3	0.1	0.0	0.0	0.0	4.4	1142.2	0.7	0.0	0.1	0.0	0.3	5.6	0.0	0.0	223.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.7	1.4	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	14.3	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.7	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	31.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.5
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875934-23879748	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	959	"salivary gland: 2156.1"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 1: 9.6;Langerhans cells: 3.4"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 11: Alveolar cells - Smell perception"			"CAB024944: , HPA061449: AB_2684523"	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.3	0.4	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2156.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66012008-66013505	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"skin 1: 761.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0"	"Group enriched"	"Detected in many"	5	"thyroid cancer: 171.0;urothelial cancer: 43.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 130.2;CAPAN-2: 364.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		82000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: AB_2679158"	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	3.2	0.3	0.1	0.3	0.1	0.2	28.5	0.8	0.4	7.4	0.8	0.4	0.0	0.3	0.6	34.6	14.9	0.5	2.8	0.1	0.3	2.6	0.3	18.3	0.0	0.2	0.2	0.7	0.7	2.1	1.6	8.1	0.1	0.9	0.0	0.0	7.4	4.9	2.0	761.4	0.3	0.1	0.1	0.2	0.6	1.8	0.4	2.7	21.4	0.0	2.2	1.2	22.5	0.2	130.2	0.0	0.0	0.6	0.0	0.0	37.6	1.4	0.0	0.3	0.2	1.0	364.6	0.0	1.8	5.1	0.1	4.5	0.0	32.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.8	0.2	0.7	0.0	0.0	35.8	0.4	0.1	0.8	0.1	0.0	0.2	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.2	0.2	0.1	0.1	0.4	0.2	0.1	93.0	6.1	0.0	0.6	1.1	1.7	41.4	0.6	0.0	5.3	7.1	1.2	0.0	115.2	58.8	0.0	33.3	0.0	0.1	0.0	57.4	0.2	7.7	0.1	0.9	0.0	0.0	0.0	21.6	24.4	2.0	0.0	0.6	21.6	0.1	0.4	0.1	41.1	0.0	0.0	0.0	24.4	1.4	10.0	0.8	0.0	5.3	5.4	0.0	1.1	1.3	0.0	0.0	0.0	368.1	1.1	0.4	9.8	1.9	0.0	0.5	404.0	0.1	0.0	0.3	16.0	5.2	17.6	1.0	27.6	64.2	0.7	0.0	0.4	6.1
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949269-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 1095.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 1287.0"	"Group enriched"	"Detected in all"	27	"granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		26000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	18.0	3.6	1.3	24.2	1.6	1095.6	5.7	2.8	5.1	4.5	1.7	5.7	5.9	4.6	4.8	5.4	10.4	17.7	5.6	1.5	1.4	5.4	12.7	49.3	73.4	2.4	1.4	2.5	3.9	1.0	2.2	4.4	2.0	4.3	5.1	0.2	6.6	2.0	1.9	4.5	13.9	5.0	1.6	148.1	8.7	1.7	1.6	17.3	5.6	4.4	16.4	19.2	5.2	1.4	0.3	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.3	1.7	0.0	0.4	0.0	77.8	204.6	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	2.8	0.0	0.2	2.0	212.1	0.1	0.0	0.2	0.5	7.7	0.1	0.0	0.1	0.3	0.2	0.0	0.1	1.0	0.1	0.0	13.3	0.2	0.1	0.8	0.2	0.5	0.1	0.1	0.2	0.1	380.4	0.1	74.3	3.0	10.4	1287.0	3.4	720.2	3.7	186.8	904.7	28.4	3.9	38.8	531.2	342.2	655.3	3.5	7.2	123.0	600.8	1.3	1.6	2.8	5.1	1.5	1.4	2.4	1.4	2.0	1.6	1.6	1.4	8.1	9.6	14.1	0.0	14.5	22.8	0.3	0.0	0.0	0.0	2.5	2.4	1.4	4.3	0.6	0.0	0.0	0.2	1094.4	0.3	0.0	1.3	0.0	1.3	0.7	3.2	0.0	46.7	0.0	3.7	0.1	5.2	11.2	1.2	60.0	0.0	11.0	3.8	1.4	0.0	0.0	0.1	0.0	16.2	541.7	0.0	0.0	61.9	24.9	1.9	659.7	0.0	1385.2	0.0	0.1	0.2	0.1	0.0	90.9	0.1	0.4	2.3	2.2	0.0	0.0	2.2	3.6	0.0	0.2	0.5	23.9	1.1	544.5	0.0	0.6	0.6
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5912.9;vagina: 1853.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	30.7	4.7	0.8	27.1	0.9	297.8	56.3	1.0	3.7	961.0	1.4	3.8	1.1	2.2	10.3	5912.9	4.6	7.2	5.9	0.8	1.0	2.4	38.9	26.0	25.1	1.5	0.9	21.1	3.7	0.8	5.0	19.0	1.3	19.7	3.6	0.3	996.1	9.6	4.6	369.1	5.8	6.3	1.1	20.4	30.3	1.3	1.4	46.5	2.7	2.8	941.0	39.1	1853.3	1.6	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	0.9	1.0	3.7	0.8	1.0	1.5	0.9	1.3	1.1	1.4	1.6	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776330	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"esophagus: 11304.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 2798.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		8700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	224.3	165.6	254.1	141.6	253.6	73.8	161.9	255.4	314.6	585.8	275.2	243.8	122.9	90.1	175.0	11304.7	154.1	150.7	192.2	252.8	263.0	144.7	189.4	290.1	176.4	258.4	257.8	136.1	116.2	154.4	70.1	132.1	259.6	137.3	194.7	78.9	738.3	138.6	100.1	256.9	135.6	110.4	257.5	125.8	249.9	71.7	262.8	268.2	147.9	197.4	1484.9	611.8	1001.9	262.9	1573.6	495.5	146.3	188.1	874.5	742.6	379.6	310.1	431.0	230.7	230.6	401.6	868.6	123.0	245.8	570.1	1814.0	260.5	384.4	405.7	153.5	529.0	388.4	332.4	385.3	473.8	753.0	85.5	267.1	754.5	439.6	621.2	314.7	389.3	331.2	111.8	276.9	681.1	359.7	431.4	100.1	267.6	336.0	1052.6	791.5	169.7	80.5	1472.0	669.1	2798.2	141.8	121.6	420.2	229.2	928.8	75.7	210.4	214.0	426.3	347.7	162.7	305.5	211.8	148.5	347.4	251.1	1432.5	430.2	242.3	390.1	505.5	313.1	242.9	840.3	224.5	198.5	315.4	255.4	766.1	172.7	221.0	217.6	445.6	152.4	1322.9	93.4	406.9	475.2	254.1	253.6	255.4	314.6	252.8	263.0	258.4	257.8	259.6	257.5	262.8	262.9	210.1	176.3	298.4	43.4	140.5	385.3	460.6	5910.7	191.2	69.8	317.8	345.1	105.7	268.8	4352.8	415.6	35.5	310.4	126.5	803.9	538.1	588.4	10.4	388.8	205.1	307.8	239.3	61.4	17.0	488.2	1199.4	238.6	297.7	458.8	228.2	131.5	250.6	464.5	2827.7	67.3	18.4	308.6	1462.8	483.4	1256.2	40.8	381.1	806.9	471.4	24.4	915.9	160.6	255.4	11.1	32.4	810.9	735.6	330.2	167.7	674.3	524.9	469.9	1997.3	72.9	118.3	86.5	320.0	33.7	111.7	4910.2	596.0	402.5	202.8	170.9	367.2	3198.3
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100841520	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	6.3	7.2	5.7	9.9	6.0	10.5	7.7	6.7	6.3	7.0	5.0	12.0	8.6	7.5	8.2	19.2	8.1	6.4	6.1	5.9	6.4	8.0	5.3	6.3	12.5	5.4	5.4	7.1	4.7	8.9	5.3	7.2	5.3	7.5	13.1	8.5	7.9	8.4	4.5	8.4	8.2	7.6	5.3	7.0	6.6	12.7	6.6	12.0	6.7	5.1	19.9	10.0	8.4	6.3	36.0	41.7	27.5	24.9	14.7	11.4	37.2	29.6	24.0	47.6	68.0	45.4	32.1	35.6	35.2	19.1	61.2	35.1	64.2	35.3	57.2	36.5	39.9	32.8	38.8	29.8	19.4	46.9	33.8	11.3	16.5	49.8	32.6	12.7	29.0	31.3	56.2	33.7	29.2	41.9	38.4	31.8	76.8	55.7	39.9	35.8	46.3	42.3	17.5	34.4	24.1	30.4	49.1	20.5	20.4	27.6	20.5	20.3	25.8	26.2	42.3	38.1	37.8	22.8	52.3	45.9	22.5	48.6	32.4	20.0	16.1	11.1	23.4	18.9	17.9	17.4	21.1	21.8	23.3	16.9	19.0	17.8	2.6	23.9	25.8	16.7	24.2	15.3	5.7	6.0	6.7	6.3	5.9	6.4	5.4	5.4	5.3	5.3	6.6	6.3	4.1	3.2	1.1	3.9	8.2	4.2	4.6	20.7	9.6	2.2	3.1	3.0	4.9	2.8	12.9	0.0	2.1	16.7	3.6	5.9	5.9	12.5	13.3	6.3	4.9	4.6	4.2	12.8	10.4	8.3	18.4	4.3	6.1	4.3	3.8	5.5	2.5	1.5	10.8	3.3	10.8	3.7	14.2	2.5	3.7	2.4	4.7	4.3	1.8	1.0	5.9	4.5	4.1	7.1	5.7	15.4	6.7	4.1	6.2	2.0	5.4	4.0	9.9	2.9	6.6	2.7	5.7	18.8	25.5	14.4	4.1	7.7	7.1	5.0	6.4	5.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Nucleoplasm		NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161"	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favorable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	27.1	25.4	21.4	17.1	23.7	17.2	30.6	32.9	20.1	47.9	47.8	36.7	33.3	46.8	21.0	30.4	37.3	22.1	19.9	22.8	25.5	31.7	5.7	33.1	9.4	24.3	24.1	41.8	40.7	21.9	23.6	24.7	22.0	38.6	29.2	55.4	36.7	24.0	22.8	16.7	33.4	30.0	22.1	21.6	36.9	19.7	28.8	9.0	53.9	19.8	9.1	29.9	30.9	23.7	87.3	96.5	83.6	70.2	43.9	43.0	46.1	66.4	77.0	61.2	69.3	60.4	99.7	0.1	33.6	66.9	38.6	67.2	83.8	106.5	45.8	0.3	63.8	63.8	61.6	1.3	91.7	27.2	48.9	37.1	82.7	63.5	125.5	80.9	79.1	4.9	2.6	0.5	38.7	96.5	3.0	27.8	63.0	90.3	61.3	77.4	35.0	0.8	72.5	38.8	25.5	73.1	64.7	56.0	86.5	64.7	39.7	43.9	64.4	36.8	46.2	53.0	57.9	1.4	5.3	0.3	46.1	0.3	37.1	30.8	8.5	16.4	8.5	9.0	1.1	0.5	0.4	2.3	11.2	0.3	0.5	3.6	14.3	34.6	22.4	9.4	0.3	4.7	21.4	23.7	32.9	20.1	22.8	25.5	24.3	24.1	22.0	22.1	28.8	23.7	64.7	32.1	27.2	72.1	4.0	47.2	83.4	41.5	33.6	182.5	75.8	59.8	32.7	55.8	53.2	38.6	158.4	22.3	50.7	81.7	68.4	69.3	29.9	125.0	65.1	63.0	55.0	42.3	41.8	60.8	70.5	42.3	40.2	163.0	17.7	43.1	61.4	1.2	29.6	107.7	35.0	93.9	50.8	49.3	46.9	38.1	60.3	47.0	58.7	127.4	60.6	63.2	124.6	44.2	87.1	83.8	61.6	77.8	6.9	89.3	45.1	31.6	94.1	107.5	59.2	59.6	67.0	12.7	45.5	42.1	39.8	19.3	15.3	81.3	106.1	102.7
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549611-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"basal ganglia: 7.4"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		370000000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	1.5	1.4	0.4	1.4	0.8	3.3	1.6	1.0	0.6	1.2	2.1	1.2	0.9	1.5	3.1	1.0	1.1	1.2	1.0	0.2	0.6	1.7	3.7	1.4	1.6	1.3	0.9	0.8	1.7	1.6	0.5	1.2	1.5	2.2	1.4	1.4	3.3	0.8	0.8	2.4	1.2	1.1	0.5	2.5	1.4	0.5	0.8	1.0	1.3	0.9	1.0	1.0	0.5	1.3	0.9	0.3	0.2	0.2	2.7	3.2	0.6	0.6	2.2	0.3	0.8	0.1	1.1	1.2	0.2	1.4	0.3	0.4	0.0	0.9	0.9	1.1	0.3	0.8	0.1	0.1	1.6	0.8	0.4	2.4	1.6	0.8	1.2	1.9	0.9	0.5	0.7	2.2	0.6	0.0	0.5	0.9	0.2	0.2	0.3	0.2	0.3	0.8	1.9	0.4	0.1	0.4	0.2	0.9	1.1	0.5	0.5	0.9	1.5	1.1	0.1	1.5	0.7	0.6	0.2	0.3	0.8	1.1	0.8	0.5	0.1	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	0.4	0.8	1.0	0.6	0.2	0.6	1.3	0.9	1.5	0.5	0.8	1.3	43.6	9.6	23.4	10.4	37.4	30.3	30.2	28.0	34.1	5.9	33.1	15.6	5.8	31.5	25.5	23.9	41.7	26.8	25.4	30.2	43.0	20.2	3.3	24.1	24.4	29.9	23.0	14.1	6.2	19.2	24.2	28.1	25.0	19.4	43.8	9.7	49.6	70.8	48.2	3.3	4.3	18.9	16.2	75.5	27.9	3.7	21.1	58.8	7.2	20.6	56.5	21.8	18.6	5.5	9.0	19.1	25.2	24.5	59.8	36.7	30.0	44.4	38.2	41.9	13.1	20.2	16.6	10.4	12.8	27.3	24.7	25.6	26.8	25.3	18.4	29.9
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 184.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	84.5	55.4	42.1	43.0	47.8	53.1	76.5	41.6	42.2	82.4	40.6	72.2	56.7	80.2	31.9	71.8	74.3	46.7	79.4	36.8	38.8	83.2	118.6	74.5	49.2	55.6	47.0	82.3	79.1	56.9	28.4	77.7	44.6	104.6	44.7	8.7	65.3	57.2	60.0	71.4	75.9	48.4	45.3	92.7	88.3	16.9	45.5	48.0	78.9	53.7	45.4	82.6	70.4	43.2	29.8	37.8	21.8	71.9	58.1	53.8	80.0	38.9	56.2	37.2	32.0	49.7	72.7	18.0	33.0	69.8	25.3	59.1	32.4	47.2	19.0	63.8	25.5	68.3	48.6	67.0	69.4	42.9	89.3	61.5	56.7	28.3	31.7	58.3	55.5	27.5	56.5	62.6	39.9	84.0	37.5	122.1	15.5	47.6	37.8	51.4	30.8	39.2	47.7	36.6	14.5	36.4	34.4	72.9	38.6	27.4	40.8	101.1	48.5	58.7	35.0	45.4	17.4	40.1	28.1	42.6	52.3	39.7	33.2	54.2	30.4	74.1	24.3	24.7	15.5	7.8	14.7	15.8	15.9	7.2	9.3	12.4	56.4	17.3	26.3	5.4	13.8	21.2	42.1	47.8	41.6	42.2	36.8	38.8	55.6	47.0	44.6	45.3	45.5	43.2	65.0	44.8	40.0	15.0	43.0	27.3	29.1	24.7	37.5	14.6	34.8	34.5	35.1	58.6	23.7	31.3	2.1	42.7	70.5	95.0	33.2	36.6	1.9	15.1	35.1	43.4	21.7	52.6	0.7	42.7	43.3	44.7	45.3	27.7	18.3	23.0	67.5	57.3	39.3	6.7	1.0	53.5	12.2	83.2	28.1	4.6	59.4	59.9	33.8	14.0	56.9	55.6	184.4	13.0	12.9	38.5	43.1	44.0	35.7	39.8	85.1	51.1	10.0	28.0	26.3	36.0	44.8	1.7	8.7	37.8	20.3	54.3	55.1	29.4	41.5	30.2
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861880-37984469	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 132.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	21.1	9.2	19.4	6.3	20.6	10.0	28.1	24.3	23.2	20.3	17.1	33.4	14.3	20.2	14.0	23.8	17.9	29.3	29.4	18.8	17.3	39.7	21.5	27.2	4.1	19.2	17.7	19.6	15.8	12.0	10.7	31.7	16.6	26.5	30.2	3.2	27.1	31.3	21.2	52.9	17.6	23.2	18.1	17.3	31.7	10.6	19.5	7.2	14.0	19.9	5.5	26.4	19.1	17.3	44.5	18.9	7.6	24.0	29.2	41.0	57.2	30.0	37.0	20.1	23.5	27.4	35.3	0.2	17.9	36.9	8.4	36.3	19.2	56.1	16.0	0.1	15.1	27.2	18.8	63.1	26.4	0.0	6.4	21.5	132.3	21.2	25.5	22.4	28.2	12.0	8.9	0.0	33.7	13.7	11.1	0.1	31.5	17.7	2.7	12.3	14.9	0.2	63.3	28.7	6.3	19.9	16.5	28.7	33.5	30.5	28.1	7.3	23.2	14.4	20.4	27.3	19.1	0.6	0.2	0.2	15.8	14.8	27.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.1	19.4	20.6	24.3	23.2	18.8	17.3	19.2	17.7	16.6	18.1	19.5	17.3	26.8	67.3	27.6	170.4	1.2	30.1	17.0	17.7	27.9	10.1	25.7	59.4	42.2	65.8	25.7	23.9	0.0	34.7	1.0	35.6	23.5	14.2	21.5	7.6	17.6	22.4	45.2	7.8	189.3	4.7	9.9	32.4	10.2	27.2	1.3	15.7	22.9	18.1	7.2	10.1	126.3	18.5	2.0	13.3	6.5	51.3	71.7	11.3	8.8	22.5	1.4	9.5	1.0	87.4	48.8	14.2	17.9	98.2	0.4	15.5	9.1	19.7	12.4	1.7	26.3	55.4	40.4	10.0	16.9	17.7	28.7	9.4	2.0	65.8	42.0	14.4
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		57000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	144.4	137.1	88.3	65.9	110.4	33.1	126.4	102.9	100.6	110.9	103.2	155.8	115.5	99.2	115.7	208.9	113.4	95.6	190.7	83.7	91.3	151.8	82.4	134.4	35.6	106.8	99.4	101.5	83.8	120.4	54.3	124.6	105.2	96.3	122.9	54.0	127.7	104.0	87.1	140.6	115.2	115.5	95.9	66.0	125.3	35.0	100.2	33.0	122.9	62.0	69.3	126.8	126.3	139.0	225.3	161.1	237.9	353.6	202.2	220.8	362.0	222.0	277.9	208.1	261.1	337.9	297.4	0.8	182.9	334.3	228.0	167.7	165.9	366.0	240.0	129.6	144.0	94.3	245.7	206.5	243.6	1.7	88.2	140.5	286.0	249.1	269.6	230.6	397.7	66.0	52.9	94.3	227.2	199.4	2.3	28.9	96.2	237.4	3.6	88.8	138.0	135.7	441.9	295.5	94.9	124.8	409.7	568.2	344.3	503.4	201.5	64.4	341.1	217.1	117.4	136.5	156.5	33.8	69.9	13.5	207.0	40.3	286.7	5.1	37.8	3.4	5.8	46.4	3.8	7.9	4.1	4.3	32.3	6.6	0.3	2.1	20.9	0.6	46.8	7.9	11.1	17.8	88.3	110.4	102.9	100.6	83.7	91.3	106.8	99.4	105.2	95.9	100.2	139.0	137.3	259.6	161.0	57.1	19.4	78.5	119.5	134.4	82.0	7.3	74.6	52.3	230.8	87.2	201.8	121.4	20.9	124.8	21.1	320.7	68.4	184.9	17.2	158.0	67.9	141.1	51.0	41.7	37.6	175.5	137.8	97.1	167.1	206.9	40.5	83.3	92.4	66.6	92.8	3.3	31.5	139.0	87.5	80.5	80.9	23.6	77.9	77.9	78.2	104.0	158.5	46.2	6.2	66.4	159.7	328.7	201.4	84.7	24.8	128.7	165.6	140.1	210.1	24.5	98.6	74.9	109.1	18.1	21.0	111.3	77.3	189.9	20.4	44.4	130.6	181.4
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.0;epididymis: 67.0;retina: 80.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	96	"basophil: 55.3"	"Lineage enriched"	"Detected in single"	553	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	0.1	4.7	74.1	0.5	82.5	0.1	0.0	51.8	99.0	0.4	28.5	1.9	0.3	3.3	67.0	0.2	1.9	0.2	0.2	78.8	59.3	0.1	0.1	0.0	0.0	47.0	71.2	0.1	0.8	0.0	7.1	0.0	50.8	1.0	0.9	80.4	0.2	0.7	0.2	0.1	0.7	0.5	36.6	0.0	1.1	17.4	78.9	0.0	0.0	0.0	0.0	0.1	0.4	62.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	3.8	10.7	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.4	0.7	0.2	0.0	2.3	0.0	0.0	2.7	0.0	2.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	74.1	82.5	51.8	99.0	78.8	59.3	47.0	71.2	50.8	36.6	78.9	62.0	0.0	0.0	0.0	3673.8	0.0	0.0	0.0	0.0	0.0	17.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	560.8	12.9	7.0	0.5	0.0	0.0	1358.5	0.0	0.0	0.1	0.0	34.3	0.0	4.7	0.0	0.0	0.0	5.0	1056.9	0.0	0.0	0.0	0.0	144.4	2.5	0.5	0.0	187.4	0.0	112.1	0.0	1304.4	230.7	0.3	0.0	3.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.2	10.3	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 539.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		2000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	130.8	112.2	106.7	98.7	85.3	162.4	194.3	147.8	87.5	179.4	94.7	141.2	136.9	149.4	84.4	113.7	131.0	121.8	109.9	88.1	105.3	106.5	147.9	132.9	81.9	101.3	112.9	173.9	93.3	137.2	84.7	200.0	94.0	132.3	134.5	88.8	110.9	126.3	87.3	99.0	142.9	178.4	104.9	92.5	81.8	59.5	129.4	95.6	140.6	89.9	99.5	158.3	109.3	108.4	161.6	210.0	423.6	242.8	226.9	184.7	333.8	179.6	249.7	288.2	284.3	146.3	224.0	131.7	157.8	314.1	129.0	119.6	315.8	510.0	306.2	123.3	215.7	215.5	261.0	523.7	169.5	121.8	99.1	271.6	226.7	345.5	208.7	235.7	258.1	63.0	153.7	80.3	324.1	161.8	87.3	68.3	397.2	211.0	159.3	64.9	281.9	88.3	177.9	494.8	102.9	172.4	296.2	147.1	809.4	509.8	242.1	248.6	340.8	217.1	163.6	139.3	264.0	50.7	82.7	138.4	221.5	150.5	369.7	4.7	7.3	6.4	9.2	12.3	10.9	7.7	8.6	10.1	11.8	8.0	8.6	9.4	6.6	9.6	12.6	10.0	10.8	5.6	106.7	85.3	147.8	87.5	88.1	105.3	101.3	112.9	94.0	104.9	129.4	108.4	171.7	137.8	179.5	58.1	71.7	213.5	130.1	75.3	116.1	40.7	232.5	168.1	84.7	90.1	119.2	62.5	33.3	318.9	99.0	251.6	35.2	132.2	11.0	90.3	125.9	187.3	93.8	43.8	50.9	78.5	115.6	116.8	53.0	95.5	116.6	137.0	139.2	172.5	115.1	13.5	82.4	145.9	42.7	154.6	228.1	9.5	59.7	161.1	202.7	124.6	98.3	89.2	49.4	70.9	62.9	139.8	249.5	86.9	55.5	128.3	160.3	93.2	96.1	62.0	46.0	175.6	137.3	78.4	40.1	70.9	174.9	539.5	77.0	245.6	189.6	127.9
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	318.6	734.6	147.0	204.9	181.9	499.0	244.0	186.0	156.5	270.8	672.7	298.0	387.6	170.7	82.8	319.4	171.6	438.4	444.1	187.8	223.6	691.6	464.8	539.6	241.0	247.6	206.6	130.7	284.8	137.3	131.5	180.7	228.6	138.2	153.4	48.3	422.1	231.7	590.3	340.9	398.3	105.0	188.9	442.0	287.2	88.9	334.4	78.1	182.1	178.2	123.1	296.4	307.5	367.1	204.6	578.9	51.4	246.2	586.5	206.3	112.1	149.4	362.2	161.8	182.8	147.5	2596.6	49.2	376.8	285.8	1265.6	1072.2	63.7	142.6	35.8	206.7	222.9	70.4	92.5	196.5	736.2	171.4	787.7	350.9	621.6	82.5	136.9	2780.1	128.2	62.1	89.2	267.6	263.3	832.6	47.0	110.9	153.1	719.7	247.9	62.5	72.5	191.2	586.6	610.8	84.2	94.8	173.3	2488.5	535.0	68.6	1022.8	232.6	170.3	556.8	92.9	79.0	216.7	432.0	382.3	26.8	867.7	468.6	509.6	211.2	578.7	170.1	156.5	309.9	90.6	28.8	72.1	110.3	144.5	18.8	82.5	107.4	319.5	192.3	265.2	120.3	89.2	489.1	147.0	181.9	186.0	156.5	187.8	223.6	247.6	206.6	228.6	188.9	334.4	367.1	139.3	112.2	228.6	48.3	62.8	72.0	223.5	473.2	71.7	168.6	108.9	113.8	251.9	314.5	459.5	548.1	110.5	211.7	156.1	1475.9	109.5	911.4	3.3	118.1	67.4	128.3	159.6	132.6	18.3	370.1	165.0	157.0	237.5	203.4	474.3	119.4	695.7	678.9	3763.5	264.2	25.2	418.2	498.5	1187.8	67.5	14.6	108.4	1512.6	227.7	20.6	382.6	179.0	256.4	27.2	42.2	392.3	832.5	128.2	122.5	111.7	1699.4	311.8	270.3	102.1	111.7	70.7	135.2	26.6	63.5	141.2	82.1	471.3	155.0	96.0	399.1	357.8
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563464-66568879	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 320.9;Muller glia cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 23.1;SK-MEL-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	57.8	70.0	68.1	0.8	76.3	0.3	62.2	74.5	74.0	78.8	90.2	76.7	3.0	89.2	21.9	15.6	70.8	10.0	100.2	63.2	74.2	46.9	66.0	32.9	3.6	75.0	70.3	99.1	31.7	20.0	43.3	3.8	68.4	53.5	3.5	26.2	55.7	17.1	91.9	44.4	29.5	12.2	77.2	25.0	54.3	109.7	71.0	3.0	40.6	27.6	3.0	56.6	58.7	86.6	0.0	17.0	3.1	5.4	14.2	8.6	3.4	13.0	11.4	6.3	2.3	0.0	2.2	0.0	21.3	10.4	0.0	1.2	6.8	2.6	4.8	3.7	0.0	0.5	7.0	0.0	9.9	0.3	4.4	22.3	9.1	0.8	1.6	13.7	3.8	2.0	5.4	1.6	5.2	4.6	0.1	1.7	0.9	3.7	9.7	0.0	0.0	1.5	7.1	0.3	4.3	6.9	23.1	0.3	59.5	0.3	7.4	0.6	3.3	1.8	2.9	1.5	1.2	21.2	0.2	0.0	2.2	0.0	2.9	0.0	0.4	0.3	3.9	0.6	4.1	1.5	3.5	4.6	0.6	1.4	6.4	4.1	0.1	4.6	0.2	0.9	1.3	2.2	68.1	76.3	74.5	74.0	63.2	74.2	75.0	70.3	68.4	77.2	71.0	86.6	36.6	12.8	15.6	31.3	5.9	39.8	62.4	8.5	37.5	107.9	45.3	80.6	57.9	41.5	7.4	36.8	41.7	31.6	9.6	0.6	15.6	13.1	163.3	1.7	22.8	27.2	12.0	11.4	26.5	7.5	9.5	118.1	8.2	5.3	9.5	52.1	56.0	67.8	14.9	134.6	31.3	3.1	18.3	21.5	32.8	320.9	145.7	13.1	156.5	12.2	3.1	196.6	17.5	21.6	29.4	5.9	3.2	121.9	12.9	50.5	1.3	44.7	3.3	77.9	78.9	62.0	45.9	169.6	43.3	3.6	25.3	23.7	9.5	30.7	4.3	32.9
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573518-24576250	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	154	"bone marrow: 5352.9"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 534.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 8681.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		330000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	23.4	0.1	0.0	13.5	0.0	5352.9	25.4	0.0	0.0	16.6	0.0	25.5	5.8	9.6	10.2	22.1	2.7	25.9	3.7	0.0	0.0	2.3	3.6	11.6	6.5	0.0	0.0	0.5	3.5	1.5	1.0	2.9	0.0	3.7	25.5	0.0	11.5	4.8	1.8	28.0	18.1	7.7	0.0	16.9	4.9	3.2	0.0	26.0	0.8	7.6	6.0	34.8	4.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	303.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	3.6	41.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.2	0.0	3.6	0.0	0.0	8681.4	0.0	0.0	0.3	0.0	5.3	0.0	0.8	2.8	0.0	1287.5	0.1	0.0	6.0	0.0	1.1	1.0	0.0	0.0	0.9	3.4	5.4	0.0	0.0	1.7	7.3	5.0	0.0	6.5	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	33.3	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	534.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	11.1	9.1	0.0	1.5	5.4	0.0	1.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.3	0.3	1.7	0.0	4.0	0.0	5.1	0.0	0.4	0.0
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87724051-87731469	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 563.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 128.1;non-classical monocyte: 195.2"	"Lineage enriched"	"Detected in many"	12	"monocytes: 195.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2305.0;HSkMC: 1061.0"					"Low region specificity"	"Detected in all"			"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	232.4	86.6	49.2	136.0	55.4	84.8	110.0	52.9	67.5	69.5	67.9	110.3	39.7	108.1	81.6	33.3	108.4	85.0	112.5	47.0	52.3	207.3	333.5	154.9	101.1	54.4	54.0	96.4	61.9	151.1	69.5	563.6	57.5	68.2	58.8	32.3	77.6	91.7	71.9	39.8	57.1	125.2	52.4	124.4	71.4	80.1	112.2	33.0	76.1	79.8	49.4	209.8	48.0	59.6	88.1	423.0	32.6	55.3	514.0	2305.0	198.4	267.2	781.8	232.2	300.6	43.0	86.3	0.0	128.9	355.4	754.0	67.5	49.8	86.0	198.4	1.9	37.8	18.1	111.2	105.1	352.6	0.1	51.4	1061.0	138.9	373.7	134.9	186.6	194.9	0.0	162.5	0.7	326.6	115.6	0.5	9.9	67.7	128.6	77.5	21.6	21.5	0.6	158.6	39.0	42.8	50.6	62.1	133.5	312.3	177.9	14.5	97.9	296.9	190.8	104.7	750.6	125.9	18.5	84.1	0.9	692.6	0.2	67.9	0.3	13.5	0.6	0.3	128.1	0.0	0.0	6.6	0.1	7.9	0.1	16.7	1.3	0.5	0.2	195.2	0.3	1.7	10.1	49.2	55.4	52.9	67.5	47.0	52.3	54.4	54.0	57.5	52.4	112.2	59.6	86.1	41.7	52.9	15.3	11.2	37.7	82.1	58.0	15.4	43.8	12.2	33.4	96.8	87.2	46.4	75.4	18.8	1081.6	0.3	16.3	27.4	91.8	5.3	48.1	119.9	110.0	11.5	251.2	18.6	93.4	1012.3	261.7	10.2	27.6	29.7	63.6	580.4	122.6	1105.7	13.5	24.0	8.5	20.3	206.9	105.4	17.4	156.9	537.2	64.0	14.0	16.2	79.5	0.0	17.6	31.7	67.2	5.6	187.3	1.9	34.5	8.0	138.3	67.3	45.4	92.1	176.9	136.3	207.4	60.5	6.8	34.0	1543.6	10.8	30.8	11.7	44.8
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730079-150765957	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.0;lymphoid tissue: 164.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 698.6;Kupffer cells: 2230.8;Macrophages: 1316.2;monocytes: 2312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 2483.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 81.6;HMC-1: 187.5;U-698: 387.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		23000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	40.0	16.7	4.0	87.8	4.5	137.0	20.3	4.8	7.1	9.4	8.0	83.6	60.2	7.8	5.7	16.5	17.8	29.1	10.6	3.4	5.5	9.3	40.4	88.4	71.7	11.8	8.0	4.9	11.3	2.3	4.7	23.6	11.2	9.1	59.4	3.4	23.9	7.3	4.1	7.1	64.6	16.3	7.7	164.8	42.6	3.8	10.4	20.1	11.5	9.0	38.5	42.9	10.0	16.1	3.7	10.9	0.2	0.3	1.2	1.4	0.7	0.4	8.6	0.9	1.3	1.2	81.6	44.3	5.7	1.2	15.3	2.1	0.2	0.7	0.5	26.9	0.2	29.0	1.1	0.8	0.2	33.6	187.5	2.6	0.1	6.6	1.5	0.5	6.3	0.6	3.4	45.0	2.4	0.3	0.4	22.5	0.2	0.1	0.3	14.9	4.6	49.8	10.7	8.7	0.3	0.4	1.1	2.3	0.8	0.3	0.4	49.8	9.1	6.2	1.3	0.8	1.2	27.8	2.2	387.3	28.5	35.2	2.3	20.9	2483.4	218.0	41.3	1735.3	51.1	139.5	46.6	50.9	571.0	138.8	45.0	40.8	1022.2	41.8	1655.1	106.8	77.4	2577.6	4.0	4.5	4.8	7.1	3.4	5.5	11.8	8.0	11.2	7.7	10.4	16.1	37.6	109.0	158.7	1.6	255.3	17.0	31.3	72.0	4.6	2.3	21.0	8.9	5.3	74.4	143.4	42.3	12.5	3.7	198.0	549.2	0.0	183.6	6.6	126.9	8.6	44.1	42.4	22.5	10.3	177.0	5.7	34.4	71.9	39.0	106.8	9.5	60.3	30.6	698.6	0.0	9.5	205.7	73.2	2230.8	316.4	3.0	5.3	1316.2	56.9	27.2	2312.9	0.5	137.0	0.5	0.9	200.9	466.5	2.2	121.4	20.6	210.8	4.7	488.9	4.9	19.7	5.6	13.3	0.2	0.5	12.4	15.5	6.2	108.9	66.0	237.8	113.3
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 450.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	91.7	142.5	28.3	15.6	30.0	4.9	82.9	29.7	32.3	112.3	28.5	84.9	28.4	117.8	18.7	131.6	85.0	35.1	106.9	27.7	28.2	109.6	66.9	74.8	9.0	33.2	30.8	112.9	79.5	18.1	94.1	23.9	30.9	101.6	23.8	8.4	92.9	27.0	65.7	104.4	70.9	31.8	29.5	53.3	92.2	62.0	30.3	8.7	89.5	14.5	12.7	88.1	101.2	32.5	450.2	97.2	32.0	37.2	53.2	81.9	52.5	93.8	92.5	80.7	63.4	129.5	110.3	17.5	90.6	121.1	86.3	97.3	38.6	98.7	58.7	35.5	39.1	1.7	73.6	61.1	113.9	0.4	22.6	116.6	68.0	89.4	50.2	84.4	68.8	0.5	51.3	3.3	80.9	122.9	0.9	6.4	35.0	163.4	58.6	0.2	39.3	14.3	90.5	143.7	26.3	44.9	68.3	93.2	158.0	57.2	75.8	1.9	86.8	70.8	45.3	111.2	63.6	7.4	5.2	1.0	141.1	0.4	98.9	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.1	0.4	0.0	6.8	28.3	30.0	29.7	32.3	27.7	28.2	33.2	30.8	30.9	29.5	30.3	32.5	95.3	44.8	51.8	61.7	4.0	151.9	102.8	85.8	46.1	39.4	81.0	57.9	64.1	80.1	95.4	134.3	18.8	83.8	1.6	224.4	64.6	146.5	12.4	86.4	84.8	89.9	74.4	18.9	93.4	221.5	95.6	89.1	76.0	116.1	6.3	117.7	78.9	44.1	10.4	38.7	65.4	123.8	57.0	8.9	34.1	26.1	103.2	38.6	122.7	28.1	5.9	42.5	0.0	40.2	145.8	260.6	177.8	98.9	3.1	153.5	108.4	164.3	89.4	32.5	59.2	61.0	87.5	32.0	47.0	76.7	174.9	106.3	5.4	91.4	111.9	258.1
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 466.3;Late spermatids: 567.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: AB_2685294"	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	33.2	27.3	19.6	29.4	20.9	15.5	30.2	20.4	26.5	28.1	22.2	38.9	23.0	29.8	28.8	30.6	29.4	23.2	35.9	22.1	23.0	21.6	45.1	26.3	39.0	20.4	21.2	30.9	20.6	36.3	25.6	32.7	20.4	27.3	24.5	52.1	26.1	30.1	88.8	28.8	27.3	32.2	21.8	30.0	29.7	95.1	21.3	30.3	27.4	74.6	35.6	34.9	26.6	21.7	79.9	61.6	59.5	93.6	46.6	51.6	72.8	64.8	77.7	65.8	61.4	64.5	53.9	109.6	49.5	65.9	104.4	52.5	87.0	59.9	76.4	72.8	71.9	65.2	39.6	64.5	50.5	74.8	58.9	40.0	58.5	45.9	46.0	59.9	71.3	52.8	100.8	78.2	72.2	76.4	64.1	81.0	111.6	68.6	58.8	78.7	52.3	106.3	54.2	55.4	83.3	61.0	74.5	92.3	51.4	69.9	29.0	57.5	56.6	44.1	15.4	87.7	75.8	70.4	54.2	96.7	94.3	82.5	66.2	15.5	17.0	14.1	16.5	18.3	21.8	17.3	18.9	21.2	26.6	15.0	22.4	18.5	1.4	27.9	18.5	6.7	18.5	20.0	19.6	20.9	20.4	26.5	22.1	23.0	20.4	21.2	20.4	21.8	21.3	21.7	24.0	35.3	40.9	41.4	26.0	27.9	31.1	19.5	22.2	33.4	13.8	17.5	29.2	12.8	32.2	9.2	29.2	66.6	19.1	12.0	17.6	28.1	466.3	20.4	23.4	25.1	15.6	23.1	76.3	26.2	77.1	29.9	19.4	21.9	23.4	31.6	18.5	41.5	29.8	21.9	89.5	19.7	22.4	18.5	16.8	567.7	21.8	25.7	28.4	60.9	51.7	32.7	37.0	52.8	74.3	28.5	15.0	30.5	25.3	29.8	11.7	13.5	33.6	48.9	32.9	30.3	38.9	59.6	34.0	20.6	25.4	73.2	26.5	24.1	18.8	21.7
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120505920-120604074	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Late spermatids: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm		NA	NA		18000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868"	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	18.7	20.5	15.3	14.4	16.5	9.8	20.0	18.2	19.3	24.6	15.7	20.0	12.3	18.7	27.3	23.4	19.6	15.5	15.5	16.0	19.2	18.1	19.5	14.5	20.5	14.4	16.4	25.2	17.0	24.2	26.9	15.5	15.7	18.2	13.5	19.9	15.1	22.5	10.0	15.2	15.4	15.6	13.7	17.7	15.5	28.0	16.2	25.3	15.8	12.5	21.8	18.2	20.3	16.1	41.9	37.3	28.7	31.4	129.5	57.0	22.4	89.8	104.1	71.3	69.4	30.4	110.6	40.1	35.5	206.8	127.7	29.9	61.1	27.7	84.8	26.1	26.6	20.5	42.1	25.9	50.6	22.6	28.1	65.6	22.2	45.1	37.5	134.8	133.2	22.6	33.6	31.7	78.4	24.5	30.7	19.0	45.4	52.6	39.5	23.4	27.1	43.4	23.2	19.5	32.9	27.4	74.2	36.8	36.5	35.0	28.8	20.9	177.6	57.1	30.5	76.3	88.6	21.2	50.0	52.2	59.9	28.2	55.2	6.6	3.8	8.1	5.6	3.1	6.1	5.7	5.2	5.2	4.4	4.4	6.0	6.2	14.4	4.4	2.4	7.0	6.9	4.1	15.3	16.5	18.2	19.3	16.0	19.2	14.4	16.4	15.7	13.7	16.2	16.1	18.7	22.4	14.4	11.8	15.5	15.2	9.6	12.9	12.5	15.7	17.3	14.7	14.6	8.6	11.7	14.7	14.6	10.1	19.9	14.7	13.7	10.1	106.9	12.4	15.6	18.2	24.6	13.3	18.4	8.9	25.0	21.2	14.3	15.8	14.0	20.5	40.7	16.4	17.5	25.2	20.9	13.9	8.2	30.5	13.9	169.3	21.5	18.4	12.4	14.0	17.6	15.0	7.2	23.1	21.0	16.7	7.3	21.4	18.9	9.5	11.0	14.4	17.8	14.1	13.1	17.0	16.6	12.6	13.9	23.0	13.8	10.0	14.1	21.7	12.7	9.5
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CUX2	"CDP2, CUTL2, KIAA0293"	ENSG00000111249	"Cut like homeobox 2"	O14529	12	111034165-111350554	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.6;choroid plexus: 25.7;liver: 20.4;prostate: 11.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.1;Excitatory neurons: 175.4;Hepatocytes: 50.9;Horizontal cells: 26.9;Inhibitory neurons: 72.5"	"Group enriched"	"Detected in some"	4	"liver cancer: 5.2;prostate cancer: 11.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 20.6"	"Immune cell enriched"	"Detected in single"	70	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	70	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.6;HDLM-2: 2.9;hTERT-HME1: 3.5;SCLC-21H: 6.5;SH-SY5Y: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.87e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.83e-5)"	"unprognostic (2.67e-1)"	"unprognostic (3.54e-3)"	"unprognostic (4.31e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.90e-2)"	0.0	0.0	2.3	0.2	1.4	0.2	1.8	0.0	20.6	0.8	25.7	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	3.5	0.0	0.2	20.4	0.0	0.5	0.0	1.5	0.0	0.1	0.0	2.1	0.0	0.0	11.4	0.0	2.3	0.0	2.9	0.1	0.2	0.2	0.0	0.0	0.2	1.5	0.5	5.2	0.2	4.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.6	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.5	14.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	2.3	1.4	0.0	20.6	3.5	0.0	0.0	1.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	7.2	0.5	0.0	3.5	0.7	0.0	6.4	2.6	3.0	1.0	2.8	0.1	0.0	0.0	0.0	28.1	0.1	0.0	0.0	1.2	3.7	0.1	0.1	0.0	2.7	175.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	50.9	0.7	26.9	72.5	0.0	0.0	0.6	0.0	0.6	0.0	0.5	0.0	1.9	0.0	0.1	0.0	20.1	1.8	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372477-57385044	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis, Host-virus interaction, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 104.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal prostatic cells: 50.8;Basal respiratory cells: 51.8;Breast glandular cells: 62.3;Breast myoepithelial cells: 51.1;Club cells: 54.8;Endothelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 30.1;HDLM-2: 86.0;Hep G2: 63.8;RPTEC TERT1: 36.5;SK-BR-3: 21.5"	"Low region specificity"	"Detected in all"							"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	1870000	370000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	68.3	4.8	36.4	5.7	39.5	0.1	104.8	11.9	44.8	17.6	19.8	14.3	5.1	13.7	8.7	14.4	18.2	21.0	43.0	46.9	26.4	41.9	14.9	98.8	8.5	25.1	24.8	8.3	13.1	7.1	11.2	3.9	23.6	42.2	5.4	4.3	70.8	45.3	15.0	27.3	12.8	10.6	21.8	1.4	14.5	5.7	30.5	5.2	29.7	19.2	6.2	33.0	17.3	31.2	0.0	0.8	8.0	6.8	0.3	0.1	2.0	0.1	0.0	0.0	0.1	3.1	0.0	0.0	30.1	0.1	4.3	0.3	0.0	0.1	0.0	86.0	0.4	0.0	0.0	63.8	0.9	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.8	0.1	0.0	0.1	1.1	0.2	36.5	0.2	0.2	7.1	0.0	21.5	1.9	5.1	0.1	0.2	0.1	0.3	4.7	0.2	2.1	0.1	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	36.4	39.5	11.9	44.8	46.9	26.4	25.1	24.8	23.6	21.8	30.5	31.2	115.4	3.2	4.6	3.3	1.2	4.5	50.8	51.8	31.9	9.8	62.3	51.1	8.3	21.5	54.8	3.7	4.2	0.0	0.8	0.5	0.0	35.1	0.4	12.9	3.3	50.7	1.8	0.0	28.1	1.8	0.1	9.0	0.5	27.3	1.3	0.2	6.1	11.7	0.0	5.0	20.5	0.3	20.3	0.8	4.7	0.5	4.7	0.6	0.0	16.9	0.6	0.8	0.0	13.0	3.2	4.3	0.6	27.8	0.0	29.7	0.2	11.8	28.8	2.2	13.1	2.8	15.7	0.1	0.1	10.3	2.6	0.3	0.8	0.3	1.0	32.6
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263495-39281735	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.4"	"Group enriched"	"Detected in some"	5	"Microglial cells: 177.1;NK-cells: 350.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 449.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	21	"RPMI-8226: 589.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	6.2	6.9	6.4	1.1	5.1	8.6	6.0	2.7	1.7	1.1	1.2	2.7	4.2	0.8	6.1	2.6	2.4	7.7	8.4	2.5	2.0	9.9	2.1	17.3	14.8	1.6	0.7	4.5	1.0	4.6	18.9	3.5	1.1	0.5	7.6	7.2	6.5	2.3	0.9	3.5	21.5	11.9	1.4	1.8	17.4	2.0	2.4	2.2	5.3	2.4	0.3	26.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	6.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	24.5	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.2	0.1	589.8	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.2	0.1	16.5	0.0	0.0	0.1	0.1	0.0	0.5	1.0	0.1	0.0	28.6	0.0	7.7	99.6	1.8	264.0	261.2	3.4	0.8	55.9	145.2	94.4	0.7	19.0	122.4	20.8	39.7	449.2	7.1	1.5	232.7	6.2	6.4	8.6	6.0	7.7	8.4	17.3	14.8	18.9	21.5	17.4	26.4	0.8	0.0	0.5	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.8	3.8	0.4	0.0	0.6	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.2	0.2	0.1	3.5	0.0	2.1	0.3	0.0	0.0	0.3	0.0	0.0	5.1	0.1	0.7	0.3	4.1	0.0	0.6	0.0	0.0	15.0	28.0	0.3	0.3	43.2	0.0	177.1	50.3	0.1	350.1	2.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.7	0.2	6.6	0.4	1.3	0.7	0.2	0.0	0.6	0.0	22.6	0.1	0.1	0.0
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871308	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 102.2;lymphoid tissue: 196.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16674.3;Club cells: 7384.0;Ionocytes: 4146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	243	"neutrophil: 47.3"	"Lineage enriched"	"Detected in single"	243	"granulocytes: 47.3"	"Group enriched"	"Detected in many"	6	"BJ hTERT+: 748.4;EFO-21: 1906.7;RPTEC TERT1: 682.0"														"Secreted to blood"	NA	NA	384000		"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"prognostic favorable (7.83e-4)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	38.0	6.2	4.3	49.0	4.9	41.6	3.8	3.6	8.1	102.2	4.8	14.6	10.6	2.3	0.1	38.7	14.9	25.7	28.3	3.5	3.7	18.7	10.2	45.2	2.4	4.0	3.7	2.4	25.7	0.4	2.0	5.1	4.3	18.7	16.0	0.4	23.7	9.5	1.7	2.2	26.9	3.0	4.1	196.6	9.1	0.2	5.4	2.9	1.9	1.9	23.6	75.5	25.5	4.2	3.7	4.4	0.0	0.0	4.4	11.7	0.0	20.6	748.4	17.7	18.8	0.2	13.4	0.0	1906.7	1.3	72.5	38.6	0.0	3.5	94.2	2.8	0.0	0.0	1.3	0.0	4.4	0.0	0.0	9.7	1.3	133.2	10.6	1.4	144.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.7	5.4	0.0	0.0	0.0	682.0	16.7	0.1	0.0	1.5	0.3	40.4	2.0	0.5	1.9	173.9	0.0	6.6	37.8	1.5	0.0	1.6	3.7	1.9	0.1	26.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	4.3	4.9	3.6	8.1	3.5	3.7	4.0	3.7	4.3	4.1	5.4	4.2	7.9	44.8	273.3	0.0	2.9	126.6	991.1	16674.3	131.5	0.0	61.3	42.9	4.1	413.2	7384.0	5.5	0.0	0.3	1.4	40.3	0.0	1073.2	0.0	152.2	21.5	106.7	635.7	0.0	0.0	42.5	0.7	449.0	20.9	199.0	15.8	1.4	3.9	2.1	26.7	0.0	0.0	31.1	4146.2	10.4	467.3	0.0	0.0	110.8	124.5	0.0	56.9	0.0	0.0	0.0	0.0	232.8	7.6	0.0	0.1	2062.0	19.6	3.1	1219.7	0.0	0.0	152.9	217.7	0.4	0.2	48.7	105.1	0.4	27.8	0.1	66.0	1251.3
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021118-76023497	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 52.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	253000		"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.0	5.9	1.4	95.5	1.5	1.2	20.7	0.9	2.6	13.2	1.2	10.7	11.2	7.1	0.7	8.0	4.1	10.6	4.4	1.2	1.0	7.8	29.0	35.1	68.0	7.4	1.2	3.0	0.9	17.1	2.1	10.3	10.8	43.9	15.9	0.4	20.1	1.8	1.2	2.0	11.2	15.8	3.4	20.3	19.2	3.0	2.6	35.2	3.7	1.1	17.3	45.1	3.7	1.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.1	2.2	2.2	0.2	0.1	2.0	0.2	0.0	5.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.3	0.1	2.4	0.0	0.0	0.0	0.4	1.3	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	21.5	0.0	0.0	52.4	0.0	1.4	0.3	0.0	3.5	0.1	0.0	0.0	1.1	0.0	36.9	0.0	0.0	7.6	1.4	1.5	0.9	2.6	1.2	1.0	7.4	1.2	10.8	3.4	2.6	1.5	3.8	0.0	2.2	0.0	2.2	0.9	9.4	52.7	0.6	0.0	2.6	7.0	0.3	1.5	2.8	0.0	0.0	0.1	0.0	2.7	0.0	5.9	2.6	12.5	10.9	8.0	0.0	0.0	0.0	0.0	0.0	6.9	3.1	23.5	1.3	0.0	0.0	0.1	17.3	0.0	0.0	1.0	10.2	41.1	21.4	4.0	0.3	45.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	11.4	6.4	2.6	1.3	0.0	0.0	1.3	12.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.9	1.4
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097040-74099196	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 509.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1668.3;Basal respiratory cells: 3166.0;Basal squamous epithelial cells: 1671.5;Langerhans cells: 2390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 1.1;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.1"	"Cell line enriched"	"Detected in many"	8	"GAMG: 430.9"														"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"prognostic favorable (5.93e-5)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	95.6	12.5	4.7	28.2	3.7	88.7	39.6	3.3	6.1	61.0	4.0	9.6	3.5	15.1	0.3	12.2	17.4	52.2	49.8	4.3	10.1	14.7	509.9	87.6	12.6	5.8	4.7	9.1	88.3	2.7	7.2	3.8	4.0	13.4	21.1	1.7	20.7	10.0	21.5	3.2	11.0	14.8	4.4	7.8	26.6	1.3	9.7	3.8	6.6	35.6	1.3	82.1	3.4	4.2	1.3	3.8	0.2	0.0	1.3	4.4	0.1	4.2	52.9	2.1	6.2	0.3	8.0	0.0	7.0	0.3	430.9	0.1	0.3	11.2	8.4	0.1	0.2	3.3	5.0	0.0	35.6	1.4	0.0	4.0	38.5	27.2	37.0	1.4	4.6	0.1	0.1	0.0	1.1	0.0	0.5	0.5	0.0	4.6	1.1	0.0	0.0	0.0	26.2	0.0	0.0	0.1	2.5	0.4	1.1	0.4	0.1	0.1	7.1	1.9	0.7	7.7	4.0	0.1	0.1	0.1	30.8	8.9	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	4.7	3.7	3.3	6.1	4.3	10.1	5.8	4.7	4.0	4.4	9.7	4.2	620.7	477.5	1668.3	1.0	15.0	415.5	336.3	3166.0	1671.5	0.0	762.9	283.3	22.9	469.0	957.6	9.2	0.0	3.3	17.9	91.4	0.0	858.1	1.1	489.8	149.1	677.8	132.1	34.7	0.0	603.6	3.1	488.7	206.9	1223.1	85.2	0.1	365.1	325.8	117.3	0.0	0.0	131.6	498.5	291.4	2390.3	0.8	15.8	926.0	277.5	0.0	50.7	0.6	0.0	0.0	0.0	282.5	14.6	0.0	35.3	342.6	57.8	1.1	194.1	0.3	72.3	131.8	288.7	1.1	5.0	440.3	227.7	2.2	36.3	0.6	128.5	119.1
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.8;cervix: 20.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2244.7;Club cells: 738.5;Ionocytes: 724.2;Langerhans cells: 2366.2;Macrophages: 718.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4;stomach cancer: 18.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.5;hTEC/SVTERT24-B: 75.0;RPTEC TERT1: 43.8"														"Secreted to blood"	NA	NA	28700			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	20.8	1.0	0.7	14.4	0.4	15.8	1.6	0.4	2.2	20.7	0.6	4.1	0.7	0.7	0.0	1.0	1.3	6.9	6.4	0.5	0.6	1.4	3.9	15.8	0.7	0.6	0.6	1.0	1.8	0.1	0.5	0.6	0.5	1.7	9.2	0.1	5.9	0.3	0.5	0.5	2.5	1.6	0.5	2.0	8.9	0.3	2.7	2.0	0.7	1.0	0.7	15.9	0.6	0.7	0.5	3.7	1.5	0.0	0.8	1.4	0.0	5.3	48.5	1.3	2.9	0.1	5.9	0.0	5.2	0.0	17.6	0.2	0.3	1.7	10.5	0.0	0.0	4.1	0.6	0.0	5.7	0.5	0.0	1.1	1.2	75.0	7.3	1.2	1.1	0.8	0.9	0.0	2.1	0.0	1.1	0.2	0.7	7.0	1.5	0.1	1.7	0.0	43.8	1.3	0.0	0.0	0.5	0.0	1.1	0.7	0.2	0.0	2.0	10.5	0.6	5.3	13.7	0.0	0.0	0.0	11.9	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.4	0.4	2.2	0.5	0.6	0.6	0.6	0.5	0.5	2.7	0.7	34.2	99.3	244.9	1.6	10.1	228.4	205.6	2244.7	340.9	0.0	123.0	79.9	14.8	125.8	738.5	5.5	0.0	0.7	5.9	137.1	0.0	217.6	1.7	103.4	24.3	113.7	52.9	0.0	0.0	96.7	1.1	161.0	408.7	157.2	27.3	0.2	15.7	1.4	72.2	0.0	0.0	168.3	724.2	162.9	2366.2	5.6	14.0	718.0	188.5	1.0	28.1	0.0	0.0	0.0	0.0	186.1	33.5	0.4	5.1	225.9	95.7	0.2	144.2	0.0	39.5	78.5	92.6	1.7	8.3	50.3	148.6	8.1	14.0	0.1	197.5	79.7
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998677	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 35.9;salivary gland: 50.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 56.2;stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6"									HPA065474	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1110000	1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	2.1	0.2	1.5	35.9	0.9	1.2	3.2	0.6	8.8	7.7	0.4	0.7	0.8	0.2	0.0	0.1	0.2	4.8	0.6	0.8	2.6	0.2	1.3	10.0	6.3	1.4	2.1	0.0	0.5	0.0	0.1	0.2	3.1	1.3	0.3	0.0	50.2	0.5	0.1	0.0	2.1	0.2	1.1	2.1	8.5	0.4	5.7	0.6	0.0	0.2	0.6	8.4	0.0	0.7	0.1	191.9	0.7	0.0	0.3	6.9	0.0	3.5	2.9	1.5	3.0	0.6	1.6	0.0	157.0	0.1	34.0	0.4	0.0	0.0	17.6	0.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	111.4	0.0	81.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	603.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.0	1.5	0.9	0.6	8.8	0.8	2.6	1.4	2.1	3.1	1.1	5.7	0.7	0.2	3.2	0.0	0.0	0.0	0.9	0.7	64.6	0.0	0.0	8.0	4.4	1.2	15.7	33.2	0.0	0.0	0.0	0.1	1.3	0.0	94.0	0.7	0.7	0.1	1.8	0.0	0.0	0.3	1.4	0.1	3.6	15.3	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.7	4.1	0.3	30.4	0.3	0.0	222.6	0.0	1.0	2.1	0.0	0.0	0.0	0.1	245.4	0.0	0.0	0.3	3.1	0.0	0.1	4.3	0.0	0.0	0.6	4.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	1.1	2.0
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740541-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3301.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"cerebral cortex: 136.1"	"Immune cell enriched"	"Detected in some"	451	"neutrophil: 483.0"	"Lineage enriched"	"Detected in single"	788	"granulocytes: 483.0"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 4072.6;GAMG: 1080.2"					"Not detected"	"Not detected"			HPA057179	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7260		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	67.9	13.5	1.8	209.9	2.8	3301.3	3.6	1.7	136.1	54.5	7.6	10.6	3.6	41.0	0.2	3.7	8.9	177.2	33.8	1.7	1.6	10.8	77.7	91.2	1.2	2.1	1.6	6.0	16.1	1.8	3.2	41.1	15.1	9.6	7.3	0.9	25.4	1.5	1.3	3.2	4.9	12.7	1.9	10.3	8.8	0.7	4.9	15.2	3.4	8.1	8.7	456.7	4.0	1.9	2.7	1.4	0.0	0.1	3.9	19.4	0.2	25.7	4072.6	35.9	117.0	0.2	13.0	0.2	547.6	1.3	1080.2	48.2	0.0	1.0	562.3	1.8	0.2	0.9	0.4	6.5	6.8	41.0	2.5	12.4	1.7	119.0	2.9	12.9	124.9	0.0	1.4	0.8	0.7	0.0	0.0	55.7	0.0	14.7	20.3	0.3	0.5	0.9	317.3	17.2	0.1	0.0	1.9	0.1	61.1	0.8	0.1	5.6	308.3	56.8	5.1	15.1	55.0	0.4	0.7	1.7	252.5	30.9	88.2	1.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	483.0	0.0	0.0	0.0	0.0	0.1	1.8	2.8	1.7	136.1	1.7	1.6	2.1	1.6	15.1	1.9	4.9	1.9	28.6	51.3	254.1	0.0	26.4	0.0	13262.1	0.0	164.4	0.5	40.2	15.4	23.8	127.2	426.5	0.0	0.0	4.3	17.7	14.4	0.0	1695.0	3.2	717.6	257.1	712.2	19.1	8.0	0.0	260.7	5.2	1475.1	54.0	1708.7	51.2	0.5	15.7	3.6	367.1	0.0	0.0	26.4	0.0	543.0	0.0	1.9	0.6	3685.4	0.0	0.0	1178.5	0.5	0.0	0.0	0.0	584.9	0.3	0.4	27.3	8869.1	0.9	1.0	178.6	1.1	39.5	44.3	263.0	0.3	2.5	124.9	0.0	21.3	138.8	0.0	18.5	13149.4
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007509	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 309.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.0;Hofbauer cells: 6.2;Kupffer cells: 10.3;Macrophages: 12.6;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	902000		"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	5.5	2.0	0.1	65.1	0.2	0.2	17.5	0.1	0.6	4.9	0.3	10.2	3.0	4.8	0.7	5.3	2.8	8.5	5.9	0.1	0.1	8.7	19.1	31.8	309.9	1.8	0.2	3.8	1.4	1.5	1.0	1.7	1.6	3.7	25.3	0.0	19.0	0.7	1.5	2.9	6.0	3.2	0.3	31.2	17.5	6.0	0.2	32.8	7.1	2.5	30.6	11.1	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	1.8	0.2	1.6	0.3	0.2	0.3	3.4	0.0	1.7	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.4	0.0	0.2	1.3	0.1	1.1	2.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	5.0	1.8	6.2	0.0	0.0	0.0	0.0	10.3	3.6	1.3	0.6	12.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	3.5	1.7	8.0	0.0	0.3	0.1	0.5	0.0	0.1	0.4
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095039-144097525	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 730.0;tongue: 724.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 817.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 1125.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Approved	Mitochondria		NA	NA		45000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favorable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	84.7	173.2	92.1	62.4	97.2	104.4	72.7	115.4	103.8	71.4	102.4	162.6	171.2	75.9	35.7	155.5	67.8	39.5	527.7	92.3	105.3	152.6	180.4	56.7	55.8	99.8	96.9	63.6	101.2	163.3	58.2	45.8	103.1	67.8	111.0	42.0	104.4	70.0	730.0	106.5	127.5	59.9	94.9	70.1	139.6	38.9	106.9	63.4	64.8	724.9	61.0	92.0	86.5	99.6	172.0	381.4	98.9	208.4	80.5	88.5	189.6	96.7	116.7	240.2	156.9	269.4	208.2	241.0	210.8	129.8	116.2	247.3	217.9	191.2	89.8	148.2	289.2	259.7	306.5	250.4	143.1	154.7	162.5	129.4	234.9	153.2	301.4	80.6	141.3	163.7	240.4	208.2	127.7	616.8	292.0	143.5	115.1	476.8	1125.5	253.7	132.4	422.1	199.7	273.0	263.3	117.2	267.8	365.7	200.0	54.0	302.5	233.2	108.8	152.1	321.6	169.6	299.7	229.1	179.7	183.8	193.2	261.9	198.4	185.7	340.4	95.7	131.6	360.4	139.8	208.7	108.1	141.5	444.1	180.3	104.9	134.6	32.7	187.8	278.8	251.0	158.2	397.1	92.1	97.2	115.4	103.8	92.3	105.3	99.8	96.9	103.1	94.9	106.9	99.6	77.0	19.2	29.3	23.5	94.0	156.1	191.9	394.8	62.6	113.6	110.7	102.6	402.3	181.6	156.0	79.1	81.3	263.6	61.7	516.1	817.8	239.9	81.2	59.1	68.1	88.0	146.4	130.6	14.4	289.1	257.1	102.8	144.8	60.2	59.7	89.2	62.4	239.4	246.3	87.5	21.6	390.4	272.6	104.8	139.4	88.6	88.9	101.4	179.7	12.2	208.4	115.2	92.7	12.1	17.5	290.6	332.5	90.7	149.9	237.9	570.0	468.6	86.1	100.9	72.3	109.4	250.6	83.1	116.7	212.9	163.7	236.8	63.8	197.5	602.6	258.3
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25118656-25125260	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 799.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	86.0	115.6	65.8	89.2	70.4	85.0	59.2	79.8	101.7	45.3	87.6	263.6	150.1	42.3	41.5	105.9	43.0	52.9	476.8	72.1	82.8	174.6	115.7	54.3	63.8	71.0	72.9	48.1	38.5	226.2	57.0	43.0	69.4	54.3	238.8	153.9	58.0	60.1	483.7	47.6	120.1	91.1	70.2	48.0	108.1	61.1	83.4	74.0	74.6	799.8	89.4	119.8	60.1	71.7	336.4	185.1	195.0	273.7	108.7	83.1	199.6	314.4	128.0	229.2	264.5	307.4	222.2	383.8	152.9	138.5	678.3	385.8	396.5	295.0	401.2	115.0	179.1	318.6	208.9	218.7	170.2	739.0	271.1	111.2	257.5	230.9	492.9	99.4	209.5	232.2	597.1	397.9	246.0	155.1	408.6	284.4	365.1	746.3	343.0	282.1	235.3	364.5	360.9	322.5	392.6	190.3	164.5	689.0	267.9	338.7	359.5	436.6	152.8	209.3	383.3	329.8	591.8	401.4	507.3	860.5	281.0	526.4	606.7	65.3	56.2	42.8	68.0	106.0	82.5	102.5	62.2	71.6	105.7	90.0	58.6	70.2	8.2	73.3	96.8	81.5	87.5	83.0	65.8	70.4	79.8	101.7	72.1	82.8	71.0	72.9	69.4	70.2	83.4	71.7	244.3	83.3	118.6	42.4	337.6	689.8	818.3	698.5	237.9	163.1	210.6	179.6	770.0	144.4	314.2	183.9	77.2	192.6	304.4	827.5	1663.0	278.3	496.4	154.8	120.2	183.3	384.9	162.6	53.2	216.0	351.0	257.3	287.5	197.5	212.6	68.7	81.0	210.8	353.0	132.9	64.6	522.5	502.5	141.5	715.2	161.8	90.1	329.2	590.5	16.9	245.8	220.9	197.8	17.1	24.2	303.8	570.5	93.6	358.7	551.9	392.8	638.6	146.1	195.2	138.1	294.7	962.3	423.1	211.1	402.7	715.2	349.3	349.7	146.9	600.2	884.1
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"adrenal gland: 8229.5"	"Cell type enriched"	"Detected in some"	17	"Theca cells: 1871.0"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.4	8229.5	0.0	2.1	0.0	0.0	0.4	0.1	0.1	1.1	0.0	0.5	0.0	0.8	0.1	0.9	1.0	0.4	1.0	0.0	0.0	52.9	6.7	1.4	0.0	0.0	0.1	16.6	1.7	10.5	0.7	0.0	0.0	0.7	0.0	0.2	3.4	0.0	1.0	0.7	0.6	0.0	0.0	0.9	1.3	98.3	0.0	0.0	2.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.7	0.0	0.0	1.8	0.0	0.4	0.1	0.1	21.5	0.0	41.6	0.1	0.0	0.7	0.0	2.7	0.1	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.4	6.1	0.1	1.7	0.1	0.0	0.0	0.6	0.7	10.6	1.8	0.9	0.0	0.0	0.1	0.2	3.1	0.5	0.1	0.7	0.0	0.0	0.0	0.3	0.0	104.3	0.0	1.2	0.0	1.2	0.6	0.3	0.1	0.0	0.0	0.3	0.4	1871.0	0.0	0.1
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725536	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.1;urinary bladder: 63.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	18.5	0.6	0.2	0.0	0.2	0.0	14.7	0.1	0.3	3.6	0.0	2.0	0.6	2.4	0.6	1.9	1.2	0.7	10.7	0.2	0.4	1.4	66.1	12.2	0.0	0.3	0.4	0.5	0.6	0.0	0.5	0.3	0.3	0.7	0.1	0.3	1.8	0.6	4.1	13.9	19.8	0.0	0.1	0.1	1.8	0.3	0.2	0.2	2.0	0.2	0.1	63.6	2.2	0.1	0.3	2.1	0.2	0.0	0.5	0.1	11.7	0.0	0.1	0.7	0.3	36.9	1.6	0.3	9.6	0.0	8.8	11.4	0.7	7.3	0.3	0.0	1.0	0.5	2.6	5.5	0.2	0.3	11.5	0.0	19.5	0.3	1.4	0.4	19.1	0.3	2.3	0.3	0.1	0.7	0.1	0.4	0.2	12.1	2.9	1.2	0.0	0.4	0.0	2.4	0.6	0.3	1.7	14.7	3.8	35.6	0.4	0.2	1.0	1.6	0.5	5.2	0.0	0.7	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.4	0.3	0.4	0.3	0.1	0.2	0.1	21.9	0.0	0.0	0.0	0.1	0.5	2.4	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.4	1.1	13.7	0.0	0.0	0.1	0.2	0.0	0.2	0.0	5.9	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	16.4
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	2.0	2041.7	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.9	0.0	2.5	0.0	1.5	0.6	0.6	2.4	0.0	2.9	0.0	0.0	7.0	44.8	0.8	0.0	0.0	0.0	4.3	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.7	1.1	0.0	0.0	5.5	0.8	0.8	0.0	0.0	2.3	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843541-40850447	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	171	"liver: 1612.0"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 322.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.6	0.2	0.0	0.0	0.1	0.0	9.4	0.0	0.2	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	1612.0	0.3	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.2	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	11.4	322.3	0.0	0.0	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.5
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683729-94736190	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.8;liver: 197.0;stomach 1: 67.2"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;OE19: 1.9"	"Not detected"	"Not detected"							HPA074424			Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA074424: "	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.3	0.0	0.0	1.6	0.1	0.0	0.3	0.2	0.1	5.3	0.0	5.9	102.8	0.1	0.0	30.9	0.0	16.3	0.0	0.1	0.0	0.3	197.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.5	0.0	5.4	0.0	0.0	4.4	83.1	0.1	0.1	0.0	67.2	0.1	0.1	0.3	0.0	0.0	7.1	0.2	9.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.3	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.1	17.2	3.2	0.0	0.0	0.1	0.0	6.7	0.0	1.5	0.0	0.6	0.1	0.0	0.0	2.7	0.5	6.9	0.2	0.1	68.8	1.3	0.0	0.0	1.8	124.0	0.0	0.0	0.8	2.1	2.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	3.9	0.0	0.3	0.0	62.5	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	22.8	1.7	1.5	0.1	0.1	5.7	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94855547	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 190.2"	"Group enriched"	"Detected in some"	11	"Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, HPA074424"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA015066: AB_1847433, HPA074424: "			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.2	0.1	0.2	32.4	0.0	0.1	1.6	0.0	1.7	0.0	0.1	0.0	0.0	190.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.6	13.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.4	9.5	0.0	0.0	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2156.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.3	1.8	1.7	0.0	1.9	0.2	0.3	1.4	2.1	0.3	1.4	0.4	0.2	0.1	0.3	0.1	1.1	4.6	0.3	1.8	2.2	1.4	2156.6	0.4	0.1	1.7	2.2	0.1	1.7	0.5	3.1	0.1	1.8	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.4	1.0	6.0	4.0	2.1	0.2	0.9	0.0	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.4	2.1	1.8	2.2	1.7	2.2	1.8	1.4	2.1	1.8	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 44.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	44.7	0.1	0.1	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.9;liver: 72.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 15.6;Hepatocytes: 62.9;Prostatic glandular cells: 36.3;Urothelial cells: 26.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.1;CAPAN-2: 50.4;EFO-21: 18.5;Hep G2: 25.0;RPMI-8226: 13.5;RT4: 15.2"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.3	2.9	5.2	0.6	5.3	0.6	2.1	5.1	5.3	1.6	0.0	3.5	10.7	0.5	16.4	13.0	3.0	18.7	0.2	4.3	5.5	6.4	72.3	0.6	0.4	9.3	9.6	0.1	5.1	0.1	0.5	0.1	6.3	3.8	2.6	1.6	3.8	4.3	0.5	1.0	23.9	0.1	4.8	1.0	4.1	1.1	6.6	0.0	3.0	0.0	0.9	5.7	3.4	5.0	13.1	2.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	50.4	0.1	18.5	0.0	10.5	1.5	0.0	6.6	0.0	0.0	0.1	0.1	4.2	25.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	10.0	0.0	1.9	0.1	0.3	0.1	11.4	0.0	0.1	0.1	13.5	3.4	15.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.6	0.2	0.4	1.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.3	5.1	5.3	4.3	5.5	9.3	9.6	6.3	4.8	6.6	5.0	0.1	0.0	0.0	9.1	0.2	0.1	7.7	5.3	0.0	0.0	1.4	1.7	0.4	10.0	4.4	9.2	0.0	0.0	0.0	6.9	1.9	15.6	0.0	2.8	0.6	0.3	1.2	2.7	0.0	11.5	0.0	0.3	0.0	4.4	0.0	0.3	0.4	62.9	0.0	0.0	0.0	2.0	2.0	2.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.8	9.2	3.2	0.0	0.0	36.3	11.7	8.3	7.6	0.1	0.0	0.6	0.6	0.0	0.0	0.5	0.3	0.0	0.1	0.1	2.7	26.1
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	30.5	26.2	41.1	52.4	53.2	69.0	23.4	45.5	45.2	16.1	38.0	30.1	22.6	12.5	8.6	50.8	16.4	25.7	31.0	40.3	45.5	22.8	33.8	44.5	78.9	52.3	50.8	10.2	29.3	10.7	14.8	27.1	51.7	24.6	32.9	82.9	32.0	8.1	35.9	31.3	41.3	16.6	44.3	57.5	43.0	15.8	50.2	58.9	26.2	22.9	89.0	25.0	25.6	68.5	24.6	16.9	16.6	14.3	11.2	14.1	15.9	11.4	10.0	13.6	15.9	10.7	26.8	18.2	11.1	15.0	23.3	21.2	8.1	29.6	10.9	38.4	22.5	7.4	22.9	19.8	8.0	15.3	70.5	6.9	23.9	15.5	15.9	9.3	44.4	59.9	12.4	68.1	16.3	12.5	98.7	13.6	4.2	39.7	14.9	25.9	18.4	64.3	14.8	16.9	9.5	34.6	20.0	38.2	16.6	16.7	18.8	17.7	21.2	10.7	15.6	17.1	11.8	78.5	39.0	66.0	7.9	15.1	11.4	150.2	41.6	85.6	96.5	51.5	69.1	63.6	79.6	78.5	35.9	55.4	86.4	74.7	85.9	59.0	48.8	49.3	66.2	93.6	41.1	53.2	45.5	45.2	40.3	45.5	52.3	50.8	51.7	44.3	50.2	68.5	65.9	60.9	52.1	48.3	83.4	41.2	31.0	28.1	45.5	65.5	18.4	14.9	18.8	18.6	34.5	5.5	110.5	3.0	123.6	50.4	7.9	12.1	29.6	62.6	17.4	58.9	27.6	11.2	29.9	18.5	8.3	16.5	58.6	110.3	36.0	13.7	27.8	28.7	48.9	43.7	58.9	49.3	34.6	80.2	135.1	46.1	4.4	76.8	37.4	61.8	121.7	21.1	122.6	52.3	170.9	42.7	32.8	5.3	88.6	39.0	16.3	6.9	50.5	78.3	6.6	8.6	10.4	16.0	15.6	54.8	34.4	7.3	113.1	10.6	20.6	58.4
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469208-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: AB_2732652"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.21e-4)"	8.1	12.1	17.2	11.4	17.8	8.1	14.2	20.3	19.0	15.9	15.4	9.3	21.5	10.7	13.6	15.3	7.6	23.2	7.4	16.2	17.1	21.0	7.2	11.2	8.2	18.1	19.1	7.5	16.6	19.6	14.8	16.3	17.4	15.0	8.3	39.0	22.6	9.1	3.6	15.1	21.3	8.2	15.3	10.6	17.5	35.6	21.2	14.9	52.5	5.7	8.8	10.9	10.6	21.2	24.7	36.8	107.9	24.7	16.2	13.9	19.6	18.9	17.3	19.9	18.7	20.1	32.9	16.1	19.2	16.6	16.5	30.4	21.1	23.1	12.5	24.6	28.1	22.5	52.6	22.0	14.6	14.0	29.7	18.0	38.5	24.6	15.9	90.2	26.0	23.4	22.9	55.0	26.6	20.0	23.9	102.5	11.8	22.1	14.9	29.6	15.9	11.2	34.2	52.1	31.9	30.9	20.7	57.6	16.8	34.0	27.1	18.8	28.3	42.6	21.3	10.3	27.8	54.1	30.8	10.8	15.5	27.1	30.7	2.8	2.7	2.3	2.6	2.1	1.8	2.6	3.2	3.7	2.4	1.8	2.8	2.0	7.2	1.4	2.7	3.9	3.6	2.1	17.2	17.8	20.3	19.0	16.2	17.1	18.1	19.1	17.4	15.3	21.2	21.2	48.5	28.9	33.5	15.0	18.7	45.9	115.0	81.1	26.7	35.6	47.6	28.7	11.5	55.8	63.2	40.5	25.0	51.2	42.6	35.0	35.2	82.7	285.9	85.3	26.5	56.0	26.0	4.6	5.7	93.6	47.0	33.5	55.0	56.3	17.7	32.5	50.3	8.3	43.7	21.9	6.8	29.3	67.1	27.9	39.7	163.0	37.3	34.9	35.6	9.4	52.0	42.6	22.6	4.5	12.0	136.6	36.2	36.9	23.2	77.1	57.9	53.3	80.6	59.5	52.6	42.9	70.9	63.5	53.2	23.2	47.5	142.7	33.2	26.0	25.4	139.2
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.1;Endothelial cells: 32.0;Erythroid cells: 86.6;Fibroblasts: 16.8;Hofbauer cells: 15.5;Microglial cells: 23.4"	"Group enriched"	"Detected in many"	5	"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"NK-cell: 27.0"	"Lineage enriched"	"Detected in many"	11	"NK-cells: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 194.1;HUVEC TERT2: 152.3;NB-4: 382.2;WM-115: 89.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		270000	"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.8	1.9	2.1	1.8	2.5	13.9	6.9	2.8	3.9	12.9	3.1	5.5	0.6	9.5	1.3	4.8	7.9	4.6	1.5	2.6	2.7	1.0	0.3	4.9	4.5	4.2	3.0	1.7	1.2	1.2	1.6	46.0	3.9	10.8	1.4	0.2	4.3	14.4	0.5	3.2	2.4	4.0	3.3	1.2	4.7	0.3	3.4	4.5	5.8	0.2	4.9	12.0	7.3	4.8	0.1	0.0	0.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.1	0.1	0.0	0.9	0.0	0.0	5.0	0.0	2.7	0.0	0.0	152.3	0.0	0.0	7.5	0.0	0.0	0.0	382.2	0.7	0.0	0.0	5.7	7.7	0.2	0.0	0.0	0.1	8.8	0.3	0.0	24.5	0.2	0.0	0.0	52.7	0.0	34.6	0.1	0.0	1.0	0.2	0.4	0.0	4.8	89.6	2.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.1	27.0	0.0	0.4	0.0	0.9	2.1	2.5	2.8	3.9	2.6	2.7	4.2	3.0	3.9	3.3	3.4	4.8	14.1	0.0	0.5	0.0	1.2	2.8	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.2	0.4	0.3	0.3	32.0	0.0	86.6	0.0	0.0	0.4	16.8	0.0	0.3	8.9	0.2	0.7	0.0	15.5	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	4.7	8.8	23.4	0.6	0.0	3.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.1	0.0	0.3	1.6	0.5	0.5	8.6	0.0	0.6
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 467.3;Suprabasal keratinocytes: 332.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA		9700	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: AB_2685352"	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	14.5	6.2	13.0	6.8	13.6	5.4	10.4	12.6	12.8	13.6	22.8	13.5	4.8	13.5	5.6	19.0	7.7	5.9	19.3	11.8	14.8	6.9	12.6	10.5	11.1	7.9	8.1	8.0	9.3	20.6	5.3	9.1	8.3	11.9	8.5	24.9	9.4	11.0	5.6	30.9	7.2	10.9	7.8	13.1	7.0	6.9	11.2	4.8	7.4	4.7	15.6	9.5	15.1	10.7	18.2	1.9	13.1	3.5	7.8	5.8	17.1	2.5	2.3	4.7	4.8	9.4	16.6	20.4	4.4	5.6	9.6	39.7	11.8	10.0	4.0	9.0	4.1	6.8	4.8	11.8	4.8	7.9	3.8	3.9	10.6	3.9	4.7	10.8	11.3	10.2	11.9	9.9	2.8	17.0	6.9	4.9	7.5	12.9	5.6	6.3	11.1	2.0	6.8	13.5	20.3	4.8	15.8	23.1	16.1	8.7	30.5	2.1	10.8	3.9	7.4	8.4	2.2	2.2	2.7	22.1	5.0	1.5	8.7	7.7	2.0	2.6	2.3	2.4	3.0	10.8	3.0	2.3	2.2	4.6	2.4	2.6	2.8	6.7	3.5	18.3	4.0	1.9	13.0	13.6	12.6	12.8	11.8	14.8	7.9	8.1	8.3	7.8	11.2	10.7	62.2	35.3	27.0	160.6	37.8	467.3	172.4	128.6	30.7	110.7	56.8	40.6	149.3	38.6	82.3	29.5	308.6	33.0	66.9	47.0	23.5	63.8	40.0	68.4	142.9	71.9	87.7	140.0	143.7	93.1	27.6	67.3	21.9	54.6	26.0	155.2	102.4	47.2	32.8	195.2	202.0	56.7	73.2	16.3	55.8	16.6	60.3	36.1	90.7	66.5	25.2	96.5	16.5	74.9	24.3	191.4	45.1	74.1	30.8	104.2	24.7	12.8	102.4	168.7	32.9	84.6	66.3	51.3	46.3	52.8	332.0	34.2	25.1	25.1	38.1	84.2
DAB2	DOC-2	ENSG00000153071	"DAB adaptor protein 2"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 179.1;placenta: 226.6"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1756.4;Proximal tubular cells: 1653.7;Syncytiotrophoblasts: 1324.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"plasmacytoid DC: 48.7"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 48.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.1;ASC TERT1: 234.5;fHDF/TERT166: 356.8;TIME: 211.1;U-138 MG: 237.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA		130000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	76.9	113.6	7.3	33.1	8.3	4.1	48.2	13.4	13.1	48.4	26.2	33.2	13.5	32.5	116.8	16.8	21.6	50.1	20.0	7.5	7.7	179.1	27.3	53.3	33.2	14.6	10.0	34.0	22.8	10.1	7.9	226.6	12.6	13.0	54.5	11.6	24.2	19.8	11.4	21.2	25.6	47.8	7.8	58.5	16.6	10.6	20.1	20.9	23.5	16.4	19.0	44.6	20.6	10.8	0.2	8.3	12.9	27.9	220.1	234.5	16.0	145.7	149.5	56.3	92.5	108.1	0.5	0.1	8.8	356.8	54.8	0.3	2.0	5.2	78.9	0.2	4.2	19.9	191.1	35.5	52.4	0.2	24.3	146.5	0.2	91.7	16.5	87.2	172.4	9.9	0.0	5.0	95.2	0.6	2.1	0.3	8.9	4.1	15.8	5.4	32.7	0.0	37.8	3.2	0.1	0.4	17.4	9.3	79.2	20.4	0.6	4.9	211.1	237.9	26.1	27.7	11.9	0.2	0.1	0.3	82.6	18.1	31.5	5.8	2.3	0.5	2.1	4.6	0.1	0.1	0.3	1.4	6.3	0.2	0.2	1.7	3.2	1.7	1.3	48.7	0.4	12.7	7.3	8.3	13.4	13.1	7.5	7.7	14.6	10.0	12.6	7.8	20.1	10.8	100.2	38.5	42.2	0.0	14.5	14.5	1.2	15.3	3.4	1.1	38.3	26.7	55.1	70.1	9.9	95.6	70.9	170.8	83.8	29.6	197.6	75.7	1.4	31.7	161.0	116.9	9.7	10.1	11.0	2.0	20.1	139.5	3.6	36.4	25.3	50.6	187.4	3.7	1756.4	8.4	2.8	7.6	2.0	175.2	77.9	4.5	122.4	287.4	12.4	92.8	10.9	81.5	63.8	27.2	0.3	6.5	10.2	64.3	1.4	7.0	33.8	1653.7	7.5	3.5	6.6	62.4	50.4	0.5	4.8	3.5	13.4	1324.5	13.4	104.8	27.5	1.3
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	57.0	63.6	32.5	54.7	34.9	66.7	66.2	33.6	38.8	43.3	32.5	55.7	58.7	46.0	52.3	54.5	41.9	38.6	88.1	36.1	37.5	63.1	88.2	44.6	69.3	36.1	35.8	38.1	69.3	49.4	42.4	41.2	38.9	50.7	61.4	71.9	53.3	49.4	129.9	60.1	47.6	53.2	32.1	51.3	59.1	42.3	37.1	80.8	48.9	89.4	78.6	58.4	45.3	41.6	144.9	91.9	73.5	116.7	105.9	133.0	180.0	118.8	124.8	119.4	103.8	170.7	172.4	204.1	235.0	97.3	76.5	143.1	110.3	103.7	129.8	128.6	80.4	124.7	80.5	156.5	144.5	173.3	106.4	112.1	145.8	152.2	199.4	93.3	119.2	185.2	274.5	141.2	125.6	192.0	152.6	200.9	130.1	225.2	146.9	124.2	92.1	218.9	142.5	136.0	84.9	150.4	113.9	331.9	211.6	135.1	206.4	279.8	102.8	100.5	106.1	126.0	202.6	152.9	245.9	235.3	100.2	151.6	132.7	65.4	110.5	61.6	110.1	134.2	179.0	141.5	155.8	133.9	152.0	121.1	192.5	167.5	47.8	136.0	128.0	99.1	173.1	162.1	32.5	34.9	33.6	38.8	36.1	37.5	36.1	35.8	38.9	32.1	37.1	41.6	31.8	44.8	43.6	34.0	59.2	54.9	67.2	94.2	52.9	28.2	54.6	43.8	106.2	51.5	68.3	16.5	20.9	76.2	45.0	33.2	66.5	79.8	19.0	44.9	40.5	38.1	25.7	63.8	52.7	78.6	98.5	41.3	35.7	38.7	62.1	34.9	33.2	57.4	77.8	13.5	57.4	41.9	59.0	59.4	62.9	15.3	32.3	53.0	35.6	30.9	83.7	22.2	55.6	26.7	47.1	73.8	30.8	25.2	52.4	81.7	41.7	78.0	61.2	46.4	13.1	33.7	45.1	48.3	29.3	51.1	63.1	141.6	66.4	73.3	62.5	73.5
DARS1	DARS	ENSG00000115866	"Aspartyl-tRNA synthetase 1"	P14868	2	135905881-135986100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 85.1;Cytotrophoblasts: 115.4;Extravillous trophoblasts: 157.9;Hofbauer cells: 94.2;Syncytiotrophoblasts: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	37.5	42.1	30.1	41.2	31.2	34.0	48.7	33.3	52.1	34.7	28.0	38.5	23.5	38.4	22.8	46.0	37.8	25.8	42.3	29.5	35.2	47.3	44.2	27.8	48.3	32.6	31.2	47.2	36.1	38.4	24.6	44.4	35.6	33.6	26.6	87.1	32.5	36.5	82.8	40.2	28.0	39.3	34.0	32.3	33.3	17.8	30.7	63.1	43.4	60.1	55.4	40.0	36.4	35.3	201.6	77.0	73.4	66.3	61.0	78.1	141.6	99.8	92.6	92.2	91.1	163.0	84.0	210.0	159.8	78.4	86.6	111.7	94.9	114.9	170.3	95.6	86.0	134.0	76.8	185.6	83.9	188.3	90.8	84.5	75.6	109.1	99.8	122.9	46.8	106.3	131.6	66.0	66.6	87.3	139.2	117.4	77.8	85.3	66.9	179.3	157.9	139.0	91.8	76.9	40.3	89.6	75.0	63.5	74.8	72.2	66.8	118.2	38.2	86.0	87.4	64.5	92.8	194.9	123.3	250.2	144.1	132.3	51.0	33.7	85.4	51.2	115.2	82.6	174.7	219.9	172.6	151.4	133.7	198.8	175.2	154.2	31.7	171.9	67.4	130.4	168.9	153.3	30.1	31.2	33.3	52.1	29.5	35.2	32.6	31.2	35.6	34.0	30.7	35.3	29.4	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	115.4	20.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	157.9	18.2	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	136.4	4.4	0.0	0.0	0.0
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	44.2	34.7	20.5	55.9	21.4	69.3	37.2	22.8	23.5	31.9	23.1	45.1	45.3	33.5	10.5	64.7	32.1	13.3	55.0	19.7	20.7	40.6	51.2	37.0	49.8	23.6	21.2	32.3	48.0	20.3	22.6	22.2	22.3	33.0	23.6	20.1	32.4	17.1	65.2	42.3	46.9	19.5	18.2	49.3	39.0	77.5	25.2	47.7	32.1	21.4	34.4	42.2	36.7	27.0	275.7	98.0	64.3	117.9	27.8	33.5	183.9	120.7	59.6	95.7	78.2	98.0	132.3	320.8	72.1	58.7	47.4	151.2	84.9	114.5	80.7	225.9	135.2	165.4	95.2	101.3	64.3	203.1	136.1	33.7	73.8	65.4	119.0	41.1	85.0	133.7	251.5	164.1	60.6	111.9	357.5	178.3	198.7	99.6	97.1	254.3	102.4	199.3	72.9	91.7	127.3	114.2	79.9	124.0	149.3	83.1	113.1	266.8	93.7	79.0	107.5	139.7	267.9	192.9	212.2	256.0	95.6	194.4	123.8	1.5	2.3	1.9	2.7	3.4	2.9	3.1	2.4	2.9	2.2	2.1	2.4	2.6	1.0	3.0	2.4	2.7	2.7	1.3	20.5	21.4	22.8	23.5	19.7	20.7	23.6	21.2	22.3	18.2	25.2	27.0	57.1	9.6	27.6	29.7	50.3	69.3	90.9	37.6	34.1	55.7	46.9	33.3	40.0	38.6	28.8	25.8	35.5	43.5	68.7	60.0	23.5	44.4	49.8	26.3	37.0	45.0	33.0	96.6	17.1	55.1	108.6	39.7	46.9	34.0	26.6	58.0	36.0	41.6	47.7	26.9	16.8	71.6	28.5	49.2	54.9	65.7	28.0	50.3	40.9	16.9	36.0	35.1	34.0	18.6	45.2	63.5	49.4	23.7	73.6	110.3	50.4	48.2	23.5	45.4	26.3	50.5	58.9	111.6	41.0	67.0	74.9	69.0	53.0	41.8	81.5	107.9
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 272.7;brain: 236.6"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Region enriched"	"Detected in many"	8	"pons: 236.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	272.7	0.1	1.0	0.2	0.2	0.1	0.0	0.8	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.2	1.3	36.1	0.8	2.3	9.8	29.4	0.4	4.3	0.0	1.4	1.4	236.6	0.4	0.0	0.1	0.6	0.2	0.1	0.2	0.6	0.0	0.0	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.3	0.2	9.8	29.4	236.6	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2215.1;Proximal tubular cells: 2834.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 2479.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051428	Approved					NA	NA		9100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051428: AB_2681482"	"unprognostic (1.24e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	358.3	153.9	486.0	158.7	470.8	121.9	717.3	495.6	726.7	218.6	452.3	322.8	312.8	73.5	653.7	667.7	85.8	129.7	515.4	493.0	498.5	536.2	971.1	236.0	182.9	499.4	495.1	86.0	143.8	866.9	76.9	116.3	510.0	451.5	297.3	116.3	369.9	215.1	273.0	451.0	229.6	97.2	512.7	115.5	185.1	201.3	487.6	173.3	133.7	460.5	324.5	136.5	327.7	516.4	543.0	276.9	557.1	257.2	1339.7	1131.9	350.7	281.3	708.7	387.0	746.1	580.6	427.8	747.3	312.1	440.6	938.5	277.9	397.0	588.3	345.9	498.2	262.1	641.4	279.9	775.8	335.6	206.1	2479.2	648.2	376.5	596.2	222.1	255.4	464.3	358.8	77.0	679.2	558.8	559.1	436.5	585.9	370.2	349.7	429.7	157.4	541.4	658.5	948.1	816.5	263.2	210.1	235.3	548.5	634.9	388.8	338.0	952.8	332.5	259.3	329.8	288.8	346.3	220.9	170.5	610.0	365.7	364.8	315.3	1180.7	439.9	1077.9	472.9	489.1	347.3	461.4	367.8	465.2	748.8	505.3	279.1	419.2	285.8	450.7	402.5	791.0	615.7	792.2	486.0	470.8	495.6	726.7	493.0	498.5	499.4	495.1	510.0	512.7	487.6	516.4	505.2	150.6	613.0	46.0	256.7	289.2	249.4	724.2	190.1	37.9	806.5	1025.9	1079.6	663.4	390.0	310.8	14.6	796.5	395.6	737.5	1197.4	466.9	844.4	154.8	194.7	206.2	371.3	108.8	5.2	670.3	643.2	258.2	243.1	185.6	433.4	219.4	167.8	2215.1	1069.4	30.3	3.9	495.0	524.9	305.0	785.7	325.7	152.2	476.1	1058.3	15.0	871.5	928.6	552.0	33.2	25.0	372.7	612.0	127.5	192.0	355.0	753.6	2834.8	340.5	59.1	151.2	267.2	289.9	462.0	30.1	972.6	684.9	516.3	260.8	456.0	673.2	361.0
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 87.1;Pancreatic endocrine cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 5.8;granulocytes: 9.4;T-cells: 14.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA		2000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	59.4	9.3	44.8	17.6	52.5	6.4	36.5	19.3	71.7	59.7	18.6	67.6	9.5	84.4	10.2	30.9	44.7	24.4	39.7	70.1	45.4	52.0	4.0	24.7	9.0	33.8	25.4	34.8	16.9	17.1	45.8	7.1	32.3	29.7	5.9	5.5	33.1	23.9	27.6	36.6	25.0	28.6	24.0	14.2	47.4	27.0	39.7	14.6	33.4	9.0	4.4	61.0	33.1	35.5	17.4	56.1	182.0	319.1	42.4	66.2	56.5	198.6	50.3	113.4	94.5	193.9	59.0	0.3	139.5	155.1	39.0	27.0	80.9	144.0	53.6	5.2	70.4	111.6	72.9	82.0	149.3	43.0	20.5	87.1	37.1	127.3	38.0	113.3	189.4	131.4	54.0	26.0	84.2	25.1	115.1	63.8	264.1	5.7	123.4	338.1	197.2	34.5	85.3	23.7	213.7	289.8	67.0	28.8	111.5	58.4	78.7	42.6	298.6	126.7	169.3	28.2	94.9	6.3	3.1	177.5	53.2	40.5	80.5	9.4	1.4	1.1	10.3	0.8	14.0	0.3	0.3	7.2	1.8	0.4	0.4	5.2	3.2	0.3	0.8	5.8	0.2	2.2	44.8	52.5	19.3	71.7	70.1	45.4	33.8	25.4	32.3	24.0	39.7	35.5	44.2	3.2	1.5	8.1	1.2	10.3	13.7	24.6	9.1	7.0	7.6	9.1	5.1	2.8	11.1	9.2	4.2	1.0	4.5	1.4	1.9	87.1	16.9	8.4	44.0	43.2	40.7	4.8	15.7	43.4	2.8	56.1	11.7	18.4	10.8	49.4	20.7	0.0	1.7	42.1	13.0	2.4	40.7	1.8	8.9	41.6	50.1	6.1	8.8	2.8	2.4	13.4	1.0	5.0	1.0	64.5	0.6	41.0	4.0	16.9	0.6	6.3	5.2	4.5	19.7	10.8	43.4	6.5	26.7	20.1	7.2	0.8	10.4	8.1	3.9	7.5
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		3500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	"Vesicles, Plasma membrane"		"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	58.1	51.6	44.2	62.8	45.1	76.6	51.3	41.7	50.4	72.4	39.9	54.6	34.7	56.0	20.2	189.0	47.8	47.2	49.2	45.8	45.2	50.7	51.1	57.8	99.6	46.2	44.8	38.0	44.3	38.4	47.8	34.9	48.4	57.0	30.6	9.4	57.5	38.0	34.3	59.9	64.7	44.8	44.3	119.5	54.7	20.8	44.6	64.8	47.6	16.4	89.1	60.3	92.0	43.4	57.6	89.1	60.5	56.6	77.0	49.7	46.0	95.9	93.6	111.5	91.5	90.0	82.5	132.3	70.0	126.1	133.6	101.9	35.6	130.6	40.7	70.6	38.9	51.9	73.8	52.4	78.5	75.8	70.3	46.6	53.3	107.1	35.2	71.5	74.1	83.9	63.8	49.3	105.5	91.5	136.5	85.3	43.1	72.9	73.0	69.4	48.1	64.5	69.8	90.5	65.6	89.8	69.6	121.5	24.4	43.8	94.0	99.4	121.1	82.7	75.5	49.5	113.6	102.7	49.4	81.2	78.3	83.2	183.8	263.3	377.1	295.0	190.3	422.7	148.3	253.9	138.0	155.0	362.5	261.7	136.5	145.1	357.4	192.4	437.9	376.6	183.1	558.8	44.2	45.1	41.7	50.4	45.8	45.2	46.2	44.8	48.4	44.3	44.6	43.4	49.9	44.8	36.2	10.7	105.4	17.6	34.1	62.9	19.4	33.0	26.7	24.0	30.6	25.8	42.2	31.3	35.5	78.9	101.6	58.5	45.0	87.0	10.3	30.7	39.3	44.8	37.8	45.8	7.4	73.2	146.4	39.3	54.6	50.7	65.9	42.3	32.5	22.5	176.0	40.4	6.7	50.0	38.7	129.6	48.6	10.6	37.0	113.4	55.2	7.5	338.3	42.5	112.3	5.5	11.4	105.9	74.0	33.8	50.2	31.5	49.0	33.6	21.6	38.6	6.6	29.0	54.6	24.4	12.8	64.4	26.7	87.3	69.5	51.9	44.0	51.1
DBT	"BCKAD-E2, BCKDH-E2, BCOADC-E2"	ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	11.1	13.6	4.4	5.9	5.2	4.6	11.8	4.3	4.9	11.3	3.7	9.2	8.0	8.2	6.0	12.8	11.1	6.3	25.9	4.2	5.0	30.3	43.4	7.4	7.5	5.6	4.6	11.1	15.4	19.4	2.3	10.0	4.5	15.9	10.2	5.9	12.8	11.2	13.4	7.4	7.1	8.0	4.6	6.1	17.3	4.7	5.2	9.9	17.2	19.2	8.9	9.4	4.0	7.1	18.5	8.2	9.5	17.4	23.9	17.6	20.6	13.1	12.3	13.9	15.6	17.7	7.4	17.1	18.3	9.3	8.1	18.7	20.3	17.7	16.8	18.2	11.5	12.1	16.3	9.5	18.0	16.1	6.1	18.2	18.1	10.6	17.9	11.4	12.4	17.9	20.9	19.2	11.1	4.9	14.4	4.1	18.6	14.8	18.4	14.1	30.3	14.2	15.3	15.9	15.8	8.7	27.5	25.4	23.7	16.7	20.9	11.9	10.8	12.1	7.6	15.9	11.0	12.7	14.1	9.1	13.8	10.7	5.3	2.1	1.2	0.8	2.2	1.5	2.4	1.9	2.0	1.9	1.2	2.1	1.8	1.9	1.1	2.0	1.4	1.3	1.5	1.1	4.4	5.2	4.3	4.9	4.2	5.0	5.6	4.6	4.5	4.6	5.2	7.1	9.6	22.4	36.4	29.0	9.6	6.8	6.5	9.8	13.6	22.2	11.9	8.5	65.9	18.6	11.3	12.9	39.6	19.8	10.9	11.4	50.9	10.0	0.8	18.5	20.5	11.7	9.1	8.2	24.0	8.5	11.6	11.3	15.8	15.4	2.5	19.6	15.4	53.2	8.7	15.2	25.2	12.0	14.2	8.8	5.0	1.7	15.2	7.3	3.6	3.7	10.3	14.5	12.3	22.1	26.1	6.4	6.0	21.1	7.1	9.4	9.9	32.1	18.0	22.4	6.6	15.0	12.9	2.8	6.1	18.7	7.2	8.2	9.7	17.3	15.1	5.5
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 17.9;Granulosa cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	11.4	11.3	7.6	11.7	8.8	15.9	11.2	11.2	9.4	9.4	9.8	11.0	7.9	10.3	9.4	10.6	8.9	7.4	9.5	7.8	9.3	11.0	11.5	10.0	14.8	8.4	8.8	10.3	10.4	18.9	8.6	10.3	8.6	9.7	10.9	19.7	11.3	9.6	27.9	13.5	11.4	9.2	8.0	11.3	10.3	53.4	8.5	18.6	14.6	16.1	15.9	11.2	10.0	9.0	19.9	23.9	22.8	20.7	20.1	15.9	21.6	21.8	16.2	23.1	22.5	26.4	18.8	48.1	11.7	17.2	35.3	17.1	43.3	19.5	29.6	33.7	21.5	41.2	32.4	22.8	14.7	54.4	28.7	10.6	22.2	29.8	21.6	15.0	18.2	26.1	24.5	30.3	18.3	20.3	41.8	22.0	24.0	23.5	26.0	17.5	24.4	32.0	18.0	30.5	11.8	21.0	24.1	22.0	13.2	16.7	15.0	22.8	22.9	18.8	25.1	31.4	33.9	20.5	29.7	48.2	21.9	36.6	15.7	2.5	3.0	2.4	6.5	3.3	7.4	5.1	5.6	5.6	4.8	4.9	6.0	5.1	0.7	5.8	5.0	3.8	6.7	4.9	7.6	8.8	11.2	9.4	7.8	9.3	8.4	8.8	8.6	8.0	8.5	9.0	11.1	3.2	10.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.3	9.4	0.0	0.0	6.8	3.7	0.0	7.6	9.7	0.0	1.9	7.0	0.0	11.2	10.3	5.6	0.0	0.0	0.0	6.7	5.7	3.0	0.0	17.9	6.3	13.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.8	0.0	0.0	6.1	5.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	10.5	5.0	7.4	0.0	0.0
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340197-53535903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;testis: 7.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Approved	"Golgi apparatus"		NA	NA		64000		"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA055376: AB_2682798, HPA069552: AB_2686151"	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.0	0.6	1.2	0.2	6.3	0.0	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	6.9	3.6	0.2	0.0	1.4	0.0	0.7	4.7	0.1	0.3	0.0	0.6	0.0	1.5	0.3	0.1	0.3	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.2	0.2	7.6	1.1	1.0	0.0	0.0	0.3	0.1	0.1	0.9	0.1	0.1	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	112.5	57.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.3	0.0	3.9	6.9	3.6	0.7	4.7	1.5	0.0	1.1	0.9	1.4	0.0	6.0	10.1	0.3	0.0	0.1	0.0	0.0	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	205.7	0.0	0.0	0.1	0.0	0.0	439.7	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	455.8	0.0	0.0	0.0	0.0	174.9	1.2	0.2	0.0	54.4	0.0	0.2	0.0	1305.9	58.6	0.0	0.0	1.2	5.7	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1	2.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 2476.8"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000	"Cluster 42: Non-specific - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				100.2	0.4	3.5	0.3	3.3	1.1	354.3	3.4	5.4	0.3	3.8	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.3	3.5	3.3	0.2	0.9	0.6	0.2	3.3	3.6	0.4	1.0	0.0	0.5	0.1	3.5	0.4	0.2	0.5	0.5	0.1	14.0	2476.8	0.7	0.1	3.0	0.4	0.7	1.1	3.2	0.3	0.5	0.0	0.2	0.2	0.7	4.1	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.5	3.3	3.4	5.4	3.5	3.3	3.3	3.6	3.5	3.0	3.2	4.1	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621330-6655809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		4000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.4	2.5	7.4	8.4	6.8	0.7	9.3	6.1	6.3	19.5	0.9	19.0	4.1	28.9	2.4	5.0	13.2	8.3	9.2	6.6	10.1	4.6	2.0	10.1	4.0	7.6	6.3	11.6	3.3	2.0	3.2	10.1	5.7	9.3	3.4	0.6	3.5	11.5	4.2	3.7	8.3	16.2	4.7	12.9	8.2	3.0	8.7	3.8	4.1	4.6	2.2	14.8	9.3	3.8	0.0	0.1	33.5	0.1	0.0	0.1	0.3	1.2	8.7	5.4	6.0	0.3	0.0	0.1	5.1	9.9	0.4	0.0	2.7	0.1	3.7	0.1	0.9	0.7	0.0	0.0	0.3	0.2	0.0	1.0	0.1	2.5	0.0	0.0	47.1	0.1	0.2	0.0	2.0	0.0	1.2	0.6	5.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	2.4	32.4	0.0	0.3	0.2	3.5	0.0	1.3	20.4	0.1	10.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	7.4	6.8	6.1	6.3	6.6	10.1	7.6	6.3	5.7	4.7	8.7	3.8	34.8	0.0	0.5	12.1	0.2	2.9	0.3	0.0	0.0	1.5	1.7	3.0	3.8	4.3	0.0	0.0	0.0	0.2	1.4	0.2	0.0	1.0	3.1	0.8	17.3	29.0	0.0	2.7	2.0	0.4	0.3	17.0	1.1	0.7	0.0	19.3	61.1	0.2	2.2	0.0	7.4	0.7	0.0	4.7	4.2	3.4	1.2	2.4	16.0	4.7	0.2	0.9	0.0	10.1	1.4	0.1	0.1	1.9	0.2	0.3	0.1	0.1	0.0	0.5	0.0	7.4	4.9	4.9	0.6	0.5	1.7	0.3	1.2	4.6	1.1	0.1
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131382	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.0"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 970.6;Inhibitory neurons: 664.8"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 29.0;ASC TERT1: 27.3;fHDF/TERT166: 23.5;GAMG: 34.8;HAP1: 17.9;HSkMC: 25.5;NTERA-2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265"	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	15.5	2.5	22.0	4.0	27.5	0.0	14.2	10.2	45.3	11.8	0.0	4.2	1.1	6.0	4.1	5.4	4.6	7.2	5.5	37.1	37.8	2.8	0.1	2.4	4.2	17.9	13.2	6.1	1.2	1.1	13.7	0.1	53.0	4.1	3.8	17.3	3.4	4.0	2.1	8.4	4.1	19.1	15.7	4.5	3.6	1.3	17.5	1.6	2.8	4.6	2.2	4.3	5.9	18.7	0.0	0.4	6.8	0.0	29.0	27.3	0.0	0.2	0.4	0.2	0.2	0.0	0.1	0.0	0.0	23.5	34.8	0.0	17.9	0.3	0.0	0.0	1.0	0.0	0.8	0.0	1.1	0.0	0.0	25.5	13.0	0.6	0.4	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	37.1	0.0	0.4	0.0	2.0	0.0	1.0	0.0	7.3	4.4	0.0	0.0	2.2	10.4	0.0	0.0	0.0	0.1	6.1	7.6	1.3	0.1	0.0	0.0	2.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	27.5	10.2	45.3	37.1	37.8	17.9	13.2	53.0	15.7	17.5	18.7	8.0	9.6	0.6	132.2	0.1	15.2	1.3	1.8	0.0	9.4	7.8	7.0	5.8	0.0	7.9	3.7	4.2	0.0	0.0	0.0	0.0	0.1	1.5	0.7	1.7	3.8	0.0	0.0	970.6	0.0	0.0	82.6	0.5	0.3	0.0	75.5	0.4	0.0	0.1	10.1	664.8	0.0	4.1	0.3	14.7	1.6	20.8	0.7	14.2	44.0	0.0	73.8	0.0	31.2	19.1	0.2	0.0	4.1	0.3	0.6	0.0	0.6	3.1	4.2	6.6	10.8	22.0	1.3	1.4	1.0	9.7	0.0	0.8	30.1	0.0	1.7
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283429-53347586	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	9.3	8.2	4.3	8.7	4.9	29.9	8.9	11.3	6.8	8.5	5.5	8.5	6.1	11.7	5.8	7.9	9.1	8.2	8.0	4.6	4.9	6.0	6.4	7.7	10.3	4.6	4.6	14.9	6.3	10.3	6.3	10.2	4.8	7.9	8.4	8.6	6.1	6.9	9.5	7.4	7.3	10.4	4.1	9.2	6.8	8.2	5.2	14.2	8.7	9.5	9.8	9.0	7.0	6.3	8.3	8.3	19.4	15.8	13.1	13.5	26.3	9.5	12.5	20.5	19.0	24.7	14.5	18.9	3.7	12.0	12.3	6.8	25.3	9.7	17.8	16.9	11.3	18.5	11.8	12.9	11.4	23.0	24.6	10.7	9.4	18.5	15.0	12.6	15.1	13.2	16.4	20.2	10.1	5.0	30.6	11.2	13.1	8.6	12.1	14.0	12.9	13.2	8.6	18.2	10.1	16.7	16.3	10.7	14.3	14.4	7.0	17.8	16.3	9.8	14.1	10.3	14.5	12.9	11.9	21.9	12.0	12.8	17.8	46.9	25.0	43.0	41.0	25.5	50.4	38.9	41.4	47.8	27.1	48.7	49.6	46.8	26.0	54.3	52.3	31.4	30.9	38.5	4.3	4.9	11.3	6.8	4.6	4.9	4.6	4.6	4.8	4.1	5.2	6.3	28.6	28.9	30.7	26.4	43.6	57.5	48.5	32.4	48.9	27.5	32.7	25.5	26.4	15.7	24.7	7.3	47.9	41.1	34.5	25.5	3.9	29.2	10.8	21.5	33.4	33.5	51.8	20.2	43.4	35.1	52.3	33.6	18.3	34.0	36.8	34.8	24.7	13.2	19.9	28.6	40.5	27.6	24.4	27.6	48.9	26.3	24.8	29.2	10.6	20.6	35.2	18.3	30.9	40.7	44.2	45.0	19.6	25.9	31.8	48.4	22.3	13.5	14.2	30.3	13.1	39.2	32.5	12.8	19.1	27.4	41.2	64.0	39.1	27.7	27.9	62.1
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DCXR	"DCR, HCR2, KIDCR, P34H, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 1851.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4"	"Group enriched"	"Detected in all"	5	"liver cancer: 305.9;prostate cancer: 163.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 365.2;MCF7: 446.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	106.7	43.9	93.1	15.2	95.3	25.3	107.6	102.5	111.1	52.0	84.4	49.6	29.2	39.5	281.3	96.6	59.2	10.8	132.7	87.6	100.7	239.9	1851.6	61.0	16.6	102.4	98.0	70.0	71.6	46.1	63.9	20.2	105.9	138.0	20.9	9.7	103.4	33.6	187.3	87.6	44.4	10.4	91.8	35.8	167.0	44.8	105.9	26.1	60.7	80.6	19.6	48.9	62.1	94.9	50.3	68.2	32.8	56.4	123.2	31.8	80.4	25.0	33.9	68.5	48.4	122.0	21.3	100.3	47.4	35.9	9.4	57.4	59.6	52.6	24.1	21.4	145.9	96.9	48.8	365.2	143.2	75.6	114.5	44.6	62.2	22.7	79.8	16.0	41.1	61.1	112.4	76.3	36.5	446.2	63.7	184.1	35.0	242.9	71.3	57.9	42.0	135.3	53.3	71.9	85.5	51.0	35.5	287.5	46.0	19.7	213.4	74.5	20.5	36.6	45.0	48.9	48.2	73.7	56.2	50.2	31.4	83.0	26.7	49.5	92.6	77.9	66.5	92.0	64.1	86.8	83.0	64.7	151.3	99.2	117.7	85.4	47.2	108.9	88.1	121.6	98.9	110.1	93.1	95.3	102.5	111.1	87.6	100.7	102.4	98.0	105.9	91.8	105.9	94.9	29.0	51.3	198.2	16.6	133.6	58.5	200.3	113.5	109.8	16.0	301.8	269.2	120.7	183.0	123.4	178.4	18.8	372.1	116.6	152.9	812.0	41.4	6.0	67.0	50.9	44.6	54.7	335.7	4.7	42.6	450.6	65.0	151.4	102.3	64.7	62.7	138.5	3510.3	164.7	21.9	9.0	170.4	189.2	165.7	65.6	22.6	70.8	82.3	179.7	1.9	52.8	145.1	78.2	5.5	10.5	30.4	135.7	47.4	98.6	215.2	158.9	2919.4	55.4	26.5	19.7	40.6	79.6	10.3	48.2	219.9	73.2	342.6	135.7	118.6	154.6	178.8
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDHD1	"KIAA1705, PA-PLA1, SPG28"	ENSG00000100523	"DDHD domain containing 1"	Q8NEL9	14	53036745-53153323	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 280.9;Excitatory neurons: 140.5;Late spermatids: 146.3;Oligodendrocytes: 177.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049870	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA049870: AB_2680925"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.14e-3)"	"unprognostic (9.40e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.67e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	4.5	3.6	5.7	6.0	6.6	8.7	3.9	9.7	10.1	5.3	0.8	3.8	2.5	5.0	2.2	2.5	3.7	4.6	5.1	6.8	6.9	2.3	2.6	5.2	10.0	6.9	6.6	5.1	2.9	4.4	5.3	7.5	7.6	3.7	4.6	16.7	2.3	4.1	3.1	3.3	4.7	5.1	4.2	6.2	3.8	30.7	6.6	6.6	3.5	5.3	8.5	5.4	3.4	10.3	8.7	10.2	32.5	12.7	14.0	12.7	6.7	13.0	9.8	9.4	10.3	2.4	1.7	23.3	6.4	9.1	8.7	3.7	15.8	3.6	11.3	12.8	7.0	3.0	8.7	4.7	12.1	10.6	10.3	6.9	4.3	10.0	8.4	6.7	7.1	7.9	5.9	19.6	11.0	9.2	12.6	5.4	6.7	5.6	8.4	9.6	34.0	4.0	5.0	11.3	14.5	9.3	15.2	4.2	4.4	5.7	5.9	6.9	10.5	8.9	13.9	13.4	9.6	9.1	6.3	15.3	4.7	9.6	5.0	1.6	1.4	1.2	4.6	2.2	4.4	3.2	3.7	5.1	1.7	2.6	3.2	3.9	0.8	4.6	3.7	1.5	5.3	1.3	5.7	6.6	9.7	10.1	6.8	6.9	6.9	6.6	7.6	4.2	6.6	10.3	12.0	6.4	15.4	69.9	40.4	6.1	7.1	3.5	23.9	64.2	9.3	7.0	13.2	7.2	3.6	9.2	87.6	17.6	46.5	3.2	0.0	6.8	280.9	8.7	38.7	19.1	8.4	27.8	140.5	6.7	7.4	25.4	7.7	15.3	7.6	20.0	5.3	5.8	16.2	45.4	120.6	5.0	2.0	18.5	13.3	146.3	13.7	31.5	5.4	38.4	22.1	19.1	49.4	104.0	177.9	5.1	3.4	20.7	42.7	8.2	1.9	4.9	6.7	35.0	19.7	17.1	15.8	57.4	46.6	9.7	6.0	17.4	42.4	24.9	5.6	5.9
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617458-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	10.8	6.0	3.4	6.3	3.9	10.7	10.2	4.3	4.6	8.1	4.6	6.4	7.9	8.7	6.6	15.8	6.0	5.1	6.8	4.1	3.7	7.9	21.8	7.8	8.6	4.0	3.8	5.8	7.0	10.2	3.9	7.4	4.1	10.0	6.6	10.2	10.2	5.3	26.8	10.9	7.1	6.4	3.5	6.9	5.8	3.0	3.8	7.7	6.4	11.7	9.7	7.9	10.4	5.3	11.4	6.5	11.6	12.1	15.5	12.2	11.2	7.0	5.3	6.0	5.2	16.1	10.1	28.4	8.0	7.7	4.4	11.8	25.4	11.3	10.1	13.2	17.0	22.3	10.7	15.8	6.6	29.8	10.8	12.1	13.1	11.3	12.0	7.5	12.4	18.2	36.5	10.2	7.5	7.6	17.3	9.8	11.1	16.8	5.3	16.1	16.3	16.8	8.5	9.4	14.1	7.8	13.1	20.9	19.2	12.9	10.9	7.7	10.9	8.6	7.4	9.8	8.6	9.5	12.4	22.3	6.7	21.4	6.9	0.3	0.8	0.1	1.1	0.7	0.9	0.8	0.8	0.8	0.8	1.1	0.8	1.1	0.2	0.7	0.5	1.8	0.8	0.5	3.4	3.9	4.3	4.6	4.1	3.7	4.0	3.8	4.1	3.5	3.8	5.3	8.9	9.6	21.0	6.2	18.1	15.3	14.0	11.7	23.3	25.6	23.4	11.6	28.0	15.7	24.6	3.7	14.6	22.6	22.8	16.5	1.9	7.7	1.7	40.7	25.2	17.5	15.0	82.9	12.8	7.7	19.2	16.7	14.8	39.1	1.3	13.7	15.7	61.7	15.1	35.3	15.1	21.3	22.4	27.1	6.8	1.0	12.8	17.6	16.0	10.3	16.8	8.2	6.2	8.5	17.6	16.4	9.4	6.8	10.9	24.9	28.1	20.5	33.0	41.3	6.6	14.7	11.3	11.1	9.1	38.6	20.2	40.2	13.6	8.6	20.4	13.8
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDT	"D-DT, DDCT, MIF-2, MIF2"	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23979828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 835.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 4869.6;Proximal tubular cells: 1415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 262.9"									"HPA049871, HPA074115"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	125.7	126.7	29.6	15.1	30.6	39.6	99.0	33.1	38.0	69.6	28.7	128.5	44.2	62.6	16.2	119.1	67.3	6.3	167.0	28.9	32.2	218.2	835.9	69.2	13.7	30.7	29.6	83.0	260.9	24.3	47.7	10.7	30.7	109.0	24.2	12.8	82.7	15.7	129.3	89.8	120.7	8.6	30.7	66.3	176.2	39.2	32.9	12.3	80.1	15.7	11.9	86.8	76.4	33.9	107.6	44.8	15.4	34.9	29.0	24.9	92.6	30.4	20.7	26.1	27.1	39.8	30.6	101.9	27.8	16.1	37.7	86.3	38.3	38.1	17.1	43.6	262.9	60.8	58.9	88.3	28.9	136.2	58.8	25.5	28.5	26.3	23.1	27.9	28.7	16.0	56.8	40.2	26.9	53.0	30.1	123.1	46.2	94.4	134.2	65.3	27.0	148.9	46.4	39.2	51.7	49.2	62.8	117.7	95.9	20.6	30.8	42.3	33.1	26.8	59.9	27.8	32.2	122.6	43.9	65.1	53.1	49.7	52.5	63.5	92.9	72.4	46.0	82.8	47.5	75.3	55.3	49.1	87.8	70.7	49.2	48.9	58.3	61.6	79.1	130.4	74.5	78.8	29.6	30.6	33.1	38.0	28.9	32.2	30.7	29.6	30.7	30.7	32.9	33.9	116.9	83.3	86.3	11.1	178.3	138.9	220.5	278.8	176.4	58.4	266.6	379.7	21.3	499.0	153.2	242.8	89.6	202.6	134.1	533.1	718.1	237.2	202.1	150.8	126.4	103.4	259.6	230.2	9.1	375.7	288.2	103.9	163.1	260.3	129.4	97.1	154.9	4869.6	281.0	43.7	11.0	402.8	187.2	240.4	162.2	411.0	117.1	172.2	158.3	9.4	235.8	119.6	135.9	6.0	18.8	233.6	395.1	110.6	166.1	257.5	935.1	1415.8	97.6	100.0	78.9	109.5	127.6	117.9	43.8	280.6	188.0	299.8	140.3	212.5	558.7	291.3
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483438-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	181.2	172.4	142.0	124.3	160.1	74.5	198.5	150.9	178.4	248.7	174.8	233.8	107.8	216.1	255.3	150.4	248.1	121.1	168.7	143.5	152.1	247.2	152.8	202.2	186.4	152.8	149.4	298.8	214.0	144.7	309.9	158.8	155.3	234.4	114.2	342.0	188.4	123.3	184.8	197.0	227.2	119.7	146.8	293.0	192.1	91.1	148.2	215.2	300.0	106.6	158.2	204.4	201.5	196.5	122.0	79.9	237.6	141.8	148.2	166.0	120.7	104.3	85.9	118.3	121.2	89.0	100.5	225.8	65.8	119.5	82.9	133.2	212.5	127.9	145.9	202.5	142.1	140.4	175.8	133.5	153.4	192.9	170.8	122.3	183.7	86.8	142.9	211.7	153.3	109.6	139.7	255.3	116.0	75.6	128.7	164.0	148.0	172.1	51.6	218.0	122.9	137.1	141.2	132.6	134.1	75.3	155.0	125.9	161.2	180.5	110.0	148.4	140.8	125.7	77.6	80.0	79.3	203.7	130.3	183.4	156.7	123.1	154.2	6.7	8.1	9.5	7.6	7.9	8.9	9.0	7.1	7.3	7.0	7.2	5.7	6.8	16.6	5.1	8.7	10.5	9.1	6.0	142.0	160.1	150.9	178.4	143.5	152.1	152.8	149.4	155.3	146.8	148.2	196.5	252.6	214.7	325.5	483.8	241.9	223.6	206.1	129.3	158.2	448.3	300.7	195.3	147.2	180.1	223.5	283.3	352.3	127.6	297.5	172.8	33.2	111.7	44.4	280.0	293.4	250.4	236.1	177.1	198.9	90.2	99.9	207.5	216.1	234.2	200.7	505.3	233.8	205.3	113.9	321.4	242.1	191.6	146.5	200.6	194.8	49.1	323.7	197.7	154.7	253.9	235.1	223.4	304.9	334.3	553.3	104.7	153.1	278.7	213.1	193.5	154.8	89.8	270.8	559.4	289.3	260.5	213.6	136.4	74.2	120.4	279.9	139.4	218.6	293.7	147.0	255.3
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048287-94081212	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	80.7	130.5	23.3	3.9	24.2	23.5	75.2	25.9	29.7	80.0	24.5	85.8	3.7	93.1	37.2	48.9	81.4	6.7	114.3	24.3	23.9	61.2	43.4	69.4	10.4	31.2	25.2	87.3	49.8	7.0	109.0	2.8	25.4	69.9	3.8	8.0	53.9	4.9	123.9	67.4	59.6	4.1	23.9	75.9	66.1	114.3	25.2	8.0	73.5	4.2	9.1	80.2	65.9	26.2	6.5	1.8	11.5	7.5	6.8	8.8	2.7	17.6	14.5	22.4	20.0	2.2	4.0	29.8	6.4	3.9	6.7	4.1	11.9	1.1	24.5	13.0	0.7	15.8	4.3	9.9	5.7	23.0	6.8	1.4	6.6	4.1	3.9	7.5	3.7	5.6	8.5	8.2	9.6	18.2	7.0	19.6	7.6	1.9	0.2	9.3	26.6	3.5	17.0	2.4	9.1	8.4	17.3	4.2	8.5	1.8	6.8	8.1	11.3	6.4	4.4	8.2	5.3	3.4	24.8	31.5	9.2	12.3	5.1	9.5	2.1	1.7	3.0	1.7	0.8	1.7	1.6	1.8	1.2	2.3	3.0	3.0	1.5	3.8	1.8	1.9	2.1	3.0	23.3	24.2	25.9	29.7	24.3	23.9	31.2	25.2	25.4	23.9	25.2	26.2	164.7	169.9	160.6	45.4	245.9	182.8	186.6	147.4	171.4	184.7	86.6	94.7	228.3	64.3	146.4	147.1	131.3	94.0	332.8	74.1	272.0	147.0	98.2	244.0	248.2	142.2	97.5	75.5	62.9	98.9	72.6	189.0	95.8	201.0	154.9	251.5	109.6	103.4	85.1	232.2	73.6	89.0	118.0	92.1	147.4	67.4	231.5	143.5	99.6	45.0	158.0	133.4	122.6	31.7	56.1	91.0	67.4	244.8	225.6	116.4	70.7	242.3	160.4	200.5	164.3	185.0	198.0	506.5	435.9	127.6	145.6	157.1	342.1	305.9	74.9	123.7
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	16.5	14.6	7.6	23.9	8.8	23.1	17.7	16.1	10.8	16.3	11.4	17.3	17.0	19.8	12.3	17.5	15.0	13.4	13.4	6.8	11.2	18.8	17.7	15.8	25.6	10.0	8.4	18.5	20.8	18.4	11.1	15.7	9.2	15.5	20.7	18.0	16.8	12.1	35.2	19.4	18.7	17.6	5.4	20.6	20.0	16.3	10.0	32.1	18.7	22.9	26.6	18.2	15.6	10.3	87.1	78.0	54.4	71.1	20.8	23.2	75.0	56.8	43.7	58.8	65.6	119.2	61.7	108.9	47.7	38.3	62.3	52.5	80.9	54.2	68.7	73.8	73.3	131.0	84.7	48.5	18.0	120.5	67.8	21.0	28.9	62.1	34.8	24.9	47.3	85.9	113.6	45.3	44.1	41.5	104.2	46.9	75.2	50.1	34.8	89.7	142.0	54.8	32.0	73.9	64.2	61.3	79.4	37.2	42.7	63.0	58.3	68.0	59.0	61.8	43.2	47.9	114.0	35.6	103.2	140.2	42.8	112.0	40.0	55.6	31.9	48.2	30.7	29.2	28.0	38.1	30.4	31.3	25.3	43.4	30.9	31.5	55.9	32.3	27.5	38.5	29.7	17.8	7.6	8.8	16.1	10.8	6.8	11.2	10.0	8.4	9.2	5.4	10.0	10.3	102.4	76.9	131.5	35.9	123.6	113.8	121.5	102.7	68.9	131.5	80.6	79.4	69.3	64.3	94.9	103.0	83.4	133.7	142.3	91.3	56.7	100.5	53.4	111.4	155.8	104.7	92.2	90.6	38.7	107.9	160.4	85.1	69.3	115.9	101.2	122.3	76.8	113.1	94.4	121.1	41.2	112.4	63.1	119.3	113.2	26.7	111.9	103.4	56.9	21.5	178.5	79.9	194.7	28.1	57.6	130.7	62.6	113.2	134.7	139.5	79.2	84.1	74.5	176.0	98.6	114.9	115.2	246.3	275.7	81.0	137.0	157.2	131.8	114.5	112.7	144.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157173-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	19.6	21.7	7.4	28.9	8.6	38.8	18.7	8.0	9.7	20.0	12.0	17.9	26.8	21.4	5.6	24.0	21.1	13.3	17.8	7.4	7.3	16.2	20.8	17.0	28.5	8.9	8.1	23.2	30.3	20.7	8.4	16.8	9.3	16.2	11.4	7.3	19.7	15.8	53.9	24.7	21.0	13.5	7.7	21.5	21.8	9.2	9.2	21.3	19.0	20.4	16.5	19.9	18.2	9.0	82.7	84.0	30.8	57.1	20.2	24.1	79.3	43.8	40.3	58.3	31.9	87.1	39.0	105.8	49.7	36.8	43.4	59.8	55.0	56.8	22.0	61.3	67.7	64.0	45.1	60.3	35.3	107.5	72.1	39.8	44.1	56.7	34.7	47.7	48.4	63.2	94.2	37.1	30.4	75.8	93.0	152.4	72.1	57.6	59.2	68.2	45.6	107.8	31.7	84.3	39.8	36.0	61.8	93.4	39.9	25.2	80.4	82.6	36.3	49.2	54.8	59.1	92.7	53.3	66.4	119.5	43.4	59.0	52.9	13.0	11.3	2.9	12.6	16.7	13.1	12.4	11.5	12.6	14.5	11.3	11.6	12.9	0.6	13.1	11.7	10.9	10.1	12.7	7.4	8.6	8.0	9.7	7.4	7.3	8.9	8.1	9.3	7.7	9.2	9.0	19.1	32.1	29.8	6.5	39.4	17.3	35.9	26.4	34.7	20.5	28.2	24.3	14.5	21.5	24.1	12.9	2.1	63.9	30.6	29.2	25.4	44.5	1.2	23.3	21.8	25.7	28.2	33.4	5.9	49.9	57.2	23.2	26.0	28.5	25.3	35.6	17.9	38.2	38.6	26.9	4.3	31.5	24.4	35.9	20.9	2.4	29.5	22.3	12.4	6.5	29.5	26.8	51.5	2.0	4.8	43.0	33.4	24.0	35.0	52.9	49.3	50.5	12.8	18.1	6.6	28.7	24.9	14.8	20.1	39.5	19.6	72.4	33.3	56.8	43.8	38.0
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90053633	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 290.1;liver: 272.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 399.2;Proximal tubular cells: 485.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	60.2	136.8	12.4	9.6	14.4	24.9	54.4	12.5	14.4	29.4	22.2	65.0	20.2	28.0	14.9	52.6	26.1	7.4	290.1	12.7	13.2	103.5	272.3	34.2	15.0	12.2	13.1	35.5	44.4	13.2	32.6	5.9	12.1	28.6	18.8	8.0	42.8	6.5	121.8	43.3	61.0	9.1	12.5	47.1	44.5	52.3	15.4	10.2	33.0	34.4	13.9	31.1	35.8	12.8	13.1	7.9	19.6	16.1	8.0	17.3	5.2	13.2	12.9	5.9	8.2	2.8	13.4	7.7	5.3	15.1	4.1	6.8	7.7	11.1	11.0	12.6	1.2	18.4	13.6	14.5	11.6	8.7	4.4	12.0	7.0	7.6	10.7	10.1	17.4	16.5	21.3	15.5	20.7	16.3	12.5	7.6	1.5	9.1	24.9	7.4	5.8	13.4	23.4	43.9	1.3	10.6	13.0	81.1	7.7	1.1	10.7	7.4	20.1	11.4	6.2	12.9	6.0	10.5	7.5	12.8	8.6	12.0	10.8	3.9	9.1	6.2	7.1	10.2	7.9	7.4	6.9	8.6	8.8	4.6	8.1	7.8	15.2	3.9	9.3	3.9	9.6	5.8	12.4	14.4	12.5	14.4	12.7	13.2	12.2	13.1	12.1	12.5	15.4	12.8	66.1	76.9	59.4	72.5	52.9	41.3	70.6	180.2	35.3	11.4	51.1	57.4	268.3	82.9	96.4	71.7	2.1	50.2	57.6	119.0	399.2	137.8	165.3	68.2	65.5	60.0	104.8	77.4	27.2	92.5	49.0	60.2	61.2	40.6	50.0	81.3	47.8	244.8	115.1	32.0	55.9	105.9	116.0	95.2	82.7	52.6	85.4	85.1	85.4	29.0	107.1	52.5	74.2	66.9	35.0	87.5	111.6	51.6	67.8	30.3	250.3	485.2	69.0	7.6	72.3	54.5	61.7	157.5	24.6	68.6	41.1	41.0	64.4	135.1	139.6	86.8
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 18020.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"NB-4: 2.1"									"CAB032548, HPA052517"	Enhanced				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB032548: AB_2277258, HPA052517: AB_2681860"																		31.6	4.3	0.7	0.6	0.8	18020.9	16.8	0.5	3.0	4.0	0.6	4.1	0.0	11.3	0.0	3.2	2.2	1.3	62.5	0.5	0.6	15.0	91.6	560.5	3.5	0.7	0.7	4.1	5.5	0.1	20.6	11.4	0.7	2.7	0.0	0.3	14.5	0.0	16.8	40.3	2.3	0.0	0.8	1803.8	6.4	3.1	0.8	37.0	15.8	0.0	0.8	3.4	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	3.0	0.5	0.6	0.7	0.7	0.7	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 872.0"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052517	Supported				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 11: Alveolar cells - Smell perception"			"HPA052517: AB_2681860"																		2.3	0.3	0.1	0.8	0.1	872.0	1.1	0.1	2.0	0.0	0.1	0.2	0.0	0.9	0.0	0.1	0.1	0.0	3.8	0.2	0.1	0.9	9.1	52.1	0.0	0.2	0.1	0.3	0.1	0.0	1.4	7.2	0.4	0.1	0.0	0.1	9.4	0.0	0.8	0.2	0.2	0.0	0.1	150.4	0.6	0.1	0.4	27.8	1.2	5.8	1.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.2	0.1	0.2	0.1	0.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056739	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	768	"intestine: 9759.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	Yes	NA		110000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.3	0.4	0.1	12.7	0.1	0.2	0.5	0.1	0.5	0.0	0.1	56.6	5185.1	3.9	0.1	0.8	0.0	0.0	0.4	0.1	0.2	0.2	1.1	0.4	6.0	0.1	0.2	0.4	0.8	0.0	1.1	0.0	0.2	0.7	0.2	0.1	0.7	0.0	0.3	0.3	9759.8	0.1	0.1	0.4	0.9	0.8	0.2	0.4	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	2.5	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	325.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	399.9	0.0	0.0	0.0	1740.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	1753.0	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924697-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	863	"intestine: 4819.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 448.9;Undifferentiated cells: 904.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 21.2;colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 14.7;NB-4: 15.9;RPMI-8226: 19.7;SH-SY5Y: 12.2;U-2197: 5.7"									HPA019462	Enhanced				"Secreted to digestive system"	NA	NA		260000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.2	0.0	5.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	25.7	2862.9	2.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.2	3.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.3	3.3	0.0	0.3	0.0	0.2	0.6	4819.9	0.0	0.0	0.2	0.4	0.6	0.0	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	448.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	904.1	0.0
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
DELE1	"DELE, KIAA0141"	ENSG00000081791	"DAP3 binding cell death enhancer 1"	Q14154	5	141923855-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	42.5	54.2	26.5	22.5	29.1	39.7	42.0	30.4	32.9	43.3	33.6	43.8	30.3	41.2	14.6	35.4	38.8	24.9	78.9	26.8	27.7	44.5	53.5	46.2	30.2	29.9	28.6	37.9	42.9	38.1	34.0	29.4	28.9	41.4	31.2	14.0	33.1	24.5	71.1	32.3	39.6	30.1	27.7	65.7	42.4	15.6	29.5	19.3	40.3	49.7	27.1	43.4	38.7	29.6	23.6	31.5	44.7	65.9	34.7	45.5	29.7	29.8	48.8	51.6	56.8	46.0	54.0	55.1	33.2	32.9	29.9	35.1	27.2	62.8	28.4	31.7	24.0	33.4	37.9	34.5	43.8	48.3	63.3	55.8	31.3	45.4	37.0	46.0	54.5	11.5	21.4	72.9	26.9	30.8	13.0	26.8	17.2	28.6	49.9	43.5	29.7	61.8	37.2	33.7	25.0	31.8	35.2	54.0	72.6	28.8	70.3	42.6	44.1	38.9	23.8	20.7	27.0	20.1	23.3	34.0	32.0	38.1	43.4	21.2	43.0	14.8	21.2	56.7	19.7	20.6	16.5	20.7	56.1	19.1	13.8	18.2	18.2	24.7	66.9	22.2	27.2	25.3	26.5	29.1	30.4	32.9	26.8	27.7	29.9	28.6	28.9	27.7	29.5	29.6	31.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	16.0	17.0	0.0	0.0	0.0	11.0	0.0	26.2	13.7	0.0	13.7	12.4	0.0	12.0	13.7	10.9	0.0	0.0	0.0	24.3	13.8	6.3	0.0	12.1	0.0	24.4	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	17.2	0.0	0.0	5.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	25.7	4.8	34.5	0.0	0.0
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 258.9;Excitatory neurons: 188.2;Inhibitory neurons: 175.8;Late spermatids: 88.5;Microglial cells: 178.0;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 12.1;granulocytes: 20.4;monocytes: 21.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Approved	Vesicles,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Vesicles, Cytosol"		"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	8.5	8.3	8.2	10.3	8.3	27.0	7.1	2.7	10.3	7.9	6.8	10.6	11.3	8.3	4.6	7.7	8.7	7.2	7.3	8.1	6.2	11.4	10.8	6.9	9.0	5.6	6.0	7.9	6.2	11.9	10.2	11.3	4.9	7.7	9.6	10.3	6.1	7.6	8.4	6.9	12.6	9.9	4.8	14.2	6.9	9.5	6.4	7.1	10.8	4.8	6.2	7.6	6.5	5.7	29.0	16.7	14.7	28.0	9.8	15.3	68.3	27.4	41.0	22.9	19.6	23.0	12.5	23.1	5.5	22.3	30.1	15.9	12.6	19.9	22.2	9.8	9.7	10.9	39.1	17.1	13.2	13.2	7.0	14.2	17.6	18.9	32.2	8.0	20.6	21.8	30.3	17.2	18.7	16.5	15.8	19.1	29.4	33.1	25.2	24.3	14.4	19.5	11.4	10.1	31.1	25.3	22.1	14.4	16.9	9.6	19.8	32.8	9.7	24.5	9.4	28.9	14.6	26.0	21.7	16.0	20.6	25.9	16.5	20.4	21.1	4.3	1.8	14.6	0.9	1.7	1.3	0.8	12.1	1.8	0.8	1.0	12.8	0.8	12.8	1.9	0.6	5.3	8.2	8.3	2.7	10.3	8.1	6.2	5.6	6.0	4.9	4.8	6.4	5.7	6.4	0.0	1.5	258.9	10.0	5.1	2.6	2.5	1.8	16.1	4.8	4.3	7.7	7.2	1.7	16.5	16.7	10.0	6.8	25.3	5.9	4.3	35.1	5.0	8.2	10.5	12.0	20.2	188.2	5.1	32.2	7.6	20.9	3.9	4.5	8.8	7.5	14.5	18.0	32.0	175.8	7.6	2.0	21.4	8.2	88.5	14.6	18.7	3.6	178.0	18.7	11.6	5.2	165.4	145.2	6.1	9.5	11.3	13.1	5.3	18.3	16.0	2.9	13.1	0.0	6.7	5.9	3.8	1.4	3.8	2.8	8.8	5.3	4.5	7.8	3.9
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752824-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 227.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021783	Approved		Approved	Cytosol		NA	NA		200000	"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA021783: AB_2670820"	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavorable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	25.4	22.6	19.0	27.0	19.6	27.5	29.6	15.3	23.6	22.2	15.1	25.5	26.7	23.7	22.1	32.5	21.7	22.1	24.4	19.4	20.2	25.5	27.6	18.8	36.2	16.8	21.6	19.2	21.2	59.0	17.1	31.6	19.5	28.0	26.0	16.5	28.4	24.8	60.2	29.6	25.0	24.5	15.2	28.0	23.3	14.6	18.9	38.9	29.8	44.7	35.5	30.0	20.4	16.7	113.1	62.1	77.7	80.1	48.7	71.9	67.6	100.5	56.1	87.6	60.6	86.9	40.6	99.9	103.4	72.5	66.6	84.0	93.8	89.5	117.6	90.9	67.3	122.8	36.2	63.8	63.5	139.6	97.4	62.8	86.9	79.3	107.4	81.6	86.4	109.7	129.8	35.8	94.8	74.9	137.7	134.1	159.2	67.2	128.4	120.6	91.2	63.7	85.3	99.9	89.3	63.4	139.2	40.8	107.3	79.1	129.5	78.1	82.2	81.2	95.9	91.7	102.1	58.8	145.8	160.4	76.4	100.1	90.9	227.9	35.0	58.1	38.8	53.3	45.3	45.5	41.9	39.4	47.3	41.4	48.5	43.4	42.2	47.3	69.9	42.1	49.2	44.5	19.0	19.6	15.3	23.6	19.4	20.2	16.8	21.6	19.5	15.2	18.9	16.7	43.4	70.5	40.1	31.0	59.8	71.9	65.9	55.4	59.7	37.7	66.2	69.8	66.3	45.8	47.7	47.8	41.7	73.0	60.8	40.9	64.6	68.6	17.9	67.7	83.5	51.4	84.8	53.8	39.0	61.8	130.3	48.3	40.8	70.7	43.1	50.4	42.1	54.3	57.4	55.5	36.2	53.6	44.7	50.1	42.4	8.0	50.4	49.3	26.6	25.3	60.2	47.3	75.2	48.2	31.3	88.0	44.6	45.9	47.9	73.2	40.3	67.3	49.5	35.9	19.7	46.2	62.5	120.3	136.8	72.8	64.9	60.6	54.7	47.3	58.8	51.3
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013170-123042302	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 225.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 825.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	69.1	47.6	15.2	53.7	16.4	104.1	34.1	20.2	18.2	26.6	26.6	50.0	47.9	29.4	31.4	35.4	29.4	32.9	41.3	17.9	18.3	30.8	77.5	37.1	48.7	15.7	16.4	38.1	31.6	26.9	23.0	28.0	15.7	27.0	42.8	29.6	29.6	28.7	73.3	23.6	47.0	34.4	16.7	40.0	38.5	32.1	18.0	27.2	42.4	49.1	55.5	41.8	22.5	19.5	130.8	93.9	55.7	72.6	98.3	72.8	47.1	108.9	72.1	68.7	85.1	59.7	126.9	150.7	129.8	87.4	81.2	107.0	51.8	69.3	97.4	174.9	57.6	157.2	62.9	51.6	89.2	62.2	111.0	66.9	87.8	76.0	89.8	62.5	62.8	60.6	95.9	193.7	78.7	254.8	68.5	39.4	42.1	166.4	82.5	68.3	46.2	252.1	182.2	92.1	60.5	89.8	109.9	825.1	68.6	59.6	97.3	55.4	74.2	82.2	154.1	74.1	102.1	239.5	444.6	136.5	135.4	76.4	79.4	73.1	60.7	72.6	89.3	75.7	93.0	69.8	59.5	74.0	49.5	56.1	41.0	64.0	42.1	77.8	77.9	56.6	80.0	83.3	15.2	16.4	20.2	18.2	17.9	18.3	15.7	16.4	15.7	16.7	18.0	19.5	38.6	32.1	25.9	12.4	78.3	42.3	41.8	57.3	26.7	22.6	38.3	21.3	28.1	17.2	44.8	29.5	20.9	41.0	67.6	43.3	9.8	87.7	85.5	18.9	32.3	39.2	30.5	41.0	11.5	75.4	71.4	43.8	26.5	31.2	42.6	24.0	39.3	75.9	68.0	18.5	12.8	62.2	42.7	49.4	44.2	19.9	24.5	45.6	60.5	14.0	47.6	25.5	59.8	17.6	19.1	68.4	40.6	25.6	225.0	63.7	56.6	28.0	31.3	25.6	46.0	32.7	77.6	75.4	40.3	41.0	50.7	78.0	69.8	34.8	37.5	64.4
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 1428.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"plasmacytoid DC: 187.4"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 187.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favorable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favorable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	2.6	3.2	1.4	4.3	1.4	1.8	5.4	1.3	2.2	6.1	1.9	30.6	10.0	3.7	0.2	4.3	7.1	2.3	7.7	1.3	1.6	5.7	9.1	9.2	9.2	1.8	2.2	2.0	60.8	0.8	8.1	0.8	1.7	3.3	10.9	0.2	51.1	3.8	2.7	0.8	33.7	0.7	1.7	61.6	29.4	24.8	1.7	1.6	14.6	0.2	17.6	3.6	2.3	1.5	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.5	4.8	0.9	0.0	1.4	0.0	1.1	1.3	0.0	0.5	4.8	0.4	4.6	0.0	0.7	3.2	0.6	0.0	0.2	0.5	0.0	0.1	0.1	0.5	0.8	26.9	0.0	0.0	1.3	2.2	1.0	2.3	0.3	4.2	0.0	23.6	0.9	0.3	0.6	0.1	0.1	0.0	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.4	0.1	48.5	6.3	8.3	0.8	6.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	13.8	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.0	0.0	187.4	0.0	1.3	1.4	1.4	1.3	2.2	1.3	1.6	1.8	2.2	1.7	1.7	1.7	1.5	0.5	0.0	1.1	0.3	183.8	1.8	1.5	3.7	0.6	1.1	19.3	1.8	3.5	1.5	4.1	0.0	2.1	0.8	141.7	2.7	0.0	0.5	113.2	33.8	0.9	1.1	1.8	8.2	0.3	5.8	6.2	2.2	7.7	1.7	2.5	15.7	4.6	7.8	3.4	0.0	1.7	7.9	4.1	2.2	2.1	158.2	2.5	5.4	224.1	1.9	0.5	0.8	0.0	1.0	0.5	1.1	0.5	4.1	1428.8	2.5	0.8	0.5	30.3	0.6	0.0	0.8	2.6	67.0	32.9	1.3	2.0	15.5	17.9	2.1	10.7	2.0
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8 microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.3;Rod photoreceptor cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	5.2	4.4	5.3	6.1	5.2	7.7	4.8	9.4	5.6	6.8	5.0	7.0	5.0	8.5	3.6	7.1	6.9	4.7	5.2	5.3	4.6	4.7	4.5	5.3	6.3	5.1	5.1	8.4	6.2	6.4	5.2	11.6	5.6	5.5	5.0	6.5	7.2	5.6	14.8	7.5	6.7	6.0	4.7	5.9	6.1	15.2	5.3	9.5	6.0	9.3	5.9	6.8	5.7	6.2	22.7	15.7	20.1	11.9	7.7	12.4	25.5	21.3	12.6	14.1	9.9	17.0	11.3	20.1	11.6	20.0	9.4	21.4	18.4	17.8	12.2	19.7	27.4	21.7	17.4	14.0	20.3	40.7	17.5	10.0	21.6	14.8	10.7	12.9	12.6	12.1	78.7	14.1	16.5	14.6	24.7	12.1	19.4	16.5	11.8	29.0	21.2	6.8	8.5	20.9	22.3	14.3	19.4	11.3	13.0	12.0	10.9	17.2	18.8	20.5	17.1	13.0	21.9	7.8	11.5	19.9	15.3	18.2	20.3	0.0	1.1	0.6	2.0	0.9	1.5	0.7	0.9	2.1	1.3	0.6	0.9	1.2	0.2	1.6	3.6	1.5	1.2	1.5	5.3	5.2	9.4	5.6	5.3	4.6	5.1	5.1	5.6	4.7	5.3	6.2	8.1	6.4	7.9	11.8	6.0	9.6	5.2	6.8	10.2	37.1	9.1	8.0	4.2	11.5	7.3	5.5	39.6	13.6	6.9	9.6	0.0	6.1	61.3	5.5	8.3	10.2	7.3	10.3	12.4	10.2	11.2	7.3	12.8	7.3	3.8	19.2	9.7	14.4	5.3	43.7	12.7	10.3	4.1	8.4	6.5	39.2	18.3	5.0	5.4	6.5	7.2	10.9	11.3	9.5	14.0	10.9	5.8	10.5	9.3	8.6	6.2	3.4	8.1	60.7	6.6	9.7	8.1	25.2	17.5	10.4	9.2	13.5	9.3	15.1	9.7	5.6
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 32.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 937.7;Inhibitory neurons: 576.6;Oligodendrocyte precursor cells: 254.3"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Group enriched"	"Detected in many"	7	"basal ganglia: 32.3;cerebral cortex: 14.4;hippocampal formation: 9.2;hypothalamus: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;fHDF/TERT166: 2.6;SCLC-21H: 1.3;U-266/70: 3.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 192.8"	HPA020321		Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	0.2	2.6	2.5	0.2	32.3	0.0	0.1	0.0	14.4	2.3	0.0	1.4	0.0	3.3	0.0	0.5	1.6	0.3	0.4	9.2	11.9	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.5	2.0	0.0	0.1	0.3	0.0	0.5	1.4	0.0	0.0	0.6	0.1	0.9	0.1	0.1	1.4	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	32.3	0.0	14.4	9.2	11.9	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	70.5	0.0	0.1	0.3	0.0	0.0	26.4	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.2	5.3	0.7	0.0	0.0	937.7	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.0	576.6	0.0	0.0	0.0	0.5	1.9	1.2	0.1	1.8	43.1	0.0	0.1	0.0	254.3	17.3	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	1.6	6.6	0.5	4.9	0.2	0.5	0.1	0.4	0.0	0.1	0.1	0.0	0.3
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354494-233472104	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 30.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 143.2;Inhibitory neurons: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.3;HeLa: 21.8;U-698: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA027530: AB_2672320, HPA049101: AB_2680630"	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.2	3.4	4.3	1.9	5.5	12.0	5.9	20.5	6.2	4.5	3.2	9.0	1.6	5.9	1.6	2.2	5.7	1.0	7.6	5.8	4.0	2.5	3.6	10.6	4.3	6.5	3.9	8.9	2.7	0.4	3.7	2.9	7.4	5.7	2.3	5.4	5.9	0.5	30.4	3.0	12.9	0.7	4.1	11.4	25.2	9.6	4.4	1.0	8.3	0.9	4.5	5.3	2.6	8.8	1.7	8.5	2.1	1.5	1.5	1.4	3.0	2.4	1.0	0.6	0.5	9.7	1.9	10.3	1.1	2.4	4.5	2.0	2.4	1.0	3.2	17.3	11.3	4.7	21.8	5.8	0.9	11.7	7.2	2.3	2.2	1.1	2.1	1.8	0.8	2.1	7.8	1.8	1.6	3.1	9.2	3.3	1.6	2.8	6.9	14.5	5.7	1.6	0.9	3.3	2.1	2.2	1.4	2.3	1.0	1.8	0.6	5.2	1.0	1.2	3.0	1.2	1.7	7.1	6.2	22.7	0.8	5.6	0.6	1.7	1.6	5.6	2.1	0.6	1.1	4.8	0.5	1.5	0.4	5.0	1.7	2.4	1.2	0.6	1.0	0.4	0.2	1.7	4.3	5.5	20.5	6.2	5.8	4.0	6.5	3.9	7.4	4.1	4.4	8.8	18.9	32.1	46.2	27.1	61.1	8.9	6.4	5.6	4.6	33.8	19.6	11.6	21.0	0.0	13.8	0.0	62.6	14.6	62.0	40.6	0.0	3.6	14.9	23.4	12.5	19.1	2.4	5.0	11.1	4.4	1.2	9.7	143.2	38.1	5.7	13.1	4.6	7.0	6.8	8.4	137.9	32.8	8.2	10.4	13.8	38.7	6.5	28.7	8.8	11.2	17.5	13.9	49.4	43.2	81.5	26.0	13.5	4.5	34.7	17.6	29.6	2.6	4.8	44.3	19.7	49.4	21.2	14.4	29.3	4.5	3.7	2.5	32.5	7.6	20.1	9.9
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362234	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	1.6	4.2	14.2	0.8	17.4	9.3	1.1	28.2	11.9	2.2	0.0	3.2	1.4	1.2	8.0	4.6	4.1	0.9	9.1	20.4	3.6	1.3	0.8	3.8	0.9	20.1	6.5	1.2	0.5	5.7	6.0	7.8	20.8	1.3	0.8	1.7	0.8	1.8	1.8	0.8	1.7	2.4	0.6	0.9	2.1	0.3	9.6	0.5	1.8	1.0	0.8	3.4	1.7	13.2	3.2	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.7	0.0	3.3	0.2	0.0	0.0	0.0	23.9	0.0	3.2	0.0	3.5	0.0	7.7	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.6	0.0	0.4	0.4	0.1	0.1	2.6	0.4	0.0	1.4	1.7	0.0	2.6	0.0	0.0	0.6	0.0	0.9	0.0	2.0	0.0	0.1	4.9	0.0	0.0	0.8	2.4	2.9	0.0	9.4	0.0	14.3	7.0	2.6	0.0	2.1	1.2	0.0	1.2	0.0	0.3	0.0	0.0	1.5	0.1	0.0	0.0	2.6	0.0	1.5	0.2	0.0	0.7	14.2	17.4	28.2	11.9	20.4	3.6	20.1	6.5	20.8	0.6	9.6	13.2	0.1	0.0	1.7	223.0	3.1	0.4	0.2	0.0	0.6	0.1	0.1	0.4	19.4	1.5	0.0	1.8	0.0	0.1	0.0	0.0	0.0	1.4	2.6	0.3	0.1	5.0	0.0	0.4	111.0	1.2	0.0	0.5	0.5	0.1	0.0	0.3	22.1	0.0	2.1	1.7	63.5	0.1	0.0	3.2	1.4	4.2	1.8	3.4	0.0	12.2	5.2	6.8	0.0	334.8	7.8	1.0	0.1	0.4	0.2	0.4	0.1	0.9	0.0	0.1	13.1	1.8	14.5	0.0	0.2	0.4	0.4	0.1	0.1	0.9	0.1	0.4
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 33.5;Intestinal goblet cells: 21.6;Paneth cells: 33.1;Proximal enterocytes: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.5	8.2	11.7	9.2	11.4	9.8	6.7	15.4	15.8	9.0	3.6	20.0	22.2	7.9	2.6	10.8	7.6	5.1	6.0	14.0	10.9	8.3	8.1	9.5	11.0	14.3	8.6	6.5	9.9	3.7	10.5	3.2	10.1	9.3	6.5	1.0	9.4	4.0	3.6	13.2	23.6	2.7	6.1	15.4	8.4	9.0	11.8	7.5	8.7	1.3	4.4	8.4	9.7	7.0	5.7	9.1	3.9	13.2	4.7	3.8	14.5	10.7	6.0	6.0	5.9	6.5	11.1	7.6	8.8	6.8	12.2	6.5	2.2	7.5	1.4	6.0	6.9	11.8	10.3	11.6	8.0	5.1	15.2	7.2	12.5	4.9	2.3	5.1	7.3	15.6	9.1	0.9	4.7	8.6	10.7	29.6	6.9	15.9	15.3	17.0	1.1	0.9	6.5	7.9	2.4	6.6	3.7	4.1	11.3	3.0	9.9	12.3	10.8	10.3	4.8	11.7	7.2	20.2	9.4	6.0	8.9	10.9	9.5	2.9	0.5	1.3	2.0	0.5	0.9	0.5	0.7	1.7	0.4	0.4	0.7	1.3	0.3	2.4	0.4	0.8	0.5	0.8	11.7	11.4	15.4	15.8	14.0	10.9	14.3	8.6	10.1	6.1	11.8	7.0	4.3	3.2	3.1	8.5	3.6	2.8	1.3	2.9	1.2	3.6	3.5	3.9	3.0	4.3	2.9	3.7	4.2	0.5	15.1	33.5	0.0	3.0	0.6	2.6	3.3	3.3	7.7	5.7	12.4	4.9	2.1	2.9	3.1	4.1	0.0	6.2	2.5	5.8	2.5	3.3	11.8	21.6	0.0	4.1	2.3	1.3	4.1	4.6	3.6	5.6	4.5	3.0	10.3	3.0	3.2	5.7	33.1	2.6	4.6	3.1	29.1	0.9	4.4	1.0	0.0	2.6	2.8	3.2	4.3	2.9	3.8	0.7	6.7	3.6	14.5	3.8
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 146.2"	"Cell type enhanced"	"Detected in all"		"NK-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	27	"amygdala: 46.5;basal ganglia: 75.1;cerebral cortex: 146.2;hippocampal formation: 133.8;white matter: 51.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced	Supported	Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"		"HPA051336: AB_2681448"	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	20.7	14.2	46.5	21.6	75.1	54.6	19.4	3.3	146.2	16.5	0.0	20.3	36.4	16.8	4.0	19.5	15.3	11.1	46.5	133.8	0.0	18.3	10.5	18.3	39.9	0.0	0.0	12.4	31.5	10.0	58.7	14.1	0.0	18.6	6.6	2.5	43.4	10.7	95.7	22.3	41.2	9.1	0.0	36.1	22.2	15.4	1.4	34.0	12.5	25.1	17.1	18.2	15.3	51.0	38.1	33.2	22.1	33.2	11.5	12.8	102.1	29.0	21.5	30.0	26.3	39.8	17.1	48.4	20.5	30.1	33.0	43.3	26.7	42.0	10.6	48.8	62.5	31.7	25.2	29.5	20.5	60.5	61.2	17.3	19.3	16.5	22.2	15.3	33.4	39.3	45.1	29.1	21.5	99.8	58.6	94.3	64.3	54.5	50.3	69.0	38.2	20.6	9.1	36.6	150.3	25.6	33.2	109.6	23.0	13.8	78.8	75.2	37.9	39.2	42.4	62.6	52.9	19.1	23.4	40.3	53.8	54.0	37.2	12.4	13.5	6.0	6.8	5.6	4.1	0.3	4.3	5.9	12.0	0.8	4.3	4.6	9.5	7.6	6.4	5.7	4.4	10.5	46.5	75.1	3.3	146.2	133.8	0.0	0.0	0.0	0.0	0.0	1.4	51.0	46.0	3.2	6.6	44.7	16.4	13.3	22.3	16.3	14.2	27.6	24.6	19.8	24.4	8.6	8.7	9.2	20.9	14.6	95.8	37.7	9.8	13.2	6.1	9.9	15.2	34.2	51.5	23.4	114.0	47.8	105.1	12.4	34.1	14.1	21.0	25.7	56.7	7.1	51.2	16.8	45.0	26.3	22.4	46.1	26.9	11.4	13.1	34.0	12.4	31.9	50.6	6.4	129.8	8.5	24.7	33.5	41.0	8.2	25.3	16.6	97.0	20.2	8.2	9.9	32.9	17.8	16.8	7.0	12.2	12.3	9.2	27.4	71.8	19.4	29.9	17.2
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	30.6	43.2	44.6	23.9	48.1	21.7	29.6	51.0	57.5	35.7	50.0	40.9	28.0	33.2	15.6	29.5	38.6	20.1	41.0	46.5	48.6	34.2	41.0	29.6	32.7	46.4	45.1	40.6	49.7	47.0	52.8	19.7	50.0	34.8	29.5	69.1	34.1	27.9	92.6	41.3	32.8	29.1	47.7	31.6	44.2	16.0	45.9	45.2	28.7	70.5	34.7	36.7	33.1	56.2	70.8	50.8	80.8	41.5	34.2	57.7	18.6	44.0	64.9	82.8	82.9	35.4	33.8	71.7	49.4	48.2	75.6	41.0	55.7	63.0	57.4	64.2	37.8	48.8	51.4	47.1	43.8	57.2	72.1	47.2	74.8	49.7	85.2	82.9	59.1	141.5	45.1	49.5	61.5	137.0	105.1	83.3	64.2	90.3	85.1	65.8	29.1	106.6	63.5	34.6	106.7	144.4	44.0	64.2	76.0	48.1	59.0	96.5	29.8	94.4	38.2	93.5	69.2	160.0	184.9	49.9	59.7	66.2	94.5	37.0	58.8	82.7	51.0	54.1	53.0	86.2	59.0	52.8	63.4	82.1	77.7	56.8	18.2	64.2	72.8	64.9	77.6	70.0	44.6	48.1	51.0	57.5	46.5	48.6	46.4	45.1	50.0	47.7	45.9	56.2	40.3	41.7	30.7	10.1	54.8	55.6	79.2	93.0	38.7	75.8	48.3	64.5	8.6	37.1	49.1	33.1	45.9	47.1	52.2	35.2	86.1	53.7	20.9	38.2	24.5	35.0	41.3	26.7	11.9	37.6	55.1	35.0	33.6	27.9	24.1	46.0	30.4	34.6	42.8	42.1	12.5	60.8	79.3	37.6	42.5	27.5	45.1	35.3	49.8	6.5	62.7	115.2	53.5	8.0	14.7	48.7	70.1	34.6	51.1	73.3	87.9	84.1	49.6	129.2	46.0	39.6	53.8	33.3	62.3	39.7	51.0	71.8	51.1	37.4	54.3	71.0
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256055-55307694	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	10.6	10.6	5.3	9.7	5.7	6.7	12.0	9.1	7.0	12.5	6.7	12.1	7.2	11.4	6.8	12.7	9.5	8.9	10.7	5.7	5.1	16.9	13.1	9.4	9.5	5.0	5.0	8.9	11.7	18.7	10.4	11.4	5.1	13.4	9.8	8.7	10.3	12.0	24.2	11.6	8.4	12.6	5.5	7.9	10.4	7.4	5.1	10.0	15.4	14.8	9.7	12.0	10.3	7.1	36.7	25.5	20.9	27.2	32.3	28.2	25.6	38.9	30.9	28.2	28.7	21.3	23.0	20.7	34.9	44.5	35.8	26.0	34.0	37.1	40.5	9.1	19.4	18.8	21.6	14.6	18.3	13.3	19.6	23.8	23.0	29.9	17.2	18.5	37.9	16.5	24.4	15.0	33.4	25.9	21.4	11.1	17.5	10.5	27.1	10.9	31.8	35.7	23.0	25.3	19.6	12.5	37.4	21.3	18.6	20.5	28.7	21.7	32.9	25.9	20.2	22.8	27.4	13.2	24.1	29.0	29.9	23.0	29.1	68.6	22.5	24.3	18.0	24.4	20.4	27.3	22.5	20.0	17.5	26.3	25.0	21.6	20.6	24.5	30.1	36.8	21.9	8.9	5.3	5.7	9.1	7.0	5.7	5.1	5.0	5.0	5.1	5.5	5.1	7.1	44.5	70.5	42.6	34.0	35.2	37.6	37.5	71.8	39.3	81.6	44.9	49.8	73.6	41.5	69.4	64.4	41.7	68.3	39.5	34.4	54.8	61.4	54.8	37.4	61.5	40.7	38.4	68.4	47.3	61.7	54.6	52.7	35.7	36.5	31.6	39.0	22.9	45.0	41.2	42.1	46.9	36.4	63.1	26.0	26.6	16.6	46.6	41.5	28.4	28.1	50.7	35.7	35.0	42.7	54.9	61.9	27.3	53.0	57.0	53.2	35.2	105.2	35.9	83.6	52.6	52.8	54.2	117.5	108.1	50.1	47.5	81.3	36.1	106.4	39.9	43.3
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease variant, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 564.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004916, HPA076913"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		2000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	27.9	20.3	21.0	42.1	22.5	90.2	24.2	18.3	20.9	24.4	40.0	31.0	40.6	18.5	44.3	58.0	25.2	30.0	34.9	21.5	25.7	38.1	91.7	51.3	67.0	18.8	19.9	12.9	37.3	44.6	24.5	25.1	20.1	14.7	31.1	28.4	36.1	19.3	172.0	47.3	36.5	18.7	18.0	36.3	45.1	19.9	27.4	68.5	33.1	55.7	66.4	47.1	30.4	18.6	147.8	92.6	53.2	68.4	40.4	54.5	71.3	59.5	62.2	67.7	70.2	318.1	131.6	156.5	88.1	85.5	103.0	157.9	116.9	191.5	84.8	88.9	66.6	282.6	121.4	103.6	37.7	198.9	564.7	34.4	102.1	94.5	95.5	30.5	87.0	234.8	101.2	106.9	67.7	141.5	217.2	256.8	51.6	75.2	61.6	240.1	87.1	87.6	129.8	158.5	69.4	37.3	146.2	184.6	59.5	47.5	77.5	92.1	52.8	93.9	49.9	52.1	119.9	54.2	94.4	111.7	50.2	153.7	57.8	23.6	12.8	29.8	32.6	14.0	21.2	9.3	20.3	25.3	12.6	9.1	14.8	23.9	13.7	13.7	15.1	10.0	18.7	15.4	21.0	22.5	18.3	20.9	21.5	25.7	18.8	19.9	20.1	18.0	27.4	18.6	33.9	48.1	46.8	11.8	40.0	52.6	60.8	22.4	21.6	17.3	35.1	23.1	18.6	22.8	48.0	44.1	54.2	20.9	96.9	60.5	5.9	62.7	27.9	42.3	18.9	39.0	5.4	52.6	44.1	98.0	31.9	25.9	76.0	83.0	46.9	14.5	16.8	91.6	17.1	6.7	33.6	23.1	12.2	38.4	60.6	9.0	11.8	78.5	19.6	24.4	54.6	12.1	115.4	25.6	9.1	122.9	35.7	10.9	54.1	77.3	35.2	13.9	30.4	69.0	13.1	15.4	26.4	18.3	26.1	38.7	59.7	52.1	92.8	18.3	30.1	91.2
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	10.7	3.3	3.7	6.4	6.4	17.7	7.0	0.0	4.3	10.6	17.3	8.6	4.3	5.5	3.5	7.7	6.7	5.7	5.4	6.4	3.1	3.1	12.3	8.2	3.8	0.6	0.9	7.7	4.9	7.0	2.0	12.5	1.0	6.1	8.7	3.0	6.6	7.6	12.0	5.3	5.3	7.4	0.2	3.8	7.4	9.4	1.5	6.0	3.9	9.1	3.9	7.4	9.8	1.8	0.0	6.5	3.1	6.3	17.1	28.3	0.0	11.2	11.8	5.9	12.4	5.5	12.3	18.5	8.7	9.7	11.3	0.0	16.6	1.7	7.6	0.5	9.5	0.0	7.4	5.9	14.2	24.3	8.2	14.3	6.0	8.0	24.6	8.0	11.6	13.6	0.0	14.9	11.2	5.3	9.2	10.0	24.4	0.1	9.4	0.0	16.5	0.0	3.4	9.8	0.0	6.3	0.0	3.2	9.0	18.8	2.7	13.2	14.8	12.6	5.8	10.6	7.3	0.2	0.0	15.3	10.7	24.1	7.6	0.0	3.1	3.3	1.1	2.8	0.9	1.7	1.2	1.4	2.3	1.3	0.8	0.7	0.3	0.7	2.5	2.2	0.7	0.6	3.7	6.4	0.0	4.3	6.4	3.1	0.6	0.9	1.0	0.2	1.5	1.8	61.7	32.1	51.1	21.2	18.8	10.8	6.8	11.9	11.4	5.5	9.9	8.1	20.2	15.7	15.0	20.2	0.0	65.2	21.5	36.6	7.9	18.6	80.5	51.2	46.2	31.2	24.6	6.1	171.0	23.4	16.8	35.2	41.8	41.7	7.6	36.1	8.2	26.1	21.0	0.0	90.0	32.3	4.1	29.6	19.3	177.8	45.1	34.7	8.8	301.7	32.7	13.0	10.3	281.0	41.2	38.4	39.3	20.3	11.6	8.0	11.9	9.4	57.1	13.7	26.3	46.7	32.7	7.5	12.9	17.6	18.3	118.3	19.0	19.0	32.5	6.0
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 18.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.3	0.1	0.2	0.1	0.0	3.5	0.2	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.6	2.6	0.1	0.5	1.6	18.9	0.3	5.4	0.1	0.0	2.4	0.6	0.7	0.2	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.2	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	30.4	20.1	15.7	21.5	17.6	29.1	31.0	22.4	17.8	33.8	23.3	36.3	19.6	38.2	26.8	27.1	36.8	17.5	27.6	15.4	17.2	25.5	24.7	30.9	31.6	16.4	16.4	39.5	24.6	28.5	28.1	24.8	16.6	34.0	19.7	19.9	33.2	24.9	32.5	39.5	36.5	20.9	14.0	35.9	28.8	27.9	17.3	30.8	33.0	22.8	26.9	32.6	31.5	22.2	29.6	22.5	36.7	21.0	18.4	22.6	19.6	21.9	18.5	79.4	22.8	96.4	29.9	29.0	29.4	26.9	46.1	45.2	33.8	42.4	51.1	16.1	22.9	41.9	40.2	69.6	23.5	37.8	41.6	23.3	57.0	27.5	15.4	18.1	22.1	54.6	41.7	25.8	20.5	28.7	76.9	33.1	29.4	35.7	32.2	53.7	47.0	18.5	13.1	26.0	45.2	26.7	43.8	41.9	28.9	21.9	41.8	42.7	27.8	64.3	44.8	21.7	31.5	17.1	11.9	38.2	29.3	18.8	23.7	32.6	7.2	20.2	15.0	9.5	15.9	11.7	13.4	14.8	5.1	9.8	17.6	16.5	10.6	13.8	7.6	10.7	11.8	9.6	15.7	17.6	22.4	17.8	15.4	17.2	16.4	16.4	16.6	14.0	17.3	22.2	24.8	25.6	30.1	37.9	28.4	24.2	35.3	17.8	25.6	25.6	23.1	19.6	27.5	22.8	23.8	25.8	33.3	28.6	49.0	32.3	23.5	18.0	42.8	32.1	26.1	26.2	19.2	21.0	44.9	13.8	15.7	24.2	30.1	34.3	22.8	33.8	20.7	19.6	14.5	38.7	46.0	23.2	14.2	16.8	13.7	13.0	35.1	20.2	21.4	32.8	26.8	16.7	42.2	40.7	47.4	22.2	20.2	33.8	30.0	26.3	25.3	9.6	45.8	23.4	6.6	35.4	23.4	26.1	32.1	26.0	25.6	19.7	32.1	25.6	21.1	34.4
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 125.4;Excitatory neurons: 219.3;Inhibitory neurons: 269.9;Oligodendrocyte precursor cells: 216.2;Oligodendrocytes: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: AB_2683979"	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	12.7	7.7	13.8	3.7	18.3	0.2	8.3	18.8	19.9	11.0	0.0	22.1	4.5	12.1	5.4	9.1	8.8	8.6	14.1	13.6	10.7	14.7	8.9	4.9	2.4	16.8	14.6	13.3	8.0	8.1	6.2	4.6	17.4	8.4	4.4	9.4	4.2	9.1	34.5	4.8	7.0	12.4	7.2	3.3	7.3	7.2	18.1	2.1	5.3	20.8	1.5	10.5	7.5	32.6	0.7	6.3	11.5	6.1	19.0	20.5	9.5	13.9	8.6	10.5	8.5	1.8	1.9	0.5	3.6	22.5	2.7	0.1	7.1	1.2	6.4	0.3	6.4	0.1	4.5	2.0	9.2	0.0	8.6	16.9	5.5	6.6	0.0	16.4	2.3	0.1	0.0	1.2	8.0	17.4	0.7	0.0	3.0	5.4	2.6	9.9	4.8	2.0	7.5	7.2	5.8	8.2	2.4	5.0	20.1	6.0	6.6	0.0	0.1	11.1	2.9	33.3	4.6	0.8	14.3	7.2	13.9	0.3	6.4	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	13.8	18.3	18.8	19.9	13.6	10.7	16.8	14.6	17.4	7.2	18.1	32.6	12.6	9.6	5.8	125.4	4.0	7.9	5.4	2.2	7.4	18.6	11.8	10.0	30.3	17.2	4.7	3.7	22.9	5.2	0.6	2.2	0.0	8.5	19.0	7.9	18.5	7.8	10.8	0.0	219.3	4.0	5.8	15.4	10.2	8.8	20.3	16.3	10.4	24.2	6.2	1.7	269.9	6.2	2.0	3.5	5.2	6.1	11.5	3.6	23.2	44.0	0.6	19.4	1.0	216.2	421.7	7.7	1.3	19.5	0.9	7.7	10.2	17.0	5.3	20.5	6.6	22.7	17.6	21.7	22.5	4.3	3.8	3.8	2.0	5.6	5.7	8.9
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.2;Late spermatids: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	13.8	9.9	5.3	12.4	5.7	20.4	15.8	9.1	6.7	11.3	7.1	10.0	8.5	11.2	11.5	12.4	9.9	10.4	11.6	5.2	5.9	12.8	16.6	11.4	17.6	5.2	5.6	13.4	8.9	11.9	8.9	12.0	5.3	12.3	10.9	12.1	9.4	10.5	10.2	11.1	9.9	11.0	5.5	12.2	9.9	21.3	6.3	14.1	15.0	10.4	17.3	14.1	10.8	6.9	29.5	13.4	25.9	21.9	26.9	31.9	17.0	25.5	31.0	25.6	31.1	20.7	23.8	35.6	21.6	26.3	16.2	23.8	35.7	29.4	40.9	29.3	26.3	41.8	27.8	18.7	33.4	71.4	23.2	33.4	20.1	29.0	37.9	25.5	27.8	26.6	28.3	14.4	31.4	10.3	30.5	34.8	24.3	44.7	15.7	24.2	19.7	16.2	25.4	23.2	23.3	30.8	20.9	17.3	25.4	26.8	16.7	32.1	26.1	15.4	12.5	17.5	27.4	27.6	33.2	28.0	42.9	33.2	22.7	8.4	3.6	5.2	4.0	6.3	5.6	4.2	5.0	4.5	4.3	3.7	4.9	4.5	2.1	6.9	5.2	2.7	6.7	3.2	5.3	5.7	9.1	6.7	5.2	5.9	5.2	5.6	5.3	5.5	6.3	6.9	51.6	35.3	37.2	12.4	35.3	25.5	36.5	24.5	18.2	38.8	27.6	26.4	27.6	21.5	40.2	9.2	29.2	23.8	45.0	19.0	23.5	21.7	169.2	26.2	37.6	41.2	30.5	18.7	21.5	20.1	23.5	33.3	19.9	45.6	33.6	26.3	26.7	23.7	14.4	32.0	24.0	17.2	18.3	19.2	13.8	135.5	28.9	21.4	12.4	24.4	38.2	23.6	25.7	17.6	24.2	25.4	8.1	28.2	30.2	27.4	16.3	17.2	35.4	41.6	6.6	58.3	27.0	28.9	37.7	31.4	31.3	22.6	33.7	29.1	21.2	53.9
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.7"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.4	1.4	5.3	3.1	5.4	2.6	1.9	3.9	5.6	2.1	2.6	1.5	1.1	1.5	0.5	1.3	1.1	2.6	9.0	4.2	4.9	1.1	1.4	1.7	2.4	6.9	5.8	4.4	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.7	2.0	0.9	1.4	1.2	1.3	1.4	5.6	2.9	1.0	0.9	7.3	3.1	1.8	1.1	1.7	1.6	1.3	7.7	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.4	3.9	5.6	4.2	4.9	6.9	5.8	6.9	5.6	7.3	7.7	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 707.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		34000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (2.94e-4)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	23.5	20.4	17.1	29.9	18.1	68.8	35.3	18.3	20.5	21.3	18.9	28.5	24.2	23.2	22.3	36.4	24.4	15.3	19.4	17.0	18.4	21.7	22.6	16.5	40.2	17.9	18.2	30.8	32.6	26.5	17.6	23.2	18.8	22.2	34.8	19.8	22.0	18.9	31.2	30.6	21.3	22.8	18.0	25.7	21.5	25.3	18.1	39.4	27.8	23.2	47.8	36.8	23.8	19.7	236.5	129.3	77.4	111.4	47.2	48.2	114.9	87.2	60.5	127.2	118.9	164.3	114.2	447.2	221.3	74.7	119.4	123.5	239.6	144.8	189.3	108.8	132.9	223.4	131.1	143.3	66.9	304.6	131.2	46.3	135.6	141.1	320.8	46.6	89.7	146.2	210.1	108.0	88.0	137.7	201.5	233.7	130.2	234.0	158.8	177.1	174.1	230.3	80.4	132.0	170.0	84.4	77.8	133.3	122.7	75.0	68.1	120.8	70.8	91.4	138.2	119.3	292.6	199.8	290.5	707.7	62.2	316.5	102.0	10.8	25.0	33.1	38.6	30.1	48.8	44.2	31.1	41.6	35.5	31.3	40.7	39.1	7.4	41.2	31.2	25.5	26.5	30.3	17.1	18.1	18.3	20.5	17.0	18.4	17.9	18.2	18.8	18.0	18.1	19.7	21.6	25.6	32.3	5.9	47.6	99.7	76.2	45.4	60.3	31.6	39.2	34.0	32.0	25.8	35.2	25.8	14.6	56.6	34.8	17.7	41.1	62.8	2.7	22.4	39.8	39.7	34.1	84.1	6.4	45.3	74.8	36.4	23.0	24.1	56.8	70.0	13.6	26.0	44.5	23.5	7.1	35.9	54.9	21.6	36.4	7.9	25.7	25.8	49.8	7.5	36.4	34.8	29.9	7.5	7.7	47.3	14.8	28.6	45.1	131.2	9.5	25.6	26.7	28.5	13.1	37.8	42.6	41.0	87.2	69.9	98.3	34.2	35.9	59.6	49.9	57.9
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DLD	"DLDH, E3, GCSL, LAD, OGDC-E3"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107891162-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 357.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 356.2;Distal tubular cells: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	108.7	98.9	22.7	42.1	23.7	54.0	49.0	27.1	29.1	36.3	35.6	109.0	81.8	45.3	21.2	94.1	34.3	48.5	264.1	23.1	29.5	153.3	112.8	39.3	50.1	27.1	27.4	30.0	49.2	136.7	27.8	43.1	26.6	45.7	99.3	35.0	50.2	50.3	295.0	38.9	71.9	67.7	24.9	38.4	80.5	31.3	25.7	43.2	64.2	357.0	67.5	66.1	32.7	23.4	171.4	134.5	74.8	127.9	104.6	91.4	88.4	96.5	80.8	110.6	86.2	159.5	95.5	165.9	159.6	103.0	177.7	110.9	150.2	135.8	166.1	111.1	88.4	116.9	175.6	116.7	80.3	194.7	116.0	104.8	97.6	116.4	63.4	72.3	134.0	137.0	298.5	119.7	121.8	188.1	161.8	138.9	87.4	206.0	98.2	113.1	117.8	225.9	151.8	250.8	92.3	99.9	156.3	262.1	143.9	149.9	100.5	165.8	87.9	120.7	97.3	238.1	149.4	89.3	187.1	114.6	115.0	204.1	130.2	132.7	63.9	136.0	46.9	81.6	49.4	37.8	46.8	46.8	87.2	38.5	47.9	50.5	39.9	68.1	116.9	29.9	49.0	64.2	22.7	23.7	27.1	29.1	23.1	29.5	27.1	27.4	26.6	24.9	25.7	23.4	26.7	28.9	20.7	14.7	26.3	31.4	42.7	124.7	31.3	47.1	24.0	19.2	356.2	51.5	70.5	79.1	22.9	110.2	27.3	56.1	226.9	69.3	10.2	27.6	26.2	32.2	30.6	53.9	23.9	55.9	62.7	36.3	36.7	28.0	26.6	35.3	26.0	86.8	69.2	21.9	25.3	44.1	114.0	41.0	26.5	7.3	23.3	37.5	37.4	15.9	62.2	36.0	38.1	21.1	16.7	42.6	51.4	42.2	30.7	24.3	60.0	178.9	55.5	45.5	26.3	28.4	44.8	55.2	51.5	48.0	32.4	108.4	29.5	73.7	78.7	39.2
DLEC1	"CFAP81, DLC1, FAP81"	ENSG00000008226	"DLEC1 cilia and flagella associated protein"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 14.7;fallopian tube: 27.9;testis: 13.2"	"Group enriched"	"Detected in many"	4	"Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019077	Enhanced		Supported	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	1.2	0.3	2.3	0.3	2.1	0.9	0.4	1.6	1.2	3.5	14.7	0.3	0.4	0.5	4.1	0.1	27.9	0.6	0.2	2.5	2.9	0.3	0.1	4.8	0.4	6.6	8.6	0.9	0.1	0.1	9.6	0.1	4.7	0.9	0.4	0.0	0.9	0.5	0.0	0.4	0.4	0.1	5.3	0.5	0.3	13.2	3.2	0.1	1.1	0.0	0.3	0.2	0.1	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	2.1	1.6	1.2	2.5	2.9	6.6	8.6	4.7	5.3	3.2	2.5	0.0	3.2	3.0	2.9	0.4	0.5	0.5	3.0	1.2	1.2	0.4	0.4	0.7	0.0	14.1	0.0	0.0	0.1	0.4	1.2	0.0	0.1	4.5	45.0	1.2	0.6	1.2	0.8	1.1	0.2	0.1	1.3	0.0	1.4	2.5	0.2	0.0	0.3	0.5	0.0	0.9	0.7	6.1	0.6	1.2	6.6	0.9	1.1	0.0	2.8	0.8	0.2	2.1	0.5	0.3	0.1	1.4	0.0	2.8	0.5	0.7	0.5	74.4	0.8	0.0	0.7	1.5	6.7	1.3	1.0	0.3	0.1	1.3	0.4	0.2	0.4
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444835-70505490	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: AB_2686879"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favorable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	3.6	3.7	14.6	4.9	16.0	0.6	11.7	8.3	19.2	10.9	9.5	18.6	13.4	8.3	25.5	20.4	19.1	10.7	7.9	19.7	10.1	16.7	1.7	8.8	3.6	6.1	9.5	11.9	35.2	36.3	11.6	5.9	9.0	11.4	18.9	10.5	23.2	10.8	1.2	11.8	16.0	9.0	6.6	20.0	17.3	1.8	10.9	4.6	15.3	2.0	7.4	10.3	12.2	12.9	6.9	3.1	18.9	8.1	4.8	5.8	13.2	4.0	4.5	2.2	2.2	19.4	15.8	0.0	9.1	4.0	1.6	14.5	37.1	8.8	1.4	8.1	11.3	0.0	17.4	10.7	9.4	0.2	2.6	6.1	5.7	2.8	6.1	19.4	0.8	12.9	3.7	26.5	2.1	24.1	15.8	0.1	31.9	55.5	22.3	14.7	9.3	3.0	12.8	20.7	8.9	0.5	3.2	36.9	7.3	15.6	19.4	0.0	1.5	2.5	2.5	2.4	3.0	17.3	13.9	8.4	3.7	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.4	0.7	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.0	0.7	0.1	14.6	16.0	8.3	19.2	19.7	10.1	6.1	9.5	9.0	6.6	10.9	12.9	2.2	19.2	22.5	4.6	1.7	0.8	5.5	10.8	7.4	20.2	16.8	10.4	17.2	22.8	17.5	9.2	0.0	6.3	7.0	36.7	11.7	15.0	0.0	27.7	5.7	1.8	25.7	0.8	24.8	24.9	2.6	7.4	17.9	15.8	1.3	6.4	3.6	0.3	0.6	5.0	24.5	23.7	4.1	0.3	1.2	0.3	1.5	1.3	1.8	7.5	1.8	11.6	3.1	20.1	5.4	21.6	19.3	6.4	5.7	13.9	26.1	6.0	31.5	6.3	6.6	4.0	11.1	2.9	2.9	13.1	2.0	1.6	8.1	2.5	21.4	10.5
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.6;naive CD8 T-cell: 1.4"	"Group enriched"	"Detected in many"	13	"B-cells: 2.6;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 83.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024559, HPA056533"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA024559: , HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.0	0.0	5.1	0.1	5.7	0.0	0.0	3.1	5.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.7	0.0	0.0	0.0	0.1	4.9	4.7	0.2	0.0	0.5	3.4	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1	0.0	1.4	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.1	3.9	0.9	2.0	0.0	0.0	0.6	1.1	0.0	0.7	0.2	0.5	0.9	0.1	3.7	0.0	1.5	0.1	2.3	1.0	0.2	1.2	6.0	0.2	0.1	0.3	0.3	1.0	4.6	0.0	0.0	0.1	0.1	0.1	0.1	4.3	1.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	6.2	0.6	0.2	0.2	0.2	0.2	13.6	14.1	2.9	0.1	83.7	0.3	0.0	0.2	0.0	0.0	2.6	0.1	1.0	1.4	0.0	0.9	0.1	0.5	2.3	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.5	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	5.1	5.7	3.1	5.6	4.7	4.7	4.9	4.7	4.2	4.4	4.6	5.4	0.3	0.0	0.0	0.3	1.1	0.3	0.3	0.4	0.0	0.5	1.3	4.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.6	0.1	0.7	0.2	3.0	0.0	1.7	0.6	0.6	1.0	0.5	0.3	0.0	1.7	0.0	0.0	0.3	0.0	3.4	0.3	0.0	0.0	0.0	2.2	1.2	0.1	1.8	0.0	0.0	0.9	0.0	24.6	0.5	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.7	6.6	0.0	0.6	6.5	39.5	0.2	0.1	0.3	0.5	1.7	0.0	0.1
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018, HPA069527"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	19.3	53.8	31.7	13.2	32.3	14.6	20.6	32.4	37.4	22.8	30.1	21.1	13.5	20.3	9.7	18.9	20.0	11.7	26.5	32.6	31.0	26.0	28.7	17.9	16.9	30.9	31.2	26.6	33.9	25.5	25.1	14.6	31.0	24.3	11.7	19.5	21.3	13.2	36.1	21.3	22.0	10.7	30.2	27.6	24.2	25.2	32.0	20.9	23.4	25.2	14.4	21.6	19.5	32.8	21.1	22.2	30.6	16.0	15.5	14.6	35.0	18.3	24.4	43.3	37.2	35.7	25.9	31.5	24.1	29.7	16.9	17.0	27.4	23.6	22.8	25.0	44.3	29.0	41.2	36.2	28.0	28.7	21.2	23.0	25.8	35.8	20.5	27.9	28.3	29.5	20.6	28.2	25.7	24.5	40.4	35.9	43.6	10.8	27.0	40.5	30.8	34.5	23.1	26.2	28.0	23.3	34.4	24.3	35.8	29.1	20.1	32.8	27.5	12.2	36.5	28.5	37.6	33.9	21.8	25.4	23.1	28.2	20.6	45.0	23.1	23.1	30.8	20.9	31.9	27.7	31.2	32.2	24.0	28.3	27.8	27.5	9.9	43.8	17.6	19.2	37.5	24.6	31.7	32.3	32.4	37.4	32.6	31.0	30.9	31.2	31.0	30.2	32.0	32.8	23.4	32.1	23.8	11.1	23.6	19.2	25.9	36.4	19.4	43.0	18.6	22.2	22.8	18.6	24.5	11.0	25.0	72.6	30.9	32.8	29.4	31.9	41.9	15.4	14.1	23.9	54.4	25.7	10.4	41.5	34.4	20.5	28.5	14.8	27.3	38.1	23.6	19.1	32.6	23.5	12.1	32.0	44.7	22.3	12.7	69.2	18.0	15.4	17.8	4.7	26.3	46.3	25.7	9.0	9.6	22.9	38.6	17.7	26.8	9.7	46.9	36.2	26.8	56.1	6.6	23.9	25.1	24.5	47.2	15.7	17.8	52.4	25.5	29.3	29.8	16.3
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"skin 1: 4799.0"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	13.8	9.3	6.5	1.1	11.7	1.7	195.4	7.3	7.0	262.7	16.1	11.0	5.6	16.1	14.4	221.3	73.9	1.8	11.9	5.9	7.0	50.3	4.7	22.3	1.2	18.4	7.2	35.0	59.7	87.1	58.1	2.2	17.8	19.3	4.9	1.9	69.5	14.6	20.1	4799.0	8.4	4.2	6.6	2.9	19.9	4.1	6.6	12.2	60.0	0.2	50.6	14.1	378.5	6.2	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.5	11.7	7.3	7.0	5.9	7.0	18.4	7.2	17.8	6.6	6.6	6.2	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 192.5"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024290, HPA058487"	Uncertain					NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA024290: AB_1847601, HPA058487: "	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	35.7	29.8	104.2	6.1	134.6	136.6	21.8	0.0	192.5	13.5	0.0	33.1	9.2	15.3	14.4	18.9	30.4	13.5	71.5	142.1	36.9	67.5	28.2	20.1	3.4	27.0	14.0	3.4	29.6	54.9	109.6	7.4	27.1	25.0	15.2	23.0	22.9	20.4	66.4	24.3	14.0	14.0	0.0	19.3	23.8	11.7	32.4	3.0	39.1	41.4	3.7	12.9	12.4	90.5	44.1	68.9	0.5	1.4	1.1	0.3	5.4	4.6	4.3	14.5	4.3	29.9	26.7	0.4	43.8	0.8	0.9	14.8	2.1	2.7	6.5	0.4	13.0	225.9	5.3	63.9	1.3	0.1	65.6	0.7	29.3	0.2	0.3	8.5	14.7	2.0	21.7	2.2	0.1	18.9	5.7	0.5	1.8	67.3	6.1	0.0	0.6	3.1	87.2	12.3	15.6	21.8	7.3	0.9	3.2	3.5	11.2	2.2	26.1	0.0	22.0	0.3	24.0	0.1	0.2	0.7	0.3	0.2	15.4	0.0	0.1	0.2	1.7	0.0	1.7	0.0	3.8	1.6	0.1	0.0	1.5	1.5	1.2	0.0	0.0	0.3	3.3	9.3	104.2	134.6	0.0	192.5	142.1	36.9	27.0	14.0	27.1	0.0	32.4	90.5	9.3	3.2	10.7	10.7	1.5	2.3	4.0	3.9	1.2	34.6	9.9	5.7	37.8	0.0	5.1	7.3	12.5	0.1	2.7	15.3	19.6	11.4	12.7	11.2	1.7	10.2	20.5	248.6	45.7	11.4	1.7	2.4	7.7	12.7	0.0	4.1	3.9	15.8	0.5	28.6	29.7	8.7	0.0	1.0	1.6	7.7	0.3	44.5	14.2	5.6	1.3	2.6	0.0	1.5	4.3	18.2	10.0	2.6	1.4	3.7	1.8	29.6	9.3	7.3	0.0	1.4	5.7	1.4	2.4	3.8	5.7	0.1	6.4	0.3	13.3	4.8
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;fallopian tube: 5.1;testis: 4.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA062493			Approved	"Nuclear membrane,Intermediate filaments"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.4	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.4	0.5	0.0	0.0	1.2	0.0	2.2	2.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	4.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.4	0.5	2.2	2.1	1.4	1.5	0.5	0.5	0.0	0.0	1.1	0.7	0.0	0.3	0.7	2.0	0.0	0.0	0.1	0.1	1.7	0.0	6.3	0.0	0.0	0.3	0.0	2.0	0.0	0.0	42.7	31.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	3.6	1.3	0.0	0.0	0.0	17.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	2.5	1.7	0.0	0.8	0.0	0.0	0.5	1.3	0.0	77.8	0.0	0.0	0.2	1.0	0.9	8.8	0.5	0.6	0.0	0.1	0.0	1.9	0.3
DNAH5	"CILD3, Dnahc5, HL1, KTGNR, PCD"	ENSG00000039139	"Dynein axonemal heavy chain 5"	Q8TE73	5	13690328-14011818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7;choroid plexus: 14.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 61.7;Endometrial ciliated cells: 190.3;Respiratory ciliated cells: 258.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;LHCN-M2: 1.1;PC-3: 2.7;RPTEC TERT1: 1.3;TIME: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037469, HPA037470"	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037469: AB_10672791, HPA037470: AB_10672348"	"unprognostic (3.85e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.94e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-3)"	"unprognostic (8.87e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	0.0	0.1	0.9	0.0	1.1	0.0	1.5	0.5	0.3	0.3	14.0	0.1	0.0	0.1	0.1	0.0	3.8	0.1	0.0	1.0	1.7	0.8	1.0	1.7	0.0	4.2	6.7	0.0	0.9	0.0	2.0	0.0	4.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	0.3	1.8	0.0	1.1	0.0	0.0	0.8	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.0	0.5	0.0	0.5	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	1.3	0.4	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.5	0.3	1.0	1.7	4.2	6.7	4.0	2.1	1.8	1.4	0.3	3.2	24.4	7.2	0.2	0.0	1.7	5.6	0.0	0.0	11.7	7.0	1.5	14.3	61.7	5.5	0.0	0.0	0.1	0.0	0.0	6.7	7.3	190.3	1.9	1.2	1.8	0.0	12.9	3.6	0.2	1.8	0.0	12.4	2.5	0.0	0.0	10.9	0.0	0.0	7.8	0.0	6.1	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	4.0	0.4	2.6	0.0	0.0	0.1	14.8	0.0	4.3	258.7	0.0	0.0	1.6	2.6	2.6	3.6	0.0	0.0	0.0	0.4	0.1	0.0	3.8
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;choroid plexus: 12.1;fallopian tube: 5.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 77.5;Endometrial ciliated cells: 98.2;Excitatory neurons: 94.2;Respiratory ciliated cells: 143.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036391, HPA061401"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA036391: AB_10672220, HPA061401: "	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	0.3	0.2	1.4	0.1	2.4	0.0	0.4	0.0	1.7	0.2	12.1	0.1	0.0	0.5	1.2	0.0	5.4	0.1	0.0	1.5	1.1	0.4	1.1	0.8	0.1	4.4	4.6	0.3	0.2	1.6	0.4	0.0	2.4	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.0	0.5	2.7	1.6	0.5	1.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.4	2.4	0.0	1.7	1.5	1.1	4.4	4.6	2.4	2.7	1.6	1.6	0.6	6.4	4.1	18.6	0.6	0.1	2.2	5.4	0.0	0.8	1.4	1.8	1.2	1.5	13.7	0.0	2.1	0.9	0.3	0.3	0.0	0.3	77.5	98.2	1.5	0.9	0.0	0.4	94.2	0.9	0.2	2.7	4.1	3.0	0.0	1.6	0.0	6.9	0.1	0.0	28.2	1.0	10.2	0.3	0.2	25.0	0.6	0.3	1.8	9.4	0.0	2.0	0.0	5.5	13.7	0.3	0.3	0.7	0.1	1.0	0.2	1.0	143.6	4.8	0.0	2.1	1.7	23.3	5.1	0.0	0.0	0.3	1.3	0.3	1.1	0.3
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068837	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.9;choroid plexus: 29.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 197.2;Cone photoreceptor cells: 70.9;Early spermatids: 59.3;Endometrial ciliated cells: 103.5;Excitatory neurons: 93.0;Respiratory ciliated cells: 139.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.9;RPTEC TERT1: 2.8"					"Region enhanced"	"Detected in many"		"midbrain: 4.4"	"HPA034724, HPA044070"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA034724: AB_10670977, HPA044070: AB_2678798"	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	0.3	1.0	8.2	0.2	7.9	0.0	0.6	3.6	10.1	2.5	29.8	0.7	0.1	0.8	1.7	0.2	9.8	0.6	0.4	8.0	7.1	3.4	0.3	2.3	0.1	10.2	12.9	0.5	2.6	2.0	7.2	0.1	8.0	1.1	0.5	8.9	0.8	0.9	0.0	0.2	0.7	0.3	7.6	0.1	0.6	10.8	9.0	0.1	3.2	0.0	0.2	0.2	0.3	6.7	0.3	1.3	0.3	0.1	0.7	0.4	0.1	0.1	0.8	0.3	0.3	0.2	1.0	0.0	0.3	0.3	1.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	1.7	0.4	0.1	0.0	0.1	0.2	0.2	1.1	0.2	1.7	0.0	0.0	0.3	1.8	0.5	1.4	0.0	0.0	0.3	0.7	5.9	0.0	0.3	0.5	2.8	0.2	0.6	1.0	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.7	0.2	1.1	0.3	1.4	1.4	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	8.2	7.9	3.6	10.1	8.0	7.1	10.2	12.9	8.0	7.6	9.0	6.7	0.5	0.0	6.1	197.2	0.0	0.9	1.2	3.3	0.0	1.9	2.1	1.3	1.3	0.0	12.3	1.8	70.9	0.0	0.1	4.4	0.0	2.9	59.3	103.5	2.8	1.8	0.0	0.0	93.0	0.7	0.0	1.0	1.5	3.0	0.0	0.8	0.7	0.0	0.1	1.7	25.6	1.0	4.1	0.0	1.2	27.8	0.6	0.4	1.8	13.1	0.0	2.9	0.0	5.5	2.2	0.6	0.2	1.5	0.1	1.8	3.7	2.6	139.5	36.8	0.0	2.1	1.1	28.0	5.7	0.0	1.3	0.1	0.2	0.8	0.7	0.7
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715311-39030792	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.6;prostate: 2.1;testis: 7.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 47.1"	"Not detected"	"Not detected"							HPA028447	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.1	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.9	0.1	7.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.2	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	33.3	5.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0
DNAH9	"DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357"	ENSG00000007174	"Dynein axonemal heavy chain 9"	Q9NYC9	17	11598470-11969748	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 28.2;choroid plexus: 27.6;fallopian tube: 35.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.7;Endometrial ciliated cells: 97.5;Excitatory neurons: 26.8;Late spermatids: 56.5;Respiratory ciliated cells: 110.5"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.1;glioma: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.1;WM-115: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052641	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA052641: AB_2681895"	"unprognostic (4.16e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.31e-2)"	"prognostic favorable (6.79e-5)"	"unprognostic (8.37e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-3)"	"unprognostic (5.31e-2)"	2.1	0.8	9.7	0.3	8.1	0.0	1.5	9.2	8.0	1.7	27.6	0.2	0.0	1.4	2.2	0.1	35.4	0.4	0.2	12.1	10.4	1.7	0.1	2.8	0.0	24.0	28.2	1.4	1.8	3.6	3.2	0.3	18.1	0.8	0.0	6.6	0.3	2.0	0.2	0.3	0.1	0.5	19.5	0.1	0.3	6.3	12.1	0.1	0.9	0.0	0.0	0.3	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	8.1	9.2	8.0	12.1	10.4	24.0	28.2	18.1	19.5	12.1	11.6	0.1	3.2	1.1	8.5	0.0	0.8	0.9	3.6	1.2	2.0	0.2	0.4	1.7	0.0	6.1	3.7	2.1	0.0	0.0	0.6	1.9	1.4	48.7	97.5	2.0	0.3	0.0	0.0	26.8	0.2	0.0	1.5	0.0	2.1	1.3	1.2	0.0	0.0	0.1	0.0	17.6	0.2	2.0	0.0	0.4	56.5	0.6	0.2	0.0	3.7	0.0	1.8	0.0	11.1	8.3	0.1	0.0	3.0	0.1	0.6	0.0	0.2	110.5	8.2	0.0	1.5	2.5	5.3	2.4	0.6	1.1	0.1	0.3	1.4	0.0	0.6
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520988	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.9;choroid plexus: 28.3;fallopian tube: 33.9;pituitary gland: 9.5;testis: 33.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 29.6;Endometrial ciliated cells: 48.8;Late spermatids: 35.0;Respiratory ciliated cells: 132.2;Spermatocytes: 56.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HDLM-2: 1.4;SK-BR-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021649, HPA021843"	Enhanced					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	2.7	0.0	3.2	0.0	0.5	2.3	2.5	2.2	28.3	0.0	0.0	0.9	0.2	0.0	33.9	0.1	0.1	2.8	3.1	1.3	0.1	4.5	0.0	7.3	9.9	0.1	0.9	1.2	9.5	0.0	4.8	0.2	0.0	2.7	0.0	0.1	0.1	0.0	0.0	0.0	5.5	0.0	0.2	33.5	3.2	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	2.3	2.5	2.8	3.1	7.3	9.9	4.8	5.5	3.2	2.4	0.0	0.0	0.5	3.9	0.1	0.0	0.0	5.0	0.0	0.0	0.5	0.3	0.4	0.0	11.0	0.0	4.2	0.2	0.0	0.0	1.9	0.0	29.6	48.8	0.5	0.2	0.0	0.0	9.4	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	2.0	0.0	0.0	35.0	0.3	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.4	132.2	1.3	0.0	0.0	1.4	56.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 119.0;HUVEC TERT2: 182.3;LHCN-M2: 312.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		9500	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	31.6	49.7	21.9	11.1	24.2	6.7	15.4	24.4	74.6	24.0	19.9	14.3	6.4	21.3	10.8	26.4	13.9	32.3	50.4	23.1	27.1	20.6	20.0	17.0	9.7	23.0	24.8	16.0	22.8	14.1	11.6	26.0	23.0	23.3	11.2	15.0	7.6	14.1	44.1	9.6	9.6	29.9	23.3	42.2	12.3	7.9	25.9	10.5	44.5	71.4	6.2	23.6	12.8	35.3	6.2	11.8	14.5	8.6	61.8	115.0	6.7	119.0	28.8	50.8	56.8	3.9	8.0	8.9	19.4	55.5	20.7	9.2	18.7	10.1	86.1	10.1	5.3	4.5	32.9	28.7	84.1	2.5	2.4	47.9	27.9	66.5	18.9	28.4	182.3	2.9	19.6	6.1	312.1	0.7	3.0	6.6	9.4	1.8	5.6	5.0	25.2	5.9	12.0	3.1	10.8	3.4	13.3	10.0	11.7	15.0	3.9	3.7	88.7	72.5	17.8	51.2	15.9	5.5	1.8	7.9	9.9	5.3	12.9	3.3	0.7	1.2	1.1	0.8	1.8	1.6	1.3	1.3	0.7	1.3	3.0	2.1	0.2	1.6	0.9	2.3	1.9	0.9	21.9	24.2	24.4	74.6	23.1	27.1	23.0	24.8	23.0	23.3	25.9	35.3	81.5	60.9	6.3	35.9	23.9	41.7	112.5	16.3	48.3	29.3	90.9	57.1	98.7	18.6	20.0	18.4	68.8	51.2	15.3	40.9	37.2	11.2	144.7	55.1	37.3	84.4	21.4	42.1	41.6	14.7	23.2	87.3	45.9	51.9	56.6	16.7	42.8	22.3	19.4	30.3	39.0	37.9	12.2	18.3	70.1	62.6	24.5	33.7	65.8	21.5	5.1	40.5	8.2	28.6	53.8	11.4	27.3	35.0	70.6	33.9	16.8	31.0	34.7	56.5	26.3	82.8	120.3	23.1	12.0	55.5	39.2	181.0	52.7	32.1	30.9	43.2
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312289-103344830	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.5;Spermatocytes: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol		NA	Yes			"Cluster 42: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	15.7	13.4	10.2	12.2	10.7	42.0	13.4	12.7	19.2	13.1	10.5	11.9	14.7	12.8	9.7	13.8	12.1	9.8	13.5	10.5	10.4	16.4	15.7	11.2	16.8	10.0	10.7	15.7	13.4	9.0	12.6	11.9	10.3	12.3	11.9	8.7	12.6	7.7	32.5	13.6	11.9	7.4	9.3	12.2	12.9	31.3	11.4	12.3	12.7	12.7	13.2	18.8	12.8	11.8	52.7	38.1	21.4	38.7	16.1	22.6	41.6	35.1	25.8	38.5	28.6	52.9	37.2	74.9	53.7	24.4	55.2	35.5	57.5	25.7	58.4	40.6	43.4	55.1	38.7	47.3	28.6	97.9	41.2	19.6	21.9	44.9	39.4	16.2	25.6	27.8	128.3	46.2	32.0	83.8	95.0	102.1	75.9	56.8	57.0	59.7	43.0	70.1	22.8	24.8	40.6	38.7	47.7	66.2	39.7	39.6	28.1	49.8	30.8	37.5	59.9	83.3	68.1	48.9	67.8	146.0	27.3	97.9	47.6	61.3	9.0	9.3	10.9	10.3	12.1	11.7	10.9	11.7	9.4	13.7	12.5	12.5	3.6	16.4	15.3	11.2	12.8	5.9	10.2	10.7	12.7	19.2	10.5	10.4	10.0	10.7	10.3	9.3	11.4	11.8	31.3	25.6	47.0	10.7	46.1	64.6	78.7	37.3	35.3	27.1	26.3	36.6	32.3	22.8	50.2	22.0	41.7	43.7	45.9	31.1	35.2	45.0	248.5	43.8	50.1	39.6	35.3	29.9	24.7	46.0	75.5	41.0	42.8	44.2	53.7	50.1	18.5	30.6	39.6	21.9	17.9	39.0	26.4	24.5	41.3	37.3	39.4	37.8	19.6	13.1	42.9	19.3	44.3	24.1	20.6	50.2	32.9	31.2	36.9	79.2	36.4	31.0	43.4	29.0	39.5	63.7	64.8	238.7	131.9	33.5	62.1	55.4	43.2	58.3	51.9	91.5
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 66.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA		70000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	4.2	11.9	15.3	1.0	29.9	1.3	4.0	59.4	24.3	5.8	0.0	2.4	0.6	3.2	1.3	1.3	3.2	2.7	2.1	12.2	36.0	4.1	0.4	4.4	1.1	42.8	29.5	2.6	1.1	1.2	6.2	0.4	47.8	2.6	1.1	13.4	2.1	1.6	1.2	2.4	1.4	3.1	10.6	1.8	2.7	3.2	32.3	1.8	3.3	1.3	0.8	2.2	5.1	66.9	0.8	2.5	2.0	0.4	1.5	1.0	0.0	0.5	1.2	1.0	1.3	0.0	3.7	0.0	7.5	1.1	1.2	0.3	1.5	2.9	0.9	1.0	2.9	22.9	3.7	0.0	0.1	0.5	10.2	0.7	0.5	1.2	0.7	1.1	0.5	2.0	0.0	0.3	0.4	0.0	1.5	0.1	5.8	9.5	1.7	1.5	9.9	0.0	19.0	0.1	3.9	0.8	2.7	0.7	0.2	0.7	0.0	0.9	0.3	2.8	3.8	2.3	14.3	3.8	0.7	0.2	2.7	1.2	1.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.5	0.3	0.3	0.1	0.0	1.4	1.2	15.3	29.9	59.4	24.3	12.2	36.0	42.8	29.5	47.8	10.6	32.3	66.9	21.8	0.0	6.8	207.3	1.5	2.4	1.5	0.7	3.4	25.1	1.4	1.3	2.4	0.0	0.4	0.0	29.2	0.1	0.7	0.2	3.9	0.3	8.2	7.3	1.3	19.5	0.0	0.8	365.7	0.4	0.1	3.2	7.1	1.0	1.3	0.8	8.2	0.2	0.7	8.4	631.8	0.7	0.0	0.6	3.1	3.9	1.8	13.4	0.0	178.0	0.3	5.9	0.0	976.1	1970.9	2.5	0.1	2.6	0.3	0.7	0.0	0.8	2.2	29.0	0.0	4.5	2.2	5.3	0.4	1.1	1.7	0.3	0.9	10.3	0.8	0.7
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 127.2;Horizontal cells: 95.9;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 59.6;REH: 59.5;SH-SY5Y: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	5.6	9.0	8.9	9.8	12.6	8.7	6.2	9.3	10.7	9.1	2.4	11.3	6.7	9.3	8.7	6.0	7.5	6.3	5.9	8.8	7.9	11.3	5.3	7.3	11.1	9.0	7.6	13.0	8.3	4.2	11.5	15.7	8.6	7.2	6.6	15.4	6.2	5.9	21.0	4.9	8.9	7.1	5.2	13.4	8.5	5.2	9.4	20.6	6.9	10.2	9.0	7.3	6.2	11.3	1.6	8.1	34.6	8.3	3.8	2.7	45.2	1.9	2.2	4.7	3.8	21.1	13.2	0.0	4.7	4.7	3.5	2.2	3.8	5.2	2.8	5.7	4.3	14.7	12.8	25.4	8.8	2.9	7.6	8.2	2.6	6.0	2.2	9.1	19.5	34.0	18.0	2.9	3.5	20.6	33.7	36.5	59.6	14.3	4.2	59.5	32.5	3.8	2.9	3.4	18.6	71.5	2.7	19.6	6.2	29.5	2.1	16.2	6.8	5.4	4.7	1.0	2.5	5.6	5.1	19.6	2.2	8.4	5.5	2.8	1.0	2.1	2.7	1.7	4.0	1.3	1.7	2.4	1.3	1.6	4.6	3.9	2.5	5.5	2.7	2.3	1.9	1.2	8.9	12.6	9.3	10.7	8.8	7.9	9.0	7.6	8.6	5.2	9.4	11.3	18.5	6.4	13.1	28.1	11.0	5.2	10.2	6.6	5.7	73.3	12.1	9.8	15.8	5.7	9.9	20.2	127.2	40.6	15.3	6.3	5.9	16.9	1.6	13.3	19.1	20.5	13.1	15.8	49.4	9.8	10.7	16.4	9.7	10.7	37.4	37.3	11.0	6.4	23.2	95.9	43.2	11.4	2.0	14.2	3.9	1.9	19.3	13.7	7.2	38.4	7.4	20.6	13.4	36.7	63.4	9.3	9.4	15.4	9.8	12.4	6.2	6.6	7.3	143.5	19.7	15.1	14.3	2.8	14.6	8.1	2.6	32.2	19.6	26.1	12.1	10.2
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219372043-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.4;Late spermatids: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	25.8	18.9	15.4	25.0	15.8	18.0	23.6	14.8	18.6	24.9	14.7	34.5	56.5	22.4	21.5	25.1	25.1	22.6	39.9	16.2	16.9	22.1	32.0	27.6	23.4	15.8	15.0	30.2	27.2	25.8	13.0	37.1	15.2	22.6	30.8	9.5	26.2	24.4	64.5	31.7	56.2	19.9	16.0	24.7	25.4	58.5	17.4	17.5	15.2	46.4	16.2	29.6	21.6	14.7	47.5	25.8	15.4	45.7	39.7	32.2	122.0	23.0	46.5	59.3	62.5	72.6	61.2	27.2	48.7	49.5	76.0	45.0	18.6	53.6	21.3	56.4	12.5	46.6	25.0	79.8	107.2	38.9	32.2	54.4	55.4	61.8	50.2	37.9	41.2	38.6	53.8	45.3	31.0	103.7	60.8	44.5	25.5	67.7	15.1	77.2	35.7	36.5	33.0	74.0	19.1	26.0	27.1	86.5	34.5	26.9	25.8	43.3	23.5	55.4	46.1	31.4	33.7	49.6	31.8	21.3	80.0	37.7	24.1	8.7	17.2	7.3	16.1	19.7	18.8	13.2	13.2	18.3	20.8	16.2	14.0	18.7	1.6	21.2	17.0	7.2	16.6	14.8	15.4	15.8	14.8	18.6	16.2	16.9	15.8	15.0	15.2	16.0	17.4	14.7	43.1	12.8	18.2	8.8	35.6	38.6	74.1	55.1	52.9	19.3	41.2	36.7	33.6	55.8	27.2	25.8	33.3	90.4	26.7	70.4	49.0	62.9	364.4	16.5	36.5	41.8	48.0	19.8	3.1	66.3	96.9	43.4	29.0	19.6	24.1	39.1	30.4	47.9	51.0	10.1	5.2	110.3	38.7	31.5	26.8	462.0	52.5	26.2	32.0	4.7	53.0	29.8	45.3	3.0	3.3	52.3	75.6	41.0	38.3	113.1	202.6	79.6	16.3	37.6	26.3	31.9	120.0	20.1	20.1	43.4	44.8	66.4	34.1	36.9	70.9	74.6
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304409-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 329.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 11.3;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MOLT-4: 416.0;REH: 1415.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.0	0.2	0.1	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	329.1	0.4	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	195.3	0.0	0.0	0.0	0.0	416.0	0.0	0.1	0.0	0.0	1415.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097"	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	19.9	8.2	38.1	7.3	54.3	0.7	19.9	39.1	34.6	23.3	22.5	17.7	13.4	19.6	15.5	16.1	18.1	17.2	14.2	29.9	37.2	19.3	9.6	13.7	4.6	44.7	51.8	24.7	14.1	25.6	5.6	19.6	44.5	16.5	13.8	2.3	17.7	18.4	5.2	33.4	15.1	19.2	35.6	9.9	13.3	6.9	45.3	8.5	26.6	10.6	5.7	16.5	18.9	50.1	16.1	29.8	57.2	41.2	29.2	38.7	12.6	31.5	66.2	21.9	23.1	18.8	18.0	0.0	10.3	47.4	19.8	18.0	18.4	23.8	25.4	0.3	17.9	10.0	18.8	22.7	28.9	0.0	14.2	31.8	7.0	22.7	49.3	53.0	51.3	0.0	0.0	0.1	33.1	16.4	0.0	0.0	14.1	12.4	13.5	0.0	37.3	0.4	22.1	17.5	3.4	24.5	32.9	18.6	28.9	40.6	4.7	0.1	54.2	39.7	15.3	9.8	30.7	0.0	0.1	0.0	31.3	0.0	25.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	38.1	54.3	39.1	34.6	29.9	37.2	44.7	51.8	44.5	35.6	45.3	50.1	55.9	32.1	20.3	186.4	0.4	17.2	15.5	9.5	43.9	0.5	18.5	17.3	11.8	12.8	17.9	22.0	0.0	14.1	3.2	28.0	0.0	14.7	11.3	20.2	36.8	35.2	5.4	1.7	2.4	7.1	11.5	27.7	16.8	17.1	0.0	33.3	26.4	7.8	5.7	0.0	4.8	15.3	6.1	4.6	5.9	24.5	32.6	5.1	7.2	105.9	2.8	6.6	0.0	331.3	429.1	13.6	9.4	36.5	0.1	13.7	17.5	11.5	20.6	1.2	13.1	30.5	24.1	2.0	6.7	21.5	16.2	12.6	1.1	35.4	12.3	10.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;lymphoid tissue: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.5	8.2	22.6	18.8	49.2	10.2	3.8	33.7	33.4	8.7	9.7	6.3	4.1	3.2	1.1	3.2	2.4	6.3	1.6	28.7	35.1	3.2	5.5	7.6	27.8	45.5	38.4	17.7	1.7	2.0	1.0	2.3	48.9	1.6	6.5	5.7	2.5	1.7	1.2	5.0	12.5	4.3	32.0	29.8	6.7	2.2	37.9	32.1	2.7	0.8	19.9	6.4	4.4	83.1	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	22.6	49.2	33.7	33.4	28.7	35.1	45.5	38.4	48.9	32.0	37.9	83.1	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 61.6;lung: 16.4;lymphoid tissue: 51.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.7	3.6	1.4	34.4	2.4	61.6	3.6	1.9	2.6	3.1	2.8	7.6	5.0	2.3	1.3	3.3	2.4	9.6	1.6	1.8	2.5	1.2	5.5	16.4	42.5	6.4	3.7	1.6	1.9	1.5	0.8	7.3	4.6	1.8	7.8	0.2	2.6	1.9	0.9	1.2	9.6	7.0	4.6	36.5	8.1	1.7	6.3	51.4	1.5	1.4	46.9	9.9	1.1	8.4	0.4	0.3	0.0	0.0	0.0	0.4	0.0	3.3	0.0	8.2	14.3	0.0	0.0	123.4	4.5	13.0	3.9	0.1	0.1	0.6	19.5	172.7	0.3	71.0	3.4	0.0	0.2	132.7	135.8	0.4	0.0	6.3	0.0	5.5	0.5	65.1	1.4	60.3	8.7	0.0	94.5	27.0	0.2	0.0	0.0	59.9	4.8	49.3	3.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	64.8	0.4	5.9	6.8	4.1	9.1	18.6	40.9	112.4	7.3	85.1	0.2	19.7	28.6	22.0	12.3	48.6	12.6	13.2	11.3	12.6	29.8	9.7	7.8	9.5	29.4	13.5	72.1	10.9	11.7	24.0	1.4	2.4	1.9	2.6	1.8	2.5	6.4	3.7	4.6	4.6	6.3	8.4	1.4	0.0	3.9	2.0	53.3	0.9	0.2	0.0	0.0	0.0	0.7	2.3	1.7	0.0	2.5	0.0	0.0	0.3	78.1	0.2	0.0	0.0	5.9	0.3	0.3	1.5	0.0	15.1	9.6	0.0	0.3	1.3	1.5	0.3	33.6	0.8	1.8	1.3	42.6	0.0	4.9	0.0	0.0	93.2	31.1	5.6	0.3	78.0	5.4	173.3	72.5	0.0	47.4	4.0	21.7	0.2	0.1	0.0	39.6	0.1	0.0	0.2	0.7	0.1	6.6	0.7	0.6	2.8	1.4	0.2	2.0	0.8	50.8	0.3	0.1	0.1
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DOCK9	"KIAA1058, ZIZ1"	ENSG00000088387	"Dedicator of cytokinesis 9"	Q9BZ29	13	98793429-99086625	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 216.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 158.7;Excitatory neurons: 150.6;Inhibitory neurons: 202.2;Microglial cells: 148.0;Oligodendrocyte precursor cells: 238.8;Oligodendrocytes: 402.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 2.0;MAIT T-cell: 4.8;memory CD4 T-cell: 5.2;memory CD8 T-cell: 2.1;naive CD4 T-cell: 6.0;naive CD8 T-cell: 4.0;NK-cell: 7.3;T-reg: 2.4"	"Group enriched"	"Detected in many"	11	"NK-cells: 7.3;T-cells: 6.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 200.8;hTERT-HME1: 435.4;HUVEC TERT2: 180.9;TIME: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034061, CAB034065, HPA043940"	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: AB_2678741"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.79e-1)"	"unprognostic (7.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.31e-2)"	83.2	22.4	82.6	21.4	137.2	6.0	71.1	96.6	91.0	42.9	30.8	44.4	15.7	31.3	35.5	93.1	30.3	36.6	58.9	72.8	93.8	21.9	15.8	93.0	33.8	116.6	112.1	27.4	19.9	41.8	21.1	98.2	123.4	23.0	20.8	39.5	51.2	21.7	25.9	76.9	35.2	36.9	86.6	16.8	24.7	16.2	110.4	47.8	62.6	64.3	40.4	29.0	49.6	216.7	61.6	19.4	10.6	14.2	10.6	8.3	200.8	17.2	14.2	12.1	10.7	127.4	47.7	51.3	39.8	16.6	21.8	59.5	27.4	54.3	21.8	52.2	15.2	0.0	37.6	2.1	14.0	0.1	2.9	9.0	37.2	12.4	435.4	27.9	180.9	33.0	10.6	11.6	52.1	20.2	35.5	0.3	4.9	84.6	14.2	2.1	39.3	2.7	38.3	50.8	22.4	24.3	26.4	63.4	15.7	85.9	16.9	0.4	179.7	9.7	11.4	6.5	28.5	17.6	14.8	8.6	15.6	0.0	16.0	0.0	0.0	0.0	2.0	0.0	4.8	0.6	5.2	2.1	0.0	0.2	6.0	4.0	0.1	7.3	0.0	0.0	2.4	1.5	82.6	137.2	96.6	91.0	72.8	93.8	116.6	112.1	123.4	86.6	110.4	216.7	158.7	16.0	39.5	37.5	3.4	15.3	7.1	14.7	10.2	37.9	15.4	6.5	9.4	11.5	12.5	9.2	50.1	35.6	7.0	11.9	1.9	5.4	1.7	10.5	5.3	90.2	6.7	3.6	150.6	6.6	8.3	17.2	2.6	21.4	2.5	18.0	47.8	8.4	5.0	25.2	202.2	6.0	10.2	1.9	7.4	3.3	7.8	1.7	1.8	148.0	0.4	12.9	4.1	238.8	402.2	14.7	5.6	14.7	2.8	10.1	10.6	3.8	7.1	23.9	0.0	122.6	12.4	7.2	5.4	25.6	32.0	17.2	11.0	2.4	5.9	10.5
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"granulocytes: 36.8;Hofbauer cells: 48.6;Macrophages: 31.2;monocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol		NA	NA		80000	"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB004224: AB_627447, HPA048561: AB_2680443"	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	10.8	3.7	8.8	10.2	8.3	13.7	4.7	8.2	9.0	6.6	7.6	5.2	4.4	4.9	0.7	1.4	6.3	3.2	2.8	7.8	8.7	2.7	1.5	6.6	12.3	10.7	8.7	4.2	3.7	6.3	2.2	4.0	9.2	3.1	3.8	0.9	3.0	4.0	1.1	1.6	5.8	4.8	9.2	11.6	6.7	1.7	9.4	7.6	3.9	1.7	10.1	4.7	2.7	9.0	5.3	2.0	6.0	3.0	13.9	16.8	4.2	12.8	10.0	5.2	8.5	1.6	6.1	3.3	18.0	12.3	11.3	0.7	6.1	2.8	1.9	76.3	5.7	43.1	4.4	0.3	10.0	22.0	41.0	12.5	0.0	28.5	14.7	21.7	6.2	13.8	12.7	9.5	10.5	5.6	15.8	45.7	11.1	10.8	1.6	13.0	12.9	3.5	2.7	4.5	2.0	10.0	2.5	0.7	6.7	1.7	3.3	24.1	11.7	32.7	15.1	15.3	2.9	12.6	9.6	0.1	32.9	35.3	5.5	39.0	52.3	38.9	17.3	51.4	13.9	22.9	14.1	15.4	51.3	26.3	10.3	10.3	52.9	27.4	59.3	10.8	24.3	39.8	8.8	8.3	8.2	9.0	7.8	8.7	10.7	8.7	9.2	9.2	9.4	9.0	6.7	9.6	8.8	2.9	15.0	2.0	1.1	3.7	1.2	0.5	2.2	2.8	1.8	4.3	2.0	5.5	0.0	1.9	13.6	8.7	0.0	11.9	0.3	7.4	5.8	7.2	3.0	12.4	0.1	9.1	4.2	6.5	6.1	5.6	36.8	5.8	9.7	0.6	48.6	1.7	0.5	5.9	2.0	26.3	24.2	1.0	5.0	31.2	3.6	4.7	41.1	9.8	16.5	0.5	0.6	10.2	10.0	6.0	6.3	2.4	8.1	3.9	1.7	0.5	6.6	4.1	8.3	0.5	2.1	0.3	1.6	2.3	13.5	7.0	6.8	1.6
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2163933-2232578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 99.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	11.4	12.9	3.7	10.5	7.6	22.1	8.9	9.9	9.1	8.8	4.9	12.1	12.5	10.0	1.1	14.7	8.6	5.2	9.7	5.1	3.7	19.7	15.1	18.3	8.0	7.5	4.9	10.5	15.4	2.0	13.9	5.4	6.2	9.7	3.9	8.5	9.9	1.9	12.2	14.5	17.6	3.4	1.7	17.3	12.7	99.7	7.9	7.0	15.6	2.8	5.0	7.2	9.8	11.2	27.7	14.4	48.4	26.5	3.5	5.2	63.5	15.2	3.4	8.3	6.6	18.4	10.1	31.6	7.3	10.0	7.0	24.0	16.1	8.6	3.9	16.4	20.0	29.6	26.7	18.3	5.5	42.8	52.6	5.0	6.3	15.9	8.1	6.8	6.7	17.8	36.2	32.7	6.6	15.6	34.1	46.4	37.4	17.4	25.2	34.8	13.6	21.8	4.6	12.9	31.9	24.7	10.7	31.8	20.2	12.7	14.3	32.4	9.6	22.9	20.7	34.2	30.1	29.9	42.8	22.0	22.6	28.6	13.7	0.1	0.1	0.8	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.2	3.7	7.6	9.9	9.1	5.1	3.7	7.5	4.9	6.2	1.7	7.9	11.2	9.3	32.1	16.3	12.4	9.5	17.7	14.7	4.7	10.2	27.2	12.7	8.4	7.1	11.5	7.2	9.2	66.7	6.1	15.9	29.1	3.9	11.5	37.6	14.2	10.7	10.2	20.8	8.6	7.8	12.2	13.8	11.0	27.5	28.2	6.3	15.9	5.3	14.4	9.9	13.5	6.8	12.0	4.1	12.3	30.4	18.2	3.1	19.0	12.4	10.3	8.5	5.5	8.2	10.6	15.0	13.9	28.6	3.4	8.6	12.9	35.6	3.1	7.6	28.1	0.0	14.2	10.3	32.4	23.0	12.2	19.9	16.3	6.3	15.3	15.9	15.3
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 29.9;Kupffer cells: 55.0;Macrophages: 34.6;monocytes: 28.6;NK-cells: 25.7;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 410.0;eosinophil: 841.1;neutrophil: 358.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 841.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.1;HMC-1: 18.1;NB-4: 4.1;U-937: 6.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 12.3"	HPA035644	Approved					NA	NA		330000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	6.0	0.9	4.3	12.6	4.4	23.3	2.8	4.3	9.3	2.3	4.1	4.1	3.3	1.4	0.6	1.8	2.8	6.2	2.4	4.1	4.8	1.8	3.8	18.5	18.8	6.3	4.9	0.6	1.0	0.9	0.7	13.4	5.1	1.5	4.1	0.2	1.7	1.2	1.4	1.2	11.9	4.0	5.1	28.6	3.2	2.8	5.6	9.0	2.5	3.3	18.3	8.1	1.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.1	0.0	0.1	18.1	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.3	0.1	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.0	6.3	0.0	410.0	82.6	841.1	17.0	101.9	19.8	30.3	29.5	13.7	33.0	35.9	34.7	17.8	358.8	44.7	126.7	5.3	31.8	48.9	4.3	4.4	4.3	9.3	4.1	4.8	6.3	4.9	5.1	5.1	5.6	6.6	0.9	0.0	7.9	0.0	20.4	2.0	0.0	0.3	1.2	0.0	0.2	0.3	1.8	0.0	1.7	0.0	0.0	10.0	8.7	0.1	0.0	0.1	0.2	0.1	0.1	4.8	0.0	2.1	0.1	0.0	0.7	1.0	0.5	0.1	2.5	0.0	18.9	0.1	29.9	0.0	0.2	0.0	2.0	55.0	21.0	1.1	0.0	34.6	3.6	10.3	28.6	0.0	25.7	0.0	0.1	0.0	0.0	0.4	3.4	0.0	0.0	0.3	8.6	0.0	0.0	0.3	0.8	12.0	9.4	0.1	1.3	54.0	13.1	0.0	0.0	0.1
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333852-65354262	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020880: AB_1847845, HPA056786: AB_2683235"	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	21.2	21.0	41.3	14.2	45.1	24.7	21.6	43.6	43.3	35.0	35.2	36.1	13.1	37.6	22.8	23.1	31.3	14.7	34.2	39.5	42.2	20.8	16.8	19.5	22.3	43.1	43.7	40.9	20.5	19.7	20.1	17.6	42.8	28.6	13.8	17.6	21.1	25.8	38.6	19.3	24.3	27.8	43.7	29.7	24.2	37.7	43.0	37.6	22.5	29.2	24.5	34.2	24.1	48.7	29.9	36.4	45.9	40.5	39.7	39.8	25.5	25.0	35.1	53.5	38.6	36.0	34.8	39.5	40.8	34.0	46.6	31.2	52.2	31.9	37.7	47.6	23.1	50.4	24.6	37.7	61.1	47.0	36.5	35.0	30.4	48.4	86.6	40.1	43.3	47.0	48.7	51.0	35.2	47.3	60.0	49.3	51.6	31.9	37.4	65.1	29.9	46.8	34.0	24.1	29.9	27.3	32.1	45.7	47.0	29.7	59.0	26.2	25.8	35.2	31.3	38.9	25.9	62.7	78.8	51.1	21.6	30.6	40.4	186.4	75.4	141.1	79.7	70.8	87.0	102.0	76.9	78.4	76.2	109.1	78.6	71.9	161.5	125.8	83.0	70.6	107.3	108.4	41.3	45.1	43.6	43.3	39.5	42.2	43.1	43.7	42.8	43.7	43.0	48.7	19.2	6.4	10.1	14.0	35.7	22.7	21.8	41.7	23.9	42.2	20.1	24.9	12.7	27.1	24.2	33.1	47.9	27.2	42.0	11.5	19.6	21.2	5.2	18.3	29.5	24.2	17.4	32.8	18.5	17.4	22.9	27.2	15.3	18.5	16.5	31.8	24.3	13.3	19.5	30.3	19.9	16.8	32.6	17.5	33.8	12.3	58.7	16.9	19.6	15.0	30.0	22.8	35.0	24.1	32.3	19.3	8.6	53.4	21.6	22.6	23.7	22.0	19.3	50.5	32.9	28.8	32.2	60.2	63.5	15.4	23.2	26.5	30.6	28.7	17.9	19.7
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	40.9	53.4	23.0	34.3	23.9	59.3	42.7	24.4	31.9	31.5	26.1	38.6	36.9	39.4	47.6	45.3	32.6	36.1	60.6	24.4	24.5	47.0	63.1	29.7	56.0	23.3	22.8	38.7	48.6	43.0	25.4	45.1	23.5	34.3	42.7	27.2	38.5	31.0	57.3	34.6	39.0	37.4	23.8	37.1	38.1	39.7	23.1	43.9	48.4	55.2	53.6	51.6	33.3	27.6	139.9	55.4	83.6	50.5	72.1	80.8	92.1	52.6	62.1	102.9	80.7	252.1	110.2	84.1	112.9	71.1	141.9	156.2	68.5	129.0	103.9	40.7	53.9	87.7	69.5	171.2	101.6	141.4	50.5	70.0	187.0	71.5	73.7	66.4	80.1	89.0	135.3	104.2	103.3	61.3	127.6	148.9	85.3	131.8	124.8	69.7	120.7	112.6	102.6	83.4	62.5	68.5	135.8	203.8	189.1	64.2	138.8	164.5	66.1	130.8	109.2	76.6	112.6	74.2	99.7	122.0	143.7	92.4	60.4	13.5	16.3	17.6	16.4	18.5	20.0	17.9	18.6	17.9	20.3	16.1	20.0	22.4	20.0	19.1	18.6	21.7	19.5	16.1	23.0	23.9	24.4	31.9	24.4	24.5	23.3	22.8	23.5	23.8	23.1	27.6	36.8	19.2	42.3	27.1	37.3	116.5	143.4	248.4	29.0	11.7	37.1	24.9	48.8	35.8	119.5	31.3	2.1	153.1	46.4	31.7	117.4	75.9	207.8	49.3	38.0	53.0	23.4	30.7	35.6	73.8	104.9	53.7	18.8	57.5	74.3	25.1	49.2	67.9	87.9	5.0	31.0	52.5	144.5	42.0	58.4	43.8	56.8	36.7	49.8	18.7	65.8	27.3	43.3	20.1	34.2	70.5	50.2	51.6	33.2	73.7	40.7	96.4	135.7	12.6	72.3	50.4	71.5	109.9	103.6	32.0	105.6	245.4	47.8	36.5	55.3	125.9
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		3200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	11.6	17.5	8.2	21.4	9.1	20.7	11.2	10.2	10.4	11.0	5.4	30.2	24.8	11.7	7.8	23.5	9.8	14.5	10.3	8.4	8.9	17.1	18.6	14.3	21.8	10.2	8.8	6.8	17.3	11.9	8.7	14.3	10.8	14.4	26.3	15.9	18.8	12.9	26.5	13.6	20.5	16.2	8.6	15.4	19.2	9.8	10.2	18.6	11.7	7.4	23.3	17.3	13.5	9.9	84.1	71.6	32.5	36.3	26.4	28.3	50.4	46.5	61.8	61.4	40.7	90.8	68.4	48.7	154.0	52.9	52.2	73.6	52.1	57.0	39.4	92.5	23.8	63.1	32.1	54.2	40.7	77.6	101.1	40.5	54.5	46.2	22.8	26.5	47.8	50.1	45.1	28.2	56.7	95.3	91.0	78.7	55.5	82.0	43.2	63.1	32.7	79.6	52.6	71.7	61.1	52.2	39.7	45.6	62.5	30.3	70.8	44.7	50.1	36.5	39.4	40.7	46.2	23.3	46.6	56.6	48.5	36.5	45.9	20.7	18.8	21.3	21.4	40.0	13.3	11.5	15.8	17.7	32.3	11.1	9.4	13.9	3.2	30.8	27.9	22.5	29.6	17.7	8.2	9.1	10.2	10.4	8.4	8.9	10.2	8.8	10.8	8.6	10.2	9.9	5.8	16.0	13.2	6.8	11.6	6.0	17.4	34.8	8.6	11.4	7.1	3.8	3.0	10.0	27.0	23.9	10.4	46.9	11.5	41.6	13.7	45.6	24.6	8.7	6.2	10.5	18.6	3.4	3.4	61.3	34.2	7.4	29.0	11.5	1.3	9.9	3.6	14.7	37.4	6.7	4.0	19.5	63.1	7.9	9.0	7.0	2.1	10.8	16.0	3.7	31.3	21.6	18.6	4.5	5.6	40.8	25.2	5.3	15.7	11.0	26.4	28.7	17.3	72.9	13.1	4.4	16.2	8.8	20.7	14.4	6.0	36.0	13.1	20.1	29.5	19.5
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110546-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 997.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.0;THP-1: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	60.2	98.8	42.1	28.0	43.2	45.8	56.8	43.4	64.9	45.4	83.6	65.3	28.4	46.3	16.7	46.0	53.6	31.3	116.4	43.8	52.0	58.7	70.0	57.3	41.7	53.4	48.0	37.7	82.8	54.3	112.3	26.7	45.7	81.1	7.3	8.0	92.3	46.2	52.8	56.6	51.7	12.8	45.6	79.0	69.4	75.3	48.3	19.8	83.7	21.4	14.4	59.3	48.0	49.2	28.0	43.1	3.5	3.6	51.1	40.5	5.7	42.2	66.2	26.6	17.4	41.0	22.2	56.2	44.4	27.2	1.2	60.3	30.7	8.2	1.3	54.8	2.1	26.4	63.6	1.3	113.5	69.1	135.5	50.0	31.7	11.6	24.1	38.3	35.1	65.8	57.5	41.2	18.0	76.4	35.7	65.7	14.8	99.9	42.8	52.8	0.5	232.0	43.3	30.5	67.7	46.7	47.8	122.6	118.9	0.8	43.5	218.1	44.1	67.4	23.5	43.4	29.5	51.7	31.8	14.9	80.9	41.1	31.1	40.2	194.8	59.2	148.8	176.2	151.8	86.6	131.4	127.9	190.6	83.4	117.1	106.2	12.0	95.0	110.6	276.6	173.6	204.1	42.1	43.2	43.4	64.9	43.8	52.0	53.4	48.0	45.7	45.6	48.3	49.2	80.5	54.5	80.9	54.9	96.8	67.0	103.2	109.2	59.7	74.5	90.3	82.2	66.5	94.4	76.8	53.3	35.5	55.2	129.2	28.2	37.2	121.0	288.7	35.9	40.7	58.2	88.1	35.9	31.4	68.1	115.3	97.2	33.6	47.3	74.3	178.7	64.6	77.1	315.7	121.1	27.9	32.3	107.8	171.7	106.2	997.8	155.4	150.1	167.2	9.4	165.5	123.9	122.6	16.6	26.4	58.2	54.3	169.2	190.2	108.5	97.3	84.9	75.4	83.6	52.6	57.4	58.4	106.2	46.2	47.3	64.9	51.4	115.4	19.0	43.1	90.4
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	12.7	10.2	7.0	12.1	8.5	14.9	11.8	9.3	11.3	11.8	5.5	11.4	14.4	11.7	9.7	10.0	8.3	9.7	14.9	8.3	9.2	12.7	7.9	11.1	12.9	7.3	8.3	10.8	7.4	15.2	5.7	11.2	7.2	10.8	12.9	15.4	9.5	11.5	27.5	9.8	13.5	13.1	8.5	14.8	11.0	26.1	9.7	13.8	14.1	30.6	11.3	11.2	8.3	9.7	14.1	24.4	15.7	15.8	17.4	25.2	12.8	22.5	28.4	21.1	20.3	10.6	12.6	25.1	16.3	30.3	14.5	25.9	30.6	17.6	26.0	20.9	17.2	24.2	18.1	10.4	17.9	34.3	23.8	18.6	18.3	17.0	16.0	18.5	23.2	19.2	16.4	24.1	26.5	12.5	17.1	12.0	9.9	15.7	11.1	22.6	27.9	24.7	19.8	32.7	10.5	17.0	14.3	15.8	25.3	15.6	14.4	22.5	28.6	28.2	19.2	12.7	25.5	26.9	42.2	25.8	21.3	32.8	20.4	30.5	11.7	15.1	12.1	11.7	12.6	11.8	10.0	11.2	10.9	12.2	9.5	10.6	20.9	8.2	15.8	8.6	11.3	7.2	7.0	8.5	9.3	11.3	8.3	9.2	7.3	8.3	7.2	8.5	9.7	9.7	39.1	35.3	27.9	65.6	30.0	13.4	15.0	20.4	15.9	24.1	21.1	14.2	43.4	21.5	25.4	14.7	37.5	20.4	35.3	25.8	23.5	22.7	57.4	17.3	19.3	39.5	25.9	17.9	50.1	30.0	15.2	22.3	31.1	17.5	27.8	24.7	46.1	18.2	21.5	28.6	58.6	27.0	16.2	36.0	15.1	59.7	29.2	31.9	23.2	38.4	47.6	32.3	45.3	36.2	57.1	38.4	25.8	29.3	24.7	19.3	24.2	27.5	25.9	28.1	19.7	29.9	22.1	69.3	24.4	21.9	20.2	17.6	28.5	46.5	26.7	23.6
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514031-26658178	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 549.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 362.9;Oligodendrocytes: 367.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 65.8;intermediate monocyte: 74.5;myeloid DC: 71.2;non-classical monocyte: 48.8;plasmacytoid DC: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 71.2;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 263.7;Karpas-707: 279.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (5.41e-5)"	60.0	34.8	252.6	22.5	348.0	3.5	48.0	332.4	266.7	25.3	0.0	44.8	10.4	24.9	11.4	18.3	29.6	29.4	58.6	276.1	263.2	21.3	17.6	78.2	17.4	362.4	296.0	40.8	11.0	7.1	22.1	43.7	389.9	19.7	19.0	64.0	18.5	14.9	19.2	25.8	27.6	32.9	257.9	33.6	21.5	11.2	305.0	19.3	22.5	25.8	20.1	35.6	26.9	549.9	22.0	104.1	100.2	53.9	263.7	120.6	9.8	41.9	97.0	39.2	50.6	41.0	31.0	32.7	29.7	131.7	78.8	20.9	106.6	42.0	37.1	74.2	9.2	37.0	36.9	57.9	168.5	8.0	14.5	150.8	59.5	107.1	61.9	125.5	80.0	24.9	1.1	279.1	39.9	13.9	64.3	8.1	78.8	69.9	20.0	84.3	40.3	21.8	66.2	25.0	45.6	95.8	51.0	0.5	28.6	65.7	7.8	14.8	145.0	88.2	34.8	74.3	18.5	39.1	43.3	24.8	127.7	48.1	46.0	1.3	65.8	0.6	9.1	74.5	3.3	8.5	8.1	6.2	71.2	4.4	4.0	5.2	1.7	11.3	48.8	42.2	13.3	30.3	252.6	348.0	332.4	266.7	276.1	263.2	362.4	296.0	389.9	257.9	305.0	549.9	362.9	131.4	71.7	193.9	11.5	40.4	1.0	13.2	2.2	111.4	44.4	58.4	105.0	84.4	19.4	22.0	31.3	15.1	64.8	4.5	3.9	21.4	3.1	41.6	154.3	154.6	60.7	22.3	191.9	2.0	9.1	144.9	6.1	33.6	20.8	33.0	211.3	22.8	51.1	141.3	157.0	87.0	4.1	223.5	192.3	10.6	109.0	111.1	120.9	81.5	163.5	165.2	22.6	102.1	367.2	12.6	6.2	89.5	6.5	1.1	4.7	24.4	10.5	38.6	138.1	51.8	110.6	3.8	17.0	1.6	33.8	4.5	14.8	16.8	12.1	1.2
DPYSL4	"CRMP3, DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186948-132205759	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;heart muscle: 33.7;retina: 15.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.9;Cardiomyocytes: 20.1;Cone photoreceptor cells: 58.4;Horizontal cells: 33.7;Oligodendrocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.2;AN3-CA: 70.0;SH-SY5Y: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Mitochondria"		"HPA049066: AB_2680619"	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.11e-4)"	1.3	2.2	18.4	0.7	18.6	0.1	1.5	10.3	25.9	2.5	2.4	1.6	0.1	3.3	0.7	0.6	1.5	0.7	33.7	20.3	12.6	0.6	0.3	1.2	0.3	14.8	15.0	5.3	0.9	0.0	10.4	0.2	15.1	4.9	0.0	15.9	2.6	2.0	2.0	1.2	0.9	1.1	12.1	1.2	1.3	7.9	16.4	0.0	1.0	0.2	0.2	1.0	1.3	18.1	0.1	15.2	53.2	70.0	0.1	0.4	0.0	4.6	0.6	2.9	0.6	0.0	0.4	0.0	1.8	2.4	5.1	0.0	10.4	10.3	0.3	0.0	2.0	0.0	0.1	5.7	9.3	0.0	10.6	4.7	4.9	1.7	0.2	0.9	5.4	0.0	0.0	0.5	7.7	4.5	0.0	0.0	9.1	0.9	5.1	0.0	0.0	8.7	0.0	1.1	8.3	72.0	1.7	0.1	9.7	3.1	0.2	0.1	9.0	13.1	21.7	0.0	12.8	0.1	3.9	0.0	22.0	0.0	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.0	0.0	0.1	18.4	18.6	10.3	25.9	20.3	12.6	14.8	15.0	15.1	12.1	16.4	18.1	0.3	0.0	0.0	7.2	0.1	0.5	0.5	0.1	0.6	64.9	0.4	0.6	20.1	0.0	0.1	0.0	58.4	0.0	0.1	0.0	0.0	0.3	5.3	0.1	5.0	1.2	1.8	0.0	12.2	0.0	0.1	2.7	2.0	0.3	0.0	0.7	0.0	0.0	0.2	33.7	13.6	0.0	0.0	0.0	0.8	9.0	4.1	0.1	1.8	0.0	0.1	7.5	0.0	12.1	18.4	0.5	0.0	4.5	0.0	0.7	0.0	0.0	0.0	13.8	0.0	1.0	5.7	7.0	5.2	0.3	0.1	0.0	0.5	4.5	0.0	0.2
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 111.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	22.6	0.3	49.4	0.0	0.0	59.4	41.7	0.1	3.8	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.6	42.1	0.1	0.0	0.0	0.0	79.6	50.2	0.1	0.0	0.0	7.8	0.0	65.5	0.1	0.2	15.8	0.0	0.0	0.1	0.0	0.3	0.3	54.8	0.0	0.1	7.8	60.2	0.0	0.0	0.0	0.0	0.0	0.1	111.5	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	49.4	59.4	41.7	17.6	42.1	79.6	50.2	65.5	54.8	60.2	111.5	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399604-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 160.2"	"Group enriched"	"Detected in all"	5	"Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001218	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		22000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	31.4	32.6	22.6	21.4	23.9	32.3	35.1	27.0	31.6	27.3	22.8	24.7	22.6	27.8	38.7	27.4	32.7	19.5	44.6	23.7	24.6	35.9	37.9	20.9	29.2	23.9	23.7	35.0	34.1	38.4	18.6	35.7	25.0	25.0	30.0	30.1	30.5	28.8	100.5	23.7	21.3	34.1	24.5	20.1	24.2	160.2	22.7	40.4	34.5	85.1	38.3	30.8	20.6	26.4	80.3	61.3	73.9	63.3	64.4	75.2	61.5	70.2	81.7	125.7	104.4	100.3	38.3	111.2	38.6	86.9	60.3	64.5	128.5	82.8	134.4	52.0	152.0	71.9	64.9	99.6	91.4	174.2	65.1	65.6	60.9	103.7	152.9	64.6	87.5	61.6	93.9	48.1	97.2	88.0	75.7	88.4	62.1	114.0	65.9	98.7	118.9	97.3	82.1	68.6	80.8	50.4	78.5	79.8	107.2	70.8	59.7	77.2	50.6	57.7	79.3	59.1	81.3	67.2	78.5	108.6	57.0	77.7	77.4	25.0	43.3	46.0	34.3	49.7	39.6	53.6	36.6	43.0	45.2	39.4	40.5	39.8	9.8	46.7	37.5	39.6	50.9	47.0	22.6	23.9	27.0	31.6	23.7	24.6	23.9	23.7	25.0	24.5	22.7	26.4	22.0	19.2	15.4	3.9	29.4	38.6	40.8	77.2	29.6	18.7	27.2	27.2	52.4	35.8	37.6	27.6	25.0	126.4	20.6	22.5	64.6	56.4	798.4	23.7	24.4	34.4	11.4	37.8	10.3	45.4	104.5	33.2	21.4	21.1	33.7	27.1	35.7	36.9	60.4	15.2	11.2	31.0	48.8	31.1	24.0	651.5	35.8	22.9	17.8	7.5	39.2	27.6	33.0	9.5	11.1	42.7	27.0	37.2	27.1	48.7	42.9	60.3	28.7	18.4	59.2	35.4	36.1	469.3	92.1	33.1	32.1	117.1	25.5	26.2	41.0	45.3
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087892-18107970	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.3	19.1	14.2	12.8	14.8	15.9	19.6	14.8	15.0	21.6	13.6	19.4	14.8	22.3	12.9	21.6	19.8	12.6	19.8	14.9	15.7	18.5	16.6	15.7	18.4	15.2	15.4	22.5	19.6	15.8	17.8	12.3	16.1	20.1	10.0	5.2	17.0	15.2	36.6	20.3	17.4	13.7	15.4	19.8	17.9	8.9	14.9	16.0	18.4	16.5	14.9	20.0	18.3	16.5	37.1	51.1	17.4	17.3	31.1	31.7	33.1	24.8	24.7	40.0	37.0	55.5	21.8	35.5	31.8	29.4	21.2	38.9	28.5	35.1	27.4	32.1	74.2	16.0	26.5	31.5	33.4	14.3	24.2	36.4	30.5	39.1	33.0	22.9	38.5	46.8	27.6	13.7	23.6	42.5	38.7	25.8	12.9	51.4	36.1	41.5	41.8	66.7	24.3	21.6	9.9	28.0	25.2	15.2	31.9	102.8	30.0	21.4	29.2	19.6	18.3	23.0	42.8	15.5	19.4	20.1	27.9	26.2	36.6	17.7	21.1	23.6	24.6	23.3	20.2	14.9	17.8	20.0	24.6	17.7	16.9	18.7	2.8	28.2	30.5	13.8	24.9	19.3	14.2	14.8	14.8	15.0	14.9	15.7	15.2	15.4	16.1	15.4	14.9	16.5	23.8	0.0	12.4	8.5	19.5	16.7	19.9	21.2	11.4	14.9	18.8	23.0	3.9	24.3	13.2	7.3	2.1	37.5	26.3	20.1	29.4	29.4	7.3	12.8	19.3	20.8	21.6	10.1	11.9	27.1	40.8	19.4	17.9	12.9	12.0	32.6	16.4	19.4	32.2	6.7	10.0	19.7	16.2	21.4	12.2	14.2	21.5	18.0	12.4	8.4	23.9	19.6	23.7	4.0	8.0	24.8	16.2	24.5	22.9	17.4	31.4	31.8	9.3	13.4	6.6	22.0	21.7	12.1	13.0	18.2	11.6	39.3	21.9	33.9	24.5	14.4
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 228.8"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 166.5"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 2.7;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075379	Enhanced					NA	NA		27000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"			"HPA075379: AB_2732290"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.2	0.0	0.0	0.1	0.0	0.2	9.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	228.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	2.6	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	14.1	0.3	0.0	2.2	0.9	0.1	0.4	29.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.4	0.0	0.0	3.6	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.5	166.5	0.4	0.6	0.0	0.0	0.3
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102522	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 164.0;vagina: 97.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 28.9;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011911, HPA012615"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		24000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	Cytosol	"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (3.01e-4)"	5.5	1.8	1.3	12.7	1.4	0.7	22.2	1.3	1.6	59.2	1.9	50.5	41.6	1.5	5.9	164.0	6.1	3.7	10.6	1.2	2.0	5.9	7.3	7.9	3.7	2.6	1.5	0.6	10.5	27.0	0.5	21.3	2.2	15.8	44.5	1.0	46.8	1.0	0.3	11.9	42.9	4.0	1.8	3.0	43.2	0.8	1.6	6.6	4.0	3.1	62.2	3.6	97.4	2.3	18.1	1.9	2.9	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	9.8	48.3	0.0	0.7	0.0	0.9	71.1	11.8	4.9	0.0	0.0	6.9	27.1	8.4	16.9	0.3	0.2	0.5	0.4	76.0	0.0	7.3	6.1	0.0	0.0	13.4	0.0	0.0	14.7	0.0	1.1	11.3	60.7	17.4	13.2	0.0	0.2	0.1	0.7	0.0	0.1	0.0	44.4	0.0	43.4	12.2	18.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	28.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.4	1.3	1.4	1.3	1.6	1.2	2.0	2.6	1.5	2.2	1.8	1.6	2.3	25.1	28.9	5.6	3.3	1.0	83.7	44.5	16.4	67.7	0.8	75.3	65.7	33.8	32.9	11.1	7.3	0.0	100.8	1.0	384.0	0.0	83.5	0.1	19.1	4.0	6.7	69.4	0.4	3.3	33.2	186.6	5.9	47.4	43.8	0.0	2.7	8.2	16.0	24.8	0.0	1.5	83.1	20.3	48.8	29.3	0.2	0.3	35.3	14.2	4.7	25.2	11.2	0.0	2.0	0.2	155.7	324.8	0.7	0.3	140.6	118.2	9.7	3.8	0.7	0.0	1.2	3.0	0.1	1.3	705.6	55.0	83.9	2.0	0.3	114.0	76.1
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30989365-31042815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 99.2;skin 1: 372.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 500.7;Basal squamous epithelial cells: 214.5;Squamous epithelial cells: 419.6;Suprabasal keratinocytes: 688.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 246.2;HBEC3-KT: 54.6;hTCEpi: 156.7;hTERT-HME1: 103.6;REH: 44.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.3"					"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		6000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	4.8	0.1	0.1	0.5	0.0	0.2	12.5	0.1	0.0	23.8	0.0	0.3	0.4	0.1	1.2	99.2	1.3	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.4	0.2	3.4	0.2	12.5	0.0	6.0	0.1	0.1	19.6	1.3	1.0	372.6	0.3	0.5	0.0	0.0	0.1	0.1	0.0	7.7	0.1	0.0	24.7	3.5	48.5	0.0	17.2	1.8	0.2	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	246.2	0.0	54.6	0.0	0.1	14.6	0.9	4.7	0.4	9.7	0.1	0.2	10.2	156.7	0.0	103.6	19.6	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.9	0.1	21.8	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.1	0.3	0.0	500.7	62.0	49.5	214.5	0.0	3.1	8.0	1.3	0.0	30.3	0.0	0.0	73.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.3	2.4	0.0	0.3	0.0	14.2	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.3	0.0	0.3	0.2	12.2	0.0	34.8	0.0	0.0	0.6	39.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	32.1	0.0	0.1	10.2	0.0	0.0	0.0	3.4	0.1	0.1	419.6	688.8	25.0	2.3	0.0	0.1	89.1
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.6;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.4	0.0	5.8	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.6	4.2	0.0	0.1	0.0	0.0	2.3	2.8	0.0	0.1	0.0	4.2	0.7	3.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.8	0.1	6.6	5.6	4.2	2.3	2.8	3.5	2.9	4.1	4.1	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
DSG1	"CDHF4, DSG"	ENSG00000134760	"Desmoglein 1"	Q02413	18	31318160-31359246	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"skin 1: 564.4"	"Group enriched"	"Detected in some"	25	"Basal keratinocytes: 117.4;Suprabasal keratinocytes: 315.7"	"Group enriched"	"Detected in many"	10	"head and neck cancer: 57.0;melanoma: 16.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"hTCEpi: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA022128, HPA074188"	Enhanced					NA	NA		130000000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA022128: AB_1847620, HPA074188: "	"unprognostic (2.55e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.22e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.44e-1)"		"prognostic unfavorable (2.99e-4)"	0.4	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.1	1.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.6	0.0	2.0	564.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	2.1	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.0	0.6	0.0	3.3	0.9	1.7	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.1	0.0	0.0	8.6	3.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.2	6.5	315.7	0.0	0.2	0.0	0.1	0.0
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447741-31478702	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 313.9;vagina: 119.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 197.6;Basal squamous epithelial cells: 101.9;Squamous epithelial cells: 470.6;Suprabasal keratinocytes: 206.4;Urothelial cells: 87.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.0;head and neck cancer: 183.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	53	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.2"	"Group enriched"	"Detected in some"	7	"HaCaT: 204.4;hTCEpi: 494.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046864, HPA056863, CAB069880"	Enhanced					NA	NA		190000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.90e-4)"	0.3	0.0	0.1	0.2	0.1	0.2	3.9	0.1	0.2	71.1	0.1	0.0	5.4	0.0	0.0	313.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.0	43.6	0.0	0.1	39.9	3.9	0.0	0.0	0.0	0.2	0.1	0.2	14.8	0.0	0.0	72.7	1.2	119.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	204.4	0.0	46.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	494.7	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.2	28.9	18.5	0.0	0.2	197.6	17.4	32.2	101.9	0.3	0.5	5.0	0.3	0.0	21.1	0.0	0.0	0.4	1.5	0.2	0.0	0.2	0.6	0.1	0.3	2.7	0.0	0.0	2.7	0.4	0.4	2.2	0.0	0.1	12.6	0.0	0.4	0.3	0.4	0.0	0.1	1.3	2.0	0.3	7.7	0.5	0.0	3.2	7.2	0.0	0.7	0.1	0.0	0.0	0.1	1.3	2.5	0.7	1.2	12.3	7.1	0.1	15.9	0.8	6.6	0.0	1.8	3.3	2.8	470.6	206.4	0.3	1.3	0.0	6.5	87.2
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17570075-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 1690.3;SK-BR-3: 1421.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037094	Approved					NA	NA		3700000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	306.9	232.5	134.0	136.7	150.8	53.3	287.0	144.0	178.0	336.8	144.5	1146.3	136.1	636.1	297.1	535.6	449.9	297.4	411.6	150.0	158.2	269.0	141.3	315.8	60.2	146.7	150.3	236.8	268.9	180.0	127.1	162.3	154.4	559.2	306.8	114.0	274.6	758.3	87.2	227.8	285.6	695.0	147.6	75.2	486.8	82.0	140.4	47.8	273.0	111.4	79.0	704.4	312.7	164.1	323.0	431.3	161.5	160.5	399.8	391.5	303.8	397.7	616.4	248.1	221.7	200.4	348.6	50.1	97.7	587.8	458.5	305.3	149.4	606.5	281.9	28.0	125.5	131.9	247.2	295.3	426.2	102.9	86.5	357.9	563.1	239.3	275.9	609.0	360.6	85.4	63.4	65.7	468.1	251.7	42.2	121.6	110.4	1690.3	322.3	28.9	248.4	103.5	686.4	291.9	244.6	72.9	363.0	1421.1	441.9	263.7	654.3	55.9	345.3	294.9	93.2	324.1	276.8	39.7	52.2	134.6	139.9	43.8	250.8	33.8	17.6	59.2	55.9	32.2	46.8	11.9	56.9	52.0	22.1	9.0	37.0	47.0	11.8	48.8	46.4	51.1	46.7	45.3	134.0	150.8	144.0	178.0	150.0	158.2	146.7	150.3	154.4	147.6	140.4	164.1	372.8	1442.3	667.9	25.1	84.9	1151.6	697.0	796.7	542.4	101.5	925.2	762.2	1131.3	739.2	696.8	678.6	50.1	576.4	336.9	549.2	1457.6	1022.2	295.0	558.3	447.3	481.7	546.5	83.1	54.7	1468.6	1165.0	533.5	275.7	540.2	183.8	199.4	425.9	602.4	222.2	176.7	43.1	643.2	533.0	147.8	361.5	111.2	496.8	133.0	610.1	57.1	191.7	779.1	224.6	30.7	44.0	1018.6	572.8	1266.8	172.4	640.3	304.4	1491.4	912.0	153.1	1216.2	271.1	1745.4	390.0	298.9	515.2	1043.5	549.5	161.6	252.0	545.8	680.2
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.8;Inhibitory neurons: 214.1;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA061357	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	2.1	2.1	7.8	1.6	6.7	2.9	9.7	3.4	12.1	4.2	0.0	1.7	1.2	2.8	10.1	4.5	4.6	3.3	2.0	12.4	3.6	4.2	3.4	4.3	2.5	4.9	1.7	4.4	7.7	9.9	5.8	1.9	4.5	8.4	1.0	5.0	36.0	5.1	2.7	4.5	1.6	1.2	0.1	2.7	5.6	6.7	2.9	4.0	11.1	1.5	1.9	3.5	4.0	5.6	10.7	9.1	6.6	7.5	4.0	5.2	0.2	3.2	4.2	4.0	5.3	3.5	2.6	5.5	1.3	2.5	5.0	3.7	4.6	13.1	2.2	8.2	11.1	4.5	2.9	10.0	2.9	5.4	4.1	3.6	10.9	4.2	7.2	4.9	5.5	10.5	0.4	8.0	3.0	10.9	8.5	4.6	7.3	2.9	5.4	7.0	11.5	9.7	4.9	9.7	8.9	13.7	10.3	16.2	12.9	3.6	8.7	3.3	2.3	1.6	7.3	2.4	5.7	14.6	6.8	10.0	4.6	9.5	5.7	0.4	1.6	5.7	4.1	0.9	4.4	4.4	5.0	3.7	0.5	5.8	5.0	3.3	3.2	4.1	0.4	0.9	5.2	2.0	7.8	6.7	3.4	12.1	12.4	3.6	4.9	1.7	4.5	0.1	2.9	5.6	3.9	9.6	12.8	53.2	12.6	8.0	26.6	16.4	44.3	9.4	20.3	18.9	2.3	7.2	9.3	14.7	6.2	3.7	4.2	0.9	11.7	4.0	3.1	7.2	4.2	4.7	3.0	4.4	176.8	11.6	1.5	3.2	15.8	12.1	1.3	4.6	5.0	5.6	33.6	21.9	214.1	2.8	14.2	7.8	1.7	6.9	1.5	4.9	12.4	83.4	3.2	18.5	7.2	137.7	343.3	9.5	1.4	2.6	8.7	17.9	0.3	9.3	2.2	9.9	6.6	1.9	3.2	12.6	27.9	15.7	2.0	2.1	10.8	2.3	1.3	17.7
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349418	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 230.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011538, HPA073607"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB011538: AB_2093326, HPA073607: "	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	32.8	49.9	50.6	11.8	44.4	9.6	34.0	32.0	71.4	42.9	23.1	50.4	28.8	37.6	8.3	65.0	42.7	11.7	74.9	51.6	31.9	38.2	56.8	35.4	9.5	42.2	37.7	43.0	63.9	21.2	43.7	15.0	35.4	39.4	5.8	8.1	61.8	14.3	230.1	51.5	32.4	7.9	31.9	28.9	53.1	61.9	37.9	6.8	38.3	69.9	4.7	43.6	46.2	41.1	81.5	40.7	16.5	35.2	15.7	19.1	40.5	48.3	22.8	37.3	18.7	31.7	99.3	25.3	70.8	21.5	20.6	48.9	13.2	49.1	5.8	31.4	76.6	14.4	78.4	58.1	33.6	22.5	21.7	16.3	29.6	50.2	34.2	31.7	12.9	33.9	56.5	17.5	15.6	32.6	21.8	37.4	26.3	29.0	154.3	36.9	13.0	44.7	27.5	12.6	64.3	43.8	23.3	62.6	66.6	5.9	34.8	37.4	25.8	21.2	55.0	82.4	82.2	27.6	12.1	32.1	62.2	31.3	13.7	0.1	0.3	0.0	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.1	50.6	44.4	32.0	71.4	51.6	31.9	42.2	37.7	35.4	31.9	37.9	41.1	20.5	19.2	14.8	12.1	4.4	13.8	5.5	8.8	6.2	33.2	19.0	16.3	25.5	8.6	10.1	7.3	6.2	10.7	6.9	32.1	3.9	11.3	1.1	13.4	14.2	12.0	12.1	1.3	11.0	20.4	14.9	11.5	31.6	18.8	1.3	15.8	6.1	21.8	5.1	32.0	10.2	17.6	4.1	5.7	6.8	3.0	13.1	4.9	7.2	9.4	2.6	23.5	1.0	6.0	14.3	52.3	20.8	10.5	5.1	16.6	21.0	5.8	9.1	22.1	13.1	12.2	10.8	14.2	13.3	15.3	15.5	11.4	4.5	25.4	24.3	12.6
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964573-102056443	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		490000	"Cluster 11: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	22.4	19.3	7.8	4.9	7.2	9.2	18.2	16.1	10.9	17.2	0.0	29.1	3.6	24.6	5.0	18.5	17.5	4.0	29.7	9.2	1.1	12.6	9.4	19.9	4.4	5.2	4.3	21.0	15.8	2.0	20.9	3.0	9.0	14.5	3.1	13.2	19.9	2.9	53.1	27.6	19.2	3.1	0.6	14.2	19.7	13.0	2.1	2.0	17.6	1.2	2.4	23.4	18.0	9.2	3.3	6.6	5.0	4.6	3.0	5.0	3.2	3.0	1.8	5.1	4.5	2.6	4.5	4.2	3.4	5.4	4.9	4.0	8.2	5.3	3.6	3.4	3.5	4.1	15.1	3.3	2.7	3.6	6.4	6.4	6.3	14.1	4.9	3.2	3.9	8.0	3.0	8.9	4.5	4.2	5.6	4.1	5.1	2.1	10.2	4.6	3.3	1.6	5.2	7.6	8.4	2.8	3.2	2.2	3.4	4.9	2.5	1.5	11.5	6.8	4.1	11.5	5.1	4.3	7.6	4.9	9.1	2.9	3.0	1.3	0.6	0.8	0.6	0.4	0.5	0.4	0.4	0.4	0.6	0.5	0.3	0.5	1.2	0.4	0.6	0.6	0.4	0.3	7.8	7.2	16.1	10.9	9.2	1.1	5.2	4.3	9.0	0.6	2.1	9.2	102.1	125.0	84.7	83.9	55.9	52.4	46.4	75.0	51.2	126.4	63.1	55.5	182.9	31.5	89.1	77.3	139.7	49.6	106.3	94.2	13.7	112.6	14.8	123.6	131.0	93.7	71.3	38.1	127.3	81.2	42.9	86.5	86.6	134.6	33.5	117.9	46.1	36.7	40.2	183.4	131.0	68.0	75.3	52.7	123.6	16.8	70.5	90.7	71.2	51.5	99.2	63.3	73.2	51.8	93.3	131.3	73.6	71.5	100.0	47.6	82.6	48.5	90.7	115.4	85.5	81.4	106.1	87.1	72.2	59.2	64.1	37.4	91.3	86.1	64.4	46.5
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	Yes		890000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	268.6	261.9	912.5	186.7	967.7	126.8	268.0	895.2	1292.9	354.2	894.7	325.8	162.8	319.4	322.3	719.9	544.2	242.7	257.5	975.4	944.7	352.6	238.4	222.6	241.6	896.1	898.5	247.0	225.1	228.2	309.7	259.2	914.2	225.9	327.4	181.3	245.4	264.6	85.6	626.7	206.3	390.1	935.1	185.2	244.5	360.3	909.7	306.5	176.1	163.9	357.8	389.8	474.4	1001.2	721.6	811.4	779.2	600.8	677.1	713.6	250.8	968.0	451.6	785.6	466.7	770.8	472.3	400.6	510.3	945.1	753.0	629.6	949.3	818.3	781.0	528.3	617.9	390.4	532.9	1062.5	676.2	412.8	620.5	436.2	863.0	584.6	477.5	855.7	831.8	421.5	502.0	446.1	1056.8	960.1	541.4	894.8	642.2	917.7	935.7	543.0	403.0	499.2	1143.1	659.8	535.2	392.0	789.3	677.7	926.6	812.6	673.6	595.3	635.2	592.3	502.1	525.6	852.2	264.0	562.8	404.6	656.8	645.1	776.6	516.6	291.9	384.2	200.6	303.3	155.3	310.4	207.2	211.7	281.8	219.0	132.0	165.7	50.1	282.9	334.8	461.6	373.5	353.0	912.5	967.7	895.2	1292.9	975.4	944.7	896.1	898.5	914.2	935.1	909.7	1001.2	810.1	195.5	101.9	79.3	341.4	922.2	359.1	1275.0	356.8	138.4	800.0	949.4	170.8	303.1	764.6	399.1	83.4	524.6	484.1	689.9	1113.2	691.2	1407.2	1842.5	528.5	541.9	480.8	332.9	111.2	538.9	897.4	538.5	240.5	488.1	316.7	611.9	521.9	499.0	732.1	85.8	62.8	801.6	1121.0	329.4	706.1	4098.6	516.6	466.3	595.9	42.2	701.6	164.0	248.2	47.3	156.4	754.9	798.6	701.8	234.9	304.7	533.4	1125.0	2679.6	193.5	368.1	440.7	1016.3	961.5	721.4	1005.4	1610.1	1006.6	396.6	586.3	498.2	389.6
DYNLRB1	"DNCL2A, DNLC2A, ROBLD1"	ENSG00000125971	"Dynein light chain roadblock-type 1"	Q9NP97	20	34516414-34540958	"Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009845	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB009845: AB_2093671"	"unprognostic (2.23e-1)"	"unprognostic (7.60e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (9.10e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.00e-1)"	168.7	208.4	430.4	96.9	440.2	113.7	163.7	416.5	552.8	163.7	400.8	228.4	113.8	193.0	204.9	155.4	198.5	117.1	275.7	448.5	454.1	265.8	122.0	169.4	123.9	444.7	443.3	153.9	115.0	222.9	204.3	154.6	436.7	180.9	128.2	171.7	142.1	170.7	222.8	222.1	156.4	158.7	416.1	143.0	166.7	66.6	422.8	154.3	174.4	224.5	135.1	191.4	158.8	458.8	244.4	317.6	259.4	207.3	307.5	294.9	175.4	264.1	393.5	399.2	340.7	853.3	231.1	135.6	327.4	402.0	385.5	215.3	282.2	391.6	265.9	164.5	198.8	463.2	286.8	679.1	345.7	217.5	249.6	251.4	250.4	320.2	245.7	306.2	282.2	255.8	195.1	249.0	415.5	313.4	314.7	427.4	148.6	284.7	345.2	158.6	359.6	220.2	618.7	160.8	264.2	273.9	382.9	631.9	359.4	249.2	362.5	240.7	251.9	500.8	122.4	351.2	295.8	208.8	310.3	157.3	430.1	186.7	225.0	225.4	112.5	221.2	88.0	123.1	88.8	144.2	145.6	117.2	128.8	127.3	101.4	102.1	111.4	132.4	144.3	161.2	238.7	135.0	430.4	440.2	416.5	552.8	448.5	454.1	444.7	443.3	436.7	416.1	422.8	458.8	188.4	169.9	106.5	26.1	107.9	146.8	176.8	215.9	100.2	105.4	136.0	200.3	125.5	170.1	157.4	292.4	58.4	297.8	112.9	283.9	481.3	264.4	34.0	266.4	139.5	170.9	226.7	98.2	34.7	223.4	211.4	149.1	85.1	208.5	159.0	149.8	162.4	104.1	287.9	80.8	30.0	284.6	256.3	127.8	131.5	51.0	234.9	139.1	193.9	19.7	236.2	435.8	148.3	20.1	61.4	317.5	379.3	240.3	117.0	240.4	388.9	781.8	253.1	127.6	203.8	101.8	210.8	65.6	77.2	106.3	150.0	342.3	124.9	90.9	160.5	184.3
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 133.1;Horizontal cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	9.9	4.6	2.9	14.2	3.3	14.9	6.3	2.3	6.1	7.8	3.2	25.7	20.4	13.1	6.2	10.7	10.0	14.3	24.4	8.6	2.3	4.7	4.2	9.1	21.6	3.4	2.3	8.7	8.6	4.9	3.0	14.1	2.7	6.5	21.9	14.8	5.4	8.8	39.4	7.5	28.0	13.0	3.1	14.7	20.6	5.0	2.7	24.1	6.9	10.4	14.2	11.9	7.6	3.5	24.5	13.4	19.8	14.4	9.7	13.2	15.8	24.2	15.7	11.6	6.6	17.9	13.2	45.3	29.2	35.3	7.1	27.8	16.0	9.6	12.4	19.6	20.9	7.3	9.5	6.9	3.8	16.8	15.2	11.0	13.3	31.4	24.8	19.6	6.6	18.9	9.2	22.9	15.1	13.9	14.4	8.2	17.2	15.8	21.5	37.9	19.7	20.0	13.6	30.2	26.0	30.7	10.1	13.4	13.9	13.3	9.2	13.9	10.0	18.4	17.3	12.8	19.4	10.9	1.9	24.9	17.6	11.1	19.4	2.0	0.3	4.0	3.2	0.7	2.3	1.8	2.3	4.2	1.2	2.0	1.9	3.7	0.4	4.7	0.9	0.5	2.0	1.1	2.9	3.3	2.3	6.1	8.6	2.3	3.4	2.3	2.7	3.1	2.7	3.5	13.0	9.6	10.2	3.9	14.4	11.3	11.9	6.7	8.6	18.0	7.4	8.1	44.5	20.0	11.2	1.8	22.9	3.5	28.6	133.1	0.0	19.0	0.6	28.0	35.9	12.1	24.6	4.8	11.0	18.2	7.9	18.9	25.0	15.6	5.7	13.3	6.4	6.1	17.0	80.8	11.4	62.0	4.1	15.7	22.5	2.0	11.5	15.5	8.8	13.1	12.0	16.7	42.2	6.0	9.1	17.7	61.3	13.2	9.0	16.1	62.9	11.3	30.3	23.3	13.1	53.5	33.6	2.7	10.1	15.6	16.2	4.5	31.0	17.9	32.3	34.4
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675477-33686385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.0;Granulosa cells: 11.4;Spermatogonia: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	1.8	5.5	7.1	5.6	7.1	34.3	1.6	5.2	9.2	1.8	3.9	3.8	3.2	1.2	0.2	5.7	1.3	0.7	1.4	6.1	5.6	0.9	1.8	3.7	8.7	7.6	6.4	3.5	1.0	1.3	0.6	2.4	6.5	1.9	3.9	0.7	1.9	0.9	1.6	4.7	4.1	2.8	7.0	5.0	3.7	10.4	6.9	10.7	0.8	0.8	6.9	2.4	2.5	8.3	48.1	45.4	52.0	40.5	5.2	3.6	39.3	45.0	21.4	55.9	46.7	81.1	48.0	87.3	44.2	20.2	67.7	35.4	25.3	23.8	24.8	26.4	36.5	71.6	71.9	47.7	0.4	34.0	43.6	2.8	1.4	30.6	5.4	5.7	14.6	54.4	19.3	60.0	34.9	42.3	72.8	71.6	15.6	47.9	64.6	71.4	140.7	36.2	9.6	28.7	76.7	54.1	54.6	37.6	22.7	14.8	47.3	42.4	7.9	65.0	37.7	45.8	64.8	58.1	42.0	72.6	54.1	20.0	39.3	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.1	0.1	0.1	7.1	7.1	5.2	9.2	6.1	5.6	7.6	6.4	6.5	7.0	6.9	8.3	1.1	0.0	1.1	0.7	3.6	2.9	1.7	0.5	0.0	2.3	3.1	4.3	0.4	0.0	1.4	0.0	0.0	5.0	2.9	2.4	0.0	0.9	1.0	0.3	1.0	1.6	0.0	25.0	1.5	0.2	9.6	3.0	7.7	1.2	0.0	11.4	0.7	0.8	4.4	0.0	0.5	4.6	2.0	0.6	2.1	3.1	2.1	3.1	1.8	1.0	0.1	1.5	1.0	1.0	3.4	0.6	0.5	1.2	9.7	0.5	1.4	0.1	0.2	2.3	0.0	1.0	3.0	7.5	32.9	3.7	1.7	1.8	3.3	1.2	7.0	3.5
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506438-23531233	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 25.1;esophagus: 8.7;lymphoid tissue: 15.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 50.2;Erythroid cells: 45.7;Late spermatids: 110.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.7;Karpas-707: 38.9;U-266/84: 37.2;U-698: 38.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB016313	Uncertain					NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.2	0.2	0.0	1.8	0.0	25.1	0.1	0.1	0.1	0.9	0.1	3.4	1.5	0.1	0.0	8.7	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.8	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.1	2.1	0.0	0.8	0.0	0.1	3.5	2.1	0.3	0.0	5.1	0.7	3.6	0.1	15.8	0.2	0.0	3.7	0.3	1.9	0.1	5.4	3.9	6.4	10.2	0.2	0.2	4.5	2.5	1.2	2.4	3.1	2.5	3.1	46.7	3.0	1.3	1.1	10.6	12.9	0.6	2.2	11.8	4.2	7.4	10.7	2.8	0.0	5.4	9.3	0.0	0.1	1.7	0.2	0.3	0.7	21.4	5.8	38.9	1.1	3.2	24.3	5.0	1.4	5.8	1.9	26.4	13.7	15.7	0.9	1.4	8.3	11.6	4.3	5.4	1.3	0.8	4.0	3.9	0.5	2.2	6.1	7.0	3.6	28.5	37.2	38.0	2.1	5.8	4.3	4.1	0.2	0.8	0.0	0.6	0.0	0.4	0.3	0.2	0.5	0.3	0.0	0.0	0.1	0.1	0.9	0.4	1.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.8	0.2	0.2	1.8	0.0	1.0	1.3	0.6	0.0	0.3	1.8	0.0	3.4	0.7	14.5	0.0	0.1	50.2	0.3	0.3	0.6	1.2	45.7	0.1	0.0	4.8	1.1	3.1	1.1	0.0	4.2	0.4	0.4	2.3	0.0	0.1	5.9	0.0	3.1	0.8	110.3	0.3	2.7	0.0	1.0	1.4	0.0	0.0	0.5	0.1	0.1	7.3	0.4	14.5	0.6	1.8	0.1	0.0	0.0	0.0	0.1	0.8	2.5	5.2	10.2	1.0	0.5	1.7	0.7	9.5	1.3
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 7.8"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA075185: AB_2732282"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	5.5	5.2	5.0	2.5	5.3	3.8	4.3	5.1	6.2	3.3	5.1	4.5	2.8	5.4	3.9	2.7	4.9	3.1	7.6	4.8	5.8	2.6	2.8	3.0	2.4	5.3	5.4	4.7	4.6	3.4	5.0	3.1	5.1	3.3	2.2	3.5	3.6	3.4	14.6	3.7	3.6	4.4	5.1	3.2	4.9	2.8	5.2	2.5	2.7	11.5	1.9	4.0	3.0	5.2	4.2	5.2	10.7	6.0	4.8	3.9	8.0	4.0	7.1	4.6	4.2	10.3	5.6	8.2	4.5	4.6	9.3	3.1	7.6	5.9	4.8	10.6	11.3	14.9	4.0	12.8	9.4	15.4	14.7	6.7	5.5	5.0	5.9	3.9	4.2	7.1	11.3	15.3	3.7	10.1	8.9	16.9	15.3	5.1	6.7	15.6	12.1	8.4	5.0	3.7	9.2	19.1	4.6	6.7	18.8	4.6	6.2	7.7	3.5	6.6	8.5	4.2	9.0	22.0	17.4	19.9	7.2	14.5	10.3	7.8	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.0	5.3	5.1	6.2	4.8	5.8	5.3	5.4	5.1	5.1	5.2	5.2	15.7	6.4	4.8	7.2	8.4	24.3	23.6	10.6	13.6	12.4	14.5	9.7	9.0	10.0	8.4	3.7	16.7	17.3	8.5	3.4	7.9	11.7	1.4	11.0	14.1	12.2	6.7	3.4	13.9	11.0	13.9	14.3	13.3	14.0	0.0	13.6	8.6	8.8	12.5	13.5	14.9	4.7	8.2	5.4	11.5	2.6	8.7	11.3	17.8	6.5	7.0	10.1	5.2	3.5	20.8	9.4	3.7	11.3	6.1	21.3	5.3	8.4	4.1	11.8	0.0	22.2	12.3	15.7	48.2	8.2	21.9	22.2	8.4	11.7	6.0	16.7
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345572	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 29.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 673.8;TIME: 588.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		1300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	87.3	123.2	26.5	47.7	29.4	48.1	79.4	23.0	30.1	61.4	12.6	71.0	30.1	42.4	10.0	26.7	46.9	36.8	70.9	21.3	33.7	38.1	54.0	72.1	35.7	34.4	25.7	71.0	91.8	125.0	47.4	66.5	30.4	53.1	34.7	14.7	33.6	25.1	19.8	34.3	46.1	42.3	21.2	48.5	43.3	22.7	28.1	21.1	51.4	33.2	34.9	58.8	43.8	27.5	93.0	60.1	77.9	38.3	111.0	116.4	44.1	135.4	236.8	72.9	66.6	44.1	275.8	34.0	323.6	138.8	157.7	38.4	32.6	64.9	63.5	83.0	27.2	48.7	89.9	34.8	144.3	7.1	11.8	61.6	74.3	112.6	55.8	199.2	673.8	27.6	10.0	17.7	62.9	19.4	14.6	11.4	23.2	26.3	46.5	17.5	45.0	49.2	114.0	17.0	26.4	63.1	134.3	79.2	57.4	42.5	55.9	20.2	588.7	160.7	77.9	73.3	79.9	26.4	49.0	39.1	332.6	16.5	196.6	0.2	8.4	3.3	2.9	10.0	4.2	6.1	6.1	4.6	0.7	4.1	4.0	2.7	29.8	1.5	7.8	2.8	8.6	7.2	26.5	29.4	23.0	30.1	21.3	33.7	34.4	25.7	30.4	21.2	28.1	27.5	164.0	19.2	7.5	46.4	25.1	20.3	19.7	81.6	18.8	5.0	71.3	44.7	18.9	10.0	54.7	23.9	0.0	6.0	12.4	105.8	5.9	25.8	1.5	19.6	35.2	106.1	25.2	20.2	19.2	56.7	35.0	51.8	20.9	51.8	18.4	35.4	97.1	36.0	3.3	0.0	14.8	13.0	57.0	9.6	14.3	4.2	43.5	17.3	7.2	31.9	25.5	50.4	8.2	13.6	22.5	100.4	106.5	55.3	29.4	34.9	45.7	7.5	24.2	4.4	39.5	72.7	47.5	1.3	5.9	8.5	16.1	10.5	17.9	80.6	21.6	40.8
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288712-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA		56000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	92.9	29.4	21.8	36.8	24.5	16.2	37.3	26.4	28.6	36.4	32.3	58.4	46.8	21.4	23.0	33.5	23.2	27.5	42.6	22.0	27.0	92.5	93.8	56.8	41.3	28.1	24.7	21.1	27.9	26.2	14.1	36.2	28.5	33.8	53.8	30.0	46.3	28.4	39.3	22.7	40.7	33.4	24.4	28.4	37.0	18.2	24.7	41.1	38.7	52.2	42.6	43.4	23.4	32.3	58.3	45.6	64.0	59.3	92.9	87.7	54.1	92.7	112.1	78.0	99.0	79.7	43.1	87.6	77.8	88.6	88.4	46.9	0.1	69.6	98.3	52.4	43.3	116.9	58.4	128.3	82.6	158.0	63.4	99.6	81.9	73.1	61.6	70.6	71.8	63.2	147.6	51.6	105.7	55.1	105.7	73.5	52.9	29.0	55.8	49.0	78.7	72.3	142.8	70.8	73.3	71.2	52.1	1.8	131.3	48.3	1.8	182.6	75.2	47.8	76.9	121.8	104.8	65.7	141.0	116.3	87.2	136.4	114.7	19.0	71.6	24.0	23.4	57.5	24.7	28.6	19.8	22.9	66.6	29.2	23.7	24.2	28.6	15.3	43.1	50.5	22.1	43.9	21.8	24.5	26.4	28.6	22.0	27.0	28.1	24.7	28.5	24.4	24.7	32.3	37.0	96.1	114.0	32.3	59.7	26.1	42.3	94.2	35.3	26.4	30.8	28.3	60.8	32.9	102.4	31.3	31.3	106.8	49.3	35.6	127.2	76.1	64.7	47.0	48.3	32.6	13.8	22.9	47.4	79.5	85.6	45.8	38.2	40.2	43.7	32.9	26.0	68.8	85.8	28.6	41.0	35.7	59.0	48.4	38.7	24.4	32.9	55.9	35.6	40.3	55.3	33.5	47.4	55.3	95.0	54.4	41.1	31.2	48.3	31.1	74.4	230.3	47.0	42.3	26.3	55.7	33.0	27.6	28.6	34.7	22.9	65.5	46.3	88.2	56.9	52.7
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362485-133373354	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1128.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1476.3;Proximal tubular cells: 2336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	302.4	127.1	127.7	53.7	127.8	43.9	116.9	131.3	136.1	59.8	149.7	143.1	171.6	47.0	89.3	107.9	90.5	66.7	226.4	133.1	129.9	481.7	1128.7	48.5	52.4	129.4	129.9	71.3	96.8	98.7	74.3	73.6	128.8	102.0	104.6	39.8	163.4	123.2	294.3	68.2	153.6	59.4	130.3	48.4	84.5	52.6	134.6	40.0	88.5	271.6	59.0	87.4	57.8	136.0	185.1	229.2	120.4	303.4	173.0	111.4	110.5	132.2	175.9	183.2	154.1	509.5	174.0	139.2	111.9	151.4	94.4	167.7	160.2	136.1	132.0	107.4	281.2	138.5	128.1	367.2	145.0	180.4	93.5	124.5	115.9	121.2	153.6	160.8	165.1	98.3	127.8	117.4	181.6	443.9	90.7	352.0	84.4	289.8	272.1	152.8	146.4	74.6	227.8	236.0	78.1	123.4	137.0	224.1	178.9	69.4	174.8	171.5	132.1	81.3	115.9	169.9	177.4	87.0	58.8	159.8	192.4	98.8	68.7	96.1	184.7	86.8	105.5	212.2	137.6	178.7	117.8	115.8	242.6	148.9	119.3	115.8	19.8	166.0	168.1	104.9	123.0	233.0	127.7	127.8	131.3	136.1	133.1	129.9	129.4	129.9	128.8	130.3	134.6	136.0	99.2	44.8	82.7	16.3	60.5	68.2	86.9	271.8	62.6	57.0	98.5	119.6	255.2	210.1	161.5	174.7	6.2	470.2	34.0	298.6	565.4	162.8	29.9	148.9	92.7	71.4	131.7	72.2	11.6	101.1	163.5	92.5	87.7	226.4	91.2	120.0	88.5	1476.3	221.1	45.4	11.0	223.0	175.0	92.1	61.5	39.1	77.6	88.0	135.2	10.3	113.0	145.2	45.3	10.6	24.3	107.8	248.6	91.7	57.5	88.0	486.2	2336.5	93.2	55.2	85.5	57.0	98.8	52.9	66.1	125.2	76.3	299.1	62.5	220.0	317.2	127.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239402-2252300	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 301.3;Hepatocytes: 246.5;Proximal tubular cells: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		7300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	51.5	57.3	35.9	12.7	39.2	19.6	52.0	38.6	45.9	46.2	61.6	74.0	59.9	44.9	10.6	57.0	50.7	11.3	189.7	32.1	38.0	123.2	235.7	37.2	13.8	39.1	37.8	38.6	74.7	43.8	50.4	14.6	35.0	56.6	15.0	12.8	78.7	24.2	220.6	49.7	58.8	9.3	37.3	35.3	69.5	18.2	42.0	13.4	105.0	87.8	9.5	50.3	43.6	36.5	29.5	68.0	25.7	107.4	9.6	13.6	96.6	29.5	19.1	23.1	33.7	120.0	88.0	42.3	71.2	17.7	16.9	71.6	29.6	27.5	3.2	74.2	157.1	12.9	61.7	151.7	87.3	38.6	6.0	25.2	63.1	18.9	41.7	16.4	23.6	1.1	71.7	87.1	8.0	119.1	4.0	57.8	60.1	46.8	68.8	134.3	27.7	207.1	45.5	32.5	88.8	56.2	70.0	131.4	92.7	12.6	84.7	67.7	19.6	18.4	68.0	19.9	33.0	95.8	61.0	72.2	23.9	35.4	26.2	1.7	3.6	1.6	1.9	3.8	3.1	4.4	2.8	1.6	3.0	4.9	3.4	2.9	2.0	3.6	2.5	3.6	4.0	0.8	35.9	39.2	38.6	45.9	32.1	38.0	39.1	37.8	35.0	37.3	42.0	36.5	47.1	3.2	28.2	13.4	28.0	21.3	115.6	11.3	21.1	53.2	77.2	95.1	92.3	94.4	15.0	77.3	43.8	179.6	20.5	151.7	301.3	35.1	10.9	128.2	54.8	28.2	45.5	61.7	4.2	36.9	80.7	33.1	33.1	122.8	5.7	62.2	34.2	246.5	47.9	21.9	6.7	105.9	20.3	31.0	23.8	5.3	24.5	29.8	39.2	4.7	17.5	89.9	5.2	13.0	10.0	33.2	91.1	24.0	36.8	72.8	176.1	272.3	14.6	77.6	0.0	73.4	42.7	6.3	19.6	32.9	22.3	109.9	21.7	50.2	104.7	110.5
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 3.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Macrophages: 1.1;Squamous epithelial cells: 5.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 7.5;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	75	"T-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;HaCaT: 10.2;OE19: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA042292	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.0	0.2	0.6	0.0	1.3	1.1	0.5	0.2	3.6	0.2	0.9	0.0	0.1	0.0	0.6	0.9	0.2	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.7	1.9	0.0	0.6	0.1	0.0	1.4	1.0	0.0	0.0	0.2	0.9	0.1	0.1	1.2	0.0	0.0	1.2	1.5	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.7	0.0	0.4	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	7.5	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.4	0.0	0.1	0.6	0.5	0.0	0.8	0.0	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.8	0.0	0.3	0.8
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219958	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 184.4;U-698: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	11.2	11.3	5.5	31.3	6.6	66.5	14.4	3.7	6.2	11.6	4.4	15.6	14.1	11.9	12.6	16.7	10.7	12.2	7.2	5.2	5.6	12.5	59.3	29.8	41.4	6.5	5.2	13.1	24.9	17.2	9.4	14.0	4.9	12.4	16.9	5.6	13.3	10.7	5.7	17.2	18.7	12.5	5.4	24.4	17.7	10.5	6.7	79.1	17.6	5.4	42.5	16.7	13.2	6.4	18.0	17.8	11.1	11.1	14.3	31.6	35.1	28.8	38.8	19.5	25.5	8.2	23.4	95.9	15.2	28.6	42.3	13.9	12.1	39.8	29.6	184.4	7.1	32.7	16.9	18.7	66.2	39.0	91.8	28.7	47.4	41.6	45.5	26.4	39.2	122.1	8.7	128.2	24.4	10.6	78.9	14.9	5.6	8.2	13.4	113.2	19.6	90.0	22.4	37.0	1.4	14.5	20.8	29.6	44.4	9.8	15.2	123.3	38.7	37.2	25.7	32.1	33.6	75.1	49.4	162.3	61.8	37.1	31.8	2.9	2.6	3.1	4.0	3.7	5.7	6.7	5.9	4.4	3.3	4.4	5.2	4.1	3.0	2.1	4.6	7.5	6.7	2.0	5.5	6.6	3.7	6.2	5.2	5.6	6.5	5.2	4.9	5.4	6.7	6.4	11.8	60.9	100.7	10.7	51.1	20.6	7.0	15.5	10.2	5.3	17.2	11.0	3.1	20.0	19.9	16.5	10.4	10.0	29.1	23.8	0.0	7.0	14.4	11.4	14.8	12.6	8.4	12.6	17.4	12.2	32.8	11.3	20.9	20.0	23.5	8.1	12.8	76.2	17.0	1.7	15.4	26.4	14.2	32.9	194.0	63.1	8.4	44.3	16.0	14.0	43.1	3.3	12.3	11.1	10.3	15.2	4.7	9.1	135.5	12.5	16.1	8.5	11.0	4.0	0.0	9.4	13.6	7.8	5.5	23.1	27.3	40.9	25.5	5.1	12.3	20.7
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290361-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 44.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 4.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	44.6	1.8	14.7	7.3	13.8	4.7	23.6	13.6	18.2	6.2	9.7	10.6	10.4	7.0	6.3	12.1	9.4	13.5	7.8	12.6	12.2	7.7	3.1	36.6	5.6	15.1	13.6	2.6	9.6	1.4	1.1	18.5	15.2	5.5	14.5	1.0	12.1	8.9	7.6	11.8	9.8	11.3	13.1	12.3	10.4	4.7	15.7	1.7	3.4	6.4	2.4	9.9	5.9	14.2	10.3	57.6	1.1	0.1	0.3	0.2	0.2	18.2	16.0	15.0	12.4	74.6	8.6	0.0	660.4	7.2	9.2	5.4	0.0	10.6	11.0	0.8	0.0	0.0	2.1	2.3	0.8	0.0	0.0	0.4	6.2	3.0	2.1	4.7	446.8	0.0	0.0	0.0	56.8	1.6	0.2	0.3	0.6	10.4	0.7	0.2	5.1	0.1	35.3	9.4	0.6	0.0	1.8	53.1	0.1	117.2	137.5	0.8	334.3	37.1	30.1	0.7	23.5	0.3	0.4	1.3	0.3	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.0	14.7	13.8	13.6	18.2	12.6	12.2	15.1	13.6	15.2	13.1	15.7	14.2	190.7	173.1	23.8	2.9	0.8	189.9	749.7	99.9	151.4	0.2	68.7	26.8	2.2	8.6	110.6	38.6	0.0	1.8	0.8	189.7	3.9	316.3	13.3	187.2	16.3	236.8	15.6	2.7	3.6	218.9	0.4	9.0	22.4	289.7	1.3	0.8	169.2	1.8	1.8	1.7	3.0	43.8	12.2	5.0	6.7	19.8	5.6	5.3	8.8	6.5	10.9	0.3	0.0	3.5	0.6	268.5	145.7	0.4	0.4	185.8	119.6	8.3	27.4	0.4	6.6	1.8	21.8	1.0	0.6	53.7	64.5	0.8	9.7	0.1	196.6	141.8
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles		NA	NA		20000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	11.4	6.6	2.8	6.7	3.0	3.7	7.2	6.6	4.3	9.3	0.0	8.2	6.7	8.7	4.1	13.1	4.8	7.3	7.8	2.7	3.8	6.6	9.5	7.1	5.6	5.3	4.3	8.9	6.0	8.1	2.8	9.4	5.5	7.3	7.0	13.7	7.0	5.7	9.6	10.2	6.6	8.4	3.2	7.3	7.0	5.3	3.5	4.1	8.1	10.4	5.5	8.5	6.8	4.4	14.9	4.9	7.2	5.1	30.1	30.1	16.4	28.8	16.6	15.0	10.6	17.1	4.0	15.2	5.1	20.3	21.3	17.5	16.0	8.1	23.0	10.2	7.8	16.2	5.9	15.7	16.7	11.6	7.3	19.7	11.7	16.1	24.0	16.7	25.3	4.2	12.2	5.0	15.7	6.9	8.4	7.9	7.2	6.0	10.5	9.2	18.2	10.1	7.7	20.4	6.0	4.4	21.2	13.7	12.9	9.9	18.2	10.1	34.4	21.0	8.0	16.8	11.2	5.4	10.1	10.2	7.8	10.1	11.6	0.0	0.6	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	0.8	0.5	0.5	0.2	0.9	0.5	0.1	0.2	2.8	3.0	6.6	4.3	2.7	3.8	5.3	4.3	5.5	3.2	3.5	4.4	58.3	99.3	59.8	60.7	36.4	37.9	57.6	25.2	35.9	53.1	26.5	24.9	93.0	17.2	32.8	25.8	37.5	65.5	39.4	35.7	43.0	59.0	15.1	37.1	85.7	58.9	16.8	14.9	58.5	34.7	45.8	81.1	29.0	53.6	32.9	29.8	31.4	37.4	36.4	183.4	76.2	26.6	14.2	38.6	36.8	9.5	61.8	44.5	48.0	68.4	44.0	60.0	28.8	94.5	102.5	40.4	35.9	68.1	19.8	50.0	26.3	35.3	26.4	68.4	46.0	104.4	71.0	131.1	30.0	91.3	50.3	113.6	29.8	35.5	30.7	78.1
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73489308-73525587	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA		82000000	"Cluster 30: Non-specific - Translation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	7265.1	5743.3	2531.3	4576.8	2717.1	10489.1	10504.6	2524.2	2783.1	7953.2	2902.2	6991.5	4783.5	7397.5	7203.8	6302.2	9034.9	4902.1	4074.6	2309.3	2687.4	7520.3	6459.1	4891.3	8813.5	2792.2	2572.6	12627.2	10370.0	6942.9	3776.4	5545.3	2828.4	5639.5	6936.4	2200.9	8381.0	6045.9	1682.1	7151.8	5076.6	7695.8	2980.6	5912.7	5776.4	1701.2	2687.7	8091.2	8348.4	1938.8	11294.9	6993.4	6470.3	2900.2	5218.1	8235.8	8697.0	13940.8	18183.0	32963.3	7874.7	7061.7	21384.2	10632.9	10044.2	12591.7	8020.5	20786.6	9976.7	13824.2	6089.1	5849.1	11729.0	15249.9	9969.0	3868.8	7099.6	7824.7	6142.2	13619.5	14708.8	15773.6	9201.9	26454.1	27514.4	7357.6	24803.6	17437.1	14783.4	8434.8	15242.2	7357.1	13131.5	8385.7	7184.5	17411.3	10348.2	6259.3	4400.0	14212.5	15389.7	26105.5	12201.5	14719.8	8337.9	8853.1	3931.6	10026.7	17535.8	9067.6	6928.7	24671.0	11535.0	4637.5	6195.9	3343.0	9206.4	7296.2	6913.1	5011.8	4780.9	12625.1	7404.1	2888.1	8472.3	895.8	7474.9	7600.7	14243.9	10580.7	12006.0	10174.3	8618.3	8426.8	13912.6	12049.7	681.7	9555.0	7680.9	6461.2	9278.5	26796.5	2531.3	2717.1	2524.2	2783.1	2309.3	2687.4	2792.2	2572.6	2828.4	2980.6	2687.7	2900.2	4915.6	3169.9	6059.2	107.4	11291.6	9829.9	12187.6	10417.5	11667.5	978.9	10528.4	9476.3	160.6	6258.2	5739.8	2637.3	546.3	9401.2	8653.6	2189.4	10344.0	5796.3	1373.9	4535.2	6754.2	5952.7	3862.8	6396.8	84.5	10404.1	12700.2	5756.1	4472.5	5831.2	3736.3	5732.4	6124.7	3323.0	6415.2	494.6	109.3	6969.3	3289.7	7779.7	8970.1	2325.8	8931.5	6705.0	5112.0	175.2	18016.6	3733.0	8468.7	76.9	162.0	7231.8	5821.6	7213.5	6811.7	11638.2	7494.7	14215.0	2974.6	1469.9	3536.8	7040.7	7075.1	1092.8	703.6	12784.4	10055.1	11086.8	9616.5	6982.9	8574.9	16180.0
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		840000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: AB_2674422"	"prognostic favorable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	586.3	402.8	181.5	255.4	188.7	685.9	567.1	177.3	262.6	586.6	236.1	512.2	341.2	453.9	131.2	768.3	515.6	144.0	357.5	171.5	181.9	416.1	445.8	357.3	460.2	185.0	181.1	807.9	1586.9	95.6	219.8	139.5	188.0	357.5	292.3	53.0	468.0	147.5	1038.4	764.6	574.1	192.1	192.7	576.2	491.0	163.3	185.5	346.3	266.6	372.2	444.7	487.7	572.5	190.1	278.2	330.0	377.0	357.3	542.8	914.1	816.4	584.5	556.7	560.1	367.4	733.1	454.2	792.3	358.8	648.9	310.4	352.7	520.1	647.3	509.3	245.8	469.2	562.2	442.9	998.5	719.8	1189.2	483.1	932.9	755.6	418.1	939.0	545.0	605.2	629.9	782.8	644.2	628.0	568.2	946.5	916.2	552.5	628.0	565.3	731.7	796.0	1007.4	606.0	521.8	384.1	395.2	211.1	461.8	588.8	439.8	283.3	1349.0	431.1	290.9	403.6	391.7	529.1	681.5	631.0	918.3	338.7	751.5	224.1	93.9	357.8	44.1	432.5	370.9	794.4	1075.6	761.7	576.5	676.4	848.7	1075.2	897.6	47.9	609.1	298.1	650.3	448.7	1770.3	181.5	188.7	177.3	262.6	171.5	181.9	185.0	181.1	188.0	192.7	185.5	190.1	614.8	198.7	346.8	9.4	2022.8	1142.4	1787.7	737.1	1367.0	114.5	1353.8	2138.0	164.5	619.1	474.5	163.7	27.1	853.8	1097.6	591.9	688.7	756.0	187.8	284.9	1021.6	596.6	445.0	1188.1	13.0	1883.8	1657.1	597.5	575.4	403.4	547.2	1584.1	461.2	682.3	823.0	52.2	12.6	1316.9	270.6	826.2	1008.4	463.5	866.7	868.0	533.6	11.2	1049.6	193.2	924.8	6.0	15.4	890.3	990.9	483.7	1393.5	1529.4	1952.4	1222.5	228.5	117.9	269.5	615.5	748.0	153.7	287.4	2237.4	1259.6	950.5	1228.8	1381.0	1734.8	1525.9
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: AB_2681305"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	556.9	600.9	278.8	254.4	299.8	474.5	552.1	276.4	339.0	638.4	302.9	716.0	205.3	497.5	228.5	524.8	523.0	179.7	795.4	267.2	277.0	491.3	582.9	435.3	380.0	303.4	283.3	979.4	1349.3	160.2	328.0	147.2	292.4	609.2	148.3	67.1	577.0	201.9	916.1	615.8	505.9	179.9	281.5	609.6	634.3	288.1	281.7	338.7	504.0	433.0	307.3	538.2	554.0	322.1	454.8	644.8	284.2	246.0	251.0	307.0	314.2	344.2	438.4	536.7	424.0	886.7	420.0	345.5	352.2	386.6	160.4	441.8	295.3	556.0	231.7	274.8	487.6	340.6	1211.8	881.5	373.6	214.1	276.9	594.8	796.6	325.1	367.8	309.6	364.5	282.0	325.2	497.6	309.3	1456.4	838.7	539.7	300.3	580.3	852.3	367.2	204.4	681.0	466.3	757.9	280.0	301.6	300.1	726.3	762.5	174.1	544.3	535.7	285.2	309.9	914.8	465.5	757.5	335.2	142.9	380.2	348.4	431.6	275.3	268.2	535.1	259.6	880.1	503.5	1128.3	1400.1	1110.3	922.6	619.1	1461.9	1365.3	1110.3	408.6	864.7	458.9	874.2	1191.8	2020.0	278.8	299.8	276.4	339.0	267.2	277.0	303.4	283.3	292.4	281.5	281.7	322.1	652.3	163.5	415.9	47.7	1397.8	1846.0	1620.8	1277.4	1438.7	75.7	1568.2	2028.8	3.9	732.0	600.3	342.1	20.9	665.5	942.8	718.8	855.0	751.4	413.0	173.0	441.3	705.7	343.3	639.1	11.3	1793.7	822.0	699.2	520.9	263.8	446.1	931.0	871.7	792.9	799.6	79.1	13.0	971.5	526.9	1361.3	1492.3	1087.1	891.3	823.6	1085.1	17.8	1400.9	502.7	1071.1	15.6	30.2	938.4	799.5	633.1	1098.8	1566.2	998.9	1552.3	241.7	88.9	479.9	1005.6	844.4	34.0	142.2	969.5	1648.6	712.5	1297.8	573.3	870.0	1619.4
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559596-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040688, HPA055316"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		2500000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus"	"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	1237.6	883.6	646.7	951.1	663.7	1897.3	1890.9	640.9	722.0	1595.1	659.8	1229.0	1094.9	1078.6	1079.3	1634.9	1555.9	749.8	1089.3	616.4	690.9	1162.4	885.3	818.1	1532.7	678.1	661.0	2604.5	2191.5	835.7	708.1	780.5	675.9	1219.1	1272.4	416.0	1588.0	875.6	4810.2	2215.7	1098.5	991.5	690.1	1073.0	1090.2	441.9	677.4	1281.7	1050.2	3030.5	1951.7	1173.7	1440.6	676.7	1773.6	1824.3	1859.1	2656.2	2742.6	3529.1	1866.2	1505.0	2692.9	1830.1	1392.3	2045.9	2161.9	5161.2	2365.4	2392.2	1048.0	2018.3	2229.8	2200.1	1663.3	1693.2	2071.2	1348.7	2061.8	2120.7	2974.2	2810.2	1523.6	4060.8	3913.9	1812.1	4419.8	3014.9	2562.7	1777.2	2755.8	2451.2	2190.6	3611.0	3035.5	4895.3	2304.9	1546.3	1575.0	2545.1	2390.9	4978.7	2454.9	2276.4	1608.2	2002.3	901.7	3010.3	4214.5	1179.1	3496.3	3012.0	1759.8	1057.1	1476.4	2070.0	1338.6	1680.0	1783.1	2609.2	1210.8	2005.2	1517.1	883.9	2365.5	589.6	2182.3	2151.6	4333.1	5399.6	4153.2	2825.0	3623.0	5080.7	6117.7	4188.5	320.6	3285.2	1837.0	2869.7	3307.5	11090.3	646.7	663.7	640.9	722.0	616.4	690.9	678.1	661.0	675.9	690.1	677.4	676.7	2.8	150.6	366.9	14.4	403.6	7.9	2.5	8.8	1021.0	0.5	21.9	10.3	0.0	14.3	300.8	1.8	2.1	17.7	9.6	63.7	3.9	124.8	4.3	2.2	7.2	70.2	148.5	405.0	8.4	188.5	26.8	149.5	252.8	3.5	375.6	1.8	11.0	4.9	12.5	0.0	13.8	152.0	4.1	8.8	4.9	18.8	3.1	134.7	1.8	24.4	126.4	0.8	16.5	6.0	13.0	114.9	121.0	2.2	770.5	3.0	132.1	12.1	152.0	0.5	0.0	1.6	43.9	1.4	0.8	1166.7	6.1	21.1	235.3	1.1	223.8	2.3
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985463	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	1022.6	1037.0	771.8	507.3	755.2	920.3	946.7	737.2	1059.6	966.7	807.6	1122.4	821.4	887.6	563.7	1062.3	857.3	501.2	1396.6	740.9	729.1	843.2	1152.9	666.9	685.4	775.4	769.6	1627.6	3194.1	494.0	838.0	386.2	782.3	819.2	344.5	224.7	1276.4	500.3	2322.6	1142.7	798.9	385.4	758.3	721.6	1266.6	490.5	762.7	541.0	793.6	1112.4	499.0	927.8	797.7	745.1	1456.8	1018.4	579.3	1539.4	1515.6	2706.7	830.9	1110.4	1479.8	1036.7	1012.7	1618.1	652.7	3000.6	644.1	1032.3	461.1	1069.8	919.4	1719.4	544.2	755.0	1533.0	768.5	919.9	1677.0	2204.8	1668.0	1277.6	3515.5	1777.2	916.0	1404.1	1497.5	1086.6	1434.4	1526.7	2145.4	642.1	2095.7	1510.1	1266.3	1537.0	518.3	1015.7	1654.2	860.3	1938.3	871.2	1270.2	1575.4	1466.4	699.0	1377.1	2058.3	543.1	1344.7	1992.7	1321.8	738.2	765.7	1521.4	1738.7	2276.4	1644.3	1485.3	1100.4	2065.8	986.6	81.2	455.7	64.1	259.8	333.1	460.2	578.5	453.0	344.6	430.7	478.1	497.2	404.1	43.1	355.3	342.1	358.7	429.4	756.5	771.8	755.2	737.2	1059.6	740.9	729.1	775.4	769.6	782.3	758.3	762.7	745.1	323.1	221.2	392.2	24.5	1125.5	1321.1	1071.3	754.3	1269.7	212.6	981.3	694.3	627.9	597.7	448.3	255.6	77.2	958.1	535.9	556.9	986.1	716.0	799.2	318.2	675.4	568.2	744.2	934.8	23.2	1816.8	1305.0	679.7	619.3	428.5	373.4	596.1	656.8	690.6	610.1	203.6	28.9	982.1	411.0	885.4	859.5	1195.6	1008.4	514.2	645.7	36.5	907.5	429.1	614.8	27.2	42.2	868.2	815.5	832.8	992.8	1010.5	1562.7	1078.8	194.5	134.1	585.1	797.7	697.3	371.5	308.4	1343.0	1347.1	1243.1	727.1	1044.3	1168.4	1051.6
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 122.8;Leydig cells: 93.5;Muller glia cells: 84.8;Peritubular cells: 107.2;Smooth muscle cells: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 159.7;fHDF/TERT166: 232.6;HSkMC: 155.3;hTERT-RPE1: 159.1;LHCN-M2: 134.5;U-138 MG: 114.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	38.4	18.0	19.8	13.8	21.1	2.8	29.5	18.8	26.7	46.6	22.1	39.6	9.3	55.2	8.3	12.8	35.8	33.5	61.6	19.1	20.4	26.8	7.0	32.1	9.1	24.9	20.0	47.0	19.9	26.8	15.2	22.4	21.4	31.1	6.5	5.9	17.4	35.2	21.2	14.9	16.2	32.3	20.3	16.1	20.6	8.2	21.4	5.6	39.1	22.0	5.0	33.1	30.7	19.1	0.5	0.2	2.1	47.3	54.3	108.0	0.8	125.8	159.7	48.1	44.8	0.0	4.3	0.7	9.3	232.6	0.7	0.9	0.0	1.3	12.1	5.4	0.1	1.1	3.2	8.0	89.1	0.0	0.4	155.3	0.4	18.9	1.0	159.1	28.5	1.0	0.3	8.0	134.5	0.4	0.2	20.7	1.6	0.2	0.6	0.4	0.3	3.2	1.6	0.6	0.7	14.1	0.2	1.3	1.5	6.6	1.5	10.0	64.6	114.2	24.7	52.6	0.6	10.9	0.7	0.3	42.6	0.8	19.7	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	0.2	19.8	21.1	18.8	26.7	19.1	20.4	24.9	20.0	21.4	20.3	21.4	19.1	30.8	35.3	7.4	29.0	1.5	13.5	38.9	33.9	8.6	7.7	10.2	27.6	46.0	15.7	11.4	18.4	0.0	2.4	2.3	0.3	7.9	28.7	15.6	3.4	57.1	27.9	0.0	0.4	1.1	0.2	3.9	122.8	2.6	4.1	0.0	74.3	42.8	1.8	9.8	6.7	2.9	0.3	4.1	3.5	19.1	33.3	93.5	3.0	24.9	9.4	0.7	84.8	2.1	9.5	1.6	2.6	0.1	107.2	1.4	30.1	0.2	21.2	9.0	4.8	39.5	41.1	113.2	35.9	3.3	1.1	10.1	5.9	2.4	78.5	0.3	14.2
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68829021-68842160	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	47.0	23.7	9.3	8.2	9.5	2.3	41.2	8.7	11.8	27.1	8.7	27.6	19.1	19.4	10.7	32.0	19.6	18.3	32.5	9.1	8.9	44.0	11.6	41.6	4.3	9.4	9.1	14.3	7.6	16.5	10.3	25.4	8.9	19.8	13.2	1.2	11.2	16.2	9.1	52.5	20.6	8.8	9.6	26.1	18.1	6.3	9.7	5.6	19.6	9.5	4.8	25.9	27.9	9.3	10.4	5.3	41.9	15.6	21.7	13.4	21.9	8.7	9.5	3.8	2.8	4.8	19.0	2.5	56.7	3.3	5.0	54.3	40.0	97.0	2.1	4.3	10.2	2.6	2.3	8.5	20.0	1.9	21.3	25.0	74.1	9.4	42.4	3.4	29.3	5.3	2.8	0.2	3.3	8.5	4.2	2.0	29.0	63.5	70.9	18.6	4.4	16.6	15.9	36.1	15.6	7.5	6.7	2.0	2.6	31.7	1.6	3.6	49.7	7.2	8.9	19.6	3.3	0.1	2.3	2.5	3.6	11.3	4.7	0.0	0.6	0.3	0.4	1.7	0.3	0.3	0.4	0.4	3.5	0.2	0.3	0.2	0.1	0.7	1.1	0.5	0.2	0.5	9.3	9.5	8.7	11.8	9.1	8.9	9.4	9.1	8.9	9.6	9.7	9.3	81.1	3.2	1.1	2.6	3.2	117.3	66.2	60.7	93.4	3.3	3.6	11.2	8.2	20.0	12.8	22.0	0.0	11.4	5.9	59.4	0.0	16.4	0.4	2.6	7.6	42.4	8.4	2.7	1.0	15.6	75.9	20.5	21.4	4.5	4.5	134.5	143.5	4.8	12.4	1.7	1.0	27.6	8.2	9.1	23.8	1.3	27.4	8.6	21.4	2.8	5.9	12.5	2.1	0.5	0.6	46.3	52.6	8.2	2.3	40.2	28.6	5.7	2.8	1.3	13.1	8.7	12.5	2.0	3.8	76.2	120.5	11.2	4.7	116.2	29.8	93.6
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489745-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 239.7;Hepatic stellate cells: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		940000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	20.7	6.1	3.8	4.3	5.9	0.2	17.1	1.3	6.2	11.0	0.0	22.1	7.9	10.2	0.7	12.1	8.8	4.2	15.5	5.5	4.9	11.2	4.8	23.4	3.2	0.1	0.1	7.2	3.9	3.2	6.3	15.4	0.3	12.5	9.9	3.2	14.0	10.6	6.5	17.2	14.4	5.5	0.1	7.4	15.0	5.4	1.6	3.6	11.9	8.0	3.2	6.5	14.1	4.3	23.3	1.8	76.5	0.1	0.2	0.7	0.3	10.8	5.4	8.2	4.7	19.1	28.7	0.0	11.0	2.5	0.6	28.4	2.9	10.9	8.9	0.0	24.3	0.1	6.0	0.0	1.5	6.9	0.6	3.5	19.0	0.4	16.1	4.1	10.4	0.2	0.1	0.0	9.1	3.3	0.2	0.1	4.7	45.5	5.0	21.9	3.3	0.1	11.9	2.5	5.8	42.7	3.6	1.7	0.1	21.4	1.0	0.2	9.6	16.3	0.0	0.5	23.8	0.4	0.0	0.0	34.5	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.9	1.3	6.2	5.5	4.9	0.1	0.1	0.3	0.1	1.6	4.3	239.7	6.4	35.7	38.8	4.4	83.2	52.9	15.4	13.1	10.4	39.8	45.3	8.8	5.7	13.2	25.8	0.0	1.4	8.6	114.6	0.0	6.8	0.4	24.7	69.8	106.5	50.6	0.0	49.3	1.4	3.1	15.4	69.3	42.1	17.8	11.8	187.4	1.3	1.1	6.7	29.7	59.8	26.4	5.8	11.9	1.0	0.3	4.0	32.0	48.7	0.0	89.1	0.0	3.5	13.9	46.3	64.3	0.4	1.0	25.1	15.9	0.2	8.7	3.4	0.0	33.1	22.8	0.7	3.3	41.1	86.0	1.9	7.9	6.4	71.5	72.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912883-110013766	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 110.2;pancreas: 89.5;skeletal muscle: 29.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA	209000	680000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.0	0.0	1.0	0.1	1.0	0.2	14.7	0.2	0.8	0.0	0.2	0.8	0.0	0.4	2.4	0.7	0.3	1.0	2.8	0.9	2.0	110.2	0.0	0.5	0.0	1.4	0.9	0.0	89.5	0.2	0.4	0.0	1.5	1.4	1.1	13.6	15.7	0.4	29.6	0.7	0.2	0.5	1.2	0.1	0.0	0.1	0.7	0.0	3.0	17.4	0.0	0.4	0.1	1.8	0.2	0.2	1.9	0.0	0.0	0.1	0.0	0.4	1.1	0.5	0.4	0.1	0.0	0.0	6.4	0.6	1.6	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.6	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.1	0.6	0.1	0.0	0.0	2.3	0.0	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.0	11.6	0.4	1.2	2.8	0.0	0.0	0.9	1.3	0.0	3.6	0.0	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.0	1.0	0.2	0.8	0.9	2.0	1.4	0.9	1.5	1.2	0.7	1.8	0.1	0.0	0.0	3.3	0.0	1.0	0.2	0.1	0.0	1.0	12.9	8.1	8.2	0.0	0.5	0.0	0.0	0.0	0.2	2.0	7.9	0.2	5.6	0.2	0.1	0.6	0.0	0.0	8.5	5.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	11.2	0.1	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	26.2	0.0	1.5	0.3	1.0	0.4	0.0	0.0	1.1	0.1	1.2	1.0	1.2	0.0	8.2	0.2	0.5	0.4	0.0	1.4	0.0	0.1	0.1	1.6	0.3
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 287.9;Skeletal myocytes: 251.2;Syncytiotrophoblasts: 376.8"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"A-431: 5282.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	88000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	27.9	11.4	12.6	4.0	18.3	0.0	20.0	16.6	9.7	20.4	10.5	12.2	5.7	11.4	10.3	23.5	13.9	9.0	7.1	6.3	10.3	11.6	35.3	14.9	2.5	10.4	19.0	15.1	15.8	3.5	2.9	67.9	8.9	16.2	10.7	10.2	22.1	15.0	10.9	51.0	9.5	9.3	7.5	5.1	11.1	4.2	22.6	12.8	20.6	20.6	8.3	14.7	24.1	6.3	5282.1	61.9	16.5	22.4	102.7	63.5	16.7	47.9	68.7	30.8	23.8	11.5	54.2	2.7	11.4	43.8	130.7	197.1	0.4	230.2	37.1	2.2	3.6	0.1	27.3	3.4	27.0	0.0	0.2	31.2	205.4	74.1	409.9	45.5	4.0	0.0	0.0	0.5	68.0	3.0	0.1	0.1	5.1	21.2	30.4	0.1	9.1	0.2	38.1	52.6	0.8	20.0	42.7	50.6	9.3	16.8	4.9	12.0	15.6	27.1	7.2	215.7	45.8	0.1	4.8	3.1	37.9	1.6	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	16.6	9.7	6.3	10.3	10.4	19.0	8.9	7.5	22.6	6.3	16.4	96.1	49.9	147.6	1.2	85.8	77.1	101.5	116.1	3.5	12.1	30.4	11.1	47.1	50.6	22.0	6.2	287.9	0.0	45.9	0.0	32.9	4.9	25.9	57.2	12.5	4.2	8.0	1.2	24.3	37.1	91.6	22.4	39.8	0.0	50.6	6.8	79.5	28.3	0.0	107.5	21.6	48.8	7.7	11.6	5.8	128.3	1.9	17.8	40.3	1.6	90.0	0.0	63.3	1.4	54.8	19.9	133.5	0.0	75.4	14.1	13.4	21.7	3.8	78.9	251.2	34.7	2.4	2.5	73.3	89.9	376.8	2.2	41.9	24.9	55.8
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231422287	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 190.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 29.1"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 29.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavorable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	32.8	35.6	37.5	18.1	40.8	20.0	23.9	38.8	43.2	26.3	31.6	30.0	34.0	30.8	24.5	33.6	24.2	28.2	58.7	39.9	37.2	38.8	56.5	19.1	21.1	41.6	39.0	37.5	40.0	39.0	9.3	42.6	36.8	23.8	26.1	49.9	22.0	30.3	190.7	48.6	35.5	27.6	40.9	27.6	19.1	17.1	43.4	16.7	25.5	153.4	21.3	27.0	12.0	40.9	54.2	59.9	17.5	33.7	44.8	29.4	15.8	22.7	42.2	36.3	49.4	41.3	48.0	15.5	41.7	42.4	31.7	25.1	26.8	30.1	61.0	18.6	42.5	6.7	23.5	37.7	31.5	38.5	8.1	25.4	27.5	24.9	34.2	58.6	49.3	18.5	33.9	37.9	38.3	12.2	8.9	14.4	18.4	33.4	21.0	20.0	21.7	22.7	48.0	23.4	15.9	45.3	32.9	41.4	83.1	11.2	22.4	112.8	54.3	44.3	20.8	40.5	47.2	65.7	46.4	14.7	60.4	14.0	59.4	4.2	0.5	3.1	1.2	1.0	0.7	0.7	0.9	0.8	0.8	0.7	1.0	1.8	29.1	1.6	1.8	0.7	0.5	0.4	37.5	40.8	38.8	43.2	39.9	37.2	41.6	39.0	36.8	40.9	43.4	40.9	64.7	19.2	23.2	36.6	19.8	58.5	15.0	10.7	33.0	32.3	19.4	13.3	111.9	67.2	11.6	18.4	37.5	16.2	16.6	57.6	35.2	37.8	1.2	18.5	20.2	60.6	12.7	8.2	43.9	36.2	34.2	25.9	15.3	21.2	10.1	55.6	28.9	70.6	16.9	62.2	52.6	24.6	16.2	24.1	45.3	5.0	16.1	29.8	26.6	44.0	19.0	56.9	12.3	46.3	48.3	36.6	30.9	23.0	23.9	15.1	43.2	52.3	13.5	44.0	19.7	36.4	36.6	13.1	20.9	24.9	57.5	10.4	24.9	16.0	23.5	21.3
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808434	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 269.1;Late spermatids: 740.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	57.6	58.5	99.3	50.0	99.8	52.1	47.6	95.1	140.9	70.0	79.6	65.4	34.3	53.9	31.5	40.2	45.5	39.1	67.8	103.4	96.2	54.2	57.7	74.3	62.4	97.3	99.3	59.0	36.6	27.7	44.5	48.3	97.7	59.9	28.5	16.6	39.2	45.1	40.0	27.4	46.7	40.9	90.5	116.8	47.6	232.1	99.9	41.9	55.8	40.8	44.1	57.9	57.9	98.1	46.5	123.4	55.9	54.4	71.1	51.5	36.5	49.4	41.1	68.9	75.4	102.8	45.7	41.1	41.1	59.3	62.5	29.3	70.8	56.3	36.4	51.7	40.5	54.8	76.4	39.4	76.1	42.7	71.6	63.9	58.5	65.8	37.4	43.3	86.0	44.3	79.3	37.3	73.4	32.9	78.9	70.2	48.7	72.4	42.6	72.7	27.7	27.8	74.0	70.2	51.4	46.9	80.9	62.9	67.2	47.2	83.4	114.0	80.5	85.9	61.7	35.7	59.5	18.7	29.6	75.6	63.0	61.4	65.5	93.2	72.5	190.5	85.8	83.4	91.1	85.2	101.7	90.3	62.6	90.0	105.2	89.6	261.6	61.4	82.3	45.5	100.2	110.5	99.3	99.8	95.1	140.9	103.4	96.2	97.3	99.3	97.7	90.5	99.9	98.1	2.8	22.4	16.8	0.0	43.9	48.8	55.2	33.8	17.6	40.5	3.3	0.8	22.2	31.5	30.7	3.7	14.6	58.1	19.0	83.0	0.0	15.8	269.1	0.9	1.5	49.9	44.9	30.7	0.0	10.1	26.5	27.6	23.9	1.2	17.2	0.8	72.8	33.7	66.7	21.9	0.0	33.9	48.8	39.8	62.4	740.8	63.0	26.3	40.9	0.0	38.5	24.4	60.8	0.0	0.0	14.0	71.0	52.3	8.7	67.6	54.9	1.4	23.0	17.8	39.5	14.6	17.2	159.4	52.5	14.2	38.4	132.6	33.2	2.1	43.7	69.8
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465479-138469303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 1113.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 133.1"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 7.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.1;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	565.5	354.0	7.5	135.4	15.9	176.7	173.9	133.1	70.1	302.5	10.0	246.5	54.8	197.6	13.5	370.9	911.7	345.2	258.8	20.7	30.4	173.2	149.5	173.4	145.2	9.9	13.2	974.6	137.0	93.5	243.3	54.2	12.9	309.7	161.1	56.0	140.9	84.4	66.0	363.1	107.2	474.3	4.4	77.5	254.5	26.9	10.4	301.5	584.4	354.9	19.1	191.4	115.9	19.5	21.8	0.9	45.0	67.6	119.6	192.0	5.1	36.7	22.7	48.4	39.0	26.4	18.9	1.1	5.9	80.2	165.8	10.1	2.6	74.5	22.2	1.1	3.3	3.0	11.5	7.6	15.5	8.0	57.8	15.2	286.6	43.2	9.8	37.6	4.2	53.9	112.5	26.0	14.3	108.2	3.2	34.1	4.1	80.3	0.1	0.8	6.7	4.1	36.8	13.1	56.5	6.4	44.7	120.1	106.6	43.3	1.5	6.6	1.8	17.5	22.6	8.7	14.2	60.1	478.8	8.6	20.3	103.5	5.2	0.0	2.6	0.3	0.1	3.6	0.0	0.7	0.1	0.0	0.7	0.2	0.1	0.1	7.1	0.1	1.2	0.0	0.2	0.5	7.5	15.9	133.1	70.1	20.7	30.4	9.9	13.2	12.9	4.4	10.4	19.5	920.4	275.7	485.6	6.8	116.4	181.8	719.6	207.4	816.1	43.5	550.0	459.0	652.4	420.4	124.0	29.5	64.6	159.5	46.2	645.2	7.9	255.4	1.4	356.0	836.5	383.1	960.5	27.3	20.3	101.7	110.1	989.9	736.0	645.4	354.0	274.8	347.0	183.1	131.4	3.3	2.7	747.6	93.6	218.6	109.7	3.8	164.7	300.7	106.7	20.6	8.6	191.6	0.0	1.5	2.4	135.3	380.8	53.0	67.2	405.1	224.8	5.7	127.4	101.3	223.5	1113.1	613.2	3.2	2.9	644.8	200.3	129.7	83.4	104.9	480.2	145.4
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 203.4;Early spermatids: 220.3;Excitatory neurons: 262.3;Inhibitory neurons: 245.4;Late spermatids: 495.6;Oligodendrocyte precursor cells: 226.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (1.95e-8)"	30.0	17.2	15.1	10.7	16.3	6.4	17.4	27.7	19.3	29.0	11.7	41.9	9.7	31.1	7.9	29.5	21.3	20.4	11.7	20.0	16.5	17.1	53.9	11.6	8.8	13.3	22.1	48.0	15.9	15.2	12.2	11.9	14.1	16.0	14.2	20.9	15.7	18.6	8.0	13.0	14.9	30.0	10.9	8.1	17.5	37.4	22.6	13.4	14.4	13.1	10.2	18.1	21.6	16.2	49.7	66.9	26.8	16.4	46.1	89.0	27.2	43.6	42.4	31.6	25.9	80.4	36.2	34.2	15.4	79.8	47.5	29.1	35.1	30.5	51.9	36.3	16.5	29.7	22.9	95.2	31.5	17.5	21.5	40.9	54.1	31.6	61.9	31.3	20.5	26.7	20.6	19.1	51.1	19.4	20.0	10.9	26.3	40.8	26.2	17.8	33.8	14.9	20.8	16.1	29.6	23.6	35.1	25.9	43.0	28.5	12.6	17.0	15.2	33.3	34.4	55.8	23.0	21.5	16.2	32.7	33.3	26.3	69.4	0.2	2.2	2.5	4.1	2.4	4.0	6.3	4.2	3.9	3.7	4.9	4.2	3.6	0.8	3.4	1.3	2.4	2.5	2.2	15.1	16.3	27.7	19.3	20.0	16.5	13.3	22.1	14.1	10.9	22.6	16.2	29.0	38.5	18.8	203.4	10.4	15.6	12.0	27.1	43.3	39.7	10.5	12.8	15.2	22.8	20.7	14.7	4.2	10.9	9.9	5.3	15.6	22.1	220.3	10.3	45.4	19.9	16.2	8.8	262.3	40.5	30.1	36.6	9.2	12.1	2.5	15.2	30.0	59.6	5.0	18.5	245.4	5.4	6.1	8.6	11.4	495.6	58.4	7.6	10.6	119.0	6.5	20.1	13.4	226.7	98.7	41.7	5.0	40.3	9.6	13.9	11.4	15.1	14.5	17.8	6.6	33.1	19.4	53.7	31.1	55.4	14.2	2.9	12.7	18.2	8.1	13.1
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 151.6;testis: 159.9"	"Group enriched"	"Detected in all"	10	"Early spermatids: 1033.0;Late spermatids: 1950.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"		NA	NA		10000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	39.7	25.4	21.5	59.7	26.6	151.6	21.8	38.6	32.6	26.2	18.2	32.3	33.8	28.1	8.4	26.0	27.0	25.0	39.3	24.9	26.8	31.2	22.0	44.7	65.6	32.7	28.2	13.6	11.1	8.9	7.0	35.4	29.9	18.8	14.5	3.0	16.6	20.9	32.1	34.4	38.5	28.3	31.0	74.4	29.3	159.9	30.5	28.9	19.3	31.5	50.3	55.3	23.0	33.4	109.4	74.1	26.2	28.9	31.2	50.2	15.4	108.2	97.4	89.5	51.8	96.5	66.2	142.0	37.8	129.9	76.5	86.6	27.3	108.9	34.5	89.5	15.2	94.8	37.1	49.1	36.8	30.9	24.6	22.8	22.9	138.7	43.2	40.6	89.8	27.6	39.6	243.8	68.7	57.8	62.5	51.4	17.5	27.5	95.9	24.8	83.5	49.9	84.5	35.7	18.6	16.6	60.8	109.3	48.6	29.5	149.2	21.8	127.9	39.6	35.4	106.0	52.6	100.2	48.5	112.1	103.3	40.1	22.0	18.0	13.9	99.6	39.0	16.1	39.2	24.0	27.3	33.8	7.2	18.2	16.2	23.1	57.1	25.4	33.7	8.7	31.8	30.7	21.5	26.6	38.6	32.6	24.9	26.8	32.7	28.2	29.9	31.0	30.5	33.4	31.2	76.9	30.3	4.2	46.0	67.3	52.8	39.4	17.6	3.8	28.8	24.8	29.2	18.6	22.9	14.7	2.1	88.6	76.5	75.9	7.9	29.4	1033.0	41.9	24.4	29.3	6.6	19.8	1.7	40.8	24.5	32.4	25.5	54.9	93.8	37.2	10.4	10.9	32.2	5.0	3.5	27.7	12.2	37.4	61.0	1950.6	30.1	79.6	26.6	1.9	34.3	5.9	78.2	2.5	12.2	101.5	47.7	27.1	50.8	28.2	38.9	41.9	16.5	2.8	78.9	47.9	53.5	55.0	27.4	19.9	49.2	137.0	71.7	19.8	22.1	42.7
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234152-31269451	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.7;esophagus: 43.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 5.6"	"Lineage enriched"	"Detected in many"	7	"B-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		15000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.5	9.1	20.5	5.9	29.5	1.9	3.2	10.5	38.7	5.5	1.1	2.5	1.6	4.4	3.0	43.9	4.5	3.4	15.9	29.5	18.5	20.0	11.0	5.7	6.8	11.7	17.8	2.5	1.3	21.1	9.1	11.7	13.9	5.5	1.7	9.0	5.9	4.4	2.3	3.1	3.7	4.6	9.6	7.3	2.2	1.3	31.1	2.7	3.2	5.1	11.1	6.6	6.0	26.2	1.8	8.4	4.5	3.9	7.5	11.3	0.7	79.7	192.2	7.5	6.9	0.0	0.9	0.6	2.9	26.0	6.5	0.8	0.2	5.2	5.3	3.2	7.1	77.4	0.4	0.0	25.7	0.0	0.2	18.1	2.3	7.3	3.0	20.0	0.1	0.2	0.3	0.4	5.6	12.6	1.0	0.1	17.7	0.0	4.3	2.8	0.3	1.8	5.8	8.9	2.2	12.1	0.8	1.3	0.0	14.1	1.2	0.0	0.0	5.8	5.4	0.3	6.5	48.7	6.5	0.1	14.8	0.0	12.4	0.6	0.5	0.5	2.1	1.0	1.1	20.8	1.0	1.4	0.5	5.6	0.9	0.5	1.2	0.8	2.8	0.0	0.5	10.2	20.5	29.5	10.5	38.7	29.5	18.5	11.7	17.8	13.9	9.6	31.1	26.2	1.9	0.0	0.0	2.6	16.2	0.8	1.8	1.7	10.2	9.7	0.6	6.2	24.3	5.7	0.9	0.0	0.0	4.1	0.6	0.0	0.0	0.5	0.1	0.7	2.3	8.4	1.8	6.1	17.1	0.2	8.4	3.3	1.1	0.5	0.0	0.4	120.3	5.0	1.7	0.0	11.1	0.1	0.0	16.1	0.4	0.0	1.2	5.9	0.0	4.7	1.1	9.0	0.0	22.6	5.4	0.2	0.1	3.0	5.8	2.6	0.0	0.2	0.4	5.9	19.7	3.0	7.0	0.6	2.7	10.7	0.9	43.9	1.4	0.7	0.1	4.7
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895933-41972557	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 189.5;Urothelial cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 103.8;TIME: 172.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		440000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	21.6	4.6	3.1	11.8	3.2	10.9	16.4	7.5	3.5	9.4	5.3	12.1	5.5	9.6	10.5	15.0	9.8	15.2	27.8	3.3	3.8	14.3	9.6	15.0	12.8	4.8	4.0	5.6	14.3	12.8	5.8	8.3	4.8	9.5	10.2	6.1	10.4	9.7	4.4	14.3	12.4	12.9	5.2	7.4	9.9	2.8	4.0	5.3	18.4	4.7	8.8	23.8	9.0	6.6	28.7	9.8	9.3	9.6	4.6	6.5	8.1	14.9	31.4	25.9	36.1	41.4	16.1	5.9	39.2	18.8	51.6	28.4	13.9	32.6	19.0	35.7	11.7	8.7	13.5	7.1	11.3	4.0	24.4	5.5	12.6	26.3	28.8	9.9	103.8	8.7	9.2	6.6	21.1	12.2	4.2	4.5	7.1	27.8	33.5	0.1	24.5	9.4	23.4	57.0	15.4	6.5	10.9	23.2	17.0	9.0	22.9	5.6	172.8	8.1	15.7	30.5	73.1	18.1	30.9	12.4	10.3	9.4	71.6	1.1	14.0	9.0	4.0	12.4	6.1	2.1	6.2	5.0	14.9	2.6	2.6	3.8	2.3	4.4	5.2	2.5	7.9	8.0	3.1	3.2	7.5	3.5	3.3	3.8	4.8	4.0	4.8	5.2	4.0	6.6	94.9	6.4	44.2	3.9	20.0	81.6	189.5	68.1	34.1	4.9	31.4	20.1	36.6	30.0	69.0	44.1	31.3	10.1	22.2	96.0	7.9	71.3	16.1	66.1	9.7	114.9	22.6	5.7	1.2	62.6	20.4	21.3	25.5	72.4	61.6	16.2	54.7	8.7	89.0	1.7	0.7	22.5	28.5	35.6	52.7	34.7	7.5	46.3	19.6	12.2	53.5	37.5	4.1	26.7	2.7	75.1	70.9	4.9	31.5	49.9	71.4	4.6	60.8	27.8	13.1	8.0	29.0	5.4	8.2	29.3	79.8	17.4	27.8	21.2	37.3	200.1
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 144.3;liver: 344.5"	"Group enriched"	"Detected in many"	10	"Hepatocytes: 289.0;Proximal tubular cells: 147.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	10.8	4.3	2.1	3.0	2.9	1.2	4.1	3.9	2.7	3.5	9.2	14.2	21.5	2.8	3.5	5.5	3.6	4.4	10.7	2.1	3.1	144.3	344.5	4.3	2.1	3.2	4.1	2.6	9.9	7.8	1.5	3.2	3.0	6.3	10.8	1.6	5.7	2.2	1.7	4.5	12.9	3.7	2.5	3.7	10.4	2.7	3.1	2.1	6.5	5.6	2.8	3.6	2.1	2.8	12.3	5.0	1.4	0.0	7.3	6.1	1.5	5.7	1.8	3.7	4.1	21.9	7.5	0.0	22.1	5.7	1.4	5.8	0.0	4.8	7.6	16.2	5.2	8.6	1.3	22.5	4.7	1.0	0.2	8.7	6.0	3.7	3.4	5.0	5.5	0.0	5.7	6.1	7.2	6.4	0.2	5.1	3.0	4.3	6.3	0.0	9.9	0.5	15.4	6.8	4.4	6.4	11.2	6.4	10.5	12.1	23.7	10.1	2.6	2.4	3.6	1.9	0.5	1.7	5.6	0.5	0.8	3.9	4.0	0.1	0.9	0.0	0.6	0.8	0.4	0.5	0.4	0.9	2.4	0.0	0.6	1.0	0.0	1.2	0.8	1.0	0.6	0.4	2.1	2.9	3.9	2.7	2.1	3.1	3.2	4.1	3.0	2.5	3.1	2.8	4.9	16.0	10.9	20.9	4.5	1.5	1.4	1.9	1.2	0.7	3.2	2.3	19.2	17.2	3.9	20.2	4.2	8.9	0.4	17.8	19.6	2.1	0.2	6.5	5.1	3.9	7.7	9.7	4.9	6.8	2.9	1.6	8.6	3.1	0.0	6.1	13.6	289.0	4.4	0.0	5.7	12.8	0.0	10.5	1.0	0.7	0.6	2.7	3.6	4.7	9.4	1.9	0.0	3.5	8.0	3.7	9.3	0.4	0.8	2.5	15.0	147.1	4.0	1.2	0.0	1.1	2.4	3.7	4.2	4.9	0.4	1.4	2.2	3.6	10.8	1.8
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618992-137870016	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 167.0;Plasma cells: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	17.7	18.3	11.0	22.3	12.0	30.5	18.2	16.0	12.3	17.0	13.8	19.3	18.8	21.5	9.7	19.1	18.1	14.0	13.5	8.6	8.3	11.0	14.4	15.8	29.6	10.7	10.2	19.9	14.9	13.8	12.9	15.0	11.1	16.2	13.1	13.7	18.4	13.9	31.4	19.3	19.6	15.1	4.4	25.9	18.2	40.5	12.7	22.9	19.6	15.0	21.2	18.3	16.2	19.9	26.7	52.3	57.4	53.2	23.9	24.6	48.1	34.5	21.4	24.7	20.2	34.7	32.5	81.6	32.7	26.0	29.9	56.2	34.8	37.8	19.2	45.3	24.7	34.4	54.2	22.4	20.9	52.9	39.5	22.6	25.9	29.9	28.9	18.1	41.3	30.1	52.6	27.5	17.9	61.9	62.5	26.3	56.0	42.1	34.8	79.3	49.5	47.2	20.7	47.7	50.6	41.1	65.4	45.4	15.3	40.6	51.1	42.0	39.0	28.9	29.5	44.8	33.2	17.2	52.0	67.0	21.3	27.6	32.0	19.5	16.2	21.2	18.0	14.3	11.3	16.4	15.6	15.6	12.9	23.0	14.9	13.5	28.8	17.3	15.6	23.3	14.2	9.7	11.0	12.0	16.0	12.3	8.6	8.3	10.7	10.2	11.1	4.4	12.7	19.9	34.3	19.2	19.2	130.6	64.9	17.5	23.4	26.9	32.5	39.7	30.5	26.7	31.5	25.8	24.7	22.0	52.1	23.8	36.9	24.4	3.9	24.1	86.8	29.3	44.8	29.9	28.1	31.7	74.4	21.0	21.8	27.6	45.3	40.6	18.9	55.8	18.9	41.7	19.7	50.5	76.4	22.2	10.2	25.8	18.1	167.0	35.8	26.9	12.4	71.2	31.2	19.7	51.5	64.3	104.0	25.4	30.3	37.6	170.6	34.9	20.7	14.3	22.6	46.8	13.1	34.7	28.5	80.4	51.9	35.3	20.2	26.5	38.9	81.3	23.8	28.8
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	8.6	9.6	0.5	0.3	0.4	1.0	8.7	0.4	0.5	15.1	0.2	12.9	2.4	19.8	1.7	10.1	12.8	0.0	5.7	0.4	0.4	7.1	4.6	7.3	1.0	0.4	0.5	16.1	7.8	0.6	12.8	0.7	0.4	10.3	0.3	0.6	9.5	1.3	5.5	9.3	10.5	1.4	0.4	11.5	9.4	12.6	0.5	1.5	10.3	0.4	1.0	13.1	11.3	0.4	0.0	4.5	7.8	0.0	3.4	1.8	5.0	3.5	2.8	3.9	3.2	0.0	0.0	0.0	7.6	5.7	4.0	0.0	0.0	8.6	1.8	5.4	11.8	0.0	0.0	0.1	0.0	13.3	0.0	4.6	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	9.4	0.0	19.3	0.0	0.0	8.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	6.5	3.1	0.0	0.0	3.8	4.1	3.1	6.9	0.0	11.0	16.1	3.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	16.9	16.0	12.0	22.9	20.3	8.4	6.3	11.9	26.2	60.6	15.9	17.8	6.6	17.2	18.9	25.8	41.7	24.6	13.4	9.2	7.9	15.7	41.5	10.1	19.1	16.1	22.6	19.3	16.6	12.2	15.0	16.0	13.3	11.8	14.5	33.8	22.1	7.5	16.3	38.7	24.4	16.4	12.2	12.9	7.3	60.0	27.4	12.1	19.6	9.4	19.9	26.8	25.7	20.1	23.9	10.8	9.1	23.0	16.5	6.2	12.5	10.1	10.8	48.2	26.3	16.3	15.0	20.8	33.7	23.5	11.1	5.6	18.3	19.9	19.0	5.2
EIF1	"A121, EIF-1, EIF1A, ISO1, SUI1"	ENSG00000173812	"Eukaryotic translation initiation factor 1"	P41567	17	41688885-41692668	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2792.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		210000	"Cluster 10: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (1.43e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.63e-3)"	490.2	274.6	232.4	151.0	272.6	755.1	403.2	271.3	257.8	323.1	172.8	380.7	178.8	317.5	76.5	344.1	318.0	150.3	491.2	217.2	265.2	346.9	267.9	330.3	160.5	277.0	255.8	402.2	487.4	213.2	253.3	143.9	282.5	216.2	99.2	185.0	304.9	136.3	1241.1	361.9	250.4	144.8	256.2	266.7	403.5	159.9	254.7	213.3	212.6	482.9	117.5	335.2	322.9	307.4	337.2	171.6	195.0	184.8	384.8	354.8	187.7	436.7	310.0	234.8	229.0	101.2	234.3	451.1	339.9	332.1	243.6	416.3	263.7	296.2	226.3	484.8	224.2	236.8	82.7	150.2	796.8	379.4	452.6	430.2	561.0	320.0	779.6	344.4	233.5	354.9	383.9	674.5	223.1	92.7	447.8	239.5	167.9	2792.4	326.7	224.6	419.6	453.7	207.4	157.9	240.4	307.6	263.5	485.0	1017.9	185.0	342.5	273.6	370.0	230.8	354.5	483.5	441.4	993.5	895.6	358.8	326.5	235.0	296.7	1141.9	365.4	462.9	250.5	438.7	310.3	328.3	337.8	293.8	293.8	309.3	347.0	306.8	358.7	220.9	455.7	291.3	428.9	590.8	232.4	272.6	271.3	257.8	217.2	265.2	277.0	255.8	282.5	256.2	254.7	307.4	3115.6	810.9	974.8	63.0	2362.0	3078.5	4610.8	3421.0	1812.6	838.1	1828.6	2567.4	1099.6	1512.7	1918.4	776.1	310.6	1507.4	2857.7	1521.7	4188.9	2108.4	2701.8	1405.1	1228.6	2033.0	963.1	1790.4	66.7	3096.1	2381.2	2059.4	889.4	1606.5	1287.6	948.4	1680.6	1403.6	2488.3	804.2	70.2	1539.7	2063.0	3165.8	3449.2	6637.8	1358.8	2644.2	2440.4	85.3	3560.1	1514.7	1829.0	35.2	153.8	2423.6	2131.0	961.4	1762.7	3063.8	3025.9	3169.3	1107.9	958.4	959.8	3290.6	3039.9	1114.0	825.4	1521.7	2932.9	3955.5	2533.0	1059.7	1428.5	5190.4
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150586016	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Uncertain	Mitochondria,Cytosol		No	No		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	57.0	54.0	14.5	47.8	18.5	86.8	103.4	27.2	25.4	63.9	21.9	57.8	65.5	69.7	46.9	64.7	62.7	55.8	72.3	16.6	18.4	72.2	75.2	47.7	68.4	17.1	15.3	94.9	107.2	62.8	32.8	52.4	18.5	52.8	70.8	52.3	77.2	47.0	87.3	74.0	55.3	68.4	18.1	47.4	59.7	24.3	15.1	68.7	92.1	76.7	83.4	67.5	43.4	22.8	158.0	69.4	76.6	79.9	100.8	234.3	105.0	97.3	158.0	134.1	143.0	202.5	168.9	212.0	142.4	134.3	160.1	125.1	149.9	152.9	193.5	81.3	91.6	129.4	76.1	130.9	101.1	155.0	113.0	151.4	153.6	97.2	221.9	200.7	180.3	112.3	109.8	116.5	105.5	121.3	109.6	70.6	108.4	161.3	98.7	97.5	101.1	238.8	119.9	116.9	93.7	102.1	62.6	88.0	144.5	91.6	130.9	127.3	99.9	76.3	69.3	109.2	186.6	194.9	119.6	195.0	96.4	130.5	39.5	23.6	47.2	10.4	27.9	49.5	46.1	36.2	40.6	35.7	54.2	34.7	51.5	41.6	3.7	46.1	56.9	26.5	37.0	44.4	14.5	18.5	27.2	25.4	16.6	18.4	17.1	15.3	18.5	18.1	15.1	22.8	77.7	35.3	67.1	14.4	91.4	140.1	157.3	109.8	109.3	30.6	86.0	76.5	102.4	58.6	69.2	35.0	27.1	84.1	85.7	43.1	137.0	76.1	21.5	39.6	64.3	67.5	56.8	80.3	30.4	108.3	113.6	63.8	64.7	51.4	75.5	45.0	60.0	30.6	62.4	23.5	33.1	81.7	54.9	96.4	82.8	6.6	61.5	72.7	69.4	19.7	97.4	37.2	73.2	32.6	34.7	64.0	57.7	56.4	112.1	79.6	77.0	138.4	41.7	31.2	78.9	95.4	77.9	40.4	41.9	102.3	122.9	120.3	95.0	55.1	99.0	130.4
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184146127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	16.1	18.9	10.1	8.2	10.1	5.3	17.6	11.2	12.5	17.2	13.0	19.6	9.4	15.3	5.6	24.7	14.9	6.5	22.3	9.8	11.7	15.5	20.1	15.8	9.7	11.2	10.1	14.9	19.0	22.1	18.0	11.8	10.6	18.1	13.8	2.3	23.9	11.2	53.9	24.7	19.4	11.6	10.9	20.3	21.0	10.1	10.8	18.2	16.7	33.6	19.0	18.8	19.6	9.3	60.7	25.4	24.3	25.4	32.4	23.4	28.0	29.1	36.2	51.7	42.4	41.5	24.5	48.6	37.8	32.5	65.0	34.7	56.6	39.1	47.7	39.7	55.4	75.6	28.4	42.4	24.8	61.8	32.9	19.6	32.1	28.7	24.1	19.5	37.3	49.7	46.7	29.2	35.2	49.5	49.5	34.3	39.9	76.1	49.3	45.1	37.6	61.3	43.1	38.6	35.2	34.2	27.9	91.9	41.5	20.3	83.6	60.8	33.6	22.9	35.4	28.5	62.7	24.3	61.2	69.6	33.0	58.8	35.2	9.5	10.0	14.7	8.7	9.1	11.5	15.4	12.2	13.3	11.8	16.9	18.1	11.5	1.3	14.3	9.8	5.1	11.6	7.6	10.1	10.1	11.2	12.5	9.8	11.7	11.2	10.1	10.6	10.9	10.8	9.3	19.8	25.6	22.7	8.8	31.6	30.8	36.6	18.2	29.6	18.5	33.1	30.1	25.8	17.2	28.4	36.8	8.4	39.3	25.4	32.0	52.8	27.5	3.7	20.5	17.7	24.0	45.9	27.6	14.6	36.0	28.8	17.8	35.2	23.3	16.5	21.3	13.6	27.1	24.9	35.3	18.6	28.0	24.4	18.5	22.6	2.7	18.3	18.2	19.6	12.2	30.8	14.5	22.6	18.1	15.3	26.3	17.9	14.7	19.0	34.6	27.2	30.0	21.9	16.7	13.1	17.5	22.8	17.7	17.0	31.2	29.0	38.6	26.5	34.2	34.7	44.9
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67360328-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		210000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	28.3	24.5	12.5	29.9	14.0	25.0	25.7	15.1	17.8	18.1	10.4	25.0	21.5	19.4	19.6	38.8	15.8	21.5	28.7	14.6	14.1	24.5	35.3	18.4	30.4	13.7	12.7	17.1	26.3	22.9	9.4	26.3	13.6	22.1	26.7	21.2	18.3	22.3	49.4	23.7	21.5	27.0	13.8	19.8	19.8	33.4	13.5	27.9	27.9	40.6	33.5	39.1	19.0	16.6	265.7	86.4	59.8	92.3	56.4	63.4	127.8	115.5	68.3	127.4	110.7	101.6	92.2	118.7	57.0	87.4	85.7	100.4	139.1	110.3	192.7	86.9	51.9	76.9	80.0	70.4	59.2	82.7	71.9	52.4	62.6	113.9	172.5	49.8	105.4	73.8	132.6	89.6	127.3	131.3	113.7	64.7	61.1	157.9	142.9	85.7	99.0	84.6	78.2	120.0	85.9	60.7	83.0	96.5	91.1	52.3	164.5	70.8	81.3	167.4	180.7	82.0	124.4	77.0	90.4	180.7	97.1	145.3	110.2	51.4	50.6	33.0	47.4	71.0	58.4	55.4	54.5	51.7	70.1	45.8	50.3	51.5	6.9	58.6	62.8	48.0	64.3	70.7	12.5	14.0	15.1	17.8	14.6	14.1	13.7	12.7	13.6	13.8	13.5	16.6	64.1	28.9	40.2	17.3	44.1	142.8	88.2	77.2	37.5	22.1	32.0	30.1	92.8	30.0	55.8	22.0	12.5	78.7	38.0	23.3	70.5	89.6	81.0	34.6	48.9	60.3	13.1	64.2	21.7	63.0	104.7	51.2	34.1	44.8	35.5	35.7	26.4	39.8	70.4	37.0	20.9	30.6	61.1	37.9	51.3	33.4	31.1	40.7	51.6	15.9	61.3	32.2	36.0	15.1	23.8	70.8	18.3	40.6	56.7	79.9	26.6	65.1	35.0	35.2	26.3	60.7	85.9	204.9	96.3	49.7	130.4	93.4	46.1	57.9	39.7	79.1
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088309-34112243	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417"	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	50.7	49.2	40.1	44.0	42.1	45.0	42.3	43.1	54.5	34.8	39.8	45.8	38.3	33.7	37.9	61.2	30.6	32.5	46.2	39.0	41.7	54.0	59.2	46.8	52.8	44.3	41.3	32.0	81.4	35.8	27.7	54.2	43.9	35.0	42.8	23.7	43.5	33.9	100.8	39.0	37.6	40.5	43.6	37.9	50.8	37.1	41.6	46.6	42.4	64.0	56.3	63.1	37.9	48.4	211.9	139.1	103.4	125.5	99.1	149.3	196.6	188.7	180.2	184.1	184.6	493.4	144.5	188.5	135.1	171.9	204.1	194.5	169.7	310.6	222.0	61.0	92.3	373.8	110.0	254.5	254.7	241.9	116.7	153.6	259.1	182.7	270.2	125.8	195.5	273.7	223.6	174.8	153.5	135.8	226.0	201.3	100.6	243.7	251.1	128.2	176.0	176.2	145.5	174.2	104.7	71.3	209.3	125.2	403.7	119.2	189.9	282.4	132.8	208.7	129.0	132.5	179.8	162.4	153.8	195.9	196.5	185.0	155.1	54.2	77.1	64.8	54.7	89.0	68.1	84.8	77.2	77.2	75.8	71.2	72.0	72.8	47.3	74.9	83.8	105.3	96.1	64.0	40.1	42.1	43.1	54.5	39.0	41.7	44.3	41.3	43.9	43.6	41.6	48.4	157.4	169.9	162.1	13.7	167.8	180.5	326.3	384.9	81.4	60.5	171.7	154.6	145.1	223.1	241.7	139.8	31.3	359.2	139.6	145.7	307.2	344.2	314.9	182.9	160.1	199.2	126.7	300.7	17.6	529.2	394.4	128.5	110.6	139.1	144.4	80.1	253.4	497.1	243.0	42.1	17.1	229.6	215.7	223.1	119.3	163.7	126.5	147.0	119.2	16.9	286.8	92.8	126.7	17.1	25.2	519.3	133.8	129.4	182.6	292.7	141.5	335.0	207.7	95.3	111.7	102.6	226.6	446.4	211.6	132.7	174.5	641.7	124.0	220.6	200.4	343.8
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054946-24078810	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"	"Disease variant, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB012471	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	65.5	51.8	31.9	71.8	33.5	76.2	82.9	35.7	35.4	78.0	42.5	67.2	66.4	83.8	45.0	62.5	79.9	53.3	57.1	31.4	33.0	69.6	74.6	50.7	113.3	35.9	32.2	131.3	94.8	49.6	30.1	46.4	35.7	51.7	66.3	46.9	69.7	41.7	66.7	71.8	53.0	74.3	35.8	72.1	66.7	18.6	34.8	97.6	69.9	51.8	111.6	66.4	65.6	41.4	261.0	256.0	110.3	182.7	113.5	235.5	73.2	142.3	127.4	114.8	130.6	290.8	174.3	449.5	141.0	104.9	251.9	165.1	344.7	271.3	140.8	147.8	203.7	177.2	467.8	164.3	126.2	304.0	219.4	206.9	169.2	129.6	269.7	152.9	166.2	176.0	275.4	176.0	127.7	124.8	170.6	278.8	268.2	118.1	146.5	169.5	215.2	271.4	155.4	241.5	60.2	130.8	232.3	224.7	239.8	205.5	289.6	205.1	140.2	97.1	66.7	177.3	125.3	156.6	322.4	240.9	120.9	193.1	113.7	64.4	141.1	27.9	84.9	151.9	147.8	156.0	148.8	113.9	123.9	120.6	187.5	156.6	51.2	106.3	132.6	97.4	124.2	127.2	31.9	33.5	35.7	35.4	31.4	33.0	35.9	32.2	35.7	35.8	34.8	41.4	76.5	44.8	54.5	48.0	187.6	126.6	98.0	51.8	145.1	25.3	128.4	91.2	49.1	74.4	49.0	40.5	25.0	59.6	127.5	35.2	111.6	67.9	0.5	67.3	109.4	67.5	44.9	92.5	19.0	57.6	122.1	72.3	78.5	90.9	100.8	84.6	84.3	58.8	89.1	20.2	20.1	65.0	32.6	138.9	91.9	3.5	67.7	109.7	55.2	36.5	134.5	30.4	78.2	23.6	31.4	59.5	68.9	61.3	99.3	70.2	72.3	135.2	40.6	33.3	72.3	85.0	87.4	10.2	21.9	130.7	151.2	71.0	117.9	76.2	100.4	92.9
EIF3B	"EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB017562: AB_2246341, HPA048983: AB_2680588"	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	59.3	54.8	29.4	49.5	31.5	88.8	55.1	31.8	31.7	49.6	31.4	74.3	39.5	55.3	28.4	78.2	53.3	34.8	55.1	31.2	32.1	44.7	60.4	42.2	58.9	33.4	32.6	51.0	83.1	39.6	37.9	51.9	33.6	50.3	44.6	17.7	63.4	42.9	155.2	82.9	48.9	52.5	32.6	56.6	59.1	60.8	32.0	53.5	37.0	65.8	64.6	69.4	53.3	35.2	510.8	253.3	102.9	280.4	113.5	102.4	254.4	174.5	130.2	193.8	180.5	334.4	193.2	293.9	139.8	186.2	273.5	269.9	287.1	229.0	212.5	88.6	334.6	224.8	240.8	227.0	159.2	277.0	159.8	127.5	147.9	210.1	219.2	101.8	157.9	133.9	580.9	133.2	179.7	358.4	134.7	306.9	322.6	176.2	224.4	163.3	208.3	304.2	123.4	228.9	233.9	174.9	184.5	403.4	102.8	178.8	270.0	301.3	169.0	149.0	326.9	231.7	319.4	145.7	210.6	295.6	169.3	303.9	372.5	2.1	7.2	4.0	7.5	7.2	9.4	6.5	7.0	8.2	8.0	6.1	8.4	8.5	0.6	16.9	6.6	8.2	9.5	4.8	29.4	31.5	31.8	31.7	31.2	32.1	33.4	32.6	33.6	32.6	32.0	35.2	43.3	25.6	64.1	19.6	35.9	64.2	55.6	25.4	34.1	37.9	74.0	62.4	37.4	30.0	38.8	27.6	64.6	64.9	52.6	49.0	3.9	35.5	11.6	37.1	57.0	50.9	47.8	56.8	20.1	62.6	63.4	47.6	48.9	48.1	17.1	77.0	63.5	67.0	47.4	52.2	19.5	63.0	14.2	39.5	32.3	23.3	43.8	34.3	16.0	8.4	32.6	45.6	38.1	15.6	19.9	70.9	28.9	37.2	42.3	68.8	33.6	31.0	27.4	44.3	26.3	69.2	48.5	34.4	39.4	63.5	78.3	82.6	34.7	119.4	77.0	50.6
EIF3C	"eIF3-p110, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735727	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	174.0	99.7	86.7	113.5	94.3	149.8	185.7	77.4	92.6	136.9	83.2	189.7	148.6	138.0	51.7	159.7	185.9	86.7	135.3	98.1	89.2	172.8	143.1	104.6	124.8	87.4	91.6	236.4	219.6	227.9	86.8	122.8	92.8	115.2	166.1	94.8	187.6	112.9	360.1	188.3	145.0	149.0	80.2	116.2	124.4	140.8	84.2	91.0	175.7	291.9	189.0	144.8	104.2	89.3	182.1	321.5	419.3	481.5	368.0	453.1	627.7	444.1	380.9	587.7	425.4	620.6	333.9	461.7	556.7	322.2	366.5	214.5	361.4	618.1	650.0	188.4	376.0	518.9	466.8	860.4	471.9	791.3	344.6	521.4	367.4	370.4	582.8	253.6	679.5	439.3	595.7	394.5	314.5	783.0	622.0	299.2	652.8	304.0	491.2	638.8	612.7	447.0	317.8	406.4	379.1	573.2	396.8	531.0	478.0	263.3	551.6	356.6	570.3	372.3	370.1	180.4	299.9	325.8	279.0	860.7	378.7	320.4	398.7	54.5	198.1	90.2	122.0	204.0	140.6	114.3	131.8	129.1	213.2	113.9	127.4	120.5	14.3	163.8	220.5	98.3	147.2	267.3	86.7	94.3	77.4	92.6	98.1	89.2	87.4	91.6	92.8	80.2	84.2	89.3	5.0	67.3	101.4	1.0	9.6	11.9	10.0	3.9	15.4	7.0	5.3	3.0	157.0	5.7	91.1	5.5	41.7	3.7	6.2	4.6	1.9	3.3	2.8	8.7	7.7	16.0	6.0	17.5	1.4	3.5	3.1	33.2	10.2	12.9	39.1	7.3	7.9	4.8	3.1	0.0	1.5	5.9	2.0	5.0	8.4	3.5	6.5	12.6	5.4	5.6	3.9	1.9	2.1	4.5	1.0	4.1	5.2	5.3	21.4	5.7	7.1	5.2	168.1	16.2	0.0	6.9	18.5	3.9	4.6	16.9	13.8	5.6	11.2	6.1	6.3	8.8
EIF3D	"eIF3-p66, eIF3-zeta, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510855-36529184	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol		NA	NA		36000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA045882: AB_2679482, HPA063330: AB_2684988, HPA066216: AB_2685637"	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	121.7	84.3	46.1	105.2	48.9	176.9	184.5	48.6	48.2	127.8	59.0	118.7	107.3	121.7	123.7	144.5	158.1	84.6	95.0	46.2	48.0	88.4	88.0	87.5	174.1	51.1	48.6	193.3	228.0	108.1	55.3	109.8	51.3	97.8	135.5	45.6	132.8	102.2	152.1	153.4	100.1	118.7	48.9	138.6	129.3	63.5	50.8	162.6	113.5	93.1	211.8	134.7	116.2	52.2	312.4	171.3	172.2	197.2	237.8	462.3	287.8	235.2	321.2	319.5	313.7	270.7	171.1	395.3	173.4	271.8	202.4	230.9	295.1	374.5	320.7	215.7	313.6	215.4	151.9	209.6	428.2	507.5	214.4	419.6	427.7	357.1	515.0	365.1	347.5	128.0	238.3	195.9	363.6	194.0	180.3	281.0	188.5	484.9	141.6	318.1	278.0	305.0	314.2	214.9	135.9	190.7	153.6	311.3	337.4	180.0	196.7	472.5	243.9	247.9	222.6	188.3	333.6	247.5	171.8	316.9	252.1	318.1	242.7	166.7	383.7	141.3	320.3	353.5	520.4	518.1	461.1	381.1	528.9	509.2	558.2	455.7	95.1	402.3	348.9	303.3	608.7	826.1	46.1	48.9	48.6	48.2	46.2	48.0	51.1	48.6	51.3	48.9	50.8	52.2	115.6	60.9	92.0	13.7	184.7	212.9	287.1	299.1	134.9	37.3	231.9	216.8	67.9	130.1	167.1	46.0	31.3	224.2	151.5	68.2	150.6	191.7	126.3	108.4	95.3	141.7	112.7	101.4	8.5	207.8	240.4	99.4	78.0	88.1	187.3	128.9	126.7	41.0	219.7	25.2	8.7	149.1	109.9	211.0	176.1	46.4	138.5	121.7	129.9	8.4	275.1	75.6	137.0	10.6	12.5	185.6	134.7	108.3	72.5	230.6	176.5	160.1	119.9	46.2	72.3	147.9	260.8	106.0	83.2	140.3	215.8	246.1	159.8	162.2	219.7	288.0
EIF3G	"eIF3-delta, eIF3-p44, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115014-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1509.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 1471.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol		NA	NA		64000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	193.6	153.1	91.9	97.0	98.6	127.9	188.0	97.9	110.3	211.3	91.2	219.0	94.9	190.6	61.3	144.2	189.7	68.1	212.6	88.1	93.5	152.7	134.3	135.4	125.4	100.6	94.6	280.0	324.5	116.2	119.6	90.8	99.9	172.0	54.3	24.8	182.2	102.2	529.8	212.4	148.0	73.8	98.4	168.9	207.6	176.3	96.8	124.9	139.2	221.1	98.8	183.5	171.9	103.1	211.5	175.5	130.1	174.9	170.8	216.6	169.2	175.6	242.3	269.0	247.7	289.2	111.1	214.9	245.1	210.8	121.9	158.4	159.7	265.0	111.1	196.0	491.8	379.8	179.0	293.2	283.7	303.8	192.7	262.7	191.0	191.6	181.0	172.2	195.7	263.1	349.2	249.6	164.3	282.3	333.2	1471.2	323.1	131.9	372.0	265.3	129.2	287.2	173.4	181.8	170.0	328.9	117.6	152.0	287.9	73.2	133.4	264.4	196.1	233.0	132.6	256.1	339.1	726.8	567.8	240.2	175.6	328.5	227.9	199.9	319.1	139.5	267.6	238.7	348.0	244.5	287.0	291.8	303.2	255.3	287.5	262.4	60.3	458.6	200.3	240.7	351.5	457.0	91.9	98.6	97.9	110.3	88.1	93.5	100.6	94.6	99.9	98.4	96.8	103.1	183.9	44.8	94.5	7.2	219.3	228.2	271.7	185.8	191.2	41.5	276.0	342.9	43.3	164.5	118.1	108.5	18.8	470.9	273.6	146.4	187.9	182.7	438.1	99.7	141.5	160.6	129.9	131.1	4.2	309.1	328.2	159.1	122.3	108.9	129.3	197.3	167.4	98.9	225.1	21.9	4.1	231.1	81.4	288.5	268.9	1509.3	237.9	198.9	145.9	4.7	351.7	85.5	557.1	6.6	10.8	205.3	198.8	177.1	192.6	241.0	277.0	320.1	100.6	56.6	164.3	189.9	243.8	221.1	142.4	152.9	238.7	527.2	261.5	209.6	235.4	263.2
EIF3J	"eIF3-alpha, eIF3-p35, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537125-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 209.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050977	Approved		Approved	Cytosol		NA	NA		280000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA050977: AB_2681297"	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavorable (4.96e-5)"	48.2	34.2	40.0	40.8	42.3	38.7	39.9	41.5	51.7	26.8	34.7	36.2	36.2	26.8	30.8	48.8	22.0	26.1	40.1	39.8	45.0	46.4	58.7	25.8	38.9	44.6	47.9	22.3	65.5	34.9	22.9	44.8	46.1	32.3	37.1	21.2	56.3	29.8	209.6	37.1	31.4	35.5	41.0	30.5	35.3	31.6	44.4	34.0	35.9	104.0	49.8	49.6	31.6	47.0	103.5	55.7	88.4	55.5	60.7	60.0	113.1	161.0	46.9	108.5	72.9	165.6	59.6	96.0	184.6	67.1	102.5	192.3	137.7	99.5	129.5	114.5	79.8	222.5	129.4	108.6	115.1	239.2	98.4	54.6	130.7	72.8	141.6	65.1	117.2	111.1	294.9	119.8	97.8	73.1	124.0	160.8	55.4	190.5	92.9	141.2	145.4	146.1	122.4	118.0	118.4	74.9	150.6	137.1	89.7	69.3	118.0	196.6	140.3	117.6	140.7	127.9	216.4	145.5	302.4	244.8	80.9	249.0	114.0	64.3	40.3	40.7	35.6	41.6	40.8	59.2	45.9	43.7	46.8	53.4	44.1	47.5	18.3	60.4	40.7	76.7	52.9	13.1	40.0	42.3	41.5	51.7	39.8	45.0	44.6	47.9	46.1	41.0	44.4	47.0	92.8	60.9	54.6	16.3	93.1	175.1	112.6	86.5	49.5	56.2	174.6	114.2	95.2	108.7	79.7	145.3	20.9	148.7	122.8	148.0	193.7	145.2	149.7	118.6	141.0	92.2	117.3	139.5	22.0	149.6	170.8	69.2	50.0	175.5	127.4	73.1	99.2	404.3	110.7	43.7	24.1	172.9	61.1	98.7	106.6	103.4	91.0	78.5	60.5	18.7	108.5	50.1	109.2	16.6	27.4	152.3	118.6	71.1	91.9	119.0	94.9	266.4	43.1	66.8	46.0	74.1	94.3	205.4	153.4	70.6	172.0	247.1	88.5	54.7	180.6	102.8
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789897	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1600000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	178.4	288.5	277.5	105.8	302.9	7.3	243.4	328.0	388.2	274.5	251.6	282.5	143.3	325.0	196.3	178.1	322.0	205.3	383.9	309.0	331.3	287.8	202.6	156.2	192.3	275.4	254.5	606.8	272.1	189.2	292.5	218.8	290.2	249.7	179.7	310.3	213.5	262.9	675.3	93.7	165.7	252.8	270.6	159.0	196.0	155.3	316.9	178.0	293.8	553.2	170.0	224.3	186.8	275.6	95.4	44.6	179.1	30.2	624.9	589.3	59.3	158.9	138.5	159.1	202.1	159.9	34.2	200.0	812.8	213.7	283.4	146.8	255.2	66.5	272.0	182.6	134.8	304.8	54.4	214.5	249.6	68.3	209.0	402.5	291.8	47.8	368.3	764.1	275.2	161.6	109.6	311.9	496.8	14.2	112.5	31.2	183.7	337.0	199.4	143.3	124.1	122.2	305.9	110.4	331.8	71.9	241.4	175.4	356.9	427.3	269.6	244.3	205.6	122.8	63.0	123.9	87.7	252.1	374.8	85.9	86.9	71.0	63.9	233.4	78.5	88.5	125.8	87.5	200.8	245.4	183.2	154.5	91.0	203.0	273.4	224.2	50.5	169.6	125.3	85.4	187.3	282.3	277.5	302.9	328.0	388.2	309.0	331.3	275.4	254.5	290.2	270.6	316.9	275.6	265.3	118.6	220.2	68.6	416.9	690.3	770.9	595.8	412.6	267.4	396.7	308.2	271.3	327.5	447.9	261.1	64.6	450.1	370.8	306.7	661.2	254.3	33.0	287.9	297.5	319.2	407.8	221.4	146.8	94.5	251.2	367.8	250.2	344.2	312.1	267.2	258.1	142.4	226.6	390.3	138.0	372.9	455.7	228.6	385.2	56.8	385.8	242.9	345.1	92.8	318.1	383.9	256.4	73.9	118.7	136.0	410.8	472.8	235.7	737.4	567.9	665.2	337.8	192.8	236.7	409.7	489.9	223.8	165.4	314.8	618.0	615.5	449.2	345.6	380.1	879.5
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98879276-98929133	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 927.0;Late spermatids: 2284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004077, CAB016316, HPA068358"	Supported		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		450000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytosol, Cytoplasmic bodies"	Nucleoplasm	"CAB004077: AB_823488, CAB016316: AB_627502, HPA068358: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	38.0	37.4	27.4	37.7	28.5	57.4	35.6	32.5	34.6	28.5	20.9	45.1	35.9	30.5	38.0	51.7	31.7	31.3	37.5	27.8	34.3	47.4	43.3	27.0	44.6	29.2	31.1	29.1	27.0	45.1	17.0	35.9	29.2	31.4	52.2	54.0	31.2	30.7	39.2	24.2	34.4	39.4	36.2	31.5	35.8	62.6	31.4	53.2	52.6	48.1	58.0	54.4	29.8	34.3	101.1	85.2	139.8	96.5	73.4	74.2	87.3	184.6	105.3	137.0	100.5	111.0	122.7	194.7	59.4	104.4	94.3	49.0	181.9	124.9	158.9	133.5	56.2	135.6	52.7	105.8	62.6	199.3	104.8	54.5	78.3	104.8	82.9	81.5	108.3	97.6	226.6	95.2	120.0	82.9	189.2	110.6	115.0	189.2	72.2	119.7	94.4	90.0	122.0	85.3	123.3	80.3	85.5	188.4	65.4	93.3	89.9	85.9	86.5	110.0	121.6	96.9	153.7	71.4	185.4	179.4	99.7	102.7	127.1	39.5	34.7	59.3	38.2	42.1	44.4	50.0	43.2	40.2	39.6	43.6	47.3	47.3	26.3	54.3	54.8	33.5	46.5	50.3	27.4	28.5	32.5	34.6	27.8	34.3	29.2	31.1	29.2	36.2	31.4	34.3	45.2	32.1	42.2	29.7	93.1	362.1	227.5	202.2	149.7	87.9	81.6	41.1	27.5	55.8	106.0	60.7	35.5	105.3	56.2	140.5	256.3	88.9	927.0	76.1	84.0	77.8	64.6	192.8	45.2	67.4	150.0	87.1	80.0	119.0	51.4	28.0	40.0	77.1	121.1	85.8	45.0	77.4	227.9	61.9	327.6	2284.9	50.7	122.1	193.9	25.3	69.8	82.0	57.7	35.2	50.9	83.8	107.1	49.2	113.0	191.1	83.2	189.2	76.8	64.7	52.6	78.7	151.7	98.7	87.1	171.2	370.9	119.0	82.2	39.8	97.3	224.3
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.6;Late spermatids: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	12.5	11.9	14.3	10.4	14.8	14.3	11.9	19.7	17.3	15.9	11.4	19.4	11.4	15.0	13.0	14.0	13.8	7.8	13.2	15.3	15.0	12.3	8.4	12.1	12.6	13.6	14.7	15.0	10.5	16.7	10.8	13.6	14.3	13.5	11.5	18.0	12.1	13.2	20.2	15.7	11.8	12.1	11.6	12.3	12.3	34.7	13.8	12.9	13.5	14.5	14.9	15.6	14.3	17.3	19.8	11.6	29.4	16.0	16.1	14.2	11.7	13.7	16.8	21.4	19.8	13.4	7.0	25.3	7.9	20.7	14.3	19.1	26.9	12.5	19.7	20.2	27.0	10.3	20.0	15.4	16.7	41.0	17.9	16.6	16.9	15.8	17.8	19.5	18.4	14.8	25.4	27.0	20.3	22.4	27.8	20.3	13.5	18.3	9.5	31.1	24.5	26.0	21.7	14.7	22.6	20.9	18.9	15.4	14.5	19.4	16.4	16.1	20.5	14.3	18.6	14.4	15.5	19.3	20.4	25.1	13.7	14.8	17.1	1.3	2.4	1.2	3.4	3.0	3.5	4.8	1.8	3.3	2.2	2.0	1.8	3.2	2.0	1.0	8.1	4.4	1.4	1.9	14.3	14.8	19.7	17.3	15.3	15.0	13.6	14.7	14.3	11.6	13.8	17.3	8.4	12.8	15.2	23.2	10.6	7.4	7.3	6.2	15.4	18.0	9.6	8.9	22.7	10.0	8.5	12.9	12.5	9.8	13.8	8.6	9.8	8.9	54.6	8.0	12.8	10.2	12.0	12.4	21.0	6.4	5.5	8.1	12.2	13.0	6.3	23.1	11.0	8.9	8.0	18.5	20.5	10.8	8.2	9.5	6.2	98.9	14.6	7.5	7.2	13.1	14.5	8.1	14.4	20.1	20.2	10.2	3.6	15.4	10.3	10.7	5.7	9.4	6.3	13.7	6.6	11.8	11.0	38.7	13.3	10.7	10.5	6.7	8.2	9.0	8.1	8.0
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 348.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	86.2	91.8	24.8	75.7	22.2	84.0	69.0	17.9	22.2	66.6	34.1	81.8	62.0	71.3	32.7	126.8	59.6	50.9	90.8	23.3	29.8	53.9	113.0	74.2	55.7	38.5	36.1	57.5	96.2	99.3	57.4	59.4	32.4	62.2	56.5	22.3	93.1	59.2	348.3	116.7	67.2	74.7	24.4	58.2	79.9	64.8	37.4	49.1	71.3	177.0	63.2	76.0	85.3	16.6	559.0	232.3	173.1	205.7	196.9	192.5	322.5	298.6	204.1	315.4	238.8	486.5	173.7	348.4	381.9	367.6	358.5	292.7	322.6	365.8	230.5	375.1	345.8	321.3	226.1	206.4	173.4	321.4	212.2	199.6	206.8	292.4	268.8	152.8	278.3	128.8	239.6	267.2	205.7	403.4	219.7	105.3	368.9	241.3	180.8	221.7	183.4	281.9	156.8	331.8	197.7	174.6	258.1	415.6	187.6	144.6	445.2	206.5	364.1	227.2	228.9	297.3	567.9	203.8	263.2	629.0	260.5	271.4	258.3	8.3	16.0	6.7	11.7	14.4	10.8	7.7	7.8	9.6	12.8	9.2	6.9	7.6	5.6	8.7	21.0	18.1	6.0	12.7	24.8	22.2	17.9	22.2	23.3	29.8	38.5	36.1	32.4	24.4	37.4	16.6	63.9	76.9	72.6	23.8	41.7	59.1	78.2	58.0	70.6	24.2	69.3	46.2	109.4	50.1	72.3	62.5	14.6	64.0	37.6	135.5	13.7	98.8	151.6	53.0	67.1	69.3	55.7	82.7	10.8	135.3	74.8	64.5	75.4	85.6	48.0	163.8	43.5	152.8	66.8	21.9	12.9	97.2	50.8	40.8	39.9	202.7	73.0	48.9	33.8	14.0	53.0	23.2	30.9	4.0	10.1	149.0	69.0	56.1	112.9	96.8	77.0	45.4	51.4	23.2	78.9	81.6	78.9	24.8	41.4	120.7	91.8	79.6	46.0	94.8	108.4	95.6
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10808940	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol		NA	NA		48000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	307.1	259.9	177.4	278.4	178.0	516.4	213.7	182.9	197.9	281.1	260.2	329.2	217.0	310.5	310.1	372.0	265.0	290.0	377.9	165.0	195.9	321.8	288.7	312.8	286.6	190.0	226.5	247.1	259.6	368.6	160.2	406.4	196.9	276.2	318.6	258.5	231.1	305.5	456.4	299.5	216.3	395.9	186.5	249.5	245.4	226.4	193.0	384.8	349.7	372.4	369.3	430.0	203.0	191.1	933.5	715.1	958.4	527.9	668.2	712.0	668.4	848.9	841.7	713.1	483.6	790.1	1064.3	525.7	474.1	1029.4	545.2	537.8	1048.1	781.0	970.8	820.1	489.0	676.3	427.7	607.2	580.2	1041.8	545.9	582.3	601.0	444.6	577.3	657.1	830.2	483.5	527.8	570.5	935.1	481.8	691.7	377.9	702.1	646.8	756.0	690.3	563.8	336.1	630.7	1328.3	357.9	584.6	966.5	658.7	516.7	640.7	561.1	474.5	805.5	916.1	614.8	793.4	711.4	281.5	841.5	766.9	531.5	600.2	998.7	343.1	331.3	498.6	212.1	382.2	277.0	251.3	237.3	250.1	304.6	212.9	205.8	212.9	244.6	262.4	422.3	162.3	295.9	767.1	177.4	178.0	182.9	197.9	165.0	195.9	190.0	226.5	196.9	186.5	193.0	191.1	306.7	323.7	284.4	48.6	273.6	633.2	372.0	213.4	285.1	128.1	236.0	196.0	382.6	198.8	243.4	147.1	123.0	321.8	289.0	422.3	244.6	325.2	163.7	213.4	247.1	302.9	247.8	169.1	48.1	368.1	373.7	250.1	263.5	269.3	199.5	271.3	209.9	209.0	272.2	164.9	53.8	279.7	191.2	240.1	417.9	152.0	208.8	312.7	250.8	54.4	279.7	197.3	224.6	36.7	53.3	582.5	260.6	240.7	262.0	307.1	205.6	329.5	225.3	142.8	131.5	328.1	363.1	203.6	197.6	320.3	630.1	1056.1	267.7	281.2	289.0	518.3
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA		68000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	21.3	20.7	5.2	20.5	6.2	32.3	17.9	1.6	19.7	18.5	57.9	22.7	15.0	21.1	17.1	19.8	18.8	19.9	18.3	4.8	12.7	16.1	14.9	16.4	17.4	5.0	1.5	17.2	12.1	39.5	26.5	15.6	4.9	17.4	24.4	26.4	12.6	20.6	42.2	18.5	17.4	27.5	0.0	17.1	17.3	74.3	3.7	17.1	35.7	23.4	19.9	22.6	16.7	16.6	31.8	25.2	78.3	32.0	80.1	77.9	16.4	66.8	70.4	46.5	46.1	27.2	33.4	60.7	41.1	73.2	42.6	34.5	48.4	53.9	64.3	50.4	48.2	31.6	47.7	18.9	38.5	53.1	56.5	86.4	39.9	47.8	61.2	69.0	59.2	22.3	23.9	42.0	66.3	25.1	16.6	19.2	23.3	36.7	21.3	31.7	29.8	21.4	40.8	16.4	46.1	35.4	70.0	29.6	35.9	46.3	20.7	58.0	60.7	51.4	19.1	73.5	30.2	18.8	22.5	0.3	63.5	78.7	48.4	0.5	0.5	0.9	0.7	0.0	0.3	0.6	0.3	0.3	1.0	0.8	0.2	0.3	1.2	0.4	0.3	0.6	0.5	0.5	5.2	6.2	1.6	19.7	4.8	12.7	5.0	1.5	4.9	0.0	3.7	16.6	50.9	19.2	30.5	181.5	29.5	20.6	19.9	15.0	17.1	52.0	19.2	17.4	44.5	14.3	28.2	16.5	66.7	4.6	51.1	51.3	0.0	20.6	173.9	66.6	81.2	42.7	16.3	26.1	515.2	19.4	8.8	33.8	46.4	46.8	26.6	44.9	46.1	14.7	23.1	50.5	464.4	21.6	4.1	31.5	11.3	121.8	44.7	39.3	14.2	255.8	18.0	18.6	28.8	425.8	483.4	24.8	32.1	44.8	27.3	21.0	15.7	10.3	51.1	40.5	32.9	36.6	31.3	100.6	51.2	33.8	26.3	3.4	23.7	68.4	29.6	28.0
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174231-74197122	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 990.0;Late spermatids: 2765.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		750000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	186.9	174.9	151.0	117.8	159.3	283.3	168.3	163.8	157.3	179.8	129.6	208.4	130.2	186.4	76.6	249.3	163.6	100.0	171.0	149.9	151.9	156.6	197.0	158.4	130.3	161.9	156.9	181.2	226.4	160.7	119.9	162.8	162.2	150.3	100.2	149.8	170.1	125.1	399.8	230.9	148.9	119.2	165.2	137.4	192.9	79.9	164.6	150.2	141.2	173.4	137.2	175.3	179.7	187.1	526.3	341.4	251.3	303.1	220.8	231.8	283.4	359.8	276.3	300.3	289.5	423.3	388.6	444.3	96.6	338.8	424.2	266.6	280.5	481.5	286.3	298.0	329.2	247.5	305.2	345.9	253.1	429.0	236.9	273.2	300.8	326.2	460.7	341.5	326.8	260.1	445.8	186.4	305.2	448.2	342.0	516.8	337.6	430.3	328.9	386.9	342.7	401.5	250.9	324.7	252.7	325.4	340.9	420.3	296.0	331.3	476.8	272.4	340.2	411.6	284.6	345.1	474.4	218.8	299.8	771.4	326.3	435.1	441.4	213.7	229.7	245.6	156.9	255.6	164.5	146.4	161.4	158.3	224.2	132.9	183.9	151.7	150.1	193.5	270.2	95.1	194.7	388.0	151.0	159.3	163.8	157.3	149.9	151.9	161.9	156.9	162.2	165.2	164.6	187.1	105.8	83.3	81.2	15.7	97.1	119.2	153.8	101.5	78.0	93.1	103.0	95.5	43.3	68.6	68.7	44.1	25.0	198.8	91.9	98.7	107.6	148.1	990.0	104.8	98.3	103.0	90.4	79.5	25.3	157.7	381.4	101.6	61.2	112.5	122.4	112.1	79.6	95.7	124.2	97.6	24.6	87.2	91.6	101.2	102.7	2765.8	103.8	86.8	72.9	15.9	157.4	134.7	119.4	16.6	44.2	147.0	82.8	110.6	82.7	140.7	84.6	69.0	57.8	72.3	85.5	107.3	117.7	61.2	64.6	90.1	116.1	395.3	92.4	116.9	109.5	140.4
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337371-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		210000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	39.4	31.6	50.3	32.8	53.5	20.8	33.9	50.8	88.8	31.3	51.1	56.3	23.1	35.2	41.7	44.4	29.6	18.5	89.6	48.8	55.3	50.9	38.4	30.9	32.6	54.1	52.5	27.0	48.6	32.1	28.2	29.6	55.0	44.0	30.0	23.8	36.5	33.5	102.9	39.4	29.1	28.7	52.8	30.7	42.1	48.6	53.6	26.2	29.3	56.2	36.6	47.8	33.7	53.0	117.0	57.2	63.8	83.5	75.5	88.7	105.4	100.4	62.9	65.3	64.6	132.5	80.9	132.5	84.6	75.2	77.4	64.9	112.6	97.3	114.6	80.8	67.4	159.6	57.7	175.9	59.7	158.0	94.3	60.2	66.8	91.0	92.1	55.9	96.6	80.0	179.6	64.4	95.2	94.9	100.8	145.7	99.5	76.2	83.0	86.8	94.7	108.2	134.9	96.2	53.8	50.9	54.6	123.8	85.3	120.4	50.5	103.0	106.9	100.7	99.3	53.2	90.7	47.4	72.0	106.0	73.3	172.0	75.9	19.8	11.0	13.7	15.5	12.5	18.2	20.9	16.3	15.5	8.4	19.8	15.9	17.0	2.9	18.3	17.3	26.2	12.5	6.4	50.3	53.5	50.8	88.8	48.8	55.3	54.1	52.5	55.0	52.8	53.6	53.0	121.7	109.0	219.6	23.8	152.4	321.3	200.4	209.0	84.8	103.8	159.1	112.1	579.1	135.8	198.6	343.9	50.1	143.7	142.9	135.0	144.8	210.5	769.9	143.1	175.0	153.2	157.9	154.2	27.4	235.1	205.3	130.4	82.0	157.5	172.7	90.0	146.3	480.9	134.7	77.4	28.3	206.7	144.5	123.5	128.9	144.0	124.5	95.7	142.3	18.7	157.7	91.8	145.2	21.6	36.7	282.6	93.8	175.7	183.2	253.9	102.7	226.2	165.4	111.3	276.1	167.3	157.7	575.3	505.0	99.1	324.8	181.4	133.4	101.7	185.1	244.7
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278907-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 700.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040873	Enhanced		Supported	Nucleoplasm		NA	NA		260000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA040873: AB_2677182"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	66.5	99.4	55.8	61.7	56.9	75.8	87.3	58.2	64.9	91.0	64.4	120.2	142.6	80.3	80.7	242.6	99.1	64.7	51.8	57.6	64.4	129.6	172.4	64.0	75.5	59.9	58.3	67.4	73.7	93.1	56.4	68.2	61.6	76.7	122.8	21.6	88.7	84.2	52.2	169.0	119.4	92.9	58.0	68.8	83.3	71.8	57.9	78.9	64.8	56.9	120.4	146.5	125.6	60.1	338.1	447.4	115.3	137.1	136.9	161.9	148.6	205.5	250.8	431.5	322.3	864.0	306.2	232.1	251.2	258.2	326.7	261.8	234.6	671.8	299.9	60.0	154.8	397.5	188.7	752.0	262.6	225.1	177.1	162.8	430.3	331.3	680.3	185.8	298.1	131.4	253.1	116.6	459.7	325.8	128.2	285.5	151.2	367.4	375.3	173.1	203.9	207.1	590.5	243.6	194.2	178.3	163.4	675.6	266.5	93.3	314.7	177.0	248.2	478.8	211.7	244.0	326.3	135.0	149.4	221.8	243.2	216.7	274.6	420.1	267.8	230.4	166.0	278.1	182.5	261.7	165.1	183.9	318.5	263.4	132.7	158.1	89.6	247.4	316.1	291.0	196.8	353.2	55.8	56.9	58.2	64.9	57.6	64.4	59.9	58.3	61.6	58.0	57.9	60.1	80.8	64.1	54.2	4.9	75.7	281.3	270.0	333.6	95.6	32.6	81.9	102.4	27.8	114.4	201.0	165.5	10.4	237.5	82.5	363.7	197.6	375.8	68.9	92.3	60.1	90.3	105.7	50.9	5.7	378.8	217.7	78.5	73.9	90.2	99.0	62.2	60.7	216.0	176.6	25.2	5.0	150.7	193.3	78.6	169.8	94.5	81.7	89.9	106.7	1.9	226.8	68.3	81.4	2.0	6.2	700.9	468.3	67.0	53.9	213.1	373.0	527.0	116.8	32.2	65.7	70.7	170.7	130.5	77.8	197.3	346.5	256.0	70.0	120.4	215.0	468.0
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"bone marrow: 3894.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.1;monocytes: 4.0"	"Cell line enriched"	"Detected in some"	91	"THP-1: 3105.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced				"Secreted to blood"	NA	NA		370000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	3.4	1.0	0.3	0.0	0.3	3894.9	3.4	0.1	0.7	0.5	0.2	2.0	0.4	1.0	0.0	1.1	1.4	0.1	4.0	0.3	0.2	0.7	3.3	19.4	0.6	0.1	0.2	0.5	0.5	0.0	1.2	0.8	0.1	2.9	0.0	0.0	2.4	0.1	1.5	5.4	1.8	0.1	0.1	42.6	1.4	0.4	0.2	6.3	3.1	0.0	0.0	2.1	1.0	0.2	2.0	0.1	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3105.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.0	34.0	0.0	0.0	4.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	27.2	0.3	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	4.2	0.1	0.0	1.3	16.2	0.0	0.1	0.0	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.0	3.4	11.1	0.0	6.2	1.1	7.2	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	0.0	0.0	7.4	0.0	0.7	0.2	0.0	0.0
ELAVL1	"Hua, HUR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958573-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 227.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		230000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	27.5	27.7	14.5	33.1	15.6	27.8	25.0	16.0	15.7	29.4	19.5	27.9	25.2	31.6	25.9	30.0	34.3	22.4	34.0	15.3	15.9	24.8	29.0	24.2	40.2	13.7	15.6	31.8	28.4	37.5	21.4	32.7	13.8	26.9	27.2	19.0	29.6	29.4	37.7	24.9	25.1	35.9	16.2	30.1	24.6	46.1	15.1	52.7	27.9	32.2	44.1	37.4	25.2	16.6	127.5	84.1	137.9	104.5	52.9	52.7	76.5	89.5	78.4	136.9	106.3	122.4	73.2	153.2	125.5	104.0	76.9	86.0	155.2	107.9	114.8	134.9	131.8	135.5	58.9	115.7	77.4	129.9	103.1	65.8	63.6	95.7	57.7	64.8	106.2	115.6	140.7	112.6	95.7	95.8	215.3	103.7	122.1	96.4	101.6	239.0	89.6	100.9	87.5	93.9	98.0	70.8	88.9	89.1	71.7	82.6	101.8	101.4	79.7	127.3	87.3	119.2	161.8	109.8	114.7	161.9	71.3	154.2	112.2	29.9	19.7	37.2	16.4	17.2	17.0	20.8	24.0	26.3	25.0	27.7	21.8	16.6	5.3	33.1	22.1	12.5	20.9	16.3	14.5	15.6	16.0	15.7	15.3	15.9	13.7	15.6	13.8	16.2	15.1	16.6	45.7	25.6	23.1	18.6	56.0	72.4	79.5	29.0	51.2	47.2	54.9	37.2	31.3	30.0	20.7	47.8	56.3	86.8	48.1	32.9	66.5	37.1	227.7	41.6	46.5	52.2	42.0	95.7	20.3	33.8	102.3	53.1	40.2	47.2	21.0	59.5	47.2	89.2	64.2	60.6	21.5	52.9	18.3	57.5	79.2	164.1	50.4	47.3	51.6	23.4	43.9	43.4	57.7	33.7	26.9	35.3	45.7	56.8	88.7	98.2	38.3	65.8	27.3	55.7	52.6	45.5	71.0	164.7	61.2	72.0	71.0	74.8	50.9	44.7	60.2	84.6
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.9;Ductal cells: 41.3;Syncytiotrophoblasts: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.7	12.7	9.8	18.8	10.8	33.4	16.5	13.0	11.5	15.7	10.4	14.8	12.6	13.3	10.1	23.8	12.9	15.4	15.5	10.1	10.9	14.4	29.6	25.8	17.7	10.9	10.6	16.1	42.4	27.0	11.5	19.2	11.0	14.9	16.5	12.7	17.4	13.3	33.2	20.1	13.9	16.8	9.7	16.2	26.5	18.9	11.1	21.6	21.3	26.4	23.6	24.5	14.6	11.8	52.0	28.3	40.2	34.6	46.2	28.6	25.3	52.4	46.9	76.2	66.1	34.9	44.1	27.0	62.7	53.3	42.8	48.5	83.0	55.2	84.4	77.8	41.1	60.9	42.2	41.1	40.9	64.7	35.3	30.6	43.6	83.3	63.2	28.2	46.4	43.7	91.8	45.3	61.6	39.3	33.5	26.1	46.8	57.7	42.4	49.8	50.9	51.3	35.8	34.8	76.2	42.9	47.7	47.5	58.5	44.3	34.4	23.5	49.5	59.5	52.8	106.9	62.5	46.8	56.4	59.2	52.1	63.2	60.7	28.2	24.6	19.6	16.5	24.9	16.3	23.5	13.8	15.1	22.6	18.5	11.2	14.9	6.5	13.7	24.1	18.4	17.1	17.7	9.8	10.8	13.0	11.5	10.1	10.9	10.9	10.6	11.0	9.7	11.1	11.8	24.1	28.9	83.9	0.0	7.9	0.0	0.0	0.0	0.0	0.0	19.6	16.0	0.0	0.0	18.0	18.4	0.0	28.1	17.5	0.0	5.9	41.3	0.0	15.4	27.4	12.5	0.0	0.0	0.0	32.7	35.7	10.1	0.0	23.3	13.9	21.5	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	35.2	0.0	0.0	0.0	0.0	37.9	0.0	0.0	4.9	0.0	0.0	19.0	16.8	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	41.3	9.6	32.5	0.0	0.0
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"		NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: AB_2686877"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	78.3	83.9	86.5	45.0	89.6	93.1	59.9	88.6	116.1	47.9	79.8	61.3	30.2	48.1	67.0	75.3	46.2	39.3	141.0	92.5	85.3	97.2	76.0	62.0	52.5	83.6	83.9	46.1	41.1	58.5	57.2	56.0	83.9	45.2	44.8	69.4	46.7	43.7	190.3	48.4	40.7	54.8	84.2	48.2	57.3	111.2	85.1	64.4	43.3	125.6	65.7	69.3	52.0	89.5	211.2	169.2	151.1	110.2	113.0	146.7	108.1	203.6	165.3	194.8	199.0	151.1	178.2	106.3	160.7	181.9	263.4	147.2	168.7	203.6	256.8	123.2	141.5	185.7	174.2	243.0	147.3	120.4	133.6	149.4	159.9	177.0	226.8	144.2	184.8	180.2	166.2	137.8	260.2	155.9	311.7	214.9	137.5	341.9	271.8	111.9	95.1	100.8	216.2	181.9	142.1	134.3	85.2	458.9	202.4	155.1	169.2	127.9	142.2	140.1	160.6	156.1	208.1	155.6	204.5	198.9	169.6	130.2	175.0	138.6	66.4	85.6	62.0	78.6	68.3	83.1	74.2	70.8	73.6	73.9	66.5	67.5	79.8	73.4	77.3	118.4	99.1	60.0	86.5	89.6	88.6	116.1	92.5	85.3	83.6	83.9	83.9	84.2	85.1	89.5	236.0	67.3	98.9	0.0	24.8	0.0	0.0	0.0	0.0	0.0	147.6	185.4	0.0	0.0	49.5	119.5	0.0	220.1	74.5	0.0	266.1	216.7	0.0	147.9	98.9	77.1	0.0	0.0	0.0	227.2	326.2	66.0	0.0	168.8	69.4	65.9	0.0	0.0	313.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.9	0.0	0.0	112.7	0.0	0.0	0.0	0.0	317.3	0.0	0.0	12.1	0.0	0.0	341.3	63.4	0.0	0.0	0.0	78.2	0.0	0.0	0.0	0.0	332.5	40.7	98.8	0.0	0.0
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108866898-108934328	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 18.8;Collecting duct cells: 14.7;Exocrine glandular cells: 21.1;Theca cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"basophil: 36.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 36.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	13.6	39.7	5.8	6.5	6.2	6.5	13.6	6.9	8.1	21.5	8.4	17.5	5.8	17.1	9.5	13.0	19.9	6.7	18.2	5.9	7.8	14.4	18.4	15.2	9.6	6.6	6.5	29.9	17.6	29.3	38.1	6.8	7.9	18.0	8.1	24.8	14.8	8.3	15.7	15.9	15.9	8.9	5.9	18.2	15.5	12.0	6.9	9.5	20.1	11.4	8.8	15.5	18.3	6.3	15.6	26.7	19.7	12.8	21.7	21.1	21.1	23.4	15.1	20.8	16.9	31.5	9.2	31.0	12.0	20.2	27.5	35.7	40.7	29.8	25.8	28.6	26.6	15.2	38.2	63.3	18.6	28.7	13.7	18.7	19.1	34.5	26.7	18.0	20.9	33.6	43.1	17.9	22.9	25.3	21.2	13.6	32.1	41.0	34.4	20.7	31.9	18.3	17.3	16.1	26.6	23.9	27.8	23.3	15.7	22.4	33.3	14.1	15.4	10.4	16.2	26.0	25.1	15.5	47.2	13.8	20.0	20.2	19.1	36.6	1.4	2.8	2.9	2.2	4.4	2.2	3.4	4.6	2.4	1.2	3.1	4.0	0.2	4.5	3.3	1.6	2.6	2.1	5.8	6.2	6.9	8.1	5.9	7.8	6.6	6.5	7.9	5.9	6.9	6.3	7.3	12.8	18.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	7.7	7.0	0.0	0.0	3.1	14.7	0.0	6.9	5.8	0.0	0.0	5.8	0.0	9.9	10.6	4.7	0.0	0.0	0.0	21.1	6.2	3.8	0.0	9.6	2.5	11.4	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	0.0	0.0	2.7	0.0	0.0	6.3	6.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.6	2.8	24.4	0.0	0.0
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EMILIN1	"DKFZp586M121, gp115"	ENSG00000138080	"Elastin microfibril interfacer 1"	Q9Y6C2	2	27078615-27086403	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 64.5;Fibroblasts: 111.3;Hepatic stellate cells: 45.0;Leydig cells: 85.1;Peritubular cells: 167.3;Sertoli cells: 72.3;Smooth muscle cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.2;BJ hTERT+: 65.0;HHSteC: 99.0;HSkMC: 109.6;SH-SY5Y: 129.4;U-138 MG: 63.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002822	Supported				"Secreted to extracellular matrix"	NA	NA		4300000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA002822: AB_1078738"	"unprognostic (3.14e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (8.13e-9)"	"unprognostic (8.96e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.70e-3)"	55.5	55.7	6.9	47.0	7.1	1.9	43.6	6.4	7.1	139.8	4.6	223.5	24.9	206.3	7.4	23.3	129.2	35.4	68.9	5.9	7.5	55.5	42.4	100.7	11.7	13.0	7.6	172.4	21.2	1.4	26.9	16.2	9.5	96.4	7.9	0.3	17.5	52.1	10.3	19.1	72.0	50.3	8.3	118.1	87.6	16.9	10.4	2.4	29.7	2.6	2.2	142.9	70.2	8.6	0.9	0.7	5.9	0.9	35.8	49.0	1.1	98.2	65.0	20.7	29.7	0.5	0.8	0.6	0.9	56.6	0.1	0.9	0.2	0.2	3.8	3.1	1.3	1.8	0.5	43.9	99.0	1.5	27.0	109.6	0.1	14.2	0.0	0.2	0.2	1.3	1.0	0.9	4.3	1.1	0.9	28.8	3.2	0.5	0.7	15.6	1.3	1.2	0.0	0.4	1.6	129.4	0.3	0.5	1.1	0.4	0.4	2.5	11.9	63.6	2.0	7.6	0.4	1.7	1.8	1.1	0.7	1.3	17.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	6.9	7.1	6.4	7.1	5.9	7.5	13.0	7.6	9.5	8.3	10.4	8.6	5.2	0.0	0.5	6.5	0.4	3.3	0.2	0.0	0.0	0.6	0.8	7.1	2.9	1.5	0.0	0.0	0.0	1.6	0.6	0.2	0.0	0.4	0.6	1.9	64.5	6.3	0.0	4.0	0.2	0.4	1.5	111.3	0.5	1.3	4.5	0.2	45.0	1.0	6.4	0.0	0.3	0.3	0.0	2.5	5.8	10.0	85.1	4.1	10.6	8.4	0.5	3.6	0.0	0.5	0.3	0.8	0.1	167.3	0.8	0.2	0.5	1.0	0.0	1.1	72.3	35.3	52.4	0.6	0.4	0.4	3.1	2.9	1.3	10.7	0.1	0.1
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089846-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	21.9	17.3	32.6	10.7	56.4	5.8	16.7	48.0	38.5	22.2	12.8	34.7	10.8	17.6	15.1	24.7	18.5	15.8	13.1	30.3	43.2	24.3	5.9	13.9	10.2	48.2	49.9	14.6	5.7	36.3	14.9	15.9	55.8	47.5	38.6	3.4	17.1	28.3	52.3	30.1	19.4	20.8	43.4	32.5	10.3	10.3	47.4	4.0	16.2	34.7	8.8	13.6	23.4	77.9	3.7	5.8	7.0	4.3	194.4	61.9	29.3	27.2	6.0	7.2	7.4	28.3	48.8	26.4	32.7	21.7	16.0	36.0	6.9	37.3	2.8	21.3	5.2	57.4	2.6	12.1	21.3	10.7	71.0	56.3	47.6	4.1	13.3	48.5	24.9	24.8	11.8	16.7	26.8	9.9	4.5	0.4	1.6	41.2	18.2	19.5	0.0	11.1	21.0	30.6	3.7	2.9	11.5	11.4	21.2	9.6	11.6	2.9	17.9	38.6	11.3	26.1	11.7	13.8	11.0	2.2	11.7	5.6	87.8	1.2	0.8	0.6	3.6	2.2	3.4	4.6	2.3	3.1	1.9	4.7	1.9	2.3	0.4	2.2	3.9	0.8	1.5	4.2	32.6	56.4	48.0	38.5	30.3	43.2	48.2	49.9	55.8	43.4	47.4	77.9	34.1	9.6	19.4	22.9	15.6	8.0	18.9	14.9	7.4	2.4	8.4	15.9	10.9	20.0	16.2	11.0	0.0	3.6	9.9	99.5	1.9	5.5	2.7	7.1	13.8	32.4	16.2	29.9	24.9	8.9	7.8	16.9	10.2	22.9	14.5	93.4	43.2	3.9	3.1	0.0	30.2	22.2	8.2	3.4	4.9	4.4	10.2	15.6	28.4	16.9	4.3	2.2	23.7	19.1	122.9	7.9	44.5	15.1	3.3	17.7	26.9	9.2	5.8	0.8	39.5	15.9	34.5	0.4	2.5	27.8	12.5	12.4	8.8	18.5	21.0	8.8
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818500-128822676	"Plasma proteins, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.2"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 111.4;Late spermatids: 147.4;Respiratory ciliated cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	11.2	18.8	19.7	2.9	20.0	4.4	11.9	23.7	25.1	9.3	27.0	16.8	12.5	9.3	1.8	17.5	12.6	1.7	52.2	20.1	22.5	24.3	52.9	9.9	3.3	23.4	20.8	8.1	22.5	12.0	13.7	3.6	19.5	14.9	5.7	2.0	14.9	7.0	135.2	13.6	11.5	3.0	20.3	9.2	18.4	20.6	22.6	3.8	11.9	59.1	3.1	11.8	11.0	22.9	14.2	15.3	3.9	20.7	10.0	8.5	17.5	13.4	6.9	12.4	8.6	9.3	11.2	4.6	11.9	8.8	7.7	39.6	12.5	11.8	2.2	9.0	22.4	8.0	14.6	16.7	4.5	24.8	29.3	8.9	14.1	7.5	5.1	7.6	9.6	15.2	25.4	7.1	7.9	20.9	19.4	51.1	9.7	24.6	56.4	22.9	4.5	48.2	18.8	5.1	34.0	33.8	30.0	27.2	7.4	2.6	26.1	12.2	9.8	8.7	5.2	12.5	10.2	22.2	3.3	8.9	17.5	17.6	9.1	0.0	1.1	0.7	1.3	2.0	1.2	1.5	1.3	0.6	1.8	2.8	1.2	1.4	0.0	1.3	0.9	3.6	0.6	0.6	19.7	20.0	23.7	25.1	20.1	22.5	23.4	20.8	19.5	20.3	22.6	22.9	19.0	9.6	5.5	13.1	11.4	8.8	26.9	12.8	6.2	14.0	28.7	21.7	0.6	20.0	16.8	23.9	4.2	31.9	26.9	55.1	101.8	6.0	97.1	111.4	15.1	9.3	14.4	16.8	4.6	7.9	34.4	14.9	21.4	30.1	1.3	93.0	10.0	80.3	20.0	11.8	8.3	27.2	18.3	17.7	7.7	147.4	18.6	15.6	10.6	4.7	6.4	37.2	10.3	3.0	7.8	7.8	24.1	18.8	11.0	18.4	52.0	108.2	115.1	13.1	6.6	23.7	19.0	74.9	6.6	19.1	14.5	10.1	14.5	44.5	36.6	23.3
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879190	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394, CAB080034"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		310000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	463.4	418.4	552.9	553.3	591.7	792.8	409.1	679.7	749.9	370.7	585.6	382.6	401.2	321.7	125.7	1049.4	281.6	302.0	328.2	638.1	599.6	1063.6	612.2	453.2	492.4	624.1	607.7	295.0	220.8	347.2	245.7	362.7	602.9	279.2	358.3	741.5	581.3	354.2	231.0	548.1	382.3	471.3	583.4	394.9	321.6	217.7	585.3	455.6	271.4	146.5	695.4	485.9	519.7	571.5	3637.0	3088.4	1461.8	1258.6	1194.2	1323.8	1316.6	1919.1	2110.9	4044.1	3767.4	1986.9	2041.5	2586.5	2496.8	2328.5	1651.8	1736.8	2511.5	5127.7	4081.0	1780.5	2645.9	2191.3	2848.0	2511.0	1789.6	4421.6	1290.1	1377.4	1526.1	3208.9	4825.9	3045.2	2630.1	1294.6	2444.4	982.3	2664.2	1784.1	1685.2	2354.5	1600.3	1290.4	3063.4	1712.4	2172.9	4259.0	4815.0	843.6	1961.4	1211.1	2251.0	3232.5	2407.8	1748.4	1621.8	1302.1	2424.7	2774.5	2444.5	2402.3	3328.3	2771.0	2120.4	3906.9	4313.8	3556.1	2388.6	195.9	1198.7	232.3	528.4	822.7	597.3	411.2	552.5	543.2	1216.4	386.1	443.4	466.0	230.6	635.3	830.6	336.1	700.0	2171.2	552.9	591.7	679.7	749.9	638.1	599.6	624.1	607.7	602.9	583.4	585.3	571.5	140.0	278.9	499.1	99.6	222.3	416.5	570.9	1939.8	348.8	178.2	242.7	324.6	69.6	283.1	657.4	606.9	70.9	1045.4	194.0	455.9	925.4	2259.3	281.3	205.3	227.7	314.3	189.0	145.4	32.0	1399.1	2078.5	303.5	144.8	248.4	297.2	408.6	133.5	351.7	1147.4	482.9	33.2	297.3	787.3	356.4	524.5	699.6	171.5	454.2	448.2	30.9	1558.2	2624.9	279.1	28.6	26.9	1433.6	366.9	135.1	211.0	555.7	742.2	1005.4	245.7	216.6	151.2	156.1	402.5	215.1	154.3	468.1	349.6	1001.8	285.6	609.8	528.4	444.2
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 1695.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 318.2;Cone photoreceptor cells: 312.8;Horizontal cells: 429.0;Rod photoreceptor cells: 787.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 11.3;memory B-cell: 6.8;memory CD4 T-cell: 13.1;memory CD8 T-cell: 11.4;naive B-cell: 4.4;naive CD4 T-cell: 8.2;naive CD8 T-cell: 8.6;neutrophil: 7.0;T-reg: 7.5"	"Group enriched"	"Detected in many"	7	"B-cells: 6.8;granulocytes: 7.0;T-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 537.4;U-87 MG: 398.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		55000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	25.6	46.7	280.8	20.0	289.7	9.6	20.2	291.2	400.7	55.9	97.5	74.0	10.2	40.1	12.6	15.3	40.2	17.9	53.7	295.0	289.4	27.8	7.7	33.8	26.3	289.4	189.9	29.7	9.0	43.6	124.4	10.4	282.2	34.9	15.5	1695.6	13.8	34.4	7.4	19.3	37.1	35.0	164.3	26.4	30.4	9.6	259.0	26.7	42.0	6.4	24.4	57.4	44.1	306.2	74.3	45.3	16.2	0.5	23.7	26.0	1.5	56.5	37.3	82.0	125.9	8.6	5.8	103.9	9.5	24.3	108.8	11.0	173.0	15.4	116.1	211.9	16.6	141.0	47.7	60.3	17.4	8.3	161.2	13.0	0.7	61.1	11.5	537.4	17.5	137.9	9.5	1.1	56.3	10.3	66.9	8.8	84.9	31.7	27.2	75.0	13.9	22.9	38.5	9.8	128.3	94.0	14.3	1.0	96.3	76.4	4.5	3.9	20.9	69.4	73.7	95.7	73.0	73.3	79.5	15.4	398.4	0.3	15.2	2.1	0.0	0.2	9.9	0.0	11.3	6.8	13.1	11.4	0.1	4.4	8.2	8.6	7.0	0.4	0.3	1.2	7.5	6.1	280.8	289.7	291.2	400.7	295.0	289.4	289.4	189.9	282.2	164.3	259.0	306.2	3.2	35.3	27.4	54.2	11.2	6.2	2.3	45.2	1.8	318.2	5.2	4.3	16.1	1.5	17.2	12.9	312.8	0.3	7.5	0.3	0.0	17.0	0.5	9.6	2.1	9.9	23.9	7.0	96.2	1.8	1.1	8.3	2.0	2.7	67.2	1.0	5.3	0.2	1.7	429.0	89.4	0.5	18.3	0.6	6.9	0.3	5.6	5.9	12.4	25.3	3.5	146.1	0.0	23.6	31.5	9.3	1.2	9.8	9.2	2.5	0.1	0.2	32.2	787.2	13.1	8.1	20.2	1.5	2.5	1.1	2.3	0.3	17.1	0.3	0.4	2.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 383.3;choroid plexus: 753.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	104.7	46.7	98.9	62.0	208.4	2.7	89.7	188.1	150.1	73.6	753.4	32.6	67.5	139.2	20.2	9.0	55.7	39.9	9.9	111.0	133.0	76.6	28.5	42.7	109.8	246.2	164.4	15.2	15.9	20.2	11.8	252.3	244.4	26.4	32.3	6.9	9.9	27.3	8.9	17.5	45.8	85.1	147.8	51.4	26.9	31.3	153.7	20.8	10.8	23.9	85.8	45.1	18.1	383.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	98.9	208.4	188.1	150.1	111.0	133.0	246.2	164.4	244.4	147.8	153.7	383.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	11	"U-698: 8664.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol		NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: AB_2681425"	"unprognostic (6.27e-2)"	"prognostic favorable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	140.5	106.6	151.2	115.1	156.7	219.8	154.9	133.6	188.2	145.2	132.6	135.9	133.6	117.8	183.3	288.0	100.5	94.9	120.2	161.6	144.1	118.8	148.8	124.0	128.4	137.2	135.6	102.4	108.5	173.0	92.0	103.7	134.2	97.7	123.9	121.8	122.9	94.6	301.0	241.3	132.7	105.8	136.9	99.7	124.1	45.2	147.4	157.8	134.4	212.3	146.7	147.0	165.6	157.0	287.1	170.8	236.9	206.9	149.7	126.8	220.7	141.0	148.4	199.9	171.7	207.3	216.6	288.9	196.8	122.1	125.1	238.3	198.5	325.4	160.1	415.1	277.4	434.3	239.6	158.2	108.3	372.1	462.6	100.5	202.0	214.1	293.6	118.8	206.2	224.8	321.7	551.8	140.9	775.5	302.3	272.6	431.2	386.2	211.1	298.6	199.9	328.0	299.2	306.0	303.8	193.3	201.6	385.6	222.1	200.8	533.9	442.9	208.2	143.9	261.9	171.8	340.3	309.4	441.4	8664.2	197.1	357.6	191.8	67.3	54.4	94.3	55.6	62.9	52.2	64.3	46.3	57.5	70.7	55.3	37.7	56.0	53.0	68.8	64.3	58.3	58.2	75.1	151.2	156.7	133.6	188.2	161.6	144.1	137.2	135.6	134.2	136.9	147.4	157.0	103.1	41.7	166.1	20.9	132.9	190.3	225.1	303.9	124.7	59.7	152.7	117.1	102.6	98.7	172.9	82.8	45.9	286.5	148.9	170.7	254.3	160.3	9.7	109.1	68.5	114.2	130.8	178.2	44.7	152.4	184.2	85.9	71.9	93.7	224.3	51.1	80.3	86.9	203.3	67.3	29.3	169.1	211.6	101.1	171.4	17.7	86.0	123.3	103.2	19.7	409.7	83.6	184.4	21.6	19.3	91.5	146.8	104.2	135.6	128.0	187.2	186.0	128.8	50.0	72.3	85.5	94.4	27.6	25.0	269.7	286.8	382.8	140.4	87.9	163.9	253.7
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949942-132080460	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA016704: AB_1854888, HPA049013: AB_2680598"	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	11.9	14.0	18.5	7.6	15.6	12.2	11.9	15.0	18.1	16.8	9.3	15.7	6.0	14.4	13.2	11.4	15.0	5.9	11.6	18.2	14.6	15.4	11.7	11.3	11.4	14.0	12.1	19.5	12.5	9.5	17.4	6.4	13.1	14.3	6.6	18.1	10.3	8.8	19.3	15.4	13.1	7.3	8.7	18.6	11.7	14.6	15.5	11.7	14.3	8.9	8.6	13.1	12.6	16.5	23.5	30.6	28.3	14.2	16.6	16.3	22.3	13.0	9.9	9.8	8.4	18.3	7.1	19.9	11.8	16.2	11.1	17.6	13.7	13.0	13.2	8.3	20.6	28.5	10.8	20.8	13.7	30.9	21.3	14.0	12.1	18.1	16.3	16.7	16.9	12.7	28.3	5.5	14.3	29.6	23.5	42.1	22.6	12.7	26.3	24.6	19.0	8.1	13.3	28.3	22.8	19.2	15.1	10.4	15.0	20.4	17.4	24.1	25.4	15.6	24.3	17.6	18.9	14.1	11.6	19.8	16.2	17.0	16.0	0.7	0.7	0.6	1.1	0.6	1.1	4.0	1.0	0.9	0.6	4.0	1.2	1.7	0.6	0.6	0.6	4.7	0.7	0.6	18.5	15.6	15.0	18.1	18.2	14.6	14.0	12.1	13.1	8.7	15.5	16.5	19.1	3.2	17.9	44.4	27.8	9.9	10.5	11.0	17.1	34.2	14.0	10.5	13.9	7.2	14.3	16.5	39.6	12.6	22.4	13.2	1.9	11.3	12.5	21.3	25.5	18.6	14.4	14.9	59.6	10.4	11.4	17.3	14.8	21.8	6.3	34.1	15.7	12.1	15.0	25.2	56.4	13.8	12.2	14.1	7.6	6.8	16.4	17.9	7.2	24.4	16.7	15.7	29.9	55.8	48.9	15.3	14.0	17.0	24.3	17.8	8.8	4.2	35.9	37.2	19.7	31.2	20.2	62.8	54.3	20.0	13.1	17.8	26.5	26.9	13.5	13.4
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 12.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	27.6	28.1	5.8	27.4	5.3	4.1	11.7	17.9	49.9	6.4	0.0	17.7	49.6	7.8	5.6	10.7	13.6	9.3	6.5	7.1	24.8	33.9	4.8	13.9	7.9	59.6	14.7	11.4	6.9	59.6	10.4	21.1	53.3	5.8	13.1	45.8	4.0	7.3	6.1	4.0	47.7	13.4	7.7	12.2	3.2	62.3	29.1	6.5	4.6	10.7	3.9	10.3	5.7	29.8	0.3	0.9	3.9	0.0	54.5	62.8	43.7	12.8	0.0	0.0	0.0	0.7	0.1	0.1	0.1	39.8	23.2	0.2	38.6	0.0	0.0	0.0	34.2	0.1	0.4	0.0	0.2	0.1	4.6	33.3	0.0	12.3	0.1	16.2	59.5	0.0	0.4	0.4	0.1	0.0	0.5	0.7	7.9	0.2	12.5	0.3	0.0	0.2	0.4	4.8	65.5	0.5	0.1	0.5	25.9	31.2	0.7	4.8	164.8	0.3	57.7	57.1	71.6	0.1	0.1	0.0	0.2	5.4	6.8	0.0	4.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.7	0.0	12.4	0.0	0.0	0.7	5.8	5.3	17.9	49.9	7.1	24.8	59.6	14.7	53.3	7.7	29.1	29.8	18.2	19.2	6.4	28.7	1.3	15.9	4.1	0.0	3.4	75.6	5.3	1.7	3.5	2.8	1.9	7.3	77.2	98.6	0.2	44.0	15.6	0.4	171.9	2.2	10.1	21.9	9.1	3.2	306.8	0.7	44.2	27.7	0.0	2.1	0.0	0.0	7.1	0.8	58.8	3.3	237.4	10.0	0.0	82.2	66.7	291.6	22.4	81.9	10.6	103.0	50.9	3.3	2.1	44.2	159.2	0.8	8.3	7.9	1.6	3.8	91.2	68.4	1.6	14.7	0.0	3.0	13.1	2.7	11.5	2.3	8.4	214.0	2.6	0.2	12.3	1.7
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221018	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 98.9"	"Cell type enriched"	"Detected in many"	33	"Erythroid cells: 480.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"HEL: 85.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	3.1	0.0	0.0	0.0	0.0	98.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	1.9	1.5	0.5	0.0	4.0	0.0	0.0	0.6	1.5	0.5	0.0	6.2	4.5	0.0	1.5	0.0	0.0	14.4	0.0	0.0	1.2	0.0	480.0	0.1	0.0	2.3	0.8	0.0	0.0	4.5	0.0	2.5	1.1	1.1	6.7	0.1	0.9	4.1	2.2	2.8	10.5	2.8	1.1	1.8	0.0	3.6	2.5	14.4	0.0	0.0	0.0	1.7	0.7	0.4	1.5	2.4	0.0	0.6	8.4	6.6	1.0	1.0	13.5	4.6	0.0	2.8	6.7	3.8	0.0	0.8	2.0
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 806.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2317.0;Ductal cells: 999.6;Intestinal goblet cells: 1378.2;Paneth cells: 2437.0;Proximal enterocytes: 2681.1;Undifferentiated cells: 1607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 538.9;CACO-2: 680.9;CAPAN-2: 944.4;OE19: 911.8;RPTEC TERT1: 398.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA		22000		"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	4.4	12.2	3.1	77.0	4.0	10.2	99.7	1.5	3.1	116.2	1.0	806.0	726.5	33.0	238.9	10.8	114.3	71.1	0.6	3.3	9.2	223.1	3.1	74.7	0.9	2.8	3.2	1.2	125.4	219.5	86.9	1.7	3.4	60.5	751.0	0.6	119.8	52.8	0.1	8.8	769.6	22.2	2.6	1.4	172.4	21.7	10.4	6.4	286.8	0.1	2.8	30.9	4.2	2.6	538.9	5.4	0.4	1.2	0.0	0.0	321.3	0.2	0.0	0.6	0.0	680.9	944.4	0.1	141.5	1.0	0.4	247.3	4.6	62.2	2.0	0.1	56.3	0.3	2.5	261.6	0.1	0.3	0.4	0.0	17.6	0.0	0.0	0.0	0.8	0.0	160.9	0.0	0.3	269.7	0.5	24.0	164.3	911.8	31.4	0.3	0.0	136.9	398.6	231.3	354.0	3.2	4.3	187.7	0.6	132.7	158.3	1.0	0.7	0.3	6.3	2.0	1.1	39.2	0.6	0.8	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	4.0	1.5	3.1	3.3	9.2	2.8	3.2	3.4	2.6	10.4	2.6	3.7	310.9	148.1	1.3	7.0	9.3	227.6	127.4	14.2	0.5	184.7	112.9	2.0	243.1	222.8	448.8	0.0	16.4	2.3	2317.0	76.3	999.6	8.6	434.7	35.3	5.8	498.1	23.1	1.1	402.8	6.5	6.3	150.3	445.3	32.5	11.8	1.4	0.6	2.9	0.0	0.4	1378.2	486.2	0.0	5.2	5.6	20.5	5.6	35.6	0.0	11.5	15.7	0.0	0.5	1.2	617.5	2437.0	18.8	1.8	257.9	2681.1	195.9	219.0	0.7	13.1	0.5	13.7	83.5	130.3	33.3	10.4	6.0	9.4	70.3	1607.7	230.7
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408856	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 57.2;parathyroid gland: 206.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.3;Gastric mucus-secreting cells: 13.3;Proximal enterocytes: 13.2;Squamous epithelial cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.9;naive CD4 T-cell: 3.8;naive CD8 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 17.9;HaCaT: 16.6;HBEC3-KT: 13.5;MCF7: 15.0;NTERA-2: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB026144	Uncertain					NA	NA		32000000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.1	0.0	0.0	1.3	0.0	0.3	2.2	0.4	0.1	11.2	1.2	3.7	8.4	0.3	1.2	57.2	3.4	1.5	0.0	0.0	0.0	5.8	15.6	2.3	2.0	0.0	0.0	0.0	5.7	206.5	2.5	0.6	0.0	4.0	1.6	0.0	11.0	1.2	0.0	19.7	6.2	0.1	0.0	0.9	4.2	1.9	0.0	3.4	5.4	0.0	3.5	1.9	25.8	0.1	8.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	17.9	7.1	0.0	0.1	0.0	0.0	16.6	0.0	13.5	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.8	0.1	0.0	4.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	15.0	0.0	1.9	54.4	8.8	0.0	0.0	0.0	0.0	1.1	6.7	0.3	0.0	0.0	8.2	0.0	3.2	3.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.0	3.8	2.9	0.1	0.1	0.0	0.4	0.1	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.2	0.3	0.1	2.0	6.3	6.5	6.8	0.0	3.3	5.0	1.0	2.8	9.9	7.3	0.0	2.0	0.2	4.2	0.0	4.4	23.3	4.0	1.0	0.2	1.2	0.0	0.6	4.3	2.6	0.5	13.3	6.6	0.0	0.0	0.4	8.8	0.4	0.0	0.3	4.7	2.0	0.3	0.3	9.9	0.6	0.3	0.0	1.0	0.0	0.3	0.0	0.5	0.2	6.3	8.8	0.0	0.6	2.0	13.2	1.5	2.1	0.2	0.0	0.4	0.4	0.5	1.9	28.7	3.7	1.0	4.4	0.0	7.6	5.5
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 39.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 317.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 23.8;hippocampal formation: 20.9"	"Group enriched"	"Detected in many"	9	"basophil: 1.6;gdT-cell: 1.7;MAIT T-cell: 1.7;memory B-cell: 1.3;memory CD4 T-cell: 2.5;memory CD8 T-cell: 1.7;naive B-cell: 1.2;naive CD4 T-cell: 1.0;NK-cell: 3.5;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 77.0;ASC diff: 33.9;CACO-2: 59.3;U-2197: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		9300000	"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.8	1.6	0.0	1.9	3.9	3.7	3.9	0.0	23.8	4.5	39.7	4.6	1.0	6.4	2.8	4.8	4.9	3.1	17.4	20.9	0.0	4.8	0.8	3.6	2.7	0.0	1.5	11.1	1.1	1.9	0.6	1.6	0.0	5.3	4.5	4.2	2.6	6.1	2.7	12.9	2.8	8.0	0.0	3.4	2.3	11.7	3.7	3.8	9.5	4.0	3.2	3.6	3.5	0.0	2.6	2.4	77.0	0.0	33.9	20.9	0.1	18.2	8.3	16.9	6.2	59.3	0.9	0.0	0.1	26.7	0.0	7.0	12.3	0.1	7.0	9.7	6.4	0.0	0.9	0.0	0.9	0.0	1.4	8.5	4.2	5.3	0.1	10.3	14.9	0.0	0.0	0.0	4.4	9.5	0.2	0.0	5.6	5.9	1.7	0.1	8.5	0.0	25.8	4.3	13.2	0.0	6.2	1.3	1.3	6.2	2.9	0.0	0.0	1.7	3.2	38.4	1.0	0.0	0.1	0.0	6.9	0.0	3.6	1.6	0.0	0.0	1.7	0.0	1.7	1.3	2.5	1.7	0.0	1.2	1.0	0.2	0.1	3.5	0.0	0.1	1.2	0.4	0.0	3.9	0.0	23.8	20.9	0.0	0.0	1.5	0.0	0.0	3.7	0.0	36.3	0.0	6.4	51.9	8.2	6.1	0.7	9.7	2.8	9.8	4.3	6.0	31.6	7.2	13.7	9.2	0.0	0.1	12.2	4.7	7.9	0.2	3.9	1.9	5.7	26.3	3.5	0.0	317.9	0.2	0.0	5.1	4.6	5.2	1.3	9.0	20.0	0.4	0.3	1.7	68.8	12.8	8.2	0.0	1.5	5.8	1.2	0.9	7.2	70.3	0.2	7.2	3.1	8.0	7.9	30.9	3.6	8.6	2.1	1.4	0.1	1.7	4.5	3.2	0.0	3.6	10.2	10.0	1.9	4.1	12.5	0.0	5.4	11.3	6.6	2.4
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419687	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.6;parathyroid gland: 69.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 138.6;Inhibitory neurons: 172.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		660000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	0.3	0.0	1.2	0.4	3.4	0.0	1.2	3.4	5.1	1.4	0.0	24.6	1.5	0.9	0.2	0.2	0.5	2.2	3.6	4.9	2.6	5.9	0.0	0.2	0.0	1.2	2.2	1.9	0.1	69.9	1.2	0.4	1.5	9.7	2.5	1.8	5.4	0.9	0.1	0.2	4.4	2.1	0.4	3.9	10.3	0.9	0.6	0.0	0.1	0.1	0.0	8.2	1.8	1.2	0.0	0.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	35.1	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	1.0	5.4	31.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	3.4	5.1	4.9	2.6	1.2	2.2	1.5	0.4	0.6	1.2	0.2	0.0	0.0	4.2	0.0	0.4	0.4	0.0	0.6	18.5	3.1	1.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	13.1	1.3	1.4	1.8	0.0	0.0	138.6	0.0	0.0	5.9	0.0	3.8	0.0	3.7	0.0	0.0	0.1	11.8	172.0	0.0	0.0	0.0	0.4	3.3	0.9	0.1	0.0	11.2	0.0	0.4	0.0	4.5	8.3	0.1	0.0	0.0	0.0	0.4	0.0	11.8	0.0	1.0	0.0	0.2	0.5	0.2	1.1	0.2	1.0	0.0	0.2	0.9	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 45.1;Enteroendocrine cells: 48.7;Intestinal goblet cells: 61.1;Oligodendrocytes: 76.3;Pancreatic endocrine cells: 63.7;Undifferentiated cells: 97.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 86.5;HUVEC TERT2: 74.2;TIME: 79.2;U-251 MG: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		380000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.1	1.6	2.1	9.2	3.7	0.5	1.6	4.1	4.2	2.5	0.0	22.6	21.0	1.8	1.9	0.6	4.4	3.7	3.3	2.2	4.3	3.8	0.4	1.8	2.9	5.7	4.5	10.6	3.9	6.1	2.9	4.0	4.8	1.9	23.3	2.9	1.5	3.0	0.2	0.9	21.8	3.3	5.0	2.4	1.7	1.8	5.4	1.2	7.3	0.3	1.7	4.4	1.0	8.2	43.4	17.2	17.2	27.7	1.6	1.5	0.0	10.0	0.5	27.3	5.7	6.3	16.6	0.6	20.2	4.0	86.5	39.6	10.8	52.8	7.7	0.1	4.1	0.0	1.9	0.1	16.5	0.0	4.3	5.3	17.5	48.7	0.3	25.4	74.2	2.4	1.8	0.1	5.7	6.4	1.1	0.3	4.0	49.0	11.2	5.3	18.0	0.8	14.7	4.0	18.0	19.3	17.4	0.7	0.2	1.5	1.1	0.5	79.2	11.5	29.6	29.4	69.5	0.0	0.2	0.1	21.8	0.9	0.5	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	4.1	4.2	2.2	4.3	5.7	4.5	4.8	5.0	5.4	8.2	0.4	3.2	0.0	5.5	0.3	0.8	1.7	20.5	0.0	15.4	0.1	0.1	1.3	7.2	8.6	0.0	0.0	0.5	0.1	24.3	0.0	45.1	2.6	1.0	0.8	1.2	48.7	0.0	34.1	8.0	2.8	5.0	1.1	2.4	0.0	0.5	0.4	0.4	9.6	6.7	32.3	61.1	6.1	7.6	1.4	0.8	0.9	7.2	0.0	21.5	0.7	18.4	0.0	5.5	76.3	63.7	12.6	0.7	0.3	2.3	5.5	0.2	1.7	1.8	0.0	0.6	2.1	0.5	3.5	0.0	0.4	1.1	0.3	0.2	97.2	1.1
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827523	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.0;neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013537	Uncertain					NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	26.4	49.8	5.0	8.0	4.3	5.6	32.6	4.6	4.8	45.6	6.8	20.7	8.3	61.5	3.8	24.7	27.1	18.0	26.1	4.1	4.1	28.3	33.3	28.2	5.8	5.5	5.1	36.0	26.8	10.1	6.3	35.5	5.3	28.9	10.2	0.3	24.2	22.4	7.7	35.8	17.5	22.2	5.1	47.9	21.4	12.3	6.3	3.1	17.6	13.3	4.9	17.3	28.1	4.8	37.7	33.1	32.5	94.2	20.4	13.0	94.7	14.1	31.2	22.3	29.0	27.4	28.3	4.8	63.6	15.3	31.3	38.2	14.3	38.3	11.9	6.2	25.6	1.3	19.0	43.2	11.8	0.7	0.9	15.3	56.7	14.2	33.1	24.8	84.0	1.5	71.9	1.8	18.4	66.4	0.7	15.0	54.7	56.3	47.5	51.4	15.6	8.9	28.6	19.9	0.2	27.4	22.0	10.4	22.1	45.1	26.1	6.7	71.3	27.6	42.6	51.3	21.4	0.2	0.8	1.7	4.0	12.0	51.2	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.7	5.0	4.3	4.6	4.8	4.1	4.1	5.5	5.1	5.3	5.1	6.3	4.8	47.1	9.6	12.6	1.6	1.9	20.5	10.3	13.9	15.9	0.1	22.0	19.7	5.7	7.2	8.5	5.5	0.0	68.5	1.1	9.1	0.0	12.3	28.5	4.8	21.8	51.2	3.0	10.8	0.3	6.6	11.2	6.5	12.8	8.0	1.3	10.7	113.2	22.4	9.0	0.0	0.2	17.4	8.2	4.1	3.4	9.9	8.1	1.3	3.6	1.9	1.5	1.7	0.0	0.0	1.0	20.6	7.6	4.1	1.4	13.3	1.3	4.0	4.2	0.2	6.6	5.7	6.3	1.4	10.2	12.1	17.8	206.5	1.2	2.9	19.9	8.0
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 387.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 263.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	57.1	75.3	63.1	27.3	61.2	22.1	53.0	30.3	82.2	51.1	14.8	73.1	88.7	47.8	9.2	80.5	48.7	14.3	148.6	65.2	31.5	85.2	137.1	50.5	19.3	37.8	38.5	76.2	104.3	22.3	51.1	17.4	31.1	64.8	16.2	8.9	50.9	20.0	156.1	71.0	80.4	11.0	27.9	72.8	152.6	80.8	40.0	11.6	49.0	35.3	11.2	50.1	54.5	47.1	95.5	128.8	31.5	64.8	35.6	33.8	64.6	69.3	39.0	48.2	48.0	54.1	58.7	58.1	46.1	55.6	42.5	71.5	27.7	52.9	17.4	20.4	263.2	42.8	67.4	65.3	48.9	27.8	39.3	43.9	45.6	41.7	30.1	34.7	46.4	40.7	64.7	48.0	32.2	53.6	44.4	45.2	72.3	71.4	179.6	29.5	42.8	103.2	36.8	55.3	45.2	109.9	64.1	68.8	48.0	21.7	51.6	95.7	78.4	133.0	63.8	48.4	101.3	52.2	50.9	41.7	97.9	55.0	67.5	1.4	1.8	2.3	0.6	2.2	0.4	1.0	0.6	0.6	1.1	0.8	0.6	0.6	2.1	0.3	3.6	1.7	0.9	1.5	63.1	61.2	30.3	82.2	65.2	31.5	37.8	38.5	31.1	27.9	40.0	47.1	62.6	3.2	20.4	9.8	44.2	31.4	29.0	25.9	44.3	33.3	32.7	25.8	15.5	55.8	17.9	44.1	66.7	46.1	28.1	227.7	119.3	57.1	63.2	39.5	37.5	46.1	45.0	35.3	7.8	88.5	80.8	37.2	145.2	45.9	10.8	87.0	83.9	106.1	62.9	28.6	7.8	115.6	22.4	136.5	21.4	169.4	47.5	55.4	23.2	6.5	40.8	33.6	28.8	4.5	8.9	106.5	167.7	53.0	57.7	37.6	387.2	81.8	20.9	41.3	13.1	41.2	34.6	50.2	62.7	46.6	27.4	52.3	26.3	48.2	132.5	39.2
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"	P58107	8	143857324-143878467	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 16.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 137.1;Suprabasal keratinocytes: 274.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;EFO-21: 13.3;HaCaT: 13.8;HeLa: 26.8;MCF7: 20.2;SK-BR-3: 9.3"	"Not detected"	"Not detected"							"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA		1200000		"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.2	0.0	0.4	0.3	0.4	0.1	0.9	3.9	0.5	0.5	1.3	3.3	2.1	2.4	0.3	1.7	2.0	0.2	0.1	0.8	0.6	1.2	0.3	0.9	0.1	2.5	2.7	0.0	0.7	0.2	0.2	0.2	1.7	1.4	0.6	0.0	2.2	1.4	0.2	16.1	2.7	0.9	1.6	1.2	2.1	1.8	0.7	0.1	0.2	0.0	0.2	1.8	0.9	0.4	7.9	0.1	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	7.4	0.5	0.0	13.3	0.0	0.0	13.8	1.4	0.1	0.0	0.0	3.4	0.0	26.8	4.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.2	0.0	0.0	1.4	1.8	0.0	0.0	0.1	0.0	0.0	4.9	2.3	0.0	2.2	9.3	0.0	1.2	7.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	3.9	0.5	0.8	0.6	2.5	2.7	1.7	1.6	0.7	0.4	0.7	19.2	9.2	1.0	1.1	137.1	20.3	8.2	8.0	0.6	32.7	25.0	27.9	11.5	4.4	14.7	0.0	2.5	0.0	48.1	0.0	11.3	0.5	12.6	0.5	3.2	6.0	0.0	0.3	14.7	0.3	2.4	12.2	10.1	0.0	0.6	0.7	4.4	0.3	0.0	0.0	14.5	12.2	0.0	8.2	0.3	0.0	0.4	16.0	0.0	0.0	0.6	0.0	0.0	0.1	31.9	21.7	0.0	0.2	8.6	28.2	7.0	24.2	0.2	0.0	0.0	5.2	1.5	1.0	10.6	274.3	6.2	1.2	0.1	28.4	31.5
EPRS1	"EARS, EPRS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase 1"	P07814	1	219968600-220046530	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	28.8	24.7	18.1	34.4	19.6	26.6	35.7	22.8	24.8	30.5	17.6	36.1	27.7	25.6	25.2	30.6	26.2	20.6	31.8	17.7	21.8	31.6	27.9	24.3	36.5	21.6	20.5	34.7	49.0	54.5	22.5	23.8	22.9	23.6	39.0	43.8	83.4	26.4	52.2	28.9	29.7	32.5	22.4	27.4	35.9	20.5	21.7	34.8	43.0	55.9	42.5	30.4	18.6	27.8	125.9	78.4	55.7	152.3	114.9	126.7	138.0	160.1	111.7	102.1	113.4	93.3	98.1	239.3	86.7	170.4	41.3	130.3	140.9	129.4	136.2	117.9	88.9	130.2	97.6	80.2	125.1	217.6	106.7	92.1	161.7	130.3	161.6	84.8	113.4	113.2	228.0	182.9	100.8	61.8	94.7	53.1	107.4	146.8	159.6	98.5	98.0	236.2	92.8	54.4	128.6	101.3	93.7	152.6	166.5	78.9	141.2	235.1	101.1	48.3	88.1	149.6	151.1	122.8	150.1	197.1	111.4	153.9	156.4	8.8	17.8	10.0	19.7	24.6	27.8	21.0	19.7	22.1	23.2	18.5	22.0	22.9	0.6	22.5	22.1	7.6	20.8	17.2	18.1	19.6	22.8	24.8	17.7	21.8	21.6	20.5	22.9	22.4	21.7	27.8	22.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.7	0.0	0.0	0.0	0.0	40.8	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	59.3	17.1	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	36.5	2.6	0.0	0.0	0.0
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519266	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	31.9	35.1	40.3	25.5	48.2	20.7	25.6	38.8	55.7	23.9	25.7	19.1	15.8	22.8	17.6	21.0	18.3	26.1	26.5	43.9	39.1	24.5	26.4	26.9	46.0	38.6	44.1	28.8	14.7	29.0	15.5	31.5	40.7	26.7	20.5	23.4	16.7	20.9	47.6	24.2	17.7	24.3	40.1	34.1	21.3	46.9	45.0	27.6	25.3	40.5	45.6	22.8	20.9	57.2	35.4	10.4	22.0	20.8	49.6	49.2	54.5	24.2	37.9	19.4	28.4	14.4	19.2	71.8	24.3	38.1	39.5	32.7	28.7	23.1	29.1	81.8	18.0	64.1	16.9	17.1	46.7	36.9	56.4	40.3	21.0	34.0	45.7	33.5	36.5	25.2	40.4	31.7	29.8	17.5	29.9	19.8	30.2	24.6	16.7	24.1	33.3	15.9	25.5	43.2	15.0	20.9	28.8	50.4	42.1	60.2	20.5	25.7	51.1	18.0	19.1	36.3	20.5	37.6	41.0	47.6	26.6	41.0	16.1	18.8	10.4	12.1	9.4	10.7	14.2	15.6	11.2	14.9	10.8	9.0	6.6	9.6	7.8	10.8	13.0	7.1	19.0	8.7	40.3	48.2	38.8	55.7	43.9	39.1	38.6	44.1	40.7	40.1	45.0	57.2	51.5	35.3	41.0	142.4	78.3	43.0	32.1	16.4	30.1	18.1	28.2	15.6	59.8	24.3	22.7	44.1	31.3	22.8	65.0	28.5	19.6	15.2	27.0	22.1	50.1	43.3	28.8	81.0	77.1	19.0	18.9	52.5	41.3	35.6	24.6	36.0	61.4	37.7	83.4	28.6	60.6	30.7	12.2	80.9	61.9	61.7	65.9	67.0	103.2	110.5	57.6	38.4	27.8	29.7	314.1	23.3	19.8	48.2	78.4	62.1	20.7	28.1	31.9	26.6	39.5	45.1	38.0	74.4	44.5	33.8	51.0	28.5	74.3	28.5	21.4	50.8
EPS15L1	eps15R	ENSG00000127527	"Epidermal growth factor receptor pathway substrate 15 like 1"	Q9UBC2	19	16355239-16472085	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019237, HPA055309"	Approved		Approved	Vesicles		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA019237: AB_1848223, HPA055309: AB_2682780"	"unprognostic (3.06e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.54e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.47e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-1)"	15.3	17.6	33.4	11.8	32.4	23.6	14.2	39.6	40.5	22.4	21.5	17.0	8.3	18.1	5.9	25.2	18.7	9.6	42.4	35.6	29.1	20.5	17.9	14.6	13.9	29.3	33.4	19.1	15.5	18.2	22.6	13.9	30.8	19.5	9.2	14.0	14.9	12.9	67.6	23.3	14.3	14.1	23.5	19.8	16.8	22.9	41.0	11.8	17.5	25.7	13.0	17.6	19.7	27.6	27.3	12.8	25.8	20.4	27.4	21.1	40.3	17.8	14.9	28.8	25.1	15.3	18.2	29.2	30.4	26.1	22.8	26.6	36.3	20.8	25.1	15.8	36.8	24.7	17.4	29.8	27.7	22.8	26.7	17.6	21.1	31.9	22.3	28.6	23.6	24.5	20.1	31.2	24.5	53.9	25.4	32.5	17.7	36.4	41.7	32.2	12.5	24.3	19.8	27.9	23.3	15.3	18.6	17.5	17.7	19.2	58.3	21.3	24.5	18.2	12.2	57.3	31.4	8.8	19.4	27.7	20.2	31.9	24.5	53.5	11.9	35.9	11.1	12.0	10.5	20.8	9.8	12.0	9.2	19.3	10.1	7.8	56.2	19.1	14.4	8.6	10.7	9.0	33.4	32.4	39.6	40.5	35.6	29.1	29.3	33.4	30.8	23.5	41.0	27.6	10.8	9.6	9.8	62.3	22.1	16.6	14.0	12.0	12.0	30.7	9.5	8.1	20.4	7.2	10.9	9.2	50.1	21.7	30.8	11.7	9.8	11.0	74.9	10.7	13.0	11.8	11.3	13.9	49.7	5.7	19.7	16.0	16.3	12.1	12.0	22.3	11.0	8.2	20.0	11.8	63.4	10.7	24.4	10.6	14.8	15.1	18.6	13.8	3.6	30.9	13.0	9.9	34.0	36.2	35.6	9.3	9.1	20.3	18.7	15.0	9.0	12.9	14.7	25.9	19.7	20.3	13.9	18.5	16.7	22.3	24.4	10.9	15.8	18.7	9.8	22.2
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620134-15882329	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 22.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 253.0;HHSteC: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA		17000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	62.3	13.0	12.9	16.1	17.4	0.6	33.7	15.3	14.0	53.9	14.1	49.7	37.6	46.2	47.1	20.5	20.1	56.0	26.4	11.1	17.2	55.8	37.8	29.0	9.4	18.5	20.1	49.2	15.1	21.6	3.5	53.1	19.7	16.4	53.7	39.8	13.4	39.8	13.8	11.9	42.7	53.7	15.5	11.9	32.0	15.6	16.1	4.8	22.8	24.3	5.2	51.7	21.4	20.8	65.0	38.8	37.7	1.4	253.0	177.6	53.1	73.6	59.8	34.5	46.1	33.3	97.3	0.0	2.4	140.4	114.4	16.4	11.3	9.5	52.4	0.2	12.6	5.7	11.2	34.7	218.1	4.4	0.2	159.8	42.8	91.7	115.7	44.6	17.7	0.2	0.1	0.2	169.0	17.5	0.2	2.8	5.2	50.3	30.8	0.0	109.5	0.8	97.7	92.5	3.1	4.9	21.4	12.4	91.5	6.2	34.2	4.3	28.7	54.7	14.3	32.4	30.7	3.6	0.4	0.1	32.1	10.7	160.0	0.0	2.7	0.2	0.2	10.8	0.1	1.3	0.9	0.4	5.5	0.3	1.1	0.5	4.4	1.0	22.2	0.4	0.1	1.7	12.9	17.4	15.3	14.0	11.1	17.2	18.5	20.1	19.7	15.5	16.1	20.8	121.4	12.8	175.9	91.1	11.6	17.0	39.6	32.0	13.6	9.7	28.7	42.8	27.6	87.2	58.3	23.9	66.7	33.0	15.2	317.0	60.7	69.4	67.6	87.4	72.0	61.4	38.3	0.4	2.2	68.9	7.3	73.4	81.1	152.2	6.3	139.4	36.0	36.0	65.8	6.7	31.1	54.5	67.1	54.1	35.6	49.4	134.8	46.2	35.6	148.0	8.6	15.4	0.0	121.2	96.9	97.0	217.8	43.6	5.2	26.9	69.0	114.6	104.8	153.7	401.0	18.1	313.1	10.9	4.2	22.8	13.1	21.1	11.8	40.0	80.0	97.6
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963682-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"placenta: 6.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"breast cancer: 2.4;ovarian cancer: 7.7;pancreatic cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 3.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.7;basal ganglia: 2.9;cerebral cortex: 2.7;hippocampal formation: 2.2"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 72.8;Inhibitory neurons: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		30000000	"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: AB_2677946"	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	51.5	15.8	3.7	37.0	4.3	27.9	25.5	3.1	5.6	21.8	2.3	37.9	63.4	22.0	14.4	13.2	25.5	23.7	17.1	3.4	5.2	16.4	32.9	31.2	38.2	8.4	5.7	20.7	13.7	19.1	8.2	47.0	7.0	18.6	43.7	12.4	19.3	22.0	20.9	36.5	55.1	21.7	5.0	30.8	33.7	9.1	6.6	63.7	17.5	19.6	36.8	27.3	11.7	6.8	25.9	14.1	21.3	20.0	114.7	111.5	61.4	18.3	59.6	44.0	76.2	17.6	91.1	75.3	37.6	36.0	61.8	25.7	17.8	38.1	27.3	139.8	7.5	24.7	10.0	13.9	130.9	12.0	44.1	46.8	16.2	50.6	15.5	64.3	61.1	48.8	12.9	74.7	26.7	11.6	113.2	12.4	10.6	3.1	10.4	82.4	28.8	38.4	32.8	39.0	7.8	5.5	29.6	19.8	28.6	14.6	17.1	57.0	48.8	37.4	12.6	6.2	31.1	26.9	53.9	57.8	40.2	40.2	22.5	28.8	15.2	18.0	22.6	12.3	20.2	14.8	19.2	19.1	10.5	18.3	22.3	18.1	15.8	23.1	20.6	16.7	13.9	13.7	3.7	4.3	3.1	5.6	3.4	5.2	8.4	5.7	7.0	5.0	6.6	6.8	11.1	9.6	16.3	34.0	15.3	25.0	14.2	19.2	8.6	13.6	6.6	3.9	10.6	10.0	16.9	9.2	2.1	9.6	21.1	24.4	0.0	12.4	27.0	12.7	15.0	16.3	10.3	14.1	72.8	15.5	11.9	18.4	16.3	19.8	15.2	13.9	16.8	28.0	17.6	3.3	79.3	23.9	4.1	29.9	16.1	7.3	9.9	22.9	7.2	24.4	32.5	9.0	20.6	32.6	70.1	12.3	14.1	16.1	32.3	13.5	47.3	6.9	23.1	7.6	0.0	10.3	22.6	1.4	1.8	9.8	11.1	9.2	21.8	5.7	27.3	14.9
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025331, HPA045396, HPA070524"	Approved		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312, HPA070524: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	2.4	2.6	34.4	8.0	69.2	0.9	56.5	45.9	62.0	20.9	10.9	62.9	88.5	5.5	12.3	82.0	12.1	30.6	9.0	39.2	43.1	36.2	98.6	29.3	0.6	59.4	54.4	1.6	57.0	23.8	2.4	13.0	54.7	37.8	64.1	1.3	83.0	18.2	2.4	75.7	82.5	3.8	36.2	0.6	74.7	2.3	55.9	1.0	9.4	1.7	12.5	21.8	44.2	104.9	39.8	2.1	3.2	1.4	0.2	0.1	63.2	3.9	7.2	4.5	4.1	20.4	70.4	0.2	0.8	1.0	0.6	32.2	5.0	7.7	2.3	0.7	3.0	0.1	1.1	116.4	0.1	0.1	0.5	1.3	9.3	0.7	0.3	0.7	0.1	0.8	2.6	1.0	0.4	71.6	0.4	1.3	10.4	119.1	1.9	0.4	7.4	2.1	7.9	89.7	3.3	1.3	2.6	106.5	149.5	9.1	122.2	0.7	0.3	0.5	4.0	1.9	0.5	0.9	0.6	0.6	0.4	0.3	153.4	2.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	1.0	0.4	0.2	0.2	0.3	0.1	34.4	69.2	45.9	62.0	39.2	43.1	59.4	54.4	54.7	36.2	55.9	104.9	0.8	118.6	81.0	1.0	1.5	18.2	15.3	21.6	19.4	1.5	106.4	47.8	1.9	171.6	74.6	35.0	2.1	52.6	2.0	254.3	1.9	60.1	1.3	36.1	10.9	2.7	93.1	2.7	0.7	88.1	84.6	4.5	96.4	95.9	1.3	0.7	5.0	112.0	6.1	0.0	2.0	145.2	40.7	1.9	3.7	0.5	1.5	1.5	55.2	1.0	1.7	7.7	0.0	49.8	187.0	94.8	184.6	0.0	0.3	103.3	240.2	30.0	54.8	1.1	6.6	4.5	3.4	9.5	13.4	87.7	36.9	100.6	2.5	0.1	136.9	135.4
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;fallopian tube: 11.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.3	0.4	10.0	0.0	13.3	0.0	5.6	10.5	11.5	2.9	0.0	0.1	0.0	0.2	0.0	0.1	11.2	0.0	3.0	9.9	12.7	5.1	0.0	0.8	0.0	4.9	16.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.7	1.2	1.5	0.3	0.0	0.0	4.3	0.0	0.4	3.3	8.0	0.0	1.6	1.7	0.0	0.1	0.1	6.1	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.3	10.5	11.5	9.9	12.7	4.9	16.9	7.6	4.3	8.0	6.1	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
ERC2	"CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110"	ENSG00000187672	"ELKS/RAB6-interacting/CAST family member 2"	O15083	3	55508311-56468467	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 11.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 818.5;Inhibitory neurons: 674.8;Oligodendrocyte precursor cells: 304.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Group enriched"	"Detected in many"	32	"amygdala: 7.9;basal ganglia: 11.7;cerebral cortex: 11.1;hippocampal formation: 7.6;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.4;HUVEC TERT2: 2.1;Karpas-707: 7.9;SH-SY5Y: 2.0;U-266/70: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073739	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA073739: AB_2732240"	"unprognostic (2.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.09e-2)"	0.0	0.3	7.9	0.0	11.7	0.0	0.1	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	7.6	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.8	0.2	0.0	1.7	0.1	0.0	0.3	0.0	2.6	0.2	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.0	0.0	7.9	0.0	0.8	0.0	0.0	1.7	0.0	0.2	0.0	0.1	0.0	1.6	0.0	0.9	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.7	0.0	0.2	6.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	11.7	0.0	11.1	7.6	0.0	0.0	0.2	0.0	0.0	0.0	3.1	0.1	3.2	0.5	22.9	0.0	0.1	0.2	0.0	1.2	11.3	0.4	0.5	3.4	0.0	1.3	0.0	25.0	0.0	0.0	0.0	0.0	0.4	6.2	0.4	0.3	0.5	0.0	0.0	818.5	0.6	0.1	0.6	0.0	1.2	0.0	0.9	0.0	0.0	0.7	5.0	674.8	0.0	0.0	0.0	0.0	2.5	1.5	0.2	0.0	30.9	0.0	1.3	0.0	304.6	102.4	1.6	0.0	0.7	0.0	0.8	0.0	0.6	1.5	10.8	0.0	0.1	0.1	1.5	2.9	0.4	0.1	0.0	0.0	1.2	0.0	0.3
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920154-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 140.7;Late spermatids: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: AB_2679463"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	2.7	3.9	4.7	3.3	5.2	2.5	2.8	6.7	5.4	3.3	4.3	1.9	1.7	3.3	2.8	2.9	3.5	3.0	3.6	4.3	4.9	2.9	3.2	2.7	3.3	5.1	4.8	4.3	2.7	3.9	1.6	2.6	4.9	3.6	2.2	4.1	2.8	2.9	18.5	3.0	1.9	3.6	4.4	3.7	2.6	5.5	5.4	4.2	4.4	3.3	2.9	2.6	1.5	6.8	4.7	5.5	5.3	7.5	8.7	8.1	4.0	6.1	6.4	5.4	6.8	2.1	4.5	7.8	8.6	5.4	4.8	5.8	8.0	4.1	8.3	10.7	4.7	3.8	6.7	5.2	7.9	5.2	4.2	6.1	5.7	7.1	6.0	5.3	7.2	4.6	6.1	8.8	7.6	3.9	7.0	3.4	3.9	2.4	3.1	7.8	10.8	9.7	3.3	3.2	4.3	5.1	7.5	6.0	5.8	4.2	7.5	3.9	7.9	7.8	5.7	7.0	5.4	7.9	9.9	5.2	7.6	6.2	8.1	4.9	2.3	2.3	2.6	2.7	2.9	2.5	2.4	2.0	2.3	3.1	2.4	2.6	2.7	3.6	2.4	3.2	2.5	1.1	4.7	5.2	6.7	5.4	4.3	4.9	5.1	4.8	4.9	4.4	5.4	6.8	14.0	19.2	13.5	16.6	11.3	4.8	6.1	18.3	10.2	0.0	10.0	9.5	8.6	14.3	12.7	5.5	0.0	17.3	9.7	3.3	9.8	11.6	140.7	18.6	19.0	13.5	9.6	12.0	20.4	8.4	6.2	13.0	5.1	7.4	1.3	17.8	17.2	17.7	11.7	0.0	21.2	4.8	10.2	13.6	6.5	117.9	14.9	11.4	10.6	8.4	14.4	0.0	17.5	12.1	20.1	9.9	1.7	21.1	14.4	10.2	4.4	13.3	26.1	0.0	26.3	17.3	12.2	49.4	28.9	9.2	5.5	12.3	11.8	18.0	6.0	4.7
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102845831-102875995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045845, HPA050374"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA045845: AB_2679471, HPA050374: AB_2681106"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavorable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.82e-4)"	14.1	11.1	7.8	10.9	8.6	16.3	14.5	8.9	11.8	12.2	10.5	14.5	20.1	9.2	13.4	10.7	9.7	10.8	9.8	8.1	8.2	12.6	21.8	12.8	15.2	8.5	8.2	12.5	11.3	12.3	3.7	11.3	8.5	11.7	14.3	12.6	10.5	10.8	9.5	13.2	17.1	9.6	8.0	15.2	16.3	7.0	8.4	21.3	13.5	10.8	16.5	11.2	3.9	8.4	21.5	10.5	15.4	7.4	34.4	30.5	8.9	24.5	31.1	13.6	16.7	10.8	37.9	19.3	10.4	23.4	9.4	23.8	14.3	19.6	10.1	19.4	9.7	16.6	23.7	13.3	15.9	50.9	26.3	26.1	19.2	15.7	25.6	19.6	23.1	23.4	9.5	16.5	23.9	8.0	18.7	23.5	7.7	30.2	9.9	14.9	10.9	17.9	19.3	15.7	9.0	14.1	12.6	25.0	8.8	13.6	13.9	43.4	21.4	7.5	5.5	3.7	13.1	16.1	5.0	9.4	41.3	20.7	10.9	19.2	11.9	20.4	16.2	15.0	14.6	8.9	17.1	19.8	14.3	8.8	18.4	18.2	3.5	20.5	21.1	7.4	20.7	17.7	7.8	8.6	8.9	11.8	8.1	8.2	8.5	8.2	8.5	8.0	8.4	8.4	2.2	3.2	9.5	0.0	22.2	7.1	4.7	11.5	16.5	0.0	2.0	2.0	28.6	14.3	14.0	0.0	0.0	9.6	7.3	17.6	0.0	1.6	60.7	2.4	4.8	8.6	4.9	24.8	0.0	1.2	7.5	11.0	44.9	2.1	19.0	1.7	13.2	21.2	10.5	0.0	0.0	22.3	10.2	17.2	6.5	28.3	22.1	14.0	7.2	0.0	12.6	0.0	19.6	0.0	0.0	1.7	16.7	15.8	21.5	4.0	26.6	1.5	11.4	0.0	19.7	10.6	6.7	11.6	6.3	19.1	7.0	5.7	31.3	1.7	18.2	5.0
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"P0DP91, Q03468"	10	49454168-49539538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 53.8;hTERT-RPE1: 123.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	2.7	2.1	1.6	1.9	1.5	4.6	3.8	3.0	2.3	3.1	7.7	2.4	2.0	3.0	1.5	3.8	2.9	2.7	3.4	1.2	1.1	3.2	3.3	2.7	2.9	2.4	1.9	4.5	3.1	5.9	2.8	3.4	2.1	3.3	2.7	3.1	3.2	2.2	3.5	4.6	2.5	2.3	2.2	2.9	2.4	3.1	2.1	3.3	5.1	3.6	3.4	2.6	3.3	1.9	11.2	5.5	4.1	2.1	6.6	10.5	3.4	21.2	27.1	14.1	9.9	6.2	5.6	4.9	3.7	18.7	6.7	9.5	6.3	16.6	13.5	8.4	4.1	3.9	21.7	3.4	3.9	5.0	3.7	4.3	17.2	12.9	53.8	123.4	19.8	2.9	6.8	0.8	16.8	8.3	3.4	2.0	4.0	3.5	10.2	2.3	5.8	2.6	4.1	7.1	5.9	4.7	15.4	3.6	8.2	9.4	7.1	2.7	38.9	7.0	5.5	8.6	5.2	3.3	4.5	4.1	7.3	5.0	5.1	13.1	3.0	7.5	4.1	2.6	3.0	6.8	2.3	2.2	3.9	5.2	2.8	1.4	7.2	1.2	5.3	2.2	3.1	1.8	1.6	1.5	3.0	2.3	1.2	1.1	2.4	1.9	2.1	2.2	2.1	1.9	6.9	16.0	13.2	14.7	6.0	3.6	1.4	1.5	5.2	0.0	7.1	7.1	7.1	5.7	8.2	9.2	0.0	2.5	10.9	4.8	5.9	5.2	11.3	8.1	8.7	5.1	1.2	1.3	24.3	6.0	2.1	4.9	2.0	10.1	7.6	8.9	5.3	4.3	2.6	0.0	21.7	5.3	0.0	4.4	2.6	15.3	2.8	8.0	1.8	23.4	11.2	0.0	4.1	17.6	16.6	5.2	2.6	2.2	3.6	2.5	5.0	3.6	9.0	0.0	6.6	4.4	4.2	5.3	5.0	3.5	4.1	1.8	7.4	11.4	2.8	1.9
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	38.5	32.5	22.7	37.8	24.6	10.5	46.0	25.1	29.0	34.4	20.8	37.1	34.4	34.4	50.1	46.0	24.2	33.1	52.4	22.6	25.9	30.6	47.6	26.3	33.8	24.9	23.9	26.9	40.2	47.2	20.7	53.1	24.3	39.5	33.7	29.4	49.2	34.5	33.8	19.2	34.9	39.3	25.4	26.7	32.6	57.8	24.4	35.0	45.1	47.0	43.6	50.1	22.1	34.4	96.7	87.0	69.1	46.8	94.8	111.5	170.1	153.1	123.4	92.7	98.3	115.7	157.6	51.3	149.1	120.7	168.7	98.7	66.0	98.3	146.4	112.6	69.4	84.0	114.6	68.3	55.7	121.2	70.0	79.1	75.9	115.8	116.7	169.3	71.8	69.8	70.5	144.6	122.6	52.3	60.3	126.2	98.9	101.3	235.0	54.9	189.9	107.6	75.5	140.1	26.5	43.2	77.2	86.5	91.5	145.9	168.0	96.7	81.8	124.1	108.1	169.1	167.6	106.4	145.5	106.0	103.7	87.3	105.3	92.3	50.2	70.6	84.7	79.9	102.9	83.2	107.6	101.2	55.1	71.0	106.6	90.3	181.1	72.1	101.1	120.9	130.8	90.1	22.7	24.6	25.1	29.0	22.6	25.9	24.9	23.9	24.3	25.4	24.4	34.4	54.6	28.9	28.6	20.9	74.3	57.9	68.9	144.1	39.9	54.8	57.2	55.1	61.7	38.6	99.0	53.3	54.2	119.2	60.8	19.4	49.0	72.7	383.0	48.7	66.5	43.7	41.8	44.8	39.2	62.8	120.6	73.0	25.5	54.6	55.8	44.2	34.6	50.2	56.4	48.8	37.8	33.5	87.5	25.5	40.2	51.9	52.5	37.1	62.2	14.0	41.6	69.5	52.5	32.2	48.3	58.1	20.5	59.8	154.0	85.7	32.4	49.5	64.6	60.0	32.9	58.5	105.7	75.0	36.3	49.4	66.3	156.2	68.0	54.0	34.7	78.8
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039080-64130819	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 53.0;pancreas: 66.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported					NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	9.5	53.0	1.5	5.4	1.7	13.4	7.5	2.6	3.2	22.6	2.1	7.7	6.3	10.1	6.4	9.5	14.3	6.2	6.1	1.6	2.4	5.6	23.5	16.5	5.8	1.7	1.0	16.9	66.7	4.3	19.5	5.6	1.3	9.9	4.5	8.8	15.7	7.1	6.8	11.3	10.6	5.6	1.0	15.8	16.2	2.8	1.6	6.8	10.2	2.4	6.6	8.3	11.7	1.7	4.0	4.0	2.2	4.8	4.8	4.4	9.8	4.1	9.7	2.8	1.3	2.5	2.3	6.6	3.2	2.8	3.5	3.6	1.9	4.5	6.1	1.6	1.5	6.0	3.2	2.4	19.6	3.2	2.1	3.8	8.1	6.4	21.5	3.5	5.0	4.7	4.2	74.6	2.8	3.9	4.5	1.0	0.6	3.6	3.2	4.2	4.2	40.2	1.1	5.5	7.1	3.5	4.3	6.1	5.7	3.5	3.8	5.9	5.9	2.5	4.1	6.4	2.7	77.4	23.9	4.8	4.0	2.1	4.2	17.9	0.9	0.4	4.9	0.4	9.0	0.2	3.3	4.1	0.4	0.3	0.9	0.9	4.9	2.5	0.3	7.7	0.8	1.0	1.5	1.7	2.6	3.2	1.6	2.4	1.7	1.0	1.3	1.0	1.6	1.7	31.9	0.0	36.1	7.2	27.8	22.0	54.3	8.3	15.4	4.0	35.0	29.7	8.6	11.5	8.6	12.9	6.2	8.1	106.4	10.0	1.9	12.6	2.3	26.1	49.1	18.3	79.7	11.2	8.6	27.3	8.8	42.2	52.0	79.4	8.2	11.8	13.9	26.8	8.0	3.3	6.1	8.2	8.2	15.7	71.3	1.7	4.7	60.4	74.7	12.2	10.2	3.5	28.8	6.0	4.6	17.9	7.3	6.0	325.8	44.7	7.9	4.4	6.1	26.5	0.0	19.0	25.7	4.0	4.1	27.7	45.0	54.9	88.2	12.0	9.6	60.1
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639915-52695900	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 172.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	NA	NA		110000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.59e-4)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	17.9	8.6	12.2	20.4	11.7	47.0	16.4	11.8	12.9	59.0	11.3	18.5	17.9	12.0	15.1	172.5	10.0	18.9	15.5	12.1	16.6	14.6	31.2	15.2	14.9	11.7	13.3	8.5	18.9	11.1	12.6	44.4	12.8	9.6	17.8	30.6	37.4	14.0	9.1	18.9	16.5	12.0	9.9	14.6	29.0	5.4	15.1	8.3	13.4	8.2	30.4	32.6	62.4	10.9	100.6	24.2	19.9	21.4	54.4	61.3	38.0	42.4	52.7	34.1	56.9	33.4	158.0	26.3	50.7	28.3	42.0	61.1	27.1	84.1	84.9	22.0	14.5	3.6	25.1	42.1	46.2	60.2	72.1	54.5	54.2	43.9	44.5	79.9	48.2	32.3	18.1	50.8	46.2	15.8	36.0	37.8	11.8	46.5	15.5	21.5	59.8	38.1	52.3	97.1	18.5	49.6	28.9	17.8	39.4	25.7	24.8	22.3	40.0	60.7	29.5	49.6	37.4	26.9	28.8	22.7	88.0	30.3	28.7	20.6	5.9	11.7	5.0	6.9	11.0	4.6	9.4	6.3	4.9	3.1	5.5	5.5	14.7	6.7	9.4	3.7	11.9	2.5	12.2	11.7	11.8	12.9	12.1	16.6	11.7	13.3	12.8	9.9	15.1	10.9	33.8	16.0	27.6	0.0	18.8	0.0	79.2	0.0	19.4	23.4	29.7	11.8	0.0	38.6	15.5	38.6	16.7	24.3	23.3	33.4	3.9	221.3	0.6	32.4	23.8	32.6	10.9	9.9	0.0	130.6	215.8	20.5	56.1	64.0	6.3	10.9	21.0	62.5	42.9	42.1	0.0	10.7	0.0	42.7	0.0	1.6	6.2	49.7	0.0	0.0	45.0	12.2	15.5	0.0	0.0	264.7	18.1	12.8	60.0	171.4	29.0	15.1	13.1	26.4	19.7	14.6	20.9	0.6	3.6	25.7	0.0	91.4	32.1	10.4	20.3	145.8
ERP29	"C12orf8, ERp28, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013348-112023449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"	NA	NA		900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	62.7	100.9	56.9	77.9	58.0	202.3	84.0	65.1	62.0	78.4	91.1	94.5	100.7	60.5	109.8	91.5	74.8	64.1	59.0	56.0	68.7	93.0	179.9	78.8	123.8	61.1	62.6	78.9	174.6	123.6	99.1	73.0	64.2	93.4	91.3	68.3	122.7	87.4	34.3	113.3	96.1	47.1	57.8	118.3	131.4	57.6	60.8	107.6	90.4	34.3	111.2	75.9	71.0	61.6	145.4	137.2	98.8	194.2	367.4	143.7	211.3	139.2	163.7	108.5	139.3	215.2	164.4	152.7	106.4	244.5	117.8	175.4	187.8	181.2	89.3	133.7	104.2	174.3	150.1	239.2	246.8	432.1	164.0	207.5	227.6	178.4	201.6	287.4	156.1	157.9	203.2	277.3	84.7	166.6	140.9	765.7	161.5	513.1	102.5	114.2	120.9	501.2	229.8	213.5	88.6	119.8	173.6	140.1	426.1	187.4	177.1	575.7	116.5	92.6	142.7	88.8	103.3	303.4	379.8	128.0	157.8	268.5	73.2	96.2	241.4	346.2	131.6	178.8	140.4	259.1	170.7	164.1	229.7	264.1	186.5	154.9	47.5	86.5	170.9	455.8	179.6	307.4	56.9	58.0	65.1	62.0	56.0	68.7	61.1	62.6	64.2	57.8	60.8	61.6	102.6	83.3	183.4	13.7	324.8	141.4	205.5	249.3	132.6	125.3	207.8	199.9	91.6	198.8	178.0	185.8	110.5	497.7	396.6	210.1	93.9	239.5	7.7	142.1	84.9	114.9	197.9	134.4	14.4	211.8	405.3	118.3	131.5	149.9	88.8	164.4	146.3	346.6	373.1	80.8	20.6	280.6	343.8	306.9	192.6	16.6	128.9	230.4	168.9	12.2	269.0	152.8	160.6	11.6	22.8	128.7	288.0	106.8	350.1	195.4	355.5	274.6	187.0	164.9	52.6	79.2	112.2	100.3	195.3	143.1	161.0	441.6	221.7	252.4	285.2	219.8
ERP44	"KIAA0573, PDIA10, TXNDC4"	ENSG00000023318	"Endoplasmic reticulum protein 44"	Q9BS26	9	99979185-100099000	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001318	Supported				"Intracellular and membrane"	NA	NA		5300000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001318: AB_1080427"	"unprognostic (8.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.31e-1)"	18.4	17.3	8.1	17.7	8.5	21.3	16.2	12.9	10.5	19.5	10.1	22.0	22.4	15.2	39.3	17.8	13.7	16.7	15.9	8.2	9.1	18.0	34.2	18.6	17.9	8.0	8.7	12.4	27.4	18.7	13.3	32.6	8.5	18.9	23.6	15.8	20.8	18.3	11.6	12.9	23.8	16.8	8.4	18.4	24.1	10.6	8.6	14.6	27.1	11.6	18.6	19.3	14.1	9.0	18.5	14.7	20.7	23.6	73.5	34.9	37.6	39.9	54.2	27.6	36.3	31.2	52.4	47.3	25.7	45.5	41.1	65.9	25.7	28.1	24.9	24.5	14.4	17.8	14.3	22.8	64.3	32.2	27.0	39.4	41.5	24.2	34.7	26.2	34.2	15.7	34.7	35.7	22.7	28.8	22.1	22.6	21.5	72.0	18.9	19.2	34.7	32.9	35.9	20.9	16.2	18.9	32.8	40.2	28.9	30.5	15.0	32.8	23.8	20.5	19.2	27.4	17.7	20.5	19.3	15.8	31.3	21.0	28.3	32.8	45.7	42.7	20.2	49.2	19.5	28.1	19.9	22.1	37.4	26.5	15.1	17.6	41.5	27.4	62.3	23.4	23.5	37.7	8.1	8.5	12.9	10.5	8.2	9.1	8.0	8.7	8.5	8.4	8.6	9.0	72.3	54.5	41.8	38.8	77.5	43.3	80.3	146.6	29.0	34.3	33.9	25.3	34.7	54.3	84.6	33.1	18.8	141.4	72.5	90.0	17.6	104.4	8.4	42.2	61.4	62.5	53.1	38.3	69.4	111.8	150.5	72.0	57.1	62.3	71.0	54.2	64.6	73.3	165.7	30.3	70.0	118.1	73.2	79.5	101.9	7.7	61.2	102.2	64.0	85.3	128.5	32.7	61.8	45.8	68.9	92.8	90.0	67.7	97.9	75.9	111.2	51.4	60.2	30.6	72.3	48.9	95.9	83.3	41.4	40.0	49.6	229.3	60.3	87.5	88.9	84.2
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
ESCO1	"EFO1, ESO1, KIAA1911"	ENSG00000141446	"Establishment of sister chromatid cohesion N-acetyltransferase 1"	Q5FWF5	18	21529284-21600884	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042497	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA042497: AB_10794278"	"unprognostic (8.12e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.80e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.72e-2)"	6.0	5.3	5.8	6.1	6.4	16.3	10.4	10.0	8.8	8.0	5.3	6.7	6.3	6.8	10.1	7.5	5.6	5.2	5.7	5.4	7.3	8.0	9.9	5.3	10.1	6.1	6.2	7.4	7.2	10.1	9.0	8.7	6.5	7.2	5.9	7.8	8.0	6.6	10.3	7.8	7.0	4.8	5.9	8.3	6.9	20.2	6.3	11.1	7.3	5.3	9.9	6.9	7.2	7.0	9.3	4.3	9.3	4.7	8.3	8.8	9.6	5.6	10.7	7.9	11.1	8.8	6.3	16.3	12.5	7.1	8.7	13.3	11.6	7.9	10.9	17.1	7.8	12.7	6.1	14.9	13.5	21.3	12.3	7.4	16.6	6.1	15.9	10.4	10.9	11.9	17.7	16.4	10.9	10.7	15.9	22.4	19.3	17.7	9.9	10.2	11.9	18.3	15.7	13.9	14.4	10.3	10.5	13.2	24.3	14.6	9.7	14.4	6.1	10.1	10.2	7.4	7.0	38.8	24.0	18.8	10.0	12.2	10.1	4.9	0.5	3.9	3.3	1.1	2.8	2.2	2.7	3.1	1.1	1.9	2.6	3.3	3.2	2.2	0.9	0.8	3.1	1.0	5.8	6.4	10.0	8.8	5.4	7.3	6.1	6.2	6.5	5.9	6.3	7.0	29.1	12.8	29.5	29.0	35.5	10.7	21.0	24.4	17.1	43.1	22.6	17.4	36.2	10.0	24.2	11.0	20.9	26.0	47.0	15.8	19.6	26.2	14.4	28.6	23.9	18.5	11.4	13.7	48.8	13.4	16.2	20.1	27.5	36.7	29.2	24.4	16.8	7.6	13.7	30.3	55.2	19.4	24.4	9.5	12.4	9.2	21.1	21.3	16.0	31.9	24.1	17.0	46.4	35.7	50.1	18.8	23.6	22.6	31.6	23.5	19.9	15.7	19.7	35.5	26.3	23.1	20.4	119.1	93.6	15.7	12.5	37.6	38.4	37.4	14.1	27.3
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002132, HPA070823"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		24000	"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA002132: AB_1078807, HPA070823: "	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	53.9	37.0	24.0	25.6	25.0	34.8	33.9	21.8	28.7	30.8	22.7	38.4	22.3	36.1	30.1	45.0	34.4	32.2	35.1	27.7	25.3	27.2	24.5	33.4	27.5	22.1	24.6	48.1	29.2	30.9	20.6	43.3	24.6	25.3	30.3	14.2	32.1	30.5	44.9	31.0	27.6	38.7	21.7	21.4	25.5	15.8	30.7	37.0	39.3	41.8	25.4	35.8	29.3	19.4	92.9	57.8	19.5	19.8	62.2	72.6	55.3	47.5	48.9	36.7	40.6	29.7	106.1	27.5	52.2	86.2	66.6	46.0	27.8	50.2	35.1	31.5	28.3	26.2	44.0	32.2	64.1	95.0	55.8	53.4	51.8	41.8	55.2	73.1	44.8	81.9	56.4	97.8	61.9	71.7	96.0	66.7	29.2	53.9	56.7	82.4	37.0	38.8	58.6	38.4	46.8	30.2	151.6	109.7	66.7	43.4	37.7	96.3	69.3	40.3	18.8	178.7	60.5	68.6	17.3	27.5	102.4	93.8	121.5	1.7	1.4	1.2	6.1	1.8	3.4	1.1	5.1	4.3	2.8	0.6	4.6	5.5	0.9	5.4	1.2	1.8	4.2	2.3	24.0	25.0	21.8	28.7	27.7	25.3	22.1	24.6	24.6	21.7	30.7	19.4	65.7	38.5	32.4	55.5	18.1	46.1	12.9	22.6	19.4	15.0	32.6	21.6	30.8	21.5	33.7	47.8	16.7	31.6	54.0	41.0	3.9	15.3	18.0	60.6	17.8	48.5	21.1	17.7	137.1	20.0	26.1	44.2	15.8	47.0	12.6	36.8	23.2	20.9	20.2	13.5	119.3	31.2	24.4	20.2	83.6	5.3	35.1	27.7	51.6	185.5	21.9	12.1	43.3	67.3	61.4	29.9	14.1	54.5	36.2	23.2	28.0	8.7	61.8	10.8	32.9	42.6	60.4	10.6	10.2	22.0	51.7	40.8	43.4	19.5	26.0	25.8
ETF1	"ERF, ERF1, RF1, SUP45L1, TB3-1"	ENSG00000120705	"Eukaryotic translation termination factor 1"	P62495	5	138506095-138543236	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 456.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011686, HPA037511"	Approved					NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"			"CAB011686: AB_732263, HPA037511: AB_2675516"	"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.63e-2)"	68.3	46.5	26.9	47.1	27.3	169.5	51.9	26.7	31.3	37.4	34.0	46.2	33.7	41.7	36.7	88.2	33.9	49.1	48.3	29.4	30.0	46.2	58.9	56.8	40.3	28.6	29.2	29.4	48.4	54.6	33.0	59.8	28.4	39.1	45.6	27.3	37.7	46.3	98.1	61.1	33.6	51.6	28.8	31.1	41.6	59.1	29.7	35.5	49.1	74.2	57.8	70.1	39.5	29.3	137.9	132.2	92.0	151.4	120.5	112.5	161.4	148.1	152.2	172.4	199.7	321.5	123.3	171.6	125.1	151.2	243.6	112.4	218.0	277.2	258.0	96.7	117.2	137.2	142.9	128.8	162.0	117.3	110.5	117.8	158.5	176.4	231.2	90.4	141.4	110.4	180.1	101.9	179.0	102.9	146.3	104.4	113.5	104.8	75.8	123.5	152.2	139.7	119.0	191.7	119.6	120.6	164.8	110.8	264.0	238.4	129.6	138.3	117.4	136.1	78.2	108.9	218.4	211.9	215.0	249.2	122.2	173.4	131.1	17.7	22.9	14.4	17.0	27.1	19.7	17.2	17.5	19.7	23.8	10.8	12.3	16.3	15.1	16.7	25.6	16.9	19.9	17.1	26.9	27.3	26.7	31.3	29.4	30.0	28.6	29.2	28.4	28.8	29.7	29.3	54.8	160.3	62.4	14.4	57.2	209.3	179.0	70.4	85.4	16.1	78.9	63.6	63.3	41.5	77.9	57.0	14.6	118.0	80.0	51.0	62.6	77.9	456.1	110.3	74.9	54.1	39.9	63.7	18.6	75.0	90.1	68.5	44.4	128.4	54.5	32.1	26.0	50.8	76.5	25.2	18.1	47.4	26.4	62.5	146.6	178.4	23.3	116.1	72.9	13.1	71.4	25.6	34.0	10.1	17.8	91.3	39.6	27.1	64.2	109.2	36.9	54.5	72.1	19.9	59.2	118.4	79.8	46.3	52.7	98.1	202.0	285.5	67.6	40.5	58.9	181.5
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein subunit alpha"	P13804	15	76215353-76311472	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 389.7;tongue: 493.5"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 402.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		680000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	93.0	112.3	33.8	55.0	36.0	63.0	70.4	36.0	54.6	38.7	40.3	131.4	135.6	27.0	30.6	85.1	30.1	44.7	243.0	34.2	37.6	180.0	389.7	39.0	60.9	35.6	35.7	25.6	81.6	71.0	13.9	70.9	36.0	42.2	123.5	34.3	49.3	38.2	300.8	40.1	116.3	65.7	35.5	38.8	67.7	28.4	38.2	54.5	38.7	493.5	65.9	74.0	33.1	36.9	122.4	196.7	128.2	134.8	141.7	149.1	201.0	144.4	166.2	183.0	162.8	175.3	221.3	203.5	141.3	144.3	138.5	304.6	502.7	200.2	211.9	245.8	98.0	222.2	131.4	205.2	114.7	214.5	158.7	112.7	185.9	93.1	153.5	100.0	187.8	64.7	214.1	205.2	190.3	191.2	44.9	178.2	99.9	225.3	58.4	192.8	158.6	272.8	202.1	386.9	133.3	67.2	218.2	492.2	205.0	294.4	254.1	223.4	111.4	178.2	119.5	157.0	177.4	99.0	221.0	255.9	127.8	281.1	128.5	50.0	120.3	82.7	65.4	110.3	61.7	77.3	60.6	67.6	159.4	67.3	48.8	60.1	30.2	122.9	96.1	63.4	95.8	141.9	33.8	36.0	36.0	54.6	34.2	37.6	35.6	35.7	36.0	35.5	38.2	36.9	65.7	57.7	41.6	45.1	54.3	53.4	110.8	151.5	44.9	13.1	47.2	46.4	352.9	65.8	84.5	36.8	22.9	277.4	61.1	250.9	209.4	106.5	11.7	29.5	45.1	51.8	65.4	117.8	26.0	84.1	180.8	66.8	90.2	37.0	38.6	53.1	48.9	348.8	132.3	53.8	31.5	141.6	89.5	79.0	84.5	7.9	59.4	103.0	56.9	28.1	129.0	26.7	85.5	37.2	46.9	92.1	176.2	58.3	87.8	92.4	231.1	402.9	50.2	20.4	46.0	44.0	113.7	66.4	40.5	79.5	57.1	300.2	55.5	123.4	187.3	162.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	159.1	171.5	121.1	44.0	134.4	70.2	115.3	134.8	145.5	55.7	123.0	97.6	136.3	48.9	16.9	140.7	53.3	62.7	387.8	112.8	120.6	144.5	493.6	50.4	58.2	129.8	124.8	55.2	81.9	106.3	73.1	39.0	125.7	55.2	41.2	24.1	172.2	37.9	280.7	79.0	129.7	31.7	119.9	64.5	90.0	53.6	132.4	81.4	70.3	280.3	36.9	65.6	69.0	137.0	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	121.1	134.4	134.8	145.5	112.8	120.6	129.8	124.8	125.7	119.9	132.4	137.0	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease variant, FDA approved drug targets, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 196.4;tongue: 186.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favorable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	34.6	38.0	13.3	10.7	14.8	9.4	16.0	13.9	15.1	10.2	25.5	32.6	63.7	10.4	8.4	25.0	9.3	11.1	93.3	12.8	14.5	46.5	196.4	9.2	8.7	12.3	13.8	10.8	20.4	32.8	9.8	13.0	12.8	13.7	26.9	15.8	21.8	13.2	111.0	18.7	51.4	14.8	12.5	9.5	26.9	11.2	15.0	9.4	13.2	186.9	14.3	12.9	12.8	15.1	13.2	9.2	12.2	21.4	47.2	28.8	6.6	21.3	19.4	13.9	14.3	3.7	24.6	27.8	4.6	24.1	15.8	13.8	22.1	20.9	19.2	51.5	20.3	26.5	17.3	8.0	20.8	24.0	23.4	26.5	23.8	15.8	12.8	20.8	27.3	20.7	15.6	53.8	22.2	14.7	22.7	11.0	5.0	33.2	19.4	18.4	4.3	21.9	21.2	10.6	18.7	8.0	21.0	39.5	21.8	10.0	30.4	17.6	13.6	11.9	6.7	18.5	12.2	31.3	42.1	20.3	24.6	19.2	13.5	3.7	21.5	41.5	10.1	22.6	12.7	10.3	9.8	10.4	18.3	9.6	11.6	9.9	7.8	10.5	20.9	13.1	16.1	9.5	13.3	14.8	13.9	15.1	12.8	14.5	12.3	13.8	12.8	12.5	15.0	15.1	18.1	12.8	10.3	55.2	18.5	33.0	46.0	27.2	29.6	29.2	12.6	13.8	146.6	14.3	22.8	18.4	64.6	24.9	18.0	34.4	29.4	14.4	4.2	12.5	12.5	17.7	18.0	30.7	43.2	11.7	9.9	23.9	44.4	14.2	5.1	19.2	12.8	85.7	13.4	25.2	71.9	22.5	30.5	14.4	15.8	4.7	23.0	13.3	8.8	15.0	12.2	13.9	10.3	55.8	58.0	11.7	29.4	23.7	30.1	21.3	58.3	26.8	13.1	43.9	32.9	27.4	30.4	43.2	29.8	32.7	36.9	43.0	19.7	15.7	26.2	38.7
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETV3	PE-1	ENSG00000117036	"ETS variant transcription factor 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 361.2;monocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	13.7	7.7	6.6	11.1	6.6	24.0	12.1	7.9	20.1	8.3	5.3	8.7	15.1	9.3	7.5	15.6	7.8	12.7	7.4	8.3	8.1	6.6	6.6	12.6	10.1	7.7	6.5	11.5	6.4	23.9	5.0	12.8	7.0	10.2	9.5	5.7	9.2	8.5	9.4	31.5	14.6	10.1	7.1	10.0	10.0	9.4	7.4	10.8	7.9	8.8	12.5	17.6	11.4	7.1	11.9	11.4	11.6	10.1	17.3	11.3	9.9	10.9	11.4	10.5	9.7	12.2	11.6	14.2	13.4	13.4	5.6	18.0	12.8	16.7	13.8	31.0	8.1	11.9	12.2	6.7	10.3	19.0	18.1	12.5	19.2	15.7	13.3	8.5	11.1	8.8	13.9	10.2	12.0	15.7	5.8	10.7	38.6	16.9	8.7	8.7	13.8	16.3	8.1	43.9	9.8	19.0	11.9	28.1	29.5	20.7	14.4	20.7	18.8	13.5	11.9	13.2	13.7	24.6	13.5	16.7	15.5	10.9	45.2	6.3	4.6	3.3	4.5	4.2	6.2	2.1	3.9	4.5	4.5	2.4	3.9	3.5	5.4	4.2	4.2	1.2	3.3	2.6	6.6	6.6	7.9	20.1	8.3	8.1	7.7	6.5	7.0	7.1	7.4	7.1	22.9	35.3	16.2	3.6	20.4	70.4	18.4	20.2	71.7	2.3	18.2	14.4	9.4	5.7	24.3	12.9	10.4	7.5	37.2	22.1	0.0	6.4	9.4	18.1	18.0	19.4	10.7	5.9	8.1	6.3	9.0	16.3	15.3	29.5	22.2	6.4	15.4	8.3	8.7	1.7	6.9	12.5	10.2	13.2	361.2	7.3	4.1	69.0	16.0	5.6	97.0	3.9	10.3	6.0	4.4	10.4	13.4	4.5	25.3	16.5	16.0	3.2	29.7	6.3	13.1	16.4	15.4	10.2	9.4	64.2	78.7	14.9	40.4	6.0	14.4	51.4
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;NK-cells: 591.2;Rod photoreceptor cells: 438.0;T-cells: 373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 291.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	38.8	31.3	130.5	91.9	135.1	50.1	58.1	105.0	185.5	44.4	66.3	46.6	29.2	64.8	49.5	30.6	63.7	42.0	53.0	136.9	108.8	42.6	90.3	63.2	159.0	103.1	110.1	51.6	40.8	19.7	98.6	29.1	106.1	52.1	24.2	204.6	41.2	32.0	33.2	41.0	69.9	62.0	92.5	107.7	43.3	31.6	115.5	179.4	37.9	28.8	126.2	43.1	32.8	121.2	15.2	14.2	107.1	30.3	22.4	58.5	59.7	18.9	26.5	14.2	18.7	0.8	11.4	30.9	24.9	19.2	10.5	0.4	49.0	36.3	16.8	30.4	32.6	51.9	11.5	8.4	18.0	16.2	116.7	31.6	18.9	9.1	35.8	29.3	38.3	117.3	25.5	2.3	15.7	22.7	291.7	89.6	19.7	13.1	21.8	65.4	58.7	5.5	17.2	0.6	120.8	73.1	14.3	22.0	7.2	24.6	17.7	47.4	27.7	11.2	16.5	66.9	12.8	55.3	44.1	87.9	14.9	27.1	19.7	2.3	2.6	27.4	20.2	13.9	15.1	9.6	22.6	19.2	4.3	13.2	26.3	24.4	0.6	18.0	16.5	0.8	41.4	10.6	130.5	135.1	105.0	185.5	136.9	108.8	103.1	110.1	106.1	92.5	115.5	121.2	26.4	28.9	42.3	45.1	155.2	20.8	22.2	10.8	12.0	125.4	70.4	50.5	4.7	22.8	14.2	12.9	402.4	22.6	215.3	1.0	31.3	12.9	4.2	40.1	51.9	47.5	8.4	31.1	119.9	14.0	12.0	30.5	20.4	26.2	17.1	45.1	39.3	102.2	144.8	77.4	121.1	3.7	8.2	82.5	76.6	12.0	24.8	92.5	26.6	100.2	42.0	89.1	591.2	86.0	66.1	11.6	2.9	49.7	53.3	17.4	2.6	14.2	41.9	438.0	6.6	29.8	33.9	14.1	28.4	8.7	31.4	14.6	373.3	13.5	3.8	15.9
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	20.7	21.1	18.7	13.8	20.2	13.8	21.4	19.3	20.3	22.6	24.3	19.7	13.1	21.5	13.6	24.4	27.3	17.8	15.3	20.9	19.4	17.7	17.8	17.7	16.4	18.4	20.3	30.6	27.3	27.3	16.9	19.6	19.9	18.3	21.5	53.1	16.3	20.5	68.4	25.4	13.5	23.9	18.8	21.0	17.3	18.7	19.1	28.1	26.4	38.5	20.3	21.1	18.6	20.8	40.1	32.2	43.3	43.3	49.7	51.6	15.0	28.6	47.2	25.4	33.2	18.8	54.7	29.8	20.1	54.1	36.9	24.7	23.7	38.8	41.8	45.6	28.2	24.0	31.5	19.9	54.7	32.0	25.1	50.4	47.6	36.3	66.5	55.7	43.5	38.6	35.1	28.8	47.7	26.1	58.5	35.2	32.8	47.5	29.8	25.7	38.7	54.2	40.7	35.2	33.9	53.2	43.0	39.1	46.3	48.9	25.8	29.3	47.9	28.1	14.6	30.0	31.5	45.0	29.4	28.1	82.9	36.4	43.8	10.3	12.0	7.2	11.2	12.9	10.0	8.3	11.6	11.9	16.3	8.1	9.4	9.6	4.0	19.6	11.4	7.2	12.9	11.2	18.7	20.2	19.3	20.3	20.9	19.4	18.4	20.3	19.9	18.8	19.1	20.8	22.9	22.4	22.3	238.6	27.3	18.9	16.3	16.6	25.6	39.9	16.8	15.4	30.9	11.5	18.0	14.7	93.8	17.5	26.7	21.5	3.9	15.0	29.6	27.0	21.2	23.0	17.4	18.7	334.2	18.2	16.6	21.2	34.1	21.0	8.2	32.4	23.2	15.9	18.1	50.5	306.8	21.0	26.4	27.3	14.5	27.6	17.4	20.4	14.2	341.0	23.9	20.4	23.7	395.6	345.9	15.4	17.4	18.8	27.7	13.2	16.3	16.9	29.8	231.5	13.1	26.0	15.3	20.5	13.1	28.2	17.0	11.2	26.2	26.4	21.9	20.1
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92826831-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 164.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	8.7	14.4	5.9	8.2	7.5	12.9	8.0	7.7	8.6	6.5	8.0	9.6	8.1	6.1	5.7	4.2	5.8	10.1	7.1	8.2	6.0	6.4	10.1	10.7	9.5	3.4	2.4	3.9	10.0	6.3	6.1	37.4	3.7	8.6	10.2	164.2	5.6	4.3	31.8	5.0	9.5	7.7	3.3	9.1	7.0	9.9	6.1	8.5	28.4	19.7	8.2	10.1	3.5	7.1	19.8	24.3	25.7	16.8	1.3	1.6	9.1	9.0	24.9	8.1	9.7	9.1	16.5	22.5	19.0	4.3	6.6	12.3	20.8	5.7	10.1	20.1	20.9	35.1	8.3	11.7	9.6	36.4	30.6	2.2	3.0	7.2	4.8	14.6	113.8	14.6	29.2	14.5	4.0	10.7	15.3	23.2	3.5	40.2	7.0	22.5	11.2	11.6	17.4	13.2	8.5	11.9	9.2	9.2	11.8	6.4	18.2	18.8	22.4	0.6	8.2	7.5	14.7	10.8	12.4	18.1	2.8	41.6	9.3	6.2	4.9	15.2	3.0	3.9	3.0	6.7	3.4	2.8	5.1	6.6	2.7	3.2	30.6	2.8	3.9	11.1	3.3	2.4	5.9	7.5	7.7	8.6	8.2	6.0	3.4	2.4	3.7	3.3	6.1	7.1	28.3	16.0	16.7	33.6	27.6	3.3	10.7	8.6	3.4	40.2	9.8	6.5	12.0	20.0	15.0	16.5	39.6	22.9	24.1	14.3	5.9	28.3	5.4	8.8	3.0	53.1	25.6	39.2	181.7	15.4	7.8	7.8	13.7	16.5	10.8	24.3	77.1	14.2	21.4	23.5	100.3	16.6	14.2	18.2	12.5	12.6	4.4	18.9	5.4	146.1	22.8	27.1	19.6	157.3	84.7	14.1	10.3	14.7	13.8	14.1	10.8	8.4	10.0	177.8	13.1	13.6	9.0	25.0	25.5	4.9	4.8	20.5	18.4	29.8	11.9	15.8
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97435909-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	21.9	25.4	31.4	23.5	34.3	28.7	22.4	50.4	39.9	25.5	27.7	25.6	24.3	24.0	42.6	28.4	22.2	17.0	23.5	29.7	33.6	25.3	26.9	20.5	32.3	33.3	32.2	23.6	38.8	21.1	24.2	17.6	32.6	24.5	23.5	21.2	26.6	17.3	29.0	23.5	22.3	22.1	32.6	30.3	31.2	15.2	32.8	32.5	21.6	14.8	31.9	25.3	22.9	36.3	62.9	49.6	34.8	61.7	42.1	44.3	47.0	52.2	73.9	57.2	64.4	86.5	62.1	60.4	59.0	50.2	44.1	64.0	52.5	58.9	56.6	77.3	61.3	39.5	48.0	68.9	74.5	94.2	46.1	45.8	77.9	69.6	101.3	70.2	66.3	90.5	45.6	108.0	43.2	70.3	88.0	153.3	58.1	64.7	43.2	65.8	43.4	106.4	39.4	32.8	20.4	38.3	38.6	30.0	87.6	44.1	71.2	113.2	43.6	31.9	40.1	50.4	117.6	72.5	103.1	119.5	54.3	113.2	26.3	79.0	91.0	93.5	75.5	132.8	96.5	109.6	93.1	87.9	96.4	94.7	89.4	78.1	35.7	57.9	121.7	82.9	144.0	86.4	31.4	34.3	50.4	39.9	29.7	33.6	33.3	32.2	32.6	32.6	32.8	36.3	22.5	25.6	24.6	15.0	42.4	19.1	35.7	59.3	18.2	31.0	22.5	27.3	20.5	27.1	35.8	44.1	27.1	48.6	41.2	15.4	39.2	36.0	17.4	22.6	24.1	27.7	14.3	23.8	24.7	41.8	58.1	27.0	21.9	16.7	25.3	31.0	34.6	25.3	50.9	30.3	22.2	28.1	36.7	31.4	20.7	17.0	32.6	28.7	30.2	17.8	61.0	29.1	61.8	12.1	25.5	35.9	20.0	24.0	43.6	24.9	30.1	53.8	47.1	48.1	26.3	20.7	35.2	35.8	39.1	27.6	24.4	41.2	44.3	26.4	25.7	31.7
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease variant, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	9.1	8.2	8.6	13.8	8.7	9.9	12.6	8.9	11.1	8.9	8.6	10.3	7.7	12.8	6.8	10.0	12.8	5.6	8.8	8.9	8.9	9.7	13.0	6.7	13.0	8.5	8.6	14.8	9.9	11.5	3.2	9.2	8.4	9.3	11.9	10.6	7.1	9.0	15.0	8.4	8.3	12.9	8.9	8.3	8.2	4.1	8.6	14.6	8.4	12.0	15.8	10.1	8.6	9.3	39.9	79.7	46.6	41.2	16.8	18.9	34.0	58.6	28.1	57.4	44.1	64.4	33.7	79.0	31.2	31.8	62.9	71.0	75.8	58.8	62.9	46.9	36.7	63.1	75.2	45.3	31.3	96.7	39.9	24.0	21.7	80.8	94.1	21.1	41.6	52.3	70.1	33.1	41.0	70.3	68.2	27.3	57.8	109.3	51.0	52.3	85.8	85.5	27.5	36.4	28.6	31.8	68.3	51.4	31.1	32.8	53.5	34.1	25.5	56.1	43.5	50.2	83.3	16.8	71.4	117.2	40.0	55.0	44.7	1.7	7.3	6.0	10.0	8.3	10.6	11.6	10.2	8.9	10.4	10.0	11.1	9.4	1.6	16.5	5.7	7.1	10.1	7.7	8.6	8.7	8.9	11.1	8.9	8.9	8.5	8.6	8.4	8.9	8.6	9.3	7.6	6.4	20.5	3.6	13.5	10.6	12.6	7.7	8.0	12.4	6.1	8.3	8.7	4.3	5.7	3.7	6.2	19.1	10.6	6.0	5.9	13.4	1.4	3.8	11.4	8.0	1.2	23.5	5.3	11.3	22.8	9.8	5.1	4.5	12.7	14.0	7.1	10.7	12.8	5.0	5.2	7.9	4.1	2.5	5.7	1.7	8.4	7.8	7.2	1.9	5.4	14.7	13.4	4.5	4.0	8.3	2.7	7.9	13.7	14.2	5.0	10.4	6.7	15.0	6.6	11.7	10.2	5.8	10.9	10.6	8.4	8.3	10.1	11.9	10.0	8.1
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078648-144080648	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 94.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 320.6;Late spermatids: 856.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 430.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024792, HPA065103"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA024792: AB_1848325, HPA065103: "	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	19.3	31.2	15.1	11.4	16.5	14.9	16.9	16.0	23.4	13.1	16.1	18.8	15.4	17.0	5.0	27.5	16.1	7.2	23.7	15.6	15.0	23.6	35.0	16.0	12.1	16.8	14.9	12.3	18.8	10.3	17.6	9.2	15.5	18.8	5.7	3.5	26.6	12.5	21.2	22.1	15.2	6.1	15.4	23.8	24.0	94.9	15.8	10.1	13.9	8.2	6.6	17.4	15.2	15.9	51.8	104.8	18.1	44.2	15.6	11.7	51.8	39.9	15.2	28.9	28.9	73.4	33.4	28.9	54.6	15.5	21.0	40.4	33.8	40.5	8.3	42.5	117.8	42.7	77.9	83.3	25.9	31.4	48.6	16.9	40.9	33.2	26.2	11.4	14.8	32.0	68.8	19.8	23.8	177.8	51.4	62.0	47.6	51.2	430.6	21.7	30.2	74.8	27.7	48.3	57.6	75.4	46.6	59.7	95.4	9.3	68.1	49.0	15.2	29.9	66.3	73.6	68.1	52.4	67.8	37.5	43.1	50.8	47.7	61.5	78.3	34.1	37.4	76.6	38.7	59.7	29.3	37.4	75.0	60.2	37.7	36.2	22.9	45.6	43.0	97.4	36.1	49.5	15.1	16.5	16.0	23.4	15.6	15.0	16.8	14.9	15.5	15.4	15.8	15.9	16.3	9.6	21.3	2.9	17.8	94.4	45.2	58.6	45.5	10.0	40.7	41.4	22.3	24.3	31.9	27.6	8.4	48.2	17.2	46.6	123.3	50.6	320.6	23.8	28.3	25.5	25.9	24.6	3.2	46.3	44.2	24.7	25.0	18.8	14.0	21.0	19.2	54.9	44.7	6.7	3.3	35.6	48.8	29.8	40.7	856.7	18.6	29.9	35.6	0.0	45.7	23.5	14.4	3.0	3.6	61.7	52.4	21.1	32.5	55.5	41.0	102.5	31.7	8.2	13.1	14.7	43.5	97.0	34.7	48.1	87.9	48.2	12.8	37.8	47.1	48.7
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095673-44251962	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		NA	NA		39000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA078409: AB_2686884"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	33.5	22.8	14.4	22.1	15.4	11.2	29.3	15.4	16.3	36.1	17.5	29.1	26.5	43.1	33.3	20.1	33.7	28.1	27.3	15.6	18.1	26.5	26.9	27.9	16.0	15.5	16.0	33.5	26.5	28.9	20.1	61.9	15.5	29.8	28.7	20.9	26.7	30.2	16.2	25.8	31.0	49.3	14.7	21.6	23.8	21.6	19.4	15.2	27.6	18.4	17.3	29.7	28.5	16.1	57.9	71.6	38.3	121.5	170.4	124.2	60.8	181.1	198.0	93.1	125.1	51.2	36.5	40.4	82.1	188.8	98.5	90.0	41.0	114.0	110.0	83.2	71.5	38.4	33.7	39.7	67.5	37.5	76.6	97.7	73.4	56.3	86.6	108.8	132.7	34.8	50.0	63.9	68.4	40.3	25.9	22.3	43.8	67.1	70.9	32.3	116.1	21.1	53.9	49.1	30.9	35.5	118.1	41.4	28.1	67.0	69.8	37.2	137.8	127.4	90.6	133.1	111.4	33.4	46.0	30.4	84.7	27.9	140.0	15.2	17.5	19.4	20.9	17.7	23.5	9.0	16.5	19.3	21.3	8.8	15.4	15.2	3.4	26.3	12.8	7.4	14.2	15.5	14.4	15.4	15.4	16.3	15.6	18.1	15.5	16.0	15.5	14.7	19.4	16.1	24.5	16.0	10.6	41.4	8.7	15.2	17.3	22.0	10.8	11.5	11.0	11.4	10.2	8.6	13.5	12.9	14.6	34.3	10.6	21.1	5.9	33.5	43.2	7.9	17.1	19.2	1.8	6.7	64.3	23.7	37.0	32.3	7.7	11.5	6.3	22.7	22.9	18.3	18.3	13.5	63.3	12.9	12.2	10.8	7.2	23.0	27.4	10.4	5.4	28.1	10.2	17.4	7.2	50.3	51.8	24.0	14.9	28.6	7.0	23.6	31.6	8.2	8.1	15.0	19.7	15.8	20.7	51.2	24.4	10.2	12.6	35.3	9.2	12.2	15.0	15.3
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895179	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 214.1;Theca cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		80000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	8.8	24.6	11.4	5.0	15.0	2.2	11.5	12.0	16.4	13.9	19.1	10.8	4.8	18.1	13.7	6.5	10.9	11.4	9.2	10.3	15.4	12.9	12.6	8.4	4.2	12.9	14.9	19.6	9.0	14.6	12.9	24.9	13.7	13.4	7.6	13.9	7.1	11.9	6.9	6.5	5.4	17.0	11.2	6.5	7.3	10.7	17.8	8.2	10.1	7.1	3.7	9.2	6.9	11.3	13.0	6.9	50.2	50.7	53.2	39.3	31.4	23.2	37.5	17.5	39.4	6.1	9.9	15.2	21.8	20.9	13.5	12.7	18.3	19.6	35.4	31.8	13.4	19.0	23.6	18.3	17.5	28.9	9.3	47.3	6.8	35.9	6.6	36.5	65.0	19.2	23.9	2.0	45.1	6.9	15.5	15.5	62.2	12.2	15.5	11.2	51.5	12.1	18.4	9.7	20.6	57.5	17.4	4.6	42.0	35.8	10.9	12.7	27.7	44.0	25.8	27.8	24.4	15.5	15.0	9.8	69.2	29.3	14.4	2.0	0.5	0.0	3.4	0.7	1.5	1.2	1.1	2.3	1.7	1.7	1.2	2.7	0.1	3.9	0.5	4.6	0.0	1.2	11.4	15.0	12.0	16.4	10.3	15.4	12.9	14.9	13.7	11.2	17.8	11.3	12.3	12.8	8.4	39.8	4.9	8.5	10.2	13.8	21.1	20.7	13.2	13.5	12.7	10.0	11.0	14.7	35.5	214.1	5.0	3.3	11.7	5.8	45.3	20.3	28.7	13.1	9.5	16.2	47.1	2.1	36.9	36.0	15.3	11.0	17.7	35.3	13.6	16.4	24.3	3.3	49.9	5.6	12.2	7.3	5.7	34.9	25.1	5.8	23.2	12.2	7.4	18.8	8.2	40.7	32.9	2.4	2.6	34.6	5.9	6.2	2.9	11.9	25.3	19.7	13.1	25.4	22.4	37.1	12.3	8.5	8.1	74.3	6.1	328.5	7.1	4.9
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 160.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	21.3	8.5	1.1	1.5	1.2	0.0	11.7	2.5	2.0	53.8	1.4	5.6	10.9	13.2	16.4	8.9	23.9	10.9	40.7	1.1	1.8	4.1	160.0	14.4	3.2	2.6	1.5	27.9	7.1	0.2	4.5	4.4	2.5	12.8	2.0	0.9	5.1	7.1	6.8	20.7	11.9	2.7	1.3	3.2	8.6	10.1	1.4	1.4	8.3	6.6	1.3	11.9	25.8	1.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	2.5	2.0	1.1	1.8	2.6	1.5	2.5	1.3	1.4	1.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.1	0.2	0.1	0.0	0.0	13.1	0.0	0.2	0.0	27.6	243.2	8.4	0.0	0.0	0.3	0.3	58.9	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021343	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Urothelial cells: 242.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 165.5;neutrophil: 113.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 165.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 205.4;OE19: 202.4;SuSa: 232.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		1900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	21.1	24.5	6.6	20.8	6.3	21.3	26.8	6.0	8.2	24.2	9.6	52.6	55.9	11.9	21.1	85.5	33.1	28.7	12.8	6.3	6.5	40.4	73.6	67.1	13.2	7.8	7.5	14.0	41.7	36.3	18.8	50.7	7.5	28.7	51.7	2.2	49.4	21.2	6.1	48.2	64.0	9.0	7.2	21.5	52.6	13.0	8.6	16.5	39.2	6.3	32.0	52.2	44.1	7.1	122.9	15.5	4.7	1.4	3.3	0.2	95.5	0.6	0.1	4.0	4.1	113.5	155.9	8.9	78.6	0.2	22.6	205.4	25.3	105.2	6.4	6.9	17.8	25.8	6.2	52.3	4.8	24.2	72.6	1.4	132.5	0.6	32.7	24.1	98.6	18.8	35.6	2.5	0.6	53.5	7.6	13.6	80.1	202.4	21.9	11.3	0.0	39.2	67.2	94.4	34.3	8.8	29.2	123.4	26.2	232.8	132.6	41.7	58.8	0.3	3.0	0.4	1.2	28.2	59.3	3.1	18.0	23.4	7.5	34.6	31.0	165.5	12.6	16.3	6.7	4.7	11.7	8.0	24.6	2.9	11.1	8.8	113.4	8.2	13.0	18.7	5.7	25.1	6.6	6.3	6.0	8.2	6.3	6.5	7.8	7.5	7.5	7.2	8.6	7.1	27.7	253.2	137.2	0.0	9.8	35.2	119.7	86.2	64.3	0.9	35.0	15.5	3.3	67.2	136.2	77.3	2.1	78.6	10.2	154.9	7.9	76.8	7.2	120.8	13.9	41.5	62.2	10.3	2.7	71.0	176.2	9.1	66.8	150.9	18.3	13.7	34.2	68.8	31.0	0.0	1.1	71.5	46.8	14.4	25.5	2.1	2.1	24.7	8.8	7.5	48.7	1.5	13.4	3.0	0.4	91.4	114.1	0.7	10.8	135.3	82.5	12.6	178.8	2.4	0.0	5.1	6.2	13.4	2.9	102.3	50.6	63.1	12.3	8.1	50.7	242.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.4	0.1	1.4	0.1	1.2	2.6	0.3	0.1	1.3	0.4	0.1	0.5	0.5	0.2	0.0	1.9	0.3	0.1	0.4	1.5	0.8	0.8	604.6	0.6	0.0	0.8	0.6	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.4	1.0	0.1	1.2	0.8	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.4	1.2	0.1	1.3	1.5	0.8	0.8	0.6	0.9	0.4	0.8	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 232.8;placenta: 489.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 863.3;Langerhans cells: 205.1;Macrophages: 232.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.1;myeloid DC: 179.6"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.6;granulocytes: 50.2;monocytes: 141.1"	"Cell line enhanced"	"Detected in some"		"AF22: 24.0;LHCN-M2: 8.9;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 4: Macrophages - Innate immune response"			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	232.8	57.9	2.6	52.3	4.2	16.1	46.9	1.3	13.0	50.4	28.5	45.9	9.7	18.5	5.6	51.2	29.1	52.7	39.2	2.1	3.6	21.0	3.0	38.7	30.0	8.3	4.6	10.7	10.0	13.3	8.1	489.2	6.9	8.8	63.9	21.6	18.8	13.4	10.3	22.7	22.0	89.6	2.6	8.8	25.4	17.8	3.7	20.9	17.1	32.8	12.5	144.5	12.1	4.0	0.0	0.1	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	43.8	0.8	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	50.2	141.1	1.4	0.5	25.4	0.6	0.4	0.3	0.4	179.6	0.4	0.4	0.2	32.9	0.3	0.7	12.5	0.3	364.9	2.6	4.2	1.3	13.0	2.1	3.6	8.3	4.6	6.9	2.6	3.7	4.0	2.0	0.0	1.9	0.3	1.8	18.7	0.0	0.0	0.6	0.1	0.3	0.4	10.6	5.7	0.0	0.0	0.0	5.0	4.5	0.0	0.0	0.0	5.1	0.6	10.6	3.8	0.0	1.3	3.9	0.0	5.6	13.7	0.0	0.4	1.3	0.0	2.9	0.9	863.3	0.0	1.4	0.0	0.0	92.4	205.1	5.8	4.4	232.0	19.6	64.6	53.1	0.9	6.2	0.5	0.7	0.1	0.0	0.7	1.2	0.0	0.0	11.0	2.2	6.5	59.2	2.5	3.3	1.6	0.9	1.2	15.2	10.1	2.6	0.4	0.0	0.1
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	211	"liver: 200.2"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 54.9"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	200.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	54.9	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1518	"liver: 1217.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1217.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888999-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.0;lung: 33.4;thyroid gland: 19.2"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 30.7;HMC-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favorable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	19.0	2.6	0.7	1.5	0.7	1.3	18.0	1.9	0.7	1.1	1.2	4.3	1.5	1.6	1.6	1.5	1.5	2.8	5.6	0.6	0.7	9.8	0.5	33.4	2.3	0.5	0.6	0.8	9.3	1.1	2.7	1.0	0.5	1.4	1.3	1.2	1.2	0.5	3.2	3.1	4.9	1.0	0.0	1.3	5.0	1.7	1.2	0.4	19.2	0.6	0.9	1.9	1.2	1.3	0.3	0.3	0.8	0.4	0.1	0.2	0.9	0.4	0.1	0.2	0.2	0.5	0.8	0.6	0.6	0.3	0.3	0.6	0.2	0.3	0.3	0.4	0.4	30.7	1.3	0.5	0.2	0.3	11.6	0.0	0.1	0.3	0.2	0.4	0.9	0.6	2.5	1.1	0.2	0.5	0.4	2.9	0.4	0.4	0.3	0.3	0.2	1.0	0.3	0.6	0.5	0.3	0.3	0.2	0.1	0.7	0.6	2.0	1.2	0.6	0.6	0.4	0.3	0.5	0.4	0.6	0.3	0.5	0.4	3.3	0.9	0.7	0.9	0.4	0.8	1.6	1.0	0.8	0.3	1.8	1.4	1.3	2.2	1.8	0.6	1.7	0.8	1.4	0.7	0.7	1.9	0.7	0.6	0.7	0.5	0.6	0.5	0.0	1.2	1.3	110.4	0.0	1.1	0.0	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.9	27.5	0.0	0.8	0.0	0.5	0.0	2.7	0.0	0.2	7.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.3	0.2	0.3
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 142.8;liver: 176.2;placenta: 46.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.3	3.2	1.4	3.7	0.6	4.4	1.3	0.1	142.8	0.3	0.9	0.1	0.2	0.2	3.5	17.6	2.7	4.4	1.6	1.5	176.2	0.9	2.2	1.9	2.2	0.0	0.8	0.0	1.6	46.9	2.4	1.3	0.6	1.0	6.2	0.0	0.2	1.3	0.3	1.1	0.8	1.8	4.9	0.5	2.2	0.5	0.4	0.2	2.3	3.8	0.1	4.2	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.3	1.4	4.4	1.3	4.4	1.6	1.9	2.2	2.4	0.8	2.2	4.2	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 160.2"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 149.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 11.5;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.2	0.0	0.4	0.1	0.3	0.0	0.2	0.5	0.7	1.1	0.2	0.1	0.5	0.1	0.6	0.1	0.5	0.0	0.2	0.3	0.7	0.4	160.2	0.1	0.0	0.3	0.5	0.4	0.1	0.2	0.4	0.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.1	1.5	0.6	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.7	0.3	0.7	0.3	0.5	0.3	0.2	0.6	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.3	0.5	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	8.0	0.3	0.2	0.0	0.4	0.0	0.2	0.0	0.3	2.2	149.3	0.1	0.0	0.5	0.4	0.0	2.8	0.7	0.2	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.5	0.1	3.2	4.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.2"	"Group enriched"	"Detected in many"	10	"Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"	NA	NA		25000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	29.4	15.2	7.8	2.5	8.6	2.1	19.3	7.4	11.2	7.5	9.9	9.6	2.9	10.9	9.1	4.0	7.9	5.0	53.2	8.2	8.5	14.1	20.1	16.7	4.7	8.6	8.4	14.5	11.6	5.6	6.4	3.3	8.6	9.0	3.8	6.2	4.7	7.5	20.6	3.6	5.0	6.3	7.8	17.9	5.7	6.1	8.9	3.2	10.9	28.1	3.7	8.1	3.7	7.8	6.1	4.5	0.9	2.1	6.5	10.1	0.7	2.9	1.8	2.0	3.4	0.3	6.8	12.0	9.5	3.0	4.7	0.8	1.0	1.0	1.8	5.1	1.9	2.4	2.8	0.2	3.0	2.1	5.6	7.2	0.6	1.8	2.4	3.5	1.2	5.7	1.1	9.0	10.0	2.7	1.7	1.9	1.6	1.8	4.5	1.4	1.5	1.8	1.8	1.3	3.7	2.8	7.0	0.8	3.9	1.0	2.1	4.9	1.5	10.3	5.5	16.6	3.7	5.3	5.1	6.0	9.4	12.3	5.5	4.6	2.8	0.9	5.2	2.4	10.3	2.1	3.1	5.5	2.7	1.9	1.6	4.1	4.4	3.3	2.4	0.4	4.6	2.7	7.8	8.6	7.4	11.2	8.2	8.5	8.6	8.4	8.6	7.8	8.9	7.8	118.6	0.0	6.3	13.1	2.3	1.8	2.5	1.6	4.0	8.1	3.7	4.2	17.7	7.2	1.9	3.7	2.1	0.9	2.0	0.6	7.9	3.1	1.4	1.5	1.5	120.4	0.0	8.4	7.2	0.7	0.7	6.8	0.0	1.5	1.3	8.2	371.2	11.8	3.2	6.7	5.0	0.6	0.0	19.9	1.1	3.3	11.5	3.0	0.0	8.4	2.4	6.8	2.1	7.5	6.0	4.5	0.1	5.3	2.0	1.4	0.9	11.4	2.4	3.5	6.6	11.1	13.0	2.3	3.4	1.5	1.1	0.1	4.0	4.3	0.4	2.1
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2467	"liver: 704.9"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 609.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	704.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	609.1	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365253-31376850	"Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"ASC TERT1: 215.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	3000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	31.4	63.5	33.7	2.1	39.2	1.6	95.4	42.3	51.5	40.4	14.8	16.3	0.8	93.9	6.4	9.5	37.2	3.7	5666.1	52.0	37.3	229.8	6.6	26.4	3.4	50.5	38.3	20.3	2.2	0.3	9.0	2.8	55.2	48.9	4.8	17.8	46.5	52.2	2202.5	16.3	7.5	44.2	31.4	28.8	60.3	15.3	36.1	2.3	6.8	1442.4	1.4	12.5	32.5	36.8	1.0	0.4	8.8	1.1	50.6	215.0	2.0	2.6	17.3	0.3	6.6	1.3	1.9	1.6	17.8	5.2	0.3	2.1	2.5	0.0	0.5	0.8	3.7	1.8	2.7	5.3	2.2	1.7	0.5	16.9	0.0	3.9	0.0	2.5	0.0	1.4	2.2	0.5	2.2	0.5	0.7	1.5	11.4	0.9	3.1	0.4	5.7	0.6	4.1	0.7	2.1	0.5	1.5	0.7	28.4	13.2	0.9	3.1	1.7	1.0	1.0	6.0	1.3	1.0	2.3	1.3	2.9	1.5	1.7	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.1	33.7	39.2	42.3	51.5	52.0	37.3	50.5	38.3	55.2	31.4	36.1	36.8	4.9	0.0	1.7	2.9	7.7	3.6	1.5	0.4	0.0	6.1	629.8	13.2	2495.2	2.8	1.3	27.6	2.1	3.8	2.1	0.4	452.0	0.4	2.5	0.4	0.5	25.6	0.0	0.0	16.1	0.4	1.4	67.2	1.1	3.1	1.3	43.8	2.2	0.1	114.7	8.4	14.6	0.1	0.0	27.8	10.3	5.4	6.8	19.1	8.8	3.7	0.0	2.6	0.0	3.5	8.9	0.3	12.3	7.9	0.1	6.8	0.1	703.6	1.5	10.2	0.0	14.9	40.7	2.9	0.2	0.2	3.0	1.6	5.1	97.9	0.3	36.5
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3787.4;breast: 2195.7"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3787.4	42.2	0.8	46.7	1.1	2.8	2195.7	0.9	1.6	9.9	34.8	52.9	2.8	4.6	0.6	15.1	10.9	68.1	121.8	1.2	0.8	7.0	5.1	113.5	13.6	0.8	0.8	4.2	16.6	59.1	1.4	186.9	0.8	4.3	33.5	2.6	58.8	5.0	66.7	65.2	44.7	14.2	0.7	6.7	26.5	1.1	3.8	29.8	83.0	166.7	2.0	242.7	18.9	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	1.6	1.2	0.8	0.8	0.8	0.8	0.7	3.8	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960267	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 202.4;Excitatory neurons: 296.7;Inhibitory neurons: 278.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 269.9;Oligodendrocytes: 424.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Supported	Nucleoplasm		NA	NA		12000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	18.2	16.8	21.0	9.2	22.0	21.0	18.5	21.8	27.5	18.9	18.7	23.7	12.4	18.2	11.7	23.1	15.7	8.7	34.9	22.3	22.1	21.5	23.6	14.9	13.1	21.5	21.5	19.9	26.2	23.2	20.6	10.6	22.0	18.5	12.7	19.6	18.1	16.3	67.9	28.1	16.4	13.4	21.8	14.0	18.2	47.8	21.2	22.2	18.3	37.6	14.1	21.4	18.7	25.9	37.4	27.1	23.1	39.3	22.4	21.1	33.9	35.5	32.1	53.9	48.8	30.4	26.0	59.9	25.7	30.5	47.5	27.2	37.3	33.1	45.9	40.1	33.5	49.9	33.5	31.6	36.4	54.3	28.5	19.8	29.4	57.0	69.4	27.8	29.5	44.5	58.9	0.2	28.1	15.0	56.6	43.0	30.6	49.3	19.2	52.1	50.7	0.0	54.9	33.1	0.3	28.6	32.3	64.9	56.4	32.0	20.4	64.1	18.2	30.4	37.3	37.8	0.2	45.1	50.6	69.3	0.0	77.6	35.7	1.1	2.1	4.9	4.0	2.7	5.5	2.5	3.6	4.0	3.6	4.2	4.3	2.8	0.7	4.3	3.5	2.9	6.1	1.6	21.0	22.0	21.8	27.5	22.3	22.1	21.5	21.5	22.0	21.8	21.2	25.9	17.9	6.4	18.2	202.4	26.9	21.4	38.5	27.8	33.6	19.9	16.9	16.9	43.9	11.5	27.2	16.5	27.1	14.2	18.0	13.1	29.4	8.8	75.1	15.1	15.6	14.2	11.4	44.6	296.7	11.6	28.2	16.0	29.0	16.9	5.7	19.2	10.4	18.2	11.4	16.8	278.9	17.8	6.1	13.6	18.0	117.2	11.1	15.4	16.0	177.1	8.9	20.0	15.5	269.9	424.4	8.5	9.7	10.9	35.4	18.3	20.0	28.3	32.7	33.0	6.6	26.2	20.3	36.9	15.6	37.9	28.1	15.3	27.9	19.6	21.6	34.1
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451685-93566112	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA		12000	"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	48.1	47.8	26.7	59.7	30.8	49.9	37.8	25.8	27.0	45.0	55.0	74.4	59.0	39.2	36.0	46.6	50.8	42.3	60.9	26.0	24.2	47.7	55.7	42.0	56.5	32.6	29.3	39.1	57.9	87.3	26.8	60.3	28.8	42.7	69.1	30.6	56.2	40.8	81.7	41.9	58.4	50.9	25.3	49.0	69.3	17.4	30.3	45.5	49.0	71.4	45.6	53.4	33.0	28.7	179.7	145.4	32.0	92.8	93.7	116.6	100.3	123.2	107.8	92.9	68.0	47.5	108.2	116.1	68.9	156.2	73.7	188.8	86.5	144.3	71.1	117.0	62.8	63.8	126.1	75.3	104.6	109.0	83.5	114.3	87.2	105.7	166.3	90.9	133.7	81.0	74.4	94.9	101.3	202.8	108.2	61.4	41.2	212.7	134.3	62.1	85.6	97.4	112.3	107.2	85.8	52.5	139.5	166.4	86.0	31.4	91.0	70.6	140.6	99.6	71.6	123.8	136.4	74.2	78.6	44.8	107.9	96.6	90.9	3.1	6.6	5.2	4.9	7.5	4.1	4.4	4.3	4.8	6.1	3.5	3.0	4.4	13.1	4.3	9.3	3.9	8.3	4.1	26.7	30.8	25.8	27.0	26.0	24.2	32.6	29.3	28.8	25.3	30.3	28.7	64.0	44.8	93.9	67.9	42.7	102.2	49.6	56.6	70.6	30.0	86.5	49.0	112.3	77.2	75.2	75.4	50.1	73.8	49.2	164.3	21.5	50.1	26.1	77.5	76.2	64.9	91.8	60.2	92.1	74.7	104.9	60.5	123.8	92.3	48.8	66.1	63.1	186.6	71.0	40.4	62.5	176.8	36.7	146.4	78.6	9.8	66.8	103.4	53.4	80.6	111.0	35.7	35.0	64.3	80.9	86.4	92.0	65.5	60.8	125.8	81.0	75.7	87.8	33.7	39.5	63.5	68.6	12.3	12.4	91.1	114.2	103.4	49.3	94.4	177.2	109.0
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C golgi associated secretory pathway kinase"	Q8IXL6	7	192571-260772	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		240000000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	32.5	14.8	7.0	7.3	5.7	1.5	32.8	5.0	7.0	19.4	0.8	44.3	4.5	19.4	2.1	14.3	20.2	5.9	30.2	4.3	5.0	34.9	56.5	27.9	1.1	12.5	9.7	20.3	13.4	1.6	18.3	2.6	6.7	29.9	1.4	1.1	20.3	3.6	30.7	14.7	23.3	6.8	6.4	8.9	38.9	7.8	12.6	0.6	19.6	6.3	0.6	36.8	15.1	6.2	19.6	6.4	0.3	10.3	11.8	20.3	0.0	17.4	23.2	7.9	5.9	0.9	10.1	0.0	9.3	21.8	10.4	14.9	1.1	0.6	1.6	4.5	0.6	0.0	3.1	3.4	8.8	0.0	1.0	55.3	1.6	0.3	0.7	39.9	5.0	0.0	0.0	0.0	1.8	1.9	0.0	0.7	8.9	0.1	0.3	2.3	0.5	0.0	4.9	0.0	4.4	0.2	17.2	0.0	2.3	1.1	9.7	6.5	14.6	10.3	5.3	7.7	5.3	0.0	0.0	0.0	36.0	1.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	5.7	5.0	7.0	4.3	5.0	12.5	9.7	6.7	6.4	12.6	6.2	5.0	6.4	5.1	11.8	1.2	10.1	2.3	4.5	1.8	26.9	27.6	18.7	9.9	21.5	1.0	55.2	0.0	0.5	4.6	3.4	5.9	1.8	0.0	4.1	19.0	4.5	11.9	0.4	7.4	4.8	0.5	22.6	13.7	9.5	3.8	3.1	9.3	94.0	54.9	1.7	17.0	5.3	2.0	24.4	9.8	2.6	16.1	34.5	1.8	5.6	10.8	17.1	0.0	8.5	15.3	6.3	3.7	56.4	0.1	6.6	33.7	48.7	3.4	9.0	13.1	8.7	17.3	0.3	1.0	3.5	8.1	0.5	0.9	0.6	9.0	1.9
FAM3C	"GS3876, ILEI"	ENSG00000196937	"FAM3 metabolism regulating signaling molecule C"	Q92520	7	121348878-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 22.5;naive B-cell: 19.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 22.5"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 1257.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		48000000	"Cluster 37: B-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	40.4	45.9	23.8	38.5	26.8	9.6	42.1	20.4	46.5	96.5	15.9	46.5	177.0	51.4	57.5	32.0	34.5	35.3	64.0	33.8	22.6	62.9	49.5	34.5	44.6	29.3	20.7	36.7	74.0	57.3	29.6	44.5	30.4	31.7	54.0	47.8	38.1	32.3	19.0	32.2	158.2	44.3	19.1	47.4	61.8	24.5	21.8	17.1	111.1	24.5	44.8	56.6	31.3	25.4	133.1	33.2	60.7	64.9	100.3	164.2	55.6	139.7	61.5	41.2	52.1	26.4	1257.1	125.4	65.4	72.5	116.7	85.2	35.1	77.7	87.3	15.3	72.5	35.6	19.3	27.4	73.5	59.0	65.3	165.7	52.1	58.9	57.1	110.4	74.8	24.6	23.3	152.3	326.6	22.3	24.6	45.2	108.1	45.4	45.3	34.2	63.8	51.1	256.7	75.1	38.6	38.1	41.4	167.4	80.6	126.2	24.0	32.5	178.8	105.1	37.7	236.1	96.9	148.0	71.3	48.7	114.0	60.6	192.5	0.0	1.1	0.8	2.1	1.2	2.0	22.5	0.9	1.7	1.0	19.9	1.3	0.9	0.2	3.0	0.9	1.5	0.7	0.8	23.8	26.8	20.4	46.5	33.8	22.6	29.3	20.7	30.4	19.1	21.8	25.4	49.8	9.6	33.3	17.3	103.0	71.8	257.1	183.0	61.5	137.3	47.5	28.8	65.7	71.4	134.4	55.2	22.9	88.1	44.8	66.8	60.7	182.2	3.5	76.0	81.8	58.9	52.3	10.3	64.6	191.0	188.6	104.3	46.4	170.1	19.7	33.3	50.0	37.0	43.6	45.4	64.3	49.1	101.7	29.6	88.4	6.7	96.0	30.9	99.6	24.4	31.7	49.4	58.7	42.3	24.7	415.8	71.9	95.9	129.8	325.0	327.0	66.8	63.9	67.1	72.3	93.6	68.7	23.8	22.4	61.7	66.3	120.4	44.3	35.6	86.7	425.8
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292425	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 33.3;skin 1: 42.3;vagina: 15.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 9.9;head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 28: Keratinocytes - Keratinization"			"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.2	5.3	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.2	0.0	0.1	42.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.1	0.6	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	27.9	1.1	0.0	17.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	6.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	26.1	64.2	0.0	0.0	0.0	0.1	1.9
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA		20000	"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	12.7	11.4	9.5	12.8	10.2	9.8	12.9	16.4	12.6	9.7	7.2	15.4	9.6	13.3	9.0	9.0	8.1	7.0	12.4	10.8	10.9	13.1	7.8	8.1	13.8	9.4	9.7	11.2	6.1	19.3	6.4	12.0	10.0	12.1	11.6	19.8	6.3	10.0	13.8	8.8	10.0	9.5	10.1	11.2	9.5	8.5	9.6	28.6	11.7	16.3	13.3	11.9	7.0	12.6	30.7	16.2	77.7	40.0	14.1	25.7	37.9	38.6	28.2	37.4	37.5	35.8	14.4	21.1	41.4	32.2	37.9	31.8	47.4	39.5	52.2	21.8	25.7	62.6	33.9	27.8	20.4	59.8	34.6	23.9	24.1	33.3	38.5	27.4	38.9	45.7	45.6	25.7	36.0	13.8	50.7	31.8	42.0	34.8	22.3	53.3	42.0	17.7	32.8	39.9	47.8	48.9	42.5	27.0	19.8	34.6	33.0	36.6	32.7	42.1	51.5	28.2	44.0	47.6	46.1	78.3	23.1	38.9	44.8	2.3	0.5	1.4	2.8	0.4	2.4	1.6	2.8	2.3	0.6	1.9	3.4	2.6	0.4	2.2	0.6	1.4	1.9	0.4	9.5	10.2	16.4	12.6	10.8	10.9	9.4	9.7	10.0	10.1	9.6	12.6	17.9	16.0	21.4	16.3	16.8	14.7	12.7	14.1	14.2	36.8	15.2	11.6	48.9	12.8	18.1	16.5	16.7	30.6	16.4	11.0	7.9	16.4	3.4	19.1	21.5	16.9	12.6	16.6	22.5	19.8	22.4	16.6	16.8	17.0	13.3	18.4	16.8	13.1	12.6	20.2	20.5	22.6	12.2	15.8	12.2	2.5	12.5	10.9	5.4	18.7	21.4	18.5	21.6	12.1	23.8	14.3	9.8	17.0	18.2	12.4	11.1	12.7	18.8	27.9	6.6	21.5	16.2	27.2	17.1	19.7	14.8	21.5	15.3	14.7	19.3	14.1
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9295682	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 3.1;testis: 5.9"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 114.8;Spermatogonia: 96.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"U-266/70: 27.8;U-266/84: 32.1"									HPA035135	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.0	0.1	0.3	0.0	0.2	0.3	0.0	0.3	0.3	0.1	0.2	0.2	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.8	0.0	0.4	0.2	5.9	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	27.8	32.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.0	0.4	0.5	0.1	0.0	1.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	4.9	0.2	1.7	0.4	0.0	0.0	0.3	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.5	6.6	0.6	0.2	114.8	96.5	0.0	0.3	0.0	0.2	0.0	0.0	0.2
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.6;Hepatocytes: 42.6;Late spermatids: 87.8;Microglial cells: 49.6;Oligodendrocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"basophil: 8.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.8"	"Cell line enhanced"	"Detected in all"		"RH-30: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	2.6	1.7	1.7	3.1	2.4	3.3	3.4	8.9	2.7	4.1	1.7	4.0	5.5	3.2	1.1	3.5	2.8	3.7	2.7	1.8	2.3	6.8	24.6	4.0	2.7	3.9	2.3	2.3	4.4	1.5	3.5	3.1	3.2	3.5	4.3	2.4	3.0	1.5	3.6	5.9	6.2	2.1	1.7	2.3	3.6	9.5	2.4	4.2	3.1	1.2	2.6	3.0	3.2	3.9	21.5	14.6	18.7	16.9	2.0	5.4	11.7	8.1	5.7	14.1	13.9	16.2	9.3	12.7	6.4	7.2	10.6	25.5	21.1	8.5	8.4	12.9	10.1	9.8	16.6	9.6	2.7	11.6	11.3	4.9	3.8	11.1	5.4	3.9	8.4	10.1	14.9	5.7	10.3	17.1	9.7	5.8	9.6	23.2	8.9	17.3	47.1	7.0	6.4	6.8	26.2	13.1	18.9	7.4	4.2	8.2	6.9	8.6	4.0	13.0	17.1	14.5	14.1	5.9	12.0	6.8	6.6	9.8	15.9	8.8	0.3	0.0	0.9	0.6	0.9	0.6	0.4	0.9	0.3	0.6	0.7	0.7	0.1	0.1	1.3	0.9	0.4	0.5	1.7	2.4	8.9	2.7	1.8	2.3	3.9	2.3	3.2	1.7	2.4	3.9	3.0	3.2	2.2	9.4	2.2	2.5	2.7	1.2	2.8	6.1	3.5	3.7	1.9	5.7	2.3	0.0	4.2	3.0	2.7	3.3	1.9	4.4	178.6	3.5	5.5	4.3	0.0	3.0	22.1	4.1	5.0	3.3	2.0	4.7	5.7	3.9	5.0	42.6	2.0	10.1	13.8	4.0	0.0	3.5	1.3	87.8	6.5	1.6	1.8	49.6	2.8	2.1	1.0	32.2	48.9	3.1	1.0	2.2	4.4	3.0	5.6	8.9	1.0	4.5	0.0	4.1	2.3	19.4	13.2	4.0	2.7	2.3	2.1	4.5	4.7	2.5
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4;smooth muscle: 26.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.1;hippocampal formation: 2.4"	HPA059739	Uncertain				"Secreted to blood"	NA	NA	108000000	56000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	5.8	0.2	0.9	5.2	0.9	0.0	10.1	0.4	0.9	15.2	0.0	3.5	0.5	31.4	8.5	3.6	4.8	22.3	4.9	0.3	1.4	0.7	0.2	4.0	1.5	0.6	0.5	3.0	2.5	0.7	0.5	23.1	0.6	1.9	2.5	6.4	4.7	5.8	4.4	2.8	0.9	26.4	0.2	0.4	1.0	1.5	1.0	0.5	2.8	7.5	1.5	15.5	3.6	0.7	0.0	0.0	0.0	0.0	192.2	202.3	0.4	82.8	167.8	16.6	25.4	0.0	0.0	0.0	0.6	31.3	0.0	0.1	0.0	5.1	8.0	0.0	0.0	0.1	1.2	0.0	19.5	0.0	0.0	66.2	1.2	28.1	5.2	209.1	0.1	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.5	0.0	9.0	0.2	0.1	0.0	84.3	167.3	3.1	41.4	0.4	0.0	0.1	0.0	37.5	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.9	0.3	1.4	0.6	0.5	0.6	0.2	1.0	0.7	3.9	0.0	0.0	5.5	0.2	4.5	0.1	7.0	0.0	1.8	0.3	0.5	0.4	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.2	6.7	3.4	67.6	6.4	4.9	0.0	13.3	0.2	1.9	43.4	0.0	6.2	0.0	0.0	1.4	0.0	0.9	1.7	0.3	1.4	0.0	0.0	2.6	4.1	8.4	0.8	3.6	17.8	0.0	57.5	0.0	0.5	4.2	1.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	2.0	0.0	4.7	25.2	2.3	0.4	0.4	4.3	1.8	0.8	1.3	0.2	0.0
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	14	"dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.3	0.8	0.1	1.0	0.2	2.8	0.6	0.1	0.2	0.4	0.1	0.8	1.9	0.5	0.7	0.3	0.3	1.1	0.3	0.2	0.1	0.3	1.1	2.0	5.7	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.9	0.0	0.9	0.3	0.1	0.4	1.4	0.3	0.0	4.1	1.5	0.2	0.1	0.6	0.2	0.0	1.8	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	58.1	0.2	35.5	0.0	11.5	31.4	0.1	0.0	2.2	25.0	1.9	41.5	0.1	0.0	0.2	14.9	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.4	0.4	0.0	2.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	43.4	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.6	1.8	0.0	0.9	0.0	79.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	28.8	0.0	0.0	0.1
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 113.4;esophagus: 50.9;skin 1: 56.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in many"	7	"cerebellum: 113.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5"	"Region enriched"	"Detected in some"	18	"cerebellum: 32.0"	"Region enriched"	"Detected in many"	56	"cerebellum: 224.4"	CAB033680	Enhanced					NA	NA		300000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.2	0.4	0.0	3.8	0.1	3.6	113.4	4.8	11.5	0.0	0.1	0.1	0.1	1.7	50.9	1.0	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	15.1	2.8	0.1	0.2	0.2	0.5	0.9	17.2	5.3	0.0	0.1	8.9	4.8	0.2	56.0	0.2	0.0	0.4	0.1	0.1	13.2	0.5	2.2	0.1	0.0	3.4	2.9	24.4	2.2	1.7	0.0	0.0	0.1	0.0	0.0	35.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	21.0	0.0	0.2	51.7	0.0	23.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	70.5	0.0	3.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.1	0.0	0.1	1.1	0.2	0.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.8	113.4	4.8	0.5	0.4	15.1	2.8	17.2	0.4	0.5	2.2	0.1	0.0	0.0	0.7	0.0	18.0	5.8	31.6	27.9	0.0	3.4	12.8	1.9	0.0	11.1	1.8	0.0	0.4	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.3	0.0	0.0	5.0	0.0	20.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.0	1.5	7.8	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.1	3.0	0.0	0.0	0.0	0.4	0.5	0.1	53.2	19.6	1.0	0.1	0.0	0.0	13.0
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120630-65122177	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	817.0	787.0	976.0	655.4	1009.0	1898.7	878.5	956.5	1212.5	1024.2	887.1	905.9	604.0	780.6	535.3	720.0	907.5	590.1	862.2	928.0	953.5	632.1	756.3	614.0	1342.5	982.1	958.7	1403.7	1167.7	395.0	521.6	482.7	989.8	649.3	438.8	228.2	854.7	532.3	1191.2	905.1	712.9	441.6	1010.2	784.5	796.3	336.6	1011.9	843.5	619.9	642.1	818.5	796.7	794.0	1017.9	1305.1	1040.6	658.8	1067.9	766.4	1142.2	1033.3	727.3	887.7	1327.5	832.4	1258.7	1232.1	1782.0	1782.3	744.2	701.5	1101.2	821.5	1287.2	419.3	1075.4	1494.0	1428.1	907.1	1607.8	1612.2	1546.9	1184.9	1583.3	1944.0	1106.3	1286.5	842.2	998.5	1416.3	1334.4	1578.6	644.9	2003.0	1579.6	2925.2	1850.4	1007.2	2027.5	1464.8	622.2	2980.1	1036.0	744.3	1054.4	949.2	663.8	1490.6	2131.0	399.1	1393.3	1829.5	771.2	868.6	954.8	1327.5	1150.0	1629.0	1943.6	2802.6	1042.6	1285.4	979.3	2638.2	2997.4	1808.3	2906.6	2694.0	3986.3	7025.5	4689.8	3729.6	3181.0	6502.9	5484.9	4364.5	1905.5	2994.7	2398.9	4141.8	3794.9	10270.4	976.0	1009.0	956.5	1212.5	928.0	953.5	982.1	958.7	989.8	1010.2	1011.9	1017.9	2252.8	641.0	1035.7	17.6	3768.6	3773.3	3059.7	1883.6	2632.2	351.8	3483.5	5942.5	507.2	1712.8	1280.4	958.2	196.0	2277.7	2670.7	1454.5	2050.4	1540.6	875.1	954.7	1569.4	1671.7	1226.4	1786.0	15.9	2689.2	2487.3	1531.1	923.5	1298.4	1370.0	1483.3	1755.9	2176.7	2188.0	190.1	18.2	2143.3	907.3	2643.8	3977.8	2397.4	2285.9	2349.4	2123.8	16.9	3121.9	935.5	2472.7	15.6	40.8	2042.7	2666.5	1229.2	2317.3	3295.5	2501.4	2615.9	826.4	513.6	1117.5	2227.4	2678.6	654.4	590.6	2506.0	4195.9	2793.0	2897.4	1470.6	2184.8	3518.0
FBH1	"Fbx18, FBXO18, FLJ14590"	ENSG00000134452	"F-box DNA helicase 1"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	28.7	38.8	17.5	22.8	20.3	24.6	26.8	17.7	19.1	32.4	25.7	30.4	24.6	34.3	21.3	24.0	36.4	23.0	44.5	17.2	18.0	25.2	28.8	27.6	27.6	17.7	18.2	30.7	21.9	28.5	26.1	26.6	18.0	28.6	24.2	14.8	24.3	25.8	30.3	30.4	29.7	30.1	17.8	35.3	27.6	24.7	19.2	40.2	25.2	27.4	27.2	28.8	27.1	19.0	31.8	34.0	31.3	34.4	70.4	46.3	28.1	35.9	24.6	34.8	38.8	40.4	28.3	29.6	23.0	52.5	16.7	46.3	42.6	38.2	31.3	32.2	31.5	28.6	27.3	34.8	48.2	14.2	26.4	58.2	36.4	44.2	19.4	44.0	59.7	39.7	50.9	30.4	37.3	48.1	34.5	20.9	14.3	54.7	18.9	37.6	14.8	49.9	34.0	25.5	17.7	26.6	36.8	33.1	50.8	35.7	33.7	28.5	37.9	22.1	24.7	59.1	28.1	30.9	26.1	16.3	29.8	20.7	15.8	0.0	2.1	3.3	1.9	1.7	1.3	3.0	2.0	2.5	2.0	4.1	2.5	1.8	1.3	4.6	1.3	4.0	6.2	1.7	17.5	20.3	17.7	19.1	17.2	18.0	17.7	18.2	18.0	17.8	19.2	19.0	22.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	15.6	16.1	0.0	0.0	0.0	7.3	0.0	20.3	9.3	0.0	21.5	16.8	0.0	11.4	19.0	7.1	0.0	0.0	0.0	15.1	19.4	9.8	0.0	14.9	0.0	23.6	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	32.0	4.4	27.9	0.0	0.0
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846379	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 747.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546, HPA077724"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA		79000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: AB_2680811, HPA077724: "	"prognostic favorable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	130.3	86.7	30.0	66.3	31.0	124.9	147.8	28.4	34.0	186.5	28.8	112.1	52.2	136.9	61.2	191.5	145.3	32.8	72.8	27.5	28.4	93.3	73.4	88.2	99.2	30.6	29.4	255.1	155.9	50.1	66.0	42.9	30.2	109.9	85.6	23.3	110.5	48.2	127.6	221.8	113.4	67.3	30.0	130.8	104.8	77.2	31.1	103.0	89.5	57.2	157.3	125.6	156.2	31.5	248.5	510.6	208.0	237.2	82.6	140.5	125.0	137.5	122.8	237.6	225.9	301.8	142.8	555.9	125.9	119.7	72.0	98.3	308.2	295.4	290.8	101.2	405.3	225.2	181.9	276.8	106.5	528.3	169.1	114.2	105.9	190.3	395.0	107.4	184.2	239.5	361.8	228.0	133.2	340.3	468.9	232.7	206.4	353.8	156.1	256.3	209.7	282.5	131.4	282.1	280.2	163.2	133.5	210.9	87.7	116.2	107.1	190.6	99.8	112.3	177.2	156.8	324.8	155.5	176.1	374.1	113.4	341.6	105.2	2.7	41.8	6.4	70.6	36.3	101.7	83.5	73.9	70.3	74.8	84.5	100.6	97.3	3.2	92.5	40.5	78.1	58.3	71.6	30.0	31.0	28.4	34.0	27.5	28.4	30.6	29.4	30.2	30.0	31.1	31.5	45.9	32.1	48.1	2.3	166.6	350.3	323.8	150.2	200.9	18.8	168.3	177.3	37.5	105.8	77.4	40.5	25.0	130.7	118.9	88.5	74.3	108.8	361.1	43.4	97.9	105.4	92.8	129.3	2.7	190.9	283.2	84.2	65.7	53.7	95.9	139.0	105.7	54.1	104.8	15.2	2.6	170.0	46.8	104.3	169.8	747.7	118.1	66.5	97.8	2.8	135.8	33.3	151.4	1.0	4.1	94.5	95.6	78.6	102.8	266.6	59.1	78.7	43.7	24.9	72.3	193.9	122.8	41.7	83.4	201.8	330.7	121.6	123.3	157.3	265.3	240.1
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549125-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 6.7;naive CD8 T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2"	"Group enriched"	"Detected in many"	4	"olfactory bulb: 12.4;white matter: 3.1"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	157.3	7.6	5.9	12.7	7.7	1.0	97.3	5.2	9.0	63.4	6.4	32.7	6.2	31.1	3.2	42.4	26.8	46.2	292.8	7.0	4.9	8.7	3.7	29.2	8.4	5.3	5.3	5.8	8.6	3.0	2.3	80.3	4.8	29.1	11.8	0.6	39.4	8.8	47.7	72.5	19.8	14.7	4.1	6.0	22.3	46.7	6.9	14.2	63.7	48.9	5.6	79.6	56.7	4.4	0.0	1.4	50.9	0.0	384.0	51.7	23.8	124.9	98.2	122.4	80.4	8.1	0.3	0.0	5.9	264.3	0.2	0.2	0.0	0.5	22.9	0.1	0.1	100.7	1.9	0.0	26.0	0.2	311.6	221.9	2.0	19.3	0.0	0.2	0.0	8.6	0.8	0.9	0.6	0.3	5.2	0.6	12.2	0.0	0.7	0.2	0.0	0.5	0.9	0.1	3.0	2.4	0.5	90.3	0.1	13.6	0.2	0.3	0.1	0.1	0.1	139.2	0.1	0.2	0.0	0.0	1.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.2	6.7	1.3	0.0	3.7	0.0	0.2	0.0	0.5	0.0	0.9	5.9	7.7	5.2	9.0	7.0	4.9	5.3	5.3	4.8	4.1	6.9	4.4	92.7	0.0	1.5	1.6	3.6	30.8	0.8	10.5	2.2	0.0	1.7	1.9	8.8	0.0	12.3	7.3	2.1	7.8	1.9	0.1	0.0	0.0	3.8	2.9	84.4	43.8	0.0	1.7	0.6	0.2	4.8	458.4	6.1	2.7	23.6	0.6	47.8	0.4	3.6	0.0	0.6	0.0	0.0	1.9	49.8	12.1	170.9	4.5	39.2	26.2	0.3	1.2	0.0	30.7	0.3	0.3	0.0	227.2	1.6	1.2	2.7	0.1	1.4	0.4	13.1	29.7	26.4	3.4	13.5	2.0	28.8	6.2	5.3	0.2	0.0	1.1
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 81.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		11000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.1	5.1	0.4	0.8	0.5	3.1	0.2	0.0	0.3	2.2	3.0	0.8	0.3	1.7	0.1	0.1	0.4	0.3	5.5	0.2	0.6	0.1	0.1	0.2	0.5	1.1	1.9	0.5	0.2	0.0	0.8	81.9	0.5	0.8	1.2	0.9	0.3	0.4	0.2	0.2	0.4	1.3	0.5	0.4	0.8	7.4	0.8	0.2	0.5	0.4	0.9	0.5	0.7	0.3	0.0	16.4	58.2	0.0	9.4	16.6	11.8	62.8	0.0	56.0	41.8	0.2	0.0	0.0	0.1	85.5	0.0	9.2	37.6	9.8	52.7	0.1	13.8	0.0	27.3	0.2	134.1	8.4	0.0	94.3	5.3	24.1	215.2	17.9	122.3	0.0	0.0	0.0	35.8	0.1	0.0	3.4	24.5	0.0	18.2	19.2	18.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.6	48.0	0.0	18.7	0.0	22.1	41.9	66.8	0.3	0.0	0.0	0.0	6.9	0.0	23.8	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.2	0.6	1.1	1.9	0.5	0.5	0.8	0.3	0.1	0.0	0.5	1.6	0.2	0.0	0.1	1.2	0.6	0.0	0.3	0.3	12.7	0.0	1.4	0.0	0.0	298.1	0.0	0.0	0.0	0.3	3.8	10.0	3.9	1.0	0.0	0.0	1.1	0.0	24.3	8.8	0.0	4.7	0.0	0.1	0.0	0.0	34.0	0.0	50.5	0.0	0.0	10.7	0.4	7.2	1.2	2.7	1.8	1.9	6.2	3.8	0.0	17.6	1.5	0.1	0.0	2.2	0.0	2.0	0.0	0.2	1.6	0.1	6.6	0.1	3.5	10.7	3.5	0.1	0.4	163.5	0.1	8.4	0.1	0.1
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252663-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.6;Inhibitory neurons: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA044748: AB_2679072, HPA050397: AB_2681112"	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	4.1	5.4	7.8	3.4	8.2	8.2	4.5	6.8	11.4	4.6	1.0	4.1	3.5	4.4	3.4	4.1	4.0	3.7	3.5	8.8	9.7	4.1	4.7	4.0	3.6	3.3	4.8	4.7	4.3	4.6	3.5	5.5	5.0	3.7	4.1	8.3	3.7	3.5	3.6	6.5	4.2	5.0	2.3	4.4	3.8	12.7	8.8	7.5	3.9	5.2	4.0	3.9	4.3	5.2	4.0	8.2	8.0	8.5	10.1	7.2	4.6	5.6	7.5	6.3	7.7	2.6	9.3	6.3	12.3	7.3	12.6	9.3	9.4	6.5	9.1	12.1	12.5	6.7	7.2	7.9	7.3	9.5	8.1	6.0	7.5	6.2	7.2	8.9	7.7	8.0	13.4	4.5	6.1	5.9	9.4	6.7	2.1	8.1	3.5	4.6	15.9	4.2	3.2	6.2	5.1	4.0	10.6	65.7	7.1	10.4	10.3	9.0	6.3	7.0	6.9	5.3	5.3	7.9	8.9	5.2	8.7	4.3	5.5	30.2	5.5	18.3	4.2	4.5	3.9	4.0	3.9	3.9	4.1	6.2	3.6	3.5	26.9	8.2	6.7	5.3	8.3	2.4	7.8	8.2	6.8	11.4	8.8	9.7	3.3	4.8	5.0	2.3	8.8	5.2	13.5	19.2	20.4	61.4	15.4	4.0	7.1	2.6	10.2	31.4	13.0	10.9	6.5	11.5	6.7	12.9	58.4	14.4	23.9	18.4	1.9	11.2	14.1	28.3	16.3	12.5	9.6	34.9	122.6	6.1	8.2	14.4	5.1	25.6	8.8	23.7	22.5	12.0	10.5	20.2	126.8	10.0	12.2	25.2	3.8	15.6	18.0	16.1	1.8	71.2	24.0	12.0	32.0	74.9	79.6	13.8	10.0	11.3	14.2	15.9	26.5	6.3	8.8	39.2	6.6	15.3	14.3	51.2	39.9	10.5	5.5	24.2	18.1	11.7	10.6	15.3
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500180-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 976.2;Inhibitory neurons: 295.1;Oligodendrocyte precursor cells: 335.8;Oligodendrocytes: 766.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055464	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055464: AB_2682822"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.94e-3)"	17.5	22.7	16.9	3.7	19.5	0.0	13.9	16.0	15.9	19.1	15.9	17.2	2.0	26.4	10.3	9.7	15.8	8.4	17.0	15.5	14.2	4.7	2.1	9.6	2.6	19.7	16.5	26.8	1.9	1.0	4.7	6.6	16.1	13.3	5.2	4.3	5.6	19.5	4.0	5.0	6.8	24.6	15.1	5.0	10.2	4.4	18.4	2.4	8.2	5.7	2.1	16.6	13.1	22.3	0.1	1.4	16.1	23.5	13.1	10.0	0.0	14.1	17.0	9.9	10.3	0.0	0.0	0.0	0.0	21.7	10.2	0.0	8.1	5.2	9.8	0.0	1.1	0.0	0.0	0.0	5.1	0.0	0.0	11.8	0.0	8.0	0.7	12.1	23.2	0.0	0.0	6.1	7.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	11.4	0.1	0.0	0.0	4.7	15.9	0.0	4.9	15.3	14.5	0.0	0.0	22.9	20.6	4.1	11.7	6.3	0.0	0.0	0.0	11.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.5	16.0	15.9	15.5	14.2	19.7	16.5	16.1	15.1	18.4	22.3	21.4	3.2	1.9	976.2	0.3	2.4	2.7	2.4	2.2	3.2	0.9	1.1	11.8	0.0	1.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	2.0	11.8	16.7	0.0	0.0	3.7	0.0	0.1	15.9	0.0	2.0	1.3	13.1	15.4	0.2	0.8	30.3	295.1	0.0	0.0	0.6	2.7	0.7	30.1	0.5	5.4	146.1	0.0	2.4	0.0	335.8	766.0	0.0	0.0	41.3	1.2	3.1	0.0	1.2	3.8	2.5	6.6	16.1	8.1	1.4	2.1	1.5	1.7	0.0	0.3	20.7	0.0	2.4
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47906498	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	27.9	19.6	24.5	19.1	25.9	32.2	20.9	32.7	28.7	21.1	21.0	19.7	16.8	33.1	24.8	18.7	22.2	20.9	22.8	26.5	25.6	21.7	26.8	22.5	25.7	22.8	23.1	34.4	19.6	30.2	17.5	23.0	24.0	22.7	20.1	33.3	16.5	20.4	28.3	19.1	17.3	29.7	22.9	24.2	19.1	41.0	25.9	22.5	26.1	28.7	27.7	22.1	16.9	25.2	52.8	26.9	62.9	53.9	42.6	40.2	37.2	36.0	48.6	32.6	31.9	22.9	25.9	32.8	45.4	50.2	40.5	25.6	42.5	37.1	47.9	22.3	21.5	31.6	21.3	36.6	41.0	33.5	32.1	39.3	41.7	28.8	48.2	51.9	42.1	16.6	31.3	33.9	40.4	25.5	31.7	32.8	38.2	34.7	26.2	40.9	58.3	25.5	47.1	42.5	44.1	52.3	34.2	31.5	54.6	46.4	14.7	27.9	46.4	40.2	37.2	27.5	40.0	28.9	16.5	60.9	27.4	30.8	42.1	4.3	1.1	2.1	1.5	1.2	1.6	2.1	1.4	1.7	1.4	1.5	2.6	1.7	2.6	2.2	1.1	2.0	1.6	1.1	24.5	25.9	32.7	28.7	26.5	25.6	22.8	23.1	24.0	22.9	25.9	25.2	40.6	16.0	39.0	100.9	34.1	67.0	44.4	22.0	24.5	45.1	22.3	15.1	11.0	15.7	24.9	18.4	33.3	19.6	37.8	24.7	11.7	17.2	34.4	38.6	40.3	39.4	23.9	17.1	151.4	15.2	16.0	37.0	23.4	48.6	29.1	37.3	33.2	20.0	25.5	55.5	134.8	17.1	24.4	40.1	81.4	40.4	30.1	51.8	35.6	137.7	30.9	30.2	25.7	138.7	143.8	25.8	17.1	39.9	36.3	44.3	17.3	14.6	37.4	42.5	19.7	42.3	34.6	86.6	50.7	24.2	59.0	36.0	35.6	33.4	19.5	65.1
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114111-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003289	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	10.9	7.5	6.5	8.3	7.3	8.9	12.3	8.8	10.5	10.9	7.4	10.3	8.5	10.0	7.9	12.4	8.2	9.5	8.1	7.6	9.1	13.6	17.4	8.9	10.5	8.5	7.4	11.3	7.6	13.7	4.4	9.0	8.8	10.0	10.6	8.3	7.9	8.5	12.5	21.1	7.7	9.8	8.0	8.9	8.5	7.8	7.8	10.9	9.8	14.2	10.6	11.5	9.0	8.9	24.6	10.6	16.2	17.4	16.6	19.0	26.7	24.3	19.7	16.0	15.2	14.9	18.7	11.8	24.4	22.3	10.3	20.9	24.2	23.4	27.4	17.0	27.0	15.0	12.8	10.7	20.7	28.3	18.8	18.6	27.7	23.2	41.9	18.8	27.1	15.0	24.8	16.4	29.1	8.1	14.9	14.4	38.6	32.3	22.8	15.7	23.1	22.3	30.2	16.1	26.2	28.1	25.1	38.0	27.4	16.9	20.2	28.2	31.2	19.8	15.0	25.0	46.1	17.8	22.3	18.0	24.5	13.7	39.3	7.4	6.5	11.8	5.8	6.0	7.2	8.9	5.9	6.8	7.8	9.0	5.9	6.6	4.2	8.6	6.9	3.5	8.8	4.6	6.5	7.3	8.8	10.5	7.6	9.1	8.5	7.4	8.8	8.0	7.8	8.9	15.0	6.4	10.6	22.5	16.8	34.3	25.5	11.3	9.6	20.5	14.7	11.7	11.4	7.2	13.5	11.0	22.9	14.2	12.3	17.2	9.8	13.2	30.3	15.9	13.0	16.4	18.5	17.4	48.8	11.5	13.1	12.7	7.1	22.9	14.0	12.6	14.3	23.4	13.9	18.5	43.8	12.7	14.2	17.7	16.3	14.8	13.1	16.8	28.4	34.7	16.4	12.6	7.2	45.8	43.7	17.7	12.2	13.2	15.4	21.5	12.0	22.8	11.5	18.6	13.1	14.9	12.7	24.7	26.8	17.2	39.1	23.0	18.9	10.9	14.6	30.7
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002467: AB_2666602"	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	21.2	24.2	18.1	14.8	21.6	26.9	27.5	20.7	24.6	21.4	19.0	21.4	18.1	24.8	24.2	33.6	23.3	21.5	46.3	20.3	19.8	47.0	42.0	19.7	18.3	16.5	16.8	28.9	27.1	56.8	17.7	16.5	17.5	25.6	23.7	33.9	23.0	25.5	124.1	28.9	20.5	24.5	17.2	19.1	23.5	25.2	19.0	20.4	34.3	98.8	21.4	20.8	22.5	19.0	22.1	19.2	25.8	27.6	30.4	23.8	15.6	25.7	25.6	20.4	25.3	22.1	21.6	14.6	17.7	28.2	25.1	37.2	34.8	33.9	34.1	14.7	48.2	7.5	28.4	18.3	19.4	17.4	16.9	24.2	33.8	14.1	22.3	29.7	27.3	10.6	25.9	28.4	23.2	14.9	13.0	10.2	13.1	49.4	29.5	9.9	57.5	20.8	29.5	27.5	36.3	20.0	36.4	24.8	19.6	24.6	35.8	13.2	25.2	25.2	22.0	35.9	22.0	15.7	22.1	24.5	22.5	13.4	25.4	25.9	11.9	18.0	21.6	11.8	24.4	16.2	25.5	24.6	12.8	20.0	32.1	22.4	12.8	25.1	15.5	6.6	34.3	15.8	18.1	21.6	20.7	24.6	20.3	19.8	16.5	16.8	17.5	17.2	19.0	19.0	33.3	35.3	17.2	31.3	28.9	48.8	64.2	32.0	35.3	56.8	24.5	14.7	42.4	21.5	31.0	25.8	27.1	22.7	28.9	22.6	56.7	49.6	130.8	17.3	19.2	31.7	23.9	32.8	45.1	25.3	28.7	30.7	17.3	21.8	16.5	25.8	32.5	41.0	12.3	57.2	37.9	18.8	54.9	15.0	20.1	51.3	29.8	11.9	28.4	22.5	15.2	46.7	40.2	30.7	40.1	34.9	25.2	27.1	28.3	33.3	23.2	63.6	34.4	52.4	59.2	26.2	37.1	64.2	27.3	43.6	67.5	36.5	32.9	19.4	16.7	50.4
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	7.0	9.6	12.2	8.1	12.6	52.6	6.5	10.8	16.2	8.0	16.7	5.9	7.2	6.5	10.1	5.2	6.0	7.3	5.3	14.9	12.9	7.3	6.9	7.9	9.4	12.4	10.8	6.1	5.9	13.2	10.8	7.8	12.5	7.5	5.7	8.4	6.7	7.4	3.0	5.7	5.6	6.6	9.8	7.8	6.0	12.1	11.6	11.8	11.6	6.7	9.8	7.2	4.9	12.5	12.8	7.8	7.0	10.8	24.7	11.5	11.6	12.6	16.9	6.9	8.0	4.7	11.1	14.3	15.2	19.7	6.9	6.4	18.3	12.4	12.3	13.7	11.8	5.7	10.5	12.2	7.0	21.7	20.9	10.7	13.2	11.8	3.8	11.9	5.8	14.0	5.0	12.6	13.6	13.7	19.4	13.5	7.2	11.5	11.6	16.6	11.4	13.0	13.2	16.1	12.1	5.5	11.3	11.8	14.0	10.4	8.7	13.7	7.5	11.6	10.4	17.4	10.1	17.0	21.6	22.6	9.0	10.1	8.8	0.9	0.9	1.8	1.6	1.1	1.4	1.2	1.6	1.7	0.8	1.1	2.2	2.1	3.9	2.8	1.1	0.7	1.7	0.6	12.2	12.6	10.8	16.2	14.9	12.9	12.4	10.8	12.5	9.8	11.6	12.5	14.7	9.6	20.1	21.9	25.7	34.5	13.6	6.4	27.9	24.0	19.1	16.4	8.9	4.3	8.1	9.2	43.8	8.4	40.8	18.0	7.9	8.1	42.1	25.7	14.3	14.7	23.9	16.2	82.6	9.3	9.5	14.8	12.8	39.8	10.2	10.1	13.9	10.6	10.5	28.6	46.7	14.2	2.0	19.2	23.3	10.7	8.4	22.6	19.6	23.4	14.8	12.4	10.3	34.7	36.7	14.0	10.1	5.3	32.7	21.5	13.9	4.0	8.4	17.9	0.0	18.8	17.8	28.5	12.2	24.0	56.4	21.2	31.4	8.0	13.7	24.7
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593379-121630295	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	97	"heart muscle: 90.4;skeletal muscle: 162.2;tongue: 100.3"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 416.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in many"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	0.2	0.1	0.3	0.0	0.7	0.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	90.4	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.1	0.8	0.0	162.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	100.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.3	0.7	0.0	0.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	416.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	2.8	0.0	0.1	9.6	0.0	0.2	0.0	12.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072204	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA072204: AB_2686493"	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	19.5	20.4	33.3	13.6	38.2	8.2	17.0	34.7	41.6	19.9	27.4	14.6	12.6	22.9	12.4	24.2	27.0	17.5	36.1	38.0	35.5	23.0	20.7	17.6	16.7	33.3	34.4	25.6	29.1	33.1	14.2	13.9	33.1	19.0	16.0	37.2	13.5	20.3	34.5	13.7	13.2	26.1	34.4	18.1	20.0	14.3	37.7	17.3	21.1	35.6	22.0	19.2	15.8	42.4	35.4	35.6	52.0	45.2	39.9	40.2	26.4	37.1	51.7	45.0	54.9	36.7	23.1	32.5	44.3	46.4	72.0	22.8	37.6	56.3	74.6	42.7	37.3	26.2	35.0	28.5	35.4	29.8	36.0	28.5	38.2	36.8	59.8	48.5	38.6	27.3	16.6	31.7	55.7	26.5	20.7	15.3	19.8	20.8	39.5	30.1	43.7	22.0	34.8	29.2	21.6	37.2	32.9	27.3	70.8	38.7	34.2	31.0	33.8	44.3	22.0	27.4	37.2	31.8	38.9	22.2	31.3	27.8	34.6	25.4	7.3	7.2	5.8	5.1	6.1	8.5	4.8	5.7	7.3	8.4	4.3	5.7	7.1	14.1	5.7	8.6	5.7	6.6	33.3	38.2	34.7	41.6	38.0	35.5	33.3	34.4	33.1	34.4	37.7	42.4	35.4	25.6	21.2	75.4	52.7	19.1	15.6	21.8	32.5	43.5	26.4	22.1	59.1	42.9	20.8	27.6	8.4	8.5	49.8	25.1	43.0	33.7	32.9	42.0	47.9	26.3	28.8	27.4	86.5	36.9	7.8	24.7	38.2	51.0	20.8	25.8	29.3	43.1	12.8	35.3	85.3	21.6	20.3	29.6	25.3	34.3	29.5	26.6	12.4	62.8	24.6	63.6	16.5	75.9	94.4	54.1	14.9	28.6	36.5	30.2	21.5	52.4	17.1	34.3	46.0	28.2	33.5	34.5	16.0	28.7	23.7	12.0	28.8	17.2	15.0	32.9
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"pancreas: 6.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.4;Late spermatids: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA037491: AB_2675504, HPA037492: AB_2675505"	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.6	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 206.3;lymphoid tissue: 306.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 333.4;Hofbauer cells: 193.1;Kupffer cells: 807.9;Macrophages: 300.0;NK-cells: 579.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1763.5;neutrophil: 1169.8;non-classical monocyte: 3948.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 1169.8;monocytes: 3948.7"	"Not detected"	"Not detected"											"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	52.9	41.9	18.4	99.8	20.4	27.3	14.7	19.3	27.2	8.2	26.5	12.5	5.8	5.9	5.9	4.9	9.1	24.5	22.3	16.9	22.0	7.9	111.5	206.3	37.1	37.7	27.9	6.6	7.8	13.6	11.3	71.0	30.6	6.9	12.6	6.9	14.7	7.6	3.3	2.2	5.7	68.4	31.7	306.8	6.8	7.7	28.8	9.3	7.0	4.3	3.9	32.5	3.5	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	26.2	9.6	513.6	1763.5	4.9	3.7	4.7	205.9	175.8	1.4	3.0	184.0	1169.8	136.2	3948.7	4.6	2.6	734.1	18.4	20.4	19.3	27.2	16.9	22.0	37.7	27.9	30.6	31.7	28.8	39.8	2.7	22.4	24.6	0.7	6.5	0.5	0.1	0.0	0.0	0.2	1.4	3.4	0.7	8.6	10.5	3.7	2.1	1.2	333.4	0.0	0.0	0.2	1.4	0.1	0.0	18.9	0.0	16.4	0.0	0.0	1.4	3.9	0.0	0.1	18.9	0.1	8.6	5.3	193.1	0.0	0.1	0.1	0.0	807.9	7.4	3.7	0.3	300.0	0.0	20.6	77.2	0.1	579.9	0.0	0.1	0.0	0.0	0.0	22.1	0.0	0.0	0.8	5.8	1.5	19.7	1.1	0.4	0.0	0.5	0.2	0.0	2.1	88.0	0.0	0.0	0.3
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.6;lymphoid tissue: 82.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Club cells: 3.1;dendritic cells: 2.2;Fibroblasts: 2.2;Kupffer cells: 2.2;Macrophages: 4.3;NK-cells: 2.1;Respiratory ciliated cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.7"	"Immune cell enriched"	"Detected in many"	79	"neutrophil: 7208.7"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 7208.7"	"Not detected"	"Not detected"																"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	23.0	2.8	0.6	76.4	1.2	36.6	1.3	0.7	6.7	2.8	1.1	2.1	0.5	0.9	0.0	5.0	5.2	16.4	3.5	0.6	0.7	1.9	7.9	22.0	1.3	1.0	0.8	0.4	4.0	1.4	0.7	9.1	2.7	0.8	0.9	0.0	1.3	0.4	0.8	4.0	2.4	5.6	0.7	82.0	1.8	0.2	1.1	6.1	1.3	23.0	1.5	18.3	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.1	12.5	17.2	30.4	0.6	0.3	0.9	6.9	3.0	0.6	0.5	6.2	7208.7	3.6	90.8	0.4	0.6	18.5	0.6	1.2	0.7	6.7	0.6	0.7	1.0	0.8	2.7	0.7	1.1	1.1	0.0	3.2	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.5	3.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.0	4.3	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 158.9;lung: 46.2;lymphoid tissue: 96.3"	"Group enriched"	"Detected in many"	10	"Kupffer cells: 504.4;Macrophages: 542.4;monocytes: 1017.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1699.8;intermediate monocyte: 1195.1"	"Lineage enhanced"	"Detected in all"		"monocytes: 1699.8"	"Group enriched"	"Detected in some"	5	"NB-4: 4.7;U-937: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	36000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	15.9	1.4	0.6	47.7	0.5	158.9	5.1	0.8	0.7	2.0	0.5	3.2	0.5	1.5	0.0	1.6	6.4	3.9	5.1	0.5	0.3	4.1	7.2	46.2	3.2	0.5	0.5	1.0	2.5	0.1	1.0	2.4	0.6	2.3	1.6	0.1	2.8	0.5	1.6	1.2	2.8	12.1	0.2	96.3	3.7	0.7	0.7	2.4	2.2	1.1	1.3	10.1	2.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.1	0.0	7.2	0.1	9.3	1699.8	18.0	2.9	1195.1	3.5	5.9	1.4	1.6	492.6	1.5	1.7	1.6	277.1	2.8	582.2	13.0	2.1	1796.8	0.6	0.5	0.8	0.7	0.5	0.3	0.5	0.5	0.6	0.2	0.7	0.5	2.1	6.4	17.1	0.0	6.6	1.9	0.2	0.0	0.0	0.0	0.3	0.0	2.6	1.5	5.0	1.8	0.0	0.8	6.0	0.1	0.0	0.0	0.1	0.2	0.2	2.7	0.0	5.2	0.0	0.0	1.5	3.6	1.5	0.1	12.6	0.1	3.9	2.6	68.4	0.0	0.0	0.0	0.0	504.4	68.3	0.0	0.0	542.4	0.0	0.0	1017.8	0.0	27.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.1	0.7	0.0	0.0	1.0	0.5	0.0	0.1	0.2	0.4	1.1	6.1	0.3	0.0	0.2
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 99.7"	"Cell type enriched"	"Detected in some"	18	"Hepatic stellate cells: 1192.6"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	23	"spinal cord: 38.6"						"Secreted to blood"	NA	NA	8100000000	1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		4.7	24.6	0.4	0.0	0.4	0.1	7.6	0.3	0.5	0.3	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.6	0.4	6.4	99.7	0.1	0.1	0.3	0.5	0.5	0.5	0.2	3.1	0.0	0.4	3.2	0.0	0.0	3.2	0.4	0.1	0.2	0.1	0.0	0.2	3.1	0.2	0.2	0.4	0.0	2.1	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	9.0	0.4	0.4	0.3	0.5	0.6	0.4	0.3	0.5	0.4	0.2	0.4	0.3	0.1	0.0	0.0	0.7	3.8	0.0	0.1	0.0	0.0	0.0	3.8	0.4	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1192.6	12.6	0.0	0.0	0.1	0.0	0.0	64.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369110-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"liver: 278.3;lung: 724.6"	"Cell type enriched"	"Detected in some"	16	"Hepatic stellate cells: 2828.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	NA	NA	22800000000	14000000000		"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	62.6	35.9	1.1	5.7	1.0	0.0	40.8	1.1	1.6	2.7	10.0	4.1	0.8	3.9	0.1	2.8	3.0	1.6	62.1	1.4	1.1	55.2	278.3	724.6	4.3	1.2	1.2	2.4	12.5	2.7	6.6	22.6	1.2	5.3	0.5	0.0	2.5	0.5	9.0	1.9	6.7	1.8	1.2	11.3	8.4	2.4	1.2	0.4	20.4	7.5	0.3	3.0	1.9	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	1.1	1.6	1.4	1.1	1.2	1.2	1.2	1.2	1.2	1.0	94.1	0.0	9.3	0.0	16.6	0.8	0.6	0.5	0.6	0.0	0.8	2.8	2.4	52.9	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.5	0.4	0.2	155.1	0.0	136.4	0.1	0.0	0.0	3.8	0.5	0.2	3.8	0.0	2828.6	31.8	0.3	0.0	0.1	0.0	2.0	168.6	0.3	2.7	3.4	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.1	5.1	0.0	0.0	1.0	2.7	0.5	0.5	1.0	1.1	0.0	4.9	0.5	0.0	0.3
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792911-61797238	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		160000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	5.9	10.4	7.8	21.3	7.8	39.5	10.2	10.9	9.9	6.2	9.6	15.5	11.2	6.3	7.1	14.2	5.7	4.3	6.6	8.0	7.7	5.8	9.9	5.6	34.0	10.0	8.3	3.9	6.8	5.6	8.3	12.9	10.7	6.2	16.1	17.4	6.1	5.9	13.1	9.6	11.4	8.9	6.8	12.8	8.4	19.1	9.1	46.0	4.8	9.6	37.4	8.1	4.9	8.1	154.6	139.7	149.3	81.3	14.9	18.0	94.9	133.3	76.1	160.9	181.4	123.4	112.8	222.6	100.3	57.3	150.5	158.3	214.3	117.7	163.3	117.8	117.6	117.6	187.7	127.3	11.0	184.7	115.4	12.7	15.8	148.1	39.0	23.3	63.1	122.1	181.3	155.1	136.0	195.4	259.7	165.4	165.3	120.3	134.7	173.8	173.7	228.9	64.4	144.7	170.0	140.7	89.6	115.0	79.1	70.1	167.4	127.1	43.2	141.5	178.1	182.3	134.6	120.4	204.3	228.9	98.4	121.9	124.6	24.7	6.7	14.2	16.2	12.9	16.8	14.4	12.3	15.1	8.0	14.8	14.0	13.8	2.7	20.0	12.9	24.5	25.2	10.3	7.8	7.8	10.9	9.9	8.0	7.7	10.0	8.3	10.7	6.8	9.1	8.1	2.7	0.0	2.2	0.3	14.0	10.3	5.2	18.2	7.4	23.8	7.4	7.4	5.8	5.7	7.7	0.0	12.5	53.0	15.9	6.7	7.9	17.3	21.7	4.2	5.5	5.5	4.8	87.5	2.0	12.2	70.9	8.6	7.1	6.3	0.0	18.6	1.1	7.2	25.7	15.2	2.4	8.0	18.3	5.4	6.8	14.4	5.6	6.2	5.4	0.0	12.4	31.3	13.4	1.5	3.1	12.2	9.4	7.2	45.3	6.5	3.7	5.7	6.4	23.3	0.0	6.8	12.2	61.0	62.1	11.3	6.1	30.9	11.0	9.0	22.0	5.2
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747841-109196841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Alveolar cells type 1: 80.1;Astrocytes: 207.3;Early spermatids: 158.1;Excitatory neurons: 266.3;granulocytes: 95.5;Inhibitory neurons: 313.8;Late spermatids: 182.4;Microglial cells: 227.7;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 91.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007641, CAB022464"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	4.2	3.7	3.4	3.0	3.2	1.6	3.6	2.8	3.4	3.8	0.6	3.9	1.7	3.7	2.9	4.2	3.0	3.3	3.0	3.1	3.9	3.5	2.3	3.7	1.4	3.6	3.7	4.6	1.9	9.4	2.5	4.2	3.8	3.0	2.4	5.7	2.5	3.9	1.3	4.5	2.0	4.9	4.1	2.7	2.2	6.7	3.1	2.8	6.4	2.0	2.0	3.5	3.2	5.0	9.8	3.4	11.0	18.0	6.6	10.1	7.2	11.4	11.0	6.5	7.6	19.0	5.5	15.3	6.9	13.8	8.4	6.3	6.2	14.4	14.7	6.5	8.4	9.8	14.5	7.0	4.4	5.6	8.2	6.2	7.9	15.8	17.5	6.4	9.8	14.6	12.9	11.1	8.4	2.7	4.4	1.7	1.6	0.9	7.0	3.3	10.7	91.7	6.4	3.3	3.8	5.6	18.6	1.0	11.4	7.0	4.4	2.4	14.7	12.5	10.2	6.5	9.0	9.4	14.9	5.9	7.4	1.9	6.0	8.9	3.7	4.6	1.2	2.5	2.1	10.3	0.7	1.4	2.3	3.4	1.2	1.5	0.3	1.1	2.0	4.5	1.7	0.9	3.4	3.2	2.8	3.4	3.1	3.9	3.6	3.7	3.8	4.1	3.1	5.0	23.8	80.1	28.3	207.3	9.5	29.2	15.8	9.5	25.6	17.6	6.6	8.5	21.9	10.0	21.8	14.7	18.8	3.9	7.5	4.9	1.9	13.6	158.1	13.1	17.2	19.7	8.4	10.7	266.3	6.0	10.7	31.4	16.8	12.6	95.5	21.8	18.9	2.3	8.2	18.5	313.8	4.5	8.2	9.5	13.4	182.4	19.3	14.1	14.2	227.7	12.0	10.5	4.1	284.0	216.0	9.1	4.7	17.7	13.7	12.1	1.7	6.9	27.9	16.3	6.6	30.7	23.8	7.7	11.5	13.2	17.6	3.1	10.4	10.2	4.1	6.9
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 10.8;stomach 1: 43.1"	"Group enriched"	"Detected in some"	9	"Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054117	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA054117: AB_2682387"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.0	5.0	2.9	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	4.5	0.1	0.0	0.0	43.1	2.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	15.8	0.3	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.4	0.0	0.0	0.0	30.5	0.9	0.0	0.0	1.9	0.0	0.0	0.0	1.0	1.0	10.8	2.2	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223891	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.6;lymphoid tissue: 130.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065231			Approved	Vesicles		NA	NA		160000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	25.1	14.5	9.4	63.3	11.6	180.6	13.0	11.2	18.1	8.5	12.2	17.3	22.0	8.4	0.7	6.4	13.6	15.6	12.0	9.8	11.6	11.1	12.5	46.2	89.2	17.9	12.2	5.1	7.0	1.3	5.9	15.0	13.2	8.2	8.1	0.6	10.7	4.4	6.0	7.1	34.1	9.4	13.3	130.1	29.6	4.5	17.1	48.7	10.0	4.6	41.8	19.8	7.3	15.3	1.2	1.6	0.5	0.9	0.3	0.8	2.0	1.4	0.2	0.4	0.3	2.6	2.3	32.6	3.2	6.3	0.7	2.4	1.0	0.5	0.5	83.9	0.6	306.9	1.6	0.1	10.8	135.9	314.2	1.2	1.1	5.2	0.0	0.5	81.2	77.0	7.3	127.6	8.6	3.5	121.8	174.1	1.2	1.0	2.3	72.4	8.8	0.7	0.3	0.7	1.9	0.5	0.7	4.5	1.7	0.7	2.0	92.6	7.8	1.1	2.5	1.9	0.9	1.5	3.3	59.4	19.5	138.9	86.6	204.1	207.0	236.5	120.0	192.6	114.9	54.5	94.1	112.0	162.0	53.1	60.9	80.6	184.6	102.4	151.2	195.7	120.9	292.6	9.4	11.6	11.2	18.1	9.8	11.6	17.9	12.2	13.2	13.3	17.1	15.3	3.8	9.6	14.7	0.7	52.1	4.7	0.9	0.3	3.4	0.5	3.3	5.2	2.4	4.3	3.9	0.0	0.0	1.2	118.3	6.1	0.0	0.8	0.4	4.3	5.6	7.9	0.0	62.5	1.2	2.4	1.4	5.4	19.9	7.3	96.4	0.4	19.6	1.4	193.1	0.0	1.5	32.1	0.0	95.8	88.0	0.9	0.9	232.9	17.8	5.6	142.9	0.3	93.7	1.0	1.5	4.3	10.9	2.6	35.2	0.9	8.2	0.4	1.0	0.3	6.6	13.7	6.6	1.2	0.8	1.9	4.5	2.6	78.5	1.4	15.0	0.7
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 234.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.6	0.0	0.1	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.4	234.6	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.8	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	53.0	39.1	48.2	21.0	51.6	16.5	35.9	48.2	68.6	26.9	42.8	34.5	22.1	33.1	18.9	31.7	23.8	23.6	46.7	49.2	48.4	33.6	29.4	27.1	24.3	49.5	46.3	27.6	10.8	20.3	14.2	46.8	48.2	23.5	27.9	26.5	17.1	32.5	108.1	17.0	28.5	41.1	50.1	30.3	21.9	20.8	49.6	18.2	23.9	78.5	19.5	29.1	24.3	56.3	64.9	37.1	49.4	22.3	91.3	122.1	39.5	157.1	76.5	90.7	56.0	24.6	21.5	39.1	94.7	199.2	41.0	25.1	42.4	54.3	98.5	9.3	24.7	31.7	12.2	43.5	44.4	32.9	8.5	119.9	44.2	57.8	69.6	61.2	131.0	9.5	35.4	12.0	170.2	22.7	19.6	27.5	27.1	33.9	57.8	16.9	44.3	14.0	72.9	57.6	1.9	45.7	38.7	31.9	37.8	51.7	11.3	39.1	161.2	59.7	32.9	33.4	92.9	9.8	11.5	26.6	58.9	22.4	84.8	2.5	3.5	5.1	1.7	3.4	1.0	1.6	1.3	1.0	3.5	1.0	1.5	0.7	4.2	3.2	2.3	15.6	1.4	0.8	48.2	51.6	48.2	68.6	49.2	48.4	49.5	46.3	48.2	50.1	49.6	56.3	109.4	54.5	37.5	25.8	23.7	31.4	94.7	45.5	41.5	52.5	31.7	33.1	43.1	17.2	70.2	58.8	45.9	96.4	61.1	57.6	56.7	80.3	5.6	38.4	44.7	100.9	24.0	15.3	45.4	30.6	87.6	50.7	27.0	64.3	24.1	66.0	97.5	37.2	93.7	21.9	22.9	28.8	38.7	88.1	65.4	10.7	54.3	64.6	56.9	45.0	56.0	97.1	35.0	23.1	50.5	74.4	41.4	66.2	17.9	99.1	65.6	45.1	35.9	36.3	59.2	64.0	51.2	12.1	34.9	24.0	32.1	180.1	24.2	47.2	37.7	140.6
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 16.1;Granulosa cells: 12.6;Inhibitory neurons: 15.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000911, HPA076516"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA000911: AB_1078853, HPA076516: "	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	3.9	5.1	8.2	1.6	6.2	0.0	3.6	5.3	7.6	7.0	2.4	5.6	1.0	7.1	1.6	5.8	5.1	2.2	5.0	8.3	5.2	3.5	1.1	2.8	0.5	3.8	4.1	7.4	3.2	3.6	3.6	3.4	3.7	4.3	1.6	1.6	3.4	3.3	1.3	5.4	2.8	5.4	3.5	2.4	3.5	2.4	4.9	0.4	3.3	1.0	1.0	4.8	5.4	4.6	18.5	6.9	13.2	19.3	7.8	13.8	6.2	10.4	12.8	10.6	8.5	0.6	0.4	0.0	8.2	19.9	9.6	5.3	14.6	9.0	5.8	1.0	8.9	0.0	5.0	2.2	8.3	0.0	0.0	11.3	5.6	16.1	7.6	9.4	9.7	2.3	2.0	0.0	8.4	2.4	0.7	0.0	12.6	0.0	10.2	9.4	6.7	0.0	9.1	0.3	13.1	11.9	10.3	0.2	16.6	21.0	10.3	0.4	6.9	10.5	8.7	23.0	9.4	0.1	0.2	0.1	11.0	0.6	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.2	5.3	7.6	8.3	5.2	3.8	4.1	3.7	3.5	4.9	4.6	3.2	0.0	0.0	4.6	0.0	2.9	1.2	2.0	5.2	2.5	3.2	3.9	3.4	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.0	1.6	0.4	1.3	7.0	4.2	1.2	0.0	16.1	1.1	1.0	5.1	1.5	2.1	0.0	12.6	2.9	0.3	0.4	1.7	15.2	1.0	0.0	0.0	1.0	0.6	2.8	0.1	7.2	5.6	0.0	2.3	0.0	7.1	1.8	0.5	0.5	4.1	0.1	1.6	0.1	1.4	0.3	3.5	0.0	2.3	4.0	0.3	2.2	5.5	4.1	0.3	0.1	2.9	2.8	1.0
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947523-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 41.8;Early spermatids: 66.1;Late spermatids: 99.0;NK-cells: 69.0;T-cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.9;Karpas-707: 61.4;RT4: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	4.7	1.3	1.8	21.9	1.6	39.4	3.5	1.8	4.9	1.5	2.5	3.0	3.1	1.1	0.4	2.4	2.1	4.6	2.0	1.6	2.7	4.9	2.0	10.2	30.8	3.4	2.6	1.4	7.6	0.4	0.7	3.5	3.5	1.7	2.3	0.0	4.9	1.5	1.1	3.2	11.3	2.7	2.7	29.5	4.3	6.5	3.5	32.4	3.3	2.2	17.6	8.1	3.5	4.0	13.3	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	16.0	9.1	11.3	0.6	0.0	0.1	8.4	0.6	0.0	0.0	19.7	0.1	17.4	0.1	0.6	0.0	4.8	43.9	0.0	0.3	0.0	0.0	0.0	0.0	18.8	0.7	61.4	0.0	22.8	20.7	20.4	0.4	4.3	1.1	20.1	0.0	16.3	0.1	33.5	1.2	0.4	0.0	14.4	0.4	0.4	5.8	21.4	0.0	0.0	0.6	0.1	0.1	6.2	6.6	5.4	3.1	10.3	0.0	142.9	50.6	139.6	49.5	63.4	49.9	28.6	51.4	46.6	37.5	36.9	50.1	44.7	178.2	39.1	99.2	16.8	48.4	74.0	1.8	1.6	1.8	4.9	1.6	2.7	3.4	2.6	3.5	2.7	3.5	4.0	1.7	22.4	9.2	0.0	25.3	0.8	0.6	0.4	0.6	0.1	5.8	1.8	2.5	4.3	2.3	9.2	0.0	2.9	41.8	0.4	0.0	7.2	66.1	1.2	0.2	2.1	1.8	11.8	0.6	0.2	3.2	0.9	0.0	0.6	19.6	3.7	1.8	0.8	15.5	0.0	1.6	0.6	0.0	22.3	6.2	99.0	0.3	20.7	1.8	12.2	20.1	0.4	69.0	5.0	0.5	0.4	0.1	0.4	15.8	0.1	0.0	0.7	0.3	3.9	0.0	0.3	0.8	1.6	2.4	0.5	1.0	4.5	47.3	0.1	0.4	0.5
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992181-17002345	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enriched"	"Detected in some"	7	"Microglial cells: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"						"Secreted in other tissues"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.1	0.6	0.8	0.0	0.8	0.0	0.2	2.5	1.4	0.9	0.5	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.1	0.8	1.2	0.0	0.0	0.1	0.1	1.1	1.2	0.6	0.1	0.0	0.4	0.1	1.4	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	1.1	1.0	0.6	0.2	1.4	0.2	0.2	0.0	0.4	0.1	0.1	1.6	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.6	1.6	0.2	0.8	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	2.5	1.4	0.8	1.2	1.1	1.2	1.4	1.1	1.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379712	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 126.3;choroid plexus: 104.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 10.4;Early spermatids: 6.6;Hepatic stellate cells: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 10.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;HBEC3-KT: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	56800		"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"							"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.2	0.1	74.8	0.1	73.5	0.5	0.2	73.8	126.3	0.0	104.9	0.2	0.3	0.3	1.2	0.2	0.3	0.1	5.0	74.1	74.1	0.2	4.1	0.2	0.2	73.8	86.6	0.2	0.1	0.1	0.0	0.2	77.8	0.1	0.6	2.3	0.5	0.0	1.2	0.3	0.1	0.3	72.9	0.5	0.2	0.5	73.3	0.1	0.1	0.3	0.6	0.1	0.0	78.6	0.0	0.0	1.9	0.6	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.3	0.1	0.4	0.2	1.4	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.4	0.1	0.5	0.0	0.9	1.1	0.1	0.1	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.0	0.3	0.0	0.3	0.2	0.4	0.4	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.0	0.7	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.1	0.4	10.8	1.4	2.0	1.6	1.5	1.9	1.8	1.5	1.2	1.2	1.9	1.7	1.7	4.8	2.2	2.5	1.9	1.6	1.1	74.8	73.5	73.8	126.3	74.1	74.1	73.8	86.6	77.8	72.9	73.3	78.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.9	1.5	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	6.6	0.0	0.2	0.5	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.1	0.0	0.0	13.6	0.0	0.2	1.7	0.3	0.0	0.0	0.6	0.3	1.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960245-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.0;bone marrow: 54.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 486.6;NK-cells: 1627.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 551.3;memory CD8 T-cell: 332.1"	"Lineage enriched"	"Detected in many"	8	"T-cells: 551.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.9;T-47d: 3.2;WM-115: 1.3"														"Secreted to blood"	NA	NA	346000000	36000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	29.0	1.5	0.9	0.4	1.0	54.6	12.7	0.8	1.5	0.6	0.8	11.8	0.1	0.5	7.2	0.6	0.7	0.9	23.6	1.0	1.1	0.5	1.2	8.5	2.9	0.9	0.8	0.4	0.2	0.3	0.2	0.5	0.9	1.4	0.9	1.1	8.6	0.9	1.1	21.0	2.0	0.3	0.8	14.0	1.7	8.6	0.9	5.3	1.1	3.6	1.0	2.8	1.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.9	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	3.5	0.8	2.4	551.3	1.3	5.2	0.8	128.6	332.1	0.9	0.4	47.3	314.1	8.4	64.9	1.6	2.1	0.9	371.2	0.9	1.0	0.8	1.5	1.0	1.1	0.9	0.8	0.9	0.8	0.9	0.9	2.6	0.0	5.3	0.0	2.6	9.6	0.0	0.2	0.0	0.0	1.5	1.7	1.5	5.7	1.4	5.5	8.4	0.6	486.6	0.1	0.0	0.7	1.3	0.9	0.1	2.2	0.0	3.6	0.0	0.0	0.0	19.9	0.5	0.3	3.8	60.3	6.1	0.6	0.0	0.0	0.0	0.4	0.0	4.9	12.0	3.0	0.0	2.2	46.2	0.0	5.8	1.4	1627.2	0.0	0.1	0.2	0.0	0.4	17.5	0.0	0.0	1.3	1.3	0.4	0.0	1.8	2.5	0.7	0.1	0.1	7.7	1.0	167.2	0.2	0.1	0.0
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 508.7;BJ hTERT+: 278.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	95.1	12.8	27.5	15.9	24.6	14.1	87.1	48.8	22.4	79.8	37.2	97.2	8.8	74.2	15.8	35.8	85.9	57.1	89.9	30.9	28.8	40.1	9.1	55.7	16.6	35.9	37.3	108.2	98.6	20.4	57.1	51.3	63.7	60.5	17.9	15.8	31.4	53.6	24.8	35.6	41.7	57.1	30.3	9.9	40.4	20.4	33.4	17.1	33.7	23.3	16.1	79.3	63.9	29.6	12.9	42.0	198.0	508.7	120.1	91.2	142.9	136.7	278.8	90.0	95.8	27.3	6.5	1.8	38.3	127.7	103.9	0.2	90.0	6.8	104.3	39.2	24.1	0.0	7.7	27.8	69.7	31.1	0.6	80.5	0.7	70.9	13.3	45.6	86.9	6.0	11.9	0.4	40.5	12.5	91.5	9.2	145.9	1.6	21.6	86.3	21.1	0.4	35.6	0.3	7.9	19.4	23.4	1.0	5.1	93.4	9.3	5.4	51.4	49.2	28.9	149.6	29.7	2.4	4.1	0.5	60.3	1.7	27.1	0.2	0.3	0.1	1.7	0.1	1.1	0.3	0.7	1.2	0.0	0.6	0.5	1.5	0.6	0.4	0.2	0.2	1.0	0.1	27.5	24.6	48.8	22.4	30.9	28.8	35.9	37.3	63.7	30.3	33.4	29.6	101.0	3.2	15.8	55.8	1.8	31.5	95.9	1.1	37.0	4.4	28.7	77.7	52.5	24.3	5.1	9.2	4.2	8.3	6.3	0.4	0.0	27.3	15.3	48.2	40.6	75.5	25.0	3.6	25.4	65.2	80.5	176.7	3.1	75.3	8.2	40.4	47.5	0.8	25.3	21.9	21.1	0.6	4.1	5.6	75.2	15.0	192.0	11.7	33.8	19.7	1.7	88.1	6.2	166.4	14.2	21.6	0.3	99.6	6.4	94.7	0.1	7.9	1.0	3.3	13.1	118.9	59.9	1.6	14.1	4.8	19.7	10.4	14.1	2.1	0.7	11.7
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 82.5;lung: 65.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	1.2	14.0	1.1	4.1	1.1	0.5	4.5	2.7	2.1	3.0	1.2	18.0	21.3	2.4	0.2	3.2	4.2	10.2	2.2	1.4	1.0	40.2	82.5	65.4	0.8	0.7	0.8	27.5	29.5	0.2	2.0	2.1	0.9	5.2	6.0	1.5	1.1	0.7	6.6	1.7	20.0	1.1	0.7	22.7	8.8	5.9	1.1	0.2	0.9	1.9	0.2	6.4	3.2	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	2.7	2.1	1.4	1.0	0.7	0.8	0.9	0.7	1.1	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.7	34.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.0	1.2	0.0	0.0	8.8	16556.3	50.2	0.1	0.0	0.0	1.4	15.8	0.0	0.4	6.3	0.0	0.4	0.0	0.0	0.4	0.3	0.4	0.5	0.6	0.0	0.0	9.1	8.7	3.0	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
FGL1	"HFREP-1, HPS"	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 4163.9"	"Cell type enriched"	"Detected in many"	27	"Hepatocytes: 8261.7"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 55.4;Hep G2: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		57000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.9	0.4	1.2	0.0	1.4	0.0	1.0	1.0	1.8	0.4	0.9	0.2	0.0	0.7	0.7	0.2	0.2	0.1	0.3	1.3	1.7	0.5	4163.9	1.2	0.0	1.3	1.6	0.3	660.1	0.0	0.2	6.3	1.3	3.8	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.2	1.1	3.8	0.6	4.3	1.5	0.0	0.3	0.0	0.0	0.1	0.1	1.2	0.0	55.4	0.0	6.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	131.9	0.0	1.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	1.3	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	1.0	1.8	1.3	1.7	1.3	1.6	1.3	1.1	1.5	1.2	0.0	0.0	1.9	12.4	24.6	0.0	0.2	0.0	0.0	0.0	1.3	0.9	2.1	301.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.3	42.9	5.4	1.0	7.6	0.0	176.4	0.1	71.2	0.4	0.1	0.0	7.8	0.0	0.0	173.8	8261.7	20.4	0.0	0.3	0.0	0.0	231.6	0.0	32.7	0.6	0.2	0.0	14.0	1.6	0.0	0.0	2.5	0.0	74.1	0.0	0.4	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	1.0	12.8	0.1	0.3	0.2
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193369-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 162.5"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	45	"classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8"	"Group enriched"	"Detected in all"	59	"dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	7800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	48.5	24.4	3.3	89.4	2.7	5.8	35.1	5.3	3.5	17.2	6.1	44.9	43.7	17.8	7.6	38.5	22.1	45.4	21.6	2.4	5.4	44.9	43.5	32.7	56.5	7.7	5.9	10.9	8.3	5.2	7.9	21.6	6.7	10.5	57.2	0.8	14.8	11.7	8.8	13.9	69.8	45.7	6.2	162.5	23.5	6.2	3.9	30.1	18.8	24.6	27.5	73.3	7.1	9.8	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.2	0.3	5.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.0	5.7	2.8	256.5	226.3	3.9	380.6	1.2	4.3	2.5	3.4	160.0	2.0	1.8	3.0	294.7	2.5	379.8	6.2	4.7	174.0	3.3	2.7	5.3	3.5	2.4	5.4	7.7	5.9	6.7	6.2	3.9	9.8	102.0	6.4	12.1	0.0	26.2	38.1	1.1	0.1	3.4	1.1	1.4	3.0	4.4	0.0	5.0	88.3	10.4	1.3	60.3	17.3	5.9	1.9	7.5	2.6	0.7	50.6	0.0	7.0	0.3	0.0	1.4	102.8	2.0	5.0	10.1	0.6	45.3	5.2	36.2	1.7	0.4	0.3	0.0	466.3	571.0	9.4	27.7	430.3	49.8	33.7	463.1	13.6	39.1	0.0	0.9	0.1	10.9	19.5	82.6	1.1	42.5	5.9	2.2	7.4	0.0	166.2	8.2	0.4	0.4	2.1	31.3	3.7	24.1	0.2	0.8	1.5
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247481	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 88.1;skeletal muscle: 127.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 40.6;Theca cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HMC-1: 112.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	16.9	16.9	3.6	9.6	3.5	6.2	13.2	3.5	4.0	9.6	4.6	9.3	5.9	8.5	1.6	4.5	7.9	5.5	10.4	3.4	3.3	10.5	3.3	26.6	8.5	4.1	4.0	14.7	7.7	3.7	5.4	8.9	3.9	8.8	4.2	0.3	8.4	3.9	127.0	6.2	9.7	5.8	4.0	88.1	7.2	5.0	4.8	4.1	16.8	29.8	5.9	7.4	6.7	3.8	12.0	31.6	11.8	9.8	46.1	27.9	39.2	24.9	19.8	27.2	26.3	22.3	15.7	14.1	17.5	18.0	8.8	14.7	13.5	20.0	13.5	11.3	21.7	63.1	13.9	24.5	12.2	26.3	112.1	34.8	2.6	42.2	4.1	24.3	43.0	19.9	32.9	9.3	17.6	41.0	18.1	48.3	17.6	11.0	10.0	20.3	25.9	33.8	8.7	4.9	3.7	19.2	38.2	22.4	22.5	11.7	23.8	21.1	51.6	37.4	22.0	24.0	20.3	29.9	32.0	20.7	76.1	24.7	34.7	0.3	0.7	0.1	0.2	0.2	0.3	0.0	0.3	0.2	0.4	0.1	0.1	0.1	0.5	0.3	0.2	0.2	0.3	0.6	3.6	3.5	3.5	4.0	3.4	3.3	4.1	4.0	3.9	4.0	4.8	3.8	18.0	12.8	21.6	4.6	7.2	5.7	1.8	2.0	3.4	1.8	11.5	8.0	13.8	10.0	5.9	5.5	8.4	8.7	11.4	16.9	0.0	3.6	1.1	3.5	8.1	22.3	9.1	8.6	2.5	5.9	4.7	10.9	5.6	4.7	40.6	12.0	25.0	0.8	17.1	1.7	2.2	13.1	2.0	20.3	19.7	1.1	10.5	19.8	3.6	17.8	18.9	2.9	10.3	2.0	0.6	7.4	6.1	10.9	7.1	3.1	6.3	1.4	3.9	1.2	26.3	4.2	15.7	19.0	12.3	5.6	3.7	1.9	13.3	40.3	13.8	1.7
FIS1	"CGI-135, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 891.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017430	Approved		Supported	Mitochondria		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	205.8	227.6	202.4	60.0	231.0	110.2	195.2	234.0	230.7	149.5	194.5	211.0	83.0	168.1	100.5	155.9	166.0	70.9	382.2	198.4	213.5	250.5	294.9	140.4	73.2	238.9	222.7	152.3	208.7	201.1	209.3	75.4	237.8	160.3	69.5	34.8	142.4	90.0	475.6	174.3	137.3	83.7	223.9	163.0	194.4	145.5	217.6	84.0	178.9	284.2	63.8	163.2	141.1	256.0	110.1	124.3	94.7	133.6	103.6	136.6	63.5	118.1	139.0	103.2	88.3	81.7	173.2	107.4	145.7	159.4	98.1	64.0	65.8	184.5	56.8	87.9	101.0	49.8	154.7	100.6	124.5	93.1	75.0	131.9	172.5	73.4	111.5	117.2	185.6	60.3	109.0	142.9	155.0	445.1	145.1	160.4	100.8	221.2	123.0	70.7	53.4	235.8	155.1	107.5	120.6	141.9	57.0	261.5	83.0	81.3	88.0	101.5	159.6	120.6	76.6	127.9	125.3	122.2	98.6	61.6	111.7	103.0	159.0	153.9	137.7	135.9	122.3	141.7	126.4	152.7	115.5	115.9	149.6	152.8	115.0	120.5	104.5	126.3	131.6	123.2	155.6	207.9	202.4	231.0	234.0	230.7	198.4	213.5	238.9	222.7	237.8	223.9	217.6	256.0	301.0	102.5	119.1	16.0	127.5	104.9	158.6	158.4	114.4	48.2	220.5	309.2	349.4	207.3	114.8	229.9	16.7	259.8	120.7	334.5	561.5	263.5	208.5	145.4	120.7	205.8	219.4	423.7	13.6	293.4	309.2	166.7	110.1	126.4	136.3	132.4	182.0	384.9	297.0	35.3	13.2	317.9	128.1	170.9	133.5	730.3	193.9	136.0	218.7	15.0	214.1	281.5	171.9	6.6	83.1	232.2	460.4	179.0	184.8	221.0	603.6	891.2	130.9	59.6	98.6	161.1	233.3	188.0	201.2	192.7	135.7	324.1	127.5	247.4	277.5	192.5
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FKBP prolyl isomerase 4"	Q02790	12	2794970-2805423	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 372.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		480000	"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	35.4	38.1	92.1	22.3	95.9	24.2	53.1	127.7	372.1	41.7	89.6	35.7	20.3	32.2	44.6	69.3	38.2	24.8	42.7	96.6	104.4	68.1	57.5	38.0	19.8	101.0	101.4	50.4	52.0	47.8	36.1	50.6	106.2	44.4	37.8	52.2	48.1	44.9	69.4	49.8	25.6	40.0	97.8	24.3	58.0	58.4	103.0	25.1	44.4	48.5	29.9	44.6	46.0	141.7	91.6	198.6	56.2	94.9	68.5	40.1	268.3	87.5	31.2	141.2	95.0	199.1	108.3	120.9	24.5	56.6	98.2	121.9	353.3	118.5	168.2	222.6	226.1	133.2	141.8	71.4	52.6	105.5	35.0	36.5	106.6	167.2	165.9	84.0	83.5	119.8	124.9	166.4	57.6	261.5	186.2	94.9	480.0	266.5	141.2	110.0	98.7	72.4	119.5	114.2	80.7	116.0	101.6	272.7	45.3	348.8	368.0	70.3	44.9	69.1	216.4	78.6	224.1	40.9	67.9	177.0	61.4	154.7	72.2	17.0	11.5	6.7	12.5	10.5	13.9	14.0	11.0	11.9	6.4	14.3	11.3	13.5	1.5	9.2	15.5	5.6	11.0	11.1	92.1	95.9	127.7	372.1	96.6	104.4	101.0	101.4	106.2	97.8	103.0	141.7	31.9	6.4	11.5	10.1	39.1	143.9	261.5	38.5	80.8	60.3	133.9	96.3	13.1	54.3	26.8	53.3	75.0	186.1	27.2	111.0	154.6	82.0	125.4	49.7	47.4	43.5	106.1	77.8	12.9	25.9	117.3	42.6	41.8	74.5	38.2	45.3	20.7	49.3	62.0	97.6	15.5	124.9	63.1	17.5	102.1	40.9	34.8	67.7	92.5	4.7	40.2	48.3	25.7	10.1	17.6	60.3	100.1	38.7	47.3	272.4	77.3	141.7	21.1	63.4	85.5	28.3	117.2	149.4	74.4	111.5	132.8	223.3	74.0	38.6	148.7	147.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FKBP prolyl isomerase 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 719.1;Late spermatids: 1236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 93.4;neutrophil: 78.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA		10000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	206.9	161.5	426.8	79.8	423.7	272.9	197.3	359.7	645.5	235.3	332.7	311.1	85.5	188.6	59.0	238.3	198.1	85.5	244.3	427.4	395.7	194.8	233.7	187.6	97.9	427.6	405.1	263.6	167.2	109.1	312.3	91.2	406.1	249.4	33.6	51.4	200.0	115.3	202.7	185.9	159.2	62.5	381.7	193.6	189.3	378.4	423.4	86.2	205.9	105.5	52.7	228.3	222.4	437.8	196.3	139.0	106.0	201.7	106.2	165.6	266.8	155.0	163.1	116.5	160.2	133.3	259.1	111.6	245.0	191.7	77.7	104.4	65.0	216.5	31.4	136.6	316.5	105.3	175.4	162.3	183.3	105.5	220.6	217.3	204.8	104.0	65.4	216.1	121.9	213.2	222.4	254.8	102.1	329.1	190.4	313.1	216.3	174.6	200.2	197.8	88.4	387.3	154.9	126.6	117.1	213.2	108.8	87.7	197.5	77.8	104.5	299.4	143.2	143.2	130.3	282.1	120.0	194.6	118.2	130.8	321.5	166.7	130.8	18.1	14.7	93.4	14.2	15.5	13.3	10.2	14.6	16.3	11.1	9.8	11.1	12.6	78.0	8.8	19.0	11.3	15.8	30.1	426.8	423.7	359.7	645.5	427.4	395.7	427.6	405.1	406.1	381.7	423.4	437.8	115.9	9.6	1.1	35.3	115.1	95.3	164.1	118.4	68.3	64.8	110.9	107.4	2.0	115.8	58.0	101.2	14.6	246.4	107.0	287.7	248.4	178.4	412.3	65.6	59.2	92.3	205.9	719.1	32.0	126.9	234.8	126.5	80.5	64.6	52.8	125.0	99.6	66.4	237.3	99.3	33.2	156.8	126.1	184.1	145.0	1236.4	203.8	152.1	202.7	8.4	221.9	149.0	183.4	12.5	32.8	166.9	283.4	165.5	127.2	139.4	339.3	290.4	51.9	56.4	98.6	95.7	129.9	193.5	212.4	96.5	117.9	312.9	145.0	121.7	158.3	158.0
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FKBP prolyl isomerase 9"	O95302	7	32957404-33006930	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 108.6;Fibroblasts: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 379.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	80.7	44.8	23.9	16.8	24.0	2.3	59.1	26.5	25.3	65.9	28.1	44.8	19.7	55.7	22.4	35.6	50.6	44.4	77.1	21.4	32.1	38.2	21.1	49.6	13.6	28.9	30.2	46.3	40.8	25.1	34.8	77.4	29.3	42.3	45.3	11.7	36.0	52.1	35.0	64.4	31.0	74.4	28.0	23.7	41.0	11.4	34.2	8.2	40.8	49.7	15.8	43.3	52.2	27.9	38.9	71.4	27.6	113.4	254.1	290.2	36.4	202.6	209.9	65.5	103.9	31.6	89.2	0.2	80.7	379.5	105.1	73.3	40.8	100.0	75.2	0.1	11.9	6.6	72.3	31.6	105.6	0.4	10.8	191.8	59.6	59.0	56.9	156.3	83.9	0.1	15.0	7.7	137.3	37.1	0.2	19.4	5.8	76.6	37.3	0.3	73.7	0.3	73.0	13.0	25.7	62.4	115.6	58.4	73.4	69.6	41.1	18.7	112.8	107.0	99.8	67.4	46.8	23.9	48.9	0.2	104.4	0.3	218.5	0.9	2.2	0.5	0.0	1.6	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.0	4.0	0.1	0.4	0.1	0.0	0.6	23.9	24.0	26.5	25.3	21.4	32.1	28.9	30.2	29.3	28.0	34.2	27.9	108.6	12.8	21.7	22.9	0.6	34.3	12.7	31.4	10.2	8.2	15.7	16.5	46.1	17.2	10.3	18.4	10.4	18.8	0.6	23.2	5.9	19.5	0.5	22.6	25.8	80.1	12.2	1.7	9.8	41.5	27.7	89.1	17.9	23.0	5.7	81.0	60.0	18.0	7.6	11.8	10.2	25.4	10.2	8.6	23.5	3.2	36.7	5.4	60.5	15.0	2.9	30.5	0.0	8.5	8.8	36.5	22.1	55.3	4.4	8.1	18.8	8.1	11.0	5.2	46.0	21.2	45.8	1.0	1.3	12.1	28.6	13.1	3.1	12.3	27.7	10.5
FLACC1	ALS2CR12	ENSG00000155749	"Flagellum associated containing coiled-coil domains 1"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.8;testis: 17.1"	"Cell type enriched"	"Detected in single"	8	"Cardiomyocytes: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4;U-2197: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.9	1.1	3.9	1.0	4.3	5.0	0.5	2.8	3.9	0.7	9.8	0.8	0.5	0.7	1.1	1.2	8.3	1.1	4.5	5.0	3.2	1.3	0.7	2.5	1.6	5.8	6.4	0.3	0.9	0.7	1.1	0.8	3.7	0.5	1.0	3.3	1.1	0.8	1.8	1.2	1.0	0.6	4.2	0.8	0.5	17.1	3.0	0.7	1.6	0.4	0.5	0.6	0.4	3.7	0.1	0.2	1.1	0.7	2.7	1.1	0.0	0.8	0.3	0.7	0.4	0.0	0.3	0.2	0.6	1.2	0.4	1.1	0.4	0.1	0.3	0.7	0.1	0.1	1.7	0.4	0.6	1.2	1.0	0.5	0.3	0.7	0.1	0.8	0.1	1.2	0.5	1.6	0.6	0.0	0.6	1.0	0.3	0.4	0.6	0.3	0.5	0.7	0.4	0.2	0.2	0.7	0.7	0.0	3.4	1.0	0.4	1.4	0.9	1.5	0.7	5.9	0.5	0.8	1.8	0.5	1.2	0.6	0.7	3.1	0.4	0.4	0.7	0.3	0.3	0.3	0.4	0.4	0.2	0.7	0.6	0.7	3.6	1.3	0.3	0.2	0.3	0.2	3.9	4.3	2.8	3.9	5.0	3.2	5.8	6.4	3.7	4.2	3.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLG		ENSG00000143631	Filaggrin	P20930	1	152302165-152325239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 458.2"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 44.0"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.1;NTERA-2: 3.1;TIME: 2.1;U-2 OS: 2.4;U-2197: 2.6;WM-115: 2.0"	"Not detected"	"Not detected"							"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		3800000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.3	0.4	0.7	0.1	0.3	0.1	15.7	0.3	0.4	6.5	0.0	0.2	0.0	0.5	0.0	12.0	0.4	0.1	0.4	0.3	1.4	0.4	0.2	0.2	0.0	1.6	0.9	0.9	0.4	0.0	0.2	0.0	1.2	0.2	0.0	0.2	2.7	0.0	1.8	458.2	0.1	0.0	0.8	0.1	0.2	0.3	0.8	0.5	0.3	0.0	0.5	0.1	4.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	10.1	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.1	0.8	2.4	2.6	1.9	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.4	0.3	1.4	1.6	0.9	1.2	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.0	44.0	0.0	0.1	0.1	0.0	0.0
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 483.9"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 24.2"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028699	Approved					NA	NA		21000000		"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.3	0.0	0.1	0.0	0.0	0.1	32.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	483.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.1	0.0	1.0	0.2	0.1	0.2	0.0	24.2	0.0	0.0	0.1	0.0	0.3
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII actin remodeling protein"	Q13045	17	18244815-18258738	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.4"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 198.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Enhanced		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	57.7	50.0	9.8	22.9	11.5	26.4	55.0	12.6	11.1	50.2	13.4	56.2	19.5	49.6	7.3	65.7	41.3	13.7	75.1	9.9	11.5	42.2	30.7	53.3	20.0	15.4	13.0	39.1	57.6	16.9	39.0	17.0	15.4	41.5	12.9	4.6	63.6	17.4	245.4	46.9	50.8	18.9	12.1	58.0	45.6	35.3	14.2	17.4	44.1	73.1	15.8	61.3	50.3	13.6	198.0	73.5	18.4	30.0	44.2	38.9	29.4	53.7	64.1	59.0	36.4	93.5	45.2	39.7	56.3	61.1	33.7	89.0	26.2	90.1	34.4	32.6	42.6	20.5	54.9	36.9	50.0	23.6	44.3	36.4	53.3	47.9	71.8	36.2	58.0	35.3	18.0	15.0	34.9	61.3	34.9	20.5	20.5	85.1	37.8	34.3	87.2	48.7	43.5	58.4	7.2	10.9	63.1	51.0	28.7	117.2	90.8	17.8	73.3	53.6	54.4	104.0	64.4	15.9	12.5	11.5	50.8	23.5	28.7	10.0	27.5	25.6	12.8	39.3	12.5	9.3	9.9	13.0	30.2	6.0	7.3	8.2	22.6	10.5	51.1	8.6	12.7	24.2	9.8	11.5	12.6	11.1	9.9	11.5	15.4	13.0	15.4	12.1	14.2	13.6	44.9	60.9	36.9	12.7	23.3	22.7	24.9	35.1	26.7	15.4	29.6	23.9	37.4	22.8	47.3	25.8	18.8	25.9	24.8	62.8	15.6	53.5	45.2	37.5	27.9	38.7	23.9	21.7	7.2	56.9	28.7	28.4	42.3	56.6	46.9	28.8	27.5	19.4	48.9	26.9	7.4	26.0	24.4	46.2	39.7	9.2	32.3	52.2	16.0	14.0	55.7	11.4	12.3	3.5	14.2	134.4	49.8	35.0	31.8	40.7	48.8	21.3	50.3	12.7	32.9	28.0	30.7	40.0	20.0	33.8	19.6	25.4	32.1	33.3	40.9	38.6
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897733	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	60.2	46.4	38.4	56.8	38.6	97.1	56.2	28.1	47.6	42.8	45.2	58.9	21.0	39.1	21.2	69.3	46.8	27.0	63.5	41.1	42.5	71.4	98.4	59.5	68.2	45.9	37.1	37.7	38.8	30.0	22.3	58.4	41.3	67.8	27.2	20.3	61.7	51.6	51.6	38.2	53.0	35.3	37.5	122.7	44.6	10.4	47.1	47.8	39.6	44.1	63.6	78.8	49.6	36.1	55.5	90.8	69.6	60.2	33.6	44.2	76.6	42.5	57.9	60.9	71.3	96.0	45.7	76.9	79.3	47.6	42.0	63.3	76.5	69.7	25.9	245.5	91.4	92.7	80.5	70.3	43.6	76.8	15.2	53.3	53.6	49.3	66.9	64.1	97.4	21.8	89.0	65.6	28.9	83.5	21.2	54.0	61.4	48.6	24.6	32.6	70.6	189.3	92.0	166.9	61.9	103.3	99.8	69.6	77.5	66.7	72.3	136.3	81.5	21.4	38.2	35.2	65.0	36.5	68.2	39.5	59.9	72.3	40.7	171.9	106.0	213.2	98.8	96.6	72.6	98.5	74.6	84.5	144.3	118.1	55.3	69.0	415.2	78.5	110.2	38.8	97.6	143.2	38.4	38.6	28.1	47.6	41.1	42.5	45.9	37.1	41.3	37.5	47.1	36.1	34.2	22.4	21.9	12.7	46.8	12.6	27.1	20.6	29.6	6.9	24.9	30.1	32.9	22.8	16.5	20.2	10.4	96.6	20.5	29.0	15.6	39.3	13.0	25.8	13.2	37.0	25.8	49.2	17.0	31.1	68.9	14.8	23.0	27.6	6.3	15.6	48.9	45.1	44.4	5.0	19.2	25.9	10.2	43.3	22.6	42.3	10.8	31.1	8.8	22.5	75.2	10.7	35.0	16.1	11.0	32.2	16.5	8.6	27.8	14.8	14.8	26.7	19.1	12.4	19.7	7.1	13.4	1.6	6.9	42.4	9.2	37.1	32.5	4.2	32.0	26.7
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	17.2	11.3	3.5	4.7	4.6	0.8	14.7	2.6	3.4	9.0	2.6	4.9	2.8	8.0	3.0	4.4	9.8	3.8	9.7	5.1	2.6	20.1	6.2	16.9	5.5	3.4	3.0	4.5	2.0	2.3	7.8	6.4	3.6	5.6	1.3	0.3	2.0	2.5	4.7	4.0	7.2	4.1	2.8	17.6	3.5	3.1	4.2	1.0	25.7	4.1	1.4	5.6	5.5	2.7	0.1	2.5	3.2	10.1	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.4	0.3	0.3	0.9	0.1	0.6	0.4	3.4	0.2	0.3	0.1	15.6	1.2	0.5	0.5	0.1	9.5	0.3	0.2	0.1	0.2	0.4	0.3	9.9	12.3	0.4	0.4	2.1	5.6	0.1	0.5	7.0	0.3	0.6	8.2	0.1	0.1	0.1	0.3	0.3	1.1	0.1	0.2	0.1	3.1	14.6	0.3	15.7	0.2	6.9	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	3.5	4.6	2.6	3.4	5.1	2.6	3.4	3.0	3.6	2.8	4.2	2.7	27.4	0.0	1.7	0.7	0.7	0.9	0.2	0.0	1.2	0.2	1.4	1.4	4.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	27.1	0.0	0.0	0.2	0.0	37.1	0.8	0.0	0.1	2.5	2.4	64.6	0.6	1.2	0.0	0.1	0.0	0.0	3.3	0.8	0.7	0.3	0.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.7	0.7	0.1	5.2	0.1	1.1	1.0	1.8	0.2	0.0	0.1
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1725.9;placenta: 2928.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	151.1	31.4	37.8	131.9	44.8	0.6	76.5	36.3	51.2	135.9	85.9	444.0	33.8	156.1	61.3	251.6	174.5	187.1	410.9	38.9	41.1	42.9	1725.9	785.7	37.3	37.7	39.8	110.0	26.0	19.3	26.2	2928.1	43.5	105.6	237.2	6.0	67.0	428.9	37.7	52.7	103.4	722.6	36.2	14.3	127.2	25.8	112.1	133.8	40.4	148.4	23.9	361.7	87.1	35.3	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	44.8	36.3	51.2	38.9	41.1	37.7	39.8	43.5	36.2	112.1	35.3	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735615-82751196	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 34.3;Hep G2: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		180000		"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	14.4	47.3	47.4	2.9	64.3	12.0	8.4	64.4	56.6	10.4	36.8	15.5	22.4	9.4	7.0	4.6	12.5	6.9	47.5	46.5	54.3	49.6	48.1	7.8	2.4	63.3	56.8	22.3	18.1	21.9	22.4	5.3	62.7	12.5	9.5	13.8	28.5	12.1	23.5	5.3	14.5	6.6	49.4	4.6	17.4	5.2	55.6	1.0	10.2	10.9	2.3	8.8	7.9	79.8	1.3	16.1	4.4	23.2	6.9	5.7	2.9	2.9	2.2	5.4	2.7	21.0	3.3	0.2	3.9	2.6	4.5	0.6	34.3	2.5	2.0	1.0	2.4	12.5	12.9	66.2	18.8	0.3	10.1	4.9	9.0	2.1	0.0	5.7	10.6	1.0	22.4	0.6	1.1	1.8	0.2	0.2	2.9	7.6	13.0	2.1	0.3	0.1	11.5	4.5	7.0	22.7	5.3	1.2	15.8	3.8	15.4	4.5	2.5	0.4	1.6	5.6	4.3	1.2	0.3	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	64.3	64.4	56.6	46.5	54.3	63.3	56.8	62.7	49.4	55.6	79.8	3.9	3.2	2.0	8.8	1.9	1.5	3.7	1.5	14.8	41.9	4.5	3.7	5.8	4.3	2.5	31.3	47.9	11.7	2.6	5.7	90.1	3.2	0.2	11.6	3.0	5.2	5.4	49.2	10.2	1.2	2.6	8.6	47.9	25.9	1.3	6.9	4.2	5.4	8.2	32.0	13.0	10.4	6.1	1.0	3.4	0.4	5.3	5.7	12.4	5.6	1.2	36.2	1.0	6.0	17.1	1.7	7.3	3.0	9.1	3.9	28.2	167.2	2.5	72.9	0.0	6.1	9.8	0.8	4.1	12.8	1.8	8.3	3.1	18.6	9.5	3.5
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716706-82730328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	23.2	22.1	40.6	13.3	43.7	18.8	19.7	43.3	41.3	23.4	35.1	22.9	15.3	23.1	19.4	20.4	20.4	16.6	16.1	41.1	41.7	23.9	29.3	16.3	18.5	42.5	41.6	32.1	19.3	18.4	17.2	21.8	43.2	20.8	18.0	17.8	22.2	23.2	11.4	23.6	19.4	22.1	42.9	20.9	20.6	13.7	41.7	16.6	16.7	10.6	22.8	19.7	20.7	48.3	31.4	122.3	33.6	44.5	15.9	30.3	27.2	56.9	31.8	54.5	44.3	64.9	21.8	25.6	37.0	46.6	50.5	35.3	30.1	43.5	48.7	17.2	54.3	42.6	66.2	77.5	28.3	30.7	23.2	27.8	50.9	51.7	28.1	33.4	39.8	35.9	42.5	15.8	70.7	59.8	58.8	45.2	15.2	68.7	53.5	44.0	83.4	40.3	38.9	58.7	27.6	58.1	93.7	42.7	47.3	57.4	69.8	43.6	34.8	103.3	35.9	74.2	85.3	32.1	37.8	64.8	48.1	38.2	49.0	32.0	21.9	30.6	29.6	24.7	29.5	23.9	28.8	28.8	18.2	24.8	32.5	24.3	3.4	32.1	13.8	36.0	29.7	26.0	40.6	43.7	43.3	41.3	41.1	41.7	42.5	41.6	43.2	42.9	41.7	48.3	14.3	12.8	11.1	5.5	13.9	15.0	26.0	26.0	15.4	18.1	13.3	15.6	6.9	25.8	15.3	11.0	8.4	100.3	20.0	12.2	23.5	20.6	2.0	10.7	13.0	14.8	7.8	31.2	7.6	11.1	45.3	18.1	13.3	22.3	13.3	18.6	10.8	12.1	33.8	3.3	6.7	15.4	22.4	11.2	11.3	4.2	28.3	12.8	23.2	6.5	20.9	36.1	17.5	5.0	11.8	17.8	15.9	31.6	27.6	15.5	11.1	28.2	10.0	18.5	13.1	13.6	20.9	18.3	36.2	18.0	15.3	62.5	17.2	22.3	15.6	24.0
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	21.8	11.9	51.2	57.8	73.7	40.6	16.4	77.4	53.4	32.5	22.2	107.3	15.0	50.0	17.0	39.4	34.8	27.8	15.1	47.0	62.5	16.4	18.4	25.4	78.1	67.6	69.1	22.1	8.1	10.7	17.7	16.3	65.8	41.4	29.6	12.6	16.3	44.1	24.1	25.9	37.6	46.8	55.9	60.9	29.6	17.3	69.9	111.0	33.4	13.2	74.3	68.4	26.8	86.6	42.5	19.3	34.9	40.8	21.0	25.8	29.5	23.7	20.2	17.6	14.7	20.3	16.2	82.9	20.4	44.5	20.8	20.7	33.0	21.6	17.6	137.7	9.8	22.8	22.8	13.8	35.8	62.3	75.1	18.7	9.3	32.6	19.5	25.6	26.1	143.2	5.4	1.1	16.4	34.0	140.1	60.8	27.5	5.7	32.6	31.9	28.3	24.1	22.1	23.0	5.5	17.6	43.3	42.9	16.5	33.3	30.0	28.3	31.9	16.6	20.7	30.5	15.0	16.4	64.4	3.8	20.0	42.2	25.2	13.2	5.1	9.6	10.8	5.6	9.3	12.7	9.7	10.3	5.8	7.7	8.9	8.6	9.3	6.0	6.5	6.9	10.9	4.5	51.2	73.7	77.4	53.4	47.0	62.5	67.6	69.1	65.8	55.9	69.9	86.6	27.2	35.3	25.2	317.7	180.4	33.1	21.3	12.8	21.6	20.2	42.5	24.6	14.8	15.7	29.8	22.0	52.1	18.6	217.2	28.3	19.6	22.6	1.7	46.2	38.8	38.3	18.1	31.3	65.6	17.3	24.5	38.8	26.5	78.7	80.4	9.2	71.0	18.4	43.6	28.6	107.8	8.7	20.3	221.2	402.9	5.5	46.6	131.1	76.5	95.5	433.2	42.8	223.5	69.4	522.1	21.8	19.8	51.6	147.9	67.8	0.2	15.0	42.3	29.5	59.2	19.9	41.0	26.5	45.4	26.7	41.1	63.9	233.7	7.1	16.2	42.3
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012555, HPA012825"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus, Centrosome"	Cytosol	"HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	17.8	39.9	15.2	18.7	18.6	17.0	26.3	12.7	16.4	35.2	13.6	23.3	27.5	32.1	38.8	13.1	26.5	26.8	14.0	15.3	39.4	29.7	66.9	21.6	16.7	16.7	19.6	35.4	43.1	27.7	30.8	44.1	17.4	22.1	24.0	21.9	36.8	33.9	10.1	11.4	23.8	26.0	15.5	22.6	28.8	30.4	31.9	21.3	51.2	13.1	18.9	25.6	14.1	17.9	11.6	13.1	47.1	12.4	58.3	73.0	9.2	53.3	70.8	50.2	36.3	17.9	27.7	8.8	9.7	40.5	21.8	12.4	28.4	18.1	72.6	22.1	21.9	14.3	36.9	33.2	35.3	13.4	2.3	37.7	24.8	44.7	51.4	47.1	52.6	11.9	18.0	21.0	55.4	4.7	13.3	26.7	23.2	25.0	11.0	12.6	18.8	16.4	42.4	21.2	17.8	29.4	20.1	17.8	38.8	29.8	9.6	26.0	41.7	26.1	17.9	24.3	38.3	25.4	14.4	8.1	19.6	16.9	27.4	1.9	3.0	1.9	2.5	2.0	3.6	3.3	2.9	2.2	1.9	2.2	3.7	3.3	4.5	2.1	4.0	4.0	2.6	1.7	15.2	18.6	12.7	16.4	15.3	39.4	16.7	19.6	17.4	15.5	31.9	17.9	46.7	54.5	49.0	88.2	36.2	18.4	37.4	17.5	44.3	52.0	33.4	25.5	27.1	27.1	28.9	36.8	37.5	13.2	36.4	21.6	13.7	30.6	45.9	42.1	74.3	42.4	43.5	17.9	159.5	36.2	38.2	58.0	57.6	56.4	31.6	38.8	32.9	74.2	25.4	35.3	170.8	37.4	18.3	31.8	24.4	13.1	33.8	45.5	37.4	112.4	27.0	52.7	24.7	177.9	178.2	25.5	29.0	39.5	165.9	44.2	37.8	48.0	35.6	42.5	6.6	48.0	50.8	89.8	33.7	20.3	11.9	32.3	30.9	46.4	24.7	26.4
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 266.4;prostate: 76.0"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.8	1.1	17.3	0.9	37.3	0.7	4.8	27.1	27.7	1.9	7.9	0.7	266.4	1.7	0.9	1.5	3.5	10.2	0.5	18.3	22.4	13.5	35.5	1.3	0.9	32.7	28.4	1.0	0.3	0.2	0.0	0.3	31.5	76.0	0.5	4.0	52.8	0.6	0.2	1.7	82.9	1.0	24.1	2.4	1.1	0.8	31.1	0.1	1.0	0.2	0.6	1.4	0.3	59.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.3	37.3	27.1	27.7	18.3	22.4	32.7	28.4	31.5	24.1	31.1	59.3	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609915-1613897	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"salivary gland: 154.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 18.0"	HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	12.3	6.0	7.7	1.2	8.3	0.6	9.0	7.1	9.3	6.3	11.0	1.7	0.9	3.7	1.7	4.8	5.0	7.5	14.0	6.0	6.5	19.9	1.2	3.3	1.7	9.0	7.4	4.7	3.6	1.6	9.5	4.1	8.7	8.6	0.9	0.3	154.4	6.4	2.4	11.1	1.6	2.3	7.1	0.4	1.7	2.0	9.2	8.3	5.6	2.9	2.2	9.4	5.6	7.1	18.0	2.0	0.6	92.4	4.2	4.6	2.9	8.9	10.3	5.4	4.3	6.7	3.7	0.0	10.0	5.2	3.9	19.9	8.8	6.5	4.5	5.7	91.8	3.7	5.3	3.3	2.8	1.4	6.0	15.6	8.7	7.3	8.3	2.8	7.9	0.6	2.7	0.1	2.3	3.8	0.0	2.0	0.3	8.9	7.6	0.0	3.7	0.5	35.9	13.3	3.4	8.0	10.9	0.1	6.4	4.5	2.6	1.5	2.0	11.5	7.1	5.9	9.6	0.4	0.8	0.0	3.2	4.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.7	8.3	7.1	9.3	6.0	6.5	9.0	7.4	8.7	7.1	9.2	7.1	93.7	0.0	0.6	0.0	0.4	17.7	31.9	26.3	13.6	0.0	42.2	59.4	7.1	0.0	23.6	11.0	0.0	5.3	1.9	0.9	1.9	3.9	0.6	8.6	1.1	64.7	0.0	0.0	0.0	17.1	0.6	21.2	1.5	3.8	0.0	0.7	65.7	0.4	1.3	0.0	0.0	1.5	8.2	1.3	5.5	1.4	16.1	2.7	1.8	23.4	0.0	0.3	0.0	0.5	0.1	16.2	0.1	28.2	0.1	9.5	0.0	7.4	34.9	0.0	0.0	19.2	40.4	0.7	3.1	11.2	6.5	0.8	1.1	4.4	0.6	64.9
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70954708-71583989	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 41.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTEC/SVTERT24-B: 95.0"					"Low region specificity"	"Detected in all"			"HPA003876, CAB011501"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	16.5	3.8	5.0	20.3	41.1	38.5	14.5	0.3	12.5	11.2	9.9	28.7	12.2	15.3	6.5	23.0	14.3	21.0	12.7	7.8	0.0	7.0	13.0	22.9	22.2	3.1	6.7	32.4	16.8	6.5	9.1	13.7	0.9	21.2	23.4	2.6	29.7	9.6	8.2	10.9	15.3	22.7	0.1	17.8	20.6	14.4	6.6	26.3	14.5	11.1	25.4	21.6	14.2	8.1	9.6	8.0	16.8	13.2	8.4	21.3	8.2	26.3	30.9	22.0	17.4	51.9	11.2	31.1	4.3	12.9	17.6	6.9	31.0	22.8	40.3	7.8	11.7	13.0	17.0	52.7	20.5	25.7	31.6	21.7	10.3	95.0	42.1	18.3	36.6	15.4	13.6	36.7	10.8	42.6	11.9	9.3	19.7	7.2	39.9	38.0	30.7	4.7	18.8	30.1	14.5	27.6	32.6	7.7	1.9	15.9	5.6	21.9	47.7	34.9	14.3	48.9	42.2	9.0	7.1	41.8	22.5	35.7	7.5	46.9	15.3	15.2	18.3	13.1	19.4	58.1	38.7	22.6	13.0	62.2	60.8	40.0	27.0	22.2	25.3	21.7	35.9	28.8	5.0	41.1	0.3	12.5	7.8	0.0	3.1	6.7	0.9	0.1	6.6	8.1	158.8	73.7	121.3	130.9	266.5	183.0	170.6	58.2	176.4	30.3	98.5	115.1	42.1	148.7	72.0	33.1	18.8	47.2	122.9	118.1	31.3	79.0	156.0	116.3	48.2	184.9	271.6	111.5	391.0	95.1	12.6	90.4	95.8	128.0	219.8	117.7	184.9	72.3	49.5	6.7	139.9	231.2	154.6	117.6	209.0	89.6	42.0	101.3	37.4	414.1	120.3	15.5	116.4	184.5	286.4	124.8	102.8	24.8	66.0	178.8	91.7	19.4	83.7	42.8	92.1	102.9	119.4	13.7	33.6	111.5	101.4	52.4	168.1	33.1	157.2	146.3
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	10.5	10.5	3.7	9.9	5.6	4.2	12.9	5.4	4.9	8.9	6.2	12.0	11.7	8.7	10.6	10.7	9.2	13.2	8.7	4.0	5.0	15.4	14.1	8.9	9.0	5.8	5.4	13.3	10.4	13.5	5.3	10.8	6.2	9.9	11.1	6.8	10.6	8.5	4.9	12.0	12.3	8.8	5.3	10.1	12.6	8.1	5.0	8.5	19.5	5.6	9.8	8.3	6.0	8.3	12.4	10.1	7.5	11.0	17.0	15.8	11.2	16.0	10.6	10.8	12.7	5.7	9.1	7.6	19.2	9.5	12.2	10.3	13.6	14.6	17.1	15.4	5.8	17.3	11.1	9.7	14.1	13.2	12.7	13.1	18.6	10.8	5.1	7.4	11.3	10.5	18.2	8.8	17.1	3.3	7.4	2.7	8.2	15.9	9.1	7.8	17.5	10.8	9.5	8.9	7.8	7.8	11.8	17.1	18.6	2.4	20.6	14.9	10.3	4.7	8.8	25.8	12.2	9.6	7.3	10.2	19.0	12.8	16.2	19.5	20.1	21.7	5.5	20.5	6.5	5.0	5.5	5.2	12.6	6.1	6.2	5.6	6.1	5.8	18.4	1.2	7.6	10.7	3.7	5.6	5.4	4.9	4.0	5.0	5.8	5.4	6.2	5.3	5.0	8.3	7.1	6.4	3.2	0.0	3.0	6.8	4.9	13.3	4.6	7.1	7.6	5.6	10.2	14.3	9.3	11.0	2.1	12.7	2.5	7.8	19.6	5.3	8.9	6.0	4.8	4.9	6.0	9.5	0.0	7.1	11.0	7.0	4.1	4.2	5.1	4.9	6.4	9.8	15.1	3.3	0.0	7.3	6.1	9.4	4.6	7.3	10.2	10.3	5.4	0.0	9.0	10.6	8.2	0.0	0.0	6.5	8.9	5.7	1.2	2.5	11.0	15.3	12.7	5.5	26.3	5.8	7.2	9.7	10.4	5.7	6.5	6.2	5.2	4.9	7.3	3.0
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69168782-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported	Approved	"Nucleoplasm,Golgi apparatus,Centriolar satellite"		NA	NA		17000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Centriolar satellite"	"Nucleoplasm, Golgi apparatus"	"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	11.0	4.8	17.5	12.3	46.7	15.5	16.1	26.9	30.9	24.9	7.0	12.8	9.1	11.3	9.3	26.8	13.2	19.2	17.4	20.8	29.3	16.3	34.5	24.8	10.9	39.4	37.1	10.9	8.2	3.7	4.0	25.5	36.3	16.9	12.9	21.9	37.1	10.5	2.3	23.0	12.5	10.5	22.7	32.3	15.0	4.7	42.0	14.1	27.1	4.6	11.2	13.7	15.8	84.0	6.7	1.8	10.4	0.3	0.2	1.5	11.3	0.5	1.7	0.8	0.5	39.8	11.3	0.8	3.5	0.5	1.0	25.9	4.9	35.3	1.2	2.2	3.3	20.4	2.6	2.3	0.7	5.2	10.2	1.7	35.2	1.0	52.7	1.6	55.1	4.7	1.6	5.8	3.0	7.7	0.5	0.8	5.6	8.9	8.5	32.2	2.8	1.0	14.8	4.6	12.1	15.6	1.7	12.2	35.5	9.3	4.6	6.8	47.1	0.6	4.3	0.4	1.8	0.6	0.3	1.2	0.4	13.5	13.5	18.3	27.6	2.3	1.9	13.8	7.0	1.6	6.3	2.8	16.9	2.0	1.9	1.8	7.1	3.8	2.3	16.8	15.4	7.7	17.5	46.7	26.9	30.9	20.8	29.3	39.4	37.1	36.3	22.7	42.0	84.0	20.6	41.7	83.6	2.9	3.6	60.7	33.4	57.8	69.4	13.8	34.4	21.7	33.4	41.5	58.5	14.7	218.9	49.9	20.3	74.4	33.2	32.6	18.9	207.9	49.3	64.3	24.5	8.6	4.2	17.3	19.7	32.1	75.4	282.6	34.7	97.5	89.3	53.6	92.6	0.0	92.7	42.1	36.7	138.7	112.7	4.0	6.5	105.2	28.4	93.7	26.3	13.5	1.0	129.2	1209.1	24.5	67.0	18.4	6.9	61.1	10.7	55.6	38.2	109.2	6.6	11.8	21.0	0.0	3.5	79.9	51.4	58.3	44.6	32.1	32.2	172.8
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592816-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 256.5;Hofbauer cells: 274.2;monocytes: 1028.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 600.3;Hep G2: 464.9;K-562: 533.6;NB-4: 600.9;PC-3: 508.2;SH-SY5Y: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	27.5	39.7	41.5	31.1	62.2	8.3	24.9	26.3	57.2	33.7	10.7	12.1	4.4	19.7	0.7	69.4	15.6	7.6	15.8	39.4	28.2	17.3	8.3	27.6	14.5	49.4	42.7	47.7	5.5	2.3	20.2	27.9	22.8	10.3	1.7	3.4	23.8	2.4	7.3	56.3	12.6	5.7	20.9	55.6	9.3	42.5	79.0	9.0	25.6	2.1	8.3	20.4	41.6	77.1	62.3	139.3	91.2	326.3	34.8	65.4	600.3	144.2	62.4	24.2	26.1	98.5	15.6	1.3	172.0	63.5	24.3	231.3	52.2	229.9	2.1	70.6	28.7	4.8	142.0	464.9	18.0	0.2	13.9	40.8	66.6	46.1	37.2	40.4	118.3	0.7	533.6	0.9	31.6	6.9	2.0	600.9	238.4	4.2	508.2	140.0	22.3	2.3	34.9	5.9	73.1	482.4	121.0	2.6	5.3	58.5	3.9	38.4	246.4	167.4	289.3	99.1	151.0	0.9	0.8	0.7	107.8	0.6	317.2	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	41.5	62.2	26.3	57.2	39.4	28.2	49.4	42.7	22.8	20.9	79.0	77.1	90.0	3.2	4.1	1.6	8.3	181.2	26.7	75.1	189.5	9.4	32.3	44.3	10.4	1.5	13.4	1.8	0.0	6.7	10.8	3.9	0.0	12.8	14.3	8.0	37.8	120.6	42.1	28.0	12.1	5.1	110.8	48.9	10.7	10.1	16.5	256.5	84.6	0.8	274.2	0.0	10.9	5.4	8.2	28.0	136.1	12.3	25.4	27.4	51.6	23.4	1028.2	73.5	0.0	4.5	43.2	15.5	1.1	9.1	4.2	7.5	0.4	0.4	2.9	2.6	0.0	29.7	46.3	5.7	8.0	121.2	147.2	14.6	12.2	8.3	2.6	28.0
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	26.1	6.2	0.8	3.0	0.5	0.4	15.2	0.4	0.7	7.7	0.7	9.8	1.8	4.2	3.7	6.5	11.8	7.2	9.4	2.0	2.0	2.9	68.7	8.2	1.6	1.8	1.0	9.9	2.6	0.5	5.9	24.1	0.9	15.5	3.0	0.3	11.3	10.8	9.2	18.0	8.8	4.7	0.5	0.3	11.1	5.0	1.1	2.3	4.0	7.7	12.9	40.4	7.5	0.7	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.4	0.7	2.0	2.0	1.8	1.0	0.9	0.5	1.1	0.7	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120450993	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 12.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		34000000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	432.4	134.3	20.5	116.3	18.1	2.2	166.1	22.8	22.7	279.9	83.0	156.4	37.1	157.5	50.8	126.1	150.6	257.0	242.7	20.6	22.8	45.4	35.7	120.7	50.3	28.5	44.6	90.3	37.3	35.5	25.7	442.0	23.1	188.3	90.4	29.8	59.3	184.4	31.8	64.2	69.1	409.6	22.7	63.1	68.6	33.5	22.7	24.2	78.8	89.8	38.8	260.4	104.3	20.6	81.0	21.2	222.9	91.8	1304.4	1782.4	1.3	2156.3	1208.9	1374.5	1211.0	0.1	178.5	0.8	178.8	2692.9	112.8	20.5	68.6	270.0	1741.5	1.1	32.5	0.4	159.8	0.3	286.0	1.2	0.9	1362.7	8.5	884.5	192.7	612.1	811.6	11.2	0.5	0.3	227.6	0.5	22.6	2.0	181.3	0.4	181.9	0.7	92.7	1.0	150.4	1.7	39.2	93.5	764.6	13.6	76.5	462.6	23.5	6.2	986.8	507.4	479.8	268.0	323.8	1.0	1.1	2.3	177.4	0.9	67.0	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	2.6	20.5	18.1	22.8	22.7	20.6	22.8	28.5	44.6	23.1	22.7	22.7	20.6	76.9	64.1	9.4	56.5	1.1	64.1	31.9	36.4	10.2	2.3	25.6	24.6	127.5	8.6	42.5	23.9	0.0	114.4	2.5	0.9	0.0	62.6	2.3	44.4	176.7	111.4	3.0	3.6	9.6	5.8	352.1	521.9	3.1	23.0	1.3	66.5	142.5	17.4	20.6	1.7	16.2	0.2	8.2	10.8	91.6	9.8	327.4	11.5	110.3	30.0	9.9	116.1	0.0	9.5	0.9	117.8	0.7	270.8	0.9	108.4	0.0	5.5	74.9	4.3	59.2	62.5	129.3	1.5	4.4	2.2	48.2	54.7	7.1	47.5	0.9	65.3
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967634	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 49889.9;monocytes: 34409.9;Proximal enterocytes: 28837.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 23933.9;HHSteC: 24849.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008623	Approved					NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"			"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	6767.7	5191.4	5741.8	3546.9	5464.0	4734.2	5696.1	5591.9	7973.3	3973.1	4801.2	4701.2	1819.9	3712.8	2421.8	4025.0	3195.6	1995.6	4779.5	5252.8	5737.2	6092.3	3500.8	6057.7	1460.4	6416.7	5812.4	3069.9	3883.8	1696.4	2105.4	1800.3	6188.9	2778.8	3357.4	3123.7	3533.1	1514.8	4695.5	2125.0	4331.6	2040.7	6506.2	3496.3	4044.1	769.5	6153.5	1109.8	3167.6	2766.8	1291.2	4718.0	3163.8	6630.2	3029.8	8290.2	1236.6	3293.8	23933.9	11490.1	6794.4	2684.1	11547.3	2694.6	2698.6	1011.0	4065.8	345.3	16669.6	7830.0	10259.7	5035.8	1118.8	2235.9	1733.9	1439.0	542.9	1720.3	10802.1	6692.1	24849.2	821.6	2626.6	15711.1	10758.7	5384.0	10038.1	8476.6	3427.6	1970.7	2622.1	3874.4	9546.5	4080.7	935.3	1361.8	2114.6	10461.4	13675.6	914.9	1508.5	2502.3	13877.6	8068.8	1044.8	1325.0	9113.3	1005.9	4645.6	4045.3	1790.3	1098.4	3791.5	8310.7	1978.7	3727.4	1732.0	662.7	2516.5	1088.1	11353.7	363.1	2030.4	29466.0	19068.5	15453.6	2306.3	22407.8	2274.9	4088.8	3267.1	2296.9	9762.5	4113.3	2710.5	2108.2	45110.1	1981.1	27515.2	7217.1	4321.5	22214.4	5741.8	5464.0	5591.9	7973.3	5252.8	5737.2	6416.7	5812.4	6188.9	6506.2	6153.5	6630.2	3864.7	1317.3	2890.3	319.3	3200.9	5157.7	7723.2	23426.3	3495.0	881.7	9884.9	10192.4	11.7	4466.7	11711.1	1918.2	573.4	4541.1	4513.5	13653.9	10888.0	10748.7	274.2	4921.8	2908.5	4303.3	2520.6	6318.6	252.8	11073.9	6803.9	5931.3	2059.7	8005.0	6736.0	1798.6	3266.1	5199.9	18411.3	738.6	153.7	3927.4	10379.8	13784.1	49889.9	527.7	4666.1	22792.0	7116.5	183.6	34409.9	12189.1	1699.3	153.3	1031.0	7813.2	7936.8	3818.1	1789.1	12995.8	28837.7	21355.6	5978.6	3311.6	2084.0	2686.9	6139.1	585.4	927.1	1983.6	3555.6	4622.6	5225.4	2496.8	4921.7	18650.3
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965309-48966879	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 14422.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 125209.0;monocytes: 102128.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 24796.9;HSkMC: 20811.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020769, HPA041602"	Enhanced		Approved	Cytosol		NA	NA		170000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	6778.7	3262.2	6806.2	2353.2	7172.4	4213.8	4226.0	6782.1	10053.2	2094.3	6429.7	2451.1	2427.0	1523.4	1010.8	1306.2	2169.9	4298.0	2537.3	6497.7	6998.4	8845.6	14422.9	7261.1	3353.2	7250.8	6998.4	2455.3	2166.2	931.7	1730.4	3423.2	7218.5	1946.5	1800.0	684.9	1663.5	1390.4	1345.9	1449.7	2806.6	1842.3	7149.5	6751.4	3204.5	455.9	7581.8	1168.9	3000.4	1072.0	1334.6	4239.9	1804.7	7334.0	869.7	12906.5	949.6	1457.0	16013.9	16478.6	1693.1	2194.1	12820.0	3090.7	6903.8	2852.3	3413.2	656.4	4104.3	13203.9	6755.6	505.8	788.2	1301.8	2765.6	8895.0	507.6	1740.0	3222.8	18949.7	24796.9	4133.3	5591.2	20811.1	1735.9	5272.5	2301.6	4590.4	4549.8	774.6	3284.9	1328.2	6198.4	213.0	1152.1	2402.8	1729.8	15140.6	1306.9	947.6	643.0	6763.9	1989.7	545.0	1209.9	701.5	5761.7	313.4	1239.5	5104.1	183.2	8493.4	3438.3	3353.4	1740.1	4364.3	3083.1	5690.2	13742.1	625.1	3563.9	4334.7	6017.7	64938.4	71067.8	77353.0	6560.6	102128.9	7527.7	17097.3	7247.4	7054.3	25176.6	15607.2	8656.4	7466.9	125209.0	4978.3	91398.0	10579.6	9634.4	94147.5	6806.2	7172.4	6782.1	10053.2	6497.7	6998.4	7250.8	6998.4	7218.5	7149.5	7581.8	7334.0	2757.2	1125.0	3379.9	88.5	3311.5	2793.9	6799.5	2785.4	2159.8	474.7	2597.9	3977.3	777.8	4398.0	2550.4	2021.2	177.2	941.5	2199.4	2314.2	10704.0	4251.2	290.2	504.9	1413.1	4867.0	1613.4	4331.2	60.6	6134.8	1447.8	5703.3	1715.1	617.4	2365.7	942.2	4598.0	23702.0	74983.4	533.3	113.8	2368.8	3039.4	70127.1	16939.0	1601.8	4175.9	34584.5	5085.3	129.3	22965.8	3161.9	2020.6	55.8	309.7	6905.5	5604.7	2010.8	4884.7	9790.5	21474.5	58047.8	1908.0	682.6	1341.1	1643.8	3455.6	82.1	311.2	1985.5	2226.7	1502.7	2590.4	1492.0	2816.8	13083.6
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		300000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	29.6	37.8	13.4	35.5	15.3	79.6	30.9	24.0	17.9	28.1	18.5	24.3	24.9	36.4	36.8	24.8	28.5	16.8	29.7	13.8	15.9	39.3	17.1	31.6	42.8	15.6	13.4	46.9	33.7	23.0	41.7	23.0	15.7	24.1	27.5	57.2	30.5	13.3	33.8	27.5	27.5	19.0	15.1	35.2	26.1	17.0	15.3	35.7	36.9	15.2	38.6	25.3	27.4	24.3	49.4	36.5	106.9	40.0	11.9	19.0	77.6	53.5	23.4	35.8	29.2	34.7	49.1	91.3	22.1	31.9	49.1	51.4	54.8	45.4	48.1	91.6	38.5	58.8	87.4	56.9	25.8	104.9	22.8	25.2	35.5	39.7	36.4	39.6	29.2	59.1	65.8	45.1	31.0	39.0	74.0	60.4	75.7	38.0	26.2	94.6	78.7	30.9	35.2	49.0	54.2	61.1	41.5	42.8	44.2	44.7	52.9	38.7	50.7	50.7	66.0	14.7	62.5	44.8	39.4	106.1	21.1	45.3	44.5	6.5	10.5	12.3	20.5	17.0	23.3	19.0	19.6	20.8	9.3	14.7	19.4	23.6	5.3	29.4	19.1	15.4	24.5	15.3	13.4	15.3	24.0	17.9	13.8	15.9	15.6	13.4	15.7	15.1	15.3	24.3	38.6	73.7	57.5	48.0	70.7	84.8	107.0	49.5	39.3	44.7	48.7	31.2	76.4	24.3	71.0	33.1	41.7	46.8	68.2	27.1	43.0	59.5	33.3	54.8	50.7	52.0	55.1	43.1	48.8	72.1	66.2	49.0	28.5	60.5	77.8	59.4	30.4	23.4	33.4	18.5	53.6	35.9	36.7	32.1	37.0	19.8	48.1	41.8	39.2	61.8	61.5	32.5	52.5	56.3	88.3	69.2	33.5	30.1	68.9	54.2	23.6	28.9	73.2	40.5	32.9	70.3	65.7	33.2	41.3	40.9	63.1	35.7	72.1	38.0	37.8	72.7
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494812-143511720	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 165.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		56000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	28.9	41.4	13.5	25.4	16.4	25.8	26.3	16.0	15.3	29.2	30.2	41.5	42.6	25.6	44.9	14.2	23.7	27.8	27.9	12.4	16.5	54.8	52.3	28.9	17.2	17.1	14.2	30.4	34.6	165.8	15.8	50.5	17.8	21.9	52.8	6.1	25.4	25.8	6.9	12.3	39.3	27.6	16.4	24.6	38.3	12.6	15.9	6.6	32.0	11.6	17.0	33.5	20.4	20.9	97.4	55.7	47.6	86.9	69.0	134.4	90.1	89.9	95.4	108.1	182.0	107.1	94.8	0.2	66.1	120.8	33.9	0.6	24.1	11.7	148.9	87.2	92.6	32.6	100.1	163.2	99.3	0.3	15.8	72.3	69.4	96.6	41.5	91.6	111.4	0.2	117.6	49.3	123.2	114.6	0.2	75.9	62.1	44.2	76.0	0.2	99.7	72.1	129.0	59.5	36.0	23.6	98.7	65.3	82.3	36.3	32.1	79.6	65.9	64.1	54.0	161.6	175.4	18.3	21.3	0.7	74.1	59.1	22.5	38.8	84.9	26.2	13.2	84.0	15.0	11.3	9.8	11.3	65.4	8.3	4.4	7.9	5.5	29.6	62.0	10.3	19.8	51.9	13.5	16.4	16.0	15.3	12.4	16.5	17.1	14.2	17.8	16.4	15.9	20.9	27.3	41.7	35.9	9.1	13.5	11.2	12.6	30.3	9.1	3.7	19.2	12.6	28.0	38.6	37.9	25.8	0.0	52.5	10.3	47.6	11.7	81.9	2.0	26.8	55.2	25.0	9.6	18.7	8.7	124.9	109.8	62.6	34.7	28.9	37.4	38.1	23.6	35.2	110.3	1.7	11.8	38.1	46.8	57.5	29.2	2.6	66.8	51.7	42.7	9.4	49.1	11.1	13.4	5.5	14.5	74.6	38.2	45.5	47.7	13.8	60.3	51.4	34.8	1.1	6.6	33.8	35.0	4.8	4.6	13.2	8.0	46.4	11.5	78.8	50.4	18.4
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180138-31191605	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Supported	Nucleoplasm		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	88.6	47.6	43.6	102.9	48.6	98.9	65.1	50.6	59.2	85.3	27.2	72.5	59.5	102.0	40.9	58.5	99.2	38.8	70.4	46.9	48.6	83.6	54.3	64.8	97.9	44.3	43.0	134.2	57.3	85.0	47.2	58.3	46.9	59.1	62.8	59.4	60.0	70.4	98.6	53.8	62.6	98.1	45.7	69.3	59.4	69.1	44.8	174.1	58.6	86.0	113.2	87.5	63.2	52.1	386.6	337.2	492.6	292.9	128.3	101.7	429.3	504.1	253.1	319.6	238.3	440.7	254.9	579.6	359.3	310.7	349.4	173.0	563.6	421.0	284.3	341.5	304.7	486.6	224.6	445.3	222.7	529.7	348.5	222.4	99.8	437.5	258.9	120.1	295.7	419.6	537.6	204.7	357.0	483.0	446.2	475.5	649.0	307.7	402.0	677.0	535.9	350.1	344.0	265.6	279.1	478.9	344.5	255.7	267.8	314.9	291.8	597.5	276.3	371.5	365.5	242.1	520.5	181.4	350.4	779.0	204.4	364.2	460.9	12.3	38.2	52.8	53.6	67.3	49.9	29.1	36.5	45.9	41.7	35.2	40.3	43.9	35.0	37.3	59.3	50.3	31.0	27.4	43.6	48.6	50.6	59.2	46.9	48.6	44.3	43.0	46.9	45.7	44.8	52.1	414.6	102.5	121.2	58.1	470.7	144.8	345.7	201.0	507.6	272.6	209.8	223.8	102.1	112.9	156.3	104.8	131.3	299.3	488.8	266.8	68.4	183.6	130.8	201.0	366.1	278.4	212.1	188.2	75.4	154.8	398.5	309.0	222.8	309.7	229.7	445.0	174.2	59.1	208.5	201.9	85.9	229.5	132.2	148.4	270.7	51.2	307.3	282.7	165.4	94.6	185.4	230.8	341.9	117.6	122.2	175.7	219.4	215.5	266.6	245.4	205.4	69.7	115.4	266.3	164.3	584.4	344.2	221.0	237.1	443.6	154.3	295.1	518.2	327.9	232.6	281.2
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 788.7;tongue: 451.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 986.2;Late spermatids: 1759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA		15000	"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	35.8	40.1	54.8	22.4	65.0	48.1	31.9	62.9	76.0	36.6	54.2	49.1	21.2	41.4	26.3	40.0	33.3	25.6	118.9	51.5	66.1	26.8	33.9	24.6	30.0	63.7	60.6	49.2	34.3	32.5	25.5	39.0	64.9	38.0	20.1	42.2	29.7	32.6	788.7	21.9	22.4	36.2	60.5	23.1	32.3	132.4	60.8	50.5	31.4	451.3	30.5	38.5	28.3	93.2	144.2	65.8	138.8	108.5	104.6	118.4	62.7	111.9	114.0	123.1	120.5	97.5	70.9	73.3	179.8	77.7	193.9	67.6	113.3	68.8	171.0	97.4	76.1	74.3	88.9	112.7	110.8	46.6	58.5	125.7	77.0	62.3	147.8	183.7	126.1	70.5	60.7	86.0	157.1	52.2	89.4	78.3	156.8	88.8	71.2	61.0	177.5	78.6	95.4	44.6	58.4	74.6	96.8	110.9	149.9	193.7	154.7	88.5	101.3	92.0	102.3	58.1	223.3	79.0	108.9	86.9	96.0	65.9	120.2	9.4	12.6	10.0	11.7	13.7	12.2	12.9	12.3	10.6	14.4	9.1	15.5	12.9	10.9	11.6	10.4	10.2	22.2	9.6	54.8	65.0	62.9	76.0	51.5	66.1	63.7	60.6	64.9	60.5	60.8	93.2	89.1	64.1	75.0	58.1	81.1	78.4	97.6	68.5	78.6	72.6	67.7	72.3	224.6	48.6	74.8	35.0	56.3	96.8	93.5	28.9	58.7	84.5	986.2	158.2	132.1	78.1	53.8	105.6	75.6	75.8	99.5	78.6	33.6	114.8	126.6	106.3	62.4	70.2	67.9	87.5	87.8	36.1	40.7	76.6	58.7	1759.0	84.2	73.2	49.8	48.7	138.5	97.5	52.5	86.5	137.5	73.3	39.2	76.0	74.3	68.8	62.1	106.8	104.1	86.5	32.9	116.3	89.1	318.6	113.5	57.9	70.6	61.2	87.3	97.4	42.8	67.1
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169881	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	203.1	39.2	30.8	130.8	31.0	275.2	171.1	31.9	47.2	226.2	36.9	59.0	28.6	75.5	20.1	116.1	103.6	68.8	82.3	29.9	36.6	42.0	40.2	148.5	187.4	43.4	34.7	28.6	28.0	17.2	39.8	91.7	37.9	68.8	43.3	3.5	70.3	46.5	28.6	85.8	106.6	59.8	35.4	238.3	67.9	9.2	40.0	85.0	59.2	32.6	187.8	104.8	183.8	39.9	932.2	216.7	0.2	0.9	310.5	390.2	213.6	521.7	686.4	362.8	269.3	61.9	263.6	212.9	139.3	632.2	130.3	212.3	132.5	321.3	231.4	265.7	87.9	397.7	111.8	0.5	244.3	228.6	378.0	233.6	141.6	265.3	452.2	213.2	348.5	58.0	380.0	989.0	229.5	1.5	27.4	95.1	66.4	853.4	126.0	127.6	45.0	272.7	134.0	5.2	38.8	0.3	287.1	148.6	316.6	115.0	78.0	180.4	494.8	443.6	170.0	487.7	40.2	1.5	16.2	54.4	675.9	524.8	694.4	644.0	596.4	111.1	451.5	628.4	422.0	602.8	756.5	467.4	718.7	545.6	489.2	405.6	140.1	840.8	636.9	325.0	894.6	934.1	30.8	31.0	31.9	47.2	29.9	36.6	43.4	34.7	37.9	35.4	40.0	39.9	291.0	3.2	13.4	0.0	330.7	107.1	73.4	106.3	54.1	0.6	80.2	51.2	5.2	32.9	27.8	99.3	0.0	18.9	349.7	2.9	0.0	156.1	1.7	3.4	63.5	276.5	10.7	111.2	2.2	197.3	462.9	93.1	71.9	2.2	361.5	0.3	323.8	6.1	430.3	0.0	0.4	8.2	4.1	385.9	492.1	4.6	6.5	403.9	209.9	10.3	243.7	0.4	260.6	1.0	0.1	585.0	7.8	0.7	302.5	72.2	0.2	4.4	5.5	0.4	65.7	5.7	107.6	1.6	8.1	24.0	69.2	50.9	459.5	0.7	10.0	100.3
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8"	"Cancer enhanced"	"Detected in all"		"glioma: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"NK-cells: 69.0;T-cells: 174.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 538.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		820000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	76.6	10.8	117.1	52.4	106.4	32.3	46.8	83.8	104.3	45.5	33.3	32.9	16.4	45.6	33.8	16.0	51.4	32.1	40.5	102.1	121.5	23.9	20.4	63.5	108.9	136.3	104.9	28.8	8.5	18.7	22.9	29.7	107.0	17.6	15.6	26.9	12.9	12.5	12.3	41.5	47.1	38.0	109.9	71.9	29.3	16.5	105.7	86.1	45.7	18.3	67.6	48.4	33.4	109.8	10.4	1.5	178.6	30.2	133.4	81.4	3.2	29.1	90.8	24.2	42.9	1.3	1.6	21.0	18.3	56.1	21.0	1.3	25.8	39.9	46.8	0.7	66.5	57.0	13.6	2.7	78.7	19.5	19.0	78.8	59.1	90.5	76.8	62.9	99.5	99.6	4.9	140.3	86.8	1.5	92.7	17.9	26.0	3.3	18.0	29.1	24.0	1.4	0.0	9.1	124.6	50.7	5.7	2.4	124.7	39.6	1.3	57.0	63.9	72.3	13.5	538.7	18.5	20.0	19.7	32.5	136.0	44.3	128.9	1.1	6.4	0.2	137.0	5.6	174.8	4.8	83.9	152.7	7.4	6.4	27.9	72.3	3.0	69.0	4.2	4.3	79.2	51.5	117.1	106.4	83.8	104.3	102.1	121.5	136.3	104.9	107.0	109.9	105.7	109.8	87.8	0.0	8.3	382.6	26.0	17.1	2.5	0.6	1.8	57.2	2.9	6.9	11.3	14.3	2.1	7.3	0.0	2.7	291.6	1.2	17.6	9.3	3.7	5.6	51.7	70.3	13.2	20.9	118.7	1.0	2.4	61.9	17.9	4.9	52.0	20.9	76.4	60.3	3.0	47.1	127.6	3.8	2.0	35.8	96.1	3.2	26.4	42.7	37.4	88.1	64.5	89.1	228.6	342.8	162.3	9.7	0.1	7.2	96.2	3.9	17.7	212.2	4.4	8.3	13.1	48.8	32.9	3.9	8.6	0.7	13.4	52.0	275.8	71.1	2.9	1.1
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264433-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.0;non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;HSkMC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.4	4.4	2.4	2.7	2.5	1.1	10.7	5.8	2.4	9.9	11.1	5.9	5.1	8.6	4.3	5.2	5.5	5.7	12.7	4.7	2.9	9.6	2.5	10.7	1.3	2.5	6.2	10.1	4.7	2.4	3.9	10.0	2.3	10.3	3.7	2.0	9.0	16.4	1.9	10.4	5.1	5.3	2.3	3.2	4.6	1.6	3.4	1.8	20.5	2.4	1.3	6.4	11.2	2.0	0.8	2.5	24.8	2.6	19.8	17.0	4.5	9.2	5.8	3.3	2.3	1.1	4.3	0.0	2.2	5.9	4.2	4.7	3.9	2.0	2.2	0.0	4.9	0.2	4.6	1.3	1.4	4.2	1.0	32.3	3.6	7.6	2.4	12.6	0.7	2.8	1.5	3.6	9.7	6.2	0.8	1.1	6.4	1.3	4.2	5.1	15.3	0.4	5.3	11.8	3.4	6.5	7.0	5.6	1.6	5.7	3.0	3.8	3.8	13.9	10.4	15.0	3.8	3.3	2.5	0.4	15.0	3.5	16.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	2.4	2.5	5.8	2.4	4.7	2.9	2.5	6.2	2.3	2.3	3.4	2.0	5.7	3.2	1.5	4.6	1.1	4.2	44.9	7.0	10.8	1.6	27.7	29.5	18.5	45.8	4.6	12.9	2.1	3.4	0.6	7.4	0.0	4.3	0.3	12.0	13.1	4.5	3.5	0.8	0.6	2.0	2.2	18.5	2.0	15.7	12.7	1.8	15.4	0.9	3.5	141.3	1.0	3.0	4.1	17.4	16.2	1.1	33.2	14.3	17.8	1.9	4.6	3.0	1.0	1.0	0.2	1.9	4.8	45.1	0.4	11.7	6.0	11.6	2.4	2.9	0.0	6.2	10.3	0.5	3.7	9.1	5.1	2.1	0.6	2.6	4.6	7.3
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638247-35642296	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Gastric mucus-secreting cells: 13.7;Muller glia cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.6;PC-3: 40.3;U-138 MG: 14.8;U-251 MG: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	5.6	1.4	5.2	1.2	5.8	0.1	3.7	1.8	6.1	2.3	39.4	8.7	0.6	2.5	0.5	0.9	5.4	1.3	9.7	5.9	2.1	6.9	3.1	4.4	1.3	1.8	3.3	1.8	4.7	2.4	2.7	0.4	2.0	1.3	2.0	3.9	3.3	1.4	3.1	3.7	2.0	1.6	1.5	11.7	7.2	2.5	4.3	1.4	6.7	2.5	0.6	1.8	1.6	5.0	0.0	4.4	0.7	0.0	1.7	0.1	2.6	4.8	0.2	0.2	0.2	0.5	0.7	0.0	0.7	2.1	4.8	1.5	0.5	1.5	0.0	0.0	12.4	0.0	0.5	0.2	0.8	0.0	0.3	1.5	6.0	9.7	3.8	15.6	3.4	0.0	0.3	0.0	1.3	1.9	0.0	0.0	4.0	0.3	40.3	4.1	2.5	0.0	7.7	0.3	12.0	0.4	0.9	0.2	0.0	5.5	0.1	0.7	8.1	14.8	2.2	7.3	13.4	0.0	0.0	0.0	8.5	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	1.8	6.1	5.9	2.1	1.8	3.3	2.0	1.5	4.3	5.0	12.2	19.2	3.3	12.4	0.0	0.3	1.0	4.2	2.2	0.6	4.1	10.8	10.2	1.5	3.1	0.0	2.1	0.1	0.5	11.2	0.0	3.4	0.0	4.2	2.7	7.2	1.2	0.0	0.4	3.1	0.3	6.1	13.7	9.3	0.0	1.6	10.4	4.5	0.6	0.0	0.5	2.7	0.0	0.8	1.3	0.1	1.2	1.2	0.0	1.9	0.2	27.2	0.0	1.0	0.3	3.5	1.5	2.2	0.1	0.8	0.5	4.2	2.1	1.3	6.6	2.7	5.8	0.2	1.4	1.2	1.1	0.1	0.4	0.7	4.8	0.2
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812911	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		280000	"Cluster 13: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	52.3	46.8	32.9	60.2	36.1	27.5	54.1	42.8	44.6	42.0	41.0	47.8	34.8	42.5	33.1	54.8	51.0	38.8	51.0	30.7	36.1	57.1	69.0	36.1	78.3	34.5	35.7	62.5	30.4	41.5	16.5	58.2	35.8	41.3	50.6	18.3	31.8	37.3	112.2	43.4	33.9	47.8	35.0	46.7	40.3	65.5	38.6	66.0	42.6	92.1	85.7	66.3	31.9	43.3	204.9	267.0	177.0	96.3	253.2	119.2	232.4	204.1	190.6	290.6	348.6	413.7	310.3	384.7	307.0	188.0	231.6	210.9	319.7	395.6	333.7	122.5	173.8	232.9	201.1	334.8	128.8	281.6	163.9	123.4	186.7	243.7	232.2	98.7	209.7	140.9	191.3	173.3	254.5	179.7	273.9	142.4	231.4	146.0	209.6	254.3	235.1	187.2	163.1	290.5	195.2	132.0	200.8	307.0	319.3	169.2	246.3	174.7	238.2	202.0	239.7	187.3	364.0	104.9	171.3	305.0	132.2	229.6	337.8	132.2	102.3	84.7	189.2	135.4	255.3	168.8	215.6	186.7	141.0	160.0	201.8	193.2	37.8	203.7	134.1	134.7	249.2	287.2	32.9	36.1	42.8	44.6	30.7	36.1	34.5	35.7	35.8	35.0	38.6	43.3	88.9	19.2	41.4	32.7	112.0	239.5	101.3	82.4	148.0	37.1	74.8	60.7	62.3	44.3	66.2	64.4	16.7	94.0	91.7	47.3	78.2	69.6	49.6	80.6	104.4	112.1	50.2	96.1	25.7	53.0	94.6	98.0	70.3	87.2	73.6	73.8	76.8	169.4	78.2	57.2	30.6	59.4	50.8	81.2	195.0	30.1	65.0	73.3	87.2	37.5	83.7	54.3	45.3	29.7	45.3	59.2	42.9	57.2	89.3	160.0	33.5	80.0	74.2	36.6	39.5	111.6	90.7	58.0	89.3	155.6	256.4	67.3	99.6	72.2	78.5	98.0
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119881	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 156.2;Extravillous trophoblasts: 143.9;Kupffer cells: 122.7;Syncytiotrophoblasts: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 66.6;eosinophil: 22.8;intermediate monocyte: 50.3;myeloid DC: 39.7;neutrophil: 27.0;non-classical monocyte: 68.5"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.7;granulocytes: 27.0;monocytes: 68.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	31.7	29.9	16.9	22.6	20.8	16.7	30.1	19.2	26.5	25.8	17.1	29.2	24.7	31.2	35.2	15.8	29.1	29.9	35.1	18.3	24.7	37.6	47.3	44.4	22.5	28.2	21.6	18.8	37.2	33.3	38.8	48.5	26.6	33.2	8.7	6.6	37.7	23.6	47.0	25.5	26.9	14.6	21.0	54.3	26.9	56.0	26.0	20.4	32.6	25.1	7.0	31.5	22.0	31.4	35.6	67.8	13.2	43.2	40.4	40.2	85.1	21.8	39.6	16.2	13.2	20.3	56.3	12.7	56.5	17.3	13.8	14.8	4.1	25.2	3.8	16.5	49.9	0.2	12.8	73.3	69.7	1.7	40.4	86.7	35.4	30.6	10.5	32.8	28.9	33.5	12.9	51.5	12.4	81.3	6.0	8.4	27.3	8.7	46.8	30.9	44.8	22.2	13.1	36.5	15.1	43.4	28.5	31.3	39.0	8.1	89.5	50.1	18.8	59.7	31.5	43.6	8.1	121.4	36.5	3.8	19.1	32.8	38.4	0.6	66.6	22.8	3.7	50.3	4.4	3.1	2.8	3.8	39.7	3.0	3.2	2.3	27.0	3.0	68.5	9.5	2.1	32.9	16.9	20.8	19.2	26.5	18.3	24.7	28.2	21.6	26.6	21.0	26.0	31.4	21.9	19.2	41.3	31.6	9.3	11.2	19.6	38.7	8.0	16.1	24.1	28.2	19.9	24.3	24.7	14.7	8.4	156.2	11.8	11.5	5.9	25.2	55.7	14.3	16.7	21.6	6.1	4.8	16.2	15.8	143.9	33.0	20.4	27.8	8.8	28.5	23.6	26.4	99.8	11.8	18.9	10.9	12.2	122.7	29.6	29.3	23.9	83.9	24.9	20.6	39.1	32.1	8.2	11.6	12.5	9.4	13.5	19.2	12.9	20.2	31.4	21.5	9.3	18.5	6.6	15.0	13.9	66.0	29.4	10.3	8.4	166.2	8.2	30.2	14.4	14.8
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	20.4	18.0	10.2	2.4	10.9	2.8	20.7	6.4	9.6	45.3	0.0	33.6	0.2	42.8	0.0	14.5	39.0	0.9	28.4	3.9	0.0	16.9	4.7	20.6	2.0	0.3	2.0	40.7	10.4	1.1	30.8	1.3	0.0	34.3	0.5	0.5	16.3	4.2	6.1	19.2	20.2	1.4	0.0	39.0	18.5	7.9	6.1	0.2	22.8	0.0	1.2	25.3	31.6	0.0	2.4	0.0	1.5	6.3	0.7	1.6	1.6	1.6	0.7	1.4	0.4	1.9	0.1	1.1	1.5	0.0	0.3	2.0	0.7	0.0	0.0	5.9	2.6	6.4	3.7	0.0	0.9	0.2	3.1	0.0	0.0	1.2	0.0	1.8	0.8	3.3	5.5	0.0	0.2	1.5	0.6	0.1	0.4	0.0	0.9	2.9	0.6	0.1	0.2	0.0	0.4	1.0	0.4	0.0	2.6	0.4	1.2	0.9	3.6	2.5	6.2	0.2	3.1	5.4	0.6	0.0	1.4	2.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	10.2	10.9	6.4	9.6	3.9	0.0	0.3	2.0	0.0	0.0	6.1	0.0	16.8	12.8	20.2	150.5	10.6	11.9	6.2	4.7	10.2	30.6	13.4	17.7	13.9	1.5	10.7	3.7	0.0	0.3	5.7	0.8	0.0	1.4	4.7	1.3	30.6	17.0	7.2	5.7	58.7	0.9	0.2	16.0	1.5	1.9	7.6	14.6	22.5	0.3	1.1	23.5	68.1	4.7	2.0	5.9	18.3	3.1	15.2	14.4	0.0	19.7	11.0	9.8	0.0	72.4	16.3	1.7	1.6	25.6	0.7	7.6	0.1	1.0	1.1	17.3	13.1	12.5	18.8	1.2	2.7	5.3	11.1	0.5	5.9	6.7	1.5	2.8
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605012-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 317.8;liver: 366.0"	"Cell type enriched"	"Detected in many"	7	"Syncytiotrophoblasts: 1609.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 4.9"	"Group enriched"	"Detected in many"	4	"HDLM-2: 116.8;SCLC-21H: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023606	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	19.6	143.4	12.3	3.8	18.9	14.7	24.6	25.2	19.9	135.0	8.2	26.1	6.0	53.2	1.8	13.1	26.5	2.9	317.8	11.6	16.1	25.4	366.0	26.8	1.6	13.8	13.7	74.3	78.4	28.5	127.5	25.3	12.4	74.4	1.5	3.1	19.7	10.4	139.0	35.8	19.6	7.4	12.1	6.6	44.5	29.9	15.8	2.4	20.7	23.5	0.6	30.6	38.8	13.2	3.1	0.0	16.0	0.0	0.0	0.0	21.1	1.1	0.0	0.1	0.0	2.6	0.3	0.0	2.5	0.0	0.8	2.3	5.3	0.1	0.0	116.8	1.0	0.3	0.3	0.0	0.8	0.0	0.4	0.4	2.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	4.9	0.2	1.1	14.7	2.7	0.2	1.2	4.7	1.2	0.2	0.7	58.6	13.4	1.1	6.3	0.1	3.0	2.5	0.1	2.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	12.3	18.9	25.2	19.9	11.6	16.1	13.8	13.7	12.4	12.1	15.8	13.2	124.2	6.4	53.7	4.6	15.4	28.6	50.9	9.9	40.5	43.9	118.2	215.3	196.8	62.9	22.5	11.0	6.2	80.7	46.6	21.6	92.0	18.3	2.1	40.7	98.3	48.8	54.8	6.6	1.1	43.4	12.1	138.9	97.3	29.3	19.6	24.7	11.0	215.2	57.0	3.3	2.2	55.9	50.8	12.4	121.1	9.0	84.5	77.6	35.6	2.8	11.7	35.7	0.0	0.0	1.1	20.4	11.1	45.5	13.2	88.9	24.9	40.6	23.5	22.0	131.5	90.9	144.4	3.6	2.0	95.5	19.6	1609.4	57.5	165.8	20.0	12.4
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"brain: 645.9;pituitary gland: 885.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	13	"hypothalamus: 645.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.2	0.9	2.8	14.9	2.1	0.7	4.4	1.1	5.2	1.0	0.8	17.6	1.8	0.2	0.0	0.8	1.0	0.2	1.0	2.2	645.9	1.5	0.3	0.5	0.1	48.5	5.1	0.2	2.1	0.1	885.8	0.3	13.8	4.4	4.0	0.0	0.9	0.2	0.4	33.3	4.1	9.9	0.6	0.3	9.7	1.0	19.5	0.7	0.4	0.0	0.0	0.7	2.9	2.6	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.1	1.1	5.2	2.2	645.9	48.5	5.1	13.8	0.6	19.5	2.6	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 126.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	18.6	12.5	5.9	7.8	6.7	5.6	17.1	6.4	8.4	17.5	5.9	12.5	20.6	16.5	1.0	24.4	14.9	4.3	19.7	6.0	6.6	32.0	126.4	18.7	7.4	7.9	6.3	13.7	31.2	10.6	5.7	5.8	7.5	13.3	2.0	0.7	20.0	5.7	8.6	20.6	18.3	3.9	7.0	24.5	17.6	16.0	6.8	6.1	11.6	3.6	3.4	13.0	17.8	8.2	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	5.9	6.7	6.4	8.4	6.0	6.6	7.9	6.3	7.5	7.0	6.8	8.2	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GALNT1	GalNAc-T1	ENSG00000141429	"Polypeptide N-acetylgalactosaminyltransferase 1"	Q10472	18	35581117-35711834	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 331.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012628	Uncertain				"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA012628: AB_1849439"	"unprognostic (9.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.60e-2)"	28.9	20.6	11.9	27.4	12.1	26.0	37.2	12.3	14.2	26.5	15.1	42.8	42.9	19.4	19.7	57.6	15.9	28.9	23.8	10.9	14.4	17.4	45.9	23.3	33.5	13.1	13.2	16.9	24.6	12.2	13.5	52.0	13.5	25.4	41.1	17.1	46.8	18.0	29.0	52.4	49.3	22.7	13.1	25.4	27.1	16.9	13.1	18.6	30.0	37.3	40.8	70.5	27.0	13.9	32.5	34.9	40.5	37.6	78.5	74.0	53.4	33.2	35.4	30.3	27.4	21.0	61.9	38.3	34.9	36.0	28.7	24.4	20.2	63.8	48.1	45.0	18.5	48.7	62.8	48.8	39.2	106.6	62.1	50.7	59.7	47.6	52.1	90.1	331.4	30.8	14.8	49.3	118.9	26.1	31.6	40.5	41.6	33.5	16.4	38.9	53.0	18.5	124.8	148.9	21.8	42.9	59.4	43.0	36.2	77.1	32.9	82.8	116.3	55.7	22.5	37.0	37.1	70.1	35.7	72.5	39.1	72.1	29.5	7.2	3.4	7.6	3.2	4.5	3.6	4.1	2.2	2.9	4.0	2.4	2.0	3.0	4.3	4.6	6.6	4.4	2.5	1.4	11.9	12.1	12.3	14.2	10.9	14.4	13.1	13.2	13.5	13.1	13.1	13.9	85.6	80.1	44.1	35.9	33.4	29.8	28.4	28.8	22.2	31.3	77.2	43.8	43.3	48.6	39.9	16.5	12.5	31.0	44.8	109.1	7.9	42.6	1.4	77.6	44.7	41.7	38.9	30.9	57.5	39.9	92.7	49.8	26.0	73.0	20.3	51.7	35.7	71.3	77.9	85.8	56.3	59.0	16.2	58.8	37.1	2.9	19.0	56.7	19.6	57.1	41.3	105.9	28.8	54.3	56.8	58.5	51.4	18.0	36.7	54.4	76.8	22.0	33.5	28.5	13.1	55.2	28.7	6.5	12.2	26.3	82.1	33.2	33.7	50.3	85.3	52.8
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282122	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 429.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	32.9	49.6	17.0	34.8	19.9	13.9	21.9	15.2	16.7	24.7	22.0	28.9	19.5	27.1	6.9	21.0	22.4	21.2	27.4	15.8	18.6	18.5	100.1	27.1	14.0	23.0	19.5	39.2	68.1	9.9	13.6	27.6	18.3	21.4	12.4	19.8	22.1	14.3	67.4	14.7	23.6	25.0	15.3	17.4	33.1	19.7	25.1	42.8	19.0	27.4	11.2	33.4	19.5	15.5	79.5	103.7	59.9	71.4	112.4	95.3	122.8	146.3	90.0	58.4	55.6	45.2	146.5	20.0	106.2	77.7	135.9	150.7	39.9	123.0	48.6	200.1	52.0	60.7	217.2	50.9	60.9	23.4	114.8	136.9	59.8	78.0	30.9	127.3	69.2	110.1	77.0	29.6	65.6	21.8	122.3	23.9	82.1	52.8	97.7	134.3	85.5	61.7	57.4	92.9	18.9	70.1	148.4	7.9	91.0	31.7	46.5	43.5	165.3	56.7	107.9	129.5	118.0	97.9	60.3	44.4	146.1	46.3	429.7	1.5	10.7	3.6	4.4	9.3	3.2	3.4	2.6	4.5	7.8	5.8	2.5	5.0	3.2	2.8	10.2	13.2	3.3	7.7	17.0	19.9	15.2	16.7	15.8	18.6	23.0	19.5	18.3	15.3	25.1	15.5	18.6	16.0	21.3	71.5	32.1	15.3	20.0	52.8	20.5	30.8	13.8	10.7	13.6	18.6	30.1	23.9	33.3	7.3	21.7	24.1	5.9	49.7	47.2	18.7	15.4	17.9	16.8	27.6	67.3	133.0	123.4	36.1	21.4	24.5	13.3	20.5	19.6	98.8	24.9	28.6	82.0	18.9	4.1	42.4	9.7	24.6	35.8	28.9	24.9	106.8	44.0	10.9	18.6	72.9	44.6	88.5	21.6	29.3	109.0	23.5	17.9	19.2	23.5	73.5	13.1	33.1	25.4	3.4	14.0	16.6	8.0	16.6	21.2	32.8	17.6	29.9
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074781-76077537	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 7.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.7;Endometrial ciliated cells: 1.0;Macrophages: 1.5;Respiratory ciliated cells: 1.6;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;NTERA-2: 2.0;PC-3: 1.3;THP-1: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.1	0.1	0.2	0.3	0.0	0.9	0.0	0.1	0.2	0.3	0.0	7.7	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	5.8	1.7	0.3	0.2	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.9	0.2	0.2	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	1.1	0.0	0.7	1.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	0.1	2.0	0.0	1.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.3	0.2	0.0	0.3	3.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.4	0.4	0.2	0.4	0.3	0.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.4	1.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.3	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	0.2	1.6	0.0	0.0	0.0	0.1	0.7	1.1	0.0	0.1	0.3	0.3	0.0	0.2	0.4
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 615.1;skeletal muscle: 1234.9;tongue: 466.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	14.0	26.6	69.4	4.5	74.5	8.8	15.6	68.6	79.1	16.5	53.4	10.9	3.2	10.0	141.9	23.0	14.7	9.9	98.1	67.3	67.1	72.0	615.1	8.1	7.7	71.8	68.3	22.8	229.8	37.8	37.4	4.9	70.4	36.5	2.2	15.0	42.6	17.5	1234.9	32.8	6.4	4.6	68.8	10.7	31.8	55.0	76.1	24.8	22.2	466.4	4.3	12.9	15.3	94.5	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	69.4	74.5	68.6	79.1	67.3	67.1	71.8	68.3	70.4	68.8	76.1	94.5	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GAN	"GAN1, GIG, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314944-81390809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 24.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules		"CAB011825: AB_732515, HPA049473: AB_2680782"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	1.3	0.9	7.3	0.7	5.7	0.7	2.4	6.6	4.7	2.6	1.0	2.3	0.8	1.3	1.1	5.4	1.3	0.6	1.5	6.9	8.8	1.0	1.1	1.7	0.7	9.3	8.6	1.4	1.2	0.8	1.4	0.8	5.5	2.0	1.2	3.2	2.3	0.7	1.5	24.8	1.4	0.9	8.7	0.9	1.8	0.9	8.7	0.9	1.1	1.4	1.3	1.5	4.3	9.2	1.6	2.0	1.5	2.1	1.9	1.0	10.4	1.2	0.7	0.8	0.3	5.1	1.8	2.5	1.4	1.6	0.4	3.1	2.7	1.3	1.8	0.6	1.4	2.2	1.8	4.1	2.0	2.1	2.4	1.1	3.8	1.3	3.5	1.1	1.7	2.1	2.8	1.1	1.1	9.1	1.9	2.9	4.0	2.2	0.6	3.7	1.4	1.0	1.6	5.0	1.5	1.0	4.3	4.2	1.4	3.6	2.9	2.0	2.5	2.3	2.1	0.8	1.9	2.2	2.7	5.8	1.2	2.4	1.7	0.7	0.4	0.2	0.8	0.4	0.7	0.4	0.8	0.6	0.2	0.5	0.7	0.9	0.3	0.9	0.3	0.9	0.6	0.2	7.3	5.7	6.6	4.7	6.9	8.8	9.3	8.6	5.5	8.7	8.7	9.2	12.2	12.8	8.2	69.5	9.9	91.3	66.8	15.0	34.1	28.4	15.4	18.5	12.5	7.2	29.5	5.5	89.6	19.3	17.4	27.5	0.0	9.4	2.3	11.6	19.3	14.7	5.4	12.6	21.2	6.7	15.4	14.1	17.3	14.0	1.3	7.2	12.1	6.7	5.6	23.5	29.5	15.1	10.2	6.8	30.9	4.6	9.6	8.6	37.4	14.0	7.5	14.0	9.2	22.1	18.3	18.6	16.8	12.8	11.0	75.0	14.8	3.8	30.1	43.8	6.6	20.2	17.6	11.9	16.4	67.1	130.4	21.3	16.1	5.3	15.6	188.7
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		23000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	93.9	73.7	31.8	88.2	34.5	83.7	92.8	36.6	36.7	112.6	51.6	104.7	95.6	102.1	151.7	66.4	106.9	75.3	67.9	31.7	41.2	98.5	171.7	86.8	81.7	38.5	34.9	115.5	88.1	130.6	21.8	141.8	38.1	97.5	116.8	79.4	101.8	111.1	39.4	74.7	90.5	126.0	36.5	86.7	85.2	66.1	39.8	105.2	132.6	53.0	94.8	90.7	34.2	43.4	298.2	245.9	318.2	552.0	464.1	389.0	332.9	312.4	480.4	436.2	362.1	222.2	515.9	201.2	616.0	572.5	337.8	376.4	375.2	376.7	443.8	155.8	191.3	202.9	317.8	125.6	389.0	325.7	248.7	397.2	248.4	433.6	475.3	533.0	422.3	199.6	278.5	352.9	398.2	313.6	167.6	193.4	262.3	236.6	237.7	209.5	368.7	513.1	285.7	230.3	168.6	221.2	451.1	308.2	370.8	321.6	380.9	304.8	311.6	430.0	272.2	342.9	309.9	360.8	423.8	152.2	473.9	173.1	421.7	23.9	19.3	19.1	23.8	23.4	23.1	15.9	17.2	20.0	20.8	14.9	20.9	21.3	8.9	29.8	22.2	18.4	17.3	22.6	31.8	34.5	36.6	36.7	31.7	41.2	38.5	34.9	38.1	36.5	39.8	43.4	42.7	12.8	20.7	17.3	29.8	28.3	29.4	45.8	13.6	31.4	57.4	53.8	7.8	52.9	24.2	68.0	60.5	81.7	33.4	40.1	5.9	47.0	18.5	31.4	59.1	42.2	31.8	25.0	12.6	42.6	137.3	45.9	27.5	46.5	11.4	72.8	48.2	98.0	57.9	35.3	16.0	48.9	34.6	45.8	25.1	16.4	58.4	32.7	35.6	15.9	38.9	36.5	38.1	11.1	16.5	39.5	29.3	68.1	50.4	34.0	47.8	27.0	26.3	41.4	32.9	36.4	34.7	25.3	47.4	21.2	31.3	80.2	25.2	63.1	56.3	32.4
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 27580.7;tongue: 18892.5"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 10357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	1219.9	1815.8	2605.9	1191.3	2589.5	4608.5	1042.3	2869.0	3067.8	1163.8	2419.2	1720.0	1480.8	1080.9	769.9	2973.8	1042.8	1161.3	5572.8	2630.1	2880.0	2323.2	2557.9	1137.9	1388.3	2845.2	2861.3	1087.0	652.0	1616.0	1338.7	1190.6	2828.4	1241.0	1586.6	2386.8	1835.8	1238.7	27580.7	1775.5	1457.5	1424.4	2670.8	1208.5	1215.5	693.0	2985.1	1570.9	1022.1	18892.5	1861.0	1889.0	1672.9	2741.6	6063.0	10247.9	3109.5	4709.2	3026.2	5018.7	6516.0	4716.2	7218.1	7172.8	7491.2	7211.3	4091.6	7540.8	878.2	5947.4	4904.2	3359.8	3372.7	10829.1	5432.4	6263.1	3229.5	4224.9	5857.5	6279.2	3890.9	6710.2	3046.1	4089.0	3521.7	6553.0	7609.7	15565.8	7762.7	5052.4	2215.9	1484.1	8670.0	11849.8	7303.1	3247.3	10995.7	7254.7	3950.7	5849.8	5505.7	3512.8	7909.6	7115.9	2088.3	3331.0	4243.1	10206.4	5984.0	8874.7	1657.2	4311.2	4794.3	5049.0	5907.2	2717.1	7931.5	3178.4	2544.6	9374.4	10632.2	4050.5	8040.5	2575.4	4295.8	737.9	1325.8	2011.2	1171.4	1046.9	1364.8	1333.1	3253.6	652.5	757.6	886.9	1981.4	1227.8	1900.6	474.6	2126.1	6812.0	2605.9	2589.5	2869.0	3067.8	2630.1	2880.0	2845.2	2861.3	2828.4	2670.8	2985.1	2741.6	1036.7	237.2	259.5	228.2	1086.9	1818.8	2223.4	7367.5	4070.9	1157.6	1794.6	3689.2	40.4	1263.9	2213.7	1022.5	417.0	4237.7	1032.7	2579.6	3463.0	5198.9	759.8	770.1	702.4	1597.4	1324.3	1180.6	112.1	3794.5	10357.8	1127.1	1068.8	1021.8	562.3	2063.7	1242.9	1742.3	3895.3	2348.7	145.8	2351.2	2543.1	2586.7	2494.4	2257.7	889.4	2134.0	4220.8	86.2	3422.3	6177.9	1045.4	98.5	196.2	5681.8	3001.4	1026.9	2668.2	1714.0	5714.0	7286.7	864.3	1435.2	1150.4	1744.7	2827.8	429.9	476.2	3605.2	1600.7	4694.0	1514.9	1839.0	3140.9	2882.4
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533455-35545319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 269.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 8717.5"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		7500000	"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	1.2	2.7	0.4	4.1	1.3	2.4	0.2	1.2	1.3	0.0	0.1	0.6	3.3	2.7	0.0	3.0	1.9	3.6	4.0	0.2	0.5	0.9	0.3	1.9	6.5	0.3	0.4	3.4	5.2	0.0	0.1	1.1	0.4	2.0	0.0	3.5	5.1	0.0	1.6	13.9	3.2	0.0	0.1	5.2	2.4	269.8	0.8	0.0	11.4	0.0	0.0	1.5	0.1	1.5	6.5	22.4	6.4	9.6	0.0	0.0	5.4	1.9	0.0	0.0	0.0	13.8	10.4	10.7	2.9	0.0	2.6	7.6	0.0	0.0	0.0	10.5	11.2	7.1	16.7	7.1	0.1	6.4	8.3	0.0	0.0	0.0	0.0	3.9	0.0	10.3	17.6	6.0	0.0	19.6	2.5	3.0	8.6	4.1	3.1	7.6	4.3	8.3	0.0	6.1	11.3	5.1	2.4	5.7	7.0	4.3	4.8	2.7	2.1	7.2	7.9	1.8	2.7	16.9	4.8	6.2	3.9	11.4	2.6	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.3	1.2	1.3	0.2	0.5	0.3	0.4	0.4	0.1	0.8	1.5	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1915.7	0.0	0.0	1.6	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	8717.5	24.8	2.4	44.4	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	28.6	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.1	33.4	18.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: AB_2683904"	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	14.7	16.4	10.0	13.5	10.1	31.7	15.9	9.8	13.0	12.3	10.1	16.0	11.3	13.7	11.4	23.0	13.3	6.4	12.7	10.0	10.3	20.1	16.5	9.6	13.5	10.1	10.1	15.5	14.7	9.3	11.8	11.5	10.3	12.2	15.2	7.1	13.2	8.0	12.2	23.2	13.2	11.7	9.9	15.5	12.9	15.1	10.3	13.8	10.7	6.6	16.0	16.3	13.5	10.6	45.7	65.5	34.3	49.7	19.3	26.8	34.1	47.1	24.1	35.3	30.1	100.6	60.2	103.5	27.5	38.9	39.5	22.2	68.8	47.7	66.5	31.2	68.3	57.7	57.1	113.1	46.6	150.8	35.2	27.0	49.5	48.6	37.6	27.9	44.5	48.1	146.8	34.6	50.0	121.7	78.5	115.4	59.5	78.4	68.7	58.0	57.2	41.2	55.3	79.3	51.2	55.7	26.3	80.6	46.2	29.5	25.1	48.4	39.3	38.5	51.1	27.2	61.4	42.0	70.7	132.2	26.3	69.7	43.2	7.5	4.0	2.9	6.1	6.7	6.5	8.4	5.9	6.2	6.3	7.9	6.7	6.2	0.7	7.3	6.3	6.8	6.8	2.6	10.0	10.1	9.8	13.0	10.0	10.3	10.1	10.1	10.3	9.9	10.3	10.6	25.2	3.2	17.0	4.6	29.0	57.9	40.9	42.7	27.3	11.9	36.3	37.2	13.8	14.3	33.1	16.5	14.6	69.9	23.4	18.5	25.4	49.2	1.3	54.0	39.9	30.9	18.6	62.1	6.6	53.8	65.8	24.7	30.1	36.9	19.0	38.1	18.2	19.6	35.8	5.0	6.3	40.7	10.2	13.3	17.2	4.3	22.1	16.0	17.8	5.6	16.1	39.2	17.5	5.5	7.4	49.5	22.7	18.8	24.7	68.5	14.5	40.4	35.6	9.3	6.6	35.2	27.7	45.0	38.3	40.2	60.0	87.8	24.8	44.6	46.1	40.6
GARRE1	KIAA0355	ENSG00000166398	"Granule associated Rac and RHOG effector 1"	O15063	19	34254552-34355566	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 126.8;Cardiomyocytes: 15.7;Cytotrophoblasts: 23.8;Extravillous trophoblasts: 25.1;Syncytiotrophoblasts: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	18.8	5.6	5.0	7.2	6.7	3.4	16.8	7.3	4.5	10.8	6.7	7.8	5.4	11.0	3.0	8.0	10.1	9.5	12.0	3.6	5.6	8.2	7.3	12.4	9.1	7.0	7.0	9.4	10.4	10.8	7.7	23.3	6.6	8.3	5.6	8.1	7.4	6.4	15.4	10.3	8.2	8.6	5.2	16.1	6.6	7.1	7.1	8.5	10.9	17.0	7.5	8.0	9.9	10.3	3.4	10.2	8.9	4.6	6.0	5.7	11.6	7.6	6.2	5.7	8.4	8.1	3.9	7.7	16.4	7.1	7.1	2.4	6.6	3.6	6.2	11.0	5.8	4.7	3.9	6.2	7.6	2.1	3.7	6.7	6.2	7.5	11.0	22.6	23.7	4.3	14.4	3.8	6.2	1.8	1.4	1.9	6.8	4.6	3.7	3.4	6.2	4.1	4.8	3.8	10.3	8.5	8.7	33.9	10.9	12.9	2.7	3.8	19.7	19.5	7.2	5.0	8.1	6.4	9.5	2.4	3.7	0.8	9.7	0.0	0.7	0.0	0.8	1.4	1.3	2.3	1.8	0.8	0.8	2.8	1.6	1.0	2.2	1.5	2.1	1.1	3.0	0.8	5.0	6.7	7.3	4.5	3.6	5.6	7.0	7.0	6.6	5.2	7.1	10.3	126.8	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	23.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	25.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	34.1	2.3	0.0	0.0	0.0
GARS1	"CMT2D, DSMAV, GARS, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase 1"	P41250	7	30580533-30634033	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 34.1;Cytotrophoblasts: 47.0;Extravillous trophoblasts: 70.0;Hofbauer cells: 44.3;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		560000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	34.2	31.0	33.3	43.3	36.5	32.0	31.7	34.2	46.2	32.6	49.9	39.8	27.6	29.1	37.3	53.8	23.3	29.9	32.9	38.6	45.7	42.7	46.0	34.0	47.2	38.1	34.7	26.7	78.5	58.1	36.5	39.9	42.0	26.8	48.6	46.9	36.1	29.3	48.1	43.4	26.0	49.8	33.2	22.3	47.4	51.5	43.4	40.7	51.5	45.0	67.3	54.0	29.4	35.2	231.4	119.8	103.4	364.5	191.9	286.8	172.0	332.4	330.5	184.0	369.8	159.5	115.4	375.9	96.2	443.1	281.6	174.5	262.6	230.2	327.7	92.9	82.5	182.6	84.8	141.1	604.0	267.6	149.8	272.5	391.9	265.8	304.9	128.1	241.6	354.1	350.2	465.4	296.7	154.7	216.8	204.3	259.6	222.4	183.4	114.0	90.1	299.0	219.5	109.1	117.9	177.4	88.1	261.5	509.2	182.8	225.3	409.3	208.2	82.2	262.9	164.9	217.9	403.8	390.8	445.9	289.4	398.8	392.9	40.0	27.0	24.1	22.9	35.8	27.4	21.0	26.0	28.8	35.8	16.3	25.2	30.2	5.2	20.9	41.7	18.5	31.9	23.9	33.3	36.5	34.2	46.2	38.6	45.7	38.1	34.7	42.0	33.2	43.4	35.2	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	47.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	70.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	39.8	2.0	0.0	0.0	0.0
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.1	20.3	9.2	24.2	12.2	18.8	24.3	11.3	11.9	16.4	10.1	23.2	22.1	18.3	17.1	24.8	21.8	15.9	20.7	8.6	10.5	21.0	29.7	16.0	30.3	11.0	10.3	19.0	22.3	19.9	12.8	26.1	11.7	17.0	29.1	20.9	16.8	16.7	29.1	17.4	19.4	26.3	11.3	20.0	19.7	29.3	10.9	34.4	20.8	21.9	38.6	32.2	16.5	14.0	132.2	61.5	90.3	98.8	61.1	64.2	100.3	82.6	70.8	96.8	101.5	117.7	108.9	174.8	48.5	55.6	124.9	67.9	189.0	130.4	138.3	91.3	111.7	265.2	68.5	78.6	85.2	148.6	66.3	57.3	86.5	113.3	162.5	48.1	91.5	138.4	312.4	108.5	84.9	63.6	158.2	100.0	194.4	186.3	71.8	131.1	166.6	246.7	74.7	69.4	93.1	84.1	116.9	89.1	107.1	81.0	113.0	93.9	68.7	64.9	76.9	56.1	90.9	106.8	159.6	193.0	67.1	171.3	96.2	9.0	24.0	16.3	25.9	33.9	31.4	29.7	25.2	27.1	31.6	24.5	26.4	26.2	10.6	43.9	30.6	23.2	34.1	22.8	9.2	12.2	11.3	11.9	8.6	10.5	11.0	10.3	11.7	11.3	10.9	14.0	21.1	19.2	19.8	17.3	30.1	46.0	50.3	34.1	38.1	18.5	18.6	17.3	19.3	11.5	28.0	14.7	35.5	41.2	21.8	12.4	23.5	28.4	21.7	23.3	36.9	21.9	13.1	40.3	19.1	24.2	37.4	27.2	21.4	23.4	7.6	31.8	16.1	18.0	23.6	5.0	21.1	17.1	22.4	17.0	12.0	6.6	17.4	17.0	12.4	10.3	19.8	13.3	22.6	17.6	19.3	31.5	12.7	18.0	22.7	54.3	16.4	14.3	17.8	28.5	13.1	23.0	23.9	57.2	27.6	34.4	45.9	25.6	21.2	55.0	24.1	46.6
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 84.6;Late spermatids: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 77.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	22.6	36.3	46.7	5.5	41.8	6.5	22.4	39.4	58.5	16.2	30.4	25.8	18.1	18.4	5.3	34.3	16.5	4.2	33.5	45.4	37.8	21.0	18.6	19.3	2.3	50.0	43.3	8.9	14.4	6.6	22.1	4.1	42.2	22.2	2.0	4.0	24.7	16.9	6.5	52.8	17.8	4.4	41.8	29.1	27.4	51.3	47.3	1.1	15.6	3.9	1.8	17.6	19.6	37.4	20.4	23.1	3.5	14.5	5.5	5.2	22.6	29.7	8.9	12.3	6.4	10.6	14.2	0.1	13.1	15.9	12.9	60.5	6.0	16.8	2.2	27.6	2.9	26.5	19.9	7.5	7.0	0.2	17.8	5.6	11.5	11.9	4.7	8.9	16.5	26.2	12.8	4.1	9.0	17.2	0.5	14.8	5.3	13.5	51.6	0.6	10.3	1.7	7.5	12.8	1.2	19.0	23.0	30.3	17.0	4.4	30.2	4.1	35.5	77.0	53.0	34.6	30.3	0.3	0.4	0.3	34.1	1.0	19.3	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	46.7	41.8	39.4	58.5	45.4	37.8	50.0	43.3	42.2	41.8	47.3	37.4	34.5	6.4	1.7	28.1	0.4	28.2	7.0	12.3	21.6	3.6	24.0	18.4	5.6	14.3	8.3	1.8	6.2	24.8	0.8	13.4	7.9	12.2	33.8	19.2	9.2	26.2	1.8	19.6	14.8	6.7	14.3	12.0	9.2	10.0	1.3	28.9	84.6	12.0	14.1	13.5	11.4	5.1	20.3	14.5	23.0	89.7	9.6	37.6	12.4	7.5	7.6	5.4	0.0	4.0	4.0	10.2	7.2	11.7	0.2	6.1	41.7	10.1	4.3	20.9	39.5	35.3	23.5	5.4	12.4	27.9	32.4	6.7	2.2	17.8	11.8	4.6
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	5.2	10.3	9.5	2.8	9.7	1.4	6.3	10.0	14.3	7.8	12.3	7.7	2.6	6.5	10.1	8.4	18.9	6.1	15.4	9.5	9.9	13.8	5.5	7.1	2.8	10.3	10.0	8.9	10.5	16.3	14.1	2.1	10.1	7.3	3.0	5.0	11.4	8.6	15.1	4.5	3.9	4.4	10.3	3.4	8.2	16.8	10.9	2.5	12.5	10.0	2.0	6.3	5.8	10.2	17.9	14.5	1.8	8.5	7.8	6.2	14.3	3.6	8.8	13.9	4.1	14.1	13.0	1.0	9.1	7.1	8.4	17.8	5.9	9.9	3.3	0.0	10.7	3.7	9.0	16.2	8.7	2.2	2.8	7.9	6.0	10.4	4.7	6.3	8.3	5.8	14.3	2.1	6.1	41.9	2.5	9.9	11.6	11.3	7.4	0.7	15.7	1.0	17.4	8.5	14.6	10.7	18.4	9.7	21.0	1.6	19.6	8.4	6.2	8.6	10.3	4.7	8.3	3.4	5.4	0.0	21.3	2.7	15.1	1.7	1.2	1.4	0.7	2.0	0.7	0.4	1.0	1.4	1.7	0.8	0.8	0.7	1.5	0.0	1.3	1.9	1.6	0.8	9.5	9.7	10.0	14.3	9.5	9.9	10.3	10.0	10.1	10.3	10.9	10.2	5.9	22.4	11.3	20.5	3.1	1.1	4.7	7.0	5.7	11.9	14.1	10.8	7.9	25.8	13.4	22.0	20.9	3.0	0.7	5.9	13.7	17.1	198.3	45.5	7.1	5.8	6.0	3.0	27.5	10.9	3.6	5.5	12.2	10.0	2.5	16.1	7.1	4.8	4.1	26.9	24.6	6.3	8.2	0.8	1.4	277.8	14.0	2.3	5.4	1.9	1.3	12.4	0.0	13.0	6.0	10.0	4.6	7.5	1.1	5.8	5.3	30.9	82.3	28.0	6.6	6.7	9.5	28.7	11.9	7.2	2.6	1.6	1.6	25.2	5.3	5.8
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075198	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 109.9;skin 1: 172.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 267.1;Cytotrophoblasts: 323.5;Extravillous trophoblasts: 746.6;Suprabasal keratinocytes: 198.9;Syncytiotrophoblasts: 1134.9"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Group enriched"	"Detected in many"	5	"midbrain: 28.3;pons: 12.6"	"Group enriched"	"Detected in many"	41	"gdT-cell: 19.9;MAIT T-cell: 26.9;memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.8;naive CD4 T-cell: 19.9;naive CD8 T-cell: 18.3;NK-cell: 36.1;T-reg: 43.6"	"Group enriched"	"Detected in many"	57	"NK-cells: 36.1;T-cells: 43.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.2;MCF7: 473.4;RT4: 194.3;SH-SY5Y: 161.2;T-47d: 605.2"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"Group enriched"	"Detected in some"	11	"medulla oblongata: 5.2;midbrain: 14.0;pons: 11.8;thalamus: 13.1"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	6.7	6.4	0.9	3.8	0.2	4.1	34.2	0.2	0.2	3.4	0.8	0.7	1.0	0.6	8.6	0.6	0.5	1.2	2.5	0.1	0.6	24.9	1.0	3.4	7.8	3.9	28.3	0.1	0.3	109.9	5.0	32.2	12.6	11.2	0.7	0.0	19.9	24.9	2.1	172.9	2.4	0.3	0.5	7.2	1.5	0.2	4.1	25.0	3.0	1.0	3.8	38.8	10.8	0.2	33.8	8.1	0.0	0.4	0.0	0.0	190.2	0.7	0.0	0.0	0.1	12.4	29.9	0.0	0.1	0.0	0.0	28.9	3.2	0.6	0.1	95.8	10.2	0.2	0.3	0.1	2.1	0.1	0.5	0.0	6.9	0.1	1.8	1.0	15.3	45.8	0.4	0.0	0.1	473.4	54.2	0.5	3.5	6.5	4.5	2.8	2.6	0.8	0.0	194.3	9.8	161.2	0.5	26.8	0.0	34.1	605.2	0.1	0.0	2.4	5.9	1.4	4.3	0.9	0.0	0.0	1.3	0.0	1.7	0.1	0.1	0.0	19.9	0.0	26.9	0.4	36.7	28.8	0.0	0.1	19.9	18.3	0.7	36.1	0.0	0.0	43.6	7.0	0.9	0.2	0.2	0.2	0.1	0.6	3.9	28.3	12.6	0.5	4.1	0.2	14.6	0.0	6.0	0.0	3.4	94.8	69.6	1.6	0.0	0.0	267.1	167.3	1.3	0.0	1.5	178.4	0.0	323.5	49.2	0.0	0.0	0.2	0.2	0.5	0.4	12.6	0.0	2.1	0.0	0.4	746.6	5.3	2.6	0.7	2.5	0.0	6.8	0.6	30.7	0.0	0.0	0.0	0.0	3.5	9.9	0.1	0.0	3.8	8.8	1.0	1.5	0.0	51.5	0.0	0.0	4.1	1.1	0.0	12.2	45.8	0.0	0.6	0.3	0.0	0.0	1.1	2.8	0.0	1.4	1.0	198.9	1134.9	93.4	0.5	0.0	106.1
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	10.0	7.1	0.0	6.1	2.9	10.0	9.9	12.4	3.0	10.9	0.0	11.1	4.2	11.1	1.8	7.9	9.1	3.2	9.2	1.8	1.5	7.1	8.1	12.9	7.8	2.8	0.7	11.7	7.5	5.7	7.6	5.8	1.2	8.3	3.6	3.6	7.8	5.3	16.6	13.3	9.3	7.0	0.0	10.6	7.7	10.4	2.1	10.9	8.6	8.2	7.4	9.5	9.8	11.2	7.9	14.7	12.8	14.2	2.7	8.2	7.7	4.8	11.5	15.0	17.5	7.2	12.0	15.5	11.2	10.9	7.9	15.6	18.1	9.4	12.2	14.2	12.5	15.2	16.2	2.9	8.6	9.2	20.7	6.5	6.5	16.7	32.9	7.1	14.4	21.2	11.5	20.6	3.0	14.5	33.3	2.6	5.6	6.3	7.1	33.5	6.5	17.1	2.9	10.9	14.8	15.6	18.0	21.8	8.7	9.4	20.1	7.7	13.0	14.6	12.8	8.1	10.2	27.9	20.5	23.4	8.2	6.0	12.8	4.9	0.5	0.5	0.6	0.3	0.6	0.4	0.3	0.8	0.2	0.6	0.2	0.3	3.5	0.9	0.2	1.6	0.6	0.3	0.0	2.9	12.4	3.0	1.8	1.5	2.8	0.7	1.2	0.0	2.1	11.2	32.1	9.6	14.4	53.8	30.0	43.8	13.4	12.8	47.8	45.9	20.9	19.9	16.6	21.5	12.3	25.8	39.6	10.3	31.9	15.1	7.9	13.9	15.8	16.8	26.6	28.2	23.8	21.7	104.6	14.3	7.1	20.7	17.3	21.3	24.7	19.3	22.5	21.8	13.5	35.3	77.5	15.8	16.2	31.4	42.8	7.6	27.1	23.7	14.2	80.6	36.3	17.8	23.7	86.5	117.9	17.1	20.7	35.0	25.6	22.3	9.9	10.4	15.2	35.9	6.6	28.2	27.1	30.4	21.4	26.0	47.5	9.9	31.2	21.4	15.9	21.1
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489703-81761645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 149.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 287.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		6500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	73.9	53.8	4.5	14.9	5.7	19.7	38.6	7.1	8.2	14.2	14.2	11.8	13.2	17.3	14.2	18.1	13.8	13.0	55.6	6.2	8.2	41.4	108.6	17.2	8.6	10.7	18.7	14.2	14.2	19.1	10.4	25.6	10.3	13.2	13.8	22.0	15.5	14.9	149.1	14.4	11.5	21.8	7.0	12.0	11.1	7.9	7.4	11.4	19.6	56.6	13.2	19.2	13.9	7.4	61.3	36.2	11.9	168.7	287.6	216.8	21.5	99.1	140.1	58.1	97.6	7.1	15.6	67.9	42.7	122.5	34.5	7.1	9.9	45.7	135.4	32.3	6.4	21.2	70.0	22.8	197.5	72.2	17.8	161.2	33.2	93.5	95.5	144.9	130.5	8.0	17.0	38.0	191.1	17.8	12.5	92.7	12.0	16.8	58.0	22.9	53.6	81.1	41.4	20.5	6.0	7.9	64.6	18.7	20.9	17.2	13.3	58.9	183.4	118.9	28.1	84.7	92.8	174.8	21.4	24.6	194.1	47.8	49.8	7.5	11.8	15.6	5.2	10.8	5.1	11.6	5.6	5.7	13.8	12.5	6.4	6.6	11.4	13.5	11.8	4.8	5.1	6.5	4.5	5.7	7.1	8.2	6.2	8.2	10.7	18.7	10.3	7.0	7.4	7.4	49.7	16.0	12.4	31.3	14.9	30.7	22.2	36.8	27.3	18.6	7.5	5.5	60.2	15.7	21.9	31.3	0.0	30.3	8.4	9.5	41.1	32.1	36.2	16.3	15.2	32.0	22.1	4.6	52.4	25.4	74.0	34.9	6.6	14.7	43.1	16.0	15.4	75.2	26.3	30.3	47.4	8.7	12.2	12.9	21.3	16.9	17.4	17.3	24.9	87.1	16.3	10.4	7.2	49.3	63.0	37.8	5.8	13.2	12.8	17.7	11.3	50.8	25.0	17.8	32.9	45.8	26.7	6.9	7.3	20.6	21.3	54.9	8.7	34.2	8.3	14.5
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245371-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: AB_2675651"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.4	21.1	31.5	16.0	31.7	25.0	19.3	28.7	47.2	21.7	34.9	24.6	20.6	23.5	12.7	21.9	19.7	9.8	30.0	32.2	27.7	21.7	23.2	20.5	14.6	28.5	37.3	21.6	25.6	24.4	31.5	11.5	30.6	24.2	13.9	19.2	24.5	15.2	48.1	24.9	25.8	16.4	27.1	21.7	21.2	20.5	29.8	11.8	25.4	30.1	13.8	21.7	20.5	29.1	19.4	49.7	23.3	25.1	62.9	40.7	28.1	37.7	56.0	45.3	48.1	52.7	35.1	21.7	29.7	59.6	33.8	38.6	45.9	52.8	33.8	35.4	36.9	33.3	38.1	44.6	26.4	35.2	46.8	37.3	28.0	60.7	57.5	77.2	45.2	22.5	20.7	53.7	41.8	36.9	24.2	38.9	15.4	29.5	35.6	33.6	72.1	18.8	39.3	30.9	15.0	16.3	30.2	22.3	26.5	33.1	50.4	30.8	60.5	29.1	29.6	37.7	55.6	32.4	36.3	26.5	30.0	36.3	22.1	28.6	4.5	4.3	4.9	5.0	5.9	6.5	3.6	6.5	5.0	3.9	5.7	5.3	4.6	4.6	4.1	4.2	7.4	3.9	31.5	31.7	28.7	47.2	32.2	27.7	28.5	37.3	30.6	27.1	29.8	29.1	12.5	12.8	10.1	56.5	15.5	9.8	5.5	10.6	17.6	24.7	15.7	12.8	17.0	15.7	10.9	12.9	56.3	12.2	15.1	31.4	3.9	12.5	4.9	14.3	18.1	12.3	12.0	13.9	72.1	16.7	16.3	14.6	31.1	15.6	7.6	10.3	8.2	17.6	12.2	52.2	73.0	21.9	12.2	11.0	5.0	4.7	10.2	13.4	12.4	66.5	9.5	11.1	9.2	80.9	71.1	18.6	20.7	11.3	46.0	7.7	27.1	9.0	12.3	41.0	6.6	21.7	12.3	36.0	25.4	20.7	13.1	17.6	16.0	19.1	19.4	6.7
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89051882-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 183.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 131.4;BJ hTERT+ SV40 Large T+ RasG12V: 175.2;GAMG: 129.1"									CAB015450	Approved				"Intracellular and membrane"	NA	NA		110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	23.9	7.9	4.1	71.6	4.1	5.2	18.2	4.0	5.6	23.8	3.7	23.0	16.8	26.4	5.5	10.4	18.2	44.4	10.5	3.3	5.4	12.1	88.0	44.4	55.1	19.2	5.0	13.2	6.0	6.5	5.5	20.4	11.9	19.2	13.5	1.2	12.2	14.3	5.1	9.3	17.8	37.0	6.7	51.6	16.5	3.4	5.8	21.3	17.9	5.4	21.6	43.0	15.4	5.8	13.9	0.2	0.0	0.0	11.6	22.4	35.6	34.3	72.4	131.4	175.2	3.5	7.5	12.4	22.1	44.5	129.1	2.4	0.0	18.8	61.7	41.1	0.1	2.9	9.4	0.3	70.7	0.0	1.8	54.6	6.3	61.0	10.3	29.8	34.5	18.4	0.0	9.9	44.7	0.0	31.9	0.2	0.2	0.0	1.4	43.6	40.7	0.8	7.2	21.0	0.5	0.0	39.2	8.3	3.8	0.0	0.8	0.1	40.2	33.4	1.6	10.8	29.7	0.4	0.2	0.1	13.2	0.2	3.3	0.7	38.8	5.6	94.1	126.1	90.7	17.3	93.3	99.0	46.7	12.4	69.1	79.4	106.2	62.4	134.1	0.3	172.2	92.0	4.1	4.1	4.0	5.6	3.3	5.4	19.2	5.0	11.9	6.7	5.8	5.8	70.7	73.7	24.1	1.0	13.5	39.6	183.9	31.7	19.9	0.2	10.3	18.4	3.3	15.7	28.9	9.2	0.0	59.8	16.6	27.3	0.0	36.0	0.1	75.0	85.5	56.4	9.0	1.7	0.2	74.5	73.6	36.2	18.3	33.3	14.5	17.8	22.5	75.3	32.6	0.0	0.1	4.1	4.1	36.5	19.2	1.0	9.9	58.6	5.4	6.5	78.1	9.9	43.3	0.0	0.1	42.5	9.9	25.6	8.8	19.1	13.3	14.0	78.4	0.3	13.1	45.5	39.4	0.1	0.4	11.5	21.5	34.9	44.9	36.6	11.0	28.3
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC vitamin D binding protein"	P02774	4	71741696-71804041	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 8260.1"	"Group enriched"	"Detected in some"	27	"Cholangiocytes: 1552.8;Hepatocytes: 3017.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.0;RH-30: 3.0;SiHa: 1.8;U-698: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	73000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.6	0.1	0.0	495.5	0.1	0.0	0.0	46.1	8260.1	0.0	0.2	0.1	0.1	0.0	44.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	1.8	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1552.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	39.5	0.5	0.1	0.0	2.0	0.0	37.5	0.1	16.2	0.2	0.0	0.0	0.0	0.0	0.0	58.5	3017.1	0.1	0.0	0.1	0.7	0.0	83.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 325.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 327.4;neutrophil: 864.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 864.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	30.5	13.5	16.4	62.6	23.0	325.7	17.6	20.2	28.8	12.2	11.4	18.0	19.3	9.8	24.6	10.9	16.2	23.0	9.7	15.9	17.7	18.3	15.0	26.5	33.0	25.5	20.7	8.5	16.6	10.4	8.2	25.2	23.6	12.2	19.6	10.6	12.3	9.7	2.7	7.0	18.7	18.8	21.6	70.1	25.1	24.1	19.5	18.4	17.0	14.9	25.4	26.1	5.7	37.3	2.6	4.2	10.7	0.0	2.5	2.2	0.4	4.0	11.1	6.2	11.1	8.7	30.6	3.7	27.0	0.3	14.2	1.6	4.1	12.7	7.7	17.1	16.8	33.5	2.9	17.7	3.0	41.6	9.1	2.8	4.3	5.7	1.2	15.8	0.9	25.9	0.6	12.1	0.5	33.0	0.9	24.2	6.5	22.5	16.4	14.2	2.7	18.5	32.7	18.6	6.9	12.0	5.1	23.3	19.7	12.5	15.8	17.7	0.8	1.6	11.2	17.8	6.2	11.5	23.2	0.6	9.2	15.8	7.7	38.8	132.4	327.4	2.7	78.4	3.5	21.6	4.8	4.8	63.2	21.1	8.1	5.0	864.2	2.5	63.3	17.2	10.2	71.4	16.4	23.0	20.2	28.8	15.9	17.7	25.5	20.7	23.6	21.6	19.5	37.3	28.8	16.0	36.5	10.1	54.5	15.4	28.2	19.6	12.5	10.2	32.6	16.4	4.1	50.1	21.2	33.1	2.1	55.5	17.3	14.4	76.3	49.5	185.0	21.1	9.1	26.4	39.4	36.1	25.9	60.5	20.8	14.4	43.8	24.9	44.9	13.6	48.9	15.0	107.9	11.8	15.4	29.9	32.6	183.3	60.5	32.8	10.8	153.5	16.0	17.8	228.5	21.1	10.3	1.0	98.0	36.5	25.7	6.4	23.4	24.3	18.4	69.7	24.7	4.4	6.6	12.2	18.3	52.6	13.5	15.1	18.2	46.9	16.3	16.7	28.9	21.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 140.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Hepatocytes: 66.1;Proximal tubular cells: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020460, HPA063924"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548, HPA063924: "	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	6.6	15.7	25.1	3.2	24.8	14.1	6.5	26.2	33.3	6.3	22.5	7.3	4.9	7.8	3.0	17.0	6.0	5.0	43.4	26.1	25.0	13.0	53.3	5.6	2.8	25.9	27.4	9.0	140.2	6.0	9.7	2.7	27.8	22.8	4.9	2.2	13.3	6.8	19.5	8.1	5.4	4.2	24.4	1.5	13.2	10.3	27.9	4.3	16.0	19.1	3.1	7.1	7.0	24.6	18.7	4.7	11.9	68.2	24.0	19.4	8.4	25.9	26.9	19.2	16.3	10.5	2.1	5.8	11.8	11.7	11.3	10.6	11.9	18.3	4.3	2.6	21.9	12.9	15.0	42.5	39.0	23.0	16.4	22.8	10.9	12.7	27.7	6.2	16.0	23.0	33.2	6.6	9.2	16.2	24.3	42.3	5.0	28.8	19.0	25.2	2.5	34.4	24.6	14.3	24.5	16.7	20.0	32.3	13.9	4.2	25.8	11.1	11.8	19.3	10.6	12.9	9.2	21.9	11.5	12.1	13.3	21.1	20.5	0.1	0.6	0.4	0.7	0.7	0.3	0.1	1.6	0.5	1.3	0.0	3.5	1.4	0.3	1.3	0.4	1.3	1.7	1.4	25.1	24.8	26.2	33.3	26.1	25.0	25.9	27.4	27.8	24.4	27.9	24.6	3.5	6.4	15.4	9.8	2.8	7.8	18.5	11.2	12.5	8.9	18.6	17.4	54.6	11.5	9.4	11.0	4.2	15.7	0.7	13.1	80.3	7.2	4.1	9.9	8.1	5.5	2.4	22.7	5.0	10.3	19.6	9.8	15.3	16.7	8.9	17.6	5.0	66.1	4.7	8.4	4.7	32.3	8.2	2.9	1.3	7.7	3.7	2.1	21.4	1.0	1.0	25.1	1.0	6.6	4.1	5.4	8.7	9.8	2.0	19.1	8.6	163.8	6.4	2.2	6.6	4.8	30.1	12.6	33.2	19.6	6.0	27.8	3.0	27.8	24.0	14.4
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"kidney: 50.0;liver: 169.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 74.6"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	2.5	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.0	0.8	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	50.0	169.6	0.0	0.1	0.3	0.1	0.0	1.4	6.3	0.2	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.0	1.5	0.6	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.0	0.6	0.0	0.5	0.0	0.3	0.6	0.0	0.3	3.7	2.1	0.0	0.0	0.1	3.9	0.2	0.1	0.4	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	74.6	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.2	0.0	0.1	0.0
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1 activator of EIF2AK4"	Q92616	12	120127202-120194715	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	17.2	16.5	9.5	16.0	11.6	19.1	16.9	10.3	10.1	17.1	12.7	18.7	12.1	20.0	9.5	22.3	17.3	9.5	16.1	8.9	9.4	16.2	17.8	16.0	18.3	11.6	10.6	20.2	22.9	18.0	21.1	16.5	10.0	15.8	12.4	8.8	18.2	12.7	44.4	22.0	18.1	14.7	9.2	20.5	20.5	17.9	11.8	18.3	19.7	22.9	16.3	18.6	16.4	13.4	51.4	99.3	35.1	39.7	54.4	32.7	122.4	44.9	38.9	45.8	37.2	85.6	34.5	67.8	49.6	64.8	29.0	49.5	82.1	63.5	28.4	45.5	66.9	84.0	65.5	59.8	35.2	78.2	51.5	40.3	36.3	54.3	50.9	40.2	42.5	30.3	100.3	17.0	38.8	51.6	49.7	59.1	62.3	48.8	59.9	59.7	36.0	67.3	31.2	172.8	57.4	57.4	73.8	31.7	26.5	33.1	67.5	43.8	58.6	37.3	41.0	24.7	47.0	66.2	65.4	67.1	35.7	40.5	38.2	0.7	1.8	1.3	3.3	1.7	4.1	2.0	2.6	2.7	2.3	2.1	1.9	2.1	0.0	1.8	4.1	2.7	2.6	1.9	9.5	11.6	10.3	10.1	8.9	9.4	11.6	10.6	10.0	9.2	11.8	13.4	12.0	9.6	17.9	0.0	11.2	0.0	6.8	0.0	9.6	14.1	11.9	13.6	0.0	12.8	9.3	22.0	10.4	14.2	12.0	8.1	1.9	15.6	1.9	9.0	14.1	10.5	3.6	16.2	0.0	15.9	38.2	10.5	25.5	14.9	5.1	25.7	10.4	24.6	11.2	16.8	0.0	11.4	0.0	9.1	0.0	3.5	14.3	8.9	0.0	0.0	11.1	9.0	7.2	0.0	0.0	18.6	8.6	12.8	17.7	15.7	11.1	9.1	2.9	12.1	6.6	16.4	8.9	8.8	20.8	14.1	0.0	14.6	10.1	14.3	11.7	15.8
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081945-81096395	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 553.4;Extravillous trophoblasts: 1476.4;Proximal tubular cells: 655.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	28.7	20.1	58.9	6.9	66.5	6.3	24.2	62.9	113.8	18.2	50.8	16.0	7.2	17.5	68.9	15.5	19.8	11.7	38.1	55.8	60.9	78.2	118.9	10.8	6.7	60.1	66.0	18.4	19.7	31.0	14.3	26.0	61.1	18.7	13.0	15.6	15.6	16.7	59.3	10.1	9.5	11.8	61.7	6.3	17.5	7.4	63.7	10.4	96.4	63.6	9.3	18.3	15.2	67.8	63.6	28.3	82.4	37.0	40.4	30.9	175.5	35.9	26.4	43.3	20.6	37.0	57.2	17.2	32.3	15.9	31.9	33.3	64.5	36.5	71.6	4.7	86.7	21.8	34.9	114.6	45.7	70.3	24.1	32.0	47.8	26.8	53.7	13.0	22.3	45.1	86.3	3.4	42.9	67.7	45.9	138.8	113.0	49.6	57.5	72.7	44.1	25.5	98.4	56.4	43.7	45.3	53.3	32.9	70.8	63.9	48.3	33.2	19.8	27.6	49.3	44.0	37.8	14.7	31.8	102.1	18.2	41.3	22.6	3.6	1.3	1.3	2.8	2.1	4.6	3.5	2.6	4.0	3.9	2.5	4.4	5.9	1.7	7.0	1.7	10.8	2.2	2.4	58.9	66.5	62.9	113.8	55.8	60.9	60.1	66.0	61.1	61.7	63.7	67.8	31.1	3.2	5.9	16.3	24.8	29.1	94.6	73.6	52.3	43.7	97.9	115.6	12.9	44.3	31.4	80.9	37.5	553.4	13.8	15.3	295.4	70.0	32.4	34.8	128.3	31.9	26.4	71.1	12.6	42.5	1476.4	61.6	31.1	55.2	36.3	38.5	33.2	352.0	118.8	38.7	11.9	34.3	67.1	19.7	34.6	19.5	140.8	18.8	85.4	4.7	17.7	215.8	19.6	19.6	35.2	42.3	17.8	141.1	51.7	123.9	13.7	655.9	20.0	45.7	32.9	46.2	50.2	20.7	77.3	78.4	27.1	228.8	16.3	114.5	49.4	69.8
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300197-47313577	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.6;retina: 18.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	12.4	3.2	5.4	0.3	5.4	0.0	9.7	5.1	4.0	2.6	0.6	2.5	0.0	4.2	0.2	2.4	1.6	2.2	4.4	5.9	3.3	0.1	0.1	19.6	0.8	2.6	5.8	0.3	13.3	0.0	0.7	0.0	1.4	2.2	0.3	18.4	8.8	0.2	2.2	3.1	0.6	0.4	2.5	0.1	1.8	7.1	5.5	0.4	9.7	10.4	1.0	1.3	1.7	3.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.4	5.1	4.0	5.9	3.3	2.6	5.8	1.4	2.5	5.5	3.7	2.4	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.0	20.9	0.1	0.0	0.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.2	25.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	2.6	0.7	0.9	0.2	1.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.6	1.6	0.4	1.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 371.8;urinary bladder: 175.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	960000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	34.8	11.7	1.3	1.5	1.4	0.4	24.9	1.0	2.3	18.9	40.9	29.2	4.5	13.6	2.2	4.8	5.5	19.9	4.5	4.3	1.3	371.8	88.6	46.9	0.6	2.0	1.7	4.7	112.3	25.9	12.3	86.9	1.5	105.3	24.4	1.2	12.5	4.6	5.5	6.4	12.3	1.9	1.2	11.4	75.5	1.6	2.5	0.3	11.2	0.5	1.7	175.4	19.2	1.6	1.8	95.6	9.4	3.5	22.3	18.5	416.5	33.1	17.9	1.2	18.8	4.2	29.6	0.4	58.8	3.0	97.0	0.7	0.0	12.2	4.7	0.2	2.2	0.9	9.2	225.5	564.9	0.1	35.7	48.8	140.1	90.7	58.6	0.7	99.5	0.0	152.4	0.7	22.9	23.5	0.1	0.8	5.4	34.4	52.5	0.2	3.7	0.2	69.9	94.6	0.9	1.0	0.4	5.5	127.9	35.1	2.6	0.4	213.1	0.0	7.4	1.8	1.5	1.5	4.0	0.4	51.9	0.1	27.8	0.0	0.7	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.1	1.3	1.4	1.0	2.3	4.3	1.3	2.0	1.7	1.5	1.2	2.5	1.6	6.6	35.3	62.4	0.0	1.8	1.3	350.6	366.1	0.0	0.1	54.2	15.5	0.7	47.1	1160.8	259.3	0.0	60.6	0.4	176.0	33.2	316.9	0.0	166.8	35.4	31.9	84.8	0.0	0.1	381.9	263.4	52.9	224.8	261.8	29.2	0.2	2.5	7.0	33.8	0.0	0.1	357.6	453.7	1.6	3.7	0.0	0.9	14.1	3.6	0.0	9.9	0.5	1.0	0.0	0.0	440.4	146.6	1.5	1.3	780.2	22.9	85.7	681.4	0.6	0.0	9.5	46.7	0.7	0.5	1.3	1.7	4304.7	5.5	3.4	291.0	3294.2
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322454-47327588	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Angiogenesis	"Cytokine, Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"liver: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	NA	NA	2210000	740000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB023357: AB_2111086"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.2;Basal prostatic cells: 1.0;granulocytes: 1.3"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.6;BJ hTERT+: 5.4;GAMG: 9.4;HHSteC: 5.8;HSkMC: 14.4;U-87 MG: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA015648	Uncertain				"Secreted to blood"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	0.9	0.1	0.1	0.0	0.4	0.0	0.6	0.1	0.3	0.3	0.3	1.6	0.0	0.4	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.3	0.0	2.3	0.0	0.2	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.9	0.1	0.0	9.9	1.2	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.6	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.3	17.6	0.1	2.8	5.4	0.4	1.0	0.0	0.0	0.0	0.0	4.5	9.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	14.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.4	0.2	0.1	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 438.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Cytosol		NA	NA		31000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498"	"prognostic unfavorable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	77.3	85.9	351.5	54.9	381.7	41.2	67.4	309.6	438.5	99.7	214.0	91.8	36.7	92.2	46.2	57.5	94.6	47.3	99.1	391.8	349.9	74.4	53.9	90.1	53.9	344.5	312.7	120.0	54.7	63.4	176.0	60.4	349.5	74.9	41.7	130.9	49.7	69.5	62.9	61.6	67.5	78.9	311.4	89.4	68.5	54.1	330.6	58.7	63.0	70.8	51.1	89.2	81.2	366.2	100.2	88.9	195.9	164.6	77.7	91.4	64.5	149.6	91.1	140.4	146.0	52.6	51.1	79.5	149.3	139.4	213.2	79.7	172.7	83.9	96.5	147.5	93.8	25.0	142.6	35.5	113.5	24.6	90.5	94.7	101.3	163.4	99.6	154.6	92.4	95.7	31.1	120.5	169.4	99.2	77.9	62.1	53.0	106.1	168.8	77.6	51.6	45.0	98.8	46.5	272.5	210.3	67.6	86.1	109.0	150.3	50.9	42.5	110.4	131.9	116.8	138.4	212.0	182.1	202.0	128.3	140.7	54.5	162.5	23.7	8.4	26.9	12.1	12.6	18.0	9.9	13.0	12.0	7.0	10.1	10.0	10.1	30.0	8.7	21.3	12.1	16.2	7.3	351.5	381.7	309.6	438.5	391.8	349.9	344.5	312.7	349.5	311.4	330.6	366.2	39.3	16.0	27.4	30.3	35.9	27.1	24.8	48.3	33.6	71.3	24.1	25.7	62.6	24.3	29.0	27.6	25.0	22.7	27.0	31.4	31.3	39.4	2.9	33.1	41.1	35.3	90.8	9.2	48.8	31.3	39.3	37.5	37.8	34.3	33.7	29.7	30.4	17.7	36.3	60.6	43.2	24.8	65.1	35.9	40.9	6.0	37.6	35.5	17.8	22.5	59.0	37.7	19.6	33.2	46.4	50.2	25.9	39.9	35.7	27.4	24.3	25.5	46.8	37.1	52.6	29.5	49.8	33.9	66.6	20.7	30.3	49.5	43.2	22.0	15.0	26.2
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported		Approved	Cytosol		NA	NA		53000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA049290: AB_2680700, HPA057668: AB_2683498"	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	125.1	111.5	62.4	151.6	70.0	126.6	138.1	76.0	90.3	120.6	66.8	152.9	175.4	96.3	115.3	131.1	96.8	112.6	86.8	59.3	70.7	146.0	241.1	98.3	217.5	85.8	72.7	116.9	165.1	91.3	59.6	135.5	82.6	88.8	160.7	69.1	97.7	92.2	107.0	107.6	160.2	124.1	80.9	138.7	108.6	74.3	65.1	149.1	114.1	99.7	239.2	145.5	81.7	95.4	343.4	245.8	341.1	241.2	298.2	347.5	191.4	325.0	170.8	287.3	312.0	351.8	287.3	553.2	198.2	340.5	88.1	320.8	368.3	289.3	288.0	212.2	174.7	380.0	152.0	428.4	276.9	252.1	230.7	292.6	235.8	249.6	148.9	324.0	400.6	340.1	398.5	203.4	331.6	291.1	390.9	208.0	242.5	355.1	159.3	466.7	181.9	389.8	330.7	250.1	138.0	210.0	257.5	468.5	358.3	289.9	382.3	299.0	342.0	142.3	243.4	420.3	282.2	180.0	314.8	526.5	212.0	275.5	130.0	154.9	280.8	169.0	109.9	347.8	136.4	210.7	136.9	121.6	329.1	204.2	124.8	119.3	138.4	177.5	445.1	146.1	181.5	416.8	62.4	70.0	76.0	90.3	59.3	70.7	85.8	72.7	82.6	80.9	65.1	95.4	101.5	25.6	83.8	31.0	208.1	161.7	131.3	144.8	145.7	37.1	124.5	81.8	76.6	107.2	109.0	57.0	18.8	252.1	148.5	156.6	133.1	185.7	29.5	69.1	138.0	125.4	118.4	177.1	27.7	212.2	312.0	151.5	109.6	84.3	132.5	121.7	121.3	145.9	284.5	92.5	32.1	184.7	91.6	354.2	302.8	40.4	152.2	255.7	149.4	36.5	485.8	75.0	97.9	34.7	49.2	158.1	141.9	141.8	151.3	129.2	271.0	194.1	63.0	36.8	111.7	96.1	125.8	126.2	119.3	177.6	165.1	247.4	120.1	136.9	213.5	131.9
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744421-753999	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA065699: AB_2685534, HPA067891: AB_2685918"	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	12.4	7.7	3.0	8.2	3.0	15.5	12.3	10.5	6.2	13.4	5.9	9.5	8.0	12.1	5.7	14.8	12.3	13.0	11.2	2.9	3.3	4.9	8.6	9.8	13.6	2.3	2.4	15.6	9.7	6.3	5.7	6.6	2.6	14.4	6.3	3.4	11.7	8.2	13.9	38.9	9.8	8.5	2.1	10.0	14.5	48.9	3.1	13.2	15.6	10.1	12.3	11.8	12.4	2.6	44.8	77.8	25.5	38.3	15.8	19.9	31.7	25.0	17.4	44.4	39.1	44.5	23.6	77.9	32.5	21.6	23.6	55.4	48.3	47.0	35.3	29.6	72.3	28.0	40.9	25.1	11.3	30.1	36.8	19.3	23.3	36.5	25.6	15.4	25.3	44.9	39.6	31.7	24.0	31.7	49.8	17.0	24.7	37.4	33.0	53.1	12.1	36.6	18.9	32.5	26.4	21.4	25.7	26.1	11.7	18.2	27.8	21.7	20.2	27.3	24.6	35.6	61.4	5.3	12.4	44.8	23.5	41.9	31.8	1.6	7.0	0.3	7.9	9.6	13.6	11.8	8.6	8.4	9.3	12.3	10.1	10.2	0.9	8.7	11.6	5.2	6.0	10.0	3.0	3.0	10.5	6.2	2.9	3.3	2.3	2.4	2.6	2.1	3.1	2.6	2.9	16.0	6.7	1.3	8.5	20.4	14.3	6.6	9.1	2.9	4.6	4.7	38.4	4.3	8.5	0.0	0.0	8.4	4.4	3.1	3.9	7.5	148.3	2.6	3.9	5.8	1.2	3.0	1.2	6.4	8.3	6.4	7.7	2.9	1.3	11.1	4.6	5.2	5.4	5.0	1.5	7.0	8.2	3.9	5.7	157.2	11.5	2.6	5.4	1.0	4.8	2.4	2.1	0.0	0.5	8.4	1.8	6.8	4.3	7.4	2.3	2.2	4.4	1.4	0.0	6.2	6.4	57.0	11.2	8.7	16.1	4.0	3.2	7.4	8.7	9.8
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 13076.3"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.9	1.8	5096.2	2.2	5407.4	14.1	3.5	5902.8	4887.4	1.9	2342.2	1.4	0.4	0.9	1.5	3.7	2.2	1.6	8.2	5059.3	9869.7	2.1	1.7	1.3	1.9	13076.3	9001.4	2.1	1.5	1.6	33.9	0.7	9204.1	1.3	1.0	117.7	1.9	1.0	2.1	2.6	0.7	0.9	10040.2	1.5	1.5	1.4	8068.5	0.4	1.7	0.3	1.1	1.4	0.9	10496.9	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	5096.2	5407.4	5902.8	4887.4	5059.3	9869.7	13076.3	9001.4	9204.1	10040.2	8068.5	10496.9	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 414.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020735, HPA029914"	Approved					NA	Yes		2100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	58.6	25.6	18.1	28.4	20.5	22.4	44.8	16.9	24.4	19.2	19.5	38.6	31.3	17.3	105.2	51.7	24.4	25.9	13.0	20.0	18.3	31.9	35.6	16.6	27.8	18.0	18.1	15.5	23.3	43.5	15.9	34.8	17.3	24.9	39.4	10.7	33.4	15.9	16.9	56.5	26.6	21.2	17.3	16.0	22.7	12.1	19.7	21.9	19.3	20.8	32.2	33.1	31.2	17.8	194.0	50.0	79.4	107.7	32.6	58.8	92.5	64.6	25.1	60.5	72.4	66.6	66.1	123.7	42.0	24.3	68.9	238.8	84.1	67.8	78.6	24.0	93.1	87.7	104.6	88.6	42.6	150.1	65.4	57.6	53.4	63.4	81.0	20.9	62.1	58.7	126.8	69.4	48.6	108.6	91.4	202.1	115.6	198.3	79.5	90.1	91.9	123.8	59.5	174.0	100.3	101.2	58.0	355.9	73.5	102.8	228.7	140.7	37.7	39.6	75.6	75.6	128.6	50.8	129.2	96.7	30.9	201.4	75.9	10.4	19.9	7.0	14.1	20.4	19.9	22.7	18.8	18.4	34.2	17.2	17.8	17.4	1.1	25.0	12.2	30.0	26.1	17.2	18.1	20.5	16.9	24.4	20.0	18.3	18.0	18.1	17.3	17.3	19.7	17.8	37.9	16.0	39.4	10.1	25.1	77.0	50.1	96.0	60.3	23.4	107.0	109.5	51.6	24.3	67.0	44.1	4.2	414.7	21.8	56.9	123.3	99.8	29.2	129.6	40.4	46.3	28.3	53.0	26.0	80.1	167.7	41.4	44.9	103.8	27.3	53.5	33.5	51.4	129.8	33.7	10.1	90.1	67.1	44.5	57.4	10.0	24.8	42.8	62.2	12.2	36.2	32.2	24.7	8.5	8.9	60.1	50.6	39.1	33.4	68.8	60.6	188.4	69.4	15.1	26.3	25.2	45.1	63.3	46.7	147.0	74.7	135.6	26.7	67.7	138.0	69.6
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63014881-63039407	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.7;liver: 188.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 510.3;Early spermatids: 471.0;Extravillous trophoblasts: 273.4;Proximal tubular cells: 340.8;Syncytiotrophoblasts: 754.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 30.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 30.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	NA	NA		1200000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	9.8	5.4	11.1	14.2	11.1	43.7	16.5	10.7	14.3	5.9	13.1	54.3	11.3	6.3	4.4	20.7	3.5	4.3	3.1	11.1	12.3	125.7	188.6	8.0	10.9	13.3	11.1	3.1	9.9	13.1	1.9	54.9	13.7	4.4	74.4	2.1	13.0	3.7	2.1	27.2	9.9	11.6	10.1	5.5	8.2	33.9	14.4	17.8	2.4	3.2	22.5	8.5	10.8	11.1	110.5	97.6	97.4	15.7	94.1	39.6	69.6	64.3	105.1	94.2	137.7	144.5	183.8	69.8	18.0	77.1	166.8	87.2	97.2	101.9	138.9	139.0	71.6	112.3	50.3	105.1	17.6	53.5	65.9	29.1	29.2	93.9	50.7	59.4	116.1	66.9	62.4	255.2	177.3	64.3	28.8	71.1	51.0	231.6	86.0	77.6	95.2	98.1	75.8	40.3	38.6	69.9	91.8	103.6	98.5	91.6	116.6	65.8	65.5	104.2	115.6	99.4	111.3	112.6	127.2	88.3	158.0	0.1	185.0	0.0	2.1	2.3	1.1	1.7	0.8	6.5	1.5	1.7	0.9	2.7	1.8	1.9	3.0	4.4	2.0	30.6	2.7	1.9	11.1	11.1	10.7	14.3	11.1	12.3	13.3	11.1	13.7	10.1	14.4	11.1	13.1	16.0	7.3	11.1	26.1	30.2	23.2	66.6	9.1	2.0	14.9	21.0	3.2	17.2	31.1	22.0	0.0	510.3	11.7	49.2	37.2	19.7	471.0	5.4	11.5	13.1	13.2	62.5	11.5	7.4	273.4	27.2	11.7	7.6	10.8	21.4	13.6	219.5	72.4	0.0	8.7	70.7	44.7	21.0	15.5	154.2	5.9	12.0	24.9	1.0	32.1	23.1	2.1	3.5	2.9	4.3	23.7	8.2	106.9	10.5	4.3	340.8	18.3	1.3	26.3	12.8	20.4	80.3	133.0	35.9	43.0	754.5	8.5	9.3	102.0	23.1
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 212.7;Late spermatids: 290.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.0	23.5	20.4	17.3	21.4	7.8	34.1	23.0	27.6	24.5	18.5	24.8	21.2	23.3	30.4	22.4	21.2	20.0	23.5	21.1	22.5	27.8	21.7	20.1	21.3	21.8	20.6	23.3	16.4	21.1	17.6	19.2	22.3	29.4	23.9	38.8	31.2	19.7	29.8	20.3	20.6	25.7	22.3	20.5	20.4	48.2	20.9	27.6	27.4	28.9	21.9	23.6	17.0	25.7	41.3	22.3	54.5	41.5	41.7	59.9	20.5	36.2	50.7	23.6	33.1	17.5	64.5	28.1	51.3	40.6	38.1	33.5	29.4	37.8	31.2	28.8	54.4	24.0	19.7	29.9	46.9	30.0	19.7	39.3	66.5	32.2	43.0	41.8	42.5	46.2	58.5	24.7	31.5	24.6	37.0	35.7	46.4	109.9	11.5	22.6	17.3	32.6	66.2	22.4	43.3	59.8	27.3	61.5	54.7	20.1	76.7	46.5	35.9	27.9	20.8	47.6	34.7	42.0	55.8	34.3	35.4	33.3	51.4	43.7	31.0	48.5	31.5	37.3	32.1	38.6	39.5	33.8	30.4	32.8	36.2	33.4	27.8	31.9	54.2	25.2	42.5	36.8	20.4	21.4	23.0	27.6	21.1	22.5	21.8	20.6	22.3	22.3	20.9	25.7	18.3	32.1	34.5	16.3	27.2	39.9	60.4	64.6	27.9	32.1	29.1	22.4	24.5	17.2	39.5	20.2	43.8	30.7	24.1	21.4	72.4	37.5	212.7	16.8	15.1	29.4	17.4	12.0	26.5	28.3	43.7	31.0	14.3	12.9	24.6	16.4	28.9	13.0	26.8	48.8	25.7	26.1	69.2	26.9	49.0	290.7	35.8	24.3	67.6	20.6	36.7	55.4	36.0	15.6	23.2	31.8	23.3	35.0	8.5	65.6	29.3	61.3	30.4	51.2	26.3	26.1	32.5	111.6	50.0	18.7	40.6	47.1	33.0	30.9	22.7	55.9
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	15.7	32.9	14.3	10.1	15.2	11.8	15.8	15.1	16.2	18.6	15.2	15.3	15.8	15.1	11.0	8.8	15.9	10.6	12.3	13.9	15.8	24.5	18.6	15.9	13.2	18.3	15.7	22.2	26.4	12.8	16.7	9.3	16.7	20.7	5.3	3.8	24.1	14.2	7.8	9.8	19.4	5.3	15.0	32.2	19.5	5.9	15.5	7.4	26.8	5.7	6.5	15.5	13.3	16.3	7.5	26.1	1.8	20.5	6.8	6.0	16.1	9.9	7.7	5.0	6.5	8.4	35.4	11.4	34.9	9.2	6.1	0.6	5.8	0.2	1.2	18.8	21.1	17.3	11.9	18.0	17.7	13.9	70.4	9.1	5.3	13.7	4.2	6.1	7.8	6.9	16.8	50.0	2.6	9.2	9.0	27.1	4.4	28.1	0.0	8.7	9.5	49.8	13.8	6.0	4.0	13.9	0.3	46.1	34.4	0.4	31.8	22.0	6.7	23.3	9.2	20.4	4.7	37.3	31.3	7.7	19.7	17.3	9.6	0.8	3.2	1.8	2.3	3.0	1.0	2.5	1.5	2.3	2.7	4.1	1.5	1.8	1.6	1.1	4.1	2.4	1.4	2.6	14.3	15.2	15.1	16.2	13.9	15.8	18.3	15.7	16.7	15.0	15.5	16.3	16.2	0.0	9.6	4.9	9.9	2.9	9.3	8.8	2.2	7.6	8.8	7.1	2.1	14.3	6.7	16.5	6.2	13.1	8.7	5.1	3.9	12.9	1.0	5.6	8.5	12.6	13.8	4.6	2.6	19.3	11.6	10.0	6.1	8.9	13.3	6.5	28.5	15.3	27.9	8.4	4.3	10.7	8.2	25.5	5.4	1.3	11.5	12.6	8.8	2.8	9.3	16.2	13.4	1.0	3.5	10.3	4.8	13.9	4.7	6.5	25.6	16.5	7.8	5.5	0.0	12.8	6.3	2.8	0.5	2.2	1.8	7.3	9.5	15.9	9.4	5.4
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285666-10292947	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"stomach 1: 356.1"	"Cell type enriched"	"Detected in many"	52	"Gastric mucus-secreting cells: 1123.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	350000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	0.5	0.5	3.5	3.1	4.1	4.4	1.5	4.0	7.6	0.5	3.0	2.2	19.0	0.7	4.8	1.8	0.7	2.3	1.3	3.3	2.8	0.9	1.4	1.0	7.4	3.2	2.8	1.3	4.1	0.7	0.7	0.5	3.5	1.0	0.6	2.0	1.4	0.3	2.0	2.1	3.1	0.9	2.0	2.5	356.1	1.1	2.7	1.3	1.3	0.2	3.1	1.4	0.5	2.9	0.6	0.2	2.6	2.0	1.8	0.0	4.8	2.4	0.0	0.7	0.2	2.9	0.5	1.5	0.9	0.1	2.1	0.4	0.0	0.6	0.0	0.4	2.9	3.1	2.1	6.3	0.0	3.2	5.3	0.3	0.0	0.0	0.1	0.2	0.5	1.9	1.3	14.4	0.0	0.7	1.2	4.3	1.3	0.5	5.3	0.8	0.2	0.8	0.0	2.4	1.9	0.3	1.6	1.1	0.1	1.7	1.1	3.8	2.6	1.2	0.7	1.1	1.7	1.7	2.6	2.9	0.4	3.5	0.5	17.5	11.0	12.4	0.2	5.5	0.1	2.1	0.2	0.0	41.8	1.0	0.3	0.1	25.7	4.4	0.4	28.5	0.2	3.8	3.5	4.1	4.0	7.6	3.3	2.8	3.2	2.8	3.5	2.0	2.7	2.9	0.6	0.0	1.1	1.3	4.9	1.3	4.6	0.2	0.0	7.8	0.8	0.6	0.3	0.0	0.2	1.8	10.4	1.7	10.5	0.5	0.0	1.0	0.3	0.2	0.7	1.5	0.0	0.0	1.0	1.3	1.5	1.0	1123.8	0.8	0.0	0.6	1.8	0.1	1.8	3.3	0.6	0.1	0.0	3.8	8.8	1.0	0.3	5.7	1.8	2.8	7.4	2.2	21.6	0.0	0.7	0.9	0.1	0.4	0.7	4.9	1.5	0.2	0.2	9.1	6.6	4.0	0.9	1.7	1.3	0.0	0.6	0.3	4.0	0.7	0.8	2.2
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	209	"intestine: 259.5"	"Cell type enriched"	"Detected in single"	4	"Intestinal goblet cells: 1.9"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 6.6;BEWO: 5.9;Hep G2: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900	540000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	259.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.7	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.5	5.9	0.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	9.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573475-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 97.8;Late spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"		NA	NA		36000	"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	30.2	13.5	79.4	18.0	89.3	14.4	29.9	29.1	122.3	22.0	14.9	20.5	17.9	20.9	7.6	28.6	22.5	15.5	28.9	101.2	38.0	18.4	7.6	34.8	21.3	42.5	45.3	21.3	21.9	18.0	23.7	21.1	39.7	21.3	10.1	12.1	19.0	14.4	31.9	34.2	20.5	12.9	31.7	22.3	19.1	88.8	51.8	23.1	23.2	18.5	15.2	21.6	23.6	62.1	49.7	80.9	39.1	69.9	30.4	19.1	45.3	23.9	23.4	28.2	25.1	33.1	18.0	37.3	37.3	31.5	50.5	79.5	41.6	61.4	14.4	48.3	49.7	26.9	39.8	29.8	37.0	34.4	21.3	23.4	69.2	32.4	50.5	40.0	53.0	48.6	22.3	31.2	20.5	50.9	109.0	45.7	29.2	49.9	19.2	81.7	52.3	55.6	25.8	26.7	82.0	70.0	33.8	77.2	117.7	27.9	38.0	45.0	66.2	26.7	38.2	59.3	49.0	25.8	39.3	41.5	43.9	29.0	45.9	0.1	1.6	1.4	1.9	2.5	0.9	0.7	1.9	2.1	2.2	0.6	1.6	1.1	0.5	2.4	1.8	1.8	1.3	1.8	79.4	89.3	29.1	122.3	101.2	38.0	42.5	45.3	39.7	31.7	51.8	62.1	54.6	3.2	1.5	21.9	9.5	27.1	6.7	9.2	10.2	15.5	12.6	16.3	8.7	4.3	4.9	5.5	10.4	5.1	17.3	19.2	1.9	7.5	97.8	9.4	16.8	30.8	14.9	1.7	16.8	9.4	8.0	9.7	11.2	10.5	1.3	17.9	22.5	4.0	8.3	11.8	14.1	13.8	8.2	9.5	18.9	99.2	14.3	10.6	8.8	15.9	7.4	13.3	9.2	12.5	16.9	9.5	11.5	10.5	8.7	13.4	17.2	6.1	9.8	10.2	13.1	17.3	9.5	30.5	11.5	14.4	28.1	3.6	12.4	8.6	14.6	8.3
GIT2	"KIAA0148, PKL"	ENSG00000139436	"GIT ArfGAP 2"	Q14161	12	109929802-109996389	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004681	Approved		Approved	Microtubules		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Microtubules		"CAB004681: AB_425820"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.41e-2)"	16.6	18.0	12.1	25.5	18.1	60.2	13.0	20.3	17.0	14.0	9.8	15.0	11.2	14.1	10.8	11.5	12.1	15.4	17.4	16.4	12.1	11.7	11.8	16.9	33.1	16.2	13.9	17.8	17.2	14.1	13.8	22.9	16.5	12.8	13.8	9.1	13.5	12.8	14.7	13.1	19.0	19.8	12.1	36.0	10.7	13.9	15.3	37.0	16.4	15.6	32.1	16.3	12.8	16.2	20.6	24.6	16.6	18.4	28.6	26.3	11.9	42.1	41.3	37.0	23.2	12.5	10.8	49.8	16.3	51.7	14.6	14.9	14.5	18.8	38.1	42.1	14.3	32.7	15.0	14.6	18.1	47.7	49.6	22.0	17.4	34.9	18.7	34.0	39.5	28.5	17.2	12.4	46.0	13.1	42.0	66.4	11.7	11.7	17.7	34.5	41.7	27.9	18.2	17.1	10.1	14.9	27.1	12.5	16.6	17.0	17.9	39.3	37.3	25.0	12.6	20.0	22.0	25.0	22.8	49.3	21.5	34.9	21.2	85.6	76.4	172.9	42.7	72.0	41.6	42.4	42.3	43.9	74.7	49.4	36.0	32.2	165.1	49.3	71.3	30.6	46.5	63.7	12.1	18.1	20.3	17.0	16.4	12.1	16.2	13.9	16.5	12.1	15.3	16.2	26.3	19.2	15.3	24.8	44.8	9.6	6.4	11.3	11.4	24.7	10.8	10.0	7.8	14.3	12.2	27.6	8.4	13.1	37.7	9.9	3.9	16.0	6.5	7.6	16.9	24.0	7.8	19.4	73.2	14.0	11.3	15.3	14.8	11.1	14.5	36.1	24.7	13.7	35.1	33.7	82.2	6.7	8.2	65.5	32.0	5.2	18.6	45.1	14.2	66.5	64.5	9.3	61.8	28.6	39.8	18.4	8.6	19.9	26.1	4.3	22.8	7.2	12.4	18.7	13.1	29.4	14.5	36.1	20.1	11.8	11.4	6.2	36.5	19.1	9.9	7.4
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406361-79408228	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	306	"testis: 89.5"	"Group enriched"	"Detected in some"	92	"Early spermatids: 589.0;Late spermatids: 163.3;Spermatocytes: 194.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"SCLC-21H: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060687	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA060687: AB_2684343"															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	89.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	589.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980980	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1840	"stomach 1: 37425.0"	"Cell type enriched"	"Detected in some"	28	"Gastric mucus-secreting cells: 9780.9"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		18000000		"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	3.0	1.8	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	0.0	1.4	0.0	0.3	0.0	3.6	0.4	0.0	1.0	0.0	0.0	1.8	0.8	3.5	0.0	0.0	0.0	0.4	4.8	0.0	0.3	20.3	0.0	0.7	0.3	0.0	0.4	0.1	1.0	0.5	0.4	0.0	0.0	10.4	37425.0	0.4	0.0	1.1	0.2	0.2	0.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.4	0.0	16.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	10.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	3.3	9780.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.5	0.0	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.0;Microglial cells: 76.8;Oligodendrocytes: 154.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 2.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		240000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	9.1	12.2	6.7	5.6	7.8	0.9	8.9	35.8	6.2	8.2	8.4	12.8	14.2	6.4	6.9	10.0	5.5	7.5	6.3	6.0	6.7	13.3	16.8	8.4	3.5	5.7	8.5	12.7	4.7	8.7	6.4	13.4	7.2	5.8	14.2	13.2	10.9	5.8	4.1	10.4	11.5	7.0	7.5	4.4	9.1	3.9	8.8	4.9	4.1	4.9	5.1	6.6	4.6	8.0	9.6	8.5	5.6	9.7	18.6	17.6	2.0	17.6	23.2	13.3	25.2	7.1	23.6	5.8	8.5	14.4	16.8	14.0	12.1	11.4	27.1	2.2	13.4	9.7	15.0	7.2	17.9	4.2	19.0	12.1	7.8	16.6	18.6	9.7	119.4	4.3	3.9	6.0	25.4	5.9	2.6	7.4	2.7	9.7	5.9	5.8	22.6	7.3	12.3	10.1	17.9	3.7	18.0	11.0	38.1	3.8	7.9	5.8	41.8	12.7	15.7	14.3	15.8	2.5	3.7	1.3	12.9	7.0	18.8	0.0	2.1	0.0	0.3	1.6	0.5	0.2	0.8	0.4	1.8	0.2	0.5	0.7	0.0	0.2	2.3	1.9	2.0	0.9	6.7	7.8	35.8	6.2	6.0	6.7	5.7	8.5	7.2	7.5	8.8	8.0	16.9	0.0	15.4	4.9	6.2	4.8	10.1	8.3	26.2	10.3	18.8	19.4	8.1	7.2	8.8	11.0	10.4	22.7	12.1	21.3	5.9	13.0	3.9	4.0	5.4	22.6	20.4	9.4	79.0	13.8	12.7	14.0	28.1	4.9	2.5	11.8	16.4	27.2	16.4	8.4	41.5	27.1	10.2	13.3	4.4	5.1	6.2	10.7	8.8	76.8	13.7	13.1	4.1	35.7	154.9	16.9	28.2	17.7	7.1	5.3	32.4	18.3	18.2	16.6	13.1	6.6	9.4	29.8	25.9	27.9	6.5	33.0	5.9	17.1	26.4	13.3
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1443.6"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	753.5	76.0	694.3	156.9	746.5	232.9	573.5	717.5	1237.1	161.4	583.2	157.8	24.4	116.7	115.7	218.7	224.3	105.4	129.7	676.6	764.7	65.3	280.7	221.7	75.2	891.0	783.7	303.0	204.7	32.3	70.5	176.6	767.0	103.4	92.5	891.1	233.5	96.0	1443.6	231.4	148.2	124.1	725.0	216.4	648.2	87.1	811.4	97.0	257.4	472.0	103.2	185.5	292.0	810.4	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	694.3	746.5	717.5	1237.1	676.6	764.7	891.0	783.7	767.0	725.0	811.4	810.4	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 224.7;Hofbauer cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 30.9;dendritic cells: 39.6;monocytes: 40.4"	"Cell line enhanced"	"Detected in all"		"BEWO: 207.1;HBEC3-KT: 291.8;hTCEpi: 287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		19000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	17.4	20.5	29.3	30.0	39.7	20.6	28.0	38.9	31.1	30.8	17.9	19.7	15.8	15.1	30.8	56.2	15.4	23.4	26.2	27.1	34.3	11.4	24.8	39.0	61.4	42.6	37.9	21.3	14.9	28.3	6.6	57.9	44.3	21.1	26.3	11.7	17.0	17.9	7.2	81.8	16.3	20.0	39.0	36.0	15.8	11.6	36.2	72.3	13.0	10.5	77.9	40.3	49.5	46.7	22.3	14.8	15.1	71.7	98.0	48.2	207.1	35.0	75.1	19.0	25.6	30.3	26.1	71.9	35.1	26.9	51.1	60.0	16.7	291.8	27.2	41.4	10.5	11.7	16.8	37.9	23.7	19.1	117.1	65.4	287.0	24.4	16.4	26.0	27.6	85.1	11.4	30.7	30.1	9.6	38.4	18.0	10.2	11.4	32.3	17.7	7.1	46.3	18.4	43.3	3.9	13.4	29.1	133.0	58.3	52.0	30.7	22.5	24.6	46.0	17.6	38.3	10.6	75.2	96.8	187.0	53.1	30.1	19.4	7.6	40.4	2.4	3.7	13.6	2.7	30.9	4.3	3.9	39.6	29.8	6.1	4.8	8.7	4.4	3.4	28.0	5.4	18.6	29.3	39.7	38.9	31.1	27.1	34.3	42.6	37.9	44.3	39.0	36.2	46.7	5.8	16.0	23.0	5.5	25.0	14.9	18.5	63.2	26.7	5.8	5.4	15.5	30.9	0.0	29.7	18.4	2.1	53.6	8.3	4.4	1.9	7.2	0.5	5.7	6.8	7.3	3.6	5.0	2.2	8.1	224.7	10.2	10.7	7.7	69.6	16.3	8.6	24.2	100.8	6.7	2.7	5.4	10.2	55.7	32.5	1.6	8.1	67.8	8.8	2.8	52.5	8.0	7.2	3.5	9.5	6.0	4.7	13.9	28.8	6.7	6.2	5.4	19.9	3.7	0.0	7.9	6.9	1.8	4.2	45.6	23.9	52.5	5.6	6.4	6.7	36.5
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less 1, spermatogenesis associated"	Q96IK5	2	69829660-69881384	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 93.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039579	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	9.4	6.5	4.4	8.1	4.8	13.6	10.6	5.3	6.7	8.6	11.6	10.7	15.9	7.7	8.8	8.2	7.9	8.5	4.8	5.2	4.4	11.5	10.7	7.7	12.0	4.4	4.7	8.5	9.1	19.1	6.5	9.3	4.3	11.1	12.2	6.1	9.4	8.7	4.1	8.8	13.1	6.4	4.6	9.1	8.6	16.3	4.5	18.5	9.2	5.4	12.2	8.3	6.3	5.3	14.7	10.3	17.2	18.4	15.0	13.1	18.4	12.1	8.0	8.1	13.7	9.9	13.5	30.7	9.7	8.0	9.5	14.2	20.3	10.5	14.1	14.2	21.2	48.0	11.3	22.8	9.9	36.1	32.4	7.2	11.3	6.4	14.9	10.5	14.5	23.2	19.5	21.8	12.9	12.6	37.1	33.7	18.4	24.9	9.6	26.1	22.6	23.6	11.9	22.2	27.0	22.5	13.2	19.1	14.8	13.4	12.6	22.2	9.0	12.4	15.5	19.4	14.7	22.1	28.6	18.9	12.8	29.5	13.0	93.5	8.0	40.1	11.1	6.3	19.1	8.8	10.9	13.7	7.5	8.3	15.6	15.5	26.8	26.8	10.3	7.9	15.5	9.4	4.4	4.8	5.3	6.7	5.2	4.4	4.4	4.7	4.3	4.6	4.5	5.3	17.9	28.9	27.4	22.9	25.9	26.8	21.4	19.5	27.3	22.5	28.3	20.4	7.6	74.4	22.0	18.4	27.1	38.3	42.5	40.0	41.1	36.1	264.8	26.7	21.8	19.5	23.4	29.0	68.1	17.5	51.9	19.4	16.3	18.4	22.2	24.2	26.4	25.4	15.9	21.9	63.8	37.0	44.7	23.8	13.1	50.8	15.8	15.0	16.0	11.2	22.8	44.2	50.4	42.7	45.6	15.2	21.7	22.6	28.2	33.0	42.1	23.2	38.4	37.0	13.1	26.0	21.1	44.2	45.1	38.4	27.7	81.5	36.7	17.5	30.6	25.7
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668778-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	4.7	3.0	2.3	5.7	2.2	13.6	4.3	5.9	3.1	5.1	3.1	4.4	2.9	4.9	3.0	5.2	4.4	4.2	3.1	2.5	1.9	3.6	3.4	4.3	6.7	2.5	2.2	5.6	4.1	3.3	3.7	5.7	2.5	3.5	4.4	5.6	3.4	3.1	5.3	5.0	4.4	4.8	1.9	5.5	4.1	6.0	2.6	10.6	3.5	4.4	8.0	4.3	4.4	3.1	12.1	8.5	14.1	12.9	4.6	8.5	10.0	12.5	9.0	7.9	11.7	2.7	9.4	22.1	6.5	11.7	4.7	4.6	12.7	9.7	10.2	25.4	7.9	20.4	8.9	5.2	6.9	17.1	10.2	6.8	6.8	19.2	12.3	6.9	11.1	10.8	12.6	17.1	9.6	10.5	10.7	5.7	18.9	8.0	5.7	7.2	9.7	10.3	6.0	9.6	10.4	8.6	12.1	8.0	8.1	9.4	6.1	8.7	11.2	5.4	13.1	9.3	17.0	7.6	13.8	12.1	6.6	15.8	8.7	8.1	5.4	9.9	6.7	7.0	5.1	4.0	6.5	7.9	6.3	6.0	5.3	5.5	7.6	7.5	9.0	4.6	6.0	4.6	2.3	2.2	5.9	3.1	2.5	1.9	2.5	2.2	2.5	1.9	2.6	3.1	12.9	6.4	20.0	3.9	20.5	17.0	19.9	8.6	8.6	23.6	9.0	10.2	4.0	10.0	11.0	14.7	12.5	14.1	17.7	12.7	5.9	10.9	13.3	10.1	12.5	13.2	7.8	26.7	7.0	11.1	16.6	10.0	9.2	16.3	28.5	12.8	16.8	6.1	10.7	25.2	5.9	13.1	10.2	13.4	7.9	2.8	9.6	12.2	1.8	4.7	14.8	17.5	29.9	5.0	9.2	11.5	14.1	7.9	11.5	12.4	8.5	5.7	7.1	24.7	19.7	18.3	13.0	34.8	28.6	8.3	16.8	32.3	19.5	13.2	11.0	19.6
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489026	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	25.2	21.8	62.8	23.5	68.8	28.8	26.0	61.6	90.4	18.6	39.8	35.0	33.5	19.3	14.0	15.8	14.2	16.5	17.2	61.4	75.6	33.6	25.8	24.2	25.3	73.0	64.5	16.1	12.8	20.1	12.3	26.5	71.4	14.8	35.2	18.4	10.7	12.9	7.0	13.7	29.5	18.2	84.0	18.4	19.0	11.1	71.9	16.2	21.9	10.2	24.4	22.3	11.4	85.3	92.7	36.9	71.8	53.2	75.8	94.5	53.9	93.2	67.9	66.2	82.1	42.6	79.4	85.2	42.4	92.0	39.5	33.4	73.7	64.0	104.4	30.9	25.4	42.5	37.4	39.9	64.7	59.9	35.5	72.0	58.8	57.1	56.0	67.9	60.8	38.4	31.4	28.8	106.1	45.7	36.8	22.9	46.4	52.1	38.9	36.9	84.7	24.4	84.4	86.3	42.4	65.5	64.6	54.4	71.4	59.0	59.8	46.4	48.1	94.9	71.9	48.7	58.4	10.4	19.4	52.0	80.0	36.3	61.5	6.8	10.2	9.1	5.0	13.3	7.0	6.6	5.9	5.1	12.6	7.8	6.2	6.6	16.1	8.0	14.0	4.4	8.5	6.2	62.8	68.8	61.6	90.4	61.4	75.6	73.0	64.5	71.4	84.0	71.9	85.3	23.3	25.6	16.2	8.1	39.3	59.9	50.2	33.6	48.9	18.4	28.0	18.0	17.3	20.0	22.6	25.8	4.2	39.3	33.7	61.8	21.5	38.7	27.3	21.5	29.5	22.2	29.9	14.5	16.8	23.3	84.5	35.1	23.9	36.1	21.6	25.4	16.8	24.5	45.4	21.9	13.6	33.6	26.4	34.6	36.4	7.5	20.2	43.0	46.2	8.4	37.8	25.7	25.7	14.1	16.5	37.3	32.1	15.8	16.9	56.0	26.0	60.5	16.4	15.4	13.1	77.0	54.5	16.0	11.4	33.5	43.8	58.3	26.2	18.8	36.2	56.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Approved		Approved	Nucleoplasm,Nucleoli		No	No		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	45.0	92.1	24.5	19.7	25.7	19.3	44.3	25.8	30.2	44.7	28.2	44.2	30.9	38.2	29.9	38.7	44.9	32.0	39.6	24.8	25.7	70.1	56.0	38.8	26.9	26.2	25.6	51.2	49.0	67.7	48.1	22.7	26.8	41.7	25.5	18.8	41.8	26.3	40.6	35.2	45.8	21.2	26.0	55.9	50.7	21.9	26.1	28.4	58.4	19.8	27.3	43.1	40.3	26.2	27.1	34.2	29.0	26.7	50.9	74.7	40.0	32.1	59.2	47.3	55.7	38.8	24.6	34.7	22.5	49.8	25.5	43.6	42.4	69.2	69.5	19.0	25.5	24.3	25.0	159.1	46.8	53.7	51.4	72.2	54.9	23.6	47.7	61.1	69.7	52.3	12.5	33.3	46.6	51.8	50.1	57.1	34.3	39.5	37.3	33.5	24.2	22.6	69.1	52.7	22.0	36.2	16.9	45.8	52.6	39.5	38.6	41.1	36.2	23.0	15.8	32.0	20.6	59.4	63.1	21.8	16.6	38.9	20.2	24.3	34.2	15.0	19.7	27.5	21.6	13.7	21.5	23.7	35.9	15.9	19.3	20.2	56.0	14.9	27.9	15.8	31.5	26.5	24.5	25.7	25.8	30.2	24.8	25.7	26.2	25.6	26.8	26.0	26.1	26.2	25.2	25.6	18.7	10.7	23.2	11.0	44.5	49.9	27.3	19.6	24.8	32.9	12.5	38.6	35.7	53.3	4.2	67.2	22.6	35.6	101.8	43.6	18.3	29.6	16.6	26.3	10.3	20.6	7.8	33.0	48.5	18.8	17.9	20.0	31.7	29.7	16.8	24.8	50.0	18.5	8.0	19.8	30.5	46.6	14.6	10.5	28.9	32.5	21.4	9.4	32.1	43.3	25.7	7.5	11.7	33.7	32.1	25.2	21.2	19.0	50.2	123.1	43.2	19.7	26.3	16.0	24.5	19.8	10.3	20.7	10.7	49.3	24.6	51.3	28.4	30.5
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870650-155944020	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No		50000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	18.8	20.7	7.2	20.0	7.7	44.6	24.1	22.7	11.0	21.2	7.9	19.7	15.8	20.6	16.0	22.1	17.1	14.0	17.9	6.8	8.5	15.9	22.6	18.2	27.0	7.8	6.8	17.0	26.4	23.1	11.5	20.8	8.3	17.4	22.5	10.1	20.9	17.5	20.0	25.0	16.7	23.4	6.3	19.2	18.0	100.3	8.0	32.3	20.3	16.7	29.4	23.3	19.9	8.8	241.0	93.1	123.0	101.1	49.0	77.0	118.9	99.8	91.6	128.2	128.8	170.5	156.2	171.7	116.1	77.1	98.1	114.6	105.7	104.2	175.0	101.1	81.8	183.2	63.7	92.8	55.9	188.5	68.7	57.3	62.9	99.4	150.5	68.2	79.9	91.3	131.7	63.8	96.8	160.1	153.9	99.4	118.5	130.4	68.3	149.2	145.8	207.5	66.3	103.5	73.3	68.0	111.0	156.0	101.8	83.9	163.6	122.3	56.9	84.4	68.5	121.0	204.3	88.8	58.5	288.5	84.8	137.4	77.0	23.7	16.1	11.5	24.7	20.2	29.1	16.0	23.6	22.3	26.1	11.6	23.3	22.3	2.2	29.3	29.5	14.2	27.1	17.5	7.2	7.7	22.7	11.0	6.8	8.5	7.8	6.8	8.3	6.3	8.0	8.8	23.8	19.2	20.2	19.6	21.5	39.9	47.4	43.9	22.8	22.0	19.5	18.5	16.4	15.7	28.4	7.3	2.1	44.1	21.6	8.3	25.4	33.8	272.7	14.3	37.5	29.9	7.2	68.5	40.9	29.5	56.2	32.4	19.9	18.4	28.6	34.0	22.1	11.6	29.9	21.9	41.6	19.7	26.4	18.5	27.1	193.6	23.0	25.2	23.2	22.5	31.7	17.8	30.9	30.2	31.6	21.3	11.9	24.8	21.9	50.6	17.8	22.8	17.3	8.7	19.7	28.6	65.2	171.2	65.5	29.0	38.2	30.8	30.4	63.2	26.8	42.4
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 144.5"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.7	22.5	21.3	41.5	23.9	144.5	15.8	25.0	22.5	17.6	21.3	27.7	21.0	17.9	10.5	18.2	15.9	26.5	12.6	20.2	26.6	17.6	27.0	27.1	46.8	26.9	21.7	22.6	15.3	15.8	8.3	39.3	30.1	15.1	26.2	17.2	10.4	16.1	36.8	12.1	23.3	22.9	25.4	33.5	18.0	15.4	23.7	49.9	17.9	38.6	44.6	30.5	12.3	35.2	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	23.9	25.0	22.5	20.2	26.6	26.9	21.7	30.1	25.4	23.7	35.2	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136033-3163749	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.6;esophagus: 108.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8"	"Group enriched"	"Detected in all"	4	"cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 67.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043113	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA043113: AB_10967343"	"prognostic favorable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	6.8	3.1	4.0	12.4	3.8	75.6	4.6	4.0	7.3	13.3	4.7	2.5	1.7	1.3	0.4	108.8	2.4	4.6	1.9	4.1	4.1	2.0	1.4	13.1	4.2	5.4	4.5	0.8	1.2	0.4	1.4	7.6	5.1	11.6	1.8	0.1	19.5	2.5	0.6	50.8	2.5	3.1	4.9	8.8	4.3	1.4	6.6	32.0	1.2	0.9	12.1	28.1	41.6	6.4	44.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	18.7	0.1	0.1	0.0	0.1	36.2	0.0	65.4	0.0	0.1	0.0	19.1	0.1	0.0	0.0	27.2	152.1	0.0	40.0	0.2	26.2	0.0	0.0	16.6	0.1	0.3	0.0	0.0	162.4	59.8	0.1	2.9	0.0	119.3	0.0	0.2	0.0	23.6	0.2	0.0	4.6	0.2	0.2	0.0	0.0	62.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.3	29.8	0.1	19.4	29.1	14.3	0.0	21.8	1.1	0.0	2.0	0.3	28.8	0.0	0.0	0.0	6.9	4.4	15.5	67.1	8.7	13.3	4.0	3.8	4.0	7.3	4.1	4.1	5.4	4.5	5.1	4.9	6.6	6.4	1.0	9.6	8.8	0.0	2.2	67.2	141.5	65.5	9.1	0.2	7.4	3.7	0.5	0.0	39.0	3.7	0.0	0.5	27.6	0.5	0.0	0.7	0.5	1.4	0.5	3.1	6.6	21.0	1.3	0.0	0.8	2.5	3.6	3.9	34.3	0.0	0.7	0.0	66.5	0.0	0.4	2.2	57.0	36.2	190.6	0.8	0.0	78.3	21.4	7.5	32.0	0.0	0.0	0.0	0.2	13.2	0.3	0.0	3.6	69.3	0.0	0.1	21.7	0.1	19.7	0.3	3.3	4.0	2.0	38.0	95.8	0.4	19.6	0.1	1.4	173.8
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	79768028-80226181	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 220.0;Oligodendrocytes: 410.7;Suprabasal keratinocytes: 214.2;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1600000	"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: AB_2677870"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	47.5	26.2	8.9	2.6	18.8	0.4	34.9	14.9	17.7	18.5	4.4	25.4	4.7	14.8	0.7	19.7	10.9	3.2	9.4	10.8	13.3	36.6	15.2	15.2	2.0	18.8	15.0	17.1	4.5	1.3	10.9	13.6	18.4	8.8	2.6	1.5	10.4	3.0	6.2	47.9	9.9	4.1	15.5	5.9	17.7	13.0	14.2	1.3	14.2	2.9	1.5	24.7	19.9	36.6	2.2	18.6	10.5	0.0	14.5	7.9	9.1	14.3	7.2	5.5	8.7	0.0	3.4	0.0	4.5	9.3	5.1	2.6	7.0	9.5	5.4	0.0	11.9	10.4	12.9	1.2	14.8	1.8	0.0	12.0	19.9	4.1	9.5	4.4	3.5	0.0	0.0	0.1	7.7	0.6	0.0	0.1	6.1	0.2	11.0	8.6	5.2	7.8	15.7	7.0	12.5	9.2	13.5	0.0	10.3	5.4	2.0	0.3	13.0	21.8	15.6	5.1	4.4	0.0	0.0	0.2	6.1	1.2	10.2	1.3	0.4	0.4	0.1	0.4	0.0	0.0	0.1	0.1	1.9	0.1	1.1	0.5	0.3	12.8	1.0	0.2	0.1	0.4	8.9	18.8	14.9	17.7	10.8	13.3	18.8	15.0	18.4	15.5	14.2	36.6	121.1	19.2	13.8	11.4	0.9	220.0	20.6	81.6	35.3	3.9	7.0	7.7	6.7	21.5	42.3	29.5	0.0	83.6	1.3	11.1	88.0	7.2	1.7	23.2	58.5	31.5	19.9	4.2	71.4	3.8	84.6	35.9	4.6	40.3	30.3	43.9	17.5	20.0	10.0	26.9	77.4	7.8	36.7	1.0	28.6	7.0	33.5	3.9	103.2	4.7	2.9	49.1	0.0	53.3	410.7	9.4	6.3	74.4	1.2	17.4	0.9	18.4	36.8	5.0	111.7	10.6	70.8	9.7	45.7	31.9	214.2	183.5	2.9	2.9	10.7	19.2
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548615-109600195	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	12.7	8.2	5.8	14.2	6.1	27.7	11.9	7.3	7.5	10.9	8.6	11.8	10.4	12.1	8.0	21.8	8.0	11.3	4.2	6.0	6.5	11.2	15.3	9.7	14.1	6.7	5.9	8.8	9.3	8.9	1.8	14.8	6.8	10.3	11.8	17.8	7.7	9.0	3.8	18.4	10.6	13.6	6.3	11.4	9.0	8.7	6.2	14.2	8.0	5.5	15.9	15.5	4.0	7.3	48.3	16.4	31.0	17.3	28.4	35.0	25.7	35.3	28.6	36.0	35.5	24.4	16.1	25.3	22.4	37.6	21.6	24.5	30.0	35.3	49.4	29.2	18.0	22.1	26.3	21.9	25.1	34.9	18.8	25.2	30.4	41.3	27.8	24.2	42.8	19.1	29.8	24.2	35.5	32.9	27.3	28.4	31.3	23.0	19.1	19.2	73.6	16.6	37.4	35.4	19.5	34.9	24.7	27.6	39.4	22.8	21.1	30.5	36.7	29.4	40.7	44.9	39.2	25.6	30.2	29.2	47.6	34.4	47.1	32.4	29.7	57.8	21.1	44.3	22.4	20.1	20.4	20.6	31.9	17.1	16.8	19.4	53.8	19.9	44.6	14.2	23.8	36.3	5.8	6.1	7.3	7.5	6.0	6.5	6.7	5.9	6.8	6.3	6.2	7.3	104.0	44.8	31.5	17.0	76.6	151.2	104.3	92.2	63.2	29.9	67.7	45.3	14.3	37.1	61.0	58.8	350.3	80.3	98.8	63.9	64.6	97.9	14.7	65.5	71.5	82.6	84.3	43.8	37.5	101.7	153.7	69.2	55.5	110.9	46.3	50.1	56.7	57.2	107.9	25.2	36.4	72.3	59.0	115.0	106.9	9.4	48.7	127.4	74.7	31.9	102.4	47.9	45.3	35.7	31.3	101.6	58.9	47.4	66.3	72.5	48.9	53.5	51.7	26.2	52.6	59.0	77.6	68.6	54.7	82.1	188.4	106.9	94.3	51.7	63.5	143.0
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"retina: 426.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.9	1.4	6.3	1.6	6.0	1.0	0.6	6.7	9.5	2.3	6.7	1.4	1.7	2.2	0.7	0.4	1.6	1.1	4.4	5.9	6.6	2.0	0.2	0.7	1.6	5.7	5.3	2.8	0.7	1.5	36.2	0.4	5.6	2.1	0.6	426.5	2.1	1.4	1.3	0.7	1.5	3.2	5.2	0.9	1.0	0.6	5.7	0.3	1.6	0.3	1.6	1.6	1.1	6.4	0.4	1.2	9.4	3.1	1.3	2.0	0.9	4.8	0.8	2.5	2.1	1.9	0.5	14.1	0.1	5.1	0.1	0.5	9.2	0.3	2.3	1.2	2.1	3.4	6.8	1.5	0.9	1.1	2.3	2.4	0.5	2.4	2.7	9.6	2.5	1.8	1.5	1.3	1.2	0.7	0.7	0.8	17.0	0.1	0.5	0.7	2.8	0.9	0.5	0.4	1.1	2.2	0.4	0.1	1.0	2.5	0.1	0.6	4.0	3.2	3.8	4.8	6.7	1.4	1.0	40.9	1.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	6.7	9.5	5.9	6.6	5.7	5.3	5.6	5.2	5.7	6.4	0.3	0.0	0.0	5.2	1.3	0.4	0.4	0.2	1.2	471.3	0.8	1.3	6.1	0.0	0.1	0.0	932.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	3.3	0.0	1.3	12.3	0.0	0.0	2.3	2.0	0.1	0.0	0.1	1.1	0.0	0.1	74.0	12.4	0.0	4.1	0.3	0.4	0.0	3.7	0.1	1.8	3.7	0.1	86.7	0.0	6.0	1.2	0.1	0.0	3.4	3.2	0.8	0.0	0.1	0.6	462.8	0.0	0.3	1.4	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.2
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115100-52191392	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 120.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 267.5;Cone photoreceptor cells: 279.4;Muller glia cells: 206.9;Rod photoreceptor cells: 296.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853"	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favorable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	11.2	14.5	20.7	11.8	22.5	5.4	12.7	26.7	28.3	27.1	8.7	18.8	5.9	28.3	17.2	11.8	26.8	20.8	22.8	21.9	25.6	36.3	18.8	8.9	21.9	22.5	13.6	49.4	18.9	40.6	25.9	5.7	23.4	16.6	5.5	120.0	11.2	25.5	2.5	8.7	13.1	17.4	9.4	13.5	11.1	15.7	23.6	14.9	21.7	4.7	19.9	20.8	18.1	15.1	18.9	47.6	12.9	23.1	21.5	26.9	12.5	36.1	34.8	31.4	34.0	13.3	13.9	32.6	11.0	29.7	52.9	27.0	23.1	34.3	23.6	25.5	17.5	21.8	60.7	15.6	25.7	11.0	75.8	25.0	28.3	25.2	9.3	33.3	19.9	28.2	1.7	29.9	34.8	33.6	17.6	31.4	12.1	6.3	20.9	23.4	44.9	40.0	22.4	56.7	20.8	18.0	34.6	3.2	28.7	15.8	11.1	33.9	49.5	28.1	30.7	32.2	36.8	18.9	39.0	35.7	58.9	26.6	46.2	10.1	3.8	0.4	21.4	3.8	17.6	41.5	27.2	25.5	10.1	43.8	25.2	21.9	2.2	23.6	3.2	20.6	42.5	18.7	20.7	22.5	26.7	28.3	21.9	25.6	22.5	13.6	23.4	9.4	23.6	15.1	15.9	22.4	23.8	17.0	79.5	19.2	22.8	15.5	21.1	267.5	20.7	27.9	18.3	34.3	21.8	18.4	279.4	4.8	27.1	2.7	19.6	28.9	1.8	28.3	28.7	17.7	19.7	6.1	72.8	18.5	24.8	23.5	8.6	59.9	29.8	20.1	13.6	10.0	3.8	111.0	67.7	1.7	14.2	6.2	15.2	4.6	39.7	20.5	19.6	8.4	4.0	206.9	15.5	22.1	7.8	19.1	5.1	116.9	18.7	10.9	0.8	36.3	24.6	296.5	46.0	16.6	23.9	2.1	6.2	10.8	16.3	2.9	31.9	20.1	2.8	17.8
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase subunit gamma"	Q9UJJ9	16	1351931-1364113	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 135.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		560000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	34.8	94.0	33.5	19.3	41.3	25.0	34.5	37.8	43.3	31.4	43.2	27.9	17.7	29.7	28.9	23.6	28.5	23.7	28.7	32.6	34.8	37.1	40.9	28.4	27.9	38.8	35.5	35.7	39.6	40.2	32.9	20.9	39.3	29.9	16.2	15.6	42.9	20.7	34.6	37.2	30.9	14.9	35.1	38.3	34.8	21.4	35.7	13.3	33.9	16.9	14.4	28.8	26.5	44.5	13.3	21.2	15.3	26.9	135.2	50.3	20.1	38.3	49.6	14.9	28.4	19.1	37.0	8.4	43.0	51.8	22.5	24.0	9.2	22.4	7.6	27.0	20.2	11.3	73.9	33.0	57.6	18.2	43.2	67.3	38.4	14.2	20.3	41.6	27.5	15.2	13.7	48.4	24.6	30.7	8.7	18.7	14.4	33.9	11.8	30.5	12.9	38.6	37.3	17.1	12.0	15.5	38.5	39.2	28.7	8.5	36.9	27.3	27.0	29.8	25.5	24.6	19.1	50.6	40.4	17.7	24.4	15.6	20.3	70.5	77.0	49.5	43.3	74.4	39.6	32.1	36.7	40.8	61.5	31.1	33.4	30.8	32.0	32.6	73.9	52.2	46.9	49.7	33.5	41.3	37.8	43.3	32.6	34.8	38.8	35.5	39.3	35.1	35.7	44.5	39.7	41.7	41.7	17.3	31.9	20.9	26.5	25.4	46.7	15.1	34.0	42.9	9.4	37.1	43.2	20.2	25.0	25.0	34.9	25.8	9.8	27.4	2.6	17.7	29.8	25.6	9.1	9.9	22.7	14.5	20.3	49.7	47.4	23.7	24.6	21.1	30.7	35.2	50.2	8.4	20.5	18.0	14.2	43.4	41.7	4.6	30.1	47.8	33.8	9.4	25.7	31.0	30.9	15.1	32.4	14.8	32.9	17.7	76.1	22.1	32.1	41.7	28.5	24.5	19.7	24.4	22.9	25.4	24.2	48.1	20.3	31.1	30.6	20.5	21.7	24.5
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	19.9	25.2	11.0	7.1	12.7	14.1	24.1	15.0	12.9	21.9	26.5	18.8	12.2	17.4	32.1	15.1	15.8	13.3	18.5	13.2	10.5	18.6	17.9	15.3	8.4	8.5	9.9	21.9	27.1	20.7	25.0	13.4	9.0	25.8	17.1	31.0	25.2	19.9	14.2	20.2	19.0	10.0	9.6	16.6	19.7	14.6	9.3	11.3	21.0	11.1	9.8	16.3	15.7	11.5	19.9	15.7	15.3	9.9	28.8	31.0	9.6	12.6	27.5	11.9	13.4	13.8	7.1	4.3	10.4	23.6	11.9	9.0	9.2	13.7	14.1	6.3	17.5	12.2	20.1	19.2	17.2	13.7	16.0	25.4	31.9	7.5	18.7	25.8	15.3	7.3	5.8	9.6	12.7	14.3	4.1	9.9	9.9	19.1	16.4	5.4	12.0	10.3	17.7	20.2	10.8	12.0	15.5	11.0	16.7	17.3	13.6	15.2	21.5	11.4	6.9	4.9	9.2	17.8	11.4	7.2	15.3	6.6	4.3	1.6	4.1	4.3	4.3	2.2	3.5	3.4	3.5	3.3	2.6	2.8	3.3	3.6	15.4	3.9	1.7	5.5	3.9	1.6	11.0	12.7	15.0	12.9	13.2	10.5	8.5	9.9	9.0	9.6	9.3	11.5	118.9	291.7	233.9	101.2	97.3	51.6	89.1	62.1	96.8	101.4	110.2	130.3	274.8	74.4	179.2	53.3	123.0	78.7	134.7	148.6	11.7	104.3	56.0	247.9	186.4	102.7	91.9	36.8	72.9	111.0	53.0	135.5	144.8	284.0	115.6	220.7	74.3	68.9	34.5	69.0	80.2	176.8	65.1	47.2	48.3	23.8	198.5	82.1	33.8	68.4	76.8	82.1	54.6	50.3	72.8	100.2	95.7	199.0	176.0	74.9	79.9	29.3	165.7	193.6	85.5	165.9	120.5	155.0	66.8	70.2	45.7	150.8	102.6	197.7	101.7	88.3
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 396.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 372.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		81000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	22.2	159.8	72.5	33.8	78.8	6.6	39.5	69.2	84.5	70.0	99.0	195.7	235.1	40.1	15.7	13.6	38.1	131.0	12.7	72.1	93.8	74.7	19.0	14.7	9.7	73.4	76.1	36.9	41.6	37.6	36.4	17.2	69.9	143.2	163.9	25.5	173.4	10.5	9.4	14.9	61.3	28.4	80.1	41.7	396.2	17.4	108.0	45.4	68.1	4.8	5.6	38.3	14.9	79.2	146.0	139.5	102.4	116.7	129.3	74.3	108.0	64.8	46.6	99.9	80.5	69.4	282.9	2.7	62.6	126.2	96.6	109.4	63.7	64.1	71.9	5.0	101.2	45.3	89.1	3.4	76.8	67.3	34.9	113.4	34.2	94.1	34.0	124.9	172.9	21.2	28.7	4.2	57.3	68.4	8.3	49.6	161.9	188.9	99.6	42.9	116.9	21.8	166.0	61.2	115.1	72.0	88.2	189.0	73.8	66.1	106.7	68.1	110.5	25.9	72.6	79.3	78.3	372.3	37.4	0.9	112.2	29.8	57.8	1.9	3.6	0.4	3.5	2.6	0.4	0.6	0.2	0.5	0.4	0.6	0.4	0.7	4.2	0.7	4.2	1.5	0.1	1.8	72.5	78.8	69.2	84.5	72.1	93.8	73.4	76.1	69.9	80.1	108.0	79.2	13.8	9.6	15.3	30.3	1.7	2.3	10.8	11.3	4.6	20.1	41.4	21.1	4.9	80.1	80.9	35.0	8.4	8.4	10.7	362.8	25.4	168.4	339.0	78.0	49.8	20.5	73.1	11.2	47.0	222.2	35.0	30.4	245.6	56.8	1.3	65.9	8.6	11.1	11.8	67.3	43.2	95.5	325.5	5.0	2.6	391.6	18.3	6.6	23.2	6.5	6.9	16.9	12.3	82.0	19.3	282.9	265.2	13.2	3.2	72.6	71.8	16.0	78.6	6.7	0.0	13.5	19.5	10.3	38.7	2.9	1.0	6.4	5.2	60.7	245.6	29.1
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 511.1;liver: 369.5;skeletal muscle: 489.9;tongue: 1011.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 449.0;Distal tubular cells: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		100000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	14.7	54.9	67.8	14.7	71.1	8.0	22.7	70.3	119.1	53.1	82.6	50.9	62.0	13.1	25.9	42.7	17.9	49.0	511.1	70.0	77.6	143.1	369.5	15.5	14.1	83.5	55.0	18.1	34.0	142.4	22.5	14.4	83.7	22.7	59.2	106.2	48.6	27.4	489.9	23.9	45.8	21.4	48.4	16.9	58.9	33.6	69.1	17.7	47.7	1011.6	30.3	22.3	21.0	70.1	73.7	40.3	46.0	114.4	35.1	30.7	127.1	58.9	108.7	101.8	109.8	89.9	56.4	71.9	20.4	50.2	89.2	88.6	107.1	78.9	105.8	25.7	46.7	28.1	46.7	114.3	184.9	77.9	44.0	47.3	82.5	86.9	228.4	69.5	49.5	48.6	71.1	106.2	65.4	64.9	42.5	56.5	29.2	118.7	56.1	45.5	44.4	72.8	173.7	37.5	19.6	28.7	44.8	59.3	222.6	66.8	115.7	27.1	23.3	25.4	56.3	28.0	68.7	76.8	99.7	74.3	65.4	40.8	34.1	4.0	8.7	6.8	19.7	25.8	18.4	17.6	21.5	20.7	21.9	21.2	15.6	22.7	0.8	20.5	31.5	36.4	27.6	15.6	67.8	71.1	70.3	119.1	70.0	77.6	83.5	55.0	83.7	48.4	69.1	70.1	10.3	16.0	16.2	26.1	38.8	11.9	41.8	82.7	24.5	95.6	18.8	21.2	449.0	72.9	34.4	73.5	62.6	35.9	10.7	62.1	240.7	51.9	166.7	17.8	9.3	16.7	19.7	39.5	47.4	30.8	18.1	23.5	76.9	21.5	31.8	20.2	17.2	191.8	31.6	75.7	63.3	45.3	54.9	12.4	6.9	24.1	11.1	13.0	49.8	13.1	10.5	36.6	6.2	21.1	37.2	27.6	34.4	14.3	22.4	13.1	97.0	163.3	27.9	76.5	13.1	15.2	20.5	116.7	10.4	40.9	10.4	55.1	14.6	47.0	66.4	42.3
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734342	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 698.4;tongue: 726.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 341.9;Hepatocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018139, HPA058537"	Enhanced				"Intracellular and membrane"	NA	NA		2800000	"Cluster 13: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA018139: AB_1849903, HPA058537: "	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	19.6	73.9	52.4	27.4	55.9	21.1	36.3	62.5	66.9	34.1	129.4	57.6	37.4	36.5	66.3	66.9	46.7	24.1	313.2	57.9	59.3	88.0	321.4	25.2	35.6	60.6	51.0	29.4	33.2	98.6	46.7	24.7	62.5	59.0	65.0	91.4	47.7	65.7	698.4	41.1	35.7	46.7	50.1	28.5	54.9	28.9	58.7	35.9	42.6	726.8	57.0	57.0	45.1	61.0	137.2	182.4	93.8	114.8	66.6	59.8	122.0	101.4	108.8	197.6	107.7	158.9	120.1	302.3	117.3	114.6	86.5	195.5	203.2	199.2	250.1	83.1	182.0	81.4	92.1	179.3	84.2	132.3	71.9	58.4	110.9	125.2	108.2	112.4	201.8	141.9	167.0	30.6	102.2	122.5	164.0	128.0	127.7	90.8	338.0	177.8	142.7	291.1	187.9	197.7	148.2	107.6	195.2	208.5	74.8	84.2	105.5	42.7	82.3	71.4	129.3	56.2	132.4	69.9	68.6	247.4	76.7	130.9	73.8	4.6	20.6	7.4	28.3	16.9	43.7	26.5	33.1	34.1	34.7	22.3	30.1	28.4	1.8	30.2	18.4	30.0	48.7	31.2	52.4	55.9	62.5	66.9	57.9	59.3	60.6	51.0	62.5	50.1	58.7	61.0	15.1	9.6	15.8	11.8	19.8	32.0	37.0	39.4	34.1	34.5	27.5	16.3	341.9	22.8	22.5	36.8	77.2	42.6	11.8	42.6	56.7	50.8	4.0	30.4	20.0	23.8	20.5	39.3	24.7	42.5	38.8	21.1	30.1	25.4	14.5	37.5	23.2	176.1	39.1	20.2	27.1	33.5	26.4	17.0	15.1	8.1	18.0	13.5	24.9	5.6	12.7	16.1	8.2	11.6	17.6	40.3	13.3	22.6	39.2	38.2	27.6	63.2	17.5	48.9	0.0	15.2	24.0	11.9	15.0	68.9	30.0	23.7	17.4	36.4	54.4	69.6
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet subunit alpha"	P07359	17	4932277-4935023	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Macrophages: 14.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.1"	"Immune cell enriched"	"Detected in single"	13	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	24	"HEL: 71.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					NA	NA		1600000000	"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.5	0.1	0.1	3.8	0.4	4.9	0.4	2.1	0.2	0.4	0.1	0.7	1.2	0.3	0.0	0.5	0.4	0.3	0.5	0.1	0.0	0.5	0.8	1.5	14.7	0.1	0.0	0.4	0.3	0.0	0.2	0.3	0.1	0.4	0.5	2.3	0.9	0.0	2.7	2.4	1.8	0.0	0.0	3.6	0.8	0.4	0.1	0.6	0.4	0.0	7.7	0.4	0.5	0.0	0.1	2.3	0.5	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.2	0.3	2.3	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.8	1.8	71.6	1.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.7	0.7	0.0	0.8	0.6	0.3	0.3	0.2	0.4	1.2	0.5	0.3	0.0	1.4	0.1	0.3	0.9	0.0	0.3	0.6	2.9	1.3	0.3	0.4	0.4	1.5	0.2	1.2	0.5	1.7	1.0	1.1	0.7	7.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.2	0.1	0.4	2.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.3	1.5	0.6	0.4	0.0	1.8	0.2	0.5	1.1	0.0	0.2	0.0	2.1	0.3	0.4	0.1	3.9	0.2	0.3	0.8	1.8	0.5	0.0	1.7	0.2	0.0	0.2	0.7	0.0	2.4	0.0	0.1	2.5	0.9	0.1	0.0	0.2	0.0	0.0	0.9	3.3	0.6	0.3	14.2	0.0	0.0	2.6	0.3	1.0	0.0	0.1	0.0	0.0	1.9	0.3	0.4	0.3	0.9	0.0	2.7	0.0	1.4	0.5	1.0	0.6	0.0	1.8	0.3	1.0	0.1	0.1	0.3
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Early spermatids: 14.3;Excitatory neurons: 9.9;Inhibitory neurons: 10.2;Late spermatids: 8.7;Macrophages: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 9.4;K-562: 4.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047611, HPA066482"	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA047611: , HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.1	0.0	0.1	0.0	0.1	0.9	0.2	0.7	0.5	0.5	0.0	0.2	0.0	0.2	0.0	1.4	0.4	0.0	0.7	0.1	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.4	0.1	0.1	1.2	0.1	0.0	0.0	0.9	0.2	2.7	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	9.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.7	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.3	0.3	0.0	2.0	0.3	0.4	0.7	1.5	0.3	0.0	6.2	0.1	0.4	0.7	0.0	0.1	14.3	1.4	0.4	1.2	0.0	0.0	9.9	0.4	0.3	0.6	0.0	2.2	1.3	0.8	3.3	0.2	0.1	3.3	10.2	0.0	0.0	0.8	0.2	8.7	0.3	10.3	0.0	1.0	0.3	0.4	2.1	1.5	1.5	0.2	0.1	0.0	0.0	0.4	0.1	0.0	1.9	2.6	0.0	0.4	0.2	1.4	1.2	0.0	0.1	0.5	0.4	0.0	0.3	0.7
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 215.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 775.5;Intestinal goblet cells: 211.6;Paneth cells: 420.3;Proximal enterocytes: 266.1;Undifferentiated cells: 147.2"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 24.2;T-reg: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 24.2"	"Cell line enriched"	"Detected in some"	8	"OE19: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.4	0.0	0.0	18.5	0.0	0.7	0.2	0.0	0.2	0.0	0.4	215.9	150.0	0.3	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	7.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	196.2	0.0	0.0	0.4	0.3	0.0	136.9	7.2	0.0	0.9	1.5	0.2	0.2	2.3	0.0	0.1	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.3	1.8	14.4	0.0	0.0	0.8	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	3.8	1.6	0.2	10.9	5.7	2.7	2.2	24.2	3.5	0.2	0.2	2.6	0.0	19.5	6.8	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	775.5	0.0	0.0	3.9	0.0	0.0	0.1	26.1	0.8	0.4	0.0	0.0	0.0	0.5	0.0	4.5	0.0	0.0	0.0	0.5	0.0	0.3	211.6	0.0	1.9	1.3	2.3	0.3	1.8	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.1	420.3	0.0	0.0	0.0	266.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	3.1	0.0	147.2	0.2
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661228-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	14.5	11.8	1.5	2.7	1.9	3.9	14.7	3.6	2.8	14.9	1.4	15.9	1.6	15.9	2.5	11.4	14.9	2.1	21.5	1.5	1.8	14.7	16.0	13.2	3.8	2.0	1.7	17.3	15.1	3.3	13.5	1.8	2.2	14.0	2.4	2.3	13.8	2.0	28.4	15.8	15.6	1.1	1.4	16.7	15.4	36.4	1.8	6.7	12.8	2.8	2.3	15.0	13.3	2.6	3.3	3.3	1.7	5.6	8.3	6.6	4.4	3.2	5.2	3.1	4.2	0.2	4.8	10.8	5.2	3.4	4.2	3.9	0.0	8.1	2.3	6.4	5.6	11.3	0.0	3.7	5.7	3.7	4.3	3.2	4.3	10.4	6.9	6.1	3.8	10.9	3.0	8.8	4.2	2.6	13.1	4.4	0.0	5.1	1.2	5.4	7.5	7.9	5.1	2.6	12.6	8.4	4.3	1.9	5.4	4.6	5.1	9.2	4.8	7.3	7.0	0.5	0.0	6.5	10.8	4.1	8.6	7.9	4.2	11.8	3.1	9.9	4.1	2.5	4.1	2.0	3.2	2.5	3.1	2.9	3.7	3.3	9.5	4.5	2.6	3.8	4.6	2.7	1.5	1.9	3.6	2.8	1.5	1.8	2.0	1.7	2.2	1.4	1.8	2.6	22.6	38.5	21.7	5.9	30.5	25.0	24.2	27.6	23.3	29.1	25.0	23.4	35.9	30.0	21.6	18.4	35.5	30.1	28.3	26.4	45.0	31.6	55.4	21.9	21.4	29.1	27.1	33.0	3.2	23.6	39.7	23.8	13.3	22.9	35.4	21.9	27.8	30.3	27.7	11.8	3.5	29.9	22.4	27.0	18.5	51.5	34.5	21.0	19.6	3.7	43.5	37.8	47.4	5.0	7.3	21.9	43.3	24.8	29.2	32.3	90.5	74.5	20.1	47.3	19.7	21.6	29.7	180.8	87.2	16.2	34.2	47.1	26.9	17.3	26.9	19.9
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	4.1	4.2	3.5	4.1	4.0	3.2	7.1	3.0	4.8	5.9	6.3	4.3	4.9	6.5	5.9	5.5	5.0	6.1	3.5	4.3	5.1	5.2	4.9	4.2	5.1	2.9	3.2	4.8	3.9	6.9	4.4	6.3	3.1	6.9	4.6	5.7	3.7	5.3	6.6	4.4	4.8	5.1	3.2	4.8	4.8	6.2	4.5	6.3	6.6	2.9	5.6	6.1	4.1	3.8	8.4	9.4	9.9	7.8	8.6	8.7	8.2	7.7	9.4	10.5	9.9	8.3	10.6	8.9	7.6	6.7	6.5	9.7	11.2	9.1	12.2	6.6	6.4	5.9	7.9	5.3	10.6	9.0	6.7	7.7	13.0	12.3	20.0	9.1	7.3	9.8	14.7	0.1	7.7	7.9	12.2	6.4	18.0	6.7	10.2	5.9	22.7	10.7	7.4	17.9	11.6	16.5	13.7	12.5	10.7	15.5	11.7	8.7	7.5	9.8	6.8	13.9	7.2	9.0	6.8	8.4	7.4	5.9	7.1	4.1	3.1	1.1	2.6	1.9	1.8	2.6	3.0	1.8	3.4	2.8	2.7	2.4	0.4	2.7	2.9	5.0	2.9	1.5	3.5	4.0	3.0	4.8	4.3	5.1	2.9	3.2	3.1	3.2	4.5	3.8	17.5	12.8	15.9	43.8	19.4	15.6	16.1	13.4	14.8	55.4	27.2	27.9	14.4	21.5	15.3	18.4	171.0	20.8	24.5	22.4	13.7	20.4	62.6	41.3	36.4	20.5	20.8	12.0	113.1	18.0	22.2	23.0	19.4	24.0	9.5	32.9	20.7	12.4	15.7	50.5	60.5	21.5	18.3	9.2	9.2	22.8	19.9	16.6	5.4	39.4	17.2	27.7	28.8	46.3	47.1	15.0	17.2	23.0	24.5	17.5	17.9	18.1	22.3	144.2	19.7	36.8	20.2	53.3	23.8	12.9	19.5	21.6	20.0	41.4	23.1	19.0
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395281-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 312.1;Inhibitory neurons: 287.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	10.5	9.2	12.0	11.3	13.3	18.3	11.0	15.0	14.0	10.6	9.3	8.9	11.1	14.5	11.8	9.4	11.1	8.8	8.9	11.8	12.5	9.0	7.0	10.7	15.7	12.9	12.9	17.3	8.0	14.4	0.4	13.1	12.7	9.5	10.4	30.1	9.3	10.2	33.4	15.5	11.0	12.5	12.1	13.1	8.8	10.8	13.0	20.8	11.0	13.8	15.4	9.8	0.8	13.5	22.0	12.8	22.8	18.9	17.5	20.2	23.1	16.7	21.1	18.3	19.2	19.0	13.9	31.1	10.9	23.7	15.8	16.7	23.3	19.3	27.2	25.7	20.8	26.5	15.5	22.5	20.9	25.7	20.3	22.9	20.5	20.9	27.2	18.4	20.2	19.4	20.1	18.7	16.8	10.0	33.7	9.9	16.0	12.5	16.2	27.1	25.8	21.7	16.0	10.6	15.9	19.3	16.6	10.6	20.9	27.0	13.9	17.3	22.5	18.0	12.6	19.3	23.4	20.1	17.9	29.2	16.8	14.1	19.3	8.2	6.1	4.9	9.4	6.0	8.7	8.6	8.2	7.8	6.5	7.1	7.5	7.3	4.6	10.3	13.6	8.0	4.1	5.2	12.0	13.3	15.0	14.0	11.8	12.5	12.9	12.9	12.7	12.1	13.0	13.5	38.8	22.4	32.5	148.5	64.6	48.7	53.1	52.0	47.8	72.7	28.8	22.7	40.5	30.0	46.0	25.8	123.0	42.4	76.6	25.2	9.8	32.8	19.6	38.7	63.3	38.8	38.8	50.1	312.1	24.5	39.3	48.4	23.9	56.5	42.4	44.6	44.3	19.4	23.0	146.4	287.3	20.3	36.7	36.2	42.3	7.6	63.0	38.6	23.2	108.7	42.5	43.5	161.7	172.9	204.1	34.7	24.7	43.2	58.1	45.3	30.2	14.6	29.8	125.3	52.6	68.6	51.2	93.1	74.2	33.7	46.9	53.4	69.8	43.1	25.4	56.8
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 609.9;skeletal muscle: 577.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	609.9	4.7	9.1	1.6	16.8	0.2	229.2	22.7	12.8	0.3	5.5	6.4	76.4	0.2	5.3	4.9	0.5	16.6	9.2	10.1	14.2	149.3	147.6	18.4	1.0	32.6	18.3	0.3	7.2	13.0	1.3	0.0	26.5	1.3	3.3	1.0	33.0	1.3	577.1	10.2	76.9	1.3	32.7	0.4	3.3	0.8	18.4	1.5	2.7	215.7	0.4	4.1	1.0	49.4	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.8	22.7	12.8	10.1	14.2	32.6	18.3	26.5	32.7	18.4	49.4	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 151.1;Late spermatids: 95.5;Oligodendrocyte precursor cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.3;eosinophil: 1.7;intermediate monocyte: 1.6;myeloid DC: 2.7;neutrophil: 1.1;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 1.7;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		620000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	8.2	5.7	13.3	8.1	17.7	13.4	16.2	15.2	18.6	10.3	6.5	18.6	14.4	6.8	5.2	20.3	18.2	8.9	6.2	19.8	16.3	8.0	3.4	11.4	7.0	13.5	16.2	8.6	6.8	20.5	5.5	6.7	13.1	10.9	18.0	9.6	14.9	7.1	24.7	12.5	15.7	6.1	14.5	8.5	17.4	5.5	18.5	6.1	12.2	14.3	8.6	14.3	9.5	13.6	39.0	27.2	15.3	24.5	32.6	39.6	0.1	48.0	31.2	32.1	38.6	53.9	35.7	8.4	31.9	27.4	13.2	44.5	28.9	44.5	41.4	23.9	9.5	6.0	46.9	0.0	12.0	11.2	12.6	19.5	15.4	55.6	27.1	20.6	24.1	3.7	12.0	1.9	41.7	24.4	0.3	1.0	28.7	15.2	31.0	12.3	9.8	9.2	41.8	50.7	27.3	9.9	45.0	34.4	30.4	25.9	10.9	30.8	22.8	5.7	26.9	26.5	36.5	1.3	0.3	0.4	32.9	3.0	47.1	0.3	3.3	1.7	0.3	1.6	0.5	0.1	0.1	0.4	2.7	0.2	0.3	0.2	1.1	0.4	2.3	0.3	0.5	1.5	13.3	17.7	15.2	18.6	19.8	16.3	13.5	16.2	13.1	14.5	18.5	13.6	12.1	19.2	12.3	151.1	7.8	20.0	23.3	24.9	21.1	5.5	23.4	12.8	13.1	7.2	19.8	22.0	6.2	9.6	6.2	52.1	1.9	9.5	84.8	12.3	6.1	11.3	17.4	6.9	27.9	13.4	15.2	9.2	30.5	23.3	12.7	13.0	10.4	3.4	21.3	5.0	46.9	17.1	10.2	18.6	18.7	95.5	12.2	21.0	24.9	61.8	10.8	4.2	4.1	148.3	48.7	16.2	17.4	7.2	5.6	66.7	16.0	3.9	18.2	11.1	0.0	8.3	12.3	2.6	3.2	41.7	21.5	11.1	7.6	7.0	19.4	77.8
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.0;Late spermatids: 1127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		86000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	196.9	283.2	83.4	74.5	101.9	222.8	129.0	67.7	130.5	95.0	84.8	162.9	113.7	92.4	27.2	197.8	88.8	87.1	407.2	108.5	73.6	196.8	222.6	91.2	66.4	73.5	58.5	97.0	84.2	166.3	147.2	47.5	69.3	94.4	84.3	156.1	105.1	61.0	416.6	120.1	126.5	78.4	34.0	102.2	122.5	95.9	83.2	50.1	100.8	374.6	76.0	147.9	121.5	95.8	572.9	596.1	58.7	433.3	167.5	121.9	134.1	183.4	132.4	206.3	253.7	314.9	169.6	303.5	311.4	177.9	149.1	343.7	337.7	437.0	259.4	461.0	105.1	382.1	252.3	310.8	108.4	517.6	259.3	173.7	136.6	289.0	132.7	273.3	209.3	230.5	210.3	261.8	140.2	319.2	245.5	133.5	158.0	421.3	174.6	242.7	149.1	649.4	254.1	275.4	304.9	185.8	331.9	634.3	131.7	100.5	144.4	161.7	171.9	80.8	185.5	256.7	312.8	535.5	383.7	318.4	287.4	372.3	170.6	188.8	93.2	331.3	80.4	141.2	99.1	59.9	73.7	93.1	101.0	50.5	61.8	72.8	7.4	58.0	180.3	31.6	83.4	123.4	83.4	101.9	67.7	130.5	108.5	73.6	73.5	58.5	69.3	34.0	83.2	95.8	34.2	28.9	40.0	98.9	43.8	25.9	30.1	104.5	42.7	98.8	34.1	27.2	232.5	42.9	51.4	57.0	75.0	44.5	41.6	76.7	115.4	101.7	331.0	35.9	41.2	38.0	63.7	46.7	121.8	66.9	69.2	47.1	109.1	58.0	23.4	36.1	42.8	89.5	89.6	237.2	127.2	75.8	50.8	52.9	40.5	1127.2	37.0	58.1	35.6	17.8	44.4	32.6	23.7	43.7	87.7	77.6	39.4	30.5	77.1	31.5	111.8	103.0	33.1	68.3	19.7	44.3	65.0	7.8	22.3	139.1	32.8	39.3	64.3	74.8	126.9	37.2
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.2	0.9	2.0	0.6	1.7	0.9	1.3	7.6	4.7	1.1	0.1	1.0	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.3	2.4	0.6	46.1	0.9	0.9	1.8	1.9	1.2	0.6	2.5	1.7	0.2	1.9	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.4	1.4	0.6	0.6	0.7	1.4	1.4	5.1	2.4	0.6	1.3	1.1	1.5	2.1	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	2.0	1.7	7.6	4.7	1.3	2.4	1.8	1.9	1.9	0.6	1.4	2.1	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 581.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 327.1;Fibroblasts: 285.8;Hofbauer cells: 814.1;Macrophages: 328.9;Melanocytes: 597.7;Suprabasal keratinocytes: 359.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.1;intermediate monocyte: 3.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.9"	"Cell line enriched"	"Detected in many"	6	"ASC diff: 5015.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 9.7"	"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		33000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	152.9	25.9	20.9	41.7	20.9	6.6	135.6	19.0	70.9	303.9	77.6	78.8	22.5	180.9	43.8	111.8	72.8	270.7	323.5	21.2	23.1	32.7	52.5	215.8	169.0	32.2	21.5	77.7	20.6	15.3	12.8	148.6	31.0	30.4	92.9	2.9	66.1	55.8	15.4	581.2	48.5	151.5	27.3	31.9	37.1	26.2	34.6	89.5	51.5	72.4	103.4	190.9	151.0	66.5	19.2	0.8	0.1	0.6	5015.0	908.0	0.4	33.6	564.1	27.9	116.2	0.2	0.8	0.7	1.4	109.5	49.1	118.3	0.7	0.7	14.2	1.3	1.3	0.1	0.9	2.5	61.5	1.5	0.6	630.3	134.8	46.3	4.7	734.9	0.3	1.4	0.3	0.6	150.2	3.5	0.7	0.7	0.6	0.5	0.5	0.4	1.4	7.6	71.2	443.4	2.4	0.6	0.1	175.6	841.5	1.3	2.3	2.8	0.1	163.0	17.8	297.8	5.5	5.1	8.6	1.2	56.3	2.6	166.1	0.6	2.1	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.0	0.5	20.9	20.9	19.0	70.9	21.2	23.1	32.2	21.5	31.0	27.3	34.6	66.5	18.0	19.2	24.3	0.3	3.2	327.1	7.1	58.5	150.2	0.4	6.6	24.5	204.2	2.8	16.0	75.4	0.0	7.2	2.2	0.1	3.9	0.6	3.0	2.5	44.0	15.0	0.0	0.0	0.5	0.8	4.6	285.8	12.2	2.5	22.7	0.1	4.6	5.1	814.1	1.7	1.2	0.0	12.2	188.4	100.7	5.5	129.8	328.9	597.7	12.2	3.2	0.2	1.0	55.8	0.1	0.6	0.0	108.0	10.2	1.9	0.0	1.2	3.4	0.6	0.0	20.6	53.4	3.9	1.4	65.3	359.7	28.9	5.7	0.1	0.0	11.9
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR83	GPR72	ENSG00000123901	"G protein-coupled receptor 83"	Q9NYM4	11	94377316-94401419	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 11.5;thyroid gland: 3.0"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 2.7;Excitatory neurons: 2.6;Inhibitory neurons: 4.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 67.5"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (6.74e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.36e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.47e-12)"	"unprognostic (3.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.28e-3)"	0.1	0.7	1.3	0.1	3.0	0.4	0.0	11.5	3.4	0.3	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.4	4.4	4.1	0.3	0.2	0.0	0.2	0.3	4.9	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.7	0.1	0.0	0.3	0.2	0.1	0.1	0.8	0.2	0.1	0.4	2.2	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.3	3.0	11.5	3.4	4.4	4.1	0.3	4.9	0.9	0.8	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	2.7	0.1	0.0	0.0	0.0	2.6	0.4	0.0	0.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA		78000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	55.6	64.4	55.9	32.0	56.7	42.7	54.6	59.2	80.5	53.3	53.7	58.8	35.0	56.3	30.9	50.9	49.5	28.1	91.1	59.2	57.6	81.9	101.7	48.6	37.5	60.1	59.2	56.4	69.8	48.4	62.6	29.7	60.0	64.5	18.1	20.5	58.8	40.7	148.5	56.6	46.8	25.5	55.1	54.9	65.5	70.6	56.5	37.3	58.7	63.7	24.9	53.7	48.0	59.2	112.5	204.9	74.7	98.0	51.7	49.5	105.4	73.6	58.2	114.1	93.9	180.7	68.1	55.0	64.5	74.1	83.1	83.1	71.6	94.2	38.7	37.0	256.7	93.5	112.2	203.5	85.5	102.9	86.8	71.2	67.9	101.3	60.0	45.9	120.4	93.4	89.1	62.0	64.3	220.8	176.8	116.4	95.3	107.2	151.3	107.0	102.5	89.5	71.1	114.8	127.6	199.8	74.9	136.6	110.0	56.7	155.1	91.7	69.3	113.3	133.3	88.6	120.5	112.6	51.4	58.9	88.7	65.5	104.5	57.6	85.7	65.9	77.5	81.0	81.8	64.5	80.9	78.3	93.4	64.2	56.9	71.8	13.2	81.6	78.1	64.2	115.2	98.7	55.9	56.7	59.2	80.5	59.2	57.6	60.1	59.2	60.0	55.1	56.5	59.2	24.0	12.8	24.8	27.1	24.9	25.1	22.5	37.1	17.6	30.6	31.0	27.6	53.7	30.0	30.7	20.2	25.0	71.1	22.7	78.6	60.7	50.7	33.0	22.7	22.4	30.0	41.3	21.7	12.1	69.4	67.6	31.0	35.7	23.3	24.7	45.2	28.5	50.6	60.9	48.8	14.2	42.7	52.9	37.3	31.5	76.7	30.1	32.0	33.8	7.5	42.4	46.3	29.9	10.6	16.4	48.1	56.1	31.6	50.1	25.4	58.4	100.9	33.9	27.2	6.6	28.3	36.3	50.9	50.3	27.1	30.0	54.0	31.1	41.9	57.2	23.2
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 179.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	22.6	2.4	2.2	4.6	1.9	2.3	12.5	3.3	4.7	0.7	3.5	36.0	18.3	0.5	0.4	2.4	1.3	2.4	40.3	2.1	0.4	13.9	179.6	0.4	0.3	0.8	0.5	1.1	10.3	1.4	2.9	0.1	0.6	1.8	5.8	0.6	14.6	1.2	50.1	17.1	18.0	0.4	0.2	0.6	15.0	2.6	0.9	0.0	0.9	24.3	0.2	0.6	1.3	0.9	0.2	0.8	0.2	0.5	0.4	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.9	0.4	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.7	1.3	0.3	1.5	2.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	2.8	0.0	1.3	0.4	0.4	0.3	0.6	0.5	0.5	0.1	1.5	0.0	0.9	0.5	0.8	0.2	0.7	0.1	0.1	1.9	0.1	0.2	0.1	0.6	0.7	0.1	2.9	0.2	0.2	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	1.9	3.3	4.7	2.1	0.4	0.8	0.5	0.6	0.2	0.9	0.9	0.2	0.0	0.0	14.4	5.3	1.7	1.3	1.2	0.6	0.9	14.1	4.6	8.5	34.3	1.8	7.3	0.0	0.0	0.4	176.9	21.5	1.1	16.5	0.5	0.4	1.1	2.4	43.2	0.8	2.4	3.3	0.3	51.0	0.7	8.9	0.3	14.3	237.3	0.1	3.3	0.5	30.4	0.0	14.4	2.1	48.1	0.6	1.2	1.8	1.0	0.1	15.6	0.0	2.0	0.0	1.3	88.4	0.4	0.1	1.2	139.7	164.9	0.5	2.0	0.0	2.0	0.4	1.0	0.6	2.4	4.5	0.0	1.8	0.4	62.1	1.6
GPX1		ENSG00000233276	"Glutathione peroxidase 1"	P07203	3	49357176-49358353	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3273.8;Kupffer cells: 3971.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1534.3;granulocytes: 1010.7;monocytes: 1337.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011582, HPA044758"	Approved		Supported	Cytosol		NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB011582: AB_2112120, HPA044758: AB_2679076"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (7.78e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.73e-3)"	"unprognostic (5.03e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.64e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.64e-3)"	321.4	200.0	178.3	151.9	186.6	246.7	151.5	190.2	298.9	90.9	247.3	86.9	122.2	82.2	17.8	134.3	86.5	91.1	95.5	173.1	198.9	152.9	281.6	168.3	174.3	234.0	213.0	61.9	74.4	35.2	85.7	121.2	208.3	107.0	42.7	8.3	113.1	53.9	157.1	70.4	113.6	70.4	218.0	195.9	92.9	31.5	217.6	75.3	82.1	61.7	86.6	116.8	94.9	256.3	322.8	189.2	72.6	95.4	113.5	205.9	225.9	217.7	114.7	151.5	80.1	157.8	229.7	0.6	301.6	139.8	181.7	93.2	98.8	660.3	31.6	200.2	271.6	224.8	190.2	397.4	575.6	161.0	594.4	455.9	267.6	292.4	221.5	190.0	341.5	78.6	0.5	179.3	125.9	0.8	51.2	407.0	441.3	147.4	510.5	190.8	93.8	120.3	258.2	385.6	87.7	178.5	249.5	1.5	287.3	75.7	1.5	559.5	546.5	209.7	236.0	385.8	453.6	1.1	127.9	116.3	390.5	436.3	507.8	1010.7	1337.0	707.6	69.8	483.7	100.9	314.2	127.7	83.7	1093.1	276.8	118.4	116.2	136.4	107.4	275.8	1534.3	233.3	1401.2	178.3	186.6	190.2	298.9	173.1	198.9	234.0	213.0	208.3	218.0	217.6	256.3	0.0	109.0	323.5	6.2	148.1	249.7	432.8	985.0	92.2	32.1	0.0	0.0	0.0	220.2	616.7	0.0	10.4	499.9	491.5	229.5	0.0	0.0	300.7	0.0	0.0	227.8	251.3	364.1	12.8	0.0	830.3	131.0	73.4	0.0	480.6	0.0	585.7	888.1	3273.8	1.7	17.9	285.0	386.6	3971.6	965.7	1102.9	134.5	1305.5	273.9	41.2	828.6	63.4	138.0	8.0	7.6	0.0	179.0	67.0	82.4	481.0	349.9	0.0	490.0	14.6	210.4	150.6	151.8	12.7	169.4	112.1	154.1	278.8	112.2	0.0	367.3	517.0
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11673.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4524.7	443.8	57.8	75.4	68.3	7.9	3188.6	62.7	73.8	917.6	578.2	741.2	88.3	416.0	90.7	568.6	1038.4	136.4	2362.4	68.2	117.5	11673.5	986.3	2471.8	133.2	317.7	104.5	517.8	257.0	112.4	793.7	592.2	136.6	557.5	93.4	4204.9	481.4	140.0	847.9	669.7	720.6	61.0	67.5	555.7	641.1	80.4	135.8	26.8	3627.5	458.9	44.9	1196.7	891.7	70.3	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	57.8	68.3	62.7	73.8	68.2	117.5	317.7	104.5	136.6	67.5	135.8	70.3	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 18580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	927.8	535.3	415.1	127.4	428.7	178.0	733.3	440.7	519.1	280.8	478.7	249.0	259.0	188.4	318.9	220.4	199.2	196.6	426.0	419.2	450.3	536.5	687.8	307.9	216.4	430.9	448.3	260.3	157.9	285.5	398.4	147.2	454.1	322.1	110.9	167.5	304.9	193.8	672.3	290.4	236.2	87.9	418.2	213.2	219.0	1403.5	444.0	158.7	291.5	399.7	182.5	319.0	245.2	429.1	258.1	286.8	405.8	863.0	1202.1	706.0	449.3	199.3	713.5	371.1	375.9	590.5	339.8	92.8	211.8	405.8	313.5	283.1	239.7	289.3	180.5	522.3	436.5	175.0	246.9	849.2	697.4	207.6	269.4	707.3	432.1	188.3	314.7	665.9	527.1	317.5	249.4	225.7	311.1	660.4	353.8	354.9	386.2	569.7	458.9	482.8	55.3	271.3	408.9	629.9	348.3	220.6	390.5	366.1	422.1	246.7	358.1	498.0	450.9	392.3	257.4	680.6	254.6	786.5	582.0	224.3	369.4	412.2	230.9	578.9	539.6	564.4	219.8	405.4	256.9	352.7	319.7	230.7	404.0	309.9	339.4	245.0	265.1	196.6	462.2	278.8	310.3	841.7	415.1	428.7	440.7	519.1	419.2	450.3	430.9	448.3	454.1	418.2	444.0	429.1	415.9	179.5	189.7	21.2	281.7	510.0	525.8	1188.1	512.2	332.2	845.1	868.2	264.6	316.0	600.6	472.6	98.0	562.5	231.3	479.1	1592.6	515.8	4209.7	546.8	326.3	268.7	397.1	215.0	24.5	368.7	1327.3	536.1	99.9	442.3	346.1	242.6	322.0	826.2	1184.1	208.6	33.1	328.7	671.4	583.1	1304.8	18580.2	384.9	735.2	677.7	21.5	1786.8	502.6	192.6	13.6	35.4	484.0	507.9	312.9	189.2	694.7	1861.9	3024.7	800.9	246.0	243.3	244.6	587.1	1310.8	202.4	357.7	467.0	978.1	281.0	186.7	336.4	662.6
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	37.9	36.9	17.8	28.0	15.9	23.9	31.1	16.4	24.5	33.2	17.5	30.1	15.1	32.5	5.3	11.6	36.2	16.5	30.3	17.4	18.5	27.4	21.2	58.1	28.8	21.8	20.7	38.4	80.8	17.8	29.2	16.8	21.5	32.6	8.4	5.1	55.6	17.0	47.8	14.5	23.3	18.9	18.2	42.1	35.8	16.6	21.5	18.7	25.4	18.9	12.8	35.7	20.1	17.1	17.3	106.0	21.3	41.5	23.9	27.5	19.6	21.6	27.5	21.8	21.6	39.8	11.9	10.8	41.2	25.2	19.3	9.5	22.2	31.9	8.2	48.9	47.3	24.6	25.5	36.8	48.3	21.7	41.1	46.5	19.9	16.1	26.7	36.6	71.5	54.1	31.8	5.7	16.0	13.2	46.5	23.6	38.6	28.4	12.7	47.1	6.9	10.7	24.8	2.5	30.8	64.4	20.0	12.7	33.7	18.4	19.4	20.6	38.9	34.9	22.3	8.0	29.6	8.8	26.3	22.4	23.5	19.6	27.0	23.1	5.7	5.4	3.5	9.6	7.3	0.6	4.6	2.7	5.1	1.2	3.5	5.4	12.7	5.7	19.9	1.7	4.1	3.8	17.8	15.9	16.4	24.5	17.4	18.5	21.8	20.7	21.5	18.2	21.5	17.1	51.0	22.4	37.3	28.1	23.6	20.8	64.4	15.1	18.2	15.8	22.0	18.7	12.3	0.0	16.1	16.5	16.7	13.1	32.3	3.5	3.9	36.8	1.4	15.3	19.9	63.2	39.4	20.4	8.9	57.8	35.8	25.6	10.7	16.5	9.5	39.5	66.4	5.6	53.8	8.4	12.1	15.0	14.2	39.4	81.6	3.0	25.7	37.7	33.8	15.0	146.0	23.1	19.6	12.5	15.1	41.2	9.6	25.2	40.4	68.6	1.4	15.1	11.5	14.9	13.1	15.4	26.0	1.2	5.7	3.4	15.3	33.1	48.1	50.6	19.7	51.9
GRAP		ENSG00000154016	"GRB2 related adaptor protein"	Q13588	17	19020656-19047011	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;B-cells: 21.2;Endothelial cells: 19.8;Hepatic stellate cells: 30.7;Microglial cells: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 99.7;T-cells: 133.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 87.1;HUVEC TERT2: 38.9;JURKAT: 30.1;REH: 47.8;TIME: 70.4;U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046595, HPA066654"	Uncertain		Approved	Centrosome		NA	NA		1400000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	6.3	3.5	6.7	13.9	6.2	6.5	5.9	6.1	6.9	3.9	5.0	2.6	1.9	3.3	0.5	1.8	4.6	5.3	3.7	5.8	6.1	4.9	6.0	7.1	36.9	6.8	6.5	1.8	0.9	0.6	1.9	6.1	6.8	2.7	1.8	0.4	1.6	3.7	1.7	2.4	15.7	3.3	6.5	37.5	2.2	6.3	7.0	31.9	5.5	1.4	30.7	3.6	2.2	6.0	0.0	0.2	4.5	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.0	87.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	5.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	38.9	30.1	0.2	0.0	0.0	0.2	19.9	1.9	0.9	0.0	0.0	47.8	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	6.8	70.4	0.0	0.2	9.8	0.1	0.1	0.0	60.2	0.1	0.1	0.3	21.5	9.4	1.3	21.5	4.8	21.5	99.7	67.4	28.4	10.5	82.7	133.6	66.5	2.9	21.4	0.4	7.9	62.3	48.9	6.7	6.2	6.1	6.9	5.8	6.1	6.8	6.5	6.8	6.5	7.0	6.0	11.2	6.4	1.8	0.0	21.2	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.6	0.0	0.0	0.1	3.1	0.0	0.0	0.3	2.3	1.1	0.2	19.8	0.0	4.0	0.0	0.0	0.7	0.4	0.0	1.2	2.5	0.1	30.7	0.8	8.2	0.0	0.0	0.4	0.0	4.4	0.7	0.8	0.0	1.9	0.0	9.4	2.9	0.2	2.1	0.0	0.1	0.2	0.0	0.4	3.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.7	0.3	0.0	1.0	0.3	6.9	0.5	0.3	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 652.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 864.6;Proximal tubular cells: 817.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	58.9	143.1	72.6	35.5	83.9	40.5	55.7	84.1	74.3	53.0	76.1	60.5	63.5	58.5	62.6	62.5	51.0	36.6	107.6	69.7	76.4	156.5	652.5	42.9	55.8	76.3	76.2	63.4	64.2	49.1	35.7	35.2	77.6	50.7	35.4	20.8	74.8	46.4	168.5	64.2	51.4	42.8	75.9	41.7	60.7	37.9	78.4	34.7	43.4	146.4	51.5	52.9	51.8	89.4	111.7	157.7	87.5	81.0	80.1	86.4	87.7	86.2	114.3	115.8	125.2	60.3	47.2	106.5	50.0	105.3	85.8	49.3	51.7	113.5	69.3	140.3	62.8	61.6	144.1	107.5	124.3	58.7	61.6	104.2	97.2	67.6	87.4	98.0	102.2	67.5	116.1	42.9	104.2	85.3	58.9	60.8	53.5	101.1	67.5	55.4	62.1	59.1	155.9	63.0	36.3	64.3	74.4	143.8	84.1	79.1	80.1	75.7	109.7	63.5	100.4	44.0	76.9	33.1	27.4	70.8	90.8	33.5	95.7	45.0	64.7	33.9	39.3	66.9	32.7	61.6	40.8	44.6	70.3	65.6	39.6	33.9	14.5	64.5	56.7	63.4	57.8	52.0	72.6	83.9	84.1	74.3	69.7	76.4	76.3	76.2	77.6	75.9	78.4	89.4	50.7	57.7	30.2	24.2	37.5	43.3	52.5	87.3	41.5	39.0	53.7	65.7	103.7	177.3	53.8	51.5	20.9	152.6	33.9	65.3	248.4	78.0	14.9	38.4	65.4	47.9	62.2	54.7	10.3	89.0	93.0	67.7	52.0	44.8	50.1	93.3	67.5	864.6	110.8	23.5	11.0	79.7	71.2	82.9	45.8	16.0	74.6	49.2	80.0	14.0	71.1	102.8	33.0	16.1	44.9	73.8	56.9	98.6	30.1	46.4	135.6	817.7	36.0	29.1	78.9	54.3	71.8	22.3	19.0	74.6	56.3	88.9	32.5	233.3	80.9	48.1
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 83.7;retina: 32.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 322.4;Inhibitory neurons: 608.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;ASC diff: 3.5;BJ: 5.5;BJ hTERT+: 2.9;LHCN-M2: 8.1;U-266/70: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035202	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035202: AB_2674516"	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.2	0.4	38.7	0.1	42.8	0.0	0.4	43.5	79.8	0.2	0.0	0.6	0.2	0.1	0.7	0.1	0.1	0.0	0.8	83.7	23.2	0.1	0.0	9.3	0.0	3.4	3.6	0.2	0.3	0.2	1.2	0.0	2.7	0.1	0.1	32.6	0.1	0.5	0.2	0.3	0.3	1.0	5.3	0.0	0.6	0.9	27.9	0.1	0.3	0.4	0.0	0.1	0.3	18.1	0.0	0.0	11.6	0.0	3.5	2.3	0.0	5.5	2.9	0.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	42.8	43.5	79.8	83.7	23.2	3.4	3.6	2.7	5.3	27.9	18.1	0.2	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	36.3	0.3	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	5.1	0.1	5.6	0.4	0.0	0.0	322.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	608.8	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	7.5	0.0	49.0	0.0	94.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034515	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;intestine: 7.8;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 39.1;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 72.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 13.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.60e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.08e-2)"	0.5	1.9	12.1	0.6	10.3	0.0	2.4	3.2	5.4	1.0	0.0	7.8	0.7	0.2	1.8	1.2	0.3	0.8	1.1	11.2	9.9	0.1	0.0	0.1	0.1	15.7	9.0	0.3	0.5	0.6	9.2	0.0	17.0	1.6	1.3	4.4	0.8	2.4	0.1	0.3	2.2	0.6	1.8	0.2	1.5	0.7	8.4	0.0	0.2	0.4	0.4	1.0	0.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.4	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	10.3	3.2	5.4	11.2	9.9	15.7	9.0	17.0	1.8	8.4	8.3	0.1	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.7	1.9	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	39.1	0.0	0.0	0.7	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	108.1	0.0	0.0	0.0	0.3	6.9	0.3	0.0	1.8	1.0	0.0	14.3	0.0	72.9	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 132.6;Inhibitory neurons: 134.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	0.0	0.1	15.7	0.2	46.4	0.0	0.2	0.0	186.7	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	35.9	0.0	0.0	0.0	0.1	0.1	1.3	19.5	0.0	0.1	0.2	0.7	0.0	3.8	0.7	0.0	3.7	1.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.4	0.0	1.9	0.0	2.5	0.0	0.0	5.2	3.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	46.4	0.0	186.7	35.9	0.0	1.3	19.5	3.8	0.0	0.0	35.6	0.0	0.0	0.0	8.5	0.0	0.0	0.3	0.1	0.0	28.0	1.2	0.9	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.9	0.2	0.1	0.2	1.8	0.0	132.6	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.7	134.4	1.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	9.4	2.0	1.7	0.0	10.1	7.6	0.2	0.1	0.0	0.0	0.7	0.5	0.1	0.3	7.8	0.0	0.0	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.7	0.0	8.4	0.0	0.1	0.0	31.7	0.3	0.0	0.2	0.3	0.3	2.5	1.1	2.1	0.1	3.0	20.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.1	0.1	0.6	0.2	0.2	0.2	0.1	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.4	0.0	31.7	20.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 58.7;heart muscle: 18.6;thyroid gland: 16.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.7	2.4	27.3	0.2	29.5	0.6	0.2	58.7	27.6	0.4	8.9	0.6	0.2	0.2	0.1	0.2	0.2	0.2	18.6	23.2	18.0	0.3	0.1	0.1	0.1	33.8	19.7	0.3	0.2	0.1	0.6	1.8	36.7	0.2	0.1	3.3	10.5	0.2	0.4	0.2	0.4	0.2	14.5	0.2	0.3	3.8	24.9	0.0	16.6	0.2	0.0	0.3	0.3	22.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.3	29.5	58.7	27.6	23.2	18.0	33.8	19.7	36.7	14.5	24.9	22.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.3;skeletal muscle: 35.8;tongue: 12.5"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.1	1.1	3.0	0.7	2.7	0.0	1.0	0.0	6.2	1.1	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.3	0.2	3.5	2.3	0.3	0.4	0.4	2.9	5.8	3.4	0.5	0.3	1.0	3.9	2.1	0.9	1.0	0.3	0.9	0.4	35.8	2.0	1.0	1.0	1.7	1.6	4.5	0.7	9.6	0.3	0.8	12.5	0.7	1.0	1.2	1.8	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	6.2	0.2	3.5	2.9	5.8	2.1	1.7	9.6	1.8	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667219-113737736	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"retina: 42.6"	"Group enriched"	"Detected in some"	16	"Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 84.9"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266473-67286556	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 197.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 318.0;REH: 417.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA060707"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: "	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	41.2	35.6	42.4	73.0	42.7	197.1	38.0	31.6	63.8	41.3	16.9	54.3	38.2	34.7	10.4	68.1	41.6	28.8	49.1	44.4	32.5	38.6	47.4	64.1	102.4	36.4	31.6	30.1	33.1	16.2	37.5	25.5	36.5	59.1	33.3	7.9	47.1	22.8	55.6	68.3	88.7	25.1	29.1	186.8	45.4	24.1	36.9	74.7	32.2	40.9	77.8	41.3	47.4	41.8	43.1	29.8	28.1	48.0	22.2	19.9	28.7	24.7	23.4	33.0	27.4	67.1	69.0	215.3	39.5	23.0	44.0	56.7	41.3	33.5	17.2	264.4	26.3	122.5	35.4	30.8	27.9	259.5	238.3	18.0	38.2	26.5	34.8	24.4	42.8	87.7	45.3	107.7	29.0	80.7	147.5	318.0	35.3	125.8	44.4	417.0	55.3	65.2	34.0	54.6	57.0	30.8	36.9	52.9	90.5	16.9	49.7	283.0	24.5	26.7	34.8	33.6	28.4	69.2	67.5	195.3	34.0	153.6	24.6	12.6	17.8	19.2	8.4	27.6	6.3	6.1	6.3	7.0	10.2	6.4	5.0	4.9	35.7	6.9	33.7	9.0	4.4	15.9	42.4	42.7	31.6	63.8	44.4	32.5	36.4	31.6	36.5	29.1	36.9	41.8	33.4	3.2	17.9	0.0	16.7	0.0	0.0	0.0	0.0	0.0	24.5	19.7	0.0	0.0	4.3	5.5	0.0	8.9	80.2	0.0	1.9	10.3	0.0	16.6	14.7	9.0	0.0	0.0	0.0	12.6	5.9	6.1	0.0	18.9	21.5	22.3	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	32.4	0.0	0.0	17.7	0.0	0.0	5.6	0.7	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	9.6	31.0	36.3	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345246-44353106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1420.7;Kupffer cells: 892.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	138000000	110000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	158.9	123.2	61.5	160.4	67.2	478.5	120.7	67.7	97.3	156.7	73.9	189.8	130.9	108.3	134.0	534.0	87.1	157.3	153.0	61.0	69.7	167.4	118.9	309.5	183.2	81.0	71.5	73.8	108.9	87.8	84.4	183.2	87.6	111.7	110.3	12.5	262.9	100.6	60.6	189.7	179.0	91.9	71.8	349.8	127.9	59.4	94.3	67.8	127.7	45.9	107.8	150.0	198.3	97.3	119.3	197.5	52.7	159.5	443.2	231.8	181.2	147.3	447.5	231.6	309.8	86.3	294.0	364.0	299.4	217.6	312.9	185.3	68.6	334.5	75.8	55.8	186.8	38.4	93.8	175.2	245.5	61.6	493.6	332.4	450.5	188.1	106.0	391.2	269.8	64.3	75.1	51.3	148.8	183.1	32.8	172.8	44.3	110.5	334.0	97.7	180.8	433.0	248.2	145.9	54.7	74.7	201.0	92.7	360.9	138.0	209.4	229.0	340.7	437.6	104.6	300.5	97.8	116.3	313.9	122.3	268.1	149.6	124.2	215.1	2057.5	176.5	35.1	1122.4	27.8	174.0	37.1	31.1	1534.2	112.2	27.8	26.5	851.2	30.6	548.1	1331.9	55.4	1613.4	61.5	67.2	67.7	97.3	61.0	69.7	81.0	71.5	87.6	71.8	94.3	97.3	113.0	86.6	83.3	12.7	82.8	112.7	151.1	574.2	97.9	23.6	85.7	69.7	90.7	133.0	332.7	218.8	18.8	429.1	195.7	494.8	9.8	447.7	2.1	103.8	83.8	170.9	124.3	38.7	6.8	307.3	324.1	149.4	83.6	372.5	75.5	90.0	207.8	84.7	1420.7	47.1	6.6	214.6	146.5	892.0	360.8	6.8	60.9	699.2	208.1	20.6	501.6	58.9	20.6	11.1	11.8	285.3	581.7	57.2	65.8	70.7	312.1	120.5	70.0	11.8	85.5	45.4	83.3	25.1	72.2	255.5	96.5	640.0	30.8	89.6	274.5	175.6
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 2486.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1649.5;Fibroblasts: 4145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1135.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1313.9;HaCaT: 533.6"	"Region enriched"	"Detected in all"	4	"white matter: 869.2"	"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	240000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	1892.9	162.5	169.7	109.7	317.4	175.0	1244.6	291.2	213.0	577.4	155.6	867.4	152.0	767.7	108.2	435.1	663.2	226.1	2486.9	163.4	219.8	153.1	40.6	308.7	93.2	380.9	284.6	303.8	140.7	70.9	260.6	79.0	354.7	344.0	204.6	57.8	508.7	400.9	420.4	612.9	384.1	350.0	270.6	136.5	469.7	78.1	279.0	99.7	702.6	687.8	87.3	897.2	655.5	376.1	38.4	60.9	39.0	129.8	1313.9	351.8	26.4	130.9	264.7	30.1	56.5	64.2	130.1	3.0	36.6	182.8	48.5	533.6	3.2	84.3	16.9	6.5	7.6	31.2	57.1	167.5	32.0	7.0	146.0	140.0	84.9	51.7	34.4	83.1	120.4	6.1	10.4	5.3	137.0	81.1	0.4	304.4	12.7	76.2	45.1	8.4	13.1	4.3	156.4	63.4	7.7	10.4	60.9	62.5	197.2	84.6	245.3	158.8	217.4	100.0	33.2	10.4	12.8	1.8	2.0	3.2	105.3	18.2	278.1	302.9	122.0	1135.9	1.9	84.9	0.8	17.6	0.8	1.4	345.3	6.7	0.8	0.7	307.1	217.8	23.7	243.2	4.2	105.4	169.7	317.4	291.2	213.0	163.4	219.8	380.9	284.6	354.7	270.6	279.0	376.1	1649.5	147.4	55.7	82.3	22.7	341.2	278.1	252.7	103.0	7.5	120.8	212.0	272.0	85.8	354.3	121.4	77.2	55.8	74.9	557.7	105.7	258.5	9.9	141.9	163.1	724.8	63.1	17.2	17.1	202.3	94.3	4145.2	322.7	220.6	104.0	31.8	273.5	16.5	492.6	1.7	9.0	762.9	512.7	139.0	798.7	20.2	588.7	273.7	537.2	155.5	487.5	220.6	55.6	33.2	443.1	315.8	590.5	671.8	24.1	91.4	77.4	39.8	583.7	86.5	611.4	362.4	740.4	8.7	13.7	175.9	299.1	84.0	58.7	34.3	52.2	144.7
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Vesicles	"HPA052488: AB_2681849, HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	60.8	57.5	22.3	49.5	24.7	76.3	46.0	24.4	33.3	42.0	27.4	56.0	33.8	34.5	46.6	67.9	30.1	35.2	53.4	23.9	24.5	53.6	76.3	47.7	55.4	25.0	23.1	33.3	62.2	62.7	27.5	50.0	26.2	47.8	59.6	35.3	41.0	41.8	127.0	43.5	34.3	46.9	25.0	40.2	49.8	68.7	23.1	56.3	57.7	97.8	82.0	85.7	39.6	29.3	220.1	212.9	116.1	161.0	164.2	169.3	167.5	238.0	245.9	187.1	185.4	153.1	197.8	295.7	303.9	207.5	130.1	164.3	297.8	220.3	312.9	142.4	153.6	202.0	163.1	325.5	137.9	258.7	103.5	133.5	170.0	212.0	288.3	122.4	210.4	146.2	331.7	148.7	220.0	211.2	219.8	134.0	232.9	163.0	120.1	256.4	200.5	345.6	184.7	189.3	186.4	99.6	342.0	256.3	144.2	164.3	222.4	122.6	163.3	206.8	129.5	151.5	190.3	146.6	233.2	253.8	145.4	258.1	128.5	1.4	5.8	7.7	6.3	11.1	8.8	7.9	8.1	7.7	7.0	6.5	8.2	8.1	1.9	7.2	9.9	3.8	10.5	4.3	22.3	24.7	24.4	33.3	23.9	24.5	25.0	23.1	26.2	25.0	23.1	29.3	69.4	76.9	160.2	39.5	92.3	242.2	232.0	47.1	170.8	47.7	95.0	61.6	123.4	57.2	69.1	86.5	50.1	76.1	94.5	88.1	103.7	58.9	94.9	109.0	95.6	74.4	66.6	328.5	61.6	63.4	118.3	77.2	81.1	153.9	24.7	93.2	43.5	77.9	75.2	52.2	47.0	107.2	32.6	60.8	116.3	51.6	47.8	80.9	64.0	35.6	50.1	43.6	25.7	38.7	42.9	73.0	66.9	47.4	166.2	271.0	38.3	120.3	52.7	41.5	59.2	94.6	123.0	138.3	83.5	198.5	257.7	102.1	132.1	128.1	114.1	270.4
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm		NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	18.8	46.9	24.2	17.7	25.6	27.1	23.8	21.4	26.2	21.1	24.6	41.1	30.4	17.4	67.7	43.4	26.9	17.9	24.8	25.4	25.3	42.7	44.8	21.7	15.9	23.7	25.1	14.3	15.7	27.7	26.4	19.8	25.5	34.2	40.6	15.7	28.9	18.6	20.4	34.6	28.4	19.1	22.9	23.7	28.5	23.7	25.9	21.5	23.2	16.9	18.5	22.9	26.1	25.4	63.7	75.7	36.2	51.2	41.4	42.8	51.5	52.9	48.7	81.6	67.1	139.9	75.5	44.8	68.6	54.9	78.7	58.7	53.6	134.8	68.5	20.9	30.4	176.1	46.8	140.1	58.1	44.8	59.5	45.3	141.8	77.0	128.8	36.3	58.4	59.5	87.1	35.7	100.6	70.1	72.5	63.5	21.4	83.2	96.0	64.8	72.7	106.9	117.7	63.9	71.0	41.3	93.6	86.5	70.9	19.7	106.5	40.5	46.7	93.1	52.5	61.7	46.5	35.7	35.9	49.1	79.4	48.6	56.7	17.5	36.2	8.7	30.4	39.2	27.6	12.8	24.0	31.4	43.6	8.7	27.7	23.7	8.4	29.3	36.6	23.9	32.6	29.0	24.2	25.6	21.4	26.2	25.4	25.3	23.7	25.1	25.5	22.9	25.9	25.4	10.6	19.2	10.5	13.4	9.9	26.3	32.5	72.4	38.7	23.0	32.8	20.8	17.1	27.1	38.1	25.8	10.4	79.4	19.1	58.1	25.4	51.6	55.6	14.8	18.2	16.1	23.4	26.9	12.2	47.2	52.5	19.3	37.2	16.4	17.7	80.1	10.0	27.3	59.9	35.3	13.8	50.6	48.8	17.2	17.3	164.1	10.2	26.8	16.0	5.6	31.0	29.6	19.6	10.1	9.9	39.8	40.1	18.4	19.6	21.4	33.8	121.5	18.1	16.9	26.3	12.0	21.0	14.7	18.9	38.1	24.2	49.0	20.6	52.1	77.7	33.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	150.9	180.9	77.5	135.9	82.5	187.0	159.1	82.7	89.2	154.5	141.0	217.9	317.2	95.2	110.7	154.0	144.7	140.6	271.7	75.7	82.7	257.2	449.3	125.1	185.0	85.2	84.0	71.1	138.0	308.2	79.7	104.2	85.3	111.4	230.8	26.9	213.0	96.4	238.6	132.6	277.1	106.6	79.8	236.5	163.4	85.1	83.3	96.2	160.1	324.1	183.7	129.5	112.4	88.6	150.7	106.1	14.7	130.1	224.2	319.7	68.8	87.0	148.4	76.3	150.8	64.5	375.2	85.4	120.8	126.7	114.5	222.4	57.5	136.2	66.0	165.0	62.3	69.6	80.9	102.9	154.1	84.7	108.4	290.4	164.3	88.0	62.0	113.1	205.3	109.5	99.3	100.9	207.2	116.2	87.3	152.9	34.7	291.3	158.6	73.9	2.4	169.6	266.1	81.6	59.7	81.4	159.4	256.3	137.4	88.3	123.6	117.0	122.2	41.0	37.7	108.5	75.2	171.0	86.5	20.0	148.5	336.0	86.6	351.1	537.1	210.7	298.5	597.9	289.7	254.5	554.6	386.4	445.2	183.2	281.3	274.6	165.0	188.3	641.7	187.0	800.5	917.1	77.5	82.5	82.7	89.2	75.7	82.7	85.2	84.0	85.3	79.8	83.3	88.6	181.9	70.5	95.6	17.0	134.1	114.2	174.9	244.0	118.4	11.6	181.9	198.2	172.9	211.6	219.5	121.4	12.5	295.3	151.4	301.6	291.6	160.5	561.3	102.7	95.8	117.0	153.6	63.3	25.8	120.3	132.0	96.4	185.5	92.9	145.1	47.4	155.3	322.1	304.2	8.4	28.8	252.8	154.6	288.3	174.1	1160.2	72.7	195.8	151.2	16.9	228.5	85.9	194.7	16.6	14.3	104.5	505.2	50.8	130.0	82.9	670.0	620.2	154.0	15.4	85.5	65.9	121.7	6.9	10.3	166.3	116.4	183.7	250.7	150.7	366.5	218.9
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 479.1;liver: 609.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Region enriched"	"Detected in all"	18	"cerebral cortex: 479.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4"	"Low region specificity"	"Detected in all"							"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	55.5	155.7	26.1	17.4	26.4	9.7	56.9	24.9	479.1	61.5	26.9	39.1	27.9	38.1	69.6	152.3	45.8	29.4	30.5	25.9	25.8	37.3	609.6	28.2	1.8	25.5	26.3	178.4	66.8	48.7	33.5	8.7	26.1	47.0	22.4	10.2	43.8	128.6	69.3	73.5	47.3	64.3	25.0	63.6	59.5	57.0	26.6	33.5	27.7	0.0	17.9	127.0	135.2	25.3	0.3	0.6	0.3	1.3	0.0	0.0	0.5	0.0	0.3	0.2	0.4	1.0	7.0	26.9	0.1	41.6	0.0	1.3	0.1	0.6	0.7	0.1	0.4	87.0	96.1	1.7	78.6	0.0	0.7	0.1	0.1	73.0	0.3	48.1	62.4	50.1	0.0	56.8	2.5	0.0	115.4	0.7	54.6	0.1	0.0	0.4	0.6	11.1	9.0	0.1	5.3	0.7	0.0	0.3	0.5	2.6	1.1	44.5	0.2	35.5	2.0	0.9	0.1	45.1	64.4	3.7	30.7	1.1	2.0	2.2	26.1	32.2	28.8	39.1	31.0	30.8	31.4	28.5	77.8	32.5	33.1	32.6	2.0	30.1	17.4	41.1	38.9	28.5	26.1	26.4	24.9	479.1	25.9	25.8	25.5	26.3	26.1	25.0	26.6	25.3	0.3	9.6	6.8	0.0	0.2	1.8	0.6	2.0	0.0	0.1	2.7	1.9	6.0	2.8	6.7	0.0	0.0	0.0	0.8	0.4	0.0	1.2	0.0	0.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	2.5	0.0	5.0	5.5	0.1	0.0	0.0	0.3	0.0	7.1	2.2	0.4	3.7	0.5	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.6	0.1	2.2	0.0	0.1	1.9	0.0	5.1	0.0	0.0	0.3	1.4	0.5	0.4	0.0	1.6	0.0	0.8	0.0	0.2	1.8
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 657.7"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 676.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 1106.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037603, HPA037604"	Enhanced					NA	NA		120000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	95.0	145.4	119.1	102.8	123.1	191.6	89.9	121.3	166.7	90.1	118.0	92.7	167.6	72.0	96.2	79.3	75.4	84.8	277.4	117.3	124.8	154.4	657.7	154.7	93.1	121.3	127.1	83.1	80.5	129.7	102.9	113.6	122.7	80.3	94.8	38.2	75.6	89.6	148.4	63.8	165.2	86.9	122.2	107.1	93.3	14.9	128.8	124.8	82.9	122.5	77.4	109.6	82.6	136.4	287.7	194.5	142.9	249.3	201.4	385.1	62.8	358.3	640.7	237.9	257.2	247.2	292.8	254.2	152.8	245.6	296.8	158.8	97.0	329.2	244.5	128.4	233.7	186.6	122.1	542.7	359.7	241.5	294.5	291.5	136.7	346.3	414.5	331.3	464.1	231.2	394.4	153.4	511.4	159.3	188.3	330.0	130.4	308.1	134.8	136.0	94.9	108.1	358.4	185.1	72.1	88.6	117.6	81.0	1106.0	238.2	92.0	192.7	426.6	276.9	143.6	427.3	328.4	2.7	3.3	2.0	517.7	416.2	112.0	842.8	532.4	157.9	133.0	457.0	164.5	148.8	164.6	172.9	429.3	111.9	143.0	144.3	151.8	185.0	369.1	203.0	204.8	632.1	119.1	123.1	121.3	166.7	117.3	124.8	121.3	127.1	122.7	122.2	128.8	136.4	107.4	76.9	72.6	8.8	64.8	93.7	328.2	297.6	51.2	36.9	63.5	105.5	328.2	218.8	113.3	101.2	20.9	394.2	82.0	101.6	332.6	341.0	22.4	68.1	79.6	164.5	103.5	192.8	12.1	248.4	176.6	173.0	49.5	81.7	146.3	107.6	388.0	628.2	676.5	23.5	11.7	163.8	124.1	321.8	223.6	17.3	114.6	484.5	126.3	8.4	277.7	81.2	95.8	8.5	21.8	347.6	150.7	112.8	39.9	169.4	483.2	538.0	114.3	29.8	151.2	85.3	176.1	5.7	5.1	55.8	78.7	111.0	81.4	224.8	196.6	204.9
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583742-67586656	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2087.9"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 4033.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4998.3;OE19: 7810.3"	"Low region specificity"	"Detected in all"							"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	290.5	276.2	346.8	232.1	370.3	601.3	288.7	358.9	425.7	641.9	695.8	329.6	394.6	331.9	280.3	2087.9	647.5	435.8	367.2	341.4	381.9	567.7	45.1	468.3	321.8	375.7	379.2	306.9	340.9	737.4	320.2	326.9	378.5	291.7	197.1	137.9	541.2	780.4	355.0	731.4	321.7	214.2	367.0	257.2	535.5	45.8	378.1	296.9	579.0	312.5	380.8	526.5	946.2	377.7	1202.5	1599.4	763.7	1198.9	577.8	645.2	705.3	511.3	678.1	761.2	589.3	2956.3	1225.0	3.3	1144.7	813.5	683.7	1707.8	2073.9	2248.5	214.4	848.0	765.3	59.9	1107.6	0.5	852.2	400.3	667.6	807.2	4998.3	609.9	583.3	560.9	1160.2	847.2	1318.2	321.8	605.7	4.3	918.2	1100.6	1475.2	7810.3	681.3	844.8	129.6	3.8	1236.8	3.6	260.6	754.3	719.1	230.9	2394.0	598.2	3.6	656.3	634.5	351.6	883.8	740.6	378.6	200.0	1353.9	447.1	400.0	652.4	747.8	56.0	3145.4	246.6	720.0	2470.8	271.9	509.2	322.4	597.7	3582.7	476.3	267.8	466.5	130.5	1443.8	1608.5	1435.1	363.3	3948.4	346.8	370.3	358.9	425.7	341.4	381.9	375.7	379.2	378.5	367.0	378.1	377.7	466.7	1153.8	872.3	25.5	296.8	865.6	1914.8	3813.8	767.2	170.0	628.7	838.3	297.3	987.9	2763.5	1230.4	33.3	2116.8	372.4	655.0	1805.9	1811.9	4.9	1381.0	589.0	431.4	368.2	166.3	6.8	1444.4	1703.9	710.5	781.9	1020.9	269.9	795.0	382.3	10.5	861.2	70.7	10.1	992.4	1930.7	597.9	1090.3	25.5	572.3	703.5	1531.5	27.2	2166.5	558.5	459.3	17.6	38.4	1412.1	948.9	400.2	591.6	2266.2	844.4	3495.5	3715.4	274.4	361.6	401.3	941.7	4.8	54.9	4033.7	1061.7	1645.5	342.5	527.8	1118.5	3418.6
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852633-88891944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"HPA061626: AB_2684570"	"prognostic favorable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	25.3	26.4	14.8	18.8	15.7	62.2	28.3	16.4	24.0	22.9	17.7	22.6	17.9	21.8	30.3	26.3	22.7	23.8	15.7	15.5	16.5	22.9	32.6	22.0	28.9	15.5	15.9	26.3	23.3	22.7	20.3	25.2	15.7	18.1	23.1	17.9	22.9	16.3	23.1	28.3	23.9	20.7	16.2	28.7	23.0	16.3	15.1	40.2	21.2	18.5	31.3	31.5	23.7	17.0	40.0	13.6	34.6	18.8	49.8	34.4	42.9	32.1	39.4	44.1	46.4	17.9	24.3	45.5	37.8	28.0	53.3	22.0	36.8	32.1	38.3	42.8	34.3	48.6	21.2	32.1	31.9	56.8	28.7	30.0	32.1	38.2	21.7	33.4	25.1	41.1	43.1	33.6	47.0	12.6	54.9	46.7	28.8	35.4	29.3	34.4	46.8	34.2	47.0	47.2	26.7	22.4	28.5	35.4	57.8	30.7	15.9	51.1	22.3	19.2	24.0	35.0	38.8	35.1	29.9	62.6	12.8	48.8	16.7	91.2	49.3	82.1	45.9	57.1	53.2	57.8	52.1	50.5	62.5	48.2	62.9	53.9	99.7	54.9	60.4	40.5	70.1	50.9	14.8	15.7	16.4	24.0	15.5	16.5	15.5	15.9	15.7	16.2	15.1	17.0	106.6	6.4	29.7	13.7	114.9	46.3	75.4	63.3	58.6	14.6	39.7	104.9	12.3	21.5	45.6	11.0	2.1	74.0	122.3	39.1	39.2	49.2	22.9	53.9	28.4	30.3	20.3	51.1	22.7	38.6	60.0	53.0	41.8	29.8	48.9	30.2	16.8	17.6	40.5	18.5	21.4	30.5	52.9	32.3	42.5	7.9	36.4	93.4	28.4	22.5	40.3	30.7	33.0	18.1	25.2	49.9	70.5	29.3	74.3	27.8	26.9	47.4	55.2	18.5	13.1	86.6	65.0	24.2	29.0	40.1	50.0	150.1	122.8	34.5	22.7	79.4
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	5.2	7.7	4.2	6.6	4.9	4.4	5.1	4.6	5.5	4.9	7.9	5.0	4.6	4.6	4.5	4.2	4.2	3.7	5.1	4.4	4.8	4.3	5.0	4.9	9.1	5.0	4.7	5.7	4.5	4.6	2.9	6.6	4.9	4.6	5.8	5.6	4.2	5.6	7.0	3.6	4.2	5.7	4.5	7.7	4.7	9.9	4.9	8.3	5.5	9.3	9.0	5.5	4.2	5.4	13.7	18.7	23.0	14.1	16.9	7.8	20.0	9.0	8.2	13.8	14.7	22.5	9.6	22.3	15.3	6.8	10.7	16.1	21.4	11.8	19.2	15.6	5.0	28.7	12.8	19.0	13.1	26.1	16.8	10.4	12.6	10.3	14.5	9.4	21.4	18.9	20.4	11.3	14.8	15.6	21.6	13.2	22.0	13.1	17.2	17.7	27.0	16.6	13.8	8.6	4.9	15.1	13.5	11.6	12.6	20.6	14.7	19.8	18.9	12.9	14.0	4.1	10.2	9.9	11.8	31.5	13.5	26.0	12.5	18.0	7.2	11.6	6.6	11.2	8.3	9.3	8.1	9.5	8.7	7.3	8.6	8.4	5.0	10.8	10.5	4.1	10.2	7.6	4.2	4.9	4.6	5.5	4.4	4.8	5.0	4.7	4.9	4.5	4.9	5.4	4.1	3.2	4.4	3.3	6.8	1.9	3.0	4.1	3.4	5.3	4.6	1.8	4.9	8.6	6.3	7.3	0.0	9.0	4.7	3.8	5.9	5.1	7.7	8.1	6.0	5.4	1.2	5.5	3.8	4.4	8.4	3.8	3.1	6.1	12.7	9.1	7.5	5.3	9.2	16.8	4.0	3.2	6.1	8.3	2.2	2.9	2.1	7.0	3.6	8.4	12.5	5.5	14.4	4.5	7.2	4.9	2.5	4.9	5.3	3.3	3.4	5.9	5.1	4.4	0.0	3.5	3.9	14.3	22.8	2.8	2.6	8.8	5.7	9.7	3.9	3.1
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74650231-74760692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA		55000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	61.2	75.3	32.5	48.2	36.4	32.7	52.2	36.7	35.7	57.5	64.7	41.9	52.8	57.5	41.3	54.9	66.9	47.0	51.2	32.3	31.5	70.9	57.6	52.3	56.7	31.2	33.7	64.4	49.8	106.0	42.9	56.1	31.6	64.2	39.9	82.8	69.4	54.1	84.2	62.9	48.0	61.5	31.0	47.6	67.6	25.4	35.1	70.6	118.0	56.8	68.8	49.4	38.8	46.4	136.4	110.4	222.6	219.9	120.6	106.7	46.3	83.7	76.9	90.5	89.6	76.9	161.6	165.4	33.7	104.1	121.6	116.3	221.1	101.3	116.2	126.4	115.9	85.6	128.0	107.7	72.3	159.5	126.9	98.8	84.7	68.8	70.0	132.6	123.3	55.2	165.3	80.0	110.9	126.8	133.7	147.5	243.6	286.9	67.1	146.0	77.5	133.1	118.7	232.2	185.5	236.3	153.0	226.5	78.7	185.8	116.4	105.2	111.7	123.6	66.8	62.8	108.8	90.2	83.3	256.2	70.9	95.8	126.6	20.4	10.0	17.4	11.3	7.3	16.6	22.1	14.6	16.7	14.6	24.1	17.8	17.4	4.1	21.3	6.6	23.0	8.7	9.7	32.5	36.4	36.7	35.7	32.3	31.5	31.2	33.7	31.6	31.0	35.1	46.4	118.5	80.1	60.6	55.8	80.3	60.2	83.3	136.3	125.7	276.4	140.7	113.7	30.3	210.1	106.3	119.5	283.5	112.6	101.5	46.0	56.7	155.4	37.1	368.7	201.3	98.2	112.5	91.7	68.6	83.0	64.4	78.8	117.8	321.8	13.3	246.1	115.3	101.0	80.3	250.7	74.1	71.0	73.2	106.7	53.7	39.8	152.8	76.0	55.2	46.9	122.3	200.9	101.0	102.5	98.1	132.5	70.6	193.0	81.4	117.6	150.6	110.2	233.3	184.3	85.5	96.8	87.8	34.1	51.9	145.8	91.9	72.2	60.5	172.7	63.9	124.3
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162690-42164745	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"intestine: 927.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 3728.7;Paneth cells: 17085.1;Proximal enterocytes: 12113.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 52.1"	"Not detected"	"Not detected"							HPA018215	Enhanced				"Secreted to blood"	NA	NA		18000000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.8	0.1	0.0	3.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	716.9	56.5	0.9	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.4	0.2	1.2	0.7	0.0	0.0	0.1	1.2	0.0	0.2	7.3	0.0	0.1	725.9	0.0	0.0	2.0	0.1	0.0	927.5	17.2	0.0	0.2	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3728.7	0.0	2.6	0.1	0.0	0.0	0.0	47.7	0.0	0.0	1.1	4.4	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17085.1	0.0	0.0	0.0	12113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	3.8	0.0	206.6	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153410-42155820	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 143.1"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 18841.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 1.4;CACO-2: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"						"Secreted to blood"	NA	NA	77700	1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	89.4	36.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	5.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.6	0.0	0.1	143.1	0.6	0.0	0.0	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1098.8	0.0	0.9	1.0	0.0	0.0	0.0	22.8	0.0	0.0	47.9	0.3	0.0	0.0	0.0	22.3	0.0	0.4	3.1	0.1	0.0	0.0	107.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	18841.5	0.0	0.0	0.0	2568.9	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	55.3	0.9
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.2;Ductal cells: 22.9;Glandular and luminal cells: 15.5;Proximal tubular cells: 22.2;Smooth muscle cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 23.9"	"Lineage enriched"	"Detected in many"	13	"monocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 46.0;Karpas-707: 23.7;MOLT-4: 29.9;RPTEC TERT1: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	13.8	7.1	23.6	15.6	30.0	2.2	10.0	5.3	36.6	12.6	0.0	28.9	5.8	16.4	6.0	8.1	13.7	13.3	18.7	30.1	28.2	13.2	7.7	16.5	10.4	9.8	13.9	5.8	10.9	50.3	6.0	43.6	22.8	13.6	8.7	34.7	5.5	12.2	5.9	3.5	11.1	25.0	6.4	11.0	13.8	2.4	14.8	7.2	7.3	14.9	7.3	10.0	11.1	17.0	0.0	0.5	6.5	0.0	2.2	11.4	0.0	2.0	3.6	0.2	0.1	0.0	0.0	0.0	3.0	1.1	5.0	0.1	13.6	0.3	0.8	0.0	4.6	46.0	0.0	0.0	1.2	0.0	0.0	5.1	0.4	0.0	0.2	4.2	0.1	10.2	0.0	23.7	3.0	2.1	29.9	0.1	0.4	0.0	3.2	3.5	0.9	0.7	42.9	4.4	0.7	7.8	0.0	0.2	0.0	6.4	0.0	0.0	0.0	7.3	1.6	12.4	9.5	0.3	0.0	0.0	15.6	0.0	0.0	1.4	0.5	0.5	0.0	7.2	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.5	1.3	23.9	1.6	0.0	5.8	23.6	30.0	5.3	36.6	30.1	28.2	9.8	13.9	22.8	6.4	14.8	17.0	20.2	6.4	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.2	0.0	0.0	0.0	9.2	0.0	1.1	1.1	0.0	5.9	22.9	0.0	3.7	4.3	3.4	0.0	0.0	0.0	4.2	0.2	5.4	0.0	15.5	1.3	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.0
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482086	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	145	"retina: 42.2"	"Cell type enriched"	"Detected in some"	26	"Rod photoreceptor cells: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"							"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP PTB domain containing engulfment adaptor 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 83.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 136.5;Inhibitory neurons: 115.5;Muller glia cells: 129.4;Syncytiotrophoblasts: 204.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.9;SH-SY5Y: 83.4;WM-115: 228.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020587	Enhanced		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favorable (4.25e-6)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	9.4	24.5	2.0	5.8	6.4	0.2	13.1	0.0	4.3	27.7	33.0	13.3	13.5	35.3	83.0	19.2	18.2	17.5	5.2	3.6	7.3	21.3	0.8	13.3	1.7	22.7	4.1	31.8	22.2	26.1	3.4	19.7	23.2	27.7	7.8	17.7	16.1	28.1	9.6	6.2	15.8	21.7	0.3	5.9	22.6	28.0	4.0	1.7	7.8	16.7	3.3	11.9	14.3	0.1	12.5	26.9	106.9	23.8	17.1	15.5	18.6	16.5	27.0	25.1	19.9	18.9	62.6	0.0	13.2	13.2	28.2	8.3	20.0	1.5	18.9	0.0	13.9	27.0	20.5	0.2	15.1	0.0	0.2	10.1	4.2	13.0	14.2	42.9	12.7	0.0	22.5	0.5	19.3	1.8	0.0	0.4	27.4	18.1	46.0	0.1	25.1	14.0	60.0	4.7	0.5	83.4	0.0	14.6	40.2	47.9	4.7	0.1	5.9	7.8	3.8	26.3	9.6	0.0	0.1	0.0	4.6	0.0	228.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.0	6.4	0.0	4.3	3.6	7.3	22.7	4.1	23.2	0.3	4.0	0.1	22.8	16.0	13.4	43.4	1.6	15.7	23.9	3.6	10.2	1.5	10.6	12.2	1.6	45.8	28.2	23.9	0.0	41.1	0.6	3.7	45.0	33.0	5.0	23.9	35.4	32.1	136.5	0.0	82.7	38.2	5.9	55.3	39.8	52.1	0.0	2.2	10.0	1.5	3.2	1.7	115.5	4.6	14.2	1.0	10.5	7.9	20.5	2.0	35.6	53.4	1.1	129.4	0.0	3.0	3.1	51.3	9.8	61.3	1.4	79.8	30.8	43.2	43.5	3.7	6.6	42.2	27.9	79.6	23.9	38.9	27.6	204.4	2.7	27.0	4.7	34.5
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968130-48993310	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	32.4	26.3	17.9	16.2	18.8	46.0	23.7	26.4	23.3	17.1	22.2	21.7	15.3	18.8	8.9	38.2	18.7	10.1	118.5	19.7	17.6	21.8	14.9	16.0	15.5	22.2	20.9	19.7	13.6	15.7	15.5	11.3	19.6	27.4	14.7	19.2	22.2	15.5	319.4	20.7	19.9	16.7	16.4	18.5	23.2	6.1	20.2	14.7	15.9	201.6	14.4	24.3	23.2	18.3	67.3	26.3	19.0	26.3	43.2	16.9	37.6	45.5	31.7	46.8	54.3	25.8	21.3	28.0	27.0	44.7	12.4	46.6	32.0	57.7	40.6	17.4	46.5	23.1	33.3	23.1	24.3	25.4	15.9	41.8	27.2	30.2	25.4	40.5	39.8	28.8	16.4	36.1	59.4	25.4	31.8	21.9	10.2	29.0	29.8	26.6	33.2	27.5	46.7	70.6	11.8	16.4	40.5	52.1	10.4	25.2	27.7	26.1	31.0	57.1	22.0	26.1	50.5	29.8	33.1	13.5	58.3	22.2	13.1	7.7	9.4	6.6	7.0	5.3	8.6	5.2	6.0	6.5	13.4	3.9	4.7	4.4	3.7	10.6	8.0	7.2	8.6	7.1	17.9	18.8	26.4	23.3	19.7	17.6	22.2	20.9	19.6	16.4	20.2	18.3	3.5	0.0	14.2	21.9	5.9	5.1	3.7	11.7	11.4	4.2	7.3	5.5	67.9	2.8	5.8	0.0	16.7	7.6	6.8	13.2	0.0	8.1	0.3	6.9	8.9	7.1	7.2	4.8	14.7	6.9	31.7	5.0	12.8	11.9	4.5	6.7	9.7	5.2	8.3	0.0	16.6	9.2	4.1	7.0	5.7	0.7	5.3	7.2	7.2	4.7	9.8	3.3	10.3	8.5	6.9	11.8	8.2	5.7	9.7	5.4	9.2	6.0	6.2	11.7	0.0	5.0	7.3	1.3	2.9	15.3	4.1	4.0	5.2	3.8	11.7	3.3
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 22.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 385.8;NK-cells: 810.5;T-cells: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 583.9"	"Group enriched"	"Detected in all"	33	"NK-cells: 194.9;T-cells: 583.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.7;HMC-1: 2.1;JURKAT: 3.5;MOLT-4: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015624	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	2.2	1.1	0.9	10.0	0.9	21.6	1.1	3.6	2.0	1.4	0.3	1.5	2.1	0.8	0.2	0.8	1.3	1.8	0.8	0.9	0.9	1.0	3.3	5.3	19.2	1.0	0.8	0.7	0.4	0.0	0.9	0.4	1.0	1.3	0.3	0.2	2.8	0.4	0.7	0.8	6.2	0.2	0.7	22.7	3.7	1.8	0.9	8.7	1.6	0.1	3.8	1.5	1.4	1.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.1	0.0	0.4	1.3	0.6	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.1	0.5	0.1	0.3	0.1	9.1	1.4	1.3	583.9	1.7	366.5	0.9	189.2	471.3	1.5	4.0	182.8	379.2	11.9	194.9	2.3	3.6	99.1	227.5	0.9	0.9	3.6	2.0	0.9	0.9	1.0	0.8	1.0	0.7	0.9	1.0	3.4	0.0	0.0	0.3	5.7	3.1	0.1	0.0	0.6	0.5	2.4	2.2	0.1	1.5	0.0	0.0	0.0	0.2	385.8	0.1	0.0	0.4	0.9	0.6	1.5	1.4	0.0	12.0	0.3	0.4	0.4	2.2	13.3	1.1	0.0	0.1	3.6	1.4	0.2	0.0	0.2	0.4	0.0	3.7	4.7	1.6	0.0	5.9	1.8	1.0	8.6	1.6	810.5	0.5	0.3	0.3	0.0	0.0	35.8	0.1	0.0	1.2	0.0	1.4	0.0	1.5	1.2	0.5	1.1	0.9	1.4	0.5	243.6	0.2	0.1	0.1
H1-0	"H1.0, H1F0, H1FV"	ENSG00000189060	"H1.0 linker histone"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 660.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"OE19: 662.8;U-2 OS: 823.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	89.8	53.5	56.6	36.7	55.4	660.5	121.4	72.5	64.1	218.3	42.5	146.2	129.9	168.2	43.5	230.6	119.7	56.3	86.5	55.4	67.1	292.8	179.3	72.4	24.4	58.4	54.2	120.7	125.9	93.2	58.2	80.0	57.7	151.7	120.0	39.9	155.3	40.2	216.2	228.6	137.1	97.7	52.6	36.7	131.2	42.4	58.3	136.2	93.9	93.5	46.6	85.6	194.9	55.8	159.6	67.9	206.0	91.8	53.4	48.4	291.6	126.9	262.3	362.6	512.6	278.1	247.3	0.2	31.1	106.3	84.1	303.8	0.0	87.2	256.0	0.9	15.3	268.2	25.3	187.4	185.8	0.1	0.7	45.4	152.4	182.3	203.2	4.0	97.8	60.4	0.1	0.5	28.5	263.3	45.4	26.5	80.2	662.8	329.9	74.6	122.6	56.1	58.0	42.7	47.3	263.9	349.9	235.4	473.9	91.8	184.2	167.1	65.4	27.4	823.3	122.7	25.9	0.7	18.5	1.2	33.5	95.9	80.3	17.1	9.9	15.7	0.1	11.7	0.1	0.0	1.0	0.2	8.1	0.1	2.8	0.4	5.4	0.1	10.3	7.4	0.2	6.9	56.6	55.4	72.5	64.1	55.4	67.1	58.4	54.2	57.7	52.6	58.3	55.8	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	125.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0
H1-10	"H1FX, H1X, MGC15959, MGC8350"	ENSG00000184897	"H1.10 linker histone"	Q92522	3	129314771-129316286	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1004.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 937.8"	"Low region specificity"	"Detected in all"							"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	121.4	54.7	39.9	42.6	43.9	1004.3	145.0	60.6	68.6	162.4	25.2	125.0	44.6	143.1	9.2	107.8	142.2	13.9	82.0	43.1	48.4	162.7	100.1	115.8	44.3	29.5	26.0	168.9	100.0	30.1	112.6	25.4	25.1	124.5	11.9	13.9	98.7	20.8	110.7	258.4	106.7	13.2	27.8	127.7	115.7	40.9	38.2	131.5	94.4	12.3	18.3	130.9	140.7	46.4	141.8	73.4	135.8	59.3	13.6	16.1	129.1	60.5	43.5	70.4	74.3	44.5	75.5	17.8	65.5	21.6	47.2	139.1	57.3	39.0	10.8	129.4	111.7	53.8	55.5	61.1	57.3	62.6	14.1	32.4	51.9	28.7	64.7	32.0	40.7	241.7	83.7	308.5	10.0	147.9	290.9	124.1	127.2	25.8	81.6	207.4	58.1	170.9	22.1	29.1	216.0	250.1	64.1	31.7	196.3	26.1	124.1	125.1	40.9	54.4	283.5	53.5	51.2	937.8	385.2	156.9	44.5	58.6	61.1	0.5	5.5	17.8	4.4	4.2	4.0	5.7	6.7	5.2	7.9	5.3	8.4	4.3	1.2	5.2	3.9	11.4	6.1	2.4	39.9	43.9	60.6	68.6	43.1	48.4	29.5	26.0	25.1	27.8	38.2	46.4	188.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	66.8	73.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	114.2	46.9	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	68.4	17.6	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AJ	"FLJ10903, H2AFJ, MGC921"	ENSG00000246705	"H2A.J histone"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 565.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 256.2;MCF7: 338.4;RT4: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	236.7	186.0	29.1	33.8	34.1	60.4	223.6	33.7	40.9	123.7	37.9	126.6	55.4	105.6	20.9	155.7	106.6	36.0	125.5	27.7	31.3	115.7	82.7	129.6	29.6	37.1	32.5	63.6	182.3	21.1	34.2	57.7	35.7	275.8	29.3	5.3	166.8	35.0	91.4	198.4	85.2	25.1	33.4	94.8	111.1	565.0	33.1	34.2	85.0	24.8	18.2	122.8	124.9	38.7	107.9	256.2	10.0	0.0	112.2	73.8	163.2	78.9	43.4	31.3	30.4	50.9	172.4	0.1	48.7	38.6	0.2	100.7	6.2	60.1	8.5	5.7	4.6	4.3	92.6	43.8	160.5	0.1	39.0	97.0	64.5	43.3	40.0	12.7	63.0	0.0	0.1	0.1	15.9	338.4	0.7	28.7	16.0	77.8	58.0	42.4	0.0	21.0	51.0	239.0	3.0	1.0	99.8	122.3	0.4	34.6	187.0	32.6	63.1	0.3	29.6	46.2	15.6	25.0	39.4	0.4	8.6	0.3	25.4	84.0	127.6	29.3	51.3	76.4	46.3	16.8	49.6	38.0	117.2	21.7	34.9	38.2	46.6	61.2	69.4	58.2	78.1	72.1	29.1	34.1	33.7	40.9	27.7	31.3	37.1	32.5	35.7	33.4	33.1	38.7	58.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	130.2	56.4	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	124.3	59.5	0.0	0.0	0.0	0.0	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	0.0	0.0	160.3	6.5	0.0	0.0	0.0
H2AW	"HIST3H2A, MGC3165"	ENSG00000181218	"H2A.W histone"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 29.7;U-266/70: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	6.0	35.9	6.3	0.8	6.1	5.9	6.8	13.4	6.9	27.9	9.9	5.9	3.2	5.4	1.6	19.2	7.2	1.2	17.8	5.8	6.7	4.4	1.1	4.4	1.2	5.0	4.9	14.1	3.9	3.7	12.9	1.0	5.3	11.1	0.9	4.9	10.3	0.4	1.0	18.0	5.5	0.3	5.0	13.0	6.3	5.8	6.9	1.8	2.1	0.7	0.9	5.4	24.2	5.5	5.9	3.1	4.0	5.6	3.3	3.3	4.8	2.9	2.8	8.2	5.7	3.1	4.8	2.7	3.4	0.6	0.0	14.3	2.9	1.4	1.9	4.2	29.7	4.2	4.0	0.0	7.6	3.0	8.1	7.3	8.4	1.5	3.5	3.3	3.5	5.4	15.0	0.0	0.0	8.4	3.9	0.0	6.2	3.5	7.5	0.0	0.0	22.9	1.4	3.5	24.7	17.4	10.2	8.9	20.7	0.6	15.7	2.2	1.3	0.0	0.1	11.0	2.6	29.4	22.4	0.0	2.9	3.0	2.1	4.4	1.4	0.0	5.8	2.8	4.3	2.7	5.5	4.3	3.0	2.1	4.2	4.1	0.6	6.5	7.0	0.5	10.4	3.4	6.3	6.1	13.4	6.9	5.8	6.7	5.0	4.9	5.3	5.0	6.9	5.5	0.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	14.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	53.8	2.4	0.0	0.0	0.0
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
H2AZ1	"H2A.Z, H2AFZ, H2AZ"	ENSG00000164032	"H2A.Z variant histone 1"	P0C0S5	4	99948086-99950355	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 621.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 211.4;Cytotrophoblasts: 625.4;Extravillous trophoblasts: 1438.5;Hofbauer cells: 711.2;Syncytiotrophoblasts: 403.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB022549: , HPA057236: AB_2683377"	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	104.6	88.6	104.7	193.5	115.0	621.6	120.9	112.0	156.8	116.8	114.4	206.7	149.4	156.0	99.2	220.9	105.5	110.5	98.8	108.9	113.5	137.5	104.4	137.9	348.0	103.2	105.5	130.2	88.3	79.2	110.5	146.0	106.9	123.6	193.6	123.7	122.5	114.6	127.5	140.1	155.3	207.2	110.6	161.6	155.3	150.3	107.4	545.3	88.9	121.7	385.4	165.3	129.5	113.6	1249.7	864.3	1753.9	911.2	354.8	314.7	581.6	1287.6	930.7	1319.4	1229.9	897.5	1422.2	2205.2	451.5	666.0	862.3	442.9	1558.6	1268.1	1566.7	956.4	1088.7	1130.4	974.2	1029.1	212.4	2028.8	914.6	235.3	549.6	1004.5	561.1	369.3	1322.2	1313.0	1133.0	1293.1	1558.8	1751.0	1710.7	1697.0	1013.0	1402.9	822.1	1443.6	1279.6	928.0	741.0	750.1	1142.6	875.9	796.4	1507.4	1509.1	608.7	772.0	1550.7	686.7	841.6	1589.0	578.0	1674.1	736.1	1208.3	2671.0	939.8	1348.6	1342.7	780.2	689.8	1375.4	351.5	788.5	393.9	493.8	580.9	475.6	590.8	419.7	533.4	437.6	1482.5	453.8	1053.0	379.0	868.9	1555.4	104.7	115.0	112.0	156.8	108.9	113.5	103.2	105.5	106.9	110.6	107.4	113.6	211.4	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	0.0	625.4	147.1	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	1438.5	78.5	0.0	0.0	0.0	0.0	0.0	0.0	711.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	403.2	39.0	0.0	0.0	0.0
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H2BC13	"dJ97D16.4, H2B/c, H2BFC, HIST1H2BL"	ENSG00000185130	"H2B clustered histone 13"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.7;cerebral cortex: 1.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.3;U-266/84: 12.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	0.1	0.2	0.3	0.0	0.3	6.1	0.1	2.7	1.6	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.4	0.2	0.2	0.3	1.2	0.3	0.0	0.4	0.1	0.2	0.3	2.2	2.0	0.6	2.1	0.0	0.0	0.1	1.3	0.3	1.1	2.8	0.9	1.5	0.8	0.5	0.2	0.6	1.4	0.0	0.2	0.4	1.0	2.9	1.6	2.7	3.5	0.0	2.6	2.1	0.9	0.0	0.0	0.0	0.2	0.6	1.8	2.1	5.2	0.0	5.6	12.3	4.5	1.9	1.5	3.0	2.8	0.0	1.3	0.0	2.0	2.7	1.0	3.5	1.4	0.2	0.2	1.2	0.9	0.5	0.1	1.4	1.1	0.9	2.9	12.5	3.9	0.3	4.7	0.5	0.5	0.3	2.3	0.5	0.1	0.7	1.0	0.3	0.6	0.7	0.6	0.2	0.3	4.1	0.2	0.3	0.4	1.1	0.5	0.3	0.3	2.7	1.6	0.5	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	4.3	3.4	9.5	6.0	17.4	25.0	6.7	11.4	8.8	9.1	9.9	3.1	3.2	1.2	3.6	14.7	7.1	4.6	3.6	10.5	15.0	5.3	13.1	8.0	2.9	20.3	10.9	2.6	2.6	0.9	5.8	7.2	16.3	21.8	2.3	1.5	7.5	0.9	14.5	6.7	3.0	1.2	21.5	5.1	7.0	6.4	9.4	14.9	3.6	8.0	2.3	3.5	10.2	27.6	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	9.5	17.4	11.4	8.8	10.5	15.0	20.3	10.9	16.3	21.5	9.4	27.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2BC6	"H2B.h, H2B/h, H2BFH, HIST1H2BE"	ENSG00000274290	"H2B clustered histone 6"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;REH: 5.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.8	0.4	1.6	0.5	2.0	2.7	0.6	3.0	1.5	3.6	3.6	0.7	0.4	0.4	0.4	0.7	0.6	0.4	0.6	1.6	0.3	1.0	0.6	1.3	0.9	1.9	0.8	0.9	0.2	0.1	0.7	0.3	0.4	2.6	0.5	1.1	1.3	0.2	0.8	1.7	0.3	0.2	1.8	0.9	0.8	0.5	0.6	2.9	0.5	0.6	0.6	0.4	2.1	1.5	0.3	2.1	1.9	0.5	1.6	0.2	0.2	1.9	0.6	0.3	0.1	0.5	1.3	0.4	0.8	0.3	0.9	2.7	0.3	0.7	0.3	0.9	0.5	0.2	1.0	0.1	0.1	0.1	1.6	0.4	0.1	0.4	0.1	0.6	0.2	0.5	1.4	1.0	0.0	1.0	3.0	5.3	1.5	1.0	0.5	5.1	0.1	1.5	0.8	1.1	1.5	2.2	2.3	0.8	0.5	0.8	1.6	1.0	0.5	0.8	1.5	0.6	1.2	1.3	2.7	0.3	0.4	0.8	0.3	2.9	0.6	1.0	0.7	0.5	0.5	1.0	0.7	0.9	0.2	1.2	0.6	0.6	2.1	0.6	0.6	1.2	1.1	0.3	1.6	2.0	3.0	1.5	1.6	0.3	1.9	0.8	0.4	1.8	0.6	1.5	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in single"		"Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 24.8;U-266/84: 18.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.9	0.2	0.6	0.2	1.1	1.2	1.6	4.0	0.9	3.3	1.5	1.4	0.0	0.1	0.0	3.2	1.8	0.2	0.4	0.8	0.6	1.4	0.6	1.7	0.3	1.9	1.7	0.8	0.2	0.0	0.6	0.2	2.4	7.4	0.2	0.6	1.1	0.0	0.0	0.9	0.7	0.0	2.1	2.3	0.7	0.6	1.2	1.7	0.6	0.1	0.4	0.4	4.5	2.4	0.5	0.3	0.2	0.5	0.3	0.0	0.2	0.2	0.1	0.7	0.1	0.7	0.1	0.6	1.0	0.0	0.3	1.0	0.5	0.1	0.3	0.8	0.2	0.4	1.8	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.0	0.1	0.5	2.0	4.5	0.0	0.1	4.0	1.6	0.6	0.8	0.6	1.5	0.7	3.0	0.1	0.1	2.4	0.4	4.9	0.9	0.1	0.3	4.4	0.2	0.1	0.3	2.2	0.0	0.6	24.8	18.8	1.3	0.1	1.2	0.5	0.0	0.0	0.6	0.2	0.1	0.6	0.2	0.2	0.3	0.1	1.0	0.2	0.5	2.4	0.2	0.3	0.3	0.2	0.5	0.6	1.1	4.0	0.9	0.8	0.6	1.9	1.7	2.4	2.1	1.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0
H2BC8	"H2B.1A, H2B/a, H2BFA, HIST1H2BG"	ENSG00000273802	"H2B clustered histone 8"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	3.1	0.9	1.5	1.2	1.4	6.7	13.2	8.0	1.8	23.9	4.8	5.9	1.1	0.9	2.0	9.1	4.3	0.9	3.3	1.5	1.9	4.3	3.1	7.5	1.6	1.4	2.2	5.7	1.1	0.1	2.9	1.1	3.6	19.7	2.0	1.6	6.9	0.5	0.1	13.2	3.2	0.4	2.8	7.1	3.7	1.8	1.9	4.1	2.6	0.0	1.4	1.6	18.4	4.6	3.0	0.1	1.4	0.0	4.4	0.2	0.4	3.7	0.3	2.3	0.9	0.4	2.6	0.0	3.7	0.3	1.0	3.2	1.3	1.2	1.3	2.6	1.6	0.8	1.5	1.4	0.7	0.3	2.4	1.7	0.6	0.7	0.1	0.1	0.5	0.1	9.6	0.2	0.0	2.2	2.8	2.1	1.5	7.1	1.9	1.8	0.8	5.4	1.3	0.7	8.5	1.3	10.5	3.8	1.2	3.7	21.2	0.9	0.3	0.0	1.2	0.3	0.5	19.6	0.1	0.0	0.3	1.3	0.7	18.1	1.3	3.2	2.0	0.9	6.4	4.4	3.2	4.0	5.1	5.3	1.5	1.3	5.8	1.4	1.8	16.0	3.0	2.2	1.5	1.4	8.0	1.8	1.5	1.9	1.4	2.2	3.6	2.8	1.9	4.6	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.2	0.0	0.0	0.0
H6PD	"GDH, H6PDH"	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234774-9271337	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		140000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	29.0	30.5	7.5	12.6	11.6	9.7	23.0	8.2	9.0	22.6	18.8	15.1	11.2	25.7	14.4	13.5	28.3	12.6	18.9	6.4	7.8	11.5	94.5	20.3	12.4	14.4	10.8	44.9	18.9	10.6	12.7	14.1	11.4	19.5	9.1	4.2	56.2	13.1	48.3	35.7	16.8	16.6	9.6	14.5	18.7	8.1	11.4	13.1	14.7	21.0	11.4	16.7	16.5	10.9	9.9	8.0	6.8	25.5	68.9	78.9	6.4	9.8	24.0	7.1	10.9	1.5	20.1	10.9	11.2	15.3	9.1	10.3	1.8	4.8	10.3	32.8	2.2	0.0	2.8	6.7	38.6	3.5	4.1	77.7	9.1	17.2	11.1	15.6	32.9	5.9	2.9	18.2	14.0	5.7	3.9	8.2	3.7	7.5	4.6	1.2	0.9	9.3	9.1	4.0	2.3	12.0	12.9	10.0	12.0	4.7	7.5	17.4	32.9	24.3	3.9	6.2	2.8	24.1	7.6	2.5	40.8	15.6	15.7	1.6	2.3	0.3	1.6	2.4	1.3	1.3	1.2	1.5	1.0	1.6	1.2	1.1	1.5	1.2	2.3	1.4	1.1	1.5	7.5	11.6	8.2	9.0	6.4	7.8	14.4	10.8	11.4	9.6	11.4	10.9	24.1	25.6	29.5	17.9	10.1	14.3	13.2	16.9	18.8	19.6	10.3	8.3	17.5	58.6	18.8	20.2	27.1	11.2	9.1	16.6	0.0	22.9	0.8	11.2	36.0	19.8	7.8	9.0	8.4	21.3	8.5	33.6	5.6	15.5	3.8	29.9	19.6	164.0	12.1	16.8	9.1	15.1	8.2	25.4	11.4	2.9	48.1	14.2	12.4	13.1	51.6	10.4	19.6	16.6	18.6	20.0	17.0	36.9	4.5	17.2	23.1	7.4	19.1	10.9	0.0	50.5	11.7	4.6	5.5	10.5	12.8	5.9	11.6	26.1	23.6	14.2
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 437.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 124.4;Hepatocytes: 221.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 64.7;RPTEC TERT1: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000		"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.9	0.0	0.0	3.1	2.9	1.7	0.0	2.2	36.0	3.8	0.1	0.0	14.2	437.3	0.8	0.0	0.0	0.0	0.0	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.1	12.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	64.7	0.0	0.0	0.1	0.0	50.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.3	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	124.4	0.0	1.8	0.0	0.0	0.0	0.0	3.9	31.4	0.5	10.8	0.8	0.4	0.0	5.3	1.0	3.9	0.0	0.0	17.9	6.5	0.0	0.0	5.3	221.4	1.0	0.0	0.0	0.2	0.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	12.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 502.5"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		470000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	105.0	125.3	57.7	31.1	60.7	46.3	94.9	65.0	69.6	72.6	59.1	108.4	115.0	61.8	30.7	90.1	60.1	32.4	330.2	52.8	61.9	99.0	156.7	66.9	35.3	64.4	62.2	77.8	101.4	95.0	57.4	39.2	64.2	60.2	76.1	14.9	77.9	33.4	502.5	95.7	106.2	57.4	61.8	68.4	93.8	49.0	62.4	46.7	59.5	300.7	58.5	79.1	73.6	67.2	105.7	88.1	58.4	90.8	221.1	139.9	51.5	80.6	84.7	78.5	67.7	114.7	104.1	71.7	50.2	138.4	78.6	66.8	103.4	152.6	72.5	139.1	103.6	103.3	86.2	197.9	73.3	132.2	69.2	142.7	101.6	112.4	109.3	82.8	127.7	70.4	140.2	133.2	101.1	128.2	63.4	137.7	50.1	77.5	134.1	52.9	128.5	143.7	90.3	125.3	41.9	85.1	94.6	104.6	102.4	44.5	52.2	125.8	127.1	48.8	70.7	69.9	58.0	44.8	86.5	113.4	77.6	150.2	56.2	22.5	84.0	33.5	31.8	92.3	39.1	40.5	36.8	38.7	80.8	31.2	42.6	40.1	20.9	38.8	86.1	31.3	50.9	89.9	57.7	60.7	65.0	69.6	52.8	61.9	64.4	62.2	64.2	61.8	62.4	67.2	122.4	89.8	99.0	47.0	101.2	89.0	137.5	139.9	97.3	35.6	89.7	96.4	349.9	82.9	128.0	77.3	52.1	182.0	95.1	242.1	131.0	120.8	39.2	73.3	121.1	99.1	91.4	155.9	22.8	108.5	94.7	96.1	100.4	85.5	139.9	140.3	84.3	185.1	163.0	20.2	28.2	156.5	89.5	136.8	106.0	74.3	92.6	145.0	81.8	12.2	170.7	65.4	93.7	30.7	37.4	90.0	195.6	84.2	90.4	76.2	527.4	182.5	84.8	62.3	52.6	129.9	109.6	147.9	54.9	136.5	103.3	129.2	100.5	154.7	216.7	104.4
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827157	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 378.7;Proximal tubular cells: 501.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	41.2	109.0	81.5	20.2	84.2	82.1	35.1	82.7	103.9	22.8	78.9	53.7	45.3	24.6	31.1	29.0	28.5	21.9	138.6	89.9	83.8	100.1	236.2	39.2	24.6	82.8	80.2	22.0	63.5	54.0	72.7	23.1	83.7	33.5	23.3	32.2	32.5	37.7	198.8	31.2	44.8	24.7	80.1	35.2	52.9	91.7	84.0	35.8	35.1	156.2	18.4	34.8	24.6	87.6	31.1	46.1	40.9	46.5	35.1	13.8	37.0	38.1	35.2	57.7	46.1	23.7	26.5	6.4	76.5	32.9	39.6	33.2	39.1	38.2	17.2	64.5	63.4	12.0	47.9	69.3	50.2	15.7	62.6	16.9	80.6	28.8	19.6	50.6	50.1	79.8	16.1	56.3	18.3	51.2	41.1	34.0	15.7	32.0	42.3	34.2	25.8	73.6	74.5	13.8	54.7	47.4	41.8	52.9	84.9	30.8	38.7	52.0	38.7	17.5	21.5	36.9	44.6	63.3	64.7	19.8	29.8	14.5	28.5	37.3	33.3	64.9	26.0	59.1	19.0	31.3	34.0	27.3	30.7	30.4	32.0	27.4	29.7	25.5	88.2	64.8	42.8	30.3	81.5	84.2	82.7	103.9	89.9	83.8	82.8	80.2	83.7	80.1	84.0	87.6	46.2	9.6	39.0	11.8	33.7	23.8	45.1	59.7	12.0	117.1	39.5	31.1	84.2	65.8	39.7	46.0	64.6	52.4	43.2	60.9	158.5	45.6	193.1	75.0	12.1	35.3	39.6	378.7	24.6	38.3	38.5	25.6	23.9	35.5	30.4	36.0	41.0	186.9	76.2	138.0	22.2	41.2	93.6	49.0	41.6	60.1	46.9	47.6	55.2	12.2	50.1	95.2	64.9	7.1	19.7	49.7	68.8	54.9	50.4	48.3	168.9	501.7	70.2	117.0	72.3	33.3	61.1	245.2	68.3	29.1	45.6	68.7	44.1	45.3	39.9	49.9
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	2.9	0.1	11.5	2.2	0.1	0.4	0.8	0.1	0.5	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	198.2	2.3	0.5	0.1	0.1	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.1	0.8	0.5	0.0	7.6	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.2	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
HARS1	"HARS, HisRS, USH3B"	ENSG00000170445	"Histidyl-tRNA synthetase 1"	P12081	5	140673035-140691537	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	31.6	39.9	64.8	27.1	67.0	24.3	29.3	64.9	88.7	32.9	57.9	39.2	21.8	34.5	27.1	42.9	30.8	21.0	38.3	67.8	72.2	30.7	47.3	27.2	29.6	71.2	69.9	31.3	40.8	37.1	60.0	18.5	72.8	33.0	29.6	18.5	29.2	32.0	56.7	53.9	28.6	35.2	62.1	32.2	36.0	25.6	77.4	32.2	27.1	33.4	36.8	34.3	32.0	71.9	66.8	94.3	55.5	120.5	68.9	74.9	57.9	104.8	75.0	118.6	109.4	174.8	54.1	88.4	90.3	118.3	94.3	66.6	85.9	169.2	111.6	74.5	105.0	63.7	115.4	111.8	86.3	101.1	49.8	80.4	51.5	129.0	72.6	69.5	122.1	52.2	56.5	68.6	125.6	111.0	71.8	100.6	43.3	52.3	60.9	65.4	82.0	70.9	97.0	82.2	86.5	83.7	86.1	121.5	84.2	54.9	89.5	55.5	100.3	107.8	41.6	61.5	144.7	68.5	90.5	89.4	82.8	83.1	76.1	16.2	31.2	24.0	61.0	46.3	54.2	34.9	54.1	57.6	48.5	34.6	58.1	55.4	8.1	59.3	54.9	34.3	51.3	56.7	64.8	67.0	64.9	88.7	67.8	72.2	71.2	69.9	72.8	62.1	77.4	71.9	9.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	41.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	48.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	36.0	1.7	0.0	0.0	0.0
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003614			Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome"		"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favorable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	19.0	13.0	29.1	9.2	31.3	11.0	16.2	26.3	54.0	42.3	24.3	15.9	7.1	17.8	15.1	11.4	21.3	13.2	23.5	32.3	26.3	25.2	13.6	19.5	14.4	28.3	27.0	16.0	8.2	5.0	11.9	12.3	28.4	22.5	5.8	3.0	12.5	17.9	12.0	44.7	13.3	11.5	26.4	28.5	11.5	12.6	29.0	10.4	19.2	9.2	9.5	17.4	21.7	32.3	28.2	44.9	24.1	51.2	8.9	14.1	37.2	17.8	12.1	30.1	51.4	36.2	17.3	25.5	59.2	18.5	43.1	32.0	39.6	29.4	15.6	23.6	59.6	19.3	33.5	26.9	9.3	26.9	35.5	21.1	7.4	29.5	16.4	13.1	22.4	32.5	21.7	17.6	15.7	68.9	41.7	60.5	15.7	67.5	65.8	36.5	30.2	47.0	10.2	17.3	25.1	20.5	10.3	27.4	9.6	8.9	10.8	20.8	10.7	27.1	42.9	50.8	36.1	24.0	33.7	97.6	11.7	68.9	34.6	14.8	53.2	22.7	32.6	66.7	34.5	44.0	36.1	33.6	46.7	36.5	35.2	32.2	6.7	39.1	62.0	26.0	33.8	34.3	29.1	31.3	26.3	54.0	32.3	26.3	28.3	27.0	28.4	26.4	29.0	32.3	9.4	6.4	8.1	45.4	5.3	7.1	1.6	3.6	1.2	2.1	2.7	3.0	2.5	4.3	2.6	0.0	4.2	12.6	6.0	9.3	5.9	10.4	0.1	1.0	1.8	5.6	2.4	6.6	11.9	8.0	24.6	6.3	3.6	0.7	19.7	1.6	15.4	4.2	12.2	3.3	4.9	13.8	4.1	10.0	6.8	0.5	5.9	5.0	3.6	4.7	13.4	2.0	12.3	31.7	3.5	7.4	7.7	7.5	2.5	3.3	6.9	14.9	3.5	1.9	6.6	1.9	6.5	2.2	6.7	1.3	4.7	9.3	4.9	1.7	14.9	1.5
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24344.4"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	893.7	183.0	112.1	82.0	216.3	24344.4	316.6	159.4	246.9	237.7	340.5	141.4	10.6	41.4	2.4	244.9	350.9	60.1	1766.9	56.9	92.1	1405.5	1100.4	2201.7	5.0	141.5	169.4	159.7	100.5	5.1	465.7	1992.7	183.4	170.1	11.5	3.1	138.1	43.7	234.0	194.6	85.0	7.0	211.1	5527.7	135.9	104.8	125.3	20.7	609.2	1123.2	3.6	167.2	351.2	113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	112.1	216.3	159.4	246.9	56.9	92.1	141.5	169.4	183.4	211.1	125.3	113.5	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 38218.6"	"Cell type enriched"	"Detected in many"	22	"Erythroid cells: 198314.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 486.7;granulocytes: 955.3"	"Group enriched"	"Detected in some"	18	"HEL: 1196.2;K-562: 328.3"									"CAB038417, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	1592.0	322.5	162.6	186.3	292.4	38218.6	545.3	268.0	377.0	573.3	570.7	254.0	21.6	85.9	5.9	432.5	570.5	147.6	2590.3	86.6	156.5	2302.8	1853.6	4204.3	9.7	210.6	249.2	288.5	141.3	11.4	807.8	3618.9	260.6	302.7	26.7	4.0	305.4	131.9	568.3	188.5	154.3	12.9	316.4	8125.4	264.0	185.0	185.4	34.6	1192.5	1744.6	10.1	325.2	632.8	179.9	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.1	0.0	0.0	3.2	0.0	1.9	4.9	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.6	1196.2	0.5	0.0	0.0	0.2	1.7	0.4	0.1	0.4	0.0	0.0	0.0	0.1	328.3	0.0	0.1	0.6	0.0	0.3	0.1	0.5	0.0	0.0	0.0	43.4	0.0	0.9	11.9	9.7	1.1	0.0	0.0	0.1	1.4	0.2	5.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.2	119.6	28.1	315.1	99.6	1.7	3.7	39.2	8.5	7.1	42.5	19.1	22.8	73.9	955.3	49.5	3.3	486.7	1.0	15003.3	162.6	292.4	268.0	377.0	86.6	156.5	210.6	249.2	260.6	316.4	185.4	179.9	184.7	3.2	1.5	0.0	97.6	44.4	0.4	0.1	0.6	1.7	20.2	22.2	6.8	70.1	0.7	0.0	0.0	0.0	162.2	6.9	54.8	0.0	3.4	0.6	0.8	50.9	3.0	198314.0	0.0	0.0	0.0	241.0	4.1	0.9	1.3	0.3	142.8	131.2	0.0	0.0	0.0	7.5	4.1	770.6	149.6	16.9	0.0	402.9	8790.3	0.0	37.5	2.3	954.7	0.0	0.0	0.0	3.6	0.0	0.3	0.2	0.1	29.6	2.5	58.6	0.0	25.2	171.5	1.0	9.9	1.1	44.6	0.0	306.3	0.1	5.0	0.1
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 133301.6"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 672352.3"	"Group enriched"	"Detected in all"	4	"cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1"	"Region enriched"	"Detected in all"	11	"cerebral cortex: 3368.5"	"Group enriched"	"Detected in all"	5	"neutrophil: 658.1;plasmacytoid DC: 379.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 379.7;granulocytes: 658.1"	"Cell line enhanced"	"Detected in some"		"HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2"									"CAB009526, HPA043234"	Enhanced					NA	NA		10000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	1641.5	481.4	155.7	217.3	219.2	133301.6	637.4	235.7	3368.5	546.2	384.6	278.2	28.8	78.8	45.6	505.7	829.6	792.7	2658.8	108.9	154.4	2333.1	1907.3	4039.6	26.8	209.6	243.5	289.0	158.5	50.5	808.2	6345.0	303.0	312.0	148.9	31.0	548.1	290.6	578.8	135.3	169.8	66.3	316.2	9225.9	269.1	170.6	171.4	196.8	1152.0	12902.5	40.3	320.1	633.5	180.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.1	4.2	0.0	0.0	0.0	0.0	99.5	25.3	73.7	37.8	1.3	4.0	21.5	6.8	1.1	35.2	13.8	13.7	39.9	658.1	47.9	5.0	379.7	1.4	22388.9	155.7	219.2	235.7	3368.5	108.9	154.4	209.6	243.5	303.0	316.2	171.4	180.7	441.7	3.2	8.4	0.0	280.5	157.0	2.3	5.1	0.0	4.0	54.7	72.0	3.4	217.3	4.5	7.3	4.2	2.2	369.9	5.2	50.9	0.0	0.0	6.8	6.6	151.7	3.6	672352.3	0.0	0.0	11.3	276.1	0.0	5.1	0.0	4.6	443.4	420.5	7.3	3.3	0.0	7.2	6.1	1452.1	702.6	0.0	0.0	1091.0	27383.1	0.0	72.7	9.7	38.1	0.0	0.0	0.1	3.5	0.0	1.9	0.0	0.1	272.4	84.9	117.8	0.0	126.0	396.8	0.0	0.0	0.0	252.5	2.2	769.8	0.3	3.0	0.1
HBD		ENSG00000223609	"Hemoglobin subunit delta"	P02042	11	5232678-5243657	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"bone marrow: 2797.6"	"Cell type enriched"	"Detected in some"	318	"Erythroid cells: 22112.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5"									"CAB037087, HPA043234"	Supported					NA	NA		6600000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB037087: AB_260051, HPA043234: AB_2678378"	"unprognostic (1.32e-2)"		"unprognostic (4.87e-2)"		"unprognostic (4.14e-2)"	"unprognostic (2.26e-3)"		"unprognostic (1.52e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.04e-1)"		"unprognostic (8.67e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.17e-1)"	2.2	0.3	0.5	0.6	0.6	2797.6	0.7	0.8	2.7	0.1	0.7	0.5	0.0	0.1	0.0	0.3	2.8	0.1	2.5	0.5	0.4	3.2	7.5	6.2	0.5	0.6	0.5	0.3	0.2	4.5	2.2	19.5	0.7	0.2	0.3	0.1	2.2	0.3	0.5	0.6	0.2	0.0	0.6	49.1	0.3	0.1	0.5	4.3	1.0	11.5	0.2	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	74.5	0.0	0.0	0.0	0.3	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.4	25.5	0.0	0.0	0.1	0.0	0.4	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.2	0.0	1.6	0.0	105.0	0.5	0.6	0.8	2.7	0.5	0.4	0.6	0.5	0.7	0.6	0.5	1.0	0.0	0.0	0.0	0.0	11.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	22112.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	13.6	13.4	0.1	0.0	0.0	0.0	0.0	16.9	1.9	0.1	0.0	6.2	69.4	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0
HBE1	HBE	ENSG00000213931	"Hemoglobin subunit epsilon 1"	P02100	11	5268345-5505652	"Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 174.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"K-562: 10059.8"	"Not detected"	"Not detected"							HPA043234	Approved					NA	NA		510000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"			"HPA043234: AB_2678378"	"unprognostic (7.59e-2)"			"unprognostic (6.70e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.25e-1)"		"unprognostic (1.64e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.02e-3)"		"unprognostic (2.14e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.34e-2)"	0.5	0.3	0.4	0.0	0.7	0.3	0.2	0.0	1.1	0.5	0.0	0.2	0.0	0.3	0.4	0.1	0.4	0.0	0.3	0.5	0.8	0.3	1.3	0.3	0.0	0.7	0.2	0.6	0.2	0.0	0.3	0.8	0.5	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.2	0.0	0.4	0.2	0.5	0.4	0.2	0.3	0.0	0.0	0.2	0.3	1.1	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	649.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10059.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.7	0.0	0.0	31.9	0.1	0.9	19.4	0.1	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	1.1	0.5	0.8	0.7	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.9	0.0	0.3	4.3	0.0	16.0	0.5	0.0	31.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	174.7	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	14.8	0.1	0.0	0.9	0.1
HBG2	HBG-T1	ENSG00000196565	"Hemoglobin subunit gamma 2"	P69892	11	5253188-5505605	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	132	"placenta: 10310.3"	"Group enriched"	"Detected in some"	17	"Erythroid cells: 66.1;Macrophages: 74.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	192	"HEL: 8197.4;K-562: 8088.4"									"CAB016143, HPA043234"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB016143: AB_2295004, HPA043234: AB_2678378"	"unprognostic (4.48e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	6.8	1.6	1.6	0.5	2.0	78.2	2.5	1.5	4.7	4.2	2.0	2.8	1.4	1.1	0.5	2.0	2.0	5.3	8.2	1.8	1.1	5.9	6.1	16.4	0.3	1.1	1.2	2.2	9.3	0.8	3.1	10310.3	1.1	1.5	0.1	0.4	3.7	0.2	4.2	1.2	0.9	4.4	0.7	27.3	3.3	0.8	1.2	2.4	4.8	0.6	0.4	0.4	3.1	2.0	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.2	23.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8197.4	0.5	0.4	0.0	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8088.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.0	8.9	1.9	0.1	0.3	0.2	0.0	0.0	42.3	0.1	0.6	3.0	0.1	0.6	1.9	1.9	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	6.5	1.6	2.0	1.5	4.7	1.8	1.1	1.1	1.2	1.1	0.7	1.2	2.0	2.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	66.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.6	0.3	74.6	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.3	0.2	1.5	0.9	0.0	0.0	0.0	0.6	0.3	0.0	0.1
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947557-153971818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA078588	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	18.8	25.5	18.4	15.5	16.9	40.2	17.1	14.9	22.5	21.9	10.3	29.7	11.4	33.6	8.5	25.1	24.3	7.6	23.1	19.7	14.1	22.1	23.8	21.6	19.0	16.6	16.8	25.5	21.1	11.4	33.9	8.7	15.2	23.5	7.0	7.2	19.2	12.8	28.4	18.6	25.3	11.1	13.6	32.8	24.8	17.9	16.8	26.1	21.1	10.5	12.1	23.6	19.8	17.1	45.3	57.7	38.4	48.9	15.8	11.2	56.3	18.2	14.0	21.1	19.1	61.5	29.8	81.6	45.3	23.6	34.6	36.4	41.8	29.7	11.0	43.6	49.2	49.0	47.7	48.8	10.8	60.9	77.8	17.6	19.1	36.8	15.9	12.7	22.7	58.2	69.4	50.2	15.0	63.0	84.6	78.2	50.0	29.4	35.1	97.5	31.6	49.3	16.0	41.4	42.5	46.2	33.7	34.4	19.4	18.4	31.7	54.4	30.2	39.9	49.0	35.0	59.4	79.1	117.0	100.2	32.5	58.6	38.6	0.9	2.1	0.9	3.0	3.1	2.1	2.4	2.4	2.3	2.4	2.4	2.4	3.4	0.4	1.5	2.2	4.2	1.7	2.3	18.4	16.9	14.9	22.5	19.7	14.1	16.6	16.8	15.2	13.6	16.8	17.1	19.1	19.2	17.8	7.5	21.9	16.6	13.4	15.5	20.5	21.0	24.6	18.7	35.9	20.0	13.6	12.9	14.6	16.5	26.8	20.1	3.9	17.4	0.6	16.7	18.4	21.2	19.2	39.9	8.4	16.5	21.3	17.7	19.9	21.6	3.8	25.0	15.7	29.5	21.3	20.2	8.3	23.2	8.2	35.2	13.8	1.8	17.4	26.0	5.4	9.4	28.6	13.6	17.5	8.0	7.2	19.5	13.3	21.8	32.0	25.7	12.6	8.8	13.4	12.4	6.6	21.8	21.2	11.3	25.0	28.9	13.9	15.9	22.8	14.3	23.9	20.5
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 17.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		0.0	0.4	1.8	0.0	2.5	0.1	0.0	2.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.4	7.2	2.5	1.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	24.5	0.0	0.1	0.1	0.0	0.0	29.4	0.0	0.0	7.4	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	671.7	0.7	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	6.7	766.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.5	0.0	14.8	0.0	21.1	14.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	199.4	0.0	0.3	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277463-155289848	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.7"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 9.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.5	3.1	0.7	0.5	0.4	0.1	1.7	2.6	0.9	4.7	0.0	5.0	2.6	2.6	0.0	4.6	1.5	0.0	1.2	0.1	2.3	6.0	14.7	1.4	0.3	1.5	1.3	3.6	2.5	0.1	7.3	0.2	2.3	2.9	0.5	0.2	3.4	0.2	0.7	5.8	5.1	0.0	0.1	1.5	2.3	1.2	1.0	0.0	2.9	0.0	0.1	2.4	4.2	0.0	2.0	0.7	2.4	0.7	0.6	0.0	1.3	1.6	0.7	0.0	0.3	0.0	2.7	1.8	1.2	0.0	1.2	5.1	0.3	0.0	0.0	2.5	3.1	0.7	2.6	0.5	0.0	0.8	1.3	0.0	0.0	0.0	0.1	0.7	0.2	2.7	4.3	3.1	0.4	0.0	1.4	0.7	1.9	0.3	2.3	3.0	2.0	2.7	0.0	0.3	4.3	5.2	1.3	1.7	0.0	0.0	1.4	0.3	0.2	1.3	1.3	4.0	1.5	1.6	0.7	1.1	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	2.6	0.9	0.1	2.3	1.5	1.3	2.3	0.1	1.0	0.0	1.1	0.0	0.6	2.3	0.2	1.3	0.9	1.3	1.8	3.1	2.0	1.8	1.8	1.5	1.4	1.8	4.2	0.4	0.2	5.8	0.0	1.1	0.6	0.5	0.9	0.6	4.2	0.4	5.0	0.4	0.4	1.1	2.0	1.4	1.3	1.3	2.5	2.1	0.8	0.0	9.3	2.0	4.1	0.3	1.0	0.8	0.9	0.8	0.0	2.8	0.6	1.4	0.0	4.5	1.5	1.3	2.6	1.2	0.7	0.8	6.1	1.2	0.2	1.9	0.0	0.6	0.6	3.6	3.6	2.2	2.7	0.0	0.6	1.5	4.0	0.9
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	31.4	42.8	20.8	76.7	22.1	59.3	56.0	21.9	28.0	56.6	20.3	119.5	74.5	48.1	51.4	81.3	56.8	55.4	29.0	20.4	21.9	47.9	41.7	41.2	119.7	23.3	21.8	65.7	40.0	62.3	31.6	53.0	23.1	57.6	108.3	18.9	52.1	57.2	15.3	38.0	80.8	46.8	21.8	61.7	84.1	36.2	22.0	103.9	78.4	17.5	123.9	63.7	51.7	23.4	152.5	90.6	57.4	114.7	32.9	39.0	118.7	105.1	117.1	138.0	126.6	168.0	266.3	233.4	190.3	116.9	140.2	173.1	178.1	143.1	151.5	219.3	176.8	161.3	105.7	130.1	77.4	288.1	223.4	70.7	77.0	107.1	70.3	107.7	106.1	298.5	215.2	90.1	61.6	115.7	331.6	161.4	133.2	180.2	229.6	225.0	136.0	104.0	149.5	216.1	44.7	56.6	176.0	117.0	227.9	224.0	137.9	220.6	123.8	91.3	106.2	28.5	261.1	54.4	124.9	319.2	75.3	235.8	121.4	147.5	87.7	200.1	130.0	115.9	107.5	151.6	126.2	140.6	103.0	142.0	143.7	133.6	63.7	144.2	156.4	64.9	142.0	204.6	20.8	22.1	21.9	28.0	20.4	21.9	23.3	21.8	23.1	21.8	22.0	23.4	45.3	25.6	45.4	25.5	82.7	24.9	57.4	99.1	38.7	15.1	35.1	29.1	22.1	61.5	73.4	68.0	16.7	93.1	64.0	142.4	95.9	75.7	20.2	33.7	39.8	56.2	86.3	60.8	1.9	73.6	110.9	25.8	65.2	39.5	30.4	23.6	63.5	28.1	43.6	11.8	8.8	122.8	52.9	38.2	19.0	8.7	41.0	35.0	28.4	16.9	52.7	34.2	69.0	14.6	19.4	92.5	141.5	44.4	38.4	28.5	57.0	30.0	67.3	14.6	59.2	22.8	38.1	72.5	69.8	60.2	25.4	93.4	73.6	102.6	136.0	55.8
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.65e-4)"	52.5	41.8	7.7	28.5	8.1	23.6	45.3	3.2	9.7	46.2	24.6	44.2	8.9	51.4	13.6	23.5	50.3	16.8	31.6	4.1	4.8	29.3	6.0	55.0	27.3	17.2	7.1	44.9	14.5	20.1	20.6	19.5	10.2	34.4	4.8	2.8	30.6	17.1	16.2	40.1	28.6	16.9	3.4	38.4	27.2	7.9	10.7	80.0	39.2	9.4	15.2	44.3	38.5	7.6	41.6	28.1	28.6	46.9	21.9	60.2	25.3	39.4	30.7	28.3	18.8	37.4	38.4	80.5	126.8	37.1	13.9	37.8	6.7	31.4	10.5	38.8	13.6	27.6	29.9	8.6	23.6	9.1	1.2	39.4	10.8	28.6	15.4	51.6	58.6	45.9	29.9	33.4	18.6	18.0	83.2	21.8	39.4	9.1	29.1	64.2	14.7	29.6	12.1	26.9	8.1	18.8	30.6	14.1	14.4	18.4	13.4	12.0	66.6	56.9	61.0	47.6	28.9	70.8	58.8	67.4	23.8	41.9	19.1	0.0	1.4	0.0	0.8	0.5	0.9	0.8	0.7	0.7	0.4	0.5	0.8	0.6	6.5	0.9	0.5	0.3	0.3	1.5	7.7	8.1	3.2	9.7	4.1	4.8	17.2	7.1	10.2	3.4	10.7	7.6	80.6	41.7	32.1	34.9	32.7	13.8	26.8	28.7	8.6	20.3	22.5	17.4	13.4	28.6	28.6	36.8	0.0	4.8	18.6	5.3	1.9	31.6	15.5	26.2	39.4	79.3	7.3	40.4	19.9	23.0	3.5	37.8	25.5	58.4	8.8	20.2	101.7	2.0	15.6	28.6	17.5	9.6	24.4	32.7	14.1	6.9	55.0	13.3	14.2	46.9	20.5	11.7	28.8	10.6	13.6	66.8	7.3	33.1	42.9	69.1	0.6	3.8	31.8	4.0	26.3	18.3	26.9	1.1	3.7	10.3	21.6	2.9	28.2	9.3	8.1	46.8
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742109-156766925	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm	"Secreted to blood"	NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	96.3	89.7	95.9	72.8	98.8	305.3	90.6	98.4	113.4	91.4	98.0	109.2	130.2	77.6	70.0	186.3	112.8	62.5	119.0	92.8	95.1	135.4	222.3	113.5	64.6	106.3	99.7	86.8	93.2	92.8	67.8	71.8	98.8	81.7	118.1	68.9	96.6	56.8	234.9	155.3	128.4	70.5	100.8	77.2	99.1	42.6	99.6	157.2	90.7	132.5	114.9	106.7	102.7	105.7	491.5	249.1	258.2	125.6	150.0	203.0	296.8	158.4	406.3	366.8	234.4	279.4	500.9	335.5	310.6	325.0	158.6	338.8	408.9	365.0	356.0	276.1	299.9	278.1	339.4	241.2	202.0	411.9	227.4	152.4	335.7	292.8	560.4	278.6	272.4	249.6	387.0	260.4	293.7	369.3	345.5	459.2	472.1	755.4	347.7	384.8	156.9	435.1	401.0	162.6	396.9	432.0	380.4	480.3	199.3	319.8	387.6	621.9	242.4	181.1	286.5	230.3	408.9	364.0	486.0	555.6	238.9	318.4	235.2	6.2	9.9	9.2	6.6	8.8	4.9	5.6	5.6	5.9	11.6	6.6	5.0	4.7	5.6	5.2	10.0	11.9	8.2	6.8	95.9	98.8	98.4	113.4	92.8	95.1	106.3	99.7	98.8	100.8	99.6	105.7	51.9	70.5	99.2	12.1	35.3	147.3	185.1	90.5	76.2	66.7	89.9	66.0	91.0	98.7	75.3	71.7	27.1	44.1	72.4	121.4	80.3	112.2	48.4	144.0	79.2	66.1	124.6	217.8	12.0	132.0	107.3	66.7	62.7	91.8	30.4	67.4	35.0	164.5	52.7	53.8	12.4	104.3	48.8	45.6	89.1	47.0	40.7	71.0	39.2	14.0	57.3	71.4	25.7	5.5	16.1	165.7	59.5	45.9	59.0	281.3	138.2	118.1	126.8	34.9	19.7	70.9	57.8	27.7	28.3	108.6	159.4	54.9	50.5	83.2	114.9	228.6
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004189, CAB026457"	Enhanced		Supported	Cytosol		NA	NA		95000	"Cluster 14: Monocytes - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.39e-5)"	"prognostic unfavorable (4.12e-4)"	159.7	135.7	54.9	114.0	62.4	105.4	150.9	54.7	55.0	204.1	169.6	181.9	136.2	138.5	180.0	194.2	212.9	156.1	160.3	59.3	55.3	135.1	247.7	112.8	81.2	67.6	65.4	151.4	603.8	164.1	141.6	176.1	62.1	182.0	171.1	66.8	446.8	143.0	367.6	118.6	136.0	171.8	60.2	79.2	231.6	226.5	78.0	74.7	191.3	365.8	111.1	158.6	98.6	76.0	310.0	239.5	237.4	383.7	587.9	715.3	362.6	736.7	719.9	319.7	451.3	233.1	299.2	93.2	88.1	1039.3	334.0	235.2	356.9	465.8	528.2	150.4	236.0	323.0	305.1	535.7	566.7	233.0	251.4	528.8	369.1	466.0	515.9	500.4	448.1	140.9	310.1	120.0	511.9	309.5	120.4	106.1	237.9	290.4	161.2	111.7	511.9	175.5	255.1	380.1	208.4	223.5	332.3	334.5	278.4	304.2	262.6	201.8	585.4	402.1	255.1	551.5	325.3	136.2	130.8	166.5	488.1	161.1	371.8	26.0	39.3	17.4	15.6	41.0	20.3	19.6	17.7	18.8	41.3	12.7	15.5	15.1	22.0	19.2	58.1	26.4	18.1	27.5	54.9	62.4	54.7	55.0	59.3	55.3	67.6	65.4	62.1	60.2	78.0	76.0	53.9	76.9	102.7	38.5	60.6	70.2	117.4	80.4	150.2	41.0	125.3	98.8	220.5	71.4	124.9	75.4	43.8	133.9	34.7	176.2	135.0	106.7	111.0	152.8	178.3	80.8	96.5	72.6	44.5	122.1	166.5	156.3	203.4	168.2	68.4	199.3	86.7	199.3	94.6	69.0	45.9	291.1	30.5	70.3	66.4	398.0	148.8	75.1	56.9	46.9	77.8	53.5	20.6	46.3	58.1	116.5	118.4	174.9	354.7	203.9	136.3	117.9	163.3	40.0	65.7	126.5	117.0	132.1	120.7	192.4	77.6	215.5	50.7	134.0	163.2	156.1
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 331.5;Hepatic stellate cells: 99.2;Inhibitory neurons: 375.4;Oligodendrocyte precursor cells: 143.2;Oligodendrocytes: 460.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.7;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.7;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.1;hTEC/SVTERT24-B: 16.3;HUVEC TERT2: 20.9;SCLC-21H: 31.6;TIME: 26.3;U-138 MG: 21.7"	"Low region specificity"	"Detected in all"							HPA034609	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	4.1	1.5	2.4	1.2	3.5	0.1	1.7	4.4	6.1	2.2	0.0	0.4	0.4	0.8	0.3	3.1	3.5	2.1	8.1	3.3	0.0	1.6	2.7	5.3	2.0	1.1	0.8	0.2	0.6	4.3	1.2	7.4	2.1	0.4	0.4	2.7	0.9	0.5	1.4	0.8	0.5	1.3	0.0	6.0	0.9	3.5	1.7	0.8	3.8	3.5	2.4	1.0	0.6	8.2	0.1	1.4	2.3	0.0	1.4	4.2	1.6	2.7	7.3	2.1	2.6	0.3	0.1	1.4	0.5	13.4	3.3	3.2	0.9	0.1	4.5	30.1	1.6	0.0	2.3	0.2	0.2	0.5	0.3	1.0	1.3	16.3	5.7	4.1	20.9	0.0	0.2	0.1	6.7	1.8	0.0	0.7	2.5	0.2	1.0	0.0	0.5	0.0	0.1	0.0	31.6	2.5	2.0	0.5	0.0	0.4	0.1	0.2	26.3	21.7	1.4	4.6	0.7	0.2	0.0	1.3	5.4	0.1	0.2	0.1	0.3	0.8	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.5	0.0	0.0	4.7	0.0	3.7	0.0	0.0	0.1	2.4	3.5	4.4	6.1	3.3	0.0	1.1	0.8	2.1	0.0	1.7	8.2	61.2	0.0	12.1	12.7	3.6	2.2	0.3	0.1	3.4	9.5	1.1	0.8	18.7	0.0	0.1	0.0	0.0	0.2	0.7	0.6	0.0	0.1	11.1	0.4	1.6	34.2	2.4	0.0	331.5	0.0	0.3	4.2	0.5	0.3	1.3	4.9	99.2	1.5	0.1	0.0	375.4	0.6	0.0	7.2	3.0	5.3	0.0	1.4	3.6	14.0	1.2	12.0	0.0	143.2	460.7	0.1	0.0	2.6	3.4	0.4	0.0	0.1	1.0	1.1	0.0	1.2	2.2	0.5	6.1	9.2	1.6	0.1	1.4	0.7	0.1	0.6
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055997	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		510000000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	30.1	9.9	19.3	19.2	23.2	1.9	14.8	27.0	15.0	20.8	28.3	11.9	8.0	19.2	6.2	16.1	13.2	38.9	67.3	14.3	22.7	15.2	7.5	55.1	16.5	32.0	28.1	12.4	31.6	16.1	3.6	33.4	28.6	13.9	12.2	46.8	7.7	14.6	14.3	5.2	9.4	25.4	27.3	17.9	9.8	13.5	30.3	8.6	52.2	24.2	15.7	30.0	10.1	30.6	7.0	7.1	54.7	4.2	73.2	58.7	21.1	64.9	90.1	72.6	83.5	58.5	1.0	2.8	43.8	174.1	52.3	15.3	7.4	31.6	97.9	6.5	3.7	1.3	42.3	8.4	241.5	1.8	80.6	77.8	10.1	87.4	21.5	351.3	69.3	5.0	0.1	1.0	25.7	1.3	2.8	0.1	10.1	0.1	5.5	4.8	41.0	0.2	14.6	1.2	1.0	5.6	134.8	10.6	6.4	55.1	24.2	4.3	93.9	37.7	41.3	150.5	29.1	6.9	19.7	0.4	76.8	6.5	82.4	1.1	0.1	0.0	1.9	1.7	1.1	0.5	0.6	1.7	0.4	0.3	1.2	0.8	0.0	3.9	1.9	0.4	0.2	0.5	19.3	23.2	27.0	15.0	14.3	22.7	32.0	28.1	28.6	27.3	30.3	30.6	90.1	86.6	5.8	28.7	4.9	5.0	8.0	25.4	6.8	6.1	2.4	5.7	90.5	7.2	6.5	27.6	264.8	1.8	19.2	0.5	0.0	32.0	7.0	4.0	20.1	121.5	0.0	6.1	0.9	6.4	65.3	44.8	1.1	2.2	26.6	24.9	130.3	3.5	6.8	1.7	14.9	0.5	4.1	18.4	7.3	9.4	5.0	7.1	7.2	92.8	4.0	6.0	35.0	13.0	57.6	6.4	0.1	13.9	8.6	5.2	0.8	1.3	1.0	66.8	0.0	24.0	28.7	1.0	1.1	2.7	4.4	3.3	14.2	3.1	0.1	1.3
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070444-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli, Nucleoli rim"	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	6.3	6.6	3.8	8.5	4.9	12.5	6.6	12.0	5.7	7.6	8.4	5.8	4.8	7.4	6.1	4.7	6.1	7.1	6.1	3.6	6.9	6.9	10.9	6.8	9.8	4.1	5.2	12.3	7.8	12.0	6.1	11.2	4.0	6.1	6.6	14.3	6.2	6.2	9.1	4.4	5.9	7.5	3.3	9.1	6.5	10.8	5.5	15.4	8.7	14.0	8.9	6.6	5.0	3.3	10.3	10.0	12.3	12.3	14.8	8.4	18.7	9.0	8.8	11.8	12.4	14.7	7.9	21.2	7.2	12.0	7.4	10.5	23.3	11.3	18.4	8.2	7.3	27.2	10.7	12.5	7.1	22.3	15.6	9.8	10.5	11.4	14.1	8.8	18.1	15.6	19.1	12.9	9.8	13.0	29.0	7.6	7.4	9.2	9.7	19.3	21.6	9.2	9.1	14.3	12.0	11.0	14.3	11.5	15.2	16.9	13.7	13.7	16.1	14.5	16.6	8.0	8.1	10.7	13.4	15.5	7.2	13.7	15.5	2.3	3.3	2.8	5.1	2.8	6.3	1.7	3.1	3.2	2.8	2.8	1.9	2.6	2.3	2.6	1.9	2.2	3.0	2.3	3.8	4.9	12.0	5.7	3.6	6.9	4.1	5.2	4.0	3.3	5.5	3.3	42.9	19.2	37.1	89.1	44.3	32.1	24.6	30.2	29.6	50.8	32.8	23.6	31.1	24.3	30.2	27.6	93.8	32.9	95.8	29.4	7.9	19.1	5.2	49.4	55.8	32.3	38.3	48.8	93.1	14.2	42.8	30.9	38.7	118.5	33.7	51.9	61.8	52.1	31.9	67.3	112.1	30.2	16.2	79.4	28.8	10.5	38.8	55.4	14.2	107.7	62.0	24.0	104.0	134.2	72.6	19.2	23.1	42.9	67.1	29.3	27.7	14.6	26.1	54.9	13.1	45.9	34.0	36.0	26.0	33.6	20.2	18.3	71.0	32.6	26.3	45.8
HELZ2	"KIAA1769, PDIP1, PRIC285"	ENSG00000130589	"Helicase with zinc finger 2"	Q9BYK8	20	63558086-63574239	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 46.1;Urothelial cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 59.4;GAMG: 34.5;SK-MEL-30: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051267	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA051267: "	"unprognostic (1.86e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.16e-1)"	6.6	4.2	4.0	5.6	2.9	15.6	5.6	2.3	2.1	5.7	1.6	5.5	3.8	4.2	0.6	7.4	5.0	3.0	7.0	1.9	2.6	6.6	7.7	9.9	4.8	6.2	3.1	3.9	5.8	0.8	5.1	2.3	4.1	4.6	0.9	0.1	12.2	1.1	1.8	4.8	6.3	1.0	6.4	12.3	7.6	1.2	4.7	3.0	5.9	0.9	1.8	3.9	3.9	2.7	10.0	3.7	1.2	3.7	2.2	2.8	7.1	3.5	5.2	59.4	23.0	10.1	12.4	0.2	7.5	1.3	34.5	15.3	0.7	3.6	2.3	3.7	1.7	0.2	4.6	3.5	4.8	0.3	23.4	3.5	2.5	4.3	0.7	1.3	2.8	0.2	1.8	4.1	0.7	9.9	1.1	10.2	1.9	2.6	11.4	2.2	2.0	3.9	1.7	11.4	0.9	3.3	10.9	0.7	25.4	0.7	3.4	3.0	4.5	5.7	8.4	4.7	3.6	5.2	0.7	0.2	6.2	1.6	5.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	4.0	2.9	2.3	2.1	1.9	2.6	6.2	3.1	4.1	6.4	4.7	2.7	24.7	9.6	6.0	0.3	10.5	8.7	22.7	8.8	4.6	1.0	8.8	5.5	4.5	8.6	12.1	9.2	0.0	2.1	15.9	26.0	0.0	8.8	0.1	11.6	9.6	24.9	30.9	3.2	0.1	7.7	13.4	11.6	26.0	17.5	0.0	46.1	10.4	6.0	3.5	0.0	0.3	19.5	4.1	4.3	17.1	0.0	7.2	10.8	3.6	4.7	7.0	1.7	24.7	1.0	0.4	20.4	20.7	2.2	6.4	28.9	17.9	0.8	9.6	2.7	6.6	12.2	9.9	0.7	0.3	5.1	8.4	1.9	14.7	17.7	14.5	47.4
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 174.9;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 201.4;fHDF/TERT166: 226.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: AB_2686247"	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	13.9	19.6	18.2	14.4	18.9	10.9	14.3	19.5	23.5	15.2	15.3	14.1	13.8	14.9	14.0	14.5	13.4	13.3	13.6	20.6	22.4	13.7	16.6	13.9	21.0	19.4	19.7	15.3	11.1	12.0	14.1	16.5	19.4	12.2	15.9	13.9	11.5	11.4	13.5	13.4	14.6	15.6	18.1	18.2	11.6	14.2	21.1	15.2	13.1	12.3	19.4	16.2	14.3	26.7	75.4	30.4	16.7	28.5	47.5	63.9	15.5	201.4	125.5	75.5	47.6	17.5	35.3	29.7	14.3	226.7	40.6	40.9	21.1	28.9	102.0	17.6	9.2	13.7	51.3	12.2	22.6	17.3	21.3	30.2	33.8	39.3	34.4	89.1	47.5	15.0	14.9	14.3	117.4	35.2	11.3	19.9	9.9	15.8	49.0	15.3	7.6	8.2	32.3	23.7	8.7	9.4	66.1	26.4	26.5	37.6	15.4	20.1	65.0	38.2	17.5	94.7	31.9	8.7	11.2	17.8	67.7	32.3	13.6	10.8	5.0	6.6	3.9	4.1	5.0	3.4	4.1	4.5	5.7	3.4	4.1	4.2	6.7	5.2	4.1	1.6	5.6	3.7	18.2	18.9	19.5	23.5	20.6	22.4	19.4	19.7	19.4	18.1	21.1	26.7	29.8	48.1	29.3	127.0	41.0	50.3	33.7	27.2	26.2	50.1	29.1	16.6	23.0	14.3	24.1	18.4	43.8	29.3	38.7	78.7	7.9	19.5	66.4	44.3	45.4	30.9	22.1	32.4	170.2	12.2	40.8	30.3	34.1	70.9	30.4	31.3	28.5	24.5	23.6	53.8	148.8	29.9	26.4	42.9	23.3	47.4	26.8	30.9	17.8	149.9	36.0	18.9	40.2	174.9	209.2	38.6	52.3	19.2	17.4	42.6	37.8	24.9	25.5	45.8	6.6	33.2	28.1	25.2	12.4	23.4	60.9	15.6	40.9	38.5	21.9	48.5
HERPUD1	"HERP, KIAA0025, Mif1, SUP"	ENSG00000051108	"Homocysteine inducible ER protein with ubiquitin like domain 1"	Q15011	16	56932142-56944864	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 2680.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 497.6;U-266/70: 533.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037041, CAB037104, HPA040754, HPA041219"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"		"CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.39e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.41e-9)"	"unprognostic (1.06e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.27e-3)"	75.3	108.4	68.4	102.0	70.6	113.6	128.9	73.7	92.6	127.1	99.0	149.5	98.2	65.7	220.2	53.2	86.5	77.8	92.0	67.9	77.9	193.1	193.0	92.0	114.1	77.3	72.8	188.8	377.0	206.9	78.8	97.1	75.2	213.0	141.8	39.7	170.0	102.0	102.9	58.7	84.9	77.8	78.4	114.8	144.1	25.0	74.6	58.0	213.6	120.9	246.6	94.5	45.0	82.8	28.6	30.9	29.8	61.8	66.9	86.9	105.2	65.9	104.6	83.5	64.9	43.1	63.5	115.0	82.7	64.6	84.6	47.9	51.0	23.3	82.4	67.1	30.8	9.9	48.3	156.3	364.6	21.1	49.5	106.0	219.2	38.0	119.6	100.4	64.4	125.9	15.9	159.6	236.3	24.1	39.8	42.7	19.1	164.8	68.9	27.0	74.9	497.6	179.8	31.8	32.7	37.5	57.5	278.8	308.2	41.9	31.3	77.4	40.0	34.8	34.4	30.8	26.8	533.9	191.0	182.6	49.3	28.7	46.4	224.0	291.2	139.5	113.2	238.1	124.0	383.2	120.1	149.7	230.6	340.4	77.2	117.8	215.9	179.6	175.0	915.5	263.8	417.7	68.4	70.6	73.7	92.6	67.9	77.9	77.3	72.8	75.2	78.4	74.6	82.8	316.4	70.5	105.9	16.6	964.5	364.0	561.8	316.3	203.7	134.6	191.3	185.2	221.5	91.5	193.4	71.7	281.5	131.9	577.3	369.1	170.2	192.7	73.3	162.5	121.3	199.8	434.4	40.8	29.9	197.7	182.4	223.8	251.8	260.5	151.8	108.8	134.2	164.0	194.7	47.1	32.2	569.7	290.9	241.6	395.9	251.6	104.1	507.7	948.0	88.1	197.0	94.3	81.4	21.1	30.7	144.8	336.5	95.5	2680.7	447.4	156.1	209.0	95.6	117.1	98.6	178.8	215.6	54.7	10.6	146.6	255.3	693.8	342.6	137.4	311.4	456.8
HES1	"bHLHb39, FLJ20408, HES-1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136148-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"eosinophil: 15.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	64.2	32.2	13.6	7.9	14.9	0.9	87.0	12.5	15.0	66.0	11.8	44.1	31.2	22.5	9.0	127.8	22.4	17.7	65.6	14.7	16.8	87.3	68.7	47.1	7.0	15.3	17.4	25.3	34.8	22.6	42.7	27.5	13.5	90.1	35.7	66.5	79.9	31.5	69.9	184.5	23.9	9.8	13.5	23.4	42.1	12.8	14.5	11.9	93.2	22.4	11.8	59.8	136.6	11.6	9.3	2.6	20.8	27.1	6.1	0.0	5.2	4.3	12.2	0.9	0.5	36.4	26.1	1.3	74.6	1.6	12.6	51.4	3.9	24.2	0.3	7.7	44.0	33.1	3.5	9.4	0.1	0.2	30.1	2.2	94.1	0.8	10.9	14.3	28.6	1.7	16.1	1.2	0.0	43.9	47.5	45.7	19.4	95.8	17.8	0.1	1.5	1.0	28.0	71.2	1.2	1.6	21.0	78.9	38.9	23.6	22.2	2.6	22.3	2.3	21.8	0.3	31.3	0.2	0.1	0.2	1.6	0.1	43.7	0.0	0.0	15.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	13.6	14.9	12.5	15.0	14.7	16.8	15.3	17.4	13.5	13.5	14.5	11.6	684.0	25.6	96.0	70.2	54.2	122.9	498.5	736.7	159.4	15.9	352.0	164.1	128.8	517.6	355.1	196.8	16.7	41.1	4.7	696.8	189.8	268.9	2.2	231.9	37.6	401.8	160.1	19.2	1.2	199.1	6.0	274.1	105.0	257.4	303.4	16.1	850.6	163.1	24.4	10.1	0.4	579.7	213.6	95.3	76.2	8.7	58.7	74.6	80.0	5.6	22.8	1146.0	0.0	4.5	0.1	227.1	1137.2	18.8	5.0	231.1	297.5	126.6	190.2	54.9	164.3	76.8	291.7	1.2	13.2	367.8	296.5	209.2	24.1	31.4	882.7	358.1
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699010-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 311.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 94.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000	14000	"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	7.9	19.8	1.6	6.3	3.3	12.3	5.2	1.5	7.8	7.2	1.8	4.4	2.6	8.1	3.6	2.9	5.4	16.6	4.7	2.9	3.6	11.8	30.3	19.5	2.2	3.6	2.3	1.8	2.1	2.1	2.4	311.9	4.3	7.2	3.4	14.2	2.4	6.4	0.8	0.9	2.3	7.1	1.8	6.5	3.9	2.4	2.9	1.5	5.6	3.9	1.5	10.4	6.3	3.3	0.0	0.0	0.1	0.0	21.6	171.6	0.1	0.7	33.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	135.8	82.4	0.4	41.4	0.0	87.4	0.3	0.0	2.2	0.0	0.1	240.7	0.6	0.0	0.0	56.4	0.0	0.0	0.2	0.8	0.0	7.5	0.0	0.0	0.2	9.3	0.0	0.1	0.0	0.2	0.0	3.5	0.4	2.0	0.0	0.1	0.0	0.1	0.0	0.0	62.6	16.9	0.1	94.0	15.2	3.9	0.0	18.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	3.2	0.0	17.3	1.0	0.0	4.3	1.6	3.3	1.5	7.8	2.9	3.6	3.6	2.3	4.3	1.8	2.9	3.3	6.2	0.0	4.1	16.3	0.0	1.0	0.2	0.0	1.8	0.2	0.3	0.5	1.3	1.5	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	15.2	1.0	23.8	6.2	0.0	2.1	0.3	0.0	4.9	95.8	0.5	0.9	1.3	0.0	25.0	0.5	18.4	0.0	22.4	0.0	0.0	12.5	1.9	2.3	18.3	14.0	1.8	7.5	10.5	36.2	1.0	0.0	0.1	0.0	0.0	10.9	0.3	0.4	0.0	0.0	0.0	0.7	13.1	0.9	26.2	0.2	0.3	0.3	0.1	12.0	0.6	1.3	0.0	0.4
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441968-3449486	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"liver: 217.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	9300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	1.5	0.0	2.3	0.0	0.1	2.2	2.6	0.5	0.7	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.1	1.3	0.6	0.6	217.1	0.1	0.0	0.9	0.6	0.1	0.1	0.0	0.7	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	3.8	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	2.2	2.6	1.3	0.6	0.9	0.6	0.9	0.5	0.8	0.6	0.1	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.6	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	4.4	2.2	72.0	0.0	3.3	3.9	0.0	0.0	3.2	0.0	165.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	21.5	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	73.3	95.6	101.5	24.8	102.2	54.5	69.7	98.9	127.1	81.4	98.2	75.7	29.3	66.7	32.7	118.8	70.2	27.0	82.1	103.3	99.3	100.8	85.7	80.1	30.6	105.9	103.2	74.4	85.1	28.1	81.7	24.8	104.3	86.3	25.3	15.7	72.4	29.6	93.7	95.2	81.2	28.5	98.1	100.6	84.6	105.9	102.7	35.3	68.5	18.5	24.8	81.1	83.9	104.1	104.2	93.1	47.8	66.6	56.0	59.8	57.3	65.5	86.6	99.6	76.8	72.6	65.0	23.4	47.2	106.4	88.6	63.2	43.7	100.6	45.8	19.7	76.0	58.8	98.8	117.5	92.8	47.1	55.4	78.1	100.9	93.9	121.9	82.7	120.9	44.5	54.8	30.4	92.1	77.9	58.1	71.4	43.8	75.9	88.9	51.3	48.6	41.0	94.5	87.7	54.9	86.1	54.6	114.9	78.3	48.3	82.3	98.6	87.3	119.5	82.4	69.6	123.3	41.6	17.6	21.8	96.9	53.3	89.4	48.8	28.7	38.9	24.5	32.3	16.6	16.4	18.5	19.4	23.5	15.8	14.1	16.0	44.7	27.1	33.6	19.3	22.3	35.9	101.5	102.2	98.9	127.1	103.3	99.3	105.9	103.2	104.3	98.1	102.7	104.1	20.8	25.6	28.7	17.6	22.0	27.9	23.8	27.7	29.6	30.6	27.0	25.9	3.1	17.2	27.6	22.0	35.5	34.0	27.4	60.9	1.9	43.3	72.3	45.6	28.7	26.3	11.4	23.4	14.2	42.6	36.5	21.8	68.8	66.1	23.4	26.3	16.1	20.7	29.5	23.5	12.6	32.4	22.4	22.9	26.6	137.8	28.9	30.3	23.2	15.9	28.1	20.6	25.7	6.6	16.1	68.2	42.7	23.0	27.6	53.9	41.1	14.6	32.3	35.5	13.1	17.8	24.0	36.9	32.5	37.0	30.3	50.2	23.5	22.1	36.2	50.8
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662883	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 543.9;Proximal tubular cells: 355.1;Syncytiotrophoblasts: 272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced					NA	NA		820000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	62.1	79.0	15.0	11.9	18.0	7.6	56.5	18.8	18.4	37.2	27.6	33.8	35.0	35.3	11.6	20.4	41.6	28.4	66.7	13.2	18.2	160.5	197.9	20.4	15.1	16.1	17.0	33.4	34.2	97.4	14.1	47.4	16.9	44.7	34.5	31.5	45.4	42.4	117.4	13.1	32.0	37.2	15.6	18.0	34.0	26.4	17.4	21.2	54.5	203.2	14.8	33.5	18.0	17.5	74.0	46.8	31.0	50.1	89.1	109.8	29.3	44.8	83.8	46.3	52.8	27.6	85.2	29.9	38.4	81.4	79.4	67.1	34.5	66.5	67.3	20.9	34.6	14.6	73.0	114.3	73.8	22.4	16.1	101.2	54.1	34.8	120.6	112.1	61.7	35.3	59.7	29.2	117.2	31.2	21.4	34.7	30.0	110.4	56.0	21.2	31.2	33.1	106.5	43.6	28.6	31.7	93.8	173.5	77.9	76.4	75.0	48.6	40.3	28.6	49.5	47.1	31.2	51.8	39.7	17.8	41.2	67.8	85.1	5.3	17.3	8.2	16.7	22.8	22.5	18.2	18.4	19.3	19.3	16.4	24.0	19.8	3.0	22.9	22.0	9.1	13.2	17.4	15.0	18.0	18.8	18.4	13.2	18.2	16.1	17.0	16.9	15.6	17.4	17.5	17.3	9.6	6.4	56.2	14.1	21.3	43.6	51.9	17.1	15.8	58.8	28.2	105.8	58.6	37.7	47.8	4.2	181.1	8.1	23.3	543.9	35.8	58.5	22.8	28.5	21.5	15.6	33.2	64.4	29.1	138.9	44.6	43.3	27.3	2.5	12.0	25.4	149.8	53.7	23.5	85.9	28.9	40.7	28.3	10.0	62.3	44.7	18.5	65.8	51.5	11.0	34.1	8.2	147.2	131.6	28.0	24.1	36.9	20.1	46.1	58.4	355.1	50.8	11.9	46.0	31.6	35.4	35.0	44.3	22.4	15.5	272.4	15.2	77.3	38.8	47.3
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 subunit alpha"	Q16665	14	61695513-61748259	"Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 448.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 155.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 155.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 941.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	64.9	133.7	22.1	146.6	24.0	448.3	36.2	28.2	26.1	132.9	24.7	42.8	33.6	52.4	74.8	62.1	41.1	145.4	36.5	21.1	28.4	104.2	51.6	75.7	71.4	29.7	29.7	35.3	36.0	91.7	30.7	77.6	33.3	46.9	41.7	35.5	45.3	67.2	12.1	34.2	37.3	59.1	27.2	72.4	37.6	32.4	38.5	55.8	49.5	17.6	88.2	169.9	43.1	26.5	313.6	123.6	112.7	344.7	185.2	297.1	161.5	253.8	270.1	288.7	258.9	54.1	100.3	75.8	186.2	293.0	73.6	71.8	71.0	416.1	352.5	33.7	41.0	46.5	105.3	93.1	414.8	20.1	49.3	523.4	129.2	216.5	225.6	408.6	198.1	44.4	32.3	0.4	941.4	65.6	59.2	24.3	108.9	49.6	159.7	4.3	269.1	22.8	400.2	204.3	100.3	111.9	472.5	67.0	170.7	148.9	70.6	36.3	119.2	700.2	157.3	235.9	215.2	39.1	61.2	84.1	369.9	38.5	194.7	43.8	22.3	155.0	11.5	18.0	14.4	19.5	15.0	13.3	19.6	19.0	22.6	15.6	56.3	19.7	19.4	9.2	11.0	18.4	22.1	24.0	28.2	26.1	21.1	28.4	29.7	29.7	33.3	27.2	38.5	26.5	93.3	70.5	116.0	69.2	157.3	106.4	101.8	102.6	97.9	54.1	38.5	30.1	43.5	87.2	69.0	261.1	50.1	24.8	65.1	44.1	103.7	278.5	3.6	95.6	131.3	152.3	66.4	35.3	45.6	251.6	67.1	81.4	49.5	272.3	223.6	339.7	176.0	30.7	136.4	156.5	39.3	39.0	57.0	145.9	111.7	6.2	24.2	240.2	103.2	53.4	87.1	134.0	26.8	78.9	35.8	236.9	21.9	48.5	60.0	59.3	20.2	192.1	37.7	54.8	52.6	75.8	136.9	80.5	44.2	128.7	87.9	25.4	91.6	92.2	51.8	116.0
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131155383-131224468	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 3537.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2800000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	132.6	175.0	235.7	139.8	245.1	259.3	172.7	241.6	326.2	117.6	243.8	227.6	176.1	119.6	187.5	181.3	165.6	108.0	167.2	245.9	247.8	256.7	474.2	119.0	206.5	241.6	237.2	121.5	165.5	285.6	152.5	87.5	249.1	155.1	226.5	110.8	172.8	116.4	334.1	170.0	196.3	124.2	242.6	126.9	136.5	80.1	240.8	166.5	177.2	278.4	192.3	152.9	129.7	245.3	437.1	522.7	448.2	877.2	273.1	297.1	441.3	300.3	230.9	235.4	272.1	547.1	516.8	563.3	625.7	329.6	569.1	253.4	315.4	635.3	244.1	500.0	514.6	199.1	814.0	771.9	532.6	349.4	65.4	400.1	618.6	295.8	528.2	533.7	314.1	727.8	313.4	1132.1	338.8	419.9	548.0	945.6	415.6	425.6	362.0	407.9	436.1	988.1	500.6	567.0	563.3	351.9	380.5	243.5	612.0	574.4	291.2	520.8	396.0	351.7	244.0	323.0	684.2	342.3	561.4	578.8	497.8	586.8	346.3	179.8	187.9	85.0	196.3	109.9	298.0	384.9	462.0	294.2	396.9	332.6	416.0	325.5	35.6	269.0	128.0	521.4	362.5	608.6	235.7	245.1	241.6	326.2	245.9	247.8	241.6	237.2	249.1	242.6	240.8	245.3	582.7	282.0	279.1	34.3	718.2	1301.2	1472.2	1928.1	889.5	191.2	1134.3	1831.1	517.0	1028.0	882.2	715.4	45.9	780.9	641.6	1245.1	1663.0	1024.5	783.0	718.9	443.7	501.2	698.1	669.7	53.8	774.3	1632.8	400.2	355.2	753.7	108.2	666.5	436.2	2380.1	887.1	148.0	48.0	947.2	915.5	472.4	906.9	206.3	392.4	447.0	965.8	34.7	1269.4	405.1	488.1	26.7	55.4	894.3	1094.2	418.6	679.7	1998.9	1690.3	3537.5	708.3	194.0	243.3	287.0	730.3	625.5	197.9	1109.1	1146.1	456.8	671.1	464.3	1280.4	1713.2
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	50.8	79.5	41.7	15.5	43.9	27.0	48.5	44.9	46.8	23.2	40.3	42.6	34.9	25.9	48.6	27.5	29.9	14.9	87.4	39.8	43.1	91.1	169.2	30.2	21.0	43.8	42.5	19.2	65.9	72.6	41.2	17.6	42.0	33.9	34.2	20.4	39.7	26.1	80.1	33.4	34.2	20.1	43.9	33.8	56.9	29.8	47.3	38.8	38.4	85.5	23.8	30.6	24.2	44.0	30.3	76.1	47.1	45.6	29.0	24.3	33.2	27.8	39.2	42.3	46.1	49.9	31.1	39.9	31.7	25.3	59.8	29.3	21.2	40.9	44.1	87.8	40.7	42.2	64.1	45.8	68.1	25.1	40.0	27.3	36.8	40.2	64.8	16.7	33.2	91.4	25.5	117.4	34.0	60.3	61.3	31.3	21.4	70.0	138.7	60.8	33.1	53.6	61.5	21.5	38.4	46.4	36.0	42.7	49.6	27.5	45.9	44.6	16.5	22.0	37.7	30.4	35.7	107.0	127.3	57.4	49.8	32.2	36.2	41.0	77.5	4.7	68.9	58.5	62.4	98.9	73.7	69.8	113.4	96.7	56.4	58.6	7.6	66.8	56.9	246.1	107.3	81.2	41.7	43.9	44.9	46.8	39.8	43.1	43.8	42.5	42.0	43.9	47.3	44.0	49.3	22.4	17.5	5.2	57.9	45.4	63.4	137.6	49.5	39.8	99.1	105.8	115.1	130.1	68.3	80.9	20.9	154.9	69.3	148.2	633.9	115.5	67.3	83.9	28.6	47.8	96.0	100.8	1.7	172.1	71.7	53.2	52.5	44.6	18.4	43.5	63.1	457.4	113.9	20.2	2.5	127.4	126.1	61.1	51.4	128.0	40.4	47.7	120.9	1.9	74.1	123.7	87.6	1.5	4.5	85.6	157.5	44.8	77.7	40.7	181.4	578.1	105.1	45.5	46.0	54.2	72.6	38.4	77.4	64.7	45.9	56.8	51.0	85.1	126.7	84.8
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929324-113977869	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	Centrosome	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	19.8	20.0	24.7	20.2	23.5	142.0	16.8	44.5	20.9	24.4	42.4	19.0	12.7	18.1	17.2	23.1	35.0	22.2	18.0	20.6	32.5	18.2	17.8	23.4	20.9	37.2	39.4	22.8	21.8	21.3	20.5	17.7	29.8	15.4	18.9	56.5	15.2	17.7	25.7	23.4	16.8	18.2	36.9	20.7	17.8	47.1	27.5	57.4	29.8	27.1	20.6	19.7	18.8	25.6	23.4	18.8	25.4	19.5	29.2	15.2	17.1	15.8	19.0	22.2	20.9	21.8	8.8	31.4	21.2	25.3	8.2	15.5	33.1	18.6	31.7	23.0	16.7	45.8	23.7	23.0	24.3	36.7	54.2	16.5	26.5	28.3	28.7	20.8	33.2	54.2	31.8	32.8	32.1	176.4	48.8	21.0	26.2	17.1	15.8	29.1	74.4	10.9	19.8	19.9	11.2	15.0	28.9	30.6	20.5	27.9	17.7	52.3	32.6	21.5	29.0	35.3	24.3	20.1	17.2	26.7	23.7	29.3	50.3	2.1	2.5	5.0	3.0	2.1	3.0	0.9	2.7	2.8	1.7	1.1	2.6	3.3	5.8	2.7	1.6	3.7	2.0	1.5	24.7	23.5	44.5	20.9	20.6	32.5	37.2	39.4	29.8	36.9	27.5	25.6	30.1	54.5	37.2	14.4	26.0	61.4	16.2	16.7	15.4	57.7	29.8	20.2	34.6	22.8	24.5	27.6	70.9	10.7	125.8	38.9	5.9	14.6	95.2	147.9	33.4	28.9	37.2	64.4	27.4	21.0	10.3	24.3	20.9	47.0	46.9	26.3	21.8	37.4	22.2	74.0	33.9	25.4	12.2	49.5	77.7	101.4	22.1	50.2	21.4	31.9	43.1	30.6	36.0	21.1	26.5	18.8	22.4	37.2	43.5	33.7	17.8	16.4	116.4	64.8	26.3	36.5	44.3	49.7	31.5	25.6	80.6	14.2	69.7	21.9	28.3	32.7
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"HIVEP zinc finger 2"	P31629	6	142751469-142956698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 326.2;Inhibitory neurons: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	7.9	6.9	5.2	10.4	7.8	3.1	6.2	10.1	15.6	4.2	0.0	5.4	4.5	6.1	5.0	8.5	11.4	9.8	7.4	9.5	1.3	6.0	5.6	7.9	12.0	1.0	4.9	13.1	10.1	8.3	5.9	7.2	1.2	5.0	4.3	5.7	8.7	5.1	21.0	8.0	6.0	5.5	0.8	8.2	4.9	1.8	5.8	19.0	8.2	13.9	12.1	13.8	5.5	10.5	6.0	1.1	1.4	5.2	11.1	12.3	4.1	8.5	21.8	5.2	6.3	0.4	4.9	9.5	5.2	37.7	9.9	3.8	2.3	17.4	12.7	3.7	2.7	2.6	3.9	2.4	8.4	8.4	0.1	11.4	16.9	21.3	24.3	12.1	2.8	7.5	0.1	8.4	8.9	6.8	11.1	3.6	1.3	1.4	8.5	14.4	9.3	0.8	4.8	10.4	14.0	5.9	11.3	9.2	6.3	2.5	1.7	4.9	3.0	17.5	4.4	14.8	7.5	17.4	3.1	19.8	4.9	6.4	8.3	0.0	0.1	0.0	0.6	0.2	1.4	0.9	1.4	1.2	0.4	0.4	1.4	1.1	0.9	0.7	0.2	0.2	1.2	0.5	5.2	7.8	10.1	15.6	9.5	1.3	1.0	4.9	1.2	0.8	5.8	10.5	22.2	22.4	25.5	65.6	18.4	94.3	45.2	9.1	5.2	15.1	13.7	7.6	18.3	5.7	27.6	7.3	25.0	2.8	22.4	5.1	0.0	12.5	2.1	53.2	29.4	26.5	3.5	4.2	326.2	14.8	1.2	30.5	2.0	101.0	3.8	6.1	8.6	4.5	2.8	30.3	223.0	4.9	16.2	4.4	52.7	1.2	11.8	17.5	24.9	67.5	5.1	2.5	4.1	98.0	75.3	22.8	6.6	15.8	22.1	53.6	5.3	3.3	25.1	2.2	0.0	37.6	25.7	0.6	0.9	11.5	94.6	4.7	29.5	2.6	3.4	56.8
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 374.0;Horizontal cells: 304.5;Late spermatids: 1034.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		560000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	47.0	24.4	61.0	45.0	65.7	60.3	40.6	58.0	76.6	54.7	64.2	60.1	13.1	41.3	11.2	129.9	37.0	25.7	150.8	69.1	62.7	49.2	8.5	48.1	34.1	56.7	59.8	19.9	12.3	25.0	44.9	49.3	71.1	52.9	31.9	147.6	67.1	53.1	193.5	102.6	29.2	49.8	40.0	40.3	61.6	77.2	53.5	44.9	71.0	146.7	47.6	74.3	80.9	54.1	101.6	56.6	74.2	71.1	81.0	60.4	47.1	98.3	256.5	128.5	138.0	16.3	11.0	7.3	75.8	165.9	92.9	86.2	69.9	220.0	122.0	67.5	54.5	250.0	58.3	1.1	91.7	5.1	181.2	91.5	125.8	184.5	407.6	160.8	135.4	36.8	424.5	51.3	178.7	167.7	29.7	13.1	113.8	51.7	247.0	44.8	45.0	0.6	88.7	117.4	75.7	88.7	112.6	215.4	65.2	104.3	117.7	16.5	140.4	190.5	86.4	106.5	139.6	61.1	42.8	17.4	247.3	130.4	56.1	68.7	88.8	44.6	41.5	125.2	69.0	33.5	47.9	47.6	81.0	19.9	41.7	33.9	20.9	31.2	135.4	9.1	58.1	110.4	61.0	65.7	58.0	76.6	69.1	62.7	56.7	59.8	71.1	40.0	53.5	54.1	26.1	25.6	32.4	38.2	26.5	48.3	50.5	37.8	43.9	83.9	33.1	21.7	130.6	4.3	34.2	27.6	54.2	70.6	14.6	30.3	13.7	28.6	374.0	32.6	28.0	37.9	18.7	104.8	53.8	30.6	93.3	30.3	41.3	34.5	23.4	72.6	26.7	1.1	49.4	304.5	49.8	28.7	44.7	41.7	21.9	1034.1	15.2	51.3	37.4	29.0	35.3	32.9	20.6	14.1	3.5	54.6	11.1	18.4	19.1	29.1	0.7	1.1	30.7	95.5	19.7	22.2	43.1	5.3	6.2	86.0	51.7	118.9	30.5	28.3	19.3	43.5
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74834127-74893359	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 144.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 216.4;Early spermatids: 89.5;Paneth cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 51.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 172.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA		100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	58.2	2.7	2.7	14.6	3.9	45.7	16.0	4.8	5.6	7.8	2.7	46.6	2.8	5.1	66.1	19.9	9.7	9.5	7.9	3.5	3.6	1.9	2.7	15.2	5.8	11.1	6.3	14.9	2.9	2.5	1.9	13.1	8.5	4.9	37.3	144.0	14.7	1.1	45.6	14.6	13.0	3.3	5.9	6.9	18.7	32.8	6.0	3.7	14.1	83.7	7.8	27.1	15.9	8.6	55.9	0.4	12.5	45.4	103.3	10.8	46.5	21.3	30.6	23.4	33.4	44.0	9.8	40.7	20.1	9.9	30.2	19.0	57.0	44.7	67.0	11.6	12.5	55.1	12.4	61.0	32.5	80.8	86.3	18.2	47.3	44.5	77.1	26.3	11.3	23.0	49.2	0.2	6.9	39.6	19.8	82.0	45.3	52.4	38.2	31.8	26.2	31.7	14.2	77.2	9.2	44.6	13.5	67.4	27.4	17.8	3.6	12.8	9.4	74.0	13.4	31.2	39.2	27.1	8.2	20.2	172.5	57.9	19.9	16.8	14.0	51.7	0.2	11.0	0.6	1.2	0.8	0.1	11.8	1.3	1.2	1.2	11.2	0.0	7.7	0.3	1.5	4.7	2.7	3.9	4.8	5.6	3.5	3.6	11.1	6.3	8.5	5.9	6.0	8.6	1.6	16.0	45.3	4.9	5.7	51.6	9.5	26.7	5.7	14.8	16.0	5.6	7.2	4.3	24.2	5.5	83.4	2.3	0.6	216.4	0.0	4.6	89.5	5.8	4.1	4.4	39.0	4.2	0.2	4.5	33.5	6.4	14.8	15.0	22.2	27.2	1.4	0.3	15.8	21.9	0.1	37.7	6.1	20.8	35.1	46.0	14.6	22.8	23.2	25.3	18.9	6.3	2.1	0.5	0.7	25.6	108.3	7.9	4.7	34.3	5.4	0.2	15.2	42.1	13.1	19.9	3.3	3.9	4.2	10.7	57.0	8.2	3.6	5.8	51.7	70.0
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899346	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 129.3;lymphoid tissue: 76.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 1.4;cerebral cortex: 1.6;thalamus: 2.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 569.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 569.7;monocytes: 200.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		2000000	"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	8.4	4.5	0.0	19.0	0.2	129.3	2.6	1.4	1.6	0.8	0.2	2.5	2.0	1.0	0.1	0.9	5.1	2.1	4.0	0.2	0.0	1.8	5.2	25.1	4.2	0.0	0.0	1.0	1.5	0.1	0.7	2.8	0.0	1.1	1.4	0.1	1.5	0.3	0.9	0.5	3.1	7.9	0.0	76.6	2.1	1.3	2.4	1.4	1.3	0.5	0.7	4.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	0.1	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.6	0.0	569.7	92.5	204.8	0.3	179.4	0.2	0.4	0.2	0.1	30.2	0.2	0.1	0.1	32.2	0.2	200.9	1.4	0.2	43.6	0.0	0.2	1.4	1.6	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.4	1.3	0.0	0.4	0.2	34.5	0.0	0.4	0.0	0.0	43.9	0.9	1.8	0.0	38.8	0.0	1.0	14.6	0.0	2.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.0
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLA-C	"D6S204, HLA-JY3, PSORS1"	ENSG00000204525	"Major histocompatibility complex, class I, C"	P10321	6	31268749-31272130	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1445.7"	"Cell type enhanced"	"Detected in all"		"NK-cells: 3899.1;Proximal enterocytes: 3582.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3"														"Intracellular and membrane"	NA	NA		240000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.16e-2)"	538.6	417.5	0.7	274.6	2.4	122.3	507.4	0.8	0.9	464.4	1.5	594.3	1.6	434.8	259.5	277.6	411.7	103.9	424.3	0.3	1.1	561.0	485.7	1078.3	334.0	1.6	0.9	266.3	245.3	0.2	269.6	34.5	0.9	344.2	27.7	13.7	389.5	0.4	190.6	449.6	750.0	51.0	1.3	1445.7	419.4	62.3	1.2	2.4	382.9	0.3	0.7	372.7	377.5	0.8	760.0	1.1	0.0	0.0	120.1	94.1	1.7	3.1	0.9	1.1	2.3	0.9	0.0	0.4	795.5	190.8	208.7	0.5	0.0	188.1	0.0	1.4	170.4	0.8	8.1	0.1	0.8	0.5	0.5	80.5	0.2	0.5	0.0	272.4	0.0	92.5	0.4	0.0	0.0	0.0	7.8	4.8	0.5	0.0	0.8	1.9	0.3	1.9	462.7	0.0	0.9	1.5	0.2	0.1	2.2	0.3	0.3	3.3	0.6	196.4	65.8	2.3	2.5	481.6	401.0	289.3	0.3	8.2	0.2	1.9	2.8	2.3	0.7	0.8	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.5	2.8	0.8	0.3	0.1	0.9	46.1	0.7	2.4	0.8	0.9	0.3	1.1	1.6	0.9	0.9	1.3	1.2	0.8	1903.4	227.6	328.1	13.1	1576.5	729.1	757.8	1082.3	236.8	33.4	457.0	342.8	61.2	807.8	662.7	483.7	10.4	39.5	2429.1	1994.0	84.1	1966.4	25.6	233.7	343.8	1466.2	482.2	301.2	3.9	1511.3	1010.7	608.5	648.8	557.2	344.1	256.3	1390.0	469.2	1579.0	99.3	5.8	1375.7	923.7	2050.7	1492.7	32.1	507.3	1595.9	836.0	76.8	2570.1	207.3	3899.1	18.6	3.8	1272.7	2195.7	333.6	2482.6	1038.0	3582.3	232.5	548.5	24.0	1203.0	336.7	558.8	142.0	43.5	192.6	651.7	121.6	2212.1	786.8	1003.1	1160.6
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004182-33009591	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.3;B-cells: 61.5;dendritic cells: 20.3;Kupffer cells: 29.4;Langerhans cells: 59.0;Macrophages: 37.7;monocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 17.8;naive B-cell: 21.0"	"Group enriched"	"Detected in many"	11	"B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HDLM-2: 9.1;REH: 40.5;U-698: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045038, HPA076922"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA045038: AB_10959457, HPA076922: "	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	7.1	6.1	0.2	7.8	0.4	1.5	6.5	0.4	0.4	4.9	0.3	3.2	5.0	3.0	1.2	2.3	5.0	2.1	2.2	0.3	1.0	8.0	2.8	12.7	15.1	1.8	0.8	2.8	2.4	0.9	3.5	0.0	1.5	5.0	4.2	0.4	3.2	2.1	0.8	2.8	15.2	1.1	0.8	28.7	4.0	0.4	0.7	7.0	4.5	1.0	19.8	3.0	3.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	40.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	8.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.0	0.0	14.6	0.1	0.3	17.8	21.0	0.3	1.3	0.7	0.2	4.7	5.0	1.0	2.4	0.2	0.4	0.4	0.4	0.3	1.0	1.8	0.8	1.5	0.8	0.7	1.2	7.5	3.2	30.3	0.0	61.5	1.9	0.6	0.1	0.6	0.0	0.5	2.4	1.6	1.5	2.0	3.7	0.0	0.1	20.3	0.3	0.0	6.6	0.1	0.3	0.2	8.5	0.0	2.5	0.0	0.2	0.1	1.2	0.5	0.3	5.1	3.5	1.1	0.0	13.4	0.0	0.0	0.1	2.0	29.4	59.0	0.2	0.3	37.7	0.0	6.5	41.9	0.6	4.1	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	2.9	1.4	0.2	0.0	0.7	0.6	0.0	0.2	0.5	1.1	0.1	4.1	1.0	0.3	1.2
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439878-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 940.2;lymphoid tissue: 1277.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 4744.7;Kupffer cells: 4311.3;Langerhans cells: 24286.4;Macrophages: 6377.4;monocytes: 6924.4;Proximal enterocytes: 3639.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 36.2"	"Group enriched"	"Detected in all"	4	"classical monocyte: 209.3;intermediate monocyte: 408.8;memory B-cell: 379.6;naive B-cell: 418.5;non-classical monocyte: 255.2;plasmacytoid DC: 229.8"	"Group enriched"	"Detected in all"	5	"B-cells: 418.5;dendritic cells: 229.8;monocytes: 408.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 715.7;HDLM-2: 1623.6;REH: 277.1;U-266/70: 242.2;U-698: 730.2;U-87 MG: 258.0"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		950000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	510.2	294.8	3.3	304.4	3.6	1.0	370.7	3.6	36.2	176.5	3.6	175.6	117.9	124.0	260.4	129.1	145.1	61.5	128.4	3.6	3.6	290.3	95.8	940.2	1277.8	7.8	7.5	58.5	73.9	0.1	125.6	23.5	5.9	141.5	151.1	8.3	156.0	8.5	79.4	195.5	713.3	1.4	3.5	1091.9	388.0	25.6	4.0	198.8	175.5	0.0	805.5	172.8	143.3	6.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	715.7	6.3	0.0	0.0	1.5	0.0	0.0	0.0	1623.6	0.0	17.7	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.1	0.1	0.0	0.0	277.1	0.4	0.9	0.0	0.1	0.6	0.7	1.3	0.3	22.8	0.0	0.0	0.8	0.0	8.9	1.4	2.7	1.6	242.2	6.1	730.2	258.0	0.5	0.5	5.9	209.3	74.1	2.1	408.8	1.1	379.6	2.4	10.8	4.6	418.5	1.2	2.2	17.9	15.0	255.2	229.8	19.8	137.8	3.3	3.6	3.6	36.2	3.6	3.6	7.8	7.5	5.9	3.5	4.0	6.0	935.5	291.7	1070.1	0.3	4744.7	748.4	18.1	160.7	84.2	4.1	101.2	172.6	22.5	115.8	458.0	150.8	0.0	12.7	983.5	79.5	29.4	329.2	8.7	26.9	5.2	803.1	64.9	228.5	0.2	59.8	18.3	128.0	159.6	27.1	174.8	80.9	167.4	19.8	2809.0	1.7	0.2	175.0	146.5	4311.3	24286.4	25.8	30.1	6377.4	773.7	59.0	6924.4	8.4	81.4	0.0	0.1	46.3	182.5	4.5	107.5	32.9	3639.5	303.5	487.1	19.7	72.3	27.8	78.0	3.5	5.2	35.3	576.1	25.9	218.8	0.8	245.4	273.3
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"	P13747	6	30489509-30494194	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 109.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.3;U-266/70: 284.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	724.7	217.2	9.6	173.7	10.0	410.3	578.9	10.9	109.5	360.1	7.3	329.4	0.6	313.5	119.3	330.9	336.5	186.1	356.0	7.7	13.1	375.2	332.8	1144.6	336.3	16.6	22.7	213.2	156.6	95.8	121.8	117.3	16.1	251.2	116.8	12.4	252.5	93.0	179.2	518.3	428.9	89.0	10.0	1007.2	259.5	41.1	11.7	86.0	381.9	0.0	137.5	295.0	366.3	14.2	100.7	16.7	6.8	57.0	212.3	166.4	0.9	0.0	0.0	0.1	0.3	40.0	189.1	65.6	98.7	92.7	148.3	121.6	12.8	53.1	0.0	67.6	32.7	78.6	18.7	0.0	0.0	0.2	38.3	135.4	94.4	67.7	0.0	0.0	0.2	34.6	9.8	0.9	54.5	0.2	0.3	0.8	0.5	32.0	0.0	20.6	0.2	97.4	82.7	58.4	0.3	4.8	63.3	56.9	0.3	1.2	0.0	132.7	102.0	60.7	0.1	0.5	14.7	284.8	171.6	29.4	0.3	62.1	149.2	1140.0	335.4	1153.0	723.3	550.2	602.2	449.1	539.9	709.2	158.5	450.3	531.5	547.8	1916.1	512.9	648.0	138.3	611.7	1441.6	9.6	10.0	10.9	109.5	7.7	13.1	16.6	22.7	16.1	10.0	11.7	14.2	2347.3	310.9	411.0	8.1	950.6	484.6	386.6	284.2	183.8	2.7	238.7	204.0	108.3	231.6	270.0	123.2	6.2	88.2	1304.6	603.0	17.6	484.9	5.0	157.7	157.9	1554.7	216.2	172.3	0.1	677.2	277.0	402.8	233.4	325.6	531.6	59.2	1647.8	120.1	700.6	5.0	0.1	545.3	248.2	1220.4	512.2	11.0	132.0	821.6	466.0	105.9	740.5	100.2	1874.4	2.0	0.5	682.2	559.1	76.3	716.6	436.9	473.9	79.9	214.7	9.5	177.5	535.1	350.1	10.6	7.0	170.0	426.5	359.0	1162.1	196.5	285.0	544.4
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 220.4;NK-cells: 339.8;Proximal enterocytes: 298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 36.3;GAMG: 13.5;HEK 293: 12.5;HEL: 8.9;HHSteC: 10.1;JURKAT: 7.6;U-266/70: 8.5;U-937: 13.6"															NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"	58.0	36.6	1.3	1.9	1.6	1.8	52.2	1.0	2.0	43.4	1.1	60.4	28.8	41.2	2.3	21.0	38.1	18.7	40.0	1.0	1.2	35.6	29.9	91.8	41.4	1.6	1.3	19.8	14.4	0.2	25.7	1.1	1.5	31.5	2.7	1.0	28.1	2.2	14.7	40.8	101.4	0.3	1.4	188.3	36.2	7.3	1.2	1.9	40.6	0.0	10.2	30.0	38.5	1.6	36.3	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.1	13.5	1.4	0.0	1.3	0.0	0.8	12.5	8.9	0.4	0.1	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	7.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.4	2.3	0.0	0.0	0.1	0.0	0.5	1.7	0.0	0.0	0.6	0.1	0.1	1.2	0.2	8.5	1.9	0.1	0.0	13.6	0.1	54.3	16.8	42.8	34.9	21.6	25.9	19.4	22.8	28.5	1.1	16.9	21.5	21.2	31.9	32.7	32.0	6.5	25.1	15.2	1.3	1.6	1.0	2.0	1.0	1.2	1.6	1.3	1.5	1.4	1.2	1.6	180.1	38.5	64.7	2.6	133.4	40.9	32.7	58.4	12.5	1.5	19.9	17.0	12.2	50.1	37.0	7.3	2.1	0.4	220.4	214.3	1.9	75.9	2.2	8.6	13.9	110.6	22.8	29.9	2.7	87.8	0.8	27.3	69.8	14.2	50.0	3.4	71.7	30.4	55.3	0.0	6.2	119.2	69.2	96.9	50.3	1.4	28.3	99.4	28.4	12.2	207.1	4.6	339.8	4.5	0.7	71.4	122.0	21.1	92.3	41.8	298.8	4.9	34.3	1.3	46.0	20.7	36.2	10.0	3.9	11.4	37.5	0.3	198.9	24.9	90.8	62.5
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514410-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 324.9;Plasma cells: 400.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	78.6	102.9	10.5	60.9	13.5	61.7	63.4	13.6	15.7	100.0	42.4	54.5	52.6	72.9	111.4	128.6	70.4	46.7	55.9	12.5	17.1	61.4	136.1	83.7	40.7	17.8	17.9	59.2	241.1	68.8	90.0	64.6	17.4	66.0	44.4	20.8	217.7	80.3	44.6	51.6	52.1	49.1	14.2	70.2	92.5	21.9	23.9	30.5	74.7	14.1	54.2	64.9	72.2	20.9	143.8	147.6	56.6	87.7	260.2	163.5	197.6	239.0	221.3	159.7	162.8	287.3	166.8	90.4	312.8	262.7	209.7	253.8	74.9	162.0	97.7	46.2	112.0	201.3	99.7	179.3	287.0	118.1	78.1	152.5	103.5	133.7	182.7	159.0	124.5	56.0	90.2	364.0	148.8	170.3	100.0	84.0	67.8	234.9	248.5	63.6	272.6	436.5	154.4	75.6	76.3	90.4	243.5	234.9	199.2	56.4	182.0	109.5	153.3	243.1	129.8	246.3	136.2	225.5	145.5	71.7	328.7	413.0	219.4	117.7	380.9	190.8	116.7	372.6	159.7	91.9	108.0	112.9	260.8	74.4	70.6	84.1	282.8	117.5	363.7	271.9	104.1	374.1	10.5	13.5	13.6	15.7	12.5	17.1	17.8	17.9	17.4	14.2	23.9	20.9	67.4	51.3	55.4	23.8	78.2	33.4	59.0	127.8	31.3	45.4	65.6	49.1	13.6	71.4	102.2	53.3	123.0	154.0	70.7	115.2	13.7	145.6	15.5	55.0	111.5	60.9	61.5	38.9	40.5	169.7	139.0	93.2	80.0	128.4	42.4	55.5	53.2	86.4	324.9	43.7	39.2	134.5	63.1	81.2	83.1	15.9	60.6	106.1	65.8	28.1	77.4	52.2	53.5	33.7	23.8	144.3	81.2	43.6	400.6	92.4	54.8	51.0	49.3	44.8	32.9	49.2	79.2	26.1	26.4	60.0	35.4	213.6	60.1	97.2	70.8	69.3
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 170.8"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 935.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	10.3	15.9	9.3	9.3	10.4	170.8	9.4	11.5	10.4	7.9	10.1	13.7	12.5	10.2	11.9	14.4	7.7	4.0	17.3	9.1	10.0	12.3	22.8	8.8	9.2	10.7	10.2	3.8	16.2	9.2	8.5	10.6	10.6	8.6	14.9	5.9	9.9	8.6	30.4	10.5	10.1	10.5	10.4	15.2	11.7	5.7	10.7	7.6	8.9	23.9	11.9	9.6	8.0	12.6	40.0	59.9	27.7	47.5	21.6	27.2	41.7	31.1	34.8	45.0	38.2	74.4	60.2	59.4	68.3	40.1	42.0	53.7	41.6	60.1	28.2	42.0	42.4	97.2	22.5	55.0	40.8	37.6	31.2	29.8	38.0	71.5	53.1	18.7	21.5	55.9	154.6	25.7	35.9	158.4	36.3	72.6	32.1	72.8	36.5	41.9	27.8	59.5	45.3	36.2	31.1	41.4	24.6	38.4	29.3	19.3	64.7	52.3	20.0	33.0	25.5	32.9	36.0	14.2	16.7	36.6	22.7	47.4	40.0	48.5	38.5	4.4	13.6	35.2	17.8	21.4	12.5	15.1	52.8	24.4	19.7	14.7	1.3	11.5	22.2	35.1	14.2	26.6	9.3	10.4	11.5	10.4	9.1	10.0	10.7	10.2	10.6	10.4	10.7	12.6	5.2	9.6	9.0	4.2	12.1	7.9	11.0	26.7	13.6	5.6	14.5	16.8	13.7	18.6	12.8	11.0	27.1	57.8	12.1	12.4	19.6	25.6	1.7	5.8	10.4	6.2	13.2	935.9	3.8	31.2	61.1	9.0	5.6	5.8	2.5	6.3	4.6	23.7	29.1	10.1	5.7	19.1	14.2	13.0	10.4	3.0	5.9	9.5	14.2	1.9	15.3	7.5	8.2	4.5	8.6	23.3	13.0	8.6	25.0	14.5	9.2	24.5	13.6	25.9	0.0	8.6	11.7	1.7	32.0	18.8	8.1	23.3	6.1	16.7	31.0	10.5
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824460-65966291	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;testis: 3.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1"									"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	0.4	0.0	0.3	0.3	0.2	4.9	0.2	0.7	0.5	1.1	0.0	2.1	1.3	0.4	0.0	0.3	1.2	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.6	0.9	0.0	0.4	0.2	0.2	0.0	2.4	0.5	0.1	0.1	1.5	0.4	1.0	0.1	0.1	0.1	1.1	3.8	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.4	47.9	21.4	324.4	45.8	15.0	82.0	0.1	148.5	68.5	26.0	25.8	28.1	19.8	0.0	92.3	7.0	120.0	20.5	54.2	129.3	123.8	0.2	56.2	0.2	0.7	169.3	8.4	4.7	0.4	62.7	8.0	55.2	98.4	232.6	105.0	0.2	0.1	0.6	149.9	0.2	0.4	27.8	190.3	4.6	89.2	12.7	16.1	0.1	68.9	0.3	0.0	0.0	0.1	0.1	85.0	216.1	0.5	0.7	120.8	89.5	26.9	71.2	45.3	0.2	0.2	0.4	112.0	0.3	21.4	1.4	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.6	0.1	0.0	0.0	0.3	0.2	0.7	0.5	0.2	0.1	0.4	0.2	0.2	0.1	0.2	0.4	0.0	0.0	1.1	5.9	0.2	0.0	3.6	16.0	2.8	0.0	0.1	0.1	1.7	0.0	3.0	0.0	0.0	0.8	0.0	5.0	0.0	2.5	18.4	10.4	0.8	0.6	0.0	7.4	0.8	0.8	0.5	2.3	3.1	17.3	0.0	29.7	0.7	0.0	9.0	0.0	0.9	5.1	4.1	0.0	0.0	9.0	0.3	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.9	19.9	4.5	0.0	0.4	5.5	4.0	0.3	7.3	0.0	0.0	1.1	33.7	13.5	0.6	0.3	0.1	0.8	0.3	0.3	8.4	1.1
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003506, CAB005873, HPA073663"	Supported		Supported	Nucleoplasm	"Secreted to blood"	NA	NA		2800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: "	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	312.0	224.3	266.2	355.1	282.2	1021.3	318.2	267.6	362.4	319.0	227.0	327.8	281.9	363.6	270.1	297.0	265.5	227.0	242.2	250.1	282.9	243.7	360.8	242.2	664.8	281.5	273.3	254.9	189.3	226.1	163.3	252.1	286.2	265.9	381.2	174.8	224.5	280.1	388.5	244.2	309.2	319.5	277.7	284.9	269.0	153.9	269.9	900.3	267.4	364.7	738.9	282.7	274.1	308.2	816.7	617.4	1402.5	1054.0	384.5	380.1	551.4	1012.6	547.9	957.3	643.5	983.6	1328.6	1639.3	515.5	924.0	880.6	886.5	1484.7	817.4	1639.6	869.6	622.4	1727.4	455.4	913.5	210.3	2513.6	1009.8	253.4	426.0	713.3	656.6	497.8	1302.2	1350.8	1167.9	571.7	855.6	1508.3	3224.3	2682.1	1184.3	1424.3	683.7	2673.3	1927.8	965.8	908.1	792.8	1264.0	1139.8	928.6	682.0	541.0	672.3	668.5	1857.9	814.7	637.2	921.8	689.7	1197.1	513.9	714.8	3508.3	261.1	1634.0	1369.3	1036.6	503.7	926.1	467.3	410.9	522.1	582.6	532.3	530.7	520.1	590.7	477.4	459.7	631.7	615.4	411.0	512.5	702.6	1072.0	266.2	282.2	267.6	362.4	250.1	282.9	281.5	273.3	286.2	277.7	269.9	308.2	948.9	458.3	496.6	188.4	920.7	791.1	986.7	942.7	752.4	414.3	471.9	630.0	172.5	561.9	561.3	603.2	131.3	998.9	759.9	408.1	766.9	941.3	113.4	611.2	1040.2	766.0	423.0	1808.9	58.5	967.2	1441.4	676.5	486.3	728.3	546.8	772.2	589.0	749.5	728.8	196.9	47.2	675.6	710.1	549.9	884.4	107.2	720.1	694.2	674.1	81.5	578.7	609.9	879.5	99.5	149.3	1212.3	554.8	666.9	1252.9	811.2	506.7	827.5	418.7	252.8	650.8	588.9	1005.9	549.1	1211.0	1045.8	691.9	465.7	797.9	515.7	839.1	867.9
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331376-173334432	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"bone marrow: 2347.2;lymphoid tissue: 939.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 798.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 2454.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	NA	Yes		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	90.3	31.0	36.3	146.1	38.4	2347.2	89.1	35.4	49.9	79.0	33.0	117.1	93.2	92.3	47.3	115.6	78.8	43.5	85.8	33.2	38.3	74.3	37.8	83.8	390.4	37.5	36.8	118.9	27.2	18.3	35.4	111.0	38.0	46.9	122.2	134.1	59.8	35.2	72.4	75.1	108.7	65.5	36.3	159.5	66.0	136.0	36.1	939.2	56.4	57.0	388.9	68.2	86.1	40.1	498.2	114.6	976.8	444.4	118.2	118.2	375.1	366.3	271.3	386.7	345.7	329.0	673.6	1645.5	79.2	203.0	207.4	190.3	645.0	196.1	601.0	1004.0	303.4	1823.2	308.8	487.8	115.7	1642.8	683.4	114.7	59.2	194.2	439.1	211.5	402.8	866.1	703.9	2282.4	358.9	409.9	2454.9	1513.7	355.4	289.4	199.3	1226.7	499.7	620.4	227.0	208.8	838.6	759.0	365.5	209.6	166.6	340.8	291.1	1173.2	236.0	175.5	513.6	219.0	554.9	734.8	437.1	1869.4	149.1	1178.4	464.4	798.0	135.9	407.0	94.1	57.6	86.2	72.5	137.8	131.1	112.8	57.6	88.4	85.3	316.7	83.0	49.1	43.2	266.4	107.6	36.3	38.4	35.4	49.9	33.2	38.3	37.5	36.8	38.0	36.3	36.1	40.1	167.0	28.9	64.1	5.9	153.2	158.8	141.5	131.8	75.1	48.9	75.3	107.8	229.0	38.6	78.3	55.2	35.5	472.6	222.9	116.5	142.8	25.9	30.4	71.2	71.7	128.0	74.7	1915.4	2.7	16.1	872.5	121.5	63.2	76.5	110.6	210.5	171.7	26.5	210.1	45.4	4.7	191.2	109.9	295.0	142.9	33.1	105.3	233.9	67.6	6.5	241.9	81.8	132.8	1.0	4.8	11.3	75.2	57.6	268.6	114.2	65.4	51.0	149.8	143.5	78.9	71.7	134.4	493.6	400.9	233.6	134.0	128.7	289.5	42.3	284.7	89.0
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990771	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 136.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 11.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 738.7;U-698: 675.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062583, HPA073663"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Nucleoli	"HPA062583: AB_2684800, HPA073663: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	8.9	13.7	10.5	19.7	10.5	85.6	15.6	10.4	20.3	34.0	6.5	43.9	27.1	16.4	44.8	26.1	16.9	9.7	11.3	14.5	13.9	19.6	101.4	15.9	25.2	13.0	11.2	5.9	17.2	85.4	4.2	136.6	11.3	13.9	32.4	3.1	23.8	15.9	53.5	19.2	28.1	13.8	10.2	21.2	16.1	40.1	13.4	65.2	14.3	8.9	35.8	18.7	10.5	9.5	263.5	115.5	351.9	184.2	14.5	42.9	437.4	112.9	73.6	127.9	66.1	91.6	106.0	183.0	354.8	87.5	72.3	123.3	324.4	738.7	143.3	125.6	94.7	159.4	110.2	145.6	21.5	243.9	78.0	33.9	171.6	52.5	131.5	32.7	168.3	110.5	84.5	105.4	154.2	201.9	269.3	186.2	209.2	171.0	138.1	325.4	286.3	103.6	95.2	125.3	252.7	164.4	167.4	177.7	56.0	199.3	157.8	158.5	128.0	53.0	123.9	169.9	253.1	94.9	128.7	675.7	63.1	121.3	109.9	0.0	4.3	11.3	0.4	3.0	0.1	2.7	2.0	2.9	6.1	0.5	0.0	0.2	0.7	0.8	5.0	3.1	5.8	2.5	10.5	10.5	10.4	20.3	14.5	13.9	13.0	11.2	11.3	10.2	13.4	9.5	10.4	38.5	31.2	0.7	15.1	23.7	18.9	158.6	12.5	0.5	24.2	16.0	16.0	8.6	123.5	31.3	2.1	419.1	4.5	32.1	37.2	82.4	232.3	61.9	18.9	19.6	65.7	136.1	1.3	86.5	820.7	17.6	22.4	55.9	8.2	44.2	13.6	84.4	101.0	0.0	3.7	37.0	219.7	20.8	43.7	75.9	3.7	22.1	21.4	2.8	23.6	4.1	1.0	1.5	0.5	91.5	35.7	3.4	47.1	27.5	31.8	66.5	113.3	1.8	0.0	39.8	29.0	22.7	50.2	41.1	20.3	1400.2	10.1	10.4	60.7	18.5
HMGCL	HL	ENSG00000117305	"3-hydroxy-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 322.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.4;Proximal tubular cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	27.5	63.0	26.3	16.8	27.5	7.5	25.8	27.5	28.3	27.5	33.0	53.3	45.7	20.2	47.2	32.8	35.6	26.3	42.5	24.6	26.9	115.5	322.5	23.6	21.7	28.0	26.2	21.6	33.4	60.2	26.3	19.9	27.7	31.7	52.9	16.1	30.3	27.9	63.7	25.5	40.0	23.3	27.4	26.8	40.9	17.9	30.1	23.4	40.5	70.2	25.1	28.6	24.2	29.6	28.5	16.0	17.7	13.4	70.6	53.5	6.8	22.0	38.3	23.3	28.2	10.2	53.7	14.8	44.3	34.6	19.0	22.4	21.3	35.7	25.2	30.4	16.1	19.8	13.8	23.5	90.9	7.8	12.7	62.4	52.0	30.8	58.5	62.5	32.2	27.4	20.6	20.3	43.3	29.3	12.2	15.3	4.6	77.4	22.1	17.2	14.5	27.9	55.4	14.5	14.8	13.2	28.6	10.8	49.3	23.3	33.9	19.3	24.3	19.3	11.6	35.5	9.7	28.7	15.2	13.3	47.7	28.7	23.0	103.5	67.0	66.0	36.3	66.0	39.8	45.9	39.1	42.1	58.0	51.2	39.6	37.7	25.5	54.4	77.5	43.9	45.5	61.7	26.3	27.5	27.5	28.3	24.6	26.9	28.0	26.2	27.7	27.4	30.1	29.6	19.9	12.8	25.7	14.0	16.3	5.9	29.9	54.3	9.6	24.6	19.9	17.1	33.7	41.5	30.6	49.7	18.8	43.0	10.0	48.1	119.3	57.7	2.3	25.0	17.5	22.5	9.0	18.7	4.3	24.0	27.3	20.8	30.5	23.1	17.7	29.7	30.4	172.4	61.6	35.3	5.3	49.5	28.5	23.5	7.7	3.6	21.8	23.5	21.4	8.4	41.4	37.1	24.7	6.0	12.5	31.2	53.8	24.5	8.3	29.4	70.9	216.8	31.5	25.5	6.6	17.1	21.6	6.6	5.4	13.8	6.5	41.3	15.2	65.6	48.9	24.3
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75364001	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 105.7"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 239.5;Theca cells: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797, CAB078688"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"CAB016797: , CAB078688: AB_2665607, HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	10.8	39.5	19.8	18.1	20.7	24.6	30.8	15.7	23.0	20.1	16.2	45.2	38.1	16.8	25.3	49.1	12.2	15.2	7.4	21.5	25.0	21.1	105.7	24.2	14.7	26.6	21.3	9.7	16.5	24.8	8.2	17.7	25.2	23.3	37.3	18.7	15.5	8.1	6.4	55.2	26.5	12.9	14.2	14.8	27.6	23.3	20.5	17.8	23.4	7.1	18.6	14.1	26.7	17.5	68.5	25.6	260.7	89.2	54.9	103.4	65.5	19.3	53.6	38.6	85.0	95.8	163.7	60.3	68.7	31.7	245.2	84.5	136.4	225.9	39.4	20.8	50.8	47.0	36.7	78.6	80.8	39.8	32.9	66.8	130.7	133.6	65.6	19.2	31.5	84.8	50.4	86.4	61.0	45.2	72.7	39.9	112.5	17.7	19.7	50.7	78.7	86.5	155.2	154.5	91.0	41.3	41.4	43.7	38.3	89.6	43.1	102.4	37.2	20.5	30.0	22.4	32.8	28.1	38.1	83.2	29.7	75.2	43.7	10.0	14.8	8.8	7.7	8.9	6.2	5.1	5.2	7.8	16.9	5.2	5.3	7.2	28.8	12.5	10.5	4.9	9.0	7.5	19.8	20.7	15.7	23.0	21.5	25.0	26.6	21.3	25.2	14.2	20.5	17.5	11.6	19.2	43.3	23.2	14.9	41.4	10.1	37.6	43.3	23.5	19.0	12.1	7.0	12.8	33.3	27.6	18.8	19.7	25.7	80.4	3.9	13.5	46.6	124.4	34.3	13.4	43.0	11.6	49.9	22.0	24.0	13.7	28.5	239.5	24.1	71.3	7.9	97.5	13.1	40.4	35.8	56.0	28.5	14.8	11.8	22.2	9.3	19.5	16.0	15.0	12.1	9.7	7.2	28.1	24.7	15.0	40.0	6.0	14.4	18.4	15.5	6.9	31.6	15.2	13.1	7.0	20.2	23.4	12.0	69.8	91.6	46.7	19.2	148.7	30.4	18.8
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 511.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 797.7;GAMG: 523.5;HBEC3-KT: 467.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 15: Hepatocytes - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	19.2	55.2	25.2	27.2	32.9	15.8	40.1	23.0	38.6	56.4	16.8	50.2	93.6	19.8	36.1	137.5	12.4	23.3	16.1	36.1	44.6	32.8	390.2	51.4	21.5	46.5	34.7	21.6	26.6	31.7	15.0	22.5	47.2	40.5	45.4	34.2	53.2	15.7	17.8	85.9	47.2	19.9	24.7	14.8	43.4	33.2	35.3	19.1	23.6	16.7	31.5	18.3	69.5	30.4	103.4	48.8	797.7	93.0	45.8	178.4	54.1	16.2	63.8	22.8	45.2	86.6	146.6	108.4	35.6	23.3	523.5	80.2	199.7	467.2	24.1	23.5	240.7	40.1	45.3	119.3	71.3	88.0	28.0	98.5	56.2	119.5	47.9	14.0	23.7	98.4	73.1	291.7	19.4	48.9	81.3	111.9	143.1	41.7	25.9	57.5	111.9	121.8	357.7	158.2	68.2	33.0	83.6	41.4	25.9	114.5	63.6	116.7	28.3	17.1	85.7	18.0	15.5	38.8	64.0	148.3	15.0	106.2	15.5	3.3	1.8	1.9	2.4	3.3	2.4	3.8	2.6	3.4	3.5	2.9	2.2	3.1	3.0	3.2	3.6	2.9	2.6	1.6	25.2	32.9	23.0	38.6	36.1	44.6	46.5	34.7	47.2	24.7	35.3	30.4	27.8	67.3	172.6	70.5	44.8	108.3	42.3	93.8	68.3	43.6	46.3	30.0	8.9	47.1	79.2	47.8	52.1	22.3	43.3	211.2	13.7	43.0	9.0	47.1	20.2	31.3	92.1	22.3	44.9	59.8	41.1	32.3	100.4	98.6	58.5	56.6	22.1	511.7	25.5	48.8	42.6	101.9	75.3	21.9	38.2	3.2	12.8	27.5	26.6	15.0	49.1	26.4	14.4	53.3	41.8	50.4	132.3	14.3	38.1	149.2	56.8	21.4	51.1	50.1	0.0	40.1	32.8	20.0	8.7	197.9	236.4	44.5	36.4	129.4	62.9	74.5
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113699-81201913	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 107.4"	"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.6;Karpas-707: 298.5"	"Low region specificity"	"Detected in all"							"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA		41000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	13.2	24.6	31.6	6.1	31.8	34.0	14.5	28.8	60.6	12.7	27.7	16.6	23.0	17.2	65.2	14.8	17.5	11.0	10.2	29.3	32.3	27.6	23.0	8.7	5.3	35.3	32.5	20.4	12.7	20.3	29.7	4.8	32.6	15.4	16.3	7.3	13.0	19.4	9.4	12.0	21.5	10.8	32.1	12.9	13.8	107.4	32.7	30.7	17.9	8.7	6.6	12.1	11.6	33.1	1.1	9.6	26.4	130.0	22.2	6.8	5.5	7.4	11.5	2.2	3.2	3.1	49.6	209.6	22.7	3.1	2.1	8.9	158.6	19.2	4.8	123.5	62.9	87.6	97.0	1.6	2.6	147.9	83.1	5.6	4.9	8.1	7.9	7.3	10.4	132.2	118.2	298.5	13.3	4.4	135.2	51.8	117.9	29.5	34.5	5.1	110.1	98.3	32.0	3.5	1.1	3.1	0.9	2.9	9.1	22.6	16.3	34.6	12.2	4.2	33.5	20.4	28.5	20.7	9.4	33.8	12.4	57.5	7.4	1.3	3.1	1.2	7.5	1.6	6.6	3.8	4.4	4.0	5.2	6.0	8.7	7.6	1.4	3.4	2.2	10.0	1.7	2.9	31.6	31.8	28.8	60.6	29.3	32.3	35.3	32.5	32.6	32.1	32.7	33.1	18.1	9.6	16.4	19.9	9.0	15.9	27.6	12.8	17.6	3.5	18.9	17.5	11.1	27.1	16.2	46.0	0.0	0.6	6.4	22.7	68.4	12.8	24.5	44.0	11.0	18.1	17.4	64.8	11.6	18.7	0.4	15.4	16.8	31.1	13.3	39.4	22.1	87.2	15.7	1.7	16.5	34.2	28.5	11.3	10.8	79.7	29.5	10.2	8.8	13.1	2.9	25.8	7.2	25.6	8.5	7.1	19.6	41.0	9.6	15.0	27.4	113.6	55.9	1.7	46.0	13.3	19.6	18.9	8.7	32.8	14.9	0.4	8.3	31.0	45.0	24.4
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 117.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	13.9	17.0	10.4	9.5	11.4	20.0	17.3	10.2	12.0	14.1	14.2	11.8	8.0	14.2	15.3	10.6	14.5	12.4	12.7	11.0	10.6	14.6	13.5	16.5	11.8	10.5	11.4	15.3	13.6	117.1	17.1	12.5	10.3	20.2	11.0	11.6	13.3	12.5	14.6	15.2	11.6	11.4	10.1	16.1	14.1	14.3	12.9	14.9	16.0	13.3	12.0	12.4	11.8	12.3	23.5	27.2	19.4	30.6	27.2	22.6	32.8	22.2	41.1	33.0	41.7	39.7	28.5	22.3	25.4	31.3	70.7	17.0	36.9	39.9	29.0	20.9	26.0	19.4	30.8	20.1	38.3	38.0	42.8	30.1	29.3	48.9	39.1	42.6	24.5	17.8	26.2	23.2	36.4	19.5	23.5	20.9	14.4	16.1	41.2	20.6	26.1	21.9	20.8	29.6	24.1	24.6	19.3	48.2	51.4	16.8	22.3	25.6	20.5	49.3	21.0	24.2	42.2	27.0	27.0	31.5	57.2	29.2	26.0	3.5	2.5	2.3	3.3	3.1	2.6	3.0	2.8	2.4	3.2	2.6	2.1	2.4	0.2	1.2	2.1	2.5	4.4	2.1	10.4	11.4	10.2	12.0	11.0	10.6	10.5	11.4	10.3	10.1	12.9	12.3	34.8	9.6	12.8	14.0	22.0	11.3	27.0	14.2	17.6	29.5	33.2	26.7	8.0	11.5	17.0	9.2	35.5	16.3	36.1	13.3	21.5	22.2	6.2	47.7	37.5	24.7	15.5	12.8	20.4	21.9	12.6	23.9	30.1	47.5	18.3	36.7	15.0	12.6	27.9	72.3	20.0	12.8	6.1	11.9	13.7	3.1	13.4	18.9	3.6	16.9	23.5	19.8	29.9	15.1	18.5	34.3	8.4	12.4	29.5	41.1	7.4	13.8	24.7	43.1	13.1	23.5	19.5	28.9	24.4	15.6	12.1	15.5	23.3	42.8	15.6	29.4
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 515.3;Late spermatids: 2001.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		12000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	63.0	51.3	43.7	23.2	51.9	18.3	55.7	56.9	55.2	47.1	36.2	41.0	34.8	35.8	22.5	84.5	35.9	26.9	149.9	47.7	50.0	71.2	109.5	46.6	33.2	55.8	49.2	25.6	39.7	38.6	43.8	17.9	57.1	34.5	25.1	22.5	44.1	14.1	37.9	44.4	42.6	22.7	44.7	67.8	100.2	152.2	54.3	24.3	41.9	32.3	36.3	33.2	49.0	53.5	82.9	38.2	20.5	45.6	65.8	31.5	33.8	53.9	26.5	48.3	43.7	48.3	55.5	36.9	64.0	55.7	34.6	51.5	75.4	126.9	48.4	51.5	48.4	27.5	35.2	63.3	43.7	56.8	44.4	48.7	41.7	55.7	37.6	37.9	83.7	46.9	44.7	18.1	44.5	114.3	48.7	58.4	34.2	81.1	35.7	54.3	33.7	84.4	72.3	51.8	34.4	19.4	43.1	95.1	66.4	33.9	58.2	36.3	91.7	25.7	39.9	120.3	30.1	24.3	30.0	78.0	16.5	52.5	35.2	87.6	37.1	252.6	166.3	46.5	142.1	69.8	153.8	168.5	73.6	66.8	145.5	151.6	125.1	99.0	35.7	39.2	155.4	142.3	43.7	51.9	56.9	55.2	47.7	50.0	55.8	49.2	57.1	44.7	54.3	53.5	33.8	35.3	41.5	7.8	37.2	54.8	35.7	73.5	19.4	29.3	26.4	29.1	70.6	32.9	54.5	36.8	20.9	75.3	59.8	70.7	129.1	79.7	515.3	38.6	30.9	53.4	31.8	14.3	23.0	90.7	69.6	39.4	89.7	53.3	19.7	38.8	75.0	93.0	67.2	28.6	21.6	37.6	85.5	23.9	52.9	2001.6	45.4	30.6	62.2	5.6	29.3	53.9	141.1	9.5	32.9	114.9	70.7	56.1	47.1	37.7	110.8	239.3	39.9	27.8	72.3	14.6	58.0	199.7	149.8	28.2	51.6	38.4	88.3	47.4	48.9	28.7
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26171151-26201529	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	367.0	421.3	101.3	151.4	105.4	77.6	314.1	110.9	140.3	403.5	106.4	381.8	124.8	404.3	116.1	417.6	376.3	62.4	463.6	99.7	106.4	530.8	388.5	364.9	184.1	106.4	105.0	527.8	350.2	80.8	337.6	118.9	108.2	300.8	127.5	131.1	325.1	79.2	764.9	280.5	419.0	84.2	102.3	447.5	353.4	370.5	105.4	174.8	367.2	92.0	172.5	339.9	360.8	111.7	202.5	101.8	491.6	312.7	110.7	117.5	249.6	255.8	110.7	149.6	183.6	159.8	338.5	210.2	104.2	180.1	218.8	300.0	196.3	268.7	288.5	74.9	191.2	232.6	309.9	212.1	72.9	374.6	359.4	123.6	192.4	156.3	253.3	194.6	161.1	273.9	210.9	250.4	280.4	229.1	216.5	817.2	320.7	81.7	117.7	239.5	122.1	159.3	287.0	335.8	190.7	245.6	203.5	291.8	127.7	393.6	326.3	359.7	222.0	193.2	265.6	184.6	253.7	367.0	296.0	308.7	149.9	453.8	316.5	0.0	1.7	1.3	4.8	1.0	4.0	2.7	3.0	0.8	0.8	0.8	2.7	2.6	0.6	3.3	0.8	1.6	1.0	0.5	101.3	105.4	110.9	140.3	99.7	106.4	106.4	105.0	108.2	102.3	105.4	111.7	717.8	487.2	591.0	194.6	667.5	738.5	797.7	793.2	560.5	469.4	361.0	361.3	702.1	316.0	665.8	343.9	298.2	971.6	707.7	435.1	461.8	568.0	128.2	465.8	640.8	600.5	491.4	683.2	123.3	452.2	939.9	602.7	449.6	591.1	644.7	680.5	333.4	382.8	613.1	312.9	147.2	533.1	496.4	388.5	681.9	150.0	411.0	640.3	393.1	157.4	572.0	545.4	484.1	198.0	320.6	438.2	438.7	390.0	751.0	520.4	428.4	506.8	608.0	547.0	440.4	599.4	726.5	596.9	490.6	573.8	600.5	1082.8	701.7	652.2	541.4	632.1
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1800000	"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	162.9	119.0	101.6	210.8	104.5	235.2	144.2	107.5	114.6	183.8	98.8	185.3	129.2	180.1	178.1	244.6	164.3	75.4	118.4	93.7	124.1	193.6	144.3	175.2	232.9	111.8	103.1	208.2	141.4	130.5	137.5	158.5	106.9	141.0	194.7	181.7	138.8	118.1	136.3	179.9	152.3	164.2	103.8	174.7	143.1	175.8	108.6	308.3	176.0	93.0	304.8	153.3	189.2	108.1	657.6	432.9	934.3	469.8	248.2	221.2	717.8	489.3	235.7	382.8	358.5	885.1	337.4	1315.9	366.5	388.4	518.3	370.6	944.2	616.7	712.9	609.6	556.2	996.1	620.3	1727.6	264.8	1064.7	584.0	249.8	288.3	569.9	422.1	217.9	537.3	587.4	723.1	414.3	492.1	891.1	746.9	444.4	507.3	762.5	405.0	947.2	790.1	414.2	547.9	1227.6	545.1	484.7	729.6	228.1	316.4	700.8	325.6	652.5	582.2	476.3	540.4	338.0	719.0	387.6	759.5	1117.2	305.4	699.5	320.0	8.9	21.2	10.8	25.0	22.6	20.2	21.2	20.0	22.0	23.4	20.4	17.5	18.1	8.2	23.5	23.0	37.8	25.9	14.5	101.6	104.5	107.5	114.6	93.7	124.1	111.8	103.1	106.9	103.8	108.6	108.1	274.8	166.7	255.1	84.5	277.4	351.8	429.6	442.1	224.8	192.8	155.2	135.1	64.2	114.4	302.7	160.0	98.0	512.7	368.9	200.7	121.3	257.2	47.2	296.5	387.2	289.7	275.0	288.6	56.9	273.8	563.0	231.4	184.0	343.0	278.1	222.6	196.7	165.0	342.7	148.0	70.5	315.0	193.3	221.0	372.5	44.0	204.7	258.3	192.1	73.1	311.1	187.1	232.8	65.9	88.6	276.1	184.0	209.5	336.6	288.9	136.8	156.7	257.8	164.4	151.2	319.3	461.9	362.8	208.3	331.1	330.5	496.0	307.9	214.1	310.7	382.6
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204533-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	86.7	103.2	33.2	92.5	34.9	139.7	63.9	35.6	37.0	66.0	37.3	144.7	98.2	75.5	43.8	122.0	64.4	51.1	83.1	32.4	39.1	91.9	88.3	69.1	95.7	36.9	35.4	56.7	55.4	76.2	46.2	64.0	36.9	59.8	119.0	27.1	68.1	54.0	119.0	115.4	88.9	74.4	35.5	79.9	85.5	38.2	36.9	117.0	52.0	58.7	102.7	122.3	72.7	38.5	347.4	282.5	424.1	414.7	153.8	134.6	613.2	378.5	174.3	296.9	317.2	525.4	251.8	555.2	340.3	204.7	361.1	223.2	373.1	516.7	363.8	865.9	439.5	349.8	223.7	325.1	153.7	446.1	285.6	134.0	239.2	267.3	266.8	122.3	270.3	218.4	290.1	245.7	302.0	934.2	542.6	429.7	389.5	354.0	401.7	436.3	255.6	329.8	254.2	364.8	389.5	302.4	295.2	407.9	278.8	264.0	244.7	270.7	244.0	359.7	305.2	256.2	527.8	285.4	360.2	649.3	145.2	488.2	298.8	3.2	4.4	15.7	5.1	7.0	5.7	5.9	4.1	6.0	4.4	5.2	3.9	4.7	0.8	5.8	7.5	10.9	4.8	2.2	33.2	34.9	35.6	37.0	32.4	39.1	36.9	35.4	36.9	35.5	36.9	38.5	124.7	32.1	41.0	4.6	115.4	281.6	212.1	42.7	243.0	26.5	129.6	141.3	45.9	41.5	42.7	49.7	18.8	106.3	148.5	251.2	50.9	118.9	9.3	112.4	225.6	107.1	119.2	273.2	3.5	151.7	208.9	110.1	167.7	124.7	44.5	102.0	53.6	101.2	101.0	16.8	4.3	219.0	48.8	67.0	129.9	11.1	74.0	109.9	67.6	8.4	56.2	34.7	76.2	3.5	6.1	204.2	138.2	88.0	179.6	275.0	90.5	116.8	25.8	28.3	78.9	149.7	173.6	81.6	122.4	362.5	339.8	114.4	129.7	238.1	247.9	235.5
HNRNPC	HNRPC	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	286.9	309.2	274.1	319.5	290.1	540.3	328.5	283.9	332.6	307.8	248.8	266.7	232.3	318.9	311.9	318.3	328.5	246.4	269.5	275.3	289.2	372.9	334.4	251.8	497.7	287.2	275.4	427.3	237.7	257.8	237.7	342.0	299.0	249.6	290.9	407.3	225.9	247.9	288.2	260.1	255.2	265.9	295.2	306.5	232.3	193.7	276.6	557.8	259.2	244.0	496.0	374.6	278.6	327.1	1076.2	832.7	1277.7	748.5	754.8	704.7	910.2	673.2	764.3	1034.3	900.6	799.4	787.6	1935.6	414.1	772.1	656.8	775.6	1611.4	1035.4	1389.0	1236.1	918.1	992.8	614.2	1241.4	920.6	1495.2	762.6	731.8	854.2	756.5	1781.1	897.8	1078.4	957.7	1483.6	787.1	829.5	1020.0	1713.7	1435.2	1351.4	990.3	770.1	1375.0	1073.9	925.3	1159.7	956.9	699.0	665.5	838.5	760.9	786.4	1057.3	725.2	1332.6	783.1	388.9	698.2	473.8	972.8	708.8	1144.4	1873.6	370.6	1215.3	794.1	480.2	515.1	516.9	419.0	450.9	544.5	531.4	494.0	451.2	716.3	467.0	552.1	478.2	810.8	471.0	439.4	460.5	575.7	1220.5	274.1	290.1	283.9	332.6	275.3	289.2	287.2	275.4	299.0	295.2	276.6	327.1	172.7	153.8	233.9	69.5	307.2	536.2	583.9	512.2	331.8	169.8	259.9	191.5	137.9	173.0	393.2	275.8	198.1	612.6	309.4	134.0	283.7	315.0	169.0	365.1	352.2	257.5	224.0	389.9	74.3	216.6	746.8	287.1	197.2	555.6	415.9	281.3	174.2	233.9	388.5	116.1	79.2	276.0	260.4	293.8	500.1	76.5	270.0	325.7	208.1	99.3	341.9	157.9	227.6	97.5	112.2	210.7	151.1	230.9	293.6	531.5	135.0	370.8	381.9	296.1	151.2	285.1	282.6	391.5	249.0	315.5	539.9	874.9	339.1	311.8	318.0	590.3
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm		NA	Yes		2500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: AB_2686166"	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	114.6	77.7	43.3	133.9	48.6	161.3	102.9	49.8	47.9	86.8	65.2	124.5	134.2	78.3	58.9	114.9	119.4	88.9	63.7	40.2	45.9	94.4	173.2	97.6	181.4	52.4	51.4	87.3	87.5	73.1	50.5	113.6	51.5	90.8	118.9	80.4	85.2	74.8	93.6	104.5	130.7	89.1	49.2	123.5	118.0	84.0	49.4	193.3	72.7	79.6	182.8	160.0	81.8	58.3	292.1	302.9	184.2	280.7	220.5	239.5	269.1	222.5	371.0	305.6	358.2	285.5	394.7	581.8	139.2	242.0	179.3	401.7	496.8	363.6	249.5	245.6	297.2	371.2	178.6	370.9	271.4	550.5	360.9	293.2	282.4	237.6	434.6	177.1	266.4	281.3	382.0	256.2	234.2	453.4	542.5	300.5	139.5	439.1	252.4	449.0	172.7	276.8	314.9	442.7	226.1	226.8	226.6	410.4	344.3	199.2	457.4	265.3	200.4	140.1	264.4	231.8	356.8	228.5	415.8	352.6	227.1	520.0	139.7	205.5	234.9	227.2	247.0	269.2	301.0	238.9	256.6	273.3	251.8	200.7	213.8	204.0	152.2	287.9	253.6	140.6	315.8	460.5	43.3	48.6	49.8	47.9	40.2	45.9	52.4	51.4	51.5	49.2	49.4	58.3	223.8	134.6	102.8	13.4	206.9	336.0	336.5	204.9	189.5	51.4	156.8	126.4	66.3	157.3	147.9	112.2	47.9	292.9	201.7	164.7	176.1	218.6	360.1	203.8	153.3	176.6	126.8	199.6	10.8	142.2	414.8	157.0	154.9	147.0	116.1	106.9	127.5	222.3	226.0	48.8	12.0	230.1	164.8	193.3	181.7	92.7	146.0	178.5	99.6	24.4	213.0	116.9	219.4	16.6	32.7	161.4	152.1	117.8	163.3	280.8	189.7	233.1	242.0	163.6	98.6	179.7	278.1	184.5	167.3	210.2	330.5	210.4	229.9	126.3	238.8	314.0
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343193	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm		NA	NA		650000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	71.8	65.3	80.6	65.7	82.6	101.8	58.8	81.2	96.6	79.4	69.1	74.4	56.4	92.5	44.5	55.1	72.1	44.1	67.2	76.4	82.4	84.2	56.7	63.5	79.1	85.8	83.7	109.7	44.7	54.4	55.0	83.2	87.2	59.9	63.7	81.1	47.7	60.2	92.2	63.2	64.6	68.0	86.4	63.9	59.2	69.1	81.4	98.1	75.1	66.9	78.2	68.6	69.2	87.5	233.2	220.5	343.4	107.6	131.8	81.0	221.6	199.1	104.2	183.2	150.0	379.3	200.7	364.7	106.8	132.5	145.2	151.9	280.2	192.8	280.9	226.4	148.2	282.9	194.1	231.7	115.4	326.9	149.4	53.6	172.7	209.0	368.0	151.0	142.8	191.2	356.8	122.7	205.2	323.6	291.3	350.6	229.2	169.0	258.6	239.6	288.2	119.0	148.3	189.7	155.0	168.5	211.9	144.2	221.7	195.4	153.7	164.5	154.6	170.9	284.8	89.8	273.4	147.6	213.7	368.2	94.1	159.0	135.1	22.7	18.6	37.6	17.0	21.2	18.1	16.2	20.4	20.2	21.6	16.2	25.7	21.6	23.8	22.3	26.0	17.6	20.2	13.4	80.6	82.6	81.2	96.6	76.4	82.4	85.8	83.7	87.2	86.4	81.4	87.5	133.6	102.5	117.3	33.6	111.1	325.8	275.5	99.9	113.3	114.2	83.2	102.6	115.5	64.3	114.5	73.5	95.9	149.6	111.7	71.6	60.7	89.6	29.0	108.2	138.9	125.7	107.7	127.9	39.8	83.8	202.2	143.6	69.3	162.5	141.1	111.5	75.0	39.6	95.5	87.5	41.9	80.2	73.2	69.5	153.2	21.1	96.3	97.1	129.9	50.6	105.7	107.8	75.2	51.8	84.6	76.8	99.7	120.4	97.9	214.3	84.6	72.0	115.2	146.7	131.5	150.0	174.6	277.3	164.5	89.7	266.8	191.8	128.5	90.8	84.4	215.1
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		7100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	283.6	308.1	186.1	326.2	197.1	637.3	265.3	202.4	236.6	264.5	227.4	270.2	287.0	297.0	227.3	276.8	269.7	243.8	275.8	188.8	220.3	279.2	346.8	240.4	401.9	203.1	187.8	317.5	247.4	350.8	198.2	325.8	203.0	251.3	277.5	342.2	242.2	251.4	315.3	256.1	282.9	287.6	205.7	298.3	250.1	183.4	194.4	548.5	297.2	312.9	423.7	351.2	230.7	241.0	926.1	624.2	1048.4	625.7	492.2	540.7	840.0	634.1	785.0	778.2	726.4	527.0	641.2	1087.2	425.8	671.1	673.8	689.5	1061.5	772.9	941.8	753.7	624.2	765.1	511.9	754.6	648.7	958.6	726.5	554.6	577.4	665.6	876.1	583.7	806.1	605.5	792.8	541.4	776.4	809.0	1198.4	652.1	934.7	929.3	599.3	1030.2	835.0	727.6	760.3	747.6	677.1	802.6	669.6	703.8	645.5	721.8	698.6	801.6	665.8	537.9	631.7	552.7	844.2	564.7	795.5	784.6	514.3	762.6	779.5	582.0	438.9	559.2	302.2	419.8	378.9	347.8	346.6	348.7	457.5	324.4	354.8	327.2	546.1	477.9	429.1	270.8	457.4	1012.5	186.1	197.1	202.4	236.6	188.8	220.3	203.1	187.8	203.0	205.7	194.4	241.0	354.7	205.1	270.0	58.4	398.4	506.0	540.7	421.5	313.0	180.9	281.6	203.3	195.0	230.2	322.4	263.0	89.6	585.3	379.9	288.1	395.2	448.2	43.4	326.2	329.0	331.7	387.0	447.9	45.9	368.3	738.5	323.4	233.9	384.2	336.8	300.0	260.9	356.6	388.4	156.5	51.2	379.2	307.2	352.9	412.9	45.4	334.6	333.4	327.3	58.1	448.9	362.5	338.8	71.9	116.2	397.0	282.7	321.2	281.0	353.3	260.0	416.7	308.1	182.6	276.1	340.9	479.7	345.9	241.7	309.5	448.7	728.5	368.6	334.9	406.9	453.2
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		470000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	51.1	47.9	18.4	48.7	21.6	56.6	49.0	26.0	22.9	55.0	22.3	44.7	33.6	66.1	25.8	54.9	52.6	29.0	40.4	18.1	22.2	43.8	27.2	47.6	58.0	20.2	19.6	61.6	34.0	42.3	33.9	50.0	21.6	35.0	43.2	40.2	46.7	31.8	55.9	51.2	46.7	44.7	20.1	41.9	38.9	31.0	19.2	71.9	43.5	27.7	60.0	48.3	50.1	26.8	161.7	103.9	200.9	123.5	70.0	73.6	103.6	102.7	118.0	178.3	123.0	73.2	113.4	202.3	52.1	141.4	88.9	89.5	211.0	143.9	208.5	142.3	161.4	192.5	131.0	121.9	68.4	224.2	125.1	74.8	86.7	141.5	113.4	73.3	112.9	153.0	185.4	139.9	119.2	98.3	268.3	71.6	111.6	105.3	103.4	196.9	186.5	144.1	96.5	88.7	137.3	132.6	141.8	116.0	88.7	109.5	98.6	102.6	121.0	102.6	133.4	123.8	129.5	81.3	149.0	276.8	71.9	200.7	117.7	21.7	35.9	44.9	49.0	47.2	51.7	41.4	45.0	47.7	45.8	41.6	48.0	45.5	12.8	53.9	48.1	30.0	58.4	46.6	18.4	21.6	26.0	22.9	18.1	22.2	20.2	19.6	21.6	20.1	19.2	26.8	112.0	118.6	109.1	29.0	132.7	127.6	207.1	139.0	95.6	127.8	89.1	78.0	72.3	84.4	138.0	88.3	43.8	253.0	125.8	60.2	92.0	126.6	22.9	110.5	183.8	129.3	116.4	150.4	28.6	126.5	274.4	135.3	92.2	146.2	172.0	171.4	61.8	73.1	106.6	126.2	32.6	107.8	138.4	77.7	92.4	17.2	120.9	98.8	83.6	36.5	147.7	159.9	112.3	63.3	60.6	125.2	64.1	116.6	144.3	208.5	59.6	76.9	114.5	111.1	85.5	159.1	170.2	170.4	148.3	136.4	129.9	206.7	136.5	157.3	116.8	182.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	110.3	111.9	123.7	76.1	132.5	177.5	100.9	131.8	139.8	101.6	122.3	93.3	65.5	103.0	121.3	99.9	106.6	62.7	92.7	122.5	123.5	129.9	105.6	80.7	98.3	125.7	127.9	134.5	99.4	109.6	88.2	96.0	127.3	92.2	84.2	126.3	86.8	79.5	116.5	91.9	94.5	76.7	129.8	103.0	95.0	90.2	127.6	141.2	103.6	61.6	115.5	97.0	86.8	144.6	308.9	242.9	311.8	249.4	160.5	136.4	307.9	215.2	138.2	193.3	171.1	234.0	198.6	481.9	195.6	183.0	185.4	235.3	424.4	244.0	304.5	204.8	280.2	417.4	203.4	360.7	168.8	482.7	242.9	156.2	143.9	211.6	220.1	169.8	200.4	296.9	553.0	174.0	264.3	221.2	517.8	497.8	545.5	227.4	217.2	510.6	392.7	261.9	314.3	222.9	260.6	257.5	339.2	220.4	280.9	226.8	305.2	531.7	244.5	192.6	283.7	207.0	384.3	283.4	332.9	458.6	156.8	403.1	282.2	23.0	14.4	20.6	18.0	12.9	19.2	22.6	22.0	22.1	15.8	21.8	25.5	21.5	20.6	19.8	15.0	31.3	21.3	10.1	123.7	132.5	131.8	139.8	122.5	123.5	125.7	127.9	127.3	129.8	127.6	144.6	269.6	326.9	375.8	67.9	271.9	271.2	416.4	137.1	277.2	149.5	254.3	166.5	186.8	118.7	281.4	193.1	183.5	202.2	323.4	163.7	97.8	215.5	389.9	283.4	530.1	248.6	198.1	269.4	61.8	180.9	259.5	267.1	202.9	429.8	363.6	375.3	133.2	121.9	184.5	141.3	65.2	208.0	109.9	223.7	268.6	481.9	153.7	402.7	122.7	45.9	251.4	151.4	228.6	67.8	107.7	188.9	141.8	142.6	331.6	215.8	141.4	133.2	240.1	213.7	144.7	317.0	364.3	194.9	162.7	292.7	239.2	252.7	310.6	379.9	234.6	288.1
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307787	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	85.7	65.9	53.2	89.1	62.4	176.2	75.0	64.3	63.8	78.0	58.9	85.7	81.3	85.0	49.1	81.4	82.8	58.0	75.7	52.9	58.9	48.3	52.5	75.0	102.4	63.9	56.3	116.3	71.7	64.7	58.3	48.8	60.6	59.6	73.1	91.2	84.7	66.7	92.7	93.2	78.7	79.0	53.1	86.4	73.5	79.8	56.1	140.0	69.9	75.6	109.6	75.2	72.1	66.0	284.3	371.2	216.5	200.4	104.3	124.0	82.2	163.1	194.1	207.1	187.8	218.7	213.2	250.1	112.3	206.4	116.8	91.2	208.1	191.3	234.6	248.5	172.9	272.9	168.8	170.4	121.0	259.5	244.3	132.9	116.8	185.8	171.6	186.5	195.7	187.1	203.1	233.8	185.9	217.0	341.0	151.8	165.0	270.8	126.7	219.0	171.6	142.3	149.0	298.8	171.2	154.2	363.3	212.6	95.4	147.7	163.7	290.2	188.4	231.6	218.6	105.4	318.3	264.3	184.5	238.4	147.5	210.8	311.6	13.2	6.2	11.0	11.9	6.7	18.1	8.8	14.4	12.4	7.3	9.0	9.9	7.9	13.5	12.6	7.9	13.7	10.9	5.7	53.2	62.4	64.3	63.8	52.9	58.9	63.9	56.3	60.6	53.1	56.1	66.0	57.0	80.1	69.6	14.7	105.4	56.2	42.9	35.9	71.7	63.2	69.0	58.5	64.1	52.9	36.1	31.3	73.0	50.1	151.9	51.4	45.0	65.1	51.6	52.7	76.8	57.7	76.7	129.4	13.9	62.2	58.8	67.7	55.5	54.2	58.9	78.8	60.3	43.0	63.6	48.8	16.2	66.4	30.5	102.4	76.5	73.9	86.3	92.3	35.6	16.9	81.1	70.8	93.7	21.6	22.2	68.6	39.4	71.5	152.2	48.6	49.5	29.5	49.9	97.3	78.9	74.7	70.3	113.6	108.9	99.1	60.2	53.4	134.2	60.3	73.6	43.6
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 70.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.6;Collecting duct cells: 99.3;Early spermatids: 37.9;Endometrial ciliated cells: 25.6;Glandular and luminal cells: 35.0;Hepatic stellate cells: 25.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"medulla oblongata: 28.3;pons: 13.0;spinal cord: 24.5;white matter: 13.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;HEK 293: 47.4;RPTEC TERT1: 35.0;U-251 MG: 38.2"	"Region enriched"	"Detected in single"	39	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	22	"medulla oblongata: 10.1;pons: 3.9;spinal cord: 12.2"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	22.7	11.3	0.2	7.8	0.1	1.8	19.3	0.2	0.2	23.3	0.3	43.6	6.5	13.6	70.5	13.5	38.5	7.6	5.2	0.3	0.1	38.7	4.1	12.6	4.8	28.3	1.0	1.6	4.8	20.0	0.2	4.2	13.0	9.3	11.8	0.0	0.6	25.4	10.6	7.7	27.5	9.4	24.5	15.7	17.7	10.3	0.4	1.3	4.8	8.2	1.2	11.3	10.2	13.6	6.6	13.9	10.1	4.6	8.7	12.1	2.5	0.2	0.0	0.2	0.2	6.2	43.9	3.5	34.0	30.1	4.4	0.3	2.0	0.7	0.1	10.6	47.4	10.9	7.0	0.0	13.4	0.0	27.3	12.3	0.0	13.3	0.7	6.5	13.8	13.2	14.8	0.4	8.4	0.2	0.7	0.3	0.2	14.3	1.3	0.0	7.0	1.4	35.0	6.7	0.0	0.1	1.5	0.0	7.8	7.5	13.9	3.0	15.1	4.5	13.6	2.5	38.2	3.5	4.5	0.4	9.5	0.0	8.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.6	0.2	0.1	0.2	0.1	0.2	0.2	0.3	0.1	28.3	1.0	13.0	24.5	0.4	13.6	26.6	0.0	1.9	0.0	0.5	2.5	3.0	0.0	11.4	0.0	5.9	2.7	1.8	1.5	0.7	99.3	0.0	3.2	2.0	11.4	7.9	0.2	37.9	25.6	4.3	13.6	2.4	0.8	0.0	0.0	0.8	8.1	0.0	35.0	8.8	0.0	25.0	0.4	0.7	0.0	0.0	7.5	0.0	1.6	4.2	12.9	0.3	0.8	5.4	0.0	0.3	0.0	6.2	0.0	0.0	0.4	7.7	0.4	0.4	3.2	7.6	0.9	0.0	0.0	0.0	4.8	6.2	6.1	11.7	13.9	1.4	0.4	2.0	0.0	9.5	7.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954903-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 1.2;brain: 1.1;skin 1: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8;stomach cancer: 2.0"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 23.4;OE19: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"liver: 61113.6"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 29.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	673.1	11.4	1.3	26.9	1.7	231.5	34.2	1.4	2.9	71.9	3.6	3.6	1.5	3.5	2.9	5.3	74.6	1.3	146.7	1.4	1.4	19.8	61113.6	91.3	1.7	29.7	2.0	9.9	7.6	0.2	49.9	2.5	3.7	7.3	0.6	0.7	6.1	0.2	5.0	3.4	4.4	4.5	2.3	72.0	6.2	2.1	8.3	2.7	6.3	0.4	3.0	3.8	3.3	5.9	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	1.3	1.7	1.4	2.9	1.4	1.4	29.7	2.0	3.7	2.3	8.3	5.9	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
HPCA	DYT2	ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 517.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basal ganglia: 1309.6;hippocampal formation: 990.7"	"CAB012340, HPA043245"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	0.2	0.4	99.4	0.0	517.5	0.0	0.1	50.3	322.2	0.7	37.5	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.3	326.8	52.2	0.3	0.2	0.1	0.0	43.0	54.8	0.6	0.5	0.3	1.8	0.0	41.6	0.5	0.4	18.4	0.1	0.1	0.2	0.1	0.4	0.2	54.8	0.1	0.2	3.6	105.8	0.0	0.4	0.0	0.0	0.2	0.4	82.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	517.5	50.3	322.2	326.8	52.2	43.0	54.8	41.6	54.8	105.8	82.6	0.1	0.0	0.0	3.6	0.0	0.0	1.4	0.5	0.0	198.3	0.4	0.9	0.4	0.0	0.1	0.0	6.2	0.1	0.1	1.7	0.0	0.3	155.4	0.0	0.4	0.3	18.0	0.0	21.9	0.5	0.3	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.1	13.5	7.8	2.8	0.0	0.0	0.0	119.7	1.2	0.1	0.0	2.8	0.0	9.1	0.0	4.5	3.7	0.3	5.9	0.4	0.0	1.3	2.0	2.0	0.2	19.3	0.0	0.1	0.5	4.2	8.5	0.1	0.3	0.1	0.0	0.0	2.2	1.4
HPCAL1	"BDR1, HLP2, VILIP-3"	ENSG00000115756	"Hippocalcin like 1"	P37235	2	10302889-10427617	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 182.4"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 228.8;Intestinal goblet cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 310.6;HDLM-2: 324.5;PC-3: 354.2;U-87 MG: 334.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Supported					NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA043245: AB_2678385"	"unprognostic (3.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (2.73e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (4.06e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	47.1	62.1	123.2	24.1	140.0	14.4	31.4	182.4	146.9	42.8	54.3	43.2	35.2	90.4	9.3	16.9	40.3	15.1	49.6	114.1	132.2	71.4	62.5	102.3	27.7	129.9	114.8	15.5	52.6	8.5	65.0	22.1	138.2	21.9	21.3	21.2	20.4	9.0	27.3	18.8	63.7	28.1	84.0	47.3	73.3	46.8	123.8	16.6	33.1	15.1	17.3	20.9	23.0	81.1	51.8	88.6	6.2	25.5	13.8	35.4	59.8	41.0	110.5	58.3	63.6	31.4	128.5	20.1	47.3	30.6	310.6	18.9	16.7	56.8	26.1	324.5	30.1	44.8	94.8	69.2	61.4	27.8	86.5	19.3	25.9	139.1	43.1	207.3	77.7	30.5	41.8	129.1	105.5	70.5	23.2	168.4	32.5	43.2	354.2	29.5	24.3	88.8	85.0	14.8	22.8	152.5	43.0	51.6	102.7	21.6	16.2	72.5	94.2	72.8	22.4	77.7	69.8	38.5	44.7	10.5	334.9	67.4	174.0	24.5	50.9	61.9	21.6	39.9	23.6	26.7	38.9	27.4	43.5	21.3	46.3	30.7	70.0	24.5	36.3	15.7	36.0	29.5	123.2	140.0	182.4	146.9	114.1	132.2	129.9	114.8	138.2	84.0	123.8	81.1	88.6	83.3	86.8	9.4	48.2	33.8	23.4	4.3	11.4	76.9	19.9	12.4	15.9	30.0	16.9	18.4	16.7	4.9	30.1	39.7	93.9	48.6	25.7	10.3	15.1	72.2	62.6	18.7	23.5	37.1	145.6	22.9	53.0	10.8	55.2	26.3	81.8	32.7	67.6	228.8	23.3	308.8	4.1	79.2	77.9	19.2	17.1	65.1	56.9	31.9	43.9	51.7	46.4	12.5	10.3	46.1	64.5	10.9	45.5	14.8	111.7	100.3	6.8	33.6	6.6	18.2	14.5	20.8	14.9	15.6	30.1	41.3	45.0	6.2	44.8	19.2
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2530.4"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 7.8"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.3	5.3	0.6	0.7	0.4	0.9	4.6	3.2	0.6	2.0	119.0	1.2	0.1	4.1	0.7	0.7	6.4	1.1	3.5	7.8	0.5	531.0	2530.4	2.0	0.3	1.5	1.0	4.7	3.9	0.1	1.1	0.3	0.8	2.3	0.5	0.3	0.2	7.3	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.2	3.5	0.1	0.7	0.1	0.1	3.7	1.9	1.0	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.6	0.4	3.2	0.6	7.8	0.5	1.5	1.0	0.8	0.6	3.5	1.0	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063148-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 811.9"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 503.0;Smooth muscle cells: 128.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 50.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	55000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		5.5	0.5	14.1	0.2	15.3	0.1	2.0	13.9	16.7	1.2	11.3	1.2	0.6	0.3	0.4	0.3	1.3	0.7	137.2	13.7	14.3	4.0	811.9	1.5	0.7	14.4	14.3	2.0	0.6	0.0	0.3	0.0	13.6	1.6	0.1	0.8	0.3	0.3	1.7	0.6	1.1	0.1	12.8	0.3	1.7	1.9	15.2	0.2	1.1	0.2	0.1	0.4	1.9	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	2.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.6	0.6	0.0	14.1	15.3	13.9	16.7	13.7	14.3	14.4	14.3	13.6	12.8	15.2	13.1	0.0	0.0	7.5	2.3	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.0	22.4	12.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	5.3	0.2	0.2	0.0	2.6	0.0	0.0	0.0	1.1	10.8	503.0	0.0	0.0	0.2	0.0	2.0	12.8	0.0	2.8	9.9	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	13.0	0.2	0.1	0.0	6.1	128.8	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460165-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 226.9;Spermatocytes: 213.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006360, CAB012200"	Enhanced		Supported	Cytosol		NA	NA		9400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	15.6	26.2	37.3	24.3	39.4	54.7	20.4	26.0	63.7	13.6	22.9	25.5	20.4	14.0	62.7	20.3	16.9	14.6	24.5	40.3	47.1	45.5	45.8	14.5	32.1	31.2	32.1	16.8	37.1	21.9	31.5	16.3	34.7	15.4	23.5	74.1	13.5	16.0	22.6	14.8	26.5	17.3	24.6	16.9	32.2	76.1	31.4	31.3	22.1	17.8	30.6	25.4	13.9	31.3	138.0	64.9	18.0	37.2	39.4	56.1	54.1	71.6	68.7	89.5	116.8	58.7	85.5	154.4	158.7	46.7	106.8	82.0	117.4	98.2	153.4	129.2	219.3	84.0	85.0	60.2	38.9	182.9	74.0	41.6	36.1	80.1	126.4	49.5	104.9	90.3	65.5	3.8	71.0	141.0	141.9	157.0	37.0	160.7	171.8	83.8	91.1	158.6	109.6	65.7	113.0	61.6	51.7	41.5	50.1	48.8	35.5	75.2	52.4	60.5	45.6	175.0	181.5	56.5	105.1	0.9	74.6	199.5	33.8	5.8	21.9	20.4	20.8	36.5	30.0	24.0	30.4	27.6	37.9	24.8	24.8	26.9	5.6	39.4	35.5	15.7	57.4	25.3	37.3	39.4	26.0	63.7	40.3	47.1	31.2	32.1	34.7	24.6	31.4	31.3	32.1	19.2	8.2	11.1	39.6	39.6	55.7	75.6	18.8	38.3	26.4	22.0	23.8	30.0	29.9	57.0	4.2	17.9	28.1	16.8	226.9	50.1	11.9	30.1	28.3	39.2	27.5	101.8	55.3	32.3	30.5	29.5	30.1	41.8	34.9	29.0	20.7	22.2	71.2	25.2	43.1	30.4	63.1	60.7	81.7	32.2	40.7	56.2	55.2	10.3	122.5	37.2	26.8	22.1	30.7	36.6	28.2	26.7	30.9	78.1	24.1	30.2	28.9	78.0	52.6	31.6	39.4	213.5	172.6	40.4	38.8	6.0	53.8	30.2	51.3	46.8
HPS5	"AIBP63, BLOC2S2, RU2"	ENSG00000110756	"HPS5 biogenesis of lysosomal organelles complex 2 subunit 2"	Q9UPZ3	11	18278668-18322198	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077851	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA077851: "	"unprognostic (2.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.89e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.72e-1)"	7.4	8.4	4.4	5.8	5.5	3.7	10.5	4.7	4.5	5.1	5.9	4.8	6.1	5.0	2.8	7.3	5.1	3.9	5.9	4.0	4.6	5.4	35.7	8.6	9.2	5.6	5.0	7.1	6.8	3.6	8.5	7.1	5.9	4.8	3.3	8.9	16.3	3.5	5.5	6.3	8.1	3.9	5.2	9.0	4.6	14.8	5.4	5.9	6.0	3.1	8.3	4.9	5.5	7.4	5.9	8.5	9.0	9.1	11.9	6.6	9.8	15.3	12.6	9.9	10.4	5.3	1.8	14.1	5.8	13.3	12.4	8.3	10.6	10.1	12.1	11.8	7.7	6.9	7.1	6.7	11.2	15.2	12.4	10.6	9.9	6.1	12.9	10.0	8.0	9.0	9.1	8.0	16.1	4.8	8.1	11.0	4.5	6.8	9.3	11.8	12.9	6.0	9.6	5.3	3.0	5.9	19.2	6.8	22.8	8.9	5.1	8.8	5.9	11.3	6.1	14.8	7.1	3.4	12.0	16.1	6.2	7.8	32.4	12.3	3.6	2.9	2.1	5.4	2.6	5.3	2.6	2.2	8.3	4.4	2.5	2.6	1.0	2.8	6.0	3.2	2.6	2.5	4.4	5.5	4.7	4.5	4.0	4.6	5.6	5.0	5.9	5.2	5.4	7.4	17.2	96.1	14.6	13.1	30.8	15.6	14.2	16.2	12.5	17.5	17.4	23.0	18.2	17.2	14.7	7.3	31.3	22.2	16.0	4.7	5.9	5.2	50.9	20.7	11.2	13.4	10.7	11.6	16.7	8.4	10.6	11.8	18.3	30.0	14.5	17.8	7.9	45.1	18.1	10.1	21.0	5.0	12.2	22.7	45.0	18.6	8.4	35.8	28.4	11.2	32.3	16.1	0.0	21.1	24.0	6.2	8.5	13.2	17.4	15.2	27.1	6.5	21.1	26.1	6.6	17.1	13.1	16.2	12.6	19.6	15.3	17.4	17.8	10.5	6.0	21.8
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5440.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 6095.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	1.1	0.8	0.8	0.1	0.7	0.1	5.9	1.0	1.0	1.6	0.6	1.2	0.4	1.0	0.2	0.5	1.6	0.3	0.9	0.7	0.7	1.4	5440.6	1.2	0.3	0.7	0.7	1.6	5.5	0.1	1.2	0.3	0.7	2.4	0.6	1.7	1.1	0.6	0.3	1.6	1.1	0.3	0.6	3.8	0.9	1.1	0.8	0.1	0.9	0.0	0.1	1.1	1.2	0.7	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.3	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.2	21.3	0.0	3.0	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	0.2	1.1	0.0	0.5	0.3	0.2	1.0	0.1	0.4	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.0	1.0	0.7	0.7	0.7	0.7	0.7	0.6	0.8	0.7	0.5	3.2	0.5	0.3	15.1	0.6	0.2	0.2	0.0	1.5	19.1	7.7	0.7	80.1	0.2	0.0	2.1	0.1	0.1	0.6	0.0	0.1	2.3	0.2	0.3	6.2	0.0	157.7	0.7	0.6	0.1	0.4	0.0	1.2	0.0	1.1	132.8	6095.8	0.2	0.0	0.8	0.7	0.0	155.3	0.2	2.9	0.3	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.7	0.2	0.0	1.0	2.1	0.0	0.4	0.5	0.6	0.5	0.0	0.3	0.0	11.3	0.2	0.5	0.3
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5433.2"	"Cell type enriched"	"Detected in some"	29	"Hepatocytes: 479.7"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;RH-30: 3.0;SiHa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.4	5433.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.6	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	479.7	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212076-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 1.0;Horizontal cells: 1.7;Rod photoreceptor cells: 3.5"	"Cancer enriched"	"Detected in single"	4	"melanoma: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.9"	"Not detected"	"Not detected"							HPA031469	Uncertain		Approved	Mitochondria		No	No		180000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.1	0.2	0.9	0.0	0.4	0.0	0.1	0.0	0.6	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.0	0.2	0.4	1.9	0.3	0.1	0.1	0.0	1.8	0.7	0.4	0.4	0.0	0.2	0.0	1.1	0.2	0.0	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.4	0.7	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.0	0.6	0.4	1.9	1.8	0.7	1.1	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;skeletal muscle: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 102.5;Excitatory neurons: 154.8;Inhibitory neurons: 130.9;Oligodendrocytes: 606.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 4.6;RT4: 6.8;SCLC-21H: 14.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.0	0.3	3.5	0.1	9.7	0.2	0.0	3.6	4.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.0	7.2	7.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.1	1.1	0.0	1.3	3.2	0.2	0.1	0.1	6.5	0.0	0.2	0.1	7.6	0.0	0.0	1.4	0.0	2.2	0.0	6.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.9	4.6	0.0	0.8	0.0	0.0	6.8	14.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	4.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.7	3.6	4.4	2.8	4.5	7.2	7.0	7.3	6.5	7.6	6.0	0.0	0.0	0.0	102.5	0.0	1.3	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	11.0	18.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	154.8	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	130.9	0.4	0.0	0.0	0.0	0.8	3.7	0.0	0.0	9.4	0.0	0.0	0.0	11.6	606.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	7.9	0.1	1.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434370	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, tRNA processing"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 444.0;Proximal tubular cells: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	71.1	110.7	63.5	52.5	67.5	64.8	62.7	70.0	64.7	58.1	64.6	62.8	58.0	62.0	56.2	111.6	55.4	33.4	103.8	62.0	68.4	99.1	261.3	48.4	59.4	70.4	68.2	67.1	74.8	73.4	66.1	37.2	67.8	50.7	62.9	12.7	55.0	46.0	90.5	90.0	50.3	62.0	66.6	52.0	66.4	21.5	69.1	60.1	66.4	81.6	76.3	56.3	59.8	69.2	121.9	203.1	97.2	181.3	93.4	41.0	146.5	73.7	72.9	192.0	125.3	210.3	101.8	205.8	65.6	84.9	124.2	124.5	316.1	148.7	104.3	164.1	177.7	97.1	283.6	177.0	156.3	185.1	145.5	87.6	138.9	148.7	82.8	41.6	142.2	181.2	141.6	158.1	90.3	426.7	165.3	277.0	269.9	163.0	259.5	166.2	179.2	364.9	149.3	132.2	171.1	225.1	211.7	250.2	138.6	123.0	263.3	169.8	64.2	81.7	129.7	171.9	113.4	128.3	194.1	256.5	113.4	384.9	123.2	54.2	127.8	40.4	84.8	125.1	87.2	98.8	78.0	84.1	176.7	111.4	64.4	67.9	10.5	98.7	94.5	96.5	114.8	126.6	63.5	67.5	70.0	64.7	62.0	68.4	70.4	68.2	67.8	66.6	69.1	69.2	42.8	48.1	37.3	4.9	61.8	86.4	90.2	150.8	44.9	11.8	72.5	74.9	62.0	107.2	70.2	101.2	4.2	173.2	55.0	73.8	283.7	131.5	1.6	26.1	64.7	58.3	104.6	71.3	2.5	135.4	228.1	72.0	28.1	51.9	56.5	75.3	56.4	444.0	136.8	13.5	3.3	78.2	99.7	73.9	98.6	5.7	78.3	65.4	96.0	3.7	118.7	61.3	89.6	6.6	6.2	101.9	54.1	94.8	83.3	74.6	78.5	427.8	31.5	13.2	78.9	63.1	117.9	23.6	56.3	91.3	116.2	151.6	62.4	104.1	103.0	83.7
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 429.0;liver: 217.9;placenta: 381.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	1.6	0.0	0.4	4.2	0.2	0.7	26.4	0.9	0.4	4.3	0.2	74.8	429.0	1.2	0.1	9.6	0.1	21.1	0.2	0.3	0.2	9.6	217.9	2.3	0.3	0.1	0.0	0.3	23.2	0.0	1.2	381.8	0.1	2.0	56.9	17.4	22.1	0.2	0.1	4.2	188.6	2.4	0.0	0.2	20.1	0.3	0.1	0.4	0.1	0.0	3.4	78.6	1.4	0.3	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.9	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.3	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112380080-112472405	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 181.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	76.3	63.6	28.1	13.3	30.1	11.6	22.8	25.1	29.5	23.3	27.6	31.7	38.9	22.8	11.5	29.8	21.2	19.0	89.9	24.8	33.1	69.0	149.0	28.7	13.9	25.4	33.2	50.8	20.0	21.8	8.8	16.8	27.1	20.3	26.9	12.6	18.8	15.9	151.7	31.1	32.2	20.5	26.6	18.6	24.6	14.0	32.0	19.6	30.4	181.3	15.8	29.2	15.0	28.5	45.0	39.4	29.0	14.8	49.0	48.4	33.4	30.1	18.6	21.1	17.7	77.0	49.4	28.5	16.2	44.4	26.9	50.6	31.9	42.2	25.8	120.9	21.0	30.0	58.5	76.1	30.7	17.1	18.5	52.0	29.9	31.3	22.8	30.5	24.8	34.7	42.3	18.9	58.2	29.6	42.5	15.3	17.2	106.9	50.3	27.1	87.4	42.7	44.5	40.4	20.7	14.5	75.8	49.5	26.0	23.7	70.0	20.0	28.3	30.2	27.9	85.2	29.6	21.5	57.3	13.5	37.0	24.8	18.2	54.3	8.4	32.8	4.6	8.1	6.8	6.9	4.8	5.0	9.5	8.4	5.6	5.9	48.0	5.9	11.5	9.4	8.7	4.9	28.1	30.1	25.1	29.5	24.8	33.1	25.4	33.2	27.1	26.6	32.0	28.5	32.0	99.3	84.3	48.6	14.1	13.3	17.5	21.6	29.6	9.3	12.0	13.3	214.8	14.3	32.2	14.7	6.2	26.5	18.3	23.7	64.6	15.5	153.9	38.6	38.3	19.1	14.9	32.8	10.8	18.7	30.9	31.1	29.0	27.8	30.4	187.2	17.2	124.2	35.7	6.7	12.2	32.2	8.2	23.6	12.5	163.0	27.4	27.5	8.8	15.9	47.3	24.1	6.2	16.1	19.3	13.2	23.5	47.0	20.9	16.0	52.4	111.1	37.7	14.5	46.0	18.1	46.9	12.9	16.4	34.2	16.2	31.7	16.2	108.9	36.2	29.5
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314720	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	51.7	55.7	20.0	14.7	19.2	18.0	47.9	18.2	24.0	48.6	17.0	70.6	14.1	51.7	7.4	48.1	52.1	12.4	133.5	18.6	19.1	50.2	46.0	49.5	14.5	22.3	21.4	57.3	68.7	18.7	48.1	17.0	20.2	53.2	10.8	7.6	39.8	17.1	125.1	49.2	39.7	15.3	18.6	42.8	57.8	107.8	21.7	14.7	45.7	32.2	12.6	58.7	46.2	18.0	40.8	53.8	22.9	19.6	37.6	35.0	37.9	29.7	26.6	28.8	25.0	36.3	34.6	46.7	42.5	41.5	28.2	28.9	35.2	42.7	18.3	29.9	40.7	58.4	51.8	50.1	59.1	17.1	43.4	34.2	39.3	40.6	74.2	30.6	39.4	41.9	39.6	27.1	29.4	82.0	58.0	26.2	29.4	52.6	154.2	37.2	19.9	59.2	20.6	40.5	34.3	27.9	45.4	35.9	52.8	23.8	40.5	34.5	40.2	29.5	66.3	46.8	49.5	18.8	15.4	39.9	41.8	31.4	28.8	14.2	23.2	26.3	16.7	24.9	17.2	19.2	17.8	21.1	24.6	17.3	17.1	15.9	9.7	16.3	32.2	12.6	22.9	19.2	20.0	19.2	18.2	24.0	18.6	19.1	22.3	21.4	20.2	18.6	21.7	18.0	46.5	6.4	11.2	8.5	40.4	51.4	73.8	53.8	39.9	67.8	37.0	30.5	46.4	22.8	34.7	29.5	62.6	69.9	38.2	43.3	150.6	39.2	248.7	35.1	20.5	44.4	40.9	120.8	12.1	41.1	80.6	34.7	44.9	34.6	37.5	51.1	40.7	63.8	49.5	69.0	14.7	36.8	42.7	25.7	45.6	106.7	37.3	32.7	33.8	12.2	59.7	24.9	34.0	6.0	12.9	45.3	49.3	42.9	40.4	76.6	63.8	34.9	25.9	33.1	59.2	41.3	39.2	84.4	47.7	36.3	45.5	111.0	39.0	105.9	45.8	76.4
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 38.5;Excitatory neurons: 30.9;Horizontal cells: 43.7;Inhibitory neurons: 30.0;Leydig cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 17.1;T-47d: 12.9;U-266/70: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048584			Supported	"Nuclear speckles"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	12.4	23.7	43.6	1.3	44.3	1.8	12.7	44.6	69.2	17.9	39.2	10.1	4.8	12.4	4.8	11.0	21.1	3.6	20.0	44.6	43.7	17.1	20.3	8.7	1.6	45.0	41.9	19.8	35.9	4.3	30.1	3.3	46.4	28.3	1.8	5.6	19.0	1.9	25.9	14.5	6.1	2.1	41.3	6.0	14.4	7.0	43.3	1.1	17.9	4.1	1.1	18.8	10.9	45.8	1.6	1.1	0.0	1.1	0.5	3.0	5.2	0.5	0.6	0.2	0.0	2.4	3.5	0.1	2.5	1.1	0.7	5.9	0.4	0.7	0.2	2.3	2.2	0.6	4.5	3.1	2.3	0.3	4.4	1.3	4.8	0.2	2.5	17.1	0.9	4.0	1.5	5.1	2.3	1.5	0.8	1.8	0.1	3.4	3.2	2.0	1.7	8.7	4.4	2.5	3.5	7.6	4.9	3.0	7.8	2.1	12.9	4.5	0.9	1.6	1.6	6.4	1.5	22.3	3.7	1.5	4.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	44.3	44.6	69.2	44.6	43.7	45.0	41.9	46.4	41.3	43.3	45.8	2.6	3.2	7.7	38.5	1.1	3.1	3.4	2.9	4.6	10.8	9.1	7.7	5.3	4.3	2.7	3.7	2.1	1.0	0.7	2.9	0.0	1.0	0.5	4.1	2.8	1.6	1.2	0.0	30.9	1.3	0.6	6.0	14.8	7.0	1.3	2.3	2.9	5.7	21.9	43.7	30.0	3.0	2.0	0.8	2.5	1.8	32.9	4.6	10.6	5.6	1.5	8.8	0.0	4.0	15.2	1.4	3.5	22.2	1.5	4.0	0.4	2.4	4.8	11.4	0.0	5.4	3.2	0.4	2.3	3.6	3.4	0.7	0.9	1.9	2.9	2.0
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953931	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Plasma cells: 4874.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		330000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 12: NES - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	330.4	340.6	166.0	423.5	183.7	438.9	341.8	185.3	234.2	363.2	225.6	340.5	261.4	302.2	1032.5	157.5	305.5	218.9	309.5	164.4	206.2	317.1	736.4	271.1	245.9	205.0	191.3	302.6	397.1	336.0	247.2	521.1	201.6	360.2	387.5	185.6	254.9	382.8	87.5	120.0	269.5	385.7	188.8	322.4	297.6	180.7	196.5	228.2	1411.8	91.2	328.0	356.6	164.6	237.3	856.5	459.9	926.2	940.0	960.1	897.5	1229.9	1449.4	1133.4	776.0	1038.1	839.1	805.3	243.8	1102.2	1579.2	995.1	583.2	934.6	1578.9	1063.2	607.3	307.4	684.5	447.6	861.0	1457.4	702.1	514.6	519.6	690.9	920.0	1342.8	2643.7	1513.9	293.8	560.0	914.8	1039.9	314.7	409.2	768.3	756.9	925.5	544.5	372.2	597.1	1079.2	1064.3	527.1	271.5	645.7	889.2	912.0	932.7	1468.4	743.9	1016.2	854.4	566.1	476.0	462.8	607.9	945.5	949.0	455.6	1106.9	494.7	904.5	113.8	81.3	30.3	199.7	88.6	244.9	108.5	118.5	187.8	111.8	71.1	75.9	133.8	18.7	199.3	83.3	322.7	81.1	188.5	166.0	183.7	185.3	234.2	164.4	206.2	205.0	191.3	201.6	188.8	196.5	237.3	507.5	237.2	373.8	28.7	646.0	309.3	905.1	743.6	196.9	50.3	261.4	334.0	687.8	235.9	475.3	257.5	156.4	568.4	480.6	424.0	56.7	471.2	89.6	570.8	751.1	439.6	406.6	213.5	34.0	250.4	1081.0	714.0	390.9	690.9	405.3	500.6	446.9	891.9	553.1	77.4	41.9	631.5	238.0	300.1	309.8	47.0	563.2	378.4	421.6	52.5	240.5	141.0	199.8	30.2	61.3	321.8	419.1	337.7	4874.6	760.6	246.1	271.4	404.2	111.6	216.9	325.7	569.3	489.0	154.4	196.3	260.7	921.0	316.0	542.6	494.6	620.0
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732685-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 65.0;Endothelial cells: 50.1;Hepatic stellate cells: 16.1;Late spermatids: 16.8;Microglial cells: 15.0;Peritubular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.9;EFO-21: 4.9;HUVEC TERT2: 9.5;TIME: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013659: AB_1234541, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	23.1	4.1	9.3	3.0	8.9	1.3	23.0	6.6	7.8	15.0	4.2	6.6	1.8	12.5	1.2	4.2	10.3	4.7	29.3	6.6	7.0	11.8	1.7	20.6	1.7	8.2	7.9	8.2	2.6	1.5	2.9	11.3	8.4	4.9	1.2	0.4	5.4	1.9	12.3	7.7	6.1	4.0	6.8	25.3	5.1	5.2	10.4	0.7	9.2	10.2	0.9	10.2	10.2	6.0	0.5	1.7	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.2	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.4	9.5	0.4	0.3	0.2	0.0	1.0	0.4	0.9	1.0	0.0	0.8	1.8	0.2	0.5	0.0	0.0	0.9	0.7	0.3	0.2	0.1	0.1	0.2	0.5	5.3	0.1	2.2	0.7	0.4	0.4	0.3	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.3	8.9	6.6	7.8	6.6	7.0	8.2	7.9	8.4	6.8	10.4	6.0	65.0	0.0	0.0	0.3	0.4	1.9	0.1	0.0	0.0	0.5	0.7	0.3	5.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.8	0.2	3.2	50.1	0.0	0.0	0.5	0.0	0.2	10.5	0.0	0.1	0.0	0.1	16.1	0.3	0.5	0.0	0.4	0.0	0.0	1.4	2.5	16.8	7.5	0.2	0.0	15.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	2.0	3.5	1.7	0.3	1.1	0.4	0.3	0.7	0.0	0.2
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815283	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 63.2"	"Group enriched"	"Detected in many"	22	"Early spermatids: 212.5;Late spermatids: 560.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;EFO-21: 1.5;HEK 293: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		53000000		"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	1.2	1.4	0.0	0.0	0.2	0.1	0.9	1.4	0.3	1.5	0.0	1.8	0.1	1.8	0.0	0.6	2.4	0.0	1.4	0.1	0.2	1.5	1.2	1.3	0.0	0.2	0.2	2.2	0.9	0.0	1.7	0.0	0.3	1.1	0.0	0.1	1.0	0.0	3.9	1.0	1.5	0.0	0.2	2.4	1.3	63.2	0.4	0.0	1.5	0.1	0.0	1.6	1.1	0.6	0.1	1.1	0.1	0.4	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.4	0.4	0.1	0.0	0.1	0.3	4.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.4	0.6	4.2	0.0	1.1	2.9	3.5	0.9	1.3	0.4	2.2	2.6	1.9	2.0	4.5	0.0	0.9	0.0	8.4	0.6	1.4	1.4	0.0	0.7	212.5	2.0	0.7	2.2	1.8	3.2	0.6	0.2	0.6	1.3	0.0	1.3	0.0	0.9	1.8	1.1	1.3	3.3	0.8	1.4	0.0	4.4	2.5	560.9	5.0	2.1	5.4	2.8	4.1	3.6	1.0	0.5	2.0	0.4	1.4	2.2	1.9	0.9	0.9	0.6	2.2	2.8	0.0	0.8	2.9	17.0	8.7	1.7	0.1	0.4	3.8	0.9	1.5	0.3
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 320.2;skeletal muscle: 170.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 342.0;Distal tubular cells: 238.7;Extravillous trophoblasts: 509.9;Spermatocytes: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A549: 75.4;BEWO: 114.4;BJ hTERT+: 99.0;CAPAN-2: 52.9;SCLC-21H: 101.4"	"Low region specificity"	"Detected in all"							"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA		63000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favorable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	9.8	6.5	83.9	7.5	161.2	0.7	6.4	148.0	116.3	12.5	84.2	94.1	5.5	51.6	18.6	42.3	17.0	5.3	39.7	88.5	96.0	73.0	4.2	14.2	3.8	170.1	122.9	5.6	8.8	7.8	15.2	61.5	174.9	10.8	9.5	1.2	16.4	4.5	170.4	31.7	29.6	28.7	128.5	20.2	18.5	121.0	125.3	3.0	2.7	60.6	5.0	42.9	16.0	320.2	30.4	75.4	11.4	0.2	8.1	0.7	114.4	42.3	99.0	16.6	27.3	2.9	52.9	7.4	16.8	46.4	3.6	33.6	0.0	2.2	10.1	4.3	5.8	0.1	4.0	0.2	7.9	0.2	10.0	3.7	1.7	2.4	0.1	4.1	1.1	0.5	0.0	6.0	8.4	13.5	0.5	0.4	8.4	11.7	9.1	6.0	0.0	0.1	26.1	4.6	101.4	5.8	1.8	3.7	0.1	3.9	2.9	3.1	1.6	0.3	0.2	3.7	0.2	7.6	0.2	0.2	9.2	0.1	11.4	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.0	1.0	0.1	83.9	161.2	148.0	116.3	88.5	96.0	170.1	122.9	174.9	128.5	125.3	320.2	74.7	0.0	5.2	18.6	21.1	54.0	31.2	35.1	342.0	1.9	37.5	57.1	39.1	5.7	8.8	132.4	0.0	42.5	30.8	29.2	238.7	8.3	35.7	56.4	63.8	59.6	28.1	0.0	0.5	5.6	509.9	40.7	83.6	54.5	13.3	1.4	32.2	0.8	15.7	0.0	1.1	63.4	24.4	3.1	25.7	27.3	8.7	24.0	30.2	6.5	0.0	14.2	0.0	2.5	157.4	5.5	15.6	7.5	7.1	7.5	8.5	1.5	4.6	2.4	26.3	48.6	66.2	578.6	77.1	175.8	42.3	75.9	29.8	4.5	12.9	11.3
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133052013-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	31.3	36.9	33.8	41.0	37.2	35.6	26.9	38.1	63.7	26.6	52.0	31.8	26.6	27.5	29.3	62.0	26.8	27.8	50.8	39.8	43.8	44.3	47.2	26.3	47.4	37.6	41.0	21.3	29.7	43.5	24.0	37.7	45.0	26.3	34.7	104.0	27.9	26.9	57.7	26.1	26.0	35.3	38.4	28.7	26.6	62.8	40.3	40.2	39.7	41.7	60.9	48.4	23.7	48.2	160.8	215.8	147.6	241.7	137.5	114.6	267.3	171.0	127.8	162.1	199.2	408.0	163.2	264.4	175.2	165.8	382.6	138.9	259.4	282.9	232.7	122.9	148.3	195.4	136.5	225.7	109.6	122.6	163.8	115.1	117.3	209.7	136.3	92.9	157.2	126.5	207.9	79.6	179.8	141.4	173.5	91.0	202.4	123.8	98.7	156.6	180.4	140.2	146.7	207.4	117.0	96.0	163.4	84.4	234.6	273.5	124.3	118.5	139.0	146.8	210.8	127.1	206.1	90.7	215.2	199.9	125.5	198.7	149.2	29.5	22.6	24.9	18.1	35.8	21.5	34.2	16.6	19.0	27.7	42.0	17.1	16.2	14.7	22.9	27.1	10.5	18.0	18.5	33.8	37.2	38.1	63.7	39.8	43.8	37.6	41.0	45.0	38.4	40.3	48.2	30.5	64.1	47.0	12.4	74.8	41.8	116.8	25.5	52.9	58.9	30.3	26.8	113.1	28.6	47.3	22.0	54.2	67.3	38.5	42.9	27.4	48.4	68.7	54.7	48.5	40.8	47.2	46.9	24.2	49.9	66.1	45.3	38.2	46.1	54.6	66.9	19.6	32.9	64.3	35.3	24.8	34.4	36.7	28.2	40.9	31.9	23.3	50.7	30.2	21.5	55.0	60.1	22.6	18.6	24.2	50.1	24.9	25.9	66.5	61.5	27.7	49.7	60.7	152.4	26.3	41.8	85.1	107.4	101.0	71.7	41.8	87.2	58.2	68.0	39.4	69.7
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 242.2;lung: 94.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebral cortex: 242.2"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 317.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 317.9"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 50.7"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	26.2	15.7	11.3	9.9	16.3	3.6	3.6	22.1	242.2	2.9	24.7	9.3	1.7	1.7	0.7	7.3	3.8	8.7	31.7	12.9	12.4	27.2	33.0	94.4	2.3	15.1	12.4	46.8	5.9	1.1	23.8	20.5	28.7	3.3	1.7	1.8	3.3	5.0	3.8	8.4	5.1	2.3	13.8	63.5	34.5	2.4	15.5	1.3	12.8	3.6	1.7	18.5	10.9	20.1	0.8	1.5	0.0	0.3	0.0	1.1	1.0	0.6	0.5	0.2	0.4	0.5	0.7	0.2	2.2	0.2	0.8	0.4	0.5	0.4	0.3	0.5	0.1	0.3	1.4	0.0	0.0	0.1	3.3	0.2	1.0	0.5	0.0	0.0	0.0	0.2	0.6	50.7	0.0	0.0	0.3	1.3	0.1	0.3	5.4	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.2	0.9	3.1	0.1	0.4	0.7	0.2	0.1	0.5	0.4	3.6	6.9	0.4	0.0	1.3	1.3	2.3	6.5	35.1	13.4	6.4	44.1	1.0	0.2	0.7	3.4	12.2	0.0	0.0	1.6	317.9	8.3	37.7	0.2	0.0	11.8	11.3	16.3	22.1	242.2	12.9	12.4	15.1	12.4	28.7	13.8	15.5	20.1	14.0	9.6	9.3	0.3	23.8	29.3	335.3	4.4	5.2	42.5	8.7	36.2	11.1	0.0	12.2	5.5	127.2	1.8	12.8	25.3	0.0	0.4	3.2	16.2	16.4	36.7	71.0	24.0	0.0	0.0	11.2	98.8	30.1	26.2	2.5	0.0	3.9	0.3	76.0	10.1	0.0	71.0	4.1	47.8	478.8	1.1	5.6	213.7	103.2	1.0	15.8	36.1	5.2	0.0	0.1	0.3	16.5	0.0	104.1	180.1	0.0	1.5	17.1	36.9	0.0	11.1	235.6	2.9	0.6	16.5	21.7	18.3	391.3	3.6	67.3	92.7
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138553756-138575675	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	88.6	226.3	10.3	51.5	15.1	98.8	72.4	25.4	26.0	60.3	28.8	80.3	61.2	67.0	33.9	87.8	56.5	38.3	179.5	10.9	19.6	112.1	194.2	62.5	43.6	19.6	20.7	80.0	79.8	169.4	71.4	46.5	23.8	56.4	56.5	48.8	78.9	46.7	288.9	77.5	64.3	44.2	21.6	54.7	91.8	50.1	17.8	44.6	91.3	193.6	55.7	73.8	65.6	29.1	196.0	276.6	111.4	231.0	138.1	94.3	274.7	198.3	196.7	255.4	268.6	579.4	194.4	419.3	263.7	150.8	382.0	158.6	334.0	314.1	298.2	219.7	177.9	230.5	209.0	270.4	360.4	229.0	201.3	142.6	317.7	299.5	494.8	78.7	128.0	167.8	280.4	297.5	134.7	220.6	206.7	82.9	182.5	191.6	173.3	252.1	188.8	302.4	192.8	267.4	150.1	112.4	242.5	338.5	630.7	269.0	230.5	200.5	117.7	204.1	126.5	174.9	313.5	324.6	300.5	378.6	249.6	301.4	202.6	11.8	31.3	10.7	39.8	34.9	46.2	31.7	30.6	36.8	42.0	22.4	34.1	33.9	4.3	28.3	38.8	17.9	31.3	53.6	10.3	15.1	25.4	26.0	10.9	19.6	19.6	20.7	23.8	21.6	17.8	29.1	63.0	99.3	123.8	43.1	101.7	87.8	228.6	157.2	84.8	88.2	83.4	63.8	337.3	70.1	153.8	99.3	83.4	194.7	114.7	80.8	223.0	151.4	12.1	90.1	98.4	83.1	73.0	75.1	41.1	106.1	132.9	109.6	73.9	126.6	167.8	86.1	43.5	175.9	133.9	99.3	48.4	95.4	148.5	54.1	76.4	12.6	67.4	100.1	83.6	25.3	92.3	92.5	43.3	27.6	43.3	93.8	66.0	72.6	102.3	131.1	85.8	231.3	119.7	89.3	46.0	134.3	136.2	52.5	91.4	93.2	73.9	175.5	130.7	157.9	150.7	141.2
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302673-76304295	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 5909.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 2482.8;MCF7: 3979.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	964.4	856.4	810.6	329.6	835.1	52.3	560.5	821.6	1798.8	2123.4	864.3	2043.6	208.7	2824.2	131.7	5909.6	993.8	217.2	2981.9	776.6	944.5	986.4	554.9	790.9	99.0	894.1	838.7	731.6	751.7	221.1	303.3	324.3	870.8	979.0	73.8	10.2	1075.3	522.5	3669.8	2258.3	523.8	1066.9	808.2	224.5	770.3	99.8	840.0	218.7	627.1	628.1	279.3	1579.4	3398.4	869.5	1251.1	902.4	79.5	576.8	487.3	447.5	5.1	514.9	249.8	260.9	325.8	84.8	660.7	8.5	389.1	599.1	514.1	1094.2	359.0	279.6	76.5	690.9	106.4	41.5	611.4	345.5	267.9	69.9	466.5	542.8	2482.8	370.0	50.5	436.6	831.3	169.5	459.4	1079.7	276.5	3979.7	117.1	508.9	407.4	212.7	800.6	417.3	195.8	974.5	342.8	423.2	7.6	529.1	363.8	1323.3	456.0	224.5	1674.9	551.6	504.2	778.8	1200.3	221.7	1310.1	85.7	145.9	10.7	575.9	247.2	579.5	19.7	13.6	10.9	58.8	78.2	28.1	115.0	92.4	62.1	31.5	105.5	102.1	88.2	5.8	79.7	112.8	56.5	64.5	46.7	810.6	835.1	821.6	1798.8	776.6	944.5	894.1	838.7	870.8	808.2	840.0	869.5	708.2	272.4	186.4	78.4	145.4	1849.8	16589.4	3603.0	1728.4	243.4	312.5	174.4	822.3	264.5	1899.4	1144.0	323.2	161.7	62.0	824.2	1500.7	2021.4	11.9	1181.8	1060.9	1038.7	422.0	136.1	4.3	6539.7	399.4	998.5	219.2	1227.1	216.7	136.3	725.7	234.7	1199.8	70.7	2.2	433.0	1245.1	147.7	2828.9	30.8	299.5	1024.8	2056.2	35.6	188.0	171.4	50.4	8.0	2.7	2719.4	1417.1	534.5	296.9	3854.8	95.3	2324.4	1253.9	29.2	611.4	551.2	2129.1	20.3	105.5	6300.1	2241.7	2432.7	758.2	68.2	390.5	13091.2
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486584-197516737	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 790.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1737.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		18000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	179.4	790.6	188.6	128.3	191.6	110.6	168.8	204.9	401.9	96.9	217.8	170.0	158.1	90.8	89.3	124.5	132.6	69.1	145.0	184.3	198.6	374.9	462.6	136.6	149.2	199.6	198.5	167.6	219.0	159.2	116.0	148.6	205.3	104.5	195.1	71.8	93.9	93.6	162.7	83.3	148.7	104.5	195.1	94.6	155.4	57.6	198.6	99.3	138.7	176.7	172.7	144.6	92.3	201.4	559.7	650.1	541.3	496.9	373.6	389.2	786.5	573.2	304.7	686.1	495.6	2219.1	326.2	1724.4	730.0	304.1	834.2	538.4	2232.9	633.2	943.0	417.0	888.2	1209.8	984.8	2562.8	353.2	1331.4	349.1	445.5	717.1	599.5	1053.2	471.4	542.6	919.1	1535.3	606.8	501.7	690.4	853.6	1304.2	1086.4	735.2	1424.9	1000.1	679.7	1235.5	709.5	539.7	716.5	400.8	582.0	608.5	771.0	1116.3	425.0	789.4	242.2	405.8	570.4	532.8	910.0	331.1	861.4	1399.5	485.7	795.3	456.7	12.1	52.3	11.4	36.4	81.8	71.7	63.8	59.6	54.3	84.6	54.0	81.0	70.3	11.0	62.6	72.1	49.4	51.8	70.6	188.6	191.6	204.9	401.9	184.3	198.6	199.6	198.5	205.3	195.1	198.6	201.4	216.4	166.7	172.5	38.8	220.4	246.6	1737.2	247.5	264.0	75.8	216.0	263.1	239.2	195.9	287.9	79.1	256.5	825.7	197.7	213.7	375.6	235.0	6.2	322.2	304.5	233.9	274.6	241.6	31.9	145.9	419.8	356.0	215.6	445.2	299.5	407.1	63.1	312.5	328.0	95.9	47.2	302.2	166.8	88.6	479.3	12.8	130.5	381.9	163.7	30.0	138.5	125.7	68.0	20.6	35.6	171.4	163.2	113.6	322.9	705.9	160.1	797.1	328.6	117.1	85.5	199.0	471.7	88.5	106.0	262.4	207.1	1001.2	467.2	1017.4	512.1	861.5
HSPE1	"CPN10, EPF, GroES, HSP10"	ENSG00000115541	"Heat shock protein family E (Hsp10) member 1"	P61604	2	197500140-197503449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1077.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1907.6;Proximal tubular cells: 1978.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 4135.5"	"Low region specificity"	"Detected in all"							"CAB017366, HPA038755, HPA048272"	Supported					NA	Yes		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB017366: AB_10998950, HPA038755: AB_2676190, HPA048272: AB_2680336"	"unprognostic (2.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.83e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.08e-3)"	152.1	709.5	383.2	143.9	387.5	116.8	212.7	410.3	1077.6	122.3	402.1	257.2	164.9	84.3	213.0	132.9	131.4	97.4	208.0	383.7	400.8	410.7	662.7	111.0	154.5	400.9	394.7	130.1	112.6	173.0	125.5	164.0	399.9	137.9	246.3	85.8	121.9	114.8	181.4	80.5	168.2	116.8	403.6	86.5	130.5	58.7	391.2	144.8	104.5	213.1	207.9	216.6	85.5	440.8	593.1	926.1	675.1	521.5	560.5	314.0	905.5	586.2	307.9	620.8	577.3	2796.6	504.6	1079.2	782.2	333.8	1542.1	510.4	1895.0	681.2	782.0	512.3	874.7	1099.8	1789.0	4135.5	239.0	1503.6	497.2	382.4	532.1	577.8	297.6	392.7	631.0	720.9	1588.2	338.0	481.1	1027.2	1107.2	1706.9	1077.5	985.2	1513.4	747.6	568.2	1388.5	967.4	1028.3	581.5	375.1	546.4	713.9	545.5	1588.2	287.1	881.7	355.7	466.1	643.3	501.0	1019.4	427.8	1016.0	1758.3	515.6	726.7	640.6	33.2	95.5	24.4	166.3	174.5	216.3	287.1	223.6	210.1	156.6	221.8	251.7	264.1	12.6	200.3	143.1	263.4	198.7	176.0	383.2	387.5	410.3	1077.6	383.7	400.8	400.9	394.7	399.9	403.6	391.2	440.8	341.6	195.5	160.2	0.0	380.6	435.1	1907.6	690.4	301.7	90.7	393.6	511.2	355.6	381.8	363.3	195.0	250.2	839.3	334.4	553.8	911.7	354.0	22.3	520.7	291.3	296.3	440.3	233.1	0.0	231.2	634.0	370.0	274.2	493.3	324.6	215.7	94.6	1092.0	517.2	63.9	0.0	605.0	427.2	150.6	616.4	36.1	216.6	534.4	409.1	0.0	214.2	204.2	133.9	0.0	0.0	285.3	466.2	141.8	323.4	830.7	562.1	1978.2	475.8	160.2	131.5	283.6	642.5	140.0	241.9	381.2	371.8	976.7	685.9	791.7	775.5	1111.7
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937528-87016679	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;ovary: 4.2"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 125.4;Inhibitory neurons: 104.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"PC-3: 1.7;SH-SY5Y: 6.6"					"Low region specificity"	"Detected in many"			HPA004931	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.0	0.0	1.7	0.0	3.0	0.0	0.0	0.0	4.2	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.2	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.0	0.0	4.2	2.6	1.3	0.2	0.3	0.1	0.0	1.2	2.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	1.1	0.0	0.0	0.0	125.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	104.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529725-74533332	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA		260000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	11.4	8.6	8.1	8.1	8.7	11.1	6.8	9.1	9.7	7.1	7.7	6.4	6.9	6.9	1.0	6.0	7.1	4.7	9.4	8.1	8.3	8.1	6.5	6.6	7.8	8.6	8.5	10.9	7.4	9.4	4.7	6.3	8.3	4.8	3.3	2.5	8.5	5.3	14.5	5.4	7.9	5.3	8.2	9.9	6.4	6.2	9.6	9.1	6.8	9.0	4.8	6.5	5.8	9.2	19.1	14.7	14.7	12.6	21.3	9.0	30.1	17.0	10.3	10.3	7.0	21.1	8.5	16.6	12.9	10.7	26.0	19.7	12.0	19.6	2.4	34.0	31.4	33.3	10.8	19.0	19.8	15.3	22.4	9.9	13.7	18.4	19.5	18.4	14.2	23.5	43.9	24.9	9.7	14.1	22.0	31.1	10.0	22.8	37.7	15.8	37.0	17.1	9.6	8.2	15.1	17.7	8.9	18.6	32.5	7.3	9.3	13.2	10.6	19.2	19.7	33.4	35.3	29.5	10.2	9.8	13.6	23.4	13.0	5.8	7.0	4.0	4.8	5.7	5.8	11.0	4.8	4.1	8.6	9.9	4.3	4.1	2.6	5.0	4.5	4.5	5.7	5.5	8.1	8.7	9.1	9.7	8.1	8.3	8.6	8.5	8.3	8.2	9.6	9.2	30.7	0.0	4.8	6.2	27.3	20.6	19.7	33.8	13.6	12.0	17.4	21.7	0.9	21.5	15.7	11.0	0.0	24.7	25.8	12.5	35.2	32.4	30.8	11.9	18.1	29.6	9.0	118.5	6.3	17.7	37.8	23.3	11.2	12.9	27.3	20.9	22.9	12.7	31.5	10.1	6.3	12.3	20.3	10.7	19.4	48.9	24.8	14.6	30.2	2.8	26.3	20.2	30.9	5.5	7.5	26.1	16.8	20.7	36.0	21.3	24.8	36.8	13.5	16.3	26.3	18.7	56.5	64.3	43.3	16.7	22.0	20.2	20.6	27.1	20.0	15.7
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3041363-3243960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favorable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	8.3	9.3	10.5	8.2	11.7	8.1	7.6	7.8	14.2	6.1	8.2	8.1	6.0	7.1	8.3	10.4	6.7	5.1	7.1	15.7	3.5	7.9	8.9	10.1	11.5	8.7	5.2	7.2	21.3	12.3	9.0	6.9	7.8	7.0	6.5	10.3	7.2	5.8	15.3	15.1	9.7	5.8	3.0	11.5	8.9	10.1	6.8	11.3	9.1	12.4	8.8	7.3	7.0	11.0	19.5	14.2	17.6	10.3	30.9	20.2	17.7	9.0	10.4	13.0	12.6	17.3	12.2	28.6	8.9	20.9	21.6	10.7	20.6	15.3	12.0	7.8	15.4	27.4	18.0	18.8	7.5	17.7	37.9	11.1	9.5	25.4	10.7	9.3	14.3	13.0	17.7	9.9	11.4	17.9	22.4	17.1	21.2	9.7	20.7	17.7	16.9	5.7	14.2	18.1	18.5	13.9	15.0	5.7	14.6	12.9	16.1	10.8	20.6	16.8	11.1	12.4	19.0	7.6	8.8	22.9	13.4	16.4	13.3	0.0	0.7	0.9	1.0	1.1	0.7	0.8	0.8	1.3	1.1	0.6	0.4	0.7	0.1	0.9	1.5	0.7	1.2	0.7	10.5	11.7	7.8	14.2	15.7	3.5	8.7	5.2	7.8	3.0	6.8	11.0	15.8	25.6	14.8	41.1	20.7	13.8	8.0	12.4	9.1	48.1	20.4	15.4	10.4	17.2	14.6	14.7	181.4	11.8	26.1	22.4	5.9	12.0	9.4	23.1	20.8	17.2	18.5	18.5	88.8	17.5	11.7	13.9	20.9	25.3	11.4	54.9	22.1	17.1	26.7	45.4	75.1	13.3	4.1	23.4	15.4	10.3	16.1	25.4	8.8	40.3	18.2	20.8	24.7	59.8	52.4	20.0	21.2	11.7	15.3	15.7	20.9	12.2	12.0	50.7	13.1	19.2	13.6	13.0	21.3	21.9	20.0	8.3	19.5	16.8	20.9	11.6
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044188-119057227	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 201.9"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 118.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 35.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 418.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"	NA	NA		130000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049296: AB_2680702"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favorable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.38e-2)"	38.2	48.5	30.7	27.1	32.2	18.6	31.0	28.3	34.1	37.2	25.5	40.9	18.1	44.6	51.2	47.4	40.8	14.0	56.5	32.9	41.0	63.0	201.9	47.7	17.4	32.6	34.5	36.1	165.9	18.8	100.1	19.9	34.2	47.9	21.3	11.9	46.3	20.7	19.1	25.0	39.0	19.0	28.5	47.6	60.3	85.7	35.2	21.7	87.2	8.4	20.9	39.9	31.7	32.9	40.5	34.5	77.2	224.4	41.2	19.7	107.7	56.1	38.0	63.1	47.2	105.0	103.0	85.3	418.9	40.7	122.1	59.5	71.5	69.3	53.8	92.8	26.1	151.8	32.6	76.7	187.7	88.6	73.5	23.9	91.1	55.2	185.3	57.9	100.2	57.2	53.5	136.8	33.9	97.8	59.4	49.6	55.5	83.2	33.6	63.1	55.9	144.3	48.6	67.8	45.7	70.0	80.4	103.8	53.3	65.5	78.8	82.9	75.0	59.9	46.4	27.2	77.5	88.1	64.0	61.2	53.8	76.2	135.6	4.4	4.5	2.2	11.7	6.1	12.6	5.4	6.4	8.7	5.0	4.0	4.0	6.1	1.3	7.6	4.4	35.9	5.5	4.7	30.7	32.2	28.3	34.1	32.9	41.0	32.6	34.5	34.2	28.5	35.2	32.9	16.4	9.6	14.1	6.2	22.7	17.8	18.5	17.5	14.2	11.5	28.5	21.1	12.4	15.7	16.8	25.8	43.8	11.2	36.6	35.3	9.8	20.7	74.0	20.4	29.1	20.0	35.8	17.0	12.0	18.8	26.6	21.0	39.8	38.1	15.8	43.1	13.9	49.9	22.2	25.2	13.7	52.1	18.3	8.2	21.6	38.8	13.1	17.8	23.2	5.6	15.5	8.7	17.5	4.5	9.3	31.4	24.2	13.5	118.7	44.4	14.9	17.6	16.7	14.5	13.1	16.4	15.6	27.8	29.1	16.2	19.9	19.3	20.8	14.8	27.3	24.7
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289952-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 40.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	239	"amygdala: 13.6;basal ganglia: 15.4;cerebral cortex: 26.2;hippocampal formation: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	14	"amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4"	"HPA008943, HPA009083, CAB025178"	Enhanced					NA	NA		3300000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.3	0.0	13.6	0.0	15.4	0.6	0.2	0.0	26.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.2	40.2	0.0	1.0	0.0	6.2	0.2	0.0	0.0	2.1	0.0	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	3.5	0.0	0.0	7.4	0.0	0.0	0.3	5.0	0.8	0.2	0.5	0.0	0.1	5.6	2.3	0.0	0.0	6.5	0.2	0.0	0.0	0.2	1.0	16.3	6.1	0.5	0.1	0.0	3.1	0.0	0.6	0.1	0.0	0.0	0.0	2.0	13.2	0.1	0.0	0.8	0.0	2.3	0.0	0.3	4.9	0.1	0.0	14.7	0.2	0.0	0.9	0.1	2.3	0.2	0.5	0.0	2.7	0.0	0.0	1.5	0.0	0.9	0.0	17.5	3.1	3.5	9.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	15.4	0.0	26.2	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.4	2.8	1.6	0.4	0.3	0.2	0.3	1.8	0.7	1.6	5.2	33.9	0.0	1.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.5	0.6	0.5	2.8	0.0	8.2	17.7	0.0	0.1	1.1	1.1	1.3	2.5	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.3	1.7	0.0	0.0	2.1	0.0	2.8	0.3	0.0	0.0	1.5	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.4	0.5	0.0	0.0	0.7	1.7	1.7	1.3	0.4	0.1	0.1	0.7	0.1	0.2	0.2
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 112.8"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	22.6	23.0	12.4	13.6	18.1	4.0	15.8	18.2	13.1	20.3	17.7	20.9	19.6	20.1	20.9	21.6	16.2	13.1	27.1	12.5	12.9	25.9	13.6	14.9	10.2	12.6	14.9	9.1	17.4	26.8	22.0	21.0	12.7	17.3	17.4	28.7	17.1	18.9	53.0	19.2	18.3	21.9	12.3	9.1	15.7	5.2	14.5	14.9	18.1	82.6	11.0	17.4	16.0	12.0	35.8	32.6	43.7	43.0	131.2	51.8	18.7	84.9	56.1	48.7	36.9	35.0	28.2	39.0	31.7	66.7	42.0	47.4	50.5	35.6	51.5	78.8	51.3	26.8	46.0	26.8	25.5	42.5	36.4	33.3	23.5	51.2	19.2	32.4	38.5	31.6	26.5	29.8	55.7	22.3	43.2	29.6	29.7	64.1	46.0	35.8	61.5	22.6	59.3	25.8	59.2	28.8	41.3	96.3	37.2	48.4	25.2	35.4	48.1	55.3	21.7	65.4	61.6	27.7	57.8	30.5	27.1	96.5	29.3	2.6	1.9	1.6	3.1	2.2	2.7	1.1	2.5	3.1	1.7	1.8	2.1	1.8	0.6	1.8	1.9	2.7	1.4	1.9	12.4	18.1	18.2	13.1	12.5	12.9	12.6	14.9	12.7	12.3	14.5	12.0	18.0	22.4	12.1	5.9	7.7	6.2	9.6	12.2	7.4	18.0	16.3	9.8	39.3	15.7	19.6	29.5	31.3	57.6	12.3	40.7	13.7	21.9	3.5	19.5	18.8	18.1	22.8	14.9	10.2	22.2	85.7	19.6	12.8	16.9	5.1	13.9	21.8	23.9	29.1	48.8	9.4	21.4	12.2	12.0	7.0	5.1	20.8	9.8	7.2	7.5	12.1	18.9	10.3	2.0	5.4	26.8	12.2	26.4	18.3	14.1	45.5	36.9	41.7	58.8	13.1	9.9	22.1	15.4	26.8	28.2	10.4	32.0	10.4	13.9	23.1	14.7
ICOSLG	"B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;brain: 33.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 28.5;Glandular and luminal cells: 22.7;Langerhans cells: 39.0;monocytes: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"									"CAB026037, HPA029179, CAB079997"	Approved		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA		130000000	"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , CAB079997: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	3.1	3.6	12.1	4.9	21.8	18.2	2.6	10.7	17.9	3.9	0.2	2.1	2.5	1.9	1.4	5.4	3.4	4.1	5.2	11.7	12.4	8.3	3.3	3.1	8.0	18.7	17.9	0.8	2.1	0.7	1.4	3.1	17.1	3.3	1.8	1.4	3.0	1.4	1.5	6.6	3.8	1.3	11.0	4.3	4.9	1.4	18.2	2.6	2.3	1.8	5.5	3.2	3.5	33.3	0.5	4.6	0.2	3.9	1.0	1.5	10.4	1.0	0.9	0.5	0.3	7.9	0.6	19.9	2.9	0.5	1.8	5.8	2.7	1.6	0.3	2.0	2.0	0.6	4.0	2.3	0.9	8.7	14.1	1.4	2.6	1.2	1.3	0.3	1.1	0.7	3.3	1.7	0.3	5.2	0.4	11.4	2.7	13.2	4.8	17.1	1.3	11.6	0.8	10.3	2.0	0.1	12.9	18.2	0.4	1.4	5.1	12.2	1.1	0.6	4.4	0.4	0.4	16.4	12.2	16.2	5.8	8.0	2.5	0.3	0.3	0.2	0.1	0.3	0.1	1.8	0.3	0.1	0.2	2.4	0.3	0.4	0.3	0.2	0.2	0.7	0.1	0.2	12.1	21.8	10.7	17.9	11.7	12.4	18.7	17.9	17.1	11.0	18.2	33.3	1.2	0.0	1.5	0.3	28.5	7.5	5.8	8.4	3.4	1.7	8.7	5.8	0.6	1.5	2.4	9.2	0.0	0.4	2.0	7.9	0.0	2.0	1.9	9.8	2.1	4.6	5.3	0.8	0.0	0.7	1.1	5.6	4.6	22.7	0.0	0.2	1.4	2.8	3.7	0.0	0.0	4.5	8.2	8.8	39.0	4.0	3.1	15.6	8.8	0.0	21.0	1.2	2.1	0.0	0.5	0.8	3.8	10.9	4.7	16.0	3.6	3.5	0.6	1.2	0.0	4.5	6.1	0.1	0.2	4.7	6.5	0.5	2.9	0.3	4.5	7.9
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	NA	NA		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	6.7	10.1	3.4	2.8	3.6	3.5	6.1	3.7	4.2	8.1	5.9	8.6	3.3	7.4	9.7	9.8	6.5	2.9	11.7	3.4	3.7	5.9	11.4	5.9	3.4	3.8	3.7	5.4	12.3	9.5	4.7	2.7	3.9	9.1	3.8	10.3	7.8	4.2	28.8	36.4	6.8	3.7	3.6	6.3	8.2	25.8	3.6	2.4	6.7	9.7	4.1	8.9	7.9	3.8	12.1	22.9	6.2	15.1	10.5	5.8	8.5	10.4	13.3	6.1	5.2	19.4	9.5	12.5	16.4	14.3	7.2	16.3	14.6	10.0	3.9	14.7	8.8	5.1	13.7	25.9	11.5	14.9	6.5	5.4	6.6	9.1	14.0	7.8	8.6	3.3	10.0	8.1	5.4	18.0	6.6	8.8	10.2	10.4	5.2	10.2	10.8	9.0	10.9	19.3	2.2	5.6	14.3	6.4	6.7	6.8	12.6	6.3	15.3	4.4	8.2	5.0	10.4	11.2	12.2	14.5	6.9	10.9	4.4	0.3	3.5	1.4	2.0	4.2	2.2	2.9	2.6	2.9	4.6	2.1	1.9	2.0	0.0	3.7	5.9	1.3	3.9	2.3	3.4	3.6	3.7	4.2	3.4	3.7	3.8	3.7	3.9	3.6	3.6	3.8	12.9	9.6	14.1	20.9	11.1	5.2	6.1	10.5	5.2	15.0	8.7	4.3	45.7	7.2	10.6	7.3	47.9	11.2	10.0	14.0	1.9	14.0	46.4	14.9	19.3	10.8	10.8	19.6	43.3	20.2	5.7	9.1	22.4	16.5	1.3	9.9	11.7	24.1	11.9	6.7	42.6	12.7	18.3	16.6	5.4	12.0	6.5	12.5	8.8	23.4	7.8	7.8	4.1	20.6	24.0	16.5	5.7	10.1	24.2	12.2	9.0	10.7	23.3	26.9	6.6	7.6	13.2	51.5	11.0	19.6	16.3	3.8	8.5	9.8	9.8	9.6
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA		8300	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	55.6	61.3	51.8	33.4	53.0	57.9	54.7	60.8	57.9	56.6	49.4	70.8	73.9	57.3	35.9	62.4	49.8	29.6	185.8	53.8	56.3	71.0	60.5	43.9	41.9	58.0	54.0	57.7	46.0	75.3	36.8	41.1	60.0	45.7	59.7	46.1	49.1	43.1	204.0	61.9	59.9	44.7	50.6	53.1	63.7	36.6	56.6	59.5	49.4	236.6	56.5	55.5	53.4	56.0	111.6	147.4	66.0	57.9	71.3	55.9	76.0	58.2	74.0	134.5	106.7	191.4	113.4	124.5	52.2	80.4	123.7	152.7	122.9	189.0	122.6	34.7	96.7	151.2	58.4	200.6	69.7	166.5	31.8	74.4	71.5	125.9	65.7	59.2	80.4	105.6	194.9	67.7	83.0	61.1	146.1	190.4	128.3	113.4	137.9	117.7	120.2	140.2	77.7	102.5	118.5	85.5	71.9	235.0	127.3	50.8	118.1	73.0	72.4	104.2	65.4	35.8	136.3	91.2	225.3	129.8	49.1	169.9	101.2	76.0	111.7	72.2	84.9	120.8	64.5	96.3	72.8	77.7	131.9	84.6	84.6	73.1	31.4	84.8	110.9	61.2	108.1	102.1	51.8	53.0	60.8	57.9	53.8	56.3	58.0	54.0	60.0	50.6	56.6	56.0	50.7	38.5	28.2	10.4	52.1	56.7	60.2	103.8	48.9	37.9	38.5	38.2	186.0	52.9	49.5	23.9	33.3	133.9	71.3	81.7	156.5	88.5	59.3	28.2	36.0	53.7	50.7	41.6	7.0	102.1	86.3	49.2	37.2	35.9	48.2	54.1	41.7	55.4	97.6	13.5	7.6	68.4	71.2	57.7	60.9	115.1	45.1	51.7	69.4	10.3	78.7	49.3	56.7	6.6	8.9	70.8	72.5	47.4	38.1	37.5	121.7	174.9	33.4	33.4	78.9	50.0	64.1	52.8	55.3	48.4	60.0	108.5	49.1	63.4	113.7	54.3
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria		Yes	No		19000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	52.0	67.1	45.5	38.5	50.0	60.3	49.9	47.8	61.3	44.1	46.5	57.2	52.3	50.7	23.5	50.2	44.8	35.0	91.9	54.9	48.8	68.5	49.2	42.0	40.3	50.5	45.7	49.3	48.3	45.5	47.9	28.3	52.3	43.8	34.6	24.4	51.7	39.9	100.5	51.7	54.7	34.5	43.9	51.8	52.2	32.1	49.1	35.2	48.0	82.9	34.9	44.3	43.2	47.2	94.9	90.0	47.3	65.9	74.4	59.4	62.0	47.3	64.1	80.5	84.3	76.0	66.5	121.4	80.2	74.7	68.2	67.2	72.6	69.2	30.0	38.9	101.7	43.0	118.9	59.0	85.5	61.6	87.5	76.1	48.0	64.4	69.4	50.4	65.3	50.3	24.7	60.4	64.7	138.5	72.0	76.0	21.6	84.2	118.0	62.7	43.3	105.8	94.4	61.1	59.5	42.8	30.2	96.3	48.0	20.8	39.6	51.9	56.0	49.9	34.1	76.8	112.5	89.0	22.6	152.1	81.8	75.8	57.6	178.1	159.3	165.8	71.8	163.9	68.0	68.5	73.2	71.2	163.1	78.9	57.9	63.7	57.8	86.5	169.6	101.3	107.5	140.1	45.5	50.0	47.8	61.3	54.9	48.8	50.5	45.7	52.3	43.9	49.1	47.2	44.4	35.3	33.8	5.5	49.2	80.9	67.5	103.9	37.5	34.9	48.4	57.9	55.1	50.1	55.0	51.5	29.2	99.8	48.2	145.0	207.4	93.4	132.0	42.2	39.4	44.6	62.3	41.4	5.6	90.5	98.7	48.2	47.9	39.8	93.8	43.6	43.2	35.4	131.0	18.5	6.4	107.0	79.3	98.0	77.0	284.2	53.4	75.6	67.6	3.7	116.4	50.8	64.9	3.0	5.0	73.5	133.8	58.6	49.7	35.6	222.4	253.1	50.7	49.3	52.6	47.4	68.2	15.9	18.3	50.3	77.4	110.8	55.2	103.0	112.7	64.2
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI27	"FAM14D, ISG12, P27"	ENSG00000165949	"Interferon alpha inducible protein 27"	P40305	14	94104836-94116698	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 3792.9;Distal enterocytes: 2150.5;Endothelial cells: 1972.1;Exocrine glandular cells: 1603.8;Intestinal goblet cells: 1638.8;Pancreatic endocrine cells: 1678.1;Paneth cells: 2179.2;Proximal enterocytes: 3048.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.0"	"Group enriched"	"Detected in many"	6	"monocytes: 7.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 2026.8;BJ hTERT+ SV40 Large T+ RasG12V: 1782.5;EFO-21: 547.7;Karpas-707: 501.5;SK-MEL-30: 607.2"									HPA028875	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA028875: AB_10601434"	"unprognostic (1.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.78e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.65e-1)"	470.3	323.3	178.3	115.7	177.4	162.8	410.3	180.9	232.6	351.4	162.7	374.4	129.2	137.8	39.9	310.4	163.2	344.1	471.5	174.5	182.4	217.9	150.4	608.2	48.3	203.8	187.7	75.6	39.3	30.3	65.3	183.8	215.0	85.0	221.4	6.1	156.9	47.0	113.1	129.8	256.2	117.4	194.9	797.8	697.0	140.2	194.1	202.8	149.8	152.4	54.2	116.9	213.7	190.8	181.3	0.4	1.3	0.4	0.5	21.7	1.7	2.8	8.8	2026.8	1782.5	3.8	146.8	1.5	547.7	115.3	33.8	5.7	1.1	0.2	79.7	2.1	3.7	1.0	1.4	0.9	13.7	0.6	1.1	2.0	2.0	353.8	0.1	1.1	284.0	1.3	1.1	501.5	0.1	0.5	1.7	1.1	0.5	0.5	24.7	1.8	0.5	0.6	1.2	0.6	0.4	1.1	0.0	0.1	607.2	1.4	0.9	3.0	0.3	0.2	2.7	325.8	1.0	9.4	14.6	3.9	0.9	0.5	1.4	0.0	1.3	0.5	0.3	7.0	0.3	0.0	2.6	0.7	0.8	0.1	0.0	0.4	0.0	0.4	2.1	0.1	2.5	2.1	178.3	177.4	180.9	232.6	174.5	182.4	203.8	187.7	215.0	194.9	194.1	190.8	3792.9	391.0	82.7	1.3	26.8	171.2	6.5	126.9	91.6	4.9	23.4	38.2	45.9	151.5	237.4	12.9	8.4	7.3	14.9	2150.5	1.9	50.6	13.6	1035.5	188.3	1972.1	267.8	42.3	0.6	1603.8	221.2	330.8	892.5	838.5	45.1	1174.4	742.5	5.8	158.3	5.0	0.4	1638.8	107.8	106.9	163.5	36.7	172.1	59.6	350.4	84.3	26.1	8.3	0.0	0.0	0.7	1678.1	2179.2	417.5	6.3	11.1	3048.1	23.7	548.1	20.5	276.1	45.2	295.8	20.3	12.1	151.9	140.4	5.2	34.1	302.4	523.4	80.4
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327307-89377473	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 89.5;Ductal cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 488.1"	"Group enriched"	"Detected in all"	19	"granulocytes: 488.1;monocytes: 125.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 198.8;BJ hTERT+ SV40 Large T+: 468.4;BJ hTERT+ SV40 Large T+ RasG12V: 540.2"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	21.3	20.1	10.5	20.4	22.7	42.9	14.3	15.9	14.8	11.5	1.5	11.2	25.4	12.9	11.7	6.8	17.7	24.6	15.5	11.8	15.9	19.3	28.6	44.2	9.0	24.7	17.0	18.1	7.4	5.4	6.1	31.1	25.0	6.0	9.0	3.8	34.6	12.5	7.1	6.4	18.7	18.1	37.2	47.6	12.6	6.8	15.7	33.1	7.4	14.8	5.3	13.5	7.8	35.0	38.7	2.7	0.9	10.3	41.7	43.9	0.5	25.4	198.8	468.4	540.2	2.0	54.3	3.3	11.2	39.0	112.0	33.6	0.6	4.9	34.0	5.6	0.7	15.9	10.1	1.2	23.8	4.5	13.8	27.8	0.6	40.6	3.4	17.9	2.8	1.5	1.1	8.3	12.7	0.3	10.7	11.7	0.7	0.1	12.1	10.2	3.3	2.4	13.3	19.1	0.4	0.2	5.9	0.7	96.8	1.4	1.4	5.7	4.0	8.2	1.9	14.7	7.4	13.8	11.3	0.9	12.0	19.9	7.9	105.7	45.8	172.5	4.6	101.9	1.0	9.7	6.6	3.0	15.6	10.9	3.7	4.5	488.1	2.1	125.0	3.5	16.3	19.4	10.5	22.7	15.9	14.8	11.8	15.9	24.7	17.0	25.0	37.2	15.7	35.0	89.5	51.3	10.1	5.9	8.0	3.2	6.7	13.0	4.0	10.7	3.1	5.5	32.5	10.0	12.5	9.2	4.2	5.2	8.3	6.8	21.5	70.6	0.9	26.0	16.6	66.4	0.0	10.3	9.1	36.3	12.8	20.1	4.6	39.3	13.9	19.8	20.0	13.6	34.6	60.6	8.4	4.0	4.1	21.7	4.4	0.5	30.4	26.8	3.6	17.8	22.0	20.8	8.2	6.0	50.2	23.3	9.4	28.2	2.5	10.0	34.6	14.5	12.3	2.1	46.0	16.0	22.2	1.2	1.6	2.9	1.8	1.9	6.3	14.4	3.7	6.2
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440439-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;hTERT-RPE1: 2.2"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"Cluster 20: HeLa - Mitochondria"				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.1	0.1	0.4	0.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Cell type enriched"	"Detected in single"	17	"Granulosa cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 40: Granulosa cells - Unknown function"			"HPA047557: AB_2680087"																		0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.2	1.0	0.6	0.5	0.6	0.7	0.5	0.1	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324429-33359864	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	40.8	22.3	14.3	36.4	14.6	30.8	32.3	15.7	15.2	26.3	9.6	28.9	26.7	22.4	23.2	25.2	23.8	30.2	21.2	15.0	16.2	32.0	76.6	29.7	28.8	17.4	15.6	23.5	29.2	40.5	7.7	49.5	16.9	27.2	30.5	23.6	30.2	24.1	32.7	20.5	27.4	24.0	15.7	33.5	31.6	20.9	17.5	33.1	41.2	24.8	29.7	39.8	9.0	18.6	47.3	24.4	27.4	24.2	55.8	80.8	23.7	44.6	74.2	32.9	36.1	31.7	57.2	42.4	35.4	49.4	36.3	28.4	23.3	37.0	43.8	33.8	26.0	62.8	29.0	20.2	33.9	50.8	43.3	58.2	38.4	43.6	37.7	39.4	63.1	40.3	67.6	198.2	56.5	22.8	38.7	22.2	24.9	46.6	25.6	29.5	75.0	62.4	33.7	44.0	22.5	24.1	50.5	42.4	39.3	20.8	58.2	36.8	61.3	39.3	24.7	58.2	28.2	102.3	132.7	43.2	66.3	64.4	50.5	77.3	45.4	27.7	23.6	64.0	23.1	56.2	31.5	28.6	37.4	57.0	37.0	29.0	166.7	28.0	80.3	54.3	41.2	35.2	14.3	14.6	15.7	15.2	15.0	16.2	17.4	15.6	16.9	15.7	17.5	18.6	101.2	109.0	45.8	17.6	69.3	45.8	57.0	72.3	18.8	51.9	42.5	29.7	33.5	34.3	78.8	44.1	29.2	28.1	43.8	25.3	21.5	73.0	17.7	37.9	58.4	75.5	26.9	27.1	26.3	90.5	92.4	61.1	35.7	44.5	39.2	30.3	53.9	81.3	69.2	58.9	29.4	28.9	46.8	82.1	47.5	10.7	32.6	77.6	37.4	30.9	86.8	34.3	42.2	34.2	27.2	64.7	25.5	30.9	137.3	63.9	37.6	28.7	59.6	30.0	19.7	54.9	44.9	38.5	17.5	21.5	44.9	20.1	38.3	25.1	27.5	72.2
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 283.2;T-cells: 200.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 7: Non-specific - Mitochondria"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	0.7	0.7	0.1	3.5	0.2	11.5	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.0	0.0	0.3	1.5	1.8	7.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.9	0.2	0.0	0.0	0.3	0.2	0.0	1.3	0.4	0.1	0.1	0.5	0.3	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.4	6.6	0.0	0.4	0.5	3.7	0.1	0.9	0.0	0.0	0.1	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.0	0.0	0.0	3.1	3.2	1.3	0.0	0.0	0.0	4.8	5.5	0.2	1.5	0.0	0.0	0.0	0.0	283.2	0.1	0.0	0.0	0.2	1.0	1.1	1.3	0.0	0.4	0.0	0.0	0.0	1.5	6.1	1.1	0.0	0.0	1.4	1.2	0.1	0.0	0.0	0.5	0.0	4.4	5.5	0.0	0.0	10.4	7.2	0.0	0.0	0.0	19.6	0.0	0.1	0.0	1.1	0.0	10.9	0.2	0.0	0.3	0.0	0.0	0.0	1.0	2.9	0.0	0.0	0.8	4.0	0.0	200.1	0.0	0.2	0.2
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IGF1	"IGF, IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 86.7;cervix: 89.0"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 1279.3;Leydig cells: 1103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.9;HDLM-2: 49.6;K-562: 22.4;Karpas-707: 11.3;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048946	Approved				"Secreted to blood"	NA	NA	103000000	330000000	"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA048946: AB_2680566"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	86.7	5.1	1.2	27.1	1.8	0.9	38.7	0.3	2.3	89.0	1.3	6.9	5.4	46.9	10.6	6.6	13.0	21.5	15.1	2.2	1.0	3.1	83.5	11.6	6.5	2.5	1.1	9.0	3.9	1.4	1.2	24.2	2.0	38.5	6.7	5.4	7.6	33.4	8.5	4.9	5.7	74.3	1.2	9.8	7.7	7.6	2.0	3.1	25.4	5.9	3.7	21.3	22.7	0.9	0.3	0.0	0.0	0.0	37.9	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	22.4	11.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.2	1.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.4	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.8	0.3	2.3	2.2	1.0	2.5	1.1	2.0	1.2	2.0	0.9	11.8	3.2	2.2	1.0	8.5	2.5	0.7	0.0	1.8	168.1	4.0	6.2	0.4	2.8	0.7	0.0	0.0	1.1	0.6	0.2	0.0	0.0	17.5	35.8	1279.3	38.9	0.0	5.3	1.2	0.6	1.5	259.7	2.6	34.5	0.0	0.3	6.4	243.0	122.0	0.0	123.9	0.0	16.2	25.8	12.5	58.0	1103.2	42.0	14.2	27.2	3.6	4.4	0.0	0.5	0.9	0.1	0.0	193.4	66.9	1.2	0.0	1.4	0.1	9.0	0.0	139.3	19.6	1.9	1.2	1.6	2.7	1.2	9.1	69.4	0.2	0.4
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648539-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 239.4;Inhibitory neurons: 194.6;Microglial cells: 245.4;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 261.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.3;T-cells: 1.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010268, HPA045563"	Approved					NA	NA		46000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"			"CAB010268: AB_671792, HPA045563: AB_2679368"	"unprognostic (1.30e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	7.3	11.3	10.1	3.6	11.2	11.0	12.2	12.0	12.0	10.1	35.5	12.5	2.5	11.0	11.1	7.5	13.0	4.5	9.6	9.5	8.2	11.6	0.9	9.5	2.7	12.4	13.4	15.8	15.4	2.1	8.8	12.1	11.2	14.7	4.5	16.0	10.0	9.6	7.0	11.1	6.5	6.1	10.3	5.8	9.6	8.4	13.2	6.1	12.9	11.6	3.4	9.9	10.0	11.1	6.1	34.0	22.6	0.2	11.9	8.3	16.3	8.0	14.5	2.5	2.2	15.6	17.5	1.6	22.1	13.8	14.7	31.6	10.9	25.0	1.9	0.1	11.1	27.5	32.3	31.2	10.4	11.1	2.5	12.1	14.9	4.5	18.6	9.3	8.4	2.8	1.4	5.4	9.9	48.1	5.4	9.8	23.0	11.8	1.3	7.7	19.3	6.7	7.4	37.8	8.1	35.9	56.0	3.3	30.1	50.2	16.7	3.8	24.5	1.5	26.5	6.5	12.0	1.9	9.8	5.9	4.6	10.0	5.9	1.9	0.3	0.9	0.4	0.2	0.2	0.1	0.3	0.1	0.1	0.4	1.4	0.4	4.3	0.5	0.3	0.1	0.0	0.3	10.1	11.2	12.0	12.0	9.5	8.2	12.4	13.4	11.2	10.3	13.2	11.1	30.8	28.9	13.4	157.7	3.5	32.8	28.8	31.1	35.3	51.5	58.3	33.4	30.8	5.7	30.2	22.0	91.8	33.7	8.0	10.7	1.9	16.6	27.6	79.7	39.6	26.1	35.0	7.8	239.4	11.2	20.3	25.2	11.2	91.3	0.0	106.5	52.5	1.5	6.5	75.7	194.6	21.1	20.3	6.6	8.3	53.4	18.0	8.3	21.4	245.4	8.5	45.6	14.4	237.7	261.0	29.1	12.9	13.5	4.3	70.9	5.3	21.8	55.4	36.1	0.0	20.4	27.6	4.0	17.2	17.9	32.0	27.5	6.4	20.9	24.5	51.5
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2141238	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 2749.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 86.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1200000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	99.7	58.4	5.5	9.2	32.6	0.9	41.8	12.6	86.0	75.5	236.8	22.3	4.7	75.2	52.7	18.8	128.4	34.8	91.7	6.5	7.1	31.8	305.9	9.8	3.4	20.2	6.6	117.8	37.5	5.2	25.4	2749.2	10.1	14.5	4.8	0.5	11.6	15.2	82.1	8.4	10.9	14.7	13.0	14.4	11.9	23.7	10.9	3.4	12.4	114.0	4.7	24.2	23.6	9.0	0.0	2.8	0.3	0.6	0.2	0.3	1.8	112.8	1.3	3.6	0.4	862.0	0.4	0.1	8.4	0.0	2.1	0.1	0.9	7.0	7.9	0.1	0.5	0.2	0.2	600.5	143.4	0.7	0.0	174.7	0.5	0.7	0.2	0.1	1.4	0.0	0.3	0.0	333.7	2.2	0.1	0.8	1.2	0.2	1.5	0.1	408.5	0.9	0.0	0.9	32.7	495.6	0.7	0.1	0.0	83.0	4.2	0.0	0.4	0.2	20.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	32.6	12.6	86.0	6.5	7.1	20.2	6.6	10.1	13.0	10.9	9.0	40.6	3.2	3.1	0.0	2.6	5.4	0.5	0.5	0.6	0.4	0.0	0.0	6.5	8.6	0.9	3.7	0.0	1104.3	0.0	0.0	0.0	0.0	13.1	0.0	0.0	498.4	0.0	16.0	0.0	0.0	3196.3	334.2	0.0	0.0	0.0	0.0	171.4	494.9	218.2	0.0	0.0	0.0	0.0	11.6	5.5	91.1	3007.5	3.4	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	643.9	0.0	1.1	0.0	0.0	0.9	0.5	65.7	33.5	37.5	3.8	6.3	1.5	4.1	1612.9	1.8	0.0	0.0	0.4
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643130-185825042	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 263.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	8.0	9.0	0.9	4.1	1.1	11.9	5.3	6.4	2.0	7.2	1.3	12.6	15.0	5.0	0.7	3.3	11.2	7.5	9.0	1.0	2.1	8.2	1.6	11.7	1.3	2.2	2.1	6.6	4.9	6.4	1.4	15.1	1.3	1.9	14.9	22.3	9.3	1.1	2.0	4.4	16.0	4.6	1.5	4.4	13.2	6.1	1.9	2.2	7.3	3.4	1.8	3.8	5.5	1.2	129.4	11.0	124.2	22.5	64.8	102.5	73.2	68.5	94.2	102.2	121.6	94.1	36.2	0.0	98.2	56.9	130.1	57.7	58.4	97.3	163.9	0.2	58.2	37.7	0.6	64.1	140.2	1.2	0.2	75.0	50.4	67.6	263.9	53.2	95.3	10.1	37.6	0.1	75.2	1.1	0.3	27.8	87.3	22.1	45.7	13.5	48.1	38.8	63.7	0.4	7.7	1.2	5.0	0.2	113.5	120.5	10.1	82.1	144.8	34.8	74.8	44.6	78.2	0.4	0.2	0.3	34.7	0.1	50.3	0.4	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.7	1.7	0.4	0.0	0.6	0.9	1.1	6.4	2.0	1.0	2.1	2.2	2.1	1.3	1.5	1.9	1.2	6.2	12.8	11.6	2.3	0.6	19.8	20.1	48.1	1.2	5.2	18.4	6.2	15.7	44.3	49.2	25.8	16.7	2.8	0.9	82.0	3.9	38.9	126.6	86.4	13.8	18.9	35.6	46.9	0.7	25.4	18.0	25.3	20.9	117.7	2.5	64.5	39.7	0.5	16.4	1.7	1.1	44.7	46.8	8.8	16.9	81.7	5.3	10.5	14.2	13.1	11.3	21.2	6.2	4.5	0.2	61.1	80.1	0.4	1.5	63.0	68.8	11.4	74.8	176.7	0.0	2.0	18.8	4.7	14.4	1.2	14.6	6.3	1.1	0.8	45.9	77.8
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 116.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.3	0.2	0.5	0.3	0.9	0.4	0.4	1.4	0.8	0.5	0.9	0.6	0.3	0.2	0.1	0.1	0.7	1.6	0.2	0.3	0.1	1.0	116.7	0.8	0.0	0.7	0.4	0.7	2.5	0.0	0.7	0.0	0.8	0.5	0.1	0.2	0.8	0.1	0.5	0.9	0.6	0.0	0.4	0.3	11.0	1.9	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.4	0.8	0.3	0.1	0.7	0.4	0.8	0.4	0.4	1.8	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1198.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000		"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	2.6	0.1	0.2	0.0	0.2	0.0	2.4	0.2	0.3	0.3	0.1	0.0	0.3	79.6	0.1	0.0	4.1	0.3	0.5	0.2	0.3	1.6	1198.4	0.1	0.1	0.8	0.3	46.3	0.5	0.0	0.5	204.5	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.3	1.1	0.3	0.0	0.0	0.0	0.2	0.2	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.8	0.3	0.9	0.2	0.3	0.2	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 956.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	810000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	219.5	58.8	15.9	28.3	14.8	21.4	90.5	15.6	30.2	86.9	123.3	85.5	76.8	232.5	59.9	145.6	157.0	26.9	169.2	15.6	16.3	187.3	607.7	71.0	8.8	15.3	21.7	281.7	956.0	12.4	66.9	81.0	19.3	217.3	35.0	2.4	76.4	196.2	23.3	30.8	44.6	49.7	13.2	398.9	492.2	58.0	16.0	33.6	57.8	21.9	14.5	132.6	97.4	13.2	0.1	52.3	402.1	396.3	2139.8	652.9	8.5	125.2	61.9	6.1	0.6	1.2	1.5	0.1	171.7	0.8	15.2	11.5	145.4	156.9	0.6	0.8	84.9	91.3	0.2	26.3	53.3	38.6	5110.0	219.3	15.8	2.5	7.1	12.5	0.2	184.7	3.9	11.7	2.8	103.1	162.8	1106.5	437.4	98.2	4.8	139.2	9.1	2.0	2.0	117.1	84.1	443.4	0.3	3.4	2.6	362.2	332.4	67.3	0.5	1.6	2.4	1.6	6.2	6.2	0.9	9.7	6.0	177.4	478.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	15.9	14.8	15.6	30.2	15.6	16.3	15.3	21.7	19.3	13.2	16.0	13.2	354.3	3.2	0.6	2.0	3.3	13.8	534.0	238.2	19.4	0.2	79.0	498.0	12.5	11.5	40.1	264.8	2.1	1.8	5.4	86.4	29.4	3.0	1.0	153.2	1379.1	149.2	321.0	31.1	4.5	128.4	7.7	296.7	411.8	176.0	4.5	1649.7	92.1	658.6	5.3	0.0	0.8	191.6	54.9	24.1	5.0	4.9	5.6	21.8	3.6	13.1	1.3	3.6	3.1	1.0	1.0	60.7	51.3	79.4	0.4	255.7	4.2	1.2	195.9	1.7	105.2	17.9	435.7	6.0	35.8	103.3	5.5	2.2	16.0	2199.1	133.8	304.0
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 1864.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 457.7;Basal respiratory cells: 777.7;Extravillous trophoblasts: 2064.1;Fibroblasts: 463.4;Urothelial cells: 809.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 377.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 54.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 54.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8578.6;U-2197: 3469.4;U-87 MG: 1774.2"	"Low region specificity"	"Detected in all"							CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	3250000000	3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	350.6	16.2	15.6	28.5	20.2	1.2	278.2	12.2	24.1	291.8	18.9	96.7	67.8	547.3	43.1	28.2	130.9	44.6	284.6	16.5	22.5	65.9	721.3	37.5	68.3	20.7	13.7	233.1	14.4	28.0	98.1	1864.4	21.0	87.4	58.4	11.9	46.2	81.1	57.9	176.5	77.9	198.1	12.8	191.0	81.7	10.8	16.5	18.2	40.8	73.3	67.4	369.7	165.3	15.9	199.6	59.5	113.1	1.0	83.9	34.7	0.9	850.6	153.8	71.9	38.8	0.2	157.4	0.2	263.2	8578.6	35.6	466.5	1.5	3.4	29.2	0.6	0.1	0.3	20.8	0.2	21.9	0.4	1.6	285.7	12.8	15.1	53.8	112.3	0.7	0.0	0.1	3.2	26.8	1.2	1.3	1.4	7.8	1.8	10.9	0.8	0.4	81.4	53.2	423.6	13.6	32.7	293.9	11.4	15.3	250.6	1.5	0.7	0.5	815.4	1.7	3469.4	49.3	11.6	0.7	1.1	1774.2	0.3	282.1	0.0	0.0	0.0	10.1	0.0	8.0	0.0	10.9	10.7	0.0	0.0	4.9	8.1	0.1	0.0	0.0	54.5	0.8	4.5	15.6	20.2	12.2	24.1	16.5	22.5	20.7	13.7	21.0	12.8	16.5	15.9	260.4	3.2	3.9	0.7	1.9	457.7	148.9	777.7	8.0	2.8	12.6	30.4	12.6	8.6	409.7	228.1	0.0	94.1	10.0	0.7	11.7	145.6	1.3	32.3	220.1	168.0	273.7	5.3	2.5	2.0	2064.1	463.4	1.5	31.3	1.3	12.2	182.0	2.6	80.9	0.0	5.6	8.4	57.0	7.2	21.9	3.5	288.3	3.5	16.0	1.9	7.2	0.6	0.0	0.5	0.2	19.0	2.5	6.8	1.0	212.1	0.8	1.0	136.0	0.5	0.0	12.6	124.6	0.8	1.4	9.3	244.6	154.2	9.3	3.6	2.0	809.9
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443450-40457725	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.7;Endometrial stromal cells: 542.2;Endothelial cells: 502.3;Fibroblasts: 585.4;Hepatic stellate cells: 566.5;Hepatocytes: 501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 19.5;NK-cell: 37.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 37.0;T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"A549: 1334.8;ASC diff: 961.5;ASC TERT1: 933.8;BJ: 1066.4;BJ hTERT+: 1088.2;HSkMC: 2001.2;U-2197: 882.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	NA	NA	227000000	410000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA066240: AB_2685643"	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	884.7	248.1	26.0	307.7	26.9	2.4	754.6	25.3	46.5	1020.7	65.0	618.0	82.8	795.8	141.9	246.7	791.1	391.4	502.9	25.6	28.2	464.4	1475.9	390.1	60.0	29.5	34.1	1270.4	164.4	44.6	203.7	231.8	28.9	470.0	133.5	13.1	264.4	279.0	107.3	241.7	289.5	645.1	28.3	295.5	369.6	67.7	35.3	38.9	501.4	97.4	44.2	552.1	576.2	25.8	0.2	1334.8	66.8	0.5	961.5	933.8	2.2	1066.4	1088.2	199.7	154.4	59.7	17.3	0.3	563.7	511.0	27.2	11.9	22.6	6.8	90.2	4.8	1.3	4.3	91.3	89.9	601.2	2.9	0.5	2001.2	4.6	267.7	37.7	23.8	350.6	0.1	21.7	0.2	290.5	41.2	0.8	252.5	37.2	58.9	178.2	67.2	1.3	2.1	8.4	42.1	18.3	53.0	482.3	2.0	17.0	63.5	486.6	24.7	534.7	276.0	14.4	882.1	1.1	0.9	0.6	1.7	163.8	9.9	72.4	0.0	0.0	0.0	2.7	0.0	19.5	0.8	5.0	6.7	0.0	5.2	0.3	0.6	0.0	37.0	0.0	0.2	0.0	1.4	26.0	26.9	25.3	46.5	25.6	28.2	29.5	34.1	28.9	28.3	35.3	25.8	672.7	9.6	37.4	1.3	17.6	56.3	97.1	36.7	79.1	3.2	118.9	163.2	16.9	90.1	16.2	7.3	0.0	6.1	10.6	93.3	17.6	4.1	6.7	69.8	542.2	502.3	8.4	37.9	3.8	2.4	7.2	585.4	13.7	59.1	2.5	230.9	566.5	501.2	273.6	1.7	3.4	74.7	4.1	42.8	94.0	16.5	246.4	21.3	72.9	18.7	3.4	3.8	1.0	1.0	0.3	39.1	72.1	118.5	7.4	63.8	71.6	204.7	18.5	1.1	190.7	13.8	299.9	1.9	8.2	26.8	47.7	7.5	20.3	25.9	109.0	73.6
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695549	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1492.5;ovary: 1323.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	110000000	380000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	375.1	221.8	35.6	178.2	35.1	0.7	354.6	21.9	30.9	1492.5	46.9	232.3	35.0	837.7	121.3	166.4	953.0	129.3	155.0	50.4	41.8	479.1	34.2	78.2	71.3	36.3	37.9	1323.4	30.7	30.7	272.8	290.7	31.5	241.4	66.2	105.4	111.0	121.8	470.9	129.0	139.3	621.2	28.1	38.7	323.5	28.8	43.8	95.0	326.2	292.9	45.9	259.2	382.9	62.4	0.0	0.0	210.6	0.9	237.1	7.5	0.8	831.3	2192.6	108.8	10.4	0.0	1.0	0.1	3.3	2.3	0.0	0.1	26.2	0.0	5.6	0.1	8.2	218.1	4.4	0.2	103.1	0.1	1.8	33.1	0.0	14.7	0.1	24.8	0.1	0.2	0.7	0.1	0.5	70.9	0.9	1.2	2.3	0.0	3.4	0.3	0.8	1.2	70.3	249.1	14.5	8.5	14.6	100.4	0.0	12.8	531.7	0.1	80.3	710.2	42.2	109.3	41.0	0.7	0.1	0.1	1.4	0.1	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	35.1	21.9	30.9	50.4	41.8	36.3	37.9	31.5	28.1	43.8	62.4	237.3	3.2	4.4	40.1	20.6	102.5	13.5	211.0	25.0	8.7	73.9	199.9	92.0	5.7	251.6	112.2	6.2	3.9	1.7	0.0	5.9	10.3	8.4	140.2	250.7	120.8	0.0	0.0	6.0	0.0	4.5	1104.1	30.5	128.5	2.5	11.4	49.6	1.4	8.7	3.3	13.7	0.0	980.6	0.6	189.7	39.9	1828.2	18.4	101.4	29.0	0.6	674.4	0.0	5.5	0.4	2.2	0.0	981.7	5.5	17.0	0.0	1.1	120.9	18.7	1275.3	2750.9	1376.0	2.2	3.0	17.7	67.9	5.6	18.4	124.7	0.1	16.8
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
IGHA2		ENSG00000211890	"Immunoglobulin heavy constant alpha 2 (A2m marker)"	P01877	14	105583731-105588395	"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 5017.7;salivary gland: 3728.4"	"Group enriched"	"Detected in many"	22	"B-cells: 3713.4;Plasma cells: 10918.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	876	"memory B-cell: 279.6;naive B-cell: 123.8"	"Lineage enriched"	"Detected in single"	1214	"B-cells: 279.6"	"Group enriched"	"Detected in some"	42	"U-266/70: 181.9;U-266/84: 63.9"	"Not detected"	"Not detected"							"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		67000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (1.98e-9)"	"unprognostic (3.20e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.40e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.50e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.47e-1)"	24.3	3.7	0.0	14.2	0.0	12.4	329.7	0.0	0.0	47.6	0.0	5017.7	15.3	8.9	0.0	219.7	35.0	0.9	4.8	0.0	0.0	49.7	35.1	134.2	6.8	0.0	0.0	5.3	30.3	0.0	4.9	0.3	0.0	37.7	8.8	0.0	3728.4	0.1	2.1	17.8	2261.3	1.0	0.0	700.9	670.1	1.1	0.0	22.4	59.8	0.0	13.0	93.4	67.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.9	181.9	63.9	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	279.6	0.0	0.1	0.1	123.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	12.4	0.0	3713.4	0.0	2.4	0.0	2.8	0.0	1.4	0.3	1.2	5.7	0.6	0.0	0.0	0.1	3.2	3.7	0.0	0.0	0.0	0.0	0.0	15.6	8.5	56.2	0.0	0.0	0.0	8.0	10.7	0.0	15.2	0.0	78.9	6.0	0.3	0.0	0.0	2.9	0.0	10.8	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	10918.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	12.3	0.0	0.4	325.4	0.0	4.8	0.2
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11451.9;urinary bladder: 3998.0"	"Group enriched"	"Detected in many"	16	"B-cells: 3900.5;Plasma cells: 9883.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.7"	"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 766.8"	"Lineage enriched"	"Detected in many"	123	"B-cells: 766.8"	"Group enriched"	"Detected in many"	9	"Karpas-707: 157.8;U-698: 392.7"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	NA	NA		230000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.49e-9)"	"unprognostic (3.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.61e-2)"	526.0	696.8	0.7	1661.1	0.6	681.1	203.2	0.5	4.5	518.2	2.8	302.1	103.7	210.6	18.4	334.4	661.5	312.9	143.2	0.4	2.2	491.7	356.1	962.4	3281.1	4.7	3.2	407.0	38.5	7.9	35.8	2.3	2.3	209.8	85.1	0.3	391.6	250.8	13.1	28.5	1008.8	27.6	12.7	11451.9	608.9	172.8	1.2	1773.7	1277.9	0.1	5826.8	3998.0	267.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	8.4	0.0	5.3	0.0	0.0	0.0	22.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	157.8	0.0	0.0	1.7	2.1	2.6	0.0	0.0	2.9	15.1	3.7	0.0	0.0	18.2	17.0	3.1	0.0	0.0	0.0	0.0	0.2	10.8	0.0	3.2	3.3	4.5	4.9	0.3	392.7	0.1	3.7	0.0	0.2	0.3	0.1	0.3	0.0	0.2	766.8	0.6	0.3	0.4	134.9	0.0	0.1	6.2	0.1	0.1	0.1	0.2	96.2	0.7	0.6	0.5	4.5	0.4	2.2	4.7	3.2	2.3	12.7	1.2	1.8	2.9	73.7	378.5	0.0	3900.5	0.0	8.1	0.0	0.0	0.0	0.5	0.0	2.8	22.8	9.3	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.5	0.0	0.1	8.5	13.9	83.4	0.0	0.0	0.0	13.6	8.2	0.0	209.4	0.0	46.1	52.9	0.1	0.0	0.0	5.0	0.0	62.8	0.0	0.9	0.0	9.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	5.4	0.0	9883.3	9.1	0.0	10.9	1.5	0.1	0.0	0.0	1.5	1.9	1.0	0.0	0.0	0.0	415.6	0.0	13.6	0.1
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2478.2"	"Group enriched"	"Detected in some"	10	"B-cells: 964.5;Plasma cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 122.7;naive B-cell: 73.7"	"Lineage enriched"	"Detected in single"	571	"B-cells: 122.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 339.7"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		170000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"unprognostic (7.29e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (4.58e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (9.09e-8)"	"unprognostic (2.84e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.72e-2)"	80.0	2.1	0.4	2478.2	0.6	42.2	5.8	0.5	1.0	33.9	0.3	40.6	85.5	10.8	0.2	401.2	28.5	101.3	19.2	0.3	0.4	44.0	43.7	49.4	136.5	0.6	0.4	3.9	4.2	0.5	1.9	0.2	1.3	31.2	44.3	0.1	16.4	4.1	0.8	4.7	186.2	1.8	1.1	831.6	57.4	2.2	0.4	49.9	108.3	0.0	872.5	588.7	29.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	43.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.6	339.7	0.0	0.0	3.5	3.7	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.3	1.5	0.6	0.1	57.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.7	0.0	0.0	0.1	73.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.6	0.4	0.6	0.5	1.0	0.3	0.4	0.6	0.4	1.3	1.1	0.4	0.3	1.3	6.4	118.8	0.0	964.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.0	8.6	3.7	0.0	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.0	0.4	2.5	27.8	26.7	0.0	0.0	0.0	4.3	0.0	0.0	50.4	0.0	16.4	36.7	0.0	0.0	0.0	10.5	0.0	51.9	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2099.3	0.2	0.0	10.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	152.3	0.0	12.8	0.1
IGHM		ENSG00000211899	"Immunoglobulin heavy constant mu"	P01871	14	105851705-105856218	"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 1315.0;lymphoid tissue: 4112.3"	"Group enriched"	"Detected in many"	14	"B-cells: 3757.1;Plasma cells: 9906.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	16	"memory B-cell: 4278.4;naive B-cell: 6731.2"	"Lineage enriched"	"Detected in all"	19	"B-cells: 6731.2"	"Group enriched"	"Detected in many"	9	"Daudi: 4983.6;U-698: 4905.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB008643	Uncertain				"Immunoglobulin genes"	NA	NA		110000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008643: AB_1617732"	"unprognostic (2.91e-3)"	"prognostic favorable (6.49e-4)"	"unprognostic (9.30e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.70e-6)"	"unprognostic (9.61e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.28e-3)"	52.0	9.0	0.4	373.7	0.4	395.3	56.6	0.2	1.7	67.9	1.8	446.8	1204.9	11.1	10.2	66.8	38.5	141.7	50.5	0.2	0.4	48.4	84.7	180.6	3192.1	1.9	0.3	9.7	44.5	0.6	8.7	3.6	0.7	15.1	201.4	0.0	325.1	6.1	2.7	1.7	1315.0	7.9	1.0	4112.3	528.9	70.9	0.7	117.3	37.0	0.7	497.1	128.0	10.5	0.5	4.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4983.6	2.9	0.0	0.0	0.8	0.0	0.0	0.0	21.6	0.0	3.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	1.7	28.7	1.2	0.0	0.0	580.2	2.2	6.9	0.0	0.0	4.0	5.8	3.0	0.5	1.2	0.0	0.2	3.8	6.5	0.0	13.8	1.2	2.5	1.5	1.5	4905.9	0.0	2.4	0.0	10.8	5.4	5.6	3.1	1.2	2.3	4278.4	5.5	6.8	5.4	6731.2	4.5	3.8	25.4	11.4	4.5	346.1	11.4	815.2	0.4	0.4	0.2	1.7	0.2	0.4	1.9	0.3	0.7	1.0	0.7	0.5	1.0	38.5	254.5	0.0	3757.1	0.0	0.2	0.0	1.2	0.0	2.2	0.8	0.3	31.5	14.2	0.0	0.0	0.0	63.8	1.8	0.0	0.0	0.0	0.0	0.1	4.2	6.7	474.1	0.0	0.0	0.0	10.8	27.5	0.0	152.6	0.0	56.7	147.9	0.1	0.0	0.0	2.2	0.0	158.1	0.0	0.0	0.0	12.4	0.0	0.0	5.2	0.0	11.3	0.0	0.0	0.0	1.2	0.0	9906.5	0.3	0.0	2.2	1.5	0.0	0.0	0.4	16.8	0.0	0.0	0.2	0.0	0.0	415.0	0.3	4.1	0.1
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 70.0;testis: 25.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.8"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.8"	"Cell line enriched"	"Detected in some"	32	"REH: 787.7"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		48000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.3	0.3	0.3	70.0	0.0	0.3	0.4	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.1	1.4	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.2	25.2	0.2	10.1	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	14.3	2.6	0.0	0.0	0.0	787.7	0.3	17.3	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.1	6.2	0.0	0.0	0.3	0.3	0.0	0.6	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.3	0.3	0.3	0.4	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.9	0.0	78.0	0.2	0.3	0.3	0.0	10.5	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	140.7	1.2	0.4	119.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	6.2	0.0	0.0	0.0	1.5	0.3	17.1	0.6	0.0	0.3	0.0	17.9	0.1	0.0	0.2
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog signaling molecule"	Q14623	2	219054424-219060921	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 14.0;intestine: 22.3;stomach 1: 15.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.5;Enteroendocrine cells: 49.2;Granulosa cells: 122.4;Intestinal goblet cells: 34.7;Proximal enterocytes: 18.8;Undifferentiated cells: 23.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8;endometrial cancer: 30.9"	"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 16.4;OE19: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		23000000		"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.1	2.4	4.9	0.0	22.3	12.2	14.0	0.0	0.3	0.9	0.7	0.0	0.0	0.0	2.4	3.5	1.3	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.1	0.4	2.4	12.4	0.0	0.0	0.7	0.0	0.0	12.9	0.7	0.2	0.0	15.0	0.1	0.1	0.0	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.3	0.1	0.4	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.8	0.0	1.8	0.0	0.0	0.4	31.5	0.0	0.1	0.0	6.0	0.5	0.1	49.2	0.0	0.0	3.3	0.0	0.1	12.2	8.9	0.0	122.4	0.0	0.6	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	14.0	0.0	0.0	1.8	18.8	3.2	0.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	23.6	0.3
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332460	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.46e-6)"	9.4	8.2	9.1	4.7	9.8	4.8	8.3	9.2	10.9	7.2	11.7	6.8	4.8	8.1	7.3	10.2	11.6	8.6	5.6	9.2	9.5	6.8	6.6	11.3	12.2	10.5	9.9	6.1	6.2	13.5	4.0	8.2	10.0	7.9	6.8	12.3	8.9	9.3	13.7	11.4	4.9	12.7	9.7	10.5	5.5	3.2	10.1	10.8	9.4	24.3	11.6	11.1	6.8	10.2	6.2	15.7	8.0	13.6	17.3	18.9	5.8	9.2	18.2	15.2	17.2	3.1	13.9	14.1	10.0	16.5	12.5	5.6	8.4	18.3	17.8	9.8	10.8	17.8	7.8	5.9	20.9	6.1	24.0	12.3	13.7	15.0	19.1	36.1	20.7	11.6	12.8	6.9	34.6	5.1	13.9	11.3	6.1	18.9	6.0	11.1	15.3	10.0	19.6	5.7	1.3	4.7	6.4	6.4	11.7	10.0	8.7	23.6	13.6	7.2	3.9	13.9	6.1	2.8	4.0	10.3	13.8	7.6	16.7	7.4	5.0	5.6	4.6	4.1	4.3	4.4	5.1	5.5	3.7	4.8	4.8	4.7	5.2	5.1	5.5	8.5	5.9	2.9	9.1	9.8	9.2	10.9	9.2	9.5	10.5	9.9	10.0	9.7	10.1	10.2	31.3	12.8	26.9	19.2	28.4	24.3	34.1	13.9	25.6	12.7	20.6	15.5	8.8	14.3	15.4	16.5	135.5	10.4	34.1	15.9	1.9	13.4	2.3	13.9	15.6	27.4	11.4	10.1	19.7	13.6	5.3	12.4	21.9	16.5	38.0	24.0	19.6	12.0	18.6	18.5	20.6	16.4	8.2	32.3	24.0	3.4	16.4	23.4	19.6	58.1	33.7	8.7	47.4	17.1	30.2	16.6	15.0	12.8	18.2	31.9	13.2	5.5	20.2	47.9	6.6	13.1	11.4	4.8	7.0	17.8	29.1	15.2	24.3	6.2	14.1	30.8
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206774541	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.7;lymphoid tissue: 7.7"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 28.3;Kupffer cells: 44.4;Langerhans cells: 35.5;Macrophages: 99.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"thalamus: 3.5"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1;intermediate monocyte: 1.8"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 14.6;U-266/70: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670		"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	6.7	2.1	0.1	7.7	0.1	3.2	0.7	0.2	0.7	0.8	0.9	1.0	0.8	0.3	0.1	1.5	1.4	3.5	1.1	0.2	0.5	0.2	1.6	1.5	5.7	0.7	0.4	0.4	0.1	0.2	0.4	1.9	0.6	0.4	1.3	0.0	0.2	0.7	0.0	0.1	1.1	3.1	0.5	4.9	0.8	0.8	3.5	2.9	0.2	1.2	2.0	2.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.1	0.2	0.7	0.2	0.5	0.7	0.4	0.6	0.5	3.5	1.2	0.5	0.0	1.9	0.0	5.6	1.0	0.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.1	0.2	1.9	0.0	0.4	0.0	0.0	0.1	0.8	1.1	0.2	1.3	0.0	0.7	0.5	28.3	0.0	0.0	0.0	0.0	44.4	35.5	2.9	0.0	99.5	1.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.8	0.0	0.2	0.7	1.1	0.1	12.9	0.0	0.0	0.4
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266367-33310187	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 198.4;Extravillous trophoblasts: 164.9;Syncytiotrophoblasts: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB020670, HPA047550"	Approved		Approved	Cytosol		NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	24.6	14.5	8.2	30.3	8.2	19.8	18.1	8.1	11.3	20.2	8.6	40.6	36.5	14.7	9.9	27.6	23.9	23.9	13.8	8.1	7.8	16.8	27.5	25.8	27.6	9.0	8.1	20.4	25.4	10.7	11.3	62.5	8.9	18.6	38.0	4.8	23.6	12.3	12.4	20.2	45.7	19.8	8.6	43.1	33.8	5.0	9.5	30.5	14.0	9.8	26.0	29.3	19.3	9.8	28.8	21.6	4.9	19.1	82.7	61.3	30.0	22.9	62.3	23.5	33.6	20.6	36.1	10.9	25.0	37.8	48.3	34.5	13.2	14.8	17.3	28.5	15.5	30.8	15.1	15.2	58.3	29.5	54.6	62.5	26.8	41.2	23.5	36.8	34.6	25.6	20.6	79.7	32.5	29.1	22.6	27.4	4.2	59.1	11.4	18.5	14.4	33.9	22.6	16.6	7.5	8.0	45.4	35.3	37.5	9.7	21.3	104.5	31.0	24.1	22.7	40.0	12.4	49.9	48.3	6.8	40.5	44.5	19.4	103.8	115.0	98.9	32.0	134.9	35.2	51.6	39.3	38.1	67.9	54.1	36.8	36.3	219.4	56.9	141.6	73.6	77.6	87.5	8.2	8.2	8.1	11.3	8.1	7.8	9.0	8.1	8.9	8.6	9.5	9.8	3.1	35.3	20.5	11.8	26.5	14.5	38.0	54.0	19.4	5.8	3.3	2.8	12.3	32.9	32.3	3.7	14.6	198.4	33.6	102.1	0.0	20.1	1.1	2.3	3.5	23.5	10.2	17.7	14.5	30.1	164.9	24.2	29.6	2.4	35.5	2.1	31.8	23.2	116.6	8.4	12.7	64.4	30.5	111.3	25.3	1.6	31.7	54.3	14.2	23.4	80.6	6.7	49.4	14.6	18.5	23.4	86.8	23.7	39.9	44.3	103.1	1.1	15.8	6.4	19.7	16.9	9.1	2.9	5.0	21.7	14.6	315.6	21.0	0.2	41.4	67.6
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988835-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.8"	"Not detected"	"Not detected"			HPA001886	Uncertain				"Secreted to blood"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.3	0.4	0.9	0.6	0.9	1.5	0.7	0.9	2.0	0.2	0.3	0.8	0.5	0.3	0.1	4.1	2.1	0.2	0.8	0.8	0.8	0.4	0.1	2.1	0.8	0.9	1.1	0.5	0.5	0.0	0.5	0.1	1.0	0.3	0.4	0.1	0.3	0.1	0.2	0.1	0.8	0.2	0.7	1.2	0.5	0.3	0.9	0.4	0.2	0.7	0.5	0.7	0.6	1.1	3.1	0.3	0.4	2.6	0.0	0.2	0.2	3.3	2.1	3.9	8.1	1.2	0.1	0.0	0.2	0.5	4.5	0.3	0.8	0.5	3.6	13.2	4.1	0.1	0.2	0.9	2.5	0.7	6.1	0.6	1.0	6.9	2.7	2.7	1.2	0.3	0.0	2.1	2.4	0.1	0.1	0.0	0.4	0.1	1.8	2.4	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.6	0.5	0.6	0.9	1.4	0.9	0.8	0.8	2.3	6.3	1.4	0.0	0.0	1.5	5.9	0.8	0.0	0.0	0.5	0.3	0.1	0.5	0.5	0.1	0.6	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.9	0.9	2.0	0.8	0.8	0.9	1.1	1.0	0.7	0.9	1.1	1.0	0.0	0.6	1.0	3.4	0.1	2.1	1.0	1.2	0.0	1.6	2.2	0.4	0.0	1.1	0.0	0.0	0.1	0.7	0.3	0.0	1.5	0.0	3.9	0.2	1.4	2.4	0.8	0.1	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.9	4.1	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	4.0	1.3	0.4	0.2	0.0	2.1	2.9	0.1	0.0	6.1	0.0	6.6	1.5	0.3	0.4	2.9	2.6	0.1	0.0	0.7	0.1	0.5	1.3
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330487	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 6.7"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	NA	NA	140000		"Cluster 11: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 3: Monocytes - Immune response regulation"			"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 24.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 96.7;Late spermatids: 200.7;Spermatocytes: 44.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	187	"HDLM-2: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	40000			"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	96.7	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	200.7	2.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.5	44.4	1.2	0.0	0.6	0.0	14.7	0.0	0.0	0.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in single"	14	"T-cells: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Karpas-707: 2.7;U-266/84: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920			"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143253-112164096	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.5;skin 1: 149.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	NA	Yes	196000	16000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	19.9	6.1	5.3	18.2	5.4	31.6	12.6	5.9	8.6	38.0	7.0	34.1	22.0	2.4	3.3	124.5	8.0	23.0	3.0	5.3	6.0	23.8	9.1	23.0	67.8	7.5	6.2	1.9	17.9	1.3	2.9	6.7	7.4	6.1	29.1	6.9	15.0	3.0	6.0	149.6	22.0	3.6	6.7	29.3	13.4	1.9	5.7	8.0	3.7	2.1	25.7	25.3	77.0	11.3	117.9	40.0	0.0	0.4	0.0	0.0	0.7	2.0	0.0	0.0	0.1	22.4	182.3	0.1	25.7	0.3	3.2	167.0	0.0	125.8	0.0	0.3	1.2	17.5	35.6	9.9	3.9	9.3	32.6	0.2	188.5	0.3	43.5	0.2	0.1	0.1	0.5	0.3	1.6	0.2	0.2	0.9	0.2	31.9	110.2	0.1	0.1	0.4	79.9	24.8	0.1	0.0	78.4	52.1	0.5	1.0	31.0	25.4	0.3	0.4	208.9	1.2	35.9	0.4	0.3	0.6	0.2	67.1	0.2	6.8	8.7	16.0	0.1	10.9	0.0	0.7	0.1	0.0	25.8	0.7	0.0	0.5	9.5	19.6	6.3	5.6	0.0	2.5	5.3	5.4	5.9	8.6	5.3	6.0	7.5	6.2	7.4	6.7	5.7	11.3	1.0	173.1	38.4	0.7	6.0	122.9	33.5	186.4	215.1	2.6	4.6	7.7	1.0	41.5	66.1	9.2	0.0	2.3	10.8	109.9	80.3	24.7	2.4	94.9	1.4	4.6	14.5	26.3	3.8	143.0	3.7	18.8	20.9	32.5	101.2	2.8	8.2	1.9	68.4	0.0	4.6	30.1	57.0	241.0	37.3	1.9	0.0	123.8	3.6	61.8	38.8	2.7	6.2	2.0	1.1	161.4	104.6	4.5	4.6	23.6	67.5	22.3	69.6	39.1	6.6	0.6	3.9	1.5	1.3	152.6	111.2	1.8	9.6	0.3	47.8	90.5
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773925-112784493	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.3;testis: 10.4;urinary bladder: 26.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.6;Club cells: 9.8;Endometrial ciliated cells: 11.5;Glandular and luminal cells: 29.4;Macrophages: 30.6;Squamous epithelial cells: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 447.6;hTCEpi: 216.2;hTERT-HME1: 283.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10800			"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.5	0.0	0.3	1.3	0.4	1.0	0.4	0.5	0.4	4.8	0.2	0.3	0.1	2.5	0.8	13.3	0.1	2.3	0.0	0.4	0.5	0.0	0.0	2.3	0.3	0.9	0.8	0.0	0.0	0.4	0.2	1.5	1.0	0.1	0.2	0.1	1.2	0.4	0.0	0.8	0.1	0.0	0.7	0.3	0.1	10.4	0.5	0.3	0.2	0.0	8.7	26.0	1.3	1.2	12.5	0.0	0.5	0.0	0.1	0.0	0.2	0.4	13.5	0.0	0.2	0.5	0.8	0.0	52.5	0.0	65.9	3.6	0.0	447.6	1.7	0.1	0.1	0.1	0.7	0.2	1.0	0.2	0.1	0.0	216.2	3.8	283.4	3.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.2	0.2	0.5	0.0	0.0	0.0	0.1	55.0	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.1	1.7	1.3	0.6	0.3	0.3	0.0	0.1	0.2	5.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.4	0.5	0.9	0.8	1.0	0.7	0.5	1.2	0.9	6.4	1.1	0.0	2.2	1.5	0.7	22.6	1.2	0.0	0.5	0.3	0.2	0.0	9.8	0.0	0.0	0.3	0.3	0.6	0.0	4.6	8.3	11.5	2.8	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.0	29.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.0	4.8	3.8	0.0	30.6	0.0	5.6	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.4	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	9.4	1.0	0.0	0.4	0.1	0.2	2.4
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 201.7;urinary bladder: 126.2"	"Group enriched"	"Detected in many"	11	"Langerhans cells: 1451.9;Macrophages: 1510.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 649.3;HBEC3-KT: 293.3;HMC-1: 235.1;hTEC/SVTERT24-B: 319.1;hTERT-RPE1: 277.0;U-87 MG: 571.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	2330		"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	43.9	7.6	2.5	53.6	2.2	201.7	2.0	3.1	4.6	3.7	4.2	8.1	3.0	7.4	2.0	3.4	4.1	19.0	3.3	2.3	3.4	7.7	9.1	17.4	9.5	4.8	4.6	0.8	4.4	3.0	2.6	7.8	3.8	6.1	6.5	0.3	3.8	1.8	0.1	0.7	3.5	9.2	4.4	17.8	25.5	1.1	2.8	9.4	2.6	7.0	12.8	126.2	1.0	6.6	6.3	0.1	0.2	0.0	0.4	0.0	0.0	2.1	649.3	3.1	6.5	0.0	0.0	0.0	18.0	0.5	11.3	14.7	0.0	293.3	39.2	0.0	0.0	29.5	0.4	0.0	2.2	0.0	235.1	1.1	8.9	319.1	103.5	277.0	0.0	0.1	0.0	0.8	0.6	0.0	0.0	2.9	0.1	1.2	26.2	1.0	0.0	0.0	0.0	48.2	0.0	0.0	1.7	0.0	2.5	0.0	0.0	2.8	0.0	15.3	0.2	0.7	0.5	0.1	0.0	0.2	571.5	14.0	22.7	1.7	12.3	4.4	0.0	19.5	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	94.1	0.2	7.7	0.0	0.0	3.4	2.5	2.2	3.1	4.6	2.3	3.4	4.8	4.6	3.8	4.4	2.8	6.6	23.8	9.6	28.2	0.0	14.1	30.8	5.4	25.4	0.0	0.2	8.2	13.3	4.8	0.0	16.2	1.8	0.0	1.5	7.5	2.8	0.0	33.2	0.3	4.9	5.0	20.0	0.0	58.9	0.0	0.6	2.6	8.1	44.4	8.4	41.7	0.0	1.4	0.4	108.1	0.0	0.0	12.7	14.2	130.5	1451.9	0.7	0.0	1510.7	23.2	1.9	7.9	0.3	0.0	0.0	0.0	2.9	10.0	0.0	9.3	4.7	0.2	0.7	8.6	0.3	0.0	1.5	4.3	0.0	0.4	8.3	20.3	4.4	6.3	0.0	1.9	6.1
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991960-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 6.4;pons: 1.9"	"Immune cell enriched"	"Detected in some"	26	"neutrophil: 377.5"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 377.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 469.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	27000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	19.7	5.9	0.2	35.5	0.7	52.8	3.7	0.3	6.4	10.3	1.9	29.7	0.8	2.5	3.5	41.2	17.7	5.3	4.0	0.2	0.5	16.0	11.6	30.8	3.3	0.5	0.4	1.2	3.7	0.3	0.8	20.1	1.9	2.3	43.7	0.1	7.9	2.2	1.2	30.7	4.6	3.4	0.3	90.1	33.0	0.5	0.7	7.4	1.9	2.9	38.5	6.2	20.5	0.3	7.3	0.9	0.0	0.0	0.9	1.2	0.8	0.0	0.2	0.0	0.1	7.7	0.2	0.1	14.7	0.0	0.3	2.9	0.0	0.5	0.0	469.8	0.4	0.1	0.1	4.0	2.5	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	60.4	0.0	0.0	0.0	0.0	24.0	1.7	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	0.4	7.2	0.2	0.0	0.3	0.0	0.5	0.2	0.0	0.1	4.3	0.0	0.0	2.3	0.0	0.0	0.9	0.0	14.5	0.0	0.0	0.0	377.5	0.2	0.1	0.2	5.9	1.5	0.2	0.7	0.3	6.4	0.2	0.5	0.5	0.4	1.9	0.3	0.7	0.3	1.2	6.4	1.1	0.0	1.7	147.9	13.5	2.0	495.7	0.0	0.5	0.4	0.6	10.0	0.3	1.8	0.0	1.2	1.2	23.8	5.9	15.0	2.8	14.5	1.5	4.4	6.7	2.7	0.0	8.3	36.3	6.1	18.3	8.0	2.5	0.0	3.6	16.2	5.8	0.0	0.0	117.4	0.0	207.9	1083.3	4.0	0.3	210.8	32.0	0.0	3.5	0.0	0.0	0.0	0.0	211.0	26.8	0.0	1.6	20.4	0.0	0.7	2.2	0.0	6.6	0.7	3.8	0.7	2.2	38.1	84.0	27.8	2.7	0.4	26.8	14.4
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 225.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 23.8;neutrophil: 95.0"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 95.0"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		350000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	6.2	2.9	4.0	11.4	1.1	20.3	4.3	0.0	8.7	4.4	0.5	2.2	1.8	4.0	2.6	13.1	5.4	12.1	3.9	4.6	3.1	3.3	225.8	8.2	2.7	2.4	3.7	3.0	3.9	1.5	1.2	37.0	3.3	3.9	2.2	2.4	5.2	3.4	1.3	11.9	2.2	6.4	1.5	5.4	4.5	1.3	5.5	4.6	4.0	2.1	4.8	9.4	5.5	3.3	13.3	3.0	5.5	0.8	9.5	7.7	10.0	5.8	11.9	13.4	13.2	5.8	29.3	2.2	59.2	16.4	31.1	34.1	3.0	57.6	18.7	2.5	3.6	2.9	5.3	14.5	19.6	20.2	9.5	10.3	23.1	19.7	59.2	27.8	6.0	5.9	0.4	0.2	6.4	6.5	1.7	9.4	8.5	6.0	6.0	9.5	8.2	4.8	5.3	14.8	1.0	0.0	26.3	15.0	247.1	5.2	9.6	14.6	7.9	10.3	10.4	32.1	26.6	5.0	0.2	0.5	17.2	18.0	60.9	11.7	3.8	23.8	1.8	4.3	3.3	2.1	2.1	2.3	3.8	2.1	2.0	1.3	95.0	0.3	6.3	0.6	2.1	1.4	4.0	1.1	0.0	8.7	4.6	3.1	2.4	3.7	3.3	1.5	5.5	3.3	3.5	0.0	14.7	6.5	6.8	44.7	16.5	45.8	68.9	6.5	2.5	4.7	5.5	40.0	22.8	3.7	8.4	8.5	3.6	1.8	0.0	7.7	4.4	8.6	3.8	8.0	5.4	4.4	44.3	7.5	109.2	7.3	7.1	12.3	7.6	0.7	7.5	295.8	7.8	0.0	63.3	1.4	4.1	33.7	17.7	0.6	4.4	28.8	8.8	53.4	5.0	1.0	6.2	298.6	1.5	19.7	0.8	2.6	5.3	11.5	0.7	1.1	8.7	0.6	0.0	18.0	5.1	0.1	0.6	30.9	37.2	24.2	5.2	1.4	1.1	14.3
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587446-29956718	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Receptor"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 33.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1315.7;Inhibitory neurons: 2598.6;Oligodendrocyte precursor cells: 1954.3;Oligodendrocytes: 6420.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 33.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 8.7;WM-115: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	0.1	0.0	3.9	0.0	12.1	0.0	0.1	1.9	8.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.4	3.3	4.0	0.0	0.2	0.0	0.0	7.8	4.5	0.3	0.1	0.0	0.0	0.1	5.7	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	3.9	0.0	0.1	0.1	8.5	0.0	0.1	0.1	0.0	0.3	0.0	33.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	12.1	1.9	8.1	3.3	4.0	7.8	4.5	5.7	3.9	8.5	33.4	0.5	0.0	0.5	64.6	0.0	0.1	0.2	0.0	0.6	2.4	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1315.7	0.0	0.0	1.6	0.0	0.0	26.1	0.1	0.0	0.0	0.1	0.0	2598.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.8	42.2	0.0	0.3	0.0	1954.3	6420.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.7	1.5	0.0	0.1	0.1	1.1	0.4	0.1	0.0
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 1969.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 184.4;Hofbauer cells: 306.0;Langerhans cells: 292.6;Squamous epithelial cells: 469.7;Suprabasal keratinocytes: 336.6;Urothelial cells: 464.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 63.8;myeloid DC: 61.7;neutrophil: 240.2"	"Group enriched"	"Detected in many"	694	"dendritic cells: 61.7;granulocytes: 240.2;monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"A-431: 59.1;HaCaT: 112.3;RT4: 106.6;THP-1: 27.3"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000	45000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	13.0	2.1	0.2	46.7	0.4	233.3	9.0	0.4	1.3	278.1	1.1	4.4	10.7	2.5	2.9	1969.7	2.1	17.0	2.5	0.3	0.3	1.6	248.5	20.1	1.4	0.4	0.5	0.9	1.8	2.0	2.3	21.1	0.8	2.4	4.0	0.0	287.1	7.5	0.8	128.6	8.8	3.9	0.8	14.7	45.5	6.4	1.3	5.2	6.4	3.0	311.7	185.7	465.0	0.6	59.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.2	0.0	0.6	0.2	0.2	0.0	1.1	112.3	0.0	3.3	0.0	0.1	0.0	0.3	0.0	17.3	0.0	0.3	20.3	0.0	14.3	0.7	0.0	2.0	0.0	0.0	0.3	0.3	0.0	0.5	0.1	14.7	0.0	13.2	0.0	0.0	0.1	0.1	0.0	106.6	0.0	0.0	0.1	0.8	0.1	0.0	0.0	27.3	0.3	1.4	0.0	0.7	0.1	0.6	0.1	0.2	10.3	10.5	0.3	0.0	63.8	1.9	0.0	27.7	0.0	0.1	0.0	0.0	61.7	0.1	0.1	0.1	240.2	0.0	13.7	0.8	0.1	19.8	0.2	0.4	0.4	1.3	0.3	0.3	0.4	0.5	0.8	0.8	1.3	0.6	1.7	6.4	7.7	0.0	4.1	184.4	81.3	151.8	56.9	0.0	4.9	3.4	0.4	11.5	60.6	3.7	0.0	1.8	0.2	6.5	0.0	27.5	34.8	7.8	1.4	4.8	0.0	3.2	0.3	28.0	2.9	11.0	44.4	23.6	10.1	0.0	3.3	53.0	306.0	0.0	0.2	1.1	6.1	39.8	292.6	93.3	0.6	111.1	24.9	0.0	22.6	0.0	2.1	0.5	0.2	149.9	0.1	0.4	2.8	58.4	9.3	0.2	20.2	0.0	0.0	0.3	3.8	0.8	0.2	469.7	336.6	4.5	3.3	0.0	3.2	464.9
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Melanocytes: 3.6;T-cells: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300					"Cluster 7: Non-specific - Mitochondria"			"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.4	0.0	0.0	0.0
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122610108-122621066	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"lymphoid tissue: 5.9"	"Group enriched"	"Detected in some"	18	"Early spermatids: 13.7;Late spermatids: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	55700			"Cluster 16: Immune cells - Immune response"		"Cluster 34: Spermatids - Unknown function"											"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201349-68225810	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.6;T-cells: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 13.5"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	35700		"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"					"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	3.8	0.1	0.0	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;lymphoid tissue: 17.4;urinary bladder: 11.2"	"Group enriched"	"Detected in some"	6	"granulocytes: 80.8;monocytes: 177.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 175.9;T-reg: 248.0"	"Group enriched"	"Detected in many"	14	"granulocytes: 175.9;T-cells: 248.0"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 1113.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced					NA	NA		410000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	18.9	1.9	0.0	14.2	0.0	0.4	1.4	0.1	0.2	0.5	1.1	3.3	1.9	0.5	0.2	2.6	0.3	2.9	0.8	0.1	0.1	0.7	0.5	2.4	17.4	0.5	0.1	0.1	0.5	0.3	0.9	2.5	0.4	0.4	2.1	0.0	0.5	0.8	0.1	0.4	6.5	4.7	0.1	7.5	1.2	0.2	0.2	5.2	1.3	0.6	12.9	11.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1113.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	0.4	18.9	0.0	0.3	0.0	175.9	0.1	20.1	0.6	0.0	2.2	14.7	27.3	3.1	0.2	7.3	2.0	0.2	0.9	13.4	0.3	0.2	248.0	3.2	0.0	0.0	0.1	0.2	0.1	0.1	0.5	0.1	0.4	0.1	0.2	0.2	0.4	0.0	1.8	1.0	13.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.2	0.2	0.6	0.4	0.0	0.8	0.2	0.6	0.0	0.7	1.1	0.1	80.8	0.0	0.4	0.2	0.3	0.0	0.2	0.0	0.0	7.7	4.8	0.1	0.0	19.3	3.6	1.9	177.6	0.0	2.1	0.0	0.3	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.1	0.6	0.0	19.6	0.0	0.1	0.2
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 829.3;pancreas: 674.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1696.0;Exocrine glandular cells: 1490.0;Pancreatic endocrine cells: 2546.1;Proximal enterocytes: 4916.6;Proximal tubular cells: 4315.8;T-cells: 1711.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 4625.7"	"Lineage enriched"	"Detected in all"	8	"T-cells: 4625.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 514.7;CAPAN-2: 328.6;HDLM-2: 707.9;Hep G2: 504.3;Karpas-707: 404.6;MOLT-4: 319.9;RH-30: 348.0;U-937: 314.5"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"	NA	NA	46100		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	91.1	36.7	21.3	206.7	21.0	49.1	58.7	20.3	27.6	19.2	19.0	206.5	339.8	30.4	13.5	45.5	20.6	117.4	180.6	19.1	20.0	418.8	829.3	271.5	402.7	24.0	20.4	22.3	674.4	10.2	17.7	62.8	23.0	54.2	142.7	1.0	87.1	42.2	543.7	26.9	558.9	88.4	21.2	440.7	87.4	19.2	24.8	198.0	84.3	328.6	200.2	118.8	23.1	21.3	254.1	10.7	1.2	0.3	0.5	28.4	19.5	12.4	31.3	14.9	24.8	514.7	328.6	0.6	59.8	7.0	92.1	10.7	1.0	29.6	18.0	707.9	2.7	1.2	49.8	504.3	55.7	1.4	20.5	34.2	3.4	12.9	54.9	12.1	60.0	7.9	0.7	404.6	19.5	1.7	319.9	8.2	7.2	3.2	7.6	0.7	348.0	34.4	239.3	16.7	0.7	3.9	109.9	7.4	1.9	50.9	7.2	4.0	161.6	56.9	67.2	3.1	36.5	4.7	10.7	1.6	1.1	314.5	29.7	30.8	10.9	12.7	2570.7	9.1	2584.2	9.3	2337.1	2483.4	9.2	7.8	884.8	1712.5	46.9	553.7	11.3	13.4	4625.7	2238.1	21.3	21.0	20.3	27.6	19.1	20.0	24.0	20.4	23.0	21.2	24.8	21.3	334.4	198.7	64.9	0.0	81.7	59.5	68.0	462.2	12.0	0.4	50.3	44.3	5.6	221.6	119.6	119.5	0.0	9.0	550.3	1038.3	252.4	1696.0	0.2	46.5	36.7	286.4	135.1	64.6	0.1	1490.0	14.1	136.7	118.3	53.7	52.6	1.5	68.6	124.1	4.2	0.0	0.1	273.1	244.1	40.5	116.1	1.9	35.1	60.7	65.8	5.6	225.8	0.0	518.0	0.0	0.1	2546.1	1004.5	45.9	81.7	101.2	4916.6	4315.8	55.1	0.6	19.7	278.5	117.4	5.8	1.3	7.1	51.6	6.6	1711.8	27.8	182.2	105.7
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"T-cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	861	"basophil: 474.9"	"Lineage enriched"	"Detected in single"	861	"granulocytes: 474.9"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	NA	NA	13600		"Cluster 38: Basophils - Unknown function"		"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB078477: AB_417057, HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.1	0.3	0.1	0.4	0.1	0.3	0.1	0.5	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.5	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	474.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066324-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.0;fallopian tube: 10.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	192	"basophil: 178.4;eosinophil: 355.1"	"Lineage enriched"	"Detected in many"	255	"granulocytes: 355.1"	"Cell line enriched"	"Detected in some"	28	"HMC-1: 71.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		910000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.2	0.2	0.8	0.6	0.7	0.6	1.0	0.6	0.3	1.0	9.0	0.7	1.7	0.4	0.2	0.5	10.7	0.7	1.0	0.8	1.2	0.4	0.1	2.7	0.4	5.0	4.6	0.1	0.4	0.0	1.5	0.1	3.2	1.8	1.1	0.0	0.7	0.1	0.4	0.1	1.6	0.3	4.5	1.8	1.1	1.1	1.2	0.5	0.2	0.0	1.5	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	2.5	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	178.4	0.1	355.1	0.9	0.1	0.1	0.4	1.0	0.7	0.1	1.3	0.3	0.7	1.0	0.0	0.1	0.1	0.1	0.7	0.8	0.7	0.6	0.3	0.8	1.2	5.0	4.6	3.2	4.5	1.2	0.9	0.2	0.0	2.5	0.0	4.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.3	1.5	1.4	0.0	0.0	0.1	2.8	0.0	0.0	0.0	2.4	28.0	0.3	0.1	0.0	0.8	0.7	0.0	0.0	0.2	0.0	0.5	19.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.3	5.7	0.0	0.1	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	9.9	0.8	0.0	0.1	13.9	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 217.6;urinary bladder: 281.3"	"Group enriched"	"Detected in many"	4	"Adipocytes: 188.5;Endometrial ciliated cells: 163.9;Endothelial cells: 287.4;Fibroblasts: 593.3;Glandular and luminal cells: 322.2;Smooth muscle cells: 449.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	44	"memory B-cell: 3.9;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	48	"B-cells: 4.8"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 2214.7;GAMG: 1447.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	217.6	13.9	3.6	30.8	3.8	46.8	31.3	3.7	6.0	4.7	9.2	22.1	1.9	5.7	0.0	34.9	18.9	41.6	55.1	3.8	3.8	17.7	13.0	114.9	9.1	4.0	4.3	6.2	19.5	10.0	38.3	11.3	4.9	16.5	17.3	1.4	12.0	2.0	7.8	7.6	8.3	19.5	3.9	7.0	18.0	1.2	4.7	6.3	14.2	4.1	3.7	281.3	5.7	4.1	0.1	0.0	0.0	0.0	0.7	2.2	7.5	8.9	2214.7	43.2	151.0	0.0	0.6	0.2	71.6	15.2	1447.6	1.7	0.0	0.3	59.9	94.2	0.2	0.0	3.7	0.0	47.3	0.0	0.6	5.6	0.0	413.8	63.1	44.2	18.2	0.0	10.6	0.5	1.9	0.1	0.0	0.3	1.6	0.7	0.5	0.0	0.0	0.0	124.2	0.0	0.0	0.0	144.5	0.1	0.6	7.9	0.1	0.1	14.5	15.2	1.4	28.2	4.7	0.0	27.8	0.4	98.5	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	3.8	3.7	6.0	3.8	3.8	4.0	4.3	4.9	3.9	4.7	4.1	188.5	6.4	22.7	0.0	27.0	44.6	3.4	28.5	1.8	0.1	1.4	1.1	1.4	0.0	17.7	3.7	0.0	1.1	0.4	0.1	0.0	9.8	0.4	163.9	44.6	287.4	0.0	0.0	0.0	2.8	4.0	593.3	0.0	322.2	6.3	0.0	3.6	0.1	4.1	0.0	0.0	0.0	0.0	9.3	76.5	0.2	0.0	27.4	40.9	2.8	4.2	0.0	0.0	0.0	0.1	4.3	0.1	0.0	0.9	16.4	0.0	0.0	8.1	0.0	0.0	28.9	449.0	0.0	0.1	0.4	33.4	1.4	8.6	0.2	0.0	20.6
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.3;skeletal muscle: 94.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 115.4;Hepatocytes: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 88.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 224.4;U-266/84: 274.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	24800000	35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	11.0	5.8	6.8	25.5	8.0	16.6	5.9	7.4	11.3	7.6	4.8	14.7	15.6	8.4	2.5	7.4	12.4	9.0	6.6	6.2	6.4	14.2	58.3	16.3	27.3	10.9	8.8	8.9	8.7	1.2	8.9	6.6	9.8	6.0	9.8	1.4	3.3	2.9	94.2	6.4	19.8	8.8	10.4	19.8	10.2	3.4	10.6	9.3	2.7	26.4	22.4	9.3	5.3	10.4	3.3	5.8	0.4	0.4	3.4	5.1	0.4	3.3	2.5	2.0	1.0	0.6	3.9	0.2	7.4	4.1	12.0	1.7	1.1	17.8	1.6	62.6	1.9	0.8	2.2	13.9	0.5	9.6	5.0	3.0	10.5	1.7	26.1	0.6	2.6	0.1	0.7	24.0	0.6	1.4	0.2	16.0	1.8	1.1	13.5	0.3	0.3	53.6	10.9	4.5	0.5	0.3	1.1	36.2	59.5	4.5	3.3	224.4	2.5	3.5	3.4	3.3	2.2	43.1	274.1	0.4	4.4	61.0	5.7	7.5	29.4	28.1	0.6	18.0	1.5	1.5	15.2	1.6	36.1	0.6	14.9	5.4	88.2	1.3	8.0	13.1	21.2	15.8	6.8	8.0	7.4	11.3	6.2	6.4	10.9	8.8	9.8	10.4	10.6	10.4	3.4	115.4	82.7	18.6	11.0	37.9	72.9	8.3	13.1	0.1	7.5	7.4	9.9	25.8	33.9	1.8	0.0	0.5	16.9	38.5	0.0	4.3	35.1	34.1	5.7	10.9	7.7	3.8	5.7	1.2	1.2	26.3	25.5	48.7	61.3	1.3	3.9	108.6	42.9	0.0	5.9	6.5	14.2	41.8	79.3	14.5	0.3	63.7	24.9	44.0	76.8	3.8	4.1	3.0	3.3	7.5	8.7	0.4	41.9	58.9	60.1	15.5	29.0	0.2	0.0	28.3	19.2	0.4	1.1	7.2	29.7	1.0	17.1	0.1	15.4	17.0
IL6ST	"CD130, GP130, sGP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55995022	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 16.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		160000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	67.1	46.0	26.8	14.1	31.0	9.6	51.3	30.9	36.7	43.0	21.3	33.9	4.2	35.2	18.5	18.4	34.2	23.6	35.1	23.5	31.4	30.0	77.6	53.3	15.9	32.1	27.0	36.9	21.9	39.6	22.5	101.7	35.9	32.6	14.3	28.6	31.9	29.9	41.0	17.8	31.1	28.7	35.1	34.7	27.8	8.9	25.3	23.6	40.4	34.7	16.2	37.7	35.1	42.9	14.4	35.6	9.4	18.8	75.5	151.3	22.3	54.5	175.2	44.1	62.4	40.5	16.3	1.1	33.7	52.5	71.6	7.8	9.8	19.2	84.1	1.6	8.5	4.6	20.1	14.2	155.1	0.4	6.2	135.1	11.1	103.1	42.7	43.6	101.8	1.9	3.7	51.0	47.0	2.9	0.7	0.8	1.5	1.8	10.1	1.1	22.5	14.4	22.5	12.1	3.8	5.9	26.6	5.7	19.7	13.7	29.5	3.1	147.8	12.4	10.1	44.5	24.6	14.6	8.2	0.5	28.9	1.1	31.1	0.0	3.9	0.1	0.7	3.4	0.3	0.8	3.7	0.8	2.1	0.4	16.7	4.8	0.6	0.8	0.5	1.9	4.1	4.0	26.8	31.0	30.9	36.7	23.5	31.4	32.1	27.0	35.9	35.1	25.3	42.9	221.6	134.6	149.8	59.4	30.0	103.9	98.0	60.6	71.2	56.5	202.4	81.3	81.5	124.4	105.4	68.0	35.5	77.9	33.1	34.5	7.9	85.3	12.3	76.4	227.6	256.2	19.8	41.1	25.7	62.0	75.5	285.5	59.1	580.3	32.9	58.6	808.5	219.8	56.0	16.8	70.0	34.1	46.8	93.7	99.1	16.7	105.9	60.3	80.0	188.3	45.8	190.8	7.2	75.4	64.2	80.8	35.6	130.5	100.6	163.9	33.6	52.2	80.3	39.3	98.6	158.7	150.3	54.4	38.6	44.9	83.5	101.8	75.5	228.7	17.1	106.1
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 108.8;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 9.7;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;HDLM-2: 15.4;HEL: 18.2;HMC-1: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019590	Approved				"Secreted to blood"	NA	NA	60700		"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	2.3	1.2	0.2	4.1	0.3	2.1	1.5	0.4	0.2	2.3	0.3	5.1	6.7	1.1	0.3	3.5	4.8	3.1	0.6	0.3	0.5	1.4	4.2	3.3	8.7	0.6	0.4	0.9	1.0	0.0	0.5	0.3	0.5	1.8	4.4	0.7	1.1	0.9	0.1	8.8	8.7	1.1	0.4	3.5	3.8	1.7	1.2	0.8	1.3	0.1	4.2	2.8	1.5	0.2	0.3	0.0	0.1	0.0	0.4	0.4	0.0	1.4	1.4	1.3	1.9	0.0	7.6	0.1	0.0	4.4	4.5	4.2	0.1	0.0	0.0	15.4	0.0	18.2	0.6	2.1	0.1	0.1	25.4	1.3	0.0	0.2	0.6	4.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.0	5.4	3.2	0.0	2.4	2.6	0.3	0.2	0.0	0.1	0.0	0.2	0.8	0.9	0.0	2.0	0.3	0.0	0.0	3.4	0.0	1.9	5.2	0.3	0.0	0.4	0.2	0.0	9.7	1.0	1.0	2.2	8.7	0.2	0.3	0.0	0.5	0.8	0.3	7.3	0.6	0.2	0.3	0.4	0.2	0.3	0.5	0.6	0.4	0.5	0.4	1.2	0.2	0.6	0.0	3.6	5.9	12.2	6.0	3.2	1.2	10.8	0.1	1.3	0.9	0.7	5.7	2.4	1.8	0.0	0.0	1.3	7.8	9.8	1.2	108.8	22.9	0.8	4.9	3.0	10.5	16.0	5.1	0.0	2.5	11.2	0.6	0.0	0.1	1.8	2.4	0.9	0.0	11.0	6.2	2.0	1.0	3.3	145.5	0.6	1.9	0.0	1.0	3.4	2.0	0.0	20.1	6.0	2.6	11.5	1.2	1.0	1.2	12.4	9.5	24.2	0.4	0.0	2.2	0.5	2.3	0.9	5.2	6.5	0.0	1.6	0.1	4.6	1.7
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm		No	No		3400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavorable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	81.4	84.2	42.3	81.5	44.1	158.1	100.7	45.9	51.1	75.4	51.2	80.5	57.4	75.6	85.7	99.1	77.5	61.0	71.3	43.5	47.9	97.6	69.0	76.1	97.7	44.8	44.9	75.4	79.7	101.7	75.3	86.1	46.1	63.5	91.3	43.4	84.3	61.2	114.6	90.0	63.3	79.2	46.8	78.1	76.9	101.2	44.6	189.7	88.7	85.9	132.4	105.8	69.5	50.6	323.3	244.7	420.1	297.8	173.1	162.4	336.2	233.5	263.6	411.9	294.5	362.1	254.3	441.5	349.5	233.6	198.8	239.3	508.8	248.3	394.6	242.0	328.9	330.5	182.2	310.0	158.6	521.0	234.7	149.6	139.7	314.4	339.1	171.7	389.3	256.0	423.5	203.4	347.2	424.3	702.8	215.4	607.5	468.5	366.2	502.1	367.2	418.3	194.8	304.0	379.5	350.2	272.3	336.1	272.3	392.0	367.2	442.7	239.5	210.7	266.4	191.6	391.8	348.6	522.6	882.9	177.2	314.1	327.2	168.7	158.1	118.1	147.4	156.0	188.0	198.7	169.8	160.3	219.2	165.0	190.7	164.8	14.8	218.5	129.7	212.2	212.6	357.3	42.3	44.1	45.9	51.1	43.5	47.9	44.8	44.9	46.1	46.8	44.6	50.6	101.4	57.7	68.5	6.8	102.1	197.9	220.9	238.0	129.7	38.0	113.5	112.1	62.2	70.1	130.4	38.6	27.1	215.3	99.0	54.2	131.0	209.9	73.9	81.6	84.4	114.0	106.8	113.0	9.4	156.4	259.3	110.8	50.4	103.0	94.4	107.0	49.2	31.5	124.8	28.6	10.5	87.2	164.8	54.9	117.4	33.1	60.0	74.0	112.1	9.4	112.9	82.8	61.8	10.6	17.1	145.4	63.5	65.8	125.4	139.9	45.5	201.6	80.7	36.3	65.7	102.4	124.2	360.3	159.9	119.1	158.8	260.4	101.4	144.9	110.9	181.0
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP U3 small nucleolar ribonucleoprotein 3"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	45.8	61.8	37.1	26.4	38.7	29.3	43.9	39.3	49.1	36.9	46.6	43.4	36.6	30.1	30.4	79.8	32.7	14.2	53.1	38.3	41.6	49.6	90.4	33.9	34.9	38.7	36.7	33.3	50.6	23.2	40.1	21.1	39.5	39.7	24.4	17.8	44.8	22.2	71.5	71.6	51.6	14.0	40.0	63.0	50.9	16.8	38.7	34.7	36.1	33.1	38.4	35.1	47.4	41.2	75.1	82.9	39.5	68.8	68.6	39.0	58.5	61.6	48.8	49.3	56.6	64.1	64.3	88.7	65.5	32.2	54.5	121.7	131.1	100.0	43.4	67.2	157.3	93.6	64.9	112.8	50.6	95.9	62.5	36.1	81.0	39.8	48.8	36.6	32.8	71.3	122.8	70.4	45.4	89.9	76.3	232.9	106.4	75.7	86.4	82.1	48.4	98.3	68.1	100.2	67.1	69.4	52.2	89.8	119.4	56.8	78.5	87.9	37.6	64.0	51.9	46.4	84.6	95.4	188.5	100.3	70.7	153.2	43.0	80.6	109.0	85.2	137.4	87.3	148.8	143.2	131.5	133.8	117.4	127.3	150.7	144.3	13.7	126.4	87.4	119.3	140.9	192.2	37.1	38.7	39.3	49.1	38.3	41.6	38.7	36.7	39.5	40.0	38.7	41.2	85.9	38.5	41.6	6.5	81.4	228.5	93.1	177.0	149.7	22.4	72.1	79.4	12.1	77.2	89.7	40.5	14.6	106.8	79.0	47.5	144.8	105.2	1.6	71.7	54.9	74.0	43.9	56.8	6.8	105.9	106.5	63.0	78.0	70.9	48.7	50.8	76.4	114.1	94.2	21.9	7.1	71.2	93.6	54.3	106.6	6.6	60.9	51.0	97.8	8.4	118.0	58.2	152.4	6.0	10.2	113.7	56.0	44.0	66.5	107.0	113.8	209.5	65.2	23.7	26.3	46.1	50.7	13.9	38.2	144.4	237.4	54.9	83.3	77.2	98.8	86.9
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029447	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		340000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	109.1	89.3	42.1	68.0	43.0	105.3	188.6	44.2	41.6	169.6	37.3	100.8	75.3	113.5	48.2	169.0	199.3	64.9	70.0	39.5	45.2	67.5	63.5	83.3	78.7	46.9	43.2	331.0	313.9	55.7	65.0	81.0	46.6	97.6	121.2	22.0	87.9	66.4	272.8	180.0	74.1	100.9	45.1	68.6	93.4	36.1	43.8	95.9	75.1	124.4	122.0	119.7	137.5	48.9	271.8	150.6	201.6	211.3	309.2	558.4	200.6	180.8	298.2	425.5	361.0	265.8	235.2	485.7	128.2	220.7	119.5	183.1	433.6	369.8	371.1	119.9	135.3	362.2	205.0	257.8	264.4	388.4	139.0	497.7	403.1	414.6	756.5	331.8	313.5	337.7	221.7	266.2	354.1	213.4	327.0	258.9	269.0	255.4	300.2	143.5	218.4	487.9	251.7	166.2	130.2	128.9	198.1	216.5	341.3	170.2	277.3	166.1	151.4	181.0	347.7	449.5	468.8	253.3	193.3	227.3	214.1	421.9	188.1	21.8	27.8	10.7	43.6	46.8	81.9	79.7	58.4	47.7	51.1	79.6	84.9	71.6	10.9	60.5	41.6	38.0	40.2	45.2	42.1	43.0	44.2	41.6	39.5	45.2	46.9	43.2	46.6	45.1	43.8	48.9	40.5	64.1	60.9	3.9	92.2	202.7	255.0	253.8	229.9	16.1	202.7	231.8	32.3	74.4	122.4	36.8	14.6	327.3	34.5	51.1	80.3	133.6	2.7	49.0	120.5	60.9	60.7	112.5	2.9	187.1	280.6	104.4	70.3	51.2	66.1	98.0	52.8	24.9	95.3	15.2	4.1	124.4	114.0	55.9	105.4	6.7	123.3	50.0	88.9	1.0	67.3	26.5	24.7	4.0	5.2	108.8	70.8	71.1	64.6	160.1	47.4	92.0	53.7	15.8	39.5	149.4	215.1	22.6	62.5	195.7	195.6	314.0	52.3	166.8	266.5	157.2
INHBA		ENSG00000122641	"Inhibin subunit beta A"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 94.4;Langerhans cells: 68.0;Leydig cells: 137.6;Smooth muscle cells: 218.3;Syncytiotrophoblasts: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.9;hTEC/SVTERT24-B: 227.0;hTERT-HME1: 92.9;hTERT-RPE1: 139.2;TIME: 120.1;U-138 MG: 174.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		210000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	2.3	1.5	2.1	5.1	2.0	10.4	0.9	2.3	7.8	1.5	0.7	1.0	0.8	17.3	3.7	2.1	1.2	21.6	5.4	8.7	3.3	2.8	9.5	11.0	1.2	4.3	8.1	6.8	0.6	0.5	0.5	10.9	3.4	3.2	0.6	2.3	5.4	5.0	0.5	2.0	0.5	4.3	4.5	0.5	0.8	1.7	3.0	0.2	1.2	4.6	0.4	10.3	1.1	3.4	4.2	0.0	0.4	0.1	3.3	7.1	0.0	18.2	1.9	9.9	3.3	0.0	0.4	0.0	1.1	6.9	11.6	15.3	0.0	75.9	9.6	5.1	0.0	0.0	0.0	0.0	13.9	0.0	0.2	7.0	4.2	227.0	92.9	139.2	8.2	0.0	0.5	0.0	23.0	0.2	0.0	0.3	1.5	0.0	10.5	0.0	0.0	0.0	0.0	0.1	0.1	5.7	11.1	0.6	0.0	6.2	0.1	0.2	120.1	174.7	49.7	18.9	19.0	0.0	0.0	0.0	6.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.1	2.0	2.3	7.8	8.7	3.3	4.3	8.1	3.4	4.5	3.0	3.4	0.7	3.2	15.7	0.0	0.9	17.3	10.8	13.5	2.2	0.1	3.5	6.5	6.0	0.0	4.4	0.0	0.0	1.4	0.3	0.1	0.0	23.6	0.6	1.4	4.1	5.9	0.0	0.0	2.4	2.0	4.6	42.0	0.0	2.6	7.6	94.4	0.7	18.5	1.5	0.0	0.2	0.2	4.1	1.4	68.0	5.9	137.6	55.8	14.2	0.0	27.0	16.1	0.0	4.0	0.3	11.1	0.1	23.3	0.0	12.5	0.0	0.1	2.8	1.3	0.0	4.9	218.3	0.7	0.3	1.4	8.9	178.4	1.7	18.8	0.2	2.3
INHBC		ENSG00000175189	"Inhibin subunit beta C"	P55103	12	57434784-57452062	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	172	"liver: 165.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Hepatocytes: 5.7;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;Karpas-707: 6.3;RH-30: 2.8;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050755			Approved	Cytosol	"Secreted to blood"	NA	NA		21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA050755: "	"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	165.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.2	0.0	6.4	0.0	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	1.6	0.0	6.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	2.8	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"liver: 148.4"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Region enhanced"	"Detected in some"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	148.4	0.1	0.1	0.9	0.0	0.0	0.9	0.1	1.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.1	0.9	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 12983.6"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000			"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.2	4.0	0.1	0.2	0.1	49.8	0.6	0.0	0.0	0.7	0.0	12.8	1.5	1.4	0.0	1.8	0.3	3.7	5.6	0.1	0.1	40.7	1.4	1.7	5.4	0.2	0.4	2.6	12983.6	0.0	0.3	1.4	0.8	0.5	0.0	0.0	3.1	0.0	0.3	96.4	0.7	0.0	0.0	1.4	42.2	0.3	0.0	0.0	1.3	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 563.4"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	79.2	37.3	25.3	35.4	36.9	45.5	37.4	47.1	39.1	25.5	58.0	29.8	53.0	19.5	31.8	40.1	17.6	31.6	21.0	30.2	40.9	45.6	563.4	43.2	30.9	61.1	51.7	24.0	111.7	17.4	18.9	34.2	62.8	62.6	26.4	40.5	70.9	11.3	9.0	42.5	35.2	20.3	36.6	19.0	61.1	34.4	36.5	40.4	12.5	12.0	25.3	36.7	23.3	86.3	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	25.3	36.9	47.1	39.1	30.2	40.9	61.1	51.7	62.8	36.6	36.5	86.3	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 54.9;U-266/70: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	Yes		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.0	22.6	12.5	2.8	16.8	5.6	13.0	17.3	12.8	14.6	18.8	15.0	10.0	18.4	6.3	4.1	16.9	8.2	26.3	10.0	12.2	21.8	33.0	7.2	2.3	18.3	16.3	39.9	64.2	13.0	16.3	7.4	18.7	15.2	10.4	6.5	16.9	9.9	23.5	11.5	12.2	11.5	14.1	48.2	12.5	5.4	16.6	2.7	14.5	13.3	3.5	12.3	9.2	22.5	6.2	3.2	3.6	5.7	18.8	6.1	11.1	3.5	2.9	1.6	1.6	8.4	7.0	9.0	8.2	6.8	4.0	1.6	8.9	1.4	1.2	0.0	6.4	0.0	2.3	22.6	8.2	4.3	6.7	10.0	4.5	0.2	4.9	4.2	3.8	4.8	9.5	54.9	1.8	3.2	3.1	7.8	3.3	3.8	5.2	29.0	2.1	7.6	0.1	27.8	6.6	5.2	6.5	3.8	3.3	6.4	1.4	21.6	3.6	3.4	2.1	8.2	5.1	40.4	23.9	20.2	4.3	7.3	0.0	2.7	8.6	5.9	0.2	8.8	0.3	0.8	0.3	0.1	9.8	1.1	0.7	0.1	1.9	1.0	12.5	8.2	0.0	1.6	12.5	16.8	17.3	12.8	10.0	12.2	18.3	16.3	18.7	14.1	16.6	22.5	75.6	48.1	34.7	64.9	10.6	64.9	63.6	34.7	8.0	40.4	134.0	76.2	92.1	137.2	83.3	62.5	79.2	17.8	6.7	124.1	15.6	55.1	4.7	26.8	106.8	123.9	163.6	25.0	68.3	78.7	53.7	43.7	20.4	42.1	3.8	168.4	255.2	246.0	9.2	38.7	100.8	97.3	32.6	49.0	31.1	9.0	96.3	35.0	51.6	62.8	24.2	31.6	0.0	62.8	183.5	50.7	68.8	245.3	21.8	107.9	122.9	114.1	65.3	23.6	59.2	37.6	44.2	5.2	3.6	3.2	68.8	38.3	4.7	81.4	65.2	130.0
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324687	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	39.7	40.8	26.0	24.0	28.6	29.0	39.0	37.2	40.1	64.7	27.7	70.6	32.8	66.6	26.4	43.9	61.1	24.1	54.9	27.2	28.4	40.4	45.7	35.6	31.8	30.3	27.2	63.6	53.6	28.9	40.0	28.2	30.6	52.9	20.8	13.0	38.3	27.6	90.3	47.2	44.9	26.7	24.5	45.4	52.4	76.0	28.0	29.6	40.7	44.2	25.1	67.5	50.6	33.6	58.4	56.2	31.5	62.1	52.4	41.7	34.1	31.2	49.9	67.6	50.1	53.2	71.0	63.2	43.6	60.7	40.6	41.4	46.3	67.7	29.9	60.3	60.5	49.8	79.7	70.2	80.2	39.1	52.5	72.1	35.9	61.7	91.7	38.2	71.7	59.7	59.5	56.3	34.2	50.8	77.6	52.1	39.1	53.6	60.1	61.0	30.8	93.1	47.6	31.3	45.0	42.1	31.9	83.8	91.7	23.4	45.5	57.0	54.5	43.6	39.6	50.8	40.0	87.3	101.8	85.1	60.4	68.7	22.0	66.5	69.6	48.0	65.2	82.1	68.9	50.3	56.4	59.8	81.2	44.0	52.2	50.2	33.2	64.8	101.7	52.9	78.7	81.0	26.0	28.6	37.2	40.1	27.2	28.4	30.3	27.2	30.6	24.5	28.0	33.6	36.4	38.5	33.7	0.0	9.5	0.0	0.0	0.0	0.0	0.0	32.6	33.9	0.0	0.0	13.0	18.4	0.0	77.3	24.1	0.0	31.3	56.4	0.0	27.1	27.2	14.0	0.0	0.0	0.0	53.9	63.9	18.7	0.0	23.2	10.1	40.4	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	36.2	0.0	0.0	0.0	0.0	54.8	0.0	0.0	6.8	0.0	0.0	34.4	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	77.0	12.7	49.8	0.0	0.0
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 22.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	16.0	9.1	13.4	9.7	13.7	6.6	14.4	13.6	14.6	10.6	16.3	9.2	6.9	9.4	8.5	12.0	10.2	10.7	14.7	14.7	13.7	11.9	11.4	7.7	10.4	14.1	13.7	9.4	8.6	13.4	6.0	16.5	13.6	9.0	8.6	6.3	8.5	8.4	12.6	8.8	7.9	11.0	14.4	13.4	8.5	21.4	13.9	10.0	14.0	14.4	10.1	13.4	9.9	15.7	27.1	25.4	22.3	34.6	17.0	23.4	30.9	28.4	20.5	29.1	31.9	27.5	20.2	45.3	22.2	28.9	35.5	21.4	47.3	32.0	45.6	17.5	24.6	21.6	24.5	24.4	12.8	23.7	11.6	16.7	17.7	34.3	35.7	13.7	113.8	22.4	41.5	14.5	27.9	26.0	26.1	32.2	28.0	15.4	14.5	31.6	33.7	41.6	17.7	26.4	24.1	13.9	24.8	19.3	21.0	21.9	24.9	17.0	51.8	17.4	19.3	19.8	26.4	11.3	20.0	31.3	21.2	33.4	21.3	16.5	2.4	2.2	3.8	3.8	4.5	3.3	3.9	3.9	4.0	4.8	5.5	4.0	2.5	22.7	7.0	2.4	2.8	3.6	13.4	13.7	13.6	14.6	14.7	13.7	14.1	13.7	13.6	14.4	13.9	15.7	39.6	9.6	3.7	35.9	11.8	8.5	4.2	3.3	13.6	4.2	6.2	4.8	13.2	5.7	4.5	7.3	2.1	7.6	7.9	2.7	3.9	4.2	42.2	8.4	7.0	40.0	3.0	21.7	68.4	5.5	6.7	7.6	6.1	5.6	13.3	9.6	65.0	6.2	5.2	5.0	55.0	4.4	2.0	6.5	6.4	25.3	5.6	7.4	3.6	20.6	2.6	3.9	10.3	28.1	48.3	3.3	1.7	4.1	10.7	5.2	2.6	3.6	25.6	4.9	6.6	9.7	8.7	14.6	16.2	10.9	8.8	5.1	8.8	4.6	5.7	4.8
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750653	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	5.5	4.4	3.2	3.8	4.7	3.4	6.1	3.9	2.9	4.8	3.7	5.6	4.9	6.5	5.3	6.3	6.5	5.0	7.0	2.6	4.1	7.1	6.8	4.3	4.4	3.5	3.9	7.5	6.6	9.5	2.2	4.0	3.7	7.1	5.7	7.4	5.7	6.4	14.3	5.0	5.3	5.6	3.7	3.8	5.0	10.2	3.6	6.6	9.7	9.0	4.9	3.8	2.8	4.9	9.6	9.1	8.0	11.8	9.8	18.2	6.2	9.9	7.1	6.9	7.0	5.6	6.8	5.2	10.1	12.3	7.9	6.7	8.8	7.3	9.9	12.2	5.2	7.3	7.7	6.9	9.8	2.1	6.2	15.5	8.3	15.0	8.1	8.0	6.8	9.4	9.0	10.3	12.2	6.4	7.3	0.4	4.8	7.0	4.9	3.1	14.7	4.3	5.7	10.4	11.5	7.5	19.1	10.3	9.5	9.1	10.0	1.8	7.9	7.5	9.2	5.3	7.9	8.3	10.4	9.2	12.0	3.1	11.9	4.1	0.6	3.5	4.6	0.4	3.4	3.1	2.7	3.7	0.7	2.6	3.4	4.0	2.6	3.7	0.8	0.6	4.7	2.5	3.2	4.7	3.9	2.9	2.6	4.1	3.5	3.9	3.7	3.7	3.6	4.9	7.6	12.8	10.0	11.1	7.9	2.5	5.6	7.6	6.8	12.4	6.5	4.8	18.8	5.7	8.1	5.5	12.5	7.8	4.7	10.1	3.9	6.5	26.0	10.7	10.1	5.2	5.4	3.0	5.4	7.3	6.9	9.6	9.7	6.7	12.7	15.9	3.3	5.9	1.4	18.5	7.1	6.8	6.1	1.3	1.1	7.6	7.2	2.8	1.8	4.7	3.4	19.0	18.6	6.0	11.9	5.8	4.6	6.4	7.4	3.9	9.5	8.4	10.1	16.8	0.0	14.0	9.3	40.8	14.7	6.7	4.7	7.7	8.4	23.5	5.8	4.9
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388242-90502239	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	57.3	31.1	14.4	69.3	30.0	69.7	51.6	19.8	20.5	62.0	26.9	67.1	32.3	72.2	21.3	75.6	45.1	55.0	22.9	17.0	21.5	35.6	18.8	74.2	58.9	29.0	24.6	39.6	30.1	49.7	12.1	79.8	28.1	36.2	66.9	7.1	72.2	38.0	15.0	64.9	37.9	81.3	16.5	57.7	52.6	13.0	27.9	65.4	64.3	25.4	63.4	63.5	31.4	63.4	148.9	81.5	39.8	46.6	99.3	128.4	229.6	139.7	127.0	124.7	132.4	93.6	150.5	82.7	66.2	231.5	111.4	259.2	80.6	153.5	149.5	106.4	56.6	55.5	145.8	34.3	120.2	102.9	113.6	76.2	139.5	147.2	206.5	152.7	172.8	53.0	49.0	112.8	192.3	76.5	55.4	30.8	51.6	235.8	45.6	67.5	106.5	72.1	126.9	233.8	49.5	37.3	195.1	96.9	100.7	162.8	85.1	86.5	224.2	141.1	73.4	120.4	145.6	43.3	67.0	82.4	128.3	98.5	77.5	30.6	27.5	20.0	21.8	25.2	19.3	12.6	13.5	18.9	23.3	12.5	7.9	14.0	89.9	27.6	31.0	13.8	16.1	16.9	14.4	30.0	19.8	20.5	17.0	21.5	29.0	24.6	28.1	16.5	27.9	63.4	180.9	266.0	286.3	36.2	129.2	103.0	124.9	87.7	72.8	4.6	115.1	88.4	18.0	54.3	167.2	77.3	16.7	89.7	215.3	204.5	7.9	95.9	8.8	133.8	127.9	135.7	60.7	46.7	39.7	98.7	159.4	116.5	91.7	242.0	209.3	130.2	95.3	11.6	149.0	1.7	24.4	121.1	63.1	407.5	175.1	13.2	47.8	261.6	71.2	60.9	272.2	13.5	200.8	9.5	316.0	128.1	112.1	48.2	137.3	98.6	72.7	19.6	134.2	30.2	78.9	108.8	131.0	18.9	32.6	99.3	113.4	95.6	176.8	56.0	152.0	151.5
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	8.6	6.5	4.0	13.6	4.6	10.0	8.9	4.5	5.1	7.9	5.1	7.9	9.1	6.8	7.0	10.5	7.0	8.8	5.4	3.9	4.6	8.0	9.2	8.5	17.5	5.5	4.7	5.6	15.1	6.9	6.2	8.3	5.4	7.5	8.4	12.3	8.4	7.0	3.0	13.3	11.9	7.2	4.8	18.6	10.5	5.8	4.9	18.5	10.9	3.2	16.3	7.8	7.9	5.3	9.3	6.8	4.7	6.2	16.5	27.6	6.7	12.9	9.1	10.0	9.1	5.8	8.7	15.8	12.4	10.7	6.6	7.5	5.3	8.3	14.2	22.8	4.9	15.2	5.2	3.7	9.4	21.2	17.7	14.7	12.7	12.7	7.4	17.4	15.0	15.1	14.4	11.6	27.8	5.1	18.6	11.7	1.7	0.0	7.9	12.2	5.8	8.4	7.8	8.8	3.4	3.3	6.3	7.9	6.2	6.4	9.9	18.5	13.4	12.2	2.3	15.1	9.0	14.0	19.4	13.7	12.7	56.2	6.9	20.8	4.0	8.7	6.1	4.6	6.3	3.3	4.9	5.3	3.7	4.4	4.4	4.8	7.9	7.9	5.9	5.1	6.7	4.6	4.0	4.6	4.5	5.1	3.9	4.6	5.5	4.7	5.4	4.8	4.9	5.3	24.1	19.2	15.6	5.2	36.5	10.8	11.3	10.7	17.1	5.8	15.2	11.2	4.5	17.2	11.3	33.1	20.9	14.9	52.1	15.7	21.5	12.7	18.4	14.1	12.4	17.3	3.6	12.0	2.9	17.8	8.4	13.7	33.6	15.2	22.1	10.7	16.1	8.7	16.9	8.4	3.4	11.9	14.2	24.7	20.2	23.2	12.5	25.1	10.6	20.6	28.2	9.9	60.8	2.5	14.7	13.3	7.2	11.3	33.2	8.9	18.6	13.8	9.5	27.2	6.6	9.5	11.0	28.2	12.5	17.2	11.8	27.9	41.1	15.0	9.2	13.5
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501453	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	17.1	25.2	7.5	18.2	7.7	27.7	18.8	16.3	9.3	15.2	8.4	17.4	17.9	17.9	11.8	15.2	14.6	14.9	12.5	7.4	10.5	18.3	23.1	14.9	22.8	7.0	7.2	22.0	11.4	17.8	8.2	21.8	7.1	16.5	20.3	19.4	10.6	15.4	18.8	14.4	18.4	16.1	7.0	24.8	16.4	15.1	9.5	29.7	28.7	23.5	20.9	13.4	11.7	8.8	19.9	34.9	52.8	33.2	45.5	29.7	35.5	33.3	26.0	29.7	26.9	34.6	33.8	73.1	22.1	28.0	20.3	37.8	124.7	33.2	26.1	23.4	43.0	63.6	35.0	24.4	23.8	69.4	65.7	31.5	22.4	22.9	27.7	30.2	35.4	42.6	67.9	25.4	25.5	29.7	42.8	35.2	69.1	24.1	12.4	49.6	53.0	20.8	32.4	54.2	31.7	47.3	45.1	31.4	35.7	59.2	29.5	59.7	28.9	30.3	20.8	16.8	29.2	31.5	74.8	41.7	21.8	63.1	22.2	3.8	2.5	2.0	2.4	3.3	3.1	2.7	2.6	2.4	3.5	2.6	2.5	3.5	2.8	3.0	2.6	4.0	2.3	1.4	7.5	7.7	16.3	9.3	7.4	10.5	7.0	7.2	7.1	7.0	9.5	8.8	24.3	22.4	40.7	33.0	37.5	14.1	16.6	19.3	14.8	55.6	23.1	18.4	24.9	25.8	26.1	23.9	66.7	35.0	56.2	45.3	0.0	19.9	18.1	19.3	38.2	26.6	31.9	42.3	52.3	19.6	23.7	27.7	32.1	21.2	17.7	66.2	38.9	41.8	26.1	79.1	55.6	31.0	18.3	61.3	18.4	10.8	32.9	37.7	14.2	28.1	52.9	22.4	54.6	50.3	49.0	26.3	49.8	30.5	28.5	33.7	49.1	19.6	25.7	51.1	6.6	29.5	23.2	33.9	29.6	24.5	18.6	30.6	33.9	56.3	36.0	29.6
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028708	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	26.1	25.3	12.2	9.2	13.9	5.6	28.5	13.4	12.0	20.1	12.8	32.4	6.9	25.8	5.1	13.3	33.7	6.5	22.6	14.1	21.1	28.7	19.1	20.9	6.2	15.2	14.8	32.4	17.5	19.8	22.6	7.9	10.9	18.4	3.3	7.3	19.2	10.1	16.8	25.2	15.1	8.0	12.6	19.0	18.8	13.5	19.0	9.7	18.7	4.2	3.3	26.4	18.2	9.4	15.4	13.2	32.2	36.3	9.6	8.8	45.8	15.9	13.0	4.4	5.9	6.2	24.8	5.4	11.3	13.6	12.4	23.6	5.6	11.8	3.7	25.8	19.1	6.9	13.0	8.5	12.5	1.9	29.7	11.8	9.1	7.8	6.8	34.8	6.0	10.9	10.4	59.4	5.7	42.2	21.0	14.5	14.5	6.6	68.2	4.4	9.1	13.0	15.6	22.4	24.9	36.0	22.5	23.2	42.5	8.6	16.1	3.4	10.4	20.2	19.5	6.8	10.3	22.9	26.3	9.0	31.3	4.7	25.8	1.7	1.4	1.3	2.8	1.9	2.7	1.4	2.5	2.6	1.3	1.6	2.0	2.3	9.0	5.9	2.3	10.7	2.6	0.8	12.2	13.9	13.4	12.0	14.1	21.1	15.2	14.8	10.9	12.6	19.0	9.4	71.4	22.4	14.3	5.9	40.2	73.7	32.5	22.5	115.5	57.1	54.6	41.5	19.5	32.9	11.6	64.4	29.2	22.8	58.9	10.8	37.2	19.6	1.3	25.3	26.0	44.0	47.6	10.8	8.2	19.0	49.7	47.8	12.2	25.6	26.6	15.2	55.6	60.5	33.3	10.1	8.6	14.7	16.2	54.7	78.9	4.0	30.1	26.6	35.6	9.4	10.0	57.8	38.1	8.5	4.8	17.8	7.0	34.3	21.1	30.0	6.7	23.1	13.8	10.4	39.5	56.4	83.2	1.6	50.5	54.2	50.6	46.0	39.0	27.5	12.8	20.6
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731312-226799820	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 75.4;Theca cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.6	9.7	1.7	2.9	1.6	0.5	11.7	5.2	3.1	14.7	1.8	10.3	3.9	17.4	1.9	3.6	15.0	5.6	5.0	1.6	1.0	3.4	10.5	5.0	1.7	1.8	1.6	20.9	3.5	3.3	1.5	9.5	1.2	7.8	2.7	1.5	3.0	7.0	28.0	5.2	5.1	10.3	2.0	2.0	5.3	0.8	1.6	8.1	20.0	2.9	1.3	11.6	6.6	1.5	5.7	26.0	18.6	0.7	25.0	14.8	0.0	15.6	12.2	20.4	13.0	15.0	14.4	2.3	2.5	10.6	14.0	10.0	1.2	15.0	11.5	5.9	1.0	0.1	1.7	7.1	12.5	0.5	0.1	20.7	8.1	16.1	14.5	12.3	0.0	2.3	3.0	22.7	14.0	22.6	4.9	6.6	7.5	3.6	14.3	1.1	24.1	0.1	9.3	18.9	3.2	0.5	5.0	3.6	8.4	14.9	13.7	0.3	1.3	26.8	24.2	20.9	15.1	10.6	4.6	3.4	26.5	0.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.2	3.1	1.6	1.0	1.8	1.6	1.2	2.0	1.6	1.5	1.7	19.2	4.6	5.9	2.7	35.4	31.9	29.7	19.4	19.3	36.9	28.1	13.4	14.3	12.8	0.0	0.0	6.4	0.0	13.2	17.6	15.4	1.6	22.1	28.4	2.1	2.4	0.0	17.3	11.4	0.6	28.3	2.0	24.3	0.0	75.4	1.8	57.4	1.7	20.2	31.3	6.5	24.4	1.3	4.6	1.8	22.7	3.6	16.0	15.0	0.8	8.4	0.0	26.7	1.7	11.1	8.2	14.7	9.5	14.5	23.4	3.0	8.1	1.7	13.1	9.5	22.8	1.0	1.2	4.2	23.7	18.3	1.2	110.3	7.7	22.8
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.5;breast: 16.2;kidney: 28.9;salivary gland: 17.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		7.3	0.0	3.6	0.0	4.2	0.6	16.2	6.8	1.6	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.8	5.4	28.9	0.0	3.1	0.1	16.9	10.2	0.0	0.2	0.2	1.0	0.0	17.5	0.1	0.0	0.1	17.8	0.5	0.1	8.9	0.0	0.0	7.5	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	6.4	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.2	6.8	1.6	1.8	5.4	16.9	10.2	17.5	7.5	6.8	6.4	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.8;heart muscle: 14.3;skin 1: 22.5;vagina: 12.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	3.2	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	14.3	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.9	0.0	1.2	9.9	0.0	0.0	9.5	0.0	0.6	22.5	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.8	0.7	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
IST1	"CHMP8, KIAA0174"	ENSG00000182149	"IST1 factor associated with ESCRT-III"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041802, HPA054532"	Approved		Supported	Vesicles		NA	NA		270000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041802: AB_10794491, HPA054532: AB_2682517"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favorable (8.88e-4)"	47.7	44.1	43.2	38.8	49.7	81.0	50.5	46.2	50.6	49.0	43.9	68.3	52.4	55.9	42.4	50.5	61.4	46.8	50.4	42.9	45.3	68.7	37.9	50.0	64.3	47.2	47.6	60.0	46.9	90.4	57.2	60.1	47.1	45.7	62.9	32.4	52.0	45.8	64.1	52.5	52.0	60.8	45.5	50.6	52.5	47.4	46.1	62.2	59.4	80.8	81.6	53.0	44.3	53.8	57.0	81.9	113.3	73.2	110.7	77.9	95.7	70.0	87.1	95.2	98.9	90.1	77.1	80.5	84.2	81.2	67.7	83.8	112.0	74.2	120.4	53.7	54.1	68.1	46.8	146.9	83.8	66.9	91.9	92.7	100.8	85.5	81.6	94.8	120.6	74.8	94.5	28.7	99.5	94.9	87.4	55.6	129.7	92.7	50.6	135.7	62.0	99.1	78.5	81.8	85.0	63.3	77.2	40.3	63.9	138.2	73.7	82.2	60.7	71.8	70.9	44.5	55.9	75.0	145.5	226.7	60.7	59.2	88.6	234.9	195.1	243.5	158.7	185.4	172.6	179.1	150.6	166.9	180.1	178.5	159.6	150.1	300.0	193.7	185.1	124.9	244.9	293.9	43.2	49.7	46.2	50.6	42.9	45.3	47.2	47.6	47.1	45.5	46.1	53.8	59.7	48.1	51.8	39.8	57.1	70.1	41.2	49.8	39.9	29.2	69.1	50.0	43.9	60.1	48.1	46.0	25.0	56.7	68.4	130.6	35.2	47.1	18.4	50.0	52.8	55.4	75.4	30.7	35.5	41.7	44.3	48.1	42.3	70.1	61.4	55.1	61.1	40.8	53.4	21.9	41.6	76.3	46.8	81.1	73.8	22.5	41.0	57.2	42.7	38.4	75.9	22.2	51.5	34.2	59.7	58.1	88.4	47.8	45.2	51.5	82.2	52.4	56.2	30.3	59.2	45.3	44.4	52.4	57.3	34.4	70.0	65.7	51.8	31.3	57.6	66.4
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain					NA	NA		6300000		"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	13.9	22.4	0.6	1.0	0.8	0.0	10.2	0.7	0.9	5.1	0.4	36.6	1.1	16.3	2.5	5.7	9.9	2.2	10.6	0.5	0.8	11.0	17.1	22.1	0.8	0.8	0.8	3.6	3.1	2.1	2.3	5.8	0.8	12.6	2.7	0.1	2.3	7.2	4.6	2.3	12.5	5.8	0.8	27.9	16.6	0.8	0.8	0.2	9.7	2.5	0.4	17.9	5.1	0.9	0.0	0.0	0.3	0.0	1.4	0.4	0.1	0.3	1.3	0.3	0.7	0.7	0.0	0.0	0.1	4.5	0.5	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.3	0.3	4.5	0.0	0.0	0.7	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.5	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.7	0.9	0.5	0.8	0.8	0.8	0.8	0.8	0.8	0.9	264.1	54.5	26.8	2.9	1.7	3.2	4.7	1.5	2.8	1.8	3.6	13.8	12.6	5.7	8.7	5.5	2.1	1.5	2.9	5.5	1.9	3.0	21.3	7.7	41.8	120.5	16.4	5.3	3.6	5.4	16.8	40.2	6.1	22.1	10.1	1.0	77.1	110.5	2.2	0.0	19.5	14.0	0.0	7.2	8.2	6.1	9.3	5.6	7.2	63.7	9.1	0.4	0.0	1.5	4.2	19.6	7.7	8.2	2.9	3.2	6.5	15.1	6.3	2.0	98.6	18.6	143.9	0.9	1.1	0.5	3.1	3.4	46.0	13.6	14.0	2.3
ITGA10		ENSG00000143127	"Integrin subunit alpha 10"	O75578	1	145891208-145910111	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Endothelial cells: 22.7;Hepatic stellate cells: 55.3;Horizontal cells: 20.2;Late spermatids: 44.8;Microglial cells: 19.7"	"Cancer enriched"	"Detected in many"	4	"melanoma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 50.7;HSkMC: 46.3;hTERT-HME1: 41.0;LHCN-M2: 72.6;TIME: 125.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"prognostic favorable (7.18e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.37e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.48e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.58e-6)"	"unprognostic (2.77e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.57e-2)"	3.8	2.0	4.2	0.8	4.3	0.2	8.3	4.4	5.8	6.9	10.5	4.6	1.4	4.0	2.1	2.1	4.5	1.4	8.3	4.2	4.3	3.0	1.8	16.5	0.9	4.1	4.4	3.6	1.6	0.7	5.8	1.9	4.2	5.0	0.7	3.8	5.3	0.7	13.6	2.9	5.7	1.9	4.3	2.0	4.6	2.8	4.7	0.5	5.6	2.8	0.9	6.6	3.5	3.7	0.0	1.4	0.2	0.3	1.3	50.7	0.0	0.6	14.2	0.2	0.6	0.0	0.7	0.3	0.8	0.3	0.1	0.3	0.4	1.3	0.5	0.6	0.1	0.2	0.0	0.5	9.2	0.2	0.7	46.3	2.7	1.9	41.0	19.4	23.5	1.5	0.1	0.2	72.6	0.3	0.1	0.5	0.2	1.1	1.1	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.6	0.5	0.8	0.3	125.7	22.2	0.3	0.3	0.3	0.2	0.8	0.1	2.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.3	4.4	5.8	4.2	4.3	4.1	4.4	4.2	4.3	4.7	3.7	7.3	0.0	3.7	0.7	1.8	2.3	6.3	0.6	0.6	10.5	10.2	16.5	4.3	0.0	2.8	7.3	8.4	0.8	2.7	0.4	0.0	0.1	36.0	1.1	1.3	22.7	0.0	0.0	3.9	0.2	0.5	4.2	2.0	1.4	0.0	0.2	55.3	0.8	0.6	20.2	4.0	0.2	0.0	0.6	2.2	44.8	0.9	1.2	0.0	19.7	0.6	0.6	2.1	2.5	0.8	0.0	0.1	0.7	0.1	3.6	0.2	0.0	0.4	7.3	0.0	4.8	3.9	5.8	1.9	2.0	2.7	0.8	1.8	0.4	0.7	1.3
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 406.2;Oligodendrocytes: 370.9;Pancreatic endocrine cells: 558.7;Prostatic glandular cells: 299.3;Urothelial cells: 363.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 91.4;HaCaT: 92.5;hTERT-RPE1: 83.2;HUVEC TERT2: 83.5;TIME: 71.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		43000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.4	12.8	2.4	4.9	6.7	0.4	7.8	4.4	3.7	5.0	0.9	6.1	7.7	4.9	7.4	11.0	2.6	9.0	1.1	2.4	4.2	9.8	0.5	12.5	0.9	4.8	4.9	1.0	1.6	9.3	1.2	4.8	5.4	6.6	5.9	2.4	10.4	11.1	0.5	17.1	7.7	2.4	3.3	6.8	7.5	0.4	4.8	4.3	2.3	0.7	4.6	15.6	8.0	12.9	60.4	15.4	1.3	0.8	3.9	7.1	4.5	60.2	91.4	2.2	3.6	29.0	41.8	0.1	9.8	25.4	33.5	92.5	4.9	67.1	8.5	0.0	4.4	4.3	3.7	17.5	13.3	0.7	1.3	2.9	11.4	59.2	10.5	83.2	83.5	3.1	0.1	0.2	1.6	11.4	0.6	0.1	3.7	15.7	29.6	0.0	0.4	0.1	18.9	32.0	0.6	3.2	3.2	4.1	6.1	2.3	9.6	0.2	71.2	10.8	6.3	1.7	12.1	0.0	0.1	0.1	64.0	0.0	48.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	6.7	4.4	3.7	2.4	4.2	4.8	4.9	5.4	3.3	4.8	12.9	7.4	57.7	13.7	9.1	0.6	151.0	406.2	141.3	56.9	2.7	24.4	39.0	1.3	15.7	133.2	53.3	4.2	1.9	0.9	23.2	9.8	144.0	0.1	20.3	5.0	39.0	13.8	0.0	0.5	169.3	2.2	11.6	13.3	90.6	1.3	45.4	5.3	0.2	0.3	0.0	0.9	37.8	20.3	0.0	6.1	0.2	1.2	2.5	12.4	14.0	1.1	14.7	0.0	0.0	370.9	558.7	20.3	0.0	2.6	299.3	20.6	3.8	103.6	4.3	0.0	4.4	12.1	0.0	1.3	57.0	37.2	0.4	5.8	23.7	30.9	363.9
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;epididymis: 10.7;lymphoid tissue: 11.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.1;Erythroid cells: 43.5;granulocytes: 17.8;Late spermatids: 24.8;Macrophages: 23.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 64.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 64.5"	"Group enriched"	"Detected in some"	14	"HEL: 404.6;HMC-1: 631.7"	"Not detected"	"Not detected"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		NA	NA		90000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.8	0.2	3.7	0.2	3.6	16.6	0.4	4.0	4.8	1.5	3.8	0.3	0.0	0.9	10.7	0.3	1.5	0.8	1.4	3.5	3.6	1.0	0.5	5.1	0.2	3.6	3.5	1.5	0.1	1.3	1.9	1.1	3.6	0.6	0.1	1.6	0.1	0.8	0.6	0.1	0.3	0.2	3.3	11.2	0.3	2.9	3.5	0.1	3.1	1.1	0.1	0.2	0.7	3.7	0.5	0.7	2.2	0.3	0.1	0.3	18.4	0.3	0.1	0.8	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.6	1.8	0.0	0.4	0.4	1.1	404.6	0.3	1.3	0.0	0.2	631.7	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.7	1.1	0.0	0.7	0.5	36.4	0.8	0.0	0.7	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.5	0.5	0.1	1.5	4.5	0.9	0.3	0.2	0.7	0.0	0.0	0.4	0.2	0.3	0.4	0.3	0.8	64.5	0.3	4.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	4.5	0.0	0.0	0.8	0.0	19.3	3.7	3.6	4.0	4.8	3.5	3.6	3.6	3.5	3.6	3.3	3.5	3.7	0.3	0.0	1.5	1.0	0.4	0.3	0.4	0.1	1.8	5.1	0.2	1.1	1.5	1.5	1.3	5.5	8.4	1.3	0.1	0.6	0.0	0.0	16.1	1.0	0.7	2.1	0.0	43.5	4.1	0.0	1.4	1.1	0.0	3.2	17.8	0.1	3.6	0.0	0.2	3.3	2.8	0.0	0.0	3.1	0.7	24.8	1.8	23.0	0.0	1.0	2.9	1.3	0.0	9.5	4.6	0.1	0.0	1.9	0.1	0.3	0.0	0.0	0.0	3.0	0.0	1.8	0.7	3.4	7.4	0.5	0.0	0.7	0.6	0.1	0.3	0.3
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 47.1;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	4	"B-cells: 86.3;dendritic cells: 151.5;Erythroid cells: 169.3;Macrophages: 72.0;monocytes: 73.8;NK-cells: 126.7;Plasma cells: 141.6;T-cells: 129.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.0;HEL: 308.1;JURKAT: 142.3;MOLT-4: 373.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 12.9"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.3	2.3	1.2	31.5	0.5	47.1	3.8	4.1	1.5	12.7	3.0	8.7	8.7	3.3	1.4	2.3	1.5	9.8	1.5	4.1	1.3	2.7	5.7	12.7	37.2	1.4	1.6	1.4	1.5	0.9	0.4	14.7	2.9	3.5	10.3	8.6	2.9	2.5	0.6	1.2	11.7	5.2	0.9	45.5	10.4	0.8	2.4	74.1	2.0	0.9	26.1	9.5	1.4	1.3	0.3	1.3	4.6	0.1	38.9	55.0	0.0	42.3	46.7	19.5	42.0	0.0	0.0	32.4	0.2	164.0	17.4	23.4	14.0	0.7	22.3	0.0	3.4	308.1	1.1	0.0	4.0	123.4	6.8	39.2	0.0	1.2	0.0	20.5	2.3	142.3	0.1	45.5	12.7	0.0	373.6	117.9	3.7	0.0	0.2	78.1	20.3	5.1	0.0	0.0	8.2	2.6	0.1	0.4	1.4	1.6	0.0	82.9	23.2	6.5	4.1	0.7	8.5	90.9	77.5	18.6	3.7	59.5	90.3	29.5	55.0	137.4	42.0	131.3	32.1	37.3	46.9	52.4	66.0	33.0	26.5	33.1	7.1	32.2	139.6	17.5	13.4	65.2	1.2	0.5	4.1	1.5	4.1	1.3	1.4	1.6	2.9	0.9	2.4	1.3	2.8	0.0	6.7	0.0	86.3	0.3	0.2	1.2	0.0	2.3	1.1	1.4	1.2	2.8	1.8	0.0	6.2	0.1	151.5	0.1	0.0	0.0	0.0	4.4	6.5	1.4	0.0	169.3	9.4	0.0	0.3	6.3	7.1	6.4	18.9	0.3	1.8	0.2	5.9	0.0	0.5	0.1	0.0	24.5	4.4	0.0	0.6	72.0	0.0	7.5	73.8	0.2	126.7	15.6	0.3	0.0	0.4	0.0	141.6	0.3	0.0	0.2	0.8	6.4	0.0	0.7	8.3	0.7	1.2	0.3	0.6	0.4	129.9	0.4	0.2	0.2
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419266	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 398.8;smooth muscle: 361.9;urinary bladder: 386.5"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 101.5;Extravillous trophoblasts: 391.9;Hepatic stellate cells: 88.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 615.4;HUVEC TERT2: 1360.8;TIME: 1277.7;U-87 MG: 623.6"	"Region enriched"	"Detected in many"	5	"basal ganglia: 10.4"	"Low region specificity"	"Detected in many"			"HPA002642, CAB009008"	Enhanced					NA	NA		26000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavorable (4.07e-6)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavorable (2.91e-4)"	"prognostic unfavorable (2.23e-5)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (2.18e-3)"	114.4	47.1	8.7	136.2	9.2	46.4	69.1	9.2	13.8	64.0	9.7	398.8	15.3	106.1	5.0	72.3	71.1	50.8	113.9	8.5	9.0	26.6	48.6	121.7	17.5	11.3	9.9	39.3	20.9	14.9	10.5	91.6	11.3	141.9	40.6	1.3	24.5	114.9	29.1	50.5	87.6	361.9	10.6	16.3	90.8	4.0	17.1	13.2	40.5	25.7	12.5	386.5	76.9	9.8	65.4	23.9	43.6	0.6	130.8	278.7	113.5	286.0	308.2	300.9	220.6	17.1	15.3	0.5	206.9	308.5	149.1	10.1	12.5	81.4	197.4	0.4	12.2	28.1	31.3	1.1	179.5	88.7	44.4	206.8	39.2	351.9	258.3	615.4	1360.8	15.6	25.6	0.8	165.4	6.4	13.7	99.2	18.1	4.2	19.1	13.7	29.2	6.2	46.9	1.1	0.1	0.6	57.7	4.3	2.2	93.8	7.1	79.9	1277.7	353.0	62.3	85.9	121.5	0.3	3.6	0.7	623.6	83.0	118.5	16.4	64.9	0.5	14.2	27.3	11.2	0.1	10.9	10.9	62.6	0.3	7.7	6.6	89.1	26.4	24.0	3.4	4.9	42.9	8.7	9.2	9.2	13.8	8.5	9.0	11.3	9.9	11.3	10.6	17.1	9.8	58.3	3.2	4.4	1.6	2.7	14.3	3.4	11.3	4.0	1.1	6.1	2.8	16.3	14.3	4.9	0.0	0.0	5.4	19.6	0.0	0.0	34.0	0.3	1.7	32.1	101.5	0.0	3.4	1.4	3.4	391.9	45.0	0.5	3.0	19.7	5.1	88.9	27.1	28.4	0.0	1.2	0.0	2.0	22.8	58.5	0.5	6.5	38.5	10.6	14.0	24.6	0.0	21.6	0.0	0.2	8.8	0.0	4.5	8.7	3.6	0.0	0.2	1.8	1.1	13.1	11.1	30.7	0.2	0.7	1.3	10.7	34.6	14.3	2.4	0.0	2.0
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 144.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.9"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		3300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	45.9	8.3	20.1	27.8	16.7	5.8	55.6	16.6	20.3	64.3	42.8	65.4	74.2	43.1	9.5	25.1	25.3	37.2	29.2	17.2	20.9	42.7	8.8	29.3	18.7	20.8	18.8	5.6	42.0	14.0	6.2	76.8	19.3	24.4	62.4	7.3	81.0	30.8	27.7	46.6	67.4	39.0	20.5	41.2	66.1	26.1	25.0	33.9	21.1	42.6	21.4	55.0	26.8	16.5	77.5	64.8	26.7	49.1	1.4	0.9	146.3	326.2	34.6	32.1	20.0	36.2	141.3	0.7	90.9	86.8	73.8	356.8	17.7	705.8	58.1	0.7	16.6	1.9	64.8	58.7	4.8	21.4	2.4	6.2	298.9	2.0	301.4	32.9	209.6	40.8	0.3	5.5	41.6	3.7	5.9	17.8	48.2	214.2	54.5	1.1	82.3	1.6	48.0	106.6	0.8	3.4	61.2	0.1	69.7	28.0	13.1	1.4	97.9	44.9	41.1	84.2	56.8	4.8	3.6	1.9	1.7	7.2	185.0	4.4	0.2	22.9	5.3	0.0	10.7	0.2	6.7	6.4	0.1	0.5	12.8	5.9	0.7	7.1	0.0	0.0	8.1	4.3	20.1	16.7	16.6	20.3	17.2	20.9	20.8	18.8	19.3	20.5	25.0	16.5	327.2	9.6	19.5	88.5	8.8	244.7	236.4	43.4	88.8	1.4	55.0	72.8	32.5	22.8	10.5	27.6	56.3	103.8	14.4	139.6	5.9	34.4	31.2	82.5	34.8	196.0	57.4	1.7	4.0	62.1	26.5	20.8	219.7	149.3	8.2	103.4	11.7	21.5	25.5	1.7	6.1	128.8	20.3	3.2	20.8	46.8	4.1	10.0	51.6	119.9	1.7	1.3	29.9	1.5	8.8	127.9	104.2	2.6	109.0	184.8	54.5	52.2	9.2	13.9	0.0	11.8	18.4	7.7	20.2	141.5	84.0	22.3	30.1	44.0	146.3	247.6
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513954-15719922	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 37.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.8;Inhibitory neurons: 56.1;Microglial cells: 34.7;Oligodendrocyte precursor cells: 64.8;Plasma cells: 25.5;Sertoli cells: 52.6;Smooth muscle cells: 57.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;HMC-1: 19.8;HSkMC: 8.7;U-266/84: 9.7"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 14.1"	HPA003432	Approved		Approved	"Plasma membrane"		NA	NA		200000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	8.6	10.5	1.6	2.1	2.1	0.1	2.7	1.9	5.0	23.8	8.0	6.1	6.7	9.7	5.5	9.8	8.8	6.7	7.7	7.0	0.9	10.0	0.7	20.8	3.2	1.5	2.8	5.7	0.8	4.7	3.2	0.2	1.1	37.4	6.1	1.6	1.8	30.8	2.9	3.3	6.8	9.1	1.5	19.9	19.3	0.6	1.5	1.0	5.6	6.9	4.4	15.7	9.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	8.4	2.5	0.0	0.0	0.0	0.0	19.8	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.7	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	1.9	5.0	7.0	0.9	1.5	2.8	1.1	1.5	1.5	2.2	1.2	0.0	1.3	0.7	2.4	1.0	1.9	0.0	0.6	6.3	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.0	11.4	0.0	0.0	82.8	0.0	0.0	10.1	0.0	0.2	0.0	0.0	4.2	0.0	0.1	0.0	56.1	0.0	0.0	0.0	1.8	0.1	0.9	0.5	1.8	34.7	0.0	13.6	0.0	64.8	4.0	0.0	0.0	0.0	25.5	1.5	0.0	0.0	0.0	0.3	52.6	11.3	57.6	0.0	0.2	0.4	1.1	0.0	1.2	0.1	0.1	1.4
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 51.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.9;Late spermatids: 8.8;Macrophages: 15.8;Proximal tubular cells: 4.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 5.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 167.8;HEL: 163.4;RPTEC TERT1: 109.8;U-87 MG: 78.3;WM-115: 255.9"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		38000000	"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	8.0	0.6	0.3	9.5	0.7	6.2	5.3	0.7	1.0	3.8	1.0	16.9	3.5	13.2	2.6	4.2	7.6	3.5	5.5	0.5	0.8	15.0	3.4	5.6	0.9	2.3	1.0	1.5	0.7	1.2	1.2	4.5	2.0	4.8	7.0	0.9	2.6	16.1	1.5	2.7	5.8	22.9	1.2	2.9	3.8	2.5	1.2	0.3	51.4	2.4	1.2	9.6	2.6	1.1	0.1	1.5	0.7	0.1	8.6	3.8	0.1	4.7	23.1	9.6	8.6	0.3	0.1	0.6	167.8	1.2	13.4	0.0	0.1	0.0	12.6	3.4	0.0	163.4	0.5	0.0	7.8	0.0	0.2	3.4	0.0	54.6	1.4	6.7	43.6	2.5	0.5	0.3	2.1	0.0	1.0	0.1	0.1	0.0	0.8	0.0	4.2	0.0	109.8	0.2	0.0	0.5	5.6	0.0	33.2	8.8	0.1	0.2	47.1	2.1	2.4	1.3	11.7	0.2	0.1	1.1	78.3	0.0	255.9	5.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.0	6.8	0.3	0.7	0.7	1.0	0.5	0.8	2.3	1.0	2.0	1.2	1.2	1.1	1.3	0.0	0.0	0.0	0.5	0.1	0.2	0.9	0.0	0.0	0.1	0.3	0.8	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	3.9	0.8	0.9	3.1	0.0	0.0	0.4	0.4	0.0	2.1	0.0	0.9	0.0	0.6	1.8	0.7	0.8	0.0	0.6	0.0	0.0	0.3	0.7	8.8	0.3	15.8	0.0	1.0	0.4	0.0	0.0	0.0	0.4	1.5	0.0	1.2	0.0	0.3	0.0	4.6	0.2	0.0	6.6	0.3	2.1	0.0	2.0	0.1	0.4	1.2	0.3	0.4	0.0	0.2
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 200.6;skin 1: 205.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 173.6;Distal enterocytes: 133.3;Gastric mucus-secreting cells: 165.1;Pancreatic endocrine cells: 284.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 897.3;HaCaT: 345.1;HBEC3-KT: 768.6;hTCEpi: 256.9;RT4: 254.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 37.4"	"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		980000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	39.2	5.3	82.8	12.4	87.8	1.6	66.6	74.9	91.8	58.4	76.4	87.5	56.9	24.0	3.6	101.2	43.8	20.0	22.7	80.5	86.9	18.2	5.6	18.4	4.5	104.6	104.8	8.5	24.5	2.8	21.1	35.4	82.6	85.3	15.7	8.7	200.6	18.5	6.8	205.9	75.5	6.4	102.4	76.9	79.9	4.9	82.0	4.1	17.6	6.0	7.2	58.4	98.8	99.6	172.7	148.5	0.3	2.1	0.4	1.3	199.2	0.7	0.6	0.5	0.9	16.1	897.3	0.1	31.5	0.3	1.3	345.1	1.0	768.6	0.5	0.7	0.6	0.9	39.6	17.0	1.2	0.2	1.8	1.1	256.9	0.6	159.2	18.0	5.5	0.6	0.5	15.7	0.1	95.8	2.0	2.0	1.0	92.8	127.8	2.7	4.4	2.2	204.8	254.9	0.2	1.9	4.9	15.2	2.2	5.3	63.9	1.5	16.9	4.6	7.8	0.7	1.9	5.6	2.1	0.7	2.0	0.8	2.7	0.0	0.2	0.0	0.4	0.4	1.1	0.7	0.1	0.5	0.0	2.0	0.4	0.3	0.7	0.0	0.0	4.6	0.8	0.4	82.8	87.8	74.9	91.8	80.5	86.9	104.6	104.8	82.6	102.4	82.0	99.6	26.9	12.8	2.2	50.3	1.4	49.5	45.1	173.6	67.2	0.3	21.2	36.6	7.5	25.8	38.9	23.9	2.1	89.8	1.8	133.3	1.9	33.3	0.4	61.3	5.7	26.8	9.6	0.8	0.7	28.8	20.2	5.2	165.1	60.2	2.5	1.1	17.9	0.4	9.4	0.0	0.7	59.2	18.3	0.3	5.4	0.4	3.7	1.9	12.4	1.9	0.1	34.4	0.0	1.5	0.7	284.4	68.4	1.5	2.6	17.1	94.0	2.6	53.3	1.0	0.0	1.2	5.0	1.1	8.2	28.1	13.1	111.1	1.8	0.5	60.1	42.0
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		64000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	102.7	32.5	24.4	26.0	33.4	3.3	71.3	32.6	20.3	84.7	71.0	48.1	33.1	75.9	16.4	54.9	33.2	71.7	68.8	24.6	28.7	48.6	51.4	53.9	6.0	38.2	32.9	28.0	23.1	21.8	20.5	82.3	35.4	37.3	24.9	14.3	49.6	46.9	30.0	88.9	32.5	60.1	32.3	41.0	29.7	13.5	32.5	12.2	34.3	33.7	9.9	40.3	70.0	35.8	189.1	459.9	32.4	82.7	296.6	84.2	166.3	197.5	120.0	35.9	57.6	92.6	240.3	0.8	93.5	336.3	177.0	148.0	29.5	102.7	31.2	2.0	20.1	66.3	69.5	98.0	51.0	0.4	116.8	51.2	23.2	91.1	46.9	508.7	121.2	0.2	60.7	98.1	122.7	190.0	0.8	1.1	145.8	105.1	50.4	0.4	52.2	71.8	98.8	41.2	0.9	67.5	146.6	214.5	165.7	56.4	121.9	4.2	318.2	134.9	200.7	118.5	103.7	16.6	18.4	1.3	141.3	0.8	477.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	2.5	24.4	33.4	32.6	20.3	24.6	28.7	38.2	32.9	35.4	32.3	32.5	35.8	50.4	6.4	6.7	55.5	1.0	17.2	23.1	18.8	6.2	8.1	20.6	27.2	28.9	42.9	10.0	29.5	4.2	68.5	0.6	34.9	11.7	38.3	10.7	22.0	21.4	27.5	3.5	2.7	0.9	18.8	7.4	52.1	11.2	13.4	0.0	135.9	31.1	39.1	72.3	35.3	18.1	12.9	2.0	36.8	17.5	4.1	20.2	28.5	10.6	60.9	0.4	50.2	0.0	16.6	12.5	70.4	27.0	16.6	0.6	24.9	21.0	10.7	6.2	14.9	39.5	31.3	52.1	2.6	7.0	15.6	22.3	55.1	1.7	1.0	16.3	14.8
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	99	"Karpas-707: 4821.4;RPMI-8226: 3980.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.6	1.4	1.7	20.0	1.8	15.5	1.9	1.7	2.2	2.7	2.0	9.7	11.7	1.6	2.8	6.4	2.9	3.9	0.8	1.5	2.0	4.7	5.3	6.6	29.2	2.3	1.8	0.7	1.2	0.7	1.3	0.5	2.0	1.7	9.5	1.0	4.1	2.3	0.7	11.9	17.3	2.4	1.9	30.0	8.2	0.6	2.8	8.6	3.1	0.6	26.5	6.2	2.9	2.1	0.1	0.0	0.0	0.3	0.1	0.7	1.4	0.5	0.0	0.0	0.5	0.0	2.1	44.5	0.8	0.0	0.0	9.4	0.0	0.3	0.0	16.5	0.0	1.5	0.0	0.0	0.0	1.0	18.5	1.0	1.8	0.2	0.1	0.6	0.0	2.2	0.4	4821.4	0.0	1.6	0.9	7.0	0.3	41.7	0.1	1.8	0.0	3980.8	0.0	1.2	1.9	0.6	0.1	1.8	0.5	0.0	0.8	10.4	0.0	0.3	0.6	0.9	0.0	8.9	17.9	3.8	3.8	2.6	1.6	80.7	5.6	97.7	52.0	1.4	38.2	28.1	51.8	63.0	44.5	29.8	44.5	44.4	1.5	23.7	0.4	11.9	71.8	17.3	1.7	1.8	1.7	2.2	1.5	2.0	2.3	1.8	2.0	1.9	2.8	2.1	1.0	3.2	5.5	1.3	45.1	2.2	0.3	1.7	3.4	0.1	1.3	1.0	0.5	2.8	1.3	7.3	4.2	0.1	62.3	0.6	7.9	0.3	0.0	1.2	0.4	0.9	0.0	2.1	0.0	0.5	0.1	1.3	2.6	2.4	29.2	0.1	0.4	2.2	13.3	0.0	0.1	0.5	0.0	3.7	10.3	0.3	0.0	17.3	7.2	1.9	13.3	7.0	134.9	0.0	0.5	0.9	1.7	0.0	115.9	0.2	0.0	7.6	0.2	0.8	0.0	1.0	8.2	0.2	1.4	3.3	3.7	0.1	62.5	0.1	1.2	1.4
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777595-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	782	"liver: 1504.9"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1087.0"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	59000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.2	1504.9	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	1.9	0.4	0.4	0.0	0.4	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.1	0.0	29.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	1087.0	0.1	0.0	0.0	0.0	0.0	20.2	0.0	1.7	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.1
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	668	"liver: 2156.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.3	0.1	1.1	0.1	3.0	1.6	3.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.6	1.0	0.8	2156.1	0.6	0.1	0.6	0.5	0.0	0.2	0.0	1.7	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.9	0.3	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	1.6	3.2	0.6	1.0	0.6	0.5	0.6	0.9	0.9	0.7	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 792.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1183.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 17.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	5.0	0.7	0.5	0.9	0.7	0.0	2.1	0.5	0.8	5.3	0.4	1.1	0.3	3.5	1.7	1.3	3.4	1.2	0.7	0.5	0.4	0.7	792.7	3.0	2.5	0.4	0.4	2.8	0.3	0.1	0.3	1.7	0.5	1.1	1.0	0.1	0.4	2.4	0.6	1.3	1.2	1.2	0.4	8.1	1.2	3.5	0.4	0.2	1.2	0.4	1.7	1.4	2.3	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.5	0.8	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.1	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.5	0.1	1.4	0.8	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.1	0.1	3.5	0.0	90.9	0.0	0.0	0.1	2.1	0.0	0.0	0.0	12.3	66.4	1183.8	0.0	0.0	0.0	0.0	0.0	85.1	0.3	132.0	1.2	0.1	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	9.1	0.4	0.3	0.0	0.1	0.3	3.6	19.2	0.0	0.1
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain 4"	Q14624	3	52812962-52830688	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"liver: 1863.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	58000000000	"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	4.2	18.5	4.1	1.2	4.2	10.0	3.0	3.7	5.0	4.2	3.5	3.6	1.0	2.9	1.7	1.4	3.8	1.1	3.2	3.9	3.6	5.4	1863.4	4.9	1.7	3.9	3.8	2.4	48.9	0.1	4.3	0.7	3.9	4.0	1.0	3.3	2.1	1.8	40.3	2.5	3.4	1.5	3.6	7.4	3.9	1.8	3.8	2.2	5.2	2.8	1.2	5.3	3.3	3.9	0.0	0.1	0.4	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.0	0.0	0.2	2.4	0.1	1.0	0.0	1.2	0.4	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.0	0.3	0.8	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.3	0.1	0.0	0.4	0.4	0.0	3.0	1.4	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	4.1	4.2	3.7	5.0	3.9	3.6	3.9	3.8	3.9	3.6	3.8	3.9	0.7	0.0	1.1	22.5	0.9	0.8	0.3	0.3	0.0	10.0	0.6	1.3	1.1	2.8	0.8	0.0	12.5	0.0	0.4	0.1	0.0	0.3	119.2	0.7	0.7	0.8	0.0	8.4	11.6	2.6	0.0	0.6	1.1	0.4	0.0	2.7	2.5	134.6	0.5	5.0	8.6	0.2	0.0	2.2	1.0	126.5	1.2	1.3	0.0	5.6	1.9	2.3	2.1	3.0	3.1	2.3	0.5	1.9	0.7	0.2	0.0	0.3	0.3	6.0	6.6	6.2	2.4	1.3	1.5	0.0	0.3	0.3	1.2	3.2	0.1	0.1
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876540-160885180	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 757.3;intestine: 1247.8"	"Cell type enriched"	"Detected in many"	14	"Intestinal goblet cells: 1818.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 9.2;non-classical monocyte: 24.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 24.1"	"Group enriched"	"Detected in some"	4	"HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	6400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	757.3	0.3	0.0	26.4	0.0	2.6	0.5	0.0	0.0	0.3	0.0	444.2	272.7	0.5	2.1	0.4	6.2	0.8	233.8	0.0	0.0	35.5	3.1	40.3	0.3	0.0	0.0	9.7	3.3	0.0	0.4	1.3	0.0	0.6	1247.8	0.0	24.9	3.3	0.7	0.2	415.7	7.7	0.0	2.5	15.9	2.0	0.0	0.7	0.6	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	71.4	2.1	3.7	0.0	0.1	0.1	46.4	0.0	37.7	0.8	0.0	0.0	4.3	18.0	4.0	0.0	3.6	1.4	87.8	8.6	0.0	1.3	1.4	60.7	1.9	0.8	0.0	0.0	1818.6	0.0	124.7	0.0	0.7	14.6	1.8	0.0	0.0	0.3	0.0	1.0	0.0	0.0	7.3	17.7	3.0	0.0	0.3	15.4	0.1	0.8	0.0	0.0	0.0	10.8	0.1	0.9	0.0	0.0	0.3	2.1	15.3	59.4	0.1
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26335352-26833194	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 551.4;Excitatory neurons: 287.2;Microglial cells: 802.9;Oligodendrocyte precursor cells: 441.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: AB_2683925, HPA062260: AB_2684728"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.3	10.4	10.5	8.1	7.3	6.0	17.3	6.3	9.7	4.8	3.4	6.2	5.3	5.2	5.7	7.4	5.5	5.5	3.7	7.7	8.7	12.6	44.3	5.6	7.9	19.1	13.2	5.9	7.7	11.4	2.2	10.9	14.9	5.5	6.6	8.8	16.9	2.9	1.8	10.2	4.9	4.5	13.1	6.7	5.2	2.5	16.1	20.1	4.3	4.1	6.8	4.9	4.7	15.6	4.9	2.0	2.9	4.6	8.5	8.6	3.0	4.4	6.1	3.0	3.1	0.2	2.4	16.5	2.7	5.9	3.3	5.2	15.1	9.3	4.0	3.9	5.1	13.5	4.4	27.1	7.9	12.0	5.8	8.1	1.2	6.3	11.6	6.2	28.5	6.5	6.4	5.1	3.9	4.0	8.6	17.8	12.2	4.4	1.5	2.9	7.0	10.7	7.3	7.4	0.9	4.5	19.8	3.5	11.4	11.3	7.7	6.0	62.6	6.0	2.3	5.9	5.7	4.9	4.2	31.2	5.7	5.6	3.9	32.4	6.4	9.9	2.9	2.7	2.5	5.4	2.6	2.4	1.4	5.0	3.0	2.7	17.3	4.8	4.3	11.9	4.4	1.0	10.5	7.3	6.3	9.7	7.7	8.7	19.1	13.2	14.9	13.1	16.1	15.6	27.1	48.1	52.9	551.4	45.7	20.9	17.8	3.3	31.3	3.2	87.0	57.1	24.5	34.3	8.6	23.9	146.0	21.0	39.1	7.7	7.9	20.8	3.1	13.3	64.9	38.5	78.5	33.4	287.2	23.4	9.5	20.3	16.8	22.7	44.4	60.0	25.0	123.7	39.5	0.0	99.1	46.1	32.6	46.3	8.2	6.7	18.0	68.7	33.8	802.9	28.2	13.0	41.2	441.8	22.3	17.6	37.0	17.7	83.6	25.9	14.5	14.6	5.0	64.7	0.0	22.7	17.6	3.6	6.3	54.3	26.7	27.9	29.2	43.4	11.7	15.8
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
ITPRID2	"CS-1, KIAA1927, KRAP, SPAG13, SSFA2"	ENSG00000138434	"ITPR interacting domain containing 2"	P28290	2	181891730-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 175.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 30.7;Cardiomyocytes: 30.0;Cytotrophoblasts: 25.7;Extravillous trophoblasts: 26.8;Hofbauer cells: 20.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 6.1;monocytes: 5.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	30.8	20.7	55.0	20.6	62.9	42.4	32.1	57.2	66.2	30.9	50.3	50.4	36.4	25.8	18.4	22.8	20.3	37.7	24.4	45.5	61.5	48.4	79.3	44.9	17.6	65.2	60.5	13.6	175.8	20.9	18.3	34.7	63.3	34.0	44.2	16.9	69.9	17.1	31.9	112.9	34.0	25.6	57.3	32.4	56.1	37.4	62.6	24.1	36.5	23.4	16.0	31.3	29.5	61.1	56.0	25.8	71.6	12.6	53.8	41.3	21.7	94.6	82.6	29.1	37.0	25.9	56.0	1.2	30.7	59.7	31.5	46.2	14.5	41.6	56.6	25.2	20.3	52.5	106.6	23.5	45.7	28.5	48.9	30.0	64.4	51.3	57.7	66.7	145.8	22.3	25.0	29.5	82.9	28.7	25.4	41.0	5.0	47.0	62.5	18.7	29.3	19.2	87.0	16.3	13.7	12.1	55.7	19.7	91.0	27.6	14.2	61.6	68.1	73.1	37.0	27.5	50.3	20.9	9.4	21.9	34.0	17.1	57.2	6.1	2.8	4.2	0.9	2.7	0.6	0.4	0.6	0.6	2.7	0.9	0.8	0.7	4.7	0.8	5.1	2.1	0.4	1.3	55.0	62.9	57.2	66.2	45.5	61.5	65.2	60.5	63.3	57.3	62.6	61.1	30.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	25.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	26.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	33.4	1.1	0.0	0.0	0.0
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.4;Inhibitory neurons: 151.9;Rod photoreceptor cells: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.5;non-classical monocyte: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	55.5	15.5	18.0	9.9	18.4	6.8	27.9	16.4	26.2	19.8	22.8	14.7	8.9	20.3	12.0	11.4	16.7	19.8	20.9	18.3	14.0	10.9	26.4	11.5	6.8	14.5	13.6	19.6	5.0	7.0	6.7	24.4	14.9	14.5	11.0	28.5	7.9	22.3	22.0	11.9	9.7	18.4	8.8	15.4	11.1	12.3	17.0	5.0	10.3	22.0	3.9	15.4	13.4	14.1	36.3	14.9	70.4	23.4	32.3	30.8	115.3	35.8	34.4	20.6	19.8	56.7	27.0	8.5	28.3	43.1	42.7	13.7	42.2	24.9	22.0	3.5	18.6	10.3	30.9	26.7	24.4	7.4	9.9	30.5	22.0	38.6	21.2	23.5	55.3	9.8	13.7	5.8	33.4	8.2	10.3	9.8	104.5	12.6	11.3	13.2	33.7	17.6	30.9	14.7	13.2	14.4	51.4	10.6	12.6	44.6	13.0	7.2	50.2	22.9	30.9	18.1	12.5	7.0	20.8	7.9	20.8	22.9	26.0	0.0	4.2	5.5	0.3	3.2	0.3	0.0	0.5	0.1	1.3	0.0	0.2	0.1	0.2	0.1	5.1	0.3	0.0	0.8	18.0	18.4	16.4	26.2	18.3	14.0	14.5	13.6	14.9	8.8	17.0	14.1	19.8	25.6	18.6	217.4	1.8	18.1	22.6	10.8	36.5	73.1	12.2	8.1	81.8	18.6	14.5	11.0	91.8	20.8	1.1	22.4	0.0	19.9	10.2	13.3	67.7	21.3	9.1	47.4	110.9	12.5	28.0	31.9	19.4	21.0	2.5	30.7	28.2	54.2	55.6	65.6	151.9	7.2	20.3	30.0	10.9	8.6	24.8	27.3	10.6	74.0	10.8	46.9	0.0	80.4	46.4	37.1	10.3	71.5	3.1	18.3	16.8	16.6	18.8	146.2	13.1	20.1	39.7	32.4	47.7	8.9	11.8	15.6	2.7	21.4	10.5	27.2
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	162.3	0.0	0.0	0.0	0.0	18.2	298.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	94.5	0.1	0.4	160.9	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.5	0.1	0.0	36.9	17.4	235.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	44.2	10.1	10.3	13.0	9.5	21.8	30.3	8.4	12.0	44.0	8.9	23.7	13.8	27.3	19.5	52.4	27.0	21.6	20.7	12.8	9.8	21.7	6.2	23.9	8.4	12.4	14.2	20.3	22.0	20.9	8.2	67.9	10.0	25.9	23.0	22.1	15.8	26.7	9.8	57.2	13.6	23.6	9.7	23.3	25.1	4.5	12.1	9.3	19.9	22.8	15.6	28.5	50.0	8.5	4.1	20.6	63.1	78.1	11.8	11.3	2.3	2.4	11.9	3.3	1.8	18.5	11.2	0.7	59.0	2.4	17.7	85.8	9.4	219.2	2.7	0.2	4.5	7.0	2.2	87.9	5.8	28.4	0.5	4.6	63.7	10.6	131.1	12.5	21.1	0.3	0.1	8.8	6.0	0.2	0.0	20.2	18.2	68.7	20.3	5.3	3.9	13.1	29.9	25.6	2.8	2.1	6.3	4.4	26.2	49.8	0.3	3.3	80.5	14.2	9.9	11.8	187.9	3.6	0.6	0.9	9.1	10.3	11.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	10.3	9.5	8.4	12.0	12.8	9.8	12.4	14.2	10.0	9.7	12.1	8.5	73.0	41.7	15.4	5.9	1.1	104.6	54.9	76.3	211.1	9.7	13.2	29.1	20.6	30.0	34.4	16.5	43.8	16.9	6.8	64.3	1.9	31.6	5.0	197.4	22.2	102.5	5.3	0.0	6.9	30.4	1.0	41.9	76.0	96.4	7.0	2.7	60.0	1.8	4.2	21.9	9.2	12.8	20.3	5.9	33.9	9.6	21.5	9.1	14.2	22.5	2.8	11.9	2.1	24.6	1.3	97.3	18.3	33.8	4.3	24.5	7.8	2.3	30.2	69.1	85.5	46.7	190.1	0.9	3.2	343.9	106.8	2.2	4.3	107.2	39.1	33.7
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-65067754	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 700.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 336.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB013088: "	"prognostic favorable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	99.6	38.2	44.8	73.9	42.6	51.4	60.7	46.7	45.4	58.2	61.7	50.5	33.9	56.7	60.8	38.7	40.7	64.2	49.5	46.0	53.9	55.4	86.6	62.1	110.1	56.0	47.0	77.1	46.7	55.0	35.6	57.0	49.1	42.2	54.5	41.7	34.2	55.2	83.4	79.2	50.8	64.2	44.0	88.3	49.5	46.8	59.8	103.8	45.0	118.6	101.7	81.2	39.3	45.5	50.4	66.2	27.7	3.0	336.8	177.2	35.1	76.3	116.1	64.6	75.7	21.4	27.7	76.5	59.1	142.8	118.7	27.8	19.4	63.6	93.8	102.7	29.5	104.0	32.1	56.2	126.6	40.2	68.4	159.9	92.6	97.2	103.0	78.4	208.7	37.0	37.9	78.9	80.1	31.2	22.3	39.6	18.6	65.3	37.4	30.5	77.8	28.5	213.8	84.9	19.8	57.9	107.4	51.6	52.9	56.6	104.3	28.6	180.8	74.7	34.1	174.2	42.0	47.7	23.6	60.4	70.5	57.9	34.1	162.4	52.1	146.8	94.0	66.3	105.7	89.1	90.2	100.7	69.4	73.1	97.0	80.6	177.9	305.4	76.2	55.0	117.1	130.8	44.8	42.6	46.7	45.4	46.0	53.9	56.0	47.0	49.1	44.0	59.8	45.5	211.2	51.3	94.9	62.3	219.8	116.6	150.7	91.3	78.0	37.0	66.2	71.6	112.8	87.2	84.2	112.2	22.9	9.0	345.0	89.2	43.0	171.3	125.2	90.1	167.0	183.0	66.4	52.8	59.6	213.8	105.2	131.9	91.3	151.2	57.0	48.7	174.2	91.4	58.5	21.9	85.3	62.0	69.2	160.2	148.9	101.7	96.0	177.9	49.8	80.6	234.8	53.5	700.3	61.3	42.7	217.5	58.6	84.7	175.2	183.8	53.7	79.0	61.9	38.6	164.3	70.6	191.8	40.8	53.1	71.2	166.1	12.2	256.0	95.7	47.6	200.1
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585438-147782775	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.0;T-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA046929: AB_2679867, HPA065023: AB_2685407"	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	0.2	3.3	11.4	1.0	12.5	0.5	0.1	24.8	14.3	0.5	0.1	2.2	0.4	1.0	0.2	1.3	0.1	1.4	0.4	11.4	12.1	0.3	2.6	2.0	0.9	11.7	11.8	0.1	0.8	1.0	8.3	0.1	12.4	0.6	0.5	5.3	0.2	0.4	0.0	0.3	0.6	1.5	10.4	0.8	1.8	2.9	13.0	7.0	0.1	1.6	0.9	0.7	0.2	16.6	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	3.1	6.9	2.0	0.0	0.0	0.3	0.0	5.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	47.5	0.0	0.1	5.1	0.0	11.4	0.1	0.1	2.0	47.8	16.0	0.0	0.1	22.4	15.4	0.0	0.3	0.1	2.5	0.0	0.0	0.0	3.5	4.0	0.0	1.1	3.3	2.0	4.6	8.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	5.3	0.7	2.8	5.5	0.1	0.3	0.7	4.6	0.5	7.0	0.2	1.1	1.3	1.5	11.4	12.5	24.8	14.3	11.4	12.1	11.7	11.8	12.4	10.4	13.0	16.6	0.2	0.0	1.5	195.5	1.5	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.7	0.0	1.3	0.0	2.1	0.0	13.3	0.0	0.0	0.8	11.3	0.2	0.5	0.3	1.2	3.0	250.7	0.0	0.0	1.2	0.5	0.1	29.1	10.3	0.7	3.1	1.3	85.8	229.4	0.8	0.0	0.9	0.0	8.4	0.0	4.2	0.0	11.2	0.4	24.4	23.7	159.3	198.5	0.2	0.0	0.0	3.1	0.0	0.1	0.1	1.5	7.9	0.0	0.4	0.7	7.8	2.0	0.1	0.1	0.3	13.8	18.9	0.0	0.3
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.1;Late spermatids: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	7.4	6.2	4.2	7.6	4.4	1.7	8.8	4.5	4.9	9.8	4.3	7.1	7.2	8.4	7.4	5.9	10.1	6.6	6.1	4.0	5.3	6.7	4.2	6.2	9.3	4.7	4.7	13.2	5.1	6.9	4.1	8.4	4.8	8.4	9.0	11.1	8.8	6.9	4.1	7.8	8.4	6.9	4.4	7.5	8.6	11.7	4.7	9.6	9.6	4.4	9.2	6.8	6.0	5.3	9.4	5.8	11.8	8.9	23.1	25.7	8.6	15.6	10.5	10.9	14.2	9.8	22.2	12.8	22.3	14.4	13.9	14.5	5.9	10.6	12.6	13.9	5.5	11.9	17.0	7.5	18.7	6.8	7.4	12.2	16.3	15.8	19.6	20.3	10.0	14.5	6.4	5.5	17.9	1.9	8.8	19.8	1.8	16.7	7.9	8.9	11.5	10.5	13.5	9.7	4.7	8.6	9.1	6.2	7.1	11.0	7.6	9.1	12.4	21.1	9.4	18.6	6.4	4.7	10.9	7.5	9.8	10.9	9.2	3.3	2.6	2.6	1.6	2.1	2.3	2.2	2.6	2.0	2.6	1.6	3.2	2.9	0.9	1.8	2.5	4.1	1.3	1.6	4.2	4.4	4.5	4.9	4.0	5.3	4.7	4.7	4.8	4.4	4.7	5.3	6.2	9.6	5.8	4.2	5.0	4.7	10.3	6.6	2.8	7.4	7.6	8.9	6.8	15.7	12.0	0.0	4.2	6.0	11.7	9.0	1.9	11.5	171.1	9.9	13.6	5.8	6.0	4.8	3.4	5.1	5.0	9.9	7.1	6.8	3.8	5.0	6.4	2.2	5.0	8.4	3.0	10.5	4.1	7.2	5.2	49.3	8.4	6.0	1.8	1.0	6.9	5.2	6.2	3.5	8.2	8.2	4.5	9.4	2.4	8.4	7.6	6.1	25.3	12.3	0.0	6.0	9.6	9.9	4.9	5.3	6.0	4.0	4.8	7.5	9.7	8.4
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977674	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006514	Approved		Uncertain	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	105.6	119.8	121.1	60.4	125.1	127.0	103.0	122.3	153.9	99.8	149.0	117.8	89.5	89.8	96.3	110.8	91.8	53.7	121.0	120.8	122.2	135.4	207.1	110.2	80.4	125.4	122.2	98.4	232.2	93.9	185.9	68.0	121.5	131.0	86.7	49.8	162.0	68.0	166.5	99.8	115.3	50.1	123.3	136.9	164.8	46.6	126.6	77.7	120.5	82.7	80.2	96.3	89.4	123.4	206.3	139.4	57.9	108.0	189.0	116.2	163.5	144.6	142.3	95.9	96.0	135.3	166.7	193.7	198.7	171.8	59.1	181.0	151.0	113.2	78.1	180.5	296.0	112.5	158.4	139.0	198.1	221.4	165.7	110.4	210.4	101.1	119.1	131.0	115.4	223.7	169.3	139.2	68.4	359.6	161.5	280.5	125.8	402.1	239.1	163.9	79.3	393.1	123.7	110.9	158.4	158.8	115.3	332.7	208.4	107.4	209.1	316.4	89.6	46.5	80.4	144.4	189.0	201.8	244.7	211.3	114.5	209.6	103.7	98.7	119.5	173.2	74.7	86.4	90.9	143.5	104.0	118.7	88.9	139.9	107.0	85.6	104.9	85.3	96.5	147.4	98.5	97.7	121.1	125.1	122.3	153.9	120.8	122.2	125.4	122.2	121.5	123.3	126.6	123.4	127.7	80.1	101.1	15.7	184.3	156.8	177.4	227.5	104.7	56.6	253.4	207.3	96.5	213.1	171.4	99.3	22.9	308.8	237.3	273.4	258.2	251.9	7.1	145.0	95.3	120.4	212.0	178.8	26.3	411.8	405.0	155.6	149.9	125.9	82.5	113.2	125.7	341.3	289.1	57.2	24.0	423.4	213.6	235.8	185.8	20.1	151.6	176.3	170.7	19.7	207.9	140.4	257.5	19.6	29.1	274.1	302.2	123.4	344.8	346.0	368.2	274.1	138.2	60.2	105.2	105.3	114.0	58.9	71.5	173.4	190.2	289.5	173.6	136.6	315.2	304.0
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791486-12793315	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 679.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 679.4;monocytes: 182.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 629.0;U-266/70: 256.4;U-266/84: 411.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	722.8	259.5	22.9	110.3	28.0	455.2	248.5	90.1	65.2	283.3	30.4	287.0	52.8	130.1	2.2	449.1	874.8	92.6	383.5	28.3	68.8	184.2	279.0	399.2	65.0	83.5	29.8	649.5	150.0	20.8	351.9	39.4	33.6	195.0	22.0	32.0	131.6	56.1	144.6	605.9	145.0	58.1	51.5	153.3	309.8	30.0	31.3	78.8	198.7	73.3	12.9	333.0	330.6	34.8	52.9	10.4	2.8	6.4	11.3	27.4	10.2	22.8	19.2	11.0	10.0	6.8	30.4	18.2	77.4	8.4	33.5	98.5	2.5	34.3	1.2	629.0	9.9	18.0	42.2	9.0	15.1	24.3	80.5	34.9	97.6	10.0	7.5	22.0	5.3	12.9	48.1	32.6	3.6	158.8	16.8	147.5	1.7	36.1	40.0	22.4	7.7	38.8	7.5	65.5	23.7	36.0	98.4	59.5	30.5	1.7	10.5	27.0	17.6	32.2	18.7	64.3	28.9	256.4	411.4	17.1	37.7	62.7	8.9	29.1	132.2	132.2	33.4	182.7	33.4	30.6	36.8	42.0	87.1	25.4	25.5	28.5	679.4	18.6	177.2	7.9	38.7	124.1	22.9	28.0	90.1	65.2	28.3	68.8	83.5	29.8	33.6	51.5	31.3	34.8	3158.0	115.4	423.2	130.2	1751.7	1463.9	1778.3	2367.7	1985.1	81.0	1296.9	1693.1	374.0	474.7	707.4	154.5	39.6	129.7	1766.9	819.7	49.0	833.3	9.5	468.5	1091.4	1469.5	1502.1	244.8	8.7	546.7	224.7	2182.3	1060.1	627.8	510.5	310.0	852.4	84.6	1178.4	21.9	4.4	1029.3	740.6	674.1	2747.6	27.9	815.2	1583.3	894.6	20.6	379.3	634.6	115.4	4.5	2.4	1026.7	875.3	263.3	842.5	1036.7	701.0	84.2	337.3	168.8	1163.6	2566.6	2624.1	9.4	10.5	1164.3	1804.1	440.3	2362.6	417.0	687.7	472.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279694-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 2129.8;dendritic cells: 1844.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favorable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	296.3	189.3	190.3	38.9	201.6	429.1	257.3	172.1	208.5	159.7	153.1	185.2	62.9	186.6	37.5	118.3	291.4	30.0	210.6	187.5	192.5	148.8	211.8	227.3	28.8	261.3	213.2	424.2	178.4	40.4	256.4	45.1	180.9	159.1	33.0	25.7	112.7	33.8	81.0	287.7	161.3	57.5	182.5	100.5	201.4	97.4	180.4	58.2	154.8	37.1	15.9	129.5	147.7	263.8	84.2	35.3	33.3	37.9	25.9	28.8	150.5	35.0	40.8	19.2	25.4	38.3	72.9	42.1	39.4	34.8	31.1	46.1	8.2	8.3	9.5	84.6	75.9	62.7	30.3	84.9	58.6	29.5	81.4	27.8	33.7	20.0	25.9	44.5	15.3	18.8	86.5	119.8	5.2	113.6	89.9	92.5	69.7	22.7	50.6	32.7	20.9	94.0	27.8	13.1	184.2	75.1	41.7	45.4	122.0	37.5	38.6	43.9	54.7	11.8	54.8	74.4	20.9	171.3	73.8	36.3	41.5	44.7	27.9	10.5	6.5	6.8	4.9	8.2	3.8	8.4	6.4	4.5	4.9	8.7	4.5	5.0	19.7	4.8	8.3	11.3	5.7	2.4	190.3	201.6	172.1	208.5	187.5	192.5	261.3	213.2	180.9	182.5	180.4	263.8	2129.8	179.5	386.7	104.5	1176.8	317.1	400.4	76.0	188.4	129.8	1147.5	1419.1	158.8	291.7	84.4	257.5	79.2	78.5	1844.7	810.5	31.3	96.5	80.8	1026.0	1289.3	468.1	568.8	78.3	51.6	140.8	112.9	950.9	336.4	1561.4	257.7	514.1	338.4	436.1	100.1	139.7	41.0	569.6	67.1	332.7	506.0	59.2	123.3	847.7	249.1	65.6	91.7	625.2	27.8	44.7	132.0	154.4	464.2	88.8	734.5	253.6	538.1	65.4	90.4	174.3	131.5	1064.7	798.4	11.8	22.7	172.0	394.1	164.3	1158.2	448.7	297.4	232.7
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 355.5;Late spermatids: 228.7;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.1;dendritic cells: 4.0;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	42.6	9.6	49.0	9.5	52.7	1.5	31.2	42.3	47.5	40.9	61.8	49.2	12.1	62.2	13.0	64.6	31.7	15.2	88.2	45.1	44.9	31.6	101.9	13.6	7.6	51.6	44.9	22.1	28.3	9.4	27.9	25.8	48.3	42.5	14.9	11.0	29.9	31.8	66.4	51.8	23.6	37.4	47.6	6.9	25.9	15.4	48.4	9.4	30.8	39.9	11.8	70.1	52.3	48.9	5.9	12.2	4.0	72.0	57.8	21.9	19.9	37.1	25.8	3.1	3.7	30.2	2.5	46.2	8.9	46.0	7.0	12.3	15.7	30.4	5.3	22.7	8.3	0.1	17.0	96.0	8.1	11.2	0.0	12.6	41.6	3.2	35.6	13.2	31.2	1.6	2.4	56.4	23.1	14.4	4.5	46.9	5.3	8.9	9.0	1.7	7.9	8.6	24.5	36.1	1.8	0.0	3.6	10.9	50.9	33.3	7.1	8.7	46.1	8.4	3.2	10.8	17.1	9.8	61.9	0.2	5.6	21.1	15.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	1.3	0.4	0.4	1.1	2.4	0.8	0.0	0.1	0.0	4.0	1.7	0.5	49.0	52.7	42.3	47.5	45.1	44.9	51.6	44.9	48.3	47.6	48.4	48.9	18.3	12.8	34.2	355.5	4.9	23.1	102.1	11.4	37.0	22.2	16.8	18.0	94.1	24.3	8.1	18.4	41.7	89.2	15.7	8.3	7.9	11.6	102.3	14.2	15.4	21.9	18.0	9.1	12.1	7.9	6.8	21.8	7.7	13.1	1.3	38.5	23.6	70.0	13.3	0.0	29.0	12.8	4.1	6.9	6.5	228.7	32.3	3.3	23.2	60.9	1.2	6.5	0.0	322.7	191.4	9.6	7.5	20.7	10.7	50.5	17.6	13.6	7.0	20.2	26.3	129.9	24.0	28.4	25.6	36.2	25.7	66.2	4.7	6.9	26.0	63.6
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31114489-31131393	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.9;Late spermatids: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA066324: AB_2685658"	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	28.8	30.9	40.4	17.8	41.6	32.9	31.3	50.6	50.4	40.8	38.2	36.9	16.6	39.2	46.5	21.1	41.7	14.7	42.0	41.5	41.6	28.4	29.0	31.3	24.6	42.0	41.3	60.7	31.8	37.4	31.0	20.4	41.3	32.0	17.3	27.5	34.7	23.7	49.8	33.8	30.2	25.5	40.0	39.7	28.2	32.8	41.6	39.6	35.5	49.8	23.3	30.9	31.0	43.1	18.1	27.4	33.5	10.7	38.5	28.9	34.3	16.0	29.6	24.7	26.8	13.6	38.1	42.3	24.5	19.6	22.8	22.5	53.6	26.4	24.1	35.8	35.0	18.7	21.5	43.3	34.5	30.5	31.9	27.9	51.4	18.5	52.4	33.2	23.6	44.1	49.5	33.7	13.1	51.4	47.4	57.2	38.0	43.1	15.9	75.1	28.1	49.5	20.1	10.7	35.2	35.9	9.4	25.9	14.1	20.7	28.6	49.6	14.7	11.0	22.2	12.1	11.6	32.4	34.8	24.2	16.0	40.7	16.3	8.0	7.4	29.9	3.0	4.1	3.7	3.6	3.6	4.1	6.6	2.9	4.6	3.3	28.4	3.2	8.3	2.7	2.4	3.4	40.4	41.6	50.6	50.4	41.5	41.6	42.0	41.3	41.3	40.0	41.6	43.1	26.2	19.2	18.2	16.0	30.4	20.8	41.9	18.1	34.7	19.0	21.5	26.2	16.8	21.5	21.0	9.2	14.6	30.5	20.9	17.8	21.5	21.9	113.9	17.5	18.2	21.8	24.6	29.5	16.4	26.6	21.7	29.4	17.9	18.0	27.3	33.9	23.2	12.4	29.1	32.0	18.6	21.2	18.3	30.1	25.4	147.5	53.7	28.1	24.9	12.2	32.6	41.0	15.5	11.1	13.2	15.0	25.8	54.2	16.5	35.2	25.1	17.5	11.8	26.9	26.3	32.8	30.6	27.5	26.2	20.6	15.6	45.4	24.6	24.5	22.9	23.2
KBTBD11	"KIAA0711, KLHDC7C"	ENSG00000176595	"Kelch repeat and BTB domain containing 11"	O94819	8	1973677-2006936	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5;Proximal enterocytes: 58.0;Proximal tubular cells: 32.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;HEK 293: 2.0;MOLT-4: 1.4;REH: 1.8;SCLC-21H: 2.0;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051159	Uncertain		Approved	"Intermediate filaments"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Intermediate filaments"		"HPA051159: AB_2681367"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.76e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-2)"	3.0	6.6	3.6	0.2	5.0	0.0	2.8	2.3	10.8	1.5	0.0	7.0	0.1	0.9	0.0	1.2	2.6	0.0	2.6	7.6	0.7	9.2	7.8	2.7	0.0	6.2	1.9	1.3	3.6	0.1	3.7	0.0	3.4	2.8	0.0	0.0	1.2	0.1	1.1	1.6	9.8	0.0	3.3	7.5	2.0	1.2	2.9	0.0	3.9	0.0	0.0	1.9	1.1	9.3	0.5	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.0	2.3	10.8	7.6	0.7	6.2	1.9	3.4	3.3	2.9	9.3	6.1	0.0	8.1	17.6	0.6	1.0	0.4	0.0	0.0	24.3	1.0	0.6	5.2	8.6	0.1	12.9	35.5	0.0	0.6	25.6	25.4	2.0	0.8	0.6	0.4	7.9	6.0	3.6	29.2	3.8	0.2	2.0	1.1	0.7	0.0	1.3	4.2	18.2	3.6	20.2	12.6	13.0	0.0	13.5	1.9	0.3	5.0	8.0	1.8	9.4	15.7	9.6	2.1	9.5	16.3	11.9	10.7	10.5	1.5	3.1	58.0	32.2	1.7	31.3	0.0	15.1	1.3	0.3	3.7	0.0	0.9	0.3	1.0	0.1	19.7	1.4
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 6.1;brain: 20.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 62: Horizontal cells - Visual perception"			"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			1.5	6.1	4.7	0.0	20.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	4.7	4.4	0.2	0.0	0.7	0.0	1.6	1.7	0.0	0.0	0.0	1.3	0.2	1.3	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	20.0	0.0	6.5	4.7	4.4	1.6	1.7	1.3	0.1	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.4	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978321	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.3;pituitary gland: 43.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 217.3;Cardiomyocytes: 83.2;Erythroid cells: 76.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 197.7;NB-4: 97.8;SH-SY5Y: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	0.8	3.7	9.8	2.6	8.0	42.3	0.1	13.5	9.0	4.4	4.4	36.1	2.7	16.9	1.7	1.5	7.3	3.2	29.6	5.6	14.8	1.1	0.2	2.0	0.3	23.5	14.7	3.2	3.4	18.1	43.3	1.4	23.0	9.8	1.0	6.7	1.1	8.0	0.2	0.3	8.3	7.8	6.3	1.8	10.9	30.8	17.1	0.4	0.2	0.0	0.1	12.9	2.7	4.1	0.0	0.3	0.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	8.0	2.9	0.0	0.2	0.0	3.1	0.0	0.0	0.8	0.4	18.3	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	197.7	0.0	0.0	0.9	1.6	97.8	1.3	0.2	0.0	0.1	0.1	10.1	0.0	0.0	3.8	78.2	0.0	0.1	0.0	1.1	0.0	1.8	0.6	0.0	1.5	0.0	0.0	5.3	0.2	2.1	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	8.0	13.5	9.0	5.6	14.8	23.5	14.7	23.0	6.3	17.1	4.1	0.0	0.0	0.0	1.6	1.6	0.0	0.2	0.1	0.0	217.3	0.4	0.3	83.2	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	2.1	2.0	0.5	0.8	0.9	16.3	76.4	5.2	0.2	0.9	5.0	0.5	0.1	26.1	6.3	1.4	0.1	0.3	16.8	13.9	0.7	12.2	0.0	0.3	4.8	2.5	0.0	0.0	2.8	0.0	4.5	0.0	5.5	1.7	0.3	0.0	13.2	1.4	0.1	0.2	0.1	0.4	10.3	0.0	1.7	2.6	2.5	5.1	0.0	0.0	0.3	0.9	0.7	0.3	0.4
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNK3	"K2p3.1, TASK, TASK-1, TASK1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 181.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.1;Collecting duct cells: 103.0;Enteroendocrine cells: 23.4;Exocrine glandular cells: 95.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.1;EFO-21: 11.0;HeLa: 3.6;SCLC-21H: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	3.8	181.6	5.1	1.3	4.4	0.1	2.9	4.9	6.0	8.4	0.0	5.5	1.2	6.3	1.5	2.1	4.0	1.2	13.1	3.0	14.3	2.7	0.5	25.7	0.1	27.0	19.3	2.1	35.5	12.1	8.4	24.8	26.8	6.3	0.9	3.3	0.4	3.3	0.8	0.7	2.4	2.7	5.4	1.1	4.2	0.6	10.4	0.1	3.6	0.0	0.0	4.2	2.8	3.9	0.0	0.7	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.0	0.0	1.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.4	0.0	25.9	2.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	5.1	4.4	4.9	6.0	3.0	14.3	27.0	19.3	26.8	5.4	10.4	3.9	0.3	0.0	2.8	0.3	0.1	0.0	0.2	0.3	0.0	82.1	0.2	3.6	12.7	0.0	0.0	103.0	0.0	0.2	0.1	0.0	0.0	1.0	0.4	0.3	7.7	1.2	23.4	0.0	2.1	95.2	0.2	2.7	0.0	0.2	0.0	1.2	0.4	0.0	0.4	1.7	14.5	1.8	0.0	0.0	0.9	1.9	0.9	0.3	0.0	0.0	0.6	1.4	0.0	1.5	0.3	19.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	4.1	6.6	0.6	4.9	0.0	1.5	0.0	0.1	0.5	0.4	11.5	0.1	0.4
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 27.8;brain: 20.8;liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.4	27.8	7.8	0.2	10.8	0.0	0.5	11.3	14.0	2.0	2.2	1.4	0.3	2.9	0.3	0.2	0.4	0.4	6.8	20.8	7.5	3.9	31.3	2.3	0.4	11.1	4.7	0.7	4.5	0.4	7.6	0.0	6.7	9.6	0.7	2.5	0.5	4.3	9.5	1.3	0.3	2.0	9.0	0.5	0.7	3.0	8.2	0.2	0.3	6.7	0.2	2.3	1.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	17.5	2.7	0.3	0.0	0.0	0.2	0.0	0.5	0.0	2.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.2	0.0	0.3	0.0	1.4	6.4	0.0	0.0	0.0	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.2	12.9	0.4	0.3	21.8	0.3	0.0	0.5	1.8	0.0	0.1	0.0	0.1	2.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.8	11.3	14.0	20.8	7.5	11.1	4.7	6.7	9.0	8.2	11.1	1.4	0.0	1.1	36.2	0.0	0.3	0.3	0.0	0.0	7.9	0.6	1.3	15.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.6	0.5	0.0	8.2	0.0	0.0	149.9	0.9	0.0	0.8	0.0	1.3	0.0	0.8	5.0	18.3	0.0	0.0	97.0	1.0	0.0	1.0	0.3	0.5	0.0	0.1	21.4	6.5	0.0	0.4	0.0	63.3	9.2	1.0	0.1	0.0	1.2	4.7	0.0	0.7	0.0	7.8	0.0	0.1	0.3	0.3	6.5	0.3	0.3	0.0	0.0	0.2	0.5	0.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 91.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	0.0	6.2	55.7	0.1	37.2	0.0	0.0	27.8	91.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.2	68.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	1.1	0.0	19.1	0.0	0.1	1.6	0.0	2.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	10.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	21.2	35.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.6	0.0	8.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.5	0.2	0.0	0.0	0.1	0.0	0.0	67.8	119.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	55.7	37.2	27.8	91.9	68.1	0.0	2.6	0.0	0.1	0.0	1.0	12.9	0.6	0.0	0.0	7.2	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	16.5	0.0	0.1	1.0	0.0	0.0	61.7	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.5	37.5	0.2	0.0	0.0	0.0	8.1	0.6	0.1	0.0	1.0	0.0	0.9	0.0	50.8	2.1	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.1	0.1	7.4	28.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880175-76886405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 281.2;Endothelial cells: 192.2;Enteroendocrine cells: 386.7;Hofbauer cells: 218.9;Kupffer cells: 395.9;Macrophages: 221.3;monocytes: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 3.9;myeloid DC: 3.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 3.7;granulocytes: 1.0;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 111.4;HUVEC TERT2: 229.0;TIME: 186.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria		NA	NA		21000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	76.1	27.8	21.4	55.7	20.1	12.0	52.4	27.0	20.8	44.5	12.4	39.5	22.5	51.3	17.8	38.3	75.0	55.0	22.6	26.9	27.8	31.0	13.9	58.0	39.4	36.2	33.5	47.1	12.5	25.2	6.4	83.9	31.4	14.7	42.5	3.4	20.0	18.5	16.6	22.9	28.1	65.3	37.0	64.8	28.0	26.9	31.4	18.3	16.4	37.1	33.4	39.2	17.4	34.4	1.7	1.5	15.3	0.0	111.4	52.5	4.3	6.9	1.5	4.2	5.5	0.5	0.3	0.0	3.8	18.8	4.9	53.9	6.6	66.4	3.5	1.5	35.1	0.2	38.3	0.0	4.7	18.6	0.1	21.4	21.5	2.7	48.9	8.5	229.0	13.2	0.3	0.2	53.9	1.4	8.5	0.3	7.8	16.6	7.7	0.4	7.4	19.6	17.7	0.2	4.3	7.9	17.3	0.5	2.2	18.5	1.0	12.1	186.0	2.7	4.9	0.4	14.0	2.7	0.5	0.0	42.5	4.0	16.1	0.0	3.9	0.7	0.0	2.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.0	0.0	1.5	1.9	0.0	0.9	21.4	20.1	27.0	20.8	26.9	27.8	36.2	33.5	31.4	37.0	31.4	34.4	281.2	25.6	8.4	2.9	7.5	40.0	2.7	11.9	28.5	4.4	11.2	27.3	21.8	4.3	16.3	97.5	14.6	3.0	30.4	19.7	17.6	6.5	3.6	4.9	44.6	192.2	386.7	6.1	4.8	0.6	90.6	80.0	12.2	3.3	7.0	53.1	61.1	2.5	218.9	0.0	11.5	71.5	12.2	395.9	75.4	11.8	157.2	221.3	51.6	45.9	206.7	4.8	7.2	0.5	0.9	0.5	15.7	44.8	7.6	4.5	0.7	7.5	72.8	1.5	26.3	153.2	32.2	1.9	7.0	16.9	34.4	4.2	5.5	24.0	46.6	1.9
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 24.6;choroid plexus: 9.4"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 2.6;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 9.5"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 20.7;hTERT-RPE1: 12.5;RPTEC TERT1: 11.8;U-138 MG: 13.9;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.1	0.0	20.2	0.0	24.6	0.1	0.5	8.3	17.6	0.1	9.4	1.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	16.6	11.3	0.2	0.0	0.0	0.0	10.9	10.7	0.0	0.2	0.0	1.8	0.2	9.7	0.0	0.2	0.0	0.5	0.1	0.0	3.1	0.5	0.7	12.4	0.0	0.0	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.2	0.0	0.0	0.0	0.5	0.6	20.7	0.0	0.0	2.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.7	12.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.0	3.1	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	24.6	8.3	17.6	16.6	11.3	10.9	10.7	9.7	12.4	13.2	13.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	10.1	9.5	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119263-67258082	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.5	13.2	10.7	27.2	10.6	47.1	19.7	18.0	12.1	24.3	14.1	23.3	14.7	29.1	17.4	31.9	19.3	19.0	17.4	10.6	11.2	14.3	19.9	24.0	27.5	12.6	10.7	24.5	13.0	16.1	13.1	18.0	10.9	21.6	17.1	18.5	21.3	19.2	33.8	29.4	23.9	24.0	9.7	27.0	18.9	29.0	11.9	27.8	19.0	24.5	28.7	23.9	25.9	10.9	49.9	31.8	17.6	27.7	17.1	27.0	13.5	21.5	26.6	41.0	27.9	48.7	25.4	38.8	37.5	33.3	23.8	48.2	31.3	22.5	33.1	66.4	13.4	28.9	39.2	11.7	16.9	24.5	38.1	21.7	23.9	39.4	25.7	20.7	29.9	22.7	27.4	54.4	18.6	35.4	32.5	18.1	36.1	29.8	25.6	39.9	29.4	21.4	14.7	33.7	24.2	18.9	71.0	38.6	39.0	21.6	59.9	23.9	38.7	25.0	16.7	34.5	18.8	29.3	35.4	25.4	22.0	17.2	17.8	0.4	1.1	0.3	2.5	0.8	2.7	3.6	1.9	2.3	0.6	3.6	1.9	1.9	2.7	2.7	0.5	0.9	2.6	1.9	10.7	10.6	18.0	12.1	10.6	11.2	12.6	10.7	10.9	9.7	11.9	10.9	41.4	38.5	35.8	75.1	56.6	41.2	23.3	23.4	75.7	75.3	40.3	30.9	31.1	34.3	31.0	16.5	137.6	23.9	77.5	43.2	0.0	17.3	20.6	84.8	63.0	38.4	31.8	22.1	89.4	14.5	13.4	32.4	42.8	112.3	27.3	42.1	29.3	35.5	21.5	95.9	89.8	27.5	24.4	46.5	59.6	11.2	21.5	49.1	19.6	104.0	43.3	19.8	33.0	96.0	99.5	25.9	25.5	23.0	72.5	37.2	21.2	10.3	40.0	111.7	19.7	40.2	32.3	52.0	38.1	78.7	47.7	32.3	66.9	33.8	29.5	48.7
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352685-138437028	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	21.7	19.4	22.6	16.9	23.0	25.4	25.3	22.2	22.8	22.7	21.1	23.9	18.6	23.0	28.3	21.2	24.2	14.2	20.0	21.3	20.7	21.4	14.5	19.3	23.0	23.4	22.7	30.8	20.3	34.2	16.5	20.5	21.5	21.8	24.0	36.3	22.2	25.9	41.5	28.1	23.4	20.8	21.9	26.0	21.6	19.4	23.9	35.9	23.2	27.1	29.4	24.8	19.9	21.8	24.3	32.4	65.0	58.7	27.2	23.3	47.0	15.6	27.1	30.0	33.5	35.7	27.2	46.3	27.9	30.3	41.0	24.3	53.2	37.8	32.6	30.3	29.3	39.2	28.6	27.1	25.4	32.2	43.3	26.9	39.0	22.1	26.7	23.2	34.6	29.3	31.8	26.1	34.3	30.3	46.4	41.0	31.0	34.1	13.7	53.1	48.5	30.9	40.4	31.6	32.7	35.9	27.0	28.0	25.7	93.2	27.3	43.5	31.9	17.9	17.4	19.3	28.8	32.8	16.7	40.2	12.5	45.6	25.6	0.2	2.9	4.2	2.3	2.2	3.2	2.3	2.7	3.0	2.5	2.0	2.5	2.3	5.5	4.2	2.3	3.0	1.7	1.3	22.6	23.0	22.2	22.8	21.3	20.7	23.4	22.7	21.5	21.9	23.9	21.8	22.8	16.0	15.7	43.1	22.1	15.9	13.7	15.1	20.5	21.3	29.1	29.5	33.2	17.2	17.0	22.0	29.2	13.4	24.0	26.8	0.0	16.0	6.1	22.8	19.9	18.9	21.0	25.4	40.9	16.8	10.7	18.5	17.9	24.2	13.3	26.3	18.2	23.0	17.6	23.5	39.1	26.4	18.3	39.2	18.3	2.8	21.1	27.9	16.0	50.6	27.0	17.3	16.5	41.7	56.9	19.9	28.0	23.0	16.2	21.2	20.9	16.1	25.6	31.9	26.3	21.8	18.7	13.0	15.5	26.2	21.6	10.9	19.1	17.1	24.6	21.0
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153598	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7"	"Cell line enhanced"	"Detected in all"		"T-47d: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071568			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA071568: "	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	12.4	19.4	7.8	8.9	9.4	13.5	16.8	15.8	10.0	23.4	5.1	14.7	6.6	18.4	6.7	17.0	20.2	4.7	16.0	9.3	5.3	10.4	21.2	12.5	11.7	9.2	7.3	17.8	13.7	6.6	18.4	9.5	7.5	25.6	2.9	14.7	14.1	7.4	32.2	21.7	13.8	4.9	4.7	22.1	12.6	16.1	8.8	8.8	29.4	8.3	7.2	13.4	18.2	11.9	16.1	5.5	12.8	15.4	7.3	7.2	25.7	7.9	5.8	6.8	8.5	9.6	4.4	22.4	8.2	9.1	5.5	8.9	7.8	9.3	4.2	10.1	19.9	7.5	9.9	8.0	13.6	7.6	16.7	11.2	9.9	5.6	4.7	12.3	9.3	12.4	18.7	13.3	6.2	8.3	8.8	11.5	11.3	5.8	13.6	14.7	9.7	19.0	6.8	10.5	23.7	18.1	10.3	11.2	12.5	12.3	61.5	19.7	13.5	10.1	5.7	12.5	8.0	36.5	16.4	17.1	20.0	15.1	6.0	1.5	0.6	1.9	0.3	0.2	0.2	4.2	0.2	0.2	0.3	5.1	0.4	0.5	4.7	0.8	0.3	1.7	0.4	0.3	7.8	9.4	15.8	10.0	9.3	5.3	9.2	7.3	7.5	4.7	8.8	11.9	15.3	6.4	10.4	18.9	73.2	7.4	14.1	10.8	7.4	72.5	36.1	22.2	15.3	10.0	9.4	7.3	98.0	25.7	25.5	15.3	7.9	10.5	17.0	25.4	18.7	16.4	8.4	9.4	33.6	7.6	26.2	14.6	26.5	30.2	8.2	34.3	15.4	30.9	9.0	74.0	30.6	16.7	16.2	14.2	7.8	12.1	18.3	15.8	10.6	27.2	17.0	23.5	19.6	29.7	28.7	18.0	14.1	23.3	23.9	19.3	7.4	6.6	11.7	69.2	6.6	23.1	13.7	25.2	9.1	14.1	15.3	24.1	13.9	29.7	9.5	12.9
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 206.9;Inhibitory neurons: 235.9;Microglial cells: 148.0;Oligodendrocyte precursor cells: 189.0;Oligodendrocytes: 347.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA069357: AB_2686128"	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	10.0	9.6	9.8	12.8	12.0	30.1	11.3	30.6	11.5	10.2	13.5	13.7	13.1	10.4	11.8	10.1	10.3	9.7	7.8	9.9	11.1	8.7	11.1	10.6	19.1	13.8	11.7	11.5	16.1	17.8	11.8	8.9	13.3	9.9	16.1	28.9	11.6	8.8	8.3	15.2	14.4	10.8	9.7	13.9	15.1	9.8	11.9	23.6	13.4	6.0	18.8	10.3	10.7	16.4	17.2	9.8	4.0	6.0	13.4	14.3	11.8	7.6	9.6	8.5	8.1	11.3	9.1	20.1	4.6	10.3	8.7	5.1	8.6	12.8	11.1	60.6	7.4	27.9	13.8	15.1	12.4	10.8	18.5	12.5	8.4	6.7	14.0	21.1	10.4	16.4	4.7	13.4	9.3	8.3	18.0	40.4	7.0	18.0	3.8	10.8	3.4	12.9	12.3	9.2	14.0	8.3	7.1	12.7	6.8	10.7	6.6	17.5	11.0	8.4	4.0	9.9	7.5	10.2	8.1	21.3	8.2	10.0	3.3	7.5	7.1	13.5	9.6	7.7	11.2	12.1	10.4	11.2	9.6	13.8	11.3	8.8	1.6	11.2	13.1	3.7	10.0	8.0	9.8	12.0	30.6	11.5	9.9	11.1	13.8	11.7	13.3	9.7	11.9	16.4	11.3	6.4	14.4	110.4	40.6	19.9	7.9	10.5	18.8	22.6	11.2	8.0	9.2	11.5	9.2	7.3	45.9	5.2	22.7	10.3	3.9	7.0	84.8	10.0	12.2	9.4	9.7	42.1	206.9	6.2	5.3	6.9	34.7	16.8	8.8	6.0	6.8	13.0	6.7	11.8	235.9	14.7	6.1	10.0	19.4	83.3	9.6	16.5	7.2	148.0	15.0	3.3	19.6	189.0	347.2	7.6	9.5	9.4	27.1	6.2	14.1	4.0	10.8	28.3	13.1	7.3	7.6	6.6	5.4	14.4	23.9	5.9	28.2	6.2	8.1	8.0
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 46.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 60.4;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049086			Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	16.0	29.9	2.3	11.8	2.4	17.4	12.8	3.2	13.2	0.0	5.3	22.2	18.0	0.0	15.2	12.3	0.0	11.7	13.3	2.2	2.5	12.1	12.7	16.7	8.7	2.9	2.0	0.0	18.9	4.9	16.2	9.2	2.8	25.5	21.6	9.0	15.6	18.0	15.7	12.9	35.2	0.0	1.6	30.8	16.0	12.1	2.6	0.0	18.6	25.7	20.5	19.9	0.0	4.4	0.1	8.0	0.0	0.0	0.0	0.0	15.9	15.4	12.9	8.6	9.4	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	9.4	22.6	0.0	60.4	0.0	18.5	11.5	0.1	0.0	12.9	12.9	0.0	0.0	0.0	0.0	10.6	0.0	0.0	20.1	0.0	24.6	0.1	11.6	0.0	0.1	0.0	10.1	10.9	17.0	28.7	13.2	0.1	0.0	0.0	5.9	27.2	0.0	12.5	18.9	25.9	0.2	0.2	6.6	24.2	16.6	51.4	2.5	0.1	0.0	0.0	1.8	2.1	2.3	1.1	1.7	3.2	2.2	2.2	1.7	2.6	2.4	1.9	0.2	1.9	0.9	2.6	1.8	1.3	2.3	2.4	3.2	13.2	2.2	2.5	2.9	2.0	2.8	1.6	2.6	4.4	0.0	19.2	16.5	9.4	22.2	6.4	9.2	5.3	18.2	39.9	0.0	0.0	12.2	2.8	7.7	18.4	20.9	7.0	14.6	2.8	5.9	5.4	0.8	0.0	0.0	10.8	3.5	22.7	26.0	0.0	2.5	10.6	19.9	0.0	11.4	0.0	13.2	3.1	4.8	13.5	23.2	5.8	2.0	7.6	12.1	3.8	36.7	10.3	10.6	10.3	14.5	7.5	13.4	12.1	15.2	1.7	5.0	33.8	46.3	8.6	13.9	4.2	5.5	30.5	26.3	8.5	8.5	3.3	9.7	12.2	10.9	5.6	16.4	0.0	6.6	8.8
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413102-6424811	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		710000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	78.3	90.9	39.2	44.8	37.0	63.9	73.6	35.0	44.6	109.8	14.0	90.2	53.8	121.7	17.0	111.3	105.3	27.5	62.5	39.3	32.0	66.8	89.9	73.5	52.1	35.8	34.4	120.7	89.5	24.7	77.5	44.0	32.6	75.7	34.2	41.0	75.1	33.1	100.5	93.7	88.4	36.3	31.1	79.6	81.8	106.5	35.5	53.8	83.4	26.0	45.7	94.5	91.5	44.1	302.1	128.6	148.0	139.2	62.0	67.0	216.8	103.7	84.0	147.2	148.3	259.2	77.2	286.8	187.3	76.7	82.8	162.6	203.5	104.5	162.2	2.6	240.3	209.2	94.9	158.2	86.0	204.9	186.2	74.9	47.6	108.3	117.0	65.8	124.0	138.6	328.7	142.5	95.7	146.9	290.7	182.3	264.3	78.9	187.9	284.3	124.5	206.5	73.0	143.9	152.5	160.7	133.8	119.7	144.3	121.7	118.5	222.4	111.4	108.0	160.9	230.4	230.9	257.1	306.8	279.8	107.3	298.1	130.9	1.6	2.7	2.1	2.2	3.1	2.5	2.4	2.6	2.9	2.9	3.2	1.5	1.6	1.9	1.3	2.8	4.8	1.9	1.7	39.2	37.0	35.0	44.6	39.3	32.0	35.8	34.4	32.6	31.1	35.5	44.1	39.8	9.6	17.5	9.1	27.9	58.8	23.6	18.7	33.6	44.6	50.9	49.7	12.8	41.5	23.5	31.3	50.1	41.8	35.7	46.5	5.9	28.0	84.2	38.5	52.4	32.7	57.6	41.8	12.3	30.9	47.5	33.8	21.9	51.9	18.4	41.8	41.4	44.0	38.9	50.5	12.9	50.5	10.2	42.9	44.2	24.4	50.7	32.0	26.6	12.2	26.7	37.9	15.5	11.1	19.1	32.9	34.9	46.3	33.8	36.9	36.0	23.0	17.4	57.4	26.3	39.7	29.9	92.1	57.3	48.8	72.5	40.0	22.9	34.6	60.4	32.1
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA036891: AB_10672272, HPA036892: AB_2675366, HPA061498: AB_2684541"	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	13.0	12.0	18.6	8.5	19.9	16.2	13.3	20.2	20.9	12.0	17.8	14.0	8.5	15.4	12.6	20.6	15.3	12.4	33.2	18.0	22.3	18.8	15.0	12.0	7.5	18.2	22.5	13.1	10.6	23.9	10.3	10.4	19.8	14.7	12.3	24.7	8.9	14.6	32.5	7.6	11.5	13.1	20.1	12.9	10.9	12.0	23.4	11.7	15.1	51.1	8.6	10.4	9.8	21.0	13.7	13.0	26.7	16.7	18.8	20.2	14.0	17.4	18.1	12.0	10.1	8.2	11.3	9.0	5.8	19.7	18.5	7.0	13.7	7.7	15.5	5.1	5.6	26.7	11.1	11.0	9.9	11.6	33.6	13.6	17.7	13.4	7.4	15.4	12.6	8.9	20.3	7.6	15.4	6.7	22.3	11.7	14.1	10.2	14.3	15.7	27.3	4.2	20.3	12.8	20.2	13.1	12.9	11.4	12.1	18.3	14.5	21.1	16.0	11.0	12.8	9.8	15.2	13.1	14.1	7.0	13.5	12.2	30.3	2.0	2.0	5.7	2.1	1.4	2.9	1.3	1.6	2.5	1.3	1.3	1.5	1.6	10.6	1.8	2.1	2.0	1.6	0.9	18.6	19.9	20.2	20.9	18.0	22.3	18.2	22.5	19.8	20.1	23.4	21.0	27.6	32.1	39.2	62.3	19.1	12.7	27.4	12.9	24.5	77.2	29.0	20.6	132.1	10.0	29.0	12.9	37.5	14.7	23.6	47.9	41.1	23.4	45.0	74.4	28.0	20.6	25.1	49.9	123.8	11.7	7.7	27.7	44.9	38.7	12.6	16.3	15.0	42.9	11.2	99.3	120.7	20.9	30.5	23.9	11.8	64.2	24.8	28.4	7.2	73.1	34.8	49.7	27.8	90.0	138.0	21.8	24.8	33.1	24.2	28.0	29.6	24.6	58.0	44.6	26.3	39.4	31.6	31.6	22.4	19.2	11.1	22.4	27.4	27.0	17.5	35.7
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152331-122362758	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 245.2;Inhibitory neurons: 246.5;Oligodendrocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	29.3	24.9	39.5	13.7	48.4	60.3	31.7	41.7	42.8	29.8	62.3	29.6	18.8	27.6	29.8	17.5	27.2	19.8	22.9	36.0	38.5	27.8	21.3	28.2	19.8	48.4	39.1	41.6	24.8	56.3	47.1	17.5	44.6	21.9	22.1	82.4	22.4	21.7	55.5	28.7	28.3	22.1	35.4	26.4	23.3	26.6	44.0	23.1	31.5	42.2	16.8	24.5	25.6	60.5	30.5	9.5	22.3	14.8	36.3	46.7	11.6	13.5	25.3	13.6	14.9	7.2	15.7	15.9	7.6	32.2	18.4	11.2	13.7	16.7	22.0	12.1	8.8	17.7	18.4	13.7	18.9	16.7	9.4	27.2	19.6	16.4	22.3	37.2	29.3	17.0	11.6	18.8	28.5	10.3	14.5	13.0	7.4	14.6	10.7	8.2	30.8	4.1	24.1	22.6	13.0	11.6	8.4	9.7	18.8	35.8	10.6	13.5	39.8	16.8	16.7	14.0	14.0	18.1	12.5	11.5	17.8	14.4	12.6	1.8	0.7	4.3	1.6	1.8	1.7	1.2	1.1	1.1	0.7	1.8	0.9	1.1	3.3	1.0	0.9	1.1	1.6	0.4	39.5	48.4	41.7	42.8	36.0	38.5	48.4	39.1	44.6	35.4	44.0	60.5	94.6	86.6	42.8	245.2	36.0	20.9	22.0	19.8	26.2	126.0	36.2	27.6	69.2	22.8	35.9	42.3	125.1	12.0	59.6	42.4	1.9	13.8	35.1	34.3	52.8	47.2	21.6	27.1	194.0	17.5	7.0	41.2	59.7	47.2	21.5	64.4	35.0	24.1	12.7	92.5	246.5	27.3	20.3	30.1	17.5	27.7	51.3	41.0	16.0	153.6	32.5	60.9	26.8	161.9	239.9	20.7	34.9	50.8	47.9	19.3	50.0	10.3	33.1	145.0	32.9	63.1	54.9	63.2	33.9	28.9	24.4	13.0	52.0	34.0	32.0	23.0
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067278-29263124	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 64.5;parathyroid gland: 161.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 140.2;Oligodendrocytes: 371.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favorable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	11.7	25.9	6.8	47.6	5.1	9.2	34.9	30.6	8.7	16.6	18.3	16.1	6.7	9.4	8.4	7.1	8.4	5.3	20.0	29.4	18.5	10.2	8.5	4.3	47.3	43.7	7.2	10.9	161.5	10.0	3.8	42.1	10.9	13.8	7.9	15.6	8.5	4.7	20.0	15.7	5.5	29.3	8.9	19.2	6.6	40.1	5.1	9.0	3.0	4.6	9.5	6.1	64.5	12.4	13.2	4.6	3.8	7.5	4.3	6.7	0.7	2.9	3.9	6.2	8.3	6.9	2.6	6.9	0.8	7.1	8.2	3.7	2.1	5.1	3.9	3.6	6.6	1.8	8.4	7.2	1.8	19.2	5.0	3.9	8.9	3.6	8.3	17.1	4.9	8.6	9.5	12.9	3.8	9.7	3.1	2.3	17.4	2.2	5.5	10.6	4.9	17.0	13.2	1.3	9.1	2.4	8.0	11.7	4.8	5.9	3.7	22.8	2.8	7.6	0.8	5.6	6.9	11.1	4.4	16.4	3.4	13.2	0.1	1.5	1.7	1.5	1.1	0.7	1.4	0.6	0.9	0.5	0.8	0.5	0.6	0.7	0.9	0.6	2.2	0.6	0.5	25.9	47.6	34.9	30.6	20.0	29.4	47.3	43.7	42.1	29.3	40.1	64.5	22.2	44.8	24.8	30.0	16.5	4.5	13.8	17.2	5.2	13.3	23.5	11.2	5.3	20.0	36.8	35.0	60.5	6.4	35.8	95.8	11.7	25.7	8.0	55.3	12.7	14.2	25.2	7.4	26.7	25.0	0.9	10.0	55.0	140.2	41.0	10.6	13.9	18.6	8.9	16.8	35.3	44.1	36.7	25.7	6.3	3.5	8.1	24.4	7.2	41.2	12.1	9.5	12.3	47.3	371.1	39.7	58.0	20.3	42.5	28.1	34.7	17.8	34.9	26.2	6.6	36.4	7.4	6.3	7.7	9.8	6.8	5.1	31.8	5.9	36.0	32.5
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761721-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.5;Late spermatids: 78.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035516, HPA035517, HPA061469"	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: "	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.2	0.1	0.1	1.2	0.1	5.0	0.4	0.2	0.2	0.3	0.0	1.4	1.4	0.3	0.0	1.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	1.6	0.1	0.2	0.1	0.0	0.8	1.4	0.4	0.1	0.4	0.8	7.3	0.1	9.2	0.0	0.0	2.2	0.3	0.4	0.1	7.5	3.9	17.6	12.8	1.2	1.4	3.9	8.6	5.3	10.8	9.0	6.6	7.2	13.8	2.8	3.1	4.0	6.3	10.1	4.7	13.1	11.6	2.3	14.9	7.7	8.4	0.1	15.6	6.6	0.3	0.2	7.3	7.1	1.6	8.6	18.4	9.3	17.2	8.2	3.9	30.0	5.7	18.2	9.7	7.0	11.9	19.0	7.9	2.4	4.9	8.2	7.8	14.2	4.6	2.9	4.6	7.7	11.7	4.8	10.4	8.5	8.8	11.5	7.2	12.7	17.3	5.5	16.3	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.6	1.6	1.9	0.4	0.9	0.0	0.1	0.5	0.8	1.8	0.0	0.7	0.0	2.1	3.3	0.8	2.5	0.0	0.8	177.5	1.3	1.7	1.2	0.0	28.0	3.2	0.0	5.9	1.9	5.1	1.4	0.0	12.3	0.0	0.2	3.5	0.0	3.8	2.6	0.0	1.6	1.4	78.0	0.0	1.8	0.0	0.0	0.3	0.7	1.0	3.0	4.7	0.5	0.1	0.4	9.7	0.5	0.5	0.1	0.2	0.0	0.0	0.4	1.9	20.2	14.7	6.0	1.0	0.7	3.1	1.1	5.3	0.5
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 18.9;Early spermatids: 44.0;Hepatic stellate cells: 15.4;Late spermatids: 88.7;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;hTERT-HME1: 3.7;U-2 OS: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.0	0.2	2.3	0.0	2.2	0.0	0.0	0.0	3.3	0.3	1.8	0.2	0.1	0.4	0.0	0.0	1.8	0.0	0.0	2.3	4.9	0.4	0.1	0.2	0.0	0.6	1.4	0.2	0.0	0.0	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.3	0.0	0.0	23.2	3.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.8	0.7	0.4	0.0	0.0	0.0	0.1	1.2	1.6	0.6	0.4	0.2	0.4	0.0	0.5	0.9	0.3	0.0	0.6	0.4	0.4	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.3	0.5	3.7	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	3.3	2.3	4.9	0.6	1.4	0.4	0.3	3.1	0.0	18.9	0.0	0.0	0.7	0.2	1.7	0.0	0.1	0.6	0.0	0.2	0.3	2.8	0.0	0.2	1.8	4.2	0.1	2.8	0.1	0.0	0.0	44.0	2.8	0.3	15.2	0.0	0.0	11.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	15.4	0.5	5.1	0.0	2.8	0.0	0.0	1.6	9.8	88.7	1.2	3.2	1.8	1.9	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.1	0.1	0.1	0.3	3.5	0.3	19.7	0.5	2.7	3.2	4.3	0.1	1.3	1.6	0.2	5.2	0.1	0.2
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210570-10381603	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Motor protein"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 103.6;retina: 127.4;skeletal muscle: 202.3;tongue: 150.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 413.9;Cone photoreceptor cells: 579.6;Excitatory neurons: 297.4;Inhibitory neurons: 281.6;Oligodendrocytes: 521.3;Rod photoreceptor cells: 389.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved		Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Nucleoli fibrillar center"	"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	11.1	14.8	64.1	8.2	73.5	16.0	12.4	68.4	67.0	11.0	0.0	16.7	9.5	15.5	6.8	18.3	10.5	10.3	29.7	65.9	58.2	14.6	12.1	11.0	4.2	74.7	61.6	15.7	13.2	20.5	12.6	10.2	78.1	11.9	9.2	127.4	12.8	9.3	202.3	14.2	10.6	15.2	44.0	7.3	9.4	19.7	60.4	4.8	10.9	150.9	5.0	11.6	12.5	103.6	25.0	17.7	81.3	31.8	22.0	24.6	7.0	24.0	16.6	24.8	25.0	19.5	12.2	3.6	23.4	38.9	13.2	17.7	58.9	18.8	34.2	35.1	19.3	14.7	25.8	23.0	17.6	5.2	4.5	19.0	18.8	42.3	26.7	18.0	31.1	15.4	16.6	14.4	27.7	7.5	5.9	5.2	17.9	10.9	13.0	24.6	47.2	6.6	10.3	12.2	55.3	27.0	33.8	16.1	32.9	33.5	11.5	7.0	36.4	29.1	18.4	33.0	23.1	7.8	13.9	7.7	25.1	15.8	14.9	2.3	1.0	5.5	0.6	0.9	0.3	0.5	0.6	0.7	0.7	0.5	0.4	0.4	4.7	0.6	1.2	0.5	0.8	0.5	64.1	73.5	68.4	67.0	65.9	58.2	74.7	61.6	78.1	44.0	60.4	103.6	38.3	60.9	21.6	413.9	9.3	50.9	24.5	15.2	25.0	248.2	33.6	26.5	120.0	14.3	18.1	22.0	579.6	6.9	17.5	26.4	0.0	18.8	85.8	34.6	41.8	39.8	28.8	4.2	297.4	18.1	6.1	42.6	22.4	63.1	7.0	104.6	20.3	37.6	22.1	139.7	281.6	17.7	20.3	22.0	43.5	48.4	18.6	36.8	51.6	75.9	19.5	56.1	6.2	238.8	521.3	23.8	23.4	20.7	21.1	25.8	31.7	14.2	19.9	389.3	19.7	85.4	42.3	37.3	37.7	40.8	59.1	6.7	14.4	63.0	21.3	20.8
KIF1C	"SAX2, SPAX2, SPG58"	ENSG00000129250	"Kinesin family member 1C"	O43896	17	4997950-5028401	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 244.8;choroid plexus: 142.7;heart muscle: 185.0;skeletal muscle: 561.0;tongue: 389.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 315.4;Distal enterocytes: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024602, HPA045020"	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA024602: AB_1852480, HPA045020: AB_2679187"	"unprognostic (3.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.90e-3)"	"prognostic favorable (2.26e-9)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.10e-3)"	54.6	18.6	200.1	25.1	230.9	6.3	36.3	184.0	210.0	33.9	142.7	63.3	53.3	44.4	7.9	75.7	31.5	28.0	185.0	164.4	175.0	37.9	46.4	49.6	10.0	219.0	216.9	24.1	51.6	55.1	10.5	18.6	197.0	36.4	33.2	4.3	38.3	36.7	561.0	53.4	51.4	36.3	200.7	26.5	51.2	17.7	200.8	11.3	38.7	389.2	16.7	51.4	37.3	244.8	104.1	97.6	32.2	69.4	74.5	44.5	51.0	80.8	64.3	63.2	38.3	70.7	24.5	16.6	46.7	127.2	41.2	105.3	58.4	107.2	44.6	40.2	68.7	12.0	124.1	57.4	50.7	4.9	34.6	46.0	109.9	85.2	58.0	59.6	87.2	14.5	45.9	28.4	62.6	61.5	14.7	8.0	25.1	68.1	63.4	15.1	54.1	17.2	55.7	71.9	7.8	15.3	114.2	63.0	34.9	30.6	62.0	14.9	185.5	84.8	63.7	62.2	99.3	10.8	9.9	8.9	62.6	20.9	43.0	0.5	0.4	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.4	0.2	0.2	1.2	0.3	0.2	0.2	0.3	0.1	200.1	230.9	184.0	210.0	164.4	175.0	219.0	216.9	197.0	200.7	200.8	244.8	24.8	54.5	50.6	6.5	6.8	16.8	19.0	25.6	12.5	12.5	24.8	14.2	315.4	48.6	28.1	25.8	0.0	14.8	6.5	168.9	19.6	32.2	71.6	13.0	15.1	37.8	14.4	4.4	5.7	43.1	14.0	21.9	51.0	29.3	12.7	21.6	37.1	82.7	16.1	23.5	7.3	77.3	12.2	18.5	11.0	32.1	16.8	11.9	16.0	10.3	16.1	7.7	6.2	4.5	5.0	63.0	83.8	42.5	11.4	44.1	92.9	42.9	18.4	5.8	6.6	35.0	35.1	18.7	23.6	21.3	20.2	23.3	7.9	12.4	65.4	36.6
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805384	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.5;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048213, HPA075670"	Enhanced		Supported	"Nuclear speckles"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA048213: AB_2680316, HPA075670: "	"unprognostic (3.71e-2)"	"prognostic favorable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	9.2	7.0	9.5	19.7	9.9	88.5	13.4	8.1	10.4	10.5	6.9	22.6	16.6	8.2	8.6	22.3	12.3	6.4	10.8	9.5	8.9	11.2	8.3	8.5	34.1	8.4	8.3	8.2	7.3	33.8	9.2	15.7	8.3	24.9	20.6	8.9	10.5	12.0	8.4	32.8	16.9	8.0	8.9	18.6	11.8	28.3	9.4	73.0	26.0	11.0	34.7	10.1	13.3	9.3	89.3	103.9	120.6	87.6	8.0	11.9	104.8	65.8	52.1	123.1	113.9	97.9	103.3	130.6	60.4	34.4	61.2	90.0	118.9	67.5	57.4	84.8	100.4	72.4	115.1	119.0	2.7	79.1	76.0	6.7	17.7	68.5	51.3	17.1	67.2	144.7	109.4	104.1	65.5	186.5	173.1	196.1	101.8	65.7	59.6	237.9	110.6	122.4	44.9	45.0	99.8	65.4	48.5	94.7	33.1	39.4	84.8	105.2	29.8	63.8	66.6	57.7	72.6	96.6	105.3	141.4	41.9	129.0	83.3	58.7	14.1	39.5	49.7	21.1	37.3	30.4	50.0	53.1	14.7	27.3	40.0	38.4	6.2	31.5	18.3	9.6	56.5	40.5	9.5	9.9	8.1	10.4	9.5	8.9	8.4	8.3	8.3	8.9	9.4	9.3	13.9	32.1	115.4	5.5	23.0	30.8	25.8	56.7	52.9	27.5	56.5	56.4	288.7	57.2	38.5	69.9	25.0	81.7	20.1	44.2	62.6	16.6	9.9	29.5	18.9	29.2	41.4	85.2	4.8	50.1	85.4	50.1	25.0	31.1	43.6	29.5	49.2	565.5	46.3	6.7	6.1	39.5	34.6	47.7	40.4	8.5	15.5	36.7	35.6	4.7	38.6	69.8	29.9	4.0	5.3	17.3	44.0	12.8	49.9	26.1	18.0	194.0	29.7	20.5	13.1	23.7	34.2	50.9	61.6	41.4	27.6	76.9	34.2	12.2	42.3	22.5
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277651-32335011	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	12.2	14.0	25.1	11.1	25.4	8.5	12.1	18.2	25.5	14.5	34.6	18.7	19.9	11.6	17.5	7.7	20.5	14.9	8.1	30.3	20.8	35.4	17.8	12.9	11.5	20.8	22.7	13.5	23.0	46.7	17.3	8.5	18.8	11.7	19.0	30.8	11.1	10.9	8.4	7.8	24.1	12.1	22.4	9.9	17.6	22.2	26.9	8.2	19.2	5.6	11.9	11.4	8.5	21.4	49.9	33.2	22.6	29.1	29.3	46.3	23.0	24.2	33.7	28.7	22.4	56.9	26.7	26.7	28.4	45.8	40.8	31.4	29.3	35.8	36.3	12.7	13.3	23.1	25.6	28.2	18.6	19.6	16.9	28.6	25.2	49.5	19.5	23.5	23.7	10.7	14.5	10.4	23.4	22.8	9.1	8.9	12.2	26.5	28.8	8.3	37.1	9.7	29.2	36.1	37.0	31.1	63.2	16.7	24.7	18.9	36.8	15.1	28.9	53.4	36.4	31.4	30.2	17.3	26.5	13.5	53.2	33.7	22.2	0.7	1.5	1.9	3.2	2.2	2.6	3.2	2.4	3.0	0.9	3.1	1.4	2.2	1.6	1.4	3.2	1.5	2.0	1.0	25.1	25.4	18.2	25.5	30.3	20.8	20.8	22.7	18.8	22.4	26.9	21.4	10.6	22.4	23.4	11.1	12.2	6.6	8.5	12.8	13.6	32.4	14.1	10.7	9.2	40.0	15.0	12.9	106.3	8.1	10.8	67.9	3.9	34.4	67.1	48.5	21.3	16.8	39.4	6.3	31.4	39.1	6.3	14.2	20.9	31.3	8.2	13.7	13.9	28.7	8.1	32.0	37.7	26.3	14.2	7.7	5.5	88.2	13.4	9.0	0.0	8.4	10.9	19.2	8.2	10.1	11.4	32.4	33.4	20.3	16.3	12.1	82.4	23.7	59.1	63.6	0.0	21.0	11.7	33.4	7.4	10.7	5.1	6.6	12.4	17.6	27.3	9.3
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926598-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 75.5;retina: 19.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.1	6.8	28.4	2.3	40.2	1.5	2.9	6.9	75.5	4.0	0.0	5.4	1.3	3.6	1.7	2.2	2.7	3.6	2.9	46.1	18.6	1.6	0.7	2.0	1.2	37.5	10.9	6.8	1.4	3.7	11.7	2.1	32.7	2.9	1.7	19.6	2.2	3.8	1.8	2.5	2.5	4.2	0.0	1.6	2.3	2.3	13.8	2.6	3.0	2.5	1.1	2.7	3.7	37.8	25.7	38.1	19.9	15.4	11.4	13.1	15.9	13.1	6.4	7.7	8.7	6.8	3.8	0.0	10.6	11.9	24.1	2.7	15.2	7.8	5.2	4.5	7.3	9.3	2.6	14.0	6.7	2.3	7.7	9.6	2.3	24.2	4.8	29.6	25.8	7.3	3.3	3.2	8.3	1.8	6.7	3.2	20.5	0.7	11.1	10.4	9.9	1.7	17.7	6.2	24.2	54.4	5.2	2.2	27.3	16.4	0.8	3.1	20.6	13.4	13.7	6.1	12.9	0.8	4.6	3.1	30.4	12.5	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.5	0.2	0.0	0.0	0.4	0.3	28.4	40.2	6.9	75.5	46.1	18.6	37.5	10.9	32.7	0.0	13.8	37.8	1.9	0.0	0.0	9.4	0.2	0.5	1.6	1.5	1.2	16.7	2.0	2.4	3.5	2.8	1.1	0.0	6.2	0.6	2.1	0.1	0.0	8.4	3.4	1.0	2.1	5.6	3.0	0.0	53.5	1.4	4.2	2.6	0.5	1.4	7.0	8.8	7.9	0.1	3.5	42.1	45.9	0.3	2.0	4.6	1.1	4.8	1.8	2.6	3.6	12.2	2.0	7.0	0.0	27.6	13.7	10.1	0.0	4.5	1.5	1.0	0.0	1.2	1.3	9.6	6.6	2.8	3.1	0.3	1.6	1.0	0.3	1.2	1.7	5.1	0.2	1.0
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009015-32056425	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		97000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	59.7	41.8	110.0	46.7	128.2	84.9	45.3	107.7	149.7	47.3	75.6	66.4	52.0	54.1	30.3	52.7	39.2	59.8	87.4	85.8	100.2	44.7	31.9	52.5	39.9	121.9	123.8	27.6	41.8	91.6	22.9	54.4	120.6	65.9	63.6	45.1	39.1	52.0	65.0	38.9	54.7	81.3	128.1	48.1	51.4	64.4	116.8	44.0	50.5	67.3	36.6	60.8	29.8	143.4	115.8	96.4	127.3	89.9	89.2	97.7	54.4	155.6	73.3	117.6	99.6	106.6	124.0	78.7	65.8	185.8	66.9	93.3	117.6	99.4	156.4	68.4	64.1	100.2	87.9	104.5	102.5	70.5	105.6	79.9	138.0	135.8	94.0	93.4	152.8	68.2	122.9	80.5	164.7	69.7	74.0	39.7	20.7	110.1	43.4	95.7	237.2	32.6	90.6	79.5	123.3	89.9	120.4	47.5	117.3	88.0	57.5	99.4	128.4	118.7	111.0	139.3	117.2	24.2	29.8	90.9	113.2	142.2	114.1	41.8	25.9	44.0	19.1	33.0	18.7	23.7	24.0	20.6	24.7	24.3	21.1	20.8	51.1	24.3	35.7	47.9	29.4	18.4	110.0	128.2	107.7	149.7	85.8	100.2	121.9	123.8	120.6	128.1	116.8	143.4	160.3	182.7	206.8	49.3	86.3	213.1	177.7	200.6	66.0	181.9	119.0	103.8	396.0	115.8	198.4	104.8	100.1	121.0	125.5	145.0	45.0	209.4	185.5	167.8	171.4	181.0	132.3	69.2	44.6	176.0	134.9	141.2	85.6	158.9	91.2	159.7	88.5	46.2	132.7	151.4	56.0	227.3	213.6	111.8	129.1	51.8	59.0	137.2	101.4	84.3	169.3	160.5	82.4	61.9	83.3	202.2	164.9	130.9	84.2	254.1	120.2	59.5	206.1	123.8	85.5	176.0	244.8	566.0	195.6	87.6	236.7	331.9	116.0	137.4	208.1	246.8
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875227-149026759	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 252.2;Early spermatids: 568.4;Excitatory neurons: 267.2;Inhibitory neurons: 249.1;Late spermatids: 702.5;Oligodendrocytes: 270.7"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7;prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA035210: AB_10671931, HPA062272: AB_2732678"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	0.5	5.1	41.3	0.6	17.6	0.0	0.5	13.9	65.2	1.4	0.0	1.1	0.3	0.5	3.7	0.1	0.9	0.1	0.6	28.9	13.7	0.2	0.0	0.2	0.3	15.4	9.0	1.6	2.3	0.3	5.5	0.0	24.6	10.4	0.6	7.8	0.2	2.8	0.3	0.3	0.8	0.4	16.3	0.2	0.6	12.1	49.8	0.1	1.3	0.9	0.2	0.6	1.4	32.0	0.0	0.0	17.8	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.2	0.0	0.7	0.0	0.2	5.4	0.0	14.1	0.0	1.3	13.7	3.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.7	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	22.4	0.0	9.2	0.0	0.1	0.1	0.0	3.6	117.1	27.1	0.2	0.5	0.2	2.8	0.0	0.0	0.0	0.0	3.3	0.0	3.7	3.0	0.4	0.0	8.8	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	17.6	13.9	65.2	28.9	13.7	15.4	9.0	24.6	16.3	49.8	32.0	1.8	0.0	0.0	33.6	2.4	1.3	6.1	0.1	2.2	252.2	8.0	3.7	14.9	4.3	0.0	18.4	108.4	0.0	0.8	1.1	0.0	0.3	568.4	0.9	1.6	6.1	129.7	0.0	267.2	0.0	0.1	4.9	2.0	0.2	0.0	1.1	0.7	0.0	0.2	99.3	249.1	2.7	4.1	0.3	1.9	702.5	8.1	0.8	5.4	10.3	0.8	8.5	2.1	125.2	270.7	0.9	3.4	12.8	1.7	35.8	0.1	0.1	0.0	15.1	6.6	1.6	9.1	15.8	10.7	0.2	0.4	0.0	11.9	0.3	4.9	2.3
KIFAP3	"FLA3, KAP-1, KAP3, SMAP"	ENSG00000075945	"Kinesin associated protein 3"	Q92845	1	169921326-170085208	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 193.9;Excitatory neurons: 190.5;Inhibitory neurons: 192.4;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023738, HPA023742"	Supported		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA023738: AB_1857285, HPA023742: AB_1857286"	"unprognostic (5.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.22e-2)"	17.8	34.8	46.8	11.9	50.0	6.9	16.4	37.4	60.0	18.8	27.7	19.9	11.6	17.3	23.3	12.6	19.4	15.4	51.1	50.8	55.7	23.5	16.6	15.4	13.1	50.0	43.3	19.2	14.0	27.1	29.1	14.5	52.0	14.4	15.9	56.4	13.0	16.2	22.4	14.1	14.5	15.6	39.2	10.8	10.0	35.1	44.2	18.8	16.7	23.1	13.9	13.5	18.1	49.9	13.0	11.8	17.6	19.0	41.0	43.2	9.9	16.1	19.9	19.7	24.2	5.8	20.5	23.2	23.1	33.3	9.1	27.6	37.7	22.6	18.5	49.3	19.9	56.3	13.8	5.3	20.4	16.6	9.4	30.5	30.3	34.7	30.1	23.3	22.6	29.5	47.7	17.1	24.9	3.5	31.2	9.8	3.8	33.7	10.7	12.3	15.5	14.8	37.2	4.8	20.8	32.0	22.1	17.9	25.1	40.5	16.7	10.4	24.1	42.0	9.7	26.7	19.5	33.0	23.9	21.2	19.6	6.0	27.3	16.8	3.8	14.8	13.0	10.6	15.0	7.5	13.2	14.9	8.8	7.6	14.9	15.3	1.4	22.3	19.3	7.6	18.6	8.4	46.8	50.0	37.4	60.0	50.8	55.7	50.0	43.3	52.0	39.2	44.2	49.9	33.2	32.1	27.8	64.6	14.4	9.1	11.9	12.3	12.0	56.5	13.8	18.2	37.3	28.6	27.6	29.5	43.8	14.2	22.8	14.5	9.8	25.9	193.9	51.5	35.4	20.9	32.2	25.9	190.5	8.2	16.0	32.4	9.2	25.5	31.0	15.5	12.8	13.6	9.8	48.8	192.4	12.5	24.4	13.4	5.9	200.7	38.5	17.1	10.6	51.5	8.6	42.7	29.9	84.4	65.0	12.0	9.4	21.8	27.8	4.9	13.2	37.3	64.3	70.7	0.0	34.5	31.1	77.8	64.0	14.6	10.7	8.8	20.3	17.4	17.0	9.9
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423358-127003460	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 21.5"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	0.2	1.4	17.3	0.5	21.5	0.3	0.1	4.9	19.9	0.6	0.0	3.8	0.4	0.1	0.0	0.4	0.1	0.2	2.1	15.5	8.5	0.2	0.1	0.0	0.6	12.2	14.6	0.5	0.2	0.0	0.1	0.3	7.6	0.3	0.4	2.5	1.4	1.1	0.0	0.1	0.8	0.5	14.0	2.5	0.6	0.2	16.0	0.0	0.1	0.2	0.4	0.6	0.3	17.8	0.4	3.0	0.2	0.0	0.0	0.1	0.2	25.2	14.7	9.3	9.7	0.0	0.1	0.0	0.1	18.3	0.1	0.1	0.0	0.0	5.7	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.7	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	6.1	0.2	0.4	0.5	0.0	0.0	1.3	0.0	0.1	2.8	0.2	0.1	0.2	0.0	0.0	0.1	0.4	0.0	11.3	7.8	4.5	14.1	0.0	0.0	0.0	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	17.3	21.5	4.9	19.9	15.5	8.5	12.2	14.6	7.6	14.0	16.0	17.8	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.2	0.0	17.3	0.1	0.1	2.2	1.5	0.4	0.0	0.0	0.0	5.4	0.9	0.0	0.1	5.2	0.0	0.1	0.2	0.0	0.0	274.4	0.0	0.0	0.5	0.0	0.1	1.3	0.3	0.4	0.0	0.0	0.0	482.6	0.4	2.0	0.0	0.3	12.9	0.0	0.2	1.8	18.7	0.1	0.5	0.0	23.1	390.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 83.6;Collecting duct cells: 69.9;Excitatory neurons: 46.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 299.8;SK-BR-3: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		260000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA070395: AB_2686264"	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	13.2	3.9	2.3	8.2	3.5	0.3	10.6	0.2	3.1	12.9	1.2	18.7	9.6	15.1	2.8	14.3	4.0	18.5	7.0	2.9	0.3	16.0	2.3	31.6	3.3	0.0	2.5	6.0	3.7	3.7	0.2	15.0	0.0	15.1	22.6	2.3	8.8	14.8	3.1	7.1	11.6	18.8	0.3	3.5	17.4	6.3	5.2	5.1	5.9	14.4	10.4	12.3	1.3	6.2	14.3	7.1	7.1	0.9	29.0	61.5	0.0	77.6	60.1	13.5	6.4	299.8	11.0	0.0	2.2	73.3	14.9	49.5	11.5	20.1	14.2	0.1	9.5	0.0	9.5	2.6	4.4	1.9	0.0	53.5	20.6	41.6	26.8	6.3	17.9	0.0	0.0	0.3	6.8	2.5	0.2	0.0	4.8	17.7	17.9	0.0	12.6	0.0	25.0	6.5	2.3	4.8	18.5	118.9	2.2	6.5	57.2	4.3	10.0	60.7	7.4	69.0	6.8	0.0	0.0	0.0	8.4	0.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.2	3.1	2.9	0.3	0.0	2.5	0.0	0.3	5.2	6.2	42.5	19.2	38.3	9.4	0.5	13.5	11.2	7.5	83.6	2.7	12.2	8.1	4.4	1.5	16.5	69.9	0.0	0.1	0.0	12.0	1.9	4.4	0.4	3.1	6.8	43.1	9.5	0.0	46.5	18.2	0.1	34.5	43.3	3.4	0.0	2.1	5.0	0.4	1.2	21.9	61.4	8.5	18.3	3.2	5.7	0.9	14.0	1.9	12.4	18.7	0.0	0.3	0.0	3.0	0.6	8.7	3.0	3.8	1.4	11.2	2.3	1.4	9.8	1.2	13.1	2.2	27.2	0.2	0.5	18.5	5.3	0.0	1.0	4.4	14.7	3.2
KLF13	"BTEB3, FKLF-2, NSLP1, RFLAT-1"	ENSG00000169926	"Kruppel like factor 13"	Q9Y2Y9	15	31326835-31435665	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 275.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (2.13e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (2.37e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.03e-2)"	25.0	11.7	2.8	13.0	8.2	62.0	19.3	16.8	13.7	13.3	0.0	21.5	15.1	17.5	8.6	18.5	21.0	2.7	27.7	10.0	0.0	17.4	20.5	31.8	17.7	5.7	3.4	14.2	44.3	10.9	11.6	4.8	4.6	9.9	13.5	3.9	12.8	10.7	38.6	33.7	29.2	20.8	0.0	29.6	22.6	6.7	16.9	48.8	28.3	18.8	18.1	15.2	13.0	20.8	10.7	0.9	14.8	6.0	34.3	18.2	1.3	10.5	16.7	5.7	6.9	8.8	7.4	2.1	21.5	19.8	18.6	16.1	4.1	12.6	4.3	50.9	3.5	25.6	27.6	7.0	49.3	23.3	33.1	10.7	85.8	4.6	31.9	9.4	0.2	17.3	11.2	5.2	2.9	3.3	32.2	28.1	2.9	42.5	21.0	18.4	14.6	17.3	11.2	4.6	16.7	36.5	13.4	21.6	0.0	17.7	3.3	13.6	22.3	4.3	11.6	16.7	0.1	32.3	19.2	6.6	3.7	34.6	5.1	2.2	4.7	7.0	13.1	2.3	13.8	26.5	7.7	12.6	1.2	24.2	6.7	21.0	8.6	1.5	1.9	21.0	21.3	4.3	2.8	8.2	16.8	13.7	10.0	0.0	5.7	3.4	4.6	0.0	16.9	20.8	56.6	131.4	66.0	7.5	65.4	58.5	32.9	20.2	33.0	34.7	18.9	22.1	47.9	50.1	24.8	16.5	0.0	14.7	149.3	74.0	9.8	19.2	7.7	49.5	36.2	45.1	40.6	74.5	18.6	26.5	25.0	46.0	24.5	67.1	26.6	13.3	42.5	102.5	11.6	275.9	9.1	39.1	10.2	84.8	28.5	6.5	25.4	34.4	32.0	4.7	90.7	28.7	120.5	12.1	40.6	29.8	22.4	46.6	150.0	40.5	56.7	26.0	9.5	12.3	26.3	68.6	52.5	1.5	8.2	35.1	51.3	14.6	82.1	54.2	45.8	44.1
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232356-56291531	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 37.6;Peritubular cells: 27.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;hTCEpi: 7.8;RPTEC TERT1: 3.9;RT4: 5.0;SK-BR-3: 5.4;T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA071740: AB_2686440"	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favorable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	14.7	2.1	1.1	1.3	1.7	0.6	13.9	1.5	1.4	11.7	0.6	6.4	0.5	10.0	3.7	23.5	9.5	1.7	4.9	1.3	0.8	7.4	0.7	6.1	1.6	0.5	0.6	9.8	2.0	1.1	2.0	3.9	0.6	4.8	1.8	0.6	9.9	2.0	3.8	29.4	5.8	4.9	0.6	5.2	3.7	3.1	0.8	1.2	6.1	1.8	3.0	7.5	17.8	0.9	1.3	0.0	0.0	0.1	1.1	0.4	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	2.9	0.0	0.0	0.0	2.0	3.7	1.0	0.0	0.0	0.1	0.1	0.3	0.0	7.8	0.0	0.6	0.0	0.0	0.3	0.9	0.6	0.2	0.1	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	3.9	5.0	0.0	0.0	2.4	5.4	0.0	3.3	9.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	1.2	0.3	0.4	0.6	1.2	0.1	0.0	0.2	1.5	0.0	0.2	0.1	0.1	1.1	1.7	1.5	1.4	1.3	0.8	0.5	0.6	0.6	0.6	0.8	0.9	12.1	0.0	4.1	2.3	11.2	6.9	4.5	3.6	6.2	0.4	8.0	4.1	3.5	0.0	2.2	14.7	2.1	6.3	1.3	1.0	0.0	0.8	0.6	1.9	4.1	11.1	0.0	4.8	14.0	1.0	15.0	6.2	0.0	5.6	1.3	3.5	21.4	0.0	1.2	0.0	5.4	0.7	2.0	1.3	13.9	2.0	37.6	3.2	5.4	8.4	2.1	0.5	5.2	2.5	3.6	0.4	0.3	27.4	5.6	7.5	0.4	7.5	1.5	0.1	19.7	5.2	8.1	0.9	1.1	27.0	11.6	4.5	2.2	3.1	1.2	10.9
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 186.3;Microglial cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 323.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	41.4	22.4	53.9	32.3	53.8	9.0	18.7	44.8	56.5	17.0	29.4	44.4	12.7	19.1	13.5	32.0	9.4	23.1	14.4	49.8	50.0	25.0	42.3	20.2	33.7	53.5	50.2	18.4	11.3	12.9	7.5	28.0	53.0	35.9	16.1	11.8	10.2	66.0	10.7	6.1	13.2	46.1	56.7	21.0	13.1	11.0	55.2	14.6	21.5	18.9	38.9	34.8	9.5	52.6	56.7	78.2	40.9	30.2	22.9	58.5	59.1	44.2	323.1	36.6	35.4	64.6	40.4	86.4	52.4	45.5	192.7	3.3	50.7	112.3	46.6	8.8	10.1	36.8	71.4	46.5	195.6	10.9	11.9	74.5	61.9	55.5	137.7	134.1	73.7	13.8	28.2	17.0	87.1	23.8	11.5	19.6	12.6	14.3	75.5	20.9	53.7	2.1	31.3	23.0	2.8	29.7	25.0	8.0	21.8	49.0	19.3	22.9	94.2	96.8	65.4	25.5	53.8	19.3	18.7	79.0	78.6	28.3	22.9	5.4	2.2	0.4	0.7	3.2	1.1	5.1	1.4	0.8	2.5	3.7	1.1	0.5	2.3	1.0	1.4	0.9	0.2	0.8	53.9	53.8	44.8	56.5	49.8	50.0	53.5	50.2	53.0	56.7	55.2	52.6	74.9	16.0	1.1	45.7	38.0	3.7	9.4	22.9	7.4	18.8	16.5	11.2	4.5	17.2	33.7	11.0	4.2	1.0	6.3	0.3	17.6	39.3	2.8	4.0	11.1	43.6	1.2	10.9	46.1	21.0	57.9	12.6	3.1	5.3	2.5	9.5	22.9	35.6	13.3	70.7	186.3	0.4	12.2	25.4	25.8	6.6	8.1	28.6	17.8	190.2	27.5	12.1	7.2	69.9	79.0	24.3	0.1	13.9	43.0	31.5	2.0	21.8	32.7	3.4	0.0	14.2	17.3	9.8	5.6	3.3	3.4	5.7	10.7	32.4	0.7	14.1
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329665-21335404	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	11.2	10.2	7.8	10.9	8.4	8.9	16.8	10.2	9.2	14.9	8.4	12.0	7.1	15.5	14.6	10.4	13.3	10.2	7.9	7.3	9.1	14.3	10.9	11.2	12.1	8.0	7.9	19.6	10.8	12.8	5.2	16.8	8.1	15.7	12.1	17.7	12.2	11.3	4.6	8.4	10.4	14.2	8.7	15.2	13.4	7.2	8.0	14.4	16.0	8.4	11.5	10.9	7.1	12.3	12.3	14.7	32.6	17.7	41.3	40.7	7.1	22.5	22.9	16.7	18.8	5.6	9.5	5.5	14.2	33.1	16.8	6.6	19.2	22.0	20.6	30.7	14.0	0.0	27.4	14.5	28.7	9.8	6.5	40.2	23.3	13.1	21.1	27.3	25.8	0.0	0.0	7.0	38.6	7.8	20.4	33.9	13.4	12.7	12.4	0.0	14.3	6.6	20.8	15.1	10.3	19.6	13.0	11.6	14.3	30.0	21.0	0.0	31.2	0.1	11.7	9.4	13.2	7.6	11.2	5.7	0.0	10.1	11.5	8.4	6.0	16.5	4.8	6.8	5.5	3.1	5.9	4.4	4.7	2.3	7.1	4.9	1.9	6.2	7.2	3.5	4.5	4.6	7.8	8.4	10.2	9.2	7.3	9.1	8.0	7.9	8.1	8.7	8.0	12.3	20.3	25.6	20.5	9.1	12.2	10.3	34.3	15.4	22.8	27.3	14.8	12.4	17.9	17.2	25.9	16.5	18.8	16.4	12.7	19.5	11.7	14.8	0.8	12.1	26.2	20.2	27.6	10.5	14.2	15.3	7.8	22.6	25.5	12.7	12.0	24.6	37.9	23.1	15.4	18.5	17.0	22.0	22.4	22.8	8.4	1.9	21.5	14.7	17.8	20.6	14.7	20.1	9.2	15.1	23.8	12.2	13.9	24.0	16.3	25.2	13.7	19.3	20.8	21.4	13.1	20.1	22.0	13.4	9.7	19.5	10.4	10.0	17.2	18.7	16.9	21.0
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 324.2;skin 1: 239.8;vagina: 186.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 53.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;HaCaT: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		1800000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	28.4	0.2	0.0	0.4	0.0	0.0	17.1	0.9	0.1	109.8	44.5	1.9	0.7	7.2	2.6	324.2	34.2	59.3	2.0	1.7	0.0	0.3	0.8	18.9	0.0	0.2	0.1	1.6	89.1	0.0	8.8	0.0	0.3	64.9	0.6	0.7	169.5	4.2	1.9	239.8	1.4	0.3	0.0	0.1	113.3	14.4	0.6	2.5	0.4	0.3	27.2	1.4	186.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	13.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.7	0.0	0.2	0.1	0.3	0.0	0.6	0.0	0.2	86.6	10.4	0.0	0.4	106.9	152.1	131.6	13.1	0.2	33.4	35.3	0.8	88.6	217.9	0.0	0.0	0.0	0.0	0.1	0.0	9.2	111.6	4.7	1.1	3.8	20.3	0.0	0.0	130.2	0.0	9.1	91.3	15.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	10.7	118.0	0.0	11.4	339.0	2.8	1.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	79.4	0.0	0.4	0.5	234.8	0.1	0.0	26.9	1.3	0.0	0.2	7.9	2.1	2.5	176.4	217.1	0.0	1.7	0.0	0.4	186.1
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 9.7"	"Cell type enhanced"	"Detected in single"		"Club cells: 2.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.7;HEK 293: 2.9;U-266/84: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB026228	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.5	0.3	2.1	0.2	2.2	0.1	1.6	2.3	3.3	4.2	1.9	0.4	1.3	0.5	0.6	0.9	0.7	0.3	0.8	2.2	1.7	0.5	0.3	0.4	0.3	2.1	1.9	1.1	0.7	0.0	0.6	0.0	2.2	0.8	0.3	0.6	0.8	0.5	0.3	9.7	0.7	0.1	1.6	0.6	0.6	0.9	2.0	0.3	0.4	0.1	0.5	0.6	3.9	2.3	1.4	0.5	0.1	0.6	0.4	0.4	0.6	0.1	0.0	0.0	0.1	1.2	1.4	0.6	0.4	0.2	0.3	10.7	0.1	0.2	0.0	0.3	2.9	0.2	0.9	0.0	0.1	0.2	0.2	0.2	0.3	0.4	0.4	0.1	0.1	0.4	0.2	0.3	0.0	0.9	0.2	0.5	0.6	1.2	1.1	0.1	0.1	0.6	0.0	0.6	0.1	0.0	0.2	1.0	0.3	0.2	0.4	0.0	0.0	0.1	0.4	0.6	0.2	2.6	5.5	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.2	2.3	3.3	2.2	1.7	2.1	1.9	2.2	1.6	2.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	87	"prostate: 566.2"	"Cell type enriched"	"Detected in some"	40	"Prostatic glandular cells: 777.2"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 5.6"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.7	1.1	3.2	1.2	2.3	6.4	0.5	5.2	4.3	0.2	2.2	0.4	1.5	0.6	1.1	0.5	0.3	0.2	0.3	2.6	2.2	0.4	0.8	0.5	1.0	2.2	3.1	0.4	0.0	0.8	0.0	0.2	2.9	566.2	0.3	1.7	1.9	0.4	1.0	0.8	1.0	0.1	0.6	0.7	0.5	3.0	2.4	0.0	1.9	0.0	0.2	0.2	0.0	6.3	0.9	0.6	0.3	0.7	0.0	0.4	3.5	0.2	0.1	0.1	0.1	0.3	0.4	1.0	0.1	0.0	0.3	0.9	0.1	0.0	0.1	0.9	0.6	0.0	0.7	0.0	0.0	0.1	1.7	0.2	0.1	0.1	0.2	0.2	0.0	0.6	0.7	0.9	0.2	1.0	0.6	5.6	0.5	0.9	0.0	0.4	0.0	1.6	0.0	1.1	0.5	0.5	0.1	0.7	0.6	0.1	0.5	0.2	0.4	0.6	1.0	2.6	0.9	0.8	1.8	0.4	1.0	0.6	0.7	0.4	0.6	0.5	0.3	0.3	0.2	0.3	0.2	0.3	0.1	0.6	0.2	0.4	1.7	0.4	0.2	0.5	0.1	0.2	3.2	2.3	5.2	4.3	2.6	2.2	2.2	3.1	2.9	0.6	2.4	6.3	0.0	0.0	0.6	0.0	0.2	0.3	10.2	0.0	0.0	0.0	16.1	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	777.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	19.3	7.2	0.0	0.9	0.0	0.6	1.7	0.0	12.0
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 8011.8"	"Cell type enriched"	"Detected in some"	77	"Prostatic glandular cells: 3438.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	173	"BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000		"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		4.3	7.6	0.0	5.6	0.0	0.0	9.0	0.0	0.0	0.5	0.0	2.6	4.8	1.6	14.4	0.2	4.0	0.0	0.5	0.0	0.0	1.4	1.5	1.2	1.7	0.0	0.0	0.3	0.9	0.6	0.2	0.3	0.0	8011.8	1.1	0.0	4.5	25.0	0.3	0.5	3.7	0.0	0.0	0.2	1.0	6.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	12.4	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	1.8	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3438.6	0.1	0.1	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	4.2	0.2	0.4	44.6
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 118.0;skin 1: 87.1;vagina: 47.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	5.7	0.0	0.1	0.0	0.0	0.0	8.4	0.8	0.7	24.7	0.2	0.0	0.0	0.9	0.4	118.0	13.2	0.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	17.1	0.1	0.7	87.1	0.0	0.1	0.0	0.2	0.1	1.2	0.2	1.1	0.5	0.0	9.6	0.0	47.2	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.7	0.2	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 328.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.6	1.8	5.9	0.3	6.5	0.0	0.6	6.0	7.6	1.4	9.3	2.3	2.8	0.6	1.0	0.4	1.3	2.5	2.6	6.3	6.2	7.7	328.4	1.0	0.7	7.0	6.5	0.7	4.8	1.0	3.6	0.2	6.4	1.7	1.4	13.1	0.7	0.6	2.4	0.3	2.6	0.6	6.1	2.4	0.8	2.0	6.0	0.4	1.9	1.8	0.4	1.5	0.9	6.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.5	6.0	7.6	6.3	6.2	7.0	6.5	6.4	6.1	6.0	6.3	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: AB_2679141"	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	9.9	6.7	8.0	8.5	8.6	19.5	9.9	21.2	9.3	10.3	1.6	10.8	5.4	10.7	8.2	6.8	10.3	6.4	6.5	7.4	9.6	6.7	6.0	10.5	12.4	6.3	6.3	21.2	11.1	9.8	10.2	5.6	6.6	9.2	6.4	23.9	9.4	8.4	7.4	10.4	9.8	7.6	3.2	9.7	8.2	5.3	7.0	14.1	9.9	8.4	11.3	10.7	9.3	11.9	17.9	8.6	20.1	14.5	11.1	16.1	6.2	8.7	11.8	9.0	9.6	17.3	11.4	23.1	15.9	10.8	14.6	16.0	22.9	7.2	17.9	26.0	10.0	45.7	8.9	9.3	6.1	28.5	7.8	7.2	7.4	20.3	24.0	8.9	12.8	13.3	32.8	18.8	9.2	12.7	18.2	12.7	13.6	6.6	13.7	13.8	21.9	6.9	9.8	13.8	18.0	11.8	22.0	6.7	3.9	9.8	11.9	9.1	20.4	14.1	12.7	9.4	14.7	5.1	4.4	15.6	4.7	17.6	8.3	2.1	0.6	1.9	1.6	0.6	1.6	2.5	1.8	1.5	0.3	1.8	1.8	1.2	0.5	2.0	0.7	1.4	1.7	0.4	8.0	8.6	21.2	9.3	7.4	9.6	6.3	6.3	6.6	3.2	7.0	11.9	87.1	70.5	65.8	93.4	83.4	86.9	67.6	29.4	64.9	158.1	76.8	73.9	44.5	40.0	32.2	38.6	152.2	13.9	81.0	26.2	3.9	33.0	10.1	62.1	101.4	74.4	66.4	67.3	146.0	25.6	10.2	65.6	44.4	85.2	29.0	57.5	60.0	27.3	16.8	195.2	170.1	29.6	20.3	37.0	63.7	5.8	66.8	44.8	42.7	62.8	49.9	98.9	78.2	106.6	131.9	28.2	20.1	78.6	83.3	88.3	22.7	10.5	52.7	152.4	65.7	113.4	84.6	25.5	30.7	46.3	80.6	6.0	102.8	55.8	30.6	64.8
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436641	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 363.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA074736: AB_2686709"	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	12.7	11.2	16.7	7.3	25.7	16.4	12.9	16.7	15.7	15.3	5.5	13.1	5.7	14.3	13.7	14.1	11.9	7.7	10.2	13.0	18.9	8.9	10.4	12.7	8.1	25.3	19.4	16.8	18.5	12.4	12.1	10.3	20.6	9.3	7.6	21.7	14.2	9.0	25.9	17.6	12.8	7.5	12.2	12.2	15.2	13.4	19.1	16.1	14.6	16.9	9.5	11.3	12.7	28.6	13.4	6.1	11.6	11.7	19.0	13.9	10.2	4.7	6.4	5.0	5.5	10.9	4.7	22.4	8.9	11.3	9.2	5.2	14.3	7.5	9.2	12.7	6.5	14.0	7.3	4.5	8.9	22.9	12.8	6.6	9.1	7.1	8.2	7.2	8.4	9.7	22.5	15.0	11.7	12.7	14.8	11.1	6.8	8.5	7.9	9.5	12.3	8.4	5.8	10.9	19.6	12.8	13.4	15.8	6.3	10.6	4.6	15.7	12.8	8.0	4.4	9.0	8.9	15.3	7.7	22.4	10.7	14.7	8.4	6.1	3.0	4.4	1.9	2.7	1.6	6.9	2.0	1.5	1.4	3.9	1.9	1.4	15.2	2.2	2.6	3.7	1.3	0.8	16.7	25.7	16.7	15.7	13.0	18.9	25.3	19.4	20.6	12.2	19.1	28.6	62.4	76.9	71.9	292.8	75.0	89.1	38.3	31.5	62.0	89.0	59.6	35.2	65.8	44.3	72.4	46.0	173.0	38.0	61.9	61.7	5.9	37.6	32.1	94.4	92.1	58.9	67.9	55.5	180.7	33.1	51.7	58.3	89.2	200.5	65.2	52.8	56.7	46.0	33.7	80.8	172.2	53.5	42.7	54.7	79.6	17.3	67.4	90.5	42.7	202.4	77.1	57.7	59.8	299.6	363.2	37.6	49.0	60.2	90.3	53.6	36.3	14.7	46.9	73.0	26.3	83.0	55.5	42.3	33.9	80.9	96.3	127.2	76.8	54.8	39.1	61.4
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717348-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 3195.2"	"Group enriched"	"Detected in some"	25	"Distal tubular cells: 655.4;Hepatocytes: 1816.9"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	47000000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	464.1	3195.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	48.6	0.0	33.1	0.0	0.0	0.0	1.8	655.4	0.0	0.4	0.0	0.0	1.5	0.0	40.2	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.0	1816.9	0.1	0.0	0.8	0.1	0.0	47.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.5	0.1	1.1	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.7	0.0	0.1	0.1
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4;Erythroid cells: 29.5;Plasma cells: 28.7;Spermatocytes: 40.7;Spermatogonia: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favorable (8.69e-4)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	7.1	7.6	3.7	11.7	3.6	42.3	7.6	4.9	5.3	9.1	3.5	9.8	9.0	5.3	5.2	12.2	6.8	3.4	4.1	3.6	3.4	6.7	6.4	8.0	16.4	3.8	3.4	8.2	6.6	2.9	5.7	5.8	3.9	7.3	11.9	5.5	7.7	2.9	2.5	15.1	14.5	4.6	3.1	18.2	7.2	28.2	4.0	17.8	5.4	1.4	17.4	6.2	8.9	5.0	33.8	27.6	77.8	17.9	5.9	10.8	35.0	30.6	19.8	29.7	27.9	26.2	27.6	40.2	15.6	14.9	19.5	45.4	34.1	19.1	39.1	28.8	23.7	49.7	57.1	27.1	2.0	49.3	32.8	5.8	4.3	30.7	20.2	15.5	20.5	50.5	50.4	29.4	22.6	25.0	40.9	113.0	39.4	16.3	34.5	55.4	37.8	44.8	17.8	35.6	24.1	31.0	55.7	11.7	16.7	46.2	44.4	28.1	15.1	33.7	32.3	33.3	36.3	39.3	42.3	61.0	20.1	31.3	39.6	2.5	0.5	1.8	0.7	0.7	0.6	1.6	1.1	1.3	0.5	0.9	0.8	1.0	1.6	0.9	1.0	0.8	0.5	0.3	3.7	3.6	4.9	5.3	3.6	3.4	3.8	3.4	3.9	3.1	4.0	5.0	4.3	0.0	2.6	3.3	8.1	4.2	1.9	1.9	2.2	2.2	3.1	3.4	1.8	0.0	1.9	5.5	4.2	7.0	3.8	3.0	0.0	1.5	30.4	3.3	3.9	2.9	0.0	29.5	6.2	0.4	5.9	2.9	10.2	5.2	1.3	14.7	2.2	1.3	4.8	0.0	4.5	2.3	0.0	2.2	4.7	17.7	4.7	4.0	1.8	4.7	1.6	1.1	2.1	2.5	4.4	0.8	1.0	3.0	28.7	1.0	1.5	0.5	5.0	5.0	6.6	3.1	2.9	40.7	39.9	4.9	2.3	2.9	5.3	2.1	5.8	1.6
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skin 1: 13006.6"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 10030.4"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 313.8;melanoma: 478.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	14	"HaCaT: 94.9;hTCEpi: 39.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002153, HPA017917, HPA062908"	Enhanced					NA	NA		35000000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901"	"unprognostic (8.05e-2)"	"unprognostic (8.49e-3)"	"unprognostic (5.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.23e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.09e-2)"	10.3	1.4	0.0	0.1	0.0	7.7	464.1	0.0	0.1	473.6	0.0	2.6	0.2	1.3	0.4	30.8	0.4	0.3	4.5	0.0	0.0	1.2	3.5	2.6	0.0	0.0	0.0	1.4	3.7	0.0	1.4	1.6	0.0	1.5	0.1	0.0	270.2	0.1	47.8	13006.6	2.0	0.2	0.0	1.6	2.1	1.9	0.0	76.8	2.0	0.8	0.5	0.9	1257.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	39.3	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1681.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	22.3	0.0	0.0	0.0	17.4	0.0	0.0	234.7	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	267.0	0.0	0.0	0.3	265.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.5	0.0	0.0	1.1	10030.4	0.0	7.8	0.0	0.3	0.4
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822614	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"skin 1: 15851.5"	"Cell type enriched"	"Detected in all"	5	"Suprabasal keratinocytes: 12515.3"	"Group enriched"	"Detected in all"	4	"head and neck cancer: 310.0;melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"hTCEpi: 718.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000132, HPA012014"	Enhanced				"Secreted in other tissues"	NA	NA		18000000000	"Cluster 37: B-cells - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	66.1	47.9	9.4	7.6	9.8	13.4	432.0	9.9	14.9	548.0	10.4	45.2	7.9	55.0	5.5	78.6	45.5	2.2	95.7	9.9	9.8	67.2	64.5	39.7	6.2	9.8	9.7	52.3	69.1	8.2	77.2	3.8	9.8	60.0	3.4	6.9	163.9	5.5	123.1	15851.5	48.2	4.0	9.8	56.8	58.0	64.9	9.8	44.0	53.5	5.8	13.7	48.5	1106.2	10.4	30.3	31.2	11.0	12.2	14.4	11.5	10.4	29.9	16.5	11.4	10.6	11.2	11.7	8.7	42.0	13.1	16.2	158.5	5.4	11.3	13.4	20.1	27.0	9.2	44.7	19.4	16.4	17.1	24.9	10.1	718.0	9.0	17.3	15.0	7.4	12.3	102.1	16.0	12.2	17.3	25.5	16.2	14.6	23.1	19.1	17.8	16.7	17.7	12.3	26.3	8.9	11.1	19.9	46.0	39.0	17.3	35.5	24.3	9.3	17.6	29.5	22.5	34.4	0.4	19.8	22.4	24.5	10.4	23.4	12.8	2.6	11.1	4.8	2.3	5.4	11.2	5.4	6.8	4.1	5.6	5.8	5.9	0.8	6.9	3.2	8.1	5.5	1.9	9.4	9.8	9.9	14.9	9.9	9.8	9.8	9.7	9.8	9.8	9.8	10.4	197.8	35.3	40.0	19.2	187.5	2239.7	320.6	370.2	255.6	47.0	304.4	328.2	194.2	174.5	197.2	112.2	20.9	117.4	163.2	138.9	305.2	232.5	150.4	174.3	172.2	170.0	181.1	87.7	19.1	376.9	295.7	204.5	126.9	164.5	74.3	87.0	159.5	237.6	105.0	21.9	16.3	237.6	195.3	90.3	350.7	65.6	216.6	116.8	393.1	20.6	100.1	221.4	162.7	17.6	35.0	236.0	149.8	174.9	311.6	342.0	155.3	233.2	116.8	68.6	105.2	141.0	167.7	345.1	121.2	295.0	12515.3	160.1	164.3	131.4	173.1	515.6
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867223	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 3.9;Paneth cells: 12.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055217, HPA055835"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40925.1;vagina: 13409.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	7.7	7.5	0.0	0.0	0.1	6.8	5.1	0.0	0.0	6884.6	0.0	5.6	0.1	10.2	0.0	40925.1	7.0	8.8	9.2	0.0	0.1	5.6	12.8	6.0	0.3	0.0	0.0	9.9	17.2	0.0	26.9	0.0	0.0	115.2	0.0	0.0	6881.1	3.8	9.8	20.5	8.5	14.2	0.0	7.7	31.3	6.9	0.0	13.6	6.1	0.0	1855.2	924.7	13409.3	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586895	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6940.5"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 5910.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"spinal cord: 36.3"	"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1600000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	15.8	1.2	0.0	0.0	0.0	2.7	332.7	0.0	0.0	412.0	0.0	1.7	0.0	0.9	0.0	1304.2	1.7	0.0	3.5	0.0	0.0	0.8	2.5	1.7	0.0	0.0	0.0	1.3	2.9	0.0	4.3	2.2	0.1	29.1	0.0	0.0	702.1	3.8	15.9	6940.5	2.1	0.1	0.0	0.9	1.7	1.5	0.0	186.7	2.3	0.0	262.3	0.7	846.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.0	4065.2	0.0	2003.9	0.2	0.0	0.0	0.1	1.6	0.0	0.1	0.2	2.5	0.1	2448.6	3.0	794.2	0.0	0.1	0.0	0.5	3.6	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.3	9.1	1.7	696.0	0.0	0.9	0.0	0.0	3.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.5	35588.3	1072.7	181.5	2407.4	0.0	103.5	740.9	0.3	0.0	6.0	0.0	0.0	17.9	3.2	7.3	0.0	0.1	0.0	0.1	0.0	129.0	0.0	0.0	0.0	0.0	127.0	116.5	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.4	0.0	0.0	1833.4	0.0	0.0	9.3	1990.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	9.9	702.0	96.8	0.0	2.3	0.0	0.0	0.0	96.3	0.0	0.1	83.2	11677.1	2.5	62.1	0.1	2.3	100.0
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	4.7	0.3	0.1	0.2	0.0	0.7	419.1	0.0	0.1	148.2	0.2	1.1	1.5	0.3	2.2	1156.7	32.4	2.8	0.7	0.1	0.0	0.3	0.6	4.3	0.0	0.1	0.1	0.4	1.4	0.0	1.2	0.3	0.1	182.8	1.6	0.0	140.0	4.1	0.7	1319.5	2.3	0.1	0.0	0.3	1.6	8.0	0.1	93.7	0.5	0.0	77.6	9.5	423.3	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 307.2;esophagus: 1025.8;skin 1: 360.7;vagina: 489.4"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;hippocampal formation: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 816.8"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		1700000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	7.1	1.4	0.2	0.1	0.3	0.3	17.4	3.9	0.6	307.2	0.0	0.2	0.0	1.0	0.0	1025.8	0.7	2.4	0.5	1.0	0.0	0.8	0.4	0.2	0.1	0.0	0.0	0.3	0.7	0.0	1.4	0.1	0.1	6.3	0.0	0.0	180.6	37.7	0.5	360.7	0.2	0.1	0.0	0.2	0.6	2.6	0.0	16.9	0.3	0.0	112.1	5.5	489.4	0.4	20.0	1.7	0.0	0.0	0.2	0.0	0.2	1.5	0.4	0.5	0.2	0.3	4.9	0.1	2.9	0.1	0.2	24.8	0.0	5.6	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	816.8	0.3	17.6	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.0	0.3	0.0	127.1	0.7	0.0	0.2	98.1	0.8	6.2	0.0	0.0	57.1	1.5	0.0	0.9	0.0	0.0	0.2	0.0	1.6	4.5	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	3.9	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	906.1	596.6	70.1	16.5	0.0	37.8	27.1	0.1	0.0	94.6	1.8	0.0	0.1	0.6	0.0	0.0	1.0	0.0	2.6	0.6	9.2	0.0	0.0	0.0	5.8	3.2	11.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	94.1	0.0	0.3	1.1	64.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	127.3	0.0	0.0	17.1	0.0	0.0	0.0	9.3	0.0	0.3	88.1	1348.4	0.1	3.4	0.0	0.0	506.9
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619442-41624842	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 382.1;skin 1: 949.4;urinary bladder: 632.2"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"hTCEpi: 20287.9;SiHa: 8539.7"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		610000000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	5.1	0.4	4.9	0.8	5.3	2.8	382.1	3.5	5.8	102.2	3.5	2.0	0.8	4.3	14.1	320.4	6.9	1.9	2.7	6.3	3.3	3.1	0.6	9.8	0.3	3.5	3.4	0.9	2.6	0.5	6.6	7.0	3.5	132.4	0.3	0.3	263.2	116.1	0.9	949.4	0.6	1.0	3.4	0.4	2.3	4.5	3.3	142.7	1.6	0.0	97.8	632.2	212.3	4.7	212.5	0.2	0.0	0.0	0.8	0.9	48.8	1.9	0.4	2.8	2.7	16.8	1.9	1.0	14.7	0.2	0.4	2101.7	0.1	2129.1	1.9	0.3	1.6	2.0	910.8	2.0	0.5	1.9	2.2	0.4	20287.9	1.3	1539.9	0.0	1.0	0.0	1.0	1.5	0.4	0.7	0.7	0.3	0.4	237.2	0.0	0.7	3.1	1.7	0.8	770.5	0.3	0.2	8539.7	3.8	0.9	4.8	0.3	1.4	0.8	0.0	401.5	0.2	1.0	0.9	0.4	3.1	1.4	77.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	3.5	5.8	6.3	3.3	3.5	3.4	3.5	3.4	3.3	4.7	5.6	22.4	7.2	0.3	0.5	139.6	13196.1	338.0	327.8	0.2	158.4	792.8	0.1	0.0	415.8	36.8	0.0	21.5	3.8	0.9	0.0	567.7	0.4	116.9	13.5	54.5	1.8	0.0	3.2	202.1	148.5	87.9	0.0	134.1	3.8	0.0	0.0	0.0	3.8	20.2	0.5	0.6	36.7	0.0	14.1	1.6	2.1	37.5	10.6	3.7	6.7	0.0	0.0	0.5	1.4	1754.5	2.5	212.5	0.0	5931.6	0.1	0.4	100.1	0.0	0.0	0.9	101.0	0.3	0.4	48.2	124.3	5.7	60.8	3.1	0.8	8499.3
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		300000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	89.3	18.7	2.0	61.7	2.4	0.3	403.3	7.9	2.5	250.0	1.6	525.7	348.3	57.9	72.0	889.0	176.1	298.6	13.5	1.5	1.7	141.8	7.7	204.1	0.4	1.6	2.9	74.4	48.8	14.3	15.6	175.1	2.2	208.3	359.2	0.1	810.7	194.2	1.3	141.9	776.1	46.5	1.4	1.2	631.5	3.4	1.8	127.8	28.3	1.6	98.3	781.4	317.0	1.8	2.6	343.4	0.0	6.3	0.7	1.8	1169.3	412.1	0.5	12.8	2.9	992.6	1945.3	0.4	393.3	199.0	1.5	1044.6	0.1	2945.0	2.5	0.8	10.4	0.2	213.4	692.3	30.3	0.0	82.0	0.7	524.9	9.0	0.4	0.2	26.2	0.0	148.4	2.5	0.1	2220.9	5.9	3.0	18.5	1323.5	492.7	2.9	0.1	5.8	1335.4	3146.7	40.0	1.7	3.3	5446.1	0.1	266.5	3674.2	0.3	1.7	3.6	6.1	7.7	0.7	1.1	0.8	2.0	1.5	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	2.4	7.9	2.5	1.5	1.7	1.6	2.9	2.2	1.4	1.8	1.8	10.5	673.1	185.5	0.0	17.8	5.2	4317.3	7444.0	1715.8	0.0	1393.0	867.5	2.9	662.0	5055.9	892.0	0.0	1160.8	20.5	3599.6	1.9	4717.9	0.1	737.2	102.8	41.9	362.5	0.0	0.1	2589.9	6919.3	171.8	1571.4	1010.7	94.6	1.0	1.1	0.7	179.0	0.0	0.1	1382.4	2720.0	2.6	2.5	2.6	37.9	25.5	190.3	1.0	30.0	0.8	0.0	0.0	0.0	7374.9	3399.6	88.8	19.9	2228.8	8623.3	26.7	1954.3	0.0	0.0	0.0	240.0	1.1	1.6	1302.6	1.1	2127.5	36.1	4.8	1619.0	5959.8
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4660.3"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	3.0	0.5	0.0	0.1	0.0	1.0	81.9	0.0	0.0	0.8	0.0	0.9	1.6	0.4	0.3	1.1	0.1	0.0	1.7	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	47.8	4660.3	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.8	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875889-40885242	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 646.9"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		NA	NA		30000000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	1.3	0.0	0.0	49.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	597.7	295.9	2.1	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	480.1	0.0	0.0	1.2	0.0	0.1	646.9	27.0	0.0	0.0	124.9	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1328.5	0.0	0.1	0.0	0.0	0.0	0.0	43.9	0.0	0.1	0.0	0.0	0.0	115.7	0.1	13.4	0.0	0.0	0.0	0.1	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1606.6	0.0	0.6	1.9	1107.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	160.4	1.4
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703752	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 178.0;lymphoid tissue: 76.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0"	"Group enriched"	"Detected in some"	4	"cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 7.0"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Low region specificity"	"Detected in some"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA		300000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	8.0	0.0	0.1	16.7	178.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	5.8	0.2	2.2	1.6	0.0	0.0	0.3	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	76.3	2.6	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755331	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"skin 1: 112.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.8;Late spermatids: 9.2;Spermatogonia: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPTEC TERT1: 1.3"	"Region enriched"	"Detected in some"	7	"cerebellum: 8.6"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 7.3;hippocampal formation: 4.8"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			2.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.3	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782550	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"skin 1: 71.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9;thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"hippocampal formation: 80.6"	HPA055114	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	8.8	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 3.0;salivary gland: 10.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.7;head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 9.4;HMC-1: 5.6"					"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"							NA	NA		280000000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.0
KRT31	"Ha-1, KRTHA1"	ENSG00000094796	"Keratin 31"	Q15323	17	41393721-41397608	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skin 1: 284.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 39.1;Basal squamous epithelial cells: 21.6;Endometrial ciliated cells: 7.2;Glandular and luminal cells: 10.9;Squamous epithelial cells: 16.5;Suprabasal keratinocytes: 7.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049550, HPA055194"	Enhanced					NA	NA		440000000		"Cluster 61: Skin - Cornification"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA049550: AB_2680813, HPA055194: AB_2682733"	"unprognostic (3.92e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.71e-2)"		"unprognostic (4.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.84e-1)"			"unprognostic (4.07e-1)"			"unprognostic (4.26e-2)"	"unprognostic (1.65e-1)"	3.8	0.0	0.4	0.0	0.1	0.0	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	4.7	284.4	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	39.1	0.3	2.9	21.6	0.0	0.2	0.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	10.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	16.5	7.7	0.0	0.1	0.2	0.0	0.0
KRT33B	"Ha-3II, KRTHA3B"	ENSG00000131738	"Keratin 33B"	Q14525	17	41363498-41369813	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"skin 1: 82.8"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 2.9;Ionocytes: 2.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BJ: 4.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.1"									HPA055194	Supported					NA	NA		350000000		"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA055194: AB_2682733"		"unprognostic (3.34e-2)"				"unprognostic (5.19e-2)"		"unprognostic (3.04e-1)"					"unprognostic (1.55e-2)"				"unprognostic (6.28e-2)"	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"skin 1: 66.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 5.4;Late spermatids: 15.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BJ: 201.8"	"Not detected"	"Not detected"							"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		170000000		"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	1.1	1.8	0.0	1.6	0.0	0.0	0.0	0.1	1.9	0.0	201.8	8.8	23.5	46.4	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.1	26.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 59.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025750, HPA078713"	Enhanced		Approved	"Intermediate filaments"		NA	NA		220000000		"Cluster 61: Skin - Cornification"			"Intermediate filaments"		"HPA025750: , HPA078713: "																		2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	59.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KRT36	KRTHA6	ENSG00000126337	"Keratin 36"	O76013	17	41486136-41492546	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 3.5;skin 1: 1.7"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;Late spermatids: 2.1;Prostatic glandular cells: 1.0;Spermatogonia: 2.4;Squamous epithelial cells: 2.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Karpas-707: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA		180000000		"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (4.39e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.85e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.11e-2)"	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.4	0.0	0.2	0.1	3.5	0.0	0.0	1.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.3	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.8	0.0	2.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.4	2.0	0.0	0.0	0.0	0.1	0.2	0.9
KRT38	KRTHA8	ENSG00000171360	"Keratin 38"	O76015	17	41436154-41440983	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"skin 1: 16.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.1;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA		160000000		"Cluster 61: Skin - Cornification"											"unprognostic (1.37e-1)"				"unprognostic (4.05e-1)"								0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19735.6"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.5	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	513.5	0.0	1.1	0.0	1.2	0.0	19735.6	9.5	3.1	7.2	0.0	0.0	0.9	2.6	17.3	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.3	0.0	0.0	2124.1	0.0	2.6	3.9	1.7	0.9	0.0	1.5	8.6	0.8	0.0	2.0	1.0	0.1	1418.0	4.4	1040.2	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487176-52493257	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 2523.3;esophagus: 7338.5;vagina: 4945.4"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 9761.7"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		4500000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	3.1	1.5	0.0	1.9	0.0	0.1	6.9	0.0	0.0	2523.3	0.0	1.2	0.0	1.3	0.0	7338.5	9.1	0.9	1.8	0.0	0.0	1.1	2.6	3.4	0.0	0.0	0.0	2.3	3.3	0.0	3.1	8.8	0.0	5.0	0.0	0.0	1025.5	0.0	1.9	480.0	1.3	0.4	0.0	1.4	4.9	1.0	0.0	33.6	1.5	0.0	628.6	19.7	4945.4	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.9	0.0	0.0	1143.8	0.0	2414.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.6	0.3	9761.7	0.2	306.7	0.0	0.3	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	14.0	0.3	0.1	0.5	0.0	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.2	0.2	0.4	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.5	79.0	674.0	12.0	0.0	0.6	1.7	0.0	0.0	200.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	5.5	0.0	0.0	0.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	100.4	0.0	0.0	24.5	0.0	0.0	0.0	11.8	0.0	0.0	876.0	151.4	0.0	1.7	0.0	0.1	306.8
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 228.2;esophagus: 934.5;skin 1: 285.1;vagina: 229.6"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 217.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 1424.3;melanoma: 472.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 148.7"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.9	0.2	0.0	2.0	0.0	0.1	16.2	0.0	0.0	228.2	0.0	0.5	0.0	0.1	0.0	934.5	0.2	0.2	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	168.6	0.0	0.3	285.1	0.2	0.0	0.0	0.1	0.7	0.2	0.0	2.1	0.1	0.0	74.3	0.2	229.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	27.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.7	1.1	0.0	0.1	13.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	20.6	1.8	40.4	0.0	0.0	28.7	16.8	0.1	0.0	16.3	0.0	0.0	0.0	0.9	0.3	0.0	46.2	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.6	0.0	0.0	2.8	0.0	0.0	0.0	1.4	0.0	0.2	217.5	32.7	0.0	0.3	0.0	0.6	5.9
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 211.7;esophagus: 799.4;vagina: 333.5"	"Cell type enriched"	"Detected in some"	60	"Squamous epithelial cells: 234.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 564.7;melanoma: 242.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 94.1"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	211.7	0.0	0.1	0.0	0.1	0.0	799.4	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	144.3	0.0	0.1	24.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	9.5	0.1	333.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	1.3	2.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	234.3	2.4	0.0	0.0	0.0	0.2	3.9
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 905.8;thyroid gland: 593.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315, CAB079970"	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA		1300000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	27.1	0.7	0.0	1.4	0.0	0.3	272.9	0.0	0.2	48.4	0.0	1.6	0.4	12.9	15.2	91.7	75.9	82.4	5.6	0.0	0.0	147.5	14.2	325.2	1.7	0.2	0.0	2.4	57.4	5.6	12.0	265.1	0.2	58.1	0.7	0.3	905.8	213.2	1.7	78.3	1.3	0.4	0.1	0.8	17.8	0.8	0.1	3.3	593.0	2.0	6.7	389.8	20.1	0.4	4.9	2418.2	0.6	1.7	2.8	0.0	2737.9	509.6	0.6	261.3	23.6	7.6	1683.1	0.3	1.4	176.3	0.8	1871.6	0.2	6225.3	13.3	3.0	0.0	2.2	1179.8	8.0	57.4	1.5	1.5	1.3	380.7	1.3	2433.8	1.0	267.4	0.0	0.7	2.2	0.1	13.7	1.8	3.7	7.6	1.1	2.6	2.0	4.8	38.6	1520.5	7463.2	3.5	2.4	5833.6	3363.4	0.0	27.5	130.3	0.0	2028.2	1.9	3.7	2.4	1.1	1.8	0.4	2.0	2.0	1.6	1.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	8.1	653.9	109.4	0.0	2.5	3.6	1172.6	173.6	8.0	0.0	451.3	426.3	0.8	724.9	684.8	360.5	0.0	1756.7	8.9	2.2	135.0	2931.3	16.1	106.2	20.4	30.6	6.6	0.0	0.1	2143.5	4196.1	29.9	14.3	253.2	3.8	0.1	4.2	2.9	189.9	0.0	0.0	3.5	954.2	3.4	4.6	140.0	3.7	11.0	131.6	0.0	35.6	0.0	0.0	0.0	0.0	6163.7	0.3	0.4	1.4	2386.6	0.2	8.5	249.2	0.0	0.0	7.6	72.1	0.6	1.3	35.3	2.3	1442.5	9.2	0.0	4.4	1900.8
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553145	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skin 1: 100.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"CACO-2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049404	Enhanced					NA	NA		110000000		"Cluster 61: Skin - Cornification"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049404: AB_2680748"	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 10.5;testis: 23.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.3;Late spermatids: 67.5;Spermatocytes: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced					NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.1	0.1	0.0	0.7	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.5	2.2	0.0	0.0	2.2	0.0	23.7	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	26.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.5	1.5	0.1	0.0	0.0	0.1	0.0	12.3	0.0	0.1	0.0	2.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.2	0.0	0.4	0.0	0.3	0.0	0.1	0.0
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.0"	"Cell type enriched"	"Detected in some"	5	"NK-cells: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	13	"T-cells: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044031	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.3	0.0	0.0	0.7	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	8.8	3.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434371	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 27.5"	"Cell type enriched"	"Detected in some"	7	"Ductal cells: 20.4"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 38.5;U-2 OS: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000000		"Cluster 61: Skin - Cornification"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	50.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2
KRT76	"HUMCYT2A, KRT2B, KRT2P"	ENSG00000185069	"Keratin 76"	Q01546	12	52768155-52777345	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 2.5;salivary gland: 2.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA019656, HPA019696"	Approved					NA	NA		310000000		"Cluster 16: Immune cells - Immune response"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA019656: AB_1852241, HPA019696: AB_1852243"		"unprognostic (2.00e-1)"				"unprognostic (1.89e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 273.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.6	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	273.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 972.7"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 2.4;Glandular and luminal cells: 1.9;Spermatocytes: 2.1;Spermatogonia: 8.0;Squamous epithelial cells: 6.7;Suprabasal keratinocytes: 4.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 5.5;RT4: 1.6;SK-BR-3: 3.6;U-87 MG: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039724	Enhanced					NA	NA		70000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.4	0.2	0.0	0.0	0.0	0.1	3.4	0.0	0.5	227.1	0.0	0.1	0.0	0.1	0.0	972.7	0.1	0.9	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	141.7	0.0	0.3	126.7	0.2	0.0	0.0	0.1	1.0	1.5	0.3	0.4	0.3	0.0	134.2	0.4	221.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.5	0.6	0.0	0.8	2.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	8.0	6.7	4.4	0.3	0.0	0.0	0.2	0.5
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1335.5;stomach 1: 800.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"spinal cord: 44.0"	"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1700000000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	135.0	43.6	2.2	158.6	1.3	1.0	113.8	2.0	1.6	183.4	21.3	1079.2	1112.0	34.7	66.4	48.2	134.3	217.5	147.8	1.9	1.9	240.2	463.9	172.5	7.9	8.3	4.5	10.3	654.1	59.9	278.7	368.7	8.8	151.6	564.2	0.4	318.0	73.6	1.5	49.3	1335.5	50.6	0.4	16.3	800.1	7.6	4.9	47.6	237.5	0.3	13.8	209.0	36.7	1.7	2787.7	6130.6	0.2	7.8	0.7	3.2	3998.7	11.1	47.9	6.1	6.3	7686.4	4774.8	1.1	1130.2	14.7	6.9	947.1	17.6	752.6	5.9	4.6	130.8	4.3	1184.4	2234.2	212.8	1.2	2.4	9.5	12.6	14.8	50.8	419.9	17.0	1.0	484.7	1.7	0.1	10521.8	6.5	10.6	418.5	2740.6	132.8	3.8	2.2	15.2	1198.1	1354.5	129.9	5.0	1063.2	5126.4	7.8	1263.8	4325.7	10.5	18.8	5.7	443.4	9.3	10.0	1.6	7.0	7.6	3.3	1.7	13.4	1.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.5	0.1	1.7	0.1	0.2	2.2	1.3	2.0	1.6	1.9	1.9	8.3	4.5	8.8	0.4	4.9	1.7	7.7	400.6	176.5	0.3	26.9	6.0	1948.0	684.7	303.3	2.3	521.6	342.8	30.2	1069.5	734.8	491.1	0.0	2208.2	8.5	4302.8	297.4	6037.3	13.9	419.2	41.0	42.3	942.5	8.6	0.5	5457.6	5323.4	94.7	1740.1	557.1	76.3	88.0	24.3	310.9	252.2	1.7	0.5	2876.3	1625.5	9.9	7.2	69.9	8.1	22.2	131.6	0.0	55.0	3.4	1.0	1.0	0.3	5278.1	4937.3	1.9	6.6	994.7	6802.6	569.1	594.8	4.3	0.0	2.2	167.4	2.0	11.4	258.9	1.7	5268.8	33.4	13.4	2337.3	1542.5
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 219.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		No	No		230000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Intermediate filaments"		"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavorable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.4	5.3	0.0	0.3	0.0	0.1	8.7	0.3	0.6	18.5	0.0	0.1	0.5	1.2	0.9	51.0	3.4	2.7	0.3	0.1	0.0	2.7	0.7	3.4	0.0	0.0	0.0	0.2	11.6	7.0	0.4	7.3	0.0	1.5	0.1	0.5	24.8	3.4	1.3	219.1	0.3	0.1	0.0	0.1	0.5	0.3	0.0	0.8	0.8	0.0	41.1	9.9	36.5	0.0	202.5	66.7	0.0	0.0	0.0	0.0	54.2	2.9	1.8	15.3	4.6	4.5	85.9	0.0	94.4	2.3	99.4	98.5	0.0	1.3	5.3	0.4	0.0	0.0	99.4	2.4	10.1	0.1	0.1	1.1	11.9	3.5	23.0	70.2	23.2	0.0	0.0	0.1	5.4	287.3	0.2	0.1	0.4	58.5	10.1	0.2	79.4	3.0	87.1	35.7	24.5	1.3	50.1	127.7	1.2	5.6	24.1	1.0	13.5	0.3	174.4	0.2	71.6	0.1	0.3	0.5	18.0	7.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.2	3.9	4.4	0.0	0.0	14.7	4.6	0.4	10.0	9.4	11.0	0.0	25.9	0.1	0.3	0.0	63.0	0.9	33.0	3.7	0.5	0.0	0.0	0.1	20.4	3.4	0.4	0.0	33.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	12.2	0.0	1.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	4.8	0.1	1.8	21.7	0.0	0.0	0.4	2.2	0.1	0.0	2.9	37.4	58.3	0.3	0.3	0.3	8.5
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"skin 1: 144.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	49	"basophil: 170.8"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 170.8"	"Cell line enhanced"	"Detected in many"		"A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1"									HPA049778	Supported					NA	NA		130000000	"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA049778: AB_2680877"	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	1.4	0.0	0.3	0.2	0.4	0.3	3.1	0.3	0.6	0.1	0.1	0.3	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.1	1.0	0.3	0.3	0.0	0.0	2.1	0.2	0.2	144.7	0.2	0.0	0.3	0.2	0.1	0.4	0.4	0.2	0.9	0.0	0.0	0.1	0.1	0.4	3086.0	2296.0	0.0	0.0	0.0	0.0	0.3	18.6	3.2	23.9	2.2	6.7	0.7	0.0	3.0	0.3	1.6	43.2	0.0	0.0	4.2	4.6	0.0	0.0	1.3	0.2	1.4	0.0	0.2	0.0	0.0	0.4	1.1	32.9	0.0	0.0	0.0	1.6	0.2	700.1	0.3	6.4	0.2	0.1	1088.7	0.5	0.0	10.4	0.6	0.2	0.7	0.0	1.0	179.1	11.1	0.1	0.5	12.9	0.2	0.4	564.4	0.2	2151.1	0.3	4.4	3.1	0.4	7.2	0.2	170.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	3.3	4.4	0.0	0.0	41.0	4.6	0.3	0.0	20.4	0.0	0.0	0.1	12.8	0.1	0.0	67.3	0.9	1.9	0.3	0.4	0.0	0.0	3.9	1.3	2.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	4.1	0.0	0.4	2.5	0.0	0.1	0.0	1.0	0.0	0.0	6.2	0.0	3.3	27.2	0.0	0.0	0.1	2.6	0.0	0.0	2.0	0.0	0.0	1.2	6.8	0.0	0.1	0.0	0.3	2.9	10.5	0.0	0.0	6.0
KRT82	"Hb-2, KRTHB2"	ENSG00000161850	"Keratin 82"	Q9NSB4	12	52393931-52406335	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"skin 1: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058715, HPA067230"	Enhanced					NA	NA		29000000		"Cluster 61: Skin - Cornification"					"HPA058715: AB_2683798, HPA067230: AB_2685807"		"unprognostic (3.04e-1)"				"unprognostic (3.59e-3)"												0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 1.5;skin 1: 1.9"	"Cell type enriched"	"Detected in single"	22	"Cardiomyocytes: 2.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported					NA	NA		67000000		"Cluster 31: Skin - Epidermis development"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA039714: AB_2676641"		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"skin 1: 172.7"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"A549: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049778	Supported					NA	NA		110000000		"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049778: AB_2680877"	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	172.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRT9	"CK-9, EPPK, K9"	ENSG00000171403	"Keratin 9"	P35527	17	41565836-41572059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 3.4;Breast myoepithelial cells: 2.9;Extravillous trophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	6	"melanoma: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;HaCaT: 16.8;U-2197: 3.0;U-937: 5.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 25.1"					"HPA007261, CAB037322"	Supported					NA	NA		24000000000		"Cluster 63: T-cells - Adaptive immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB037322: , HPA007261: AB_1079182"	"unprognostic (2.13e-2)"	"unprognostic (5.08e-2)"		"unprognostic (4.97e-2)"		"unprognostic (3.65e-2)"		"unprognostic (2.89e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.92e-7)"	"unprognostic (1.28e-1)"		"unprognostic (3.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (4.15e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.2
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371390-30372271	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 12.8"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 31.1;Paneth cells: 27.0;Prostatic glandular cells: 11.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA		1000000		"Cluster 61: Skin - Cornification"		"Cluster 53: Intestinal epithelial cells - Unknown function"												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	12.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.4
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skin 1: 6146.5;vagina: 1735.6"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 5277.0"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"hTCEpi: 100.2"	"Region enriched"	"Detected in single"	6	"white matter: 1.6"	"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	NA	NA		34000000		"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	5.5	1.0	1.0	0.0	1.6	1.8	406.4	0.9	1.8	845.7	1.1	1.8	0.1	0.8	0.7	111.0	1.3	0.0	2.5	1.0	1.0	0.8	3.0	1.7	0.0	1.1	0.9	1.7	3.4	0.7	1.3	0.0	1.2	1.6	0.0	0.1	205.3	0.3	22.5	6146.5	1.3	0.1	1.0	0.8	1.5	3.3	0.9	20.0	2.5	0.3	90.1	0.7	1735.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.4	100.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.9	1.8	1.0	1.0	1.1	0.9	1.2	1.0	0.9	1.0	0.3	0.0	0.0	0.0	0.0	348.5	0.8	0.4	0.0	0.0	0.5	1.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.4	0.2	0.1	3.6	0.0	0.0	0.1	0.2	0.0	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	63.4	0.9	0.1	42.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	2.4	42.9	19.1	0.0	5277.0	0.0	1.5	0.0	0.0	0.5
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968990	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.0;pituitary gland: 7.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 161.8;Excitatory neurons: 284.7;Inhibitory neurons: 234.9;Oligodendrocyte precursor cells: 95.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.5;SCLC-21H: 3.2;TIME: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.0	0.9	2.3	0.0	2.4	0.0	0.2	1.1	10.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	7.7	0.0	0.7	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.6	7.9	0.0	0.6	0.1	0.3	1.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.3	0.0	0.6	0.0	0.1	0.2	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.4	0.9	3.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	6.9	0.0	0.5	0.0	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.1	10.0	7.7	0.0	0.7	0.0	0.6	0.1	0.3	2.7	0.9	0.0	0.0	17.6	0.5	0.3	1.2	0.1	0.0	55.2	2.8	2.4	2.2	5.7	0.2	161.8	39.6	0.9	0.0	1.3	0.0	2.3	10.8	4.0	0.3	0.5	20.4	5.3	284.7	1.5	0.4	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	47.1	234.9	10.3	2.0	0.3	0.4	12.5	0.0	0.0	0.0	5.6	0.0	2.4	0.0	95.0	4.2	0.4	1.5	0.0	0.0	1.4	0.1	0.8	0.3	28.2	0.0	0.3	0.1	0.6	3.1	0.0	0.3	0.3	0.6	0.0	3.0	1.3
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		55000	"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	81.6	77.7	90.8	52.8	98.9	36.1	81.6	92.8	106.3	61.4	165.0	97.4	43.4	58.1	97.1	72.7	53.2	58.6	134.6	81.0	94.2	104.0	106.6	67.0	61.8	100.2	95.3	63.9	67.2	143.0	67.4	69.4	100.7	77.5	90.8	127.9	73.5	73.5	378.2	137.6	53.2	60.3	95.2	53.4	61.1	145.1	99.4	54.7	107.7	281.6	61.0	113.1	55.2	110.3	200.5	133.4	100.3	106.5	132.8	127.3	140.2	159.7	127.3	97.2	85.2	89.4	233.9	152.8	213.4	166.7	102.7	347.2	122.5	138.2	162.7	251.9	65.2	109.1	223.0	174.4	126.3	160.3	83.3	119.1	124.6	122.1	208.4	208.3	161.9	122.2	107.4	88.1	189.0	154.6	141.3	95.0	76.8	91.1	194.3	109.6	258.2	73.5	244.8	307.0	122.4	100.0	245.8	113.2	143.2	201.7	115.3	101.7	230.0	193.9	250.4	100.0	151.2	38.9	55.9	110.4	229.4	93.4	109.5	117.0	42.7	48.0	56.2	40.3	54.7	95.6	69.4	65.8	44.0	106.6	71.1	62.1	29.6	64.9	52.6	185.8	48.4	16.0	90.8	98.9	92.8	106.3	81.0	94.2	100.2	95.3	100.7	95.2	99.4	110.3	363.1	307.7	239.8	72.5	171.7	654.5	285.8	215.6	270.9	206.5	460.6	348.7	852.7	270.2	214.7	428.6	360.7	155.1	194.9	575.2	31.3	249.7	721.9	351.3	186.6	345.0	224.0	165.3	93.9	304.0	199.1	211.9	95.3	298.1	134.9	384.5	295.9	401.7	116.8	326.4	112.1	226.4	207.5	181.3	261.6	377.9	248.5	168.9	172.5	104.9	194.3	449.2	142.2	90.0	139.8	341.2	325.7	441.6	184.6	283.5	152.6	109.3	319.3	400.9	335.2	333.5	292.1	694.3	386.4	217.8	723.0	164.7	168.3	162.4	282.4	328.0
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134599923-134651636	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 16.3;skin 1: 9.6;tongue: 27.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.0	2.7	1.7	0.2	1.8	0.3	0.8	1.6	2.9	0.8	0.1	0.9	0.4	1.9	0.8	2.0	1.9	0.4	3.1	1.6	1.7	0.3	0.0	0.1	0.0	1.9	2.3	0.9	0.0	2.2	3.3	0.0	2.1	2.2	0.2	1.7	0.8	1.7	16.3	9.6	0.2	4.2	1.5	0.1	0.7	0.3	2.0	0.9	3.0	27.7	0.0	0.6	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.1	0.7	0.0	5.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	2.9	1.6	1.7	1.9	2.3	2.1	1.5	2.0	1.9	0.0	0.0	0.0	15.0	0.0	0.6	0.1	0.0	0.0	0.4	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.0	0.0	2.5	0.0	24.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
LACRT	LACRITIN	ENSG00000135413	Lacritin	Q9GZZ8	12	54630811-54634895	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"salivary gland: 13.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	304	"breast cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"	NA	NA		230000		"Cluster 24: Salivary gland - Salivary secretion"																							0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201380833-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 362.1;skin 1: 215.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.5	0.1	0.0	15.9	0.1	0.1	15.8	0.0	0.2	65.4	0.0	67.6	75.6	5.0	11.0	362.1	14.7	50.2	8.4	0.2	0.6	38.6	21.6	10.6	2.9	0.0	0.0	0.4	50.7	2.4	0.7	4.1	0.0	15.7	51.0	0.0	51.9	22.6	5.1	215.4	74.5	2.9	0.0	1.4	66.9	0.3	0.0	6.2	3.5	0.2	47.7	71.4	135.2	0.0	159.9	1.3	0.0	0.3	0.0	0.0	57.0	0.0	0.0	0.1	0.1	127.3	158.5	0.0	8.9	0.0	0.0	220.4	0.0	190.3	0.1	0.2	0.0	0.0	0.1	79.3	0.0	0.1	0.2	0.1	181.5	0.1	36.8	0.0	0.1	0.0	0.1	0.7	0.1	218.3	0.2	0.4	3.7	246.5	2.6	0.2	7.4	2.3	126.0	164.7	9.1	0.2	0.1	250.6	3.1	5.4	37.6	0.4	0.0	0.1	0.5	0.5	0.6	0.1	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	35.4	0.0	0.9	88.5	112.1	47.2	46.7	0.0	15.4	14.1	2.1	110.1	31.3	31.3	0.0	3.8	0.5	174.7	45.0	178.0	1.1	26.2	2.6	1.6	18.1	0.0	0.0	121.9	5.9	2.6	85.1	34.5	0.0	0.0	0.4	9.0	0.5	0.0	0.0	53.8	18.3	0.6	16.0	3.6	0.0	2.6	10.6	0.0	248.6	0.0	0.0	0.0	0.0	227.0	109.6	0.4	2.9	77.1	214.7	71.8	4.8	0.0	0.0	0.0	3.2	0.0	0.3	265.6	152.7	10.4	1.5	0.0	136.2	150.2
LAMA1	LAMA	ENSG00000101680	"Laminin subunit alpha 1"	P25391	18	6941742-7117797	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 5.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Distal enterocytes: 173.6;Granulosa cells: 77.3;Intestinal goblet cells: 44.2;Paneth cells: 35.8;Proximal enterocytes: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 56.0;ASC diff: 41.0;BEWO: 199.6;hTEC/SVTERT24-B: 41.7;SK-MEL-30: 38.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB010179	Enhanced				"Secreted to extracellular matrix"	NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB010179: AB_2133741"	"unprognostic (2.75e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.85e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.34e-3)"	0.7	0.0	2.0	0.2	1.5	0.0	1.6	1.9	1.1	0.8	0.5	0.1	0.0	0.9	1.4	0.1	0.2	0.0	0.2	2.0	2.0	2.9	0.1	0.3	0.0	2.0	2.8	1.4	1.1	0.0	1.0	0.1	2.1	0.2	0.0	0.4	1.3	0.6	0.0	0.2	0.0	0.3	2.2	0.1	0.0	5.9	3.0	0.1	2.5	0.0	0.0	0.3	0.2	2.9	0.0	0.0	56.0	0.0	41.0	36.5	199.6	2.0	9.8	9.9	21.5	24.4	0.0	0.0	0.5	3.4	8.0	0.1	0.0	7.3	4.1	0.0	3.2	0.0	11.8	0.0	4.8	0.0	0.0	31.1	1.1	41.7	23.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	2.8	0.0	0.0	38.4	11.6	0.0	0.0	0.0	7.5	20.5	4.2	0.1	0.0	0.0	0.0	3.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	1.9	1.1	2.0	2.0	2.0	2.8	2.1	2.2	3.0	2.9	2.6	6.4	0.0	90.8	0.0	0.0	0.8	0.8	0.6	0.5	2.3	7.2	1.9	4.3	0.0	0.0	0.0	4.1	0.0	173.6	0.0	0.0	1.6	4.1	0.6	0.2	1.2	0.0	1.4	0.5	3.1	4.2	0.0	4.3	0.0	77.3	0.0	0.1	0.9	0.0	1.7	44.2	0.0	0.0	0.0	3.7	0.0	0.2	0.0	15.0	0.0	3.4	0.0	4.0	1.8	0.0	35.8	0.0	0.0	1.0	47.5	1.4	0.1	0.3	0.0	0.6	3.4	0.4	2.5	0.3	0.0	4.8	0.2	4.6	16.5	0.3
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883138-129516566	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 106.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 363.1;Fibroblasts: 151.1;Leydig cells: 184.2;Microglial cells: 692.3;Oligodendrocytes: 160.9;Peritubular cells: 224.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 255.1;ASC TERT1: 184.5;HHSteC: 55.5;HSkMC: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	NA	NA		55000000	"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (3.65e-5)"	37.6	9.2	2.7	2.6	10.2	0.0	25.0	4.1	5.8	24.1	10.8	14.8	1.7	17.1	4.1	8.0	34.9	18.0	64.0	1.8	3.4	4.1	4.4	26.5	1.0	13.8	4.6	53.4	8.0	2.8	6.9	106.0	8.3	7.3	4.7	2.5	14.9	9.0	22.0	14.1	13.7	14.2	4.7	5.0	17.4	9.2	7.5	2.7	14.6	42.9	0.7	18.1	18.1	6.4	0.0	0.1	2.8	0.1	255.1	184.5	0.0	26.1	9.5	0.6	0.6	0.0	0.2	0.0	0.3	28.2	0.2	0.1	1.6	0.1	0.6	0.1	0.0	0.1	0.0	0.0	55.5	0.0	0.3	156.4	0.1	13.5	0.3	0.2	0.3	0.0	0.0	1.0	44.1	0.0	0.0	0.1	0.5	0.8	0.0	0.0	14.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	22.2	1.4	0.1	0.3	8.9	0.3	0.0	1.7	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	2.7	10.2	4.1	5.8	1.8	3.4	13.8	4.6	8.3	4.7	7.5	6.4	7.7	0.0	0.5	24.8	0.0	3.7	2.2	0.5	1.2	1.3	1.1	0.8	90.7	0.0	0.9	0.0	0.0	2.1	0.5	0.0	0.0	1.4	7.5	6.5	75.1	8.5	0.0	0.0	363.1	0.2	1.9	151.1	11.7	6.5	0.0	1.0	3.6	0.0	3.0	0.0	8.6	0.0	0.0	0.0	4.4	11.7	184.2	1.9	1.8	692.3	0.1	11.1	3.1	8.0	160.9	0.9	0.0	224.2	0.5	1.0	0.0	0.6	4.5	1.1	118.3	122.1	8.8	2.6	1.9	1.2	2.8	3.8	1.7	44.5	0.0	1.1
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Cytotrophoblasts: 104.4;Glandular and luminal cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 114.9;CACO-2: 159.6;EFO-21: 114.4;HaCaT: 107.2;HeLa: 118.3;TIME: 138.4"	"Low region specificity"	"Detected in many"							"HPA058389, CAB078157"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		1800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"CAB078157: AB_2665809, HPA058389: "	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	27.1	11.8	4.7	5.0	2.2	1.3	27.0	15.2	7.0	26.3	18.9	66.7	5.3	31.3	1.2	24.5	31.8	7.9	26.6	2.4	2.0	32.7	13.2	43.9	3.0	3.2	1.9	9.3	13.9	4.8	12.1	20.0	2.5	36.7	1.2	0.6	17.8	15.4	11.0	36.0	19.9	7.3	0.6	14.0	25.1	4.6	9.3	2.7	28.6	2.8	1.9	32.6	30.2	0.4	15.1	114.9	2.2	14.8	2.7	31.0	85.9	4.2	2.2	3.3	0.6	159.6	59.1	1.3	114.4	0.1	3.6	107.2	3.1	45.8	0.2	0.3	6.5	3.8	118.3	46.1	9.9	0.0	16.6	1.6	29.6	7.9	8.0	5.7	15.0	0.0	7.0	1.7	0.0	22.3	0.1	0.4	7.3	19.3	65.9	0.2	1.4	12.8	28.6	70.3	1.1	44.5	63.2	62.2	1.2	11.6	62.0	0.9	138.4	1.6	41.2	0.7	18.9	0.8	0.2	0.6	31.7	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	2.2	15.2	7.0	2.4	2.0	3.2	1.9	2.5	0.6	9.3	0.4	60.2	76.9	37.1	19.9	6.9	17.1	16.0	56.8	52.9	3.6	16.7	20.8	20.5	12.8	43.9	38.6	8.4	104.4	3.9	0.6	0.0	28.6	4.3	35.5	11.7	49.6	2.4	6.1	5.9	4.5	23.3	13.0	6.1	82.0	2.5	0.9	18.9	12.7	13.1	3.3	12.7	0.3	14.2	0.6	5.4	1.3	9.9	2.2	1.8	10.3	1.1	8.2	1.0	3.5	1.3	13.2	0.1	19.5	8.5	21.9	0.0	12.2	49.6	1.8	26.3	11.0	39.4	0.6	1.7	23.4	12.6	57.3	2.2	1.7	0.6	27.5
LAMB1	CLM	ENSG00000091136	"Laminin subunit beta 1"	P07942	7	107923799-108003213	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 185.6;Fibroblasts: 99.6;Peritubular cells: 141.8;Theca cells: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 593.0;ASC TERT1: 815.3;HSkMC: 779.6;TIME: 547.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004056, HPA004132, CAB004256"	Enhanced				"Secreted to extracellular matrix"	NA	NA		250000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.01e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-1)"	141.4	21.8	1.2	26.5	1.6	0.1	74.1	0.9	1.7	46.4	23.0	87.0	29.3	78.9	3.3	25.2	44.1	53.4	53.9	2.4	0.7	81.4	14.7	104.3	9.4	0.0	0.8	29.4	48.2	12.1	11.8	154.3	0.2	18.1	40.4	0.7	24.6	29.7	20.4	39.3	67.5	73.2	0.1	42.4	49.5	11.4	1.4	19.7	43.5	40.6	5.2	53.5	31.0	0.4	94.5	148.6	77.3	3.6	593.0	815.3	291.9	103.5	182.5	68.6	72.1	306.7	166.6	0.0	127.7	200.3	90.8	41.9	24.8	143.6	49.9	0.1	24.8	4.8	52.6	87.9	364.3	0.0	2.8	779.6	49.0	175.9	193.4	409.2	450.0	2.8	17.0	0.0	126.5	29.9	0.1	0.5	42.9	54.9	103.6	0.4	51.9	0.3	238.5	96.0	24.3	142.1	75.1	100.9	68.5	180.2	37.6	1.1	547.1	179.9	44.3	60.2	133.1	0.0	0.2	0.4	89.9	0.0	301.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.9	1.7	2.4	0.7	0.0	0.8	0.2	0.1	1.4	0.4	81.8	0.0	5.6	2.9	2.2	8.9	5.2	16.7	10.8	12.1	2.0	9.5	16.3	15.7	7.6	27.6	4.2	85.5	3.5	10.5	3.9	18.0	2.0	22.6	185.6	57.8	19.2	0.0	51.6	11.2	27.1	99.6	2.6	34.6	2.5	2.9	20.7	3.5	10.1	8.4	23.7	8.0	8.2	2.8	3.8	4.7	71.1	2.4	8.8	11.2	2.0	2.1	5.2	6.0	3.2	21.6	17.0	141.8	0.4	3.6	9.5	11.6	2.9	8.6	52.6	10.2	54.4	5.5	5.1	4.7	6.7	32.6	3.2	174.7	19.2	2.1
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 299.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		25000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	75.2	73.2	12.8	18.2	14.2	2.6	58.2	15.1	14.9	68.0	47.7	63.1	24.6	72.7	25.5	31.9	63.8	62.2	169.1	13.1	14.5	41.3	31.7	55.1	16.9	20.0	14.8	94.4	32.7	104.7	15.4	99.0	15.4	50.4	18.0	11.7	40.3	81.0	67.5	40.9	32.5	80.2	14.1	29.8	48.4	21.4	17.3	6.7	60.2	70.0	12.8	52.2	55.9	13.5	15.7	38.7	34.4	122.0	196.3	201.5	31.1	131.9	161.8	73.8	75.7	18.3	52.0	0.2	44.4	299.0	38.3	49.3	30.0	47.6	52.3	0.1	9.5	6.9	63.4	32.1	132.5	0.3	0.3	176.9	69.4	61.6	62.1	184.3	75.9	0.0	4.1	0.1	61.4	30.3	0.1	0.3	15.1	20.7	32.0	0.2	16.6	0.5	53.5	19.1	0.2	20.4	74.9	42.9	68.3	57.5	93.4	0.9	126.9	82.2	34.9	28.5	35.4	0.1	0.4	0.4	39.1	0.3	57.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	14.2	15.1	14.9	13.1	14.5	20.0	14.8	15.4	14.1	17.3	13.5	83.7	118.6	53.5	26.1	2.4	31.2	13.9	33.6	33.0	1.7	39.4	40.5	151.8	37.1	43.6	55.2	6.2	11.3	0.9	3.6	5.9	26.4	3.5	15.4	24.4	77.8	0.0	0.4	0.2	9.4	6.4	120.1	50.4	27.2	1.3	88.9	94.9	49.9	10.4	8.4	0.4	3.1	32.6	10.1	31.1	12.3	146.3	7.5	42.7	15.9	3.5	46.7	2.1	1.0	0.6	14.1	14.9	140.7	0.5	10.2	16.4	28.6	11.2	2.6	118.3	80.8	92.3	4.3	8.6	14.2	24.4	9.4	3.8	27.6	5.6	9.3
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652425	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.2;urinary bladder: 73.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 370.0;Basal respiratory cells: 447.6;Pancreatic endocrine cells: 853.8;Urothelial cells: 392.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 223.9"	"Region enriched"	"Detected in many"	7	"cerebral cortex: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 353.8;HaCaT: 538.2;HBEC3-KT: 1315.0;hTCEpi: 412.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		20000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	10.9	16.0	2.6	13.1	2.9	10.7	20.7	0.9	21.3	13.2	0.5	26.2	31.5	18.0	2.6	47.2	16.4	11.9	6.8	2.9	2.1	16.3	9.3	28.4	1.2	1.5	1.5	1.1	4.2	0.1	1.7	5.8	1.6	25.9	16.6	0.2	41.5	24.1	6.8	42.1	43.7	2.3	1.7	1.0	73.2	1.0	1.9	5.8	1.2	0.3	13.2	73.1	32.6	2.8	178.4	25.8	0.0	0.4	18.1	11.7	1.0	5.1	15.4	6.0	9.1	68.9	353.8	0.1	15.1	3.7	8.9	538.2	0.1	1315.0	9.1	13.1	1.4	1.1	86.9	1.1	2.4	1.0	1.3	2.6	412.8	19.1	253.4	11.7	6.4	0.1	2.5	6.7	1.9	0.3	0.2	1.2	0.6	81.0	74.0	0.2	17.1	165.4	70.9	109.0	0.5	0.5	73.9	8.5	15.4	1.0	2.0	9.7	138.3	29.1	61.3	1.0	104.6	1.7	3.4	0.4	42.2	0.8	2.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.6	2.9	0.9	21.3	2.9	2.1	1.5	1.5	1.6	1.7	1.9	2.8	0.4	221.2	67.7	1.6	1.2	109.7	370.0	447.6	159.9	0.3	11.5	64.4	8.4	4.3	168.5	47.8	0.0	1.1	0.4	247.5	0.0	180.5	6.0	50.8	10.0	3.5	7.8	0.4	2.5	153.0	1.4	7.5	195.7	135.0	18.4	0.2	0.4	3.9	2.0	3.3	2.3	71.7	18.3	0.3	30.0	10.9	1.8	9.9	8.8	0.0	2.1	0.4	0.0	1.0	1.7	853.8	229.1	0.7	2.1	185.0	111.9	2.3	52.2	0.3	0.0	5.3	10.4	0.3	0.6	51.7	26.0	0.5	4.0	0.0	63.1	392.7
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023420-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 231.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 187.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1582.4;ASC TERT1: 863.5;HSkMC: 980.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		100000000	"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.85e-5)"	117.2	16.4	6.3	34.9	7.2	1.1	79.3	9.2	7.1	55.1	13.8	78.3	16.0	63.2	19.3	44.5	63.8	54.7	61.7	7.2	8.7	19.4	13.8	58.7	15.3	6.9	7.7	36.1	19.2	20.0	9.5	231.7	6.0	31.3	34.3	3.7	28.1	50.9	50.5	40.8	48.9	102.3	6.4	8.4	51.1	18.7	8.6	14.7	40.3	60.1	12.0	66.9	47.7	5.4	52.5	83.5	268.4	76.7	1582.4	863.5	405.0	374.8	373.0	147.8	87.1	249.4	58.2	18.8	168.6	180.8	87.9	127.4	51.7	99.2	112.7	0.6	52.6	0.9	71.1	91.3	248.1	16.6	8.9	980.4	52.2	177.0	138.7	262.7	261.0	0.2	0.6	55.5	182.5	22.8	0.2	17.4	109.3	96.0	15.7	13.5	226.2	9.9	237.6	137.0	17.6	50.1	98.9	0.7	95.6	459.0	21.2	43.6	486.5	179.1	70.0	168.2	95.4	21.6	0.3	12.4	148.7	12.3	177.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	7.2	9.2	7.1	7.2	8.7	6.9	7.7	6.0	6.4	8.6	5.4	81.2	35.3	21.6	32.7	8.1	31.4	46.1	44.4	35.9	3.1	7.1	17.4	57.5	27.1	21.0	36.8	4.2	101.9	0.2	1.6	1.9	59.2	5.7	32.5	58.5	80.9	1.2	0.0	69.2	23.3	69.0	187.8	8.6	78.5	2.5	53.0	26.7	19.1	18.7	1.7	50.0	2.4	18.3	10.7	20.6	6.8	120.9	4.5	33.8	106.8	6.0	2.2	1.0	35.2	2.5	44.7	2.6	62.4	11.0	59.9	0.5	12.4	14.8	0.7	72.3	73.9	102.1	17.6	36.8	17.0	16.9	72.1	2.8	74.4	3.5	25.8
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183245127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.3"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 1531.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, HPA046539, CAB078165"	Enhanced		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	No	No		130000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum, Golgi apparatus"		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: "	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	3.5	0.1	0.2	16.2	1.9	0.1	20.9	2.6	0.6	15.1	0.2	12.1	2.6	12.3	2.1	7.7	34.9	13.0	3.0	0.2	0.2	13.8	0.7	24.9	8.0	0.0	0.1	1.0	3.3	0.0	4.2	10.9	0.1	5.4	12.9	0.1	12.9	6.1	1.7	17.5	15.0	3.3	0.0	0.9	14.9	2.8	0.1	11.3	18.5	2.3	12.3	39.3	6.3	0.2	574.7	25.4	0.0	0.7	4.9	11.9	40.2	4.3	4.7	2.1	0.7	41.4	501.6	0.0	207.9	1.4	16.4	252.4	0.1	2492.2	2.7	0.7	0.2	0.0	0.5	0.1	1.2	0.0	0.2	6.1	189.7	6.0	1487.5	2.3	32.6	0.0	0.0	0.2	2.5	1.1	0.0	0.1	4.5	206.7	35.2	0.1	1.2	0.0	579.4	147.1	30.5	0.1	14.7	0.4	0.9	14.9	2.0	2.7	3.8	2.2	30.2	15.0	7.8	0.9	0.7	0.7	4.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	2.6	0.6	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	218.0	17.8	0.0	0.2	86.3	227.1	232.7	105.3	0.0	8.2	26.2	2.3	10.0	56.8	23.9	0.0	30.7	0.4	74.4	0.0	183.4	19.6	68.9	3.6	7.8	9.0	0.0	0.4	94.0	11.7	17.2	59.7	97.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	34.1	14.2	0.0	4.9	11.8	3.4	3.1	8.8	1.0	2.6	0.0	0.0	0.0	0.3	1531.1	91.2	0.4	0.3	302.0	16.7	0.2	69.3	0.0	0.0	3.4	9.6	3.6	1.0	60.3	29.7	83.3	5.3	0.1	15.3	169.9
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009174-131094473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 118.4;Peritubular cells: 364.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022814	Enhanced				"Secreted to extracellular matrix"	NA	NA		1100000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA022814: AB_2670960"	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.5	13.5	1.3	0.3	1.8	0.0	1.5	1.3	2.4	22.3	1.9	1.6	0.4	3.3	3.5	1.7	1.1	2.7	1.2	1.4	1.2	9.2	4.9	23.3	0.0	1.4	1.3	1.7	3.5	0.9	11.6	48.7	1.2	4.2	0.1	0.0	1.4	3.8	0.3	8.6	0.3	0.3	1.2	11.3	0.5	19.0	1.7	0.2	1.2	1.1	0.0	15.0	8.2	2.0	0.0	0.5	4.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.2	0.0	1.5	6.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	2.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.4	0.1	6.7	0.0	2.6	0.4	0.0	0.7	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.3	1.8	1.3	2.4	1.4	1.2	1.4	1.3	1.2	1.2	1.7	2.0	1.5	0.0	0.0	1.0	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.4	1.3	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.1	1.9	1.6	48.5	1.7	0.0	0.0	1.7	0.0	0.8	20.7	0.0	1.1	0.0	27.8	3.6	0.1	1.5	0.0	4.1	0.2	0.0	0.0	10.2	12.6	118.4	0.5	10.6	36.5	0.1	0.0	0.0	0.0	1.0	0.1	0.0	364.1	0.0	0.2	0.0	0.2	0.0	0.0	46.0	0.1	10.0	1.0	3.5	0.0	4.4	1.0	0.8	38.1	0.0	0.1
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297239-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 709.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported					NA	NA		370000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (3.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.15e-5)"	"unprognostic (2.06e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-1)"	139.2	95.3	83.6	84.1	118.7	72.1	124.6	114.3	89.9	119.3	54.5	108.0	109.8	136.0	103.4	125.1	98.7	91.3	101.3	82.9	96.9	149.1	183.8	148.7	77.2	120.6	106.5	101.7	174.3	109.9	95.0	107.9	119.7	98.0	65.9	35.7	145.0	94.8	71.3	182.3	112.7	92.5	104.7	102.3	108.5	84.8	112.6	63.4	126.7	46.6	55.6	118.6	110.9	138.0	271.7	92.3	93.9	258.1	514.7	192.5	176.7	311.9	325.1	189.8	252.1	181.8	491.1	63.7	139.1	318.6	324.9	338.7	92.9	198.1	128.7	133.8	153.1	105.5	167.6	172.5	265.9	324.5	236.2	236.4	264.6	176.3	114.4	308.4	232.2	61.0	89.3	90.9	236.8	108.9	66.0	158.2	71.5	258.4	99.9	96.1	81.4	96.5	172.3	200.9	85.7	90.1	183.3	268.5	187.6	89.8	259.6	228.0	355.1	193.5	208.2	258.8	141.4	169.4	178.8	66.6	323.4	318.8	229.7	3.8	4.9	9.5	4.0	4.0	3.4	2.2	3.1	4.4	2.5	2.1	3.4	2.8	6.8	3.9	4.4	5.4	3.6	2.1	83.6	118.7	114.3	89.9	82.9	96.9	120.6	106.5	119.7	104.7	112.6	138.0	152.4	86.6	67.2	31.3	64.5	140.8	144.5	68.3	70.0	42.4	131.1	92.5	56.9	123.0	51.4	183.9	77.2	195.6	103.6	248.7	41.1	99.0	272.1	72.7	73.4	113.9	119.2	50.9	22.3	62.3	198.5	173.6	60.6	101.3	71.0	71.3	162.1	303.3	282.9	30.3	22.4	111.1	32.6	208.9	56.8	709.0	163.8	167.6	99.6	34.7	77.6	50.1	104.0	29.7	83.2	82.7	199.2	170.4	51.8	101.4	288.1	178.1	45.1	84.5	118.3	85.0	107.1	163.1	124.7	96.1	197.5	312.4	94.8	72.4	128.6	124.0
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 556.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 556.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles		NA	NA		520000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	54.2	68.7	80.3	38.3	144.2	62.8	56.3	109.1	135.5	64.9	52.7	39.2	44.3	44.3	55.1	79.4	44.1	69.6	45.3	81.6	101.8	85.5	129.9	54.2	34.1	113.0	112.6	49.1	57.8	64.2	32.2	47.9	120.6	62.2	35.0	32.6	102.1	55.1	111.6	67.2	42.4	42.8	100.5	39.5	51.8	26.2	100.9	59.3	61.7	67.4	36.6	43.4	63.3	211.7	53.8	47.5	40.1	49.7	367.0	140.9	91.5	79.3	130.4	77.1	134.4	42.7	90.3	47.9	73.1	132.7	236.2	84.9	56.7	67.2	125.5	43.6	37.2	35.8	46.4	54.3	148.1	158.9	73.2	151.5	114.8	108.1	75.1	188.6	107.5	32.5	42.1	122.9	117.2	79.3	45.3	80.2	29.0	63.7	42.6	35.1	65.3	73.1	102.3	36.9	14.0	22.6	99.7	93.0	196.5	57.4	64.7	173.0	122.5	114.1	58.7	176.2	261.5	68.5	78.6	30.2	131.4	182.4	284.4	30.6	114.9	224.1	27.1	97.1	20.6	17.1	24.3	24.5	64.2	22.5	23.4	21.8	556.6	31.8	96.2	33.4	33.4	66.3	80.3	144.2	109.1	135.5	81.6	101.8	113.0	112.6	120.6	100.5	100.9	211.7	75.7	73.7	53.8	52.2	29.8	100.9	92.5	262.7	64.9	17.6	74.0	58.3	37.3	173.0	155.3	66.2	14.6	163.7	44.3	52.1	39.2	217.7	3.3	103.4	74.1	69.9	36.6	14.1	32.4	70.6	128.3	113.7	38.7	168.1	17.7	46.7	87.8	176.8	208.0	18.5	40.7	32.6	134.3	133.1	80.4	8.6	113.7	135.5	131.6	33.7	132.7	116.3	50.4	57.3	507.2	62.5	54.4	109.9	66.6	100.8	97.5	154.7	75.6	11.5	39.5	176.8	61.7	6.4	13.7	78.8	136.2	402.4	34.5	71.0	34.8	92.9
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1113.2;Proximal tubular cells: 2532.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006812	Approved		Supported	Cytosol		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (6.66e-2)"	143.6	134.9	152.2	79.5	156.3	250.3	127.7	167.7	179.0	107.7	168.0	108.3	85.7	86.2	162.6	121.0	93.2	101.9	269.7	150.9	163.6	433.9	150.2	115.2	114.1	159.6	155.4	121.0	95.3	192.3	141.2	120.7	157.9	109.4	110.9	140.0	100.1	77.6	260.3	98.7	102.2	81.5	165.1	126.0	127.8	88.6	161.4	102.2	107.8	277.3	122.6	124.2	109.4	168.1	272.1	223.2	197.3	118.5	325.3	245.3	196.1	224.4	176.5	186.8	176.6	196.0	130.0	214.5	233.0	220.9	228.4	107.5	203.4	189.2	229.8	231.4	227.9	157.7	257.1	402.1	247.1	227.7	188.0	216.3	287.3	193.9	122.6	236.2	227.7	156.9	189.3	196.0	275.8	443.0	208.7	274.7	140.1	151.8	366.9	141.9	355.1	164.2	439.0	302.0	145.4	189.6	198.8	287.7	516.4	169.5	111.0	317.3	217.8	140.5	182.9	355.7	214.4	204.5	250.7	277.2	459.1	225.6	329.6	295.4	223.1	485.8	125.9	229.5	112.1	345.3	146.6	137.6	187.9	322.3	127.1	134.4	347.7	149.2	225.0	321.5	181.1	250.6	152.2	156.3	167.7	179.0	150.9	163.6	159.6	155.4	157.9	165.1	161.4	168.1	131.2	160.3	174.4	16.3	208.2	307.8	284.1	661.5	101.3	111.0	186.0	197.9	597.6	211.6	371.9	445.1	25.0	424.5	141.5	225.1	1113.2	389.2	67.5	215.8	141.8	193.1	222.3	158.9	15.4	331.0	370.7	194.0	99.9	191.1	146.4	97.0	133.9	311.9	424.8	89.2	17.6	302.6	449.6	154.4	189.2	112.8	264.7	175.3	350.4	18.7	320.9	297.9	137.0	9.5	23.3	403.9	296.4	239.2	100.6	360.9	315.4	2532.5	340.9	150.5	170.9	168.2	185.2	297.9	361.3	121.3	322.5	500.5	125.7	163.2	252.0	441.8
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LARP1	"KIAA0731, Lar1, LARP, Lhp1, MGC19556"	ENSG00000155506	"La ribonucleoprotein 1, translational regulator"	Q6PKG0	5	154712843-154817605	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	42.5	50.0	30.9	36.5	28.4	37.0	36.4	12.2	44.8	38.4	15.8	38.4	33.8	43.6	37.4	51.6	39.9	29.3	48.6	34.3	25.8	40.0	36.7	34.8	41.1	26.7	40.3	45.0	103.0	70.3	39.8	37.9	47.2	31.3	34.6	32.1	57.4	32.9	78.8	45.4	37.7	38.7	5.4	35.7	44.0	38.2	27.6	42.1	53.8	46.4	44.8	38.0	40.0	37.4	93.3	140.3	107.6	124.1	93.3	73.1	103.1	99.0	101.8	114.7	110.0	218.1	116.8	252.2	128.0	127.5	168.5	92.9	196.1	185.9	135.7	83.4	94.1	187.1	143.8	106.1	117.6	250.6	81.2	91.2	108.4	144.5	185.2	66.4	103.9	114.0	149.2	180.2	111.9	102.9	156.5	100.0	107.3	89.8	60.5	158.8	97.5	120.5	74.1	120.7	180.7	93.5	132.2	215.4	112.3	112.9	126.0	119.0	130.4	140.3	83.0	106.2	170.3	136.8	126.0	219.5	92.1	134.8	99.1	2.2	2.4	0.7	2.6	3.0	3.3	2.5	3.0	3.0	2.4	3.3	2.5	2.6	1.4	5.9	5.6	3.9	2.1	1.7	30.9	28.4	12.2	44.8	34.3	25.8	26.7	40.3	47.2	5.4	27.6	37.4	37.6	44.8	33.8	67.9	37.2	78.3	39.7	38.0	34.7	64.4	45.1	33.0	104.4	50.1	33.7	40.5	37.5	43.7	35.3	45.1	29.4	42.2	14.4	70.1	70.6	48.8	43.9	73.4	72.0	82.5	35.2	46.2	46.9	65.5	17.2	63.2	47.8	66.9	57.9	87.5	92.5	49.6	18.3	53.3	42.6	12.1	69.6	43.6	37.4	46.9	49.1	26.5	33.0	47.7	69.5	62.1	37.7	80.1	47.3	75.2	53.0	50.1	46.5	38.7	13.1	63.6	39.4	56.2	40.5	54.6	84.5	23.9	34.6	71.6	68.8	53.6
LARS1	"FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase 1"	Q9P2J5	5	146110566-146182696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	35.4	37.0	40.0	26.6	42.0	20.2	46.3	42.8	48.9	33.9	44.0	34.4	18.4	33.9	35.4	35.0	34.8	18.7	38.5	40.4	44.3	34.6	25.6	26.4	29.7	42.3	42.9	37.2	49.7	34.7	37.0	22.2	41.8	35.6	34.8	34.7	40.0	28.3	70.6	31.7	28.1	33.4	43.1	35.7	29.8	23.9	43.2	32.7	34.7	58.8	34.8	35.6	30.9	46.2	56.1	59.5	65.9	125.9	88.0	95.7	102.5	45.5	57.8	71.4	92.4	66.1	59.8	67.8	32.7	91.2	72.6	52.9	107.2	116.5	106.4	45.2	88.2	65.5	76.0	58.5	122.7	101.4	51.9	83.7	153.6	92.0	173.3	73.2	87.7	108.0	67.4	121.3	83.4	56.9	102.8	116.1	126.8	63.8	86.8	75.0	62.0	101.9	73.6	44.1	77.7	97.3	50.2	111.6	221.2	76.6	103.1	159.3	63.4	61.2	44.3	56.7	89.4	79.3	82.3	86.3	89.8	164.1	79.1	1.1	11.8	5.4	14.5	19.2	19.6	18.9	16.6	14.9	21.2	15.5	21.2	21.9	0.7	19.2	16.7	16.6	19.6	14.9	40.0	42.0	42.8	48.9	40.4	44.3	42.3	42.9	41.8	43.1	43.2	46.2	26.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.7	0.0	0.0	0.0	0.0	39.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	40.3	16.6	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	33.0	2.8	0.0	0.0	0.0
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 591.7;Proximal enterocytes: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		9400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	86.4	38.0	60.8	75.9	56.7	126.4	55.5	45.5	56.7	46.9	48.6	93.0	131.9	43.8	32.3	45.9	46.0	56.8	40.3	56.1	61.0	55.9	76.4	68.6	76.1	56.2	63.5	48.5	59.0	25.5	33.0	81.4	59.0	30.9	92.3	26.8	44.8	33.9	23.7	44.4	168.8	51.2	52.9	74.3	96.2	23.9	67.4	74.1	34.9	27.7	78.2	53.2	37.3	50.1	214.1	441.0	124.1	111.0	182.8	196.9	218.7	267.8	257.8	274.5	198.5	134.3	225.8	98.8	214.1	417.3	154.9	332.4	58.5	204.1	239.6	71.6	31.6	47.5	124.2	235.8	173.0	110.4	134.1	176.3	69.6	234.6	66.1	170.7	188.0	59.0	81.9	30.3	389.4	72.0	127.1	163.6	63.0	189.9	109.4	70.7	67.6	123.8	332.7	187.9	19.0	45.4	159.3	160.5	134.7	233.5	255.7	128.2	331.4	160.0	233.0	189.7	162.0	79.7	115.8	75.2	170.2	96.7	197.2	21.8	31.4	35.0	30.7	33.1	20.3	11.7	15.2	20.4	27.3	10.8	12.7	19.8	67.0	34.2	42.1	20.5	21.4	32.5	60.8	56.7	45.5	56.7	56.1	61.0	56.2	63.5	59.0	52.9	67.4	50.1	54.5	41.7	27.6	17.6	41.8	41.8	21.5	26.0	51.8	66.4	82.4	43.2	1.1	55.8	30.4	73.5	10.4	7.5	69.5	225.2	17.6	65.7	89.6	27.5	31.7	54.3	86.5	21.0	16.4	76.5	59.1	50.1	119.3	46.4	52.0	37.4	64.6	115.4	83.9	26.9	16.0	101.9	28.5	127.7	73.0	591.7	51.9	71.9	35.6	24.4	94.3	22.2	164.8	11.1	4.4	111.0	116.4	39.9	32.8	24.2	292.7	72.9	57.3	23.1	65.7	65.4	53.4	2.9	5.7	62.2	28.4	6.4	63.4	19.2	97.8	31.8
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990784	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8"	"Group enriched"	"Detected in all"	142	"granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8"	"Cell line enhanced"	"Detected in many"		"HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5"	"Not detected"	"Not detected"							"CAB002223, HPA011157, CAB012978, CAB079960"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		140000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	8.1	4.4	9.1	23.9	9.6	17.5	6.6	9.0	11.9	15.6	8.1	31.3	9.2	19.3	5.2	8.1	11.6	9.6	3.9	9.2	8.5	15.3	10.5	14.1	65.9	9.2	8.5	7.7	5.7	2.0	14.2	3.9	9.0	21.6	5.2	3.5	7.8	9.5	4.2	10.7	22.7	5.7	8.0	32.0	13.4	4.1	9.7	117.9	17.6	1.6	29.0	24.7	13.3	8.9	1.0	2.3	1.5	2.5	3.7	2.4	4.9	5.5	1.4	1.7	2.2	2.3	3.0	0.7	7.2	2.2	0.6	2.9	2.6	1.3	0.8	1.6	3.3	189.8	5.4	3.3	1.0	5.9	765.9	2.1	3.8	1.7	0.7	2.8	0.9	62.7	2.6	21.7	0.8	5.6	279.5	38.3	3.4	0.4	2.7	3.2	0.8	24.9	1.9	1.6	5.3	1.0	0.9	1.8	2.7	1.4	2.7	31.7	3.6	3.6	18.0	3.9	1.3	7.6	7.0	3.1	45.5	2.7	2.9	307.7	1.4	0.7	303.4	1.5	212.5	1.7	295.1	307.2	1.1	1.7	276.0	266.9	14.6	114.6	1.3	1.9	410.8	196.5	9.1	9.6	9.0	11.9	9.2	8.5	9.2	8.5	9.0	8.0	9.7	8.9	5.2	0.0	13.1	4.6	6.2	7.1	2.1	1.1	2.8	11.0	3.7	4.3	1.7	7.2	3.1	9.2	6.2	2.6	80.7	1.2	1.9	1.7	0.3	1.5	2.3	4.7	0.0	16.6	4.7	0.5	0.9	3.0	7.7	2.7	78.9	4.9	8.6	2.9	14.3	6.7	5.5	1.5	0.0	7.3	9.4	0.1	1.5	55.9	10.6	5.6	9.2	3.0	152.4	3.0	3.5	1.0	0.7	0.7	17.0	2.2	1.3	1.3	1.3	9.6	0.0	3.0	3.8	1.7	2.1	1.9	5.3	2.7	151.7	1.7	1.4	1.3
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1338.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.2	0.5	0.0	24.2	0.1	0.5	6.6	0.0	0.2	4.6	0.0	0.5	0.0	2.6	0.0	0.1	0.6	0.2	3.3	0.0	0.0	8.7	1338.5	1.2	2.8	1.1	0.1	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	22.8	0.6	0.6	1.5	0.0	0.5	0.6	0.7	0.4	0.1	3.9	2.0	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 283.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	29.5	20.8	29.3	8.3	29.8	4.2	27.2	56.7	37.5	41.4	37.8	30.6	5.0	28.7	9.1	13.4	26.1	11.5	42.0	28.5	32.3	33.2	283.0	36.1	7.5	41.9	32.7	28.5	17.7	8.0	17.5	17.8	31.6	40.0	4.8	2.8	16.9	18.6	13.2	32.0	17.8	12.3	31.9	23.3	16.5	11.3	33.4	9.4	43.2	8.9	4.4	27.5	27.3	32.0	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	29.3	29.8	56.7	37.5	28.5	32.3	41.9	32.7	31.6	31.9	33.4	32.0	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330582	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039401	Approved		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA039401: AB_10805478"	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favorable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	5.1	4.7	5.3	4.8	5.2	1.9	6.3	6.8	10.2	6.3	6.4	4.8	3.4	6.0	7.6	5.0	6.3	3.1	5.5	5.0	6.2	7.3	6.0	4.0	6.5	5.1	5.2	5.7	3.8	8.0	4.2	3.6	5.5	6.2	4.6	7.3	3.9	6.4	4.0	3.8	4.3	5.3	5.2	4.4	4.1	3.9	5.2	7.8	5.7	4.7	9.2	5.2	3.2	5.3	8.8	6.7	15.7	13.7	16.3	5.1	7.7	10.7	12.3	13.2	14.6	10.2	4.0	7.5	20.8	12.0	14.2	20.0	0.0	13.8	10.1	11.6	7.3	13.3	18.3	5.9	9.9	0.0	9.8	7.8	13.0	9.8	9.0	8.9	4.3	16.9	17.1	9.6	16.1	13.4	15.4	6.3	6.8	19.0	5.8	17.8	13.7	7.2	23.4	9.8	21.1	17.6	13.8	11.6	6.0	12.1	14.1	20.2	3.7	15.6	7.1	18.1	17.4	6.5	16.6	3.0	9.7	10.9	16.5	1.7	2.6	3.8	2.3	2.4	3.3	3.2	3.9	2.9	4.4	3.5	6.0	4.1	0.8	2.0	2.2	2.6	3.3	3.2	5.3	5.2	6.8	10.2	5.0	6.2	5.1	5.2	5.5	5.2	5.2	5.3	1.5	0.0	3.1	1.3	3.5	3.1	3.7	1.9	1.8	7.6	2.9	2.8	3.6	5.7	5.7	3.7	8.4	4.3	2.7	2.8	3.9	6.5	2.1	3.6	3.9	3.1	5.4	4.8	1.1	4.0	2.3	3.7	2.0	4.1	1.3	2.2	5.0	4.1	2.7	3.3	1.6	2.2	4.1	1.3	0.8	1.5	5.0	2.7	0.0	1.9	2.4	7.3	4.1	0.5	1.7	3.4	2.1	1.5	2.5	3.3	1.8	4.7	6.2	6.6	6.6	5.1	3.7	23.4	10.5	2.7	2.8	2.5	2.6	2.4	3.3	2.8
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526540	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 12.8;seminal vesicle: 8.0"	"Cell type enriched"	"Detected in some"	8	"Basal prostatic cells: 8.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		3800000		"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.0	0.4	0.0	0.0	0.0	0.0	12.8	1.9	0.0	0.5	1.1	0.4	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.1	0.0	1.9	0.2	0.4	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.9	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153453	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 2768.7;gallbladder: 2223.2;salivary gland: 1308.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 944.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	88	"basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	83	"granulocytes: 11.9;monocytes: 4.7"	"Group enriched"	"Detected in many"	11	"CAPAN-2: 3623.8;EFO-21: 1450.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 149.7;spinal cord: 102.4"	"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	590000000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	4.9	3.6	0.0	125.5	0.1	2768.7	22.0	0.1	0.5	810.5	2.0	249.1	34.4	14.2	20.5	677.6	52.6	2223.2	3.1	0.0	0.1	31.6	67.8	76.1	1.1	0.3	0.1	1.1	74.8	7.3	21.2	2.6	0.3	74.5	131.0	0.0	1308.3	13.5	1.2	28.1	157.3	11.9	0.1	82.0	363.9	0.5	0.1	14.2	27.1	0.3	199.1	669.9	480.7	0.1	117.7	35.1	0.0	4.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3623.8	0.2	1450.9	0.0	3.7	236.4	0.0	6.9	0.1	5.3	0.0	30.4	0.0	0.8	0.2	0.0	1.1	0.1	230.4	0.0	12.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	1.9	80.9	0.2	0.2	0.3	0.3	1.0	20.1	0.1	0.1	2.0	65.3	1.0	0.0	8.4	1.8	0.0	2.9	16.9	0.0	2.9	0.6	4.6	4.7	0.2	0.6	2.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	4.7	0.0	0.0	12.1	0.0	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	0.0	20.8	0.0	15.9	0.3	376.6	4054.2	1.8	0.0	38.1	29.3	0.2	1328.2	5757.0	138.0	0.0	0.8	1.2	315.6	0.0	6457.0	2.0	25.6	4.3	11.5	57.9	11.2	0.0	1837.0	0.3	12.2	237.0	52.3	13.4	0.0	2.2	43.2	0.6	0.0	0.0	264.3	956.2	2.7	0.0	15.8	3.4	34.9	0.0	0.0	60.3	0.0	1.0	0.0	0.0	5424.3	183.4	0.0	1.4	420.6	509.8	1.6	3161.5	0.0	0.0	0.0	337.7	0.0	0.3	51.1	0.0	0.3	7.7	0.0	475.5	7112.9
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LCT		ENSG00000115850	Lactase	P09848	2	135787850-135837184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	187	"intestine: 225.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 3.3;Early spermatids: 1.3;Proximal enterocytes: 2.8;Undifferentiated cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"JURKAT: 2.5;MOLT-4: 4.9;RPMI-8226: 9.7"	"Region enriched"	"Detected in some"	15	"hippocampal formation: 15.7"	"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	225.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	4.9	0.8	0.0	0.0	0.0	1.1	0.0	9.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394560-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	444.5	358.1	64.3	139.5	68.4	184.6	330.4	54.0	72.1	203.1	58.4	278.5	158.1	151.1	43.8	450.6	189.2	75.5	361.2	68.4	73.7	440.2	729.2	242.0	97.2	73.6	74.9	149.7	171.5	26.6	95.9	113.9	94.9	170.1	117.4	443.8	267.5	81.8	947.5	468.6	296.6	124.2	58.5	185.3	181.1	95.2	67.4	115.3	180.8	500.3	146.5	266.2	314.4	65.9	1261.4	730.9	28.4	415.2	599.8	399.3	400.6	1186.1	1148.5	936.9	1366.4	324.5	196.6	909.3	380.3	1110.8	727.1	979.2	716.1	1715.1	2082.2	331.3	422.6	329.6	629.4	588.5	148.9	811.2	235.8	411.1	760.3	380.3	373.7	1670.8	550.8	292.3	462.8	431.7	1127.7	319.4	674.8	509.3	182.7	413.2	849.4	432.0	298.0	768.0	1546.6	284.5	220.5	279.3	642.7	518.6	230.8	431.4	241.7	192.9	546.9	1228.3	455.3	1094.7	14.3	348.0	545.1	899.4	1767.1	415.0	434.1	98.4	147.1	79.7	93.8	165.0	105.2	70.4	122.1	99.6	202.1	54.4	78.1	81.0	47.1	91.3	169.3	68.0	140.8	237.6	64.3	68.4	54.0	72.1	68.4	73.7	73.6	74.9	94.9	58.5	67.4	65.9	421.7	73.7	201.6	21.5	220.8	2198.1	475.6	2133.0	523.0	464.2	213.6	229.5	241.8	175.8	837.3	309.0	146.0	509.8	427.2	696.1	434.3	1293.9	204.4	180.0	317.4	492.8	45.6	123.2	38.7	1532.3	2086.2	544.4	163.6	485.8	262.9	205.3	205.6	514.4	659.3	514.8	33.5	285.1	649.0	224.4	1155.1	129.6	287.7	373.9	1177.5	20.6	973.4	444.2	170.0	9.5	12.6	1771.4	590.3	205.0	376.0	546.8	1765.0	682.5	178.1	481.4	190.7	251.6	706.3	195.5	44.0	422.9	1723.2	501.7	410.9	196.2	362.1	530.8
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479601	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.3;Excitatory neurons: 3.5;Late spermatids: 7.4;Spermatocytes: 19.3;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HL-60: 11.0"															NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.1	0.5	0.2	0.3	0.3	1.0	0.1	1.6	0.4	0.0	0.0	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.3	0.1	0.1	1.1	0.2	0.2	0.1	0.9	0.5	0.0	0.0	0.3	0.3	9.8	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.1	0.3	0.0	0.2	0.3	0.5	0.5	0.4	0.7	0.3	0.0	11.0	0.5	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.3	0.7	0.0	0.2	0.3	0.8	0.2	0.1	0.4	0.5	0.3	0.2	0.1	0.7	0.3	0.3	0.3	0.2	0.1	0.3	0.2	1.5	0.5	0.4	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.6	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.2	0.7	0.3	0.1	0.0	0.3	0.1	0.2	0.3	1.6	0.4	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	13.3	0.1	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	7.4	0.9	0.1	0.0	0.0	0.0	0.9	1.0	1.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.2	0.0	19.3	3.5	0.0	0.0	0.3	0.0	0.3	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1947.7;kidney: 1726.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2502.3;Cytotrophoblasts: 1693.0;Distal tubular cells: 3306.5;Proximal tubular cells: 3483.9;Syncytiotrophoblasts: 1639.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 6021.8"									"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		560000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	549.9	424.8	509.1	259.2	528.2	352.8	321.1	593.7	617.0	238.6	549.8	320.2	84.4	273.1	169.0	166.6	252.9	232.9	1947.7	484.1	581.9	1726.6	70.5	220.4	425.8	564.4	575.4	472.4	370.3	447.3	161.3	298.2	556.2	240.9	277.0	290.0	162.3	287.2	309.4	81.4	171.3	309.7	537.8	182.0	459.1	119.5	582.5	534.5	348.5	950.4	449.4	417.9	171.2	517.8	647.2	1697.3	1457.5	966.0	1021.7	1126.6	1689.4	879.8	873.0	1201.5	1179.4	2712.9	3.6	2268.6	561.5	597.3	1170.1	315.8	2031.4	1631.4	1518.4	586.5	1413.1	2339.5	1619.0	3.0	975.0	2212.8	967.9	1300.5	572.1	1056.8	1423.4	1416.9	1395.2	1610.8	1304.6	332.6	1342.7	3.2	1895.9	2665.6	4216.4	1051.1	727.7	1681.3	2032.0	1838.7	6021.8	2832.7	467.2	1077.8	403.6	618.1	1586.1	3842.2	5.3	1704.6	548.3	803.7	1048.1	578.5	1684.5	291.0	420.9	2953.4	891.8	1037.5	978.2	540.8	201.9	25.1	346.8	124.7	583.1	349.4	1341.5	723.8	367.2	250.9	1722.4	1124.1	31.7	459.0	95.2	427.7	1405.8	1431.2	509.1	528.2	593.7	617.0	484.1	581.9	564.4	575.4	556.2	537.8	582.5	517.8	89.8	141.1	316.4	68.2	242.2	73.0	439.5	1103.1	221.4	151.5	332.4	325.0	2502.3	298.8	433.9	474.5	68.8	1693.0	208.0	69.6	3306.5	18.4	10.5	224.3	325.0	227.3	92.4	361.2	39.4	314.9	870.1	299.4	222.8	309.4	268.6	412.6	155.7	11.2	612.9	141.3	55.6	152.2	956.2	189.8	104.3	34.3	274.6	174.8	179.7	33.7	197.3	277.6	159.6	47.7	40.3	99.7	84.3	415.2	303.1	310.6	0.2	3483.9	363.0	118.1	236.7	195.2	363.7	21.5	124.3	216.3	64.2	1639.5	398.1	1105.3	257.0	344.9
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089462-11133820	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 112.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 397.4;Alveolar cells type 2: 468.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 46.0"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		23000000	"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	43.6	112.1	6.4	27.3	7.5	27.4	15.6	8.6	13.0	27.5	22.0	20.0	23.6	21.6	3.8	50.1	21.6	36.9	19.3	8.4	10.8	15.2	60.4	54.8	4.8	24.3	14.4	37.7	50.7	10.1	6.9	16.6	20.0	20.2	12.2	2.3	19.1	4.6	3.9	25.5	18.3	28.6	9.9	10.5	36.5	8.4	11.7	4.0	7.7	4.0	5.1	22.6	25.8	14.5	113.6	52.2	61.1	29.9	80.5	152.7	21.0	23.5	89.8	41.3	88.6	52.9	105.3	37.2	94.1	46.1	135.6	88.3	31.1	185.6	19.9	27.5	6.1	18.1	34.5	47.1	120.2	19.2	100.9	192.5	67.5	139.6	30.2	28.5	45.8	29.5	38.9	213.8	31.9	41.4	25.3	25.9	66.4	56.0	67.5	17.1	44.9	48.2	103.1	89.5	14.8	15.4	21.1	45.7	3.8	45.2	19.0	44.6	50.8	36.1	26.3	23.2	44.7	26.8	24.4	23.3	42.8	43.7	83.6	46.0	2.9	0.1	5.4	2.6	1.3	0.6	2.2	1.7	1.6	0.5	2.3	2.2	0.8	2.5	0.8	0.5	1.6	3.2	6.4	7.5	8.6	13.0	8.4	10.8	24.3	14.4	20.0	9.9	11.7	14.5	106.3	397.4	468.6	16.3	8.1	143.4	176.8	182.2	85.4	11.4	144.0	108.7	35.9	92.9	205.7	14.7	6.2	18.4	24.7	273.7	1.9	57.9	1.2	95.3	61.7	75.8	61.9	6.6	10.7	89.0	32.1	42.9	195.2	278.6	75.9	32.9	22.9	149.2	14.9	1.7	8.1	157.2	77.3	16.5	26.5	1.6	19.6	47.4	56.9	7.5	2.7	6.8	8.2	7.5	19.4	86.7	209.7	7.2	30.7	142.7	32.5	0.6	99.1	6.6	6.6	133.4	48.4	4.1	2.8	155.3	197.2	48.2	32.8	214.3	110.7	184.2
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132873444-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 532.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1650.6"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;Hep G2: 4.7;U-266/84: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		790000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.68e-4)"	0.9	0.9	0.9	0.3	0.8	0.5	1.0	2.3	1.2	1.3	0.4	1.7	12.3	0.8	0.2	1.3	1.2	4.5	1.2	0.8	0.8	11.9	532.0	1.1	0.5	0.8	0.7	1.2	1.9	0.7	1.1	0.2	1.0	2.4	1.6	1.0	1.3	0.2	1.4	1.4	23.4	0.1	0.6	2.2	2.0	1.1	0.8	0.3	1.9	0.5	0.5	7.8	1.6	1.8	0.1	0.7	0.4	1.5	0.6	0.4	0.4	0.1	0.1	0.4	0.6	3.4	0.5	0.2	0.1	0.1	0.4	0.7	1.4	0.6	0.0	1.2	1.0	0.3	1.2	4.7	0.1	0.5	0.2	0.1	0.5	0.0	0.1	0.3	0.1	1.1	0.5	0.4	0.0	0.3	0.8	0.6	1.1	1.1	0.5	0.0	0.2	1.1	0.0	0.2	0.5	0.3	0.3	0.7	0.5	0.4	0.8	0.4	0.0	0.2	0.3	0.6	0.1	1.1	3.8	1.1	0.0	0.7	0.2	1.3	0.7	0.3	0.6	0.4	0.8	1.0	0.6	0.7	0.6	0.8	1.0	0.8	1.7	1.0	0.3	0.8	1.1	0.3	0.9	0.8	2.3	1.2	0.8	0.8	0.8	0.7	1.0	0.6	0.8	1.8	2.5	0.0	2.6	1.3	7.9	10.1	10.8	4.1	2.8	17.1	4.9	2.8	1.9	64.3	2.6	0.0	33.3	3.3	7.6	39.2	9.8	2.9	6.2	4.8	3.8	5.2	4.8	9.3	1.1	9.8	7.9	5.8	1.5	10.3	7.0	6.7	14.3	1650.6	1.4	13.5	1.4	12.1	0.0	17.3	14.1	0.5	1.5	4.2	5.4	1.0	2.2	5.2	13.4	2.0	1.8	2.9	30.9	1.9	3.1	14.0	279.9	51.8	1.7	25.2	0.0	13.5	4.8	7.0	2.9	1.4	7.7	7.3	6.2	4.1	8.0	10.2
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135954983	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 477.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Region enhanced"	"Detected in some"		"cerebellum: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	5300000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.2	0.5	0.4	0.4	0.8	2.4	0.4	6.3	2.8	0.1	0.0	0.2	0.5	0.3	0.8	0.4	0.1	0.4	0.1	0.9	0.0	0.6	477.9	0.3	0.9	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.1	0.4	0.2	3.1	0.7	0.2	2.1	1.4	0.9	0.1	0.0	0.9	0.3	8.8	0.0	0.2	0.4	0.0	0.2	0.1	0.0	1.1	0.3	0.4	0.5	0.7	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.8	0.6	0.3	0.3	0.5	0.0	0.2	0.0	0.3	1.0	0.7	0.7	1.3	0.3	1.0	0.1	0.2	0.1	0.3	0.3	0.6	0.1	0.8	0.2	0.3	0.6	0.0	0.4	0.4	0.5	0.3	0.6	0.5	0.5	0.2	0.2	0.9	0.3	0.6	0.0	0.2	0.0	0.9	0.1	0.5	0.8	0.3	0.4	0.4	0.1	1.1	0.5	0.3	0.3	0.9	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.8	6.3	2.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.1	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	100.7	0.0	0.0	0.1	0.0	0.0	2.9	0.0	55.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Cell type enhanced"	"Detected in many"		"Melanocytes: 33.8;Microglial cells: 145.2;T-cells: 70.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Group enriched"	"Detected in many"	5	"JURKAT: 579.6;MOLT-4: 569.0;REH: 454.8"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	1.0	12.7	10.7	13.8	7.6	11.6	2.0	6.1	7.9	4.2	14.3	1.5	0.7	8.0	4.8	3.2	5.1	3.9	0.2	5.7	9.9	2.5	0.3	3.3	31.3	8.9	11.2	1.1	0.1	0.3	1.0	11.0	9.4	3.7	1.4	0.5	1.0	1.0	0.1	2.8	4.1	3.9	5.9	9.8	1.5	12.3	18.2	349.2	3.0	0.1	22.8	5.5	3.0	5.5	0.1	0.0	8.0	0.0	0.0	0.0	0.0	0.2	7.2	1.8	4.7	27.1	0.0	0.0	0.1	0.0	2.5	0.2	7.9	0.0	3.7	0.3	17.6	6.9	0.0	0.0	0.0	23.6	2.9	0.4	0.4	0.0	0.7	3.5	0.0	579.6	14.2	0.0	2.6	1.0	569.0	0.0	1.7	6.3	1.4	454.8	9.1	0.2	2.4	1.3	3.0	5.2	0.0	0.5	83.8	6.7	2.4	0.2	0.0	11.9	10.3	0.0	15.3	38.3	17.0	100.9	7.8	0.0	48.4	0.3	0.2	0.0	8.2	0.0	1.6	0.6	68.3	29.9	0.1	0.9	142.6	102.2	1.9	32.9	0.3	0.5	97.7	36.8	10.7	7.6	6.1	7.9	5.7	9.9	8.9	11.2	9.4	5.9	18.2	5.5	1.4	3.2	1.9	2.0	4.4	3.3	1.4	1.0	24.5	0.1	0.4	5.0	1.6	0.0	0.7	0.0	0.0	0.1	6.2	0.0	13.7	0.0	4.2	5.8	22.3	22.0	0.0	9.2	0.2	0.0	0.2	2.1	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	4.1	0.3	1.4	7.9	0.6	2.0	33.8	145.2	3.5	0.6	10.3	0.5	0.6	0.1	0.0	0.0	5.4	1.8	0.0	0.5	2.3	0.3	0.0	0.6	9.0	16.1	6.6	11.3	1.3	0.4	70.3	0.0	0.9	0.4
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241278-128257629	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"adipose tissue: 307.5;breast: 90.1"	"Group enriched"	"Detected in some"	44	"Extravillous trophoblasts: 124.2;Syncytiotrophoblasts: 432.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010490	Approved				"Secreted to blood"	NA	NA	17000000	19000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	307.5	0.8	0.1	5.0	0.1	0.1	90.1	0.5	0.3	0.1	0.1	2.0	0.1	0.0	0.0	0.2	0.1	1.2	1.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.0	4.6	0.1	0.0	0.4	0.0	1.1	0.0	0.7	3.9	1.2	0.1	0.0	0.2	0.5	0.2	0.1	0.3	0.2	1.2	0.0	1.0	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.8	0.1	0.6	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	124.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.1	432.2	0.1	0.1	0.0	0.1
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 130.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 80.5;Fibroblasts: 94.2;Hepatocytes: 175.2;Langerhans cells: 66.6;Microglial cells: 129.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"K-562: 114.7;RPTEC TERT1: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Intracellular and membrane"	NA	NA	8240000	14000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	24.3	7.2	5.2	3.9	5.1	5.0	20.6	4.9	6.5	21.5	25.0	5.9	3.9	24.6	6.7	9.2	16.1	14.7	6.9	5.3	12.3	7.8	130.4	22.5	9.5	5.2	5.7	25.0	3.0	2.9	11.7	5.3	5.2	9.0	5.1	2.5	11.9	7.3	2.1	15.1	5.6	18.7	6.3	3.2	13.7	3.9	7.7	4.7	10.4	32.1	5.7	9.1	4.8	5.2	3.3	2.0	2.6	2.9	11.5	10.6	9.0	14.2	8.1	4.8	4.5	1.5	7.6	1.4	10.1	18.0	1.3	2.7	2.2	12.3	12.7	17.2	3.7	18.8	7.9	0.3	7.0	1.4	1.6	29.7	6.8	2.9	10.8	36.2	13.9	1.4	114.7	2.2	22.5	0.9	1.4	0.4	4.2	2.0	0.2	0.4	2.2	0.8	52.3	1.4	1.6	26.3	3.5	1.5	4.0	14.9	5.0	5.0	5.3	4.9	10.0	1.1	7.8	3.0	2.2	0.5	10.2	5.3	4.8	4.5	0.8	1.2	0.5	0.6	0.4	0.2	0.4	0.4	0.7	0.1	0.3	0.5	0.4	0.4	0.7	0.5	1.0	0.7	5.2	5.1	4.9	6.5	5.3	12.3	5.2	5.7	5.2	6.3	7.7	5.2	97.7	0.0	11.3	47.0	2.6	35.3	1.9	3.3	2.2	4.0	3.1	3.3	6.6	11.5	4.2	9.2	0.0	1.6	1.6	0.5	3.9	1.5	1.1	2.0	4.4	80.5	0.0	10.3	20.9	1.1	2.6	94.2	2.6	12.8	1.3	2.6	52.5	175.2	2.0	1.7	21.8	0.8	2.0	6.3	66.6	2.3	34.5	6.1	35.6	129.3	3.4	0.4	2.1	29.1	24.5	1.7	1.9	7.5	2.4	7.5	0.7	6.4	2.6	1.0	0.0	41.1	10.3	1.1	1.2	4.1	29.5	2.6	4.7	3.3	0.8	2.1
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675636-37679802	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3949.7;Langerhans cells: 4906.5;monocytes: 7118.4;Smooth muscle cells: 4703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 1649.6"	"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	No	Yes	10000000	20000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (5.10e-4)"	1921.2	778.5	482.4	523.8	520.7	324.7	1490.9	613.5	695.3	1805.7	465.2	1634.7	197.7	2270.1	196.8	387.4	1147.0	556.0	1397.4	457.7	549.0	362.4	277.4	920.2	176.7	694.5	576.1	1440.2	155.5	188.1	254.8	426.1	661.5	903.0	207.2	39.5	397.5	756.3	1172.9	472.8	475.3	1353.4	593.8	460.7	582.7	244.9	624.9	153.9	290.9	691.9	116.9	1059.7	1156.4	782.4	2850.9	1664.3	36.5	1440.9	3314.6	6505.1	32.7	6450.7	7619.4	4761.9	4716.9	189.6	368.3	3.3	649.1	6661.4	1609.2	296.3	58.8	4309.2	1663.3	2917.2	30.9	251.3	1606.3	791.1	2155.3	145.1	3167.7	4031.7	294.2	3785.7	1609.9	4271.1	5325.7	1.7	186.6	1163.4	3771.1	1287.6	5.2	2038.4	14.3	629.6	3914.9	5.4	2388.6	799.7	2000.0	6.4	5.5	843.4	1287.4	224.3	1644.5	66.7	1187.2	1689.0	7122.0	6224.0	3070.2	2788.9	3349.3	701.8	530.6	13.6	7291.9	762.0	2535.9	1086.5	3047.4	110.2	766.5	2320.4	113.6	567.7	694.9	754.2	3653.1	287.5	114.3	478.1	122.2	415.4	2556.7	899.2	1514.7	4667.0	482.4	520.7	613.5	695.3	457.7	549.0	694.5	576.1	661.5	593.8	624.9	782.4	1505.8	166.7	90.4	12.7	294.3	730.3	144.0	2796.6	49.5	10.0	144.2	477.9	986.3	74.4	213.4	163.7	6.2	88.0	466.5	49.9	17.6	690.2	30.9	183.0	3011.6	1063.6	3.0	74.9	7.5	90.4	1573.3	2540.4	28.1	230.3	540.0	172.2	653.2	614.1	3949.7	8.4	5.4	8.4	339.7	2159.0	4906.5	106.4	975.5	1700.0	2856.6	15.9	7118.4	278.0	588.1	4.0	17.1	233.5	6.1	1300.7	590.9	118.8	0.5	28.7	109.8	45.4	1650.1	1873.6	4703.8	33.8	13.1	18.2	588.0	151.5	767.5	197.2	11.6	57.0
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1194.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4097.0;Paneth cells: 3445.9;Proximal enterocytes: 4397.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 651.4;intermediate monocyte: 544.6;myeloid DC: 397.8;non-classical monocyte: 441.2;T-reg: 251.9"	"Group enriched"	"Detected in all"	13	"dendritic cells: 397.8;monocytes: 651.4;T-cells: 251.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1169.3;CAPAN-2: 968.0;OE19: 1613.0;SK-MEL-30: 2329.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003162, CAB005191, HPA076528"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1900000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937, HPA076528: "	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	404.5	72.0	111.4	219.8	111.8	346.9	323.1	110.7	148.1	331.4	104.3	1194.1	691.9	162.3	53.8	437.8	223.1	273.0	246.2	110.3	109.4	120.0	27.3	356.1	84.5	118.6	111.9	251.4	79.9	19.8	60.6	141.2	108.6	143.1	875.4	68.3	358.6	177.4	78.6	473.1	853.4	158.8	110.4	61.9	340.7	63.5	125.2	53.0	72.3	105.6	114.1	300.8	273.5	114.0	298.6	96.5	3.3	2.5	581.2	1169.3	344.9	226.7	496.2	64.0	113.2	225.4	968.0	0.7	121.3	272.8	114.6	289.0	6.1	245.4	37.5	357.1	4.4	1.0	104.7	103.8	446.8	1.0	1.1	363.4	375.2	73.9	152.8	145.1	101.5	0.7	1.4	283.1	148.8	218.5	1.3	74.4	5.6	1613.0	271.1	0.7	11.3	22.4	604.8	434.2	7.8	22.6	529.0	0.9	2329.1	16.2	242.8	31.4	180.5	297.8	41.5	112.0	4.4	154.0	535.6	2.8	426.8	18.6	31.8	18.5	651.4	32.4	15.7	544.6	99.7	11.5	58.4	44.2	397.8	4.7	2.5	8.3	28.7	24.2	441.2	9.6	251.9	449.6	111.4	111.8	110.7	148.1	110.3	109.4	118.6	111.9	108.6	110.4	125.2	114.0	1157.4	721.1	359.8	33.3	42.0	631.3	624.1	1278.9	241.9	2.9	307.3	478.7	218.2	258.7	1463.3	119.5	0.0	766.1	38.8	4097.0	673.1	605.9	21.7	636.2	742.7	397.8	173.4	578.1	0.2	1057.8	1051.7	666.3	281.4	846.8	580.5	6.3	64.6	2.3	1137.4	1.7	0.5	1733.8	1778.1	287.8	844.6	44.4	555.7	651.2	848.4	14.0	639.1	300.1	9.2	2.0	0.3	1289.6	3445.9	384.0	77.4	708.4	4397.2	81.3	1506.5	14.7	144.7	220.2	521.0	11.5	6.6	524.8	797.6	483.8	119.5	2.9	1880.1	1139.7
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78979947	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"monocytes: 27.2;T-cells: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 862.9;SK-BR-3: 2270.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	NA	NA		7100000000	"Cluster 32: T-cells - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	192.8	218.6	51.2	75.0	91.4	48.6	109.5	95.6	62.3	188.8	159.8	210.8	312.9	121.4	45.2	114.2	155.6	240.8	311.4	46.6	81.4	103.1	68.5	182.8	52.7	145.6	88.3	155.6	79.1	107.8	134.9	147.0	116.8	114.3	92.6	10.0	498.7	154.2	20.0	54.0	260.9	80.2	104.3	76.8	315.6	70.1	89.8	48.8	102.0	20.4	25.3	125.0	119.0	152.5	499.0	255.3	7.2	11.2	157.3	181.4	147.9	55.7	49.0	371.3	725.7	107.5	862.9	2.8	372.7	33.5	361.7	200.1	53.6	203.7	11.5	1.2	319.0	33.8	206.0	481.0	387.7	0.4	31.6	305.8	111.5	197.5	12.6	83.8	9.9	68.7	3.4	1.5	87.7	62.8	151.2	6.0	13.0	163.7	170.7	100.1	209.9	4.8	155.5	352.6	235.1	267.4	52.7	2270.3	754.5	14.0	57.5	16.1	16.3	245.5	169.8	7.1	225.8	0.8	2.2	3.7	332.1	96.8	263.7	0.8	17.7	4.9	12.0	27.2	25.0	4.7	43.3	17.9	7.6	2.4	68.4	33.0	1.2	9.4	14.7	0.6	26.0	25.1	51.2	91.4	95.6	62.3	46.6	81.4	145.6	88.3	116.8	104.3	89.8	152.5	88.0	189.1	144.3	9.8	5.6	31.1	146.8	462.5	60.3	37.2	60.5	43.1	180.7	127.2	306.2	139.8	6.2	179.1	3.4	629.8	17.6	275.0	7.2	77.4	118.7	26.8	168.2	4.4	0.3	136.5	336.0	284.6	257.9	126.9	13.3	316.5	46.8	45.8	88.3	74.0	5.3	328.7	309.3	36.8	23.7	37.1	282.7	36.0	81.8	8.4	27.9	80.8	2.1	11.6	33.9	132.4	584.1	266.3	3.5	72.4	931.4	49.2	123.9	24.3	177.5	80.5	119.6	4.5	2.1	83.8	27.3	108.9	15.4	228.3	400.5	128.2
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"intestine: 1307.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.1	0.4	0.5	5.5	0.5	0.6	1.4	0.2	1307.1	812.2	3.2	0.2	1.4	2.4	137.1	0.9	0.3	0.3	2.9	79.5	1.2	1.1	0.3	0.3	1.6	31.5	0.0	0.8	0.2	0.3	2.3	933.0	0.2	1.1	2.3	1.6	1.6	691.9	55.2	0.2	4.0	135.2	0.9	0.3	0.3	1.7	0.2	0.4	11.2	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 393.1;skin 1: 877.2"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 275.1;Squamous epithelial cells: 639.7;Suprabasal keratinocytes: 725.7"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 7.1;OE19: 2.2"	"Low region specificity"	"Detected in single"							"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"	NA	NA		4000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	1.0	0.2	0.0	0.0	0.0	0.0	13.6	0.0	0.0	63.2	0.0	0.3	0.0	0.4	0.0	393.1	0.4	0.2	0.5	0.0	0.1	0.7	0.3	0.4	0.0	0.1	0.1	0.3	0.4	0.0	0.4	0.0	0.1	2.0	0.0	0.0	25.5	0.2	10.7	877.2	0.2	0.0	0.0	2.3	0.5	1.5	0.0	0.5	0.7	0.4	2.2	0.3	155.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	275.1	0.9	124.3	89.4	0.0	0.3	2.8	0.2	0.0	57.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	7.5	1.1	0.0	0.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.4	10.7	0.0	0.0	1.7	3.8	1.5	0.8	639.7	725.7	0.0	0.5	0.1	0.0	1.5
LGALS7B	GAL7	ENSG00000178934	"Galectin 7B"	P47929	19	38789200-38791754	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6695.7"	"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 1529.6;Suprabasal keratinocytes: 5136.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 142.7;head and neck cancer: 185.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HaCaT: 3.9;OE19: 3.9"									"HPA001549, CAB025100"	Supported				"Intracellular and membrane"	NA	NA		4000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"CAB025100: , HPA001549: AB_1078938"	"unprognostic (4.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.29e-3)"	6.1	1.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	490.5	0.0	1.8	0.0	1.0	0.0	1463.3	0.9	0.0	2.6	0.0	0.0	2.1	3.0	2.6	0.0	0.0	0.0	1.4	2.7	0.0	2.2	0.0	0.0	5.0	0.0	0.0	167.2	0.1	10.2	6695.7	1.7	0.0	0.0	22.0	3.0	4.9	0.0	0.2	2.3	0.0	1.6	1.0	834.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1529.6	6.3	253.5	102.4	0.0	1.2	13.3	0.4	0.0	64.4	1.8	0.0	0.0	0.0	0.3	0.0	0.0	5.4	3.1	0.2	3.2	1.2	0.0	0.0	0.2	0.1	3.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	41.3	12.3	0.0	0.3	44.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	2.1	0.3	0.3	9.3	0.0	0.0	1.3	4.2	7.5	1.9	329.6	5136.5	0.0	1.6	0.4	0.1	14.0
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 90.6;skin 1: 93.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.6;Rod photoreceptor cells: 152.8;Suprabasal keratinocytes: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.5;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 50.2;CACO-2: 35.6;HAP1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		NA	NA		4100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	9.3	16.9	7.1	4.1	8.3	8.1	17.2	9.5	8.7	8.8	8.6	12.6	10.1	7.2	8.9	24.6	5.3	6.3	13.5	7.4	8.6	9.2	9.6	15.9	2.1	5.7	5.4	6.4	6.3	19.2	7.5	10.6	5.7	15.5	11.8	90.6	9.3	7.1	60.1	93.6	10.9	7.3	5.4	6.0	8.8	4.3	5.8	2.9	5.3	18.2	15.8	4.4	10.0	6.6	11.6	7.5	20.7	50.2	0.7	0.2	6.2	2.9	8.1	6.3	6.0	35.6	2.4	0.0	4.7	1.6	12.2	14.3	72.8	13.7	5.0	13.8	19.1	0.2	4.0	17.8	6.2	3.4	4.4	3.1	8.6	2.6	9.7	5.6	3.9	7.7	0.1	3.5	0.2	9.3	4.9	0.6	16.8	7.1	8.8	5.3	12.0	3.5	7.5	8.5	3.5	13.1	10.5	7.2	6.2	12.7	5.1	0.5	1.7	4.0	12.4	2.5	6.2	14.7	7.1	10.0	0.0	2.1	5.4	0.0	0.1	1.5	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	7.1	8.3	9.5	8.7	7.4	8.6	5.7	5.4	5.7	5.4	5.8	6.6	28.9	22.4	66.2	2.3	6.0	67.6	25.5	9.7	29.0	31.9	39.0	20.8	16.5	10.0	6.3	11.0	33.3	1.4	1.6	45.2	15.6	6.2	11.8	10.9	8.1	18.2	9.1	0.8	6.6	13.3	2.7	14.8	23.4	23.0	1.3	4.1	17.9	11.9	1.0	13.5	6.0	38.6	6.1	6.6	14.4	6.3	8.1	26.2	10.6	1.9	2.4	95.6	2.1	5.0	2.4	19.9	22.6	4.5	29.8	24.1	31.0	14.3	1.6	152.8	19.7	15.1	45.9	8.1	5.1	51.9	137.0	1.5	2.7	2.8	24.3	36.2
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030946	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"parathyroid gland: 127.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Inhibitory neurons: 33.3;Oligodendrocyte precursor cells: 10.1;Skeletal myocytes: 8.6;Smooth muscle cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.2;HAP1: 5.2;RPMI-8226: 13.3;SCLC-21H: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Uncertain	Centrosome	"Secreted to blood"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	3.4	1.6	2.7	7.5	3.5	0.0	0.8	5.7	4.1	1.5	1.0	3.1	0.7	6.7	2.7	1.4	7.8	7.1	3.3	1.9	9.2	4.3	0.3	1.0	2.9	12.0	13.1	2.1	1.7	127.8	0.3	3.9	6.7	0.5	1.6	2.3	0.3	1.2	0.2	0.3	1.8	13.6	4.0	0.9	1.4	0.7	4.2	2.3	1.1	0.4	8.4	3.0	0.7	3.3	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.0	0.2	0.0	5.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	1.2	13.3	0.5	0.0	18.2	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.3	2.0	0.0	0.8	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	5.7	4.1	1.9	9.2	12.0	13.1	6.7	4.0	4.2	3.3	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	2.0	2.1	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.7	0.0	4.8	1.7	33.3	0.0	0.0	0.6	0.5	0.1	0.6	1.0	0.0	2.8	0.0	0.5	0.0	10.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.6	8.5	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.1
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 112.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	44.2	0.1	79.7	0.1	0.2	81.1	84.6	2.9	5.2	0.8	0.3	1.2	0.3	6.5	1.6	0.1	2.2	43.4	70.4	0.4	0.1	15.9	0.0	85.8	72.4	0.2	0.8	0.3	2.8	0.0	90.7	1.3	0.1	3.9	1.7	2.8	0.2	15.0	0.5	0.6	57.1	0.1	0.9	0.8	86.3	0.3	13.0	0.1	0.3	0.2	2.5	112.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	79.7	81.1	84.6	43.4	70.4	85.8	72.4	90.7	57.1	86.3	112.6	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193799-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 9.0;Cardiomyocytes: 10.5;dendritic cells: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 15.4;memory CD8 T-cell: 9.1;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"T-cells: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;CAPAN-2: 15.4;HaCaT: 8.3;HeLa: 3.9"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 24.4"	"Low region specificity"	"Detected in many"			HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.2	2.3	0.4	5.4	1.4	5.1	8.2	1.5	3.7	0.3	1.4	0.1	1.2	2.2	5.0	8.8	6.2	14.7	1.0	7.2	0.8	2.1	3.4	0.8	14.7	7.6	1.8	0.2	0.0	17.5	0.3	8.0	5.9	0.7	0.0	5.3	1.4	0.3	4.1	1.3	0.3	6.1	6.7	0.6	7.2	9.8	0.3	5.1	0.5	0.3	2.9	3.8	2.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	1.0	0.0	1.7	9.1	0.0	0.0	0.7	4.8	0.0	0.4	0.0	0.0	0.5	3.4	2.3	5.4	8.2	1.5	1.0	7.2	14.7	7.6	8.0	6.1	9.8	2.0	0.1	0.0	0.0	2.6	0.2	1.3	3.6	0.5	23.3	0.0	1.5	9.0	10.5	0.0	0.6	0.0	0.0	0.9	6.0	0.8	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.4	1.0	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.8	1.6	0.0	0.6	0.3	4.1	0.0	0.2	0.0	1.9	0.0	0.0	4.1	0.0	0.2	0.0	0.7	0.0	2.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	5.6	5.5	3.3	0.3	0.1	0.8	4.3	0.0	2.7	0.9
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF interleukin 6 family cytokine"	P15018	22	30240453-30246759	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.7;urinary bladder: 91.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 95.5;Club cells: 56.3;Endometrial ciliated cells: 71.7;Fibroblasts: 51.9;Glandular and luminal cells: 192.9;granulocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 88.3;hTEC/SVTERT24-B: 113.0;hTERT-RPE1: 104.4;U-138 MG: 123.9;U-251 MG: 94.5;U-87 MG: 97.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	37.9	4.3	0.6	22.4	0.7	1.6	4.7	0.6	1.7	6.8	6.6	7.5	6.7	11.7	0.6	3.1	9.8	47.7	18.4	0.9	0.8	14.2	5.0	29.9	4.3	1.2	1.3	2.3	13.4	0.4	10.4	2.7	0.9	12.0	8.0	3.0	4.9	2.1	0.8	10.7	9.3	8.3	1.1	1.5	7.8	0.6	2.6	1.3	5.4	1.0	1.7	91.0	2.4	1.1	29.0	47.9	1.3	10.6	0.0	3.9	17.1	4.1	17.2	5.1	12.1	7.7	47.3	0.0	10.1	0.2	88.3	7.3	1.1	13.1	6.9	6.8	2.1	3.7	19.7	10.9	4.5	0.1	36.7	4.3	2.5	113.0	3.3	104.4	0.0	0.2	0.8	0.1	22.6	21.5	0.6	0.1	1.8	27.0	29.5	0.9	15.9	0.0	40.7	11.0	0.2	0.6	4.9	0.4	8.8	5.0	1.0	0.5	0.3	123.9	45.3	47.3	94.5	0.0	0.2	0.1	97.4	0.1	58.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.6	1.7	0.9	0.8	1.2	1.3	0.9	1.1	2.6	1.1	0.6	22.4	44.2	0.3	0.0	3.4	14.0	95.5	0.0	0.1	40.0	10.9	0.2	10.0	56.3	5.5	0.0	0.2	2.9	3.9	0.0	39.6	0.3	71.7	16.2	3.6	0.0	0.0	0.0	3.4	0.7	51.9	0.5	192.9	67.0	0.2	0.0	0.0	1.1	0.0	0.0	3.5	10.2	0.6	3.2	0.0	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	40.3	3.8	0.0	0.4	15.7	5.3	1.0	15.6	0.2	0.0	17.7	30.2	0.1	0.2	1.5	2.8	0.3	5.5	0.1	7.1	20.3
LIFR	CD118	ENSG00000113594	"LIF receptor subunit alpha"	P42702	5	38474668-38608354	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 318.9;Astrocytes: 376.8;Endothelial cells: 279.5;Hepatic stellate cells: 809.2;Oligodendrocytes: 275.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 88.0;HHSteC: 38.7;SCLC-21H: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		260000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.00e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.65e-1)"	50.0	18.1	38.8	6.2	55.1	0.1	41.7	43.6	24.8	33.5	3.0	10.2	5.8	33.0	16.5	12.1	30.9	12.4	19.9	23.4	43.9	23.9	30.9	23.8	21.0	42.7	55.2	18.6	22.3	13.4	5.0	35.9	50.2	28.9	8.8	17.4	34.1	16.8	23.4	9.7	11.0	33.4	39.6	29.9	21.9	10.0	54.1	21.3	38.5	42.8	10.2	11.7	14.5	47.5	1.3	4.3	88.0	6.8	25.4	27.0	0.6	6.7	3.8	4.7	2.9	0.9	4.6	0.0	1.2	10.1	12.4	0.7	5.5	2.1	9.0	0.0	7.0	0.0	8.7	3.7	38.7	0.0	0.5	23.5	1.6	12.0	1.5	6.1	8.6	0.9	2.3	12.3	7.3	1.3	0.0	0.2	2.1	0.0	14.8	0.1	18.4	0.0	6.0	2.0	56.6	7.2	28.3	1.6	0.0	11.7	1.9	0.0	1.5	9.0	15.7	21.0	4.3	0.0	0.0	0.0	15.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	55.1	43.6	24.8	23.4	43.9	42.7	55.2	50.2	39.6	54.1	47.5	318.9	12.8	39.7	376.8	2.6	23.2	6.3	1.2	10.8	6.4	16.8	22.1	33.1	8.6	7.3	14.7	8.4	12.1	0.6	0.0	5.9	2.0	15.0	11.0	12.4	279.5	0.0	13.5	33.7	9.3	28.0	62.9	14.3	16.9	1.3	29.6	809.2	11.8	3.5	1.7	54.2	0.0	6.1	50.3	17.7	29.7	113.7	2.3	17.8	45.0	0.0	6.2	0.0	111.6	275.5	7.0	0.0	19.9	0.0	18.5	0.0	12.3	8.3	37.3	39.5	65.9	30.8	9.6	7.3	2.0	18.2	28.6	3.7	15.8	0.0	5.5
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248"	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavorable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	2.8	3.2	3.3	9.0	3.2	34.5	3.6	3.6	3.5	5.5	2.3	6.8	8.6	4.0	2.5	7.4	5.9	2.3	1.6	2.9	3.2	2.9	4.0	3.4	15.6	4.4	2.9	6.0	7.0	4.2	4.8	5.1	4.5	4.0	4.2	2.7	4.8	3.0	3.8	10.4	9.6	2.2	2.6	6.0	5.2	8.2	3.1	20.7	5.1	1.0	9.7	3.5	5.0	3.9	43.4	64.1	57.1	37.6	2.6	4.2	41.7	27.0	19.1	44.1	47.2	35.0	42.9	83.7	15.3	11.2	11.9	30.1	24.7	26.7	16.9	45.2	48.8	56.4	38.7	47.5	1.0	63.0	43.7	5.7	2.5	23.0	3.4	5.0	24.0	51.0	46.3	29.8	23.3	44.0	107.3	123.7	33.6	46.7	15.9	84.1	48.4	43.6	12.3	64.8	36.3	36.5	32.3	33.6	10.1	12.5	22.7	44.5	22.6	31.7	54.3	23.9	40.3	29.3	49.0	83.1	12.7	38.0	33.3	0.0	1.6	2.6	7.8	6.8	7.7	10.9	8.8	8.3	1.6	10.0	11.5	8.2	1.3	12.1	3.3	1.5	10.9	5.7	3.3	3.2	3.6	3.5	2.9	3.2	4.4	2.9	4.5	2.6	3.1	3.9	3.9	3.2	13.6	5.9	16.1	8.3	9.5	8.7	24.5	21.5	7.8	12.3	3.9	7.2	10.3	3.7	10.4	31.1	9.6	10.2	7.9	5.8	19.3	12.0	5.1	8.3	0.0	36.2	4.2	5.2	35.8	6.8	5.1	8.3	6.3	23.1	5.0	5.3	16.4	8.4	5.6	10.0	6.1	3.5	6.8	8.5	2.1	6.6	3.6	3.7	7.2	10.9	11.3	3.5	8.4	3.0	4.4	1.9	23.0	2.8	7.6	4.7	19.5	11.3	13.1	4.5	6.5	13.5	26.1	15.9	9.1	10.0	13.9	6.0	15.3	8.7
LIG3	"LIG2, LIG3alpha"	ENSG00000005156	"DNA ligase 3"	P49916	17	34980512-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	4.9	6.4	3.2	7.3	3.3	7.1	8.7	3.8	4.4	7.9	4.7	8.2	5.9	12.5	6.4	8.9	11.9	5.3	7.6	3.4	1.9	6.6	6.3	5.2	7.2	2.2	2.0	11.5	8.7	13.7	6.6	8.3	1.8	11.1	9.0	7.2	10.6	9.0	10.6	8.4	6.7	10.2	1.0	7.6	6.6	21.1	2.1	13.9	10.1	9.3	8.5	8.9	7.2	3.1	16.6	32.6	38.3	33.9	7.4	9.3	29.2	15.7	11.4	20.9	20.8	15.8	8.8	27.0	12.7	20.6	20.5	15.2	43.9	20.3	26.7	12.8	29.4	28.4	14.6	23.2	11.7	44.9	48.1	7.0	17.5	15.5	24.0	10.3	25.6	40.8	45.3	30.2	15.2	18.6	56.7	14.1	36.8	20.6	13.7	30.4	35.2	28.6	10.2	17.7	31.2	22.3	23.6	19.0	15.2	55.9	34.5	22.3	12.3	13.5	16.8	16.8	25.6	27.0	31.5	35.1	9.7	20.9	26.5	0.6	3.4	4.2	4.6	5.1	6.7	3.7	3.1	4.1	8.4	3.0	4.1	3.0	0.3	9.3	2.8	4.9	2.1	3.9	3.2	3.3	3.8	4.4	3.4	1.9	2.2	2.0	1.8	1.0	2.1	3.1	7.6	3.2	10.3	1.6	8.0	5.0	10.5	3.6	12.0	18.2	10.0	7.5	10.1	10.0	9.2	12.9	16.7	14.6	11.9	7.0	9.8	6.7	41.8	18.5	11.9	8.5	6.7	8.2	5.0	6.0	17.8	7.3	16.8	15.8	9.5	16.7	3.6	8.9	7.9	16.8	5.2	7.9	8.2	5.3	2.7	80.0	7.2	6.7	3.6	2.8	6.4	7.6	16.5	4.0	5.8	3.6	7.5	7.9	15.4	11.6	6.8	6.5	5.3	17.7	6.6	11.8	7.0	32.7	13.2	11.2	5.3	21.6	8.9	10.8	9.5	10.2
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 22.0;Kupffer cells: 79.9;Macrophages: 39.1;monocytes: 48.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 31.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 31.6;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.7;REH: 2.0;THP-1: 4.0;U-937: 9.1"														"Secreted to blood"	NA	NA		140000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	5.2	3.2	0.9	2.8	1.0	15.5	1.8	1.0	1.5	0.9	0.9	1.5	0.2	1.0	0.2	0.9	4.0	0.4	1.9	1.0	1.0	1.4	3.4	10.3	0.2	2.0	1.2	0.8	1.4	0.1	0.8	0.1	2.0	1.4	0.2	0.2	1.7	0.1	0.5	0.7	1.7	0.4	1.1	57.4	1.6	0.8	1.6	0.2	0.8	0.2	0.3	2.2	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	5.3	7.6	3.0	0.1	11.6	0.1	0.1	0.1	0.1	3.3	0.3	0.1	0.1	31.6	0.4	11.3	0.7	0.1	6.1	0.9	1.0	1.0	1.5	1.0	1.0	2.0	1.2	2.0	1.1	1.6	1.8	0.2	3.2	3.0	0.0	0.3	0.3	1.6	0.0	0.0	0.9	0.4	0.1	0.5	1.5	1.8	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.0	0.2	0.2	0.6	0.0	0.1	6.3	0.1	0.4	0.4	22.0	0.0	0.0	0.0	0.0	79.9	5.9	0.6	0.0	39.1	0.0	8.4	48.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.0	0.1	1.5	0.6	0.0	2.1	0.3	0.3	0.3	0.0	0.1	0.4	1.4	0.0	0.0	0.6
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249421-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.9;lymphoid tissue: 49.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 61.1;Kupffer cells: 103.4;Macrophages: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012069	Approved					NA	NA		58000000	"Cluster 17: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	17.9	10.3	0.2	1.7	0.5	0.9	7.2	0.3	1.0	1.6	1.3	6.1	4.6	1.1	0.8	1.8	4.4	2.8	5.1	0.2	0.2	1.6	7.1	5.3	1.8	0.5	0.3	1.3	0.8	0.3	0.7	4.8	0.4	0.6	4.8	0.1	2.9	0.6	1.8	2.3	6.8	2.4	0.2	49.1	2.5	1.1	1.0	1.0	1.4	1.3	0.7	4.2	1.2	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.3	1.0	0.2	0.2	0.5	0.3	0.4	0.2	1.0	1.1	0.5	0.0	1.1	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	1.7	0.0	0.1	0.2	0.0	2.7	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.1	8.6	0.9	61.1	0.0	0.0	0.0	0.0	103.4	9.8	1.8	0.0	40.1	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	0.1	0.3	1.1	0.8	0.4	0.5	0.0	0.0
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686341	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA		8100	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	7.1	3.8	4.3	7.8	4.7	6.0	5.4	3.5	4.8	5.4	9.5	7.3	7.1	6.6	4.6	5.6	6.1	7.2	9.7	3.5	3.8	3.7	11.1	17.1	10.6	8.3	5.4	4.1	10.2	9.0	2.8	6.4	6.6	6.2	7.5	2.8	9.8	4.8	17.4	6.5	7.9	5.5	4.7	10.8	8.2	2.5	6.9	8.0	12.2	8.6	8.6	6.0	4.8	6.9	13.3	24.7	8.8	11.9	7.6	14.7	17.7	12.4	17.0	12.7	11.0	11.7	6.8	1.7	8.1	11.4	26.1	8.8	18.8	10.0	10.5	28.1	11.7	14.7	20.5	9.7	7.7	13.3	18.2	6.2	8.3	19.1	10.0	9.2	11.3	14.7	12.4	40.0	12.6	8.7	16.2	8.3	14.2	10.4	23.7	7.9	10.3	20.2	6.8	23.3	4.1	8.0	10.5	18.8	12.4	9.0	11.4	11.8	20.7	14.3	12.9	14.5	13.4	38.1	52.7	6.5	30.9	11.7	16.0	3.8	0.9	1.1	1.0	2.0	0.6	2.4	0.8	0.8	0.9	4.0	0.8	0.8	1.0	0.7	4.0	5.8	0.8	0.8	4.3	4.7	3.5	4.8	3.5	3.8	8.3	5.4	6.6	4.7	6.9	6.9	5.0	38.5	27.4	17.6	17.8	2.9	5.7	4.3	4.0	1.6	5.2	3.8	16.5	21.5	12.4	7.3	2.1	6.4	23.9	8.0	1.9	7.2	1.2	7.9	10.2	5.9	6.7	10.3	1.4	5.3	12.8	9.0	9.7	10.7	3.8	11.1	9.7	22.9	17.1	6.7	3.6	15.9	10.2	17.0	10.1	0.9	11.8	13.5	5.4	18.7	11.1	4.8	12.3	74.4	22.5	6.2	6.9	3.4	9.7	9.1	5.9	2.9	11.9	1.5	6.6	8.2	15.2	1.0	3.5	4.1	2.3	5.3	7.9	2.5	9.6	5.4
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 379.6;Macrophages: 405.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.5"									"HPA058455, HPA061230"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	41.0	45.0	7.0	33.8	10.4	32.9	28.9	9.4	8.4	22.7	10.8	22.1	16.7	35.8	11.6	26.9	31.5	31.2	38.0	6.9	11.4	16.7	20.1	37.0	37.9	12.9	11.0	20.5	15.0	12.0	8.0	32.2	12.8	19.5	18.0	11.5	17.6	26.7	99.1	14.2	20.0	35.8	11.3	21.0	22.2	16.8	15.0	21.4	24.8	35.8	32.8	30.0	17.6	15.9	44.7	49.0	19.0	22.8	30.8	44.5	91.6	49.0	56.0	37.1	37.6	85.3	93.7	43.1	145.4	63.0	55.0	28.3	29.0	50.2	49.3	106.7	52.0	225.6	32.1	45.8	70.4	42.7	402.5	43.5	45.5	98.3	80.3	44.2	135.9	37.3	81.0	58.2	115.4	36.5	41.4	31.4	37.5	29.0	49.6	52.2	65.9	35.0	70.2	79.5	34.3	46.3	76.6	32.5	34.5	25.0	16.8	39.6	184.2	166.6	75.6	37.5	101.2	56.4	81.6	60.6	139.3	47.6	43.6	211.9	69.6	196.2	16.6	119.3	30.5	18.7	72.3	22.4	59.4	18.0	19.2	7.3	31.6	35.9	156.2	7.7	89.0	140.3	7.0	10.4	9.4	8.4	6.9	11.4	12.9	11.0	12.8	11.3	15.0	15.9	143.5	99.3	55.6	80.6	43.2	74.1	63.0	65.1	63.7	26.2	34.9	37.0	61.6	38.6	53.4	29.5	54.2	45.1	40.6	19.2	39.2	80.9	22.5	266.8	122.9	187.6	118.1	84.5	32.6	233.5	130.3	109.4	32.6	379.6	101.4	107.0	76.1	34.6	189.0	15.2	34.6	24.0	48.8	181.1	265.4	12.0	81.4	405.4	44.4	115.2	118.5	69.2	41.2	54.3	66.8	122.3	17.2	88.0	76.3	82.1	33.5	44.0	84.8	18.8	65.7	116.2	161.2	45.4	51.1	75.2	77.0	27.9	82.4	51.3	32.4	66.4
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 149.3;thyroid gland: 242.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Extravillous trophoblasts: 67.9;Glandular and luminal cells: 49.0;Hepatocytes: 78.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 122.6;HaCaT: 189.8;RPTEC TERT1: 122.4;TIME: 247.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	810000		"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	4.6	0.2	0.9	16.3	0.6	0.3	1.0	4.0	2.6	0.9	1.7	5.9	6.4	1.4	2.9	1.3	0.5	14.0	1.2	3.2	0.7	6.7	34.7	7.2	1.8	2.8	2.8	0.2	1.9	0.2	0.4	149.3	1.6	1.5	7.2	4.9	0.5	20.9	2.5	1.4	7.2	7.7	1.4	0.4	1.7	7.0	3.7	1.9	242.5	0.1	1.7	14.4	0.6	1.2	2.2	0.3	53.6	122.6	0.5	0.1	0.9	0.6	5.8	0.0	0.1	54.5	19.6	0.2	29.7	0.0	37.2	189.8	8.1	39.0	0.0	0.6	0.3	0.1	0.2	0.3	8.1	0.1	0.8	5.4	43.0	19.1	36.8	0.3	28.0	0.2	0.3	0.3	0.0	0.0	0.0	0.2	8.1	1.4	0.5	0.1	0.0	3.0	122.4	14.8	0.8	0.1	1.0	1.4	0.1	6.9	0.2	0.2	247.4	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	4.0	2.6	3.2	0.7	2.8	2.8	1.6	1.4	3.7	1.2	0.3	0.0	1.1	0.7	0.3	1.8	5.6	3.3	0.0	0.6	2.8	1.9	1.8	24.3	3.5	14.7	60.5	5.5	0.1	9.3	0.0	3.3	8.4	19.1	8.3	7.9	13.8	0.0	0.2	1.4	67.9	6.0	2.6	49.0	0.0	11.5	5.3	78.2	1.8	0.0	0.3	5.3	2.0	1.9	0.0	8.1	0.3	0.8	1.8	2.8	0.7	1.1	0.0	1.0	0.2	12.8	2.7	0.0	0.3	10.6	10.1	1.3	0.5	2.9	0.0	1.0	2.0	1.4	0.9	0.4	2.6	19.4	1.1	0.1	11.2	11.4
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140081	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1533.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 85.1;T-reg: 83.2"	"Group enriched"	"Detected in all"	8	"dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660"	Supported		Supported	"Nuclear speckles"		NA	NA		5700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	280.2	174.8	17.6	64.9	27.1	58.1	231.5	24.1	20.6	221.7	33.0	183.3	72.8	271.4	14.5	256.2	173.8	92.1	221.7	15.8	23.1	120.9	93.2	188.5	18.2	30.3	25.2	178.2	81.8	21.3	76.9	53.0	26.1	125.3	38.2	4.7	176.1	42.8	190.0	364.3	136.8	78.8	21.0	84.1	160.6	61.9	30.9	15.3	147.4	23.8	22.9	168.7	217.6	41.8	518.8	269.7	26.2	72.4	119.5	238.7	169.4	607.3	379.6	221.3	146.8	68.3	311.9	2.8	338.7	417.9	94.6	515.4	31.4	227.8	70.3	188.6	50.8	175.4	168.4	130.8	124.0	25.7	412.9	133.0	92.0	154.8	134.7	120.2	207.5	0.7	82.8	21.9	205.8	193.1	1.0	67.8	32.1	202.9	706.0	1.6	195.9	137.7	128.9	105.6	33.8	114.9	414.3	154.2	427.4	56.2	230.1	74.2	727.9	241.6	233.0	389.1	393.3	39.5	10.5	4.9	449.2	24.8	760.4	23.9	8.3	0.4	2.8	2.1	2.5	2.4	17.8	7.3	85.1	0.2	0.2	0.7	2.1	3.7	0.2	0.3	83.2	14.6	17.6	27.1	24.1	20.6	15.8	23.1	30.3	25.2	26.1	21.0	30.9	41.8	353.5	262.8	350.0	16.0	179.1	610.5	1235.3	446.2	531.6	7.2	542.5	374.9	94.1	191.6	320.3	161.8	47.9	478.8	239.8	614.1	109.5	429.3	38.6	215.4	209.4	386.0	431.5	70.4	9.9	360.2	387.8	622.1	505.1	270.5	1181.8	145.5	277.7	103.1	343.0	13.5	15.1	601.2	177.0	60.6	1533.4	45.4	288.6	409.0	859.2	10.3	20.4	37.2	3.1	17.1	20.1	513.0	384.1	287.3	331.3	340.6	262.6	125.0	170.5	17.8	203.8	1028.4	766.8	107.4	42.2	404.1	602.4	680.9	472.3	111.6	513.8	942.6
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456959	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 220.2;Extravillous trophoblasts: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	9.7	10.1	8.9	15.3	8.6	17.3	7.7	11.5	9.8	11.9	6.4	13.1	10.9	11.9	2.4	32.1	10.7	3.4	10.6	8.5	10.1	9.5	6.0	11.2	12.8	8.7	9.0	13.4	8.1	3.6	12.3	14.6	8.4	9.8	6.2	3.5	9.1	4.9	14.9	10.6	12.2	5.5	8.0	12.3	10.4	10.9	10.5	23.1	8.7	5.2	10.5	10.0	12.4	8.0	181.5	114.0	80.8	105.7	17.3	27.2	107.5	119.2	57.7	117.7	88.8	152.0	75.6	83.5	47.8	55.9	68.1	185.6	72.4	84.8	60.0	102.4	86.3	66.4	40.3	119.8	20.9	93.5	64.6	24.5	21.4	63.4	49.7	22.0	60.9	76.2	117.8	51.9	56.4	105.4	107.9	51.8	154.0	97.8	98.6	150.1	102.4	70.0	33.7	89.8	118.7	68.8	99.6	65.6	39.6	44.7	65.9	95.7	85.1	112.5	116.6	174.8	180.6	45.6	41.8	83.5	91.3	88.5	148.3	0.0	0.6	0.8	1.0	0.6	1.6	0.4	1.1	1.0	0.8	0.9	1.1	1.3	0.0	0.9	2.1	3.5	0.4	0.6	8.9	8.6	11.5	9.8	8.5	10.1	8.7	9.0	8.4	8.0	10.5	8.0	8.6	3.2	4.2	2.6	9.4	20.6	14.8	7.9	10.2	8.2	8.8	8.1	5.7	2.8	5.3	5.5	8.4	30.4	9.7	17.5	9.8	7.0	220.2	7.7	14.9	12.7	6.0	19.6	3.0	11.8	81.6	14.3	14.3	11.7	4.5	31.4	8.2	2.7	21.2	13.5	3.9	15.1	6.1	6.8	18.2	31.4	9.3	10.3	1.8	3.7	12.2	9.4	11.3	2.0	3.3	12.7	9.1	7.9	25.5	24.4	12.7	4.9	5.7	10.8	13.1	14.3	11.2	8.6	15.0	30.0	20.0	13.8	11.4	12.0	23.1	19.2
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 248.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 1682.7;Urothelial cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	177	"amygdala: 12.6;basal ganglia: 19.9;cerebral cortex: 25.6;hippocampal formation: 14.9;white matter: 15.4"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 13.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 343.4;fHDF/TERT166: 568.2;LHCN-M2: 525.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 20.8;basal ganglia: 32.8;cerebral cortex: 26.6;hippocampal formation: 33.8"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA		8200	"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	4.4	5.3	12.6	10.6	19.9	4.1	9.3	0.0	25.6	12.8	4.8	47.4	66.3	5.7	12.1	153.7	14.5	43.3	248.8	14.9	0.0	44.1	61.9	178.7	11.0	0.0	0.0	18.6	25.5	11.8	6.4	41.3	0.0	27.3	32.5	4.8	32.4	15.1	143.5	21.1	79.7	7.9	0.0	5.0	62.7	18.2	0.0	56.8	53.5	99.5	37.1	24.5	38.4	15.4	77.8	43.6	1.7	1.3	86.5	61.4	14.9	343.4	168.3	85.4	91.6	107.4	97.8	6.6	25.7	568.2	21.2	73.5	18.9	16.6	97.8	105.4	4.5	47.8	229.2	102.2	25.0	15.3	24.0	42.0	31.1	37.0	42.3	207.9	36.2	14.7	1.7	0.5	525.9	30.4	11.6	6.4	2.2	119.6	65.0	7.2	159.5	1.6	36.0	18.1	5.4	11.6	62.2	10.8	13.8	8.6	14.0	11.3	55.6	208.7	38.7	25.4	84.9	22.6	18.4	27.8	61.6	17.0	97.0	4.5	0.2	2.7	0.6	0.5	0.9	1.1	3.2	1.0	0.4	2.3	13.6	8.6	0.1	0.6	0.4	1.1	1.4	2.6	12.6	19.9	0.0	25.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	15.4	1.5	1682.7	279.7	22.2	4.3	24.0	74.7	59.9	72.8	6.8	10.5	13.2	362.6	51.5	317.2	62.5	2.1	45.5	3.6	378.5	15.6	81.5	6.2	92.0	19.0	9.0	71.2	3.6	162.3	37.8	8.7	38.0	276.3	244.4	20.3	9.5	6.1	72.7	6.0	6.7	82.5	96.6	67.1	3.5	4.4	8.0	42.0	6.4	16.0	39.4	2.8	1.9	3.1	30.7	48.4	228.8	351.2	42.5	2.1	344.9	213.8	15.5	199.5	10.5	13.1	27.2	18.1	11.2	6.3	100.9	45.3	17.0	12.9	2.5	75.2	435.7
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	21.9	2.5	2.7	2.1	6.0	1.0	14.3	0.1	10.3	6.1	0.0	6.7	9.4	4.2	0.6	24.4	6.4	5.5	8.7	7.5	0.1	10.6	4.4	2.7	2.1	0.0	0.1	2.1	16.3	11.9	4.3	24.6	0.4	5.9	6.9	3.8	25.1	7.2	5.9	11.8	9.0	3.0	0.0	0.9	9.5	4.4	0.6	3.3	17.9	12.0	4.1	4.3	7.9	3.1	1.4	0.5	1.6	0.9	2.7	5.8	8.0	1.2	0.6	0.0	0.0	2.9	8.9	1.7	1.1	4.3	0.4	1.4	0.0	0.2	0.0	0.4	4.6	2.2	1.5	1.5	1.3	2.4	0.7	4.4	0.2	0.3	0.0	1.9	2.7	0.8	1.9	0.8	6.4	4.5	2.2	1.7	4.3	17.7	0.7	1.2	0.6	0.7	5.6	8.2	2.2	2.1	0.6	10.8	0.9	9.1	5.7	1.1	7.8	10.0	2.6	3.1	1.6	3.6	0.5	1.1	8.7	2.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.2	0.2	0.0	2.7	6.0	0.1	10.3	7.5	0.1	0.0	0.1	0.4	0.0	0.6	3.1	77.5	0.0	3.9	4.9	1.7	8.2	18.0	14.5	24.5	7.5	13.3	7.1	1.6	12.8	15.5	7.3	6.2	30.6	1.5	18.5	19.6	13.7	171.7	37.7	7.6	16.0	13.8	3.6	123.8	11.7	22.1	4.8	14.3	83.0	2.5	1.5	2.9	6.2	2.5	42.1	42.2	13.4	14.2	0.3	2.1	47.9	4.4	1.3	5.4	11.2	0.4	2.2	2.1	43.7	4.0	12.3	26.5	8.6	0.9	8.5	14.5	2.9	17.9	5.8	0.0	10.0	2.2	0.9	2.6	32.2	11.9	14.9	1.9	1.4	14.2	15.2
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545913-27620529	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favorable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	3.2	6.7	2.0	3.7	2.3	3.8	6.9	5.1	3.0	4.0	6.5	10.7	14.2	3.0	4.8	10.6	4.6	7.9	8.7	2.4	2.8	7.9	20.5	11.5	4.0	1.7	1.8	4.3	19.6	7.1	3.2	3.7	1.7	6.4	10.5	8.0	9.4	4.8	5.9	6.6	13.4	3.8	1.9	3.1	9.9	12.3	2.4	7.8	9.9	5.9	5.1	6.2	6.7	1.9	6.4	3.5	6.5	7.2	6.7	3.1	6.8	5.6	4.9	5.4	4.9	12.7	12.5	9.6	4.7	4.9	9.8	12.0	11.8	15.0	7.0	6.0	4.9	12.3	7.2	9.3	10.5	6.6	7.6	2.6	22.8	3.8	14.7	15.4	9.9	9.9	3.8	3.6	7.9	7.9	10.0	4.4	7.2	29.0	3.9	9.2	12.7	5.0	11.9	11.1	16.7	3.5	7.6	15.4	10.1	8.0	10.7	5.2	12.6	3.1	4.3	3.1	4.6	3.5	6.3	9.9	2.0	6.3	4.4	2.0	0.3	0.9	0.5	0.1	0.7	0.5	0.6	0.7	0.3	0.5	0.6	0.6	0.3	1.1	0.2	0.1	1.0	0.2	2.0	2.3	5.1	3.0	2.4	2.8	1.7	1.8	1.7	1.9	2.4	1.9	4.5	32.1	27.6	9.8	5.6	25.4	27.7	15.8	23.9	8.9	13.3	7.6	11.4	25.8	11.4	20.2	2.1	1.5	5.5	27.8	3.9	10.2	16.4	11.0	2.7	7.2	10.2	18.9	23.2	14.2	8.1	3.2	11.7	14.7	1.3	10.8	9.3	59.2	2.3	5.0	8.0	17.0	8.2	5.0	7.7	7.3	2.8	2.8	10.6	21.5	2.3	4.4	5.2	3.0	6.7	11.0	23.5	3.4	5.4	16.8	17.8	7.8	15.9	16.3	0.0	3.1	3.5	15.6	17.5	14.8	22.0	3.0	5.5	11.1	11.9	20.9
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 67.1;Club cells: 38.4;Early spermatids: 41.9;Endometrial stromal cells: 34.0;Extravillous trophoblasts: 44.2;Fibroblasts: 79.1;Peritubular cells: 39.1;Smooth muscle cells: 32.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 39.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 777.3;fHDF/TERT166: 1790.7;HSkMC: 356.3;U-138 MG: 475.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		550000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	27.9	2.4	0.4	6.8	0.4	0.2	17.6	0.5	0.9	10.8	0.8	4.2	3.8	6.2	1.7	5.6	8.9	18.8	23.9	0.3	0.4	4.5	2.1	13.6	3.3	1.3	1.4	5.4	3.3	0.9	1.2	8.1	0.8	4.1	4.5	1.1	3.2	2.6	1.9	12.4	3.7	10.0	1.2	2.6	4.4	1.4	0.5	0.9	6.9	2.1	1.4	14.1	4.8	1.0	0.8	0.2	2.0	0.9	168.7	185.2	0.1	777.3	205.3	73.2	246.4	0.5	0.3	0.1	16.5	1790.7	3.7	0.2	4.5	3.5	196.4	0.1	2.0	0.0	16.3	9.3	203.4	0.4	0.1	356.3	4.4	137.6	7.4	329.3	95.3	0.1	0.0	0.1	83.6	0.0	0.1	0.3	6.4	0.1	1.9	0.1	7.4	0.9	4.9	0.5	0.5	4.2	72.1	0.1	12.9	29.8	0.6	0.6	6.8	475.5	23.2	272.8	9.3	0.0	0.1	0.2	207.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.9	0.3	0.4	1.3	1.4	0.8	1.2	0.5	1.0	20.0	9.6	1.1	0.0	0.2	7.8	1.9	67.1	0.0	0.6	1.3	1.1	2.1	0.0	38.4	0.0	0.0	0.8	0.1	0.0	0.0	7.2	41.9	8.4	34.0	9.4	0.0	0.0	0.3	0.6	44.2	79.1	0.0	6.6	0.0	0.1	10.8	0.5	2.2	1.7	2.0	0.0	2.0	0.8	21.6	5.0	14.0	1.3	5.4	1.9	0.6	0.0	0.0	0.0	0.0	1.3	0.0	39.1	0.3	2.8	0.0	0.1	8.3	1.7	19.7	1.1	32.7	0.8	0.6	1.8	10.7	4.8	1.1	0.4	0.1	0.9
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.4"	"Lineage enriched"	"Detected in single"	34	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		280000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	12.4	3.1	1.4	5.4	0.8	0.8	6.8	0.2	1.4	12.7	12.3	10.2	1.9	16.0	1.4	4.7	8.3	5.0	27.9	1.7	1.9	8.7	1.5	10.1	4.4	1.4	1.7	8.0	3.3	2.2	9.2	8.0	1.1	15.3	1.4	0.0	7.6	11.9	3.8	6.4	5.6	4.9	0.8	3.2	7.8	2.4	1.9	0.9	5.2	1.9	2.3	16.6	14.8	0.6	3.3	0.0	0.9	0.0	45.6	54.8	2.2	66.5	75.2	27.6	48.7	1.3	1.7	0.0	12.1	49.1	6.9	19.9	0.3	0.2	6.5	0.0	4.3	0.2	2.0	0.3	6.2	0.0	0.1	45.0	0.0	20.8	0.2	73.7	1.0	1.2	0.0	0.3	33.3	2.4	0.4	1.3	6.3	4.4	45.1	0.0	38.7	0.6	2.5	12.0	5.5	0.0	2.0	0.4	0.0	6.5	0.4	0.0	4.9	53.8	47.0	42.8	25.8	0.2	0.0	0.0	61.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	1.3	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	3.4	0.2	1.4	0.8	0.2	1.4	1.7	1.9	1.4	1.7	1.1	0.8	1.9	0.6	4.1	0.0	0.6	3.3	0.1	5.9	7.6	6.0	4.0	0.9	2.3	4.8	92.3	2.8	0.9	9.2	0.0	2.2	0.6	0.1	3.9	5.2	1.7	9.2	8.0	4.1	3.5	0.0	0.5	1.3	145.8	76.0	8.6	9.3	1.3	5.5	12.1	0.1	6.6	0.0	0.4	0.6	2.0	0.0	6.2	1.3	9.9	0.9	10.6	0.0	0.1	6.4	0.0	1.5	0.3	12.2	0.1	21.1	0.1	4.8	0.4	2.5	1.2	0.4	0.0	6.0	32.7	8.9	4.9	2.4	3.4	5.1	3.4	0.3	1.1	5.0
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	2.0	0.0	1.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.8	6.3	0.5	76.7	0.1	0.0	1.8	1.9	0.2	0.6	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.2	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	1.1	0.8	6.3	1.8	1.9	1.3	0.2	4.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 937.4;heart muscle: 407.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 453.0;Cardiomyocytes: 489.0;Granulosa cells: 495.2;Horizontal cells: 206.9;Sertoli cells: 236.7"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cell line enriched"	"Detected in some"	5	"AF22: 391.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 79.2;spinal cord: 59.3"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		4200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	937.4	15.9	6.8	9.1	53.2	0.9	255.4	20.3	12.2	2.7	8.9	12.0	1.5	3.7	0.5	2.8	2.7	8.6	407.8	10.7	9.5	19.1	0.7	62.1	8.5	7.4	7.7	10.6	6.3	181.5	4.1	14.7	7.9	3.8	5.8	11.1	24.4	64.7	86.4	8.3	13.3	4.1	5.5	1.6	8.4	1.0	11.5	4.3	10.6	127.3	2.8	6.1	4.7	8.8	0.0	0.0	391.6	0.1	8.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.1	0.3	0.0	71.5	0.0	0.2	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.1	0.7	9.6	0.0	0.0	0.0	0.0	68.4	0.0	0.0	8.4	0.2	0.0	0.0	0.1	13.5	0.0	1.8	0.0	0.0	8.1	0.0	3.5	0.0	0.1	0.1	0.1	0.1	32.6	0.0	0.9	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	6.8	53.2	20.3	12.2	10.7	9.5	7.4	7.7	7.9	5.5	11.5	8.8	453.0	12.8	104.9	1.0	0.4	1.5	0.1	0.0	0.6	2.8	114.7	5.7	489.0	0.0	0.6	0.0	2.1	0.4	0.9	0.1	15.6	0.0	0.8	0.2	2.5	56.1	0.0	0.0	1.9	0.0	0.7	13.6	0.0	0.3	6.3	495.2	2.9	0.0	108.5	206.9	0.4	1.0	0.0	14.8	4.2	1.3	1.2	38.2	14.2	1.9	2.0	2.3	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.4	2.9	2.7	236.7	91.4	68.1	0.4	0.2	0.2	0.6	0.4	2.3	4.3	2.8	0.1
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 566.5;Late spermatids: 1737.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 97.0;EFO-21: 115.2;U-698: 200.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		2700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	29.3	10.8	6.7	28.4	8.9	9.9	18.8	9.1	9.7	27.5	27.3	73.3	13.8	61.9	11.8	49.4	32.2	21.3	16.7	6.1	11.2	11.5	12.1	19.1	17.2	15.6	7.9	14.7	8.8	9.9	2.9	11.5	12.6	39.0	31.7	2.4	12.0	53.1	12.4	12.0	23.0	81.3	6.6	10.8	32.7	18.6	13.8	8.0	8.8	9.1	21.4	57.0	22.1	7.8	25.6	23.3	16.7	11.3	35.3	36.0	17.9	16.0	20.9	11.8	7.8	42.2	12.1	97.0	115.2	37.3	14.7	10.7	5.2	11.0	29.5	10.7	5.7	4.6	18.4	11.1	15.0	2.0	5.5	25.7	15.3	26.4	22.5	16.9	20.1	5.2	0.2	2.0	21.0	8.1	5.1	2.1	6.6	16.3	7.6	6.2	12.3	0.5	13.1	26.8	1.1	0.3	35.3	11.4	19.2	27.3	9.0	8.8	43.7	27.1	20.8	19.6	41.1	0.2	4.0	200.0	13.6	4.3	24.9	0.8	4.9	2.2	5.1	4.5	3.3	3.3	4.5	3.8	2.6	5.6	2.4	2.9	18.9	4.8	4.6	5.3	1.8	1.9	6.7	8.9	9.1	9.7	6.1	11.2	15.6	7.9	12.6	6.6	13.8	7.8	104.7	89.8	69.8	357.5	48.5	78.0	84.9	65.0	70.0	9.5	141.8	111.5	143.0	100.1	86.2	69.9	14.6	44.7	65.7	207.1	29.4	139.7	566.5	49.3	134.4	91.8	77.5	12.0	132.8	90.9	24.1	124.9	97.9	93.6	18.3	136.6	126.4	94.8	42.5	5.0	191.2	91.7	44.7	65.1	121.0	1737.1	225.3	75.8	80.0	308.2	55.8	24.8	54.6	395.6	214.9	120.2	158.1	476.9	24.6	172.5	127.5	80.2	60.9	7.1	335.2	159.2	368.2	9.8	8.0	64.2	68.2	18.6	55.3	46.8	151.3	149.3
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 944.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	7.2	4.5	0.6	17.8	0.5	31.4	4.3	1.2	2.6	8.7	1.1	7.3	6.7	1.9	5.9	22.7	10.0	15.5	1.2	0.6	0.6	9.8	944.2	7.8	0.8	0.7	0.7	1.5	44.1	0.1	1.6	1.9	1.9	4.4	4.7	0.1	20.9	6.2	1.0	4.8	3.3	2.2	0.5	16.2	13.6	0.3	0.9	1.2	1.3	1.4	6.5	13.3	3.8	0.9	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.2	2.6	0.6	0.6	0.7	0.7	1.9	0.5	0.9	0.9	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131016	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2119.8;Excitatory neurons: 3755.5;Inhibitory neurons: 2917.8;Oligodendrocyte precursor cells: 5568.9;Oligodendrocytes: 1203.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.8;glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.5;HEK 293: 1.7;U-138 MG: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069094, HPA074788"	Approved		Approved	Vesicles		NA	NA		370000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA069094: AB_2686082, HPA074788: AB_2797273"	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	3.1	1.4	18.6	0.0	22.5	0.0	1.6	7.2	18.7	0.3	0.0	0.3	0.0	0.0	2.2	0.0	0.3	0.1	0.3	21.5	8.7	0.4	0.2	0.1	0.0	6.8	9.4	0.6	0.1	0.1	1.9	0.0	8.2	0.9	0.0	2.6	0.6	1.0	4.4	0.4	0.1	0.0	3.3	0.0	0.4	0.3	11.5	0.2	5.6	3.5	0.0	0.1	0.9	19.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.6	22.5	7.2	18.7	21.5	8.7	6.8	9.4	8.2	3.3	11.5	19.8	1.4	0.0	0.0	2119.8	0.0	0.3	0.5	0.0	3.4	14.9	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.1	1.7	0.2	0.0	0.0	3755.5	0.0	0.0	9.1	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.0	2917.8	0.0	0.0	0.0	0.5	5.4	1.2	0.1	0.0	142.4	0.0	2.4	0.0	5568.9	1203.1	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.8	0.0	1.1	0.4	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.8
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRP6	ADCAD2	ENSG00000070018	"LDL receptor related protein 6"	O75581	12	12116025-12267044	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 96.6;Oligodendrocyte precursor cells: 108.0;Oligodendrocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004490, HPA029925"	Enhanced					NA	NA		390000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB004490: AB_627894, HPA029925: AB_10601768"	"unprognostic (1.80e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.47e-1)"	3.7	2.2	2.0	1.2	3.9	0.2	4.5	2.5	2.0	6.6	13.5	4.6	2.8	6.5	1.9	2.0	4.4	2.8	3.3	2.0	2.8	4.4	7.9	4.6	0.8	2.2	2.7	5.4	4.9	6.2	2.6	8.3	1.7	3.4	2.8	2.8	6.8	3.2	4.5	3.4	2.7	4.1	1.8	0.9	3.4	2.1	2.8	1.2	4.5	4.6	1.0	3.4	5.3	2.9	3.9	13.3	9.9	5.3	6.1	4.0	7.8	5.8	5.4	4.6	5.3	6.5	3.6	0.0	2.8	5.6	3.8	3.7	14.6	3.7	8.7	0.0	3.9	4.1	4.9	3.2	2.1	5.7	2.8	3.2	2.0	6.9	5.4	5.1	4.8	4.1	5.0	0.0	3.0	3.2	4.2	1.1	14.4	2.2	1.7	5.3	9.2	1.0	6.8	7.6	2.0	5.6	7.4	2.5	6.0	11.5	2.0	3.7	6.9	3.6	13.2	2.6	4.9	0.0	0.0	1.9	2.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.9	2.5	2.0	2.0	2.8	2.2	2.7	1.7	1.8	2.8	2.9	21.6	41.7	49.5	96.6	1.0	15.4	8.6	11.9	9.6	28.2	20.1	19.0	15.4	11.5	16.6	14.7	22.9	3.7	0.5	20.4	1.9	9.0	1.0	18.0	39.0	25.9	10.8	0.4	58.2	13.7	3.2	24.0	25.5	29.1	0.0	32.8	22.1	46.7	2.3	6.7	58.0	12.9	10.2	2.4	6.0	5.1	30.4	1.7	14.2	35.6	0.6	19.9	1.0	108.0	97.0	11.3	20.5	38.7	1.6	14.7	15.1	5.2	6.0	29.0	0.0	21.5	17.3	21.5	26.4	11.0	13.8	3.4	1.9	23.7	14.4	8.1
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRC3	"C21orf102, C21orf30, DKFZP434C128, LRRC3DN"	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455510-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.7;U-2 OS: 6.3"	"Low region specificity"	"Detected in all"							HPA017975	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	1.9	1.4	0.8	0.7	0.5	0.6	1.5	0.2	0.7	1.4	0.3	6.6	1.7	1.3	0.4	1.1	1.5	2.2	1.9	0.6	2.0	0.7	15.5	1.6	0.5	0.6	0.9	3.4	0.7	0.3	1.3	0.9	0.6	0.8	0.8	0.3	1.0	0.6	0.4	1.8	1.6	1.5	0.2	1.1	3.8	1.7	1.2	0.5	0.6	1.0	0.3	2.0	1.3	0.6	0.5	0.4	3.5	2.9	0.0	0.0	8.7	1.5	0.0	0.1	0.0	1.3	1.2	0.0	2.6	0.7	1.9	0.1	1.7	0.0	0.0	0.2	3.8	0.0	0.4	4.0	0.6	0.0	2.3	1.1	1.4	0.0	0.0	0.0	1.4	0.6	0.3	4.5	0.0	1.3	0.5	0.2	0.9	4.5	1.4	1.9	0.0	1.5	0.1	0.1	2.8	3.2	1.3	0.3	0.6	1.9	0.8	1.9	2.8	0.0	6.3	0.0	0.0	2.5	5.2	0.0	0.0	1.6	0.5	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.7	0.6	2.0	0.6	0.9	0.6	0.2	1.2	0.6	2.6	0.0	1.5	0.0	0.8	0.6	1.1	0.0	3.4	1.1	0.6	0.9	2.0	1.5	0.0	1.8	0.0	0.2	0.3	1.6	0.0	0.3	0.3	0.2	0.4	0.6	4.2	2.7	0.0	0.4	6.6	2.5	1.5	0.9	1.3	2.4	1.1	30.7	2.5	0.0	0.1	1.8	0.0	2.5	0.5	1.5	0.6	1.1	0.0	0.0	3.2	1.4	1.0	0.0	0.1	1.7	0.3	0.7	0.2	1.3	1.8	0.0	0.0	0.0	0.0	0.8	1.4	0.9	2.0	0.6	0.6	0.3	0.8	0.3	1.7	0.7
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882133-128918039	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 192.0;Prostatic glandular cells: 207.0;Urothelial cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	31.4	17.4	68.2	16.2	69.4	17.3	27.3	69.4	77.1	30.8	44.6	31.4	9.7	36.3	7.3	71.7	23.5	23.3	32.0	57.2	67.9	18.2	28.9	42.4	9.3	76.7	77.2	18.8	21.2	32.4	13.7	23.1	67.9	29.3	8.5	13.4	28.1	25.5	13.9	35.2	17.3	29.1	63.9	16.2	25.0	11.8	82.6	9.9	25.6	18.4	10.1	32.7	44.2	52.4	35.1	54.2	32.0	27.5	73.6	28.3	40.4	39.8	26.2	24.1	17.1	24.1	73.2	12.8	43.6	43.3	30.1	163.8	19.9	87.5	11.3	13.1	16.4	11.5	33.4	29.2	49.8	13.8	20.3	22.1	60.9	42.7	50.8	48.6	84.1	17.5	25.8	12.4	31.8	30.3	15.6	13.2	95.9	58.3	58.4	21.4	37.0	20.6	37.9	17.3	19.2	39.9	44.4	27.3	15.8	23.9	19.9	10.2	149.4	69.9	30.2	29.9	58.8	14.4	36.5	15.5	38.7	10.3	41.3	0.7	0.7	1.9	3.9	1.1	1.8	1.2	1.9	2.5	1.0	0.9	1.9	1.8	1.4	3.5	0.3	1.6	3.5	1.0	68.2	69.4	69.4	77.1	57.2	67.9	76.7	77.2	67.9	63.9	82.6	52.4	98.8	16.0	15.6	57.1	7.5	105.7	192.0	91.6	113.3	13.1	38.3	29.2	31.3	17.2	73.6	7.3	6.2	13.8	17.4	31.9	0.0	28.9	6.9	22.0	50.5	57.4	16.1	13.7	11.8	21.2	17.6	27.5	24.5	47.0	6.3	35.1	55.6	16.5	6.1	25.2	14.2	28.7	24.4	5.0	17.4	4.5	23.0	9.9	26.6	12.2	5.1	41.3	36.0	8.5	9.7	78.1	23.0	44.4	13.5	207.0	10.9	8.1	33.2	10.2	65.7	38.2	35.2	3.2	8.6	91.6	145.1	20.8	15.5	9.6	14.5	328.5
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.9;retina: 41.3"	"Group enriched"	"Detected in many"	9	"Astrocytes: 3381.0;Excitatory neurons: 1001.8;Inhibitory neurons: 2137.4;Oligodendrocyte precursor cells: 2480.6;Oligodendrocytes: 933.9"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.0;SH-SY5Y: 22.5;WM-115: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol		NA	NA		150000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA054051: AB_2682358, HPA076122: AB_2686779"	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	3.1	15.7	47.8	5.6	45.4	1.0	1.7	22.6	73.9	21.8	0.0	9.9	2.0	5.0	3.1	3.9	3.1	13.5	2.3	64.2	36.3	2.6	0.8	10.6	4.9	37.5	32.2	5.5	14.4	8.9	3.8	1.0	37.8	26.1	3.8	41.3	1.2	7.3	0.2	5.1	2.6	3.8	28.5	1.9	3.8	4.6	56.4	1.2	5.0	0.2	6.7	6.5	4.8	31.9	0.2	3.2	11.0	0.3	1.1	3.4	1.1	1.0	0.5	0.4	1.1	0.2	0.7	0.8	0.2	6.0	0.3	0.2	0.2	0.1	0.5	0.5	0.1	0.3	1.0	0.3	0.2	0.8	0.5	2.8	0.0	1.3	0.1	0.2	0.1	1.3	0.4	1.2	0.0	0.3	1.3	0.8	4.1	0.1	0.9	0.2	0.2	0.2	2.8	1.1	2.4	22.5	0.0	0.2	3.5	4.5	0.3	0.8	0.0	2.0	1.5	2.7	0.6	1.3	1.2	0.3	0.4	0.3	55.9	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.0	47.8	45.4	22.6	73.9	64.2	36.3	37.5	32.2	37.8	28.5	56.4	31.9	0.5	0.0	1.1	3381.0	0.6	7.6	0.3	0.0	0.0	54.2	1.2	0.4	25.5	4.3	0.6	0.0	2.1	0.2	0.0	0.0	0.0	0.0	22.5	0.9	26.5	5.8	0.0	0.0	1001.8	3.6	0.0	25.0	2.6	1.1	0.0	20.1	4.2	0.0	0.3	220.4	2137.4	0.0	0.0	0.0	3.2	22.2	126.2	1.9	56.9	111.5	0.0	126.9	0.0	2480.6	933.9	0.4	0.0	91.7	1.0	18.3	0.0	0.2	0.0	11.3	0.0	0.1	4.0	0.9	0.5	0.6	5.1	0.0	0.4	4.9	0.0	0.6
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640791-194672463	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	14.9	12.8	13.2	15.8	13.8	28.1	15.8	13.9	15.9	12.8	14.0	15.1	17.2	15.2	19.8	15.9	14.5	12.6	14.0	13.1	14.5	16.6	21.7	12.8	18.7	14.7	16.4	14.2	15.5	16.8	11.1	17.2	15.8	14.6	18.1	14.0	13.8	13.9	23.0	19.3	14.9	14.5	14.0	15.4	13.6	14.4	14.4	17.2	15.5	18.9	21.3	18.2	14.3	15.4	55.6	36.0	21.2	35.3	32.3	17.8	43.1	31.0	30.1	42.9	37.6	47.9	25.1	43.1	93.5	29.4	75.5	39.5	68.2	35.0	52.1	56.3	32.5	46.8	38.4	27.6	22.9	51.1	42.4	17.3	31.5	44.4	41.7	16.0	47.1	29.4	39.5	46.2	36.0	76.6	46.3	30.8	57.7	73.5	65.6	56.2	35.0	49.3	23.7	46.9	40.5	27.9	39.9	38.2	40.0	39.7	90.3	32.9	36.5	32.4	37.3	46.2	66.6	50.6	71.1	97.7	26.2	64.7	52.4	3.5	10.1	13.6	15.3	13.2	17.1	16.6	12.5	13.9	17.2	14.3	14.4	12.9	1.3	21.0	8.9	9.0	15.4	10.6	13.2	13.8	13.9	15.9	13.1	14.5	14.7	16.4	15.8	14.0	14.4	15.4	25.0	19.2	29.6	10.4	22.5	16.2	13.4	8.9	25.0	18.3	12.1	11.9	17.2	18.6	27.9	9.2	12.5	25.1	21.2	14.0	5.9	23.3	12.0	22.1	24.5	23.7	7.8	16.2	10.5	22.4	19.4	17.7	21.9	24.0	53.7	21.9	11.7	14.0	13.0	15.2	8.3	14.2	12.2	4.4	10.2	8.9	15.5	15.5	12.4	8.4	14.0	18.2	12.3	12.5	12.2	19.7	8.0	14.7	23.8	11.5	10.8	9.7	34.3	18.6	19.7	22.1	14.6	26.4	35.7	30.5	16.1	28.5	24.0	23.2	17.6	9.0
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178817-14201122	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		30000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	12.6	10.8	12.1	11.0	12.6	18.9	12.6	13.2	16.6	8.7	12.1	12.1	12.4	9.1	10.4	12.1	8.2	6.5	17.4	12.6	12.7	23.3	18.4	8.2	12.9	12.3	12.0	9.4	9.5	11.0	9.0	10.3	12.5	9.8	11.2	10.7	9.2	8.3	30.1	10.1	12.9	8.1	12.4	9.7	10.5	12.3	12.6	16.8	10.7	22.4	11.8	10.3	8.7	13.2	36.0	28.6	30.1	31.3	13.8	16.0	76.3	29.0	19.3	36.6	34.8	32.6	27.6	39.5	23.5	20.3	25.7	16.4	34.5	28.4	36.0	37.5	42.3	41.8	38.1	31.5	7.1	47.3	29.0	12.0	20.2	36.8	15.6	16.4	19.1	34.0	45.9	30.7	27.4	41.5	50.4	64.2	52.1	40.2	38.5	27.4	37.3	43.5	34.6	36.7	16.8	27.2	33.2	46.1	28.6	34.3	53.2	59.7	17.3	23.3	37.2	28.3	50.6	21.4	67.3	73.6	29.5	45.9	33.8	44.1	18.9	30.0	14.8	23.7	17.7	27.3	17.1	17.5	18.3	21.7	18.4	19.7	17.8	21.9	20.3	28.7	22.9	25.7	12.1	12.6	13.2	16.6	12.6	12.7	12.3	12.0	12.5	12.4	12.6	13.2	114.2	67.3	94.3	11.4	118.2	97.8	135.4	328.8	115.5	52.5	124.2	171.4	263.4	155.8	164.6	126.9	18.8	391.8	114.2	158.2	485.2	220.4	337.8	111.2	97.8	104.5	104.7	111.9	8.3	265.5	409.6	120.0	67.8	115.2	138.2	142.4	128.8	234.8	235.5	55.5	8.3	195.4	175.0	132.9	115.0	153.1	140.1	119.6	97.8	5.6	202.4	180.7	170.0	7.1	13.3	219.2	196.7	139.9	154.2	110.2	203.9	752.2	122.3	68.2	105.2	111.5	117.9	288.5	295.5	150.8	101.2	318.4	93.6	144.6	205.7	177.2
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184144-118204035	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	26.8	19.1	6.2	22.3	8.3	44.8	25.6	16.5	7.7	20.5	6.2	22.0	15.5	19.9	16.5	24.4	18.7	9.2	19.2	6.3	7.5	23.7	18.5	21.2	28.9	7.5	7.4	19.8	24.9	8.4	16.3	10.1	7.7	20.8	14.2	16.7	22.7	7.8	21.7	21.6	26.0	8.3	6.8	30.9	21.3	17.3	7.2	18.2	22.1	7.8	27.5	20.0	20.6	10.5	37.2	21.2	53.7	43.6	11.3	19.4	25.3	36.1	26.4	19.2	21.5	16.8	35.6	70.0	78.9	13.4	51.5	28.2	23.1	16.3	18.6	35.9	27.7	49.5	63.3	48.6	29.2	63.9	59.1	20.8	19.6	24.6	25.8	17.7	19.6	55.8	45.8	71.2	26.1	13.2	142.9	155.6	43.6	28.9	26.0	40.8	32.0	53.3	20.3	27.8	28.2	41.6	29.2	83.0	89.1	36.9	17.3	72.7	17.4	36.9	27.7	56.3	51.2	69.9	52.0	101.1	29.1	66.9	61.5	65.3	46.5	45.5	61.8	66.7	59.8	68.0	67.8	75.6	51.5	58.0	64.6	67.5	15.4	43.9	65.7	93.2	74.2	39.5	6.2	8.3	16.5	7.7	6.3	7.5	7.5	7.4	7.7	6.8	7.2	10.5	108.5	25.6	58.6	15.0	130.3	0.0	93.6	0.0	82.6	41.5	71.8	92.1	43.5	74.4	35.3	62.5	47.9	133.2	141.2	76.8	90.1	101.2	54.6	76.1	92.8	79.6	86.4	83.1	19.5	172.0	193.6	69.0	66.3	76.4	101.4	87.1	88.5	75.3	139.8	42.1	22.4	99.1	0.0	148.9	0.0	19.1	97.3	102.2	0.0	36.5	184.9	52.6	158.6	23.6	39.1	144.8	109.0	76.0	95.6	108.6	83.6	106.8	36.5	42.0	85.5	65.3	66.2	135.3	117.8	106.7	0.0	120.8	121.1	76.1	100.7	121.2
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1087.8;dendritic cells: 183.5;Ductal cells: 280.4;Pancreatic endocrine cells: 296.2;T-cells: 554.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.6;Daudi: 127.4;HDLM-2: 82.2;HMC-1: 38.1;NB-4: 62.3;REH: 58.6;U-698: 90.8"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	3.5	0.7	0.2	82.6	0.3	19.1	1.3	0.1	0.5	1.3	0.2	6.7	8.2	1.2	0.0	4.3	1.2	4.8	1.1	0.1	0.2	10.3	4.8	8.7	103.9	0.4	0.2	0.4	2.5	0.2	0.7	0.9	0.3	2.4	2.7	0.0	4.2	0.3	1.0	2.2	66.7	1.9	0.2	229.2	13.9	0.2	0.3	83.3	3.8	1.4	47.6	8.7	1.4	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	35.6	127.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	82.2	0.0	1.4	0.0	0.0	0.0	0.4	38.1	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	18.5	62.3	0.0	0.0	0.0	58.6	0.0	11.4	32.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.8	90.8	0.0	0.0	0.0	79.2	9.2	542.5	95.7	55.9	646.7	1027.3	924.3	419.4	14.5	1021.9	713.6	317.0	327.8	142.5	94.5	412.0	672.0	308.9	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.2	0.3	0.2	0.3	0.2	3.0	0.0	9.0	1.3	1087.8	16.3	0.5	45.7	2.2	0.7	2.9	3.7	0.5	2.8	4.7	90.1	0.0	0.9	183.5	0.9	1.9	280.4	3.5	2.2	2.0	8.4	0.0	11.2	0.9	113.1	0.3	6.3	3.1	1.5	14.0	0.1	10.8	3.5	10.1	0.0	0.9	0.4	160.7	31.0	112.1	0.2	0.6	49.8	42.7	0.0	72.3	1.8	99.9	0.0	0.3	296.2	1.6	0.0	13.6	3.0	0.0	11.6	0.9	0.2	6.6	1.3	4.3	0.4	1.2	1.2	12.4	0.3	554.0	0.3	3.6	0.3
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946953-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 161.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Fibroblasts: 116.1;Leydig cells: 90.4;Peritubular cells: 161.0;Skeletal myocytes: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 569.4;HSkMC: 185.3;HUVEC TERT2: 194.5;U-2197: 181.1;U-87 MG: 255.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025428	Approved				"Secreted to extracellular matrix"	NA	NA		96000000	"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025428: "	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	22.9	13.1	7.8	22.1	9.4	11.5	14.5	7.1	7.5	161.4	10.5	27.2	10.2	58.9	37.8	21.2	37.0	73.0	89.0	8.8	9.1	38.6	18.6	27.5	6.9	12.1	10.6	30.2	7.9	2.4	9.0	73.2	9.2	46.9	16.5	0.7	14.6	73.6	15.7	10.8	15.0	96.7	9.1	8.3	32.8	17.9	8.8	8.2	6.5	28.4	18.7	53.9	28.3	13.4	0.3	12.5	31.3	0.3	26.1	569.4	13.5	46.5	95.7	6.4	9.3	25.3	4.6	41.3	1.0	6.0	8.8	2.4	0.7	1.5	22.0	0.6	15.3	135.6	15.0	4.1	118.6	0.5	15.7	185.3	4.4	141.2	6.9	61.8	194.5	6.3	8.7	0.3	51.1	19.9	5.5	0.2	22.4	1.0	39.2	4.7	65.8	0.6	0.4	22.4	6.3	3.4	9.5	72.1	0.8	49.1	27.9	0.4	126.4	6.4	26.2	181.1	37.6	74.8	80.0	58.8	255.9	5.2	10.8	3.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	5.3	7.8	9.4	7.1	7.5	8.8	9.1	12.1	10.6	9.2	9.1	8.8	13.4	33.6	0.0	0.6	108.4	0.4	13.5	5.6	13.0	10.2	0.0	6.9	6.6	80.9	4.3	3.6	1.8	0.0	45.2	0.3	12.9	0.0	9.6	6.3	7.3	18.3	28.1	1.2	30.3	30.4	6.5	23.4	116.1	10.2	10.5	0.0	11.8	20.3	11.0	7.6	0.0	54.3	2.8	2.0	0.3	18.1	7.1	90.4	12.0	19.6	39.4	0.4	0.2	0.0	70.4	52.4	19.1	3.3	161.0	1.3	19.1	0.7	0.3	6.3	0.3	59.2	85.8	67.9	0.7	11.9	6.9	9.8	43.5	2.0	2.6	4.1	33.4
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498183-74612378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease variant, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.3;olfactory bulb: 2.4"	"Region enhanced"	"Detected in many"		"olfactory bulb: 15.4"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		14000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	34.2	4.0	1.1	15.2	2.9	0.6	24.4	4.1	5.6	66.2	9.5	6.6	3.1	22.5	23.9	10.7	11.7	33.1	45.4	1.2	1.1	4.1	2.1	64.9	8.3	2.2	1.1	39.4	8.7	9.6	7.3	28.0	1.4	15.7	2.6	2.3	26.7	19.6	13.6	12.6	6.9	16.0	2.2	3.9	8.5	5.4	1.9	3.1	53.0	21.4	6.1	14.2	21.6	1.0	2.5	4.9	1.2	0.2	36.9	67.7	0.2	47.4	16.2	9.2	5.7	0.0	17.4	0.4	13.8	240.8	4.1	4.8	0.2	17.7	3.8	0.2	0.8	0.8	2.2	2.1	8.8	0.1	0.6	70.2	7.7	50.7	29.1	68.9	129.1	0.1	0.2	0.1	129.4	1.1	0.1	0.3	0.3	0.2	4.5	0.5	1.1	0.1	11.3	6.7	1.0	3.3	33.1	0.1	1.1	3.4	1.1	0.2	564.5	3.3	54.0	17.0	18.0	0.7	0.7	0.1	13.1	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	2.9	4.1	5.6	1.2	1.1	2.2	1.1	1.4	2.2	1.9	1.0	3.8	0.0	2.2	2.3	0.1	5.6	15.1	13.0	13.1	2.1	1.9	60.6	6.4	0.0	6.1	0.0	0.0	0.5	1.2	0.1	5.9	1.4	1.2	0.5	7.9	6.5	0.0	5.7	1.1	0.4	0.3	59.5	1.5	0.9	1.3	1.9	9.3	0.4	4.2	3.3	0.7	0.0	20.3	0.3	5.8	5.8	16.4	3.7	0.0	22.5	0.1	0.4	0.0	1.0	0.3	4.4	0.0	82.4	0.3	10.7	0.0	0.0	0.3	1.0	6.6	3.2	10.8	2.8	3.8	5.2	1.0	1.2	0.9	2.2	0.1	2.1
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LTBR	"D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3"	ENSG00000111321	"Lymphotoxin beta receptor"	P36941	12	6375045-6391571	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1"	"Group enriched"	"Detected in many"	36	"dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 393.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026202, HPA061617"	Uncertain		Supported	"Golgi apparatus"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus"		"CAB026202: , HPA061617: AB_2732666"	"unprognostic (2.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.24e-3)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (3.66e-2)"	"unprognostic (9.84e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.86e-1)"	67.6	64.4	13.9	36.4	14.6	11.7	60.3	14.7	15.9	65.8	18.0	72.7	48.6	68.1	20.7	81.3	49.6	48.3	37.2	13.3	15.8	55.1	135.8	66.0	14.6	19.6	17.3	46.3	78.7	54.9	26.3	48.6	18.8	61.9	34.3	1.9	61.5	44.0	26.3	75.1	51.1	62.6	17.4	44.8	67.7	13.3	18.1	11.7	57.2	23.5	18.0	65.8	65.1	17.0	98.2	130.3	0.0	41.1	245.9	183.7	89.9	67.9	153.1	98.8	101.1	62.0	148.7	0.1	39.5	145.7	0.5	112.2	0.5	140.5	38.9	0.0	0.2	58.1	53.2	36.6	393.1	4.1	94.6	270.8	255.2	70.7	197.1	102.6	91.2	0.0	55.5	0.5	115.0	93.5	0.4	29.3	1.2	155.7	74.4	0.0	6.6	0.2	149.2	112.2	0.7	0.5	63.6	122.9	143.6	5.0	20.5	105.3	58.0	34.6	39.6	129.0	72.1	0.0	0.4	0.1	14.6	35.9	129.5	5.4	71.3	0.5	0.2	66.3	0.0	0.1	0.1	0.1	49.8	0.1	0.3	0.2	45.0	1.5	50.1	11.8	0.1	27.2	13.9	14.6	14.7	15.9	13.3	15.8	19.6	17.3	18.8	17.4	18.1	17.0	47.0	60.9	68.9	2.9	3.6	39.0	87.2	46.4	72.3	4.1	33.9	35.9	15.5	45.8	60.7	31.3	0.0	31.3	12.4	78.3	9.8	52.2	0.7	23.8	48.6	49.3	52.0	15.8	0.5	99.8	43.6	50.5	89.7	45.2	29.7	30.1	50.7	66.5	48.7	0.0	0.5	57.1	34.6	77.3	34.6	5.1	52.8	50.8	23.2	14.0	43.1	9.6	11.3	5.5	1.1	69.5	82.3	39.9	3.3	110.7	136.9	30.1	42.8	1.6	26.3	33.1	42.0	1.6	0.9	78.9	61.7	37.5	4.9	28.0	63.4	97.6
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 4255.5;salivary gland: 1162.5"	"Cell type enriched"	"Detected in many"	5	"Breast glandular cells: 1519.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"neutrophil: 5.4;non-classical monocyte: 17.0"	"Group enriched"	"Detected in many"	23	"granulocytes: 5.4;monocytes: 17.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 43.2;TIME: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted to blood"	NA	NA		350000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	6.9	1.2	2.5	36.1	3.4	4255.5	333.3	4.6	4.2	658.3	2.2	2.8	1.2	4.1	157.5	23.0	4.3	7.5	5.7	3.7	6.2	105.3	3.3	29.4	8.6	4.8	21.5	0.5	18.6	6.2	7.0	3.1	12.6	154.2	2.2	0.9	1162.5	378.9	1.7	11.8	5.1	1.9	7.1	70.5	331.6	0.4	14.5	29.8	10.1	1.6	345.7	2.4	1.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	43.2	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.3	1.2	0.1	0.6	0.0	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	17.0	0.4	0.0	29.5	2.5	3.4	4.6	4.2	3.7	6.2	4.8	21.5	12.6	7.1	14.5	9.9	15.5	0.0	2.8	0.7	4.3	1.1	8.6	82.8	0.0	0.0	1519.6	198.4	1.0	2.8	298.0	71.7	0.0	0.0	6.2	0.1	0.0	1.4	1.2	0.3	0.2	8.8	0.0	3.0	0.1	0.9	0.2	2.5	56.1	2.3	1.3	0.1	5.0	0.0	0.0	0.0	0.0	0.2	14.2	0.0	0.7	1.5	5.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	78.6	0.0	18.6	14.9	0.0	0.0	0.3	9.9	0.2	0.1	15.4	0.1	0.1	4.0	0.1	0.1	101.7
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA		28000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	38.6	32.2	43.0	29.9	43.4	79.4	46.5	45.0	63.4	51.9	37.0	40.4	26.0	40.4	39.7	44.4	46.7	33.0	40.8	41.2	49.4	42.5	49.0	34.2	49.5	42.2	41.8	50.8	46.0	40.3	26.1	36.6	42.4	46.4	35.2	43.6	38.1	37.1	62.3	49.3	37.3	35.5	38.6	40.0	40.6	35.8	43.4	62.7	60.8	41.4	53.6	41.9	45.2	52.9	65.7	37.4	79.3	73.6	53.0	43.6	58.0	74.4	71.6	71.5	74.6	41.4	61.2	108.5	43.4	60.7	44.6	46.3	96.5	75.7	100.7	51.1	94.7	92.5	56.1	41.9	44.8	150.2	75.4	38.6	93.6	67.3	81.9	49.5	58.5	56.1	119.5	57.1	78.6	62.5	180.4	140.9	65.2	87.6	53.1	107.7	77.7	98.7	81.9	72.7	68.2	65.2	82.0	82.5	75.5	59.3	55.8	59.1	56.0	54.7	31.8	61.1	68.3	86.5	88.0	230.1	60.5	143.8	74.3	10.7	9.4	17.9	17.7	14.3	19.8	16.0	17.3	18.6	12.8	14.9	21.3	18.3	8.7	16.3	17.1	13.2	19.0	12.3	43.0	43.4	45.0	63.4	41.2	49.4	42.2	41.8	42.4	38.6	43.4	52.9	53.5	54.5	56.8	0.0	63.0	0.0	74.8	0.0	72.8	54.0	54.4	45.1	0.0	35.8	39.6	38.6	52.1	77.0	48.5	16.5	54.8	45.1	18.7	31.4	43.1	46.8	21.9	102.9	0.0	38.5	74.3	48.2	57.1	32.8	60.5	37.7	42.1	58.5	43.9	43.7	0.0	29.0	0.0	42.5	0.0	8.5	53.1	41.9	0.0	0.0	46.4	46.7	43.3	0.0	0.1	34.9	18.7	67.7	68.6	62.0	34.6	40.8	37.2	49.2	59.2	54.9	45.6	74.1	68.7	51.5	0.1	82.4	63.7	43.0	28.0	56.2
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719565-50756219	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		15000	"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	86.8	108.2	128.2	91.1	134.2	75.9	96.4	165.6	193.2	172.2	131.4	163.3	99.4	144.8	88.1	98.3	157.5	63.8	102.8	126.1	138.7	112.7	90.8	119.0	132.4	131.3	128.4	223.5	111.6	63.6	172.0	78.5	132.5	141.3	75.1	175.8	94.8	73.4	151.9	105.3	131.2	65.8	124.6	133.6	113.7	73.7	133.5	84.1	144.0	43.2	88.4	130.1	136.5	148.4	176.7	114.3	222.8	143.1	91.5	87.9	105.5	162.8	63.0	77.0	92.1	214.5	132.4	212.5	171.1	65.2	87.5	148.8	149.4	67.5	132.2	226.6	242.5	251.5	445.3	174.9	50.5	223.4	136.0	84.2	94.5	84.2	48.7	193.7	79.9	164.9	202.9	188.0	99.1	99.1	221.4	218.0	146.2	125.3	83.4	238.2	208.4	224.0	105.5	109.8	158.1	163.2	96.8	121.5	179.3	192.6	196.3	164.9	113.7	170.9	146.3	72.8	171.5	167.8	191.7	265.1	108.1	152.5	123.9	49.1	32.3	32.6	32.0	24.0	28.2	67.3	35.7	27.6	21.2	55.4	37.1	30.5	47.8	23.3	19.8	64.7	29.6	12.1	128.2	134.2	165.6	193.2	126.1	138.7	131.3	128.4	132.5	124.6	133.5	148.4	129.7	150.6	194.2	231.8	177.8	216.2	200.9	99.4	200.3	512.3	121.1	129.5	111.5	70.1	148.3	93.8	229.4	104.8	237.1	130.8	74.3	102.6	18.9	111.1	171.8	151.9	207.8	191.2	121.5	85.3	108.5	149.8	99.4	144.8	148.0	364.8	94.2	83.1	76.4	380.2	145.9	151.8	81.4	87.4	122.5	48.4	394.5	105.1	96.0	107.7	184.2	207.8	197.8	181.5	239.1	86.5	158.0	355.0	134.5	151.2	157.8	56.2	130.1	402.2	236.7	204.5	172.3	122.2	159.3	135.7	177.0	99.9	162.8	253.1	141.7	191.7
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784882-142786539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2074.3;skin 1: 850.4;vagina: 491.2"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 1171.6;Squamous epithelial cells: 1913.0;Suprabasal keratinocytes: 3866.1"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"A-431: 162.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					NA	NA		210000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	1.7	47.6	0.6	0.2	0.6	0.0	20.4	0.5	1.4	297.4	0.5	0.9	0.0	0.3	0.0	2074.3	1.0	1.4	0.8	0.6	0.5	0.3	0.8	0.5	0.0	0.5	0.5	0.5	1.0	0.0	1.0	2.5	0.5	15.3	0.2	0.0	235.4	0.3	2.6	850.4	0.5	0.0	0.5	0.5	12.4	0.4	0.5	4.6	0.4	0.0	75.6	65.2	491.2	0.7	162.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	6.0	0.0	1.3	0.0	0.2	0.0	0.0	4.0	11.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	1.2	4.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.4	0.6	0.5	0.5	0.5	0.5	0.5	0.5	0.7	0.1	3.2	0.0	0.0	0.0	1171.6	9.4	244.9	138.3	0.0	14.8	14.1	0.2	0.0	154.0	1.8	0.0	0.9	0.1	0.4	1.9	1.1	0.0	0.4	0.1	10.7	0.0	0.0	0.3	0.2	5.7	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	22.4	0.0	137.3	0.0	0.0	0.8	163.7	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	2.5	18.9	0.0	1.2	12.2	0.0	0.0	0.6	16.1	0.0	0.0	1913.0	3866.1	8.2	4.0	0.0	0.4	164.6
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.7;choroid plexus: 35.0;pituitary gland: 55.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.0;Endothelial cells: 18.7;Enteroendocrine cells: 54.9;Excitatory neurons: 24.8;Inhibitory neurons: 47.8;Ionocytes: 22.4;Oligodendrocyte precursor cells: 22.6;Spermatogonia: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 2.9;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077218	Enhanced				"Intracellular and membrane"	NA	NA		12000		"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	2.2	0.4	78.5	0.2	90.6	0.0	0.8	35.7	114.7	1.5	35.0	24.0	2.5	1.6	0.0	1.3	2.0	0.0	0.3	97.9	111.5	0.6	0.1	1.4	0.1	43.4	56.3	1.0	1.0	0.0	55.5	0.0	48.7	0.9	0.0	0.5	0.1	0.0	0.2	0.4	6.6	0.4	46.2	0.2	11.8	5.8	92.6	0.0	0.9	0.0	0.0	0.6	0.4	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.5	90.6	35.7	114.7	97.9	111.5	43.4	56.3	48.7	46.2	92.6	54.3	20.0	0.0	0.0	9.1	0.0	0.6	0.2	0.3	0.0	5.8	0.6	0.0	6.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	18.7	54.9	0.0	24.8	0.0	0.1	3.7	12.2	0.0	0.0	2.7	0.0	0.0	0.1	0.0	47.8	0.9	22.4	0.0	0.0	2.2	0.0	0.1	0.0	13.1	0.0	2.3	0.0	22.6	5.9	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.2	3.5	0.0	0.1	0.4	1.9	22.4	0.3	0.0	0.0	0.0	2.5	0.2	0.5
LYPLA1	"APT-1, LPL1"	ENSG00000120992	"Lysophospholipase 1"	O75608	8	54046367-54102017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 787.7;Late spermatids: 796.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		330000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	25.8	30.3	8.8	31.8	7.6	43.6	45.0	10.5	12.7	23.3	14.7	42.6	44.4	19.7	16.1	55.0	22.9	25.9	40.9	7.9	10.8	63.4	83.5	25.9	49.0	9.9	9.5	11.7	23.8	40.8	8.8	50.4	9.1	35.0	42.1	45.9	35.5	15.0	54.5	41.4	42.8	24.3	9.7	30.2	35.4	65.1	10.3	28.8	28.4	70.7	52.0	63.1	27.5	10.0	124.0	69.3	85.9	78.7	31.0	49.4	109.8	71.7	41.6	65.0	61.1	53.2	116.7	214.8	83.6	47.2	70.5	80.7	122.8	119.9	89.8	78.9	70.0	148.8	37.9	80.0	50.8	91.4	196.1	44.6	103.8	50.8	114.0	55.6	171.6	91.6	154.5	63.4	91.3	32.7	141.1	69.9	129.3	206.3	31.5	85.3	45.2	99.3	100.2	163.6	45.2	77.6	50.1	93.6	113.4	81.0	137.0	81.7	83.4	39.0	56.9	68.7	67.8	89.3	143.8	194.0	52.9	97.1	78.7	93.7	80.7	111.1	44.8	79.6	44.6	73.0	42.2	43.5	92.3	64.4	42.1	41.1	49.3	69.6	108.2	59.7	75.5	98.3	8.8	7.6	10.5	12.7	7.9	10.8	9.9	9.5	9.1	9.7	10.3	10.0	60.4	28.9	53.3	19.9	83.8	61.7	94.8	96.6	82.6	34.9	103.8	64.0	70.8	57.2	71.8	62.5	52.1	199.7	74.5	70.4	303.3	82.8	787.7	86.6	34.7	69.3	57.5	50.0	30.0	89.0	318.3	36.4	74.9	96.3	49.5	31.5	81.4	120.1	121.0	18.5	43.7	77.3	99.7	108.4	83.3	796.2	28.3	82.6	74.7	25.3	102.1	36.9	69.0	20.6	9.8	127.4	63.7	23.0	104.5	171.0	91.6	194.3	62.9	70.3	46.0	24.5	43.1	92.1	239.1	118.2	81.1	334.2	57.0	94.0	90.2	229.7
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 126.4;placenta: 149.3"	"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 81.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.8"	"CAB025860, HPA042953"	Supported					NA	NA		3300000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	126.4	68.9	2.7	19.3	3.5	0.9	37.3	2.0	5.1	17.6	8.9	19.9	13.3	8.1	5.7	26.2	23.0	20.2	13.5	2.9	2.4	8.1	44.2	23.8	8.4	3.0	2.2	11.8	4.9	2.3	2.7	149.3	3.1	4.0	20.0	0.3	5.4	11.2	5.0	7.1	17.6	67.1	2.1	61.6	10.5	4.3	3.3	1.7	13.5	27.4	3.0	35.1	6.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	81.6	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	3.5	2.0	5.1	2.9	2.4	3.0	2.2	3.1	2.1	3.3	3.2	5.7	0.0	2.8	8.1	2.1	3.7	0.1	0.0	0.0	0.0	0.5	0.3	4.6	8.6	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.0	0.0	0.2	102.7	0.0	5.3	0.8	0.0	5.7	3.4	0.0	0.0	1.3	0.0	238.8	4.5	807.4	0.0	0.4	0.0	0.0	338.1	10.7	2.3	3.7	86.0	7.2	12.2	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.4	2.7	0.2	0.0	0.0	1.5	0.0	13.1	3.4	6.8	0.0	0.0	1.4	3.3	11.1	1.4	0.7	0.0	0.2
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.8;parathyroid gland: 54.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	3.7	1.7	13.1	1.5	11.6	0.1	3.0	0.0	14.8	2.0	0.0	1.3	0.5	2.9	0.9	5.3	1.6	3.5	5.0	14.5	0.6	4.7	0.7	7.0	1.1	0.0	0.1	1.2	1.5	54.2	2.2	6.5	0.3	2.8	0.4	3.5	1.4	1.1	1.9	4.6	0.9	2.5	0.0	0.5	1.4	7.5	2.3	1.9	2.7	2.0	0.5	2.3	1.7	9.2	0.1	0.0	9.7	8.3	0.0	0.0	1.2	5.0	0.1	4.3	3.7	0.3	0.1	11.1	3.5	3.1	1.6	0.2	0.5	0.2	2.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	1.7	0.9	0.1	1.8	0.0	0.6	0.0	11.7	0.0	0.1	14.4	0.0	19.7	0.1	12.2	0.0	0.0	0.0	15.6	0.0	2.7	0.4	14.8	12.9	0.0	0.0	75.0	8.2	0.1	0.4	0.0	5.1	3.5	0.1	1.5	0.1	0.1	23.2	0.1	1.1	50.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	11.6	0.0	14.8	14.5	0.6	0.0	0.1	0.3	0.0	2.3	9.2	3.9	0.0	0.0	1.6	0.0	1.3	0.8	1.0	17.6	1.8	0.3	11.3	4.6	0.0	0.1	0.0	4.2	7.1	0.4	0.0	1.9	0.0	0.5	0.6	1.3	3.2	0.0	0.0	26.2	0.0	2.3	2.4	0.0	0.5	0.0	3.5	0.0	0.0	0.9	20.2	2.9	0.0	2.0	0.0	0.0	0.8	1.2	0.2	19.6	1.9	0.0	0.9	0.0	6.0	0.8	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	18.5	65.7	1.1	15.4	0.2	1.1	7.3	0.1	0.8	1.4	2.5	0.0	0.0
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055623-120066858	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.9;lymphoid tissue: 5.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.8;Extravillous trophoblasts: 119.2;Spermatocytes: 127.8;Spermatogonia: 76.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (5.15e-5)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	0.3	0.4	0.5	2.1	0.6	5.9	1.2	0.8	0.7	0.5	0.2	2.2	1.8	0.7	0.3	1.6	1.4	0.4	0.5	0.5	0.5	0.4	0.5	0.4	4.0	0.4	0.4	0.5	0.2	0.4	0.1	1.4	0.5	0.6	2.6	1.0	0.3	0.5	0.2	1.0	1.9	0.8	0.4	0.8	0.9	2.3	0.4	5.7	0.4	0.2	3.6	0.7	0.5	0.6	27.2	11.6	26.9	17.5	2.8	3.4	11.5	21.0	11.8	21.5	16.5	15.7	16.3	39.6	6.8	7.6	9.5	7.1	27.1	16.1	30.0	18.8	18.8	22.0	10.5	14.9	0.8	36.3	12.0	1.9	2.3	14.6	9.1	5.4	12.6	16.4	26.7	22.0	11.4	12.0	35.0	15.6	18.3	14.1	13.0	17.8	35.9	16.2	8.7	10.3	28.4	20.1	10.5	12.8	6.5	12.9	8.4	13.0	7.8	14.2	16.1	14.6	27.0	20.1	23.2	25.7	13.3	18.4	19.1	0.9	0.1	0.1	0.4	0.1	0.6	0.5	1.2	1.0	0.1	0.4	1.1	1.1	0.3	0.9	0.2	0.7	1.3	0.5	0.5	0.6	0.8	0.7	0.5	0.5	0.4	0.4	0.5	0.4	0.4	0.6	2.4	0.0	1.3	1.0	11.5	17.3	7.3	23.5	4.0	9.7	7.2	8.3	3.4	1.5	6.0	7.3	2.1	52.0	7.6	7.5	0.0	3.4	2.4	31.3	6.0	5.4	1.8	81.8	1.3	1.5	119.2	13.7	8.6	7.8	15.2	34.6	3.9	2.9	27.9	20.2	1.2	13.7	36.7	7.3	13.4	4.8	4.7	6.1	8.8	0.0	3.1	12.3	5.2	0.5	1.0	1.6	3.7	1.5	33.1	5.0	3.7	7.2	12.9	3.8	13.1	7.3	14.9	127.8	76.2	26.0	8.9	10.8	20.1	11.9	29.2	8.7
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313807	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 731.4"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 267.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enriched"	"Detected in some"	22	"WM-115: 36.6"	"Region enhanced"	"Detected in all"		"white matter: 2742.2"	"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	0.3	1.3	121.5	0.0	366.4	0.0	0.3	314.0	237.4	0.3	4.2	0.1	0.0	0.2	0.0	0.0	4.2	0.0	0.5	157.7	195.2	0.3	0.2	0.3	0.1	459.9	317.3	22.4	0.1	0.0	0.5	0.3	417.5	0.3	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.0	247.8	1.1	0.1	0.6	303.0	0.0	1.0	0.0	0.0	0.2	0.5	731.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	121.5	366.4	314.0	237.4	157.7	195.2	459.9	317.3	417.5	247.8	303.0	731.4	1.2	0.0	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	4.4	4.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	1.9	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.5	0.5	5.4	2.7	0.0	0.0	4.5	21.0	12.8	0.0	1.0	0.0	0.6	0.0	0.0	0.6	0.0	0.1	1.8	1.2	0.0	1.0	0.1	0.0	0.0	0.5	267.8	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	4.3	0.0	0.0	0.3	0.4	11.0	0.0	0.0
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.3"	"Group enriched"	"Detected in some"	9	"Sertoli cells: 6.6;Spermatocytes: 17.1;Spermatogonia: 13.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 54.3;Karpas-707: 51.6;U-2 OS: 33.8;U-2197: 65.4;U-266/70: 46.5;U-266/84: 44.4"									"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.6	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.3	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.1	33.8	65.4	0.1	46.5	44.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	17.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	81.6	125.1	102.3	52.8	97.8	31.8	162.6	104.9	112.2	174.5	111.7	106.8	54.3	134.3	101.9	67.4	149.0	94.3	142.2	95.5	121.9	141.0	57.5	85.9	48.0	125.4	118.4	255.9	75.5	148.0	195.3	177.1	128.8	208.8	53.5	74.4	103.3	169.9	88.9	60.5	62.5	140.6	108.5	60.8	77.6	63.1	110.1	68.8	149.2	91.4	46.2	111.7	95.7	108.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	102.3	97.8	104.9	112.2	95.5	121.9	125.4	118.4	128.8	108.5	110.1	108.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	11.3	5.0	3.7	1.3	4.8	0.0	12.5	6.3	5.9	5.5	3.9	9.7	5.0	6.2	2.0	8.0	5.8	5.3	9.0	4.7	5.3	10.2	13.4	8.8	1.1	3.7	3.8	2.7	12.6	5.9	7.7	5.3	2.6	7.1	4.2	7.0	11.6	4.9	3.8	12.5	6.4	3.1	2.7	11.9	14.7	10.3	4.1	2.0	13.4	4.1	1.8	5.4	7.2	4.9	4.1	2.2	12.3	1.3	2.4	1.7	5.5	7.0	5.9	2.6	4.0	15.1	3.5	0.0	1.0	8.3	2.1	1.2	3.4	2.4	4.1	0.0	1.9	36.1	4.3	10.2	1.5	0.0	1.1	2.7	2.0	8.9	1.8	6.8	6.0	4.7	15.6	0.0	2.8	3.1	0.0	0.0	16.6	12.2	2.1	0.0	3.5	0.9	3.1	13.5	3.9	10.8	2.7	3.3	0.1	8.0	6.4	0.0	1.6	8.2	6.0	2.1	2.9	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.8	6.3	5.9	4.7	5.3	3.7	3.8	2.6	2.7	4.1	4.9	102.8	76.9	29.8	204.7	1.3	22.3	17.7	7.9	26.2	98.3	46.5	37.5	35.6	102.9	22.5	23.9	75.0	20.2	0.5	51.0	3.9	44.3	179.1	35.8	35.5	55.5	36.5	2.7	497.7	31.8	2.4	9.6	47.4	50.8	1.3	78.4	82.5	60.9	4.8	232.2	809.8	40.3	12.2	5.0	3.6	27.0	6.5	1.8	5.4	170.5	0.6	15.2	0.0	368.4	532.1	40.3	25.4	8.6	0.2	14.7	33.2	12.2	40.3	26.4	32.9	7.0	17.5	44.7	12.3	12.7	18.8	5.1	2.7	27.1	26.3	11.9
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"retina: 118.9"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 369.1;Early spermatids: 119.7;Rod photoreceptor cells: 330.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.3	0.1	0.2	0.6	0.0	0.6	0.4	1.5	0.4	0.3	5.4	0.0	0.1	0.4	0.0	0.2	5.4	0.4	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.7	0.9	0.1	0.2	4.6	0.8	0.1	0.1	0.2	0.0	118.9	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.7	0.3	4.7	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.6	0.3	0.3	0.3	0.3	0.1	0.3	0.2	0.3	0.4	0.3	0.5	6.3	0.2	0.6	0.3	0.1	0.1	0.2	0.0	1.5	0.4	0.1	0.0	0.7	0.9	0.1	0.2	0.2	0.4	2.1	0.0	6.4	16.3	1.5	0.4	2.3	0.8	2.8	14.6	4.0	3.9	0.9	0.0	5.3	3.7	369.1	0.5	0.5	0.1	0.0	0.4	119.7	43.3	1.7	1.8	0.0	1.3	45.6	0.2	1.0	2.2	1.1	3.8	2.5	0.3	1.1	0.1	0.2	5.0	39.4	0.0	2.0	0.6	0.7	47.1	0.6	1.3	1.8	12.2	1.3	23.6	0.0	30.7	21.5	0.1	0.0	0.4	1.0	1.1	0.0	0.1	48.9	330.1	0.0	5.4	1.5	15.2	5.5	0.7	0.4	0.8	0.8	0.3	0.0	0.8
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		2000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	15.6	11.7	6.7	13.0	12.0	6.3	12.9	8.8	11.6	17.5	7.7	12.5	11.1	16.4	13.7	15.2	14.2	12.3	11.0	7.2	8.5	15.3	21.1	10.8	14.1	1.6	5.0	14.3	36.2	32.9	6.7	21.7	1.6	14.4	12.5	18.2	14.0	13.1	8.4	10.3	11.6	18.0	1.0	12.2	14.2	10.8	6.2	14.7	25.4	10.1	13.8	17.8	7.7	9.8	32.4	13.8	23.2	20.1	29.8	35.7	74.2	26.3	40.9	11.6	10.9	10.7	18.2	24.2	47.4	33.9	10.8	18.7	11.0	22.3	26.0	30.3	16.4	14.4	18.5	11.8	18.1	22.7	31.6	24.2	23.5	17.8	15.5	21.3	35.0	16.7	23.5	36.1	24.5	62.6	14.0	7.2	11.9	16.4	14.4	12.5	50.5	16.7	15.9	43.3	12.6	18.4	26.2	27.6	21.1	30.1	13.8	14.2	33.6	26.0	21.4	18.6	27.2	24.4	18.0	15.9	34.4	17.8	63.1	0.9	1.5	2.6	3.0	1.2	3.6	1.9	2.4	2.5	1.4	1.9	2.0	2.9	1.2	3.8	1.1	2.7	6.3	1.5	6.7	12.0	8.8	11.6	7.2	8.5	1.6	5.0	1.6	1.0	6.2	9.8	40.3	38.5	33.4	71.5	45.1	31.0	34.8	26.7	39.3	63.5	43.3	46.0	101.8	35.8	39.1	44.1	22.9	55.1	52.6	24.7	17.6	32.3	33.1	43.2	52.0	40.6	21.7	43.8	188.5	60.4	236.1	50.7	28.5	54.7	16.4	32.3	42.1	88.7	29.4	43.7	238.0	37.1	20.3	36.2	22.0	22.5	53.7	37.2	40.9	101.2	39.2	51.3	55.6	136.7	149.1	37.5	25.1	65.5	120.2	43.0	28.6	22.1	40.9	42.2	39.5	69.1	53.5	72.9	56.2	53.0	34.5	380.5	45.8	68.3	30.8	47.3
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086985-137109183	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051516	Approved		Uncertain	Vesicles		NA	NA		940000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	25.3	32.2	21.3	12.1	21.2	9.1	25.1	21.1	32.9	22.6	26.3	24.1	15.5	20.7	20.4	32.1	22.0	20.1	27.3	22.4	23.1	31.8	39.6	23.0	15.4	22.6	22.7	28.0	36.0	20.0	32.6	21.4	25.2	26.1	9.9	3.6	34.2	15.2	17.6	32.6	22.9	12.1	21.7	28.7	25.6	28.3	22.9	13.8	27.1	9.9	10.1	22.0	21.9	22.8	22.8	50.7	18.2	49.9	67.0	57.7	57.0	37.9	78.4	48.6	43.7	24.9	67.4	20.0	118.8	64.7	69.2	74.3	11.0	36.3	9.1	27.7	17.3	8.7	41.2	33.2	59.6	16.0	33.1	65.1	66.9	29.1	25.1	67.1	32.4	26.5	24.5	32.7	36.4	45.0	16.7	37.8	23.5	67.3	50.0	9.7	30.6	63.9	41.6	11.3	20.4	18.3	55.2	55.9	38.7	9.6	63.5	31.5	46.5	69.6	25.9	52.9	43.6	13.0	11.1	13.3	84.6	19.9	61.6	17.9	31.2	27.0	32.4	34.4	30.2	19.1	25.1	30.4	36.0	16.4	24.3	25.0	9.0	31.0	42.2	26.6	34.5	32.1	21.3	21.2	21.1	32.9	22.4	23.1	22.6	22.7	25.2	21.7	22.9	22.8	18.8	19.2	27.3	23.5	18.3	11.6	12.6	33.0	12.0	20.7	23.5	21.7	10.3	14.3	21.5	25.8	16.7	53.2	24.3	39.1	7.9	32.0	5.8	21.5	16.4	19.7	30.5	14.3	13.0	32.0	72.4	26.9	23.4	20.3	21.0	47.8	25.0	25.2	32.1	30.3	10.2	28.1	22.4	22.9	17.4	6.8	21.1	21.8	23.2	11.2	29.3	16.0	16.5	6.6	12.8	27.6	25.0	21.8	25.4	9.0	35.9	15.9	24.9	19.3	13.1	19.4	20.2	16.1	28.4	16.3	16.2	45.4	21.5	41.1	25.6	8.2
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689927-109869625	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.8"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 2117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	11.2	17.0	28.0	13.9	66.1	12.7	11.3	41.4	29.6	13.8	3.8	20.7	30.1	12.0	4.2	8.5	9.0	18.1	3.7	21.7	31.5	17.4	42.4	10.1	15.8	64.5	49.9	9.8	22.2	20.7	0.9	15.3	62.1	9.1	20.8	1.7	6.5	10.2	6.0	7.4	25.7	18.3	39.4	14.1	15.7	9.5	42.8	22.7	14.7	11.5	14.7	16.1	2.7	107.8	23.1	18.6	26.5	11.0	56.2	42.2	97.5	49.3	78.0	26.1	46.7	23.2	37.0	17.4	30.7	63.3	18.5	26.5	14.5	56.0	59.7	16.3	9.7	32.6	13.5	30.7	34.6	15.9	15.5	39.7	25.0	43.4	61.4	37.3	54.5	16.9	8.8	87.0	70.5	13.8	27.6	9.1	20.4	17.9	7.3	10.8	40.0	78.5	34.1	32.8	3.7	3.3	22.6	24.9	16.1	29.1	20.5	17.1	56.4	53.7	21.3	30.1	32.9	48.7	58.7	13.6	41.8	22.4	30.3	4.1	2.0	0.6	1.6	2.8	1.3	1.9	2.8	2.8	1.8	1.6	3.3	2.7	1.6	0.5	4.4	2.0	2.8	1.1	28.0	66.1	41.4	29.6	21.7	31.5	64.5	49.9	62.1	39.4	42.8	107.8	20.9	6.4	8.4	100.9	41.1	17.8	15.8	12.7	29.6	0.6	20.0	9.5	7.6	34.3	14.7	31.3	0.0	19.4	28.9	65.8	1.9	27.1	13.7	10.2	35.8	21.6	24.7	29.2	220.8	35.3	98.0	32.3	45.3	33.3	15.2	19.2	36.8	130.3	18.0	0.0	115.2	35.2	22.4	74.8	24.6	8.3	9.9	47.4	26.6	102.1	39.6	5.9	13.4	46.8	2117.7	28.8	28.4	6.8	84.0	39.8	60.6	24.7	12.1	0.2	19.7	52.6	16.5	16.5	19.9	33.6	23.7	23.7	34.7	14.2	49.6	24.2
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.6;Rod photoreceptor cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.8;neutrophil: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 100.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		43000000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	24.8	18.3	29.7	12.8	53.6	78.2	22.9	43.4	38.9	12.3	12.7	18.2	13.3	11.0	9.4	9.2	14.7	9.6	41.7	29.8	36.6	15.1	34.5	22.9	14.1	51.9	47.4	15.8	44.3	13.4	25.0	11.4	53.3	14.3	8.9	74.9	28.1	12.9	61.0	16.8	20.9	7.7	34.7	35.1	24.4	15.4	49.0	12.3	21.9	44.0	9.9	13.3	10.6	85.1	14.4	15.4	9.6	22.3	27.7	7.0	20.2	11.3	9.6	11.9	8.6	13.2	9.6	2.1	24.6	12.0	9.2	16.0	11.0	6.5	6.0	35.2	29.5	100.7	23.8	8.8	8.4	16.4	55.4	5.4	10.9	13.1	9.7	20.2	13.4	26.8	41.7	11.7	4.7	20.4	8.8	30.9	3.2	22.3	5.0	12.5	10.1	13.8	12.1	35.1	25.1	15.6	15.0	24.2	20.3	9.2	11.5	42.5	11.9	8.5	9.3	10.4	12.8	19.6	62.3	5.2	9.8	21.0	14.5	8.8	1.2	0.5	1.0	0.8	0.7	0.8	0.4	0.6	0.2	0.9	0.3	0.3	7.9	0.1	2.9	1.6	1.1	1.4	29.7	53.6	43.4	38.9	29.8	36.6	51.9	47.4	53.3	34.7	49.0	85.1	22.3	12.8	22.6	20.2	5.5	6.0	3.4	2.8	4.0	26.4	9.9	8.8	14.7	12.8	7.7	9.2	27.1	10.0	10.6	12.2	0.0	5.0	9.1	6.6	9.6	9.5	4.2	19.1	27.3	6.5	2.3	7.5	13.3	12.9	15.8	7.1	7.1	22.5	6.0	25.2	26.6	6.4	2.0	13.9	14.1	7.1	6.8	17.9	30.2	11.2	11.7	17.4	3.1	29.7	92.6	3.8	4.3	4.9	6.9	5.3	8.7	2.9	4.5	74.5	13.1	12.0	11.4	12.4	9.6	5.2	4.7	7.5	10.2	1.6	9.3	3.6
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575189-6623362	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		15000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	20.0	13.6	12.9	13.8	18.2	14.8	16.4	7.7	14.3	17.6	26.0	14.5	13.4	18.6	14.1	11.3	17.7	15.9	22.6	13.2	15.6	15.1	23.7	18.2	13.5	13.0	13.2	26.6	22.0	9.2	17.9	12.9	11.8	18.0	7.9	5.2	16.7	11.5	4.7	13.6	15.8	10.3	10.6	17.7	20.1	4.4	15.0	9.0	23.2	4.7	8.5	19.3	15.9	11.9	17.5	15.6	2.9	21.0	44.7	30.9	19.7	35.0	40.5	16.8	22.9	9.0	32.3	8.7	16.5	38.2	39.2	17.4	1.0	11.1	9.2	10.4	8.8	11.7	10.9	10.2	19.5	22.0	51.8	41.0	10.9	13.4	3.6	30.3	19.7	10.8	5.1	21.9	22.1	10.8	10.9	13.9	3.8	21.8	11.9	10.7	14.4	10.4	8.8	17.4	5.0	5.5	23.4	13.9	8.9	10.0	27.7	29.1	36.3	30.3	9.1	38.2	22.5	9.0	8.4	4.2	35.4	25.5	26.7	15.4	9.0	14.3	11.7	13.2	8.9	4.2	7.0	10.7	8.6	4.4	6.3	8.2	11.0	6.8	17.5	3.3	10.7	11.0	12.9	18.2	7.7	14.3	13.2	15.6	13.0	13.2	11.8	10.6	15.0	11.9	9.8	16.0	18.9	7.8	11.6	5.0	5.5	4.9	11.4	8.9	8.2	5.6	17.0	20.0	11.1	11.0	6.2	13.5	12.9	18.3	1.9	9.7	0.6	18.7	15.8	8.2	7.8	5.7	9.4	10.7	10.2	18.4	11.7	36.8	10.8	11.1	17.5	44.1	20.9	10.1	8.3	11.0	2.0	30.2	8.2	1.1	19.6	18.0	3.6	8.4	11.2	13.0	5.2	6.0	8.9	10.1	9.0	24.5	15.1	7.1	11.7	4.2	9.5	7.4	13.1	7.5	8.5	1.1	0.6	8.0	3.8	8.5	15.6	4.4	8.9	4.6
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"	P55145	3	51385291-51389397	"Plasma proteins, Predicted secreted proteins"	"Stress response, Unfolded protein response"	"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 426.1;Syncytiotrophoblasts: 459.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 109.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		7500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	39.4	36.7	34.4	70.9	34.5	35.3	41.8	37.8	50.5	59.4	44.2	55.4	42.5	48.2	169.3	53.2	42.8	32.1	51.1	34.8	42.7	48.6	109.2	44.3	50.5	38.4	35.7	28.7	81.1	38.8	56.4	59.9	37.2	51.3	58.8	17.7	51.0	50.5	12.4	36.6	39.5	47.2	36.2	56.1	59.5	43.2	37.9	47.7	117.8	20.8	76.1	67.8	35.5	38.1	128.6	61.2	164.7	207.7	107.8	139.4	173.8	200.2	160.6	194.0	184.5	99.6	292.6	271.6	162.6	121.9	449.8	77.7	201.4	200.0	187.3	128.9	92.2	220.2	93.5	230.3	349.8	108.2	137.1	60.6	168.5	201.3	271.7	189.9	252.7	112.3	48.3	299.5	181.6	75.5	184.8	215.6	144.6	298.0	237.6	76.4	105.3	288.7	162.8	86.9	64.4	201.6	165.3	104.2	130.3	175.8	83.7	141.2	129.3	117.4	112.1	140.4	222.6	247.9	105.0	186.5	195.4	217.5	221.2	73.2	15.3	9.4	28.8	13.0	35.5	17.4	20.2	27.5	16.0	12.1	14.9	16.0	8.5	26.0	8.3	109.8	13.4	16.9	34.4	34.5	37.8	50.5	34.8	42.7	38.4	35.7	37.2	36.2	37.9	38.1	55.9	32.1	21.5	5.2	134.1	163.1	223.7	232.5	31.3	15.1	50.5	40.5	69.3	61.5	104.0	55.2	6.2	188.1	142.8	75.7	43.0	172.6	99.0	73.3	101.9	88.3	116.6	26.1	5.8	124.6	387.0	101.2	71.9	99.4	62.9	77.9	79.6	156.1	179.5	11.8	8.5	235.9	118.0	36.1	170.6	123.3	60.0	63.0	181.5	7.5	79.1	39.6	117.4	5.0	9.5	167.8	90.5	51.6	426.1	245.0	47.7	78.9	71.1	19.1	65.7	59.7	194.2	176.8	91.1	42.8	160.5	459.0	94.8	40.6	120.9	202.0
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350242	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"neutrophil: 98.3"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 98.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9"	"Low region specificity"	"Detected in all"							"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	18.9	12.1	3.4	4.3	4.1	3.5	19.5	3.9	6.5	16.9	5.0	22.9	11.7	22.1	11.5	42.3	16.6	10.2	11.2	4.1	3.0	13.2	9.7	12.3	2.3	3.2	3.3	11.3	25.2	11.3	17.9	9.5	3.2	15.1	15.8	5.4	70.0	10.8	4.0	21.7	15.2	12.1	2.6	11.3	21.5	8.4	3.8	1.4	13.8	4.4	6.4	16.3	20.6	4.0	0.3	5.7	1.8	0.1	5.6	5.5	6.2	3.9	4.6	2.0	2.5	4.8	18.2	0.0	4.2	3.9	2.1	0.8	7.1	3.3	1.5	0.0	6.9	8.3	6.4	4.2	0.9	1.4	2.3	3.5	5.3	1.3	0.9	13.8	50.7	0.1	5.6	0.1	0.6	11.0	0.0	0.6	6.5	54.3	3.0	0.2	0.0	0.1	25.9	18.8	2.6	10.3	2.1	16.9	6.0	2.8	15.4	5.0	20.5	2.8	2.3	0.7	5.5	0.4	0.2	2.8	2.0	0.0	2.1	6.6	1.2	1.0	0.1	0.9	0.0	0.2	0.3	0.0	0.6	0.4	2.5	0.4	98.3	0.6	0.4	0.1	0.0	0.6	3.4	4.1	3.9	6.5	4.1	3.0	3.2	3.3	3.2	2.6	3.8	4.0	29.0	9.6	21.2	8.8	3.3	4.0	7.1	7.2	6.2	6.1	21.2	13.5	2.6	28.6	11.9	23.9	8.4	35.4	4.5	33.6	1.9	19.0	0.9	15.1	5.2	28.8	21.7	3.6	16.6	37.9	7.4	10.4	23.0	20.5	2.5	8.6	37.1	9.8	8.0	10.1	13.5	33.4	8.2	5.5	0.7	2.2	13.7	2.0	0.0	15.0	2.7	11.4	9.2	7.5	11.4	16.3	25.2	16.6	1.0	7.4	16.7	3.0	18.1	13.1	0.0	4.8	6.5	2.1	1.5	22.1	4.7	17.0	3.0	9.7	26.5	8.8
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 325.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol		No	No		55000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (1.09e-5)"	"prognostic unfavorable (1.66e-5)"	7.2	6.0	65.3	3.8	78.6	0.9	4.4	39.5	325.5	8.0	0.0	16.5	1.2	8.2	2.4	3.0	7.2	4.2	15.5	92.8	37.5	1.2	0.2	2.2	1.0	201.4	41.4	5.0	1.0	2.0	11.7	2.7	186.0	4.8	3.5	21.7	2.5	7.5	4.5	3.2	4.0	13.1	22.5	0.9	4.3	3.8	85.8	24.0	4.1	5.1	0.9	11.9	4.5	156.7	0.3	2.5	11.1	6.4	60.7	41.5	0.1	36.3	61.8	10.5	10.1	4.4	0.1	0.2	15.3	94.0	3.3	0.5	15.0	0.1	6.1	5.5	1.4	14.2	3.5	0.3	5.8	0.4	5.8	31.3	0.1	58.1	0.3	15.8	8.0	41.3	24.0	0.3	42.8	0.5	26.6	0.8	8.1	0.0	1.0	7.2	32.1	0.1	0.2	0.1	34.8	10.6	1.2	0.1	0.3	14.6	2.3	0.6	1.5	33.7	11.3	11.3	0.5	0.0	1.6	5.0	121.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.1	0.1	65.3	78.6	39.5	325.5	92.8	37.5	201.4	41.4	186.0	22.5	85.8	156.7	6.7	3.2	1.1	11.8	2.2	5.5	1.4	1.4	2.8	43.4	1.7	3.6	55.1	0.0	7.9	3.7	25.0	0.3	90.9	1.0	0.0	0.4	13.1	33.2	19.5	5.7	11.4	3.0	34.4	0.0	0.6	46.9	2.6	1.0	7.0	16.7	4.2	0.0	2.4	299.5	45.1	1.7	10.2	0.3	7.4	5.6	51.0	9.4	8.8	12.2	0.7	16.7	0.0	9.5	51.4	0.7	0.0	76.3	1.1	0.5	0.0	0.5	63.6	27.2	32.9	45.7	48.2	10.6	25.6	1.1	4.1	1.1	5.6	3.1	1.4	0.5
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 253.3;retina: 411.0"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 875.7;Excitatory neurons: 883.3;Inhibitory neurons: 823.6;Oligodendrocyte precursor cells: 688.6;Rod photoreceptor cells: 514.5"	"Group enriched"	"Detected in many"	4	"glioma: 30.4;thyroid cancer: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 296.9;NTERA-2: 106.7;SCLC-21H: 148.6;SH-SY5Y: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012558, HPA012828"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	5.5	11.6	89.2	1.2	115.9	0.3	5.5	2.7	253.3	4.3	0.0	2.9	0.9	2.3	3.9	6.5	2.5	7.6	8.4	135.2	215.6	5.4	3.8	13.5	1.8	37.7	52.2	7.4	10.7	15.5	33.8	0.8	75.3	7.6	1.7	411.0	7.8	4.9	1.7	16.9	1.6	2.8	14.5	1.7	3.3	6.5	123.9	3.5	16.7	4.6	2.4	1.6	5.3	88.2	2.6	0.6	296.9	0.0	3.9	2.2	0.1	1.9	2.1	0.7	2.2	0.0	16.1	0.0	1.7	3.8	14.0	4.1	23.4	1.8	1.0	0.1	1.4	1.2	8.9	0.1	36.7	0.3	0.2	3.1	9.6	0.1	5.8	17.3	7.8	0.1	0.0	3.1	0.3	1.1	0.1	0.0	106.7	0.5	0.5	0.0	0.6	0.3	3.8	0.1	148.6	82.7	6.3	0.9	3.7	34.8	8.2	0.0	0.2	0.3	1.7	0.1	4.1	1.9	0.0	0.0	15.5	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	89.2	115.9	2.7	253.3	135.2	215.6	37.7	52.2	75.3	14.5	123.9	88.2	16.8	96.1	3.2	127.3	1.8	5.9	3.3	12.0	4.6	144.7	6.2	8.0	4.9	27.1	3.7	5.5	875.7	0.4	0.1	0.0	3.9	26.8	22.1	2.2	1.1	15.7	32.4	2.7	883.3	11.0	0.1	5.3	3.6	4.4	1.3	1.6	18.5	0.4	0.5	33.7	823.6	0.2	6.1	1.4	1.5	10.7	28.6	1.4	19.6	74.0	0.0	129.7	0.0	688.6	53.8	10.0	0.0	15.4	0.1	12.3	0.0	0.4	3.4	514.5	32.9	5.1	26.1	6.6	22.7	2.3	6.5	0.3	0.3	6.6	0.0	0.7
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020829-12143830	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.9;Inhibitory neurons: 189.3;Oligodendrocyte precursor cells: 148.3;Oligodendrocytes: 203.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 177.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	11.4	13.1	27.3	10.1	30.2	3.6	14.5	18.7	44.8	12.0	8.7	12.0	10.1	12.1	17.5	18.8	11.4	10.9	15.8	32.7	28.5	16.2	21.8	11.7	11.7	30.0	21.8	12.6	11.5	19.4	13.8	15.8	30.9	14.3	13.1	15.4	10.5	12.7	24.1	15.1	10.5	13.8	19.0	11.6	11.2	11.0	25.9	15.2	16.7	28.2	14.4	14.7	13.0	30.1	31.1	26.2	33.8	17.5	18.3	23.5	21.3	20.6	27.1	23.1	21.9	15.6	10.4	12.8	16.4	32.4	15.2	20.2	29.7	28.8	34.3	22.7	33.7	14.2	14.1	29.8	21.4	13.7	20.5	19.6	27.9	27.0	28.0	23.9	21.3	17.8	15.4	7.3	29.4	11.5	16.8	12.9	19.6	33.2	12.4	20.3	37.8	8.9	31.6	19.7	6.8	19.9	23.8	12.7	20.3	177.7	16.1	10.0	19.6	11.3	17.4	15.8	24.9	14.2	16.9	9.9	21.3	10.7	16.8	0.4	2.1	1.7	2.2	1.2	1.9	2.1	1.8	1.8	1.5	2.7	1.5	2.4	10.4	2.7	3.9	1.5	2.2	1.8	27.3	30.2	18.7	44.8	32.7	28.5	30.0	21.8	30.9	19.0	25.9	30.1	13.9	9.6	19.4	71.8	27.1	41.4	36.1	12.7	66.0	15.3	20.4	16.3	22.6	7.2	18.3	14.7	8.4	12.6	17.7	19.1	25.4	12.3	7.2	16.9	16.4	12.0	12.0	14.5	226.9	14.3	10.3	19.4	42.3	27.3	1.3	20.1	11.0	20.8	11.7	18.5	189.3	13.1	20.3	19.9	14.7	8.9	11.8	15.4	12.4	68.4	24.1	11.3	14.4	148.3	203.0	16.9	9.3	12.8	26.9	37.7	11.0	25.2	8.6	10.0	13.1	19.2	20.2	7.3	9.3	56.7	39.2	25.3	20.7	15.0	13.3	41.5
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	19.1	17.0	17.9	11.7	17.8	19.4	19.5	16.8	19.0	25.1	10.4	24.4	13.1	26.1	3.7	20.2	20.5	5.9	20.8	14.8	15.2	18.7	24.7	17.1	11.7	17.3	17.3	23.2	21.6	9.6	23.4	9.2	17.1	21.0	4.6	5.6	19.2	7.9	52.4	27.9	20.1	6.2	15.1	24.5	18.8	17.5	17.3	10.9	19.0	16.4	6.1	22.0	22.4	19.9	25.8	14.4	12.2	20.2	9.7	9.3	22.8	16.5	8.0	11.0	11.3	20.9	15.2	30.5	25.9	8.8	10.7	22.9	10.7	12.8	4.3	24.7	53.3	21.4	20.9	15.6	12.4	20.1	26.0	10.8	16.1	8.7	9.8	14.5	10.0	21.9	31.9	38.5	6.5	13.4	28.8	48.6	21.7	13.6	32.0	28.5	13.4	31.0	9.8	21.0	22.4	22.5	11.3	19.4	23.9	7.3	21.0	22.7	15.3	33.2	19.0	23.7	22.7	55.5	27.7	28.8	16.6	29.2	13.6	0.0	0.8	0.6	0.6	0.8	0.4	0.7	0.5	0.6	0.4	1.0	0.5	0.7	1.5	1.0	0.5	0.8	0.2	0.4	17.9	17.8	16.8	19.0	14.8	15.2	17.3	17.3	17.1	15.1	17.3	19.9	15.4	25.6	18.1	11.1	27.0	38.6	37.2	22.7	22.2	52.9	23.5	16.5	14.4	24.3	14.5	20.2	77.2	28.3	27.8	31.1	13.7	22.8	4.8	16.2	20.3	19.5	36.5	23.6	9.9	19.0	31.1	18.5	16.3	24.8	10.8	33.3	21.4	22.2	18.6	57.2	11.0	24.0	32.6	22.2	17.1	11.7	28.9	20.5	32.0	6.5	25.3	23.9	46.4	9.0	15.0	25.7	20.8	12.4	30.4	39.8	38.7	18.4	15.3	65.7	32.9	30.2	22.1	17.7	36.4	22.7	42.6	49.3	30.3	30.3	27.6	33.2
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696305	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"CAB007764: AB_562314, HPA035410: AB_2674614, HPA035411: AB_2674615"	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	30.1	12.3	11.3	23.7	12.4	31.5	23.6	13.9	12.3	21.6	13.6	28.8	8.7	23.8	6.5	17.7	24.2	21.8	40.9	10.5	12.1	22.9	13.9	28.7	22.3	14.9	12.7	24.0	12.9	15.2	13.8	22.9	13.2	22.2	8.5	6.9	15.1	18.4	23.7	19.3	18.7	22.0	13.1	34.5	18.7	17.2	12.9	15.1	18.0	30.3	14.5	23.4	19.1	13.6	22.6	16.3	20.4	20.1	37.7	30.2	9.4	22.0	24.4	27.0	21.2	7.8	4.5	24.2	15.0	43.2	18.7	8.3	13.4	15.5	16.9	21.7	29.3	19.6	22.6	11.0	19.5	15.6	20.1	22.3	10.4	33.6	17.1	16.3	65.7	17.4	12.2	31.1	21.4	15.9	27.3	15.9	12.5	4.5	16.8	14.3	53.0	15.6	9.4	10.3	10.6	25.3	14.6	17.1	17.9	24.9	17.3	14.8	60.5	67.8	17.8	37.3	26.9	30.3	33.6	8.9	14.4	12.0	18.0	15.0	11.4	15.3	2.8	11.8	3.0	2.0	3.4	2.8	4.9	2.4	3.3	3.2	25.1	1.9	12.5	1.9	2.9	3.5	11.3	12.4	13.9	12.3	10.5	12.1	14.9	12.7	13.2	13.1	12.9	13.6	31.6	19.2	14.5	23.5	11.0	7.8	5.4	3.9	5.7	15.8	9.5	8.9	10.3	12.8	5.1	16.5	14.6	3.2	25.8	3.3	9.8	4.5	8.3	10.0	12.3	33.0	4.2	2.1	39.8	8.1	3.3	13.6	3.1	9.3	3.8	7.1	48.2	10.1	16.3	18.5	34.2	3.9	2.0	47.1	13.0	6.4	14.9	35.1	23.2	54.4	42.7	8.8	24.7	31.2	36.1	5.2	1.9	13.2	8.3	8.2	3.7	2.4	5.4	14.0	19.7	21.9	12.9	23.9	17.8	6.1	11.2	1.4	15.6	6.2	4.5	3.8
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557046-136792477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 88.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	13.2	88.1	21.7	11.7	23.6	14.1	9.5	21.6	18.9	8.4	7.0	8.7	7.3	11.3	7.7	10.0	12.9	7.5	11.3	18.6	18.9	10.6	9.0	11.9	12.1	17.2	20.7	49.3	30.9	1.9	16.2	5.3	16.1	18.0	9.7	14.5	7.1	7.1	6.3	8.0	9.0	5.1	16.6	11.7	14.8	12.0	24.8	8.2	12.8	6.1	12.3	18.5	9.2	15.7	5.6	3.4	0.0	0.0	7.6	20.2	1.9	8.0	42.6	4.0	3.8	0.3	5.6	3.3	11.5	11.1	3.0	7.6	13.6	4.1	10.5	4.6	10.6	28.9	7.6	0.0	36.3	13.6	0.1	26.8	5.3	6.3	17.9	15.4	13.6	4.1	7.3	31.2	28.7	10.9	0.3	11.6	1.3	10.9	4.5	7.6	8.9	13.2	16.2	35.3	9.7	6.4	6.6	6.3	1.8	1.4	1.4	12.0	12.0	6.7	2.1	0.4	7.5	25.3	18.0	0.0	5.3	18.6	6.0	3.5	1.8	2.1	1.5	1.4	2.9	1.1	2.5	2.2	1.5	1.5	0.2	0.8	5.2	2.3	1.4	1.5	4.6	0.9	21.7	23.6	21.6	18.9	18.6	18.9	17.2	20.7	16.1	16.6	24.8	15.7	11.9	6.4	22.0	383.6	14.3	5.0	20.5	32.0	3.4	18.2	10.0	5.0	21.2	4.3	35.1	11.0	6.2	1.0	25.9	12.3	3.9	3.0	6.4	17.3	31.4	7.7	34.8	14.9	170.4	23.1	1.1	12.1	20.9	62.5	5.7	67.7	9.7	11.2	8.0	0.0	204.8	18.2	14.2	23.5	10.2	4.2	23.6	26.6	0.0	216.4	21.7	43.3	12.3	210.1	4.2	17.8	8.7	14.3	13.5	18.8	7.2	8.3	20.5	2.6	13.1	5.3	17.9	3.4	15.5	13.1	10.1	2.7	18.5	16.2	11.2	23.4
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27354067-27366961	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: AB_2681380"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.13e-4)"	"prognostic favorable (7.26e-4)"	"prognostic unfavorable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	42.9	17.8	17.2	5.5	17.0	0.6	42.6	17.4	20.7	50.2	16.8	25.4	1.8	30.9	4.1	70.0	38.8	4.7	61.8	16.6	17.4	37.3	10.4	54.2	4.7	18.4	17.5	15.6	15.2	5.2	18.0	5.1	17.6	41.3	4.5	1.4	30.3	7.3	15.2	65.7	17.7	12.1	17.3	22.3	23.6	8.3	18.4	2.8	30.3	11.3	7.9	39.8	53.4	16.6	7.2	7.2	6.9	4.4	9.9	12.5	1.4	9.0	5.3	7.2	4.4	2.0	9.4	0.1	8.4	16.4	3.2	10.1	2.0	6.4	3.6	6.5	7.1	0.3	16.0	4.7	2.7	0.5	0.4	10.2	17.6	7.8	2.3	8.8	4.0	0.7	2.0	2.7	10.2	25.1	0.2	9.0	2.2	8.7	8.1	2.3	3.2	1.7	12.9	9.1	2.0	3.0	8.5	7.1	6.3	3.1	4.4	5.0	11.6	13.2	7.2	16.6	5.2	3.5	4.1	0.0	12.1	5.8	4.3	0.9	0.6	3.3	2.8	2.0	3.7	1.5	2.5	3.1	1.3	2.0	1.8	1.6	1.2	0.7	4.5	0.0	3.0	1.2	17.2	17.0	17.4	20.7	16.6	17.4	18.4	17.5	17.6	17.3	18.4	16.6	45.8	19.2	17.8	6.2	3.9	12.5	11.9	8.8	17.1	1.1	8.1	8.9	12.2	5.7	10.3	3.7	0.0	1.2	4.3	8.4	3.9	2.8	0.4	2.3	6.0	27.7	0.0	0.8	1.5	4.4	2.5	10.3	8.6	5.2	2.5	1.2	28.9	0.9	2.8	5.0	1.7	6.1	4.1	8.5	7.1	1.2	16.1	6.4	5.4	5.6	9.3	5.4	8.2	0.0	0.2	12.8	1.9	15.1	3.1	9.5	1.1	1.7	6.2	0.8	6.6	10.8	11.1	13.5	7.7	14.7	14.8	0.1	8.2	0.3	8.8	14.9
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 743.9"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038149, HPA038150"	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA		880000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"	"Plasma membrane"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	127.4	55.7	475.5	50.4	483.4	16.1	98.0	433.2	406.8	118.0	215.5	193.2	35.1	111.7	69.7	90.7	94.7	52.9	380.9	351.2	408.7	88.3	66.0	105.0	35.0	567.9	490.6	90.0	71.4	31.4	56.1	64.8	509.2	92.7	47.6	149.0	71.4	88.1	743.9	120.6	80.6	94.5	526.1	64.0	93.9	80.0	552.3	42.1	61.1	491.0	37.8	135.5	115.2	533.2	121.9	95.7	117.1	89.3	168.6	298.5	49.5	222.6	241.2	184.1	204.9	81.3	74.4	102.3	50.7	337.9	172.8	79.2	151.4	201.6	204.7	148.7	63.8	69.3	102.8	106.0	228.6	48.6	53.9	251.4	246.4	224.0	271.6	167.1	245.1	70.6	91.2	115.3	146.9	69.1	69.5	58.9	70.9	59.9	195.0	36.6	110.1	128.1	118.2	100.1	46.4	72.3	171.0	68.3	118.6	163.0	50.1	44.8	334.5	172.7	132.3	182.9	144.4	80.4	66.9	47.8	222.2	58.6	167.3	10.5	6.6	3.7	15.6	10.6	7.5	12.3	10.2	12.7	7.1	11.5	4.9	7.6	2.6	13.4	27.3	10.8	13.0	9.7	475.5	483.4	433.2	406.8	351.2	408.7	567.9	490.6	509.2	526.1	552.3	533.2	147.9	70.5	48.2	124.4	45.1	74.8	55.4	53.1	42.7	392.2	34.7	36.2	921.5	48.6	53.4	80.9	625.5	33.8	54.6	43.7	27.4	97.8	116.2	78.2	143.2	110.4	28.8	21.6	63.7	65.3	81.0	105.5	39.8	93.4	27.8	81.6	50.0	57.3	38.0	47.1	71.2	31.7	34.6	28.3	50.5	38.8	77.0	40.0	78.2	95.5	72.0	82.8	47.4	77.9	167.2	92.0	28.0	103.0	47.2	89.0	37.1	39.2	43.6	97.5	72.3	149.0	119.0	65.6	64.3	58.7	69.6	22.4	60.5	137.4	39.5	44.7
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784918-64803241	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	5.0	3.9	8.9	6.9	7.2	15.5	4.1	9.8	9.9	4.6	4.9	5.6	3.3	4.8	2.5	2.7	3.8	4.2	4.3	7.6	7.0	5.4	2.0	9.7	17.6	7.8	8.0	3.4	5.0	3.2	5.8	8.9	8.1	4.7	3.0	5.3	6.6	5.8	2.5	3.5	8.9	3.7	6.6	18.0	5.2	4.6	9.7	7.4	7.0	1.5	14.2	4.6	3.5	8.8	9.4	8.4	5.4	9.8	4.7	2.9	12.7	7.0	6.5	8.2	5.8	3.7	4.3	16.4	12.6	8.0	14.5	2.8	6.5	6.8	4.9	21.5	3.1	28.9	12.0	7.9	5.8	15.3	10.4	2.9	3.4	6.4	4.1	5.7	20.3	28.0	2.5	1.5	2.5	11.8	9.2	15.2	3.6	5.6	11.2	18.8	0.6	18.9	4.6	4.7	6.4	9.3	6.0	7.8	6.4	6.1	15.5	23.2	15.8	6.8	15.0	6.3	2.9	1.8	3.8	18.1	6.0	22.8	5.1	2.2	4.3	5.9	4.9	12.5	4.9	9.9	6.5	4.4	4.4	6.6	7.7	6.0	8.0	2.5	15.8	5.0	9.5	7.3	8.9	7.2	9.8	9.9	7.6	7.0	7.8	8.0	8.1	6.6	9.7	8.8	21.6	3.2	4.8	6.8	32.9	1.3	2.8	1.8	6.2	20.6	8.1	10.4	4.7	7.2	2.4	1.8	25.0	7.6	9.4	6.8	3.9	1.7	33.8	2.6	3.8	20.0	6.0	5.0	5.9	1.7	11.3	4.9	9.2	6.0	1.3	7.7	24.3	2.0	11.0	11.8	4.6	1.8	6.1	8.9	3.1	46.8	4.1	16.2	1.8	18.7	13.4	7.2	14.4	2.0	7.2	0.9	16.2	7.2	15.6	1.8	1.6	3.6	1.5	14.6	6.6	3.7	4.3	2.1	13.8	5.2	1.4	5.1	19.9	22.6	2.2	2.0
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437301	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 118.8;Excitatory neurons: 201.0;Inhibitory neurons: 198.3;Microglial cells: 144.3;Oligodendrocyte precursor cells: 160.4;Oligodendrocytes: 129.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"AF22: 102.3;RT4: 97.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	15.8	17.1	11.6	6.7	12.5	10.5	16.6	21.6	16.7	15.0	15.3	15.5	13.2	17.2	13.4	10.2	13.6	14.7	19.3	14.2	11.2	24.5	15.1	13.3	6.1	9.9	10.0	20.2	12.2	25.3	12.2	27.4	10.0	16.9	13.0	28.0	10.8	14.0	30.9	16.4	14.3	14.5	11.3	11.6	26.6	21.3	10.2	8.1	24.4	22.2	6.1	18.3	11.4	14.4	25.6	15.6	102.3	16.3	16.3	32.4	28.0	22.1	28.3	21.6	18.3	13.3	12.6	5.5	24.3	15.3	22.1	13.6	39.0	19.7	32.6	6.3	16.0	9.2	10.8	30.9	42.3	4.0	14.5	29.3	19.0	28.1	30.1	22.6	18.8	5.0	12.1	9.9	29.2	13.9	9.0	6.0	30.7	24.0	23.4	9.9	33.3	4.2	28.3	97.3	18.2	20.7	12.9	20.7	58.8	32.0	13.9	5.6	15.4	16.7	19.7	15.0	12.1	15.1	9.3	1.9	20.5	6.6	19.0	0.7	0.1	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	11.6	12.5	21.6	16.7	14.2	11.2	9.9	10.0	10.0	11.3	10.2	14.4	36.2	3.2	8.4	118.8	8.1	17.6	17.9	11.0	16.5	24.7	14.1	12.3	38.2	21.5	16.5	22.0	25.0	13.1	4.1	12.5	19.6	10.3	45.1	22.3	19.9	20.6	9.6	4.6	201.0	12.4	6.7	18.2	25.5	59.4	2.5	15.6	14.3	18.6	9.7	6.7	198.3	13.9	2.0	10.9	20.6	103.0	20.8	14.4	5.4	144.3	4.4	13.2	3.1	160.4	129.2	17.5	5.7	17.7	14.3	18.6	14.0	11.9	19.5	37.9	19.7	18.7	17.6	22.6	19.8	11.8	19.2	10.4	5.9	17.4	10.6	30.2
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 472.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 337.3;Oligodendrocytes: 1134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	54.1	9.1	272.6	42.9	316.1	72.5	32.2	208.8	252.5	23.9	95.0	21.1	10.6	27.4	12.1	35.2	19.7	34.5	44.8	219.4	256.3	15.0	32.8	29.2	54.1	317.5	286.1	23.1	16.1	15.0	10.0	49.4	273.1	13.9	17.8	22.7	19.3	10.2	37.4	21.1	17.7	28.7	246.7	24.2	22.0	40.1	348.5	44.3	15.8	30.6	60.1	33.1	25.6	472.1	112.7	83.8	175.2	84.3	162.4	288.6	219.5	139.8	114.3	122.2	100.1	139.5	145.6	163.1	118.3	210.3	36.0	45.5	56.0	123.2	121.1	219.8	38.0	122.4	62.5	367.7	136.7	59.1	5.5	261.3	55.3	301.9	133.5	122.1	322.5	90.3	80.9	0.4	325.4	61.3	137.8	36.5	89.2	42.5	131.5	164.1	120.0	0.6	81.2	38.8	68.5	113.6	96.5	0.4	104.0	160.8	22.4	105.1	409.1	240.5	102.9	70.6	168.6	0.3	0.4	96.7	155.2	73.2	180.1	8.8	3.2	0.0	2.3	3.2	1.6	3.4	2.9	1.5	1.1	5.0	2.2	2.5	13.5	1.1	3.1	6.0	3.7	1.5	272.6	316.1	208.8	252.5	219.4	256.3	317.5	286.1	273.1	246.7	348.5	472.1	104.3	19.2	23.9	283.0	64.5	30.0	41.9	17.4	12.5	109.1	14.3	17.4	71.0	28.6	29.6	18.4	50.1	13.1	38.4	12.0	0.0	57.4	31.5	67.2	77.1	84.2	17.4	48.0	197.5	53.2	23.4	49.7	26.5	101.0	24.0	151.8	67.1	39.2	38.8	35.3	122.4	13.6	14.2	26.9	245.9	46.0	55.0	54.7	19.6	337.3	88.0	49.2	10.3	228.7	1134.5	128.1	12.0	17.3	18.0	72.1	5.3	6.3	22.9	10.4	52.6	65.2	73.3	29.0	82.1	24.3	24.6	7.8	38.4	17.2	14.4	40.4
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 341.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079930, CAB079932, CAB079933"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear speckles"	"CAB004229: AB_627547, CAB079930: , CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	31.1	33.1	64.8	35.9	84.4	41.2	29.8	37.3	80.9	31.4	32.9	36.1	25.8	29.6	30.1	43.0	29.0	28.9	42.2	91.3	46.4	42.1	34.2	38.5	36.8	29.1	45.1	29.2	38.1	51.7	12.0	33.1	35.9	32.8	36.2	30.3	28.9	32.7	38.1	45.0	29.5	39.1	43.8	40.5	33.9	43.7	60.1	44.4	46.1	41.9	41.9	35.5	18.9	43.2	78.7	48.0	60.5	37.2	75.9	76.7	25.9	84.7	77.5	73.2	72.0	43.8	40.8	45.8	41.3	112.7	67.5	74.6	73.9	67.9	97.8	180.4	72.1	78.9	43.0	67.7	73.5	113.2	80.5	56.9	60.1	89.4	81.6	58.0	101.7	45.4	341.9	50.5	97.5	36.6	72.0	38.5	24.4	104.5	46.8	79.4	149.6	13.2	55.5	62.9	50.0	28.6	91.5	64.2	57.2	60.4	42.4	47.1	90.1	61.5	79.6	71.9	54.2	47.1	59.4	65.8	60.0	60.0	68.4	1.4	4.9	7.2	15.9	6.0	4.9	2.3	3.6	6.0	4.1	2.6	3.5	6.1	16.5	9.3	6.9	4.0	3.4	4.0	64.8	84.4	37.3	80.9	91.3	46.4	29.1	45.1	35.9	43.8	60.1	43.2	36.8	48.1	35.8	97.6	44.0	60.2	28.4	25.1	28.5	25.5	32.5	24.5	41.5	42.9	31.2	51.5	54.2	21.8	151.7	74.4	19.6	28.5	49.0	33.5	40.3	39.9	59.6	63.8	109.2	39.2	23.2	38.4	52.0	45.0	92.8	28.8	52.1	63.5	53.2	28.6	91.2	42.2	26.4	89.0	77.1	14.7	32.6	74.9	40.9	68.4	75.0	35.8	143.2	82.4	75.1	45.3	35.2	44.4	37.0	43.8	32.8	46.0	32.2	22.4	32.9	44.6	37.3	74.1	53.4	44.9	61.8	19.2	91.4	43.3	38.6	38.8
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560087-50731826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;parathyroid gland: 51.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6"	"Cancer enriched"	"Detected in many"	4	"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	0.9	26.8	56.5	0.2	79.9	0.0	0.8	56.4	46.0	1.5	28.0	6.8	0.6	0.8	3.1	2.3	1.5	1.8	22.1	41.6	57.5	3.3	4.5	2.3	0.0	65.4	70.0	2.9	1.4	51.0	17.8	2.6	56.7	5.0	0.8	22.6	0.9	9.8	1.5	1.3	1.6	1.8	48.8	0.1	2.1	2.4	81.9	7.3	6.2	1.5	0.0	4.6	1.3	38.7	0.0	0.0	1.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	1.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	2.8	0.0	0.8	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	79.9	56.4	46.0	41.6	57.5	65.4	70.0	56.7	48.8	81.9	38.7	0.4	9.6	0.0	202.7	0.0	0.0	0.4	0.0	0.0	11.4	0.9	1.1	22.9	1.5	0.0	0.0	0.0	4.6	0.0	0.0	5.9	0.9	30.1	0.0	0.0	0.3	0.0	0.0	105.2	0.0	0.3	1.0	0.0	0.0	0.0	0.7	0.0	1.0	0.4	5.0	58.5	0.0	0.0	0.0	0.0	66.4	0.9	0.1	0.0	7.5	0.0	62.6	0.0	18.6	1.9	0.4	0.0	1.5	0.0	0.7	0.0	0.2	0.0	1.0	0.0	1.0	0.7	0.8	0.6	0.0	0.0	1.8	0.0	0.4	0.0	0.1
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.8;pituitary gland: 118.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	4.8	23.3	127.9	2.3	131.0	1.3	4.8	122.0	147.7	8.2	29.6	8.3	1.4	10.9	3.5	2.2	11.3	3.5	5.5	166.8	120.6	11.5	5.6	4.0	0.6	154.9	130.9	9.1	43.1	19.2	118.2	1.4	142.6	11.6	1.2	11.5	11.4	6.1	2.4	4.0	3.7	5.7	124.6	2.3	9.0	27.7	139.3	1.0	7.0	2.5	0.4	6.7	4.8	164.4	0.0	7.1	9.4	26.2	3.4	1.8	0.3	5.1	4.6	9.9	7.2	6.3	1.1	0.4	2.5	5.9	16.8	5.8	10.2	4.8	4.4	4.0	13.1	0.1	8.6	4.1	3.1	0.6	4.4	2.4	1.0	6.4	1.3	6.6	2.2	0.9	11.5	1.6	2.8	3.9	0.4	0.6	24.9	3.3	10.5	0.6	15.4	0.3	4.6	0.2	76.4	28.5	8.4	6.8	10.0	3.6	11.0	0.4	2.1	12.5	19.1	19.0	9.3	1.1	1.3	0.5	7.9	0.2	3.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	127.9	131.0	122.0	147.7	166.8	120.6	154.9	130.9	142.6	124.6	139.3	164.4	1.7	6.4	4.1	7.2	0.9	2.4	5.8	2.0	2.8	34.4	6.1	5.3	1.1	5.7	3.3	11.0	22.9	1.6	0.4	2.2	13.7	6.9	43.8	23.9	15.9	2.9	40.2	0.0	10.3	28.9	0.6	6.5	4.1	19.9	0.0	2.8	0.4	4.6	0.5	67.3	11.6	1.6	4.1	0.8	3.5	39.2	6.2	1.1	3.6	1.0	1.6	41.3	0.0	3.5	48.7	11.6	0.5	6.4	0.1	6.3	1.4	8.9	10.9	18.3	0.0	14.2	6.0	10.6	8.2	0.9	1.0	5.7	1.3	7.7	0.9	5.5
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819954-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"		NA	NA		11000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	66.7	44.5	41.2	69.7	46.7	192.7	48.3	45.3	45.5	45.9	41.9	69.0	39.7	61.0	52.9	62.7	44.8	57.4	58.2	37.0	50.0	54.1	30.4	50.6	75.8	48.0	52.5	37.8	40.4	38.3	24.3	66.8	47.9	56.0	58.0	16.1	32.7	70.6	34.1	34.7	41.2	91.3	47.7	57.7	43.9	54.4	47.5	88.0	74.1	39.7	69.3	83.1	37.8	47.0	179.7	161.4	176.6	102.0	93.5	84.3	250.7	171.3	106.3	261.0	191.0	470.0	161.9	271.2	167.4	154.8	265.6	159.9	213.1	191.6	283.7	92.4	83.1	523.3	105.0	253.2	98.7	190.6	222.8	91.6	94.1	213.8	141.7	89.3	165.0	151.4	240.0	150.6	232.4	111.0	263.0	166.2	127.6	182.7	147.5	174.4	312.8	145.9	143.0	121.8	109.7	115.3	307.2	134.3	179.4	160.6	194.3	140.0	147.5	291.9	157.7	147.3	224.7	131.5	194.5	289.6	154.9	428.3	166.0	256.8	125.8	262.1	100.1	150.8	104.0	75.1	94.1	92.9	97.4	81.8	94.6	104.3	139.7	111.1	170.6	89.5	107.1	185.6	41.2	46.7	45.3	45.5	37.0	50.0	48.0	52.5	47.9	47.7	47.5	47.0	71.6	19.2	30.2	8.1	67.0	132.8	194.4	48.1	62.0	11.1	54.7	42.3	36.5	25.8	44.5	55.2	8.4	108.0	82.0	67.6	84.1	68.8	90.2	43.5	44.7	64.8	71.5	52.8	7.8	78.3	130.0	61.4	40.8	60.9	115.4	45.7	39.3	14.9	107.0	10.1	8.5	43.6	36.7	94.6	121.2	76.6	35.8	99.5	71.2	12.2	120.5	36.5	92.7	7.5	12.6	75.0	40.5	64.3	71.1	115.3	32.6	74.3	39.4	11.5	65.7	61.5	102.8	72.1	62.1	65.2	110.8	169.2	89.8	76.6	44.4	123.1
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skeletal muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.7	4.3	26.2	0.3	27.1	0.0	9.1	8.3	67.7	2.4	0.0	8.4	0.5	1.0	0.2	8.4	1.0	0.8	9.4	30.0	20.4	14.7	0.6	0.8	0.3	11.6	11.4	0.6	1.5	2.9	29.5	3.4	22.4	5.4	0.3	17.6	8.5	3.4	79.0	6.3	1.8	0.3	2.7	0.4	1.7	20.3	14.8	0.4	0.9	27.4	0.2	10.2	2.3	19.7	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	26.2	27.1	8.3	67.7	30.0	20.4	11.6	11.4	22.4	2.7	14.8	19.7	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 94.9;lung: 199.6;lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 4.1;thalamus: 12.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	64.7	31.1	0.4	87.9	1.4	3.4	7.4	0.7	4.1	0.7	4.4	5.7	2.0	0.7	1.3	2.4	25.5	2.4	19.0	0.9	1.0	1.6	94.9	199.6	17.7	1.2	1.7	7.5	0.8	0.3	1.5	2.8	1.9	1.8	2.1	0.0	4.4	2.3	1.5	2.5	3.1	29.8	1.2	37.1	3.5	2.0	12.6	1.3	1.5	5.0	1.1	25.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.4	1.4	0.7	4.1	0.9	1.0	1.2	1.7	1.9	1.2	12.6	0.7	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1346.5"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.4	0.1	0.8	0.0	0.4	0.1	0.5	0.2	0.9	0.2	0.2	0.1	57.5	0.1	1.2	0.0	0.2	0.2	0.2	0.9	1346.5	0.4	0.1	0.6	0.8	6.3	43.8	0.1	0.8	0.1	0.4	0.0	0.0	0.0	0.3	1.9	0.0	4.2	0.0	0.2	0.8	0.5	0.2	3.7	0.2	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.5	0.2	0.2	0.6	0.8	0.4	0.8	0.2	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"pancreas: 24.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.4;Fibroblasts: 8.5;Langerhans cells: 6.3;Spermatogonia: 4.9;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;NB-4: 2.5;U-937: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	24.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	6.4	0.7	1.0	0.0	0.0	1.6	1.9	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.1	0.7	0.2	0.4	0.0	0.0	1.0	2.5	0.0	8.5	1.1	0.8	0.0	0.3	0.4	0.2	0.1	0.0	0.4	0.1	0.0	0.0	6.3	0.5	0.0	0.1	1.8	1.0	0.0	0.0	0.0	3.0	0.4	0.9	0.1	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.4	0.4	1.6	4.9	0.3	4.3	0.3	0.3	0.1	0.2	1.0
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293674-139331677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 155.9;Inhibitory neurons: 160.2;Langerhans cells: 122.3;Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 162.4;Respiratory ciliated cells: 127.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		260000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	112.9	127.9	145.2	93.6	156.1	323.5	161.0	172.2	224.5	144.1	109.6	106.3	76.9	166.6	124.0	103.3	131.1	115.3	111.4	158.4	146.1	150.1	112.9	115.2	157.9	126.2	132.1	199.3	102.8	168.6	95.1	122.9	131.4	130.2	106.5	223.4	93.5	133.2	119.6	82.0	90.0	142.4	144.8	124.5	89.1	114.9	139.3	221.7	190.5	114.0	170.2	133.5	91.2	156.3	209.0	191.1	559.5	260.7	192.4	212.5	283.2	172.2	300.9	300.4	347.5	273.1	208.8	351.2	236.8	244.1	284.8	135.8	376.8	269.6	403.0	278.4	189.1	236.5	205.0	285.0	183.2	262.5	174.4	222.5	203.7	247.4	226.3	247.1	296.1	219.4	216.9	170.3	313.8	186.7	496.0	285.8	303.6	205.2	182.6	304.7	416.4	217.8	278.0	316.5	279.5	348.7	248.3	176.7	264.6	426.3	194.4	254.5	192.2	272.0	177.7	180.6	246.3	171.0	300.4	423.0	189.8	226.5	268.0	187.0	71.2	116.3	109.6	82.2	134.8	116.3	114.3	124.6	92.6	97.7	124.4	116.5	34.7	150.9	106.7	50.7	136.1	159.8	145.2	156.1	172.2	224.5	158.4	146.1	126.2	132.1	131.4	144.8	139.3	156.3	0.1	44.8	50.2	83.6	17.6	114.6	0.8	99.2	15.9	1.8	0.3	0.3	0.7	0.0	92.0	0.0	2.1	1.2	0.0	27.6	0.0	0.0	0.3	0.2	0.2	13.6	83.5	15.5	155.9	0.0	1.0	17.5	5.1	0.4	100.3	0.1	0.0	0.0	1.3	1.7	160.2	35.3	87.5	0.0	122.3	0.6	0.6	4.7	103.2	60.9	0.1	0.7	0.0	117.6	162.4	0.1	12.4	0.7	7.3	0.7	0.8	0.2	127.9	1.3	0.0	1.0	33.3	1.1	0.5	15.1	111.2	0.8	21.8	0.5	41.9	1.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	8.1	4.6	1.2	1.5	1.2	0.3	43.4	1.2	2.2	2.9	0.9	14.6	1.8	2.3	0.3	736.1	18.7	4.1	13154.5	1.0	1.9	2.8	5.8	14.9	5.3	1.4	1.4	5.3	26.9	16.1	10.6	3.1	1.2	214.2	12.9	0.2	367.1	0.5	40709.4	23.0	11.1	1.4	1.2	2.1	3.8	4.5	1.5	0.8	8.5	29085.2	1.8	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.2	1.0	1.9	1.4	1.4	1.2	1.2	1.5	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2810	"liver: 280.9"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	142	"brain: 30812.9;choroid plexus: 9144.9"	"Cell type enriched"	"Detected in many"	11	"Oligodendrocytes: 2895.5"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 99.3;SK-MEL-30: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA		54000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	27.3	7.1	15448.6	20.9	21296.6	43.0	20.9	19749.8	26916.8	17.3	9144.9	19.0	18.6	13.2	7.9	20.5	31.5	17.2	24.1	12696.6	16271.8	28.7	23.5	20.0	26.9	30812.9	22193.8	22.3	22.8	47.5	26.7	4.7	25986.2	15.3	16.9	7.5	22.0	13.0	140.8	28.7	20.7	8.7	23219.4	28.0	17.5	6.1	19406.0	12.5	22.2	81.6	27.8	19.0	20.2	30044.2	26.1	22.4	0.2	0.8	35.8	53.1	8.5	0.6	0.6	0.8	0.6	3.2	39.2	15.9	4.4	1.7	0.2	49.9	3.8	22.1	0.7	60.7	5.3	10.4	3.9	5.2	22.5	99.3	65.3	7.7	18.4	19.8	30.3	16.4	6.5	37.9	0.0	3.6	0.0	3.2	4.1	50.6	2.2	15.6	18.1	1.5	0.4	35.9	34.5	34.3	1.8	0.3	3.2	0.0	204.7	6.1	0.6	60.5	0.1	0.2	0.5	0.2	2.8	0.1	0.5	16.9	5.8	62.0	2.5	21.7	8.5	32.4	21.6	8.1	13.1	5.9	15.4	28.1	9.2	5.1	9.1	17.0	39.5	28.0	8.1	11.9	14.9	11.6	15448.6	21296.6	19749.8	26916.8	12696.6	16271.8	30812.9	22193.8	25986.2	23219.4	19406.0	30044.2	5.5	48.1	39.5	10.7	86.8	118.8	61.1	28.1	84.2	52.8	24.2	22.7	45.0	35.8	50.3	103.0	2.1	0.7	221.8	48.7	41.1	43.7	5.9	159.8	11.2	9.4	49.8	68.8	32.4	35.8	0.8	36.2	59.1	161.1	71.5	2.1	10.0	30.2	44.4	1.7	47.1	51.4	44.7	78.3	123.1	6.3	28.3	98.2	92.5	45.0	84.4	25.7	247.2	124.7	2895.5	60.4	25.5	14.3	45.3	117.6	37.5	36.0	54.0	6.1	0.0	88.7	8.4	7.7	1.1	75.6	154.7	0.7	151.6	0.0	42.1	103.7
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 153.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	37.9	22.6	9.5	9.5	10.9	13.9	33.2	9.9	13.4	12.3	13.8	17.4	16.1	10.1	14.6	17.6	12.2	11.9	34.2	9.2	9.3	58.8	59.3	17.9	11.7	9.5	9.1	17.2	31.2	18.7	8.4	6.3	10.6	15.1	18.6	10.8	18.0	13.4	21.9	12.2	13.8	10.6	9.3	11.8	21.7	9.1	11.1	16.0	18.9	26.3	15.5	26.5	9.4	13.3	43.1	16.5	10.3	10.6	42.6	19.1	20.4	19.5	26.4	21.1	23.5	22.9	17.1	47.6	31.0	17.2	35.8	22.0	15.4	12.9	26.4	16.6	17.0	40.0	18.3	23.9	28.7	27.5	22.0	21.6	14.5	10.0	23.3	14.0	28.6	40.7	22.7	24.7	23.6	35.4	27.1	15.9	11.2	66.3	17.9	22.4	22.6	60.1	32.2	67.2	22.0	16.4	75.3	100.1	21.1	10.7	153.9	37.8	14.0	15.8	12.5	12.8	28.6	24.3	48.8	48.2	16.8	38.4	15.2	14.4	13.3	25.0	10.7	15.6	12.3	17.9	14.1	11.8	26.6	15.4	14.7	13.1	2.1	25.4	16.8	17.3	9.6	10.7	9.5	10.9	9.9	13.4	9.2	9.3	9.5	9.1	10.6	9.3	11.1	13.3	6.2	9.6	53.9	44.7	14.6	7.0	20.1	17.9	15.9	13.0	10.6	9.5	32.8	31.5	20.2	27.6	10.4	35.4	6.3	7.2	33.2	25.3	5.4	11.0	10.2	6.6	6.0	10.9	66.6	17.2	5.4	10.3	21.4	21.9	7.6	19.0	6.1	36.5	16.5	8.4	56.9	13.6	16.2	11.1	8.6	5.5	8.7	10.5	7.2	44.0	10.5	12.0	4.1	47.7	61.6	13.4	15.8	10.5	12.5	10.4	13.5	40.6	21.4	11.2	6.6	11.6	9.6	8.1	4.4	22.3	5.8	28.3	10.1	24.3	20.5	21.7
MCF2	"ARHGEF21, DBL"	ENSG00000101977	"MCF.2 cell line derived transforming sequence"	P10911	X	139581770-139708227	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.5;seminal vesicle: 17.0;testis: 18.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 98.0;Excitatory neurons: 27.8;Inhibitory neurons: 36.2;Oligodendrocyte precursor cells: 20.6;Theca cells: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"U-251 MG: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.11e-4)"	"unprognostic (8.95e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.62e-4)"	"unprognostic (4.02e-2)"	0.2	29.5	5.8	0.4	4.5	0.7	0.1	6.4	8.8	0.0	1.7	0.1	0.0	0.1	12.3	0.0	0.8	0.7	1.0	4.4	7.0	1.5	0.2	0.1	0.6	9.1	7.4	10.2	0.2	0.0	3.4	0.0	9.7	1.2	0.0	9.2	1.0	17.0	0.1	0.1	0.3	0.0	5.5	1.1	0.2	18.6	14.1	0.5	1.1	0.2	0.1	0.2	0.1	5.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.5	3.1	0.0	0.5	0.6	2.5	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.6	37.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	4.5	6.4	8.8	4.4	7.0	9.1	7.4	9.7	5.5	14.1	5.9	0.2	0.0	0.0	3.6	0.3	0.1	0.3	0.2	0.6	2.2	0.6	0.4	1.8	0.0	0.0	0.0	98.0	0.0	0.3	0.1	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	27.8	0.0	0.0	0.7	0.0	0.1	0.0	2.2	0.4	0.2	0.1	0.0	36.2	0.0	0.0	0.6	0.3	2.5	1.2	0.2	0.0	4.7	1.4	1.0	4.1	20.6	7.6	0.1	0.0	8.2	0.1	0.4	0.0	0.6	0.0	2.4	0.0	0.1	0.4	0.6	0.8	0.1	0.0	0.0	0.3	22.8	0.0	0.2
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit"	Q8NI22	2	46901870-46941855	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 253.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022410, HPA034593"	Supported				"Intracellular and membrane"	NA	NA		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"CAB022410: , HPA034593: AB_2674239"	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.64e-4)"	52.0	155.5	41.3	35.6	43.1	34.7	55.1	38.1	40.3	50.4	69.5	32.2	32.5	54.5	42.1	45.9	41.9	44.9	42.3	41.3	46.8	59.4	111.8	45.0	32.1	33.5	41.3	79.2	104.1	52.5	38.7	70.1	41.6	54.0	26.9	83.3	149.7	82.9	83.3	26.0	33.4	52.5	28.0	44.6	33.9	30.9	48.6	30.8	121.0	84.6	34.2	41.2	29.2	34.7	147.7	86.9	74.7	59.7	151.5	215.1	115.4	248.4	254.1	129.4	116.8	116.9	109.4	96.4	297.7	294.7	154.3	81.8	67.0	127.0	207.7	64.5	67.2	101.9	87.1	182.5	236.5	94.8	158.6	163.2	77.8	206.7	178.7	247.9	210.8	28.0	199.3	56.0	266.8	48.7	56.9	67.6	63.9	102.3	84.1	68.3	133.2	106.7	80.3	59.3	23.9	62.2	93.1	46.9	116.0	86.3	33.1	80.6	341.1	298.3	130.5	97.0	164.2	42.0	43.8	76.4	320.2	88.0	100.8	27.2	21.4	29.7	9.6	23.3	12.2	12.5	10.9	10.2	18.4	12.8	14.3	9.8	12.0	9.9	18.3	16.9	9.7	14.0	41.3	43.1	38.1	40.3	41.3	46.8	33.5	41.3	41.6	28.0	48.6	34.7	50.8	105.8	89.1	16.6	29.6	48.2	56.5	65.3	36.5	69.3	64.4	48.5	70.3	38.6	68.8	47.8	39.6	75.5	25.4	26.6	21.5	88.6	144.3	76.4	60.2	64.7	26.8	28.2	19.6	178.5	64.5	70.1	20.4	69.9	50.5	44.1	53.9	155.1	54.5	38.7	23.8	28.5	18.3	40.5	31.3	113.7	62.7	39.2	12.4	7.5	33.8	253.2	12.3	16.1	16.2	152.7	23.1	59.5	43.8	82.4	42.2	41.3	69.6	51.3	65.7	63.9	55.4	48.9	32.6	39.6	44.9	102.1	23.4	74.3	22.8	75.8
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568145	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	22.3	29.7	29.2	27.3	29.9	32.1	23.4	28.3	33.4	26.4	27.8	30.3	27.3	31.3	23.7	34.9	30.1	22.9	68.2	29.6	27.2	34.5	24.6	24.3	33.2	29.9	28.1	23.6	32.7	35.7	24.0	24.5	28.5	31.3	25.9	17.2	27.0	26.9	53.2	26.9	29.2	26.1	28.2	32.8	31.8	35.2	29.4	39.4	35.5	61.4	31.1	29.3	26.2	31.4	43.8	81.5	62.9	54.5	33.2	40.9	69.3	37.5	40.4	95.7	53.2	127.3	69.7	72.6	76.4	66.0	43.7	48.5	97.8	89.0	38.3	57.6	120.3	72.4	53.4	46.9	59.6	85.0	76.0	47.7	68.3	63.8	51.3	56.0	71.0	66.0	90.9	48.0	55.4	77.8	59.1	51.1	87.4	40.7	60.1	69.1	50.7	84.0	59.4	40.3	60.6	63.5	40.8	51.7	36.5	42.8	84.4	101.7	51.6	45.8	58.4	44.7	56.7	47.3	50.9	69.2	60.1	49.8	27.8	96.2	63.7	76.4	63.2	82.7	49.1	44.5	53.6	68.1	79.1	46.1	46.8	51.0	31.8	90.7	64.7	53.5	60.4	76.3	29.2	29.9	28.3	33.4	29.6	27.2	29.9	28.1	28.5	28.2	29.4	31.4	17.0	35.3	13.8	6.2	23.3	10.7	25.1	38.5	10.8	15.6	19.8	19.7	24.2	28.6	22.4	23.9	8.4	52.1	22.1	34.3	52.8	37.7	32.1	16.3	15.3	17.4	27.5	35.1	12.8	36.1	51.8	20.2	39.8	15.7	27.3	24.3	15.0	10.5	40.6	23.5	12.6	27.2	28.5	22.0	12.5	37.8	27.4	20.9	28.4	9.4	38.0	28.1	40.2	7.1	12.3	39.7	37.1	27.1	24.3	26.7	34.1	45.4	22.8	20.5	6.6	14.7	26.9	41.6	64.0	27.4	12.6	59.2	25.6	23.7	33.8	27.0
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50879080-50954257	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 176.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		84000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.1	15.7	12.7	21.9	13.6	15.6	9.3	14.1	16.8	8.9	55.5	30.6	38.3	9.0	8.9	12.8	8.5	12.7	45.0	14.8	15.4	12.6	15.1	11.6	25.8	15.6	16.2	8.0	20.9	32.2	10.0	13.1	16.2	13.8	32.4	14.6	7.2	19.9	26.2	8.8	32.3	18.1	13.9	27.2	26.5	18.8	15.4	21.4	10.9	22.9	22.6	16.8	3.4	14.3	40.5	39.9	52.0	61.0	23.2	25.6	24.2	33.2	24.7	42.2	35.5	18.4	21.8	143.3	12.8	29.7	38.5	32.6	78.1	33.3	48.2	60.0	11.6	36.5	22.8	21.5	68.1	123.9	42.5	16.0	40.3	53.1	85.8	27.8	55.0	83.5	39.9	34.1	29.1	8.4	90.4	12.3	34.8	29.0	15.9	58.0	25.8	41.1	45.9	8.6	63.9	34.0	31.0	18.7	33.0	31.0	14.4	59.0	34.6	30.0	32.7	15.8	44.7	62.9	27.1	70.6	30.2	86.5	32.5	7.5	16.4	20.7	6.5	19.0	5.1	7.1	4.2	7.9	13.3	7.2	3.6	4.5	18.1	9.8	25.7	4.4	4.4	7.4	12.7	13.6	14.1	16.8	14.8	15.4	15.6	16.2	16.2	13.9	15.4	14.3	20.9	9.6	11.9	40.1	32.8	15.2	20.2	13.6	12.5	17.0	10.9	10.0	103.6	11.5	22.6	14.7	14.6	16.7	37.9	39.0	39.2	31.9	18.0	18.5	22.6	18.7	12.0	16.6	35.6	38.6	16.3	19.1	43.3	19.1	16.4	176.4	24.3	9.1	89.7	8.4	45.9	27.3	18.3	93.8	15.1	6.7	11.5	54.5	12.4	47.8	48.3	18.0	48.4	52.3	32.5	35.6	22.3	16.6	61.5	25.0	72.4	17.1	10.6	55.0	6.6	23.0	23.2	59.8	30.6	13.2	10.7	8.6	28.1	22.4	36.5	17.4
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 54.2;Excitatory neurons: 103.7;Inhibitory neurons: 147.8;Oligodendrocyte precursor cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 54.4;hTERT-RPE1: 64.1;HUVEC TERT2: 36.3;TIME: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA038473	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	17.4	24.4	25.5	5.0	27.2	6.2	19.5	12.2	31.5	24.5	14.4	16.4	7.1	16.7	5.6	4.2	13.6	11.5	26.2	27.0	15.7	25.1	6.2	11.3	4.2	24.8	25.9	27.9	15.9	16.2	22.4	4.7	22.9	19.9	13.7	10.8	12.6	9.0	21.9	4.5	8.9	14.1	5.3	10.9	21.0	13.0	20.4	3.5	12.5	19.5	2.4	17.1	14.2	16.5	0.0	18.1	5.2	0.0	7.9	16.6	0.1	5.9	9.6	12.9	16.0	14.0	54.4	0.0	5.3	5.7	31.5	0.2	0.0	0.1	5.6	9.2	0.0	9.6	16.8	0.0	11.9	1.2	0.0	11.8	2.8	10.2	0.1	64.1	36.3	0.0	0.2	0.0	9.1	1.8	2.7	0.1	1.2	1.7	7.7	8.3	0.0	0.6	11.4	21.4	6.2	0.1	3.8	0.1	0.0	2.1	0.9	1.5	40.0	1.5	1.2	26.3	0.9	0.1	3.3	0.0	1.4	17.1	1.6	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.7	1.2	2.3	0.0	0.9	1.1	0.0	1.0	0.1	0.3	0.0	0.5	25.5	27.2	12.2	31.5	27.0	15.7	24.8	25.9	22.9	5.3	20.4	16.5	13.6	3.2	3.3	30.3	1.1	2.3	4.6	5.4	5.7	16.5	7.5	9.1	54.2	2.8	8.1	3.7	0.0	0.3	1.9	19.2	43.0	9.1	0.7	3.2	6.1	11.5	9.0	4.2	103.7	7.9	0.4	8.4	19.9	1.6	0.0	33.4	14.6	1.6	6.8	20.2	147.8	14.8	4.1	1.6	3.5	2.5	6.2	1.8	1.8	14.0	1.1	2.0	1.0	75.4	4.8	11.5	21.1	6.4	0.5	6.4	3.5	6.5	14.9	2.5	13.1	7.0	8.2	0.4	0.2	2.6	1.6	0.0	1.6	38.8	11.0	6.6
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451272	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 206.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: AB_2681962"	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	10.3	8.7	7.2	11.3	7.7	12.9	10.6	8.5	8.2	9.7	7.4	10.6	7.7	11.0	5.9	9.8	9.3	7.6	9.6	6.9	7.4	8.8	9.0	8.7	13.3	7.2	7.3	11.3	7.9	16.8	6.0	10.4	7.5	8.3	9.5	8.0	8.6	7.7	13.7	11.1	9.7	11.2	7.4	11.2	8.6	10.7	7.7	16.9	9.1	12.2	14.7	10.9	9.1	8.8	20.1	24.5	32.5	22.7	23.1	23.7	25.8	24.0	25.6	30.6	30.1	24.9	20.1	51.4	26.2	28.9	37.2	38.3	38.0	22.9	50.0	49.2	31.8	32.3	24.1	24.0	24.4	59.8	33.9	22.1	23.6	39.3	55.0	20.1	28.1	30.6	42.1	28.4	25.7	10.7	56.5	23.2	20.9	19.4	15.1	41.3	43.1	22.9	18.5	22.4	20.3	23.2	30.9	206.2	27.6	28.0	38.5	33.4	23.7	24.8	31.1	28.1	42.3	25.3	36.4	53.6	24.3	28.4	32.0	1.3	1.4	1.8	1.6	1.4	1.9	2.2	1.8	1.8	1.5	2.0	1.8	2.1	1.2	1.9	0.8	1.5	1.5	1.0	7.2	7.7	8.5	8.2	6.9	7.4	7.2	7.3	7.5	7.4	7.7	8.8	18.8	25.6	13.9	10.1	24.7	27.1	14.2	13.1	19.4	13.7	18.0	13.8	18.9	12.8	21.0	9.2	14.6	17.2	20.6	12.7	3.9	12.3	7.9	19.0	27.1	21.2	13.8	26.9	13.4	12.0	12.8	19.7	10.7	27.0	9.5	19.9	17.2	20.2	14.9	11.8	13.9	14.8	16.2	20.0	16.5	7.7	14.6	16.4	21.4	11.2	21.0	13.5	17.5	11.1	16.0	13.7	12.1	18.0	20.2	19.9	9.4	8.5	17.4	12.0	19.7	26.1	21.2	22.3	17.0	21.7	32.7	22.2	22.8	18.7	15.0	18.7
MED24	"CRSP100, CRSP4, DRIP100, KIAA0130, MED5, THRAP4, TRAP100"	ENSG00000008838	"Mediator complex subunit 24"	O75448	17	40019097-40061215	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 178.1;Club cells: 100.6;Ionocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 244.1;SK-BR-3: 283.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-1)"	28.4	30.6	21.6	24.8	23.0	37.3	29.1	20.7	29.2	37.8	18.3	29.5	28.6	33.9	19.0	32.6	31.8	16.8	35.3	24.2	19.0	29.1	25.7	46.5	26.7	18.3	21.2	38.8	25.6	31.2	39.1	23.8	19.5	28.1	24.5	26.4	31.4	17.9	84.0	35.2	30.1	24.3	16.9	30.1	30.5	35.8	19.3	32.7	28.9	48.9	27.9	25.8	30.1	19.6	31.8	63.3	57.3	59.1	38.7	36.1	44.6	41.7	32.5	56.7	50.4	63.1	42.2	65.0	71.6	46.5	28.2	72.8	89.7	244.1	45.3	59.8	147.2	34.0	59.2	84.0	32.2	84.4	63.0	45.0	45.5	56.3	34.1	36.8	75.0	42.8	98.1	41.9	38.6	42.1	93.7	55.2	37.7	36.7	72.4	71.2	45.2	54.5	29.7	36.5	79.9	57.8	43.9	283.0	33.4	49.3	62.4	75.4	45.2	31.1	26.0	34.5	53.6	39.0	41.4	49.5	56.5	42.2	42.7	0.5	4.8	6.0	5.3	6.0	4.2	4.6	3.7	6.1	6.8	4.0	3.5	4.2	0.3	3.5	3.9	2.8	3.9	5.1	21.6	23.0	20.7	29.2	24.2	19.0	18.3	21.2	19.5	16.9	19.3	19.6	14.9	22.4	51.3	13.1	12.7	11.3	25.1	178.1	13.1	11.9	31.4	24.9	16.3	20.0	100.6	23.9	16.7	28.9	8.3	24.8	15.6	15.1	14.8	20.6	10.2	43.3	28.1	27.0	17.6	18.0	23.3	12.2	42.3	27.0	10.8	28.5	9.3	14.8	20.0	10.1	20.3	34.1	99.7	12.0	19.2	8.6	9.9	8.6	14.2	9.4	15.4	10.8	6.2	13.6	13.9	18.5	43.7	9.4	14.2	10.4	23.7	17.6	66.3	11.5	6.6	10.9	13.5	13.4	15.5	12.0	18.6	22.6	10.7	18.0	33.3	28.6
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	30.4	27.8	24.0	20.9	25.1	27.0	26.5	24.6	29.1	24.0	27.3	25.1	23.1	21.8	24.0	43.5	20.6	16.8	20.7	24.6	25.1	27.3	43.6	24.4	21.7	26.8	25.0	21.9	29.5	20.9	36.3	25.5	26.1	23.7	24.7	40.3	26.9	20.5	22.4	36.4	22.9	24.3	24.8	25.9	28.2	22.3	25.3	17.5	25.6	14.5	28.1	24.1	27.3	27.2	56.8	35.3	31.8	38.0	48.7	48.2	42.7	56.5	51.4	65.8	69.3	65.7	40.7	33.2	39.7	71.8	43.2	34.7	50.2	47.7	62.9	47.9	48.5	56.5	60.5	82.8	82.3	50.7	57.5	47.5	60.6	71.2	84.6	39.4	53.3	31.1	50.8	57.1	42.9	36.4	26.1	40.8	30.5	52.3	39.9	30.9	37.3	53.6	43.5	35.8	33.2	25.1	33.2	53.7	111.9	43.6	36.3	97.8	39.9	29.2	52.0	55.9	80.5	67.5	83.4	40.2	60.8	61.2	39.0	44.7	57.0	54.9	33.6	53.1	32.1	44.5	30.5	38.0	57.0	36.8	30.7	32.0	45.3	32.6	48.4	26.2	43.3	38.8	24.0	25.1	24.6	29.1	24.6	25.1	26.8	25.0	26.1	24.8	25.3	27.2	25.6	16.0	12.9	5.9	25.8	18.7	23.2	35.6	11.4	27.7	23.9	23.4	12.6	27.1	28.2	14.7	14.6	52.9	26.2	26.4	33.2	51.1	13.6	16.3	23.9	25.1	19.3	42.5	11.5	75.6	72.3	30.3	23.0	19.7	31.7	21.8	16.4	27.8	60.4	16.8	8.0	29.2	28.5	18.2	32.0	22.8	24.5	26.2	19.6	4.7	35.9	32.3	28.8	6.6	13.8	57.9	30.0	21.8	41.2	24.6	40.8	48.5	16.0	58.7	26.3	12.3	42.9	64.6	45.0	24.3	25.4	88.4	23.3	31.9	22.6	39.9
MEGF8	"C19orf49, EGFL4, FLJ22365, SBP1"	ENSG00000105429	"Multiple EGF like domains 8"	Q7Z7M0	19	42325609-42378769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 38.7;Cone photoreceptor cells: 77.2;Horizontal cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049248	Approved					NA	NA		510000000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA049248: AB_2680691"	"unprognostic (5.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (6.03e-4)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.17e-7)"	"unprognostic (1.18e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	13.0	12.3	23.4	4.3	20.9	2.3	10.0	11.1	30.6	10.4	6.7	11.8	4.8	11.9	7.0	7.3	9.7	4.6	16.6	21.7	18.0	11.3	6.9	6.8	3.9	16.1	19.7	13.5	8.7	20.5	12.3	6.1	17.4	10.0	4.3	10.9	8.5	8.1	10.2	6.8	8.6	6.7	12.1	9.1	9.3	7.9	23.0	3.8	10.7	6.8	3.3	10.2	7.9	17.3	12.7	21.1	22.2	5.5	48.6	23.1	8.2	10.6	14.8	6.0	9.3	4.2	11.6	10.7	22.4	14.7	7.9	6.6	16.2	13.8	6.0	13.1	14.1	8.0	10.3	6.9	18.7	10.9	9.5	28.0	13.6	7.3	10.9	39.9	20.7	3.1	11.8	4.7	11.3	8.3	2.5	6.6	11.3	11.5	3.5	10.4	20.0	2.4	16.1	16.6	11.5	29.3	13.0	6.8	14.4	23.8	7.2	24.3	31.1	12.7	12.3	4.0	14.6	10.9	6.4	5.9	13.8	6.5	31.2	0.4	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.1	23.4	20.9	11.1	30.6	21.7	18.0	16.1	19.7	17.4	12.1	23.0	17.3	6.2	6.4	10.8	13.7	3.2	2.2	2.4	7.3	4.6	38.7	5.7	6.3	15.9	2.8	10.3	7.3	77.2	3.7	3.2	8.4	0.0	7.2	3.4	7.9	9.8	7.0	13.2	1.7	24.4	3.7	1.5	9.2	4.6	6.7	3.8	26.2	7.1	8.9	5.9	40.4	27.2	6.7	6.1	4.7	3.9	1.2	12.8	3.2	8.8	8.4	4.0	13.1	2.1	10.1	10.0	4.6	3.1	14.3	3.2	2.6	5.4	4.4	7.2	16.3	0.0	11.9	8.9	5.9	4.2	5.7	1.0	2.3	2.5	18.9	10.9	1.4
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600811-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 68.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.0;Cone photoreceptor cells: 212.7;Oligodendrocytes: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.2;monocytes: 7.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		96000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	18.1	10.1	24.1	11.5	28.7	18.8	13.6	28.7	26.1	12.0	4.8	7.2	7.0	6.3	5.6	14.0	14.0	8.5	6.4	26.0	34.4	13.5	38.7	20.3	6.5	37.2	33.6	9.7	5.6	11.5	5.3	5.1	27.3	8.7	6.0	68.2	7.7	6.6	7.3	21.5	7.2	8.9	28.2	15.2	8.0	3.3	34.0	5.6	28.4	8.5	6.2	9.7	7.4	37.3	5.0	19.4	16.7	5.2	22.6	13.9	5.3	5.0	4.4	1.3	1.8	1.1	2.9	18.6	7.4	4.8	6.0	21.2	24.1	8.7	3.6	15.2	6.9	2.5	34.1	8.1	9.6	7.5	15.3	6.5	26.1	8.2	6.6	46.0	11.8	9.9	6.0	8.6	13.9	14.4	14.8	2.7	0.7	11.1	5.2	11.2	18.6	7.9	34.0	16.1	16.4	13.9	6.0	4.8	14.7	2.7	14.5	7.5	13.9	5.0	2.8	18.4	7.7	15.5	19.5	6.0	7.0	8.7	28.8	0.6	7.4	5.1	0.8	2.5	0.3	0.4	0.7	0.6	3.0	0.4	0.6	0.5	25.2	0.5	4.5	0.2	0.7	1.9	24.1	28.7	28.7	26.1	26.0	34.4	37.2	33.6	27.3	28.2	34.0	37.3	6.5	86.6	65.0	143.0	8.4	27.4	5.6	8.4	25.0	31.5	30.3	12.8	28.2	14.3	15.6	23.9	212.7	0.5	10.8	7.5	0.0	4.0	0.9	11.8	5.8	7.6	6.6	18.9	85.9	5.4	1.9	10.3	14.3	19.3	7.0	8.4	10.0	48.0	5.8	13.5	63.8	4.7	16.2	45.2	13.9	2.7	11.5	41.3	26.6	22.5	107.2	30.9	13.4	93.0	240.7	13.8	8.6	11.7	11.5	8.3	7.4	6.6	6.1	75.4	13.1	26.5	9.3	14.8	7.3	41.3	43.9	1.2	11.4	4.8	5.5	6.2
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 21.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017214	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	0.9	0.5	0.0	5.7	0.0	10.0	1.4	0.0	0.1	1.3	0.0	6.8	5.2	1.0	0.0	7.9	0.3	0.6	0.2	0.0	0.0	0.3	0.7	0.9	10.0	0.0	0.1	0.2	0.3	0.1	0.0	5.3	0.1	0.3	8.5	0.0	1.2	0.1	0.0	3.4	4.4	2.4	0.0	2.0	3.2	9.2	0.3	21.0	0.3	0.1	11.7	1.7	2.3	0.0	123.4	62.1	81.6	48.5	11.1	18.8	47.1	88.8	62.2	121.5	148.2	47.8	47.3	40.9	27.8	43.8	106.5	41.0	71.7	55.5	133.1	112.3	28.6	32.0	69.1	48.1	4.3	50.2	39.0	6.9	9.8	93.9	53.0	15.6	62.2	61.9	41.7	63.2	100.9	40.9	63.1	23.4	65.1	55.1	47.9	57.4	54.9	25.8	37.7	40.7	55.1	40.8	47.4	45.3	28.6	45.2	38.0	23.7	30.8	65.4	81.8	56.1	82.3	12.3	47.9	60.7	41.2	36.8	91.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.9	4.6	0.9	3.5	0.0	0.0	0.9	0.8	0.4	0.0	2.0	0.0	0.0	16.1	0.7	4.5	0.0	1.1	2.8	2.9	1.4	1.3	0.0	15.2	0.8	1.1	44.1	3.3	4.6	2.1	0.0	7.8	1.4	0.7	10.1	0.0	0.7	4.7	4.1	1.6	3.0	2.7	1.2	1.9	0.0	0.0	3.1	0.0	2.1	1.0	0.4	1.7	2.7	0.0	10.2	0.5	0.6	0.1	2.0	0.0	0.0	0.0	3.7	23.2	21.3	9.3	1.7	8.9	2.7	0.7	8.9	2.3
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029817	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1;salivary gland: 68.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 162.1;SK-MEL-30: 201.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	NA	NA		41000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	10.0	1.7	2.3	3.8	1.7	2.3	7.4	2.1	3.8	8.1	27.2	4.0	2.4	6.8	0.7	2.9	8.6	1.6	7.5	2.5	1.9	35.1	1.6	1.9	1.9	0.6	2.8	1.2	4.6	10.3	2.9	1.5	0.4	4.1	2.1	0.3	68.7	5.5	1.1	16.4	9.9	1.2	0.5	1.1	1.7	3.4	6.5	2.9	3.1	1.0	1.6	3.2	7.3	2.0	162.1	34.6	0.4	1.2	4.8	6.0	4.0	2.8	1.5	5.2	6.3	9.8	23.6	4.5	33.3	5.6	4.5	49.6	1.8	0.1	2.3	7.4	10.8	5.6	7.9	4.1	30.5	0.8	30.8	33.0	4.3	4.3	0.4	0.2	0.8	8.9	4.3	30.5	3.1	9.8	9.3	0.0	3.6	6.9	22.5	13.4	5.3	2.0	0.8	1.5	3.1	11.3	32.5	2.8	201.4	3.8	9.5	4.8	1.2	1.2	26.8	5.5	19.9	5.3	46.0	4.5	3.9	9.5	0.2	0.0	0.1	0.0	0.2	0.2	0.8	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	2.3	1.7	2.1	3.8	2.5	1.9	0.6	2.8	0.4	0.5	6.5	2.0	0.8	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	21.1	20.6	0.0	0.0	1.8	14.7	0.0	0.2	1.0	0.0	0.0	28.3	0.0	3.2	6.1	0.6	0.0	0.0	0.0	5.7	0.3	3.7	0.0	4.4	0.0	3.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	66.4	0.0	0.0	1.7	0.0	0.0	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793389-46839778	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"intestine: 467.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2"									"CAB025163, HPA029416"	Enhanced					NA	NA		2100000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.2	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	115.6	269.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	4.2	0.0	0.0	0.5	0.1	0.1	102.5	0.0	0.0	0.2	0.0	0.0	467.7	2.6	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	309.4	0.0	0.0	7.7	0.1	0.0	0.0	15.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	87.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.0	156.9	0.4	0.0	0.0	902.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	45.8	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.6;Club cells: 99.8;Glandular and luminal cells: 161.4;Pancreatic endocrine cells: 93.9;Prostatic glandular cells: 149.3;Urothelial cells: 128.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 7.5;hippocampal formation: 6.6;midbrain: 2.5;pons: 4.9;white matter: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 203.8;CAPAN-2: 219.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	100000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	10.3	0.8	0.1	3.4	0.6	7.4	8.9	0.1	7.5	13.1	9.6	9.7	6.5	6.4	2.5	6.1	4.7	11.9	6.2	6.6	0.8	20.1	42.9	20.3	2.3	1.1	2.5	0.8	6.6	0.8	3.8	26.4	4.9	6.7	9.3	3.9	8.7	11.2	14.3	7.7	8.2	5.7	0.3	6.0	15.4	0.5	0.5	3.7	17.6	11.0	3.2	18.4	4.4	7.8	203.8	115.3	0.1	0.6	8.6	8.7	7.9	113.7	48.2	60.3	51.1	25.0	219.0	8.4	179.0	72.1	163.3	51.8	19.7	110.0	123.7	0.3	23.4	0.1	112.5	21.4	1.5	0.3	0.2	11.4	42.4	40.6	129.1	109.4	42.4	0.2	4.5	0.8	114.1	5.0	0.1	0.1	17.3	32.9	113.0	0.2	95.3	0.2	105.8	24.0	16.5	0.0	45.4	15.4	44.9	19.8	0.4	0.9	72.3	89.7	30.6	46.7	88.9	2.5	19.1	1.5	99.3	0.3	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	7.5	6.6	0.8	1.1	2.5	4.9	0.3	0.5	7.8	32.6	28.9	103.6	0.3	1.0	39.0	70.5	58.1	38.1	6.7	6.5	6.9	12.3	11.5	99.8	31.3	0.0	76.0	0.4	20.5	0.0	38.5	0.0	52.5	11.6	20.1	7.2	0.0	2.6	46.9	7.5	7.4	32.6	161.4	0.0	0.0	3.9	30.5	7.0	0.0	1.0	20.5	18.3	1.3	2.2	0.1	0.6	4.4	3.6	1.9	1.0	7.6	0.0	0.5	7.7	93.9	5.5	0.0	0.4	149.3	11.2	15.6	34.5	0.3	0.0	37.8	5.2	0.0	0.6	7.9	17.8	21.8	1.2	0.0	16.4	128.6
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		70000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	52.5	58.0	41.1	51.6	44.5	102.2	55.0	45.0	53.2	46.0	39.7	50.7	36.7	54.2	52.6	54.7	42.6	47.0	65.9	40.2	49.9	55.6	84.5	49.0	78.0	46.5	43.8	60.5	52.7	52.3	36.6	51.3	48.8	43.3	50.9	30.8	40.6	101.0	119.5	58.3	37.7	54.9	42.4	40.3	37.4	61.8	44.7	69.1	51.8	78.7	125.0	62.2	41.5	50.2	192.3	157.8	163.7	129.6	98.4	156.4	125.9	186.0	127.6	177.7	125.7	228.0	88.6	542.1	113.5	133.4	101.9	120.5	187.4	142.4	203.8	131.2	161.2	244.9	113.7	165.6	104.5	313.5	117.1	137.5	148.1	164.9	164.0	210.7	192.9	184.2	321.8	60.5	135.3	125.8	230.3	213.0	204.5	109.4	233.4	179.6	141.5	178.5	123.5	198.3	127.0	165.3	166.0	132.7	169.0	140.6	159.4	146.5	165.1	100.7	98.5	115.0	195.7	87.7	246.8	585.1	58.1	173.7	129.9	77.5	70.5	32.0	60.0	52.2	74.3	114.2	66.8	67.8	66.0	101.8	79.2	74.1	3.4	72.8	65.6	85.3	71.6	46.4	41.1	44.5	45.0	53.2	40.2	49.9	46.5	43.8	48.8	42.4	44.7	50.2	87.0	282.0	238.9	22.9	101.3	233.2	130.2	141.3	97.3	70.6	119.7	95.9	143.6	100.1	133.3	290.6	66.7	146.2	87.7	96.8	164.4	115.2	189.5	114.9	260.0	110.2	91.7	278.4	35.1	145.8	161.5	112.2	53.0	153.7	122.9	140.5	112.1	314.6	98.1	75.7	49.5	119.7	73.2	141.0	89.8	123.3	100.3	83.8	92.5	20.6	103.5	72.6	81.4	26.2	41.4	130.1	105.8	106.8	87.0	108.1	93.4	186.6	92.4	83.8	98.6	137.4	133.4	378.4	207.6	95.2	215.0	172.0	80.7	101.4	144.8	110.5
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772119	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	13.6	23.2	8.9	9.8	9.2	11.0	12.8	8.7	11.9	9.8	9.9	8.4	4.0	10.8	20.8	13.1	10.2	5.5	10.3	9.2	9.4	22.0	17.5	9.3	8.1	9.2	9.3	11.3	28.0	9.1	12.7	8.7	9.0	13.4	10.8	3.7	10.6	7.1	15.5	11.7	6.9	12.3	8.9	9.0	9.8	9.9	9.6	4.8	14.3	6.9	9.3	16.5	9.4	9.0	24.7	44.1	17.7	14.9	22.6	15.7	23.4	24.8	23.1	41.9	24.7	32.0	32.6	28.8	45.7	33.0	23.1	27.9	27.4	39.8	38.0	17.2	32.6	34.9	17.4	35.0	17.9	39.0	17.4	14.7	32.7	47.8	33.5	18.9	22.2	17.8	34.1	28.2	23.1	47.0	26.1	39.6	40.6	29.1	41.5	23.0	293.1	43.1	33.6	29.8	18.7	16.2	26.9	29.6	22.9	16.0	38.5	32.0	17.1	17.4	18.0	29.6	34.0	13.2	9.3	32.6	24.4	25.3	34.5	0.0	7.1	0.0	8.0	10.8	27.4	6.9	10.0	9.6	16.3	10.5	13.4	13.2	1.1	12.9	1.8	19.3	5.1	7.5	8.9	9.2	8.7	11.9	9.2	9.4	9.2	9.3	9.0	8.9	9.6	9.0	6.3	9.6	3.3	0.7	8.3	10.5	17.1	14.8	13.6	3.7	12.2	12.4	4.3	10.0	14.1	5.5	0.0	18.7	3.1	6.3	25.4	16.8	12.1	5.3	13.2	8.2	6.6	6.3	0.8	24.1	25.3	11.3	10.2	8.9	12.7	8.7	3.3	7.9	22.7	3.3	0.6	8.4	12.2	2.2	9.8	10.9	11.1	6.4	7.2	0.0	16.7	2.6	3.1	3.5	1.1	12.3	2.3	4.9	14.9	15.4	1.1	60.4	2.6	5.4	0.0	9.7	13.0	8.0	17.7	12.1	10.4	9.7	4.1	14.0	10.7	11.3
METTL2A	"FLJ12760, METTL2"	ENSG00000087995	"Methyltransferase like 2A"	Q96IZ6	17	62423875-62453385	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.33e-3)"	"unprognostic (6.86e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.00e-1)"	2.5	3.5	2.7	2.3	2.6	1.9	2.6	3.2	3.0	1.8	2.9	3.1	1.8	2.5	2.4	3.1	2.5	1.7	3.7	2.8	2.9	2.5	3.0	2.3	2.5	2.5	2.5	2.7	3.7	2.6	1.8	2.0	2.6	2.2	2.6	2.7	2.8	1.2	6.4	3.9	2.4	1.9	2.4	2.5	2.9	1.7	2.7	1.8	3.2	2.8	2.4	2.1	2.1	3.0	3.9	3.8	5.3	8.5	2.9	3.7	4.2	4.2	2.6	4.2	2.7	2.6	3.7	4.6	2.2	2.9	1.7	4.2	9.2	4.3	5.7	4.4	7.6	9.2	3.1	3.0	4.8	11.2	4.0	3.4	5.2	2.8	5.4	3.6	2.4	5.9	9.5	4.3	3.8	4.9	11.9	5.1	7.1	5.0	5.1	7.8	15.5	4.4	3.6	4.4	5.4	12.2	2.4	4.9	6.3	2.3	9.9	6.6	5.3	4.5	5.8	4.2	6.8	5.2	6.4	5.7	7.8	6.1	5.7	1.8	1.0	0.9	1.9	1.0	1.6	1.4	1.5	1.5	0.6	1.9	1.4	1.8	2.1	2.4	1.1	1.7	1.5	0.8	2.7	2.6	3.2	3.0	2.8	2.9	2.5	2.5	2.6	2.4	2.7	3.0	10.9	25.6	12.1	4.2	9.2	9.2	17.0	21.5	7.4	17.0	9.1	9.1	11.1	12.8	20.3	12.9	18.8	21.8	9.2	11.1	23.5	19.3	9.7	10.8	11.6	9.0	7.2	9.4	6.8	14.5	14.3	10.3	10.7	11.4	3.8	14.9	7.1	10.8	13.0	5.0	7.1	9.8	10.2	4.4	8.1	5.3	5.0	5.4	3.6	0.0	6.9	14.5	12.3	4.5	5.7	16.0	15.6	13.2	17.7	20.9	8.5	15.0	19.7	16.4	13.1	13.4	11.6	23.3	11.8	11.9	14.2	15.7	8.9	17.2	15.3	24.0
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511342	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Oogenesis, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	12.1	18.5	12.1	11.3	13.0	5.8	16.0	12.6	13.1	12.9	12.5	11.9	7.6	13.2	18.1	11.7	18.8	9.8	16.7	12.5	12.9	14.1	11.7	12.9	19.0	14.1	13.1	15.0	11.5	19.0	13.0	15.2	13.7	17.3	12.9	8.6	14.2	16.7	16.8	16.5	10.6	16.3	13.1	13.9	11.2	19.8	13.4	17.8	16.8	18.6	21.2	14.4	12.4	13.7	39.6	57.7	55.0	22.2	40.5	33.4	27.5	35.9	26.0	41.7	48.5	22.0	46.4	40.8	22.6	22.3	54.2	41.6	66.4	35.2	65.7	39.1	39.8	25.9	31.9	88.1	16.6	34.8	28.2	25.0	30.3	26.0	30.2	18.6	54.8	20.8	32.0	23.5	55.9	29.1	31.0	28.6	46.4	66.1	70.7	30.7	42.6	36.5	38.8	26.6	33.4	36.6	38.7	50.6	37.5	42.7	39.8	22.8	36.6	15.0	24.8	27.6	24.9	24.9	32.5	29.0	18.2	27.7	32.0	6.5	8.9	8.9	8.0	11.5	12.4	14.3	10.0	9.4	10.9	10.8	10.3	9.3	0.9	15.7	9.6	13.0	15.5	8.4	12.1	13.0	12.6	13.1	12.5	12.9	14.1	13.1	13.7	13.1	13.4	13.7	12.5	12.8	20.1	15.7	16.2	14.9	23.3	21.2	21.1	23.4	15.1	16.5	30.6	12.8	13.6	12.9	14.6	31.1	16.2	5.4	3.9	14.5	188.2	11.7	11.4	14.7	10.8	20.4	15.0	10.0	15.7	15.3	7.1	10.0	8.8	20.4	9.7	9.5	16.6	21.9	13.7	8.7	14.2	10.0	9.9	24.3	17.1	10.8	16.0	10.3	17.9	14.9	15.5	19.1	21.7	10.8	6.5	19.9	14.9	18.8	5.5	9.1	15.3	21.0	32.9	16.4	17.5	42.4	20.3	12.4	12.4	25.3	13.2	13.2	13.4	19.0
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 242.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.5;Extravillous trophoblasts: 1015.1;Fibroblasts: 579.7;Syncytiotrophoblasts: 252.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 31.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 172.2;BJ: 63.7;EFO-21: 150.4;HeLa: 55.9;SuSa: 137.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 42.6"	HPA010553	Enhanced				"Secreted to extracellular matrix"	NA	NA		3200000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.81e-4)"	141.7	10.9	3.5	5.4	5.0	3.5	79.7	31.7	9.2	59.9	1.8	37.8	7.2	242.1	11.1	35.0	25.8	28.2	54.4	4.8	0.8	3.1	12.7	8.7	4.8	2.9	0.4	2.4	5.5	2.4	3.7	94.5	1.9	6.4	42.0	7.9	17.2	49.7	28.5	38.7	19.0	142.1	0.0	1.9	23.6	6.9	1.7	3.2	14.4	118.1	3.4	43.1	60.7	6.6	1.4	5.7	1.6	2.6	29.4	12.4	172.2	63.7	1.2	0.8	1.1	2.3	1.0	0.6	150.4	19.8	1.6	9.1	0.6	13.1	0.0	0.5	0.4	1.6	55.9	1.9	0.4	1.3	0.6	8.7	4.4	7.3	0.0	3.3	0.0	2.0	2.7	3.7	52.7	0.8	1.9	0.8	3.2	0.9	2.9	1.2	1.3	6.5	6.5	2.6	0.7	0.9	1.9	0.7	1.0	137.1	24.0	0.8	2.3	10.7	21.5	45.7	3.0	2.1	1.9	2.3	6.0	0.7	0.1	2.9	0.8	0.7	0.2	0.7	0.4	0.1	0.1	0.1	0.4	0.3	0.4	0.1	1.1	0.2	0.5	0.3	0.0	0.3	3.5	5.0	31.7	9.2	4.8	0.8	2.9	0.4	1.9	0.0	1.7	6.6	61.5	12.8	5.8	0.3	0.5	23.1	0.4	1.8	0.6	0.2	0.6	0.9	7.0	0.0	2.0	0.0	0.0	140.5	0.5	0.0	0.0	0.5	0.3	5.1	3.9	20.1	0.0	0.0	0.2	0.0	1015.1	579.7	3.6	28.0	0.0	0.2	4.2	0.0	27.7	0.0	0.1	0.0	0.0	9.5	36.3	0.5	61.2	8.8	12.4	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.9	0.0	40.2	35.2	0.1	0.2	0.6	18.0	252.3	5.3	0.1	0.0	0.3
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"	Q8IWA4	3	179347709-179394936	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	9.5	9.0	5.6	9.4	6.6	8.4	11.0	8.8	8.5	9.5	8.8	12.5	8.9	11.4	14.9	14.1	10.2	9.6	23.4	5.6	5.5	10.4	8.8	8.8	12.8	6.3	5.8	9.1	17.9	13.3	6.7	7.9	6.0	12.4	10.5	10.3	14.1	9.6	14.0	14.5	9.8	11.4	5.2	9.9	10.8	9.0	5.7	8.6	10.4	16.4	11.9	12.7	8.9	9.5	32.2	9.4	17.9	29.1	25.1	23.2	23.6	19.6	20.2	20.2	23.9	23.5	13.0	10.8	20.0	29.1	40.9	18.5	25.4	19.4	35.3	17.2	19.5	17.8	19.4	13.1	20.5	9.5	16.3	16.2	16.7	21.9	15.4	16.8	26.0	17.9	13.2	14.1	28.6	17.1	14.0	7.1	21.3	32.1	17.3	9.7	28.1	40.4	19.1	33.4	16.8	23.9	18.3	48.5	26.6	18.2	66.6	6.8	22.0	17.6	19.4	27.6	29.0	18.6	21.9	18.0	19.7	15.8	19.5	4.2	2.5	5.8	2.6	3.1	4.5	5.1	3.0	2.7	2.3	6.2	2.7	3.2	5.8	2.9	2.4	2.8	2.9	1.4	5.6	6.6	8.8	8.5	5.6	5.5	6.3	5.8	6.0	5.2	5.7	9.5	21.3	25.6	36.8	39.8	27.3	16.7	12.3	12.6	20.5	18.8	19.1	14.4	29.3	14.3	23.7	18.4	39.6	11.2	20.9	18.2	9.8	12.6	6.6	36.9	28.5	16.3	10.2	24.0	77.2	17.4	11.0	22.6	26.0	43.4	8.8	22.1	14.6	18.3	7.8	11.8	92.5	18.2	12.2	11.7	11.4	3.3	13.4	14.9	12.4	28.1	12.2	11.2	18.6	56.8	85.1	16.5	11.8	17.7	21.2	20.0	10.4	13.4	31.9	16.5	6.6	26.8	21.2	33.2	13.7	24.9	27.0	13.1	15.1	25.3	16.6	20.7
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486393	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	22.2	7.1	8.9	37.0	8.9	40.3	14.8	8.4	10.8	8.9	6.4	10.5	8.6	9.7	2.4	7.5	11.0	14.5	14.6	7.9	9.2	9.5	7.1	26.3	69.1	18.1	10.8	3.1	3.9	2.6	3.1	30.3	20.5	6.6	7.8	0.7	5.4	5.7	7.5	5.0	24.0	11.5	10.2	58.9	8.6	2.9	11.0	50.5	9.6	8.8	42.5	13.9	6.2	10.3	6.0	2.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	7.1	3.0	174.6	0.7	0.0	0.8	10.8	45.1	8.7	0.2	81.6	1.0	143.4	0.6	1.5	0.6	220.9	266.9	0.0	2.6	1.7	3.2	0.9	232.9	69.0	0.7	73.8	0.0	1.5	27.8	3.0	0.4	6.1	1.0	67.0	1.8	128.7	0.4	0.1	94.1	0.9	0.5	0.3	0.3	0.8	1.3	14.1	134.7	0.0	5.8	22.8	0.6	0.4	0.4	166.8	1.1	201.1	2.7	210.3	198.9	386.5	196.1	196.1	214.5	103.0	222.7	206.1	204.1	113.5	243.4	209.9	127.9	217.1	218.7	51.7	284.3	314.0	8.9	8.9	8.4	10.8	7.9	9.2	18.1	10.8	20.5	10.2	11.0	10.3	51.4	0.0	3.8	0.0	35.4	3.7	0.4	0.2	0.0	6.3	1.0	1.3	1.6	5.7	3.1	0.0	0.0	0.3	54.6	1.1	0.0	2.9	0.2	0.4	0.2	37.1	1.2	30.1	0.1	0.9	0.3	1.1	2.0	1.0	31.6	0.1	53.2	1.5	31.9	0.0	0.1	2.1	0.0	45.8	20.2	0.3	0.0	33.5	3.6	6.5	40.6	0.1	72.1	0.0	0.0	3.7	4.0	0.0	35.0	0.5	2.3	0.3	0.1	0.6	0.0	1.6	1.0	0.1	0.7	0.3	2.4	0.7	51.0	0.1	0.8	0.4
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	P26572	5	180784780-180815652	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 280.2;Syncytiotrophoblasts: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved					NA	NA		12000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	130.4	66.7	44.0	65.8	43.8	60.6	113.7	40.7	59.9	70.7	64.6	69.8	50.2	75.2	28.2	103.2	85.8	39.9	103.2	38.4	42.0	63.3	146.9	113.3	68.5	56.7	43.2	75.1	115.3	20.3	61.7	67.3	54.0	75.5	30.1	29.2	82.0	37.1	61.1	73.4	82.2	40.9	47.4	139.9	78.1	36.4	64.9	38.3	96.1	35.6	42.2	85.0	72.3	49.3	58.3	58.2	30.9	66.3	149.6	68.7	111.0	130.1	154.4	77.4	96.7	79.4	45.6	50.2	77.3	122.3	78.2	68.8	17.0	190.8	46.1	271.6	47.6	44.2	34.1	61.7	72.8	40.6	137.6	79.7	91.5	63.1	62.9	53.6	67.9	34.2	26.1	84.7	70.9	78.3	38.9	55.2	29.6	37.5	72.0	46.2	44.5	66.8	30.9	67.3	27.2	32.1	54.6	56.5	115.7	27.2	43.8	68.5	72.9	94.7	44.7	42.7	61.1	165.9	149.2	44.7	77.6	78.9	49.8	93.0	228.6	104.6	83.5	186.7	91.6	48.3	60.2	70.3	161.7	42.0	51.4	59.1	152.2	70.4	149.4	152.9	75.3	235.1	44.0	43.8	40.7	59.9	38.4	42.0	56.7	43.2	54.0	47.4	64.9	49.3	157.8	48.1	31.1	9.8	57.7	61.2	44.6	52.8	50.1	20.7	41.5	29.7	18.4	44.3	32.7	29.5	56.3	94.9	114.7	43.8	37.2	49.0	31.7	26.2	34.2	94.2	49.8	47.6	7.5	79.0	280.2	80.5	33.6	48.7	30.4	27.2	125.7	88.1	200.5	63.9	8.5	54.9	20.3	195.5	142.1	43.2	62.7	234.9	81.8	26.2	112.1	18.9	87.6	8.0	14.6	54.0	34.7	76.0	169.7	76.9	57.2	22.5	20.4	78.8	32.9	72.1	51.5	26.8	22.5	46.8	63.9	384.9	59.3	43.7	36.7	56.8
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA SH3 domain ER export factor 3"	Q5JRA6	1	222618097-222668007	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA055922, HPA056816"	Supported		Enhanced	Vesicles		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	25.6	22.0	11.0	23.4	13.1	33.2	21.4	12.9	14.9	23.9	13.2	24.3	23.9	23.7	29.2	13.7	16.0	20.6	20.6	10.9	13.6	21.1	74.5	21.5	26.9	10.8	12.3	25.4	38.7	30.1	15.2	23.1	11.7	39.3	29.5	24.4	33.2	22.1	23.7	17.4	25.9	23.8	10.7	27.3	45.0	36.5	11.5	25.7	31.7	20.5	26.2	21.0	14.1	12.8	24.8	18.8	26.5	42.5	92.8	47.1	46.5	34.8	49.4	36.2	43.1	16.6	26.2	24.0	33.0	41.8	20.5	39.9	28.5	31.3	37.8	38.1	21.6	27.7	21.5	31.5	88.6	50.7	34.7	45.2	35.0	35.9	60.8	44.8	41.4	28.9	34.8	44.4	30.7	15.9	34.3	33.8	33.2	76.8	27.5	24.4	70.8	47.8	23.1	22.8	30.4	31.3	38.6	36.2	30.4	36.2	38.2	37.5	31.7	27.5	17.9	44.5	41.3	48.4	30.9	23.8	36.7	25.4	37.5	26.8	15.6	36.5	17.6	22.4	17.7	20.7	14.7	17.5	11.7	18.6	16.4	17.8	27.1	22.5	26.0	13.2	19.2	13.5	11.0	13.1	12.9	14.9	10.9	13.6	10.8	12.3	11.7	10.7	11.5	12.8	48.5	70.5	49.6	31.3	46.9	18.7	26.8	20.4	29.0	60.9	24.3	35.3	65.0	25.8	47.1	5.5	31.3	28.6	73.8	35.2	0.0	25.1	37.0	34.9	72.5	36.4	60.4	26.3	51.4	34.8	17.0	53.0	79.5	42.0	17.7	44.2	25.4	63.3	20.4	45.4	58.0	95.3	32.6	22.0	14.0	24.9	37.0	32.9	19.6	35.6	32.1	31.8	44.3	41.2	29.1	26.4	25.8	48.9	54.4	39.0	41.3	19.4	44.7	41.5	19.7	57.9	46.6	55.7	42.1	21.9	16.1	35.8	47.8	70.2	24.6	29.4
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553461	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		370000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	8.5	21.3	6.6	7.2	6.7	31.1	9.4	6.9	9.1	8.8	9.4	12.6	17.6	7.0	10.0	3.6	8.5	8.4	5.8	6.8	8.0	17.5	29.1	8.3	7.7	6.4	6.8	8.8	11.9	9.0	8.1	18.9	6.4	11.7	12.9	11.9	6.9	7.6	4.9	9.1	13.6	7.6	6.9	6.9	8.5	7.9	7.7	8.1	11.6	5.7	7.0	8.6	5.7	7.4	18.6	28.1	28.1	40.9	46.4	38.1	23.2	29.5	51.1	28.8	38.3	15.0	35.5	16.4	27.0	35.9	19.4	28.2	29.9	27.1	33.2	37.1	35.7	41.1	10.4	55.7	34.6	18.0	36.0	33.7	34.7	32.6	19.5	52.5	37.0	14.3	24.5	75.9	34.4	13.8	11.9	25.6	20.0	14.2	20.2	0.0	15.8	11.0	38.5	10.4	10.2	31.5	28.1	5.9	51.5	31.5	16.7	14.7	32.4	18.3	21.9	22.1	28.7	24.5	27.1	4.2	29.3	26.8	13.7	10.5	10.8	4.9	11.5	13.8	10.1	8.7	10.8	13.0	14.3	8.2	10.2	11.4	0.7	11.7	12.5	8.2	17.3	10.5	6.6	6.7	6.9	9.1	6.8	8.0	6.4	6.8	6.4	6.9	7.7	7.4	11.7	6.4	12.8	9.1	8.1	2.8	8.3	25.5	8.0	14.4	9.0	4.3	4.9	15.7	16.2	7.3	2.1	20.4	4.9	14.0	5.9	17.2	15.9	7.1	13.4	10.5	13.1	288.9	18.3	16.7	19.2	17.9	7.1	6.7	24.7	17.8	16.4	58.3	12.9	10.1	20.8	25.5	20.3	16.0	5.8	4.0	9.3	8.7	10.6	7.5	11.7	11.1	10.3	25.6	19.1	10.5	17.2	8.2	18.6	6.8	17.1	26.0	19.0	14.8	0.0	4.8	11.1	10.6	12.1	4.0	3.4	8.1	8.2	13.7	11.6	4.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.2;Excitatory neurons: 159.4;Inhibitory neurons: 141.1;Late spermatids: 129.2;Oligodendrocyte precursor cells: 91.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA002893: AB_1079386, HPA050179: AB_2681043"	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	2.5	2.7	1.8	1.2	1.6	0.4	4.0	1.0	1.6	4.7	1.8	2.7	1.3	4.4	2.2	3.4	3.4	3.3	2.8	1.4	1.7	4.0	1.9	2.4	0.3	1.9	1.7	6.2	4.5	6.5	2.8	1.4	1.8	5.5	2.1	2.9	3.4	3.3	2.0	1.8	1.2	3.5	1.8	1.2	3.5	7.9	1.8	0.9	5.3	2.8	0.6	3.4	3.5	1.9	5.3	2.2	0.8	7.4	5.3	8.7	0.0	4.8	3.2	4.0	5.9	2.9	3.2	0.0	4.6	4.0	1.6	6.1	0.0	6.6	5.4	0.0	7.8	0.0	3.6	12.8	3.4	0.0	0.1	5.5	6.6	1.1	12.8	4.9	25.2	0.0	10.5	0.1	6.0	5.3	0.0	0.0	3.1	3.5	16.3	0.0	0.7	0.0	5.8	5.9	6.2	0.0	6.2	5.3	5.5	5.4	6.6	0.0	13.4	0.0	3.9	0.0	5.5	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.8	1.6	1.0	1.6	1.4	1.7	1.9	1.7	1.8	1.8	1.8	1.9	7.9	76.9	59.2	41.4	1.2	4.2	15.7	5.8	18.2	13.8	8.0	6.6	14.3	11.5	55.8	9.2	52.1	0.1	0.7	1.6	9.8	4.9	138.2	5.6	13.8	10.4	9.1	1.3	159.4	7.4	0.1	16.2	14.3	6.0	46.7	10.8	3.9	3.0	0.1	11.8	141.1	1.9	6.1	1.6	5.7	129.2	8.4	5.2	7.2	45.0	0.2	6.0	1.0	91.0	24.9	11.3	0.8	9.1	0.1	16.2	0.9	4.0	70.0	23.0	0.0	19.9	16.7	36.2	15.1	6.3	6.3	0.0	4.7	16.2	3.5	8.6
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MLEC	KIAA0152	ENSG00000110917	Malectin	Q14165	12	120687149-120701859	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Undifferentiated cells: 397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA		880000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.60e-6)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.39e-1)"	"unprognostic (9.77e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (1.98e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	51.7	93.1	35.4	51.8	36.7	34.6	44.3	33.0	34.5	52.8	40.3	127.0	78.3	37.2	138.1	24.5	48.5	48.5	65.9	34.7	40.0	73.5	78.2	34.9	30.3	42.3	39.4	49.2	62.7	101.2	36.7	45.7	37.8	62.4	117.3	25.3	50.7	64.9	79.8	27.8	86.0	50.0	40.0	30.1	45.3	69.1	42.9	33.3	101.0	82.9	37.3	34.1	17.4	37.6	122.7	177.9	113.6	151.8	196.3	107.4	127.9	144.5	126.3	108.9	80.1	127.5	75.1	100.3	129.0	142.2	85.4	101.9	140.4	87.4	138.7	86.5	76.9	142.4	79.4	100.6	72.1	199.3	123.1	82.2	82.7	116.0	91.4	174.1	97.2	93.9	85.9	112.2	116.3	127.8	106.4	122.2	158.1	156.6	91.7	115.7	82.0	109.1	132.2	204.0	58.2	69.2	166.5	85.9	86.0	143.0	127.0	144.6	79.2	115.8	108.5	112.8	100.3	83.3	165.0	76.8	147.6	147.9	120.1	0.5	6.0	8.0	3.8	7.5	4.1	4.7	2.3	3.4	5.0	6.9	4.0	3.4	1.6	3.9	6.5	18.6	2.4	2.2	35.4	36.7	33.0	34.5	34.7	40.0	42.3	39.4	37.8	40.0	42.9	37.6	151.4	25.6	62.2	23.2	65.7	72.8	70.6	32.0	55.2	40.9	99.7	76.3	145.3	97.2	40.0	86.5	45.9	88.4	105.7	155.3	37.2	134.2	243.3	78.3	127.6	94.1	80.3	68.5	21.4	183.7	176.9	90.5	69.3	80.2	49.5	99.8	27.1	206.1	126.8	84.1	24.7	199.2	30.5	61.7	73.2	228.0	82.6	70.1	193.9	34.7	56.4	81.8	74.2	32.2	23.0	95.8	86.0	108.0	217.4	152.6	135.4	121.7	41.9	45.3	85.5	61.4	78.5	165.6	153.4	52.8	58.7	115.6	51.2	142.5	397.0	82.2
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.6	17.9	7.3	17.4	8.0	22.1	15.4	7.1	9.1	17.4	7.6	17.4	12.0	16.3	14.0	14.3	14.9	11.1	35.4	6.9	8.3	16.0	19.1	15.8	21.9	8.6	7.4	15.1	16.6	22.4	22.7	14.8	7.6	16.2	14.5	9.6	12.1	14.0	49.1	13.4	13.4	19.2	7.1	18.8	15.5	25.4	7.7	28.4	19.2	42.2	24.3	17.2	14.0	9.0	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.3	8.0	7.1	9.1	6.9	8.3	8.6	7.4	7.6	7.1	7.7	9.0	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MLH3		ENSG00000119684	"MutL homolog 3"	Q9UHC1	14	75013769-75051532	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060570			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA060570: AB_2684323"	"unprognostic (2.94e-1)"	"unprognostic (6.70e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.35e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	4.3	9.4	7.2	5.6	11.7	2.3	7.9	12.7	8.6	7.2	5.8	5.8	5.3	7.4	7.5	5.3	6.5	6.1	6.0	6.3	9.3	7.5	7.3	5.2	6.6	8.1	8.8	8.1	5.3	12.6	5.1	5.8	9.3	7.6	6.6	8.5	5.4	8.6	6.6	4.7	4.8	5.5	7.9	6.4	4.5	6.7	9.0	6.4	11.1	7.8	7.7	5.3	3.2	19.8	13.1	13.5	10.3	1.7	10.6	17.0	10.4	4.5	4.2	7.0	6.3	11.7	16.5	14.2	3.7	5.5	9.2	9.2	0.2	4.3	10.4	14.1	0.2	9.3	8.7	7.1	8.6	4.0	6.3	6.3	10.4	7.2	0.5	8.7	12.0	0.1	8.8	11.4	15.8	11.3	6.3	4.5	8.7	10.6	7.6	11.3	6.3	3.1	17.4	13.4	14.9	10.5	14.4	9.9	0.9	10.3	13.1	9.0	6.1	2.9	5.9	4.3	4.5	14.4	15.0	15.4	10.7	0.4	13.2	5.1	2.6	1.7	4.6	2.1	3.5	3.0	2.5	4.2	2.9	5.9	4.1	3.3	1.1	6.3	1.5	2.4	3.1	5.9	7.2	11.7	12.7	8.6	6.3	9.3	8.1	8.8	9.3	7.9	9.0	19.8	19.4	25.6	17.3	47.3	16.6	7.9	23.3	14.3	8.6	49.8	11.6	11.0	19.5	27.1	15.6	36.8	43.8	16.2	15.0	8.5	7.9	16.4	6.0	13.6	35.3	18.5	13.1	6.7	43.4	11.1	6.8	25.8	6.6	10.8	23.5	40.8	13.6	15.6	10.3	35.3	52.9	12.4	12.2	9.1	6.1	7.9	39.7	47.7	16.0	31.9	14.6	28.5	29.9	51.8	106.7	12.3	12.0	51.1	8.7	16.9	29.2	17.1	17.6	59.3	46.0	29.7	23.3	54.4	10.8	7.9	8.7	10.1	13.6	31.0	18.9	12.2
MLPH	"exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a"	ENSG00000115648	Melanophilin	Q9BV36	2	237485428-237555322	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 135.9;salivary gland: 122.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA014685	Enhanced					NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA014685: AB_1853997"	"unprognostic (3.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.14e-6)"	"unprognostic (2.26e-4)"	"unprognostic (1.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.34e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-3)"	13.2	1.4	0.6	2.4	0.7	0.1	56.9	0.7	1.6	69.3	1.3	20.4	8.8	18.1	8.9	6.4	18.0	31.0	69.2	1.1	0.7	4.3	39.0	62.7	0.6	1.1	1.0	11.8	16.1	9.0	2.1	1.9	0.8	135.9	21.7	0.3	122.0	13.0	6.6	11.6	15.2	2.8	0.6	0.2	98.1	2.5	0.8	0.9	39.9	2.5	1.2	22.1	21.9	0.9	0.3	133.7	0.3	0.3	58.5	39.5	0.4	26.8	31.5	14.7	18.5	1.1	101.1	0.2	0.1	49.6	51.0	0.3	0.1	0.9	13.0	0.1	0.3	0.1	0.1	0.0	23.3	0.1	0.7	48.1	14.7	43.4	56.2	75.6	0.1	0.0	0.1	0.3	142.9	255.4	0.4	0.6	0.4	105.4	77.1	0.5	0.1	0.2	0.5	3.2	1.5	0.2	0.1	234.5	182.2	0.7	61.5	1.7	26.8	80.1	2.3	0.9	38.0	0.2	0.2	0.2	236.0	0.1	63.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	1.6	1.1	0.7	1.1	1.0	0.8	0.6	0.8	0.9	12.3	125.0	389.7	0.0	0.8	4.1	17.3	6.0	0.0	0.0	95.6	59.7	63.2	52.9	64.2	12.9	0.0	0.4	0.7	34.9	1.9	12.0	0.2	9.5	10.1	10.1	14.4	0.0	0.2	41.3	0.3	4.5	251.8	17.5	187.3	0.2	1.4	28.8	1.2	0.0	0.1	189.0	32.6	0.8	2.9	0.7	8.4	7.4	30.2	5.6	0.6	0.0	0.0	0.0	0.0	58.1	22.4	3.0	0.8	54.4	9.1	0.6	48.5	0.0	0.0	3.1	3.7	0.3	0.6	1.2	2.4	0.7	6.1	0.4	30.5	38.6
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MAX dimerization protein MLX"	Q9UH92	17	42567072-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: AB_2681940, HPA064438: AB_2685265"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	31.3	28.0	15.8	21.7	16.4	16.4	26.2	16.6	18.0	19.3	19.1	38.5	47.5	15.7	16.6	29.1	17.2	20.3	55.5	16.2	16.9	28.7	51.5	27.9	27.5	16.9	15.9	14.8	32.7	19.6	18.8	21.5	16.8	18.2	38.8	9.3	24.7	18.1	74.4	25.6	42.2	20.3	16.7	24.1	35.4	8.1	16.8	30.1	24.8	86.4	29.4	27.9	20.8	17.2	36.8	41.5	32.1	33.1	48.0	55.3	22.0	53.5	47.5	57.1	51.4	38.0	37.5	43.6	36.8	46.4	51.6	54.4	59.4	34.8	50.0	35.2	55.5	45.4	27.2	43.1	56.3	61.6	63.4	47.9	38.4	45.6	41.8	38.9	42.9	52.2	50.7	38.3	66.2	49.3	87.0	31.3	22.9	90.9	37.3	39.2	66.1	47.5	46.8	44.7	49.9	24.6	23.9	31.2	61.8	42.5	63.3	72.1	30.2	50.7	32.5	55.7	80.8	38.7	47.2	41.2	56.5	39.2	60.8	43.3	64.0	91.4	34.2	80.1	37.6	35.2	35.0	34.6	66.5	30.2	30.5	31.1	82.7	33.7	90.9	35.7	48.0	68.3	15.8	16.4	16.6	18.0	16.2	16.9	16.9	15.9	16.8	16.7	16.8	17.2	31.6	67.3	69.8	9.4	35.6	41.9	28.1	41.5	33.0	29.4	39.8	30.4	24.1	40.0	47.2	27.6	25.0	37.8	35.8	97.7	60.7	48.9	19.1	30.5	29.1	28.2	25.8	42.7	8.0	68.9	49.5	26.0	55.5	26.3	46.7	18.7	27.8	49.7	68.6	25.2	8.1	46.9	30.5	63.4	62.3	24.5	35.1	59.5	32.0	7.5	58.3	13.1	51.5	5.5	7.1	77.5	86.4	31.2	61.8	24.4	132.3	62.1	30.4	31.7	52.6	22.9	31.4	9.3	41.2	45.2	49.9	44.1	38.3	48.0	54.2	36.4
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789401-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.7;stomach 1: 47.6;urinary bladder: 52.2"	"Cell type enriched"	"Detected in many"	10	"Pancreatic endocrine cells: 2239.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Region enriched"	"Detected in single"	7	"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1139.1;HBF TERT88: 1094.4;HUVEC TERT2: 2954.4;WM-115: 1454.1"	"Not detected"	"Not detected"							HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	55000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.3	0.1	0.0	26.7	0.0	0.3	0.2	0.0	1.3	0.1	0.0	6.1	7.9	10.7	0.0	4.2	0.1	75.7	0.4	0.0	0.1	1.0	0.8	6.7	0.1	0.0	0.0	0.0	1.8	0.0	0.1	7.2	0.0	0.4	6.8	0.0	6.9	0.2	0.0	0.6	13.0	1.2	0.0	2.1	47.6	0.1	0.1	0.3	0.2	0.0	1.7	52.2	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	517.1	1139.1	456.6	118.2	9.1	1.0	0.0	5.2	275.5	175.2	4.6	0.0	160.0	1094.4	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.5	0.3	0.8	470.1	39.6	0.1	2954.4	0.0	1.5	0.5	0.3	0.0	0.0	0.0	0.4	189.3	20.8	0.0	0.1	0.0	0.7	2.2	0.0	0.1	4.8	0.0	1.6	0.1	0.5	0.0	155.0	374.1	0.6	16.8	1.3	0.1	0.0	0.0	8.8	0.0	1454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	3.2	2.6	0.0	0.2	2.3	22.4	90.4	0.0	0.0	0.0	0.0	0.1	30.0	15.8	3.7	0.0	0.0	0.0	0.2	0.0	143.7	0.0	0.1	0.2	113.2	0.0	0.0	0.1	204.8	0.1	11.5	25.5	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	1.9	0.4	0.0	0.0	15.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2239.5	1.2	0.0	0.0	30.9	0.7	0.2	1.3	0.0	0.0	1.8	10.5	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	44.3
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955732	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"urinary bladder: 12.9"	"Cell type enriched"	"Detected in some"	12	"Basal respiratory cells: 426.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 17.9;PC-3: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	12.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	17.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	426.0	0.0	0.0	0.0	0.0	0.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.8
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025754-58046901	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favorable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.08e-4)"	11.9	3.8	8.9	4.4	6.0	0.4	7.6	7.3	11.2	5.7	5.8	28.0	40.2	3.5	1.1	4.6	6.1	14.3	41.2	6.9	8.7	14.9	50.1	9.9	2.1	15.8	10.6	1.1	18.5	12.7	8.8	28.4	16.8	4.4	14.3	1.5	8.4	9.5	7.0	4.3	33.0	3.7	5.8	9.3	29.6	34.9	18.7	1.0	46.7	5.6	1.3	5.1	2.8	8.6	15.3	11.4	5.8	30.4	6.0	0.3	93.6	1.4	0.8	5.4	1.2	9.1	38.3	0.2	17.7	1.6	4.2	21.0	5.1	4.4	1.6	0.1	10.0	0.1	4.9	51.1	7.7	0.3	19.5	3.1	7.8	0.9	2.3	8.4	3.7	8.5	12.9	0.1	1.8	7.6	0.7	2.6	17.2	44.6	3.2	7.6	0.7	8.3	16.6	5.4	1.6	10.4	20.0	47.3	9.5	13.2	5.2	8.2	3.4	0.4	9.1	3.5	1.3	0.2	0.1	0.3	1.9	2.3	78.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.9	6.0	7.3	11.2	6.9	8.7	15.8	10.6	16.8	5.8	18.7	8.6	14.3	19.2	14.4	9.1	0.7	2.5	1.0	4.9	2.8	3.4	5.0	3.0	24.7	55.8	12.6	18.4	16.7	48.2	1.6	109.3	1.9	35.7	5.0	3.6	1.1	17.2	11.4	2.7	1.4	12.0	49.2	4.5	35.2	6.4	0.0	18.6	13.6	39.2	12.9	1.7	1.2	33.3	10.2	3.0	0.3	6.9	0.9	0.9	1.8	1.0	0.0	2.1	0.0	4.5	1.4	13.3	38.5	3.4	0.3	1.3	67.3	7.3	6.0	1.9	0.0	0.7	2.4	0.9	4.6	3.3	2.3	48.4	0.7	23.2	45.0	1.7
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	14.7	2.0	18.7	0.5	18.1	0.2	8.3	12.1	18.8	4.1	11.9	17.5	1.8	5.2	2.1	13.5	6.1	1.4	3.8	16.2	15.6	1.9	0.3	14.1	0.2	15.2	17.8	1.1	0.8	0.1	1.3	2.0	12.9	5.0	10.5	3.0	2.5	3.5	1.8	23.7	10.2	4.1	14.4	1.1	8.8	22.3	19.3	0.3	5.9	2.4	3.2	16.3	7.6	13.9	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.1	1.5	0.0	0.1	86.9	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.0	4.3	0.0	0.0	1.2	38.3	0.0	3.1	0.7	0.3	0.3	0.0	0.2	0.0	0.3	0.1	0.3	0.0	41.7	0.1	0.8	0.0	0.0	0.0	15.7	0.2	0.7	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.6	0.2	1.0	0.0	0.4	6.3	3.7	0.0	0.9	0.2	0.9	0.0	0.4	18.7	18.1	12.1	18.8	16.2	15.6	15.2	17.8	12.9	14.4	19.3	13.9	31.5	28.9	26.5	47.7	0.4	38.5	5.3	56.8	21.1	2.7	1.0	1.5	1.3	7.2	15.2	7.3	0.0	0.0	0.2	82.0	0.0	1.2	6.7	0.1	0.0	16.8	3.6	0.4	2.8	0.4	0.0	4.4	12.2	0.1	0.0	0.0	17.9	0.0	0.1	1.7	4.8	32.9	2.0	0.0	1.8	13.4	1.2	0.5	3.6	10.3	0.4	9.4	1.0	1.0	0.6	16.7	46.2	3.0	0.1	8.6	47.2	0.8	4.5	0.5	6.6	0.7	5.5	1.1	3.7	34.9	33.1	0.0	1.0	0.1	21.5	43.9
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843609	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;salivary gland: 286.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Region enriched"	"Detected in some"	4	"thalamus: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	460000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	90.7	0.1	0.3	20.1	0.4	0.0	36.6	0.2	1.6	0.3	0.1	6.1	2.4	38.1	0.2	0.8	0.2	1.9	0.2	0.4	1.6	0.4	1.6	0.3	0.0	0.4	0.4	0.1	0.3	0.1	0.9	0.4	0.3	2.2	2.3	0.0	286.1	2.2	39.6	63.7	4.5	1.6	0.3	0.0	10.5	0.1	7.3	0.1	2.6	0.4	1.3	13.9	0.5	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1545.7	4229.3	27.0	8.7	0.1	0.2	0.0	0.0	1846.6	96.9	0.0	0.1	0.1	45.1	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	4.6	0.2	122.0	5.3	0.0	0.0	0.0	0.2	0.3	4.7	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.9	0.0	0.3	0.0	140.5	13.1	1.6	0.5	0.0	0.0	0.2	56.8	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.6	0.4	1.6	0.4	0.4	0.3	0.3	7.3	0.3	0.0	3.2	0.0	0.0	0.0	8.4	20.4	25.8	0.0	0.0	0.1	0.1	0.3	4.3	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	24.2	0.0	0.3	0.5	0.0	0.0	0.2	1.4	13.4	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	2.2	1.2	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	4.0	0.0	0.0	11.9	1.0	0.9	0.1	0.0	0.0	1.8	10.2	0.0	1.8	0.0	3.4	0.3	0.6	0.0	0.8	7.4
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530750	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2"	"Cell type enriched"	"Detected in many"	8	"Ductal cells: 8176.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000	35000		"Cluster 5: Breast - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	3.8	0.1	0.0	2.0	0.0	0.3	168.7	0.0	0.3	13.3	0.0	1.6	0.6	97.4	27.9	21.3	91.2	509.9	0.2	0.0	0.0	140.2	3.4	31.6	1.9	0.0	0.0	0.7	85.2	0.0	0.3	0.8	0.0	54.0	1.0	0.0	267.9	34.9	0.1	32.4	0.6	4.8	0.0	0.2	7.3	0.6	0.4	3.3	0.4	0.0	29.3	211.2	1.7	0.0	0.2	145.9	0.0	0.4	0.0	0.0	0.2	0.0	2.1	0.1	0.1	1.9	815.9	0.0	189.8	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.6	1.0	0.1	0.2	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	11.8	0.0	0.0	0.0	0.0	350.1	1.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.1	0.0	0.7	3.0	0.0	1.6	0.1	0.6	0.4	1.0	5.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	86.6	43.3	0.0	1.5	1.0	382.2	135.4	1.2	0.0	124.2	93.7	0.7	100.1	401.2	1017.0	0.0	0.7	2.9	1.2	0.0	8176.2	6.1	62.1	3.3	8.8	0.0	0.0	0.0	209.4	0.3	3.4	0.0	124.6	2.5	0.0	0.0	0.0	98.0	0.0	0.0	0.0	38.7	0.6	0.3	10.3	11.8	12.6	0.0	0.0	65.2	0.0	0.0	0.0	0.0	850.9	0.0	0.0	0.1	603.3	0.0	33.9	72.6	0.0	0.0	0.0	31.4	0.1	0.2	17.0	2.4	0.8	3.6	0.0	2.3	840.8
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711796-102727050	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 501.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 4.0;Macrophages: 1.5"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.7"	"Cell line enriched"	"Detected in some"	8	"WM-115: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA021763, HPA022935"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		360000	"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	0.5	0.0	0.0	0.3	0.1	501.1	0.2	0.1	0.2	0.0	0.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.0	13.8	0.1	0.0	0.6	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 158.0;Hepatic stellate cells: 146.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"NK-cell: 6.3;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.2;NK-cells: 6.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 1242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	22.6	3.8	0.8	10.9	0.8	1.8	27.3	0.8	1.1	28.5	1.4	9.9	5.4	15.0	2.8	14.5	23.1	21.1	3.6	0.6	0.9	1.1	8.7	16.1	14.0	1.4	1.4	4.9	3.4	0.5	0.7	40.1	1.2	3.8	14.9	0.5	2.7	4.6	1.1	8.2	13.5	16.8	1.1	0.6	5.2	12.7	1.5	3.7	23.1	6.6	7.6	19.6	9.8	1.1	0.0	0.0	94.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1242.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	6.3	0.0	2.2	0.2	1.2	0.8	0.8	0.8	1.1	0.6	0.9	1.4	1.4	1.2	1.1	1.5	1.1	15.4	0.0	12.0	0.3	2.3	4.2	0.1	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.6	0.0	0.0	0.0	3.9	0.0	1.9	0.0	17.7	0.3	0.7	158.0	0.0	25.9	0.2	0.0	0.0	1.9	0.0	0.4	2.5	0.1	146.3	2.4	0.6	0.0	0.1	0.0	0.0	5.7	5.9	7.7	0.3	9.1	1.8	21.5	0.7	0.8	2.1	0.0	0.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	1.5	0.4	0.0	0.3	0.9	15.4	0.0	0.8	4.5	0.0	1.6	0.0	0.0	0.1
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		84000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	63.2	13.9	14.0	10.1	12.7	1.5	54.5	11.5	12.5	20.6	11.0	14.2	10.5	28.1	13.8	16.9	22.7	16.6	38.8	11.4	11.9	22.0	8.6	32.1	9.7	13.6	12.4	23.1	10.5	10.6	7.6	73.8	13.7	14.1	8.9	3.0	26.6	28.7	26.8	38.9	13.8	27.3	13.2	34.6	11.9	15.3	15.8	6.5	25.8	32.5	13.3	32.3	19.1	12.0	11.4	2.9	0.4	0.2	1.2	6.3	7.1	4.1	11.1	4.8	6.8	6.4	89.2	0.1	39.5	7.6	11.6	21.9	0.0	5.2	6.4	8.1	0.0	2.3	10.2	0.2	0.9	0.0	4.6	1.5	26.4	5.7	38.6	13.0	196.6	2.4	2.1	35.0	1.8	7.1	0.4	4.4	2.0	0.4	4.9	0.2	0.1	0.1	2.0	17.5	4.8	0.0	3.1	3.7	1.4	0.9	14.9	1.2	237.1	1.9	11.0	1.9	0.1	2.6	4.0	0.1	5.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	12.7	11.5	12.5	11.4	11.9	13.6	12.4	13.7	13.2	15.8	12.0	229.3	0.0	5.8	1.6	0.3	9.4	0.9	0.0	4.6	0.2	1.4	2.0	13.2	5.7	0.7	1.8	0.0	0.7	0.4	0.0	0.0	0.1	1.0	0.3	0.4	127.1	0.0	2.7	0.9	0.0	0.1	8.1	0.0	0.5	0.0	0.2	182.0	4.1	1.7	0.0	1.2	0.0	0.0	6.5	4.4	2.8	2.5	0.7	3.6	15.9	0.0	0.7	0.0	1.0	0.1	0.0	0.0	3.0	0.1	0.6	0.5	0.2	0.0	0.6	6.6	3.9	9.4	1.8	2.3	2.2	7.7	0.3	0.8	3.6	0.2	1.0
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	19.8	23.3	12.1	11.5	13.2	8.6	18.4	14.2	16.2	14.0	19.3	22.6	27.1	15.2	15.6	17.9	13.9	14.2	31.0	12.1	13.5	50.6	199.0	12.5	11.8	13.0	12.7	24.2	24.6	31.1	11.7	13.2	13.2	20.8	21.5	17.2	18.7	15.8	23.6	15.0	20.1	14.9	14.1	9.4	20.1	14.6	13.3	12.2	19.2	36.1	11.2	13.0	11.9	16.3	23.9	8.3	24.6	28.8	47.8	45.1	13.6	20.9	27.3	21.6	31.7	9.7	12.1	21.9	16.3	22.4	32.6	13.3	27.6	14.8	30.2	18.9	20.0	11.7	17.5	25.4	34.8	15.1	10.8	27.4	21.6	22.0	25.4	19.3	21.1	23.4	21.6	25.6	25.7	15.0	17.9	14.9	10.5	25.0	6.0	15.8	30.8	30.7	24.9	22.6	22.7	15.8	23.0	16.3	35.7	25.6	14.2	23.9	15.4	20.0	14.6	27.4	28.7	10.0	12.2	18.8	28.1	17.6	17.9	16.0	6.5	11.4	6.4	8.8	8.2	7.6	7.7	8.1	7.8	6.9	9.6	7.2	3.8	12.5	14.7	5.5	10.9	5.8	12.1	13.2	14.2	16.2	12.1	13.5	13.0	12.7	13.2	14.1	13.3	16.3	6.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	26.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	36.6	24.7	12.6	64.2	11.8	90.5	31.4	12.9	13.5	36.4	18.6	41.0	42.3	35.0	25.5	40.2	33.2	35.5	25.3	11.4	15.6	48.1	30.7	38.9	91.9	15.8	13.6	31.9	16.0	28.6	9.1	35.8	16.7	30.3	42.7	10.2	19.5	29.4	13.2	38.9	41.7	40.5	15.8	61.1	34.2	19.8	12.8	56.1	33.6	19.4	93.1	46.6	26.0	17.9	78.2	43.9	53.9	58.5	86.9	94.0	63.5	61.3	82.0	78.1	76.6	60.2	55.4	159.0	51.3	77.4	58.2	63.7	69.6	70.2	117.7	113.0	41.5	143.7	28.0	64.3	69.1	126.1	222.1	80.2	67.1	62.6	52.5	58.6	83.3	60.4	62.5	57.2	76.8	42.1	159.4	106.9	50.3	66.4	35.6	108.2	185.2	85.2	67.3	96.1	27.3	35.6	87.1	63.6	56.4	40.4	51.0	59.1	79.6	100.9	53.0	71.4	98.7	42.2	40.5	119.5	68.0	105.3	55.3	103.7	65.3	91.5	37.3	106.1	40.3	57.8	33.3	40.3	60.5	46.1	30.2	36.4	65.6	56.4	126.0	42.1	37.2	79.7	12.6	11.8	12.9	13.5	11.4	15.6	15.8	13.6	16.7	15.8	12.8	17.9	82.6	51.3	58.0	3.9	173.0	136.9	96.5	107.4	60.9	13.3	66.8	45.1	40.0	35.8	79.5	82.8	6.2	63.8	170.1	114.1	92.0	60.9	11.1	88.3	91.3	73.1	37.7	48.8	7.4	52.6	101.9	67.2	55.0	102.2	110.4	58.5	61.1	43.0	169.5	26.9	7.9	67.4	65.1	196.6	246.9	11.8	62.4	226.1	67.6	14.0	350.8	25.2	117.4	6.0	10.1	83.4	85.7	68.4	106.4	127.8	80.4	170.2	116.6	14.5	72.3	60.6	75.3	99.5	44.6	86.6	132.0	66.4	124.4	79.3	74.0	155.3
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898139	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: AB_2684655"	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	272.8	306.3	183.9	237.6	193.6	427.6	241.5	197.6	285.5	283.8	188.9	270.1	169.4	305.1	213.0	201.1	257.9	256.5	396.6	187.9	240.5	332.2	258.9	243.4	251.8	232.8	221.6	318.2	165.5	263.6	175.1	300.9	223.4	228.7	225.7	265.5	195.9	282.7	559.3	140.5	187.4	331.5	205.4	217.4	186.9	588.7	220.1	297.6	270.2	425.2	279.6	266.2	184.3	227.9	362.0	480.3	863.5	355.4	603.2	620.4	453.2	644.3	636.0	570.7	554.0	436.9	532.7	446.7	517.2	649.1	376.0	442.1	1054.3	432.8	534.3	446.0	420.3	493.5	483.5	406.5	617.9	410.4	424.3	436.7	482.5	323.1	447.6	550.1	689.1	309.7	526.3	398.2	659.2	335.3	392.9	301.6	930.7	472.9	208.5	431.8	673.0	431.0	459.2	488.1	443.6	457.7	578.1	367.2	825.7	871.1	441.7	533.9	543.1	667.2	471.6	359.0	549.6	256.4	770.6	499.2	412.3	647.4	501.4	118.5	195.0	197.5	123.0	188.4	149.4	172.7	176.9	141.6	225.5	163.7	241.9	174.2	154.9	145.1	155.8	214.4	214.2	318.6	183.9	193.6	197.6	285.5	187.9	240.5	232.8	221.6	223.4	205.4	220.1	227.9	374.2	301.3	249.0	38.2	300.0	418.1	624.1	724.2	256.6	104.5	236.1	198.9	372.2	286.0	512.3	290.6	62.6	611.9	309.4	173.4	686.7	545.5	740.6	377.8	352.6	391.1	275.2	298.0	69.6	312.8	815.0	468.2	153.4	282.5	465.8	179.5	372.3	328.6	379.1	200.2	68.5	263.6	451.6	310.9	601.3	504.6	389.5	325.7	501.6	52.5	450.8	322.0	306.9	40.2	80.0	407.4	185.5	464.9	232.0	489.8	178.6	805.1	582.5	97.5	315.5	368.3	500.6	1322.3	467.9	185.3	370.4	663.0	338.2	279.9	199.0	597.1
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031872: AB_2674081, HPA054102: AB_2682379"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	142.9	184.7	173.9	97.3	180.9	99.0	179.3	156.9	261.5	249.3	183.1	113.4	89.5	262.5	217.7	121.1	209.8	129.2	138.4	180.9	210.1	130.2	204.9	132.6	72.5	170.8	180.3	358.2	137.2	137.2	198.8	242.6	191.2	161.9	140.1	94.1	121.2	191.6	175.6	103.9	99.6	328.5	166.9	90.6	118.0	90.1	183.6	79.3	159.2	130.7	109.6	172.1	143.1	179.1	404.7	257.2	372.6	167.3	541.7	388.2	486.6	533.0	479.4	437.1	462.2	259.6	369.5	289.1	401.4	533.5	522.0	272.0	477.1	406.9	535.6	120.9	219.0	157.5	413.9	308.9	602.7	212.2	141.6	449.6	351.2	380.8	489.6	389.2	478.9	142.2	249.5	383.0	551.5	403.7	188.0	207.6	355.5	512.0	322.3	186.9	340.9	292.1	456.5	221.4	347.3	275.5	425.7	310.1	418.5	385.2	203.3	198.1	433.8	263.2	171.2	459.1	289.3	179.3	221.3	241.2	472.1	420.1	403.8	54.1	40.9	32.9	41.2	44.0	46.9	37.0	38.9	38.2	41.8	32.3	41.7	37.0	16.1	46.0	47.3	70.2	36.1	40.3	173.9	180.9	156.9	261.5	180.9	210.1	170.8	180.3	191.2	166.9	183.6	179.1	102.5	125.0	160.1	39.8	75.8	363.5	572.5	292.0	75.1	46.9	198.6	103.6	130.1	123.0	242.0	110.3	10.4	443.3	106.2	103.2	246.5	269.1	46.9	231.7	235.5	146.6	178.6	68.5	109.6	129.9	1214.1	266.0	90.7	187.2	155.8	153.5	118.5	196.8	163.6	58.9	104.4	202.0	219.7	61.7	254.9	34.2	330.9	90.8	188.5	32.8	68.7	117.0	40.2	59.3	78.2	176.8	118.9	574.8	120.9	332.7	105.1	282.9	429.7	38.8	144.7	164.9	287.9	37.2	48.0	112.7	317.8	583.5	118.2	171.5	134.4	396.8
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031627			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	7.6	13.2	3.4	9.7	3.7	4.7	7.6	2.9	3.4	10.2	4.7	10.9	22.1	10.2	9.5	13.2	13.5	9.4	5.2	3.1	6.2	10.3	19.4	9.1	8.5	4.7	4.1	9.7	8.2	12.8	11.2	23.6	4.0	11.5	10.7	3.0	14.3	11.2	3.1	27.2	20.2	10.8	4.1	12.1	10.7	16.6	5.4	16.2	9.8	4.2	7.0	9.3	10.8	3.4	29.5	17.9	10.4	40.2	8.3	23.5	39.1	19.8	46.5	56.9	80.7	33.2	31.7	0.0	13.2	27.4	21.1	30.5	39.7	47.4	19.6	32.4	24.2	20.2	26.7	37.8	35.3	8.5	19.3	39.9	14.2	34.6	10.9	37.4	49.2	40.7	27.2	9.8	17.8	54.7	32.7	6.6	23.4	12.2	18.1	57.9	26.2	1.3	26.4	31.9	4.4	15.0	40.9	27.5	31.5	20.2	21.4	19.4	29.7	17.6	31.0	12.4	17.8	11.3	3.3	0.1	34.9	17.4	51.4	0.9	3.5	0.7	12.5	10.3	12.4	2.1	10.8	11.1	6.8	1.5	10.3	8.0	1.1	12.7	12.2	1.0	10.2	7.6	3.4	3.7	2.9	3.4	3.1	6.2	4.7	4.1	4.0	4.1	5.4	3.4	13.0	9.6	10.5	26.4	6.3	8.8	10.4	15.5	8.0	2.4	7.8	7.0	4.1	8.6	17.4	16.5	0.0	54.7	5.6	29.2	3.9	15.5	5.9	5.8	7.3	16.9	15.0	3.8	4.1	15.5	18.4	9.4	23.9	7.0	1.3	36.5	16.8	18.3	15.8	5.0	2.3	18.0	12.2	7.5	6.0	6.2	9.3	10.3	3.6	12.2	14.4	15.1	10.3	18.1	3.3	12.4	26.9	7.5	3.6	11.1	46.2	13.9	18.4	1.1	13.1	4.0	7.4	2.7	3.4	11.7	7.0	38.2	9.2	22.4	15.5	12.1
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105706-13279692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 85.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.5;Excitatory neurons: 213.6;Inhibitory neurons: 271.3;Oligodendrocyte precursor cells: 158.8;Oligodendrocytes: 279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.1;HUVEC TERT2: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Enhanced					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	22.7	9.9	18.0	5.3	23.2	0.2	13.2	20.3	20.6	14.3	21.7	16.1	2.8	17.8	15.3	7.6	17.5	11.7	29.8	18.0	20.4	18.8	85.7	11.1	3.9	19.8	22.4	25.6	4.6	11.3	10.7	24.7	20.3	19.2	5.3	33.0	6.3	23.2	19.9	3.8	6.4	18.6	21.4	11.1	7.6	11.5	17.7	4.3	11.7	31.3	1.8	12.6	9.9	35.3	16.1	21.2	58.1	26.0	39.2	35.4	11.8	15.9	16.4	13.8	13.1	0.0	0.0	0.0	4.5	39.6	14.2	0.3	17.3	8.8	22.3	0.0	10.2	10.5	21.9	3.9	20.8	0.1	5.4	26.5	3.6	9.7	6.6	35.3	53.5	0.0	0.3	0.1	12.5	4.2	0.0	0.2	24.9	0.0	9.0	0.0	14.2	0.0	13.7	8.5	7.2	26.9	12.6	2.8	15.5	39.7	8.1	0.1	42.8	14.1	2.7	4.7	12.4	0.0	0.0	0.0	6.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	23.2	20.3	20.6	18.0	20.4	19.8	22.4	20.3	21.4	17.7	35.3	70.9	32.1	7.9	121.5	0.2	5.1	10.1	4.8	3.4	30.9	8.6	15.6	109.7	1.5	14.7	7.3	39.6	16.1	0.4	0.1	1.9	4.2	4.2	27.0	12.4	44.6	1.8	2.1	213.6	2.0	22.9	27.4	1.5	6.3	1.3	39.5	42.5	74.4	5.8	26.9	271.3	0.2	6.1	0.6	6.8	3.7	24.2	0.9	17.8	60.9	0.6	40.2	0.0	158.8	279.6	1.8	0.0	33.8	0.1	12.9	0.0	16.4	36.6	25.4	39.5	35.1	40.8	6.7	13.9	0.1	4.0	10.8	0.8	7.6	0.0	4.7
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"bone marrow: 4023.1"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.5	0.4	0.8	0.6	0.6	4023.1	0.3	0.6	1.1	0.0	0.3	0.2	0.0	0.2	1.1	0.1	0.1	0.3	1.1	0.8	0.7	0.2	1.8	8.4	1.7	0.9	1.0	0.1	0.1	0.0	1.5	1.4	0.9	0.2	0.2	0.4	66.3	0.1	1.1	4.3	0.2	0.3	0.8	21.7	0.1	0.4	0.8	10.9	0.3	0.3	0.2	0.5	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.8	0.6	0.6	1.1	0.8	0.7	0.9	1.0	0.9	0.8	0.8	0.7	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67240713-67336061	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favorable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.4	8.7	13.9	6.3	20.9	5.6	10.6	17.6	16.5	8.8	26.6	12.7	20.4	6.3	21.1	13.6	7.3	7.9	7.4	11.9	17.4	31.4	19.6	12.3	4.8	18.2	18.2	6.1	8.7	19.6	7.2	9.8	18.3	16.2	12.0	17.2	18.4	12.7	18.0	8.4	20.7	7.2	18.1	6.6	9.4	8.8	17.5	10.3	25.1	13.6	6.1	9.0	8.4	27.5	156.4	24.4	24.1	18.5	13.3	12.3	20.6	46.4	23.6	33.2	21.6	23.8	45.9	12.7	21.5	37.8	11.0	31.0	13.9	26.1	50.2	5.5	9.5	11.8	23.6	16.8	15.5	4.5	8.5	13.1	10.0	17.9	23.7	24.2	19.0	13.5	12.6	4.7	53.9	20.4	14.4	5.0	7.7	22.2	16.2	12.2	37.1	15.2	30.1	36.8	13.2	9.4	28.2	27.0	15.5	21.1	28.6	9.2	29.2	41.4	87.2	13.8	19.9	7.8	7.6	19.3	27.2	10.1	14.7	0.1	0.5	0.8	0.4	1.0	0.3	1.1	0.5	0.6	0.8	0.4	1.1	0.6	0.0	2.2	0.7	0.6	0.3	0.4	13.9	20.9	17.6	16.5	11.9	17.4	18.2	18.2	18.3	18.1	17.5	27.5	13.2	64.1	28.9	37.2	8.8	21.0	26.0	14.6	22.2	8.5	22.4	12.8	24.7	11.5	21.1	22.0	43.8	23.1	5.2	47.2	13.7	21.7	5.9	29.5	15.0	17.7	5.4	6.7	24.8	26.9	11.3	17.3	18.3	46.2	5.1	15.8	17.2	20.7	17.6	3.3	34.7	21.2	12.2	11.9	13.4	4.5	8.1	9.2	3.6	22.5	6.6	23.4	3.1	41.2	129.8	26.7	32.5	11.3	13.1	30.1	54.3	33.5	14.9	34.3	6.6	17.7	22.2	22.4	36.1	29.2	17.3	17.5	7.7	7.5	22.4	38.7
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 122.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 19.3;TIME: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		170000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	54.4	28.7	0.8	24.0	1.7	0.7	16.3	0.3	3.5	17.2	9.2	16.1	9.9	7.2	1.7	13.1	11.9	27.7	10.2	1.1	0.7	7.6	40.9	122.3	15.2	1.4	0.9	6.2	8.1	4.6	1.5	54.3	1.1	2.2	18.5	0.1	4.9	8.0	1.8	2.8	17.5	30.3	0.7	50.6	9.7	7.5	2.8	8.0	5.5	8.7	3.0	29.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.3	3.5	1.1	0.7	1.4	0.9	1.1	0.7	2.8	1.3	4.0	32.1	43.5	1.3	3.5	0.4	0.0	0.0	0.0	0.0	128.9	1.7	3.6	11.5	7.4	0.0	0.0	0.9	1.0	1.4	0.0	0.1	27.3	0.0	0.1	39.0	0.0	3.2	0.8	0.4	1.4	2.5	0.0	0.1	13.9	0.1	397.7	13.1	176.1	0.0	1.3	0.9	0.0	361.4	46.8	19.4	1.5	316.5	0.0	60.9	0.5	0.0	0.0	0.5	0.5	0.1	1.5	0.0	1.0	0.0	2.2	0.1	5.8	0.0	32.9	3.0	2.2	0.4	2.3	1.2	0.4	2.1	4.7	1.7	0.8	0.1
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	9.1	6.1	3.4	11.7	3.7	22.6	13.9	6.8	3.4	8.8	6.0	7.6	6.8	11.7	8.9	7.1	7.9	7.3	5.0	3.3	3.5	6.0	6.4	7.7	12.6	5.1	4.4	11.1	7.5	5.6	3.1	12.1	3.8	9.3	11.5	6.3	7.8	7.3	5.0	15.6	7.7	9.9	4.0	12.7	7.3	8.3	4.4	14.3	7.4	5.4	16.1	8.5	7.4	6.7	21.5	21.5	39.9	5.0	13.1	18.2	22.8	29.4	19.0	25.9	30.6	39.4	43.3	55.8	47.0	15.3	32.5	40.1	33.7	22.1	34.1	37.5	20.0	48.7	31.5	22.7	6.0	32.7	33.6	12.8	13.4	33.7	21.0	11.7	23.0	26.8	34.9	35.6	20.9	15.5	33.2	30.5	13.0	49.3	23.3	29.0	35.3	28.1	16.8	29.6	14.1	19.8	40.6	26.0	8.6	33.2	43.4	19.3	16.9	38.7	28.6	33.9	21.5	8.8	33.2	54.4	10.4	50.3	31.5	5.7	8.0	6.5	8.2	10.0	8.3	6.4	6.0	8.9	11.6	6.9	5.1	8.4	3.8	8.6	8.4	8.7	8.8	6.7	3.4	3.7	6.8	3.4	3.3	3.5	5.1	4.4	3.8	4.0	4.4	6.7	23.6	28.9	14.3	0.0	6.3	0.0	0.0	0.0	0.0	0.0	12.5	13.7	0.0	0.0	9.3	9.2	0.0	39.2	20.8	0.0	3.9	11.4	0.0	19.5	22.2	8.4	0.0	0.0	0.0	8.1	15.8	8.9	0.0	16.3	17.7	34.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	8.8	0.0	0.0	6.1	0.0	0.0	6.5	11.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	28.0	7.2	16.8	0.0	0.0
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796473-62801729	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 124.0;Late spermatids: 408.9;Spermatocytes: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017012	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	7.0	7.5	8.8	5.5	8.9	6.7	6.8	9.4	9.8	7.9	7.9	8.8	8.1	6.7	3.2	7.5	6.8	4.6	9.8	8.7	8.7	8.4	13.6	7.1	7.8	8.7	8.8	10.8	6.7	8.7	7.8	7.3	8.7	7.1	4.0	6.6	7.4	4.4	9.2	7.2	8.8	3.2	8.0	9.7	7.6	48.0	9.0	7.0	7.5	6.7	5.3	7.3	7.5	10.2	32.2	20.0	16.1	24.8	8.7	13.1	15.6	18.2	23.5	69.2	30.0	71.5	25.1	29.3	35.4	14.1	34.3	26.7	18.5	30.7	38.9	9.2	15.8	21.4	22.9	41.8	13.5	25.2	38.7	11.3	22.2	18.9	20.0	14.7	16.6	27.8	29.6	15.7	17.5	48.8	48.0	47.7	13.6	33.5	35.7	42.5	30.5	21.8	10.5	13.1	22.6	18.2	25.9	22.9	33.9	8.9	28.3	36.5	17.4	42.9	44.6	29.4	39.2	20.9	13.7	34.9	42.3	24.8	24.6	0.0	0.6	0.9	0.5	1.0	0.7	0.4	0.6	0.7	0.4	0.4	0.5	1.0	0.7	0.1	0.4	0.5	0.8	0.3	8.8	8.9	9.4	9.8	8.7	8.7	8.7	8.8	8.7	8.0	9.0	10.2	15.2	0.0	2.2	6.2	17.1	14.7	14.8	9.0	13.1	12.3	14.4	11.9	9.4	18.6	5.3	12.9	8.4	12.6	18.0	9.2	19.6	23.3	124.0	9.3	11.5	12.0	2.4	12.8	7.9	22.2	24.7	13.1	12.8	9.7	1.3	14.5	11.0	14.5	14.3	13.5	7.3	9.6	8.2	11.3	16.5	408.9	12.2	16.1	7.2	2.8	12.4	16.5	8.2	5.0	5.2	24.3	8.0	7.9	18.8	23.5	12.4	18.6	3.2	14.5	0.0	10.2	13.8	113.0	27.8	16.4	13.1	14.6	15.6	19.5	12.0	17.6
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	31.3	30.1	21.8	18.9	27.4	13.9	28.6	26.5	23.5	29.1	14.8	27.8	23.7	21.7	25.2	25.0	18.1	20.7	35.0	18.8	26.7	56.0	63.7	17.8	20.3	23.4	24.4	17.4	23.6	45.2	12.2	25.7	25.4	21.6	30.9	19.3	24.1	25.1	66.4	23.9	19.9	29.0	26.8	16.9	18.4	16.5	24.9	24.3	36.9	44.8	25.1	24.5	15.1	32.5	100.7	57.5	53.3	48.3	57.0	68.1	75.6	63.4	57.0	78.5	62.2	88.5	40.6	56.5	62.1	69.2	73.8	69.5	83.7	95.8	117.8	63.2	72.4	77.4	44.4	114.3	61.0	82.9	44.5	45.6	72.4	79.7	72.3	49.6	84.1	60.8	86.4	32.3	78.5	61.9	76.1	64.9	69.9	102.9	65.2	94.5	116.5	74.5	134.1	61.9	58.8	50.2	62.2	71.2	72.4	53.3	61.1	32.8	57.0	68.3	75.4	61.2	94.6	33.3	53.8	47.1	53.9	81.0	61.1	17.7	20.2	14.2	22.1	26.8	25.1	26.8	22.7	23.8	29.7	22.7	19.9	24.6	1.4	24.4	24.9	35.0	26.5	17.2	21.8	27.4	26.5	23.5	18.8	26.7	23.4	24.4	25.4	26.8	24.9	32.5	31.8	19.2	29.6	10.7	27.4	29.1	28.6	77.8	21.1	38.3	32.4	29.5	40.2	25.8	49.4	49.7	52.1	90.3	26.3	24.0	125.2	88.7	27.6	42.7	48.4	27.7	27.6	32.8	13.9	61.1	87.3	33.7	36.7	50.3	19.0	35.8	27.1	67.6	47.3	48.8	14.3	36.5	44.7	14.6	17.0	11.2	35.4	23.7	33.8	12.2	35.0	39.6	34.0	15.1	20.0	53.6	27.7	36.5	36.5	36.1	36.5	167.7	32.8	50.9	19.7	31.4	38.1	55.5	17.6	44.3	28.3	57.7	25.3	62.2	50.7	35.6
MRPL27		ENSG00000108826	"Mitochondrial ribosomal protein L27"	Q9P0M9	17	50367857-50373207	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 377.6;Proximal tubular cells: 409.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021416: AB_1854103"	"unprognostic (2.09e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.76e-3)"	51.4	92.4	103.3	36.8	105.9	35.7	55.2	108.9	129.4	48.5	105.6	73.5	53.8	46.2	115.5	72.8	44.1	29.9	106.5	102.6	106.3	90.7	109.4	37.3	44.8	106.6	105.7	45.9	59.2	75.5	52.3	57.2	107.4	58.2	84.4	32.9	50.3	45.0	141.1	60.2	52.2	50.9	106.1	45.6	91.2	42.4	109.0	61.2	49.7	140.5	64.7	58.0	51.0	108.0	160.2	231.3	105.5	69.8	66.5	98.9	154.3	117.1	111.8	216.9	195.5	535.5	82.6	139.3	143.5	146.0	168.0	97.3	160.9	177.8	176.2	142.2	273.0	145.5	199.8	393.1	123.4	121.9	125.3	114.3	242.9	172.8	103.0	94.7	149.0	75.8	157.4	81.0	153.4	304.2	135.6	154.0	76.4	279.4	252.4	74.4	143.6	114.5	187.8	213.6	108.1	130.4	55.0	71.3	104.9	140.0	171.2	100.6	89.8	145.0	110.5	109.4	192.1	97.6	120.5	127.8	97.6	101.7	76.4	212.7	175.6	124.6	99.3	209.2	82.9	211.4	117.2	104.5	177.1	186.4	113.9	99.0	27.9	108.7	153.6	193.5	159.0	179.3	103.3	105.9	108.9	129.4	102.6	106.3	106.6	105.7	107.4	106.1	109.0	108.0	33.6	38.5	43.7	12.7	50.7	60.0	97.2	220.9	56.9	35.5	50.1	65.8	180.5	88.6	111.2	90.1	14.6	240.7	36.8	179.7	377.6	136.5	27.7	60.1	61.7	58.1	103.0	55.3	10.0	146.5	181.9	70.6	99.9	63.9	29.7	52.1	57.8	221.4	150.6	15.2	12.9	193.3	132.2	52.5	33.9	31.1	83.0	52.0	69.4	12.2	88.8	72.5	42.2	15.6	14.5	153.8	139.0	83.8	58.2	83.9	199.5	409.5	73.5	42.1	72.3	57.1	85.8	88.7	74.6	81.6	75.4	273.4	36.4	97.5	155.3	102.6
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19432545-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	39.4	54.4	59.9	26.1	61.6	28.3	47.6	63.9	79.7	50.0	60.3	33.6	26.1	31.3	77.4	35.6	54.8	31.5	100.7	59.0	62.3	69.1	118.8	28.9	35.5	62.5	60.6	44.5	57.1	85.0	11.2	30.7	62.5	46.4	35.9	35.0	72.1	43.0	135.8	29.2	24.7	32.6	63.6	27.1	33.8	31.4	61.7	29.7	79.0	142.0	40.9	36.4	7.0	65.0	84.8	83.8	26.9	64.0	111.5	98.8	45.4	62.1	95.6	116.9	133.6	105.5	49.0	73.2	71.0	93.7	67.8	82.9	118.8	141.2	122.6	69.8	129.7	72.8	76.0	184.4	158.1	117.7	46.1	102.3	123.6	101.1	179.8	77.3	95.6	35.0	265.8	91.2	127.5	106.9	44.9	77.6	22.7	190.2	100.3	49.7	110.6	44.2	135.9	67.9	45.6	48.3	100.7	94.0	159.7	60.2	80.2	52.9	60.6	118.6	127.3	41.6	64.0	78.1	115.7	147.6	79.2	71.6	99.5	45.1	88.3	76.6	71.7	108.9	82.7	162.7	72.4	74.6	100.1	155.6	85.9	75.6	10.4	90.5	90.2	106.5	91.9	103.5	59.9	61.6	63.9	79.7	59.0	62.3	62.5	60.6	62.5	63.6	61.7	65.0	43.3	44.8	35.3	8.8	53.8	40.4	73.3	181.9	52.3	31.0	59.4	85.9	86.1	71.4	106.6	47.8	12.5	129.6	42.9	35.2	260.3	83.8	114.9	104.4	61.9	40.3	34.9	27.1	3.6	97.9	128.9	55.9	32.1	46.1	33.7	44.2	40.0	146.3	135.6	21.9	5.8	47.8	91.6	43.6	40.0	152.4	72.4	42.9	85.4	4.7	73.9	120.4	37.0	3.5	12.0	73.9	48.6	72.2	92.6	53.6	89.8	254.9	163.5	50.3	46.0	53.9	74.3	82.9	72.1	64.8	38.5	62.9	35.1	103.8	49.3	52.2
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604649	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 399.7;Spermatocytes: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	27.2	34.8	30.6	24.0	31.7	48.8	27.2	34.2	41.1	19.4	34.2	32.1	23.7	23.0	22.8	31.8	18.9	18.5	54.9	29.4	34.7	44.4	35.5	20.1	30.0	32.0	31.8	16.6	17.4	33.9	24.0	22.2	32.6	20.6	31.8	26.6	21.1	18.9	52.5	21.5	22.6	24.7	33.3	24.3	26.2	53.1	32.6	33.3	21.0	56.9	30.4	32.0	21.7	34.2	128.6	48.6	83.0	76.7	51.5	53.5	95.2	73.2	65.1	112.3	93.2	198.6	51.8	104.7	140.6	62.5	137.2	94.5	103.5	76.9	120.5	121.0	90.9	99.8	46.1	112.5	99.8	182.2	54.2	49.6	65.7	83.4	84.7	53.1	77.2	95.9	59.5	81.4	88.1	98.9	98.4	168.4	144.3	115.4	114.6	102.7	81.1	175.3	120.4	79.6	71.8	83.5	80.7	128.6	151.2	61.9	198.6	136.6	61.6	60.7	87.4	77.1	204.5	102.1	182.4	229.3	70.7	147.4	75.8	38.2	32.4	44.2	31.7	43.8	32.2	35.1	35.1	34.7	48.4	31.8	30.4	31.7	8.5	41.5	54.4	41.9	48.9	35.8	30.6	31.7	34.2	41.1	29.4	34.7	32.0	31.8	32.6	33.3	32.6	34.2	45.3	22.4	21.7	5.5	51.4	74.9	82.0	179.7	38.7	20.2	36.4	33.4	89.7	54.3	78.6	57.0	10.4	100.0	61.2	46.3	258.2	112.3	399.7	72.8	56.0	55.5	54.9	62.9	7.1	115.9	109.6	51.8	36.2	50.0	56.4	34.0	44.3	62.5	99.3	10.1	9.2	52.8	105.8	42.4	55.7	95.4	42.9	53.5	48.0	4.7	80.3	43.4	39.1	7.1	12.4	118.7	53.6	49.2	54.6	72.6	45.2	201.7	85.5	26.0	59.2	57.9	68.2	301.2	54.0	52.2	70.5	104.1	57.8	102.3	71.9	83.8
MRPL49	"C11orf4, L49mt, NOF, NOF1"	ENSG00000149792	"Mitochondrial ribosomal protein L49"	Q13405	11	65122183-65127371	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 93.9;Syncytiotrophoblasts: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046778	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046778: AB_2679802"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.21e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.22e-15)"	"unprognostic (9.09e-3)"	"unprognostic (1.12e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.45e-3)"	23.1	87.3	25.5	21.9	26.5	26.7	35.2	24.1	27.5	29.4	29.5	33.6	28.1	28.3	41.8	43.0	42.1	21.3	32.4	26.6	29.2	55.1	50.9	28.1	30.9	26.3	25.7	42.8	26.9	42.8	36.0	27.0	26.2	35.4	34.8	16.9	29.2	39.4	38.0	41.6	28.3	30.0	25.3	26.0	29.1	18.1	29.0	33.9	45.8	36.4	44.1	31.1	28.5	23.6	68.7	64.0	48.0	44.0	39.7	26.4	47.9	49.4	73.8	98.9	70.2	77.4	95.2	68.7	70.9	56.2	93.6	69.3	97.7	71.1	78.9	57.5	33.5	64.0	43.3	62.0	63.7	65.8	54.6	43.3	61.7	81.6	119.7	54.6	61.2	82.4	82.7	40.1	59.2	99.4	82.3	70.9	79.8	77.9	87.5	71.2	46.0	91.0	81.5	51.9	69.3	48.9	76.7	98.2	89.3	38.1	174.4	51.1	31.2	41.7	62.5	61.6	46.5	75.5	110.0	141.4	57.2	44.7	72.7	133.5	39.3	78.4	68.2	39.5	77.8	77.9	73.6	83.8	52.1	74.8	81.2	69.3	32.7	95.8	56.8	50.2	74.8	96.2	25.5	26.5	24.1	27.5	26.6	29.2	26.3	25.7	26.2	25.3	29.0	23.6	19.8	16.0	15.9	2.3	20.6	11.1	22.8	21.1	13.1	15.3	22.7	21.6	16.6	20.0	16.6	12.9	10.4	60.4	21.6	23.1	93.9	31.6	1.0	17.4	11.2	16.0	22.7	44.8	5.3	20.3	51.1	14.9	10.2	16.2	12.6	21.6	12.8	17.9	21.5	11.8	4.8	23.5	18.3	6.5	9.9	3.4	14.6	12.4	23.2	1.9	35.4	31.1	13.4	0.5	4.3	28.2	16.6	24.5	24.3	20.8	22.3	49.2	28.6	17.9	6.6	10.4	24.6	5.9	15.6	12.8	16.1	111.0	24.6	77.9	22.9	21.4
MRPS17	"HSPC011, MRP-S17, RPMS17"	ENSG00000239789	"Mitochondrial ribosomal protein S17"	Q9Y2R5	7	55951877-55956500	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 195.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047159	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047159: AB_2679961"	"unprognostic (3.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-1)"	9.6	13.6	14.8	7.8	15.0	10.2	11.2	14.8	18.3	7.4	11.6	13.0	8.9	9.9	9.2	13.5	10.1	5.1	20.0	15.6	15.1	16.8	22.1	6.9	9.1	14.3	13.9	9.5	13.6	9.7	8.3	6.5	14.8	10.4	9.8	5.6	9.0	10.5	32.9	8.2	9.1	9.3	13.0	10.2	11.6	11.9	15.9	9.1	8.2	32.7	9.3	11.0	7.8	14.6	195.1	25.3	17.4	36.6	17.3	16.9	22.0	20.6	20.3	25.0	28.4	31.0	26.0	49.3	29.6	16.9	57.9	43.3	38.6	39.3	30.1	20.7	30.0	14.7	35.8	32.2	24.9	37.4	14.5	19.4	31.6	25.0	41.2	18.3	26.5	27.8	57.9	19.2	22.6	21.8	29.9	51.4	37.4	47.7	43.2	23.9	16.8	38.9	40.4	23.4	25.7	22.6	23.4	76.1	28.5	29.6	49.9	29.3	17.9	8.3	40.8	60.2	47.8	16.7	34.2	83.2	8.4	18.9	38.2	3.6	8.7	2.7	10.5	10.7	12.7	17.1	14.4	15.2	13.3	14.2	16.1	14.3	2.3	12.5	11.0	13.2	15.5	7.9	14.8	15.0	14.8	18.3	15.6	15.1	14.3	13.9	14.8	13.0	15.9	14.6	9.6	22.4	11.7	2.6	12.3	0.0	21.3	0.0	26.7	6.7	14.3	14.4	0.0	22.8	14.2	5.5	0.0	30.4	8.7	8.2	29.4	48.1	22.6	18.5	9.5	11.3	4.9	30.9	3.5	54.5	26.2	9.9	23.0	10.0	5.1	10.3	18.9	33.7	19.2	18.5	3.9	15.5	0.0	11.6	0.0	5.5	9.3	9.1	0.0	1.0	20.6	10.6	21.6	3.0	4.6	46.0	14.8	10.9	21.3	19.9	24.2	28.9	13.8	7.0	6.6	10.0	11.2	29.2	12.0	31.2	0.0	21.3	10.7	10.8	21.8	11.9
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	32.6	56.9	30.7	14.7	31.3	23.2	30.8	30.3	37.9	29.2	34.9	35.4	23.0	29.6	12.9	37.7	35.7	15.8	67.0	31.2	30.2	46.1	79.7	22.0	21.0	29.9	31.3	34.9	45.8	32.2	26.4	16.8	31.1	33.1	17.3	7.7	31.3	21.2	75.5	39.1	28.1	15.2	29.7	32.0	39.3	17.0	33.1	16.2	25.8	50.4	17.7	33.8	28.8	30.8	59.9	98.4	35.3	48.0	39.1	43.5	60.0	43.0	39.0	71.7	53.0	149.0	55.4	75.4	57.2	40.1	75.8	132.6	88.9	101.4	27.7	46.2	137.4	37.4	96.1	101.8	68.4	76.6	44.3	58.6	77.6	78.3	55.6	45.7	67.9	74.2	125.1	54.3	42.3	185.8	73.9	133.7	80.2	110.8	153.9	81.3	57.3	159.5	59.9	50.8	104.9	55.2	58.8	110.9	63.2	23.6	92.4	60.5	42.4	52.3	58.4	90.3	78.8	58.9	124.5	84.1	53.0	69.2	49.1	8.4	28.4	13.6	30.0	27.5	34.5	34.4	30.1	32.4	29.1	34.3	32.4	32.9	2.4	28.7	24.0	25.1	41.8	26.4	30.7	31.3	30.3	37.9	31.2	30.2	29.9	31.3	31.1	29.7	33.1	30.8	23.8	12.8	14.1	4.9	32.5	44.7	38.8	55.0	33.0	22.2	37.3	51.7	31.2	42.9	31.6	12.9	6.2	71.3	19.0	21.5	72.4	50.7	14.7	27.8	34.2	32.6	21.7	41.4	4.6	38.6	65.8	27.9	21.4	77.7	8.2	37.9	21.8	46.5	42.5	25.2	5.9	37.9	28.5	17.6	15.4	32.5	24.2	21.0	19.6	1.9	31.7	24.8	20.6	4.0	4.5	39.9	27.1	23.0	38.6	48.6	36.3	84.5	14.7	17.0	32.9	27.1	29.4	13.3	21.5	47.1	45.7	37.4	23.4	77.5	55.7	35.5
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729128-40771190	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 412.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoli	"HPA039083: AB_2676340, HPA046344: AB_2679629"	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	11.7	14.8	9.1	14.0	9.6	14.4	16.9	10.5	12.5	10.7	9.1	15.8	14.8	16.6	13.8	14.7	15.1	10.2	24.0	8.7	9.5	19.6	28.8	11.5	23.5	9.6	9.7	19.2	10.4	14.3	7.5	12.6	10.1	11.3	15.6	13.7	13.7	11.0	27.5	13.5	15.3	15.2	9.3	13.2	15.0	17.9	9.2	17.8	19.6	26.2	24.9	13.2	10.0	11.8	19.0	17.9	29.5	19.5	19.8	23.2	29.6	23.7	16.5	30.7	20.5	46.0	27.4	110.5	22.6	13.7	41.3	48.8	37.4	29.6	36.2	29.4	28.1	45.9	12.7	29.7	16.5	47.4	21.3	18.8	21.4	25.3	21.2	20.3	23.8	31.2	31.3	11.3	19.8	21.5	37.2	46.2	28.7	64.2	20.9	35.0	24.3	20.8	40.3	21.6	12.9	18.7	16.5	27.0	39.3	35.1	23.7	41.5	14.6	9.5	16.0	22.3	24.9	8.7	17.4	55.7	19.5	33.3	18.6	30.9	15.3	24.9	29.4	16.4	28.8	36.8	32.5	29.9	19.5	33.5	38.5	34.3	11.3	28.7	18.4	19.1	36.5	17.8	9.1	9.6	10.5	12.5	8.7	9.5	9.6	9.7	10.1	9.3	9.2	11.8	27.5	48.1	19.2	24.5	35.0	9.7	33.0	106.0	33.0	35.1	22.4	31.6	73.7	28.6	77.2	22.0	18.8	62.7	31.2	18.7	109.5	43.0	74.9	55.5	38.6	32.5	23.4	29.8	28.8	33.6	41.5	27.9	18.8	38.1	23.4	32.8	37.9	76.9	26.0	42.1	37.8	37.4	91.6	17.0	12.5	14.2	35.4	18.1	19.6	26.2	39.8	32.3	32.0	36.7	45.1	30.0	19.5	30.5	52.1	15.8	32.4	93.4	412.5	51.2	46.0	39.5	38.1	72.6	49.8	30.2	13.4	68.0	37.7	45.2	35.5	25.5
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773150	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 354.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	40.2	84.4	15.0	8.2	15.6	14.9	38.9	18.8	30.2	39.6	8.4	56.9	17.6	41.4	1.8	74.2	38.1	3.9	66.5	14.3	14.7	53.4	83.8	33.1	9.6	20.1	14.9	32.5	85.4	7.5	43.2	6.0	18.3	44.2	3.0	1.5	51.9	9.7	88.1	63.3	48.9	3.0	17.3	59.4	55.9	22.3	17.2	6.6	35.2	6.2	4.3	43.9	43.6	19.7	72.4	77.1	10.6	26.9	9.1	10.7	86.5	75.8	14.9	26.2	20.2	51.7	40.7	89.1	120.7	9.6	14.9	82.3	15.7	37.3	4.0	63.2	354.6	63.9	68.2	56.3	19.9	116.7	63.3	9.8	17.5	16.1	7.1	11.8	20.4	45.1	105.7	18.6	7.5	113.3	63.1	209.4	101.5	19.1	229.5	137.9	51.9	201.0	10.2	19.4	132.2	100.6	85.8	42.4	82.5	2.9	54.9	46.5	51.9	28.2	88.9	37.1	62.8	154.8	116.9	141.9	22.1	65.3	36.1	68.6	185.4	108.3	144.9	172.6	153.3	189.3	160.0	154.2	205.6	224.2	150.2	135.6	40.6	165.1	153.9	192.1	204.7	189.6	15.0	15.6	18.8	30.2	14.3	14.7	20.1	14.9	18.3	17.3	17.2	19.7	72.0	38.5	31.7	13.1	92.5	100.3	60.8	132.6	103.6	45.6	108.8	127.9	59.9	101.5	77.3	97.5	10.4	181.3	87.9	170.1	250.5	116.1	5.9	65.3	82.8	59.6	91.1	90.6	10.1	182.5	181.9	66.2	105.0	66.2	36.1	75.6	65.3	168.1	173.3	55.5	12.0	174.0	109.9	96.1	66.2	11.6	72.7	74.8	81.8	8.4	108.8	87.8	110.2	11.6	17.1	155.4	153.4	70.0	183.8	94.0	265.6	261.8	43.1	38.2	19.7	48.2	73.7	30.9	49.2	192.3	120.6	68.4	83.2	140.7	232.3	75.7
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105038069-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Supported	Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	17.2	33.5	21.4	17.9	22.7	24.6	23.3	24.1	26.5	18.3	25.7	29.8	29.5	20.7	19.2	23.8	24.2	13.4	64.1	21.4	23.3	32.7	31.8	15.4	24.7	24.0	22.8	30.8	24.2	32.8	19.6	12.9	24.3	23.4	33.3	22.3	23.3	21.6	98.6	21.9	23.4	19.8	22.7	18.5	25.9	33.5	22.8	30.8	21.4	97.0	27.1	20.2	17.9	25.1	68.2	28.9	59.4	55.1	30.6	31.5	69.6	42.6	40.6	66.2	59.2	155.0	46.4	70.6	41.1	33.9	68.9	59.8	118.0	62.1	69.9	44.0	77.5	69.7	42.4	94.4	51.0	52.2	29.9	37.9	41.5	54.6	45.4	38.3	51.6	84.8	101.5	35.9	45.7	54.9	70.6	68.6	93.9	57.4	62.6	88.9	50.9	98.3	83.2	47.3	51.4	30.9	49.4	71.5	59.9	58.0	58.9	52.2	34.0	38.8	78.2	38.9	46.6	32.6	41.5	56.3	33.6	79.1	33.3	21.7	23.8	10.1	39.3	31.5	43.3	44.4	43.0	41.7	43.0	35.3	42.9	42.4	2.8	46.0	39.9	32.1	49.9	31.7	21.4	22.7	24.1	26.5	21.4	23.3	24.0	22.8	24.3	22.7	22.8	25.1	18.2	22.4	28.2	28.1	21.0	19.5	25.3	56.4	22.2	24.7	15.4	22.2	110.2	22.8	30.4	22.0	12.5	39.9	29.1	17.7	107.6	40.7	51.7	35.9	18.6	22.5	19.7	47.5	43.4	42.7	40.7	21.2	18.8	12.9	22.8	34.6	18.2	31.2	28.8	8.4	54.2	27.9	24.4	15.2	9.9	14.6	23.9	15.9	30.2	17.8	26.2	21.2	29.9	49.3	69.4	22.6	18.3	27.1	25.0	17.4	23.1	72.3	42.1	32.0	39.5	24.8	28.1	112.8	40.7	23.4	13.2	20.4	25.2	62.9	40.5	19.0
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841560-71844412	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 40.9;Fibroblasts: 31.4;Leydig cells: 42.6;Melanocytes: 26.6;monocytes: 50.7;Pancreatic endocrine cells: 27.5;Peritubular cells: 41.3;Sertoli cells: 26.3;Skeletal myocytes: 70.0;Smooth muscle cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 25.8"	"Group enriched"	"Detected in many"	37	"B-cells: 6.9;dendritic cells: 6.4;T-cells: 25.8"	"Cell line enriched"	"Detected in many"	15	"HDLM-2: 819.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 16.3;hippocampal formation: 13.2"	HPA062878			Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	13.3	8.9	2.5	11.4	1.2	3.9	7.0	0.4	4.5	6.7	0.9	3.0	2.2	4.8	0.9	3.1	4.2	11.1	19.9	5.9	0.6	6.3	3.6	9.5	12.1	3.1	0.7	5.1	5.2	0.3	3.3	16.3	1.0	5.5	1.1	0.0	4.3	3.1	3.0	3.5	5.3	2.3	0.6	6.4	5.4	3.0	0.7	1.6	4.4	2.4	3.5	20.5	6.5	2.8	0.1	6.2	0.0	0.0	28.1	4.9	0.0	1.2	23.8	0.5	1.3	0.0	0.0	0.0	0.3	4.8	28.5	1.3	0.0	1.5	0.0	819.3	0.3	0.0	0.0	0.0	49.8	0.0	2.8	11.1	0.0	49.2	30.1	11.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	55.3	0.0	0.0	0.0	2.4	0.0	0.1	0.0	44.9	0.5	0.0	5.5	0.0	0.2	0.1	7.8	0.3	5.0	0.2	0.1	20.4	0.1	34.5	0.0	0.1	0.0	5.2	0.1	7.2	6.9	9.2	25.8	0.1	6.2	0.2	8.7	0.2	0.0	0.3	6.4	13.0	3.2	2.5	1.2	0.4	4.5	5.9	0.6	3.1	0.7	1.0	0.6	0.7	2.8	1.2	0.0	0.0	0.0	2.7	5.1	0.2	0.4	0.0	0.0	0.2	0.3	1.9	0.0	0.0	1.8	0.0	0.1	4.3	0.0	0.0	16.1	0.6	0.3	1.0	4.5	0.0	0.0	1.1	40.9	0.1	31.4	1.5	0.1	0.0	0.0	3.9	0.0	1.8	0.0	0.1	0.0	0.0	0.3	8.9	1.5	42.6	5.8	26.6	0.0	50.7	0.0	0.0	0.0	0.2	27.5	0.0	41.3	7.0	0.7	0.0	1.2	0.0	0.0	26.3	70.0	27.8	0.4	0.3	0.3	3.3	0.0	10.0	8.1	0.0	0.3
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654652-80876815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	9.4	4.6	1.8	4.3	2.4	5.0	5.5	1.6	2.0	6.6	1.5	6.0	6.0	5.2	5.3	5.0	7.0	5.7	4.9	1.7	2.0	12.5	11.4	4.2	4.9	1.7	2.0	5.3	5.2	8.8	3.3	4.3	1.7	5.2	6.2	3.7	4.5	5.2	5.1	5.1	5.6	5.1	2.2	4.1	5.0	3.9	2.5	7.1	10.8	4.7	6.1	6.3	3.9	2.0	12.4	15.0	11.7	13.1	6.6	12.3	16.6	12.2	11.8	13.6	16.7	10.0	15.6	22.2	14.0	15.3	12.8	10.4	15.6	20.5	17.3	14.2	13.9	8.4	13.4	9.9	6.8	9.9	8.5	10.9	9.5	15.8	16.6	13.8	12.9	7.9	12.1	12.9	16.1	11.9	19.0	4.7	9.0	4.8	7.7	13.2	24.2	16.4	15.2	13.0	11.6	13.9	10.4	11.5	13.0	14.4	15.2	9.4	12.4	7.8	9.5	6.2	23.0	8.7	15.6	21.6	12.2	16.8	10.2	0.7	2.9	1.9	3.3	3.4	3.8	3.4	3.5	3.6	3.3	2.2	2.6	2.6	1.7	3.1	4.6	2.8	4.8	2.4	1.8	2.4	1.6	2.0	1.7	2.0	1.7	2.0	1.7	2.2	2.5	2.0	16.7	35.3	9.3	66.9	18.1	10.5	12.3	12.4	12.5	25.8	19.4	12.8	17.6	8.6	14.3	14.7	14.6	18.9	18.7	18.2	15.6	12.4	14.6	28.4	20.2	12.0	14.5	17.0	95.1	10.3	12.9	15.9	31.6	18.9	8.2	19.9	10.0	20.1	11.5	21.9	98.9	13.2	8.2	13.0	7.0	17.2	13.7	16.3	3.6	72.1	19.9	22.5	19.6	71.9	92.3	10.6	9.6	25.9	22.0	6.5	16.8	43.6	65.4	28.3	19.7	20.2	14.7	24.7	25.5	22.3	10.1	13.1	25.4	14.7	17.4	10.7
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739677-31762676	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 5.2"									HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	1.3	1.2	0.1	0.5	0.1	0.7	1.5	0.1	0.4	1.7	0.2	1.6	0.0	1.4	0.0	2.2	1.9	0.0	1.0	0.1	0.1	5.6	2.0	1.4	0.6	0.1	0.2	2.3	1.6	0.0	2.2	0.0	0.1	2.9	0.0	0.1	1.6	0.0	0.6	1.8	1.8	0.0	0.1	2.4	1.6	14.0	0.1	0.0	1.5	0.0	0.0	1.6	1.7	0.2	0.3	1.1	0.4	0.9	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	1.0	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.7	1.1	0.1	0.6	0.0	0.3	1.3	0.0	0.0	0.1	0.3	0.5	0.9	1.2	1.9	1.6	0.0	2.1	0.5	5.2	0.9	0.9	0.0	2.1	0.1	2.4	0.3	0.5	0.2	0.8	0.3	0.2	0.0	0.0	0.3	1.8	0.0	0.3	1.6	0.1	0.6	0.3	2.1	1.7	0.0	0.5	0.8	2.5	0.4	0.0	0.4	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.1	0.1	0.6	0.1	0.6	0.8	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	2.3	0.0	3.6	0.5	0.5	0.3	3.4	0.7	0.5	0.5	0.3	2.8	0.8	3.7	18.8	0.6	0.5	1.0	0.0	0.2	0.1	1.6	1.3	0.6	1.2	8.0	0.0	0.2	0.4	0.9	10.7	2.8	3.8	3.1	0.4	0.3	0.5	0.0	0.0	1.2	0.0	0.8	1.3	0.5	1.2	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.5	0.7	10.7	0.5	2.0	0.8	0.9	7.3	0.0	1.0	1.4	10.9	8.3	6.2	0.4	0.5	2.5	0.9	1.9	0.4
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810063	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 119.6;Theca cells: 114.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes		15000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	11.7	22.7	9.3	17.7	13.7	24.0	16.2	15.0	12.7	15.5	12.7	13.0	9.0	27.7	10.2	11.7	17.8	10.9	9.3	8.9	11.5	12.1	19.8	11.6	28.4	12.7	11.7	53.0	31.3	17.0	9.8	20.3	13.0	15.0	12.4	21.6	10.8	15.6	10.5	13.1	9.8	27.2	10.7	12.7	10.9	35.3	11.3	36.3	17.2	11.2	31.0	12.8	12.2	19.9	116.5	77.6	128.4	37.5	42.3	46.3	67.9	63.6	51.1	60.2	59.8	67.2	41.4	158.1	84.5	59.5	82.0	46.0	130.3	74.3	82.1	80.7	69.0	117.0	60.8	71.1	28.8	131.5	37.8	38.6	28.3	60.7	41.6	53.8	40.8	5.3	115.9	69.8	61.8	85.5	144.2	80.1	130.7	81.3	37.7	219.6	204.3	84.7	44.5	76.2	92.8	100.3	79.1	40.4	42.7	124.3	54.6	42.6	33.4	72.2	92.3	54.6	80.6	63.8	79.3	276.2	61.9	77.9	42.4	7.7	3.7	3.8	4.8	6.2	5.5	4.3	5.5	5.0	5.5	4.2	8.4	4.5	2.5	5.9	6.4	2.7	5.3	3.6	9.3	13.7	15.0	12.7	8.9	11.5	12.7	11.7	13.0	10.7	11.3	19.9	19.8	28.9	21.4	5.9	19.2	25.2	22.0	12.3	31.9	25.4	14.4	15.1	8.6	2.8	21.8	7.3	35.5	35.6	20.7	7.4	3.9	15.7	46.4	27.1	31.1	18.4	4.8	47.1	8.5	9.6	21.8	24.0	8.6	31.7	17.7	119.6	13.6	10.2	13.0	15.2	12.1	9.7	20.3	5.6	13.2	17.5	25.4	16.8	3.6	7.5	10.0	22.7	8.2	9.5	27.4	9.1	3.7	22.6	31.1	16.1	2.6	6.7	22.1	31.4	6.6	27.4	33.0	54.3	48.8	22.0	17.5	9.6	19.8	114.9	12.1	11.7
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775772	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favorable (3.28e-4)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favorable (2.17e-4)"	17.6	11.8	13.4	23.1	14.3	17.0	15.9	12.7	15.4	12.9	13.1	15.4	8.6	13.4	5.4	17.8	14.0	10.0	12.9	14.5	15.0	12.5	13.9	21.9	31.3	13.3	14.1	12.1	11.0	6.8	11.1	10.4	13.4	14.5	8.5	5.7	14.4	8.5	35.8	16.0	25.4	9.9	13.8	49.3	13.6	15.7	16.2	38.8	14.5	22.6	27.0	14.8	14.5	13.2	18.6	20.3	28.0	15.0	21.6	30.1	10.2	24.0	21.9	25.2	30.9	13.7	16.8	22.5	25.2	21.6	16.2	14.0	29.7	17.0	34.1	12.6	20.2	14.0	23.0	7.0	18.5	19.6	20.8	18.7	21.6	29.1	10.9	20.6	38.4	26.6	22.2	14.2	24.5	18.3	19.0	19.3	22.3	21.2	32.7	10.8	25.8	34.1	16.1	21.2	17.8	20.8	22.0	10.4	16.9	23.5	18.0	13.0	34.4	23.7	18.2	40.0	22.6	10.6	20.1	32.9	18.1	12.4	21.0	46.6	53.6	37.2	36.6	47.0	31.9	41.7	42.6	41.3	42.3	45.9	57.9	52.2	66.2	39.4	60.4	41.5	60.4	62.1	13.4	14.3	12.7	15.4	14.5	15.0	13.3	14.1	13.4	13.8	16.2	13.2	30.1	9.6	19.2	7.8	52.7	13.3	15.1	10.7	22.2	10.4	19.1	17.9	16.1	17.2	12.7	7.3	8.4	22.9	73.5	12.7	9.8	18.0	57.0	32.0	30.1	29.1	6.7	24.4	10.7	17.1	33.7	18.2	15.8	25.2	26.6	24.3	27.8	16.8	21.9	8.4	7.3	16.4	8.2	58.2	36.1	24.5	12.5	46.9	14.2	14.0	68.4	10.9	41.2	8.5	8.3	22.5	8.7	16.6	41.3	12.6	12.2	15.2	23.2	7.7	6.6	20.5	21.8	41.8	24.8	24.9	18.5	11.8	54.5	21.6	13.6	13.2
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 93.4;fallopian tube: 278.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	93.4	0.2	0.7	1.1	1.0	3.2	0.5	0.6	1.5	15.9	0.3	8.9	7.1	6.2	24.1	7.1	278.2	16.4	8.4	0.7	0.8	6.5	0.2	71.8	0.2	1.9	1.2	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.3	9.9	0.0	1.4	2.9	3.4	1.0	0.4	13.0	1.1	1.2	0.8	0.2	0.0	27.2	2.9	2.9	1.0	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	1.0	0.6	1.5	0.7	0.8	1.9	1.2	1.3	1.0	1.2	1.0	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 337.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		130000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	213.3	83.3	66.6	259.8	71.4	269.8	144.6	80.0	70.9	113.9	79.6	116.0	43.9	155.8	45.0	87.9	110.0	123.1	130.2	64.8	95.9	139.7	91.8	281.5	207.5	101.9	79.6	91.9	41.0	39.2	48.2	150.6	98.8	72.5	78.4	24.0	76.0	126.6	56.2	100.7	96.6	251.6	91.8	200.0	78.4	21.9	87.3	177.0	152.5	75.7	242.2	154.8	98.0	95.5	298.3	223.2	214.0	177.9	250.6	328.9	1.9	733.9	472.2	397.3	305.5	0.6	50.9	247.7	638.8	654.4	210.3	199.4	228.5	523.4	514.1	461.7	63.0	687.5	355.0	0.6	236.0	845.3	1063.8	248.1	110.7	733.1	641.5	384.2	892.3	338.5	339.5	747.1	638.4	0.6	503.0	631.0	266.1	0.3	418.9	259.8	384.0	189.0	426.5	0.2	1.7	0.8	590.6	4.4	231.5	239.7	2.7	453.8	1426.9	449.5	285.3	613.2	494.6	268.6	438.4	262.5	328.9	1053.3	513.0	219.9	312.4	194.0	214.8	359.3	160.4	91.9	116.9	170.6	225.3	76.9	78.3	121.9	334.3	177.5	460.3	31.9	97.0	673.8	66.6	71.4	80.0	70.9	64.8	95.9	101.9	79.6	98.8	91.8	87.3	95.5	243.4	179.5	163.0	19.9	140.8	205.5	62.2	56.5	38.7	0.7	27.9	30.9	27.5	11.5	45.4	68.0	4.2	6.0	227.3	7.5	29.4	177.3	1.4	35.7	64.9	256.2	0.0	71.9	2.2	170.0	16.0	85.7	16.3	62.9	164.6	22.6	100.3	51.2	167.2	5.0	3.8	3.2	2.0	255.3	206.2	5.3	73.7	251.9	69.4	67.5	291.9	43.6	337.8	7.1	14.7	327.7	3.3	109.4	105.7	102.2	0.0	113.6	25.6	2.4	72.3	85.0	131.0	1.9	3.6	24.3	149.5	4.2	206.9	24.4	2.2	54.0
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 120.1"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 137.3;Kupffer cells: 322.8;Langerhans cells: 86.0;Macrophages: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.9"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 105.2;REH: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					NA	NA		67000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	25.9	18.4	4.2	17.5	5.4	13.0	9.7	5.5	10.6	11.6	13.6	8.5	6.6	8.0	6.3	6.2	5.6	29.8	8.7	3.8	6.5	6.7	24.9	120.1	7.0	15.0	7.5	6.1	11.4	6.3	2.6	27.4	10.8	3.6	10.6	5.9	6.3	6.4	2.3	3.5	9.4	17.9	6.9	16.0	6.2	6.2	16.9	4.4	5.2	1.4	2.9	17.4	1.9	22.9	1.5	2.1	3.0	1.5	1.4	1.3	1.4	0.7	105.2	0.3	0.6	3.7	0.4	3.4	5.1	1.0	0.7	0.7	0.7	1.0	2.0	0.4	4.3	4.6	5.1	4.2	0.9	2.4	2.5	0.7	0.8	0.8	1.5	1.8	0.2	1.9	1.7	2.9	1.9	4.3	1.4	1.4	0.5	1.6	1.3	40.7	2.3	1.0	2.0	5.8	2.8	1.2	1.0	2.8	0.2	5.0	0.4	1.2	2.4	2.8	0.9	10.8	2.8	9.5	8.6	7.4	1.1	1.5	2.2	1.7	3.3	0.6	1.0	16.9	0.4	1.1	0.7	0.7	1.1	1.5	1.3	0.9	3.2	0.4	8.8	0.5	0.7	0.8	4.2	5.4	5.5	10.6	3.8	6.5	15.0	7.5	10.8	6.9	16.9	22.9	2.0	22.4	35.9	0.0	2.7	2.7	0.0	0.0	0.0	1.6	0.5	1.4	2.0	2.8	8.1	3.7	25.0	0.5	0.1	0.0	1.9	0.0	2.9	0.0	0.0	6.3	0.0	2.7	0.3	0.0	1.0	2.1	0.0	0.0	17.7	0.1	4.6	1.7	137.3	0.0	3.0	0.1	0.0	322.8	86.0	3.6	1.8	172.5	0.0	28.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.4	6.6	0.7	19.7	1.0	0.7	4.2	1.3	0.1	2.0	0.8	2.6	0.2	0.0	0.3
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MT2A	MT2	ENSG00000125148	"Metallothionein 2A"	P02795	16	56608584-56609497	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 5788.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 8010.7;Hepatocytes: 20955.4;Proximal enterocytes: 9666.9;Proximal tubular cells: 18370.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 30056.8;LHCN-M2: 13670.8;RPTEC TERT1: 8267.0;U-87 MG: 8331.2"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.14e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (5.69e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (2.92e-9)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.03e-2)"	2473.0	2348.4	1352.9	558.0	1442.3	242.3	886.1	1442.7	2196.5	408.6	1146.9	678.6	272.3	156.4	87.5	584.0	574.5	785.3	400.2	1280.6	1429.1	1149.5	5788.9	1104.0	185.9	1546.3	1538.3	288.9	1625.7	63.7	210.3	278.3	1498.0	618.3	302.3	56.9	330.7	125.7	2332.2	561.1	702.8	321.4	1388.5	134.6	675.0	69.0	1615.7	96.2	869.7	475.8	71.8	975.0	395.6	1323.0	813.8	474.4	10.3	313.8	2919.3	4441.2	47.3	6998.3	4553.1	1693.0	1546.9	2.9	1499.9	137.5	941.0	709.0	502.6	874.6	394.4	30056.8	856.7	1324.8	255.2	164.3	499.3	217.2	1297.5	1020.9	99.3	2558.0	1541.9	3695.4	1569.0	1744.1	2273.5	55.6	10.6	12.4	13670.8	853.9	132.6	1393.5	677.8	0.5	3925.4	123.8	402.4	13.6	8267.0	9.8	173.8	40.0	1688.2	613.6	492.6	38.6	100.3	127.7	2200.6	7229.9	2617.8	1165.3	1973.0	8.4	20.7	14.3	8331.2	1530.1	451.2	251.3	135.0	177.0	250.2	210.3	166.7	29.3	149.8	274.6	108.7	19.1	105.0	203.1	75.8	90.3	237.8	18.2	261.4	180.8	1352.9	1442.3	1442.7	2196.5	1280.6	1429.1	1546.3	1538.3	1498.0	1388.5	1615.7	1323.0	8010.7	298.1	186.5	254.0	227.0	1833.4	1766.0	3977.6	2360.7	0.0	748.4	1639.4	110.5	762.0	642.7	1116.4	0.0	642.4	860.3	3180.2	2807.6	863.8	56.4	1744.2	565.0	2039.5	242.1	890.0	0.9	358.8	888.1	3744.8	792.0	4445.9	257.0	335.0	1201.1	20955.4	280.3	0.0	0.6	2411.2	480.1	1616.0	972.8	16.5	340.8	1565.2	626.1	47.8	387.6	0.0	224.6	25.6	15.0	702.2	6836.2	74.1	405.1	4471.7	9666.9	18370.1	434.3	0.0	1091.3	5048.3	6135.5	4.1	11.7	974.0	729.8	449.4	629.8	394.2	2478.5	439.7
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.1	23.8	24.1	10.8	23.4	15.4	24.6	23.7	31.0	31.7	19.4	31.2	13.1	29.9	11.6	22.6	31.8	6.2	39.2	24.1	20.1	24.7	24.1	19.6	12.1	22.2	21.5	38.6	30.1	9.4	36.9	9.2	20.1	31.8	5.6	8.3	23.6	12.7	25.6	21.1	22.1	9.0	20.0	26.7	22.5	37.6	22.5	16.5	30.4	7.7	9.1	29.2	24.4	22.3	33.6	26.3	47.9	48.2	18.0	30.5	42.3	26.2	19.9	25.4	24.3	34.4	44.1	65.4	26.7	19.3	17.9	45.3	35.1	25.0	17.1	43.2	59.0	34.1	25.2	35.5	39.6	43.2	25.3	34.4	30.9	18.0	41.1	35.5	36.4	48.0	39.3	27.7	13.4	60.4	78.3	85.2	69.1	47.7	55.1	73.1	29.1	21.5	20.6	26.0	76.9	80.1	35.5	40.5	40.8	24.3	36.7	40.7	26.6	20.4	21.6	34.1	27.8	55.9	28.9	41.3	25.6	28.7	36.6	0.1	0.2	0.8	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.0	0.4	0.1	0.9	0.2	0.2	24.1	23.4	23.7	31.0	24.1	20.1	22.2	21.5	20.1	20.0	22.5	22.3	32.1	3.2	16.0	37.9	20.9	15.6	28.8	14.6	13.1	0.0	64.8	38.6	9.2	27.1	15.2	35.0	0.0	11.6	17.7	17.2	17.6	13.2	32.8	25.0	28.4	20.4	18.6	25.4	17.2	19.6	8.0	21.8	28.1	23.9	5.7	47.6	18.2	15.5	11.0	0.0	16.1	21.6	10.2	18.5	13.5	11.3	36.1	15.7	12.4	21.5	13.8	0.0	20.6	32.6	27.0	16.3	11.5	32.0	17.8	45.4	18.5	8.8	27.0	0.0	19.7	30.5	25.4	21.5	13.3	16.8	19.0	9.3	18.7	27.1	24.9	46.2
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 137.0;Oligodendrocyte precursor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	11.8	41.8	16.4	5.6	18.9	1.6	14.9	9.1	19.4	18.5	7.1	16.6	7.8	16.8	27.5	21.8	16.1	10.0	12.4	21.9	14.9	13.6	7.9	8.8	10.7	12.3	13.9	29.2	18.8	17.3	15.1	15.3	18.8	14.4	13.2	9.3	13.6	16.8	9.1	19.1	11.4	12.0	11.7	7.8	16.8	21.0	16.1	70.4	12.6	9.9	14.5	15.3	17.8	14.8	13.0	16.6	20.1	14.3	17.4	28.0	46.6	7.4	18.6	21.7	19.2	22.2	26.2	45.4	12.6	22.1	15.9	8.2	51.6	25.2	34.2	14.1	21.0	6.7	8.8	36.4	21.9	5.0	29.0	29.5	29.1	13.4	16.6	28.1	30.4	23.9	16.5	6.1	25.7	27.8	30.3	22.0	84.4	20.8	9.7	18.4	18.9	0.0	25.7	12.1	12.3	37.1	13.5	45.5	17.8	61.6	23.2	7.0	14.2	8.9	12.1	7.2	8.1	11.5	4.7	63.5	12.6	5.7	11.1	2.5	0.9	0.0	1.7	0.6	2.6	1.2	2.0	2.9	1.5	1.3	4.4	3.0	0.2	1.8	0.9	0.4	1.1	1.5	16.4	18.9	9.1	19.4	21.9	14.9	12.3	13.9	18.8	11.7	16.1	14.8	12.7	12.8	12.5	60.4	10.8	15.3	21.1	33.0	15.4	0.0	24.6	19.6	12.5	15.7	25.7	22.0	0.0	58.5	5.1	19.1	17.6	22.9	10.7	44.5	23.1	13.1	9.6	2.5	137.0	28.0	42.0	21.7	31.1	32.3	12.0	72.3	20.7	13.3	12.4	0.0	81.8	20.0	50.8	6.6	7.1	26.0	33.8	5.2	17.8	53.4	6.9	0.0	9.2	106.1	65.9	20.2	21.8	39.9	10.9	17.7	25.2	33.1	18.4	0.0	13.1	15.8	35.9	25.5	41.1	24.5	18.3	59.9	12.6	44.5	21.5	17.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802636-21937651	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046915, CAB080036, CAB080037"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		3000000	"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB080036: AB_11128130, CAB080037: AB_11129069, HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	5.9	6.5	4.1	5.4	4.8	5.8	8.5	4.2	5.7	7.8	7.6	6.7	4.8	8.8	7.1	8.8	7.1	4.9	7.0	3.8	4.0	6.9	10.9	5.8	6.3	5.0	4.5	12.1	6.6	8.4	2.8	8.9	5.1	7.2	8.0	3.9	6.5	7.0	4.5	7.0	5.9	9.0	4.0	7.3	7.2	2.9	5.4	6.8	7.2	5.4	7.3	10.1	7.4	6.0	30.4	1.0	23.0	19.0	19.4	19.0	28.3	42.3	21.0	21.9	24.3	21.7	14.6	15.3	13.4	21.1	16.3	15.2	24.4	59.5	36.8	0.3	19.8	0.3	56.8	28.8	18.6	24.5	26.3	23.5	0.1	38.6	42.6	24.4	22.6	0.5	0.3	20.1	21.9	3.1	26.8	0.7	27.5	14.7	35.2	0.4	18.0	26.0	18.3	0.4	14.4	15.3	14.4	17.1	21.1	17.9	10.9	0.6	23.8	0.3	15.7	0.2	34.4	13.7	25.5	30.0	0.2	24.3	12.0	1.2	5.6	0.2	3.6	4.5	6.1	5.9	5.3	4.2	6.9	8.4	4.6	4.2	0.7	6.7	2.9	6.3	3.2	2.7	4.1	4.8	4.2	5.7	3.8	4.0	5.0	4.5	5.1	4.0	5.4	6.0	18.8	22.4	19.8	26.1	16.3	14.1	58.4	22.4	16.5	0.0	20.2	23.9	22.4	24.3	27.9	14.7	0.0	52.3	11.4	6.8	15.6	38.6	77.9	28.8	28.5	14.9	9.6	19.1	14.8	28.0	80.0	18.7	15.3	40.6	10.8	30.0	17.5	22.2	27.1	0.0	9.1	14.3	30.5	25.5	11.1	14.8	14.9	15.1	10.6	48.7	15.0	0.0	10.3	40.7	32.9	41.5	6.8	14.7	13.7	45.0	9.2	19.5	19.1	0.0	13.1	20.6	23.1	1.3	13.9	35.1	13.1	22.6	15.1	33.0	20.7	62.9
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 90.1;intestine: 28.1;retina: 34.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 26.0;Excitatory neurons: 86.4;Granulosa cells: 28.9;Inhibitory neurons: 80.4;Oligodendrocyte precursor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 90.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 32.0"	HPA046245	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.6	0.9	0.0	2.5	0.6	0.5	1.4	90.1	10.1	4.7	0.0	28.1	1.8	2.3	0.7	2.7	1.0	8.1	2.9	0.7	0.5	2.5	1.3	1.2	0.8	4.9	2.6	1.1	3.7	2.8	5.6	2.3	7.3	1.7	1.7	34.0	1.4	3.0	2.1	2.5	4.3	5.2	0.9	0.6	8.9	8.0	0.0	3.7	0.4	1.1	0.5	9.4	4.6	6.3	16.8	35.3	17.4	10.2	7.6	14.1	0.7	22.9	16.9	18.6	13.4	10.4	5.8	10.5	12.8	16.1	13.9	2.5	5.5	9.4	8.5	2.1	4.5	5.1	10.1	9.4	10.9	0.1	7.3	8.3	6.8	10.5	7.2	12.1	14.8	8.8	1.1	17.8	8.7	5.0	0.7	2.5	7.9	40.2	15.2	14.0	12.5	3.8	26.9	29.9	39.3	8.8	10.5	3.0	2.7	14.3	1.0	0.6	28.2	33.8	17.6	27.4	23.8	3.4	2.8	5.1	8.4	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	90.1	10.1	0.7	0.5	4.9	2.6	7.3	0.9	0.0	6.3	0.4	0.0	1.1	9.4	1.3	0.0	2.8	0.0	4.6	0.0	1.5	1.9	6.5	8.6	0.6	1.8	0.0	5.0	1.8	1.8	1.9	5.6	26.0	2.8	2.3	2.1	1.2	4.6	86.4	3.5	0.4	1.5	5.6	7.8	2.5	28.9	4.6	1.0	0.6	0.0	80.4	1.5	0.0	0.6	0.0	8.8	1.2	0.3	0.0	8.4	0.1	0.0	0.0	24.1	18.3	8.6	0.2	0.4	1.9	4.6	0.2	1.9	0.0	0.0	0.0	0.8	1.9	0.9	5.2	3.0	0.0	1.0	0.4	1.3	1.2	1.3
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880702	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	4.7	6.1	4.0	7.9	5.1	10.1	9.2	4.7	5.1	5.5	4.1	7.6	7.0	7.0	7.6	7.3	5.9	5.4	5.9	4.2	5.2	8.4	11.3	5.2	14.0	4.5	4.1	8.3	5.9	6.5	5.0	7.1	5.0	6.1	7.8	6.5	7.5	5.9	5.0	6.3	6.8	6.1	4.1	9.7	8.1	6.6	4.8	11.4	7.5	8.9	13.3	5.7	5.8	6.8	17.3	15.0	13.3	9.0	12.2	13.9	12.6	14.2	14.3	15.8	19.6	16.9	17.7	36.8	11.9	11.0	21.3	15.2	21.3	13.4	23.9	1.9	14.5	16.1	17.2	13.4	11.6	29.3	15.7	17.2	16.3	15.8	18.5	11.4	12.9	8.1	31.2	15.0	18.1	22.2	31.5	27.0	22.2	20.1	16.5	9.3	19.2	23.4	15.8	17.5	12.8	23.4	13.9	30.1	29.0	24.3	10.9	19.4	9.5	18.4	22.2	25.4	14.9	19.4	21.9	48.7	13.0	9.4	26.9	46.0	12.9	18.5	14.6	11.2	18.5	22.0	19.2	21.9	14.1	23.9	26.1	20.7	6.2	16.1	13.5	11.2	20.1	15.1	4.0	5.1	4.7	5.1	4.2	5.2	4.5	4.1	5.0	4.1	4.8	6.8	5.5	9.6	10.6	6.2	10.5	0.0	3.9	0.0	14.8	0.0	5.3	6.7	5.3	5.7	2.5	3.7	0.0	9.3	8.0	3.4	5.9	5.9	1.5	4.5	7.0	4.9	1.2	8.2	7.9	5.2	6.3	6.2	7.7	4.0	5.1	8.3	6.4	9.6	5.1	0.0	7.2	2.6	0.0	6.0	0.0	2.1	6.8	5.9	0.0	5.6	7.1	0.0	10.3	8.0	15.2	4.1	3.1	7.2	12.6	3.9	7.2	8.2	1.5	0.0	13.1	5.0	5.3	14.0	10.5	6.3	0.0	4.5	8.0	8.5	4.1	2.7
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 6.4;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	0.8	0.5	0.4	3.6	0.3	16.3	1.0	0.4	0.6	0.6	0.2	2.9	2.8	0.5	0.3	2.6	0.3	0.3	0.3	0.4	0.3	0.6	0.4	1.2	6.4	0.4	0.5	0.3	0.4	0.0	0.4	1.8	0.3	0.4	3.8	0.5	0.8	0.2	1.2	1.9	2.3	1.1	0.4	2.2	1.2	7.0	0.4	6.2	0.3	0.1	5.3	0.8	0.9	0.4	15.2	11.5	9.7	18.2	1.6	2.8	17.4	19.6	13.6	22.8	31.7	20.7	12.2	39.2	11.7	7.9	30.1	23.1	22.3	14.4	33.8	22.1	17.1	31.0	7.8	18.9	1.0	57.4	28.1	2.3	3.1	25.5	16.1	2.7	12.4	33.8	33.9	29.6	17.2	20.2	32.5	47.8	9.8	20.2	14.1	29.3	15.5	19.7	9.9	11.6	7.7	7.6	12.4	21.5	11.3	11.9	9.1	39.1	6.8	11.3	11.8	40.2	30.4	11.2	28.3	26.1	6.5	38.5	17.6	0.0	0.2	0.0	0.3	0.9	0.1	0.4	0.4	0.7	0.9	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.7	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.4	0.5	0.3	0.4	0.4	0.4	2.0	0.0	1.1	0.0	2.2	1.0	0.6	3.1	0.0	0.0	3.4	3.6	0.4	0.0	2.3	0.0	0.0	8.4	1.3	2.2	0.0	1.1	7.9	2.4	1.3	1.7	0.0	9.9	0.5	2.5	23.6	1.5	2.6	2.5	1.3	3.5	0.7	0.5	6.6	0.0	0.4	2.1	4.1	3.8	2.1	5.9	0.3	2.5	0.0	1.0	2.3	0.0	1.0	0.5	0.0	1.3	0.4	0.0	7.4	1.2	1.3	1.4	2.5	0.0	0.0	5.3	1.8	27.6	13.0	5.3	0.3	3.0	3.1	0.8	4.6	0.9
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765108	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 79.3;Excitatory neurons: 61.2;Inhibitory neurons: 58.1;Oligodendrocyte precursor cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 104.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018502, HPA075953"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA018502: AB_1854185, HPA075953: "	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.7	7.2	11.3	11.1	13.0	11.9	12.5	11.7	13.0	9.3	7.1	10.2	9.0	7.9	7.1	20.6	9.7	7.2	12.2	17.3	10.8	8.3	9.0	9.5	21.8	7.5	10.0	8.5	10.0	17.9	9.2	14.2	7.6	10.9	9.4	22.1	12.4	10.9	22.9	21.4	10.4	7.3	9.2	14.3	10.7	8.0	11.9	31.3	10.0	16.0	25.5	12.6	13.5	8.7	32.3	20.3	21.5	17.7	4.9	5.7	28.8	28.1	36.0	28.0	39.4	19.8	24.9	70.2	40.1	22.9	27.1	28.4	43.9	40.8	43.2	28.4	26.3	4.4	31.6	8.5	14.5	20.7	14.6	15.6	27.7	30.8	0.4	26.8	17.1	22.9	13.8	17.5	20.3	27.7	30.6	5.3	9.9	35.9	30.3	16.0	34.1	31.2	22.0	36.4	31.9	19.9	10.7	23.7	8.8	17.0	30.3	11.8	21.7	18.3	14.6	2.3	42.1	22.2	24.6	104.8	3.7	13.3	14.4	0.0	0.5	5.0	2.1	0.9	1.5	1.7	2.3	1.9	1.4	1.9	2.0	2.8	1.5	3.9	0.9	5.0	3.2	1.2	11.3	13.0	11.7	13.0	17.3	10.8	7.5	10.0	7.6	9.2	11.9	8.7	3.7	16.0	6.5	79.3	11.4	11.2	11.0	8.0	6.8	0.0	7.8	5.5	8.2	2.8	7.5	5.5	0.0	10.1	19.3	4.6	0.0	5.9	0.0	10.0	3.7	3.6	9.6	6.5	61.2	6.6	7.3	4.5	7.7	9.2	1.3	4.8	2.9	8.0	4.6	0.0	58.1	5.5	8.2	9.4	8.8	1.7	5.6	4.8	3.6	30.0	6.2	0.0	8.2	54.8	22.6	10.6	8.6	5.3	7.9	11.0	3.8	3.1	8.4	0.0	6.6	6.7	3.9	2.5	3.0	10.3	16.8	10.4	8.8	5.9	5.9	12.5
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246222-25287488	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	13.4	19.0	9.6	14.2	10.6	31.9	12.5	10.6	14.2	10.7	6.1	10.9	8.5	12.2	7.7	10.8	8.7	12.8	15.6	11.0	11.8	14.8	13.4	13.0	15.0	11.1	9.6	9.3	12.8	16.3	6.1	12.2	11.0	12.9	12.1	21.9	16.1	13.3	11.8	7.7	8.8	15.8	10.4	14.2	10.9	18.6	10.4	16.7	15.3	14.9	14.4	14.3	6.5	14.0	12.3	12.6	20.3	17.3	21.2	22.1	9.9	38.0	42.6	36.9	28.9	8.4	21.4	18.8	11.0	35.7	18.7	14.9	13.1	22.5	42.6	22.7	8.6	23.1	8.4	6.9	25.5	48.5	40.8	15.9	25.9	26.8	35.8	21.1	30.4	24.8	10.9	20.9	37.5	8.7	27.8	13.1	6.1	23.6	9.4	11.8	28.5	25.9	26.7	14.2	10.7	15.2	12.4	21.8	20.2	19.2	8.4	30.2	39.4	22.6	11.6	25.2	22.5	11.3	14.0	24.6	11.4	18.6	37.6	22.9	9.8	8.0	5.8	14.0	7.4	6.5	6.1	6.2	7.9	4.2	6.2	6.4	18.9	6.0	13.0	4.7	8.9	8.9	9.6	10.6	10.6	14.2	11.0	11.8	11.1	9.6	11.0	10.4	10.4	14.0	24.5	16.0	32.1	20.5	44.3	11.0	8.0	8.7	8.0	0.0	16.7	10.4	29.5	8.6	11.9	16.5	0.0	5.8	21.8	14.5	13.7	13.1	64.0	19.0	18.9	20.7	16.7	6.1	29.4	15.0	6.9	16.7	14.8	10.5	19.0	10.6	27.1	23.1	16.3	0.0	63.9	16.0	12.2	40.5	27.7	23.4	12.5	36.4	19.6	26.2	28.1	0.0	5.2	33.2	51.6	22.3	10.0	19.9	28.3	10.2	7.3	31.3	26.6	0.0	0.0	20.4	17.7	62.1	20.4	10.3	11.9	8.2	26.3	17.5	12.3	11.9
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284816-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Centrosome	"Actin filaments"	"HPA070944: AB_2686325"	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	4.6	3.7	7.8	4.3	7.9	3.4	4.9	7.0	8.1	3.5	3.3	6.5	2.4	4.5	2.9	3.4	3.1	3.2	7.5	8.4	8.7	4.4	3.0	3.5	4.0	7.2	8.4	3.6	2.9	4.2	3.0	4.2	8.0	5.0	3.1	17.5	2.6	3.9	5.7	3.8	3.1	5.8	6.3	3.8	3.0	7.7	7.4	3.5	3.7	8.6	3.9	3.7	3.2	8.1	2.9	4.2	7.1	4.8	8.4	7.1	5.0	8.7	5.6	5.1	4.3	3.7	1.5	6.8	2.1	8.1	5.0	3.7	5.2	5.3	6.7	1.2	3.8	6.8	4.5	3.4	8.9	2.2	5.0	6.9	5.9	6.2	9.1	5.8	7.8	3.8	5.0	3.9	10.5	2.1	3.9	2.6	12.4	6.9	4.0	3.0	9.7	2.0	7.7	5.1	2.2	10.6	4.6	2.7	6.7	10.5	2.7	5.4	11.2	7.9	2.3	4.8	4.8	1.3	1.9	3.3	6.9	5.6	7.9	0.2	0.4	0.3	0.7	0.4	0.5	0.5	0.6	0.5	0.2	1.1	0.7	0.7	0.5	0.5	0.4	1.0	0.4	0.2	7.8	7.9	7.0	8.1	8.4	8.7	7.2	8.4	8.0	6.3	7.4	8.1	17.8	12.8	16.8	26.4	27.7	13.6	11.6	12.9	11.4	0.0	11.7	8.4	25.3	24.3	14.5	14.7	0.0	12.4	27.4	7.4	3.9	11.6	17.7	5.1	15.0	18.9	16.2	10.8	44.8	7.1	12.7	18.3	4.6	8.0	14.0	24.9	26.7	17.3	14.5	0.0	42.1	10.7	12.2	21.0	32.7	8.5	23.3	20.2	16.0	18.7	24.3	0.0	25.7	32.2	48.7	15.0	11.1	19.5	11.7	21.6	13.4	10.9	18.0	0.0	39.5	19.0	17.7	84.9	33.1	10.1	12.9	4.5	20.7	14.6	9.5	9.3
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262551	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"CAB069425: , HPA071227: AB_2686367"	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	16.3	19.4	18.2	13.5	19.0	14.0	16.8	18.4	20.1	15.2	18.6	22.8	11.0	17.5	21.8	18.3	14.6	9.0	23.6	19.7	17.7	24.1	27.6	15.2	15.3	16.5	21.2	14.2	18.3	20.6	21.8	11.8	18.4	19.8	16.0	26.9	16.5	13.8	36.4	17.1	19.6	13.8	14.6	21.2	18.7	33.8	22.7	19.2	17.8	17.8	15.9	17.1	14.9	18.7	28.5	25.2	33.3	25.4	39.4	18.6	16.6	23.4	22.3	30.6	29.9	26.0	25.5	31.4	19.6	27.8	18.8	33.1	45.3	35.8	39.3	25.2	33.2	41.7	53.8	33.4	24.7	41.1	29.7	24.0	26.8	43.7	44.0	14.5	39.3	29.6	47.4	26.1	21.6	32.4	28.5	31.2	25.3	29.6	23.5	28.2	39.2	21.0	27.2	25.3	33.4	24.5	50.1	26.8	31.2	36.5	21.8	24.0	42.3	26.5	23.9	20.5	31.8	25.5	25.5	60.5	19.1	43.6	28.6	0.3	1.1	1.3	1.9	2.4	1.6	1.4	1.1	1.0	1.6	1.1	1.3	1.1	0.8	1.1	1.3	1.2	2.4	1.0	18.2	19.0	18.4	20.1	19.7	17.7	16.5	21.2	18.4	14.6	22.7	18.7	9.2	16.0	11.8	40.8	10.0	3.4	5.2	7.6	8.6	0.0	7.7	7.5	25.1	2.8	10.3	9.2	0.0	7.9	9.8	9.4	1.9	8.5	42.0	13.8	16.1	11.0	10.3	14.3	43.8	6.2	7.2	9.2	16.8	18.6	13.3	12.9	5.3	13.4	6.9	0.0	49.2	7.8	6.1	8.2	4.1	36.1	7.8	9.1	8.8	36.5	9.2	0.0	10.3	38.2	37.4	10.4	5.4	8.2	17.2	8.9	7.0	4.5	6.3	0.0	39.5	11.4	12.1	49.3	37.4	15.6	5.7	9.9	9.8	15.3	10.0	5.7
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926760-135977359	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	68.9	49.5	66.7	65.1	75.5	151.1	50.7	41.6	79.4	67.1	45.6	50.5	40.2	65.1	50.9	125.5	62.2	50.5	77.1	79.5	65.0	58.5	49.7	57.8	89.4	77.7	60.0	49.2	23.8	75.9	34.0	61.7	54.0	52.9	55.4	39.9	36.8	51.3	47.6	46.8	46.6	66.1	56.3	79.7	41.2	56.6	65.2	72.5	88.2	48.0	107.8	67.2	58.5	53.3	126.0	90.6	111.5	170.4	160.3	187.2	55.8	189.5	208.0	129.3	137.7	104.5	139.4	229.7	132.7	255.6	188.6	78.9	107.1	161.1	246.1	153.1	84.2	152.9	94.6	77.2	127.3	211.5	213.5	136.5	158.5	152.9	147.7	180.1	205.5	163.6	182.3	138.1	253.2	94.3	208.4	163.0	155.9	121.9	118.9	120.0	83.8	187.7	144.5	103.1	140.6	248.3	157.1	105.8	158.4	102.8	75.4	130.7	215.2	193.5	85.0	192.3	189.7	103.8	160.2	325.9	307.5	185.0	420.2	117.4	75.4	85.2	54.7	105.7	46.0	107.9	33.5	41.7	89.3	125.0	21.5	31.7	180.3	46.0	169.4	82.8	32.6	70.5	66.7	75.5	41.6	79.4	79.5	65.0	77.7	60.0	54.0	56.3	65.2	53.3	110.6	48.1	40.6	0.0	149.8	119.2	58.9	86.8	72.8	0.0	68.6	72.8	82.0	70.1	61.9	69.9	0.0	63.4	131.6	67.1	90.1	69.6	77.8	83.8	153.3	108.5	33.0	91.9	0.0	51.3	73.1	92.4	45.9	131.9	98.6	64.8	87.4	59.2	100.5	0.0	0.0	46.9	46.8	247.5	232.7	28.6	86.3	214.0	101.4	0.0	234.2	0.0	125.7	0.0	0.0	99.9	67.0	123.8	59.2	96.2	52.6	88.3	50.0	0.0	92.1	99.8	79.8	65.8	123.8	143.3	149.0	68.8	86.1	106.5	52.4	106.9
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 7.2;cervix: 15.9;fallopian tube: 5.9;salivary gland: 6.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 40.3;Club cells: 81.8;Endometrial ciliated cells: 74.3;Glandular and luminal cells: 157.8;Ionocytes: 99.7;Respiratory ciliated cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"ovarian cancer: 21.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 23.3;HeLa: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"	NA	NA		25000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.9	0.0	0.0	0.0	2.1	0.0	0.3	5.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	6.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.6	2.8	0.0	0.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.3	0.1	40.3	0.0	0.0	4.1	0.9	3.4	1.5	81.8	0.0	0.0	2.1	0.2	0.0	0.0	0.2	14.3	74.3	14.8	1.2	0.0	0.0	0.4	0.0	0.4	1.0	0.0	157.8	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	99.7	0.3	0.0	16.4	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	197.4	0.0	0.0	0.0	8.6	0.3	0.2	0.0	0.3	3.3	0.6	0.0	0.0	0.7
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	20.3	51.1	24.2	15.7	27.5	7.0	16.4	26.2	37.5	30.5	19.3	32.3	35.1	20.3	2.2	77.8	13.5	4.9	22.8	24.7	27.8	28.8	78.8	31.0	12.3	32.4	27.8	19.6	25.3	8.3	18.9	6.3	39.3	23.5	4.2	3.4	25.1	6.5	27.2	52.3	26.6	5.7	24.0	24.6	31.5	42.3	24.7	7.0	21.1	8.3	6.8	17.6	36.9	25.6	50.6	34.2	52.4	33.1	18.1	38.7	29.5	25.1	26.0	17.7	14.6	86.1	119.7	24.4	39.8	15.7	63.7	72.8	25.0	133.1	4.9	15.7	38.3	17.8	18.2	127.0	35.9	11.6	11.8	30.9	24.6	46.6	13.5	8.7	18.0	58.0	51.7	13.1	10.2	115.9	39.3	56.6	61.5	17.7	31.3	40.2	15.0	62.3	49.8	33.0	52.2	17.9	62.0	13.3	18.5	11.4	67.8	51.3	39.0	14.7	29.8	27.2	14.2	34.9	17.6	83.2	17.9	55.7	25.7	5.6	12.6	2.4	26.8	13.7	20.4	16.1	18.0	17.9	15.0	22.6	13.2	16.6	1.8	28.3	15.4	28.0	20.4	15.4	24.2	27.5	26.2	37.5	24.7	27.8	32.4	27.8	39.3	24.0	24.7	25.6	17.2	25.6	48.2	22.2	21.5	15.2	12.9	106.3	4.0	27.2	26.5	14.1	16.7	21.5	56.9	20.2	6.2	20.2	79.6	117.5	25.4	30.8	61.6	17.7	10.0	15.8	32.9	26.5	23.4	62.3	29.2	15.5	41.8	26.5	16.5	27.4	20.7	147.2	38.6	23.5	17.0	75.3	32.6	25.5	21.6	96.2	8.1	20.3	21.4	6.5	32.2	16.5	55.6	11.1	14.5	30.0	79.4	9.1	46.3	20.1	47.1	22.6	21.5	18.1	6.6	7.0	20.7	50.8	13.0	13.8	21.6	48.8	36.3	35.5	65.2	20.6
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555386	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No		47000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	12.3	11.0	3.8	13.4	3.8	11.4	15.9	1.3	7.6	13.3	0.8	11.9	9.6	14.6	4.6	17.0	15.2	6.2	11.0	5.0	4.2	9.8	10.8	11.4	13.8	5.2	4.9	14.1	24.4	6.7	12.7	5.2	3.5	17.1	5.1	3.8	18.9	10.1	27.9	22.0	12.9	7.3	2.1	14.0	12.4	8.1	3.4	7.4	11.2	8.0	8.7	14.9	13.8	3.8	60.1	90.0	11.9	56.2	15.4	17.1	40.8	39.8	17.5	39.5	30.8	67.1	24.4	80.4	47.2	23.9	19.8	74.2	50.1	61.3	19.0	40.3	133.8	38.8	58.3	62.2	25.2	45.5	34.7	25.7	34.6	58.8	29.1	11.0	26.6	45.0	64.2	37.1	18.2	51.4	54.2	19.5	56.0	19.1	48.0	69.8	19.7	54.0	9.8	45.5	25.5	48.5	40.8	29.7	28.2	8.6	27.5	19.1	34.3	35.1	31.5	32.7	118.6	32.1	26.5	34.4	32.5	53.9	45.3	0.0	1.9	0.3	2.8	1.6	3.4	2.9	2.3	3.1	2.9	1.7	2.5	2.8	0.1	2.4	3.4	2.1	1.0	2.7	3.8	3.8	1.3	7.6	5.0	4.2	5.2	4.9	3.5	2.1	3.4	3.8	13.4	9.6	14.5	4.6	13.1	12.9	6.8	7.1	12.0	8.2	12.9	14.4	4.1	8.6	13.3	3.7	12.5	2.9	5.8	9.2	0.0	7.7	0.5	6.7	15.3	17.0	11.4	7.2	11.3	12.7	5.4	10.2	10.7	8.5	5.1	12.2	8.6	7.8	6.5	10.1	6.1	8.0	4.1	4.5	6.8	0.6	5.6	6.3	3.6	7.5	3.8	3.8	6.2	3.5	6.5	8.2	4.5	12.0	13.7	13.9	4.6	3.2	12.2	6.2	6.6	10.8	12.9	2.6	11.1	12.8	11.9	1.1	9.7	13.8	12.4	6.2
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYBPC3	"CMH4, cMyBP-C, FHC"	ENSG00000134571	"Myosin binding protein C3"	Q14896	11	47331406-47352702	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	584	"heart muscle: 1725.4"	"Cell type enriched"	"Detected in some"	42	"Cardiomyocytes: 1876.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-937: 6.4"	"Region enriched"	"Detected in some"	33	"cerebellum: 34.4"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					NA	NA		21000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.4	2.9	0.0	0.7	0.0	1.5	0.7	0.2	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	1725.4	0.0	0.0	0.3	0.3	2.0	0.5	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.6	0.0	0.4	0.2	0.3	0.1	0.0	2.8	2.8	1.4	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.9	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1876.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.3	0.0	0.0	14.3	0.0	0.0	0.2	0.0	0.0	43.9	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	19.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.9	0.0	0.0	0.3	0.0	17.4	0.6	0.0
MYD88		ENSG00000172936	"MYD88 innate immune signal transduction adaptor"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 172.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	20.1	14.2	6.9	43.5	7.4	51.8	15.0	7.2	7.5	15.2	8.0	30.3	32.2	12.1	18.6	36.6	14.4	23.5	9.4	6.7	7.7	13.7	61.1	42.6	35.2	9.5	7.5	11.4	11.6	11.6	9.2	22.6	8.0	14.3	31.7	2.1	18.0	12.0	3.2	17.7	32.2	24.5	8.6	40.7	27.6	7.7	9.2	38.3	9.4	8.8	41.6	47.4	20.3	8.5	25.1	34.2	5.9	33.2	25.0	32.0	10.8	23.6	39.0	68.1	72.9	22.7	30.9	52.8	13.8	44.7	15.8	30.9	43.2	24.2	22.1	39.5	8.7	28.5	16.6	36.6	21.4	36.2	72.0	38.4	26.6	39.2	15.3	13.2	39.9	40.3	13.3	22.3	36.8	25.7	61.3	12.2	22.1	52.8	35.7	24.8	7.0	23.1	37.6	58.9	3.0	12.0	33.4	172.1	22.3	4.8	25.8	40.8	35.5	13.8	7.9	60.6	24.0	28.9	32.9	38.5	25.0	63.0	28.9	288.5	236.9	296.9	67.2	333.6	58.1	43.7	60.6	69.3	203.6	35.2	42.1	59.5	284.7	54.6	436.1	99.9	87.4	257.3	6.9	7.4	7.2	7.5	6.7	7.7	9.5	7.5	8.0	8.6	9.2	8.5	13.4	6.4	15.2	2.0	19.5	14.4	13.5	12.7	14.2	1.0	11.3	10.8	1.6	5.7	16.4	5.5	0.0	14.6	35.3	40.8	7.9	24.5	1.4	10.9	30.2	15.9	9.6	9.7	0.2	27.3	24.4	10.8	23.9	18.6	24.1	10.0	10.4	33.2	32.2	0.0	0.4	14.9	10.2	75.4	40.5	0.9	13.7	61.5	3.6	1.9	58.1	4.1	28.8	2.5	0.3	64.0	34.8	10.5	12.9	16.0	28.0	12.2	12.1	0.1	13.1	4.3	7.2	8.6	0.6	15.1	17.2	12.0	19.6	10.2	15.9	49.4
MYDGF	"C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20"	ENSG00000074842	"Myeloid derived growth factor"	Q969H8	19	4641374-4670362	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 768.1;Plasma cells: 857.6;Syncytiotrophoblasts: 581.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1043.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041872, HPA046744"	Approved				"Secreted to blood"	NA	NA	285000	2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041872: AB_2677718, HPA046744: AB_2679783"	"unprognostic (3.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.50e-7)"	"unprognostic (4.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.99e-12)"	"unprognostic (4.42e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	84.7	94.2	42.5	83.8	43.5	92.0	73.2	44.4	48.7	79.1	47.6	81.4	75.7	75.1	114.6	67.5	71.0	44.1	66.3	43.1	48.1	70.8	259.5	91.7	61.9	45.7	44.0	72.1	210.0	41.7	126.1	76.1	45.8	84.2	65.5	13.0	135.6	52.8	24.7	59.3	71.1	52.9	45.5	123.0	94.5	54.5	45.0	30.8	75.4	15.1	45.5	74.3	63.3	50.2	250.5	118.7	74.6	189.8	228.0	190.2	133.0	449.6	378.1	210.8	263.8	194.9	155.8	145.0	206.5	455.4	171.9	122.7	88.6	157.7	121.8	137.7	152.0	87.6	212.7	250.0	353.9	310.9	201.6	159.0	187.8	154.6	292.3	263.0	233.0	78.8	155.4	1043.7	194.9	134.4	83.9	174.1	94.5	235.3	417.1	80.0	126.3	701.0	169.1	114.2	114.1	117.0	151.0	189.1	227.5	64.2	111.4	366.6	268.9	162.8	135.1	449.2	325.9	505.8	229.6	122.2	401.8	405.8	260.1	156.8	216.6	82.6	148.7	232.2	151.6	123.6	118.7	121.1	264.0	101.0	99.8	107.0	13.8	151.5	209.0	426.0	96.3	225.2	42.5	43.5	44.4	48.7	43.1	48.1	45.7	44.0	45.8	45.5	45.0	50.2	134.4	44.8	68.1	4.6	185.1	0.0	160.1	0.0	46.1	31.0	153.8	133.9	6.6	110.1	18.6	77.3	4.2	284.0	135.6	39.8	43.0	355.9	8.7	65.9	168.2	131.9	31.5	55.3	7.3	351.1	768.1	177.0	92.8	158.8	16.4	135.8	126.7	207.3	415.6	26.9	9.6	96.2	0.0	118.8	0.0	12.8	140.5	155.4	0.0	9.4	250.8	51.3	116.4	8.0	10.6	401.8	71.3	91.0	857.6	342.0	182.9	86.8	9.5	32.7	92.1	92.7	157.1	183.2	125.1	64.4	0.0	581.6	84.9	145.5	101.0	260.7
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518542	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	137	"skeletal muscle: 7882.0"	"Cell type enriched"	"Detected in some"	10	"Skeletal myocytes: 77.4"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		98000000		"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	2.6	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	3.5	0.1	0.1	0.6	0.3	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	1.3	0.0	0.0	9.1	0.1	7882.0	0.7	0.2	0.1	0.0	0.1	0.2	1.8	0.0	0.0	0.5	57.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.6	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
MYH13	MyHC-eo	ENSG00000006788	"Myosin heavy chain 13"	Q9UKX3	17	10300865-10373130	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.5;stomach 1: 1.6"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-2 OS: 2.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA		29000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (8.86e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (8.35e-2)"		"unprognostic (1.42e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.40e-9)"	"unprognostic (2.44e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.06e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549700	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	84	"skeletal muscle: 12790.2;tongue: 6140.2"	"Cell type enriched"	"Detected in some"	18	"Skeletal myocytes: 129.6"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HSkMC: 1.9;NTERA-2: 8.3;SuSa: 1.7"									"HPA001349, CAB010760"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		81000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			0.5	0.1	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	46.5	0.3	0.0	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	21.5	0.0	0.0	113.1	1.0	12790.2	1.1	0.2	0.4	0.0	0.1	0.2	0.2	0.0	0.3	0.9	6140.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.0;seminal vesicle: 18.3;skeletal muscle: 20.6"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 411.9"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"HSkMC: 59.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA021808	Enhanced					NA	NA		29000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.6	0.9	1.8	1.1	1.7	0.8	1.5	1.5	1.9	2.9	1.5	7.9	1.1	3.4	1.2	9.1	2.6	0.5	1.0	1.6	1.6	2.1	3.3	1.2	1.3	1.8	1.8	2.3	2.4	0.3	1.5	0.4	1.7	29.0	1.0	1.8	1.5	18.3	20.6	2.8	2.5	1.7	1.4	2.6	1.7	4.6	1.8	3.0	3.4	6.0	0.6	4.4	3.8	1.8	0.2	1.1	0.8	1.1	1.0	0.3	1.0	0.8	0.4	0.5	0.5	1.0	0.1	0.7	0.3	0.4	0.2	1.1	0.5	0.2	1.0	0.7	0.9	1.0	0.3	1.6	0.3	0.6	1.4	59.6	0.4	0.6	0.8	0.1	0.1	1.3	0.4	0.1	0.2	0.7	1.0	2.3	0.9	0.3	0.6	0.8	0.8	0.3	0.3	0.3	0.0	0.4	0.4	0.0	0.3	0.7	0.3	0.3	0.3	0.1	1.0	0.3	0.1	1.3	1.1	0.3	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.5	1.9	1.6	1.6	1.8	1.8	1.7	1.4	1.8	1.8	0.5	0.0	9.8	4.6	0.7	2.9	0.9	0.1	0.6	4.9	0.7	1.8	3.6	1.5	0.7	0.0	6.2	0.4	0.8	0.9	0.0	0.6	411.9	0.5	0.8	1.4	0.0	2.7	3.9	0.6	0.8	1.1	1.1	0.5	7.6	0.8	0.4	0.6	0.1	0.0	3.4	0.5	0.0	0.8	0.3	56.0	2.8	1.2	1.8	1.9	0.2	1.8	0.0	7.5	5.4	0.7	0.2	2.6	0.0	1.5	1.8	0.3	0.3	4.6	0.0	5.5	0.8	10.7	4.2	0.3	1.6	0.5	1.4	0.2	0.8	0.3
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"skeletal muscle: 10.6"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"OE19: 9.0"									HPA001349	Supported		Uncertain	"Focal adhesion sites"		NA	NA		86000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381982-23408273	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"heart muscle: 2882.7"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 8051.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"NTERA-2: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		25000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2882.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.9	5.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	1.9	0.0	53.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	50.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8051.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	31.7	0.0	2.7	0.1	0.0	0.0	449.6	0.0	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	60.3	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	71	"heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8"	"Cell type enriched"	"Detected in some"	127	"Cardiomyocytes: 10295.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"HSkMC: 11.4"	"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		43000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	2.0	1.3	1.4	0.0	1.9	0.1	2.5	0.1	1.1	0.3	1.4	1.2	0.5	0.4	0.0	129.2	0.1	1.1	7569.2	1.2	2.9	0.9	1.4	3.2	1.5	0.8	1.6	0.7	7.8	0.0	1.5	0.0	0.9	76.8	0.0	0.0	37.0	0.0	14554.3	4.8	0.9	0.0	0.9	0.5	0.9	1.4	3.2	0.1	1.8	5378.8	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.1	1.1	1.2	2.9	0.8	1.6	0.9	0.9	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10295.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	80.9	0.0	0.0	0.2	3.1	0.0	70.5	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.2	51.2	0.1	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"esophagus: 15.9;lymphoid tissue: 10.7;skeletal muscle: 16.7;tongue: 10.0"	"Group enriched"	"Detected in some"	8	"Proximal tubular cells: 84.8;Skeletal myocytes: 52.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"HSkMC: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		53000000		"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	10.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	0.0	52.0	0.1	0.5	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281280-36387967	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 1343.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Nuclear bodies,Plasma membrane,Actin filaments,Cytosol"		No	No		410000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments"	"Nuclear bodies, Cytosol"	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	295.9	95.5	42.3	181.1	42.1	245.9	231.5	40.6	54.7	181.2	65.5	192.6	107.0	356.4	39.3	153.8	182.2	134.5	161.1	50.8	39.4	140.7	101.6	286.2	161.7	52.7	51.7	121.1	160.3	55.0	52.6	166.5	48.1	131.8	89.8	9.7	177.2	98.4	84.0	160.6	163.5	174.1	48.8	232.5	135.8	38.2	52.1	125.1	141.2	46.3	104.1	168.8	166.8	48.2	612.2	277.0	86.2	74.2	156.8	195.1	437.3	398.4	507.5	554.6	413.2	302.1	170.3	156.9	230.1	666.1	265.0	412.7	125.2	779.4	559.6	356.1	120.9	302.6	294.3	259.9	481.1	346.9	463.8	233.0	234.7	751.9	626.4	540.3	461.8	113.2	67.3	205.8	448.9	161.9	124.4	204.0	51.7	171.1	169.2	233.3	267.3	146.7	314.5	581.5	129.6	53.0	559.7	217.0	251.6	218.5	162.4	177.1	1343.7	1222.6	370.3	237.5	731.5	135.2	114.7	129.0	463.2	172.3	363.1	72.6	25.2	64.7	32.4	19.8	28.4	13.4	23.5	26.4	17.2	11.9	18.3	20.4	41.2	9.0	26.5	8.0	26.3	54.5	42.3	42.1	40.6	54.7	50.8	39.4	52.7	51.7	48.1	48.8	52.1	48.2	303.9	118.6	87.1	12.7	108.4	144.0	182.4	123.1	72.8	2.6	90.5	89.4	62.6	80.1	89.7	92.0	2.1	87.0	151.7	359.8	7.9	309.4	35.8	89.7	121.6	258.7	73.8	51.9	42.5	245.8	193.1	82.9	123.8	194.7	93.1	117.1	132.8	102.8	100.4	82.4	6.7	131.0	59.0	119.6	124.2	37.4	68.0	168.8	85.4	61.8	196.6	11.9	137.0	7.5	33.3	344.6	186.8	211.4	125.9	184.4	159.8	27.5	51.5	5.3	203.8	39.9	275.2	6.9	10.4	133.6	135.1	46.4	213.2	141.3	139.5	134.3
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315174	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	88	"skeletal muscle: 21805.2;tongue: 15591.3"	"Cell type enriched"	"Detected in some"	246	"Skeletal myocytes: 492.9"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HSkMC: 51.4"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.0"	"Low region specificity"	"Detected in all"			"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	NA	NA		21000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavorable (6.59e-4)"									"unprognostic (1.88e-1)"			2.3	0.5	0.1	0.0	0.1	0.0	3.3	0.0	0.1	0.1	0.0	1.1	0.0	0.5	0.0	212.7	0.0	0.0	2.0	0.1	0.0	0.7	1.0	0.9	0.0	0.0	0.0	0.6	1.1	0.0	0.4	0.0	0.0	164.2	0.0	0.0	170.2	0.0	21805.2	4.0	0.7	0.0	0.0	0.4	0.7	0.5	0.0	7.4	2.3	15591.3	0.9	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	492.9	2.0	0.1	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261479-3278461	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	360.1	441.4	172.7	232.6	179.2	301.8	377.8	181.2	233.2	317.9	206.8	436.4	420.1	265.9	482.9	509.1	297.0	278.9	312.6	185.2	186.5	559.9	406.1	426.9	272.3	186.2	180.1	231.7	224.3	418.7	189.7	405.2	184.9	244.1	439.6	103.9	364.9	273.0	269.7	342.1	403.5	248.4	180.4	274.1	321.4	152.9	183.3	303.8	340.5	214.7	314.8	404.3	347.9	181.5	565.6	294.1	253.8	247.3	726.9	598.1	437.1	839.9	719.9	751.9	769.3	611.7	439.0	282.5	360.1	1154.6	576.7	277.3	424.3	967.7	748.6	166.1	180.7	285.0	297.2	482.8	744.0	645.0	428.0	533.6	879.0	512.7	320.4	659.9	1128.1	283.3	247.8	266.3	971.9	1146.7	372.0	450.3	170.1	666.5	249.7	181.0	320.2	228.5	1572.8	995.6	208.1	217.4	836.3	497.2	524.7	403.6	429.2	379.3	1422.8	736.3	1111.3	654.0	1036.9	148.1	153.2	342.8	448.2	256.9	586.8	1484.7	500.6	1513.2	643.7	666.4	548.3	436.8	619.3	701.5	582.0	360.0	501.2	582.5	1141.6	485.2	799.0	797.2	742.7	1294.1	172.7	179.2	181.2	233.2	185.2	186.5	186.2	180.1	184.9	180.4	183.3	181.5	846.5	807.7	516.2	16.3	279.4	634.5	889.6	2141.6	412.6	82.6	394.7	556.9	755.3	444.7	1157.4	542.6	25.0	1084.6	470.9	1301.7	1048.7	1453.7	164.3	617.3	362.5	674.4	243.9	269.7	21.9	1470.9	1082.5	447.4	290.0	705.2	446.8	372.9	683.9	292.2	614.1	65.6	20.4	590.3	990.7	375.7	450.1	225.0	446.4	448.1	345.1	52.5	911.6	185.7	461.4	14.1	21.6	2199.0	1180.2	433.3	121.6	814.9	1459.2	1477.9	891.9	94.5	355.0	269.5	542.6	240.0	208.9	486.5	568.4	1402.6	532.9	671.1	568.9	1097.6
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46835111-46882172	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2"	"Cell type enriched"	"Detected in some"	53	"Cardiomyocytes: 3626.2"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		7300000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	5.8	4.1	11.3	0.9	11.1	1.5	8.9	11.4	14.8	6.7	8.4	2.5	1.6	3.3	3.4	157.0	4.2	3.6	9155.0	11.0	12.8	50.3	4.1	5.7	3.3	15.2	13.0	5.2	2.7	1.3	1.7	4.7	12.1	25.1	0.8	1.9	19.6	1.5	5135.3	4.0	2.3	2.0	13.2	7.9	2.1	2.3	12.6	0.7	2.4	2074.2	0.5	2.4	4.7	13.2	0.5	0.7	0.4	0.3	4.4	1.5	3.6	0.7	0.4	0.4	0.6	8.6	0.8	1.6	1.4	0.1	0.2	0.5	0.4	0.1	0.7	0.3	0.1	0.8	2.6	0.3	0.7	0.9	0.8	8.7	0.2	0.3	0.1	0.2	0.1	0.5	0.4	1.2	0.2	1.2	0.3	0.5	1.0	0.4	0.4	0.9	0.3	0.1	34.2	1.3	0.6	0.4	0.3	0.7	0.1	0.7	0.3	0.5	0.2	1.0	0.8	0.6	0.3	0.5	0.4	0.7	0.3	0.8	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	11.3	11.1	11.4	14.8	11.0	12.8	15.2	13.0	12.1	13.2	12.6	13.2	0.7	0.0	0.0	1.0	0.0	0.8	0.2	0.0	0.0	0.2	2.3	0.1	3626.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	54.8	0.0	2.4	0.1	2.2	32.8	0.0	0.0	0.1	0.0	16.4	23.7	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	12.8	1.2	0.7	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	68.1	0.0	0.4	6.6	27.9	20.4	0.2	0.5	0.0	0.4	0.8	0.4	0.1	0.0	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"heart muscle: 6347.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.1	0.5	0.2	0.4	0.3	134.6	2.7	0.2	0.4	0.4	0.4	0.8	0.8	0.8	0.0	0.6	0.5	1.0	6347.0	0.3	0.4	1.3	1.4	9.4	0.9	0.3	0.3	0.8	8.6	0.3	0.5	9.1	0.4	1.1	0.3	42.2	3.0	0.2	3.5	1.2	1.3	0.8	0.2	3.1	3.4	15.5	0.3	2.4	11.0	6.4	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.3	0.2	0.4	0.3	0.4	0.3	0.3	0.4	0.2	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
MYL6	"ESMLC, MLC1SM, MLC3NM"	ENSG00000092841	"Myosin light chain 6"	P60660	12	56158346-56163496	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046859, HPA063034"	Approved					NA	NA		60000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (1.10e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.01e-1)"	2247.0	1427.5	830.7	1207.0	830.7	1756.5	1977.9	864.2	962.6	1767.3	901.0	5900.2	1027.9	2971.8	1635.0	1777.8	2197.9	905.8	1153.9	809.9	863.8	1915.8	1172.0	1946.7	882.9	900.5	874.9	1155.2	1032.8	1466.7	747.7	1441.7	869.2	2037.5	2360.3	927.1	1167.6	2912.2	411.1	1090.1	1867.5	4209.9	858.5	1547.8	2128.0	494.6	899.3	1151.3	1316.7	578.7	1404.7	3041.7	1685.0	869.9	1924.9	1739.1	3199.3	958.8	2063.5	2065.5	1755.8	4056.4	4162.8	5469.7	3191.3	2738.5	1720.0	735.0	2274.3	5778.4	1417.7	1222.8	1995.9	2846.0	3556.8	1423.1	666.5	1311.5	2481.7	1536.9	1512.2	913.8	2304.1	2389.9	2013.5	3242.3	1263.1	4706.8	4854.4	867.2	708.1	2121.5	4585.6	2052.1	1291.6	1402.8	1629.5	1071.6	1746.1	1027.3	1265.3	932.9	5125.1	2361.7	1169.2	862.9	4456.0	1380.0	760.4	2312.4	2148.7	2383.0	5212.3	1486.3	1011.6	2077.3	2746.8	635.3	1150.3	867.7	1953.3	1168.9	1578.1	11449.4	4509.8	13302.4	3191.2	5016.0	2404.9	2844.7	2828.6	2994.0	4747.3	2558.5	2020.7	2528.3	8440.7	2233.9	6531.2	5167.0	4209.8	14776.8	830.7	830.7	864.2	962.6	809.9	863.8	900.5	874.9	869.2	858.5	899.3	869.9	2044.5	1733.9	1161.8	16.0	704.4	2114.0	2470.4	2988.3	746.1	278.4	896.3	1394.8	672.8	946.5	2016.5	1475.0	316.9	1704.4	1144.5	2568.2	2406.5	4126.7	292.4	1134.2	1714.2	1628.1	1017.3	857.4	15.6	4820.4	2604.5	1264.0	871.6	1676.6	994.3	1307.8	1328.6	887.8	3370.3	80.8	19.8	1572.3	1845.3	1148.3	2472.8	910.7	1064.0	1872.2	1469.2	39.4	4426.3	820.8	1195.7	17.6	31.3	6222.1	2715.8	2775.1	892.8	1762.1	3007.9	2956.9	1870.9	763.7	1735.5	685.8	3305.2	76.2	115.0	1139.6	2066.1	1929.9	1191.9	1039.1	1406.1	2558.6
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 635.0;tongue: 390.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 340.7;Late spermatids: 1215.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 18.4"	"Group enriched"	"Detected in all"	5	"B-cells: 6.3;dendritic cells: 18.4;T-cells: 14.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced					NA	NA		7200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	22.7	27.3	133.2	13.8	134.3	17.0	23.8	125.1	177.1	39.5	110.9	23.1	7.5	27.1	34.5	23.4	36.3	27.6	44.8	135.2	133.9	41.4	17.0	16.3	21.9	126.5	128.9	54.3	12.7	77.5	72.0	14.1	130.4	36.2	10.2	23.6	23.1	21.2	635.0	20.4	14.4	22.8	124.0	16.2	18.2	140.0	129.2	43.1	29.3	390.4	25.8	19.0	26.4	125.3	34.1	57.4	152.1	146.4	31.6	112.7	106.0	39.0	170.0	150.8	146.4	41.3	55.4	56.6	83.6	83.9	57.8	19.1	72.2	94.4	80.6	102.9	104.9	59.6	54.8	73.6	99.5	43.7	40.0	189.4	37.6	140.0	54.1	320.2	165.6	134.8	64.2	56.6	126.0	44.5	121.0	145.3	128.3	32.1	97.5	125.7	94.4	75.1	117.0	22.7	139.3	204.6	43.1	52.6	80.4	110.6	43.0	74.0	93.2	88.3	75.1	46.1	84.8	79.9	49.2	47.5	94.7	43.9	98.8	0.9	2.8	0.9	2.0	2.7	1.1	6.3	4.0	3.3	6.4	4.0	3.0	2.5	2.1	2.3	1.1	18.4	14.9	4.3	133.2	134.3	125.1	177.1	135.2	133.9	126.5	128.9	130.4	124.0	129.2	125.3	29.4	67.3	32.4	13.4	28.2	33.1	54.6	72.4	67.7	59.6	67.4	101.7	17.6	38.6	30.6	110.3	25.0	34.2	24.1	21.5	150.6	50.4	340.7	83.0	58.9	44.0	157.4	24.6	18.9	20.2	68.3	55.3	26.0	93.1	12.7	134.9	53.9	32.2	43.5	33.7	23.7	35.0	46.8	22.3	25.0	1215.9	80.8	19.1	40.9	6.5	47.7	149.9	4.1	11.6	7.6	26.9	19.5	66.5	44.2	39.4	28.0	156.4	23.9	51.4	52.6	63.2	53.0	126.4	54.4	71.3	25.4	22.6	15.6	52.2	32.7	47.9
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129086-16148248	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	37.0	18.9	12.8	12.8	20.0	92.1	30.2	12.5	16.4	42.2	13.6	24.3	12.9	40.3	30.6	18.1	32.6	21.3	14.2	13.4	13.3	21.6	4.9	29.5	22.8	13.7	14.3	35.8	15.5	24.6	8.2	63.4	12.0	16.4	16.5	4.7	25.7	23.1	41.1	25.7	24.5	28.4	12.3	30.8	22.7	15.0	15.7	15.2	50.2	22.8	15.4	25.0	24.7	22.4	3.4	6.0	2.8	3.3	28.3	6.9	7.3	2.4	5.4	5.4	12.0	18.4	3.3	16.0	11.5	3.9	4.0	8.2	13.0	4.4	4.9	5.2	12.8	10.2	7.1	3.8	4.1	7.4	10.0	11.5	5.5	2.6	2.2	2.8	12.5	3.4	29.8	18.6	2.1	12.6	0.2	40.6	8.0	8.4	5.7	3.5	12.9	57.9	6.7	40.0	13.5	6.2	2.9	31.2	17.1	23.9	5.8	18.8	3.5	2.6	6.2	2.2	6.1	16.0	7.5	8.1	1.6	20.9	9.0	6.1	1.5	7.8	5.8	1.8	5.4	4.2	3.7	4.1	1.1	3.3	4.0	3.9	9.4	2.6	1.5	0.5	2.3	1.2	12.8	20.0	12.5	16.4	13.4	13.3	13.7	14.3	12.0	12.3	15.7	22.4	102.6	22.4	50.2	5.5	67.7	98.0	38.9	8.8	126.3	9.3	67.6	117.0	90.7	50.1	17.7	22.0	0.0	134.2	78.5	49.5	9.8	22.1	47.5	82.7	56.2	70.9	84.3	52.6	17.1	18.4	80.0	79.6	54.0	77.7	35.5	35.1	41.4	1.4	32.0	11.8	8.4	41.1	10.2	61.7	121.2	20.2	38.5	56.0	80.0	7.5	27.3	16.9	56.7	3.0	55.3	7.6	32.4	61.7	30.2	28.1	27.8	21.1	25.7	7.8	138.1	90.8	96.7	53.0	22.6	100.9	84.0	352.3	103.8	3.9	45.4	35.1
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 732.0"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	0.1	0.0	0.6	0.1	0.6	0.4	0.1	0.6	0.7	0.0	0.5	0.2	0.0	0.1	0.1	4.7	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.1	0.0	0.6	0.7	0.1	5.5	0.0	0.1	0.0	0.7	1.1	0.0	0.0	2.4	0.0	732.0	0.6	0.1	0.1	0.6	0.3	0.2	0.2	0.7	0.2	0.2	60.3	0.0	0.0	0.0	0.6	0.3	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	1.3	0.8	0.5	0.1	4.1	0.1	0.6	0.5	0.3	0.5	0.0	0.3	0.6	10.5	8.8	0.0	0.1	0.5	0.5	2.7	0.1	0.0	0.1	0.1	0.1	2.1	0.2	0.7	0.4	2.4	0.0	0.8	0.2	0.1	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.7	0.7	0.6	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661907-16936288	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.5;Muller glia cells: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 182.1;SK-MEL-30: 205.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli rim"	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	13.8	3.0	47.4	6.2	46.3	3.2	7.9	24.6	41.1	6.7	55.1	19.3	22.8	6.2	3.5	9.3	4.3	8.4	4.5	39.8	24.8	14.7	7.7	19.0	1.3	32.6	30.9	15.8	32.2	10.7	9.5	31.5	27.6	5.8	19.1	15.1	11.0	5.0	8.2	15.6	19.5	4.9	27.3	13.9	32.0	15.6	46.4	4.9	37.5	4.4	2.0	11.1	7.8	45.7	68.2	108.3	31.3	14.9	24.7	17.0	35.1	117.2	89.2	35.5	27.4	63.1	10.2	1.5	78.9	52.9	42.3	33.4	139.1	73.7	57.1	0.2	16.7	0.1	182.1	13.7	81.5	0.4	1.5	30.9	26.8	78.5	92.1	57.4	110.5	0.2	0.2	4.8	28.7	10.5	0.2	0.4	80.5	56.6	37.2	26.1	10.3	66.9	22.0	49.6	5.2	2.8	27.0	11.4	205.0	53.2	8.1	9.1	137.8	77.6	23.6	0.7	61.1	0.7	0.5	0.5	38.3	11.2	76.2	0.5	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	0.3	0.1	2.5	0.1	0.1	0.1	47.4	46.3	24.6	41.1	39.8	24.8	32.6	30.9	27.6	27.3	46.4	45.7	53.5	35.3	34.6	158.7	1.4	40.9	31.0	23.0	29.6	11.0	18.6	11.6	3.8	55.8	26.3	31.3	18.8	20.4	0.3	46.4	17.6	110.8	30.2	118.5	20.8	61.3	74.0	0.0	3.9	40.6	63.4	13.7	68.3	116.0	27.8	189.5	77.1	1.7	5.6	82.4	5.4	53.2	20.3	7.1	4.8	9.5	12.8	5.7	67.6	87.1	3.8	233.8	0.0	103.5	23.5	114.7	50.3	19.2	0.4	42.6	28.3	4.2	18.8	9.2	65.7	8.2	31.5	3.8	12.2	30.7	31.8	147.8	2.4	4.1	66.9	38.6
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179802	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"pituitary gland: 62.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 69.9;Late spermatids: 53.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078501	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA078501: AB_2732383"	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.4	0.5	0.3	0.4	0.1	0.6	0.5	1.5	1.3	0.0	0.7	0.3	1.0	1.5	0.3	1.4	0.2	0.6	0.0	0.6	0.6	1.9	0.9	0.1	1.8	0.5	2.2	0.5	0.8	62.9	0.1	2.1	0.9	0.3	0.3	0.6	0.9	0.4	0.3	0.6	0.2	0.5	0.5	0.6	7.2	1.4	0.8	0.9	0.0	0.2	0.7	0.8	0.4	0.0	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.5	1.5	0.0	0.6	1.8	0.5	2.1	0.5	1.4	0.4	0.3	0.0	1.1	0.7	0.8	1.5	2.1	0.2	1.2	2.9	0.9	0.6	4.0	1.5	0.1	0.0	0.0	0.5	0.3	0.7	0.0	0.8	69.9	0.8	0.9	1.0	4.2	0.0	8.5	0.9	0.3	1.4	0.5	1.2	6.3	1.3	0.4	1.7	0.6	10.1	4.5	0.5	0.0	0.8	1.4	53.6	1.2	0.8	3.6	1.0	1.3	2.6	2.1	1.5	0.9	0.6	0.1	1.2	0.1	1.9	0.4	0.3	0.2	2.5	0.0	4.6	1.1	9.2	13.4	0.4	1.3	0.7	0.6	0.7	0.8	1.0
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071122-29180398	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 404.2;tongue: 124.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 33.6;Oligodendrocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019646	Supported					NA	NA		3400000	"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	9.2	4.0	16.0	7.5	36.0	12.9	10.5	13.3	28.0	13.1	0.0	16.4	14.1	15.3	2.9	19.0	10.6	10.4	95.5	11.9	18.3	5.7	20.4	7.2	6.6	37.2	27.1	7.1	14.8	8.4	5.4	4.5	38.4	10.6	5.9	3.8	15.9	5.9	404.2	20.6	14.4	7.6	8.7	6.3	14.4	5.1	35.6	4.1	7.8	124.0	4.8	12.4	14.4	56.3	29.6	40.9	15.5	8.0	4.0	7.0	24.8	13.8	13.7	11.8	8.2	10.3	20.5	3.1	15.2	10.0	17.3	33.2	6.0	23.1	4.6	34.4	11.4	2.6	12.9	11.3	6.1	3.7	3.6	8.1	13.2	7.2	3.2	19.5	4.3	12.3	37.1	5.3	5.9	10.2	10.8	2.9	3.2	60.1	9.0	37.3	17.3	9.1	9.0	21.7	8.1	8.3	13.7	45.5	9.8	10.2	10.6	4.4	5.0	7.7	9.3	5.2	9.6	10.0	18.1	5.9	9.7	2.6	20.9	0.6	0.2	0.4	0.3	0.3	0.4	0.1	0.3	0.3	0.3	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.2	0.1	16.0	36.0	13.3	28.0	11.9	18.3	37.2	27.1	38.4	8.7	35.6	56.3	14.8	12.8	7.0	13.4	5.4	1.0	1.0	0.5	10.8	7.1	3.7	3.3	33.6	2.8	8.3	1.8	10.4	0.4	2.8	8.6	0.0	2.9	1.4	1.9	4.4	8.1	2.4	9.0	13.6	1.4	2.7	4.9	21.4	2.3	1.3	15.3	2.2	5.0	1.1	1.7	13.3	4.0	0.0	0.6	1.3	0.6	2.1	6.1	0.0	9.4	2.0	2.6	2.1	14.6	38.8	4.2	5.1	3.0	6.8	1.0	5.0	1.7	1.7	4.2	0.0	4.7	2.0	1.3	1.3	9.5	0.9	0.3	5.5	3.2	4.1	1.1
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 330.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 8.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.1	0.4	0.1	0.1	0.8	0.2	0.0	0.7	68.3	330.0	0.4	0.0	0.2	0.1	4.1	0.0	0.1	0.2	0.1	0.1	0.2	0.3	2.1	2.0	0.0	0.2	0.0	0.1	0.2	1.8	0.1	65.7	0.1	0.0	0.2	0.1	0.1	309.8	3.0	3.7	0.1	16.3	1.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.2	0.1	0.2	2.1	2.0	1.8	3.7	0.6	8.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 111.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 193.1;Excitatory neurons: 201.4;Oligodendrocytes: 578.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.7;CACO-2: 148.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA054744: AB_2682589"	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.53e-6)"	37.7	27.5	10.4	15.6	27.3	3.7	21.0	24.1	15.5	25.5	12.7	111.2	84.4	21.0	22.3	36.0	16.6	31.3	13.2	10.7	13.0	27.1	14.3	31.9	6.3	26.5	22.3	24.6	26.2	27.2	12.3	13.9	25.0	17.8	91.6	1.7	33.1	13.0	5.5	40.6	83.7	18.2	18.5	9.5	26.7	9.8	22.4	7.0	41.0	3.6	14.3	24.6	25.8	52.9	32.3	1.5	0.9	0.3	105.7	60.0	1.2	18.9	36.5	3.4	20.9	148.0	50.0	18.2	3.9	83.7	0.8	29.6	3.8	47.0	5.3	2.3	38.6	16.5	0.1	10.5	6.8	0.0	8.6	17.3	29.3	26.7	24.0	0.4	45.8	9.5	28.2	28.9	16.3	38.6	0.1	0.5	5.8	36.2	28.0	0.0	21.1	21.0	14.6	61.8	36.3	6.2	6.4	11.4	93.2	9.1	50.1	0.2	57.2	16.3	8.2	0.6	0.4	35.2	43.4	0.2	21.6	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	10.4	27.3	24.1	15.5	10.7	13.0	26.5	22.3	25.0	18.5	22.4	52.9	14.3	22.4	13.1	5.5	8.4	8.0	10.1	11.7	26.2	0.9	8.8	8.4	5.0	20.0	12.9	23.9	18.8	19.4	2.7	193.1	5.9	20.8	126.0	7.2	2.8	12.3	26.5	8.2	201.4	23.8	3.1	11.4	30.1	21.3	1.3	24.5	3.9	11.0	8.8	0.0	28.9	93.4	10.2	1.6	8.2	37.6	5.9	4.4	16.0	18.7	0.3	1.2	4.1	9.0	578.3	46.4	94.4	18.4	42.8	18.7	126.5	2.5	25.2	0.9	6.6	5.3	22.8	20.5	7.2	25.4	11.2	12.4	5.7	9.8	81.7	23.3
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 201.0;RPMI-8226: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	10.3	8.3	17.0	12.1	20.8	21.8	6.5	3.0	39.1	6.8	0.0	6.1	3.8	5.0	3.7	5.3	4.0	8.5	5.8	19.0	3.6	5.3	2.9	8.8	15.0	9.6	4.2	5.7	5.2	47.4	8.9	6.3	9.8	5.1	5.9	26.1	5.2	3.5	5.4	11.8	5.0	9.4	0.0	9.5	4.7	5.9	6.6	11.0	8.4	5.0	13.1	9.7	5.3	20.8	19.5	33.7	17.6	21.3	16.2	19.3	19.0	34.7	31.1	18.1	14.0	3.2	7.8	18.7	8.9	41.8	26.5	15.7	40.7	35.6	22.3	105.5	9.6	16.7	8.8	4.2	8.3	9.0	16.3	13.0	21.9	26.6	52.4	17.6	106.8	12.0	0.7	201.0	34.8	34.4	8.2	1.2	8.1	0.5	26.6	14.5	27.8	140.8	15.1	14.0	12.7	7.8	32.3	26.2	59.4	13.1	14.0	9.1	52.0	36.4	15.7	17.1	34.1	20.9	49.9	22.0	39.4	25.1	53.5	0.4	2.4	3.1	1.4	1.7	2.1	1.1	1.3	0.9	2.7	0.7	0.2	0.4	3.0	0.3	1.4	1.5	2.2	1.1	17.0	20.8	3.0	39.1	19.0	3.6	9.6	4.2	9.8	0.0	6.6	20.8	11.2	12.8	11.4	68.2	19.8	20.8	9.3	10.5	7.4	75.1	6.7	5.5	12.1	2.8	19.8	14.7	39.6	0.6	18.4	0.3	0.0	5.4	18.0	9.3	8.0	12.7	1.2	2.5	353.0	6.3	0.4	7.5	3.1	6.7	22.8	5.0	2.5	1.3	24.4	26.9	241.0	0.2	2.0	27.1	28.0	10.8	3.7	50.2	97.8	52.5	36.7	6.0	15.5	330.8	404.2	6.1	2.5	1.9	32.4	10.2	0.0	2.8	11.1	28.7	6.6	16.7	10.8	14.0	9.4	3.9	11.6	1.1	23.7	2.1	0.3	7.3
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822789-50195147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 147.3;Inhibitory neurons: 90.5;Pancreatic endocrine cells: 106.6;Proximal enterocytes: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 65.5;HaCaT: 100.3;RH-30: 152.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	3.2	1.7	1.0	7.9	3.3	0.1	13.7	0.5	3.6	17.7	15.9	45.3	60.2	2.6	18.5	37.4	12.2	11.3	2.7	4.4	10.4	19.7	18.7	11.9	2.6	0.5	3.4	0.5	16.6	23.0	13.4	3.8	1.6	10.1	43.6	40.9	25.4	7.1	0.4	27.4	62.0	3.1	0.4	1.7	33.3	11.4	1.9	3.1	29.4	0.2	13.0	14.2	21.6	1.4	65.5	17.3	0.3	0.3	0.0	0.0	34.0	0.3	2.6	1.4	0.1	45.8	27.2	0.1	15.6	0.1	5.0	100.3	22.6	27.3	1.3	0.2	6.9	0.2	7.5	32.8	0.0	0.2	0.2	0.0	23.6	0.6	16.2	5.1	2.3	0.3	0.5	24.7	2.7	25.3	0.0	0.2	4.6	37.8	7.0	0.0	152.5	11.0	56.8	13.2	33.7	0.7	24.4	28.3	0.0	8.6	16.8	0.2	1.5	0.0	34.0	0.4	6.8	16.7	11.2	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	3.3	0.5	3.6	4.4	10.4	0.5	3.4	1.6	0.4	1.9	1.4	0.1	54.5	15.8	2.6	1.6	0.4	9.0	7.9	2.2	7.7	14.3	7.7	3.5	15.7	21.5	7.3	10.4	4.4	0.3	147.3	5.9	49.0	22.4	38.5	3.1	1.1	6.7	5.3	4.4	47.3	1.1	3.7	48.4	29.1	0.0	27.1	0.0	18.4	0.9	0.0	90.5	35.4	2.0	1.3	0.8	4.5	0.9	1.0	3.6	3.7	2.0	31.9	0.0	2.0	9.0	106.6	70.7	0.7	1.4	60.1	177.6	18.9	38.1	30.2	0.0	0.9	2.3	9.5	6.7	8.3	6.5	4.7	0.7	0.1	46.7	56.2
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822291-72118577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 61.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.5;Inhibitory neurons: 192.9;Rod photoreceptor cells: 462.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	6.5	3.9	11.3	4.8	14.9	4.8	10.7	14.3	13.3	8.7	2.5	7.1	2.1	9.9	7.4	7.7	7.2	5.2	6.7	12.8	9.2	13.7	3.7	8.8	6.4	8.7	8.0	12.1	3.3	7.4	4.7	7.6	9.2	8.0	6.3	61.7	4.5	7.5	8.1	8.7	4.6	10.2	6.7	7.3	5.2	28.7	9.5	6.7	13.2	14.9	6.4	6.5	6.1	13.5	9.7	14.6	9.6	6.8	14.2	16.5	5.7	9.1	9.8	9.0	9.1	7.1	6.6	43.3	5.4	17.9	11.8	9.0	19.2	10.3	11.9	9.5	11.1	11.1	8.9	3.2	9.0	11.2	8.5	9.5	10.2	10.6	15.2	7.6	11.5	7.7	7.2	10.3	12.2	6.0	6.4	4.5	5.2	3.5	5.9	4.6	18.2	4.3	10.9	14.3	5.4	5.9	12.0	10.0	9.5	11.6	8.0	5.3	15.5	18.0	8.7	29.7	10.4	6.5	17.3	11.3	10.8	9.2	8.1	1.7	1.5	3.7	3.6	1.4	4.9	3.1	3.5	3.0	1.6	4.0	3.6	3.4	0.2	2.8	2.6	6.3	3.1	0.9	11.3	14.9	14.3	13.3	12.8	9.2	8.7	8.0	9.2	6.7	9.5	13.5	37.0	115.4	77.4	145.6	18.4	20.9	22.2	12.4	20.5	56.3	26.2	25.0	35.5	5.7	24.1	29.5	54.2	11.9	30.2	21.1	17.6	6.1	131.8	27.9	47.3	29.6	12.6	19.6	225.5	8.0	11.3	35.6	15.8	41.2	10.1	53.1	22.1	5.7	9.0	53.8	192.9	9.7	8.2	54.8	10.0	161.9	38.8	17.7	23.2	113.4	13.0	24.0	14.4	177.0	180.2	10.9	15.5	42.9	12.2	25.0	10.4	14.1	28.3	462.1	19.7	54.9	32.6	115.2	41.8	18.4	23.9	12.0	18.5	17.0	12.8	15.7
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652688	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 110.8"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 244.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	47.1	1.1	0.0	0.0	0.0	0.0	19.2	0.2	0.0	1.8	0.0	13.0	3.5	16.5	4.9	19.6	15.3	1.5	18.3	0.0	0.1	0.2	0.1	7.4	0.1	0.5	0.1	1.3	3.0	0.1	0.2	0.2	0.2	5.3	3.5	0.0	14.0	6.4	33.8	4.7	4.8	2.9	0.0	0.0	50.2	1.4	0.1	14.1	28.7	110.8	0.2	22.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.1	0.1	12.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.1	3.1	0.0	0.0	0.1	0.0	0.0	244.4	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	1.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	2.4	0.1	0.0	0.0	0.0	0.0	0.0	15.1	6.3	0.1	0.1	1.1	0.0	0.0	1.1	0.2	0.0	0.0
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.2	1.0	0.4	4.3	0.7	0.0	1.2	0.3	0.8	9.4	1.6	24.2	2.6	13.0	2.4	13.1	8.5	4.6	14.2	0.4	0.4	0.7	0.2	2.7	0.1	0.5	0.5	4.4	0.3	0.1	0.2	3.4	0.8	8.8	4.9	0.0	0.2	20.7	0.5	1.3	5.1	15.8	0.5	0.6	6.1	2.1	0.8	0.1	0.7	0.8	0.1	17.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.8	0.4	0.4	0.5	0.5	0.8	0.5	0.8	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	47.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.0	48.5	1.2	7.8	0.0	1.2	0.2	0.1	3.6	0.0	1.0	0.0	8.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.5	0.6	0.2	0.0	9.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	100.8	0.0	0.1	0.0	0.1	0.0	0.0	26.3	0.2	32.9	0.3	0.8	0.1	0.9	0.5	0.4	6.0	0.0	0.1
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482334	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 20.4;non-classical monocyte: 26.6"	"Group enriched"	"Detected in many"	57	"dendritic cells: 8.1;monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 452.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	31.7	8.1	2.9	20.6	4.1	1.5	43.3	5.0	2.5	56.4	37.4	22.4	5.3	27.5	7.1	36.4	36.9	26.6	13.8	3.4	4.1	10.9	2.9	32.2	4.4	8.9	6.8	9.8	5.9	23.8	3.8	55.2	8.1	27.5	29.3	0.9	19.7	31.4	3.6	56.1	9.0	44.3	6.2	6.5	13.4	2.2	5.4	5.1	35.7	6.2	9.1	62.0	29.4	6.2	228.9	206.3	21.4	14.6	159.4	318.4	62.0	190.3	452.7	110.1	109.2	51.1	177.1	0.0	76.9	353.7	116.2	350.0	1.8	204.7	82.6	1.4	0.9	0.0	80.8	2.1	55.2	0.0	0.2	183.0	71.6	77.7	323.8	289.4	299.7	0.0	0.0	0.5	275.6	39.4	0.1	0.9	1.6	72.0	171.6	0.0	15.8	0.1	314.3	281.5	0.1	0.0	130.4	29.7	46.1	83.1	141.5	4.7	378.5	167.3	11.8	111.3	113.9	0.2	0.3	0.3	128.2	2.6	201.0	0.0	5.4	0.0	0.0	20.4	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	26.6	2.8	0.2	1.6	2.9	4.1	5.0	2.5	3.4	4.1	8.9	6.8	8.1	6.2	5.4	6.2	42.5	60.9	52.5	1.6	1.2	23.7	63.0	101.4	39.3	0.1	48.4	34.3	9.2	14.3	91.5	22.0	0.0	56.6	3.8	74.1	1.9	54.8	0.6	50.9	45.9	28.8	1.8	0.0	2.7	33.7	23.7	38.1	23.0	123.4	1.3	1.7	35.7	0.4	22.9	0.0	0.8	29.6	42.7	29.2	20.2	0.6	5.9	28.5	8.8	60.0	12.8	0.1	0.0	2.0	0.7	153.7	22.2	9.1	0.8	86.7	0.6	1.5	60.7	0.8	6.6	15.9	39.6	0.1	0.3	53.4	30.7	51.2	1.9	8.3	18.7	100.7
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.0;tongue: 46.7"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.2	4.1	0.0	101.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.6	0.0	46.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.4	0.2	2.5	0.4	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752636-61788518	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 168.0;stomach 1: 88.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cholangiocytes: 60.1;Gastric mucus-secreting cells: 130.0;Oligodendrocytes: 255.8;Pancreatic endocrine cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 38.8;CACO-2: 63.6;CAPAN-2: 34.0;EFO-21: 48.6;Hep G2: 21.8;OE19: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	15.4	0.6	31.3	1.1	99.0	0.3	0.4	67.9	67.5	2.2	0.0	3.8	11.4	13.1	0.1	2.4	15.4	17.3	2.4	36.9	48.8	12.0	16.9	22.3	0.1	101.7	89.4	17.6	31.6	0.0	0.4	1.1	84.9	0.7	1.1	0.4	0.6	0.3	0.1	0.5	10.8	1.9	43.5	0.5	88.3	3.1	85.7	0.0	0.3	0.0	0.1	0.5	0.6	168.0	3.1	38.8	4.7	1.5	0.0	0.0	0.2	0.2	0.1	0.9	0.8	63.6	34.0	0.9	48.6	0.0	1.2	0.3	1.3	0.0	0.9	0.1	0.6	0.2	0.7	21.8	18.9	0.0	0.4	0.3	0.0	0.6	0.0	10.9	0.1	1.6	11.7	0.3	0.2	0.5	0.0	0.9	1.6	37.2	4.8	0.0	0.1	1.9	6.5	0.0	0.1	0.9	0.0	0.4	0.3	10.6	0.6	0.4	1.4	0.4	19.5	0.0	0.6	0.2	0.1	0.3	0.1	2.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	99.0	67.9	67.5	36.9	48.8	101.7	89.4	84.9	43.5	85.7	168.0	0.1	48.1	5.1	2.3	0.6	0.1	0.1	0.2	0.0	0.5	0.8	0.8	1.3	60.1	3.4	3.7	0.0	0.4	1.6	6.4	0.0	31.7	0.2	1.4	3.2	0.6	1.2	0.0	0.9	36.7	0.3	5.6	130.0	4.1	0.0	4.4	0.7	6.0	0.9	0.0	1.1	4.5	6.1	0.0	0.6	1.2	5.9	0.8	3.6	0.0	1.0	3.5	0.0	5.5	255.8	70.5	13.0	3.8	0.4	0.2	12.8	2.2	1.3	0.3	0.0	0.2	1.2	1.4	3.7	0.8	0.0	0.8	0.7	0.3	7.7	3.1
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.0;HeLa: 41.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.5	13.5	5.4	6.5	5.5	5.8	8.5	6.5	8.5	14.7	12.7	11.3	11.6	12.0	7.0	9.6	17.5	4.4	7.5	5.5	5.1	13.5	11.4	10.0	5.9	8.1	6.6	15.8	11.4	6.7	16.9	3.6	6.3	15.4	4.0	9.2	10.1	6.0	10.8	10.3	10.4	4.3	5.4	8.2	12.8	6.6	6.2	4.5	19.0	2.4	2.9	10.7	10.6	7.2	8.0	19.9	8.1	5.0	4.5	4.0	10.1	7.2	3.5	1.2	2.4	4.3	9.4	5.7	3.5	1.9	5.9	9.0	2.0	4.7	0.6	10.3	46.0	6.0	41.5	2.6	2.7	4.5	10.0	2.7	12.3	1.8	5.3	7.7	4.1	6.4	5.0	7.0	1.8	8.8	2.7	2.6	3.1	4.6	8.1	7.4	2.0	10.5	4.1	16.9	7.9	11.0	3.7	6.7	4.6	1.6	7.1	6.1	5.1	13.0	4.1	2.3	3.7	12.6	15.3	4.9	10.5	5.0	3.4	0.0	0.9	0.4	2.1	0.6	3.2	2.1	3.6	2.6	1.6	2.7	5.9	3.8	1.7	5.3	0.7	0.4	2.4	2.4	5.4	5.5	6.5	8.5	5.5	5.1	8.1	6.6	6.3	5.4	6.2	7.2	7.9	12.8	17.0	28.4	15.0	8.0	11.4	11.9	22.2	39.4	22.0	22.4	5.9	10.0	8.0	11.0	33.3	6.0	11.1	20.3	3.9	8.3	22.1	39.1	9.8	7.2	16.8	10.7	23.4	5.4	3.6	8.8	43.3	16.7	4.5	15.8	9.7	10.7	4.9	30.3	20.1	14.5	16.2	5.3	3.3	28.7	10.5	7.6	10.6	7.5	4.2	19.4	15.5	10.6	21.3	6.5	13.4	13.2	9.0	9.6	14.7	10.6	29.8	47.8	19.7	16.6	7.7	10.2	3.8	11.2	8.2	6.4	12.5	16.3	11.9	7.8
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N-alpha-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86025462	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	7.7	12.2	6.9	6.3	7.3	6.6	9.3	9.8	7.0	8.9	8.2	11.1	8.6	9.4	7.8	10.9	8.4	5.7	8.8	6.9	7.2	8.4	8.7	7.1	6.2	6.3	6.0	9.9	10.8	9.4	12.0	7.4	6.2	9.7	10.5	14.3	10.1	6.8	17.4	9.1	8.1	7.0	6.4	6.5	8.8	15.4	8.4	7.3	10.4	13.2	7.2	9.0	9.1	8.9	25.4	15.8	17.7	13.5	9.8	13.1	24.8	15.5	15.1	16.1	13.1	12.4	15.7	8.4	8.5	15.4	13.1	34.9	15.0	18.4	16.8	22.3	13.1	21.6	19.9	14.6	16.6	30.4	17.6	13.1	15.2	17.0	24.6	12.4	14.0	15.6	25.3	15.6	14.9	14.6	15.7	16.0	17.8	28.0	18.2	14.4	26.9	12.6	17.3	20.4	16.7	15.5	17.6	15.8	13.6	17.0	11.9	11.7	14.0	11.2	12.4	16.9	15.0	22.3	29.1	5.7	16.3	12.5	10.2	1.7	2.5	5.1	3.4	2.6	4.3	9.5	3.5	3.1	3.0	9.3	4.6	3.4	1.3	3.5	1.9	2.2	3.1	2.6	6.9	7.3	9.8	7.0	6.9	7.2	6.3	6.0	6.2	6.4	8.4	8.9	14.6	3.2	14.1	58.4	16.8	16.3	20.2	19.0	19.9	25.5	18.0	13.1	23.3	18.6	22.8	11.0	22.9	22.6	14.9	20.2	1.9	19.7	8.7	29.4	18.6	14.3	20.9	14.5	51.8	25.8	18.9	13.6	16.3	22.5	12.0	32.9	9.3	9.8	12.2	21.9	58.7	14.5	30.5	11.0	8.4	5.3	9.3	10.7	14.2	52.5	12.3	18.7	14.4	44.7	68.8	18.3	16.6	11.7	17.1	22.0	12.0	8.9	33.7	36.6	13.1	21.4	24.7	56.7	36.3	17.7	16.6	31.1	15.8	24.4	16.6	19.2
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058553	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"intestine: 99.3"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	13.9	3.2	4.4	6.6	4.1	21.1	12.1	4.7	6.0	23.5	7.0	18.4	19.8	18.8	4.6	7.3	15.2	9.4	10.5	3.9	4.1	7.4	2.6	10.9	10.9	4.7	4.3	16.6	2.3	2.0	6.0	2.3	4.6	13.8	7.1	1.9	4.9	11.5	2.7	5.4	99.3	10.5	4.6	15.3	8.2	8.7	4.4	3.4	5.7	4.1	6.9	12.7	14.5	4.0	0.0	0.0	0.1	0.2	0.5	5.8	1.0	2.3	0.0	2.8	1.3	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.2	0.1	0.9	0.4	0.0	0.2	3.5	20.2	0.0	0.0	13.5	0.0	2.7	0.0	0.1	3.6	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.0	0.1	0.1	0.1	0.0	1.0	0.2	0.0	10.5	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.8	0.0	0.1	0.1	182.0	21.2	35.9	29.6	14.6	15.8	25.7	23.8	14.8	16.3	29.8	27.0	15.0	3.7	80.2	8.8	0.7	45.2	24.6	4.4	4.1	4.7	6.0	3.9	4.1	4.7	4.3	4.6	4.6	4.4	4.0	19.1	0.0	0.0	0.0	8.0	3.6	3.4	5.6	6.2	2.0	0.8	9.1	1.8	1.5	0.4	0.0	0.0	0.2	9.8	31.3	3.9	0.1	0.8	0.4	5.8	11.1	1.2	2.5	0.3	0.8	0.3	11.4	1.1	0.2	19.7	4.3	16.8	0.4	2.8	10.1	0.4	21.0	2.0	5.6	5.7	2.6	11.8	5.2	16.0	1.0	17.3	12.2	41.2	1.0	0.1	0.2	50.0	18.0	1.1	0.5	588.6	0.5	0.5	0.9	0.0	8.3	11.1	1.6	3.5	1.3	3.3	0.4	11.1	3.9	11.8	0.4
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57089043-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 98.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favorable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	21.8	16.1	25.2	9.9	26.8	6.8	14.2	30.3	31.0	33.7	24.0	29.8	10.1	32.3	21.0	24.5	31.0	17.4	20.5	28.3	25.0	20.1	22.3	24.0	12.0	23.2	23.1	51.1	10.2	19.5	35.4	11.1	22.1	25.4	5.0	10.7	11.6	16.6	7.6	33.4	15.7	13.4	21.6	16.9	15.9	16.8	25.4	17.4	20.7	9.9	10.4	27.7	33.8	24.8	15.2	9.8	49.2	45.2	43.3	56.7	5.5	44.1	40.8	28.0	23.1	15.6	8.7	9.6	17.6	44.4	8.1	27.0	16.9	34.0	14.3	4.0	4.5	11.4	8.1	16.6	33.2	9.1	26.5	64.4	36.1	32.6	10.9	43.7	7.5	7.2	26.5	9.6	32.4	73.4	14.0	44.5	9.9	12.9	16.6	10.4	64.1	5.1	11.8	6.0	5.5	13.1	21.9	12.5	98.3	12.3	28.0	20.0	8.4	40.7	34.1	28.8	13.2	22.7	6.0	5.1	39.5	5.9	25.1	0.0	1.1	0.2	0.5	2.7	0.6	0.9	0.9	0.7	0.6	2.3	1.1	1.1	0.4	0.4	2.9	0.0	1.0	0.6	25.2	26.8	30.3	31.0	28.3	25.0	23.2	23.1	22.1	21.6	25.4	24.8	7.6	12.8	13.0	5.9	11.6	29.6	19.5	23.4	39.3	20.3	17.3	13.8	2.9	2.8	13.6	9.2	2.1	3.7	4.9	1.1	7.9	7.4	0.6	22.9	21.2	13.7	6.6	4.8	11.4	1.4	10.5	19.7	8.6	25.4	17.1	7.8	18.2	17.1	11.2	10.1	5.4	1.1	10.2	16.3	43.7	2.9	19.6	14.3	21.4	8.4	1.6	7.9	1.0	1.0	1.9	4.1	0.0	18.8	8.7	12.9	8.7	5.6	5.9	4.4	19.7	9.8	16.3	2.6	18.7	23.4	32.5	56.2	10.7	2.5	1.5	8.6
NACA	NACA1	ENSG00000196531	"Nascent polypeptide associated complex subunit alpha"	"E9PAV3, Q13765"	12	56712305-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073152, HPA073648"			Approved	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA073152: AB_2686575, HPA073648: AB_2686621"	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	1348.3	1065.0	446.1	607.2	455.9	1524.0	1460.8	456.4	614.8	1642.2	421.9	1252.3	618.6	1067.1	1084.0	1511.9	1216.9	545.1	946.9	431.4	473.1	1038.4	893.7	839.1	1026.5	465.7	442.5	2391.0	1384.8	764.5	811.6	607.7	469.4	1139.7	845.2	453.0	1016.0	699.0	1192.4	1706.1	890.4	689.9	492.3	901.9	1035.1	364.0	450.6	1043.6	918.0	376.8	1432.0	1183.1	1447.1	485.1	1128.5	1333.7	1555.7	1198.7	1795.5	3053.1	1489.5	1117.9	1619.4	1509.9	1051.6	1602.0	1220.7	2014.8	1191.0	1019.4	599.8	963.6	1324.0	1814.9	1600.2	1002.6	2111.7	1463.4	890.3	1640.8	1607.2	2139.1	899.1	2430.3	2204.4	1226.9	2477.6	2669.6	1628.2	1184.8	1896.0	2594.7	1445.5	1118.9	1341.7	2670.1	1528.3	1072.6	1440.8	1543.1	1268.7	2180.1	2124.9	1157.6	1130.2	1197.4	835.8	1977.1	1774.5	1027.8	2109.8	2398.2	1085.4	770.4	933.2	834.0	1127.0	1217.9	1475.1	1768.0	1134.0	1422.3	997.9	462.6	987.0	503.8	581.4	1371.7	851.7	969.7	823.0	726.5	1006.8	812.1	941.6	834.7	350.2	748.7	1842.6	1082.7	944.3	1951.8	446.1	455.9	456.4	614.8	431.4	473.1	465.7	442.5	469.4	492.3	450.6	485.1	1444.2	445.5	645.8	38.8	1822.8	2027.4	2219.5	2022.2	2405.1	325.2	2494.6	5365.8	722.7	1159.6	1095.8	395.4	66.7	1867.2	2037.7	656.8	1778.5	1368.9	701.0	899.4	1625.1	1206.0	647.6	1213.0	31.4	2023.3	2894.2	1085.3	649.4	1079.9	735.9	1600.7	993.4	881.6	1594.4	183.4	35.5	1461.3	801.5	1436.7	1664.7	589.5	2409.8	1430.9	1239.8	40.3	2261.1	1195.0	1528.3	26.7	35.1	1574.8	1306.2	1431.2	1160.8	2248.0	1444.7	2734.4	523.2	455.2	802.0	1977.5	1718.3	542.4	479.1	2363.5	2231.6	2323.4	1549.8	2175.1	1762.0	2618.2
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome		NA	NA		100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (9.44e-5)"	"unprognostic (1.97e-1)"	23.9	28.3	26.0	26.0	26.0	38.8	32.5	28.8	29.6	23.0	27.1	31.9	32.4	32.9	35.2	30.3	26.8	24.2	29.7	25.5	27.1	26.5	28.6	22.5	36.1	25.8	26.1	35.6	27.3	41.5	22.6	28.4	27.1	28.8	35.3	33.9	25.9	26.7	35.0	33.1	33.2	30.3	27.0	22.2	21.6	47.1	27.1	35.0	32.3	33.0	31.6	28.6	22.1	30.3	107.6	81.1	140.4	139.4	55.1	78.9	116.9	79.9	80.3	115.6	139.8	99.5	80.9	118.1	89.1	60.4	74.8	105.6	107.7	96.5	162.0	43.8	122.1	83.9	53.6	153.9	63.2	157.3	100.7	64.0	69.6	92.8	80.7	61.0	82.5	141.2	201.9	40.3	89.9	37.5	165.7	177.7	196.2	83.4	144.6	175.7	167.8	157.7	89.1	92.6	151.3	110.6	239.5	50.7	94.7	86.0	54.2	105.2	64.7	80.2	80.1	84.7	93.9	75.3	125.3	423.8	72.3	103.0	99.7	2.8	6.0	13.4	27.3	5.8	34.9	18.2	29.0	30.1	8.2	14.4	31.0	31.4	2.7	17.1	6.5	12.2	27.4	18.3	26.0	26.0	28.8	29.6	25.5	27.1	25.8	26.1	27.1	27.0	27.1	30.3	29.2	32.1	32.2	23.5	30.1	33.0	66.6	87.2	17.1	52.0	28.4	31.4	30.7	18.6	53.4	31.3	12.5	101.3	33.9	28.0	39.2	70.0	4.6	27.7	23.2	30.7	22.9	38.9	41.3	60.2	70.9	38.4	20.9	22.9	35.4	55.9	19.2	21.3	28.6	50.5	40.7	33.3	67.1	10.4	13.5	14.3	48.7	16.2	49.8	17.8	25.7	68.4	51.5	33.2	39.8	65.0	114.3	54.2	32.0	68.8	34.7	48.2	44.8	35.9	19.7	41.0	63.7	145.4	219.3	33.6	32.1	52.4	36.9	49.4	42.5	49.5
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536241-42544449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		270000000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	41.6	37.9	12.5	14.8	21.6	20.3	35.3	16.6	16.7	31.1	28.7	25.1	24.3	34.7	12.8	19.5	27.6	27.4	20.1	12.0	15.0	39.3	59.3	30.8	24.0	18.0	19.2	35.2	63.8	21.3	22.5	26.1	20.1	28.3	16.4	3.1	37.7	18.4	16.0	25.1	30.9	13.8	14.2	40.7	35.1	8.7	19.5	17.1	37.6	9.7	13.4	28.9	23.9	30.0	16.0	55.3	10.8	24.6	106.6	34.5	36.4	24.0	56.9	24.9	31.7	14.9	40.4	20.3	23.7	37.4	54.7	38.3	9.7	11.7	5.5	15.8	20.2	11.2	31.3	31.8	35.3	13.3	27.7	41.4	17.8	13.6	16.9	27.3	32.8	3.6	16.6	39.3	27.9	38.9	2.2	23.0	12.6	34.6	7.0	8.7	23.6	47.2	33.1	36.1	16.2	24.4	12.9	17.6	20.4	15.6	82.1	14.1	25.8	59.3	9.7	23.8	15.7	52.6	25.8	17.6	35.9	14.4	43.1	1.1	2.4	1.9	2.5	1.8	2.4	2.4	1.0	1.3	2.1	1.8	1.8	1.4	1.1	2.1	2.9	2.8	0.2	1.1	12.5	21.6	16.6	16.7	12.0	15.0	18.0	19.2	20.1	14.2	19.5	30.0	14.1	12.8	7.8	17.3	9.0	2.8	6.1	3.9	2.2	15.5	14.2	8.9	3.8	18.6	4.9	18.4	4.2	23.8	11.4	21.1	3.9	18.4	0.3	5.8	14.5	12.2	6.7	4.4	2.3	33.2	14.5	26.4	27.0	12.1	2.5	40.1	24.3	43.7	37.6	15.2	3.1	17.6	0.0	26.0	3.5	2.4	19.9	19.0	16.0	10.3	5.9	13.2	8.2	6.0	19.2	15.8	5.4	12.8	12.9	10.7	23.0	31.8	3.7	6.7	6.6	18.0	12.8	0.4	6.0	6.1	3.4	18.5	6.0	74.6	15.0	6.0
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248298-106285966	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 279.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 279.2"	"Cell line enhanced"	"Detected in all"		"HHSteC: 387.5;U-87 MG: 434.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	308.5	74.2	14.4	360.5	15.6	312.5	103.3	15.2	35.4	47.3	21.7	62.5	38.5	38.6	6.9	228.2	107.6	113.7	103.1	15.2	20.9	82.9	317.9	218.5	23.2	75.7	24.9	58.4	80.9	25.9	30.1	87.3	30.3	70.1	30.3	17.2	126.0	13.4	135.9	54.1	55.9	48.0	21.3	88.2	102.4	11.7	46.3	15.6	42.2	44.4	39.9	283.3	86.7	21.5	103.6	41.0	14.6	16.8	85.8	95.0	34.4	26.1	194.7	57.0	90.6	25.7	38.7	77.7	78.8	32.1	131.5	58.2	38.8	88.1	93.8	50.5	51.7	35.8	17.2	22.6	387.5	61.3	49.4	94.8	94.2	114.9	115.0	70.6	187.3	32.0	70.5	225.6	68.1	49.4	58.1	19.4	36.6	33.6	59.7	25.8	30.4	147.6	46.2	60.8	33.4	19.3	46.0	61.1	107.9	43.0	25.4	9.4	168.2	75.6	52.9	105.9	51.9	212.1	142.7	115.7	434.3	69.3	105.6	39.6	6.5	16.0	1.8	21.8	2.4	3.9	2.2	2.7	7.0	3.4	2.8	2.2	279.2	4.4	30.5	5.5	7.1	4.8	14.4	15.6	15.2	35.4	15.2	20.9	75.7	24.9	30.3	21.3	46.3	21.5	323.8	131.4	245.7	12.1	78.0	207.6	321.0	105.7	169.0	23.8	184.2	132.0	94.8	197.3	161.4	42.3	12.5	26.2	67.5	105.8	46.9	320.6	12.2	128.0	160.8	192.8	25.1	29.5	25.3	141.3	58.9	239.6	132.0	296.5	188.4	18.8	159.5	580.0	107.0	40.4	28.8	51.9	63.1	390.3	1123.7	6.9	40.4	947.3	161.9	46.9	102.7	22.6	9.2	12.1	22.4	138.1	49.7	31.2	93.7	364.0	112.8	50.7	94.1	30.8	26.3	264.6	185.6	30.5	65.8	98.3	207.8	25.3	110.3	38.4	79.4	334.5
NAP1L1	"MGC23410, MGC8688, NAP1, NAP1L, NRP"	ENSG00000187109	"Nucleosome assembly protein 1 like 1"	P55209	12	76036585-76084735	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028861	Approved		Uncertain	Microtubules		NA	NA		10000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Microtubules		"HPA028861: AB_10603880"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.29e-9)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.14e-13)"	"unprognostic (5.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.15e-1)"	270.7	293.7	240.6	215.5	261.7	337.4	248.4	224.3	295.7	341.7	182.2	255.2	76.7	274.1	172.3	156.9	260.9	217.2	250.2	207.8	239.1	155.4	113.2	320.7	456.3	249.6	239.0	602.9	137.4	125.5	175.6	201.9	257.8	228.5	123.5	199.8	193.1	211.0	378.2	142.5	175.1	190.2	285.6	278.3	158.5	127.7	254.0	341.4	178.1	144.9	386.7	253.7	244.1	275.2	765.7	575.6	1061.5	673.3	667.4	1066.2	596.5	479.3	655.2	724.9	532.1	633.5	278.5	1791.9	521.0	601.8	305.7	496.1	636.3	763.4	892.0	570.1	627.7	667.6	407.6	646.4	950.1	1075.1	624.2	748.0	810.0	502.4	842.5	1778.1	891.6	640.5	995.1	379.3	1162.6	366.2	1380.9	868.2	1214.7	278.7	529.9	1071.8	1053.2	748.8	640.6	421.8	455.7	654.4	400.9	580.4	1180.9	818.0	860.4	765.8	704.5	561.5	635.1	403.2	687.9	472.7	601.0	1115.1	343.2	552.1	371.0	6.9	114.4	183.5	95.1	350.0	192.7	248.1	218.5	154.4	226.1	205.7	250.8	207.1	28.1	153.6	732.5	165.3	242.4	225.4	240.6	261.7	224.3	295.7	207.8	239.1	249.6	239.0	257.8	285.6	254.0	275.2	184.6	166.7	227.5	77.4	506.6	459.2	637.5	478.4	352.3	158.1	308.0	327.8	453.8	197.3	271.3	136.1	79.2	523.7	313.5	39.7	238.7	360.5	225.9	333.6	833.9	340.2	247.1	254.9	181.9	281.7	460.0	386.6	66.8	198.3	435.9	345.2	260.9	125.6	428.1	252.4	149.0	160.6	195.3	546.8	738.3	249.5	709.3	644.0	403.8	93.7	839.2	372.8	241.0	92.5	109.3	397.4	61.3	832.8	183.4	601.2	9.7	266.6	341.6	127.0	374.7	457.2	448.4	350.7	159.2	268.7	337.6	417.0	408.4	353.4	182.9	430.0
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm		NA	NA		3100000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.54e-1)"	39.6	43.5	44.3	36.1	59.2	50.3	41.3	53.0	178.1	46.7	70.3	60.3	20.1	45.4	17.3	79.6	41.2	32.5	111.4	41.3	52.1	63.7	56.2	40.5	65.7	57.2	53.8	42.9	38.0	63.5	61.4	36.8	60.2	51.9	34.2	38.6	66.4	32.1	146.1	49.0	53.8	39.1	52.2	59.0	56.6	87.4	56.4	78.8	44.6	110.7	75.8	61.9	52.1	72.2	82.8	59.9	81.7	65.7	83.9	92.4	37.7	159.8	104.1	145.4	132.5	129.7	208.4	149.5	95.3	98.0	15.1	140.0	21.9	136.3	166.8	159.2	57.5	106.7	151.4	168.2	57.7	93.0	110.5	77.8	65.1	78.6	59.1	12.0	88.9	77.6	139.3	150.7	128.0	74.5	206.4	4.2	199.8	98.9	75.2	101.4	98.1	117.0	12.2	131.7	121.4	104.3	80.5	118.1	78.3	82.5	7.3	7.4	67.8	112.5	104.4	152.4	13.8	79.3	136.5	201.5	8.4	66.0	75.3	67.5	22.9	32.6	42.3	24.0	39.9	24.7	51.9	53.0	27.2	28.4	45.7	52.1	14.5	57.6	30.4	25.0	70.5	48.0	44.3	59.2	53.0	178.1	41.3	52.1	57.2	53.8	60.2	52.2	56.4	72.2	53.6	44.8	49.8	56.2	64.3	70.1	67.4	76.9	83.1	80.4	54.6	48.3	200.4	42.9	69.0	75.4	45.9	103.8	99.4	37.2	97.8	78.7	97.0	107.7	65.9	55.4	45.4	168.7	36.9	50.4	109.2	56.6	54.0	91.1	74.6	100.6	43.5	50.0	47.3	65.6	56.6	41.4	67.1	30.8	44.7	142.6	48.1	49.7	35.6	38.4	65.3	67.5	95.8	60.8	125.3	74.1	26.8	50.0	100.7	76.1	39.8	76.9	92.6	68.1	46.0	58.8	64.7	166.1	129.0	102.3	66.9	91.3	123.8	79.7	55.1	83.7
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 1075.5"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 3072.3"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 4.3;dendritic cells: 8.7"	"Cell line enriched"	"Detected in some"	31	"U-698: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		1500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.4	0.9	0.8	1.6	0.9	0.1	0.5	0.9	0.9	0.7	0.7	0.6	0.4	0.5	2.0	0.4	1.0	0.1	0.4	0.8	0.9	106.3	1.2	1075.5	1.2	0.9	0.8	2.1	1.0	0.2	0.6	0.4	0.9	1.0	0.4	0.4	0.6	1.0	0.2	1.1	1.5	0.1	0.8	1.1	0.9	1.8	1.0	0.4	1.7	0.0	0.5	0.4	0.7	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.4	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.7	0.2	0.5	0.2	0.3	0.4	0.6	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	1.0	0.0	0.2	0.4	42.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	4.3	0.2	0.3	2.6	1.7	0.4	0.4	0.5	0.4	0.7	8.7	0.0	1.1	0.8	0.9	0.9	0.9	0.8	0.9	0.9	0.8	0.9	0.8	1.0	1.1	0.3	522.4	3072.3	0.3	3.8	0.1	0.5	0.2	0.0	1.3	0.8	0.9	0.4	1.5	45.9	46.0	4.2	0.5	0.4	0.8	9.8	0.6	47.2	12.6	0.4	6.2	0.0	0.4	0.5	0.8	0.3	5.8	0.5	1.5	69.4	1.0	0.4	0.4	0.3	0.0	0.5	1.0	0.0	1.6	5.3	9.1	0.9	7.9	0.0	1.9	0.2	1.5	1.0	0.0	1.4	0.1	2.3	0.4	0.6	0.4	2.0	276.1	16.4	0.9	0.0	0.3	0.3	1.4	1.4	0.0	0.6	0.1	12.9	0.4	0.9	0.1
NARS1	NARS	ENSG00000134440	"Asparaginyl-tRNA synthetase 1"	O43776	18	57600656-57622213	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 221.3;Cytotrophoblasts: 116.0;Extravillous trophoblasts: 85.2;Hofbauer cells: 117.4;Syncytiotrophoblasts: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol		NA	NA		76000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB034257: AB_2151043, HPA040017: AB_2676801"	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	67.2	65.9	51.7	62.1	53.8	48.8	68.3	58.8	77.7	57.5	60.1	108.7	87.3	52.7	66.5	64.2	58.5	56.0	94.8	53.4	60.4	135.1	75.5	51.7	52.8	59.6	55.6	45.4	63.1	125.3	33.2	56.1	58.5	68.4	99.5	68.2	68.8	65.4	127.2	49.6	72.0	65.5	55.9	46.8	79.4	32.7	63.7	59.1	95.0	130.6	67.3	78.0	41.9	60.1	215.1	133.2	129.6	199.1	172.8	130.7	202.5	302.5	161.7	179.2	215.4	100.3	97.0	270.7	136.2	208.7	172.1	241.7	211.0	191.6	259.0	127.5	75.5	217.8	105.4	171.8	299.9	433.0	212.5	146.0	331.2	233.8	245.8	130.6	154.6	169.4	246.5	201.6	200.9	86.2	172.4	111.9	189.6	145.1	118.6	139.8	154.5	229.9	340.3	224.4	140.9	147.6	153.1	184.0	309.4	137.3	108.8	242.6	179.7	190.5	127.7	78.8	215.8	449.1	559.2	260.3	175.1	285.7	227.7	50.9	108.5	38.8	41.8	92.6	50.9	52.6	43.3	44.7	71.7	51.4	58.2	52.6	34.4	43.6	76.8	64.0	49.4	74.9	51.7	53.8	58.8	77.7	53.4	60.4	59.6	55.6	58.5	55.9	63.7	60.1	26.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.3	0.0	0.0	0.0	0.0	116.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	85.2	23.1	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	158.6	3.5	0.0	0.0	0.0
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 476.2;Spermatogonia: 514.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		170000	"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	66.2	39.6	57.4	55.9	62.6	165.0	58.8	60.6	95.7	67.4	57.1	52.7	34.6	54.6	29.9	55.2	65.6	26.7	51.0	57.2	68.0	48.6	52.0	50.4	91.5	65.0	61.6	72.4	34.9	41.1	40.9	61.9	63.0	54.1	51.5	38.2	43.5	43.4	41.7	46.7	58.3	45.1	56.0	83.3	47.3	108.9	62.4	100.7	48.1	22.2	97.7	51.1	56.0	65.3	191.3	110.8	520.2	184.6	85.8	44.9	243.8	150.9	112.4	230.5	286.5	205.7	134.4	357.9	103.5	65.8	251.9	180.2	351.9	161.0	291.5	164.0	222.9	462.7	201.6	326.9	30.2	489.3	186.4	52.5	38.3	254.0	87.6	60.1	159.5	294.8	396.3	204.1	157.6	131.4	559.6	445.0	755.5	189.5	93.1	697.4	454.0	343.8	115.3	189.4	198.3	239.8	248.7	140.4	159.7	389.2	100.8	377.0	86.7	105.5	322.8	204.4	250.0	124.5	251.2	616.2	107.6	306.7	107.3	6.4	9.4	10.9	14.1	12.1	16.4	16.1	16.1	16.3	14.3	22.3	13.9	13.7	4.0	9.7	7.3	14.7	22.0	9.1	57.4	62.6	60.6	95.7	57.2	68.0	65.0	61.6	63.0	56.0	62.4	65.3	196.5	57.7	106.7	70.8	136.1	78.1	135.2	72.4	133.7	45.3	77.4	87.4	58.4	37.1	99.1	36.8	37.5	319.3	150.8	64.8	31.3	55.0	16.6	119.6	138.1	138.4	51.3	142.8	32.7	37.4	223.2	100.6	81.1	137.9	115.2	134.2	90.3	38.6	108.1	43.7	34.8	68.1	44.7	43.7	62.6	26.6	94.8	82.7	40.9	31.9	52.3	60.9	62.8	63.8	160.3	29.8	44.9	78.2	107.4	88.6	28.9	36.6	109.1	77.3	85.5	148.1	106.6	476.2	514.5	92.1	57.0	268.2	142.2	90.7	101.7	85.3
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942270-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 23.5;retina: 65.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.1;SH-SY5Y: 80.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	2.4	7.2	7.7	1.5	10.7	0.3	4.9	19.0	23.5	3.5	2.8	5.8	1.4	6.1	2.2	3.3	5.5	3.4	6.9	17.4	2.8	4.1	0.6	2.0	1.6	4.1	0.1	6.2	3.1	7.1	8.3	0.6	4.8	6.6	2.5	65.7	4.7	8.4	5.6	1.5	2.5	6.5	0.4	3.2	2.7	3.5	0.0	5.6	6.3	5.7	1.2	3.6	2.8	4.5	0.0	4.5	10.9	6.1	0.7	0.1	0.3	7.0	10.8	7.9	6.6	0.1	1.0	3.0	0.0	12.9	4.7	0.3	3.7	1.5	16.3	1.4	3.6	0.0	3.4	1.2	0.5	1.9	4.7	2.1	1.2	0.1	0.7	33.1	1.8	1.2	0.1	17.6	1.1	1.9	1.1	0.0	4.6	6.2	2.0	1.1	4.7	0.9	9.3	2.1	6.2	80.1	5.4	0.1	3.6	8.1	2.0	0.4	0.1	2.0	1.2	0.0	1.6	1.9	0.5	1.3	5.4	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	7.7	10.7	19.0	23.5	17.4	2.8	4.1	0.1	4.8	0.4	0.0	4.5	19.7	28.9	9.2	132.9	5.2	1.0	5.3	2.7	1.2	124.8	5.0	6.5	51.8	11.5	14.1	9.2	146.0	0.1	4.4	0.3	1.9	9.2	19.3	5.6	18.4	10.1	22.9	0.8	1016.1	1.8	0.1	12.3	2.0	0.6	25.2	20.7	11.0	0.3	0.9	47.1	953.0	2.1	6.1	3.5	3.9	13.6	17.7	3.5	7.2	150.9	1.2	69.1	0.0	466.9	163.7	2.3	0.1	19.2	5.8	8.5	0.2	7.6	56.5	87.0	6.6	22.2	13.1	8.5	8.0	0.3	0.9	0.0	1.2	11.9	1.1	13.5
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 290.1;heart muscle: 145.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.7"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA	1200000	2300000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	4.6	65.7	124.0	3.9	169.1	1.5	2.7	118.1	140.3	35.1	0.0	47.8	4.6	62.7	3.5	7.0	40.4	4.8	145.5	135.6	179.1	3.2	2.9	1.8	1.3	140.4	134.2	43.8	2.6	0.0	22.2	0.5	147.4	14.9	6.6	117.7	3.6	17.7	31.2	2.1	18.3	46.9	129.7	4.7	23.0	5.0	137.0	0.4	30.2	29.5	1.0	34.8	24.3	290.1	0.1	0.0	20.8	0.3	0.2	0.5	0.3	1.0	0.0	0.7	1.2	0.3	0.3	3.1	18.2	20.1	0.8	0.3	0.1	0.0	0.0	0.4	12.1	61.3	0.1	0.0	2.1	0.0	9.5	12.4	0.1	0.1	18.6	0.1	0.0	0.1	0.0	1.0	20.8	0.0	0.2	5.2	1.8	0.0	0.4	0.1	132.5	10.0	0.0	0.0	107.4	52.7	0.1	0.5	0.1	2.0	0.2	0.8	0.2	72.8	33.4	0.3	31.8	0.1	0.5	0.1	8.3	28.4	79.0	0.0	0.2	0.0	3.6	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	1.4	0.7	53.7	0.0	0.0	0.2	1.9	124.0	169.1	118.1	140.3	135.6	179.1	140.4	134.2	147.4	129.7	137.0	290.1	13.7	0.0	0.0	530.8	0.4	1.7	0.5	0.0	0.0	123.5	5.7	0.6	131.7	0.0	0.0	0.0	37.5	0.6	27.7	0.1	1.9	18.3	6.7	0.3	2.4	2.8	5.4	0.0	461.4	0.0	0.2	12.8	5.1	0.5	1.3	11.7	7.1	0.7	0.4	175.0	441.2	0.0	8.2	4.7	3.8	5.9	15.2	1.8	0.0	35.6	1.2	216.6	59.8	939.0	1013.5	1.3	0.0	10.1	5.6	0.4	0.0	0.2	0.7	98.0	0.0	107.5	4.8	1.0	2.8	0.4	1.7	0.1	13.4	5.6	0.0	0.2
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998409-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.0;brain: 26.0"	"Group enriched"	"Detected in some"	19	"Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.6;glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		120000000		"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	0.7	12.0	14.1	0.9	19.0	0.0	1.6	8.4	17.5	1.6	0.0	2.0	0.2	1.0	0.5	0.5	0.6	1.2	2.0	21.3	22.7	0.2	6.7	2.8	0.1	8.6	14.4	0.3	0.2	0.6	0.8	0.5	8.8	0.9	1.0	1.2	0.7	1.0	0.4	0.8	0.7	1.4	8.8	0.8	0.6	6.3	26.0	0.1	0.3	0.8	0.2	0.6	1.2	21.6	0.0	0.0	0.5	0.0	4.6	4.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.5	1.3	0.0	2.2	0.0	0.1	11.3	0.0	3.5	0.0	0.4	0.0	0.0	11.4	2.4	0.2	15.4	0.2	0.0	0.4	0.0	0.0	1.0	0.0	4.7	0.0	0.0	0.0	5.3	0.0	0.8	0.6	0.1	92.1	7.2	0.0	1.3	0.9	0.1	0.0	0.6	0.0	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.0	8.4	17.5	21.3	22.7	8.6	14.4	8.8	8.8	26.0	21.6	0.4	3.2	1.3	713.0	0.1	0.5	0.3	0.0	0.0	1.0	2.0	1.4	1.8	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	57.6	0.3	6.1	0.4	0.0	0.0	866.5	0.0	0.4	4.8	0.0	0.2	0.0	0.2	2.2	0.0	0.3	0.0	909.2	0.0	0.0	0.0	0.3	24.7	0.9	0.1	1.8	30.9	0.0	1.0	0.0	1729.1	1526.6	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.1	0.0	2.4	1.6	3.7	9.6	0.1	0.1	0.3	0.2	1.9	0.0	0.2
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"brain: 73.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.8	0.0	53.1	0.0	0.0	15.2	73.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	44.2	0.0	0.0	0.0	0.0	33.3	32.3	0.0	0.0	0.0	0.3	0.0	38.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.9	61.5	0.1	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	53.1	15.2	73.6	55.6	44.2	33.3	32.3	38.1	21.5	61.5	49.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.0;Late spermatids: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes		34000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	8.3	7.4	7.3	21.5	11.4	35.5	10.9	9.9	8.3	10.2	7.4	17.9	17.0	10.7	10.6	15.9	11.2	9.8	7.6	7.2	8.0	7.4	4.8	10.6	38.1	11.0	10.0	8.0	7.7	11.3	5.5	17.5	11.7	9.4	20.4	11.1	11.8	10.2	7.9	21.9	16.0	13.4	8.4	16.1	12.1	18.2	10.2	76.8	11.3	10.2	44.8	10.1	9.3	13.9	125.3	99.3	134.6	97.9	29.9	28.4	159.2	76.1	69.8	138.3	109.1	123.5	150.8	135.8	24.2	63.2	126.7	128.6	188.0	105.4	194.1	214.1	92.8	112.2	113.8	79.4	12.5	145.0	96.5	20.5	31.6	112.4	107.8	61.9	89.9	94.0	71.0	63.4	104.7	79.6	162.2	73.8	207.5	129.9	78.2	153.7	260.6	77.7	39.5	64.1	54.0	61.9	121.5	64.9	44.3	189.1	27.0	101.7	51.0	94.1	149.6	60.8	168.4	45.3	51.7	181.0	55.7	92.2	126.1	11.0	1.7	3.7	7.1	2.8	5.3	5.1	6.4	7.3	3.4	3.5	7.3	7.3	1.4	8.1	2.2	4.1	8.3	3.9	7.3	11.4	9.9	8.3	7.2	8.0	11.0	10.0	11.7	8.4	10.2	13.9	4.3	6.4	7.4	4.9	11.0	3.6	3.8	4.4	17.1	3.7	4.7	6.9	4.1	5.7	3.4	1.8	8.4	13.5	8.9	7.3	0.0	4.5	18.3	5.3	6.3	5.4	1.2	48.0	5.6	3.7	17.8	6.4	7.1	5.8	3.8	20.0	8.9	3.3	10.1	5.0	5.0	9.9	6.1	16.4	4.4	34.3	5.9	10.8	0.0	2.8	9.5	11.8	15.5	2.5	17.8	5.3	4.6	6.0	22.6	4.1	6.0	2.4	4.2	8.4	0.0	4.2	5.2	21.3	13.7	19.3	3.4	6.3	12.0	6.1	14.7	4.1
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150113-134225454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 58.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA040286: AB_2676918"	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.7	5.5	1.9	3.1	2.0	10.0	4.9	4.0	3.8	4.2	2.3	4.4	3.5	4.0	3.3	7.1	3.8	2.6	5.0	3.1	1.6	3.6	8.8	4.9	4.2	2.0	1.1	3.4	4.5	1.9	7.0	3.1	1.1	58.5	1.5	4.5	5.7	0.9	3.7	9.0	5.4	1.3	0.9	6.2	5.1	9.5	1.6	3.1	6.0	0.9	1.7	3.7	5.2	3.0	5.5	1.9	12.3	25.3	1.8	1.3	10.6	11.5	1.9	3.5	4.0	5.6	3.4	6.1	11.1	3.5	9.8	6.1	3.5	5.2	4.4	9.2	21.7	26.6	5.1	8.5	2.3	13.1	15.4	1.7	1.1	5.1	2.0	3.6	2.6	11.6	7.1	4.7	4.2	6.0	10.9	15.1	8.6	5.5	13.8	2.9	13.7	8.5	4.1	3.2	22.1	13.4	9.1	5.9	1.7	10.0	9.7	6.9	1.7	11.8	5.7	11.8	9.9	4.5	4.5	5.5	8.3	16.4	15.2	1.6	3.3	1.6	5.7	2.7	2.2	2.3	3.7	3.8	2.5	5.2	5.5	5.8	1.6	1.7	2.2	8.0	6.5	1.9	1.9	2.0	4.0	3.8	3.1	1.6	2.0	1.1	1.1	0.9	1.6	3.0	7.7	3.2	8.1	8.5	12.1	9.2	4.4	6.0	8.0	20.2	9.9	8.6	6.7	2.8	7.0	12.9	10.4	13.0	13.2	5.4	0.0	2.7	7.2	7.8	12.8	5.6	7.8	32.8	19.7	2.6	9.9	7.5	7.7	9.0	2.5	19.6	5.7	9.7	8.8	11.8	16.7	7.2	10.2	6.4	8.7	10.4	4.7	10.9	1.8	15.0	17.1	9.0	17.5	11.1	16.0	2.8	1.6	4.1	22.9	8.8	3.2	3.6	4.9	20.9	0.0	9.5	9.2	21.5	14.4	10.7	9.1	4.5	14.2	11.3	11.6	3.4
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878017	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.2;lymphoid tissue: 162.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1235.8"	"Cell line enhanced"	"Detected in some"		"HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA		7800	"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	29.5	14.4	4.8	43.1	5.0	180.2	12.7	4.9	7.5	4.6	6.4	19.2	11.7	4.5	1.0	7.2	13.9	13.0	9.4	4.9	5.4	8.9	10.1	45.1	39.8	6.8	5.9	3.3	4.1	1.4	5.3	24.3	6.4	7.4	11.8	0.1	10.7	4.5	3.6	4.9	42.6	10.5	5.8	162.3	9.3	1.8	8.6	12.9	8.1	7.1	33.5	18.7	7.2	7.1	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	78.3	0.0	0.0	0.0	12.8	396.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	26.8	0.0	0.8	0.0	148.7	0.0	0.0	0.0	76.5	0.0	144.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	137.9	0.0	0.0	0.2	0.1	0.2	0.5	0.1	23.7	0.1	76.8	0.1	657.3	184.6	750.1	2.3	92.5	9.8	108.2	32.0	6.9	86.1	85.9	1.9	2.1	1235.8	4.4	62.0	100.7	96.3	106.3	4.8	5.0	4.9	7.5	4.9	5.4	6.8	5.9	6.4	5.8	8.6	7.1	1.5	3.2	18.7	0.0	70.9	2.8	2.2	1.3	0.6	0.0	3.1	2.5	2.1	0.0	5.8	1.8	0.0	3.2	21.1	1.3	0.0	0.6	0.2	0.2	0.1	3.6	0.0	28.8	0.0	3.1	16.0	1.8	2.0	0.4	74.1	0.0	1.4	0.7	198.4	0.0	0.0	0.5	2.0	85.3	55.8	1.0	0.6	85.7	14.2	3.7	38.5	0.0	3.1	0.0	0.1	0.9	22.5	0.0	68.2	0.3	0.2	0.2	0.9	0.3	0.0	0.5	1.6	0.0	0.4	0.5	2.3	13.0	17.5	0.7	1.7	4.3
NCK2	NCKbeta	ENSG00000071051	"NCK adaptor protein 2"	O43639	2	105744912-105894274	"Plasma proteins, Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 184.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016116, HPA031004"	Approved					NA	NA		87000	"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 24: Non-specific - Transcription regulation"			"CAB016116: AB_2150588, HPA031004: AB_10795571"	"unprognostic (2.39e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.21e-3)"	"unprognostic (4.22e-2)"	37.8	19.7	18.6	20.5	19.2	17.6	33.6	26.3	29.0	36.4	16.7	39.1	54.7	29.7	18.9	68.8	25.4	19.0	31.9	27.9	18.4	28.9	11.1	37.1	27.6	21.8	22.4	25.1	39.8	13.6	19.7	36.8	22.0	24.7	16.4	10.3	46.8	18.7	53.5	33.4	51.7	17.9	22.5	52.0	40.3	27.3	23.9	18.6	28.3	27.2	19.1	35.6	50.4	20.4	25.8	20.2	51.6	23.9	15.0	10.7	73.3	19.0	25.0	21.6	12.5	58.8	20.9	11.2	23.4	24.2	31.0	25.1	21.9	47.7	14.6	79.5	24.5	5.0	9.4	37.8	39.2	28.1	9.8	21.4	34.0	23.5	30.0	18.7	22.0	27.3	7.7	38.5	17.9	21.7	29.3	48.2	28.8	21.6	23.0	23.4	36.2	41.7	28.1	51.2	32.9	45.4	14.4	37.2	184.4	30.4	13.6	70.3	25.0	37.9	55.2	1.0	27.2	28.8	19.6	3.8	16.7	24.5	61.6	26.2	1.0	12.5	7.0	1.0	9.2	7.7	13.1	11.8	1.2	11.1	13.6	12.5	9.3	11.9	1.0	1.8	24.5	5.0	18.6	19.2	26.3	29.0	27.9	18.4	21.8	22.4	22.0	22.5	23.9	20.4	41.8	16.0	7.9	28.1	32.8	17.6	13.9	14.2	7.4	13.5	27.1	35.9	21.3	71.4	9.6	16.5	12.5	39.0	30.3	31.2	7.9	28.1	15.5	18.0	21.8	23.7	19.2	2.5	60.0	18.8	15.2	16.2	13.3	19.9	5.7	33.0	18.2	2.3	26.0	82.4	48.4	23.1	18.3	14.2	13.9	9.2	23.6	18.7	10.6	77.8	10.5	61.4	18.6	24.6	18.3	29.9	29.2	28.2	15.8	17.7	51.3	8.4	18.9	4.6	32.9	33.1	54.4	4.2	9.6	10.7	16.8	29.7	52.4	18.1	31.2	30.0
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497752-54548243	"Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.2;dendritic cells: 92.3;Hofbauer cells: 115.5;Kupffer cells: 175.1;Macrophages: 108.1;monocytes: 153.2;NK-cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 112.4;HMC-1: 112.4;NB-4: 82.6;REH: 59.1;THP-1: 121.3;U-937: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Plasma membrane"	"HPA039490: AB_2676540, HPA040772: AB_2677129"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	9.7	4.6	3.3	34.8	4.0	28.4	4.7	3.6	3.7	4.0	4.0	19.7	5.8	2.5	1.3	6.1	3.4	7.3	2.6	2.9	3.7	2.3	7.1	20.2	42.5	6.9	4.8	1.8	1.6	4.0	1.5	11.0	6.5	4.7	9.7	0.4	3.5	5.2	1.2	2.3	18.1	10.3	5.4	44.9	6.7	1.2	6.8	37.4	2.2	2.0	43.4	27.9	2.8	8.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.3	47.9	0.0	0.0	0.0	112.4	112.4	0.0	0.0	0.0	0.0	0.0	0.7	40.1	7.7	43.7	0.0	0.0	47.9	82.6	0.1	0.0	0.0	59.1	0.2	47.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	121.3	0.0	0.2	0.0	0.1	0.1	2.4	2.9	38.4	0.2	70.4	0.0	31.7	68.6	55.0	31.7	103.9	26.2	30.2	28.3	32.7	72.0	28.8	17.9	26.4	16.9	36.1	121.3	40.8	45.1	65.1	3.3	4.0	3.6	3.7	2.9	3.7	6.9	4.8	6.5	5.4	6.8	8.4	1.0	0.0	11.6	0.3	66.2	1.3	0.3	0.0	0.0	1.3	0.6	2.2	1.5	4.3	1.8	0.0	0.0	0.7	92.3	0.2	0.0	0.1	0.9	0.2	0.3	3.6	0.0	22.1	0.8	0.4	1.0	2.7	2.0	0.3	56.3	0.1	7.5	1.4	115.5	0.0	0.5	0.0	0.0	175.1	28.5	2.3	1.2	108.1	5.4	42.2	153.2	0.4	113.3	0.5	0.0	0.0	0.1	0.0	40.0	0.1	0.0	0.3	0.7	0.9	0.0	0.8	1.3	0.9	1.6	0.1	0.6	1.4	59.7	0.2	0.0	0.2
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501887-47656877	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 155.8;Plasma cells: 168.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 187.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	14.7	8.2	4.7	22.9	4.7	13.4	11.5	5.7	9.0	11.1	3.8	9.9	8.8	11.8	7.1	14.3	10.7	10.3	13.3	4.0	5.5	9.4	10.5	14.8	35.0	6.5	5.3	14.1	11.1	11.2	6.0	28.1	6.9	9.6	11.2	11.6	11.3	8.8	25.2	14.0	14.8	11.5	5.3	27.5	14.8	7.5	5.9	17.9	12.9	16.5	39.2	15.3	12.5	6.4	17.6	50.1	16.1	21.5	37.5	41.9	105.2	16.4	24.2	27.3	14.1	25.2	19.0	61.8	11.0	28.5	36.1	43.2	12.2	20.7	20.9	31.3	6.4	8.1	15.3	39.3	22.6	6.8	43.3	19.9	61.2	24.4	30.3	23.5	20.0	10.0	18.7	14.0	16.2	187.0	9.9	12.8	5.8	14.2	20.6	17.8	11.0	27.4	16.8	38.2	3.1	5.7	41.0	53.7	18.8	18.0	24.3	17.8	35.8	16.4	12.9	20.5	7.4	38.5	35.9	60.6	19.4	7.0	10.8	2.8	3.9	3.0	2.5	5.2	2.2	9.3	2.3	2.2	5.0	6.8	2.6	2.9	4.5	2.1	5.0	4.2	3.1	2.6	4.7	4.7	5.7	9.0	4.0	5.5	6.5	5.3	6.9	5.3	5.9	6.4	86.7	12.8	23.7	27.7	155.8	34.5	15.7	25.0	52.9	18.1	23.8	13.8	26.1	20.0	29.0	14.7	8.4	69.5	39.9	12.5	5.9	12.9	12.1	36.4	29.1	49.8	14.9	14.9	48.5	19.6	26.2	26.4	26.5	78.8	8.8	15.3	68.2	20.0	22.8	13.5	64.3	10.7	36.7	46.8	62.2	6.0	24.8	58.2	33.8	109.6	46.1	9.3	28.8	49.3	54.1	21.0	16.9	27.4	168.8	28.1	9.0	6.5	39.8	23.8	19.7	19.7	30.3	43.2	30.0	63.3	51.7	89.2	47.6	14.2	11.7	59.2
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	22.1	18.3	37.8	28.1	39.7	42.8	29.0	60.8	84.7	27.3	41.0	44.0	47.1	30.7	20.3	30.6	25.1	26.4	23.4	39.3	34.7	33.6	46.2	26.9	29.9	32.7	35.7	33.5	34.2	42.3	17.1	28.3	31.0	27.6	40.6	41.4	22.4	31.4	42.0	31.6	38.2	29.7	28.2	29.3	42.7	32.4	35.4	51.9	34.8	39.9	34.7	28.8	18.3	43.4	68.0	110.6	77.7	65.1	62.4	47.1	38.6	48.9	54.8	52.4	47.1	59.8	30.3	70.9	33.6	85.9	39.3	50.4	96.4	59.2	77.3	95.6	71.1	70.7	96.3	71.1	60.8	45.3	80.7	48.5	60.6	81.2	94.4	45.2	73.9	98.0	63.0	28.8	52.3	44.3	79.3	29.1	38.6	118.6	29.9	78.1	78.5	33.5	54.9	76.0	26.5	43.8	80.7	34.7	37.7	197.5	33.5	50.3	65.5	53.7	32.6	39.9	68.3	19.7	25.0	40.4	51.0	52.4	47.0	408.4	104.8	240.4	126.9	86.0	106.7	188.4	144.0	141.0	76.3	191.4	139.8	139.0	205.2	139.9	112.3	130.3	144.7	98.8	37.8	39.7	60.8	84.7	39.3	34.7	32.7	35.7	31.0	28.2	35.4	43.4	90.9	80.1	113.2	116.2	130.0	67.8	106.2	91.3	86.0	150.3	76.8	60.8	91.5	82.9	86.9	53.3	158.4	102.1	121.7	198.1	35.2	95.5	69.7	75.7	109.5	88.4	87.9	132.1	127.0	96.5	101.7	77.1	149.4	103.7	87.3	88.9	67.5	126.4	76.1	129.5	122.2	118.8	81.4	81.9	76.7	43.6	101.5	96.7	37.4	107.7	172.8	83.1	197.8	123.1	151.4	111.7	148.3	121.5	88.5	95.6	194.4	46.7	63.8	167.1	92.1	106.0	106.2	98.7	90.2	78.0	68.2	87.6	142.1	89.5	153.0	122.9
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.0;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.0;monocytes: 2.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	48.1	51.1	41.2	34.3	15.8	29.9	49.7	27.2	45.6	62.9	13.6	56.2	25.2	58.6	9.0	33.3	49.0	21.4	56.7	61.3	12.6	37.6	27.5	62.8	19.5	56.4	29.2	70.8	49.3	18.1	84.1	20.2	53.0	57.7	10.9	20.7	55.1	22.0	109.2	56.2	36.8	22.5	5.4	35.7	45.8	26.1	26.4	19.9	40.5	19.9	11.2	47.4	43.9	27.0	78.6	143.6	40.4	38.7	23.0	31.1	120.4	79.3	39.0	45.2	20.1	76.9	56.3	78.7	57.0	65.1	40.7	72.6	16.2	84.7	18.5	83.6	31.5	63.6	142.1	48.0	46.0	48.3	77.5	50.1	30.9	56.6	33.4	69.2	43.7	35.5	83.3	22.9	41.2	67.4	174.3	55.5	56.4	29.8	139.0	55.8	67.1	40.2	21.6	89.9	106.0	77.1	97.3	81.1	47.7	30.2	66.3	59.8	212.0	104.5	178.9	104.3	170.5	43.5	48.0	48.1	59.4	35.4	100.1	6.0	0.4	1.0	1.0	0.2	0.3	0.3	0.3	0.8	0.2	0.1	0.3	0.2	0.9	0.1	2.5	0.9	0.0	0.3	41.2	15.8	27.2	45.6	61.3	12.6	56.4	29.2	53.0	5.4	26.4	27.0	30.6	115.4	58.9	46.4	14.7	33.3	24.6	22.2	33.0	95.3	33.3	28.3	30.4	18.6	38.8	18.4	39.6	8.8	27.4	39.1	3.9	22.1	2.2	28.0	53.4	28.2	18.7	11.6	61.9	27.2	39.7	50.6	37.8	32.4	42.3	43.5	18.5	19.0	28.4	121.1	37.0	20.3	4.1	50.0	48.7	7.1	62.1	44.8	16.0	51.5	27.0	28.0	20.6	70.9	65.9	38.0	22.2	65.1	22.6	23.7	25.4	8.0	16.8	65.9	6.6	63.0	35.5	1.8	11.6	17.7	24.4	12.6	25.1	69.4	21.9	23.1
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687305	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	46.8	49.4	43.3	11.1	40.5	1.2	35.1	26.0	39.7	70.5	30.4	35.9	11.1	63.7	24.0	16.8	47.2	23.8	34.6	36.7	89.6	13.0	4.5	19.6	10.9	36.0	41.3	69.8	11.8	8.7	56.3	32.6	46.2	27.3	10.7	20.8	12.7	39.3	14.7	11.9	20.8	33.5	36.7	19.1	20.3	18.5	69.6	6.8	17.4	22.4	6.6	31.4	40.4	32.3	0.1	0.0	55.0	0.0	52.9	20.1	0.1	35.4	0.0	0.8	9.6	0.0	0.0	0.0	0.1	10.6	8.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	31.8	71.3	0.0	10.2	0.0	0.0	0.0	21.7	1.2	0.0	18.0	0.0	27.6	0.1	44.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	0.4	0.0	0.4	0.0	57.4	9.4	0.0	0.0	2.6	80.4	0.0	0.1	51.7	51.7	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	43.3	40.5	26.0	39.7	36.7	89.6	36.0	41.3	46.2	36.7	69.6	32.3	24.1	25.6	11.0	6.8	0.3	13.0	13.8	0.3	27.9	66.0	2.3	19.8	36.8	15.7	1.4	12.9	20.9	1.9	2.9	18.5	23.5	17.9	2.5	1.4	60.8	18.7	6.7	4.2	7.8	10.7	1.4	103.1	4.1	1.1	0.0	83.9	38.9	0.2	7.3	50.5	21.8	4.3	0.0	7.6	13.3	8.6	236.4	2.8	39.2	9.4	0.7	88.7	0.0	9.5	16.4	4.5	2.6	207.6	0.0	6.9	8.1	1.1	4.1	51.0	98.6	91.4	94.0	28.5	21.8	13.4	8.2	2.5	1.4	121.8	7.1	4.1
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237175-133302022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 613.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol		NA	NA		200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	161.2	72.9	299.1	55.9	523.6	130.0	107.6	413.5	300.2	169.4	132.8	130.0	242.2	92.9	34.3	343.1	106.4	87.8	99.8	254.5	316.6	192.4	49.6	116.6	38.7	523.2	500.0	126.1	52.8	69.1	82.2	110.8	476.8	354.3	77.8	86.0	130.8	60.0	28.2	262.6	258.1	61.9	333.7	39.4	154.0	28.1	423.1	55.1	80.5	44.6	88.1	105.5	273.8	613.9	191.6	24.0	1.7	0.8	116.3	86.8	26.0	13.7	103.0	9.8	52.5	12.5	27.6	1.5	133.0	58.0	21.9	62.4	1.7	316.8	18.0	13.3	226.8	1.9	55.6	14.7	46.3	7.0	4.6	79.2	606.9	51.2	1226.9	124.2	45.2	27.9	2.0	138.3	17.2	11.0	19.1	20.8	3.0	69.8	155.8	1.7	19.4	86.2	29.7	28.0	13.8	13.0	31.0	312.1	73.3	48.6	1.3	20.0	58.5	84.4	43.6	40.7	10.4	96.3	280.3	0.8	772.5	69.5	161.5	10.9	4.3	0.0	5.8	3.4	9.1	1.6	5.3	6.9	6.0	1.4	3.9	3.1	4.0	1.5	4.2	13.0	8.1	3.7	299.1	523.6	413.5	300.2	254.5	316.6	523.2	500.0	476.8	333.7	423.1	613.9	123.0	144.2	47.4	14.4	23.6	571.9	141.3	207.3	42.1	68.8	28.6	31.2	20.6	80.1	102.9	187.6	2.1	12.8	68.1	405.4	33.2	33.2	5.3	57.4	59.0	217.7	22.1	17.4	7.7	13.7	138.2	90.5	151.4	167.7	22.2	41.0	112.8	64.0	16.5	588.9	5.7	140.9	83.4	31.1	109.5	5.9	49.0	42.7	101.4	28.1	25.7	81.2	14.4	20.6	136.2	62.9	155.9	44.0	23.5	264.3	402.5	87.5	38.7	40.3	46.0	65.2	44.3	1.2	7.1	113.0	667.4	43.4	45.7	32.6	124.7	280.8
NDUFA11	B14.7	ENSG00000174886	"NADH:ubiquinone oxidoreductase subunit A11"	Q86Y39	19	5891276-5904006	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA072209			Uncertain	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA072209: AB_2686495"	"unprognostic (2.24e-1)"	"prognostic favorable (4.54e-5)"	"unprognostic (8.20e-3)"	"prognostic favorable (3.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.16e-3)"	199.0	429.8	203.3	93.4	207.7	158.1	188.9	226.1	305.6	202.1	205.3	312.2	124.9	219.6	53.1	283.4	201.5	106.6	687.5	206.8	223.5	290.2	380.5	155.1	145.3	212.7	213.8	200.7	205.7	138.7	205.9	96.9	215.7	228.3	56.1	31.7	231.2	105.4	425.5	187.6	185.6	89.4	218.3	196.4	250.4	96.3	218.8	120.7	188.9	330.6	62.7	209.4	215.5	225.2	315.2	227.6	168.7	273.1	138.9	231.5	191.2	209.8	243.9	369.4	341.5	271.9	155.5	300.4	320.0	209.6	163.9	195.4	118.6	250.8	85.7	271.2	466.9	124.4	194.5	434.4	374.3	188.8	174.4	317.3	221.9	219.9	106.6	147.6	250.7	284.5	257.3	316.4	192.4	228.2	484.1	325.0	249.9	249.1	609.2	325.0	214.2	427.9	238.3	194.9	236.2	254.3	163.5	254.3	381.5	72.9	196.1	395.0	224.9	202.8	194.7	410.1	340.1	493.5	460.1	400.6	341.0	443.1	263.7	421.2	526.8	313.4	313.2	440.5	323.9	394.4	341.2	314.6	461.1	343.7	321.0	281.1	239.0	303.9	387.8	550.1	474.0	870.2	203.3	207.7	226.1	305.6	206.8	223.5	212.7	213.8	215.7	218.3	218.8	225.2	189.9	144.2	198.0	22.5	179.2	205.6	236.8	306.8	99.6	60.1	279.3	430.3	436.9	267.4	202.9	292.4	25.0	585.4	164.2	429.9	841.2	286.0	157.4	199.8	146.9	175.6	351.5	208.9	12.9	301.6	595.6	224.3	114.7	137.6	213.0	135.5	272.7	735.4	423.7	50.5	16.6	477.0	207.5	347.7	234.1	452.4	194.8	197.7	286.4	14.0	403.3	198.0	220.4	5.5	31.2	287.1	446.6	167.3	208.5	283.5	606.9	1107.9	176.7	89.6	118.3	174.3	210.0	97.2	91.8	162.5	243.5	593.4	156.9	159.0	451.1	241.3
NDUFA9	"CI-39k, COQ11, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 617.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042268, HPA073212"	Supported		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (5.75e-4)"	19.6	29.2	25.6	14.8	26.5	35.3	19.1	29.1	38.5	18.4	29.5	41.1	30.6	20.4	14.7	30.9	17.5	6.1	116.7	26.1	25.7	43.4	49.4	18.0	11.8	26.0	25.5	14.7	24.2	34.2	21.9	10.2	26.7	21.4	31.2	20.1	24.3	11.1	110.3	24.1	31.0	12.7	25.7	23.7	31.6	14.3	26.4	18.1	19.3	110.6	14.5	21.2	19.8	27.0	29.8	52.5	25.3	33.9	18.3	18.1	73.1	22.1	22.4	41.9	31.6	114.4	58.0	33.2	11.6	24.2	47.5	48.9	37.1	32.9	27.0	64.8	65.3	32.5	51.0	88.1	40.0	48.0	33.8	23.3	31.2	28.7	38.6	26.0	32.0	46.8	23.1	60.8	31.5	57.6	48.5	55.1	65.5	55.6	43.2	67.4	37.5	34.5	59.2	66.6	18.2	20.6	27.9	74.4	41.9	54.4	15.4	45.4	22.2	31.8	64.7	29.3	52.3	11.9	15.1	57.1	33.2	29.4	35.7	75.9	134.3	53.3	99.2	165.1	102.1	148.3	102.4	109.3	161.9	110.0	88.9	91.1	11.8	107.5	133.5	168.0	143.6	265.0	25.6	26.5	29.1	38.5	26.1	25.7	26.0	25.5	26.7	25.7	26.4	27.0	37.5	28.9	32.1	26.1	45.2	48.6	63.7	199.3	21.6	48.6	40.1	37.0	185.1	45.8	99.4	64.4	58.4	111.1	45.7	89.4	166.3	130.0	112.2	29.3	29.6	46.4	47.4	36.0	21.0	131.3	118.7	38.5	35.2	26.0	57.7	36.6	34.6	78.5	114.7	33.7	26.3	125.4	140.4	35.6	31.8	617.2	28.3	41.8	55.2	15.9	60.0	48.2	49.4	27.2	20.1	108.0	83.5	36.9	50.8	40.5	108.5	163.2	74.9	67.8	19.7	32.0	54.8	30.6	31.3	38.5	47.2	99.9	43.4	66.3	147.7	69.4
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 876.5;Proximal tubular cells: 881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	152.6	199.3	431.2	103.4	439.3	171.5	135.8	427.1	606.3	127.3	416.7	237.8	161.0	145.8	163.0	170.2	132.4	88.0	482.4	444.8	441.9	249.9	262.0	108.6	132.0	438.5	439.4	130.4	115.5	331.0	186.7	83.0	441.9	132.2	145.0	127.1	163.6	135.8	408.9	128.2	147.8	125.5	411.8	133.3	201.0	66.2	442.5	140.6	130.1	512.8	119.9	162.9	132.9	448.3	250.2	419.6	222.3	383.1	159.6	158.8	238.5	168.1	370.9	259.3	278.8	575.4	278.1	260.7	146.4	185.6	189.1	289.5	162.9	269.7	194.5	172.9	417.8	183.9	350.3	465.7	217.6	379.3	302.6	191.6	240.7	249.2	329.3	180.4	283.7	361.1	194.5	159.3	218.4	304.1	369.7	472.9	144.7	324.3	377.9	252.4	237.6	346.1	298.8	281.3	147.9	209.7	122.0	227.4	250.9	147.3	338.2	332.8	185.5	139.5	158.7	151.5	296.8	288.4	286.4	334.8	277.6	398.2	159.3	299.4	530.8	478.1	406.0	558.8	483.1	616.1	498.0	468.1	589.7	546.7	538.1	514.0	122.7	478.0	489.6	655.0	817.6	1113.4	431.2	439.3	427.1	606.3	444.8	441.9	438.5	439.4	441.9	411.8	442.5	448.3	184.8	76.9	132.7	41.8	107.6	0.0	187.1	0.0	12.5	186.4	162.2	210.2	392.9	204.5	48.3	198.6	58.4	333.1	175.8	109.0	876.5	268.1	24.9	105.8	86.3	142.7	105.6	114.3	72.6	264.7	305.1	128.8	35.2	87.1	109.7	112.0	153.8	346.5	399.1	153.1	82.6	171.6	0.0	184.4	0.0	56.0	218.1	142.2	0.0	33.7	231.0	219.5	158.6	40.2	62.3	250.6	191.7	217.4	59.3	203.2	560.2	881.6	85.2	183.5	170.9	117.2	176.0	85.5	83.1	31.5	0.0	307.7	112.9	225.5	237.6	221.5
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068297-78079862	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	202.3	278.0	118.8	84.5	126.1	126.1	143.0	128.7	150.7	103.0	125.6	143.6	218.4	125.3	68.4	142.6	120.2	108.6	240.7	129.0	145.8	151.1	286.8	100.0	109.1	121.6	117.1	96.2	168.8	186.1	133.5	74.8	124.2	88.7	66.1	59.8	275.1	83.2	487.6	121.9	194.3	63.6	136.8	96.2	130.0	103.0	126.1	73.5	207.0	254.0	62.8	97.1	100.1	136.3	287.6	342.2	183.3	118.8	168.3	105.6	227.2	335.7	190.9	252.4	179.9	910.4	311.8	166.3	583.3	155.8	210.2	293.1	136.1	190.9	99.5	318.8	386.7	183.8	337.4	727.9	270.9	409.7	164.2	147.9	177.8	195.6	75.2	156.0	172.9	158.8	365.3	278.4	137.9	478.7	254.5	722.4	212.4	670.4	415.6	224.5	352.5	570.5	196.4	420.7	261.2	229.0	235.0	499.5	182.3	158.8	391.4	328.2	241.0	256.4	314.9	611.8	297.9	251.5	541.9	400.4	146.4	236.6	251.0	374.5	337.6	354.0	150.1	293.0	138.3	230.8	172.4	163.4	363.5	212.1	144.5	159.8	102.2	225.4	243.0	290.4	202.7	410.9	118.8	126.1	128.7	150.7	129.0	145.8	121.6	117.1	124.2	136.8	126.1	136.3	256.6	166.7	194.7	0.0	106.4	95.5	166.1	443.7	40.5	145.8	346.2	414.0	240.9	243.1	288.2	391.8	66.7	408.8	166.4	206.3	305.2	395.6	311.8	413.8	129.3	183.7	167.9	106.5	0.0	431.5	392.8	165.7	43.3	241.7	153.2	158.1	184.9	856.9	346.2	90.9	0.0	317.9	429.3	174.5	110.7	84.7	215.6	129.4	245.5	0.0	246.7	310.0	175.1	0.0	0.0	456.5	329.1	201.6	102.5	239.0	461.8	454.6	300.0	131.6	236.7	154.5	222.7	384.4	162.1	67.5	114.4	387.1	109.9	226.3	373.2	215.6
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 292.3"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 405.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004484, CAB034894"	Enhanced		Supported	"Nuclear bodies,Mitochondria"		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nuclear bodies"	"CAB034894: AB_2151118, HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	52.4	91.3	47.4	16.5	52.6	44.1	50.7	55.6	50.2	43.5	59.4	97.5	53.8	49.7	26.2	78.7	42.6	18.1	210.3	49.3	51.9	94.2	96.2	40.5	25.5	48.8	49.3	37.3	56.7	53.6	67.5	17.6	49.4	44.0	52.7	23.5	60.9	27.5	292.3	66.2	69.4	26.6	50.3	55.5	81.4	48.2	54.7	33.8	49.7	194.2	33.3	51.4	52.0	47.7	37.7	68.7	59.8	62.9	48.8	52.3	48.2	35.0	60.3	84.6	80.4	103.6	65.1	81.8	34.8	49.7	63.0	64.9	81.7	61.8	69.4	44.2	137.2	49.5	90.6	106.5	49.7	121.5	62.1	50.1	46.6	32.0	52.2	37.5	55.3	69.2	73.7	57.1	57.7	118.6	87.0	164.9	83.6	109.6	97.7	100.7	81.8	68.7	76.4	60.2	63.9	47.1	43.4	76.9	83.5	35.2	84.4	118.2	37.0	49.3	56.4	57.0	80.4	61.2	93.5	91.8	50.1	94.9	51.3	38.3	69.3	48.9	43.2	79.8	46.4	60.6	45.2	47.5	83.3	59.2	42.4	46.0	18.4	45.6	66.7	89.3	61.3	90.3	47.4	52.6	55.6	50.2	49.3	51.9	48.8	49.3	49.4	50.3	54.7	47.7	54.7	54.5	42.6	23.5	54.6	65.6	67.4	217.5	62.6	45.6	60.2	72.5	176.9	81.5	108.5	69.9	41.7	122.0	70.8	183.1	405.0	113.0	132.3	56.8	58.6	60.0	84.7	73.8	12.7	111.3	116.5	60.8	81.1	40.5	57.7	67.1	58.5	126.3	195.9	60.6	14.5	162.8	173.0	66.9	59.3	63.2	67.4	62.8	119.2	7.5	83.9	117.9	58.7	12.5	13.1	91.7	109.3	69.2	69.8	53.0	257.8	297.0	109.7	59.5	105.2	55.5	154.8	85.5	74.7	115.3	75.9	89.1	55.5	128.3	210.7	85.3
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801407-1816048	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 615.4"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 972.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1796.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA064221: AB_2685217"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	110.8	84.1	111.5	83.9	111.9	116.4	51.0	116.6	146.9	44.8	117.4	123.2	146.4	48.4	51.9	79.8	50.2	38.9	265.4	110.3	123.2	96.0	116.5	51.8	75.2	116.1	114.2	42.4	107.7	122.5	40.9	57.2	115.3	70.8	68.1	49.3	110.9	57.3	615.4	69.8	115.4	51.5	110.4	71.2	106.5	56.5	115.5	70.4	51.1	304.4	61.6	58.1	41.9	115.2	241.2	487.3	206.4	310.5	81.7	74.9	483.3	180.6	108.8	161.7	139.8	556.8	291.0	344.0	531.4	117.6	261.5	247.6	174.3	221.5	91.9	404.3	576.4	250.4	1796.7	476.9	155.0	320.8	230.0	106.8	157.4	136.0	103.7	85.0	158.6	226.8	344.6	314.2	181.6	607.0	433.4	679.5	218.8	355.9	678.9	345.0	211.5	477.9	162.9	388.6	237.1	213.7	638.5	507.5	275.2	110.3	341.1	403.3	206.2	221.6	386.0	201.5	355.1	283.2	512.4	443.0	250.5	511.4	243.6	239.5	283.7	233.5	207.5	342.7	207.9	246.2	213.6	209.2	349.1	197.9	177.9	196.9	124.8	218.9	307.5	347.1	261.1	261.5	111.5	111.9	116.6	146.9	110.3	123.2	116.1	114.2	115.3	110.4	115.5	115.2	166.4	67.3	107.6	12.7	129.7	125.5	153.6	328.8	82.6	95.5	164.5	206.0	698.3	198.8	164.8	207.8	47.9	358.0	142.9	574.7	972.4	270.1	246.9	165.2	132.4	155.6	267.1	162.0	10.6	341.5	246.0	146.8	170.2	133.5	104.7	163.1	153.8	526.3	413.9	65.6	11.3	468.0	236.0	224.6	167.8	308.1	154.7	162.9	218.7	12.2	239.8	208.5	178.2	9.5	20.1	296.2	447.5	157.2	178.7	186.2	615.8	868.5	158.8	166.9	164.3	147.0	188.1	288.0	159.1	227.7	167.5	245.2	124.7	200.4	480.7	219.2
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 665.9"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Proximal tubular cells: 774.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (7.36e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	52.9	51.3	78.2	31.2	96.8	33.8	33.8	116.0	120.6	32.1	86.6	50.0	104.2	31.2	5.2	62.2	28.8	17.6	170.7	72.6	92.3	67.9	68.2	30.2	36.7	103.6	85.5	31.7	89.6	43.9	50.2	19.9	108.2	34.1	9.8	5.7	75.6	26.3	665.9	37.9	73.8	10.5	95.6	41.8	53.0	58.9	88.5	19.3	32.1	159.4	11.4	36.7	37.7	120.2	127.0	109.3	17.5	77.6	16.0	20.3	68.8	52.0	19.3	39.4	39.0	155.3	52.8	146.2	71.4	13.0	9.7	85.4	17.3	44.1	1.0	157.6	143.2	47.0	113.1	125.7	53.4	76.5	90.1	27.2	47.4	17.7	0.0	13.2	40.2	110.5	103.1	196.6	13.6	130.0	138.6	77.0	67.5	40.8	141.0	144.6	36.3	254.9	23.6	86.9	105.7	89.5	48.5	117.8	158.6	2.1	84.0	118.1	72.3	67.3	49.5	85.5	100.0	326.9	218.4	121.5	110.9	159.0	70.4	176.5	299.0	143.8	166.6	342.4	147.5	249.4	161.6	159.7	354.9	235.6	151.8	146.9	75.6	160.6	308.0	276.8	241.8	193.2	78.2	96.8	116.0	120.6	72.6	92.3	103.6	85.5	108.2	95.6	88.5	120.2	98.5	80.1	92.5	14.0	117.7	89.9	98.4	275.0	100.2	74.3	116.7	146.0	77.1	158.7	167.0	145.3	50.1	225.2	75.0	482.1	812.0	161.8	443.2	69.2	74.2	88.4	175.4	94.9	13.8	163.3	197.1	92.2	162.1	66.2	111.7	99.4	72.5	243.9	333.4	52.2	15.1	332.9	248.2	188.4	129.7	414.5	83.9	154.6	261.5	7.5	182.1	111.2	111.2	14.6	57.0	121.1	346.7	74.1	155.2	81.0	616.5	774.9	122.4	81.9	72.3	105.0	120.2	268.8	134.9	266.2	106.0	186.8	100.9	128.8	410.8	138.7
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	20.5	18.1	9.2	3.2	9.3	6.8	17.5	9.5	8.9	16.6	7.5	24.2	5.1	19.1	7.9	18.9	17.3	2.4	47.2	7.6	8.0	18.0	26.9	13.7	3.1	9.5	9.7	19.1	24.0	7.5	16.6	3.0	9.2	16.3	4.1	7.7	17.3	4.0	88.0	19.0	16.1	3.6	8.4	17.0	19.7	20.9	9.2	2.5	14.9	21.1	3.2	18.4	15.9	10.1	3.3	4.9	9.1	8.1	7.9	5.0	10.4	6.6	4.2	5.2	3.4	10.6	6.2	4.9	4.2	4.1	11.7	5.4	8.8	8.1	3.5	2.8	7.4	20.1	8.7	9.0	9.4	6.0	7.8	8.0	8.2	6.9	12.0	4.2	6.1	5.6	13.5	7.3	5.6	10.5	3.7	6.2	10.2	15.7	6.9	4.6	5.3	12.3	9.5	7.5	5.8	4.7	9.0	10.3	4.8	4.4	10.2	4.6	8.9	3.2	3.0	4.4	4.8	12.1	7.1	3.5	5.7	7.7	4.6	3.1	5.7	3.8	2.8	7.1	2.4	2.9	2.4	2.2	5.0	3.5	2.9	2.8	3.3	4.4	6.6	4.4	2.7	2.8	9.2	9.3	9.5	8.9	7.6	8.0	9.5	9.7	9.2	8.4	9.2	10.1	42.8	54.5	46.7	14.4	36.5	19.9	53.7	97.7	24.5	81.2	64.9	65.7	770.8	92.9	58.6	90.1	68.8	57.5	32.5	89.3	230.9	86.5	502.9	84.5	64.9	48.1	78.3	112.4	19.4	101.5	59.5	57.2	55.5	56.9	31.6	45.5	68.2	334.5	114.4	57.2	22.1	114.8	87.5	88.3	38.1	1712.0	66.5	62.3	37.4	17.8	86.4	88.7	49.4	15.6	19.5	98.6	80.9	62.4	39.0	109.3	176.4	372.6	85.9	104.7	72.3	54.0	66.1	243.5	77.1	50.0	23.4	89.9	29.9	83.8	95.4	65.3
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	69	"skeletal muscle: 9300.2;tongue: 2495.6"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 662.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8"	"Group enriched"	"Detected in some"	6	"cerebellum: 6.5;olfactory bulb: 4.0"	"Region enriched"	"Detected in some"	6	"cerebellum: 11.8"	HPA016601	Enhanced					NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	2.3	6.4	2.2	0.7	5.0	1.3	2.9	4.0	2.6	0.5	1.4	1.3	1.1	0.6	1.6	16.2	0.5	12.7	40.7	2.2	5.4	3.3	4.9	2.3	1.3	2.9	2.9	0.9	2.0	0.1	2.6	0.8	2.4	22.1	0.1	3.5	85.9	0.2	9300.2	9.3	1.8	0.2	2.0	3.0	1.1	1.7	2.9	1.1	13.0	2495.6	0.8	0.4	1.2	2.9	0.5	0.5	0.8	0.7	0.1	0.1	2.3	0.4	0.0	0.0	0.0	6.1	0.7	1.7	1.2	0.1	0.2	1.2	0.1	0.0	0.0	0.8	0.9	0.6	1.1	2.0	0.0	1.1	1.5	5.0	0.3	0.1	0.0	0.3	0.8	0.5	1.2	8.8	0.5	0.7	0.6	1.1	1.4	3.0	1.0	1.6	34.3	0.2	0.1	1.2	2.0	0.3	0.3	0.4	0.2	1.3	0.9	1.1	0.8	0.9	1.2	0.1	1.2	12.8	2.0	0.4	0.2	0.8	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.2	5.0	4.0	2.6	2.2	5.4	2.9	2.9	2.4	2.0	2.9	2.9	0.3	0.0	1.1	14.0	2.0	0.8	1.2	0.2	2.8	2.4	0.5	0.4	82.6	18.6	0.7	0.0	0.0	0.5	1.2	0.0	0.0	0.5	7.6	1.4	1.5	2.1	1.8	0.0	13.1	0.0	0.4	10.6	2.0	2.5	1.3	2.2	0.7	2.4	0.7	3.3	9.2	0.0	4.1	1.3	0.7	7.6	0.6	2.7	0.0	7.5	0.2	0.4	0.0	6.0	5.2	0.1	0.0	0.0	2.0	1.1	0.3	0.4	0.1	1.7	0.0	662.8	1.9	1.4	1.6	0.2	1.3	0.8	1.1	1.5	0.0	0.2
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729200	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 128.8;skin 1: 134.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	NA	NA		180000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	4.4	4.0	14.8	4.7	25.6	24.3	8.2	17.4	32.3	14.0	0.0	12.4	16.6	3.4	2.3	128.8	4.0	3.4	8.1	30.5	15.3	5.1	4.3	3.4	2.1	23.8	26.5	2.3	18.8	2.7	7.8	7.3	18.4	12.8	12.9	18.5	18.0	6.2	1.9	134.4	12.0	4.5	16.3	3.3	4.6	1.3	26.9	6.7	2.2	1.6	27.9	28.9	36.8	38.8	16.6	13.6	12.6	18.2	6.5	2.1	88.2	6.6	6.1	5.4	3.8	28.8	55.2	21.8	26.1	7.6	10.9	229.2	32.5	117.6	2.4	51.8	4.9	3.0	4.4	13.2	2.6	14.9	35.4	2.0	139.2	17.1	62.5	2.1	16.3	6.2	0.6	113.2	7.2	42.7	0.3	9.0	41.6	55.3	18.7	1.2	75.7	26.3	5.1	157.4	30.6	68.6	22.1	57.4	1.8	18.8	52.3	2.2	9.0	4.8	17.6	39.2	5.9	20.6	28.0	0.2	1.7	11.9	11.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	1.6	0.0	0.0	14.8	25.6	17.4	32.3	30.5	15.3	23.8	26.5	18.4	16.3	26.9	38.8	4.2	0.0	3.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	12.1	27.3	0.0	0.0	4.3	1.8	0.0	4.1	4.1	0.0	0.0	8.7	0.0	4.6	3.2	1.3	0.0	0.0	0.0	12.3	1.3	2.1	0.0	10.9	0.0	68.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.5	0.0	0.0	1.9	0.0	0.0	3.3	1.5	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	8.9	1.3	1.7	0.0	0.0
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889223	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 136.6;Ductal cells: 215.6;Exocrine glandular cells: 154.2;Glandular and luminal cells: 126.1;Pancreatic endocrine cells: 241.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 10.4"	"Lineage enhanced"	"Detected in many"		"granulocytes: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"		NA	Yes		5900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	71.4	79.1	30.8	32.1	28.4	15.8	66.0	29.8	34.3	41.7	44.3	42.3	55.3	45.0	58.2	76.3	43.9	52.5	71.3	29.2	33.1	79.6	118.5	72.9	15.8	35.8	33.0	41.7	55.0	61.5	39.1	77.2	32.9	69.2	32.8	16.7	62.6	30.4	20.1	52.5	47.5	31.3	31.8	58.1	75.4	65.8	34.7	6.9	57.4	17.7	25.3	55.8	49.3	28.9	73.8	89.3	118.3	140.6	59.3	35.8	123.7	62.6	83.9	120.4	136.6	194.8	171.0	0.6	79.2	79.0	61.1	98.5	106.6	55.6	91.7	3.2	53.2	43.0	30.8	128.6	145.0	0.7	117.9	64.9	22.5	56.2	44.8	123.2	149.3	3.0	71.1	0.7	59.2	146.4	0.6	5.6	92.8	249.8	27.7	4.3	37.7	3.2	139.5	100.1	5.4	15.2	74.9	127.0	28.7	210.4	97.2	47.1	140.1	31.3	105.5	23.7	48.6	9.0	25.8	0.6	57.3	10.0	83.0	1.8	2.0	10.4	0.0	0.7	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	0.0	0.4	0.3	0.0	0.7	30.8	28.4	29.8	34.3	29.2	33.1	35.8	33.0	32.9	31.8	34.7	28.9	136.6	35.3	31.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	108.4	54.9	0.0	0.0	6.8	58.8	0.0	109.3	2.6	0.0	3.9	215.6	0.0	73.8	66.3	58.8	0.0	0.0	0.0	154.2	97.8	30.4	0.0	126.1	3.8	75.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	80.1	0.0	0.0	0.0	0.0	241.8	0.0	0.0	0.1	0.0	0.0	27.1	3.6	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	101.8	2.2	58.3	0.0	0.0
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913758-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 689.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"HEK 293: 3890.8"									"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA		220000		"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	0.3	19.5	61.1	0.9	27.9	0.0	0.1	150.0	689.9	9.6	0.0	2.8	0.1	4.0	0.0	4.0	5.3	0.2	0.2	57.7	54.0	1.9	0.1	0.2	0.1	610.3	89.1	1.7	2.0	0.0	17.9	0.2	487.1	1.5	0.7	90.8	0.3	27.6	1.7	0.6	1.3	2.5	86.8	0.1	0.9	18.9	430.5	1.7	0.1	0.7	0.5	0.4	6.5	203.6	0.0	0.0	154.3	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3890.8	0.0	0.0	0.0	79.4	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.2	5.9	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.7	32.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	27.9	150.0	689.9	57.7	54.0	610.3	89.1	487.1	86.8	430.5	203.6	3.1	0.0	0.0	12.4	0.0	1.3	0.2	0.1	9.1	30.9	1.1	21.2	2.4	0.0	0.6	0.0	6.2	0.0	3.2	0.1	0.0	0.1	92.6	0.7	19.5	2.9	3.5	0.0	46.6	0.2	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	20.2	17.5	0.0	0.0	0.0	0.7	114.6	0.9	0.7	1.8	13.1	0.0	22.8	0.0	9.5	13.6	0.0	0.0	4.5	0.4	0.3	0.0	0.4	0.0	69.1	0.0	3.3	5.7	43.8	1.0	14.0	0.3	0.0	4.1	0.0	0.1	0.4
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357115	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8"	"Group enriched"	"Detected in many"	11	"B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;HeLa: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	8.0	14.6	2.0	3.1	3.1	4.3	11.6	6.2	5.0	14.7	2.0	9.3	5.8	10.0	1.7	7.3	12.9	3.9	5.8	2.2	1.7	8.8	12.8	8.3	6.1	1.4	0.4	13.3	10.9	3.3	11.0	2.5	0.7	12.4	1.1	2.6	16.6	4.1	9.0	8.9	8.3	1.9	0.0	8.8	10.5	3.7	1.1	2.7	10.7	0.6	3.0	8.2	10.9	2.2	2.2	3.6	2.3	1.4	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.5	2.1	0.2	1.1	6.1	1.4	0.4	0.0	5.7	9.1	2.0	11.8	1.7	0.9	2.1	2.6	0.3	1.7	0.6	0.0	5.6	1.4	1.1	1.4	3.3	0.3	2.9	0.4	6.3	2.1	0.4	0.8	2.1	1.5	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.2	1.2	4.2	3.5	6.3	1.3	2.3	1.8	1.2	5.2	5.5	9.7	1.1	9.4	1.2	0.0	0.6	0.0	5.2	0.3	1.3	4.8	0.9	1.2	0.2	6.4	1.4	1.4	0.8	15.8	0.2	0.3	0.3	1.4	2.0	3.1	6.2	5.0	2.2	1.7	1.4	0.4	0.7	0.0	1.1	2.2	15.9	22.4	19.2	19.9	33.7	6.4	15.4	10.1	23.3	20.0	22.1	15.9	2.9	10.0	21.9	14.7	10.4	10.8	19.1	13.6	1.9	9.0	20.4	31.8	7.3	16.9	21.6	8.0	33.5	8.3	3.6	7.7	22.4	15.4	11.4	105.6	24.3	11.5	3.4	10.1	29.9	20.0	10.2	5.7	7.0	2.6	19.0	3.3	8.8	8.4	1.7	14.6	55.6	5.5	4.5	7.3	16.0	13.5	9.1	9.2	21.4	8.9	41.9	6.5	6.6	6.6	6.4	1.6	1.5	11.0	5.8	4.8	10.0	2.0	14.5	8.7
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708444-52770946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.0"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	6.3	8.2	6.1	7.4	6.7	7.0	9.4	9.1	7.4	8.5	8.6	7.3	6.5	8.7	8.9	6.7	13.6	6.2	6.1	5.9	7.8	9.7	10.8	6.7	8.3	6.8	8.9	13.3	8.1	11.5	7.3	7.6	6.3	7.7	8.2	16.9	7.3	9.0	8.0	3.5	5.6	8.1	6.9	7.2	9.6	46.0	7.8	9.5	13.5	6.1	9.4	7.9	4.9	5.9	19.9	15.2	20.5	16.2	18.2	13.1	22.1	13.9	18.6	25.3	25.4	13.5	14.4	20.4	6.4	13.6	27.9	9.2	25.2	16.3	33.8	20.4	10.6	16.0	18.4	17.3	11.4	39.4	15.4	8.1	14.8	32.5	21.5	13.5	9.6	17.4	20.2	16.1	16.1	17.1	21.4	14.4	17.7	20.9	14.9	18.5	17.8	15.1	14.3	28.3	15.0	9.0	29.1	17.7	14.1	15.7	16.5	23.4	8.9	16.9	17.1	27.3	26.0	17.8	27.9	19.7	19.3	18.2	18.7	13.6	9.8	5.0	3.5	6.1	3.7	2.8	3.0	3.6	5.2	3.5	3.6	3.1	1.4	4.0	4.2	2.6	2.6	5.2	6.1	6.7	9.1	7.4	5.9	7.8	6.8	8.9	6.3	6.9	7.8	5.9	6.2	12.8	8.2	19.2	11.8	4.1	5.3	3.4	4.6	14.1	10.6	6.2	4.6	2.8	11.6	5.5	12.5	7.0	4.8	6.5	9.8	7.0	20.7	24.0	10.6	7.3	4.8	13.3	30.5	9.6	8.1	7.8	12.8	9.9	7.6	14.0	6.8	14.5	8.2	6.7	29.4	9.3	6.1	16.8	4.6	19.5	14.6	10.4	1.8	7.5	14.0	19.4	10.3	16.6	19.3	8.5	2.9	12.4	10.6	5.3	5.4	17.1	22.4	18.9	6.6	12.6	7.3	75.9	27.9	6.9	4.1	6.7	5.8	11.8	9.1	5.2
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	24.2	18.5	6.7	18.6	8.4	11.8	17.3	7.5	7.9	24.3	9.0	14.3	15.5	26.0	10.5	17.8	25.2	17.9	37.2	6.1	7.8	18.4	21.0	18.8	21.0	8.2	7.7	35.8	16.0	34.2	3.1	21.2	7.9	23.5	16.3	16.5	12.4	28.1	43.6	8.1	16.9	32.2	7.5	19.7	13.1	20.4	7.7	28.3	19.7	36.9	23.5	16.3	2.9	9.1	21.3	30.8	44.8	45.4	86.3	88.8	37.9	32.4	54.6	29.7	29.4	25.5	24.7	52.7	0.1	54.2	23.1	31.8	45.0	27.0	38.5	38.2	16.8	23.0	27.3	17.3	48.6	10.8	26.8	76.6	32.8	31.8	26.7	71.6	46.1	36.2	23.8	31.4	40.2	4.8	35.5	11.5	21.9	43.3	18.8	53.5	49.4	23.9	21.3	28.2	19.5	41.3	39.5	19.3	30.0	50.4	41.7	37.6	46.3	30.2	12.7	31.5	15.8	34.3	36.5	49.6	24.9	24.8	26.4	3.4	3.5	3.1	2.5	3.4	4.0	1.3	2.4	2.3	5.0	1.9	3.1	2.8	1.2	3.3	2.5	1.1	1.5	2.9	6.7	8.4	7.5	7.9	6.1	7.8	8.2	7.7	7.9	7.5	7.7	9.1	15.3	12.8	30.2	49.3	21.2	8.8	7.7	6.6	21.1	16.8	14.5	12.4	55.7	12.8	14.8	11.0	35.5	17.4	11.1	10.2	7.9	6.9	11.9	13.3	23.1	17.6	5.4	16.2	31.3	4.9	16.2	18.1	10.7	10.4	16.4	36.8	17.9	30.3	13.9	13.5	35.9	10.7	6.1	18.6	11.8	8.3	24.8	17.0	3.6	30.9	16.0	12.0	15.5	41.2	59.5	5.3	11.7	26.4	14.7	7.4	13.1	8.4	17.4	23.1	0.0	18.9	16.7	28.8	13.9	17.4	10.2	14.0	16.5	20.8	10.5	5.6
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 105.5;choroid plexus: 59.5;fallopian tube: 60.1;retina: 85.2"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Group enriched"	"Detected in many"	15	"amygdala: 48.9;basal ganglia: 60.0;cerebral cortex: 105.5;hippocampal formation: 89.6;white matter: 42.0"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	4.6	16.9	48.9	10.9	60.0	7.3	1.9	1.3	105.5	23.1	59.5	2.0	26.3	2.2	0.4	1.2	60.1	1.9	0.4	89.6	4.5	1.2	1.0	5.0	20.7	0.0	0.0	0.8	0.9	0.2	34.6	0.3	0.0	27.2	2.1	85.2	1.4	2.0	0.3	13.4	15.3	2.8	0.0	6.2	2.9	3.0	0.8	8.7	6.5	0.6	15.7	4.1	4.2	42.0	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	48.9	60.0	1.3	105.5	89.6	4.5	0.0	0.0	0.0	0.0	0.8	42.0	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49852821	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		830000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	16.5	13.8	9.5	18.0	13.0	42.1	14.7	18.1	14.7	16.2	5.9	13.6	10.0	16.2	13.5	22.5	12.2	13.2	17.7	7.9	10.6	14.9	11.9	13.8	17.9	11.8	11.6	15.2	15.2	24.8	10.3	18.2	11.9	16.0	14.5	14.7	14.6	15.8	23.0	14.3	13.6	15.7	10.9	15.5	14.1	10.7	10.7	16.3	18.5	21.5	17.9	18.0	11.6	18.4	34.3	39.2	35.9	24.1	37.3	31.0	32.1	42.0	28.3	27.6	27.3	23.2	35.3	13.3	32.0	35.7	21.2	47.5	34.1	26.7	42.2	38.9	22.7	38.7	40.3	29.1	23.8	50.7	33.4	26.8	19.6	29.9	27.2	36.3	39.8	23.8	47.3	36.2	37.7	30.6	31.2	17.9	21.9	28.6	36.8	32.6	35.5	20.8	33.7	44.8	23.6	22.2	41.6	40.4	39.2	37.2	37.6	31.1	47.2	39.2	34.4	26.6	28.9	24.5	47.6	40.9	14.7	23.9	35.5	76.4	38.9	45.8	45.7	36.9	44.8	83.7	47.1	44.4	33.9	86.7	55.6	59.1	61.3	47.8	54.4	79.7	46.1	20.3	9.5	13.0	18.1	14.7	7.9	10.6	11.8	11.6	11.9	10.9	10.7	18.4	66.2	41.7	76.7	65.3	81.1	34.4	67.4	81.6	29.6	92.1	31.7	43.1	97.2	34.3	74.4	44.1	100.1	85.8	78.4	51.8	37.2	57.0	13.9	52.2	60.1	65.2	54.0	57.0	75.7	39.1	58.1	53.0	41.8	60.7	89.3	68.0	49.6	28.1	58.9	131.2	80.7	48.9	71.2	48.7	57.0	13.1	65.9	57.9	24.9	62.8	79.4	54.8	82.4	56.8	99.5	46.4	68.5	67.4	50.0	66.1	59.4	29.9	82.4	90.0	72.3	65.7	70.7	83.0	58.3	32.5	34.1	108.4	66.9	64.1	54.6	88.6
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432920-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 512.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain				"Secreted to blood"	NA	NA		4000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA026763: AB_1854379, HPA028488: AB_2672638"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	63.9	53.4	132.2	16.8	149.0	26.9	65.7	141.3	188.1	82.8	137.7	53.8	19.8	59.8	70.2	45.9	58.3	23.9	141.0	130.9	138.5	70.0	62.7	45.4	16.4	142.5	142.7	82.7	68.7	64.1	148.1	29.4	143.2	69.4	36.1	22.7	72.4	50.5	95.0	55.6	35.2	44.7	142.7	33.6	47.7	16.7	138.3	23.0	57.6	104.5	25.6	58.0	57.7	156.0	78.8	65.3	26.6	103.2	155.3	116.6	38.9	39.5	94.5	67.5	65.7	74.0	49.8	36.0	29.0	93.0	68.4	49.7	55.1	56.0	55.1	45.7	107.2	26.5	39.9	24.4	59.3	25.1	66.2	83.9	82.5	47.8	40.0	76.1	44.1	54.1	60.2	39.0	60.5	40.2	45.4	95.3	39.0	73.9	137.9	42.1	62.6	50.2	70.3	23.1	43.2	77.5	59.2	89.6	74.0	40.4	70.8	75.2	9.1	54.9	49.0	76.8	73.3	36.2	62.6	26.9	57.5	36.0	43.0	0.9	4.8	2.1	3.9	7.1	6.9	8.1	4.7	8.8	7.8	5.3	6.1	6.2	0.5	0.9	5.0	13.5	5.8	2.5	132.2	149.0	141.3	188.1	130.9	138.5	142.5	142.7	143.2	142.7	138.3	156.0	124.8	12.8	21.6	14.0	72.0	166.2	233.0	10.8	173.6	44.0	322.5	418.5	152.9	163.0	13.4	248.3	12.5	291.4	64.3	101.0	164.4	50.9	5.3	40.7	119.1	87.4	135.8	135.0	11.9	49.0	182.0	219.7	65.7	58.4	47.1	45.7	145.3	211.8	189.3	38.7	12.6	143.7	6.1	149.4	198.1	23.9	297.6	127.2	186.7	11.2	69.2	329.6	34.0	21.6	80.5	32.7	70.7	223.8	136.0	322.9	56.1	512.7	7.6	28.4	118.3	162.1	233.9	13.3	138.5	158.8	170.6	184.4	70.4	61.8	157.0	264.5
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305205	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		390000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	9.6	7.4	28.9	8.9	43.8	1.5	16.7	38.1	31.4	18.2	10.7	46.0	27.3	19.6	9.9	11.5	21.9	19.6	7.8	29.4	29.2	23.4	8.7	15.9	3.9	34.6	38.0	24.8	17.2	41.8	6.7	1.7	35.6	33.0	55.1	19.5	18.3	36.0	30.9	37.5	26.5	23.3	28.7	5.3	22.9	13.5	36.6	7.2	18.2	24.8	6.2	10.5	9.6	60.0	8.9	42.9	50.1	33.2	29.6	8.6	12.5	3.3	4.1	8.2	1.7	6.4	42.8	2.5	4.9	9.4	30.8	1.9	35.3	19.5	3.5	15.8	26.0	29.0	0.5	6.0	8.6	0.8	0.9	21.3	35.4	1.6	16.2	9.5	0.0	22.3	0.2	53.9	2.0	26.8	10.5	0.7	47.9	6.7	3.6	23.9	26.8	5.8	15.8	23.7	22.7	32.1	40.2	17.6	20.7	39.9	18.6	5.3	0.1	38.0	19.9	12.5	9.3	22.8	45.2	6.2	8.2	8.3	10.9	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	28.9	43.8	38.1	31.4	29.4	29.2	34.6	38.0	35.6	28.7	36.6	60.0	3.1	9.6	10.4	231.8	2.3	14.1	8.2	20.7	13.6	15.7	14.2	18.2	6.9	21.5	11.4	22.0	14.6	0.5	4.8	55.6	1.9	11.6	3.3	14.4	13.4	3.4	60.1	3.0	124.5	6.4	0.8	14.6	20.9	24.6	0.0	11.8	5.7	8.9	0.9	10.1	72.8	51.2	10.2	1.2	2.7	7.1	31.7	1.2	10.6	62.8	0.1	12.5	2.1	120.1	439.4	9.9	40.0	62.8	2.6	11.5	39.6	15.5	12.7	21.9	6.6	22.2	10.2	11.8	20.3	14.7	25.4	0.3	6.0	3.1	60.5	7.2
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677407	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 161.6"	"Group enriched"	"Detected in many"	4	"Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5"	"Cancer enhanced"	"Detected in all"		"glioma: 147.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No		100000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	40.0	8.5	24.4	13.8	24.8	0.0	28.2	27.2	22.7	27.1	16.5	16.8	5.3	41.1	12.9	8.2	30.3	11.3	161.6	21.1	26.5	35.2	4.8	42.1	4.8	32.8	27.1	10.1	5.6	10.4	12.8	16.7	25.8	21.2	6.6	8.2	9.7	36.1	55.7	8.6	12.5	30.3	30.0	49.1	10.8	6.2	26.4	2.7	19.9	47.3	2.3	24.2	19.0	30.9	0.2	2.5	627.3	134.7	1.3	33.4	0.6	154.7	120.7	2.3	3.4	102.5	1.9	0.6	35.8	14.9	0.1	2.8	63.9	0.0	1.8	0.0	1.1	0.9	9.7	47.3	5.5	0.3	37.1	28.5	0.0	5.7	0.0	5.3	321.5	0.1	4.9	0.2	512.6	4.3	0.0	0.3	102.3	6.0	88.1	0.7	518.3	0.4	0.6	0.0	1.6	100.4	3.6	4.5	124.9	340.7	1.3	0.9	235.1	0.8	34.5	4.1	8.8	0.2	24.0	0.2	13.4	0.1	247.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.8	27.2	22.7	21.1	26.5	32.8	27.1	25.8	30.0	26.4	30.9	102.2	0.0	4.4	0.0	0.7	2.4	0.4	0.2	0.6	0.5	9.4	32.9	279.9	0.0	0.6	18.4	0.0	0.2	1.0	0.6	0.0	2.1	0.4	2.1	31.9	105.5	0.0	0.0	0.3	0.0	1.9	29.4	0.5	2.7	0.0	0.2	26.7	0.1	1.8	0.0	0.6	0.2	0.0	0.8	3.1	0.1	8.1	1.7	1.8	12.2	1.0	17.4	0.0	3.0	2.2	0.3	0.1	4.1	0.1	0.5	0.0	0.1	0.0	1.5	105.2	10.9	70.5	0.5	5.0	1.2	2.4	0.1	1.1	1.4	0.3	0.5
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412557-5459056	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 242.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 252.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	48.8	10.8	35.5	23.4	34.2	40.5	52.8	38.5	57.6	43.7	52.8	92.2	56.2	41.8	56.2	68.4	46.2	35.9	13.2	30.2	32.4	49.3	45.1	22.2	26.7	41.8	37.2	28.5	37.9	5.4	10.6	65.7	43.8	41.3	88.2	6.5	93.1	24.3	25.0	39.8	74.7	36.9	37.5	8.1	77.8	14.4	41.1	30.4	26.2	28.0	33.0	60.8	59.3	40.1	115.9	67.7	45.2	51.0	26.8	11.9	252.9	69.1	37.6	53.4	50.4	36.4	215.2	40.6	27.7	42.4	11.4	185.5	54.9	104.3	63.9	38.1	38.5	77.5	22.9	84.0	7.2	21.5	31.1	18.2	61.0	54.0	12.3	47.6	31.1	42.6	138.5	64.4	30.0	54.3	74.3	30.6	61.5	158.6	51.0	45.0	85.0	32.4	33.4	57.6	38.5	20.6	60.7	110.9	20.3	76.2	36.7	65.3	29.5	20.3	30.9	30.7	56.0	39.3	23.1	53.4	18.1	33.1	43.4	2.0	0.6	1.4	0.6	1.0	0.0	1.4	1.2	0.4	4.9	0.6	8.7	1.7	0.1	0.8	0.4	2.0	4.0	2.2	35.5	34.2	38.5	57.6	30.2	32.4	41.8	37.2	43.8	37.5	41.1	40.1	18.4	32.1	55.8	2.6	12.7	40.3	127.2	49.0	103.0	11.0	52.6	28.3	12.1	41.5	84.3	12.9	4.2	110.2	8.4	242.2	5.9	13.1	2.4	97.7	30.6	42.7	80.8	54.1	5.1	24.4	109.1	33.2	107.0	131.4	15.2	16.9	12.5	55.7	14.5	3.3	7.7	145.3	34.6	10.5	59.8	2.4	21.8	31.2	35.6	44.0	48.7	3.8	0.0	8.5	5.7	62.1	148.3	87.6	39.2	67.8	123.6	29.2	85.7	3.5	111.7	183.0	185.0	26.3	16.0	158.1	32.4	117.5	9.3	2.9	145.0	186.5
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535964	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Bipolar cells: 9.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA						"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573422	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 5.4;intestine: 2.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Group enriched"	"Detected in some"	20	"cerebral cortex: 4.5;hippocampal formation: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"THP-1: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 254.0;Excitatory neurons: 325.3;Inhibitory neurons: 412.5;Oligodendrocyte precursor cells: 428.2;Oligodendrocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA045502: AB_2679352"	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	7.4	8.4	8.9	7.1	10.7	3.4	11.5	13.2	12.2	10.0	1.6	8.5	6.8	10.2	10.0	6.1	9.0	8.0	11.3	9.7	11.7	12.0	9.4	7.3	7.7	11.7	9.2	13.5	10.4	15.9	7.8	12.4	9.1	9.5	8.8	20.9	9.1	9.5	8.1	7.4	7.5	8.7	8.2	7.1	8.2	10.0	11.8	13.5	19.5	10.6	7.8	10.4	6.8	14.4	15.8	20.3	24.2	13.1	20.1	25.8	12.2	13.4	24.1	19.5	21.8	18.4	10.5	15.2	3.8	25.1	22.9	26.8	22.2	18.7	32.6	7.5	14.1	13.4	18.8	9.5	14.2	24.4	10.6	20.7	11.8	20.8	25.1	21.8	9.5	15.7	19.8	14.8	18.8	12.4	20.4	8.8	7.1	9.7	6.8	15.8	36.8	12.3	14.7	22.5	10.0	14.9	25.4	8.3	13.8	16.8	25.0	15.3	14.1	15.3	21.5	18.8	5.1	13.2	6.9	16.3	12.6	10.0	16.2	4.4	0.3	0.6	1.5	0.1	1.0	1.4	2.8	2.5	0.4	1.2	2.0	2.0	0.7	0.7	0.3	0.4	5.9	0.6	8.9	10.7	13.2	12.2	9.7	11.7	11.7	9.2	9.1	8.2	11.8	14.4	30.9	32.1	31.1	254.0	18.3	38.6	48.1	38.9	31.9	62.7	33.7	24.9	43.9	41.5	29.8	40.5	137.6	57.5	23.8	37.8	23.5	27.1	210.4	27.4	39.4	35.8	19.8	9.7	325.3	22.5	26.6	39.1	39.3	45.8	10.8	44.0	33.2	35.7	22.5	70.7	412.5	24.3	38.7	27.6	34.1	94.6	37.3	28.2	21.4	215.5	20.9	47.5	21.6	428.2	317.4	33.3	43.0	50.4	30.8	54.2	32.1	28.6	36.9	62.8	46.0	51.9	43.3	30.5	28.7	19.8	34.0	49.3	19.8	36.1	27.4	64.5
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.1;Late spermatids: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	8.8	13.6	19.7	8.4	17.2	8.0	7.6	13.6	28.7	8.9	10.7	10.8	6.2	11.1	6.2	13.4	8.6	5.3	21.4	27.3	13.9	17.2	10.5	9.3	6.4	14.4	18.1	8.5	12.7	27.4	9.5	4.6	14.3	9.9	5.4	7.3	8.5	6.7	22.8	10.2	8.8	8.0	14.3	9.9	10.0	20.9	17.6	9.3	11.1	19.1	7.1	9.3	7.7	16.6	75.8	36.7	12.2	74.3	21.5	22.0	7.7	57.3	37.9	74.1	53.7	32.7	18.4	21.1	50.4	69.9	48.9	27.1	25.1	37.8	52.0	31.9	12.5	26.8	24.4	26.4	22.4	35.1	28.6	20.1	16.4	53.3	51.0	21.8	47.7	13.7	12.0	18.7	64.5	35.1	21.4	16.6	8.3	16.9	20.4	24.2	56.8	18.8	68.5	37.3	17.0	11.6	36.0	24.5	14.0	9.4	14.9	15.4	92.7	101.1	109.6	44.8	112.5	30.0	26.7	25.5	27.0	14.5	68.5	10.0	10.0	4.2	15.5	14.7	13.1	8.3	11.5	10.4	15.1	8.6	9.7	9.2	2.3	13.2	21.0	10.2	10.7	12.2	19.7	17.2	13.6	28.7	27.3	13.9	14.4	18.1	14.3	14.3	17.6	16.6	8.1	6.4	20.1	14.7	9.4	14.1	11.6	9.8	8.6	16.3	14.5	9.0	23.1	18.6	10.0	14.7	10.4	11.7	12.7	9.0	21.5	40.0	77.1	14.5	17.7	13.2	13.1	13.9	27.5	24.9	6.7	12.5	7.7	15.2	22.9	12.2	11.7	14.4	13.5	30.3	27.1	7.9	6.1	14.7	7.5	121.4	7.2	10.2	8.8	18.7	8.6	19.1	14.4	17.6	16.7	40.1	14.5	12.4	14.7	13.6	10.5	30.1	8.6	9.6	6.6	13.7	15.6	29.5	8.1	15.5	14.3	3.8	12.9	17.4	11.2	9.5
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.0;Excitatory neurons: 148.4;Horizontal cells: 220.4;Inhibitory neurons: 139.0;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 226.6;Rod photoreceptor cells: 195.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 27.6;fHDF/TERT166: 50.3;hTERT-RPE1: 24.0;SCLC-21H: 22.8;U-138 MG: 62.7;U-87 MG: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced					NA	NA		2200000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	5.2	7.5	7.8	3.7	31.5	0.1	3.2	8.4	15.2	5.0	0.0	8.6	4.5	8.3	9.0	10.0	12.1	5.9	15.3	10.7	5.6	9.8	1.9	5.0	2.3	13.1	14.1	10.1	5.9	1.0	5.6	10.6	7.8	7.5	5.9	22.6	2.1	16.3	3.0	4.3	5.0	14.2	3.9	6.5	4.4	1.5	35.6	0.6	2.9	3.8	2.9	9.4	7.7	50.1	0.0	0.1	3.1	0.1	0.4	1.0	0.1	27.6	0.0	19.9	5.9	0.2	0.1	0.0	0.1	50.3	18.5	13.4	0.6	0.8	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	12.7	0.7	24.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	7.0	0.9	0.3	0.0	2.3	0.0	0.0	0.0	22.8	1.3	0.0	1.5	0.0	2.0	0.3	0.0	0.0	62.7	13.5	0.1	0.0	0.0	0.0	0.0	31.3	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	31.5	8.4	15.2	10.7	5.6	13.1	14.1	7.8	3.9	35.6	50.1	2.5	0.0	0.6	64.3	0.0	2.2	1.5	1.9	0.6	151.0	1.7	10.5	23.9	1.5	1.5	0.0	12.5	0.5	0.0	0.3	0.0	0.2	7.3	0.5	0.4	7.6	37.8	0.0	148.4	0.0	0.5	14.2	1.1	0.1	0.0	0.1	3.3	1.7	0.4	220.4	139.0	6.0	0.0	0.6	1.9	17.9	6.5	0.4	1.8	15.0	0.0	14.2	0.0	87.9	226.6	0.5	0.5	5.7	0.0	1.1	0.0	1.5	5.9	195.5	52.6	2.3	49.9	1.7	3.9	5.5	4.7	0.7	0.3	0.7	1.0	0.8
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152198-26187137	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 34.4"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 305.9;Syncytiotrophoblasts: 698.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 133.5;NTERA-2: 113.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.6	3.1	4.2	10.6	7.3	2.5	2.2	19.5	19.7	1.5	2.3	6.3	8.0	2.2	0.2	2.4	1.6	4.3	1.4	6.3	4.8	2.5	1.6	4.8	8.0	7.0	4.6	1.1	4.8	0.4	1.3	34.4	7.2	1.4	4.8	5.1	3.2	0.6	2.7	7.3	5.7	1.0	5.1	7.6	7.3	1.4	6.3	5.9	1.0	0.2	7.0	4.8	1.5	10.8	40.9	3.5	1.6	4.0	0.0	0.0	133.5	7.9	15.2	15.0	27.3	26.2	68.8	3.0	51.2	0.8	57.5	8.6	6.0	13.4	33.7	27.9	8.5	5.7	7.0	19.8	10.5	5.0	52.3	1.3	1.6	6.2	2.3	22.4	35.0	11.3	8.6	69.9	3.0	5.5	3.5	8.8	113.9	11.1	13.9	5.0	0.4	20.5	20.5	40.5	12.3	14.7	0.2	3.2	1.2	37.5	1.9	3.0	76.0	1.4	2.3	0.6	32.6	42.0	72.2	3.4	0.2	17.5	53.1	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.4	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.0	0.2	0.6	0.1	4.2	7.3	19.5	19.7	6.3	4.8	7.0	4.6	7.2	5.1	6.3	10.8	14.6	6.4	2.8	3.9	4.6	1.8	4.2	12.7	5.2	1.4	3.1	2.3	1.9	14.3	6.9	11.0	0.0	305.9	1.6	6.1	0.0	13.0	1.0	6.1	1.8	7.6	1.2	12.0	3.8	5.3	33.9	2.8	14.3	6.4	27.9	35.2	2.2	0.3	24.3	0.0	4.4	6.6	12.2	15.6	17.2	0.3	0.0	16.7	1.8	2.8	11.1	1.1	4.1	1.5	11.6	15.6	4.1	0.0	18.2	10.4	2.7	0.5	8.9	1.9	0.0	2.9	2.7	0.6	7.1	5.5	1.6	698.6	9.0	4.8	9.8	6.7
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285904-115338770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 20.8;ovary: 18.9"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 15.7;Leydig cells: 29.2;Sertoli cells: 118.3;Smooth muscle cells: 51.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 87.9;BJ hTERT+ SV40 Large T+: 30.1;GAMG: 46.2;hTEC/SVTERT24-B: 29.8;hTERT-RPE1: 49.0;U-2197: 60.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"	NA	NA	40000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	13.9	2.5	1.7	1.6	1.7	0.0	4.0	1.3	2.1	7.1	2.1	5.0	0.1	8.8	1.4	1.1	13.2	1.7	20.8	1.6	2.2	6.4	4.0	1.6	0.5	1.9	1.7	18.9	0.8	0.4	2.7	1.1	1.9	2.6	0.6	0.1	2.1	1.0	0.9	0.9	2.1	4.0	1.4	3.7	2.1	1.1	1.9	0.2	3.3	1.1	0.1	5.5	5.0	1.6	0.0	0.3	0.0	0.0	1.8	0.1	0.0	87.9	9.9	30.1	21.9	0.0	0.0	0.0	1.9	21.1	46.2	3.6	0.0	0.6	13.8	0.0	0.2	0.0	0.6	0.0	12.1	0.0	0.0	0.1	0.6	29.8	21.6	49.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	3.0	0.0	1.3	0.0	1.2	0.0	0.0	0.0	1.1	0.3	1.6	0.6	0.0	3.9	0.0	0.0	0.8	1.8	3.7	60.0	3.5	0.0	0.0	0.0	3.6	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.3	2.1	1.6	2.2	1.9	1.7	1.9	1.4	1.9	1.6	0.4	0.0	0.0	0.3	0.0	3.1	0.5	3.9	0.0	0.0	0.1	1.5	0.7	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	5.6	0.2	0.2	0.8	0.8	0.0	0.0	0.3	0.0	1.3	7.3	0.0	0.3	0.0	0.0	4.2	0.0	0.1	0.0	15.7	0.0	2.0	0.0	1.7	0.4	29.2	0.2	1.8	1.9	0.0	0.0	0.0	12.1	0.5	0.1	0.0	6.0	0.0	0.6	0.0	0.0	0.1	0.0	118.3	0.8	51.6	0.3	1.0	0.0	2.3	2.5	0.6	0.0	0.0	0.3
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	3.2	4.1	2.9	1.3	2.4	0.4	2.8	0.0	4.2	6.1	6.8	4.1	0.8	4.8	2.8	1.8	2.7	1.6	0.9	1.8	2.5	5.1	0.2	1.1	0.5	3.3	2.8	3.5	0.5	0.3	2.8	2.6	3.0	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	1.7	1.0	2.2	2.5	3.8	2.2	2.6	0.7	0.5	4.0	3.7	0.9	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	2.9	2.4	0.0	4.2	1.8	2.5	3.3	2.8	3.0	1.7	3.8	0.9	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NIBAN2	"bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Niban apoptosis regulator 2"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 606.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	48.7	107.5	26.7	36.6	24.7	27.3	42.0	25.2	24.5	96.0	45.3	74.6	50.8	38.9	12.6	606.7	39.4	39.6	39.4	22.7	35.0	72.3	16.7	121.9	6.6	48.9	34.3	31.6	142.6	26.2	34.0	84.8	36.3	66.5	30.3	2.7	142.1	32.2	13.6	111.3	53.9	22.0	39.7	32.2	83.3	11.0	34.7	5.6	110.6	11.3	53.6	68.4	189.6	31.9	134.0	149.8	29.9	39.3	87.9	170.1	138.2	259.1	238.5	140.1	86.4	48.2	143.7	0.4	100.4	295.5	172.9	217.5	25.9	192.2	45.9	25.2	27.5	22.8	218.9	50.4	173.1	1.0	62.0	187.3	118.3	231.4	80.8	256.8	213.6	8.4	43.5	1.2	269.8	157.3	1.6	37.6	30.9	228.0	194.4	16.0	99.9	70.1	120.5	105.6	47.4	22.1	212.3	149.0	93.4	42.1	98.2	7.5	279.9	143.1	62.4	182.2	218.0	2.5	5.1	0.6	403.3	21.6	271.1	0.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	26.7	24.7	25.2	24.5	22.7	35.0	48.9	34.3	36.3	39.7	34.7	31.9	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	73.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	40.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	120.9	0.1	0.0	0.0	0.0
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065109	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 230.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 362.9;Fibroblasts: 137.6;Hepatic stellate cells: 191.3;Leydig cells: 177.3;Peritubular cells: 125.6;Sertoli cells: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"classical monocyte: 5.7;intermediate monocyte: 11.2;myeloid DC: 4.4;non-classical monocyte: 7.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 4.4;monocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1569.3;ASC TERT1: 726.8;HSkMC: 619.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010044	Approved				"Secreted to extracellular matrix"	NA	NA		150000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	110.0	35.5	4.1	30.5	6.8	2.6	88.9	3.4	7.4	78.9	8.8	95.9	21.7	87.6	21.3	26.8	88.1	66.2	53.7	3.8	4.3	28.4	76.9	56.4	12.3	4.2	4.0	77.7	18.3	12.6	10.4	230.9	3.9	33.1	21.3	2.0	17.3	40.2	25.1	24.6	61.0	79.8	3.9	38.0	67.0	6.2	5.3	5.4	27.6	26.9	6.1	62.9	53.4	3.8	1.2	5.3	55.3	0.1	1569.3	726.8	106.2	128.1	105.3	78.0	50.7	30.5	39.8	0.0	25.0	191.2	21.3	4.5	36.3	0.4	45.2	0.2	61.3	8.1	5.9	46.3	295.6	0.0	0.7	619.5	5.3	38.2	1.5	30.3	165.7	0.0	0.0	0.0	26.9	0.0	0.1	0.3	56.9	0.0	6.7	0.0	0.1	0.1	0.0	16.6	0.3	47.0	1.0	0.0	10.2	21.3	0.1	52.1	146.5	67.5	44.8	0.1	57.4	0.1	0.0	0.1	0.8	0.0	105.4	0.2	5.7	0.0	0.0	11.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.1	7.3	0.0	0.0	2.1	4.1	6.8	3.4	7.4	3.8	4.3	4.2	4.0	3.9	3.9	5.3	3.8	48.7	3.2	1.5	18.9	1.7	6.0	1.3	1.5	0.0	0.2	1.2	2.0	24.0	10.0	2.0	0.0	0.0	13.5	0.6	0.0	0.0	0.5	1.4	11.5	362.9	49.4	0.0	5.3	0.6	0.9	10.2	137.6	0.5	9.6	1.3	2.1	191.3	73.4	8.0	3.3	3.3	0.0	10.2	15.1	19.3	5.7	177.3	9.9	17.8	30.0	10.0	2.2	1.0	1.0	0.3	4.3	0.0	125.6	0.0	5.3	0.0	8.6	0.1	0.1	243.3	18.7	92.3	0.8	0.2	0.8	5.3	15.7	2.9	5.7	0.1	7.3
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		6300000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	28.3	5.2	0.9	9.2	1.2	0.7	9.6	0.6	1.4	7.5	44.0	8.8	2.3	17.4	5.8	5.4	6.7	19.0	15.6	1.4	0.5	4.8	5.9	6.1	3.5	1.8	0.6	18.9	3.4	13.2	2.5	60.8	0.5	8.4	6.8	0.1	3.6	10.4	4.3	1.7	3.5	11.4	1.1	1.9	6.8	1.4	0.9	2.1	31.6	5.5	1.4	15.4	5.4	1.6	0.0	3.4	76.6	0.0	285.4	113.0	0.2	152.1	131.8	14.5	15.0	0.4	0.0	0.0	22.2	17.3	0.0	10.7	9.9	0.1	3.9	0.1	2.0	0.0	3.0	0.0	158.1	0.0	0.0	591.5	0.0	59.6	0.1	82.5	8.1	0.1	0.0	0.0	8.6	0.0	0.0	0.4	3.3	0.0	5.1	23.5	0.2	0.1	19.9	0.0	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.0	0.9	54.4	0.6	33.0	0.0	0.0	0.0	0.1	17.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.6	1.4	1.4	0.5	1.8	0.6	0.5	1.1	0.9	1.6	31.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	1.4	0.2	0.3	2.1	0.0	0.0	1.8	0.0	0.7	0.7	3.7	0.0	0.1	14.0	1.5	11.3	19.7	0.0	0.0	0.8	0.0	1.1	46.0	1.1	0.4	1.3	0.4	8.6	0.0	1.6	0.0	1.7	2.0	0.0	0.3	1.2	4.4	6.2	0.3	3.6	19.7	1.0	0.0	0.0	2.0	4.8	0.2	1.3	8.6	0.1	0.2	1.7	0.4	0.0	0.8	6.6	6.1	22.6	0.2	0.1	0.1	1.0	0.8	0.4	19.1	3.0	0.2
NIF3L1	"ALS2CR1, CALS-7, MDS015"	ENSG00000196290	"NGG1 interacting factor 3 like 1"	Q9GZT8	2	200889327-200903938	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036335, HPA036336, HPA061466"	Supported		Approved	Vesicles		NA	NA		9800000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (2.48e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.04e-3)"	"unprognostic (8.61e-2)"	13.2	19.2	14.1	15.2	15.8	11.0	24.3	15.7	23.8	17.7	13.7	21.8	16.5	15.9	26.3	16.7	22.5	13.2	21.5	14.9	14.8	24.3	22.9	15.6	26.5	15.3	13.8	21.4	15.5	27.0	9.7	19.1	16.2	17.2	28.0	32.7	19.8	19.8	23.5	21.6	15.7	19.1	15.6	18.1	20.1	18.5	14.1	26.5	19.4	30.6	32.4	17.1	12.7	17.5	39.5	42.1	66.9	41.3	29.8	37.1	45.9	42.6	45.4	88.6	71.3	66.1	44.7	31.8	40.2	36.5	64.1	42.7	96.8	56.0	94.6	42.4	90.8	47.4	73.6	70.9	27.0	56.8	31.3	31.7	52.3	58.6	55.8	39.9	29.9	65.6	70.2	31.4	52.7	51.4	69.9	71.1	79.1	44.7	73.5	41.1	37.1	61.6	46.8	40.6	42.3	49.5	36.6	36.8	51.9	94.4	36.5	50.5	15.6	42.2	39.8	38.3	39.0	28.4	58.3	68.4	41.4	45.6	41.6	70.1	23.0	30.7	27.8	34.9	29.1	31.4	31.8	35.3	28.8	23.7	35.4	29.1	7.8	33.6	31.1	29.8	32.0	24.2	14.1	15.8	15.7	23.8	14.9	14.8	15.3	13.8	16.2	15.6	14.1	17.5	6.0	0.0	7.0	2.6	11.7	3.7	7.7	43.1	12.5	90.5	6.9	9.3	13.9	10.0	26.5	5.5	14.6	34.3	8.0	7.5	15.6	20.3	16.2	10.2	9.3	7.0	1.8	23.2	6.2	18.2	35.6	9.8	9.7	7.8	9.5	12.7	6.8	9.3	17.2	18.5	5.7	10.5	26.4	7.3	2.2	6.5	16.1	9.5	5.4	5.6	17.2	18.8	8.2	2.5	5.7	13.2	9.2	19.2	23.9	6.3	10.1	21.3	24.9	27.4	6.6	7.2	14.5	30.9	24.4	12.9	8.2	22.6	10.0	11.1	11.4	6.2
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831162	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 240.5;Muller glia cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 31.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim, Centrosome"	Nucleoplasm	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	11.2	4.4	10.1	19.9	10.8	43.2	8.9	9.5	15.0	7.2	0.0	8.3	4.8	7.7	2.8	12.9	10.5	8.9	18.2	10.4	0.9	6.7	5.7	9.5	25.9	0.0	1.3	9.7	7.2	9.0	8.9	16.8	0.0	6.9	8.6	19.1	5.4	5.4	6.0	12.9	7.1	10.3	0.0	16.2	9.3	5.2	3.0	19.9	7.7	7.4	23.7	13.6	5.7	7.5	29.1	21.6	42.4	36.8	16.7	26.8	20.4	26.5	22.1	21.4	18.0	14.7	14.6	48.5	17.7	35.5	19.9	32.5	34.2	16.3	45.3	34.7	10.4	25.1	13.2	12.3	9.8	41.6	57.5	18.4	11.4	37.2	14.9	13.3	34.6	25.9	6.6	26.3	31.8	36.8	22.6	14.0	6.4	10.1	23.6	37.1	81.6	5.7	20.1	42.9	18.6	22.2	34.0	9.6	25.1	10.2	21.2	39.3	50.9	55.2	74.3	20.5	29.0	18.6	12.1	34.3	14.4	32.8	30.4	31.9	2.9	24.0	3.9	2.5	3.3	8.9	2.4	6.2	2.0	6.2	5.1	4.7	9.6	2.9	2.1	7.7	2.5	1.4	10.1	10.8	9.5	15.0	10.4	0.9	0.0	1.3	0.0	0.0	3.0	7.5	34.0	6.4	7.7	100.2	85.6	18.4	9.1	10.2	18.8	13.3	13.3	10.9	68.0	14.3	27.1	11.0	62.6	12.4	102.7	8.7	3.9	7.3	22.2	17.3	28.5	26.7	12.6	29.0	240.5	4.2	11.3	32.9	7.7	14.9	31.6	3.9	21.8	4.4	22.7	6.7	110.4	5.7	20.3	46.8	42.2	10.4	8.4	61.3	23.2	63.7	63.2	150.2	57.7	105.6	75.1	5.2	6.2	9.4	48.1	16.5	3.2	7.3	29.4	21.0	32.9	44.9	24.1	0.2	4.3	20.1	21.0	9.7	56.2	21.8	6.9	15.5
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL cohesin loading factor"	Q6KC79	5	36876769-37066413	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: AB_2683650"	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	11.5	9.4	5.6	14.7	8.6	25.1	13.5	12.0	7.3	12.9	7.8	12.2	10.0	13.4	6.6	11.4	10.5	11.1	7.7	5.3	5.9	11.6	12.7	11.9	16.5	7.3	6.6	17.6	13.1	19.6	5.0	13.9	8.2	11.1	12.2	22.4	11.2	10.7	9.5	14.2	13.2	12.4	6.3	15.3	13.4	14.2	6.9	29.8	17.2	14.3	16.7	12.6	7.5	11.1	22.5	13.1	33.3	15.6	20.7	22.3	24.4	17.6	19.3	18.9	15.7	18.2	22.6	33.5	11.3	21.6	22.2	19.2	28.9	15.9	27.0	27.9	14.7	40.9	57.4	13.3	14.0	48.4	26.4	16.5	19.3	21.3	28.1	18.1	24.0	20.8	39.3	24.5	17.9	10.8	33.8	18.1	16.0	12.9	11.3	28.2	51.9	13.0	13.1	31.4	24.5	17.2	84.6	22.5	18.0	26.2	23.0	27.3	26.3	24.9	27.1	21.0	13.3	17.7	25.5	39.1	13.6	32.4	19.1	10.9	2.9	4.3	3.2	2.2	3.0	2.8	2.7	2.9	2.3	3.1	2.9	3.3	7.7	2.8	3.3	3.4	2.1	1.6	5.6	8.6	12.0	7.3	5.3	5.9	7.3	6.6	8.2	6.3	6.9	11.1	80.6	131.4	108.6	169.8	84.8	48.4	66.2	34.2	58.1	62.6	43.6	49.4	87.0	38.6	63.3	33.1	77.2	44.1	107.1	45.9	5.9	55.5	13.4	72.9	75.7	74.1	41.5	85.4	179.2	46.7	34.1	64.3	61.2	91.7	84.0	77.7	44.6	28.2	37.1	40.4	165.5	46.3	38.7	51.8	46.6	15.1	66.5	86.7	24.9	236.1	103.3	49.2	97.9	229.2	303.7	55.0	48.6	56.4	84.5	66.4	45.2	12.2	65.2	72.8	52.6	102.9	80.1	185.8	133.6	58.2	47.0	75.9	92.0	73.8	42.9	88.0
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581327	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 291.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.7;Proximal tubular cells: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059227	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	10.7	43.9	35.4	17.5	37.8	15.5	31.5	31.8	38.5	21.5	33.4	37.4	67.0	19.4	24.9	25.8	26.8	19.8	21.8	37.6	41.7	117.8	291.8	17.8	23.3	37.1	36.5	32.3	24.4	68.0	36.5	17.3	39.3	23.9	38.5	46.2	26.0	27.2	4.4	20.6	49.2	17.8	30.7	19.1	29.3	11.9	36.7	36.7	32.9	5.4	28.3	20.1	18.3	31.7	69.1	81.1	165.3	206.9	29.2	59.4	30.7	39.5	70.7	53.2	68.7	55.5	90.6	48.8	76.8	56.9	56.0	68.2	87.7	100.7	65.1	98.8	90.5	16.8	37.0	173.5	44.1	36.5	23.0	59.5	50.8	44.1	55.0	129.0	73.4	105.3	31.8	78.9	49.2	156.4	59.3	50.1	140.0	106.2	67.5	115.9	51.7	142.6	128.3	59.1	203.9	179.5	46.1	83.2	92.1	79.5	137.1	57.7	34.7	23.2	79.6	28.6	31.9	106.4	56.5	45.6	62.1	57.3	39.4	10.8	9.4	15.9	34.2	17.4	41.2	29.0	34.4	36.2	21.6	27.3	32.6	39.5	13.8	39.5	10.7	11.0	44.9	22.1	35.4	37.8	31.8	38.5	37.6	41.7	37.1	36.5	39.3	30.7	36.7	31.7	7.4	25.6	15.7	6.8	16.3	4.8	12.6	15.8	18.8	22.6	25.5	18.5	22.9	28.6	18.6	42.3	10.4	44.4	9.2	14.4	68.4	45.8	2.1	6.2	13.7	10.1	41.9	24.6	16.9	18.5	14.6	14.2	25.5	12.0	26.0	33.5	11.7	116.7	14.4	10.1	19.9	31.5	26.4	8.7	4.3	6.1	11.1	8.1	5.4	3.7	21.3	38.7	28.8	6.6	10.3	17.8	20.2	14.3	7.3	6.8	35.2	134.7	9.8	24.4	13.1	7.2	12.3	1.4	8.3	20.5	8.1	14.8	20.5	48.1	47.4	8.8
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580004-36582614	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;esophagus: 2.6;testis: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;PC-3: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.0	0.0	0.4	0.0	1.1	0.0	0.0	1.2	0.5	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.0	2.3	1.3	0.0	0.0	0.1	1.1	0.0	2.4	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	7.9	2.1	0.0	1.4	0.0	0.0	0.0	0.0	4.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	1.2	0.5	0.2	2.1	2.3	1.3	2.4	2.0	2.1	4.4	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.9	6.8	0.0	1.0	1.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	3.4	0.4	0.0	0.0	0.0	0.0	0.4
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722205-65871725	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.8;Excitatory neurons: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		64000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	2.2	1.0	3.8	2.4	3.9	1.5	3.7	2.9	5.3	1.8	1.6	3.6	1.1	2.7	2.4	2.5	1.5	1.2	2.6	3.8	3.6	3.9	9.9	1.7	1.7	3.9	3.4	1.8	2.5	1.5	0.9	2.4	4.0	2.6	3.2	2.5	1.9	1.1	8.9	2.8	2.7	2.7	3.3	1.3	4.0	1.1	3.9	0.9	2.7	6.5	2.0	2.7	1.5	4.8	13.3	12.5	7.2	12.0	9.0	15.3	14.5	13.1	5.5	7.6	8.2	7.2	7.7	18.8	16.1	15.8	15.1	10.3	9.5	20.2	13.1	5.6	6.4	5.2	8.7	18.5	7.7	12.0	3.0	11.7	10.8	10.5	12.4	6.3	21.7	8.3	11.4	3.9	16.5	10.2	8.3	10.8	22.2	6.7	3.6	9.6	15.3	29.9	12.6	5.9	22.3	11.5	10.6	10.7	11.0	19.4	12.9	14.1	12.5	5.0	5.9	7.4	10.0	3.3	7.1	8.2	7.7	23.2	7.7	0.1	2.6	0.1	0.1	3.4	0.1	0.4	0.2	0.1	2.2	0.4	0.3	0.2	0.3	0.5	2.3	0.1	0.0	1.0	3.8	3.9	2.9	5.3	3.8	3.6	3.9	3.4	4.0	3.3	3.9	4.8	5.9	6.4	2.8	19.6	4.0	5.7	9.0	6.2	8.6	2.4	10.1	8.9	14.5	7.2	8.5	12.9	4.2	5.3	0.6	52.8	5.9	17.8	0.3	7.4	12.9	8.3	1.8	9.0	58.9	14.5	14.0	7.1	20.4	20.9	15.2	16.2	4.6	32.4	28.8	5.0	32.2	5.8	6.1	22.9	8.9	0.4	4.4	13.5	1.8	5.6	17.9	13.1	2.1	22.6	44.5	30.2	35.9	2.2	4.9	16.5	32.3	22.4	3.1	4.7	0.0	19.7	8.1	2.1	5.2	15.3	5.3	2.9	2.3	15.8	8.2	6.1
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	1.0	0.8	0.3	7.8	0.4	4.1	0.7	0.8	0.7	0.9	1.0	1.5	1.7	0.9	0.4	0.8	1.2	1.4	1.5	0.3	0.0	1.3	1.1	2.4	13.6	0.3	0.3	0.7	0.5	0.2	0.9	0.9	0.1	1.1	1.2	1.1	1.1	0.3	1.1	0.5	6.5	0.5	0.0	11.8	2.1	0.9	0.3	11.3	1.5	0.9	11.1	1.5	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	8.7	0.1	0.0	0.0	18.6	9.0	0.0	0.0	0.0	0.0	0.5	0.2	9.2	0.2	0.0	0.0	0.4	7.7	19.7	0.0	0.0	0.1	5.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.1	4.9	0.5	0.3	0.1	0.2	0.1	0.4	0.2	28.9	0.2	13.6	0.1	2.9	0.0	0.0	2.3	0.0	2.1	0.8	1.7	2.2	0.0	0.6	1.4	1.5	0.0	2.6	0.0	0.0	2.0	2.1	0.3	0.4	0.8	0.7	0.3	0.0	0.3	0.3	0.1	0.0	0.3	0.1	1.7	3.2	0.0	1.0	10.3	0.0	0.3	0.0	0.0	1.6	0.4	0.3	4.6	1.5	0.6	1.8	4.2	0.0	18.8	0.0	0.0	0.0	4.0	1.3	0.8	2.3	0.0	6.5	3.8	0.0	0.0	0.5	1.5	0.7	2.5	0.2	3.9	0.1	0.1	0.0	3.7	0.0	0.0	1.0	0.0	1.3	0.0	1.1	0.0	1.9	1.3	0.3	37.0	1.0	0.6	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.7	5.1	0.0	0.9	0.7	0.5	0.3	0.0	0.0	0.0	23.8	0.1	0.0	0.3
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 561.7;Muller glia cells: 151.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.4;Karpas-707: 90.9;U-266/70: 45.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	27.9	4.0	3.6	27.8	3.7	25.0	22.1	3.2	5.3	22.9	3.5	10.8	5.8	13.8	1.8	16.2	14.4	13.4	15.7	2.9	3.7	9.4	5.3	26.9	38.1	5.5	3.8	5.8	3.2	1.8	4.1	12.1	5.5	13.2	7.8	0.3	10.8	9.0	7.7	50.8	31.1	9.7	3.7	56.3	6.9	6.1	4.0	15.1	21.8	7.7	32.4	15.8	27.7	4.1	14.2	0.0	0.0	0.0	8.6	10.2	1.8	6.9	6.3	2.6	5.7	0.2	5.5	5.3	20.8	7.6	1.1	6.5	0.0	23.4	4.0	55.4	0.0	1.4	4.8	0.5	7.1	0.0	1.6	6.6	14.5	20.7	13.7	10.4	25.6	1.1	13.0	90.9	11.8	0.0	0.1	4.6	0.0	0.0	0.3	6.0	4.0	23.0	0.0	4.8	0.7	0.0	0.0	0.2	0.4	0.6	0.0	0.5	25.2	5.3	3.0	3.2	1.1	45.0	15.9	4.1	8.7	0.6	0.3	18.3	7.1	5.0	5.9	4.9	6.6	4.4	5.1	6.3	5.0	4.9	5.5	5.2	18.9	4.2	8.6	0.5	7.7	4.6	3.6	3.7	3.2	5.3	2.9	3.7	5.5	3.8	5.5	3.7	4.0	4.1	46.4	0.0	7.8	1.3	29.0	17.7	7.1	8.0	15.4	60.6	2.7	6.2	4.9	2.8	10.4	7.3	4.2	0.8	30.3	0.3	3.9	0.4	561.7	4.9	18.0	26.9	77.9	3.6	2.9	0.0	1.1	31.6	3.6	1.0	3.8	7.8	44.6	0.6	7.0	85.8	1.5	1.2	0.0	23.0	24.3	93.4	25.4	26.2	7.2	56.2	27.0	151.8	26.8	1.5	0.8	7.0	0.0	28.2	25.9	2.0	0.0	0.4	12.7	11.6	6.6	33.1	17.3	25.0	11.0	10.7	24.9	1.5	37.6	3.6	0.2	8.0
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7957537-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 6.3"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7"	"Region enhanced"	"Detected in some"		"olfactory bulb: 2.1"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 10: BJ & FHDF - ECM organization"		Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.1	0.0	0.3	0.1	5.9	2.8	1.3	2.8	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020479-7071526	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.3;Bipolar cells: 2.2;Cone photoreceptor cells: 2.1;Distal tubular cells: 1.9;Early spermatids: 2.2;Excitatory neurons: 2.2;Rod photoreceptor cells: 3.2;Spermatocytes: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol		NA	NA						"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.5	0.1	0.1	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	2.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278407-285388	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 39.9"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 9.9;T-cells: 2.6"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 3.6"	"Group enriched"	"Detected in many"	4	"neutrophil: 15.4;non-classical monocyte: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"REH: 2.0;U-266/70: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043681, HPA048500"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.7	0.0	0.1	2.2	0.2	0.5	0.2	0.1	3.6	0.1	0.2	0.6	39.9	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.5	1.3	2.6	0.9	1.2	0.9	0.3	0.0	0.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.1	38.0	0.1	0.3	3.6	0.3	0.2	0.3	0.3	0.1	0.1	0.3	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	0.2	0.4	0.1	0.0	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.6	1.1	0.1	0.1	1.8	2.3	15.4	1.0	4.6	0.0	0.0	0.7	0.1	0.2	0.1	3.6	0.1	0.5	0.9	0.3	0.6	0.3	0.3	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.7	0.0
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Early spermatids: 7.0;Excitatory neurons: 2.3;Inhibitory neurons: 4.5;Late spermatids: 2.1;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 2.5;Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026665			Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.6	0.2	1.3	1.0	1.1	1.5	1.1	0.5	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		12000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	34.0	84.4	21.3	8.0	22.7	3.9	34.2	21.0	36.3	41.9	16.8	47.7	15.9	36.7	3.4	27.2	44.3	2.1	36.0	20.2	23.1	44.6	36.3	29.1	5.4	23.7	22.2	43.7	37.2	4.5	71.9	5.2	19.6	59.4	3.1	1.8	35.9	13.0	17.1	31.1	33.8	3.2	22.5	39.4	38.6	16.0	22.0	1.0	40.3	3.1	1.9	38.5	33.5	24.9	1.6	26.9	0.6	21.8	6.1	3.2	2.5	15.7	4.5	2.7	2.1	0.0	31.8	0.4	42.6	2.2	2.8	23.0	1.3	8.8	0.3	32.1	70.9	0.0	12.0	13.0	11.3	5.5	9.8	14.0	7.9	2.7	1.5	5.1	5.6	0.2	11.2	4.4	2.7	40.4	0.4	10.8	28.0	5.4	21.5	15.3	0.3	43.5	4.5	1.2	30.6	23.6	47.1	35.2	4.2	1.2	33.7	13.1	19.9	5.8	21.4	18.5	10.8	11.1	3.7	2.5	8.1	0.9	13.3	10.0	50.7	34.6	33.3	49.6	32.9	36.8	46.3	31.4	45.1	31.9	39.6	31.3	10.8	44.8	55.4	70.3	45.4	41.3	21.3	22.7	21.0	36.3	20.2	23.1	23.7	22.2	19.6	22.5	22.0	24.9	128.8	35.3	62.7	69.9	64.6	72.5	141.3	97.7	179.8	116.3	147.3	165.6	28.0	90.1	76.6	126.9	60.5	86.6	77.9	76.2	60.7	62.9	22.1	66.5	102.9	84.1	135.5	25.7	34.6	37.6	46.3	100.9	76.0	77.6	50.8	71.6	99.9	63.0	74.8	65.6	30.2	109.4	50.8	60.3	91.0	20.3	149.5	71.1	81.8	29.0	136.5	126.9	77.2	40.7	63.7	37.0	104.7	127.5	93.1	98.4	157.2	150.2	70.9	126.7	118.3	75.9	100.8	2.0	40.4	100.9	65.6	46.1	87.3	183.8	107.6	100.6
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 250.5;Erythroid cells: 311.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	89.3	136.1	78.3	26.2	75.6	127.7	72.9	73.5	101.5	88.1	77.3	192.9	21.9	79.5	55.7	50.1	89.1	41.2	101.2	76.4	81.7	60.4	175.2	48.3	21.1	88.6	77.9	86.8	43.7	56.7	64.3	30.8	79.8	143.7	23.5	11.1	70.4	81.9	34.7	31.4	59.7	51.9	78.6	43.8	97.7	44.7	80.3	29.3	51.6	27.2	15.8	145.6	64.3	73.6	1.0	305.4	265.6	366.7	104.0	181.0	59.5	143.6	170.4	211.8	180.6	205.4	176.2	3.0	105.8	230.2	76.9	3.9	145.0	153.9	62.0	126.5	218.7	151.9	40.2	279.9	195.7	111.0	53.1	234.7	79.8	130.5	12.8	152.2	137.6	210.7	159.6	25.8	160.4	255.4	98.5	139.2	271.8	76.1	67.8	485.8	59.3	79.0	150.6	1.2	77.7	419.2	36.8	2.7	139.9	97.2	178.3	257.5	174.0	149.7	216.8	101.8	36.8	2.7	2.0	83.1	65.8	19.8	177.2	12.9	13.3	39.8	14.9	11.9	12.7	27.6	14.4	16.3	17.6	29.9	26.0	13.4	4.2	2.5	10.6	58.3	0.9	10.7	78.3	75.6	73.5	101.5	76.4	81.7	88.6	77.9	79.8	78.6	80.3	73.6	52.2	0.0	13.9	18.6	40.6	32.2	56.3	49.0	40.9	15.2	116.6	135.8	44.5	52.9	25.1	58.8	2.1	71.7	45.7	19.3	250.5	116.5	5.0	30.8	113.3	55.3	45.1	311.8	16.8	40.3	26.1	87.3	29.6	59.8	29.9	199.9	55.6	132.2	131.2	8.4	21.1	38.6	26.4	46.5	68.6	21.6	89.2	35.4	62.2	10.3	46.5	45.9	19.6	10.1	3.6	58.3	23.8	94.8	34.5	121.8	9.0	75.5	7.9	5.6	52.6	40.1	105.8	1.7	32.7	38.6	24.6	21.8	26.2	89.4	54.9	60.9
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 239.1;tongue: 384.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 344.3;Hepatocytes: 314.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Cytosol	"CAB004975: AB_425908, HPA004829: AB_1079495"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	26.0	16.5	12.8	11.8	16.0	15.0	13.7	11.2	21.7	16.4	34.9	25.9	17.2	11.0	16.7	16.8	10.7	15.0	137.7	16.1	11.5	57.0	116.4	13.2	16.5	10.3	12.0	10.1	17.8	55.6	9.6	12.7	9.5	18.3	27.8	12.9	26.6	18.2	239.1	10.4	16.1	20.6	9.3	11.5	31.2	6.2	15.8	26.8	31.1	384.0	17.2	17.3	9.3	15.1	15.4	12.6	30.5	59.6	44.0	50.3	9.9	17.5	39.8	24.8	20.8	19.0	30.4	18.5	21.5	43.9	22.3	16.6	120.5	5.4	27.4	31.1	33.6	24.0	70.7	23.8	27.5	50.2	43.1	37.9	17.5	16.3	18.6	42.6	56.3	22.7	21.4	81.3	60.0	15.1	55.8	35.8	6.4	0.1	15.2	54.7	73.8	70.8	58.0	15.5	44.2	37.7	62.9	1.4	46.7	6.9	47.7	58.3	23.2	29.5	28.3	12.0	8.3	36.1	45.1	26.5	7.1	68.8	22.1	12.5	18.2	16.0	16.7	23.0	17.1	12.0	17.1	15.5	32.0	12.0	15.5	14.7	2.9	23.2	24.7	9.1	22.2	19.3	12.8	16.0	11.2	21.7	16.1	11.5	10.3	12.0	9.5	9.3	15.8	15.1	12.0	54.5	37.8	60.7	19.6	11.5	9.5	19.0	13.1	17.9	9.6	6.3	344.3	38.6	27.0	27.6	35.5	8.7	20.4	34.4	27.4	14.4	16.7	18.5	16.6	19.2	19.9	34.9	124.8	10.7	2.3	27.2	23.9	25.1	25.2	26.8	21.0	314.3	25.0	6.7	110.6	22.6	20.3	40.6	11.9	4.6	14.9	19.8	14.2	45.9	25.9	12.5	35.0	77.9	63.4	9.5	16.7	19.2	20.0	11.7	23.6	21.7	18.1	12.8	0.0	14.0	20.1	4.0	1.4	17.6	8.1	2.1	20.9	18.8	28.9	9.9
NOLC1	"KIAA0035, NOPP130, NOPP140, P130, Srp40"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	36.5	23.9	10.7	41.9	12.3	37.2	32.3	14.6	20.5	27.1	4.5	31.8	21.8	30.3	18.7	33.3	34.4	29.0	24.0	12.6	18.2	21.4	37.5	24.9	43.1	10.9	14.4	34.4	38.4	42.9	14.6	38.3	11.9	31.5	39.1	38.0	26.3	26.6	45.3	21.9	22.8	33.8	10.8	27.6	27.4	19.3	12.2	54.2	37.6	46.4	55.7	64.2	19.6	18.3	202.1	175.1	98.2	209.0	84.7	66.0	166.6	108.5	87.8	150.1	130.5	302.1	132.4	401.5	118.1	69.5	73.9	225.1	285.0	236.1	173.3	127.0	194.8	267.9	143.6	200.3	112.0	389.8	122.8	86.3	169.8	158.3	328.7	94.5	96.5	194.3	286.6	172.6	102.6	170.3	373.7	95.0	196.5	150.7	137.1	277.3	261.6	233.3	100.2	123.5	148.3	141.9	103.5	124.1	144.5	95.6	207.5	99.3	79.3	67.7	93.5	81.3	256.9	165.5	254.4	442.4	110.5	422.7	60.7	2.4	12.5	11.6	20.4	14.4	24.9	16.6	16.1	19.2	16.2	12.1	18.5	22.6	1.3	17.3	17.2	12.4	13.0	17.9	10.7	12.3	14.6	20.5	12.6	18.2	10.9	14.4	11.9	10.8	12.2	18.3	47.8	60.9	74.7	6.2	47.6	120.4	112.6	37.7	101.9	20.8	52.6	48.0	35.3	20.0	68.2	16.5	14.6	49.2	29.1	28.3	25.4	42.2	29.0	38.5	56.3	47.3	27.6	56.8	8.8	23.1	62.7	63.9	43.3	73.1	44.2	28.6	16.8	23.4	27.1	10.1	7.9	38.3	18.3	11.2	46.0	9.7	23.0	26.8	26.6	4.7	22.9	15.1	32.0	2.5	6.8	48.8	21.0	21.1	62.3	89.5	10.2	19.9	56.6	20.0	6.6	85.8	58.9	32.1	53.5	103.3	117.5	48.6	44.5	40.1	49.1	100.5
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833721-14896157	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.3;Hep G2: 126.5;LHCN-M2: 65.8;RPMI-8226: 90.4;SiHa: 144.9"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	24.1	27.6	4.4	10.3	4.4	0.0	23.6	4.4	16.0	22.0	4.4	32.3	0.7	25.6	0.0	24.9	20.4	0.4	92.3	4.5	9.6	32.0	28.3	26.9	2.7	4.8	4.3	21.3	133.9	0.0	29.2	6.8	4.5	21.6	8.2	4.2	31.1	4.5	101.7	28.1	26.1	8.2	4.3	19.9	36.4	31.0	4.5	0.0	21.5	1.4	0.2	28.8	22.2	5.1	1.2	56.8	51.4	76.3	0.0	4.6	42.2	3.4	9.1	11.5	11.0	0.8	2.8	4.3	2.8	8.8	1.0	0.7	8.8	0.7	11.3	6.2	0.0	3.7	57.8	126.5	48.7	5.8	2.7	0.6	0.5	6.2	6.3	1.2	9.0	0.0	29.7	2.6	65.8	0.0	1.6	0.0	0.0	0.0	0.0	1.9	4.3	90.4	0.0	2.6	1.1	45.8	144.9	0.0	0.1	1.7	63.1	0.6	2.1	1.9	0.1	2.6	58.1	0.3	2.1	4.7	2.3	2.3	1.3	3.7	0.2	0.2	0.0	0.4	0.3	0.0	0.1	0.3	0.1	0.5	0.2	0.3	0.6	1.9	2.0	1.6	0.3	0.6	4.4	4.4	4.4	16.0	4.5	9.6	4.8	4.3	4.5	4.3	4.5	5.1	5.6	3.2	10.5	9.1	5.3	6.4	1.4	10.6	3.4	8.7	7.8	5.8	58.4	7.2	8.6	11.0	6.2	6.8	4.2	14.4	0.0	15.6	32.9	3.3	3.1	7.3	7.7	5.5	12.7	29.4	12.4	7.9	11.7	4.2	23.6	13.0	7.9	7.6	6.3	35.3	16.2	11.7	2.0	12.7	2.8	12.0	2.8	10.3	5.4	7.5	11.2	5.4	16.5	13.6	32.1	27.4	10.8	6.4	16.2	2.1	16.1	7.9	7.4	8.5	6.6	5.7	7.5	16.1	13.1	6.7	5.8	9.6	4.2	9.5	13.0	1.6
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652593-2658393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB075757: AB_2665763, HPA049918: AB_2680952"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	41.4	31.3	39.9	42.6	39.7	60.4	37.1	38.8	59.7	30.9	35.3	33.8	28.8	39.9	34.7	37.1	50.7	26.3	30.9	41.1	45.8	29.8	30.5	25.9	53.5	40.4	40.6	49.7	38.6	27.1	31.5	37.4	43.4	31.1	39.9	21.0	27.1	35.6	43.2	38.4	28.1	52.0	39.9	37.7	25.9	28.3	45.4	51.9	33.4	29.2	62.2	52.4	28.4	44.4	152.8	147.3	108.4	108.0	122.8	89.8	184.2	150.4	97.3	198.3	134.9	204.3	122.2	330.5	82.7	104.2	117.7	253.3	287.5	221.4	196.6	93.5	171.4	195.0	76.0	225.3	125.9	179.4	91.3	123.6	137.2	254.8	260.4	78.2	117.4	153.1	215.7	151.2	138.1	103.1	317.8	214.1	233.8	270.9	180.9	257.2	156.2	188.5	120.8	146.7	115.5	101.1	171.0	193.4	302.8	115.7	167.6	152.7	91.6	170.2	115.9	132.6	227.2	91.9	186.0	274.0	45.9	209.4	128.5	5.1	23.2	18.9	33.0	26.4	41.1	35.8	35.9	36.6	23.6	32.4	34.0	34.0	1.8	33.6	19.8	41.1	33.4	24.8	39.9	39.7	38.8	59.7	41.1	45.8	40.4	40.6	43.4	39.9	45.4	44.4	75.0	44.8	59.8	14.0	89.3	96.4	103.6	76.4	88.2	39.5	62.9	78.6	39.0	42.9	100.1	23.9	62.6	117.5	132.2	71.8	25.4	78.2	8.0	64.6	100.6	73.3	72.3	93.2	24.6	86.5	124.2	87.5	44.4	48.5	79.1	97.5	52.5	40.9	86.9	50.5	24.1	81.2	54.9	46.8	45.9	14.0	57.2	57.5	30.2	12.2	64.9	32.8	80.3	18.1	21.5	75.6	34.6	54.9	79.6	92.0	38.7	53.8	81.2	37.6	26.3	110.0	141.5	50.3	185.9	89.1	81.7	56.5	102.6	99.4	110.0	58.0
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299850-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	9.9	13.0	6.3	5.5	6.7	7.0	9.3	6.2	6.1	8.6	4.6	11.1	7.8	9.9	3.5	16.1	9.5	3.3	13.2	5.8	6.3	8.6	13.8	8.7	6.2	6.7	6.5	11.7	12.6	6.7	7.9	4.1	6.4	9.0	5.5	7.4	10.6	4.4	27.2	12.6	11.4	4.9	6.9	17.3	10.6	7.7	6.8	5.9	8.6	11.2	6.7	9.8	9.3	6.3	6.5	12.8	10.2	12.8	8.7	7.3	9.8	11.4	8.5	13.2	10.2	9.7	11.3	16.7	6.3	10.5	10.7	16.6	20.4	14.2	13.7	10.6	7.8	12.3	18.3	22.4	7.0	28.4	13.5	7.4	10.9	9.7	8.9	7.0	12.4	9.3	10.6	8.0	9.3	11.3	13.2	10.7	4.6	22.9	16.2	16.0	6.1	10.6	8.1	14.8	10.2	7.8	16.1	18.4	3.5	7.3	6.9	7.4	12.8	8.7	7.2	6.9	10.9	11.1	10.6	12.2	4.8	12.7	7.1	0.3	0.6	0.5	0.4	0.7	0.4	0.3	0.3	0.2	0.5	0.4	0.2	0.2	0.1	0.1	1.2	0.3	0.3	0.4	6.3	6.7	6.2	6.1	5.8	6.3	6.7	6.5	6.4	6.9	6.8	6.3	4.0	3.2	3.3	2.6	6.2	12.5	3.2	4.9	6.2	8.1	5.3	3.9	1.2	7.2	8.5	9.2	8.4	6.3	6.7	15.2	0.0	7.3	3.1	5.2	4.8	5.6	10.7	9.9	3.6	10.3	5.8	4.5	6.1	5.0	1.3	9.6	6.1	18.1	7.3	6.7	4.3	7.6	0.0	10.7	6.3	1.3	6.5	5.8	0.0	1.0	7.6	5.5	2.1	3.0	5.0	11.6	8.5	4.5	5.5	5.2	12.5	6.6	7.7	8.0	6.6	5.4	5.4	4.6	5.7	8.1	13.5	6.4	4.9	5.5	14.3	4.6
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800529	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.1;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 40.3;Extravillous trophoblasts: 27.7;Granulosa cells: 57.3;Proximal enterocytes: 10.7;Undifferentiated cells: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 16.5;SCLC-21H: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002014	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	0.9	0.5	0.2	14.4	0.5	0.0	0.3	0.1	2.1	0.3	0.0	6.8	12.1	0.2	0.0	0.7	0.4	0.4	0.4	0.7	0.2	1.6	0.1	1.8	0.8	0.3	0.1	0.6	0.3	0.1	1.3	0.6	0.5	0.6	8.9	0.2	0.1	0.2	0.8	0.2	21.1	1.8	0.1	0.1	0.1	0.3	1.0	0.1	0.4	0.7	0.1	3.6	0.2	0.9	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.9	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.1	0.7	0.2	0.3	0.1	0.5	0.1	1.0	0.9	1.2	0.0	0.0	1.3	0.6	0.0	0.2	3.6	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.2	0.0	0.0	0.7	2.4	0.0	4.1	0.0	27.7	0.2	0.0	0.1	0.0	57.3	0.0	0.0	0.7	0.0	2.2	3.8	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.9	0.4	0.0	1.4	10.7	0.1	0.5	0.1	0.0	0.3	1.2	0.0	1.5	0.0	0.0	0.5	0.3	0.1	10.2	1.0
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150991017-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 62.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Early spermatids: 81.9;Endothelial cells: 32.6;Hepatic stellate cells: 29.3;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.1;HUVEC TERT2: 44.7;K-562: 16.6;TIME: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	19.3	6.3	8.4	5.8	6.8	0.8	13.2	5.7	6.7	7.3	3.4	5.9	2.6	9.7	0.4	5.8	8.1	4.7	20.6	5.7	6.1	24.2	4.3	11.2	2.7	9.2	7.7	3.2	2.9	1.2	7.2	4.8	8.6	7.6	1.2	0.8	4.4	1.7	3.9	4.2	6.7	3.7	7.5	62.4	5.4	7.2	11.0	0.6	9.1	3.5	1.2	9.7	7.4	6.0	0.4	0.1	1.3	4.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	2.2	0.4	2.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.4	2.2	0.3	6.4	0.6	0.5	10.4	0.1	0.2	0.0	0.0	0.1	44.7	5.1	16.6	3.6	0.0	0.0	0.2	0.5	1.7	0.7	0.1	3.0	0.0	1.8	0.0	0.3	0.5	0.4	0.2	1.4	0.0	0.4	0.1	1.4	82.5	0.2	0.7	0.4	0.1	2.4	8.9	2.2	0.0	7.5	0.0	0.2	0.1	0.1	1.1	0.2	0.7	0.3	1.7	0.9	0.2	0.5	2.3	0.9	0.3	0.2	0.2	0.2	2.1	0.5	8.4	6.8	5.7	6.7	5.7	6.1	9.2	7.7	8.6	7.5	11.0	6.0	20.4	9.6	2.2	0.3	0.7	0.9	0.1	0.1	0.0	0.2	0.2	0.3	3.1	0.0	0.7	0.0	0.0	0.2	0.7	0.1	0.0	1.0	81.9	4.9	0.7	32.6	0.0	0.0	0.2	0.0	0.1	2.9	0.5	3.2	5.7	0.7	29.3	0.7	0.4	0.0	0.2	0.4	0.0	0.6	0.5	29.3	0.9	0.4	0.0	7.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	1.2	1.5	0.4	0.1	0.2	2.2	0.3	0.0	0.6	2.6	6.9	5.3	0.2	0.6	3.6	1.6	0.9	0.1	0.9
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOTCH2		ENSG00000134250	"Notch receptor 2"	Q04721	1	119911553-120100779	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		160000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	27.1	12.9	16.4	20.4	13.6	13.7	24.8	11.9	16.4	31.0	20.3	16.0	5.4	21.2	20.8	24.9	25.7	18.5	14.2	15.9	13.7	10.9	19.6	20.2	16.7	20.6	18.6	33.9	20.1	12.1	5.5	24.9	13.9	20.4	13.6	19.3	17.1	22.2	6.4	32.3	11.9	26.6	15.7	25.3	10.5	25.4	19.3	15.3	21.2	8.9	17.9	19.0	24.1	14.8	54.2	17.7	27.0	20.7	108.5	92.7	26.6	39.7	54.8	51.8	55.8	16.3	14.2	1.4	32.6	75.3	46.2	20.1	42.8	35.3	82.5	64.0	27.2	32.1	45.7	1.6	40.5	32.7	8.0	75.5	22.5	155.2	103.7	78.4	26.9	14.5	0.8	65.3	63.7	59.2	13.9	9.2	34.6	5.0	19.6	9.1	94.2	36.1	27.3	33.4	1.1	13.4	54.5	50.0	27.9	53.4	28.0	11.7	97.0	67.0	45.8	102.7	63.1	27.9	16.8	16.5	98.7	29.5	65.2	15.0	14.9	22.9	1.4	7.3	1.4	39.0	1.6	0.9	23.7	33.3	3.1	2.0	8.9	2.4	10.5	12.3	3.8	4.4	16.4	13.6	11.9	16.4	15.9	13.7	20.6	18.6	13.9	15.7	19.3	14.8	4.6	35.3	19.5	125.4	36.6	46.3	56.6	14.8	31.3	3.3	38.1	25.3	16.0	24.3	28.5	18.4	6.2	1.6	26.0	6.2	0.0	46.8	17.7	33.8	21.9	5.4	6.1	18.3	4.2	12.9	8.9	67.8	5.1	61.1	15.8	78.3	3.9	41.5	32.7	3.3	22.6	7.9	20.3	74.7	78.2	12.6	55.0	76.6	39.2	43.1	79.3	46.2	15.5	75.4	0.6	26.8	105.5	85.4	14.2	37.2	3.2	4.9	16.4	10.5	19.7	83.6	34.0	10.0	4.3	75.1	88.9	1.6	18.5	22.0	15.8	66.9
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch receptor 3"	Q9UM47	19	15159038-15200995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		46000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: AB_2678926"	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	85.7	5.3	14.8	10.4	12.4	0.2	50.5	11.0	21.3	49.4	7.1	14.8	5.5	39.9	16.9	74.3	35.8	23.5	43.6	9.5	11.3	26.0	3.2	38.3	9.2	12.0	15.2	18.9	10.7	12.6	10.3	59.8	14.3	22.0	4.2	0.5	24.4	16.5	29.7	82.1	14.3	16.9	8.2	15.0	11.6	3.8	15.8	34.1	32.3	25.1	10.4	26.3	55.1	10.0	13.0	8.1	66.3	30.3	9.2	7.3	29.8	10.2	0.4	0.4	0.3	15.6	13.4	0.4	7.7	18.9	0.1	15.1	12.1	0.2	0.6	0.1	3.1	0.4	12.4	3.5	4.5	0.0	1.2	8.4	7.3	15.5	1.6	0.6	0.8	4.6	0.5	0.6	1.2	66.9	15.9	0.1	38.8	11.2	0.0	0.1	3.7	0.3	0.0	41.2	1.9	21.4	0.1	37.8	0.0	19.6	40.3	0.1	0.0	1.9	21.0	0.3	0.1	0.1	0.7	0.0	45.7	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	14.8	12.4	11.0	21.3	9.5	11.3	12.0	15.2	14.3	8.2	15.8	10.0	39.6	9.6	1.5	5.9	0.4	24.1	7.8	17.8	4.6	0.4	41.5	30.7	60.7	0.0	28.5	16.5	0.0	20.2	1.0	0.0	5.9	14.8	0.5	4.8	13.5	32.0	0.0	0.0	0.6	0.0	3.9	24.2	2.0	11.8	0.0	5.9	4.2	0.0	2.8	0.0	0.3	0.3	6.1	10.4	12.3	0.1	9.0	4.1	17.8	13.1	0.7	0.8	0.0	0.0	0.2	0.9	0.1	11.7	0.0	13.0	0.1	0.0	4.2	0.8	414.2	131.6	317.0	0.9	1.2	72.1	72.2	31.5	2.0	1.2	0.2	36.0
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874359	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"intestine: 71.7"	"Group enriched"	"Detected in some"	8	"Distal enterocytes: 45.8;Intestinal goblet cells: 21.4;Paneth cells: 29.1;Undifferentiated cells: 64.8"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 30.9;OE19: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favorable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.3	0.5	0.0	2.9	0.0	0.0	0.1	0.1	0.1	0.1	0.0	58.9	0.5	0.3	0.0	0.5	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	71.7	0.3	0.2	2.4	0.1	0.7	1.6	1.6	0.0	0.1	0.1	0.2	0.1	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.4	1.1	0.4	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	30.9	0.4	0.4	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1.4	0.5	0.6	0.9	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.3	0.0	0.3	1.3	1.2	0.8	11.6	1.1	0.7	0.7	0.5	0.0	1.1	0.5	0.6	0.7	0.3	0.7	0.3	0.2	1.0	0.3	0.4	0.3	0.5	0.8	0.3	0.7	0.3	0.8	1.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	64.8	0.6
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16783.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	260.1	297.0	127.1	261.3	145.4	305.3	221.3	152.2	190.6	284.5	434.0	259.7	201.7	196.7	16783.1	185.0	170.0	356.0	215.1	118.1	156.9	322.4	202.4	786.0	360.3	185.7	145.6	283.1	219.9	241.3	197.5	263.1	179.2	164.2	220.8	48.6	221.9	261.3	58.7	181.6	193.3	180.5	151.1	305.6	206.8	156.8	172.1	134.4	444.7	114.7	241.9	347.4	187.9	195.5	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	127.1	145.4	152.2	190.6	118.1	156.9	185.7	145.6	179.2	151.1	172.1	195.5	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47624665	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		3000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	32.2	50.0	30.6	19.4	34.8	7.3	30.1	30.7	41.1	41.5	26.1	38.6	20.3	32.0	11.1	92.2	32.6	22.2	30.6	32.9	30.3	30.9	23.8	30.5	18.4	35.7	34.2	39.9	34.2	30.1	26.7	27.3	35.7	27.9	27.4	21.0	44.4	20.6	114.5	47.3	37.1	33.7	26.1	31.9	33.4	19.2	34.2	26.4	26.8	86.6	27.5	34.8	58.2	30.5	105.7	81.7	67.3	49.4	92.1	81.9	147.5	47.5	63.9	70.4	66.5	55.7	100.6	68.4	76.1	69.2	70.1	62.0	83.7	44.8	108.7	31.5	73.2	76.5	62.3	59.2	48.3	48.8	46.6	61.5	41.1	52.7	26.8	99.2	77.5	20.1	72.5	30.7	109.9	37.2	66.0	34.7	47.8	74.4	68.0	50.5	107.2	60.1	82.6	81.0	59.7	46.0	59.1	34.9	44.7	122.0	256.3	35.5	88.6	44.1	35.2	72.5	34.9	63.7	81.1	39.9	64.8	25.3	33.5	14.2	9.9	12.4	8.8	7.9	9.6	7.7	7.2	9.2	9.7	6.9	6.3	7.8	28.4	8.8	9.1	10.1	8.8	6.3	30.6	34.8	30.7	41.1	32.9	30.3	35.7	34.2	35.7	26.1	34.2	30.5	32.0	83.3	59.1	68.6	44.7	77.9	68.9	40.2	109.8	144.6	76.6	33.8	60.3	55.8	53.6	42.3	268.9	81.2	35.6	87.0	27.4	69.3	34.2	95.2	80.9	45.4	44.3	44.6	98.0	54.4	74.4	66.0	58.1	158.1	41.7	62.7	45.7	32.5	40.5	112.7	95.3	44.1	38.7	51.0	62.1	50.8	52.8	45.4	58.7	37.5	51.5	38.7	38.1	69.4	74.9	103.4	61.6	50.0	52.5	106.2	58.7	46.5	63.8	153.3	78.9	53.8	53.5	52.0	28.6	101.6	102.6	104.7	40.4	45.9	51.5	195.2
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	873	"heart muscle: 60060.6"	"Cell type enriched"	"Detected in some"	23	"Cardiomyocytes: 62235.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.6;SH-SY5Y: 9.5"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 22.8"	"Low region specificity"	"Detected in all"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		1200000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	8.3	3.0	1.7	0.7	2.1	0.6	18.0	1.8	2.4	1.2	2.3	5.0	0.2	3.3	12.9	2.8	1.3	0.9	60060.6	2.2	1.5	2.6	5.0	58.1	1.2	1.7	1.5	12.1	68.7	0.9	3.9	5.9	1.4	5.1	0.0	0.4	28.5	0.0	8.9	5.8	6.1	0.7	1.3	3.1	3.6	3.9	1.7	0.5	7.1	0.0	0.0	1.2	3.9	2.0	0.5	0.2	0.3	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.6	0.8	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.4	1.0	0.3	1.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.3	0.3	1.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.6	9.6	9.5	0.0	0.0	0.5	0.3	0.3	0.1	0.0	0.4	0.7	0.6	0.1	0.4	0.8	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.1	1.8	2.4	2.2	1.5	1.7	1.5	1.4	1.3	1.7	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62235.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	339.1	0.0	0.0	0.3	0.0	0.0	2684.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	636.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858945	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	767	"heart muscle: 5154.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 351.7;Ductal cells: 266.6;Pancreatic endocrine cells: 86.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Group enriched"	"Detected in some"	4	"basal ganglia: 3.4;cerebral cortex: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 135.5;CACO-2: 362.2;SuSa: 67.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.4"					HPA077324			Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	9680			"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	Cytosol	"HPA077324: "				"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			1.0	0.3	0.3	0.1	3.4	0.0	0.7	0.4	1.8	0.3	0.1	0.3	0.0	0.3	0.3	0.2	0.0	0.6	5154.6	0.3	0.3	0.3	0.5	6.7	0.9	0.3	0.4	0.8	4.0	0.1	0.5	0.8	0.3	0.5	0.0	0.1	1.2	0.0	0.8	0.5	0.4	0.0	0.6	0.1	0.7	0.8	0.5	0.1	0.5	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	135.5	0.3	0.0	2.1	1.1	362.2	0.0	0.0	0.1	0.1	0.3	3.8	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	67.7	0.0	0.0	0.0	0.0	32.0	0.2	0.2	0.0	0.1	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.4	1.8	0.3	0.3	0.3	0.4	0.3	0.6	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	351.7	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	266.6	0.1	0.8	0.1	4.9	0.0	0.0	0.2	8.3	2.2	11.7	0.0	1.4	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.2	0.0	0.0	0.0	86.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	17.6	5.8	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.1
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138677	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	9.6	10.4	17.5	7.2	18.2	19.1	8.5	16.7	22.2	10.1	15.7	6.5	7.3	10.5	5.2	9.3	12.1	6.3	8.9	17.7	18.0	8.0	10.0	7.8	9.4	17.1	18.1	12.9	10.9	12.7	11.7	6.6	16.9	8.8	4.8	7.1	11.0	7.1	15.5	9.9	5.6	7.2	15.5	8.3	6.8	9.4	18.2	7.0	11.0	10.3	6.6	6.5	8.2	18.2	14.5	29.0	12.6	32.2	33.7	16.9	19.8	17.2	16.8	21.3	16.6	46.6	25.6	26.5	22.5	25.5	13.8	17.0	20.5	29.7	12.3	29.2	16.0	38.8	17.3	34.2	31.1	15.9	25.6	20.7	22.2	28.4	24.9	16.0	20.3	21.1	38.6	24.6	19.1	51.2	17.6	12.3	11.9	10.0	20.8	30.1	10.8	37.9	21.6	12.2	26.9	17.1	22.8	30.1	14.3	6.5	22.2	11.1	19.2	32.9	18.2	20.0	13.3	25.9	14.7	37.7	1.1	19.2	18.3	0.0	2.4	0.3	3.0	2.2	3.2	2.0	2.6	2.5	3.5	2.0	2.5	2.9	0.2	2.0	3.1	2.6	2.9	2.2	17.5	18.2	16.7	22.2	17.7	18.0	17.1	18.1	16.9	15.5	18.2	18.2	10.4	12.8	11.7	30.0	22.2	9.4	17.6	15.7	14.8	58.1	16.6	16.8	9.0	12.8	9.2	11.0	66.7	24.6	20.4	6.8	23.5	16.4	31.0	11.8	18.1	13.0	9.6	134.5	29.7	8.9	35.2	17.3	15.8	9.4	3.8	49.2	15.7	10.2	19.7	55.5	30.8	11.7	10.2	14.2	6.4	73.8	22.7	12.8	12.4	15.9	16.4	29.5	79.3	21.1	40.4	11.4	6.6	19.5	14.0	23.3	8.0	23.9	11.0	57.2	6.6	15.6	14.9	62.2	43.0	16.0	5.5	15.3	18.8	28.2	14.4	10.4
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38844028	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 280.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Excitatory neurons: 41.7;Inhibitory neurons: 50.4;Oligodendrocyte precursor cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 280.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 23.3;SCLC-21H: 30.8;SiHa: 23.6;U-87 MG: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		420000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.7	5.0	91.6	1.9	75.4	0.3	2.8	0.3	145.7	8.7	0.0	9.5	1.3	10.9	3.8	3.0	7.9	2.0	15.7	280.2	17.0	1.6	1.9	1.9	1.6	4.1	15.2	8.1	5.2	7.0	6.8	0.4	0.7	8.1	1.5	5.3	4.8	7.0	0.6	1.1	3.3	7.6	3.1	2.5	5.0	1.8	58.0	0.7	2.7	2.5	1.5	7.3	4.8	46.0	1.0	6.2	0.2	1.8	12.2	1.2	0.0	4.1	0.9	7.9	2.7	6.2	1.3	0.0	7.2	1.1	23.3	0.8	1.7	0.2	2.6	0.6	2.0	0.0	0.2	9.6	1.2	0.1	0.3	3.9	0.4	7.2	0.1	11.4	0.3	0.1	7.7	0.3	0.3	9.7	0.0	0.5	7.3	3.0	2.2	1.6	0.0	15.3	2.0	17.1	30.8	2.0	23.6	0.1	0.7	1.7	9.9	2.5	0.4	14.1	8.4	0.0	0.7	2.1	0.0	0.0	87.9	18.5	7.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	91.6	75.4	0.3	145.7	280.2	17.0	4.1	15.2	0.7	3.1	58.0	46.0	4.7	0.0	0.0	9.4	0.3	1.1	2.7	0.9	0.0	6.6	3.3	1.5	18.0	4.3	3.0	3.7	2.1	0.0	2.3	0.0	0.0	7.3	1.7	1.7	3.2	4.2	1.8	0.0	41.7	3.8	0.0	1.5	0.5	3.0	0.0	1.5	5.0	0.4	0.2	0.0	50.4	0.2	6.1	0.3	0.9	0.8	1.8	0.3	1.8	1.9	0.0	4.8	6.2	19.1	10.5	2.0	0.0	2.2	0.9	3.8	0.1	0.5	2.2	3.3	0.0	2.4	2.8	0.2	1.3	0.1	1.0	0.0	1.7	0.3	0.0	3.4
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284188-24291862	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Neuropeptide	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 122.6;brain: 423.9;prostate: 332.8"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Region enriched"	"Detected in all"	7	"hypothalamus: 423.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"SH-SY5Y: 700.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000	21000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.8	122.6	32.8	12.8	59.0	5.6	2.2	11.0	39.1	1.3	11.3	2.9	9.7	0.3	0.3	2.3	0.5	1.1	0.8	31.7	423.9	0.5	0.2	0.3	0.0	24.2	25.1	0.5	8.8	0.1	4.7	0.0	15.2	332.8	1.9	4.4	0.3	3.9	0.2	0.2	13.1	1.2	18.8	0.0	8.8	1.1	29.2	0.2	0.9	0.2	0.0	1.4	23.8	33.1	0.0	0.0	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	2.0	0.0	0.2	20.5	0.0	0.6	0.0	0.0	0.8	700.2	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	59.0	11.0	39.1	31.7	423.9	24.2	25.1	15.2	18.8	29.2	33.1	0.0	0.0	0.0	2.0	0.5	0.1	1.3	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	56.7	0.0	0.0	0.0	0.0	16.1	0.3	0.7	1.8	1.0	0.0	0.8	0.0	2.0	1.9	0.3	0.0	0.4	0.0	100.6	0.0	0.0	0.0	0.7	0.0	15.6	0.3	2.4	2.8	0.0	0.0	5.1	0.3	0.0	0.0	2.0
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309390	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 32.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 62.5;RT4: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.2	32.7	1.4	0.0	1.3	0.0	0.2	1.0	1.5	2.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	1.4	1.3	3.6	2.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.7	19.3	5.9	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	62.5	0.0	0.0	2.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.0	1.5	1.3	1.8	1.4	1.3	1.3	1.2	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	8.2	0.0	0.0	1.9	1.2	0.1	1.8	0.0	2.6	0.0	0.0	10.6	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.0	0.1	0.0	0.0	4.9	0.0	0.1
NR1H3	"LXR-a, LXRa, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269033	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 13.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 45.3;HSkMC: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	60.7	19.9	11.3	19.4	11.8	3.3	51.1	11.2	14.3	25.3	10.2	24.6	48.4	13.6	17.6	7.6	20.3	19.6	18.5	10.3	11.1	23.4	83.8	24.1	46.7	11.0	12.1	15.2	16.7	6.8	7.2	25.4	11.7	19.4	12.0	2.2	14.8	11.5	9.1	11.7	41.0	7.9	10.5	53.2	16.3	21.8	13.8	11.0	20.3	6.3	13.6	22.4	17.5	11.5	3.5	13.8	6.4	6.1	41.0	45.3	31.1	3.5	17.9	5.7	8.8	17.0	43.2	6.1	6.5	2.8	2.1	9.2	7.6	6.1	3.8	5.8	6.1	8.3	18.7	26.1	17.5	2.9	1.0	61.2	3.7	8.7	5.5	9.7	5.0	9.4	10.2	2.5	4.5	14.8	5.8	17.0	7.1	18.7	4.5	8.4	8.3	4.1	5.0	31.9	6.1	2.3	12.2	7.9	10.4	6.1	19.5	8.8	1.3	4.5	6.1	9.1	2.0	11.9	18.3	7.6	8.2	3.9	2.2	7.8	2.7	2.5	1.4	13.3	1.9	1.0	1.5	1.3	4.3	0.7	1.7	1.4	1.6	5.8	4.2	0.7	3.8	1.9	11.3	11.8	11.2	14.3	10.3	11.1	11.0	12.1	11.7	10.5	13.8	11.5	27.2	0.0	11.3	8.1	3.0	3.3	8.6	4.6	2.2	2.4	12.7	12.1	6.6	15.7	4.9	5.5	2.1	11.0	1.5	24.4	11.7	5.8	31.0	2.4	15.3	12.5	1.8	7.0	9.2	8.7	13.3	14.1	17.9	2.8	13.3	7.1	24.7	66.6	54.4	1.7	10.9	14.6	2.0	100.9	3.3	49.0	9.0	24.7	3.6	1.0	5.4	4.4	2.1	3.0	5.6	4.2	10.7	6.0	2.4	4.1	69.5	26.1	2.5	0.8	19.7	7.4	16.3	32.4	16.8	3.0	2.4	6.6	2.1	5.4	19.0	6.3
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	14.1	12.4	11.4	18.0	12.0	19.1	13.6	21.6	13.3	15.7	2.5	16.9	18.4	17.1	9.8	12.4	15.3	11.3	15.7	12.4	9.0	13.9	13.0	16.8	18.0	7.6	6.1	18.6	14.2	14.2	19.2	9.7	4.6	13.7	11.7	36.2	13.5	11.5	20.1	19.5	18.8	12.8	4.7	19.9	14.8	20.7	8.7	22.4	24.3	17.9	15.7	14.4	13.7	13.5	18.3	20.2	22.8	17.7	15.8	18.8	52.0	25.8	20.7	20.5	21.0	13.0	17.4	28.0	13.2	23.3	17.9	17.9	21.2	13.3	21.2	37.1	30.0	36.8	45.8	12.0	13.4	27.3	27.3	15.0	17.2	25.9	13.4	17.1	23.5	27.2	26.6	18.7	18.3	16.2	41.9	21.3	15.1	8.6	20.7	33.4	27.1	18.8	9.9	27.1	14.5	36.1	23.5	19.4	23.2	17.9	19.5	26.7	30.5	31.6	37.2	29.1	35.6	28.4	40.0	30.4	22.7	25.6	28.2	2.7	0.9	0.7	1.6	1.2	1.5	0.8	0.9	1.0	0.9	1.8	1.2	1.1	1.2	1.0	1.1	1.5	0.9	0.6	11.4	12.0	21.6	13.3	12.4	9.0	7.6	6.1	4.6	4.7	8.7	13.5	14.0	22.4	12.2	35.9	15.7	3.7	11.1	1.0	17.1	17.4	15.1	9.7	6.2	11.5	4.7	7.3	14.6	7.8	15.2	16.5	5.9	6.6	58.8	8.0	10.3	13.4	25.1	20.4	35.5	7.2	7.3	11.5	14.3	9.1	9.5	17.2	18.9	8.2	7.8	13.5	39.9	10.2	0.0	20.1	2.3	65.4	19.3	14.2	5.4	52.5	13.6	13.9	9.2	50.8	92.2	12.3	12.4	20.7	14.2	19.6	13.0	6.8	13.7	17.2	0.0	18.8	10.3	33.9	22.2	13.3	3.1	14.9	15.3	17.0	10.4	18.4
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 2363.9;tongue: 1144.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	24.8	0.0	0.2	428.6	0.2	0.0	0.1	0.5	0.4	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	20.4	1.0	0.0	22.1	0.0	2363.9	0.8	0.1	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.4	1144.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 37.3;brain: 38.3;epididymis: 34.4;retina: 38.0"	"Group enriched"	"Detected in many"	7	"Astrocytes: 612.5;Excitatory neurons: 764.5;Inhibitory neurons: 392.4;Oligodendrocyte precursor cells: 1259.2"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"A549: 99.6;AF22: 94.8;EFO-21: 175.4;HMC-1: 187.9;SH-SY5Y: 115.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in brain"	NA	NA		110000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	3.1	37.3	19.8	1.8	31.9	0.3	1.5	2.4	34.6	5.0	0.0	0.8	0.7	2.1	34.4	0.7	3.6	7.3	0.4	33.1	9.4	6.2	0.4	2.3	0.8	2.3	22.7	1.5	29.4	7.3	11.4	7.8	2.0	0.8	0.7	38.0	1.9	14.2	0.2	0.8	0.6	0.7	1.5	4.8	1.8	1.7	38.3	2.8	4.1	0.4	2.7	0.5	0.4	2.6	0.1	99.6	94.8	0.0	11.4	2.2	1.8	0.7	0.4	1.0	1.7	40.7	0.0	0.0	175.4	0.7	1.5	0.4	2.2	1.6	1.0	0.1	12.7	0.0	0.7	1.0	0.2	0.9	187.9	15.5	0.0	0.2	0.6	0.2	61.7	0.2	0.2	0.8	1.5	38.2	0.4	0.3	13.1	60.1	0.0	0.0	27.8	33.3	21.4	0.1	18.6	115.9	1.3	0.0	1.9	3.3	0.2	0.1	66.2	4.2	1.0	0.1	16.4	0.2	0.5	0.9	0.7	0.1	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.2	19.8	31.9	2.4	34.6	33.1	9.4	2.3	22.7	2.0	1.5	38.3	2.6	0.2	0.0	0.0	612.5	0.8	0.4	0.1	0.8	1.2	66.2	1.5	0.9	0.7	7.2	0.1	5.5	102.2	3.6	0.0	0.2	3.9	1.6	37.3	10.4	2.4	1.3	0.0	0.0	764.5	12.1	0.2	2.0	3.6	25.0	23.4	4.4	1.4	0.4	0.8	13.5	392.4	0.3	0.0	0.8	0.4	8.3	0.9	0.2	3.6	51.5	0.6	45.1	0.0	1259.2	21.9	3.7	0.0	0.4	2.6	1.2	0.0	3.3	0.1	8.8	0.0	1.0	2.6	1.1	2.7	0.2	0.1	4.4	1.1	34.2	0.0	0.0
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267860-90331969	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, DNA damage, Mitosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.3"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA047050: AB_2679917, HPA050583: AB_2681182"	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	1.0	1.0	2.1	1.4	3.0	3.5	1.2	7.3	2.9	1.3	2.3	1.3	2.5	1.6	1.3	1.1	1.2	0.9	1.2	2.1	2.8	1.1	1.7	1.2	1.2	2.5	2.1	1.5	1.2	1.4	1.8	1.1	2.4	1.3	1.0	3.1	1.4	0.9	1.6	2.0	1.5	1.1	1.8	1.6	1.3	0.9	2.8	1.7	1.7	1.0	1.1	1.1	1.2	3.6	0.7	1.4	2.0	1.2	0.3	1.0	1.4	1.4	0.9	1.0	1.1	1.8	1.3	1.3	0.7	1.4	1.3	1.9	1.1	1.9	1.9	2.5	1.7	1.7	5.0	1.3	0.5	4.6	2.2	1.8	1.3	1.0	0.6	2.1	0.9	3.3	0.8	2.0	0.9	1.4	2.1	1.9	0.7	0.6	1.1	1.8	2.9	0.5	0.6	2.9	1.8	2.1	0.6	3.8	1.0	0.7	1.7	1.9	1.2	1.5	0.7	0.9	0.6	1.6	1.9	1.3	1.4	0.8	1.8	1.6	0.8	1.0	0.8	0.5	0.6	0.8	0.5	0.6	0.4	1.0	0.5	0.6	1.3	0.7	0.4	1.1	0.5	0.2	2.1	3.0	7.3	2.9	2.1	2.8	2.5	2.1	2.4	1.8	2.8	3.6	18.2	35.3	29.7	11.4	21.6	5.9	7.0	13.3	17.1	79.4	19.7	14.9	13.2	37.1	18.8	18.4	87.6	19.1	26.4	23.3	7.9	16.6	8.6	15.2	23.8	20.8	24.7	13.7	10.0	14.6	13.0	16.7	18.8	18.0	38.6	24.7	28.2	42.1	11.8	53.8	12.2	24.2	14.2	17.6	6.7	9.7	23.6	12.8	8.8	4.7	25.1	30.4	30.9	15.1	18.8	14.0	17.7	33.1	9.4	8.0	36.5	18.6	11.4	111.3	0.0	26.6	16.5	24.3	39.4	9.3	6.3	25.2	18.6	18.3	23.7	5.5
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639222-32855666	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 1466.4;Inhibitory neurons: 411.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"classical monocyte: 55.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 55.3"	"Cell line enhanced"	"Detected in many"		"A549: 132.5;BJ: 91.3;fHDF/TERT166: 98.1;GAMG: 95.4;U-2197: 84.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.5	1.2	3.5	6.1	3.2	1.4	5.7	8.7	13.2	8.0	3.2	3.2	2.9	1.2	0.6	2.8	1.1	2.3	1.9	0.4	12.7	8.6	17.0	3.7	0.4	35.4	8.0	1.9	0.7	0.6	3.8	0.2	35.3	2.6	3.2	11.6	2.6	1.0	0.1	4.9	2.5	1.0	2.7	1.6	2.5	5.3	2.6	0.8	9.9	0.0	2.1	9.4	3.4	8.2	0.4	132.5	1.8	0.0	0.9	2.5	0.2	91.3	60.0	65.3	55.8	0.0	2.9	0.0	16.4	98.1	95.4	76.7	0.3	34.5	69.4	0.2	0.7	1.3	1.8	2.0	0.4	0.1	0.2	1.3	3.4	81.1	74.6	5.7	41.2	0.1	0.0	0.7	24.4	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.9	0.0	52.9	3.6	3.4	4.0	7.5	0.0	0.1	5.0	0.0	0.3	34.7	50.7	15.8	84.4	53.6	0.1	0.0	0.9	28.2	0.1	6.6	0.2	55.3	0.9	0.2	4.7	0.2	0.1	0.1	0.0	12.1	0.1	0.0	0.0	2.0	0.2	0.2	0.2	0.0	14.2	3.5	3.2	8.7	13.2	0.4	12.7	35.4	8.0	35.3	2.7	2.6	8.2	0.1	38.5	2.7	29.7	0.8	26.0	48.0	5.1	21.1	11.0	4.3	18.2	2.0	8.6	7.9	3.7	8.4	0.0	1.3	0.0	9.8	1.8	41.5	0.1	1.9	5.7	0.0	0.0	1466.4	0.2	0.0	10.5	0.0	0.2	1.3	3.2	7.1	5.3	0.5	28.6	411.8	0.0	2.0	10.2	1.9	23.5	0.3	22.1	1.8	36.5	49.2	5.0	0.0	54.3	19.2	0.9	0.0	0.4	0.0	42.9	0.0	18.7	2.4	3.1	0.0	0.1	9.3	11.3	5.0	3.2	6.1	0.0	0.6	0.0	0.0	6.5
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875194-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.3;retina: 5.2"	"Group enriched"	"Detected in some"	18	"Astrocytes: 2921.6;Excitatory neurons: 3761.0;Inhibitory neurons: 3088.3;Oligodendrocyte precursor cells: 1175.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;SK-MEL-30: 2.7;U-2 OS: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075789			Uncertain	Vesicles	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.1	0.4	16.4	0.3	11.4	0.0	1.3	0.0	17.3	0.1	0.0	0.4	0.1	0.0	0.0	0.1	4.7	2.8	0.4	16.1	2.6	0.7	0.5	0.7	0.1	1.2	6.3	0.0	0.1	0.1	2.0	0.3	0.4	0.1	0.1	5.2	2.6	0.2	0.0	0.6	0.1	0.1	2.5	0.1	0.3	1.8	9.9	0.0	0.2	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	11.4	0.0	17.3	16.1	2.6	1.2	6.3	0.4	2.5	9.9	3.5	0.1	0.0	0.0	2921.6	0.1	0.0	0.0	0.0	0.0	15.9	0.7	0.6	0.8	2.8	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.9	31.4	0.0	0.0	0.7	0.0	0.0	3761.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	3088.3	0.0	0.0	0.0	0.0	12.8	0.6	0.1	0.0	148.0	0.0	6.7	0.0	1175.2	50.2	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	30.4	10.2	5.8	10.2	5.2	26.4	14.2	14.9	6.9	24.7	6.5	18.2	16.8	18.2	13.4	9.4	21.4	10.3	5.4	6.4	8.1	15.9	26.9	8.9	8.7	4.8	4.5	13.3	14.4	7.4	3.2	14.6	5.3	10.3	18.1	31.8	6.1	8.4	22.3	4.1	18.3	20.1	6.4	13.1	8.9	8.1	6.7	17.0	5.6	23.8	7.2	14.1	8.4	8.3	22.1	43.5	34.6	0.0	17.4	11.3	12.6	26.1	11.7	16.0	12.5	8.7	17.3	0.1	14.5	23.3	7.9	11.0	2.2	15.6	33.9	0.0	10.0	33.4	15.3	27.2	10.5	16.7	6.7	14.1	21.3	17.6	20.5	17.8	12.6	4.8	24.1	17.4	11.4	11.8	7.8	0.1	14.5	8.8	13.9	92.4	28.0	0.8	9.8	35.8	3.2	0.1	21.7	11.3	8.8	27.7	27.2	12.9	22.0	13.7	9.1	21.4	10.8	8.5	0.2	0.1	29.0	0.0	6.8	0.0	0.4	0.2	0.3	0.2	1.8	0.3	0.3	0.4	0.6	1.0	0.5	0.2	0.1	0.5	0.5	0.6	0.2	0.2	5.8	5.2	14.9	6.9	6.4	8.1	4.8	4.5	5.3	6.4	6.7	8.3	33.2	48.1	37.6	60.7	27.4	18.6	122.6	16.2	22.8	33.9	52.9	26.8	18.3	21.5	40.9	29.5	50.1	16.4	20.7	50.1	9.8	23.0	15.8	60.9	99.1	43.0	37.7	24.2	123.7	27.6	120.8	42.3	26.5	130.9	31.5	94.0	27.1	44.7	45.7	21.9	95.0	41.6	18.3	50.4	21.9	19.3	37.6	57.9	8.8	219.2	40.4	56.2	27.8	102.1	78.2	31.4	42.6	27.1	10.1	49.5	43.0	36.5	15.9	63.1	32.9	112.1	38.6	12.1	6.3	23.1	18.8	14.1	19.9	71.0	47.7	99.8
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 48.6"	"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.3"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		780000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	125.2	42.3	9.3	43.3	9.4	3.7	62.2	0.0	26.0	36.9	13.3	26.6	21.3	51.6	35.7	19.7	34.5	54.1	80.8	48.6	9.1	52.7	53.1	63.7	23.7	4.0	3.9	43.0	33.0	24.4	9.0	133.7	2.1	21.3	23.6	11.6	19.3	38.4	55.9	22.1	21.0	55.9	5.7	66.7	18.6	12.9	13.4	18.2	49.7	46.6	12.4	35.3	20.0	10.7	57.4	217.8	11.1	1.1	204.8	224.7	1.3	224.4	216.2	109.6	118.2	28.9	132.4	1.1	26.6	444.6	116.8	15.8	13.8	65.2	89.3	0.7	11.2	0.6	24.5	48.7	74.3	20.8	1.6	277.3	11.2	261.7	116.8	371.6	304.0	1.4	0.7	1.4	221.3	96.8	1.4	3.9	5.5	11.9	204.2	9.6	24.8	1.2	109.7	1.3	5.1	2.7	23.0	17.5	0.9	9.2	1.0	3.3	369.5	156.4	36.9	193.0	153.8	0.7	1.1	0.7	425.2	26.4	143.5	0.4	2.5	0.5	0.6	0.4	1.0	0.7	0.7	0.6	2.3	0.6	0.6	0.6	0.4	1.2	0.3	39.3	0.6	0.9	9.3	9.4	0.0	26.0	48.6	9.1	4.0	3.9	2.1	5.7	13.4	10.7	366.0	0.0	20.2	80.3	4.3	15.7	10.6	5.5	7.4	10.5	4.2	5.5	67.6	28.6	13.0	18.4	4.2	61.5	29.4	0.6	1.9	57.9	1.3	11.3	116.9	174.4	4.2	3.2	105.4	18.9	13.4	58.5	6.6	11.0	7.6	62.3	184.6	12.5	135.4	0.0	14.4	1.8	16.2	62.7	33.3	5.5	42.3	46.0	12.4	78.7	5.8	3.4	0.0	11.6	2.3	15.4	0.0	21.1	1.6	4.1	3.0	59.8	5.4	0.9	282.7	13.1	117.9	0.2	1.3	2.7	10.5	67.2	3.8	61.1	1.5	3.3
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 78.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 134.4;Hepatic stellate cells: 137.8;Hofbauer cells: 141.3;Langerhans cells: 129.8;monocytes: 224.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 123.6;HUVEC TERT2: 105.7;TIME: 106.3;U-251 MG: 217.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039980, HPA054974"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA		29000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA039980: AB_10795517, HPA054974: AB_2682657"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (7.80e-5)"	18.8	22.2	18.0	17.8	13.8	4.6	12.6	9.3	11.7	18.8	7.0	78.7	5.3	51.8	3.7	13.3	21.1	31.1	6.3	21.7	42.5	4.9	9.6	24.3	8.2	30.4	23.9	46.8	1.9	2.5	9.6	47.0	19.6	13.0	10.5	3.6	3.3	30.9	2.3	4.8	14.9	54.8	13.2	7.5	25.9	1.4	33.9	6.1	10.8	3.4	4.5	38.3	15.9	12.4	2.5	50.4	32.2	0.2	30.1	9.6	9.3	8.5	14.8	10.0	9.5	48.0	123.6	0.0	11.9	25.3	20.5	19.2	1.5	15.9	16.8	0.1	6.8	0.5	2.4	0.4	80.7	0.0	2.1	68.5	12.2	14.4	12.3	64.5	105.7	0.2	0.2	0.1	6.8	0.2	0.0	0.0	41.5	0.1	9.2	0.2	2.0	12.0	21.7	0.0	29.0	1.0	1.1	0.3	75.4	84.9	0.1	0.8	106.3	43.1	0.4	11.3	217.0	0.0	0.2	3.2	96.9	0.3	88.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	13.8	9.3	11.7	21.7	42.5	30.4	23.9	19.6	13.2	33.9	12.4	88.7	89.8	57.5	2.0	3.8	19.4	19.5	30.8	97.9	36.5	1.3	11.3	4.5	5.7	53.2	1.8	0.0	89.7	0.1	0.6	0.0	6.4	6.3	8.8	8.1	134.4	1.2	2.7	4.1	3.8	8.7	47.0	1.5	13.2	3.8	2.7	137.8	1.8	141.3	0.0	9.4	1.1	4.1	28.0	129.8	18.9	2.8	53.7	19.6	53.4	224.8	4.8	0.0	4.0	8.1	53.2	0.0	4.9	0.2	9.1	0.0	0.6	48.1	2.7	0.0	4.6	32.2	1.4	1.4	17.8	12.6	25.7	2.4	48.1	0.4	51.5
NRXN3	"C14orf60, KIAA0743"	ENSG00000021645	"Neurexin 3"	"Q9HDB5, Q9Y4C0"	14	78170373-79868291	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.8;retina: 42.9"	"Group enriched"	"Detected in many"	10	"Excitatory neurons: 3526.5;Inhibitory neurons: 5083.8;Oligodendrocytes: 2145.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 106.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 9.7;RT4: 24.7;SK-BR-3: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002727	Approved					NA	NA		710000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002727: AB_1079468"	"unprognostic (7.96e-2)"	"unprognostic (5.70e-4)"	"unprognostic (8.18e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.31e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.83e-7)"	"unprognostic (4.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	0.8	5.9	13.4	2.8	17.0	0.1	1.6	106.8	48.3	3.9	0.0	23.0	2.3	5.4	1.7	4.7	5.0	2.5	3.0	23.6	21.3	1.7	0.4	2.6	0.4	8.6	24.2	0.7	3.1	8.8	4.9	1.3	7.2	6.7	4.1	42.9	2.8	11.3	0.3	1.8	8.4	21.1	0.0	5.8	9.3	7.5	4.2	1.0	0.5	0.5	0.4	4.4	2.7	21.5	0.0	0.0	7.6	0.0	0.2	0.3	0.0	3.0	2.2	9.7	7.3	2.6	0.0	0.1	0.0	0.3	0.0	2.8	0.1	0.3	6.8	3.0	6.0	0.0	0.2	0.0	0.7	0.0	0.0	1.8	0.3	4.3	1.4	4.6	2.5	0.0	0.0	0.2	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.2	0.0	0.0	5.2	24.7	1.3	0.0	0.0	9.3	0.5	3.1	0.0	0.0	0.0	0.1	6.2	0.0	3.2	0.0	0.0	0.0	1.8	0.3	5.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.4	17.0	106.8	48.3	23.6	21.3	8.6	24.2	7.2	0.0	4.2	21.5	0.2	12.8	5.5	100.2	0.0	4.6	7.0	0.4	0.6	180.7	3.2	3.0	3.9	1.5	3.4	3.7	12.5	9.2	0.0	1.1	0.0	2.2	15.9	36.3	2.2	0.8	6.0	0.0	3526.5	3.1	0.5	1.8	0.0	31.5	0.0	0.8	1.4	0.1	0.7	116.1	5083.8	0.6	4.1	0.0	0.3	18.9	7.5	0.3	17.8	88.1	0.0	54.3	0.0	328.2	2145.0	0.7	0.2	6.4	1.2	7.5	0.0	0.1	9.3	10.7	0.0	0.4	2.2	2.1	0.8	0.1	0.9	37.9	0.6	0.0	1.0	3.0
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300213	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	8.7	7.2	8.9	12.0	13.4	21.2	10.9	26.2	10.4	11.1	9.8	10.1	8.4	11.5	10.3	11.4	10.1	8.0	9.1	7.7	10.0	10.6	6.6	9.2	13.7	9.7	10.8	12.3	11.3	12.8	9.0	10.7	12.2	9.3	10.8	11.9	10.4	9.6	13.6	12.0	9.4	12.0	6.6	11.3	8.9	23.2	12.0	20.2	15.5	11.5	14.7	9.3	7.9	17.5	20.5	25.9	26.0	22.8	12.5	16.1	0.9	18.2	17.9	24.6	22.8	5.7	16.6	41.7	19.9	24.8	22.7	17.0	41.9	40.0	29.7	72.9	25.9	18.6	29.5	0.2	20.7	40.4	21.2	15.2	23.6	29.4	27.3	17.5	36.4	26.0	25.9	14.3	25.2	42.3	28.3	13.1	28.5	13.7	22.5	31.0	3.4	12.9	15.9	24.4	31.6	21.9	46.7	20.1	13.8	24.1	20.2	33.0	27.4	17.1	25.0	11.0	22.6	16.7	15.7	29.5	9.9	19.3	18.7	14.7	9.0	10.5	7.2	6.1	6.0	8.5	6.1	5.0	7.2	10.3	7.5	6.0	18.6	11.3	12.2	9.4	6.4	3.4	8.9	13.4	26.2	10.4	7.7	10.0	9.7	10.8	12.2	6.6	12.0	17.5	37.4	22.4	31.4	84.9	71.7	17.0	32.8	27.2	34.1	94.4	29.8	25.7	44.5	34.3	35.0	55.2	150.1	43.6	66.1	19.7	17.6	27.8	31.9	27.1	65.7	36.4	41.9	48.3	107.0	21.2	23.7	32.7	41.8	41.9	41.7	64.0	33.5	19.9	27.7	89.2	110.3	25.6	12.2	36.8	25.7	50.3	51.0	47.1	16.0	115.2	75.0	29.2	95.8	140.8	157.5	23.7	31.0	33.1	55.8	29.4	33.6	19.2	17.3	112.3	52.6	42.9	36.1	83.7	62.1	41.8	20.6	35.4	62.0	55.9	28.2	30.0
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1900000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	22.8	37.7	38.3	13.5	39.5	27.8	21.5	37.0	45.9	23.2	41.6	23.0	14.9	22.5	26.8	28.5	26.1	13.5	29.1	39.7	38.6	21.4	26.3	18.0	15.2	39.0	39.0	25.7	15.5	23.9	14.1	21.1	39.8	20.9	18.4	22.6	19.3	26.4	69.0	36.6	17.6	22.9	36.4	19.8	18.0	14.8	38.6	21.0	20.0	43.3	18.6	22.4	21.6	39.7	55.6	64.4	35.9	32.0	30.5	31.4	28.7	21.0	41.8	57.7	41.3	53.9	43.1	31.6	16.6	47.8	47.2	50.4	25.9	70.3	40.8	12.3	25.1	29.8	10.3	61.4	33.8	30.7	16.4	23.5	33.3	55.3	20.3	30.8	46.8	23.4	42.5	26.5	36.2	29.1	31.4	54.7	40.7	42.5	65.4	14.7	41.1	29.8	68.6	37.1	20.5	23.4	29.6	59.8	26.7	18.8	36.5	22.0	37.8	38.7	29.4	23.9	40.2	21.9	41.8	24.7	28.9	43.0	29.3	31.4	21.3	80.3	20.0	26.6	19.7	35.0	21.2	19.5	29.7	36.0	23.4	20.7	69.1	16.7	28.1	23.1	28.2	25.5	38.3	39.5	37.0	45.9	39.7	38.6	39.0	39.0	39.8	36.4	38.6	39.7	34.6	22.4	23.2	17.3	36.1	89.2	63.5	106.3	44.3	60.2	28.6	26.0	35.4	24.3	57.8	31.3	22.9	150.7	29.7	68.2	56.7	104.7	23.0	51.0	29.6	44.3	43.6	41.0	24.0	94.5	146.0	41.1	30.5	54.9	40.5	49.1	31.1	42.2	81.1	70.7	24.8	42.5	61.1	43.7	43.6	38.8	39.1	43.8	42.7	14.0	52.9	61.7	32.0	17.6	31.2	123.4	65.7	46.3	41.8	76.0	66.4	73.8	43.2	44.5	78.9	44.2	64.7	106.1	103.2	55.1	75.7	151.6	31.6	48.9	44.0	88.5
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 35.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 159.5;Late spermatids: 300.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.5	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.1	2.6	0.1	0.7	0.1	0.0	1.0	0.1	0.7	0.6	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.0	0.1	0.2	0.8	35.5	0.4	0.0	0.7	0.0	0.0	0.3	0.1	0.2	1.2	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.4	0.1	0.0	1.0	0.0	0.1	0.2	0.2	0.6	0.1	0.2	0.3	0.0	1.1	0.8	0.4	0.9	0.1	0.5	0.1	0.2	0.2	0.6	0.5	0.3	1.0	0.1	0.3	0.2	0.7	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.4	0.4	0.1	0.3	0.8	0.7	0.0	0.2	0.0	1.2	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	159.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	300.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG45, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103087185-103277605	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	24.6	27.0	25.0	19.0	27.2	29.7	23.0	27.3	28.5	37.6	36.8	27.3	9.9	18.8	17.3	67.1	26.5	16.4	28.5	25.2	28.8	32.5	27.8	30.8	18.3	26.9	29.5	32.4	22.0	21.7	34.0	17.9	27.2	32.4	16.7	47.3	46.4	18.4	51.6	19.9	20.4	13.4	26.4	32.8	22.3	30.8	27.2	28.6	55.4	18.1	24.5	33.3	42.7	28.6	148.4	52.5	32.6	67.5	27.2	33.2	18.2	66.0	64.7	29.9	32.4	34.6	91.7	49.2	47.7	45.6	27.6	62.8	23.4	33.8	38.3	40.3	21.6	38.7	21.1	39.6	48.5	64.2	21.0	50.4	34.1	28.0	24.8	57.5	25.6	19.4	29.4	36.4	54.5	73.8	53.7	64.6	34.6	43.2	68.6	102.6	30.0	19.6	43.3	72.5	10.0	24.9	35.8	25.9	50.3	33.7	39.2	38.1	30.5	20.5	24.8	39.7	51.7	32.9	71.6	85.5	23.9	64.6	7.8	29.5	16.5	31.3	10.0	18.8	10.3	8.9	8.4	8.7	14.7	5.2	6.7	8.0	27.4	14.4	23.0	9.6	9.3	10.5	25.0	27.2	27.3	28.5	25.2	28.8	26.9	29.5	27.2	26.4	27.2	28.6	16.2	83.3	34.9	141.7	17.2	7.4	29.0	26.9	5.7	24.4	13.9	13.6	2.6	18.6	60.4	27.6	45.9	19.4	23.3	48.7	11.7	28.5	103.7	29.5	17.1	19.8	11.5	12.4	79.8	26.0	11.7	17.5	25.5	46.2	8.8	18.2	13.9	17.4	19.9	47.1	83.6	17.6	18.3	29.8	14.2	61.9	24.8	27.1	26.6	78.7	25.9	85.5	16.5	70.4	107.5	57.9	23.1	13.5	21.0	35.7	11.7	15.3	44.1	59.1	32.9	22.9	21.7	25.3	20.5	22.9	7.5	35.0	16.6	15.8	18.0	80.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 321.8;choroid plexus: 89.2;retina: 74.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	175	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	175	"dendritic cells: 17.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"	NA	NA		58000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	17.9	4.7	137.2	2.3	138.8	0.0	2.9	165.1	321.8	1.6	89.2	12.0	2.5	1.3	0.6	9.4	0.9	9.6	30.5	136.9	131.5	2.3	0.3	25.8	0.4	144.0	135.4	0.3	0.9	22.1	0.9	0.7	143.6	1.9	3.8	74.8	2.7	2.8	0.9	6.1	4.6	4.5	135.0	0.5	2.0	0.6	154.2	0.5	1.1	5.0	0.4	3.5	1.8	158.4	0.1	0.0	7.5	0.1	0.9	22.2	0.0	36.7	19.5	11.7	6.8	0.1	0.0	0.0	0.0	20.3	0.0	0.3	0.0	43.6	12.6	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.2	2.0	0.0	38.0	45.0	29.0	7.5	0.0	0.0	0.3	122.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	3.9	20.8	0.0	2.4	3.8	0.0	0.0	0.2	1.3	0.0	0.1	8.1	47.7	81.8	2.2	31.6	0.0	0.0	0.2	0.1	0.0	166.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	137.2	138.8	165.1	321.8	136.9	131.5	144.0	135.4	143.6	135.0	154.2	158.4	1.2	608.9	27.6	2164.2	0.0	1.8	0.0	1.5	2.2	225.3	0.9	4.4	13.7	0.0	29.7	20.2	950.8	0.0	5.4	0.4	0.0	0.6	10.9	0.0	0.5	2.9	0.0	2.7	651.0	0.0	0.0	22.2	0.5	0.0	53.0	0.1	0.7	0.0	0.1	40.4	1056.6	0.1	0.0	0.0	3.8	2.2	0.3	0.7	3.6	139.6	0.0	30.5	0.0	1930.7	1257.6	0.1	0.2	0.4	0.1	0.1	0.0	0.1	1.5	1415.0	0.0	20.6	7.5	0.4	0.9	0.5	4.8	0.0	0.8	0.0	0.8	0.1
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027054	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 230.0;thyroid gland: 116.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1144.3;Excitatory neurons: 750.1;Inhibitory neurons: 877.7;Oligodendrocyte precursor cells: 557.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;HaCaT: 3.0;RPTEC TERT1: 9.7;SH-SY5Y: 11.2;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Supported	"Plasma membrane"		NA	NA		20000000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	40.5	2.7	201.9	1.7	177.8	0.1	62.2	133.3	190.6	9.8	69.8	5.9	0.4	3.9	3.9	8.2	5.6	33.3	15.2	173.3	230.0	20.4	1.8	10.0	3.1	119.4	218.9	9.7	34.3	2.5	10.1	1.8	151.7	4.7	3.6	41.2	14.4	19.1	2.9	11.6	1.6	3.3	116.6	10.9	1.9	2.4	222.1	4.0	116.9	13.8	4.3	4.9	12.0	117.7	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	9.7	0.7	0.7	11.2	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	201.9	177.8	133.3	190.6	173.3	230.0	119.4	218.9	151.7	116.6	222.1	117.7	17.4	0.0	0.5	1144.3	0.7	56.6	1.0	1.8	93.9	30.3	144.1	116.8	11.4	0.0	0.2	9.2	6.2	0.0	1.0	8.7	27.4	36.1	1.8	1.2	0.4	8.0	0.0	0.0	750.1	0.7	0.1	76.6	0.0	2.3	0.0	0.1	5.0	0.0	0.2	242.3	877.7	0.7	0.0	0.0	14.2	3.6	104.1	1.4	17.8	65.6	0.6	241.0	0.0	557.9	109.5	0.5	7.0	48.2	0.3	0.9	0.0	7.1	1.7	12.2	124.9	9.9	114.4	0.8	2.3	5.2	24.6	0.0	3.3	0.2	7.2	0.9
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 100.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		19000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	12.8	3.7	31.3	0.8	33.2	0.1	7.8	30.7	34.3	12.8	0.0	3.4	0.5	10.4	3.2	1.3	15.0	1.6	5.8	38.8	25.8	5.1	1.0	5.3	1.2	21.5	19.6	7.2	1.0	0.1	12.2	1.0	22.1	9.0	2.0	5.2	6.8	4.3	1.8	4.8	2.2	3.7	10.9	2.5	3.2	9.8	33.4	1.2	3.0	1.9	2.0	8.7	7.4	21.5	0.0	13.1	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	2.6	0.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	100.6	1.8	0.0	1.3	0.0	0.0	0.0	3.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	31.3	33.2	30.7	34.3	38.8	25.8	21.5	19.6	22.1	10.9	33.4	21.5	0.5	0.0	0.0	239.3	0.0	0.5	6.4	0.0	0.0	53.8	3.7	6.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	119.6	0.4	25.0	1.2	0.0	0.0	360.0	0.0	0.0	5.7	0.0	0.5	0.0	0.0	2.2	0.0	1.0	1.7	277.8	0.0	0.0	0.0	0.6	148.9	3.4	0.6	0.0	177.1	0.0	8.6	0.0	499.6	7.4	0.0	0.0	27.4	0.0	1.3	0.0	0.1	0.0	3.7	52.6	20.3	40.9	11.0	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.7
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900312-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		27000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	181.3	103.5	55.8	106.8	60.4	82.3	141.6	65.5	68.1	115.0	79.4	122.1	179.9	127.6	61.3	111.2	116.9	108.3	204.0	58.2	63.0	154.6	264.5	157.1	82.1	65.9	62.9	125.6	130.1	173.5	69.5	114.8	67.5	109.2	54.8	30.2	117.8	103.0	180.1	96.6	163.6	106.0	57.7	111.1	118.8	34.7	73.1	49.5	122.2	110.7	53.1	130.1	108.9	61.6	54.8	182.1	84.2	188.5	304.6	249.2	97.6	208.1	189.9	103.3	144.2	92.9	203.1	54.7	151.8	250.6	98.9	132.0	48.6	107.0	43.3	194.6	90.3	141.6	119.0	131.6	156.6	85.1	183.6	288.0	52.1	96.8	62.9	275.2	167.2	60.7	173.1	278.8	107.0	71.6	42.3	68.6	42.2	132.1	93.5	78.7	125.3	114.9	90.2	134.6	61.2	123.2	247.1	152.2	88.1	79.7	78.8	112.1	234.6	172.3	114.3	107.0	99.3	210.8	501.1	37.1	132.5	54.3	207.3	102.9	108.5	105.7	100.6	128.5	75.3	46.8	67.5	77.2	79.0	37.3	55.3	56.7	104.7	69.2	114.2	113.9	74.6	129.5	55.8	60.4	65.5	68.1	58.2	63.0	65.9	62.9	67.5	57.7	73.1	61.6	154.5	41.7	72.1	17.6	51.0	48.3	67.2	81.3	66.0	21.7	57.6	57.5	58.0	78.6	51.5	69.9	14.6	101.5	69.6	153.0	41.1	148.0	10.8	27.4	65.5	116.0	74.4	54.5	14.5	118.3	150.9	126.7	76.0	50.2	95.2	64.1	122.0	149.2	213.7	20.2	18.9	109.9	69.2	138.3	74.6	9.3	110.3	101.9	101.4	17.8	120.3	52.6	74.2	8.5	11.8	100.0	149.2	124.1	126.3	63.8	453.3	135.4	24.4	20.5	92.1	51.0	79.0	21.9	37.6	65.6	49.9	102.1	73.0	103.9	123.3	68.1
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"	P80303	11	17208153-17349980	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 758.3;salivary gland: 771.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 1867.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000	690000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	56.2	75.7	23.9	62.1	27.8	619.9	141.1	28.8	32.1	137.2	58.0	68.3	57.3	60.8	458.2	146.3	107.2	60.8	95.7	22.8	34.7	43.2	102.2	49.8	60.2	25.7	28.2	56.0	758.3	479.1	113.0	90.9	26.8	70.9	68.4	64.5	771.4	190.9	38.5	21.1	40.7	78.5	26.2	42.2	92.9	119.2	28.4	334.2	153.9	30.4	78.5	61.8	44.9	26.6	119.9	49.0	53.7	163.4	118.9	162.3	65.0	260.5	381.0	115.1	203.0	48.7	26.8	182.9	63.5	250.7	107.1	50.1	34.4	66.8	178.7	126.7	76.3	135.8	57.8	85.2	340.5	1867.0	238.6	71.1	86.8	82.9	200.9	284.9	143.3	672.1	120.1	361.1	114.9	105.9	656.2	670.3	12.9	194.0	50.5	239.8	130.4	15.1	51.9	37.5	63.5	35.4	114.6	114.2	61.4	78.0	93.5	498.1	128.1	120.9	110.9	369.1	112.1	70.3	41.3	101.1	140.5	646.1	106.4	210.5	43.5	168.2	94.1	30.5	122.9	22.7	88.5	173.7	40.6	14.5	246.7	271.2	39.3	277.9	25.6	426.0	42.7	119.8	23.9	27.8	28.8	32.1	22.8	34.7	25.7	28.2	26.8	26.2	28.4	26.6	118.7	44.8	70.4	16.3	54.8	27.5	60.2	156.3	14.8	71.0	152.8	87.0	193.8	55.8	176.5	42.3	54.2	127.1	136.5	17.6	27.4	91.1	690.6	112.4	92.9	94.7	42.4	137.8	21.9	132.6	319.1	148.8	40.2	97.0	67.6	80.0	108.5	141.8	70.7	35.3	23.5	189.0	189.2	29.4	40.0	508.5	149.8	37.6	69.4	18.7	24.1	111.2	95.8	13.6	10.8	75.2	13.2	114.3	256.5	108.7	3.9	28.5	618.8	99.3	46.0	50.8	75.4	174.9	61.3	87.7	30.1	1158.2	92.3	88.3	45.3	61.2
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165330-12196144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	35.1	32.4	23.0	30.6	26.4	24.1	26.7	27.5	30.5	24.6	29.5	32.0	27.5	14.3	23.7	40.7	24.6	18.4	14.9	23.4	26.0	36.3	88.8	26.0	39.3	27.3	24.9	18.0	25.9	33.1	35.5	31.1	27.4	21.0	36.0	27.4	25.1	14.0	6.2	33.2	25.4	17.6	25.0	34.2	22.6	13.1	25.4	53.5	27.8	7.6	47.4	28.9	27.8	31.8	136.4	98.0	114.6	107.1	107.5	105.6	100.8	96.9	61.5	111.9	119.1	142.5	125.9	134.2	82.4	79.2	70.0	133.1	162.0	150.6	102.1	110.8	160.8	111.9	114.3	209.3	112.0	77.1	75.2	111.7	88.4	122.3	61.7	86.3	144.9	209.4	153.5	88.9	103.2	123.8	143.5	87.0	100.4	215.0	60.1	128.0	42.4	157.2	106.0	46.1	56.6	82.3	117.4	90.8	142.2	132.0	155.9	77.9	91.6	47.0	90.6	134.3	121.9	74.3	141.6	179.3	99.7	97.3	36.0	29.6	60.8	115.2	69.9	65.7	80.4	72.7	73.9	82.6	87.6	64.6	50.4	68.4	163.8	57.4	52.2	149.2	123.4	71.6	23.0	26.4	27.5	30.5	23.4	26.0	27.3	24.9	27.4	25.0	25.4	31.8	42.1	25.6	55.1	23.2	43.8	43.0	57.8	121.2	28.5	21.1	28.6	30.7	4.5	32.9	72.3	23.9	16.7	82.6	49.8	35.0	74.3	82.2	35.3	61.1	44.4	42.6	38.3	43.5	34.6	82.9	150.6	40.3	33.1	31.9	31.7	41.4	41.7	131.8	128.7	21.9	38.2	41.2	79.3	41.8	32.2	11.7	39.4	39.7	30.2	12.2	85.0	37.4	62.8	34.2	41.2	73.8	35.2	29.0	66.1	33.7	52.6	130.6	103.9	25.5	32.9	21.2	40.1	20.2	33.6	52.4	60.5	58.1	49.7	54.4	57.4	46.9
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUMBL	"CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23"	ENSG00000105245	"NUMB like endocytic adaptor protein"	Q9Y6R0	19	40665905-40690972	"Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 42.6;Peritubular cells: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA058251, HPA058380"	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058251: AB_2683653, HPA058380: AB_2683698"	"unprognostic (2.78e-2)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (7.55e-15)"	"unprognostic (1.91e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.69e-3)"	31.3	16.2	25.0	8.1	27.7	3.0	22.2	19.1	31.2	49.3	0.1	35.2	8.4	45.2	6.2	17.6	46.6	11.4	25.9	31.3	18.5	12.4	15.4	25.6	3.9	6.3	11.9	38.8	10.1	2.4	72.4	5.7	10.6	35.2	3.8	5.2	14.7	13.9	11.4	17.9	18.2	12.5	3.9	12.6	22.2	25.3	17.4	2.3	28.4	6.1	2.6	36.2	38.0	13.9	17.0	46.4	9.7	25.7	22.8	22.4	5.4	20.2	17.5	11.7	14.1	17.5	12.4	6.2	19.7	29.4	8.8	16.4	7.1	8.8	6.2	16.8	11.8	6.8	47.0	2.4	24.2	3.4	7.7	21.5	5.9	19.2	8.1	18.2	16.7	5.4	20.0	7.1	8.2	15.5	10.8	3.3	11.3	9.9	10.7	9.1	26.5	12.7	3.4	4.7	19.3	34.1	22.2	12.9	19.7	6.1	13.1	5.7	31.9	21.2	24.1	33.7	25.6	9.3	11.9	3.9	34.1	10.8	12.3	0.0	0.1	0.0	1.1	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.4	0.2	0.0	0.8	0.2	0.0	0.2	25.0	27.7	19.1	31.2	31.3	18.5	6.3	11.9	10.6	3.9	17.4	13.9	6.9	0.0	3.4	13.4	2.7	13.6	14.6	2.4	4.6	14.2	4.9	6.1	4.0	4.3	3.4	0.0	0.0	2.8	4.1	1.8	0.0	2.5	24.7	10.4	24.7	6.0	7.2	1.7	12.9	1.8	5.4	24.2	6.6	7.9	0.0	5.5	5.7	2.2	1.6	11.8	7.4	3.5	0.0	1.9	6.8	10.1	42.6	2.3	3.6	3.7	0.5	3.0	0.0	9.0	4.9	1.7	3.3	51.6	1.4	18.7	2.5	0.6	9.2	4.6	0.0	20.6	10.4	1.4	3.3	5.6	21.0	2.2	2.3	6.9	3.3	8.8
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125586-131234663	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 124.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.4;Granulosa cells: 169.2;Kupffer cells: 274.8;Late spermatids: 404.3;monocytes: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 425.3;neutrophil: 1259.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1259.6;monocytes: 425.3"	"Cell line enhanced"	"Detected in all"		"K-562: 260.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	29.0	21.2	17.0	18.5	20.9	42.0	26.0	19.1	23.2	21.1	17.7	23.1	11.8	21.1	17.5	33.0	22.6	12.3	26.1	18.0	18.2	43.8	32.0	22.7	15.1	20.9	19.6	22.1	32.8	16.0	21.5	14.4	20.1	21.9	13.4	15.2	21.3	12.2	24.0	28.9	23.8	13.0	17.0	68.8	25.6	124.2	20.4	41.8	22.0	13.1	15.4	21.2	22.1	26.3	23.1	31.3	28.1	15.4	20.2	25.1	26.9	20.9	20.4	24.7	20.2	25.2	17.0	36.7	16.8	29.6	26.5	50.1	35.2	24.0	32.6	26.4	16.0	25.7	45.7	45.5	18.3	37.4	23.3	20.7	21.9	31.0	27.5	16.9	25.1	23.2	260.6	20.5	28.0	39.4	52.8	41.8	27.7	30.2	27.1	17.8	35.2	36.4	25.0	24.8	21.4	24.8	35.5	30.0	17.3	18.4	41.0	90.3	23.5	44.9	25.2	30.1	31.6	18.8	49.7	39.0	22.3	20.7	28.2	53.2	425.3	174.5	6.7	181.7	8.1	13.5	8.4	6.4	162.2	11.8	6.5	7.5	1259.6	10.2	154.8	16.9	5.2	211.2	17.0	20.9	19.1	23.2	18.0	18.2	20.9	19.6	20.1	17.0	20.4	26.3	24.3	19.2	17.9	46.7	27.8	8.7	11.3	11.4	20.5	31.0	14.7	14.6	21.3	10.0	15.6	23.9	45.9	13.2	31.2	18.6	9.8	10.4	281.4	17.3	20.1	18.6	20.4	20.4	39.7	15.2	11.8	17.8	20.4	18.8	8.8	169.2	21.4	14.5	81.2	16.8	41.1	16.6	22.4	274.8	35.3	404.3	23.3	120.6	10.6	50.6	224.1	14.9	33.0	41.2	75.8	13.8	7.7	20.3	23.4	14.3	15.0	9.1	19.8	32.3	6.6	24.4	36.3	90.8	49.8	16.5	10.9	10.9	22.4	23.0	17.6	11.3
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730118-56850286	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA		38000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	17.9	13.9	13.2	21.3	17.4	52.7	15.5	6.8	23.9	15.3	0.2	17.7	9.9	16.9	12.4	22.3	15.3	12.4	14.2	30.6	10.7	12.8	9.3	15.3	27.7	10.7	9.3	14.9	14.2	14.8	10.8	19.1	9.9	17.7	18.1	31.7	12.2	12.7	20.0	21.6	14.5	19.5	8.3	24.2	15.2	39.8	11.4	34.1	34.3	14.2	30.3	17.1	16.1	11.5	71.3	84.5	71.6	81.0	25.9	34.8	81.0	58.7	48.2	156.2	100.1	119.4	66.1	107.7	60.4	54.9	54.2	120.6	143.3	90.1	149.8	34.0	81.3	72.6	64.7	97.3	35.0	96.7	82.8	29.3	35.7	104.2	64.7	31.6	90.8	95.3	87.8	22.3	72.3	52.4	136.2	81.1	92.1	44.2	95.4	163.9	129.4	108.9	53.1	47.8	66.6	44.1	159.1	54.6	47.3	77.4	43.0	57.9	55.3	68.1	74.0	57.8	67.5	35.0	60.7	190.2	47.4	88.5	67.5	19.3	49.9	195.7	38.9	77.2	45.2	45.4	28.3	40.9	60.9	45.4	28.7	41.0	11.8	51.8	77.5	28.7	39.7	47.4	13.2	17.4	6.8	23.9	30.6	10.7	10.7	9.3	9.9	8.3	11.4	11.5	11.3	6.4	12.3	17.6	13.4	12.0	13.6	20.7	6.2	68.6	9.0	7.6	11.8	1.5	20.2	9.2	10.4	21.1	9.4	8.6	11.7	24.6	11.7	10.9	8.8	16.5	4.9	33.2	51.1	25.5	31.7	12.8	13.7	10.6	17.2	22.3	10.8	7.2	26.6	38.7	49.4	11.2	24.4	17.8	23.8	7.7	23.3	17.3	16.0	33.7	30.3	11.7	8.2	18.1	22.1	21.4	7.2	13.5	8.1	16.5	3.6	11.0	13.0	20.8	13.1	11.4	27.9	54.6	62.2	14.3	16.1	10.3	13.5	22.3	15.3	18.0
NUP98	"NUP96, Nup98-96, Nup98-Nup96"	ENSG00000110713	"Nucleoporin 98 and 96 precursor"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.7;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	22.9	14.7	7.2	25.1	8.4	76.0	25.3	15.1	12.4	21.8	13.8	21.1	17.8	22.2	20.7	23.1	20.8	21.6	20.8	7.2	8.8	19.3	31.9	23.4	27.6	9.8	10.5	28.4	24.0	25.7	16.7	25.6	8.3	21.9	23.6	23.2	23.3	22.3	41.9	21.2	17.7	23.4	7.1	21.9	17.6	78.4	9.1	34.4	29.1	31.0	30.6	32.7	18.6	12.7	81.2	63.7	51.7	54.5	54.7	46.1	44.5	57.9	67.7	78.3	69.9	69.4	97.4	80.6	26.0	68.6	77.1	85.5	90.0	56.1	105.6	56.7	67.0	86.4	51.7	48.1	46.1	111.1	67.5	51.9	37.6	41.8	75.2	33.7	61.9	88.3	109.3	60.6	82.5	33.2	110.2	36.3	64.5	87.8	48.4	65.9	62.6	37.8	43.4	63.4	46.8	31.5	83.4	64.9	38.1	52.0	40.5	43.4	45.9	59.9	51.1	67.5	53.0	37.0	67.0	83.5	41.0	46.5	64.4	40.5	11.7	23.3	15.0	15.0	15.1	12.8	14.7	13.5	14.3	10.8	16.1	14.4	35.2	9.7	9.5	3.9	20.1	13.3	7.2	8.4	15.1	12.4	7.2	8.8	9.8	10.5	8.3	7.1	9.1	12.7	24.7	28.9	25.2	32.7	37.4	49.8	36.3	12.6	34.7	14.9	28.2	24.5	19.5	22.8	20.1	7.3	16.7	22.2	41.6	18.8	3.9	12.2	118.7	32.1	30.4	22.5	21.5	42.5	43.6	11.8	17.5	22.7	42.3	62.0	18.3	16.3	15.7	23.6	16.8	15.2	43.7	15.1	6.1	19.8	51.1	158.6	17.1	29.3	16.0	25.3	24.9	11.1	12.3	31.7	44.4	13.2	16.1	14.3	36.3	25.1	11.8	9.0	16.6	14.1	32.9	36.9	23.2	56.2	31.0	30.3	50.4	46.5	44.5	13.7	19.5	32.5
NUTF2	"NTF2, PP15"	ENSG00000102898	"Nuclear transport factor 2"	P61970	16	67846923-67872567	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040915, HPA040956"	Supported					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA040915: AB_10794073, HPA040956: AB_10796233"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.17e-3)"	"unprognostic (9.80e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	57.1	53.7	86.4	36.5	86.6	42.0	49.8	88.8	93.4	47.4	75.3	57.9	27.4	60.7	49.4	53.7	47.9	26.6	74.7	88.4	96.6	50.8	51.5	49.9	47.8	96.2	99.6	42.4	56.9	41.6	43.0	49.8	99.2	44.6	42.6	17.2	40.5	32.5	93.4	58.7	42.8	58.0	90.7	41.4	45.9	56.6	88.3	57.4	39.3	79.2	53.3	57.9	45.2	91.7	149.0	174.8	186.9	212.2	92.8	94.1	249.9	118.8	102.8	165.4	134.1	222.3	152.5	169.2	107.7	161.3	95.9	130.3	235.4	176.2	179.3	65.9	225.5	114.2	73.6	357.5	124.0	161.6	83.1	123.4	114.1	152.9	190.7	91.0	175.5	127.7	164.2	59.1	173.6	301.8	257.3	311.1	318.9	152.4	117.6	228.2	121.5	254.2	218.9	128.5	169.6	164.4	266.4	109.5	93.6	174.5	161.0	137.3	147.4	140.3	168.3	104.2	144.0	94.8	131.0	367.5	92.9	113.0	147.8	47.8	64.0	27.4	61.0	95.7	70.1	52.7	64.9	60.3	81.5	51.8	48.8	55.9	17.9	71.9	88.3	78.7	72.8	101.8	86.4	86.6	88.8	93.4	88.4	96.6	96.2	99.6	99.2	90.7	88.3	91.7	67.6	57.7	20.2	4.9	58.6	68.2	79.5	136.5	64.9	15.9	62.8	53.7	38.7	27.1	58.5	49.7	2.1	208.2	62.4	66.2	137.0	196.5	9.9	71.4	66.1	71.9	98.3	126.4	6.9	105.1	336.1	57.6	60.6	52.7	39.3	65.1	28.2	22.5	149.4	20.2	7.4	69.1	89.5	32.4	83.6	20.8	33.2	75.2	58.7	4.7	130.2	26.5	69.0	4.0	8.3	198.8	93.3	42.9	86.2	166.0	96.5	124.1	53.7	7.6	13.1	48.5	187.5	54.6	82.0	88.7	87.7	183.5	62.9	62.1	95.6	114.5
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120211032-120230334	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 396.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 2.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	66.0	91.5	47.7	18.0	56.8	10.8	42.6	35.8	57.1	66.7	40.5	61.9	47.7	54.2	16.0	22.8	54.6	34.5	55.1	48.1	36.5	51.4	396.6	19.2	5.8	39.0	37.8	61.0	74.1	6.7	27.4	8.1	37.1	33.5	36.5	30.7	53.9	13.7	13.2	12.0	57.3	29.1	35.9	54.4	33.5	3.7	45.0	4.6	25.9	12.2	3.7	42.6	40.4	44.6	24.9	7.5	30.9	14.4	47.8	53.4	1.7	47.7	53.8	20.5	30.0	7.5	37.3	0.0	115.5	35.6	33.7	25.7	8.9	13.2	8.2	18.7	21.1	21.1	4.7	190.1	42.4	46.7	7.9	66.8	7.9	19.8	54.8	39.9	59.7	12.7	14.0	22.7	5.0	9.4	0.3	139.9	11.6	7.3	40.8	11.8	0.9	23.7	31.8	13.4	1.5	10.0	14.0	15.2	40.2	8.6	4.8	74.7	32.7	39.3	14.7	40.8	4.6	0.8	0.7	0.4	30.3	76.2	14.1	0.0	3.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.1	0.8	47.7	56.8	35.8	57.1	48.1	36.5	39.0	37.8	37.1	35.9	45.0	44.6	19.4	0.0	0.6	102.2	3.7	9.4	33.6	7.3	12.5	3.2	6.0	7.0	5.5	34.3	3.5	71.7	2.1	2.1	1.1	135.9	27.4	14.8	0.2	4.7	70.9	40.0	22.8	12.8	0.6	28.7	5.5	135.9	11.7	12.2	1.3	2.6	12.5	218.8	6.0	0.0	2.3	56.5	4.1	11.5	20.9	1.1	16.8	11.0	16.0	23.4	10.2	279.4	0.0	5.5	11.0	28.2	56.5	4.5	14.5	31.3	111.1	79.3	0.4	10.6	52.6	8.6	40.8	0.7	6.9	11.3	10.2	6.2	3.1	149.0	45.8	192.5
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 67.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.8;Endothelial cells: 21.4;Macrophages: 27.6;monocytes: 26.1;NK-cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 364.3;BJ hTERT+ SV40 Large T+ RasG12V: 297.5;Daudi: 88.7;SK-MEL-30: 135.0;U-266/70: 118.4;U-266/84: 115.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	11.9	4.3	5.1	25.7	5.5	15.1	7.2	5.6	7.9	9.8	4.6	8.6	9.3	6.2	2.9	13.4	6.2	17.8	8.7	5.1	5.0	5.8	19.6	26.3	38.0	10.6	6.4	2.1	1.6	2.8	2.3	23.4	8.0	7.2	9.0	1.0	67.2	3.6	2.5	2.7	9.1	12.9	12.0	43.5	18.5	3.8	6.0	36.7	5.2	6.9	33.1	22.8	5.6	6.5	3.0	0.5	0.2	0.2	1.7	12.3	0.2	0.5	41.9	364.3	297.5	0.6	5.9	88.7	8.4	6.9	71.3	3.4	0.8	0.9	12.1	22.8	0.2	0.2	0.8	0.5	2.5	0.1	0.2	0.8	6.0	19.7	0.0	0.3	5.2	4.2	0.1	42.2	0.2	1.2	2.4	4.2	0.1	0.4	12.4	20.5	0.1	13.5	0.1	31.2	0.1	0.1	3.3	0.6	135.0	0.2	2.6	5.4	8.1	0.6	0.1	1.1	0.3	118.4	115.4	13.6	2.6	4.5	2.7	3.9	35.5	2.7	25.6	55.6	33.5	24.3	30.0	29.6	26.9	15.5	28.9	21.7	3.6	32.1	60.2	11.5	35.4	30.9	5.1	5.5	5.6	7.9	5.1	5.0	10.6	6.4	8.0	12.0	6.0	6.5	22.8	3.2	6.0	0.3	16.6	2.0	1.6	4.0	2.8	0.1	2.1	1.3	1.6	0.0	5.1	1.8	0.0	0.2	15.1	1.2	0.0	1.0	0.7	3.5	3.4	21.4	0.0	4.0	0.2	1.2	2.4	4.8	6.1	1.7	1.3	2.5	12.1	2.6	16.1	0.0	0.5	3.8	0.0	19.7	4.7	1.2	0.6	27.6	5.4	10.3	26.1	0.4	26.8	2.0	0.1	3.8	1.2	3.4	15.5	2.6	0.4	0.3	12.2	0.2	0.0	1.0	2.7	0.1	0.1	7.6	1.1	0.1	15.5	6.0	0.4	10.4
OAZ1	"AZ1, AZI, MGC138338, OAZ"	ENSG00000104904	"Ornithine decarboxylase antizyme 1"	P54368	19	2269509-2273490	"Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009291	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles	"Centriolar satellite"	"HPA009291: AB_1079519"	"unprognostic (2.37e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (4.10e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.01e-2)"	201.8	252.4	114.7	170.0	125.3	330.3	177.6	107.3	189.7	143.2	111.9	204.3	161.5	134.3	91.4	167.2	151.5	109.0	289.8	132.7	121.1	203.4	172.7	194.2	244.7	119.7	122.1	139.9	209.8	46.5	173.4	134.2	117.0	150.9	77.8	36.4	226.8	89.2	525.6	177.4	197.7	85.1	116.0	294.9	188.3	67.5	120.1	68.0	144.6	123.4	138.3	170.7	152.7	113.9	577.1	117.7	88.3	152.7	181.1	287.5	228.9	400.4	275.4	197.9	269.7	169.5	181.2	389.7	210.6	187.6	78.3	163.1	87.7	120.8	129.6	523.1	303.3	301.2	108.7	267.3	184.6	425.7	456.4	192.6	207.3	74.8	112.7	177.8	227.4	141.3	297.8	439.1	226.1	210.8	357.1	442.7	291.5	83.5	210.7	291.3	176.1	519.0	184.3	164.0	207.9	220.2	264.0	236.7	464.8	70.6	198.4	890.0	293.1	140.2	173.9	610.5	427.8	423.8	188.0	468.9	636.6	660.5	217.3	1887.3	1649.6	1940.9	466.4	1685.5	469.7	962.1	506.3	502.1	1155.4	941.6	464.3	466.0	2063.4	366.1	2039.6	778.3	779.9	2803.0	114.7	125.3	107.3	189.7	132.7	121.1	119.7	122.1	117.0	116.0	120.1	113.9	492.6	365.4	510.0	54.5	1096.3	1476.0	1102.4	828.6	715.9	325.4	748.2	626.1	746.8	579.0	543.0	294.3	106.3	1065.2	1149.3	1018.3	1230.6	1043.4	95.1	452.9	335.6	591.2	613.7	1446.6	85.6	1018.2	1605.0	711.4	305.3	325.4	713.5	385.8	529.0	773.2	2248.7	222.1	78.6	816.9	547.3	2400.4	2984.5	286.7	558.6	2391.4	1136.6	60.0	2929.3	362.0	1001.1	46.3	62.2	1071.2	1388.3	477.3	1143.0	1314.8	1700.6	1540.0	553.2	285.5	460.2	487.9	821.8	251.8	256.5	751.8	1283.3	1683.5	911.1	666.9	733.6	1692.6
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 481.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	3.5	2.5	2.4	1.4	18.4	1.6	3.7	10.4	4.4	8.1	18.1	5.2	0.7	3.7	1.8	4.6	5.1	1.1	78.5	0.9	2.7	6.6	1.3	8.9	2.1	4.3	2.7	8.6	5.4	1.1	13.6	0.9	2.4	9.9	0.5	0.8	9.4	1.7	481.3	4.7	5.4	0.5	1.0	9.3	5.2	1.9	6.3	4.9	7.5	112.8	1.3	3.2	7.4	0.1	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	2.4	18.4	10.4	4.4	0.9	2.7	4.3	2.7	2.4	1.0	6.3	0.1	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 560.8;Late spermatids: 834.9;Prostatic glandular cells: 412.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	47.2	23.2	31.0	69.3	31.5	172.9	33.0	30.5	32.2	33.5	48.5	64.8	32.4	66.0	49.2	29.4	56.3	43.7	55.9	29.9	33.0	132.2	92.1	52.4	111.0	32.4	33.0	54.8	61.8	99.6	92.5	20.0	30.6	91.1	72.0	46.2	27.0	55.1	163.3	29.2	41.6	71.2	34.1	42.9	51.5	133.3	34.0	77.1	58.5	73.5	149.1	113.6	26.9	35.7	166.8	130.6	177.1	211.4	31.1	92.4	410.1	234.6	114.9	216.3	99.9	697.3	75.4	870.2	114.6	143.6	208.6	30.2	549.1	265.5	261.2	334.0	231.5	398.1	212.2	429.9	250.8	680.1	91.8	62.5	70.5	490.1	608.3	111.4	176.3	237.6	674.2	274.3	121.7	109.0	680.1	267.3	324.9	228.3	418.8	478.5	556.0	586.3	130.9	119.5	246.6	209.9	293.6	88.8	121.8	135.7	60.0	300.5	124.7	174.4	362.6	227.9	511.7	128.0	416.1	780.8	156.7	443.6	109.9	0.0	1.5	3.0	2.9	2.9	3.3	14.8	4.1	4.8	3.4	15.0	2.8	4.5	0.5	1.4	1.8	12.2	4.4	3.2	31.0	31.5	30.5	32.2	29.9	33.0	32.4	33.0	30.6	34.1	34.0	35.7	78.2	44.8	161.4	7.5	228.9	58.0	123.7	48.8	19.4	36.8	53.2	68.3	55.1	81.5	33.9	40.5	31.3	1.5	188.1	77.7	72.4	50.6	560.8	90.9	66.2	52.2	271.0	111.3	7.5	27.6	70.0	63.2	204.4	127.6	58.9	103.8	14.6	50.3	46.8	6.7	4.1	234.1	22.4	32.1	22.4	834.9	15.5	191.8	23.2	8.4	22.1	126.3	37.0	4.5	2.4	28.6	64.5	11.3	287.4	412.4	31.6	154.1	21.9	77.4	0.0	223.0	79.9	186.5	75.8	52.2	87.5	3.4	133.0	30.2	180.5	142.2
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1 centriole and centriolar satellite protein"	O75665	X	13734745-13769357	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 64.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 64.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (2.76e-7)"	5.8	5.9	8.3	11.7	8.7	15.6	14.6	10.8	9.8	11.2	10.1	9.4	10.2	10.5	11.5	9.9	9.6	7.3	5.9	8.2	9.4	9.6	7.2	9.2	19.1	9.7	8.3	11.2	11.2	15.3	10.9	5.3	8.9	11.7	8.2	11.2	15.6	6.5	5.2	11.8	12.8	7.6	8.2	13.9	12.2	9.9	8.4	10.1	12.9	4.1	16.8	8.5	10.4	10.0	16.0	7.1	10.3	18.4	8.4	13.0	7.7	4.9	11.3	5.7	7.3	12.8	17.7	23.2	12.5	5.9	10.6	15.3	7.5	13.7	9.2	11.6	18.9	10.8	22.3	10.8	6.4	14.4	19.1	10.4	9.1	12.9	12.7	10.6	6.4	4.2	16.5	20.4	6.4	12.6	9.9	17.3	10.8	5.8	10.2	24.9	11.9	46.6	8.9	13.5	10.5	16.6	23.2	18.5	11.6	22.7	17.5	13.0	5.8	10.0	5.2	12.1	6.3	15.1	15.1	26.9	8.3	6.4	8.3	4.3	1.7	6.2	11.6	2.2	13.4	13.7	10.1	14.2	3.8	15.4	8.3	12.5	4.7	14.1	3.1	64.2	8.6	4.4	8.3	8.7	10.8	9.8	8.2	9.4	9.7	8.3	8.9	8.2	8.4	10.0	40.2	70.5	64.1	60.4	90.8	22.4	89.3	51.8	38.1	47.9	65.9	64.1	17.8	35.8	66.7	31.3	89.6	34.5	219.8	82.3	7.9	60.2	178.6	232.2	33.0	39.5	48.6	30.1	43.3	59.3	23.4	31.2	58.1	180.8	27.3	41.1	24.7	13.3	25.2	37.0	50.2	60.3	42.7	19.8	43.0	187.4	52.2	35.1	17.8	32.8	38.2	41.3	145.2	76.9	64.5	60.7	72.9	33.8	50.5	84.4	83.8	15.3	81.3	107.2	39.5	42.4	25.2	72.7	59.9	32.6	27.3	87.0	102.2	30.7	52.2	82.8
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	12.6	13.8	18.6	13.2	18.3	12.2	12.8	20.5	19.6	18.2	12.5	14.8	18.9	17.1	10.3	9.6	16.9	8.4	11.8	19.6	15.8	30.3	20.7	10.7	26.2	18.8	16.7	22.5	10.6	6.6	10.8	8.6	17.9	15.7	8.1	12.1	12.2	10.1	7.2	9.6	17.2	9.8	16.2	15.2	12.4	8.6	17.5	13.5	13.1	8.0	21.2	15.3	14.3	17.4	11.3	20.7	20.3	13.1	19.9	22.3	38.4	14.5	14.8	21.6	25.6	19.9	10.8	68.5	9.5	18.3	34.1	10.8	12.1	15.9	9.0	25.1	17.6	33.9	32.5	29.3	20.7	13.3	20.9	22.3	20.0	37.4	16.0	17.4	27.3	9.6	11.0	10.9	20.9	21.3	10.7	13.2	11.0	10.3	29.3	7.8	13.7	22.4	12.4	5.7	9.0	15.9	18.4	15.2	11.5	10.4	23.7	22.9	17.5	21.9	22.7	17.2	24.0	10.7	16.9	35.9	17.4	37.9	13.7	15.1	10.9	20.7	18.7	9.0	18.4	13.9	15.8	15.3	9.8	16.5	12.1	11.5	2.9	27.0	7.3	15.9	21.0	10.9	18.6	18.3	20.5	19.6	19.6	15.8	18.8	16.7	17.9	16.2	17.5	17.4	9.5	0.0	3.4	15.3	16.7	5.5	8.9	8.3	9.1	20.9	6.7	7.4	2.3	10.0	4.9	9.2	35.5	6.4	16.5	9.0	11.7	7.7	0.9	5.0	12.2	10.4	18.0	22.3	11.2	6.7	10.1	11.7	6.1	4.4	2.5	10.0	10.0	11.8	18.0	8.4	9.2	8.8	6.1	9.0	5.8	1.8	14.3	9.3	7.2	10.3	15.8	11.3	27.8	13.0	9.9	8.8	11.0	13.5	10.0	5.2	47.1	86.3	4.1	34.7	26.3	11.1	10.3	10.2	21.5	5.0	4.5	4.0	12.9	12.0	14.0	5.4
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383268-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.0"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		170000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	100.1	22.5	1.4	6.0	3.0	0.2	53.8	4.7	6.8	216.0	11.0	43.0	10.6	130.5	44.9	30.8	67.1	164.7	79.8	1.7	2.3	6.4	4.1	18.6	2.1	1.8	1.8	91.8	11.1	117.3	19.1	22.7	2.0	57.9	32.2	0.0	3.2	19.3	2.6	3.8	23.6	118.0	2.3	2.4	22.0	13.3	2.2	4.5	14.7	22.0	5.6	54.0	23.3	2.1	0.0	0.0	0.0	0.0	4.4	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	32.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	1.4	3.0	4.7	6.8	1.7	2.3	1.8	1.8	2.0	2.3	2.2	2.1	10.3	6.4	1.5	1.0	0.4	4.2	0.1	0.0	1.2	0.6	0.7	0.4	2.6	10.0	7.4	3.7	0.0	2.0	0.6	0.1	0.0	0.0	1.2	2.9	104.1	5.2	0.0	0.0	1.9	0.0	1.7	326.2	7.7	1.7	1.3	0.0	20.0	0.1	4.6	0.0	1.8	0.0	0.0	0.3	11.1	4.2	166.2	2.3	1.8	16.9	0.2	0.1	0.0	2.0	1.6	0.0	0.0	212.1	0.7	0.4	0.0	0.0	2.9	0.2	6.6	4.7	22.7	0.6	0.6	0.7	4.5	5.7	2.1	1.6	0.0	0.2
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893584-72933036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 110.8"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 372.3"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 4.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 2.3;Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		52000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.3	0.5	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	1.5	110.8	0.3	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.1	0.0	0.0	7.8	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	14.6	0.0	10.7	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	372.3	10.6	0.0	0.0	0.9	0.0	0.0	31.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248599	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol		NA	NA		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	42.2	44.3	39.7	38.2	42.7	53.7	57.3	42.5	48.9	34.3	30.0	48.0	50.1	34.7	38.8	58.1	38.0	35.1	57.4	44.5	43.8	56.4	43.0	23.5	47.9	38.0	36.6	31.1	56.3	44.1	27.4	42.0	40.1	41.1	52.7	42.5	36.3	33.6	105.6	52.0	45.7	37.0	38.0	24.6	35.2	48.8	40.7	58.3	59.7	93.1	53.3	48.3	31.0	39.1	181.4	84.1	134.9	225.5	70.1	152.2	243.0	142.1	142.8	194.2	147.1	200.9	104.4	246.5	138.9	114.5	143.9	139.9	165.3	164.6	227.3	113.7	142.5	231.3	76.4	209.9	135.3	264.3	90.2	134.8	200.6	206.3	217.4	177.4	174.5	88.0	256.8	82.3	170.3	116.6	241.4	272.9	159.1	193.9	273.0	180.4	217.8	170.7	245.1	192.0	218.3	124.7	96.8	141.6	206.2	142.2	101.2	220.6	127.5	127.1	161.4	128.5	210.8	76.2	207.3	190.5	124.6	180.0	115.4	18.1	24.9	7.4	16.2	24.2	23.4	17.9	18.6	20.8	37.1	16.4	21.5	21.2	2.1	26.1	20.0	22.5	25.3	22.7	39.7	42.7	42.5	48.9	44.5	43.8	38.0	36.6	40.1	38.0	40.7	39.1	43.2	35.3	33.0	57.5	49.0	62.7	73.5	92.4	76.8	47.3	86.0	83.8	68.3	47.1	57.0	31.3	35.5	153.7	47.7	44.6	103.7	145.1	267.8	37.1	55.2	47.8	70.7	92.5	132.6	105.3	112.8	53.0	60.1	43.1	41.2	73.3	29.3	25.8	97.3	33.7	129.8	79.6	65.1	59.6	54.4	99.5	40.4	55.9	32.0	65.6	83.1	60.3	52.5	101.6	101.8	112.8	51.8	51.1	56.3	84.2	78.4	141.7	36.1	35.9	26.3	69.7	92.3	104.8	35.9	113.7	64.1	105.9	55.9	94.6	107.6	79.3
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121180	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 555.7;choroid plexus: 246.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 2.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		200000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	36.7	25.4	410.4	13.0	427.0	0.2	36.8	309.6	555.7	29.9	246.9	24.0	5.0	29.0	70.4	12.1	30.3	8.6	20.7	474.7	309.0	20.3	4.8	15.0	14.5	296.6	301.7	19.4	12.3	4.9	82.8	1.0	293.9	19.3	13.8	47.3	14.0	18.1	17.5	15.3	16.5	17.9	279.9	35.1	15.4	6.8	317.0	11.5	17.5	23.0	19.1	25.0	26.7	372.3	0.0	6.1	12.1	0.2	1.7	1.4	0.5	3.6	0.0	0.0	0.0	0.1	2.7	0.1	0.8	5.2	49.2	2.3	2.6	0.0	0.0	14.4	0.9	0.2	96.0	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	84.1	0.5	0.3	104.9	78.9	0.0	0.1	0.3	48.3	0.0	0.1	155.6	20.5	131.8	0.4	8.6	7.9	200.2	0.0	0.1	7.7	16.6	87.1	0.2	0.2	0.1	0.3	0.7	0.1	4.3	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	410.4	427.0	309.6	555.7	474.7	309.0	296.6	301.7	293.9	279.9	317.0	372.3	44.2	0.0	7.9	43.8	0.1	9.7	3.3	0.0	3.4	21.6	3.1	3.0	5.9	11.5	1.8	0.0	43.8	0.0	0.1	2.4	0.0	9.7	5.8	0.5	20.4	50.0	2.4	0.0	193.1	2.7	0.0	17.3	0.0	0.7	2.5	14.4	78.1	1.1	0.4	38.7	70.0	2.5	0.0	3.2	7.3	11.9	44.4	2.8	21.4	32.8	2.7	38.6	0.0	48.7	17.3	2.5	2.5	29.3	0.4	5.1	0.0	0.1	0.0	15.7	0.0	13.3	8.8	0.6	3.7	1.3	6.3	0.0	0.7	12.9	4.2	1.4
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 202.6;skin 1: 94.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Basal keratinocytes: 125.0;Muller glia cells: 91.1;Oligodendrocyte precursor cells: 124.7;Suprabasal keratinocytes: 118.1"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.7"	"Group enriched"	"Detected in many"	26	"granulocytes: 49.7;T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;ASC diff: 23.4;BJ hTERT+: 18.5;SH-SY5Y: 24.3;U-2 OS: 28.7;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA		2700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA049961: AB_2680972, HPA057771: AB_2683524"	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	36.8	30.7	130.8	3.4	134.5	0.2	25.0	118.5	202.6	17.2	80.7	4.8	2.1	16.7	4.5	5.6	11.1	6.7	10.1	134.0	127.3	9.2	41.9	10.1	7.9	152.5	168.8	9.7	11.2	9.6	19.1	7.1	162.0	10.1	1.1	24.6	10.0	13.4	1.8	94.8	3.8	6.7	130.0	2.5	2.2	10.7	123.2	16.5	13.2	1.0	4.8	3.0	14.1	120.7	0.0	3.7	3.0	25.6	23.4	14.3	1.7	5.6	18.5	1.2	1.5	0.3	2.4	0.1	2.3	4.2	2.1	1.5	9.8	1.7	0.1	0.1	2.1	0.0	0.2	0.3	0.1	0.0	4.3	7.5	1.5	0.1	0.2	0.7	0.1	4.8	0.3	0.3	0.0	8.2	0.3	0.2	15.8	2.5	0.0	0.1	0.0	0.0	0.0	0.9	0.1	24.3	0.9	0.1	5.2	9.7	0.9	0.0	0.3	10.5	28.7	0.1	0.1	0.0	0.0	0.0	0.3	0.0	25.6	21.2	0.0	49.7	6.2	0.0	6.6	0.0	7.0	5.5	0.0	0.0	13.5	8.9	0.5	1.2	0.0	0.1	17.0	2.9	130.8	134.5	118.5	202.6	134.0	127.3	152.5	168.8	162.0	130.0	123.2	120.7	12.9	0.0	0.0	108.4	0.3	125.0	4.7	5.9	8.6	4.9	6.9	13.8	0.8	7.2	0.4	7.3	0.0	0.1	1.0	0.1	1.9	0.9	8.6	0.9	2.2	4.3	1.2	0.4	27.3	2.4	0.0	17.2	0.0	1.0	4.5	6.5	1.4	24.7	0.3	1.7	51.0	0.2	2.0	0.3	32.6	52.8	13.7	0.6	17.8	15.0	0.4	91.1	7.2	124.7	3.5	4.1	0.0	9.8	0.5	7.9	0.0	0.2	0.2	3.7	0.0	7.4	24.3	3.0	10.4	1.4	118.1	0.1	7.7	0.6	0.1	2.9
OMG	OMGP	ENSG00000126861	"Oligodendrocyte myelin glycoprotein"	P23515	17	31272013-31297539	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 116.5;choroid plexus: 44.1"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 458.9;Respiratory ciliated cells: 708.8"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.5;glioma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008206, HPA012693"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA008206: AB_1854240, HPA012693: AB_1854239"	"unprognostic (8.05e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.96e-13)"	"unprognostic (7.80e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.42e-2)"	0.0	0.1	69.7	0.0	78.1	0.7	0.0	70.7	116.5	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.9	71.6	0.0	0.0	0.1	0.0	68.6	66.5	0.0	0.0	0.0	0.3	0.0	71.5	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.1	0.0	69.6	0.3	0.1	0.0	70.5	0.0	0.0	0.0	0.0	0.0	0.0	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	78.1	70.7	116.5	71.9	71.6	68.6	66.5	71.5	69.6	70.5	88.4	0.5	0.0	3.7	18.3	0.3	0.4	0.0	72.8	0.0	4.2	0.1	0.1	0.7	0.0	44.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	458.9	3.8	1.6	0.0	0.0	28.0	0.0	0.6	1.5	0.0	7.0	0.0	0.0	0.7	0.1	0.5	0.0	18.7	0.0	61.1	20.1	0.7	0.0	0.0	1.1	0.0	3.7	0.2	78.2	1.0	78.4	101.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	708.8	2.4	0.0	0.7	19.1	0.0	0.0	0.2	0.1	11.8	1.4	0.0	0.0	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPCML	"IGLON1, OBCAM, OPCM"	ENSG00000183715	"Opioid binding protein/cell adhesion molecule like"	Q14982	11	132414977-133532519	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 39.2;parathyroid gland: 10.3;retina: 11.6"	"Group enriched"	"Detected in some"	34	"Excitatory neurons: 2120.9;Inhibitory neurons: 1900.4;Oligodendrocyte precursor cells: 3173.2"	"Cancer enriched"	"Detected in some"	4	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BJ: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		7100000		"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.59e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.31e-4)"	"unprognostic (8.23e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.19e-1)"	0.2	0.4	13.2	0.1	16.6	0.0	0.1	22.3	39.2	0.4	0.0	0.1	0.1	0.6	0.1	0.4	0.5	0.2	0.3	18.4	3.1	1.4	0.0	0.0	0.0	0.0	5.1	0.3	0.0	10.3	1.3	0.0	0.0	0.1	0.1	11.6	0.2	0.6	0.1	0.1	0.1	0.5	0.2	0.7	0.2	0.4	9.6	0.0	0.1	0.3	0.0	0.1	0.1	13.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	9.4	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	16.6	22.3	39.2	18.4	3.1	0.0	5.1	0.0	0.2	9.6	13.4	0.0	0.0	0.0	25.5	0.0	0.1	0.0	0.0	0.0	40.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.7	0.0	0.0	0.4	0.0	0.0	2120.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.7	1900.4	0.0	0.0	0.3	0.4	14.9	0.0	0.1	0.0	69.3	0.0	1.3	0.0	3173.2	30.3	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	4.2	6.6	0.0	1.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	67949349-68433913	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 20.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	4.1	5.1	20.8	1.8	18.6	3.9	4.5	14.2	19.5	6.0	1.0	3.4	2.5	5.6	3.7	3.8	3.2	2.7	3.1	18.0	14.6	4.3	1.3	4.4	1.9	9.5	11.9	4.5	3.1	3.6	2.7	5.6	5.8	10.1	3.4	11.5	5.4	5.0	6.5	6.4	2.9	4.0	6.1	2.3	3.8	2.6	16.3	1.2	4.7	4.8	1.4	2.3	3.8	11.5	23.6	5.1	3.2	7.3	7.1	6.8	5.0	4.2	5.6	8.3	10.1	3.3	4.5	1.5	13.7	4.9	3.4	5.7	3.1	2.9	12.6	0.9	2.1	5.2	6.9	3.7	2.4	2.1	5.2	4.6	4.8	6.9	6.4	10.6	5.6	1.1	3.2	3.1	4.3	10.1	0.8	1.8	7.5	10.0	4.8	0.9	7.3	1.3	8.5	7.6	1.7	2.8	7.2	9.1	13.7	7.1	6.2	1.6	6.0	5.0	7.3	18.1	4.5	2.9	3.4	1.0	4.0	2.8	3.5	1.0	1.0	0.4	0.5	0.4	0.4	0.5	0.4	0.3	0.4	0.8	0.4	0.5	4.6	0.5	0.6	1.6	0.3	0.2	20.8	18.6	14.2	19.5	18.0	14.6	9.5	11.9	5.8	6.1	16.3	11.5	13.8	16.0	19.3	383.9	0.0	3.2	5.4	2.0	10.2	5.4	6.7	5.0	3.3	2.8	6.4	18.4	6.2	23.0	2.3	3.9	0.0	1.2	2.0	7.2	4.3	8.1	4.2	1.3	84.6	0.8	11.7	18.0	14.8	12.9	8.8	36.3	5.0	0.2	4.6	0.0	78.8	3.0	2.0	2.1	9.5	1.7	21.1	5.9	8.8	54.4	1.2	16.0	3.1	600.2	41.7	1.3	2.4	12.0	0.1	8.5	3.8	1.8	10.9	5.1	0.0	24.1	5.4	0.3	1.9	8.9	5.1	66.9	1.4	4.2	4.1	4.2
OR12D2	hs6M1-20	ENSG00000280236	"Olfactory receptor family 12 subfamily D member 2"	P58182	6	29395631-29398008	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2Y1		ENSG00000174339	"Olfactory receptor family 2 subfamily Y member 1"	Q8NGV0	5	180739042-180740099	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR3A2	"OLFRA04, OR17-228, OR228"	ENSG00000221882	"Olfactory receptor family 3 subfamily A member 2"	P47893	17	3276942-3386317	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 3.3;retina: 1.1;testis: 3.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.9;granulocytes: 1.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 11.3;JURKAT: 11.8"					"Low region specificity"	"Detected in single"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (7.58e-2)"				"unprognostic (5.10e-2)"						"unprognostic (6.89e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.32e-1)"			0.1	0.0	1.0	0.1	1.1	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.1	0.3	0.3	1.2	0.2	0.0	0.0	0.2	0.2	0.4	0.1	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	3.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.2	0.0	0.4	0.9	0.3	0.0	0.2	0.1	0.3	0.4	0.2	0.1	0.0	1.0	0.1	0.2	1.0	1.1	0.0	1.1	0.4	0.8	0.3	1.2	0.4	0.1	2.7	3.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
OR4C16		ENSG00000279514	"Olfactory receptor family 4 subfamily C member 16"	Q8NGL9	11	55572128-55573060	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 9.6;prostate: 28.9"	"Cell type enriched"	"Detected in some"	6	"Enteroendocrine cells: 77.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;BJ hTERT+: 1.1;hTERT-RPE1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"				"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.6	0.2	0.3	1.0	0.4	0.1	0.5	0.4	0.5	0.7	0.6	9.6	0.2	1.3	0.3	0.0	0.5	0.3	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	4.0	0.4	28.9	2.2	0.1	0.0	2.3	0.4	0.2	0.8	2.1	0.1	0.0	0.4	0.3	0.5	0.0	0.1	0.4	0.0	0.4	0.2	0.7	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.5	0.4	0.2	0.3	0.3	0.4	0.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	77.4	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1
OR51F2		ENSG00000176925	"Olfactory receptor family 51 subfamily F member 2"	Q8NH61	11	4821321-4822456	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																					"unprognostic (2.85e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8J1		ENSG00000172487	"Olfactory receptor family 8 subfamily J member 1"	Q8NGP2	11	56354291-56361511	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR9Q1		ENSG00000186509	"Olfactory receptor family 9 subfamily Q member 1"	Q8NGQ5	11	58023881-58181616	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Excitatory neurons: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"																"unprognostic (2.65e-3)"	"unprognostic (2.27e-1)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	193	"liver: 42973.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	13.4	10.3	0.1	12.7	0.3	223.1	6.6	0.0	0.4	2.7	0.2	1.5	0.1	2.7	0.3	1.9	1.9	1.0	3.4	0.2	0.2	4.9	42973.6	24.4	0.7	0.4	0.2	1.6	8.1	0.0	1.4	1.3	0.1	57.6	0.0	1.1	1.4	0.0	2.0	1.7	2.3	0.3	0.2	51.3	19.2	2.7	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.1	0.3	0.0	0.4	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8873.2"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	4.0	4.0	0.2	3.2	0.4	27.1	3.0	0.0	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.8	0.1	0.1	1.7	8873.2	5.8	1.1	0.2	0.3	0.3	2.1	0.0	0.2	0.2	0.1	23.6	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.2	7.3	21.9	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OSBPL5	"KIAA1534, OBPH1, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087107-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	22.0	8.0	7.1	7.2	7.7	13.6	19.2	7.8	11.5	42.2	2.1	28.2	5.9	26.6	2.9	12.5	22.3	5.0	14.9	5.2	6.4	13.5	3.1	17.5	2.4	50.3	13.3	14.5	10.4	2.3	10.3	5.0	56.0	25.6	3.2	1.8	16.4	9.9	9.9	25.9	16.6	7.6	5.4	24.9	15.5	3.3	19.8	22.0	14.9	5.9	1.4	24.6	28.3	10.5	3.7	5.6	6.6	7.6	18.9	8.8	0.1	17.9	8.8	7.1	5.0	0.0	10.4	0.0	5.3	10.1	4.9	13.3	1.3	5.0	1.1	3.5	6.0	15.1	19.2	0.0	15.9	13.6	2.3	13.9	5.7	2.5	2.6	5.2	4.8	26.7	5.5	0.0	3.5	10.3	30.7	75.5	4.8	2.4	11.5	15.9	9.0	2.2	3.0	3.3	10.8	1.3	7.6	26.1	7.0	3.7	10.8	35.9	16.4	8.8	12.1	21.2	3.1	3.8	0.0	0.5	9.5	25.3	11.5	0.2	3.6	1.2	9.0	4.7	1.2	0.0	0.9	3.3	3.0	0.0	0.6	3.4	0.4	11.0	11.5	1.3	0.1	5.2	7.1	7.7	7.8	11.5	5.2	6.4	50.3	13.3	56.0	5.4	19.8	10.5	19.5	0.0	5.5	8.1	0.5	4.8	2.6	4.2	5.2	11.5	7.7	5.2	6.9	2.8	4.8	3.7	8.4	0.4	34.6	8.3	1.9	3.0	0.1	2.2	22.1	12.1	0.0	5.7	25.6	2.0	0.6	12.3	5.1	2.5	1.3	3.5	3.9	0.5	1.7	62.2	20.6	8.0	2.0	8.7	3.1	1.2	9.0	3.9	3.6	17.8	2.3	4.1	56.7	20.1	28.2	2.2	8.5	17.0	4.9	3.2	6.1	3.2	5.5	1.2	13.1	7.4	11.4	0.1	0.6	3.8	6.8	0.0	9.1	2.5	8.2	2.5
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Cytokine, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 118.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 74.4;Macrophages: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 65.2;neutrophil: 34.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.7;HL-60: 3.8;HMC-1: 11.1;Karpas-707: 3.5;NB-4: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	39700		"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	7.2	3.6	0.8	14.3	1.0	118.2	0.8	0.8	4.2	1.2	2.0	1.0	0.5	1.1	0.1	0.8	2.3	6.2	1.4	0.6	1.5	2.0	1.9	7.8	1.6	1.8	0.9	0.5	1.2	0.9	1.5	5.5	1.7	1.0	0.5	0.1	1.1	0.2	0.2	0.2	0.7	3.1	1.6	5.0	0.9	0.4	4.7	2.6	0.8	2.9	0.8	12.7	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.3	0.0	0.0	0.0	3.8	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	3.5	0.0	0.0	0.5	6.6	0.0	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	65.2	0.5	2.0	2.0	0.3	6.5	0.0	4.8	2.6	0.8	0.2	0.9	2.4	34.9	4.3	0.1	0.2	1.4	1.6	0.8	1.0	0.8	4.2	0.6	1.5	1.8	0.9	1.7	1.6	4.7	2.9	0.9	9.6	10.6	0.0	3.2	0.8	0.2	0.0	0.0	0.0	0.7	1.8	0.6	0.0	3.7	0.0	0.0	0.8	13.2	0.0	0.0	0.1	0.1	0.6	0.2	1.9	0.0	1.3	0.1	0.0	0.9	1.4	0.0	1.1	15.2	0.0	0.4	0.0	74.4	0.0	0.1	0.1	0.0	6.1	12.4	0.0	0.0	51.6	0.0	0.0	1.8	0.1	1.0	0.0	0.1	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.7	0.2	0.0	0.7	0.4	0.0	0.0	0.3	0.3	0.8	14.2	0.1	0.0	0.0
OSMR	"OSMRB, OSMRbeta"	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 74.9;Pancreatic endocrine cells: 72.4;Prostatic glandular cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 154.3;GAMG: 162.7;HSkMC: 192.7;U-2197: 158.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA		51000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	59.3	29.8	7.8	25.3	7.6	0.1	37.3	7.4	8.4	26.0	9.7	25.2	5.5	22.9	7.6	17.1	27.8	28.8	27.6	6.5	10.5	29.9	19.2	46.2	16.0	13.4	10.8	24.6	16.4	6.5	10.4	35.3	10.2	24.6	10.5	4.3	27.4	13.5	11.8	21.9	15.1	39.0	9.3	17.9	18.4	5.6	11.5	13.9	23.9	8.5	15.1	40.9	22.3	8.1	32.6	41.2	6.9	17.7	72.6	154.3	23.4	51.7	81.7	49.8	66.4	0.1	85.9	0.0	23.9	55.3	162.7	43.9	8.9	63.6	79.8	0.1	5.1	2.2	31.2	31.6	82.4	0.0	0.6	192.7	37.3	111.9	94.9	92.3	7.7	0.0	0.0	0.2	31.8	8.8	0.1	0.1	1.1	6.8	13.3	0.0	2.3	0.0	99.8	9.5	0.1	0.3	116.8	0.2	0.2	9.5	35.4	0.3	12.2	120.6	45.1	158.1	28.0	0.0	0.1	0.1	96.8	0.1	26.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.6	7.4	8.4	6.5	10.5	13.4	10.8	10.2	9.3	11.5	8.1	41.5	44.8	56.8	13.4	0.6	30.3	74.9	55.0	27.3	0.2	21.7	10.8	5.0	15.7	51.4	12.9	0.0	6.9	0.2	0.2	0.0	48.7	0.6	6.6	38.9	47.0	0.0	0.4	2.0	48.6	6.8	37.2	6.6	9.2	1.3	2.6	55.0	16.6	1.6	0.0	1.8	0.0	8.2	6.1	7.6	1.4	41.7	1.1	7.2	46.9	1.6	0.7	0.0	13.6	3.6	72.4	0.0	7.5	0.6	73.8	0.0	5.9	19.3	0.6	19.7	32.4	33.6	0.3	1.6	10.5	24.0	17.1	1.7	4.7	0.0	57.7
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558756	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 23.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 4.0;Skeletal myocytes: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HDLM-2: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.2	0.5	23.1	0.3	16.3	6.4	0.2	0.2	13.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.3	0.1	4.1	3.3	0.0	0.0	0.2	0.1	5.2	2.8	0.0	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.1	4.2	0.5	0.2	1.1	3.0	0.9	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.1	16.3	0.2	13.1	4.1	3.3	5.2	2.8	4.0	4.2	3.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.8	0.3	0.0	0.0	0.1	0.5	0.4	0.0	0.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	44.8	57.0	69.9	43.0	78.0	63.5	47.3	53.0	93.4	54.1	39.7	51.9	42.0	49.0	37.4	85.4	55.8	35.9	62.4	79.3	62.5	61.3	47.0	47.1	59.8	65.0	58.0	44.5	43.9	47.1	48.6	49.3	66.1	53.5	39.3	25.6	54.3	42.6	70.2	78.1	51.9	38.0	51.2	58.6	54.0	57.1	65.0	56.0	51.9	48.4	57.1	52.5	56.7	67.7	113.4	198.9	107.2	95.7	70.7	77.8	83.0	66.0	97.1	143.6	105.1	138.1	104.5	59.3	122.0	106.6	124.4	138.1	140.4	165.4	88.1	69.9	111.7	99.3	114.1	172.9	98.8	99.2	104.3	83.4	106.4	110.2	69.8	74.4	137.2	54.6	71.2	65.3	97.9	237.2	109.2	133.0	126.5	95.4	94.1	88.3	41.8	102.5	151.1	162.1	81.5	117.5	74.6	114.1	123.3	72.9	178.2	86.3	100.1	75.8	74.2	103.3	88.4	76.2	51.7	86.4	98.4	64.0	74.5	228.8	186.8	189.9	165.5	244.2	131.2	149.6	152.1	153.6	203.1	139.3	117.1	130.4	184.6	161.8	218.9	140.7	224.7	313.4	69.9	78.0	53.0	93.4	79.3	62.5	65.0	58.0	66.1	51.2	65.0	67.7	37.0	19.2	56.5	15.0	67.2	48.3	70.9	137.8	83.6	44.4	42.5	48.8	31.9	37.1	82.5	46.0	39.6	146.2	56.5	104.7	74.3	80.7	72.6	55.4	36.2	43.4	87.8	35.5	17.8	85.5	109.2	50.0	71.9	44.3	48.7	54.6	35.7	33.2	90.4	30.3	16.9	70.8	101.7	57.4	65.9	87.1	34.2	61.0	51.6	8.4	98.0	43.2	78.2	12.5	18.8	90.1	92.0	25.6	80.8	51.8	90.8	85.2	89.2	55.7	26.3	28.1	62.0	48.0	71.4	77.7	52.6	194.8	73.7	51.7	62.7	71.6
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414319-111427735	"Plasma proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	134	"fallopian tube: 2071.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 9.7;Excitatory neurons: 10.4;Glandular and luminal cells: 12.0;Inhibitory neurons: 8.5;Syncytiotrophoblasts: 17.4"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.9;OE19: 6.4;SK-BR-3: 5.0"	"Region enhanced"	"Detected in many"		"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA031666, HPA062205"	Enhanced		Supported	Vesicles,Microtubules	"Secreted in female reproductive system"	NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles	Microtubules	"HPA031666: , HPA062205: AB_2684710"	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favorable (3.93e-5)"	4.1	1.6	7.6	1.1	7.8	1.9	3.5	8.0	10.6	3.8	5.8	3.4	1.1	15.4	5.1	3.0	2071.7	1.1	2.3	7.7	7.0	5.0	8.0	3.9	2.2	7.3	6.9	6.7	1.5	6.8	2.4	2.0	7.2	5.5	2.2	4.3	4.2	1.5	2.6	7.6	5.2	1.4	6.5	4.6	2.8	9.2	6.9	1.2	2.4	1.0	2.0	4.6	3.8	8.2	0.4	0.4	0.9	0.5	1.8	2.0	1.7	0.2	1.4	0.3	0.7	0.6	0.0	0.8	1.7	0.6	0.0	0.5	0.3	0.3	0.5	2.0	4.9	0.3	0.8	2.4	0.6	0.9	2.2	1.8	2.9	0.0	1.0	1.4	0.4	3.2	0.3	1.5	0.1	0.5	0.6	1.2	0.2	6.4	1.7	0.6	0.2	0.7	1.4	3.7	0.6	0.6	0.1	5.0	0.7	2.4	0.3	0.8	0.8	0.1	0.2	2.5	0.7	1.8	0.5	0.4	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	7.8	8.0	10.6	7.7	7.0	7.3	6.9	7.2	6.5	6.9	8.2	1.2	0.0	1.1	3.3	0.6	3.1	1.1	0.3	0.0	2.1	1.7	1.9	0.6	0.0	0.5	0.0	0.0	5.6	0.2	1.1	1.9	0.2	4.0	9.7	0.7	1.6	0.0	0.0	10.4	0.0	2.6	0.6	0.0	12.0	0.0	1.0	1.4	2.9	0.6	0.0	8.5	1.5	2.0	0.6	1.4	6.1	1.5	0.5	0.0	3.7	0.0	0.4	0.0	1.5	2.4	0.2	0.5	1.9	0.1	1.6	0.6	2.8	1.3	0.6	0.0	0.7	1.1	3.8	0.7	1.0	3.1	17.4	0.8	0.2	1.6	1.6
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"brain: 1167.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.0;Hepatocytes: 41.2;Late spermatids: 66.3;Proximal enterocytes: 15.7;Proximal tubular cells: 36.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in many"	141	"hypothalamus: 1167.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;HMC-1: 1.1"	"Region enriched"	"Detected in many"	6	"hypothalamus: 179.3"	"Group enriched"	"Detected in some"	903	"basal ganglia: 794.6;hypothalamus: 1854.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	3.2	1.7	8.3	0.0	0.8	0.1	1.7	0.5	0.9	0.9	0.7	0.4	1.0	0.4	0.0	0.2	0.3	0.0	0.5	0.2	1167.9	4.1	19.3	0.2	0.1	0.2	0.7	0.3	0.1	0.0	15.9	0.0	0.2	0.7	0.0	0.0	0.5	0.1	0.2	2.3	1.0	0.0	1.3	0.2	0.2	2.6	7.8	0.0	0.6	0.0	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.4	0.2	0.5	2.1	0.8	0.5	0.4	1.6	1.4	1.7	0.5	0.2	0.0	0.7	1.3	0.3	8.3	0.8	0.5	0.9	0.2	1167.9	0.2	0.7	0.2	1.3	7.8	0.2	0.6	0.0	1.8	0.3	3.5	0.8	0.7	0.1	1.2	0.0	1.2	1.7	0.2	0.0	1.3	5.5	0.0	0.0	2.3	0.1	1.9	0.1	30.0	0.2	2.4	0.3	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.0	41.2	0.2	0.0	0.1	1.8	0.0	0.3	1.6	66.3	0.9	0.6	3.6	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.7	1.2	1.2	0.4	15.7	36.5	0.9	0.0	0.0	1.8	0.7	1.1	7.8	0.3	1.0	0.0	1.1	0.0	2.0	0.3
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 494.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No		60000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	28.1	26.0	25.7	20.8	26.4	15.5	26.3	29.6	58.5	31.9	34.7	16.3	11.0	27.0	18.9	10.1	41.1	26.3	38.7	26.5	27.1	35.8	72.8	27.8	16.2	32.9	30.0	34.9	17.5	17.0	11.6	65.3	33.0	20.0	17.4	33.3	13.0	18.4	110.9	17.4	14.4	28.5	30.2	19.6	19.8	19.3	30.1	12.9	13.9	54.0	14.6	29.6	18.2	39.0	84.0	21.2	60.1	117.6	181.2	138.3	50.1	239.9	215.8	90.8	215.8	35.6	63.6	28.4	89.7	239.0	55.1	92.5	38.3	87.7	197.1	36.5	14.5	24.4	18.6	42.5	75.3	45.1	16.4	84.5	50.3	77.7	101.6	494.2	43.5	23.8	38.3	14.7	79.3	22.4	17.9	42.9	21.6	38.9	92.3	16.4	40.2	52.4	51.0	35.6	5.5	33.7	49.2	143.2	58.3	135.0	21.9	41.9	41.9	110.5	44.8	31.3	56.9	81.8	31.3	13.7	198.1	64.5	54.9	1.1	18.8	14.9	6.7	23.5	8.7	8.2	8.1	7.9	20.7	9.2	5.9	6.1	10.4	5.2	25.7	16.6	10.7	9.1	25.7	26.4	29.6	58.5	26.5	27.1	32.9	30.0	33.0	30.2	30.1	39.0	29.0	6.4	28.4	87.1	31.7	36.3	33.0	138.0	22.2	13.5	23.8	15.7	42.0	7.2	69.2	23.9	27.1	31.5	24.9	25.1	0.0	33.1	16.8	85.6	89.2	25.9	10.3	7.2	48.8	19.5	116.4	67.7	14.3	131.4	40.5	16.9	20.0	29.8	43.9	11.8	41.6	9.5	46.8	54.1	75.7	8.1	51.9	51.5	44.4	62.8	39.0	34.0	6.2	86.5	44.8	36.6	27.1	47.0	32.9	24.9	13.5	25.1	94.6	17.2	39.5	37.0	44.7	61.7	34.0	9.8	23.9	33.2	27.7	31.1	7.0	17.6
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104537-56113910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol		NA	NA		2300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	78.4	59.6	46.7	89.3	50.4	132.9	76.2	50.7	58.0	64.8	43.0	78.7	74.1	64.7	48.2	132.5	64.7	43.7	76.9	48.6	51.8	62.1	72.8	62.5	96.6	49.4	48.3	71.2	75.1	83.7	36.3	69.2	51.0	53.2	90.5	38.3	63.9	55.4	144.0	106.1	69.7	68.4	49.8	61.2	65.5	63.1	48.9	123.4	61.4	92.5	120.7	105.3	76.9	57.2	429.6	374.8	248.9	275.5	112.5	169.8	499.6	441.3	209.7	530.9	293.8	464.7	307.5	850.8	291.2	209.6	155.9	343.5	574.2	493.1	510.9	243.9	517.6	659.1	242.5	400.4	219.7	898.8	232.4	172.5	247.2	460.2	410.8	218.1	327.3	292.0	812.8	380.7	294.7	383.5	700.8	496.2	410.9	264.5	460.9	569.3	449.8	577.2	272.0	315.7	372.8	225.6	290.5	451.6	275.0	183.1	488.7	343.5	264.8	256.3	364.7	300.3	495.5	234.4	345.1	822.1	232.3	532.6	340.9	34.3	87.0	54.6	129.9	96.0	174.7	98.0	136.8	141.3	102.1	81.3	129.7	131.2	13.8	151.5	82.0	98.6	170.9	155.9	46.7	50.4	50.7	58.0	48.6	51.8	49.4	48.3	51.0	49.8	48.9	57.2	135.7	54.5	91.2	9.8	136.3	368.5	244.7	187.4	224.8	56.2	151.9	165.7	37.3	118.7	161.3	130.6	18.8	232.0	163.1	123.4	193.7	235.8	530.6	127.1	218.4	154.2	93.3	552.1	12.8	249.1	321.7	139.5	112.7	142.2	170.9	103.7	107.8	197.5	208.6	33.7	13.0	159.0	99.7	124.2	127.8	238.9	132.0	126.2	129.9	6.5	155.4	117.1	178.2	10.6	14.8	269.3	100.8	126.7	163.5	360.7	118.6	264.7	103.6	48.8	144.7	188.1	191.7	344.6	110.9	295.2	362.7	193.5	176.2	132.2	254.1	242.7
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol		NA	NA		3900000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	627.6	341.5	48.8	490.8	73.4	364.0	575.7	54.9	58.6	700.3	86.2	524.3	450.2	453.5	68.3	1353.3	437.0	227.1	233.8	35.3	80.2	296.4	347.7	490.3	542.4	104.1	58.7	724.0	728.0	126.7	167.7	214.5	92.2	473.9	270.3	80.2	1287.6	172.7	197.7	732.4	502.0	226.5	64.1	483.1	524.7	507.9	92.7	421.0	303.4	75.8	532.3	630.5	853.3	81.6	2069.1	644.4	372.2	842.0	585.0	1050.0	793.4	504.4	593.5	451.8	468.7	791.5	1107.8	3230.4	1609.1	809.5	291.3	792.4	554.6	1092.3	459.5	758.2	555.4	1713.1	302.2	562.6	835.7	673.3	891.0	1338.6	1050.2	554.8	2126.1	950.7	690.8	1071.8	1339.4	1120.1	477.5	857.3	2617.8	949.5	882.3	1487.3	929.6	967.5	541.7	1074.2	301.8	953.1	629.2	650.1	415.8	548.6	1200.7	513.2	1031.7	949.5	1005.1	512.4	809.4	723.9	897.9	753.6	606.1	1523.2	609.7	1378.1	538.8	122.8	401.3	131.2	159.3	405.2	348.9	297.4	333.0	264.3	421.4	263.0	437.4	370.4	112.5	306.9	468.5	277.2	301.5	568.0	48.8	73.4	54.9	58.6	35.3	80.2	104.1	58.7	92.2	64.1	92.7	81.6	348.4	371.8	939.1	28.7	1089.1	787.4	1075.3	735.0	1067.7	66.5	1036.1	641.2	139.7	459.0	1020.8	110.3	50.1	454.2	872.8	457.0	264.1	467.0	1727.8	352.1	628.4	523.0	477.1	999.1	42.4	769.0	860.8	458.8	530.1	436.1	1054.1	357.3	570.8	308.3	615.5	72.3	34.1	853.8	360.1	1520.8	1162.9	306.0	498.9	1144.3	370.0	53.4	1583.7	167.7	679.7	29.7	41.1	626.9	698.0	424.3	674.4	655.3	446.1	388.4	473.5	88.4	499.6	530.4	876.7	1433.1	476.0	929.6	765.3	777.9	1041.1	408.3	1061.2	1296.9
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	133.2	178.7	187.0	86.4	183.9	136.9	127.7	193.4	249.3	165.6	184.5	184.1	107.6	176.0	130.3	151.0	175.6	63.4	138.1	185.8	196.6	187.7	194.8	130.0	103.9	186.0	182.2	176.3	138.8	101.0	199.0	79.7	181.6	179.4	101.5	126.6	130.4	85.8	131.5	136.9	167.8	97.4	175.6	174.3	159.3	230.1	186.3	147.6	189.8	94.1	116.5	146.3	144.0	190.4	127.2	133.9	298.3	216.6	125.5	143.1	191.4	120.4	121.6	168.4	157.4	168.0	223.0	229.7	67.0	157.0	180.6	186.4	337.7	169.7	230.7	195.2	116.7	173.5	208.1	435.5	145.2	273.5	220.2	157.1	164.7	125.0	149.1	240.9	188.1	196.0	164.5	174.6	159.8	239.6	296.1	334.5	328.6	151.2	149.3	289.1	114.8	136.2	196.1	256.2	205.6	159.9	161.4	143.2	129.6	196.9	114.2	196.3	153.2	112.1	153.8	110.4	161.8	207.3	153.0	276.5	51.4	221.4	138.7	15.7	7.6	8.5	6.0	5.8	4.9	7.4	6.1	5.5	6.1	9.3	7.5	7.0	10.0	10.1	7.2	13.8	7.6	2.5	187.0	183.9	193.4	249.3	185.8	196.6	186.0	182.2	181.6	175.6	186.3	190.4	66.3	35.3	49.4	0.0	83.3	157.8	84.4	74.0	158.2	120.1	110.2	89.5	14.3	77.2	51.2	126.9	146.0	70.0	102.5	85.5	13.7	52.6	55.6	71.8	80.8	75.0	161.4	94.2	0.0	57.2	67.4	72.4	68.8	78.6	24.1	169.3	66.0	121.6	63.2	77.4	0.0	107.2	54.9	84.7	119.0	45.9	81.1	85.5	53.4	0.0	104.4	55.8	65.9	0.0	0.0	59.2	91.6	59.8	102.2	88.7	88.9	40.3	49.8	80.2	72.3	57.5	85.0	41.8	33.3	187.4	179.9	62.8	67.3	107.6	108.1	114.6
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070272-66244744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol		NA	NA		17000	"Cluster 46: Basophils - DNA binding"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	30.6	24.0	26.4	33.7	28.4	26.0	26.4	28.4	29.0	30.4	11.0	29.7	13.3	26.7	17.7	32.1	22.2	23.6	45.4	27.2	18.5	28.0	11.4	30.2	49.8	18.2	20.4	32.4	26.8	18.7	21.6	18.9	17.1	34.6	10.2	35.1	92.8	22.2	22.4	27.6	25.6	30.3	13.0	34.9	24.9	42.2	20.7	35.1	34.0	17.2	46.2	33.9	29.6	18.8	44.1	45.6	21.1	13.3	38.5	46.1	23.7	59.3	41.9	40.6	25.2	28.4	34.3	27.6	38.2	102.5	37.7	27.9	15.6	42.7	54.4	43.7	18.3	45.0	41.7	41.2	45.8	6.5	34.6	46.8	19.8	37.0	47.2	78.1	39.8	18.2	16.7	52.2	44.7	83.3	48.1	16.8	9.8	12.0	21.2	31.6	21.5	47.9	28.9	43.4	29.8	33.6	61.5	34.5	29.1	33.9	39.7	8.3	54.4	52.2	23.1	71.9	25.6	26.2	19.1	7.4	45.0	10.4	26.0	3.7	1.3	2.8	3.4	1.0	2.2	2.9	3.1	2.9	1.3	4.8	3.5	3.1	7.4	2.0	2.9	0.8	4.0	3.0	26.4	28.4	28.4	29.0	27.2	18.5	18.2	20.4	17.1	13.0	20.7	18.8	19.9	3.2	3.0	93.7	41.3	10.1	17.6	8.8	16.5	31.4	16.5	16.3	16.9	8.6	12.1	12.9	50.1	8.1	31.9	2.8	5.9	20.5	17.0	11.1	17.3	18.2	6.1	14.1	113.5	62.7	10.9	15.8	13.7	16.3	23.5	80.3	26.0	4.6	13.1	92.5	90.0	2.2	6.1	14.5	14.7	27.6	18.6	22.7	10.6	96.5	33.4	13.9	38.1	87.4	49.2	54.7	1.2	18.0	13.5	23.3	1.0	13.1	11.8	41.2	13.1	12.3	16.5	20.6	21.8	16.5	9.9	5.7	36.3	16.5	3.6	17.0
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177522-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 161.8;skeletal muscle: 480.9;tongue: 279.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	14.4	66.5	19.6	4.5	28.2	0.4	18.4	24.5	20.9	33.3	18.8	50.2	4.7	33.5	11.4	52.6	29.1	7.2	161.8	18.0	19.4	14.8	43.6	15.9	2.0	33.8	27.5	23.2	33.1	11.0	6.2	16.1	32.1	35.2	2.7	4.5	40.8	20.6	480.9	41.4	11.3	21.2	25.0	4.5	33.5	4.5	25.4	2.0	24.5	279.4	5.2	21.5	31.8	39.0	56.4	27.1	12.5	51.5	10.3	10.2	59.8	19.4	24.6	33.9	19.1	40.8	7.3	0.3	5.9	9.2	23.0	90.0	23.7	40.2	13.0	8.7	44.8	8.4	105.5	91.7	19.9	2.0	8.4	28.2	52.3	17.9	28.3	27.2	15.3	15.2	18.4	0.7	13.9	106.7	0.7	40.8	15.5	43.7	58.7	33.1	48.0	9.0	14.3	49.3	0.3	42.6	28.2	17.9	24.6	24.6	127.3	6.9	6.9	57.6	62.5	7.5	47.1	10.1	4.4	5.3	18.6	19.2	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.6	28.2	24.5	20.9	18.0	19.4	33.8	27.5	32.1	25.0	25.4	39.0	6.1	0.0	8.1	4.9	0.3	35.9	29.1	25.1	30.7	0.7	32.2	24.3	112.0	38.6	18.1	5.5	0.0	31.0	0.6	0.2	9.8	37.7	0.0	3.1	8.4	7.8	0.0	2.7	0.8	15.5	60.6	12.6	9.7	6.2	0.0	3.0	8.6	33.1	6.0	0.0	1.1	0.2	14.2	1.6	4.6	0.4	16.1	1.0	17.8	2.8	0.0	63.6	0.0	0.0	9.5	41.0	0.0	12.4	2.6	56.8	1.5	24.3	5.0	3.2	32.9	18.5	25.4	0.2	7.5	39.7	29.8	18.3	0.7	4.8	1.4	29.8
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 105.1;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 183.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017007, HPA042825"	Enhanced					NA	NA		29000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.8	0.1	0.2	0.7	0.4	105.1	0.3	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.4	1.0	0.4	1.1	0.3	0.2	0.5	1.7	7.9	0.3	0.3	0.1	0.1	0.3	0.0	0.2	0.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.0	29.9	0.4	0.1	0.1	1.6	0.3	0.3	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	79.9	71.3	97.5	0.4	5.7	0.2	1.1	0.5	0.7	13.9	1.8	2.6	4.5	183.0	4.5	1.8	6.2	0.4	35.8	0.2	0.4	0.2	0.8	0.3	0.2	0.3	0.1	0.3	0.0	0.1	0.4	0.0	0.0	3.7	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.6	0.6	0.0	0.0	12.6	0.1	0.0	0.4	0.2	0.0	0.4	0.0	0.0	3.3	0.4	0.2	0.0	14.6	0.0	0.0	22.3	0.0	20.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 640.0;Late spermatids: 1864.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome		NA	NA		860000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	34.8	32.2	35.5	27.2	43.1	4.0	32.6	31.5	46.5	38.3	6.7	46.4	30.5	43.9	26.9	38.0	36.7	31.8	51.1	46.2	47.4	41.4	30.0	37.3	30.9	41.3	38.4	35.4	26.3	56.4	38.4	32.4	48.1	32.6	32.8	47.2	32.4	38.6	87.7	42.1	36.5	44.4	30.2	31.0	34.6	55.7	36.7	41.5	43.9	73.2	38.8	35.7	37.8	38.0	51.3	53.3	81.8	28.4	66.9	74.1	27.3	76.5	67.1	56.3	53.0	69.7	18.7	64.5	63.5	100.3	27.4	53.5	74.4	59.8	80.6	50.9	48.4	56.4	48.8	27.3	69.3	37.5	66.4	68.8	73.5	58.8	58.1	71.7	58.1	51.8	38.8	32.7	84.8	21.1	58.3	28.6	36.7	30.5	27.0	39.5	67.6	30.0	62.5	30.5	37.4	62.0	63.0	34.5	65.5	51.8	36.5	30.1	84.9	71.5	17.1	57.1	61.0	24.7	32.1	28.8	60.4	33.7	66.2	2.6	1.7	3.4	4.7	2.5	5.2	2.9	4.1	3.3	2.5	2.4	4.9	3.8	2.6	3.6	3.8	1.5	5.1	2.4	35.5	43.1	31.5	46.5	46.2	47.4	41.3	38.4	48.1	30.2	36.7	38.0	73.7	121.8	92.2	90.8	82.7	118.7	114.8	74.3	63.2	102.4	52.1	42.9	136.3	30.0	101.6	35.0	50.1	56.4	117.2	77.4	35.2	77.2	640.0	82.2	95.5	77.2	34.1	45.9	178.1	56.3	76.7	74.7	87.7	100.9	93.7	45.1	43.2	32.3	60.2	102.6	161.8	43.7	57.0	46.3	77.0	1864.4	64.0	77.6	56.9	104.9	90.3	60.7	97.9	115.1	193.5	100.8	61.5	56.8	91.7	91.6	76.9	55.0	80.7	65.8	46.0	84.5	133.0	256.8	78.1	69.7	132.6	129.6	92.7	54.7	39.2	122.4
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 157.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Approved		Approved	Cytosol		Yes	No		490000	"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.16e-1)"	24.5	40.2	22.7	40.1	26.7	46.8	54.6	28.3	25.0	29.3	21.6	42.8	32.1	29.7	22.1	36.3	35.4	17.8	19.7	20.3	27.8	42.7	109.7	14.1	51.3	26.0	30.1	30.7	21.7	39.5	17.7	45.9	26.1	31.0	54.7	30.4	26.4	25.8	32.4	37.6	30.8	35.7	25.6	18.3	20.7	29.5	26.8	56.4	32.4	24.1	64.5	37.4	25.4	27.2	239.3	175.3	354.3	220.6	74.3	166.1	304.0	201.7	145.1	282.5	276.0	280.5	275.7	548.0	228.3	136.0	154.1	143.6	565.5	293.0	480.8	110.4	198.8	298.7	259.5	313.4	141.8	537.1	127.6	141.9	207.9	301.0	225.0	155.7	235.4	308.6	524.7	198.5	246.8	159.3	621.5	267.2	407.5	454.8	216.5	496.2	151.7	361.5	268.4	164.5	378.8	226.4	198.6	273.7	124.3	287.2	181.2	169.8	127.7	222.6	290.1	221.8	419.0	139.1	128.2	571.1	234.8	385.2	251.0	6.0	5.2	0.4	5.2	8.7	15.0	17.8	14.4	9.2	15.3	11.0	17.4	15.5	1.1	15.9	6.9	17.0	11.2	8.7	22.7	26.7	28.3	25.0	20.3	27.8	26.0	30.1	26.1	25.6	26.8	27.2	16.4	22.4	22.9	17.0	35.7	56.6	71.9	66.0	54.1	27.4	35.8	37.5	23.3	50.1	32.3	33.1	6.2	134.4	15.3	20.5	37.2	45.0	69.4	15.2	49.1	25.1	24.7	80.8	9.1	26.3	157.5	34.2	15.3	23.3	21.0	69.1	13.2	78.7	51.5	28.6	14.6	41.0	34.6	16.1	17.2	10.6	29.8	16.1	17.8	6.5	20.2	14.0	6.2	13.0	12.2	27.4	18.6	23.3	48.1	81.7	15.9	47.7	17.9	24.6	0.0	31.3	29.2	40.0	50.3	53.1	50.4	54.6	16.8	66.4	69.7	48.9
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77322017-77474635	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		560000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	12.7	13.4	32.4	33.9	44.5	59.0	18.2	13.9	57.7	21.1	0.0	43.2	43.1	20.9	29.8	21.4	21.9	30.9	9.4	58.3	8.0	26.1	14.5	16.8	20.4	19.2	12.2	21.1	17.5	20.5	20.7	14.7	19.4	19.1	46.5	25.1	19.9	19.7	87.0	16.2	45.7	27.0	0.9	29.3	41.2	25.7	17.1	29.1	40.6	18.8	23.1	27.7	20.7	30.0	39.9	26.7	56.7	25.5	22.8	37.6	45.9	44.6	32.1	42.0	48.7	38.7	52.8	36.3	16.0	39.4	54.4	20.2	40.2	47.8	65.5	41.4	32.6	38.2	17.6	2.3	15.3	64.3	53.5	28.2	28.8	49.2	73.1	36.6	10.1	41.3	25.5	61.2	77.6	2.9	42.3	30.2	84.5	166.2	22.5	62.6	72.3	1.4	10.6	32.9	24.6	23.9	23.6	9.7	19.5	55.0	45.4	29.0	0.9	27.3	47.5	148.9	37.9	165.7	92.4	23.4	23.0	42.5	30.6	2.5	182.2	292.7	11.2	177.7	9.4	16.8	8.4	10.7	264.3	12.9	7.4	14.5	431.8	28.4	202.6	22.9	7.3	92.3	32.4	44.5	13.9	57.7	58.3	8.0	19.2	12.2	19.4	0.9	17.1	30.0	3.1	3.2	20.5	24.2	23.9	11.9	33.3	28.2	23.9	51.6	25.1	19.7	6.2	35.8	30.8	25.8	8.4	25.4	10.2	78.6	45.0	32.4	38.8	37.3	13.5	3.2	37.8	30.5	219.1	56.3	53.5	24.0	45.9	39.7	132.2	35.2	3.6	11.4	49.8	1.7	118.5	50.8	28.5	59.6	152.9	28.3	14.3	80.0	30.2	54.4	121.7	14.9	10.3	53.3	70.7	50.9	57.9	13.2	28.6	28.7	47.9	55.7	39.0	6.4	13.1	13.8	25.2	50.4	53.8	23.6	10.4	95.0	19.3	10.3	52.8	33.2
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1700000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	31.8	18.1	21.2	34.6	24.9	28.1	19.5	25.0	21.7	21.1	19.8	25.6	23.0	21.9	16.0	26.5	20.5	23.8	24.0	19.5	24.6	22.1	33.8	26.3	40.9	26.7	23.4	19.8	18.5	32.6	8.4	33.3	27.7	20.1	26.6	17.4	14.5	18.9	28.3	16.6	22.5	27.0	24.8	43.5	20.9	15.1	23.0	45.1	19.7	25.9	39.4	34.1	16.0	34.1	140.7	49.1	67.6	49.8	47.1	61.9	100.0	69.1	57.0	73.7	66.8	117.5	70.1	89.4	192.7	70.8	75.1	70.2	72.5	66.2	113.6	39.9	35.2	132.2	52.1	92.5	95.0	130.2	122.0	49.6	53.1	66.2	139.2	78.1	74.3	97.3	65.0	107.5	72.9	146.7	124.8	67.2	40.5	74.7	73.4	112.4	38.6	80.9	64.8	96.7	39.6	44.7	92.8	64.7	52.7	51.9	227.0	92.6	76.9	60.9	33.6	64.3	103.1	72.5	138.9	216.4	50.4	127.6	59.1	37.3	20.0	48.0	10.9	23.2	14.7	11.2	12.7	12.6	25.4	11.3	9.1	10.9	47.6	12.2	21.2	9.3	20.7	14.9	21.2	24.9	25.0	21.7	19.5	24.6	26.7	23.4	27.7	24.8	23.0	34.1	164.9	80.1	40.2	37.9	142.8	97.4	89.2	41.8	96.2	42.6	59.7	47.5	59.3	62.9	45.1	82.8	52.1	50.3	135.1	69.6	33.2	71.5	57.1	107.9	112.6	104.0	44.9	72.3	32.2	59.0	101.4	68.9	58.1	96.1	148.8	70.9	66.0	138.6	104.3	55.5	38.9	46.4	57.0	160.5	115.9	75.5	60.9	169.6	33.8	46.9	183.2	63.7	140.1	37.2	61.3	100.4	52.1	45.5	100.0	149.4	58.2	85.2	76.4	45.0	39.5	86.0	75.9	24.5	43.0	103.2	86.2	34.9	139.1	96.3	51.0	124.1
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1560.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		98000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	119.3	202.5	71.6	34.6	81.4	10.1	99.0	50.7	82.5	595.0	96.2	125.1	52.6	140.9	678.2	69.4	87.6	97.3	1560.4	75.2	179.9	116.0	20.1	88.3	27.7	86.5	99.8	136.4	104.4	257.8	137.0	60.0	170.9	91.6	80.4	37.6	205.4	236.5	155.3	66.9	52.1	157.9	55.7	52.5	131.6	22.4	106.0	17.9	95.1	159.4	30.5	103.3	116.1	50.0	111.3	16.3	195.9	87.2	529.9	314.8	78.0	307.6	457.0	89.1	268.9	53.5	143.2	0.1	65.0	714.5	125.7	36.8	11.0	135.3	244.0	13.5	44.7	22.9	60.0	17.7	80.3	7.4	23.9	173.4	57.3	65.6	49.2	562.6	186.8	8.9	0.9	15.0	255.6	22.9	0.1	3.2	35.3	19.7	59.3	8.5	108.9	62.4	346.1	13.0	92.3	63.9	131.2	8.3	83.3	114.0	34.0	7.3	144.9	280.8	72.4	133.3	93.4	33.1	8.6	0.4	322.3	30.8	247.6	4.2	8.0	0.2	20.7	1.5	14.9	0.8	12.3	15.6	3.1	0.4	4.1	6.8	16.6	26.3	3.4	1.6	19.9	10.8	71.6	81.4	50.7	82.5	75.2	179.9	86.5	99.8	170.9	55.7	106.0	50.0	45.7	54.5	39.3	47.0	3.9	28.2	12.0	26.1	12.0	19.1	27.5	12.1	1406.5	0.0	30.4	60.7	2.1	1.6	12.6	13.7	7.9	12.6	8.8	47.6	48.6	63.5	321.4	3.4	229.2	21.5	40.6	220.4	26.0	83.0	9.5	68.3	74.6	3.5	5.9	8.4	487.7	13.8	18.3	10.3	48.3	8.1	60.3	9.3	37.4	192.0	9.5	11.6	22.6	154.8	9.3	30.6	6.3	58.6	12.1	26.4	4.8	43.8	19.2	3.8	19.7	36.4	44.9	2.6	5.6	8.0	23.7	6.7	16.6	19.3	6.3	18.2
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929887	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	13.0	12.3	14.5	16.8	13.7	20.9	12.2	15.3	15.9	11.9	14.1	11.4	8.4	11.0	11.3	20.0	16.3	12.1	8.7	15.5	13.5	15.7	18.3	14.1	18.5	12.7	14.1	12.9	10.3	10.9	8.9	15.3	13.3	12.0	14.2	10.3	11.9	10.7	9.6	11.7	11.6	13.7	12.7	14.9	9.1	25.9	13.9	16.8	15.4	11.2	22.0	15.6	9.9	12.4	39.3	29.4	33.7	18.6	39.3	32.6	15.0	25.6	34.2	38.3	48.3	40.8	25.4	34.6	10.6	34.9	70.2	34.9	34.7	57.3	49.3	8.8	9.8	47.4	22.7	80.2	33.3	33.6	15.9	28.7	26.4	39.7	28.7	17.0	36.0	23.3	34.7	30.5	42.5	11.7	30.0	30.3	28.8	22.9	19.5	20.3	46.0	22.4	26.2	45.7	36.2	16.7	30.0	44.3	78.1	32.6	23.6	28.1	24.6	47.7	17.8	60.7	43.3	14.0	50.8	23.3	15.0	30.7	34.2	3.0	10.5	3.4	3.6	11.1	3.5	3.8	3.7	3.4	8.5	4.5	4.1	3.4	5.9	6.8	9.4	3.0	5.9	4.0	14.5	13.7	15.3	15.9	15.5	13.5	12.7	14.1	13.3	12.7	13.9	12.4	23.8	19.2	11.7	23.8	29.2	25.5	17.5	12.0	41.5	22.0	15.8	17.3	9.8	7.2	13.4	14.7	25.0	29.4	38.6	14.4	23.5	19.4	83.1	24.1	20.6	26.7	20.3	42.7	28.6	17.8	36.0	21.1	24.5	24.1	7.6	20.1	26.0	14.0	33.8	35.3	25.3	12.7	10.2	52.8	37.9	17.3	21.1	34.3	19.6	29.0	55.0	14.1	35.0	23.1	17.7	15.9	12.8	22.6	33.2	20.9	15.1	20.6	20.2	21.1	6.6	14.1	23.1	54.6	25.9	37.7	24.3	18.6	31.6	21.2	15.0	20.0
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 119.8;Endometrial stromal cells: 37.9;Leydig cells: 34.5;Peritubular cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.4;granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 16.1;HSkMC: 30.6;hTCEpi: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		76000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA048682: AB_2680492, HPA053453: AB_2682155"	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	16.1	6.6	15.7	8.4	17.0	2.3	10.7	12.1	23.5	30.3	15.7	13.4	3.0	20.4	14.9	7.1	23.0	5.6	8.0	14.4	13.3	42.6	3.2	13.4	15.2	14.1	14.6	16.8	4.0	0.4	16.4	4.0	13.1	13.6	4.5	9.5	7.5	7.5	2.1	15.7	17.8	6.3	12.3	29.1	11.3	6.4	14.4	5.1	24.8	1.8	13.6	5.1	9.1	12.3	2.7	2.6	1.0	0.4	1.9	2.3	5.8	0.5	0.0	0.1	0.2	3.4	0.8	0.5	2.7	0.0	0.1	4.3	2.7	2.0	0.3	3.0	3.9	1.2	4.7	0.3	16.1	0.4	2.1	30.6	11.4	0.5	1.7	0.2	0.6	2.5	0.8	0.3	0.0	1.4	0.3	3.0	0.6	0.3	0.8	0.4	0.3	2.8	2.3	0.6	0.3	0.5	6.2	7.0	1.3	7.9	0.2	4.8	0.5	0.7	2.3	0.2	0.3	1.3	0.1	0.3	1.4	1.4	0.6	0.8	0.5	0.3	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.5	0.2	0.2	2.5	0.3	0.2	5.4	0.3	0.1	15.7	17.0	12.1	23.5	14.4	13.3	14.1	14.6	13.1	12.3	14.4	12.3	0.4	0.0	2.6	119.8	0.3	2.0	0.7	5.1	0.6	1.2	1.8	1.4	1.9	7.2	4.8	5.5	8.4	0.5	5.7	0.4	0.0	4.0	0.3	11.8	37.9	3.4	0.0	0.0	0.3	0.0	1.1	8.3	0.5	16.1	0.0	0.2	3.3	0.1	1.2	0.0	0.9	0.4	2.0	0.3	1.6	1.7	34.5	1.8	1.8	10.3	1.6	15.7	0.0	3.0	0.3	0.4	0.0	44.0	0.2	1.4	0.2	10.2	3.7	3.0	6.6	1.4	1.8	0.6	0.1	0.8	3.0	0.4	0.7	0.1	1.0	0.4
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1036.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001788	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	52.6	60.5	62.7	66.6	65.1	96.9	62.7	71.7	87.4	61.7	70.1	70.5	57.1	68.5	72.5	59.6	57.9	56.1	61.0	59.9	64.4	60.7	81.6	50.0	77.8	63.0	61.7	76.1	71.6	73.2	53.0	85.3	64.3	54.2	71.8	92.4	63.8	54.0	46.7	57.9	67.6	61.6	62.8	69.3	65.9	75.8	62.1	93.0	68.9	56.4	82.8	66.4	53.5	80.7	126.6	119.4	150.5	152.6	107.2	119.4	331.6	112.9	120.4	132.1	125.8	132.9	125.6	170.9	125.3	134.1	115.2	104.4	50.1	156.9	235.0	141.1	81.1	131.9	88.9	138.5	110.6	166.2	133.4	110.6	134.1	148.0	131.1	127.8	150.5	79.5	128.2	146.5	128.9	184.6	140.5	91.1	102.9	205.0	135.3	146.7	183.5	98.7	132.0	192.7	154.0	102.0	151.4	115.8	111.6	167.9	165.3	158.3	119.0	91.3	72.6	104.1	140.7	114.3	186.7	138.6	144.5	137.5	158.9	73.5	32.0	56.1	23.8	39.3	29.0	38.9	30.2	34.2	38.8	42.7	35.3	33.9	41.3	41.3	37.7	25.1	32.7	36.6	62.7	65.1	71.7	87.4	59.9	64.4	63.0	61.7	64.3	62.8	62.1	80.7	126.3	80.1	122.4	64.6	171.4	229.7	406.3	196.6	126.9	78.2	140.0	101.6	157.2	88.6	160.1	84.6	95.9	346.2	139.6	124.1	183.9	121.4	634.7	326.1	145.4	150.7	117.2	126.8	87.9	137.0	440.7	129.9	95.3	371.7	136.4	113.8	85.6	112.3	155.6	63.9	111.5	154.9	168.9	141.3	239.4	275.3	96.3	153.2	168.9	104.9	171.8	93.4	135.9	105.1	115.2	129.6	118.9	80.5	197.4	373.0	122.5	136.5	253.1	107.2	105.2	131.6	185.0	256.8	203.0	146.0	247.6	1036.0	167.8	131.2	166.1	540.3
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857738-4862030	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"testis: 29.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 94.8;Late spermatids: 89.7;Smooth muscle cells: 18.5;Spermatocytes: 37.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA047285			Approved	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047285: "					"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.4	1.2	0.2	0.0	0.9	0.2	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.8	0.2	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	89.7	2.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.8	0.0	0.7	18.5	37.4	4.0	0.0	0.9	0.3	0.1	0.1	0.0	0.3
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153791-116402321	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 72.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		78000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.1	1.5	0.7	1.8	0.2	0.0	0.8	0.5	0.9	4.2	2.2	2.0	0.3	3.9	0.6	2.5	3.1	2.0	2.6	0.3	1.6	3.8	0.3	1.9	1.2	2.5	2.5	2.5	0.8	9.1	0.4	72.3	2.0	1.1	1.5	1.0	0.4	2.1	0.3	0.9	0.9	4.2	0.4	0.3	1.1	0.8	1.6	0.8	1.0	1.4	1.0	4.5	2.4	1.3	0.0	14.9	22.3	0.0	50.0	37.8	0.0	12.2	21.4	3.3	5.6	0.0	0.0	0.0	0.0	8.6	1.1	1.7	0.0	0.0	15.6	0.0	0.0	2.6	12.8	0.1	24.3	0.0	0.0	137.4	0.0	16.4	1.9	26.9	0.1	0.0	0.5	0.0	3.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.1	1.2	1.8	0.0	0.0	6.8	0.0	0.0	28.9	36.3	1.8	1.0	1.4	0.0	0.0	0.0	25.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.9	0.3	1.6	2.5	2.5	2.0	0.4	1.6	1.3	0.2	0.0	1.5	3.9	1.0	2.9	0.2	4.0	92.2	17.6	0.8	0.4	3.4	0.0	1.6	165.5	12.5	0.5	0.1	0.1	9.8	5.9	20.1	4.7	101.3	1.4	0.0	0.0	10.0	0.9	19.5	31.8	0.5	2.6	1.3	10.4	4.6	0.1	0.4	0.0	19.6	0.0	0.0	0.0	5.8	17.9	14.3	1.0	1.8	7.5	0.0	2.5	1.0	15.1	2.9	0.3	0.0	8.6	1.2	1.2	0.2	51.5	1.6	2.9	0.0	3.3	10.9	2.2	0.6	19.7	1.1	14.0	1.3	0.2	0.1	0.3
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 455.4;Inhibitory neurons: 147.0;Microglial cells: 193.0;Oligodendrocyte precursor cells: 367.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	50	"basophil: 9.6"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		21000	"Cluster 34: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	13.1	15.9	19.6	4.8	17.0	0.5	21.5	10.9	12.4	25.9	16.0	30.4	10.6	20.7	12.2	47.8	20.6	14.9	14.6	17.8	20.6	25.1	22.1	15.2	2.6	15.7	22.1	38.5	34.2	20.7	7.3	21.7	15.9	17.0	21.7	13.6	20.1	23.9	40.5	52.1	13.4	21.8	16.0	4.2	17.7	14.0	24.0	13.5	15.2	30.9	12.4	21.3	30.8	13.9	50.6	121.1	40.1	28.6	28.5	24.2	59.1	22.2	25.4	37.3	40.0	44.3	43.3	0.3	31.4	44.6	30.4	35.8	34.7	56.7	46.1	0.4	26.8	0.0	14.9	44.1	36.2	5.7	0.1	28.7	54.9	50.9	38.1	35.9	23.3	32.4	34.7	14.9	44.8	35.4	59.3	4.2	18.0	32.7	41.4	44.9	39.0	21.9	80.9	38.4	20.1	20.9	26.8	37.3	42.9	49.6	21.1	6.7	28.4	18.7	56.1	35.5	24.2	13.2	17.1	0.1	21.0	0.2	22.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	19.6	17.0	10.9	12.4	17.8	20.6	15.7	22.1	15.9	16.0	24.0	13.9	6.4	35.3	35.3	455.4	0.2	34.0	42.3	19.8	19.9	8.7	17.1	24.9	39.0	21.5	24.3	14.7	29.2	24.9	0.2	25.6	0.0	34.1	19.9	22.3	29.9	9.4	24.0	2.7	5.4	36.4	25.0	22.3	13.3	33.4	1.3	33.1	8.9	24.8	3.4	11.8	147.0	30.1	14.2	0.6	4.7	20.3	30.4	7.7	5.4	193.0	0.8	28.8	1.0	367.9	13.9	38.8	23.8	38.4	1.4	31.4	13.7	25.6	29.3	19.7	26.3	23.4	26.1	6.2	27.6	40.4	61.5	40.1	1.5	32.1	22.0	47.2
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PARP12	"ARTD12, FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023749-140062951	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 42.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA003584: AB_1079568, HPA063872: AB_2685139"	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	6.4	4.7	4.1	12.3	4.3	15.8	6.6	3.6	5.3	4.0	5.2	12.1	18.3	7.6	9.6	4.8	8.1	9.3	5.9	3.6	4.2	5.0	7.8	15.4	13.4	8.3	4.4	6.3	9.2	10.2	2.3	9.9	5.4	7.0	11.6	1.8	17.2	4.8	2.9	15.0	18.1	7.9	6.3	17.1	13.1	10.4	4.9	10.7	5.8	2.5	9.5	8.7	2.4	5.0	20.8	7.6	0.6	0.8	2.4	5.7	15.1	4.7	10.4	36.3	42.5	4.9	12.6	8.6	11.5	3.9	28.0	9.3	5.4	17.6	6.0	33.4	8.7	9.2	4.9	6.8	15.2	2.4	6.2	5.7	6.7	12.7	15.5	9.9	28.2	10.4	19.0	6.0	2.7	8.4	25.7	14.3	1.3	10.7	18.0	15.2	0.0	2.7	7.1	7.9	4.6	0.0	14.2	7.7	11.2	0.7	9.2	5.6	31.0	4.3	10.2	0.3	14.5	0.5	1.5	2.0	7.9	12.2	5.2	1.2	3.0	4.3	1.5	5.5	1.3	1.7	2.1	1.6	2.1	2.4	0.9	0.7	1.0	2.5	6.4	0.2	5.8	1.2	4.1	4.3	3.6	5.3	3.6	4.2	8.3	4.4	5.4	6.3	4.9	5.0	24.1	6.4	10.6	2.6	17.9	6.5	7.2	4.4	8.0	2.9	6.2	5.5	5.4	7.2	5.8	11.0	2.1	6.0	13.0	48.9	1.9	13.9	0.7	7.0	6.4	18.1	24.0	4.8	1.2	26.0	19.1	6.9	18.3	6.3	19.7	38.2	7.9	10.9	24.2	0.0	2.6	19.4	4.1	13.6	9.7	0.9	7.2	20.5	7.2	26.2	17.5	2.9	11.3	9.5	3.1	35.2	37.0	7.2	8.3	12.4	44.2	6.9	9.0	2.5	0.0	7.3	7.9	35.0	15.6	8.7	9.9	2.1	15.6	8.4	11.6	10.6
PARP14	"ARTD8, KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680839-122730840	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	14.0	12.6	4.3	24.3	5.1	20.1	11.3	3.6	2.7	11.4	5.5	11.5	15.3	8.2	2.4	9.0	10.7	15.2	11.1	2.8	5.1	14.9	24.5	33.5	24.0	15.1	5.9	9.2	7.8	7.3	7.6	17.8	8.6	13.0	8.7	1.1	11.7	7.2	5.0	5.3	17.5	10.2	10.9	37.4	11.7	2.2	8.9	15.4	14.7	8.3	26.8	13.7	9.4	7.8	15.6	13.0	8.0	8.3	9.1	26.2	0.0	6.1	40.1	74.7	113.1	6.9	28.7	0.0	24.2	13.4	41.8	11.5	11.9	11.6	15.0	24.0	1.5	14.6	5.8	8.7	20.4	6.4	6.8	14.7	4.7	13.0	4.8	16.4	32.2	12.3	7.0	22.7	2.1	7.9	24.8	1.5	1.1	2.1	11.1	34.2	8.3	4.3	9.5	16.2	0.6	0.0	15.3	3.1	14.1	0.8	5.7	9.3	22.0	4.0	9.4	2.3	5.5	8.7	1.6	2.7	12.0	13.8	7.2	13.1	10.8	5.8	8.6	13.7	7.2	12.8	4.5	5.6	5.6	20.3	3.6	4.1	29.5	9.5	14.7	0.7	9.9	4.3	4.3	5.1	3.6	2.7	2.8	5.1	15.1	5.9	8.6	10.9	8.9	7.8	111.5	246.8	98.4	17.3	115.3	16.8	17.0	35.9	13.1	2.1	19.6	15.6	14.6	24.3	65.9	25.8	4.2	14.1	64.9	43.0	3.9	36.0	0.3	118.8	59.8	94.7	10.7	18.5	0.5	41.2	28.4	37.2	24.5	149.8	32.2	69.6	67.1	32.5	36.5	0.0	3.0	18.2	26.4	61.6	39.9	2.1	28.0	83.9	16.0	124.6	132.2	15.1	58.7	47.3	1.1	44.0	20.2	17.3	50.9	31.8	29.5	11.5	73.0	1.0	13.1	32.7	30.3	1.9	1.1	13.7	10.5	4.8	51.4	42.8	16.0	25.9
PARP9	"ARTD9, BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 113.4;SK-MEL-30: 93.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	20.1	29.4	14.0	35.8	15.1	20.8	17.6	13.8	17.4	20.3	14.8	22.5	21.2	19.6	19.1	24.8	20.1	28.8	18.3	13.5	15.1	22.0	68.3	36.5	30.5	21.3	15.5	12.9	22.0	23.7	18.5	20.1	16.8	18.9	19.5	5.8	39.9	12.6	13.6	11.6	21.4	29.1	17.6	44.3	20.0	6.4	17.4	30.6	16.8	17.3	25.9	26.0	16.5	16.1	23.1	7.7	2.8	1.9	16.9	34.6	2.6	7.6	41.0	95.8	113.4	12.0	24.9	5.2	16.4	15.3	60.2	24.8	6.6	13.4	19.9	40.3	4.5	24.9	7.6	6.4	18.0	8.1	15.9	28.4	12.9	13.6	3.4	19.1	20.8	15.7	2.3	20.7	3.9	10.2	26.0	10.1	1.1	4.7	21.1	27.3	27.2	1.7	37.0	13.1	1.7	6.6	20.2	3.3	93.8	1.5	10.7	9.0	12.6	4.1	11.8	0.9	4.7	12.8	7.1	9.5	14.1	8.7	7.7	41.9	29.9	36.9	19.8	41.1	18.5	15.9	20.6	22.3	27.5	11.4	15.6	19.3	87.5	30.2	45.2	3.3	24.9	23.3	14.0	15.1	13.8	17.4	13.5	15.1	21.3	15.5	16.8	17.6	17.4	16.1	37.0	41.7	44.2	13.4	18.9	7.1	10.8	13.8	12.5	0.8	10.5	6.3	5.8	10.0	35.1	20.2	0.0	5.2	14.0	32.5	1.9	30.4	1.6	23.6	28.1	37.4	10.7	19.0	0.3	39.9	19.3	19.9	22.4	23.2	10.1	19.5	21.8	50.1	42.0	0.0	1.3	11.5	10.2	32.3	9.2	4.5	18.3	41.2	7.2	45.0	50.2	12.1	32.0	17.1	3.9	36.8	11.7	24.0	13.6	8.9	17.5	19.3	48.8	1.0	19.7	18.9	16.3	0.9	1.9	15.7	6.7	1.6	23.5	17.0	8.6	14.4
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"	Q9NVD7	11	12377563-12535356	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 229.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		7300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	61.8	17.6	9.3	22.7	9.0	0.1	40.9	7.2	10.1	53.9	16.5	92.4	17.5	71.8	16.7	42.8	38.8	31.9	34.3	9.8	11.6	23.0	16.9	28.8	6.4	11.0	7.3	31.9	36.0	16.9	11.7	35.9	8.4	50.6	38.4	8.9	20.9	68.9	8.1	14.0	26.1	95.5	11.3	11.3	42.5	6.8	8.6	4.6	17.9	11.7	9.1	55.0	28.2	11.0	34.0	33.1	30.2	39.4	147.8	110.6	69.1	126.5	130.1	87.7	81.6	24.7	51.8	0.0	41.1	229.5	9.9	20.7	0.4	66.4	104.0	0.6	14.9	0.1	42.4	18.7	114.7	0.1	0.9	91.3	22.3	37.1	57.4	107.5	110.9	0.0	0.1	0.3	131.8	20.4	0.0	0.2	14.2	20.2	26.4	0.0	75.2	0.2	44.9	32.8	4.8	0.1	97.6	39.1	65.5	66.9	18.4	0.9	138.2	105.1	43.8	57.2	35.4	0.1	0.1	0.2	58.5	0.1	118.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	9.0	7.2	10.1	9.8	11.6	11.0	7.3	8.4	11.3	8.6	11.0	37.0	99.3	33.0	47.3	1.1	13.8	25.0	29.3	20.5	4.3	24.4	24.8	45.1	18.6	27.0	27.6	0.0	39.9	0.7	39.6	39.2	56.1	0.9	26.9	62.5	33.3	27.1	0.0	31.4	67.1	92.2	59.1	24.5	35.9	5.1	34.8	39.7	19.1	6.5	0.0	34.9	26.2	18.3	1.8	8.8	2.5	41.0	2.0	46.2	36.5	1.0	25.3	0.0	30.7	1.0	51.7	25.4	51.9	0.2	33.5	23.1	38.1	54.8	2.5	52.6	32.6	60.6	1.1	3.4	20.2	8.9	19.0	2.3	25.1	32.4	25.1
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172939	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.9;tongue: 170.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 113.2;Hofbauer cells: 90.6;Macrophages: 78.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 158.0;RPMI-8226: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		NA	NA		24000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	42.6	30.7	26.7	21.3	19.4	43.4	33.0	18.7	24.3	21.8	22.6	21.8	7.4	22.2	13.5	11.9	19.2	10.7	86.9	34.1	24.7	23.0	14.4	29.7	19.2	23.3	25.7	27.1	11.9	18.5	24.3	21.4	26.9	17.0	8.6	10.5	11.4	13.7	195.9	14.2	18.6	22.9	20.8	35.3	15.0	6.6	28.3	9.4	12.8	170.6	16.1	23.9	16.7	19.7	23.5	27.7	0.4	19.1	28.1	35.5	0.1	32.4	20.1	20.9	15.6	28.9	13.8	0.2	17.5	87.2	16.4	0.9	45.9	2.1	11.5	33.1	28.5	100.4	45.8	0.2	46.5	76.5	86.7	55.4	24.0	15.2	0.2	15.0	158.0	0.4	36.6	67.0	22.9	15.9	0.4	50.4	9.8	20.4	18.7	0.2	0.8	159.5	0.5	0.6	24.6	17.1	8.6	1.6	84.9	3.3	15.9	30.7	99.2	19.0	20.0	29.4	3.4	16.2	15.3	0.7	82.8	22.1	106.0	6.9	6.8	1.6	1.0	7.1	1.6	6.2	1.7	1.5	7.2	6.4	0.4	0.9	4.7	0.8	2.9	14.9	2.4	9.5	26.7	19.4	18.7	24.3	34.1	24.7	23.3	25.7	26.9	20.8	28.3	19.7	70.3	0.0	10.6	5.2	48.2	5.2	3.4	1.3	4.0	11.2	8.3	9.4	55.0	4.3	0.9	1.8	16.7	1.0	29.0	0.3	27.4	1.5	6.6	8.0	12.6	63.7	1.2	113.2	15.1	3.1	10.8	18.4	4.1	11.7	64.7	20.2	53.2	12.5	90.6	6.7	12.5	0.7	6.1	49.7	39.5	21.6	19.9	78.7	19.6	28.1	44.7	8.9	9.2	2.5	5.9	4.7	0.0	10.9	58.1	5.1	0.0	30.0	3.8	15.2	6.6	18.2	14.2	1.9	5.8	0.7	4.4	1.8	16.7	2.3	0.6	1.5
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771792	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 117.6;Oligodendrocytes: 155.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.43e-4)"	"prognostic unfavorable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	5.8	6.2	7.3	6.4	8.4	28.6	7.2	10.1	9.8	7.4	8.5	6.8	10.2	8.3	7.2	5.8	7.4	4.9	4.6	7.0	9.2	6.7	6.6	6.3	9.4	8.5	8.1	10.9	6.9	4.7	5.8	6.3	8.5	5.8	7.6	13.0	5.7	5.2	9.3	8.0	7.9	5.3	7.7	7.4	5.5	8.3	8.0	10.1	6.2	6.7	8.0	6.3	6.0	10.5	14.5	11.5	24.4	19.7	9.2	7.4	32.0	10.4	7.0	13.7	10.0	24.3	12.8	16.9	7.9	6.2	10.9	14.1	23.7	9.8	14.5	14.0	18.2	29.6	19.7	17.9	4.5	33.6	17.1	3.9	14.5	16.0	7.5	9.7	9.5	18.4	34.3	15.9	10.3	12.6	23.1	19.8	64.5	16.4	11.0	21.1	22.0	25.0	11.0	13.1	19.3	11.2	15.2	17.3	12.1	15.1	11.3	18.7	8.2	10.5	13.7	11.8	16.5	15.5	19.8	31.0	7.8	30.0	10.7	0.0	0.3	0.1	0.6	0.1	0.8	0.5	0.7	0.5	0.4	0.6	0.7	0.7	0.0	0.2	0.2	0.3	0.4	0.1	7.3	8.4	10.1	9.8	7.0	9.2	8.5	8.1	8.5	7.7	8.0	10.5	28.9	12.8	21.6	62.3	22.0	25.5	21.5	5.6	31.3	50.6	26.0	20.2	12.3	21.5	15.3	20.2	62.6	16.7	39.2	19.4	5.9	7.4	36.8	47.8	51.6	22.3	22.1	17.9	61.6	8.0	12.1	27.1	30.1	45.6	12.0	42.4	15.4	12.7	10.2	21.9	66.1	23.7	6.1	13.9	19.3	32.8	14.6	24.3	21.4	55.3	14.1	28.6	24.7	117.6	155.4	6.8	12.8	17.0	29.1	25.1	17.4	7.9	24.5	81.6	32.9	51.5	23.5	32.2	18.2	26.5	25.4	17.8	29.4	26.3	21.7	32.4
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184733-32190202	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	30.3	39.6	4.9	14.2	4.5	9.0	27.6	3.9	5.5	47.4	5.0	51.2	10.6	47.8	30.4	33.5	47.1	4.9	32.1	4.5	4.7	37.9	31.0	43.9	16.7	5.1	4.6	52.3	28.2	4.5	52.0	25.2	4.8	39.3	12.2	8.5	27.6	12.3	29.8	34.1	39.8	13.0	4.3	64.5	36.7	23.9	5.0	23.9	55.2	2.3	17.8	42.4	39.2	4.6	4.8	7.9	32.3	17.7	23.5	29.4	13.9	3.7	8.9	9.7	10.0	6.5	7.8	21.9	23.5	13.7	3.8	13.4	8.1	26.8	10.6	19.5	30.3	20.5	7.1	3.8	20.7	13.2	18.7	43.2	14.9	7.4	24.8	16.6	19.1	38.8	26.5	11.1	3.7	18.1	13.6	29.7	0.6	2.9	2.2	18.8	5.0	26.1	21.2	7.7	9.4	12.6	3.0	6.8	26.5	18.3	16.9	25.0	6.5	8.5	19.8	3.4	4.2	54.1	36.9	27.2	17.3	9.9	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	4.5	3.9	5.5	4.5	4.7	5.1	4.6	4.8	4.3	5.0	4.6	27.7	6.4	11.0	14.4	18.5	18.2	18.5	11.8	15.4	19.2	17.0	12.2	3.7	31.5	10.1	16.5	8.4	32.2	29.4	9.6	3.9	17.1	1.0	12.3	24.5	24.8	30.5	19.1	7.8	14.0	25.6	16.0	12.2	16.6	15.2	21.8	28.9	23.0	19.0	26.9	7.0	15.5	10.2	34.5	55.5	4.2	20.2	25.3	8.8	9.4	23.9	21.0	35.0	6.0	9.1	13.9	12.5	19.5	17.7	19.4	12.5	10.2	9.6	4.9	6.6	19.7	19.8	1.6	6.1	19.7	19.5	47.2	16.7	22.8	13.2	18.1
PBX4		ENSG00000105717	"PBX homeobox 4"	Q9BYU1	19	19561707-19618693	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.1;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.5;Gastric mucus-secreting cells: 17.3;Plasma cells: 18.8;Spermatocytes: 26.6;T-cells: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD4 T-cell: 1.2;naive CD8 T-cell: 1.0;T-reg: 3.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;RT4: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049859, HPA056469"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA049859: AB_2680918, HPA056469: AB_2797256"	"unprognostic (5.36e-3)"	"prognostic favorable (8.69e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.44e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-2)"	"prognostic favorable (5.94e-7)"	0.2	0.0	0.6	0.4	0.6	0.4	0.2	0.3	0.8	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.6	0.1	0.0	0.3	1.2	0.5	0.5	0.2	0.0	0.1	0.3	0.2	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.4	0.0	0.4	0.3	0.4	2.1	1.0	1.0	2.3	0.0	0.6	0.1	0.1	0.5	2.5	0.1	1.0	0.0	0.2	0.0	1.7	0.0	0.8	1.1	0.8	0.0	1.1	0.3	0.4	0.6	0.9	1.1	1.4	0.0	0.3	0.1	0.5	0.0	0.4	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.5	1.0	0.7	0.2	1.8	1.9	0.5	0.0	0.0	0.8	3.2	0.8	1.1	1.1	0.1	0.8	0.1	0.4	0.1	0.0	0.0	0.5	1.5	0.3	0.2	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.2	1.2	1.9	0.0	0.0	1.2	1.0	0.2	0.0	0.0	0.0	3.1	0.5	0.6	0.6	0.3	0.8	0.6	0.6	0.5	0.5	0.5	0.4	1.0	0.5	0.7	0.0	4.1	9.8	8.7	4.8	2.6	1.3	1.8	0.6	1.1	1.8	0.4	1.5	1.6	0.0	0.0	0.0	14.5	1.1	1.9	0.7	3.1	8.3	1.1	0.4	0.0	0.8	5.0	0.0	1.1	3.4	17.3	3.5	0.0	1.2	0.4	0.0	0.4	0.0	7.3	2.9	0.0	0.3	3.8	1.5	0.3	1.6	1.8	1.0	1.5	1.4	6.2	1.5	1.4	2.4	0.1	0.7	18.8	2.6	0.2	0.0	5.4	0.1	6.6	1.4	1.4	26.6	10.7	0.7	2.6	0.0	50.4	0.5	0.7	3.1
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087477-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		1600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	278.3	276.3	145.5	199.8	155.0	390.0	240.4	168.5	203.5	209.3	159.1	259.9	172.8	253.9	142.6	278.4	193.8	134.9	223.2	142.1	155.6	218.1	304.3	233.6	227.1	163.7	146.9	186.0	249.9	174.6	140.2	194.8	159.2	143.9	125.8	90.5	185.0	139.5	782.3	216.6	203.1	172.4	163.8	241.3	214.5	95.2	150.4	301.0	170.8	308.3	209.6	233.8	206.0	190.9	384.9	387.5	327.1	257.5	345.1	262.4	525.9	280.5	257.2	272.0	227.0	453.0	250.6	522.9	140.9	320.7	293.7	334.7	388.4	408.6	276.5	376.2	299.9	419.2	219.5	701.3	388.0	350.8	385.8	230.3	261.6	224.5	310.5	203.4	350.7	138.9	437.2	375.6	346.2	475.7	454.7	524.7	331.5	361.1	253.2	362.9	358.0	527.1	375.5	389.6	309.7	249.1	230.3	465.8	342.1	229.8	277.6	314.2	325.1	253.5	317.6	217.6	359.4	495.7	551.2	531.7	268.6	480.4	319.5	42.6	89.7	141.5	80.3	92.5	73.8	41.1	62.1	69.3	82.9	36.4	62.8	71.2	138.2	95.4	80.5	58.9	81.7	100.5	145.5	155.0	168.5	203.5	142.1	155.6	163.7	146.9	159.2	163.8	150.4	190.9	241.0	153.8	132.7	27.4	312.7	484.0	296.0	192.1	196.9	64.9	270.8	212.6	0.6	208.8	134.5	196.8	22.9	372.4	208.7	401.7	272.0	196.0	34.4	187.6	220.8	242.8	178.6	485.3	19.1	199.2	470.1	196.9	227.9	284.8	114.2	129.6	227.0	392.7	385.7	58.9	18.0	239.8	138.4	509.2	795.9	34.4	186.1	382.4	300.6	30.0	422.9	122.3	347.1	14.1	49.1	211.7	311.7	186.5	357.1	278.5	338.4	481.0	128.6	56.1	170.9	222.9	241.9	131.0	65.5	267.0	545.8	703.4	291.2	148.4	232.9	366.6
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038356, HPA073145"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		970000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA038356: AB_10697248, HPA073145: "	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	467.6	429.4	213.6	263.0	232.5	863.1	396.1	260.1	240.3	385.9	238.8	318.2	334.8	345.0	366.4	314.4	407.8	301.5	340.3	197.9	232.9	534.9	509.0	350.9	380.4	228.2	223.5	507.3	501.5	437.3	220.7	299.7	232.8	265.5	325.5	665.2	322.1	264.5	481.1	416.6	324.5	333.8	227.4	323.8	390.4	363.6	228.8	543.6	414.9	401.7	455.6	313.3	323.5	263.2	527.6	809.2	755.8	614.7	1068.5	809.3	582.3	547.0	722.3	844.6	605.4	951.9	760.5	916.9	518.6	796.7	398.6	501.2	830.1	720.1	830.0	579.1	617.4	917.3	597.0	946.0	1071.1	922.5	592.1	937.8	593.9	719.6	1147.1	1451.3	819.3	583.5	810.8	1621.9	762.9	1444.3	856.8	1030.1	975.1	447.8	559.7	690.0	686.4	1098.4	667.5	814.6	742.4	655.6	736.2	656.2	553.9	767.2	918.2	791.8	615.9	443.9	614.0	412.7	561.7	908.2	666.0	840.7	523.9	572.6	494.4	19.1	34.5	25.9	27.7	34.0	44.6	38.1	42.3	35.7	41.6	34.3	48.1	41.8	30.8	23.9	33.3	57.2	52.3	30.1	213.6	232.5	260.1	240.3	197.9	232.9	228.2	223.5	232.8	227.4	228.8	263.2	306.1	115.4	179.2	64.9	433.6	390.7	302.9	352.6	569.1	88.0	361.5	389.9	73.7	253.1	193.0	296.1	110.5	329.2	313.6	242.9	493.1	233.0	68.3	264.2	289.3	285.1	206.5	525.1	54.6	240.0	365.1	285.8	326.2	298.1	155.0	360.3	283.4	302.2	368.2	102.6	58.1	279.1	223.8	437.6	473.8	65.6	309.1	376.0	233.1	74.0	476.5	152.9	292.5	58.8	101.4	250.8	266.5	229.0	483.8	256.3	446.8	714.4	159.5	188.3	190.7	346.6	435.1	292.8	183.4	511.3	382.3	443.3	341.6	240.4	325.7	345.0
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6;retina: 81.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 159.4;Cone photoreceptor cells: 50.1;Horizontal cells: 116.1;Late spermatids: 79.8;Muller glia cells: 49.3;Rod photoreceptor cells: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.0;HDLM-2: 56.9;HSkMC: 40.8;SH-SY5Y: 46.9;U-87 MG: 25.0;U-937: 31.3"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 229.1"					"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	7.3	7.1	8.9	7.5	6.8	8.9	4.5	34.6	11.9	8.2	2.8	13.7	1.7	8.7	7.5	1.4	5.3	2.6	3.4	13.5	8.1	4.8	1.3	2.8	3.3	32.3	12.0	3.9	2.7	0.1	22.6	1.2	31.3	2.3	1.6	81.5	1.8	0.8	0.4	2.1	8.7	7.8	8.9	10.0	4.7	14.8	17.9	18.9	1.0	1.7	2.9	4.1	2.8	9.5	0.0	0.0	0.5	0.0	13.7	29.0	0.2	1.8	0.4	3.1	1.4	0.0	0.0	0.0	0.7	8.2	3.9	0.1	1.7	0.0	0.5	56.9	0.2	0.0	0.0	0.0	13.7	0.0	0.0	40.8	0.2	0.5	0.8	0.0	0.0	2.0	0.0	0.2	1.8	0.7	16.5	3.3	0.8	0.1	2.8	0.0	0.1	2.4	0.0	0.0	4.9	46.9	1.2	0.0	0.0	1.3	0.0	8.7	0.0	0.0	0.1	12.3	0.0	0.7	3.1	0.0	25.0	31.3	1.1	2.1	0.2	3.0	0.7	0.1	0.1	1.3	0.4	0.0	0.0	1.4	0.7	0.1	0.7	0.3	0.1	0.0	0.4	0.2	8.9	6.8	34.6	11.9	13.5	8.1	32.3	12.0	31.3	8.9	17.9	9.5	0.6	0.0	0.0	2.3	6.2	0.3	0.1	0.3	0.0	159.4	0.1	0.5	3.6	0.0	0.7	1.8	50.1	0.1	0.3	0.0	0.0	0.1	36.5	0.2	8.9	2.2	3.0	0.0	3.8	0.2	0.1	2.3	0.5	0.3	0.0	0.2	2.2	0.0	0.4	116.1	4.6	0.1	0.0	0.0	0.7	79.8	8.4	0.9	3.6	1.0	0.0	49.3	0.0	0.5	5.5	0.9	0.1	12.8	4.1	1.3	0.0	0.4	0.0	83.1	0.0	1.1	3.9	34.1	21.2	0.0	0.0	0.0	2.5	0.2	0.2	0.5
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase subunit alpha"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		NA	NA		290000	"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	35.4	56.3	29.0	12.4	29.8	6.2	25.8	55.5	34.6	22.3	44.4	37.5	13.2	14.9	218.2	19.4	17.4	11.6	35.4	28.6	26.3	111.7	104.3	12.0	8.0	28.9	27.4	19.9	27.6	25.7	12.3	21.3	31.1	25.9	27.6	25.2	26.9	16.9	17.6	18.6	18.0	13.7	30.3	17.2	40.9	9.2	33.9	11.4	20.4	27.2	6.4	21.3	17.5	38.7	10.6	18.5	29.8	9.9	27.9	24.2	16.6	10.2	15.4	9.5	9.0	23.0	13.9	0.8	15.2	10.1	12.0	11.8	9.1	14.1	15.6	17.5	10.1	24.6	12.7	49.7	15.4	1.2	11.3	22.4	15.2	8.8	14.6	23.0	19.6	13.0	9.8	13.4	17.1	11.6	2.6	54.8	18.6	37.2	8.1	21.4	12.9	17.3	167.0	20.5	91.1	10.9	7.0	38.4	17.9	31.9	27.9	43.1	14.3	9.6	8.0	6.7	7.3	13.1	12.9	0.4	18.4	131.6	6.9	1.6	9.1	1.7	4.5	11.2	5.9	3.6	2.8	4.2	13.5	2.3	3.9	4.9	1.1	8.7	12.3	1.1	6.5	5.2	29.0	29.8	55.5	34.6	28.6	26.3	28.9	27.4	31.1	30.3	33.9	38.7	11.3	3.2	8.7	152.8	6.6	1.9	29.1	12.7	8.6	15.5	13.5	8.8	10.5	52.9	14.8	20.2	29.2	25.7	4.3	20.7	99.7	19.7	17.6	76.5	22.4	12.0	3.6	3.4	152.8	8.4	6.9	12.9	12.2	72.9	14.0	20.7	12.1	48.8	11.8	28.6	166.5	12.4	12.2	14.2	2.2	12.0	8.7	8.2	5.4	217.4	6.0	11.5	10.3	200.6	182.5	5.8	17.5	13.5	9.4	11.2	13.2	86.9	13.2	31.7	13.1	12.3	10.1	7.2	6.2	10.6	3.8	30.2	6.4	17.6	27.6	19.2
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase subunit beta"	P05166	3	136250340-136337896	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 202.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7;Late spermatids: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		120000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	34.4	75.1	23.3	15.2	33.6	37.9	27.5	31.4	29.3	17.5	35.5	43.6	38.1	13.8	13.9	26.3	19.2	17.0	94.6	23.6	28.5	88.9	202.1	14.8	16.2	31.1	29.4	12.1	32.0	57.0	15.6	19.6	30.4	23.7	41.9	17.2	23.6	21.7	83.8	15.1	27.5	22.6	27.1	12.7	26.1	38.8	29.8	21.1	37.9	91.4	20.7	20.5	11.4	47.8	64.8	45.8	42.4	64.4	30.2	34.5	75.4	33.0	35.5	49.1	69.6	67.9	44.7	80.3	89.4	46.6	44.0	35.1	50.3	44.0	69.4	47.8	43.0	140.8	49.5	101.4	66.4	107.3	60.2	40.8	41.4	31.0	69.4	30.5	56.1	131.6	104.5	41.0	38.0	123.1	109.3	63.1	36.0	96.8	40.9	29.3	34.6	116.6	89.9	69.4	84.0	62.9	84.4	48.9	77.5	35.2	98.3	62.9	42.0	24.5	26.0	69.2	29.6	78.3	70.0	66.9	34.9	41.7	29.9	7.3	29.5	7.5	22.6	30.8	25.4	21.7	14.7	23.2	44.6	19.8	15.1	18.7	2.7	25.9	28.7	38.5	14.8	22.6	23.3	33.6	31.4	29.3	23.6	28.5	31.1	29.4	30.4	27.1	29.8	47.8	5.6	9.6	14.0	16.0	9.2	4.1	9.4	37.9	3.4	16.0	12.5	5.3	51.1	8.6	28.4	20.2	10.4	57.1	8.0	15.1	39.2	24.6	316.7	14.1	9.5	8.1	9.1	53.2	16.5	14.0	27.1	13.6	14.8	14.1	29.2	18.1	9.3	76.3	35.1	11.8	22.7	15.1	24.4	11.7	5.2	159.0	13.7	11.4	19.6	16.9	16.5	11.8	10.3	22.1	50.9	14.4	16.7	10.9	22.6	10.4	19.2	97.3	23.6	13.2	13.1	13.6	13.1	11.3	29.0	16.2	3.3	50.9	9.9	52.8	25.1	12.2
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943581-141969741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 38.5;Endothelial cells: 40.0;Hepatic stellate cells: 41.0;Hofbauer cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"non-classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	41	"monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 25.9;Karpas-707: 66.5;U-937: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"	NA	NA		14000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA051242: AB_2681402"	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	13.4	5.0	0.8	2.5	0.9	0.5	4.9	2.5	1.7	2.7	1.2	2.0	2.0	2.8	0.4	2.1	2.1	4.0	10.8	0.6	0.8	6.0	4.0	15.5	2.6	0.5	0.3	1.7	1.4	2.9	3.6	30.2	0.6	1.9	1.3	1.6	1.4	2.3	4.0	1.7	2.1	5.2	0.3	18.6	2.0	1.1	1.4	0.8	6.5	5.1	1.0	3.2	1.9	0.3	0.1	0.1	1.9	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	5.0	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.6	1.4	0.2	0.1	0.2	0.5	0.2	0.0	0.0	0.4	0.0	0.4	25.9	0.3	0.0	66.5	0.0	0.4	0.1	0.3	0.5	0.0	0.3	0.5	0.2	3.0	0.0	0.1	0.3	0.7	0.1	0.1	0.3	0.2	0.0	1.8	1.8	0.6	0.1	0.9	0.1	0.4	0.4	0.1	0.4	11.7	2.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.8	0.9	2.5	1.7	0.6	0.8	0.5	0.3	0.6	0.3	1.4	0.3	38.5	0.0	1.1	0.0	0.5	0.6	0.0	0.0	1.2	1.3	0.1	0.1	4.0	0.0	0.0	0.0	2.1	0.3	0.3	0.0	3.9	0.1	1.7	0.1	0.1	40.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	1.3	0.0	41.0	0.5	34.6	0.0	0.2	0.0	0.0	8.5	0.3	2.5	0.0	1.5	1.8	6.5	0.3	0.5	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.4	0.0	0.7	1.0	0.0	0.2	0.2	0.3	0.5	0.2	1.4	0.0	0.2
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 19.0;brain: 21.2;retina: 61.7"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocyte precursor cells: 2965.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.1;U-266/70: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074437		Supported			"Intracellular and membrane"	NA	NA		22000		"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.2	19.0	13.4	0.3	9.5	0.1	0.0	3.1	10.3	0.2	0.0	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.5	16.6	19.6	8.0	0.0	2.5	0.4	13.8	13.7	0.0	0.0	0.5	4.7	0.2	12.6	0.2	0.0	61.7	0.1	0.0	0.0	0.1	0.2	0.0	9.7	0.7	0.3	3.3	21.2	0.1	0.0	0.0	0.5	0.5	0.0	6.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.1	0.0	0.0	3.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	9.5	3.1	10.3	16.6	19.6	13.8	13.7	12.6	9.7	21.2	6.2	0.0	0.0	0.0	14.4	0.0	0.3	0.0	0.0	0.0	5.1	0.6	0.0	4.8	0.0	0.0	0.0	87.6	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.3	0.0	0.0	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	216.2	0.1	0.0	0.0	0.0	7.5	0.0	0.1	0.0	3.7	0.0	4.4	0.0	2965.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	92.8	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Group enriched"	"Detected in many"	8	"Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4;RH-30: 120.4;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		340000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	1.8	3.2	10.5	5.2	14.6	0.0	3.0	0.0	33.7	23.9	0.0	19.2	3.2	16.9	25.1	14.3	9.7	8.1	19.1	23.7	50.1	2.0	1.0	2.9	1.4	13.0	14.3	4.7	0.9	1.1	0.2	0.2	14.3	10.6	7.8	3.4	0.8	18.2	0.6	11.6	5.0	22.1	3.9	18.6	11.4	1.0	46.3	1.4	4.1	0.4	1.2	16.3	5.9	11.8	0.0	1.1	14.4	20.1	29.5	28.5	0.0	3.8	0.0	1.9	0.9	1.9	26.5	0.0	0.1	0.2	0.0	15.3	1.3	38.5	3.4	0.0	43.4	0.1	26.8	0.0	30.4	0.6	0.0	17.2	8.8	1.0	10.7	17.5	7.5	0.0	0.0	0.0	9.0	0.1	0.0	0.1	8.8	9.3	4.0	0.0	120.4	0.0	0.9	65.2	0.9	0.2	0.4	1.2	1.3	8.2	1.8	6.9	0.0	24.1	6.2	6.7	0.0	0.0	0.0	0.0	18.8	0.1	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	14.6	0.0	33.7	23.7	50.1	13.0	14.3	14.3	3.9	46.3	11.8	1.1	0.0	0.0	311.8	0.3	85.0	92.4	25.7	46.7	46.8	0.7	9.0	83.2	0.0	13.7	64.4	0.0	0.1	0.0	0.3	0.0	0.6	16.9	66.8	8.4	7.6	0.0	0.0	1152.0	0.7	0.1	24.0	20.9	60.4	1.3	0.8	19.2	0.1	0.3	10.1	882.3	0.5	4.1	1.0	3.5	10.4	0.3	1.3	21.4	43.1	0.0	1.3	0.0	917.3	26.4	26.5	0.0	28.6	1.3	26.1	0.0	0.2	27.0	3.4	0.0	51.3	11.0	1.1	2.7	18.5	38.6	0.1	1.8	1.7	0.3	50.3
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 28.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.0	0.0	5.8	0.0	12.1	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	4.5	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	1.4	0.0	1.3	1.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	5.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	12.1	0.0	19.7	28.4	4.5	1.1	1.2	1.3	5.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.1	2.1	0.0	0.0	18.2	0.4	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	24.8	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	3.7	0.0	25.8	0.0	2.5	2.2	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.4	0.1	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.1
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 159.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4339.5;Excitatory neurons: 5259.8;Inhibitory neurons: 2489.4;Oligodendrocyte precursor cells: 6313.8;Oligodendrocytes: 14117.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 4.5;memory B-cell: 5.3;naive B-cell: 17.3"	"Group enriched"	"Detected in many"	9	"B-cells: 17.3;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 25.1;LHCN-M2: 41.6;TIME: 48.9;U-698: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		2900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	3.8	2.2	37.1	0.4	84.0	3.3	1.0	41.5	53.2	0.9	0.0	1.2	0.2	0.2	1.2	0.3	0.4	1.5	4.9	37.8	51.3	2.5	1.5	1.5	0.7	49.9	52.1	0.6	1.3	0.0	2.0	0.0	56.8	1.6	0.5	9.4	0.3	4.2	1.3	0.2	0.5	0.5	27.1	0.9	1.9	0.9	76.1	2.2	1.0	1.1	0.6	0.7	1.0	159.3	0.0	19.3	25.1	0.0	6.6	5.1	0.0	3.8	0.2	2.7	1.0	0.1	0.1	5.7	0.1	2.9	0.9	0.0	2.1	0.6	1.2	0.0	10.1	0.3	0.2	0.0	6.3	0.7	0.3	12.1	0.7	3.1	5.0	0.6	2.1	2.2	0.6	0.3	41.6	1.6	12.2	0.0	0.2	0.5	2.5	18.2	0.8	0.0	0.5	0.0	3.2	1.3	0.0	0.1	0.3	0.6	0.0	0.1	48.9	1.4	1.2	5.9	2.0	7.3	0.0	64.2	10.6	0.0	5.0	4.5	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	17.3	0.1	0.1	0.1	0.9	0.0	1.2	0.0	0.2	37.1	84.0	41.5	53.2	37.8	51.3	49.9	52.1	56.8	27.1	76.1	159.3	5.6	19.2	68.0	4339.5	29.1	1.9	2.5	0.0	1.8	318.8	9.2	14.7	152.5	0.0	4.4	5.5	20.9	0.2	4.3	0.9	9.8	1.9	3.6	0.3	6.4	4.7	62.4	2.5	5259.8	0.0	0.2	76.3	11.7	0.3	1.3	1.0	19.2	8.6	0.3	198.5	2489.4	1.4	0.0	1.9	1.4	3.0	29.5	3.7	10.6	237.0	0.3	87.8	2.1	6313.8	14117.8	0.3	1.2	14.7	1.4	2.0	0.0	0.8	0.0	27.1	6.6	27.9	25.4	6.8	5.4	1.2	0.3	0.0	2.7	3.7	0.8	0.8
PCDHA9	"KIAA0345, PCDH-ALPHA9"	ENSG00000204961	"Protocadherin alpha 9"	Q9Y5H5	5	140847772-141012347	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.2;testis: 1.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.9;Early spermatids: 1.7;Horizontal cells: 1.7;Rod photoreceptor cells: 1.7;Spermatocytes: 4.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 7.1"															NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"		"unprognostic (7.54e-4)"	"unprognostic (1.28e-2)"			"unprognostic (4.65e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (8.79e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-1)"		0.1	0.1	0.5	0.0	0.5	0.1	0.0	3.2	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	3.2	0.6	0.3	0.1	0.7	0.2	0.3	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.2	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.7	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHB13	PCDH-BETA13	ENSG00000187372	"Protocadherin beta 13"	Q9Y5F0	5	141213919-141218979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Exocrine glandular cells: 3.1;Horizontal cells: 3.3;Ionocytes: 4.1;Melanocytes: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 7.3;T-47d: 14.4;U-2197: 11.6"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (9.91e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.55e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.93e-3)"	1.1	1.3	0.2	0.5	0.6	0.2	1.1	0.5	1.2	1.4	0.0	1.0	0.2	1.6	1.2	0.7	1.1	1.6	1.4	0.7	0.0	0.8	0.6	0.9	0.3	0.1	0.2	1.4	1.9	0.7	1.5	1.3	0.0	1.2	0.6	1.2	1.5	1.1	0.5	1.8	0.4	1.3	0.1	0.8	0.8	1.0	0.1	0.1	0.9	0.7	0.2	0.8	0.9	0.5	0.0	0.1	1.8	1.4	4.6	4.9	0.4	0.3	2.4	0.7	1.4	0.0	2.0	0.0	7.3	1.8	2.5	0.5	1.7	0.0	0.4	0.0	0.1	0.0	0.9	0.3	0.1	0.0	0.9	0.4	1.2	0.1	0.1	2.1	0.7	0.2	0.3	1.8	2.3	0.3	0.2	0.1	0.4	0.0	0.2	5.6	0.8	0.0	0.1	0.1	1.7	0.6	2.4	0.2	0.7	0.5	14.4	0.1	2.2	0.5	1.3	11.6	0.0	0.0	0.1	0.0	3.2	0.1	3.6	0.9	0.2	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.2	0.2	2.9	0.1	0.1	0.2	0.1	0.0	0.2	0.6	0.5	1.2	0.7	0.0	0.1	0.2	0.0	0.1	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.8	0.2	1.5	1.8	3.7	0.4	0.4	1.5	2.8	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.0	0.5	2.1	1.6	0.0	0.0	0.0	3.1	0.0	1.2	0.0	0.6	0.0	0.5	1.1	0.7	0.1	3.3	0.0	0.2	4.1	0.0	0.0	0.0	0.9	0.1	3.6	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.2	1.2	0.1	0.2	0.0	0.8	0.1	0.3	0.0	2.1	0.8	0.4	0.2	0.9	0.9	0.0	0.0	0.1	0.1	0.6
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094606-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Endometrial stromal cells: 7.2;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 51.0;EFO-21: 28.7;U-138 MG: 22.2"	"Low region specificity"	"Detected in many"							HPA007548	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA007548: AB_2667859"	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.84e-4)"	2.7	0.9	0.7	0.4	1.2	0.1	2.6	0.9	2.6	1.8	0.0	2.3	0.6	2.3	0.6	0.9	1.3	1.4	1.9	2.4	1.0	1.0	0.2	2.2	0.2	0.9	0.9	1.7	1.0	0.1	1.8	0.7	0.7	1.5	0.9	1.4	1.7	0.4	1.0	2.0	0.9	1.4	0.9	0.6	0.8	5.5	0.8	0.2	1.3	1.3	0.1	1.2	1.3	1.8	0.4	3.4	23.7	51.0	6.7	3.1	10.8	0.9	3.7	0.0	0.0	0.6	0.2	0.9	28.7	1.7	5.6	0.0	1.2	0.3	0.0	0.3	0.8	0.0	0.1	6.9	0.0	0.0	2.4	1.6	0.0	0.0	0.4	1.0	0.5	2.9	0.8	0.7	7.1	0.2	6.9	0.0	10.5	0.3	6.7	0.0	17.6	0.2	2.6	0.0	13.1	3.6	0.0	3.4	7.6	13.2	14.6	4.3	2.8	22.2	6.6	10.5	3.4	0.3	0.1	0.2	4.8	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	2.6	2.4	1.0	0.9	0.9	0.7	0.9	0.8	1.8	5.1	0.0	0.5	0.0	0.0	0.8	1.1	0.6	4.0	3.1	1.8	1.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.6	2.1	7.2	2.5	1.2	0.0	0.0	0.4	0.0	3.7	0.5	1.3	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.3	1.0	1.2	0.1	3.6	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	1.5	0.0	0.8	0.0	0.3	0.8	1.4	0.0	3.0	1.9	9.9	4.0	0.7	0.4	0.0	0.1	0.1	0.1	0.7
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172644-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 38.4;Late spermatids: 27.3;Spermatocytes: 24.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.9;EFO-21: 4.8;U-138 MG: 3.2;U-2197: 9.6;U-87 MG: 3.3;WM-115: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059271	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA059271: AB_2683962"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	1.7	0.7	0.5	0.9	0.6	0.0	2.0	0.6	1.6	2.9	0.0	1.5	0.4	4.5	1.6	0.3	2.6	1.5	1.6	1.0	0.7	1.0	0.3	2.0	0.2	1.7	1.2	2.3	0.4	0.3	2.4	0.2	1.2	1.1	0.4	1.4	0.6	1.0	0.4	0.7	0.8	3.1	0.9	0.7	0.7	2.0	0.6	0.2	1.0	0.6	0.2	1.3	1.5	1.0	0.0	0.0	0.4	0.4	3.9	1.9	0.0	0.2	0.5	0.1	0.1	0.0	0.1	0.0	4.8	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	1.4	1.0	0.3	0.0	0.8	0.0	2.1	0.0	0.7	3.2	0.6	9.6	0.1	0.0	0.0	0.0	3.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.6	1.0	0.7	1.7	1.2	1.2	0.9	0.6	1.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	4.9	0.2	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	38.4	0.3	2.4	1.1	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.0	6.1	0.0	0.0	27.3	0.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.3	6.6	3.4	2.1	24.5	0.7	0.0	0.9	0.1	0.0	0.3	0.0	0.0
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512975	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Bipolar cells: 2.5;Hepatic stellate cells: 1.1;Horizontal cells: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 25.9;GAMG: 47.4;hTERT-RPE1: 69.8;WM-115: 43.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	0.8	0.7	1.4	0.7	1.8	0.0	0.6	5.1	1.3	0.8	0.7	1.0	0.2	0.7	0.3	0.7	0.9	0.5	1.6	2.1	2.3	0.5	0.4	0.6	0.4	1.8	1.2	1.1	0.5	0.3	0.6	2.2	2.1	0.5	0.3	3.1	0.7	0.7	1.1	1.7	0.4	0.8	2.4	0.3	0.4	0.8	1.9	0.3	0.8	0.5	0.3	0.6	0.8	2.9	0.0	0.0	0.7	2.4	24.3	25.9	0.9	5.5	10.6	4.2	6.6	0.1	0.2	0.6	9.1	5.6	47.4	3.7	0.1	0.6	6.6	0.2	2.4	0.1	0.1	0.0	4.0	0.4	0.0	19.0	0.3	7.4	0.1	69.8	6.5	1.2	0.0	0.1	0.1	0.0	0.0	0.3	2.9	0.0	0.1	17.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	9.9	0.5	3.2	7.9	0.8	0.1	0.6	0.1	0.0	0.4	0.0	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	1.8	5.1	1.3	2.1	2.3	1.8	1.2	2.1	2.4	1.9	2.9	0.5	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.1	0.5	0.8	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.2	1.1	0.0	0.4	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430507-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.2;Bipolar cells: 3.8;Cardiomyocytes: 1.6;Endometrial stromal cells: 2.3;Endothelial cells: 2.2;Fibroblasts: 3.2;Skeletal myocytes: 2.0"	"Group enriched"	"Detected in many"	5	"glioma: 1.7;melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 9.3;BJ hTERT+: 15.4;fHDF/TERT166: 23.3;HHSteC: 7.2;HSkMC: 16.5;TIME: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	3.0	4.3	5.3	0.8	6.8	0.0	1.5	5.5	3.7	2.0	0.8	1.3	0.2	2.6	0.4	1.0	1.9	3.9	4.2	5.1	8.4	1.0	0.7	3.1	0.4	10.0	4.2	1.9	1.1	0.3	1.4	2.2	4.5	1.0	0.3	1.4	0.9	1.5	1.3	1.7	0.8	1.7	5.5	1.2	1.0	0.3	5.2	0.9	1.6	1.1	0.4	1.2	2.0	4.6	0.0	0.0	0.1	1.9	0.8	1.4	0.1	9.3	15.4	0.0	0.0	0.0	0.0	0.5	0.0	23.3	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	4.5	0.0	0.0	5.4	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.6	7.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	6.8	5.5	3.7	5.1	8.4	10.0	4.2	4.5	5.5	5.2	4.6	2.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.8	0.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	2.2	0.0	0.0	0.0	0.2	0.0	3.2	1.1	0.1	0.0	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.7	0.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Bipolar cells: 3.2;Cardiomyocytes: 1.8;Fibroblasts: 1.5;Leydig cells: 1.2;Peritubular cells: 2.6;Skeletal myocytes: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;BJ: 3.9;fHDF/TERT166: 4.4;HSkMC: 3.4;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	2.2	1.6	1.8	0.7	1.4	0.0	1.9	2.7	2.5	3.0	0.7	1.5	0.1	2.9	1.9	0.8	3.1	1.4	4.9	2.9	1.5	1.1	0.7	2.0	0.2	3.8	3.2	6.3	1.8	3.8	2.6	0.7	2.6	1.9	0.3	2.3	1.2	2.2	1.0	1.0	0.6	2.1	3.5	0.6	0.9	2.3	2.6	0.8	1.6	1.1	0.2	1.4	1.7	2.2	0.0	0.7	0.3	0.2	2.8	6.4	0.0	3.9	1.3	0.3	0.5	0.0	0.0	0.1	0.4	4.4	0.5	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.4	0.1	0.0	0.2	3.9	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.5	0.0	0.2	0.5	0.0	2.3	0.1	0.3	0.4	0.0	2.3	0.6	0.3	0.2	0.0	0.0	0.3	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.4	2.7	2.5	2.9	1.5	3.8	3.2	2.6	3.5	2.6	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.2	0.3	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.1	0.9	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.5	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 4.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.5;Endometrial stromal cells: 9.2;Horizontal cells: 10.1;Sertoli cells: 6.6;Skeletal myocytes: 5.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 15.8;ASC TERT1: 6.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	1.0	0.6	1.0	0.3	1.6	0.1	1.2	4.9	1.1	2.5	0.0	1.1	0.1	2.0	0.6	0.8	1.4	1.1	1.9	1.2	1.2	0.3	0.2	1.1	0.2	2.2	2.1	2.0	0.6	0.6	0.9	0.6	1.0	1.4	0.3	1.2	0.8	0.9	0.6	0.7	0.4	1.0	1.2	0.2	0.5	0.3	1.2	0.3	0.5	0.7	0.1	1.0	1.3	2.0	0.0	0.4	0.2	0.1	15.8	6.2	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.8	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.5	0.6	0.3	0.5	0.6	0.1	0.0	0.3	0.8	0.6	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.3	0.2	1.4	0.0	0.9	0.5	0.1	0.9	0.6	0.1	0.9	0.1	0.3	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	1.0	1.6	4.9	1.1	1.2	1.2	2.2	2.1	1.0	1.2	1.2	2.0	1.8	0.0	1.1	0.0	0.2	0.1	0.8	0.1	0.6	11.5	0.3	0.4	2.6	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.4	9.2	1.9	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.2	1.3	0.6	1.4	0.3	0.1	10.1	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.5	0.0	0.1	0.1	1.3	6.6	5.7	1.7	0.0	0.3	0.3	0.0	0.0	0.6	0.9	0.0	0.4
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370242-141512975	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.4;ASC TERT1: 8.4;fHDF/TERT166: 3.5;TIME: 5.5"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	0.7	0.3	0.4	0.2	0.8	0.0	0.5	3.8	0.8	0.8	0.0	0.8	0.0	1.0	0.6	0.3	0.7	0.4	1.2	0.9	0.5	0.3	0.2	0.5	0.2	1.3	1.4	1.2	0.7	1.1	0.7	0.4	0.6	0.4	0.3	0.8	0.8	0.4	0.5	0.6	0.3	0.7	0.6	0.4	0.4	0.4	0.8	0.3	0.6	0.5	0.2	0.6	0.6	1.4	0.0	0.6	0.4	0.3	10.4	8.4	0.2	1.2	2.0	0.7	0.8	0.0	0.0	1.8	0.3	3.5	0.6	0.5	0.0	0.2	0.5	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	2.1	0.4	0.2	0.1	0.2	1.0	0.0	0.2	0.8	0.2	0.4	0.6	0.9	0.1	0.0	0.1	1.5	0.6	0.0	0.2	0.1	2.4	0.5	0.0	0.0	0.2	0.3	0.6	0.0	5.5	0.5	0.1	0.5	0.6	0.2	1.8	0.2	0.4	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	3.8	0.8	0.9	0.5	1.3	1.4	0.6	0.6	0.8	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512977	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 308.1"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Bipolar cells: 8.4;Endometrial stromal cells: 5.5;Fibroblasts: 10.2;Horizontal cells: 11.8;Skeletal myocytes: 6.6"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"plasmacytoid DC: 15.3"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 15.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 200.7;HSkMC: 186.2;U-138 MG: 244.1;WM-115: 382.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832"	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (6.00e-4)"	63.3	64.3	248.0	15.4	241.0	0.2	59.9	221.6	308.1	107.8	165.1	60.4	7.4	81.3	60.8	54.5	62.6	30.2	77.8	232.3	227.5	36.6	29.5	101.9	9.5	236.9	241.0	65.1	34.7	36.8	79.0	37.1	216.6	66.0	20.4	36.3	46.4	40.7	27.6	64.7	32.0	39.5	216.5	22.2	38.7	22.0	263.5	15.7	45.7	26.3	14.8	60.6	80.0	220.8	12.8	7.7	48.1	14.0	200.7	178.3	0.6	58.6	162.6	30.9	32.5	0.0	12.7	43.5	39.7	108.0	111.7	46.2	6.1	20.7	28.2	0.2	20.0	0.1	1.2	1.2	62.6	0.5	1.5	186.2	31.6	46.9	37.2	104.2	19.7	0.0	0.2	1.6	79.2	24.8	1.0	5.4	2.3	0.8	0.1	30.0	97.1	0.4	17.9	13.7	16.6	69.8	17.3	0.6	115.9	16.8	40.0	66.9	22.1	244.1	12.2	46.7	72.2	0.1	0.6	0.7	60.3	0.1	382.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.3	0.0	0.1	248.0	241.0	221.6	308.1	232.3	227.5	236.9	241.0	216.6	216.5	263.5	220.8	2.5	0.0	0.0	0.0	0.3	0.3	0.5	0.3	8.0	8.4	0.2	1.1	0.8	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.2	1.4	0.3	5.5	1.9	0.0	0.0	0.0	0.2	0.2	10.2	0.0	0.5	0.0	0.2	1.1	0.0	0.3	11.8	0.0	0.2	0.0	0.3	0.3	0.7	1.2	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.6	0.0	0.1	0.0	1.0	0.0	6.6	1.7	1.6	0.0	3.9	0.1	0.7	0.1	3.5	0.0	0.5
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Skeletal myocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA040779: AB_2677133"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.03e-5)"	20.1	13.9	9.8	23.5	15.0	42.5	23.7	29.1	13.6	19.2	6.0	19.6	16.3	22.4	15.2	19.5	17.7	17.2	13.5	9.3	10.9	14.9	16.9	22.8	32.4	13.1	12.7	28.3	17.0	16.6	10.4	16.7	14.0	18.7	19.9	26.6	15.4	16.2	26.3	27.8	20.8	23.8	10.9	28.7	16.4	24.7	12.1	33.4	24.3	19.5	29.6	17.0	13.5	17.9	26.3	18.4	29.4	25.3	34.4	33.4	23.5	24.7	18.2	23.2	17.7	31.5	25.7	58.9	18.1	18.0	21.9	25.8	43.2	17.0	22.3	42.1	14.8	34.5	26.3	22.4	19.4	40.9	36.8	23.9	32.1	17.7	25.6	31.2	23.8	38.8	40.9	27.9	21.9	27.9	38.7	45.2	30.7	44.6	20.5	36.4	37.1	35.2	20.2	38.4	24.4	27.0	30.1	23.7	24.3	26.9	23.7	28.0	24.6	33.0	16.9	24.5	16.6	25.0	45.2	124.6	14.5	26.8	26.0	14.8	7.2	14.9	10.1	6.8	8.5	10.9	6.9	7.3	6.9	9.9	7.8	8.2	17.1	13.5	5.5	7.1	5.5	5.8	9.8	15.0	29.1	13.6	9.3	10.9	13.1	12.7	14.0	10.9	12.1	17.9	96.4	41.7	63.5	58.1	90.6	53.7	79.8	30.7	101.9	48.4	84.4	81.0	42.7	35.8	43.4	46.0	33.3	30.2	90.1	49.8	25.4	22.9	203.3	55.5	70.8	66.8	31.8	62.5	32.0	18.1	26.9	58.8	40.2	83.6	37.2	48.0	56.7	21.7	37.6	55.5	37.9	51.0	26.4	57.8	41.0	40.3	60.3	87.4	28.4	45.0	52.5	34.5	58.7	40.7	72.0	19.2	46.2	45.1	69.0	71.6	83.4	14.2	29.0	55.3	39.5	227.3	66.8	46.7	17.9	100.4	62.7	39.4	81.7	42.7	50.3	71.1
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754012-83162930	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 25.6;pituitary gland: 11.1;retina: 21.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 655.4;Inhibitory neurons: 746.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 25.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	28	"REH: 263.3;U-2 OS: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA		6000000		"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	1.8	4.2	4.0	0.2	5.5	0.0	2.4	25.6	22.4	1.5	0.0	2.1	1.5	0.3	3.8	2.3	1.0	0.9	1.4	7.8	1.7	4.4	0.1	0.8	0.1	0.0	0.0	0.8	3.9	4.4	11.1	0.3	0.0	2.5	1.7	21.7	2.5	2.5	0.1	2.0	1.7	0.1	0.0	0.5	1.5	3.7	1.3	1.2	4.6	0.1	0.2	0.6	2.6	4.2	1.2	1.6	1.9	0.0	0.8	0.1	0.0	0.7	0.7	0.5	1.0	0.3	0.7	0.0	0.0	0.8	7.7	0.6	5.7	2.4	2.4	0.3	0.8	0.0	1.2	0.1	0.0	0.8	0.2	0.4	1.8	0.0	9.6	0.5	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.0	2.0	1.0	4.7	263.3	4.2	0.0	1.9	0.9	4.9	3.4	0.2	2.7	0.6	1.2	3.4	0.6	0.0	0.0	284.5	1.2	0.6	0.2	0.0	0.5	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.5	25.6	22.4	7.8	1.7	0.0	0.0	0.0	0.0	1.3	4.2	0.6	9.6	17.9	40.5	0.0	2.5	9.0	3.2	13.6	121.9	11.0	9.7	31.2	22.8	12.6	1.8	131.3	1.9	0.0	22.9	7.9	6.4	13.0	7.4	6.7	2.5	60.1	0.0	655.4	4.9	0.4	2.4	20.4	13.5	0.0	24.2	0.0	0.2	1.7	85.8	746.4	15.0	2.0	0.0	0.0	7.9	2.8	0.4	0.0	50.6	0.0	16.2	0.0	73.9	73.7	2.5	21.9	6.4	0.0	3.9	13.5	23.0	7.7	86.9	0.0	0.3	3.2	5.0	19.5	19.3	3.4	0.7	0.3	37.5	9.3	6.0
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1022.2;Late spermatids: 428.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		4100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	48.7	43.2	77.5	32.8	85.1	75.9	46.2	70.2	107.1	46.4	56.4	45.5	36.6	38.8	48.5	45.3	39.2	28.4	121.7	87.5	84.8	51.1	73.8	37.9	41.4	80.3	73.0	39.3	38.1	46.3	43.3	42.9	86.2	52.1	43.1	55.8	39.8	50.1	211.9	44.6	34.6	48.9	71.1	34.5	37.8	76.7	72.3	57.4	49.0	163.3	46.7	40.7	38.0	79.2	87.3	68.4	70.4	88.6	152.1	125.9	77.6	140.7	82.9	114.7	143.4	200.1	65.4	117.9	113.0	127.5	126.5	106.6	123.9	143.6	159.9	79.2	180.0	175.5	122.2	192.1	99.2	203.7	197.7	62.8	105.2	128.5	138.5	80.7	107.6	89.8	256.5	107.7	142.3	258.9	98.5	150.4	56.5	84.7	78.6	83.4	89.7	82.6	108.9	62.4	137.5	52.4	111.2	173.9	97.7	82.5	107.8	146.1	83.3	67.2	80.7	124.7	151.2	64.1	109.9	115.4	103.6	135.8	137.7	162.9	193.2	178.0	93.0	182.4	94.7	105.0	93.7	102.8	176.0	81.5	86.5	98.0	101.6	108.5	185.7	79.9	129.2	204.1	77.5	85.1	70.2	107.1	87.5	84.8	80.3	73.0	86.2	71.1	72.3	79.2	57.0	54.5	41.4	21.2	62.6	175.1	74.4	204.4	56.3	72.6	48.0	40.6	154.1	60.1	96.4	79.1	37.5	169.3	66.8	56.6	78.2	113.5	1022.2	51.9	58.4	69.8	55.2	170.1	77.0	110.7	214.0	79.2	26.0	48.8	107.7	38.8	53.9	115.6	119.1	65.6	52.8	72.9	187.2	78.7	127.5	428.1	71.7	78.2	138.7	31.9	143.7	121.2	74.2	30.7	72.2	106.6	57.9	73.7	71.8	67.8	65.1	89.3	106.2	66.3	111.7	64.0	110.4	224.9	96.3	60.7	157.6	148.3	83.0	55.0	58.7	59.1
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324141-46445769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 239.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016820, HPA019887, HPA032101"	Uncertain		Supported	"Centriolar satellite,Centrosome,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 37: Myocytes - Muscle contraction"	Centrosome	"Centriolar satellite, Cytosol"	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	9.7	11.1	7.6	5.9	10.5	17.7	8.9	4.2	11.9	8.6	5.3	10.7	4.1	8.2	4.3	11.7	8.5	3.6	28.3	6.0	5.4	7.7	10.9	8.2	8.2	9.0	3.9	9.6	7.8	4.3	20.3	3.5	9.5	8.2	4.3	4.6	9.7	4.2	239.2	12.3	10.1	4.4	2.6	11.5	9.5	25.6	4.7	12.5	8.4	52.0	5.5	9.6	9.2	7.4	15.4	11.6	18.0	11.1	8.9	8.8	11.3	11.6	8.0	11.3	10.0	14.2	9.7	15.2	7.3	13.4	15.3	10.8	14.6	9.9	7.8	44.9	20.4	40.2	24.1	11.3	3.1	20.6	16.1	4.8	7.5	15.2	7.6	5.5	8.8	15.8	20.9	22.4	15.8	25.4	20.6	21.3	18.0	13.9	8.0	25.3	7.2	13.5	8.7	16.3	22.1	9.8	25.4	15.7	8.0	4.4	14.8	16.0	12.1	20.4	10.2	11.7	18.9	19.3	17.2	16.4	12.6	19.9	11.1	6.0	0.6	1.2	1.5	0.5	4.6	0.3	0.7	4.8	2.0	0.1	0.5	8.8	0.4	0.4	1.0	4.6	0.8	2.0	7.6	10.5	4.2	11.9	6.0	5.4	9.0	3.9	9.5	2.6	4.7	7.4	10.5	28.9	32.0	19.9	8.6	8.3	5.7	7.0	13.6	15.0	8.9	8.6	35.7	10.0	15.3	0.0	6.2	6.4	36.7	14.0	0.0	7.1	20.4	17.0	19.9	10.1	15.6	36.2	38.1	7.6	7.4	13.1	25.0	17.8	16.4	25.4	7.1	9.0	23.3	23.5	39.0	11.2	4.1	6.9	5.5	25.6	12.8	12.7	0.0	17.8	14.7	6.8	25.7	10.6	21.9	5.7	5.7	12.0	31.4	4.2	5.7	4.1	13.0	11.1	26.3	61.3	14.2	40.5	39.8	25.0	7.1	6.4	18.8	15.1	10.4	5.1
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362975	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 2447.1;neutrophil: 626.3"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 2447.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		290000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	17.6	4.2	6.6	5.9	6.6	2.3	6.9	22.2	23.8	9.0	0.0	10.2	25.0	7.1	9.6	8.5	6.9	8.6	5.3	7.4	7.8	3.8	1.7	6.1	2.7	21.7	17.3	13.5	3.0	5.9	2.3	9.4	20.0	3.3	8.4	6.0	3.5	3.0	3.0	3.6	26.4	6.6	23.0	3.3	3.3	6.3	5.3	9.1	4.8	5.4	2.5	5.3	8.8	2.4	2.5	1.8	5.1	3.4	3.2	1.0	32.6	4.7	0.4	0.3	0.0	18.7	2.0	0.8	1.3	0.6	0.1	46.9	2.4	1.4	0.3	0.6	4.1	6.3	4.5	1.6	0.8	1.9	2.8	6.0	0.4	1.0	0.5	0.3	9.6	3.1	7.5	2.4	3.3	11.5	7.4	11.1	22.8	4.3	1.9	1.3	30.4	1.9	42.5	2.9	0.7	0.5	7.1	1.5	0.5	9.5	2.6	8.0	7.6	1.5	66.5	3.8	2.0	0.7	0.3	1.0	5.1	2.7	25.7	2447.1	43.1	192.4	100.0	25.9	85.2	92.3	100.8	93.7	21.8	116.5	98.2	125.2	626.3	135.5	51.6	135.0	96.9	10.1	6.6	6.6	22.2	23.8	7.4	7.8	21.7	17.3	20.0	23.0	5.3	2.4	41.1	6.4	7.2	189.7	0.1	6.5	3.5	8.6	13.6	4.8	0.7	2.0	5.8	11.5	14.3	5.5	0.0	2.1	9.6	47.3	0.0	8.2	19.0	6.0	35.1	19.5	1.2	0.0	33.5	6.1	34.3	26.6	9.7	10.6	0.0	32.1	15.0	0.9	2.9	55.5	81.9	10.2	6.1	4.1	3.9	39.4	20.5	7.5	1.8	70.3	11.4	30.3	82.4	149.3	5.8	10.1	18.5	25.2	0.4	2.9	99.2	4.2	23.4	1.4	19.7	9.1	11.4	1.0	1.9	6.2	3.0	2.5	6.2	5.6	23.9	0.9
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039447-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 48.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 22.4;Gastric mucus-secreting cells: 8.2;Hepatocytes: 32.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.4;medulla oblongata: 2.1;pons: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 82.5;CACO-2: 37.0;HaCaT: 108.8;HeLa: 90.7;RPTEC TERT1: 56.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	143000000	420000000		"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"	0.3	0.2	0.0	0.7	0.1	0.4	0.1	3.4	0.3	1.0	0.0	4.5	3.1	0.3	0.3	5.5	0.4	0.1	0.0	0.1	0.1	0.1	48.7	7.9	0.0	2.1	0.3	0.1	5.4	0.2	0.1	0.0	2.0	0.0	1.6	0.0	0.5	0.2	0.0	1.4	3.4	0.7	0.0	0.3	1.3	0.4	0.1	0.0	0.0	0.0	0.3	0.4	1.5	0.2	82.5	17.6	2.8	0.0	6.4	4.4	0.2	0.0	0.0	0.2	0.2	37.0	13.2	0.0	13.9	7.8	0.3	108.8	3.5	35.2	0.0	0.0	0.0	0.0	90.7	26.5	2.2	0.0	0.0	6.4	25.5	25.2	18.4	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	15.1	1.5	1.9	0.0	0.0	0.9	56.4	0.1	1.3	0.0	10.5	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.3	0.1	0.1	2.1	0.3	2.0	0.0	0.1	0.2	0.0	16.0	22.4	0.0	0.2	0.5	0.0	2.1	1.2	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.2	0.8	0.1	0.1	4.2	2.7	0.1	1.5	0.0	0.6	8.2	0.8	0.0	0.1	1.1	32.9	0.1	0.0	0.1	4.3	2.0	1.6	0.5	0.6	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.6	1.3	1.4	0.6	0.0	0.1	0.0	5.4	0.4
PCYOX1	"KIAA0908, PCL1"	ENSG00000116005	"Prenylcysteine oxidase 1"	Q9UHG3	2	70257386-70281185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 599.4;Hepatocytes: 187.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 313.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035193	Approved				"Intracellular and membrane"	NA	NA		510000000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA035193: AB_10602017"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	78.5	33.5	15.4	12.7	15.7	3.7	34.4	12.1	18.4	56.5	29.3	26.9	24.9	39.9	33.6	38.8	35.6	31.7	37.7	14.7	27.8	92.6	103.5	56.2	14.6	16.5	22.0	39.6	20.6	66.0	17.9	29.0	24.9	44.3	23.6	30.7	70.1	46.6	92.1	33.0	24.5	40.8	14.6	15.6	22.1	14.2	28.4	11.1	60.0	50.4	14.2	25.7	25.2	13.2	38.8	54.9	43.2	48.6	313.2	160.0	37.9	64.8	59.4	35.4	26.5	86.5	33.6	4.0	27.3	89.2	58.2	62.2	31.7	50.2	40.5	22.1	26.9	14.9	41.0	75.7	31.4	14.1	12.7	154.9	54.1	47.4	13.3	93.9	42.6	14.2	27.0	27.8	50.7	23.6	10.7	22.8	26.1	55.9	23.1	19.6	90.2	34.5	50.1	42.8	11.3	24.1	97.8	47.7	45.5	61.0	39.1	18.2	53.4	59.2	32.7	52.9	34.2	22.9	55.1	5.1	71.3	19.3	22.1	16.3	6.5	6.8	8.3	5.4	10.4	3.7	8.0	6.7	5.9	2.8	10.8	9.2	4.1	6.1	6.0	7.4	7.8	6.5	15.4	15.7	12.1	18.4	14.7	27.8	16.5	22.0	24.9	14.6	28.4	13.2	37.3	599.4	77.5	16.0	12.2	21.3	23.1	43.9	29.6	48.7	46.0	31.8	81.1	40.0	49.9	53.3	43.8	43.4	12.1	30.7	7.9	26.7	1.7	18.4	65.9	33.4	8.5	12.0	24.7	10.2	36.0	81.9	22.4	36.2	10.1	20.9	39.7	187.8	22.1	57.2	36.8	21.0	36.7	17.4	9.2	3.9	89.2	14.3	24.9	23.4	8.6	90.3	11.3	21.6	18.0	13.9	21.0	120.7	26.2	27.0	47.7	69.0	25.0	36.9	72.3	65.5	63.7	14.7	32.2	40.8	28.3	22.0	14.5	56.2	26.5	18.4
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408597	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		410000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	25.7	29.6	35.8	22.6	36.2	23.2	24.4	36.5	39.3	26.2	34.1	32.4	17.9	26.9	17.5	37.2	22.6	11.9	40.2	34.4	36.1	28.5	31.3	24.0	18.9	37.3	37.9	25.7	26.6	22.5	21.9	19.2	37.4	26.0	18.0	22.9	26.2	20.9	105.0	27.9	23.3	21.1	37.6	23.8	26.3	19.7	37.0	25.5	24.3	59.7	22.4	29.3	26.4	36.6	96.9	82.4	54.6	71.0	41.5	43.2	34.7	76.7	44.9	61.6	51.8	83.9	47.4	41.3	67.2	74.7	78.4	50.2	66.3	78.4	60.5	59.8	74.4	43.6	80.8	74.1	60.8	80.1	40.5	45.6	58.5	68.1	110.3	56.3	62.7	67.5	103.0	75.6	61.4	200.3	110.4	111.2	68.7	98.1	88.3	50.5	54.3	73.6	63.6	73.0	54.8	110.6	58.0	92.4	43.4	61.3	41.1	42.5	57.6	83.6	91.4	100.8	123.6	71.4	87.5	91.0	67.7	72.2	89.1	13.4	12.1	12.5	15.4	16.6	13.9	15.7	14.2	11.2	10.2	14.9	9.8	13.2	31.6	28.0	15.6	21.1	20.9	6.6	35.8	36.2	36.5	39.3	34.4	36.1	37.3	37.9	37.4	37.6	37.0	36.6	82.9	86.6	94.7	6.2	73.6	62.2	110.6	104.6	57.5	97.4	84.3	76.6	63.6	72.9	86.7	42.3	33.3	213.1	84.7	101.6	168.3	176.1	60.3	91.3	118.6	99.1	117.9	151.7	10.1	171.0	223.0	87.4	59.7	88.3	72.2	83.4	61.8	80.8	114.9	77.4	11.6	116.5	75.3	38.3	63.3	78.3	83.6	66.1	103.2	5.6	102.1	166.4	119.4	8.0	17.4	177.4	92.2	92.2	102.5	184.3	100.0	134.5	96.8	101.0	52.6	85.6	127.2	132.5	123.0	131.9	65.6	184.4	79.5	115.2	114.0	122.5
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581190-32587453	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		47000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	95.7	96.1	86.2	73.8	87.0	46.8	82.0	85.4	110.2	73.2	80.8	100.1	65.8	68.8	50.8	109.3	70.9	34.8	170.9	86.7	91.1	97.8	101.2	68.0	58.6	87.1	87.7	71.8	102.4	52.6	95.1	61.2	88.4	64.3	55.7	39.2	70.1	41.9	224.2	60.5	62.0	65.8	85.8	56.8	78.9	144.4	94.6	41.8	60.6	132.2	59.5	91.1	80.3	89.9	499.0	630.0	168.8	163.7	223.8	334.0	190.0	353.2	225.6	295.2	252.2	525.0	188.3	272.6	498.7	177.1	286.3	133.2	213.6	281.7	254.4	493.1	333.6	412.4	303.9	382.8	284.0	587.0	157.3	219.7	253.8	195.9	315.0	145.1	198.8	214.9	381.0	298.8	247.2	332.0	243.6	298.6	164.9	410.5	211.6	238.9	248.8	323.6	231.9	167.6	326.0	178.4	338.1	351.8	283.4	125.2	152.6	294.6	299.4	272.6	291.7	274.2	602.7	270.6	413.0	504.4	302.3	459.8	244.2	40.7	93.4	50.9	106.4	149.0	134.3	147.3	167.4	132.1	120.6	116.3	115.3	114.3	13.7	116.9	197.6	123.6	217.8	122.7	86.2	87.0	85.4	110.2	86.7	91.1	87.1	87.7	88.4	85.8	94.6	89.9	115.4	73.7	62.7	16.6	70.4	121.6	174.0	292.0	97.3	43.2	129.1	216.4	336.1	94.4	119.4	75.4	27.1	194.7	69.0	94.6	189.8	245.3	469.7	94.0	166.4	121.3	71.3	44.8	24.0	247.3	216.5	150.4	64.2	115.0	46.9	84.9	83.6	151.1	146.7	50.5	29.3	113.6	140.4	48.3	93.1	481.2	142.6	67.4	124.5	11.2	113.8	104.0	66.9	17.6	16.8	292.2	100.4	123.0	124.4	392.4	125.1	216.8	107.9	45.3	72.3	126.8	218.4	487.0	413.1	170.9	119.9	143.0	78.4	164.9	157.8	140.4
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-314974	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	63.3	108.3	89.0	48.7	90.4	42.1	74.8	95.4	102.6	73.4	88.1	83.0	71.6	63.4	98.2	134.8	64.8	48.4	53.5	91.1	92.9	114.6	85.0	53.1	59.9	92.2	88.9	61.7	65.5	77.3	76.4	61.4	90.5	64.3	85.4	29.6	73.9	54.4	42.3	72.7	71.8	52.8	94.9	77.0	69.0	50.3	90.3	81.2	72.8	27.3	74.5	72.7	86.9	100.1	151.8	208.6	88.4	133.5	156.1	141.9	185.6	115.5	151.9	144.2	134.6	147.3	186.4	119.6	283.2	155.4	187.2	112.9	137.3	288.2	116.0	409.9	170.9	105.9	508.7	194.0	193.3	155.7	129.5	128.1	175.0	117.4	208.9	148.3	137.9	81.2	136.8	90.3	130.7	237.7	125.7	270.1	95.6	183.8	295.1	102.0	83.8	171.5	344.7	192.6	86.3	117.5	297.2	309.4	224.7	91.9	215.1	210.7	108.5	94.0	76.9	82.8	100.0	121.4	163.4	141.8	138.9	198.9	128.9	172.8	209.7	284.4	158.2	206.0	199.7	251.9	196.4	179.6	229.3	224.6	217.8	175.5	231.0	260.7	206.6	183.2	236.7	356.2	89.0	90.4	95.4	102.6	91.1	92.9	92.2	88.9	90.5	94.9	90.3	100.1	134.6	64.1	57.4	9.4	99.5	82.1	129.6	250.6	85.4	47.9	140.1	182.1	50.4	78.6	146.7	103.0	37.5	239.1	104.4	146.4	252.4	172.0	55.4	130.9	91.6	110.7	79.7	83.9	10.7	129.1	321.6	104.3	68.8	99.9	82.5	101.3	69.9	77.7	140.4	63.9	11.3	187.5	219.7	84.1	75.5	55.5	117.4	90.0	124.5	10.3	175.3	136.8	137.0	5.5	11.0	164.0	136.7	116.6	57.7	170.7	175.6	205.1	181.9	42.0	85.5	85.3	109.5	100.8	137.8	123.8	92.5	356.7	92.6	173.3	192.3	176.6
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798571-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 299.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011905, CAB016212, HPA051604"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		4100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Centrosome	"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favorable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	33.1	27.6	16.3	24.5	17.9	21.2	32.9	18.4	23.3	35.0	23.0	46.4	36.2	35.1	26.4	46.0	30.9	25.9	30.5	17.6	19.7	35.0	33.2	35.2	26.1	25.2	18.1	34.3	25.0	40.6	22.8	31.2	26.4	30.0	41.5	30.5	29.7	23.7	33.9	39.8	38.8	31.8	18.6	27.5	37.2	23.8	18.8	24.4	34.2	22.1	30.1	26.9	35.9	21.4	47.2	46.4	30.2	25.1	78.5	80.6	34.3	67.2	56.2	50.9	52.2	33.3	43.8	75.9	33.8	77.7	32.2	45.5	47.8	61.4	57.8	27.4	39.5	56.7	37.4	28.2	50.8	56.5	57.6	62.2	69.5	57.6	67.8	60.5	77.1	32.4	50.3	26.2	74.4	27.0	36.3	31.8	29.9	43.5	57.8	32.8	36.5	43.8	64.6	39.2	14.7	26.8	61.6	67.8	30.7	48.9	62.0	51.4	101.1	59.5	28.2	50.1	46.9	26.6	37.6	55.6	56.7	62.6	28.8	6.8	13.5	11.0	8.0	18.1	8.7	12.0	8.9	8.1	12.4	10.8	7.7	7.5	6.8	12.1	18.0	5.0	9.4	10.0	16.3	17.9	18.4	23.3	17.6	19.7	25.2	18.1	26.4	18.6	18.8	21.4	78.5	86.6	84.8	85.8	76.1	41.7	62.6	62.7	51.8	28.6	42.5	34.0	53.4	62.9	80.6	64.4	52.1	53.0	58.5	299.9	37.2	67.2	85.3	121.6	84.0	68.8	36.1	40.6	83.5	78.3	52.8	54.3	96.8	77.8	53.7	53.0	54.3	57.3	60.6	25.2	69.2	97.1	63.1	93.0	44.7	50.4	74.0	85.0	28.4	75.9	71.0	23.1	42.2	96.0	161.7	122.5	127.1	80.5	46.9	56.5	130.2	61.0	130.9	49.9	46.0	42.3	50.4	93.0	48.4	61.5	43.2	96.6	55.2	47.7	86.7	70.3
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857953-149944793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"retina: 1119.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 2946.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.1	0.7	0.5	0.2	0.5	0.9	0.2	1.4	0.7	0.1	0.2	1.2	0.2	0.1	16.3	0.9	0.2	0.2	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.2	1.7	0.1	0.5	0.3	0.9	1119.5	0.4	0.2	0.3	0.6	0.1	0.1	0.2	0.2	0.2	1.5	0.6	0.0	0.4	0.0	0.2	0.0	0.1	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.2	0.3	0.4	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.1	0.4	0.4	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.5	0.5	1.4	0.7	0.5	0.5	0.3	0.3	0.5	0.2	0.6	1.2	0.9	0.0	5.8	0.0	0.4	1.1	0.6	0.8	0.0	150.5	0.5	0.4	6.7	0.0	2.8	0.0	244.0	1.1	1.6	14.3	0.0	0.1	18.4	1.5	0.5	11.6	0.0	0.0	1.2	0.2	2.2	1.2	0.0	2.5	3.8	1.9	2.2	0.6	0.3	75.7	0.6	0.4	2.0	1.9	0.4	5.5	1.2	1.5	0.0	0.0	1.4	263.1	5.2	0.5	0.2	0.1	2.8	0.4	0.3	0.4	0.4	0.1	3.2	2946.4	0.0	1.0	1.2	2.3	0.8	5.4	0.6	2.9	1.5	2.2	2.7	0.2
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244982	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	950000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	32.6	6.4	14.7	7.1	10.7	0.4	24.0	10.3	22.2	7.5	4.8	20.6	4.9	8.9	5.2	6.2	7.2	11.7	31.2	12.0	9.8	17.0	3.7	28.1	7.4	13.6	12.4	3.8	8.8	8.9	4.0	40.2	12.0	7.6	3.5	0.8	10.6	5.2	18.7	10.3	9.1	9.2	10.6	6.6	7.9	3.4	16.0	2.1	16.1	11.0	1.6	8.5	6.6	9.4	33.8	2.6	8.4	0.0	0.0	0.0	9.9	0.1	0.4	0.2	0.0	13.0	10.3	0.0	69.2	0.0	3.1	12.4	0.5	2.8	0.0	0.1	0.2	0.7	1.1	4.8	4.3	0.0	18.1	0.0	0.3	0.0	0.4	0.9	52.6	0.0	1.3	6.1	1.9	13.7	0.1	0.1	3.2	8.1	3.4	0.0	0.3	22.8	27.7	0.1	0.2	0.0	0.6	53.5	0.2	6.0	24.3	0.1	68.1	0.1	6.4	0.1	7.5	0.1	0.4	0.3	0.1	1.5	31.3	0.0	0.0	0.0	7.3	0.1	10.0	0.0	4.3	5.6	0.0	0.0	3.6	1.9	0.1	0.0	0.4	1.3	2.3	2.1	14.7	10.7	10.3	22.2	12.0	9.8	13.6	12.4	12.0	10.6	16.0	9.4	75.0	0.0	1.1	0.0	0.6	2.8	1.2	3.8	1.2	0.7	5.1	7.1	3.1	0.0	1.3	7.3	0.0	7.3	4.0	0.1	0.0	20.0	1.3	4.0	0.7	60.6	1.8	0.0	2.8	3.6	6.5	1.6	0.0	5.6	0.0	13.1	16.8	1.4	7.7	0.0	0.9	0.7	4.1	2.6	44.3	0.1	0.6	25.5	1.8	14.0	1.1	0.3	0.0	0.0	0.2	54.7	0.0	0.0	0.0	2.7	0.1	1.9	0.9	0.1	6.6	4.7	9.6	0.3	1.6	1.1	1.4	4.5	2.0	1.2	0.1	0.6
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746410-43773278	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1048.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		200000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	17.0	16.6	7.5	16.5	8.0	27.1	15.6	9.2	7.6	24.7	13.9	20.6	23.6	16.4	44.7	18.9	15.4	13.5	17.3	7.7	9.8	15.3	34.5	16.8	18.7	9.3	8.2	16.5	36.0	22.6	16.2	23.8	9.1	25.2	22.5	8.4	21.6	19.1	7.6	17.3	21.4	17.0	9.0	12.5	20.4	10.8	9.3	9.6	56.0	4.1	12.3	15.6	15.2	9.8	29.4	11.9	24.6	55.1	48.9	51.9	70.8	58.6	62.1	46.0	56.7	33.6	32.1	33.8	37.4	72.9	30.8	47.8	31.8	61.5	39.7	24.3	44.7	47.2	17.6	30.9	80.1	26.0	33.8	33.6	49.8	35.0	58.5	54.0	81.3	11.1	27.7	17.4	45.5	11.1	9.1	30.4	24.4	48.5	44.0	17.9	36.7	26.2	39.3	26.0	22.9	25.4	48.7	49.0	19.4	25.0	33.1	28.1	50.9	37.7	18.9	29.7	29.1	7.1	8.6	33.9	48.1	41.2	28.8	11.6	8.8	13.3	12.1	9.2	12.8	5.4	6.8	9.5	8.3	6.1	6.0	7.1	2.4	12.7	9.9	17.6	5.8	15.8	7.5	8.0	9.2	7.6	7.7	9.8	9.3	8.2	9.1	9.0	9.3	9.8	224.9	192.3	183.9	31.6	177.8	192.2	313.7	665.2	114.4	56.5	137.9	95.5	58.3	124.4	427.7	167.3	41.7	655.2	319.6	228.7	70.5	401.2	24.3	178.8	300.3	223.7	186.1	95.3	29.2	390.4	807.8	350.7	261.0	328.5	261.6	255.1	233.1	342.2	426.0	70.7	38.3	523.1	231.9	157.3	292.2	26.7	253.5	246.5	243.7	36.5	258.0	128.3	279.1	29.7	38.8	279.9	196.8	276.8	341.1	286.5	234.3	129.1	245.6	61.9	124.9	138.4	389.7	186.4	147.6	138.9	148.5	1048.8	237.8	390.8	335.4	291.7
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028662	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 386.7;Hepatocytes: 595.4;Plasma cells: 556.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	50.3	30.0	22.8	91.5	27.5	35.7	38.2	31.1	24.1	92.8	33.6	84.8	74.1	58.6	163.5	38.9	81.6	53.5	40.4	22.1	31.2	49.5	241.7	48.5	59.0	35.3	29.3	47.3	112.6	26.4	44.6	92.0	34.2	69.3	85.5	8.4	56.1	47.4	9.3	30.0	66.3	71.9	29.6	63.6	95.6	30.8	33.8	46.7	234.1	10.1	72.4	65.6	33.3	49.8	251.3	236.0	249.8	703.3	223.2	158.2	358.2	343.5	230.5	194.8	314.5	196.6	661.5	179.4	748.2	287.0	532.2	160.1	170.6	329.1	168.9	129.0	99.0	86.6	62.7	436.6	298.4	198.5	233.9	156.4	145.1	213.6	169.8	251.7	401.0	90.6	143.6	476.1	173.4	276.4	190.9	226.0	371.1	510.9	134.0	123.6	192.5	440.5	228.2	194.9	79.1	207.6	313.0	223.7	124.1	295.7	127.4	151.9	220.6	152.1	84.5	372.0	247.5	357.5	173.7	125.5	354.2	231.1	528.9	74.4	80.5	51.0	130.4	85.6	135.4	99.1	83.7	100.8	77.6	58.2	77.4	82.7	11.0	91.9	91.4	251.8	68.7	160.6	22.8	27.5	31.1	24.1	22.1	31.2	35.3	29.3	34.2	29.6	33.8	49.8	43.3	28.9	36.2	6.8	87.9	34.7	88.0	142.5	29.0	4.2	50.8	31.5	31.0	95.8	92.4	42.3	4.2	177.8	86.9	135.4	15.6	129.0	3.1	91.1	93.1	57.0	61.6	41.2	3.2	91.0	386.7	102.8	119.8	107.1	57.8	72.0	81.4	595.4	147.9	0.0	5.7	282.9	61.1	84.7	49.6	5.5	59.0	55.3	87.2	9.4	51.8	15.6	68.0	4.5	11.9	94.5	88.6	42.9	556.7	108.1	71.3	66.3	114.8	6.7	32.9	35.2	66.0	47.6	86.1	29.2	28.6	230.4	46.7	52.4	155.6	72.4
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1202.1;Plasma cells: 883.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	118.3	112.3	54.5	155.8	64.6	140.8	124.9	57.1	66.7	178.8	71.2	156.0	122.4	131.6	418.5	98.2	133.5	96.7	113.4	55.9	60.8	130.3	260.5	103.8	118.1	61.1	55.4	99.8	252.1	149.7	74.0	171.3	60.7	127.4	171.6	48.0	184.1	135.5	59.3	64.3	121.5	155.5	60.9	107.4	155.4	55.1	62.6	86.6	363.3	59.4	153.7	130.9	75.7	66.4	287.0	304.6	425.7	672.6	535.6	459.4	753.4	677.8	625.9	348.3	465.1	435.1	548.5	460.9	464.7	668.9	674.1	228.0	324.1	568.3	371.1	363.2	253.4	374.2	228.4	713.2	577.5	387.9	268.9	334.2	428.4	338.1	603.3	642.1	798.0	171.8	328.0	963.6	348.7	338.8	150.5	400.8	356.6	923.4	236.4	355.7	433.0	846.4	498.3	339.9	272.0	543.2	267.6	387.0	396.2	547.8	136.8	648.5	395.0	324.4	409.8	296.3	399.1	900.0	596.6	297.1	438.5	479.6	464.8	276.1	200.0	95.5	198.4	210.9	219.0	197.6	154.2	187.6	215.0	161.0	74.3	125.1	35.0	241.6	161.4	268.9	174.4	319.2	54.5	64.6	57.1	66.7	55.9	60.8	61.1	55.4	60.7	60.9	62.6	66.4	217.1	57.7	124.2	17.6	193.9	103.0	294.2	552.8	61.5	69.1	121.1	91.7	35.9	148.7	264.6	196.8	29.2	456.3	164.6	125.8	43.0	338.6	8.2	146.5	382.9	176.2	157.7	89.2	47.4	240.6	1202.1	228.2	138.1	255.0	131.3	210.6	211.3	355.6	413.1	42.1	30.5	276.3	170.9	155.7	149.8	16.2	121.2	145.9	199.3	15.0	132.1	106.5	142.2	32.6	25.3	175.4	131.2	135.1	883.2	385.4	99.9	149.6	145.8	60.1	85.5	96.9	225.3	98.5	117.9	95.4	102.6	554.1	125.7	254.3	248.3	265.3
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.4;Plasma cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;granulocytes: 25.2;T-cells: 21.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 71.8;U-87 MG: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017554, HPA027376"	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB017554: AB_2161138, HPA027376: AB_1855139"	"unprognostic (2.14e-1)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	7.7	16.0	2.5	11.6	3.0	15.8	10.1	5.6	5.3	5.5	2.7	16.7	16.5	4.0	3.1	8.5	3.6	6.0	28.1	3.1	2.1	4.8	11.2	4.2	13.1	2.7	6.7	12.2	6.9	4.3	3.8	6.4	3.2	4.7	13.3	27.1	10.2	5.0	9.0	18.1	9.1	4.4	1.3	10.5	13.6	12.2	5.0	8.3	3.9	7.6	19.1	11.0	7.6	2.5	34.0	1.4	8.4	21.0	3.4	5.1	12.1	29.1	23.4	14.3	30.4	8.6	7.1	32.1	15.8	9.1	11.9	14.5	5.8	18.2	45.5	6.6	11.7	39.3	7.1	10.2	6.2	19.6	14.0	6.6	6.4	10.0	16.6	19.8	7.7	16.7	8.5	21.5	19.2	3.5	12.5	24.5	20.8	6.9	9.2	13.1	13.8	52.5	7.4	10.8	15.7	18.0	7.6	8.8	11.1	7.0	5.6	8.0	9.2	22.7	7.4	12.0	7.9	71.8	44.8	26.9	72.6	14.0	4.6	19.6	3.4	25.2	3.7	2.3	4.2	7.3	5.9	4.0	3.5	8.6	21.2	13.5	12.7	2.2	3.2	0.6	12.2	9.2	2.5	3.0	5.6	5.3	3.1	2.1	2.7	6.7	3.2	1.3	5.0	2.5	9.2	3.2	5.0	12.1	33.7	50.1	5.1	15.8	4.6	29.4	7.0	4.7	35.5	2.8	7.0	3.7	47.9	10.2	9.9	11.9	5.9	8.7	130.4	6.4	7.2	9.6	7.8	4.2	35.4	3.7	13.2	8.5	9.7	12.1	5.7	13.3	19.6	20.2	10.2	55.5	32.7	6.6	12.2	12.0	15.2	43.8	3.4	12.9	30.2	30.9	11.4	7.4	10.3	12.1	14.8	9.6	17.5	3.8	144.8	7.2	6.7	1.9	5.0	18.5	6.6	4.6	11.6	9.6	10.4	8.9	43.3	4.1	17.3	5.3	7.0	6.1
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 675.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0"	"Group enriched"	"Detected in all"	7	"B-cells: 223.8;granulocytes: 189.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		93000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	301.7	32.4	10.7	91.5	10.8	25.0	236.0	10.2	18.5	133.1	30.2	220.0	179.4	115.0	91.8	182.3	155.3	114.9	393.2	11.7	10.9	82.8	160.3	337.2	104.5	20.4	12.7	35.6	98.3	65.9	29.5	141.1	14.1	116.9	218.5	36.9	166.1	114.7	675.1	136.8	249.0	146.0	14.0	148.3	148.3	13.7	13.8	105.9	194.7	290.0	123.7	276.3	165.3	11.2	274.4	181.8	12.4	0.4	64.1	43.3	277.1	82.6	266.4	218.8	356.5	387.0	429.8	0.3	21.9	233.8	110.4	766.3	91.5	498.1	220.6	0.2	132.0	277.9	50.1	635.3	731.0	0.1	13.2	125.5	257.0	111.9	400.6	233.2	396.8	24.2	60.0	70.3	52.7	51.4	0.8	4.9	24.6	137.7	137.2	234.1	10.0	98.4	114.4	268.9	48.3	18.9	91.2	84.6	0.9	293.8	68.2	125.7	345.1	84.5	19.7	0.7	0.7	31.2	0.1	91.6	92.5	0.2	41.0	0.4	2.4	189.7	11.9	0.8	0.1	223.8	2.3	14.1	31.0	213.0	0.5	8.1	7.5	8.9	1.5	3.2	2.2	44.5	10.7	10.8	10.2	18.5	11.7	10.9	20.4	12.7	14.1	14.0	13.8	11.2	435.0	76.9	123.5	0.0	145.6	366.3	805.9	763.8	244.7	10.1	100.6	131.4	266.2	223.1	250.2	51.5	29.2	538.2	20.5	657.0	15.6	420.1	8.4	218.6	319.3	359.3	101.3	41.6	0.9	172.5	116.7	149.2	100.9	113.0	12.6	47.2	459.7	100.4	50.0	1.7	0.4	488.9	152.5	19.4	105.2	8.0	5.0	88.8	40.9	2.8	8.8	11.6	32.0	0.0	0.0	227.0	769.2	0.7	103.5	256.5	1059.7	109.0	316.4	59.5	315.5	21.0	213.1	4.3	35.7	170.4	197.9	117.0	25.8	1.9	419.2	554.3
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 4781.7;tongue: 1519.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	36.3	11.5	12.7	25.7	13.3	0.0	34.5	16.8	14.8	22.7	10.9	201.2	20.8	235.3	59.1	216.2	97.5	40.1	314.0	12.0	15.7	13.9	7.7	55.2	10.7	19.9	14.2	38.1	18.7	0.8	20.7	18.8	13.8	87.0	32.5	11.2	56.3	148.1	4781.7	12.1	69.0	127.6	17.9	24.5	95.8	8.2	14.6	4.1	32.7	1519.6	26.2	141.1	40.8	14.2	0.0	0.0	0.9	0.0	0.3	0.0	0.8	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	0.0	15.1	0.0	0.8	4.7	13.5	0.0	0.0	8.7	0.0	2.6	0.0	12.3	9.1	0.0	0.0	0.0	115.6	0.0	0.0	0.1	2.4	0.0	1.0	0.0	26.9	0.3	0.0	0.0	17.6	13.3	0.0	0.0	7.3	2.8	0.6	0.0	7.9	0.0	7.6	0.1	7.1	111.2	34.8	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	13.3	16.8	14.8	12.0	15.7	19.9	14.2	13.8	17.9	14.6	14.2	22.4	9.6	6.0	37.2	2.6	8.9	11.4	0.7	12.5	12.1	72.8	105.7	228.9	5.7	2.2	0.0	12.5	2.5	0.6	0.2	0.0	332.7	0.4	1.4	0.8	39.0	3.5	0.0	2.5	16.7	2.7	82.9	1.1	1.1	0.0	1.3	67.5	0.9	1.6	5.0	0.5	0.5	2.0	1.8	11.7	2.6	19.6	2.3	124.5	1.0	3.2	36.4	0.0	6.6	2.6	31.2	0.0	196.0	7.3	12.2	0.0	0.2	3.2	44.3	105.2	428.3	131.4	4.0	12.6	2.4	7.1	12.2	2.5	2.4	0.3	3.9
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537979-2603188	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.6	13.5	15.1	12.4	25.2	16.1	11.1	10.2	20.6	10.9	1.5	15.8	17.3	11.8	13.2	13.3	14.7	9.5	15.1	19.2	5.2	17.0	12.4	13.6	15.0	10.8	6.1	14.0	19.4	27.1	11.2	12.1	11.3	13.0	14.9	15.5	17.8	12.2	18.9	14.2	19.6	12.3	3.7	13.9	13.6	14.7	7.7	16.8	15.8	19.2	14.1	11.1	10.4	12.5	13.1	16.5	20.1	13.5	20.3	16.9	21.5	21.7	13.6	18.7	15.6	16.6	15.2	21.4	14.5	20.7	15.9	20.2	24.3	15.3	17.6	39.6	17.1	11.4	23.0	27.7	17.7	19.2	29.0	15.4	27.5	20.1	13.3	17.9	17.3	19.1	22.2	17.0	22.1	27.7	19.2	13.3	12.8	24.3	15.1	39.0	20.2	19.5	18.0	11.5	31.7	16.3	27.9	31.3	11.5	12.8	29.0	23.5	21.6	20.2	20.2	20.0	18.8	22.6	23.4	33.3	9.7	13.1	17.9	5.4	7.1	8.4	4.1	8.3	3.9	4.2	3.8	5.0	5.8	3.4	4.3	4.0	12.5	5.2	8.9	8.0	1.9	4.7	15.1	25.2	10.2	20.6	19.2	5.2	10.8	6.1	11.3	3.7	7.7	12.5	17.6	16.0	19.1	45.1	32.9	26.6	20.8	25.7	26.7	60.2	30.0	22.0	33.8	40.0	23.0	11.0	54.2	47.0	35.2	41.1	13.7	23.1	14.4	35.6	23.8	19.1	21.6	28.0	46.7	23.6	27.9	23.2	23.0	45.3	7.6	18.1	22.5	46.1	26.0	74.0	41.7	29.9	10.2	55.7	51.1	30.4	31.7	37.1	21.4	31.9	43.3	42.3	25.7	37.7	44.2	31.6	24.0	44.4	27.1	30.3	50.2	44.8	41.1	44.9	46.0	30.5	30.0	46.8	36.8	38.5	34.1	104.7	25.7	24.2	31.4	27.1
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1717.4;Late spermatids: 4366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		830000	"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	25.6	21.8	79.4	7.6	62.2	12.9	18.4	23.9	87.0	14.3	17.5	17.1	14.1	12.3	10.2	19.7	14.0	7.0	15.5	62.5	51.7	50.4	21.5	20.9	7.0	48.8	59.7	19.1	21.3	17.8	37.3	7.8	54.7	17.2	9.4	10.0	22.7	10.6	6.7	13.9	19.7	6.9	34.4	12.5	16.6	23.9	70.5	10.2	19.1	5.4	9.3	10.9	12.6	57.6	43.4	51.9	8.1	15.5	19.4	27.3	9.9	15.2	23.8	14.5	12.1	42.5	65.7	14.4	15.7	21.9	20.0	31.9	15.8	43.4	9.5	16.2	13.4	14.7	60.9	31.7	38.1	14.0	20.6	38.9	40.7	15.3	16.9	23.6	6.9	6.3	26.2	31.9	13.8	29.1	2.0	24.9	22.3	41.9	19.7	16.7	4.8	40.4	62.9	51.9	7.8	9.3	63.3	57.7	23.2	3.3	19.0	19.4	12.5	10.5	20.3	14.2	14.4	19.3	9.8	8.4	43.2	39.9	10.3	0.6	2.4	0.1	0.8	2.2	1.5	0.6	0.8	0.9	1.3	1.7	0.8	0.6	0.6	0.9	4.3	0.6	0.7	1.4	79.4	62.2	23.9	87.0	62.5	51.7	48.8	59.7	54.7	34.4	70.5	57.6	15.8	80.1	66.6	44.1	37.7	28.4	142.4	72.2	27.3	46.3	74.8	53.5	48.0	34.3	73.2	101.2	22.9	42.9	23.6	97.6	180.0	146.4	1717.4	66.9	28.3	36.1	30.1	15.8	49.3	196.6	86.3	39.4	63.2	73.2	31.8	23.8	17.2	54.2	207.6	52.2	48.7	55.4	12.2	58.2	101.0	4366.5	50.1	118.7	42.7	61.8	38.4	14.9	20.6	16.6	13.5	223.4	36.4	54.2	146.4	184.7	108.4	95.7	71.1	43.3	6.6	17.0	35.0	678.1	30.4	60.7	28.4	124.1	27.3	22.1	57.5	239.8
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118136124-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2083.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		51000000	"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	217.9	1754.1	941.2	84.0	966.0	121.8	235.5	987.9	1049.0	258.0	958.4	208.9	601.4	186.6	383.7	219.5	218.4	154.8	463.8	932.6	951.5	1046.1	2083.1	176.4	122.7	959.0	965.9	335.9	357.5	1162.7	292.3	128.8	982.6	261.6	191.2	336.1	344.5	233.2	580.3	190.3	510.6	167.6	1006.6	121.2	201.7	152.2	1025.0	138.1	739.7	546.8	160.2	200.8	179.0	1081.7	289.2	241.6	340.0	348.8	493.5	250.2	500.0	214.5	262.3	347.7	177.1	151.6	96.4	439.6	221.3	336.2	139.9	194.4	495.0	202.8	257.7	115.1	454.2	220.0	274.7	1021.7	289.2	403.6	94.5	240.8	334.7	203.9	140.0	396.1	162.7	240.9	375.8	169.2	356.4	346.3	226.8	813.7	319.7	243.1	273.9	446.1	235.6	829.7	428.7	277.2	397.5	306.9	439.9	306.2	446.0	200.4	443.6	293.0	168.9	253.7	147.0	254.0	237.3	161.6	315.1	234.1	301.1	303.2	280.9	5.0	67.5	20.0	155.2	76.4	247.0	271.7	258.9	193.1	205.1	210.0	244.6	201.2	8.0	138.1	68.6	231.6	259.7	258.4	941.2	966.0	987.9	1049.0	932.6	951.5	959.0	965.9	982.6	1006.6	1025.0	1081.7	193.7	403.8	433.3	101.5	230.9	318.1	449.3	367.6	288.5	539.4	538.4	590.7	697.3	713.4	243.2	783.5	95.9	999.6	144.6	207.1	3705.6	507.9	44.3	499.3	319.0	186.5	320.6	218.1	93.7	244.6	862.3	347.9	169.2	369.8	371.8	419.7	213.8	2242.4	591.6	721.8	99.6	378.8	335.7	201.4	239.0	84.4	543.1	195.3	743.5	53.4	296.8	1792.2	101.0	39.2	199.8	184.2	313.3	731.6	279.3	517.4	2177.7	4542.6	291.6	411.6	368.1	337.5	347.8	330.6	145.7	367.7	325.2	615.5	216.7	921.6	631.3	399.5
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 382.5;skeletal muscle: 670.8;tongue: 581.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 177.3;Cardiomyocytes: 144.7;Muller glia cells: 198.7"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA025064	Uncertain				"Secreted in other tissues"	NA	NA		190000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	1.1	3.4	12.3	0.3	16.7	0.0	3.3	21.2	9.2	0.6	19.2	0.6	0.0	0.5	382.5	6.8	2.2	1.1	200.7	8.5	15.8	2.6	0.9	115.1	0.7	15.6	20.3	1.7	34.5	82.6	13.2	0.3	20.2	45.8	0.2	12.9	21.1	2.8	670.8	1.4	0.6	0.4	8.7	0.8	9.2	6.6	28.7	1.2	56.7	581.4	1.6	0.3	0.5	15.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	12.3	16.7	21.2	9.2	8.5	15.8	15.6	20.3	20.2	8.7	28.7	15.5	1.5	109.0	177.3	15.3	2.2	1.9	1.0	0.1	0.0	10.2	5.7	4.7	144.7	0.0	7.4	1.8	2.1	0.8	1.4	0.3	3.9	0.0	34.8	1.7	2.0	2.4	0.0	0.0	10.0	9.3	0.2	10.1	2.0	7.0	7.6	0.4	3.9	0.7	1.2	10.1	9.6	0.3	2.0	0.0	0.8	28.4	3.4	1.4	1.8	6.5	0.1	198.7	5.2	6.6	0.9	0.3	0.1	10.9	1.5	23.8	0.5	5.9	2.9	8.6	0.0	25.2	2.1	14.8	1.2	0.0	0.9	0.0	1.6	1.1	0.3	1.0
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301524	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	11.6	3.0	8.1	4.3	7.8	18.6	7.7	27.9	5.9	6.7	5.4	7.0	11.0	6.7	2.5	4.4	6.3	10.0	2.9	5.6	6.6	9.2	2.8	6.7	4.0	8.8	10.9	15.0	28.6	1.9	2.7	3.1	9.3	4.7	3.9	15.1	7.7	3.5	2.4	5.9	9.2	3.3	8.0	6.8	14.4	10.0	10.4	19.1	4.1	3.8	2.0	10.6	5.7	9.2	0.1	3.1	8.8	0.0	4.8	7.2	0.2	1.2	4.2	0.9	0.1	0.2	0.7	0.2	4.2	2.5	0.0	0.9	6.9	0.0	0.4	2.3	2.4	7.9	13.0	0.0	4.1	1.1	33.3	4.5	0.4	0.0	0.0	4.8	1.6	43.8	6.0	0.1	0.9	0.0	39.5	0.4	14.5	0.1	1.2	19.2	0.5	1.8	3.6	15.4	17.5	0.0	0.8	0.1	10.2	5.5	0.0	6.3	0.5	2.6	4.4	0.8	4.4	0.7	0.1	1.0	4.6	5.4	2.6	0.9	1.9	2.4	0.3	1.0	0.5	0.1	0.3	0.2	1.3	0.4	0.2	0.1	5.6	0.3	0.8	0.3	0.0	0.7	8.1	7.8	27.9	5.9	5.6	6.6	8.8	10.9	9.3	8.0	10.4	9.2	13.9	0.0	10.0	114.3	7.7	14.3	10.4	1.7	9.6	30.7	7.1	7.7	2.7	8.6	6.7	12.9	29.2	0.1	11.8	15.0	3.9	5.9	3.7	23.7	14.5	18.0	7.2	5.5	13.5	14.1	0.1	13.5	34.1	21.2	5.7	5.7	17.5	1.0	1.2	21.9	22.1	7.9	2.0	19.7	14.0	5.7	17.1	20.3	17.8	100.2	22.9	9.7	10.3	150.8	77.5	9.1	6.0	18.0	5.6	7.8	12.4	10.1	8.8	19.7	13.1	5.4	22.0	2.0	24.0	4.7	18.3	0.1	6.2	5.6	3.1	12.6
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 26.5;Horizontal cells: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	7.5	10.2	19.1	2.6	18.7	1.2	7.7	21.1	33.2	12.4	4.4	15.3	3.2	13.9	5.6	6.9	11.2	6.8	8.8	20.5	15.0	6.2	4.2	5.5	3.2	22.7	17.2	13.5	8.2	11.7	13.4	2.4	23.6	14.6	1.7	5.5	8.7	14.8	18.3	7.7	6.3	5.6	13.9	5.1	9.4	7.6	19.5	1.0	6.3	4.6	1.5	14.7	9.1	19.8	20.2	8.1	6.5	5.0	10.2	4.0	5.6	6.2	8.0	5.7	4.9	11.8	4.3	5.0	6.1	6.9	10.3	10.2	4.0	7.8	2.4	9.6	4.1	1.3	7.2	3.5	6.4	1.0	9.2	3.8	8.6	5.8	2.1	8.3	1.2	6.4	2.3	7.2	2.5	11.5	4.2	3.0	3.9	10.2	8.4	13.6	4.7	5.2	3.2	6.3	7.9	4.4	3.2	8.8	21.6	2.8	10.3	5.3	3.4	5.0	7.6	21.7	5.4	6.9	4.2	2.7	10.6	3.1	4.1	0.5	1.0	0.2	1.0	0.8	0.8	1.2	0.8	1.2	1.4	1.5	0.9	0.7	0.0	0.5	3.4	0.4	1.0	0.6	19.1	18.7	21.1	33.2	20.5	15.0	22.7	17.2	23.6	13.9	19.5	19.8	5.0	6.4	2.0	2.0	0.7	1.7	3.8	0.9	4.0	13.3	3.0	4.4	8.1	4.3	0.6	0.0	10.4	2.5	0.4	0.6	1.9	3.2	5.0	0.4	2.6	2.7	26.5	0.0	7.1	2.5	2.1	4.2	2.0	1.1	0.0	2.9	3.3	2.8	3.3	21.9	7.7	1.4	2.0	1.9	1.4	10.4	7.5	2.9	0.0	1.9	2.8	7.5	0.0	2.0	2.5	1.8	1.4	9.8	1.0	2.5	0.9	2.9	0.2	9.7	6.6	3.1	4.9	3.0	3.5	1.8	0.3	0.3	1.3	1.5	0.8	1.5
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446671	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 376.2;brain: 164.1;testis: 129.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3626.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 923.2"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	8.6	376.2	29.9	4.4	164.1	0.0	4.9	45.2	45.6	9.2	0.5	23.1	1.1	8.1	0.0	1.4	7.6	12.5	25.6	2.7	74.0	0.2	0.2	3.7	0.1	81.4	15.9	29.7	1.1	0.0	17.1	2.9	51.3	22.4	2.0	0.6	2.7	23.4	3.0	0.8	4.2	4.6	54.0	0.1	10.0	129.0	38.0	0.2	1.0	5.3	0.1	0.6	6.2	10.1	0.0	0.0	0.1	0.0	14.3	8.6	0.0	7.7	2.5	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	164.1	45.2	45.6	2.7	74.0	81.4	15.9	51.3	54.0	38.0	10.1	0.2	0.0	1.5	0.3	0.5	0.1	0.2	758.4	0.0	0.3	0.1	0.6	0.8	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	85.7	0.1	3.1	0.9	0.0	0.0	0.4	0.0	0.1	16.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	2.0	0.0	0.7	60.8	1137.9	1.2	0.0	1.9	0.0	0.0	0.0	0.5	0.4	0.0	0.0	225.7	0.0	0.2	0.0	0.0	3.6	0.0	6.6	1.7	1.2	274.1	19.1	0.1	0.4	0.0	0.2	3.1	0.0	0.0
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	5.8	6.9	2.6	6.0	4.7	4.1	8.7	4.6	4.3	6.4	2.5	8.6	6.6	6.7	11.2	6.1	5.6	4.7	8.9	2.4	3.1	14.2	13.0	5.3	6.9	3.5	3.5	6.8	8.8	11.7	6.3	4.2	4.1	7.8	9.5	13.2	9.1	7.0	9.1	7.9	8.1	5.4	2.8	6.0	8.2	6.7	3.0	7.9	8.6	9.9	6.7	5.6	5.8	6.3	8.3	8.9	14.4	24.6	8.9	7.6	13.0	5.4	7.1	6.3	9.1	5.5	8.7	12.2	12.0	6.3	9.6	8.4	11.0	9.9	10.0	12.7	9.7	5.8	9.5	7.0	6.2	10.6	6.4	8.2	8.6	9.4	12.7	8.0	9.9	12.6	21.9	17.2	10.1	15.5	21.3	10.4	10.0	12.3	8.3	15.0	16.0	15.3	8.8	12.0	10.6	17.1	12.4	34.3	10.8	20.2	7.1	4.4	8.1	6.0	8.1	23.0	5.7	18.9	15.9	16.7	5.7	6.2	9.8	0.8	1.1	1.8	2.5	1.8	2.5	3.0	2.6	2.8	1.2	2.8	2.9	3.3	0.9	4.7	2.2	0.7	2.8	1.1	2.6	4.7	4.6	4.3	2.4	3.1	3.5	3.5	4.1	2.8	3.0	6.3	14.2	28.9	18.4	26.1	14.1	5.9	8.4	8.1	10.8	43.5	11.7	12.6	29.7	5.7	13.1	5.5	35.5	9.0	13.6	17.2	9.8	6.6	7.3	22.6	14.7	11.6	13.9	12.4	30.0	7.5	3.9	11.6	21.9	14.2	8.8	20.5	8.2	14.2	5.4	40.4	45.7	12.0	8.2	7.6	3.1	4.8	14.3	8.4	7.2	13.1	12.7	14.2	14.4	23.6	55.2	6.0	11.3	15.1	11.6	9.6	16.5	19.2	32.4	42.9	6.6	15.5	12.6	36.6	14.4	11.2	7.7	8.3	12.0	11.8	15.2	7.7
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.5;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.2"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000		"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.8	0.2	0.1	0.7	0.3	66.5	0.3	0.1	2.2	0.1	0.7	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.9	0.1	0.1	0.6	2.2	10.5	0.3	0.3	0.2	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.5	0.9	0.1	0.2	0.0	0.6	2.5	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.3	0.1	2.2	0.1	0.1	0.3	0.2	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853296-73854483	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 2.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 10.0;Club cells: 2.6;Enteroendocrine cells: 5.3;Macrophages: 6.4;Theca cells: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"basophil: 14.2;neutrophil: 9.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in single"		"EFO-21: 1.7"									HPA052485	Supported				"Secreted to blood"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.2	0.0	0.0	0.1	0.2	1.2	0.2	0.0	0.3	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.7	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.9	0.0	0.0	2.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.1	0.3	0.0	11.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.1	0.0	10.0	2.6	1.8	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.7	2.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	1.4	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.5
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles		NA	NA		670000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	8.4	9.9	4.7	7.8	5.1	9.8	8.2	6.2	5.8	7.8	2.8	6.7	4.8	9.0	2.6	8.4	8.0	2.8	6.3	5.1	3.3	11.0	10.1	5.8	9.8	3.9	3.9	9.7	10.3	5.6	5.5	5.2	4.6	6.9	5.6	5.8	6.4	4.7	6.4	6.8	7.7	6.8	3.3	11.0	7.8	7.8	3.9	7.5	7.8	3.2	8.2	7.6	6.2	6.0	15.6	67.0	33.8	50.2	12.1	10.0	38.7	19.4	7.4	35.1	26.4	32.9	13.7	69.8	30.8	11.4	12.4	35.1	78.5	25.6	25.8	30.6	64.0	40.0	63.2	41.9	10.4	32.9	28.3	9.5	6.2	40.5	25.5	9.9	29.5	36.6	54.8	10.1	13.7	23.0	58.1	28.4	55.7	8.5	29.9	86.0	35.2	32.6	16.1	25.5	20.4	31.7	24.1	15.3	22.2	17.9	15.3	14.9	20.9	19.2	25.0	35.7	49.0	11.8	23.5	33.7	21.0	45.4	32.9	20.2	5.1	12.7	6.8	4.5	8.7	14.8	8.8	7.9	4.4	16.7	10.9	8.6	49.1	5.2	3.7	12.9	5.0	2.3	4.7	5.1	6.2	5.8	5.1	3.3	3.9	3.9	4.6	3.3	3.9	6.0	2.9	0.0	7.9	3.9	6.0	2.4	1.7	1.9	1.8	8.1	4.5	3.7	4.3	1.5	4.1	3.7	6.2	5.2	3.2	2.1	0.0	3.7	2.1	2.4	5.9	3.6	0.0	9.2	5.8	3.0	4.3	4.0	5.6	3.7	1.3	9.7	2.5	4.2	4.6	1.7	5.4	3.5	2.0	2.5	1.4	1.1	5.3	3.4	3.6	4.7	4.5	1.6	4.1	6.6	3.9	1.9	4.9	1.5	5.3	2.9	0.8	2.7	5.1	7.3	0.0	5.1	3.2	5.6	8.8	3.9	2.0	3.1	3.3	7.7	6.2	1.4
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118055	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 641.9;Suprabasal keratinocytes: 642.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol		NA	NA		85000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028700: AB_10603983, HPA058304: AB_2683673"	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	99.3	80.2	157.9	55.4	167.4	110.5	71.6	168.7	195.3	59.5	144.7	65.7	43.9	59.2	67.2	73.9	57.7	39.7	103.1	159.4	180.9	95.5	103.2	71.0	64.0	171.8	173.3	60.0	49.8	53.5	100.5	57.0	171.8	54.3	41.9	53.6	50.9	45.6	183.3	54.0	46.8	46.3	165.8	54.5	52.8	58.6	169.4	67.1	48.5	114.5	61.3	82.6	59.9	176.0	305.9	205.3	154.0	201.1	141.3	134.1	167.2	218.4	205.1	190.9	150.6	274.2	228.4	204.6	252.4	148.1	185.6	220.0	241.6	279.1	235.2	224.6	236.3	226.1	322.4	394.9	405.9	314.5	217.1	149.0	362.8	305.6	877.0	144.1	222.4	208.9	343.6	142.6	177.8	316.4	237.2	372.6	300.1	359.7	495.8	200.4	154.9	249.8	212.1	186.7	202.5	334.1	168.3	224.3	367.6	200.5	184.9	394.3	188.9	195.4	283.8	245.1	472.2	211.6	226.3	403.5	236.7	214.2	273.1	112.6	104.8	115.5	58.5	107.5	66.9	116.6	72.5	72.1	129.2	120.0	74.7	72.1	54.1	66.1	135.1	201.5	98.8	73.5	157.9	167.4	168.7	195.3	159.4	180.9	171.8	173.3	171.8	165.8	169.4	176.0	178.2	32.1	39.7	13.1	94.6	641.9	320.5	407.2	124.7	76.3	105.5	140.2	125.2	62.9	163.9	115.8	16.7	183.1	114.3	83.6	342.4	168.0	36.1	152.7	140.4	162.3	101.3	93.0	21.5	150.6	242.9	157.2	55.5	176.1	99.5	116.8	97.5	143.5	175.0	21.9	21.8	97.3	248.2	64.2	399.6	26.9	126.5	120.0	184.9	7.5	123.8	94.8	80.3	11.6	62.4	230.3	78.9	110.2	79.1	426.2	86.2	281.2	135.0	77.6	78.9	135.7	298.2	142.7	269.8	153.3	642.6	179.6	113.8	137.3	95.9	355.6
PFDN4	"C-1, C1, PFD4"	ENSG00000101132	"Prefoldin subunit 4"	Q9NQP4	20	54208087-54228052	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024055	Approved					NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA024055: AB_1855236"	"unprognostic (2.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (9.40e-4)"	"prognostic unfavorable (7.66e-5)"	"unprognostic (7.87e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.44e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.47e-10)"	"unprognostic (9.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	5.5	6.2	12.6	4.8	12.9	5.3	6.0	12.5	19.0	5.8	10.7	3.7	2.0	8.0	5.8	5.3	4.7	5.8	14.2	13.1	14.4	6.4	4.0	3.9	6.8	13.3	13.9	7.9	3.7	5.8	2.6	6.6	13.8	5.4	4.2	3.4	4.1	5.2	8.8	4.4	2.7	6.3	12.7	3.2	2.3	7.6	13.2	4.8	6.9	8.2	4.9	5.8	2.7	13.1	9.9	3.4	11.6	3.8	8.1	19.4	11.5	9.2	7.1	21.8	9.6	12.6	9.9	7.2	30.1	10.4	12.6	8.4	13.3	11.9	36.7	7.2	10.0	6.1	13.1	42.6	10.5	12.5	6.8	10.3	16.8	9.4	17.3	11.3	13.8	8.9	11.6	8.2	20.0	38.8	12.8	29.5	14.1	6.2	16.5	9.9	4.1	13.2	18.7	12.7	13.6	14.4	11.2	30.3	31.9	10.5	9.4	25.4	6.9	15.5	18.8	21.8	20.8	5.1	8.1	11.0	15.4	11.0	13.7	3.6	5.4	2.6	4.4	5.8	6.2	6.0	5.9	5.3	7.8	5.2	6.1	5.7	0.8	7.6	5.5	8.6	12.5	5.0	12.6	12.9	12.5	19.0	13.1	14.4	13.3	13.9	13.8	12.7	13.2	13.1	46.7	28.9	32.9	6.2	47.3	91.1	86.4	190.5	59.7	16.5	67.6	82.2	73.6	52.9	68.7	40.5	0.0	124.4	53.2	45.5	107.6	147.5	196.9	67.6	53.5	65.3	71.2	77.2	14.7	137.9	147.1	66.6	19.9	82.1	43.1	52.1	84.6	71.6	95.3	13.5	14.6	56.7	85.5	104.3	104.8	35.7	78.9	46.8	62.2	8.4	172.5	41.7	52.5	12.1	11.9	145.8	68.5	68.1	35.1	69.0	42.7	135.4	66.6	15.7	105.2	55.5	64.6	181.4	92.8	57.3	88.5	93.4	53.6	48.5	66.5	76.7
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 220.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		89000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	45.3	78.2	23.7	13.7	24.4	12.9	45.4	24.2	27.3	49.2	22.6	55.9	9.3	54.8	14.2	70.2	46.2	6.7	85.1	24.4	24.4	78.8	98.1	41.7	15.9	24.6	24.6	45.3	51.7	14.4	62.7	13.6	24.7	51.0	11.6	8.6	47.6	8.0	129.3	49.6	45.3	9.9	23.7	49.9	58.4	91.4	24.0	17.1	45.6	14.7	17.0	55.6	46.7	25.2	49.4	36.0	34.9	56.7	22.7	17.3	43.4	37.2	20.6	48.0	48.7	42.6	24.0	102.8	43.1	20.5	83.5	42.2	69.5	47.6	58.3	49.3	52.9	89.8	39.4	78.3	33.2	56.3	49.3	20.7	50.9	64.8	41.6	28.5	40.2	61.2	107.2	29.6	36.7	36.0	73.9	58.7	47.7	33.0	37.6	71.9	38.0	65.2	58.9	23.4	61.3	83.9	32.1	83.3	61.3	35.0	44.4	65.0	22.5	24.7	36.0	26.0	68.7	71.2	220.3	89.4	20.5	71.9	38.1	1.8	2.6	1.8	1.9	3.2	2.1	3.3	2.3	3.1	2.4	3.2	1.8	2.5	1.1	2.1	3.5	3.5	3.5	1.9	23.7	24.4	24.2	27.3	24.4	24.4	24.6	24.6	24.7	23.7	24.0	25.2	17.4	25.6	8.7	5.2	49.1	55.7	45.2	92.6	43.9	24.5	30.2	17.1	20.7	60.1	51.6	55.2	10.4	127.5	37.6	90.0	121.3	87.6	94.2	106.5	64.7	30.6	50.4	48.4	4.3	103.8	126.1	32.6	44.4	66.9	61.6	32.9	19.2	74.0	79.2	18.5	4.1	75.7	87.5	35.4	45.2	42.7	61.8	37.2	71.2	2.8	66.3	51.0	50.4	1.5	7.1	88.0	71.3	49.2	55.3	53.9	76.4	210.0	53.0	29.0	39.5	43.6	96.3	208.2	60.4	64.3	63.9	110.8	36.9	47.4	82.7	46.7
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 273.7;Proximal enterocytes: 331.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	62.7	36.1	36.5	41.6	40.3	45.2	57.3	43.8	40.7	60.0	36.0	79.5	99.9	47.9	12.9	79.7	42.9	40.9	41.5	35.6	29.7	95.4	60.6	51.0	42.1	54.0	45.6	42.6	40.0	21.1	38.8	41.7	50.3	47.6	24.9	23.8	58.5	38.1	18.8	68.7	92.2	18.6	48.4	59.6	64.6	44.7	54.3	26.0	47.7	17.8	23.1	57.5	58.2	57.7	127.9	54.8	38.4	111.2	58.0	43.2	167.6	93.9	60.2	53.3	51.9	74.5	27.5	74.9	108.8	62.5	50.3	67.6	30.3	84.4	12.3	62.9	67.7	152.5	47.2	123.4	45.1	116.1	93.1	57.0	51.0	54.5	27.0	80.6	79.2	53.9	95.9	83.7	36.9	161.3	50.8	89.9	60.2	114.0	60.2	122.1	35.7	206.6	23.9	139.0	67.0	49.7	137.3	114.9	60.7	15.4	90.9	101.6	116.7	80.4	50.9	53.0	37.1	159.7	45.6	31.1	132.9	89.7	65.4	17.7	71.5	17.2	37.8	119.0	31.2	41.0	48.9	34.4	83.4	54.5	28.3	22.9	14.0	26.1	126.8	52.4	78.5	84.2	36.5	40.3	43.8	40.7	35.6	29.7	54.0	45.6	50.3	48.4	54.3	57.7	56.2	22.4	27.9	53.2	45.3	35.7	40.3	95.2	37.0	74.6	41.3	36.6	14.4	27.1	51.6	92.0	66.7	119.6	38.7	273.7	99.7	85.5	2.3	40.7	29.6	49.0	46.3	45.6	15.7	51.4	174.8	44.6	126.4	83.1	41.9	61.2	40.7	70.0	108.6	30.3	9.3	131.4	57.0	64.7	44.5	8.2	39.1	60.0	69.4	29.0	129.4	67.6	33.0	10.1	41.7	52.7	174.2	55.7	39.2	54.9	331.6	142.4	33.7	53.6	26.3	21.3	47.8	1.8	12.2	42.3	36.1	160.8	31.8	31.2	178.6	54.2
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137718	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 277.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 459.8;Late spermatids: 516.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		1900000	"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	35.0	11.5	41.6	41.5	39.3	14.4	23.5	13.8	49.9	26.3	61.7	43.8	48.8	55.5	5.6	67.1	34.9	34.1	128.6	60.4	65.0	44.6	4.7	19.1	32.5	30.7	50.9	19.1	15.9	15.2	29.9	15.5	58.0	35.6	30.7	277.0	39.8	62.0	70.4	40.3	59.6	44.1	8.3	19.1	36.8	141.1	47.0	29.7	38.5	21.0	21.2	64.7	42.8	31.7	314.8	420.2	25.9	0.6	26.8	56.9	336.9	187.2	66.6	186.2	222.8	444.5	320.4	37.0	147.8	134.9	174.9	243.0	141.7	292.3	173.1	102.1	111.0	132.0	189.1	24.2	65.2	53.7	203.4	27.0	61.2	190.0	96.0	273.7	367.8	153.7	37.0	1.3	195.7	239.8	182.5	44.4	42.9	133.9	149.3	138.8	46.9	150.1	185.7	115.9	69.5	64.7	133.7	111.0	172.0	307.8	93.7	80.3	449.2	124.6	65.3	380.5	199.3	195.4	200.1	135.7	331.0	98.0	78.5	30.8	8.5	2.9	26.8	4.2	21.2	13.7	26.2	25.0	14.5	15.3	9.6	15.4	1.3	26.7	1.6	22.5	37.6	16.5	41.6	39.3	13.8	49.9	60.4	65.0	30.7	50.9	58.0	8.3	47.0	31.7	30.5	3.2	7.0	128.6	14.8	28.7	58.5	96.8	14.8	40.4	10.3	7.7	147.4	8.6	57.9	64.4	54.2	7.8	16.3	72.6	43.0	115.7	459.8	41.2	9.0	36.0	37.2	10.3	49.4	10.8	205.8	25.9	35.7	63.8	55.9	25.8	14.6	0.7	33.9	42.1	25.9	23.1	124.1	7.6	31.4	516.3	7.5	14.3	19.6	15.0	15.4	113.1	16.5	16.1	6.7	116.8	57.2	6.8	14.2	80.9	53.2	5.9	62.6	133.4	13.1	43.2	34.6	149.4	3.5	25.1	22.6	26.5	28.8	11.2	28.9	64.2
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PFN2		ENSG00000070087	"Profilin 2"	P35080	3	149964904-150050788	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 461.8;Ionocytes: 231.9;Muller glia cells: 289.3;Proximal tubular cells: 198.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035611, CAB037073"	Enhanced					NA	NA		19000	"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB037073: AB_1079600, HPA035611: AB_10672870"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.42e-4)"	"prognostic unfavorable (2.19e-7)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.99e-1)"	27.3	39.1	188.0	19.8	205.1	3.1	35.9	147.7	261.5	42.4	165.3	44.3	25.2	60.9	151.8	25.0	97.1	35.8	45.7	268.1	182.4	116.0	25.0	20.2	7.2	162.1	154.4	60.5	37.8	79.3	61.7	21.4	164.3	66.2	27.4	154.9	49.0	64.7	255.3	14.1	34.4	58.8	165.3	16.3	38.4	27.4	166.3	28.4	99.5	89.9	10.2	52.1	32.5	192.3	556.7	189.8	446.3	184.0	97.5	330.3	119.1	174.0	262.9	268.3	310.1	71.2	435.7	0.1	357.8	383.1	457.2	5.7	187.0	247.5	386.7	17.8	111.3	6.5	94.7	206.0	130.1	31.3	8.8	209.1	205.4	263.9	341.5	285.9	159.3	87.9	1.6	21.3	282.9	206.0	27.3	1.5	195.0	3.7	248.1	31.1	321.7	2.6	200.8	278.6	241.6	248.8	86.4	41.1	239.6	306.6	65.3	4.5	116.1	127.2	177.3	214.1	228.4	28.5	2.3	14.7	275.3	1.8	159.2	1.7	0.2	0.4	2.2	0.1	4.7	2.0	4.8	4.1	0.1	1.0	7.3	4.4	1.2	1.4	0.0	0.2	1.4	2.1	188.0	205.1	147.7	261.5	268.1	182.4	162.1	154.4	164.3	165.3	166.3	192.3	16.2	6.4	6.9	26.4	4.5	9.8	52.4	106.0	100.2	52.1	54.3	37.0	48.3	32.9	47.3	136.1	18.8	11.9	1.9	12.8	461.8	42.1	57.6	75.5	28.3	22.6	121.2	0.0	65.0	27.3	11.5	54.7	7.7	10.6	8.2	39.5	25.4	12.3	3.2	26.9	33.8	27.9	231.9	1.2	9.3	27.2	74.0	2.9	35.6	15.9	4.8	289.3	1.0	21.6	30.3	14.9	19.4	96.7	3.4	57.9	103.2	198.2	116.4	42.2	13.1	52.7	71.8	28.5	19.2	51.5	7.5	10.3	5.0	55.8	30.5	37.7
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA029888, HPA029889, HPA029890"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.05e-4)"	3.2	3.6	3.5	5.4	3.7	4.3	5.8	5.4	3.9	4.9	2.8	4.6	5.9	4.8	5.1	6.0	3.8	4.7	2.8	2.9	4.3	3.7	7.2	3.6	7.5	3.5	3.0	5.6	6.7	3.3	2.7	5.8	3.6	5.1	6.1	4.4	5.4	3.3	1.4	8.1	7.1	3.6	2.1	9.4	5.2	6.0	4.1	5.6	6.5	2.4	7.1	4.4	4.7	6.3	4.4	5.7	8.5	5.2	7.7	5.0	10.7	4.1	3.4	6.9	6.3	4.2	5.6	11.2	5.0	3.9	3.8	6.9	4.7	5.2	7.6	6.7	2.1	10.7	10.0	6.4	4.4	5.9	10.3	4.5	5.5	8.2	4.5	5.5	3.9	3.8	17.5	9.5	5.0	7.3	2.0	6.5	8.4	14.6	6.6	13.1	2.8	3.5	4.0	5.5	3.0	5.6	6.0	8.5	7.0	5.9	3.6	11.2	5.0	4.7	4.5	4.3	4.6	8.8	9.2	4.1	5.0	12.7	4.4	11.0	6.0	9.4	6.1	4.4	6.1	8.3	5.5	5.9	5.5	8.4	5.5	6.8	4.6	5.9	6.8	2.7	4.1	4.1	3.5	3.7	5.4	3.9	2.9	4.3	3.5	3.0	3.6	2.1	4.1	6.3	5.3	0.0	8.9	2.6	11.2	5.2	2.9	7.6	14.8	3.6	7.3	5.6	2.2	2.8	9.1	5.5	2.1	11.5	7.9	6.9	1.9	5.1	3.5	6.0	4.9	5.9	1.2	17.9	2.3	3.0	4.4	3.5	6.1	6.9	2.5	7.8	3.3	3.4	2.9	1.7	2.7	4.3	6.1	3.3	4.4	2.7	3.1	3.7	7.2	2.8	4.6	3.2	6.2	6.0	4.3	2.2	6.0	1.9	5.7	2.8	9.0	3.0	4.6	2.7	0.0	4.0	5.6	14.5	10.2	7.9	6.5	27.8	7.8	4.8	5.1	2.1
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420511	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 400.2;esophagus: 572.4"	"Cell type enhanced"	"Detected in all"		"monocytes: 214.9;Squamous epithelial cells: 496.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1074.7;monocytes: 321.0"	"Cell line enhanced"	"Detected in all"		"A549: 1445.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		41000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	115.8	51.0	49.5	59.8	49.2	400.2	89.0	52.9	49.3	75.9	52.5	52.9	91.6	23.1	41.9	572.4	30.0	94.2	34.3	47.4	54.3	53.2	81.3	88.5	38.1	57.0	54.6	35.7	32.0	52.7	43.8	47.4	55.4	30.4	46.3	49.1	133.7	22.9	34.7	50.0	70.7	35.0	49.7	110.4	61.4	68.3	59.2	53.6	71.8	28.2	73.8	61.8	126.9	52.0	191.5	1445.2	319.3	340.6	445.4	274.0	71.8	124.8	185.9	144.4	195.3	219.2	190.4	163.5	151.0	109.2	202.4	148.0	225.6	192.1	96.4	127.5	199.9	227.8	264.3	452.1	136.3	390.9	249.7	196.5	92.2	229.4	55.5	186.9	344.0	223.0	305.3	145.7	183.5	202.5	321.4	179.4	194.7	221.0	109.1	252.7	298.1	312.2	199.6	105.5	178.0	154.1	99.1	153.5	137.5	196.7	173.3	308.5	369.3	81.1	149.6	98.3	134.5	111.6	256.0	323.5	175.1	393.9	73.6	1060.2	321.0	1074.7	23.2	137.7	26.5	33.1	21.4	20.8	144.6	23.3	21.1	22.3	332.6	19.7	105.6	98.7	23.1	225.0	49.5	49.2	52.9	49.3	47.4	54.3	57.0	54.6	55.4	49.7	59.2	52.0	7.4	19.2	35.0	11.8	24.9	13.0	30.8	78.0	70.6	7.8	30.4	18.5	11.0	50.1	73.2	20.2	18.8	134.6	29.8	24.3	52.8	52.1	10.9	17.8	18.6	22.6	23.4	55.7	8.6	40.3	40.7	37.5	41.8	24.5	25.9	53.9	16.1	66.2	134.6	1.7	12.6	30.2	59.0	163.8	30.9	13.4	17.1	150.9	17.8	4.7	214.9	16.5	10.3	13.6	9.0	38.7	26.7	10.5	41.9	43.5	66.6	55.1	46.2	20.2	19.7	23.4	21.5	41.5	38.4	496.0	16.6	81.3	19.4	27.3	51.7	76.1
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.5;thyroid gland: 52.5"	"Group enriched"	"Detected in many"	11	"Extravillous trophoblasts: 1604.4;Syncytiotrophoblasts: 2122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"BEWO: 422.4;HUVEC TERT2: 199.1"	"Low region specificity"	"Detected in all"							HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	No	No	20800		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	11.8	4.9	7.4	7.8	7.6	0.1	11.3	7.3	11.7	22.4	20.2	7.0	2.4	7.6	1.4	10.0	21.8	5.9	18.8	8.7	20.6	8.1	6.0	7.2	6.4	9.5	15.7	6.4	4.9	8.4	5.5	50.5	9.3	19.3	2.0	1.2	10.5	10.3	9.9	15.7	12.5	7.8	7.0	3.3	4.8	3.2	8.6	3.9	52.5	5.9	3.3	13.6	14.8	7.8	1.4	1.5	1.3	1.3	2.0	0.2	422.4	4.0	3.6	1.8	2.2	10.9	0.6	0.3	9.1	2.8	0.2	0.5	1.8	19.2	1.6	0.2	2.4	0.0	0.1	11.3	1.5	0.2	11.0	4.7	4.5	7.5	1.8	0.5	199.1	0.0	0.0	0.1	55.6	0.9	0.0	0.5	2.1	0.1	3.4	0.2	51.3	0.0	0.5	1.0	31.0	17.0	0.0	0.8	7.7	25.0	0.1	0.5	40.6	0.3	10.2	0.1	17.0	0.4	0.2	0.7	6.3	0.5	0.5	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	7.4	7.6	7.3	11.7	8.7	20.6	9.5	15.7	9.3	7.0	8.6	7.8	32.4	9.6	4.6	1.0	1.0	24.6	10.3	111.4	34.7	1.3	8.9	16.0	3.6	0.0	26.0	0.0	14.6	83.8	2.4	2.0	0.0	2.7	0.1	1.1	3.3	169.4	7.1	2.7	0.1	0.5	1604.4	30.8	1.1	0.8	6.3	0.2	5.3	0.3	37.4	0.0	0.2	2.1	18.3	0.6	8.9	0.8	13.1	2.1	21.4	0.0	0.0	1.9	0.0	0.0	0.2	0.5	1.2	19.5	0.2	3.2	0.6	1.1	12.1	7.8	105.2	7.1	86.4	0.2	6.8	8.1	19.6	2122.6	3.0	3.0	2.3	5.8
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262877	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	9.4	8.1	4.6	11.1	6.1	12.8	9.6	6.1	4.2	7.6	5.6	14.6	13.0	8.0	3.6	9.6	7.5	7.4	6.7	4.2	5.9	8.1	12.8	7.4	9.8	5.3	5.9	7.3	9.6	12.6	3.2	8.3	6.4	8.4	15.1	12.0	6.6	5.9	7.8	4.9	11.1	9.8	5.8	10.3	11.7	5.6	5.6	9.4	8.6	9.1	11.0	11.3	5.4	6.8	14.7	15.6	17.5	22.7	10.0	8.3	8.6	17.7	10.4	14.5	14.8	17.1	15.3	29.6	23.4	12.4	14.9	11.2	23.3	23.3	21.5	32.9	12.9	17.1	21.0	13.9	13.3	23.7	24.2	12.5	14.0	14.3	14.8	9.2	14.7	17.2	14.1	12.3	16.7	22.8	20.9	7.9	13.0	16.4	12.0	22.6	23.3	30.3	15.2	27.3	17.0	13.0	21.0	15.8	17.6	10.4	21.2	17.4	17.0	14.8	14.0	10.3	20.9	20.4	24.5	15.5	10.7	24.1	20.9	13.7	19.0	34.1	7.0	25.3	8.0	9.7	7.8	8.9	17.2	11.3	7.4	6.8	19.5	10.5	27.0	15.5	7.6	10.3	4.6	6.1	6.1	4.2	4.2	5.9	5.3	5.9	6.4	5.8	5.6	6.8	21.8	12.8	20.8	24.8	26.2	9.9	11.8	12.2	9.1	23.3	18.3	10.4	17.1	5.7	18.3	16.5	47.9	15.3	27.2	29.0	27.4	19.3	49.2	15.8	21.3	20.3	30.1	9.5	30.5	21.6	14.9	15.5	19.9	13.5	23.5	17.2	20.7	25.7	22.6	23.5	27.6	22.4	10.2	21.9	13.2	10.2	13.4	24.8	10.6	33.7	26.8	27.8	24.7	38.2	38.0	24.0	27.2	15.4	12.0	15.6	20.7	22.8	20.3	111.2	13.1	20.5	16.7	14.7	13.9	10.7	12.4	13.5	16.1	19.6	23.9	20.3
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129295	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 1126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	120.7	141.8	87.3	149.0	94.1	252.8	89.1	103.2	119.0	100.2	117.2	127.4	123.4	72.3	73.0	154.1	79.3	110.1	247.4	92.7	109.2	233.5	143.8	117.1	139.0	104.8	95.1	61.9	61.1	188.8	30.0	138.6	109.5	92.8	143.1	298.8	93.2	101.8	452.0	92.6	119.1	116.7	102.4	97.2	86.1	29.2	111.1	158.3	105.6	266.7	189.6	148.4	49.4	101.3	943.0	426.7	139.7	283.8	236.1	190.0	331.3	469.2	324.0	402.9	670.0	390.2	287.7	373.9	473.7	326.5	479.5	397.6	624.8	729.3	800.7	229.8	246.6	290.3	657.8	341.8	258.0	671.8	309.2	238.5	302.2	366.7	192.7	646.1	418.8	361.9	308.5	553.4	557.4	371.2	593.5	506.0	433.3	628.5	800.7	421.8	374.4	1157.0	423.8	385.4	208.0	286.6	486.3	409.0	422.9	352.6	214.8	347.9	340.2	428.1	294.3	433.4	329.0	609.5	1221.7	391.5	1207.0	750.5	286.6	170.6	360.2	321.1	121.9	382.0	135.9	128.4	144.3	132.9	333.7	101.2	130.9	140.7	281.9	140.3	527.0	130.2	168.4	606.0	87.3	94.1	103.2	119.0	92.7	109.2	104.8	95.1	109.5	102.4	111.1	101.3	166.3	150.6	168.6	20.2	174.8	144.3	272.2	1126.6	122.3	211.3	72.4	67.2	480.4	140.2	436.9	174.7	77.2	298.4	200.6	196.5	471.6	715.8	19.3	123.7	112.4	182.3	102.4	95.9	32.5	236.4	746.4	131.3	95.3	145.1	195.5	98.1	139.6	200.2	499.0	309.6	37.0	164.3	518.8	298.4	188.8	12.1	94.8	310.4	167.2	25.3	499.3	245.7	131.8	20.1	21.9	510.2	149.9	127.2	214.8	118.3	221.5	566.0	235.6	188.8	124.9	84.0	191.8	8.8	57.4	138.4	119.1	349.6	251.9	278.7	203.5	225.8
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785660-49787285	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	531	"testis: 199.9"	"Group enriched"	"Detected in some"	9	"Early spermatids: 1143.9;Late spermatids: 2784.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1143.9	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2784.5	14.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	204.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511636-17521288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	65.0	85.9	31.6	20.0	33.8	40.6	60.9	33.8	41.8	53.2	33.9	53.9	26.2	42.6	13.2	107.4	44.6	16.9	32.1	30.1	33.3	64.7	75.6	46.5	27.2	36.5	32.4	59.7	88.2	28.5	43.0	17.1	35.2	57.3	16.1	3.7	66.1	19.0	18.0	83.6	49.0	15.9	34.5	73.6	54.7	23.2	34.6	26.2	58.3	11.6	20.6	50.1	62.6	38.5	68.7	62.2	38.7	26.3	57.6	94.8	70.6	45.4	76.5	46.4	59.5	29.7	104.0	74.4	50.0	74.9	33.1	46.6	21.9	73.6	14.5	37.3	80.9	35.3	28.0	54.1	97.8	38.7	38.6	111.8	100.5	27.9	83.9	48.3	63.3	29.4	40.7	18.7	58.5	77.2	84.6	108.6	50.6	72.9	244.0	57.3	23.3	49.9	64.3	56.3	47.3	56.0	28.3	33.2	70.3	21.1	47.9	69.7	57.2	47.9	12.9	96.0	26.6	31.4	23.9	32.2	68.2	97.5	48.0	73.0	163.5	194.6	55.3	185.4	44.9	61.5	49.5	50.1	185.0	71.4	45.4	46.1	158.8	72.5	180.2	137.2	57.3	102.7	31.6	33.8	33.8	41.8	30.1	33.3	36.5	32.4	35.2	34.5	34.6	38.5	93.7	28.9	38.3	7.2	84.8	64.5	94.5	132.5	100.2	22.2	128.9	177.8	8.9	110.1	89.4	47.8	16.7	122.4	98.8	194.0	111.6	177.5	35.5	89.4	99.7	72.0	133.0	48.4	3.5	208.8	169.6	94.2	82.0	90.9	25.4	163.7	99.2	94.0	263.4	26.9	4.9	147.0	75.3	306.5	142.4	70.8	90.7	208.2	74.7	8.4	325.3	79.4	139.0	8.0	11.8	175.7	211.6	69.2	40.4	107.6	263.1	211.1	66.7	28.1	52.6	51.4	103.9	28.7	25.8	210.7	96.2	105.2	85.2	178.3	173.4	143.5
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023053	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 629.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.2;Excitatory neurons: 1.7;Inhibitory neurons: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Group enriched"	"Detected in some"	202	"eosinophil: 443.7;neutrophil: 494.6"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 494.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;HEK 293: 1.8;HeLa: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045702, HPA070227"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA		35000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Nucleoplasm, Cytosol"	"HPA045702: AB_10960204, HPA070227: "	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	1.5	0.3	0.3	1.8	1.1	629.4	0.3	3.4	1.5	0.1	0.0	0.3	0.6	0.2	0.0	0.5	0.6	0.2	1.7	0.6	0.0	0.8	2.5	8.7	0.5	0.0	0.1	0.1	0.5	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.5	0.0	0.3	1.0	0.7	0.1	0.0	42.5	0.4	1.0	0.0	3.3	0.5	2.3	0.0	0.4	0.2	0.0	0.3	3.1	0.5	0.3	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.2	0.8	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.8	1.8	0.3	1.7	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.3	0.0	0.2	0.2	0.9	0.2	0.0	1.2	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.7	0.6	0.3	0.4	0.7	0.0	0.2	0.4	443.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	494.6	0.0	2.3	0.0	0.1	3.9	0.3	1.1	3.4	1.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 258.8"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	258.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593411-63660245	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 1559.1;tongue: 788.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Supported	Cytosol		NA	NA		21000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	113.7	70.8	31.6	20.7	34.7	21.5	57.4	34.3	38.4	33.9	53.1	58.9	60.8	22.9	19.2	49.3	17.0	30.3	178.9	31.4	34.0	52.2	279.8	42.6	14.7	44.7	34.1	51.0	112.2	65.3	31.8	26.9	32.7	46.6	49.9	22.6	41.8	49.7	1559.1	30.6	55.1	41.4	31.9	14.7	30.6	11.1	36.5	14.3	27.5	788.0	19.4	38.4	22.1	30.2	113.4	47.0	17.3	57.0	111.0	81.4	138.6	45.7	61.8	48.9	79.0	38.8	51.3	35.8	93.2	71.2	107.4	26.5	24.0	96.3	55.9	44.0	32.1	75.3	72.6	40.3	91.6	66.8	4.3	103.4	60.7	57.1	88.5	129.8	29.6	36.3	0.1	46.3	78.8	6.9	19.6	36.7	78.3	3.4	73.9	26.8	80.0	11.8	70.0	35.3	10.4	66.7	100.0	103.0	157.4	78.6	32.4	25.2	3.1	71.6	36.0	64.0	39.4	29.1	45.5	57.8	117.0	58.0	31.5	46.0	33.2	49.2	40.5	22.4	32.7	22.4	23.5	31.0	48.4	11.8	21.0	24.7	38.7	43.9	21.2	13.9	20.4	35.4	31.6	34.7	34.3	38.4	31.4	34.0	44.7	34.1	32.7	31.9	36.5	30.2	8.4	93.0	29.4	48.3	16.9	17.8	29.0	58.8	47.8	9.2	33.8	21.8	139.2	48.6	24.2	16.5	10.4	76.6	14.2	81.8	88.0	55.9	32.0	8.2	12.1	12.7	13.1	5.7	17.9	238.4	185.9	37.0	27.0	13.5	5.1	134.3	15.0	214.4	24.6	0.0	26.3	47.5	20.3	17.0	10.8	8.5	22.1	13.5	26.6	4.7	32.8	75.8	29.9	32.2	9.8	70.5	31.6	38.0	40.4	29.2	90.2	74.8	17.0	11.4	13.1	53.4	25.5	5.6	10.1	57.3	18.2	58.8	19.0	20.2	81.5	19.0
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404052-49414901	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis, Host-virus interaction"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 473.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 749.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		360000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.58e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	81.6	88.4	39.2	23.3	42.2	19.8	77.4	44.2	49.8	55.3	54.0	104.5	52.6	68.0	34.1	88.6	55.7	26.9	147.0	40.6	44.4	143.4	120.4	59.0	27.0	43.9	42.5	59.7	62.5	70.1	51.1	33.1	44.1	67.2	60.0	12.1	135.9	44.7	138.1	67.5	68.0	35.7	40.9	61.1	79.7	33.5	41.9	26.2	61.5	98.5	26.8	75.2	59.4	46.0	86.0	339.1	46.4	96.9	81.9	48.3	111.8	69.8	72.3	175.1	122.4	749.5	80.2	119.2	88.1	60.0	67.3	63.4	151.7	135.3	128.4	72.9	327.1	77.7	122.8	361.8	53.0	109.6	58.1	54.9	125.9	130.9	41.6	45.7	87.6	68.6	112.7	27.6	77.5	224.0	106.0	118.5	99.9	135.9	311.1	74.9	144.0	103.8	144.0	116.1	122.1	75.9	35.4	59.1	113.7	71.7	112.2	33.4	58.9	96.3	124.7	78.4	98.4	35.3	65.7	59.1	58.0	125.6	110.7	11.7	45.9	13.4	61.6	53.4	80.5	61.2	56.6	56.3	62.3	46.7	59.4	59.7	8.9	69.0	59.5	155.1	61.4	79.8	39.2	42.2	44.2	49.8	40.6	44.4	43.9	42.5	44.1	40.9	41.9	46.0	88.5	48.1	46.8	8.8	78.3	117.5	147.5	182.6	70.0	44.8	135.7	180.0	8.4	100.1	101.9	84.6	37.5	230.2	144.4	220.8	406.9	233.1	14.0	93.4	85.5	92.6	131.9	77.2	7.8	158.6	278.7	87.8	74.9	131.0	73.0	124.6	61.4	101.8	228.1	21.9	10.0	281.7	223.8	51.9	87.9	24.7	89.5	70.9	158.3	1.9	120.3	83.1	88.6	11.1	15.3	162.8	139.8	115.1	93.0	242.8	151.4	473.6	68.0	42.1	52.6	72.8	306.5	18.0	47.3	107.6	124.0	152.4	75.9	159.9	337.2	161.9
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970780	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		77000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	134.3	166.6	75.6	95.2	75.6	149.4	138.7	76.7	81.3	152.2	78.8	162.3	149.8	134.0	122.6	168.7	137.0	80.3	157.0	72.9	75.1	112.7	233.4	88.0	141.9	74.8	75.2	244.3	199.5	130.9	76.3	84.9	75.8	114.0	145.4	48.2	138.1	97.8	303.5	150.6	127.4	102.3	75.5	113.6	141.8	36.1	77.5	144.5	103.4	231.1	162.8	135.8	125.4	75.9	270.5	261.1	214.1	295.8	170.6	295.0	469.2	183.6	245.6	329.7	259.8	420.5	283.0	567.8	78.8	187.4	200.6	225.0	395.9	337.5	267.2	306.9	316.1	296.4	146.3	409.2	284.1	488.8	212.4	307.2	229.2	208.0	452.5	331.8	331.4	157.0	270.1	127.1	238.5	277.2	449.0	452.9	813.3	236.8	224.7	307.4	338.3	356.7	270.0	312.8	111.7	372.9	152.2	434.9	503.8	440.1	67.6	379.3	191.8	141.5	227.4	115.2	402.2	128.1	166.3	586.7	186.7	251.0	207.6	78.5	88.3	43.8	84.2	107.2	103.8	102.8	96.2	98.1	138.5	98.1	85.0	85.1	35.4	117.8	94.8	129.0	123.6	114.2	75.6	75.6	76.7	81.3	72.9	75.1	74.8	75.2	75.8	75.5	77.5	75.9	114.1	48.1	54.8	14.7	155.0	74.4	106.8	110.1	191.8	42.9	155.1	230.8	45.1	91.5	62.1	35.0	39.6	212.9	99.8	104.6	115.4	134.1	2.8	68.2	124.8	86.0	100.6	143.7	10.0	162.3	282.2	97.7	100.4	88.0	63.5	177.2	92.1	172.5	163.0	18.5	11.4	142.7	77.3	125.0	70.4	7.2	97.3	105.0	72.9	8.4	131.0	87.3	102.0	12.5	12.9	119.8	90.3	68.8	145.9	99.4	197.3	142.4	40.1	46.8	72.3	109.1	128.7	33.3	57.0	245.3	76.3	170.1	102.9	218.5	268.5	113.4
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032325-22251310	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 45.3;Granulosa cells: 161.7"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	37	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HUVEC TERT2: 2.8;PC-3: 3.0;TIME: 3.1;U-87 MG: 6.5;WM-115: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (7.68e-2)"	0.0	0.0	1.0	0.5	1.0	0.0	0.7	1.8	0.7	0.9	0.4	0.3	0.5	2.0	0.1	0.2	0.1	0.9	0.0	0.8	2.2	0.1	0.0	2.7	1.5	1.6	1.6	1.6	0.0	0.0	0.2	0.1	1.9	0.6	0.0	0.3	0.2	0.4	0.0	0.1	0.6	1.5	1.8	0.4	0.0	0.1	1.3	0.3	1.0	0.3	0.9	0.2	0.3	2.1	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	3.7	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.3	0.7	0.7	2.1	0.1	2.8	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.6	0.0	0.4	0.1	0.1	0.1	0.2	1.5	0.5	0.4	1.8	0.0	3.1	0.6	0.1	0.4	0.5	0.0	0.0	0.0	6.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	1.0	1.0	1.8	0.7	0.8	2.2	1.6	1.6	1.9	1.8	1.3	2.1	0.0	0.0	0.0	3.9	0.8	0.0	5.8	2.3	0.0	0.4	3.0	1.8	0.5	0.0	1.6	0.0	0.0	0.2	45.3	0.7	0.0	0.9	0.4	1.3	1.4	0.2	0.0	0.0	2.2	1.2	0.1	2.9	0.0	1.8	0.0	161.7	0.0	0.0	0.0	16.8	1.9	0.5	4.1	0.0	0.4	0.3	1.8	1.2	1.8	0.0	0.0	0.6	0.0	1.5	0.5	0.8	0.0	0.0	0.3	1.8	8.2	0.9	4.5	0.5	0.0	2.1	2.6	0.1	0.4	0.1	0.1	0.8	0.4	18.9	0.4	3.3
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	35.0	31.9	0.3	4.6	0.2	11.2	37.6	0.2	1.1	65.8	0.4	49.6	5.9	51.8	18.1	19.4	57.8	4.2	41.6	0.3	0.2	38.2	22.8	41.1	6.3	0.6	0.2	89.6	41.5	2.1	76.6	1.8	0.3	49.9	2.3	6.1	32.8	4.2	42.2	25.5	38.6	2.6	0.3	47.3	39.7	70.2	0.3	5.5	58.4	13.1	10.3	49.1	40.6	0.6	1.4	2.0	4.5	2.8	1.9	1.1	10.3	3.1	4.8	2.5	2.6	2.8	1.3	0.5	2.0	7.4	25.9	0.4	0.9	1.6	0.6	1.8	0.9	4.3	3.6	1.2	0.3	2.5	20.0	2.2	2.0	4.6	4.0	3.3	1.5	1.4	1.7	3.6	1.9	1.1	0.8	1.5	1.9	0.4	1.4	1.8	0.6	1.5	0.3	1.9	2.9	3.3	1.6	1.6	2.6	1.0	1.2	3.0	3.0	4.5	1.2	2.7	3.4	2.9	4.5	8.3	3.3	2.6	2.7	0.2	0.2	1.0	0.7	0.2	2.1	0.6	1.6	1.9	0.3	0.9	1.6	0.9	1.5	0.7	0.2	0.1	0.6	0.7	0.3	0.2	0.2	1.1	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.6	32.9	19.2	24.8	19.2	70.5	33.9	89.0	26.8	34.1	74.4	36.0	37.1	19.6	15.7	20.5	23.9	37.5	16.9	53.3	16.7	35.2	13.1	153.8	14.9	15.3	29.9	12.0	3.8	19.1	17.9	16.3	32.6	15.3	20.3	69.2	21.4	33.2	7.6	11.8	45.4	30.3	16.0	34.6	14.1	43.1	88.6	43.2	20.9	37.4	13.1	11.4	34.7	27.8	26.2	18.0	17.9	14.5	41.0	54.8	59.0	29.6	22.9	22.1	73.6	78.9	28.9	42.3	80.9	51.2	15.9	24.0	37.5	71.4	19.1	10.1	75.1
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 198.5;Excitatory neurons: 93.4;Inhibitory neurons: 102.6;Late spermatids: 124.5;Spermatocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	5.8	8.0	7.8	6.5	7.7	18.7	3.9	15.5	8.5	5.1	18.9	4.8	3.5	5.0	7.2	2.5	10.5	6.9	5.6	7.4	9.2	8.6	8.1	8.1	5.6	7.7	7.7	3.0	6.8	11.5	12.1	6.8	9.1	4.3	4.9	14.2	4.0	5.1	4.6	1.8	4.1	6.6	6.2	8.6	6.7	30.4	8.0	3.3	4.7	2.9	6.3	6.3	3.0	7.3	28.5	14.7	40.5	21.5	20.1	18.0	9.4	25.6	34.0	22.3	36.4	16.0	22.3	8.1	35.3	17.8	16.6	15.3	15.6	10.2	25.7	33.8	15.5	19.6	30.0	18.5	16.4	24.4	26.7	15.0	2.7	29.9	6.6	32.3	41.9	0.0	12.0	36.1	27.4	41.9	0.3	23.6	32.4	10.6	21.3	25.5	60.8	16.3	35.9	12.3	27.7	26.0	28.7	13.9	16.1	20.9	5.6	19.6	44.4	17.5	23.8	32.6	25.2	48.9	53.5	14.8	43.0	20.8	48.6	1.4	1.2	2.5	1.3	0.7	1.1	1.7	1.6	1.6	2.1	0.7	0.0	1.2	2.8	2.2	0.9	1.5	2.9	0.9	7.8	7.7	15.5	8.5	7.4	9.2	7.7	7.7	9.1	6.2	8.0	7.3	12.5	6.4	10.5	34.3	16.7	2.4	6.8	7.9	6.8	30.1	8.7	6.0	8.5	14.3	10.0	5.5	54.2	19.9	22.9	4.7	9.8	12.6	198.5	51.7	18.7	19.7	19.2	12.0	93.4	20.9	10.1	10.8	15.8	9.6	21.5	13.6	10.0	9.0	12.6	28.6	102.6	3.1	18.3	13.4	19.2	124.5	8.1	18.0	5.4	21.5	11.0	6.6	18.6	25.1	13.6	19.6	1.2	9.1	31.0	8.3	1.4	5.9	58.7	43.9	0.0	13.5	12.2	130.8	41.3	6.1	1.7	26.4	23.1	16.9	4.6	7.7
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174902-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2267.8;lymphoid tissue: 2103.1;vagina: 1595.8"	"Group enriched"	"Detected in many"	10	"Basal respiratory cells: 5354.5;Club cells: 2170.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Group enriched"	"Detected in some"	22	"cerebral cortex: 12.0;pons: 7.3;thalamus: 19.0"	"Immune cell enriched"	"Detected in some"	1021	"neutrophil: 1763.3"	"Lineage enriched"	"Detected in single"	4377	"granulocytes: 1763.3"	"Group enriched"	"Detected in many"	5	"EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		1400000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	6.1	0.7	0.2	101.9	0.5	1.8	8.8	0.2	12.0	180.1	1.2	124.3	1.9	2.3	1.1	2267.8	4.8	56.6	1.7	0.2	0.4	1.5	3.3	32.5	0.4	0.3	0.3	0.7	1.6	0.2	2.8	1.1	7.3	11.7	43.3	0.0	460.8	3.5	0.6	78.6	42.3	7.5	0.3	20.0	9.0	0.5	19.0	90.6	0.8	1.9	2103.1	44.7	1595.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.4	0.0	3.1	2.1	1.4	89.3	0.0	1.1	109.8	0.0	23.2	0.1	1.2	0.0	0.5	6.3	0.9	0.0	0.7	0.0	0.0	21.7	17.8	1.9	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.1	0.2	103.7	189.9	0.0	1.0	0.0	21.9	0.4	0.0	0.0	15.7	2.1	0.1	0.0	0.0	0.0	0.8	1.0	10.9	0.3	0.9	0.3	1.8	0.4	14.3	0.7	0.1	0.3	0.4	1.7	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1763.3	0.0	0.1	0.1	0.1	0.6	0.2	0.5	0.2	12.0	0.2	0.4	0.3	0.3	7.3	0.3	19.0	0.3	0.1	0.0	8.6	0.0	7.4	0.1	4.7	5354.5	0.0	0.0	39.4	8.4	0.2	8.6	2170.2	18.4	0.0	0.2	0.5	375.4	0.0	46.6	0.1	3.7	0.7	3.0	16.6	0.0	0.0	317.3	0.0	0.8	2.6	6.9	4.5	0.0	0.0	0.0	0.1	0.0	0.0	31.8	197.4	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.8	219.6	0.0	0.2	29.1	33.9	0.2	152.9	0.0	0.0	0.0	50.5	0.0	0.0	36.2	3.8	0.0	2.5	0.1	154.1	150.4
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 209.1;Inhibitory neurons: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	18.8	21.6	45.2	19.2	61.0	24.1	16.8	2.1	74.4	20.4	9.6	23.7	15.8	24.2	9.9	14.3	19.5	13.5	21.5	65.3	9.0	21.3	25.2	19.1	20.5	14.6	4.8	21.4	18.7	34.5	25.2	17.9	14.5	19.5	14.9	27.7	16.5	16.9	23.6	15.1	22.9	21.9	0.0	21.0	26.0	25.7	8.6	34.3	18.0	15.9	18.0	22.2	16.9	43.3	24.5	20.2	17.4	26.3	48.7	29.1	24.9	21.6	32.6	31.3	30.4	15.9	10.2	45.6	12.6	43.9	30.7	21.1	33.4	20.9	19.0	38.9	50.9	47.1	27.1	18.3	24.3	47.0	36.1	26.2	12.9	26.7	14.7	20.4	25.8	13.8	130.2	37.6	24.6	33.8	41.6	16.0	13.8	43.4	20.6	41.1	38.1	8.5	17.3	38.3	42.6	31.0	28.4	32.6	22.6	24.3	27.6	21.3	26.2	56.4	29.1	21.1	18.5	28.6	31.3	35.8	37.4	33.2	24.1	2.1	3.7	5.3	3.2	3.8	3.1	3.4	3.6	3.9	2.5	3.4	3.6	5.0	5.1	7.0	3.3	8.5	4.3	2.2	45.2	61.0	2.1	74.4	65.3	9.0	14.6	4.8	14.5	0.0	8.6	43.3	13.0	12.8	30.4	65.6	14.7	10.1	6.5	7.6	9.6	35.8	17.2	14.4	30.2	20.0	10.5	7.3	47.9	17.8	21.5	19.7	1.9	9.7	36.5	10.3	17.9	15.5	19.2	12.4	209.1	6.3	19.6	15.6	38.7	15.8	12.0	13.8	11.4	19.7	20.1	37.0	127.4	16.7	10.2	21.0	12.6	25.3	19.9	20.2	10.6	39.4	10.9	23.1	16.5	50.3	88.4	8.9	9.7	24.0	15.5	10.1	23.8	10.3	9.6	25.4	26.3	14.5	19.3	35.3	29.6	14.1	9.8	20.0	15.3	26.1	14.3	8.9
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782133-73016461	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 334.5;Oligodendrocyte precursor cells: 143.7;Oligodendrocytes: 138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite"		"HPA052269: AB_2681779, HPA066120: AB_2685621"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	7.6	9.1	5.2	6.7	5.5	10.2	12.2	7.4	7.3	11.5	9.8	7.4	7.0	11.5	10.7	7.1	11.0	8.4	7.5	4.6	4.8	8.3	9.8	8.7	9.9	5.1	5.0	12.6	5.5	8.5	7.5	9.7	4.7	9.8	8.8	10.2	7.4	8.2	6.6	8.5	6.9	8.5	4.7	8.4	8.7	14.3	5.0	13.0	15.5	7.4	8.4	10.1	8.0	6.0	13.1	4.2	16.8	9.8	14.4	25.3	6.5	11.9	15.9	11.8	14.4	5.8	22.1	12.0	13.7	13.2	6.2	11.1	9.1	12.0	18.9	12.2	8.7	8.2	10.9	6.7	18.4	31.0	7.5	16.4	9.4	12.7	30.7	15.1	15.5	8.2	11.7	6.1	15.9	3.7	15.2	18.6	8.9	23.3	3.9	12.0	12.4	12.4	24.5	7.0	9.6	15.4	9.2	6.3	16.3	13.5	10.6	21.8	11.8	6.0	6.3	9.5	7.2	9.7	7.5	6.0	18.0	17.3	13.3	8.4	3.4	6.1	6.0	3.7	6.4	5.9	6.4	6.5	3.0	5.6	8.7	7.3	3.3	8.6	3.6	5.1	5.3	2.5	5.2	5.5	7.4	7.3	4.6	4.8	5.1	5.0	4.7	4.7	5.0	6.0	33.8	32.1	30.8	101.2	21.6	10.3	16.3	10.5	16.5	17.1	15.5	17.8	28.1	14.3	27.7	5.5	16.7	9.4	19.3	6.6	13.7	11.6	334.5	41.5	33.6	20.0	7.2	15.2	115.1	11.1	10.2	20.4	21.4	18.5	24.1	21.8	9.7	5.6	7.1	18.5	119.3	9.7	12.2	8.6	3.5	50.4	19.3	10.3	8.8	92.8	9.8	11.9	17.5	143.7	138.6	12.0	8.5	15.4	11.6	11.8	7.1	6.5	46.3	31.3	13.1	28.9	17.9	59.4	39.2	11.8	8.9	6.0	23.1	25.6	10.0	13.7
PIGH	GPI-H	ENSG00000100564	"Phosphatidylinositol glycan anchor biosynthesis class H"	Q14442	14	67581955-67600286	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Autism spectrum disorder, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031624	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA031624: AB_10601046"	"unprognostic (1.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.69e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.68e-7)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.73e-1)"	15.4	34.2	19.9	8.2	23.6	27.2	19.2	23.4	26.4	25.9	22.5	14.2	12.6	14.0	36.6	14.0	15.5	13.6	15.1	19.4	23.4	34.7	23.9	13.7	11.9	23.9	22.4	23.8	29.2	66.7	13.6	12.5	23.9	28.9	11.6	47.6	26.2	16.0	32.2	19.9	16.1	10.9	22.6	16.5	19.6	20.7	22.7	11.8	28.8	24.7	13.3	16.4	14.4	27.4	24.5	15.6	14.7	30.3	32.1	12.3	12.4	13.3	16.1	18.2	17.7	25.4	8.3	16.5	12.9	9.1	30.4	17.5	26.3	18.9	20.1	25.4	34.8	17.3	12.4	26.1	25.2	12.8	19.9	17.9	23.8	13.7	21.0	5.6	11.8	28.5	39.7	11.5	13.3	21.4	18.8	21.4	2.7	33.8	41.9	6.3	14.8	9.9	19.6	20.0	18.3	22.1	10.1	19.4	33.8	10.8	22.0	12.5	6.1	18.1	23.2	23.8	15.8	21.9	15.2	11.2	13.9	27.1	25.7	42.0	24.8	52.5	44.9	35.1	58.5	61.8	46.5	41.8	25.4	72.0	48.3	45.0	12.1	51.5	45.7	29.6	48.2	35.0	19.9	23.6	23.4	26.4	19.4	23.4	23.9	22.4	23.9	22.6	22.7	27.4	14.8	3.2	14.1	5.5	23.6	20.6	20.4	37.1	19.4	35.5	22.8	25.9	4.9	22.8	17.8	22.0	35.5	29.8	28.7	9.5	29.4	22.3	12.1	20.3	10.5	16.1	7.2	13.2	8.0	37.1	28.7	20.8	9.2	10.9	7.0	13.4	13.9	14.6	22.7	26.9	10.4	14.9	26.4	7.6	12.9	9.4	21.5	12.3	35.6	7.5	7.0	96.6	23.7	8.5	10.3	24.3	10.6	21.1	31.2	26.8	29.4	31.3	12.2	45.5	0.0	22.7	18.7	78.8	59.5	17.7	20.9	56.4	20.7	34.6	14.1	18.2
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928522-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2641.0;salivary gland: 1645.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7090.1;Intestinal goblet cells: 2361.1;Paneth cells: 3208.3;Proximal enterocytes: 1558.6;Undifferentiated cells: 4954.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Secreted to digestive system"	NA	NA		1300000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favorable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	2.4	0.5	0.4	187.3	0.2	0.3	131.0	0.5	0.4	547.0	0.2	1693.4	2641.0	20.5	0.2	12.4	3.6	455.0	0.5	0.4	0.2	108.9	34.5	101.6	1.7	0.2	0.2	0.6	13.3	0.1	1.3	0.3	0.4	13.6	1222.6	0.1	1645.1	5.3	0.3	0.6	809.8	39.1	0.1	0.8	414.6	0.3	0.6	0.4	0.2	0.0	0.6	80.3	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	36.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	1.9	0.3	0.0	0.0	0.2	0.0	6.9	0.2	1.7	0.8	2.5	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.3	0.6	0.3	0.4	1.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.8	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.5	0.4	0.4	0.2	0.2	0.2	0.4	0.1	0.6	0.6	2.1	93.0	604.3	0.0	22.1	0.3	4.0	106.6	0.0	0.0	392.4	192.0	1.4	876.4	638.4	108.5	0.0	0.1	2.5	7090.1	17.6	92.5	0.0	65.9	14.6	5.4	426.4	2.7	0.0	64.5	0.0	4.7	482.1	120.1	52.0	0.0	1.8	28.0	0.4	0.0	0.0	2361.1	59.0	2.2	1.1	0.0	0.0	5.7	1.8	0.0	0.6	0.0	0.0	0.0	0.0	221.5	3208.3	0.0	0.7	53.9	1558.6	328.4	415.4	0.0	0.0	0.0	21.0	0.0	0.0	6.9	0.0	0.0	15.6	0.1	4954.6	761.3
PIGS		ENSG00000087111	"Phosphatidylinositol glycan anchor biosynthesis class S"	Q96S52	17	28553383-28571794	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018149	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA018149: AB_1855373"	"unprognostic (2.29e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.65e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (5.31e-4)"	25.0	15.5	8.3	15.5	8.5	25.3	11.4	8.2	8.6	12.9	18.6	25.5	30.9	12.0	3.3	23.5	20.1	15.6	25.4	10.5	9.1	16.6	4.9	20.2	18.9	8.8	9.4	13.3	16.8	28.5	3.3	17.4	8.8	17.7	15.7	3.4	14.8	16.2	31.4	18.5	32.2	16.1	7.8	18.2	26.9	13.4	8.7	17.5	24.3	19.7	13.7	17.7	5.3	8.0	34.7	57.4	26.5	67.9	51.1	38.2	40.1	42.3	34.5	44.4	58.1	60.4	33.8	22.3	62.9	57.8	43.1	64.5	32.4	48.2	16.6	65.8	92.5	30.1	45.3	26.2	47.8	58.5	73.8	46.7	33.6	27.8	37.8	44.5	60.3	37.8	89.3	34.1	38.5	42.6	36.9	40.2	13.2	77.9	17.6	31.2	87.8	73.6	30.6	36.9	54.3	37.7	60.3	115.4	32.8	26.4	105.4	69.5	52.2	31.5	32.5	27.1	35.0	56.5	84.0	17.0	56.6	56.8	45.1	86.2	60.4	78.9	34.3	55.0	31.0	23.5	27.5	32.5	64.9	22.3	28.8	24.0	29.4	43.0	39.6	49.8	45.2	46.3	8.3	8.5	8.2	8.6	10.5	9.1	8.8	9.4	8.8	7.8	8.7	8.0	15.7	44.8	21.4	10.7	15.9	8.3	11.3	21.1	13.6	20.5	20.5	17.1	40.7	20.0	18.8	46.0	64.6	35.0	31.6	48.5	11.7	43.5	9.5	15.3	15.7	18.7	40.7	17.9	10.9	26.3	53.4	14.9	18.3	21.5	3.8	17.1	26.4	7.9	31.1	52.2	12.6	28.3	24.4	28.1	8.0	13.1	23.9	22.9	7.2	1.9	66.1	17.5	93.7	9.0	11.7	22.5	21.6	22.6	16.8	15.0	49.0	19.1	14.4	56.1	6.6	12.3	15.9	74.2	62.0	19.3	12.5	36.4	21.8	25.0	27.6	12.4
PIGT		ENSG00000124155	"Phosphatidylinositol glycan anchor biosynthesis class T"	Q969N2	20	45416084-45456934	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.06e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.18e-3)"	"unprognostic (6.68e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (5.48e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-2)"	57.4	51.9	30.7	39.4	38.9	70.8	52.7	41.2	37.5	65.5	44.6	75.8	49.9	69.6	89.5	37.7	61.2	48.3	113.5	29.9	37.2	47.1	48.9	45.3	26.6	41.0	38.1	46.1	65.0	105.4	48.9	48.5	38.9	39.5	77.2	13.0	48.2	55.6	61.2	46.0	54.3	69.7	37.6	36.5	62.1	38.1	38.8	25.8	57.0	51.8	27.4	57.0	42.8	47.6	79.0	95.3	35.8	138.7	218.0	152.9	68.5	90.4	172.8	126.8	99.7	179.9	123.6	47.1	122.0	142.9	108.4	152.4	43.6	124.8	67.8	25.2	53.5	49.0	80.8	100.9	99.9	93.5	203.1	117.3	117.0	99.9	108.6	179.4	109.3	39.2	65.0	163.8	107.4	165.3	44.8	74.7	29.4	227.5	162.1	38.0	107.6	168.0	102.5	51.1	60.2	77.0	177.7	173.2	88.7	61.4	150.6	169.8	96.5	301.4	138.1	57.1	128.8	93.9	144.0	30.0	190.7	74.7	140.9	58.9	77.9	66.3	57.4	83.2	43.6	27.2	41.0	53.8	92.2	28.1	35.7	41.8	30.7	57.6	79.2	71.4	61.6	83.1	30.7	38.9	41.2	37.5	29.9	37.2	41.0	38.1	38.9	37.6	38.8	47.6	41.9	41.7	29.5	9.1	43.9	30.0	46.4	86.8	13.6	21.0	43.7	31.4	169.2	41.5	63.7	44.1	14.6	62.1	58.9	106.1	13.7	107.5	31.8	45.2	32.3	46.0	65.5	24.2	7.6	114.5	73.9	94.2	44.9	59.2	33.6	58.5	39.7	41.5	76.8	38.7	9.8	145.3	85.5	49.6	42.6	81.4	60.6	44.3	88.9	4.7	39.8	25.8	37.0	6.0	27.1	79.5	61.8	56.1	69.2	40.7	103.8	26.1	46.2	15.6	65.7	39.4	47.2	88.4	96.9	23.5	27.8	52.1	43.4	47.9	111.6	57.7
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 70.3;RT4: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.0	3.6	10.4	15.2	23.6	5.0	9.7	8.5	23.3	7.4	0.0	15.8	14.4	8.4	4.8	12.9	6.5	8.0	10.6	11.2	18.8	10.2	4.9	17.2	23.4	19.2	20.4	3.0	5.2	3.2	3.3	12.8	17.1	6.2	12.9	2.9	7.2	5.4	20.9	21.2	14.9	9.9	7.3	13.6	18.9	1.9	28.0	22.3	8.1	10.8	22.1	10.9	10.7	44.2	7.5	14.8	12.9	11.9	7.4	0.6	70.3	0.9	2.9	2.8	2.1	8.8	19.2	12.7	2.7	1.7	2.5	18.3	7.7	5.2	1.1	7.7	2.1	0.3	30.1	3.3	0.4	4.5	9.3	0.9	5.4	0.7	0.4	1.1	19.1	12.6	4.7	8.3	0.2	16.7	15.4	12.8	11.8	29.3	9.3	16.6	3.3	2.4	3.5	75.6	14.1	7.8	26.0	35.9	8.4	4.7	16.1	2.4	0.7	0.4	4.5	1.3	0.2	8.9	2.6	16.4	0.5	6.7	1.9	0.0	0.1	0.0	0.5	0.0	0.5	1.5	0.6	0.4	0.1	3.2	0.3	0.3	0.2	0.8	0.0	0.0	1.2	0.2	10.4	23.6	8.5	23.3	11.2	18.8	19.2	20.4	17.1	7.3	28.0	44.2	26.7	0.0	12.2	16.0	15.3	3.8	2.1	7.9	1.2	16.6	5.3	4.4	6.9	5.7	6.9	3.7	0.0	4.4	3.3	29.2	0.0	1.8	0.6	2.0	2.5	26.1	9.6	0.0	14.3	3.4	4.4	4.5	28.5	2.4	32.4	8.5	31.1	5.5	4.2	15.2	22.8	23.8	2.0	1.6	5.1	0.7	1.2	2.9	3.6	27.2	2.3	2.7	4.1	23.6	111.5	4.7	14.5	7.5	4.9	2.4	14.6	2.1	9.1	1.0	0.0	7.7	3.3	0.1	1.5	8.1	8.0	2.2	5.0	9.4	15.5	13.8
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18242961-18648416	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;stomach 1: 21.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 44.9;Breast glandular cells: 30.4;Breast myoepithelial cells: 37.6;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 140.6"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.2;HaCaT: 2.1;hTERT-HME1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.0	0.6	0.4	0.0	0.1	0.1	9.7	0.3	0.4	0.2	0.1	0.1	0.5	0.1	16.7	2.4	1.2	6.3	0.0	0.1	0.7	4.6	12.0	0.3	0.1	0.1	0.2	0.0	1.4	4.8	0.0	0.0	0.1	0.9	0.2	0.1	3.7	9.4	0.0	9.7	3.3	0.0	0.3	0.1	21.7	0.4	0.4	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.4	0.1	0.7	0.1	0.2	0.1	0.3	0.4	0.3	1.1	0.0	0.0	1.3	0.7	17.5	8.5	0.3	44.9	0.0	30.4	37.6	0.3	27.1	0.8	40.5	0.0	1.2	0.4	0.2	1.9	2.0	9.0	4.5	1.5	1.2	0.0	2.7	2.9	0.0	4.8	0.4	140.6	10.1	0.0	0.0	0.7	27.4	0.2	0.0	1.8	2.3	0.0	0.8	1.1	1.8	0.0	0.5	1.8	7.5	0.0	0.0	0.0	1.5	1.4	0.8	5.1	0.0	1.3	0.8	18.4	1.3	0.1	0.0	0.0	0.1	0.5	2.4	3.0	27.3	21.5	0.8	1.0	0.0	3.0	1.6
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3IP1	"HGFL, MGC17330, TrIP"	ENSG00000100100	"Phosphoinositide-3-kinase interacting protein 1"	Q96FE7	22	31281594-31292534	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"T-cells: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 499.2"	"Lineage enriched"	"Detected in all"	6	"T-cells: 499.2"	"Cell line enhanced"	"Detected in many"		"RT4: 24.1;SK-BR-3: 26.1;U-698: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes		6800000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.02e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.65e-3)"	"unprognostic (4.42e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (3.80e-4)"	51.2	41.7	35.4	59.3	42.5	41.7	39.5	38.3	40.2	21.4	23.7	35.5	17.5	34.9	13.2	21.7	24.1	27.0	34.8	33.4	39.3	27.6	9.3	45.7	109.8	53.5	40.4	22.8	11.3	16.9	15.1	25.3	48.5	27.1	15.5	11.4	52.4	31.7	20.9	58.2	61.6	22.9	43.8	71.3	24.7	20.3	42.4	68.2	37.6	16.1	79.7	34.8	27.1	52.7	0.5	0.2	0.8	0.1	11.8	20.4	0.9	3.1	9.7	0.2	1.1	0.3	20.4	15.9	11.4	4.9	1.3	13.4	0.1	5.8	0.2	2.6	1.9	0.5	2.3	2.2	4.0	1.1	0.7	20.0	8.3	0.2	0.1	18.9	6.4	2.3	0.9	19.6	1.5	1.3	0.1	2.5	0.9	1.8	0.4	1.2	0.8	11.9	5.1	24.1	1.2	2.6	1.0	26.1	1.2	10.7	2.1	2.3	20.0	0.0	4.5	0.2	0.0	8.9	4.1	34.7	0.5	2.8	0.4	46.0	18.4	16.5	79.7	22.8	95.5	38.2	207.1	113.7	5.9	79.3	499.2	318.3	7.6	59.2	34.2	2.6	257.0	214.7	35.4	42.5	38.3	40.2	33.4	39.3	53.5	40.4	48.5	43.8	42.4	52.7	26.1	44.8	12.3	17.6	63.7	10.3	19.0	44.6	5.7	29.9	15.5	11.3	11.3	10.0	36.9	31.3	10.4	30.7	89.8	8.3	1.9	50.2	1.6	10.6	10.3	20.9	8.4	12.0	6.5	10.5	3.7	23.8	10.7	24.4	30.4	10.1	32.9	2.0	45.1	6.7	8.6	13.1	32.6	42.5	11.4	3.8	24.5	40.3	12.4	9.4	19.2	82.0	74.2	9.5	25.1	51.7	8.6	30.9	33.1	23.4	19.8	7.9	25.1	9.2	6.6	10.2	14.6	16.5	32.3	4.9	11.5	12.3	143.6	27.4	10.1	60.0
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215756-68301821	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 410.2;Endometrial stromal cells: 479.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 265.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	60.6	27.3	13.6	27.8	33.3	126.4	92.1	12.5	40.8	51.2	0.6	38.2	17.2	65.8	45.0	43.2	69.0	35.0	72.3	29.9	13.0	35.9	100.8	26.7	28.5	11.2	22.1	53.3	13.4	40.2	7.3	32.4	12.0	26.7	22.2	59.9	64.5	31.9	63.5	28.7	24.5	74.8	9.9	38.1	18.3	8.6	20.3	46.5	20.6	33.9	23.7	27.0	31.7	36.0	4.3	8.2	23.8	71.4	265.5	76.9	10.4	23.2	10.6	8.8	9.4	20.4	7.4	21.8	38.5	32.0	4.3	10.2	6.7	46.9	11.0	90.6	8.9	26.1	6.5	17.0	89.2	27.0	20.1	81.9	104.2	16.1	83.6	4.1	11.7	25.0	4.1	16.1	8.1	11.3	65.7	10.5	6.9	14.7	4.3	61.1	11.3	17.0	11.5	47.9	4.7	21.3	4.0	6.3	15.0	13.7	34.3	19.0	14.0	10.3	10.4	17.3	14.8	18.0	29.2	25.2	11.1	32.9	7.8	22.0	1.7	8.8	11.5	2.4	16.6	1.7	14.9	11.1	3.0	3.9	18.6	14.1	2.2	11.7	6.5	1.2	12.3	5.5	13.6	33.3	12.5	40.8	29.9	13.0	11.2	22.1	12.0	9.9	20.3	36.0	47.7	51.3	24.8	112.3	47.7	14.4	23.5	30.8	175.2	46.0	61.4	168.4	263.0	38.6	19.3	5.5	25.0	13.4	410.2	28.4	72.4	15.8	12.6	38.7	479.9	39.0	9.6	43.5	232.8	9.5	18.5	151.0	43.8	93.2	68.9	110.4	31.1	198.3	30.7	48.8	82.7	32.6	28.5	69.2	24.7	11.9	172.1	68.8	33.8	117.1	37.6	194.1	137.0	281.5	199.9	12.3	19.8	122.2	173.2	8.4	24.3	39.1	8.7	89.4	19.7	127.2	76.5	1.7	4.5	37.2	10.2	10.0	309.9	45.4	36.5	8.1
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153163-18170532	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 14.4;Undifferentiated cells: 16.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA069291	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA069291: AB_2686109"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	7.2	25.6	26.2	6.9	22.9	9.7	7.6	1.1	41.5	17.6	2.0	13.4	20.5	17.5	12.0	26.0	16.7	12.3	12.8	41.0	6.7	9.5	10.5	9.1	5.2	4.4	7.1	21.5	11.0	20.8	21.5	8.7	4.9	15.5	9.6	7.9	15.0	10.4	12.4	26.3	16.7	9.8	4.7	8.7	15.1	11.5	9.4	11.6	10.5	9.9	6.2	15.3	15.3	16.4	39.1	18.0	25.4	36.8	35.3	36.6	40.5	29.4	38.3	21.6	16.6	18.3	20.4	28.0	48.8	41.9	17.5	28.7	15.6	33.2	11.3	25.0	65.5	10.8	21.3	44.0	29.7	24.6	13.4	45.7	36.4	15.0	21.5	36.8	6.6	11.9	33.6	10.8	30.3	57.0	21.5	17.0	32.9	35.8	48.5	19.6	33.4	23.5	37.7	22.8	63.0	68.0	27.1	28.5	28.9	16.0	19.1	15.8	11.4	40.9	20.8	49.2	27.5	22.9	26.4	10.9	33.9	39.4	26.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.2	22.9	1.1	41.5	41.0	6.7	4.4	7.1	4.9	4.7	9.4	16.4	1.0	6.4	1.1	7.2	0.8	1.9	1.3	1.0	1.8	6.3	3.6	3.2	1.5	2.8	1.0	3.7	4.2	1.7	0.8	6.9	0.0	6.0	0.3	1.3	1.7	0.8	6.1	7.4	11.7	6.2	2.9	1.7	1.1	0.8	2.5	1.4	1.4	1.3	2.2	10.1	11.2	10.5	0.0	4.7	1.0	0.0	1.8	1.7	0.0	3.7	1.6	5.7	0.0	10.6	9.2	6.4	7.0	1.9	0.9	1.1	14.4	1.1	0.5	4.3	0.0	1.4	1.4	0.5	2.1	1.3	2.3	1.2	0.9	3.2	16.4	0.6
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960768-49964072	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 163.3;SK-BR-3: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	97.8	48.4	25.9	31.3	31.3	114.3	80.2	32.8	38.1	49.2	26.9	55.1	23.8	40.8	12.7	80.8	54.0	25.8	68.7	25.2	32.6	113.3	92.9	107.1	28.2	40.6	36.1	35.7	73.1	21.6	51.3	21.3	38.0	87.3	10.4	3.1	93.5	22.6	112.0	116.4	51.6	9.9	30.3	80.7	118.1	33.9	35.2	19.0	54.9	35.0	13.0	71.0	68.6	39.9	26.8	17.7	11.6	21.9	9.0	6.7	65.5	16.5	26.7	19.4	14.0	29.5	22.3	47.3	20.1	4.6	39.1	22.5	22.3	12.6	6.9	35.8	92.1	19.5	46.3	36.0	41.8	42.5	36.0	12.8	41.0	11.9	20.2	10.5	63.5	31.7	27.0	163.3	5.9	60.6	21.7	76.4	24.2	28.1	27.8	100.3	19.2	57.6	10.6	20.3	41.1	28.6	32.2	144.7	109.2	10.7	19.0	56.4	16.8	12.1	51.5	19.8	27.1	82.2	56.9	41.4	30.1	24.1	33.2	0.0	4.0	0.1	2.2	4.1	2.5	4.3	5.0	4.4	3.1	7.5	4.8	1.9	20.7	1.7	5.2	7.0	5.8	2.7	25.9	31.3	32.8	38.1	25.2	32.6	40.6	36.1	38.0	30.3	35.2	39.9	120.2	64.1	85.9	6.5	107.7	227.3	236.8	79.1	96.8	31.5	99.2	67.3	32.8	121.5	72.8	80.9	2.1	56.9	79.5	57.9	84.1	50.9	5.1	114.2	76.3	167.7	97.7	10.8	10.2	54.5	346.5	69.0	202.3	170.5	69.3	16.8	98.6	45.9	69.7	62.2	6.7	101.7	81.4	41.1	408.4	4.8	32.3	134.8	108.5	6.5	35.8	14.0	11.3	6.6	20.5	71.0	94.6	11.3	95.1	298.4	58.1	88.5	40.9	16.5	26.3	39.4	57.3	26.1	37.7	95.3	204.7	389.9	90.4	11.6	79.0	266.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139739	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"salivary gland: 16791.8"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 1117.6;Breast myoepithelial cells: 324.2;Melanocytes: 403.8"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	333	"T-47d: 703.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"	NA	NA		66000000	"Cluster 37: B-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	9.1	3.6	0.7	0.2	4.8	0.1	3458.7	2.7	2.7	5.6	0.0	0.5	0.0	0.1	2.7	1.3	4.2	0.1	4.8	0.9	4.6	0.5	2.0	6.4	0.8	8.5	4.4	3.8	21.1	0.4	1.9	2.3	6.8	33.3	0.0	0.0	16791.8	3140.5	1.7	189.7	0.6	0.0	3.5	0.6	0.6	0.7	4.6	0.3	0.7	0.0	1.8	0.6	1.5	11.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	703.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.8	2.7	2.7	0.9	4.6	8.5	4.4	6.8	3.5	4.6	11.5	6.9	0.0	2.0	0.0	3.6	10.8	6.6	18.8	0.0	0.0	1117.6	324.2	0.1	0.0	48.2	1.8	0.0	0.0	7.0	0.0	0.0	9.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.5	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.4	0.0	1.6	0.0	0.0	1.5	403.8	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	0.0	13.1	0.0	0.1	147.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.7	0.0	2.5	0.0	0.0	13.7
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534854-22714578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 498.1"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1585.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		4900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	28.4	15.5	162.5	47.8	329.4	44.8	15.0	239.0	239.9	26.5	49.8	17.8	13.2	21.1	11.8	19.8	15.2	32.9	13.5	169.7	193.6	16.5	18.6	25.9	81.2	260.6	273.4	8.8	10.9	24.8	8.5	23.7	271.7	9.3	19.1	15.3	7.8	13.0	5.1	8.3	20.6	31.5	171.8	62.6	19.3	12.5	233.3	60.4	12.8	10.9	88.5	24.1	10.5	498.1	30.2	29.2	33.4	10.8	52.3	70.6	25.3	55.0	58.1	29.1	35.7	27.6	47.2	63.2	19.4	111.0	63.7	10.4	29.2	15.4	29.2	140.5	30.4	118.7	21.6	60.9	92.5	23.1	89.1	35.6	13.7	39.7	38.2	44.6	43.7	83.5	67.4	119.1	54.5	12.5	92.3	20.5	13.7	14.5	20.7	36.9	47.8	86.3	43.0	5.8	6.1	13.9	17.7	9.0	86.4	37.6	7.6	39.1	53.0	22.3	32.8	41.7	33.9	75.1	46.3	45.0	60.5	68.3	17.6	72.6	32.6	104.0	119.5	57.9	164.0	52.1	94.2	139.9	43.7	33.1	62.8	118.2	40.5	144.2	67.3	44.8	75.9	183.4	162.5	329.4	239.0	239.9	169.7	193.6	260.6	273.4	271.7	171.8	233.3	498.1	22.5	3.2	6.7	84.9	43.2	17.6	4.0	2.0	3.4	5.7	12.9	5.5	8.1	14.3	5.6	18.4	2.1	8.6	196.9	3.4	11.7	9.7	22.9	7.4	15.7	29.2	4.9	236.9	65.6	10.7	5.4	19.6	6.6	24.8	22.8	13.4	62.4	8.7	31.8	13.5	62.0	2.9	0.0	98.6	80.0	34.5	16.8	82.8	104.9	142.4	81.3	5.0	159.6	167.9	1585.0	22.1	3.7	10.1	36.4	7.1	1.0	15.6	2.2	9.1	19.7	14.1	30.6	6.1	7.9	3.3	16.9	12.4	130.7	8.5	2.8	6.6
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057216	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"kidney: 146.0;liver: 506.6"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 225.4;Proximal tubular cells: 163.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 73.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 36.7;Hep G2: 120.2;NTERA-2: 68.4;RH-30: 90.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		380000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.4	0.6	14.3	0.6	17.5	0.3	0.3	17.5	15.6	0.7	11.4	3.6	13.6	1.6	24.4	1.8	8.8	3.4	0.4	13.8	15.3	146.0	506.6	1.2	0.9	15.1	16.3	0.9	0.7	1.7	0.8	4.2	14.7	2.0	1.1	4.4	0.5	3.4	0.3	0.7	4.3	2.0	13.0	1.0	0.9	0.3	16.3	0.4	0.2	0.1	0.5	1.3	0.5	14.2	0.0	0.0	36.7	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.2	0.6	0.0	0.1	0.5	0.5	0.5	0.2	120.2	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.1	0.0	0.2	0.0	0.7	68.4	2.4	0.0	0.3	90.7	2.2	0.0	0.1	11.2	3.8	0.3	0.2	0.5	5.9	0.2	4.4	0.0	0.1	0.2	0.1	4.3	0.9	11.4	0.4	0.0	0.6	3.6	1.0	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.4	1.8	0.2	0.1	0.8	1.4	0.3	0.1	0.1	0.4	0.3	14.3	17.5	17.5	15.6	13.8	15.3	15.1	16.3	14.7	13.0	16.3	14.2	0.4	0.0	0.6	12.4	1.4	0.3	0.3	0.2	0.0	2.9	0.2	0.3	0.5	5.7	0.1	0.0	4.2	0.2	0.7	0.2	9.8	0.0	1.5	0.2	0.3	0.8	1.2	5.3	0.2	0.2	7.7	0.7	1.5	0.2	5.7	1.3	5.3	225.4	1.2	0.0	0.5	0.0	0.0	6.0	2.1	2.1	0.3	2.2	0.0	1.0	2.2	29.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.3	1.9	163.7	0.0	1.4	0.0	0.7	0.4	0.1	1.0	0.0	0.1	0.4	1.2	0.1	0.1	0.1
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 48.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA		35000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	19.1	19.9	20.2	5.2	23.7	5.7	15.4	23.5	24.3	12.4	21.2	10.0	6.5	11.7	15.3	29.6	13.3	11.4	17.3	18.7	22.9	11.4	21.0	15.4	2.7	23.0	22.6	13.1	3.3	4.9	11.3	10.5	22.8	10.1	6.7	7.9	10.3	14.2	14.7	11.9	8.6	10.4	22.5	20.1	11.9	6.2	22.5	6.2	15.7	6.4	7.1	30.4	17.4	25.7	14.3	76.6	45.0	66.3	26.1	29.0	14.4	4.2	26.5	11.0	24.5	21.5	118.9	0.0	147.2	12.3	292.4	96.7	52.8	21.3	4.0	0.0	11.6	8.4	80.7	63.9	33.4	4.4	29.8	8.3	72.3	41.9	14.4	19.2	683.9	0.0	6.4	19.2	9.4	29.8	3.3	4.1	48.4	62.1	47.7	0.0	8.9	37.9	22.2	136.0	17.2	47.5	36.7	20.5	267.9	76.8	42.4	26.7	43.2	5.9	11.0	28.5	8.7	9.1	39.6	0.3	28.6	15.8	59.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	20.2	23.7	23.5	24.3	18.7	22.9	23.0	22.6	22.8	22.5	22.5	25.7	24.5	0.0	4.1	0.0	1.1	8.7	24.3	48.4	10.8	2.8	4.2	4.8	5.8	10.0	19.4	1.8	0.0	96.1	0.0	4.8	9.8	5.9	0.6	59.6	3.8	40.3	11.3	11.6	0.2	2.5	12.8	15.6	15.8	20.0	0.0	21.7	22.9	24.0	22.0	20.2	0.2	3.4	38.7	6.4	3.4	4.0	37.6	4.1	40.9	0.0	11.9	30.8	0.0	0.0	0.0	3.4	1.7	28.6	3.6	18.1	5.9	12.0	38.0	4.8	13.1	8.4	11.3	0.6	3.5	34.5	12.6	85.6	0.6	56.2	4.3	50.9
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"	"Cataract, Deafness, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 80.7"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	34.1	13.7	6.7	12.2	6.3	18.7	16.0	14.3	9.8	7.4	7.5	8.9	8.8	10.1	4.8	7.3	10.8	7.1	7.3	6.1	7.5	18.9	6.3	14.7	8.4	7.0	6.0	7.6	9.2	5.0	12.6	19.9	6.8	9.0	2.0	3.5	7.5	5.3	5.3	7.8	7.8	3.2	3.8	18.0	8.2	20.3	7.2	3.8	11.5	3.2	4.3	7.3	7.1	5.1	21.7	19.7	5.8	5.8	17.3	6.6	13.2	17.4	13.6	11.9	12.9	28.6	6.6	12.9	18.0	8.8	15.8	24.0	7.9	15.5	1.9	14.4	16.9	13.5	12.8	23.7	35.9	28.7	34.2	12.4	8.5	21.2	9.1	4.9	10.6	9.0	40.3	7.6	6.9	80.7	12.5	12.4	5.7	14.2	8.1	17.4	6.5	13.0	7.6	18.9	14.2	8.4	10.1	31.8	11.0	4.7	26.5	15.5	21.0	14.9	17.7	9.6	16.3	8.9	13.3	16.2	14.2	19.0	12.1	24.1	21.7	16.1	10.6	15.8	10.3	11.9	7.7	9.0	18.3	11.9	10.3	8.6	47.0	10.4	8.7	8.9	8.2	13.8	6.7	6.3	14.3	9.8	6.1	7.5	7.0	6.0	6.8	3.8	7.2	5.1	11.1	16.0	15.6	17.3	12.4	25.6	34.7	31.5	38.7	26.0	18.6	12.6	55.5	12.8	31.1	42.3	20.9	223.5	12.9	12.0	11.7	33.2	60.0	36.2	17.9	19.6	20.9	32.4	40.3	16.8	25.9	13.6	17.3	87.3	18.3	13.2	8.9	7.5	36.4	18.5	35.5	12.9	22.4	36.4	12.7	81.9	9.6	19.8	3.6	9.4	27.1	11.8	24.7	16.1	19.9	15.9	8.4	7.2	11.4	52.1	12.3	13.9	10.9	25.8	19.7	4.9	11.1	25.0	17.9	27.7	21.3	245.0	11.8	8.3	14.2	43.5
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.6;Cone photoreceptor cells: 54.2;Excitatory neurons: 51.3;Horizontal cells: 40.4;Inhibitory neurons: 41.3;Late spermatids: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 29.5;JURKAT: 35.6;MOLT-4: 55.0;WM-115: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	4.6	9.0	11.4	4.6	12.3	5.2	3.7	6.7	15.6	6.1	18.7	5.7	4.7	4.6	3.7	4.7	3.7	2.6	4.9	13.1	1.8	8.7	11.0	6.8	3.2	4.9	3.6	15.3	3.5	6.6	8.4	3.6	1.6	3.5	2.5	15.2	2.4	3.8	5.0	4.1	4.9	5.7	0.4	4.4	4.6	7.3	4.9	87.3	3.7	3.3	1.9	7.0	4.9	3.8	4.6	8.7	2.8	4.1	1.9	3.7	16.8	0.7	1.1	2.3	1.2	3.8	3.7	0.0	3.7	1.5	4.8	12.8	2.3	2.2	0.8	0.3	2.8	29.5	5.7	10.5	1.3	1.1	6.0	1.8	3.8	3.0	2.3	10.8	4.5	35.6	6.8	0.3	2.9	2.9	55.0	6.1	3.2	1.4	3.9	15.7	0.2	11.4	4.1	4.7	2.5	0.9	6.3	5.2	4.1	1.6	1.1	3.1	13.3	3.3	3.7	5.4	5.1	0.8	1.0	20.4	8.2	2.2	25.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.6	0.0	0.2	0.5	0.4	0.0	1.9	0.0	0.0	0.3	0.7	11.4	12.3	6.7	15.6	13.1	1.8	4.9	3.6	1.6	0.4	4.9	3.8	16.2	0.0	5.0	33.6	2.8	3.6	0.7	0.7	2.2	19.6	1.5	1.5	7.3	2.8	1.6	9.2	54.2	1.3	6.3	6.3	1.9	3.3	33.0	3.7	3.6	9.3	0.0	1.7	51.3	4.5	6.5	3.8	2.0	5.2	1.3	0.8	6.4	16.3	0.5	40.4	41.3	3.7	0.0	0.6	1.1	87.7	1.8	3.6	1.8	10.3	1.3	3.7	10.3	22.1	1.8	3.9	0.3	4.9	2.2	1.1	6.1	2.6	0.1	15.8	0.0	2.1	2.5	8.2	4.7	3.6	1.6	3.7	4.8	0.4	2.6	0.6
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 186.1;Late spermatids: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	40.8	64.9	22.7	19.1	24.9	26.0	36.9	23.8	34.2	40.9	22.9	40.9	19.6	40.5	23.8	38.4	38.0	18.3	60.2	25.2	24.5	50.5	44.9	40.4	21.0	25.3	26.0	54.4	41.1	33.3	42.3	17.0	26.0	42.6	22.1	49.6	41.3	22.1	94.9	39.2	32.7	25.8	21.0	30.4	37.0	43.6	26.1	42.4	41.7	59.6	21.7	43.6	38.4	28.5	81.8	67.2	21.7	31.7	62.1	67.6	22.3	125.9	51.0	92.5	49.1	55.5	45.5	38.5	39.5	70.7	33.2	55.8	37.8	82.4	74.3	72.3	55.0	61.1	42.9	39.2	36.2	21.8	62.3	50.4	57.0	103.5	55.8	55.4	81.2	56.3	60.1	44.5	115.7	67.1	59.6	14.0	15.0	97.9	71.0	27.5	34.1	54.0	67.9	54.8	29.4	16.4	95.9	57.5	46.6	35.8	67.2	23.9	114.5	63.7	17.2	160.5	47.8	36.1	48.6	41.7	108.8	38.2	31.5	3.1	6.9	1.5	10.3	8.8	10.5	10.4	9.5	10.9	13.3	5.3	9.7	11.1	0.3	13.7	11.9	5.3	12.6	8.5	22.7	24.9	23.8	34.2	25.2	24.5	25.3	26.0	26.0	21.0	26.1	28.5	12.2	28.9	29.0	13.4	9.3	6.8	17.6	11.1	6.2	13.1	10.7	12.2	44.9	8.6	23.5	3.7	20.9	13.4	7.9	12.4	7.9	18.2	186.1	14.5	14.6	14.0	18.0	10.7	18.4	29.2	20.0	14.7	16.8	23.1	14.5	18.0	7.1	16.3	14.8	6.7	17.9	12.7	20.3	10.1	6.3	98.7	17.1	10.0	19.6	6.5	9.9	7.1	4.1	11.1	14.7	34.8	10.0	14.7	13.7	23.9	10.6	8.5	19.1	19.7	6.6	16.9	15.3	28.1	21.6	17.0	5.7	13.5	10.1	30.4	12.9	17.7
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088708-2135898	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 72.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.1;Horizontal cells: 119.5;Inhibitory neurons: 101.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		840000		"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	14.8	9.5	7.9	4.9	10.4	3.9	13.7	65.4	32.1	22.1	0.0	40.3	3.8	30.6	2.0	11.3	25.9	3.7	23.9	9.6	1.6	7.5	8.9	13.4	3.4	16.2	1.7	23.8	10.4	2.3	72.4	3.7	12.6	19.9	1.5	7.4	10.4	8.7	47.7	16.8	15.3	6.1	0.1	9.9	19.1	10.3	4.7	2.8	10.3	8.3	1.5	24.5	15.5	4.9	4.2	8.9	4.8	10.9	8.2	8.8	9.3	14.2	5.9	4.0	4.0	8.0	3.1	6.3	8.9	7.3	4.3	10.4	1.4	2.1	1.5	7.4	7.1	3.9	25.8	3.2	16.1	5.4	7.8	8.2	7.0	7.5	4.6	5.6	3.1	6.6	5.7	6.2	2.6	6.9	7.7	16.5	4.3	1.7	6.6	21.6	7.7	9.6	2.1	2.8	19.9	22.2	12.9	8.5	8.9	1.7	7.0	18.3	7.4	12.7	10.3	9.6	10.5	9.0	4.3	7.0	7.1	5.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	10.4	65.4	32.1	9.6	1.6	16.2	1.7	12.6	0.1	4.7	4.9	21.3	12.8	12.2	61.7	6.9	24.3	10.3	14.7	30.7	79.8	15.4	18.9	26.4	4.3	10.9	9.2	41.7	6.0	11.2	13.6	9.8	5.2	51.9	16.0	32.1	17.1	30.5	4.8	138.1	3.1	4.0	30.4	8.2	16.9	8.2	21.3	15.7	24.2	5.2	119.5	101.0	17.6	4.1	7.2	12.6	10.6	27.7	7.8	23.2	18.7	6.2	36.4	11.3	38.2	29.5	4.5	5.9	45.9	9.0	10.3	8.9	7.7	32.9	35.2	32.9	41.4	25.2	10.1	15.8	26.0	20.0	3.1	10.9	10.1	14.2	6.9
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47740202-47948466	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	1.7	0.1	1.1	0.4	0.9	1.1	0.5	2.1	1.9	0.2	0.0	0.4	0.9	0.3	0.6	0.4	0.3	0.4	2.6	0.4	1.3	0.3	0.8	0.4	0.9	0.5	0.7	0.3	0.3	0.1	0.4	0.6	0.7	0.3	0.5	1.7	0.4	0.1	2.8	0.5	0.4	0.4	0.1	0.3	0.4	1.5	0.8	1.5	0.4	3.3	0.6	0.6	0.1	1.1	0.4	0.7	0.6	0.8	0.1	0.0	1.2	0.3	0.2	0.2	0.4	0.8	0.4	0.3	0.3	0.4	0.4	0.8	0.5	0.6	0.6	0.2	0.4	0.3	0.3	0.8	0.0	0.5	0.3	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.4	1.1	0.5	0.2	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.3	0.1	0.7	0.5	0.4	0.5	0.3	0.4	0.5	5.9	0.1	0.1	0.5	1.1	0.2	0.3	14.7	5.7	0.5	0.2	0.2	0.3	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	1.1	0.9	2.1	1.9	0.4	1.3	0.5	0.7	0.7	0.1	0.8	1.1	9.1	0.0	0.0	13.4	0.3	0.1	0.0	0.0	0.0	3.1	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.5	0.1	3.7	0.0	0.0	25.7	0.2	0.2	1.7	0.0	0.3	0.0	0.2	2.2	0.1	1.4	1.7	37.9	0.7	0.0	0.3	0.0	5.3	0.3	0.2	0.0	15.0	0.0	0.5	0.0	11.6	17.1	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.2	1.4	0.6	0.0	0.0	0.0	0.1	0.3	0.8	0.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;lymphoid tissue: 7.9;retina: 13.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.2	0.1	5.4	0.4	5.6	0.9	0.7	4.8	10.8	0.1	4.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	4.9	0.3	1.6	2.3	1.5	4.9	5.2	0.1	0.1	0.0	0.1	0.5	5.1	0.3	1.2	13.3	0.1	0.0	0.1	0.0	0.6	0.0	5.0	7.9	0.0	2.3	5.0	0.9	0.0	0.0	1.7	0.2	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	5.4	5.6	4.8	10.8	5.4	4.9	4.9	5.2	5.1	5.0	5.0	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	13.6	60.6	0.4	0.0	0.0	14.4	0.0	20.1	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1 ciliary IPT domain containing fibrocystin/polyductin"	P08F94	6	51615299-52087613	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.7;kidney: 13.6;pancreas: 9.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.1	1.1	0.0	0.0	0.0	13.6	1.5	0.0	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.4	60.1	0.0	46.0	0.0	0.1	0.0	0.1	1.9	18.2	293.6	0.2	0.0	0.3	0.0	0.0	3.2	0.9	0.1	0.1	2.6	0.4	0.0	0.0	0.0	3.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	83.1	2.1	0.5	5.4	0.0	0.0	3.1	0.0	0.5	0.7	2.6	0.0	0.4	0.0	0.4	0.0	23.3	0.0	0.1	0.0	0.0	0.1	15.0	1.7	0.0	0.0	0.0	0.3	0.0	0.1	0.8
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 4207.6;tongue: 2900.8"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 2065.2;Late spermatids: 1763.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		310000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	190.5	600.9	539.0	341.4	552.3	439.0	190.5	586.8	629.9	406.8	755.0	225.0	170.8	202.8	205.7	658.3	240.0	212.0	779.6	549.1	561.6	549.5	32.2	236.9	284.1	640.0	559.1	169.4	112.6	269.6	224.1	168.6	636.2	252.6	206.2	1266.7	389.8	291.6	4207.6	350.5	218.0	298.9	522.3	239.2	228.6	235.1	677.1	203.5	174.6	2900.8	429.2	578.5	374.9	530.6	1584.6	3937.1	788.9	938.8	914.3	1009.4	638.7	1684.6	3878.2	2619.1	2623.6	1094.4	1931.2	1184.5	1627.3	3157.6	1937.8	2253.9	2480.9	3383.2	2051.7	2134.0	1126.5	727.7	1809.1	929.7	637.1	955.2	1525.1	926.4	1559.2	2025.1	810.9	3403.0	1558.6	587.3	182.8	933.3	4267.0	965.1	359.4	419.6	966.2	2438.6	1433.3	1046.5	2560.0	2301.7	3557.2	1973.8	804.4	871.5	2226.3	1344.7	1755.4	1291.4	932.0	675.7	1247.3	3003.7	1622.0	2928.7	3110.3	1170.0	1762.1	1037.2	3720.5	1534.4	3002.3	131.9	836.3	138.6	192.6	466.7	187.9	205.2	254.1	190.4	685.6	142.9	215.8	162.5	100.7	108.4	380.1	140.5	334.0	1261.7	539.0	552.3	586.8	629.9	549.1	561.6	640.0	559.1	636.2	522.3	677.1	530.6	95.9	118.6	88.1	107.7	169.6	565.5	708.9	2065.2	307.9	480.7	157.8	174.7	313.2	87.2	759.4	829.4	369.1	566.1	100.2	358.9	802.2	1395.6	315.0	169.2	77.3	207.7	282.2	44.8	90.2	597.0	1416.7	220.1	138.1	188.0	206.7	144.0	73.2	4.3	750.0	1065.0	97.6	166.8	925.7	297.7	532.9	1763.1	157.2	558.8	355.8	38.4	1255.0	784.1	78.2	53.3	33.4	1213.2	264.5	268.1	209.9	431.4	389.1	208.7	396.9	708.6	124.9	160.9	398.2	43.4	98.6	341.6	389.0	575.7	192.7	157.4	380.7	860.7
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 416.7;skin 1: 699.9;vagina: 200.4"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2500000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	9.7	0.2	0.3	0.2	0.2	0.2	31.7	0.0	1.1	102.9	0.0	0.4	0.2	0.2	3.3	416.7	1.0	0.1	0.6	0.2	0.0	0.4	0.3	5.0	0.2	0.0	1.1	0.2	0.5	0.0	0.6	5.5	0.5	32.3	0.2	32.4	60.5	9.1	6.6	699.9	0.6	0.0	0.0	0.1	0.4	0.2	0.0	23.7	0.5	2.9	48.0	3.2	200.4	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	1.1	0.0	0.2	0.1	0.0	234.6	0.0	144.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	501.4	5.6	132.5	0.0	0.0	0.1	0.0	0.2	0.0	38.4	0.0	0.1	0.0	0.0	192.6	0.0	0.4	0.0	0.0	1.1	0.0	0.0	18.3	4.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.1	0.2	0.0	0.0	1.1	0.5	0.0	0.0	0.0	39.9	0.0	0.0	0.3	0.0	139.7	58.2	57.1	63.7	34.7	7.7	17.9	1.9	0.0	20.0	0.0	2.1	0.1	0.1	0.1	0.0	2.5	0.1	0.2	0.1	4.1	0.0	0.0	0.6	1.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.1	1.6	4.1	0.0	16.5	0.8	0.0	0.4	16.0	0.0	0.0	5.2	0.0	0.0	0.1	16.1	0.1	0.0	0.0	25.7	0.2	0.1	2.8	37.4	0.0	6.1	2.0	0.0	0.1	234.5	409.0	0.1	1.1	0.0	0.1	47.5
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456952-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 261.0;Inhibitory neurons: 260.9;Oligodendrocyte precursor cells: 235.3;Oligodendrocytes: 864.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	13.4	6.5	165.2	6.7	229.0	8.3	26.2	186.6	212.7	31.9	89.3	12.6	12.4	14.0	14.2	17.8	19.6	15.3	22.1	130.2	179.5	57.0	16.8	12.6	6.0	256.9	217.1	13.3	15.1	18.1	9.6	6.2	213.7	12.9	13.4	18.5	34.0	20.9	8.2	16.1	11.3	14.3	222.9	6.1	13.8	10.3	194.1	16.1	30.4	9.8	10.1	16.5	12.4	239.5	36.9	21.8	26.7	30.4	12.1	13.4	25.7	29.1	15.9	44.5	38.4	72.4	32.5	23.4	21.5	35.4	16.0	29.0	35.2	29.8	74.1	35.4	19.2	21.2	23.5	56.3	20.9	34.4	4.6	5.7	28.1	30.0	46.3	26.7	23.0	28.9	30.1	33.3	34.7	42.6	15.2	14.3	28.8	51.4	15.9	20.6	40.2	19.3	64.6	26.6	46.2	8.2	20.3	30.4	24.5	24.9	34.7	31.3	10.6	25.9	29.2	19.3	38.2	19.8	18.0	17.0	14.8	19.2	25.4	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.1	0.0	0.4	0.1	0.4	0.0	2.0	0.2	0.7	0.2	165.2	229.0	186.6	212.7	130.2	179.5	256.9	217.1	213.7	222.9	194.1	239.5	59.8	41.7	18.9	28.7	3.1	27.0	21.3	23.5	34.1	44.5	44.3	35.9	49.7	38.6	28.7	47.8	29.2	0.2	3.5	17.7	23.5	21.3	14.6	21.0	12.2	71.1	9.0	24.6	261.0	18.1	0.3	15.3	26.0	38.5	10.1	11.8	23.2	28.6	3.1	5.0	260.9	16.6	16.2	7.6	10.0	9.2	10.8	6.2	7.2	163.9	4.5	8.6	2.1	235.3	864.7	17.4	16.7	17.0	5.2	44.6	12.4	33.1	29.0	19.2	13.1	11.4	13.9	15.4	6.3	30.4	30.4	0.3	5.0	15.5	19.4	26.8
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72934762-72954806	"Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;kidney: 14.4;liver: 71.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 52.2;Proximal enterocytes: 70.0"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 9.1;Hep G2: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA		2300000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.2	27.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	14.4	71.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.3	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.8	52.2	0.0	0.0	0.3	2.4	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	70.0	13.4	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	6.3	0.0
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.2;placenta: 23.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 372.2;Macrophages: 140.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 43.4"	"Group enriched"	"Detected in many"	49	"dendritic cells: 14.1;monocytes: 43.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;PC-3: 3.4;RT4: 1.6;U-2 OS: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	290000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	4.5	3.1	1.6	22.9	3.6	2.8	2.6	2.7	4.5	2.5	0.4	7.5	4.1	4.8	1.1	0.6	1.9	6.0	0.6	2.6	1.4	0.3	6.9	7.2	26.8	3.9	2.6	1.1	0.8	21.0	2.1	23.3	4.2	13.1	10.3	0.6	1.4	2.6	0.4	3.6	3.3	2.8	2.6	27.2	2.9	0.9	8.9	4.9	20.2	0.0	10.0	11.1	0.3	7.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	3.4	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.3	43.4	0.3	0.1	9.2	0.3	0.3	0.0	0.0	14.1	0.0	0.0	0.1	0.5	0.0	0.5	0.3	0.0	11.9	1.6	3.6	2.7	4.5	2.6	1.4	3.9	2.6	4.2	2.6	8.9	7.4	0.5	0.0	1.3	0.3	3.6	0.8	4.4	0.0	0.0	0.2	0.3	4.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.6	0.1	1.6	50.3	0.6	3.5	0.0	7.1	0.0	5.1	1.8	0.0	1.5	0.0	0.0	0.0	0.0	372.2	1.7	4.8	0.3	0.0	24.6	4.9	0.1	0.0	140.9	10.6	11.2	29.3	0.3	0.0	6.0	0.3	0.3	0.0	0.0	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.1	0.1	3.1	0.8	8.9	0.2	3.8
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26903372-26947242	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	16.0	16.9	8.5	16.2	9.0	42.0	12.6	9.3	11.2	11.3	9.6	15.2	13.6	17.5	13.4	18.8	9.8	13.0	18.8	9.5	9.7	15.4	21.5	12.8	15.0	8.1	8.3	11.0	12.0	16.9	8.0	16.0	9.0	12.9	15.9	14.1	10.9	12.5	50.3	12.1	12.6	19.3	8.3	13.3	12.7	20.4	8.1	18.0	15.9	29.1	18.1	14.7	11.2	10.2	64.6	37.0	46.1	46.3	30.4	38.2	34.6	58.4	33.1	43.9	42.2	13.1	29.8	56.9	48.0	45.0	30.6	25.1	45.8	46.0	47.7	75.7	19.1	35.2	57.9	25.5	30.9	28.8	46.3	34.4	27.0	53.2	38.8	33.0	44.3	41.7	22.1	56.6	47.6	26.6	56.3	28.1	66.8	33.2	31.6	39.4	28.7	34.4	33.5	37.6	29.2	49.9	31.3	36.5	19.1	44.8	25.5	22.5	54.3	0.2	53.8	28.5	48.3	18.4	43.7	59.5	30.8	40.4	23.4	21.9	12.7	21.0	11.0	18.2	12.6	14.3	11.5	11.4	13.1	11.9	10.3	12.0	11.4	14.9	21.2	6.6	18.0	9.6	8.5	9.0	9.3	11.2	9.5	9.7	8.1	8.3	9.0	8.3	8.1	10.2	10.8	16.0	11.2	18.3	18.8	11.0	11.3	14.6	17.1	9.1	7.5	6.6	23.8	5.7	16.1	9.2	0.0	24.9	14.9	11.9	9.8	17.6	27.7	10.2	12.3	17.1	9.6	25.9	31.9	16.2	26.6	11.5	15.8	14.7	40.6	13.2	12.5	10.7	20.7	5.0	30.8	8.6	14.2	15.8	8.2	6.6	8.7	17.5	1.8	21.5	15.9	9.5	16.5	24.6	32.1	15.2	8.7	8.2	23.1	10.6	11.0	12.3	12.7	6.7	19.7	13.0	34.1	28.1	24.9	20.9	9.5	49.3	18.3	21.5	12.6	11.6
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029642	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 89.5;Theca cells: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	14.8	12.9	14.3	4.6	16.1	4.3	10.6	15.4	15.6	15.9	9.7	15.7	4.9	11.5	4.2	26.2	9.8	5.6	7.2	12.8	19.0	10.1	5.4	11.3	6.6	20.3	18.5	12.7	6.0	3.9	9.3	3.8	19.6	9.1	10.1	2.8	13.0	8.8	2.9	18.5	8.3	5.6	19.4	7.2	8.3	32.6	16.9	9.1	8.3	4.1	6.6	15.7	19.0	21.9	1.0	2.7	9.4	2.6	25.3	22.2	2.8	2.8	11.1	4.2	6.4	1.0	2.3	0.6	1.4	26.3	2.9	15.0	4.8	3.0	1.3	3.9	1.2	0.5	1.7	4.7	14.7	0.0	1.6	18.0	31.6	12.9	1.7	9.4	8.2	2.2	16.3	1.3	9.6	1.2	2.2	1.1	2.4	5.5	2.7	0.9	1.3	3.6	5.1	5.0	0.1	2.6	0.8	12.4	3.2	3.1	2.7	1.2	4.4	2.5	6.3	6.7	0.1	5.2	2.2	0.6	6.4	0.1	1.3	14.6	2.7	0.2	13.0	3.7	15.2	1.3	16.9	12.8	3.8	0.6	10.1	7.9	9.9	5.9	2.2	2.0	16.6	7.4	14.3	16.1	15.4	15.6	12.8	19.0	20.3	18.5	19.6	19.4	16.9	21.9	5.2	3.2	7.5	22.9	3.6	2.8	12.4	9.6	8.0	0.9	5.4	6.1	4.7	8.6	7.3	9.2	2.1	1.8	4.2	89.5	3.9	11.4	1.7	3.3	11.3	8.1	4.9	3.6	1.9	3.0	5.1	10.2	6.6	3.8	4.5	3.6	20.0	4.1	4.0	3.3	2.3	28.3	10.2	3.8	14.5	3.6	12.8	4.3	1.8	3.7	3.4	13.3	1.0	7.1	2.2	4.1	34.7	14.3	5.9	13.2	10.0	5.8	6.2	1.7	6.6	5.4	7.2	3.1	3.7	12.6	5.8	0.8	7.4	53.4	11.3	14.7
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.4;T-cells: 6.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	33.3	22.4	36.2	21.7	37.3	10.0	31.8	43.8	41.3	42.5	27.8	25.2	17.8	36.1	13.7	18.9	31.9	19.9	31.9	35.6	32.9	23.2	9.7	32.4	36.4	34.8	36.2	42.6	11.4	13.3	21.6	23.8	34.2	30.2	13.7	10.9	20.2	20.5	18.5	31.5	28.8	22.9	32.0	30.0	19.4	26.3	39.5	60.5	45.0	20.3	24.0	30.4	32.0	38.6	16.6	20.8	97.2	71.6	38.0	26.5	30.9	26.7	34.1	52.4	44.3	50.1	5.4	37.0	31.9	29.1	55.0	30.2	42.7	47.8	30.4	10.5	22.7	2.6	36.4	59.6	28.9	14.7	9.7	34.1	26.3	38.8	30.0	47.2	59.4	77.3	28.0	23.6	48.0	123.8	90.7	11.5	36.2	21.3	37.6	71.1	70.8	18.2	28.7	30.1	34.4	65.7	47.8	22.1	48.4	54.1	25.8	17.0	64.6	124.4	40.3	40.2	32.9	26.1	12.4	30.3	29.7	15.6	52.9	0.0	0.0	0.0	4.7	0.0	6.4	0.2	4.1	3.9	0.0	0.5	4.3	4.3	0.0	3.4	0.0	0.0	3.8	3.0	36.2	37.3	43.8	41.3	35.6	32.9	34.8	36.2	34.2	32.0	39.5	38.6	33.4	16.0	7.0	69.2	5.1	5.6	1.8	5.3	14.8	4.3	4.7	5.8	9.6	1.5	3.8	3.7	10.4	1.9	7.4	9.4	0.0	3.3	7.0	5.4	16.9	24.2	1.8	2.1	9.7	1.6	2.0	11.5	10.2	10.3	1.3	19.8	11.7	3.1	4.0	3.3	9.1	9.5	4.1	2.9	4.3	7.2	15.2	1.7	3.6	16.9	1.2	6.7	2.1	13.0	16.4	3.3	4.8	18.4	6.3	2.3	7.8	3.0	1.8	5.1	13.1	8.5	10.2	15.9	13.0	6.1	7.0	0.8	17.0	5.7	6.4	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 384.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	41.8	30.9	44.2	22.6	25.4	43.2	37.9	20.4	39.7	57.4	6.7	58.0	21.1	55.2	8.5	59.7	47.9	22.8	78.9	42.2	31.0	30.0	31.3	49.2	22.1	48.5	28.6	47.1	27.6	8.1	33.0	18.3	30.8	49.5	13.0	3.9	42.9	19.8	256.5	83.1	53.8	27.7	28.8	46.1	49.1	15.3	43.2	14.4	25.7	74.7	15.8	56.5	55.7	25.9	92.6	247.3	15.1	20.3	31.6	66.9	62.8	125.9	49.3	32.3	18.7	39.2	88.5	8.9	82.9	179.7	54.6	98.9	10.3	162.6	13.3	58.7	10.0	24.9	268.0	34.0	54.0	9.6	26.1	71.8	40.7	84.6	164.2	28.3	43.0	7.6	16.2	25.9	39.7	175.3	5.1	19.8	12.2	29.4	384.8	1.8	46.2	24.6	67.7	147.7	16.6	16.8	217.4	50.0	21.1	21.7	55.7	12.4	125.7	117.8	217.3	110.6	155.1	4.7	3.7	6.3	106.9	15.2	176.2	0.0	2.0	0.1	0.6	1.7	1.3	0.6	1.2	0.9	1.6	0.6	0.8	0.5	0.4	0.3	1.2	1.3	1.4	2.0	44.2	25.4	20.4	39.7	42.2	31.0	48.5	28.6	30.8	28.8	43.2	25.9	83.8	28.9	15.6	78.0	27.0	108.0	53.1	62.9	50.7	15.8	29.4	27.9	39.3	31.5	42.9	40.5	25.0	34.4	27.1	257.8	0.0	39.3	1.4	39.4	52.6	68.2	32.2	11.8	47.3	20.2	32.1	45.7	170.2	57.3	8.2	14.4	63.1	69.0	35.2	30.3	36.5	79.9	10.2	67.5	100.4	5.0	44.4	61.2	33.8	27.2	54.9	11.2	15.5	14.6	3.4	157.8	194.1	74.9	39.3	144.9	124.9	4.6	50.3	10.8	6.6	42.1	61.5	1.2	7.1	72.2	76.7	69.0	35.0	18.8	61.6	121.0
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129733-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 555.7;Inhibitory neurons: 506.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 22.6;MAIT T-cell: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.6;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 65.5;NTERA-2: 64.4;SuSa: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	10.5	61.3	7.2	5.2	15.7	3.7	15.3	3.9	15.8	30.7	1.3	12.1	13.0	29.8	32.3	20.7	20.0	18.5	35.2	12.6	7.7	42.7	16.2	12.8	3.1	13.6	16.1	32.7	14.9	21.9	12.6	12.7	11.5	17.3	13.6	35.1	15.5	28.0	2.4	17.7	13.3	15.3	11.8	3.4	18.6	20.5	10.4	8.6	14.6	5.1	4.9	23.5	25.0	14.7	25.8	12.5	45.2	0.4	14.9	20.1	15.8	10.8	23.7	6.5	10.2	19.1	22.8	0.5	3.5	12.1	13.2	10.9	30.8	20.3	13.5	65.5	10.8	15.4	28.1	9.1	14.0	0.3	2.0	11.8	20.4	18.6	35.2	35.5	7.1	12.9	6.7	0.7	7.0	8.0	10.2	1.8	64.4	21.1	6.5	0.2	21.0	0.2	45.6	30.5	4.1	9.1	10.6	5.9	40.3	61.0	7.4	3.5	10.8	4.0	17.3	0.9	0.4	0.6	0.5	0.3	9.8	0.2	8.3	22.6	0.3	0.3	2.4	0.4	5.7	0.2	2.2	2.1	1.8	0.3	0.3	1.6	0.8	1.6	0.2	2.5	2.1	0.4	7.2	15.7	3.9	15.8	12.6	7.7	13.6	16.1	11.5	11.8	10.4	14.7	19.9	25.6	28.2	145.9	3.2	20.5	46.6	42.2	25.0	86.2	27.8	49.7	157.9	57.2	49.5	46.0	137.6	26.8	9.0	25.6	35.2	33.7	25.8	84.2	187.3	17.2	32.4	7.8	555.7	33.1	38.7	79.8	37.8	98.8	3.8	11.3	20.3	38.9	6.6	126.2	506.4	17.9	22.4	10.5	94.1	15.3	40.4	11.4	117.4	178.0	168.2	97.5	0.0	158.8	82.0	52.6	30.9	28.2	4.9	33.4	30.4	115.3	60.6	139.7	32.9	24.7	38.1	45.5	48.8	39.4	25.7	26.4	12.0	75.3	36.9	47.2
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.1	0.2	0.3	240.9	2666.4	0.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 956.3;breast: 463.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	956.3	11.3	12.0	3.5	14.8	0.3	463.0	7.4	10.6	1.4	5.3	9.3	0.5	0.7	0.4	1.3	1.4	6.6	10.4	10.0	10.3	2.7	40.8	0.7	1.7	6.9	11.5	2.1	6.1	0.2	1.3	0.2	7.8	2.6	3.7	0.6	20.8	0.6	9.5	16.0	13.9	1.5	6.6	1.0	5.5	13.2	10.6	2.3	5.3	17.3	0.1	7.9	3.1	8.2	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	14.8	7.4	10.6	10.0	10.3	6.9	11.5	7.8	6.6	10.6	8.2	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 621.3;liver: 905.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 743.3;Hepatocytes: 527.0;Syncytiotrophoblasts: 1815.2"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 776.5;eosinophil: 581.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 776.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 2345.1;HHSteC: 2025.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	621.3	127.5	15.4	44.8	18.1	119.3	460.1	15.9	47.2	96.4	17.4	51.5	186.1	56.1	13.6	20.5	60.0	71.2	215.5	15.8	16.2	169.4	905.1	126.3	38.4	18.9	17.9	44.2	29.6	18.8	34.4	155.9	20.2	30.5	23.2	13.1	47.3	27.9	435.5	103.1	164.3	35.4	15.6	43.9	44.3	24.3	54.5	33.8	32.4	127.4	32.4	107.6	61.9	21.5	0.5	35.0	39.3	28.9	2345.1	318.3	434.8	113.5	87.6	67.7	76.5	54.1	8.3	0.4	2.0	232.9	432.1	4.7	39.1	0.3	115.1	146.9	0.8	191.8	5.4	205.2	2025.0	23.3	336.2	338.2	39.7	165.7	0.4	54.4	84.8	0.1	35.3	40.6	266.2	10.0	53.5	79.4	52.6	1.1	69.5	127.0	18.4	1.3	0.2	133.2	3.0	64.7	52.8	13.2	113.6	49.6	27.0	50.8	134.1	0.1	20.6	105.6	0.5	24.4	26.7	76.2	0.6	39.0	10.9	776.5	111.0	581.9	80.7	149.5	69.9	23.6	69.8	57.9	63.8	25.8	67.3	57.6	6.7	17.2	169.0	7.9	74.7	106.5	15.4	18.1	15.9	47.2	15.8	16.2	18.9	17.9	20.2	15.6	54.5	21.5	280.4	19.2	51.4	7.5	43.9	206.2	507.2	69.5	42.1	2.4	213.3	24.1	62.3	91.5	62.1	12.9	0.0	173.6	77.5	43.3	27.4	105.6	3.6	83.5	188.1	91.2	14.9	78.5	0.6	16.0	743.3	182.0	24.5	232.5	422.1	8.1	94.9	527.0	410.7	11.8	0.8	26.1	26.4	214.1	81.1	12.3	39.7	277.1	87.2	10.3	50.2	44.4	30.9	3.5	2.6	37.4	45.7	69.2	45.3	109.0	382.5	267.9	16.9	4.8	13.1	36.1	68.8	8.0	25.9	12.3	108.5	1815.2	123.3	21.4	44.3	263.3
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867694	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Supported	"Lipid droplets"		NA	Yes		11000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	30.8	69.9	23.3	41.4	39.6	70.8	29.5	44.2	27.5	50.4	25.9	37.6	70.8	22.6	14.4	124.7	22.9	34.5	25.3	22.1	28.6	38.0	26.5	25.7	29.1	51.1	36.1	40.0	20.3	9.8	9.3	33.3	48.9	28.0	20.9	1.7	45.9	21.0	112.0	87.5	73.9	23.9	36.2	32.3	28.5	34.3	39.1	28.0	24.8	36.4	33.0	37.5	55.4	66.0	138.2	79.1	53.6	50.5	59.8	189.8	24.1	196.8	178.9	152.0	142.9	52.6	124.9	72.5	43.3	242.2	82.1	61.3	25.1	108.2	88.2	82.7	35.4	79.1	43.0	97.8	41.4	56.7	112.9	147.1	46.2	107.4	23.6	90.5	81.2	23.5	122.4	31.3	192.1	57.1	78.3	72.9	42.5	63.3	127.7	136.2	74.9	40.2	133.8	31.7	2.3	26.3	62.5	55.5	49.5	43.2	70.4	125.9	125.1	83.3	80.5	333.8	102.9	44.1	58.9	50.8	250.7	79.6	97.3	128.3	141.7	64.8	13.8	100.4	14.6	46.3	24.7	15.9	109.1	36.3	19.4	12.4	173.9	39.5	76.7	82.8	34.1	86.4	23.3	39.6	44.2	27.5	22.1	28.6	51.1	36.1	48.9	36.2	39.1	66.0	19.2	19.2	25.6	5.5	28.5	142.2	62.9	58.8	90.0	0.4	108.0	43.1	2.3	14.3	51.3	11.0	2.1	152.2	34.4	169.7	37.2	114.7	9.7	65.2	50.9	27.7	40.7	18.5	0.8	86.8	77.3	62.9	33.1	78.4	55.8	112.9	26.0	18.2	101.2	0.0	1.1	67.0	28.5	57.8	103.4	14.0	35.8	74.7	55.2	2.8	62.3	23.9	15.5	5.0	17.1	243.4	223.0	53.0	37.1	39.3	268.8	38.8	65.2	0.7	52.6	37.8	66.2	75.1	14.6	109.0	229.3	194.8	20.3	193.4	54.8	69.2
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 764.9;breast: 316.5;skeletal muscle: 249.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.3;Astrocytes: 12.1;Cardiomyocytes: 35.9;Hepatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"ASC diff: 249.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		55000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	764.9	3.9	8.5	6.4	9.4	2.7	316.5	8.0	5.1	8.8	2.5	70.7	2.3	28.7	2.0	9.6	18.5	8.5	112.8	5.0	6.7	7.6	87.1	3.4	0.8	9.8	9.7	21.8	24.7	0.1	4.4	0.1	7.3	13.4	3.9	0.2	22.6	15.1	249.9	16.3	18.9	20.4	8.5	4.9	25.1	2.7	11.1	0.9	4.1	163.4	0.2	34.3	7.2	7.1	0.1	0.4	0.1	0.7	249.6	1.6	8.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.4	0.0	1.2	0.1	0.0	1.8	0.0	0.6	0.3	0.0	0.1	1.4	3.6	0.1	0.1	8.1	4.7	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.2	0.3	0.1	5.7	0.3	0.0	0.2	0.0	29.7	0.1	0.4	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	9.4	8.0	5.1	5.0	6.7	9.8	9.7	7.3	8.5	11.1	7.1	12.3	0.0	7.2	12.1	0.2	0.3	1.2	0.4	0.6	0.3	0.9	3.9	35.9	7.2	2.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.3	1.6	0.4	1.0	0.0	0.0	0.3	1.5	0.3	1.7	3.6	0.6	0.0	1.0	7.5	30.6	0.1	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.5	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.9	0.9	0.0	6.6	5.9	1.8	0.5	0.4	0.3	0.3	0.4	0.1	0.3	0.3	1.9
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 236.8;Sertoli cells: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.43e-4)"	58.1	34.6	46.3	35.2	51.2	16.1	41.2	48.6	56.6	65.4	46.4	47.3	37.7	65.0	30.5	21.3	51.1	42.0	71.2	44.5	47.4	45.5	78.1	44.4	15.4	49.6	50.8	54.4	39.0	36.9	29.6	83.8	52.4	34.7	23.2	10.6	75.9	40.6	40.5	27.2	35.6	78.4	44.8	31.5	35.5	11.6	52.2	7.9	34.9	41.6	12.9	42.4	36.0	53.1	112.5	91.4	51.3	239.7	343.4	190.6	39.0	330.4	436.1	170.4	287.1	105.2	71.5	63.1	339.5	367.3	125.9	93.4	75.6	115.6	115.6	66.2	78.3	34.0	136.6	137.3	212.5	21.9	162.7	234.0	59.7	206.2	81.9	573.3	305.0	14.8	97.6	30.9	180.2	71.1	5.7	58.6	22.9	115.4	131.6	25.8	100.0	141.0	98.7	24.3	19.2	77.7	137.3	97.4	164.8	80.4	48.3	55.9	298.7	190.1	141.6	236.3	161.9	71.4	123.7	38.7	425.1	75.5	316.8	0.0	40.3	2.0	17.3	34.4	3.1	1.7	3.0	8.4	32.7	3.4	1.2	6.4	35.5	5.4	32.3	4.9	2.0	22.6	46.3	51.2	48.6	56.6	44.5	47.4	49.6	50.8	52.4	44.8	52.2	53.1	19.4	0.0	7.9	9.4	3.7	7.0	8.0	22.8	8.0	5.7	17.9	17.5	18.3	8.6	8.6	11.0	2.1	39.7	8.7	14.8	3.9	30.3	1.0	11.0	62.2	33.9	8.4	3.0	4.2	9.8	236.8	47.5	17.3	24.8	0.0	20.4	36.8	37.1	46.3	6.7	5.8	12.5	4.1	26.5	8.3	2.4	44.4	16.3	10.6	15.9	17.9	7.9	15.5	3.0	9.8	22.4	15.4	24.5	19.4	8.0	41.5	16.7	4.5	3.1	105.2	77.2	47.3	0.5	3.3	7.4	5.1	33.7	5.5	37.1	16.6	3.9
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192335-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	60.2	43.8	30.2	9.4	28.2	2.3	41.9	30.9	32.5	28.9	11.6	27.4	6.8	30.1	15.7	23.2	41.2	45.6	28.0	28.7	38.5	25.3	69.0	37.4	10.5	39.3	44.0	36.4	20.5	4.3	11.2	56.4	32.6	13.8	25.2	13.7	23.6	25.8	7.4	16.1	13.6	33.7	36.9	30.1	14.4	21.6	41.8	6.6	31.2	18.8	6.7	19.8	25.5	32.2	0.0	9.9	1.7	0.0	60.5	48.2	0.3	11.5	15.7	5.0	10.9	1.0	12.6	0.0	12.3	21.0	5.0	1.4	2.4	1.1	2.8	0.1	0.1	5.0	7.9	1.3	28.1	0.1	1.3	29.6	1.6	10.4	3.0	62.1	50.8	0.0	0.2	0.9	7.4	0.3	0.0	0.1	2.1	5.1	3.4	0.0	0.8	0.0	0.1	0.0	0.6	0.0	20.1	0.1	3.9	2.5	0.7	0.6	106.4	10.4	2.6	23.6	2.1	0.3	0.0	0.0	2.6	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	28.2	30.9	32.5	28.7	38.5	39.3	44.0	32.6	36.9	41.8	32.2	77.3	3.2	10.3	151.1	1.0	10.8	5.6	0.8	12.0	0.6	10.2	8.6	4.1	25.8	6.0	3.7	0.0	0.7	0.3	27.4	0.0	8.2	1.1	3.6	11.6	63.4	10.3	15.6	1.7	11.6	0.5	57.1	2.0	1.5	1.3	7.0	110.3	44.1	0.8	0.0	0.6	11.7	0.0	7.1	11.8	3.8	42.9	1.1	3.6	40.3	0.1	51.4	0.0	61.3	0.6	4.7	13.3	32.4	2.8	2.6	6.4	28.3	6.4	1.5	0.0	18.9	23.6	1.2	0.9	4.8	8.7	0.8	1.8	20.0	8.1	2.7
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		94000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: AB_2683872"	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.5	7.0	5.7	3.5	6.4	1.7	6.0	7.5	7.2	10.7	5.3	7.5	3.6	8.1	4.3	5.3	8.7	3.9	7.1	5.5	8.6	5.8	2.8	8.4	3.8	6.4	7.3	17.0	7.6	2.0	24.8	3.6	7.2	10.5	2.2	1.5	12.0	3.4	1.7	10.1	7.8	2.6	4.6	8.0	5.5	3.7	9.0	2.2	10.2	1.1	2.6	7.4	9.7	8.6	11.2	2.2	6.3	16.1	6.5	8.3	8.4	15.6	3.3	3.6	4.9	8.2	4.6	2.0	8.2	16.9	8.4	9.6	6.4	7.6	1.3	0.9	4.8	2.0	29.0	4.5	5.2	1.0	8.8	11.3	5.5	5.4	0.4	12.4	4.1	3.2	5.2	1.6	5.7	13.8	1.9	8.4	2.0	3.4	4.9	7.2	0.5	0.7	4.8	7.2	13.2	6.8	5.7	10.3	2.6	4.4	6.2	2.4	10.4	7.8	7.0	0.8	6.7	1.2	0.2	2.9	14.5	1.5	2.1	0.7	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	5.7	6.4	7.5	7.2	5.5	8.6	6.4	7.3	7.2	4.6	9.0	8.6	5.2	12.8	7.7	13.4	9.8	8.7	9.0	7.3	9.6	18.7	13.9	10.3	6.5	2.8	6.8	11.0	12.5	3.0	10.3	15.9	0.0	11.5	0.1	14.4	23.2	3.9	7.2	0.0	6.5	5.8	7.2	11.0	17.9	30.4	8.8	21.3	2.9	1.6	8.5	5.0	5.4	15.1	0.0	3.5	9.2	0.8	11.5	10.5	14.2	6.5	4.7	6.5	4.1	6.0	4.1	13.6	11.4	8.6	8.5	10.3	9.4	1.5	10.9	7.8	13.1	26.5	9.4	0.9	2.3	8.1	7.4	9.3	13.2	2.5	9.6	8.2
PLXNB1	"KIAA0407, PLXN5, SEP"	ENSG00000164050	"Plexin B1"	O43157	3	48403854-48430086	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 121.1;Oligodendrocytes: 70.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040586	Enhanced				"Intracellular and membrane"	NA	NA		95000000		"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA040586: AB_10794034"	"unprognostic (1.31e-3)"	"unprognostic (7.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.60e-4)"	9.0	2.8	26.6	3.3	54.5	1.0	13.7	34.3	28.6	17.1	33.0	19.5	9.7	19.5	5.6	22.9	25.3	10.3	10.4	22.0	28.3	27.6	28.9	11.4	1.6	42.9	43.9	19.1	26.0	6.1	17.9	6.8	41.5	22.9	5.4	4.2	17.3	15.8	1.7	24.6	13.0	7.5	26.5	6.5	14.7	3.9	40.4	5.0	35.8	1.4	2.0	16.3	21.4	61.0	5.5	9.2	16.7	9.9	6.1	4.9	34.1	4.6	2.6	2.6	1.7	11.3	20.7	0.0	16.6	3.2	1.7	16.3	3.6	37.0	0.5	9.7	0.7	0.0	19.9	21.5	8.9	7.5	3.1	8.8	31.5	0.6	7.5	10.1	4.3	3.7	1.4	0.8	2.5	9.5	1.3	6.5	29.7	12.0	2.0	8.4	3.6	1.3	15.6	24.5	8.5	18.4	5.9	34.6	5.3	4.4	18.5	6.2	8.5	2.6	7.8	3.8	5.3	0.3	0.0	0.2	0.5	2.2	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	54.5	34.3	28.6	22.0	28.3	42.9	43.9	41.5	26.5	40.4	61.0	3.2	35.3	24.3	121.1	0.7	11.5	15.8	26.1	32.5	2.6	23.3	31.5	17.7	30.0	27.5	46.0	2.1	23.7	0.2	36.2	5.9	18.5	4.3	54.2	9.3	5.0	52.7	3.2	1.4	15.8	2.4	7.2	26.5	41.8	0.0	11.2	5.3	59.7	2.9	3.3	2.6	21.2	30.5	3.1	1.2	5.1	15.2	1.0	1.8	4.7	0.7	24.3	0.0	21.6	70.1	21.9	21.8	15.4	0.3	11.4	21.5	12.7	56.5	5.7	0.0	6.1	13.0	1.4	2.7	22.3	9.7	9.9	1.3	0.5	28.3	11.6
PLXNB2	"KIAA0315, MM1, PLEXB2"	ENSG00000196576	"Plexin B2"	O15031	22	50274979-50307646	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 296.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 11.1;intermediate monocyte: 16.4;myeloid DC: 8.3;non-classical monocyte: 21.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	25	"dendritic cells: 8.3;monocytes: 21.2"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 306.0"	"Low region specificity"	"Detected in all"							HPA003100	Uncertain					NA	NA		78000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA003100: AB_1079638"	"unprognostic (4.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (8.47e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (4.75e-4)"	"unprognostic (1.61e-2)"	"unprognostic (9.41e-3)"	"unprognostic (6.05e-2)"	28.1	42.9	12.5	31.2	11.5	14.6	25.0	43.2	14.7	38.8	61.2	45.8	45.0	44.0	7.7	48.6	50.6	51.5	20.1	9.8	12.3	42.5	33.2	40.2	22.8	21.1	22.9	49.6	47.5	22.5	33.8	35.7	16.9	40.0	16.4	9.3	53.0	45.6	7.0	50.2	50.3	20.2	13.2	74.2	87.4	18.6	16.7	7.8	53.8	3.1	15.3	33.3	41.3	15.5	77.0	125.0	58.2	78.7	35.2	43.2	98.9	104.8	55.8	36.8	36.1	87.0	102.0	59.9	114.1	86.8	22.6	145.9	10.2	77.5	9.1	10.8	50.3	11.2	233.2	64.3	79.2	2.0	54.6	67.8	117.5	39.1	29.9	64.8	30.0	0.1	15.9	14.3	38.7	132.4	1.1	21.0	15.5	45.9	31.3	64.2	97.8	18.8	39.4	237.5	29.6	53.6	103.0	306.0	22.6	16.9	119.9	72.0	64.9	76.1	112.6	39.7	37.9	8.1	1.5	11.0	60.4	3.5	101.5	0.0	11.1	0.0	0.0	16.4	0.2	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.4	0.1	21.2	6.6	0.5	7.7	12.5	11.5	43.2	14.7	9.8	12.3	21.1	22.9	16.9	13.2	16.7	15.5	15.2	64.1	54.5	33.0	6.2	22.9	22.7	70.6	23.9	15.5	48.2	40.8	15.5	62.9	94.4	136.1	16.7	3.1	11.8	172.0	3.9	93.1	9.0	87.8	33.4	24.8	49.7	2.1	13.5	57.5	29.3	28.7	296.2	72.6	5.1	43.2	21.4	58.8	36.3	13.5	9.3	77.9	40.7	46.8	38.2	4.3	24.2	49.9	14.2	24.4	45.1	54.1	2.1	4.5	1.6	117.5	111.4	19.2	4.9	54.3	110.5	36.4	154.6	10.4	26.3	18.9	35.8	2.2	2.4	34.5	25.1	6.4	4.1	48.5	56.5	45.1
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 210.2;intestine: 57.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 43.8;Oligodendrocytes: 72.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"WM-115: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048046	Enhanced					NA	NA		390000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048046: AB_2680239"	"prognostic unfavorable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	14.7	28.8	74.4	2.0	122.8	0.7	16.0	86.1	110.8	10.8	28.7	57.2	2.3	23.6	3.9	7.0	11.9	4.9	9.6	77.4	83.0	1.8	1.1	2.8	0.5	105.0	102.2	1.8	6.5	0.2	3.1	0.4	101.5	16.6	2.0	2.4	26.3	8.5	0.8	10.0	9.3	6.5	71.3	0.7	13.6	11.5	123.9	0.1	1.7	0.4	0.3	20.8	13.0	210.2	9.3	1.1	1.1	0.7	1.2	0.7	0.7	8.5	1.7	1.1	3.0	0.0	0.1	0.0	5.4	2.4	1.6	1.0	0.0	7.2	0.9	0.1	0.0	5.8	12.0	6.6	2.3	0.0	0.6	1.8	5.2	5.2	3.2	19.8	3.4	0.2	0.5	3.1	2.3	7.6	0.1	1.4	0.2	6.3	14.0	2.8	0.9	0.1	1.4	4.2	2.4	7.5	0.4	7.8	20.2	0.2	10.4	0.0	15.0	8.6	4.4	6.8	10.9	3.0	0.8	0.2	18.6	0.5	70.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	74.4	122.8	86.1	110.8	77.4	83.0	105.0	102.2	101.5	71.3	123.9	210.2	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	6.6	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0
PLXND1	KIAA0620	ENSG00000004399	"Plexin D1"	Q9Y4D7	3	129555214-129606676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.3;Endothelial cells: 102.1;Hepatic stellate cells: 132.1;Hofbauer cells: 81.5;Kupffer cells: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 392.3;HSkMC: 286.1;HUVEC TERT2: 346.1;TIME: 414.4"	"Group enriched"	"Detected in all"	4	"amygdala: 36.6;basal ganglia: 33.1;cerebral cortex: 27.4;hippocampal formation: 26.3"	"Low region specificity"	"Detected in all"			CAB020819	Approved					NA	NA		120000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB020819: "	"unprognostic (8.97e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.93e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.00e-2)"	72.6	22.1	32.0	37.4	38.1	26.5	47.4	36.2	35.6	58.4	26.1	19.5	6.0	33.5	17.6	21.5	35.0	39.4	39.8	29.3	34.2	24.7	18.3	67.5	34.7	48.7	43.5	16.3	13.9	18.0	11.1	112.4	43.8	19.0	16.9	3.5	13.3	27.0	12.9	19.5	20.9	52.6	38.8	33.6	15.8	10.8	49.0	62.7	29.5	39.8	23.2	37.1	26.8	43.2	10.0	57.7	47.4	16.3	392.3	167.9	98.4	42.8	123.1	25.5	29.5	13.4	8.1	2.1	179.9	152.9	13.2	0.6	25.9	0.6	7.5	1.9	3.2	40.7	30.2	61.4	44.8	13.5	11.0	286.1	1.7	26.4	2.8	36.6	346.1	2.1	14.5	1.5	34.8	31.0	2.4	44.2	11.8	2.4	8.0	47.4	32.0	51.8	10.2	2.3	27.6	1.1	11.0	3.5	15.9	107.6	15.5	59.7	414.4	21.5	28.5	0.6	32.4	1.9	2.2	19.9	7.5	29.2	19.0	0.0	10.7	0.0	1.7	5.1	6.8	0.0	1.2	1.4	2.9	0.0	0.0	0.1	0.2	3.1	5.2	3.6	0.0	1.7	32.0	38.1	36.2	35.6	29.3	34.2	48.7	43.5	43.8	38.8	49.0	43.2	107.3	3.2	27.2	12.4	3.6	8.0	0.4	2.1	0.6	0.1	7.6	3.4	10.6	5.7	3.1	0.0	0.0	7.1	16.9	0.2	0.0	1.4	1.4	3.7	52.5	102.1	13.1	12.6	10.4	3.5	16.4	19.5	5.6	6.2	22.2	1.3	132.1	7.7	81.5	0.0	0.6	3.2	6.1	75.6	31.8	1.8	38.8	41.7	8.8	27.2	29.4	6.5	10.3	0.5	27.7	2.7	0.1	13.9	12.9	0.5	0.0	0.3	1.2	0.3	32.9	14.4	37.1	0.6	4.0	1.5	4.4	5.3	14.4	49.5	0.5	0.6
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"PML nuclear body scaffold"	P29590	15	73994673-74047827	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	84.4	29.4	14.4	25.6	13.8	38.1	77.0	11.8	16.4	53.7	11.6	46.7	18.4	47.1	7.5	38.3	44.6	21.6	39.3	13.8	13.1	35.4	25.4	75.2	25.6	18.2	13.8	37.5	20.3	8.3	26.8	23.7	14.8	41.5	8.5	3.9	44.2	17.2	22.5	47.4	39.0	19.5	14.6	48.6	35.3	11.3	15.2	17.0	48.1	7.9	15.2	42.7	44.5	13.1	37.2	13.8	11.8	11.4	30.2	43.2	40.6	18.5	31.6	55.9	63.3	14.6	64.2	16.4	63.7	31.6	53.3	66.6	16.3	37.1	7.6	58.0	25.1	35.8	21.3	16.3	36.9	33.9	31.1	83.7	24.8	37.5	19.2	39.3	38.3	26.1	30.6	28.3	32.7	17.3	28.3	52.6	12.8	7.7	25.0	21.6	13.4	30.8	60.3	59.5	10.1	11.1	29.7	16.3	44.8	10.3	12.8	28.7	66.1	56.6	15.5	28.5	38.1	29.4	20.0	8.0	38.9	42.2	18.2	7.4	14.7	23.4	13.0	20.2	9.8	12.4	10.4	14.1	14.5	10.2	8.2	8.5	12.0	14.5	22.6	9.2	14.3	10.1	14.4	13.8	11.8	16.4	13.8	13.1	18.2	13.8	14.8	14.6	15.2	13.1	127.8	16.0	12.2	8.8	24.9	22.9	14.3	30.4	37.5	8.1	13.5	12.8	10.0	5.7	16.7	5.5	2.1	9.4	18.8	13.1	7.9	25.8	3.4	16.0	16.7	48.0	14.3	29.3	4.7	19.1	15.0	20.7	58.1	26.0	12.0	11.5	32.2	11.3	30.8	8.4	4.8	14.3	14.2	20.1	18.5	4.0	27.7	19.6	7.2	7.5	24.6	8.5	20.6	4.5	6.0	62.8	15.5	24.0	21.6	26.2	22.8	10.4	18.3	5.4	39.5	7.7	20.4	1.1	4.0	27.1	19.6	4.9	20.4	16.8	12.1	26.0
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2058	"pancreas: 444687.5"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 4086.8"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		14000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						13.8	3.1	0.0	10.5	0.0	1.1	8.9	0.0	0.0	7.2	0.0	3.8	64.8	9.1	0.4	4.8	1.5	0.0	78.2	0.0	0.0	3.0	10.2	2.1	16.9	0.0	0.0	216.0	444687.5	0.0	2.5	24.4	0.0	4.5	0.0	0.0	71.7	0.0	2.9	4.6	34.0	0.0	0.0	3.8	28.2	2.3	0.0	0.0	2.0	0.0	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.5	0.0	0.0	0.3	0.0	0.0	0.1	4086.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	14.5	0.0	0.0	0.5	0.1	507.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 158.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"CAB017029, HPA043412, HPA051005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	5.3	158.3	15.9	0.2	28.9	2.1	8.4	17.3	16.3	7.6	7.4	4.2	0.5	4.4	1.4	3.0	9.0	0.3	22.6	9.9	17.0	3.7	0.5	8.9	0.3	17.3	22.7	3.0	1.7	7.4	30.7	3.2	20.0	8.5	0.0	0.1	3.2	21.3	21.1	3.1	7.2	0.2	10.8	2.1	6.9	4.5	25.7	0.1	1.8	17.5	0.0	6.5	5.9	11.7	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	5.3	0.2	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	24.1	4.5	0.5	0.1	0.1	0.0	0.3	0.0	0.0	6.4	5.8	0.1	2.3	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.9	28.9	17.3	16.3	9.9	17.0	17.3	22.7	20.0	10.8	25.7	11.7	3.1	0.0	0.0	1.0	0.5	0.5	0.7	0.0	0.0	0.3	20.1	15.1	13.4	1.5	0.0	5.5	0.0	0.1	1.1	0.1	1.9	0.0	0.7	24.0	2.6	5.0	3.0	16.6	0.5	0.0	0.9	1.1	0.0	9.0	0.0	0.7	27.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	2.1	0.2	0.0	1.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.0	0.5	0.0	48.0	0.8	1.0	2.3	0.0	0.4	0.0	11.0	0.0	0.3	1.8
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157888-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056928			Supported	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	15.1	14.2	6.4	12.1	8.0	19.5	11.6	7.0	11.8	7.6	6.9	9.7	7.6	9.8	11.2	11.1	8.8	9.9	10.2	12.0	7.3	14.1	12.6	8.6	12.6	6.7	6.9	7.0	12.7	12.5	7.1	12.7	6.8	10.0	9.1	19.0	7.1	10.8	20.1	9.1	6.7	11.5	6.7	8.2	8.8	8.9	6.9	8.1	12.5	12.6	12.2	19.8	7.6	7.4	37.8	40.1	18.5	30.5	22.5	18.3	46.0	34.7	23.0	39.1	27.8	77.9	21.9	51.4	28.5	23.6	54.0	31.6	60.6	41.9	61.3	35.2	40.6	49.7	17.4	58.2	34.6	40.2	22.4	24.1	30.2	39.4	45.0	11.3	29.1	32.7	69.7	27.3	35.7	27.4	39.9	38.1	52.0	68.7	43.1	33.3	45.2	54.8	29.8	31.7	32.7	24.0	26.1	32.4	57.8	29.7	22.9	22.4	21.2	44.2	48.0	40.1	97.9	21.6	33.1	78.1	36.3	59.1	62.1	0.9	12.6	2.8	12.2	18.1	19.1	19.2	13.8	14.4	16.8	14.5	16.0	14.6	2.4	15.0	13.0	11.8	16.0	21.3	6.4	8.0	7.0	11.8	12.0	7.3	6.7	6.9	6.8	6.7	6.9	7.4	23.7	16.0	13.2	3.3	29.9	83.2	62.8	29.5	25.6	22.7	18.6	18.4	11.9	18.6	36.2	7.3	12.5	39.5	20.2	7.9	19.6	36.7	33.5	28.7	37.7	25.5	17.3	21.4	10.6	29.8	43.5	28.3	9.7	20.9	31.6	13.6	12.5	15.8	26.0	18.5	9.0	12.1	30.5	10.4	38.7	7.7	12.5	20.7	12.4	4.7	18.9	21.0	14.4	7.1	10.4	29.1	5.8	16.6	27.8	56.6	4.6	34.7	28.6	51.3	6.6	40.4	29.6	28.9	41.7	21.0	56.1	47.6	25.7	20.5	20.2	37.6
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477089	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 333.9;epididymis: 594.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 531.3;U-937: 593.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		58000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	78.6	24.8	16.1	46.8	16.6	333.9	34.6	22.6	22.7	25.3	18.9	52.2	120.3	14.2	594.8	87.4	18.2	56.8	29.0	17.7	19.6	206.8	98.0	48.6	46.7	20.3	18.1	5.0	23.2	32.0	19.8	132.6	20.1	15.0	61.8	27.1	22.6	27.4	7.3	29.6	60.3	38.7	23.1	44.5	50.6	7.4	21.1	33.5	17.8	10.0	64.4	100.4	41.5	20.1	86.1	113.4	24.0	53.9	26.0	21.0	71.8	85.2	40.3	68.2	67.0	66.1	76.5	227.1	96.8	45.5	81.5	89.9	125.2	159.8	89.5	75.0	109.6	189.1	89.9	109.3	24.2	531.3	94.7	14.4	57.4	206.0	91.0	37.8	295.9	141.0	95.4	137.4	86.7	79.1	157.6	311.3	67.5	215.7	186.1	130.2	35.9	88.3	243.7	79.6	101.9	22.6	163.4	205.0	13.2	32.6	75.5	92.5	240.0	46.1	62.6	105.1	148.4	63.1	113.3	258.9	39.3	593.0	4.6	12.0	30.6	10.3	39.8	27.3	73.6	25.7	44.2	45.0	48.1	28.8	27.6	35.9	3.7	38.5	26.6	27.3	16.7	31.1	16.1	16.6	22.6	22.7	17.7	19.6	20.3	18.1	20.1	23.1	21.1	20.1	149.6	0.0	23.5	5.9	50.3	84.6	67.4	12.6	112.7	4.7	56.3	62.6	3.5	27.1	13.4	82.8	14.6	360.6	45.2	61.1	39.2	43.2	1.3	36.0	12.7	139.4	46.4	227.3	0.6	51.5	41.8	32.4	106.5	65.3	57.7	5.0	24.3	30.6	70.9	16.8	1.1	51.3	18.3	18.1	58.4	0.8	0.3	83.3	30.2	3.7	13.2	78.8	29.9	3.0	0.9	130.8	83.9	0.7	88.6	27.5	41.2	118.9	10.5	18.1	0.0	23.9	41.3	0.4	0.7	114.7	63.9	646.2	62.3	3.1	51.4	77.1
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Proximal tubular cells: 126.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003656	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	20.8	27.6	11.9	9.7	12.6	8.7	22.6	12.0	11.8	13.9	16.9	15.4	18.9	14.0	18.1	21.0	24.7	9.4	42.1	11.1	14.2	41.2	40.1	9.8	10.8	12.1	13.5	22.4	28.8	25.2	13.5	8.0	12.4	12.8	12.3	16.8	26.9	10.8	77.9	15.0	11.4	12.1	12.5	9.4	19.5	7.8	15.6	16.3	29.9	66.0	10.2	8.9	13.3	11.9	44.7	18.1	2.8	44.4	0.9	0.5	11.9	13.7	1.5	23.0	14.1	18.1	16.1	13.9	0.1	4.5	0.3	25.7	0.0	45.6	39.2	0.4	32.0	10.0	32.8	38.6	28.6	17.8	14.1	29.5	45.7	11.7	27.3	5.5	16.2	0.3	39.9	0.5	0.3	11.8	0.3	17.2	46.9	30.7	38.0	0.3	0.2	15.6	30.6	20.3	25.3	12.7	41.2	16.8	23.7	49.7	26.1	13.0	9.4	0.2	11.4	35.5	0.2	20.3	0.3	27.0	0.2	0.1	3.7	7.4	11.4	9.7	6.1	13.5	7.0	14.7	8.7	6.7	22.2	16.7	11.3	10.8	0.7	11.9	12.5	16.3	6.0	9.3	11.9	12.6	12.0	11.8	11.1	14.2	12.1	13.5	12.4	12.5	15.6	11.9	10.7	9.6	12.5	3.3	8.2	11.9	16.7	46.0	17.6	11.3	38.2	33.5	55.0	20.0	24.3	20.2	0.0	28.7	7.8	31.2	95.9	34.2	3.1	35.9	20.6	10.6	19.8	15.6	2.8	48.7	21.3	14.6	13.7	15.5	8.2	17.3	13.2	62.1	28.7	10.1	3.6	30.6	38.7	9.2	10.2	3.7	16.4	12.1	17.8	1.0	13.3	36.1	6.2	2.5	1.0	39.8	25.1	20.3	14.2	15.3	47.6	126.4	31.0	15.0	6.6	6.6	14.6	22.2	21.4	24.0	16.8	14.0	6.4	49.0	32.3	16.0
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		33000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	20.8	6.8	27.7	8.9	26.5	0.3	21.9	25.2	34.4	26.0	19.0	8.4	5.1	27.5	5.6	8.1	49.0	14.5	29.1	25.2	25.3	96.2	3.0	31.8	5.6	29.2	28.1	6.1	26.0	18.9	1.1	29.3	29.5	8.7	8.6	67.8	16.1	18.9	15.3	4.8	6.2	28.9	22.0	5.6	5.6	2.4	42.0	3.7	28.5	26.1	6.1	9.6	1.0	22.0	50.9	18.9	42.6	16.3	0.5	0.0	2.6	5.4	4.2	16.9	6.1	121.4	83.1	0.3	109.7	295.8	57.1	34.9	34.3	0.7	15.3	5.4	17.3	0.2	115.0	2.7	1.1	4.2	4.0	0.2	0.4	50.5	0.8	9.4	146.3	1.5	10.5	1.8	16.9	18.0	0.5	1.3	509.7	10.0	43.6	16.2	73.1	15.8	1.6	16.6	34.3	8.9	34.7	7.0	0.2	640.8	4.1	2.2	474.0	6.8	26.6	72.5	226.1	2.5	4.5	1.2	27.1	20.1	48.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	26.5	25.2	34.4	25.2	25.3	29.2	28.1	29.5	22.0	42.0	22.0	165.8	6.4	9.9	3.6	2.4	5.2	0.9	14.0	0.6	9.7	33.3	20.7	22.9	4.3	25.4	27.6	87.6	0.8	1.0	1.0	0.0	4.6	0.8	44.8	13.0	181.1	2.4	2.7	9.4	18.3	0.4	9.2	1.1	121.3	2.5	2.2	65.0	1.0	0.4	5.0	3.3	12.9	4.1	0.9	9.6	1.3	4.7	2.6	5.4	92.8	0.7	10.6	0.0	7.1	3.1	42.7	0.8	0.4	4.3	3.6	0.7	0.8	10.3	188.4	0.0	6.3	8.4	0.3	1.1	1.3	3.1	0.7	3.3	1.9	2.7	5.8
POGZ	"KIAA0461, ZNF280E, ZNF635"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459494	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 347.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	27.0	32.4	29.4	15.6	42.8	40.2	29.0	51.0	42.9	42.7	20.9	45.4	15.2	36.5	56.2	22.5	45.5	23.7	26.9	27.3	27.9	36.3	29.1	26.4	21.1	44.5	29.0	66.5	29.2	34.5	61.6	16.0	36.2	40.4	21.4	55.3	27.3	25.0	26.1	36.7	29.1	28.2	23.6	32.5	29.8	33.6	34.9	27.3	46.9	20.1	21.7	35.8	32.5	79.1	22.1	28.0	68.4	38.8	29.8	28.7	23.3	18.9	17.3	21.1	21.9	31.3	22.2	45.4	31.5	23.6	16.7	18.6	40.9	20.0	27.5	38.4	22.4	27.8	41.1	18.4	21.8	38.5	26.9	25.7	16.0	23.4	27.8	39.3	34.2	33.4	26.3	42.2	21.5	55.7	42.7	24.4	48.4	22.8	16.5	41.2	33.1	22.8	22.9	34.8	36.6	37.8	31.5	26.3	31.2	56.0	34.3	49.9	28.3	25.2	29.8	21.0	27.2	30.6	27.6	86.1	18.0	20.3	21.7	3.3	1.0	2.5	1.8	0.9	1.5	2.1	1.7	2.4	1.0	2.0	1.8	1.8	2.1	1.3	1.2	1.8	1.4	0.8	29.4	42.8	51.0	42.9	27.3	27.9	44.5	29.0	36.2	23.6	34.9	79.1	42.7	60.9	41.6	167.8	60.6	45.2	26.8	25.2	54.1	83.7	48.4	34.9	18.8	37.1	30.0	64.4	83.4	17.1	34.4	31.8	3.9	22.3	17.0	31.5	40.9	45.0	58.2	29.3	147.8	14.7	11.3	40.2	34.7	43.6	27.8	87.6	47.2	44.4	21.3	79.1	142.4	32.4	20.3	30.0	49.2	12.2	53.7	32.8	51.6	112.4	30.7	37.8	26.8	155.8	347.4	23.7	26.3	73.7	58.9	31.4	29.3	13.7	29.7	60.1	65.7	55.8	41.3	32.3	49.9	40.3	34.1	11.5	39.9	44.0	36.4	28.8
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 254.5;Late spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 280.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013"	Enhanced		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	12.4	17.5	26.6	13.5	27.4	51.3	27.4	82.3	35.5	18.9	24.3	12.3	10.8	12.9	19.7	26.5	13.2	17.4	26.1	28.1	29.0	18.0	33.9	14.2	20.2	27.1	27.8	20.4	16.9	18.8	26.7	11.1	28.9	24.8	13.2	18.0	30.3	11.3	85.3	23.1	10.8	10.6	27.6	17.2	14.0	53.1	30.2	24.8	14.2	70.0	22.2	30.8	18.9	28.9	40.2	23.5	40.6	80.4	21.8	20.7	33.8	25.2	29.3	41.5	37.7	33.1	46.0	36.4	31.1	16.5	43.4	20.0	34.1	29.5	50.3	23.8	36.7	26.5	18.2	45.3	34.1	18.6	280.6	18.8	34.4	30.1	35.4	51.8	32.1	77.2	58.4	22.4	40.3	23.6	78.0	52.6	54.4	48.4	26.7	44.2	40.8	31.4	78.4	32.1	22.7	41.8	29.9	19.9	79.0	41.4	52.5	31.5	17.8	19.1	27.0	48.8	24.6	32.5	58.4	52.2	19.3	39.4	52.2	47.6	15.1	48.1	12.0	18.8	13.3	12.2	12.5	13.0	15.7	11.1	14.1	13.3	63.6	22.2	26.3	84.9	19.3	11.5	26.6	27.4	82.3	35.5	28.1	29.0	27.1	27.8	28.9	27.6	30.2	28.9	13.9	3.2	13.6	6.8	20.2	16.8	30.1	14.2	31.3	2.9	14.3	15.1	21.6	7.2	20.7	7.3	8.4	7.5	51.9	3.1	5.9	11.7	254.5	13.8	7.7	12.5	6.0	7.6	15.8	9.6	7.0	9.7	10.2	9.9	23.4	12.7	8.6	12.7	7.4	6.7	20.3	5.4	4.1	5.7	9.9	133.9	7.2	18.2	7.2	19.7	11.2	8.3	13.4	12.5	16.7	33.6	5.8	3.8	21.9	41.6	4.3	6.8	16.4	4.4	0.0	6.6	12.3	19.4	15.4	27.3	20.0	11.1	16.2	7.8	6.6	31.6
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418018	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 51.3;Spermatogonia: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004375: AB_675487, HPA046524: AB_2679684"	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	5.6	5.1	3.2	9.2	3.7	26.3	6.3	4.5	3.8	7.6	2.5	8.9	5.4	8.4	0.4	10.7	6.5	2.1	5.8	2.7	2.7	6.5	6.4	9.5	11.2	5.1	3.7	7.1	7.9	2.3	4.7	5.9	4.1	6.1	2.2	1.9	7.4	2.6	5.6	9.2	10.1	2.3	3.5	12.8	6.2	13.3	4.1	11.0	9.8	1.5	5.2	5.9	7.7	4.4	52.1	77.9	27.9	22.4	3.0	2.8	45.6	34.0	9.6	30.0	34.9	42.4	39.2	84.6	19.4	7.1	13.9	45.1	27.4	25.1	6.8	64.4	145.0	66.1	73.0	54.6	3.7	67.0	57.7	6.4	7.1	26.1	6.5	6.0	14.2	58.2	77.4	54.3	9.1	40.6	92.2	110.6	48.7	25.3	55.4	105.4	62.2	67.7	7.4	44.9	39.3	38.6	33.0	35.9	8.8	10.1	21.1	50.7	17.4	21.4	70.7	22.0	56.5	60.0	91.3	76.3	21.2	66.9	20.8	1.3	4.3	1.5	4.3	5.6	4.0	6.0	4.0	3.5	3.9	5.4	4.0	3.9	0.6	4.2	6.9	7.1	3.1	4.0	3.2	3.7	4.5	3.8	2.7	2.7	5.1	3.7	4.1	3.5	4.1	4.4	3.5	3.2	3.9	0.7	8.7	6.4	2.3	3.5	3.4	4.0	4.3	5.3	3.4	2.8	3.8	3.7	6.2	19.2	3.8	12.2	0.0	4.8	1.9	2.8	1.6	3.4	7.2	15.2	1.2	4.0	15.0	4.1	3.1	3.0	0.0	9.5	1.1	2.2	15.1	0.0	0.9	7.4	0.0	5.7	5.3	1.9	3.1	5.8	5.4	1.0	4.8	1.2	6.2	1.5	2.2	4.7	51.3	5.3	10.6	2.8	6.3	2.8	3.0	4.3	0.0	3.5	4.0	11.5	25.6	5.5	5.3	7.7	5.4	3.4	14.3	1.3
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114680-44124358	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	48.4	58.8	48.9	35.0	46.7	44.6	44.4	46.4	53.8	53.4	52.0	39.0	32.4	47.3	14.0	86.6	75.8	18.5	86.8	46.5	47.6	51.6	113.5	36.2	36.9	49.0	49.3	59.3	73.4	62.0	53.0	27.1	49.3	46.8	28.9	22.6	46.6	30.1	118.8	59.9	32.9	32.4	46.9	35.9	48.0	48.7	56.7	46.2	40.6	77.5	33.4	48.2	54.3	45.6	162.2	209.3	114.1	240.5	99.5	105.5	112.9	97.2	97.5	130.6	97.4	178.0	151.4	371.1	121.2	141.1	261.0	218.3	188.9	265.6	84.4	105.9	222.1	82.2	216.3	152.3	112.8	253.4	96.1	96.8	159.6	202.4	195.1	136.3	110.7	245.8	305.4	173.2	146.3	262.7	310.5	476.0	180.0	231.0	203.0	206.4	153.4	528.9	114.0	102.7	225.0	176.2	121.5	430.6	83.7	73.5	249.7	321.6	88.0	171.7	215.8	213.3	310.5	269.3	430.3	359.1	154.1	252.7	248.6	1.7	41.2	10.4	51.6	38.9	77.3	82.2	61.7	52.5	70.8	80.2	81.4	60.5	3.3	44.9	38.8	112.7	54.1	69.7	48.9	46.7	46.4	53.8	46.5	47.6	49.0	49.3	49.3	46.9	56.7	45.6	25.6	6.4	31.8	11.8	35.3	49.3	83.0	111.8	42.7	41.6	57.1	62.7	58.2	44.3	54.1	29.5	31.3	69.9	24.3	31.0	103.7	71.9	108.9	53.5	52.4	33.6	41.9	52.2	5.0	59.5	84.1	49.3	40.2	24.9	26.6	65.6	19.2	95.6	46.8	53.8	5.1	53.6	30.5	14.4	26.6	288.0	41.7	15.0	49.8	4.7	13.0	58.1	18.6	5.0	7.8	44.5	25.0	53.4	38.0	127.6	10.0	95.2	69.7	52.0	19.7	55.4	78.6	48.2	52.4	70.5	60.5	35.4	25.7	103.9	81.5	71.3
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687376	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.1;cerebral cortex: 1.1;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.0	2.9	0.2	6.1	0.2	24.7	6.0	4.1	1.1	6.4	0.3	7.3	6.5	5.4	2.1	7.0	6.2	3.1	4.3	1.6	0.0	3.0	8.6	5.0	7.2	0.3	0.1	7.8	6.5	2.6	2.7	5.3	0.3	6.4	6.3	2.4	6.1	3.3	7.5	13.2	8.5	3.7	0.1	16.2	8.0	16.2	0.5	15.7	4.7	3.0	7.1	6.1	6.2	0.3	25.3	33.3	48.7	22.0	10.2	7.6	39.9	26.0	11.7	30.3	21.8	38.3	14.5	28.7	10.2	14.1	11.6	33.6	35.4	16.7	18.8	13.3	41.2	45.4	45.7	15.2	1.9	37.2	24.9	5.5	6.0	31.8	10.5	8.1	10.8	35.1	53.4	15.7	14.9	33.3	61.8	46.8	36.9	9.3	18.5	48.0	27.6	13.0	6.9	40.8	40.6	22.0	30.0	22.7	4.7	23.4	35.0	19.1	9.9	26.5	24.7	20.6	25.9	20.3	14.5	44.8	14.7	26.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	4.1	1.1	1.6	0.0	0.3	0.1	0.3	0.1	0.5	0.3	3.2	0.0	6.7	7.5	4.0	5.7	3.8	3.0	4.0	8.7	7.8	6.7	6.9	1.5	1.6	1.8	0.0	8.8	5.6	18.8	0.0	2.3	8.2	3.2	3.8	4.9	7.2	14.9	13.6	3.3	10.8	5.1	11.2	6.8	2.5	16.2	8.9	10.5	13.2	0.0	7.6	9.1	2.0	6.9	5.4	9.7	6.8	2.9	5.4	4.7	1.6	2.6	2.1	3.5	2.9	2.6	6.0	3.4	6.3	4.0	4.1	1.0	1.9	6.1	26.3	7.0	6.1	46.6	18.2	5.8	7.7	4.0	5.8	2.9	10.9	2.8
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 236.8;Oligodendrocytes: 159.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	4.7	4.3	2.3	3.7	5.0	2.7	5.4	7.0	4.5	6.8	1.9	3.2	2.4	6.3	4.6	3.4	4.0	3.7	4.6	3.1	5.4	4.7	4.9	4.9	4.0	5.6	4.2	6.0	4.3	5.5	3.2	6.3	5.7	4.3	3.1	5.2	4.2	3.9	4.6	4.1	3.1	4.1	3.6	5.6	3.7	3.1	4.7	3.9	7.6	3.3	3.6	3.2	3.9	10.5	6.7	6.7	4.1	5.3	5.3	10.5	3.5	12.5	8.8	9.5	9.8	4.3	5.2	6.9	10.0	8.3	6.2	2.5	3.8	4.3	11.4	7.6	4.5	6.3	5.7	2.1	10.1	4.0	4.9	5.0	5.1	7.7	5.3	7.6	8.0	4.4	5.6	3.9	9.1	0.5	7.9	3.2	1.5	0.7	3.9	3.3	10.6	4.8	5.7	2.2	4.1	4.6	9.4	2.5	3.4	2.8	3.7	3.8	10.4	6.9	3.6	3.3	7.2	4.5	4.4	6.0	4.6	6.2	12.2	5.8	5.3	2.7	2.4	6.0	2.0	5.1	2.6	3.0	4.8	4.1	3.2	2.2	4.6	3.9	11.5	5.8	3.4	2.0	2.3	5.0	7.0	4.5	3.1	5.4	5.6	4.2	5.7	3.6	4.7	10.5	45.8	32.1	44.6	65.6	36.3	14.7	21.8	22.1	20.5	32.9	19.5	15.0	21.8	24.3	26.1	29.5	20.9	17.3	37.5	8.3	23.5	20.3	236.8	19.5	32.1	34.4	14.9	29.2	63.5	15.8	13.0	33.7	17.3	21.0	51.9	33.8	57.1	25.0	21.8	65.6	60.0	11.3	24.4	39.2	25.0	58.7	37.6	33.3	23.2	73.1	55.8	19.6	25.7	84.4	159.6	19.1	15.1	38.4	26.4	14.6	17.8	21.2	20.8	38.8	6.6	38.5	27.8	61.3	23.6	14.5	12.9	6.7	27.6	48.8	12.2	11.6
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1B	"FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112579818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center"	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	5.7	4.6	2.9	5.6	3.0	4.1	8.2	3.5	3.1	5.3	3.8	5.5	4.4	4.7	4.4	8.1	6.7	3.7	4.1	2.8	3.5	8.1	10.7	4.1	9.3	2.6	2.7	6.3	8.1	11.9	4.4	5.6	2.5	5.0	6.2	5.2	3.8	4.7	7.5	5.2	3.8	5.3	2.6	6.7	4.3	8.4	3.1	7.2	10.7	6.4	10.8	7.9	3.6	3.4	21.1	21.6	11.2	28.2	13.9	13.2	24.0	15.1	11.9	24.0	21.5	48.8	12.5	46.1	22.9	9.8	18.8	29.5	56.1	30.6	28.4	22.3	30.9	26.5	21.4	37.1	14.2	43.6	18.1	12.7	21.6	25.4	39.6	9.8	19.9	10.2	55.0	16.8	13.2	17.5	20.5	29.7	66.3	29.5	42.8	30.9	21.3	54.1	17.2	19.2	34.3	29.1	12.1	34.7	19.7	13.8	16.3	15.6	15.9	14.6	23.2	13.7	21.8	24.3	44.4	40.9	11.0	28.8	13.1	0.4	8.0	3.3	10.0	8.3	21.5	11.4	9.9	10.7	14.2	11.6	12.4	12.5	0.8	15.3	6.5	3.5	15.2	9.6	2.9	3.0	3.5	3.1	2.8	3.5	2.6	2.7	2.5	2.6	3.1	3.4	4.8	16.0	5.9	4.6	8.5	15.0	4.7	4.1	9.6	3.6	4.2	3.7	6.4	7.2	5.8	9.2	2.1	3.4	6.5	2.0	5.9	3.9	181.9	3.5	7.6	5.8	3.6	5.9	8.8	4.6	2.8	3.5	8.6	4.2	5.1	6.5	1.4	9.4	3.8	1.7	9.2	3.8	0.0	4.3	3.7	40.9	3.1	3.8	1.8	3.7	4.5	4.3	8.2	7.5	8.1	3.8	5.8	3.0	6.4	6.2	1.2	5.1	3.2	2.9	0.0	5.1	3.5	10.3	7.9	12.7	17.2	0.5	6.2	6.8	5.5	3.9
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031158	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	28.2	29.1	11.8	38.3	14.0	34.1	34.1	21.0	17.6	32.9	16.9	34.7	32.6	34.9	26.5	30.0	32.9	30.2	48.1	14.2	16.0	35.7	30.0	27.7	49.9	14.1	11.8	31.6	28.3	50.3	17.8	32.9	15.4	32.5	36.3	36.8	30.6	32.4	64.7	28.0	30.9	38.3	12.8	36.5	31.1	39.8	12.8	61.2	37.6	56.7	51.3	42.4	19.8	17.6	78.9	64.3	110.5	98.2	89.3	80.3	61.2	94.6	101.3	98.3	91.1	82.9	80.1	126.5	86.1	94.3	71.4	52.2	140.5	77.2	139.8	54.2	66.3	96.9	70.0	71.5	102.2	156.0	100.6	86.8	76.1	114.3	68.5	81.0	119.5	95.0	145.4	100.0	115.9	56.8	142.3	60.5	92.0	101.5	77.9	105.9	75.7	68.4	66.8	90.7	95.3	106.8	67.5	120.3	89.6	90.7	65.8	88.3	91.2	74.4	95.2	75.8	132.2	77.3	75.5	172.8	82.4	83.1	92.4	51.9	17.0	22.8	27.7	17.0	29.5	27.9	26.6	28.8	22.2	18.9	25.9	30.8	14.4	26.5	19.8	17.6	30.9	19.8	11.8	14.0	21.0	17.6	14.2	16.0	14.1	11.8	15.4	12.8	12.8	17.6	39.5	28.9	52.0	26.8	61.5	41.3	60.9	60.3	39.9	45.5	31.5	26.5	35.7	35.8	56.3	36.8	43.8	49.2	77.1	36.9	19.6	60.9	5.9	53.4	52.7	39.5	29.9	50.5	31.1	55.0	30.7	42.8	59.1	45.8	58.2	36.8	30.7	30.8	29.1	45.4	32.0	36.9	50.8	45.8	36.8	8.8	57.5	42.5	44.4	33.7	74.3	26.7	115.4	23.6	40.4	54.0	36.2	38.0	50.5	59.4	36.6	32.7	80.6	49.0	72.3	46.5	45.7	74.0	63.6	32.7	39.9	41.0	75.2	46.2	35.4	74.6
POLR2D	RPB4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843553-127858155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 170.2;Spermatocytes: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear speckles"		"HPA034694: AB_2674284, HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	12.3	10.4	7.2	14.4	9.8	32.4	11.9	9.6	8.3	9.4	7.3	12.0	9.7	10.3	8.0	12.3	10.6	8.4	10.0	7.5	8.7	8.8	19.2	10.2	19.7	8.0	8.9	15.0	14.7	10.4	8.3	15.9	8.3	9.5	14.7	8.1	8.4	9.2	29.3	11.3	9.3	15.0	8.4	12.8	9.4	74.3	8.1	28.3	9.1	27.1	26.9	15.3	8.4	11.0	63.4	40.6	73.9	51.9	26.8	29.2	59.0	59.1	27.9	69.6	61.9	92.0	50.9	97.7	49.6	40.0	39.8	32.7	107.0	51.2	107.3	57.7	58.3	96.6	37.9	85.4	31.4	104.9	51.6	20.8	37.8	93.3	53.2	19.3	46.1	70.4	137.1	84.8	40.4	50.1	105.0	47.5	103.6	65.9	46.4	99.3	77.8	88.0	23.1	42.6	45.7	60.9	39.9	48.9	50.7	54.7	54.6	71.4	47.0	60.1	84.4	34.4	69.0	99.4	173.4	173.0	52.4	51.2	60.5	9.9	22.8	17.3	26.3	31.7	25.0	22.8	21.0	23.2	29.9	20.2	27.6	23.7	7.3	25.8	35.0	19.5	20.6	21.3	7.2	9.8	9.6	8.3	7.5	8.7	8.0	8.9	8.3	8.4	8.1	11.0	10.9	3.2	11.7	2.6	22.0	10.8	22.0	7.6	15.9	15.1	9.8	6.2	10.4	11.5	10.1	12.9	8.4	33.0	23.4	7.6	11.7	20.3	70.8	13.2	16.1	12.5	8.4	31.1	4.7	17.5	31.0	15.2	9.7	10.4	18.4	23.1	11.4	17.0	21.7	33.7	5.2	11.9	8.2	11.1	14.1	170.2	17.7	13.3	8.8	2.8	23.4	13.2	16.5	2.5	7.5	18.4	8.4	18.4	46.6	26.2	10.2	11.1	6.8	13.7	13.1	18.5	15.5	86.1	48.9	19.3	10.1	26.7	17.1	31.5	14.0	18.9
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II, I and III subunit L"	P62875	11	837356-842529	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1813.6;Proximal tubular cells: 1989.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 569.0;PC-3: 706.8"	"Low region specificity"	"Detected in all"							HPA073614			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA073614: "	"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favorable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	112.1	101.2	68.2	21.5	69.9	27.2	91.0	69.0	98.3	48.0	90.5	63.5	26.1	48.9	16.5	87.1	43.3	16.4	161.8	72.9	75.3	112.7	107.6	68.3	20.4	68.3	71.0	37.3	111.5	30.4	71.7	21.1	70.1	67.9	15.4	11.9	62.6	31.3	101.0	65.3	46.2	24.9	67.9	68.4	63.3	34.3	70.1	21.0	72.5	43.1	17.6	63.3	54.1	69.7	106.4	569.0	52.9	66.5	150.1	107.8	45.6	134.5	94.1	129.6	86.5	166.2	97.6	64.4	35.6	166.6	110.4	69.5	79.7	160.8	39.9	59.9	381.6	63.4	160.7	216.6	88.3	62.3	49.3	178.9	71.6	74.2	36.6	79.2	101.7	63.9	67.0	71.3	156.1	268.4	59.7	63.1	82.6	124.7	706.8	58.8	41.9	99.3	160.7	81.1	104.1	32.1	133.3	135.2	107.3	28.2	81.2	36.7	117.9	87.5	69.1	48.3	83.8	40.0	50.0	62.3	130.8	58.3	78.2	93.3	119.5	121.7	92.9	109.0	100.1	75.5	86.0	92.0	114.0	73.6	71.8	89.3	32.1	123.7	76.6	141.1	92.5	134.7	68.2	69.9	69.0	98.3	72.9	75.3	68.3	71.0	70.1	67.9	70.1	69.7	364.4	410.3	390.2	9.8	265.9	611.8	245.0	767.6	279.4	68.1	491.1	412.0	500.6	584.8	415.4	526.0	25.0	625.4	305.0	669.3	1287.4	444.0	84.2	388.4	377.2	400.3	501.7	363.4	5.0	684.1	467.7	392.3	283.4	301.7	266.2	194.4	649.6	1813.6	700.2	50.5	5.3	641.6	323.5	434.5	582.0	235.7	305.7	307.3	658.1	11.2	493.6	368.5	389.3	3.5	9.0	751.1	589.2	255.1	382.8	300.0	813.6	1989.1	329.9	82.5	157.8	195.2	340.8	182.6	268.6	459.8	696.6	449.6	286.1	284.9	553.1	289.7
POLR3A	"C160, hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029515	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	4.3	6.0	6.6	5.2	7.1	3.9	6.2	6.7	7.9	5.1	4.7	4.8	5.1	5.5	7.5	5.0	4.8	3.7	4.9	8.1	3.7	5.2	5.6	4.0	5.7	5.5	3.4	6.5	5.4	6.8	10.4	6.1	5.5	5.8	5.7	12.8	5.0	4.5	11.5	6.7	4.7	5.6	2.2	5.1	4.7	6.0	4.0	7.6	5.6	8.7	6.3	5.0	4.8	6.5	14.2	16.3	17.4	28.8	11.2	14.2	11.6	16.0	20.7	20.2	19.8	22.1	10.0	17.6	9.7	14.0	11.5	15.7	30.3	17.5	24.4	13.0	22.2	14.2	13.6	26.6	10.5	24.6	11.5	12.2	12.3	35.9	33.0	19.4	18.0	14.1	26.8	10.6	19.9	10.6	18.7	15.6	19.0	11.0	75.1	17.5	11.0	11.5	10.0	8.6	15.5	20.0	15.4	28.3	16.6	15.5	21.0	12.7	19.8	12.9	12.5	14.2	32.0	16.4	18.6	21.0	23.0	25.4	6.4	5.4	2.6	1.5	3.5	3.1	3.5	2.6	2.8	3.4	2.4	3.2	2.5	3.0	1.5	3.4	2.9	2.6	4.6	1.9	6.6	7.1	6.7	7.9	8.1	3.7	5.5	3.4	5.5	2.2	4.0	6.5	8.5	0.0	9.1	17.0	8.7	9.9	5.1	5.3	11.4	28.3	9.6	8.3	11.7	8.6	9.5	0.0	64.6	8.0	12.6	6.1	1.9	7.0	1.6	8.3	14.4	8.1	7.2	11.6	26.4	6.2	6.9	8.2	8.2	8.9	6.3	15.7	5.3	9.5	5.5	15.2	26.3	10.2	0.0	6.9	3.7	1.2	13.1	5.9	1.8	10.3	7.8	13.0	12.3	16.1	18.7	8.1	8.3	8.2	11.2	4.7	8.0	5.0	10.4	31.5	6.6	13.6	8.3	12.5	18.0	10.1	9.1	4.1	7.8	13.7	8.6	3.6
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 616.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.4	3.8	2.1	0.5	2.0	0.0	31.2	1.7	1.9	5.3	1.4	2.0	7.9	0.9	3.6	0.5	1.3	4.4	1.0	1.8	2.1	2.7	616.7	14.2	0.1	2.3	2.2	12.4	14.3	0.2	24.9	0.8	2.9	0.9	2.8	0.1	26.3	3.9	0.3	7.4	3.1	0.2	2.1	0.3	2.3	9.0	2.1	1.6	7.1	0.3	5.9	1.4	0.9	1.9	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	1.7	1.9	1.8	2.1	2.3	2.2	2.9	2.1	2.1	1.9	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 313.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 489.2;Proximal enterocytes: 274.2;Theca cells: 647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 328.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		12000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	53.4	197.4	19.9	32.1	20.7	17.9	44.7	14.1	18.6	42.0	15.5	35.9	105.2	32.1	29.4	53.6	50.2	37.0	43.3	20.7	30.2	38.1	313.3	55.0	19.9	22.2	24.5	52.2	44.5	77.6	71.4	46.3	20.9	31.8	21.9	12.7	29.9	113.1	56.2	43.8	92.4	28.2	16.9	43.8	41.5	25.5	34.7	38.0	131.3	68.1	23.2	36.6	42.3	15.3	59.6	133.0	57.0	106.3	212.9	79.8	98.0	24.4	79.3	44.7	62.3	100.7	257.0	56.1	21.9	53.1	151.8	28.3	76.0	38.4	19.6	48.1	57.9	26.0	36.9	189.4	146.5	26.2	45.5	163.9	47.4	59.2	43.2	36.3	42.3	27.1	79.1	24.0	40.8	90.9	29.0	49.4	71.7	92.9	74.8	41.0	37.6	61.1	50.0	72.8	59.3	57.4	65.4	328.4	91.0	32.6	94.0	44.2	38.6	41.7	45.8	63.6	48.7	23.8	38.3	39.0	59.3	39.8	54.9	65.9	42.6	60.4	20.6	39.6	17.1	11.0	17.5	19.4	45.6	11.2	17.1	14.7	53.8	25.9	30.2	12.5	19.3	36.6	19.9	20.7	14.1	18.6	20.7	30.2	22.2	24.5	20.9	16.9	34.7	15.3	34.3	38.5	39.7	23.2	17.1	17.1	29.4	172.3	13.1	31.4	20.5	14.0	10.9	54.3	201.4	73.5	12.5	99.9	26.0	97.7	1.9	65.0	27.6	62.1	28.0	27.1	19.8	11.8	10.1	29.4	95.0	40.1	67.8	46.6	24.7	121.4	32.2	489.2	67.8	15.2	17.1	41.7	124.1	35.2	16.1	9.5	75.8	47.3	12.4	11.2	20.5	25.9	12.3	11.6	8.8	27.9	102.0	112.5	17.0	20.7	274.2	31.7	178.6	23.0	65.7	32.7	46.9	21.3	30.8	18.2	14.6	193.2	25.4	647.6	44.5	45.9
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
POTEE	"A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma"	ENSG00000188219	"POTE ankyrin domain family member E"	Q6S8J3	2	131218067-131265278	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 1.9;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 6.0;Breast glandular cells: 2.5;Prostatic glandular cells: 2.8;Smooth muscle cells: 2.4;Spermatocytes: 4.9;Spermatogonia: 2.0;Urothelial cells: 2.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;K-562: 1.4;U-2 OS: 2.3"									"HPA041264, HPA041271, HPA043260"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-3)"		"unprognostic (3.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.61e-3)"	"unprognostic (5.77e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.2	1.1	0.5	0.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.0	0.2	0.0	0.0	2.5	1.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	2.4	4.9	2.0	0.0	0.1	0.4	0.1	0.2	0.0	2.2
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 homeobox associating factor 1"	Q16633	11	111352255-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 119.4;stomach 1: 40.1"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 566.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 33.5;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	9	"B-cells: 33.5"	"Group enriched"	"Detected in many"	4	"Daudi: 307.2;Karpas-707: 339.3;U-266/70: 326.6;U-266/84: 159.9;U-698: 610.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011193	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB011193: AB_532299"	"prognostic favorable (1.68e-4)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	1.9	1.2	6.4	49.0	4.9	8.1	5.6	4.2	7.0	1.7	20.3	15.7	22.2	1.5	1.3	2.9	1.3	4.7	1.4	5.4	3.6	1.4	1.4	3.3	99.3	6.2	6.1	1.1	0.6	0.3	0.1	2.8	7.2	1.8	13.4	6.5	12.9	1.9	1.8	1.1	38.6	1.2	2.7	79.5	40.1	1.6	5.4	9.6	2.8	0.3	119.4	9.3	1.9	7.3	0.9	0.9	0.3	0.4	5.6	5.2	1.0	0.2	0.1	0.1	0.1	1.1	0.3	307.2	0.7	0.3	0.2	0.8	0.9	0.4	0.1	0.9	0.2	0.5	1.0	1.1	0.1	0.6	1.7	0.2	0.3	0.3	0.6	0.5	0.3	3.4	11.8	339.3	0.3	0.8	1.5	1.6	0.4	0.5	0.5	65.3	0.7	83.0	0.2	0.8	0.6	6.1	0.7	0.3	0.2	2.4	1.3	0.9	2.7	0.5	3.1	0.6	0.5	326.6	159.9	610.8	0.4	0.7	0.5	3.8	0.2	0.6	0.3	0.2	0.2	33.5	0.5	0.2	0.1	24.0	0.4	0.2	1.6	0.5	0.4	0.3	1.2	1.2	6.4	4.9	4.2	7.0	5.4	3.6	6.2	6.1	7.2	2.7	5.4	7.3	0.0	0.0	3.6	0.3	131.3	0.3	7.1	12.3	0.0	0.0	0.0	0.9	1.9	10.0	20.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.4	24.9	0.6	0.2	3.0	6.6	0.1	5.7	0.0	0.8	4.6	0.5	0.0	0.1	0.7	2.4	0.1	0.0	0.1	0.7	2.0	0.6	0.4	10.9	0.3	0.8	8.8	1.0	0.3	0.0	1.0	0.0	4.6	0.4	1.2	0.4	566.8	1.2	0.0	0.4	65.0	0.0	0.0	0.1	1.0	6.3	1.8	0.8	0.0	0.0	4.2	0.0	0.8	8.4
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPAN	"BXDC3, SSF, SSF1, SSF2"	ENSG00000130810	"Peter pan homolog"	Q9NQ55	19	10106362-10112012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 243.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043265	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA043265: AB_10793943"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (8.75e-3)"	"unprognostic (7.52e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.92e-3)"	23.3	20.5	4.9	15.8	5.3	12.3	20.2	6.6	7.7	18.3	2.5	18.8	12.3	19.3	4.0	27.8	18.9	6.9	17.6	5.1	4.0	18.9	24.5	14.8	18.1	4.1	4.2	19.6	23.2	8.4	13.8	7.5	4.3	19.5	5.8	4.8	16.6	6.8	32.8	28.2	20.0	6.9	1.9	26.5	18.4	18.9	5.5	10.0	16.0	11.1	12.0	20.4	20.5	8.8	51.0	42.0	16.0	35.9	10.8	11.4	34.2	26.7	12.8	33.7	26.3	56.0	19.5	59.0	48.0	17.2	24.4	42.6	42.0	47.7	14.5	31.8	104.6	104.1	47.6	55.2	27.5	66.4	62.5	17.9	36.0	37.0	46.0	22.0	17.2	45.6	76.1	54.9	17.7	72.2	82.5	243.5	75.1	26.8	103.2	60.2	20.5	80.4	19.0	44.8	33.7	41.7	23.9	42.9	40.8	10.6	23.8	37.2	21.1	45.8	24.3	50.6	70.9	111.0	59.3	61.2	31.8	60.2	41.4	2.4	7.1	4.0	6.7	5.0	8.6	17.0	9.2	10.7	6.6	20.6	12.9	5.9	4.7	5.6	3.7	5.0	9.7	3.2	4.9	5.3	6.6	7.7	5.1	4.0	4.1	4.2	4.3	1.9	5.5	8.8	12.2	3.2	6.4	0.0	20.2	57.4	50.3	15.4	4.0	11.3	12.8	14.1	3.9	10.0	12.1	5.5	6.2	26.4	24.0	20.0	3.9	33.2	9.0	4.6	10.5	13.0	6.7	10.3	0.0	30.6	32.0	14.1	6.1	5.1	7.0	13.8	10.4	11.4	32.4	18.5	0.0	17.7	16.2	7.6	17.0	9.1	18.6	10.5	12.4	0.0	15.7	5.0	18.6	0.0	0.0	31.7	12.6	10.5	9.9	33.2	10.3	18.9	5.8	9.9	0.0	18.8	16.7	22.7	42.1	6.8	52.8	17.8	18.9	19.9	24.9	27.9
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 165.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	165.1	3.9	4.0	8.7	3.0	3.0	74.3	3.2	4.7	9.7	0.6	48.7	23.6	7.0	1.2	6.2	7.0	10.5	14.6	4.0	2.7	14.3	17.1	28.5	4.9	3.7	3.5	14.5	2.8	7.9	0.5	43.6	3.4	5.5	40.6	1.0	5.7	1.7	5.2	6.2	15.1	8.7	3.2	12.0	35.5	6.9	3.5	4.1	13.2	8.1	2.1	67.7	9.1	5.0	44.0	38.6	0.0	0.2	198.7	113.7	247.5	3.7	44.7	5.4	2.1	7.8	111.6	0.0	0.1	4.0	72.9	17.3	14.4	0.7	1.0	106.4	20.3	0.0	8.1	10.3	51.8	0.2	0.1	118.9	9.7	9.8	37.5	20.6	0.7	1.0	0.0	0.0	8.3	11.0	0.1	0.8	0.7	99.2	112.0	0.0	0.0	0.2	30.6	157.5	0.1	1.2	18.8	6.7	2.2	6.7	0.0	34.2	35.0	7.8	10.6	4.6	0.2	0.0	0.1	0.3	3.2	0.5	1.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	3.0	3.2	4.7	4.0	2.7	3.7	3.5	3.4	3.2	3.5	5.0	284.1	3.2	7.2	1.6	0.6	1.0	50.5	0.4	4.6	0.9	1.9	2.8	9.2	1.5	2.5	5.5	0.0	110.4	1.8	93.4	1.9	1.1	4.9	5.2	1.4	26.1	8.4	0.0	39.3	0.7	217.8	12.3	83.1	20.8	8.9	232.9	25.7	3.4	49.9	0.0	74.1	21.3	0.0	19.4	4.8	2.2	4.1	19.1	3.6	38.4	1.8	0.6	0.0	6.6	1.2	17.3	84.1	0.0	1.6	42.1	17.0	14.3	1.5	0.2	13.1	1.9	31.3	10.9	22.8	4.6	1.1	88.9	2.2	0.8	24.5	239.6
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 98.7;lymphoid tissue: 53.6"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.3	0.5	0.3	0.5	0.4	98.7	0.6	0.3	2.2	0.1	1.0	0.1	0.0	0.1	0.0	0.2	0.8	0.8	1.3	0.2	0.3	0.9	2.9	19.4	0.0	0.5	0.4	0.1	0.1	0.0	0.4	5.2	0.8	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.8	53.6	0.2	0.0	0.7	0.1	1.0	4.2	0.0	8.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.3	0.4	0.3	2.2	0.2	0.3	0.5	0.4	0.8	0.8	0.7	0.4	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.8;testis: 14.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 64.0;Late spermatids: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.2	1.3	0.0	2.0	1.0	2.3	1.8	2.6	0.1	0.8	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	1.6	1.4	0.2	0.1	0.3	0.1	3.5	2.1	0.2	0.1	0.0	0.5	0.6	2.4	0.4	0.0	1.4	0.1	0.3	0.1	0.4	0.1	0.0	1.8	0.2	0.1	14.6	1.5	0.1	0.2	0.0	0.1	0.2	0.1	5.8	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.0	1.8	2.6	1.6	1.4	3.5	2.1	2.4	1.8	1.5	5.8	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	4.7	0.0	0.0	0.0	0.3	139.0	0.6	0.0	3.6	1.0	0.1	0.6	0.0	0.5	2.2	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	1.2	1.2	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.8;heart muscle: 22.0;skeletal muscle: 18.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 12.7;Cardiomyocytes: 35.3;Excitatory neurons: 36.9;Inhibitory neurons: 31.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 58.8;cerebral cortex: 37.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 8.0;hTERT-RPE1: 13.1;RH-30: 13.6;U-266/70: 8.5;U-87 MG: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.5	0.6	9.5	0.4	4.2	1.0	0.6	58.8	37.4	3.5	0.0	1.4	0.5	2.3	2.4	1.1	1.0	1.7	22.0	7.6	0.0	5.3	0.3	0.8	0.2	2.2	0.0	0.9	0.1	0.4	1.6	2.8	1.5	1.0	0.2	7.2	1.4	0.6	18.9	2.0	0.8	1.2	0.0	1.6	0.8	3.2	2.5	0.4	0.5	12.0	0.2	0.6	2.0	3.1	8.0	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.2	0.4	0.3	0.4	1.6	1.8	0.2	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	13.1	0.0	1.6	0.1	0.3	6.5	1.1	0.6	1.0	0.9	0.0	0.3	1.4	13.6	2.3	0.0	0.0	2.6	3.3	0.8	0.2	1.1	1.2	0.2	0.6	0.0	4.8	2.8	0.1	0.1	8.5	0.2	0.1	12.4	0.7	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	4.2	58.8	37.4	7.6	0.0	2.2	0.0	1.5	0.0	2.5	3.1	0.1	0.0	0.0	12.7	0.1	0.0	0.1	3.7	0.6	5.1	0.5	0.3	35.3	0.0	0.9	0.0	6.2	0.1	0.1	0.0	0.0	0.9	2.7	0.4	0.3	0.6	0.0	0.0	36.9	0.0	0.4	1.7	0.0	0.7	0.0	1.8	0.7	0.0	0.3	6.7	31.9	0.1	0.0	0.0	0.0	3.6	0.3	0.7	0.0	4.7	1.9	1.5	1.0	5.5	1.9	0.4	0.1	1.9	0.0	0.1	0.0	0.1	1.0	1.5	0.0	1.1	0.8	0.6	1.4	0.3	0.0	0.3	0.1	0.1	0.0	0.0
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 201.3;Endothelial cells: 189.5;Excitatory neurons: 206.1;Oligodendrocytes: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001924, HPA071162"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001924: AB_1079665, HPA071162: "	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	32.4	27.0	22.5	13.7	33.6	3.3	37.9	0.3	29.5	24.0	18.3	25.0	11.9	27.7	11.4	28.6	26.6	20.1	77.0	29.0	10.0	36.3	26.7	39.6	9.3	7.0	14.9	85.2	21.3	17.1	19.6	60.2	11.2	24.7	18.2	5.1	21.6	29.3	25.9	30.4	15.0	31.3	5.9	29.9	25.5	11.9	31.6	18.5	39.0	44.3	10.5	24.4	29.5	22.9	18.8	37.1	29.7	25.5	48.4	133.3	52.9	67.0	75.2	38.6	55.4	98.0	55.9	14.2	75.6	135.7	51.5	46.0	16.3	61.0	69.1	32.3	9.0	31.3	28.3	14.6	21.0	9.8	16.9	104.8	41.3	112.1	114.0	75.2	134.0	18.9	16.7	13.9	138.5	14.4	9.1	2.8	53.4	26.8	28.5	14.6	74.0	5.5	56.6	41.0	2.4	12.1	33.4	17.6	91.3	206.5	22.7	14.3	131.3	107.7	36.0	59.8	68.8	0.2	0.4	1.2	119.7	13.7	173.7	0.9	0.2	0.1	0.3	0.0	0.6	0.3	0.5	0.3	0.3	2.7	0.5	0.5	0.6	0.1	0.1	0.9	0.8	0.2	22.5	33.6	0.3	29.5	29.0	10.0	7.0	14.9	11.2	5.9	31.6	22.9	201.3	99.3	19.8	7.5	9.4	41.0	76.5	42.8	68.3	15.5	19.6	40.3	164.0	10.0	18.3	80.9	4.2	37.2	2.5	8.0	11.7	42.2	3.5	40.2	12.7	189.5	18.6	8.6	206.1	24.8	23.2	74.6	46.9	73.3	3.8	132.8	157.8	14.0	8.9	45.4	68.4	15.9	10.2	16.7	30.9	5.4	21.1	6.2	62.2	174.3	3.1	6.3	0.0	116.6	202.9	33.9	19.7	42.2	4.6	45.0	8.6	48.7	9.0	1.8	19.7	71.7	78.9	2.4	8.6	48.2	27.6	91.9	5.9	25.4	12.5	84.5
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;OE19: 100.4;RT4: 105.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favorable (1.34e-5)"	10.8	11.7	21.5	12.0	34.2	7.6	16.6	24.9	24.4	14.7	51.3	22.4	26.4	6.7	33.5	27.3	17.2	15.7	13.0	21.8	26.2	19.0	35.4	11.6	15.2	27.4	29.8	14.3	9.4	66.5	4.8	21.0	29.0	18.2	26.5	2.8	54.8	32.8	33.4	33.2	26.0	5.4	20.6	11.1	44.1	31.5	31.7	4.5	37.5	21.4	25.0	29.5	21.8	43.8	2.0	32.7	5.3	3.1	6.1	0.4	80.5	7.1	16.1	4.1	4.0	26.7	4.6	9.7	3.7	4.1	15.1	14.2	21.0	2.1	3.7	3.9	2.4	0.0	0.3	17.1	8.4	19.6	9.3	10.7	7.6	0.0	4.5	0.4	1.5	2.0	0.9	26.5	4.0	15.9	0.0	19.0	37.8	100.4	0.1	3.3	0.1	17.4	0.1	105.0	1.5	12.4	1.1	28.9	21.9	14.6	4.0	14.7	0.5	1.9	2.8	6.4	0.7	14.1	11.1	8.3	2.3	4.5	13.0	3.4	9.1	6.5	3.1	11.2	2.3	12.7	5.0	2.1	8.3	7.2	6.6	5.2	4.2	2.6	14.4	0.6	1.1	5.2	21.5	34.2	24.9	24.4	21.8	26.2	27.4	29.8	29.0	20.6	31.7	43.8	1.7	16.0	13.6	3.9	21.2	5.5	18.7	4.5	10.2	1.5	10.1	7.7	5.2	11.5	13.7	14.7	18.8	9.1	1.6	29.8	9.8	5.8	53.4	6.7	4.8	3.2	3.6	0.0	3.8	9.6	56.2	7.7	40.2	35.7	7.0	0.6	1.1	17.3	7.1	0.0	6.0	23.2	8.2	10.4	7.2	47.2	4.7	11.3	16.0	17.8	15.7	1.7	3.1	49.8	70.5	6.9	22.8	7.2	9.0	13.4	26.8	19.7	7.5	3.3	0.0	5.7	10.2	22.2	2.6	10.7	9.9	4.8	2.0	1.2	18.0	18.6
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	NA	NA		230000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	1148.4	1085.6	1707.2	714.4	1757.6	1052.9	1368.0	1733.9	2245.6	943.7	1718.8	1352.6	603.7	854.8	981.6	2149.0	771.3	548.8	781.6	1785.4	1791.4	1412.8	1318.6	1099.2	1067.1	1857.4	1728.1	799.5	967.7	1286.3	670.1	805.9	1860.7	766.1	1196.0	496.7	1020.3	782.9	566.1	1516.0	953.4	943.4	1767.2	1134.4	896.7	366.0	1742.4	2333.2	884.9	517.9	1647.3	1339.3	1208.7	1822.8	2141.8	3020.1	3731.1	2509.6	2798.6	4154.8	1115.0	3173.6	4588.0	5531.3	5393.2	3414.3	3127.1	4614.1	1893.1	3828.8	6554.2	3209.5	4495.7	5727.5	5062.6	2674.3	3204.3	1883.6	3911.6	4682.5	2255.3	3890.0	2246.2	3103.5	3820.5	3988.9	4295.5	2888.1	5717.2	3277.9	3933.2	3789.6	5790.6	3665.7	4667.5	7562.4	4612.9	7628.9	3689.2	3554.4	2050.1	5969.7	8018.9	4215.4	2548.3	2218.7	2500.5	7185.8	2493.3	4091.8	4303.8	5202.3	2587.0	2865.0	3656.5	2027.1	4050.5	3861.7	6522.3	9409.0	2614.0	4314.6	4455.2	475.6	1239.3	594.8	1421.6	1449.2	1534.2	2104.8	1500.3	1491.1	2196.1	1769.5	1217.2	1394.4	133.3	1349.0	1374.8	2618.5	2085.4	3631.4	1707.2	1757.6	1733.9	2245.6	1785.4	1791.4	1857.4	1728.1	1860.7	1767.2	1742.4	1822.8	713.8	794.9	759.9	37.2	1037.1	866.6	867.8	1097.5	1878.1	94.3	1226.2	1628.0	47.6	526.1	743.6	603.2	18.8	852.7	1067.7	658.4	1414.6	1172.4	78.2	539.3	770.8	719.7	529.6	1120.3	57.3	1218.7	1683.7	672.4	820.1	862.1	622.1	650.0	669.7	766.9	1582.1	111.0	50.4	1003.5	587.9	1110.0	786.1	81.4	582.2	988.1	691.9	41.2	1283.2	221.6	995.9	27.2	79.8	1222.6	715.0	613.1	1215.3	922.1	831.6	1636.8	481.4	101.5	394.4	588.7	942.7	366.7	246.1	2608.3	990.4	609.2	924.5	1157.5	1262.6	947.0
PPIB	"B, CYP-S1, CYPB, OI9, PPIase, SCYLP"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155740-64163134	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease variant, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	No	No		33000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	375.5	377.5	230.7	449.5	240.3	571.9	361.9	247.9	259.2	611.5	257.2	401.0	365.0	383.9	899.0	298.8	401.5	379.2	262.0	229.7	256.9	312.3	737.4	351.1	344.5	258.1	241.4	386.2	644.2	345.4	416.8	515.2	255.1	375.7	411.3	72.3	513.1	488.6	62.2	205.5	334.3	482.4	247.0	360.5	375.0	110.0	254.9	315.6	672.8	91.1	346.4	510.9	295.6	262.6	675.6	847.9	736.7	1666.7	2577.0	1492.3	641.9	1570.3	2108.3	1248.7	1472.3	1242.6	1223.1	653.6	1227.4	2513.0	1235.3	1067.7	1384.6	1080.4	641.1	406.2	491.0	914.5	915.3	1643.7	2682.9	915.0	778.1	1374.2	1149.4	725.9	1751.3	1516.7	1539.2	301.1	645.9	2174.7	966.0	1102.6	280.6	1404.9	625.1	1879.0	529.5	520.6	784.1	3347.9	1312.7	1062.6	410.5	647.7	726.0	1224.5	1194.2	1086.0	727.6	2767.0	927.6	1213.7	975.8	679.2	1079.4	1152.5	1269.5	693.4	1129.0	1478.0	1238.2	716.7	712.5	491.7	929.6	547.3	931.8	827.8	645.0	762.4	930.9	541.4	411.3	558.0	347.5	668.1	369.3	2643.5	569.3	1512.3	230.7	240.3	247.9	259.2	229.7	256.9	258.1	241.4	255.1	247.0	254.9	262.6	389.3	125.0	209.0	16.6	375.3	160.2	426.2	614.6	234.5	34.5	264.3	303.8	0.8	270.2	328.7	272.2	31.3	625.9	560.0	271.0	90.1	665.1	19.0	295.8	910.1	285.0	297.0	172.6	10.2	566.4	1473.7	627.8	441.4	494.2	181.2	540.4	322.7	473.2	630.1	45.4	15.8	603.9	205.4	216.9	333.4	29.5	456.3	316.6	281.1	19.7	299.1	149.1	368.7	35.2	37.0	435.1	338.9	393.1	2242.6	569.3	338.6	287.4	168.2	43.7	230.1	204.3	445.6	38.4	76.6	337.0	144.8	1118.9	352.3	674.0	477.2	422.3
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709127-158723396	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		480000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	26.8	38.3	38.0	24.4	40.2	25.1	22.8	40.4	77.6	25.4	46.4	33.9	50.6	24.2	19.0	27.7	24.1	18.8	49.6	40.1	44.2	39.5	87.6	19.8	28.6	39.0	39.4	24.2	31.7	17.0	28.6	21.6	40.2	23.5	20.3	36.2	23.3	18.7	88.9	36.1	45.3	18.9	39.6	29.1	29.0	24.1	42.2	24.3	23.9	45.5	25.8	27.4	24.0	46.9	46.7	42.3	41.8	57.7	60.7	45.2	63.1	44.9	24.3	40.3	30.4	55.4	30.9	48.9	19.7	42.0	63.4	35.1	127.9	51.5	48.8	162.9	44.4	87.5	36.5	76.9	46.8	55.6	63.0	28.9	41.2	34.6	51.5	52.0	44.6	81.9	111.0	84.4	45.5	44.6	80.0	49.9	57.9	75.5	55.8	35.9	20.7	41.7	44.6	23.0	70.2	47.1	33.8	69.2	65.6	60.0	31.9	52.2	43.7	40.1	45.3	44.7	60.2	48.3	107.2	62.0	51.1	59.4	41.1	68.8	23.9	55.2	31.1	35.4	36.0	22.3	30.2	29.1	26.4	25.4	30.9	32.0	32.9	40.5	37.7	26.9	37.0	28.0	38.0	40.2	40.4	77.6	40.1	44.2	39.0	39.4	40.2	39.6	42.2	46.9	29.2	6.4	13.4	13.1	24.8	10.1	29.7	17.5	9.1	30.2	19.1	20.8	59.7	25.8	27.9	27.6	22.9	41.5	38.7	17.1	37.2	39.2	39.0	66.1	39.9	25.1	19.6	17.4	24.3	23.0	49.5	24.3	14.3	28.5	32.3	24.4	17.2	18.5	41.9	75.7	28.6	28.3	22.4	17.0	14.7	23.1	20.5	26.0	14.2	9.4	51.6	23.3	48.4	15.1	28.3	29.5	27.4	22.6	22.3	31.6	39.7	33.7	62.3	32.3	6.6	17.7	58.2	96.0	77.5	16.9	11.8	47.6	33.7	33.7	32.0	20.2
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355334	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 370.9;Macrophages: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 75.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		320000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	62.7	227.7	42.7	42.8	48.4	168.8	42.4	57.9	69.6	27.6	63.7	50.0	36.3	14.0	7.2	66.0	22.9	19.5	119.1	38.1	45.2	63.3	174.9	29.1	32.3	49.0	56.2	19.3	86.9	77.6	18.3	27.1	48.8	18.8	52.4	8.9	39.5	45.5	99.5	71.9	31.3	21.0	50.6	58.7	98.2	35.0	57.1	28.3	26.0	133.6	55.5	60.0	35.1	60.8	220.4	90.6	62.3	123.5	57.0	73.6	79.8	124.2	161.2	265.7	249.6	213.5	102.7	224.8	68.0	87.4	188.6	127.8	195.3	115.4	410.5	72.2	186.4	352.8	87.5	380.7	96.4	245.7	80.4	173.2	81.3	264.5	262.3	86.5	47.5	86.4	351.6	268.3	91.6	111.7	64.1	204.2	53.0	99.6	500.6	109.8	96.4	114.7	103.9	200.0	124.1	92.0	63.6	253.8	97.9	40.5	111.4	187.2	43.5	116.1	106.3	137.9	242.0	124.7	137.7	181.9	114.5	313.9	32.0	15.2	34.3	18.0	10.4	27.5	10.9	19.1	9.1	9.6	43.3	7.7	8.1	7.9	75.0	9.0	10.4	5.4	10.0	16.6	42.7	48.4	57.9	69.6	38.1	45.2	49.0	56.2	48.8	50.6	57.1	60.8	8.4	6.4	6.8	7.2	32.7	42.6	30.2	23.8	31.3	4.0	41.8	40.8	124.6	14.3	14.4	12.9	6.2	99.4	26.4	39.9	92.0	42.1	14.5	12.4	24.0	10.1	21.6	37.0	4.1	28.0	127.1	25.1	78.0	15.5	13.4	73.4	6.1	98.5	91.1	8.4	5.7	69.5	18.3	40.3	370.9	14.1	6.2	160.8	35.6	4.7	32.0	13.0	5.2	5.5	15.0	39.8	26.6	6.0	48.7	41.4	21.3	41.2	12.6	5.2	19.7	18.2	28.6	14.8	22.5	52.9	37.6	142.3	23.9	60.2	81.1	34.2
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584342-169641406	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.0	23.2	23.1	28.4	22.1	54.2	27.5	28.8	58.6	27.6	22.9	26.3	26.6	28.8	31.5	27.5	23.6	22.0	25.6	21.5	29.9	29.2	47.1	24.7	36.9	24.6	25.6	26.5	21.2	32.6	25.8	28.0	24.3	27.9	26.0	29.3	26.5	22.9	27.6	25.4	29.7	21.7	22.9	32.3	27.4	20.1	23.7	36.1	29.9	26.2	35.4	26.3	26.5	25.9	56.4	25.5	70.8	35.9	35.4	42.5	63.7	58.9	42.3	45.0	45.9	66.3	58.9	94.8	52.5	44.1	55.5	50.5	56.6	48.4	65.6	68.0	45.7	129.9	36.7	88.3	34.4	136.8	58.9	36.6	54.0	58.5	64.6	40.6	50.4	53.5	142.7	76.2	49.5	43.5	101.0	81.9	100.8	45.3	25.1	90.7	71.7	90.5	53.9	81.2	60.5	41.2	63.4	47.2	68.9	52.9	44.2	78.7	52.7	53.9	43.7	38.4	52.6	41.1	65.3	126.8	38.5	68.1	54.1	31.9	22.5	36.7	22.8	25.1	26.7	32.9	30.9	29.2	18.2	38.4	33.4	27.6	40.4	21.1	31.4	30.0	26.8	17.0	23.1	22.1	28.8	58.6	21.5	29.9	24.6	25.6	24.3	22.9	23.7	25.9	159.7	221.2	175.1	53.5	188.8	151.4	191.4	185.9	101.3	204.6	120.8	156.1	148.4	107.2	169.5	93.8	54.2	170.0	160.1	91.6	80.3	103.1	11.0	104.6	142.3	141.1	104.8	163.5	82.4	103.3	177.0	142.4	66.8	126.3	179.1	115.8	121.7	181.2	151.7	220.4	81.8	135.8	116.0	130.3	126.5	15.6	142.0	129.6	110.3	46.9	152.4	137.6	133.9	53.8	69.7	93.9	118.0	146.7	130.1	161.8	121.1	113.8	132.2	109.1	164.3	150.2	193.9	276.4	183.8	108.3	172.8	205.5	166.7	147.1	149.9	167.7
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658335-42676758	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059019	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA059019: AB_2683885"	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	22.9	23.2	22.1	27.8	23.1	56.8	27.7	23.7	29.5	24.8	20.8	33.2	24.4	23.5	25.4	36.4	23.5	17.9	25.8	23.0	22.5	22.1	17.5	22.4	44.5	22.2	22.0	25.8	19.2	18.3	13.4	24.7	22.7	21.2	32.8	22.4	23.9	18.3	19.8	27.5	27.8	21.5	21.8	32.3	23.4	22.9	22.5	60.3	26.0	21.1	50.4	26.6	25.8	23.3	105.8	66.4	80.1	113.3	24.9	51.5	101.4	67.6	50.1	127.4	114.4	98.1	111.8	171.5	85.9	52.8	61.7	82.3	150.8	108.2	133.9	150.2	119.7	156.4	104.4	98.6	21.4	322.0	90.7	31.2	57.5	117.9	90.6	49.1	60.6	161.2	205.7	91.7	63.8	84.2	250.1	451.0	200.4	100.4	77.7	136.8	150.2	152.2	64.1	64.8	59.2	113.5	59.6	101.1	77.4	100.8	54.5	465.0	48.1	53.2	143.1	77.0	171.7	60.0	140.2	319.6	62.8	294.9	94.8	29.7	15.1	33.3	35.0	23.5	33.3	33.6	35.7	39.9	20.7	32.9	36.1	43.5	3.6	36.4	21.8	25.9	38.2	25.0	22.1	23.1	23.7	29.5	23.0	22.5	22.2	22.0	22.7	21.8	22.5	23.3	31.3	19.2	20.7	9.8	48.1	28.9	48.2	51.7	38.7	10.0	30.1	44.4	14.1	11.5	25.8	22.0	4.2	62.5	37.7	15.7	45.0	29.4	33.2	23.4	27.4	25.1	21.5	49.8	12.7	26.4	104.5	25.5	27.5	21.6	31.0	46.9	19.2	11.2	52.1	5.0	9.6	27.3	34.6	18.6	25.6	7.3	29.2	28.5	16.0	9.4	26.2	22.2	52.5	11.6	11.6	25.8	17.6	21.4	45.6	28.0	16.1	34.1	19.6	16.1	19.7	21.5	42.0	19.7	32.3	54.6	21.5	37.9	42.7	46.4	40.0	38.7
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 728.1;vagina: 288.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Squamous epithelial cells: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;HaCaT: 191.1;MCF7: 71.5;SiHa: 102.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		80000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	56.3	4.9	2.5	1.0	3.2	0.2	39.8	0.3	4.2	163.0	3.3	10.4	6.5	5.7	7.3	728.1	11.5	7.1	5.7	3.6	0.0	13.2	13.3	18.6	0.4	0.0	2.8	5.9	10.6	4.1	14.3	6.4	1.1	17.3	3.4	2.4	149.5	11.5	12.0	188.4	12.3	1.7	0.0	0.3	11.1	1.9	0.0	3.5	22.1	5.3	57.0	22.0	288.6	0.5	24.0	8.6	0.1	0.1	60.0	86.5	29.6	0.1	1.6	0.2	0.6	39.5	59.5	0.4	13.5	1.2	3.4	191.1	1.3	23.0	0.0	0.0	1.3	0.1	46.3	7.1	3.8	0.1	0.1	4.2	20.7	0.2	7.1	4.6	0.1	0.2	0.2	0.2	0.1	71.5	0.1	0.2	6.0	31.3	18.1	0.1	0.1	30.0	44.6	37.5	30.9	0.3	102.5	33.8	0.3	8.9	17.4	0.5	0.3	0.2	0.3	0.3	0.1	0.4	1.1	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.2	0.3	4.2	3.6	0.0	0.0	2.8	1.1	0.0	0.0	0.5	4.1	73.7	29.1	1.6	1.2	35.1	32.5	30.5	35.9	8.4	18.8	13.8	5.1	35.8	42.6	57.0	6.2	2.1	2.0	3.6	1.9	18.4	0.7	31.6	4.1	8.0	39.4	0.0	6.6	4.5	1.6	38.0	9.2	28.0	0.0	0.8	2.9	12.7	0.7	1.7	2.5	3.8	18.3	0.9	9.0	1.3	55.3	1.4	17.8	1.0	1.2	3.7	2.1	1.0	1.7	23.4	8.3	4.1	0.2	35.1	13.5	1.2	32.5	12.5	0.0	28.7	4.3	3.9	3.1	138.0	51.3	1.4	2.7	0.4	4.8	53.2
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 639.3;Late spermatids: 923.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	63.3	64.9	58.8	76.8	61.7	103.6	72.5	67.1	69.7	59.4	53.2	110.5	193.2	66.7	57.5	92.0	59.2	57.2	91.5	56.1	66.5	60.4	64.4	53.6	139.0	60.0	62.7	90.3	74.0	68.4	41.5	53.2	60.5	58.5	108.4	125.0	71.6	55.2	157.7	60.7	147.7	76.8	59.8	73.4	73.5	142.3	62.7	107.7	54.9	175.8	131.4	86.3	53.6	65.7	221.0	130.2	217.5	160.0	128.9	176.6	166.0	124.1	183.1	201.0	159.6	223.8	109.0	341.7	91.2	133.8	125.8	122.5	295.3	162.7	278.9	200.2	198.9	221.7	93.0	230.4	105.1	285.5	184.4	112.4	130.5	152.8	135.2	213.2	236.4	190.3	225.1	90.0	186.6	91.7	232.8	318.3	343.6	144.0	190.8	224.9	150.2	216.9	129.6	164.2	174.7	140.3	137.2	162.4	246.7	190.5	254.6	219.9	106.1	102.2	168.8	139.1	158.0	140.4	157.4	291.2	96.2	203.8	159.2	38.3	33.3	54.7	13.2	26.3	12.8	31.7	23.8	18.8	32.8	27.4	19.8	16.4	27.8	14.9	35.0	12.8	25.4	24.3	58.8	61.7	67.1	69.7	56.1	66.5	60.0	62.7	60.5	59.8	62.7	65.7	71.3	35.3	32.2	27.7	163.4	209.2	124.0	89.6	150.8	203.2	77.6	63.6	138.5	78.6	52.4	36.8	68.8	136.5	61.3	103.9	93.9	75.7	639.3	43.9	72.1	88.8	85.0	131.3	17.9	125.9	204.6	129.6	74.5	47.9	58.4	87.8	62.2	43.4	132.7	102.6	29.9	109.8	93.6	161.3	111.8	923.3	89.8	88.9	128.1	30.0	96.0	91.8	57.7	34.7	34.3	88.3	144.0	138.8	234.3	159.7	305.2	94.6	28.9	110.5	111.7	75.9	133.8	314.6	51.7	161.1	210.0	132.2	106.5	121.8	164.8	156.3
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 356.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	40.0	11.1	5.1	36.0	12.6	8.3	17.8	8.9	9.9	51.8	15.5	151.0	24.1	222.0	30.5	150.1	52.6	72.5	356.9	5.5	6.5	14.3	8.4	24.8	18.6	17.2	15.3	38.3	7.2	6.2	5.0	34.4	18.0	142.8	64.8	7.6	20.0	198.6	84.1	11.0	30.9	246.4	16.2	30.8	41.5	7.1	9.2	7.7	10.9	80.5	15.1	86.7	23.0	27.3	2.2	4.4	3.3	3.2	4.6	3.3	5.4	1.7	1.7	1.8	1.7	1.9	3.9	2.5	0.8	3.2	4.3	7.0	5.0	2.7	1.9	3.3	3.1	2.5	7.1	1.2	1.1	5.4	2.8	2.6	3.0	2.5	2.6	9.1	1.5	2.8	3.9	2.9	3.1	1.7	4.1	3.4	2.3	2.4	0.9	2.6	8.5	3.7	1.4	8.1	4.0	3.1	3.3	3.9	1.9	4.4	3.4	2.4	1.9	2.5	1.5	1.9	1.5	4.2	4.3	2.7	2.4	4.4	10.2	2.4	1.7	1.5	1.6	1.0	1.4	2.0	1.1	1.0	1.5	2.1	1.3	1.0	16.2	0.7	1.5	1.7	1.7	0.5	5.1	12.6	8.9	9.9	5.5	6.5	17.2	15.3	18.0	16.2	9.2	27.3	12.5	12.8	19.8	181.5	6.0	17.3	49.0	35.6	8.6	59.3	11.1	20.6	836.8	11.5	23.0	12.9	75.0	18.1	8.6	52.9	11.7	10.1	39.2	19.3	16.1	15.2	24.0	5.2	225.7	12.9	8.4	51.4	17.3	7.6	18.9	438.3	16.4	9.6	9.4	26.9	205.0	17.2	63.1	23.5	10.9	13.1	12.2	8.2	8.8	102.1	7.8	10.2	5.2	102.5	647.4	6.3	21.1	51.1	9.6	24.3	12.8	7.1	27.4	30.4	32.9	38.6	162.7	19.3	13.9	7.1	10.9	25.4	10.7	14.2	33.9	28.4
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733195-103847575	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 106.1;Granulosa cells: 83.4;Inhibitory neurons: 105.9;Late spermatids: 78.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favorable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.0	4.7	3.4	3.2	4.2	0.7	7.4	6.6	8.5	6.8	4.0	7.7	7.1	7.6	2.1	11.6	9.8	4.7	21.2	7.6	3.9	6.9	5.0	9.9	2.7	1.2	2.0	10.9	8.3	7.8	6.5	6.0	1.7	10.7	5.6	8.0	10.2	5.3	7.5	12.5	7.6	5.2	0.3	11.3	10.1	19.1	3.8	2.0	23.4	6.2	5.1	8.0	7.1	4.2	4.9	4.2	0.5	5.4	0.9	0.4	1.9	3.2	2.3	4.0	1.8	3.3	4.4	1.1	11.7	2.2	4.9	9.8	5.8	3.7	3.5	2.2	4.0	0.0	1.3	5.7	3.6	0.5	4.4	1.0	4.4	0.3	4.7	1.7	7.9	2.8	0.7	1.7	2.7	20.3	0.0	0.5	1.0	12.3	5.1	11.3	3.2	2.7	7.8	12.7	6.6	16.9	9.9	7.3	2.5	2.6	18.4	0.7	7.1	2.9	4.0	2.4	3.0	4.0	5.8	8.4	1.8	2.9	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	4.2	6.6	8.5	7.6	3.9	1.2	2.0	1.7	0.3	3.8	4.2	35.1	19.2	39.5	31.0	7.1	13.5	16.6	6.9	18.8	15.8	31.3	20.6	45.4	14.3	11.8	7.3	12.5	2.9	11.9	26.9	3.9	7.9	58.0	37.9	7.9	30.3	15.6	2.7	106.1	6.4	1.0	7.7	37.8	48.5	0.0	83.4	14.3	9.0	2.9	15.2	105.9	14.2	6.1	1.6	5.7	78.4	4.4	3.0	3.6	49.6	0.4	5.8	1.0	31.7	33.2	6.8	18.7	20.3	6.3	13.1	14.6	7.8	8.3	12.9	6.6	10.9	6.7	17.8	15.1	24.1	12.9	2.2	9.0	8.7	15.8	13.7
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PPP1R14B	"PHI-1, PLCB3N, PNG, SOM172"	ENSG00000173457	"Protein phosphatase 1 regulatory inhibitor subunit 14B"	Q96C90	11	64244479-64246943	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 653.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	75	"plasmacytoid DC: 382.3"	"Lineage enriched"	"Detected in all"	75	"dendritic cells: 382.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053882	Approved					NA	NA		190000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA053882: AB_2682291"	"unprognostic (1.36e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (1.14e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (6.86e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-1)"	90.7	107.4	31.1	49.6	32.0	49.0	71.5	33.1	38.2	82.1	34.4	76.2	51.6	54.2	14.5	238.8	48.9	19.1	128.5	30.4	33.3	97.6	139.5	64.3	32.7	35.7	33.1	40.4	247.8	19.8	39.3	38.1	32.8	49.6	24.2	3.9	83.6	18.3	217.3	172.4	65.0	22.1	32.4	83.8	74.6	61.2	38.6	31.0	52.9	53.2	36.5	92.3	107.9	31.6	409.8	236.0	147.4	237.1	69.9	93.6	224.7	211.4	130.8	215.4	95.2	138.6	351.1	204.0	369.8	198.0	181.1	264.8	112.2	214.0	80.6	178.7	176.0	145.3	260.5	218.4	126.8	227.7	137.3	86.4	223.9	165.5	283.4	189.5	194.1	149.3	201.2	108.4	240.2	483.3	246.2	341.4	416.4	209.3	520.0	236.8	475.2	540.3	191.4	190.8	220.3	319.0	165.2	227.3	314.3	72.5	156.3	138.4	180.0	311.1	291.1	614.7	320.2	102.2	70.2	204.7	269.0	189.7	362.2	0.0	2.3	1.9	1.5	3.1	3.1	5.0	2.4	1.7	4.0	3.8	1.3	1.2	4.8	3.0	2.8	382.3	0.7	2.7	31.1	32.0	33.1	38.2	30.4	33.3	35.7	33.1	32.8	32.4	38.6	31.6	107.4	9.6	11.7	6.5	49.3	228.5	90.0	66.2	41.5	21.9	211.7	273.7	38.7	41.5	32.2	79.1	8.4	58.4	333.8	69.9	76.3	131.9	6.3	60.8	180.6	81.8	83.0	37.6	3.0	234.2	653.6	77.5	45.3	126.1	27.3	273.4	46.8	101.4	87.4	20.2	4.6	109.8	44.7	33.0	119.5	9.0	9.3	75.2	60.5	2.8	72.8	38.7	12.3	6.6	1.8	306.8	51.2	11.7	55.0	365.5	129.8	63.1	10.2	19.3	26.3	332.6	136.6	5.9	14.8	169.1	259.0	132.8	37.4	179.6	107.4	258.3
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	64	"heart muscle: 40.8;skeletal muscle: 152.9;tongue: 104.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 157.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"THP-1: 14.6"	"Region enriched"	"Detected in single"	12	"thalamus: 1.1"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 294.1;Excitatory neurons: 262.8;Inhibitory neurons: 201.5;Oligodendrocyte precursor cells: 593.1;Oligodendrocytes: 308.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 6.8;NK-cell: 10.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.8;NK-cells: 10.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 12.2;RH-30: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	1.7	7.0	13.0	0.9	20.1	0.2	4.9	6.0	14.5	2.7	0.3	8.2	1.7	3.0	4.9	1.6	5.7	2.4	5.2	14.4	7.5	4.7	0.4	3.7	0.3	5.9	6.9	3.3	8.8	6.7	4.6	2.5	8.0	2.3	3.8	18.5	9.6	2.8	4.9	0.5	2.2	2.2	6.6	1.8	4.9	6.7	10.2	0.5	6.6	4.9	0.3	2.6	0.5	13.9	0.0	11.0	6.6	7.6	0.0	0.0	5.3	0.5	0.1	1.0	0.8	6.1	3.7	0.0	9.0	0.5	0.6	0.0	12.2	0.0	1.2	0.0	4.5	11.4	4.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.8	4.8	0.1	0.0	5.5	4.9	1.8	0.0	11.8	0.0	10.7	9.2	7.3	7.4	0.0	0.9	1.4	4.0	2.1	0.0	0.0	0.1	4.4	0.1	4.0	7.3	11.5	0.0	0.2	0.0	0.9	6.8	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	10.3	0.1	0.3	0.0	0.1	13.0	20.1	6.0	14.5	14.4	7.5	5.9	6.9	8.0	6.6	10.2	13.9	4.5	41.7	66.6	294.1	2.4	0.4	0.9	0.0	0.6	58.2	24.4	12.2	127.7	18.6	16.5	47.8	56.3	21.6	3.3	15.7	3.9	25.1	17.9	40.3	4.5	6.8	38.9	2.5	262.8	7.0	3.1	9.4	21.4	57.1	5.7	39.5	7.9	1.5	1.7	1.7	201.5	15.0	4.1	0.6	0.3	15.3	2.5	0.8	7.2	41.2	0.0	46.9	3.1	593.1	308.4	6.6	14.4	0.7	2.7	4.8	1.8	9.6	20.6	88.9	0.0	118.4	9.2	25.1	12.6	0.5	0.9	33.1	1.7	22.9	15.7	2.6
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190048-52229518	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	98.5	300.7	305.0	60.5	311.1	58.1	98.7	292.0	394.2	126.9	261.4	115.7	91.5	126.8	101.0	164.4	126.8	63.2	322.8	342.6	299.4	156.9	106.0	87.5	72.7	308.9	301.1	163.7	100.7	129.9	123.9	69.1	312.8	123.3	82.2	89.8	99.8	92.2	239.7	119.3	98.5	96.0	280.1	87.6	106.0	67.2	331.7	76.9	107.9	170.7	90.0	123.5	121.9	299.2	153.6	248.4	210.9	182.0	166.9	173.4	105.3	130.3	173.2	174.1	151.1	129.3	122.1	132.5	91.0	213.9	95.7	108.8	228.0	197.9	100.6	101.3	562.8	99.6	126.9	148.2	152.6	105.6	93.1	234.3	163.8	163.5	149.2	162.9	167.9	92.1	114.3	96.8	196.3	178.6	159.6	215.4	204.6	162.2	218.4	148.6	118.3	152.5	285.0	251.7	153.3	161.3	149.0	160.1	100.3	136.3	141.9	197.3	153.1	133.2	120.5	65.7	154.2	96.9	151.5	160.0	143.1	109.7	170.5	172.6	172.0	169.4	143.9	212.2	131.0	143.1	126.3	134.3	192.8	157.1	101.6	119.6	103.7	228.6	199.0	119.7	177.5	255.6	305.0	311.1	292.0	394.2	342.6	299.4	308.9	301.1	312.8	280.1	331.7	299.2	55.3	44.8	35.4	21.5	76.0	70.4	99.0	178.0	56.9	114.0	64.5	71.1	100.2	74.4	99.5	119.5	25.0	203.7	47.3	157.0	117.4	213.5	4.4	77.5	79.7	72.4	107.0	39.7	27.4	155.7	259.9	85.7	77.5	100.7	68.5	96.7	65.0	52.8	146.2	144.7	39.5	128.8	144.5	68.1	39.3	10.4	72.4	58.0	53.4	17.8	103.7	118.0	62.8	25.6	29.9	168.2	189.0	85.4	60.3	88.3	147.5	135.3	80.6	61.5	78.9	49.2	90.3	16.5	68.8	74.4	63.2	182.0	64.2	99.7	185.2	104.2
PPP2R5B	"B56B, B56beta, FLJ35411, PR61B"	ENSG00000068971	"Protein phosphatase 2 regulatory subunit B'beta"	Q15173	11	64917553-64934475	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036607	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA036607: AB_10670235"	"unprognostic (2.20e-2)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.12e-2)"	16.7	14.4	39.0	9.1	43.2	14.6	14.5	42.8	48.2	13.4	13.8	26.2	7.6	16.9	11.3	11.2	14.4	16.5	25.2	42.2	37.0	21.3	13.7	21.8	9.6	45.7	38.8	11.6	18.0	12.4	26.0	10.1	43.3	17.7	8.5	22.7	13.3	14.8	20.1	17.0	16.6	14.4	28.1	24.9	16.8	5.7	41.1	6.9	19.1	12.8	8.4	16.6	14.3	44.6	12.2	5.9	7.7	18.0	15.8	11.6	1.2	13.4	12.2	18.7	15.0	4.4	9.1	3.0	9.2	15.9	20.7	8.1	7.4	11.6	10.5	17.7	5.2	3.5	12.0	2.9	15.1	1.4	15.2	7.4	19.5	20.3	22.8	21.3	15.1	10.3	6.9	7.5	14.1	4.8	2.1	5.5	2.4	3.7	16.9	3.6	2.1	7.0	14.0	5.4	20.0	18.7	8.2	6.0	12.6	6.6	6.8	2.9	15.2	23.9	7.9	25.9	5.1	9.0	7.9	2.4	29.8	2.2	11.1	0.9	0.6	8.9	0.6	1.0	0.5	0.7	0.3	0.6	0.4	0.9	0.3	0.4	0.3	0.7	1.3	0.3	0.8	0.2	39.0	43.2	42.8	48.2	42.2	37.0	45.7	38.8	43.3	28.1	41.1	44.6	17.1	0.0	3.0	17.6	5.9	8.5	6.4	19.2	9.1	35.6	6.4	3.0	3.3	5.7	6.2	1.8	27.1	1.8	7.2	16.4	13.7	9.9	0.9	3.2	4.9	12.4	15.6	44.8	19.3	6.6	4.0	5.7	7.1	6.2	4.5	2.7	15.0	3.3	6.8	28.6	22.5	8.4	10.2	5.5	4.0	1.5	5.9	6.3	7.2	11.2	3.7	15.4	6.2	13.0	20.9	17.0	7.6	8.2	6.1	11.1	6.1	14.4	3.8	19.3	13.1	6.3	8.9	0.7	2.7	3.6	9.7	2.9	5.6	3.9	3.7	18.3
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	28.5	11.9	11.8	16.5	11.8	26.5	20.8	17.7	15.3	18.1	31.1	16.6	9.1	14.5	10.6	16.9	15.6	15.7	34.5	11.3	10.8	12.9	12.4	21.5	33.0	12.1	11.0	14.0	14.3	18.4	11.7	19.3	12.2	14.4	10.3	77.9	14.0	8.2	89.4	13.6	15.4	15.5	10.0	22.4	14.6	56.0	13.1	15.0	16.6	54.2	26.9	17.0	16.4	14.8	12.2	8.8	7.7	9.4	19.8	24.4	11.2	16.5	28.9	23.9	26.5	5.1	7.5	45.7	19.7	25.6	40.0	8.4	17.9	16.5	30.5	26.3	9.5	9.8	10.5	14.7	26.8	7.1	15.6	15.0	22.3	16.2	16.5	25.6	21.1	22.0	19.6	58.8	27.2	5.7	16.8	11.7	5.6	12.5	12.0	54.0	18.1	15.2	22.4	11.3	5.4	12.7	12.3	7.4	17.4	14.4	4.9	11.8	22.8	37.1	7.9	56.7	12.9	29.3	38.5	48.3	19.6	9.3	25.1	5.4	2.7	10.7	16.6	3.2	12.7	26.3	19.0	23.6	5.1	21.3	18.1	14.9	0.6	19.2	4.7	6.2	17.2	7.1	11.8	11.8	17.7	15.3	11.3	10.8	12.1	11.0	12.2	10.0	13.1	14.8	27.2	6.4	5.1	49.6	74.7	16.6	21.3	32.6	12.0	12.8	10.0	6.0	8.0	14.3	14.0	7.3	47.9	18.0	50.3	6.7	7.9	15.0	145.8	6.5	12.7	24.2	10.3	10.8	78.9	21.0	23.8	25.1	6.6	14.6	3.8	3.9	23.6	7.8	13.1	3.3	83.6	2.5	38.7	10.8	24.6	22.6	22.4	19.3	28.4	76.8	30.4	13.1	59.8	99.5	64.8	21.1	7.4	21.4	96.8	26.3	10.6	11.6	7.8	50.5	32.9	19.5	23.3	131.8	29.6	17.1	11.4	14.1	53.4	4.8	6.3	25.5
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	21.9	35.6	23.5	20.9	27.3	21.4	23.2	24.3	32.2	23.7	19.2	28.5	24.5	25.4	11.5	28.3	23.8	18.0	36.7	25.4	19.7	29.6	72.4	25.2	27.3	26.9	22.2	24.8	29.0	21.4	41.0	14.8	21.8	31.4	11.8	12.6	27.9	17.1	65.8	27.6	28.7	14.0	18.2	32.4	30.1	62.7	26.0	25.8	30.8	31.7	16.5	23.9	22.3	25.8	30.9	17.8	27.3	34.8	19.7	21.0	24.4	30.1	31.9	31.5	31.7	15.0	18.7	36.9	14.5	30.0	17.4	24.6	16.9	22.4	11.8	19.3	30.9	19.8	37.7	37.7	25.6	46.9	52.1	31.2	23.8	19.0	10.1	24.8	27.8	30.8	20.5	31.5	23.2	50.0	32.3	33.9	11.3	19.5	21.9	44.8	20.9	24.3	23.1	36.1	17.0	23.1	31.0	47.6	25.0	10.1	17.2	35.2	32.5	29.3	26.4	24.6	20.3	33.6	8.7	32.7	30.6	22.6	41.2	4.0	8.6	5.8	9.0	9.4	10.4	7.9	6.2	9.6	8.8	8.4	5.9	7.9	13.7	5.9	6.8	11.0	13.3	8.5	23.5	27.3	24.3	32.2	25.4	19.7	26.9	22.2	21.8	18.2	26.0	25.8	28.5	22.4	20.6	79.0	32.0	8.8	14.4	12.9	22.8	43.7	25.5	21.8	19.2	37.1	17.1	27.6	56.3	17.3	39.9	39.8	31.3	19.3	84.0	30.8	39.0	18.1	26.9	19.8	83.0	32.5	11.8	15.3	35.2	34.8	31.8	23.9	18.9	65.1	16.0	65.6	80.8	23.0	16.2	25.3	8.8	48.6	19.6	23.4	10.6	61.8	32.1	25.0	50.4	52.8	59.9	33.3	29.0	19.9	42.0	19.4	27.0	23.6	17.9	43.2	26.3	16.9	18.7	78.5	47.1	17.9	8.5	28.5	28.4	17.8	25.2	17.5
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.2	3.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.2	0.0	3.4	10.0	0.0	0.5	0.0	0.3	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	4.7	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.1	105.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRAMEF12		ENSG00000116726	"PRAME family member 12"	O95522	1	12773738-12777906	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045286, HPA051704"	Uncertain		Uncertain	Nucleoplasm		NA	NA							Nucleoplasm		"HPA045286: AB_10794782, HPA051704: AB_2681581"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82822936-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 348.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		42000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	74.8	87.3	81.1	57.8	82.1	37.7	70.0	84.3	109.1	91.9	95.0	49.3	28.6	62.9	81.4	62.1	57.0	64.3	70.0	76.6	85.6	144.7	151.9	58.1	92.1	84.4	82.1	53.5	37.9	78.4	34.5	152.8	80.9	52.5	46.6	21.9	85.6	55.5	15.9	54.1	31.8	80.8	89.0	54.0	32.0	41.8	86.0	33.7	63.7	28.5	85.0	100.2	57.5	86.7	34.9	41.8	49.6	121.0	463.5	146.7	67.1	67.5	131.9	70.9	97.0	103.5	70.7	55.9	100.7	117.9	72.6	53.2	53.7	45.2	72.0	43.9	38.3	37.7	56.5	76.7	86.2	31.0	124.7	122.0	39.3	72.7	68.6	166.5	224.0	26.3	39.1	69.8	72.7	19.5	4.9	171.7	33.9	90.3	31.1	27.1	97.0	65.1	118.0	71.2	24.0	51.9	101.9	60.2	41.5	80.6	66.6	49.6	65.0	78.8	77.4	71.1	33.5	64.2	113.6	46.3	32.9	41.7	44.5	53.5	76.9	50.9	13.7	79.0	16.1	31.7	14.0	15.9	140.2	34.2	12.0	17.4	89.0	34.7	64.8	27.9	14.8	49.6	81.1	82.1	84.3	109.1	76.6	85.6	84.4	82.1	80.9	89.0	86.0	86.7	86.9	19.2	12.9	58.8	45.5	31.4	41.5	53.4	25.0	11.7	26.2	25.1	26.6	37.1	25.2	62.5	2.1	65.1	29.0	9.8	29.4	32.9	44.9	17.4	37.7	180.4	19.7	13.7	42.2	12.0	120.1	73.6	23.9	29.9	12.7	18.2	348.7	65.4	80.7	16.8	38.5	19.1	14.2	152.9	118.9	47.6	44.1	88.0	71.2	33.7	79.5	53.5	28.8	34.7	10.5	8.2	10.2	46.3	62.2	23.3	3.9	83.8	9.1	5.3	65.7	25.5	25.6	60.8	6.3	54.3	34.9	52.9	22.3	27.7	20.9	39.2
PRDM11	PFM8	ENSG00000019485	"PR/SET domain 11"	Q9NQV5	11	45095806-45235110	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 60.0;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057072	Approved					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA057072: AB_2683328"	"unprognostic (3.32e-4)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.10e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.57e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.93e-6)"	"unprognostic (9.25e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	5.5	4.3	8.8	2.6	8.2	2.5	4.5	7.1	10.6	11.0	5.1	11.2	2.1	13.0	3.0	6.6	10.1	3.3	10.8	8.2	8.2	5.3	2.6	5.5	2.5	6.8	7.6	10.3	5.2	2.8	8.6	4.1	6.6	8.9	2.3	2.5	4.2	7.8	6.8	3.8	5.5	9.2	5.7	5.4	6.5	1.9	8.5	2.4	9.0	8.2	2.6	8.7	9.0	7.7	4.6	12.7	3.1	1.6	5.1	4.3	0.7	2.3	5.1	7.7	5.0	11.7	1.7	5.1	5.2	3.3	9.9	5.5	6.2	2.8	2.5	1.6	4.8	3.8	18.3	2.2	8.1	4.5	4.9	5.5	10.2	0.4	8.1	5.4	7.7	0.9	1.7	0.0	3.8	2.3	0.0	6.0	3.7	4.1	8.3	5.8	11.6	0.1	4.2	4.2	4.0	4.9	5.3	0.8	5.8	1.9	19.3	2.4	4.1	16.5	7.8	4.0	5.2	3.9	4.7	4.7	0.7	1.0	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	8.8	8.2	7.1	10.6	8.2	8.2	6.8	7.6	6.6	5.7	8.5	7.7	3.1	6.4	6.2	11.4	2.9	2.2	5.4	0.9	2.8	5.7	3.1	3.7	8.2	0.0	6.0	5.5	2.1	0.8	2.8	1.1	0.0	1.4	1.3	4.8	4.3	4.3	0.0	2.1	11.4	1.1	0.3	4.4	3.6	2.7	0.0	3.2	6.8	1.4	0.8	10.1	10.3	1.9	2.0	0.8	0.3	7.8	5.3	1.3	0.0	60.0	1.6	3.6	1.0	9.5	8.2	0.5	0.6	7.2	0.6	3.5	0.5	1.4	3.0	1.6	19.7	6.5	5.5	0.4	0.7	1.8	0.9	0.3	2.9	3.9	2.9	2.4
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.5;Plasma cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Daudi: 31.1;U-266/70: 32.2;U-698: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971"	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	2.0	1.8	1.8	4.5	1.7	1.7	2.1	1.3	1.9	2.2	1.2	2.3	2.8	2.2	1.6	2.5	2.4	1.4	1.7	1.7	1.4	1.5	2.1	1.9	8.3	1.4	1.4	2.4	2.3	1.8	2.1	1.2	1.4	2.4	1.8	1.6	2.3	1.5	4.5	3.9	2.9	1.4	1.0	3.7	2.2	2.0	1.3	3.2	2.2	1.7	7.4	1.9	2.2	1.6	2.8	6.0	4.4	5.8	1.9	2.4	4.4	2.2	1.8	2.2	1.6	4.1	3.0	31.1	2.5	2.7	2.1	4.1	3.9	2.9	2.1	3.3	5.5	6.5	15.1	5.0	1.3	5.6	3.9	1.1	3.9	2.7	1.8	2.4	3.3	3.4	5.6	2.0	3.0	6.4	5.5	3.7	5.1	3.1	3.1	8.5	3.5	2.5	2.3	4.8	7.5	4.3	10.1	5.1	1.5	1.7	3.8	2.7	3.3	3.8	2.1	2.9	4.3	32.2	3.5	76.0	3.6	6.5	5.3	0.0	0.4	0.5	0.2	0.8	0.2	0.6	0.1	0.3	0.4	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.2	0.4	1.8	1.7	1.3	1.9	1.7	1.4	1.4	1.4	1.4	1.0	1.3	1.6	2.4	3.2	12.5	6.2	5.1	2.9	1.8	1.6	2.2	3.4	2.8	2.4	4.4	1.5	7.8	1.8	6.2	1.4	2.0	2.3	0.0	1.3	2.2	2.6	2.5	2.5	0.0	2.5	9.0	2.6	0.9	2.6	3.1	2.0	3.8	3.3	1.1	2.2	1.9	3.3	6.4	1.3	2.0	2.8	2.2	4.3	1.2	3.3	1.8	6.5	2.9	1.1	4.1	3.5	8.0	1.7	0.8	0.4	15.9	2.3	1.1	0.8	5.3	3.1	0.0	3.1	2.3	2.3	2.9	3.2	3.4	0.7	2.7	1.3	2.2	1.8
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45510914-45542732	"Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 2690.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004682, HPA007730"	Approved		Approved	Mitochondria		NA	NA		110000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.89e-4)"	277.8	362.9	642.4	290.2	667.1	86.7	454.3	700.7	747.3	314.1	627.0	326.7	501.4	255.3	459.4	945.8	306.3	297.4	542.9	613.0	700.8	785.5	841.2	340.2	371.4	712.1	706.3	255.5	122.7	214.6	210.0	353.3	711.6	256.0	327.1	347.3	348.6	307.2	571.4	296.5	402.1	329.3	713.5	265.8	355.5	143.7	671.4	262.8	802.3	477.7	603.3	393.2	375.3	766.6	1028.1	1743.7	735.2	942.9	828.4	701.9	1459.3	1134.8	1144.1	1183.0	964.3	932.3	429.2	899.1	1125.9	1237.6	1448.6	967.6	1640.2	1101.3	1193.0	696.9	1266.4	678.6	2042.8	2484.7	361.0	793.6	848.9	610.4	813.6	1201.7	283.8	657.7	1409.7	1044.0	1271.8	292.7	1225.2	829.4	1053.7	772.5	2339.8	2241.0	1867.3	1863.6	934.0	1177.7	2211.5	872.4	987.5	495.1	1035.3	2524.2	73.3	2157.3	760.6	631.1	1208.1	474.8	1071.9	1034.4	1541.5	206.1	1220.5	1678.2	791.4	537.9	278.7	469.3	325.6	111.6	155.7	367.1	205.4	253.8	246.8	209.3	293.9	221.6	150.3	166.6	12.1	123.8	407.5	195.9	438.2	416.3	642.4	667.1	700.7	747.3	613.0	700.8	712.1	706.3	711.6	713.5	671.4	766.6	530.7	522.4	259.0	48.3	330.1	607.3	1115.3	1161.1	745.0	161.3	387.0	510.9	54.9	397.5	685.2	617.9	104.3	1258.6	151.5	339.3	946.9	1015.7	19.7	662.7	281.2	437.8	174.5	304.2	15.5	442.8	1773.2	462.0	500.0	435.5	325.3	463.2	326.3	875.2	1467.4	206.9	17.1	295.0	545.3	366.9	980.7	44.2	498.6	534.8	581.7	12.2	545.7	416.4	62.8	24.1	90.5	804.4	384.9	410.7	612.8	1100.9	995.0	2690.9	919.1	402.2	309.0	279.0	982.6	84.5	329.2	1346.9	528.6	1114.9	270.9	499.4	398.8	1462.7
PRDX2	"MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA"	ENSG00000167815	"Peroxiredoxin 2"	P32119	19	12796820-12801800	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1316.7;Erythroid cells: 3153.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008713	Approved					NA	NA		800000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB008713: AB_1620974"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.58e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"prognostic favorable (5.66e-11)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.41e-1)"	199.0	622.0	350.8	88.3	366.6	686.7	159.7	408.2	461.5	167.8	365.6	208.1	251.7	178.8	144.5	271.8	153.5	133.9	704.0	369.6	400.0	287.7	310.2	109.1	118.3	407.5	380.4	218.2	201.7	454.5	314.6	87.8	408.2	175.3	141.5	207.1	200.1	124.4	722.9	260.7	201.1	127.0	357.0	118.1	226.6	32.8	399.1	181.3	156.3	847.9	129.2	163.6	171.6	355.5	420.4	1.1	553.9	721.3	79.5	54.2	408.4	189.0	188.0	253.9	143.4	438.1	102.8	122.7	430.9	185.0	30.2	389.5	354.7	309.7	72.9	528.5	561.4	222.6	537.4	665.1	212.4	0.7	1.4	233.6	140.5	191.1	93.0	327.6	238.8	255.3	485.7	187.0	98.7	763.3	500.1	190.2	409.1	289.6	789.4	485.8	0.7	593.0	343.1	450.0	683.8	538.5	449.5	454.9	153.7	100.7	408.0	318.0	105.7	188.2	156.9	526.7	417.7	226.3	242.1	573.5	178.9	75.5	43.8	35.4	170.0	85.6	436.1	129.4	460.6	375.2	589.8	446.2	211.6	288.5	594.7	460.9	22.4	213.2	148.0	124.5	697.4	686.6	350.8	366.6	408.2	461.5	369.6	400.0	407.5	380.4	408.2	357.0	399.1	355.5	192.2	22.4	36.7	39.5	117.5	221.3	255.6	877.7	187.2	317.9	271.2	322.2	37.1	265.9	347.7	279.6	100.1	692.8	83.5	367.4	1316.7	329.5	3.1	138.6	218.5	130.3	333.7	3153.4	31.8	167.2	558.8	204.3	214.6	197.7	47.0	466.0	137.8	489.7	234.0	215.4	50.8	360.7	754.8	63.8	128.8	13.0	293.9	58.7	281.1	23.4	61.4	531.2	56.7	41.7	29.1	179.6	250.6	321.2	263.4	169.3	765.6	1097.9	152.7	373.2	157.8	142.4	273.2	4.8	7.7	368.5	229.4	508.4	144.4	816.6	475.7	243.1
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167720-119178812	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1060.4;Proximal tubular cells: 937.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	165.7	335.3	92.4	96.0	92.6	82.3	138.3	101.3	116.0	103.4	139.2	133.3	137.8	87.0	120.8	83.3	116.7	88.0	278.2	95.2	104.5	385.7	571.2	74.9	108.4	97.2	97.1	74.9	96.2	223.8	60.0	126.3	99.0	126.7	139.8	52.5	132.1	131.7	376.0	38.0	132.1	130.0	100.4	76.3	97.5	48.3	98.6	98.3	176.7	402.7	104.0	112.8	65.1	102.7	350.6	392.2	234.1	267.3	241.7	259.8	145.9	244.8	414.8	364.5	380.7	303.4	339.9	407.2	208.8	290.8	173.4	155.5	391.5	296.1	408.8	401.5	411.4	183.7	149.7	542.4	252.5	347.8	212.7	306.8	186.4	292.1	269.7	261.2	268.6	245.2	230.0	82.5	338.7	140.2	265.1	292.7	218.9	264.0	229.3	276.5	339.7	281.5	623.8	164.6	103.0	149.2	259.8	346.1	332.2	201.0	179.6	411.5	190.5	118.3	178.1	170.9	323.1	128.0	200.7	327.0	185.7	507.4	107.3	144.4	429.1	246.9	110.5	369.5	142.7	179.9	145.6	134.6	382.1	149.8	149.5	134.0	239.9	132.8	333.9	214.8	205.7	510.2	92.4	92.6	101.3	116.0	95.2	104.5	97.2	97.1	99.0	100.4	98.6	102.7	61.4	48.1	74.5	14.4	65.1	69.8	117.8	274.0	81.4	27.5	145.2	105.2	236.5	131.5	119.0	147.1	10.4	328.4	50.6	84.5	1060.4	124.5	5.0	105.1	76.0	78.3	110.9	132.8	15.4	75.1	212.0	100.8	116.7	77.3	52.6	131.0	73.2	390.0	247.6	40.4	15.4	132.5	221.8	164.2	96.0	10.5	77.3	127.9	133.4	10.3	158.4	76.9	39.1	12.5	18.8	63.8	99.3	101.2	153.7	95.1	176.1	937.8	163.4	24.8	72.3	63.1	105.3	11.2	23.2	146.4	52.6	155.0	56.1	440.0	207.0	119.6
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318121-64321811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 2430.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria		NA	NA		6900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	181.8	400.3	346.0	112.7	342.6	285.7	170.1	375.9	429.4	227.2	480.2	346.6	213.3	153.7	176.6	448.5	400.3	120.7	467.4	340.4	384.6	377.1	280.3	217.2	110.1	382.8	373.3	246.0	224.9	254.5	313.3	164.1	387.0	165.5	299.6	109.0	286.2	164.4	504.0	181.1	226.1	97.1	365.2	162.9	313.9	150.1	377.8	167.7	354.5	439.6	137.8	192.5	244.8	346.4	225.3	453.4	267.9	444.5	284.3	424.4	308.5	274.9	442.3	199.8	247.4	332.9	451.8	329.2	467.0	447.4	712.6	503.5	253.3	589.4	125.8	456.6	200.8	333.3	728.8	386.3	581.0	127.8	271.3	432.4	757.2	334.9	337.8	387.6	308.4	380.6	191.5	755.6	285.5	572.0	220.9	547.8	402.6	356.5	573.9	210.9	274.5	1178.8	760.1	442.9	224.7	424.9	230.8	506.8	818.8	254.3	370.5	283.3	298.3	281.8	258.6	326.7	123.1	383.1	490.8	392.4	340.7	253.7	223.6	703.9	465.4	630.7	251.0	432.9	218.3	393.5	229.0	205.1	369.8	409.0	224.5	225.9	802.3	368.5	399.0	487.9	297.1	639.6	346.0	342.6	375.9	429.4	340.4	384.6	382.8	373.3	387.0	365.2	377.8	346.4	213.7	266.0	463.4	17.6	182.1	326.5	760.2	1591.9	405.2	159.0	266.2	435.9	617.6	371.8	931.2	450.6	70.9	1122.2	185.8	846.1	1612.1	788.4	79.6	865.2	221.3	204.7	801.9	200.6	12.4	1039.2	1144.0	296.1	365.4	285.9	104.7	299.8	205.6	405.2	476.9	92.5	14.0	1041.6	1072.1	206.5	261.0	294.9	279.0	210.8	435.8	8.4	339.7	309.6	278.1	14.1	15.3	1487.3	641.3	226.8	288.9	401.3	922.4	1468.5	2430.7	150.3	197.2	176.2	433.1	150.2	333.9	482.8	257.7	978.9	165.2	713.3	1231.7	1077.1
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477330-173488815	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	340.7	157.5	169.5	68.3	181.3	100.1	211.2	197.6	210.1	112.3	164.8	189.1	46.4	108.8	206.3	127.9	149.8	71.9	261.8	184.1	196.6	184.4	482.5	116.7	72.2	181.0	198.3	115.5	114.4	217.5	67.4	70.7	187.5	152.1	221.6	53.9	85.6	99.0	563.5	106.6	59.8	160.2	175.8	70.7	135.2	119.1	176.7	70.7	106.0	382.4	79.0	99.5	109.8	185.5	420.3	127.7	204.7	230.9	778.5	372.7	169.5	843.9	284.3	342.7	241.8	243.9	276.4	272.4	256.4	694.2	120.4	239.8	272.0	259.9	279.0	234.0	243.6	179.5	200.0	277.7	425.7	191.3	56.1	301.0	262.6	181.3	256.6	210.8	339.5	106.7	405.4	52.8	392.9	86.3	131.7	249.1	456.2	219.8	760.5	154.5	236.6	277.0	518.1	95.4	94.9	173.4	285.0	334.0	199.2	296.3	283.8	262.9	228.2	132.5	149.9	201.8	229.5	76.4	123.2	220.7	159.4	162.3	124.3	36.2	42.5	24.8	29.8	39.8	32.8	32.6	29.8	38.4	53.5	24.4	39.8	47.9	25.2	25.7	36.5	79.7	36.1	58.1	169.5	181.3	197.6	210.1	184.1	196.6	181.0	198.3	187.5	175.8	176.7	185.5	278.1	176.3	170.8	127.3	127.4	235.4	404.1	382.8	209.5	31.9	186.1	250.7	528.6	301.7	228.6	277.7	29.2	714.3	158.6	1315.9	860.8	178.6	237.5	206.9	226.8	191.8	142.1	449.5	13.8	202.3	939.1	307.0	111.6	200.0	348.6	216.6	214.2	1120.2	345.0	45.4	13.2	257.4	205.4	164.3	161.0	667.5	340.5	227.1	183.2	17.8	212.9	462.5	83.4	12.5	15.4	147.2	663.4	416.8	176.4	427.1	264.4	827.3	209.1	52.0	184.1	185.7	253.8	123.5	76.8	305.9	264.1	963.5	157.7	512.5	303.6	308.9
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303799-177306949	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	89.1	106.5	63.6	89.2	63.5	90.7	78.9	64.0	70.5	69.9	64.6	121.8	109.3	69.3	37.5	146.9	61.4	37.1	70.6	63.8	65.2	140.1	182.3	76.0	79.0	64.3	65.8	64.0	262.3	48.1	67.4	58.6	66.2	74.9	85.8	24.4	95.7	29.8	32.2	108.3	121.8	47.2	66.6	117.4	103.2	43.0	69.0	30.9	65.9	13.7	87.4	81.5	78.7	62.8	221.4	193.8	116.1	307.1	103.3	111.0	400.6	154.5	106.6	214.6	206.1	443.2	232.5	181.4	181.6	143.7	236.0	118.1	212.5	400.0	145.8	826.0	291.9	154.9	195.7	291.1	109.6	243.6	215.1	102.7	142.2	170.6	144.9	89.1	269.0	129.2	181.4	247.7	210.5	556.7	160.5	362.5	242.1	251.6	319.7	52.7	232.1	324.5	140.0	171.5	186.3	237.7	136.8	266.9	267.5	144.4	172.5	293.4	148.5	189.3	174.9	157.4	365.5	155.4	270.9	267.4	162.2	328.0	200.4	411.1	764.6	1198.6	248.0	988.0	238.5	276.0	202.6	245.4	775.1	238.7	175.7	195.7	553.7	327.4	989.8	281.9	246.6	614.3	63.6	63.5	64.0	70.5	63.8	65.2	64.3	65.8	66.2	66.6	69.0	62.8	174.4	22.4	23.4	8.1	198.3	348.3	297.0	331.8	152.5	60.8	339.3	415.4	0.4	168.7	159.0	104.8	22.9	756.9	231.4	572.7	303.3	382.9	6.6	114.1	111.2	171.5	157.5	128.9	9.7	563.3	552.7	134.0	110.6	129.9	108.1	145.9	120.3	247.5	352.2	60.6	10.0	311.3	219.7	271.0	337.1	24.6	114.0	293.8	256.1	7.5	410.1	117.1	325.4	4.0	12.2	752.9	664.0	109.1	393.9	612.4	853.7	567.0	60.5	68.9	46.0	126.6	177.3	81.5	218.6	246.7	420.8	883.6	169.7	221.0	433.6	480.2
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475806-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 206.6;Leydig cells: 100.6;Melanocytes: 192.1;Muller glia cells: 152.4;Peritubular cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 18.0;BJ: 7.7;fHDF/TERT166: 11.7;SuSa: 5.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 82.4"	HPA059225			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA059225: "	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.02e-4)"	114.8	23.4	12.6	4.2	14.2	0.5	77.5	7.7	20.2	126.7	20.0	136.4	6.6	147.7	7.6	41.3	108.6	40.4	212.0	11.6	10.0	25.3	15.6	124.7	8.0	10.2	8.2	128.2	13.1	2.5	22.6	12.0	9.4	73.6	8.9	21.5	32.7	77.1	35.6	56.4	61.0	51.4	8.3	44.2	41.3	7.2	10.3	3.2	60.4	36.9	15.9	147.8	92.9	9.4	0.2	0.2	0.5	0.1	18.0	0.5	0.4	7.7	1.0	0.2	0.2	0.0	0.1	1.2	0.6	11.7	0.1	0.6	0.2	0.3	0.3	0.0	0.1	0.2	0.5	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.2	2.1	0.0	0.4	0.2	0.4	1.3	0.1	0.1	0.5	0.4	0.3	0.1	0.4	0.2	0.4	0.0	0.3	1.0	0.2	0.2	0.2	0.8	5.2	0.2	0.1	0.6	0.5	0.2	0.3	0.1	0.2	0.3	1.2	0.1	0.2	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	12.6	14.2	7.7	20.2	11.6	10.0	10.2	8.2	9.4	8.3	10.3	9.4	8.8	0.0	5.8	5.2	0.9	18.2	1.0	0.0	2.2	3.6	4.2	5.1	7.4	1.5	0.6	0.0	2.1	0.1	0.3	0.1	0.0	0.0	1.1	0.6	1.7	15.6	0.0	2.7	1.6	0.0	0.1	206.6	4.6	1.6	5.1	0.2	22.9	0.3	0.3	1.7	0.2	0.0	0.0	0.3	19.2	5.3	100.6	0.9	192.1	22.5	0.0	152.4	0.0	7.5	0.5	0.0	0.0	199.7	0.4	0.6	0.0	0.1	1.5	8.9	26.3	9.6	38.3	3.1	2.4	1.6	9.9	0.3	1.6	0.1	0.0	1.3
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952046-68237032	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 717.6;Microglial cells: 120.9;Oligodendrocyte precursor cells: 422.2;Oligodendrocytes: 222.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.0;HUVEC TERT2: 19.2;JURKAT: 8.3;NTERA-2: 12.1;RH-30: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	9.3	1.0	11.5	1.2	15.2	0.1	5.5	15.8	9.4	4.4	0.1	2.6	1.7	2.5	1.7	1.7	5.5	3.2	3.8	12.5	10.1	1.6	1.2	4.4	0.8	16.1	13.5	1.9	1.1	1.1	1.9	8.1	13.2	2.5	1.7	3.6	1.3	2.2	2.2	1.7	1.8	2.5	12.6	1.3	1.6	0.9	13.4	0.9	7.3	5.0	1.0	2.7	2.6	14.1	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	8.3	0.0	0.0	0.0	0.0	3.0	0.0	12.1	0.0	0.0	0.0	5.5	0.0	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	15.2	15.8	9.4	12.5	10.1	16.1	13.5	13.2	12.6	13.4	14.1	103.3	3.2	5.0	717.6	0.3	4.0	3.6	0.0	0.0	21.8	0.6	0.8	6.1	1.5	3.1	1.8	2.1	0.0	0.6	0.0	0.0	0.2	52.7	15.2	3.2	57.0	0.0	0.0	2.2	0.0	0.0	19.7	0.0	26.2	1.3	0.0	56.4	0.7	0.1	5.0	81.3	0.0	0.0	2.7	5.1	9.6	11.1	0.8	8.8	120.9	0.0	65.8	0.0	422.2	222.1	0.0	0.0	10.5	1.3	0.8	0.0	0.0	0.7	4.1	26.3	3.9	13.8	0.9	1.2	0.5	2.6	0.0	1.1	0.2	0.0	1.6
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386780-57390650	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 2616.3"	"Group enriched"	"Detected in some"	10	"Erythroid cells: 44.3;Extravillous trophoblasts: 107.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 7.2"	"Group enriched"	"Detected in some"	62	"HL-60: 3328.5;HMC-1: 5009.7;NB-4: 10560.9"	"Not detected"	"Not detected"							HPA038515	Supported				"Secreted in female reproductive system"	NA	NA		100000000	"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA038515: AB_10675800"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.39e-2)"		"unprognostic (3.49e-1)"	"unprognostic (8.62e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.40e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.32e-1)"	0.7	0.0	0.0	0.1	0.0	215.8	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	2.5	1.1	1.4	0.0	0.0	0.3	3.8	0.0	0.2	2616.3	0.0	0.0	0.4	0.0	0.9	0.0	0.2	2.1	0.4	0.5	0.0	3.0	0.3	0.0	0.0	8.7	0.2	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	101.3	0.0	0.0	0.2	3328.5	5009.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	9.0	0.6	0.0	0.0	0.8	10560.9	0.0	0.0	0.0	0.3	0.8	1.0	0.0	0.0	1.6	4.2	0.4	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.4	0.2	0.4	0.3	7.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	44.3	0.0	0.0	107.2	0.5	0.0	0.0	6.3	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314567	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 93.2;liver: 185.7"	"Group enriched"	"Detected in some"	15	"Fibroblasts: 320.6;Hepatocytes: 364.7"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Region enriched"	"Detected in single"	33	"hypothalamus: 30.8"	"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 284.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB054258	Supported				"Secreted to extracellular matrix"	NA	NA		4300000000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB054258: "	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	93.2	2.3	0.0	2.3	0.0	0.3	15.1	0.4	0.9	0.6	3.9	1.2	0.0	0.6	0.9	0.3	20.0	0.4	31.7	0.0	30.8	0.2	185.7	26.4	0.4	0.0	0.0	2.1	1.5	0.0	2.1	0.0	0.1	0.6	0.1	0.1	3.9	0.1	9.5	7.7	0.4	0.3	0.2	0.7	1.4	0.2	0.2	0.3	1.7	8.1	0.3	2.6	0.5	0.0	0.0	0.1	0.0	0.0	284.6	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.1	0.2	0.2	0.0	26.2	0.0	44.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.7	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.9	0.0	30.8	0.0	0.0	0.1	0.2	0.2	0.0	5.1	22.4	16.2	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	2.7	10.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	3.7	4.1	0.0	2.7	0.0	0.0	0.0	320.6	0.0	0.8	16.4	0.0	6.4	364.7	0.1	0.0	0.1	0.0	0.0	9.4	1.9	0.8	0.0	2.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	0.1	0.0	0.0	10.9	0.0	0.0	3.5	1.5	0.0	0.3	0.0	1.1	0.0	2.3	0.1	0.0	0.1
PRICKLE2	DKFZp686D143	ENSG00000163637	"Prickle planar cell polarity protein 2"	Q7Z3G6	3	64092236-64445476	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035493			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Vesicles	"HPA035493: AB_10696504"	"unprognostic (2.87e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.77e-1)"	20.8	3.0	14.1	3.9	14.9	0.3	8.0	3.4	15.8	16.4	9.1	18.4	2.3	17.3	6.8	7.7	11.7	8.8	5.6	28.5	10.0	3.8	3.1	10.6	0.8	4.4	8.9	8.4	3.8	5.4	5.6	5.6	6.2	7.3	4.6	10.1	4.9	13.8	1.9	4.3	5.9	16.6	6.3	1.4	8.1	1.7	11.7	1.0	6.9	3.9	1.0	12.4	8.8	9.3	0.0	4.7	1.3	0.1	24.1	14.9	0.0	3.5	4.5	2.8	4.2	8.3	0.1	0.0	0.5	3.4	7.6	0.1	0.0	3.2	2.8	3.3	0.1	0.0	0.5	0.1	6.7	0.0	0.0	22.1	4.0	8.2	3.5	8.4	1.7	0.0	0.0	1.8	3.9	4.6	0.0	0.1	3.0	0.0	0.1	0.0	0.2	0.1	4.5	11.7	1.2	0.2	0.0	0.9	0.1	7.7	1.6	0.1	0.1	11.9	5.4	2.9	6.9	3.7	0.0	0.7	15.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.1	14.9	3.4	15.8	28.5	10.0	4.4	8.9	6.2	6.3	11.7	9.3	12.4	0.0	10.9	114.3	1.5	6.2	4.1	7.3	7.4	25.6	4.3	8.4	6.2	1.5	7.3	3.7	64.6	1.4	0.3	1.6	0.0	2.7	15.1	24.7	47.5	9.5	0.0	0.0	185.5	0.4	0.4	20.3	0.0	8.7	0.0	5.2	33.5	1.7	4.1	16.8	232.4	0.6	4.1	1.2	1.8	3.5	9.9	0.6	5.4	112.4	0.0	7.5	1.0	103.5	26.4	0.7	0.3	23.0	0.2	0.9	0.0	6.2	7.6	4.4	13.1	14.6	14.3	2.0	1.0	6.2	3.0	4.9	0.6	6.6	1.1	2.7
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646850	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 30.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	4.3	3.3	3.9	6.6	4.6	15.0	6.9	6.0	4.3	5.6	6.9	6.9	6.0	7.2	6.9	4.3	6.2	4.3	3.3	3.9	5.6	3.9	5.0	4.8	10.6	4.2	4.7	7.2	4.0	3.9	1.9	7.5	4.4	30.6	8.4	4.0	4.2	5.6	2.3	5.8	5.2	8.0	2.8	5.5	4.8	6.5	4.5	15.3	4.4	2.4	11.8	5.8	4.1	7.1	44.8	17.7	34.1	37.6	16.8	29.5	27.3	53.1	48.8	57.0	74.7	26.6	21.1	39.4	27.7	66.6	39.6	27.9	30.2	29.2	71.6	35.1	24.2	47.6	22.7	43.0	7.3	43.5	27.4	12.1	12.0	61.0	20.3	14.2	26.9	44.1	46.2	38.9	48.3	28.2	49.8	37.6	22.0	37.1	17.2	34.7	46.9	31.2	21.0	20.7	24.5	19.2	31.5	15.9	21.3	38.9	33.3	47.4	17.9	54.7	55.5	106.2	44.2	14.4	29.3	47.2	26.6	50.5	30.4	0.7	1.9	1.8	4.1	3.7	4.3	3.5	3.5	5.4	3.0	4.0	2.8	5.7	1.4	5.2	4.2	5.1	4.7	2.1	3.9	4.6	6.0	4.3	3.9	5.6	4.2	4.7	4.4	2.8	4.5	7.1	5.9	0.0	2.7	30.0	11.2	4.0	6.7	4.1	11.4	5.6	6.2	4.2	1.1	2.8	4.6	3.7	12.5	17.0	15.1	4.3	3.9	5.1	10.3	4.9	7.1	5.0	1.2	26.5	38.0	5.2	22.0	6.9	4.1	6.0	12.0	13.7	4.2	3.5	9.3	6.7	32.6	6.5	10.2	6.6	6.4	3.7	6.5	7.0	0.0	70.3	7.3	4.8	17.5	56.8	54.5	4.9	5.3	6.8	12.7	7.1	4.4	1.8	4.1	5.6	19.7	4.9	6.8	10.1	11.2	8.7	3.0	5.7	13.6	8.0	8.6	5.3
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 606.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol		NA	NA		1800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"CAB019378: , HPA049979: AB_2680980"	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	125.9	158.2	72.0	124.1	83.2	57.1	118.4	76.7	119.1	151.2	97.3	70.0	51.7	145.5	122.3	98.5	141.3	125.2	430.0	89.0	102.1	164.3	150.8	163.7	111.4	85.6	91.8	202.8	63.1	300.2	88.0	164.3	105.0	114.5	79.1	132.2	169.7	137.6	250.6	63.8	58.7	132.1	71.7	121.7	86.9	130.8	91.8	109.4	173.6	147.4	103.6	136.4	67.6	93.5	95.5	180.0	225.9	136.1	294.6	331.7	33.9	125.7	257.9	192.2	168.6	70.5	125.5	96.3	84.3	276.7	196.8	77.2	168.8	204.2	273.8	65.8	60.4	149.1	154.0	233.0	213.0	115.8	160.2	239.1	207.4	222.3	185.9	215.0	324.6	80.8	68.5	147.2	236.4	181.0	128.2	60.9	83.9	97.7	121.4	88.1	373.6	106.7	292.4	204.3	81.8	110.3	115.4	207.6	496.8	208.5	162.8	161.1	232.2	269.4	127.6	123.3	119.0	121.6	93.5	142.4	163.0	107.8	171.8	149.6	108.3	189.4	48.6	101.0	48.8	42.8	35.9	43.6	105.9	32.3	32.1	35.9	208.2	76.1	120.9	34.7	50.9	113.5	72.0	83.2	76.7	119.1	89.0	102.1	85.6	91.8	105.0	71.7	91.8	93.5	134.1	147.4	263.4	38.5	126.0	142.8	100.1	136.8	116.7	99.6	106.8	65.4	606.2	81.5	156.4	252.0	66.7	77.4	127.4	58.1	178.1	80.7	407.9	142.9	116.4	131.8	136.9	52.5	76.1	52.0	86.8	163.2	78.5	110.3	185.0	78.2	158.1	120.7	146.1	139.7	78.4	53.3	136.3	176.2	171.1	93.7	133.6	151.1	192.1	46.9	142.3	125.1	78.2	57.3	76.3	74.6	51.5	190.7	95.6	85.3	27.1	210.1	307.7	59.9	85.5	123.2	210.9	219.8	54.2	122.4	131.7	82.5	117.3	184.0	43.9	112.8
PRKAR2A	PRKAR2	ENSG00000114302	"Protein kinase cAMP-dependent type II regulatory subunit alpha"	P13861	3	48744597-48847874	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.7;testis: 82.5"	"Group enriched"	"Detected in all"	8	"Early spermatids: 788.7;Late spermatids: 1370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005023, HPA038268"	Uncertain					NA	NA		210000	"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"			"CAB005023: AB_562330, HPA038268: AB_2675921"	"unprognostic (2.81e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.17e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (4.77e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-2)"	19.0	14.8	8.3	11.6	7.4	18.5	13.0	8.1	9.1	10.4	11.7	23.5	12.9	9.9	9.3	18.5	17.6	8.3	17.2	7.9	14.3	18.1	15.8	12.5	8.9	12.4	10.1	10.7	12.5	16.5	6.8	11.4	11.7	14.3	19.6	15.8	17.1	14.4	82.7	13.8	13.9	16.2	11.8	9.3	14.2	82.5	10.8	4.9	17.2	39.4	12.5	11.8	10.0	12.0	39.2	25.9	21.2	16.4	31.1	31.4	23.8	44.0	21.8	37.7	23.7	34.4	17.1	34.3	30.1	45.7	24.4	17.6	61.0	38.4	50.4	28.3	22.6	45.8	44.7	25.4	22.8	48.6	28.3	26.2	29.5	48.5	35.4	14.1	40.2	11.5	52.3	21.4	35.9	15.2	0.4	15.7	15.1	28.6	28.4	14.7	26.9	43.6	24.2	42.4	21.0	21.6	43.2	50.8	29.1	22.8	34.2	37.1	51.5	33.0	26.3	54.2	61.0	36.2	76.4	32.5	44.5	52.5	25.4	8.0	6.5	8.0	6.7	6.1	6.6	6.0	5.8	5.8	6.3	5.0	3.9	4.0	9.2	7.0	12.0	3.9	5.5	5.2	8.3	7.4	8.1	9.1	7.9	14.3	12.4	10.1	11.7	11.8	10.8	12.0	61.5	19.2	62.2	42.1	36.5	41.9	25.5	26.9	48.9	44.2	51.0	34.9	70.8	50.1	33.1	46.0	68.8	25.0	61.2	92.3	21.5	41.3	788.7	64.2	60.4	48.8	42.0	22.9	62.4	60.3	34.6	37.6	43.8	41.3	13.3	29.4	55.0	121.4	48.8	62.2	73.1	42.5	34.6	52.2	45.3	1370.7	55.0	48.0	30.2	38.4	48.3	24.8	39.1	42.7	90.9	66.4	46.9	55.7	48.6	34.0	45.2	41.2	50.3	46.2	52.6	51.8	46.6	82.1	61.0	79.0	62.8	23.5	54.1	32.8	87.9	26.6
PRKCA	"PKCA, PKCα"	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302613-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 564.8;Excitatory neurons: 247.6;Inhibitory neurons: 400.0;Microglial cells: 281.1;Oligodendrocyte precursor cells: 849.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 157.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	3.1	21.1	37.0	6.9	35.0	1.8	2.3	20.8	51.4	7.5	11.8	18.5	11.9	11.7	4.8	3.2	4.6	7.5	4.4	76.8	32.8	12.8	7.3	4.5	4.9	37.3	36.1	15.7	5.1	0.9	6.3	5.0	25.3	13.0	8.6	30.1	2.3	16.9	5.8	3.0	10.6	10.7	30.1	6.5	8.4	2.6	36.9	3.1	3.2	4.3	4.6	8.9	5.6	27.3	7.3	38.0	7.7	7.8	18.2	46.0	1.0	40.8	26.4	28.8	24.3	4.5	4.6	9.6	10.9	65.9	48.1	0.9	3.9	4.8	61.9	16.4	9.3	0.0	22.2	20.2	24.9	12.2	62.8	20.2	1.8	36.0	30.5	41.8	25.0	45.6	25.8	0.2	44.8	2.3	24.9	7.4	3.1	18.9	20.2	4.5	56.5	0.2	10.2	6.4	4.6	25.6	13.5	7.7	0.4	8.0	0.8	17.0	75.1	49.6	28.6	31.4	25.8	0.1	0.0	1.2	157.6	0.1	25.1	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.8	0.4	0.3	0.0	1.2	0.7	0.0	0.0	1.1	0.4	0.1	0.3	37.0	35.0	20.8	51.4	76.8	32.8	37.3	36.1	25.3	30.1	36.9	27.3	10.0	0.0	8.4	564.8	5.7	10.6	15.0	10.3	13.6	198.3	7.9	11.2	9.8	45.8	7.2	40.5	2.1	4.1	24.6	27.1	7.9	16.1	3.2	5.5	40.1	5.6	8.4	5.7	247.6	6.8	3.4	17.5	23.9	6.3	20.3	39.9	27.8	14.7	25.4	10.1	400.0	38.4	2.0	11.9	7.6	3.0	53.4	20.9	10.6	281.1	6.8	34.3	12.3	849.0	198.3	8.8	21.0	48.5	11.8	12.8	27.0	21.3	7.0	77.1	26.3	6.5	41.4	1.3	3.9	6.1	10.4	15.2	36.9	47.1	26.4	17.2
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cell line enhanced"	"Detected in many"		"HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.8	0.7	5.3	5.2	8.5	5.7	0.9	6.1	6.3	1.6	12.1	1.4	1.5	2.5	8.3	2.2	3.9	1.5	0.3	5.5	8.2	10.9	1.0	5.3	12.3	6.5	8.6	1.3	3.4	0.7	0.8	0.2	6.4	1.8	1.7	1.5	1.4	1.1	124.5	0.3	3.3	0.7	5.5	5.0	2.1	1.1	7.2	33.6	14.9	112.6	9.4	2.2	0.6	9.8	0.1	5.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.4	3.4	0.3	0.0	0.0	0.0	0.0	3.3	6.0	0.0	0.0	3.9	57.8	0.0	0.4	0.7	2.8	0.6	0.3	3.5	0.1	0.2	0.0	0.5	40.0	12.8	0.1	0.0	0.0	43.9	8.0	5.8	0.5	0.0	8.5	1.3	0.0	11.6	2.9	0.4	2.1	0.0	0.0	0.0	3.4	0.0	5.8	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	2.4	0.1	0.3	23.0	0.4	18.0	0.1	24.5	24.5	0.2	0.0	19.1	17.9	1.6	13.3	0.0	0.0	39.7	10.5	5.3	8.5	6.1	6.3	5.5	8.2	6.5	8.6	6.4	5.5	7.2	9.8	0.2	3.2	7.0	22.9	0.8	0.0	0.3	0.3	0.6	1.6	0.3	0.3	0.4	0.0	0.7	1.8	0.0	0.0	22.4	0.0	7.9	0.3	2.1	0.5	1.2	0.2	1.8	8.0	13.7	0.8	0.1	0.7	1.5	3.0	1.3	8.2	1.1	0.0	0.5	0.0	14.7	0.5	0.0	1.3	0.5	5.6	0.0	1.7	0.0	7.5	0.8	1.2	32.0	24.6	75.2	0.1	0.1	0.0	10.2	0.2	0.0	0.3	0.9	0.4	0.0	4.2	0.4	1.0	2.2	0.5	0.0	0.0	31.7	0.3	0.4	0.1
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435284-11450968	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		55000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	115.3	107.6	76.4	81.2	86.7	169.6	117.6	85.1	97.6	144.0	91.4	119.7	120.0	123.0	113.0	106.5	126.2	92.0	90.4	76.4	82.0	108.8	159.9	105.5	93.3	89.9	83.9	196.9	186.2	116.3	118.3	108.8	85.9	108.5	98.9	46.6	145.9	97.8	74.8	129.3	121.7	78.5	79.6	111.2	124.9	88.5	83.3	83.9	135.5	44.9	86.2	109.9	122.6	88.8	274.8	216.7	211.6	391.5	351.2	426.4	241.5	305.5	387.6	331.5	302.7	328.3	327.5	204.4	478.1	409.2	165.4	283.4	226.3	309.6	292.1	193.3	173.5	178.0	269.4	268.8	258.0	263.0	236.4	404.5	228.6	312.5	261.4	425.6	232.8	210.1	204.8	422.4	289.0	470.1	187.9	322.1	485.0	129.7	283.3	201.8	215.3	505.6	223.2	260.1	146.9	291.5	282.3	280.4	280.5	200.8	292.5	296.7	263.6	437.1	198.2	416.0	361.0	471.9	575.3	132.3	330.1	276.8	306.5	38.8	47.2	45.1	37.9	36.2	42.6	35.9	31.8	36.4	36.1	38.7	30.2	33.1	56.3	32.8	41.2	75.7	37.5	39.5	76.4	86.7	85.1	97.6	76.4	82.0	89.9	83.9	85.9	79.6	83.3	88.8	45.2	12.8	16.9	15.3	65.1	41.8	72.2	90.0	39.9	18.2	56.9	47.5	10.5	71.4	44.9	64.4	33.3	174.9	54.6	152.0	33.2	88.7	18.1	47.4	65.0	52.0	58.8	40.6	12.3	127.5	189.1	62.6	70.3	67.2	41.9	104.5	60.3	86.4	93.4	10.1	12.5	123.2	65.1	80.0	43.4	55.9	78.6	59.3	53.4	14.0	81.4	59.8	61.8	6.0	39.0	89.0	132.8	72.6	91.4	45.9	187.8	62.7	32.7	30.2	39.5	39.8	52.0	36.8	55.2	49.5	37.8	143.5	55.5	84.2	128.2	66.6
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	4	"Late spermatids: 708.3;Syncytiotrophoblasts: 1107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;OE19: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.7	11.1	23.6	4.6	25.7	2.1	5.6	58.0	41.3	4.3	0.0	13.2	29.3	2.2	7.8	16.0	9.5	4.4	9.7	23.7	10.2	16.0	11.0	31.6	8.0	18.6	8.3	2.7	12.5	14.7	17.6	43.8	19.0	8.4	11.3	14.8	10.8	3.9	0.3	13.8	28.0	1.6	5.6	10.5	8.9	31.9	7.2	3.7	21.8	0.6	7.8	5.8	8.0	24.8	14.7	9.7	3.4	17.2	0.0	0.0	44.5	1.2	0.5	11.1	0.7	23.8	31.0	0.1	27.4	3.9	9.4	25.4	20.5	25.5	7.9	1.0	21.8	0.0	15.2	33.5	3.2	0.1	11.0	0.6	14.9	0.0	8.6	0.0	0.0	4.0	6.6	0.2	0.2	17.9	0.9	0.0	6.4	41.9	22.5	0.0	0.0	5.1	18.6	16.0	24.1	18.7	11.6	27.5	5.2	28.7	17.7	4.0	0.0	0.1	13.1	0.1	0.1	6.8	1.3	0.3	1.2	0.3	16.8	0.3	0.0	16.3	0.5	0.3	2.5	0.3	0.9	0.6	0.0	0.4	0.8	0.3	1.1	0.9	0.0	0.3	0.9	0.3	23.6	25.7	58.0	41.3	23.7	10.2	18.6	8.3	19.0	5.6	7.2	24.8	0.9	121.8	72.2	2.3	6.5	13.0	11.8	11.0	10.2	27.1	11.3	11.0	1.4	5.7	21.1	7.3	4.2	118.7	7.5	48.9	7.9	12.3	224.4	14.0	4.7	6.3	10.2	6.6	39.5	10.7	66.3	3.1	17.9	11.7	8.2	12.5	10.0	16.5	14.5	62.2	35.2	25.5	10.2	0.8	2.9	708.3	9.6	4.4	7.2	2.8	4.5	19.1	8.2	13.0	41.3	14.2	45.7	8.6	7.4	19.5	78.4	24.7	22.1	25.9	0.0	0.3	4.1	28.3	28.4	13.4	13.4	1107.9	9.8	2.6	31.3	14.3
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 362.1;Excitatory neurons: 147.4;Inhibitory neurons: 171.1;Microglial cells: 89.0;Oligodendrocyte precursor cells: 390.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.6;fHDF/TERT166: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	8.0	9.6	5.6	2.2	8.0	0.0	7.7	6.5	6.7	6.4	3.7	9.5	1.0	7.9	3.5	2.1	6.5	4.4	6.1	7.5	7.5	17.5	1.6	7.5	0.3	8.6	8.6	11.2	5.4	10.6	5.6	1.9	8.7	14.7	1.3	4.7	2.9	9.3	1.6	2.8	3.6	6.3	8.9	2.3	4.6	11.7	8.1	2.4	5.9	2.6	0.5	13.1	4.6	10.3	0.0	4.4	4.8	3.1	21.6	16.5	0.1	14.1	10.4	16.7	7.3	0.0	0.3	0.0	1.9	19.4	4.0	0.1	7.9	2.1	6.8	0.0	6.2	0.0	0.0	0.5	8.8	0.0	0.1	18.4	0.3	1.4	1.5	6.1	2.6	0.0	1.4	0.4	17.4	1.8	0.0	0.0	2.6	0.0	9.6	0.0	6.3	5.2	9.7	6.6	4.3	13.0	2.6	0.0	4.5	4.6	0.0	0.1	5.6	13.6	6.7	1.0	3.7	0.0	0.0	0.0	3.5	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.0	6.5	6.7	7.5	7.5	8.6	8.6	8.7	8.9	8.1	10.3	4.6	0.0	7.4	362.1	0.2	0.5	4.8	0.4	0.6	1.4	1.4	1.5	1.2	10.0	0.0	12.9	6.2	0.0	0.0	0.1	29.4	2.4	39.5	2.8	9.2	6.1	3.0	2.7	147.4	4.2	0.1	6.4	0.5	8.4	0.0	18.7	10.8	2.5	0.2	1.7	171.1	0.2	0.0	1.6	0.9	16.9	7.5	0.7	7.2	89.0	0.0	16.7	0.0	390.6	76.6	2.0	0.1	12.8	0.4	12.4	0.2	4.5	0.1	2.9	0.0	13.3	4.5	3.2	7.8	0.0	0.9	0.3	0.6	29.6	0.1	1.3
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22302826	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1022	"pituitary gland: 37505.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.8;Late spermatids: 28.4;Rod photoreceptor cells: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.0;SCLC-21H: 8.9;U-937: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	7200000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			3.2	11.2	0.3	1.4	0.0	0.0	1.2	0.6	0.1	0.8	0.1	2.7	0.1	11.5	0.0	11.7	1.6	0.1	4.6	0.0	0.2	2.4	9.6	2.1	0.0	0.9	0.7	4.0	5.5	0.0	37505.3	36.6	1.1	2.3	0.0	33.7	3.6	0.0	2.4	7.7	2.5	2.2	0.0	4.0	19.3	4.0	1.0	4.0	14.2	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1	0.4	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.2	0.9	0.7	1.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	13.8	0.1	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.5	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 444.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm		NA	NA		8500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB022550: , HPA069769: AB_2686193, HPA072136: AB_2686490"	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	79.7	102.2	62.5	76.2	63.2	65.0	76.7	68.1	74.7	107.0	59.4	87.2	55.1	115.4	44.5	90.7	109.7	49.8	149.2	65.7	71.1	77.9	61.8	76.5	94.0	66.5	65.2	106.7	66.3	65.6	101.1	65.3	68.8	77.1	45.5	71.3	67.6	73.9	242.6	74.8	71.8	74.0	66.3	91.6	69.4	78.4	71.3	79.6	70.9	163.2	84.5	92.6	81.6	68.7	262.5	584.9	396.5	481.7	105.4	118.7	208.4	163.7	283.1	461.8	394.0	439.5	202.2	425.9	119.0	193.4	181.1	188.0	337.3	345.8	200.1	333.7	580.5	311.5	156.4	484.6	256.8	378.7	214.2	166.7	169.3	259.2	369.0	154.8	277.1	338.3	334.0	293.2	182.5	394.1	493.2	467.0	420.5	324.9	375.6	344.8	319.9	388.8	264.0	540.9	440.0	342.4	188.9	193.2	103.4	126.9	146.8	220.6	173.9	269.9	262.5	125.4	398.6	280.0	457.4	429.3	165.7	271.0	289.8	25.0	76.8	37.5	104.0	93.8	129.6	198.9	95.4	111.0	131.5	171.6	105.2	103.3	14.8	162.3	71.9	158.9	97.7	132.5	62.5	63.2	68.1	74.7	65.7	71.1	66.5	65.2	68.8	66.3	71.3	68.7	169.7	3.2	10.3	15.7	112.4	207.0	228.7	444.9	123.5	228.9	71.3	96.8	17.2	40.0	117.3	44.1	106.3	195.6	74.4	45.1	127.2	204.0	5.4	88.9	124.5	167.8	115.2	38.3	9.8	135.2	177.5	101.7	51.5	87.5	54.7	154.2	109.6	22.1	104.1	129.5	15.8	74.5	227.9	27.0	125.7	19.4	104.1	52.9	112.1	15.9	149.4	119.3	57.7	14.6	20.2	125.6	45.6	89.1	117.8	263.0	35.2	87.5	62.8	168.7	92.1	89.7	236.3	66.8	121.8	94.9	158.8	235.2	76.8	200.7	105.0	183.2
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920525-22929408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		45000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	27.6	31.0	19.9	27.9	21.6	21.7	34.9	21.0	25.9	33.3	24.4	38.4	24.0	36.9	30.6	49.0	44.6	19.4	35.1	20.9	21.8	37.0	28.3	23.2	26.6	20.2	22.2	45.3	32.9	47.3	24.5	30.6	22.0	27.9	35.6	30.8	27.7	33.3	65.8	34.4	23.3	35.5	20.4	26.3	29.2	30.3	21.6	33.1	37.9	42.1	34.3	31.4	33.5	22.8	161.7	169.2	114.2	112.9	62.3	67.7	125.6	104.1	91.6	192.7	156.6	159.2	160.1	171.3	83.2	88.5	108.3	135.8	246.4	212.8	213.9	98.5	119.3	104.5	108.3	256.3	111.4	221.7	85.7	69.3	113.2	143.1	264.8	72.7	91.0	128.5	160.0	91.7	108.5	171.4	151.3	102.9	103.1	160.8	221.8	176.0	140.3	122.7	98.8	110.7	126.0	79.8	125.7	132.3	65.5	94.3	91.3	82.6	70.9	75.1	103.1	103.0	145.9	116.6	246.0	207.2	46.1	109.2	116.0	3.0	31.3	0.4	14.2	31.7	22.9	30.6	19.0	23.0	42.8	27.9	24.4	20.4	7.7	19.8	25.1	25.9	17.6	29.1	19.9	21.6	21.0	25.9	20.9	21.8	20.2	22.2	22.0	20.4	21.6	22.8	8.5	19.2	15.1	5.5	11.4	26.5	26.5	33.8	15.4	10.8	13.9	15.4	1.1	28.6	19.4	7.3	8.4	41.7	8.6	11.1	23.5	32.0	2.3	18.5	21.4	12.3	6.1	24.4	6.1	27.0	33.4	16.7	12.8	12.6	7.0	21.9	10.4	15.1	19.6	16.8	5.8	17.5	20.3	4.4	11.7	3.7	16.4	8.0	26.6	0.0	11.8	18.2	3.1	5.5	4.0	92.8	12.7	21.1	12.4	23.6	7.4	24.6	31.1	11.2	6.6	25.9	19.5	43.1	47.3	20.3	27.8	33.4	8.2	27.5	21.1	17.9
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 598.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.2	0.0	0.6	0.1	1.1	1.1	0.1	0.6	1.0	0.4	0.0	1.0	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	1.0	14.8	598.5	0.2	0.6	1.6	0.8	0.2	0.3	0.0	0.3	0.1	1.5	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.4	0.4	2.6	0.1	0.8	0.6	0.2	0.0	0.3	0.4	0.2	1.1	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.6	1.1	0.6	1.0	0.6	1.0	1.6	0.8	1.5	0.4	0.8	1.1	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172072-35216240	"Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 126.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 114.2;Fibroblasts: 83.4;granulocytes: 63.1;Hepatic stellate cells: 74.6;Sertoli cells: 170.9;Syncytiotrophoblasts: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 385.0;HUVEC TERT2: 611.1;TIME: 365.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 8.9"	HPA039461	Enhanced					NA	NA		980000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA039461: AB_10673359"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (7.62e-6)"	"unprognostic (3.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.19e-2)"	126.8	23.1	6.8	19.6	7.3	8.6	53.9	12.0	7.7	31.2	14.6	25.2	16.3	36.2	13.4	12.0	42.9	21.2	43.5	7.0	6.8	15.6	6.8	19.8	10.0	8.9	7.3	18.0	12.6	6.1	8.6	31.3	8.8	19.5	21.4	1.8	8.7	17.3	10.1	25.2	21.4	28.4	7.5	27.5	23.2	5.0	8.9	3.0	26.0	10.3	4.0	34.2	28.4	10.1	15.2	88.9	0.2	9.2	93.6	76.1	20.2	20.8	90.4	33.7	65.2	115.2	76.7	2.9	63.3	21.0	93.6	48.5	20.2	131.8	27.8	0.7	27.5	33.2	19.8	4.7	22.8	1.3	385.0	65.1	48.8	159.0	131.1	49.2	611.1	1.1	11.8	4.2	35.3	5.0	1.1	1.6	12.2	18.8	90.4	0.6	16.7	0.4	58.3	5.8	2.7	1.2	11.3	23.9	18.8	11.0	8.1	5.0	365.5	86.0	43.2	32.8	35.4	0.3	1.1	0.9	99.1	33.5	18.6	5.0	1.5	0.8	8.2	1.8	14.8	0.9	2.5	5.2	7.8	1.3	0.6	5.9	4.0	3.3	1.3	1.3	2.2	2.2	6.8	7.3	12.0	7.7	7.0	6.8	8.9	7.3	8.8	7.5	8.9	10.1	19.9	0.0	12.6	2.3	0.5	13.9	18.5	10.1	10.2	0.5	1.1	4.4	2.4	5.7	4.9	5.5	0.0	12.1	2.0	0.5	1.9	32.2	1.6	1.0	24.0	58.8	6.0	2.7	3.6	16.4	114.2	83.4	1.5	0.9	63.1	15.9	74.6	1.9	21.9	1.7	2.5	0.7	0.0	1.6	8.8	1.0	15.5	13.5	3.6	9.4	2.2	0.3	7.2	0.5	5.6	15.6	0.5	2.6	0.6	9.7	9.8	6.3	1.8	0.6	170.9	4.3	45.9	20.4	19.7	2.8	8.4	69.0	4.4	4.2	2.0	11.9
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5299218-5316954	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 1.7"	"Region enhanced"	"Detected in many"		"olfactory bulb: 17.0"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	1.3	0.1	1.4	0.8	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.5	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.0	0.1	0.1	0.4	0.2	0.0	1.3	1.4	0.2	0.9	1.2	0.2	0.1	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 107.5;heart muscle: 116.6;liver: 283.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 83.1;Hepatocytes: 307.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 64.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	5000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	33.6	8.7	1.7	8.1	1.3	0.3	24.7	1.6	2.7	14.9	107.5	17.3	13.5	16.4	2.0	16.6	19.4	33.7	116.6	3.2	2.2	37.7	283.1	39.2	4.7	2.1	2.4	32.6	5.6	13.5	8.5	32.0	2.2	8.4	21.6	4.6	12.3	10.3	4.9	20.5	20.6	19.2	1.6	11.2	10.5	5.0	2.3	1.5	17.0	16.9	3.7	18.5	15.1	1.7	0.4	2.7	3.0	27.1	112.3	100.1	1.6	4.6	9.4	1.0	6.6	12.7	1.4	0.0	30.0	3.0	18.8	0.0	1.4	0.9	1.8	0.1	7.3	51.4	1.4	29.8	8.7	1.5	1.2	78.2	0.4	4.0	0.6	63.0	7.2	3.7	32.8	0.1	49.2	0.0	0.1	0.0	3.1	2.7	6.5	0.3	1.2	0.0	27.7	0.0	7.6	19.8	5.0	0.0	157.0	0.6	0.0	19.9	9.4	14.8	2.8	8.2	1.7	0.0	0.0	0.0	60.4	30.4	27.8	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	3.2	1.7	1.3	1.6	2.7	3.2	2.2	2.1	2.4	2.2	1.6	2.3	1.7	55.9	64.1	33.8	17.9	1.9	14.8	3.6	2.1	4.0	0.5	1.7	14.0	44.6	14.3	7.5	1.8	10.4	0.6	0.5	7.5	3.9	9.8	3.2	2.1	30.7	47.1	15.7	16.4	28.4	4.4	0.7	83.1	2.0	1.1	30.9	5.0	65.7	307.1	12.8	1.7	19.7	11.6	0.0	31.5	20.6	6.3	28.6	14.6	19.6	27.2	1.3	22.8	0.0	10.6	4.6	5.6	19.3	36.9	0.3	4.5	1.9	42.2	56.6	8.1	13.1	32.4	28.4	0.4	0.7	11.8	33.2	1.6	2.1	10.8	12.6	2.3
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 109.2"	"Group enriched"	"Detected in some"	52	"Hepatocytes: 63.5;Proximal tubular cells: 20.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;Hep G2: 3.6"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	14.4	109.2	0.1	0.3	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.4	1.1	0.4	1.6	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	0.5	0.3	0.4	0.8	1.4	0.1	0.6	0.1	0.1	0.0	0.5	1.3	0.0	0.0	0.1	0.6	0.7	0.0	0.4	0.3	0.3	0.0	0.3	0.1	0.7	0.4	0.3	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.5	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	20.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890547-60906585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA		71000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	46.1	70.6	89.8	49.8	87.9	67.0	48.8	73.7	100.2	57.4	60.2	54.5	42.9	55.4	34.2	81.7	57.3	29.4	47.9	91.3	94.1	50.4	77.2	34.6	64.1	92.0	80.7	66.6	69.4	79.8	79.3	42.9	92.9	62.1	51.8	46.1	56.5	48.2	75.2	80.3	49.5	47.9	75.6	54.3	54.3	30.5	81.1	78.5	43.4	38.9	73.7	58.7	55.9	84.5	197.5	147.0	161.8	116.2	92.7	80.8	155.6	102.4	137.5	200.2	149.0	162.7	141.1	280.5	145.2	98.2	120.2	179.0	229.2	184.6	153.4	207.0	153.4	232.4	111.3	184.9	134.2	308.6	161.1	86.3	137.0	154.4	171.9	58.7	158.7	167.4	248.2	155.3	99.5	270.6	328.9	249.5	292.6	150.5	197.7	285.8	165.5	227.5	101.7	127.5	142.3	172.9	126.6	208.3	178.0	73.1	225.8	170.2	101.9	89.6	147.2	161.8	171.2	147.2	223.3	287.9	111.6	208.6	138.6	4.2	7.8	2.0	2.4	3.8	1.7	0.9	1.8	1.7	3.6	2.4	2.2	2.0	0.5	1.8	2.3	3.9	1.7	1.0	89.8	87.9	73.7	100.2	91.3	94.1	92.0	80.7	92.9	75.6	81.1	84.5	15.8	19.2	23.7	10.1	26.7	42.1	35.2	40.2	33.0	32.0	24.6	19.4	17.6	20.0	28.6	27.6	10.4	94.7	16.2	20.4	27.4	48.5	21.6	21.4	19.7	27.3	39.0	45.2	19.8	51.6	90.2	24.9	23.4	28.4	22.8	25.4	20.0	46.1	46.3	62.2	22.2	40.0	32.6	23.0	21.6	3.6	37.0	19.3	26.6	11.2	41.2	25.4	21.6	10.1	11.8	33.4	27.7	38.7	31.9	40.4	27.8	27.9	17.8	25.3	46.0	22.4	22.6	25.2	38.0	37.4	41.6	40.6	24.8	24.8	55.1	26.3
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321479-150353233	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	26.0	24.7	18.1	22.3	20.2	44.8	27.0	23.2	23.1	27.5	22.8	25.2	16.9	25.0	26.7	22.2	25.7	13.8	19.5	17.8	21.4	29.0	30.4	24.3	28.6	19.7	18.9	34.1	23.8	17.6	27.0	20.9	19.3	27.5	19.6	43.5	21.7	19.5	22.2	23.8	24.6	18.7	17.3	33.8	19.1	20.1	19.7	30.9	32.0	14.9	28.5	24.3	24.3	21.6	44.8	47.5	47.1	30.3	31.0	33.5	63.8	45.6	31.9	69.1	47.5	36.6	40.8	58.7	29.7	37.6	64.4	51.5	86.1	32.2	61.7	29.7	38.3	50.7	72.1	35.2	30.7	62.5	31.6	24.6	43.7	59.0	50.5	32.9	42.7	39.0	61.3	34.8	50.0	66.5	52.3	55.0	67.6	114.3	41.9	75.1	38.5	38.8	28.5	26.7	40.3	35.7	37.9	44.2	34.9	63.3	52.9	150.5	34.3	43.2	33.3	36.7	75.8	33.1	62.8	64.7	28.8	56.2	45.9	9.3	9.0	13.3	14.9	11.8	14.6	13.0	10.8	9.8	9.5	10.0	11.0	11.4	5.3	11.5	21.8	7.6	9.1	8.3	18.1	20.2	23.2	23.1	17.8	21.4	19.7	18.9	19.3	17.3	19.7	21.6	26.1	35.3	23.4	31.6	26.1	11.7	13.1	13.0	10.8	30.4	10.8	10.8	13.2	11.5	19.7	11.0	18.8	16.1	22.9	15.8	13.7	15.6	11.5	13.2	20.0	22.5	2.4	19.0	19.5	11.9	16.0	16.3	17.9	17.8	22.8	25.5	14.6	11.0	12.1	32.0	17.5	17.5	4.1	8.6	11.8	5.3	20.2	14.5	10.6	15.0	14.2	27.8	17.5	18.1	28.4	13.4	9.5	18.4	12.4	12.6	12.6	5.0	20.6	42.6	13.1	19.1	21.2	44.3	23.5	11.6	10.1	20.0	24.0	11.3	11.6	10.0
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275642-113294009	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	11.6	14.7	9.2	15.2	9.5	15.1	13.4	10.3	10.9	11.2	8.6	11.1	9.9	13.5	19.4	14.9	12.3	10.3	11.0	9.4	9.5	15.4	16.2	9.4	15.6	8.9	8.9	14.8	14.4	25.4	12.2	12.5	9.2	13.3	12.3	13.1	11.2	11.1	18.1	14.6	9.8	13.2	9.0	11.6	10.3	11.6	9.1	16.9	10.2	15.2	17.6	16.7	11.3	9.6	36.6	61.3	40.3	44.4	27.8	28.6	40.4	56.1	28.1	60.2	44.2	60.4	33.4	76.5	32.5	30.3	62.2	81.8	84.9	48.8	66.2	54.2	32.1	39.1	50.4	43.7	25.2	68.0	34.2	20.7	32.7	63.1	59.9	22.6	28.9	41.8	67.5	40.9	51.2	57.3	65.1	47.9	63.9	94.2	66.5	59.4	95.9	51.4	26.0	28.9	52.7	35.5	82.9	44.0	26.0	32.0	68.3	35.0	29.8	49.1	37.3	63.0	72.4	52.1	153.1	73.3	37.6	42.9	63.8	27.4	16.2	16.1	14.7	19.4	17.1	17.1	14.4	13.3	20.4	17.4	14.5	14.6	5.2	18.4	24.6	13.4	14.6	14.8	9.2	9.5	10.3	10.9	9.4	9.5	8.9	8.9	9.2	9.0	9.1	9.6	15.7	9.6	18.4	6.8	23.7	15.7	17.6	10.4	18.8	22.9	12.7	14.6	12.9	12.8	15.2	18.4	18.8	27.7	26.6	5.8	25.4	18.6	17.2	17.5	24.7	12.6	17.5	20.0	8.6	16.9	34.5	16.4	10.2	21.9	19.0	21.5	6.4	9.9	18.4	28.6	8.3	13.0	10.2	13.5	17.8	13.0	11.5	20.5	5.4	2.8	27.3	22.7	18.6	4.0	5.7	15.5	9.6	10.9	15.7	20.6	8.1	16.9	14.3	24.1	0.0	16.9	17.5	28.6	21.0	21.4	18.8	21.5	20.0	24.7	14.0	16.9
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA038272: AB_2675923, HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	16.7	16.7	9.0	24.7	9.8	45.0	21.5	14.3	10.4	16.8	9.4	24.2	23.0	18.6	15.7	27.6	18.0	17.4	15.3	8.7	10.3	18.9	21.7	17.4	30.4	10.4	8.7	18.9	19.7	24.0	10.5	22.2	10.9	18.4	20.9	16.7	16.6	15.0	22.8	21.0	23.0	17.4	9.9	20.7	22.2	25.5	8.7	31.5	24.6	20.0	28.1	27.1	15.1	12.3	63.4	62.9	68.9	70.8	39.1	51.8	95.5	61.8	55.2	86.0	78.9	120.0	57.8	130.9	88.0	62.7	49.2	63.8	90.8	74.3	91.6	72.4	78.6	121.8	55.7	79.9	50.7	135.4	81.6	41.7	61.9	113.8	127.3	52.4	67.5	60.8	133.2	60.6	52.9	38.4	57.2	63.4	102.9	41.2	75.8	110.4	73.3	86.9	43.7	99.8	82.2	56.0	73.9	53.5	67.6	50.6	46.8	85.4	79.1	90.3	56.6	51.9	81.4	38.8	67.7	130.6	57.9	78.2	56.1	87.6	70.1	91.7	66.7	86.5	62.3	65.5	62.1	60.7	79.4	70.3	65.5	58.8	61.1	70.4	101.1	84.8	58.8	80.1	9.0	9.8	14.3	10.4	8.7	10.3	10.4	8.7	10.9	9.9	8.7	12.3	98.5	112.2	118.5	48.3	120.3	141.0	120.0	117.9	101.3	65.0	73.6	70.6	64.4	55.8	122.1	53.3	73.0	123.1	123.7	67.2	49.0	110.0	150.3	101.0	126.6	97.4	78.3	105.6	56.4	111.5	155.9	96.4	74.9	121.0	123.4	111.0	53.9	72.5	109.2	60.6	53.3	81.5	87.5	95.7	114.5	36.4	69.3	125.5	55.2	44.0	184.1	62.7	107.1	44.7	71.3	128.3	86.8	79.7	112.1	131.7	69.5	75.7	152.6	75.2	98.6	104.8	132.1	239.0	121.4	141.6	151.7	132.2	119.9	164.9	103.7	148.4
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	9.1	7.2	4.8	11.3	5.4	27.3	8.1	7.5	6.7	5.8	5.2	8.6	10.2	9.9	10.1	8.4	4.4	6.1	5.0	4.7	5.1	4.2	4.3	6.8	14.2	5.4	5.5	8.4	6.8	4.2	3.3	7.6	5.3	6.3	8.6	15.9	8.4	5.5	16.3	13.3	9.0	5.6	4.9	11.2	8.1	3.8	5.5	8.8	6.5	4.5	10.0	6.7	7.0	6.9	6.0	3.9	14.4	12.1	8.3	7.3	12.3	7.7	3.4	4.7	5.2	6.9	7.1	8.1	5.7	5.1	4.8	12.8	10.1	6.8	7.1	4.4	11.1	6.7	19.1	11.5	3.6	11.2	10.6	5.7	6.9	5.4	6.6	11.0	5.1	6.5	11.6	3.1	7.4	2.7	7.2	26.3	6.0	3.8	4.3	9.9	6.1	11.2	8.4	10.2	7.9	7.3	4.7	3.9	5.5	16.9	9.6	7.9	7.3	11.2	6.5	4.3	8.2	7.5	7.9	6.9	3.2	7.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.4	7.5	6.7	4.7	5.1	5.4	5.5	5.3	4.9	5.5	6.9	122.4	109.0	103.2	35.6	110.5	83.5	64.0	43.1	69.4	88.6	80.4	49.5	79.1	61.5	75.1	97.5	89.6	61.8	151.3	94.9	72.4	64.4	15.6	115.9	143.5	85.8	75.3	79.1	42.8	56.8	49.9	78.7	88.2	113.4	90.5	96.2	61.1	85.8	41.1	106.0	49.8	88.8	50.8	71.6	49.4	20.6	98.8	71.4	35.6	49.6	97.4	81.2	118.4	50.8	68.1	62.8	61.5	89.1	101.9	62.8	55.5	89.5	71.7	184.0	59.2	105.3	85.8	66.1	76.5	66.7	91.4	63.6	106.2	93.1	87.7	65.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981132-64033100	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	44.0	32.2	33.6	30.8	37.4	33.3	40.1	44.9	37.1	38.5	34.5	39.9	30.0	43.5	27.9	38.9	49.3	27.2	39.0	32.9	34.7	35.3	29.8	32.1	40.9	37.7	35.5	50.6	44.2	37.2	36.7	30.9	37.1	34.5	25.9	36.4	38.3	36.4	64.6	58.3	38.1	29.7	34.6	40.9	37.3	41.0	35.5	44.4	36.2	37.1	40.5	40.5	36.2	46.8	72.8	86.5	62.3	66.3	69.5	48.6	81.5	56.1	62.8	167.9	74.6	233.6	86.2	90.9	133.4	74.5	107.1	110.0	101.2	116.1	88.7	44.0	59.0	76.8	112.7	213.3	76.7	105.3	102.3	55.2	81.4	77.5	89.2	59.9	63.3	83.7	76.2	76.6	56.8	89.2	106.8	131.0	55.4	114.4	106.7	116.0	53.0	87.3	64.4	71.9	61.8	72.4	108.6	110.0	74.1	43.2	108.0	135.5	90.1	96.2	55.1	77.4	104.6	63.7	66.5	94.6	70.3	62.5	76.3	90.8	59.7	73.7	67.0	62.7	93.3	67.1	82.3	72.5	58.6	58.4	95.8	80.9	50.3	130.5	77.8	54.5	79.7	92.3	33.6	37.4	44.9	37.1	32.9	34.7	37.7	35.5	37.1	34.6	35.5	46.8	60.7	60.9	62.6	19.2	69.3	38.4	45.3	50.7	63.2	81.6	54.2	59.8	70.5	34.3	71.6	62.5	37.5	72.5	53.2	43.8	82.2	59.3	49.1	70.3	66.8	55.7	52.7	43.5	12.5	56.7	47.6	51.2	38.7	62.0	91.2	49.0	63.9	55.2	46.3	42.1	14.8	60.6	57.0	44.8	34.1	28.7	58.1	49.9	48.0	5.6	79.7	86.5	57.7	12.5	17.8	65.9	43.9	52.6	67.8	33.5	58.0	65.8	87.7	112.7	59.2	68.2	61.9	120.6	118.9	59.8	46.3	94.5	60.0	32.6	47.7	34.3
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684867	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Rod photoreceptor cells: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm		NA	NA		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	78.5	128.7	82.6	45.7	85.0	70.5	78.6	93.2	121.3	98.5	98.7	93.5	33.0	94.5	44.1	85.3	94.2	30.8	100.9	84.4	84.0	78.2	91.2	84.2	52.8	83.6	82.1	131.6	78.3	82.7	130.4	44.7	86.2	89.7	44.5	115.6	78.1	49.1	146.7	92.6	84.2	51.7	80.9	98.2	80.5	100.1	81.5	83.9	89.0	80.1	61.6	96.9	84.3	88.0	104.0	240.7	149.0	116.1	120.8	90.4	107.9	78.2	109.5	160.3	122.4	208.2	50.0	150.0	73.2	150.5	113.4	152.9	356.3	139.5	181.6	99.4	170.0	124.3	187.1	161.0	73.5	145.4	138.9	86.0	91.2	194.8	146.7	84.5	146.1	106.2	121.1	126.6	117.9	112.7	114.4	117.4	97.0	97.7	74.4	218.4	82.3	80.7	63.1	121.1	71.0	103.8	145.0	61.5	69.3	121.6	87.4	91.3	122.1	91.7	78.3	130.2	176.1	46.6	46.7	101.9	81.6	108.1	121.6	23.1	8.9	10.1	19.1	14.4	23.6	17.5	17.7	20.9	15.7	18.3	16.7	20.0	9.0	14.2	21.7	25.2	23.2	11.2	82.6	85.0	93.2	121.3	84.4	84.0	83.6	82.1	86.2	80.9	81.5	88.0	45.7	60.9	84.3	24.5	72.8	30.1	30.0	42.5	56.9	128.0	31.8	34.4	39.4	42.9	53.9	47.8	252.3	43.3	66.6	42.9	7.9	35.5	11.8	45.4	38.8	46.3	36.5	73.0	23.6	40.9	26.7	48.3	56.1	40.3	52.6	55.9	37.9	38.7	39.8	72.3	29.3	40.2	32.6	40.1	26.5	11.2	73.3	42.6	19.6	19.7	48.3	55.9	46.4	21.6	19.0	42.7	36.5	52.3	70.0	31.4	48.7	18.3	51.3	293.2	72.3	65.4	44.8	100.4	99.1	57.3	27.8	39.5	62.8	50.2	50.3	31.5
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"salivary gland: 6616.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.8;Cone photoreceptor cells: 139.7;Horizontal cells: 85.8;Rod photoreceptor cells: 119.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"OE19: 2.8"									HPA042133	Supported				"Secreted to digestive system"	NA	NA		14000000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	1.9	2.0	0.6	0.0	0.6	0.1	9.7	0.6	1.8	0.1	0.6	0.2	7.6	0.0	0.0	148.1	0.0	0.0	0.4	0.6	0.6	0.2	0.2	74.4	0.0	0.8	0.6	0.1	2.7	0.0	2.0	0.1	0.6	4.0	0.0	0.0	6616.8	0.1	0.8	73.4	0.2	0.0	0.6	0.1	66.0	0.5	0.6	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	1.8	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	0.3	3.2	0.0	0.0	22.0	3.1	6.8	19.9	9.6	92.8	7.5	2.8	1.8	7.2	8.2	1.8	139.7	16.4	20.1	6.3	1.9	0.1	10.2	0.1	0.2	9.6	16.2	14.1	0.0	0.4	2.5	9.3	10.7	0.1	8.9	0.4	14.6	5.9	7.7	85.8	0.0	6.4	24.4	8.7	6.0	13.9	21.8	6.1	28.4	0.0	7.9	18.2	56.7	0.0	0.0	3.4	14.4	24.5	17.1	9.3	7.9	0.2	6.8	119.2	13.1	23.0	7.1	13.5	5.7	8.1	2.3	4.0	20.1	0.5	9.6	4.0
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1923	"pancreas: 341429.7"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	45.2	9.9	0.0	4.7	0.0	0.0	25.7	0.0	0.0	19.9	0.0	11.2	54.5	8.9	0.8	15.2	5.6	0.0	51.0	0.0	0.0	9.6	29.7	6.4	6.5	0.0	0.0	177.5	341429.7	0.1	10.3	13.9	0.0	15.2	0.0	0.0	44.2	4.2	8.9	12.1	12.7	0.0	0.0	13.4	77.1	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	452	"pancreas: 239420.0"	"Cell type enriched"	"Detected in some"	11	"Exocrine glandular cells: 108258.7"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 4.1;T-reg: 2.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		890000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	65.1	12.5	0.1	0.2	0.1	3.2	25.4	0.0	0.1	27.6	0.0	12.6	358.5	11.4	0.0	18.2	9.6	0.1	25.0	0.0	0.0	9.4	32.2	8.2	1.3	0.0	0.0	64.9	239420.0	0.0	13.4	8.1	0.0	17.2	0.0	0.0	25.4	0.9	10.1	11.3	529.2	0.1	0.0	16.9	54.7	8.6	0.0	0.9	8.3	0.0	0.0	7.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.4	4.4	0.5	0.0	0.0	0.0	1.9	0.0	21.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.9	3.8	0.0	2.9	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	378.7	0.0	0.4	0.1	11.4	0.0	0.0	0.0	108258.7	0.0	0.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	348.9	0.0	0.0	0.0	0.0	9565.7	8.9	0.0	0.1	0.0	60.0	0.1	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	85.4	0.2
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 84.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 16.1;eosinophil: 33.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 33.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	38	"basal ganglia: 8.9"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.1	0.0	0.1	0.5	0.1	7.8	1.3	0.0	0.1	1.6	0.0	0.7	0.5	0.2	0.0	1.5	2.7	1.8	0.0	0.0	0.1	0.1	0.1	2.5	1.2	0.1	0.0	0.1	2.0	1.5	0.1	0.0	0.1	3.8	0.5	0.0	20.5	0.3	0.0	0.9	0.8	0.1	0.0	1.7	0.8	84.6	0.1	1.1	0.0	0.0	1.2	0.4	1.4	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	28.5	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	13.8	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	16.1	3.5	33.0	3.1	2.6	4.8	1.2	1.5	2.6	0.9	0.8	2.2	3.2	0.3	1.8	0.5	2.2	1.0	2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	4.6	1.1	37.9	9.4	13.1	0.0	6.1	8.4	84.1	0.0	2.7	0.0	0.0	0.3	2.1	1.4	0.0	1.1	111.0	0.3	2.6	1.6	0.0	9.7	0.0	0.4	9.0	0.7	0.0	0.4	0.0	0.4	0.0	0.0	11.1	0.0	0.0	1.5	4.1	0.6	0.7	349.7	6.5	5.7	0.0	0.0	1.1	0.0	4.1	0.0	0.1	0.7	0.6	3.8	20.4	32.7	0.1	0.1	0.5	0.0	46.0	0.0	1.0	453.2	270.2	2.8	0.6	0.1	3.4	0.0	2.4	14.5
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 249.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 104.6"	"Group enriched"	"Detected in many"	25	"NK-cells: 34.2;T-cells: 104.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		440000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	55.0	21.4	7.8	35.3	7.8	2.1	43.2	7.1	8.7	249.1	12.9	103.6	19.2	103.4	13.4	22.1	24.9	83.8	28.3	7.9	8.0	42.4	15.0	63.3	21.8	14.0	13.9	26.8	29.8	36.0	16.4	61.7	8.8	61.3	50.3	2.7	52.4	128.2	79.6	19.4	29.0	115.5	7.1	18.0	54.2	31.8	14.1	17.5	40.9	18.7	10.2	99.6	79.1	7.4	62.7	153.3	161.1	1.0	70.4	172.3	0.7	269.0	244.4	293.2	232.6	368.1	484.7	0.2	208.2	414.7	1093.7	126.2	2.6	205.0	70.9	0.7	13.0	21.1	74.7	1.4	36.3	0.1	0.9	137.4	26.8	143.2	162.1	1296.9	604.8	0.9	1.3	0.3	223.4	87.7	0.2	0.3	9.8	211.7	16.8	0.0	0.0	0.7	111.5	82.3	1.5	1.0	59.9	4.5	18.7	397.6	6.0	0.6	1138.2	174.0	2.3	351.7	154.5	1.3	1.3	0.8	124.2	0.5	176.3	0.2	0.2	0.1	104.6	0.1	0.2	0.2	17.8	60.0	0.2	0.0	4.7	50.4	1.6	34.2	2.7	0.2	0.0	39.9	7.8	7.8	7.1	8.7	7.9	8.0	14.0	13.9	8.8	7.1	14.1	7.4	95.8	28.9	14.5	14.0	3.2	15.4	96.2	367.1	2.8	1.6	44.7	78.0	4.3	37.1	231.3	53.3	2.1	18.4	53.4	154.8	7.9	162.6	3.1	10.3	130.3	502.1	13.8	20.4	26.3	83.5	15.7	117.1	22.4	7.0	2.5	347.3	591.8	5.2	5.0	0.0	16.5	30.6	85.5	36.6	18.2	6.6	14.3	5.4	72.9	39.4	1.5	0.8	180.2	11.6	2.3	257.7	80.1	7.5	5.8	100.1	5.2	5.7	90.1	0.9	39.5	14.4	105.9	3.0	7.3	1.7	9.8	4.5	24.0	445.1	11.1	60.2
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750679-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	268	"pancreas: 31113.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	104	"basophil: 158.7"	"Lineage enriched"	"Detected in many"	104	"granulocytes: 158.7"	"Group enriched"	"Detected in many"	5	"OE19: 316.6;PC-3: 852.5"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		700000000	"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	3.8	4.6	23.5	7.2	29.3	0.6	1.7	25.8	35.4	30.8	16.9	87.0	92.6	0.4	0.0	116.2	0.3	22.8	6.3	28.2	25.6	3.7	12.4	0.6	0.7	25.0	24.5	12.9	31113.6	0.0	0.7	1.7	25.7	1.1	77.8	0.3	20.9	0.3	0.5	79.7	105.4	3.1	19.4	0.7	22.8	5.1	25.6	0.8	0.4	0.0	15.2	4.2	56.9	24.7	12.0	13.7	0.7	0.0	0.2	5.9	0.1	33.6	7.7	4.1	1.6	34.3	3.0	0.0	0.2	14.9	0.2	15.0	0.0	31.7	10.1	0.4	0.2	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	10.8	110.2	0.3	68.8	0.2	0.0	0.0	0.0	0.2	0.7	0.4	0.2	316.6	852.5	0.0	0.0	0.0	0.0	1.7	0.3	81.2	0.2	0.0	0.0	0.5	0.0	0.0	78.3	0.0	0.0	12.8	0.0	0.0	0.0	0.1	18.1	0.0	0.1	158.7	0.0	0.0	0.2	1.5	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.3	23.5	29.3	25.8	35.4	28.2	25.6	25.0	24.5	25.7	19.4	25.6	24.7	0.1	0.0	0.0	0.7	1.9	57.1	0.6	1.3	0.0	0.2	0.1	2.8	1.0	47.1	1.2	1.8	0.0	0.0	0.1	1022.9	3.9	43.2	31.4	0.0	0.0	3.2	192.6	0.0	32.8	2040.4	0.0	0.8	39.3	0.0	8.9	0.0	0.7	4.2	0.0	0.0	4.7	146.4	0.0	0.3	12.1	79.7	1.5	1.2	7.2	3.7	5.7	0.0	0.0	3.5	1.2	478.8	969.9	0.7	0.3	12.1	1127.1	14.7	0.1	0.2	0.0	0.0	1.7	0.5	0.9	1.1	134.1	0.1	2.1	0.0	329.0	56.2
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2098.1"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.8	0.2	0.6	0.0	0.7	2098.1	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.6	0.4	0.3	2.8	11.7	0.4	0.3	0.4	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.2	0.1	0.2	0.6	7.1	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.6	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.4	0.2	0.6	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393766-40414793	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 34.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"spinal cord: 114.2"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	4.5	4.7	6.2	1.3	6.8	1.6	3.9	5.2	6.5	4.8	2.9	3.6	1.1	4.4	1.0	2.0	4.2	1.8	3.1	4.7	4.4	6.7	1.0	34.6	1.3	5.4	4.9	6.2	3.8	5.9	1.5	5.1	6.7	4.6	0.7	0.8	3.8	3.5	4.9	3.2	2.2	2.0	4.9	2.0	3.7	1.6	5.7	0.7	9.6	5.5	0.8	4.3	3.1	4.1	1.6	2.6	2.1	2.7	1.3	4.4	2.6	1.4	1.5	1.9	1.4	1.0	1.7	0.5	1.6	1.3	1.2	0.9	1.0	0.6	0.7	0.8	0.9	0.3	0.3	0.5	2.1	0.1	2.3	3.3	3.2	1.2	1.1	1.7	1.6	2.9	2.0	0.5	1.0	2.2	1.0	0.6	0.6	3.8	1.7	3.2	1.8	1.5	0.4	1.8	0.2	1.0	2.7	2.3	2.0	0.9	3.2	1.2	1.4	3.8	2.9	1.6	0.8	5.3	5.0	0.7	1.1	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.2	6.8	5.2	6.5	4.7	4.4	5.4	4.9	6.7	4.9	5.7	4.1	17.8	3.2	5.9	0.7	1.4	6.2	2.3	0.3	5.7	0.1	8.1	23.2	15.4	2.8	0.9	1.8	0.0	1.1	1.7	1.0	0.0	0.3	0.1	1.3	1.7	9.2	0.0	0.4	0.6	0.6	0.7	7.0	0.0	3.0	0.0	2.0	6.8	1.3	1.1	0.0	0.5	0.7	2.0	1.6	2.5	0.1	3.4	2.5	3.6	7.5	0.3	3.3	0.0	0.0	0.5	0.5	1.4	4.5	0.9	1.7	1.2	1.9	0.2	0.1	0.0	30.3	6.1	0.3	0.7	5.0	4.1	2.7	1.1	1.3	1.5	1.0
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	135	"placenta: 106.3"	"Cell type enriched"	"Detected in some"	60	"Syncytiotrophoblasts: 277.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.2;GAMG: 16.3;HBF TERT88: 9.3;SuSa: 10.7;U-2197: 9.7"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		43000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA046327: AB_2679624"	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	106.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	5.2	2.9	4.5	2.3	0.1	0.1	0.0	0.2	1.4	16.3	0.3	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	10.7	4.3	0.0	0.2	0.1	2.1	9.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	1.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	277.3	0.0	0.0	0.0	0.0
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome 20S subunit alpha 2"	P25787	7	42916828-42932185	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 439.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008188	Uncertain					NA	NA		61000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	100.7	113.4	53.7	89.0	54.1	120.2	100.1	55.7	82.8	71.2	56.4	90.9	104.3	75.6	83.1	110.0	70.5	49.4	119.2	52.5	56.6	117.0	319.5	85.9	101.4	55.6	54.5	66.4	91.0	71.0	63.8	78.9	55.5	91.1	86.8	42.2	76.0	58.2	227.5	86.9	96.7	67.3	58.6	94.1	104.8	56.1	55.4	137.5	67.4	120.1	108.8	92.4	77.0	62.8	202.8	212.5	243.4	296.4	128.1	142.1	181.1	174.7	202.8	274.9	292.3	316.5	322.2	371.5	301.7	155.5	431.6	273.3	254.3	242.4	314.2	270.3	202.3	189.8	279.1	337.1	137.3	325.8	197.7	131.7	172.7	211.7	125.7	196.1	265.1	226.0	389.8	219.4	223.5	235.9	295.0	634.9	482.4	331.3	259.9	282.1	235.5	364.3	268.2	271.6	196.8	199.1	189.5	429.9	200.9	328.3	312.4	375.6	189.9	161.0	295.3	174.5	348.6	282.6	470.3	611.1	276.0	406.0	468.9	278.5	185.4	351.9	133.9	193.4	156.9	195.4	163.3	157.9	199.8	175.2	146.0	155.2	93.1	160.7	210.0	225.0	240.8	363.3	53.7	54.1	55.7	82.8	52.5	56.6	55.6	54.5	55.5	58.6	55.4	62.8	92.2	89.8	100.5	11.1	100.6	0.1	89.3	0.2	41.5	32.4	125.2	121.4	0.0	123.0	66.8	95.6	22.9	293.3	141.3	130.3	170.2	348.6	23.9	42.3	41.5	93.2	154.9	126.9	15.3	380.0	300.1	67.2	23.9	37.6	166.0	27.5	122.8	204.8	193.5	28.6	16.0	199.8	0.0	173.5	0.3	19.1	79.2	94.1	0.0	12.2	439.1	85.3	153.5	17.1	27.9	314.5	166.9	84.7	72.6	97.8	332.7	301.5	58.3	46.6	131.5	55.3	74.4	125.8	115.6	44.3	0.0	279.1	81.8	39.1	252.8	98.2
PSMA3	HC8	ENSG00000100567	"Proteasome 20S subunit alpha 3"	P25788	14	58244843-58272012	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000905	Approved					NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"			"HPA000905: AB_1079702"	"unprognostic (3.60e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.91e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (2.16e-1)"	74.1	88.6	50.0	84.8	52.6	82.8	82.1	54.9	61.8	59.6	54.2	76.7	81.3	55.4	127.6	75.8	57.9	60.7	99.9	51.2	55.2	94.3	162.2	69.0	104.1	53.2	52.3	40.4	55.4	72.9	46.6	90.8	53.3	60.9	82.9	48.3	54.7	76.3	170.6	53.1	74.3	78.6	55.8	66.6	61.0	41.3	51.9	108.6	74.9	130.4	96.9	102.5	48.6	56.6	359.2	214.3	215.1	179.2	166.4	154.3	277.8	187.2	209.3	257.4	256.8	317.8	294.2	304.1	330.9	171.3	202.4	243.9	249.2	200.9	299.7	262.3	148.9	208.5	150.9	360.8	314.2	340.4	170.0	132.8	142.2	179.2	169.1	151.7	307.2	242.0	201.3	174.6	209.3	400.4	299.7	314.4	144.9	286.8	328.3	249.3	279.6	222.7	377.5	339.7	202.9	100.3	167.5	261.8	189.5	201.6	273.3	244.9	198.3	148.4	287.1	167.6	249.4	68.4	137.3	314.1	215.7	260.2	184.1	95.3	78.9	52.0	71.2	98.9	92.2	85.8	87.1	86.0	91.8	61.9	69.5	80.8	48.2	94.1	85.6	122.4	112.6	95.5	50.0	52.6	54.9	61.8	51.2	55.2	53.2	52.3	53.3	55.8	51.9	56.6	132.9	118.6	119.2	21.9	93.7	118.7	169.6	418.7	71.2	43.5	69.2	77.6	117.0	71.4	195.7	88.3	35.5	387.5	104.5	83.3	166.3	241.3	24.7	127.6	95.6	137.7	64.4	60.6	27.6	231.1	269.2	108.5	59.1	109.1	95.7	412.6	66.4	145.4	184.0	42.1	29.1	103.8	250.3	59.2	77.5	27.4	109.3	89.4	108.5	26.2	206.0	87.3	84.5	32.6	33.6	192.9	89.0	106.1	118.4	167.5	108.9	297.5	157.4	68.6	98.6	83.7	279.6	109.3	66.9	89.8	106.0	403.5	99.3	104.9	108.4	171.6
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSMA5	ZETA	ENSG00000143106	"Proteasome 20S subunit alpha 5"	P28066	1	109399042-109426448	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol		NA	NA		20000000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	3.5	4.7	5.1	4.3	6.2	3.8	6.8	4.0	7.7	5.8	2.7	7.4	7.5	5.5	8.6	6.8	9.1	5.4	7.7	6.8	6.7	10.9	20.2	5.9	12.7	5.0	4.7	5.2	3.2	5.9	1.4	6.9	4.5	5.4	8.5	4.8	5.0	6.2	6.1	6.2	6.7	6.5	4.1	4.8	5.2	3.5	5.3	6.4	10.2	5.1	9.3	6.1	0.9	6.6	10.1	11.7	6.2	5.7	17.6	16.9	12.6	4.9	29.8	23.2	17.9	15.0	5.5	28.1	7.8	21.2	4.2	5.7	13.8	13.7	16.1	10.7	13.1	13.4	7.7	12.4	14.0	15.2	5.3	8.5	12.3	12.7	14.3	6.2	15.0	8.2	17.1	6.5	12.4	18.6	54.4	10.3	5.7	7.0	16.5	4.4	16.9	7.4	19.0	11.5	7.3	5.2	10.5	16.2	8.9	5.0	5.9	14.1	11.7	4.6	4.6	7.9	10.3	3.6	11.6	19.7	20.0	26.0	7.4	11.0	4.3	3.1	7.7	6.3	8.4	5.7	9.0	8.3	5.9	4.7	9.7	9.7	1.4	7.2	6.1	4.2	11.4	7.0	5.1	6.2	4.0	7.7	6.8	6.7	5.0	4.7	4.5	4.1	5.3	6.6	68.9	41.7	56.8	9.4	77.4	63.6	73.5	231.0	38.1	32.6	59.5	75.7	89.5	75.8	120.9	42.3	6.2	227.0	114.5	82.1	140.8	164.9	82.0	157.6	74.1	71.6	56.3	85.0	21.7	183.0	181.4	60.4	74.9	81.9	82.4	77.7	51.4	117.4	166.9	13.5	18.4	144.1	168.9	57.8	73.6	23.4	67.7	86.3	58.7	15.0	184.8	50.2	114.4	13.0	20.2	191.6	103.5	62.1	113.1	122.2	138.0	205.6	172.4	31.7	46.0	56.1	182.6	120.3	89.1	70.4	65.9	241.2	106.1	121.4	135.3	104.2
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome 20S subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 156.3;Late spermatids: 474.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003049	Approved		Supported	Nucleoplasm		NA	NA		18000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	118.4	141.3	88.3	117.3	92.4	155.5	131.1	88.9	140.7	81.3	86.6	128.6	115.1	82.4	98.7	126.0	84.0	69.7	169.1	92.2	97.6	98.0	172.8	123.6	137.6	92.6	90.5	71.3	91.9	82.8	83.2	120.7	96.0	74.7	130.0	63.9	87.8	81.1	350.1	107.5	114.8	94.4	92.8	114.4	95.9	247.9	94.7	290.1	82.3	203.9	139.7	132.6	85.7	92.4	502.2	367.2	257.6	264.9	209.8	214.5	523.1	252.2	300.3	368.2	329.0	338.8	341.7	322.9	492.1	244.4	220.4	337.5	306.6	280.0	434.5	337.9	170.1	257.6	233.6	1011.6	235.8	542.0	225.8	166.7	229.4	256.6	324.7	178.2	312.2	548.1	284.2	220.4	298.7	522.9	838.2	458.2	249.3	391.0	407.0	1249.4	261.3	256.9	312.8	634.9	275.1	230.8	285.5	402.2	274.7	211.9	473.8	351.4	267.1	235.8	231.8	245.7	283.6	234.0	576.3	605.9	192.4	335.7	272.0	232.1	364.6	242.2	241.0	344.8	243.0	212.8	230.9	248.9	373.6	171.5	182.5	217.5	131.9	300.6	343.7	385.3	317.0	711.5	88.3	92.4	88.9	140.7	92.2	97.6	92.6	90.5	96.0	92.8	94.7	92.4	20.8	44.8	40.7	20.2	37.7	33.3	14.9	37.2	69.4	13.7	16.5	15.0	1.4	22.8	45.7	14.7	25.0	32.2	24.8	22.4	21.5	34.2	156.3	21.2	14.9	30.5	18.0	56.8	32.7	36.7	26.0	28.4	46.4	28.2	54.5	10.1	29.6	20.0	22.6	25.2	31.2	18.3	22.4	36.7	89.5	474.9	22.7	62.2	24.9	22.5	34.1	8.6	34.0	20.6	29.4	32.8	19.5	17.3	114.6	15.9	43.1	25.4	59.5	19.4	13.1	17.8	31.3	35.1	20.0	89.8	33.1	41.3	53.7	9.2	22.2	17.1
PSMA7	"C6, HSPC, RC6-1, XAPC7"	ENSG00000101182	"Proteasome 20S subunit alpha 7"	O14818	20	62136733-62143440	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 753.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046007, CAB046008, HPA047266"	Approved					NA	NA		22000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: AB_2680006"	"unprognostic (1.49e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-1)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.98e-2)"	223.2	200.1	127.6	148.5	132.0	260.4	198.0	136.9	146.2	134.6	127.1	180.3	132.2	163.4	102.9	191.0	140.5	91.3	266.2	131.9	137.0	168.9	214.0	170.3	164.9	134.0	131.7	134.4	140.2	114.1	104.1	115.0	136.7	117.8	108.0	54.5	129.2	104.2	753.9	136.6	151.3	117.1	134.7	163.3	152.9	61.3	136.4	188.0	121.9	375.3	155.4	168.2	141.3	143.7	532.8	674.6	390.9	419.4	357.2	277.8	345.0	398.3	343.6	1024.7	428.8	1785.8	504.0	438.2	926.2	421.0	644.1	627.2	371.9	752.5	497.0	261.0	261.1	1009.7	641.9	913.2	454.0	434.3	570.4	297.9	602.0	525.1	454.5	248.8	509.2	436.1	439.2	419.2	441.8	568.6	696.1	673.6	332.5	595.0	859.8	476.9	753.5	482.6	385.3	515.4	526.2	321.6	625.9	777.1	701.9	252.7	468.3	643.3	416.1	898.9	725.4	473.3	631.1	286.9	483.9	531.2	626.7	327.7	536.1	754.4	682.6	801.5	536.5	692.6	458.2	579.3	533.3	531.4	632.2	522.7	415.1	427.3	582.2	421.7	720.3	676.3	723.4	1131.2	127.6	132.0	136.9	146.2	131.9	137.0	134.0	131.7	136.7	134.7	136.4	143.7	402.9	211.5	180.8	20.9	252.3	374.5	350.6	616.4	167.4	127.5	223.0	296.4	304.9	327.5	369.2	257.5	73.0	666.2	309.5	375.2	498.9	581.9	355.5	290.2	345.4	397.3	232.0	439.4	19.2	727.7	775.7	321.9	132.0	276.5	251.4	304.7	335.5	787.5	807.0	82.4	18.4	325.6	453.7	435.7	453.1	211.0	334.6	414.8	368.2	18.7	598.4	219.3	377.9	15.1	28.9	663.3	386.4	293.8	234.5	639.7	455.1	759.6	288.8	122.5	230.1	237.0	659.7	81.4	126.3	291.9	309.3	852.6	310.4	410.0	386.9	438.7
PSMA8	"MGC26605, PSMA7L"	ENSG00000154611	"Proteasome 20S subunit alpha 8"	Q8TAA3	18	26133852-26193355	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 16.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 229.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	72	"Daudi: 25.5;JURKAT: 7.1;U-266/70: 15.9;U-266/84: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (5.39e-3)"	"unprognostic (7.45e-5)"			"unprognostic (2.94e-1)"	"unprognostic (3.04e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.30e-2)"		"unprognostic (7.54e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.56e-1)"		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	16.9	0.0	0.5	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	17.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.4	0.8	1.2	0.0	1.2	0.9	1.9	0.1	0.4	0.0	0.7	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.4	0.1	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.4	0.6	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	6.9	1.2	0.3	1.8	1.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.5	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	229.1	37.2	0.0	0.0	1.0	0.7	0.5	0.0	0.0
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome 20S subunit beta 10"	P40306	16	67934506-67936864	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	26.3	26.9	5.7	81.8	6.0	71.3	24.9	6.9	8.8	18.9	6.6	51.6	110.5	18.4	5.7	22.8	30.4	31.2	16.2	5.6	8.0	35.1	37.1	42.2	122.3	12.6	7.4	14.6	15.0	6.3	13.2	23.1	8.6	28.9	22.9	0.4	65.1	22.4	6.8	18.1	95.8	14.0	9.5	102.7	62.5	5.3	7.8	61.9	23.6	3.5	37.5	36.4	18.6	11.7	31.8	26.9	0.7	2.2	6.7	17.2	99.6	10.8	42.3	38.5	50.6	13.9	148.5	111.9	23.4	13.2	12.9	47.9	0.0	13.4	2.9	50.3	1.9	39.2	7.6	16.4	65.7	78.5	115.2	26.9	8.4	15.2	1.5	12.1	20.6	32.1	3.6	48.2	9.0	42.6	140.7	84.9	1.0	1.1	10.2	183.4	8.3	169.4	31.6	52.5	0.9	2.3	31.1	67.5	17.2	0.4	14.5	171.3	32.0	21.2	6.6	9.7	15.3	189.8	43.9	88.4	57.1	97.9	47.0	539.5	714.6	571.1	511.7	787.1	376.4	402.6	397.9	437.3	594.8	390.2	326.2	364.6	786.2	588.6	607.4	604.4	495.9	1155.7	5.7	6.0	6.9	8.8	5.6	8.0	12.6	7.4	8.6	9.5	7.8	11.7	24.7	22.4	26.8	4.6	72.9	17.2	14.3	101.2	26.2	1.0	15.8	13.8	1.6	28.6	43.9	18.4	0.0	29.5	66.2	80.8	23.5	58.5	14.0	17.6	20.1	22.8	16.3	32.6	3.4	104.3	30.0	23.4	110.6	12.3	51.9	7.2	37.1	10.2	87.4	0.0	5.0	74.6	52.9	81.9	66.4	35.9	30.1	88.5	48.0	9.4	123.3	3.0	112.3	2.5	7.3	51.2	139.7	21.1	110.5	12.1	173.5	69.4	83.9	1.1	19.7	10.3	26.6	16.4	7.5	24.1	9.9	22.6	93.9	16.9	79.5	24.8
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.4	29.3	10.0	13.9	10.3	21.7	25.0	9.7	11.6	23.6	9.4	24.3	12.9	26.9	11.5	31.8	21.9	9.1	27.3	10.6	10.4	22.6	45.9	25.6	15.8	9.9	9.7	21.0	25.2	11.3	19.6	15.2	11.0	20.0	12.7	12.1	22.3	10.8	63.1	30.9	23.2	13.4	9.9	25.4	24.2	15.6	9.5	20.5	18.7	14.8	16.7	22.9	23.9	11.8	68.8	42.4	45.5	32.2	23.3	27.9	55.5	31.8	36.6	63.2	51.1	51.6	79.3	68.8	71.3	37.6	38.6	41.2	59.3	53.4	54.5	54.5	54.1	63.4	44.5	50.1	41.4	66.1	34.7	30.4	33.4	77.0	36.8	25.9	50.8	54.1	76.6	37.7	41.9	30.7	85.5	50.1	59.3	29.7	44.0	52.3	47.5	48.7	45.3	35.9	39.8	30.1	36.0	34.5	52.1	50.3	24.9	29.3	35.2	32.0	37.5	30.9	76.5	31.8	55.0	66.9	49.9	70.4	55.6	20.5	23.6	18.2	19.6	30.3	19.9	22.3	19.3	20.6	26.4	18.5	14.0	17.3	8.8	23.6	35.4	27.4	26.3	26.1	10.0	10.3	9.7	11.6	10.6	10.4	9.9	9.7	11.0	9.9	9.5	11.8	110.8	64.1	68.9	6.2	80.4	111.1	145.2	298.5	50.7	48.0	65.8	95.1	59.8	67.2	145.0	66.2	16.7	406.6	83.6	72.4	144.8	286.2	118.0	95.4	78.8	115.9	98.3	78.7	20.8	227.3	341.0	101.3	61.2	75.9	35.4	109.6	85.6	158.1	222.6	58.9	20.9	96.9	187.2	92.7	70.3	22.8	100.6	94.1	76.5	15.9	184.1	68.4	87.6	17.1	23.4	252.0	76.6	91.4	141.7	186.0	108.5	221.7	126.8	50.4	92.1	66.8	291.4	224.4	144.0	80.4	111.5	442.1	81.4	123.9	111.7	178.9
PSMB3	"HC10-II, MGC4147"	ENSG00000277791	"Proteasome 20S subunit beta 3"	P49720	17	38752741-38764225	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042775, HPA048147"	Approved					NA	NA		25000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA042775: AB_2678158, HPA048147: AB_2680285"	"unprognostic (1.86e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (4.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.03e-2)"	95.7	139.3	65.9	95.7	70.8	138.7	92.9	68.2	76.1	83.0	67.4	105.6	82.5	90.6	101.8	110.9	81.4	73.0	154.2	74.4	80.3	120.7	187.3	101.8	137.0	70.0	73.2	59.3	78.1	86.2	81.4	90.9	70.6	85.6	106.1	42.4	84.1	66.6	201.7	99.0	90.3	92.7	69.4	122.0	93.8	53.2	76.1	106.3	87.6	119.5	132.5	102.8	83.0	80.1	246.1	457.3	168.8	277.2	180.9	158.6	237.1	167.6	265.8	563.8	489.1	486.3	324.1	279.5	276.3	228.8	371.1	401.6	279.3	294.3	301.1	373.6	500.2	184.2	226.6	562.5	96.5	289.3	278.1	151.0	184.6	393.5	131.1	132.9	289.3	283.1	301.2	320.4	246.2	319.6	461.1	457.0	250.6	278.8	328.3	261.1	383.3	446.2	312.1	253.4	216.8	145.7	191.8	157.3	201.3	243.8	360.1	356.6	173.1	138.0	269.5	308.9	421.1	202.1	367.2	397.7	285.2	294.8	242.0	227.2	323.7	150.4	176.6	271.4	118.1	148.5	145.2	154.4	274.5	114.6	93.0	94.9	569.6	142.8	209.6	352.6	176.1	372.0	65.9	70.8	68.2	76.1	74.4	80.3	70.0	73.2	70.6	69.4	76.1	80.1	146.2	76.9	124.5	8.8	142.0	199.6	203.6	517.8	79.1	66.7	100.9	105.8	328.0	104.4	281.6	176.6	25.0	434.0	141.4	215.0	406.9	362.1	51.5	140.6	123.8	185.5	133.4	156.4	8.6	497.7	428.3	160.8	100.9	117.7	154.0	110.0	118.9	247.6	416.7	30.3	7.8	207.1	368.2	161.5	266.5	48.2	149.5	231.8	200.9	7.5	309.8	167.5	179.2	3.0	12.6	401.0	242.9	145.9	205.1	189.9	219.9	642.6	274.9	72.2	124.9	110.2	507.6	152.2	76.7	114.0	201.5	504.2	154.0	186.7	224.7	239.9
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome 20S subunit beta 4"	P28070	1	151399560-151401937	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006700, HPA073499"	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA		12000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA006700: AB_1079704, HPA073499: "	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	189.5	242.7	200.2	156.7	202.1	172.9	174.2	210.6	212.4	167.0	201.9	194.3	150.0	195.5	225.6	170.4	178.3	139.1	241.8	201.7	212.9	196.6	269.5	143.2	214.0	206.8	203.9	179.5	164.0	218.6	168.0	187.1	211.7	162.4	166.4	94.3	169.6	190.6	299.1	186.6	152.8	191.7	210.5	173.8	171.8	69.0	205.8	233.5	156.1	237.5	235.4	196.7	151.3	218.4	428.3	451.9	373.0	447.8	412.9	392.3	507.8	247.6	549.2	719.3	503.1	608.6	569.5	384.1	730.7	424.3	379.1	419.7	383.2	472.7	407.6	535.6	391.1	268.6	320.8	463.3	444.4	377.0	355.7	431.7	444.8	672.5	276.2	364.8	506.1	419.1	434.3	740.0	512.7	1174.2	463.5	452.0	952.8	638.6	576.2	433.8	266.9	688.2	594.4	354.2	408.6	488.0	283.6	626.5	879.8	459.1	564.1	594.6	320.7	310.4	326.1	333.8	557.0	726.9	902.5	769.1	459.5	337.8	667.8	291.8	343.4	227.0	265.0	342.2	314.8	293.6	303.7	301.0	421.7	257.5	260.4	272.8	251.5	347.3	270.5	468.1	405.1	395.2	200.2	202.1	210.6	212.4	201.7	212.9	206.8	203.9	211.7	210.5	205.8	218.4	72.2	153.8	127.4	10.1	82.2	76.6	81.9	131.5	82.0	56.3	62.0	71.6	128.0	68.6	123.2	71.7	16.7	209.8	79.7	87.8	103.7	127.9	16.0	118.1	107.5	97.7	66.4	87.1	10.4	195.8	146.7	91.9	47.4	110.0	111.1	81.1	92.8	151.7	125.0	48.8	11.5	80.5	89.5	108.1	88.8	15.6	104.4	89.4	96.0	12.2	186.2	89.5	64.9	6.6	14.7	131.7	75.0	105.3	89.1	75.5	117.5	148.9	141.5	62.8	65.7	86.0	127.5	54.5	49.7	80.0	75.9	267.3	80.2	124.5	96.0	89.1
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	85.3	86.1	106.8	64.7	117.3	96.1	77.9	105.3	131.0	73.7	105.8	110.2	52.2	89.9	62.5	88.7	69.0	44.0	172.1	107.8	106.3	73.8	117.7	76.2	65.3	108.6	114.7	58.2	81.4	74.1	55.4	78.8	111.0	74.2	59.1	30.9	73.0	69.8	292.0	103.4	64.0	77.5	104.6	67.8	87.7	74.7	115.2	90.6	69.4	162.9	76.5	80.8	71.7	107.0	223.7	248.2	233.5	173.3	109.6	117.3	226.5	181.5	267.4	445.7	313.8	223.3	126.8	179.5	110.1	230.1	195.7	218.3	206.7	237.7	199.0	269.4	268.1	173.1	301.1	218.5	141.4	203.7	177.0	131.4	126.1	181.6	202.5	98.4	253.8	182.7	249.2	164.7	276.0	497.0	259.5	258.4	229.5	280.7	296.1	269.3	458.8	157.3	209.5	165.2	170.0	147.1	148.7	206.9	116.2	98.2	255.7	209.8	181.3	253.7	321.1	363.8	474.7	176.5	220.0	209.2	262.4	201.7	325.1	111.5	154.3	121.8	160.8	194.6	146.7	146.8	132.9	147.8	160.6	122.4	116.5	118.6	33.9	173.3	211.6	160.0	191.0	254.7	106.8	117.3	105.3	131.0	107.8	106.3	108.6	114.7	111.0	104.6	115.2	107.0	81.5	57.7	42.0	3.9	59.5	86.3	112.8	198.5	50.7	41.2	61.4	64.1	217.6	81.5	103.7	68.0	16.7	265.9	60.0	143.9	152.6	199.2	152.5	72.0	75.7	96.0	64.5	136.6	6.4	202.6	257.9	100.4	54.0	70.1	75.3	79.2	77.1	144.2	158.2	37.0	5.3	111.5	75.3	62.4	80.0	217.6	88.6	62.5	99.6	1.9	132.0	120.2	74.2	3.0	5.2	214.2	110.8	100.1	96.3	102.8	127.7	191.3	76.9	47.4	118.3	75.1	193.3	147.0	63.6	51.3	77.3	352.9	61.8	74.1	117.6	101.6
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971165-39981764	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	41.3	54.8	21.8	21.0	22.5	14.5	38.2	24.1	24.8	38.0	21.3	41.6	20.4	50.9	26.9	54.8	38.2	16.7	58.9	22.9	25.4	48.4	69.1	35.9	18.2	24.1	23.5	32.0	32.5	30.9	37.1	19.3	25.8	35.2	19.0	13.8	36.5	20.3	112.7	48.1	39.0	20.8	24.6	40.3	43.6	43.2	22.7	22.3	41.1	30.2	23.1	41.6	38.0	26.1	68.7	221.3	43.8	53.5	38.0	31.3	47.0	38.6	50.4	87.0	66.4	129.0	46.8	33.0	72.7	49.2	50.5	35.6	61.6	52.7	72.1	60.6	63.0	46.9	39.2	110.4	52.5	52.2	54.7	31.3	46.0	69.1	48.6	25.8	60.5	42.3	63.0	48.5	57.2	108.3	62.4	32.1	80.5	88.3	66.8	54.6	49.7	48.2	64.3	105.7	56.9	74.8	42.3	69.3	38.9	41.9	47.8	45.5	36.2	53.2	54.9	52.2	97.1	62.2	114.6	51.9	69.7	54.0	62.8	38.0	41.5	33.5	44.8	64.8	39.0	35.8	39.8	46.6	66.9	34.7	32.6	32.8	22.3	43.8	89.8	34.8	59.8	61.9	21.8	22.5	24.1	24.8	22.9	25.4	24.1	23.5	25.8	24.6	22.7	26.1	52.5	32.1	19.8	8.1	53.6	64.0	84.8	191.9	40.9	50.1	31.2	31.9	38.1	52.9	96.2	44.1	14.6	174.7	53.7	119.7	92.0	143.3	203.9	70.3	46.3	63.2	59.2	48.8	8.5	110.9	118.9	55.8	53.5	57.1	41.2	41.9	29.6	50.9	163.7	42.1	8.5	41.7	126.1	42.7	66.3	120.0	55.0	57.4	44.4	12.2	91.6	59.5	63.8	6.6	10.7	127.0	103.1	70.0	58.3	65.4	95.2	179.2	88.0	49.9	92.1	49.0	152.1	114.6	45.7	44.7	58.2	399.5	57.5	69.5	69.1	79.8
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 596.6;Late spermatids: 1350.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	90.4	99.0	134.8	80.9	137.5	82.4	80.6	141.3	159.0	79.6	130.2	106.1	68.0	80.1	112.3	104.9	83.2	59.4	107.5	136.2	139.3	120.9	112.7	68.1	93.0	140.5	140.2	63.3	71.0	161.1	82.5	75.5	141.2	81.4	84.4	85.3	73.4	86.7	236.2	121.5	70.6	90.3	137.7	82.4	84.5	73.3	139.6	93.3	86.4	168.7	108.0	93.4	79.6	138.9	240.1	369.1	233.9	172.9	171.4	174.7	202.8	225.3	197.0	327.1	243.8	390.3	154.7	158.7	154.7	241.6	246.0	182.8	239.1	228.5	383.5	136.8	289.7	330.3	288.9	362.4	180.1	336.0	230.4	177.5	171.4	291.9	266.6	139.1	263.7	180.9	258.4	210.2	284.9	450.7	279.4	237.4	215.6	266.3	330.0	248.9	445.5	244.3	249.0	270.9	203.2	274.1	158.6	313.9	152.3	254.4	306.8	197.8	238.8	360.3	329.9	161.5	482.6	220.5	335.2	250.4	225.8	255.7	241.5	105.1	120.4	149.4	164.1	176.3	222.8	142.7	191.6	179.3	140.0	122.0	161.3	183.1	37.7	167.4	206.3	108.6	272.1	216.1	134.8	137.5	141.3	159.0	136.2	139.3	140.5	140.2	141.2	137.7	139.6	138.9	97.9	51.3	78.6	8.5	82.7	94.6	145.0	206.3	71.7	84.9	71.1	79.1	156.0	110.1	139.6	68.0	18.8	250.4	85.1	98.8	246.5	195.2	596.6	75.4	69.4	104.7	90.9	107.7	7.9	214.5	187.2	101.4	69.3	68.1	90.2	53.3	86.4	130.9	162.9	72.3	7.9	92.7	197.4	89.8	85.0	1350.2	133.0	93.4	99.6	5.6	148.0	221.4	109.2	7.5	10.5	167.5	96.3	153.4	88.0	125.6	163.7	330.3	95.1	108.4	111.7	113.0	228.7	151.6	150.2	95.0	102.9	369.0	102.9	124.7	97.9	137.9
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056845-231173116	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.63e-12)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	37.3	38.2	21.9	31.7	26.1	20.1	29.0	21.9	33.7	26.3	20.9	34.8	35.5	37.4	25.6	41.5	24.3	20.3	51.3	27.5	28.5	34.1	42.1	27.0	28.8	26.9	24.9	19.2	17.3	72.7	32.9	36.8	28.3	29.7	36.8	25.4	25.8	33.4	136.3	34.9	29.3	44.9	24.5	25.2	27.9	29.0	24.5	36.6	27.4	81.6	38.3	37.3	27.8	24.4	103.9	113.1	120.6	93.8	122.2	88.7	115.4	135.3	139.4	133.4	134.0	136.5	97.6	80.0	123.3	150.5	138.0	95.0	169.4	125.0	174.3	124.3	93.3	148.7	81.6	155.5	62.9	133.3	119.4	76.5	57.8	142.4	73.9	73.4	159.6	70.3	212.1	56.8	158.7	100.3	103.0	68.3	157.8	100.1	89.3	86.0	190.4	77.7	96.5	104.0	78.8	74.1	108.7	94.1	65.7	120.6	75.3	74.7	152.3	101.4	110.8	126.0	129.8	48.6	80.2	140.4	162.7	100.0	123.4	34.6	27.8	18.8	25.1	39.0	27.3	21.0	25.8	23.8	30.9	17.2	19.2	22.9	12.5	35.9	42.5	18.9	32.3	25.7	21.9	26.1	21.9	33.7	27.5	28.5	26.9	24.9	28.3	24.5	24.5	24.4	51.9	51.3	48.5	77.7	32.9	33.1	37.7	57.0	19.9	46.4	23.0	25.8	125.4	31.5	53.0	33.1	41.7	119.2	27.0	63.6	17.6	83.9	6.2	51.2	67.5	51.7	39.4	61.6	100.0	102.2	101.4	54.6	42.3	60.9	103.9	67.8	30.0	86.9	72.3	90.9	96.0	30.0	57.0	44.2	23.5	9.9	34.8	49.8	17.8	54.4	62.6	46.6	29.9	67.3	93.1	98.6	26.2	45.9	49.4	46.5	46.9	32.1	66.9	53.2	72.3	54.6	128.2	247.9	158.8	39.2	33.1	167.5	36.6	65.5	42.9	38.8
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444379-32483319	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 308.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		95000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.9	26.5	25.6	29.4	26.4	34.5	22.6	24.6	29.5	22.8	20.3	27.3	27.2	28.8	23.1	36.3	21.8	22.7	37.0	26.0	25.6	30.1	37.7	24.3	30.2	27.0	25.3	20.6	25.9	35.0	18.5	34.1	28.1	25.0	32.0	23.8	23.3	21.8	96.0	33.8	23.2	35.0	24.4	24.0	22.9	34.2	25.9	38.4	21.6	58.6	39.1	34.0	24.8	31.2	127.0	136.8	98.4	106.2	65.4	48.4	103.8	71.5	90.0	151.9	122.0	139.9	111.5	99.1	110.7	77.0	145.9	143.0	114.5	98.5	147.8	50.9	81.2	81.0	68.7	108.3	63.3	95.5	81.6	43.7	51.0	134.3	91.8	49.0	108.7	87.0	155.5	110.9	90.8	78.0	143.1	57.4	134.5	67.4	68.8	89.2	127.2	132.4	75.2	92.2	86.3	58.8	89.8	63.4	71.0	100.3	154.2	45.1	77.8	84.3	99.5	105.6	166.5	62.2	105.0	129.1	122.5	74.8	145.2	48.3	41.2	26.7	40.2	41.8	44.2	36.3	39.1	40.6	46.6	34.2	34.5	36.4	19.1	47.7	45.6	38.2	51.5	45.6	25.6	26.4	24.6	29.5	26.0	25.6	27.0	25.3	28.1	24.4	25.9	31.2	62.7	48.1	31.5	36.6	56.3	126.9	108.7	116.3	44.9	44.5	47.8	40.8	71.9	41.5	78.0	25.8	31.3	178.2	57.8	87.5	80.3	117.8	205.4	45.8	46.2	69.7	48.8	100.8	36.0	107.3	146.1	63.8	43.8	59.9	45.7	79.8	55.3	107.0	92.3	37.0	36.4	58.7	77.3	48.4	72.6	48.0	49.0	61.1	26.6	15.9	77.5	63.1	40.2	33.2	55.6	117.2	48.0	48.5	79.3	131.9	66.4	120.6	52.6	43.3	52.6	68.0	189.7	152.7	98.4	85.3	117.5	308.9	54.8	52.0	67.6	109.5
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308425-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm		NA	NA		26000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: AB_2667057"	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavorable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	35.2	38.3	38.6	39.7	40.0	38.8	36.4	42.5	47.5	26.2	36.7	35.2	29.1	24.7	30.1	40.7	27.3	23.7	44.6	40.7	43.3	44.4	48.4	26.9	37.8	42.1	41.7	14.5	25.6	51.1	21.4	42.0	43.7	31.0	41.0	37.9	20.8	29.9	98.0	33.2	26.4	39.6	43.8	22.9	27.2	38.7	41.1	49.7	34.7	76.0	52.0	42.5	19.6	46.6	170.3	145.8	158.8	140.8	113.9	97.0	194.2	173.6	168.2	246.1	198.6	216.2	140.2	200.2	258.0	128.7	144.3	126.5	176.8	185.6	244.6	210.3	133.1	200.8	110.8	245.9	139.7	196.7	113.8	74.4	138.8	277.4	256.8	94.0	185.5	117.1	222.1	139.6	207.7	164.1	145.0	148.0	220.5	124.3	218.2	123.6	154.4	196.0	218.6	145.0	138.4	101.3	117.8	131.7	167.5	131.4	90.2	124.3	147.2	162.7	152.4	111.6	193.8	82.5	242.7	186.7	174.1	129.6	182.2	47.4	48.2	25.2	65.3	69.6	68.7	64.2	69.4	71.0	75.4	57.4	55.4	66.5	4.9	70.2	56.2	74.5	83.7	73.3	38.6	40.0	42.5	47.5	40.7	43.3	42.1	41.7	43.7	43.8	41.1	46.6	40.1	51.3	38.2	35.3	49.4	49.5	48.1	146.8	25.0	43.7	40.2	36.2	89.8	52.9	80.3	23.9	18.8	159.5	60.4	47.7	90.1	124.3	82.5	52.4	51.8	49.9	52.5	56.2	64.0	118.3	154.6	48.1	29.6	58.4	51.2	59.0	31.8	125.3	104.7	47.1	56.1	53.5	118.0	41.1	40.0	36.0	27.7	46.1	48.0	25.3	61.1	87.7	44.3	50.3	64.6	155.0	48.0	34.3	60.2	57.0	36.5	106.1	55.4	60.6	32.9	36.6	64.5	137.0	77.7	34.3	56.0	220.3	47.8	63.6	64.5	50.8
PSMD2	"MGC14274, P97, Rpn1, S2, TRAP2"	ENSG00000175166	"Proteasome 26S subunit, non-ATPase 2"	Q13200	3	184299198-184309050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 332.9"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 349.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045192, HPA062363"	Enhanced					NA	NA		430000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"			"HPA045192: AB_10961324, HPA062363: "	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (9.98e-4)"	"prognostic unfavorable (6.63e-7)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.74e-3)"	64.1	102.6	65.0	61.9	67.6	77.8	53.3	68.3	71.7	58.4	65.1	73.2	49.4	69.1	45.5	84.3	53.5	41.3	116.3	67.6	73.7	62.7	68.8	59.3	57.9	74.8	81.1	50.3	48.0	82.9	58.8	58.4	84.6	52.2	63.2	46.9	60.6	59.8	332.9	79.7	55.8	76.7	68.9	59.1	63.4	101.9	73.2	73.4	55.3	183.3	77.1	64.5	58.8	65.2	800.0	248.6	194.3	328.7	226.2	129.6	238.8	478.3	363.6	580.3	327.6	349.1	163.4	251.5	643.4	393.8	467.1	254.3	290.3	516.4	725.0	383.6	234.1	268.4	229.6	211.9	123.7	191.9	211.8	147.3	156.8	549.5	339.0	219.1	353.6	188.9	201.1	226.9	476.0	310.7	199.4	110.1	279.4	290.8	438.1	217.6	287.8	262.9	240.4	248.7	174.5	134.7	376.2	321.3	174.7	208.4	446.5	145.1	463.6	361.2	383.9	293.3	1049.9	219.7	501.3	412.9	438.7	204.2	256.7	48.8	86.0	82.2	61.9	74.5	56.7	59.0	60.1	68.0	103.1	53.5	58.5	56.3	26.6	76.7	79.6	48.3	66.9	96.3	65.0	67.6	68.3	71.7	67.6	73.7	74.8	81.1	84.6	68.9	73.2	65.2	49.0	67.3	61.7	13.4	53.4	71.1	66.2	101.1	58.1	66.9	38.7	31.5	113.3	38.6	81.8	57.0	20.9	153.8	60.6	67.3	90.1	183.2	161.8	56.1	55.0	63.0	79.6	105.9	21.0	130.8	117.9	60.3	45.3	61.3	40.5	111.3	35.0	60.5	83.8	72.3	20.0	40.0	79.3	38.8	54.0	90.3	48.7	58.5	53.4	15.9	94.1	117.1	51.5	12.5	16.6	349.2	33.3	65.8	84.4	63.1	59.1	97.0	71.5	60.5	32.9	48.2	183.0	184.6	138.9	65.2	67.1	222.9	53.0	94.3	55.8	57.7
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010550-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 285.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 513.3;Late spermatids: 717.7;Spermatocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"MCF7: 1458.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain					NA	NA		120000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"			"HPA036921: AB_2675383, HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	47.2	67.9	43.9	43.3	45.2	115.0	49.5	47.5	63.2	37.1	44.7	46.2	34.0	43.1	60.1	61.4	35.2	28.2	74.9	46.2	47.5	62.9	74.9	37.9	50.2	47.5	47.5	32.8	285.7	72.9	30.8	54.2	49.2	42.1	43.4	48.4	43.7	45.6	160.8	54.6	34.8	49.5	49.2	38.8	46.1	120.2	45.2	54.8	40.3	90.9	63.9	52.3	40.4	49.0	98.4	102.5	141.1	99.5	97.6	87.0	125.9	136.3	128.8	221.5	162.4	193.0	79.8	136.9	57.6	132.4	154.7	66.1	166.4	144.7	207.3	141.1	104.6	183.6	76.3	128.2	142.9	204.9	112.2	93.7	100.8	184.2	80.3	107.4	141.5	117.7	187.3	86.1	157.8	1458.7	141.0	125.3	180.7	157.3	71.9	117.2	101.1	132.4	177.1	140.7	52.1	85.0	101.6	85.4	136.2	123.4	74.3	125.0	125.7	98.1	106.5	145.2	217.1	108.2	171.0	204.1	144.3	190.8	116.1	99.2	113.9	140.3	103.4	133.0	107.3	124.7	114.0	112.9	120.1	120.3	113.6	110.5	139.4	111.5	139.8	84.0	137.1	167.2	43.9	45.2	47.5	63.2	46.2	47.5	47.5	47.5	49.2	49.2	45.2	49.0	46.4	32.1	43.2	7.5	48.7	62.1	71.7	152.5	27.9	37.0	33.9	34.9	100.0	22.8	86.4	44.1	22.9	197.8	47.3	27.6	86.1	104.0	513.3	49.0	42.3	55.3	25.8	99.9	11.7	133.7	102.3	47.6	27.0	48.9	45.6	46.7	28.9	47.4	92.2	33.7	10.9	27.3	73.2	38.1	40.5	717.7	51.9	51.7	48.0	4.7	71.0	81.8	39.1	10.1	15.4	87.1	30.4	51.1	58.1	44.7	29.7	95.9	73.0	41.2	59.2	41.3	145.8	336.9	131.3	53.4	69.9	290.6	50.4	68.7	35.8	66.1
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374550-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 708.9"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 1164.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	224.8	130.8	102.3	78.0	109.6	118.8	184.9	104.1	114.8	109.6	97.6	111.8	98.1	115.8	119.4	156.6	104.0	69.2	361.8	114.4	117.5	122.4	143.0	114.9	90.8	109.2	104.3	82.1	117.3	150.2	111.1	101.1	121.9	107.1	98.9	60.6	118.8	84.5	708.9	178.4	106.4	105.2	105.4	99.4	117.6	145.8	112.6	120.3	91.2	361.1	109.9	106.3	111.0	112.6	337.3	522.7	202.2	231.9	322.0	256.9	105.9	238.7	322.9	358.9	372.3	362.0	196.3	234.7	242.8	320.0	220.1	114.1	341.7	296.8	321.6	389.8	225.6	256.1	159.6	226.4	415.1	260.8	217.9	261.2	290.8	309.7	408.8	197.3	286.5	279.9	324.9	255.7	400.6	332.8	247.6	146.1	157.8	492.8	282.7	254.7	324.6	187.4	255.7	275.1	210.8	214.3	247.3	315.7	233.8	187.1	165.3	242.0	212.7	272.1	251.5	289.0	355.8	257.2	322.4	318.0	410.1	264.8	310.1	169.0	239.5	132.6	188.2	265.1	160.0	172.8	162.0	181.0	263.1	173.6	133.0	129.5	89.0	182.7	319.8	183.2	295.2	352.3	102.3	109.6	104.1	114.8	114.4	117.5	109.2	104.3	121.9	105.4	112.6	112.6	137.4	67.3	67.9	8.1	122.9	206.0	224.5	293.5	80.2	102.6	116.3	141.0	263.8	81.5	158.8	80.9	54.2	367.2	128.2	194.6	348.3	276.0	422.3	137.2	158.2	127.0	146.0	129.2	14.7	267.4	327.5	146.8	71.4	122.5	93.8	146.9	81.4	123.1	296.9	77.4	15.4	183.9	219.7	93.1	169.5	1164.7	118.4	126.9	199.3	10.3	224.0	179.8	143.2	8.0	19.8	296.8	181.2	117.8	178.9	255.0	305.7	332.4	128.5	120.4	151.2	106.6	221.1	305.1	135.4	120.3	212.3	570.3	133.0	201.0	182.5	218.7
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888732-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	16.5	4.6	7.5	2.3	8.1	19.2	4.8	8.0	10.0	5.8	11.8	13.8	11.5	7.1	2.2	6.2	6.4	3.8	5.5	7.9	8.1	10.8	4.6	6.0	5.7	9.0	8.9	5.9	10.6	4.8	3.5	3.9	8.3	4.6	2.2	3.6	8.8	6.7	18.5	5.9	6.2	3.3	8.3	8.9	14.9	5.1	8.7	6.6	5.1	6.0	3.2	4.1	5.5	9.4	54.8	81.8	6.7	12.2	11.2	11.6	13.9	54.5	17.8	27.3	15.5	60.0	6.3	40.5	45.0	28.6	9.2	22.1	20.0	29.1	16.3	78.5	41.6	33.3	40.9	30.5	27.5	23.3	22.7	20.4	14.0	30.4	11.7	9.9	16.6	24.7	30.1	5.3	17.6	63.2	47.1	17.8	14.0	7.1	63.4	35.6	18.3	24.9	13.4	53.9	14.1	19.3	54.4	7.7	29.3	5.8	23.3	11.3	43.3	25.4	29.0	50.1	38.4	30.4	73.0	62.1	45.5	30.1	23.8	41.8	43.6	53.0	33.9	46.2	27.3	47.6	32.6	31.0	38.5	38.5	25.0	21.2	41.3	29.3	41.7	63.7	48.1	51.6	7.5	8.1	8.0	10.0	7.9	8.1	9.0	8.9	8.3	8.3	8.7	9.4	22.8	48.1	33.7	10.1	32.6	60.5	11.4	64.1	67.2	7.3	40.9	34.8	8.0	34.3	40.0	35.0	18.8	30.3	45.8	66.6	52.8	116.9	34.9	32.6	28.7	29.7	46.6	121.4	12.9	121.4	30.7	30.5	42.8	27.4	44.4	11.0	33.9	26.8	39.8	15.2	10.7	66.5	54.9	37.9	55.3	11.4	37.9	43.6	55.2	7.5	93.9	17.2	35.0	7.1	18.7	138.2	64.2	38.7	73.2	9.5	146.8	100.7	36.6	14.8	39.5	19.5	46.8	33.9	37.5	69.4	71.6	37.8	44.9	12.9	67.7	12.8
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136163-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		7500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favorable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.62e-3)"	163.2	231.2	36.4	102.1	37.3	120.3	157.1	37.1	47.1	159.0	36.4	182.2	133.9	128.6	85.0	177.6	139.6	68.3	145.2	35.7	38.9	224.5	219.7	184.1	156.8	40.5	37.6	154.3	131.0	84.6	115.0	72.4	39.0	146.3	119.9	24.5	151.6	85.9	140.7	142.9	211.6	79.8	39.6	272.6	160.4	30.7	38.2	129.1	150.6	67.3	150.7	135.2	157.1	40.3	98.6	79.0	59.8	115.9	127.6	146.0	91.6	61.5	199.0	193.2	274.8	51.9	233.5	252.1	44.8	102.7	101.7	139.1	86.8	127.3	128.7	211.2	52.5	112.9	34.9	289.6	280.0	144.8	137.6	128.2	80.4	87.4	76.3	182.6	147.4	158.1	17.5	218.5	76.3	249.3	376.0	175.1	5.8	162.3	135.9	293.2	123.4	182.9	246.8	259.8	37.7	67.3	78.0	200.7	124.6	35.5	131.9	139.5	85.1	52.8	61.0	60.6	92.7	201.8	224.5	120.9	71.9	128.0	86.6	394.8	441.9	552.3	484.5	570.1	484.8	399.4	448.4	463.2	425.0	370.1	318.6	395.7	653.9	515.6	575.2	408.3	537.9	978.6	36.4	37.3	37.1	47.1	35.7	38.9	40.5	37.6	39.0	39.6	38.2	40.3	305.5	208.3	172.7	7.5	353.8	156.4	241.6	570.7	199.2	28.2	159.6	169.2	59.6	248.8	296.5	283.3	10.4	393.3	406.7	347.8	318.9	500.0	3.5	171.4	250.5	228.0	189.7	244.9	1.4	549.8	293.2	184.8	138.6	223.9	240.1	124.7	242.4	266.6	313.7	6.7	1.9	397.6	280.8	295.3	294.2	16.5	189.2	275.4	188.5	4.7	930.4	98.3	620.0	3.0	6.6	373.6	461.2	124.8	422.0	280.6	754.3	700.5	236.3	23.5	105.2	121.4	283.6	3.5	24.9	200.0	156.0	304.4	424.6	243.6	406.6	301.3
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 126.2;Inhibitory neurons: 125.8;Oligodendrocyte precursor cells: 203.1;Oligodendrocytes: 625.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RH-30: 72.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	14.8	8.0	19.2	6.0	20.6	15.7	13.5	19.1	25.8	20.8	11.2	33.4	4.2	18.0	5.2	7.9	15.4	5.8	7.8	20.5	21.0	10.7	7.5	8.6	6.0	18.6	21.6	13.1	7.1	2.4	11.4	4.1	19.4	12.4	6.5	14.7	8.2	9.6	11.3	8.6	12.9	13.1	20.4	11.5	12.2	23.7	22.0	10.5	11.9	9.0	4.8	17.5	14.3	25.2	6.6	3.5	27.2	15.4	6.3	6.8	15.1	5.7	6.5	9.7	9.1	4.3	5.7	22.4	6.6	3.4	22.1	3.9	17.8	4.0	14.1	4.1	5.1	12.6	8.4	5.9	3.8	5.9	6.1	4.6	2.7	12.2	4.6	7.5	4.9	10.9	9.3	5.2	13.0	2.1	21.0	18.0	17.2	2.7	7.9	11.3	72.0	3.2	9.6	3.2	16.7	16.8	7.4	4.4	9.5	13.4	4.5	13.4	4.8	5.8	12.6	5.0	7.5	4.5	4.0	25.7	2.9	9.5	2.8	0.3	0.5	0.3	0.8	0.6	0.7	1.2	1.1	0.8	0.3	1.3	1.3	0.9	0.5	1.4	0.7	0.6	1.1	0.2	19.2	20.6	19.1	25.8	20.5	21.0	18.6	21.6	19.4	20.4	22.0	25.2	26.1	9.6	13.9	116.2	16.9	13.9	9.6	4.1	14.2	27.4	14.4	13.8	10.9	10.0	6.0	20.2	14.6	5.6	13.9	3.8	13.7	6.8	4.8	11.5	27.9	16.7	24.5	16.2	126.2	5.1	4.2	20.5	10.7	18.3	7.6	21.4	8.2	8.4	3.3	30.3	125.8	6.2	6.1	13.0	13.9	7.1	9.0	8.5	14.2	102.1	7.1	47.6	10.3	203.1	625.1	4.9	3.9	7.9	14.4	7.3	4.5	9.1	8.1	22.6	6.6	15.0	33.1	79.0	35.4	12.1	7.1	2.1	13.7	11.0	5.5	6.3
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 4898.3;testis: 3242.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 38051.3;Peritubular cells: 65156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	27	"plasmacytoid DC: 1386.8"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 1386.8"	"Group enriched"	"Detected in some"	6	"HHSteC: 518.7;HSkMC: 252.0"									"HPA004938, CAB009916, HPA067456"	Uncertain				"Secreted to blood"	NA	NA		2500000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"CAB009916: AB_2174617, HPA004938: AB_1855745, HPA067456: "	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	391.1	297.1	1849.2	247.1	2423.8	9.9	121.1	2440.1	2559.6	1675.5	1508.4	84.8	31.5	320.4	735.9	172.5	492.1	396.7	4898.3	1760.9	2034.8	466.5	80.2	607.8	824.1	2339.4	2228.2	66.8	113.2	9.1	398.4	227.8	2318.0	727.0	17.7	146.1	97.8	813.1	108.3	164.9	205.9	99.7	1999.6	317.5	93.0	3242.2	2264.9	127.4	55.1	60.0	306.0	230.3	1181.0	2580.3	0.1	0.0	0.1	0.0	5.4	16.7	8.8	0.3	0.0	0.0	0.0	0.0	0.2	0.6	4.0	24.0	0.0	0.8	0.6	0.2	0.0	0.0	0.0	0.0	1.4	0.3	518.7	0.3	1.3	252.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.0	0.2	0.0	0.0	6.6	0.9	8.2	0.0	0.1	0.2	1.6	0.0	0.0	1.6	2.0	0.0	0.6	0.0	0.1	0.6	68.3	0.7	0.2	0.2	2.1	0.1	0.3	0.0	0.1	3.9	0.0	0.9	0.0	0.3	0.4	50.5	1.0	3.4	0.3	4.3	6.3	1.8	0.2	0.9	9.9	2.3	3.8	0.2	1386.8	1.4	11.2	1849.2	2423.8	2440.1	2559.6	1760.9	2034.8	2339.4	2228.2	2318.0	1999.6	2264.9	2580.3	29.3	0.0	0.6	665.0	1.5	70.4	3.2	0.1	5.7	46.8	6.6	14.7	333.6	8.6	0.1	138.0	52.1	14.4	1863.6	0.2	68.4	0.3	215.9	29.7	1156.5	167.8	0.0	13.5	4.0	0.0	55.0	1584.0	1.1	20.1	1.3	0.3	46.1	1.6	57.3	21.9	12.8	0.0	0.0	3.4	161.8	1230.9	38051.3	57.0	209.9	176.1	4.6	4625.8	583.9	63.3	850.4	1.7	0.0	65156.8	6.0	20.7	0.0	1.1	0.0	130.3	164.3	787.4	124.8	130.7	111.1	12.0	80.1	35.4	61.3	0.1	0.0	14.5
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		660000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	141.7	128.0	198.0	137.2	210.0	150.2	171.2	217.0	454.6	168.2	185.5	169.9	151.7	172.9	159.0	161.3	217.6	114.9	122.8	195.5	215.6	180.5	218.6	133.9	157.2	214.9	213.0	250.0	121.9	133.7	111.7	164.9	218.5	141.6	172.8	118.0	124.0	147.6	208.6	123.5	155.4	138.8	213.0	125.0	117.1	135.0	204.3	167.2	162.3	158.5	185.0	158.7	145.8	278.0	616.6	528.8	416.5	249.8	300.2	270.3	634.3	392.8	298.5	494.5	366.9	452.5	629.6	676.0	588.5	338.3	331.7	385.4	790.0	514.2	621.8	509.8	529.8	529.7	309.5	524.4	219.4	637.9	367.2	197.0	367.3	375.1	450.3	468.5	518.1	425.7	866.0	628.2	490.4	385.3	636.5	602.1	714.7	538.3	609.3	549.2	392.3	914.4	436.8	473.2	538.4	313.8	401.7	570.1	355.8	546.5	658.3	526.9	314.0	294.7	341.8	358.3	552.8	262.8	777.5	540.4	321.1	516.7	543.8	141.1	166.1	107.1	130.9	261.6	172.3	172.3	170.6	156.7	160.2	127.0	167.3	147.7	64.7	132.2	346.2	135.3	191.6	316.1	198.0	210.0	217.0	454.6	195.5	215.6	214.9	213.0	218.5	213.0	204.3	278.0	265.8	179.5	137.1	39.5	251.0	386.6	826.7	248.5	272.6	128.3	208.5	197.1	166.0	178.7	161.4	189.4	77.2	457.2	245.6	246.5	373.7	310.4	42.5	493.7	221.5	242.1	261.3	452.0	43.4	214.8	676.3	268.7	143.2	291.3	234.2	224.5	188.8	187.0	349.9	112.7	41.3	295.9	201.4	209.5	363.6	107.9	238.9	261.7	282.8	47.8	283.3	244.1	178.2	38.7	71.4	220.8	207.1	213.3	299.8	657.6	218.9	343.8	345.5	128.0	144.7	185.1	337.7	558.4	348.4	350.4	377.6	566.0	359.3	219.0	358.9	556.3
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 80.7;urinary bladder: 81.7"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 28.1;Fibroblasts: 70.8;Hepatic stellate cells: 117.8;Leydig cells: 26.8;Peritubular cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 45.1;ASC TERT1: 45.2;U-2197: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	43.2	4.7	0.7	9.0	2.5	0.3	24.0	0.3	1.9	29.5	1.8	38.9	3.2	79.0	16.1	16.5	80.7	31.3	40.4	0.5	0.8	4.0	6.0	18.2	0.7	0.6	0.4	38.1	2.5	0.3	0.9	1.1	0.4	22.2	6.6	0.2	7.6	8.3	4.0	7.2	10.5	40.5	0.6	0.5	17.9	5.1	1.0	0.3	7.8	2.4	0.8	81.7	18.2	0.6	0.0	0.1	1.9	0.1	45.1	45.2	0.5	1.0	5.7	0.2	0.0	0.0	0.0	0.1	18.4	13.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	3.3	0.0	0.6	0.0	15.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.2	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.2	0.0	8.2	0.1	0.0	0.0	0.8	2.4	143.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.7	2.5	0.3	1.9	0.5	0.8	0.6	0.4	0.4	0.6	1.0	0.6	5.3	3.2	2.7	0.0	0.0	3.7	0.7	0.0	0.0	1.1	2.2	1.3	5.0	2.8	1.9	3.7	0.0	0.3	0.3	0.0	0.0	0.6	1.8	0.0	0.9	28.1	0.0	2.7	2.7	0.0	0.2	70.8	1.5	0.1	0.0	25.0	117.8	1.0	0.3	0.0	2.4	0.0	0.0	3.1	6.7	3.3	26.8	1.0	1.8	6.5	0.1	0.4	0.0	1.0	0.2	1.2	0.0	104.9	0.3	0.4	0.0	0.2	2.2	4.5	0.0	7.9	3.5	0.7	1.4	0.5	4.8	0.3	1.0	0.5	0.0	0.6
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599893	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 278.5;liver: 594.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 5.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.9"	"Cell line enhanced"	"Detected in many"		"OE19: 909.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		2400000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	44.9	87.7	14.6	11.5	16.3	3.0	37.2	15.4	21.6	35.9	16.7	37.4	232.9	32.4	39.1	112.0	71.5	75.3	29.2	22.6	16.0	234.3	594.1	22.1	7.3	13.0	14.4	25.1	16.7	43.9	23.3	15.3	13.4	60.4	33.9	22.6	47.5	31.1	13.0	31.0	278.5	38.1	11.8	7.9	86.0	8.3	16.4	6.4	27.9	29.0	31.6	88.8	44.4	14.4	49.1	207.1	60.6	0.1	220.1	220.4	45.1	79.4	121.8	74.4	81.2	52.9	67.4	0.1	22.9	78.0	153.9	60.7	47.5	83.4	90.3	0.1	15.4	12.5	129.3	279.0	50.4	7.4	25.6	157.3	127.3	99.8	51.1	88.2	201.0	0.0	8.7	0.1	148.5	16.1	0.4	2.0	22.8	909.3	49.8	0.2	17.1	1.4	82.8	152.8	68.4	3.4	98.9	30.0	31.7	59.6	94.6	34.8	161.8	15.4	29.3	169.7	15.0	0.1	0.5	0.3	72.0	0.1	18.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.3	14.6	16.3	15.4	21.6	22.6	16.0	13.0	14.4	13.4	11.8	16.4	14.4	28.9	19.2	28.3	16.6	4.3	38.6	57.6	135.5	66.6	18.7	43.7	41.4	37.4	271.7	78.4	141.6	25.0	47.0	6.4	34.4	150.6	73.4	4.2	100.3	36.2	26.1	26.5	18.7	38.4	178.3	32.5	48.6	174.3	89.3	1.3	35.0	49.6	791.5	53.4	0.0	31.2	76.1	59.0	26.8	16.7	3.6	33.2	15.9	35.6	12.2	22.6	47.0	0.0	17.1	16.1	139.6	86.3	39.5	0.5	63.8	1230.1	581.3	80.3	46.4	13.1	17.4	61.8	15.2	5.3	242.9	30.5	20.5	5.8	46.8	145.9	156.5
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492054-13496181	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	245	"parathyroid gland: 50184.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.0;Oligodendrocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"	NA	NA	28000			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	50184.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.2	205.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 295.2;Excitatory neurons: 584.9;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 791.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	Yes		25000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	51.0	40.4	83.8	19.5	115.1	6.7	42.1	62.4	99.9	40.3	51.0	37.2	25.8	37.3	49.7	25.6	34.0	32.1	36.9	84.5	77.3	42.6	30.1	39.4	25.3	79.1	87.6	33.7	32.1	53.1	21.3	74.2	81.0	34.0	35.3	35.5	39.9	41.6	38.7	29.6	29.5	37.6	67.6	22.8	32.8	38.9	86.7	11.9	38.7	39.4	25.8	43.9	34.0	154.5	52.6	81.9	111.0	40.3	45.8	48.8	71.6	50.8	70.0	46.3	45.3	35.9	42.1	31.7	111.7	65.3	65.0	60.3	66.1	116.0	69.6	0.3	30.8	70.1	44.3	50.0	62.5	0.1	31.8	33.4	55.8	58.0	81.0	121.5	139.0	44.0	72.0	0.8	62.9	91.0	0.9	0.7	43.2	113.2	90.3	46.8	60.9	1.5	97.7	117.3	43.9	54.8	79.0	25.0	52.0	97.2	59.2	1.2	84.9	45.2	85.5	54.0	58.1	0.0	0.6	3.4	58.7	0.6	62.9	1.6	3.3	0.0	0.2	1.4	0.0	5.3	0.6	0.0	4.5	6.3	4.4	1.6	1.3	4.7	0.8	6.1	0.2	3.9	83.8	115.1	62.4	99.9	84.5	77.3	79.1	87.6	81.0	67.6	86.7	154.5	71.3	32.1	33.1	295.2	20.6	33.3	70.1	36.3	64.9	55.2	29.3	23.5	29.6	32.9	32.1	55.2	60.5	37.0	8.0	23.1	23.5	27.2	68.4	29.3	43.3	54.3	25.8	8.4	584.9	23.3	53.7	37.2	37.8	46.5	9.5	84.7	37.5	15.7	8.1	67.3	263.6	23.0	30.5	15.2	15.9	38.8	23.9	19.4	24.9	159.3	3.9	40.9	0.0	353.9	791.4	43.1	23.5	21.8	1.7	82.4	29.3	25.6	33.7	55.0	98.6	32.7	128.4	88.9	65.5	42.8	25.9	33.2	3.4	67.0	24.1	87.3
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.3;brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 127.4;REH: 141.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	19.7	10.8	46.9	52.6	54.4	106.3	11.5	22.8	102.9	11.5	38.3	29.8	34.1	9.9	8.9	19.2	15.6	12.7	10.6	96.3	8.5	15.9	15.2	28.6	78.3	0.0	26.0	4.7	12.6	7.1	13.7	8.0	0.0	25.5	23.5	4.4	26.6	12.3	5.0	45.2	48.8	10.7	0.2	78.3	22.2	9.5	27.0	86.0	12.5	5.4	73.6	21.0	15.1	37.0	38.2	10.4	2.8	3.0	76.6	5.5	21.5	2.9	1.9	1.9	2.7	9.9	21.5	127.4	4.0	5.8	3.1	34.3	1.1	31.3	1.1	8.7	0.8	26.4	10.6	2.0	15.7	28.5	45.5	41.6	46.0	2.6	17.3	13.0	1.0	36.0	31.7	85.6	2.1	4.0	49.1	57.0	2.2	33.0	2.6	141.2	0.7	88.3	8.5	29.5	19.2	3.5	13.4	9.3	5.0	6.5	11.5	72.1	17.5	1.3	2.8	2.5	1.0	68.0	32.0	68.9	5.2	60.6	2.4	47.3	48.4	36.9	33.9	43.0	22.2	46.0	17.0	24.3	36.1	46.6	20.8	25.9	45.8	29.0	53.5	11.7	18.2	50.1	46.9	54.4	22.8	102.9	96.3	8.5	0.0	26.0	0.0	0.2	27.0	37.0	6.9	3.2	29.8	16.6	64.3	37.7	38.7	19.7	6.8	5.4	5.9	7.7	3.7	8.6	13.0	14.7	0.0	2.9	33.4	65.5	0.0	8.0	1.2	7.1	1.8	9.6	7.8	20.2	109.2	8.3	26.5	3.5	22.4	5.3	28.5	1.1	5.0	24.1	23.1	8.4	9.2	21.9	10.2	68.4	32.1	1.0	1.5	55.3	8.8	22.5	62.5	2.8	70.0	7.5	15.1	13.3	42.0	0.7	68.1	18.6	44.6	16.1	13.9	3.9	0.0	3.3	3.3	4.2	6.4	4.8	30.1	1.9	46.6	1.0	18.1	17.9
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076307-43161719	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 317.3;Endometrial stromal cells: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 13.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 13.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		12000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	15.0	5.0	9.6	6.7	8.4	2.8	17.5	8.5	8.9	69.5	36.0	9.4	6.5	87.4	87.1	30.1	38.2	24.7	8.8	8.7	10.8	29.3	1.6	33.9	3.9	10.2	11.4	85.3	16.4	13.0	21.1	48.8	8.7	37.9	8.5	6.0	36.7	25.4	0.6	34.6	9.5	38.7	9.0	27.8	12.2	41.7	11.2	30.4	23.0	1.5	6.4	22.3	43.6	8.2	9.1	2.5	83.6	141.6	88.0	89.9	119.4	94.2	145.5	77.0	99.4	77.0	31.0	0.2	74.0	107.3	56.4	99.5	38.0	87.5	49.3	0.7	52.0	8.5	17.1	105.2	132.5	0.3	0.4	129.1	77.4	103.2	32.6	135.8	10.1	35.0	6.2	0.2	36.4	7.0	32.5	12.6	39.1	0.8	7.0	33.3	119.0	0.3	61.0	42.4	48.3	91.6	14.8	1.5	50.0	87.8	51.9	19.5	6.8	84.1	53.1	0.4	51.0	0.5	0.9	3.2	19.1	0.3	14.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.4	0.2	0.7	0.0	13.5	0.0	0.8	9.6	8.4	8.5	8.9	8.7	10.8	10.2	11.4	8.7	9.0	11.2	8.2	3.0	16.0	13.1	10.7	0.8	17.3	19.9	40.4	27.9	4.3	23.5	32.5	1.6	5.7	14.6	12.9	56.3	19.1	6.3	1.7	1.9	21.0	317.3	23.5	84.7	8.7	21.6	4.0	8.7	6.9	2.2	30.0	8.6	25.2	1.3	25.3	2.2	0.0	3.5	0.0	5.3	3.9	42.7	0.0	9.8	48.9	18.3	4.1	16.0	1.0	1.0	20.1	0.0	3.5	1.4	10.5	4.1	18.4	1.4	11.8	0.6	0.6	15.4	2.2	13.1	8.7	27.9	2.8	21.2	13.7	10.4	8.2	3.0	17.7	6.3	11.8
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	47.2	118.0	157.8	56.2	154.0	52.9	60.9	136.2	185.0	73.5	124.6	105.2	49.6	87.4	55.8	116.8	77.3	49.3	176.7	158.5	141.6	125.5	154.2	72.6	49.9	151.3	148.8	63.8	70.4	146.7	73.1	49.8	147.6	119.0	51.3	43.4	97.1	86.8	340.8	73.7	57.1	92.1	143.2	82.8	83.5	124.5	162.7	59.1	75.3	206.2	54.9	71.1	62.2	148.5	108.9	183.9	111.0	219.9	74.4	94.5	118.3	115.5	120.2	144.8	100.1	103.4	135.4	113.9	83.3	187.3	173.1	184.1	110.9	138.2	100.6	198.6	68.1	64.6	193.6	101.7	229.1	113.1	147.2	114.6	133.1	109.8	101.8	230.9	146.5	120.3	102.0	124.7	117.1	293.8	103.0	76.6	186.8	301.0	193.0	108.3	93.7	216.2	159.0	119.8	120.6	86.9	220.4	237.3	147.3	99.4	253.4	55.0	101.7	127.6	113.8	129.9	165.2	114.9	284.1	96.8	153.2	79.1	180.7	7.6	19.2	9.8	20.8	18.4	19.9	10.8	15.8	18.5	23.0	13.4	13.8	13.9	6.1	20.4	18.3	16.4	16.9	20.4	157.8	154.0	136.2	185.0	158.5	141.6	151.3	148.8	147.6	143.2	162.7	148.5	19.8	3.2	8.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	51.9	38.6	0.0	0.0	3.1	53.3	0.0	49.5	9.2	0.0	54.8	70.3	0.0	33.7	21.8	19.0	0.0	0.0	0.0	62.3	44.2	12.2	0.0	32.9	8.8	24.8	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.9	0.0	0.0	41.9	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	37.9	4.0	31.8	0.0	0.0
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 63.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 48.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 26.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 29.4;RPTEC TERT1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	4.0	2.2	7.1	1.7	1.0	0.1	7.5	0.0	2.6	6.6	8.5	9.5	12.4	2.2	17.7	13.2	10.1	2.7	21.1	3.2	5.2	23.0	29.5	5.7	1.1	0.3	14.7	0.6	14.8	10.7	2.9	7.3	1.6	5.9	10.1	2.5	8.5	5.1	63.5	30.1	12.9	1.4	0.4	0.3	9.7	3.2	26.7	3.6	10.1	46.9	4.4	4.2	7.2	0.4	11.1	13.5	0.5	3.5	0.0	0.0	21.1	2.3	0.0	2.9	3.2	7.2	17.7	0.0	2.4	0.1	7.3	25.8	3.7	15.2	2.9	6.2	8.2	0.0	6.2	7.5	0.1	0.0	0.1	0.2	16.0	3.6	7.7	1.2	0.0	4.5	0.0	0.1	0.2	14.0	19.3	3.3	1.6	29.4	10.0	0.1	4.4	0.3	34.0	21.1	8.6	1.8	5.9	21.8	0.0	7.1	12.5	1.8	0.1	1.0	8.2	1.4	0.0	10.4	18.2	0.0	11.2	0.0	7.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	7.1	1.0	0.0	2.6	3.2	5.2	0.3	14.7	1.6	0.4	26.7	0.4	0.4	16.0	28.4	0.7	0.5	11.9	25.9	19.3	4.0	13.4	7.8	8.6	48.6	24.3	24.7	31.3	0.0	23.6	0.1	30.0	17.6	14.5	21.5	27.6	3.1	3.3	13.1	0.0	16.1	19.2	23.7	1.8	15.8	38.4	1.3	0.9	4.6	36.3	2.6	0.0	5.2	18.7	8.2	0.0	1.8	18.5	1.2	0.8	3.6	1.0	0.7	0.3	1.0	0.5	0.6	29.1	24.0	1.9	0.2	26.1	27.9	19.2	28.4	2.2	6.6	3.2	6.0	1.6	10.4	7.0	20.6	10.8	0.8	0.4	18.4	29.0
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 161.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 59.0;Inhibitory neurons: 51.9"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 161.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;NTERA-2: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	1.5	0.5	37.2	0.2	161.0	0.1	1.1	0.0	55.2	0.7	0.0	1.0	0.1	0.8	0.0	0.5	1.1	0.3	11.9	32.1	25.5	1.7	0.0	1.5	0.1	11.3	6.4	2.1	0.4	0.2	2.1	0.0	6.7	1.0	0.3	2.0	1.2	0.6	0.7	0.6	0.6	0.4	4.7	0.4	0.9	2.9	19.9	0.0	0.7	3.3	0.0	1.0	1.1	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	161.0	0.0	55.2	32.1	25.5	11.3	6.4	6.7	4.7	19.9	29.5	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.2	6.9	0.0	0.0	59.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase receptor type A"	P18433	20	2864184-3039076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	48.8	36.6	83.9	31.9	89.3	39.6	47.4	84.2	96.1	56.4	59.5	41.6	31.0	53.0	36.7	46.1	52.7	43.7	29.5	87.7	83.5	44.2	28.6	45.4	38.9	74.7	81.9	55.8	31.2	81.9	44.8	60.8	78.3	46.3	40.6	61.5	36.3	41.9	16.9	45.8	32.7	52.4	76.3	39.4	34.5	43.4	92.6	59.6	65.5	30.7	44.3	46.6	38.9	81.1	74.0	44.2	124.7	38.4	134.4	243.3	26.5	54.1	105.1	65.5	79.6	53.1	99.5	48.1	41.6	73.1	66.1	77.2	51.0	77.4	73.4	74.7	32.7	68.5	18.3	68.0	48.1	69.5	31.1	109.8	78.2	54.4	56.8	80.3	92.0	67.7	69.9	59.7	65.8	30.4	80.8	78.3	48.3	66.0	35.0	61.0	60.5	60.3	55.1	56.2	68.7	65.7	52.3	87.8	81.4	54.0	55.2	58.7	66.5	58.1	28.6	65.6	48.5	43.4	64.7	62.7	26.9	64.5	55.7	5.7	2.8	4.8	6.1	2.9	4.9	5.3	4.0	4.4	2.1	2.6	4.0	4.8	3.3	4.0	4.3	3.2	4.9	2.3	83.9	89.3	84.2	96.1	87.7	83.5	74.7	81.9	78.3	76.3	92.6	81.1	87.0	22.4	19.2	128.6	46.7	15.8	34.0	15.0	34.7	88.9	49.0	43.9	10.1	54.3	24.5	46.0	31.3	35.3	111.7	39.8	27.4	14.8	17.0	62.0	109.0	39.7	44.3	42.3	138.2	15.8	40.5	67.5	25.0	55.3	22.9	60.3	43.5	33.6	39.4	70.7	136.4	27.9	24.4	37.6	20.4	17.2	60.3	40.1	37.4	52.5	29.9	88.3	110.2	102.5	147.5	16.6	30.2	48.9	58.6	32.9	27.1	23.6	26.6	60.5	39.5	53.3	61.8	68.7	84.1	32.9	17.2	32.7	59.7	41.4	30.4	31.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 314.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		160000000		"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	91.7	11.9	47.1	14.0	48.4	1.8	57.4	22.3	45.6	36.3	4.7	79.5	70.5	28.0	71.9	101.7	70.5	30.4	7.6	45.3	39.9	27.7	107.2	35.4	4.7	33.1	43.6	22.1	56.8	31.1	23.5	55.7	33.1	67.3	51.4	24.7	101.7	43.1	2.7	107.9	78.5	35.0	30.4	4.0	49.7	9.4	45.6	29.6	23.8	3.4	26.2	40.0	51.2	37.4	165.6	76.5	49.0	58.0	11.2	0.6	274.3	92.1	36.1	73.9	62.6	82.0	214.9	0.4	25.6	40.2	59.2	124.7	57.5	200.7	89.1	2.0	72.1	1.0	48.7	75.3	33.8	1.2	1.3	11.3	113.2	106.4	174.9	92.6	111.5	7.7	25.4	7.1	27.5	94.0	1.2	1.3	75.9	89.8	21.0	57.2	86.9	3.7	28.3	241.5	73.3	28.0	90.8	314.0	11.8	128.8	91.5	17.3	88.2	1.6	116.5	7.5	126.1	3.1	2.7	0.4	7.4	3.9	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	48.4	22.3	45.6	45.3	39.9	33.1	43.6	33.1	30.4	45.6	37.4	2.3	157.0	101.1	39.2	2.3	62.8	51.3	67.4	52.9	33.5	146.3	102.9	7.6	130.1	74.9	86.5	43.8	64.3	1.4	259.9	0.0	147.4	4.9	80.6	17.2	7.7	100.9	8.0	40.6	120.8	290.1	19.8	93.8	70.6	5.1	72.8	10.4	159.6	14.1	185.1	16.1	171.7	50.8	4.9	5.8	8.5	6.8	3.4	12.4	7.5	2.9	27.2	2.1	16.6	68.1	165.0	124.7	7.2	1.8	68.0	208.1	13.9	128.3	31.0	0.0	15.8	18.5	9.0	37.5	107.5	91.4	66.2	3.9	9.6	142.5	78.7
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase receptor type G"	P23470	3	61561569-62297609	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.7;HSkMC: 61.1"					"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	18.0	13.2	7.6	4.6	7.8	0.0	12.8	4.9	10.4	11.9	23.4	8.2	3.7	10.6	8.4	4.1	9.0	8.3	10.0	13.7	6.2	14.4	5.8	12.8	1.8	8.4	7.2	12.0	3.9	26.6	5.2	9.9	5.9	7.8	6.1	8.6	5.2	8.4	7.4	4.5	5.9	13.0	10.0	7.0	5.8	7.7	9.1	2.1	13.1	10.4	1.7	7.0	6.7	5.0	0.0	5.3	27.3	0.0	81.7	41.6	13.5	17.6	28.5	18.2	24.4	13.2	0.5	0.6	10.1	20.7	14.5	0.2	13.4	13.6	28.3	1.5	7.7	1.4	0.1	15.0	27.5	7.5	0.1	61.1	5.3	25.9	30.9	5.8	19.7	2.0	0.0	17.3	16.3	7.6	0.0	0.1	17.0	0.1	0.0	11.9	8.6	0.6	18.2	8.2	2.1	4.5	4.3	0.1	6.9	11.2	0.2	0.3	46.0	25.4	24.1	41.0	14.7	5.5	6.8	0.0	19.2	3.2	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	7.8	4.9	10.4	13.7	6.2	8.4	7.2	5.9	10.0	9.1	5.0	45.3	12.8	32.4	356.8	2.2	9.2	6.4	5.0	13.1	98.5	9.6	6.3	12.5	8.6	5.8	22.0	6.2	10.5	0.9	12.1	5.9	9.6	3.6	14.4	31.9	55.5	24.6	0.0	416.1	1.8	0.8	47.7	4.1	30.5	0.0	64.6	90.3	32.7	19.7	154.8	684.3	8.9	22.4	2.9	8.8	4.3	66.5	1.1	17.8	771.0	0.6	40.8	2.1	920.3	11.8	5.3	5.6	56.8	4.2	10.9	13.9	18.2	2.8	5.7	72.3	81.1	60.6	2.0	8.6	2.1	4.8	12.6	2.3	20.0	12.1	2.7
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		670000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	6.0	3.2	10.2	20.5	13.8	29.5	6.1	6.9	14.9	6.2	18.5	10.2	9.4	2.4	7.8	1.9	4.1	7.1	2.7	10.0	12.7	13.9	11.9	10.0	15.5	9.7	11.7	1.6	6.1	15.8	10.1	7.6	12.4	7.9	8.7	8.1	10.1	7.0	2.4	4.2	14.5	5.9	6.0	23.3	14.6	2.3	18.5	7.0	19.6	2.7	11.0	6.9	2.1	14.7	7.6	28.3	12.1	7.0	1.9	4.1	4.2	7.5	5.5	12.9	9.2	2.0	40.8	6.9	51.8	19.1	19.6	6.0	19.0	2.0	14.9	46.6	5.4	1.9	34.9	2.8	12.1	2.7	41.5	3.2	0.6	3.8	1.0	31.7	7.8	0.5	2.6	4.4	4.7	17.0	0.1	17.3	9.7	25.7	4.4	1.6	1.6	4.0	52.6	11.1	7.9	2.5	20.2	12.0	19.4	8.9	13.0	20.3	25.7	9.9	10.8	20.5	23.4	1.1	1.7	11.4	11.7	8.0	37.3	0.7	1.1	2.8	1.6	2.0	1.0	0.8	0.9	1.2	0.8	0.5	0.7	0.9	9.5	1.0	4.7	1.5	1.0	0.8	10.2	13.8	6.9	14.9	10.0	12.7	9.7	11.7	12.4	6.0	18.5	14.7	1.5	9.6	16.7	43.1	11.3	0.3	9.8	0.8	0.6	13.6	8.3	4.1	3.7	17.2	13.0	38.6	6.2	1.9	32.7	35.5	0.0	7.4	5.5	13.5	2.2	4.5	12.6	3.2	81.0	5.0	0.6	4.0	22.4	22.9	13.9	2.5	5.0	15.6	30.0	10.1	167.5	10.1	2.0	74.2	5.7	8.2	0.3	40.2	1.8	189.3	36.0	10.3	21.6	239.8	167.7	11.8	28.0	0.4	12.9	25.3	37.6	13.5	4.9	1.3	0.0	3.3	4.9	0.2	4.8	0.5	0.3	1.9	22.0	2.3	7.6	8.2
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase receptor type M"	P28827	18	7566782-8406861	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 142.0;Astrocytes: 188.1;Inhibitory neurons: 751.6;Microglial cells: 263.3;Oligodendrocyte precursor cells: 224.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 4.7"	"Group enriched"	"Detected in many"	33	"dendritic cells: 1.8;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	Yes		130000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	53.1	24.1	18.9	11.9	37.6	1.2	41.8	13.0	27.7	18.4	44.2	25.3	8.7	24.2	11.9	14.2	23.3	32.4	61.2	12.7	38.7	29.5	11.8	38.9	15.5	21.7	53.0	26.4	13.2	23.4	16.1	33.2	34.3	16.7	11.5	19.3	10.9	36.0	52.5	12.3	15.1	24.8	5.8	23.1	18.4	22.8	47.6	16.7	54.8	63.4	11.9	23.9	12.2	14.4	4.6	33.4	15.7	0.2	98.0	67.4	38.7	41.1	35.6	26.9	39.5	30.9	7.1	0.0	39.0	49.1	0.5	0.3	0.2	14.3	36.9	0.5	7.2	0.0	22.2	15.2	27.9	0.0	0.4	77.1	29.3	14.9	42.1	51.1	27.2	0.0	0.0	13.8	21.8	0.7	13.7	0.3	2.6	9.9	7.3	0.5	13.5	63.9	64.9	57.6	1.4	8.6	1.1	0.2	34.6	24.9	0.2	0.0	28.2	54.9	34.6	26.4	7.2	1.1	0.4	0.3	46.8	0.2	10.4	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.8	4.7	0.0	0.0	1.0	2.0	0.0	0.0	0.0	1.8	0.7	1.1	18.9	37.6	13.0	27.7	12.7	38.7	21.7	53.0	34.3	5.8	47.6	14.4	142.0	44.8	36.0	188.1	1.1	6.0	7.3	3.0	2.8	28.3	2.5	3.2	26.7	14.3	7.1	5.5	2.1	11.4	5.4	0.9	1.9	17.6	25.9	28.9	15.6	68.9	1.8	0.4	70.1	8.3	3.4	14.0	8.2	59.6	2.5	13.0	47.2	25.3	9.9	0.0	751.6	1.4	0.0	8.0	5.7	42.0	2.8	5.1	30.2	263.3	0.6	2.9	3.1	224.7	50.3	14.3	1.2	5.3	2.3	8.3	3.0	13.3	15.6	2.2	6.6	7.4	9.9	8.6	9.9	0.9	2.8	12.6	5.7	3.7	0.8	8.6
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	89	"plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in single"	89	"dendritic cells: 12.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 121.8;HaCaT: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		150000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	54.7	21.2	34.4	5.0	25.5	1.5	36.2	3.2	30.9	40.2	0.0	25.2	2.6	30.5	2.2	16.5	41.1	13.7	37.0	34.3	10.0	11.2	6.0	26.9	5.5	16.4	16.4	35.8	32.4	9.7	29.1	2.3	17.6	30.5	1.6	5.7	18.6	14.6	14.4	20.6	13.6	8.6	1.6	9.0	23.2	9.9	27.3	4.2	29.4	7.4	4.4	32.0	31.8	34.9	11.3	64.0	56.2	121.8	25.3	20.5	7.4	19.4	22.5	22.8	18.5	0.7	6.2	0.2	44.5	32.2	18.0	124.6	15.1	0.2	10.0	1.5	24.3	0.0	27.2	40.5	11.7	0.0	14.1	21.8	5.4	4.8	0.9	29.4	0.6	7.9	18.5	0.2	9.1	48.0	5.2	12.3	31.7	0.4	27.0	0.0	12.4	0.0	4.7	22.5	43.1	58.9	18.3	3.4	34.6	10.7	22.0	4.8	2.8	20.2	34.3	46.9	23.6	6.2	0.1	36.9	10.5	0.0	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	34.4	25.5	3.2	30.9	34.3	10.0	16.4	16.4	17.6	1.6	27.3	34.9	1.1	6.4	1.1	53.8	3.2	60.9	42.4	16.1	22.2	49.6	3.3	5.5	14.1	27.1	4.9	12.9	2.1	0.7	56.4	0.1	9.8	1.4	3.4	5.4	11.4	9.7	3.0	0.0	76.8	0.9	32.2	51.2	5.1	5.3	0.0	4.0	25.4	20.2	1.7	11.8	104.2	0.0	10.2	0.3	20.0	5.4	46.6	3.4	80.0	15.9	0.8	46.6	0.0	71.9	90.2	0.5	0.0	36.1	6.3	35.0	0.0	2.9	1.7	10.1	13.1	46.4	22.6	7.4	14.8	16.8	36.7	1.0	2.0	2.7	0.4	30.0
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 22.1;Respiratory ciliated cells: 24.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	7.1	2.1	12.6	1.1	18.3	0.1	6.9	6.4	16.1	31.1	6.1	5.3	0.7	11.9	3.3	4.3	11.5	4.8	8.7	14.4	10.0	4.9	9.1	9.9	0.6	29.1	18.9	13.0	11.1	9.2	10.2	11.5	28.0	14.0	1.4	18.8	14.6	12.9	17.5	10.1	2.4	1.9	6.3	2.1	5.9	4.0	9.7	1.0	5.2	9.9	1.3	12.3	12.2	11.1	8.1	10.8	0.6	1.6	28.7	1.0	95.7	8.4	7.4	0.3	0.5	9.4	34.7	1.4	16.2	1.6	1.0	42.3	38.5	27.1	0.1	0.5	19.7	1.7	12.1	39.8	12.1	0.0	1.7	13.3	14.4	0.0	2.5	11.3	0.2	4.7	0.3	1.3	7.6	13.2	0.5	0.2	15.8	15.9	4.9	0.0	11.3	0.5	11.7	39.4	32.3	42.0	8.5	26.3	5.8	6.6	15.6	1.8	7.1	1.4	9.3	2.6	1.2	0.8	1.1	0.1	18.8	1.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	6.4	16.1	14.4	10.0	29.1	18.9	28.0	6.3	9.7	11.1	1.0	9.6	13.6	0.7	0.1	1.5	6.7	22.1	1.8	5.3	4.8	5.6	5.2	5.7	20.2	5.5	12.5	18.7	0.5	0.3	0.0	6.2	1.3	8.6	9.4	1.3	0.0	0.0	12.1	2.7	10.5	4.6	0.0	10.1	1.3	0.7	1.8	5.3	2.6	0.0	8.0	0.2	6.1	0.6	1.1	1.2	4.7	0.4	8.8	3.7	0.0	16.7	0.0	8.5	4.4	7.3	0.0	7.2	1.2	6.5	0.0	0.3	24.3	42.6	6.6	5.5	4.1	2.1	6.4	0.2	0.6	9.0	0.6	0.0	0.2	10.0
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436850-157443633	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 231.5;urinary bladder: 191.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 16.2;Fibroblasts: 44.7;Glandular and luminal cells: 24.0;Langerhans cells: 23.6;Macrophages: 27.0;Melanocytes: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;thalamus: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1219.3;ASC TERT1: 1751.7;BJ hTERT+: 1201.8;HHSteC: 2261.1;HSkMC: 2364.2;hTEC/SVTERT24-B: 1276.5;TIME: 1761.1;U-2197: 1605.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	970000	"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	231.5	11.1	0.4	38.8	0.4	89.0	57.9	0.6	1.9	2.8	1.1	13.0	0.8	2.5	0.5	2.9	21.4	7.7	46.8	0.6	0.5	6.8	2.6	83.2	0.9	0.7	0.6	1.4	41.6	1.1	4.4	11.4	0.6	6.9	2.3	0.4	5.4	0.5	5.2	25.4	9.7	5.7	0.3	23.6	24.8	0.7	4.0	1.6	5.8	0.5	0.3	191.7	3.1	0.4	1.2	0.0	752.4	0.2	1219.3	1751.7	0.3	132.3	1201.8	56.2	60.9	0.7	7.9	0.2	460.6	157.4	87.6	0.0	0.3	1.1	110.5	0.8	0.3	2.0	0.1	0.0	2261.1	2.5	0.0	2364.2	0.8	1276.5	429.8	110.2	266.4	0.1	0.3	0.0	380.1	0.0	0.3	2.9	11.2	0.0	4.6	0.2	0.0	0.2	5.3	53.1	6.0	0.8	7.6	1.0	0.9	0.1	0.6	2.4	1761.1	252.2	12.2	1605.1	23.0	0.2	0.5	0.9	52.8	6.4	74.2	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	1.9	0.6	0.5	0.7	0.6	0.6	0.3	4.0	0.4	2.3	0.0	1.7	0.0	0.1	1.7	1.7	0.3	0.0	1.8	3.6	0.6	0.6	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	7.2	2.4	16.2	10.3	5.1	0.0	0.0	0.5	0.0	0.1	44.7	0.0	24.0	0.0	0.7	3.3	0.0	2.6	0.0	1.0	0.0	0.0	10.0	23.6	1.2	0.3	27.0	14.2	0.0	2.3	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.8	0.0	4.0	7.2	0.0	0.4	0.4	1.0	0.3	0.4	0.0	0.0	0.4
PURA	"PUR-ALPHA, PUR1, PURALPHA"	ENSG00000185129	"Purine rich element binding protein A"	Q00577	5	140107777-140125619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 220.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		260000	"Cluster 15: NK-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (2.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.28e-2)"	"prognostic favorable (4.77e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.09e-1)"	7.6	9.0	29.6	8.1	19.3	2.5	5.2	11.3	18.6	8.5	0.0	6.4	10.0	6.9	5.5	5.7	5.6	5.6	8.4	14.4	22.7	12.2	8.6	6.8	6.0	24.2	21.4	10.1	7.2	13.5	4.8	8.1	23.6	9.5	4.4	12.6	9.7	8.0	9.6	7.3	9.0	5.6	24.0	9.8	9.4	5.2	26.7	5.8	11.7	8.2	5.7	5.9	4.8	25.8	15.1	9.2	3.7	21.5	9.3	13.4	20.1	32.5	13.4	15.0	11.7	19.2	15.5	15.8	25.2	12.7	10.0	13.4	8.9	18.6	12.7	25.7	28.0	11.8	13.1	6.7	5.8	9.6	19.0	6.2	8.9	14.1	8.5	9.7	4.3	11.3	11.1	16.4	7.7	18.6	15.3	12.1	4.7	5.0	23.3	15.4	14.6	11.3	9.4	11.9	11.7	12.1	16.5	19.1	18.7	3.6	17.2	9.2	15.2	26.8	19.5	9.5	23.4	26.0	13.5	16.8	12.7	10.5	22.7	6.4	1.8	3.4	2.8	1.2	2.1	3.0	3.1	3.2	1.6	3.7	2.7	3.4	0.9	5.2	1.5	2.5	2.9	1.0	29.6	19.3	11.3	18.6	14.4	22.7	24.2	21.4	23.6	24.0	26.7	25.8	82.2	51.3	43.3	28.4	43.5	34.3	48.5	15.0	54.1	162.0	58.5	62.2	76.2	62.9	21.7	77.3	125.1	47.2	53.6	48.8	13.7	22.2	25.4	46.2	66.4	71.2	62.9	27.8	45.3	25.4	44.4	57.5	49.5	40.8	25.4	35.9	77.4	62.1	26.4	220.4	46.0	47.9	12.2	32.3	26.2	10.0	76.4	29.2	37.4	34.7	27.0	95.1	49.4	27.2	43.4	26.4	33.9	102.0	43.5	61.7	57.6	48.9	22.5	106.7	72.3	99.8	76.7	38.6	38.7	39.7	45.5	43.4	49.9	52.7	44.0	48.8
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"PVR cell adhesion molecule"	P15151	19	44643798-44666162	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.5;intermediate monocyte: 4.5;myeloid DC: 3.8;non-classical monocyte: 5.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"TIME: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		720000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	13.9	17.5	10.2	7.1	9.1	5.1	9.6	9.0	10.0	8.7	9.3	10.3	12.5	13.9	5.2	8.4	11.8	6.2	28.5	9.0	16.6	13.6	30.7	19.4	2.7	9.7	11.0	12.5	14.0	10.3	17.3	12.5	12.4	9.7	8.8	5.4	9.9	6.4	19.0	7.1	11.1	10.5	7.4	4.6	12.3	5.8	14.9	2.5	10.6	6.2	2.8	9.1	8.5	7.9	58.8	52.1	5.6	25.0	8.6	9.7	7.4	96.7	38.8	40.7	45.8	31.9	28.2	0.1	50.6	43.7	60.2	44.4	24.3	51.1	31.7	7.8	27.1	8.8	40.3	23.3	43.7	4.1	22.2	10.6	28.0	40.9	82.5	49.7	50.7	6.6	4.3	0.5	23.4	7.8	4.2	5.8	12.5	30.1	31.7	0.1	23.2	5.0	111.8	25.5	21.2	22.9	66.3	54.3	14.7	7.2	22.8	12.5	175.3	39.0	52.8	33.7	78.2	0.3	6.3	0.2	35.3	23.4	24.6	0.2	4.5	0.0	0.1	4.5	0.0	0.0	0.0	0.2	3.8	0.0	0.2	0.1	1.1	0.7	5.5	0.5	0.0	1.7	10.2	9.1	9.0	10.0	9.0	16.6	9.7	11.0	12.4	7.4	14.9	7.9	11.1	16.0	25.2	2.3	1.6	3.6	16.0	6.9	4.0	5.7	4.7	3.4	14.4	14.3	12.2	1.8	2.1	2.9	0.2	18.5	3.9	37.9	10.5	5.4	6.3	20.4	13.1	2.1	11.4	35.3	34.8	7.7	13.7	11.6	1.3	6.5	7.9	41.1	8.4	1.7	13.7	11.3	2.0	8.9	7.5	14.3	5.6	6.8	1.8	5.6	17.2	1.8	2.1	6.0	4.6	69.6	18.0	15.8	0.2	14.4	10.8	5.7	2.8	3.4	0.0	23.8	10.4	10.4	1.5	5.8	5.5	1.0	0.9	10.8	12.7	7.4
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.1;Endometrial stromal cells: 99.4;Endothelial cells: 95.1;Hepatic stellate cells: 71.4;Skeletal myocytes: 120.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 323.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA012375	Approved				"Secreted to extracellular matrix"	NA	NA		9100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	59.5	5.5	4.1	24.3	3.5	0.9	33.7	1.9	4.1	18.2	27.5	36.1	7.9	32.8	4.0	4.9	18.0	22.7	22.7	3.1	7.7	9.0	12.4	27.6	5.0	4.2	6.2	32.7	3.8	3.0	11.7	33.4	4.7	17.5	8.7	5.2	13.6	11.1	7.7	6.9	16.3	61.8	2.6	10.0	13.2	6.4	5.2	2.1	8.4	11.5	2.1	33.8	13.5	3.4	39.9	13.9	72.0	0.1	198.3	180.9	54.6	231.4	182.3	99.0	107.9	0.1	0.5	0.0	323.8	230.3	4.5	8.3	0.3	142.3	125.5	0.6	2.4	0.0	139.3	0.0	196.4	0.6	0.0	200.7	41.0	112.2	83.8	299.5	247.0	35.9	0.1	0.0	142.6	23.6	6.8	8.0	58.3	0.0	52.3	13.2	250.8	0.6	115.9	0.1	0.2	131.9	0.2	73.6	0.4	142.9	27.0	0.9	242.4	162.8	79.7	6.2	180.7	0.2	205.4	1.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	3.5	1.9	4.1	3.1	7.7	4.2	6.2	4.7	2.6	5.2	3.4	79.1	6.4	2.3	2.6	0.4	2.9	2.8	12.8	0.6	2.5	17.5	14.1	5.8	17.2	7.0	1.8	0.0	0.6	0.2	0.3	0.0	10.4	33.4	4.2	99.4	95.1	1.8	0.0	6.6	0.0	11.3	45.2	0.0	3.4	1.3	43.7	71.4	1.8	1.9	0.0	7.3	1.3	20.3	5.7	4.4	40.7	26.8	0.7	7.2	8.4	0.6	10.0	1.0	55.8	0.7	0.5	0.1	15.1	0.0	14.0	0.0	0.2	6.7	0.8	46.0	120.1	51.1	22.0	16.0	0.5	2.8	1.4	1.0	33.3	0.5	1.4
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
PYGL	GSD6	ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944483	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 145.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 151.2;Hofbauer cells: 177.6;Muller glia cells: 265.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 141.1;neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 279.1;HMC-1: 304.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	110.1	21.0	5.9	24.1	6.6	108.9	36.4	5.0	8.4	33.6	10.4	19.0	3.7	20.7	6.4	55.8	19.1	13.0	14.9	5.2	6.2	10.2	145.6	26.1	6.3	10.7	17.6	18.2	5.7	21.1	7.5	49.3	8.7	13.0	24.0	78.2	26.8	29.7	5.1	37.0	8.4	26.7	8.6	49.4	9.6	5.2	9.0	4.8	10.2	5.8	6.8	41.7	38.1	10.3	145.7	40.8	10.1	64.3	47.0	56.2	114.5	28.6	24.1	77.4	117.3	107.4	18.3	0.1	54.4	171.7	91.2	279.1	107.0	144.8	132.0	0.5	46.8	28.0	60.5	82.4	83.8	106.9	304.4	119.4	56.8	104.1	43.6	75.4	69.3	0.8	11.6	0.5	55.4	144.7	0.4	141.7	39.3	12.8	152.0	2.7	36.2	6.1	104.7	95.1	4.5	4.4	131.0	43.3	1.7	38.6	20.6	200.4	3.2	29.7	49.6	56.0	92.9	1.2	0.3	0.5	27.3	107.7	15.9	50.2	55.9	141.1	0.0	24.2	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	153.7	0.6	15.7	1.2	0.2	24.8	5.9	6.6	5.0	8.4	5.2	6.2	10.7	17.6	8.7	8.6	9.0	10.3	6.7	22.4	6.3	1.3	1.8	30.7	10.5	40.5	6.8	4.6	7.0	3.8	3.4	5.7	35.4	7.3	0.0	28.9	0.2	11.2	3.9	10.9	1.0	35.4	18.9	7.8	1.2	9.0	1.8	2.1	151.2	18.8	6.6	62.6	6.3	9.3	8.2	65.4	177.6	1.7	2.2	7.1	14.2	56.7	7.9	1.5	14.3	54.6	19.6	15.9	52.4	265.1	2.1	14.1	0.6	7.4	5.2	21.8	1.8	9.7	0.0	6.4	24.5	11.9	6.6	15.4	8.8	0.7	1.4	22.4	22.3	21.1	2.3	4.0	14.0	9.2
PYGM	GSD5	ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64759974	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	65	"skeletal muscle: 8468.3;tongue: 3594.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.7;NB-4: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		10000000	"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	15.2	3.0	35.4	2.1	30.1	1.2	7.7	55.5	29.4	5.8	15.5	25.5	1.5	10.4	6.4	92.2	14.6	3.8	70.8	26.8	26.1	2.4	1.2	2.7	2.2	48.8	30.4	4.0	1.6	0.3	1.7	1.4	39.6	25.6	3.6	2.9	50.0	26.3	8468.3	4.2	7.0	14.7	44.9	3.3	6.9	6.7	47.3	1.3	5.2	3594.2	1.2	16.7	5.2	38.1	0.1	0.0	0.7	0.1	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.3	0.4	0.1	3.7	0.2	0.2	0.1	0.0	0.0	1.1	0.7	0.6	0.0	1.1	0.7	2.2	0.7	0.1	0.1	0.4	0.7	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.4	0.4	0.3	0.4	0.3	0.0	0.4	0.1	0.0	1.0	1.4	0.4	0.0	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.3	0.0	0.2	0.2	0.1	35.4	30.1	55.5	29.4	26.8	26.1	48.8	30.4	39.6	44.9	47.3	38.1	2.4	0.0	2.3	29.7	3.0	0.8	0.6	0.2	5.2	3.5	2.9	4.7	47.5	0.0	0.8	0.0	4.2	0.6	1.9	1.0	0.0	0.1	11.7	1.6	5.2	2.0	0.0	0.0	0.2	0.0	0.2	5.1	1.1	4.0	0.0	0.8	1.8	0.0	0.5	0.0	0.2	0.9	0.0	0.6	1.3	49.2	16.4	2.3	0.0	1.0	0.5	9.9	4.1	0.5	0.4	0.3	0.2	44.0	0.3	1.3	0.6	0.0	0.1	1.3	6.6	64.3	12.8	1.2	0.9	2.5	0.6	0.1	2.9	0.9	1.1	0.3
PZP	CPAMD6	ENSG00000126838	"PZP alpha-2-macroglobulin like"	P20742	12	9148840-9208395	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 81.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0;liver cancer: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Group enriched"	"Detected in some"	9	"HeLa: 5.7;SiHa: 2.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	NA	NA		15000000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.2	0.0	0.4	0.0	1.3	0.1	0.2	0.9	0.6	0.2	0.6	0.0	0.0	1.3	0.1	0.0	1.2	0.0	0.7	0.9	0.6	0.2	81.6	0.8	0.0	2.3	6.7	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.6	0.0	2.3	1.0	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.9	0.6	0.9	0.6	2.3	6.7	3.9	0.9	1.0	1.3	1.9	3.2	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.6	0.0	2.7	0.0	2.1	0.0	1.4	0.0	0.0	0.0	26.2	4.7	0.2	2.1	0.0	0.0	3.7	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.8	26.4	0.0	0.0	2.9	0.0	0.0	0.3	0.0	11.0	0.0	0.2	0.0	2.8	0.0	0.0	2.1	8.5	4.6	0.0	0.0	0.4	0.7	0.0	0.0	0.0	24.7	0.6	0.0	0.3	0.4	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0
QARS1	QARS	ENSG00000172053	"Glutaminyl-tRNA synthetase 1"	P47897	3	49095932-49105130	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		58000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	61.1	58.8	20.0	57.2	21.3	96.6	89.5	23.5	18.5	58.3	34.2	104.8	101.6	45.5	58.5	102.5	71.0	48.3	72.0	18.4	21.1	57.1	51.1	52.3	75.8	23.8	21.0	69.0	73.9	78.1	33.0	76.7	23.0	60.4	121.0	21.4	103.2	61.1	156.1	105.0	84.6	60.2	22.7	60.1	75.0	30.0	23.0	92.3	53.2	146.2	118.8	72.8	58.1	24.6	95.9	97.8	128.0	197.4	146.4	180.8	159.2	90.5	188.2	160.5	152.9	123.0	113.5	257.1	61.4	136.7	95.3	119.9	166.3	137.8	111.4	78.2	148.0	206.4	156.0	216.1	91.2	187.2	130.9	184.8	123.1	127.4	108.1	175.3	184.7	144.6	95.3	112.4	118.0	89.2	130.7	154.9	116.1	159.0	122.9	76.0	123.7	200.6	108.5	163.9	48.7	161.6	85.4	211.0	147.8	122.7	184.4	205.5	137.6	82.8	127.3	131.7	117.9	111.9	176.5	142.9	88.4	156.3	60.3	30.7	84.3	25.8	44.5	104.1	57.4	62.2	54.1	47.0	127.0	49.9	46.6	49.0	8.0	71.8	94.5	57.4	82.1	81.2	20.0	21.3	23.5	18.5	18.4	21.1	23.8	21.0	23.0	22.7	23.0	24.6	15.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	193.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	156.7	14.7	0.0	0.0	0.0	0.0	0.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	187.0	2.0	0.0	0.0	0.0
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 752.2;choroid plexus: 301.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	66.6	74.3	515.1	10.2	720.1	15.1	26.4	696.9	571.9	15.8	301.8	21.2	25.6	16.5	40.1	15.6	17.3	17.7	43.4	457.6	578.5	110.1	197.2	23.3	11.9	663.0	752.2	18.3	28.8	49.9	32.7	11.8	688.6	28.7	17.0	40.1	36.3	19.5	108.6	16.2	23.9	17.9	524.9	14.3	23.7	12.4	602.6	13.6	22.1	61.2	13.3	14.5	15.1	663.7	33.1	62.5	30.2	35.8	66.1	32.3	41.5	43.2	22.3	47.5	41.6	52.2	46.4	12.2	28.0	30.3	50.8	18.4	40.3	58.4	33.7	35.3	7.3	34.8	33.4	128.3	37.3	46.2	2.9	40.8	35.6	31.6	40.3	25.9	24.5	33.2	37.0	29.0	50.6	19.2	65.0	77.8	44.8	36.7	45.4	27.0	21.0	52.2	48.2	17.5	47.1	64.3	31.9	6.7	156.6	35.0	15.7	19.0	37.7	23.6	41.1	26.5	38.2	43.1	67.7	85.3	52.0	43.1	41.7	0.3	38.9	3.0	31.3	61.3	29.8	18.6	33.1	32.3	48.3	18.3	37.4	32.6	1.1	29.8	48.4	115.1	20.3	34.4	515.1	720.1	696.9	571.9	457.6	578.5	663.0	752.2	688.6	524.9	602.6	663.7	20.3	28.9	31.5	10.7	14.8	20.0	21.3	32.2	18.8	36.2	37.6	28.3	74.4	50.1	19.5	38.6	8.4	69.6	22.8	13.7	109.5	41.1	1.0	11.8	19.1	17.2	174.3	30.1	23.1	23.4	34.2	27.1	27.5	17.8	25.4	42.3	20.7	337.6	80.3	82.4	21.9	31.1	34.6	38.1	23.9	4.8	22.7	32.2	152.9	12.2	23.4	387.2	16.5	15.1	481.3	16.9	11.6	38.0	23.6	23.2	41.4	527.2	6.2	31.4	26.3	27.5	25.4	3.3	58.9	29.7	16.1	18.3	18.5	90.0	35.7	17.3
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37342827-37373322	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 170.3;epididymis: 104.0"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 217.0;Ionocytes: 138.4;Langerhans cells: 163.4;Melanocytes: 528.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 1527.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 1527.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 117.1;SK-MEL-30: 426.8;U-266/84: 341.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	5.6	170.3	8.4	14.2	7.5	47.3	15.8	5.1	11.5	21.2	4.2	25.3	5.6	9.8	104.0	3.4	2.2	10.8	5.1	8.9	27.4	6.1	2.6	5.6	8.1	9.7	11.6	1.0	13.7	14.8	27.0	9.2	14.7	7.2	10.2	11.9	25.5	6.7	4.1	36.3	4.5	8.3	7.8	13.9	7.6	2.0	20.3	5.1	3.8	2.8	12.5	15.2	4.6	6.7	1.0	40.7	0.1	0.0	6.0	13.3	0.1	6.6	86.5	6.4	10.1	2.9	7.1	0.2	3.0	32.6	72.9	0.1	2.7	0.6	10.3	0.6	76.0	18.7	0.3	7.7	0.6	3.0	0.1	8.5	0.0	47.3	0.2	0.4	26.2	0.0	0.0	0.0	0.2	4.5	0.0	1.7	0.6	0.3	0.0	0.0	0.0	0.8	42.6	10.9	117.1	0.2	6.4	1.4	426.8	8.0	0.7	2.9	19.4	0.0	0.2	0.1	0.6	15.3	341.7	0.3	25.8	0.3	0.0	9.8	344.8	3.2	0.4	38.7	1.0	2.6	0.6	0.5	124.7	1.2	0.5	0.3	1527.7	0.2	3.3	2.4	0.1	169.8	8.4	7.5	5.1	11.5	8.9	27.4	9.7	11.6	14.7	7.8	20.3	6.7	1.8	3.2	2.3	0.3	12.5	39.0	13.6	40.0	2.2	21.8	7.9	8.5	1.1	1.5	17.7	22.0	2.1	0.7	0.8	6.1	1.9	45.4	0.6	2.6	24.7	17.5	217.0	1.7	8.5	2.4	6.1	26.7	3.1	4.0	55.3	1.6	22.5	0.3	20.5	43.7	7.3	6.6	138.4	21.2	163.4	2.9	3.1	26.8	528.3	6.5	64.3	0.8	3.1	3.0	1.3	31.8	1.8	23.7	26.0	9.1	0.2	11.7	4.3	3.2	13.1	0.6	6.6	1.7	0.7	0.6	14.5	4.7	5.6	5.0	7.3	5.8
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29663279-29698699	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 119.4;liver: 183.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.8;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 597.1;Hep G2: 258.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		780000	"Cluster 7: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	8.4	89.4	20.6	4.3	20.2	4.8	6.7	25.8	19.8	50.6	19.4	19.2	61.6	26.1	95.2	4.0	43.6	10.2	26.8	18.5	22.2	119.4	183.5	9.2	6.8	28.6	26.6	31.0	34.5	16.2	5.8	27.3	32.4	7.0	15.2	7.5	13.4	26.1	5.1	5.1	30.3	13.7	23.6	17.2	7.1	4.1	22.8	8.2	6.5	1.2	5.2	10.5	11.5	23.3	0.6	1.4	51.8	56.4	8.8	21.6	167.8	6.0	5.2	8.6	11.0	145.9	91.9	2.3	597.1	10.8	10.0	1.0	18.5	0.6	4.5	0.8	16.7	27.1	2.2	258.0	52.5	4.1	10.4	69.8	1.4	4.8	0.2	12.8	0.2	28.2	75.1	2.9	0.4	154.6	17.6	100.3	162.1	1.9	0.2	89.3	16.3	58.5	47.9	4.2	48.6	103.5	0.0	142.1	118.8	85.1	106.5	112.8	0.6	2.5	24.9	0.9	0.5	1.8	4.9	18.8	4.4	10.4	8.1	0.0	4.2	0.3	0.8	5.3	0.9	0.1	0.6	0.7	5.8	0.0	0.1	0.4	0.8	0.4	9.0	3.1	0.9	1.9	20.6	20.2	25.8	19.8	18.5	22.2	28.6	26.6	32.4	23.6	22.8	23.3	3.1	9.6	24.8	5.2	10.1	3.6	11.7	0.5	1.8	3.3	5.0	2.0	43.2	8.6	3.0	64.4	0.0	404.7	5.8	84.5	50.9	1.2	0.0	93.8	49.5	5.5	28.3	10.5	1.3	55.2	315.1	35.8	0.5	81.0	5.1	6.7	9.7	367.4	147.5	6.7	5.6	47.3	0.0	21.2	18.3	0.5	29.2	19.8	42.7	12.2	4.4	20.8	3.1	11.1	0.5	11.5	78.5	27.1	8.7	4.2	161.0	598.8	1.5	5.0	6.6	3.3	16.2	0.5	3.0	0.2	2.0	215.6	5.7	36.5	104.7	8.3
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154869-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 1616.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1918.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	84.8	84.9	35.8	52.1	39.4	115.5	53.2	42.7	47.3	81.7	41.1	100.1	67.5	75.2	70.2	178.4	82.3	150.3	244.9	41.5	43.4	73.8	81.7	200.0	16.3	50.0	40.7	196.1	136.3	21.0	60.2	158.9	43.2	92.3	80.9	15.2	105.6	57.5	91.2	58.6	85.7	60.0	44.0	61.9	178.3	172.9	42.6	12.1	31.9	46.0	19.6	174.1	108.7	57.7	441.4	62.0	14.8	181.0	179.1	367.8	712.5	456.5	456.6	381.6	267.1	7.3	137.7	6.8	276.7	367.8	52.6	93.7	17.6	123.5	185.0	26.4	28.0	14.1	33.6	19.4	1918.6	48.6	129.2	197.9	55.5	408.0	484.3	499.9	569.4	32.1	20.2	66.3	255.3	76.4	10.4	89.7	49.4	302.6	174.6	19.7	33.0	11.8	63.1	123.6	51.9	52.6	133.8	179.8	91.9	32.2	33.0	226.3	678.3	473.8	187.5	322.0	392.9	48.3	84.4	12.2	180.9	153.9	146.0	16.2	53.1	20.6	14.0	29.9	10.2	5.4	9.1	9.6	39.2	3.2	8.1	8.0	40.2	16.9	28.6	8.0	11.5	28.6	35.8	39.4	42.7	47.3	41.5	43.4	50.0	40.7	43.2	44.0	42.6	57.7	36.6	57.7	101.6	8.5	7.7	13.8	27.4	81.2	7.4	11.5	86.2	47.9	48.3	51.5	112.5	71.7	25.0	19.5	10.7	138.1	0.0	230.4	49.2	49.2	19.4	41.7	46.2	6.9	17.2	130.1	1616.7	78.0	136.6	80.4	25.4	27.1	89.3	4.3	68.6	6.7	17.0	185.7	132.2	45.2	35.3	20.1	177.7	48.9	44.4	8.4	49.7	53.5	10.3	24.6	23.9	249.8	165.6	71.1	12.8	35.7	9.0	9.1	47.8	6.7	32.9	13.6	31.3	30.2	32.7	10.2	9.9	154.3	13.9	13.9	89.9	68.0
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Late spermatids: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Centriolar satellite"		"HPA036406: AB_2675105, HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.0	5.3	5.2	2.3	4.7	0.5	7.5	2.3	19.8	6.9	0.0	6.5	2.0	10.6	1.5	5.8	7.5	3.7	6.6	6.0	6.2	11.7	2.3	6.8	1.0	17.4	6.2	6.9	7.4	12.2	5.4	1.7	16.1	5.1	0.8	0.8	7.5	3.3	11.5	8.2	3.4	3.2	4.2	14.3	5.9	44.7	11.6	0.4	5.1	3.0	0.9	6.7	5.8	6.0	20.0	8.8	0.6	6.2	6.7	7.9	11.1	28.6	15.9	10.1	8.0	6.9	4.4	0.0	15.3	16.3	10.7	8.1	4.1	8.6	4.4	38.1	11.1	7.8	4.0	4.2	7.8	0.0	1.4	9.5	8.9	12.5	8.3	9.3	13.5	3.6	6.0	3.6	7.1	0.6	0.1	0.2	4.8	3.2	15.0	7.1	7.8	18.3	8.7	2.7	2.8	2.9	10.0	3.3	4.3	2.1	2.2	0.5	35.4	24.4	13.2	17.3	15.0	13.8	4.3	0.1	18.0	8.5	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	5.2	4.7	2.3	19.8	6.0	6.2	17.4	6.2	16.1	4.2	11.6	6.0	12.1	6.4	3.6	4.6	1.3	25.5	8.3	6.7	12.5	4.4	13.0	6.9	12.0	12.8	3.7	20.2	0.0	1.2	5.5	7.7	27.4	12.1	86.2	6.1	3.2	20.4	1.8	0.0	11.1	18.4	12.2	9.0	3.1	12.8	0.0	34.5	16.8	6.1	2.1	6.7	11.5	2.5	2.0	1.3	8.1	171.6	14.3	1.9	8.8	7.5	1.0	7.4	1.0	1.0	1.3	22.7	2.7	8.6	6.1	13.4	0.4	46.9	5.0	2.6	26.3	7.2	6.2	39.8	6.6	5.1	17.6	14.8	4.5	6.4	4.6	16.4
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178133-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		2700000	"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	39.0	38.7	37.5	35.6	39.7	66.5	42.1	40.3	47.7	37.8	32.6	42.8	39.9	35.6	34.2	63.2	34.0	30.7	32.4	38.4	40.9	50.0	82.8	49.2	41.1	39.6	39.9	35.9	27.6	45.8	28.9	43.1	40.5	38.8	42.4	45.5	34.6	38.1	39.4	56.4	38.9	33.4	40.8	38.3	44.3	33.8	40.2	35.2	43.8	38.9	49.5	43.9	40.8	46.8	53.8	53.7	66.9	56.3	76.2	82.5	52.6	74.8	59.6	56.6	44.7	42.6	57.0	51.2	42.5	72.0	49.2	100.1	48.1	55.8	63.6	44.4	31.7	55.7	69.0	43.9	52.6	60.1	63.8	53.0	98.5	58.2	63.4	62.5	81.2	47.1	42.8	45.6	85.6	50.8	58.5	48.1	39.7	104.8	59.9	45.8	72.3	60.4	62.3	76.0	58.9	34.4	89.0	78.0	53.8	47.1	82.1	46.8	76.0	60.1	43.9	75.3	53.0	40.8	82.6	52.3	56.6	51.9	80.7	34.4	29.4	33.5	22.4	41.5	22.4	24.6	20.9	24.7	31.4	23.4	24.6	25.0	31.8	26.5	43.7	19.0	29.3	24.0	37.5	39.7	40.3	47.7	38.4	40.9	39.6	39.9	40.5	40.8	40.2	46.8	102.6	160.3	103.9	23.5	64.4	157.9	78.2	84.8	97.3	93.8	70.7	58.8	39.2	62.9	96.2	62.5	37.5	85.2	79.6	95.1	86.1	81.3	41.9	80.7	89.8	84.5	60.3	44.4	42.5	64.4	83.0	68.7	64.7	94.4	77.2	58.1	61.1	113.6	91.0	94.2	38.0	59.8	95.6	89.9	105.4	36.2	51.9	80.7	110.3	44.0	84.8	100.5	49.4	38.2	59.0	80.7	52.9	56.4	50.2	81.0	63.2	103.3	86.8	62.0	59.2	64.0	105.6	112.9	113.6	120.0	202.4	116.2	74.3	82.5	64.0	106.0
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070696-65130331	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 911.4;Syncytiotrophoblasts: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		3000000	"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: AB_2683051"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	142.5	142.9	84.2	90.6	86.8	232.4	119.1	85.2	105.2	122.6	103.7	128.1	133.6	109.7	179.9	155.0	103.5	100.1	127.3	89.0	91.9	194.1	194.9	141.9	70.5	86.0	88.4	94.4	133.9	113.1	117.2	148.3	91.3	96.6	126.8	89.4	131.8	93.8	100.3	101.3	127.6	117.4	87.7	88.6	135.9	86.2	90.4	59.0	129.6	80.4	91.1	119.2	120.5	91.3	211.3	150.7	186.2	110.5	445.5	261.2	287.5	299.9	212.3	134.8	142.8	270.1	137.5	85.8	167.9	311.2	221.4	130.6	173.7	277.6	214.1	96.3	100.6	108.3	119.2	403.8	281.9	115.4	93.7	232.0	279.6	176.9	158.5	213.3	271.2	67.7	157.2	96.6	271.1	190.6	67.3	138.6	148.6	329.1	134.6	68.3	177.3	137.3	266.1	236.0	133.9	118.5	139.2	230.6	282.4	218.7	143.3	106.9	253.4	172.5	214.6	183.2	171.8	147.6	95.3	205.6	230.2	173.9	170.4	96.8	84.6	78.7	41.9	86.3	46.7	42.6	45.4	45.8	76.0	29.3	43.2	45.1	102.1	56.4	80.9	63.1	59.0	54.3	84.2	86.8	85.2	105.2	89.0	91.9	86.0	88.4	91.3	87.7	90.4	91.3	84.8	83.3	89.1	51.2	64.6	297.2	322.0	384.6	74.0	48.5	117.1	71.8	120.7	87.2	218.6	125.0	6.2	309.5	70.3	182.0	328.7	216.5	350.3	102.8	110.9	133.0	133.4	45.0	50.7	219.5	366.9	171.6	105.0	162.8	50.7	67.1	102.4	183.7	375.3	58.9	53.4	200.4	262.4	122.9	221.6	911.4	145.7	153.3	197.5	83.4	110.5	144.7	41.2	50.3	71.7	234.0	148.2	212.9	107.1	323.2	168.4	441.7	162.4	45.6	72.3	103.8	210.9	193.8	106.7	90.7	293.8	703.8	70.5	76.5	168.4	477.9
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268590-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	127.1	129.7	121.7	84.0	117.4	91.1	120.9	117.7	137.7	113.7	106.2	129.3	112.5	111.2	82.3	180.9	105.7	83.0	146.7	117.5	116.8	127.2	126.4	116.5	90.3	122.7	121.0	103.5	96.1	132.9	112.6	88.4	119.3	140.6	90.3	46.5	128.0	105.1	233.2	147.6	112.9	86.9	119.3	125.3	125.5	79.9	124.2	105.5	111.5	152.8	86.1	113.6	119.2	118.9	226.5	248.0	126.2	166.1	205.6	150.9	113.8	182.7	212.8	232.2	163.4	141.4	223.7	91.7	235.7	263.1	172.1	209.0	140.7	253.9	125.9	190.3	128.0	144.7	156.0	124.2	135.0	124.3	258.2	158.7	212.4	199.6	102.4	163.2	221.1	144.9	153.1	158.8	223.6	434.5	219.1	197.1	131.5	196.1	230.8	133.0	101.8	237.2	234.7	204.5	122.9	137.1	132.7	319.2	133.7	91.4	487.5	141.6	228.1	221.4	152.9	267.9	164.9	89.9	77.9	121.5	251.2	104.3	207.8	173.1	199.8	329.3	227.5	211.9	171.7	109.8	135.5	188.1	163.0	130.2	115.3	140.6	420.5	203.5	243.9	188.3	165.5	375.6	121.7	117.4	117.7	137.7	117.5	116.8	122.7	121.0	119.3	119.3	124.2	118.9	56.3	38.5	59.6	7.8	41.7	33.6	31.4	42.4	53.5	22.0	55.0	53.1	1.1	40.0	47.9	36.8	29.2	56.2	50.8	137.1	50.9	49.3	13.4	41.3	38.6	50.6	54.0	27.1	7.2	71.3	84.2	36.5	58.1	44.9	53.8	24.6	48.9	47.8	54.2	16.8	8.0	85.0	36.7	55.2	26.4	27.2	35.8	51.4	24.9	5.6	47.7	37.8	43.3	5.5	13.1	71.6	80.6	42.2	61.0	41.4	79.6	49.5	36.0	18.2	39.5	36.2	39.7	23.8	17.4	64.5	42.1	80.2	57.4	28.1	64.9	43.5
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561722	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	31.1	55.4	5.7	21.7	5.5	25.3	23.4	5.6	7.9	11.7	9.6	20.7	27.6	6.9	4.8	4.6	11.5	18.0	21.4	5.2	7.0	26.1	51.4	30.7	16.4	7.0	6.0	20.5	24.2	6.2	9.7	22.8	6.8	12.1	14.3	2.6	10.7	5.0	5.8	4.6	25.3	7.6	6.6	44.5	28.6	10.6	7.4	3.9	22.0	2.3	5.1	20.6	6.7	8.4	20.1	2.9	1.9	3.8	12.4	3.3	31.3	1.7	6.2	8.1	12.5	47.9	39.9	0.0	13.9	1.7	10.8	7.5	3.8	12.3	4.2	22.5	3.0	19.8	3.6	22.6	7.8	2.8	5.7	6.9	2.0	4.2	1.2	6.3	3.1	3.3	3.8	0.0	1.8	24.0	0.1	29.0	4.0	60.9	8.5	1.9	0.1	9.0	14.2	26.3	0.5	2.1	3.8	85.7	27.4	6.2	54.4	30.5	2.3	2.0	4.2	0.2	2.7	0.1	0.0	0.2	27.7	38.9	4.2	7.8	35.5	7.1	1.0	33.3	1.3	3.5	2.8	0.9	15.8	2.8	6.5	2.3	26.3	0.0	26.6	0.8	0.9	11.2	5.7	5.5	5.6	7.9	5.2	7.0	7.0	6.0	6.8	6.6	7.4	8.4	18.6	19.2	20.4	4.2	10.6	4.5	10.9	14.1	10.8	0.2	12.8	13.0	5.0	48.6	16.2	25.8	0.0	34.6	1.8	31.1	31.3	60.3	1.6	20.7	2.6	10.3	18.0	0.0	0.4	67.9	91.3	11.5	15.3	23.2	21.0	41.1	53.6	34.5	105.0	0.0	0.4	23.9	28.5	92.1	19.9	1.6	3.7	100.5	7.2	8.4	16.2	7.4	0.0	4.5	0.1	36.4	17.2	6.4	0.4	8.0	48.1	68.9	20.4	2.0	13.1	6.2	26.2	1.0	13.2	1.9	3.0	20.0	3.6	7.2	24.0	11.1
RAB21	KIAA0118	ENSG00000080371	"RAB21, member RAS oncogene family"	Q9UL25	12	71754863-71800286	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 497.9;Late spermatids: 807.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016988, CAB037048"	Approved					NA	NA		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"CAB037048: AB_1841130, HPA016988: AB_1855998"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.68e-2)"	"prognostic favorable (5.39e-8)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.31e-2)"	6.1	7.4	6.1	3.8	7.3	8.0	5.0	6.4	7.5	5.2	4.7	5.3	3.7	4.9	3.9	5.8	4.4	4.5	11.5	5.5	6.5	8.3	6.1	6.5	4.5	7.4	7.2	5.1	3.9	6.5	5.4	5.3	6.9	5.0	3.5	3.5	4.2	4.4	14.2	6.5	4.0	4.3	7.2	4.6	4.3	2.5	6.6	4.6	5.9	7.6	4.2	5.3	5.4	8.2	6.0	4.6	4.7	3.8	7.5	4.8	8.1	8.3	4.9	5.6	3.8	5.6	2.8	9.3	9.5	7.4	3.3	5.1	8.5	5.8	8.8	7.5	3.9	8.6	3.3	6.2	7.7	9.5	5.0	5.6	8.9	6.2	9.6	8.6	3.9	5.1	6.0	5.3	8.6	5.5	7.7	6.3	7.0	3.4	6.9	7.4	5.2	6.7	8.4	8.3	4.7	3.8	10.4	9.8	6.2	5.8	7.7	6.1	6.1	7.3	2.9	11.7	6.2	6.8	7.0	7.1	3.8	5.4	5.3	0.8	0.3	0.5	0.4	0.3	0.4	0.4	0.4	0.3	0.2	0.4	0.4	0.4	1.2	0.4	0.3	0.5	0.3	0.1	6.1	7.3	6.4	7.5	5.5	6.5	7.4	7.2	6.9	7.2	6.6	8.2	93.7	28.9	56.5	17.9	60.7	119.6	78.4	29.6	32.5	45.4	66.1	45.1	179.9	48.6	31.6	47.8	79.2	39.4	96.5	60.4	13.7	22.5	497.9	48.0	56.6	73.1	49.6	21.0	24.9	20.8	38.0	66.6	30.1	109.0	24.1	22.1	48.5	62.3	42.7	52.2	31.9	35.8	20.3	55.7	168.9	807.6	36.1	88.9	55.2	17.8	41.5	41.9	36.0	33.7	47.5	34.2	40.7	41.8	47.8	97.7	44.4	62.5	20.0	37.3	26.3	90.9	81.2	19.2	16.6	56.1	160.1	83.5	59.8	35.5	41.2	117.7
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543833-146554953	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 175.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 232.6;Kupffer cells: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 86.5"	"Group enriched"	"Detected in many"	42	"dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8"	"Low cell line specificity"	"Detected in many"											HPA025731	Approved		Approved	Cytosol		NA	NA		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	35.0	16.5	7.5	29.7	7.8	175.1	27.0	8.6	11.0	19.0	9.2	38.3	17.4	26.5	14.6	11.6	20.8	24.1	17.9	7.1	8.2	21.3	50.2	32.1	22.3	9.9	8.2	13.0	12.2	8.3	5.0	14.8	8.9	14.5	37.7	2.2	18.1	16.9	4.6	20.2	18.4	46.5	9.2	54.1	19.4	33.3	8.8	22.5	11.0	8.3	15.2	28.6	15.4	11.7	65.5	34.5	38.7	65.3	58.0	98.5	0.1	123.3	138.4	167.7	276.7	21.2	31.6	0.1	43.9	132.2	183.5	84.2	2.4	80.4	225.2	0.4	29.1	82.4	78.3	77.3	252.1	114.2	115.9	87.6	133.1	95.8	135.3	86.7	110.5	0.0	15.8	0.4	92.8	15.8	52.0	61.8	5.0	0.0	65.2	0.0	41.5	0.9	65.6	45.2	0.1	50.6	144.7	17.6	219.3	34.3	33.7	91.7	88.0	50.2	67.7	133.1	152.6	0.2	9.4	0.4	115.1	86.0	69.3	86.5	46.8	8.2	0.0	21.2	0.0	0.0	0.0	0.1	42.5	0.0	0.1	0.0	16.5	1.3	15.4	2.2	0.0	14.4	7.5	7.8	8.6	11.0	7.1	8.2	9.9	8.2	8.9	9.2	8.8	11.7	30.8	48.1	9.4	2.9	4.1	53.5	95.3	92.6	17.6	1.4	29.0	38.9	2.0	52.9	36.8	11.0	4.2	2.2	3.4	64.1	25.4	164.4	96.9	8.5	40.3	34.3	60.1	14.9	2.3	105.7	6.9	51.5	18.3	12.4	57.8	27.7	27.5	75.4	232.6	0.0	1.3	31.3	22.4	254.6	101.7	156.7	24.5	146.7	168.9	24.4	147.2	9.0	2.1	4.0	4.6	154.3	46.3	25.6	0.5	99.6	33.3	83.2	9.5	1.4	19.7	46.1	46.3	70.9	14.2	2.5	19.0	3.1	7.0	33.1	62.5	65.6
RAB37		ENSG00000172794	"RAB37, member RAS oncogene family"	Q96AX2	17	74670578-74747335	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;brain: 20.8;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 33.4;Excitatory neurons: 33.2;granulocytes: 50.7;Inhibitory neurons: 29.6;NK-cells: 87.6;T-cells: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 269.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.7"	"Cell line enhanced"	"Detected in some"		"HEL: 50.6;HMC-1: 58.7;OE19: 25.4;U-266/70: 84.9;U-937: 34.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (2.10e-2)"	"unprognostic (7.04e-4)"	"unprognostic (5.95e-2)"	"unprognostic (9.80e-4)"	"unprognostic (3.49e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.62e-3)"	"unprognostic (9.47e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (8.80e-6)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (4.01e-2)"	1.4	1.9	1.5	10.5	2.7	24.5	1.0	20.8	10.5	1.8	0.0	5.4	5.2	1.3	1.8	1.9	1.6	4.8	1.3	1.2	2.8	1.0	12.2	6.8	19.2	11.8	4.6	0.5	0.7	1.7	0.6	1.8	11.3	3.9	5.1	3.3	2.3	0.9	0.6	0.8	8.3	1.9	0.6	17.0	6.7	0.8	11.1	21.3	0.6	2.7	14.9	4.2	1.9	3.7	0.0	7.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	50.6	0.2	0.3	0.1	3.9	58.7	0.5	0.0	0.0	0.0	0.0	0.0	7.3	0.0	18.3	0.0	0.2	15.3	13.0	0.0	25.4	0.0	2.8	0.0	0.0	0.1	0.0	0.8	0.0	0.0	3.6	0.0	2.9	0.2	11.4	0.0	0.0	0.3	0.0	0.0	84.9	3.6	1.1	0.1	34.3	0.0	269.7	13.6	201.5	51.1	28.9	12.9	12.3	22.4	37.8	7.3	12.2	12.5	28.3	63.2	54.0	50.3	1.4	42.8	48.9	1.5	2.7	20.8	10.5	1.2	2.8	11.8	4.6	11.3	0.6	11.1	3.7	0.9	3.2	3.2	1.6	23.1	0.1	0.2	0.3	0.0	7.6	0.8	0.4	1.8	5.7	1.8	0.0	6.2	0.1	33.4	1.3	0.0	1.3	0.0	0.1	0.1	0.9	5.4	16.0	33.2	0.9	0.1	2.0	8.2	0.5	50.7	0.0	2.2	12.6	0.6	3.3	29.6	7.7	14.2	2.2	0.0	0.4	0.6	18.5	0.0	1.9	11.8	1.3	87.6	2.0	1.6	0.4	2.8	1.2	6.3	0.1	0.2	1.5	2.3	1.0	6.6	3.0	1.1	0.0	1.5	0.3	0.1	0.0	31.0	0.5	0.5	0.3
RAB39B	"MRX72, WSN"	ENSG00000155961	"RAB39B, member RAS oncogene family"	Q96DA2	X	155258235-155264491	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Autism spectrum disorder, Disease variant, Mental retardation, Parkinson disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;retina: 9.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.8;Horizontal cells: 10.1;Inhibitory neurons: 9.8;Muller glia cells: 11.6;Oligodendrocytes: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.8;Karpas-707: 35.6;U-266/70: 35.5;U-266/84: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001114, HPA042505"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA001114: AB_1079732, HPA042505: AB_2678030"	"prognostic favorable (8.95e-4)"	"unprognostic (1.20e-3)"	"unprognostic (3.52e-2)"	"unprognostic (7.10e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.00e-4)"	"unprognostic (1.78e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	0.2	1.9	6.5	2.8	6.7	0.9	0.7	6.8	10.7	0.4	3.0	0.7	0.6	0.3	6.4	0.3	0.5	0.6	0.3	7.0	7.0	0.7	0.3	0.6	5.3	6.4	6.1	0.4	2.5	3.8	6.5	0.2	6.9	1.9	0.6	9.9	0.4	1.3	0.0	0.0	1.2	0.2	6.1	3.1	1.3	0.9	7.0	5.3	2.4	0.0	5.9	0.8	0.1	8.2	0.0	0.4	5.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	27.8	1.2	0.1	14.9	0.0	0.0	0.2	0.1	11.8	0.5	2.3	0.0	0.0	1.7	0.0	4.8	0.1	0.0	0.4	7.8	0.9	0.0	10.3	0.0	35.6	0.1	2.1	10.3	0.0	6.9	0.0	0.6	0.0	0.0	2.3	0.0	0.0	13.4	10.3	0.0	0.0	6.4	1.8	0.4	0.2	0.0	0.7	2.2	0.0	1.1	35.5	26.7	6.2	6.2	0.0	0.0	0.8	0.3	2.2	4.6	0.2	4.7	4.2	6.0	6.0	4.6	2.8	6.1	6.9	2.7	3.3	0.4	1.1	4.8	3.2	6.5	6.7	6.8	10.7	7.0	7.0	6.4	6.1	6.9	6.1	7.0	8.2	0.9	0.0	0.0	2.6	7.9	0.5	0.5	0.0	0.0	11.8	0.6	0.9	2.4	0.0	0.0	1.8	8.4	0.0	7.6	0.0	0.0	0.2	0.2	0.0	0.7	0.8	1.8	3.0	7.7	0.9	0.0	0.7	1.1	0.1	0.0	2.6	1.8	0.0	0.1	10.1	9.8	0.0	0.0	0.3	3.1	0.0	0.0	1.5	3.6	1.0	2.2	11.6	6.2	8.0	10.3	0.4	0.0	1.9	9.2	0.6	0.0	0.9	0.0	8.0	0.0	0.1	2.4	0.4	0.8	0.0	0.1	0.0	9.1	8.2	0.0	0.0
RAB3D	"D2-2, GOV, RAB16, RAD3D"	ENSG00000105514	"RAB3D, member RAS oncogene family"	O95716	19	11322068-11346270	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.5;skin 1: 53.1"	"Cell type enhanced"	"Detected in many"		"monocytes: 53.1;Squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 47.3;Karpas-707: 45.6;MCF7: 54.6;SK-BR-3: 68.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 73.1"	"CAB018067, HPA063283"	Approved		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB018067: AB_606903, HPA063283: AB_2684976"	"unprognostic (4.71e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (4.17e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.34e-1)"	5.5	3.4	11.5	5.1	9.9	17.6	12.2	8.5	13.0	15.0	6.3	8.1	8.1	7.3	6.1	34.1	8.7	3.9	3.6	16.1	13.0	5.8	1.8	8.7	2.4	20.7	10.8	4.2	68.5	4.4	4.7	7.2	23.4	17.1	8.6	1.7	30.1	8.1	2.5	53.1	6.1	8.8	12.2	8.8	19.5	1.4	15.2	4.7	6.2	4.2	9.1	7.0	15.2	14.1	1.5	14.2	4.4	17.7	7.1	12.3	0.9	1.3	3.8	2.5	2.5	5.1	0.5	0.6	16.0	8.6	4.7	19.1	7.5	11.9	2.2	7.8	1.1	5.8	6.7	5.8	4.4	3.1	13.2	5.3	47.3	2.1	5.1	6.5	20.5	4.3	2.1	45.6	0.8	54.6	2.2	6.9	3.7	28.7	14.4	2.1	0.0	16.1	22.0	14.2	4.9	9.5	4.3	68.8	9.3	6.0	41.1	35.1	7.9	2.4	0.8	11.4	0.2	15.5	21.3	3.2	8.4	19.0	2.6	123.5	84.1	95.6	3.2	51.4	5.6	2.2	3.2	2.6	35.5	2.2	2.2	2.7	169.1	1.6	41.3	0.9	5.7	26.3	11.5	9.9	8.5	13.0	16.1	13.0	20.7	10.8	23.4	12.2	15.2	14.1	10.0	6.4	17.2	4.6	4.0	15.7	4.5	13.7	12.5	0.7	23.6	14.1	4.3	10.0	19.1	14.7	0.0	8.0	4.4	5.7	11.7	4.8	0.5	5.4	6.6	9.7	18.6	5.9	9.2	25.6	6.6	5.4	23.0	14.0	12.7	4.1	17.9	1.5	9.4	0.0	5.4	29.3	4.1	40.0	2.4	0.2	4.4	16.0	8.8	5.6	53.1	5.3	2.1	1.0	1.3	12.7	5.8	4.9	8.5	11.7	1.4	3.6	1.8	0.4	6.6	3.3	8.5	0.1	2.5	47.8	37.8	10.4	3.9	3.8	15.4	5.9
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124978-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	133.5	118.1	91.7	113.7	99.2	203.5	119.4	97.4	107.9	90.9	77.1	106.9	135.7	103.1	67.3	92.3	87.3	88.6	69.7	89.0	101.9	145.9	99.7	120.1	94.6	98.5	98.1	82.4	76.4	102.6	48.7	106.8	98.5	70.6	86.3	40.5	84.5	84.3	46.7	91.5	124.1	97.6	96.7	116.4	118.0	41.7	104.3	87.1	109.7	54.6	79.2	115.1	83.0	100.6	169.5	311.3	96.2	140.1	210.7	144.8	184.7	201.6	212.5	273.9	238.1	223.5	163.5	81.5	172.9	254.4	194.8	231.8	179.1	197.9	175.7	104.9	232.6	124.8	120.6	326.1	206.4	165.8	195.6	187.3	204.7	208.1	144.6	143.1	292.6	110.2	145.8	123.6	189.7	154.7	170.3	148.6	95.2	294.7	0.9	110.0	165.2	139.4	209.0	246.1	53.6	136.2	103.7	651.5	220.6	149.5	288.7	159.9	276.6	279.8	155.0	237.9	218.5	113.0	157.1	104.1	185.1	127.6	290.4	56.9	119.7	129.5	45.7	103.4	40.6	42.8	44.5	46.2	83.4	43.6	36.5	37.2	194.5	56.8	110.0	55.1	56.0	99.2	91.7	99.2	97.4	107.9	89.0	101.9	98.5	98.1	98.5	96.7	104.3	100.6	185.1	6.4	9.7	23.5	83.7	111.3	89.6	139.6	62.0	51.0	86.8	80.0	5.4	77.2	66.3	106.7	12.5	189.6	95.3	198.8	252.4	207.0	63.7	43.5	51.3	146.6	78.6	64.6	12.0	173.8	210.6	81.8	78.0	51.1	44.4	59.1	165.2	63.9	443.6	38.7	12.6	115.2	142.4	204.1	213.8	100.4	108.7	171.2	158.3	24.4	207.5	105.7	133.9	18.6	21.2	247.2	189.9	155.7	64.3	105.0	243.3	408.8	33.7	43.1	131.5	57.5	137.3	28.9	60.8	74.8	130.8	274.9	83.0	65.0	99.9	145.1
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 420.5;Late spermatids: 1201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		5900000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	73.8	47.8	26.6	44.4	27.0	82.8	48.5	40.4	37.4	42.8	22.0	47.7	41.9	41.9	68.8	63.6	40.9	34.1	48.7	29.0	29.2	44.4	140.8	39.3	39.4	26.9	27.0	37.8	64.5	50.4	30.5	77.7	26.3	48.2	47.7	42.1	38.4	43.5	153.0	64.7	40.6	55.0	22.5	36.2	41.5	59.4	27.7	58.4	42.6	123.5	49.9	67.5	42.8	30.7	132.9	114.9	158.6	102.9	107.5	166.6	179.9	200.6	162.3	172.8	116.9	190.1	140.5	184.8	79.3	218.6	156.4	181.2	221.0	175.9	172.9	126.4	73.0	96.2	112.0	147.6	140.3	174.2	79.3	141.1	161.3	165.3	248.0	136.0	124.3	79.6	158.3	133.6	159.5	215.0	169.6	88.3	170.5	231.2	133.0	125.3	209.6	87.8	149.8	122.1	144.9	98.2	138.8	193.1	125.8	237.5	197.7	70.5	114.3	129.0	127.0	161.6	152.5	91.9	181.2	98.5	138.0	101.7	138.0	0.9	1.1	1.1	1.9	1.2	2.1	1.8	1.1	1.6	1.0	2.1	1.7	1.5	2.9	2.3	0.8	1.1	2.2	0.6	26.6	27.0	40.4	37.4	29.0	29.2	26.9	27.0	26.3	22.5	27.7	30.7	49.7	44.8	40.4	32.3	54.7	195.5	148.1	40.5	79.1	40.5	65.3	36.6	117.4	68.6	42.2	35.0	27.1	269.7	37.1	82.9	50.9	89.2	420.5	69.8	80.8	68.7	101.0	76.1	54.9	77.4	259.7	79.3	60.6	90.8	36.2	83.0	55.6	209.9	99.5	50.5	47.2	83.8	38.7	65.6	131.1	1201.4	75.5	70.7	74.7	38.4	83.7	40.4	39.1	50.3	54.1	81.0	50.5	87.3	89.3	146.0	51.2	95.9	47.6	43.9	78.9	71.6	88.5	45.3	74.7	126.9	240.9	291.8	50.5	91.1	74.9	141.2
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646349	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: AB_2681786"	"unprognostic (3.46e-3)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	6.3	8.0	5.8	2.8	6.9	5.9	6.6	7.6	8.6	6.9	4.0	8.7	2.5	8.1	10.3	7.6	7.3	3.5	7.1	6.8	4.9	6.1	6.2	5.0	2.5	5.0	4.4	9.2	9.2	8.8	8.1	3.6	5.7	6.2	4.6	8.5	7.1	4.2	11.3	10.4	8.0	3.8	3.4	5.4	8.6	5.5	5.4	4.0	6.0	4.7	3.5	7.9	6.9	8.6	9.1	22.8	2.1	12.1	13.3	20.0	9.8	6.3	11.2	11.0	12.8	20.4	14.8	20.6	3.7	10.3	19.7	8.8	17.6	14.2	16.5	11.7	13.4	9.5	13.3	12.5	10.8	10.2	7.6	10.8	24.1	13.4	36.7	7.2	5.4	6.5	17.9	3.2	10.1	8.6	7.7	13.9	11.7	9.0	6.8	7.2	3.7	10.1	8.8	16.9	11.5	14.9	11.7	4.7	2.8	5.6	11.5	7.0	9.5	4.7	5.5	14.5	8.3	5.7	7.7	24.2	8.4	12.5	6.7	7.0	3.3	1.1	4.1	3.8	5.6	7.0	5.4	5.4	3.6	5.8	4.9	4.5	0.3	9.3	4.8	2.5	4.0	2.7	5.8	6.9	7.6	8.6	6.8	4.9	5.0	4.4	5.7	3.4	5.4	8.6	3.5	38.5	27.1	65.6	34.6	26.0	37.3	33.7	31.9	56.8	6.6	4.8	130.0	44.3	31.6	7.3	89.6	69.6	22.9	31.0	1.9	6.3	26.4	8.2	15.8	16.6	37.1	38.5	65.9	6.0	49.2	37.6	37.2	7.6	30.4	8.5	22.1	38.5	37.4	37.0	79.7	44.1	18.3	27.2	12.2	12.6	60.6	16.5	16.0	49.6	22.4	38.0	48.4	65.9	92.4	4.8	35.6	53.4	33.0	32.1	53.7	4.4	40.8	60.8	32.9	50.9	39.9	108.4	87.2	39.2	26.7	33.1	25.2	11.5	52.3	25.1
RAD54B	RDH54	ENSG00000197275	"RAD54 homolog B"	Q9Y620	8	94371960-94475115	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 7.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.0;Cone photoreceptor cells: 27.1;Excitatory neurons: 45.8;Inhibitory neurons: 19.0;Oligodendrocyte precursor cells: 39.7;Oligodendrocytes: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.0;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA007087	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007087: AB_1856040"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.31e-2)"	"unprognostic (8.84e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.56e-8)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.04e-12)"	"unprognostic (5.86e-2)"	"unprognostic (5.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.68e-5)"	0.6	0.7	1.3	1.7	2.0	2.0	1.9	2.1	2.1	2.4	1.7	1.5	1.4	1.1	2.1	1.4	5.0	0.7	0.6	1.2	1.6	0.8	1.4	0.7	2.7	1.6	1.9	1.0	0.8	0.7	1.2	1.4	1.6	1.6	2.1	7.0	0.8	2.0	0.3	1.8	1.2	1.1	1.3	0.9	1.5	3.6	1.7	4.2	1.1	0.3	3.0	1.2	0.9	1.6	20.5	15.7	20.9	11.2	1.6	2.5	11.0	16.2	8.9	22.7	23.1	8.1	14.8	14.5	25.3	4.3	11.7	12.7	18.7	7.7	24.6	17.5	11.9	23.2	8.1	7.7	1.5	8.4	8.5	0.8	1.8	11.7	14.9	4.5	8.3	14.7	16.6	8.9	24.6	10.6	28.5	5.7	13.5	23.4	14.4	7.1	21.3	8.7	8.9	9.8	12.0	8.0	11.6	2.8	9.7	17.9	14.9	6.1	5.8	14.8	7.6	16.7	18.1	4.5	12.2	7.8	7.7	15.9	15.4	0.0	0.0	0.0	0.5	0.0	1.9	0.7	0.9	0.4	0.0	1.0	0.8	1.1	0.0	0.1	0.1	0.0	0.6	0.3	1.3	2.0	2.1	2.1	1.2	1.6	1.6	1.9	1.6	1.3	1.7	1.6	0.5	0.0	0.5	29.0	1.7	0.4	0.9	1.7	1.2	9.1	1.1	1.1	1.8	1.5	0.6	3.7	27.1	2.0	0.5	0.7	1.9	0.8	0.3	11.5	1.6	1.3	1.2	3.8	45.8	0.8	3.2	1.3	3.1	5.6	0.0	3.3	3.3	2.0	1.5	0.0	19.0	1.1	0.0	0.6	0.6	0.4	3.4	0.9	0.0	9.4	0.6	4.4	1.0	39.7	25.9	0.7	0.4	2.2	3.9	0.4	0.2	1.4	3.3	17.5	0.0	1.0	1.7	9.4	13.1	3.7	0.6	0.3	2.6	3.0	2.3	0.7
RAE1	"Gle2, Mnrp41"	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351223-57379211	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Spermatocytes: 256.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	14.0	13.9	18.6	13.5	19.1	50.5	17.0	18.5	19.1	15.5	17.6	14.2	11.9	16.6	18.2	20.5	17.4	9.0	13.3	18.3	19.9	14.1	16.5	10.0	20.8	16.3	15.9	16.3	10.8	19.1	13.3	14.6	17.0	12.4	16.2	20.1	12.8	15.0	15.0	22.9	13.6	16.3	17.2	17.0	12.8	103.0	21.4	29.2	12.1	15.8	26.5	14.5	16.0	19.6	43.5	52.6	52.8	29.3	30.1	29.0	46.1	33.9	47.2	172.2	70.3	166.1	33.8	69.2	46.8	52.8	63.8	56.6	101.6	88.3	142.1	20.8	45.2	47.0	46.0	74.9	59.0	57.1	41.3	41.3	74.0	75.8	83.1	29.1	49.9	47.2	84.8	32.5	53.0	114.8	88.3	53.2	32.9	86.3	93.3	47.6	49.4	46.0	37.3	45.5	55.2	47.6	58.4	129.4	61.0	41.2	71.5	54.0	29.7	70.6	63.0	41.7	57.7	34.9	83.9	81.8	48.3	36.1	35.6	21.2	42.0	77.0	27.0	36.8	32.9	31.2	26.0	26.8	32.3	28.1	33.9	30.7	36.2	24.7	37.9	23.8	24.6	40.4	18.6	19.1	18.5	19.1	18.3	19.9	16.3	15.9	17.0	17.2	21.4	19.6	17.5	19.2	16.7	8.5	21.0	17.2	16.3	42.0	15.9	15.9	12.6	19.3	10.4	11.5	24.1	18.4	14.6	52.8	20.8	11.6	27.4	30.3	113.6	16.5	16.7	17.9	6.6	18.7	10.2	14.3	39.3	18.6	12.2	15.3	38.0	25.6	11.0	13.5	38.3	3.3	9.5	15.2	18.3	59.5	14.5	63.9	21.8	33.5	10.6	14.0	40.0	19.9	27.8	5.5	13.1	22.2	24.3	22.6	15.9	14.0	10.1	20.6	24.1	17.9	19.7	11.6	19.9	256.9	83.1	19.2	21.0	70.5	24.2	34.9	20.1	16.2
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"lymphoid tissue: 395.0"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Hepatic stellate cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MOLT-4: 283.5;REH: 266.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043939			Supported	Nucleoplasm		NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.4	0.5	0.1	0.2	0.1	4.3	0.2	0.1	0.2	0.4	0.2	0.4	0.8	0.2	0.8	0.1	0.3	0.4	0.3	0.1	0.1	1.3	0.8	0.6	0.1	0.1	0.1	0.3	0.3	0.6	0.1	0.6	0.1	0.3	0.3	0.6	0.4	0.3	0.1	0.1	1.0	0.1	0.1	2.6	0.5	0.3	0.1	395.0	2.4	0.3	0.6	0.3	0.1	0.1	0.4	0.0	0.5	0.1	0.2	0.6	0.0	0.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.3	0.2	0.5	54.0	0.2	0.0	0.5	0.0	283.5	0.0	2.2	0.2	0.0	266.4	0.0	1.3	0.9	0.0	0.1	0.3	0.1	0.7	0.1	1.2	1.0	0.1	1.0	0.2	0.2	0.2	0.1	2.3	1.9	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.1	1.4	0.7	0.0	1.0	1.0	0.8	0.9	0.0	0.4	1.8	0.0	0.2	0.5	1.3	3.9	0.8	2.3	0.3	0.3	1.6	0.0	0.4	1.8	0.5	0.1	0.7	0.0	0.4	0.0	0.3	8.2	2.1	0.4	0.0	1.7	0.8	0.0	0.6	0.7	1.7	0.0	0.1	0.0	1.0	1.1	0.5	2.1	1.0	1.3	1.1	0.4	0.0	0.0	0.5	3.0	2.9	0.4	0.9	0.0	0.2	0.7	1.0	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.6
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681458-17811453	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	6.8	10.5	5.9	7.4	5.2	4.9	9.3	5.7	13.0	17.2	1.4	13.1	6.3	16.4	3.4	11.6	15.1	7.4	12.7	3.9	2.4	9.2	5.3	10.8	5.8	4.9	0.4	15.9	10.1	10.2	18.0	4.6	1.2	16.1	2.7	8.9	15.3	9.5	5.7	12.5	8.4	6.3	0.1	11.8	10.9	6.4	0.8	7.1	14.5	1.8	4.3	15.6	14.4	4.3	29.3	39.0	24.2	20.0	3.2	6.5	4.2	9.9	10.5	8.1	7.9	20.4	12.1	9.4	13.3	12.9	6.9	33.8	8.5	19.7	3.4	9.3	19.0	17.2	24.4	10.4	10.5	6.9	10.4	7.5	9.4	7.4	11.0	9.6	10.1	11.8	7.5	7.5	4.2	25.9	14.7	6.7	1.7	15.1	11.4	34.2	18.9	13.4	6.6	34.6	16.8	30.0	15.6	13.6	32.2	27.8	18.3	8.6	19.6	12.8	16.3	20.7	14.1	6.6	1.6	5.9	12.5	8.4	35.7	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.6	0.3	0.7	0.0	0.2	5.9	5.2	5.7	13.0	3.9	2.4	4.9	0.4	1.2	0.1	0.8	4.3	6.1	12.8	20.5	24.8	4.7	12.1	10.8	11.7	12.0	28.7	14.1	10.2	4.0	11.5	14.0	14.7	22.9	0.1	10.0	4.8	0.0	18.4	2.5	9.4	9.6	11.0	11.4	4.6	37.3	9.0	0.8	8.0	12.8	10.5	14.0	7.7	15.4	6.2	2.4	23.5	35.9	7.1	4.1	3.5	8.7	4.9	6.8	4.5	8.8	14.0	5.9	6.8	7.2	26.2	17.1	13.5	2.5	6.0	1.7	11.6	2.2	1.8	7.3	13.1	6.6	5.0	7.6	1.2	11.7	10.5	8.8	0.4	6.8	12.4	8.5	12.9
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic subunit beta"	Q86X10	20	38472816-38578859	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051454: AB_2681490"	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	9.6	10.6	7.6	12.1	9.5	12.3	16.1	13.4	10.8	12.1	14.3	11.9	12.1	12.0	12.7	13.9	10.9	10.7	10.5	9.6	9.4	14.4	8.5	11.1	12.2	8.7	8.0	11.6	11.7	24.2	10.5	14.3	8.5	14.4	13.3	18.7	10.8	12.7	12.1	13.7	11.9	12.9	7.6	11.1	12.4	20.8	9.7	17.6	18.1	14.4	14.9	15.3	9.3	9.8	25.3	23.4	23.8	17.5	22.5	25.9	25.3	20.3	23.6	24.8	24.3	42.3	18.6	23.7	18.9	23.7	36.5	29.2	22.6	30.8	34.8	13.6	9.6	36.2	21.0	24.3	21.3	29.6	18.4	18.5	39.1	29.3	32.0	19.7	32.9	20.0	26.8	22.9	24.2	16.5	34.1	12.5	17.5	24.9	30.1	19.4	34.0	15.9	16.5	46.7	25.1	27.6	44.9	59.8	37.4	27.2	34.8	15.0	39.2	49.9	19.9	28.6	20.8	26.6	34.9	21.1	36.1	14.2	22.5	1.2	0.9	2.4	1.2	0.7	1.6	1.3	1.7	1.5	1.4	1.0	1.5	1.2	1.7	2.0	1.3	0.9	0.8	0.6	7.6	9.5	13.4	10.8	9.6	9.4	8.7	8.0	8.5	7.6	9.7	9.8	23.1	22.4	17.1	47.7	18.6	13.9	7.4	12.4	17.1	24.4	19.5	12.3	20.0	10.0	17.7	31.3	27.1	10.4	23.4	26.9	3.9	9.4	11.8	24.3	20.2	17.4	12.6	14.9	63.3	9.3	7.8	15.7	30.5	28.8	16.5	19.4	23.2	12.1	9.7	20.2	66.0	16.1	16.2	17.7	11.6	8.7	16.8	14.7	10.6	49.6	15.1	10.0	16.5	58.3	81.0	15.2	20.4	18.8	16.7	16.1	26.9	9.0	20.9	18.3	13.1	16.8	13.5	31.8	24.0	19.7	18.0	15.2	19.4	15.9	15.8	14.2
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		9400	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	109.7	65.4	72.1	90.4	83.2	189.2	98.2	82.6	79.3	108.9	81.8	127.2	109.8	96.9	41.6	119.6	84.8	70.7	143.2	67.6	77.4	104.4	68.3	117.4	116.9	87.8	81.9	101.2	78.2	62.1	55.6	77.6	84.2	88.3	87.6	55.0	105.3	64.3	178.4	114.6	117.7	70.1	83.7	109.6	101.9	116.5	80.9	161.7	125.5	106.0	99.9	99.3	98.4	100.7	250.4	138.1	247.6	193.9	115.3	110.3	210.1	172.9	136.0	215.1	183.0	375.8	204.0	204.3	238.7	140.6	290.9	259.4	135.8	252.7	119.2	132.2	119.3	468.3	81.4	375.4	147.8	236.2	215.0	122.4	141.6	161.9	175.4	160.7	203.0	245.6	201.7	300.9	135.8	185.9	589.3	266.6	137.5	306.0	277.2	344.4	360.6	250.7	126.7	135.4	235.8	266.6	271.8	248.4	376.6	125.8	256.2	234.4	167.5	414.4	270.7	212.3	206.6	310.7	308.3	353.5	213.0	169.9	201.3	139.3	110.7	221.3	138.8	137.1	100.2	96.5	122.2	150.4	135.3	99.6	107.8	104.0	173.3	186.1	195.5	110.0	141.4	165.3	72.1	83.2	82.6	79.3	67.6	77.4	87.8	81.9	84.2	83.7	80.9	100.7	91.8	54.5	61.3	23.2	98.3	79.2	126.9	102.3	74.6	24.2	74.9	67.8	63.4	58.6	61.7	55.2	18.8	161.3	118.3	287.4	127.2	149.1	48.1	36.4	48.5	92.1	93.0	87.9	19.3	160.5	227.7	78.2	70.8	66.9	59.7	69.7	76.8	39.8	159.6	8.4	14.6	143.2	95.6	112.2	118.1	46.7	65.6	96.9	115.6	50.6	151.3	62.6	163.7	15.6	57.1	190.3	270.7	62.1	206.4	157.5	220.7	107.3	38.8	36.3	111.7	47.7	97.7	106.6	121.1	103.7	80.7	171.4	117.2	51.6	178.6	176.2
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 1066.8;Endothelial cells: 562.9;Hepatic stellate cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.4;EFO-21: 80.5;HUVEC TERT2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA052020: AB_2681697"	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	190.0	29.0	60.4	19.2	61.8	0.1	168.9	61.7	72.3	100.7	67.7	35.7	12.5	63.1	27.8	25.1	51.7	39.6	123.2	59.3	65.8	70.5	16.7	163.3	26.2	65.7	68.1	33.0	17.1	23.8	20.8	97.0	72.7	42.1	21.1	4.1	45.9	27.5	43.3	55.9	44.1	72.6	62.7	40.2	33.9	11.9	66.6	11.4	71.7	98.7	24.5	45.9	49.6	62.4	0.1	1.1	4.9	0.1	120.4	6.2	4.0	0.9	2.1	10.2	4.9	11.5	0.1	0.0	80.5	3.0	0.5	0.0	4.6	0.1	8.9	0.0	0.2	0.0	0.7	3.7	3.0	0.0	0.0	4.2	0.1	1.8	0.4	3.5	37.6	1.5	0.1	0.2	0.6	0.0	0.6	0.8	23.3	0.0	0.0	0.1	0.1	0.0	0.6	0.6	4.8	9.8	2.9	0.0	17.3	4.8	1.2	3.2	6.7	19.3	7.1	0.4	2.4	0.0	0.1	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	60.4	61.8	61.7	72.3	59.3	65.8	65.7	68.1	72.7	62.7	66.6	62.4	1066.8	0.0	5.7	1.6	6.2	34.4	5.4	0.9	9.6	0.6	24.0	24.8	2.2	0.0	1.0	3.7	0.0	1.1	3.7	0.1	3.9	0.6	1.6	22.2	52.8	562.9	4.2	0.0	0.2	0.7	1.7	126.9	3.1	38.5	0.0	1.4	344.8	1.3	3.4	0.0	1.0	0.2	20.3	8.4	40.5	3.6	38.8	4.1	23.2	45.0	2.6	15.5	0.0	1.5	0.3	0.0	0.0	21.8	5.2	4.8	0.0	1.0	0.1	1.8	6.6	10.5	26.3	26.6	59.1	2.6	27.6	1.5	4.0	14.0	0.1	4.3
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127355	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 754.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 2431.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol		NA	NA		1400000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA065868: AB_2685572, HPA065931: AB_2685580"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	65.5	68.0	37.6	63.3	38.6	117.5	60.7	40.2	47.9	67.1	28.8	63.9	52.9	66.7	21.4	94.7	61.2	30.0	47.5	39.7	40.5	64.8	86.7	53.5	94.7	41.1	39.1	61.0	54.0	35.9	50.3	46.2	41.4	49.8	42.9	35.3	51.8	34.3	54.9	61.8	60.6	36.2	40.8	71.1	55.5	117.8	39.6	104.0	46.5	34.8	72.6	61.9	64.7	43.7	434.6	218.5	479.7	263.2	79.1	93.8	403.7	388.7	169.3	494.6	356.4	401.5	150.8	669.8	169.7	157.8	224.9	394.2	449.4	340.4	269.6	290.1	1071.3	562.6	218.5	426.6	120.3	913.7	294.4	103.9	158.7	393.0	139.2	114.3	227.1	300.2	2431.9	261.1	226.8	339.2	665.5	622.0	547.2	553.8	380.8	667.4	674.7	172.6	171.6	233.9	478.6	354.7	356.6	196.4	236.6	210.3	137.1	378.9	176.4	341.5	668.1	258.7	438.3	260.9	383.6	1066.0	186.9	405.9	292.7	21.1	94.7	75.8	71.3	101.6	78.8	123.1	101.6	91.1	111.5	119.1	101.8	77.0	9.5	90.8	93.6	103.6	115.4	102.5	37.6	38.6	40.2	47.9	39.7	40.5	41.1	39.1	41.4	40.8	39.6	43.7	133.1	35.3	37.1	14.7	135.0	274.4	195.0	260.6	109.3	44.4	142.3	175.6	47.1	104.4	104.8	90.1	6.2	409.2	103.8	106.4	277.8	188.5	394.2	104.6	131.1	143.5	117.6	259.2	22.2	112.3	754.9	156.7	72.4	86.7	64.7	187.2	93.5	169.5	268.7	37.0	21.4	194.0	209.5	85.5	223.3	236.1	145.1	95.3	177.9	6.5	140.6	103.5	87.6	7.5	23.9	150.0	109.3	136.9	179.6	338.0	107.3	213.7	93.8	39.0	98.6	110.9	289.5	505.1	435.2	220.1	294.9	194.7	119.2	176.5	273.6	218.2
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RAP1B	"DKFZp586H0723, K-REV, RAL1B"	ENSG00000127314	"RAP1B, member of RAS oncogene family"	P61224	12	68610855-68671901	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.20e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.22e-1)"	156.1	107.5	48.2	166.5	53.4	277.9	118.2	55.8	64.2	89.8	62.5	126.4	84.2	120.2	69.7	86.3	78.7	129.7	67.9	49.5	60.0	107.3	141.1	134.9	211.8	58.3	53.5	69.3	78.8	74.1	52.0	133.0	59.7	85.1	111.5	57.6	70.0	135.9	49.5	73.5	121.0	146.4	52.4	153.3	104.4	89.6	55.6	162.5	89.1	57.3	181.1	198.1	83.8	66.2	199.9	133.1	153.2	131.2	317.6	253.1	140.2	414.9	252.1	269.5	203.5	178.9	130.2	280.0	232.8	580.5	124.2	113.4	146.5	202.9	379.8	496.2	125.7	725.2	156.7	120.9	370.8	282.0	407.1	254.8	203.3	289.5	346.0	218.6	298.7	232.1	261.2	445.6	272.0	127.9	265.4	361.7	173.9	86.8	191.3	235.8	181.9	211.1	204.9	488.3	59.6	93.3	209.1	124.8	206.1	174.7	160.3	327.2	330.4	243.0	108.9	275.6	229.9	227.1	452.4	342.3	224.7	191.8	212.3	399.1	215.4	205.7	340.1	407.0	221.2	154.1	206.1	297.6	196.2	140.3	222.2	303.4	149.8	469.5	464.3	99.0	186.2	820.8	48.2	53.4	55.8	64.2	49.5	60.0	58.3	53.5	59.7	52.4	55.6	66.2	210.9	80.1	79.9	41.1	166.2	294.4	72.4	150.9	70.6	14.0	73.3	61.0	14.7	37.1	108.9	80.9	22.9	35.5	373.9	176.1	109.5	157.9	99.6	78.5	154.3	132.4	189.5	104.7	45.0	130.8	75.2	123.4	52.0	119.6	147.8	60.5	85.3	32.7	78.5	33.7	46.8	93.5	95.6	111.3	437.6	44.6	38.8	273.1	188.5	105.9	257.3	28.6	362.5	45.8	67.8	186.0	215.6	36.5	228.4	61.4	72.3	182.2	104.0	23.3	6.6	40.3	204.8	46.3	50.2	78.9	297.8	154.5	256.9	123.2	92.2	92.4
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 228.6"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	37.3	24.0	41.4	53.9	72.6	53.2	26.8	27.0	37.1	20.4	37.9	31.9	23.9	25.6	8.0	23.6	25.5	23.7	57.8	40.8	40.2	23.0	23.0	43.3	56.1	35.8	36.9	16.3	47.8	20.1	16.4	56.4	32.3	21.5	23.4	27.5	20.2	21.4	228.6	21.9	35.3	30.4	25.6	41.9	29.1	15.9	43.8	35.1	22.7	104.8	63.1	25.8	18.2	20.2	34.5	39.4	39.1	39.6	39.1	42.0	149.2	29.0	59.0	33.0	23.6	49.0	22.1	61.9	35.6	58.8	70.7	61.4	45.1	40.5	16.4	144.6	18.6	18.3	67.2	26.2	32.8	76.1	80.4	32.2	73.0	43.3	51.0	33.1	60.4	70.8	49.7	119.1	43.4	35.7	54.0	27.0	39.6	34.1	35.2	53.0	91.0	86.8	14.9	41.1	33.0	32.9	42.5	39.8	42.3	39.0	38.1	63.1	64.4	88.1	36.7	56.4	44.7	39.8	37.3	122.0	41.9	32.0	21.6	3.1	1.2	1.6	3.4	2.2	2.0	4.9	2.3	2.3	1.4	2.9	0.5	1.5	1.3	1.3	2.4	1.6	1.8	1.6	41.4	72.6	27.0	37.1	40.8	40.2	35.8	36.9	32.3	25.6	43.8	20.2	73.5	6.4	13.8	27.1	35.6	18.7	9.3	10.9	5.2	19.5	10.8	13.5	16.2	14.3	12.3	5.5	14.6	22.7	49.7	23.3	5.9	8.2	2.6	13.0	9.4	43.0	12.1	1.7	47.5	18.6	35.3	11.8	17.9	17.8	20.3	14.0	22.5	17.4	26.4	131.2	66.6	14.9	8.2	23.9	108.6	2.5	8.7	51.6	32.0	123.7	59.8	19.7	27.8	61.3	24.7	17.1	19.1	12.0	88.0	11.7	16.8	9.2	16.7	13.4	6.6	13.4	10.3	5.1	11.8	5.6	11.4	51.7	31.0	5.8	14.0	10.8
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 221.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	47.6	21.1	3.2	28.3	4.4	59.6	37.2	7.2	16.5	43.7	5.1	31.0	28.4	32.2	10.7	14.9	40.7	41.3	40.8	7.0	5.7	24.1	42.3	58.4	16.4	5.3	2.7	40.8	14.7	11.3	30.6	25.7	2.8	29.8	13.2	18.3	20.6	21.3	62.6	24.8	32.2	28.6	1.8	41.7	22.9	28.8	4.9	10.0	26.9	17.4	11.8	30.3	30.2	4.3	18.0	41.9	11.8	20.5	23.4	35.9	12.5	14.9	21.8	21.5	13.6	28.6	15.1	9.6	22.7	33.2	18.9	51.1	14.2	33.9	12.0	77.5	21.4	26.6	21.2	29.8	37.0	9.4	81.3	48.2	10.0	22.7	29.2	75.8	30.9	8.4	17.6	20.2	23.7	221.5	6.4	34.2	10.7	16.2	13.3	12.9	71.3	37.0	12.2	14.4	5.4	40.5	31.0	124.8	42.1	11.7	119.1	36.6	35.8	25.3	45.3	44.2	15.4	48.7	16.9	8.3	38.4	18.7	77.1	26.3	8.9	34.6	3.2	14.6	5.1	2.0	3.6	3.8	12.4	1.7	1.5	2.8	52.6	5.9	19.5	3.8	3.1	5.0	3.2	4.4	7.2	16.5	7.0	5.7	5.3	2.7	2.8	1.8	4.9	4.3	35.6	3.2	7.0	2.3	43.4	19.5	25.6	8.4	18.8	23.2	35.4	17.5	3.8	10.0	5.5	7.3	6.2	2.2	36.9	41.2	13.7	16.7	60.5	20.7	22.0	28.4	9.6	5.7	5.4	19.2	5.8	28.5	10.7	18.4	35.5	13.9	26.0	28.8	12.3	3.3	2.6	13.1	6.1	45.4	65.5	66.2	41.7	56.9	28.4	2.8	26.1	11.8	6.2	4.0	0.3	22.0	33.1	23.0	21.0	13.4	70.9	17.7	4.9	10.2	32.9	42.1	26.7	3.6	7.6	7.1	18.9	5.2	31.7	6.5	16.5	19.3
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 141.6;skin 1: 121.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 101.0;MCF7: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	17.4	16.2	10.2	5.7	9.7	3.7	19.4	13.0	10.9	55.0	10.8	22.7	2.5	23.3	6.0	141.6	27.2	15.7	17.3	9.7	9.5	12.5	3.2	15.2	5.9	10.3	10.0	20.5	8.5	7.2	8.7	9.5	9.3	26.9	7.8	3.9	30.6	16.2	6.9	121.4	10.4	13.0	10.0	10.2	14.5	4.8	9.5	5.1	22.6	10.6	22.5	26.2	69.3	10.0	22.8	24.7	5.5	50.9	55.0	46.8	1.7	23.2	50.0	29.7	23.3	8.3	101.0	0.5	12.5	93.6	16.2	74.3	18.4	44.6	7.4	5.7	9.4	3.3	18.6	7.4	23.2	0.0	9.1	34.8	63.9	28.5	6.4	74.7	12.7	4.6	0.8	9.8	11.9	110.3	1.3	1.1	16.3	30.4	42.7	7.3	1.9	18.1	8.9	37.1	4.4	22.9	47.0	50.6	32.1	6.8	43.9	1.4	13.8	35.4	16.5	23.6	1.5	4.2	2.6	1.8	43.4	3.8	51.3	1.8	3.1	0.9	7.4	0.9	18.8	2.0	6.5	5.4	6.7	0.6	5.2	4.7	0.0	2.3	0.0	0.6	1.8	4.0	10.2	9.7	13.0	10.9	9.7	9.5	10.3	10.0	9.3	10.0	9.5	10.0	10.7	3.2	7.0	21.2	2.5	34.2	24.1	21.6	42.7	0.5	18.0	15.6	3.7	11.5	11.1	3.7	2.1	7.5	6.2	3.2	0.0	10.5	0.1	3.6	14.4	11.0	1.8	0.8	2.5	5.1	1.2	19.6	13.7	3.4	1.3	0.3	20.3	0.1	2.7	0.0	3.0	2.1	12.2	4.1	13.3	0.5	5.3	4.9	8.8	6.5	1.8	3.6	5.2	7.1	0.7	14.3	4.4	5.3	3.0	19.2	0.2	0.5	3.9	5.2	6.6	9.5	22.0	0.8	5.6	69.9	55.8	1.8	7.2	0.4	5.5	45.7
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341662	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 2400.4;liver: 1994.6;pancreas: 1482.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.4"	"Group enriched"	"Detected in many"	6	"AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	460000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	525.6	2400.4	61.0	87.4	62.1	0.4	295.6	56.2	70.2	522.4	321.7	386.8	53.2	359.2	55.9	78.7	408.5	116.5	212.7	62.0	63.3	271.9	1994.6	466.8	109.8	65.9	73.6	626.3	1482.0	627.1	104.1	59.0	63.3	262.5	78.3	33.9	56.2	114.7	18.3	60.4	185.9	103.0	64.8	149.5	180.0	26.9	64.5	9.8	85.0	34.6	63.1	265.3	380.7	66.7	0.0	0.1	132.9	0.3	0.0	0.0	2.1	11.9	25.2	4.2	17.2	1.2	8.2	1.1	15.0	2.9	1.3	0.5	0.0	0.0	0.0	2.4	0.5	0.6	23.6	213.8	172.9	2.2	0.4	36.4	0.0	0.0	0.0	2.8	0.0	0.4	0.4	0.4	4.2	0.9	2.1	2.4	411.9	1.2	0.0	0.1	17.1	0.4	2.8	1.1	0.6	1.2	2.3	0.1	0.4	1.9	0.6	0.0	0.0	0.4	1.8	0.8	0.6	1.4	0.9	1.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	61.0	62.1	56.2	70.2	62.0	63.3	65.9	73.6	63.3	64.8	64.5	66.7	47.1	67.3	32.0	9.4	7.0	35.1	80.7	16.8	15.9	7.0	26.2	39.0	75.0	381.8	45.0	82.8	2.1	10.1	1.9	172.6	103.7	19.8	3.7	39.9	128.7	27.1	97.4	32.0	0.4	659.2	4.3	469.6	8.2	16.4	12.0	207.5	84.6	2819.0	11.6	10.1	0.4	233.9	541.2	53.8	42.4	19.3	454.2	8.9	44.4	7.5	1.0	785.1	0.0	9.0	0.3	209.1	107.4	194.9	1.2	82.0	1.2	269.1	29.8	25.4	13.1	302.5	181.1	4.9	5.2	4.4	28.8	14.6	12.3	307.5	418.7	31.9
RARS1	"DALRD1, RARS"	ENSG00000113643	"Arginyl-tRNA synthetase 1"	P54136	5	168486451-168519301	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		74000	"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	27.5	25.6	12.7	31.5	12.3	12.8	36.3	19.6	15.6	22.9	9.4	37.6	54.8	26.7	33.5	38.2	25.8	23.4	29.5	12.8	11.2	33.2	43.5	22.0	31.0	9.0	10.7	23.0	34.4	32.7	16.6	36.5	9.8	27.9	43.0	17.2	32.9	23.5	31.1	41.8	48.7	32.8	5.4	21.8	32.8	23.2	12.1	23.5	30.2	34.6	40.6	41.1	25.2	21.4	100.2	115.6	82.5	94.2	113.4	128.9	143.9	143.4	122.3	145.7	168.7	198.4	105.6	104.3	114.2	137.2	149.3	93.9	111.0	192.7	188.5	110.1	76.5	71.2	103.1	126.5	96.8	169.2	72.6	99.7	100.8	159.0	76.0	89.3	118.5	56.4	107.7	51.9	158.1	92.4	70.7	68.7	138.1	86.7	77.8	30.3	122.0	99.7	129.7	110.8	79.6	97.7	109.1	124.7	152.7	101.1	113.4	69.9	118.7	104.7	96.3	81.9	169.4	51.8	100.3	105.7	114.3	118.0	101.9	5.2	21.5	8.2	17.4	27.3	20.2	15.5	17.2	18.8	32.1	9.5	21.2	22.6	5.8	26.6	26.7	14.7	19.3	18.2	12.7	12.3	19.6	15.6	12.8	11.2	9.0	10.7	9.8	5.4	12.1	21.4	10.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.0	0.0	0.0	104.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	96.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	84.3	1.4	0.0	0.0	0.0
RASA1	"CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA"	ENSG00000145715	"RAS p21 protein activator 1"	P20936	5	87267883-87391931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 96.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 196.7;Excitatory neurons: 192.1;Inhibitory neurons: 234.7;Oligodendrocyte precursor cells: 165.4;Oligodendrocytes: 220.1;Syncytiotrophoblasts: 487.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007789, HPA036393, HPA064556"	Enhanced					NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB007789: AB_598183, HPA036393: AB_2675097, HPA064556: AB_2685285"	"unprognostic (1.57e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-3)"	16.4	14.6	12.3	15.1	14.5	13.9	18.6	21.8	15.6	17.4	9.9	14.7	12.4	21.1	20.3	16.7	15.6	16.2	12.9	15.6	12.5	15.2	12.4	15.0	19.7	9.6	13.2	25.8	13.3	24.8	11.5	96.8	12.7	14.1	17.5	34.6	15.4	15.3	9.5	18.6	13.8	15.5	9.5	19.1	13.7	26.7	11.2	25.3	24.4	15.7	18.1	17.0	12.6	15.5	31.7	16.1	31.0	20.6	26.5	37.3	23.5	47.5	32.0	30.3	49.2	13.0	82.9	20.7	11.1	54.9	33.8	15.4	14.0	40.7	95.0	19.9	11.1	15.6	15.3	13.7	25.3	12.7	18.6	21.0	27.1	84.1	48.5	51.5	42.5	11.8	8.8	44.4	109.3	20.5	14.7	21.8	16.6	6.9	29.5	17.5	66.4	30.0	29.0	27.7	18.2	20.1	18.4	24.4	29.6	29.4	21.7	20.4	61.3	38.3	17.6	21.1	60.0	16.0	15.6	20.5	55.1	25.3	27.3	2.1	0.6	0.9	0.9	1.2	1.6	0.7	1.2	1.0	0.5	1.1	1.0	0.9	0.8	3.9	1.2	0.6	1.8	0.5	12.3	14.5	21.8	15.6	15.6	12.5	9.6	13.2	12.7	9.5	11.2	15.5	18.6	12.8	15.8	86.5	13.9	14.9	6.7	12.5	16.5	35.7	18.5	11.4	6.4	7.2	15.2	16.5	29.2	196.7	11.5	12.5	5.9	10.4	7.7	15.7	18.3	20.2	16.2	12.8	192.1	7.8	53.7	16.2	18.3	16.5	8.8	22.1	18.2	11.7	47.8	32.0	234.7	12.9	12.2	27.1	9.5	4.8	14.0	21.2	14.2	128.4	13.6	12.6	7.2	165.4	220.1	23.4	14.8	13.5	15.9	11.9	10.7	11.2	19.1	18.6	0.0	21.6	15.0	33.9	20.0	17.7	17.5	487.5	17.7	16.4	13.8	11.2
RASA3	"GAP1IP4BP, GAPIII"	ENSG00000185989	"RAS p21 protein activator 3"	Q14644	13	113977783-114132623	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.0;Horizontal cells: 60.6;NK-cells: 48.4;Plasma cells: 40.0;T-cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046759	Uncertain					NA	NA		1400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA046759: AB_10959887"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.99e-6)"	"unprognostic (8.98e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.08e-2)"	"unprognostic (4.11e-2)"	32.2	3.5	7.6	10.9	8.7	12.7	23.2	6.5	9.8	24.4	3.8	17.0	2.9	13.7	1.1	4.9	19.2	4.6	12.9	8.5	8.3	11.2	5.0	19.3	15.6	9.6	8.9	7.6	10.8	0.7	15.2	5.3	9.3	11.3	2.7	2.6	6.8	3.6	14.2	13.0	15.8	4.7	8.0	22.6	9.4	5.9	10.0	9.0	14.4	4.2	7.7	18.5	15.0	14.6	3.8	4.6	20.2	5.8	19.2	21.3	0.0	14.8	22.1	13.1	10.9	0.4	11.6	0.4	8.2	24.1	10.9	0.0	3.0	7.0	10.1	0.9	1.3	29.4	14.1	0.1	9.7	12.3	2.5	19.2	1.4	12.7	9.1	16.2	22.3	0.6	2.2	3.3	19.9	5.1	27.1	20.5	4.3	3.2	6.8	13.6	7.4	60.6	11.9	0.1	2.9	2.1	3.5	15.2	7.5	8.3	3.8	44.7	30.5	19.7	5.4	7.2	16.2	0.1	0.0	0.8	25.7	11.9	32.1	16.7	4.5	6.4	16.9	7.6	12.8	5.2	15.6	17.0	3.0	3.9	16.3	16.4	2.5	12.7	15.3	1.0	19.2	16.9	7.6	8.7	6.5	9.8	8.5	8.3	9.6	8.9	9.3	8.0	10.0	14.6	5.3	0.0	4.2	27.1	20.6	3.7	1.2	0.7	2.2	7.9	2.0	4.6	7.5	1.5	3.5	1.8	0.0	0.1	55.0	0.3	0.0	1.1	1.5	7.8	13.3	9.3	3.0	5.5	25.6	2.0	0.2	15.2	3.6	5.1	26.0	1.8	3.9	2.4	9.3	60.6	12.2	2.6	2.0	15.1	12.1	0.7	8.7	19.6	10.6	36.5	11.4	1.3	48.4	17.6	27.5	12.5	0.2	3.8	40.0	1.6	0.1	0.4	13.2	3.5	0.0	18.9	11.5	8.6	5.4	0.4	4.8	0.5	45.2	2.5	0.7	1.6
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616756	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 254.9;tongue: 88.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 73.9;Enteroendocrine cells: 71.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 48.9"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	38.9	17.5	22.9	10.8	18.8	6.0	31.2	22.7	23.0	37.4	3.6	29.8	10.9	37.7	4.7	10.8	28.4	6.3	14.5	22.5	22.8	29.2	2.6	22.1	13.8	21.5	25.9	25.2	12.3	12.8	24.2	13.0	17.3	23.4	4.0	13.3	12.9	18.0	254.9	17.3	21.6	7.5	17.2	16.8	16.1	5.4	22.7	4.8	17.3	88.6	7.1	26.0	29.0	16.3	1.1	1.5	14.1	2.6	1.8	5.8	0.6	16.3	7.6	4.3	4.9	6.1	3.1	9.9	11.9	24.0	0.3	12.7	0.6	0.1	1.7	1.7	2.4	3.2	4.1	1.0	2.1	2.0	4.4	6.4	1.4	1.4	0.4	18.7	2.7	6.5	5.9	17.0	1.4	4.0	8.6	7.1	1.0	6.6	7.3	17.5	2.9	16.5	0.4	5.0	12.7	25.3	2.3	2.3	1.9	7.5	1.1	5.7	3.0	48.9	22.3	4.9	4.1	28.9	18.5	7.7	4.3	4.5	5.9	0.4	7.9	0.2	1.3	8.6	3.0	3.2	2.4	1.8	10.9	2.9	2.5	1.5	1.8	1.4	1.1	9.2	3.3	3.8	22.9	18.8	22.7	23.0	22.5	22.8	21.5	25.9	17.3	17.2	22.7	16.3	26.8	12.8	10.9	15.0	8.3	3.8	4.5	1.3	0.6	73.9	2.0	3.0	1.1	2.8	5.2	3.7	16.7	0.2	7.2	5.9	13.7	1.1	0.4	3.3	13.0	24.9	71.8	5.7	5.6	0.7	0.2	5.0	3.1	2.9	1.3	13.6	3.3	1.4	6.0	28.6	6.6	11.8	0.0	11.6	22.8	0.3	8.4	13.3	1.8	4.7	14.2	9.4	6.2	5.5	1.4	1.7	2.8	7.9	4.0	2.9	19.9	8.4	6.2	11.7	13.1	21.3	10.0	3.4	3.3	1.3	3.4	0.4	6.4	5.6	2.9	4.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094104-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 505.8;Inhibitory neurons: 398.4;Microglial cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	Yes				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	10.3	3.6	1.7	2.8	3.2	0.6	8.0	0.0	7.4	7.3	0.1	4.2	2.7	6.1	3.6	17.0	5.5	7.5	13.6	4.3	0.8	5.8	3.0	9.4	1.8	0.0	1.0	3.6	4.6	4.6	5.9	9.4	0.0	5.0	4.4	28.9	6.6	4.4	4.6	7.0	3.4	6.6	0.0	3.2	3.7	8.9	5.1	1.8	5.3	10.0	2.9	5.0	10.5	2.4	30.9	8.9	12.1	4.2	8.6	11.6	17.3	13.2	13.6	11.7	8.5	14.8	15.6	0.0	23.0	13.2	19.7	25.2	10.2	23.0	10.7	0.0	5.0	0.0	9.8	7.1	10.0	4.7	0.5	35.1	5.2	13.4	54.1	13.7	10.3	0.0	1.0	0.0	16.5	3.2	0.0	4.2	10.1	6.4	1.8	0.1	5.2	0.0	7.2	3.6	8.8	4.4	10.9	9.5	9.0	10.8	10.4	5.5	18.9	15.1	15.7	17.2	21.0	6.5	0.1	0.1	13.3	2.4	11.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	3.2	0.0	7.4	4.3	0.8	0.0	1.0	0.0	0.0	5.1	2.4	99.8	76.9	12.9	47.3	1.0	15.9	10.0	15.7	8.0	50.7	17.8	11.7	37.4	17.2	18.2	16.5	152.2	15.0	1.0	9.0	5.9	21.8	17.4	33.6	43.0	66.2	34.1	0.0	505.8	12.5	16.4	18.4	17.9	27.6	7.6	19.0	35.3	6.7	16.8	84.1	398.4	15.7	6.1	4.5	21.6	7.3	19.6	16.5	3.6	271.7	8.5	24.7	0.0	154.3	101.3	33.6	5.2	23.0	2.9	32.6	4.9	6.6	34.7	175.5	65.7	22.7	56.9	40.5	34.5	17.8	24.2	41.9	2.3	8.3	12.6	38.2
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 147.3;lymphoid tissue: 140.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	23.8	10.1	16.1	52.9	35.5	147.3	16.8	9.6	22.4	20.1	7.1	37.5	6.6	28.3	4.6	9.1	29.2	8.7	51.7	13.4	13.4	15.8	10.1	29.5	106.0	12.4	16.3	9.1	4.1	1.0	5.5	10.9	11.9	23.2	5.3	1.3	4.6	18.6	12.2	6.1	86.4	15.0	9.5	140.5	17.5	11.9	20.7	34.6	10.6	10.2	62.0	26.7	15.5	9.8	0.1	0.1	3.0	0.1	0.0	0.3	8.7	1.3	0.2	1.2	0.8	1.5	0.2	62.8	2.7	0.2	0.8	0.7	5.4	0.9	0.3	0.3	1.7	103.4	0.0	0.4	0.3	192.8	35.9	0.0	0.0	0.5	0.0	0.0	0.1	25.9	4.1	1.1	0.0	1.4	45.4	347.1	2.5	0.4	0.0	105.0	0.2	4.4	0.0	0.0	0.5	2.3	0.1	0.1	0.0	2.2	0.6	108.5	0.6	0.0	2.0	1.5	0.1	0.5	0.1	58.9	0.0	58.2	0.0	64.4	34.1	59.9	70.4	88.0	37.3	170.7	72.9	57.2	34.5	100.2	92.7	83.1	70.9	55.3	105.8	85.9	93.8	67.5	16.1	35.5	9.6	22.4	13.4	13.4	12.4	16.3	11.9	9.5	20.7	9.8	27.4	3.2	1.8	2.6	125.5	2.3	0.1	0.0	0.0	2.6	1.6	3.7	53.1	2.8	0.0	0.0	0.0	1.7	86.1	0.1	0.0	0.0	6.6	1.9	27.1	13.5	0.0	24.2	6.0	0.0	1.3	6.6	2.6	1.2	3.8	5.7	31.4	1.7	6.1	0.0	12.2	0.1	0.0	77.3	19.7	19.5	18.0	72.2	0.0	6.5	55.8	0.7	98.9	2.5	0.9	0.0	0.0	47.8	28.6	0.1	0.4	0.9	0.7	2.5	131.5	5.4	56.8	18.0	43.9	0.9	1.3	11.8	61.0	0.8	0.3	0.2
RASSF7	"C11orf13, CFAP88, FAP88, HRAS1, HRC1"	ENSG00000099849	"Ras association domain family member 7"	Q02833	11	560404-564025	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 127.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 224.6;Intestinal goblet cells: 179.2;Paneth cells: 194.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.5;HaCaT: 86.4;SK-BR-3: 75.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078015			Supported	"Centriolar satellite"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite"		"HPA078015: AB_2686875"	"unprognostic (1.11e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.58e-3)"	15.6	5.0	7.1	8.5	9.4	6.5	13.8	10.1	10.4	23.4	6.8	50.5	33.6	6.3	15.8	49.2	50.9	10.8	4.9	7.3	7.1	127.5	92.8	44.6	10.7	9.3	6.5	6.6	67.5	6.4	27.4	5.0	9.9	42.6	8.5	1.6	42.5	11.5	1.6	53.5	43.5	1.0	6.4	17.7	63.5	13.2	7.1	8.7	23.3	0.6	5.6	18.6	23.7	6.3	51.7	49.9	2.3	12.8	0.0	0.0	35.2	7.7	5.9	8.0	5.9	52.6	85.5	6.6	34.6	4.2	14.0	86.4	7.3	26.5	1.2	8.9	25.6	4.6	28.0	25.9	5.3	10.8	7.4	0.1	25.5	2.7	2.4	11.0	4.8	13.4	11.7	2.5	0.7	51.7	12.2	23.1	7.1	58.2	28.1	19.2	3.7	14.8	39.2	24.8	10.9	8.4	5.4	75.7	6.6	4.0	34.0	6.9	6.6	1.6	23.5	3.1	15.0	8.6	9.9	5.3	12.8	15.1	6.9	5.2	6.0	23.0	17.7	5.2	16.1	13.6	18.3	15.9	10.5	14.8	14.8	13.2	7.3	8.3	5.7	18.7	21.9	8.9	7.1	9.4	10.1	10.4	7.3	7.1	9.3	6.5	9.9	6.4	7.1	6.3	6.5	86.6	70.0	3.3	19.1	25.4	23.4	118.1	14.2	2.7	39.2	30.6	4.7	92.9	90.4	86.5	0.0	38.9	20.9	224.6	52.8	90.7	17.2	28.8	3.9	8.5	51.0	14.5	5.5	90.5	111.7	5.9	124.4	35.2	15.2	15.5	7.9	73.3	19.9	11.8	2.6	179.2	46.8	11.2	15.7	23.0	2.5	11.5	5.4	1.0	28.7	7.9	21.6	1.5	0.6	148.1	194.4	0.4	12.3	61.8	110.0	44.7	73.4	3.2	0.0	0.3	6.7	4.6	9.7	21.2	25.7	40.5	29.7	4.3	113.1	60.3
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 606.9;Horizontal cells: 430.7;Late spermatids: 722.1;Microglial cells: 229.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2197: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Mitochondria, Cytosol"		"HPA038163: AB_2675874, HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	11.3	16.3	17.7	7.5	20.1	1.1	7.7	21.6	12.3	17.1	17.0	14.0	2.5	28.3	10.9	7.5	10.9	17.2	13.9	12.2	21.1	22.8	5.8	14.9	2.4	23.7	22.8	30.1	5.9	3.6	6.9	9.0	25.3	16.5	4.9	16.9	4.1	14.0	14.4	3.3	4.3	19.8	21.8	5.9	6.0	59.6	21.1	4.5	11.3	15.6	2.1	10.4	7.5	24.6	9.8	7.7	32.8	4.0	49.9	56.0	45.5	51.6	75.3	21.4	23.5	16.7	2.9	0.7	39.8	56.1	23.7	3.7	7.2	6.1	27.3	3.5	9.6	1.7	19.0	0.8	24.9	6.0	0.4	33.5	5.9	47.7	31.6	33.1	25.9	12.1	1.9	6.7	25.1	13.0	7.1	1.2	32.8	0.2	70.9	9.1	31.7	0.5	12.9	14.4	1.5	23.4	27.3	0.5	25.3	28.3	5.0	5.0	30.9	42.0	21.7	107.9	39.3	2.9	2.0	1.0	38.9	0.5	60.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.0	0.0	17.7	20.1	21.6	12.3	12.2	21.1	23.7	22.8	25.3	21.8	21.1	24.6	22.6	38.5	16.0	139.7	0.7	7.8	50.5	5.6	5.2	17.0	5.2	11.8	34.3	24.3	7.8	22.0	10.4	9.6	10.0	0.1	13.7	10.4	606.9	7.8	50.0	22.1	0.0	0.0	15.1	4.3	21.3	41.3	1.1	12.0	1.3	9.0	16.4	6.7	5.7	430.7	89.7	0.0	2.0	2.2	10.2	722.1	18.0	5.9	14.2	229.5	0.2	31.0	0.0	78.4	92.9	5.2	0.0	15.1	1.9	29.1	0.0	24.5	1.6	11.1	13.1	30.6	20.7	27.9	10.7	1.1	5.4	4.5	3.5	13.2	0.2	13.4
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBCK1	"C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4"	ENSG00000125826	"RANBP2-type and C3HC4-type zinc finger containing 1"	Q9BYM8	20	407498-432139	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 255.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.94e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.41e-9)"	"unprognostic (5.87e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.39e-3)"	41.3	68.6	20.4	28.8	23.3	25.7	38.6	26.6	32.3	48.5	16.9	50.2	34.6	47.0	13.9	55.0	44.7	19.4	41.3	20.2	20.8	52.5	108.9	47.7	28.1	27.9	22.1	53.5	55.3	30.1	64.1	22.8	23.9	56.0	17.7	12.2	41.9	26.3	38.6	43.0	56.8	19.2	20.3	66.2	50.3	34.8	22.0	43.7	46.7	18.2	18.0	45.6	46.8	27.6	64.0	88.4	21.9	37.2	44.3	54.7	44.9	34.2	55.0	56.2	73.4	53.7	74.1	29.2	51.3	70.7	103.5	62.7	29.4	151.0	19.0	21.7	29.8	30.2	23.9	140.9	185.3	28.4	21.5	83.1	255.7	43.0	173.2	68.2	50.8	109.8	29.6	55.0	40.7	33.2	61.5	69.9	18.4	77.4	73.0	40.3	21.8	37.3	72.7	57.5	41.3	35.9	24.1	122.4	140.7	25.0	73.3	64.2	31.0	54.5	27.0	33.2	46.5	44.4	61.6	35.6	24.5	61.4	39.0	56.5	48.8	85.4	61.9	71.3	43.5	48.1	48.0	63.1	43.6	46.8	38.7	45.2	135.6	52.4	83.9	72.1	55.7	52.7	20.4	23.3	26.6	32.3	20.2	20.8	27.9	22.1	23.9	20.3	22.0	27.6	69.4	32.1	39.8	40.8	54.4	44.5	77.1	96.2	49.5	15.3	65.4	66.7	19.9	64.3	48.2	57.0	16.7	88.7	72.6	111.4	62.6	111.7	58.9	40.4	45.3	59.3	61.7	43.8	15.8	116.2	102.4	52.3	50.0	54.3	43.8	62.9	57.1	139.3	66.8	16.8	17.8	122.8	46.8	69.8	44.2	163.3	65.9	57.2	42.7	23.4	69.1	45.1	106.1	22.1	24.3	108.5	161.0	47.8	30.5	98.8	185.2	74.5	39.0	29.0	46.0	56.9	51.9	32.6	29.3	69.0	40.2	94.7	71.0	110.6	74.2	120.3
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	4.7	4.0	3.3	7.0	4.0	44.7	4.2	10.9	4.1	3.2	4.5	4.3	5.3	3.4	3.4	3.2	3.8	4.2	4.6	4.5	2.5	3.2	7.2	4.2	11.3	3.1	3.0	5.9	4.3	3.7	1.6	5.0	3.3	3.6	3.8	4.9	4.6	2.6	7.0	2.9	4.8	3.6	2.7	7.2	5.4	8.6	3.4	8.6	4.6	6.6	9.6	4.5	2.2	5.6	11.8	12.7	11.2	11.6	7.0	7.2	17.6	6.2	8.1	9.5	12.4	15.7	10.6	22.4	9.7	7.0	7.8	16.4	17.6	15.5	13.9	23.4	16.3	18.1	21.0	11.4	9.6	19.9	18.4	6.6	10.5	13.2	12.3	5.0	10.2	16.6	26.1	38.0	9.6	12.1	18.0	15.4	24.0	10.4	7.1	21.1	17.0	15.3	7.8	11.8	13.4	6.8	13.5	16.7	13.1	11.9	11.6	23.5	7.2	9.1	16.2	9.9	11.4	28.8	15.9	48.0	13.6	19.7	11.4	6.3	3.9	5.6	3.7	3.4	5.3	6.1	4.2	3.3	2.8	5.1	3.5	4.3	5.4	3.1	3.9	2.7	4.5	3.3	3.3	4.0	10.9	4.1	4.5	2.5	3.1	3.0	3.3	2.7	3.4	5.6	9.1	6.4	3.7	21.5	18.3	33.1	9.3	7.3	6.2	5.7	10.8	5.0	12.3	5.7	4.8	3.7	14.6	8.7	12.8	9.1	0.0	4.1	9.6	15.9	14.5	8.4	9.6	10.7	30.0	3.5	7.9	8.1	10.2	18.8	28.6	10.6	11.0	18.5	6.5	0.0	26.2	8.4	0.0	6.8	11.4	6.7	4.1	7.7	8.8	39.4	6.1	3.9	7.2	29.1	31.2	4.3	3.9	5.3	15.5	9.6	8.8	4.5	10.6	7.3	0.0	11.2	12.4	30.6	13.9	9.4	33.8	4.7	14.3	6.5	9.9	8.6
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6089034-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	72.4	47.0	46.3	75.3	51.6	139.5	64.4	47.2	53.5	50.2	40.1	57.6	63.8	63.5	38.7	51.9	55.3	52.6	60.8	46.9	52.3	54.6	44.6	78.0	87.4	53.5	49.5	54.7	62.9	45.5	35.8	75.7	52.7	41.5	65.2	41.6	49.9	39.4	95.4	47.0	70.5	60.4	47.3	77.6	51.6	61.9	52.5	87.7	63.3	72.1	85.4	63.5	49.4	52.4	195.9	113.0	141.1	122.7	76.5	69.4	175.5	128.4	58.0	130.2	139.8	184.7	151.2	234.1	89.3	94.4	48.5	188.1	130.3	136.4	138.6	233.7	132.1	199.3	120.4	158.5	96.7	110.0	93.6	71.7	104.0	132.4	72.4	67.9	159.6	168.1	219.0	112.1	84.1	223.6	198.8	66.2	90.3	227.8	81.3	211.4	79.9	120.8	93.5	117.3	60.5	78.9	124.1	110.1	99.0	119.5	146.3	111.3	97.3	76.9	153.4	169.0	138.1	110.2	135.6	386.7	72.0	140.3	51.7	79.7	78.2	102.6	71.6	79.0	75.2	101.8	71.8	73.4	69.9	110.2	71.8	68.1	38.7	77.8	62.3	77.0	101.1	59.8	46.3	51.6	47.2	53.5	46.9	52.3	53.5	49.5	52.7	47.3	52.5	52.4	152.3	89.8	56.0	24.8	107.7	129.2	97.4	72.7	108.7	71.3	68.5	85.3	86.0	65.8	68.1	66.2	50.1	125.6	83.3	80.8	90.1	92.0	90.2	74.7	99.5	123.9	72.7	100.5	42.2	70.9	188.5	89.5	58.6	83.9	96.8	79.7	69.7	65.3	98.8	92.5	41.4	87.1	63.1	73.6	128.6	26.3	66.2	93.9	51.6	38.4	161.5	77.9	96.8	23.6	40.7	88.0	86.4	60.5	153.8	122.3	79.8	75.7	41.3	62.2	72.3	115.6	117.4	266.4	233.3	114.4	108.7	97.0	97.4	78.9	106.5	112.6
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966325	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	11.5	14.1	7.4	12.5	8.5	16.4	13.5	5.7	8.8	13.8	7.9	13.8	8.7	13.1	8.3	12.5	12.9	6.4	11.6	6.5	7.1	13.4	12.3	12.2	14.0	8.7	7.9	18.9	14.2	10.1	12.7	9.9	8.8	15.1	8.9	7.7	12.6	8.4	16.7	12.5	13.5	9.0	5.1	13.3	13.3	11.9	10.3	10.4	20.8	9.3	12.9	14.4	12.4	11.1	13.0	25.6	15.0	29.3	14.7	11.7	22.7	22.9	17.9	25.3	18.5	34.4	17.7	23.1	13.9	19.5	18.5	18.1	35.4	22.1	19.8	42.0	20.8	49.6	28.0	33.4	11.1	37.9	22.7	14.6	14.3	31.0	11.2	16.2	18.6	17.8	54.3	9.3	15.9	19.4	21.4	28.6	32.8	12.9	21.6	28.2	14.4	20.1	17.3	24.9	17.9	14.4	20.5	29.3	14.2	12.4	32.3	10.9	21.3	16.6	20.3	14.4	14.3	16.7	13.5	22.7	22.3	26.7	21.5	0.1	4.4	1.3	7.7	7.7	6.0	7.3	5.5	6.4	6.1	5.9	4.4	6.0	0.2	7.6	12.4	4.2	5.4	4.8	7.4	8.5	5.7	8.8	6.5	7.1	8.7	7.9	8.8	5.1	10.3	11.1	8.1	16.0	9.6	18.9	15.6	13.8	14.6	5.1	10.8	11.8	10.3	8.3	20.4	7.2	9.2	11.0	8.4	10.6	13.2	6.5	1.9	11.7	7.2	9.1	11.7	11.2	9.0	12.4	13.8	13.3	9.2	13.6	10.2	9.8	15.2	15.5	4.6	6.9	12.3	6.7	13.1	8.4	6.1	7.6	8.7	9.5	10.8	9.8	3.6	24.4	16.8	5.4	8.2	11.1	15.5	14.5	5.6	7.2	15.1	15.3	6.4	9.8	12.8	13.5	0.0	14.1	12.9	16.6	15.1	11.8	11.5	11.4	15.1	10.4	7.8	11.4
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058532-73123899	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	31.4	23.2	14.7	36.0	16.2	72.6	30.7	21.5	20.9	28.7	17.2	28.9	23.4	31.4	22.7	28.9	29.5	21.2	22.2	14.5	19.3	20.8	21.2	30.3	40.0	14.9	13.7	31.1	33.2	22.7	25.3	26.7	16.1	22.5	24.0	41.9	31.4	19.8	41.1	33.3	29.9	23.2	12.5	29.7	27.7	28.5	15.9	36.4	29.3	21.9	33.4	28.1	29.8	20.7	97.8	55.6	86.9	66.6	38.1	44.6	76.5	78.4	54.6	59.5	65.2	74.5	61.2	116.7	40.5	54.0	45.1	72.3	100.9	47.2	101.6	73.8	53.3	98.2	43.2	57.7	24.1	87.5	60.0	32.4	33.3	69.7	56.7	51.1	60.0	42.4	102.7	47.6	65.2	73.3	114.4	51.1	73.8	59.6	60.1	97.4	94.8	57.1	49.0	67.4	58.5	55.8	98.5	64.4	35.0	52.2	92.7	37.9	77.2	87.5	85.5	47.3	79.7	50.2	96.0	141.5	39.1	61.3	61.2	17.4	17.2	16.6	19.9	19.2	18.7	22.3	15.8	16.9	18.2	23.7	16.6	17.6	20.3	27.2	17.5	28.7	19.2	11.7	14.7	16.2	21.5	20.9	14.5	19.3	14.9	13.7	16.1	12.5	15.9	20.7	177.8	230.8	319.9	94.7	226.2	227.4	194.3	109.8	198.6	253.8	136.2	139.2	131.5	77.2	191.8	92.0	268.9	151.8	268.4	137.5	17.6	111.0	71.1	160.4	295.6	170.2	155.2	149.3	115.4	122.6	183.5	185.1	146.8	223.2	247.8	183.3	95.3	98.3	113.1	180.0	99.3	146.3	54.9	110.8	180.8	29.2	157.8	169.9	81.8	71.2	176.9	131.2	155.5	84.9	134.1	132.9	111.0	137.7	233.2	236.5	86.3	32.9	137.0	263.0	72.3	234.2	213.4	213.8	212.9	196.7	236.7	185.4	242.9	161.0	162.5	235.1
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 251.4;Oligodendrocytes: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	21.7	26.0	17.1	28.5	21.8	37.2	25.6	32.0	30.1	24.9	13.7	21.0	18.6	28.2	28.1	20.9	24.2	17.5	18.8	19.5	18.3	20.3	21.1	21.5	40.4	14.2	14.4	32.8	27.9	19.2	30.2	24.2	15.0	21.2	21.9	40.9	23.7	18.6	26.0	32.4	28.5	20.3	13.8	33.7	25.0	30.0	16.7	29.9	25.4	19.4	34.2	20.8	21.5	22.2	55.3	29.1	70.1	35.9	30.7	32.2	38.1	37.0	30.9	37.5	38.7	39.1	45.9	82.1	29.5	27.3	24.7	51.4	53.0	36.3	54.2	49.6	56.3	63.4	68.0	35.8	23.9	119.9	48.6	21.9	29.6	38.6	53.3	34.4	39.8	50.5	49.0	26.8	41.9	18.7	73.3	63.3	43.6	49.3	16.9	72.9	57.5	43.8	34.9	31.4	53.2	35.6	31.8	38.2	23.4	42.4	34.4	99.0	38.0	31.8	31.7	25.9	38.0	38.5	36.0	100.0	51.6	66.0	38.6	3.8	1.4	2.8	2.9	2.0	3.0	3.7	2.8	2.7	0.8	5.5	4.2	3.7	2.0	2.3	1.5	2.6	3.3	1.0	17.1	21.8	32.0	30.1	19.5	18.3	14.2	14.4	15.0	13.8	16.7	22.2	50.2	57.7	83.5	148.9	80.9	34.7	35.1	25.0	47.8	63.7	36.5	31.0	42.1	35.8	35.6	25.8	73.0	34.3	72.4	34.8	9.8	25.4	49.2	29.0	59.9	43.3	49.1	41.9	251.4	26.0	31.5	41.6	32.1	36.6	55.8	75.9	60.0	40.3	32.9	57.2	170.8	39.2	32.6	53.7	23.0	27.3	65.0	41.6	16.0	137.7	58.0	37.9	56.7	217.6	253.0	27.0	31.5	47.4	65.8	51.1	28.4	19.6	37.7	72.0	52.6	71.3	43.1	102.3	78.1	47.3	35.5	23.0	54.8	57.7	37.5	33.7
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"		NA	NA		19000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	70.1	55.8	18.4	37.7	17.6	172.0	44.6	33.5	28.0	57.8	22.2	56.0	35.1	54.5	9.2	62.3	61.4	40.8	57.3	16.5	25.0	52.2	47.7	62.2	42.3	24.2	24.0	71.1	41.2	27.3	50.0	40.9	19.4	50.2	16.9	49.5	53.4	22.3	70.3	51.2	46.9	19.2	16.0	56.4	49.7	34.3	16.9	51.1	54.2	33.1	24.1	50.7	62.1	26.5	98.8	87.6	77.0	78.5	48.8	53.8	78.8	131.0	50.6	59.6	60.2	109.3	78.5	137.5	90.6	38.9	67.9	91.2	122.3	67.9	66.5	94.6	96.7	174.6	80.7	101.2	23.4	158.6	99.9	14.4	97.6	68.9	38.4	63.7	57.8	46.4	195.5	117.6	46.3	72.2	194.5	87.9	103.2	87.5	96.8	104.9	136.2	91.7	41.5	56.2	77.9	63.4	91.1	94.7	78.4	109.3	70.6	94.6	91.4	100.8	92.5	90.5	115.8	71.6	164.3	204.0	64.7	123.2	79.2	250.9	120.4	197.5	104.7	111.1	103.6	131.1	91.5	97.6	111.8	140.5	85.7	82.1	427.7	127.2	102.2	160.9	114.7	95.7	18.4	17.6	33.5	28.0	16.5	25.0	24.2	24.0	19.4	16.0	16.9	26.5	302.0	233.9	280.9	144.3	441.7	616.4	521.0	283.0	284.0	258.5	339.1	295.4	189.2	191.6	267.6	200.5	316.9	375.2	624.9	278.1	189.8	203.8	48.1	359.2	496.0	299.7	295.3	214.2	130.1	186.0	389.6	337.9	254.9	540.8	525.8	304.4	215.3	202.1	199.8	220.4	120.9	331.3	215.7	207.7	469.5	41.9	262.5	335.5	270.3	129.3	274.3	208.7	400.6	136.2	160.5	221.3	254.8	214.4	391.0	453.6	271.8	150.6	248.0	386.5	164.3	504.0	410.2	263.5	228.1	215.8	586.9	561.6	490.8	218.2	282.8	532.1
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	4.8	6.5	12.5	5.5	12.9	4.1	8.5	12.4	18.4	5.6	12.7	8.3	5.9	6.3	9.2	6.1	7.3	4.7	6.4	12.6	12.9	6.5	8.1	5.4	8.1	12.9	12.5	5.7	7.9	8.8	6.4	3.3	12.8	5.8	9.3	9.8	6.2	5.2	4.8	8.2	6.7	5.7	12.6	7.8	6.5	6.6	12.6	8.9	7.0	3.2	9.9	5.6	5.1	13.3	9.5	10.1	15.7	6.5	13.6	15.7	9.8	12.8	14.5	12.9	14.2	10.7	7.7	15.8	8.4	15.3	12.9	8.4	13.1	16.7	15.7	12.7	11.2	12.2	6.3	16.1	14.3	14.9	11.6	12.7	13.7	13.2	11.0	12.5	13.7	8.7	11.5	12.6	16.2	15.1	15.5	10.0	11.1	14.2	12.8	12.4	11.1	15.7	19.0	21.8	9.7	10.1	9.0	8.8	11.8	17.7	12.9	13.9	11.7	9.1	8.6	10.7	12.7	11.7	14.4	20.3	8.9	11.9	12.8	3.8	5.3	1.9	6.2	8.6	7.1	12.5	6.5	6.8	7.2	8.6	5.9	7.3	1.0	11.3	10.2	7.7	10.9	5.3	12.5	12.9	12.4	18.4	12.6	12.9	12.9	12.5	12.8	12.6	12.6	13.3	5.2	3.2	4.2	8.5	6.3	2.5	3.5	11.3	5.2	7.1	4.3	3.6	4.2	8.6	6.6	1.8	10.4	5.6	8.1	5.0	7.9	7.3	3.8	4.8	5.4	5.9	6.0	8.6	10.2	6.6	10.3	5.7	7.7	3.5	8.2	8.2	3.3	5.1	8.2	10.1	13.1	7.6	4.1	8.1	3.3	4.3	4.4	5.3	1.8	6.5	8.1	7.6	6.2	15.1	13.7	5.2	6.5	5.7	8.0	1.7	6.1	7.0	9.6	9.1	6.6	6.1	6.1	11.4	5.6	6.2	3.4	1.8	6.2	9.1	4.9	2.7
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	65.2	75.5	51.4	43.7	50.5	45.8	58.3	56.9	96.4	108.2	53.0	81.5	43.4	70.0	34.5	51.7	81.7	27.6	74.3	51.0	54.8	74.3	78.1	64.7	59.8	53.6	51.0	96.2	89.7	36.7	72.8	30.3	50.0	98.2	39.5	64.3	50.3	36.0	44.0	54.3	78.0	42.2	48.1	103.5	69.3	66.1	53.1	48.6	74.9	25.7	50.1	67.2	68.5	51.7	28.6	18.0	73.0	48.1	70.8	38.4	25.9	47.8	41.0	40.8	42.7	31.0	31.4	147.2	27.0	47.0	41.1	23.6	61.2	40.9	51.3	57.3	23.2	68.6	46.1	41.3	40.0	71.3	69.4	36.0	50.5	45.7	50.9	76.4	52.2	37.0	57.0	36.0	39.3	26.9	66.8	106.0	57.9	34.7	32.0	26.1	31.0	38.0	40.4	57.0	28.8	51.6	43.7	31.0	30.9	62.9	25.3	55.7	48.8	41.2	48.0	33.3	48.6	49.7	123.7	84.9	23.7	58.6	40.6	16.4	8.5	5.2	13.3	4.6	11.2	12.3	9.3	8.2	8.8	11.5	9.3	10.2	5.6	7.2	8.8	9.6	7.0	6.1	51.4	50.5	56.9	96.4	51.0	54.8	53.6	51.0	50.0	48.1	53.1	51.7	76.0	57.7	75.2	172.4	87.4	54.0	43.0	34.2	67.7	120.1	43.5	33.8	35.7	40.0	45.9	62.5	102.2	38.2	91.9	46.4	11.7	33.4	31.9	51.2	69.5	57.2	47.3	51.9	195.6	28.0	33.0	53.9	64.7	46.3	43.0	93.0	45.7	36.0	27.8	92.5	216.8	44.5	36.7	56.1	82.2	25.2	65.6	50.1	60.5	161.1	66.1	43.4	62.8	154.3	177.9	34.3	32.4	60.5	106.9	51.2	60.9	17.7	49.1	145.7	46.0	55.6	63.7	135.3	56.7	46.7	45.3	36.3	66.4	66.3	39.5	35.2
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	19.4	7.1	12.5	5.7	11.5	3.6	17.4	9.3	13.1	14.7	15.1	12.9	4.7	13.7	9.3	8.2	13.7	9.5	15.6	9.2	10.0	14.7	3.4	37.3	3.2	14.5	11.7	12.6	7.0	8.6	6.1	23.5	13.4	11.2	8.8	6.0	10.1	8.7	8.4	8.3	9.0	12.1	9.8	10.5	8.5	4.3	15.2	3.5	18.3	10.8	3.9	10.3	13.9	11.7	28.8	24.3	10.5	14.9	23.7	22.7	9.3	34.8	37.0	26.9	23.9	18.7	50.2	0.2	42.1	36.6	11.1	20.4	7.8	57.8	30.1	8.3	6.7	3.7	19.0	4.8	15.4	3.8	6.5	20.9	13.9	28.1	33.5	31.4	51.1	6.1	1.8	6.5	47.0	3.7	4.1	4.9	6.2	0.0	7.5	2.4	11.5	0.3	34.1	6.4	0.8	6.9	39.6	14.9	5.1	22.2	16.0	6.3	78.2	16.7	35.8	9.5	8.4	6.1	2.5	1.7	6.1	0.9	23.6	0.6	4.7	1.6	0.8	1.3	0.9	0.3	0.3	1.2	2.7	0.5	0.9	0.6	1.6	1.0	0.3	0.6	0.5	0.8	12.5	11.5	9.3	13.1	9.2	10.0	14.5	11.7	13.4	9.8	15.2	11.7	74.4	41.7	20.5	34.6	1.5	3.7	9.7	6.8	11.4	4.2	11.4	9.4	7.9	12.8	14.2	12.9	10.4	19.8	7.0	19.7	1.9	23.6	12.6	16.4	16.9	47.9	5.4	3.2	7.2	16.9	38.5	16.9	6.1	21.8	8.2	10.4	52.1	1.0	10.5	8.4	10.0	5.9	4.1	22.7	5.5	24.2	17.4	11.2	0.0	53.4	6.2	5.4	4.1	30.7	9.6	37.8	11.5	24.8	0.8	13.4	1.6	13.4	6.8	1.7	26.3	11.2	15.5	0.9	1.8	5.4	2.0	23.7	2.5	8.7	7.0	17.3
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA057707: AB_2683508"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	81.0	57.0	35.7	80.8	39.3	172.5	119.7	40.5	39.7	108.8	36.9	82.9	77.8	142.0	85.9	64.5	116.5	68.2	72.2	33.9	36.2	77.7	66.5	71.8	117.8	40.7	36.4	242.9	86.8	76.6	48.9	80.4	40.8	83.9	101.6	82.0	68.5	82.1	126.2	69.6	75.5	118.2	38.8	89.1	71.8	34.8	35.1	210.8	92.5	103.9	145.6	89.1	77.9	51.9	235.0	250.2	448.6	201.0	109.6	184.3	261.2	227.7	246.3	308.4	324.6	268.8	228.3	422.9	229.2	163.9	193.3	152.9	481.9	238.3	353.6	184.2	226.8	324.6	240.9	289.9	95.9	358.0	285.6	152.5	113.1	240.6	333.6	236.3	252.7	392.0	296.6	210.3	254.4	297.9	526.3	240.5	285.7	248.1	207.0	430.9	300.2	262.0	229.6	275.2	260.8	281.7	181.9	162.4	213.8	263.6	186.8	237.7	161.7	173.5	188.0	121.7	294.8	149.2	214.9	444.3	123.9	256.7	242.6	131.6	158.5	90.6	142.1	192.8	199.7	194.5	184.8	170.4	175.6	187.4	231.9	192.5	25.3	173.9	178.9	106.4	203.9	302.6	35.7	39.3	40.5	39.7	33.9	36.2	40.7	36.4	40.8	38.8	35.1	51.9	112.1	112.2	139.0	55.2	223.0	151.9	209.0	151.6	128.1	112.4	229.8	208.0	100.5	153.0	167.3	88.3	95.9	187.2	200.3	80.1	154.6	157.2	10.9	83.5	147.4	130.5	202.9	195.7	33.2	148.8	269.4	156.6	75.4	84.3	268.8	212.7	204.5	119.3	117.0	92.5	41.2	170.9	81.4	223.2	112.2	10.5	171.8	109.0	96.0	27.2	176.9	99.4	157.6	57.3	56.5	108.0	99.1	133.2	124.0	108.2	140.0	120.3	123.3	137.9	92.1	159.7	161.6	33.8	81.2	94.6	122.3	111.5	195.5	135.0	216.4	157.4
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 11920.3"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	730.7	32.4	30.2	6.2	34.4	1.1	394.2	12.4	48.1	5.8	12.4	11.2	4.8	2.3	0.9	1.1	2.1	7.5	16.7	32.2	113.0	142.8	11920.3	24.5	0.6	21.5	19.3	4.1	82.4	0.1	519.9	12.4	21.3	8.6	6.7	3.0	13.7	4.6	6.2	16.4	19.2	0.8	14.9	5.5	11.9	4.7	46.2	1.5	7.9	5.3	0.1	19.0	8.8	18.0	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	34.4	12.4	48.1	32.2	113.0	21.5	19.3	21.3	14.9	46.2	18.0	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	37.8	46.8	82.3	33.4	85.6	63.4	45.1	88.4	105.1	38.5	79.7	36.6	26.3	34.3	59.2	53.5	31.4	22.3	72.7	82.9	86.5	49.4	38.9	37.5	44.5	88.2	84.1	26.9	24.7	38.3	34.5	40.9	87.3	32.8	32.8	45.3	33.1	26.9	83.2	43.3	33.1	32.7	89.7	39.8	37.5	24.8	84.1	59.3	35.8	100.5	51.6	36.4	37.7	93.6	111.1	62.2	114.4	57.9	79.9	94.9	64.3	86.6	80.0	128.2	112.9	101.4	52.5	96.7	57.3	86.3	50.8	62.3	110.6	100.2	135.1	113.9	174.7	60.4	84.0	126.1	68.2	148.3	74.8	79.1	79.1	93.0	66.6	73.3	110.5	57.8	72.2	95.6	115.1	136.7	90.2	170.1	63.7	216.3	64.8	116.8	80.0	122.5	149.3	71.0	54.1	34.9	76.5	76.3	82.7	63.8	65.8	99.5	74.8	77.9	81.1	66.4	84.5	80.0	78.9	146.5	98.0	74.7	88.6	151.8	128.1	108.7	79.9	133.9	76.0	114.7	99.2	85.7	129.7	102.4	85.5	93.8	42.3	89.2	154.6	211.1	137.6	250.2	82.3	85.6	88.4	105.1	82.9	86.5	88.2	84.1	87.3	89.7	84.1	93.6	224.9	230.8	144.8	23.5	173.6	300.9	207.2	567.7	129.1	90.4	189.6	237.9	515.4	171.6	300.0	224.3	25.0	507.3	238.6	181.8	508.7	346.8	41.1	227.4	170.6	222.1	162.1	638.3	29.9	333.6	637.9	211.2	107.6	180.4	129.8	140.0	167.4	254.8	431.3	89.2	29.7	205.1	349.9	236.7	334.2	79.4	185.8	270.7	341.5	15.0	532.3	264.5	228.6	18.6	49.6	377.7	229.8	177.1	180.8	269.5	300.5	586.5	314.3	163.7	118.3	160.0	256.3	220.2	242.9	237.5	370.7	675.9	175.3	185.7	207.1	248.8
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792944-4885917	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.1;Hepatocytes: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 145.5;HEL: 375.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	37.2	13.4	5.8	9.0	7.8	44.3	21.7	6.5	7.3	9.4	8.2	7.5	4.1	8.3	9.9	10.4	10.6	6.3	6.6	5.9	8.0	12.3	245.8	13.1	15.0	8.4	7.9	17.6	64.6	8.7	7.0	13.8	8.8	7.0	7.5	3.8	6.8	7.1	14.4	21.1	8.0	7.7	8.3	9.2	10.4	13.8	8.1	9.7	8.2	8.6	12.5	12.5	10.6	10.2	23.3	27.6	10.3	16.5	15.0	10.1	27.3	10.8	12.0	19.9	16.8	13.9	13.4	45.2	7.4	9.7	22.1	14.4	48.0	32.5	22.8	145.5	24.2	375.0	33.5	28.1	21.5	34.1	28.9	22.4	18.2	19.0	28.7	11.2	19.7	32.4	38.9	28.0	12.0	30.4	27.8	57.8	35.7	27.7	11.0	34.2	13.8	24.2	24.3	25.9	29.6	24.3	13.6	20.0	15.8	20.4	18.9	39.8	13.9	11.6	13.3	16.6	34.0	11.5	35.3	48.1	21.3	20.8	8.1	16.2	1.6	4.3	5.7	2.5	7.0	8.7	6.5	7.7	4.3	11.5	8.7	9.0	0.6	12.1	1.3	7.4	5.9	3.7	5.8	7.8	6.5	7.3	5.9	8.0	8.4	7.9	8.8	8.3	8.1	10.2	10.9	6.4	6.8	18.9	14.7	25.5	21.8	11.9	25.0	5.4	9.3	8.0	10.6	11.5	7.8	3.7	0.0	39.8	8.5	3.0	25.4	12.4	74.1	8.3	8.8	12.1	3.0	68.4	14.1	11.5	16.6	11.9	8.6	5.7	14.5	16.7	16.1	183.4	17.7	5.0	15.9	6.4	6.1	11.3	6.2	39.7	23.0	7.6	3.6	36.5	9.7	9.2	5.2	18.1	34.3	10.6	3.7	37.6	14.3	18.1	3.2	13.7	14.0	7.0	13.1	19.1	10.2	18.2	18.4	18.6	21.2	35.4	8.9	12.1	8.9	16.6
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49528003-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.7;Fibroblasts: 105.1;Leydig cells: 38.2;Peritubular cells: 44.8;Smooth muscle cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 2.5;NK-cells: 1.8;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 166.6;ASC diff: 283.3;ASC TERT1: 175.4;BJ: 353.8;BJ hTERT+ SV40 Large T+ RasG12V: 179.6;fHDF/TERT166: 304.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		1600000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA043134: AB_2678332, HPA050402: AB_2681114"	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	67.9	35.3	15.8	33.6	17.2	6.8	48.2	15.5	24.1	78.8	23.5	43.5	39.9	47.4	4.4	11.4	41.4	25.2	56.7	16.0	19.1	41.2	62.3	40.8	8.7	17.4	17.0	50.0	16.4	3.9	20.7	31.1	19.0	32.4	11.4	1.4	19.1	12.1	11.7	25.3	43.2	25.7	16.8	65.9	23.4	17.2	24.5	4.0	26.4	7.5	4.1	43.2	46.3	18.8	3.2	4.3	2.7	166.6	283.3	175.4	1.9	353.8	86.5	122.0	179.6	4.2	1.3	1.3	19.5	304.0	1.3	0.3	6.8	0.5	49.2	0.1	2.5	19.5	1.5	9.1	105.7	0.1	43.0	119.5	0.2	93.2	0.4	3.2	43.8	2.3	8.7	1.0	87.8	2.9	0.1	2.0	1.4	8.8	24.5	0.5	3.9	4.0	1.4	0.0	1.7	10.5	0.3	1.1	0.3	2.8	1.3	11.5	121.4	1.7	52.4	135.3	0.1	14.9	44.5	2.6	7.9	9.6	13.4	0.0	0.2	1.6	0.7	0.0	0.7	0.4	1.7	0.6	0.4	0.2	6.8	2.3	2.5	1.8	0.3	0.2	1.6	1.1	15.8	17.2	15.5	24.1	16.0	19.1	17.4	17.0	19.0	16.8	24.5	18.8	12.0	0.0	6.1	4.6	2.8	18.6	0.6	2.9	3.4	0.8	1.7	3.3	2.1	1.5	0.8	1.8	0.0	2.5	1.4	10.5	1.9	1.6	2.2	1.5	54.7	10.6	1.2	0.0	1.0	0.5	5.0	105.1	6.6	1.6	1.3	7.0	27.1	3.7	22.6	1.7	1.1	7.6	0.0	11.4	23.2	3.0	38.2	11.9	10.6	10.3	3.1	0.6	0.0	1.5	0.8	1.5	7.9	44.8	4.8	0.9	13.1	0.6	0.9	0.8	13.1	37.5	66.5	6.5	6.8	2.8	13.9	6.2	2.2	17.2	8.0	0.4
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905271	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	434	"retina: 463.8"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"WM-115: 1.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA015783, CAB022363"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	0.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	463.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	230.5	0.0	0.0	0.5	0.0	0.0	0.0	475.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	11.5	0.0	0.0	1.5	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	107.7	0.7	0.0	0.0	0.0	0.9	0.7	2.5	0.5	1.8	0.0	0.1	393.9	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1926.6	0.0	1.7	0.3	0.1	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12"	Q96NR8	14	67701886-67734451	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"retina: 222.7;skin 1: 63.8"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 453.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.1	4.1	1.3	0.1	1.0	0.1	2.2	1.0	1.4	11.0	0.4	0.0	0.3	0.0	8.7	22.1	0.5	17.6	0.0	0.9	1.2	13.6	3.8	0.1	0.0	1.2	2.3	0.0	3.2	0.0	0.9	0.1	1.2	0.5	0.0	222.7	1.7	0.1	0.1	63.8	0.1	0.0	0.6	0.0	12.4	0.1	4.6	0.4	1.2	0.0	1.6	0.0	23.6	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	1.0	1.4	0.9	1.2	1.2	2.3	1.2	0.6	4.6	1.1	0.0	0.0	0.0	0.7	0.0	4.7	0.3	0.0	0.6	39.8	0.1	0.1	0.0	20.0	0.3	1.8	146.0	0.0	0.0	0.1	0.0	0.7	0.2	1.8	1.1	2.2	0.0	0.0	1.2	1.7	0.0	0.4	14.3	1.7	0.0	0.0	0.0	5.7	0.2	20.2	0.9	0.0	0.0	0.6	0.9	0.0	0.3	0.2	1.8	1.0	0.0	53.0	0.0	1.5	0.2	1.5	2.6	0.0	0.0	0.3	0.1	12.5	0.2	453.2	0.0	0.0	0.2	0.0	0.1	4.7	38.6	0.0	0.1	0.1	0.1	0.3
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 68.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.6;Gastric mucus-secreting cells: 73.9;Late spermatids: 74.5;Respiratory ciliated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HHSteC: 8.7;MOLT-4: 11.7;SH-SY5Y: 47.4;SuSa: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	9.8	6.1	3.3	2.1	3.2	6.6	2.5	5.2	3.9	6.3	5.3	8.5	1.3	7.1	0.1	2.7	14.9	8.8	2.8	3.4	4.5	12.4	3.3	9.5	3.1	8.9	4.8	3.9	2.7	0.2	68.9	0.6	8.9	7.3	0.4	1.9	4.7	6.2	0.9	1.7	7.3	2.4	3.6	13.6	25.7	29.9	5.3	10.1	3.5	0.3	3.1	4.0	3.7	4.4	0.1	0.2	10.8	0.1	0.4	0.5	0.6	0.4	0.5	1.0	0.8	0.1	1.2	0.2	0.1	0.0	0.6	0.5	0.3	0.0	0.7	1.0	0.2	0.4	0.7	0.0	8.7	0.2	1.5	4.8	0.5	0.4	0.1	4.1	1.9	0.4	0.1	1.4	0.0	0.2	11.7	1.8	3.4	0.0	0.1	0.2	0.0	0.1	0.4	0.4	0.2	47.4	0.0	0.1	0.4	26.0	0.2	0.5	0.4	0.0	0.2	0.3	0.1	1.7	0.5	0.1	0.0	0.2	0.2	2.2	0.1	9.7	4.7	1.1	5.4	1.6	1.7	2.7	3.2	1.7	0.7	2.4	0.1	2.8	5.8	5.2	2.9	1.2	3.3	3.2	5.2	3.9	3.4	4.5	8.9	4.8	8.9	3.6	5.3	4.4	9.5	12.8	10.8	3.6	6.8	1.9	4.4	15.8	8.6	14.9	2.8	2.0	2.0	25.8	14.8	27.6	0.0	1.4	10.2	5.1	5.9	2.9	150.6	43.5	10.6	4.8	4.8	25.9	3.8	2.7	3.2	10.0	73.9	21.9	3.8	7.9	3.6	2.1	2.3	6.7	5.1	2.5	10.2	5.7	3.9	74.5	4.7	6.6	1.8	2.8	4.0	21.1	2.1	5.5	4.6	5.0	0.7	3.0	11.0	1.5	4.1	24.7	51.4	2.0	0.0	3.7	3.9	8.3	43.4	1.3	2.0	0.4	11.3	33.8	2.4	4.0
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468910-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA		25000	"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	28.9	17.1	5.8	33.9	7.4	18.7	18.6	6.9	7.1	19.1	7.5	14.9	11.4	22.3	13.7	19.8	14.9	20.6	26.9	5.7	7.1	14.9	15.7	22.9	40.9	8.9	7.3	14.8	9.9	10.8	5.3	22.2	8.5	15.9	18.2	9.9	10.1	17.8	12.5	18.5	13.5	30.4	7.7	31.6	14.5	10.5	8.0	34.3	16.6	19.7	38.4	26.1	10.3	9.1	61.6	61.1	46.5	34.7	94.3	116.1	52.3	119.9	101.6	76.2	88.7	68.5	49.9	73.6	43.5	83.7	94.0	44.3	51.2	60.4	108.5	122.1	31.9	89.8	65.6	30.0	35.9	62.3	66.1	64.8	30.1	109.0	79.1	67.6	87.2	50.6	33.0	36.1	102.3	31.2	70.0	73.6	77.1	18.3	41.6	56.8	184.7	57.2	29.6	42.5	12.8	35.7	86.9	23.6	62.0	159.0	58.3	37.4	115.6	105.9	67.4	93.9	111.6	14.3	46.3	161.3	88.9	35.9	80.2	21.4	18.6	18.0	31.2	32.3	31.5	30.3	29.3	30.9	24.0	26.6	19.1	26.7	8.7	36.9	31.0	17.8	44.8	24.0	5.8	7.4	6.9	7.1	5.7	7.1	8.9	7.3	8.5	7.7	8.0	9.1	56.1	22.4	18.8	6.2	45.0	23.6	15.4	23.3	22.2	11.8	14.7	14.7	8.7	10.0	22.1	14.7	14.6	13.0	59.0	5.8	9.8	20.3	1.4	15.9	41.0	45.7	9.7	30.3	15.1	24.8	27.5	45.6	7.7	17.6	52.6	23.1	30.7	15.9	27.9	15.2	9.4	6.5	12.2	35.3	26.1	2.2	22.1	50.8	30.2	12.2	50.6	16.9	64.9	10.1	19.1	31.8	4.2	37.6	33.5	7.3	4.3	12.4	25.1	10.8	13.1	33.1	34.9	7.6	12.7	20.8	42.9	3.6	53.6	31.8	8.0	10.5
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.8	12.0	8.4	12.8	10.3	10.9	9.5	8.1	11.5	11.0	8.2	10.8	22.4	10.4	10.0	20.6	11.4	12.2	7.3	8.1	8.0	18.4	16.4	8.1	18.2	9.9	9.2	13.0	10.9	16.3	20.7	10.2	9.0	12.3	9.6	8.9	14.9	8.7	7.5	21.7	22.9	7.1	7.5	16.1	23.4	19.1	10.9	12.7	20.6	6.4	14.4	10.3	13.4	15.1	19.1	34.6	14.0	19.3	19.1	13.7	31.5	14.1	12.0	18.2	16.1	15.1	19.7	22.8	14.8	12.5	23.7	17.8	14.4	17.2	16.6	12.2	26.7	40.4	46.7	22.0	20.0	13.7	19.5	19.7	20.7	17.9	23.9	21.0	23.4	25.9	21.7	19.4	13.3	16.8	27.5	18.1	8.8	18.6	26.4	21.8	32.3	22.7	15.3	22.0	16.3	16.1	14.9	26.2	19.6	19.3	47.2	10.5	12.1	22.0	25.2	12.5	14.8	27.6	16.8	22.6	18.4	13.0	16.3	6.0	3.3	4.5	3.9	4.1	2.4	3.3	2.5	2.9	3.9	4.3	3.7	2.7	1.9	4.0	2.0	15.7	2.2	3.6	8.4	10.3	8.1	11.5	8.1	8.0	9.9	9.2	9.0	7.5	10.9	15.1	4.9	0.0	11.3	9.1	8.3	1.0	3.3	4.4	3.4	8.3	4.9	5.8	7.3	7.2	6.1	27.6	18.8	8.6	16.2	12.5	5.9	6.1	4.6	13.1	8.1	5.6	4.8	13.0	6.9	3.3	5.2	4.5	42.8	23.9	1.3	11.9	5.7	7.2	5.1	10.1	5.8	9.6	10.2	6.0	0.8	2.2	4.1	9.0	3.6	4.7	3.6	5.1	5.2	8.0	13.3	6.7	9.7	2.6	9.2	3.2	15.0	4.9	14.2	12.9	0.0	4.5	3.8	13.2	11.6	5.4	2.0	11.6	4.0	10.2	6.7	10.0
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123409	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"pancreas: 103906.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 115721.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 1268.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.3;EFO-21: 18.3;HDLM-2: 15.2;NB-4: 11.0;OE19: 10.7;RPMI-8226: 32.5;SH-SY5Y: 12.5;U-2 OS: 31.1;U-251 MG: 10.8;U-266/84: 13.3"									"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	NA	NA		68000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			26.8	5.8	0.0	198.7	0.0	20.7	9.9	0.0	0.0	10.9	0.0	96.5	7597.3	5.3	0.0	9.3	6.4	96.6	10.2	0.0	0.0	93.0	15.9	4.5	7.5	0.0	0.0	25.6	103906.5	0.0	8.5	3.4	0.0	6.1	283.0	0.0	9.4	0.1	4.3	28.1	5638.4	178.1	0.0	8.5	945.9	3.9	0.0	0.0	4.0	0.0	0.4	3.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.5	10.7	0.0	0.0	0.0	32.5	0.0	0.0	1.4	12.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	31.1	2.0	10.8	0.0	13.3	5.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	25.5	1.9	1549.8	0.1	0.1	0.0	12.7	5.3	0.0	0.0	115721.8	0.0	0.9	692.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1813.1	0.0	0.0	0.0	0.1	0.0	17.0	0.0	0.0	507.5	0.0	0.0	0.0	0.0	22774.8	732.4	0.0	0.2	0.0	5100.1	20.8	0.0	0.0	0.0	0.0	51.7	0.0	0.4	0.0	0.0	0.0	0.6	0.0	5419.7	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"intestine: 6743.6;pancreas: 12212.2"	"Group enriched"	"Detected in some"	11	"Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		23000000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				18.5	10.0	0.0	13.3	0.0	0.2	0.6	0.0	0.0	0.3	0.0	19.2	5180.0	2.9	0.0	1.4	0.2	24.9	1.0	0.0	0.0	2.6	2.0	0.5	4.9	0.0	0.0	0.9	12212.2	0.0	2.1	0.1	0.0	0.5	0.0	0.0	2.1	0.0	0.6	0.4	6743.6	0.2	0.0	1.3	156.5	0.9	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.4	0.0	0.0	0.0	24.6	0.0	0.0	1.8	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	5.4	11.0	0.0	15.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	152.8	7.7	0.0	0.0	3.0	0.0	0.0	0.0	1988.6	0.0	0.0	189.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	55.8	0.0	0.0	0.0	0.0	5382.1	32.5	0.0	0.2	0.0	215.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	315.9	0.0
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001449-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 108.5;monocytes: 112.5;Plasma cells: 108.8;Prostatic glandular cells: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 61.9;HDLM-2: 79.5;U-698: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	17.2	13.1	3.5	18.7	2.9	40.1	12.6	2.9	4.4	9.1	3.1	13.3	10.8	14.1	0.8	8.7	9.2	7.4	12.7	3.1	3.4	21.3	13.0	23.0	19.2	4.9	3.5	6.4	16.5	2.1	4.0	4.8	4.1	15.3	3.9	0.2	12.1	5.2	14.0	16.5	17.7	4.9	3.6	29.1	12.0	4.3	4.6	9.2	10.0	1.4	15.6	13.8	8.1	4.1	22.2	13.0	1.3	5.7	2.8	9.1	4.5	3.9	27.5	5.9	9.6	4.5	23.6	61.9	11.0	6.4	20.8	9.8	0.5	9.0	5.1	79.5	2.0	2.2	0.8	2.5	23.8	4.9	35.3	15.0	3.7	12.3	14.4	5.4	3.9	1.7	0.5	39.2	2.1	5.3	1.1	14.9	2.0	6.3	2.4	4.8	3.2	7.7	10.0	33.7	0.1	2.0	4.1	11.4	11.6	1.4	4.0	11.8	12.6	14.4	7.1	5.3	14.4	49.0	31.2	67.0	15.6	1.7	8.1	0.0	5.1	2.5	1.4	3.4	2.0	9.2	2.2	1.9	3.8	8.0	1.7	0.8	15.2	2.1	2.8	4.1	1.1	2.0	3.5	2.9	2.9	4.4	3.1	3.4	4.9	3.5	4.1	3.6	4.6	4.1	16.4	6.4	12.4	2.3	64.4	37.9	108.5	20.3	40.9	0.0	17.6	11.3	1.8	24.3	15.7	3.7	0.0	4.2	35.0	53.0	9.8	33.1	5.2	15.1	15.2	30.8	22.8	22.5	3.0	31.5	7.3	35.4	65.2	29.1	50.9	3.8	5.0	3.5	18.4	3.3	1.7	33.3	8.2	15.1	74.9	3.4	4.7	44.7	24.9	3.7	112.5	0.8	7.2	1.5	2.5	37.4	90.3	2.6	108.8	145.3	48.0	19.4	7.4	0.3	6.6	28.9	27.3	1.1	1.7	27.7	31.8	9.9	53.8	4.1	16.8	89.7
RELCH	"FLJ33841, HsT3308, HsT885, KIAA1468"	ENSG00000134444	"RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing"	Q9P260	18	62187255-62310249	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.0;Cardiomyocytes: 9.4;Cytotrophoblasts: 6.5;dendritic cells: 8.2;Extravillous trophoblasts: 4.4;Hofbauer cells: 7.2;Plasma cells: 5.2;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	8.3	8.8	8.7	9.6	10.8	14.2	11.9	11.1	10.0	11.8	7.2	11.5	9.5	8.5	11.8	25.4	7.7	7.9	7.5	9.7	9.3	9.6	7.9	8.0	11.8	7.9	7.6	8.2	8.3	10.3	11.0	8.1	8.2	12.1	14.4	16.3	12.5	8.8	6.8	20.6	10.8	6.2	7.6	11.2	12.7	5.3	8.8	10.8	9.5	5.9	13.2	10.0	16.2	9.4	9.7	8.7	10.4	10.0	10.8	12.7	11.1	17.0	14.1	15.0	16.5	4.5	8.8	6.6	8.6	15.1	9.8	19.7	14.9	10.2	18.3	6.0	9.3	5.6	9.7	10.4	9.6	10.8	7.4	9.4	12.3	12.8	7.8	12.3	10.3	6.2	4.2	6.5	15.9	5.7	6.7	9.3	6.0	6.5	7.3	8.2	13.0	7.9	17.1	19.1	14.7	7.8	10.2	14.9	8.9	13.4	7.7	11.6	12.9	15.9	5.0	6.9	8.6	19.0	3.7	6.4	11.2	11.4	13.0	1.4	1.0	1.2	1.1	0.8	0.8	0.8	1.0	1.0	1.0	0.9	1.1	1.3	1.7	1.1	0.7	0.7	1.3	0.6	8.7	10.8	11.1	10.0	9.7	9.3	7.9	7.6	8.2	7.6	8.8	9.4	7.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.6	1.1	0.0	0.0	0.0
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471381-103989658	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 64.4"	"Group enriched"	"Detected in some"	8	"Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	10	"cerebellum: 64.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 110.0"	HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA		30000000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	1.3	1.8	2.0	0.6	1.8	0.0	2.7	64.4	3.8	1.5	0.6	0.8	0.2	0.4	0.1	0.8	2.8	0.7	1.7	3.3	6.4	0.4	13.4	0.5	0.4	2.6	4.2	0.4	0.1	0.0	0.5	0.0	6.3	0.6	0.9	2.9	0.8	0.9	0.2	0.6	0.9	0.7	3.9	0.3	0.5	0.7	0.5	0.0	1.7	1.1	0.2	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.3	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.0	11.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	64.4	3.8	3.3	6.4	2.6	4.2	6.3	3.9	0.5	0.5	1.0	0.0	0.0	9.1	0.5	0.6	0.0	0.0	0.6	30.2	0.5	0.4	5.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	13.6	0.1	0.0	8.3	0.0	7.0	2.6	1.2	0.1	7.5	0.0	0.1	0.0	0.0	128.5	3.3	0.2	0.0	372.4	0.0	0.0	5.3	2.2	6.1	0.0	0.1	0.0	2.8	0.0	0.2	0.0	3.0	10.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.8	0.7	0.1	0.8	0.0	0.6	0.3	0.4	0.0	0.0	0.0
REST	"DFNA27, NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966808	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB068222: AB_2665651, HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	6.9	5.5	5.7	9.4	6.5	24.8	9.8	6.3	7.5	8.8	9.4	6.9	6.4	9.3	8.9	8.2	7.8	7.9	7.6	5.0	5.2	10.9	11.5	8.0	13.4	8.0	6.6	11.2	7.7	13.8	0.5	9.9	7.8	10.0	7.0	7.5	7.8	8.1	5.2	8.9	6.3	8.0	6.6	10.7	8.2	12.3	6.8	18.1	10.9	6.5	13.6	8.7	2.1	7.4	10.8	13.0	17.4	18.2	13.2	16.0	22.7	15.6	13.8	16.0	14.7	11.5	16.5	24.5	23.5	16.8	10.7	9.8	13.2	16.3	24.4	12.6	8.1	22.0	9.4	12.5	16.2	29.0	13.5	16.5	14.6	15.1	16.0	20.5	20.1	19.0	14.3	26.3	19.0	17.3	31.5	21.3	15.2	12.3	8.9	30.0	14.5	8.1	19.0	18.3	0.3	8.1	17.8	18.8	14.6	24.8	19.3	20.3	28.7	20.4	18.1	12.4	14.2	10.8	7.8	15.1	13.2	16.7	10.8	7.4	2.5	7.2	6.2	3.9	6.2	11.6	6.9	5.9	5.2	21.1	10.8	4.4	2.8	6.1	7.9	6.0	9.4	2.5	5.7	6.5	6.3	7.5	5.0	5.2	8.0	6.6	7.8	6.6	6.8	7.4	38.1	70.5	60.2	18.6	51.1	57.1	51.9	33.3	99.6	1.6	42.6	35.2	50.2	42.9	43.3	29.5	81.3	58.0	65.2	21.4	23.5	58.4	9.7	67.3	64.3	50.5	3.6	54.7	0.1	38.2	57.1	40.8	23.9	63.4	51.4	56.3	47.2	31.0	32.2	0.0	0.2	23.5	44.7	36.2	37.9	11.9	39.4	44.0	21.4	12.2	78.0	45.1	71.1	11.1	21.1	45.8	29.0	36.9	44.3	44.3	22.1	24.4	43.3	36.1	32.9	56.5	56.0	58.3	53.8	55.0	45.7	66.4	66.6	62.3	26.1	48.7
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669049-7670455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 247.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2"	"Group enriched"	"Detected in many"	4	"lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 118.7;monocytes: 170.4"	"Group enriched"	"Detected in some"	11	"NB-4: 524.3;U-937: 243.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	1200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	3.4	1.0	0.1	5.2	0.1	247.2	1.4	0.0	0.9	0.6	0.0	0.8	6.1	0.7	0.0	0.5	2.4	0.3	2.3	0.4	0.1	1.7	3.3	34.0	0.1	0.1	0.1	0.4	0.9	0.1	0.5	1.1	0.1	1.0	0.2	0.0	1.1	0.0	0.6	0.7	0.7	4.3	0.0	53.3	1.0	0.2	0.0	4.0	0.8	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.9	524.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	243.2	0.0	0.1	170.4	0.1	0.4	91.7	1.2	0.0	1.9	1.5	118.7	0.1	4.4	9.0	13.6	0.3	47.4	4.5	0.0	64.3	0.1	0.1	0.0	0.9	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	12.8	9.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	1.1	0.6	0.0	0.0	3.8	0.0	0.4	0.1	118.2	0.0	0.0	0.0	0.0	47.0	8.7	0.2	0.0	90.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	2.2	0.0	0.0	0.1
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	6.1	3.6	11.2	6.4	9.2	7.2	3.1	28.8	11.9	16.6	11.3	4.8	4.3	10.3	2.3	4.6	6.2	4.9	4.4	7.2	10.0	4.1	3.5	4.4	5.6	3.6	7.9	7.6	4.2	3.2	0.9	6.8	4.4	4.8	3.5	26.2	3.2	5.0	5.0	4.7	3.6	8.0	1.8	4.6	4.5	7.5	8.4	6.0	6.6	12.2	2.5	4.8	1.0	10.7	9.2	6.3	11.4	13.3	35.2	35.0	11.9	13.6	16.7	6.4	9.6	8.1	5.0	17.0	9.3	15.9	12.0	9.4	17.6	5.7	10.7	13.9	10.0	13.9	13.9	13.3	9.1	13.5	6.9	21.0	3.2	12.0	15.4	10.3	10.2	10.0	18.3	13.9	10.8	7.2	16.7	3.6	3.2	3.8	10.2	11.6	12.7	6.6	2.5	7.9	15.7	11.8	17.5	3.2	12.4	8.5	7.1	14.2	13.7	9.6	9.6	47.0	15.4	14.0	17.1	17.6	9.1	10.5	12.4	0.6	0.6	1.2	1.0	0.5	1.6	1.0	0.8	1.0	0.6	1.6	0.5	1.0	1.9	0.4	0.9	0.9	0.7	0.3	11.2	9.2	28.8	11.9	7.2	10.0	3.6	7.9	4.4	1.8	8.4	10.7	133.4	48.1	82.4	290.6	65.7	30.5	19.5	12.8	45.5	117.5	20.2	17.9	34.5	11.5	29.1	20.2	56.3	27.2	35.3	11.8	3.9	17.3	40.0	151.1	610.1	57.4	59.8	27.5	161.7	11.5	11.9	82.7	41.3	107.5	46.9	61.5	21.8	16.0	11.8	35.3	360.2	18.6	10.2	19.9	87.4	16.3	50.4	57.2	21.4	105.9	23.7	59.6	33.0	594.7	190.3	8.5	12.3	39.1	41.3	21.3	18.4	15.9	43.5	57.6	39.5	122.3	62.3	68.5	70.4	26.1	26.9	33.0	46.4	30.3	21.5	8.2
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.0	6.0	7.3	19.3	7.6	41.5	13.8	8.9	11.9	8.8	7.4	15.4	10.9	14.1	6.6	11.8	10.8	7.7	9.1	7.5	7.5	7.3	10.7	7.2	31.5	7.3	7.4	15.0	11.0	8.0	5.7	14.5	7.6	7.7	20.4	11.2	8.6	7.0	8.3	11.7	11.7	17.6	7.5	14.3	10.4	22.7	8.1	35.7	7.3	6.7	34.5	7.8	8.2	8.3	167.3	56.2	130.8	83.6	18.8	20.1	103.0	78.9	49.9	123.6	135.8	84.8	77.9	119.5	177.4	38.0	118.0	86.1	116.5	77.5	151.1	180.5	102.5	123.3	86.3	86.3	14.6	131.8	79.5	17.3	27.5	84.9	66.1	27.6	42.0	183.8	97.9	165.4	85.3	79.7	167.2	122.8	116.0	148.1	76.0	129.9	112.5	164.3	44.9	60.7	126.3	63.3	97.3	107.6	90.3	97.6	183.0	123.7	19.6	74.4	93.3	125.8	239.9	91.9	216.9	398.9	65.3	142.8	100.0	0.0	2.8	9.7	11.5	4.2	11.1	13.1	11.4	12.0	5.0	15.1	11.2	10.2	0.6	9.8	14.7	9.6	21.8	7.7	7.3	7.6	8.9	11.9	7.5	7.5	7.3	7.4	7.6	7.5	8.1	8.3	5.1	0.0	2.2	3.3	14.0	6.0	15.3	18.1	5.2	16.1	4.1	8.1	7.5	5.7	9.3	11.0	0.0	43.0	9.7	4.4	5.9	15.3	27.3	5.6	7.0	6.1	1.2	46.3	5.2	16.6	55.7	8.3	6.6	6.0	8.2	25.3	6.1	3.0	23.9	8.4	4.4	7.1	10.2	2.6	4.9	10.0	10.5	6.2	1.8	4.7	12.2	14.9	9.2	2.5	4.3	9.2	4.1	7.9	23.8	3.8	2.8	7.9	7.9	14.4	6.6	10.2	13.1	86.7	50.5	7.9	3.0	11.2	9.6	8.8	13.9	4.7
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA		6500	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	5.9	5.8	3.7	10.5	4.4	33.8	10.7	5.9	4.9	8.6	4.2	10.3	9.8	11.1	5.4	9.3	9.5	6.7	5.4	6.0	2.9	8.7	13.0	6.8	16.4	3.3	3.2	15.6	7.6	7.1	4.7	7.3	3.2	7.9	12.6	11.5	5.8	8.0	5.6	12.9	9.1	7.7	3.8	8.0	7.2	8.3	3.7	23.4	10.3	4.7	16.1	6.3	7.1	4.3	52.8	49.3	49.1	28.1	12.2	14.7	58.3	38.4	24.0	66.6	49.9	50.2	21.4	56.4	25.9	18.1	42.0	47.2	66.9	34.0	63.2	42.1	58.1	43.9	40.7	36.5	7.6	70.7	38.1	7.8	12.2	50.0	16.8	30.4	28.6	70.3	62.6	21.6	33.3	50.3	93.2	59.2	40.5	29.8	46.1	68.1	61.2	55.3	30.7	47.7	67.5	30.7	62.2	18.2	24.1	30.4	64.4	30.0	13.7	36.9	42.5	50.4	69.5	36.2	51.7	76.9	36.4	51.7	66.1	16.6	5.0	3.6	8.6	8.4	7.6	10.7	10.3	7.4	7.2	9.1	8.0	6.9	5.6	7.9	4.9	6.0	11.4	6.5	3.7	4.4	5.9	4.9	6.0	2.9	3.3	3.2	3.2	3.8	3.7	4.3	4.0	0.0	3.3	4.6	5.6	8.4	6.9	7.1	4.0	4.2	5.2	4.7	3.1	4.3	4.6	9.2	2.1	21.0	4.7	3.6	9.8	8.9	3.0	6.0	6.3	4.3	4.2	45.7	11.8	6.3	25.2	6.4	4.1	6.5	5.7	14.0	3.3	6.0	9.1	1.7	7.3	6.9	4.1	3.2	3.1	2.7	4.1	4.9	0.0	3.7	3.8	9.5	2.1	2.5	5.5	4.1	4.0	8.2	16.4	2.3	3.2	6.6	11.0	6.0	0.0	5.3	8.4	13.4	9.1	9.5	5.4	8.9	7.9	18.7	10.6	4.2
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HHSteC: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		1100000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	28.3	24.3	9.9	3.8	9.7	10.2	24.6	8.5	11.8	25.5	7.8	26.5	11.1	25.3	1.6	24.1	23.0	10.9	19.5	8.7	9.0	22.9	78.5	18.7	5.4	10.4	9.3	29.7	42.6	11.1	20.0	5.9	9.5	23.5	3.2	1.4	22.0	6.9	45.4	27.1	16.7	7.7	9.0	14.9	27.7	23.2	9.6	4.6	19.8	10.5	2.7	24.0	18.6	9.7	20.3	19.2	5.6	19.1	13.9	11.8	24.4	18.5	10.1	8.2	6.2	11.6	13.7	4.5	13.0	29.1	17.4	10.8	3.9	15.8	1.5	6.0	19.7	6.7	4.4	48.5	69.3	2.4	14.2	22.5	9.9	14.7	24.9	16.5	15.8	15.2	8.5	16.9	6.6	24.1	15.1	6.5	5.5	13.5	20.1	10.2	7.0	10.6	9.5	11.8	9.7	24.9	7.1	10.7	54.7	6.2	32.1	13.7	6.1	13.1	17.9	12.7	10.2	22.9	4.5	5.0	16.8	4.4	11.7	1.0	1.9	2.0	1.7	0.5	0.6	1.0	1.1	1.6	1.4	1.2	1.1	0.6	0.7	0.2	0.7	1.1	2.5	0.6	9.9	9.7	8.5	11.8	8.7	9.0	10.4	9.3	9.5	9.0	9.6	9.7	24.3	6.4	12.4	30.7	7.6	9.7	11.9	8.3	6.8	26.9	33.3	35.4	12.8	18.6	5.6	23.9	25.0	5.5	14.2	20.9	7.9	7.8	3.7	14.9	24.4	12.1	11.4	5.7	20.7	15.1	3.3	27.2	18.8	19.0	1.3	52.5	21.8	47.1	9.6	11.8	20.3	14.0	12.2	15.2	6.3	13.3	21.8	14.7	10.6	16.9	6.2	29.8	3.1	20.6	13.5	12.4	16.3	19.9	4.9	15.9	14.0	31.3	6.8	27.8	0.0	28.0	19.4	14.4	6.2	9.0	10.2	3.7	10.4	32.8	13.5	8.7
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33298942	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	10.4	8.7	2.6	0.6	2.8	2.3	9.1	2.7	1.6	13.0	8.9	10.0	2.2	11.0	0.0	5.4	12.5	2.0	8.9	2.1	3.7	8.9	2.5	11.4	0.8	6.0	3.0	12.9	6.9	2.7	20.7	5.6	2.5	9.5	0.6	0.1	7.5	3.0	18.5	5.7	8.0	4.0	2.5	24.2	9.9	5.4	4.0	1.0	16.0	8.5	0.2	9.3	7.4	2.2	15.7	2.8	0.2	1.0	2.1	7.2	0.0	1.5	6.0	2.4	1.5	0.2	2.5	2.7	14.0	2.8	5.4	0.3	0.6	5.8	1.4	0.9	0.6	6.5	0.0	2.8	12.9	1.8	5.3	5.4	6.0	5.0	3.6	2.6	19.0	0.0	4.0	0.1	2.4	0.0	1.9	7.9	1.6	1.0	9.7	4.4	0.4	4.1	4.8	3.5	2.9	11.8	0.1	0.0	20.4	0.0	0.0	4.9	22.6	5.1	5.1	3.0	14.8	2.8	1.9	1.6	3.4	4.1	10.4	4.3	4.2	8.8	2.0	3.1	1.7	1.6	1.3	1.5	3.3	2.1	0.7	1.1	9.6	2.4	1.1	0.4	1.3	2.8	2.6	2.8	2.7	1.6	2.1	3.7	6.0	3.0	2.5	2.5	4.0	2.2	75.5	16.0	41.5	52.2	20.6	28.4	36.5	30.3	37.0	30.4	58.8	40.4	28.7	20.0	38.6	22.0	22.9	30.4	18.4	8.4	13.7	21.2	5.1	19.9	13.6	60.8	28.6	7.8	13.0	14.5	39.0	20.1	16.3	21.1	11.4	21.4	75.7	10.7	32.3	32.0	18.2	10.8	22.4	27.0	23.4	17.4	16.8	23.0	17.8	30.9	13.4	22.5	19.6	17.6	11.1	22.4	25.5	14.7	7.8	30.5	5.6	11.7	39.9	30.9	26.3	20.4	26.9	26.2	18.9	20.0	24.3	102.2	16.5	28.3	10.0	39.2
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	8.4	6.5	13.6	2.9	46.6	2.3	8.7	10.2	20.5	16.1	10.5	8.3	4.8	8.6	4.7	30.4	9.9	3.9	6.7	12.9	8.5	11.1	17.3	10.6	3.5	9.5	8.5	12.5	4.9	3.3	13.8	3.7	8.2	16.6	1.9	3.8	9.4	4.7	12.3	20.7	6.2	2.6	7.8	6.0	6.7	10.3	8.7	3.6	8.0	4.6	3.3	10.4	20.2	10.5	4.8	6.0	11.9	8.6	3.9	3.1	4.9	5.1	4.1	5.2	3.8	4.9	2.8	1.1	3.1	4.5	7.6	4.6	2.3	16.3	1.7	0.1	1.9	0.5	3.6	12.0	3.5	0.3	6.5	2.6	10.9	2.7	3.6	4.6	11.5	4.2	5.6	0.2	4.8	4.1	0.8	13.1	5.6	2.7	5.7	12.3	4.6	4.0	2.7	14.1	13.3	13.8	3.2	2.2	11.4	2.9	5.4	8.2	8.7	10.0	6.5	2.0	5.5	5.9	4.9	2.7	5.9	7.2	7.3	0.4	0.3	0.0	0.2	1.1	0.0	0.0	0.2	0.1	0.4	0.2	0.3	0.1	0.4	0.0	1.1	0.2	0.2	0.2	13.6	46.6	10.2	20.5	12.9	8.5	9.5	8.5	8.2	7.8	8.7	10.5	16.1	6.4	6.4	66.9	2.6	84.4	142.0	69.3	71.2	17.3	11.0	14.9	8.6	8.6	28.6	5.5	29.2	6.2	1.3	6.4	3.9	10.4	5.0	22.8	13.3	26.6	14.9	4.8	44.3	10.4	1.3	14.6	7.7	11.8	14.0	57.7	27.8	28.8	20.8	10.1	170.1	10.8	8.2	12.4	11.3	5.5	14.9	21.7	17.8	47.8	7.8	29.3	2.1	71.4	25.5	14.7	2.7	7.9	0.8	53.9	6.0	23.9	34.6	18.9	0.0	12.5	12.7	24.0	15.3	84.4	110.0	6.7	4.3	11.8	9.0	153.8
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812275	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1871.8;Langerhans cells: 637.8;Macrophages: 621.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 3268.4;neutrophil: 4374.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 4374.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 141.8;hTERT-HME1: 96.8;Karpas-707: 94.0;PC-3: 226.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA013385: AB_2668827"	"prognostic favorable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	129.3	353.8	36.4	241.4	40.7	565.0	126.8	41.8	82.6	67.2	56.7	328.5	142.7	217.4	96.0	256.2	149.2	189.5	73.0	43.6	47.7	53.6	66.3	123.6	37.1	50.3	43.9	137.4	513.3	12.5	198.7	100.1	46.0	182.2	110.1	36.9	27.5	222.4	10.0	37.3	104.9	505.9	41.0	192.1	113.4	18.8	47.5	47.3	22.8	63.7	17.3	259.8	71.7	42.1	0.0	20.1	25.4	2.4	48.9	7.7	1.5	9.9	12.4	3.2	3.4	17.9	11.8	1.7	2.8	9.3	2.5	9.7	16.7	17.5	2.9	2.6	12.3	4.8	12.9	0.4	21.5	12.1	2.8	8.1	141.8	6.5	96.8	18.1	23.9	9.1	4.4	94.0	10.0	0.3	6.6	16.8	34.0	1.9	226.6	6.7	5.9	5.4	16.9	16.3	9.4	47.4	7.1	0.5	11.8	26.0	0.7	6.0	6.7	4.8	4.5	5.2	5.2	55.4	1.7	5.3	67.3	2.4	17.8	3268.4	517.9	754.6	14.3	200.8	32.1	6.4	10.2	10.4	118.8	3.3	5.2	6.6	4374.2	2.3	362.7	16.0	6.7	310.2	36.4	40.7	41.8	82.6	43.6	47.7	50.3	43.9	46.0	41.0	47.5	42.1	22.3	51.3	195.9	6.8	187.2	42.3	47.3	45.0	6.2	18.7	138.5	44.1	69.4	7.2	46.1	136.1	18.8	227.6	145.1	27.0	0.0	33.5	24.6	6.9	51.5	38.6	349.2	3.2	6.6	30.3	24.5	125.8	38.7	7.5	1871.8	2.3	18.5	3.1	374.4	21.9	8.4	96.9	42.7	345.0	637.8	18.3	16.4	621.2	88.9	8.4	305.0	41.5	25.7	3.5	2.4	14.8	60.3	62.8	135.9	36.3	141.5	2.5	20.4	39.0	0.0	61.4	55.5	4.2	16.9	6.1	31.1	124.2	346.1	16.6	32.3	11.3
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851795-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.5;choroid plexus: 3.9;retina: 4.9"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 238.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.7;SK-MEL-30: 30.4;U-87 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA070193: AB_2732150"	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.1	0.0	8.5	0.0	12.5	0.0	0.1	6.6	11.3	0.8	3.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.2	6.3	0.0	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.1	1.2	5.0	0.0	0.0	4.9	0.3	0.0	0.0	2.6	0.0	0.0	5.4	0.0	0.0	0.1	7.3	0.0	1.3	0.0	0.2	0.0	1.0	7.8	14.6	10.1	19.3	0.3	0.7	2.3	0.0	7.9	4.6	6.7	4.0	0.0	8.8	0.0	0.4	2.2	27.7	10.6	0.4	12.8	4.5	0.0	1.5	2.5	1.5	1.7	3.1	0.0	0.9	0.4	8.1	5.5	16.0	14.9	2.6	0.0	0.7	0.0	11.3	0.0	0.0	0.4	0.3	2.1	4.0	0.0	0.6	0.0	12.9	0.9	12.0	1.1	0.6	0.0	30.4	2.8	0.0	0.1	8.5	1.7	0.0	14.4	5.9	2.4	0.0	0.0	28.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	12.5	6.6	11.3	8.2	6.3	5.4	5.1	5.0	5.4	7.3	7.8	0.2	0.0	0.0	238.6	0.1	2.0	0.5	10.9	0.6	1.3	0.2	0.0	0.8	0.0	2.7	0.0	31.3	0.7	0.0	0.1	0.0	0.6	0.5	4.2	1.0	0.2	0.0	0.0	3.2	0.4	0.8	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	6.0	0.0	4.1	0.0	0.0	0.0	0.3	0.1	5.4	9.4	0.0	5.5	0.0	5.0	0.7	1.3	0.0	0.0	0.0	5.1	0.0	0.0	2.6	13.7	0.0	0.1	0.5	0.1	1.3	0.4	0.4	0.7	0.1	0.0	0.0	0.6
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.6;Horizontal cells: 158.2;Proximal tubular cells: 195.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 248.4;HDLM-2: 413.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044234			Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA044234: "	"prognostic unfavorable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	60.5	31.5	32.0	18.1	37.3	9.3	43.7	33.7	29.7	17.9	49.7	30.4	16.9	20.8	11.4	10.8	15.2	42.4	95.0	24.0	31.5	70.9	54.5	64.2	23.9	32.2	44.3	10.3	23.9	12.3	16.6	32.3	32.5	26.3	15.8	10.3	10.8	10.2	48.2	15.2	20.0	18.0	28.2	31.9	27.6	31.2	58.0	7.9	24.5	19.2	11.4	26.5	15.4	34.0	4.5	16.6	40.1	37.0	12.2	18.1	2.9	41.2	248.4	32.9	27.9	40.8	14.7	17.9	29.7	33.6	32.8	10.6	0.6	16.0	19.2	413.2	0.1	1.7	13.0	24.8	24.8	0.4	5.5	32.4	16.6	91.4	13.2	72.6	125.4	1.0	0.3	17.1	60.5	18.7	1.2	1.9	10.6	28.6	13.7	1.3	19.8	2.9	67.7	8.1	31.3	4.2	3.9	31.3	24.7	19.6	21.5	3.8	61.2	109.7	11.8	5.1	79.1	8.6	1.5	2.7	126.2	3.8	51.6	10.2	6.8	3.7	24.7	7.1	16.7	2.4	5.7	20.3	6.6	2.4	2.4	10.8	18.5	42.3	6.0	0.3	3.8	15.6	32.0	37.3	33.7	29.7	24.0	31.5	32.2	44.3	32.5	28.2	58.0	34.0	49.5	16.0	13.9	14.4	5.6	12.0	9.9	7.4	4.6	1.4	9.1	10.7	55.8	72.9	8.4	22.0	6.2	4.6	23.5	28.0	82.2	65.1	38.8	9.9	14.9	111.6	0.0	6.1	2.4	30.4	3.7	29.3	27.0	4.0	47.7	12.8	66.0	35.2	15.6	158.2	3.4	7.4	4.1	14.3	13.8	17.4	4.7	14.6	55.2	21.5	10.3	3.5	50.4	3.5	24.4	31.0	23.4	13.9	4.5	5.0	20.5	195.7	7.5	6.4	6.6	8.4	35.4	9.9	1.8	4.1	11.4	3.0	18.4	55.5	11.5	12.9
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775514-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 28.1;retina: 12.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 288.3;Excitatory neurons: 1353.2;Inhibitory neurons: 1095.0;Oligodendrocyte precursor cells: 615.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 6.2;HaCaT: 5.3;hTERT-HME1: 7.2;RH-30: 6.4;SH-SY5Y: 5.6;U-2 OS: 5.9;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.0	8.0	11.6	0.0	13.5	0.0	0.1	18.9	28.1	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.0	15.9	8.6	2.4	0.4	0.1	0.3	2.5	3.8	0.4	0.5	0.2	2.8	0.0	6.8	0.1	0.1	12.8	0.0	0.5	0.0	0.1	0.1	0.0	2.6	0.2	2.9	5.3	6.4	0.0	0.0	0.0	0.2	0.0	0.0	13.9	0.9	0.0	0.0	0.0	0.2	0.7	0.0	2.5	4.8	6.2	0.4	0.0	0.0	0.0	0.3	3.3	3.4	5.3	0.0	0.0	3.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.5	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.3	0.3	0.2	0.0	6.4	0.0	0.0	0.0	5.3	5.6	0.3	0.2	0.2	0.2	0.0	0.0	2.6	0.0	5.9	0.3	7.2	0.0	4.1	0.0	0.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.6	13.5	18.9	28.1	15.9	8.6	2.5	3.8	6.8	2.6	6.4	13.9	0.0	0.0	0.0	288.3	2.8	0.0	0.1	0.0	0.0	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	2.3	0.0	3.5	0.2	7.2	0.0	1353.2	0.0	0.0	0.5	1.5	0.1	0.0	10.0	0.4	0.4	0.1	62.2	1095.0	0.4	0.0	0.0	0.3	4.1	0.0	0.1	0.0	29.0	0.0	1.0	0.0	615.8	86.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.7	6.3	10.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0"	"Group enriched"	"Detected in many"	42	"NK-cells: 4.0;T-cells: 9.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1"	"Region enriched"	"Detected in all"	9	"basal ganglia: 248.1"	"Region enriched"	"Detected in all"	10	"basal ganglia: 110.0"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	0.8	1.5	6.2	1.2	23.5	0.2	0.8	4.3	9.4	1.6	3.8	8.5	1.1	1.7	2.5	1.5	10.3	1.0	0.8	5.1	9.3	2.4	2.3	5.1	2.1	5.3	5.9	2.6	1.4	5.5	12.1	1.2	6.9	4.6	1.3	1.3	1.3	3.3	0.1	1.4	3.8	1.4	5.2	1.7	3.8	0.4	7.4	0.6	0.6	0.3	3.0	2.9	2.8	4.6	0.4	0.0	1.3	0.1	0.1	0.2	0.0	0.1	2.6	0.0	0.3	0.2	0.0	1.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	25.9	0.6	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.2	4.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.7	0.0	2.5	0.0	0.8	6.8	0.0	0.0	0.0	3.2	0.1	4.0	0.0	0.1	0.0	1.7	6.2	23.5	4.3	9.4	5.1	9.3	5.3	5.9	6.9	5.2	7.4	4.6	1.3	3.2	1.5	33.3	0.4	0.4	1.4	0.9	0.6	25.0	7.8	14.5	0.4	0.0	1.3	1.8	325.2	0.0	27.5	0.1	3.9	8.9	0.6	2.5	1.8	2.6	59.7	0.0	2.3	3.1	0.1	5.8	1.1	4.2	0.0	3.3	1.1	0.0	0.1	52.2	2.3	2.3	0.0	0.0	3.0	2.4	0.9	2.9	1.8	1.9	19.4	39.2	18.6	2.5	1.2	2.7	0.1	4.9	6.3	0.1	0.1	14.2	0.8	480.2	0.0	0.5	1.9	0.1	0.4	0.0	0.1	0.1	10.3	12.8	0.6	0.3
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	6.5	13.3	11.5	26.6	9.9	47.4	5.5	21.6	12.0	14.3	10.6	24.3	31.8	13.2	21.8	11.7	10.0	9.8	15.0	10.4	11.0	16.2	3.9	20.6	41.0	13.0	12.2	8.9	6.1	7.7	5.1	5.7	13.4	9.2	19.3	9.9	11.5	9.8	11.8	9.2	32.3	11.5	8.7	33.3	28.2	9.0	10.6	25.6	14.6	2.8	31.4	9.1	7.3	11.7	58.3	69.2	12.4	15.3	4.4	6.4	5.6	5.3	5.2	2.5	4.4	28.8	129.0	6.3	42.6	6.0	1.4	8.6	23.2	33.7	2.2	177.1	8.0	37.9	47.5	27.7	10.1	38.6	25.8	9.0	7.5	5.4	2.9	23.8	17.6	44.7	5.6	9.9	1.4	41.7	50.7	56.7	10.4	13.6	147.3	26.5	0.7	10.8	127.9	4.9	9.9	9.4	38.5	4.5	2.6	5.6	19.9	15.0	21.4	4.0	40.1	12.5	1.5	12.3	7.6	20.0	5.0	42.9	2.6	23.8	10.9	41.5	97.0	36.5	92.7	55.5	77.2	82.5	31.0	45.2	59.5	73.2	24.4	61.4	69.8	74.3	90.2	43.3	11.5	9.9	21.6	12.0	10.4	11.0	13.0	12.2	13.4	8.7	10.6	11.7	3.1	38.5	10.7	1.0	54.1	8.7	1.9	5.5	3.4	8.1	9.3	3.8	1.5	15.7	11.3	23.9	0.0	2.7	111.8	273.9	41.1	34.0	20.2	16.5	5.6	3.5	6.7	12.2	5.3	55.3	3.9	5.3	50.4	37.1	20.8	13.1	10.0	4.0	14.4	0.0	3.9	28.6	2.0	10.9	224.9	53.8	4.1	40.3	21.4	3.7	241.2	4.7	103.0	1.0	1.2	191.7	279.6	2.2	39.4	3.8	121.6	15.1	13.5	9.7	6.6	2.6	4.5	17.7	2.9	2.5	13.2	5.5	99.2	23.4	17.3	44.3
RHOG	"ARHG, MGC125835, MGC125836"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840959	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 625.4"	"Low region specificity"	"Detected in all"							HPA039871	Enhanced					NA	NA		86000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	61.2	39.5	62.6	82.5	90.0	273.1	45.7	84.0	70.5	46.2	56.0	50.1	44.7	46.7	19.5	82.6	44.6	34.4	47.0	60.4	71.2	35.6	39.3	87.5	85.2	91.1	83.6	38.0	30.5	18.3	25.4	43.5	91.7	36.8	28.3	4.3	39.1	28.4	53.0	50.1	64.2	39.2	76.5	168.4	42.2	15.3	81.7	68.0	29.0	27.0	67.3	56.5	48.6	107.2	74.1	99.0	19.8	34.1	74.8	84.1	21.4	48.1	59.6	73.7	77.8	61.0	78.7	74.9	24.9	89.2	74.9	85.3	31.2	68.0	47.6	66.6	75.3	170.3	44.7	57.9	75.3	150.0	625.4	82.0	61.1	46.1	44.4	42.6	85.8	99.5	101.3	80.8	61.0	86.5	126.5	206.8	31.5	53.4	78.8	63.7	21.4	44.4	53.1	50.9	10.6	26.7	34.0	77.7	39.4	22.5	41.0	111.6	67.2	88.8	44.5	95.3	57.2	44.8	66.4	42.5	81.0	135.8	50.6	441.3	351.1	739.9	114.8	468.1	101.8	79.8	125.6	128.7	310.8	78.1	87.4	101.6	981.2	97.9	561.9	77.2	206.6	346.7	62.6	90.0	84.0	70.5	60.4	71.2	91.1	83.6	91.7	76.5	81.7	107.2	38.4	19.2	21.5	2.9	109.0	68.7	62.4	35.3	22.8	0.9	24.0	26.3	6.6	20.0	26.9	20.2	0.0	100.4	105.2	99.1	15.6	67.2	1.6	10.2	20.6	58.5	16.2	71.9	1.9	56.6	82.1	38.2	22.4	19.1	200.0	62.8	43.5	19.5	247.7	3.3	1.9	26.7	14.2	365.2	356.6	3.6	38.5	250.6	53.4	8.4	391.7	18.0	166.9	3.0	45.9	86.6	143.6	36.1	45.1	70.4	135.4	24.8	9.7	3.0	19.7	21.6	34.0	10.2	23.9	45.1	59.5	124.2	124.8	11.2	28.9	95.7
RHPN1	"KIAA1929, ODF5, RHPN"	ENSG00000158106	"Rhophilin Rho GTPase binding protein 1"	Q8TCX5	8	143368876-143384221	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.1;thyroid gland: 20.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Collecting duct cells: 38.6;Cone photoreceptor cells: 31.3;Respiratory ciliated cells: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 28.3;MOLT-4: 25.8;RPMI-8226: 19.0;T-47d: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024288, HPA024671"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA024288: AB_1856274, HPA024671: AB_1856275"	"unprognostic (2.04e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-2)"	2.6	1.6	11.8	0.9	9.1	2.1	4.7	6.7	12.9	3.3	8.5	2.0	0.1	1.3	1.3	2.4	5.0	0.7	1.1	13.5	8.2	13.6	1.3	3.5	1.1	7.5	9.3	0.7	4.2	2.9	20.1	0.1	7.2	4.0	0.1	0.6	3.6	1.9	0.3	2.7	3.0	0.3	5.9	5.3	3.0	4.0	9.9	8.8	20.4	0.0	0.5	2.6	1.9	7.1	2.9	4.9	1.2	3.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.7	1.9	0.2	9.8	0.0	0.2	1.3	0.0	0.0	0.0	0.6	4.4	0.0	3.5	0.3	0.4	0.3	3.1	0.0	0.8	0.0	0.0	0.9	1.0	11.5	1.1	5.8	0.0	28.3	25.8	2.6	1.7	5.9	13.4	7.0	0.0	19.0	3.9	4.6	7.2	2.7	1.5	8.1	1.8	0.0	44.2	0.0	0.0	0.0	5.1	0.1	0.2	1.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	9.1	6.7	12.9	13.5	8.2	7.5	9.3	7.2	5.9	9.9	7.1	6.7	6.4	7.5	47.0	2.0	2.5	2.7	3.9	3.4	3.4	13.4	8.9	1.0	2.8	5.9	38.6	31.3	1.6	3.3	2.4	11.7	8.7	5.1	21.9	1.2	5.7	22.7	1.7	20.2	2.8	0.2	1.1	11.7	4.1	0.0	6.6	5.3	1.4	3.2	6.7	10.2	3.1	6.1	1.3	6.0	11.2	0.3	1.6	7.2	3.7	1.4	11.5	0.0	15.1	3.6	3.3	1.2	1.5	1.4	3.2	0.0	15.8	38.6	25.2	0.0	0.7	1.5	7.6	7.2	2.5	1.4	1.9	5.5	1.1	4.3	3.7
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 496.2;liver: 1536.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.1	48.4	93.1	11.4	96.4	7.5	19.1	95.5	131.7	11.2	83.8	24.5	30.5	8.4	22.7	14.3	9.4	22.7	32.3	89.2	95.0	496.2	1536.9	9.5	10.1	91.6	97.8	23.4	27.0	24.6	10.0	10.8	95.5	19.3	24.6	26.6	16.4	11.6	40.0	10.6	21.8	10.8	92.6	7.4	24.8	17.2	100.0	11.2	15.9	41.0	12.3	15.5	7.9	91.0	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	93.1	96.4	95.5	131.7	89.2	95.0	91.6	97.8	95.5	92.6	100.0	91.0	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 365.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 653.2;Inhibitory neurons: 572.7;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in many"	16	"cerebellum: 365.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;EFO-21: 8.8;LHCN-M2: 10.0;RPTEC TERT1: 15.0;SH-SY5Y: 10.7;TIME: 5.4;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 352.9"	HPA076565	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.2	1.2	5.5	0.8	14.1	0.0	0.5	365.0	22.5	0.3	0.0	0.3	0.7	0.2	0.0	2.1	0.0	3.9	0.1	16.3	8.4	0.0	0.0	0.2	0.0	0.3	9.0	0.0	0.4	1.6	2.4	0.0	20.8	3.0	0.1	7.4	1.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	1.4	4.1	5.4	0.0	0.0	0.9	0.0	0.1	0.0	13.2	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.2	1.4	0.0	0.2	0.0	0.0	5.2	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	15.0	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.7	0.0	5.4	5.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	14.1	365.0	22.5	16.3	8.4	0.3	9.0	20.8	0.0	5.4	13.2	0.2	0.0	0.5	120.2	0.0	0.0	0.2	2.1	0.0	69.1	3.0	3.2	1.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.9	2.5	0.0	0.0	653.2	0.8	0.0	1.8	0.0	0.0	1.3	0.3	3.6	0.0	0.0	62.2	572.7	0.0	2.0	0.0	0.0	10.2	0.3	0.3	3.6	16.9	0.0	109.7	0.0	323.2	76.5	0.5	0.0	1.5	0.0	1.0	0.0	0.4	3.6	9.9	0.0	1.3	2.7	21.3	13.6	0.0	0.1	0.0	0.1	0.3	0.0	0.5
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183247	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	15.0	14.6	12.5	13.5	13.7	21.5	14.7	16.6	21.3	12.9	14.1	13.3	13.0	11.6	12.2	13.5	12.3	7.8	16.3	12.5	14.7	14.2	18.1	10.3	14.3	13.5	13.5	14.8	16.7	11.3	15.1	12.1	13.5	12.0	12.7	19.4	11.8	9.3	21.4	11.3	11.2	9.3	13.9	14.6	13.3	12.6	13.7	13.7	11.9	14.2	13.6	13.2	12.1	15.9	19.0	22.0	20.3	38.5	25.9	28.6	32.1	48.1	29.0	33.0	43.2	30.4	32.5	41.7	53.1	21.3	51.6	21.7	34.2	27.4	44.9	29.3	18.5	20.3	44.0	42.9	23.6	38.5	27.2	18.5	20.8	40.1	39.8	25.0	27.0	30.8	31.7	25.4	38.0	31.9	46.4	47.8	22.5	10.6	23.9	51.9	38.3	61.9	25.7	16.9	23.7	17.9	27.5	28.3	35.6	29.6	29.6	36.4	28.5	41.2	28.9	33.0	51.8	25.3	36.4	95.2	24.0	39.7	38.4	17.9	26.2	15.8	24.6	30.7	34.4	24.0	31.5	27.8	29.4	18.6	33.9	36.5	5.0	30.7	23.8	29.2	31.7	22.7	12.5	13.7	16.6	21.3	12.5	14.7	13.5	13.5	13.5	13.9	13.7	15.9	14.9	9.6	12.8	7.8	16.9	26.4	17.9	25.2	12.5	16.2	11.1	11.4	20.5	10.0	17.4	7.3	12.5	19.6	26.9	6.4	17.6	17.3	1.3	10.7	18.0	14.0	9.6	8.4	10.9	14.9	24.8	21.1	14.8	10.5	27.9	12.7	8.2	8.1	18.3	13.5	11.0	12.7	18.3	9.4	9.2	3.0	13.4	11.0	5.4	3.7	16.5	13.4	14.4	9.0	15.0	11.4	10.1	16.1	19.1	10.4	11.8	17.3	13.3	17.7	6.6	17.4	22.9	23.5	20.7	10.1	18.9	17.4	19.6	19.4	12.6	12.0
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"RLF zinc finger"	Q13129	1	40161387-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"HPA054653: AB_2682557, HPA057300: AB_2683404"	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	8.7	4.9	5.5	6.2	6.0	32.8	8.3	12.0	7.9	8.4	2.5	7.6	5.1	7.9	4.7	7.3	7.0	6.6	7.5	6.0	5.6	4.9	7.7	8.2	7.7	4.1	4.3	8.3	5.6	6.5	5.1	7.3	4.2	6.6	5.2	15.4	5.7	5.4	8.5	12.2	6.2	6.1	4.3	6.2	5.7	10.3	5.2	10.2	5.8	7.1	8.5	7.8	8.4	8.2	18.3	6.9	13.3	13.9	11.6	9.4	15.8	6.7	9.9	11.3	14.9	14.0	9.4	18.1	8.6	8.6	8.4	16.8	16.9	11.8	20.4	8.5	11.4	14.9	8.0	8.7	9.2	12.5	8.7	9.3	12.1	12.0	13.5	13.5	7.8	9.8	23.0	10.8	10.4	5.8	10.6	7.5	17.8	6.7	7.9	8.2	21.8	10.6	7.2	18.2	9.4	13.1	12.5	16.5	12.0	20.5	7.8	44.6	6.7	13.2	14.1	11.0	12.6	9.8	9.8	16.6	11.5	11.4	8.4	6.9	1.5	3.0	1.8	2.0	2.4	2.3	1.8	1.9	1.9	2.1	2.3	2.0	3.2	2.4	2.4	0.8	1.8	1.3	5.5	6.0	12.0	7.9	6.0	5.6	4.1	4.3	4.2	4.3	5.2	8.2	36.7	32.1	15.1	52.2	55.8	65.6	50.3	12.7	30.7	17.8	25.5	18.4	16.9	2.8	23.9	3.7	16.7	8.9	40.6	10.4	5.9	13.8	41.3	43.8	41.6	24.9	20.2	11.3	87.1	6.7	10.6	34.9	29.6	56.0	26.6	23.0	16.1	9.0	9.7	26.9	84.7	8.8	14.2	13.8	45.2	8.7	9.0	39.9	17.8	60.9	17.5	14.1	9.2	71.9	89.0	10.1	15.5	7.9	44.6	28.7	8.9	5.5	26.0	17.2	13.1	52.8	36.1	32.2	20.8	29.3	61.1	17.2	45.8	17.0	10.8	33.0
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334930-5339876	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"prostate: 23.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Enteroendocrine cells: 4.8;Prostatic glandular cells: 10.6;Spermatocytes: 2.4;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"														"Secreted to blood"	NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.2	0.0	0.5	1.0	0.8	0.2	2.8	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.6	1.6	0.7	0.2	0.1	4.8	1.7	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.4	10.6	0.0	0.4	1.0	0.8	0.0	0.2	0.1	2.4	3.1	0.0	0.1	1.1	1.6	0.1	0.2	0.3
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20802855	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"pancreas: 9121.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7;myeloid DC: 20.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.3;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1100000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	694.2	501.3	336.6	131.3	466.1	6.2	353.3	404.4	556.1	203.9	294.9	378.4	176.7	139.4	112.0	194.0	232.0	406.4	377.7	351.3	380.9	253.0	54.5	775.9	187.8	438.9	408.3	190.6	9121.6	60.6	43.9	897.4	403.7	83.9	425.2	3.1	168.0	149.7	127.6	118.1	201.8	285.6	357.3	353.1	1003.5	977.5	465.4	177.6	119.7	280.6	68.8	374.7	107.9	533.7	0.0	1.4	0.5	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	0.0	0.3	1.7	0.0	2.2	0.6	0.0	1.4	0.0	0.1	0.1	5.3	0.1	0.8	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	286.8	0.0	31.4	0.4	0.0	0.0	0.3	2.0	1.2	67.4	0.0	0.2	0.1	1.5	0.2	114.2	1.2	1.4	0.0	0.8	0.3	2.0	0.3	0.1	179.3	0.0	2.7	1.8	0.3	0.6	0.1	0.1	4.6	0.1	3.8	1.6	9.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	2.4	336.6	466.1	404.4	556.1	351.3	380.9	438.9	408.3	403.7	357.3	465.4	533.7	826.6	929.5	818.4	1.6	11.1	35.6	1.0	1.9	15.9	0.1	6.2	11.7	59.8	27.1	174.0	16.5	0.0	12.9	5.7	261.8	0.0	8.8	20.0	3.8	1.9	581.7	48.7	28.0	0.5	315.2	14.6	58.4	821.1	3.4	25.2	103.8	650.3	7.9	1583.4	1.7	0.8	663.8	8.2	267.9	197.5	57.1	32.0	632.8	40.9	36.5	3.4	0.8	0.0	1.0	232.3	286.8	246.7	10.9	7.5	1.4	81.7	0.9	34.9	2.7	98.6	20.7	31.4	16.4	6.6	16.6	28.1	25.9	10.6	392.8	162.9	3.8
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955487-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"bone marrow: 1713.7"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 457.5;eosinophil: 1352.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1352.6"	"Group enriched"	"Detected in some"	303	"HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		200000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	7.1	6.0	3.0	9.1	2.8	1713.7	1.7	2.9	5.5	2.3	4.4	2.2	0.2	2.1	0.3	0.9	5.7	2.6	4.0	2.8	4.2	1.7	4.6	12.2	1.9	5.4	4.1	1.5	1.7	0.5	1.7	1.8	4.4	1.7	0.7	1.7	1.9	0.2	0.7	2.9	1.4	9.7	4.5	35.1	2.1	0.7	4.2	14.8	0.9	0.6	0.6	5.2	1.4	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	0.0	539.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	539.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	1405.4	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.7	0.0	1295.9	0.0	457.5	109.0	1352.6	0.4	19.3	0.8	0.3	0.4	0.0	191.8	0.4	0.4	0.4	9.8	0.1	2.8	2.6	0.1	39.9	3.0	2.8	2.9	5.5	2.8	4.2	5.4	4.1	4.4	4.5	4.2	6.3	0.2	3.2	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.0	1.9	0.0	0.5	0.0	0.0	1.3	0.0	30.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.4	2.2	13.0	0.0	0.0	0.0	0.0	174.3	0.7	1.7	0.3	82.2	0.0	0.0	54.6	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684560-20701216	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 478.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		61000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	106.4	7.8	5.5	8.9	5.7	1.2	96.6	5.4	8.3	95.6	8.5	56.5	22.0	59.2	37.0	20.1	77.3	55.6	44.1	5.5	8.1	40.3	478.8	40.3	12.2	6.9	6.6	111.7	41.0	14.7	12.5	5.7	6.9	76.7	65.2	4.7	74.8	45.8	14.1	47.4	41.9	25.9	6.7	11.8	84.7	10.6	5.3	5.8	26.5	31.5	10.6	65.3	75.9	7.8	2.7	12.1	2.6	0.1	92.6	107.2	0.5	10.5	23.8	1.4	4.5	3.4	4.1	0.1	2.9	24.6	6.2	2.5	1.4	2.6	1.7	17.2	1.8	0.3	2.9	136.9	10.2	1.3	0.6	63.1	5.8	1.6	10.3	34.6	12.6	4.2	0.1	12.2	6.9	1.5	1.0	0.2	0.5	92.3	10.3	0.6	2.1	3.6	2.9	2.4	0.1	0.5	5.0	2.3	2.6	4.2	3.4	0.2	13.3	3.0	1.7	4.1	0.3	2.6	3.5	0.4	4.7	1.3	2.7	0.2	24.1	0.1	0.8	1.2	1.0	5.3	1.5	0.6	13.8	4.9	0.3	0.6	0.6	0.6	0.1	3.3	3.3	8.4	5.5	5.7	5.4	8.3	5.5	8.1	6.9	6.6	6.9	6.7	5.3	7.8	1.8	38.5	19.1	2.0	3.4	2.8	1.7	2.5	11.4	0.0	9.9	2.5	0.2	28.6	4.7	3.7	0.0	0.2	0.3	30.4	0.0	34.4	0.2	0.1	0.8	4.0	67.3	8.4	0.1	22.2	0.4	39.2	47.4	0.8	1.3	0.3	5.0	55.8	1.6	0.0	0.2	110.0	2.0	6.2	4.0	0.3	12.5	3.6	3.6	1.9	2.7	1.3	1.0	0.0	0.9	12.8	33.2	4.1	5.9	1.7	41.7	10.2	11.6	0.3	0.0	2.6	8.1	0.2	0.1	10.2	4.1	0.4	0.8	0.1	39.6	1.5
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	5.6	6.4	3.2	8.8	3.5	3.6	5.9	3.4	3.9	6.6	3.7	8.1	7.0	6.5	9.6	6.2	5.2	6.9	3.4	2.9	3.4	6.2	3.5	6.9	9.6	3.4	3.5	11.3	3.1	7.9	5.4	6.9	3.6	7.2	9.0	5.7	5.0	8.3	2.0	5.4	8.0	7.1	2.8	8.9	7.8	2.2	3.6	8.0	9.1	4.5	9.9	6.0	6.3	3.3	2.6	3.6	1.5	0.6	7.9	13.7	2.8	4.9	6.1	4.9	4.5	2.1	5.6	5.6	8.4	5.6	2.2	4.7	3.6	5.1	1.9	4.5	3.1	6.6	1.3	0.3	4.1	12.4	12.5	9.8	11.4	2.6	0.7	3.1	2.1	8.2	2.4	4.2	4.3	3.8	3.6	5.1	1.2	8.4	1.0	5.3	1.2	2.9	5.2	3.4	0.7	0.2	4.4	5.3	4.3	3.9	5.4	13.6	2.8	2.5	2.0	2.7	2.7	3.7	1.3	0.7	4.0	7.5	3.8	41.7	14.8	53.1	9.4	15.8	12.4	10.3	11.1	10.1	12.4	7.9	17.3	12.8	55.3	10.9	30.3	14.7	10.0	10.5	3.2	3.5	3.4	3.9	2.9	3.4	3.4	3.5	3.6	2.8	3.6	3.3	4.5	6.4	4.2	5.2	6.5	1.0	2.9	4.9	1.2	4.3	2.8	2.4	1.3	1.5	9.0	3.7	4.2	4.2	8.2	14.8	7.9	6.7	0.0	2.5	9.6	5.1	2.4	4.8	4.2	1.8	3.7	6.4	7.7	3.4	5.7	5.5	3.9	1.6	6.2	1.7	6.6	9.3	8.2	9.7	1.2	0.8	2.8	5.8	0.0	1.9	7.3	8.7	5.2	6.0	3.6	2.2	3.2	6.4	2.7	3.5	7.2	7.3	9.1	6.1	19.7	5.8	5.2	0.4	0.9	4.5	1.0	2.6	7.5	12.1	4.0	4.6
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990292	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008716, HPA064746"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA008716: AB_1856337, HPA064746: "	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.06e-2)"	48.4	51.8	31.5	26.0	32.7	20.2	45.6	32.7	42.8	36.6	30.6	40.7	33.2	33.6	43.2	32.6	29.7	32.6	71.2	33.3	35.6	65.3	67.6	30.2	32.3	35.3	38.2	32.3	37.2	104.0	23.7	39.8	36.3	44.0	41.2	40.4	37.1	40.2	66.7	23.5	36.4	43.3	33.4	28.9	35.4	74.5	36.5	36.7	55.1	85.8	33.7	32.1	23.4	33.7	38.3	62.5	43.1	85.1	75.7	78.8	29.0	76.8	42.6	52.8	58.1	52.4	43.4	67.1	87.5	79.3	79.4	20.6	55.6	75.4	47.0	51.1	48.5	42.9	30.2	24.0	83.2	47.7	36.9	59.7	64.9	70.3	87.6	45.6	66.2	46.0	53.0	91.7	109.4	45.7	46.6	15.3	18.3	46.2	71.0	30.2	47.8	73.8	71.7	65.2	47.5	38.3	67.3	121.3	133.2	47.8	85.0	36.7	69.3	69.6	22.6	33.2	74.0	56.8	72.1	61.8	59.7	57.4	87.9	79.6	22.0	23.2	26.9	26.9	26.0	19.5	23.2	26.9	27.4	18.1	17.6	25.9	5.5	30.1	33.9	28.9	29.1	19.7	31.5	32.7	32.7	42.8	33.3	35.6	35.3	38.2	36.3	33.4	36.5	33.7	18.1	9.6	19.3	12.7	12.5	10.7	15.9	19.6	11.4	20.2	18.4	15.0	45.4	11.5	18.1	22.0	16.7	29.1	13.3	22.9	68.4	29.2	257.1	14.1	20.8	21.7	15.0	59.1	25.1	24.9	26.1	18.2	18.3	16.4	22.2	32.0	20.7	33.1	24.5	23.5	22.9	14.9	24.4	29.7	10.4	39.3	19.3	17.1	32.0	13.1	14.8	28.7	29.9	15.6	18.6	26.3	14.0	33.4	13.5	19.2	28.3	50.5	15.8	16.3	39.5	15.8	23.0	38.7	25.8	15.6	10.5	60.5	16.4	25.0	15.0	15.0
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 99.1;Late spermatids: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	18.9	17.3	12.4	18.7	13.3	32.5	17.9	13.4	18.4	13.4	13.5	18.4	17.5	12.4	13.7	18.5	14.5	13.7	13.7	13.9	11.7	18.2	16.6	16.2	22.4	10.4	13.5	11.5	14.1	22.3	10.7	19.9	11.5	16.0	18.5	26.6	13.5	13.9	21.2	17.3	18.8	15.7	10.8	19.7	17.2	33.6	13.7	25.3	17.5	15.3	23.8	18.3	10.1	11.5	33.3	28.9	10.7	15.8	36.3	28.2	23.9	56.3	45.2	35.4	24.9	36.4	41.8	59.5	27.3	53.5	31.5	43.7	30.2	45.3	58.4	57.7	19.2	64.8	23.9	31.3	56.6	68.7	65.4	26.8	86.1	39.8	84.2	34.3	36.0	25.5	25.6	0.1	55.3	30.0	38.5	39.8	8.7	59.5	19.8	30.4	41.5	23.7	43.6	43.3	19.3	11.9	29.9	54.0	54.1	24.8	20.7	66.3	47.6	30.4	18.6	41.1	40.5	14.8	14.9	34.9	27.8	38.4	40.7	46.6	14.5	34.7	15.6	18.4	17.1	18.6	17.1	17.7	17.6	12.5	16.8	14.8	9.7	20.0	23.3	9.1	19.2	14.2	12.4	13.3	13.4	18.4	13.9	11.7	10.4	13.5	11.5	10.8	13.7	11.5	20.9	22.4	19.8	6.8	26.5	30.5	12.7	17.5	14.8	22.2	15.1	10.5	13.5	5.7	19.7	7.3	25.0	20.2	31.6	24.8	33.2	15.1	99.1	37.4	16.9	23.0	11.4	24.8	14.4	15.4	21.8	16.1	17.3	19.9	26.6	12.1	17.5	12.3	17.5	30.3	17.2	15.5	24.4	22.4	19.9	191.0	14.6	23.0	14.2	12.2	21.6	24.9	29.9	11.6	16.2	24.4	20.1	11.3	18.0	22.0	15.8	21.4	40.1	43.2	26.3	21.6	14.5	83.5	29.1	19.2	29.1	42.1	26.2	17.1	12.6	23.5
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 262.3;monocytes: 299.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	163.5	137.2	27.3	29.0	41.8	46.3	133.7	42.4	33.9	156.4	28.9	123.0	27.1	140.8	10.0	215.0	119.5	29.7	198.0	26.3	32.5	118.6	111.9	146.7	30.8	48.6	39.7	119.1	89.5	25.6	80.6	27.3	38.2	100.9	8.8	5.6	112.5	31.0	145.9	257.4	91.1	25.3	35.3	113.3	101.1	90.1	38.3	15.6	106.6	21.8	13.9	144.5	160.3	49.4	86.5	123.9	13.2	39.8	66.3	93.8	43.9	70.6	51.3	68.9	58.3	61.9	92.9	41.8	54.3	175.1	41.9	72.7	20.6	76.5	10.4	51.3	104.9	28.2	28.5	65.7	243.3	39.8	90.0	77.1	108.2	40.2	46.7	29.2	47.9	27.7	36.2	71.3	37.7	86.6	30.5	78.4	19.8	45.3	112.6	37.7	22.3	55.8	40.7	34.6	35.7	23.2	41.8	59.1	73.7	7.4	44.6	122.2	77.3	109.3	32.8	39.8	49.5	44.9	53.0	32.2	117.5	81.9	74.3	37.6	246.2	57.3	51.1	298.9	59.9	63.0	55.3	51.1	262.3	48.4	49.8	45.1	17.1	54.2	299.1	71.7	58.4	236.5	27.3	41.8	42.4	33.9	26.3	32.5	48.6	39.7	38.2	35.3	38.3	49.4	156.0	112.2	83.5	18.9	92.3	202.1	239.0	265.0	89.4	102.4	82.0	105.5	83.3	88.6	138.6	79.1	110.5	222.2	85.3	126.6	225.0	188.8	105.1	72.8	132.4	136.1	57.4	59.7	10.9	164.4	217.4	194.9	64.2	82.8	140.2	93.8	101.7	68.6	374.0	168.2	14.5	115.6	148.5	191.8	323.0	42.7	211.6	230.3	193.9	12.2	334.2	144.6	79.3	10.1	70.8	171.6	120.5	179.8	101.7	161.0	139.4	242.3	97.9	146.4	177.5	99.1	178.0	153.4	157.8	140.0	260.0	305.5	96.5	199.7	114.4	217.4
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		7800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	25.2	31.1	8.0	22.8	8.3	25.2	25.8	8.1	8.5	26.7	16.1	53.6	68.5	25.6	39.0	53.8	40.6	22.3	14.7	8.5	8.7	25.9	32.4	30.5	22.1	9.9	9.1	23.4	34.1	25.4	13.3	27.5	9.1	25.9	57.0	4.2	38.3	27.6	18.8	37.0	58.1	28.1	9.1	33.4	28.5	17.9	10.6	21.7	33.2	12.7	26.5	23.3	28.8	11.8	66.2	71.0	40.8	62.7	65.1	61.3	102.1	49.5	95.6	60.9	67.6	51.8	83.1	14.3	61.8	87.8	38.0	117.4	52.5	97.2	42.4	39.1	67.6	35.5	32.5	48.7	55.1	92.3	121.3	55.9	97.9	54.1	62.0	74.7	110.6	34.8	82.5	21.6	62.1	61.0	12.8	40.2	58.4	105.4	34.4	48.3	57.5	101.6	128.7	61.2	46.9	39.9	122.2	155.9	52.1	78.9	116.6	52.4	79.9	28.9	38.0	28.7	61.3	45.3	39.6	12.9	27.8	77.3	58.1	22.9	14.9	22.1	3.0	25.9	4.1	2.5	3.2	3.4	19.8	4.6	2.8	3.2	11.0	2.9	29.9	7.2	5.4	4.0	8.0	8.3	8.1	8.5	8.5	8.7	9.9	9.1	9.1	9.1	10.6	11.8	26.7	9.6	21.5	8.5	19.7	28.8	40.5	31.2	40.5	15.5	32.8	33.1	12.2	38.6	26.7	25.8	10.4	116.6	21.4	136.6	19.6	71.1	5.4	35.9	17.7	26.1	44.9	19.0	12.7	51.2	91.1	26.1	45.3	21.5	15.2	23.2	27.1	51.4	103.7	11.8	11.1	71.9	14.2	81.0	39.4	4.9	25.4	72.9	24.9	15.0	86.7	12.6	17.5	5.5	8.1	47.8	83.4	23.0	23.6	25.0	201.7	65.8	39.1	8.0	26.3	11.4	28.2	22.7	9.5	53.6	21.6	87.6	17.7	33.2	86.6	34.8
RO60	"SSA2, TROVE2"	ENSG00000116747	"Ro60, Y RNA binding protein"	P10155	1	193059454-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 53.0;Cardiomyocytes: 53.0;Cytotrophoblasts: 47.1;dendritic cells: 41.3;Extravillous trophoblasts: 45.2;Hofbauer cells: 33.4;Syncytiotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002835	Uncertain		Supported	Cytosol		NA	NA		50000	"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA002835: AB_1857490"	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (5.62e-2)"	10.8	8.3	10.6	8.8	16.4	29.7	8.1	15.5	8.7	7.3	3.9	7.5	6.0	9.5	6.4	9.5	6.5	7.4	10.0	6.8	13.9	7.4	9.3	7.6	9.8	17.7	12.8	10.0	7.5	7.0	4.7	8.7	18.6	8.8	6.1	15.4	6.9	6.1	9.9	7.6	6.4	9.4	15.9	10.0	6.4	13.0	11.1	8.2	9.7	10.2	8.9	8.4	7.5	22.6	13.4	25.5	22.5	25.2	20.0	17.7	15.9	19.5	19.8	14.8	18.9	11.8	18.0	25.1	15.7	18.4	14.5	18.7	19.0	13.3	23.2	40.7	14.4	31.4	22.2	15.6	16.5	35.4	23.4	15.9	13.2	25.4	25.1	11.4	19.4	11.5	34.7	38.0	20.3	26.6	21.1	9.3	16.1	10.2	10.8	18.2	21.1	30.7	11.8	28.0	9.4	17.6	25.0	24.8	25.0	15.3	24.2	14.4	26.8	26.0	11.4	25.7	25.8	20.5	29.0	26.8	11.8	18.1	38.9	102.1	31.6	46.0	53.4	29.9	52.3	47.7	37.2	47.0	32.4	44.6	39.6	45.2	53.9	45.2	33.2	29.1	44.7	39.8	10.6	16.4	15.5	8.7	6.8	13.9	17.7	12.8	18.6	15.9	11.1	22.6	53.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	47.1	41.3	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	45.2	17.8	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	48.0	6.2	0.0	0.0	0.0
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865432-124881471	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Muller glia cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 18.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low region specificity"	"Detected in many"			HPA071053			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.8	1.8	0.5	0.0	0.3	0.2	1.9	0.0	3.2	0.7	0.0	1.3	0.3	0.8	0.0	0.7	2.0	0.0	1.8	0.7	0.2	1.6	0.4	1.1	0.1	0.9	0.9	6.4	0.7	0.0	0.8	0.2	0.2	1.4	0.0	0.2	1.2	0.0	0.5	0.7	0.9	0.8	0.2	1.6	0.6	1.2	1.7	0.0	1.4	0.0	0.0	0.7	1.2	0.9	0.0	0.0	18.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.0	1.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.6	0.9	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.0	3.2	0.7	0.2	0.9	0.9	0.2	0.2	1.7	0.9	13.2	0.0	7.3	32.3	0.4	2.9	14.5	16.2	4.0	1.9	5.9	10.9	2.7	1.5	5.9	12.9	0.0	0.2	8.5	2.1	0.0	9.3	0.4	0.4	0.5	11.4	3.5	2.1	6.9	0.8	0.2	19.0	0.5	0.7	8.9	19.0	7.5	0.3	1.6	0.0	2.3	2.4	10.2	1.6	20.1	0.6	13.4	8.0	3.6	11.2	1.6	45.3	8.2	4.5	9.2	1.2	2.5	8.2	0.7	8.2	1.0	0.8	0.6	2.1	0.0	14.3	4.4	10.1	10.8	2.3	1.0	0.1	3.6	3.5	2.7	6.5
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111813	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 406.2;Late spermatids: 505.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	8.0	4.2	3.8	5.7	4.8	18.2	6.0	4.4	3.9	5.3	4.6	5.0	3.6	5.9	4.6	4.2	6.3	4.2	5.5	2.8	3.5	4.4	4.8	7.6	5.5	5.4	4.0	5.4	5.1	2.9	2.9	4.4	4.9	4.4	3.2	4.8	4.4	3.4	2.6	3.7	5.2	3.2	4.4	6.2	5.8	2.6	4.5	5.5	4.5	1.9	4.2	6.6	5.4	5.3	6.5	3.9	3.9	3.8	7.2	7.7	6.3	8.9	4.3	3.9	4.2	6.6	2.7	8.0	6.2	10.5	2.1	5.2	3.6	5.2	7.8	11.4	4.1	6.4	7.3	2.9	3.6	17.9	9.6	5.6	4.6	5.8	4.7	3.2	6.0	3.1	3.7	7.9	4.6	4.1	8.5	3.8	3.2	4.3	6.6	11.9	4.5	3.1	3.7	5.9	4.5	3.5	7.1	4.6	3.6	3.4	4.6	6.7	9.9	7.7	6.4	7.1	7.2	10.7	5.3	9.0	5.8	7.5	4.8	3.0	5.0	6.8	5.0	3.2	4.0	3.9	3.6	3.8	4.2	5.0	3.5	3.5	18.0	2.8	4.0	5.5	3.6	2.5	3.8	4.8	4.4	3.9	2.8	3.5	5.4	4.0	4.9	4.4	4.5	5.3	98.2	96.1	88.7	64.6	112.6	46.3	60.4	30.7	43.9	100.4	32.2	35.6	138.6	28.6	61.4	33.1	131.3	57.5	136.9	36.6	15.6	62.5	406.2	64.8	86.9	94.4	99.0	47.9	81.3	38.0	64.9	78.4	62.7	73.8	72.7	68.5	60.0	47.4	60.3	60.6	74.2	45.8	40.7	135.3	126.7	505.0	97.6	166.2	65.8	106.8	137.1	52.3	204.9	87.0	140.0	70.9	62.8	138.8	83.2	63.2	32.3	21.0	44.6	128.6	170.9	81.4	197.6	107.4	80.9	38.7	36.7	43.0	127.4	70.5	38.9	73.3
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	18	"retina: 1186.9"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	12.8	7.9	57.9	2.2	60.5	1.2	9.3	56.8	67.4	9.1	48.1	9.8	1.8	7.7	4.7	7.6	10.7	4.6	8.1	54.5	59.0	7.0	7.1	6.0	2.5	67.4	61.0	13.5	3.6	5.2	7.0	1.4	62.1	8.2	2.6	1186.9	4.2	5.0	3.3	5.4	5.3	5.4	60.0	7.5	7.0	6.2	63.1	1.6	6.0	3.7	2.5	9.6	7.3	62.1	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	57.9	60.5	56.8	67.4	54.5	59.0	67.4	61.0	62.1	60.0	63.1	62.1	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA		82000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	21.1	17.7	14.1	22.5	15.7	22.0	20.6	18.1	16.3	21.8	15.6	21.8	20.8	22.8	17.5	23.4	25.4	15.5	26.7	14.4	17.1	14.6	17.1	17.1	35.8	15.0	15.2	31.8	15.3	18.9	14.8	16.9	17.2	22.2	17.2	22.4	21.8	21.8	52.4	25.9	20.6	21.9	16.6	21.8	17.0	14.4	16.3	37.6	23.2	34.3	37.8	22.1	19.7	19.0	93.5	90.7	77.9	76.2	35.3	35.9	88.1	73.5	40.7	85.1	87.7	132.0	41.2	128.4	68.1	41.3	34.9	83.4	93.4	58.3	93.5	86.3	116.3	77.8	113.6	51.0	23.4	57.7	65.5	29.9	37.0	84.1	36.2	30.1	62.9	77.0	75.8	72.4	60.2	47.8	127.3	33.7	63.5	58.2	53.2	173.8	44.0	72.1	37.3	62.3	34.9	54.7	103.9	35.1	63.8	52.0	75.1	43.4	56.2	66.5	56.7	75.3	113.9	19.8	56.5	76.0	46.5	88.6	82.2	43.2	25.0	54.5	53.1	36.4	54.2	51.2	55.1	53.0	30.2	35.8	53.0	48.4	11.9	80.8	47.8	31.7	56.7	60.5	14.1	15.7	18.1	16.3	14.4	17.1	15.0	15.2	17.2	16.6	16.3	19.0	14.9	9.6	14.7	12.4	24.3	29.6	16.3	22.4	17.6	19.2	25.1	21.0	23.7	22.8	14.4	40.5	4.2	69.4	27.0	13.5	5.9	20.6	18.9	13.4	16.6	21.7	15.6	67.6	12.2	19.8	68.9	23.2	7.7	14.2	33.7	25.0	25.4	24.2	46.1	37.0	14.0	19.3	26.4	49.1	14.6	42.4	32.3	35.1	28.4	14.0	37.6	39.7	35.0	12.1	18.2	15.0	7.2	34.6	23.0	14.1	24.6	11.7	19.4	19.5	0.0	19.2	21.5	14.7	21.8	24.3	29.1	43.5	30.3	15.6	23.1	11.7
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		520000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	3787.4	2419.1	1394.0	2169.7	1436.7	4648.6	4838.0	1413.7	1627.7	4522.8	1418.2	3090.4	1960.7	3234.2	2327.8	3175.9	4434.1	1996.7	2795.8	1340.4	1450.2	2318.6	2457.5	2593.7	4447.8	1490.4	1395.4	7892.2	8248.7	1574.9	1262.1	1879.3	1495.2	2998.1	2852.0	605.3	3991.5	2220.8	4760.6	4580.4	2644.6	2899.6	1535.3	3002.5	3262.2	372.8	1456.6	3691.0	2499.0	3882.7	5285.1	3395.7	3633.5	1537.6	5771.5	2604.6	2556.3	1973.1	5665.6	10627.4	2257.6	2147.4	4944.5	4036.4	5092.8	2323.7	2507.2	11250.6	5101.5	3609.5	4017.7	2175.5	5072.8	5166.9	3441.7	2507.6	4032.6	1534.4	1719.4	2591.8	6623.5	3314.4	2163.5	8104.7	8023.2	2435.8	7540.7	6953.8	6482.3	4734.1	2197.3	3482.7	4027.7	2869.8	3643.7	3212.1	2023.6	5617.9	4482.1	4301.7	2425.2	6334.8	4477.5	2015.0	2043.5	3397.3	526.0	4516.0	6630.0	2442.8	1643.7	4541.0	3144.3	1405.7	2655.1	3210.9	4865.5	8226.6	6458.7	11466.6	2139.0	4722.1	1803.6	2544.3	4388.3	622.1	4542.5	3596.8	7775.4	8121.0	7534.8	5653.3	4873.3	7698.6	8993.4	6990.0	410.0	5161.3	3275.5	5417.4	5907.4	18184.4	1394.0	1436.7	1413.7	1627.7	1340.4	1450.2	1490.4	1395.4	1495.2	1535.3	1456.6	1537.6	5788.7	1791.6	2556.0	46.7	10527.8	12070.0	13158.5	11320.6	8610.2	480.8	13969.8	18711.5	332.5	4499.5	4867.7	2039.7	248.1	6871.3	8329.8	1997.2	6751.9	4614.2	76.2	2214.5	6544.8	5970.8	2893.6	4044.6	45.3	13505.4	10754.4	5761.0	3039.8	3854.9	2982.2	5292.3	6493.4	4196.6	7070.4	269.2	50.7	6837.3	3196.2	8756.2	13887.5	284.8	8462.7	6722.9	8167.8	49.6	10601.8	1879.6	6844.6	56.3	89.0	7721.0	5174.6	3567.3	7282.8	12796.7	5976.0	8673.5	1751.3	859.1	2991.1	7996.0	6645.8	94.6	354.5	9576.3	14556.9	7562.7	9597.3	5236.0	6657.3	13414.3
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468401-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		740000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	1323.4	939.9	613.7	824.8	622.4	2051.4	2092.0	591.3	764.2	1803.2	604.3	1445.1	776.4	1350.0	1255.9	1583.0	1911.2	720.6	845.6	594.7	625.1	957.2	840.9	835.2	1625.6	619.7	603.1	3180.4	1894.4	682.3	731.1	747.7	627.8	1322.3	1178.3	255.2	1271.7	1007.2	1411.5	2166.4	1075.0	1114.2	654.0	1063.9	1188.8	230.5	628.8	1585.0	1084.1	1009.5	1733.0	1434.0	1506.3	642.7	1205.5	1211.3	1349.6	1275.9	1967.9	3560.6	1522.8	1213.7	2475.5	1671.2	1320.9	1765.5	1126.2	3571.4	1089.8	1650.2	819.4	1036.0	1832.7	2764.1	1374.0	1249.1	1618.0	1375.9	1007.0	2501.0	2909.6	2031.3	1096.1	4179.2	3172.8	1225.0	4066.4	2689.3	2481.9	1760.1	1652.9	1712.2	1920.0	2112.5	2158.4	2452.2	1421.3	1879.5	1057.5	1681.9	1298.7	2801.6	2124.0	1949.5	945.6	1384.7	747.8	1688.0	3632.5	1076.1	1831.0	3628.9	1450.9	541.4	975.4	729.4	1559.5	1073.4	1889.4	2381.8	681.1	2322.7	992.7	215.5	1232.7	120.6	1478.3	1210.1	2629.7	3176.9	2436.2	1905.6	1990.0	2806.5	3252.5	2601.9	113.1	2069.4	1077.8	1875.3	2059.9	5496.8	613.7	622.4	591.3	764.2	594.7	625.1	619.7	603.1	627.8	654.0	628.8	642.7	973.2	535.2	1036.5	19.2	3101.2	5399.7	5910.9	3550.3	2636.7	221.4	4627.1	4144.2	270.8	1742.9	1828.0	597.7	73.0	4048.8	1980.0	867.3	2983.7	1701.7	243.5	992.0	2446.8	1604.3	1512.3	1533.0	23.1	3272.4	5396.6	1667.3	884.8	1150.5	917.2	2228.2	1601.0	1519.3	2201.2	109.4	23.8	2834.0	1084.4	1989.9	3307.5	430.7	2517.0	1457.1	2406.5	17.8	2486.8	530.4	1845.5	31.7	32.4	2092.1	2269.8	1479.8	1382.6	4479.8	1447.6	2791.4	790.8	252.3	769.2	3139.6	1955.7	236.4	357.1	3510.2	6623.0	4105.6	2341.0	2848.1	3482.8	5438.5
RPL11	"L11, uL5"	ENSG00000142676	"Ribosomal protein L11"	P62913	1	23691742-23696835	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA002734	Approved					NA	NA		420000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 32: Non-specific - Translation"			"HPA002734: AB_1079838"	"prognostic favorable (2.55e-4)"	"unprognostic (3.98e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.70e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (5.93e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.90e-1)"	2197.5	1349.1	758.6	346.3	785.5	806.8	2374.3	764.5	1074.4	2495.3	749.2	1713.2	317.9	1551.7	1107.6	2043.6	1984.4	265.0	1422.6	736.6	795.9	1543.3	1447.9	1462.7	701.7	809.3	768.6	3879.7	3207.9	637.6	1144.7	507.5	800.5	1788.9	985.9	386.7	1763.2	645.4	1526.0	2752.4	1715.1	689.7	795.4	1949.2	2314.0	460.2	781.0	1219.1	1414.8	880.4	1842.1	1717.0	2090.6	813.7	662.3	1068.4	1257.9	639.1	2123.4	2978.6	437.2	431.4	1845.0	1641.4	1217.1	1937.6	719.7	1370.3	470.9	1511.4	665.7	543.3	1611.2	2187.0	1824.5	492.7	2157.9	633.6	3936.3	2610.9	1589.8	1086.5	499.1	2928.6	3156.8	1394.3	2498.9	2009.5	1767.1	2371.5	747.4	713.2	1768.6	2068.0	650.7	1737.1	313.0	2165.7	1216.9	800.7	608.8	1319.0	1877.2	1173.3	491.0	601.2	337.3	697.8	1360.9	1083.0	514.3	1352.0	524.4	391.2	546.3	672.8	554.2	658.6	643.2	968.8	499.0	1529.0	458.4	1028.5	1455.4	431.6	1270.6	1217.3	2184.9	3261.3	2593.8	1881.3	1736.4	2812.9	3379.5	2575.7	211.5	1567.3	990.9	1725.9	2092.7	5471.7	758.6	785.5	764.5	1074.4	736.6	795.9	809.3	768.6	800.5	795.4	781.0	813.7	3418.4	1179.5	2275.5	43.8	6392.9	6628.5	7570.4	5085.6	5306.4	352.5	7418.2	12717.3	617.0	3247.0	2566.9	1125.5	154.3	4728.5	4068.6	1693.1	4807.1	2915.5	1052.2	1501.4	3771.6	3056.2	2161.7	2833.3	27.2	6657.0	7929.6	2968.4	2193.7	2008.2	2101.5	4064.4	3524.6	3426.2	3894.7	206.9	29.6	3865.1	1462.8	4584.6	6984.2	2224.6	4602.4	3661.8	3758.4	46.9	5264.1	1582.9	3300.8	24.1	64.1	4149.5	3575.9	2083.0	3334.0	6327.0	4545.4	5429.1	1260.7	664.2	1413.4	3920.1	3380.5	604.1	699.6	6295.1	7993.4	4651.9	5029.1	4961.7	4420.7	7534.5
RPL12	L12	ENSG00000197958	"Ribosomal protein L12"	P30050	9	127447674-127451406	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 16277.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003403	Approved		Approved	"Golgi apparatus"		NA	NA		710000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"		"HPA003403: AB_1856432"	"unprognostic (5.89e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (4.98e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.80e-2)"	1951.8	1231.3	835.3	1038.0	851.8	2761.0	2915.7	839.5	1071.0	1971.7	849.8	1701.0	1014.9	1367.8	2197.8	1898.6	2181.0	1058.6	1075.1	814.9	877.7	1217.9	1183.9	1195.7	2118.1	883.8	861.1	3020.6	2703.8	700.7	888.2	879.2	891.8	1637.0	1384.7	360.7	1784.8	997.7	2166.7	2609.6	1237.2	1202.9	884.9	1349.8	1401.3	339.2	851.4	1696.8	1423.5	1318.1	2422.7	1851.7	1787.9	901.5	1511.6	1359.5	1474.8	2976.3	2773.6	6171.2	2266.6	1317.9	3562.5	2315.3	1802.2	2949.5	1529.4	2855.4	1745.3	2256.0	1161.2	1774.7	1887.1	3068.4	1578.4	1451.5	1731.1	1678.1	1705.9	2724.4	5881.5	2596.8	1735.1	6766.3	6013.6	1628.4	6142.1	4589.1	3178.6	1755.1	2307.8	2371.9	2920.2	5170.1	2464.7	3988.0	2166.2	4448.6	2519.6	2073.6	2828.6	3141.2	3458.6	1497.1	1295.6	1882.9	989.8	3291.6	4287.8	1727.6	2707.1	3536.1	1796.2	866.3	1546.2	1504.9	2645.1	1223.5	1630.1	2951.4	901.8	2447.8	1351.3	354.9	961.6	274.4	997.8	982.9	1845.3	2714.4	1857.1	1366.2	1536.6	2602.0	2177.6	1891.8	114.3	1265.6	973.6	1398.4	1772.9	3151.7	835.3	851.8	839.5	1071.0	814.9	877.7	883.8	861.1	891.8	884.9	851.4	901.5	2021.8	695.5	1593.2	9.1	5219.3	6047.5	4680.5	5696.6	6688.2	186.4	9458.0	16277.6	445.0	2522.1	2427.5	1272.7	85.5	3455.7	2702.3	1424.3	4073.5	2502.6	320.6	1210.9	3910.1	2415.0	2095.3	2939.8	7.4	7126.9	5794.1	2409.3	2320.1	1688.1	1876.4	1940.1	3301.1	2861.4	3348.2	95.9	7.5	4283.6	1810.7	5716.7	5579.1	839.4	5405.5	2945.4	3601.9	13.1	4509.5	782.7	2582.9	5.5	13.4	4166.6	2911.7	2389.9	2741.9	4582.4	3159.4	6003.0	879.7	309.3	986.1	3458.1	2319.6	334.8	584.2	7183.3	6963.2	3724.4	3677.5	3289.4	4446.0	4896.3
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560677-89564542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	2508.9	1855.2	1068.8	1015.2	1070.1	2207.4	2514.6	1007.8	1300.0	2885.7	1027.9	2382.3	1082.7	1830.7	799.8	2804.1	2342.7	756.7	1661.7	984.6	1007.1	1722.4	2142.4	1560.6	2106.2	1129.1	1023.0	5001.9	4316.1	896.0	1581.0	636.9	1076.3	2852.9	719.0	215.3	2413.8	826.7	2404.7	4466.0	2067.4	689.9	1159.2	2545.7	2148.6	856.8	1078.9	1718.3	1609.7	1175.1	1635.1	2301.1	2682.5	1123.0	1402.1	1524.2	1063.0	1733.2	1869.8	3083.4	2218.9	863.7	1857.6	1768.8	712.9	2316.0	2113.8	1954.1	1729.3	1484.1	700.0	1903.0	1279.4	2281.5	873.2	551.7	3534.0	666.7	817.4	3149.0	3985.0	818.9	781.2	3770.4	4759.6	1136.6	2847.0	2870.3	1870.2	2424.6	2074.1	1084.5	1380.2	4385.7	2272.4	6404.2	2180.5	2755.6	1601.9	3323.5	1128.8	2786.0	2205.4	1162.1	1491.3	2176.3	1195.0	1544.6	2735.2	665.7	3044.3	4780.1	1101.8	1132.3	1218.4	1008.8	1211.3	1626.1	1668.7	2104.6	1479.4	2863.7	1220.5	1017.1	3191.4	507.1	3779.3	2446.7	7007.7	7792.3	6813.4	5173.6	3626.5	8215.0	8509.1	6722.0	323.4	4085.8	1910.1	5071.9	5277.8	13749.1	1068.8	1070.1	1007.8	1300.0	984.6	1007.1	1129.1	1023.0	1076.3	1159.2	1078.9	1123.0	3260.3	1804.5	3489.0	39.8	9318.5	12528.7	15921.0	7329.9	8523.7	675.1	10709.1	13191.6	465.3	3808.9	4064.9	1616.6	189.7	6201.2	5935.5	1800.0	4652.6	4068.5	4125.7	2011.7	5627.8	4627.9	2937.8	3784.5	39.1	10909.9	11178.8	4536.6	2934.8	2679.4	2651.1	6392.0	5119.5	4261.1	5228.5	249.0	52.5	6292.1	2089.4	7058.1	8832.3	12884.5	8244.9	5051.4	5457.0	66.5	7569.8	1941.5	5395.5	158.3	86.4	7077.2	4715.7	3652.3	4667.7	14016.4	5245.4	7448.2	1834.7	786.9	2084.0	5936.3	5693.8	1721.1	1052.9	9022.1	16171.5	6165.5	7831.2	7839.7	7465.8	15137.1
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487510-49493057	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	2188.0	2248.7	1092.3	1522.1	1122.8	3160.3	2279.6	1064.6	1616.8	2808.8	1147.7	1987.3	1681.3	1743.7	742.1	2699.3	2138.4	1061.8	1522.6	1034.5	1074.4	1532.8	1642.1	1467.3	2995.9	1117.3	1065.6	4462.0	4145.5	956.8	1244.7	1070.5	1119.3	2042.8	957.8	585.8	2381.8	963.3	2940.7	3275.0	1966.3	780.3	1131.1	2267.8	2148.1	451.9	1123.9	2070.4	1594.9	1484.8	1783.2	2092.3	2369.7	1115.7	2693.9	3191.9	1553.5	4384.1	2927.6	4606.7	1812.7	2265.3	2944.1	1696.6	1823.7	2817.9	2001.2	6730.4	1792.9	1804.0	687.0	1724.4	1978.2	3463.6	974.1	1895.7	4496.8	3377.7	1945.3	3984.3	3562.3	5127.9	2581.9	5363.6	5688.6	1203.5	4051.7	3536.9	2763.2	2430.9	2982.0	2472.0	1975.0	2322.6	3629.2	5266.7	2905.4	2535.0	2987.2	3504.5	3396.6	2968.4	2319.3	4481.3	2545.5	3362.0	1184.7	5205.9	5408.7	1180.0	2303.0	5907.2	3249.6	2026.5	2165.3	1276.1	3061.9	2474.5	3628.5	3102.4	1267.1	3505.6	1898.9	1499.6	2615.2	669.3	3673.1	2167.5	5384.1	8504.2	6249.9	5035.0	3741.0	7985.6	7293.6	5930.8	400.5	4696.2	1914.5	4364.8	5054.0	13490.7	1092.3	1122.8	1064.6	1616.8	1034.5	1074.4	1117.3	1065.6	1119.3	1131.1	1123.9	1115.7	759.0	1618.6	1998.3	5.9	5793.5	11583.3	12255.7	8593.4	1801.8	534.6	8903.0	5580.5	544.1	4340.8	4712.7	1590.9	214.8	7997.8	3602.5	2445.5	5433.2	4560.9	304.1	1462.1	3740.3	3725.7	3984.3	2696.0	5.1	12776.9	10340.4	3277.8	916.9	2114.2	2546.8	1496.7	5087.0	4397.2	5887.8	220.4	6.0	7002.5	2705.8	7291.2	8449.9	709.7	9127.2	3169.3	5695.4	9.4	7891.8	1658.7	5864.1	8.0	12.4	7364.8	6114.5	4432.7	1348.9	11217.2	5888.9	7303.9	2192.4	723.4	2655.9	5724.7	2897.9	456.9	817.2	2602.1	14282.8	8401.6	4958.9	2454.2	8198.9	13221.0
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		270000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	193.3	125.9	50.3	29.2	53.0	64.2	199.2	53.9	66.4	280.8	49.7	204.9	39.0	173.8	28.5	178.6	203.5	25.3	89.8	49.2	53.3	157.1	133.0	157.7	45.3	54.0	50.7	401.6	236.4	45.5	161.1	40.7	52.9	180.5	39.8	37.0	173.9	58.2	165.5	226.7	125.3	33.5	54.0	126.1	193.3	27.8	53.7	59.1	161.1	62.9	56.0	210.4	214.5	49.9	53.1	23.4	116.6	55.7	103.6	281.6	80.4	85.8	140.4	152.1	110.9	48.9	18.5	205.9	64.9	64.6	76.4	17.2	78.1	103.7	104.9	79.7	80.6	115.3	43.1	44.7	149.4	153.1	53.2	172.9	301.8	70.6	143.1	220.9	168.3	179.7	111.7	30.1	117.1	38.1	53.4	111.8	44.8	172.9	75.7	26.9	65.6	95.4	140.3	33.2	46.3	75.2	43.2	40.2	102.6	128.0	58.5	74.5	93.3	50.8	41.5	67.4	102.5	90.9	129.3	125.0	22.9	106.1	47.5	15.4	49.1	19.2	76.5	46.0	118.9	98.6	110.8	98.1	62.1	89.8	133.6	126.9	6.5	56.9	38.0	54.4	97.1	236.2	50.3	53.0	53.9	66.4	49.2	53.3	54.0	50.7	52.9	54.0	53.7	49.9	1374.3	830.1	1146.4	29.7	2884.7	3113.4	5120.8	2595.4	3076.6	225.8	3891.2	6163.2	346.3	1634.2	1633.6	676.8	102.2	3352.5	2285.9	971.2	2529.8	2063.4	290.0	898.3	1997.2	1471.6	1228.6	2245.7	39.0	4163.8	4729.5	1652.6	1184.6	1362.2	1565.2	1640.0	1678.7	1340.0	2207.8	101.0	45.7	2528.3	805.6	2102.2	2691.6	617.6	2160.3	1804.6	1782.2	32.8	2894.7	491.4	2368.7	23.1	41.3	2772.7	2061.9	1084.8	1855.0	4343.4	2359.1	3658.8	667.3	328.8	966.3	2109.4	2212.8	265.0	405.3	4161.2	3418.2	3314.5	2819.7	1921.9	2787.9	4891.9
RPL15	"EC45, L15, RPL10, RPLY10, RPYL10"	ENSG00000174748	"Ribosomal protein L15"	P61313	3	23916591-23924374	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"				"unprognostic (8.73e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.17e-2)"	1235.0	974.6	932.8	988.5	948.8	3173.3	1985.3	910.8	1017.8	1476.6	865.3	1256.2	916.2	1233.3	1364.2	1590.2	1684.8	1032.7	1064.9	889.6	947.1	924.1	963.9	881.7	2139.0	956.2	935.2	3508.3	2314.0	1132.0	875.3	999.3	954.7	1056.4	1082.2	492.2	2541.7	933.6	1204.2	1598.4	944.7	1146.3	1028.4	1135.6	1189.7	543.9	985.7	2145.3	1420.4	1470.7	1967.5	1622.0	1298.3	983.7	1884.4	1672.6	1865.3	2205.4	2938.4	4771.0	2306.5	1735.1	3111.2	2614.8	2272.5	1911.8	2160.2	3773.1	1663.6	2599.8	1395.8	1246.8	2257.1	3847.8	1873.7	1781.3	3198.5	1482.3	1665.5	2318.9	3919.5	2624.0	1883.9	4784.3	5359.8	2903.6	4909.4	3783.5	3360.8	2616.7	1920.5	3044.4	2731.4	2598.3	3423.7	3345.9	3254.1	2354.3	2745.2	2980.8	1645.5	4025.3	2762.8	2203.8	987.6	2402.2	1020.5	4416.6	3791.8	1655.3	2958.9	5102.2	1849.1	1569.5	2056.3	1645.1	3196.8	2579.1	3758.6	3500.8	1570.9	3483.4	1852.3	897.2	2250.3	454.1	1698.4	1878.9	2960.6	3476.6	2599.4	2357.9	2917.1	3310.7	3182.8	2831.7	263.1	2346.0	1602.6	2369.7	2475.9	6597.8	932.8	948.8	910.8	1017.8	889.6	947.1	956.2	935.2	954.7	1028.4	985.7	983.7	1499.2	746.8	1100.3	44.7	3602.1	7074.5	6959.4	8223.9	3122.1	541.8	6066.8	6379.1	385.1	2546.4	3484.1	1029.9	181.4	4812.5	2798.4	1007.2	4187.0	3163.6	3239.1	1167.3	1989.0	2798.6	1720.1	2338.9	63.9	4491.5	6879.4	2261.8	1083.6	1607.8	1478.8	2969.2	2682.2	1755.9	3583.6	277.6	77.7	2855.1	3013.0	3552.7	6451.3	4965.7	3662.3	2601.6	3966.5	50.6	4609.7	1412.2	2856.9	45.8	91.3	3499.5	2558.2	2337.3	2291.1	7001.0	1750.8	3801.2	1422.6	570.1	1360.8	2679.8	4368.3	1786.6	962.8	4001.9	8678.9	5061.5	2967.3	3017.0	3549.9	7926.6
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 2876.9;Squamous epithelial cells: 3332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	1966.5	1982.7	942.7	997.8	948.6	2559.4	2698.3	978.7	1418.8	2426.3	974.0	2075.1	880.2	1747.2	1295.2	2261.4	2040.5	820.1	1417.0	919.9	975.3	1619.5	1470.2	1410.7	2009.4	955.0	944.3	4472.1	4182.0	862.3	1495.0	888.2	967.1	1829.2	1089.6	612.3	1788.1	899.7	1351.1	2405.0	1619.7	912.2	988.0	1850.3	2038.0	574.8	969.5	1637.0	1607.1	868.1	1672.5	1972.7	2087.9	978.7	2205.3	1360.2	1937.9	2315.0	3146.0	6392.2	1829.3	2400.4	2783.7	2229.8	1677.4	1860.7	1039.7	3785.8	1572.2	2399.7	1250.1	2569.5	2690.1	4329.7	2377.4	1547.4	2773.8	1999.8	1500.4	2560.9	2718.4	6578.1	1526.2	6150.1	4787.7	2333.9	5487.0	5189.2	3100.5	2538.6	1995.5	2685.2	2794.0	1781.7	2386.9	4203.2	1993.4	1327.9	1110.7	2333.6	2538.1	4932.3	3037.1	2571.4	1462.8	1741.2	882.6	1827.5	3949.5	2366.9	1726.9	4230.9	2473.3	1633.3	1389.1	815.2	2570.9	2341.0	2404.3	3520.5	1564.3	3936.3	1593.2	312.8	840.7	151.3	1081.4	743.0	2106.6	1907.9	1763.3	1442.8	1305.7	1574.1	1936.2	1697.1	104.4	1431.9	618.7	1427.3	1509.5	2477.8	942.7	948.6	978.7	1418.8	919.9	975.3	955.0	944.3	967.1	988.0	969.5	978.7	104.8	663.4	916.1	0.0	1445.5	701.8	237.9	319.7	2876.9	15.3	704.3	451.7	0.7	348.9	969.4	103.0	10.4	396.5	311.7	386.7	497.0	864.7	195.8	102.2	169.2	426.4	819.2	1193.5	0.0	1630.2	582.5	558.6	1132.5	98.5	998.9	58.9	414.1	217.3	272.3	10.1	0.0	1233.6	81.4	561.1	588.8	452.1	527.2	616.8	291.7	0.0	973.9	42.7	515.9	0.0	0.0	1268.6	909.2	272.3	1659.1	177.3	768.9	648.6	561.5	23.8	249.8	401.7	297.5	100.8	100.5	3332.8	922.5	414.8	1066.7	61.1	1437.8	216.6
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619184	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 16079.5"					"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: AB_2679705"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	1000.7	1074.9	985.7	753.7	981.5	1976.6	1333.2	932.2	1170.2	1491.2	910.5	995.0	912.2	1051.5	782.6	1786.5	1415.0	719.4	754.8	924.1	955.5	756.7	974.7	730.6	1740.2	980.7	953.9	3084.6	2343.7	580.6	905.7	746.8	972.6	1262.1	814.4	139.0	1779.2	702.0	1056.9	1944.3	956.6	709.9	999.1	1151.6	1122.4	332.2	993.5	1091.5	880.0	643.0	1399.0	1017.9	1356.0	989.5	1874.4	2697.1	1148.7	1520.6	1267.0	2299.6	1455.1	1042.7	1489.0	1754.3	1471.6	2497.8	1407.6	3436.1	874.1	1007.2	803.9	1400.0	1211.2	2056.9	844.3	1349.6	3380.2	1286.3	1234.0	2438.1	2166.6	1793.6	1309.6	2633.8	3015.8	1031.9	1603.7	1760.0	1836.8	2149.2	1629.3	2043.5	1297.6	2236.5	1926.2	16079.5	1421.6	3171.4	1469.5	2058.1	1073.4	2438.4	1527.9	2370.7	1410.8	1739.1	850.4	2306.0	2082.3	641.1	1241.4	2618.1	1220.9	1032.3	1275.0	727.4	2119.8	1970.9	2939.2	1934.2	649.6	2246.7	1257.7	381.1	1022.8	217.6	1066.6	890.3	1889.0	2384.8	1921.2	1461.0	1380.1	2368.0	2373.9	1981.4	140.7	1357.8	681.2	1451.1	1707.2	3192.5	985.7	981.5	932.2	1170.2	924.1	955.5	980.7	953.9	972.6	999.1	993.5	989.5	1729.2	593.0	983.1	22.9	4066.2	4468.5	4767.6	3561.4	4933.7	393.5	3680.3	5354.2	264.0	1637.1	1809.1	708.1	143.9	3891.0	2534.2	1344.7	1387.2	1853.2	80.5	1067.0	2619.6	1812.4	1673.5	1713.1	21.7	4530.2	5344.1	1765.9	1597.9	1584.8	1021.6	2791.1	1810.1	1426.6	2225.3	134.6	28.2	3186.8	1253.2	2491.6	3341.9	221.3	3248.9	2059.4	2278.5	16.9	2958.8	1413.2	2345.1	22.6	51.3	3022.6	2516.1	1459.7	2801.6	4727.0	2534.3	1832.5	697.3	433.7	1032.1	2596.1	2246.5	283.4	558.4	5421.3	5559.5	4138.0	2961.3	3084.2	3163.6	5183.8
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859910-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 682.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055259	Approved		Approved	Nucleoli,Cytosol		No	No		44000	"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA055259: AB_2682764"	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	1984.9	1325.9	783.3	1207.3	801.9	2675.9	2006.4	765.1	966.5	2276.5	976.5	1896.2	1072.6	1684.5	414.2	2432.1	1900.0	848.3	1178.2	738.0	778.4	1205.8	1161.2	1350.6	2511.2	806.4	757.5	3627.6	3907.4	541.6	923.3	757.2	789.9	1596.6	718.5	205.8	2590.5	635.5	2533.1	3581.5	1721.9	686.3	819.5	2048.4	1928.7	350.6	801.3	1573.9	1398.1	1213.3	1488.2	1737.1	2164.1	808.5	2623.4	2001.4	1299.0	1847.0	1923.3	3152.4	3291.2	1559.5	1979.9	2038.9	1930.5	2789.2	2550.3	3921.7	3523.0	1365.1	805.3	1913.5	1555.9	3350.6	708.6	2020.7	4206.5	1833.5	1792.6	3238.9	3314.5	2660.3	1916.4	3952.5	4349.3	1127.8	2410.2	2094.2	2265.6	3157.8	2386.5	2462.6	1313.5	4085.3	3633.0	3514.7	3067.9	2909.3	3049.2	3210.9	1376.3	4708.0	1887.0	2464.1	1879.4	2817.6	554.3	3813.0	5042.2	637.7	1814.7	5079.9	1738.1	1244.6	1438.8	2512.2	2674.5	3251.9	3283.4	2639.9	1632.9	4270.0	1580.0	1247.5	4513.0	690.0	4974.8	4521.9	8679.3	14996.3	8499.1	6207.0	6569.7	15438.5	9988.2	7821.6	433.2	5415.3	3633.6	7634.4	8027.2	21239.5	783.3	801.9	765.1	966.5	738.0	778.4	806.4	757.5	789.9	819.5	801.3	808.5	1797.3	519.2	1033.4	1.3	6570.0	8683.5	6503.8	6346.6	5314.4	252.0	7203.4	8120.9	437.2	2077.4	2572.8	923.2	127.2	4676.6	3414.9	1440.2	2387.0	3503.1	57.0	1112.5	3101.7	2919.9	1842.7	2735.0	1.8	8949.1	8763.1	2652.7	2316.6	1639.3	1447.9	3627.9	2837.8	2144.2	3317.2	131.2	2.2	3965.3	1881.8	4748.0	8399.9	194.1	4165.1	3240.6	4747.4	1.9	6119.2	908.2	3084.5	1.5	2.5	5684.1	3130.7	1627.9	3619.6	6541.4	3169.3	3629.8	1019.5	499.6	1255.6	3061.1	4561.4	199.9	834.7	6806.4	11135.4	4659.3	4511.8	4057.7	4606.2	8094.9
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204840	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 37509.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	2108.0	1641.8	1232.8	1325.7	1302.0	3445.4	2213.5	1236.2	1473.8	2449.2	1230.5	1983.7	1161.3	1717.3	1256.1	2160.0	1997.7	1159.4	1539.0	1175.0	1252.5	1725.6	1485.2	1453.6	2835.1	1303.7	1237.8	3638.0	3006.2	1537.0	1362.5	1050.7	1304.9	1733.7	1231.5	383.6	2136.0	1214.5	2763.0	2809.4	1733.8	1104.6	1324.2	2003.5	1872.5	615.5	1268.5	2335.8	1462.6	1879.2	2543.6	1915.1	2121.1	1325.7	1943.7	2617.7	1849.0	2258.4	3300.1	4133.6	1894.3	1788.5	3631.1	3629.7	2895.6	2872.0	1801.2	4740.4	3047.1	2580.8	2122.7	3228.2	2807.4	3714.8	1852.4	1922.4	4931.8	1693.5	1876.5	3797.5	5133.2	4201.0	2240.4	4647.6	3995.5	2805.3	5031.4	3396.2	3177.6	3991.6	3007.3	2696.5	2544.2	1939.5	5610.7	5814.7	1891.0	2269.3	1912.1	3270.3	2620.6	4777.9	3324.4	2419.1	2225.5	2457.9	1084.0	37509.3	5867.6	1982.1	3626.8	5201.1	1883.8	1410.9	1894.7	2165.8	3336.2	3504.5	3756.7	3505.5	1906.0	3147.3	1854.1	1051.1	2648.2	975.0	2486.9	2147.2	3862.3	4698.0	3984.2	3158.7	3263.9	4349.1	4920.5	4086.9	380.6	2830.2	1793.7	3012.9	3456.9	9398.3	1232.8	1302.0	1236.2	1473.8	1175.0	1252.5	1303.7	1237.8	1304.9	1324.2	1268.5	1325.7	2477.2	884.6	1438.4	49.0	5591.4	5551.7	6227.1	4092.6	3998.1	241.7	5532.9	7926.2	556.3	2332.0	2100.3	1138.5	93.8	3720.2	4011.1	1443.7	3623.4	3025.0	1451.9	1129.0	2357.2	2714.5	1957.2	2708.2	30.8	6238.2	5441.3	2425.2	1705.4	1503.7	1586.0	3024.3	2836.8	2406.3	4189.9	132.9	33.6	3550.3	1464.8	4218.0	5326.1	4539.9	3920.2	3259.8	3272.8	46.9	4282.6	1495.1	3932.1	20.1	51.1	3972.8	3267.4	2040.2	3289.0	6219.8	3226.4	5182.0	1049.1	390.5	1531.7	3215.1	3875.5	962.9	981.4	5376.4	6619.2	3899.7	4615.5	3399.1	3895.2	7406.6
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6185020-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA068294			Approved	Nucleoplasm,Nucleoli		NA	NA		860000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA068294: AB_2732781"	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	579.0	489.0	252.3	511.9	262.0	1064.4	599.4	258.1	400.1	716.0	257.9	573.4	475.0	513.3	313.9	621.7	590.5	220.4	390.9	243.7	261.0	473.0	480.3	396.9	659.8	256.3	250.3	1096.7	690.5	312.2	331.9	308.3	259.9	487.3	320.3	316.6	589.4	218.3	912.3	686.8	461.4	247.4	263.7	501.7	500.7	137.8	255.5	484.9	400.4	398.8	509.7	551.5	600.5	274.7	1443.4	400.8	836.4	858.6	576.1	897.0	659.0	1224.2	488.1	440.4	372.9	802.5	1213.4	2217.7	981.3	458.1	304.2	810.7	636.9	638.2	576.9	1093.6	1033.3	2159.0	948.8	1016.3	569.4	2893.0	828.4	799.9	516.3	393.5	808.6	907.3	560.1	610.3	1817.3	1301.1	512.9	634.7	1274.0	2340.3	522.1	953.0	880.1	1207.4	1731.8	1731.8	656.1	490.4	1149.9	1051.9	996.9	2846.8	2387.4	721.1	918.2	2247.5	1380.1	623.1	689.2	833.9	1170.4	1037.2	1544.9	3289.7	413.0	2911.2	395.5	109.0	297.7	71.2	268.2	270.0	474.9	547.1	502.6	373.2	451.6	500.6	679.0	560.8	22.0	337.5	227.9	472.2	416.3	664.1	252.3	262.0	258.1	400.1	243.7	261.0	256.3	250.3	259.9	263.7	255.5	274.7	1090.2	445.5	731.5	5.9	2372.5	1821.1	2035.3	1455.3	2241.2	217.6	1764.0	2190.8	277.9	1225.3	883.4	584.9	131.3	1816.1	1450.8	669.0	1905.6	1332.1	442.9	736.9	1377.2	1104.5	912.5	1508.9	15.3	1823.0	2751.0	1022.5	940.9	944.1	921.5	1256.6	1457.4	1491.7	1504.9	141.3	14.2	2032.2	449.6	1997.8	2098.8	320.1	2027.4	1440.8	1076.1	14.0	2435.3	890.1	1442.9	8.0	10.7	1575.3	1413.5	1234.1	1218.7	1837.3	1182.5	2505.6	437.3	390.8	775.7	1773.9	1169.1	358.6	473.0	2759.8	1935.8	1851.9	1791.5	1289.9	2231.0	2084.3
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847860-38853764	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	2078.9	1410.2	882.7	972.2	902.3	2444.5	2530.4	888.8	1161.1	2151.7	925.6	1577.9	805.2	1497.6	1786.7	1678.9	1807.0	820.5	1232.2	860.7	927.0	1410.9	1228.9	1247.9	1934.3	926.0	901.9	3960.2	2100.0	1007.4	906.0	1087.5	937.4	1501.3	1208.1	512.2	1409.8	893.5	1901.2	2283.1	1290.8	1029.7	943.8	1607.9	1409.4	336.7	908.6	1998.6	1268.0	1617.6	2264.0	1591.5	1782.4	943.3	1912.8	1871.0	2422.1	2063.9	4227.9	5507.5	1695.5	1866.3	2802.6	2301.3	1716.5	2721.1	1652.1	4214.1	1806.8	2066.8	1701.9	3284.2	2131.0	3622.1	2803.5	1466.9	3178.0	1553.9	2573.8	3929.6	3170.2	4326.7	1561.7	5216.3	4409.6	2003.4	4154.8	4103.3	2475.7	2891.2	2507.1	2069.3	3000.0	1705.8	3818.5	4600.5	1778.3	2488.3	1131.0	2560.7	3549.4	4180.4	3262.5	2384.2	1643.0	2433.7	1001.5	1707.3	3998.7	3317.1	2828.9	5324.1	1746.6	1052.1	1617.9	1666.2	3155.0	1327.3	2217.4	3326.8	1613.0	2551.5	1388.0	568.8	1536.7	318.0	1179.7	1207.3	1463.1	2374.0	1868.0	1451.6	2065.6	2159.5	2473.1	2142.2	227.0	1404.4	1069.0	2578.5	1498.0	3233.2	882.7	902.3	888.8	1161.1	860.7	927.0	926.0	901.9	937.4	943.8	908.6	943.3	764.4	1012.8	1606.1	8.5	1481.6	2446.7	2204.6	1828.9	747.3	147.1	1240.8	1011.2	532.6	1243.9	1379.0	472.6	68.8	1809.9	1282.7	652.1	1352.0	1390.0	309.2	1084.8	2160.4	1122.6	919.7	808.5	11.3	2090.7	2633.3	985.1	306.3	1353.6	1350.3	1137.2	1572.1	1581.2	1666.5	58.9	10.9	1609.3	594.1	2477.5	2490.5	233.0	2682.2	1456.6	1108.1	11.2	2741.1	735.2	1365.6	5.0	11.5	1909.4	1437.5	1447.7	491.4	2347.2	799.6	2260.6	650.8	223.6	749.4	1743.9	1908.2	259.2	219.9	1022.2	3164.9	1904.2	1207.9	1159.8	1854.8	2378.9
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719985-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		86000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: AB_2681593, HPA077474: AB_2686841"	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	1584.8	1113.1	654.3	671.5	688.0	1394.2	1570.3	652.4	1022.2	2187.2	625.1	1445.1	612.6	1394.1	718.6	1571.9	1634.3	535.3	1187.3	618.4	650.0	1099.0	883.0	1093.0	1433.2	673.2	651.5	3435.1	1784.0	525.5	1098.5	674.5	679.4	1319.5	821.4	343.6	1355.9	639.7	2007.1	2167.8	1341.4	670.2	718.7	1621.7	1365.0	394.3	691.1	970.1	1098.0	887.1	1529.3	1516.5	1724.7	701.9	1011.7	2016.2	1187.9	1478.2	1541.3	2460.3	1167.5	919.9	1609.3	1530.9	1285.0	2069.6	945.7	2272.0	842.9	1288.6	794.8	1336.2	1604.1	2059.1	1570.9	1207.4	4393.8	1090.0	1875.4	2228.4	1393.9	2286.0	1078.5	2415.4	2592.8	1218.4	1907.0	2198.5	1679.1	1024.9	1440.9	1494.0	1555.3	1668.7	2566.5	3014.5	1145.8	2554.4	1212.9	1485.1	2158.1	2703.9	1672.0	2029.6	1233.6	1432.9	656.5	4676.5	2224.2	1655.3	2336.4	2637.5	1009.1	833.0	1177.1	985.4	1663.8	1819.6	1831.8	1323.2	1314.2	1241.1	939.6	1095.3	1931.7	552.4	4031.6	2107.3	5926.1	6793.2	5786.8	5255.4	2964.7	5683.7	6315.4	5951.4	244.7	4162.0	1738.1	3784.3	4293.0	7336.1	654.3	688.0	652.4	1022.2	618.4	650.0	673.2	651.5	679.4	718.7	691.1	701.9	987.8	862.2	1387.4	42.1	4276.8	5192.7	5364.3	4497.6	1889.4	237.4	3483.7	2581.2	292.2	2254.7	2254.3	864.4	70.9	4486.2	3010.4	1253.0	3083.4	2444.1	968.0	1089.8	2060.3	2031.0	1846.3	1943.9	13.5	4593.6	6595.0	1928.4	821.6	1503.9	1512.6	1814.9	2939.2	2626.6	2651.7	163.2	17.2	3659.6	1310.2	3406.8	5015.0	360.5	4557.4	1983.9	3066.4	14.0	3997.3	1072.1	4293.5	16.1	23.3	2801.3	3326.6	2366.6	1803.5	5056.3	2925.9	3669.2	886.9	363.6	1709.2	3461.4	2748.7	674.8	779.0	2554.1	6196.5	4927.6	3651.6	2266.4	3979.8	5957.0
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686718	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	1220.4	963.7	1179.4	795.9	1197.2	1813.7	2016.7	1206.7	1802.8	1786.4	1168.9	1269.8	843.8	1272.5	1658.1	1155.1	1363.2	709.5	1161.8	1152.6	1190.2	1145.5	1195.3	882.4	1514.7	1190.0	1168.8	2886.8	1989.8	967.9	1101.6	889.8	1190.1	1124.9	937.9	588.3	1605.5	795.5	1501.5	1285.7	866.2	822.5	1216.9	917.6	1117.4	324.3	1203.7	1558.3	1217.1	1347.0	1338.5	1222.0	1282.4	1226.6	3341.0	1122.5	1638.4	1892.9	1823.4	3249.1	2499.1	1832.0	2161.4	2560.1	1868.3	2262.4	1480.2	3669.7	2253.5	1494.6	1002.0	1749.4	1967.8	2398.5	2584.5	1982.6	1939.0	2147.6	857.8	1715.0	1772.2	2451.8	1122.7	3142.6	3062.3	1585.9	2863.5	2474.3	2226.2	1741.3	2028.0	1830.4	2427.7	2323.0	2566.8	3835.9	2991.2	3052.1	2372.1	2332.6	1598.0	3622.8	2686.7	1508.6	3587.0	1629.7	966.3	1775.0	4454.7	1413.3	2184.7	4483.3	1579.9	1138.3	2019.4	613.4	2332.7	1512.4	2049.7	6425.0	1484.6	2643.4	1919.2	668.3	1239.3	311.8	1468.5	1083.5	2151.6	2246.8	2305.6	1787.9	1641.5	2185.0	2880.6	2249.1	194.6	1677.3	1115.5	1957.8	2261.4	4700.1	1179.4	1197.2	1206.7	1802.8	1152.6	1190.2	1190.0	1168.8	1190.1	1216.9	1203.7	1226.6	1628.0	948.7	1279.6	15.7	2074.3	2283.7	3314.0	1938.2	2129.6	268.3	2541.6	4149.7	333.2	1313.9	1327.7	610.6	85.5	2064.2	1870.1	882.2	2267.6	1579.1	885.8	1200.6	2281.6	1502.9	1364.3	1421.6	22.5	2930.3	3255.0	1518.4	813.5	1574.5	1350.0	1547.4	1509.5	1509.9	1594.8	117.8	22.0	2147.0	708.0	1759.2	2028.7	689.6	3003.4	1452.0	1378.5	30.0	2166.2	1045.3	1578.8	20.1	26.8	2412.1	1728.7	1501.5	1499.8	3372.3	1679.5	2895.9	676.1	432.6	874.4	2783.8	2675.9	498.4	345.7	2210.2	2326.7	2341.6	1952.8	2206.1	2242.3	3363.9
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA		470000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	2058.6	1934.3	965.6	1484.2	985.8	2965.1	2704.2	936.9	1071.1	2705.4	1023.2	2078.1	1515.1	2007.3	1653.7	2522.3	2423.9	1128.4	1326.4	894.6	951.2	1745.2	1894.1	1421.2	2460.9	984.1	951.1	4838.0	4514.8	1462.2	1861.5	1099.8	977.1	2180.0	1361.7	809.1	2210.1	1551.8	558.4	3337.9	1722.9	1388.1	1050.0	1824.1	1982.0	752.6	1002.9	2006.1	1709.0	417.1	2320.5	2012.9	2317.5	996.1	2010.5	1836.9	2035.9	2149.6	2535.3	5394.1	2745.1	1497.8	2703.5	1400.5	1249.7	2327.8	1425.1	8262.2	2062.9	1734.1	873.2	1246.8	2275.3	3060.5	923.2	1448.3	2207.4	2039.5	2153.8	3438.2	3887.7	2932.6	1619.9	5321.2	4063.7	1265.0	4504.5	3956.7	2765.5	2217.6	2407.8	2657.6	2135.0	2597.5	2974.5	4241.1	2054.6	2172.9	1273.8	2369.5	1924.0	4017.5	2609.2	2927.6	1823.4	2180.2	936.2	2925.4	5031.9	1242.2	2226.2	4761.3	2864.1	951.4	1534.4	1027.8	1788.2	2074.0	1741.6	3606.5	2111.3	2564.4	1093.9	638.7	1690.8	351.4	3488.7	1481.6	5383.7	5629.1	4993.5	4037.9	2821.8	5113.1	6376.7	5111.7	215.7	4472.3	1339.8	3182.6	3668.7	11623.3	965.6	985.8	936.9	1071.1	894.6	951.2	984.1	951.1	977.1	1050.0	1002.9	996.1	2118.4	984.0	2299.9	16.3	4551.5	10412.0	9836.0	9475.4	2792.1	1065.7	9967.6	10172.3	182.6	4213.6	3849.3	1441.9	425.4	5623.9	4123.0	1288.7	5893.0	2943.4	2097.6	1061.7	2644.4	3666.1	2726.6	2263.9	17.0	6539.7	7508.2	2678.8	1207.4	1390.0	1784.7	4203.6	3429.3	2085.8	3282.5	358.4	18.3	3696.8	2925.6	3062.8	6215.2	4622.8	5581.1	2203.8	5104.8	17.8	3733.3	2455.8	4243.1	9.5	25.1	3814.3	2946.3	3499.2	2308.1	8261.9	3481.6	5422.4	1350.6	1305.5	1577.7	4469.5	4329.1	1074.6	1014.8	3712.4	12290.3	5489.4	4201.1	4673.7	4830.3	9407.7
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		310000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	2169.1	1286.7	1542.9	1403.8	1616.7	3766.6	4078.2	1552.0	2178.4	2624.2	1490.6	1879.4	1171.1	1990.6	2424.1	1907.8	2592.8	1319.4	1503.2	1501.7	1591.6	1375.6	2352.0	1477.3	3296.1	1596.1	1538.2	5616.9	2583.9	1413.7	1079.4	1341.1	1621.2	1773.7	1967.2	634.7	2148.1	1530.1	2778.6	2895.1	1788.4	1618.1	1613.6	1983.8	1841.8	658.7	1566.5	3112.9	1744.0	2442.9	3898.8	2116.9	2144.4	1661.2	3358.5	2302.6	2395.7	2319.1	3463.7	6460.5	2290.5	1929.4	3501.7	3277.9	2880.0	2560.3	3121.6	4403.5	4934.1	2851.4	1408.4	2158.4	3072.1	3675.9	3436.7	1734.7	2547.3	3817.6	2173.7	3445.6	5063.9	2047.0	1830.0	5463.0	5859.2	2408.7	6912.4	3818.6	3479.7	3804.8	2814.6	2850.5	2866.9	4562.1	4848.6	3870.2	2142.9	8254.3	3304.7	2578.5	1815.0	4130.4	2718.3	3174.1	3464.7	2947.9	1117.1	2785.7	4699.0	2414.5	3667.8	4793.0	1873.6	1253.2	1328.9	1885.1	2357.7	2931.8	2681.4	3686.5	1758.0	4203.3	1869.4	1087.1	1542.9	674.9	2014.7	1325.2	2975.8	3533.8	3482.3	2704.0	1937.3	3224.2	4471.8	3686.3	520.5	2037.1	1212.6	1921.8	2476.6	4634.7	1542.9	1616.7	1552.0	2178.4	1501.7	1591.6	1596.1	1538.2	1621.2	1613.6	1566.5	1661.2	3373.1	852.5	1462.3	22.2	6269.8	3791.4	4320.2	2146.2	5538.1	251.5	4342.6	9218.9	66.3	1441.3	1424.1	555.4	139.7	2675.7	4184.6	1233.9	1792.1	1872.1	1333.5	1359.6	3432.8	2196.1	1647.4	2350.9	24.2	3733.5	3914.4	2206.6	1829.8	1820.2	1560.7	3526.6	2224.6	2204.3	2298.9	144.7	28.3	3237.2	642.9	2912.4	4020.1	2532.2	4373.5	3115.9	1988.6	33.7	3957.1	1623.5	3901.2	18.1	54.5	2580.0	2676.0	2403.1	3084.7	4207.4	2142.3	2511.0	640.5	392.2	1406.8	3481.1	2754.6	926.1	635.4	5831.2	4174.6	2901.7	5319.1	2561.6	3407.3	4410.9
RPL31	L31	ENSG00000071082	"Ribosomal protein L31"	P62899	2	101002229-101024032	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA072263	Approved					NA	NA		110000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA072263: AB_2686502"	"unprognostic (4.82e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.51e-2)"	2836.5	1934.3	1831.5	1386.1	1850.8	4256.9	3080.8	1746.6	2503.7	3518.1	1791.4	2505.6	1186.7	2435.5	1712.5	2918.7	2787.5	926.1	2000.5	1782.3	1807.5	2132.0	1653.2	1865.3	2372.9	1811.2	1791.3	5933.5	3677.5	1196.2	2117.3	1310.0	1804.2	2434.0	1371.4	636.0	2261.9	957.0	2619.9	3250.2	2054.7	1032.7	1858.5	2183.6	2282.1	766.8	1876.1	2235.6	1952.8	1399.7	2240.6	2587.6	3039.2	1851.7	2131.8	1223.9	2161.3	3354.1	4081.4	5576.9	4033.6	3365.3	2630.1	2057.6	1635.4	3869.0	2441.5	5448.6	2542.4	2168.0	2092.3	2298.5	2112.3	3408.0	2154.0	1942.4	3326.5	3222.5	3926.9	4547.4	3203.0	5735.5	2507.1	4590.2	5268.6	1810.4	4133.3	4419.6	2364.2	2877.4	3081.2	1252.2	2394.2	2822.0	4274.2	7185.2	4047.5	2859.0	1460.9	2363.2	3273.8	4437.9	3238.0	3345.3	2666.9	2906.1	1424.2	4883.1	6312.3	1954.6	2369.4	7643.6	3601.4	1663.1	2960.9	1965.0	2671.1	2618.3	3840.8	3720.7	2310.8	5301.1	1651.1	1913.5	3911.6	860.5	4359.8	2983.4	7228.7	8467.2	7801.4	6122.4	5140.0	7039.0	10632.6	8774.1	567.2	5348.4	2507.4	5182.9	5414.0	14433.2	1831.5	1850.8	1746.6	2503.7	1782.3	1807.5	1811.2	1791.3	1804.2	1858.5	1876.1	1851.7	371.3	1352.6	2182.1	17.3	2271.0	3559.8	3859.2	3734.6	1044.3	69.1	2577.6	1284.6	809.5	1870.1	2378.5	1259.8	33.3	4002.6	1393.0	1267.4	3644.9	2181.4	1237.0	750.6	1149.8	1613.1	1770.7	1556.4	23.5	4152.0	4687.5	1518.2	498.9	849.8	2176.4	458.5	2626.5	2193.9	2563.9	48.8	19.5	3731.2	1055.9	2680.9	4079.7	2108.6	4234.0	1331.1	2459.9	16.9	3560.2	409.0	3318.3	21.6	16.7	3288.7	2799.4	2097.7	609.8	3081.4	2175.4	4409.4	1292.7	99.5	1255.6	2624.5	1366.9	600.1	397.6	1504.9	4376.2	3853.0	2405.7	543.9	3818.3	3606.7
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841582	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		45000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	1907.8	1194.0	1183.6	985.6	1234.6	2971.9	2518.6	1157.9	1625.9	2186.9	1121.8	1558.0	888.8	1458.5	2020.0	1799.9	1857.7	928.0	1266.4	1148.0	1212.7	1252.7	1295.7	1185.9	2346.7	1206.9	1168.5	3697.3	2765.5	775.2	986.3	974.3	1231.2	1537.4	1561.1	523.9	1561.0	780.3	2422.9	2644.1	1380.3	1321.4	1242.7	1511.9	1420.5	567.9	1204.2	1741.0	1134.2	1544.1	2984.9	1566.9	1867.1	1268.7	1494.9	1746.7	1497.4	1918.8	2298.7	4080.5	4927.7	1200.0	2217.5	2476.7	1684.5	2327.2	1482.5	2572.0	1066.1	1735.3	812.9	909.5	1718.2	2495.2	2023.2	1198.1	2874.3	1501.4	2099.3	2562.1	3427.6	2450.0	1456.5	3696.3	5338.3	1895.4	3629.5	2438.7	2198.5	1863.5	1879.0	2323.9	2054.2	4479.6	2773.8	4208.3	2534.9	2129.5	3285.7	2180.2	1344.1	3390.6	2540.9	2434.9	945.7	1887.9	807.8	2141.2	2740.7	1329.5	3137.0	4624.7	1280.6	1066.6	1359.4	1419.3	2254.0	1557.7	2671.2	4640.8	1357.9	3466.6	1629.6	1259.1	2347.0	621.3	2399.6	1800.7	4325.6	5980.2	4749.7	3485.2	3077.9	5413.0	6661.3	5216.7	320.4	2897.7	1489.1	3049.5	3940.9	9478.6	1183.6	1234.6	1157.9	1625.9	1148.0	1212.7	1206.9	1168.5	1231.2	1242.7	1204.2	1268.7	3508.6	1070.5	1834.7	48.6	7663.9	9224.7	7932.7	5817.1	6926.2	342.4	9401.1	14609.2	488.6	3061.2	2689.8	1460.3	166.8	4947.7	4337.7	1512.3	4560.6	3028.0	1986.6	1422.0	4295.9	4075.7	2307.8	4056.3	39.3	6515.0	7623.3	3321.2	2414.9	1972.5	2387.6	3801.4	4734.3	3694.7	4285.0	180.0	41.2	5268.2	1723.2	5797.3	8513.9	7985.2	6662.4	3978.7	4845.2	43.1	6310.8	1703.6	4092.7	18.1	47.3	4383.7	3899.5	2998.1	3398.6	7138.0	3381.8	6786.8	1088.2	684.5	1965.6	5442.0	4616.2	1064.1	1260.6	8612.8	10963.5	4878.3	6299.1	5026.8	5534.7	8006.9
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034600	Uncertain		Approved	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		1300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	831.6	565.7	367.7	738.6	404.0	1928.0	2030.6	377.1	545.7	1385.7	370.7	970.8	451.2	1276.0	1088.2	1289.4	1454.2	776.9	914.1	385.6	388.6	751.5	914.9	666.3	1630.2	376.4	380.9	3022.1	1740.5	954.0	504.0	746.1	386.6	709.1	1143.5	350.6	1234.8	1092.1	1314.7	1327.1	507.9	1353.5	383.2	776.9	643.8	296.4	373.4	1883.4	1289.5	1921.7	2451.3	1322.4	782.5	406.8	1192.9	2343.4	973.0	1646.3	4272.4	7697.6	1710.1	1416.1	2899.7	2143.0	1648.1	2611.3	2025.2	4676.6	1572.3	3396.6	1011.9	2105.0	7026.5	5476.3	2352.2	1301.4	4208.3	2872.9	1955.7	2201.2	6007.7	3042.0	1376.1	7627.4	6980.3	2334.4	9237.8	2620.8	3489.1	2180.2	2682.6	1785.2	3252.1	1956.0	2044.2	1348.1	2136.9	2634.2	1661.9	2256.2	2213.4	4588.3	2958.1	2321.4	1718.4	1794.6	872.3	2447.5	3515.4	2022.2	1812.5	4303.4	2059.2	1111.1	1662.1	1048.4	2297.9	1736.5	2937.8	3118.9	1368.2	4015.4	1281.7	46.4	455.3	62.2	359.4	370.9	668.1	711.1	698.6	506.5	586.8	644.5	888.5	721.6	26.9	478.1	361.3	372.8	589.8	1758.0	367.7	404.0	377.1	545.7	385.6	388.6	376.4	380.9	386.6	383.2	373.4	406.8	393.9	451.9	1004.9	28.1	1553.4	2423.4	2769.6	2082.8	1295.3	122.6	1594.0	1140.4	403.3	760.7	1165.2	342.1	81.3	2059.9	1055.8	364.9	1651.3	1162.8	672.5	337.9	821.0	840.2	761.1	1195.8	26.2	2141.0	3735.7	879.7	467.9	430.0	945.5	899.2	711.0	715.5	1211.2	40.4	23.9	1089.8	636.8	1281.3	2031.3	1392.4	1334.0	991.6	1088.5	27.2	1920.9	417.7	1196.8	15.1	30.0	1239.9	737.1	996.0	1019.5	2031.3	370.6	1572.3	603.9	169.9	460.2	1196.4	934.7	376.4	454.9	1632.1	2583.2	2398.3	1289.5	1184.6	1371.2	2628.6
RPL5	"L5, PPP1R135, uL18"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92832013-92841924	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		430000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	1236.3	1035.1	515.2	786.9	538.3	1743.3	1798.7	522.4	778.1	1690.1	510.7	1412.8	798.0	1295.2	1388.7	1185.6	1420.7	647.6	890.3	487.5	544.8	858.2	794.9	794.7	1435.7	527.8	511.9	3356.4	2236.0	695.4	869.5	736.1	541.3	1103.1	982.0	346.6	1189.5	847.1	1115.8	1320.8	960.1	962.1	549.0	899.0	1135.5	374.3	528.7	1351.4	1179.5	830.7	1438.8	1309.6	1274.2	552.5	2211.5	924.6	1611.4	1369.2	2045.7	4096.6	2577.6	1283.0	1703.7	1560.0	1108.9	2467.5	933.6	4112.3	2002.9	1451.6	1477.1	1370.3	1871.2	2405.7	1976.3	1314.2	2557.4	2142.3	1402.4	2303.5	2447.2	3322.0	864.6	3382.6	3711.3	1390.4	3027.2	2813.9	2191.6	2129.9	2706.3	2106.7	1814.5	1247.7	2665.7	3741.2	2497.9	1659.1	1724.1	2407.7	3118.5	2702.2	1912.0	1798.7	1367.2	1632.0	836.3	2298.6	3961.6	1316.4	1268.8	4480.6	1345.5	781.6	1429.6	1498.4	2357.4	1290.8	1314.5	2793.5	531.3	2814.4	544.2	234.9	665.6	101.3	758.7	619.1	1520.2	1320.3	1385.5	1151.0	1138.3	1105.7	1729.8	1570.9	56.7	1005.7	552.2	942.7	1140.0	2356.3	515.2	538.3	522.4	778.1	487.5	544.8	527.8	511.9	541.3	549.0	528.7	552.5	1586.8	653.9	1042.2	29.7	3056.7	2843.0	4383.1	2206.0	3168.8	339.6	3182.0	5498.6	375.2	1522.7	1266.7	412.0	89.6	2557.1	2009.8	595.2	1993.7	1697.1	1438.3	840.8	2334.8	1567.8	1236.6	1980.6	35.0	2708.5	4211.6	1464.3	978.1	1009.8	1041.9	2287.9	1546.3	1087.2	1452.5	146.4	33.8	1986.9	720.2	1758.7	2200.6	1189.4	2829.9	1536.8	1406.9	35.6	2171.5	806.3	1969.1	27.2	37.7	1851.6	1567.8	2156.4	2067.8	3935.4	1225.7	2454.6	571.0	298.8	1051.8	2546.2	2122.7	682.8	501.7	3198.9	2893.0	2613.1	2318.2	2797.0	2572.8	3991.1
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290242-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 17748.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		380000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: AB_2683694"	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	2254.0	1352.4	835.1	1322.3	886.2	3071.3	3298.9	846.6	1224.8	2495.7	843.0	1841.6	1316.8	1844.3	1839.2	2058.4	2057.2	1033.9	1342.4	799.0	860.0	1634.0	1593.8	1327.3	2285.6	859.3	828.4	4528.2	3067.3	1217.6	1195.0	1202.5	870.8	1650.4	1681.7	889.4	1843.5	1261.6	2391.6	2826.4	1420.5	1381.5	914.8	1388.9	1853.0	527.0	848.2	2225.3	1616.5	1832.1	2665.8	1978.5	2103.5	900.4	2902.0	2050.6	2163.3	2615.7	4308.7	5473.7	2120.8	3100.6	2474.6	2069.9	1621.0	2487.3	2940.4	8517.8	2467.6	2517.8	1409.2	2703.0	2888.8	3960.2	3204.7	2313.1	2394.1	4682.9	2687.5	2594.4	2583.2	3343.2	2298.0	5174.5	4574.0	1921.5	5950.9	3797.5	3412.0	2840.5	4261.7	3140.1	2980.2	2448.1	5345.2	5080.8	2528.5	5238.5	2182.9	3552.8	2474.4	3353.9	3241.5	2848.0	2977.1	2160.3	1454.9	17748.7	4599.1	1766.2	4497.4	4312.2	3227.1	1575.4	2407.3	2031.7	2913.1	1799.2	2782.6	5514.9	1649.7	4062.8	2654.8	3331.3	7192.1	1787.5	6932.4	5967.0	12630.9	14333.5	12042.7	9069.1	9565.2	12188.2	17585.4	12433.8	894.5	9240.8	5307.0	7970.3	10207.4	26909.6	835.1	886.2	846.6	1224.8	799.0	860.0	859.3	828.4	870.8	914.8	848.2	900.4	622.3	817.3	1610.8	26.1	2654.7	8054.8	9929.5	10766.1	1684.6	268.0	5251.9	4462.2	623.2	2396.3	3812.0	1311.3	125.1	4882.8	1798.3	926.5	5576.1	2795.4	1720.0	1068.3	2371.5	2338.1	1617.8	1779.1	27.0	5044.8	7032.5	2096.9	721.7	1300.7	1491.1	1110.8	2680.0	1876.1	3252.9	94.2	27.6	3112.1	3057.8	3661.5	5169.4	806.4	4246.4	1893.5	3705.1	25.3	4752.6	1792.8	3105.1	19.6	33.6	3149.3	2514.2	2310.6	952.9	5766.4	2274.7	5797.7	1454.2	380.6	1459.4	4118.3	2651.4	953.5	374.0	2143.1	9487.1	4878.7	2546.9	2145.3	4018.0	7816.6
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348218-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles		NA	NA		490000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Vesicles	"HPA046794: AB_2732534"	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	1864.3	2099.0	555.5	499.0	565.3	1295.5	1857.6	551.6	615.8	2259.5	549.3	1694.1	544.2	1635.0	1065.1	2717.9	1828.7	498.1	1316.3	539.3	556.2	1385.9	1390.8	1257.4	1006.5	570.3	558.1	3860.4	4112.2	606.1	1325.3	534.3	570.5	1665.0	909.8	237.3	1758.0	610.4	1999.9	2751.6	1419.1	767.3	588.2	1542.6	1762.7	692.1	563.8	1108.8	1287.3	862.8	1354.0	1718.9	2072.4	577.6	738.0	1094.6	1223.6	1227.0	2101.3	3459.0	1165.5	904.3	1835.4	1592.3	882.0	1676.1	941.1	2286.8	542.9	1587.3	858.2	1754.6	1831.4	2172.0	1273.6	977.8	1036.3	807.6	1533.7	1656.6	1389.2	1932.4	915.0	3509.5	3187.7	1154.6	1984.2	2581.3	2055.4	1579.3	1573.5	1170.9	1855.9	2494.0	1509.9	2010.8	1336.2	3265.2	1067.1	1307.0	1533.0	2946.8	2077.6	925.6	1144.0	1009.2	739.8	1878.6	1209.1	1008.0	2050.7	2009.1	1133.2	1042.8	746.6	950.3	1094.7	453.3	975.5	1410.1	814.8	1328.8	830.2	115.2	309.8	65.6	395.1	280.0	583.3	624.2	535.6	488.8	452.9	544.4	591.3	560.4	43.6	433.2	255.0	449.1	453.7	959.4	555.5	565.3	551.6	615.8	539.3	556.2	570.3	558.1	570.5	588.2	563.8	577.6	2135.7	519.2	830.9	22.5	3484.9	3244.6	4561.0	2878.3	4056.7	324.7	4450.1	8182.0	389.0	1720.0	1397.0	597.7	143.9	3617.6	2668.7	1136.8	2122.9	2037.3	1992.4	1277.7	3110.1	1843.9	1503.3	2592.1	30.3	4412.9	5135.5	1931.5	1701.4	1613.2	851.9	3717.2	1779.5	1292.4	2514.0	131.2	28.5	2769.2	876.9	2202.6	2161.8	4012.3	3736.3	2023.9	1511.9	22.5	2569.6	1085.1	2398.6	22.6	34.9	2672.7	2176.1	1929.6	3366.8	4776.6	2603.2	2708.5	569.1	516.9	966.3	2340.4	2271.5	1087.3	793.2	6499.1	3980.6	3307.4	2539.1	5934.2	3443.7	5327.8
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 6599.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		170000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	1100.4	864.4	197.2	397.5	201.1	1020.7	1162.7	197.3	361.6	1387.5	199.5	1138.7	688.7	1042.4	63.7	1406.6	1118.6	146.4	962.6	174.2	193.7	889.8	709.6	796.1	424.5	214.1	195.2	2192.7	2021.1	150.3	784.2	264.4	199.9	974.9	110.0	22.9	1320.1	201.8	1651.4	1800.7	885.7	115.6	222.7	918.6	1003.5	304.7	218.2	150.0	739.9	194.0	196.4	1099.7	1240.2	218.1	2486.1	2860.3	200.1	874.6	220.0	496.0	1913.2	1747.7	325.3	522.4	369.7	2518.8	1299.5	3296.6	2461.9	208.4	174.3	1470.7	263.8	609.1	95.7	1446.1	3218.7	1962.1	2166.5	1805.2	546.9	1299.9	1027.5	537.1	680.7	235.9	400.8	246.5	387.8	703.1	2695.3	742.2	226.0	6599.2	1862.9	1754.6	1865.3	674.7	3196.8	1806.5	1154.4	3160.7	280.1	1842.0	1215.9	2028.4	1677.7	899.2	2541.5	81.0	2093.2	1233.3	1573.7	689.8	2622.6	1454.9	2127.3	1344.2	1235.8	2856.3	1372.4	2117.5	968.7	534.8	1464.1	574.8	1160.0	1504.9	1934.6	2970.9	1937.9	1430.4	2051.1	2991.2	2181.6	1718.2	166.1	1469.4	1479.6	1129.7	2070.5	5473.9	197.2	201.1	197.3	361.6	174.2	193.7	214.1	195.2	199.9	222.7	218.2	218.1	2510.5	852.5	1309.5	28.7	4225.5	6439.6	7085.5	5724.6	4563.8	424.0	6122.9	9469.1	1049.0	1988.8	2513.8	1028.1	268.9	4313.8	1790.8	1780.8	4433.5	2429.1	891.2	1083.4	2465.0	2455.7	1698.3	2407.7	24.0	5851.2	6733.6	2161.3	1804.3	1452.8	1044.4	2390.5	2116.1	1309.7	3031.0	166.5	28.5	3563.5	1698.8	2811.4	5097.7	2782.3	3122.7	2281.9	3520.0	30.9	2951.5	1300.3	1607.7	16.1	32.8	3402.4	3311.1	1432.3	3168.7	6500.7	3930.7	4195.9	961.7	689.1	1078.1	2701.0	3865.8	591.8	583.4	5817.5	8224.4	4365.8	2704.6	3472.7	4291.2	7522.7
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452587-39458931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 2512.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	1868.9	1181.0	377.9	809.5	384.9	2487.2	2132.6	378.2	2512.5	2407.6	382.9	1776.6	737.5	1418.3	2338.6	1568.7	1896.6	785.0	1168.4	368.3	462.3	1318.1	1056.3	1130.2	613.9	381.0	381.1	3607.4	2794.6	510.7	1060.0	419.0	382.5	1562.6	605.5	314.2	1387.6	681.5	1550.4	2153.4	1327.8	551.1	407.5	1400.1	1484.5	386.8	388.4	43.6	1072.2	1767.5	705.8	1675.7	1773.4	395.9	52.4	41.7	2173.3	48.2	57.0	90.0	72.9	1109.3	1618.3	1306.1	981.0	131.1	1243.5	2771.5	93.8	1081.2	1040.1	1169.0	67.3	79.3	1422.3	964.2	2080.2	80.0	415.4	131.2	81.3	153.2	711.1	113.8	3249.4	56.1	1445.8	1907.5	69.6	70.4	2126.4	1196.8	60.9	69.4	1556.5	163.4	1954.7	1523.9	57.6	1417.2	2327.7	76.3	1656.7	63.7	74.3	915.0	31.6	899.8	115.5	1976.1	1864.0	98.7	63.2	51.1	72.1	1486.9	134.2	1806.3	2754.2	2483.9	1456.9	1717.2	56.6	447.2	556.1	171.7	664.4	585.3	1320.8	1566.4	1311.6	919.0	779.1	1361.8	1804.5	1436.1	94.8	927.3	456.8	1013.2	1101.2	2263.3	377.9	384.9	378.2	2512.5	368.3	462.3	381.0	381.1	382.5	407.5	388.4	395.9	1634.0	663.4	908.4	2.3	3629.4	4132.6	5621.6	3089.9	1994.2	406.0	4149.6	3833.2	428.0	2051.8	1359.8	709.9	160.6	3011.2	2723.2	1300.0	2733.2	2184.8	1549.9	1126.9	2738.2	2121.2	1850.2	1755.0	3.0	4399.8	5910.8	1698.9	828.7	1534.0	913.2	2226.7	2439.5	1991.3	2775.3	198.5	3.2	3581.7	1053.8	3282.8	3322.0	1707.8	4819.6	2242.3	1851.6	2.8	4568.2	1398.0	3045.4	3.0	3.6	3145.0	2925.6	2394.1	1420.3	4718.4	2823.2	3698.3	656.7	581.0	1512.0	3760.1	2630.9	684.0	593.6	2325.1	4675.5	3400.0	2937.1	2567.2	3793.6	5564.6
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196699-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003512, HPA073501"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		770000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	1626.2	1344.7	561.3	1155.2	565.6	3283.8	2720.3	554.1	640.3	1534.6	616.4	1752.1	1554.5	1257.0	987.6	2694.1	2220.6	979.7	1047.9	552.7	585.8	878.9	1433.5	1081.9	1835.1	618.4	571.6	2860.3	3265.5	696.8	753.7	1202.7	602.2	1195.7	1776.6	523.0	1791.6	848.6	2407.5	2585.8	1260.0	1337.9	603.4	1135.2	1608.7	396.8	599.5	1835.9	1154.9	1590.0	2433.7	1778.7	1703.7	603.6	3354.4	3355.3	2339.0	4061.4	4653.6	7635.7	3627.8	2397.9	4274.8	3734.5	2395.4	4364.8	1919.1	7137.6	2541.5	4307.9	945.2	2583.2	4120.3	5060.1	2324.4	2764.8	3209.4	3343.3	2263.6	4630.2	5153.3	4498.4	2490.2	6817.1	8686.1	2619.4	8018.0	6670.0	4528.8	4037.2	4292.7	2014.6	3645.7	5140.3	4443.4	5661.6	4494.0	3290.9	3704.7	3321.6	3175.0	5868.8	3881.1	5170.2	2606.2	3183.0	1722.7	2593.0	5541.7	2631.2	4773.6	6518.2	3016.5	1807.3	2718.5	2322.7	3249.7	4551.6	5143.0	3549.4	3136.7	3560.7	1492.7	337.6	1714.3	136.4	1750.8	1555.9	3999.6	3712.1	3171.7	2361.5	3455.6	3456.2	3255.0	2728.7	123.0	2340.3	927.0	3805.3	2342.6	7075.7	561.3	565.6	554.1	640.3	552.7	585.8	618.4	571.6	602.2	603.4	599.5	603.6	594.8	586.5	1363.0	12.7	2571.7	3876.3	4947.2	3409.7	5507.4	208.7	3351.1	3986.1	277.8	1312.6	1946.7	562.8	154.3	4464.2	1352.3	967.9	1886.1	2150.7	448.8	811.6	1878.9	1354.0	1217.3	2826.9	12.8	4812.2	7058.4	1577.5	1782.3	1217.8	796.8	1334.4	963.1	1249.9	2014.1	94.2	19.7	2395.8	950.1	1281.9	2122.5	944.5	1740.7	1327.5	1700.4	17.8	1794.6	366.3	1030.9	19.6	28.6	2966.5	1712.5	795.1	4088.9	4142.9	1870.9	2089.5	859.3	486.4	420.7	1701.5	3223.9	309.4	759.2	7221.2	4751.9	4413.0	1892.0	2405.0	3317.6	5180.7
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452814-69456205	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 28402.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003368			Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	1779.5	1664.6	852.0	893.4	872.7	2781.2	1895.2	821.7	1109.7	2465.3	920.5	2035.4	1200.3	1805.3	349.4	2773.4	1670.9	579.0	2121.7	813.6	844.4	1703.1	1566.2	1439.7	1583.3	871.6	857.5	3354.5	2003.6	264.6	924.6	565.5	866.0	1991.6	449.1	157.6	1705.8	417.0	4746.4	4498.6	1693.4	529.7	892.5	1992.0	2147.0	492.5	873.6	643.5	1140.9	761.4	1017.9	2099.9	2372.6	891.4	1890.5	1882.4	827.9	1919.4	1172.4	1394.2	1770.4	1615.7	960.9	892.0	711.8	1918.7	1861.9	2622.2	2346.4	869.5	811.2	2521.6	1296.6	1287.5	193.1	2639.9	3956.6	2208.5	2153.1	1914.5	2045.2	1976.4	1931.2	1782.1	2199.9	653.6	1219.6	1438.9	1092.7	2265.9	2127.7	2160.7	642.2	1757.0	2163.4	5781.3	3098.7	1172.2	1802.9	2192.5	2696.6	3893.7	876.0	2002.9	1319.3	2558.5	1620.5	1978.2	6979.8	742.8	1633.9	4449.5	1915.7	1273.2	2851.6	1535.0	2672.3	4382.2	7690.0	2245.6	1524.1	4968.6	1076.9	2903.3	5350.5	1819.3	3182.4	3677.4	5811.2	9096.0	6532.4	4349.4	6100.6	7551.7	6871.8	6057.1	733.9	5147.0	2138.6	6392.6	5921.8	13416.9	852.0	872.7	821.7	1109.7	813.6	844.4	871.6	857.5	866.0	892.5	873.6	891.4	3508.0	1891.0	3795.4	16.0	11229.3	24186.3	18565.6	9896.5	18630.1	626.6	14197.1	19613.8	1854.3	3877.6	5293.4	2265.9	350.3	9217.3	6668.2	2484.5	5141.7	5608.7	475.1	2702.4	5765.4	5131.7	2926.5	6423.8	19.7	7158.4	12076.7	5235.1	3541.4	4232.4	2605.7	4287.7	5261.2	6536.1	8166.9	373.5	22.5	7238.9	2396.6	8309.7	12226.0	1764.3	8447.2	6779.7	9051.8	28.1	11829.2	4015.4	6451.2	15.6	42.8	7495.3	5127.5	4732.9	10308.0	16198.4	5565.3	8039.9	2204.8	1167.3	2530.9	5356.8	5872.6	690.3	1864.1	18779.3	28402.5	9502.3	9179.6	6940.6	8549.1	17342.5
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809965-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053635, HPA075365"	Approved		Approved	"Nuclear speckles,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		2900000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear speckles, Cytosol"	"Mitotic spindle"	"HPA053635: AB_2682212, HPA075365: "	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	2013.7	831.3	1119.2	993.1	1162.5	2166.9	1656.6	1099.7	1368.9	1256.2	1084.1	1277.1	1016.8	930.2	701.6	1241.3	1240.4	564.0	869.3	1057.5	1116.3	885.0	657.0	851.0	1924.7	1138.0	1095.8	2092.8	2087.8	545.7	595.5	830.9	1154.3	925.8	887.8	180.9	1908.3	775.7	1802.7	1760.4	1191.7	624.4	1204.8	1543.8	1006.0	377.6	1167.5	1545.7	785.0	936.1	1715.4	1075.5	1137.9	1217.7	2773.5	2229.6	1070.4	1864.1	2343.2	2458.2	2389.5	1728.2	1285.0	2090.8	1638.4	3307.6	2218.5	3851.6	1225.0	1629.9	1107.9	2546.7	1786.2	2778.3	836.3	1713.6	8117.9	1901.7	1416.9	3996.4	2837.3	3540.8	1905.4	3393.9	4684.6	764.1	2182.7	1860.8	2111.9	2798.2	3432.2	2040.5	1317.9	2656.6	2969.5	6002.3	3188.8	3394.5	6045.3	3345.1	1465.6	4369.9	1759.0	1281.0	2222.2	3142.1	1118.5	2825.8	3582.4	885.1	1198.9	3577.2	1881.2	1142.3	1393.9	964.1	1981.6	3838.4	3778.8	3419.3	1790.5	2952.3	1340.6	1565.3	3908.1	1299.1	4402.2	3129.1	6208.3	10718.3	8296.0	6323.4	4273.6	9867.1	10158.6	8083.9	529.9	4310.4	2525.7	5882.9	5140.5	13330.7	1119.2	1162.5	1099.7	1368.9	1057.5	1116.3	1138.0	1095.8	1154.3	1204.8	1167.5	1217.7	1311.8	1067.3	1685.0	16.3	5889.9	6113.3	6658.4	2808.0	2619.1	206.2	5955.7	4736.9	638.4	2505.0	1972.2	1601.9	79.2	5046.4	3469.2	2296.4	2592.4	3688.3	1403.0	1105.9	2434.1	2724.8	2370.2	3482.2	18.6	7413.9	8045.8	2074.3	1401.2	1787.6	1721.9	1543.2	4028.6	3068.9	4514.0	146.4	17.8	5925.5	870.8	5458.4	6404.8	3133.4	6393.4	3169.4	2986.4	27.2	5854.8	1052.2	5787.9	6.0	19.0	5201.1	4547.7	2821.7	2403.4	6640.3	4473.8	4234.1	900.4	235.5	1991.9	3688.9	2346.3	1123.1	2093.1	4264.4	7887.4	5841.1	4889.3	1629.7	6189.1	7014.0
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241619	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	112.6	132.5	48.2	131.9	50.4	180.8	146.1	49.9	55.9	161.8	98.0	156.9	125.5	108.7	344.1	106.8	122.9	119.8	107.3	49.5	56.5	145.1	212.1	129.7	109.2	54.0	50.6	94.8	159.6	180.9	79.1	257.9	53.9	164.4	175.2	117.0	158.2	157.5	110.4	91.5	110.9	156.6	53.8	118.1	145.1	144.2	55.4	108.5	232.5	75.1	143.3	165.4	87.9	61.9	328.2	290.6	302.7	401.2	413.1	308.2	586.7	426.7	516.8	544.8	459.2	939.2	564.8	255.3	501.6	572.3	506.4	468.4	318.8	516.4	492.0	121.2	196.5	295.3	308.4	634.1	398.9	468.4	467.0	294.6	505.1	432.3	447.5	519.8	530.4	239.2	458.7	805.1	389.1	300.9	270.6	451.0	240.4	839.3	415.7	242.3	549.1	852.7	371.6	304.3	246.4	261.0	517.9	1231.1	489.4	353.6	606.1	765.6	338.0	600.8	358.2	317.1	371.9	474.7	608.4	259.9	583.4	314.9	493.2	424.2	427.5	285.5	365.5	410.5	417.0	291.0	336.1	363.8	481.2	232.4	298.8	308.7	78.3	398.8	357.6	591.0	338.2	676.5	48.2	50.4	49.9	55.9	49.5	56.5	54.0	50.6	53.9	53.8	55.4	61.9	85.7	118.6	158.0	22.2	107.8	61.8	134.1	264.6	62.0	72.6	90.0	74.2	81.4	133.0	197.7	80.9	45.9	461.6	109.6	113.9	23.5	278.0	37.3	73.2	103.5	98.6	63.0	91.7	18.8	241.1	599.6	127.4	84.1	151.2	105.2	109.3	100.6	206.3	233.2	63.9	18.6	168.5	162.8	150.4	75.3	24.4	105.0	117.0	90.7	20.6	122.2	136.8	65.9	24.1	20.5	160.1	109.5	110.9	392.3	121.3	64.6	82.3	98.5	100.8	85.5	65.3	122.0	335.2	288.9	67.7	57.8	621.0	81.5	213.7	138.7	117.6
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426069	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 4571.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	1437.4	1373.5	1054.1	937.6	1054.4	2688.5	2003.3	1013.6	1284.2	1984.1	1022.8	1472.3	919.9	1332.0	1064.3	1995.2	1606.9	756.7	1024.5	1010.7	1034.1	1114.4	1161.4	1006.5	2137.6	1058.2	1024.2	2878.3	2424.5	633.4	929.2	829.4	1051.3	1432.9	916.2	273.2	1532.7	895.2	1419.3	2399.7	1342.9	909.8	1088.6	1538.6	1455.3	558.6	1091.1	1486.2	1090.6	774.4	1696.6	1470.6	1716.1	1069.7	2314.3	1481.2	1486.9	3397.3	2550.1	3757.4	2454.7	1847.4	2604.3	3061.1	2200.4	3633.8	1140.6	4393.3	1873.0	2105.8	1522.9	1688.8	2814.8	3224.9	1840.0	1869.0	5082.5	1974.1	1475.4	3504.8	3492.4	3158.5	2028.2	4156.0	5548.7	2111.2	3977.8	2642.2	2725.4	2459.5	3452.0	2175.2	2327.1	3633.7	2591.3	4761.0	2242.3	5664.1	2144.7	2409.8	1736.7	4221.2	2314.1	2558.9	2492.6	1515.7	1328.4	2213.1	5332.3	1391.5	2878.1	7936.5	1837.0	1338.8	1699.0	1543.5	3072.5	1764.4	4423.0	3815.8	732.4	4092.2	2465.9	746.2	1242.2	378.2	1406.3	996.8	2067.1	2824.8	2408.2	1994.5	1679.6	2732.8	3083.6	2462.3	251.9	1676.0	963.1	1983.5	1767.5	5386.9	1054.1	1054.4	1013.6	1284.2	1010.7	1034.1	1058.2	1024.2	1051.3	1088.6	1091.1	1069.7	597.4	359.0	714.8	0.0	2967.8	1351.9	563.2	354.6	3754.5	62.0	1279.7	1271.1	65.3	1096.6	494.1	263.0	29.2	1497.5	1221.5	911.7	598.7	1451.9	447.1	169.2	282.1	670.4	1232.9	1778.0	0.0	2404.1	1918.4	612.0	1241.6	181.4	589.1	215.5	1258.9	970.6	1034.5	52.2	0.0	2462.2	130.2	1695.5	1330.7	1537.7	849.0	1006.5	633.3	0.0	1923.1	488.6	1562.3	0.0	0.0	1813.3	1843.4	472.4	2267.5	640.3	2166.8	1066.8	284.9	103.5	263.0	652.5	649.4	268.8	270.0	4571.8	1657.0	1454.1	1851.6	284.8	2985.5	573.4
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499708	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		39000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: AB_2680860"	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	2814.3	1967.1	2353.0	1926.7	2400.8	5134.9	4378.8	2317.2	2969.3	3860.2	2321.9	2702.6	1771.3	2682.7	2738.1	2407.0	3426.0	1647.5	1778.5	2271.3	2375.3	2155.4	2117.7	1996.8	4054.9	2375.8	2309.1	6075.5	3741.4	1881.9	2119.6	1859.8	2411.6	2569.3	2712.5	1006.4	2752.4	1960.9	3200.5	3819.2	2355.1	2297.6	2434.1	2818.2	2473.8	735.7	2397.5	3791.6	1978.6	3380.1	4757.2	2689.4	2908.0	2437.6	2932.3	4522.4	3340.7	5169.4	4778.9	7228.3	2239.9	2418.7	4891.5	3444.6	3294.2	3167.0	2392.5	7154.4	1461.9	3373.2	1470.8	1926.2	4003.2	4879.0	3375.9	3065.7	6870.8	4318.3	2858.4	4634.4	4446.2	7694.0	3083.3	7191.2	7968.8	2279.2	5867.3	5774.3	5106.5	4307.3	4374.9	3709.1	3792.3	3324.7	3612.0	5845.5	3067.8	7346.6	4594.6	3450.4	4209.9	3875.7	5006.0	6932.7	3555.4	4741.2	1646.4	5505.8	3793.8	3223.4	1790.9	7907.9	2886.2	2667.3	2377.5	1302.4	3236.1	3646.3	6191.7	5179.5	1104.6	5297.2	2335.7	1161.8	2103.1	653.8	1900.0	1810.3	2537.9	4890.5	2741.7	2206.3	2979.8	4589.4	3192.9	2762.8	507.2	2120.9	1563.8	3733.9	2382.4	6125.5	2353.0	2400.8	2317.2	2969.3	2271.3	2375.3	2375.8	2309.1	2411.6	2434.1	2397.5	2437.6	820.0	836.6	1502.6	30.0	2589.7	2685.3	2499.6	1615.7	971.5	289.1	1028.9	947.2	716.6	1155.3	1344.7	474.5	143.9	1915.2	1891.9	1130.4	1216.9	1295.8	900.1	1044.9	2292.8	1236.5	1501.5	1404.7	9.6	2816.1	3575.5	1178.0	550.0	1527.0	1341.6	1228.9	1633.8	1645.8	1898.6	94.2	12.1	2720.4	612.3	2780.4	3206.1	1773.6	3212.5	1749.5	1538.5	22.5	2825.6	1123.6	2614.9	10.1	22.3	2021.0	1960.1	1538.8	1006.3	2063.5	1353.7	1873.6	857.0	493.5	874.4	2214.3	2008.7	603.1	589.5	1334.2	3413.1	2356.3	1587.9	1273.7	2434.5	2570.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814569-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		450000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	2199.7	1325.2	1393.3	1767.2	1454.1	5388.1	3551.2	1388.1	2027.8	2357.3	1375.8	1849.3	1597.8	1747.6	1664.7	2450.9	2149.5	1415.7	1311.3	1347.6	1419.0	1576.6	1443.7	1565.4	3948.0	1445.0	1406.0	4883.9	3660.2	1000.1	871.2	1633.7	1443.1	1696.0	1905.2	608.3	2167.8	1216.4	1965.9	3365.2	1692.7	1357.1	1484.2	2110.3	1718.3	682.0	1446.6	2534.1	1959.6	1376.9	3053.4	2011.6	2108.4	1482.0	1993.8	1568.3	2260.4	3581.3	4521.2	5855.0	2728.8	2502.9	3598.4	2772.7	2665.2	3294.5	1880.3	4497.8	3443.9	3368.1	1338.8	1900.3	2613.1	4373.5	2576.9	2895.0	3346.5	3013.3	1944.0	4743.1	5047.1	8481.4	2221.0	6167.0	7332.7	2340.5	8322.4	4658.3	3754.7	3556.4	5166.0	2858.9	3487.9	4342.3	3620.8	5030.3	2772.9	3420.0	2533.0	3993.0	1799.7	2884.6	3698.6	2185.9	1991.3	1573.0	833.4	5314.3	7184.2	2173.7	2276.5	8489.5	3027.8	1121.1	3111.7	3721.2	4696.8	4153.6	4104.8	3493.8	3635.1	5063.0	1621.7	599.0	1545.5	220.8	2412.5	1426.7	3728.9	4156.1	4210.9	3131.6	1971.7	3564.5	5201.1	4454.7	151.1	2031.9	1170.8	2722.3	2519.7	7450.3	1393.3	1454.1	1388.1	2027.8	1347.6	1419.0	1445.0	1406.0	1443.1	1484.2	1446.6	1482.0	3755.5	1660.2	3063.5	22.9	9470.7	8277.4	8259.7	3758.1	8926.6	531.5	10637.2	15674.0	827.7	3777.4	2693.4	1237.8	179.3	7566.9	6150.1	1808.1	4574.3	4058.0	792.6	1406.5	4602.8	3829.0	2863.4	5499.5	18.9	8085.7	9433.9	3353.4	3537.2	2309.6	1773.2	3890.7	4755.4	5136.7	5871.9	212.0	17.7	6806.4	1116.9	6161.6	5357.0	2335.6	6075.0	4790.9	3938.0	20.6	6667.5	2216.0	5160.7	10.1	25.0	6009.9	4480.8	2990.3	4762.0	10484.3	3517.1	5647.3	792.4	713.1	1617.2	5397.5	3117.8	1035.0	3063.2	11325.5	10512.6	7894.9	7990.4	4517.7	6783.0	9815.1
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074388-17077715	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	1087.7	732.8	827.4	821.7	866.8	2404.4	2065.5	844.9	1205.2	1301.5	834.4	1135.5	854.6	1115.2	1152.5	1160.4	1285.2	950.2	1064.7	797.8	862.5	845.3	1101.5	696.5	2031.2	867.4	824.3	2669.7	1736.0	646.3	520.4	981.3	878.5	814.1	1136.1	660.8	1368.0	829.6	1934.5	1450.1	817.7	947.1	897.4	1102.7	962.6	356.6	856.5	1737.4	997.0	1525.9	1845.3	1318.5	1070.0	910.6	2115.6	1619.7	1524.1	1279.1	2680.1	4138.4	1660.6	1430.9	1991.9	2194.7	1774.8	2580.3	2640.4	3164.1	975.4	1710.4	1405.0	1546.0	2213.2	2387.6	2309.0	1326.2	4617.5	1347.9	1531.6	2761.0	3226.4	2821.8	1400.8	3174.0	3942.6	917.4	3647.4	2486.7	2632.2	2073.1	2128.5	1736.5	2173.6	2173.4	2377.2	3920.5	1727.0	2853.9	3099.3	2189.8	2064.2	2008.3	2147.5	2483.2	1249.0	2080.7	682.1	2723.3	3495.9	1527.1	1238.1	4255.9	1550.7	997.4	1660.5	2271.0	1835.2	1186.2	2726.3	2444.2	1143.1	2407.0	1352.5	582.6	2489.7	362.9	1356.0	1807.4	2715.0	3719.8	2904.9	2027.9	3004.4	3245.9	4371.9	3365.9	232.1	1880.4	1483.8	3192.8	2173.3	6018.5	827.4	866.8	844.9	1205.2	797.8	862.5	867.4	824.3	878.5	897.4	856.5	910.6	2429.5	926.3	1565.1	24.8	4390.9	4567.0	4447.1	4666.4	4408.4	271.6	5079.9	8516.0	778.1	1998.8	2361.4	665.8	104.3	3971.3	2743.0	912.1	2915.1	2434.7	1352.5	1075.0	2375.9	2226.1	1369.9	2311.8	19.4	4554.7	5434.6	2170.0	1711.1	1305.6	1506.6	2246.3	2328.4	2036.1	2923.8	90.9	24.7	2896.7	1501.4	4367.6	4707.0	1820.3	3551.8	2950.1	2180.6	30.9	4862.5	1677.2	2326.5	18.6	33.1	2988.2	2321.6	1774.6	2669.5	4100.7	1793.2	3790.7	1206.8	482.6	874.4	3314.3	2545.4	616.6	352.4	5638.8	5447.9	4488.7	3426.6	2642.9	3153.8	4835.4
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449739	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		810000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	1391.9	1014.8	819.9	689.6	838.3	1880.5	1567.1	800.3	929.8	1696.9	799.6	1268.2	563.9	1214.3	1001.9	1525.4	1339.5	469.2	1022.8	786.7	832.9	949.3	1027.8	936.0	1126.0	832.7	803.8	2394.3	2431.0	731.9	809.7	636.1	843.8	1228.1	796.4	300.5	1310.9	690.3	1536.8	2210.9	1198.3	684.3	868.0	1343.1	1319.3	344.8	845.6	1142.5	1013.3	1030.0	1170.9	1289.1	1444.9	851.7	1196.9	1768.7	1201.2	2749.6	1497.8	2857.8	1828.0	815.2	1278.2	1298.3	1158.5	2702.9	1799.1	2098.0	1280.9	1583.7	1411.4	1091.9	1548.1	3878.5	782.1	1066.7	2153.7	879.0	1504.7	2171.0	2252.7	2642.0	1164.7	2193.0	1297.4	1441.2	3088.3	1496.2	1933.8	1975.8	1067.3	1250.1	1720.0	2804.7	1499.8	2478.0	1323.5	1935.2	1959.3	1446.0	1134.7	3166.8	2005.3	1827.0	1339.8	1410.9	634.1	3959.4	3109.0	892.6	1703.5	3152.8	1107.3	925.5	711.0	723.0	1229.2	1511.3	1853.6	1722.2	1174.2	2578.4	634.9	2439.8	6736.3	1518.4	6807.8	4685.2	9622.7	14519.2	11377.7	8377.3	7039.4	12461.6	16778.9	11703.6	982.1	6730.0	4055.3	8079.0	8024.6	34303.5	819.9	838.3	800.3	929.8	786.7	832.9	832.7	803.8	843.8	868.0	845.6	851.7	1954.3	1336.5	2464.0	15.0	5469.0	11670.8	9205.1	9468.6	4143.2	501.8	11009.9	13334.3	1873.1	3179.9	4229.9	1478.7	185.6	7225.8	4299.3	2121.7	4527.4	3485.4	1233.0	1626.2	3782.1	3867.8	2390.3	3230.5	23.3	8687.4	8833.9	3287.4	1852.2	2336.3	2293.4	4816.8	4223.5	4186.4	4707.3	203.6	20.0	5595.6	2931.6	5536.1	9991.5	1739.5	4356.7	3703.4	6474.4	21.5	6224.3	2062.0	4655.1	13.0	31.1	5196.5	4753.4	2235.0	3173.0	7998.6	5612.4	5302.3	1902.7	691.9	1604.1	3185.0	5116.9	726.4	815.9	6399.3	15358.6	7126.8	5488.0	4091.6	6155.8	10058.0
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433137-39435949	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064222	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		No	No		66000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA064222: AB_2685218"	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	2066.2	1324.7	798.1	879.8	835.8	1620.8	2008.5	795.8	967.9	2510.0	825.8	2148.1	738.9	1858.7	479.5	2097.7	1978.7	622.2	1817.6	766.2	806.7	1441.4	1565.9	1510.3	1710.4	830.8	794.2	4203.5	2970.3	547.7	934.3	739.1	834.3	1615.4	540.7	353.9	1548.0	495.9	2746.6	2516.9	1665.1	572.1	839.0	1889.3	1918.6	461.2	832.1	1190.8	1324.5	1391.5	1152.9	1877.2	2027.6	843.8	2467.5	5000.7	1350.4	1532.5	1939.7	2339.0	1237.4	1101.9	1229.3	1357.5	1238.9	3198.4	1315.0	2031.9	1385.6	1352.5	532.5	799.6	1562.2	2618.4	848.4	2412.3	3743.7	1628.3	1567.4	3393.7	1972.1	2412.1	1062.9	2779.4	3934.7	1215.3	1923.9	1896.4	1761.4	2602.9	2091.4	2251.5	1431.2	3675.5	3334.0	2400.6	1675.5	3079.8	1839.9	2199.4	1395.6	2489.8	1527.5	2664.4	1347.7	1950.3	825.4	3672.6	2999.5	905.9	1052.2	4589.3	1111.5	1149.8	1537.2	1247.2	2447.7	3155.8	3400.5	2644.9	1202.5	2217.9	1146.0	350.3	1144.7	180.1	1224.6	931.6	1759.2	2334.1	2023.4	1543.3	1424.7	2147.3	2531.4	2095.3	201.2	1187.1	800.4	1650.5	1520.8	4276.8	798.1	835.8	795.8	967.9	766.2	806.7	830.8	794.2	834.3	839.0	832.1	843.8	910.4	1131.4	1882.8	14.4	3414.1	3891.4	3738.4	2461.1	2290.1	317.5	2872.0	2269.1	1043.3	1983.2	1869.9	814.7	193.9	4378.5	2221.4	1360.9	2208.9	2060.1	596.1	1173.6	2134.8	1782.9	1477.7	1833.5	9.9	4296.3	6085.5	1656.8	846.6	1591.3	1121.0	1849.0	1788.3	2609.9	2812.3	114.4	14.5	2971.8	767.0	3231.7	4694.9	1402.8	4220.6	2451.1	2036.6	23.4	4047.9	1192.7	2671.5	6.0	23.9	2510.0	2427.6	1858.1	1983.1	3836.9	1742.4	3524.6	1041.6	614.4	1281.9	2376.7	1775.6	466.9	929.6	2878.6	4533.1	4741.0	2853.2	1988.4	3314.4	4435.0
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272075-33276511	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	3268.2	2353.2	1862.8	2097.6	1883.3	6071.7	6110.7	1827.2	2345.5	3989.9	1782.7	3060.6	2024.5	2386.7	2877.9	4570.6	3069.7	1608.3	1778.5	1806.3	1863.3	2052.0	2248.2	2034.3	4842.9	1889.4	1840.1	6497.6	5554.4	1294.1	1412.1	1956.1	1895.2	2780.5	2977.4	697.1	3045.6	1415.3	2861.9	6539.3	2565.0	1891.5	1948.2	3087.2	2634.1	789.9	1920.2	3097.1	2084.7	2140.2	4485.9	3011.2	3685.5	1926.5	4603.2	2645.2	3377.1	8930.5	5769.4	11474.6	5486.7	4471.1	6678.3	5939.4	4461.0	6787.2	2617.5	15106.6	4694.9	4890.5	2759.3	3293.1	5472.9	7251.7	4665.1	4722.4	8590.2	5617.0	2868.6	9108.9	11226.3	9771.0	2849.3	12386.6	14318.8	4498.5	13349.4	5436.5	5770.2	4373.8	7686.7	4590.7	5362.0	7880.9	4994.9	10924.1	4652.3	5367.0	3798.3	5853.7	5446.7	10293.5	5524.1	6007.1	3902.3	5714.2	1754.6	8884.0	14781.0	2429.4	6105.7	16713.0	4642.3	2714.4	3129.5	2894.4	5978.6	5376.3	12310.7	11828.5	1512.3	10665.4	3350.2	578.7	1878.9	236.8	2362.1	1653.6	4023.7	5634.6	4545.5	3382.7	3273.4	4515.8	4968.4	4374.8	184.7	3177.0	1265.3	2962.7	3727.6	9405.4	1862.8	1883.3	1827.2	2345.5	1806.3	1863.3	1889.4	1840.1	1895.2	1948.2	1920.2	1926.5	4065.5	1480.8	2569.4	9.4	8276.1	20537.2	16151.5	18150.8	5757.2	343.9	19342.8	26385.3	596.5	4185.0	6755.1	1841.0	231.4	8761.7	5535.7	2348.6	5106.4	4750.1	1164.5	1985.2	7580.0	5826.2	3089.9	3782.1	7.5	12662.2	14558.3	4617.6	2073.4	3457.9	3051.1	5393.6	6329.9	4513.1	6281.1	159.9	8.1	7793.0	4418.8	6115.9	12428.1	3197.4	9895.8	4296.2	8448.8	13.1	6356.1	1521.4	4753.9	5.0	11.5	8283.0	5985.7	4056.9	3499.7	14221.0	5563.4	5974.5	1936.4	683.4	2005.0	7010.5	6802.2	773.3	1827.1	8678.7	31942.8	8778.2	6742.0	7987.5	9896.2	16152.8
RPS19	"DBA, eS19, LOH19CR1, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41860255-41872925	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm		NA	NA		260000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA063217: AB_2732699"	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	1929.6	1900.6	1567.9	1417.3	1592.2	2933.3	2052.3	1529.9	2038.1	2531.8	1544.4	2004.3	1389.8	1628.2	679.3	3488.9	2151.1	766.0	1349.4	1501.4	1560.9	1424.1	2262.6	1640.4	2271.7	1631.4	1548.2	3787.9	3981.7	585.6	1015.9	818.9	1606.1	2231.8	1105.1	370.4	1748.9	760.8	1573.4	3885.1	2168.6	767.5	1626.1	2909.0	2099.7	639.3	1585.0	1825.5	1516.5	728.6	1869.1	2025.4	2512.4	1619.6	3536.2	4978.2	3109.1	2770.4	3924.8	5205.4	3456.4	2731.6	3132.5	3378.6	2982.1	3854.2	2341.3	5185.2	2985.2	2483.1	1670.6	1819.8	2701.4	4647.3	1563.5	2183.2	5098.9	2626.1	1471.5	4029.3	6775.6	4355.4	2564.0	7419.1	8959.5	2132.0	3942.4	5453.7	3421.0	4849.8	2911.6	3476.5	2845.7	4010.8	3975.9	3021.3	3619.2	9954.1	2087.6	4372.0	2503.1	2511.1	3188.1	3714.9	2216.7	2693.9	1539.3	4915.7	3951.2	4649.7	2787.7	6840.6	2694.1	2157.5	3396.5	1451.9	4383.8	3886.3	4520.6	5054.3	2348.3	3672.5	2498.9	1309.9	5303.2	586.8	9147.6	9536.3	13783.0	18138.6	13464.4	11872.3	8174.5	17813.4	15114.7	13788.0	724.9	12054.7	12053.9	11257.8	11367.1	30500.3	1567.9	1592.2	1529.9	2038.1	1501.4	1560.9	1631.4	1548.2	1606.1	1626.1	1585.0	1619.6	2154.8	1644.2	2318.8	17.6	7536.2	13338.7	9463.4	12098.6	8008.7	295.5	11387.2	17068.7	680.0	2778.1	4886.7	1430.8	127.2	6635.1	4648.2	1753.9	2641.3	4446.2	482.4	1178.2	3145.6	3665.9	2227.6	2708.0	15.4	8576.4	9609.3	2834.8	2442.4	1645.3	1825.2	4566.6	3793.4	3258.5	4591.9	136.3	20.2	4777.7	3497.2	6041.3	8631.8	1752.6	4036.7	4053.7	4557.0	52.5	5989.0	991.8	4541.7	13.6	42.4	7669.3	4181.6	1892.7	4036.1	8714.9	4183.2	3284.5	1889.5	479.3	1584.3	3428.0	5508.3	608.5	1952.5	7919.1	16952.4	6534.4	6030.8	3718.5	6131.8	8160.5
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962058-1964841	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		320000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	1690.3	1371.4	724.2	1077.5	741.5	2753.6	1803.0	715.7	944.0	1873.9	730.0	1509.2	957.5	1382.0	615.7	2558.8	1584.3	696.4	1237.7	712.7	742.4	1051.6	1423.2	1204.2	1914.1	797.8	741.9	3256.7	4556.8	388.1	972.5	832.6	777.7	1473.5	762.9	148.1	1477.9	636.9	2367.2	2781.5	1482.9	616.5	775.9	1849.7	1599.6	419.7	767.4	1570.4	1025.2	1558.8	1602.3	1750.8	1810.5	777.2	2258.0	3020.8	1716.3	5571.2	2433.0	5946.5	3093.8	1506.8	3381.7	3653.7	2581.3	5415.0	1451.8	4124.7	2329.8	2599.8	1226.5	2625.3	2553.6	4786.8	1372.0	2720.7	4959.5	1437.5	3382.8	4939.7	6019.8	3263.4	2174.4	8105.2	6715.4	3155.0	5057.6	3734.5	3606.2	3601.3	3014.4	2244.9	2591.9	9854.0	4110.2	5683.0	5591.7	2742.4	2706.1	4981.3	2846.5	4915.9	3411.9	1993.3	3154.5	2856.4	1465.0	4355.3	3538.6	1481.8	2933.7	5612.6	1757.9	1961.2	2605.3	499.3	3123.2	908.6	1554.7	5464.5	1056.9	2809.3	2532.6	74.1	438.2	239.9	562.4	545.5	932.7	1765.0	1096.6	864.3	805.8	1525.5	1366.1	1034.5	88.0	667.8	449.4	803.5	844.5	749.9	724.2	741.5	715.7	944.0	712.7	742.4	797.8	741.9	777.7	775.9	767.4	777.2	1261.2	519.2	1240.7	8.8	5674.4	11938.0	10835.5	3903.6	3510.9	362.3	12291.0	12660.6	252.4	2427.7	2182.1	910.4	187.7	8328.8	4158.8	1406.9	3212.6	4491.8	298.5	1154.3	4108.9	4082.2	2111.6	4032.5	13.2	11401.9	14898.5	2987.2	1703.4	1777.4	1021.9	4053.7	3477.4	2195.6	6029.4	277.6	15.7	4569.6	1627.6	5640.5	9869.6	489.7	4210.7	3709.4	5115.6	15.9	6772.9	965.3	3821.9	13.0	25.5	5585.7	2941.4	1575.6	3202.3	9790.4	2044.2	2439.2	906.1	477.8	1255.6	4193.6	3603.8	388.8	1997.9	5900.2	15069.3	8184.0	4718.2	6863.0	6345.9	11758.5
RPS20	"S20, uS10"	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067254-56074510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	2422.2	1415.6	1315.1	1437.6	1380.2	4350.7	2956.6	1314.4	2021.9	2421.6	1346.7	1883.7	1075.9	1542.4	1867.0	1732.4	1773.1	1364.6	1704.0	1265.2	1344.7	1472.6	1677.3	1532.7	3682.4	1368.1	1323.4	4823.5	2312.4	967.6	1157.1	1216.1	1376.0	1847.0	1162.5	646.1	2385.0	1153.2	2332.3	2599.0	1612.4	1057.6	1411.0	2022.1	1776.0	770.6	1360.6	2421.2	1631.2	1656.7	2569.3	1939.8	2002.2	1419.8	3154.0	2878.4	2662.3	2623.1	3875.2	4572.0	2296.1	2060.3	3243.9	2550.2	2328.3	3056.4	2994.9	4688.2	2496.8	2293.0	1686.1	1922.9	1731.7	3416.4	2167.2	2011.7	2418.6	3834.9	2434.8	3830.1	3733.9	2152.1	2396.3	4425.9	3555.4	1638.9	4725.2	3971.6	3184.3	3477.9	3210.0	2689.0	2585.6	4101.1	5915.4	4351.3	3574.7	4325.3	1233.6	3196.9	977.9	2459.6	3093.5	3500.9	896.6	2761.2	891.7	2403.8	4246.6	2210.3	3493.0	4411.0	1954.8	1824.1	3074.6	2401.4	3337.6	2829.2	2756.3	3479.1	2754.4	3895.2	1655.6	2076.5	2125.0	869.1	2514.0	1746.2	3620.8	5471.6	4594.4	3362.7	2643.7	4621.2	5940.0	4391.6	374.5	2151.7	1671.8	3772.4	3333.2	8768.9	1315.1	1380.2	1314.4	2021.9	1265.2	1344.7	1368.1	1323.4	1376.0	1411.0	1360.6	1419.8	531.6	1259.6	2162.2	18.6	2262.9	3750.0	3713.6	2367.9	409.2	140.6	956.6	590.0	1017.9	1684.3	1791.9	693.4	112.6	2885.6	1645.2	793.6	2201.1	1970.4	1979.3	746.1	1507.7	1533.9	1208.0	1268.8	13.3	4091.1	4246.0	1266.3	189.1	983.9	1670.0	570.3	2543.6	2301.4	2511.0	55.5	11.6	2235.2	679.5	3405.9	3567.2	1769.8	4496.9	1619.2	1949.5	15.0	3676.2	815.3	2747.7	10.1	16.2	3313.5	1714.9	1990.1	364.9	3196.6	1259.1	3235.5	956.0	354.6	1400.3	1958.0	1531.1	1536.1	1483.5	473.0	3924.2	3019.4	2078.3	664.6	2291.2	4097.9
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387103-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		250000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	1584.8	1416.8	1374.5	789.4	1408.7	2392.8	1877.1	1365.4	1771.9	2177.4	1327.1	1555.5	746.0	1459.7	550.8	2064.4	1803.0	465.4	989.2	1361.6	1356.9	1244.1	1088.1	1150.8	1513.8	1351.9	1347.8	3181.1	2441.5	527.1	968.9	561.5	1373.6	1408.6	629.9	210.2	1471.7	509.7	2133.5	2936.6	1592.2	420.1	1392.9	1836.6	1581.4	476.4	1420.6	1510.6	1172.3	873.8	982.5	1503.0	1900.1	1424.0	2398.5	2358.8	1184.4	2320.2	1321.3	2309.7	1609.5	1472.3	1141.8	3554.0	1348.8	7961.3	3131.7	2835.0	3019.8	1156.5	1283.3	3239.7	1343.1	4099.0	1252.7	729.2	3445.4	4723.0	3120.5	6137.2	2650.8	3692.8	2066.1	2581.1	5669.7	1370.4	2496.5	1451.4	1705.6	3116.1	2436.0	2351.9	1269.6	3506.2	4242.3	5294.5	1862.4	4129.5	7157.1	2799.7	3043.3	4437.6	1745.8	2581.8	2240.7	2206.7	1508.4	6850.0	3365.8	753.9	2935.2	4792.0	1810.4	2182.4	2852.5	1853.4	2993.0	3660.0	4580.0	3219.1	2607.4	2209.6	1179.5	379.7	1000.3	242.1	1322.7	872.6	1890.4	2692.5	2242.4	1753.8	1447.0	2532.7	2648.9	2404.8	152.8	1251.1	707.2	2013.1	1578.6	3102.5	1374.5	1408.7	1365.4	1771.9	1361.6	1356.9	1351.9	1347.8	1373.6	1392.9	1420.6	1424.0	1364.6	586.5	941.1	7.8	3935.3	2655.4	1626.1	981.0	3107.4	142.2	3889.4	5494.5	366.2	1229.6	931.4	489.2	223.1	1664.7	2299.9	1067.8	692.6	1619.1	132.9	556.3	999.9	1124.0	1212.9	2581.9	9.4	3548.5	2106.0	1019.6	1460.2	940.4	958.8	1067.6	1729.4	1728.5	1271.3	149.7	8.2	2684.6	321.4	2098.5	2590.7	133.6	1556.1	1493.7	974.7	5.6	1999.4	676.9	2139.1	4.0	6.5	2264.9	2168.9	802.3	2205.5	1561.5	1866.1	1305.7	429.3	305.3	558.8	1930.9	1036.6	265.6	853.2	3960.0	3136.3	1638.4	2731.0	645.0	3215.9	1523.2
RPS24	"eS24, S24"	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033760-78056813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		90000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	2458.4	1993.8	1538.1	1424.8	1549.0	4673.1	4757.9	1530.6	2756.8	3012.3	1536.9	2576.1	1756.5	2519.4	2811.2	2293.7	2474.3	1606.6	1604.1	1488.8	1645.6	1754.0	2209.3	1458.8	2669.4	1576.3	1569.3	5844.6	2955.3	1438.5	1178.1	1754.5	1586.4	1958.8	2573.9	964.5	2512.4	1637.4	3019.3	3045.0	1693.7	1946.0	1586.5	1916.9	1651.7	776.1	1538.2	2798.0	2252.7	2553.7	2707.5	2652.8	2547.2	1623.3	3390.5	1308.2	3303.3	5221.9	4021.6	7048.4	2884.3	3654.6	5055.0	3773.7	3323.4	1878.5	2339.0	7039.0	1940.5	3205.9	1303.4	2612.8	3847.7	4674.9	3460.7	2403.0	4325.8	2868.1	822.8	1879.0	4533.9	6943.1	1575.6	6732.0	6867.2	2652.4	9675.7	7591.6	4592.2	2981.8	4007.0	1455.6	4191.8	1388.2	3770.5	11229.0	2318.2	5976.0	12085.6	2567.9	3934.7	3482.3	4773.4	1608.2	1658.6	3234.9	1805.2	6010.8	4716.9	3414.2	3356.5	7559.6	3894.3	1175.5	2712.7	1570.9	4896.7	1774.5	3875.7	5354.8	1459.5	9444.0	970.5	1058.0	2124.4	809.3	1585.0	2036.3	2627.9	2796.4	2178.6	2037.5	2932.4	2380.3	2861.9	2644.0	276.9	2801.9	1626.7	2569.0	1916.3	4390.5	1538.1	1549.0	1530.6	2756.8	1488.8	1645.6	1576.3	1569.3	1586.4	1586.5	1538.2	1623.3	2643.8	743.6	1535.6	44.1	4070.7	4105.7	5007.7	2774.6	5333.8	344.3	4139.9	6421.4	617.1	2051.8	1719.2	801.9	108.4	3406.3	3424.5	1200.3	3279.1	2335.3	1414.9	1799.8	4602.7	2194.2	2090.5	3250.6	40.4	4508.1	6260.1	2099.8	2310.4	2451.6	1237.2	3541.5	2346.6	2252.0	3311.9	151.4	42.6	3944.5	880.9	4754.9	4734.0	5440.1	5670.8	3861.9	2031.3	49.6	5590.7	1395.6	3262.7	23.1	45.9	2886.9	3231.4	2588.2	3109.6	4622.7	2703.3	3770.5	768.5	465.7	1268.8	3609.7	2661.0	653.8	709.0	7289.7	4590.1	3541.8	3518.7	4105.6	4384.9	4943.2
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990762-153992155	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"prognostic favorable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	5616.3	3455.2	3594.8	2840.3	3661.4	7200.5	8666.0	3567.1	5829.2	7430.2	3632.2	5066.8	1888.2	4501.2	4042.3	4706.9	5856.4	2273.3	3532.4	3573.6	3695.5	4491.5	3641.9	4076.2	7137.0	3672.3	3637.9	12404.9	7506.0	3141.5	3807.8	2215.5	3648.3	5395.9	3581.3	1411.8	4351.2	3444.9	4963.3	7568.0	5438.8	2777.4	3605.2	6878.7	5028.9	1668.1	3632.1	8478.3	4692.8	4124.9	9185.3	5497.1	5730.0	3661.3	3446.4	3986.5	5147.0	2805.0	11901.1	11649.6	3148.9	4096.1	9832.9	5421.0	4866.7	8059.8	3705.0	7817.4	3304.5	6009.8	1792.6	3390.5	4624.1	6847.5	4577.2	3804.0	5945.0	3090.0	5442.0	5323.3	7881.7	6945.8	3888.2	11426.5	13193.2	4334.0	7920.5	8011.4	4546.6	6426.6	3865.0	4112.2	5239.5	8711.2	7513.7	4328.1	6227.9	11540.0	5775.4	4735.7	3753.2	6114.5	5064.7	6938.6	2702.3	5977.7	2340.0	8120.1	7572.9	6970.2	4531.0	13542.1	2672.3	1841.0	3043.3	2963.9	4141.0	8191.3	9166.7	9585.2	3202.5	3805.3	2591.7	12942.7	11463.1	5536.5	28801.5	11225.6	34790.5	56947.7	43040.6	37135.0	13993.9	48738.8	53667.4	42304.0	2458.8	27662.5	10603.9	23115.6	32257.9	76381.9	3594.8	3661.4	3567.1	5829.2	3573.6	3695.5	3672.3	3637.9	3648.3	3605.2	3632.1	3661.3	3187.7	2201.9	3978.4	11.4	13562.6	12494.3	5398.2	7693.2	4868.2	411.9	6937.5	6570.1	939.8	5752.0	4175.1	2155.5	193.9	6037.3	9149.7	2192.5	4431.5	4142.9	2927.6	1809.2	4392.1	3779.0	3022.4	4789.2	5.4	10431.2	6808.0	4116.6	2102.4	2597.5	4306.7	4628.6	6451.6	8222.0	4303.1	191.8	6.0	6849.8	1953.1	9173.5	14035.0	10184.0	7097.1	4890.7	5914.2	5.6	9465.8	1961.9	9527.4	3.0	6.8	6134.0	5941.1	3543.1	3703.6	4365.2	6412.1	6526.1	1955.9	646.0	2734.7	5847.6	4188.0	1563.3	1638.3	4859.8	14322.5	6382.1	11013.6	1757.5	6839.1	4530.7
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399515-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		560000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA063339: AB_2684990"	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	1139.4	747.7	431.1	955.9	446.8	2080.0	1950.0	427.3	575.6	1529.6	427.4	1220.4	946.0	1060.9	708.7	1669.8	1270.5	556.5	734.1	417.1	441.6	672.3	631.7	846.0	1663.4	446.6	430.8	2914.0	1761.9	356.4	660.5	760.6	442.8	929.1	919.3	352.7	1049.9	662.1	1125.5	1783.9	1128.2	739.8	444.4	1346.4	1082.2	287.7	435.1	1403.5	717.1	749.0	1360.4	1054.9	1384.5	446.9	1899.8	1145.7	1595.6	1767.5	1970.0	3482.1	2060.8	1763.7	2256.3	2289.4	1481.2	3331.6	2196.8	6547.1	2108.6	1598.8	1261.5	2672.3	2085.6	3290.7	2093.8	1749.1	1618.9	2688.6	1042.6	1490.2	2931.1	4398.6	1690.0	4124.1	4397.7	1568.8	4323.1	2684.0	3055.0	2876.5	2736.9	1809.7	2089.7	2071.2	2660.9	2112.4	2007.4	6591.3	1342.5	2482.3	5580.2	4834.0	2275.9	1551.8	1366.7	1933.6	1299.3	3050.2	1897.1	1535.9	3123.3	3289.9	2470.7	1099.6	1822.9	1515.3	1627.3	1647.2	2198.0	7283.3	660.4	2409.4	1138.1	430.3	770.8	245.5	1405.7	515.5	1924.9	1602.2	1823.1	1489.0	1099.3	1454.0	2102.1	1633.9	174.3	1142.6	512.4	960.4	1283.7	4244.2	431.1	446.8	427.3	575.6	417.1	441.6	446.6	430.8	442.8	444.4	435.1	446.9	1993.9	932.7	1604.3	18.6	4790.5	6297.7	7369.7	5554.5	4497.7	423.9	6945.0	9521.7	418.9	2088.9	2555.7	726.4	133.5	6188.6	4009.1	1694.4	2183.4	2376.0	430.9	939.2	3054.9	2780.8	2067.1	3428.9	28.3	5373.2	9079.0	2364.6	1651.9	1363.9	1641.6	4246.7	2916.7	1369.0	3662.5	132.9	32.6	4425.4	1621.5	3089.2	4666.7	968.5	3755.0	2393.1	2835.3	38.4	3626.4	957.1	4120.5	19.6	47.5	3805.0	3535.7	1803.2	2848.0	5827.8	2969.4	2226.4	797.6	505.5	1117.5	3204.8	3221.9	449.3	618.6	5734.6	7842.8	5867.5	4904.4	4865.2	5657.1	7206.9
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099624-151104642	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	2233.9	1361.3	1032.4	1357.8	1063.0	4321.5	4603.8	1034.9	1672.3	3236.5	1041.5	1964.3	1314.5	1964.8	2303.4	2250.6	2307.9	1186.8	1430.3	992.0	1052.4	1657.2	1371.0	1471.0	3341.7	1038.8	1025.1	4877.7	3514.8	1107.6	1325.8	1372.7	1059.4	1982.7	1778.1	861.8	2107.7	1322.9	1967.9	2992.3	1848.5	1337.8	1102.5	2038.6	1898.7	586.2	1056.2	2991.3	1965.5	1499.1	2764.4	1969.9	2486.8	1089.1	2090.9	1501.8	2780.1	2751.6	3524.5	6867.8	2849.1	2150.7	3334.5	3006.4	1848.2	2933.6	2944.4	9381.3	1048.4	2383.2	1050.5	1339.3	2877.1	3624.3	2840.5	2075.6	2762.0	2023.6	1589.8	3421.2	4067.8	4855.0	1999.1	5125.5	7353.9	1849.5	4874.5	4195.4	3639.4	3417.8	3320.0	4722.3	3632.8	3124.8	5289.7	5604.8	2624.1	3296.7	1147.0	3798.0	2719.3	3175.4	3505.2	2487.1	2668.0	2635.2	971.4	3495.1	5019.9	1954.5	2341.0	5780.5	2212.2	1451.6	1915.8	1618.1	2424.7	3626.8	6367.6	5820.6	1863.4	3508.9	1758.5	1918.8	3362.4	977.5	3828.9	2626.4	6462.8	7155.1	6390.5	5052.0	5393.2	6165.0	8750.8	7174.2	495.2	5199.2	2256.0	6377.8	5103.3	18540.3	1032.4	1063.0	1034.9	1672.3	992.0	1052.4	1038.8	1025.1	1059.4	1102.5	1056.2	1089.1	2387.5	971.2	1605.1	15.0	5574.2	6158.3	8280.0	5535.6	4255.3	412.4	6080.4	8681.6	381.3	2194.8	2530.5	825.8	120.9	4538.4	4799.4	1188.9	4284.8	2316.3	1754.6	1570.1	3613.3	2564.2	2154.3	3366.6	17.8	3732.2	7502.1	2388.6	1599.9	1895.7	1468.6	3424.3	2653.9	1441.0	3403.7	163.2	18.6	4137.0	1454.6	4309.4	5658.7	4012.5	4428.4	3332.7	3260.3	20.6	5502.6	1760.6	4551.0	23.6	22.4	2788.3	3029.1	2592.3	2412.5	6111.5	2682.0	5073.3	1084.8	593.9	1768.4	4410.8	3918.5	834.4	820.8	5042.0	6756.0	4591.7	4520.4	4186.2	5049.9	7641.8
RPS4X	"CCG2, DXS306, FLJ40595, RPS4, S4, SCAR, SCR10"	ENSG00000198034	"Ribosomal protein S4 X-linked"	P62701	X	72255679-72277248	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 16435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000857	Supported					NA	NA		980000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA000857: AB_1079849"	"unprognostic (1.09e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.53e-3)"	"unprognostic (7.05e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.50e-6)"	"unprognostic (1.03e-2)"	"unprognostic (9.78e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (6.87e-2)"	853.8	549.4	365.5	430.2	373.9	1256.3	1420.5	357.6	559.4	1390.0	369.5	841.1	599.4	968.2	1434.8	912.9	1165.4	410.4	553.0	353.4	385.3	665.8	559.4	576.4	1101.4	373.6	367.7	2123.3	1665.4	423.6	820.3	437.3	376.6	759.1	654.5	265.5	841.5	561.1	852.5	1451.3	689.9	713.6	385.5	728.1	763.9	139.7	375.8	1163.5	773.4	435.5	1050.0	832.7	1178.3	380.8	824.3	739.2	978.8	721.5	1348.9	2149.0	712.1	558.1	1459.1	1258.7	996.5	1211.2	569.5	2612.6	1327.0	527.8	931.7	464.3	958.1	1188.4	1312.8	543.5	2220.1	451.1	868.8	902.3	1721.6	1110.2	1087.7	2272.6	1372.4	541.6	1732.2	1232.7	1089.7	840.1	744.8	1579.2	1236.8	1205.1	1334.9	1776.2	969.4	2272.0	857.4	801.1	1371.1	2103.2	827.3	1083.2	911.3	1105.5	920.3	2068.4	1790.3	583.4	413.6	1715.2	586.9	296.5	830.9	619.4	542.5	594.3	598.6	815.8	516.1	2034.5	625.5	307.3	853.9	161.2	1093.0	761.1	1737.7	2010.7	1780.2	1421.2	1240.9	1781.6	2191.8	1787.8	76.4	1291.3	725.8	1413.6	1556.5	3744.0	365.5	373.9	357.6	559.4	353.4	385.3	373.6	367.7	376.6	385.5	375.8	380.8	2558.8	541.7	1356.5	33.0	4448.1	7308.4	7295.0	5549.2	4584.9	274.3	11267.1	16435.1	373.2	2240.4	2347.4	958.2	64.6	4734.2	3564.6	1259.3	5636.8	2116.8	40.7	1732.9	3743.4	2920.8	2538.3	2604.8	30.8	6446.6	7517.1	2559.8	1270.6	1992.9	1314.0	3898.1	2557.6	2057.1	3296.7	67.3	32.6	4050.7	1755.7	2881.5	4938.2	172.0	3729.8	2563.0	3656.9	35.6	3293.0	890.5	2435.7	18.1	46.7	3064.4	3542.1	2188.7	3329.3	5760.5	3103.2	4152.2	995.8	383.9	1216.2	3044.3	3471.7	48.8	229.8	5478.7	9764.3	5159.5	3869.0	4946.8	5023.8	7162.0
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 11301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		880000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	1081.7	1079.0	621.2	604.4	637.5	1609.5	1273.6	612.1	781.7	1432.2	592.8	1109.0	590.3	1053.8	378.7	1577.3	1221.4	504.3	811.8	587.0	617.8	800.1	997.5	789.2	1269.3	637.9	617.7	2437.6	2886.2	520.6	669.0	520.1	631.9	1225.4	575.6	182.5	1064.0	484.2	1456.9	2062.5	905.6	571.2	657.5	1033.5	1075.5	331.4	642.5	1007.9	830.1	821.3	1002.1	1098.4	1304.4	641.0	1779.4	2543.8	953.2	1524.9	1812.8	2328.6	1485.9	967.6	1590.9	1162.4	737.1	1909.7	1270.7	3655.5	1185.5	1379.5	1134.2	1126.2	1529.9	2381.7	478.7	1000.1	11301.4	1451.3	1247.3	2444.6	2241.6	2459.7	1183.1	2980.8	3882.4	1210.7	2740.2	1288.9	1539.0	1662.6	1880.1	1897.8	1260.5	1432.8	2399.9	1683.0	1589.7	2782.4	3399.7	2289.6	1364.6	3236.9	1296.9	2199.0	1424.2	1776.2	677.7	1916.6	2066.3	556.4	1109.2	2923.7	980.7	1743.4	1276.4	705.7	2149.8	2527.3	4650.9	2768.7	1092.1	1817.9	980.8	322.0	652.6	131.2	739.4	621.6	1360.4	2219.4	1272.0	962.1	1196.9	2071.6	1829.6	1435.3	92.8	1022.1	467.6	1253.3	1128.4	2583.3	621.2	637.5	612.1	781.7	587.0	617.8	637.9	617.7	631.9	657.5	642.5	641.0	1118.4	679.5	1091.0	10.1	3747.2	5916.6	5060.2	3028.2	3999.8	242.5	5685.5	7711.0	243.7	1499.9	1654.2	526.0	123.0	3220.8	1739.2	1023.0	1823.4	1792.4	490.1	640.6	1967.1	1631.2	1236.3	2005.8	10.6	4571.3	4191.9	1629.9	1014.8	915.6	1003.0	2412.5	1452.8	1468.4	1973.5	163.2	15.2	2390.3	958.2	1800.2	3567.2	1482.6	2160.0	1414.9	2431.5	12.2	1874.2	700.7	1618.0	12.1	25.1	2022.9	1856.1	945.2	2346.5	4934.9	1734.6	2607.0	711.5	456.9	696.8	2096.0	3046.0	489.6	758.2	4308.1	7256.9	3174.7	2382.2	2244.1	2922.0	4637.7
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	34.2	9.0	40.3	8.0	41.0	10.5	27.8	35.0	35.2	18.1	8.6	16.6	6.1	26.0	7.1	20.1	18.7	18.2	61.8	37.8	42.1	13.6	6.6	45.1	7.5	48.3	41.7	29.2	19.4	49.6	27.2	17.9	42.0	14.9	10.3	28.9	14.7	14.2	24.1	16.4	16.5	22.7	35.3	26.0	21.4	7.7	47.3	5.9	36.3	30.5	7.3	24.5	14.9	49.3	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	40.3	41.0	35.0	35.2	37.8	42.1	48.3	41.7	42.0	35.3	47.3	49.3	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950574	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	14.0	11.3	7.1	11.9	7.8	18.0	13.3	11.8	9.8	11.8	9.4	10.7	10.0	13.8	10.1	16.3	10.2	9.4	10.6	7.2	6.6	9.8	15.2	9.9	14.2	7.3	7.0	14.9	16.9	14.9	7.4	15.4	7.5	10.6	11.0	10.9	9.4	10.2	22.7	10.6	9.3	14.3	6.2	12.4	11.1	6.9	7.5	15.2	11.9	18.3	17.3	14.9	11.0	9.6	34.5	33.5	27.5	26.2	18.1	26.2	20.8	31.2	28.3	26.3	29.3	27.6	16.8	41.7	37.9	25.4	32.1	17.3	36.0	27.3	42.7	23.3	41.5	28.7	21.2	31.2	26.9	44.5	27.1	26.7	20.7	31.0	22.8	21.9	35.0	26.0	38.5	25.9	19.7	243.6	53.2	18.4	18.6	29.8	24.9	30.8	46.7	38.8	21.9	25.1	20.1	23.8	26.2	15.2	16.6	31.7	29.7	24.2	31.1	25.8	42.9	21.2	42.0	46.2	42.0	46.3	19.4	26.7	21.2	43.8	12.1	11.4	12.7	12.2	15.5	10.4	11.6	14.7	15.3	9.4	13.5	14.3	11.5	11.9	14.4	9.5	11.9	10.3	7.1	7.8	11.8	9.8	7.2	6.6	7.3	7.0	7.5	6.2	7.5	9.6	22.8	22.4	34.2	29.0	32.6	33.0	21.4	13.0	30.7	18.0	23.1	17.8	16.8	12.8	30.4	3.7	18.8	24.3	33.5	12.4	3.9	12.9	5.1	24.0	31.7	25.5	13.2	11.8	47.3	16.4	18.2	24.8	26.0	37.7	23.4	20.0	13.6	15.1	12.1	18.5	45.2	14.1	4.1	15.2	20.4	3.8	15.8	19.0	10.6	28.1	20.0	12.8	18.6	25.6	54.8	15.1	10.9	18.0	34.6	27.9	9.3	9.2	21.1	18.9	26.3	33.4	32.6	13.0	13.7	34.5	32.0	30.5	29.9	26.0	13.9	25.4
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	1838.1	1827.8	968.1	1263.3	996.7	3485.5	2382.9	960.6	1219.3	2442.2	981.5	1524.8	1195.0	1642.4	1374.2	2245.4	1928.1	992.2	1051.9	924.3	990.0	1152.9	1081.3	1080.0	2599.6	1010.5	958.9	5416.4	2647.7	800.3	1015.0	1237.3	1021.9	1591.5	1241.2	330.7	1794.6	903.9	1677.0	2755.2	1403.7	1147.3	1051.9	1577.9	1376.4	332.0	993.7	1888.8	1095.1	1233.4	2230.7	1661.8	2073.9	1049.9	2441.2	1215.3	1875.4	2510.4	3244.1	5078.7	3072.1	1749.9	2806.5	2463.5	1966.2	2104.1	2601.9	4624.8	1869.5	2168.8	1554.5	1629.2	2474.1	3090.7	1814.6	1684.7	4320.2	1721.5	1606.0	2864.5	4578.2	3450.8	1612.1	4061.4	5060.2	1638.3	4357.4	3481.0	3002.5	2729.6	2630.2	3148.3	2334.1	1961.4	3810.0	3659.2	4103.8	2046.8	2070.8	3020.4	2294.4	5221.6	2795.6	2097.6	2026.9	2298.2	946.6	5242.8	7264.1	1814.9	1835.0	6739.3	2030.0	1204.7	2069.4	1857.6	3031.1	2418.8	2600.5	3553.2	1458.2	4134.2	1478.9	201.9	847.4	259.3	827.7	813.6	1414.6	2308.1	1504.1	1152.2	1266.5	1942.3	1855.5	1597.6	78.9	1020.7	652.7	1553.9	1384.4	3322.6	968.1	996.7	960.6	1219.3	924.3	990.0	1010.5	958.9	1021.9	1051.9	993.7	1049.9	2553.4	1416.6	2077.3	17.9	8208.6	7906.9	9285.2	4955.0	10969.2	235.7	6782.7	6808.8	749.2	2836.7	2980.6	1092.5	91.8	5226.0	3583.3	1280.8	4149.8	2597.7	491.8	2480.8	7101.2	3339.7	2141.2	5081.3	22.7	6066.6	7604.6	3510.7	3144.2	2929.1	1842.5	4531.7	3832.6	2417.2	3576.9	60.6	24.8	4271.4	1249.2	4339.4	5493.4	663.3	6143.9	3744.2	2947.3	23.4	4350.2	1090.6	2637.5	19.6	24.2	3967.8	3960.4	2751.4	6055.5	7588.1	2355.6	4494.0	1621.0	281.4	1505.4	4004.0	4560.2	415.9	479.9	14643.0	11209.1	5363.5	4833.7	4645.1	5165.6	8250.4
RPS9	S9	ENSG00000170889	"Ribosomal protein S9"	P46781	19	54200809-54249003	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048746	Approved					NA	Yes		64000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA048746: AB_2680510"	"prognostic favorable (9.23e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	1846.1	1581.0	641.4	518.8	641.4	1359.3	1991.4	639.9	975.3	2001.5	638.1	1524.9	564.9	1523.5	469.1	2126.8	1633.0	302.8	1353.2	643.2	640.4	1437.6	1647.5	1359.5	682.3	654.2	658.1	3458.6	3439.2	314.2	932.7	325.4	645.0	1662.3	355.4	79.1	1512.6	167.0	1680.6	2686.6	1454.5	368.3	640.7	1812.7	1610.9	455.4	649.9	968.4	1272.0	627.6	652.3	1582.5	1861.8	647.6	500.8	204.0	257.8	695.7	1424.1	1563.5	602.5	440.1	254.9	246.2	124.4	216.2	861.6	899.9	518.5	785.5	398.8	677.4	922.7	1119.2	196.3	505.5	310.3	328.7	42.2	221.0	1293.3	708.5	711.7	2154.8	1199.7	686.8	882.1	838.6	861.4	831.0	452.2	978.5	693.8	148.0	1452.1	2013.6	770.5	636.4	200.7	865.5	406.3	1507.6	1201.0	228.9	532.3	926.3	255.6	749.5	1308.2	304.6	1003.0	2054.0	249.1	425.4	652.4	545.4	725.2	748.9	663.0	773.2	638.7	752.2	525.7	178.8	847.5	163.1	533.1	712.2	877.4	1075.6	917.4	673.0	741.2	1129.0	1237.5	1060.6	534.1	658.8	677.2	1018.9	627.1	2882.7	641.4	641.4	639.9	975.3	643.2	640.4	654.2	658.1	645.0	640.7	649.9	647.6	1501.4	458.3	1166.6	22.2	3076.3	6471.6	6044.0	4452.4	2423.9	346.2	6390.8	6524.1	198.1	1996.0	1877.7	886.5	175.2	2267.8	2511.4	1539.2	2488.7	1954.7	794.3	1011.6	2061.6	2294.9	1974.5	1549.2	13.6	5626.0	4374.8	1874.4	911.8	1416.2	838.2	2875.5	2494.0	2045.6	2693.9	175.0	14.6	3345.8	1377.3	3888.3	5294.3	1889.2	2872.7	2675.0	3283.5	25.3	3499.1	1219.7	2250.3	16.6	45.8	2925.9	2828.6	1518.0	1474.4	5077.4	3010.2	3183.8	786.3	682.9	1051.8	3030.1	2744.3	526.5	484.2	2627.6	7500.0	2470.4	2489.3	2886.3	3908.4	5842.9
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406716-39412542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	1063.0	929.1	813.4	685.7	824.8	1574.8	1068.4	782.0	979.1	1260.0	761.8	1158.4	605.8	1022.1	351.0	1922.5	1128.3	372.5	783.9	778.6	794.3	905.9	972.5	894.3	1281.4	817.8	809.6	2153.7	2616.3	605.5	813.4	468.8	812.9	1212.6	872.2	273.3	1039.7	446.9	1087.1	1529.4	1133.1	718.3	842.4	1525.8	1209.3	358.0	831.9	1259.9	862.6	730.4	1466.4	1127.5	1293.1	821.5	1800.4	1646.5	1367.5	2265.9	1203.3	2661.2	2155.0	1251.2	2005.9	2775.9	1611.8	1811.6	1513.7	3949.6	737.0	2535.3	747.6	695.4	2983.8	2945.7	2402.3	1459.6	1599.6	1783.6	1390.5	1750.2	2322.7	2546.4	1649.2	3043.3	4729.8	2147.2	3475.3	2030.8	2942.7	2343.5	1909.3	1883.8	2031.1	1282.1	3031.0	1960.4	4574.2	2756.9	2755.1	1412.2	1958.4	2974.8	2004.4	814.2	985.3	1989.0	674.8	5156.5	2202.9	1843.5	1509.0	3544.5	1156.6	845.2	1545.8	1422.3	3102.3	1440.6	2363.4	2437.5	1355.7	2481.7	1143.9	98.3	240.5	56.7	572.9	294.6	993.1	1010.3	942.1	758.8	654.2	951.8	1036.2	936.1	34.3	726.0	247.5	723.6	765.5	1499.7	813.4	824.8	782.0	979.1	778.6	794.3	817.8	809.6	812.9	842.4	831.9	821.5	532.1	519.2	800.2	10.7	2802.5	1802.5	2606.9	1585.5	2040.3	270.4	1864.7	1423.4	64.0	1095.2	906.4	325.5	95.9	2852.5	1768.9	625.4	992.0	1598.4	144.3	536.7	1178.5	891.2	1033.6	1733.9	21.3	3417.4	4473.1	927.1	821.6	747.7	778.4	1654.5	937.3	717.7	1608.4	173.3	21.5	1847.0	455.7	1304.9	1469.6	283.7	1240.5	1086.9	738.2	12.2	1605.2	621.1	1858.9	19.1	29.3	1889.5	1184.2	747.4	1501.8	2136.7	724.4	1257.1	476.2	364.4	473.3	1053.5	1002.2	352.2	1255.8	2879.8	1916.2	2420.7	2100.0	1539.2	2442.4	2884.6
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	5.9	4.6	3.5	4.4	3.3	4.1	3.6	2.0	4.4	4.3	0.1	5.7	4.8	5.6	1.8	4.5	4.5	2.9	6.1	3.8	2.6	3.1	3.4	4.2	3.3	3.3	2.8	4.8	5.5	5.3	4.0	3.6	3.3	4.5	2.4	2.6	4.6	5.0	14.1	5.1	4.5	4.6	2.0	3.8	4.4	4.0	3.5	4.4	3.6	7.0	2.7	5.4	3.6	3.2	16.2	34.7	6.8	12.9	9.5	7.0	15.5	12.7	9.5	17.9	12.4	21.5	13.8	13.3	10.1	12.9	13.8	11.6	10.5	15.7	8.9	5.6	19.6	20.8	16.8	21.2	8.9	19.8	15.3	12.3	9.9	17.3	9.1	5.9	16.6	15.7	24.9	4.6	8.6	8.8	12.4	7.8	7.4	9.2	24.0	10.2	12.9	11.2	4.6	17.8	13.4	17.4	14.4	22.9	14.9	6.6	16.3	14.5	9.6	37.1	17.8	11.6	15.7	8.9	3.9	12.6	22.4	10.1	23.6	0.0	0.1	0.0	0.5	0.3	0.3	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.0	0.4	3.5	3.3	2.0	4.4	3.8	2.6	3.3	2.8	3.3	2.0	3.5	3.2	4.3	0.0	3.9	46.0	8.5	3.2	3.0	2.4	4.6	6.8	4.2	3.3	4.5	5.7	1.6	5.5	4.2	4.4	7.2	3.8	1.9	3.6	6.7	3.9	5.4	4.3	6.0	4.8	70.1	3.8	5.9	4.8	8.2	4.9	2.5	7.5	2.2	7.5	4.7	11.8	66.3	3.1	6.1	5.7	3.2	10.9	3.1	6.7	1.8	32.8	1.7	4.3	2.1	50.8	66.2	4.7	3.5	5.3	9.4	4.5	4.6	2.7	2.0	7.0	0.0	5.5	4.1	4.5	3.5	5.1	3.0	4.4	9.3	6.0	5.6	3.8
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 497.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 588.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.8;plasmacytoid DC: 44.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		320000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	64.2	72.3	27.0	62.8	41.9	28.1	54.6	41.1	32.2	69.1	52.3	98.3	76.1	59.5	55.0	67.8	45.1	71.5	59.1	27.5	35.3	77.4	219.0	80.2	28.2	49.3	42.2	48.3	497.7	72.4	63.4	107.9	45.5	66.5	65.9	17.7	228.2	63.4	21.9	43.6	82.7	46.0	37.7	57.7	123.1	48.4	40.9	14.4	130.4	14.7	27.0	57.6	55.2	49.2	173.5	121.0	35.7	80.4	160.3	172.2	186.2	264.3	221.3	110.0	148.2	271.2	159.3	66.5	87.3	252.2	113.4	170.4	38.7	215.4	89.1	30.9	29.7	76.2	34.9	283.6	229.4	29.0	93.0	228.9	63.8	178.7	104.3	161.7	109.7	23.4	32.6	62.9	167.6	78.8	11.4	65.5	41.6	383.3	115.8	20.1	94.2	231.3	93.0	58.4	18.2	13.7	151.1	353.2	108.4	75.0	62.0	43.5	198.7	232.7	85.9	122.1	88.5	114.6	93.6	21.6	88.1	30.7	121.1	11.7	8.4	37.8	4.3	5.5	3.2	1.0	1.4	2.6	4.6	1.4	1.4	1.6	7.8	10.7	8.4	44.4	1.5	3.1	27.0	41.9	41.1	32.2	27.5	35.3	49.3	42.2	45.5	37.7	40.9	49.2	146.8	96.1	197.1	15.0	72.5	59.1	92.3	90.3	55.2	21.9	127.0	76.3	46.4	144.4	158.2	95.6	31.3	262.0	180.6	588.9	45.0	199.7	47.2	117.5	228.4	155.8	97.0	31.6	3.0	414.6	235.8	219.7	294.6	322.8	118.9	78.1	118.9	279.9	117.4	25.2	4.9	507.9	50.8	62.0	85.7	44.3	127.1	91.6	71.2	17.8	75.1	144.3	79.3	23.1	27.6	357.7	452.3	83.1	570.6	145.6	221.6	57.2	121.8	35.5	32.9	165.1	169.8	77.5	139.9	73.2	55.8	532.9	56.9	114.6	329.3	218.5
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	16.6	21.2	5.1	24.8	5.3	32.8	22.7	7.1	6.1	16.9	4.7	25.7	19.3	16.2	10.1	26.5	15.5	11.8	16.4	5.1	5.7	13.4	18.4	12.8	34.4	6.1	5.5	16.4	14.6	24.7	7.1	20.4	6.6	18.5	29.4	23.6	14.7	16.0	30.3	36.1	20.2	20.1	6.2	13.0	17.6	17.9	5.1	56.7	15.6	30.0	45.2	15.6	18.9	6.2	221.6	117.8	188.4	110.0	28.4	56.2	73.0	198.0	98.2	220.7	225.9	106.8	163.8	237.4	47.0	100.1	95.9	173.0	176.9	143.2	259.3	117.3	187.9	121.0	159.8	83.1	11.2	208.9	84.6	26.6	37.8	121.7	86.4	48.3	107.8	140.1	161.1	107.3	186.8	99.6	246.7	41.9	118.2	152.2	119.2	196.1	147.0	84.3	59.4	61.8	159.8	88.1	175.1	104.8	30.0	75.8	102.8	71.4	62.3	203.4	106.0	206.9	147.4	70.3	103.5	252.5	114.1	137.6	130.3	8.3	4.0	4.5	11.3	11.2	21.1	9.2	22.3	16.6	7.3	5.2	17.2	15.0	0.0	10.5	15.6	4.4	41.7	10.3	5.1	5.3	7.1	6.1	5.1	5.7	6.1	5.5	6.6	6.2	5.1	6.2	12.4	19.2	14.4	4.9	17.0	33.4	26.8	31.0	17.6	15.6	15.1	14.4	33.5	14.3	24.7	18.4	6.2	62.8	14.9	13.3	7.9	25.6	69.9	11.5	14.5	15.7	18.0	81.2	11.2	22.2	62.5	22.0	20.4	13.9	7.0	27.3	10.8	15.0	28.3	18.5	12.0	25.0	16.2	11.7	10.3	83.9	13.1	13.9	10.6	6.5	10.7	24.0	5.2	12.1	11.9	15.8	10.4	16.6	31.3	10.1	12.5	8.4	15.5	22.7	13.1	19.5	27.1	102.8	63.1	36.5	29.0	39.7	23.2	18.1	34.3	20.6
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060033-15094311	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	"Nucleoli rim"		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli rim"		"HPA049837: AB_2680906"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	21.9	17.1	8.5	11.2	8.2	28.1	20.1	10.8	13.5	15.3	7.5	16.1	7.0	16.6	11.1	13.3	16.0	12.0	16.3	8.3	9.0	15.2	31.1	12.7	15.6	8.2	10.5	20.7	20.0	20.7	15.5	12.2	9.0	16.9	18.2	23.9	13.0	13.3	41.4	15.6	14.7	13.5	8.1	16.2	15.1	13.7	9.0	19.0	16.4	39.1	18.1	18.2	14.0	10.2	17.3	8.5	25.6	22.8	20.2	24.2	7.6	19.4	19.9	28.5	29.9	5.6	31.6	39.2	28.9	27.8	27.7	18.0	40.5	26.3	46.9	20.4	21.9	95.6	17.3	52.4	44.5	17.9	103.4	19.9	41.4	38.2	41.0	25.2	20.9	13.6	18.6	32.0	44.9	26.3	17.0	44.1	25.5	23.3	4.6	61.7	26.4	41.0	26.6	18.4	42.3	33.8	30.5	38.2	24.7	16.4	43.3	25.4	19.4	34.5	14.2	19.8	26.8	27.7	32.8	56.1	20.4	30.2	43.7	8.4	3.4	3.9	3.8	2.3	5.3	4.7	2.8	3.4	3.6	2.2	4.1	3.0	0.4	6.8	2.7	1.8	3.1	4.6	8.5	8.2	10.8	13.5	8.3	9.0	8.2	10.5	9.0	8.1	9.0	10.2	31.6	9.6	13.7	13.1	28.1	17.8	10.3	8.6	28.5	14.4	16.5	12.8	22.3	8.6	10.2	16.5	20.9	11.7	21.4	14.3	5.9	10.1	18.1	9.6	22.3	20.2	7.2	22.5	13.7	8.0	10.9	19.9	20.9	15.0	10.1	22.4	15.4	18.2	15.1	11.8	16.4	17.0	12.2	14.1	15.0	7.7	14.6	21.2	16.0	14.0	15.9	19.0	18.6	13.6	12.7	11.0	13.7	18.0	23.2	12.2	12.8	15.1	5.9	18.9	0.0	14.9	19.1	15.5	21.3	27.9	21.9	6.7	27.6	19.4	14.9	11.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42508344-42519796	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	14.0	16.5	15.8	9.8	18.0	12.3	15.4	14.3	17.0	13.9	11.6	13.9	6.2	13.7	28.2	18.7	13.9	4.7	15.6	16.4	14.1	22.3	18.4	13.0	14.2	15.0	15.3	17.3	14.5	11.1	11.2	6.6	15.5	22.3	6.1	5.2	15.6	7.5	13.8	15.7	13.8	6.4	13.1	18.4	15.0	12.8	14.6	10.3	13.6	5.2	10.2	14.8	14.0	15.7	23.9	34.6	21.1	24.7	13.7	8.8	35.9	21.0	13.7	27.0	22.8	47.4	14.3	41.4	10.6	15.5	13.4	29.3	25.4	28.1	11.1	11.2	50.3	21.8	26.4	23.6	11.2	57.1	19.4	12.1	16.4	35.6	17.7	10.5	15.6	21.6	30.7	12.1	15.9	51.5	54.8	23.0	17.9	20.5	25.5	88.9	19.9	17.6	13.7	31.5	9.8	8.4	14.8	50.5	20.7	8.9	18.2	23.9	12.4	22.9	25.1	16.4	21.1	18.5	16.0	48.8	18.2	20.3	31.2	16.1	28.0	22.4	21.2	33.2	20.4	26.1	18.4	19.7	21.8	32.5	20.0	18.8	5.7	20.4	37.2	37.6	17.1	26.2	15.8	18.0	14.3	17.0	16.4	14.1	15.0	15.3	15.5	13.1	14.6	15.7	32.2	22.4	36.6	5.9	48.6	43.8	95.1	41.4	12.5	26.6	28.6	28.3	16.0	31.5	37.2	22.0	16.7	93.0	50.3	48.4	17.6	71.3	55.8	24.2	25.4	38.6	26.4	64.6	7.5	27.2	133.8	31.0	34.7	28.8	47.5	46.3	37.5	32.6	94.8	26.9	6.8	39.8	28.5	43.3	47.4	118.3	22.1	39.5	33.8	6.5	116.5	24.8	68.0	1.0	7.9	52.1	46.0	18.4	51.4	94.3	38.5	42.1	34.4	28.5	6.6	30.2	37.0	33.5	24.7	27.3	37.8	120.4	40.2	45.2	59.4	106.3
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	18.5	17.1	13.2	11.8	12.0	15.1	16.4	16.9	17.2	16.0	6.2	14.8	8.7	14.2	11.6	12.7	10.7	10.2	16.0	8.0	12.7	15.9	16.5	10.6	13.7	14.5	15.5	12.8	15.6	15.6	11.6	11.8	12.6	13.1	13.5	18.7	13.5	12.3	19.3	12.9	10.2	13.8	11.0	11.8	12.1	11.3	17.6	13.2	17.0	11.0	14.2	13.6	13.4	13.8	73.6	37.3	24.1	32.1	60.7	41.4	34.1	36.2	29.3	37.8	41.5	51.8	56.8	68.6	66.9	42.9	47.2	32.8	48.4	31.8	58.3	107.6	40.4	71.0	30.4	41.3	9.3	61.5	43.2	32.3	30.0	32.4	29.1	43.4	17.7	38.8	45.4	50.2	31.6	63.7	43.2	41.5	21.4	44.3	33.4	54.7	45.4	86.1	29.5	23.8	47.4	51.7	40.7	26.6	44.6	27.1	59.2	51.7	20.3	52.6	31.6	63.3	69.4	41.0	51.0	72.6	48.5	79.5	61.2	40.4	36.3	20.3	25.1	38.6	25.9	49.5	25.6	24.3	22.0	45.5	23.9	25.7	25.4	17.7	37.2	62.3	22.4	12.9	13.2	12.0	16.9	17.2	8.0	12.7	14.5	15.5	12.6	11.0	17.6	13.8	36.0	32.1	23.1	51.6	51.1	37.3	36.1	32.3	15.4	78.1	39.4	28.7	44.9	45.8	27.0	82.8	33.3	37.5	41.1	33.2	74.3	52.6	49.9	32.8	48.4	35.5	33.0	68.8	71.3	60.5	52.8	47.5	26.0	29.9	76.5	44.0	32.2	74.5	38.3	63.9	82.4	54.9	40.7	45.6	67.6	11.0	46.3	42.4	44.4	80.6	50.0	52.2	44.3	46.3	142.2	45.8	34.2	35.7	35.4	27.7	21.8	67.8	29.7	95.6	19.7	34.8	49.5	39.5	40.4	27.4	27.4	29.6	37.4	39.8	35.9	29.3
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025927	Uncertain		Approved	Vesicles		NA	NA		33000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	35.6	14.2	8.8	22.0	8.9	27.9	25.4	8.8	10.1	21.2	10.1	27.8	12.0	30.3	19.9	27.7	19.2	19.7	25.1	8.7	10.1	19.4	16.7	27.7	22.3	10.5	9.4	21.8	21.2	14.1	3.9	23.2	9.8	17.9	23.8	9.9	14.5	27.0	15.8	15.9	13.7	41.8	8.6	20.4	15.6	5.5	10.4	18.1	18.7	13.8	22.3	24.0	18.0	9.6	27.3	18.6	15.0	88.5	78.4	80.3	18.3	66.3	28.2	45.1	48.6	17.3	25.0	27.0	10.5	91.2	24.1	23.9	18.3	34.7	48.3	40.6	14.6	85.2	11.1	16.7	34.5	13.1	47.8	40.0	36.0	43.3	13.7	40.9	47.8	27.8	14.0	18.2	61.6	17.6	30.5	23.5	15.7	39.6	10.5	19.6	20.3	18.4	44.0	10.0	5.9	11.6	33.1	21.6	33.6	26.8	7.6	34.4	58.8	38.4	13.3	48.5	34.6	15.9	20.6	23.3	51.0	37.1	16.9	33.0	20.9	22.8	24.7	26.0	28.0	16.6	28.1	26.7	34.7	17.9	20.5	25.8	14.6	31.3	25.5	25.9	36.0	48.5	8.8	8.9	8.8	10.1	8.7	10.1	10.5	9.4	9.8	8.6	10.4	9.6	111.1	35.3	24.5	26.4	29.9	36.7	30.3	74.0	12.0	1.7	22.5	36.2	41.2	27.1	48.3	42.3	2.1	131.9	41.6	57.0	68.4	72.1	80.5	20.7	47.2	69.6	7.2	74.7	52.8	119.2	83.0	52.8	28.5	24.8	34.2	20.5	64.2	32.7	121.7	3.3	34.7	19.0	52.9	61.1	80.7	163.3	39.4	106.2	60.5	52.5	92.3	5.8	66.9	45.8	51.7	81.2	16.8	68.4	36.7	17.4	14.9	58.3	48.8	17.9	65.7	32.4	136.1	3.9	22.6	34.1	42.8	96.2	46.8	35.9	27.2	24.9
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	4.9	7.0	1.3	6.1	1.6	8.2	5.2	5.7	4.7	6.8	0.5	8.5	4.8	10.0	3.0	4.6	6.2	3.0	3.9	1.2	0.9	4.1	4.8	6.0	4.2	2.9	0.6	6.4	8.6	2.8	12.2	4.2	1.8	6.7	2.1	2.5	6.3	4.5	5.4	4.5	5.8	3.1	0.2	6.1	6.6	7.6	1.2	4.8	7.8	2.3	2.4	6.5	6.0	1.5	8.3	11.7	7.9	15.5	1.6	1.7	14.5	16.8	4.5	26.0	6.6	22.2	7.0	11.0	8.6	5.2	9.8	15.3	5.5	11.1	6.1	5.5	11.0	13.8	21.2	21.5	5.7	13.4	24.1	2.2	6.0	6.4	7.9	4.9	9.0	19.6	17.4	10.4	5.8	8.7	21.3	17.5	7.8	7.1	22.3	17.2	7.4	11.6	4.1	9.7	15.7	9.3	9.3	27.5	2.2	3.6	7.2	15.2	12.1	29.4	9.5	10.1	13.2	9.4	4.2	7.1	7.1	9.5	10.4	0.0	1.0	0.0	0.9	1.1	0.5	0.3	0.5	0.6	1.3	0.5	0.9	0.4	0.0	0.1	1.0	1.1	0.5	0.8	1.3	1.6	5.7	4.7	1.2	0.9	2.9	0.6	1.8	0.2	1.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.0	3.8	0.0	0.0	0.0	0.4	3.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA053986: AB_2682333"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	73.8	72.7	101.4	65.9	113.3	128.5	65.7	117.4	106.7	66.2	88.3	79.2	60.5	70.6	48.9	64.2	64.8	49.2	85.9	97.2	106.7	68.7	63.8	58.1	70.7	113.7	109.6	71.1	59.3	63.0	67.8	55.4	115.0	58.2	54.2	61.3	51.2	62.2	181.4	69.6	60.8	65.4	111.1	67.8	59.3	57.0	108.4	79.2	60.6	111.1	76.2	73.8	57.5	123.5	132.8	93.3	91.1	91.3	111.1	97.9	85.9	198.5	148.1	280.0	158.5	192.6	125.2	110.4	232.0	161.5	139.7	144.9	92.4	153.8	190.7	52.6	72.9	138.9	97.4	150.8	127.9	201.3	186.6	88.1	156.5	126.0	106.9	119.7	121.3	118.1	109.6	114.3	139.1	253.9	171.6	173.0	68.8	185.2	175.9	116.3	247.2	149.5	119.1	86.1	95.1	103.1	208.2	355.0	199.0	66.7	165.0	191.7	131.5	242.2	156.0	133.0	165.1	94.6	116.1	156.9	190.7	134.7	135.1	309.4	205.4	562.3	125.6	192.8	106.2	115.7	106.4	122.5	223.6	134.0	119.7	110.6	580.4	197.4	200.5	189.6	152.2	254.1	101.4	113.3	117.4	106.7	97.2	106.7	113.7	109.6	115.0	111.1	108.4	123.5	87.2	51.3	61.2	0.0	20.9	0.0	0.0	0.0	0.0	0.0	54.1	56.9	0.0	0.0	34.0	66.2	0.0	162.8	50.9	0.0	156.5	104.5	0.0	47.8	51.2	38.8	0.0	0.0	0.0	96.3	109.5	37.3	0.0	47.7	90.8	57.9	0.0	0.0	110.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	92.0	0.0	0.0	0.0	0.0	101.9	0.0	0.0	5.3	0.0	0.0	149.9	34.2	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	182.9	26.4	89.8	0.0	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 3547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 95.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1801.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		3400000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	586.2	302.7	376.3	150.9	461.9	115.4	253.1	465.9	534.3	118.0	297.1	186.9	236.2	153.9	176.5	217.9	130.0	196.8	166.0	411.8	431.6	442.5	551.9	211.8	83.6	498.6	456.5	132.0	122.7	236.7	84.0	177.3	524.8	223.9	179.2	640.6	127.1	183.4	996.0	252.9	292.5	246.4	440.8	110.3	124.0	78.6	453.2	87.1	130.7	777.9	88.2	291.2	147.9	591.2	402.9	285.3	273.3	71.7	908.4	845.0	153.2	1301.6	1097.4	393.5	365.7	235.5	371.7	87.1	673.8	889.9	657.7	355.6	181.5	524.4	596.2	248.3	139.4	120.3	159.6	376.6	1801.9	218.1	59.7	638.5	490.8	540.3	1041.9	792.3	751.3	215.6	249.8	195.0	1724.1	117.8	268.3	222.0	245.9	86.8	252.0	118.5	360.3	180.0	924.0	475.9	179.2	211.3	297.7	173.3	378.1	465.1	147.2	165.1	1074.9	764.8	326.1	304.8	756.5	118.0	103.4	56.1	778.7	247.9	630.1	95.8	9.5	27.5	9.2	11.6	7.6	6.8	14.7	8.2	9.2	3.8	24.1	10.2	15.6	41.1	19.0	13.7	37.6	9.9	376.3	461.9	465.9	534.3	411.8	431.6	498.6	456.5	524.8	440.8	453.2	591.2	451.4	176.3	203.4	201.4	102.3	1062.1	1456.6	367.0	225.9	644.6	297.6	260.6	182.0	243.1	251.0	676.8	379.5	529.6	173.6	408.6	291.6	559.7	459.7	316.6	264.6	308.0	222.1	98.2	454.5	323.4	611.9	421.9	98.4	324.7	150.4	161.5	181.3	633.4	669.1	425.7	370.4	280.5	231.9	339.0	578.4	266.6	167.4	371.7	341.5	215.5	396.4	3547.4	137.0	249.3	1334.3	571.2	309.7	226.1	81.6	921.4	897.1	678.3	233.6	540.0	216.9	420.5	324.6	382.7	90.1	247.1	1059.3	362.0	145.5	100.1	238.1	1226.5
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460528-57477534	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 39.1;liver: 40.7;thyroid gland: 30.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.9;Cholangiocytes: 12.8;Excitatory neurons: 16.7;Hepatocytes: 14.0;Oligodendrocyte precursor cells: 9.5;Spermatocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.1;Karpas-707: 67.5;REH: 42.3;RPMI-8226: 134.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"amygdala: 13.5;cerebral cortex: 23.8;hippocampal formation: 21.0"						"Intracellular and membrane"	NA	NA		27000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	4.1	0.7	19.0	0.3	39.1	0.8	3.5	0.0	27.3	2.1	0.0	1.0	1.1	2.0	0.2	1.6	1.7	3.0	3.3	25.2	0.0	2.8	40.7	2.6	0.4	0.0	0.0	1.1	2.4	3.7	3.6	1.9	0.0	1.6	0.1	1.0	3.4	0.3	1.7	4.3	1.1	0.7	0.0	1.0	1.5	1.8	0.0	1.9	30.5	0.4	0.3	1.2	1.6	8.2	7.4	10.1	7.6	13.1	3.1	4.4	1.0	0.1	2.9	0.3	2.7	1.3	1.4	0.2	0.2	0.4	4.3	0.2	11.9	0.2	0.1	1.7	4.7	2.3	1.1	7.2	4.4	1.7	44.1	11.9	1.3	1.1	1.1	1.3	0.1	12.9	1.6	67.5	0.1	1.4	0.2	5.3	13.3	0.5	7.6	42.3	5.4	134.0	0.1	0.2	14.0	1.2	1.1	0.6	7.7	0.6	8.5	2.0	0.1	0.5	22.7	3.1	2.4	4.1	9.2	1.4	16.7	7.3	5.8	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.0	39.1	0.0	27.3	25.2	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.7	0.0	0.0	2.0	0.4	5.7	0.4	0.3	2.8	19.9	2.1	1.5	0.4	12.8	0.1	0.0	0.0	0.0	0.9	0.2	3.9	1.3	2.6	0.6	0.9	2.1	1.8	0.8	16.7	0.6	5.5	1.6	0.5	2.1	0.0	0.0	1.1	14.0	0.4	0.0	1.1	0.6	0.0	0.0	2.1	1.3	0.3	0.6	1.8	3.7	0.5	0.8	2.1	9.5	1.2	0.8	0.1	1.2	0.0	1.0	0.0	1.1	0.0	1.4	6.6	1.0	5.4	10.2	1.7	1.1	2.8	0.0	0.9	0.1	0.2	0.2
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550554-179610012	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		25000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	28.2	33.1	9.6	13.4	10.5	13.3	26.1	9.8	10.2	27.2	11.3	29.1	9.4	27.5	8.1	33.9	24.5	8.8	20.4	9.5	10.1	24.1	21.3	26.6	14.2	10.2	10.0	23.9	24.4	13.5	22.7	9.0	10.1	22.4	8.2	7.4	25.8	8.6	33.8	33.1	25.9	7.8	9.9	35.2	24.2	10.9	10.0	13.6	24.7	10.1	11.5	26.3	27.2	10.6	13.9	22.5	11.8	15.7	22.3	18.2	13.4	24.2	17.2	14.1	16.3	22.0	31.6	22.4	13.4	29.6	16.2	12.6	21.9	31.6	16.4	71.2	16.6	39.2	17.1	16.0	22.8	22.0	20.7	18.5	17.1	9.5	27.0	24.6	15.5	12.5	16.2	20.8	12.7	42.0	23.5	15.2	12.6	15.0	10.5	20.9	8.4	20.9	23.5	22.4	11.7	16.7	35.4	22.5	13.2	14.8	18.0	26.6	18.8	18.3	6.2	10.0	19.3	12.8	21.2	39.8	16.9	39.0	17.2	14.9	4.8	11.9	2.2	5.1	1.3	3.8	2.7	2.3	4.2	5.7	1.9	2.4	7.9	1.8	7.1	4.8	4.5	29.8	9.6	10.5	9.8	10.2	9.5	10.1	10.2	10.0	10.1	9.9	10.0	10.6	19.8	35.3	30.8	30.0	23.6	10.3	11.5	11.7	16.5	9.3	17.8	17.5	22.8	28.6	23.1	14.7	20.9	21.7	15.7	20.0	9.8	19.7	8.0	28.2	21.9	20.9	10.8	27.7	31.8	14.4	15.8	19.7	19.9	20.0	29.8	20.4	12.5	14.1	31.1	11.8	28.4	17.5	8.2	30.7	21.0	3.4	23.0	137.2	10.6	21.5	43.7	11.9	15.5	23.1	33.9	22.1	18.5	27.1	18.3	14.2	14.1	34.0	32.8	12.0	6.6	20.8	17.8	11.1	8.4	21.9	11.4	21.2	19.5	25.0	15.3	10.2
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"RUNX family transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	14.8	3.8	2.9	20.3	2.1	45.5	27.1	2.6	4.0	15.3	5.1	6.7	5.1	3.3	3.1	9.2	4.7	16.0	6.3	2.8	3.2	4.6	7.0	22.4	11.3	6.0	4.3	6.3	4.0	1.5	5.1	8.5	6.5	13.5	6.5	0.3	39.2	3.5	18.9	11.6	6.8	9.2	4.9	10.2	16.9	3.8	9.1	28.2	4.8	1.4	9.9	20.8	12.8	7.9	50.9	3.8	0.1	0.3	12.5	16.0	32.0	28.1	28.4	15.3	11.6	2.5	37.7	24.9	1.8	24.9	25.5	45.0	3.0	33.6	21.4	38.7	3.8	251.3	10.1	11.6	22.9	29.4	145.3	30.9	19.8	46.6	45.6	21.2	8.8	226.3	17.3	14.1	32.7	10.7	119.3	46.5	2.2	27.4	14.5	119.2	84.6	15.3	20.7	19.9	1.4	0.0	28.9	7.2	10.5	6.8	14.7	67.8	37.0	25.1	32.4	37.8	42.8	46.4	20.7	23.3	31.2	63.4	37.4	23.9	3.1	7.1	3.4	1.4	3.2	4.1	3.0	3.2	0.9	3.6	4.5	3.7	3.4	1.5	4.7	3.4	4.5	2.2	2.9	2.1	2.6	4.0	2.8	3.2	6.0	4.3	6.5	4.9	9.1	7.9	6.2	54.5	35.4	1.6	27.0	41.6	52.7	61.2	54.7	2.3	175.5	94.6	3.2	28.6	60.8	20.2	0.0	2.1	39.5	18.7	1.9	39.7	19.4	89.6	21.5	9.2	6.0	47.3	3.5	28.1	21.4	49.2	84.6	155.8	17.7	29.2	4.6	5.4	68.4	0.0	3.2	12.4	28.5	77.0	122.5	27.1	4.7	84.4	28.4	195.8	42.2	0.5	39.1	1.5	1.6	101.0	15.8	4.5	27.7	43.6	8.3	1.6	78.6	0.8	0.0	111.3	51.2	29.0	28.0	53.7	20.2	2.5	41.6	2.7	17.0	75.3
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38587564	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1618.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4"	"Low region specificity"	"Detected in single"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		46000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	1.4	2.4	10.3	1.6	8.0	0.3	2.1	8.5	9.3	2.1	1.0	1.2	0.5	0.7	1.3	17.2	1.7	1.1	0.9	7.5	20.5	1.9	0.4	2.6	2.1	8.6	9.7	0.9	0.4	1.9	1.5	1.8	7.7	3.8	0.3	10.6	14.0	1.4	1618.9	13.3	1.3	0.8	2.6	1.7	1.0	8.9	22.6	1.5	1.2	286.6	2.6	1.0	3.3	6.1	0.0	7.7	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.4	0.5	6.3	0.0	0.0	18.9	0.2	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	1.7	7.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.0	15.3	1.5	0.8	0.0	0.0	1.5	30.7	0.0	0.0	0.6	0.7	5.9	0.0	0.0	12.4	0.3	0.0	0.4	1.4	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.2	0.2	0.1	0.3	2.9	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.3	10.3	8.0	8.5	9.3	7.5	20.5	8.6	9.7	7.7	2.6	22.6	6.1	0.3	0.0	1.1	29.4	1.4	11.3	3.8	6.6	22.8	8.9	0.5	7.9	3.6	0.0	1.1	0.0	2.1	0.2	1.2	0.0	5.9	0.1	6.7	0.2	0.9	1.0	0.0	0.4	10.2	0.0	0.4	0.9	0.0	0.5	0.0	0.3	0.7	0.0	8.8	1.7	17.2	0.0	2.0	2.9	15.2	5.9	3.1	6.2	0.0	49.6	1.3	50.6	0.0	13.6	2.0	0.0	0.0	1.9	0.9	0.8	0.0	0.2	0.4	1.8	0.0	41.7	1.2	6.3	7.4	7.5	4.7	0.3	2.6	0.4	0.0	0.7
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 132.0"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	0.7	0.7	9.1	0.8	15.9	0.0	0.6	8.7	24.0	1.5	0.0	2.0	0.2	0.7	0.4	2.9	0.7	1.9	132.0	10.5	0.0	0.1	0.1	1.8	0.1	0.0	0.0	2.9	8.4	0.0	1.8	1.2	0.0	2.9	0.5	6.5	0.5	1.7	0.1	0.3	0.5	0.7	0.0	1.3	1.5	1.1	0.0	0.1	4.4	0.3	0.0	1.2	0.4	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.9	0.3	0.0	0.0	7.7	8.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.0	0.0	0.0	2.7	3.1	0.6	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.1	15.9	8.7	24.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.2	0.0	0.5	17.0	0.0	0.4	0.0	0.0	0.0	74.2	0.3	0.1	2180.6	0.0	1.3	1.8	10.4	0.1	0.1	0.0	0.0	0.0	21.1	0.2	3.4	10.6	3.5	0.0	1320.5	2.9	0.1	53.6	0.0	0.5	0.0	0.5	1.1	0.0	0.1	1.7	790.6	0.0	0.0	0.0	0.2	15.3	1.2	1.3	8.8	48.7	0.0	1.3	0.0	29.7	140.6	0.4	0.0	0.0	0.1	0.0	1.0	0.2	0.7	5.3	0.0	0.5	21.6	5.8	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310962-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.7;choroid plexus: 33.3;skeletal muscle: 24.2;tongue: 44.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 788.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"A549: 4.4;RH-30: 6.5;RPTEC TERT1: 3.1;SuSa: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 23.4"	HPA062004			Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA062004: AB_2797267"	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.7	0.7	35.2	0.2	43.7	1.4	2.0	33.5	39.7	4.2	33.3	10.1	0.4	7.2	0.1	1.2	5.4	0.5	0.2	35.6	29.3	2.0	0.0	0.3	0.1	35.5	30.2	0.9	0.1	6.1	1.3	0.1	33.5	1.4	1.3	2.2	0.5	2.0	24.2	1.0	1.8	4.4	24.3	0.5	2.1	0.5	37.1	0.6	0.3	44.2	0.4	4.0	2.8	28.8	0.2	4.4	0.9	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.1	0.1	0.2	0.4	0.0	1.4	0.1	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.3	6.5	0.1	3.1	0.3	0.1	0.3	0.4	0.0	0.1	2.8	0.0	0.2	0.5	0.1	0.1	0.0	0.4	0.2	0.9	0.4	0.3	1.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	43.7	33.5	39.7	35.6	29.3	35.5	30.2	33.5	24.3	37.1	28.8	2.9	0.0	1.1	788.8	0.2	0.4	0.0	0.0	0.0	8.0	0.2	2.5	2.2	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	15.5	7.7	1.4	1.8	0.0	8.4	162.5	0.0	0.7	0.6	0.0	8.0	14.0	0.2	0.0	0.0	1.0	69.0	115.2	0.0	0.0	0.0	1.0	41.9	0.3	0.3	0.0	36.5	0.6	0.3	0.0	22.1	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	5.9	0.8	0.0	51.3	0.4	0.1	1.5	0.0	0.6	0.1	0.4	2.5	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373711-153375621	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3489.7"	"Group enriched"	"Detected in many"	20	"Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 1321.1;neutrophil: 1781.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 1781.4;monocytes: 1321.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.6;THP-1: 1.6"					"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	NA	NA	28500000	8300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	54.9	3.2	2.6	82.0	3.1	3489.7	7.0	2.9	7.7	21.9	3.2	5.5	1.7	2.1	0.0	52.4	19.3	6.7	16.6	2.7	2.6	15.2	25.6	148.4	1.9	3.2	2.9	2.1	3.6	1.3	4.3	19.8	3.9	3.5	0.4	0.3	11.4	0.2	4.0	3.7	4.4	40.4	3.0	523.2	8.9	0.9	2.9	30.2	6.0	14.8	46.5	41.9	33.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	1321.1	5.2	1.9	44.9	1.0	3.2	0.8	1.5	122.7	1.0	1.1	0.5	1781.4	0.4	9.6	8.3	2.0	1031.8	2.6	3.1	2.9	7.7	2.7	2.6	3.2	2.9	3.9	3.0	2.9	2.9	0.0	19.2	24.4	0.0	6.1	0.1	0.3	9.8	0.0	0.0	0.1	0.0	1.1	8.6	9.2	1.8	0.0	0.5	2.9	0.0	0.0	0.1	1.4	0.0	0.0	2.1	0.0	14.1	0.1	0.2	0.9	4.1	1.1	0.0	13.9	0.0	6.8	3.8	8.6	0.0	0.1	0.0	0.0	711.7	0.8	1.8	0.0	475.0	0.0	1.0	998.3	0.0	36.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	7.8	0.0	0.0	0.8	0.4	0.0	0.2	5.7	0.0	0.5	6.9	0.0	0.1	0.2
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 37545.1;Urothelial cells: 17431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 17071.6;RPTEC TERT1: 20988.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	1873.9	666.6	435.5	1129.7	452.5	2003.6	1499.2	456.2	549.9	2306.1	425.9	2872.2	1504.1	1058.4	404.8	1300.4	879.9	1485.5	1046.0	425.8	593.7	2326.6	91.9	2216.9	365.1	520.2	488.9	556.8	204.2	68.4	311.2	709.2	489.1	827.7	2252.2	36.6	1123.5	1169.3	478.1	858.6	1367.0	965.1	488.8	519.1	1586.3	170.1	573.3	191.6	970.0	1010.8	504.8	3867.5	1276.0	530.4	3666.6	4412.8	4.3	330.6	7597.2	10482.0	9.3	4560.1	13403.9	2582.7	3352.7	273.3	8022.5	4.5	1319.7	7774.8	2078.7	1589.3	80.7	7340.5	1322.0	1340.0	1.6	731.2	2579.1	255.8	2730.2	28.1	458.7	4550.0	6406.8	2638.7	4734.2	3259.1	6078.3	0.7	3.2	12.3	7052.7	589.4	11.4	292.3	9.6	17071.6	7563.4	5.5	463.0	1250.1	20988.4	3918.8	1019.8	142.6	6251.9	6380.9	4628.4	3.7	835.3	1095.9	7473.3	2228.2	489.8	4463.8	7452.6	8.8	11.9	15.5	8619.0	728.4	4773.0	5517.3	6053.2	2413.8	1806.1	3258.0	1983.1	937.8	1664.9	1773.1	4240.8	583.7	1037.2	1378.3	9637.7	297.4	3066.5	2145.0	2217.6	8320.4	435.5	452.5	456.2	549.9	425.8	593.7	520.2	488.9	489.1	488.8	573.3	530.4	1177.8	4708.3	2663.1	17.6	343.0	1488.3	6868.7	7856.4	2416.5	4.9	1494.4	1445.2	326.6	1474.1	7013.9	8165.9	0.0	1368.2	999.9	8832.0	7446.5	6206.3	21.3	1148.6	3473.2	1801.5	2035.6	637.5	14.7	9903.1	2440.0	4102.1	2276.3	814.3	1817.4	126.3	946.3	21.6	2430.3	58.9	7.1	6823.9	5706.7	2853.5	7378.0	115.0	3013.4	3110.9	3070.0	30.0	6073.8	168.0	926.9	7.5	23.0	37545.1	9094.3	1143.8	346.6	9900.7	8570.5	224.3	4962.3	8.7	131.5	3234.0	2978.8	28.7	13.2	1718.7	997.6	1573.4	1283.0	5881.5	3218.9	17431.0
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 1065.7;lymphoid tissue: 1239.6;skin 1: 346.5;vagina: 1020.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 59.3;Club cells: 70.4;Ionocytes: 18.3;Suprabasal keratinocytes: 89.6;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1201.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 7.2;SK-BR-3: 16.9"									"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	NA	NA		14000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	1.0	0.2	0.9	0.0	0.8	0.8	15.6	1.4	2.1	174.8	0.7	0.3	0.0	1.2	27.6	1065.7	0.3	0.2	0.5	0.8	0.8	0.1	0.5	0.4	0.2	0.9	0.8	0.5	0.4	0.0	0.2	0.2	0.8	0.5	0.0	0.0	55.5	0.2	0.4	346.5	0.2	1.4	0.8	0.3	0.4	0.3	0.7	12.4	0.2	0.0	1239.6	1.2	1020.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.2	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.7	16.9	0.0	0.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.4	2.1	0.8	0.8	0.9	0.8	0.8	0.8	0.7	1.1	0.0	0.0	0.0	0.0	0.0	11.7	0.2	59.3	0.0	0.0	1.1	0.0	0.0	0.0	70.4	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.3	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.3	0.0	0.0	0.0	4.7	0.2	0.2	3.8	89.6	26.4	0.1	8.4	0.6	0.4
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693878-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 1410.7;stomach 1: 1742.0;urinary bladder: 1777.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1088.3;Gastric mucus-secreting cells: 2306.9;Syncytiotrophoblasts: 2773.6;Urothelial cells: 4448.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 1789.3;eosinophil: 836.9;neutrophil: 2961.8"	"Lineage enriched"	"Detected in many"	73	"granulocytes: 2961.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 879.0;Hep G2: 1283.2;hTCEpi: 1185.6;OE19: 4335.4;RT4: 2619.8;SK-BR-3: 1057.4"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	14.0	1.7	1.0	42.4	1.4	1410.7	7.4	1.6	6.3	15.0	1.4	155.6	13.2	5.9	0.0	340.6	6.9	52.1	2.7	1.4	0.9	2.1	8.8	14.7	1.0	1.1	1.1	0.5	4.7	0.4	1.7	474.7	3.2	25.5	176.0	0.1	8.2	0.5	0.4	20.9	23.8	16.6	0.6	34.3	1742.0	1.4	1.0	10.6	0.6	12.2	96.9	1777.0	34.5	1.1	115.2	89.1	0.0	0.1	0.0	0.5	879.0	0.0	1.0	0.0	0.0	5.2	17.6	0.7	40.1	0.6	1.2	137.6	0.5	1.1	0.0	54.7	0.0	1.9	106.7	1283.2	0.0	53.4	3.2	0.6	1185.6	0.0	1.1	0.2	0.2	0.8	3.1	0.0	0.0	214.5	1.6	126.5	1.5	4335.4	149.6	0.9	0.5	0.5	0.0	2619.8	1.1	0.7	156.8	1057.4	2.4	39.9	31.0	169.6	0.5	0.0	1.4	0.2	0.9	1.2	0.7	0.8	0.1	479.1	0.2	1789.3	40.6	836.9	1.4	9.5	1.1	0.4	1.7	1.1	1.6	0.5	0.3	0.8	2961.8	0.1	5.7	0.4	1.1	16.7	1.0	1.4	1.6	6.3	1.4	0.9	1.1	1.1	3.2	0.6	1.0	1.1	0.9	9.6	48.6	0.0	6.2	1.1	318.3	568.6	4.0	0.0	3.4	3.6	1.2	27.1	1088.3	1.8	0.0	550.7	2.2	322.2	0.0	4.8	12.3	37.5	38.9	8.7	16.6	0.0	0.0	31.1	783.4	13.8	2306.9	202.5	31.6	0.0	1.4	7.4	69.2	0.0	0.0	443.7	152.5	11.8	1.0	7.4	0.0	11.0	8.8	0.0	5.6	0.0	2.1	0.0	0.1	828.1	580.9	0.0	5.9	288.4	2.2	0.5	301.5	0.0	0.0	0.1	32.1	0.5	0.6	18.6	6.3	2773.6	9.8	0.1	173.2	4448.3
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231355-18236802	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"liver: 1943.5"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 28.8"	"Not detected"	"Not detected"							"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	7.4	0.5	0.3	0.4	0.3	0.0	6.7	0.3	0.6	15.6	0.3	0.2	0.0	0.0	0.2	0.5	0.5	1.0	0.1	0.3	0.3	0.4	1943.5	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.8	0.0	0.3	1.2	0.0	0.1	11.4	0.1	3.4	0.5	0.1	0.1	0.3	1.2	0.1	1.3	0.4	0.9	0.0	0.0	0.2	0.1	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.1	28.8	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	184.7	0.0	0.0	2.1	1.4	0.0	18.6	172.6	0.0	0.0	0.0	0.0	3.5	0.0	4.0	0.6	0.4	0.0	1.6	0.0	21.5	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	27.5	2132.8	0.1	0.0	0.0	0.0	71.2	38.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	706.8	0.0	0.0	0.0	23.6	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.5
SACS	"ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6"	ENSG00000151835	"Sacsin molecular chaperone"	Q9NZJ4	13	23328826-23433740	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.5;Excitatory neurons: 86.3;Inhibitory neurons: 108.2;Oligodendrocyte precursor cells: 76.4;Oligodendrocytes: 111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017714	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017714: "	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.21e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.65e-4)"	4.8	4.4	4.7	4.0	10.0	5.6	4.3	7.2	16.1	4.8	0.0	8.0	0.9	6.2	2.7	3.7	5.8	2.2	8.7	7.6	3.0	3.2	2.2	4.8	4.3	8.4	5.2	4.7	4.8	15.2	6.8	1.3	9.4	7.6	1.5	4.6	6.6	2.3	14.0	2.4	5.0	4.9	2.0	8.5	5.1	6.8	10.3	4.2	2.6	13.1	3.6	9.9	4.4	11.4	8.1	10.5	21.3	6.5	6.5	24.3	3.1	18.1	23.2	6.9	5.7	5.0	4.2	5.5	7.4	38.8	9.0	1.6	30.7	10.8	22.5	12.9	12.6	20.7	8.1	7.4	4.8	38.1	7.9	7.8	2.5	44.3	21.2	9.7	23.1	17.0	12.1	2.6	31.6	3.8	13.6	14.6	17.5	2.8	8.2	16.0	38.7	16.7	12.0	0.9	15.4	14.8	10.0	3.6	7.8	9.7	1.9	10.0	49.8	21.1	17.4	11.5	34.6	5.0	5.7	13.3	10.1	13.2	18.7	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.4	0.7	0.2	0.3	0.0	0.3	0.0	0.3	0.7	0.1	4.7	10.0	7.2	16.1	7.6	3.0	8.4	5.2	9.4	2.0	10.3	11.4	10.3	0.0	1.3	70.5	14.5	6.1	5.4	2.0	6.8	16.5	8.2	8.0	21.3	1.5	1.4	1.8	0.0	0.4	15.3	0.2	0.0	9.0	13.1	5.6	28.1	11.6	1.2	9.7	86.3	10.4	1.5	17.4	3.1	3.3	2.5	18.8	3.6	0.7	3.4	25.2	108.2	0.4	2.0	4.9	19.4	11.6	4.1	8.1	8.8	19.7	3.9	13.6	6.2	76.4	111.0	16.7	0.2	5.3	12.9	8.1	0.0	1.3	1.2	5.3	13.1	45.6	20.9	20.5	9.5	5.3	5.1	0.0	18.1	20.0	0.8	2.9
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA		48000	"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	26.8	35.8	23.3	22.4	23.8	35.2	25.8	28.0	30.3	48.4	21.0	35.3	22.2	38.2	21.0	23.1	44.0	15.6	30.8	21.7	29.6	40.6	30.7	27.8	24.4	24.2	23.9	56.2	30.5	18.0	48.6	14.2	23.1	43.0	16.1	34.7	27.6	18.6	41.5	25.8	34.3	19.3	17.5	39.9	27.8	32.5	23.9	22.3	38.9	20.4	21.2	31.5	35.0	27.5	44.9	54.8	38.8	30.4	36.7	23.7	47.6	40.9	21.3	24.4	23.3	69.9	31.4	84.9	36.9	19.9	19.6	39.9	47.2	24.9	39.2	59.8	53.5	64.4	59.5	54.6	21.2	53.0	58.2	23.5	25.4	35.2	26.9	23.9	24.6	29.3	63.6	40.6	28.7	48.9	65.7	53.1	69.9	33.1	59.9	82.2	34.2	47.6	27.7	70.5	37.6	35.3	54.7	25.3	35.3	24.4	36.5	33.0	40.5	30.7	32.7	39.3	57.6	55.2	52.2	58.6	31.2	47.1	52.2	42.8	12.6	22.0	14.6	10.8	16.8	13.9	13.2	11.7	11.3	14.9	14.5	11.7	23.4	9.4	12.3	12.5	13.4	7.9	23.3	23.8	28.0	30.3	21.7	29.6	24.2	23.9	23.1	17.5	23.9	27.5	40.6	41.7	45.1	79.7	69.7	46.7	58.1	41.4	47.3	70.2	39.1	30.6	28.7	20.0	39.3	33.1	75.0	46.8	63.0	46.4	23.5	49.7	7.6	44.5	92.6	49.0	43.0	45.8	36.2	44.4	44.7	47.3	44.4	58.3	42.3	45.4	26.7	23.3	30.6	43.7	42.7	46.5	57.0	27.6	49.5	13.3	72.4	46.6	26.6	32.8	52.2	77.5	52.5	29.7	34.6	42.2	48.6	65.8	70.0	50.3	54.1	61.5	55.3	78.4	46.0	75.4	47.9	68.3	78.8	37.3	41.9	32.3	79.1	59.7	44.8	54.2
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;prostate: 6.0;vagina: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 12.5"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"			"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.0	0.0	5.7	0.0	6.2	0.0	0.0	5.8	5.7	1.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	5.2	8.2	3.3	0.0	0.0	0.0	9.0	6.5	0.0	0.0	0.0	1.2	0.0	7.2	6.0	0.0	1.8	0.7	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.3	6.3	0.0	0.0	0.0	0.0	0.4	8.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.2	5.8	5.7	5.2	8.2	9.0	6.5	7.2	9.4	6.3	7.5	0.2	0.0	0.0	25.5	0.0	0.0	7.4	0.0	0.0	14.7	0.0	0.1	1.8	0.0	0.0	1.8	47.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	25.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	4.8	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	1.8	6.6	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.7;Distal enterocytes: 104.6;NK-cells: 109.2;Paneth cells: 171.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 28.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 66.7;GAMG: 66.0"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	4.1	3.6	1.1	13.2	1.0	9.9	3.5	1.1	1.0	8.0	1.4	11.0	7.5	3.5	2.9	39.1	3.0	7.2	2.4	1.1	1.6	3.2	3.7	7.7	15.8	2.8	1.5	5.8	1.6	1.0	0.9	7.0	2.0	2.0	11.3	0.3	4.3	2.4	0.6	1.9	7.7	4.0	2.9	17.7	10.7	1.0	2.1	20.7	2.0	2.3	15.9	7.0	8.3	2.5	28.5	3.6	1.0	0.2	12.0	15.2	0.3	10.9	45.2	51.0	66.7	0.2	30.9	11.9	16.8	27.1	66.0	32.6	0.1	10.0	17.1	40.5	1.3	17.3	18.0	0.0	5.4	19.5	23.1	6.8	14.1	16.8	4.6	2.8	7.7	13.1	1.2	28.6	10.9	0.1	29.2	15.9	0.1	0.0	7.9	9.5	9.2	13.5	0.3	3.6	4.4	0.4	8.4	3.3	9.1	0.1	1.0	9.5	33.8	11.8	4.2	36.0	6.0	16.9	3.4	10.8	12.3	11.2	12.1	21.8	4.2	15.7	8.3	8.1	7.7	5.6	6.4	7.3	3.6	5.9	6.7	6.1	17.8	8.8	12.8	2.5	8.8	3.2	1.1	1.0	1.1	1.0	1.1	1.6	2.8	1.5	2.0	2.9	2.1	2.5	43.9	9.6	3.7	0.7	53.4	2.3	8.2	40.2	4.0	1.4	4.4	5.1	1.2	5.7	33.7	14.7	0.0	1.9	92.7	104.6	0.0	23.5	0.1	21.1	18.5	29.0	3.0	19.4	0.4	12.3	7.1	14.6	37.8	7.0	43.6	21.8	12.1	1.2	11.5	6.7	1.5	34.9	20.3	29.9	9.6	0.7	15.2	32.7	3.6	21.5	41.6	2.2	109.2	2.0	2.4	50.4	171.0	12.4	35.9	7.0	12.6	2.3	37.5	0.1	13.1	14.4	12.6	0.2	0.0	21.1	1.8	0.4	69.4	25.4	5.6	34.3
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36890229-36951843	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 214.2;Endometrial ciliated cells: 173.8;Kupffer cells: 280.2;Macrophages: 326.4;monocytes: 257.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 510.8;BJ hTERT+ SV40 Large T+: 165.8;BJ hTERT+ SV40 Large T+ RasG12V: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		91000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	79.5	39.9	11.9	94.3	12.4	11.5	65.7	11.6	12.2	39.1	33.2	58.4	29.4	33.0	9.1	45.8	81.8	40.2	60.5	11.4	16.6	12.2	26.1	68.0	78.0	16.8	15.0	38.0	42.2	14.0	21.7	36.0	17.9	26.3	28.8	5.5	32.6	18.1	23.8	27.8	55.2	44.1	17.6	94.2	45.0	12.6	18.0	29.3	31.7	20.7	51.2	55.3	39.9	26.4	29.9	10.9	3.7	15.6	510.8	101.8	5.5	10.8	37.7	165.8	187.8	39.1	11.2	64.4	19.9	14.4	94.9	21.2	34.7	27.8	30.9	17.4	20.6	5.3	18.8	30.9	39.3	28.2	5.1	96.4	1.0	45.3	1.9	13.3	26.4	0.0	13.7	18.8	5.4	12.0	0.0	19.2	7.9	18.3	25.9	2.8	21.7	35.3	15.7	8.2	23.0	4.2	20.2	10.2	28.2	4.7	20.5	125.4	13.9	11.5	13.5	25.1	28.5	7.3	20.3	21.7	14.5	3.2	7.1	1.4	147.7	4.8	52.2	174.4	47.0	4.5	55.7	53.3	278.6	3.1	55.5	47.6	18.5	56.2	167.0	96.4	95.8	144.3	11.9	12.4	11.6	12.2	11.4	16.6	16.8	15.0	17.9	17.6	18.0	26.4	48.7	28.9	25.5	4.2	19.4	6.4	2.3	7.8	5.7	5.5	6.9	5.8	17.3	14.3	35.3	1.8	4.2	2.6	214.2	2.6	0.0	10.3	3.3	173.8	12.7	44.3	6.0	30.7	8.6	10.2	3.3	71.4	13.3	40.6	12.6	10.5	42.5	20.1	137.2	6.7	8.5	5.7	8.2	280.2	52.3	4.8	82.3	326.4	5.4	36.5	257.9	25.1	116.4	14.1	3.5	7.5	31.3	96.3	54.8	1.9	1.1	1.9	104.4	2.9	59.2	9.6	31.9	10.2	4.9	12.1	5.8	2.9	102.6	9.7	5.5	4.9
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		660000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (7.00e-5)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	77.1	52.8	41.8	38.4	43.5	163.2	48.1	45.1	45.7	43.1	53.3	39.1	26.6	41.0	47.0	41.4	37.3	35.0	44.8	43.8	48.3	43.3	70.2	51.4	36.7	42.8	44.9	41.0	33.9	44.2	37.9	76.0	44.0	38.9	35.5	42.0	39.9	38.9	51.1	38.5	34.5	49.7	47.3	40.7	37.9	23.5	48.4	33.2	39.8	56.3	38.4	45.8	36.2	52.1	85.8	56.3	75.7	131.9	246.1	143.1	61.1	128.3	154.4	115.6	140.0	169.7	78.2	74.4	67.1	153.7	52.8	96.6	94.5	75.9	111.6	103.9	44.3	54.1	65.8	82.5	112.4	86.7	56.6	155.9	68.4	76.4	133.2	119.0	63.8	55.9	68.7	105.9	110.0	60.0	73.8	72.6	65.2	55.6	141.3	70.8	84.4	42.5	88.7	69.7	42.6	73.8	98.0	134.6	72.2	66.8	65.8	59.7	88.6	63.7	94.3	92.2	91.3	72.3	141.3	114.0	84.9	111.7	48.7	75.5	63.5	74.0	88.0	80.9	94.8	47.7	68.5	85.9	58.5	38.6	65.7	88.7	67.9	103.3	72.9	44.8	53.2	95.9	41.8	43.5	45.1	45.7	43.8	48.3	42.8	44.9	44.0	47.3	48.4	52.1	88.4	128.2	110.2	6.8	53.5	235.7	138.0	120.2	25.0	38.6	99.2	62.4	74.7	57.2	105.3	49.7	33.3	120.6	109.8	51.6	54.8	78.4	3.0	52.3	85.8	85.2	42.7	46.1	21.2	77.3	199.0	127.8	23.9	89.7	53.2	46.3	69.7	114.1	101.0	26.9	22.2	72.1	65.1	51.2	208.9	5.6	54.7	68.1	113.8	21.5	58.4	61.9	75.2	16.1	26.4	78.8	56.2	58.6	97.7	141.4	59.1	95.9	67.1	33.4	78.9	73.7	158.8	64.1	51.8	37.2	248.8	238.9	86.3	45.2	53.2	175.2
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601149-134649271	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 413.3;Hepatocytes: 267.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		430000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favorable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	30.9	46.4	27.5	24.2	40.6	26.0	35.8	40.8	41.7	27.3	40.6	40.9	68.5	14.9	34.9	36.0	17.7	28.2	46.8	31.0	37.5	57.1	163.9	19.7	24.4	43.9	40.5	13.5	32.8	64.9	24.7	20.7	44.7	38.7	36.5	20.3	36.3	29.7	147.5	16.8	69.7	26.7	40.3	20.0	43.4	66.0	35.9	22.7	29.7	140.6	33.6	36.2	20.3	53.9	57.8	49.6	36.0	81.3	111.6	53.4	48.3	95.4	80.0	84.1	127.9	84.3	79.7	31.9	78.3	98.6	116.6	52.1	62.8	92.5	108.0	73.6	37.0	33.6	78.0	81.5	91.7	29.1	44.7	60.4	57.8	97.7	82.7	42.3	64.1	40.9	44.3	71.9	87.0	85.3	38.6	43.6	12.7	70.7	34.4	33.7	62.7	70.2	61.7	91.2	36.8	16.0	67.2	36.1	71.4	47.2	74.2	35.5	51.7	72.8	44.0	66.7	72.3	90.0	215.4	58.7	56.2	55.7	81.6	22.2	70.5	55.0	42.3	71.2	52.9	52.7	48.2	49.7	64.0	34.7	42.9	41.6	25.5	35.8	80.5	43.6	77.1	71.3	27.5	40.6	40.8	41.7	31.0	37.5	43.9	40.5	44.7	40.3	35.9	53.9	49.3	32.1	36.9	21.5	45.6	37.6	44.0	112.9	22.2	30.4	56.0	35.7	86.7	61.5	102.6	57.0	41.7	33.1	44.5	77.0	56.7	47.6	413.3	43.0	51.3	35.3	27.6	44.2	31.6	83.9	43.5	46.1	68.3	45.8	26.6	28.3	38.9	267.7	52.8	33.7	32.8	55.2	89.5	52.9	56.6	76.9	36.7	47.1	64.0	20.6	38.3	41.8	20.6	29.7	66.5	60.4	36.2	44.8	165.8	75.1	210.7	121.4	99.8	40.3	19.7	41.2	47.7	106.8	47.3	51.1	51.1	115.2	47.0	43.0	46.3	96.5
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 47.9;liver: 114.4;pancreas: 43.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.1	2.2	3.6	2.5	3.5	0.9	0.8	1.9	3.9	2.6	0.7	1.1	1.8	2.0	47.9	0.6	1.9	1.3	2.4	3.3	3.5	12.0	114.4	2.6	4.1	4.4	3.1	3.0	43.2	2.1	4.1	0.9	3.4	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.9	1.3	3.0	0.7	4.2	4.3	1.6	0.3	2.4	1.1	1.0	3.1	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.5	1.9	3.9	3.3	3.5	4.4	3.1	3.4	2.9	4.2	3.1	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SARS1	"SARS, SERS"	ENSG00000031698	"Seryl-tRNA synthetase 1"	P49591	1	109213918-109238182	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 98.8;Cytotrophoblasts: 186.0;Extravillous trophoblasts: 147.6;Hofbauer cells: 88.1;Syncytiotrophoblasts: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	86.9	89.4	78.6	55.9	78.6	35.7	80.5	77.2	98.1	79.3	57.4	89.1	63.6	85.8	64.2	97.1	71.5	53.6	96.0	81.9	92.6	77.4	102.4	102.3	60.9	88.3	81.1	78.5	150.1	102.1	88.6	76.2	91.1	66.2	74.8	68.0	86.1	73.9	113.3	111.9	69.9	79.3	72.9	64.5	112.4	46.3	78.1	66.7	139.8	87.9	76.4	88.3	82.1	90.9	208.5	82.1	152.3	230.3	224.2	201.4	261.6	213.1	222.1	183.7	227.1	161.4	62.7	224.1	107.7	307.2	102.8	111.6	241.1	305.9	212.4	159.0	150.4	86.6	96.3	118.4	448.1	110.5	93.7	249.4	526.5	217.1	467.7	155.9	221.9	279.5	201.9	273.2	181.3	205.8	124.8	57.5	63.4	125.6	193.5	101.1	192.5	102.6	139.9	111.0	210.0	111.2	102.5	164.7	601.4	114.9	93.5	131.2	174.5	108.3	135.0	155.5	151.8	205.6	89.6	183.7	341.3	119.8	376.7	191.5	193.9	219.6	228.6	212.2	240.0	235.8	238.2	227.3	198.8	252.4	246.4	229.4	89.7	193.5	226.6	128.2	300.9	460.5	78.6	78.6	77.2	98.1	81.9	92.6	88.3	81.1	91.1	72.9	78.1	90.9	30.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.8	0.0	0.0	0.0	0.0	186.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	147.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	188.4	5.9	0.0	0.0	0.0
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP"	O43290	11	65961728-65980137	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	24.6	18.3	15.5	18.3	16.8	41.6	23.1	15.4	17.4	29.2	14.7	26.0	15.6	29.1	8.0	22.7	25.6	8.6	23.2	14.9	16.1	20.4	21.8	22.9	20.3	16.6	16.2	29.2	25.8	11.7	21.4	14.0	15.9	21.7	7.7	8.0	22.2	14.4	38.1	32.0	24.3	10.9	14.6	32.7	24.8	23.5	15.7	20.9	23.5	13.0	13.3	26.2	24.6	17.9	50.4	60.8	27.2	36.8	26.1	20.7	40.8	37.5	27.2	43.8	28.6	44.2	34.3	56.9	42.4	33.8	52.9	48.7	34.6	35.6	22.0	45.8	33.5	65.6	43.6	41.4	39.0	57.4	52.7	26.2	26.4	40.8	36.3	17.4	27.6	42.3	42.2	39.8	25.6	92.6	74.0	83.5	45.7	27.3	55.9	80.8	39.0	60.7	18.4	33.7	30.5	43.0	35.6	37.2	45.5	12.6	41.7	47.0	40.6	54.5	53.0	53.9	54.1	59.6	49.4	48.3	45.0	28.8	47.0	1.4	2.8	8.1	4.3	3.5	3.6	3.9	4.8	4.4	3.6	3.5	3.5	3.9	4.1	2.8	2.0	3.2	5.4	1.8	15.5	16.8	15.4	17.4	14.9	16.1	16.6	16.2	15.9	14.6	15.7	17.9	17.5	6.4	9.1	7.8	27.8	22.7	24.0	12.2	17.6	19.2	12.2	9.1	9.4	21.5	11.3	16.5	10.4	34.1	27.2	30.5	5.9	23.7	9.0	14.2	16.3	19.8	12.5	32.8	5.1	29.3	31.9	17.6	21.9	16.8	32.4	21.8	21.0	15.6	29.4	16.8	4.8	26.5	16.2	22.5	23.6	8.7	37.0	22.9	17.8	6.5	35.7	23.8	34.0	7.1	7.8	26.3	20.1	33.1	31.2	20.5	28.3	18.5	17.5	26.0	32.9	27.6	34.9	26.7	29.7	18.3	21.7	45.3	28.4	15.5	27.5	18.2
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Spliceosome associated factor 3, U4/U6 recycling protein"	Q15020	12	108522214-108561400	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA028840: , HPA044322: AB_2678895"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	14.6	15.1	14.0	18.5	14.0	25.5	14.8	17.6	15.1	18.8	12.2	15.9	12.6	19.3	13.7	19.2	17.4	11.9	13.9	13.7	14.6	13.9	16.1	14.5	26.3	12.5	12.9	23.8	13.2	18.3	18.9	15.4	13.0	16.5	15.2	20.3	14.1	14.5	17.8	19.0	17.2	13.9	13.5	19.8	15.1	16.8	14.5	25.7	18.8	15.1	23.2	15.5	16.0	16.8	34.5	61.5	45.4	53.8	24.2	18.9	43.6	29.3	35.8	50.1	37.2	51.5	23.4	51.3	20.1	26.4	32.2	32.0	68.2	33.9	44.1	61.8	43.0	74.1	40.9	47.9	39.2	74.0	44.4	26.4	31.4	31.9	46.8	38.1	30.8	42.1	85.7	33.7	30.9	34.6	69.9	57.5	90.2	27.6	59.9	67.3	44.7	59.3	26.1	57.5	56.8	40.3	45.0	17.0	30.7	38.7	49.0	51.1	26.0	39.0	21.0	30.1	30.7	42.6	68.3	75.6	34.1	42.2	46.2	6.9	6.2	6.4	8.3	5.1	9.9	7.7	6.3	8.3	9.0	7.1	9.4	6.0	1.6	8.6	7.6	6.1	10.5	7.9	14.0	14.0	17.6	15.1	13.7	14.6	12.5	12.9	13.0	13.5	14.5	16.8	14.7	19.2	24.5	16.0	25.9	14.7	16.3	15.4	16.5	42.0	11.5	11.4	19.9	10.0	23.4	18.4	35.5	21.4	21.1	12.0	7.9	14.7	53.6	15.1	21.6	20.0	12.5	23.1	22.1	12.7	14.0	17.1	15.3	15.9	17.7	21.9	11.7	12.5	13.2	35.3	22.2	9.3	24.4	14.1	13.8	30.8	10.2	17.0	16.0	16.9	18.6	23.4	14.4	19.1	24.9	13.5	7.7	17.7	29.6	16.1	9.5	8.2	27.4	39.1	32.9	22.0	18.0	27.2	31.1	19.6	18.0	23.7	24.2	19.1	14.0	17.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345377-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 374.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 113.7"	"Group enriched"	"Detected in all"	4	"NK-cells: 63.4;T-cells: 113.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	16.1	10.3	13.4	28.8	19.1	42.8	13.2	0.8	32.2	11.4	2.6	29.9	16.0	13.6	24.0	12.2	17.9	17.6	26.0	23.4	0.4	10.8	15.4	15.7	38.1	0.3	6.1	13.8	28.8	32.4	22.5	4.9	0.0	22.5	18.5	29.8	44.0	25.9	89.5	21.4	21.0	11.8	1.4	27.4	18.5	6.7	0.9	374.2	24.5	49.0	27.8	24.6	12.3	11.0	2.1	0.0	12.7	0.0	17.2	16.6	1.4	3.4	12.3	2.9	9.8	0.5	22.9	4.7	0.4	4.1	1.0	0.2	46.4	5.4	5.9	455.3	28.0	0.1	1.1	0.0	2.5	26.7	3.8	7.4	4.0	0.1	0.6	35.1	3.3	213.3	0.6	24.3	2.2	0.4	107.7	33.9	18.5	1.5	1.5	126.5	6.2	4.9	4.8	15.7	5.9	34.5	0.0	3.9	0.3	10.0	98.5	192.7	1.7	12.6	7.9	5.9	3.7	1.3	0.4	10.0	10.3	101.3	5.7	21.1	1.9	4.6	44.2	2.0	78.6	1.6	29.9	23.0	3.5	13.0	113.7	69.5	4.1	63.4	1.1	4.0	6.0	26.6	13.4	19.1	0.8	32.2	23.4	0.4	0.3	6.1	0.0	1.4	0.9	11.0	19.3	25.6	29.6	48.3	44.6	14.3	12.3	10.9	12.0	12.1	33.2	18.0	70.0	22.8	15.0	31.3	87.6	0.5	71.1	11.0	1.9	16.9	8.2	31.6	15.3	17.0	32.4	22.5	180.2	12.5	0.2	16.4	8.6	11.6	23.4	20.6	35.0	20.9	9.3	0.0	283.4	30.8	4.1	41.5	36.4	4.3	8.4	45.5	10.6	41.2	23.0	15.5	56.7	168.9	28.8	10.5	23.6	8.2	20.6	21.7	24.6	9.1	50.9	63.1	6.6	8.3	10.2	3.2	9.3	20.5	22.0	0.3	84.0	16.8	25.7	19.7
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS ribosome maturation factor"	Q9Y3A5	7	66987680-66995587	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	139.1	107.5	136.1	57.9	152.1	157.2	113.7	151.2	168.3	97.3	115.8	143.6	127.8	117.2	83.3	128.6	99.2	84.9	238.0	133.1	148.4	117.8	126.8	113.8	43.8	156.2	142.3	90.1	89.3	145.0	87.4	106.2	155.0	107.9	111.6	90.3	80.7	122.6	374.0	92.0	114.2	128.2	152.6	57.3	104.6	60.9	143.4	38.8	107.0	263.3	52.5	113.9	90.7	169.7	168.3	68.9	59.9	54.6	212.7	157.9	67.0	281.4	225.4	206.1	157.1	143.1	83.0	62.2	209.7	253.5	136.3	80.1	101.7	164.3	219.4	59.8	136.4	31.1	125.9	86.6	188.9	78.1	40.8	144.0	215.1	157.0	269.8	105.9	129.2	39.7	227.2	65.0	324.2	100.0	41.8	112.4	67.2	227.3	165.9	31.3	132.6	129.3	218.1	73.6	91.7	63.7	142.3	235.5	194.3	131.0	176.2	64.8	176.4	276.5	96.7	142.5	205.4	40.6	51.4	141.0	95.7	125.5	157.4	75.5	33.2	61.4	64.7	37.7	81.7	62.8	82.7	75.2	33.4	59.9	104.4	85.7	13.0	51.8	35.1	45.4	80.2	62.2	136.1	152.1	151.2	168.3	133.1	148.4	156.2	142.3	155.0	152.6	143.4	169.7	169.9	304.5	128.0	10.7	101.6	464.2	466.2	213.2	145.7	73.7	118.5	154.0	286.6	108.7	160.3	92.0	12.5	130.5	98.0	270.9	262.2	177.4	583.0	93.0	131.2	153.2	101.9	51.3	12.5	165.7	232.1	197.7	96.8	128.2	150.0	29.7	138.5	102.1	107.0	58.9	15.3	221.9	142.4	47.2	238.1	2042.9	127.1	74.8	256.1	11.2	66.5	161.9	30.9	7.5	36.0	300.0	242.2	168.5	117.5	267.2	359.3	264.6	75.6	56.8	164.3	512.9	266.2	86.3	47.9	129.9	430.0	398.5	144.5	132.2	165.4	318.5
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1056.2;skin 1: 2444.7;vagina: 756.5"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 1017.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 355.2;melanoma: 153.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.9;cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.2;ASC TERT1: 107.5;HSkMC: 146.1;U-2197: 51.6;U-87 MG: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		89000000		"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	2.9	0.6	0.5	0.1	3.9	0.7	94.3	0.4	1.3	465.7	0.3	1.0	0.0	0.5	0.0	1056.2	0.2	0.3	1.4	0.5	0.4	0.4	1.7	0.9	0.0	0.5	0.4	0.7	1.5	0.0	0.9	0.3	0.5	0.5	0.0	0.0	351.8	0.0	13.1	2444.7	0.7	0.2	0.4	0.5	1.1	1.0	0.5	6.5	0.7	0.0	168.9	1.1	756.5	0.4	0.1	0.1	0.0	0.1	62.2	107.5	0.1	5.1	7.2	2.4	0.9	0.0	0.1	0.1	1.2	4.8	1.7	0.3	0.0	1.8	1.0	0.1	0.2	0.0	0.1	0.0	0.6	0.0	0.1	146.1	8.2	30.0	7.1	2.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.3	0.2	0.0	0.4	18.4	3.8	51.6	1.4	0.5	0.3	0.0	119.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.9	0.4	1.3	0.5	0.4	0.5	0.4	0.5	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	89.3	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.4	0.8	1.8	0.0	0.0	0.2	0.6	0.2	3.1	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	25.2	4.0	0.0	0.2	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.2	0.2	13.4	1017.6	0.3	0.7	0.0	0.0	0.4
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 241.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071335			Approved	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA071335: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	67.4	92.4	25.8	20.2	24.5	44.3	66.2	30.2	51.7	54.9	34.4	61.5	35.4	62.4	4.7	63.1	58.1	5.3	72.6	27.5	31.9	96.0	117.9	51.7	13.8	39.8	29.6	61.1	76.8	9.7	69.6	9.5	28.7	83.7	3.9	2.7	61.0	11.1	85.0	69.4	61.8	5.5	26.8	78.5	66.4	56.7	28.2	10.3	65.7	6.3	4.9	55.5	49.5	26.4	57.0	41.6	14.6	30.1	8.0	9.0	102.2	38.1	14.5	16.0	18.3	37.2	41.0	44.2	96.8	5.7	20.4	52.3	3.3	17.3	1.8	15.8	93.3	105.9	23.5	86.2	28.1	33.7	41.8	16.9	14.3	13.0	2.9	8.9	26.3	42.9	47.7	34.4	9.9	58.6	95.5	241.1	52.9	20.3	162.5	70.8	48.6	73.6	16.4	22.7	78.8	114.4	63.7	100.4	89.2	2.0	67.8	62.7	52.2	54.5	49.7	53.3	37.5	99.6	55.0	64.2	63.8	35.7	42.3	401.5	267.5	274.6	149.3	191.8	120.8	172.0	149.7	134.2	208.6	192.2	124.2	120.8	241.8	149.4	196.2	278.5	224.0	213.7	25.8	24.5	30.2	51.7	27.5	31.9	39.8	29.6	28.7	26.8	28.2	26.4	114.4	32.1	61.9	11.1	115.7	60.0	164.0	188.6	96.2	67.6	118.8	112.0	43.1	133.0	126.9	165.5	43.8	158.3	123.3	410.8	311.0	241.4	336.3	159.6	98.0	123.0	281.3	131.1	5.5	337.3	159.7	105.6	159.0	127.2	69.7	122.4	185.6	292.4	205.9	52.2	7.1	269.8	201.4	197.4	91.5	79.8	118.7	134.5	104.9	6.5	202.2	154.6	148.3	7.1	14.3	283.0	418.6	100.1	137.2	162.4	378.8	596.9	149.1	88.0	111.7	83.9	117.4	96.0	38.2	110.3	75.0	163.8	131.0	153.8	200.8	217.3
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 385.5;skin 1: 302.7"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	3.1	0.1	0.0	0.1	0.1	0.1	19.5	0.1	0.1	69.9	0.0	1.1	0.0	0.1	0.1	385.5	0.3	0.1	0.1	0.0	0.0	0.4	0.1	59.8	0.0	0.1	0.2	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	57.8	0.0	1.5	302.7	0.1	0.0	0.1	0.0	0.6	2.3	0.1	0.5	2.2	0.0	76.8	0.1	121.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366066	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	7.3	9.0	5.7	7.3	6.2	7.6	7.3	5.5	6.6	6.2	4.8	6.3	5.6	6.9	3.3	8.5	4.6	4.5	6.4	5.6	6.8	7.1	5.6	5.2	7.4	6.5	6.0	6.6	6.1	5.6	5.8	6.0	6.8	4.4	6.2	4.0	5.5	5.1	7.6	7.2	4.3	7.5	5.6	5.8	5.8	2.8	6.9	6.5	5.2	6.2	7.9	6.0	6.6	8.3	13.5	12.2	6.8	16.0	22.2	22.3	8.3	30.0	22.6	10.3	8.7	8.7	16.6	25.7	22.8	57.7	11.1	8.1	22.2	26.2	19.6	7.7	13.0	14.1	12.1	10.6	10.3	18.3	24.8	15.5	15.6	19.9	7.8	9.9	18.2	6.5	24.4	14.3	17.7	15.2	25.0	10.8	4.3	37.6	15.0	15.4	6.6	26.8	11.4	8.7	19.5	11.3	6.8	25.0	13.7	7.9	9.8	8.2	16.3	22.1	14.2	25.7	22.3	16.5	9.8	29.7	15.1	20.7	65.0	0.1	7.2	1.8	9.2	12.2	9.5	8.0	7.4	10.6	19.6	6.4	10.9	10.1	1.4	17.9	13.5	12.7	7.1	11.1	5.7	6.2	5.5	6.6	5.6	6.8	6.5	6.0	6.8	5.6	6.9	8.3	5.4	0.0	3.1	63.0	10.3	3.7	5.4	5.8	8.0	4.1	3.9	3.4	2.9	11.5	3.5	3.7	6.2	8.4	5.4	3.5	1.9	3.8	2.9	2.6	8.4	4.2	1.2	5.5	126.2	5.1	6.7	7.3	5.6	3.6	12.7	5.9	4.2	6.0	5.3	5.0	131.6	3.5	2.0	2.5	3.1	1.5	6.5	10.0	5.4	82.4	2.7	2.7	3.1	182.0	153.7	2.5	2.8	5.7	14.3	2.8	2.4	8.5	4.3	3.3	0.0	5.3	3.8	5.4	3.5	10.5	5.4	4.2	6.8	16.4	4.9	3.5
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lung: 3079.0"	"Cell type enriched"	"Detected in some"	4	"Club cells: 43564.7"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	71	"HaCaT: 1977.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	NA	NA		13000000		"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	1.1	2.0	0.6	0.9	0.7	0.1	0.3	1.3	1.1	0.6	0.3	0.2	0.4	0.2	0.7	11.0	334.2	0.2	0.6	0.5	0.6	0.2	0.4	3079.0	0.2	0.6	0.9	2.0	1.9	0.0	2.4	1.7	0.5	85.1	0.0	0.2	0.5	0.9	0.3	0.3	1.6	0.0	0.5	7.2	4.3	0.2	1.0	2.8	0.4	0.0	5.9	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	1977.1	0.0	0.3	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.0	0.6	1.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.0	1.0	2.0	0.0	1.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.3	1.1	0.5	0.6	0.6	0.9	0.5	0.5	1.0	0.5	0.0	1125.0	2573.3	0.0	0.0	0.0	71.4	3938.5	0.0	0.0	0.0	0.0	0.0	0.0	43564.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	113.5	0.0	0.0	0.1	0.0	0.0	304.5	0.0	0.5	691.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4534.8	0.0	0.0	0.7	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	134.7	0.0	0.0	9997.0	0.0	0.0	0.0	850.3	0.0	0.0	3.9	0.0	0.0	83.7	0.0	0.0	800.2
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590105-180591499	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 270.0;lung: 508.1;salivary gland: 746.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2883.9;Breast myoepithelial cells: 4199.8;Club cells: 13674.8;Respiratory ciliated cells: 3325.6;Urothelial cells: 3139.7"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 51.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.3;T-47d: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		10000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	1.8	1.5	1.1	0.2	1.2	0.5	122.4	0.7	1.2	270.0	11.7	0.5	0.6	1.5	1.2	74.8	29.9	2.9	0.7	1.1	5.9	1.5	7.0	508.1	0.4	1.4	1.6	2.0	18.2	0.0	12.6	0.1	1.0	37.9	0.0	0.0	746.5	2.4	0.3	4.9	1.0	0.0	1.2	9.4	50.7	3.0	3.0	0.8	3.1	0.0	0.8	14.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.3	2.4	17.2	13.3	1.8	3.3	4.5	10.1	0.0	5.9	5.0	0.0	0.0	51.8	0.2	4.3	2.6	1.1	1.2	0.7	1.2	1.1	5.9	1.4	1.6	1.0	1.2	3.0	1.5	36.4	173.1	1441.5	0.0	5.9	0.5	51.2	2883.9	0.6	0.0	1831.7	4199.8	0.4	1554.2	13674.8	0.0	0.0	0.0	30.4	0.1	0.0	20.5	0.1	1.6	0.1	40.5	0.0	10.7	0.2	1.6	0.3	15.2	3.6	1.7	35.3	1.0	68.9	1.1	0.4	0.0	0.0	0.1	1566.5	1.2	0.6	0.2	0.6	14.8	5.4	0.0	0.6	0.0	0.0	0.0	0.1	146.1	0.5	0.0	0.0	214.9	0.0	0.0	3325.6	0.0	0.0	1.6	305.2	0.3	4.4	140.8	0.4	0.0	20.2	0.1	0.2	3139.7
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660182	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.4;kidney: 47.1;placenta: 77.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 94.3;SK-BR-3: 102.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020518, HPA024264"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		2300000	"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Cytosol	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	2.9	1.0	3.6	1.3	4.5	1.3	0.9	4.6	5.3	1.3	2.9	18.3	26.7	1.3	0.5	17.9	4.1	2.8	0.3	3.8	4.8	47.1	0.3	4.1	0.6	9.4	6.8	0.7	0.9	1.1	2.6	77.6	9.7	3.2	16.0	2.4	10.7	1.1	0.5	3.6	46.4	1.1	7.1	0.5	19.6	7.1	5.7	0.6	1.1	1.7	4.3	3.5	1.3	12.3	0.2	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.1	0.1	0.5	0.1	0.5	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	10.4	0.1	1.3	0.2	0.1	0.4	0.3	0.2	1.4	0.4	0.0	0.2	0.1	0.2	0.4	20.8	0.5	0.5	0.2	1.4	0.2	5.7	3.2	0.3	0.5	0.1	94.3	3.6	4.1	0.2	1.0	102.8	0.1	0.7	10.8	0.6	0.1	0.3	0.8	2.0	0.2	3.4	0.2	0.2	0.1	0.4	0.1	1.2	0.2	0.2	0.3	0.2	0.3	1.1	0.3	0.3	0.2	0.5	0.3	0.3	0.6	0.4	0.3	0.3	0.2	0.1	3.6	4.5	4.6	5.3	3.8	4.8	9.4	6.8	9.7	7.1	5.7	12.3	3.5	0.0	23.6	0.0	0.7	2.8	1.5	1.6	0.6	3.2	3.3	1.7	1.2	4.3	8.5	334.8	0.0	23.8	0.2	100.7	82.2	0.6	124.6	25.5	1.0	6.7	9.1	0.0	0.1	0.2	4.7	2.7	55.5	11.3	39.9	0.0	0.4	0.1	99.9	0.0	0.2	62.9	46.8	3.0	0.5	87.8	0.3	2.8	10.6	15.0	1.7	0.4	0.0	0.0	0.3	8.6	138.6	1.2	1.4	4.7	318.4	3.2	17.2	3.0	0.0	0.9	1.0	3.8	5.5	26.6	6.5	65.8	2.2	0.1	21.4	23.1
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239313-18354688	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 39.7;REH: 37.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: AB_2685333"	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	1.4	4.0	0.9	1.2	1.0	6.3	2.0	1.3	1.5	2.3	1.0	1.8	1.1	2.6	1.1	1.0	1.5	0.7	0.8	1.0	1.2	0.7	1.4	0.5	1.1	0.9	0.8	6.0	1.3	1.7	1.5	1.9	1.1	1.1	1.3	3.5	8.8	1.1	1.3	2.0	0.9	2.5	0.8	1.2	0.6	11.6	0.9	3.4	2.4	1.4	1.2	1.4	1.7	1.3	1.9	6.8	24.7	5.9	1.9	2.5	7.2	4.0	2.9	7.3	8.3	9.2	1.3	0.0	0.9	1.9	5.7	0.1	32.7	0.6	9.4	0.0	26.0	0.0	5.7	4.0	0.9	21.1	5.0	1.5	1.1	5.7	6.9	1.9	0.4	20.2	16.0	0.0	5.1	3.2	33.3	10.0	39.7	0.7	9.0	37.8	11.9	4.5	0.2	0.4	14.0	16.3	7.7	6.5	0.1	26.0	8.2	8.8	1.0	6.8	4.9	15.2	3.6	0.0	20.4	32.0	2.6	13.8	5.4	0.0	0.1	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.5	0.6	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.9	1.0	1.3	1.5	1.0	1.2	0.9	0.8	1.1	0.8	0.9	1.3	0.5	0.0	0.5	3.6	1.7	3.6	1.0	0.0	2.8	2.3	0.8	1.3	1.8	0.0	0.6	0.0	0.0	1.8	1.7	0.4	0.0	0.3	1.3	0.9	2.5	1.2	1.2	4.2	7.7	0.2	0.4	2.4	0.0	0.2	0.0	6.1	0.0	0.9	1.9	6.7	15.3	0.7	0.0	0.0	0.5	1.6	1.8	0.6	0.0	0.0	0.2	1.7	0.0	17.1	10.2	0.2	0.0	1.2	0.3	1.2	0.1	0.8	0.0	3.8	0.0	2.6	0.6	26.3	27.5	1.8	4.1	0.4	0.5	9.8	1.2	0.3
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696802-38816286	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (6.57e-2)"										"unprognostic (7.85e-2)"		"unprognostic (2.09e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087526-165204050	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 16.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 78.4;Excitatory neurons: 227.3;Inhibitory neurons: 169.4;Oligodendrocyte precursor cells: 358.4"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.2;naive B-cell: 15.3"	"Lineage enriched"	"Detected in single"	32	"B-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 5.9;Karpas-707: 10.3;MOLT-4: 30.3;RPTEC TERT1: 14.9;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035396: AB_2674607"	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	1.0	1.5	10.9	0.5	10.9	0.2	1.0	7.2	12.1	0.6	0.0	0.6	0.3	0.4	0.1	0.4	0.4	0.5	0.6	10.1	16.9	0.5	0.2	0.2	0.8	6.0	8.8	0.6	0.5	0.4	0.1	0.1	9.2	0.2	0.7	1.0	0.1	0.4	0.9	0.0	0.5	0.5	3.0	0.5	0.9	0.5	13.4	3.1	0.2	0.6	1.2	0.5	0.0	6.5	0.0	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.3	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	4.9	0.0	5.9	0.0	10.3	0.1	0.0	30.3	0.0	0.0	0.1	2.4	0.1	1.3	0.0	14.9	0.0	3.8	6.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.2	0.1	0.8	0.0	1.4	0.6	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	15.3	0.1	0.0	0.0	0.2	0.0	0.4	0.1	0.1	10.9	10.9	7.2	12.1	10.1	16.9	6.0	8.8	9.2	3.0	13.4	6.5	0.9	0.0	0.5	8.5	6.5	0.0	0.2	0.0	0.6	4.4	0.1	0.4	6.5	0.0	0.0	1.8	12.5	0.0	0.0	0.0	0.0	0.2	78.4	0.0	0.0	2.9	8.9	0.0	227.3	0.0	0.0	0.5	1.1	0.0	0.0	0.3	0.0	0.2	0.1	5.0	169.4	1.2	0.0	0.0	0.3	11.5	0.3	0.2	1.8	19.7	0.0	0.3	0.0	358.4	9.2	0.1	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.8	13.1	0.3	31.8	0.7	2.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 35.0"	"Group enriched"	"Detected in many"	8	"Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 35.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	0.2	1.0	5.6	0.4	8.9	0.7	0.5	2.5	35.0	0.4	0.0	0.7	0.2	0.4	0.7	0.1	0.2	0.9	0.1	11.4	0.2	0.9	2.6	0.1	0.4	4.2	0.0	0.5	1.6	0.5	6.7	0.1	3.8	0.6	0.9	7.9	0.6	0.2	0.3	0.3	0.2	0.1	0.0	0.6	1.0	1.7	2.4	0.5	0.5	0.1	0.2	0.2	0.2	11.5	1.7	1.3	13.7	0.2	1.8	13.5	0.3	8.0	12.5	9.1	8.5	2.8	1.6	0.4	1.9	9.9	4.4	0.1	2.3	0.0	10.5	1.6	0.8	0.1	0.3	0.3	0.1	0.2	1.1	1.8	0.0	6.5	1.4	3.4	9.8	3.5	0.2	0.2	5.5	1.0	2.5	0.2	4.9	0.9	4.8	0.1	0.7	0.0	0.0	0.5	5.6	2.2	4.5	2.1	0.3	2.1	0.4	0.2	2.8	8.9	6.3	3.3	5.2	0.2	0.1	0.0	1.8	1.9	13.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	5.6	8.9	2.5	35.0	11.4	0.2	4.2	0.0	3.8	0.0	2.4	11.5	1.2	0.0	0.0	27.1	0.0	0.0	0.5	0.0	3.4	16.7	2.6	1.8	1.4	1.5	0.0	0.0	10.4	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.7	1.3	11.4	0.0	336.7	0.5	0.0	0.1	3.1	0.0	0.0	0.7	1.1	4.3	0.0	5.0	280.1	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.6	0.0	4.7	0.0	104.5	14.2	0.7	0.5	0.7	0.0	0.4	0.0	0.7	0.0	11.2	0.0	0.4	0.3	3.8	10.2	0.1	0.0	0.0	0.3	0.0	0.9	0.3
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 64.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.0	0.5	3.4	0.0	4.8	0.0	0.0	12.5	64.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	19.4	0.0	0.0	0.0	0.0	22.9	8.5	0.0	0.3	0.0	3.4	0.0	18.1	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.8	12.5	64.2	1.6	19.4	22.9	8.5	18.1	0.1	26.2	23.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.1	1.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.3	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	14.2	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 491.6;liver: 484.7;skin 1: 447.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"midbrain: 17.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	3100000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 22: Epithelial cell types - Mixed function"	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	2.4	17.4	0.7	17.2	0.2	1.2	23.8	2.3	0.8	127.2	0.7	61.8	75.8	2.2	19.9	491.6	10.5	77.1	0.6	0.3	2.0	99.5	484.7	59.6	7.3	0.6	17.3	1.6	16.6	5.4	2.0	32.6	0.8	56.3	33.3	0.7	85.8	25.9	1.6	447.4	53.6	2.2	0.2	20.1	87.3	3.3	2.5	5.1	18.3	0.0	43.2	104.8	242.1	0.1	252.6	137.6	42.7	108.1	11.6	1.6	134.9	68.7	65.4	62.7	52.8	29.5	148.9	0.3	24.8	48.8	34.8	241.4	19.0	482.2	41.8	1.3	12.5	0.0	12.2	150.2	10.3	11.0	1.0	6.4	436.6	56.5	132.9	87.2	6.9	0.0	6.4	94.7	34.0	149.6	0.6	2.6	38.7	189.6	263.1	5.3	15.7	189.9	80.5	370.0	12.4	99.7	51.9	342.4	15.2	17.1	34.5	2.8	10.7	246.9	78.6	9.2	470.0	467.4	1069.8	1.0	74.5	0.6	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	2.3	0.8	0.3	2.0	0.6	17.3	0.8	0.2	2.5	0.1	0.4	93.0	99.0	0.0	33.0	113.9	189.1	162.8	81.4	0.6	29.9	26.7	0.9	267.4	161.8	42.3	0.0	3.8	0.7	147.2	31.3	61.3	0.1	16.6	5.0	3.5	10.8	13.5	0.3	21.8	46.3	5.0	55.0	22.9	6.3	7.5	7.5	603.1	2.3	21.9	0.2	73.1	50.8	10.6	11.9	0.3	0.6	2.5	21.4	0.0	0.6	0.3	0.0	1.0	0.0	111.4	78.0	1.2	165.1	78.0	106.5	88.5	43.4	0.4	0.0	0.1	15.0	1.0	14.0	246.6	229.0	250.8	4.0	0.1	85.1	492.8
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216909-1232067	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 406.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	86.5	91.8	44.2	78.8	47.8	56.2	80.2	47.2	65.3	84.4	72.5	95.9	117.1	91.8	43.9	66.3	74.6	66.2	134.6	45.5	44.8	89.6	160.7	82.0	53.4	53.2	46.1	85.4	104.6	61.5	78.5	73.3	47.0	76.9	60.4	25.7	83.5	52.2	78.9	72.9	116.8	58.2	43.5	78.0	93.6	71.7	50.5	34.6	81.8	47.7	39.6	82.2	71.6	45.9	139.7	123.7	67.1	214.0	320.0	160.4	80.5	266.1	241.4	191.2	159.4	147.0	236.2	87.8	201.8	258.0	137.4	140.4	77.5	117.1	58.2	147.9	133.0	153.6	185.7	207.8	147.4	156.7	199.2	199.0	59.5	144.6	81.2	186.5	155.9	57.3	129.2	225.0	95.7	101.1	77.8	158.9	61.7	158.0	167.1	85.8	86.5	234.4	127.2	66.4	243.3	86.7	177.2	208.2	182.8	59.0	108.0	176.7	198.8	196.2	107.0	149.5	154.2	138.9	141.2	144.6	222.9	289.7	87.1	14.4	21.5	30.8	19.3	14.6	14.6	13.5	27.6	28.4	21.9	16.8	16.0	14.1	16.9	26.8	23.2	14.0	25.1	11.8	44.2	47.8	47.2	65.3	45.5	44.8	53.2	46.1	47.0	43.5	50.5	45.9	92.9	22.4	19.2	18.6	62.5	119.8	74.0	24.6	46.7	34.5	51.2	47.6	35.7	68.6	28.9	49.7	18.8	124.1	68.4	240.0	11.7	79.0	39.1	49.0	76.2	77.8	65.5	32.8	21.1	71.4	284.4	117.1	81.1	60.8	36.2	61.4	76.4	117.1	122.4	38.7	23.5	174.9	30.5	73.7	154.8	36.8	95.4	62.8	167.2	13.1	50.8	64.9	111.2	13.6	17.5	73.0	213.5	76.0	202.5	101.5	406.2	57.7	18.4	40.0	59.2	69.8	75.1	101.7	63.5	53.2	114.2	168.0	73.4	88.7	181.0	71.1
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 1024.6"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"myeloid DC: 11.6"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	3.2	10.0	13.5	4.3	18.8	1.5	1.9	13.2	13.0	1.1	8.7	3.3	1.9	0.9	0.3	0.3	0.6	4.1	1.2	13.4	15.2	0.5	1024.6	6.3	0.8	30.0	27.7	0.5	1.0	0.8	1.1	2.9	16.1	1.1	2.3	3.0	2.7	0.1	0.8	0.2	2.0	0.5	10.5	1.7	2.9	0.4	19.1	0.4	1.0	0.0	0.3	3.8	0.3	11.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.2	0.0	0.3	0.5	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.0	0.4	13.5	18.8	13.2	13.0	13.4	15.2	30.0	27.7	16.1	10.5	19.1	11.4	0.2	0.0	0.6	15.0	5.1	2.4	0.4	0.0	0.0	0.2	0.4	1.5	0.5	17.2	0.0	0.0	0.0	0.8	0.3	0.1	0.0	2.8	0.0	0.1	0.2	1.3	0.0	29.5	0.1	0.4	1.3	0.6	0.0	0.1	0.0	0.1	18.9	364.6	199.4	0.0	0.1	0.0	0.0	45.1	111.9	0.0	0.0	93.7	1.8	0.0	97.6	1.9	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.4	3.1	2.5	2.4	0.8	0.0	0.1
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"SEC23 homolog B, COPII coat complex component"	Q15437	20	18507520-18561415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles		NA	Yes		16000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA008216: AB_1079895, HPA069974: AB_2686223"	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	19.6	38.3	18.7	32.0	27.1	36.0	37.8	24.7	25.9	36.2	27.4	31.6	23.8	17.2	53.8	28.4	29.5	23.1	8.5	19.5	22.4	37.4	30.6	29.7	30.5	27.2	23.8	16.9	57.1	50.6	32.6	24.2	27.2	34.8	32.7	40.7	70.9	35.9	4.1	18.2	23.3	18.5	24.5	25.5	38.2	34.8	23.2	27.6	59.5	6.2	38.0	30.5	12.6	38.9	85.0	93.9	49.8	48.7	32.3	36.6	116.0	69.8	45.3	80.0	68.7	84.9	73.8	37.5	44.9	50.4	107.0	88.5	88.5	120.7	86.2	47.5	43.1	64.9	35.6	130.6	70.5	90.2	78.7	28.0	71.8	118.0	151.4	47.6	50.6	34.0	74.8	82.4	55.1	90.7	59.8	49.5	48.0	118.9	101.6	62.4	77.7	122.1	83.0	85.6	78.8	58.0	83.6	188.9	80.6	62.6	82.3	94.4	45.3	53.1	29.8	58.4	87.1	104.2	155.9	60.1	45.3	47.8	74.4	147.9	94.1	106.0	57.2	95.6	78.7	67.2	56.8	61.4	107.9	61.2	51.3	54.0	48.0	78.8	94.9	80.7	75.4	103.7	18.7	27.1	24.7	25.9	19.5	22.4	27.2	23.8	27.2	24.5	23.2	38.9	8.5	16.0	43.5	15.3	24.7	11.5	21.0	34.3	10.2	21.0	21.5	15.6	3.0	20.0	42.5	31.3	16.7	34.3	36.0	26.2	58.7	36.1	95.6	25.4	12.4	11.3	19.7	7.4	17.9	33.4	30.0	11.7	25.0	31.3	15.9	13.6	11.0	25.6	42.9	13.5	20.5	34.7	26.4	38.7	21.0	11.3	14.3	30.3	23.2	15.0	33.1	23.9	9.2	23.1	27.0	31.8	24.2	10.5	59.0	30.1	11.8	53.2	45.4	20.4	19.7	12.4	12.2	48.7	22.1	15.8	14.2	65.8	21.0	16.0	21.5	28.3
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722640-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 56.1"	"Cell type enriched"	"Detected in some"	4	"Endothelial cells: 379.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002143	Enhanced					NA	NA	8140000	180000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	29.6	5.5	1.2	12.6	0.8	0.5	12.0	0.5	1.7	4.1	4.1	4.2	0.7	5.3	0.5	4.0	23.8	10.7	8.0	0.8	1.6	7.6	6.9	10.3	3.0	1.8	1.2	3.3	1.2	12.5	4.0	1.4	1.7	27.7	2.6	0.3	3.1	3.8	0.8	5.5	2.3	18.7	1.3	0.0	5.2	2.4	2.9	8.4	13.8	1.0	3.6	56.1	5.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.5	1.7	0.8	1.6	1.8	1.2	1.7	1.3	2.9	1.1	34.6	0.0	3.8	0.0	0.0	46.1	1.1	0.0	1.2	0.0	0.5	0.3	4.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.3	379.5	0.0	0.0	0.1	0.0	0.0	12.7	0.0	0.2	1.3	0.0	3.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	81.9	3.0	0.0	0.9	46.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.3	4.1	0.2	0.0	1.2	47.7	0.0	3.4	0.1	0.1	2.5
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364304-151372707	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 509.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		59000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	128.3	18.7	49.8	24.9	53.0	95.9	76.3	45.5	54.8	57.0	47.4	509.3	74.7	31.3	43.4	31.8	132.7	52.2	69.1	47.1	48.2	77.2	261.7	181.0	10.9	47.8	51.0	49.4	29.0	11.9	15.0	20.4	46.5	44.2	471.7	3.9	61.6	48.8	72.9	25.2	94.2	49.5	46.9	51.1	126.4	6.1	51.0	7.1	115.1	138.1	6.8	58.3	29.3	45.7	0.0	17.2	31.9	1.8	144.9	59.1	8.4	5.9	2.6	3.1	6.5	18.1	5.4	0.0	30.7	10.7	0.0	0.4	0.0	0.4	2.8	0.1	14.8	120.5	53.1	28.9	30.5	0.2	0.0	75.9	1.0	5.3	0.1	0.4	19.0	0.0	12.4	0.0	8.0	13.2	0.0	0.0	26.6	92.8	32.2	0.1	1.7	0.7	7.1	0.0	0.4	0.7	0.5	274.4	0.0	25.1	49.4	1.8	1.8	0.0	1.1	16.8	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	49.8	53.0	45.5	54.8	47.1	48.2	47.8	51.0	46.5	46.9	51.0	45.7	36.6	294.9	525.6	38.2	4.0	10.8	27.7	56.4	30.7	0.3	73.0	59.9	135.7	75.8	123.9	5.5	0.0	2.4	1.9	1056.9	115.4	17.1	0.7	30.9	14.9	27.5	155.0	590.9	0.1	9.1	2.1	85.2	163.6	14.1	27.3	10.9	26.0	501.5	15.3	0.0	0.1	137.2	79.3	39.6	12.4	4.2	66.5	3.9	33.8	13.1	0.2	37.4	0.0	0.0	2.0	6.5	451.4	80.9	0.8	25.6	251.0	148.3	101.5	1.4	52.6	15.6	102.3	0.1	0.3	22.7	9.9	4.0	5.7	30.5	452.4	71.0
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"	O60613	1	86862445-86914424	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No		420000	"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	118.1	137.9	77.6	118.8	80.0	107.9	147.4	80.9	106.1	156.6	97.9	127.8	113.5	117.4	211.4	83.6	130.1	123.3	84.6	75.2	84.3	160.3	173.9	114.9	140.6	82.6	79.8	124.6	93.4	115.7	88.4	155.8	84.0	121.1	134.2	90.7	104.1	116.4	45.6	66.3	111.3	107.1	86.4	107.2	116.8	66.7	79.0	135.5	234.0	64.7	126.9	146.6	72.6	92.5	203.1	133.3	118.0	129.1	383.0	396.4	178.3	249.1	317.3	251.4	254.8	176.8	261.8	245.2	309.7	248.9	195.7	131.8	135.2	150.7	296.0	222.1	180.2	252.4	108.5	178.2	245.2	336.8	166.1	272.3	233.0	152.8	253.0	180.2	220.2	207.8	241.4	262.3	253.3	90.2	254.4	227.3	170.7	211.2	197.9	207.7	205.1	251.9	355.5	198.5	149.5	122.6	241.6	235.6	349.2	104.7	104.0	298.5	205.3	180.0	122.9	347.6	277.0	155.1	158.7	251.9	107.7	268.4	216.7	170.9	111.3	113.4	89.7	115.9	116.1	161.4	98.7	97.2	107.1	194.2	98.8	102.3	109.3	82.3	132.4	166.3	115.2	171.3	77.6	80.0	80.9	106.1	75.2	84.3	82.6	79.8	84.0	86.4	79.0	92.5	131.6	118.6	155.2	0.0	52.4	0.0	0.0	0.0	0.0	0.0	142.1	107.7	0.0	0.0	74.9	108.5	0.0	248.6	89.3	0.0	74.3	235.9	0.0	102.2	119.1	73.2	0.0	0.0	0.0	193.5	338.3	85.2	0.0	98.1	64.3	68.8	0.0	0.0	241.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	64.1	0.0	0.0	0.0	0.0	197.8	0.0	0.0	19.1	0.0	0.0	151.5	70.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	315.2	53.9	122.2	0.0	0.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818221	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 99.2;Exocrine glandular cells: 42.3;Granulosa cells: 31.2;Hofbauer cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058076	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA058076: AB_2683598"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favorable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	65.7	48.0	51.6	34.0	51.2	17.0	60.8	45.5	53.3	43.8	74.2	42.5	17.4	48.8	19.5	36.5	40.2	30.1	60.7	49.6	48.5	52.5	20.3	51.8	20.5	72.8	55.2	51.7	60.1	37.0	40.2	38.9	52.1	58.2	20.8	11.7	45.7	39.6	56.3	30.2	31.0	56.2	54.1	43.4	43.4	12.0	62.6	13.6	53.8	39.7	16.3	46.9	35.6	50.2	52.6	49.5	160.9	138.4	102.5	178.8	54.4	62.2	93.4	67.7	53.9	12.9	54.2	0.1	40.4	94.6	74.8	49.9	42.4	66.2	51.1	55.8	32.6	51.4	18.2	16.0	73.8	11.0	116.6	191.7	43.8	71.0	35.5	79.9	214.4	17.4	18.5	7.2	64.7	26.8	2.3	15.7	61.0	40.9	33.7	45.4	70.3	6.4	27.7	14.8	33.5	56.9	39.4	35.3	52.7	43.0	35.6	36.1	180.5	68.4	46.2	126.6	37.1	5.8	0.2	1.4	94.8	15.9	84.4	2.7	1.2	1.6	0.7	1.0	0.4	0.7	0.6	0.5	0.8	0.4	0.9	0.6	0.2	0.3	1.1	0.1	0.7	0.4	51.6	51.2	45.5	53.3	49.6	48.5	72.8	55.2	52.1	54.1	62.6	50.2	99.2	9.6	10.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	23.0	19.3	0.0	0.0	3.7	20.2	0.0	16.4	3.8	0.0	0.0	18.6	0.0	6.5	22.4	21.5	0.0	0.0	0.0	42.3	11.4	12.5	0.0	13.5	2.5	31.2	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.9	0.0	0.0	14.9	3.6	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	13.0	2.2	8.6	0.0	0.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 150.4;lymphoid tissue: 231.4"	"Group enriched"	"Detected in many"	5	"B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		4700000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	29.3	2.3	2.8	118.8	4.5	150.4	2.6	8.4	6.2	3.7	2.7	6.8	3.2	2.6	1.7	5.5	4.7	24.1	3.1	3.2	4.0	3.0	12.1	19.4	231.4	7.4	4.5	1.0	3.7	28.0	13.9	11.2	6.1	3.7	7.1	1.0	3.8	1.9	3.4	0.6	17.0	14.5	6.4	166.8	5.6	1.1	3.9	132.2	2.8	13.6	202.0	37.9	1.4	8.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.7	0.0	0.3	11.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	7.7	1.3	0.5	0.0	0.0	0.0	0.0	1.8	29.4	0.1	1.4	0.0	1.8	21.2	0.3	0.1	0.4	0.3	7.8	0.2	0.7	6.1	0.3	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.0	0.0	0.6	0.2	0.0	0.0	38.8	0.0	19.4	2.0	11.1	0.3	3688.4	992.6	1696.7	284.3	211.6	78.1	613.0	528.9	294.2	756.3	734.4	1169.2	683.6	4201.4	2551.1	93.1	622.9	1011.2	2052.5	2.8	4.5	8.4	6.2	3.2	4.0	7.4	4.5	6.1	6.4	3.9	8.0	1.8	9.6	13.7	0.7	221.4	0.4	0.3	0.0	0.6	0.1	0.5	0.3	0.6	2.8	1.8	11.0	0.0	13.9	206.0	0.1	0.0	0.2	0.0	0.1	0.0	3.4	0.0	25.2	0.2	0.0	0.6	3.3	2.6	0.1	10.1	0.5	3.9	1.1	5.6	0.0	0.1	0.1	0.0	68.9	2.7	0.2	0.6	86.3	1.8	1.0	208.7	2.5	110.2	0.0	0.8	0.1	0.0	0.0	25.8	0.0	0.0	0.9	1.5	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.1	28.5	104.9	0.5	0.0	0.6
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.7;Endothelial cells: 51.8;Hepatic stellate cells: 33.9;Macrophages: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 8.3;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.3;T-cells: 8.8"	"Group enriched"	"Detected in some"	38	"EFO-21: 36.0;HEL: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced					NA	NA		520000000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	11.3	2.3	0.2	11.9	0.6	2.2	10.6	0.0	0.6	8.9	3.7	3.3	5.1	6.4	4.1	5.1	6.7	9.5	6.7	0.3	0.0	5.6	2.5	12.6	7.0	0.2	0.2	1.8	1.2	3.1	2.2	6.3	0.2	6.1	4.1	0.0	2.7	5.7	1.0	3.6	4.8	14.2	0.1	1.0	2.8	0.7	0.7	2.6	4.0	1.8	12.6	14.4	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.4	0.6	0.0	0.2	0.0	1.1	0.5	0.2	0.0	0.1	0.2	0.1	2.1	0.3	0.0	0.1	8.8	7.8	0.2	0.6	0.0	0.6	0.3	0.0	0.2	0.2	0.2	0.1	0.7	0.2	14.7	0.0	3.6	0.3	0.4	3.7	0.1	0.0	0.6	0.0	0.2	0.1	1.9	1.5	0.0	1.8	0.0	2.6	0.1	0.0	0.0	0.0	2.0	0.1	0.1	51.8	0.0	5.2	0.5	0.2	0.0	1.5	0.0	0.0	0.0	0.0	33.9	0.4	0.2	0.0	0.2	0.0	0.0	1.5	3.6	0.1	0.3	10.1	3.6	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	3.4	4.1	0.5	0.0	0.0	0.3
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles		NA	NA		2700000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	17.5	9.1	12.1	47.4	10.5	21.1	6.9	11.7	12.1	9.2	8.2	9.6	8.6	3.7	2.1	8.6	7.8	17.0	5.0	12.0	14.1	4.0	6.5	40.8	62.2	17.8	13.5	2.8	3.4	4.4	3.0	13.0	16.4	3.3	8.4	0.7	7.0	3.9	2.2	4.7	15.5	11.5	17.0	86.6	11.3	2.2	17.2	52.1	3.4	7.3	30.6	21.5	3.3	24.5	0.5	0.4	1.4	0.8	0.7	1.5	0.8	4.9	4.8	1.8	1.4	0.3	1.9	0.5	1.7	7.4	2.0	0.3	0.1	0.1	1.3	136.2	0.0	45.7	0.2	0.2	0.4	35.1	130.0	1.8	0.5	2.5	0.6	5.0	0.4	102.2	0.8	195.1	6.0	0.0	28.3	18.9	0.2	0.1	1.6	0.3	0.5	286.7	2.9	0.0	0.3	0.0	0.6	0.2	2.2	3.3	0.1	42.6	1.7	2.6	0.8	3.5	1.4	326.8	214.5	6.4	1.5	74.2	1.9	1543.6	297.6	940.2	419.2	509.2	344.3	22.0	396.6	362.9	299.9	22.3	300.3	323.7	1257.2	309.2	762.7	518.3	662.2	1035.5	12.1	10.5	11.7	12.1	12.0	14.1	17.8	13.5	16.4	17.0	17.2	24.5	1.2	3.2	12.4	0.0	11.6	3.4	0.1	0.2	0.0	0.2	0.6	1.4	2.2	4.3	2.7	0.0	0.0	0.5	159.7	0.2	0.0	0.3	8.2	1.8	0.6	2.6	0.0	10.9	0.2	0.2	2.3	2.4	2.6	0.9	29.7	0.4	3.6	2.2	40.1	0.0	0.3	0.0	0.0	84.9	49.6	12.2	0.3	64.8	7.2	15.9	123.8	0.0	154.5	0.0	0.1	0.5	0.0	0.0	65.1	0.1	0.0	0.5	6.4	0.2	0.0	1.2	0.9	0.8	0.5	0.5	1.8	1.0	65.9	0.1	0.0	0.0
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.4;Cone photoreceptor cells: 45.9;Excitatory neurons: 89.7;Rod photoreceptor cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 129.3;BJ: 102.9;fHDF/TERT166: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	6.8	0.2	3.8	3.8	5.8	0.1	1.5	0.6	3.0	4.4	0.0	9.8	1.4	1.0	2.2	5.8	1.6	5.6	2.5	2.0	0.7	0.4	0.4	2.3	3.3	3.8	0.2	0.4	0.4	0.5	2.1	10.4	4.6	2.9	5.7	22.6	0.4	0.4	0.1	1.1	2.4	4.7	0.6	3.8	2.0	1.2	0.3	0.5	1.7	0.5	1.6	5.4	0.6	4.4	11.8	32.8	129.3	0.1	3.8	3.1	8.4	102.9	60.0	8.5	5.3	11.4	30.7	0.0	4.8	112.0	1.1	57.0	0.3	24.6	11.8	0.0	4.2	0.0	6.0	0.0	3.3	2.6	0.0	3.9	0.0	18.1	4.4	26.2	32.1	0.1	0.1	0.2	3.4	0.6	0.0	0.0	48.6	0.5	11.6	2.3	55.3	3.4	18.5	0.8	9.8	5.2	0.8	0.2	1.1	20.7	0.6	1.1	18.3	11.2	11.6	32.6	15.1	7.6	5.5	0.0	11.5	4.5	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.8	5.8	0.6	3.0	2.0	0.7	3.8	0.2	4.6	0.6	0.3	4.4	1.0	3.2	1.7	58.4	0.0	0.9	0.0	15.4	0.0	15.1	0.2	0.3	6.0	0.0	22.4	0.0	45.9	0.4	0.3	0.1	0.0	0.1	0.2	2.0	0.7	7.3	0.0	0.0	89.7	2.0	0.2	9.3	0.0	9.0	1.3	3.5	1.8	0.1	1.0	3.3	10.0	0.0	2.0	0.3	2.7	0.2	2.5	0.5	1.8	7.5	0.0	19.6	0.0	9.5	5.8	5.5	0.0	0.0	0.0	0.3	0.0	0.0	15.6	66.3	0.0	1.5	2.1	1.7	1.9	0.4	1.3	0.3	1.1	18.6	0.0	0.2
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	7900000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	33.8	9.0	8.8	8.6	5.7	2.7	31.9	5.1	8.1	28.3	12.0	10.5	13.4	14.5	5.4	100.8	15.6	10.8	22.6	5.0	9.2	49.2	4.8	46.2	3.7	10.2	12.7	3.6	6.7	5.5	11.1	30.4	8.7	32.7	6.3	22.0	24.6	32.5	10.4	75.1	12.5	9.1	6.3	50.7	17.3	2.4	21.8	6.1	27.1	6.1	12.6	27.0	55.4	4.7	13.9	3.1	0.7	14.2	0.2	1.3	3.0	8.0	24.2	6.5	10.2	5.4	6.1	0.5	77.9	1.1	0.7	47.5	6.9	100.7	2.4	0.1	1.8	0.8	108.1	18.5	5.7	1.7	3.2	6.2	55.3	15.1	45.4	90.7	187.0	1.2	2.9	0.1	1.3	12.4	1.5	7.5	8.6	6.2	10.1	11.8	0.0	0.5	7.2	112.3	1.1	2.6	12.8	170.2	0.3	10.4	67.2	7.3	338.6	4.2	31.9	29.7	5.5	0.2	0.0	0.9	0.3	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	5.7	5.1	8.1	5.0	9.2	10.2	12.7	8.7	6.3	21.8	4.7	40.2	0.0	1.1	0.0	0.2	6.8	3.0	9.2	5.7	23.4	10.7	6.0	9.2	1.5	6.6	18.4	10.4	11.2	0.6	5.5	0.0	0.3	0.0	6.5	2.4	24.4	0.0	0.0	0.7	0.8	0.5	1.1	16.3	6.9	0.0	0.2	25.4	0.6	1.4	6.7	1.1	10.7	0.0	0.3	0.8	0.3	0.3	0.2	0.0	3.7	0.0	8.7	0.0	0.0	0.1	6.8	3.8	0.0	0.0	2.5	5.7	0.7	5.4	19.8	0.0	0.5	2.5	0.0	0.4	17.7	8.9	6.3	0.4	0.2	5.2	8.6
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 260.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.5;NK-cells: 92.7;Oligodendrocytes: 310.5;T-cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 133.2;HMC-1: 97.2;JURKAT: 89.1;MOLT-4: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved					NA	NA		7500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (4.06e-5)"	7.2	12.8	73.5	35.1	149.7	28.7	6.1	129.0	122.7	9.1	34.2	10.4	10.6	6.5	12.2	27.3	11.0	12.3	12.1	72.0	88.4	32.0	4.1	14.2	62.4	165.2	145.6	6.5	8.0	6.0	13.8	5.5	147.8	11.9	9.7	5.0	12.0	6.6	88.0	17.4	28.9	5.5	119.1	51.3	16.7	10.6	127.0	43.4	11.8	27.5	49.8	11.4	16.2	260.2	12.7	9.2	8.4	12.4	0.4	0.8	19.0	1.1	0.5	2.6	1.7	6.1	13.8	47.3	5.1	0.2	9.7	6.4	7.5	3.6	1.1	133.2	7.5	20.1	3.3	0.7	1.5	26.4	97.2	0.3	2.8	0.6	0.3	0.3	4.9	89.1	4.8	31.5	0.0	20.9	120.9	33.9	20.6	25.0	0.5	38.2	2.8	13.4	16.5	13.0	19.7	13.1	3.4	8.9	0.3	11.7	10.1	14.4	3.2	0.1	7.6	1.0	6.1	34.9	16.3	6.6	6.0	32.1	7.6	17.2	7.5	38.2	22.0	7.0	13.3	4.3	17.5	18.6	2.6	2.5	19.9	23.2	37.0	9.4	8.1	8.0	17.7	14.5	73.5	149.7	129.0	122.7	72.0	88.4	165.2	145.6	147.8	119.1	127.0	260.2	3.4	6.4	15.7	33.6	35.4	4.6	3.3	2.1	3.4	12.4	9.5	5.5	18.7	5.7	6.9	11.0	2.1	9.0	76.5	1.5	3.9	5.4	2.2	10.9	6.4	5.2	1.8	23.1	44.5	3.3	2.1	6.7	7.7	15.4	42.5	8.0	5.3	1.6	21.6	33.7	17.2	6.3	4.1	28.2	6.1	3.8	7.5	37.4	1.8	49.6	43.7	8.9	92.7	12.1	310.5	3.7	0.7	15.1	53.7	6.5	0.5	14.2	5.7	5.1	0.0	11.4	2.6	0.9	26.1	7.1	5.4	3.7	89.7	2.3	3.3	7.7
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 84.6;liver: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	2.4	12.7	13.1	5.9	10.9	0.4	3.6	18.9	12.3	6.9	12.8	53.6	53.4	3.5	32.1	3.6	5.9	9.0	3.0	10.0	11.6	19.1	102.4	5.8	2.5	11.2	14.4	18.9	31.3	7.3	9.9	3.9	11.5	20.2	84.6	7.3	8.5	3.0	2.6	18.3	41.2	4.6	9.6	3.1	20.9	3.7	17.0	0.8	15.3	0.8	0.9	4.0	5.0	9.9	0.2	31.7	8.0	3.4	5.0	1.6	6.8	1.2	3.4	1.7	1.7	30.5	5.2	0.5	4.2	1.5	0.6	2.1	8.0	1.4	1.4	0.7	4.9	1.7	3.0	113.8	12.5	1.2	1.0	8.3	1.8	1.6	0.9	22.2	4.4	3.5	3.3	0.4	2.5	2.0	0.5	1.2	1.3	69.1	1.8	3.1	0.7	1.5	7.4	1.0	2.5	12.5	1.1	2.1	3.2	8.7	8.7	1.5	3.0	1.0	3.7	0.8	0.3	1.1	0.6	0.5	0.9	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	10.9	18.9	12.3	10.0	11.6	11.2	14.4	11.5	9.6	17.0	9.9	0.3	3.2	1.1	3.9	1.2	0.0	0.6	0.7	0.6	3.5	2.5	2.0	1.2	20.0	0.2	0.0	0.0	8.8	0.0	66.4	0.0	2.7	0.2	1.6	0.7	0.6	8.5	0.8	3.0	2.6	1.9	2.0	27.0	0.3	0.0	3.4	2.2	60.5	0.9	11.8	14.1	34.6	2.0	3.3	0.0	0.2	2.1	0.2	1.8	0.0	0.0	0.9	0.0	3.5	5.5	2.4	38.5	1.2	0.2	3.0	47.6	6.4	2.4	1.6	0.0	0.1	0.4	1.1	1.9	0.5	0.1	2.9	0.2	12.7	45.9	0.9
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443555-116574823	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 60.1;brain: 75.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		620000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	13.4	60.1	24.1	4.9	48.6	3.5	13.1	39.9	31.9	10.0	0.3	20.6	19.9	6.0	2.8	4.4	8.2	12.9	7.1	24.5	40.3	8.6	5.6	17.9	4.5	51.9	41.0	18.1	11.2	2.0	5.8	31.9	50.0	6.0	17.5	10.4	16.6	2.5	8.2	6.9	25.5	5.8	32.9	11.2	7.0	7.5	44.1	3.6	9.1	6.5	2.2	5.6	8.1	75.2	0.3	0.1	36.9	44.3	0.2	0.0	38.2	0.7	0.4	0.2	0.2	2.2	1.5	1.6	1.7	0.6	0.7	0.4	52.0	0.0	0.1	1.6	7.7	0.7	0.7	13.1	0.5	0.5	2.6	0.7	0.0	0.0	0.0	0.5	0.2	0.3	0.3	0.4	0.2	0.8	0.7	3.9	115.2	0.2	0.3	6.9	24.2	1.8	19.0	33.7	10.3	3.7	0.2	0.7	19.7	221.1	14.4	2.6	0.9	3.6	3.1	0.4	1.5	0.6	0.7	0.8	0.6	1.8	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	48.6	39.9	31.9	24.5	40.3	51.9	41.0	50.0	32.9	44.1	75.2	64.7	0.0	0.6	71.8	1.1	6.5	0.7	13.1	34.7	17.9	17.0	8.3	8.6	61.5	3.1	14.7	2.1	128.9	0.3	73.3	0.0	42.9	13.6	12.2	4.8	60.9	28.1	2.7	26.9	1.3	8.1	15.4	1.1	10.6	0.0	9.7	145.6	0.9	12.5	138.0	62.2	30.7	0.0	14.8	4.6	2.4	6.5	1.1	24.9	54.4	0.1	5.8	0.0	138.7	311.3	2.0	46.7	1.9	2.6	1.5	40.7	4.4	0.6	3.5	0.0	36.1	8.1	0.9	1.5	11.3	4.1	348.1	0.8	3.5	40.3	2.2
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4581776	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 43.6;Alveolar cells type 1: 28.9;Alveolar cells type 2: 44.6;Endothelial cells: 40.1;Excitatory neurons: 30.6;granulocytes: 29.7;Hepatic stellate cells: 37.5;Inhibitory neurons: 30.3;Macrophages: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 124.5;HMC-1: 198.1;HUVEC TERT2: 83.8;TIME: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced					NA	NA		1100000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741"	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (9.55e-2)"	25.6	19.7	44.0	11.0	30.7	7.8	17.1	0.6	72.3	8.7	0.0	6.6	4.0	10.6	0.4	3.6	8.8	5.8	20.2	65.2	12.4	13.3	2.9	10.7	1.2	13.5	11.0	3.3	4.1	9.2	7.2	8.9	1.8	7.0	1.0	1.4	3.9	1.3	6.0	4.6	7.3	6.9	0.5	31.9	6.1	1.9	30.2	0.7	9.1	4.3	0.7	10.0	6.7	17.4	7.2	25.0	2.3	21.4	0.1	1.2	0.2	0.0	0.7	2.4	0.6	0.2	2.0	0.0	23.7	0.0	3.8	4.4	6.5	0.0	0.9	0.1	1.0	0.0	0.4	124.5	0.4	0.0	198.1	7.5	0.1	0.2	0.2	24.9	83.8	0.1	1.6	0.3	0.7	6.5	0.0	0.0	26.8	1.7	0.3	0.4	46.8	0.6	1.7	0.1	17.7	1.7	0.1	1.7	11.5	1.8	2.7	1.1	107.8	3.1	34.7	0.5	18.6	1.3	0.0	0.4	0.8	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	30.7	0.6	72.3	65.2	12.4	13.5	11.0	1.8	0.5	30.2	17.4	43.6	28.9	44.6	2.6	2.3	4.7	1.5	0.5	0.0	9.0	2.1	1.9	1.9	1.5	19.3	1.8	4.2	0.6	2.3	0.2	0.0	1.1	1.1	1.1	2.5	40.1	0.0	8.4	30.6	0.2	0.6	8.2	0.0	2.0	29.7	0.5	37.5	6.0	3.3	18.5	30.3	0.1	0.0	6.1	18.1	0.4	0.6	35.2	7.2	7.5	1.4	2.0	1.0	19.1	1.4	0.2	0.1	0.7	1.1	1.2	0.0	0.4	17.7	4.1	0.0	8.8	1.8	2.0	2.2	0.0	5.1	0.3	5.4	1.6	0.1	0.9
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774228	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.5;placenta: 43.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.5	1.5	11.3	3.9	27.9	0.4	5.0	11.1	21.3	5.8	0.0	10.6	21.8	1.6	2.5	1.7	4.9	4.0	9.4	9.8	16.3	15.1	3.1	8.9	2.1	17.2	31.1	26.7	16.1	10.6	5.5	43.1	23.1	4.5	12.7	15.8	4.5	8.4	20.9	3.0	38.5	3.3	12.0	2.5	3.0	2.6	20.5	2.7	5.8	6.0	0.6	3.1	10.0	28.8	0.0	0.0	2.5	0.0	1.5	1.2	0.2	0.6	14.9	0.4	0.0	0.3	0.1	2.2	0.0	4.0	0.0	7.6	3.4	1.1	0.1	1.1	1.7	0.0	5.0	0.0	4.0	0.0	0.2	1.1	8.3	0.0	0.5	0.0	1.0	5.7	0.1	3.4	0.4	0.8	2.8	0.7	4.6	0.0	0.0	1.6	0.1	2.4	1.1	1.1	13.3	12.1	0.1	1.0	4.3	14.2	0.5	0.0	0.0	6.9	0.3	0.2	0.0	10.0	0.0	2.3	1.8	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.3	27.9	11.1	21.3	9.8	16.3	17.2	31.1	23.1	12.0	20.5	28.8	13.9	51.3	1.5	72.8	0.2	2.0	4.0	1.4	1.2	6.2	0.5	10.7	10.0	4.3	2.1	11.0	114.7	19.7	0.1	40.6	5.9	1.0	0.2	0.5	2.3	10.1	17.4	0.0	120.7	0.2	1.8	10.8	0.0	0.3	3.8	71.0	5.0	0.9	2.6	79.1	319.5	5.4	0.0	0.0	1.9	1.2	23.3	1.0	8.8	15.9	0.0	9.3	0.0	43.2	140.1	0.3	8.5	13.5	0.0	1.2	53.5	0.2	0.1	2.3	0.0	9.3	13.9	0.8	6.3	0.3	1.1	4.7	0.2	3.4	15.1	1.6
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.1;retina: 34.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles		NA	NA		38000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.0	2.5	4.6	7.0	11.0	9.9	1.9	19.1	14.4	2.2	0.9	2.4	1.5	2.9	0.9	4.8	1.4	1.8	2.3	5.1	8.2	2.8	1.6	8.1	13.2	19.9	11.6	7.8	0.9	1.9	2.7	16.3	22.9	1.8	0.9	34.6	2.2	1.2	2.0	8.5	10.8	1.1	10.6	60.1	3.5	29.5	17.2	9.4	1.3	0.3	12.9	8.2	2.5	20.2	16.7	0.2	4.8	1.4	6.0	20.1	39.7	75.2	30.1	15.5	23.8	6.5	26.6	0.1	4.3	34.2	12.6	4.9	1.5	4.8	16.0	1.3	0.9	30.0	0.1	8.3	1.3	0.9	275.8	14.3	0.2	108.7	6.0	39.0	0.2	2.0	17.5	10.1	51.2	1.4	4.3	9.9	5.2	0.4	11.3	0.6	3.3	4.4	6.5	7.1	0.3	0.5	0.5	13.4	6.1	4.1	1.0	6.0	3.0	28.8	19.2	14.1	166.3	1.8	1.3	0.3	92.4	3.4	1.5	1.8	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	4.6	11.0	19.1	14.4	5.1	8.2	19.9	11.6	22.9	10.6	17.2	20.2	1.8	3.2	0.0	1.0	22.6	0.4	1.6	3.1	0.6	13.7	1.2	1.3	1.4	0.0	4.0	1.8	68.8	25.6	5.2	0.6	0.0	19.8	0.5	4.6	1.5	5.3	0.0	21.7	12.4	13.9	58.8	1.8	1.5	10.6	8.2	65.1	0.7	0.7	7.2	1.7	5.9	0.0	0.0	0.3	12.0	2.5	3.7	4.8	8.8	0.0	28.6	6.8	1.0	4.0	16.3	91.0	0.1	1.9	6.4	3.3	0.1	0.1	2.0	58.3	0.0	0.2	9.0	0.9	0.8	0.2	1.4	166.4	5.7	22.0	0.0	24.4
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin 1"	P04279	20	45207033-45209768	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"seminal vesicle: 30405.5"	"Group enriched"	"Detected in some"	18	"Basal prostatic cells: 7.5;Prostatic glandular cells: 3.4"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	239	"eosinophil: 26.8"	"Lineage enriched"	"Detected in single"	269	"granulocytes: 26.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;THP-1: 3.1"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.1	0.0	0.0	0.0	30405.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1
SEMG2	SGII	ENSG00000124157	"Semenogelin 2"	Q02383	20	45221373-45224458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"seminal vesicle: 10407.9"	"Group enriched"	"Detected in some"	9	"Basal prostatic cells: 1.2;Collecting duct cells: 3.7;Early spermatids: 1.2;Late spermatids: 1.8;Prostatic glandular cells: 1.9"	"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"	NA	NA		5000000		"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 22: Epithelial cell types - Mixed function"			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0	10407.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	7.4	7.3	13.4	4.4	15.8	10.7	7.5	13.3	16.2	6.0	12.0	7.8	6.0	6.1	9.7	6.5	7.2	4.5	8.3	13.9	13.1	7.3	9.5	6.4	6.2	12.9	13.6	10.0	7.4	9.6	10.5	9.0	12.4	6.6	6.1	12.8	7.6	6.3	18.9	9.2	6.6	4.8	12.2	6.7	8.0	15.1	14.2	8.1	7.2	13.0	6.0	7.1	6.3	14.4	24.4	4.6	11.6	13.4	20.6	13.8	15.1	10.9	12.6	13.8	14.6	18.3	7.5	13.2	20.3	10.2	23.6	12.6	24.3	9.0	20.3	9.7	11.6	8.9	9.8	11.0	10.9	13.2	5.6	8.6	13.3	7.8	9.5	10.2	9.6	12.5	10.8	18.1	12.0	12.0	11.4	14.7	42.4	12.3	8.1	13.1	15.8	22.1	7.7	7.9	11.9	13.4	9.3	20.4	18.3	23.0	27.8	17.5	6.1	9.0	9.8	16.4	17.7	20.9	26.8	23.8	14.9	13.9	12.5	5.1	1.3	2.6	1.6	1.3	1.6	1.3	1.3	1.3	1.0	1.9	1.5	1.5	3.4	2.3	1.6	2.0	1.3	0.9	13.4	15.8	13.3	16.2	13.9	13.1	12.9	13.6	12.4	12.2	14.2	14.4	12.3	28.9	27.4	17.9	21.2	10.8	23.7	12.6	6.2	22.8	21.6	15.4	24.2	11.5	26.2	9.2	31.3	25.0	22.6	15.7	5.9	12.9	249.6	26.3	12.0	12.8	5.4	11.1	42.9	15.2	19.9	16.1	15.3	25.2	10.8	21.3	17.2	20.5	13.2	11.8	43.0	15.1	14.2	12.5	9.1	43.0	22.7	11.1	17.8	26.2	13.6	17.8	21.6	41.2	41.3	17.9	6.6	17.7	25.7	17.0	24.2	18.2	28.8	38.1	19.7	23.2	16.3	84.2	31.8	13.4	12.5	39.7	18.2	33.7	15.8	22.5
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO specific peptidase 3"	Q9H4L4	17	7561919-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	24.2	24.0	43.7	21.0	42.6	25.4	23.7	38.5	47.9	23.7	38.5	32.4	21.2	26.7	27.4	25.4	25.9	19.3	25.2	42.6	39.8	34.1	20.5	28.6	26.5	40.4	42.2	26.8	26.4	38.1	26.4	22.5	41.1	23.0	25.4	24.7	24.8	26.0	33.5	28.6	25.2	28.9	39.5	28.3	27.0	29.0	44.0	33.8	23.9	30.9	31.2	29.7	21.8	42.0	76.4	90.8	52.7	82.5	58.6	42.8	54.8	54.8	56.0	93.4	87.2	54.9	32.5	90.3	52.6	72.7	62.3	72.0	114.4	85.8	78.0	63.7	105.0	46.7	74.8	56.9	79.1	44.0	57.9	55.1	86.5	107.1	103.5	53.3	76.0	102.1	61.5	24.7	73.0	51.4	107.9	33.6	64.2	70.9	54.5	97.1	48.8	52.4	62.9	44.0	52.5	67.6	55.3	52.7	60.0	66.6	44.1	28.5	40.5	53.0	45.9	51.3	119.0	36.3	40.4	57.3	53.9	45.7	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	43.7	42.6	38.5	47.9	42.6	39.8	40.4	42.2	41.1	39.5	44.0	42.0	4.5	3.2	5.4	0.0	4.9	8.5	6.4	1.6	10.2	6.1	6.7	11.0	7.1	7.2	3.6	1.8	22.9	3.0	4.8	2.6	0.0	2.3	1.4	4.0	4.2	4.7	6.6	1.3	0.0	2.4	2.3	3.8	3.6	4.7	1.3	5.2	8.2	2.7	1.5	6.7	0.0	3.0	2.0	6.0	6.4	0.7	4.1	4.9	3.6	0.0	4.7	5.5	4.1	0.0	0.0	2.1	0.8	2.2	6.4	6.1	4.0	1.1	2.1	7.3	0.0	5.2	4.4	3.7	4.0	7.4	11.6	4.1	4.9	3.0	3.7	6.4
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317428-13348298	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm		NA	NA		21000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA037645: AB_10671631, HPA062118: AB_2732676"	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	27.8	28.6	23.2	23.6	23.9	25.3	33.5	25.3	22.3	25.6	28.1	31.2	23.2	32.3	35.9	24.6	35.3	23.8	30.8	21.7	24.1	56.5	48.6	24.3	29.3	26.7	28.4	35.7	33.6	48.1	23.5	27.8	23.1	26.4	32.7	25.0	26.9	24.7	33.3	20.9	24.6	33.2	25.9	21.8	25.6	22.1	24.6	64.3	55.4	36.6	34.3	24.8	17.4	24.4	127.7	90.8	182.4	176.3	59.4	45.1	85.8	55.4	42.6	115.6	97.9	103.5	116.4	123.1	67.2	65.0	55.9	79.6	195.2	91.4	120.5	186.7	80.9	67.4	66.8	132.9	61.4	92.0	41.4	39.6	64.6	67.7	39.5	53.9	95.0	255.9	90.7	97.5	83.2	168.1	228.8	39.3	301.8	119.8	40.9	176.3	88.8	73.7	62.2	51.0	64.5	119.5	169.6	74.1	75.7	157.7	93.8	96.1	64.1	51.1	96.3	67.6	117.6	71.3	143.4	228.1	41.2	67.6	41.9	10.2	11.6	8.8	7.7	17.1	9.5	9.5	7.8	8.9	13.6	6.4	10.0	9.4	1.7	15.4	24.8	15.4	13.3	8.3	23.2	23.9	25.3	22.3	21.7	24.1	26.7	28.4	23.1	25.9	24.6	24.4	24.1	12.8	13.1	8.1	12.3	17.2	16.5	19.3	9.6	17.1	23.8	19.4	14.1	20.0	18.0	22.0	0.0	31.6	27.1	17.6	33.2	26.4	13.5	16.9	15.4	26.1	16.7	19.3	8.2	30.1	45.2	18.0	11.7	16.1	15.8	27.7	19.6	32.7	21.1	21.9	8.3	13.7	20.3	10.1	11.7	14.1	14.9	13.1	16.0	4.7	8.0	35.2	9.2	4.0	12.9	34.1	15.3	18.4	18.7	17.5	16.4	44.6	13.4	15.6	6.6	14.2	26.1	17.6	21.2	15.0	16.9	25.6	13.2	25.9	18.0	15.1
SEPTIN11	"FLJ10849, SEPT11"	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949751-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 90.1;Extravillous trophoblasts: 266.8;Fibroblasts: 40.1;Hofbauer cells: 52.0;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 495.8;fHDF/TERT166: 604.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol		NA	NA		2800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favorable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	84.8	13.0	34.6	27.5	46.5	7.9	39.3	24.3	51.4	40.4	0.0	50.1	21.8	33.8	18.0	22.5	17.4	45.4	30.8	40.5	13.7	52.4	33.9	40.5	24.1	5.2	8.5	20.0	22.3	17.3	11.3	84.1	4.5	21.0	40.4	22.3	11.6	26.1	26.0	13.3	35.3	40.6	0.0	25.6	25.2	7.8	16.6	12.7	21.1	18.3	22.8	39.3	21.5	50.6	87.6	34.9	328.1	293.8	192.8	152.9	94.6	495.8	382.7	110.6	154.5	64.3	62.9	2.0	100.9	604.4	51.9	36.6	109.8	73.8	171.2	114.0	36.7	171.2	44.6	47.1	168.0	93.0	69.7	195.5	34.4	160.2	59.8	87.7	169.0	34.3	72.0	46.6	331.2	50.4	122.8	3.3	111.1	71.4	18.1	142.6	372.8	10.1	62.6	94.0	112.1	83.6	96.2	54.4	77.9	209.9	49.5	37.3	184.4	368.7	109.4	182.8	93.1	28.5	24.3	1.1	140.5	10.0	76.4	12.2	2.4	32.5	8.1	2.2	5.0	3.6	9.2	11.2	7.8	6.7	3.5	9.4	0.6	38.4	7.4	20.8	5.8	6.6	34.6	46.5	24.3	51.4	40.5	13.7	5.2	8.5	4.5	0.0	16.6	50.6	33.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	90.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	266.8	40.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	60.5	5.6	0.0	0.0	0.0
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2, SEPT6"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 231.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 20.3;Cytotrophoblasts: 43.9;dendritic cells: 66.5;Extravillous trophoblasts: 50.1;Hofbauer cells: 54.8;Plasma cells: 28.4;Syncytiotrophoblasts: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 273.0;MOLT-4: 300.5;REH: 271.8;SH-SY5Y: 394.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol		NA	NA		2900000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	13.1	73.4	14.5	66.7	12.8	61.1	12.7	16.9	16.9	11.5	7.8	47.4	14.3	11.2	16.9	17.9	18.1	17.5	16.1	12.4	20.8	18.1	21.3	16.5	119.7	18.3	18.0	11.4	4.6	9.9	9.8	14.7	22.1	13.4	18.5	38.9	18.2	40.5	4.6	7.1	35.3	24.4	13.5	61.9	20.0	40.3	20.5	231.3	7.6	5.9	103.9	18.6	9.7	12.0	6.5	10.1	37.9	68.5	3.5	7.7	53.9	18.9	41.7	31.4	53.8	3.4	14.4	130.7	14.6	23.9	32.6	3.7	60.2	12.1	21.7	80.6	13.9	58.1	20.3	23.5	9.1	66.3	29.4	14.0	2.6	24.8	0.6	13.1	46.4	273.0	43.6	68.0	18.7	4.8	300.5	38.6	40.2	1.9	31.0	271.8	31.3	106.7	33.5	6.8	16.8	394.7	49.1	17.9	20.6	40.7	24.3	33.8	29.0	8.5	17.2	27.5	4.7	33.8	14.5	170.7	0.8	69.0	6.3	34.2	17.2	39.9	58.6	26.1	61.4	65.0	75.3	68.6	34.0	64.0	79.3	69.4	11.8	81.3	38.8	63.7	112.4	53.9	14.5	12.8	16.9	16.9	12.4	20.8	18.3	18.0	22.1	13.5	20.5	12.0	13.8	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	43.9	66.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	50.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	43.0	15.5	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	116.2	79.6	45.9	110.1	48.9	130.5	106.9	45.7	48.5	98.3	44.4	91.2	99.6	89.9	65.7	188.2	81.5	66.5	93.4	42.5	46.5	85.9	131.4	76.6	123.8	51.6	47.5	86.8	121.1	131.5	48.0	92.9	52.4	77.3	84.5	47.6	119.0	66.2	336.9	149.6	92.7	82.1	50.3	81.4	94.1	82.9	49.3	125.7	91.1	159.0	118.1	101.4	118.4	52.8	444.4	272.4	274.9	280.4	236.9	214.0	420.9	452.9	163.8	294.7	241.6	524.8	195.4	828.9	341.1	236.0	294.6	337.4	435.2	411.2	309.5	375.7	535.8	764.1	488.7	460.7	207.0	614.9	290.8	221.3	272.1	384.6	356.0	205.9	319.7	276.0	867.4	293.0	236.2	314.9	494.9	412.9	978.1	298.1	355.2	566.3	600.4	429.8	231.0	349.8	468.8	330.8	351.0	385.6	442.4	231.1	212.0	386.4	345.9	283.4	351.5	421.2	618.3	273.6	369.2	747.9	233.0	603.3	326.9	37.8	84.1	53.7	100.4	92.5	125.4	101.3	99.0	100.9	107.5	102.1	114.6	105.6	27.1	147.4	90.1	98.2	131.5	119.2	45.9	48.9	45.7	48.5	42.5	46.5	51.6	47.5	52.4	50.3	49.3	52.8	251.3	250.0	225.5	17.6	262.6	686.4	437.3	363.8	536.7	146.7	262.1	251.8	144.8	214.4	311.4	117.7	91.8	271.5	343.7	200.0	242.6	324.4	555.9	368.1	411.9	314.9	230.1	398.8	24.1	361.5	531.0	231.0	169.7	400.5	219.2	215.6	179.2	331.5	297.9	143.0	24.6	338.7	183.1	247.7	281.2	240.9	221.2	214.2	192.1	27.2	298.4	153.6	325.4	26.7	33.2	349.3	192.0	278.7	277.4	540.5	168.4	323.0	206.3	139.7	138.1	301.6	516.0	569.8	281.6	597.9	719.7	229.3	271.4	318.8	405.0	470.2
SERHL2		ENSG00000183569	"Serine hydrolase like 2"	Q9H4I8	22	42553617-42574382	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"breast: 420.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 18.1;Hepatic stellate cells: 21.8;Sertoli cells: 19.7"	"Group enriched"	"Detected in all"	5	"breast cancer: 8.0;prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.5;naive B-cell: 8.4;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	12	"B-cells: 8.4;dendritic cells: 3.9"	"Cell line enriched"	"Detected in many"	10	"SK-BR-3: 276.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (3.14e-1)"	"unprognostic (1.56e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	2.0	2.6	4.8	1.0	5.9	2.1	420.6	5.8	7.4	3.4	3.8	2.3	0.7	3.1	36.4	2.3	3.4	1.6	3.9	4.8	5.2	3.0	1.7	1.6	4.0	4.3	4.3	13.7	0.6	5.3	1.1	0.8	4.7	10.2	1.2	1.1	6.3	5.4	1.4	13.9	2.1	2.0	4.2	1.9	3.0	2.9	5.1	0.7	2.8	1.3	1.4	2.5	2.8	5.1	0.7	0.0	1.6	3.0	3.7	8.7	0.5	2.2	2.0	2.0	2.6	0.1	0.5	1.3	1.2	5.4	1.2	1.4	1.5	0.9	1.1	0.5	0.9	1.2	0.1	2.9	1.9	1.8	2.5	8.7	1.5	1.3	0.2	1.7	0.6	0.2	11.7	0.2	2.1	5.8	29.0	1.8	0.3	0.7	0.7	15.6	0.0	0.5	0.9	0.7	0.5	0.8	0.5	276.7	0.3	2.9	1.2	1.9	2.0	1.0	0.3	1.5	0.0	1.2	0.1	13.5	1.8	0.2	1.2	0.0	0.0	0.4	0.1	0.0	0.2	3.5	0.1	0.3	0.1	8.4	0.0	0.1	0.0	0.2	0.1	3.9	0.0	0.3	4.8	5.9	5.8	7.4	4.8	5.2	4.3	4.3	4.7	4.2	5.1	5.1	2.6	3.2	0.0	3.6	3.2	1.3	6.1	1.5	1.8	1.4	18.1	6.3	0.5	1.5	2.4	12.9	0.0	5.4	3.2	0.5	3.9	1.3	3.5	2.4	2.2	8.5	0.0	2.7	5.0	0.2	3.7	4.0	0.5	5.0	0.0	0.7	21.8	1.2	1.2	1.7	4.4	1.7	0.0	1.6	1.9	3.1	5.3	2.4	5.4	4.7	0.0	4.1	1.0	3.0	9.9	0.5	0.6	6.8	0.1	13.2	0.4	1.0	2.5	1.5	19.7	3.1	3.3	5.3	8.3	2.6	1.6	8.1	1.3	3.3	1.2	4.5
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 346.9"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.4	0.6	0.7	3.3	0.6	3.2	1.4	0.6	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.4	0.4	0.5	346.9	0.4	0.8	1.5	0.5	0.9	0.5	0.2	0.2	0.5	0.8	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.4	0.7	0.7	0.6	0.7	1.3	0.7	0.4	0.4	0.2	0.1	2.5	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	3.2	1.4	0.4	0.4	1.5	0.5	0.8	0.4	0.7	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452800	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"liver: 490.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 278.7"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		230000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	5.3	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	490.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.9	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.3	0.0	0.0	4.3	1.8	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	278.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.2
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612384-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 9176.5;pancreas: 4910.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 449.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	94000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	91.8	58.0	100.4	43.4	116.5	2.1	371.0	117.7	293.8	368.8	110.3	79.5	11.7	44.9	11.5	42.5	116.6	146.0	311.7	103.6	320.0	215.5	9176.5	169.9	5.0	196.3	183.1	181.5	4910.2	1.0	271.2	14.6	138.3	580.5	13.3	131.5	1505.8	54.9	177.8	55.7	91.6	83.1	141.4	31.7	290.5	66.9	176.3	2.6	72.6	38.9	6.4	207.4	70.4	173.0	0.2	0.5	0.0	0.3	0.2	0.8	0.3	0.1	0.1	0.0	0.0	1.2	4.9	0.6	4.5	0.0	3.3	0.9	0.0	4.4	0.0	2.7	0.0	1.0	0.2	449.9	56.9	1.9	0.7	52.0	63.9	0.0	2.5	5.4	0.0	0.0	0.3	0.2	0.0	17.1	0.5	0.5	0.8	1.6	0.0	0.6	2.2	0.2	3.8	0.2	0.1	0.0	1.8	2.5	65.6	0.4	2.4	0.0	0.6	0.0	8.5	0.1	19.4	1.1	2.0	2.1	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	116.5	117.7	293.8	103.6	320.0	196.3	183.1	138.3	141.4	176.3	173.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.5	1.8	0.0	5.6	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	3.7	0.2	0.1	0.3	0.0	0.0	0.0	33.0	0.0	68.6	9.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	18.7	0.0	0.4	0.3	0.5	0.0	0.1	1.5	0.0	0.0	1.7	0.8	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593118	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 484.5;liver: 785.6;testis: 432.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078846	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA078846: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	5.1	484.5	1.8	3.3	2.4	0.0	19.6	2.2	1.7	29.6	3.0	5.3	5.5	31.8	1.2	0.8	26.3	160.5	19.0	1.6	7.2	151.4	785.6	1.0	3.6	3.5	3.8	30.1	173.9	0.2	3.2	0.1	5.3	6.8	1.9	14.0	9.4	153.3	46.4	3.3	3.6	2.1	1.7	112.2	12.1	432.4	2.8	0.9	4.1	152.6	4.7	2.3	4.0	3.7	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	12.0	12.2	0.0	8.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	261.3	0.3	0.4	0.0	1.7	0.3	0.1	0.0	2.3	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.5	0.2	3.9	0.1	0.4	17.4	0.2	0.1	7.9	0.9	0.1	0.0	0.5	0.0	0.6	0.4	1.5	0.2	0.1	0.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	2.2	1.7	1.6	7.2	3.5	3.8	5.3	1.7	2.8	3.7	0.9	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.2	18.9	14.1	0.8	400.4	0.1	33.1	2.1	0.0	0.1	0.0	64.6	103.2	78.7	175.2	19.7	40.3	0.0	2.7	0.0	122.2	0.0	18.2	0.5	345.3	0.0	78.2	2.5	198.2	0.0	8.4	0.0	0.0	0.0	3.2	0.7	277.8	57.2	1.9	0.0	0.0	0.6	5.4	0.0	0.0	0.2	18.3	0.0	144.4	0.0	0.1	0.0	7.5	0.0	1.4	6.6	11.6	1.5	11.1	2.9	0.0	0.6	0.3	1.8	58.7	0.0	0.1
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 776.6"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 204.5;Hepatocytes: 390.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"T-47d: 961.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	37000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	1.9	0.0	3.5	0.1	0.5	0.0	0.0	12.6	35.1	0.0	0.0	0.0	43.5	776.6	0.1	0.0	0.0	0.0	0.3	17.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	114.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.4	4.5	0.1	0.4	0.0	0.1	0.7	0.0	0.0	961.9	0.0	0.0	0.5	0.0	0.6	0.0	0.3	0.0	0.5	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	4.4	0.0	0.4	204.5	0.3	0.0	0.0	0.3	0.0	0.4	1.9	33.1	0.0	62.6	0.3	0.4	9.0	16.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	9.7	390.8	0.0	0.0	0.0	0.8	2.0	8.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.0	1.2	0.0	0.0	0.0	0.1	43.0	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.1
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 282.2"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 182.8"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	475	"Hep G2: 69.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	282.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	182.8	0.0	0.0	0.0	0.7	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 27.4;prostate: 32.5"	"Cell type enhanced"	"Detected in some"		"Club cells: 6.8;Prostatic glandular cells: 3.3;Respiratory ciliated cells: 4.4;Squamous epithelial cells: 13.7;Urothelial cells: 21.9"	"Cancer enriched"	"Detected in some"	5	"prostate cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"							NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"					"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	32.5	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	9.0	2.9	6.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.2	0.0	0.0	21.9
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63542369-63569329	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 13.9;skin 1: 59.1;vagina: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		8200000		"Cluster 31: Skin - Epidermis development"							"unprognostic (7.35e-2)"				"prognostic favorable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.1	0.0	0.2	0.1	3.3	0.4	0.2	13.9	0.2	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	59.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.4	0.0	0.1	2.1	0.0	25.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903888	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 239.1;lymphoid tissue: 81.2;skin 1: 89.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2243.9;Suprabasal keratinocytes: 1053.6;Syncytiotrophoblasts: 439.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.3;thalamus: 1.1"	"Immune cell enhanced"	"Detected in some"		"basophil: 22.0;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 282.7;HaCaT: 699.1;U-138 MG: 807.0;U-2197: 1243.9"	"Region enriched"	"Detected in single"	15	"cerebellum: 2.6"	"Not detected"	"Not detected"			"HPA015480, HPA076596, HPA076608"	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 28: Keratinocytes - Keratinization"			"HPA015480: AB_1855456, HPA076596: , HPA076608: "	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.55e-5)"	21.0	0.3	0.0	8.6	0.0	36.5	8.7	0.0	1.3	21.0	0.0	0.5	0.1	0.7	0.0	239.1	8.4	0.7	1.0	0.0	0.2	0.2	0.3	2.8	0.0	0.0	0.1	0.3	1.1	0.2	0.1	50.1	0.0	0.2	0.0	0.0	31.2	0.0	0.3	89.2	0.1	1.7	0.0	0.3	0.8	0.0	1.1	2.6	0.1	0.2	81.2	6.6	45.4	0.0	1.4	0.0	0.0	0.8	1.3	0.6	0.2	169.2	179.2	6.0	13.1	0.9	0.4	0.2	0.0	6.1	282.7	699.1	0.0	143.7	118.6	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.5	1.5	13.9	81.7	37.0	1.8	0.6	0.0	0.6	0.4	2.8	0.0	0.2	0.4	0.3	0.2	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	1.1	0.0	0.6	0.7	15.7	13.9	807.0	0.4	1243.9	0.0	0.2	0.1	0.0	21.6	1.8	96.7	22.0	4.9	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.5	0.0	0.2	2243.9	4.1	82.1	0.0	0.0	0.6	0.1	0.7	0.0	153.4	0.0	0.0	6.2	0.1	0.0	0.0	92.6	0.0	0.1	0.1	5.5	0.0	0.0	0.0	7.1	1.7	11.0	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	26.4	2.9	86.4	0.0	0.0	73.1	94.3	0.0	3.9	0.0	0.0	0.0	0.0	167.2	0.0	0.0	1.0	18.9	0.0	0.0	94.5	0.0	0.0	0.3	14.8	0.0	0.0	94.7	1053.6	439.3	2.5	0.0	0.0	52.0
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661893	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix: 418.5;esophagus: 809.7;vagina: 669.6"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 6903.4;Club cells: 6726.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 186.5;head and neck cancer: 69.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		9100000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.1	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	418.5	0.0	0.1	0.0	3.2	0.0	809.7	0.2	0.2	0.4	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	7.6	0.0	0.0	100.0	0.0	0.1	42.9	0.1	0.0	0.0	0.1	0.5	1.9	0.0	4.8	0.1	0.0	19.6	73.8	669.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	6.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	35.2	6903.4	2.2	0.0	0.0	0.0	0.0	0.0	6726.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	31.4	0.1	0.2	0.5	0.0	0.0	0.0	8.9	0.0	3.0	0.0	0.9	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	986.7	0.0	0.0	55.4	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	60.2	0.0	0.2	447.6	0.0	0.0	0.0	178.1	1.0	0.3	413.5	0.0	0.3	0.8	0.0	0.0	265.9
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644256	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 78.6;esophagus: 93.3;vagina: 150.9"	"Cell type enriched"	"Detected in some"	4	"Basal respiratory cells: 3577.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.1;head and neck cancer: 29.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;HSkMC: 1.1;SiHa: 1.7;U-2197: 6.1"									"HPA048341, HPA049988, HPA055992"	Supported					NA	NA		10000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	78.6	0.0	0.0	0.0	0.6	0.0	93.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	0.0	23.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.5	21.0	150.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	3577.0	0.0	0.0	0.0	0.0	0.0	0.0	825.8	0.0	0.0	0.0	0.0	0.0	0.0	23.9	1.4	0.1	0.1	0.2	0.0	0.0	0.0	21.7	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	97.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	32.4	0.0	0.3	53.0	0.0	0.0	0.0	10.7	0.1	0.0	14.8	0.0	0.8	0.0	0.0	0.0	60.5
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476958-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 216.6;skin 1: 239.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 964.1;Basal prostatic cells: 358.7;Basal respiratory cells: 272.9;Squamous epithelial cells: 535.4;Suprabasal keratinocytes: 1215.3;Urothelial cells: 564.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1279.3;HBEC3-KT: 425.6;hTCEpi: 875.0;hTERT-HME1: 217.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		770000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.6	0.0	0.0	4.3	0.0	0.2	37.1	0.1	0.1	38.5	0.1	4.8	16.7	0.1	0.1	216.6	1.4	2.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	9.9	4.5	0.0	37.6	1.7	1.4	239.7	22.1	0.2	0.0	0.0	9.7	2.8	0.0	13.9	0.1	0.0	39.9	90.9	78.7	0.1	80.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	73.4	0.1	3.8	0.0	0.1	1279.3	0.0	425.6	0.0	0.0	0.0	0.0	95.8	0.2	0.0	0.0	0.6	0.1	875.0	0.0	217.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	179.9	93.4	0.1	0.0	0.2	0.0	95.1	1.4	0.0	60.2	0.3	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.2	0.9	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	964.1	358.7	272.9	224.3	0.0	5.1	27.3	0.2	0.0	90.0	3.7	0.0	0.3	0.1	14.2	0.0	0.1	9.0	6.2	0.1	5.4	3.5	0.0	0.3	0.0	0.2	5.8	12.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.3	34.6	0.0	57.6	18.6	0.6	1.8	62.2	0.0	0.0	0.0	0.0	0.0	0.1	16.3	51.7	0.0	2.5	85.4	13.5	0.1	85.4	0.0	0.0	0.0	7.1	6.6	2.2	535.4	1215.3	0.1	4.0	0.1	30.6	564.9
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 563.0;Late spermatids: 1154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	122.7	170.7	101.1	66.9	108.4	66.6	107.9	103.6	134.3	135.9	103.8	133.7	191.2	95.9	82.2	131.5	118.9	77.7	243.9	98.6	104.2	136.7	63.3	151.7	52.7	111.7	107.1	169.7	282.5	94.4	92.0	133.5	110.6	160.4	103.3	56.4	92.5	95.6	232.0	50.9	210.3	89.4	105.8	164.5	115.0	203.8	106.7	26.7	101.3	266.8	47.2	107.7	95.5	115.4	156.2	99.6	32.2	134.3	85.6	189.2	99.2	142.1	170.7	109.9	127.3	35.0	108.5	0.8	161.6	161.7	124.8	228.8	90.3	144.1	102.2	204.9	41.2	90.7	111.8	60.0	148.5	1.1	53.0	109.4	98.5	104.8	26.9	191.1	263.7	0.5	118.7	2.0	198.0	110.7	0.5	1.5	19.1	175.5	188.8	10.1	59.3	130.7	138.7	37.1	1.5	82.5	116.9	17.3	162.4	118.6	75.3	73.8	188.7	111.1	41.4	252.0	97.1	3.0	0.6	2.7	85.4	90.8	117.8	60.6	104.9	121.2	51.5	107.6	25.7	27.3	28.9	35.5	103.6	22.9	33.7	56.1	8.6	86.0	90.7	10.3	5.0	91.1	101.1	108.4	103.6	134.3	98.6	104.2	111.7	107.1	110.6	105.8	106.7	115.4	127.8	51.3	69.6	34.3	33.0	20.5	68.4	141.8	23.9	28.4	62.4	63.0	142.6	42.9	141.6	75.4	20.9	146.4	56.8	237.9	99.7	194.6	563.0	89.4	91.4	137.5	73.0	29.9	14.2	338.3	346.6	84.9	108.6	47.8	104.5	83.5	232.7	31.9	182.3	30.3	21.5	169.7	114.0	181.9	70.2	1154.3	83.3	124.2	64.0	92.8	151.8	172.4	46.4	31.7	56.2	318.5	237.0	85.0	17.4	99.3	418.3	216.4	174.2	50.4	78.9	119.7	104.6	233.2	33.1	34.0	26.3	161.4	42.2	65.0	206.5	94.9
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1341	"liver: 5056.6"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.7	5056.6	0.3	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.2	1.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.3	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 1253.1"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.3	0.2	0.1	0.0	0.8	0.2	0.4	1.7	0.8	1.0	87.7	0.0	0.0	2.0	0.0	0.1	0.9	0.4	1.1	1.7	0.0	0.3	1253.1	2.5	0.0	0.0	0.0	1.8	0.5	10.1	0.8	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.8	1.7	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 418.0"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	13000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	215.5	75.3	3.1	91.6	3.4	1.7	56.2	5.2	12.8	62.1	5.0	31.7	7.4	31.1	1.0	16.4	41.3	360.3	136.0	3.9	6.6	166.2	345.8	260.2	21.3	6.4	3.7	105.6	135.1	11.8	12.3	418.0	4.5	37.8	5.4	4.9	10.6	8.0	17.8	21.2	13.1	74.3	4.8	13.8	30.3	5.5	12.7	6.7	59.5	4.3	3.5	359.9	19.2	6.0	77.3	64.4	1.2	5.1	766.6	1511.0	89.3	3483.8	654.6	1717.6	1487.4	9.4	5.5	2.7	812.6	1117.9	2367.3	18.1	0.4	269.4	1756.2	4.3	0.7	1.1	5.2	61.4	1532.6	0.2	3.8	596.1	106.9	2641.4	1374.8	928.5	4014.7	0.2	6.4	2.5	3874.5	0.4	0.6	2.2	18.2	1.3	41.7	0.6	6.1	4.8	5.1	30.3	1.0	0.8	286.3	77.2	8.3	410.9	3.3	9.9	10032.6	4609.6	204.0	1593.8	4256.0	0.6	2.9	4.2	1150.5	2.4	45.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	9.5	0.0	0.3	0.0	0.8	3.1	3.4	5.2	12.8	3.9	6.6	6.4	3.7	4.5	4.8	12.7	6.0	35.8	0.0	7.7	0.0	1.1	40.0	43.7	97.4	14.2	0.3	0.3	2.3	2.5	4.3	11.0	5.5	0.0	56.0	1.0	0.4	0.0	65.1	0.0	4.7	53.8	165.1	5.3	0.0	0.5	4.5	75.1	162.1	0.5	3.2	10.2	12.4	40.4	112.3	15.9	0.0	0.3	0.2	8.2	4.6	9.6	1.1	17.7	11.1	7.2	5.6	1.1	0.7	0.0	0.0	0.0	231.8	0.0	12.0	3.6	9.7	0.1	0.0	8.2	0.3	39.5	55.4	239.3	0.0	0.1	9.0	24.7	651.7	2.3	2.1	0.5	8.1
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975045-224039318	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 1091.9"	"Cell type enriched"	"Detected in many"	8	"Granulosa cells: 4466.0"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 23.2;T-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000277			Approved	"Golgi apparatus"	"Secreted in female reproductive system"	NA	NA		910000	"Cluster 48: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"		"HPA000277: "	"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.48e-5)"	28.0	19.8	120.3	75.7	125.9	6.5	14.3	128.6	158.7	28.1	71.1	22.7	28.2	17.4	5.6	36.2	20.8	46.0	100.0	115.9	145.9	39.3	10.8	14.5	30.9	158.1	152.6	145.6	8.5	3.4	8.7	1091.9	134.4	26.4	21.8	5.4	12.6	7.5	6.6	11.2	27.0	119.6	141.1	30.9	8.9	57.6	146.4	17.0	26.1	10.8	44.0	146.9	27.6	132.0	3.1	83.8	29.4	32.6	1172.5	438.7	4.4	1492.9	851.5	118.1	112.7	4.8	7.0	0.4	32.5	6425.1	188.0	5.0	3.5	102.5	101.0	0.6	26.8	16.6	49.9	22.7	57.7	12.8	1.5	128.3	68.5	342.0	505.6	304.6	9.0	5.4	0.5	1.9	412.1	4.5	2.3	3.9	56.2	31.8	92.3	10.3	25.2	64.5	1100.2	97.5	43.0	7.1	284.4	0.5	2966.9	385.2	1.2	6.4	1056.5	692.5	96.6	214.4	72.7	6.3	13.3	0.8	443.5	11.1	2183.6	0.0	0.0	0.0	0.7	0.0	0.5	0.8	0.6	0.6	0.0	1.2	12.9	6.8	0.5	23.2	0.0	0.2	0.7	2.7	120.3	125.9	128.6	158.7	115.9	145.9	158.1	152.6	134.4	141.1	146.4	132.0	13.5	0.0	1.1	233.1	3.1	23.3	16.0	132.2	351.7	5.3	7.9	8.5	5.3	0.0	4.6	7.3	0.0	106.1	11.3	19.5	11.7	13.0	2.6	5.3	17.7	20.9	24.0	23.1	86.1	33.2	524.3	556.7	5.6	5.9	2.5	4466.0	23.2	0.0	45.5	0.0	11.4	4.7	0.0	0.8	26.9	9.9	401.4	9.7	142.3	23.4	3.5	2.5	2.1	199.6	13.5	22.1	14.9	98.9	5.6	27.2	2.0	146.2	1.7	3.5	13.1	5.2	146.6	4.2	70.9	34.8	14.5	133.9	10.7	18.9	3.1	7.2
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1762029-1777565	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1875.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 245.2"	"Region enhanced"	"Detected in many"		"hippocampal formation: 85.4"	"Immune cell enriched"	"Detected in many"	18	"plasmacytoid DC: 1454.4"	"Lineage enriched"	"Detected in all"	121	"dendritic cells: 1454.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	44000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	535.5	57.5	5.7	124.2	9.6	11.9	490.2	17.9	28.0	558.7	1875.2	131.3	41.9	358.2	90.2	109.3	557.4	559.7	376.5	85.4	1.1	35.1	974.8	158.9	133.5	0.1	5.1	408.3	207.6	11.2	62.4	311.6	1.3	202.8	52.0	61.4	124.6	105.8	434.8	162.9	131.7	221.7	2.8	133.2	124.7	277.7	25.4	106.2	193.1	465.5	117.7	323.4	273.5	7.0	0.5	3.7	2.8	2.0	1232.0	956.3	20.4	56.8	49.8	0.6	0.0	9.7	0.5	2.3	1.9	71.8	0.3	3.2	86.0	4.4	0.0	0.6	46.0	1.0	1.2	606.0	410.6	1.1	1.1	1313.4	6.9	0.9	1.1	11.4	0.6	4.2	117.5	0.4	63.2	0.2	7.0	7.2	30.7	0.3	1.0	2.9	219.9	1.6	0.1	6.0	1.9	42.2	0.7	0.7	57.0	3.4	6.7	184.2	2.0	0.5	17.6	14.1	1.2	0.7	2.4	28.1	1.7	0.6	0.8	0.1	12.0	1.1	0.6	4.4	0.4	9.0	0.7	0.9	79.8	5.2	2.0	5.5	1.7	1.3	0.2	1454.4	0.8	14.2	5.7	9.6	17.9	28.0	85.4	1.1	0.1	5.1	1.3	2.8	25.4	7.0	59.0	3.2	10.4	0.3	10.8	95.0	238.0	697.8	27.9	59.3	6.7	71.2	12.1	11.5	167.7	1.8	223.1	795.6	226.1	0.0	0.0	0.3	11.2	12.5	372.4	26.2	0.0	19.2	5.3	24.5	98.7	951.9	11.2	6.7	22.9	1.7	28.2	765.0	151.6	3.3	2.6	0.0	366.2	60.4	262.6	53.0	1818.0	79.0	108.5	9.4	79.0	11.6	1.0	0.5	2.0	6.8	0.1	1045.7	7.0	155.5	0.2	27.3	105.5	39.1	19.7	193.3	202.8	12.7	8.7	4.5	78.6	534.8	14.3	10.2	0.3	47.7
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1578.5"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	11.6	2.0	1.4	4.3	1.5	0.4	18.3	1.2	2.2	7.1	11.1	4.2	0.7	8.7	101.4	3.0	19.6	0.7	2.5	2.0	1.4	74.1	1578.5	12.9	3.0	1.6	1.6	7.7	9.2	0.1	1.9	0.8	1.7	21.4	0.5	0.5	6.1	32.6	4.3	5.5	11.6	1.8	1.3	7.1	3.7	12.5	1.8	2.6	7.9	0.4	3.5	7.3	5.8	2.2	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.4	1.5	1.2	2.2	2.0	1.4	1.6	1.6	1.7	1.3	1.8	2.2	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2622.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	971.5	144.2	27.4	90.0	27.5	10.9	733.0	27.1	36.0	629.4	53.4	358.7	52.0	616.7	163.3	162.0	793.2	533.0	547.1	26.2	34.8	337.3	2622.4	785.0	147.6	67.4	34.7	918.3	267.5	55.2	138.2	198.9	34.2	329.3	97.0	34.5	250.5	258.1	151.8	293.5	283.5	226.8	42.3	240.7	344.8	50.6	37.2	36.1	338.2	173.4	64.4	555.9	519.8	35.1	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	27.4	27.5	27.1	36.0	26.2	34.8	67.4	34.7	34.2	42.3	37.2	35.1	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 291.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	Yes		920000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	214.1	101.9	46.2	106.5	50.4	3.7	107.1	51.1	291.0	137.7	66.7	95.2	23.2	160.7	27.6	41.7	119.4	72.1	159.3	46.1	50.5	116.9	52.5	199.3	21.1	59.9	47.3	157.4	40.1	18.1	50.8	251.3	58.3	66.1	36.7	2.0	40.7	53.2	22.2	47.6	51.3	207.3	51.6	53.9	76.9	27.7	54.0	21.6	91.2	33.2	18.2	156.8	85.9	60.1	57.7	192.9	349.5	722.0	528.8	484.2	162.2	514.3	349.6	380.4	483.5	1018.3	294.1	0.4	470.2	1215.2	3.1	337.2	242.2	163.2	182.5	27.5	47.0	42.7	174.0	216.5	1029.5	0.9	7.2	580.9	165.2	365.0	121.3	475.5	530.8	22.1	90.5	16.1	182.5	457.6	1.2	74.8	315.6	215.8	50.7	29.3	200.3	48.8	95.6	107.8	9.1	119.1	326.9	59.7	102.0	539.6	144.4	72.7	284.6	388.6	324.6	270.6	128.3	23.1	25.5	6.1	168.0	0.2	535.6	4.1	1.1	0.1	6.0	1.1	5.2	0.9	3.9	4.0	4.4	0.7	4.0	3.3	0.2	5.9	0.1	3.7	3.5	2.1	46.2	50.4	51.1	291.0	46.1	50.5	59.9	47.3	58.3	51.6	54.0	60.1	142.3	38.5	32.0	4.9	2.9	81.8	473.6	56.5	74.0	5.3	28.3	39.5	36.6	14.3	21.0	25.8	58.4	217.0	3.2	33.0	0.0	64.5	2.9	21.8	273.3	194.9	61.1	11.4	0.4	11.9	342.1	287.6	15.3	33.0	9.5	144.1	124.9	9.9	94.2	6.7	0.2	55.7	22.4	5.7	110.0	6.0	164.4	43.6	44.4	18.7	9.8	14.3	8.2	1.0	0.5	22.5	24.3	120.7	6.5	139.8	12.4	22.8	11.9	1.2	92.1	31.4	295.1	29.3	23.0	14.1	44.5	165.8	68.8	79.8	62.8	73.4
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2, histone lysine methyltransferase"	Q9BYW2	3	47016429-47164113	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	9.9	6.5	8.2	10.7	10.5	23.8	10.3	24.1	8.3	12.6	10.8	9.7	9.1	13.3	6.1	9.8	11.0	8.5	7.2	6.2	6.7	10.8	10.0	9.4	13.5	8.3	8.5	15.3	13.3	16.2	2.2	11.4	8.4	10.2	11.0	10.6	9.6	9.7	11.1	9.0	10.3	11.9	8.1	11.4	10.7	13.1	7.9	19.2	15.5	14.5	13.3	9.8	4.0	12.8	21.1	13.2	25.4	14.5	15.3	18.9	11.3	17.9	17.0	20.8	19.9	15.4	13.8	43.5	11.6	25.5	20.0	12.4	29.5	17.6	27.6	27.5	12.2	47.3	24.8	12.4	11.7	34.1	26.5	15.2	17.3	20.7	24.6	15.3	20.1	22.8	29.9	16.6	17.8	9.5	26.7	8.5	20.6	9.4	15.4	17.5	25.6	23.2	12.4	26.6	10.9	17.6	29.5	11.8	12.0	17.2	12.9	27.5	26.7	24.6	18.1	21.5	29.9	22.0	25.4	43.7	14.2	19.6	14.6	1.3	1.2	2.9	2.0	1.1	1.1	2.2	1.2	1.6	1.4	2.5	1.7	1.6	3.3	3.6	1.1	1.5	0.6	0.6	8.2	10.5	24.1	8.3	6.2	6.7	8.3	8.5	8.4	8.1	7.9	12.8	50.5	48.1	58.8	115.9	58.3	33.3	22.6	15.6	54.1	40.5	31.0	29.1	67.2	27.1	53.2	11.0	41.7	20.3	58.2	32.6	11.7	20.9	26.1	62.8	63.0	41.2	22.1	38.9	131.4	22.4	12.7	39.2	56.6	66.2	58.8	68.9	23.6	29.8	16.8	26.9	129.4	28.2	14.2	28.8	26.5	35.1	30.4	42.7	17.8	148.9	37.9	22.7	43.3	113.1	143.2	23.7	22.3	33.1	54.0	31.2	24.6	11.5	49.7	39.9	13.1	56.1	42.6	71.0	29.3	60.2	35.7	18.5	65.3	57.1	29.5	34.7
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated histone lysine methyltransferase 2"	Q96T68	13	49444374-49495003	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	5.3	8.9	4.2	10.4	4.6	8.2	11.1	5.7	5.2	7.4	6.2	7.5	6.4	9.0	6.1	5.9	6.3	7.7	10.5	4.7	4.1	8.1	8.0	8.1	16.7	3.4	3.9	16.0	7.1	7.8	3.9	6.3	3.6	7.6	9.3	9.5	8.2	6.9	2.5	7.8	7.2	7.5	3.8	13.1	8.0	15.3	4.7	10.1	11.1	5.3	13.9	6.4	4.7	5.5	3.0	2.0	6.0	6.2	8.3	9.3	3.0	8.4	10.5	7.4	6.9	12.5	7.1	37.1	1.6	5.5	5.5	6.0	6.4	5.7	7.2	8.5	5.6	12.9	5.7	7.6	11.7	19.9	7.1	7.3	10.2	5.6	18.5	8.0	6.3	11.8	5.7	5.0	6.8	2.6	7.6	14.8	3.2	7.9	4.8	14.6	7.5	8.0	6.8	2.8	3.1	3.5	3.7	5.2	18.2	5.1	4.4	17.0	3.8	7.0	2.5	9.4	3.4	6.1	8.9	19.4	2.2	15.9	3.3	3.0	2.7	3.3	4.2	3.6	3.6	5.4	4.4	4.4	4.9	5.5	6.1	4.7	0.9	5.1	3.0	3.4	6.5	2.8	4.2	4.6	5.7	5.2	4.7	4.1	3.4	3.9	3.6	3.8	4.7	5.5	7.8	28.9	13.3	18.6	26.9	6.9	5.7	3.9	7.4	14.4	8.0	7.4	23.2	10.0	8.0	5.5	27.1	5.6	17.0	9.7	9.8	4.0	22.1	8.6	14.7	8.8	11.5	8.8	32.9	4.2	3.3	8.5	9.7	6.8	6.3	18.8	6.4	7.6	17.1	13.5	30.4	7.0	6.1	21.5	19.8	16.5	9.9	26.4	14.2	15.9	13.8	11.0	20.6	24.1	21.5	3.6	3.7	8.2	28.9	3.5	6.7	5.5	9.8	28.1	0.0	7.5	7.7	25.5	13.1	9.2	6.0	2.9	17.3	30.7	8.6	2.5
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	111.7	89.1	47.2	73.1	47.9	230.4	100.8	70.8	73.7	106.8	39.7	112.6	62.3	110.5	46.3	98.2	118.7	53.8	93.0	44.2	64.4	97.9	100.4	85.0	95.8	51.5	40.2	142.4	103.3	52.0	97.7	53.4	42.2	105.7	42.5	46.3	87.4	58.4	149.2	96.3	110.5	63.4	27.7	133.6	104.5	110.2	53.3	91.2	99.6	73.3	80.4	98.4	92.3	57.9	141.2	165.4	151.1	131.0	82.4	65.5	178.8	98.9	83.6	130.3	100.3	142.0	154.8	223.6	120.2	111.4	119.4	163.8	172.2	171.0	110.3	167.1	115.0	144.6	107.6	107.0	130.7	155.0	143.7	86.0	87.1	165.2	172.3	77.0	118.9	145.0	216.4	141.5	100.8	145.1	294.2	217.9	206.5	126.2	117.5	253.2	104.7	177.7	87.5	151.8	119.6	157.4	138.1	118.8	138.3	95.6	182.7	163.6	104.6	145.1	131.7	134.5	158.2	163.6	139.4	205.6	129.1	132.2	180.2	3.4	9.7	10.7	12.9	10.8	12.9	9.3	9.6	12.7	9.6	7.3	11.2	11.9	13.7	9.2	9.7	10.9	10.5	9.4	47.2	47.9	70.8	73.7	44.2	64.4	51.5	40.2	42.2	27.7	53.3	57.9	131.9	60.9	88.7	82.3	326.5	184.2	205.1	121.4	350.0	267.2	158.4	127.8	63.5	107.2	87.2	55.2	225.2	118.6	194.5	133.6	37.2	80.4	156.9	156.6	180.5	134.3	209.8	115.7	60.6	73.8	116.8	126.1	138.6	170.1	107.8	212.6	164.2	120.7	98.2	175.0	52.1	115.6	109.9	137.2	167.6	67.1	157.5	122.0	96.0	72.1	146.4	121.9	166.9	62.4	141.0	88.3	106.3	113.2	188.1	192.8	118.5	56.0	83.1	325.8	78.9	145.3	132.0	116.8	84.3	246.9	183.8	148.7	250.2	249.6	129.6	194.3
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236824-2248655	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm		NA	NA		43000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favorable (7.16e-4)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	44.8	22.6	23.0	25.7	24.9	40.8	44.0	32.9	35.2	58.9	14.9	46.8	29.5	65.4	5.4	47.6	52.2	11.4	33.5	21.2	24.7	30.4	29.9	38.2	30.3	26.8	22.8	74.2	38.3	9.1	35.6	17.7	23.4	46.8	6.3	7.0	36.5	19.2	38.8	60.2	42.8	11.5	20.4	49.2	37.3	78.9	23.1	34.2	37.8	11.9	17.9	43.1	49.3	27.5	110.8	50.3	65.2	66.2	17.1	25.8	110.2	40.4	27.9	57.9	56.5	73.5	39.3	121.4	41.3	28.6	38.8	89.0	57.8	49.8	13.2	93.9	94.2	79.8	51.7	63.9	46.9	100.9	94.8	39.3	43.8	49.3	35.6	28.7	56.4	93.5	92.7	111.7	20.9	62.4	127.7	90.4	124.6	41.9	39.6	221.5	40.7	108.9	26.2	33.5	81.4	128.6	60.4	46.0	53.3	24.8	61.9	111.8	57.4	61.7	68.0	133.2	125.4	122.7	123.4	120.8	47.0	75.4	64.7	0.8	1.9	7.2	2.9	2.5	2.2	1.7	2.4	3.0	1.8	1.6	2.1	1.9	1.7	1.3	1.9	2.5	3.0	2.1	23.0	24.9	32.9	35.2	21.2	24.7	26.8	22.8	23.4	20.4	23.1	27.5	31.7	3.2	4.5	5.9	49.0	39.0	28.1	38.3	64.3	6.4	21.4	19.9	2.0	18.6	16.8	11.0	4.2	70.7	32.3	18.0	25.4	24.4	66.7	14.2	18.5	24.0	13.1	49.4	6.1	9.6	79.9	28.8	36.2	17.0	16.5	32.6	35.0	4.0	32.6	8.4	5.6	22.1	24.4	24.9	34.3	91.0	46.0	26.4	32.0	9.4	14.1	6.2	11.3	8.0	9.5	11.8	24.5	32.0	51.7	20.1	38.7	20.2	10.7	12.3	13.1	20.4	27.4	63.6	71.6	41.7	25.3	59.0	51.5	15.8	26.2	24.7
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990075	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA		57000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: AB_2674130"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	24.6	23.4	22.3	29.2	22.6	57.9	31.7	24.1	29.0	25.6	23.2	25.1	20.4	30.5	33.7	23.3	27.5	19.1	18.6	22.0	22.8	26.0	27.4	22.9	39.0	22.6	22.6	32.1	20.3	30.6	16.2	25.4	22.9	24.9	30.0	29.9	23.5	28.8	49.6	29.2	21.4	31.7	22.3	27.4	20.0	27.5	23.4	43.4	26.9	27.4	44.6	28.1	18.8	24.0	84.4	57.0	108.1	90.8	63.3	57.7	129.6	82.2	69.1	131.9	106.4	97.2	84.4	165.8	68.1	73.6	51.6	71.5	136.7	108.6	162.3	74.9	125.7	206.3	92.3	86.7	57.9	261.1	93.5	54.9	75.4	135.5	88.4	58.6	89.9	112.6	176.1	60.0	95.2	53.2	131.4	123.0	268.0	80.4	89.9	156.8	197.0	110.7	59.4	83.5	95.8	69.4	104.2	47.1	83.9	95.1	54.0	90.3	82.0	70.3	79.6	64.9	157.2	57.6	89.5	166.4	65.6	215.6	92.1	37.2	41.3	28.4	56.1	53.3	55.0	54.9	65.3	56.7	53.1	68.9	69.4	58.9	4.6	56.2	61.8	32.5	75.5	61.7	22.3	22.6	24.1	29.0	22.0	22.8	22.6	22.6	22.9	22.3	23.4	24.0	37.3	51.3	35.0	11.4	42.2	47.3	38.6	46.6	55.2	37.0	21.3	27.7	22.7	20.0	42.3	22.0	22.9	59.1	40.7	12.1	39.2	44.4	37.9	23.7	42.4	35.8	15.6	53.6	15.7	38.1	69.2	41.6	15.3	25.3	42.4	43.0	25.0	23.6	51.5	26.9	14.9	23.9	34.6	28.0	39.8	14.0	39.7	34.2	39.2	6.5	82.9	45.6	44.3	11.1	11.5	35.4	13.1	54.2	41.5	28.5	19.0	29.2	27.8	38.6	39.5	47.2	68.3	120.8	55.2	36.5	41.8	33.0	42.9	53.5	31.4	24.0
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197388515-197435079	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		94000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	183.8	173.9	101.7	132.7	112.4	304.8	180.7	120.5	126.1	222.8	136.8	170.9	110.4	195.8	200.0	136.8	183.8	123.2	135.7	98.2	100.8	135.4	168.5	162.8	203.0	105.7	101.9	226.5	200.7	154.9	147.8	165.3	111.0	163.2	147.3	138.4	180.4	133.2	172.4	156.5	231.6	116.5	107.5	287.8	169.2	91.4	104.9	221.9	167.8	144.8	199.3	154.4	167.1	135.8	134.9	105.4	288.6	155.9	222.8	219.2	237.8	172.6	196.7	163.2	205.9	233.0	147.2	247.5	116.6	193.1	165.8	133.7	273.4	151.2	271.8	196.5	154.8	237.5	257.4	294.3	155.4	270.1	198.6	232.1	163.0	175.9	209.3	278.6	205.9	171.0	210.2	174.0	192.3	134.2	251.1	285.6	231.4	167.5	163.8	234.4	197.9	182.9	245.8	286.4	154.2	186.7	174.7	118.2	139.2	345.1	115.2	242.5	186.8	126.9	109.4	123.3	145.8	168.7	238.8	342.0	123.7	174.8	146.5	49.8	50.4	57.5	54.5	51.7	55.4	46.1	46.2	50.9	60.5	44.1	48.7	49.2	60.8	56.7	52.5	37.5	71.3	56.2	101.7	112.4	120.5	126.1	98.2	100.8	105.7	101.9	111.0	107.5	104.9	135.8	175.6	179.5	222.9	92.4	187.4	119.0	172.0	127.1	125.7	103.4	96.4	83.3	129.2	72.9	194.0	92.0	73.0	116.8	224.1	90.1	56.7	104.8	9.2	123.9	191.0	143.1	110.5	109.0	55.5	94.8	102.3	151.6	132.0	179.0	246.9	171.1	107.1	74.4	100.6	94.2	59.7	108.1	89.5	124.7	144.1	20.6	120.2	166.1	76.5	75.9	163.9	111.1	116.4	87.0	121.1	112.0	68.3	104.6	195.6	103.8	84.2	70.5	221.5	98.5	118.3	159.5	227.9	104.6	100.5	94.3	118.8	142.7	216.2	119.4	91.4	156.1
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	116.0	96.0	117.5	80.4	127.1	144.6	109.0	119.4	139.5	123.3	125.1	97.4	70.7	111.6	95.5	96.6	112.3	55.2	94.7	117.9	120.4	107.1	112.0	104.3	99.0	124.2	118.9	136.1	137.4	88.9	137.2	80.6	121.3	99.2	77.0	96.5	91.3	73.8	108.1	116.9	98.5	80.0	121.4	113.9	102.9	145.2	124.0	109.4	115.2	54.6	114.0	108.3	104.7	136.9	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	117.5	127.1	119.4	139.5	117.9	120.4	124.2	118.9	121.3	121.4	124.0	136.9	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149927803	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"		NA	NA		36000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: AB_2685314"	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	35.6	36.8	27.9	42.3	28.4	74.3	31.6	30.1	35.8	36.0	29.3	55.8	39.6	48.5	37.5	45.1	51.8	33.8	28.9	28.6	30.4	29.9	27.1	36.8	48.5	31.1	28.3	47.5	34.6	53.4	26.0	40.1	28.7	32.3	44.2	20.8	40.1	47.9	22.5	62.4	40.1	46.7	28.0	39.4	32.4	46.4	29.1	58.0	39.1	26.9	57.6	50.3	33.4	29.8	153.0	144.1	119.4	110.9	75.5	58.4	172.0	119.0	118.2	188.0	143.0	152.0	125.6	144.2	87.1	139.7	103.0	154.3	150.9	158.2	161.8	95.3	110.7	130.0	77.3	112.8	121.7	156.6	163.5	74.7	122.6	184.0	84.5	59.0	94.6	126.7	116.6	119.6	172.9	456.6	203.9	148.9	199.4	175.9	146.1	157.9	106.4	157.6	137.4	128.2	79.6	147.6	109.8	151.1	92.5	141.4	229.9	205.1	78.3	154.9	170.0	122.9	222.8	169.0	259.4	161.2	124.2	133.8	147.5	70.5	81.1	130.5	84.0	109.8	87.4	80.2	79.6	90.4	71.3	73.1	74.3	71.9	111.2	104.7	120.0	84.6	100.1	67.5	27.9	28.4	30.1	35.8	28.6	30.4	31.1	28.3	28.7	28.0	29.1	29.8	30.4	16.0	13.4	4.2	39.9	54.2	47.5	83.2	65.4	20.0	34.3	41.4	3.9	21.5	41.2	23.9	4.2	80.8	54.2	42.2	60.7	64.3	80.3	38.9	30.4	30.6	26.0	34.3	4.1	51.6	77.5	31.8	27.0	44.5	39.3	32.9	16.8	14.7	53.0	8.4	4.8	40.0	59.0	24.7	42.5	13.3	45.1	34.9	24.9	3.7	61.8	27.5	44.3	4.5	7.0	62.3	35.9	29.3	38.6	32.2	28.5	43.0	49.8	15.9	46.0	30.8	64.6	64.0	51.5	47.0	51.3	94.7	44.9	27.9	36.7	43.8
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067586-24076373	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm		NA	NA		11000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	79.0	86.5	82.4	65.1	84.1	211.2	137.9	86.4	125.3	99.1	82.5	106.2	91.1	84.7	141.9	123.5	89.2	78.2	89.3	82.7	85.7	111.5	132.6	67.3	102.8	85.9	84.2	93.7	63.7	103.0	62.9	88.3	86.3	81.2	108.7	64.4	71.6	84.2	74.7	76.4	84.7	89.0	88.6	65.1	70.4	66.6	82.0	138.6	104.9	106.2	123.3	117.2	85.2	92.4	307.2	152.4	231.6	207.9	182.7	292.8	139.3	233.6	253.8	279.1	284.2	329.9	197.0	236.6	117.3	213.1	265.4	187.7	245.2	293.7	345.5	218.0	263.4	256.6	197.2	299.4	324.4	314.3	151.3	268.5	342.5	281.3	319.3	286.4	288.8	199.4	290.2	181.3	294.2	250.3	234.1	486.1	194.7	362.8	264.0	170.6	327.7	239.1	334.6	189.0	214.4	320.7	123.6	268.3	570.9	195.4	122.7	309.4	173.9	159.6	213.6	157.3	384.4	171.2	239.1	655.3	215.4	515.8	224.5	225.0	118.9	185.7	96.0	133.5	108.1	153.9	122.9	117.8	138.9	114.7	118.0	130.0	173.5	133.7	124.3	129.6	179.6	143.8	82.4	84.1	86.4	125.3	82.7	85.7	85.9	84.2	86.3	88.6	82.0	92.4	207.4	70.5	91.5	11.8	125.1	0.0	280.4	0.0	208.3	50.7	194.3	320.5	120.8	133.0	55.1	138.0	16.7	296.5	149.2	217.1	389.4	206.1	195.9	226.4	208.1	149.0	180.3	164.7	9.2	167.4	413.2	153.0	85.6	210.7	100.1	185.1	142.1	167.1	232.7	18.5	10.2	253.5	0.0	129.3	0.0	49.4	210.3	132.6	0.0	10.3	227.4	175.4	149.3	11.6	19.4	205.4	314.5	180.5	134.0	327.5	381.2	423.1	78.0	68.4	118.3	155.0	158.9	272.4	173.7	257.8	0.0	271.7	126.6	344.4	242.7	438.1
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2461.5;skin 1: 1219.1;vagina: 692.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	3.1	0.8	1.9	11.6	1.8	2.0	29.1	1.8	9.5	350.2	0.4	95.4	48.8	8.0	0.7	2461.5	2.2	21.4	1.3	1.9	1.6	16.0	3.7	56.1	0.2	9.0	4.4	0.9	2.2	0.1	2.7	1.6	4.3	77.2	32.5	0.6	332.8	3.2	5.0	1219.1	40.8	3.3	1.2	0.9	66.6	0.7	5.2	22.1	2.0	0.1	147.9	167.6	692.0	2.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	1.8	1.8	9.5	1.9	1.6	9.0	4.4	4.3	1.2	5.2	2.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193145	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	62.9	46.7	25.1	62.1	26.0	215.1	53.2	38.5	32.3	54.0	23.4	46.9	44.6	60.2	51.0	59.8	54.6	39.9	43.8	24.8	30.7	48.8	50.6	40.8	76.4	30.2	27.2	74.4	52.8	44.9	34.4	51.8	25.2	49.8	54.4	47.4	52.8	35.6	63.9	60.0	47.6	52.9	23.0	54.1	48.0	45.8	24.9	85.5	44.8	27.4	94.5	58.1	52.5	44.6	180.5	147.3	251.1	142.9	60.5	90.0	234.7	96.1	97.1	160.4	116.3	161.5	126.4	325.6	130.1	111.8	100.6	160.4	276.1	188.3	217.0	175.2	183.0	245.5	156.2	193.6	81.5	258.2	140.1	72.4	71.7	139.4	67.3	70.9	142.3	169.1	282.6	150.9	158.3	156.8	304.2	220.1	299.7	107.8	140.7	304.5	170.4	213.6	156.2	214.4	180.1	200.3	138.6	106.3	147.1	174.4	125.0	181.7	152.3	127.7	188.3	84.7	208.9	171.2	156.5	327.6	91.1	168.6	185.9	2.6	4.1	3.0	4.7	5.8	5.4	4.1	4.6	3.8	3.8	4.5	4.3	4.8	2.1	3.4	4.7	7.3	5.6	2.3	25.1	26.0	38.5	32.3	24.8	30.7	30.2	27.2	25.2	23.0	24.9	44.6	286.7	169.9	237.7	149.8	317.4	357.5	239.3	80.6	234.5	230.0	231.6	191.0	149.6	82.9	146.2	110.3	191.8	206.5	339.0	149.7	82.2	120.1	126.8	230.1	318.9	222.2	219.6	198.9	127.3	138.4	222.9	255.8	267.6	333.1	155.8	450.5	123.5	109.1	141.4	171.6	143.4	189.5	59.0	129.4	216.9	361.9	142.9	258.5	140.5	104.9	146.2	152.6	127.7	248.8	183.1	162.0	126.7	116.6	291.8	159.9	94.8	87.6	114.8	223.6	52.6	530.6	259.2	199.1	171.9	287.9	327.3	305.5	313.7	223.7	220.0	167.7
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	26.9	18.3	18.5	10.1	20.8	28.1	26.3	18.5	24.8	27.1	13.7	25.9	10.1	24.6	4.0	23.2	24.5	4.8	20.2	18.2	19.0	24.9	19.4	20.3	11.3	20.4	19.3	29.0	21.9	7.4	21.7	8.1	19.8	21.8	4.3	9.3	20.2	6.8	29.5	32.6	24.6	5.6	16.9	28.4	20.8	16.3	21.2	12.6	24.5	6.7	7.6	22.3	24.3	25.1	26.1	23.0	16.0	17.0	12.6	10.3	35.8	19.7	13.6	22.9	15.6	22.6	12.3	31.9	18.0	14.8	11.9	23.9	22.7	18.1	13.2	9.9	36.0	29.0	12.9	27.0	13.4	37.8	27.4	11.7	20.4	20.8	24.9	18.2	14.3	24.3	40.9	12.3	10.4	32.7	31.9	57.1	41.9	14.0	38.0	36.7	16.2	25.2	13.3	18.8	25.1	28.3	18.7	15.6	25.1	12.5	22.5	29.1	18.6	19.0	24.8	14.8	22.3	35.0	41.2	31.7	18.7	25.5	25.9	2.0	4.1	1.9	3.0	2.7	3.0	2.1	2.8	2.6	2.9	3.7	3.0	3.4	5.6	5.4	3.4	7.2	2.4	1.8	18.5	20.8	18.5	24.8	18.2	19.0	20.4	19.3	19.8	16.9	21.2	25.1	46.4	73.7	44.5	48.6	37.9	38.9	41.5	19.0	42.1	49.7	25.4	25.9	19.3	21.5	38.6	14.7	66.7	30.4	52.6	22.1	0.0	23.1	21.4	27.0	48.8	39.3	21.6	38.7	55.1	26.6	31.8	39.2	37.8	39.7	38.0	47.1	21.4	16.7	22.1	42.1	43.2	24.9	14.2	27.4	21.4	12.9	30.1	30.3	23.2	36.5	35.4	33.7	50.4	58.3	85.1	28.6	24.1	29.7	43.6	44.7	20.8	11.8	30.7	62.4	46.0	52.1	38.1	39.5	42.8	39.7	46.9	43.6	45.9	48.4	22.9	48.2
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"lung: 3566.0"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 15343.4"	"Cancer enriched"	"Detected in many"	5	"lung cancer: 1306.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.5;U-2197: 6.7;U-266/70: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		80000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.8	4.4	1.5	2.2	1.4	0.4	0.5	1.7	3.0	0.5	1.1	0.5	0.3	0.2	0.7	0.4	0.3	0.2	1.4	1.3	2.1	2.1	1.2	3566.0	0.3	1.4	1.1	11.0	0.9	0.2	5.4	1.5	1.5	1.2	0.4	2.9	0.5	2.0	1.2	0.8	0.7	0.1	0.8	4.1	5.1	0.4	1.4	0.3	113.1	0.3	0.2	0.2	0.4	1.5	0.1	0.2	0.2	0.5	0.3	0.5	2.8	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.1	0.1	1.4	0.0	0.3	0.2	0.1	0.5	0.0	0.4	0.3	0.4	0.1	0.3	1.1	3.5	1.6	0.5	0.4	1.3	0.2	0.3	0.2	0.3	0.4	0.3	0.0	0.4	0.2	0.3	0.3	0.3	0.0	0.2	0.6	6.7	0.1	2.4	0.6	0.2	0.6	0.5	0.1	0.3	0.6	0.2	0.2	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	0.2	0.7	0.2	0.4	0.4	1.5	1.4	1.7	3.0	1.3	2.1	1.4	1.1	1.5	0.8	1.4	1.5	0.0	3650.6	15343.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1930.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	14.4	0.0	0.0	0.2	0.2	0.0	26.9	0.0	0.0	262.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	0.3	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	185.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	36.5	0.0	0.0	0.2
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180979-23325162	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 118.8;skeletal muscle: 158.0;tongue: 144.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 134.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 66.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA007476	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	14.3	0.6	0.0	0.1	0.1	0.0	2.2	0.0	1.9	0.4	0.0	1.1	0.1	0.1	8.0	3.3	1.1	0.8	118.8	0.1	0.0	0.3	0.0	4.8	0.0	0.3	0.0	0.2	0.1	2.1	0.3	0.0	0.2	3.2	0.6	0.3	4.3	0.4	158.0	3.4	0.6	0.1	0.0	0.1	0.9	1.5	0.2	0.1	0.1	144.1	0.1	3.0	1.4	0.4	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	66.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	0.2	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.3	0.0	0.2	0.0	0.2	0.4	0.2	0.0	0.0	0.3	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	1.3	0.0	0.0	12.5	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	3.4	3.0	7.5	0.2	5.4	1.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.2	3.8	13.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SGMS1	"MGC17342, MOB, SMS1, TMEM23"	ENSG00000198964	"Sphingomyelin synthase 1"	Q86VZ5	10	50305586-50625163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045191	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA045191: AB_10959605"	"unprognostic (1.13e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.34e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.95e-7)"	"unprognostic (8.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.05e-1)"	15.8	19.3	19.8	10.7	27.4	24.0	14.5	21.5	20.3	16.9	33.9	10.1	13.5	11.9	19.9	15.3	16.6	15.4	13.2	17.2	23.0	20.2	27.9	21.9	14.9	29.5	24.1	18.6	13.3	52.9	6.4	24.6	28.5	19.5	11.7	20.2	18.0	16.8	9.9	25.3	16.0	15.8	23.6	11.7	14.3	11.3	23.4	12.0	24.7	10.5	14.5	20.9	13.1	41.3	30.2	14.0	4.0	9.0	14.2	18.6	18.8	19.6	19.7	13.5	12.6	11.7	30.3	22.1	11.3	25.9	12.2	18.7	9.5	20.6	14.0	19.4	10.2	32.7	17.9	9.0	16.5	7.5	7.6	12.1	23.6	18.0	21.7	8.7	19.3	7.9	62.6	32.2	14.6	12.7	3.3	4.2	9.2	13.7	13.7	5.5	18.4	8.8	19.7	31.2	6.2	4.9	14.4	14.2	7.5	11.3	21.4	2.7	27.1	14.6	17.8	14.1	14.6	11.0	9.5	6.3	18.2	12.0	12.1	3.4	9.3	28.4	4.6	4.9	10.3	7.0	6.2	6.8	5.2	6.5	8.2	5.4	16.7	10.1	4.0	3.2	15.6	6.3	19.8	27.4	21.5	20.3	17.2	23.0	29.5	24.1	28.5	23.6	23.4	41.3	17.1	44.8	40.0	106.7	19.9	54.4	28.9	15.6	23.9	20.1	15.8	8.9	26.3	10.0	30.0	29.5	4.2	10.9	15.6	6.2	15.6	17.6	17.0	20.9	10.5	19.6	14.9	32.0	153.1	21.6	7.7	19.8	30.5	32.4	20.8	12.1	17.9	16.0	29.0	5.0	117.2	11.1	4.1	46.5	17.6	30.6	16.1	34.5	12.4	229.5	12.4	17.4	10.3	313.1	422.0	10.7	6.4	10.5	13.7	32.3	18.4	9.3	25.1	36.4	0.0	20.5	27.1	12.8	2.3	18.7	83.4	4.9	20.0	11.8	12.4	25.4
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200584096	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	3.3	0.9	0.6	4.4	0.9	6.8	1.9	0.8	0.9	0.9	0.3	3.1	2.5	1.8	0.7	2.4	1.4	1.2	1.0	0.5	0.9	0.9	0.8	1.5	7.9	0.9	0.9	1.9	0.5	1.1	0.3	2.6	0.9	1.4	3.2	0.9	0.7	0.7	0.4	2.3	2.6	2.0	0.7	2.0	1.8	32.6	0.9	14.9	1.2	0.6	8.1	1.5	0.9	1.2	34.6	16.2	37.0	17.4	5.2	7.9	23.7	38.7	16.6	32.0	33.1	24.3	23.5	22.5	18.6	18.1	34.4	25.3	33.6	20.1	54.5	48.0	16.9	43.5	21.6	17.5	1.6	43.9	33.1	3.4	2.5	32.9	17.3	8.0	29.4	31.3	33.1	31.6	61.4	15.4	35.9	17.9	26.7	24.9	41.2	28.8	49.1	21.3	13.3	13.6	22.2	15.4	28.6	13.3	16.3	29.2	14.1	25.2	18.1	33.9	34.0	31.6	34.0	14.3	33.5	49.8	21.4	28.9	49.4	16.7	1.4	4.5	2.2	1.4	1.4	2.7	2.4	2.2	0.8	3.2	1.8	2.2	1.0	2.0	1.7	1.7	3.6	1.2	0.6	0.9	0.8	0.9	0.5	0.9	0.9	0.9	0.9	0.7	0.9	1.2	9.4	3.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.8	7.1	0.0	0.0	6.2	0.0	0.0	11.6	7.8	0.0	3.9	3.9	0.0	12.1	5.3	3.3	0.0	0.0	0.0	2.7	31.0	6.7	0.0	3.6	11.4	23.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.7	0.0	0.0	2.5	8.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.4	3.8	4.0	0.0	0.0
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"lymphoid tissue: 262.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	54	"gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3"	"Group enriched"	"Detected in many"	70	"NK-cells: 162.2;T-cells: 175.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072265			Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA072265: "	"prognostic favorable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	1.4	1.1	0.0	10.8	0.1	5.4	1.2	0.1	0.2	0.9	0.1	1.6	1.5	0.6	0.6	1.1	0.5	4.1	0.3	0.1	0.1	0.4	2.8	3.2	38.4	0.2	0.1	0.4	0.2	0.2	0.2	0.3	0.1	1.1	1.5	0.0	1.3	0.3	0.3	0.4	2.5	0.6	0.2	14.7	2.7	0.2	0.1	262.5	0.7	1.2	16.6	5.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	193.0	0.0	201.3	0.0	0.0	257.2	4.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	32.7	33.3	0.0	0.2	0.0	0.0	1.4	0.6	0.1	120.2	0.5	162.9	1.1	90.4	175.8	0.5	0.2	91.2	108.3	2.4	162.2	1.2	0.8	125.3	91.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	1.1	3.2	4.7	0.0	3.0	1.5	0.1	0.0	0.0	0.0	0.7	0.8	0.2	1.5	0.0	0.0	0.0	0.1	77.6	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	7.4	0.1	0.0	0.0	2.0	1.1	0.2	3.8	0.0	3.6	0.9	0.1	0.0	0.0	0.0	0.0	5.6	4.4	0.0	0.0	4.3	5.4	0.0	2.3	0.0	138.0	0.5	0.2	0.0	0.0	0.0	14.1	0.2	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	1.0	0.1	108.9	0.0	0.0	0.0
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81202102-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles		NA	NA		13000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA051248: AB_2681405"	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	112.1	120.0	92.4	101.1	92.4	176.7	170.8	98.1	126.3	146.2	94.3	180.8	87.6	208.5	148.8	130.4	112.3	149.1	61.1	88.0	108.2	126.0	62.6	133.0	154.9	104.8	95.6	130.7	81.3	112.3	83.5	86.4	105.2	153.1	108.5	24.9	112.5	284.9	16.5	67.1	98.1	231.7	104.4	144.4	87.0	54.3	96.1	145.1	104.7	50.2	126.8	178.3	76.0	116.3	1.0	38.2	133.4	154.1	172.1	232.0	9.2	83.4	158.3	30.1	61.1	12.5	114.6	113.7	70.1	122.9	42.4	20.7	95.9	60.0	48.0	98.7	33.3	151.2	59.7	7.4	41.6	107.3	286.0	135.6	42.9	42.4	37.6	231.4	133.8	75.9	53.0	279.6	165.9	53.9	117.0	138.7	105.2	1.4	62.3	102.0	60.9	60.8	155.7	52.8	0.4	58.5	0.1	4.2	77.9	88.0	44.8	321.2	136.9	82.7	34.1	76.4	35.0	64.3	60.6	105.6	95.1	215.9	62.9	793.9	358.5	570.7	124.9	477.3	134.8	236.3	154.7	147.8	306.2	207.4	140.8	148.8	126.7	183.0	560.5	148.0	257.5	462.3	92.4	92.4	98.1	126.3	88.0	108.2	104.8	95.6	105.2	104.4	96.1	116.3	191.3	112.2	92.6	73.8	216.1	126.3	131.5	150.4	83.1	16.2	174.6	150.2	19.7	72.9	106.4	121.4	0.0	7.1	183.9	33.2	344.4	86.9	6.3	74.9	120.0	130.7	93.3	172.9	62.8	74.7	6.0	152.4	63.2	62.6	219.7	92.8	139.9	17.8	431.4	5.0	82.4	87.0	109.9	400.9	430.7	19.2	174.3	379.0	147.7	102.1	459.0	154.2	224.6	82.9	54.3	48.0	104.2	314.1	114.4	83.5	91.2	214.3	113.6	8.5	263.0	132.4	308.8	4.5	5.9	76.0	119.5	5.7	163.4	205.9	90.3	146.4
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26280086-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		41000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	221.9	102.0	289.8	423.0	302.9	530.2	141.8	306.0	380.2	135.5	269.7	416.3	161.9	85.8	708.2	368.2	101.4	177.5	120.8	299.4	321.7	115.9	121.6	289.5	404.4	316.2	340.4	66.7	157.4	85.5	83.2	155.4	320.6	82.5	437.9	32.2	139.6	112.3	47.6	305.9	164.7	202.6	297.0	313.1	223.2	26.2	351.0	306.7	82.9	81.0	437.0	424.5	176.3	325.7	501.1	274.9	187.5	265.7	769.3	2090.9	23.2	895.6	1315.0	959.2	611.0	220.3	460.4	120.8	297.9	1963.3	268.2	182.6	108.9	1030.2	642.6	192.0	109.3	976.3	212.1	213.3	604.8	280.1	1447.9	836.8	652.4	912.9	742.0	1115.0	1200.3	244.7	112.2	430.6	1767.3	337.8	182.1	478.2	221.6	434.8	2003.4	341.1	229.0	170.5	762.6	216.7	119.7	189.8	331.2	338.1	374.1	199.3	65.7	431.9	1451.5	1071.0	370.8	1492.9	402.3	135.7	241.6	104.0	2253.9	792.3	532.5	4277.3	7085.6	6427.9	4340.1	6247.2	3228.5	2422.2	3706.5	4249.4	5891.3	2181.2	1591.2	3072.9	7753.8	2344.8	6190.5	3152.1	5092.0	13045.6	289.8	302.9	306.0	380.2	299.4	321.7	316.2	340.4	320.6	297.0	351.0	325.7	445.2	96.1	168.0	9.8	603.5	984.1	995.1	708.3	373.9	17.1	216.7	227.1	7.8	193.0	290.5	367.8	4.2	133.1	1060.9	1614.6	313.1	1108.5	15.8	178.9	410.9	502.9	339.8	220.0	12.9	1031.5	436.1	493.8	388.4	344.0	1017.6	67.2	346.6	121.7	2516.1	16.8	8.2	1430.3	205.4	1796.4	2368.4	52.8	139.1	2209.6	779.1	16.9	1116.8	76.9	1251.3	4.0	20.2	2492.4	1309.6	162.1	397.9	1754.9	391.7	498.6	202.8	16.4	151.2	71.9	336.4	9.1	23.5	788.1	1058.7	227.1	1380.4	99.2	507.5	2342.3
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793071-2841098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036789, HPA036790"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA036789: , HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	15.3	6.8	17.2	30.0	20.6	48.2	7.9	20.1	16.6	7.0	6.8	12.3	11.4	6.8	9.8	7.1	8.9	8.7	6.7	14.4	22.3	13.1	12.1	17.0	23.2	34.0	30.5	5.8	9.6	4.8	5.0	12.8	25.2	5.3	9.1	5.2	10.4	8.3	16.9	39.7	16.0	10.5	21.5	43.9	16.7	5.2	36.1	8.4	4.7	4.8	13.3	12.3	9.7	14.8	11.2	5.2	7.4	8.7	4.6	14.6	7.2	16.8	13.0	11.1	10.9	6.9	31.6	18.0	20.5	14.2	9.7	5.6	0.3	10.5	7.5	12.2	6.8	41.4	15.2	6.1	17.1	15.4	29.1	27.7	10.5	7.1	5.9	11.8	25.7	13.7	2.5	37.2	15.0	9.6	2.7	24.3	13.3	21.6	13.3	0.6	7.4	9.9	20.1	16.1	25.4	16.4	12.8	10.7	10.3	6.8	15.7	30.8	35.4	12.1	8.9	4.2	13.8	19.5	10.6	4.3	14.1	40.2	14.4	4.1	21.0	13.6	13.8	36.5	8.2	3.0	3.8	8.8	15.9	6.9	1.9	5.0	33.8	8.3	44.6	6.7	6.9	12.1	17.2	20.6	20.1	16.6	14.4	22.3	34.0	30.5	25.2	21.5	36.1	14.8	27.6	3.2	5.8	40.5	19.5	38.1	10.0	35.3	8.6	0.8	19.8	10.0	8.3	7.2	25.3	40.5	0.0	1.3	43.7	42.5	3.9	6.3	8.5	9.7	11.0	31.3	10.2	14.9	0.4	22.0	1.2	11.3	18.3	22.0	9.5	11.6	33.9	59.0	49.3	0.0	2.7	14.2	30.5	81.5	63.3	10.8	13.7	71.9	19.6	18.7	48.9	23.7	57.7	2.5	0.5	25.3	27.1	10.1	18.1	16.1	23.7	43.7	12.3	6.4	39.5	5.2	16.0	1.9	3.7	18.6	83.4	4.2	22.0	25.5	15.4	20.1
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50659255-50719802	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 71.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.7;Excitatory neurons: 29.6;Horizontal cells: 8.4;Inhibitory neurons: 32.9;Oligodendrocyte precursor cells: 7.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 28.8;cerebral cortex: 71.1;hippocampal formation: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 5.2;THP-1: 2.4;U-138 MG: 2.7;U-2 OS: 7.3;U-87 MG: 2.9;U-937: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: AB_2674169"	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.0	1.2	20.6	0.0	28.8	0.3	0.1	1.5	71.1	0.5	0.0	0.1	0.0	0.4	0.1	0.0	2.4	0.2	0.1	36.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	1.1	0.1	0.0	0.1	0.0	5.3	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.5	7.5	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.1	0.1	0.5	0.8	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	2.4	1.6	2.7	7.3	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.8	1.5	71.1	36.8	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	29.6	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.4	32.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.1	0.0	7.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467854-71252577	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"amygdala: 7.7;basal ganglia: 7.5;cerebral cortex: 9.3;hippocampal formation: 9.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Nuclear speckles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	1.3	1.2	7.7	0.5	7.5	0.0	4.5	0.2	9.3	1.3	31.7	2.4	1.5	1.0	2.2	3.4	5.1	0.8	0.0	9.5	0.0	4.9	3.8	3.7	0.1	0.0	0.0	0.1	7.5	0.1	2.2	1.9	0.0	3.2	2.0	5.5	9.8	1.8	0.0	0.9	1.3	0.4	0.0	1.1	3.0	0.9	1.0	0.0	6.0	0.0	0.4	1.1	0.3	0.9	0.5	7.4	4.1	0.0	0.6	0.4	4.5	0.7	0.3	0.0	0.0	6.6	3.1	6.2	2.2	0.0	0.1	1.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	1.9	0.1	1.8	0.0	0.0	1.6	0.0	0.1	0.0	17.5	1.7	10.5	0.0	0.1	3.5	10.2	0.3	0.0	9.9	8.2	5.2	15.9	3.5	1.1	0.0	8.4	0.0	5.2	16.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	7.5	0.2	9.3	9.5	0.0	0.0	0.0	0.0	0.0	1.0	0.9	8.0	41.7	17.0	21.5	0.2	0.0	3.2	3.2	0.6	17.9	26.9	13.0	3.7	11.5	5.4	7.3	0.0	12.8	0.4	3.2	3.9	8.4	1.7	30.0	3.2	1.3	0.0	0.0	153.5	2.2	2.9	1.8	10.2	13.0	2.5	1.2	0.4	21.9	1.2	136.3	167.5	7.9	8.2	0.0	0.3	2.1	0.0	0.4	5.4	14.0	0.0	4.6	0.0	41.7	5.3	10.7	2.7	0.7	0.4	10.9	0.6	10.8	23.3	1.0	0.0	0.3	1.3	0.7	0.9	1.3	0.6	14.6	0.3	0.1	5.5	4.0
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633382	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 63.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 51.6;Late spermatids: 124.5;Proximal enterocytes: 31.1"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.4;Hep G2: 3.0;HSkMC: 4.3"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA		9100000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.7	1.3	1.8	0.0	1.8	0.1	0.4	1.7	2.0	0.7	1.9	0.3	5.3	0.5	0.9	0.2	0.6	0.3	0.6	1.9	1.8	3.5	63.4	0.3	0.1	1.8	1.8	0.7	0.4	0.5	0.7	0.3	1.9	0.5	0.2	0.9	0.2	0.4	0.8	0.1	7.1	0.2	1.7	0.4	0.3	12.4	1.7	0.2	0.8	0.7	0.1	0.3	0.2	1.8	0.1	2.4	2.4	0.3	4.4	2.0	0.1	0.6	0.9	0.9	0.5	0.9	0.3	0.0	0.5	0.8	1.2	0.3	0.1	0.1	0.5	0.1	0.3	0.0	0.6	3.0	1.4	0.0	0.1	4.3	0.3	1.6	0.8	0.8	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.3	1.8	0.0	0.2	0.8	0.4	0.0	0.8	0.4	0.0	0.0	0.2	0.3	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.7	2.0	1.9	1.8	1.8	1.8	1.9	1.7	1.7	1.8	0.2	0.0	0.0	0.7	0.5	0.0	0.3	0.1	0.0	0.4	0.5	0.6	0.5	0.0	0.2	0.0	0.0	0.4	0.0	0.2	5.9	0.5	51.6	0.4	0.6	0.1	0.0	0.0	1.0	0.2	0.1	0.4	0.0	0.2	0.0	0.6	1.1	13.8	0.3	0.0	0.9	1.3	2.0	0.8	0.0	124.5	0.9	0.5	0.0	0.0	0.0	2.4	0.0	0.5	0.6	0.1	1.3	0.7	0.0	0.3	31.1	12.8	0.4	1.3	6.6	0.2	0.3	7.2	0.8	0.0	0.0	0.3	0.1	1.1	0.5	0.3
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178818	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.1"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 155.2;Inhibitory neurons: 179.2;Oligodendrocyte precursor cells: 333.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.1"	"Group enriched"	"Detected in many"	9	"amygdala: 16.8;basal ganglia: 24.9;cerebral cortex: 28.1;hippocampal formation: 23.6;white matter: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;hTERT-RPE1: 22.6;RT4: 7.9;SH-SY5Y: 7.6;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.0	9.0	16.8	0.2	24.9	0.0	1.7	0.0	28.1	5.8	0.0	1.4	0.4	1.7	0.9	1.0	1.7	1.8	1.1	23.6	0.0	1.4	0.2	4.6	0.2	0.0	0.0	0.2	4.0	2.7	1.1	0.2	0.0	1.0	0.7	2.3	5.0	0.6	0.3	1.8	0.7	1.0	0.0	0.1	0.8	0.3	2.3	0.0	0.6	0.6	0.2	1.4	2.9	11.4	1.4	0.4	20.7	0.0	4.5	1.4	0.0	1.5	4.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.5	0.2	0.0	3.1	0.0	2.1	0.0	22.6	5.5	0.1	0.0	0.0	0.0	0.2	0.0	1.3	2.7	0.3	0.3	0.3	0.0	4.5	4.5	7.9	2.8	7.6	0.5	0.0	0.0	0.2	0.0	0.4	3.2	0.8	0.1	1.3	0.1	0.0	0.0	0.0	11.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	24.9	0.0	28.1	23.6	0.0	0.0	0.0	0.0	0.0	2.3	11.4	0.3	0.0	21.0	17.6	0.0	0.1	0.3	0.1	1.2	7.6	1.1	1.0	1.1	0.0	0.7	0.0	0.0	0.1	0.2	0.0	1.9	0.1	1.1	0.4	1.8	0.5	0.0	0.0	155.2	0.9	0.1	4.4	0.0	0.2	0.0	0.3	0.0	0.0	0.2	3.3	179.2	0.0	0.0	0.0	1.1	1.6	1.5	0.3	1.8	15.0	0.0	7.2	0.0	333.8	9.6	0.1	0.0	3.8	0.0	0.0	0.1	0.6	0.9	0.6	0.0	0.9	0.9	0.3	0.6	0.7	0.6	0.4	0.3	0.8	0.0	0.8
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229573-57234935	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 2292.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		390000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	25.4	25.4	18.5	43.3	18.6	41.4	23.8	20.7	22.2	22.5	18.4	32.4	35.5	19.4	18.9	46.5	23.3	20.2	24.2	21.1	20.3	32.4	182.3	23.6	52.2	20.6	20.6	25.8	62.2	15.6	15.8	33.6	21.2	13.8	27.2	13.9	30.7	11.7	36.6	36.4	27.0	27.3	20.1	34.9	32.2	5.1	21.8	36.0	34.7	30.5	58.6	26.4	23.6	23.0	246.9	137.6	123.5	368.0	101.8	152.4	238.1	140.8	237.9	197.0	176.5	200.1	120.4	499.8	217.3	186.5	80.6	167.3	229.4	250.6	108.9	265.0	201.9	199.7	79.6	180.1	680.9	333.1	181.0	191.2	351.9	163.4	538.4	176.0	175.3	283.8	223.0	472.3	141.0	210.6	271.0	217.9	123.1	111.8	223.4	181.2	2292.7	433.6	95.9	151.1	265.4	119.9	73.0	170.1	518.3	48.5	222.9	424.2	108.8	84.6	150.5	96.1	185.0	574.1	338.4	421.4	169.6	320.2	154.0	34.9	41.2	23.3	26.6	50.6	31.5	127.5	46.3	29.4	59.6	137.9	21.1	22.0	2.0	40.1	34.1	20.4	202.8	53.8	18.5	18.6	20.7	22.2	21.1	20.3	20.6	20.6	21.2	20.1	21.8	23.0	9.1	9.6	14.1	4.2	58.2	34.7	23.0	43.5	39.9	7.0	26.5	24.0	12.1	21.5	23.5	3.7	0.0	55.4	11.6	9.6	13.7	45.7	0.4	6.3	22.6	17.1	9.6	53.8	3.7	47.7	52.7	25.5	23.4	10.9	29.2	18.7	22.1	182.8	50.2	8.4	3.2	24.2	34.6	36.0	25.1	0.9	18.0	23.5	39.2	3.7	32.0	45.3	21.6	4.0	2.4	40.1	18.7	16.1	74.4	18.2	15.9	63.6	13.3	6.2	6.6	23.9	40.2	1.9	6.6	52.9	32.5	37.4	21.1	39.5	37.4	23.8
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2 leucine rich repeat scaffold protein"	Q9UQ13	10	110919593-111013666	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	25.0	16.3	16.4	22.5	17.8	45.7	19.3	19.3	22.1	20.3	12.0	20.4	16.4	20.7	21.0	21.6	16.4	20.1	19.5	19.4	22.3	21.9	23.7	17.9	29.9	16.6	21.7	19.8	20.4	30.3	14.6	20.8	22.0	18.0	21.5	19.7	14.2	17.5	21.3	15.4	18.4	23.3	16.4	22.2	17.3	36.4	18.2	26.9	25.2	26.8	31.2	25.0	14.8	15.5	29.2	17.8	22.7	38.2	50.9	51.2	14.5	35.0	51.9	31.9	38.5	16.5	25.8	63.1	17.1	62.8	19.9	24.1	27.8	25.0	46.2	34.7	16.5	28.8	25.7	16.2	37.0	49.6	49.4	57.3	38.6	36.9	69.1	43.6	32.8	22.1	18.3	43.8	45.7	15.6	24.7	38.9	14.1	15.6	18.6	34.8	45.2	18.1	33.3	19.4	11.7	23.4	30.7	15.0	34.9	25.8	77.2	41.5	33.3	25.6	22.6	32.5	24.3	40.2	44.0	100.1	30.6	50.3	18.6	52.3	22.8	33.5	12.6	26.8	15.5	30.3	14.8	15.0	22.3	24.4	15.6	15.2	65.8	19.5	27.8	15.2	19.2	23.9	16.4	17.8	19.3	22.1	19.4	22.3	16.6	21.7	22.0	16.4	18.2	15.5	73.8	54.5	48.1	35.6	95.4	55.8	35.2	37.5	27.9	27.6	51.4	39.1	83.6	45.8	42.3	31.3	16.7	22.2	77.5	80.8	64.6	48.5	44.2	65.1	54.6	63.5	26.3	67.5	59.9	59.2	23.0	50.7	49.5	54.9	73.4	20.2	53.2	69.0	29.4	30.3	53.1	36.2	46.8	78.3	67.3	89.7	65.6	76.0	49.8	57.1	116.5	31.5	57.7	46.3	61.0	64.0	51.6	80.9	53.4	37.1	51.7	67.7	57.0	32.7	72.3	59.9	58.7	108.8	69.3	38.1	69.9	60.6	65.8	17.0	30.1	49.7
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435229-76783253	"Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 313.1;Distal enterocytes: 154.5;Endometrial ciliated cells: 182.9;Glandular and luminal cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 40.8;AF22: 38.2;BJ hTERT+: 36.9;EFO-21: 39.9;OE19: 40.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA047784: AB_2680155"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	2.0	0.4	6.1	1.8	0.1	15.4	12.4	3.4	5.9	18.5	20.0	15.2	3.0	13.9	17.5	15.7	17.8	3.9	0.9	0.0	7.0	6.2	8.5	0.4	6.1	2.1	0.5	6.5	12.9	3.3	4.4	5.9	9.0	17.2	9.7	25.7	6.3	0.1	3.0	14.7	9.7	5.6	6.1	21.9	0.7	0.2	0.9	3.5	0.1	2.4	4.9	2.3	3.0	40.8	7.9	38.2	25.2	0.0	0.6	1.4	12.4	36.9	0.8	1.6	6.8	26.3	0.6	39.9	34.6	3.0	20.4	5.1	17.8	0.7	0.1	6.7	0.0	7.5	0.0	0.2	0.0	0.0	0.3	4.3	1.3	6.7	9.7	0.7	0.3	0.0	9.7	0.8	3.6	0.7	0.1	16.0	40.5	4.7	3.5	6.3	6.3	6.0	0.9	15.0	19.9	5.2	28.2	2.1	23.2	6.8	0.2	0.0	6.5	5.5	0.2	5.4	12.0	13.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	12.4	3.4	0.9	0.0	6.1	2.1	5.9	5.6	0.2	3.0	0.6	89.8	53.4	313.1	1.0	0.9	5.8	14.0	2.8	35.8	69.9	46.1	11.0	81.5	40.0	35.0	75.0	0.4	0.6	154.5	0.0	33.6	7.1	182.9	27.1	2.1	86.9	2.7	54.5	36.4	0.7	4.7	103.0	350.1	0.0	11.9	0.7	42.2	0.2	1.7	19.1	104.0	30.5	1.6	0.3	3.2	0.3	1.8	3.6	29.0	1.6	7.2	0.0	6.0	2.1	73.8	92.3	0.0	0.3	35.8	102.7	6.8	65.7	31.1	0.0	0.3	7.4	3.4	2.4	3.5	0.3	0.1	1.7	0.3	70.5	11.9
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 545.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	545.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.0	0.0	0.0	0.0	0.0	0.0	448.2	0.8	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	23.3	14.1	12.0	10.8	13.9	28.2	22.8	16.2	16.0	19.3	13.3	15.9	16.0	19.4	15.6	14.0	17.4	15.8	15.0	12.3	12.4	14.6	22.6	17.6	14.0	13.6	14.6	19.2	14.1	14.6	10.3	50.1	13.2	16.8	14.6	19.1	16.1	13.8	21.5	22.3	16.2	14.5	12.2	13.4	15.7	23.3	13.5	14.1	17.5	17.3	13.0	14.1	17.1	16.9	15.5	13.7	29.1	26.3	24.5	21.3	29.6	14.2	19.2	20.6	10.1	10.5	19.7	20.1	15.3	18.0	14.4	17.6	20.3	20.7	25.3	8.1	16.4	10.8	10.6	27.8	34.2	10.7	15.8	25.8	36.5	12.1	27.9	23.1	17.5	18.5	17.7	18.4	17.0	10.6	29.1	21.9	35.5	17.1	21.0	33.3	43.7	21.3	19.5	19.3	33.1	29.3	42.0	20.9	37.7	24.8	13.3	24.4	18.8	22.0	19.8	12.0	15.4	24.0	10.7	36.8	16.3	13.1	20.2	13.7	8.1	35.4	4.1	3.6	4.5	20.4	4.4	6.3	13.0	19.2	8.7	6.6	4.7	8.7	2.2	12.5	2.5	5.8	12.0	13.9	16.2	16.0	12.3	12.4	13.6	14.6	13.2	12.2	13.5	16.9	43.0	12.8	9.7	8.8	24.7	85.7	55.7	45.0	71.2	22.3	43.5	32.0	13.3	20.0	20.5	16.5	8.4	187.4	15.3	27.3	31.3	24.5	70.5	21.9	26.7	35.7	22.6	27.0	20.1	22.7	34.0	42.5	21.9	34.5	4.5	37.8	33.9	23.6	34.3	35.3	20.9	17.8	40.7	20.3	99.2	71.3	22.7	31.1	49.8	23.4	27.0	38.3	4.1	25.6	40.2	22.3	18.2	19.5	17.9	49.7	23.5	28.9	17.0	18.6	19.7	36.2	34.4	70.0	51.0	67.7	75.7	746.2	17.3	17.4	20.6	50.8
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 23.1;ovary: 65.5"	"Group enriched"	"Detected in some"	7	"Granulosa cells: 196.9;Theca cells: 192.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.4;monocytes: 1.3"	"Cell line enriched"	"Detected in single"	16	"HEL: 10.1"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	1.1	7.3	0.5	1.8	0.8	0.4	0.4	0.4	0.7	0.3	0.6	0.5	0.8	0.3	0.2	0.1	0.9	0.3	0.4	0.6	0.6	0.4	1.7	1.7	0.6	1.4	1.0	65.5	2.7	0.1	0.2	1.8	1.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	1.0	1.2	0.8	23.1	4.7	1.5	1.6	0.1	0.2	0.1	0.0	0.6	0.2	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	10.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	1.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.1	0.5	0.8	0.4	0.7	0.6	0.6	1.4	1.0	1.3	0.8	1.6	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	19.6	0.0	0.6	0.2	0.3	1.0	0.0	0.0	0.0	1.1	0.1	4.3	0.0	0.3	0.0	196.9	5.3	0.6	7.9	0.0	0.0	0.0	0.0	26.8	0.2	0.1	0.0	6.1	0.0	5.6	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	7.5	1.7	0.7	0.0	0.1	0.1	0.2	192.3	0.0	0.0
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.9;lymphoid tissue: 6.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;renal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	38	"eosinophil: 290.2"	"Lineage enriched"	"Detected in single"	719	"granulocytes: 290.2"	"Cell line enriched"	"Detected in some"	44	"HMC-1: 147.5"									HPA012556	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.3	4.0	4.9	1.6	5.2	0.5	1.4	5.3	6.1	0.9	1.7	1.8	1.8	0.6	0.7	0.7	0.7	1.4	0.2	4.5	6.2	0.1	0.8	2.5	6.8	13.3	6.6	0.2	0.5	1.0	0.4	0.1	10.1	0.6	1.6	0.7	0.6	0.5	0.1	0.5	2.8	0.9	7.3	6.3	1.4	0.3	11.6	2.1	0.4	0.2	2.5	1.0	0.3	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.1	0.0	0.0	147.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.2	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.1	0.1	7.6	0.4	290.2	0.2	0.3	0.1	0.2	0.2	0.1	0.1	0.3	0.1	0.2	2.5	0.3	0.4	0.2	0.1	0.2	4.9	5.2	5.3	6.1	4.5	6.2	13.3	6.6	10.1	7.3	11.6	14.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	2.5	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427131	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 88.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 302.0;Basal respiratory cells: 123.5;Langerhans cells: 141.9;Suprabasal keratinocytes: 422.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;HeLa: 63.1;hTCEpi: 45.4;LHCN-M2: 45.5;U-266/84: 37.7"	"Low region specificity"	"Detected in all"							"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Vesicles	"CAB023801: , HPA038211: AB_2675894, HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	24.5	8.3	0.7	6.2	0.4	10.5	19.5	0.5	1.8	17.5	0.8	7.0	0.4	4.4	0.0	18.5	18.6	15.1	16.0	0.3	1.1	5.1	20.9	12.7	4.3	1.0	1.0	26.9	11.8	5.9	12.5	12.5	0.8	9.2	0.7	8.5	12.1	13.3	13.0	88.0	5.4	5.3	0.0	7.2	12.2	3.0	0.7	11.0	6.2	1.3	4.6	16.9	14.4	0.5	1.2	3.4	4.3	0.1	0.3	1.6	1.7	2.0	0.7	3.5	2.7	5.1	0.1	5.4	1.5	0.4	19.8	23.6	3.5	35.3	2.0	0.3	1.1	1.6	63.1	2.0	4.8	1.7	0.2	2.1	45.4	0.9	10.7	20.7	0.7	0.1	0.2	0.2	45.5	0.3	0.9	3.9	1.9	0.0	3.4	0.1	0.8	5.7	4.0	13.3	0.1	0.0	24.2	4.0	0.8	0.7	2.3	0.6	8.1	0.9	4.2	0.4	0.1	9.5	37.7	1.0	10.0	4.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.5	1.8	0.3	1.1	1.0	1.0	0.8	0.0	0.7	0.5	23.7	28.9	77.3	0.0	18.4	302.0	0.8	123.5	26.7	0.3	8.6	6.3	11.7	7.2	68.4	12.9	0.0	0.8	13.4	16.4	0.0	3.2	0.0	23.2	4.8	18.4	27.6	0.0	0.0	2.1	1.3	11.1	15.3	29.1	19.6	2.3	4.2	7.7	1.7	0.0	0.0	16.5	85.5	3.8	141.9	0.1	0.0	10.1	96.0	0.0	1.6	1.3	0.0	0.0	0.0	7.3	24.3	0.0	36.3	0.5	23.8	0.2	50.7	0.2	0.0	2.4	27.4	0.1	0.4	35.1	422.7	2.5	16.4	0.8	20.3	1.2
SIM1	bHLHe14	ENSG00000112246	"SIM bHLH transcription factor 1"	P81133	6	100385009-100464921	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;kidney: 9.9;skeletal muscle: 3.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Group enriched"	"Detected in some"	5	"hypothalamus: 4.4;midbrain: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.1"	HPA024385			Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			1.7	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.3	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	9.7	0.0	16.4	23.7	7.2	6.7	0.0	0.0	0.0	0.0	5.2	1.5	0.0	0.0	0.0	6.1	7.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	0.0	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.2	0.0	0.1	0.0	0.0	7.9	4.5	1.8	0.1	0.1	0.1	1.8	0.0	0.1	1.2	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	7.6	0.3	1.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SIPA1L2	"KIAA1389, SPAR2"	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232630571	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane, Nuclear bodies"	"Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	12.1	3.3	8.5	6.4	7.2	5.4	9.2	9.6	11.7	10.0	0.5	19.4	3.9	4.4	2.8	20.3	4.5	8.5	31.3	9.6	16.0	7.7	6.4	16.2	3.0	44.0	21.7	11.9	3.6	4.4	8.1	18.3	44.6	8.1	18.9	14.7	8.7	4.7	7.1	9.0	9.2	7.4	14.4	9.6	5.7	7.2	18.7	2.4	8.0	9.5	3.3	12.5	14.9	9.0	0.0	7.5	69.7	0.2	0.6	0.0	29.3	1.2	2.5	3.1	2.2	2.9	0.1	5.9	13.3	26.4	2.9	1.7	13.8	2.3	2.9	0.0	12.8	0.0	7.0	0.0	5.9	1.0	7.2	3.8	9.1	0.6	6.2	0.0	15.7	25.4	0.0	0.1	1.6	3.5	7.4	0.7	53.9	0.2	10.2	0.0	0.0	3.4	8.1	11.5	3.5	11.9	23.8	0.8	9.5	15.8	1.4	0.6	5.6	8.1	0.0	17.8	2.9	6.5	0.0	0.0	10.0	6.2	46.1	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.3	0.3	0.0	0.1	8.5	7.2	9.6	11.7	9.6	16.0	44.0	21.7	44.6	14.4	18.7	9.0	53.7	6.4	1.8	22.9	0.8	8.8	9.8	8.7	15.4	23.5	10.7	8.6	62.6	12.8	10.4	3.7	52.1	4.9	4.4	29.9	0.0	7.1	11.7	19.0	21.4	22.7	7.2	0.4	80.2	0.5	7.1	15.2	5.1	47.5	1.3	16.0	1.8	3.8	10.0	5.0	95.9	29.5	14.2	16.6	7.2	9.8	0.9	19.5	14.2	183.6	6.3	12.7	1.0	104.0	21.0	1.4	39.9	1.9	0.5	13.2	9.1	0.4	7.7	35.7	0.0	21.8	23.9	6.9	24.0	45.8	7.4	14.8	2.0	11.9	23.4	23.0
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 157.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 138.1;Excitatory neurons: 87.4;Hofbauer cells: 100.8;Macrophages: 82.5;monocytes: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.8"	"Group enriched"	"Detected in many"	150	"dendritic cells: 13.9;granulocytes: 50.8;monocytes: 24.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 142.7;RPTEC TERT1: 100.3;SK-MEL-30: 120.2"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced					NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	49.7	40.4	145.5	49.2	146.6	44.1	41.2	98.9	157.3	27.2	56.0	16.6	27.0	15.0	19.9	13.1	23.3	27.3	30.3	155.1	105.0	27.3	53.4	42.3	22.5	101.0	123.4	19.5	12.6	4.8	15.9	26.3	94.9	15.6	14.8	39.8	29.9	15.3	17.4	29.8	22.3	21.6	99.9	28.1	11.8	6.9	135.2	7.1	12.2	9.0	16.9	35.4	21.9	126.6	11.8	25.2	12.5	23.2	29.4	27.5	1.8	60.5	51.1	16.2	4.9	16.2	0.3	0.0	14.3	142.7	43.6	11.6	10.0	70.6	6.7	0.1	7.1	0.0	2.8	9.0	35.4	24.4	28.5	24.9	32.5	13.8	16.6	46.1	50.8	0.2	1.4	15.4	22.0	0.7	0.0	33.9	13.9	0.0	11.2	0.1	22.2	16.1	100.3	0.0	1.7	3.7	8.2	0.0	120.2	4.5	4.0	76.9	76.6	71.1	36.7	46.4	30.5	0.1	0.1	0.2	22.2	77.3	8.2	0.3	24.1	48.7	0.0	6.0	0.0	0.1	0.0	0.0	13.9	0.0	0.0	0.0	50.8	0.0	2.2	0.9	0.1	10.0	145.5	146.6	98.9	157.3	155.1	105.0	101.0	123.4	94.9	99.9	135.2	126.6	60.6	3.2	6.5	138.1	4.3	14.3	12.8	28.3	6.2	13.2	18.8	27.7	12.7	34.3	10.1	9.2	14.6	20.2	0.6	2.8	1.9	26.8	0.5	1.5	2.2	13.7	9.6	4.4	87.4	2.1	2.1	23.7	1.1	4.8	17.7	1.6	20.3	29.3	100.8	15.2	44.2	3.5	2.0	57.2	54.3	1.2	5.0	82.5	23.2	33.7	85.0	23.7	0.0	40.7	51.1	25.1	9.9	1.9	1.6	9.7	17.7	16.1	5.1	26.8	6.6	3.4	7.8	0.2	8.3	2.8	6.7	36.5	2.1	0.0	2.6	7.7
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228319-2310213	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: AB_2685692"	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	38.3	14.3	22.0	14.1	20.9	11.5	31.5	59.5	24.2	37.5	3.4	34.6	9.3	42.0	8.3	23.5	34.1	14.6	34.4	24.1	11.0	23.6	24.3	33.9	11.6	20.1	16.9	36.4	13.1	7.3	23.0	13.9	17.2	26.8	7.0	5.1	25.2	19.8	22.1	38.6	24.1	16.8	17.1	22.9	22.6	13.2	19.4	8.7	25.4	11.7	10.2	30.8	29.2	15.7	18.3	10.4	24.5	23.9	40.0	23.8	16.1	26.7	14.8	16.3	11.9	15.8	13.7	11.5	19.5	34.4	6.8	21.0	13.8	21.6	15.0	12.7	30.0	29.0	16.4	22.5	26.7	16.5	29.8	25.8	11.8	24.5	18.2	30.0	20.2	4.8	16.6	8.6	20.2	11.6	2.0	18.1	24.8	12.0	19.8	9.1	15.5	9.6	13.9	7.0	35.0	22.9	26.0	22.9	26.7	15.6	7.7	20.9	36.9	27.7	17.5	39.6	21.1	6.7	5.2	10.5	14.8	28.2	11.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	22.0	20.9	59.5	24.2	24.1	11.0	20.1	16.9	17.2	17.1	19.4	15.7	44.2	9.6	12.6	18.9	18.8	47.0	13.1	7.0	32.5	8.9	20.3	25.8	12.7	11.5	6.7	7.3	0.0	7.3	32.2	7.3	1.9	8.2	0.8	10.1	28.9	34.3	6.0	14.7	22.6	6.9	15.5	35.5	9.7	18.5	13.3	6.4	33.9	23.0	13.7	11.8	24.1	14.3	0.0	16.4	29.5	5.0	49.7	28.9	16.0	48.7	9.4	11.1	12.3	11.6	11.4	13.0	9.4	55.3	16.9	14.9	8.1	6.0	4.0	4.4	46.0	36.2	37.3	4.7	12.8	32.2	45.0	16.3	33.4	6.7	10.7	11.4
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050384-1112063	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.3"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	21.1	14.6	8.9	7.2	8.0	4.0	18.8	7.2	10.4	15.8	12.3	24.1	24.0	13.8	1.0	8.0	16.6	12.0	77.3	7.9	12.0	45.1	72.4	23.1	5.7	8.0	10.7	12.3	27.6	4.4	20.5	2.9	8.0	20.7	5.4	5.5	18.9	3.0	6.3	15.8	31.9	3.3	6.8	34.9	28.1	29.9	9.4	7.8	24.7	3.1	2.2	14.5	10.8	7.1	3.8	10.0	5.5	17.3	0.8	0.9	8.7	0.2	1.1	0.8	0.0	24.5	6.4	0.0	20.0	0.3	6.8	7.6	4.6	6.1	0.0	23.0	6.1	4.8	13.4	8.6	12.2	0.0	10.4	1.8	0.8	0.0	1.8	0.3	5.5	2.2	7.6	0.2	0.0	12.0	14.8	0.1	11.9	14.4	16.3	43.9	24.0	20.5	6.5	14.8	3.1	3.8	5.6	0.1	6.0	3.3	9.7	2.7	4.8	0.0	5.7	0.0	0.0	0.3	0.0	2.5	0.0	0.6	2.8	0.2	1.8	0.0	1.1	2.7	1.2	0.6	1.1	1.3	2.1	0.6	1.2	1.2	0.0	1.4	3.8	0.9	1.1	1.3	8.9	8.0	7.2	10.4	7.9	12.0	8.0	10.7	8.0	6.8	9.4	7.1	21.3	9.6	15.2	8.5	7.3	7.0	6.3	8.9	6.8	25.3	18.4	13.8	35.8	31.5	13.6	29.5	2.1	0.2	14.2	42.0	1.9	23.5	0.4	40.9	11.0	27.9	13.2	19.1	0.3	18.1	0.4	11.6	39.8	63.4	8.2	16.6	11.7	34.5	19.8	281.0	0.5	19.4	18.3	28.0	19.8	1.9	3.7	29.0	16.0	14.0	9.1	5.2	5.2	1.5	0.0	28.8	35.8	5.7	5.3	15.7	27.3	23.2	23.1	3.6	19.7	5.2	8.4	1.0	3.4	3.5	6.8	0.3	9.8	5.4	19.3	15.2
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683688	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;kidney: 3.2"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 77.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 4.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.9"	"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.5	1.1	0.2	0.2	0.2	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	3.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.2	4.9	0.2	0.1	0.2	0.7	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	6.4	9.6	5.2	0.7	0.6	0.9	0.3	0.0	1.1	0.4	0.3	0.9	0.0	1.9	77.3	2.1	0.3	0.6	0.3	0.0	0.0	1.3	0.2	0.3	0.9	0.0	0.0	8.8	0.0	0.5	2.4	0.0	0.3	3.8	0.1	1.1	0.0	0.4	1.7	10.6	0.5	0.0	0.3	2.0	1.4	0.6	0.8	1.8	2.8	0.2	0.9	1.0	6.6	1.0	0.1	1.2	0.7	0.1	0.5	4.9	0.2	1.5	2.0	0.0	0.4	0.2	0.3	0.4	0.0	0.1	0.8	1.0	0.2	0.2	0.5
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 51.0;epididymis: 33.3;retina: 31.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	13	"SK-MEL-30: 481.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	1.5	2.7	3.0	7.2	4.8	9.7	5.8	4.3	4.3	1.6	51.0	0.7	0.5	2.6	33.3	10.9	0.9	1.3	0.9	5.0	5.2	0.7	1.4	3.0	5.3	5.1	4.2	1.5	0.5	0.1	1.7	2.3	5.3	0.6	0.8	31.0	2.2	4.2	5.0	4.5	1.2	0.8	2.4	5.7	1.0	2.3	5.2	1.6	3.5	0.7	4.7	2.1	2.6	3.2	2.1	1.8	0.6	0.8	0.4	0.6	14.2	0.8	18.0	1.7	1.2	0.7	2.5	17.6	1.4	0.0	0.2	0.6	2.5	0.0	0.7	5.4	1.3	1.4	2.2	22.3	3.2	5.7	1.1	0.8	0.2	1.0	1.0	1.7	0.8	2.5	1.1	3.8	0.0	18.1	8.5	3.6	0.2	0.1	1.0	0.1	0.4	2.4	0.8	1.5	4.2	0.3	0.8	10.7	481.5	3.8	15.0	3.5	2.7	5.9	1.1	0.5	2.0	4.2	17.5	14.6	36.0	4.6	2.6	0.8	3.1	0.2	1.8	2.7	0.8	0.4	0.6	1.4	1.9	0.0	0.4	0.8	5.4	0.4	1.4	0.3	1.5	0.9	3.0	4.8	4.3	4.3	5.0	5.2	5.1	4.2	5.3	2.4	5.2	3.2	0.6	0.0	2.5	1.6	1.8	0.3	0.2	0.1	1.2	8.2	2.5	0.9	0.8	0.0	4.0	9.2	22.9	0.4	8.4	0.0	0.0	0.0	0.7	4.7	2.5	3.2	0.0	2.7	6.7	0.0	11.5	0.9	0.5	27.4	1.3	0.1	0.7	0.3	5.6	0.0	6.2	0.0	0.0	16.7	7.0	0.3	0.0	21.8	10.6	4.7	11.1	6.2	5.2	0.5	0.8	0.0	0.0	1.9	5.0	0.2	0.0	0.3	1.6	45.1	0.0	0.8	0.3	1.7	0.7	6.7	0.4	0.4	5.3	0.4	0.1	0.2
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 294.5;U-266/70: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	4.3	26.4	49.1	9.1	46.8	13.4	13.6	32.1	48.6	14.0	18.0	9.4	6.1	12.8	8.2	7.5	4.8	3.9	6.2	43.4	56.6	1.9	9.0	4.9	10.7	37.2	43.1	13.2	29.6	5.5	13.7	6.6	52.1	9.6	8.4	19.3	7.5	7.1	40.1	18.6	5.6	12.3	29.5	7.5	8.1	11.7	59.9	20.5	5.7	17.0	19.0	4.8	6.2	30.3	15.3	11.6	6.6	34.9	14.7	9.5	9.4	28.5	14.0	11.7	19.8	3.2	2.2	49.7	6.5	44.8	14.7	43.2	13.7	3.6	12.0	20.1	5.4	26.0	13.1	30.9	31.0	43.8	23.1	4.4	73.8	15.8	24.2	3.9	7.3	49.1	20.7	122.0	8.4	13.5	37.7	29.1	4.7	20.1	13.9	13.5	1.9	125.5	4.9	7.7	29.3	14.1	17.9	16.1	294.5	3.0	19.3	47.8	1.6	16.0	19.0	31.2	17.5	132.8	71.2	118.8	23.6	86.5	86.2	0.0	2.1	1.8	0.9	4.8	1.2	0.9	0.9	1.5	3.9	0.3	0.0	0.8	0.0	5.1	9.4	7.2	3.5	1.4	49.1	46.8	32.1	48.6	43.4	56.6	37.2	43.1	52.1	29.5	59.9	30.3	3.6	0.0	2.7	69.9	13.6	20.0	2.1	6.7	46.1	6.3	21.0	7.1	5.5	1.5	1.7	1.8	33.3	2.4	20.2	2.9	0.0	2.0	32.4	5.4	8.2	5.3	8.4	6.1	20.6	9.3	1.3	4.0	5.1	5.6	7.0	49.2	7.5	13.1	17.7	6.7	25.5	9.0	6.1	6.8	11.8	47.5	11.1	11.1	85.4	8.4	5.1	14.6	2.1	5.0	3.9	7.1	0.8	29.7	65.7	2.6	0.4	1.5	5.4	17.7	0.0	5.1	7.3	2.0	0.9	5.9	6.1	2.5	10.9	0.4	5.8	1.0
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 148.6;Erythroid cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 95.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	97.2	15.9	5.8	29.6	6.5	60.9	77.7	6.6	6.1	57.4	6.1	50.1	16.2	39.1	98.0	98.0	48.9	36.5	26.4	5.9	8.5	45.6	8.1	65.3	27.9	15.8	11.1	45.8	73.2	2.9	24.5	46.9	13.3	98.6	42.4	1.4	120.5	77.0	8.5	55.7	36.2	33.0	9.5	40.4	55.5	40.3	9.8	19.9	14.1	10.7	30.3	109.6	83.0	11.5	179.6	323.6	76.3	116.1	194.7	164.3	180.0	249.6	283.0	183.2	264.1	296.1	197.1	194.8	118.9	624.2	105.2	281.1	224.9	296.9	135.5	130.1	203.7	324.3	115.1	281.9	501.3	228.2	182.9	268.6	727.3	215.5	541.1	61.3	98.9	255.0	348.9	500.1	99.5	304.5	105.4	611.1	134.0	636.5	140.9	117.8	86.5	282.7	104.2	384.8	117.3	86.0	123.4	331.8	275.4	58.8	191.6	296.6	74.1	109.4	174.1	86.4	205.7	308.0	325.3	164.0	206.3	281.0	274.3	0.1	36.1	2.9	14.1	55.0	11.4	17.8	8.0	9.9	50.2	8.1	1.9	6.0	1.0	21.0	66.3	95.8	15.5	27.8	5.8	6.5	6.6	6.1	5.9	8.5	15.8	11.1	13.3	9.5	9.8	11.5	63.6	0.0	17.3	0.0	31.1	57.7	148.6	95.9	64.9	0.2	52.0	43.1	20.3	21.5	41.2	0.0	0.0	80.8	86.3	44.6	3.9	38.5	27.0	2.6	32.9	29.0	10.7	143.3	0.6	65.7	129.3	48.0	21.9	2.7	29.2	20.9	29.6	0.7	38.4	0.0	0.8	111.3	40.7	21.6	34.7	14.0	19.0	39.8	19.6	3.7	26.0	0.6	12.3	0.0	0.6	43.4	74.8	19.5	68.6	59.0	6.5	23.1	13.0	0.8	6.6	15.8	44.0	35.9	4.0	69.0	28.3	24.4	38.7	6.1	62.9	100.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	72	"epididymis: 10.6;kidney: 31.9;placenta: 33.4"	"Group enriched"	"Detected in some"	19	"Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;Hep G2: 1.0"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	654.0	0.0	0.0	5.9	0.0	1.2	0.0	0.2	1.7	0.0	0.0	0.0	0.4	22.5	3.4	0.0	0.0	0.0	0.0	0.4	0.2	50.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.3	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1520.6	0.2	0.1	0.2	0.0
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940053	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	35.6	52.5	69.2	33.8	70.7	31.7	32.0	77.7	79.8	35.3	70.8	46.7	47.5	36.7	22.1	50.5	41.6	30.7	233.6	76.8	73.6	66.6	66.7	30.0	40.7	69.2	72.7	30.7	27.9	70.8	36.4	27.6	69.6	34.0	36.1	23.2	41.6	38.4	314.5	48.7	40.2	33.4	70.2	37.5	39.9	10.9	77.0	45.1	38.5	450.4	33.9	38.5	33.3	71.5	51.1	134.6	67.3	66.3	64.7	39.9	47.3	56.2	57.2	96.2	79.3	85.1	24.7	78.3	74.5	55.3	46.8	99.6	88.1	101.5	37.8	99.6	113.8	86.4	70.9	74.5	66.0	37.6	100.7	57.7	65.1	85.4	71.7	46.7	67.8	83.2	38.7	74.1	82.7	91.2	121.6	38.3	35.6	56.1	89.6	108.6	41.4	71.0	74.8	52.6	59.9	62.1	70.9	79.0	65.2	33.6	73.3	58.7	46.0	43.0	28.1	58.8	109.7	39.3	25.4	30.7	84.8	62.6	108.4	126.0	170.3	132.3	98.8	176.8	90.8	87.5	75.1	87.8	160.4	74.3	74.1	81.2	111.8	151.6	165.1	107.0	97.3	186.2	69.2	70.7	77.7	79.8	76.8	73.6	69.2	72.7	69.6	70.2	77.0	71.5	39.7	25.6	23.3	12.7	32.9	38.1	47.1	92.7	25.6	60.3	47.5	51.3	150.6	51.5	40.0	66.2	16.7	132.2	39.0	67.0	185.9	60.7	15.2	30.3	29.7	41.0	27.6	50.3	8.0	53.6	138.7	40.2	30.5	28.2	39.3	45.6	33.5	61.5	109.1	47.1	10.5	51.6	99.7	45.3	44.4	19.6	30.4	56.2	51.6	9.4	106.9	59.2	47.4	9.5	10.4	47.4	58.7	38.4	45.8	43.1	99.9	202.5	26.5	56.0	52.6	43.1	48.4	15.1	31.3	46.9	44.3	102.5	38.4	57.5	88.3	42.1
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	7.4	12.3	9.4	5.3	9.2	3.3	14.3	9.9	10.7	9.3	11.5	6.3	5.4	13.2	19.6	7.1	11.4	5.7	4.3	9.2	10.2	13.6	16.9	6.6	9.4	9.9	9.6	20.6	8.8	13.6	9.2	10.0	9.7	10.7	7.3	9.2	9.8	5.9	3.9	9.6	6.0	10.5	10.1	7.3	7.8	10.0	10.0	9.3	12.7	3.6	9.7	8.1	7.2	11.2	23.5	13.5	21.0	18.5	12.8	15.9	16.8	20.7	22.7	32.5	35.7	16.5	8.8	26.7	12.2	20.4	17.7	18.6	30.6	16.6	33.4	27.0	41.3	31.1	18.4	21.1	18.3	35.8	16.2	15.3	22.8	28.6	18.4	14.7	19.4	21.4	46.5	12.9	26.5	19.2	22.0	24.2	17.7	33.2	20.6	23.8	32.4	40.3	27.6	19.7	14.2	12.5	42.8	26.6	26.7	20.3	22.0	10.7	11.8	18.5	24.4	16.1	19.2	13.9	29.6	25.7	19.7	18.4	20.4	7.0	3.3	4.2	4.9	3.9	6.9	8.4	5.8	5.5	4.2	7.6	8.2	6.7	1.5	8.3	3.3	5.4	8.6	4.7	9.4	9.2	9.9	10.7	9.2	10.2	9.9	9.6	9.7	10.1	10.0	11.2	8.4	19.2	9.5	23.2	10.9	16.6	16.8	29.8	10.8	12.1	13.6	9.3	4.0	7.2	20.7	12.9	8.4	39.8	8.0	5.8	21.5	17.9	9.6	17.9	16.5	10.4	6.1	11.6	17.3	17.7	31.9	15.9	8.2	14.2	5.1	15.5	8.2	24.8	12.9	11.8	21.5	6.5	26.4	7.9	6.0	16.0	27.1	7.4	16.0	7.5	17.6	7.9	10.3	18.1	28.0	18.1	4.4	26.7	11.9	18.1	8.2	21.1	15.0	7.0	32.9	9.3	11.6	51.0	38.0	11.7	17.2	28.6	9.7	16.4	7.5	14.9
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678190	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 78.1;Inhibitory neurons: 78.1;Oligodendrocyte precursor cells: 127.2;Oligodendrocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 53.6;hTCEpi: 24.2;U-698: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	33.7	23.7	34.7	5.9	46.5	1.5	31.6	76.5	45.5	57.9	42.1	50.4	6.7	41.4	69.9	18.6	52.9	19.8	36.0	41.3	34.0	52.2	43.8	25.2	5.7	35.9	36.7	94.3	34.1	21.1	114.7	3.0	36.5	72.2	15.5	118.8	28.4	24.4	21.2	41.1	24.4	22.2	28.5	15.8	31.7	32.5	44.9	1.2	70.8	10.9	4.8	43.0	40.9	57.1	3.5	2.3	3.9	13.1	14.6	10.0	0.1	2.0	6.2	1.8	0.4	0.0	4.9	1.4	8.9	3.3	4.3	6.9	1.8	5.8	1.2	0.0	19.7	0.0	53.6	5.0	7.7	0.1	0.6	15.7	24.2	0.1	15.2	9.4	0.4	13.5	0.2	0.1	1.6	1.4	0.0	0.2	2.0	3.5	5.2	0.0	5.0	0.2	9.7	12.5	11.8	1.3	9.2	0.6	5.4	5.7	9.8	0.0	1.4	8.1	5.3	0.8	1.7	5.3	0.0	27.4	1.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	46.5	76.5	45.5	41.3	34.0	35.9	36.7	36.5	28.5	44.9	57.1	3.6	3.2	4.6	53.2	0.2	0.9	4.4	0.5	9.1	32.0	3.6	7.5	9.5	2.8	1.7	5.5	29.2	0.0	0.0	0.7	0.0	1.2	29.0	5.7	6.1	4.5	6.0	2.5	78.1	0.7	0.1	7.2	1.1	5.1	1.3	7.3	1.8	2.2	0.2	20.2	78.1	1.3	2.0	0.3	0.3	22.7	3.1	0.8	1.8	27.2	0.0	7.0	0.0	127.2	88.5	0.2	0.7	5.3	0.2	4.5	0.5	1.0	5.0	36.2	0.0	8.8	7.5	0.5	1.8	4.4	2.4	0.0	0.2	8.8	1.5	2.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1537.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1748.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	300.9	550.7	131.2	184.7	136.0	209.2	267.5	159.3	146.5	224.3	209.3	418.9	396.4	283.5	226.1	437.7	248.9	136.2	1237.8	132.6	160.4	419.8	370.1	255.7	201.7	148.9	149.6	290.2	392.2	499.7	216.9	192.4	153.0	209.9	347.6	167.2	302.7	220.9	1537.4	275.7	321.2	257.4	150.4	235.1	423.5	90.8	159.0	205.7	225.1	1233.2	312.8	294.7	264.6	135.4	731.4	447.1	620.0	509.6	534.1	891.5	1005.3	622.8	724.1	704.3	573.4	787.6	316.4	1003.2	376.9	633.0	320.3	573.7	616.9	741.3	680.6	402.9	651.8	589.5	297.4	563.3	683.0	665.7	416.6	857.3	616.8	494.2	681.2	994.3	990.8	488.8	654.9	240.5	782.7	436.5	642.5	724.2	605.4	540.6	988.5	703.0	730.3	1075.0	858.8	559.6	355.5	506.1	740.1	565.5	1009.8	504.4	771.0	676.3	782.0	371.2	390.0	442.8	603.4	486.5	648.5	678.1	295.6	368.3	494.9	184.7	408.9	223.2	244.7	520.2	285.6	298.5	270.8	271.4	534.7	222.6	281.3	269.8	166.6	288.5	545.2	321.7	377.4	637.0	131.2	136.0	159.3	146.5	132.6	160.4	148.9	149.6	153.0	150.4	159.0	135.4	319.2	214.7	294.8	46.0	392.2	376.0	590.6	751.4	495.1	223.1	442.5	549.3	1748.6	370.3	384.5	215.2	79.2	785.9	480.8	727.5	874.6	512.1	41.7	217.9	275.3	328.6	312.4	413.5	44.9	879.5	946.2	393.1	390.4	288.7	210.4	477.9	278.1	416.3	589.4	292.7	49.7	470.7	370.2	467.9	280.7	29.0	255.1	449.1	437.6	34.7	593.5	317.3	294.5	32.2	42.2	632.9	602.7	256.5	442.7	652.4	945.5	1029.4	201.1	230.2	302.4	470.5	733.5	126.1	169.9	796.6	362.4	814.7	356.3	536.0	729.1	769.9
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468422-119471396	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	178.1	178.3	116.9	176.0	116.1	260.9	161.3	141.6	126.0	155.0	114.3	458.7	740.2	134.5	63.9	411.0	118.6	100.4	196.1	109.0	141.5	491.8	336.1	216.5	255.4	120.6	118.0	108.2	629.1	295.3	89.0	138.1	126.4	111.9	503.0	127.7	250.2	103.8	61.6	294.9	562.8	150.5	119.3	182.6	492.1	54.2	126.4	351.9	128.8	65.1	297.7	200.8	235.3	121.5	845.1	789.6	303.3	525.4	189.5	277.3	561.0	306.8	331.3	631.7	560.8	662.4	518.4	1059.3	400.9	296.1	456.1	576.9	752.1	640.5	572.5	281.1	711.2	357.5	418.7	477.0	239.8	984.0	566.1	303.7	705.2	652.2	412.6	240.1	660.4	535.0	292.5	425.9	350.1	1868.4	878.6	995.1	640.4	1147.6	1244.3	474.5	383.4	825.7	486.9	663.6	365.0	344.5	526.7	793.3	646.7	306.7	327.7	491.0	279.5	297.3	428.9	670.8	1122.2	494.6	656.3	847.4	329.5	987.7	492.2	113.4	603.4	170.2	170.7	1045.7	198.1	459.2	248.3	224.6	872.6	376.0	243.3	232.1	99.2	318.1	824.2	476.1	443.1	931.8	116.9	116.1	141.6	126.0	109.0	141.5	120.6	118.0	126.4	119.3	126.4	121.5	260.4	163.5	308.6	28.7	339.6	815.7	567.0	1615.3	398.9	109.8	406.2	413.5	131.2	301.7	609.2	187.6	60.5	1038.8	336.2	1379.0	2533.6	578.2	4.0	137.3	134.2	257.5	401.0	349.1	16.8	1056.4	463.1	214.4	543.3	157.6	192.9	306.0	146.7	333.6	881.7	26.9	25.5	856.4	1129.1	610.6	650.9	18.1	145.4	473.2	547.8	15.0	441.2	140.8	218.3	24.1	19.2	554.1	1061.8	110.6	419.9	522.3	2785.2	1622.3	239.5	199.0	131.5	163.9	506.7	11.5	119.2	1046.8	960.2	1589.1	291.2	626.6	1053.7	809.7
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	356.6	410.1	227.8	223.3	241.4	441.5	307.3	210.8	296.7	253.7	351.6	350.9	466.0	277.9	80.6	344.8	243.4	127.2	201.5	227.9	216.1	386.8	130.0	239.4	275.0	222.6	222.8	460.8	626.9	323.5	275.8	147.1	228.0	264.1	141.5	108.3	697.7	178.8	115.5	331.3	387.7	129.4	208.3	263.7	413.9	62.2	227.4	232.7	321.5	89.2	159.3	292.0	244.6	219.2	290.4	596.8	393.8	422.6	267.5	527.4	466.2	396.8	386.1	296.8	289.2	796.7	330.6	1023.0	334.1	264.9	445.6	179.2	269.5	482.0	89.8	260.3	886.0	545.0	396.0	899.7	642.2	398.1	649.8	870.1	882.2	235.8	335.9	367.5	441.6	315.7	407.2	233.8	284.5	575.4	791.1	733.3	516.0	105.5	802.2	378.8	333.8	828.3	351.4	693.6	682.9	1096.5	271.1	817.7	1239.7	224.1	466.1	832.5	505.5	305.1	169.6	596.5	422.1	606.7	110.5	705.9	48.7	389.9	170.3	34.2	739.8	47.2	319.5	808.7	466.9	671.4	431.3	377.9	985.9	532.5	396.1	399.7	34.4	359.9	832.3	461.2	447.6	1120.7	227.8	241.4	210.8	296.7	227.9	216.1	222.6	222.8	228.0	208.3	227.4	219.2	194.2	147.4	244.3	13.7	724.4	1151.2	1447.6	1800.6	421.8	286.1	981.3	710.8	106.0	371.8	704.7	316.3	98.0	1581.2	448.5	690.4	1659.2	752.6	11.4	164.4	388.1	473.0	928.4	471.3	15.1	1473.5	1229.8	507.8	374.1	245.3	343.6	698.0	529.4	149.7	1264.7	242.3	20.4	1208.1	819.9	1553.5	1299.4	45.8	667.9	764.0	754.2	17.8	1450.5	184.6	531.4	8.0	13.7	789.8	1127.8	366.3	604.9	1452.4	1564.9	1320.8	180.3	280.0	341.8	631.7	665.6	13.3	80.7	796.7	1321.5	1744.1	494.7	847.8	1524.3	1723.2
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.7;Intestinal goblet cells: 34.0;Paneth cells: 40.9;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.6	6.8	4.8	5.2	5.2	18.1	5.5	5.1	6.5	9.3	5.4	28.0	8.2	7.4	3.6	5.2	6.6	3.7	8.1	4.7	5.0	19.6	7.6	9.5	3.9	5.6	5.1	7.3	11.4	3.6	5.5	5.5	5.9	12.4	21.6	4.1	5.8	4.2	9.5	6.7	22.4	5.6	5.2	12.5	26.8	5.6	5.6	3.8	6.3	6.1	3.2	6.6	7.9	6.2	8.5	8.9	13.2	15.0	39.9	19.8	11.2	13.7	17.7	25.8	27.4	17.6	7.6	12.0	4.6	11.6	28.7	11.2	12.1	12.5	7.2	9.3	12.0	10.8	29.6	34.3	29.4	5.2	16.5	27.4	44.0	17.7	12.4	22.1	8.0	12.4	8.6	13.2	6.2	9.8	10.4	27.0	18.5	23.0	17.9	5.2	4.8	14.5	18.8	7.9	3.3	6.2	17.7	21.3	25.2	17.9	11.2	19.2	6.9	11.6	9.2	15.0	31.7	15.7	17.8	5.6	9.7	20.5	28.4	6.8	11.1	2.3	3.0	10.8	2.7	0.9	1.8	1.9	9.0	0.2	1.0	1.5	1.5	0.6	10.1	5.1	3.4	5.0	4.8	5.2	5.1	6.5	4.7	5.0	5.6	5.1	5.9	5.2	5.6	6.2	4.3	3.2	5.9	10.7	2.1	3.2	2.6	8.0	5.7	2.1	3.8	2.7	6.6	1.5	3.8	1.8	14.6	9.3	2.4	69.7	0.0	2.9	1.2	1.3	3.2	5.1	20.4	4.0	2.0	6.3	15.0	4.0	13.3	2.7	0.0	3.1	4.2	6.3	7.0	5.0	2.1	34.0	10.2	5.3	7.4	0.9	3.7	6.3	5.4	1.9	5.8	1.6	6.2	2.5	2.5	5.8	40.9	9.4	5.8	2.0	43.6	6.2	3.7	6.9	0.0	1.3	4.5	2.9	6.9	2.4	3.4	10.5	3.8	13.5	26.8	1.0
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035106-9088478	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 97.3;intestine: 109.1;skeletal muscle: 78.8;testis: 76.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 23.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 23.3"	"Group enriched"	"Detected in some"	5	"Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	7.7	3.4	9.2	5.4	9.2	97.3	5.1	10.5	11.8	2.6	10.1	4.8	109.1	1.3	10.5	3.9	2.6	1.1	2.3	10.3	12.0	38.4	0.6	1.2	20.4	24.1	14.5	2.8	0.6	1.5	2.9	4.9	20.4	15.1	3.6	2.7	2.4	5.1	78.8	6.9	85.3	4.4	14.3	5.6	0.9	76.4	16.1	1.7	0.8	65.9	18.3	3.0	4.2	19.6	0.3	0.1	0.0	0.2	0.2	1.2	0.5	0.2	0.7	0.0	0.6	1.3	0.0	190.3	0.2	0.4	0.1	0.4	1.7	0.1	0.4	25.1	0.2	0.2	3.4	0.0	0.3	3.0	1.6	2.7	2.6	0.6	0.0	2.9	0.0	0.1	0.3	2.0	0.0	0.0	0.1	10.0	0.2	0.0	0.2	4.9	0.0	5.9	0.2	2.0	0.6	0.3	0.3	0.5	0.7	0.1	0.3	47.8	0.2	3.0	0.9	0.5	0.2	154.0	0.2	178.2	0.2	68.2	0.2	4.8	2.5	0.2	0.2	0.5	0.2	4.3	0.2	0.2	0.9	23.3	0.2	0.2	1.4	0.3	0.1	0.2	0.1	1.2	9.2	9.2	10.5	11.8	10.3	12.0	24.1	14.5	20.4	14.3	16.1	19.6	0.3	0.0	0.0	2.0	5.2	2.0	2.0	0.2	10.2	0.0	0.1	0.4	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.4	7.9	0.3	64.3	0.1	0.3	4.9	1.2	0.0	1.0	0.0	1.1	0.8	0.0	0.4	1.3	0.1	0.4	0.1	4.3	0.0	1.2	7.6	0.0	0.8	1.2	19.3	2.8	2.7	0.0	31.9	0.6	0.6	0.0	2.5	0.9	0.6	55.6	0.4	35.3	2.1	189.4	24.2	0.0	0.1	6.6	2.1	0.4	83.2	8.2	2.7	0.6	0.5	0.3	0.3	8.0	0.2
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479606-45522755	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 39.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.3;Late spermatids: 78.5;Prostatic glandular cells: 39.2;Spermatocytes: 52.1"	"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	2.8	1.8	2.6	1.9	9.3	0.8	1.9	3.1	4.5	2.8	1.5	3.2	7.0	2.9	2.7	4.2	2.0	2.0	1.9	2.7	2.4	4.2	2.5	1.8	2.7	2.2	2.6	2.5	1.8	4.1	1.5	3.4	2.4	39.9	3.1	3.7	1.3	2.2	1.7	2.5	8.5	3.4	2.1	3.0	2.0	6.3	3.8	1.0	4.7	1.9	3.4	1.8	2.5	7.3	1.8	2.1	0.6	4.7	8.3	5.8	0.4	4.5	4.1	2.7	3.8	0.3	1.5	6.9	1.5	4.7	1.1	1.2	2.0	2.1	2.5	1.7	1.8	0.1	2.0	0.1	5.3	0.1	3.5	4.9	3.4	3.6	0.9	4.2	3.2	3.2	1.0	3.8	5.1	0.8	2.4	0.3	0.1	0.4	0.4	3.6	4.0	1.1	2.2	0.4	1.5	2.3	3.0	3.4	0.8	0.6	2.9	0.2	6.1	4.0	2.3	4.9	1.5	7.0	5.5	1.7	1.7	0.2	3.1	1.3	0.1	0.1	2.2	0.1	2.1	2.0	1.5	1.3	0.2	3.5	1.5	2.1	0.5	1.3	0.1	0.2	0.2	0.7	2.6	9.3	3.1	4.5	2.7	2.4	2.2	2.6	2.4	2.1	3.8	7.3	6.7	3.2	3.9	5.5	6.6	6.8	2.2	1.1	6.8	3.2	2.8	2.2	3.1	0.0	0.1	1.8	16.7	1.0	3.9	15.2	0.0	1.3	76.3	5.0	8.4	6.9	1.2	0.4	14.0	1.1	0.9	7.5	4.6	12.7	1.3	1.9	11.0	3.3	3.1	13.5	9.4	7.1	0.0	1.6	30.8	78.5	6.2	4.4	7.2	9.4	5.3	4.3	10.3	6.0	28.8	0.7	22.0	8.2	6.0	39.2	32.4	12.5	0.7	2.2	6.6	6.2	5.2	52.1	19.9	7.4	6.5	0.3	5.4	3.6	5.1	1.7
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81244811-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		70000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	37.6	37.0	12.7	23.4	14.0	30.8	31.2	12.7	16.1	33.0	14.7	31.7	31.8	35.3	17.3	24.0	31.7	25.8	36.8	10.5	13.8	31.6	75.2	31.4	21.4	21.5	14.9	37.7	91.4	15.6	62.1	24.6	15.7	34.2	9.5	4.4	51.1	20.8	20.0	25.2	34.7	15.4	13.3	43.8	38.8	30.5	16.6	12.9	41.3	6.3	10.6	37.6	26.8	19.4	45.2	77.5	13.3	70.2	49.8	23.3	77.6	53.7	48.2	32.5	38.2	36.1	73.0	34.4	59.2	37.3	36.0	53.0	13.5	27.1	12.0	34.7	40.0	34.6	28.5	61.2	44.4	34.1	78.4	40.7	19.7	29.2	18.9	26.2	62.2	24.5	26.3	51.3	24.6	56.5	21.0	59.4	12.9	41.3	37.6	33.8	27.8	34.8	22.2	42.3	25.7	65.7	43.2	26.9	59.2	18.3	38.1	70.0	61.9	52.2	29.9	38.9	29.4	44.6	21.4	20.0	30.9	51.8	54.5	12.7	10.6	18.6	7.4	11.9	8.7	6.2	7.1	9.1	6.2	7.0	4.8	5.4	8.0	4.6	15.9	9.8	5.6	9.5	12.7	14.0	12.7	16.1	10.5	13.8	21.5	14.9	15.7	13.3	16.6	19.4	24.4	25.6	35.6	25.8	28.6	8.3	12.3	21.9	13.6	10.9	25.3	18.0	19.3	31.5	24.6	11.0	18.8	61.0	29.8	66.4	5.9	31.9	25.4	17.3	13.7	22.4	45.0	22.3	12.3	26.9	62.4	35.9	44.9	32.8	15.2	64.6	27.5	79.2	49.3	25.2	14.3	58.8	12.2	40.6	15.1	75.6	32.9	35.7	14.2	28.1	29.1	27.7	23.7	9.0	20.5	25.1	53.1	27.4	96.5	16.0	59.1	23.9	21.4	9.1	32.9	17.0	21.2	19.7	22.8	11.8	7.2	62.5	25.0	39.9	48.2	11.4
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 407.2"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.5	0.3	0.7	0.3	0.7	407.2	0.2	2.2	1.4	0.1	1.7	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.9	0.6	0.5	72.1	2.2	1.8	0.4	0.8	0.6	0.1	0.2	0.0	0.6	10.9	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.8	0.3	0.3	1.1	0.7	0.3	1.5	0.1	0.1	0.1	1.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.7	2.2	1.4	0.6	0.5	0.8	0.6	0.9	0.3	1.1	1.7	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.2;testis: 40.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.1	0.2	11.0	1.5	8.9	0.4	2.6	9.5	11.4	2.3	5.5	11.5	14.4	2.0	2.0	4.9	1.8	2.6	5.7	9.0	11.1	9.4	0.1	1.2	0.4	12.9	9.8	0.9	1.6	0.2	0.3	4.3	12.3	8.0	7.1	0.6	6.1	4.0	0.6	1.8	19.2	1.7	9.8	0.2	5.6	40.1	12.5	0.1	0.5	0.9	0.8	4.9	2.5	9.7	6.6	2.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	4.6	42.1	0.0	7.0	0.0	0.6	6.9	0.0	6.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.6	31.8	4.5	0.0	0.0	1.1	0.0	12.3	0.1	0.2	7.2	15.4	0.1	0.8	20.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.8	0.5	0.1	0.3	0.1	0.2	11.0	8.9	9.5	11.4	9.0	11.1	12.9	9.8	12.3	9.8	12.5	9.7	3.8	9.6	3.1	0.0	0.1	0.6	2.2	5.3	1.8	0.4	3.2	2.4	0.7	4.3	5.3	23.9	2.1	32.8	0.0	18.8	1.9	6.6	1.1	8.9	1.1	10.8	0.0	0.0	0.1	2.0	0.9	0.4	4.6	21.3	0.0	5.9	0.0	0.0	2.6	0.0	0.0	6.0	6.1	0.0	1.3	3.2	0.9	0.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	5.2	21.7	0.4	0.1	4.3	35.5	0.1	2.4	0.1	0.0	0.4	0.6	0.6	0.8	2.3	1.1	52.1	0.2	1.3	10.8	5.8
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 163.3;salivary gland: 64.4;stomach 1: 58.8"	"Cell type enriched"	"Detected in some"	40	"Gastric mucus-secreting cells: 244.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.7"	"Group enriched"	"Detected in many"	5	"cerebellum: 5.6;hippocampal formation: 10.6;thalamus: 3.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.3	0.2	0.1	0.3	0.1	5.6	1.4	5.6	163.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	10.6	0.1	0.0	0.0	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	64.4	0.0	0.4	0.2	0.2	0.0	0.1	0.2	58.8	0.4	3.3	0.0	12.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	1.1	0.1	0.1	0.3	0.4	0.4	0.3	0.9	0.1	0.2	0.3	1.2	0.9	0.6	0.2	0.1	0.1	0.6	0.3	0.3	0.1	5.6	1.4	10.6	0.1	0.2	0.7	0.4	0.1	3.3	0.3	0.0	0.0	0.6	0.3	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.6	1.3	0.1	244.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.1	0.0	0.0	2.9	0.0	0.0	1.2	0.2	0.1	6.1	0.2	0.3	0.0	0.9	0.0	0.0	0.2
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 310.9;SK-BR-3: 337.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	42.4	8.6	27.5	14.2	25.2	18.1	31.5	24.0	30.6	9.4	46.2	13.0	20.9	14.3	67.4	10.9	11.5	7.5	7.7	23.4	23.9	8.5	104.0	7.9	13.8	24.0	24.4	10.2	11.6	9.8	8.0	39.1	25.9	9.3	12.7	6.4	12.5	11.1	17.0	10.0	15.3	9.7	23.9	9.1	10.1	23.4	30.6	11.6	8.0	8.8	26.5	11.3	8.8	21.9	78.9	79.6	49.9	66.1	45.4	16.5	310.9	28.1	19.1	41.8	28.7	118.8	27.0	54.2	41.3	15.4	44.7	42.8	108.3	32.4	29.1	42.2	63.5	96.6	34.9	184.4	53.8	125.1	47.8	57.1	27.1	51.4	39.7	11.1	38.2	43.3	143.6	21.1	27.0	161.0	42.7	60.4	144.8	90.1	29.0	70.7	58.7	78.2	24.0	74.5	42.0	61.7	30.3	337.1	40.1	48.6	74.9	26.0	17.5	45.3	62.5	27.9	76.1	35.7	88.6	84.7	24.5	86.1	65.2	0.1	5.9	1.8	7.4	6.6	8.9	5.8	7.0	7.0	8.7	5.3	7.1	8.6	0.3	6.3	8.9	8.9	7.6	5.8	27.5	25.2	24.0	30.6	23.4	23.9	24.0	24.4	25.9	23.9	30.6	21.9	2.5	0.0	4.4	7.8	13.4	8.0	8.6	3.8	7.4	5.3	41.9	31.9	6.8	8.6	3.1	7.3	4.2	119.1	12.5	6.7	1.9	9.8	15.1	3.9	7.4	6.2	5.4	12.6	7.2	8.2	111.7	6.0	5.6	6.9	0.0	18.1	7.1	67.7	21.8	11.8	9.0	9.2	4.1	9.1	6.0	32.0	7.2	6.6	0.0	29.0	47.9	2.5	6.2	6.6	5.0	7.0	4.3	13.9	10.0	14.1	11.7	3.9	2.9	3.1	13.1	5.5	5.2	35.1	21.5	7.6	6.3	227.9	8.6	9.4	15.2	7.8
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599594-20659285	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"brain: 22.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 20.6;Late spermatids: 66.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 22.2;pons: 20.0;spinal cord: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 49.3"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 30.5;spinal cord: 18.3"	CAB079052		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 31: Spermatids - Spermatogenesis"			"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	22.2	1.3	0.0	0.0	0.0	0.6	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.2	0.2	0.0	22.2	1.3	20.0	7.6	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	66.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153687926-153696588	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.0;Distal enterocytes: 382.0;Proximal enterocytes: 235.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 155.8;AN3-CA: 151.3;SK-BR-3: 156.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.87e-1)"	31.6	66.6	77.2	9.0	99.4	34.5	23.9	77.8	80.0	17.5	39.9	73.5	51.3	32.4	13.0	54.6	17.3	31.3	130.4	76.8	82.1	81.4	4.5	9.2	1.9	89.0	90.5	12.4	20.0	45.6	21.4	36.2	76.9	31.3	30.5	34.7	52.3	35.9	166.6	45.9	75.9	20.7	71.3	13.1	30.8	38.5	87.6	11.9	8.2	75.5	3.0	41.2	36.5	116.6	155.8	6.7	39.5	151.3	14.7	9.9	10.2	22.2	37.7	28.7	35.5	20.1	2.1	0.2	17.0	27.9	33.6	54.3	85.3	78.0	17.0	2.7	83.3	0.6	50.6	59.7	50.0	1.2	10.1	20.9	16.5	27.3	103.3	50.7	14.9	0.9	37.3	2.4	15.7	9.3	0.8	3.6	47.0	30.9	67.0	7.6	5.2	2.1	30.8	29.5	56.0	64.2	33.8	156.8	107.9	9.8	30.9	23.9	14.1	45.2	73.1	58.2	66.5	5.2	3.0	1.8	105.5	4.5	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	77.2	99.4	77.8	80.0	76.8	82.1	89.0	90.5	76.9	71.3	87.6	116.6	5.9	0.0	1.9	14.0	2.7	23.2	14.3	91.1	13.1	142.0	19.6	18.4	106.9	21.5	55.6	5.5	110.5	15.3	2.8	382.0	3.9	4.6	1.5	21.4	38.9	6.5	25.9	23.4	8.2	22.2	37.7	8.8	6.1	16.1	4.5	14.4	3.9	0.9	4.9	119.5	9.9	44.2	38.7	1.9	5.7	3.7	9.0	4.1	24.9	2.8	3.2	19.0	0.0	9.0	23.7	47.5	101.1	8.2	0.8	28.3	235.8	53.3	31.3	49.3	32.9	15.6	19.0	2.9	3.9	16.9	15.6	90.8	2.9	1.5	20.7	18.6
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 368.6;Microglial cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 84.2;TIME: 95.2;WM-115: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	0.2	0.1	18.8	2.2	17.5	1.0	0.4	16.5	16.5	0.9	7.2	0.7	0.4	0.3	6.7	2.6	4.5	1.6	1.7	16.2	26.5	0.1	0.2	1.7	0.4	24.3	22.8	0.5	2.7	0.3	0.8	0.7	19.0	0.6	1.0	4.2	0.7	0.1	0.0	0.6	0.4	0.1	19.8	0.4	4.9	0.8	20.1	0.3	4.6	0.0	0.8	2.7	0.5	20.1	5.2	42.1	18.4	14.5	3.9	5.0	5.1	23.2	15.9	5.2	11.8	4.7	17.7	9.7	29.5	80.8	27.6	6.7	10.0	19.8	21.7	18.5	2.1	6.9	37.7	10.7	59.6	18.1	6.3	11.9	84.2	14.6	64.6	7.6	65.1	9.6	9.5	24.4	27.3	3.7	2.5	1.7	3.6	25.1	11.9	2.8	6.1	11.5	3.1	20.1	7.6	1.5	10.1	2.9	35.4	3.9	4.4	38.1	95.2	6.7	18.8	10.2	18.3	20.5	10.3	9.7	11.4	9.7	138.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	18.8	17.5	16.5	16.5	16.2	26.5	24.3	22.8	19.0	19.8	20.1	20.1	0.5	0.0	8.4	368.6	2.5	4.6	7.5	8.8	1.8	7.3	2.2	1.3	5.4	1.5	8.1	0.0	2.1	3.6	28.5	7.9	0.0	4.4	3.2	3.2	2.3	27.8	27.0	0.8	12.5	25.1	0.7	5.7	65.2	18.3	4.5	1.0	2.9	0.4	0.6	1.7	7.3	19.8	22.4	0.3	63.5	0.8	2.5	18.3	5.4	148.9	51.7	47.9	0.0	12.1	8.6	30.4	1.5	2.2	4.1	58.5	0.4	0.1	7.3	2.0	0.0	2.1	4.0	1.1	0.7	1.9	3.1	1.1	0.9	7.0	4.2	37.6
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47471893	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.6;Excitatory neurons: 40.3;Inhibitory neurons: 13.6;Oligodendrocytes: 6.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 3.0;SCLC-21H: 8.9;SH-SY5Y: 4.4;SiHa: 3.9;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	0.3	2.6	16.9	0.1	22.5	0.0	0.1	31.6	34.0	0.8	0.0	5.9	0.2	6.5	0.1	1.1	1.9	0.1	0.1	38.3	7.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	7.7	0.0	7.8	0.0	0.0	0.8	0.3	3.4	0.2	2.5	0.2	0.1	0.8	3.5	0.0	0.0	1.3	1.5	2.5	0.1	0.1	0.0	0.0	2.0	0.5	13.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	8.9	4.4	3.9	0.4	0.3	0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	22.5	31.6	34.0	38.3	7.6	0.0	0.0	0.0	0.0	2.5	13.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	14.6	0.6	0.3	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.3	2.1	0.3	0.1	0.2	1.8	0.0	40.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.4	0.0	5.0	6.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.4	1.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	5.3	6.8	3.9	7.0	3.7	20.3	4.5	3.0	3.4	4.4	2.0	5.4	5.7	4.2	3.9	8.6	4.8	4.8	3.8	3.5	4.5	3.9	6.4	5.5	6.7	5.4	4.4	3.9	5.6	5.5	5.0	3.7	4.0	5.0	5.0	4.0	6.5	4.2	11.4	4.2	5.7	3.3	4.1	8.1	7.6	6.7	5.0	6.8	6.5	4.8	5.8	5.4	4.4	3.9	5.7	10.3	4.5	4.5	5.6	3.5	11.4	5.8	7.8	10.8	5.1	7.3	12.7	6.8	7.3	8.3	8.9	12.5	4.8	5.9	5.5	6.0	2.7	3.4	7.1	3.8	7.8	6.1	8.0	6.7	6.6	5.7	11.5	5.6	4.7	8.9	6.7	6.9	6.7	6.3	5.6	4.1	3.7	8.6	4.8	4.1	5.3	4.9	6.4	6.1	4.5	3.9	9.6	35.3	7.0	3.0	11.5	9.8	7.1	14.7	8.1	7.2	5.7	10.5	4.9	4.9	20.1	8.0	6.2	1.9	0.6	1.6	0.9	0.4	0.9	0.7	0.7	0.8	0.6	0.8	0.7	0.4	2.9	0.4	0.7	0.3	0.5	0.7	3.9	3.7	3.0	3.4	3.5	4.5	5.4	4.4	4.0	4.1	5.0	3.9	6.3	12.8	8.8	24.5	9.9	2.5	4.4	9.2	4.0	5.7	5.7	5.0	4.9	7.2	14.8	3.7	14.6	6.1	10.6	17.9	1.9	7.1	2.7	12.3	6.5	5.4	6.7	9.3	13.8	6.4	4.1	5.1	19.4	18.7	22.2	7.0	8.6	15.5	5.1	6.7	20.0	7.0	6.1	9.2	4.1	8.4	3.7	11.8	1.8	19.7	5.8	5.7	5.2	15.1	25.3	9.4	9.0	4.9	8.0	5.2	7.6	3.4	21.5	9.6	0.0	5.9	5.2	8.9	6.7	10.2	1.8	3.4	9.8	4.7	7.3	9.4
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 82.0;choroid plexus: 28.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	48.9	0.1	65.9	0.1	4.0	43.5	80.2	0.0	28.6	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	41.3	46.4	1.2	11.5	2.8	0.7	54.0	51.9	0.2	2.4	0.2	0.4	1.2	52.6	0.7	0.0	0.6	15.8	0.0	0.4	0.5	0.1	0.0	45.2	0.5	0.3	1.9	48.3	0.6	0.2	0.0	0.4	0.2	0.0	82.0	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	48.9	65.9	43.5	80.2	41.3	46.4	54.0	51.9	52.6	45.2	48.3	82.0	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853708-92172435	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.7	6.2	19.3	6.8	29.5	9.6	8.6	33.7	23.0	8.4	24.1	4.0	1.8	5.3	3.3	10.6	6.9	6.3	26.4	20.3	20.2	10.6	2.9	13.8	6.3	30.2	29.6	4.2	3.0	15.7	6.7	1.0	27.8	4.3	3.4	1.5	4.7	6.2	5.8	15.7	4.2	5.0	22.5	11.1	4.6	17.9	26.1	2.6	10.6	9.6	6.2	8.6	10.8	39.5	10.1	12.3	13.9	0.2	20.9	12.6	0.2	4.0	3.4	1.6	0.4	0.0	63.1	12.1	5.3	1.3	9.1	95.5	2.7	6.3	0.2	8.8	0.4	27.8	20.9	0.0	0.9	0.6	55.3	5.7	6.7	2.9	7.3	5.4	0.0	3.6	0.0	0.1	0.0	1.8	0.0	5.1	3.7	0.2	1.7	0.0	1.1	44.0	13.4	10.0	2.0	3.3	10.5	0.9	0.1	2.0	0.1	8.5	0.0	3.3	4.7	0.0	10.3	25.5	16.0	11.7	4.2	16.9	6.0	4.3	2.4	6.9	1.4	2.0	1.1	0.2	1.5	1.7	1.6	0.0	0.5	0.6	7.5	0.3	1.7	0.0	2.7	0.6	19.3	29.5	33.7	23.0	20.3	20.2	30.2	29.6	27.8	22.5	26.1	39.5	53.5	48.1	32.0	17.0	4.3	39.0	29.3	14.2	22.8	28.1	3.1	13.0	44.0	24.3	16.4	51.5	4.2	0.0	33.1	6.2	1.9	26.6	105.6	15.8	29.0	26.2	37.8	6.1	89.5	8.7	0.1	22.9	0.5	36.2	22.8	94.9	34.6	0.8	4.6	0.0	149.4	7.2	8.2	24.7	95.2	38.5	5.0	34.0	10.6	56.2	43.6	5.2	25.7	20.6	625.8	8.4	11.1	3.0	17.3	41.5	0.0	0.4	22.1	3.1	39.5	17.4	62.0	69.5	11.9	22.6	60.1	0.0	23.3	0.8	7.9	38.2
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882474	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 13.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.3;Excitatory neurons: 18.4;Inhibitory neurons: 14.0;Oligodendrocyte precursor cells: 25.1;Oligodendrocytes: 14.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 3.0;AF22: 1.2;LHCN-M2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074835	Enhanced				"Secreted in brain"	NA	NA		330000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"			"HPA074835: "	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.0	0.1	5.6	0.0	11.0	0.0	0.0	0.0	13.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	2.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	1.1	0.0	1.9	0.0	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	9.6	3.0	0.0	1.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	11.0	0.0	13.2	10.0	2.4	1.2	0.2	0.9	0.0	4.5	9.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	15.3	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.1	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967140-104029233	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	20.5	15.1	10.9	15.2	19.9	28.9	21.7	20.9	13.7	19.9	15.3	20.4	13.3	21.3	16.2	56.4	14.1	21.3	22.4	11.7	10.0	20.6	17.8	24.0	11.8	11.5	11.1	24.0	16.7	26.3	9.6	25.8	11.7	17.6	20.8	15.1	21.9	17.7	23.1	26.3	14.7	20.6	10.3	14.9	24.1	15.2	12.3	15.2	22.4	25.1	17.5	30.5	28.6	18.5	50.5	28.9	33.7	24.3	36.6	50.1	14.2	30.6	40.7	22.5	20.9	18.4	53.7	26.6	18.6	31.8	19.1	53.7	18.0	39.5	33.5	21.3	24.7	27.0	23.5	15.6	26.6	32.7	22.4	25.5	49.5	30.9	87.6	31.7	40.9	16.9	34.6	17.9	29.8	18.6	23.0	18.0	8.4	32.4	18.2	22.2	41.4	13.8	29.0	60.3	8.0	13.8	26.6	25.7	25.8	17.2	13.8	23.4	63.4	16.6	16.9	30.6	36.3	21.6	28.0	16.7	24.2	43.1	10.7	0.6	0.5	1.7	1.4	0.5	1.5	0.4	0.8	1.0	0.5	0.6	0.6	1.0	2.7	0.5	0.4	0.9	0.8	0.3	10.9	19.9	20.9	13.7	11.7	10.0	11.5	11.1	11.7	10.3	12.3	18.5	73.5	179.5	129.5	38.5	19.9	57.0	87.1	30.9	26.7	32.2	32.0	35.1	110.4	30.0	100.9	44.1	25.0	37.4	40.1	70.0	3.9	34.0	8.4	43.3	77.1	80.2	18.5	25.5	35.3	54.0	13.6	52.6	44.9	90.3	35.3	54.6	50.7	25.3	19.9	25.2	39.3	37.2	18.3	24.5	36.9	16.6	46.6	37.5	8.8	34.7	43.9	25.7	27.8	34.2	63.9	85.5	81.6	63.2	22.3	67.8	21.9	11.5	57.9	25.4	6.6	68.1	49.3	46.3	35.3	61.4	68.5	52.4	44.2	71.7	37.4	201.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 27919.2;salivary gland: 14140.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	79	"neutrophil: 321.8"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 321.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	9600000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	259.4	13.8	4.1	70.8	4.3	353.5	306.7	5.0	22.5	27919.2	28.9	97.8	4.5	107.1	16.5	1372.7	714.2	294.7	68.4	4.5	4.8	382.6	268.0	1181.7	2.0	5.6	5.5	11.5	36.1	5.5	470.2	8.3	5.5	112.6	106.7	0.6	14140.1	2946.3	599.9	272.4	19.9	14.0	4.8	22.5	154.7	28.1	10.4	47.7	30.4	51.5	215.8	226.6	685.3	4.8	4.9	19.4	0.0	0.3	0.2	0.0	1.1	0.1	0.0	0.1	0.0	1.5	318.7	0.9	1719.5	0.2	23.9	132.8	0.0	64.1	0.0	8.6	0.3	0.3	227.1	0.2	326.4	0.5	1.0	8.8	2037.1	0.1	134.0	0.0	0.2	0.0	0.2	0.3	0.0	0.4	0.4	24.4	0.4	767.9	120.1	0.6	0.7	0.1	355.5	14.6	0.3	0.0	622.1	131.4	1.8	0.4	2.8	531.8	0.3	0.4	8.5	1.2	1.1	1.2	9.7	6.1	0.0	33.0	0.5	3.6	0.9	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	321.8	0.0	4.0	0.0	0.0	7.9	4.1	4.3	5.0	22.5	4.5	4.8	5.6	5.5	5.5	4.8	10.4	4.8	6.3	1807.7	4134.5	0.3	5.4	100.7	1330.7	18759.4	2.2	0.0	594.2	607.6	3.9	1609.9	20435.8	3428.2	0.0	2.3	10.1	225.8	0.0	407.5	381.6	632.0	170.7	43.3	200.2	18.7	0.0	258.9	1.2	326.0	193.7	1398.8	77.0	0.0	15.7	508.5	6.8	0.0	0.0	74.7	2616.3	8.5	73.3	69.8	25.4	27.1	39.2	0.0	5.3	0.0	0.0	1.0	0.1	901.6	370.3	0.0	1.3	1289.4	2.7	3.4	8096.4	0.0	0.0	8.6	971.2	1.8	1.8	347.3	138.9	2.1	29.5	0.0	224.5	3338.5
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: AB_2685803"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	48.6	52.6	38.0	38.6	42.4	37.5	46.5	46.2	36.7	43.2	35.6	47.5	36.7	38.6	41.0	55.0	46.8	39.6	53.8	32.9	48.6	43.3	35.6	46.7	44.5	50.2	43.2	52.5	40.4	44.6	20.3	42.7	51.9	36.4	48.7	70.5	36.7	44.8	57.4	34.0	37.4	47.9	47.8	47.5	45.2	51.5	42.4	72.4	75.7	55.5	55.2	53.8	31.1	59.4	81.1	113.7	68.0	66.2	106.1	128.5	77.4	86.1	102.7	87.9	101.8	43.8	75.6	124.8	60.3	110.0	123.0	86.6	77.2	96.1	116.9	136.4	39.3	106.4	164.4	71.9	123.2	149.6	104.1	95.8	121.4	75.5	172.9	102.1	98.6	99.7	50.3	101.6	109.6	52.7	103.4	71.6	33.6	4.4	26.7	74.4	98.9	85.9	197.8	137.2	62.8	73.3	103.7	70.1	85.7	65.8	53.5	97.7	111.4	129.5	74.2	35.6	63.6	99.0	102.7	108.3	89.6	99.9	97.1	58.8	33.6	38.7	23.8	38.5	29.8	16.7	32.3	29.9	32.8	13.9	35.3	27.6	34.1	38.6	33.0	23.3	40.5	31.6	38.0	42.4	46.2	36.7	32.9	48.6	50.2	43.2	51.9	47.8	42.4	59.4	55.0	44.8	36.1	55.8	36.3	54.4	44.1	38.3	54.1	48.0	44.2	30.2	49.2	41.5	45.5	77.3	212.7	48.2	53.0	42.8	39.2	36.5	68.1	58.6	53.0	53.1	51.0	36.4	63.4	43.5	40.3	40.5	44.4	68.1	21.5	80.0	56.4	29.6	43.9	35.3	50.5	46.1	38.7	57.3	41.8	131.9	41.7	48.7	51.6	104.9	63.9	44.8	72.1	96.0	130.0	44.0	31.6	53.4	34.5	66.1	37.9	39.5	41.8	88.1	32.9	53.5	39.6	37.2	39.4	59.2	61.8	69.5	47.4	41.7	42.3	77.2
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702236-66782849	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.1;lung: 27.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (5.45e-5)"	9.5	2.6	5.2	1.6	4.9	0.1	7.6	4.9	4.3	6.8	8.6	3.7	1.9	6.2	0.6	2.1	5.4	1.4	30.1	3.4	4.1	8.9	6.7	27.9	0.5	7.6	5.4	5.9	2.7	1.1	3.4	7.4	5.8	7.0	1.1	0.9	2.1	3.5	1.6	2.4	3.9	0.9	4.4	2.6	5.5	1.8	6.8	0.4	15.5	1.5	0.2	8.0	5.7	4.6	1.3	10.2	1.6	3.5	6.0	1.6	9.4	7.2	0.1	1.1	0.1	2.0	4.6	0.7	29.8	6.1	0.9	18.2	2.2	0.0	0.2	2.3	8.4	16.1	28.6	1.7	0.7	0.1	1.2	2.0	0.0	0.1	0.0	3.4	1.3	5.1	1.4	1.0	0.5	2.0	0.1	4.4	3.0	10.5	3.8	0.0	1.8	2.2	3.4	8.1	3.6	1.6	3.9	4.3	0.8	5.9	1.4	2.9	6.2	4.3	5.5	17.6	1.4	0.5	1.8	0.3	3.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.9	4.9	4.3	3.4	4.1	7.6	5.4	5.8	4.4	6.8	4.6	19.8	12.8	6.0	5.2	0.9	0.8	1.2	2.1	0.6	0.6	0.9	1.1	4.9	4.3	3.0	1.8	2.1	0.8	0.1	4.3	3.9	4.7	3.4	8.3	5.5	25.1	0.0	0.0	0.3	5.8	0.9	4.9	5.1	6.5	4.5	5.9	91.4	4.0	1.7	0.0	0.3	2.1	0.0	10.0	0.3	1.4	2.8	1.2	0.0	57.1	0.7	10.2	0.0	0.5	0.4	8.4	1.5	8.2	0.0	1.3	2.1	1.9	0.1	0.6	0.0	0.9	1.5	0.2	3.2	0.4	0.1	0.8	0.4	0.1	5.5	0.4
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960932-11079426	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 372.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004208, HPA048340"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nucleoli fibrillar center, Nucleoli rim"	"CAB004208: AB_626762, HPA048340: "	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.8	16.2	14.4	22.6	14.3	31.8	13.0	15.3	23.7	16.1	13.2	18.1	19.9	14.5	9.5	32.9	20.8	13.3	16.2	15.4	9.6	15.7	8.6	17.9	27.0	10.4	10.4	14.9	18.3	22.9	11.1	20.2	11.0	17.7	12.9	19.7	25.9	15.6	23.7	28.1	17.2	14.5	3.9	19.5	20.4	30.2	11.8	43.1	20.6	13.9	23.7	17.4	14.7	19.3	92.5	5.0	157.2	149.8	30.3	25.4	68.9	62.7	37.2	74.6	54.9	126.9	4.0	215.4	94.2	54.9	3.0	65.9	123.6	77.5	40.8	89.5	93.3	171.3	76.5	149.6	45.7	125.5	82.0	43.1	36.7	63.1	64.5	33.3	67.5	92.0	156.7	78.3	59.2	188.0	210.0	107.5	159.9	45.1	134.7	220.6	99.5	111.7	47.9	114.8	177.8	161.7	66.6	84.4	73.5	50.1	71.9	93.3	90.9	110.3	57.3	102.5	104.9	160.6	192.2	209.1	62.6	118.5	96.0	5.7	5.8	6.4	9.3	6.9	8.2	5.3	6.8	7.9	6.1	6.8	7.6	7.5	3.4	8.5	10.8	7.9	6.4	4.7	14.4	14.3	15.3	23.7	15.4	9.6	10.4	10.4	11.0	3.9	11.8	19.3	25.4	67.3	72.6	27.4	28.5	37.0	43.7	43.8	24.5	91.3	42.2	28.4	372.9	40.0	62.7	44.1	70.9	65.9	21.2	60.1	41.1	79.8	53.0	58.8	49.2	58.3	63.2	41.8	32.2	61.4	57.3	43.8	50.0	63.5	30.4	75.3	28.5	21.9	42.3	101.0	39.6	47.7	57.0	23.8	21.5	37.6	26.1	30.4	16.0	14.0	43.8	36.1	23.7	32.6	28.1	76.4	41.8	13.5	37.6	66.0	29.8	27.6	62.5	69.1	13.1	45.1	66.4	99.4	86.0	52.2	51.7	61.0	30.4	68.1	60.5	50.1
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838009	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	35.9	46.4	2.3	6.9	2.5	3.3	40.3	4.1	10.0	51.5	2.7	40.9	8.1	51.4	0.4	51.0	40.4	2.2	44.0	2.3	2.3	47.0	36.9	32.3	5.8	4.3	2.7	63.1	43.9	1.2	48.0	1.2	2.7	36.6	1.1	25.3	44.1	0.6	48.1	50.1	51.7	0.6	2.2	51.7	40.4	68.3	2.3	3.5	41.3	1.8	1.5	37.5	40.9	2.9	2.4	1.6	28.2	2.6	2.7	0.7	5.8	9.2	2.7	2.7	4.3	3.4	2.6	24.2	7.9	1.2	2.9	4.4	6.9	4.6	4.5	4.1	10.5	20.1	3.2	2.1	3.0	21.7	5.6	1.6	3.4	3.2	6.9	1.4	1.4	3.0	5.6	12.9	1.7	6.1	17.6	5.0	8.6	7.2	5.7	11.0	23.1	10.8	2.3	4.5	13.4	10.1	2.2	0.6	17.9	14.8	2.2	3.3	2.2	2.4	9.8	3.8	2.7	13.8	14.3	17.7	1.8	11.3	6.8	7.1	12.8	6.4	4.4	13.4	6.4	24.4	5.5	5.7	12.0	9.2	4.5	3.0	1.1	9.8	16.8	13.3	10.4	8.1	2.3	2.5	4.1	10.0	2.3	2.3	4.3	2.7	2.7	2.2	2.3	2.9	33.6	6.4	8.6	17.0	120.2	50.2	73.3	85.1	51.2	55.4	42.9	49.1	6.1	47.1	37.4	47.8	20.9	120.6	61.8	36.6	84.1	94.6	42.6	40.9	54.9	37.4	71.8	57.8	14.1	77.1	228.1	46.2	41.8	41.1	34.8	112.2	41.0	20.3	76.1	67.3	18.4	54.6	99.7	23.0	41.7	18.9	35.8	36.5	56.9	15.9	51.2	92.4	45.3	17.1	18.1	74.7	53.1	32.0	139.6	74.4	41.9	86.4	28.5	49.6	19.7	47.7	62.8	138.9	163.3	64.5	53.0	160.1	42.0	96.8	65.4	65.1
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA		33000	"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	16.6	11.8	8.7	28.4	11.7	30.3	17.2	15.0	9.5	13.8	9.6	20.0	18.6	21.0	8.0	17.1	16.7	11.5	15.6	7.8	9.5	16.3	18.8	16.0	34.4	10.2	10.7	19.1	14.4	25.8	6.3	18.2	10.7	14.0	18.4	21.0	15.1	13.0	17.9	18.1	15.9	22.9	8.7	20.1	15.7	7.8	11.3	58.1	16.8	18.8	29.9	15.5	12.4	13.9	110.0	115.1	92.4	76.1	32.4	35.4	51.5	68.0	37.0	76.4	59.4	71.6	60.5	115.8	54.1	40.7	105.2	78.9	162.9	92.6	85.1	91.7	176.0	94.3	133.9	51.1	15.4	134.9	120.9	20.6	23.3	86.0	52.8	19.4	67.5	68.7	144.7	64.7	58.6	69.2	122.0	40.8	139.9	47.8	55.6	117.2	165.5	100.1	34.4	69.4	92.8	83.5	176.9	84.4	33.5	122.8	87.9	54.0	45.7	63.3	68.0	65.1	62.2	45.8	77.9	91.9	39.1	152.1	64.1	2.7	6.8	4.5	7.3	8.5	7.6	5.4	5.8	6.7	8.4	5.8	5.2	6.3	2.7	4.6	12.4	4.6	5.7	6.7	8.7	11.7	15.0	9.5	7.8	9.5	10.2	10.7	10.7	8.7	11.3	13.9	40.7	44.8	39.9	16.0	45.6	24.1	37.0	27.7	28.5	46.6	30.7	27.4	63.5	27.1	47.4	20.2	27.1	43.2	57.7	49.6	7.9	31.6	10.5	46.5	62.6	41.7	19.9	70.7	12.0	27.1	61.4	37.2	29.0	44.0	35.4	42.7	18.9	54.1	47.6	60.6	14.2	43.5	22.4	41.1	27.6	7.6	37.9	51.5	23.2	24.4	55.2	38.1	59.8	16.6	30.2	33.1	23.6	36.1	61.2	40.7	29.0	24.6	47.1	48.4	39.5	49.5	71.0	54.5	51.2	39.8	24.4	48.4	47.9	34.0	51.4	32.0
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567695-110606048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Spermatocytes: 994.2;Spermatogonia: 799.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043206	Approved		Supported	Nucleoplasm		NA	NA		630000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA043206: AB_2678362"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	19.5	13.3	9.0	18.7	10.9	43.9	19.1	18.5	11.7	18.5	11.7	18.3	15.5	20.3	15.7	19.2	16.5	11.1	12.9	8.6	10.2	14.0	15.3	14.5	25.2	10.2	9.4	25.7	19.6	20.0	14.2	20.7	10.4	14.0	16.7	27.6	16.2	15.2	21.1	20.6	19.4	16.9	9.6	18.6	14.7	38.1	9.5	39.2	16.5	14.1	24.3	15.5	17.8	12.7	73.1	44.5	95.4	67.8	30.7	26.3	40.9	57.7	56.7	51.9	50.7	56.4	59.7	94.2	24.5	38.6	40.0	56.5	68.7	35.0	78.6	77.3	60.1	76.5	56.2	51.2	30.8	109.8	56.6	21.1	28.0	57.4	89.5	48.5	38.8	31.7	61.7	70.4	45.4	38.1	85.2	58.3	66.1	38.6	35.1	71.1	171.5	51.4	32.4	31.7	53.7	61.8	62.0	17.7	48.6	61.8	28.5	53.1	40.1	41.6	65.5	47.6	84.4	40.9	38.8	99.6	37.5	103.9	34.8	20.7	6.1	15.8	9.6	8.4	12.1	11.0	11.3	10.6	6.8	11.0	11.3	11.2	6.5	12.6	7.6	8.7	14.5	6.2	9.0	10.9	18.5	11.7	8.6	10.2	10.2	9.4	10.4	9.6	9.5	12.7	74.9	80.1	62.0	16.6	73.5	60.5	53.2	64.1	34.7	81.3	44.3	49.9	64.5	47.1	64.4	55.2	75.0	119.6	94.3	29.8	25.4	96.9	56.9	52.0	65.0	74.9	40.7	104.6	26.2	45.6	111.4	66.0	20.9	49.0	56.3	124.9	40.4	31.9	59.1	60.6	29.2	40.7	54.9	37.9	42.5	34.6	115.2	49.8	37.4	19.7	96.1	54.9	98.9	33.2	43.4	53.0	70.1	114.0	65.0	44.7	70.7	30.3	68.3	78.9	184.1	102.0	110.6	994.2	799.1	48.1	64.5	49.1	80.9	112.7	51.9	37.5
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434954	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 74.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes		25000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	6.8	6.5	1.0	21.2	2.0	36.3	6.8	1.2	1.7	6.3	1.5	13.2	14.0	7.4	2.3	23.5	4.5	7.6	7.3	0.9	1.9	5.9	7.8	11.8	37.1	1.7	1.4	5.9	7.8	3.8	2.0	16.2	1.6	5.8	14.9	7.7	4.6	5.0	3.6	11.0	15.4	10.1	1.3	14.7	11.8	32.5	1.9	60.6	9.0	6.8	31.6	9.6	4.3	3.2	386.3	72.8	155.0	73.0	31.5	30.9	72.1	181.2	88.8	206.0	176.8	94.4	209.7	236.6	101.9	81.1	140.0	212.5	183.0	95.0	332.4	297.9	113.8	234.7	123.3	33.6	17.3	158.3	182.6	14.6	13.3	114.4	96.5	78.5	94.8	103.2	130.3	272.2	133.9	78.3	183.2	44.4	91.8	106.7	149.3	180.1	238.8	177.3	43.4	54.8	93.7	94.0	141.4	135.1	65.5	76.6	156.9	128.6	84.8	132.2	105.2	119.9	349.8	181.1	192.2	412.0	96.7	166.9	151.9	74.4	6.0	23.6	11.5	8.9	11.4	17.2	18.2	14.3	6.6	15.0	11.4	10.2	10.8	15.3	15.9	11.7	30.3	9.5	1.0	2.0	1.2	1.7	0.9	1.9	1.7	1.4	1.6	1.3	1.9	3.2	24.6	105.8	174.0	3.9	43.7	40.8	18.2	33.1	30.7	14.9	21.5	21.0	41.3	25.8	35.0	35.0	8.4	74.6	54.4	41.4	3.9	20.9	48.6	35.2	27.0	44.8	30.1	305.8	3.5	14.7	138.1	50.7	32.6	36.1	79.1	77.3	38.2	20.4	61.3	0.0	2.9	44.5	24.4	29.7	43.5	28.3	25.1	36.4	17.8	17.8	39.3	9.3	46.4	3.5	30.1	13.5	26.5	48.2	95.9	14.1	25.9	8.6	25.4	25.8	131.5	21.7	73.2	339.8	239.4	58.1	35.7	34.1	58.4	34.6	69.7	19.1
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6 nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303785	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.2	13.0	15.5	12.3	14.6	13.6	10.5	17.6	15.0	16.4	13.2	11.4	9.3	26.6	11.1	16.4	21.7	17.2	14.0	13.8	17.8	12.3	7.4	11.9	12.3	19.9	17.3	37.5	7.4	14.4	13.3	10.5	14.3	13.9	9.4	19.2	10.4	12.8	12.9	16.0	10.9	18.9	12.5	9.8	9.6	19.5	16.0	23.1	11.7	9.1	10.9	13.1	12.0	14.8	14.9	22.5	31.7	20.6	33.6	27.0	16.3	23.6	25.9	26.3	22.2	27.6	7.3	15.7	8.3	34.8	12.0	21.3	23.5	20.1	27.4	15.7	14.7	15.3	11.8	13.5	19.2	8.2	10.5	38.5	14.5	21.2	18.6	42.6	24.3	15.3	12.8	18.5	19.9	11.7	20.8	6.6	10.2	8.9	11.7	21.4	20.2	6.2	15.2	13.5	5.3	16.1	24.6	7.1	10.2	22.2	11.1	6.0	32.2	24.0	13.1	25.6	25.1	16.0	10.5	7.2	19.1	9.1	14.0	3.0	0.7	0.8	1.3	0.3	1.3	0.5	1.1	1.3	0.4	0.7	1.5	1.1	0.5	2.0	1.6	1.3	0.6	0.6	15.5	14.6	17.6	15.0	13.8	17.8	19.9	17.3	14.3	12.5	16.0	14.8	17.2	22.4	18.4	41.4	13.2	7.9	13.8	13.1	10.2	35.6	13.8	14.5	8.0	7.2	11.8	14.7	75.0	16.5	17.7	17.9	5.9	13.8	22.5	19.4	37.1	20.3	4.2	12.8	57.1	12.4	10.7	21.0	18.3	21.3	10.8	20.3	17.9	9.1	10.3	47.1	61.7	14.4	16.2	8.7	6.8	36.9	16.8	10.6	8.8	81.5	15.9	24.8	21.6	44.7	64.3	17.2	15.2	19.9	14.6	14.7	10.1	7.6	17.9	50.5	26.3	27.1	20.4	63.7	59.0	15.1	8.7	17.4	24.9	22.4	13.5	14.2
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7 nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	17.4	16.2	19.2	21.9	20.8	43.1	17.0	28.1	24.4	19.6	21.4	20.0	20.5	19.6	15.4	22.9	25.9	15.3	22.0	20.4	18.1	21.8	22.7	18.7	25.8	16.5	17.8	25.9	21.8	24.8	20.4	18.9	16.0	17.0	23.8	32.0	21.6	16.1	25.8	25.3	20.5	17.9	16.0	21.5	22.4	67.5	19.5	35.7	23.5	27.9	30.2	18.1	19.3	20.0	56.4	33.6	47.5	37.3	31.8	29.8	78.9	33.8	61.8	36.9	28.0	50.1	42.8	78.9	37.9	42.1	33.5	59.4	64.5	50.1	43.4	35.2	28.1	63.8	36.3	41.0	32.1	84.4	39.1	27.3	45.0	50.6	116.1	30.0	41.0	42.9	80.6	54.0	38.8	56.9	59.7	37.1	82.4	66.9	19.1	37.2	53.0	61.9	28.3	51.7	63.7	49.7	52.2	73.1	40.5	80.4	72.9	34.0	39.3	41.5	42.9	41.7	48.5	58.6	74.3	63.5	33.8	46.9	45.3	2.0	5.8	6.2	5.6	5.7	5.1	5.5	5.0	5.5	6.6	4.7	5.5	5.9	6.8	5.9	3.2	7.0	4.9	5.1	19.2	20.8	28.1	24.4	20.4	18.1	16.5	17.8	16.0	16.0	19.5	20.0	31.3	22.4	20.6	66.3	26.8	27.0	11.6	13.9	23.3	22.6	21.4	15.6	31.8	20.0	20.5	27.6	31.3	11.4	23.9	38.5	9.8	12.1	58.1	39.8	23.6	26.8	34.6	28.8	63.0	15.8	16.5	14.9	31.1	48.0	22.1	19.4	25.4	45.2	13.2	30.3	63.0	23.0	6.1	38.6	48.6	49.5	15.2	25.2	10.6	52.5	20.0	9.6	15.5	70.9	99.1	17.6	19.9	12.4	36.2	16.7	30.4	12.9	30.5	19.0	39.5	14.5	23.8	35.2	23.8	30.8	26.9	10.8	24.2	13.0	18.8	23.2
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188633-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Granulosa cells: 13.0;Leydig cells: 20.8;Muller glia cells: 16.6;Peritubular cells: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.3;AN3-CA: 84.9;NTERA-2: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	5.2	6.0	9.4	2.6	10.8	0.4	5.5	9.9	9.6	27.4	18.4	9.6	2.5	19.2	18.6	12.0	14.5	8.4	8.0	8.9	10.0	19.0	23.9	3.6	2.2	12.4	12.4	28.3	6.3	16.1	19.2	2.6	9.9	20.0	2.1	2.0	11.5	12.3	3.7	17.1	5.7	8.1	11.8	2.8	6.3	5.6	11.4	4.4	9.1	3.7	2.0	9.0	16.7	9.7	1.6	18.2	45.3	84.9	1.1	0.2	14.3	5.2	6.7	10.1	5.8	13.8	0.1	0.0	13.9	10.4	22.8	28.3	27.4	1.5	3.9	0.0	23.0	9.4	0.0	22.5	5.5	0.4	0.0	16.2	11.0	3.3	0.0	19.9	5.8	24.9	1.5	0.0	3.1	0.0	24.4	0.1	64.2	0.0	5.3	35.1	19.7	0.0	5.2	0.0	1.3	30.2	0.0	0.0	12.3	16.8	11.1	5.8	0.0	0.7	14.1	17.6	10.1	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.8	9.9	9.6	8.9	10.0	12.4	12.4	9.9	11.8	11.4	9.7	0.4	0.0	0.0	27.4	0.2	1.9	2.3	3.9	2.8	0.7	3.3	5.2	1.4	2.8	3.8	11.0	0.0	0.3	0.4	0.0	1.9	3.4	0.4	1.0	8.6	0.6	0.0	0.0	1.4	1.1	0.3	7.6	0.0	1.3	0.0	13.0	1.4	8.4	4.2	0.0	0.8	0.1	2.0	1.6	1.8	1.3	20.8	1.0	0.0	3.7	0.6	16.6	0.0	4.5	0.5	1.3	0.1	21.8	0.0	2.7	0.0	3.9	0.7	0.4	6.6	3.5	3.9	0.0	2.0	3.3	2.8	0.5	0.1	6.9	0.6	0.7
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	4.1	6.6	5.5	4.0	5.2	1.7	3.8	10.4	7.6	6.5	4.9	5.8	4.2	5.9	5.4	5.5	5.1	3.8	7.0	7.7	5.5	4.6	3.4	4.3	4.4	5.4	5.5	7.1	4.3	4.9	5.1	6.2	6.2	4.8	5.1	11.3	4.5	3.7	7.9	5.0	5.3	4.5	4.5	4.9	4.8	5.5	6.4	3.5	4.4	6.2	3.9	5.1	5.9	8.0	4.7	5.9	12.3	4.7	9.6	10.0	7.2	7.2	3.1	4.2	4.9	2.8	2.0	3.3	2.7	4.6	5.9	2.8	6.6	3.4	5.1	15.5	7.7	11.9	13.4	4.0	4.8	2.7	8.9	6.5	6.6	2.9	3.3	17.7	7.8	7.7	3.4	5.3	9.7	1.4	3.2	8.5	3.9	3.5	15.4	6.6	1.5	1.8	7.3	2.8	13.1	9.2	2.5	2.2	1.7	10.7	5.3	5.5	6.5	7.0	2.7	3.0	9.3	6.9	9.0	4.2	4.4	3.5	3.3	4.9	14.2	7.8	7.6	24.6	7.6	15.2	7.6	7.0	11.2	16.5	10.9	10.5	1.7	7.8	32.2	9.2	12.2	8.9	5.5	5.2	10.4	7.6	7.7	5.5	5.4	5.5	6.2	4.5	6.4	8.0	13.8	19.2	11.9	31.6	21.1	9.6	14.1	18.1	8.6	19.7	9.7	6.9	39.5	7.2	16.8	20.2	31.3	12.4	14.5	21.3	13.7	17.6	121.7	15.2	14.8	18.7	15.0	19.4	56.0	9.2	17.3	15.3	11.2	14.7	17.2	22.2	20.3	14.8	16.1	35.3	63.9	15.7	38.7	25.0	10.7	270.7	33.8	16.3	19.6	26.2	21.5	13.8	18.6	46.8	46.3	12.4	27.9	30.5	18.0	9.8	36.4	28.4	23.9	19.0	13.1	11.6	32.0	113.3	27.1	9.1	11.9	9.7	13.4	34.6	17.7	11.7
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		74000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	77.2	106.0	30.1	41.3	28.2	49.5	79.1	29.2	46.0	108.1	29.8	90.6	39.4	96.6	21.0	103.9	95.4	13.8	88.1	28.4	32.4	83.4	96.3	81.2	43.5	28.6	28.5	107.7	95.9	28.6	104.9	26.8	27.9	107.4	21.9	18.5	92.9	23.3	104.2	95.2	90.5	20.7	24.6	106.7	94.3	72.9	28.4	45.8	103.5	16.7	33.0	81.9	94.4	34.1	178.5	224.0	142.3	101.6	56.4	34.3	155.3	125.4	81.7	136.1	118.1	140.4	103.5	203.9	127.1	89.0	123.1	152.2	176.6	128.2	101.0	137.0	468.2	185.9	103.6	164.9	29.2	209.1	125.2	48.0	35.4	99.6	67.2	64.5	103.0	107.2	195.4	65.7	84.4	175.3	218.8	338.3	175.3	102.9	167.4	254.7	133.7	124.6	87.9	113.7	112.3	136.9	158.3	96.1	94.8	94.5	98.9	132.3	147.0	101.8	190.5	86.7	223.5	164.3	156.5	263.2	84.1	135.9	95.2	0.8	2.0	1.8	1.8	1.5	1.1	4.0	1.4	0.8	2.0	1.7	2.0	1.5	0.8	4.1	1.8	1.7	1.2	0.8	30.1	28.2	29.2	46.0	28.4	32.4	28.6	28.5	27.9	24.6	28.4	34.1	86.6	19.2	63.0	198.5	107.2	139.4	166.8	78.4	93.9	108.7	97.8	109.5	31.6	55.8	66.0	75.4	89.6	179.7	97.5	89.8	46.9	108.1	23.7	101.8	141.9	84.2	118.0	76.6	81.0	105.1	208.6	92.3	110.1	123.0	55.1	111.7	61.4	97.4	125.8	114.4	99.2	121.4	77.3	58.7	97.7	21.3	130.1	77.8	69.4	74.0	75.8	82.6	76.2	110.6	151.9	116.0	80.0	110.6	112.0	177.1	95.0	77.5	59.3	109.6	124.9	102.3	101.2	109.7	108.6	92.3	130.7	176.4	96.3	115.4	119.6	154.7
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004652: AB_425687, HPA046440: AB_2679668, HPA054834: AB_2682619"	"unprognostic (3.53e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	45.3	42.1	33.3	40.8	36.6	59.9	47.0	33.8	39.6	61.7	36.1	54.4	36.4	54.8	42.6	55.1	58.4	18.2	38.6	32.7	35.7	48.2	44.9	48.5	57.1	34.5	34.5	69.2	38.0	20.5	47.7	28.7	34.4	55.0	33.8	10.8	41.1	33.0	51.0	41.2	52.7	30.2	34.5	65.2	45.9	36.5	33.9	63.5	56.2	27.6	48.2	53.8	51.7	35.0	143.4	134.6	157.2	129.4	44.2	56.8	125.9	53.8	76.8	145.5	151.9	119.4	129.8	197.2	70.1	75.6	76.2	114.2	162.0	149.6	126.7	96.7	191.5	137.0	115.2	150.0	64.9	159.8	90.0	56.1	36.6	101.4	164.6	78.2	131.7	180.1	167.5	101.2	98.5	145.4	273.7	285.1	164.1	133.1	134.8	251.6	102.0	154.5	100.8	88.4	117.8	113.4	102.4	113.4	90.6	84.3	110.1	150.8	73.8	77.4	127.8	77.5	131.2	107.4	121.6	252.9	78.0	179.3	100.0	3.2	28.0	7.5	27.6	32.2	29.2	28.1	29.2	32.4	56.5	26.4	29.6	27.9	2.5	28.0	16.2	34.7	31.8	23.0	33.3	36.6	33.8	39.6	32.7	35.7	34.5	34.5	34.4	34.5	33.9	35.0	39.3	12.8	15.2	4.9	53.0	35.9	51.6	63.7	63.7	7.2	49.8	67.2	7.2	15.7	27.0	25.8	2.1	87.1	39.6	34.9	43.0	41.6	32.7	22.7	31.1	34.2	33.0	65.4	5.4	49.4	127.0	43.7	51.0	37.6	32.4	67.0	31.4	21.9	60.1	5.0	6.5	44.9	48.8	29.9	35.0	14.6	37.3	37.5	23.2	3.7	50.4	17.8	29.9	6.0	9.5	44.6	29.4	28.2	56.6	38.9	34.6	35.2	17.5	5.1	19.7	28.2	75.7	60.7	66.2	85.1	33.1	66.4	50.9	44.3	61.2	47.7
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	113.4	110.5	45.0	110.7	45.1	345.4	111.6	50.8	54.5	103.7	48.5	108.1	102.6	119.4	66.7	177.1	93.7	62.7	90.1	46.7	47.1	103.6	91.9	111.7	166.7	47.7	45.1	93.8	78.0	83.1	72.5	82.9	47.4	87.9	86.5	25.0	99.7	62.4	112.6	148.5	109.2	85.9	48.6	139.0	100.7	83.2	46.8	168.9	77.1	59.9	154.0	109.3	108.9	50.4	782.5	1063.7	376.7	340.4	83.8	149.1	418.7	334.6	259.8	693.8	556.2	1209.6	555.7	588.8	210.6	203.2	556.7	567.8	370.7	636.2	350.3	239.7	658.6	400.5	190.0	1148.0	290.0	560.3	236.6	171.3	237.9	564.0	252.6	132.2	389.0	491.1	561.0	414.6	288.7	543.0	897.1	916.2	825.2	405.8	520.8	531.3	379.0	711.4	266.8	407.8	405.6	442.7	414.5	554.3	503.2	162.8	524.5	612.9	266.7	404.4	340.9	360.8	764.8	345.5	938.8	877.1	137.7	623.8	419.5	167.9	166.7	133.0	202.8	210.9	170.5	210.7	178.0	179.5	226.7	210.6	144.2	167.5	87.8	166.0	221.6	237.4	241.5	266.0	45.0	45.1	50.8	54.5	46.7	47.1	47.7	45.1	47.4	48.6	46.8	50.4	197.0	44.8	69.1	4.6	206.9	478.6	335.2	309.4	150.2	46.8	156.8	151.8	17.9	112.9	167.3	93.8	12.5	365.2	251.9	163.6	144.8	347.3	17.1	98.3	143.0	202.9	142.0	170.0	6.8	295.8	647.8	155.4	89.2	128.4	144.5	215.0	83.2	60.8	294.8	30.3	6.3	239.4	203.4	102.7	308.3	20.4	159.1	158.0	190.3	6.5	189.5	68.9	265.7	6.0	8.5	404.6	171.9	123.8	176.9	421.8	119.3	143.6	98.9	57.5	157.8	169.6	228.5	329.6	308.3	181.5	423.1	373.4	210.1	306.7	293.5	433.2
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742564	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 524.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 381.4;SK-MEL-30: 378.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: AB_2681245, HPA076104: AB_2732301"	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.5	27.6	23.9	30.9	24.9	53.9	31.0	24.3	35.7	22.3	26.0	26.4	24.3	29.0	35.2	20.8	24.4	21.9	25.0	24.9	25.9	42.3	30.1	22.2	43.3	24.9	25.2	29.1	18.3	26.9	22.6	28.7	24.7	21.9	26.5	11.2	21.1	21.6	30.2	17.0	24.6	27.1	25.6	28.4	23.4	22.6	24.7	37.3	25.6	27.2	36.6	28.9	19.8	27.3	76.0	73.3	94.3	59.1	46.1	57.8	104.7	73.4	60.9	78.0	76.1	84.6	83.5	121.0	56.0	63.0	119.2	69.3	74.9	85.5	111.0	40.0	62.8	111.8	22.4	157.4	53.9	132.0	73.8	57.6	56.0	71.5	55.6	58.1	74.4	81.3	93.8	53.6	80.6	79.2	152.5	159.6	84.2	381.4	97.0	86.1	113.1	84.9	76.9	50.8	49.8	142.3	54.5	147.6	378.7	69.4	93.8	106.5	63.7	71.0	71.2	64.4	122.7	46.9	102.8	134.7	33.7	77.8	157.1	51.8	29.4	47.4	27.3	38.6	35.8	31.5	34.7	31.5	31.6	29.1	30.0	33.4	12.8	31.7	40.5	45.9	48.0	29.9	23.9	24.9	24.3	35.7	24.9	25.9	24.9	25.2	24.7	25.6	24.7	27.3	125.9	44.8	58.0	6.2	128.6	89.1	186.9	238.2	60.3	30.7	93.8	118.5	67.4	107.2	126.5	93.8	0.0	281.4	150.1	79.6	215.2	165.9	163.3	105.3	150.3	124.6	93.3	131.7	12.9	169.2	288.3	120.8	50.0	120.5	132.5	103.2	140.3	139.3	227.3	48.8	14.3	133.3	152.5	157.9	124.6	35.1	172.7	120.5	110.3	8.4	195.4	77.7	153.5	15.1	21.5	169.4	102.7	155.7	91.2	143.8	94.9	524.6	107.2	25.1	98.6	118.7	147.5	192.4	130.4	60.8	96.0	376.9	150.1	94.7	127.7	170.2
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNRPD1	"HsT2456, Sm-D1, SNRPD"	ENSG00000167088	"Small nuclear ribonucleoprotein D1 polypeptide"	P62314	18	21612314-21633524	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040516	Supported					NA	NA		480000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA040516: AB_10673236"	"unprognostic (1.83e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-3)"	"prognostic favorable (7.90e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.83e-1)"	45.9	35.7	33.1	54.5	32.6	94.6	39.0	34.4	51.8	37.1	31.0	48.8	42.2	37.3	26.4	67.0	33.6	23.0	33.0	32.6	34.0	52.3	37.7	33.1	72.6	32.6	34.0	42.0	29.9	23.5	41.9	36.5	33.5	33.1	44.2	33.0	35.0	17.8	48.7	39.6	44.9	28.4	32.8	43.7	36.6	45.0	32.8	79.3	28.9	24.8	71.6	47.3	41.4	33.7	246.1	123.1	377.9	184.5	59.1	49.4	174.4	264.5	85.4	176.9	170.4	234.4	125.5	328.0	214.6	102.7	245.2	231.2	246.0	167.7	191.3	210.4	201.4	276.3	193.1	284.2	78.5	673.4	232.5	52.9	92.1	173.1	156.1	122.0	96.8	327.9	286.5	178.5	120.4	179.7	436.3	470.2	297.7	468.0	214.2	345.1	275.7	351.0	129.9	176.2	235.7	244.4	219.0	165.9	207.3	167.0	120.5	390.7	155.0	179.0	354.4	154.6	455.6	319.8	317.6	671.2	130.4	409.8	203.3	50.1	129.4	48.5	122.5	162.0	134.4	204.4	154.0	152.1	221.4	194.6	160.7	141.6	10.8	137.0	189.7	224.2	193.3	147.3	33.1	32.6	34.4	51.8	32.6	34.0	32.6	34.0	33.5	32.8	32.8	33.7	105.6	80.1	76.3	5.2	123.2	202.5	227.3	343.6	109.8	58.4	116.4	157.6	55.4	111.5	200.4	99.3	12.5	423.3	101.8	101.8	215.2	210.8	15.6	119.2	136.9	138.4	122.8	229.5	12.1	194.3	544.1	132.0	86.2	109.4	100.8	158.7	99.9	113.2	242.9	47.1	12.5	192.1	215.7	106.3	152.5	26.3	108.7	96.9	113.8	6.5	163.6	102.6	117.4	10.1	11.8	236.3	113.2	88.8	122.6	343.1	87.3	214.8	153.4	50.0	98.6	149.0	183.0	282.8	265.2	177.2	221.9	261.9	112.5	161.1	229.8	233.9
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555958-24582052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		290000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	30.5	31.1	24.7	35.2	25.7	39.2	37.5	29.6	34.8	31.8	25.7	50.5	33.2	35.5	35.5	43.5	36.7	20.2	35.3	25.0	25.8	48.0	64.9	26.9	47.7	23.7	23.9	34.3	23.7	51.2	27.0	24.7	25.5	33.8	40.7	54.1	29.7	31.9	103.7	28.8	35.7	29.5	23.6	34.3	36.5	24.7	25.0	74.4	38.9	86.2	53.3	39.5	32.3	30.7	182.5	45.7	188.6	58.5	70.1	57.7	56.1	173.1	74.8	166.1	148.1	61.4	65.8	158.7	70.1	109.2	83.0	130.7	252.1	219.3	175.5	107.9	188.8	152.4	95.4	113.9	66.2	408.0	95.7	66.5	93.8	186.3	86.6	81.8	120.6	139.8	116.2	60.5	61.5	56.8	187.0	82.6	98.9	237.8	61.9	179.5	190.7	66.6	154.5	130.0	82.2	95.6	83.4	62.7	87.7	162.7	102.3	97.5	135.5	127.0	126.3	74.3	126.2	74.3	168.2	283.7	70.1	127.1	91.4	18.5	42.9	53.9	35.6	50.2	37.6	60.5	38.4	39.2	54.2	50.7	36.6	41.3	18.6	51.1	51.1	49.7	41.1	47.4	24.7	25.7	29.6	34.8	25.0	25.8	23.7	23.9	25.5	23.6	25.0	30.7	120.0	96.1	81.8	7.5	118.2	108.6	115.3	293.1	133.1	61.1	94.2	138.8	95.9	101.5	162.9	130.6	35.5	239.5	123.1	112.6	291.6	161.9	91.0	176.6	157.7	96.8	111.0	139.4	8.1	114.8	228.8	121.0	92.2	147.9	86.2	145.3	66.0	203.3	176.4	38.7	8.7	134.2	168.9	74.5	84.8	85.1	116.2	98.1	67.6	10.3	151.0	134.3	86.5	8.0	13.4	129.4	118.2	118.5	120.7	96.8	191.7	310.5	135.2	68.9	65.7	102.8	209.6	111.1	131.4	164.9	113.7	180.3	111.9	176.2	139.0	113.3
SNRPF	Sm-F	ENSG00000139343	"Small nuclear ribonucleoprotein polypeptide F"	P62306	12	95858928-95903828	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 486.5"															NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"				"unprognostic (6.86e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-2)"	22.5	21.5	19.2	27.4	19.6	47.7	21.9	21.3	28.4	19.7	18.8	26.2	21.7	21.2	15.8	38.2	17.9	8.0	22.8	19.2	21.0	28.4	32.3	19.6	28.2	19.3	20.5	22.7	17.2	16.4	24.5	16.0	19.6	17.4	18.7	18.4	18.3	11.8	24.0	22.3	21.3	14.7	19.7	23.0	19.9	18.6	20.6	36.5	17.5	18.2	24.9	20.1	23.1	19.5	146.0	116.9	129.9	88.7	35.2	34.7	107.2	72.7	50.7	95.9	67.7	169.1	46.9	160.3	68.2	48.8	83.8	97.7	116.9	103.4	78.5	107.3	184.7	154.7	116.1	171.7	43.9	243.4	68.3	35.7	50.1	87.3	83.9	64.2	67.3	176.7	138.7	31.5	52.2	155.3	212.2	486.5	178.1	109.9	258.0	166.4	103.4	118.3	71.9	150.7	129.0	76.2	107.6	102.5	74.2	87.6	105.6	187.4	58.8	52.2	90.0	68.6	144.3	46.2	87.0	232.1	26.0	125.9	66.7	8.4	42.6	20.0	51.4	43.4	69.8	80.2	72.0	63.2	97.8	75.1	77.3	70.7	4.1	65.9	35.8	92.9	68.2	60.7	19.2	19.6	21.3	28.4	19.2	21.0	19.3	20.5	19.6	19.7	20.6	19.5	129.3	51.3	103.2	5.5	150.7	265.2	231.1	272.4	139.5	53.7	188.1	286.3	58.4	124.4	146.5	136.1	31.3	350.9	132.8	142.8	272.0	217.4	76.2	166.0	189.1	151.0	172.8	165.7	6.1	285.9	457.3	128.1	95.3	186.8	106.5	172.1	128.2	338.6	241.1	32.0	6.8	282.2	140.4	128.7	197.9	36.8	134.2	126.9	120.9	3.7	197.1	119.9	146.2	7.1	7.0	236.7	152.5	119.6	98.1	280.1	119.7	272.1	98.2	60.6	92.1	210.5	213.9	200.9	276.0	217.6	265.2	207.8	158.2	152.9	346.3	253.1
SNRPN	"HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN"	ENSG00000128739	"Small nuclear ribonucleoprotein polypeptide N"	P63162	15	24823637-24978723	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 457.8;Horizontal cells: 333.1;Proximal tubular cells: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 789.5;SuSa: 505.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003482, HPA067842"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (9.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (8.93e-8)"	"unprognostic (4.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.74e-2)"	54.8	181.8	453.6	46.5	472.5	36.5	69.4	441.8	553.5	112.3	351.6	87.3	36.4	65.2	332.5	44.0	121.9	141.2	483.2	474.3	510.7	192.0	69.9	76.4	93.5	454.7	440.5	147.8	111.8	243.4	375.5	37.4	458.5	174.2	34.8	161.7	125.7	147.6	232.7	38.2	62.5	59.0	415.8	85.2	88.3	60.7	467.8	136.8	300.4	272.4	80.6	82.5	66.4	470.8	1.0	148.6	260.8	180.1	153.4	69.5	1.1	46.9	100.0	31.7	57.8	138.1	69.1	0.2	91.6	118.7	47.9	26.7	0.0	142.7	18.2	81.1	0.1	89.3	90.1	151.5	181.8	107.1	76.8	132.6	60.6	69.4	81.8	213.2	95.7	189.8	24.8	0.4	183.3	0.0	216.9	1.5	789.5	0.0	63.0	113.3	97.8	0.5	172.3	222.2	155.7	147.1	0.7	3.6	174.0	505.7	93.6	271.3	62.3	79.2	78.2	0.3	28.8	215.3	126.9	140.4	65.9	72.9	59.8	234.8	68.0	106.8	313.9	74.2	355.8	371.9	385.3	359.0	65.2	342.1	508.0	420.8	18.5	291.2	77.4	531.9	434.4	581.7	453.6	472.5	441.8	553.5	474.3	510.7	454.7	440.5	458.5	415.8	467.8	470.8	57.1	9.6	45.5	0.0	106.2	2.2	102.6	4.4	53.5	171.0	77.1	96.5	185.2	218.8	23.0	178.4	52.1	1.0	157.6	10.0	457.8	150.0	92.9	36.8	27.9	57.7	142.7	31.1	0.0	81.6	1.2	54.9	27.5	24.5	62.7	136.9	63.1	31.9	62.7	333.1	0.0	34.5	6.1	28.9	2.5	111.3	77.3	38.1	0.0	0.0	43.8	210.3	115.4	0.0	0.0	61.5	33.7	116.6	86.7	110.6	38.7	300.2	26.9	112.3	52.6	61.5	65.0	67.9	54.0	22.1	1.7	1.6	104.2	110.4	23.6	65.1
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024659	Uncertain				"Intracellular and membrane"	NA	NA		25000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	7.9	66.4	7.5	5.5	6.5	18.9	8.0	5.8	5.9	5.6	42.9	6.2	5.7	4.4	2.7	8.4	6.0	4.3	4.9	6.1	11.8	12.6	89.3	15.4	7.3	7.2	11.4	2.5	45.0	1.4	2.6	8.6	7.8	4.8	6.4	4.8	34.8	3.4	28.2	9.8	6.3	3.1	6.0	11.9	24.1	9.8	9.1	3.4	61.4	32.4	3.5	3.9	3.6	6.5	0.1	1.8	0.7	0.0	11.3	22.9	0.1	6.0	36.7	1.8	2.7	12.0	1.6	0.0	10.7	6.8	0.0	0.1	2.0	0.0	1.3	5.6	6.5	0.0	0.3	84.9	1.2	16.9	0.0	11.4	0.0	10.1	0.0	14.9	0.4	10.4	0.0	32.3	5.9	3.3	0.0	13.7	2.1	78.5	8.7	0.0	43.8	0.1	34.4	2.0	0.1	0.4	2.4	12.5	30.2	0.7	1.5	30.5	0.0	23.7	1.4	0.0	2.0	77.2	33.0	34.8	18.4	49.0	26.7	1.8	0.8	2.7	2.2	0.4	0.5	0.5	0.4	1.1	0.6	0.2	1.1	1.1	0.1	1.6	0.3	0.0	0.0	0.6	7.5	6.5	5.8	5.9	6.1	11.8	7.2	11.4	7.8	6.0	9.1	6.5	1.9	12.8	27.2	70.2	4.7	0.4	0.7	0.9	1.8	2.4	8.5	6.0	2.0	2.8	9.0	5.5	2.1	0.8	8.4	1.3	9.8	1.5	9.3	2.4	5.8	4.2	0.0	14.1	2.4	10.9	2.2	9.8	11.2	6.2	1.3	8.8	13.2	66.8	11.3	0.0	3.1	3.9	16.2	29.9	4.3	4.2	4.7	18.1	1.8	45.9	12.1	16.0	18.6	2.5	12.2	4.3	1.9	13.2	2.8	1.1	0.1	3.3	13.8	0.7	13.1	3.9	14.3	1.1	0.2	10.1	1.0	0.3	12.0	11.0	4.1	0.6
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SiHa: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	11.0	5.0	3.3	5.2	3.9	2.7	8.8	1.0	6.7	11.0	10.1	6.7	3.7	10.4	5.1	7.0	8.7	7.1	5.3	4.6	0.8	6.7	3.8	8.6	5.6	2.5	0.9	6.2	4.1	12.4	4.0	5.2	0.9	8.2	5.3	21.6	5.2	5.5	5.7	8.5	6.0	8.7	0.6	5.7	6.1	7.1	1.5	5.8	10.5	3.8	4.9	8.7	8.7	3.7	7.2	10.9	7.4	5.8	26.6	35.6	9.1	13.9	19.3	10.7	11.8	10.7	6.5	9.0	8.3	16.2	5.6	12.9	10.0	6.8	13.9	4.0	5.5	4.0	11.1	9.2	8.8	0.3	5.9	25.6	4.9	17.6	7.1	11.1	32.4	2.5	2.3	13.8	13.1	8.2	3.0	1.4	5.0	4.2	8.6	18.1	6.5	16.8	5.7	10.9	2.8	6.1	42.6	6.0	4.4	5.5	7.1	0.5	25.4	20.0	9.6	14.2	13.0	3.1	5.2	10.0	12.8	1.4	9.3	0.4	0.2	0.3	0.9	0.3	0.9	0.2	0.4	0.5	0.2	0.2	0.2	1.1	0.9	0.7	0.3	0.1	0.5	0.3	3.3	3.9	1.0	6.7	4.6	0.8	2.5	0.9	0.9	0.6	1.5	3.7	55.9	19.2	11.7	36.6	9.0	38.0	28.0	17.1	70.0	33.2	19.0	25.0	9.2	10.0	10.4	27.6	41.7	9.5	33.7	29.0	3.9	9.7	25.9	20.6	61.3	81.4	10.3	4.8	151.4	24.1	7.9	53.1	20.9	28.7	1.3	15.8	126.7	11.1	6.9	5.0	62.6	16.6	8.2	33.1	29.3	27.5	59.0	12.9	30.2	33.7	8.6	214.1	47.4	30.7	27.9	16.3	32.8	65.1	20.7	40.9	12.7	34.5	10.0	136.7	6.6	26.0	35.6	27.9	15.4	30.7	38.8	3.7	32.8	20.2	19.6	28.7
SNTG1	"G1SYN, SYN4"	ENSG00000147481	"Syntrophin gamma 1"	Q9NSN8	8	49909789-50796692	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;lymphoid tissue: 2.8"	"Group enriched"	"Detected in some"	25	"Excitatory neurons: 1498.8;Inhibitory neurons: 1490.6;Oligodendrocyte precursor cells: 1948.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RH-30: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072282	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA072282: AB_2686506"					"unprognostic (4.60e-2)"		"unprognostic (1.72e-2)"		"unprognostic (2.47e-1)"		"unprognostic (1.05e-2)"			"unprognostic (6.94e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.16e-3)"	0.0	0.4	2.3	0.0	5.4	0.4	0.0	0.8	10.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	5.5	2.7	0.3	0.5	0.0	0.1	0.0	2.4	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.1	0.0	0.2	0.0	0.1	0.0	2.8	0.1	0.7	5.3	0.1	0.1	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	2.3	5.4	0.8	10.5	5.5	2.7	0.0	2.4	0.0	0.0	5.3	3.7	0.0	0.0	0.5	27.7	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.4	0.0	0.6	1.8	0.0	0.0	0.2	0.0	0.0	0.0	21.5	0.1	0.0	0.1	0.0	0.0	1498.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	1490.6	0.0	0.0	0.0	0.0	56.2	0.6	0.1	0.0	64.6	0.0	0.4	0.0	1948.8	18.3	0.3	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.1	7.8	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546586	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 90.0;Kupffer cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	14.9	8.7	12.1	11.2	21.3	68.0	9.1	20.4	13.1	11.5	9.1	9.2	9.3	13.5	6.4	10.1	9.4	11.4	7.4	10.3	12.2	12.8	15.1	11.3	13.3	22.8	19.9	26.6	9.3	12.0	3.6	21.8	19.6	8.6	5.5	14.8	11.2	11.5	7.2	7.6	9.5	14.1	18.8	18.8	12.0	7.3	18.6	5.6	15.6	8.0	7.0	11.2	7.7	25.2	9.0	7.4	11.4	13.0	26.2	27.8	61.7	14.8	37.1	7.6	12.6	9.1	16.4	0.4	23.1	23.1	13.9	8.2	10.8	14.5	9.6	4.6	7.7	2.7	4.6	5.7	43.5	5.0	2.5	44.1	17.2	10.4	10.8	13.5	16.1	6.5	4.8	60.7	13.3	8.6	4.7	5.7	5.7	3.7	7.6	12.4	6.4	14.5	7.4	26.0	14.1	8.3	12.4	14.2	16.2	17.4	16.7	8.4	5.5	28.4	13.8	21.1	15.6	40.0	41.8	2.5	11.0	11.8	29.9	0.0	0.9	0.1	0.7	1.5	0.1	0.8	0.3	0.4	1.1	0.6	0.1	0.5	3.8	1.0	3.8	2.5	0.2	0.3	12.1	21.3	20.4	13.1	10.3	12.2	22.8	19.9	19.6	18.8	18.6	25.2	14.4	54.5	26.8	7.5	16.6	9.8	4.4	12.8	10.2	10.0	13.6	10.5	16.5	7.2	22.5	22.0	73.0	26.5	48.2	4.2	15.6	14.2	0.3	7.5	9.8	16.5	6.1	3.4	10.3	15.2	30.3	23.0	27.5	6.2	5.7	90.0	43.9	28.1	41.6	5.0	9.2	7.3	12.2	87.4	26.2	2.5	14.0	52.1	10.6	37.5	42.6	11.2	35.0	6.6	21.6	12.8	7.3	17.7	12.7	5.6	8.6	6.9	24.0	47.5	0.0	13.3	38.5	3.6	13.1	8.9	11.8	8.2	12.5	58.6	10.8	13.1
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130866250-130916479	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 112.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	15.9	18.5	19.0	12.4	24.3	8.7	14.8	18.0	17.9	15.5	18.2	22.3	11.8	18.0	19.1	14.7	16.3	14.9	20.1	15.3	17.6	16.6	19.3	14.6	11.0	27.4	22.5	14.0	19.4	16.1	17.2	12.6	21.1	16.6	14.1	15.5	19.4	14.4	23.8	12.9	15.4	19.5	22.1	15.2	19.0	21.3	23.8	11.1	21.5	13.1	11.7	19.1	13.5	28.7	13.8	23.2	17.4	27.7	52.9	36.9	13.2	35.7	38.1	17.9	18.1	20.6	26.2	12.4	27.0	40.3	45.3	25.6	3.2	25.1	20.8	20.9	13.7	24.3	18.3	0.1	30.9	0.0	19.1	42.1	24.4	20.0	17.9	35.3	20.9	17.9	23.5	0.1	35.3	10.9	18.6	10.6	4.9	30.0	19.3	16.1	17.2	8.0	11.9	27.8	19.6	16.4	16.7	22.4	11.1	13.4	46.6	13.0	34.4	26.7	20.9	21.8	21.3	4.5	0.0	0.1	9.7	13.5	28.9	6.5	3.6	2.5	2.1	3.2	3.0	2.8	1.9	2.5	2.9	1.8	2.3	2.0	1.7	1.6	4.0	2.7	1.9	3.5	19.0	24.3	18.0	17.9	15.3	17.6	27.4	22.5	21.1	22.1	23.8	28.7	12.6	25.6	7.9	44.4	14.8	4.0	7.2	7.8	8.6	25.6	11.6	9.1	20.4	15.7	12.9	23.9	10.4	10.3	10.0	19.4	9.8	11.5	35.8	10.8	14.3	12.2	11.4	7.4	30.0	16.0	5.7	11.4	15.8	11.0	18.4	13.5	13.9	21.3	10.1	16.8	34.9	12.5	6.1	11.7	5.2	44.7	13.7	11.9	3.6	20.6	9.6	22.4	13.4	35.7	112.6	16.6	14.5	15.8	15.5	10.2	14.4	8.6	16.9	37.9	13.1	12.7	9.8	37.1	15.5	9.8	4.3	14.0	9.2	13.1	10.3	10.8
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 21.4;classical monocyte: 35.8;intermediate monocyte: 30.8;myeloid DC: 16.3;neutrophil: 40.4;non-classical monocyte: 35.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 16.3;granulocytes: 40.4;monocytes: 35.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028551			Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA028551: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	7.6	8.6	18.1	7.7	24.7	8.7	7.2	20.2	21.1	9.1	9.2	14.4	5.3	9.1	9.2	7.5	8.6	6.7	8.8	17.1	23.2	14.5	8.5	8.9	6.8	21.5	21.5	9.7	6.9	11.8	10.2	10.7	21.8	9.5	7.4	15.9	7.2	11.6	17.6	9.6	8.3	10.0	20.5	11.2	8.5	7.9	20.1	7.2	7.4	21.3	6.5	12.4	8.2	22.3	9.7	14.2	14.7	18.6	22.9	16.8	32.7	5.1	10.5	8.9	9.5	11.6	12.5	9.1	10.9	8.3	9.5	11.7	19.1	10.4	11.0	13.1	6.9	14.7	8.4	13.1	15.1	17.8	9.6	13.4	7.7	10.2	11.6	9.0	10.1	14.3	9.0	54.8	11.8	17.3	10.6	12.2	26.1	19.0	9.0	10.8	14.3	11.8	13.9	14.3	14.7	12.6	13.8	25.4	10.1	15.8	16.3	14.9	13.4	12.5	8.2	13.1	10.9	11.4	12.2	17.8	14.8	11.2	14.2	21.4	35.8	5.4	4.6	30.8	6.6	3.2	5.8	4.2	16.3	4.4	5.5	4.6	40.4	3.5	35.4	4.2	5.1	17.3	18.1	24.7	20.2	21.1	17.1	23.2	21.5	21.5	21.8	20.5	20.1	22.3	18.4	12.8	27.1	24.8	17.9	21.2	15.5	14.6	13.1	45.8	21.6	13.7	29.9	20.0	17.3	29.5	27.1	56.0	20.4	13.8	25.4	25.7	32.6	18.5	28.0	19.7	18.7	10.8	58.3	20.9	22.4	25.4	14.3	22.7	3.8	20.8	25.7	19.4	43.3	40.4	77.6	12.8	20.3	85.4	21.3	10.4	30.4	51.9	30.2	40.3	71.4	24.6	11.3	45.2	60.0	26.9	10.5	39.9	16.4	16.2	19.6	57.7	13.7	26.6	32.9	27.6	27.0	53.3	28.8	17.0	24.7	104.8	19.4	33.8	15.3	17.9
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		270000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	224.3	220.8	217.3	131.3	220.4	296.3	182.6	216.5	304.6	169.5	208.3	167.6	119.4	137.9	152.8	172.4	144.5	132.0	266.6	224.3	219.6	168.6	199.0	147.3	184.0	214.2	219.8	187.5	123.6	124.4	95.4	199.3	215.8	104.6	112.9	88.3	134.5	119.4	323.0	129.0	125.2	157.0	221.1	145.1	122.0	109.8	218.9	123.4	123.2	285.3	163.6	166.5	147.8	234.9	164.9	98.2	94.9	314.3	505.0	377.9	147.6	241.3	240.3	187.5	231.2	155.0	118.8	138.5	232.8	315.3	328.8	128.6	212.5	207.9	254.6	161.2	136.7	268.1	110.2	182.6	272.9	183.9	175.3	324.4	279.9	180.1	202.1	296.9	312.9	131.0	261.6	161.1	263.1	156.6	70.4	403.7	80.1	199.1	166.2	76.2	229.7	145.4	300.0	225.1	111.0	154.9	155.5	197.7	260.4	212.2	100.6	623.8	235.8	161.0	108.2	218.0	319.7	65.0	90.7	148.9	284.2	332.5	197.2	118.5	75.9	169.1	37.4	70.5	48.2	215.3	43.8	39.5	109.8	181.6	44.6	37.0	48.4	64.5	68.6	132.1	48.8	70.4	217.3	220.4	216.5	304.6	224.3	219.6	214.2	219.8	215.8	221.1	218.9	234.9	329.6	105.8	70.0	39.2	332.6	378.9	328.7	264.3	231.1	44.6	254.0	244.3	395.2	161.5	160.3	191.3	16.7	685.3	219.3	199.1	643.7	307.1	387.8	144.6	161.1	352.6	128.0	611.8	55.7	253.8	581.2	323.0	101.9	120.0	167.1	127.2	275.9	240.6	974.2	43.7	43.1	154.7	189.2	451.6	786.3	496.6	288.6	415.7	368.2	31.9	409.1	325.7	209.1	27.2	39.7	260.1	200.9	266.7	187.1	247.7	321.4	697.8	198.8	53.7	256.4	186.0	304.1	316.5	173.3	354.5	440.8	618.3	181.0	259.4	180.6	337.9
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446650-125520202	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	16.7	22.1	11.0	12.7	11.2	16.3	25.3	11.5	16.7	19.9	12.4	24.9	35.8	14.1	13.7	14.9	14.2	19.8	16.5	11.1	12.3	53.8	56.5	18.1	16.3	11.9	11.1	14.9	19.5	18.0	14.4	31.7	12.0	22.7	27.7	9.1	22.4	11.4	18.9	10.2	34.2	13.4	11.8	13.0	21.6	16.1	10.8	21.1	44.9	23.3	17.1	16.8	11.3	14.0	34.8	10.9	34.5	21.8	20.9	17.4	39.1	18.5	17.5	35.9	32.1	23.7	15.5	22.0	21.4	22.5	15.5	18.0	32.4	15.6	42.9	20.6	23.8	35.6	14.5	36.0	24.5	37.8	22.1	22.7	17.0	18.2	14.5	20.0	34.1	31.8	38.6	10.9	27.6	26.2	41.8	25.4	20.2	37.6	13.0	38.2	42.0	40.3	33.0	30.6	36.1	50.9	29.8	38.3	47.4	32.0	37.7	61.3	22.3	18.0	22.9	23.4	21.9	22.1	20.1	60.2	22.0	23.8	27.8	12.4	14.0	25.8	9.7	18.8	13.0	13.8	12.4	11.2	18.3	10.3	15.8	13.8	2.6	17.4	19.1	16.1	15.1	12.0	11.0	11.2	11.5	16.7	11.1	12.3	11.9	11.1	12.0	11.8	10.8	14.0	27.1	28.9	39.4	33.6	24.5	12.1	17.9	21.3	12.5	13.4	27.2	17.1	17.7	37.1	34.1	22.0	0.0	87.2	20.6	39.9	60.7	45.4	21.6	23.8	22.1	24.7	30.0	22.7	46.7	36.6	57.8	26.9	26.0	20.9	31.0	30.9	24.7	75.8	50.9	18.5	44.9	37.0	46.8	27.0	22.6	31.5	22.1	28.3	30.2	31.9	45.7	21.3	34.0	37.7	47.8	42.9	37.9	18.0	26.2	22.5	48.8	163.4	37.1	12.0	13.1	27.8	30.3	33.0	29.8	23.0	11.8	41.2	22.9	27.2	29.6	15.7
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561093-34630160	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA049374: AB_2680734"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	50.0	36.5	38.0	46.8	44.4	42.0	36.7	41.2	62.9	40.4	40.2	50.4	74.2	33.6	30.1	40.0	31.2	39.7	33.7	35.4	41.0	44.4	38.9	33.4	56.5	45.4	42.9	31.3	25.1	78.3	14.9	74.5	44.9	25.8	49.1	14.8	27.2	29.5	30.5	30.3	49.1	43.9	44.8	49.2	39.6	36.0	42.1	45.1	34.1	29.2	47.8	50.2	29.6	51.4	112.3	65.3	73.5	48.9	114.5	224.7	99.4	113.1	124.0	110.4	95.4	61.6	115.4	73.2	79.0	153.2	44.1	67.8	81.1	85.8	187.9	93.5	31.7	44.6	34.9	115.9	108.5	77.2	46.8	154.1	98.9	80.7	109.7	100.4	151.7	53.3	48.8	56.3	146.9	68.4	69.9	41.4	40.2	97.7	73.0	74.3	84.4	64.1	135.2	84.6	56.7	61.1	89.9	72.9	94.6	65.0	77.6	47.5	150.8	74.6	52.6	67.8	72.0	55.9	95.9	82.9	37.6	41.6	86.1	73.5	74.2	93.4	73.1	97.4	95.8	71.5	97.0	84.8	66.5	68.0	73.3	79.2	126.5	74.0	101.3	47.6	102.0	109.0	38.0	44.4	41.2	62.9	35.4	41.0	45.4	42.9	44.9	44.8	42.1	51.4	130.2	86.6	49.7	17.6	77.5	51.4	63.0	109.7	69.4	43.4	51.1	67.8	73.4	27.1	87.2	80.9	22.9	166.7	108.9	73.0	125.2	88.1	6.6	74.9	110.1	87.5	52.0	55.5	25.5	64.7	126.3	88.0	68.8	114.3	85.4	93.5	124.6	36.8	251.1	21.9	31.2	62.7	67.1	196.1	73.0	15.3	64.3	155.7	62.2	26.2	155.4	69.6	88.6	21.1	52.5	74.1	77.9	94.8	51.2	84.0	54.8	127.0	73.3	39.4	59.2	74.2	133.8	164.6	167.9	90.0	65.8	254.6	109.4	346.2	82.0	76.8
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 251.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 146.6;GAMG: 145.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	57.9	25.2	19.2	25.7	20.6	14.3	41.4	21.2	20.9	38.8	20.6	34.2	33.2	41.8	20.8	57.8	26.2	46.9	33.2	18.8	19.9	26.2	39.0	21.0	24.2	22.2	21.1	28.0	28.5	37.7	13.4	48.5	21.8	31.0	29.5	2.7	35.1	41.7	24.4	30.4	35.6	41.2	20.9	18.4	37.5	11.0	20.7	13.9	29.8	34.2	21.7	49.8	33.7	23.0	26.0	19.1	18.9	22.1	96.6	78.6	37.7	46.3	146.6	36.4	48.9	16.6	27.6	0.0	25.0	85.6	145.8	18.7	22.7	36.3	21.1	23.9	23.4	17.7	25.7	23.9	48.6	7.6	31.6	51.1	33.9	37.8	37.1	63.9	49.8	23.3	80.9	0.0	15.8	17.2	0.0	15.6	14.4	18.7	21.3	0.0	17.9	32.7	59.7	15.9	11.8	20.9	34.1	16.4	90.5	16.2	6.8	20.0	41.7	41.3	16.6	128.8	30.4	0.0	0.0	0.0	84.8	6.4	25.4	0.0	0.7	0.1	0.4	2.1	1.5	3.2	0.7	0.6	1.4	2.4	5.3	1.2	0.0	0.1	6.8	10.0	2.2	0.6	19.2	20.6	21.2	20.9	18.8	19.9	22.2	21.1	21.8	20.9	20.7	23.0	71.5	0.0	1.1	40.5	102.6	43.3	109.7	17.3	30.1	15.6	28.7	18.4	28.4	28.6	19.0	9.2	0.0	40.6	37.6	97.7	21.5	57.5	73.4	112.8	53.0	57.9	15.7	17.7	105.4	55.9	41.1	83.0	70.3	251.1	12.0	16.4	37.1	34.3	41.6	3.3	90.4	43.0	8.2	59.0	74.2	26.8	44.7	84.3	21.4	48.7	39.5	11.1	7.2	100.5	161.2	107.0	108.9	46.6	14.9	127.5	52.5	46.2	14.3	1.8	39.5	43.6	49.6	21.9	15.4	22.9	29.8	109.9	48.8	9.1	29.7	137.0
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 436.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	510000000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	221.4	20.4	14.3	26.1	20.9	0.0	134.2	15.8	23.8	226.5	436.1	122.7	18.2	151.6	10.4	62.1	177.6	22.4	150.1	47.1	14.1	124.1	16.5	155.0	10.6	22.9	23.4	59.7	86.7	2.6	19.8	39.8	17.5	131.3	13.4	1.9	70.9	23.4	22.0	91.9	65.2	37.1	16.4	24.8	102.1	74.1	19.0	5.8	176.6	22.9	7.0	178.3	170.4	13.6	0.0	0.0	0.0	0.0	66.2	17.3	2.0	38.1	16.7	2.3	1.4	0.5	0.0	0.0	11.8	8.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	16.8	0.0	15.8	0.0	17.9	0.1	0.0	1.1	0.0	0.0	0.1	0.3	1.1	8.0	0.0	55.1	0.0	0.0	0.6	231.3	0.8	0.2	0.2	0.0	1.2	0.0	2.1	32.8	0.0	0.0	8.7	1.0	1.6	0.4	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	20.9	15.8	23.8	47.1	14.1	22.9	23.4	17.5	16.4	19.0	13.6	46.1	12.8	18.1	7.2	1.0	90.8	65.5	0.6	10.2	0.4	21.7	22.1	23.0	144.4	7.6	90.1	0.0	211.4	1.8	25.6	15.6	63.6	18.7	81.9	45.8	21.0	34.6	0.0	0.1	1.8	17.0	498.5	5.1	80.3	0.0	0.1	15.4	0.2	17.3	0.0	0.1	51.9	0.0	0.3	115.5	33.9	424.1	3.2	80.0	3.7	0.0	20.7	0.0	0.5	0.7	3.5	89.3	365.6	1.1	80.4	0.0	142.7	0.1	1.4	197.2	6.5	428.9	73.2	4.4	6.1	70.3	190.0	7.6	6.1	51.8	9.6
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777447-36863538	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"	NA	Yes				"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli, Cytosol"		"HPA043992: AB_2678762"	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.6	14.2	13.4	3.6	18.1	1.1	6.2	63.9	16.4	9.5	0.0	12.3	1.9	10.9	3.8	7.0	9.6	4.8	9.5	12.8	14.4	7.8	0.9	6.2	2.5	14.6	15.0	10.4	2.8	7.3	4.9	6.2	12.6	9.0	2.8	4.5	4.7	8.8	2.4	8.6	5.8	8.4	8.8	4.6	6.4	7.9	15.1	2.9	12.2	3.9	3.1	11.2	7.4	21.9	13.4	18.0	21.5	23.2	12.2	11.2	5.6	11.6	12.5	16.1	9.5	7.3	2.1	6.0	4.2	20.4	14.0	17.8	17.3	10.8	16.8	0.9	3.4	9.7	18.5	9.7	6.4	2.1	9.0	6.3	13.0	15.4	10.9	7.0	10.6	6.5	6.9	1.2	17.8	13.0	6.9	5.1	5.5	1.3	13.8	16.1	19.9	2.3	9.5	4.0	25.5	15.9	24.1	26.1	7.5	9.4	33.3	14.4	16.3	40.2	7.7	19.9	25.7	2.4	0.6	5.8	17.1	2.8	26.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	13.4	18.1	63.9	16.4	12.8	14.4	14.6	15.0	12.6	8.8	15.1	21.9	16.5	0.0	1.8	18.9	4.4	12.6	5.4	6.3	13.6	26.3	9.6	8.9	16.1	5.7	6.7	20.2	37.5	15.6	11.3	1.7	1.9	3.8	0.9	8.6	20.5	14.5	6.0	1.3	19.9	1.5	10.2	12.0	0.5	21.9	10.8	33.0	10.4	0.6	10.0	23.5	30.3	1.5	0.0	7.6	10.7	2.4	12.2	8.1	5.4	21.5	4.5	17.8	0.0	54.8	50.9	1.4	2.4	18.8	1.8	6.0	2.1	1.5	3.9	3.8	13.1	23.2	16.9	0.5	1.3	13.7	16.1	3.3	1.4	14.0	3.0	2.9
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 169.4;Late spermatids: 505.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA		7700	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.53e-5)"	173.3	65.3	59.3	26.2	59.7	5.1	129.0	67.6	72.6	156.9	49.9	105.2	29.9	124.0	23.6	65.5	118.8	38.7	105.8	53.0	55.3	84.8	121.2	111.9	21.1	85.0	60.6	125.6	49.3	35.7	73.3	66.6	65.6	127.2	34.9	11.4	88.7	48.5	64.7	106.8	71.2	53.7	61.7	80.0	63.7	128.2	65.7	7.6	93.8	37.3	13.4	103.5	133.9	57.6	83.0	101.8	54.6	61.9	86.4	114.4	55.7	83.0	127.8	95.0	58.8	103.6	36.2	0.7	55.3	130.1	38.3	69.7	82.5	75.7	48.9	58.1	36.2	6.9	58.3	48.4	98.2	0.8	0.5	72.6	55.6	33.3	48.4	105.2	74.6	42.7	18.4	2.6	68.4	32.8	7.1	2.4	19.3	14.1	42.5	79.0	36.8	7.7	43.7	15.8	3.1	48.9	40.4	9.8	52.7	56.8	16.7	29.2	116.9	83.8	59.8	61.9	59.3	1.7	2.5	11.5	49.0	19.4	58.3	0.0	2.5	0.6	11.4	4.7	23.4	0.8	12.6	13.4	8.1	1.3	12.7	7.6	0.5	5.8	1.1	2.7	0.6	5.2	59.3	59.7	67.6	72.6	53.0	55.3	85.0	60.6	65.6	61.7	65.7	57.6	89.6	19.2	7.2	27.1	5.8	29.2	24.6	23.3	39.9	2.7	29.0	27.8	12.2	31.5	18.3	12.9	0.0	24.1	4.7	53.5	9.8	21.3	169.4	10.9	39.5	51.9	14.6	2.1	3.8	19.2	30.5	48.8	8.6	20.5	17.2	19.3	79.9	49.5	35.3	5.0	4.5	35.2	8.2	39.0	31.5	505.8	61.2	23.8	24.9	13.1	5.7	21.9	3.1	19.6	7.6	26.2	53.2	58.6	3.7	38.8	65.1	26.0	10.7	3.5	59.2	23.1	84.1	7.0	8.0	25.3	21.3	20.5	19.7	7.1	31.3	23.7
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071818			Approved	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA071818: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	2.4	1.1	13.4	3.4	18.3	1.7	1.6	11.6	15.9	8.5	0.0	4.5	1.4	4.7	3.8	2.2	3.3	3.6	2.0	12.1	11.3	9.0	4.6	4.4	0.8	18.6	17.6	5.8	0.7	0.0	2.7	0.2	14.7	5.2	1.1	12.9	1.0	2.4	1.1	1.8	2.6	6.2	11.3	0.4	1.6	1.6	14.1	3.1	3.1	1.2	1.2	3.0	3.7	22.9	0.8	1.1	1.3	0.2	0.1	0.0	0.0	0.2	0.1	1.6	0.4	0.2	0.6	0.0	7.6	5.0	1.3	19.6	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.3	0.2	0.0	14.5	0.2	4.3	6.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4	0.0	0.9	0.0	1.6	9.1	0.2	0.0	0.8	0.7	14.1	0.0	0.0	0.8	0.0	8.4	0.0	4.9	1.4	0.0	0.1	0.0	0.0	0.0	1.6	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	18.3	11.6	15.9	12.1	11.3	18.6	17.6	14.7	11.3	14.1	22.9	0.1	3.2	11.3	107.1	0.0	0.1	0.3	4.6	0.0	70.3	0.1	2.4	2.0	0.0	6.9	5.5	0.0	0.0	0.3	0.0	0.0	0.2	2.2	0.4	0.4	0.3	0.0	0.0	41.4	0.0	0.0	5.0	0.0	0.9	0.0	5.4	0.4	1.6	0.2	1.7	24.3	0.0	2.0	0.3	0.0	11.6	12.8	0.4	1.8	8.4	0.1	33.0	1.0	8.0	76.2	1.1	0.0	7.9	0.1	0.4	0.4	1.4	2.0	2.7	0.0	0.9	1.0	0.1	0.3	0.0	0.4	0.0	0.3	1.5	0.0	0.6
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 163.8;liver: 247.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	2.0	15.7	4.9	3.1	3.8	2.8	53.8	7.4	8.4	163.8	1.9	5.3	7.5	4.3	6.9	10.2	6.7	8.2	5.6	5.0	4.5	50.3	247.0	3.2	2.6	4.3	3.7	2.4	5.7	4.4	3.1	2.5	4.0	87.9	7.8	4.8	5.3	27.0	2.2	16.6	7.2	3.5	4.2	2.3	9.2	12.2	3.9	3.7	89.4	2.8	3.4	9.1	6.9	6.3	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.8	7.4	8.4	5.0	4.5	4.3	3.7	4.0	4.2	3.9	6.3	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452314-121633763	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 125.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 125.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA		79000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	7.0	6.1	29.1	24.4	39.1	47.4	13.9	49.5	35.5	44.4	0.0	17.3	11.6	5.4	8.9	5.4	40.1	7.3	2.4	33.8	39.7	19.0	58.2	10.4	21.1	40.3	46.8	9.0	8.0	10.4	16.8	2.3	47.0	20.8	16.9	20.3	21.8	25.4	1.7	3.4	18.1	4.5	45.3	21.8	10.3	5.1	38.8	17.0	13.5	4.0	23.0	15.7	6.6	79.1	1.3	8.1	7.3	1.1	0.0	0.0	7.4	0.4	2.4	0.3	0.0	11.9	142.8	68.7	8.5	1.8	10.5	47.4	9.1	7.0	0.1	0.0	2.6	0.0	10.3	16.8	0.1	29.6	0.1	0.0	7.6	0.0	25.8	4.0	0.0	8.7	0.0	0.7	0.0	9.7	7.1	15.3	8.8	93.5	10.8	7.7	0.4	1.6	15.8	102.1	5.1	1.5	15.2	21.5	0.0	16.0	21.0	9.5	0.3	0.1	4.9	1.0	0.0	0.0	0.0	139.8	0.1	38.6	0.4	44.3	15.9	59.1	22.1	6.9	29.3	1.9	24.6	20.0	6.6	5.1	23.1	20.8	125.7	20.9	9.4	16.4	19.3	21.2	29.1	39.1	49.5	35.5	33.8	39.7	40.3	46.8	47.0	45.3	38.8	79.1	1.6	6.4	23.3	160.9	20.7	4.5	42.3	23.3	18.2	68.8	44.5	22.0	12.3	18.6	36.8	79.1	387.8	0.4	130.1	132.1	0.0	10.3	1.2	21.6	2.9	10.3	6.1	8.8	247.4	0.7	0.7	5.8	14.3	24.7	12.0	20.6	34.6	114.5	39.1	50.5	80.1	54.6	40.7	62.4	16.9	5.0	77.9	67.0	3.6	404.7	97.5	28.0	146.2	74.9	86.0	6.4	81.1	57.9	28.6	36.1	168.6	1.0	15.6	31.2	0.0	19.5	10.3	2.9	18.8	20.8	2.4	0.4	60.2	32.7	42.2	33.4
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981549-39124345	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 226.6;Inhibitory neurons: 224.0;Microglial cells: 161.1;Oligodendrocyte precursor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 134.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	17.5	8.4	8.2	14.8	10.2	10.8	9.8	14.1	10.3	13.1	6.8	11.0	14.7	14.3	10.3	12.3	11.2	13.5	9.5	9.7	10.8	11.0	11.9	11.0	16.9	9.5	10.2	20.1	9.1	17.1	0.1	17.0	9.5	13.4	12.9	13.2	9.0	12.2	13.7	9.4	15.6	13.8	6.7	12.5	11.5	10.3	8.7	15.4	15.1	16.4	17.8	13.5	0.1	10.6	24.8	15.1	22.8	16.2	29.1	35.0	23.8	15.3	18.7	12.0	11.4	16.3	14.6	35.8	10.3	20.1	18.5	14.4	26.9	13.9	22.1	36.3	11.9	55.5	12.8	22.0	11.8	17.9	134.9	21.6	20.5	16.3	15.8	19.5	18.9	8.1	23.9	16.4	15.4	13.5	19.4	15.8	14.3	30.4	10.4	21.5	20.5	10.5	12.1	19.8	22.0	22.0	18.3	32.3	18.2	18.5	10.4	9.3	21.5	19.8	16.0	15.7	15.4	19.3	20.9	18.4	15.8	17.3	12.0	0.0	0.5	1.4	1.3	0.7	1.9	1.6	1.3	1.4	0.4	1.0	1.5	1.4	0.6	2.7	0.9	0.6	0.9	0.4	8.2	10.2	14.1	10.3	9.7	10.8	9.5	10.2	9.5	6.7	8.7	10.6	72.3	16.0	31.2	120.5	20.9	20.8	15.5	10.9	19.9	19.0	18.4	16.9	33.9	18.6	17.8	9.2	10.4	10.2	27.6	19.5	1.9	11.0	64.9	30.0	36.6	43.2	12.0	12.8	226.6	11.9	8.4	22.9	21.4	34.0	3.8	30.0	12.8	18.6	10.3	8.4	224.0	16.9	26.4	19.1	13.2	11.4	22.7	19.9	7.2	161.1	19.6	15.1	26.8	173.4	125.2	14.2	14.6	21.8	37.5	25.3	28.0	12.8	20.4	11.2	6.6	27.1	22.7	11.3	7.0	17.1	25.3	10.4	33.2	18.4	17.0	28.4
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117130-50231578	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: AB_2680014, HPA052689: AB_2681917"	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	23.8	14.9	15.3	15.3	21.4	39.5	17.9	18.2	19.5	14.3	13.5	17.4	21.5	15.2	22.4	16.4	12.7	12.9	21.5	14.0	16.8	24.5	13.2	15.8	14.4	19.7	18.6	15.3	15.9	39.3	9.1	17.0	19.1	15.4	17.3	14.0	14.5	18.7	57.6	17.9	24.5	18.0	16.8	17.8	13.7	27.9	19.6	16.5	25.1	63.8	13.5	14.8	10.5	23.9	15.3	11.1	22.1	14.9	16.6	18.0	10.4	13.5	14.8	10.0	12.5	4.9	19.8	16.0	11.9	17.3	17.3	13.8	12.1	10.2	17.7	26.9	4.4	16.1	8.5	8.5	18.3	19.1	16.6	18.8	24.6	9.3	21.6	25.2	21.8	13.1	12.5	39.0	24.2	12.7	15.9	15.1	6.9	11.4	9.6	17.0	30.8	12.1	16.1	14.4	16.0	18.7	15.0	17.5	17.8	15.9	19.4	23.0	24.1	27.3	17.8	12.5	8.9	27.3	31.7	19.6	7.1	10.5	16.4	8.0	1.1	2.8	1.1	0.9	0.9	0.6	0.7	0.8	0.8	0.7	0.8	0.7	4.6	1.7	2.0	1.4	0.0	0.4	15.3	21.4	18.2	19.5	14.0	16.8	19.7	18.6	19.1	16.8	19.6	23.9	34.1	9.6	26.3	59.4	18.4	35.7	20.9	10.5	10.2	17.2	23.8	15.6	43.7	17.2	18.2	18.4	16.7	8.2	46.3	36.0	7.9	11.3	17.0	18.7	30.4	23.5	20.4	6.3	71.5	10.7	8.0	22.2	12.8	29.8	20.3	37.4	22.9	13.8	8.8	25.2	89.6	18.5	12.2	33.3	17.5	8.6	12.5	29.0	17.8	80.6	29.0	17.6	21.6	100.5	104.8	14.5	24.6	13.5	28.6	27.3	28.6	15.8	14.3	22.5	19.7	43.4	30.8	54.3	12.3	17.7	39.6	13.0	24.2	17.4	14.9	30.6
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box transcription factor 13"	Q9UN79	1	204073115-204127743	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.9;SK-BR-3: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	39.9	15.4	16.8	4.9	18.5	0.5	29.2	16.3	14.7	36.6	13.0	28.5	14.0	41.0	8.8	15.9	39.8	9.5	17.4	12.1	14.8	31.4	22.6	36.8	4.7	21.6	23.5	19.2	17.2	24.3	8.6	25.9	18.6	35.4	8.1	2.0	21.8	17.8	21.1	17.5	21.4	17.9	18.2	14.2	14.6	7.1	18.3	1.9	17.2	13.9	3.9	29.7	33.2	19.8	24.8	15.6	32.7	2.2	30.6	9.2	65.9	9.4	5.5	14.7	9.0	13.1	18.0	0.2	30.4	6.0	3.8	39.0	12.6	12.2	6.9	11.5	6.4	0.0	11.2	14.6	6.9	0.2	14.0	9.5	6.1	9.2	8.0	7.0	21.7	0.5	0.2	0.1	3.0	30.1	0.3	0.2	43.6	39.5	18.6	0.2	11.1	15.3	11.0	55.9	5.1	2.7	9.5	138.2	42.4	29.0	61.7	3.0	12.4	3.2	8.6	14.2	6.6	0.1	0.1	0.0	5.2	0.5	8.8	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.4	0.5	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.0	0.1	16.8	18.5	16.3	14.7	12.1	14.8	21.6	23.5	18.6	18.2	18.3	19.8	20.5	6.4	7.7	26.8	0.2	2.2	8.7	3.5	2.8	0.9	8.7	7.6	28.3	5.7	4.9	9.2	0.0	5.2	3.9	16.3	1.9	3.6	9.2	13.3	13.0	17.4	7.7	0.0	0.5	1.5	5.6	8.4	5.1	22.3	17.1	0.2	8.9	6.0	1.4	0.0	7.6	5.3	8.2	0.9	2.1	27.7	20.8	1.2	1.8	21.5	0.0	4.9	4.1	50.8	16.8	3.7	7.6	19.5	0.5	7.8	16.0	4.5	4.1	1.0	39.5	9.7	22.3	0.3	0.5	6.6	1.6	1.9	2.3	2.9	5.5	7.7
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120868	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.2;neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: AB_2684528"	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (8.10e-4)"	32.2	22.6	50.9	19.0	64.6	26.7	22.4	60.7	58.4	21.5	38.2	23.1	20.4	27.6	12.3	29.1	18.7	26.7	22.6	44.2	55.1	33.0	32.9	30.4	13.6	64.0	56.0	30.1	30.6	27.4	17.5	32.0	65.1	17.9	19.7	36.6	14.3	19.3	66.3	22.6	21.0	27.0	58.7	18.4	15.9	51.0	60.1	19.3	40.1	40.6	15.7	29.6	20.0	99.1	53.3	58.5	73.3	36.0	68.0	59.9	64.7	42.6	41.5	46.8	57.9	53.0	35.7	28.6	29.1	70.3	94.1	44.7	48.5	35.8	86.4	43.5	57.7	23.9	46.4	39.5	51.1	34.9	26.8	43.4	40.7	63.3	112.4	44.9	38.9	14.2	53.6	30.9	66.9	26.6	22.0	14.5	19.5	35.5	74.8	24.7	81.8	25.3	42.8	99.4	56.6	78.8	37.6	34.5	38.8	44.0	28.5	40.9	54.6	129.6	30.3	101.0	63.4	43.5	67.4	46.2	44.3	20.4	46.0	9.2	1.2	0.7	1.2	0.8	0.9	1.0	1.0	1.2	1.3	0.9	0.6	0.8	12.1	0.4	0.5	1.0	1.7	0.5	50.9	64.6	60.7	58.4	44.2	55.1	64.0	56.0	65.1	58.7	60.1	99.1	162.5	131.4	121.3	190.3	53.1	165.1	149.7	37.5	107.6	96.0	45.7	38.7	62.6	41.5	41.1	25.8	125.1	43.2	60.2	189.0	27.4	56.7	243.0	151.6	142.1	122.9	69.8	20.4	110.2	57.6	28.4	106.5	81.6	337.1	43.1	52.8	74.3	48.7	36.7	67.3	130.5	56.0	24.4	43.3	246.6	137.8	76.1	123.1	71.2	104.9	49.8	32.7	25.7	192.5	304.7	89.6	123.5	67.0	59.7	156.9	69.6	86.9	39.0	85.5	65.7	109.0	86.4	215.1	54.8	93.8	172.3	138.9	59.4	56.3	56.3	182.5
SPARC	"BM-40, ON, ONT"	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151686975	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 2184.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 737.1;Endometrial stromal cells: 1209.0;Endothelial cells: 781.9;Fibroblasts: 1032.1;Peritubular cells: 1111.1;Sertoli cells: 2353.5;Smooth muscle cells: 1527.3;Theca cells: 987.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.4;classical monocyte: 8.7;neutrophil: 24.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.3;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 4911.5;BJ: 4101.8;fHDF/TERT166: 6492.5;WM-115: 4789.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	8300000	130000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	1661.2	406.4	578.0	436.4	922.0	32.4	528.6	733.1	339.2	837.2	297.8	355.6	110.5	538.9	112.7	307.7	271.4	1526.8	563.5	362.9	1554.2	176.1	158.5	498.0	232.1	1370.4	1251.5	348.2	119.2	273.1	111.4	2184.6	1224.8	227.1	185.2	36.4	113.1	378.0	258.2	286.1	157.4	1251.5	995.9	260.8	143.3	406.7	1135.4	70.9	294.1	473.5	131.6	829.5	249.0	1088.4	5.9	5.0	1196.5	57.5	4911.5	1596.0	112.6	4101.8	1336.6	1649.3	1693.8	5.5	4.2	2.0	953.7	6492.5	272.0	56.7	153.4	316.2	555.0	4.8	57.1	56.7	0.4	116.8	1441.6	2.9	5.4	2567.2	436.9	1233.8	170.8	1903.1	2315.1	13.5	53.7	44.6	944.1	0.4	4.7	35.5	556.2	0.4	4.4	2.9	1192.9	4.3	0.5	0.5	45.5	88.4	2.8	1.4	534.9	1922.1	4.7	138.2	2759.9	771.0	1195.2	350.2	1304.4	3.7	6.0	7.6	648.4	3.7	4789.0	10.4	8.7	2.7	1.0	0.3	0.0	0.1	0.0	0.1	2.3	0.2	0.3	0.0	24.3	0.0	0.1	1.9	0.0	123.9	578.0	922.0	733.1	339.2	362.9	1554.2	1370.4	1251.5	1224.8	995.9	1135.4	1088.4	737.1	83.3	27.5	7.2	6.8	164.8	25.7	23.8	28.5	85.7	11.2	100.5	43.6	5.7	18.8	16.5	2.1	115.4	2.8	0.1	0.0	4.6	14.2	41.6	1209.0	781.9	0.0	15.1	4.3	0.4	354.3	1032.1	9.7	31.5	12.0	146.5	668.6	9.9	108.2	1.7	2.9	0.0	0.0	50.0	175.7	46.8	319.3	92.0	234.7	38.4	10.7	13.6	3.1	21.6	37.3	5.5	0.0	1111.1	4.1	7.7	0.0	42.0	7.8	72.7	2353.5	510.4	1527.3	14.2	10.9	4.8	108.3	147.4	21.1	987.4	0.0	5.3
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 4430.9;Endothelial cells: 2372.1;Peritubular cells: 2523.5;Sertoli cells: 4674.1;Skeletal myocytes: 2379.0;Smooth muscle cells: 2781.9"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 24.9;SuSa: 31.4;U-266/70: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		630000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	755.6	129.5	664.6	124.5	810.9	0.5	532.1	612.4	1058.4	732.7	580.4	624.3	125.1	1244.5	443.8	308.1	754.5	487.9	600.2	744.6	723.5	72.5	25.0	481.1	99.1	655.7	730.9	286.8	91.8	128.0	197.8	315.4	663.4	584.2	187.5	95.2	228.3	999.2	244.8	130.2	280.1	1191.2	774.7	157.9	347.7	97.5	694.8	103.2	369.9	594.7	100.0	488.0	466.4	681.2	0.7	0.0	24.9	0.3	0.2	0.1	2.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	1.4	2.4	0.0	0.0	1.7	0.0	0.3	1.1	0.4	1.1	0.3	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.5	0.2	3.5	0.6	0.0	0.0	0.3	0.4	1.2	0.0	0.1	0.8	1.6	0.1	0.2	0.1	31.4	0.4	0.5	0.0	0.2	0.3	1.5	0.2	9.1	1.4	0.6	3.4	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	664.6	810.9	612.4	1058.4	744.6	723.5	655.7	730.9	663.4	774.7	694.8	681.2	4430.9	12.8	56.4	1155.7	6.2	46.3	187.2	0.6	59.7	10.7	24.4	251.6	334.2	4.3	43.3	7.3	2.1	2.2	8.6	0.0	13.7	0.8	11.8	34.9	935.8	2372.1	0.0	32.0	382.3	0.4	3.2	1413.1	6.1	46.7	7.6	1.4	899.5	9.1	9.2	3.3	450.1	0.0	0.0	5.3	55.2	47.0	659.5	31.6	56.9	261.4	0.0	179.4	0.0	210.6	53.8	0.1	0.0	2523.5	25.2	50.4	0.0	24.6	7.4	34.4	4674.1	2379.0	2781.9	5.7	7.9	56.8	39.9	2.5	26.9	38.8	0.0	124.2
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 65.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 102.6;Oligodendrocytes: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.4;HDLM-2: 46.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	6.9	14.3	17.7	18.8	31.6	31.2	14.4	26.2	31.5	10.6	34.2	11.0	11.9	9.4	14.2	3.7	9.9	12.1	8.6	19.7	23.5	21.8	24.4	20.4	23.4	42.3	31.8	14.4	38.4	6.5	9.6	10.6	37.3	14.6	12.4	4.8	8.2	6.6	2.5	7.8	13.3	7.5	25.7	65.3	17.9	6.4	29.6	18.6	12.9	6.4	16.6	9.6	5.2	40.1	3.1	5.0	25.6	3.2	0.9	2.1	1.0	7.7	33.4	3.9	3.3	6.5	13.2	20.4	4.1	7.0	2.0	5.7	7.4	2.3	9.7	46.4	8.9	4.9	4.6	7.5	1.2	7.9	3.7	2.8	0.3	4.2	2.4	3.4	6.5	10.7	0.0	16.7	4.1	11.2	14.6	2.7	8.4	21.5	6.4	12.5	9.9	11.0	17.3	9.9	9.3	7.1	1.5	16.3	15.0	5.5	2.3	4.5	7.6	5.1	4.0	0.4	5.5	3.8	0.1	0.0	4.4	7.5	24.4	5.0	6.4	0.0	33.6	8.4	26.2	2.6	28.6	35.3	4.7	2.0	30.1	31.3	39.2	20.4	10.6	5.2	29.8	13.3	17.7	31.6	26.2	31.5	19.7	23.5	42.3	31.8	37.3	25.7	29.6	40.1	9.0	3.2	23.9	61.0	8.6	5.4	3.2	2.5	4.6	3.2	39.5	17.9	5.3	0.0	17.8	14.7	0.0	1.3	18.6	27.4	3.9	25.3	10.8	58.3	12.9	29.0	32.3	6.3	9.2	15.8	14.1	12.5	51.0	102.6	70.2	4.9	0.0	0.0	10.1	0.0	11.1	24.9	4.1	0.0	8.5	6.3	7.5	29.8	5.4	62.8	15.2	14.1	66.9	19.6	206.5	13.5	32.0	7.5	2.8	23.8	25.0	7.2	40.5	0.8	0.0	21.9	8.2	2.2	2.2	4.6	6.1	22.3	37.8	34.5	23.7	17.0
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979033	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 933.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013386	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	81.0	99.4	86.4	104.9	96.6	60.1	108.2	98.7	131.1	127.5	88.8	119.3	90.5	92.2	220.1	72.8	95.9	66.5	76.2	86.3	102.7	105.6	151.6	79.5	98.2	98.5	93.3	84.3	137.3	147.7	75.1	81.2	98.9	106.9	115.1	75.4	139.0	93.3	71.4	56.6	83.3	93.1	99.7	92.5	105.5	50.4	94.3	97.8	143.9	69.5	154.8	95.0	68.1	107.7	141.7	163.4	213.2	192.2	183.2	122.0	115.9	198.6	192.4	179.0	154.8	322.9	311.7	228.2	244.1	168.9	213.6	254.2	187.3	146.1	220.5	190.0	136.4	232.2	189.7	268.9	208.1	249.3	156.7	109.7	186.1	151.5	245.5	156.8	173.7	166.6	271.9	578.0	163.9	215.0	179.1	158.0	131.0	558.3	153.5	219.2	328.2	522.4	208.2	232.3	172.3	172.6	198.1	262.9	687.6	146.7	254.1	187.6	142.0	201.9	124.9	212.1	177.5	245.1	268.8	423.8	83.0	173.4	209.4	546.3	229.2	219.2	279.8	231.0	315.2	400.7	253.7	269.4	222.0	344.3	191.7	229.5	148.5	260.9	209.8	459.5	272.0	428.3	86.4	96.6	98.7	131.1	86.3	102.7	98.5	93.3	98.9	99.7	94.3	107.7	192.3	86.6	143.6	40.5	323.2	304.5	314.0	812.0	129.7	97.6	212.6	199.9	69.1	214.4	406.0	239.1	52.1	330.8	233.5	130.3	189.8	290.0	36.5	126.4	250.4	181.4	125.4	191.5	46.6	288.0	334.4	239.4	104.5	240.2	155.2	114.7	158.1	338.0	278.9	95.9	55.4	255.1	431.3	140.1	283.3	27.2	240.8	159.7	521.2	23.4	188.6	215.6	197.8	48.7	73.5	253.2	140.0	195.6	933.5	355.5	141.7	280.8	231.1	87.3	170.9	153.6	253.6	127.8	133.1	112.1	229.4	464.8	204.6	192.2	189.5	298.1
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15836095-15940456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	15.3	8.6	11.3	11.5	14.6	23.2	14.0	22.6	12.9	13.3	4.8	12.0	8.8	14.4	8.5	13.3	15.5	8.0	10.8	10.4	14.6	9.6	11.0	14.8	12.9	14.2	12.4	21.3	17.5	16.4	10.7	11.8	11.4	11.1	9.1	15.1	12.8	9.9	20.5	17.3	13.4	9.8	8.0	12.7	11.0	10.3	12.6	16.6	15.6	19.8	13.3	13.0	13.6	20.7	25.4	20.9	26.1	19.6	25.0	15.2	13.8	12.9	16.6	13.5	11.4	19.3	19.5	35.6	15.0	25.1	15.9	36.0	24.0	22.6	21.4	32.1	68.5	44.6	20.5	12.4	11.3	37.1	20.8	11.2	15.9	20.2	28.9	12.9	15.5	26.5	47.1	35.9	11.1	14.0	30.7	14.7	11.6	14.4	15.9	29.5	25.1	21.9	7.5	22.4	20.5	19.9	36.2	17.4	14.8	11.6	6.5	18.4	28.9	12.8	15.5	24.4	18.5	21.5	15.0	39.6	12.2	29.2	17.9	7.4	1.9	1.6	1.4	1.7	0.9	1.3	1.1	1.0	0.5	3.0	0.9	1.0	8.5	1.1	1.3	2.8	0.9	0.5	11.3	14.6	22.6	12.9	10.4	14.6	14.2	12.4	11.4	8.0	12.6	20.7	55.7	80.1	85.3	68.9	69.4	104.6	44.9	18.3	90.5	67.1	35.0	27.9	52.6	30.0	43.2	5.5	52.1	12.2	52.8	44.4	3.9	18.5	7.0	90.4	67.4	51.6	31.7	47.1	57.2	17.6	15.0	45.9	41.8	146.5	62.6	34.3	20.0	32.6	15.2	95.9	66.0	27.4	8.2	34.6	69.6	4.9	27.4	53.2	21.4	64.6	56.3	28.3	68.0	51.8	88.7	23.6	34.6	35.7	74.5	46.7	16.8	7.5	29.4	53.2	19.7	85.7	56.6	59.5	45.9	89.8	101.6	15.7	52.3	33.1	32.8	56.3
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388430-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 178.2;Oligodendrocytes: 220.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA000162: AB_1080079, HPA068784: AB_2686033"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	23.3	26.6	42.3	17.4	44.7	14.7	35.2	30.1	46.2	59.3	35.4	29.0	19.3	61.3	76.9	27.7	50.9	31.7	29.5	45.4	42.4	44.8	20.9	26.1	15.9	32.5	38.8	55.9	21.7	41.7	28.7	33.1	34.4	37.8	25.1	34.8	24.4	42.2	6.9	24.9	22.5	46.1	35.5	19.3	21.3	35.6	44.0	31.0	41.3	14.1	17.3	27.3	31.5	39.5	68.5	32.8	54.0	46.2	36.0	42.1	63.0	67.1	62.0	75.1	54.8	24.6	38.9	37.7	38.5	82.8	48.5	102.4	40.6	61.1	85.7	39.6	24.4	18.0	67.4	26.4	33.3	41.8	19.0	35.2	62.4	50.9	71.2	74.0	43.4	47.2	23.5	0.1	85.5	46.8	71.1	18.8	89.2	56.9	30.5	93.6	58.6	12.2	68.3	47.2	76.1	57.2	79.5	49.7	30.1	62.2	38.3	32.7	41.4	49.6	52.4	74.3	48.2	15.3	24.2	32.3	60.1	38.0	47.3	7.4	2.6	4.1	3.9	2.2	4.1	2.5	2.8	4.0	5.0	1.9	3.9	4.4	0.4	2.6	2.1	2.3	2.8	3.1	42.3	44.7	30.1	46.2	45.4	42.4	32.5	38.8	34.4	35.5	44.0	39.5	26.4	51.3	15.4	139.4	13.1	40.0	26.1	23.1	47.3	22.9	45.4	31.2	35.8	42.9	22.2	44.1	25.0	28.6	17.0	29.1	25.4	24.2	178.2	56.4	73.3	24.5	41.3	19.6	136.8	18.3	44.4	39.6	22.4	68.5	34.8	74.3	26.4	17.5	33.6	25.2	173.3	23.6	30.5	35.2	21.8	123.4	33.5	22.8	21.4	89.9	13.0	38.5	13.4	123.1	220.1	25.4	17.7	44.4	9.6	34.6	20.9	47.6	22.2	15.1	26.3	28.3	38.0	25.7	54.1	37.7	44.8	24.9	16.9	37.9	21.8	28.9
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor Kazal type 1"	P00995	5	147824572-147831671	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"pancreas: 53063.4"	"Group enriched"	"Detected in many"	9	"Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"CACO-2: 417.2;RT4: 1139.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	NA	NA		8000000		"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favorable (2.15e-5)"	8.8	1.5	0.1	36.4	0.1	6.8	4.1	0.3	1.2	3.1	0.3	428.2	394.4	5.5	0.8	2.9	1.3	111.9	12.0	0.2	0.2	142.5	491.8	2.7	2.7	0.1	0.1	25.6	53063.4	0.0	1.9	3.2	0.2	4.4	441.3	0.6	12.8	1.4	1.2	21.1	403.9	14.1	0.0	2.5	1475.2	0.9	0.3	0.4	1.0	0.0	0.3	995.6	10.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	417.2	0.3	0.1	6.8	0.0	0.8	0.9	2.2	0.0	0.0	3.9	0.0	0.0	0.0	107.0	0.3	0.0	3.9	0.0	2.1	0.0	3.0	5.8	0.0	0.0	0.0	0.3	0.0	0.3	0.8	1.3	2.1	138.9	0.8	0.8	0.0	2.5	0.0	1139.0	0.5	1.7	0.0	0.2	0.1	5.4	0.1	0.0	0.0	0.1	13.7	1.1	3.8	2.2	5.9	3.0	16.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.2	0.2	0.2	0.1	0.1	0.2	0.0	0.3	0.6	0.0	0.0	3.6	0.0	9.7	0.0	15.1	0.3	0.0	0.0	5.5	0.8	0.1	1451.2	11.1	377.0	0.0	0.0	0.0	280.8	86.1	1286.7	0.1	0.3	0.4	9.4	517.2	18.7	1.0	50621.7	0.1	1.9	1580.5	5.0	4.5	2.0	39.3	3385.8	0.1	0.0	0.2	2087.4	0.0	30.9	0.0	0.2	0.0	13.7	0.0	0.0	269.8	0.0	0.0	0.0	0.1	16750.7	563.8	0.0	1.3	173.5	1457.1	1.6	0.7	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1365.3	649.1
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor Kazal type 5"	Q9NQ38	5	148025683-148137382	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 338.5;esophagus: 1015.0;skin 1: 318.2;vagina: 582.6"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 1622.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		43000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	1.1	0.3	0.0	0.5	0.1	0.0	17.5	0.0	0.2	338.5	0.0	4.8	0.3	0.6	0.3	1015.0	0.4	1.8	1.7	0.1	0.0	0.8	0.4	2.0	0.1	0.1	0.1	0.3	0.8	1.0	2.0	2.4	0.2	1.3	10.6	0.0	145.0	0.5	1.8	318.2	0.6	0.4	0.0	0.3	5.0	1.6	0.1	9.1	2.2	1.1	292.9	0.7	582.6	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	1.8	0.0	0.0	14.7	0.0	1.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.9	19.3	0.0	2.1	0.0	0.0	2.6	2.0	0.3	0.0	0.0	0.0	0.0	5.7	2.8	0.0	0.6	0.0	0.0	6.6	4.6	0.0	0.0	0.0	0.1	0.0	0.0	5.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	5.7	9.6	45.4	0.3	0.2	53.7	1.5	331.1	102.4	0.0	4.2	3.4	1.2	34.3	115.6	0.0	0.0	1.9	0.0	177.9	0.0	0.2	11.0	2.5	0.7	12.9	4.2	0.0	0.7	1.3	2.1	2.6	17.9	4.8	1.3	0.0	7.9	0.2	0.1	0.0	0.8	33.8	16.2	0.8	2.1	3.8	0.6	0.7	3.6	2.8	0.0	0.0	0.0	2.0	1.2	7.6	60.3	0.0	3.7	0.7	0.0	0.0	9.4	0.0	0.0	0.2	2.4	1.3	4.6	1622.6	64.4	1.5	1.1	1.0	97.9	2.7
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	10.5	44.6	56.9	65.3	57.3	81.1	178.5	47.2	66.3	145.6	80.0	297.0	247.4	44.6	269.6	351.9	189.7	105.1	13.6	58.9	92.9	216.1	14.3	138.3	37.4	52.0	54.8	83.3	234.2	252.9	435.9	156.4	56.2	181.8	251.7	23.6	503.9	111.3	1.8	257.0	267.0	19.0	47.6	50.2	219.4	215.7	70.3	82.6	321.3	0.9	101.3	140.1	157.6	51.0	852.5	603.0	3.0	3.4	0.4	0.0	387.4	16.2	1.7	1.2	2.6	426.8	1219.1	6.7	65.8	4.6	1.2	274.6	42.7	587.0	1.4	7.9	51.7	159.4	15.3	0.9	0.9	1.5	0.8	0.1	662.5	0.7	278.6	71.5	2.0	144.2	4.0	0.4	1.0	652.8	25.6	2.8	60.4	1500.4	172.1	87.9	0.6	386.2	896.7	707.4	222.2	3.4	246.5	789.2	2.1	231.0	353.7	104.5	0.7	1.2	4.7	3.4	3.2	56.1	76.4	47.6	1.0	11.2	1.0	515.9	127.4	531.9	3.8	91.1	7.9	143.2	44.2	21.5	297.7	160.4	86.1	80.4	56.4	19.0	64.4	523.5	19.1	142.8	56.9	57.3	47.2	66.3	58.9	92.9	52.0	54.8	56.2	47.6	70.3	51.0	8.0	368.6	233.9	10.4	90.9	376.9	563.9	954.0	278.9	14.3	487.2	518.2	2.8	316.0	655.6	559.1	6.2	1371.3	79.5	1028.3	101.8	866.9	61.8	401.4	47.3	24.3	360.5	83.9	20.7	659.8	502.0	34.6	234.5	490.4	115.5	371.8	32.5	2.0	230.3	3.3	39.8	672.8	734.5	55.5	139.0	55.6	19.0	133.6	88.9	24.4	364.3	129.6	1.0	4.5	9.0	910.4	889.4	17.0	61.3	684.9	918.6	208.8	495.1	17.2	52.6	1.2	76.7	545.2	264.1	507.7	428.3	1413.2	42.6	3.4	582.2	989.6
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11 initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329803-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 8.5"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 98.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 187.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 427.0;Endometrial stromal cells: 256.6;Extravillous trophoblasts: 355.8;Fibroblasts: 257.7;NK-cells: 1096.8"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 255.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 255.9"	"Group enriched"	"Detected in many"	5	"HHSteC: 303.8;HSkMC: 546.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	66.2	40.4	4.0	18.8	7.7	19.5	50.6	15.6	3.9	161.4	3.5	51.5	18.5	187.1	4.4	40.6	49.7	32.2	35.5	3.5	0.8	37.1	79.1	63.0	3.9	2.9	1.7	34.4	18.7	0.9	15.1	19.2	3.5	111.8	7.2	0.7	28.8	8.4	19.1	38.3	63.5	42.7	0.2	26.9	43.8	4.7	1.8	1.8	16.3	6.6	1.0	68.4	94.0	1.5	0.4	0.6	0.0	0.0	10.2	79.0	3.0	6.2	5.0	0.8	1.0	0.0	0.1	1.8	9.7	26.9	0.9	45.0	0.0	0.2	0.0	0.3	0.1	0.2	3.0	12.7	303.8	0.2	1.5	546.6	0.0	0.6	0.0	0.0	0.0	4.1	0.3	9.2	0.0	0.3	5.3	12.2	3.5	9.7	0.7	1.0	3.3	7.9	0.0	0.0	1.7	1.1	1.1	0.0	2.9	1.7	0.4	1.5	0.1	0.2	0.9	20.5	0.0	1.3	2.7	0.6	0.1	6.5	0.0	3.7	0.9	1.0	255.9	1.1	5.5	0.7	33.1	105.8	0.4	1.0	14.4	96.8	9.8	50.4	2.2	42.9	0.1	123.2	4.0	7.7	15.6	3.9	3.5	0.8	2.9	1.7	3.5	0.2	1.8	1.5	9.8	0.0	5.6	1.3	6.6	36.8	2.0	82.5	2.2	3.7	5.1	3.8	4.0	24.3	43.0	1.8	0.0	3.4	427.0	9.7	1.9	3.8	0.2	12.7	256.6	5.7	13.8	4.0	8.4	1.3	355.8	257.7	10.7	6.6	6.3	0.2	15.4	40.4	12.8	0.0	0.6	9.7	73.2	5.8	15.4	0.5	29.8	9.5	26.6	6.5	9.2	0.9	1096.8	0.5	0.7	1.5	6.7	9.4	64.0	15.8	16.3	28.3	32.6	0.4	6.6	22.5	89.9	0.2	0.5	21.3	21.5	38.9	100.8	8.1	7.9	13.2
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4373	"liver: 519.1"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 258.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		480000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"										"prognostic favorable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	519.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.3	0.3	0.6	0.0	0.7	0.0	0.1	5.1	0.0	5.0	258.7	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765709	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	41.1	34.7	8.3	57.6	10.9	54.5	32.0	11.1	8.5	36.6	48.6	93.4	79.6	27.9	21.5	26.5	26.8	39.4	37.1	6.8	12.3	57.9	107.0	43.4	40.2	15.3	12.8	13.6	63.7	158.5	13.0	54.1	12.5	29.5	82.8	12.5	44.5	32.6	109.3	25.2	67.6	41.0	11.2	37.3	41.7	18.5	12.1	39.5	35.2	81.8	41.7	51.7	20.9	14.5	57.3	96.9	37.0	49.2	142.3	84.3	58.2	89.1	149.1	80.5	114.1	113.1	64.3	35.1	65.0	176.3	120.7	83.5	45.2	54.3	89.5	72.2	27.5	67.0	61.5	58.9	117.4	42.0	104.5	73.9	98.3	66.8	106.7	59.4	80.2	37.7	51.3	134.2	107.6	131.5	20.1	16.2	15.8	90.8	22.0	24.2	57.3	77.6	109.7	130.4	29.7	33.4	54.0	102.7	63.4	74.0	73.2	81.6	98.9	128.7	51.7	83.7	106.7	54.0	100.2	38.8	58.1	69.4	90.3	48.7	52.3	48.9	27.9	48.6	17.4	18.3	22.3	25.5	37.4	19.2	12.4	20.5	37.7	23.5	56.6	33.1	30.4	50.2	8.3	10.9	11.1	8.5	6.8	12.3	15.3	12.8	12.5	11.2	12.1	14.5	66.2	48.1	35.9	20.5	51.9	43.1	79.1	76.3	37.5	14.8	36.4	21.3	77.5	52.9	44.3	68.0	20.9	136.5	72.7	215.5	23.5	87.1	18.8	107.2	56.6	59.6	38.4	30.3	32.0	167.1	88.3	74.3	52.0	57.3	45.7	20.5	46.8	124.1	85.9	8.4	31.4	86.5	36.7	68.7	55.7	7.0	44.7	83.0	32.0	23.4	134.5	27.5	64.9	25.6	26.2	131.9	127.3	36.5	49.9	92.2	143.0	46.8	41.8	17.2	26.3	88.0	51.6	31.7	15.3	39.3	38.8	204.5	60.6	30.8	76.0	94.1
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887382-72892158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 8.9;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	25.9	50.8	26.0	7.6	27.2	0.6	20.0	27.2	61.4	14.5	39.6	36.4	23.4	13.4	36.9	19.7	26.3	11.9	44.4	26.8	30.0	44.2	99.8	15.9	3.2	27.9	31.5	12.2	63.5	38.4	10.9	6.8	29.8	26.2	32.5	3.1	31.2	16.7	43.9	9.1	22.0	11.5	27.9	9.6	42.1	7.3	28.5	2.4	20.5	25.4	5.1	25.2	13.7	28.0	47.5	130.9	0.6	20.0	51.2	18.5	31.8	21.4	31.8	16.0	15.0	84.0	48.0	34.5	25.4	26.1	80.6	43.9	58.1	35.1	13.3	10.0	43.7	51.7	30.8	87.4	19.1	8.2	13.6	16.7	38.7	17.6	19.7	32.7	42.6	25.4	54.0	6.8	21.4	100.5	3.3	31.1	10.9	139.9	118.7	0.0	82.8	20.3	85.8	73.4	8.0	14.6	39.6	89.7	31.0	16.9	40.4	9.9	52.8	17.4	42.2	30.5	38.7	7.2	16.9	2.3	25.0	17.6	31.0	0.0	8.3	0.7	0.3	2.4	0.3	0.0	0.1	0.1	8.9	0.0	0.1	0.3	0.0	0.0	0.9	0.9	0.0	2.4	26.0	27.2	27.2	61.4	26.8	30.0	27.9	31.5	29.8	27.9	28.5	28.0	13.8	12.8	7.3	0.3	1.1	8.4	23.0	14.8	20.5	0.7	22.2	16.5	46.2	38.6	10.8	42.3	0.0	18.1	0.4	85.3	21.5	56.9	0.3	12.5	4.2	16.7	11.4	6.6	0.7	81.1	10.6	13.9	26.0	6.7	4.5	8.4	17.2	62.9	42.1	1.7	0.4	39.6	12.2	6.0	7.4	1.5	9.3	9.7	14.2	1.9	20.8	13.8	0.0	0.0	0.3	43.3	50.4	5.7	1.4	33.9	71.0	91.6	11.2	0.7	6.6	8.3	8.6	0.4	10.2	17.8	6.5	4.4	1.9	8.7	57.8	15.6
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Excitatory neurons: 138.5;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 1.9;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;NK-cells: 1.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038256: , HPA064394: AB_2732712"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	23.9	11.4	12.0	9.7	15.3	7.0	21.7	11.8	22.8	13.5	5.6	16.5	14.9	16.5	8.6	10.9	13.3	13.2	14.7	14.4	11.4	13.7	24.8	18.4	14.0	14.4	12.5	14.0	18.0	16.7	11.5	15.8	11.2	12.3	16.1	10.9	15.9	10.8	8.0	11.3	13.7	11.5	11.1	8.5	19.8	7.4	13.3	28.7	17.9	13.9	15.4	15.5	14.0	12.7	60.4	32.9	32.2	32.4	41.1	40.9	22.2	16.1	25.2	10.9	14.5	43.4	16.4	41.2	9.2	20.8	29.2	18.7	18.2	37.2	21.9	52.3	11.6	9.7	9.1	45.2	21.0	25.7	18.8	33.1	22.2	37.2	36.9	22.9	6.9	24.9	39.1	16.9	17.7	40.9	22.6	26.7	16.1	43.4	35.4	17.1	28.6	24.2	34.1	52.3	13.1	45.1	18.1	14.8	44.2	20.1	15.1	23.7	11.4	27.6	35.8	23.8	27.4	33.2	13.8	73.7	44.7	27.1	54.2	0.0	0.2	0.0	0.6	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.6	1.9	0.3	4.2	0.0	0.7	12.0	15.3	11.8	22.8	14.4	11.4	14.4	12.5	11.2	11.1	13.3	12.7	49.7	19.2	16.0	108.7	1.8	39.9	29.0	12.0	41.5	17.8	22.7	17.7	7.5	14.3	6.6	9.2	6.2	11.0	3.3	32.0	13.7	11.0	1.5	16.8	11.4	18.6	11.4	1.7	138.5	8.6	8.4	21.0	14.8	35.0	1.3	2.8	13.9	14.1	6.7	25.2	122.4	24.1	8.2	7.5	67.6	4.1	17.1	10.2	19.6	68.4	26.0	7.9	0.0	124.1	23.2	13.9	21.5	12.4	0.5	23.4	17.1	7.4	7.2	9.8	26.3	17.0	17.4	3.9	10.4	16.6	16.8	3.0	3.8	4.7	10.9	24.0
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80341126	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 267.9;SK-MEL-30: 156.9;WM-115: 136.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: AB_2677896"	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	69.6	24.1	37.4	11.8	38.0	29.5	66.2	57.6	42.9	31.0	27.7	40.4	17.6	29.3	15.3	20.0	46.7	30.1	50.9	38.5	36.0	21.1	27.8	31.5	8.9	50.2	40.4	16.9	27.4	10.2	17.3	13.9	40.2	26.2	27.3	34.2	34.8	18.9	39.1	26.5	25.4	23.5	42.0	30.8	25.9	4.1	39.7	11.3	27.1	41.4	4.9	27.0	30.8	43.4	1.8	7.6	84.2	267.9	108.4	70.6	5.8	69.3	31.1	15.3	18.2	34.9	10.3	0.0	11.6	28.5	10.6	6.7	4.8	13.9	17.0	0.1	15.3	12.0	4.5	8.9	24.9	63.4	4.8	31.8	14.6	26.1	63.3	95.6	29.9	13.0	4.4	0.3	35.0	1.5	8.6	28.8	33.7	23.6	19.6	25.6	112.0	0.2	28.8	11.7	1.0	46.7	5.7	3.1	156.9	32.9	6.3	56.0	44.3	14.3	5.6	30.3	13.6	0.1	0.1	0.0	97.6	23.9	136.9	0.0	0.0	2.1	0.3	0.0	0.1	0.4	0.0	0.8	0.9	0.0	0.0	0.1	0.0	4.1	0.0	0.1	0.0	0.1	37.4	38.0	57.6	42.9	38.5	36.0	50.2	40.4	40.2	42.0	39.7	43.4	48.5	25.6	29.3	59.4	2.9	43.5	38.0	12.5	53.5	5.9	12.4	21.3	20.5	18.6	6.3	1.8	6.2	8.7	12.1	33.4	5.9	11.3	0.3	25.2	17.6	22.3	12.0	8.4	22.1	8.0	2.9	65.9	11.2	41.7	16.4	7.2	32.5	17.0	10.9	8.4	15.3	36.1	4.1	27.3	10.7	1.5	29.5	12.2	14.2	15.9	0.8	68.5	3.1	39.7	17.6	18.0	33.7	5.7	1.7	23.1	7.2	8.3	4.8	23.3	26.3	57.7	67.6	0.1	1.5	16.2	29.1	9.6	11.1	8.5	27.6	11.9
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610704-158686715	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"bone marrow: 75.7"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 255.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"K-562: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced					NA	NA		11000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.1	0.0	0.0	0.0	0.0	75.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.7	0.0	0.0	0.3	0.0	255.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456317-54671446	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 615.4;Peritubular cells: 663.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"		NA	Yes		1500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	187.3	70.9	210.6	34.7	205.1	37.6	78.7	97.4	166.1	54.1	94.2	62.8	32.7	52.0	36.3	41.7	56.2	69.2	135.9	156.2	99.7	65.3	83.8	131.6	28.9	141.2	154.4	73.2	45.5	129.2	27.8	97.4	120.4	43.8	52.4	56.0	55.1	74.4	54.0	39.4	46.8	59.9	134.8	58.7	55.6	32.6	214.6	29.3	72.8	87.2	30.0	45.6	38.6	163.6	96.5	150.5	60.4	57.2	234.7	158.8	74.8	40.2	82.3	63.7	61.4	101.7	66.6	0.4	112.1	142.0	55.1	110.9	85.1	128.0	66.0	0.8	35.6	43.7	118.4	166.2	97.7	59.7	24.4	62.3	64.8	193.8	119.7	77.6	151.6	95.1	50.0	64.0	86.1	21.6	105.0	14.5	66.3	129.6	70.2	116.2	95.0	37.2	92.2	120.6	36.3	113.3	121.5	39.5	88.1	58.9	19.6	9.9	235.2	89.9	79.0	110.2	58.2	62.8	42.8	32.7	98.1	17.7	163.7	2.3	0.4	2.8	3.7	0.0	3.9	3.7	3.4	3.6	1.3	3.5	5.0	3.6	0.6	5.2	0.0	1.1	3.2	3.1	210.6	205.1	97.4	166.1	156.2	99.7	141.2	154.4	120.4	134.8	214.6	163.6	615.4	407.1	124.6	233.4	45.7	83.1	50.0	64.7	42.7	94.4	60.8	58.0	262.9	144.4	100.6	145.3	73.0	28.3	31.7	343.6	7.9	223.7	12.1	140.4	80.3	426.4	83.1	21.5	231.3	121.9	42.0	271.6	139.7	115.7	35.4	68.2	228.5	184.6	14.2	141.3	195.4	135.5	77.3	17.7	47.0	31.5	503.2	16.6	147.7	294.2	9.7	131.9	36.0	154.8	283.1	243.3	109.9	663.5	76.3	75.6	142.8	44.1	187.3	93.6	164.3	340.3	171.9	54.7	53.3	79.7	68.2	11.1	49.2	56.6	151.9	88.1
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Bipolar cells: 65.2;Cone photoreceptor cells: 56.3;Excitatory neurons: 209.5;Horizontal cells: 74.0;Inhibitory neurons: 194.8;Oligodendrocyte precursor cells: 46.3;Rod photoreceptor cells: 64.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.8;Karpas-707: 2.5;SCLC-21H: 3.9;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA054481: AB_2682502"	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	1.1	2.1	4.8	0.1	5.9	0.1	0.7	6.4	20.1	1.1	0.0	1.6	0.3	1.5	0.1	0.4	1.3	0.4	2.1	4.8	0.0	0.8	0.3	0.3	0.0	4.0	0.0	2.6	0.9	1.4	7.8	0.0	2.2	1.5	0.0	3.4	0.6	0.4	2.1	0.5	0.5	0.3	0.0	0.2	1.2	2.0	0.7	0.1	0.7	0.9	0.0	1.1	0.7	6.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	2.5	0.0	0.6	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.5	0.0	0.0	3.9	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.9	6.4	20.1	4.8	0.0	4.0	0.0	2.2	0.0	0.7	6.0	0.2	0.0	0.0	48.6	0.1	0.1	0.2	0.1	0.6	65.2	0.7	0.6	4.9	0.0	0.2	0.0	56.3	0.0	2.7	0.1	0.0	0.2	3.4	0.3	0.8	0.5	16.3	0.0	209.5	0.0	0.0	1.0	0.0	0.8	0.0	0.7	0.4	0.8	0.2	74.0	194.8	0.5	0.0	0.6	0.2	1.3	8.1	0.6	1.8	10.3	0.6	6.1	0.0	46.3	13.4	0.1	0.0	7.2	0.1	0.4	0.3	1.7	0.2	64.2	0.0	1.6	0.7	3.5	6.0	0.3	0.4	0.0	0.4	0.4	0.3	0.2
SPTBN5	"BSPECV, HUBSPECV, HUSPECV"	ENSG00000137877	"Spectrin beta, non-erythrocytic 5"	Q9NRC6	15	41848146-41894053	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 8.8;retina: 26.9"	"Group enriched"	"Detected in many"	22	"Cone photoreceptor cells: 210.6;Rod photoreceptor cells: 211.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.7;SCLC-21H: 5.1;TIME: 13.6;WM-115: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"spinal cord: 3.6"	HPA055283	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055283: "	"unprognostic (5.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.84e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.11e-2)"	1.0	0.3	0.4	0.7	1.3	0.4	1.1	8.8	1.4	0.6	0.1	0.5	0.3	0.4	0.8	1.7	0.5	0.9	2.0	0.6	0.1	1.7	1.6	1.2	0.6	0.8	0.3	0.6	1.1	0.5	1.9	0.2	1.0	1.6	0.2	26.9	2.7	0.3	0.4	1.7	0.5	0.2	0.1	0.5	1.0	0.8	0.1	0.0	2.1	0.4	0.1	2.6	0.7	0.8	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.8	0.0	1.5	0.4	0.0	0.2	0.0	0.8	0.1	0.0	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.3	0.0	0.3	1.4	5.1	0.1	0.2	0.4	0.1	0.4	0.8	0.0	13.6	0.0	1.3	0.3	1.7	1.5	2.3	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	8.8	1.4	0.6	0.1	0.8	0.3	1.0	0.1	0.1	0.8	1.9	0.0	2.4	2.9	0.2	0.8	0.9	0.4	1.2	7.9	1.8	2.0	4.0	0.0	1.5	0.0	210.6	0.1	0.8	0.7	0.0	0.5	1.1	1.1	0.3	3.7	0.0	0.0	2.3	0.2	0.3	0.6	2.0	3.8	1.3	1.0	0.4	0.5	2.0	3.3	0.5	0.5	0.0	0.0	0.6	0.9	0.0	1.0	1.8	0.0	0.8	9.6	1.0	6.0	0.5	1.0	1.4	0.0	0.9	0.2	0.2	0.6	0.8	211.8	0.0	0.2	0.3	0.5	0.5	3.9	1.3	0.0	0.5	0.2	0.6	1.0
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115413	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	35.6	32.6	24.0	27.3	27.0	23.3	44.1	26.0	34.2	43.1	28.6	42.3	34.7	40.4	41.3	54.3	36.7	34.1	21.5	24.3	26.6	42.8	23.4	33.6	25.7	27.8	27.5	43.8	26.5	48.0	17.3	42.4	28.0	32.9	44.1	19.8	31.3	28.1	14.2	41.3	37.9	31.4	27.9	26.3	37.1	26.5	25.6	25.9	53.0	18.6	34.4	37.2	34.7	31.6	73.0	48.8	46.8	41.6	120.0	92.0	78.4	74.7	94.2	65.3	66.3	31.5	150.7	38.6	45.1	93.9	78.3	198.4	49.7	68.1	73.0	39.8	36.1	36.7	32.7	51.7	80.5	65.5	49.9	82.6	92.6	68.0	74.8	72.3	62.5	43.5	83.8	46.6	91.1	69.6	34.7	47.6	67.5	97.4	57.9	39.4	58.7	33.3	84.1	37.9	35.0	37.2	104.4	81.1	61.3	62.4	39.2	54.2	72.3	58.8	48.0	73.9	56.8	33.2	44.4	23.9	74.2	39.3	79.4	32.4	33.1	20.2	16.7	36.1	17.0	15.4	18.0	17.4	30.6	15.5	21.4	16.6	33.3	18.5	34.2	18.4	25.7	25.5	24.0	27.0	26.0	34.2	24.3	26.6	27.8	27.5	28.0	27.9	25.6	31.6	40.7	38.5	38.3	27.7	22.1	10.6	13.6	14.5	26.2	6.9	33.2	20.6	4.1	4.3	25.9	36.8	14.6	12.7	24.4	8.0	9.8	53.4	94.8	34.7	42.5	23.1	2.4	7.2	35.3	56.4	15.6	32.3	13.7	47.4	24.6	26.9	6.1	4.3	11.0	6.7	32.5	7.2	12.2	5.7	10.3	26.1	6.2	24.6	12.4	20.6	22.0	13.7	7.2	36.7	52.1	60.8	7.1	6.0	26.2	9.8	11.7	28.5	28.0	8.7	13.1	12.1	23.5	35.3	25.9	27.6	9.1	21.8	21.9	33.2	6.9	14.5
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616637	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	17.6	12.2	14.6	12.6	26.7	33.7	18.3	24.0	19.4	15.2	9.9	18.5	14.5	10.5	7.6	22.8	14.2	11.8	6.7	15.3	18.1	17.6	7.7	13.1	12.0	30.7	21.5	10.4	5.7	10.7	6.2	20.4	31.5	8.4	19.8	14.2	13.7	8.8	3.9	12.2	17.4	11.6	25.3	19.6	20.4	5.0	21.7	10.3	10.9	6.1	13.3	15.0	10.8	52.7	28.9	18.5	14.1	15.5	14.3	17.8	23.7	41.7	30.8	28.2	29.3	23.7	62.3	28.8	10.4	42.7	14.5	34.7	38.1	23.7	42.5	12.6	11.0	82.5	13.4	14.3	12.1	8.4	25.8	11.7	11.4	18.4	20.4	16.3	40.6	19.4	16.2	13.5	16.2	24.9	22.2	28.7	9.2	45.4	16.8	23.5	14.3	10.0	32.9	63.4	13.6	17.1	15.0	50.3	15.8	24.7	61.8	15.3	25.9	25.7	18.2	9.6	9.7	7.6	13.4	19.1	17.3	29.4	14.8	18.3	31.3	27.1	6.1	24.2	5.7	6.7	5.1	6.8	31.2	7.9	3.5	5.8	19.1	17.7	31.8	11.1	6.0	13.4	14.6	26.7	24.0	19.4	15.3	18.1	30.7	21.5	31.5	25.3	21.7	52.7	125.1	28.9	27.3	24.8	27.3	32.4	28.3	27.0	15.4	15.7	24.3	18.4	8.9	15.7	30.7	47.8	35.5	11.9	28.3	37.6	1.9	24.0	1.6	44.1	36.0	53.1	13.2	51.3	31.2	16.1	12.3	18.9	43.3	36.0	51.3	37.2	68.2	7.2	25.1	5.0	29.5	39.3	20.3	75.9	19.8	1.7	14.6	66.2	19.6	83.4	51.3	8.8	32.0	59.3	164.0	35.0	30.4	15.8	11.0	27.0	28.4	8.8	33.5	20.0	32.9	10.5	25.5	7.3	19.0	37.7	29.1	6.6	23.3	14.6	33.0	60.0
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837011	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 202.5;SK-BR-3: 178.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	42.2	219.2	26.8	7.9	41.5	20.1	46.5	20.4	37.2	51.5	9.4	37.7	28.7	23.4	8.9	68.7	42.7	14.0	27.4	20.0	25.9	24.7	128.5	26.4	9.1	30.1	29.7	41.4	17.0	8.4	37.0	7.8	24.2	37.2	6.7	3.9	89.5	16.7	34.5	47.8	34.0	5.6	23.4	17.2	25.2	35.4	35.8	14.4	27.0	2.9	6.3	32.5	48.8	41.7	54.1	122.5	12.0	85.2	24.9	55.8	23.5	18.5	60.0	16.4	39.2	23.3	104.2	33.5	17.2	14.8	14.5	144.0	16.7	47.2	4.0	21.1	7.2	16.8	86.4	19.1	36.1	2.5	29.6	42.0	19.6	21.8	12.5	12.2	17.6	64.9	36.8	105.8	2.5	118.7	46.9	26.1	17.8	38.3	23.1	32.6	10.8	202.5	9.0	23.1	16.3	70.5	24.4	178.7	48.0	8.9	62.0	32.6	21.5	8.2	40.5	19.5	12.5	32.2	3.1	15.5	48.9	24.6	45.2	0.0	0.3	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.6	1.3	0.1	0.1	0.1	0.0	0.2	26.8	41.5	20.4	37.2	20.0	25.9	30.1	29.7	24.2	23.4	35.8	41.7	6.1	6.4	26.0	66.9	11.9	9.3	12.0	29.2	14.8	24.5	58.0	30.6	9.4	18.6	29.7	20.2	29.2	4.5	11.4	44.5	1.9	16.5	2.7	30.9	37.2	10.5	29.9	24.8	12.8	23.5	15.7	24.7	31.1	31.9	14.7	13.2	12.8	72.2	12.1	58.9	11.3	30.8	24.4	14.0	13.3	4.9	29.8	15.1	8.8	15.0	11.0	51.7	1.0	10.6	56.7	16.7	20.8	10.9	8.4	19.0	33.2	6.6	32.1	31.6	13.1	15.6	12.9	11.4	4.9	40.2	18.3	19.8	13.4	27.5	41.1	25.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	22.8	80.7	50.1	31.1	58.7	32.3	24.5	22.3	60.5	26.5	2.5	47.1	40.8	34.4	60.5	82.0	27.4	25.3	53.8	51.8	32.3	33.3	36.2	43.2	35.2	38.5	37.8	35.8	45.8	51.4	30.5	24.5	38.3	33.5	31.6	21.0	49.1	22.9	34.1	58.4	35.9	30.1	16.1	26.1	53.8	20.4	37.8	25.0	23.3	33.5	36.2	29.7	39.0	45.1	65.5	45.8	119.4	111.6	68.4	90.9	66.7	21.4	71.1	24.8	50.5	54.3	84.2	115.8	29.7	52.6	91.1	109.6	68.7	141.8	17.5	32.9	75.0	58.0	79.7	54.6	113.8	85.7	37.9	85.8	78.7	65.1	80.6	56.7	49.2	64.2	60.6	135.9	26.4	83.1	62.5	64.5	75.7	81.2	34.9	71.3	68.1	189.0	103.3	67.6	48.2	36.3	49.1	89.3	91.7	69.5	56.3	150.2	53.0	33.2	61.0	15.9	25.8	98.3	54.3	91.7	32.4	64.0	51.9	0.0	4.7	1.6	4.6	3.6	3.1	7.0	2.5	3.3	5.0	4.8	2.2	2.6	0.7	1.4	3.1	6.3	1.5	4.8	50.1	58.7	22.3	60.5	51.8	32.3	38.5	37.8	38.3	16.1	37.8	45.1	14.5	44.8	43.3	100.6	35.4	16.3	13.5	52.2	30.7	41.0	36.3	23.1	30.3	37.1	38.0	58.8	10.4	25.4	23.5	67.0	3.9	20.3	15.9	25.2	10.5	16.8	49.1	14.1	72.6	44.3	22.6	16.3	42.8	59.2	12.7	43.2	8.2	34.3	14.8	57.2	75.1	39.4	52.9	10.3	14.8	7.0	31.4	16.3	7.2	67.5	18.1	18.6	20.6	90.5	129.5	38.4	30.5	27.4	29.2	27.9	26.3	4.8	30.0	18.7	19.7	13.7	20.5	8.4	13.8	55.7	28.1	36.5	19.0	43.0	40.3	30.2
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035690-40039181	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		440000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	309.1	307.5	330.1	118.1	327.1	252.7	300.4	323.8	426.0	301.7	320.4	272.5	121.5	311.2	282.1	257.7	270.7	155.8	390.1	317.9	349.3	391.5	229.5	220.8	168.0	357.0	402.7	323.5	192.4	324.3	306.8	143.8	339.7	264.4	158.9	212.8	237.8	158.9	354.7	201.2	215.7	163.4	321.1	219.7	247.6	165.6	326.2	276.9	275.6	338.5	172.9	266.7	253.9	355.1	131.8	163.7	399.5	301.4	300.0	275.5	189.4	232.4	265.0	213.4	223.3	297.8	113.7	107.9	245.0	305.1	319.5	216.6	322.8	260.9	207.0	257.5	230.3	258.3	530.2	364.0	231.4	238.2	211.8	276.0	298.3	177.8	213.3	391.0	360.6	297.7	280.2	204.2	356.3	204.5	370.2	291.4	217.6	520.1	301.3	247.6	176.8	192.6	477.5	401.7	287.2	255.0	231.2	243.2	171.2	243.7	332.8	448.6	290.9	240.4	160.3	229.4	171.1	161.8	494.7	291.0	234.7	255.4	229.7	729.8	525.0	875.7	484.5	485.8	473.9	600.9	547.9	549.0	562.5	509.0	522.0	510.2	452.7	525.9	459.5	1148.0	755.1	1262.6	330.1	327.1	323.8	426.0	317.9	349.3	357.0	402.7	339.7	321.1	326.2	355.1	1378.8	461.6	415.0	83.2	577.0	667.1	861.7	1395.7	427.4	432.9	617.7	914.5	880.3	649.1	906.9	995.0	125.1	867.3	812.5	742.7	2551.3	1366.9	353.1	1215.7	729.8	957.7	554.0	619.4	39.4	1087.2	1100.4	699.1	324.7	1513.6	564.0	669.5	654.7	819.4	1022.1	348.3	56.1	676.9	1226.8	631.1	882.8	377.3	1039.8	645.8	789.8	36.5	1174.3	1262.8	619.0	39.2	76.0	1240.7	894.4	986.9	610.9	826.3	874.5	2276.2	935.5	477.3	624.5	651.9	749.3	779.9	643.1	631.5	710.3	758.8	644.1	831.9	673.2	975.0
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
SRPRA	"SR-alpha, Sralpha, SRP-alpha, SRPR"	ENSG00000182934	"SRP receptor subunit alpha"	P08240	11	126262938-126269144	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 232.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.23e-3)"	"unprognostic (6.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	64.4	78.9	24.9	71.4	25.9	82.5	58.0	27.2	32.5	85.6	51.7	54.7	53.1	64.8	144.2	55.7	57.4	64.7	62.9	26.7	29.2	54.1	164.0	65.5	67.4	28.9	26.9	55.8	254.8	71.5	88.9	49.9	28.9	81.8	61.9	36.3	236.8	87.7	91.1	53.8	52.2	68.8	25.6	66.7	96.3	32.7	30.6	61.8	90.2	69.3	86.4	82.0	48.6	27.6	65.5	63.5	59.5	90.9	160.1	124.0	79.5	183.8	168.5	87.4	102.9	117.5	163.4	122.2	186.4	182.3	109.2	126.4	91.1	105.8	87.2	134.9	71.9	223.8	49.1	117.9	223.7	198.7	139.9	106.4	132.5	134.6	245.0	105.5	120.9	47.7	76.2	284.3	124.1	87.6	95.9	78.5	39.7	193.1	135.5	62.8	82.3	128.4	86.8	132.2	85.5	80.3	125.6	150.9	95.7	48.0	198.7	117.5	115.5	153.2	68.2	88.0	132.8	123.3	85.0	73.9	85.3	177.5	202.5	72.1	61.8	95.9	91.3	67.4	79.7	48.7	62.6	74.0	59.4	41.1	56.3	65.2	64.3	62.3	82.8	78.1	53.5	94.7	24.9	25.9	27.2	32.5	26.7	29.2	28.9	26.9	28.9	25.6	30.6	27.6	52.9	44.8	69.3	0.0	69.1	0.0	53.5	0.0	44.9	30.4	37.6	24.9	0.0	32.9	46.4	22.0	8.4	38.0	81.7	12.1	1.9	64.3	9.8	33.5	53.2	36.5	12.2	24.6	0.0	90.9	42.4	42.9	35.2	67.9	49.2	25.9	32.9	77.9	25.7	60.6	0.0	14.2	0.0	27.0	0.0	8.4	36.4	43.4	0.0	0.0	56.6	28.0	52.5	0.0	0.0	67.6	9.5	46.6	232.5	60.6	25.1	19.2	21.1	28.8	46.0	42.3	30.7	18.5	34.3	36.3	0.0	81.0	64.3	38.4	9.5	66.3
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 215.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 256.9;Granulosa cells: 138.9;Hepatic stellate cells: 418.7;Leydig cells: 110.3;Peritubular cells: 95.2"	"Group enriched"	"Detected in all"	5	"glioma: 64.2;melanoma: 70.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	49	"plasmacytoid DC: 7.8"	"Lineage enriched"	"Detected in single"	49	"dendritic cells: 7.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3742.4;ASC TERT1: 827.3;HSkMC: 1258.3;HUVEC TERT2: 803.2"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"spinal cord: 12.4"						"Secreted - unknown location"	NA	NA		140000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.36e-4)"	215.2	37.2	8.2	22.4	12.8	0.1	148.0	17.8	5.9	48.6	5.2	83.0	7.9	56.1	39.6	36.6	113.4	58.1	93.3	7.0	16.7	7.4	17.7	46.6	5.0	13.2	14.2	21.4	23.9	2.7	4.6	88.9	15.4	18.3	24.8	1.6	22.9	15.3	15.6	29.2	52.6	52.9	15.1	1.7	42.5	6.7	13.8	19.2	59.1	13.6	5.3	103.8	42.9	15.4	0.3	5.0	12.1	0.2	3742.4	827.3	0.9	35.3	67.8	11.9	20.2	0.5	3.6	0.1	0.3	74.3	119.9	1.9	2.0	30.8	9.8	0.2	13.8	0.1	1.0	0.4	167.8	3.0	0.4	1258.3	2.6	114.9	58.3	132.8	803.2	1.4	0.1	0.2	130.1	1.7	0.5	0.1	10.2	1.8	26.2	0.0	43.5	6.4	0.8	2.3	2.3	2.3	1.7	0.1	170.1	31.2	0.0	0.4	349.1	82.2	42.3	108.8	103.7	0.0	0.1	0.1	239.0	3.1	106.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.0	0.1	8.2	12.8	17.8	5.9	7.0	16.7	13.2	14.2	15.4	15.1	13.8	15.4	28.7	3.2	1.3	17.0	0.6	15.3	2.2	2.8	7.4	0.4	2.9	8.6	14.2	0.0	0.2	1.8	0.0	3.6	2.1	2.5	0.0	0.3	0.7	1.1	35.1	67.2	0.0	2.7	1.9	0.4	5.4	256.9	1.5	0.8	0.0	138.9	418.7	2.5	6.1	0.0	2.7	5.8	0.0	11.4	15.2	4.9	110.3	1.6	74.7	1.0	0.0	0.2	0.0	2.5	0.3	0.8	1.8	95.2	0.2	1.6	0.4	0.2	0.0	0.4	26.3	4.8	54.6	0.7	2.3	1.7	7.2	7.1	1.9	21.4	0.5	0.8
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752626-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 150.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA		17000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	195.2	215.4	203.8	115.7	211.0	270.4	193.4	229.1	374.7	255.3	232.5	239.3	127.0	219.7	69.9	222.8	253.9	94.3	246.5	205.6	201.2	212.5	252.5	198.6	125.4	222.7	197.7	265.5	315.1	115.9	171.0	89.2	208.7	217.8	102.8	134.1	243.0	86.9	306.6	224.6	261.5	100.3	180.2	250.7	269.6	146.9	227.5	108.4	231.4	96.9	95.2	211.5	211.7	234.5	108.1	134.7	212.9	147.1	147.1	141.9	125.1	119.8	68.1	105.5	93.5	111.5	123.1	192.2	87.3	134.6	88.2	151.6	170.2	153.6	110.9	139.3	177.5	164.8	284.5	192.9	65.6	171.9	229.6	146.3	145.6	155.0	182.8	210.4	110.5	136.5	187.5	184.1	98.7	186.5	162.6	270.9	196.9	76.4	75.1	286.2	84.0	150.4	136.4	109.7	138.1	120.8	158.1	162.0	98.7	141.7	147.2	137.4	157.1	148.8	150.3	97.9	149.8	161.2	131.6	402.9	51.7	124.0	102.2	150.8	24.0	13.3	8.2	10.6	7.9	15.9	10.4	8.1	5.8	22.9	9.1	12.0	48.2	60.5	10.5	31.9	5.9	3.0	203.8	211.0	229.1	374.7	205.6	201.2	222.7	197.7	208.7	180.2	227.5	234.5	286.4	141.1	232.4	134.8	221.3	310.5	430.1	204.0	178.2	416.5	271.8	283.3	139.0	147.3	180.5	167.3	291.9	179.3	289.0	244.4	66.5	156.3	83.1	285.4	457.7	230.3	189.6	191.6	71.1	179.5	204.8	235.0	296.2	379.3	134.8	273.1	158.8	183.8	157.2	439.1	76.7	245.2	162.8	124.5	238.7	77.2	251.6	208.1	120.9	116.2	160.9	239.8	195.7	94.0	109.6	159.9	188.4	192.2	262.3	352.3	192.5	99.3	146.6	358.1	197.2	366.8	391.0	231.8	253.7	219.2	365.1	276.2	237.5	339.5	236.5	377.8
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58000919-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Supported	Nucleoplasm		NA	NA		980000	"Cluster 27: Non-specific - Gene expression"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: AB_2684474"	"unprognostic (9.86e-2)"	"prognostic favorable (7.00e-4)"	"prognostic favorable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	71.1	81.1	44.0	84.0	47.5	54.7	62.8	52.1	50.0	78.6	53.8	76.1	69.7	79.1	70.0	84.0	73.5	42.5	61.8	43.0	45.9	71.0	71.4	60.8	107.1	44.1	45.7	78.4	58.6	73.0	69.2	64.8	45.0	70.2	77.1	60.5	67.5	57.4	71.2	57.2	73.4	59.6	47.4	72.6	69.0	38.9	46.3	104.5	72.7	51.5	119.7	69.3	73.6	50.7	211.4	157.1	264.9	153.3	72.3	67.3	164.6	187.0	102.9	177.9	167.8	195.9	180.6	352.0	121.1	129.8	134.3	178.9	298.4	192.6	325.5	196.8	176.1	263.0	202.2	220.9	83.2	292.4	169.9	56.3	90.5	164.6	168.3	84.3	145.1	131.9	291.0	166.9	181.2	162.6	370.2	258.4	246.5	191.7	160.9	349.4	216.1	217.1	176.6	177.5	192.4	206.8	142.5	128.6	139.5	142.0	180.8	220.5	139.3	158.6	197.0	122.7	258.8	149.7	217.3	333.3	150.1	272.2	193.8	23.9	48.3	32.5	38.9	64.4	38.6	35.7	30.7	37.1	71.1	24.9	32.8	33.3	22.0	48.1	45.1	40.5	36.9	45.2	44.0	47.5	52.1	50.0	43.0	45.9	44.1	45.7	45.0	47.4	46.3	50.7	74.1	35.3	48.3	66.0	89.1	133.7	130.0	53.1	96.2	62.9	73.1	58.0	31.3	41.5	48.6	44.1	31.3	70.3	68.1	57.5	70.5	68.2	57.8	44.9	59.2	66.2	65.8	93.2	33.0	60.1	116.6	74.7	53.5	59.3	59.6	92.2	44.6	46.3	59.1	52.2	51.8	76.2	52.9	54.0	73.5	34.0	84.2	52.3	55.2	36.5	60.7	43.5	80.3	56.3	59.2	61.4	84.9	60.2	73.3	102.8	76.3	56.4	43.4	83.1	105.2	87.7	89.5	74.6	58.0	86.6	137.5	60.9	69.4	57.3	93.3	120.6
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	76.4	67.0	39.4	51.4	42.6	136.8	76.9	48.1	64.6	86.6	40.0	73.7	44.7	75.9	70.0	62.1	83.7	45.1	51.9	39.4	46.5	68.8	94.1	70.1	75.8	42.0	40.7	96.3	85.7	43.0	79.8	56.1	43.7	73.7	45.0	57.7	69.5	40.8	66.3	75.9	84.9	39.3	39.7	89.8	72.9	58.4	41.4	75.4	86.2	32.9	64.7	68.5	75.0	47.9	92.8	46.2	118.4	76.2	59.5	79.7	162.4	111.6	57.5	89.0	80.3	81.6	68.0	156.6	74.7	56.5	58.4	77.4	151.5	61.4	120.7	105.9	118.1	159.0	112.4	98.5	71.1	221.0	63.3	64.2	76.0	82.5	83.5	111.3	80.4	79.0	159.1	96.1	88.7	36.4	133.3	163.1	190.9	72.3	76.9	156.1	130.9	99.9	104.3	65.7	99.3	82.1	94.5	101.1	139.8	109.1	80.9	98.1	96.0	97.8	70.4	71.3	102.3	110.4	94.5	169.9	70.2	161.3	87.7	111.7	63.5	103.6	65.7	51.6	74.9	76.3	67.0	65.2	66.1	70.7	72.2	67.8	31.7	85.8	64.6	91.7	80.4	52.7	39.4	42.6	48.1	64.6	39.4	46.5	42.0	40.7	43.7	39.7	41.4	47.9	198.6	211.5	224.9	90.4	208.6	354.0	295.5	229.6	222.5	164.8	166.9	171.7	119.6	115.8	184.5	195.0	118.9	242.0	243.4	123.8	115.4	151.0	64.4	160.0	267.9	186.8	173.8	218.5	219.0	135.3	253.1	228.9	165.6	231.0	194.1	218.1	146.3	152.6	150.4	159.9	183.0	158.3	150.5	124.9	244.4	56.9	255.7	155.4	168.9	126.5	183.1	115.5	145.2	168.9	219.8	144.9	104.7	264.4	234.9	317.8	122.1	101.4	157.8	158.1	170.9	199.1	218.3	270.0	138.0	181.4	353.6	303.7	226.2	195.5	172.9	315.0
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavorable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	68.3	44.5	30.5	59.3	31.8	132.8	53.3	32.3	36.0	37.3	33.9	55.0	30.4	43.8	40.7	65.3	45.2	24.0	37.7	32.3	33.6	47.0	49.4	50.5	72.0	30.8	30.2	34.6	33.6	36.1	30.0	50.7	30.8	38.9	52.2	25.0	37.4	34.5	41.9	37.8	46.2	52.9	33.3	45.8	50.6	54.0	30.7	87.0	34.3	27.7	90.1	68.4	40.9	34.4	271.3	229.3	304.4	197.1	91.8	71.8	213.7	225.2	96.6	222.9	177.9	272.9	202.4	436.1	150.9	148.2	206.9	149.2	385.7	277.1	266.7	274.7	240.9	264.3	154.8	281.2	78.1	329.3	185.4	43.4	92.8	153.3	295.0	94.3	187.9	180.3	388.5	171.1	191.6	298.9	421.2	289.9	331.5	313.3	208.4	367.8	253.4	248.0	168.2	257.3	207.2	201.6	215.3	190.1	156.5	189.7	172.8	295.0	163.1	134.3	210.2	116.3	317.6	186.6	297.8	658.9	159.1	339.1	189.3	23.4	71.2	27.8	59.8	103.3	65.0	63.3	46.1	60.3	142.4	40.7	51.4	59.7	6.8	65.7	61.7	85.8	53.4	77.5	30.5	31.8	32.3	36.0	32.3	33.6	30.8	30.2	30.8	33.3	30.7	34.4	445.1	80.1	208.8	31.3	453.7	259.5	460.8	255.9	220.3	122.7	226.9	367.2	67.8	87.2	177.0	64.4	118.9	313.7	730.0	214.7	156.5	195.4	173.6	104.6	193.5	245.7	178.0	153.5	96.6	132.2	478.1	264.0	258.9	130.4	320.4	273.2	150.0	85.3	241.9	121.1	82.2	222.5	140.4	123.4	242.6	45.2	138.5	289.2	152.9	65.6	222.6	253.9	239.9	74.9	100.8	149.0	179.3	109.9	337.7	309.9	192.1	94.1	116.4	225.8	118.3	317.9	408.1	286.7	287.3	163.0	243.5	250.2	652.4	186.4	242.8	344.7
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798499	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 3119.7"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 6002.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	213.5	311.6	152.0	232.1	153.6	498.9	252.7	157.1	186.5	319.0	195.6	366.6	341.6	192.4	885.6	233.5	201.7	185.2	295.2	148.9	190.3	203.4	397.6	236.5	319.0	161.8	156.3	182.8	3119.7	157.1	676.5	120.5	159.2	263.8	267.7	37.1	922.8	416.4	127.4	191.5	256.6	120.5	162.7	396.6	495.0	160.9	158.1	158.0	221.0	74.1	324.6	243.8	217.3	171.5	344.2	428.9	148.7	834.4	785.2	412.4	299.5	278.6	431.1	299.9	407.3	547.9	298.3	476.9	721.8	450.4	262.4	332.8	259.2	270.6	111.8	192.6	212.0	128.4	380.1	446.0	669.0	370.7	352.6	511.9	376.6	256.9	353.2	265.3	327.4	240.8	145.4	1027.1	239.8	616.8	222.3	578.1	90.8	941.3	685.7	247.3	178.4	922.7	394.2	413.9	285.8	228.8	159.3	301.7	333.1	161.9	188.8	821.6	263.9	174.4	189.9	324.4	377.5	1449.6	774.0	576.4	364.7	630.8	295.7	652.3	594.6	286.7	616.7	476.9	762.6	695.6	629.2	613.7	598.0	644.7	538.8	555.2	93.8	697.3	396.5	1751.9	515.9	1330.5	152.0	153.6	157.1	186.5	148.9	190.3	161.8	156.3	159.2	162.7	158.1	171.5	228.6	166.7	301.9	7.5	824.1	257.2	372.4	566.8	167.9	53.6	451.1	380.1	334.8	357.4	464.7	318.2	56.3	311.4	521.0	473.2	168.3	544.9	476.1	276.9	513.6	263.0	747.5	175.3	3.6	627.4	700.6	357.3	344.0	454.8	352.2	257.0	241.3	723.3	439.0	35.3	5.3	967.6	547.3	339.1	416.6	1753.1	336.7	344.5	1428.3	4.7	409.3	174.7	432.5	8.0	11.1	487.0	595.8	247.1	6002.3	633.3	581.0	414.8	340.6	83.4	118.3	174.3	300.7	199.4	207.9	306.1	322.2	564.6	473.4	600.1	548.8	490.0
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325986-57335892	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		42000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	52.3	42.7	37.6	62.9	39.1	78.9	53.7	37.9	46.4	61.0	37.2	64.7	48.3	64.9	47.7	67.7	68.3	37.0	47.0	39.3	41.2	48.8	43.3	51.7	76.1	38.2	38.9	74.1	74.0	60.9	57.4	57.5	37.1	46.6	66.1	36.0	55.0	49.6	140.6	67.0	55.1	58.4	38.5	52.6	59.8	45.8	42.4	87.8	54.0	63.9	91.9	58.6	56.4	40.2	353.0	332.0	308.3	226.9	95.1	105.1	150.7	188.9	181.1	321.8	229.2	230.0	255.2	424.4	196.7	166.7	204.5	264.8	493.7	293.9	402.2	297.7	276.9	271.5	233.1	250.5	149.3	455.4	195.3	106.7	175.7	331.8	456.8	149.1	213.3	320.7	376.0	207.9	222.6	237.1	463.3	400.3	406.1	186.1	201.7	386.1	520.4	412.0	151.7	249.3	321.4	271.6	267.6	226.2	286.7	157.0	275.3	177.0	162.7	218.2	287.1	298.3	328.9	240.9	259.9	431.9	185.0	251.6	294.6	0.8	4.1	4.6	8.6	5.1	8.2	8.4	7.4	9.5	6.0	10.5	8.2	11.0	1.0	7.2	5.2	10.0	9.9	5.0	37.6	39.1	37.9	46.4	39.3	41.2	38.2	38.9	37.1	38.5	42.4	40.2	31.2	76.9	91.2	4.6	51.0	74.9	78.1	52.0	55.8	27.3	38.3	39.8	26.4	44.3	78.1	29.5	25.0	115.6	31.7	29.9	13.7	92.5	83.0	40.8	47.2	52.0	28.8	106.8	10.5	99.4	116.9	45.3	32.1	33.2	41.0	55.6	33.2	39.7	57.5	25.2	9.1	45.2	32.6	37.9	45.5	158.0	42.6	34.9	28.4	8.4	42.5	26.3	40.2	6.0	8.4	69.0	32.9	44.4	72.2	80.0	32.3	25.7	101.0	18.9	19.7	53.1	66.1	58.4	108.0	75.3	76.3	67.6	43.5	46.7	78.4	70.7
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668912-187670394	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 1039.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 449.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	5.5	43.0	59.9	4.6	52.1	4.2	0.5	1.3	67.8	0.6	2.5	31.8	386.6	0.7	0.1	1.6	0.4	1.1	1.3	30.6	449.5	6.2	0.3	0.3	1.5	96.9	48.1	2.4	479.4	0.0	9.3	0.1	50.3	1.3	23.8	6.3	0.1	21.6	0.1	8.9	133.3	2.8	137.8	0.2	418.0	0.2	117.2	1.1	1.0	0.0	0.0	7.3	1.8	18.7	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	44.7	0.4	7.6	0.0	2.9	11.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	52.1	1.3	67.8	30.6	449.5	96.9	48.1	50.3	137.8	117.2	18.7	0.0	0.0	0.0	9.1	0.5	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	5.5	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.5	0.1	1404.1	0.0	1.7	0.0	0.2	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	146.2	460.2	215.7	0.0	0.0	0.1	0.0	0.0	0.0	9.4	3.6	0.0	0.0	3.0	9.1	0.0	0.6	0.0	0.0	0.0	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	13.8	0.2
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.9;kidney: 2.9;pituitary gland: 7.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 15.4;PC-3: 54.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.1;hypothalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA066503: AB_2685679"		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	6.9	0.3	1.5	2.9	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.0	7.3	0.0	0.1	0.7	0.0	0.2	1.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	54.7	0.0	2.1	0.6	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.3	1.5	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13 Hsp70 interacting protein"	P50502	22	40824535-40856639	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1091.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	163.2	157.5	131.9	84.2	148.3	99.0	161.6	149.9	171.9	163.0	140.4	135.6	96.7	197.5	137.2	116.6	180.6	122.8	121.9	123.8	156.8	254.2	296.7	97.0	111.7	147.3	140.5	542.6	126.2	150.8	92.3	135.3	154.8	145.0	108.0	146.4	111.3	142.6	341.2	98.4	108.3	165.0	147.2	89.0	111.1	107.7	136.1	131.6	176.6	217.9	126.2	131.5	113.5	191.9	249.0	195.1	290.6	255.4	265.7	407.1	263.7	229.0	293.2	279.6	242.3	353.7	144.3	356.8	193.2	232.9	253.7	177.3	387.7	226.3	331.2	228.4	250.3	255.0	379.1	406.4	241.2	374.6	198.5	365.5	235.7	252.6	169.7	351.2	293.6	219.3	313.2	151.2	271.3	187.1	329.5	200.1	166.4	302.0	130.7	375.7	246.4	281.9	284.2	369.8	96.4	97.1	265.0	211.7	337.7	334.1	205.5	233.2	220.8	232.1	223.0	197.0	188.2	173.5	367.9	333.4	317.4	172.0	228.2	108.9	79.5	85.7	84.7	108.7	129.1	146.2	133.0	101.9	107.1	131.6	206.6	160.7	26.3	110.6	146.3	75.5	122.3	162.6	131.9	148.3	149.9	171.9	123.8	156.8	147.3	140.5	154.8	147.2	136.1	191.9	187.0	141.1	220.5	28.1	217.5	311.6	384.6	267.7	279.4	89.5	364.6	359.2	140.1	334.6	232.5	171.0	16.7	382.8	141.7	192.9	563.4	284.8	513.2	431.6	349.8	204.1	262.0	296.3	37.4	205.1	381.2	239.7	107.0	289.6	207.1	305.0	227.7	539.2	328.6	38.7	41.5	263.7	183.1	270.6	374.5	1010.4	510.4	210.3	211.7	15.0	286.7	265.1	157.6	27.2	53.7	193.7	210.8	413.3	129.0	312.2	369.6	1091.8	281.8	73.0	223.5	212.0	268.7	306.9	191.2	193.5	274.5	500.9	200.6	227.3	333.2	325.8
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 65.9"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000		"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.8	0.9	0.5	0.7	0.9	0.1	0.6	1.0	0.0	2.8	0.3	0.9	1.5	0.8	1.3	1.0	0.4	1.3	0.1	0.4	14.7	0.5	3.9	0.4	0.0	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.1	65.9	0.4	2.2	0.3	0.0	1.1	0.0	0.4	0.7	0.5	0.1	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.6	1.3	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336236-136752403	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	13.7	9.1	7.6	12.3	8.8	15.7	15.6	17.0	8.3	16.9	9.9	13.5	9.6	19.3	10.6	10.8	13.5	10.3	10.5	6.5	8.7	12.0	10.8	11.2	14.7	9.3	7.8	21.9	12.4	13.7	5.0	17.6	9.0	10.8	14.4	13.2	11.6	12.1	15.0	13.7	11.0	16.1	8.8	11.8	10.0	8.9	7.8	22.5	15.8	15.8	15.9	12.0	11.5	11.2	34.6	17.6	29.1	25.1	21.5	36.8	15.7	37.9	48.4	35.0	33.0	30.2	14.9	26.9	23.3	39.7	28.1	23.4	31.6	17.3	47.4	33.2	14.9	28.8	25.1	16.7	16.3	50.6	27.7	23.4	19.3	25.6	28.6	20.3	27.5	28.8	18.7	52.7	22.3	29.5	33.6	16.4	19.0	23.7	13.9	29.6	31.6	35.7	19.1	24.5	14.2	22.8	40.8	16.0	17.5	15.0	22.9	21.2	23.3	40.1	29.0	36.0	33.9	39.1	28.9	59.5	24.6	17.0	26.2	4.0	3.0	4.6	4.4	3.0	4.6	6.4	3.7	4.0	2.8	4.4	4.1	3.3	8.7	5.5	3.5	4.5	4.8	2.1	7.6	8.8	17.0	8.3	6.5	8.7	9.3	7.8	9.0	8.8	7.8	11.2	44.5	25.6	24.2	95.6	42.4	40.0	31.4	18.7	38.7	43.8	24.8	26.7	10.8	22.8	23.5	16.5	39.6	29.3	39.5	42.1	11.7	20.7	2.8	23.7	59.5	34.1	18.7	29.7	161.8	22.2	26.7	33.8	23.9	39.6	22.2	30.3	31.4	21.5	18.6	28.6	166.8	27.9	8.2	16.9	22.0	4.8	49.4	25.1	16.0	231.4	27.2	25.6	42.2	223.2	188.4	27.4	17.5	32.4	53.1	27.2	24.2	13.2	14.5	68.1	26.3	67.1	36.2	54.8	50.5	27.5	36.7	31.7	39.2	16.0	23.4	24.3
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	27.9	22.9	20.7	34.2	26.3	72.8	41.5	32.6	24.1	33.3	30.4	28.8	23.8	35.7	28.3	26.8	30.1	25.2	21.5	18.0	22.6	33.7	28.5	28.6	45.0	26.2	21.9	46.0	31.7	51.9	12.0	35.8	27.8	29.8	28.2	45.5	26.5	29.6	23.3	26.1	26.5	25.8	24.2	37.4	28.5	8.0	21.2	81.4	49.3	36.0	44.3	28.4	17.6	39.6	62.6	56.9	84.5	53.0	34.9	52.3	54.4	58.0	61.8	58.5	73.2	53.8	65.1	115.0	79.6	52.3	65.5	55.6	173.6	48.8	82.5	81.9	74.7	106.6	110.8	35.7	35.6	140.7	80.0	42.2	46.4	69.5	111.4	50.2	49.7	114.2	105.4	118.9	43.1	67.8	180.6	62.9	44.5	55.8	84.4	125.9	112.0	96.1	44.9	117.3	75.7	60.6	131.2	47.7	66.9	59.2	28.9	62.2	61.5	0.3	31.1	69.4	66.6	50.9	82.2	141.6	36.8	84.3	60.3	28.2	15.2	28.0	15.0	18.9	17.8	15.0	15.6	14.6	19.1	19.0	21.3	17.5	44.5	18.8	23.1	16.5	13.5	10.0	20.7	26.3	32.6	24.1	18.0	22.6	26.2	21.9	27.8	24.2	21.2	39.6	71.1	64.1	56.6	42.4	80.9	56.2	61.5	31.5	72.3	51.0	58.0	48.4	44.9	37.1	50.6	44.1	60.5	32.2	113.4	42.9	21.5	42.3	1.1	65.1	70.4	62.3	58.1	77.0	41.8	38.2	32.7	64.5	39.8	79.3	58.1	53.6	59.3	42.2	36.0	45.4	51.9	35.0	28.5	71.4	65.0	4.2	65.9	89.9	33.8	70.3	91.4	61.2	97.9	69.4	114.0	54.9	29.3	69.2	73.8	81.4	28.0	35.7	51.4	62.9	65.7	104.0	60.3	14.8	15.4	51.0	56.1	71.4	87.2	49.5	38.9	83.6
STARD13	"ARHGAP37, DLC2, GT650, LINC00464"	ENSG00000133121	"StAR related lipid transfer domain containing 13"	Q9Y3M8	13	33103137-33350630	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Astrocytes: 212.5;Excitatory neurons: 120.7;Inhibitory neurons: 135.6;Microglial cells: 167.7;Oligodendrocyte precursor cells: 212.6;Oligodendrocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 50.2;TIME: 36.0;WM-115: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039535, HPA058867"	Supported					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039535: AB_10965929, HPA058867: AB_2683839"	"unprognostic (7.42e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.29e-2)"	16.0	10.9	10.0	5.6	13.2	0.3	11.1	8.7	10.9	16.6	13.4	28.0	4.8	14.8	5.3	7.2	10.4	10.8	12.5	12.6	8.1	8.4	6.1	12.5	2.5	11.1	11.9	7.2	10.8	16.9	4.3	24.6	9.6	9.0	6.8	1.8	6.4	8.1	5.4	5.3	7.0	15.7	8.4	7.4	11.2	2.8	11.7	1.4	20.4	6.3	1.4	14.0	9.6	13.6	11.4	1.6	3.4	2.4	6.8	16.0	0.6	21.2	26.2	17.4	10.8	0.9	4.0	0.1	2.8	10.2	10.7	10.4	1.5	7.5	22.0	10.0	3.6	5.2	3.9	5.2	5.7	0.0	4.6	13.3	4.3	19.7	24.0	9.7	17.1	0.1	0.0	1.7	50.2	3.3	0.0	0.0	2.2	1.2	5.7	0.2	16.6	0.1	10.6	3.2	0.1	5.5	3.2	8.0	2.6	3.0	18.5	4.7	36.0	8.7	9.3	22.0	11.0	2.9	0.0	0.1	7.0	0.1	40.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.0	13.2	8.7	10.9	12.6	8.1	11.1	11.9	9.6	8.4	11.7	13.6	30.5	28.9	15.1	212.5	0.1	2.4	2.8	1.1	4.0	5.3	8.6	5.1	19.8	7.2	2.0	9.2	0.0	9.4	4.2	11.8	0.0	7.7	1.2	5.5	26.6	18.4	6.7	0.0	120.7	2.2	3.7	18.8	10.7	6.4	5.1	6.2	17.9	10.7	16.7	5.0	135.6	4.4	0.0	8.8	6.8	1.4	7.2	10.8	14.2	167.7	0.8	1.1	0.0	212.6	470.9	5.5	4.3	7.5	4.7	4.4	3.4	2.1	6.3	0.4	13.1	15.6	33.1	0.1	0.3	1.0	2.3	7.5	0.6	31.1	5.4	1.5
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190908460-191020960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		92000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	41.2	35.6	8.0	113.3	7.7	35.1	27.1	5.1	10.2	33.9	5.6	43.4	51.3	27.5	15.1	35.8	25.1	66.6	35.6	11.1	14.7	45.3	66.0	69.1	145.6	18.8	9.4	33.0	40.7	39.0	23.8	28.9	13.4	34.8	40.6	20.0	107.4	24.2	29.8	24.9	41.8	47.5	27.3	114.5	55.7	31.2	17.4	104.3	33.4	29.7	59.0	62.2	25.1	13.2	54.8	58.6	26.8	41.4	105.7	158.8	79.3	82.4	257.1	533.6	595.5	95.1	62.8	21.7	48.1	180.8	173.9	45.9	29.8	62.0	108.6	179.6	24.6	99.0	43.8	47.3	72.2	48.4	58.3	94.7	36.8	100.4	31.0	56.5	63.5	38.4	56.8	103.9	93.6	42.5	38.0	41.1	36.6	34.2	95.3	31.4	71.4	27.9	58.9	70.1	37.9	35.0	100.3	35.7	236.5	37.5	38.6	59.9	56.2	105.1	57.5	90.0	51.4	202.1	330.7	21.0	80.8	40.3	47.8	50.0	143.9	104.9	51.6	191.1	71.4	38.3	129.3	77.4	61.4	31.7	128.2	94.2	203.9	77.3	117.3	28.9	227.8	210.2	8.0	7.7	5.1	10.2	11.1	14.7	18.8	9.4	13.4	27.3	17.4	13.2	46.8	73.7	34.3	14.0	48.8	22.2	17.5	32.3	22.2	13.3	27.6	26.0	44.6	51.5	40.3	53.3	25.0	13.6	48.0	44.4	7.9	47.5	18.5	30.9	43.9	42.1	21.0	15.5	9.0	37.8	53.9	44.1	51.5	39.3	51.4	38.5	28.5	54.1	92.6	3.3	12.2	26.7	16.2	72.0	26.2	5.2	21.8	96.9	17.8	31.9	107.3	13.7	62.8	25.1	11.9	36.0	21.7	29.7	69.4	26.7	24.7	44.0	47.7	19.3	39.5	35.4	31.1	25.4	24.6	28.8	31.3	8.3	78.1	37.9	29.2	26.9
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388540	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	105.6	68.1	32.4	78.5	34.5	63.2	84.4	38.7	30.2	62.6	32.4	76.9	45.9	71.6	28.2	81.6	74.0	71.7	101.2	28.6	44.6	77.2	143.1	106.0	55.3	48.4	40.7	65.4	67.3	35.3	53.3	55.6	43.4	62.9	46.5	29.9	63.5	48.2	123.9	66.8	68.1	72.1	43.9	68.0	62.3	24.6	43.0	50.5	61.9	92.1	65.2	88.6	64.3	43.1	61.5	116.0	47.4	48.2	103.7	97.6	35.4	66.5	89.7	59.6	58.3	30.3	55.8	18.5	68.2	71.2	90.3	89.2	45.8	72.6	47.7	160.6	31.4	131.2	60.4	62.4	77.3	31.8	79.0	152.1	69.8	47.4	68.9	62.2	81.1	33.4	80.1	56.4	40.1	43.8	118.7	31.3	28.5	63.4	0.0	26.6	133.8	28.1	91.3	77.2	45.2	29.8	81.4	184.9	29.2	57.2	100.5	49.1	68.7	88.9	44.9	54.8	56.5	82.9	75.3	16.4	56.1	32.8	41.6	121.1	78.4	100.0	79.5	79.9	64.4	40.2	57.5	62.6	54.3	36.6	58.7	56.5	262.6	58.3	80.8	29.3	47.9	124.5	32.4	34.5	38.7	30.2	28.6	44.6	48.4	40.7	43.4	43.9	43.0	43.1	216.0	93.0	173.7	46.0	111.6	129.5	105.3	76.8	138.3	92.6	147.1	113.0	59.7	54.3	103.2	134.3	281.5	25.2	115.1	148.9	17.6	83.2	33.5	129.3	187.0	164.7	124.0	54.3	24.2	96.8	38.2	154.0	109.1	153.9	142.0	86.3	115.3	115.7	69.1	25.2	35.8	97.8	69.2	71.0	121.7	13.7	71.7	111.7	72.9	51.5	94.1	131.3	78.2	30.7	41.7	82.9	94.5	60.9	104.6	147.9	206.4	46.3	88.5	406.7	65.7	189.5	169.7	31.5	15.3	93.4	160.1	31.2	170.2	102.3	117.5	90.6
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 78.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	78.9	40.6	4.3	28.9	5.7	52.1	48.8	5.3	4.8	19.1	5.4	24.0	8.6	17.8	5.7	9.9	19.0	13.9	13.9	3.6	7.5	13.9	8.1	23.3	37.5	8.0	7.6	22.5	12.2	2.4	10.5	7.3	7.4	15.4	9.1	1.2	15.7	13.7	23.8	18.4	22.4	14.3	6.7	29.8	14.0	4.9	7.7	24.4	13.3	13.8	27.1	24.1	15.4	8.6	3.9	4.9	0.5	0.0	35.7	17.5	0.4	2.1	8.6	4.0	2.3	0.0	3.7	0.3	9.0	8.5	0.2	0.3	0.8	0.3	1.1	101.0	0.0	153.5	9.3	1.3	15.5	13.5	85.2	36.8	2.1	1.7	2.0	0.0	12.3	2.0	262.4	0.1	2.3	0.1	163.5	64.7	1.4	2.5	0.0	4.5	1.1	13.8	1.1	2.6	0.3	0.0	10.0	3.9	17.8	0.9	2.5	13.9	7.2	8.0	2.6	3.9	0.1	0.2	0.1	0.0	1.0	25.4	2.5	9.8	15.1	7.9	10.3	18.6	14.4	8.2	18.3	15.2	18.7	6.6	18.0	15.0	18.3	17.4	24.9	6.6	14.5	12.9	4.3	5.7	5.3	4.8	3.6	7.5	8.0	7.6	7.4	6.7	7.7	8.6	14.0	0.0	10.6	2.6	18.7	7.4	3.8	4.5	5.7	2.9	35.8	24.5	29.6	5.7	3.4	5.5	0.0	1.2	17.7	5.5	5.9	5.0	0.4	7.2	5.2	21.2	0.0	33.2	0.2	13.6	2.9	15.3	5.1	11.9	22.8	6.8	6.1	3.3	21.4	0.0	1.3	4.2	0.0	24.5	41.3	3.5	32.6	31.8	8.8	5.6	41.0	3.9	8.2	2.5	5.0	9.6	8.1	41.0	12.5	12.2	1.8	14.4	8.4	0.7	6.6	13.7	10.2	0.0	0.9	4.4	7.7	1.4	29.2	7.7	6.5	7.0
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995966-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	925	"salivary gland: 9143.2"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 9.8;Early spermatids: 2.8"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	9.8	0.0	5.6	0.8	0.0	0.1	0.0	0.0	9143.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892, HPA072004"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB020839: , HPA049892: AB_2680938, HPA072004: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	46.4	40.4	33.6	34.1	36.5	66.0	40.5	35.5	41.5	41.5	33.7	45.2	54.9	42.3	36.8	47.2	66.3	48.7	49.6	33.5	35.2	88.4	122.8	41.8	36.8	39.3	39.1	36.3	69.7	81.4	15.0	49.9	39.4	46.3	47.1	36.4	39.2	46.1	62.5	41.6	50.9	52.1	37.2	33.3	52.8	35.9	36.5	42.8	69.6	47.1	40.9	51.9	31.1	42.5	113.9	85.1	90.7	40.2	90.1	111.3	100.7	84.4	100.8	246.8	111.2	292.0	121.8	77.1	141.7	106.2	118.3	121.5	122.4	150.8	205.9	30.2	70.5	63.3	62.1	233.0	76.1	51.7	59.9	89.6	126.9	100.5	117.0	100.9	123.0	57.4	112.3	46.7	94.6	72.3	90.7	83.5	74.5	109.1	117.9	69.1	119.4	75.0	100.1	98.2	104.8	93.1	209.9	199.0	124.8	91.6	127.4	72.9	113.0	148.2	128.1	92.6	101.6	41.8	52.3	86.8	108.5	54.6	87.4	31.5	19.3	19.8	17.8	15.8	19.7	16.8	18.9	19.1	16.9	15.4	17.1	16.7	38.0	14.2	20.2	15.9	22.9	13.6	33.6	36.5	35.5	41.5	33.5	35.2	39.3	39.1	39.4	37.2	36.5	42.5	76.5	89.8	82.0	45.7	66.4	112.5	125.5	79.9	95.0	32.9	87.5	65.0	63.1	97.2	71.3	77.3	14.6	105.4	72.2	98.4	93.9	130.6	18.6	146.1	80.1	83.0	76.0	137.4	47.9	118.2	45.0	84.8	71.4	87.3	48.1	79.2	72.8	158.3	64.7	43.7	42.2	77.5	59.0	62.9	91.3	21.9	65.6	66.8	49.8	26.2	85.9	57.0	61.8	39.2	51.2	138.5	89.9	70.0	86.8	189.7	107.8	170.0	105.9	29.1	59.2	72.6	74.2	109.1	69.8	92.1	119.8	194.4	78.5	64.6	69.3	196.5
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306733-76311130	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.3;skeletal muscle: 248.5;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 140.7;U-266/70: 62.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	109.7	5.3	4.3	7.3	4.0	19.9	11.8	3.5	6.3	7.0	2.9	29.0	9.6	9.3	3.2	15.1	13.7	12.8	52.7	4.0	7.0	10.0	130.3	14.1	1.3	6.7	5.4	10.0	12.0	7.9	1.7	16.8	6.2	20.7	26.4	4.0	4.7	13.9	248.5	1.5	26.1	28.0	5.6	2.2	15.5	9.7	5.6	1.3	2.6	154.7	2.1	22.1	4.5	5.6	15.9	9.9	2.0	10.0	46.3	13.9	12.7	21.9	21.6	12.0	12.6	12.6	17.9	0.0	13.1	25.8	26.2	9.2	9.6	6.1	7.4	52.4	3.6	1.7	18.2	16.5	4.8	9.5	10.5	7.1	24.0	10.2	8.2	32.4	0.9	0.0	0.6	140.7	23.7	13.0	0.6	7.4	2.5	24.1	7.2	0.0	3.8	9.9	8.0	17.2	2.6	17.7	12.9	20.2	0.3	5.0	4.9	3.7	3.9	11.6	5.9	29.4	12.5	62.8	17.1	0.0	19.6	7.5	5.4	0.1	2.6	5.7	2.0	3.1	1.1	0.1	2.4	2.4	2.5	0.0	0.5	0.9	0.3	4.4	1.2	0.3	0.8	1.3	4.3	4.0	3.5	6.3	4.0	7.0	6.7	5.4	6.2	5.6	5.6	5.6	0.0	0.0	0.5	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.2	9.1	0.0	7.9	0.0	2.8	1.5	0.1	0.0	0.4	0.0	3.9	1.4	1.0	2.6	5.1	0.0	0.3	0.0	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	3.3	2.9	0.0	7.0	0.5	19.5	0.3	6.6	0.0	0.0	1.1	3.0	0.2	0.0	1.1	0.0	0.8	0.3	0.3	1.4	0.9
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		1900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	40.6	18.4	32.9	22.3	31.5	46.4	33.1	18.1	34.5	40.4	30.5	33.7	18.1	39.3	18.2	65.6	39.0	25.1	24.0	30.5	23.1	20.0	38.0	26.8	29.8	17.4	22.9	41.2	30.1	43.7	18.0	17.5	18.9	26.0	24.6	11.4	61.1	24.3	111.9	47.1	31.3	34.3	18.6	31.5	32.2	25.4	26.9	68.6	40.9	49.7	29.7	32.2	40.4	22.4	42.4	48.5	14.1	23.5	60.9	55.4	22.2	31.1	31.0	22.6	28.5	24.3	13.8	44.7	35.4	46.2	50.9	74.3	20.1	21.5	19.3	36.7	30.5	70.1	19.2	36.0	53.0	58.9	40.1	56.8	53.2	32.0	90.7	28.2	31.7	59.6	44.2	80.1	24.7	9.8	55.8	20.7	5.4	23.3	18.1	13.8	22.1	41.7	38.2	23.7	3.4	14.2	51.2	33.5	19.2	22.5	12.7	32.4	34.0	40.2	13.8	42.2	25.1	88.0	71.9	22.5	33.4	24.0	26.0	16.6	11.2	20.0	17.8	14.8	14.5	7.9	13.1	19.5	9.6	11.4	14.8	13.3	16.7	20.8	25.5	8.3	14.7	17.1	32.9	31.5	18.1	34.5	30.5	23.1	17.4	22.9	18.9	18.6	26.9	22.4	20.1	16.0	8.2	53.8	22.2	16.4	7.4	9.5	17.6	5.3	16.5	13.2	4.6	18.6	10.5	5.5	14.6	27.3	35.2	27.9	1.9	12.4	4.9	17.5	35.5	12.6	9.1	18.1	63.5	14.5	13.5	20.2	10.7	24.0	29.8	4.7	20.3	32.6	15.7	16.8	56.3	13.0	12.2	22.2	15.2	9.2	27.4	18.7	17.8	57.1	11.0	16.5	36.0	77.4	5.1	12.3	6.7	11.3	14.8	11.2	7.9	3.6	14.2	3.9	26.3	17.1	18.4	21.4	13.5	50.6	22.3	17.4	28.5	1.6	11.8	11.9
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857601-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 84.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 187.7;U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	11.2	7.5	11.5	16.9	14.3	17.3	11.6	11.1	14.3	11.0	84.2	11.5	16.6	10.8	22.5	6.2	12.3	19.8	6.9	17.7	12.4	13.0	9.9	15.1	25.4	12.7	12.2	18.8	14.2	8.4	13.7	10.3	12.5	13.9	14.4	18.8	12.9	7.3	8.2	13.9	15.0	10.2	9.7	22.1	14.9	7.4	13.7	20.8	10.6	6.5	23.4	13.9	7.7	14.3	10.0	14.1	13.9	17.5	14.7	9.2	12.7	24.0	7.7	12.6	15.1	12.4	34.4	44.5	13.6	9.4	13.1	11.9	10.4	28.3	13.4	13.4	16.2	13.0	26.3	11.9	11.7	23.3	13.5	12.1	13.7	16.9	8.8	16.3	15.4	17.7	14.1	8.8	31.0	11.9	17.2	22.9	15.2	20.8	18.9	187.7	26.0	10.9	10.6	22.3	24.3	8.8	16.9	12.3	6.6	9.9	7.6	19.8	16.3	17.1	11.1	11.8	15.7	23.7	20.8	90.6	18.4	24.8	28.0	12.9	1.7	1.4	3.9	1.4	2.6	4.1	4.2	3.3	1.3	4.8	4.5	3.5	3.0	1.8	6.5	5.0	2.2	1.3	11.5	14.3	11.1	14.3	17.7	12.4	12.7	12.2	12.5	9.7	13.7	14.3	55.8	12.8	26.9	123.7	57.1	16.4	14.1	42.4	17.6	39.0	18.7	16.3	8.8	22.8	30.6	33.1	81.3	11.9	62.7	17.3	13.7	10.5	9.8	18.0	19.9	49.3	45.7	14.9	69.9	20.1	6.9	20.2	26.0	14.7	36.8	32.4	32.2	11.2	7.4	30.3	68.1	30.8	46.8	20.4	16.2	8.3	15.2	29.2	8.8	58.1	18.9	19.2	65.9	101.0	87.5	12.7	15.9	7.2	37.1	10.9	19.4	5.1	112.4	61.1	19.7	22.5	18.3	19.9	24.0	7.8	15.5	4.9	48.3	37.0	14.4	12.9
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 340.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.23e-4)"	"prognostic unfavorable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	68.0	128.0	114.5	70.2	119.9	61.3	49.7	124.6	340.6	69.5	122.1	72.9	40.4	74.1	49.0	79.5	72.4	43.5	98.5	120.2	133.4	86.7	68.9	70.8	72.9	124.0	131.3	87.6	53.3	61.4	71.7	77.5	139.2	60.7	56.0	62.9	56.1	56.1	140.3	60.5	53.9	66.7	123.6	69.0	66.1	126.3	134.2	66.2	57.6	92.2	88.2	81.2	63.8	159.4	321.0	486.3	298.1	251.7	161.8	108.1	271.5	277.2	150.1	393.9	228.1	361.3	265.2	371.1	322.9	220.3	475.4	329.7	745.4	280.3	427.6	302.1	311.7	521.5	302.6	336.7	142.8	278.7	325.1	109.4	174.5	327.1	242.7	162.4	284.2	276.1	537.2	209.5	232.1	468.8	432.0	388.6	366.4	306.0	407.2	418.3	279.1	385.6	282.8	271.8	242.7	217.3	314.4	338.9	266.7	310.3	357.1	194.0	253.8	252.0	310.9	333.1	389.0	189.8	434.0	388.0	328.8	282.6	374.1	61.0	66.8	57.4	87.6	95.1	88.2	85.9	65.5	79.5	69.9	68.5	72.7	81.6	20.0	108.2	114.6	58.1	66.1	119.1	114.5	119.9	124.6	340.6	120.2	133.4	124.0	131.3	139.2	123.6	134.2	159.4	31.3	44.8	32.9	7.8	40.0	80.4	184.1	61.5	40.9	37.5	32.5	29.8	46.1	31.5	59.1	20.2	41.7	124.8	39.8	38.3	49.0	76.3	31.0	65.8	48.6	45.9	67.3	69.0	9.5	55.2	146.1	49.6	24.5	51.1	79.3	47.8	14.3	27.4	91.5	63.9	14.9	39.9	97.6	21.9	90.3	77.5	27.4	46.7	62.2	12.2	51.8	36.9	53.5	11.1	17.2	69.5	32.7	39.9	56.4	75.7	22.3	39.6	85.8	36.7	26.3	36.1	65.4	96.3	118.6	47.6	72.0	211.0	67.0	62.8	48.6	95.3
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43650713	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 644.6;T-cells: 273.7;Urothelial cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018138, HPA037979"	Uncertain		Supported	"Nuclear speckles,Plasma membrane"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	"Plasma membrane"	"HPA018138: AB_2669784, HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	6.7	8.1	3.9	7.9	4.2	4.8	5.2	6.9	4.9	4.0	4.0	6.4	3.2	3.5	1.2	7.2	3.9	5.3	10.8	4.0	4.1	6.3	4.6	9.4	14.4	3.4	4.4	6.2	9.1	0.8	4.2	3.2	3.6	4.3	2.4	5.5	5.8	2.1	9.9	4.6	11.5	3.3	3.6	12.6	9.5	9.0	4.3	9.0	3.8	2.5	13.5	5.6	5.0	3.1	5.8	8.2	9.0	5.3	7.8	8.3	1.9	12.3	15.1	6.6	5.9	7.5	3.1	7.9	20.2	15.3	17.8	8.5	3.6	17.4	10.4	16.9	7.0	9.3	8.2	8.4	4.9	21.1	5.6	6.4	26.4	8.2	8.6	36.4	12.6	11.0	16.7	15.1	9.6	3.6	18.2	8.0	17.3	4.1	18.3	8.4	6.9	14.2	15.6	6.7	6.9	11.2	8.1	8.5	6.1	13.6	6.5	10.8	16.9	20.7	8.3	14.3	17.2	13.3	11.2	13.5	18.4	14.0	31.7	0.5	0.0	2.7	2.0	0.0	1.5	2.4	2.0	3.2	0.1	2.2	3.0	3.0	1.6	4.9	0.1	0.4	1.3	0.9	3.9	4.2	6.9	4.9	4.0	4.1	3.4	4.4	3.6	3.6	4.3	3.1	44.2	121.8	33.1	29.0	237.8	181.9	644.6	64.5	99.6	2.9	17.7	37.8	28.7	7.2	69.8	20.2	10.4	54.8	222.3	54.4	33.2	153.0	47.0	129.1	17.4	35.2	7.2	54.1	9.5	95.4	23.3	39.1	78.0	88.3	38.8	17.7	17.9	9.6	16.9	0.0	5.6	34.3	38.7	20.3	65.9	14.7	5.9	60.9	35.6	34.7	42.1	7.9	221.4	39.2	3.7	89.4	73.0	2.6	81.2	192.6	23.8	13.2	42.4	26.3	6.6	39.4	51.3	75.8	36.1	42.3	136.1	66.8	273.7	27.0	18.0	326.1
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133583-196176503	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 376.2;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 229.3;dendritic cells: 267.7;granulocytes: 195.1;Langerhans cells: 201.3;Macrophages: 198.9;Plasma cells: 191.8;T-cells: 342.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 122.3;HMC-1: 118.9;Karpas-707: 111.6;U-698: 132.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 63.4"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	28.2	8.9	2.1	67.0	2.9	376.2	21.5	3.7	5.3	24.2	3.3	19.1	27.8	5.4	1.8	11.9	5.8	20.4	4.6	4.1	3.3	6.5	8.5	23.6	113.3	3.1	2.0	2.2	12.7	2.1	3.0	16.7	3.2	10.5	17.5	0.4	17.0	5.7	2.4	11.2	40.1	16.8	2.2	56.9	20.1	9.5	4.0	60.9	7.2	3.5	111.1	24.4	5.2	2.9	11.0	7.5	11.2	4.2	47.7	18.1	12.4	25.7	38.4	27.7	28.5	22.8	3.9	122.3	23.1	14.8	7.3	7.4	4.7	11.1	33.4	21.8	12.7	11.6	9.1	2.2	14.2	47.0	118.9	23.1	10.9	34.3	17.7	39.2	11.5	28.5	9.1	111.6	69.4	5.9	61.6	106.0	6.3	19.9	17.2	10.1	67.5	37.4	16.3	25.6	4.2	4.2	6.6	6.4	5.4	17.2	4.3	24.3	14.0	26.8	13.1	19.3	14.7	45.5	78.9	132.1	20.2	15.9	12.1	165.1	74.3	163.1	43.7	81.3	55.4	49.2	77.0	52.8	53.0	58.6	98.6	82.4	236.7	40.8	113.1	37.7	73.8	89.3	2.1	2.9	3.7	5.3	4.1	3.3	3.1	2.0	3.2	2.2	4.0	2.9	23.3	89.8	74.0	48.3	229.3	59.9	27.1	15.1	10.8	0.9	28.9	15.2	2.6	12.8	42.5	11.0	0.0	7.9	267.7	54.0	3.9	6.6	6.8	15.3	14.1	11.3	3.0	68.8	3.4	2.8	24.0	27.2	38.2	26.5	195.1	47.4	5.3	2.4	26.1	0.0	3.1	13.9	18.3	151.1	201.3	3.6	5.6	198.9	58.7	11.2	158.0	0.6	118.4	17.6	0.7	10.9	41.6	4.5	191.8	34.3	80.7	2.5	26.9	0.3	6.6	49.7	19.7	41.1	26.3	16.4	63.4	5.1	342.5	22.6	13.2	53.8
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492670-241509730	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 489.9;tongue: 213.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	53.2	50.6	48.2	37.1	48.9	47.0	52.8	35.8	56.7	59.8	27.8	59.8	36.2	62.9	24.0	62.6	60.5	32.9	69.1	50.4	47.1	56.5	50.0	49.6	36.7	37.5	40.9	59.4	70.3	45.9	65.3	38.7	43.3	55.4	30.5	28.9	48.7	40.2	489.9	53.1	50.5	42.1	30.7	61.6	58.7	48.7	46.4	38.5	71.9	213.8	31.8	60.8	56.7	41.2	75.2	46.9	91.1	114.0	109.9	75.9	140.1	122.3	81.8	90.9	103.4	52.3	64.4	28.5	33.7	163.9	82.3	62.9	130.2	132.9	109.9	107.0	136.4	79.7	98.3	136.6	99.3	48.7	59.0	110.1	93.9	88.3	70.3	111.1	208.7	102.6	125.2	24.6	168.8	78.6	73.0	75.9	127.9	69.5	66.3	121.1	116.2	42.6	79.5	62.4	152.8	70.2	59.4	44.2	77.0	102.7	35.7	85.2	245.7	68.2	83.0	79.1	88.3	50.3	12.1	48.8	66.0	39.6	79.1	17.0	16.3	12.9	17.3	15.5	16.3	15.9	15.9	18.5	15.0	16.9	12.3	11.8	5.8	24.6	19.7	11.8	23.3	12.6	48.2	48.9	35.8	56.7	50.4	47.1	37.5	40.9	43.3	30.7	46.4	41.2	43.6	22.4	41.4	23.2	19.7	25.5	29.0	29.7	19.9	48.7	33.2	39.4	36.3	42.9	24.0	25.8	27.1	82.7	19.8	35.2	27.4	46.0	13.8	18.5	28.4	52.7	35.4	48.6	29.8	34.2	80.7	35.1	36.7	25.4	25.4	40.8	45.7	21.5	45.1	32.0	26.1	40.0	20.3	27.3	25.7	14.4	32.6	20.8	19.6	21.5	47.0	58.9	18.6	16.1	27.5	36.9	74.5	39.9	15.8	37.1	43.4	46.1	16.2	41.1	46.0	41.7	35.3	90.2	54.7	31.7	30.4	52.4	25.4	53.2	44.9	29.9
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98371228-98942827	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 152.7;Oligodendrocytes: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A-431: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	15.1	14.4	5.6	7.9	7.0	3.5	14.1	6.6	7.4	17.4	7.2	13.1	5.5	24.9	14.3	10.2	17.0	14.2	9.1	5.1	6.3	15.6	14.3	11.1	5.5	7.7	6.7	25.0	10.0	16.1	6.4	18.5	7.4	16.5	6.7	12.0	10.7	17.6	11.4	9.6	8.3	17.2	6.3	6.8	8.5	11.4	7.1	5.1	11.9	8.6	5.5	13.6	13.7	7.9	85.3	15.7	16.2	22.0	51.2	25.4	16.4	28.8	25.6	26.3	22.8	11.7	35.7	0.0	25.6	28.7	14.1	33.4	11.4	24.8	42.2	20.5	14.8	22.9	7.2	8.0	17.5	7.7	19.0	17.0	41.9	13.5	36.6	17.2	11.5	13.4	9.8	12.2	19.4	10.7	19.3	9.4	4.9	58.0	6.1	17.1	14.1	7.5	29.9	10.7	4.3	9.6	18.4	21.1	18.2	21.0	17.8	12.3	8.7	17.9	11.5	27.1	16.3	9.8	15.5	6.2	15.9	9.5	29.0	2.0	8.3	4.6	1.3	8.5	1.4	1.8	0.7	1.8	7.9	1.1	1.0	0.6	8.8	2.0	5.4	3.3	0.1	2.8	5.6	7.0	6.6	7.4	5.1	6.3	7.7	6.7	7.4	6.3	7.1	7.9	25.9	38.5	37.4	132.9	6.0	43.7	44.8	25.3	23.3	6.9	29.0	15.5	16.6	31.5	37.7	29.5	14.6	43.6	2.5	11.7	23.5	21.5	118.3	23.7	65.8	31.3	9.1	16.2	34.3	18.9	56.1	39.8	9.7	28.9	17.1	13.3	24.3	23.7	19.2	10.1	33.5	7.8	26.4	17.0	25.1	77.1	91.0	18.6	24.9	152.7	13.8	15.0	3.1	60.3	189.9	24.9	13.1	74.1	6.2	42.1	32.3	25.0	29.0	15.6	39.5	43.8	39.7	16.7	12.6	12.3	40.5	64.7	5.9	47.0	13.8	36.0
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882387-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.07e-4)"	"prognostic unfavorable (5.10e-4)"	70.4	70.2	48.1	54.7	52.5	51.8	49.8	44.4	63.7	51.8	41.4	55.5	46.2	52.2	50.5	60.9	44.4	46.9	93.1	54.8	65.3	84.9	80.3	46.8	54.9	49.9	54.5	40.3	72.0	83.9	58.4	64.6	61.6	49.3	52.8	85.5	48.8	48.7	135.9	44.1	44.9	68.8	47.6	40.3	48.5	50.3	59.0	66.5	77.7	114.6	57.2	70.4	41.3	50.9	195.6	226.2	209.7	179.8	182.3	180.6	280.5	227.9	158.2	200.8	186.4	325.9	167.2	215.6	110.6	233.5	199.3	138.0	254.6	251.0	293.2	291.3	206.1	218.6	163.8	144.7	298.8	258.2	102.0	176.9	209.7	224.6	248.6	221.6	237.9	139.6	170.9	63.9	264.3	137.3	215.6	122.6	743.6	124.8	145.8	162.4	289.7	124.5	232.5	197.8	134.8	228.8	184.7	125.5	258.7	415.8	235.5	135.9	201.3	149.0	177.0	160.3	284.7	73.0	106.1	351.5	183.7	140.1	193.9	74.2	73.9	65.8	66.3	87.4	75.1	76.1	67.8	64.2	92.5	66.7	65.8	70.0	33.7	64.3	80.5	56.8	92.2	84.5	48.1	52.5	44.4	63.7	54.8	65.3	49.9	54.5	61.6	47.6	59.0	50.9	111.7	38.5	45.2	19.9	111.2	243.4	177.6	131.5	116.7	90.1	87.8	65.9	104.0	51.5	84.8	66.2	35.5	154.3	121.2	41.5	275.9	171.1	44.3	63.2	82.1	100.3	106.2	103.7	42.8	137.2	201.2	109.7	61.7	78.6	46.3	112.1	71.7	82.1	108.8	60.6	43.4	59.7	128.1	86.2	143.8	86.2	69.9	89.4	128.1	22.5	99.2	207.9	93.7	24.1	33.9	144.2	66.1	102.0	119.5	218.3	56.0	228.5	58.9	100.9	78.9	96.4	139.0	168.1	80.4	115.6	227.9	295.1	111.3	135.2	95.6	192.5
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 128.5;pituitary gland: 98.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 139.9;U-87 MG: 92.2"	"Group enriched"	"Detected in all"	5	"amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1"	"Group enriched"	"Detected in all"	8	"amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	2.5	6.8	55.0	2.5	70.6	11.9	2.4	28.8	128.5	5.3	13.3	10.8	4.4	3.9	1.5	1.8	3.8	6.8	1.7	76.1	24.5	3.4	2.3	3.4	1.0	16.8	20.1	3.1	10.8	0.9	98.5	2.3	17.8	4.6	2.0	2.5	3.0	1.4	2.1	1.8	4.3	2.7	15.8	2.5	7.8	4.6	23.3	1.2	2.7	0.7	0.6	4.1	4.1	55.3	4.6	21.9	3.4	10.1	4.4	11.7	2.3	14.3	9.5	5.9	3.9	7.4	12.2	5.8	2.1	10.3	32.2	3.7	5.0	9.2	4.4	10.2	3.9	1.8	8.7	4.4	4.9	2.7	5.2	6.8	3.8	41.4	14.4	26.7	10.4	0.9	4.9	6.5	11.4	10.8	1.7	21.1	2.7	8.1	47.8	0.0	2.4	5.7	4.9	3.9	139.9	22.5	4.3	12.1	3.0	4.0	3.9	1.8	39.7	28.9	9.6	22.4	39.0	3.7	2.5	2.7	92.2	2.2	34.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	55.0	70.6	28.8	128.5	76.1	24.5	16.8	20.1	17.8	15.8	23.3	55.3	0.9	0.0	2.8	8.1	0.4	4.2	10.7	6.2	0.6	6.2	4.6	3.4	3.2	4.3	5.9	1.8	4.2	0.4	5.0	1.3	0.0	4.0	0.1	4.5	2.9	1.6	52.7	0.4	60.6	3.6	1.9	2.2	3.1	11.1	15.2	2.2	1.8	0.2	0.7	8.4	16.6	2.8	8.2	1.2	2.1	0.2	1.8	6.1	3.6	5.6	0.1	1.0	6.2	8.5	4.8	29.8	1.2	1.5	1.0	10.5	3.4	0.5	7.4	1.9	0.0	1.9	2.8	1.6	3.8	0.6	2.7	0.7	5.3	1.7	1.5	18.9
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		380000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 57: B-cells - Immune response"	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	35.1	17.7	17.6	41.5	20.4	21.6	21.2	20.8	21.1	22.5	11.5	25.1	37.2	27.2	12.1	33.7	22.1	33.5	36.0	19.8	21.0	51.1	18.3	31.5	76.3	23.2	22.2	30.9	14.3	20.5	7.4	42.9	22.4	19.5	29.1	15.9	20.6	25.9	23.1	20.4	37.9	29.2	21.2	45.5	28.3	8.2	18.0	17.7	30.8	22.7	71.8	26.2	16.6	29.3	17.5	17.5	28.7	20.6	56.4	49.9	22.6	33.9	34.7	34.4	49.3	30.9	28.9	87.6	32.7	41.1	51.0	22.8	25.5	31.2	46.6	30.2	30.4	33.1	14.6	33.0	44.6	22.8	24.2	28.6	28.5	35.3	31.6	46.5	37.8	19.2	36.1	30.7	39.8	24.8	10.4	18.2	11.0	25.4	20.2	24.6	22.5	25.5	57.9	20.4	23.5	7.1	15.3	24.9	91.9	42.2	17.0	21.2	66.4	20.1	20.5	44.1	36.6	29.1	18.2	37.2	28.3	17.9	23.2	53.6	51.6	49.1	10.8	58.1	4.4	85.9	8.0	7.7	61.6	106.8	5.7	6.8	83.2	9.5	61.6	73.9	12.8	31.3	17.6	20.4	20.8	21.1	19.8	21.0	23.2	22.2	22.4	21.2	18.0	29.3	37.7	70.5	36.5	34.0	151.6	42.1	23.5	33.8	26.7	26.8	26.7	22.2	51.0	85.8	33.1	42.3	2.1	85.7	111.5	50.8	64.6	56.9	1.2	27.9	33.4	38.3	13.2	57.9	61.3	30.9	54.5	34.1	42.3	28.0	40.6	25.9	43.5	19.4	177.6	37.0	60.6	39.8	38.7	99.4	78.7	2.1	30.7	109.6	133.4	109.6	110.7	25.7	54.6	44.2	77.9	57.6	63.1	46.3	37.3	24.7	113.5	155.0	43.9	16.5	39.5	30.2	38.6	2.7	17.6	36.2	41.2	55.4	24.4	17.9	28.4	24.9
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 194.2"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 262.5;Macrophages: 249.1;monocytes: 368.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 248.6;classical monocyte: 471.0;eosinophil: 295.6;intermediate monocyte: 604.8;myeloid DC: 239.7;neutrophil: 356.2;non-classical monocyte: 893.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 239.7;granulocytes: 356.2;monocytes: 893.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 244.8;U-937: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		No	No		870000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.68e-4)"	"prognostic favorable (5.13e-6)"	24.2	22.8	5.2	65.9	6.3	194.2	24.3	4.8	10.9	22.2	9.3	52.5	67.4	8.4	33.2	73.1	27.7	28.4	7.5	5.1	6.2	62.4	49.0	89.6	51.0	8.3	6.6	5.3	86.7	36.1	29.4	36.3	7.9	52.1	37.0	4.2	79.4	22.8	2.9	52.3	63.9	14.6	6.7	162.2	71.9	74.9	8.8	85.3	52.0	3.0	34.6	34.6	34.8	9.3	113.0	39.1	0.9	0.5	0.0	0.9	75.6	14.2	1.5	2.7	7.4	92.5	69.6	29.6	55.4	11.3	49.5	75.5	4.1	67.5	2.7	124.1	46.9	127.8	49.7	55.8	63.6	83.2	244.8	4.4	67.4	13.4	38.0	0.3	58.5	74.7	81.4	98.5	0.0	70.9	41.2	193.2	28.7	72.7	68.0	41.8	0.3	114.7	55.0	128.1	11.5	0.6	34.0	49.6	2.2	35.6	61.9	212.7	61.7	0.4	21.8	1.5	0.8	108.4	58.6	38.8	1.2	224.8	2.7	248.6	471.0	295.6	69.9	604.8	56.7	47.3	52.7	63.8	239.7	52.2	36.6	44.3	356.2	74.7	893.3	91.5	78.9	306.9	5.2	6.3	4.8	10.9	5.1	6.2	8.3	6.6	7.9	6.7	8.8	9.3	2.1	0.0	7.7	0.7	44.1	23.6	48.2	105.1	18.8	6.0	38.0	22.9	0.9	31.5	68.5	35.0	2.1	97.7	56.2	181.4	33.2	100.3	99.9	32.5	5.4	6.7	59.8	38.3	0.6	118.8	123.2	5.7	150.3	47.6	71.8	34.6	16.4	19.6	168.4	0.0	0.4	108.2	105.8	262.5	46.6	233.5	1.8	249.1	14.2	1.0	368.2	0.9	72.1	0.0	0.0	132.8	152.6	1.9	54.7	49.1	171.7	75.9	42.5	4.0	6.6	1.0	8.6	45.7	20.2	35.3	21.3	153.0	47.7	6.0	79.3	68.7
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 regulator of transcription"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 1838.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 1427.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	142.0	98.7	88.7	130.4	100.7	251.7	122.1	72.7	152.6	109.7	69.4	110.0	88.7	85.4	83.3	108.9	66.0	74.1	113.3	104.3	98.7	129.2	135.3	91.2	159.8	80.7	87.2	68.3	62.0	107.3	88.4	103.2	94.7	73.2	107.1	83.6	76.6	65.4	105.2	69.6	83.7	79.4	86.0	144.9	97.3	71.1	92.6	204.2	69.2	108.9	137.3	124.0	73.2	85.3	199.9	161.8	315.3	295.8	187.5	329.1	197.7	340.3	245.4	300.8	275.4	236.9	307.3	101.2	231.0	236.5	307.3	132.4	266.9	278.9	402.9	420.2	244.1	337.8	365.8	450.5	264.4	594.6	441.4	233.3	235.6	321.0	228.0	166.0	228.9	378.5	399.4	1427.8	269.5	178.6	566.8	942.9	207.8	235.9	326.9	247.8	409.9	645.7	303.0	178.2	170.4	141.1	526.9	244.9	251.9	198.2	272.0	544.9	238.7	324.7	351.5	275.8	261.0	556.0	1035.0	180.5	297.7	634.9	202.4	650.7	135.8	326.2	164.7	142.3	151.4	330.4	215.9	219.8	265.1	214.8	168.2	195.2	163.7	155.2	133.4	390.1	344.6	326.1	88.7	100.7	72.7	152.6	104.3	98.7	80.7	87.2	94.7	86.0	92.6	85.3	298.9	144.2	163.4	27.1	638.2	584.9	588.7	709.9	324.4	118.1	459.2	383.9	196.7	244.5	320.1	310.8	43.8	493.0	613.5	342.1	1009.5	711.4	131.6	319.0	263.7	280.2	281.4	379.5	71.5	327.2	785.0	323.6	227.9	329.9	307.5	188.6	223.1	375.4	500.5	85.8	60.9	362.9	484.2	319.0	721.3	68.1	239.9	422.5	528.3	37.5	587.5	223.7	500.5	64.3	50.4	416.3	516.6	344.6	1838.8	536.0	342.4	921.2	291.9	79.7	203.8	224.0	468.5	447.2	439.9	411.8	565.4	836.8	575.5	357.7	394.6	645.5
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming subunit beta"	Q96I99	3	67360460-67654612	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 278.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		300000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	66.7	44.9	16.1	36.7	17.9	18.6	48.7	17.1	19.6	42.1	22.4	169.7	136.6	32.6	32.2	50.5	39.1	48.4	85.5	14.2	17.6	147.3	278.0	34.0	39.3	19.0	17.3	39.0	47.8	34.6	10.2	28.1	19.5	49.3	146.1	7.3	46.8	42.3	154.0	26.1	132.2	40.0	17.7	44.8	110.6	10.4	18.1	24.7	49.3	130.6	35.5	39.3	24.0	18.8	43.8	37.4	36.3	44.6	59.7	102.5	44.2	51.3	74.4	58.9	65.4	41.7	95.1	55.7	16.3	72.5	38.8	22.0	28.5	70.8	75.9	23.8	19.5	50.5	31.2	65.5	76.8	67.2	33.9	77.3	60.3	46.2	105.2	73.0	63.6	41.8	39.1	49.5	129.9	30.6	25.5	21.2	34.1	199.2	23.0	17.6	56.1	83.8	100.0	66.9	7.1	24.5	81.5	92.7	68.8	24.3	71.6	42.5	55.9	58.2	38.2	64.5	61.8	33.4	52.2	39.0	85.5	51.6	70.0	17.3	36.3	13.0	30.8	44.3	37.6	45.5	44.6	39.5	24.6	42.5	68.4	53.1	1.6	68.0	37.4	9.8	45.4	48.5	16.1	17.9	17.1	19.6	14.2	17.6	19.0	17.3	19.5	17.7	18.1	18.8	40.2	35.3	50.8	66.6	48.5	37.1	44.7	38.9	21.1	2.9	54.1	29.1	172.0	84.4	51.7	80.9	8.4	55.4	31.7	223.5	244.6	85.1	3.2	49.6	43.4	40.1	58.2	17.2	6.2	80.9	44.9	47.5	90.7	46.8	30.4	31.4	45.0	402.3	56.5	5.0	5.3	212.1	40.7	68.6	49.2	5.4	41.3	36.3	42.7	90.9	35.5	29.2	36.0	72.4	60.0	59.2	164.0	47.4	30.3	41.2	222.2	354.4	58.7	4.5	32.9	41.6	50.5	1.6	6.3	55.6	49.3	38.0	48.6	78.5	306.6	50.9
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: AB_2678745"	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	27.4	31.4	33.4	25.5	38.1	32.0	23.6	38.6	55.6	23.0	33.1	25.5	27.3	19.6	20.3	30.1	19.4	19.6	37.0	34.8	37.0	31.7	36.5	22.5	27.4	34.8	34.8	21.5	30.6	19.8	26.9	25.9	36.9	19.6	26.9	22.2	25.2	16.3	29.6	24.5	26.8	22.1	35.3	23.2	26.8	34.5	36.4	29.8	21.1	28.1	29.9	27.3	24.3	48.1	47.0	50.2	72.9	55.6	70.4	57.0	69.8	100.8	66.3	61.7	49.0	110.3	114.7	102.4	27.9	62.8	89.5	79.0	90.6	57.9	90.0	85.3	37.7	95.1	65.8	84.4	51.1	74.8	68.7	40.0	51.7	63.9	48.2	79.0	105.0	64.8	90.5	32.7	95.7	33.4	70.3	136.6	85.3	183.9	47.8	79.6	42.4	44.4	108.0	51.7	24.1	30.7	52.1	42.2	49.8	82.6	43.5	70.3	76.1	51.3	59.9	59.6	87.6	25.7	38.9	91.5	30.8	59.2	75.5	63.6	29.0	49.0	24.3	34.5	23.9	30.9	31.4	33.2	32.9	30.3	23.8	26.6	4.1	33.2	34.1	41.0	46.0	25.2	33.4	38.1	38.6	55.6	34.8	37.0	34.8	34.8	36.9	35.3	36.4	48.1	82.1	38.5	36.0	22.2	46.1	39.8	65.4	68.2	38.1	52.6	40.6	55.8	126.2	32.9	51.8	51.5	25.0	67.0	78.3	52.3	78.2	88.3	185.6	112.0	79.0	65.9	34.1	65.2	19.9	89.0	143.0	60.9	50.0	75.1	36.8	49.7	43.5	38.3	97.8	50.5	23.0	58.2	54.9	44.5	43.9	95.7	58.7	54.3	48.0	13.1	123.7	91.8	58.7	21.1	47.6	85.2	55.0	59.8	58.3	44.1	74.3	100.9	67.8	56.6	26.3	72.4	92.1	146.7	101.0	45.7	43.2	74.4	61.1	56.1	55.5	52.3
SULF2	"HSULF-2, KIAA1247, SULF-2"	ENSG00000196562	"Sulfatase 2"	Q8IWU5	20	47656348-47786616	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 205.8;Oligodendrocyte precursor cells: 247.8;Theca cells: 265.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basophil: 27.2;classical monocyte: 19.6;intermediate monocyte: 17.2;myeloid DC: 21.3;neutrophil: 31.5;non-classical monocyte: 9.0;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	84	"dendritic cells: 27.1;granulocytes: 31.5;monocytes: 19.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 338.0;HaCaT: 230.1;HBEC3-KT: 259.4;hTCEpi: 815.1;MCF7: 695.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002325	Approved				"Intracellular and membrane"	NA	NA		340000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA002325: AB_1080126"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (4.39e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.14e-3)"	57.5	12.4	25.8	42.7	30.3	11.5	43.5	21.0	30.7	113.3	20.5	48.0	29.4	152.6	9.8	77.5	73.5	64.3	35.6	45.8	41.4	57.2	38.7	16.5	27.8	56.8	51.1	139.3	9.8	7.1	40.4	26.3	57.1	23.3	43.9	13.6	34.0	22.4	14.7	32.7	26.9	86.5	22.3	15.1	20.6	21.3	30.1	18.2	42.7	22.5	25.1	36.6	62.6	22.6	0.5	20.6	93.4	0.1	19.2	2.3	8.5	16.3	0.0	1.7	2.9	36.7	48.7	3.7	338.0	17.0	5.5	230.1	27.2	259.4	0.7	0.4	20.0	0.0	24.2	82.7	17.4	0.1	4.9	104.1	815.1	1.7	11.2	0.2	18.4	0.0	0.0	151.5	1.9	695.2	0.0	1.4	18.8	0.0	209.0	0.2	0.2	39.8	198.6	1.1	8.2	2.1	32.9	0.3	0.1	122.1	1.3	2.6	17.8	0.0	2.1	0.2	22.5	5.4	1.7	1.6	0.4	0.1	2.8	27.2	19.6	2.2	0.0	17.2	0.2	0.3	0.0	0.1	21.3	0.2	0.0	0.0	31.5	0.1	9.0	27.1	0.0	6.2	25.8	30.3	21.0	30.7	45.8	41.4	56.8	51.1	57.1	22.3	30.1	22.6	62.7	9.6	7.2	2.0	21.9	10.5	7.6	25.4	18.8	8.5	14.0	8.3	8.6	20.0	9.0	16.5	0.0	12.0	34.9	38.4	0.0	5.3	2.7	19.7	205.8	59.2	27.4	7.8	10.3	2.2	10.1	37.0	10.2	30.6	1.3	28.1	62.2	19.0	5.2	35.3	10.8	7.6	16.2	20.6	46.2	6.7	28.9	44.4	10.6	12.2	85.8	8.8	6.2	247.8	1.1	4.9	62.0	76.3	6.2	9.9	3.5	14.1	2.7	6.2	0.0	4.1	13.7	1.2	3.5	24.7	8.4	16.4	11.2	265.0	25.8	12.3
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.3;stomach 1: 163.3"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.2	0.6	0.2	0.0	0.9	0.2	0.6	2.4	7.5	2.5	29.2	0.5	15.9	0.3	2.0	6.2	1.1	0.5	0.2	70.3	2.8	2.2	1.8	0.3	0.4	0.2	5.3	5.9	2.9	1.3	0.6	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.2	0.5	163.3	0.1	0.7	0.4	19.4	0.6	0.8	0.7	0.5	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.5	0.2	0.3	0.4	0.6	0.2	0.7	1.2	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		750000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	64.1	64.6	26.1	43.0	29.7	51.5	57.5	29.3	27.1	91.3	45.0	67.4	89.2	57.5	64.8	46.8	102.6	70.6	30.8	25.1	27.8	93.4	94.8	71.6	50.2	35.2	29.6	59.7	91.8	115.8	31.8	45.5	33.4	79.3	69.1	11.0	69.5	77.1	22.4	47.5	74.4	57.7	29.9	57.0	92.7	23.7	30.8	57.6	91.2	21.4	51.3	57.2	43.6	35.9	352.3	102.9	46.0	211.8	214.4	147.5	68.9	114.5	156.1	92.6	114.5	57.2	278.0	57.1	96.5	162.4	90.4	172.3	27.4	131.3	61.1	90.6	42.9	36.4	63.5	54.2	138.4	89.7	108.7	116.8	124.5	83.7	143.3	186.9	137.7	101.4	116.4	236.6	151.3	76.8	77.2	115.7	63.5	272.0	52.2	61.5	45.4	359.0	127.7	39.1	54.0	65.6	142.4	294.2	140.9	98.9	294.5	144.5	115.2	85.6	121.1	211.1	98.6	160.8	130.8	84.0	139.7	165.7	283.2	58.1	60.3	22.0	71.1	80.5	90.9	59.8	70.9	71.8	72.3	49.1	75.3	75.2	4.4	49.0	90.3	132.6	82.7	90.2	26.1	29.7	29.3	27.1	25.1	27.8	35.2	29.6	33.4	29.9	30.8	35.9	44.0	57.7	30.5	20.5	47.3	33.8	44.1	46.1	39.9	25.7	57.9	25.4	10.4	87.2	31.0	90.1	14.6	44.5	85.3	45.1	19.6	95.3	3.8	93.1	70.2	43.7	59.3	41.7	21.2	55.7	96.7	54.7	55.5	78.9	54.5	47.0	51.0	91.3	68.1	43.7	24.4	61.8	22.4	79.8	38.7	8.0	69.6	50.4	53.4	14.0	73.0	23.8	70.0	10.6	24.2	48.4	64.6	47.4	65.0	50.7	91.8	45.6	34.5	13.5	52.6	41.6	44.1	31.6	28.6	52.8	41.9	46.7	52.7	58.7	85.8	42.7
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	68.6	58.1	58.5	56.7	64.6	118.8	63.6	50.6	75.5	55.5	55.9	55.2	55.1	52.9	50.3	57.2	52.1	44.6	74.3	64.4	71.8	64.0	59.3	61.7	68.8	53.3	59.0	57.6	49.4	44.7	38.3	49.1	58.3	46.2	45.8	72.0	66.5	47.4	106.6	51.0	58.0	39.8	54.5	61.6	56.3	28.8	68.5	63.7	54.8	73.9	57.5	50.0	53.6	50.9	226.4	88.8	131.7	80.2	105.1	147.9	86.5	152.0	177.2	211.5	173.6	133.6	137.2	78.4	234.6	165.4	122.4	53.0	96.8	123.0	166.3	110.0	106.3	322.7	78.8	123.1	113.3	184.5	172.1	126.0	139.5	123.9	89.9	87.8	109.8	164.6	188.7	215.2	173.8	293.1	220.0	127.7	254.4	223.1	174.9	239.0	8.0	217.1	120.2	111.9	98.8	153.4	136.5	196.2	126.3	48.1	190.6	218.6	172.4	99.1	151.4	151.6	172.8	155.4	234.8	198.7	77.9	265.2	138.6	2.8	123.1	52.0	78.9	130.0	79.7	84.6	74.9	76.5	133.3	77.7	88.7	81.0	14.0	70.6	122.3	162.8	91.2	157.8	58.5	64.6	50.6	75.5	64.4	71.8	53.3	59.0	58.3	54.5	68.5	50.9	83.4	64.1	50.4	5.5	76.5	96.0	121.7	127.9	74.6	72.2	99.4	88.5	59.5	67.2	66.5	95.6	20.9	122.9	98.1	95.6	166.3	121.7	63.1	36.4	51.7	101.4	59.2	113.8	14.3	112.4	107.8	76.7	52.0	37.9	29.8	63.8	92.8	116.6	200.5	62.2	13.3	91.5	81.4	143.4	172.3	114.2	72.1	137.9	97.8	10.3	280.0	132.4	111.2	3.5	6.5	148.7	112.6	72.6	58.2	150.7	129.2	130.2	33.0	60.5	59.2	43.8	68.7	90.7	77.5	82.7	77.9	136.3	78.2	43.2	99.9	145.1
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351476-21384019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: AB_2680881"	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	29.3	24.8	9.7	36.6	11.1	42.3	35.9	18.8	13.9	34.2	8.2	30.6	23.1	41.1	19.5	29.0	32.0	24.1	24.1	9.7	15.6	28.6	22.4	26.3	51.2	11.3	12.0	43.6	22.6	46.2	13.5	32.1	12.0	29.9	35.1	44.4	20.9	32.6	21.8	28.9	25.9	36.6	10.7	32.9	26.3	43.3	12.1	56.8	33.3	24.6	51.8	35.6	20.1	12.3	147.8	136.9	185.5	136.6	85.5	81.7	131.4	130.3	103.2	155.5	145.4	133.9	129.5	311.3	48.5	96.5	99.7	153.9	237.2	118.9	234.0	99.8	100.9	188.7	121.9	195.1	87.0	270.1	134.7	73.4	72.6	131.0	146.3	75.4	107.7	174.2	158.1	129.4	131.3	99.9	253.6	85.8	207.1	136.2	134.1	270.3	210.6	168.0	63.9	160.8	183.8	157.2	209.8	125.3	81.1	118.7	69.2	127.9	91.1	135.0	113.4	85.0	143.3	128.8	230.2	306.7	49.9	158.0	104.9	35.6	18.3	28.2	29.6	23.9	34.7	31.2	27.9	33.2	23.7	27.4	31.3	32.2	15.0	34.0	31.1	22.2	28.4	25.2	9.7	11.1	18.8	13.9	9.7	15.6	11.3	12.0	12.0	10.7	12.1	12.3	41.5	64.1	55.9	24.2	51.6	35.6	44.3	51.5	45.5	48.9	46.3	49.7	64.2	22.8	50.3	53.3	47.9	65.1	73.6	28.4	25.4	71.0	142.5	52.0	124.3	46.9	23.4	74.6	27.4	61.1	63.9	61.1	29.6	61.7	84.2	73.4	29.3	32.0	41.9	55.5	30.1	31.2	40.7	34.9	25.2	96.1	59.7	40.7	17.8	20.6	90.9	53.3	64.9	16.1	25.2	68.9	15.2	59.8	39.5	46.1	16.5	30.4	40.2	41.1	19.7	78.5	69.5	128.9	152.8	45.1	41.5	45.6	56.3	61.6	43.0	35.7
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone and transcription elongation factor"	Q7KZ85	17	28662198-28702679	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: AB_2675094"	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	31.2	33.5	24.6	25.4	25.8	65.3	28.3	25.0	26.8	27.0	26.8	36.6	20.0	30.6	26.8	26.5	26.6	24.7	28.8	24.0	29.0	25.6	35.8	28.9	28.4	24.0	25.2	31.2	31.4	30.8	34.3	27.8	24.3	28.7	20.9	29.2	29.1	25.6	54.5	39.2	32.2	27.3	21.6	34.4	31.3	21.4	28.7	34.0	28.9	32.6	30.3	32.1	25.6	25.6	49.4	101.3	49.8	57.1	59.1	39.3	38.2	66.2	70.3	76.3	67.8	94.7	21.5	52.1	33.6	66.5	58.7	57.5	73.6	48.1	78.4	97.6	65.4	72.9	83.2	59.4	49.4	77.2	77.9	54.6	28.4	81.2	53.6	50.3	50.8	50.3	72.9	59.7	55.1	59.1	76.9	33.4	38.7	43.2	32.4	38.7	91.2	42.7	37.6	95.9	37.8	49.9	77.6	120.5	41.6	67.9	74.2	54.2	80.6	59.8	49.4	57.5	85.3	75.4	62.2	74.4	67.5	34.4	50.5	14.7	4.5	4.4	3.7	2.9	3.9	4.5	3.1	4.1	3.7	4.5	3.1	2.8	6.8	4.3	5.0	6.2	3.1	3.1	24.6	25.8	25.0	26.8	24.0	29.0	24.0	25.2	24.3	21.6	28.7	25.6	33.9	38.5	51.0	24.2	36.5	22.4	19.2	16.8	43.3	29.5	27.4	26.0	51.6	22.8	28.4	20.2	56.3	24.4	38.4	29.5	5.9	22.1	5.4	31.0	45.3	32.6	31.0	33.0	21.6	21.3	21.3	32.7	46.4	49.1	50.5	36.6	22.9	33.9	23.7	30.3	19.7	23.1	8.2	23.0	22.4	17.8	25.7	41.8	8.8	16.9	29.9	22.0	30.9	17.6	19.4	31.9	18.7	26.7	55.7	20.0	23.4	10.5	25.7	44.4	32.9	32.4	32.0	19.8	19.1	40.1	24.3	49.8	38.3	42.0	22.9	25.7
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937007-32001038	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	12.3	11.8	6.3	18.8	6.3	45.4	15.0	11.1	8.5	11.6	6.8	14.9	16.0	15.2	12.0	14.0	11.0	12.0	10.3	5.4	5.8	16.4	18.1	12.6	33.0	5.4	5.9	11.4	11.5	19.8	6.6	18.7	5.6	13.3	16.4	26.5	10.5	12.2	8.1	13.0	15.3	14.7	5.2	18.4	15.2	27.4	6.1	38.5	18.3	11.0	30.0	15.6	9.0	7.1	46.5	40.4	37.2	42.9	21.1	26.8	38.2	44.2	38.8	53.0	63.7	30.9	25.5	100.7	33.2	27.7	45.4	40.1	56.0	25.5	85.7	35.8	54.0	69.9	32.9	22.3	24.8	111.5	68.7	18.7	28.1	53.1	40.4	32.1	33.1	47.3	68.8	135.6	46.2	16.2	133.3	64.4	21.3	32.4	24.4	78.5	95.3	81.9	31.1	44.6	47.5	37.1	71.3	22.7	43.3	25.8	66.0	91.5	24.7	41.9	38.0	50.8	69.3	73.5	98.4	122.5	30.7	67.4	38.7	0.6	0.7	1.6	1.4	1.1	1.1	2.4	1.6	1.6	0.6	1.8	1.5	2.1	1.6	1.8	0.7	1.9	1.8	0.4	6.3	6.3	11.1	8.5	5.4	5.8	5.4	5.9	5.6	5.2	6.1	7.1	44.5	41.7	45.8	43.1	50.1	58.5	50.2	21.8	31.9	77.6	54.2	36.8	32.3	27.1	32.6	35.0	108.4	61.5	65.2	24.0	17.6	28.3	16.2	52.8	55.8	45.1	29.4	93.6	71.6	21.9	53.1	35.1	31.1	54.2	15.8	41.4	38.2	42.3	32.9	62.2	69.5	31.8	10.2	42.1	58.2	13.9	26.8	47.3	24.9	45.0	73.1	45.7	38.1	75.4	71.3	27.8	15.4	25.6	66.2	62.8	21.5	26.6	29.6	80.9	13.1	47.2	38.4	121.7	128.9	48.6	71.7	69.5	52.5	52.8	35.6	66.7
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736959	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 808.1;tongue: 581.5"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 259.3"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 259.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 146.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		210000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	26.4	13.4	3.7	22.7	3.9	37.2	22.6	1.3	8.9	45.8	2.5	314.5	14.8	116.2	24.1	92.1	55.5	52.0	165.0	2.2	2.7	15.4	10.4	22.9	12.6	7.0	4.1	83.3	18.5	31.8	8.5	17.9	4.4	70.3	37.1	10.3	40.6	100.0	808.1	26.9	60.1	107.0	4.4	7.6	77.6	11.7	4.9	19.1	35.0	581.5	10.8	173.2	40.3	5.2	71.4	27.9	12.4	5.4	32.1	84.4	22.1	12.6	24.1	4.3	4.7	34.4	63.1	2.4	43.0	4.9	31.9	146.8	8.6	25.6	5.2	1.4	17.6	0.1	33.6	19.9	21.4	8.0	1.5	72.7	24.5	44.2	19.1	71.9	69.6	14.7	0.1	0.4	6.7	19.9	7.7	4.0	7.0	27.8	15.1	15.5	32.1	0.9	40.2	20.1	18.1	14.1	12.3	1.4	34.3	39.8	12.9	7.9	46.3	21.9	23.4	94.4	34.4	0.6	0.8	0.3	64.5	14.0	65.4	43.4	12.1	58.2	11.1	14.0	10.9	0.6	11.2	7.6	7.3	1.0	17.1	10.9	259.3	14.6	29.6	3.0	4.3	3.7	3.7	3.9	1.3	8.9	2.2	2.7	7.0	4.1	4.4	4.4	4.9	5.2	31.3	48.1	30.5	2.3	3.7	70.2	108.0	41.1	204.9	11.7	36.6	67.1	469.6	18.6	53.5	38.6	25.0	29.7	11.3	39.7	7.9	94.1	4.0	26.3	65.8	61.1	23.9	1.7	8.3	42.3	18.5	68.1	7.7	43.6	10.1	35.7	32.2	11.8	10.4	5.0	43.9	31.3	28.5	7.5	45.7	6.8	109.6	25.3	28.4	146.1	16.7	30.6	13.4	28.1	6.6	63.4	40.2	260.7	3.3	131.8	18.4	10.8	42.2	15.0	46.0	90.6	92.9	6.5	11.1	103.8	60.0	24.8	14.6	27.9	39.2	98.3
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854863-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 40.2"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 1162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	98	"THP-1: 17.2"	"Region enriched"	"Detected in single"	51	"cerebellum: 14.7"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	56.7	5.3	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1162.6	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863194	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.6;Late spermatids: 146.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	18.0	17.3	15.5	29.3	17.0	27.4	18.0	12.5	19.8	24.1	11.9	22.5	22.2	25.3	20.1	19.7	23.5	18.0	17.5	14.9	14.1	19.1	21.4	20.6	34.8	18.9	15.6	23.6	19.1	20.7	32.6	25.0	17.1	23.8	14.1	15.7	24.7	16.4	38.5	25.3	22.8	16.1	11.4	28.5	22.9	41.0	16.6	30.0	24.0	18.9	22.8	20.7	19.9	22.7	57.7	101.0	40.4	29.9	39.0	46.8	67.7	44.5	32.0	45.8	51.0	45.8	51.1	101.6	30.2	51.0	25.7	46.2	55.1	49.9	40.0	79.4	62.2	58.7	68.9	47.5	43.7	64.9	65.6	36.1	29.2	49.3	55.4	31.2	47.6	52.6	79.3	64.4	39.4	54.8	61.0	70.3	34.0	50.0	23.9	64.6	46.4	62.6	31.8	102.7	46.0	57.7	55.1	35.5	36.7	40.3	48.4	89.4	53.5	37.1	58.5	28.8	66.9	84.1	173.1	81.5	42.4	42.8	61.8	1.7	3.0	1.5	2.0	2.5	1.9	2.9	1.8	3.2	2.8	4.8	1.5	1.4	3.4	2.7	5.0	5.8	1.4	2.1	15.5	17.0	12.5	19.8	14.9	14.1	18.9	15.6	17.1	11.4	16.6	22.7	14.7	0.0	7.7	34.9	30.2	20.9	18.7	15.6	18.2	21.6	17.4	15.4	7.0	22.8	12.0	25.8	35.5	35.5	20.9	32.7	54.8	21.6	141.6	24.9	29.9	23.4	36.3	26.5	24.6	17.5	34.5	17.5	41.8	27.7	12.7	35.1	26.0	31.8	18.2	21.9	27.1	38.7	10.2	27.0	25.6	146.4	19.3	24.4	14.2	19.7	47.3	11.3	32.0	29.1	28.4	20.4	25.5	21.1	19.8	21.5	30.8	14.9	15.6	27.4	19.7	17.4	20.4	35.3	34.1	14.4	21.3	57.3	21.2	21.9	38.6	20.6
SYN1	MRX50	ENSG00000008056	"Synapsin I"	P17600	X	47571901-47619857	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 271.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 81.4;basal ganglia: 127.5;cerebral cortex: 271.3;hippocampal formation: 118.3;white matter: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced					NA	NA		48000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 41: Macrophages - Immune response"			"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	3.9	11.0	81.4	3.5	127.5	2.0	0.9	9.0	271.3	1.2	0.0	3.7	0.6	1.3	1.4	0.7	1.9	2.6	15.3	118.3	30.7	2.2	3.0	2.9	0.4	28.5	2.3	2.9	2.2	0.7	35.7	4.4	12.7	2.3	1.8	44.0	1.2	1.7	1.9	1.3	1.8	1.7	0.0	1.1	1.9	2.6	9.9	0.9	0.5	3.8	0.7	4.1	1.6	150.4	0.0	0.0	5.0	0.7	0.2	1.0	0.0	0.9	0.2	1.4	0.4	0.0	0.0	0.0	1.6	0.1	1.6	9.0	0.5	0.0	0.4	0.6	0.1	0.5	0.0	0.0	8.1	0.0	2.1	1.9	0.0	1.5	0.3	0.0	0.1	0.7	0.6	0.3	0.2	0.2	0.3	0.3	17.4	0.0	0.1	0.1	0.1	0.3	0.0	0.0	30.2	7.9	0.0	0.1	0.1	7.2	2.2	0.0	0.2	0.0	0.9	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	127.5	9.0	271.3	118.3	30.7	28.5	2.3	12.7	0.0	9.9	150.4	0.2	0.0	0.0	5.5	0.0	0.9	0.6	0.6	0.6	27.1	0.2	0.1	3.7	1.5	0.1	0.0	10.4	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.4	4.2	0.8	37.3	0.7	0.0	2.7	1.1	0.1	0.0	1.6	3.3	1.5	0.2	28.6	34.1	0.3	2.0	1.6	3.4	1.0	2.8	5.1	0.0	7.5	4.7	6.4	0.0	10.6	5.1	0.6	0.2	3.4	0.0	1.2	0.0	0.1	0.1	7.3	6.6	0.8	2.1	3.6	2.1	0.0	0.6	0.0	0.1	3.2	0.5	0.3
SYN3		ENSG00000185666	"Synapsin III"	O14994	22	32507820-33058381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 25.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.5;Excitatory neurons: 347.7;Inhibitory neurons: 198.6;Late spermatids: 250.7;Oligodendrocyte precursor cells: 75.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 25.0"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.2"	"Group enriched"	"Detected in many"	11	"B-cells: 3.2;granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 15.0;EFO-21: 12.5;NTERA-2: 7.0;PC-3: 9.0;SCLC-21H: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034566	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034566: AB_10603120"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.77e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.52e-1)"	0.7	0.8	12.4	0.6	0.0	2.5	0.6	0.0	25.0	0.3	0.0	0.7	0.6	0.6	0.6	1.5	0.7	1.0	0.6	6.8	0.0	0.8	0.5	0.8	1.2	3.6	0.0	0.4	1.2	0.4	1.6	2.6	6.4	0.6	0.6	4.1	0.5	0.4	0.5	1.8	1.0	0.6	0.0	1.4	0.8	3.9	0.0	0.7	0.9	0.4	0.6	0.3	0.2	0.0	15.0	0.7	0.4	1.9	0.0	0.4	0.6	0.5	0.1	0.0	0.2	1.4	1.1	0.7	12.5	0.1	6.2	3.6	5.4	0.1	0.0	0.3	1.1	0.7	5.1	3.0	0.0	0.9	0.6	0.2	1.0	0.1	0.0	0.3	0.1	0.3	0.9	0.6	0.0	0.1	0.6	0.5	7.0	0.2	9.0	0.4	0.6	0.6	0.0	1.0	7.4	0.6	1.2	0.1	1.2	3.3	0.2	0.4	0.4	0.7	4.8	1.0	1.0	0.5	0.7	0.6	0.4	0.4	2.8	0.9	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	12.4	0.0	0.0	25.0	6.8	0.0	3.6	0.0	6.4	0.0	0.0	0.0	1.6	0.0	0.0	8.5	1.5	0.4	0.1	0.0	0.0	3.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	54.5	0.1	0.4	0.9	0.0	0.0	347.7	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.3	5.0	198.6	0.0	0.0	0.0	0.5	250.7	1.5	0.1	0.0	12.2	0.0	0.0	0.0	75.9	8.1	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.6	6.6	0.0	0.9	3.7	9.0	0.0	0.1	1.1	0.0	0.7	0.0	0.0
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63761899-64226433	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 454.6;Rod photoreceptor cells: 568.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 73.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 73.8;T-cells: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 48.8;SiHa: 29.8;U-698: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.1	6.0	8.8	3.4	9.2	7.9	28.0	21.1	8.7	15.4	89.5	13.3	4.5	18.1	9.9	24.3	14.3	5.5	58.3	9.6	7.6	29.0	19.5	18.4	8.5	7.7	9.6	35.9	37.7	66.6	16.7	9.9	7.5	11.5	4.4	24.8	16.1	3.7	198.5	39.7	11.4	4.6	7.0	10.0	12.4	13.1	11.4	5.5	24.4	96.7	6.1	13.6	19.0	6.9	23.2	8.7	11.0	3.5	11.3	3.2	12.3	1.3	1.6	2.7	4.2	2.8	3.3	48.8	2.3	1.7	2.6	11.0	6.2	3.5	3.2	8.9	3.5	0.4	7.9	0.7	3.0	1.0	0.3	4.4	15.1	3.4	2.2	2.6	7.0	7.5	0.4	4.8	1.8	11.2	6.2	0.3	3.4	5.4	3.3	6.9	14.5	1.8	20.0	13.6	9.9	8.2	29.8	3.8	7.0	5.5	5.0	0.3	7.3	4.2	7.5	1.5	4.5	4.9	3.5	27.5	1.8	0.0	5.7	0.5	0.1	73.8	38.5	0.3	27.6	5.2	24.3	28.0	0.0	5.3	11.8	18.5	30.1	3.9	0.3	1.2	30.1	3.4	8.8	9.2	21.1	8.7	9.6	7.6	7.7	9.6	7.5	7.0	11.4	6.9	414.4	307.7	140.1	8.5	44.9	111.3	138.9	46.4	174.2	27.4	70.3	59.1	261.4	105.8	184.5	202.3	183.5	168.8	226.8	51.0	19.6	108.2	9.4	249.9	71.2	238.8	46.2	10.5	9.5	55.4	65.7	59.6	126.9	365.2	25.9	454.6	73.5	33.3	17.7	6.7	13.9	60.9	59.0	5.7	13.2	14.3	100.9	12.8	48.0	128.4	8.9	107.2	300.7	33.2	6.6	71.7	27.9	53.4	180.3	65.0	35.9	72.2	196.1	568.7	111.7	73.5	167.0	13.0	17.0	104.6	87.5	224.0	222.1	69.5	80.6	80.6
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33453689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 34.5;Horizontal cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	135	"amygdala: 11.4;basal ganglia: 11.3;cerebral cortex: 21.0;hippocampal formation: 26.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HMC-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	9.1	8.4	11.4	6.9	11.3	3.4	7.4	0.0	21.0	18.1	6.1	12.4	3.1	18.3	2.4	7.9	19.4	3.0	7.6	26.4	0.0	7.1	3.0	11.7	5.9	0.0	0.1	21.8	5.6	4.4	40.1	3.1	0.0	9.8	2.2	5.8	5.9	3.4	2.1	7.7	11.2	5.9	0.0	11.7	7.9	10.7	0.0	7.8	10.3	2.0	3.6	11.7	12.0	0.0	2.7	1.0	26.1	10.1	5.7	6.0	3.4	7.1	4.6	3.8	3.0	11.9	1.0	8.3	1.6	3.5	3.5	4.0	3.4	3.9	2.5	4.6	2.0	20.8	3.6	0.7	4.9	3.3	22.9	4.1	1.1	7.2	3.3	14.4	2.9	6.5	6.7	3.4	2.8	6.0	5.1	4.2	14.5	1.2	3.0	19.2	0.6	3.1	2.9	2.2	6.7	5.4	2.6	5.0	2.2	6.1	11.1	3.1	0.8	7.8	7.7	3.1	1.5	4.0	1.4	5.9	4.5	3.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	11.3	0.0	21.0	26.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	2.0	28.1	7.4	3.6	2.4	3.1	17.1	23.5	4.6	5.7	1.4	4.3	4.0	3.7	10.4	0.8	7.3	1.4	1.9	2.2	6.3	18.7	21.2	7.2	9.6	4.6	34.5	1.4	1.3	8.8	2.6	3.2	5.1	6.3	10.0	0.8	1.8	38.7	21.1	1.6	6.1	2.8	7.5	1.6	11.5	2.4	3.6	7.5	2.7	4.2	6.2	12.1	6.2	1.5	0.6	13.5	3.8	1.6	1.6	8.5	21.9	7.9	19.7	3.2	9.2	9.3	8.2	9.2	4.3	0.8	12.8	11.8	2.8	1.8
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.7	0.1	0.7	0.3	3.6	0.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	11.8	0.1	0.1	262.3	0.7	0.5	0.1	0.1	1.2	0.2	0.7	0.6	0.2	0.4	0.0	0.1	0.6	0.5	3.1	0.0	0.4	4.8	0.0	279.2	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.6	0.1	0.2	87.2	0.2	0.0	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.7	0.7	0.8	0.9	0.7	0.5	0.7	0.6	0.5	0.5	0.6	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153880	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 13.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.1;Early spermatids: 6.1;Excitatory neurons: 5.9;Late spermatids: 14.1;Microglial cells: 27.2;Oligodendrocyte precursor cells: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 22.0;WM-115: 15.2"	"Group enriched"	"Detected in all"	7	"basal ganglia: 31.2;olfactory bulb: 71.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.0	0.8	2.7	0.2	4.2	0.0	0.7	1.5	2.8	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.0	13.5	1.5	0.0	0.0	0.0	4.8	4.5	0.8	3.1	0.1	0.1	0.5	3.9	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	1.5	2.8	3.0	13.5	4.8	4.5	3.9	7.9	9.5	4.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	6.1	0.0	0.2	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.4	14.1	0.0	1.2	3.6	27.2	0.0	0.7	0.0	7.5	0.6	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.7	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.1	3.9	0.0	0.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006553-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;stomach 1: 12.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 37.2;Inhibitory neurons: 92.0;Intestinal goblet cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;MCF7: 5.8;OE19: 8.4;SK-MEL-30: 14.8;SuSa: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.0	8.2	6.5	0.3	7.2	0.0	2.5	0.0	5.6	5.6	0.1	2.8	2.2	2.2	0.8	3.1	0.4	0.5	1.1	6.7	10.7	1.2	4.4	0.6	0.0	3.4	13.6	0.1	5.8	0.0	0.6	7.4	6.3	0.9	3.2	0.5	2.2	0.4	0.0	0.1	2.4	3.3	2.5	0.0	12.1	0.6	8.6	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	1.2	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	6.2	1.4	0.0	0.0	0.5	2.2	0.7	0.0	0.0	0.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.7	0.1	0.0	0.1	0.2	0.2	5.8	0.0	0.0	2.5	8.4	0.0	0.0	2.0	0.0	0.0	0.4	3.2	0.0	0.3	1.2	14.8	19.5	0.0	0.0	0.0	0.1	4.7	0.0	3.3	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	7.2	0.0	5.6	6.7	10.7	3.4	13.6	6.3	2.5	8.6	0.9	0.0	0.0	2.0	1.6	0.0	0.0	0.2	0.8	0.0	0.0	4.0	1.5	0.3	0.0	8.7	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.7	3.6	0.1	3.0	0.0	1.4	0.9	3.6	0.6	37.2	4.0	0.0	1.0	0.4	1.3	0.3	0.0	92.0	20.8	6.1	0.0	0.0	0.0	0.6	0.2	0.0	1.0	0.2	0.0	0.0	0.0	1.1	4.9	3.0	2.6	0.3	0.6	0.6	0.1	3.3	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	8.9	0.1	0.0	0.7	1.0
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399778-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nuclear speckles"		"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	13.1	14.8	18.2	9.0	20.6	9.7	12.9	17.0	19.8	18.2	10.6	18.9	10.7	16.5	6.2	13.8	15.9	7.4	17.0	17.3	16.1	12.4	16.6	11.0	11.1	18.7	19.3	20.5	15.6	10.0	10.5	8.6	17.7	16.7	5.4	12.2	13.7	10.9	19.9	17.4	13.5	8.7	15.8	15.9	14.7	10.2	18.5	11.9	13.3	10.7	7.8	17.9	14.9	20.6	15.0	15.3	15.2	17.5	15.8	13.2	13.5	12.3	15.1	18.4	17.3	14.2	10.6	22.5	9.4	12.0	10.3	18.0	15.5	18.0	7.2	17.6	24.8	9.9	19.0	14.2	13.7	18.8	18.3	13.5	15.7	13.9	15.1	14.0	13.6	13.5	18.4	15.0	9.3	9.7	14.6	15.6	10.6	23.6	15.4	26.0	21.6	22.6	14.4	15.7	13.5	9.9	17.4	21.5	15.4	9.4	17.6	20.4	11.8	12.8	20.2	9.9	10.1	23.6	16.2	16.4	15.1	13.1	12.8	0.8	5.6	4.1	4.3	4.3	3.4	3.3	2.6	3.5	5.0	3.2	4.1	3.9	0.7	3.3	4.5	2.3	2.8	4.3	18.2	20.6	17.0	19.8	17.3	16.1	18.7	19.3	17.7	15.8	18.5	20.6	6.0	3.2	6.7	17.9	7.0	2.0	2.8	4.0	6.8	55.2	5.9	6.9	7.4	8.6	4.1	3.7	18.8	12.4	4.7	4.9	0.0	6.2	1.6	4.5	7.0	5.4	11.4	6.9	9.1	3.8	7.9	6.2	7.1	4.4	5.1	12.5	2.2	4.7	7.1	28.6	12.6	4.8	0.0	6.0	1.0	3.2	7.8	6.4	5.4	9.4	8.6	12.1	8.2	7.5	18.6	5.4	4.1	9.1	8.4	2.8	7.6	5.4	4.7	18.8	6.6	6.4	7.4	8.2	9.1	5.5	3.3	5.6	8.1	10.3	4.9	1.8
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF1L		ENSG00000122728	"TATA-box binding protein associated factor 1 like"	Q8IZX4	9	32629454-32635669	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"retina: 1.7;testis: 1.6"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 15.4;Early spermatids: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056605	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"			"HPA056605: AB_2683186"	"unprognostic (7.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.79e-2)"		"unprognostic (4.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.13e-2)"		"unprognostic (1.60e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.86e-2)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	15.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.6	2.1	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367976-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.7;Spermatogonia: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.36e-9)"	"prognostic favorable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	2.2	1.8	2.7	2.8	2.9	4.9	2.3	5.0	3.3	2.5	2.3	3.1	2.9	2.3	1.7	2.4	2.3	1.5	2.0	2.6	2.6	1.7	2.6	1.9	4.4	2.8	2.7	3.0	2.9	1.7	2.1	3.5	2.9	2.0	3.1	3.5	2.0	2.2	3.0	2.5	2.4	2.1	2.7	3.1	2.1	11.2	2.6	7.0	2.0	3.6	4.3	2.2	2.5	3.1	9.7	4.4	10.6	19.2	5.9	4.8	12.4	6.8	7.7	9.6	12.0	8.7	5.0	23.0	3.8	3.6	5.6	9.6	18.1	3.7	12.2	8.5	15.6	10.6	5.0	8.7	2.7	20.6	11.0	2.2	2.7	5.7	6.1	3.9	7.3	10.1	15.4	11.2	6.5	6.4	16.8	26.9	12.9	12.2	5.7	14.2	12.9	7.0	2.7	2.8	7.4	8.2	4.4	3.2	4.1	10.1	3.7	8.5	4.3	5.6	7.1	6.3	12.2	6.3	8.1	14.0	3.1	24.2	3.6	0.2	0.6	0.8	0.4	0.2	0.3	0.1	0.4	0.8	0.3	1.3	1.0	0.5	0.0	0.3	0.3	0.4	1.1	0.2	2.7	2.9	5.0	3.3	2.6	2.6	2.8	2.7	2.9	2.7	2.6	3.1	5.8	6.4	2.6	3.6	6.9	14.4	4.5	1.7	6.2	6.9	3.0	2.7	2.9	1.5	2.5	1.8	6.2	5.6	8.3	2.7	3.9	2.8	19.7	1.8	3.8	5.2	2.4	11.2	4.9	2.2	9.3	5.6	2.0	2.1	8.9	4.1	2.9	2.8	3.8	1.7	5.3	2.9	4.1	2.8	6.3	14.1	1.8	3.6	1.8	3.7	4.9	1.3	4.1	3.5	5.8	1.9	3.3	2.6	14.9	4.3	3.3	1.0	0.7	7.5	0.0	7.2	6.5	48.7	52.3	5.9	14.2	6.8	8.6	3.0	4.0	3.8
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593121-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: AB_2685929"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	16.3	6.3	7.7	10.5	8.5	22.7	10.5	8.6	8.1	9.2	4.6	12.3	10.6	9.1	5.9	10.6	9.5	11.7	8.4	7.3	7.9	6.6	15.3	11.2	14.0	8.3	8.1	9.3	8.4	9.2	3.8	14.0	8.3	9.2	12.5	10.1	8.2	8.7	14.1	7.2	9.9	11.4	7.5	11.4	9.5	5.5	8.5	14.2	10.5	12.6	10.8	14.0	5.1	9.6	30.2	17.1	23.6	19.8	16.1	16.6	62.4	20.1	23.5	24.3	22.4	23.3	23.9	33.7	20.8	21.4	15.7	24.9	26.4	24.2	22.9	25.5	38.3	26.4	17.7	14.8	17.9	35.3	29.3	18.6	22.9	24.0	20.3	9.4	23.7	34.8	36.1	29.7	22.8	14.6	39.9	18.5	34.1	33.3	13.2	35.0	26.8	34.9	16.6	27.2	23.9	29.4	17.2	22.9	27.9	8.7	27.4	35.6	21.2	20.1	24.7	27.2	42.6	16.1	13.3	37.9	15.4	21.1	32.3	0.0	0.2	0.0	0.4	0.2	0.5	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.0	0.5	0.3	0.1	0.4	0.2	7.7	8.5	8.6	8.1	7.3	7.9	8.3	8.1	8.3	7.5	8.5	9.6	15.9	3.2	9.4	19.2	8.2	5.7	4.8	2.9	6.2	5.5	8.4	5.3	7.3	5.7	7.1	3.7	12.5	11.0	14.6	12.3	1.9	4.2	3.4	11.0	8.9	8.0	12.0	7.6	11.7	8.3	32.8	7.0	6.1	12.7	0.0	6.1	6.8	13.6	9.6	6.7	15.7	10.2	6.1	6.3	8.4	4.7	4.7	10.9	5.4	13.1	11.8	3.8	4.1	22.1	24.0	6.9	8.3	4.1	10.2	6.6	6.9	3.0	5.1	9.0	13.1	15.4	11.5	6.0	4.6	9.6	5.3	10.4	8.8	5.6	9.9	7.2
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	42.1	43.5	35.5	31.9	38.6	108.2	46.0	35.4	41.4	28.3	34.4	42.5	34.2	31.5	50.4	37.4	31.1	28.8	52.7	39.2	43.0	38.4	55.7	27.7	46.6	37.1	36.4	37.8	40.8	35.5	50.6	38.0	40.5	33.7	47.5	47.2	34.7	27.7	58.0	36.1	33.2	35.9	36.6	35.0	38.0	140.4	37.7	50.9	28.7	41.7	52.3	50.6	30.3	36.1	107.0	109.3	67.7	121.6	114.4	143.5	179.3	100.1	159.8	172.3	227.0	109.7	135.1	135.9	70.2	146.7	322.2	82.2	92.4	208.1	227.4	65.6	111.0	120.4	154.0	157.8	261.3	118.7	168.3	159.4	137.4	117.1	247.7	122.5	143.1	121.4	122.4	119.8	165.9	147.7	126.1	189.5	82.0	42.6	81.6	83.0	119.7	169.0	152.7	120.7	118.1	82.6	108.3	64.3	192.8	111.3	100.9	175.7	103.3	65.9	98.2	78.2	173.1	93.2	118.3	175.6	101.3	145.7	82.8	149.3	107.8	122.5	52.8	101.3	81.2	90.1	79.7	64.2	83.9	75.4	89.6	73.6	16.0	58.7	88.4	47.0	95.5	134.4	35.5	38.6	35.4	41.4	39.2	43.0	37.1	36.4	40.5	36.6	37.7	36.1	67.4	19.2	29.3	0.0	55.2	174.0	151.4	238.7	39.3	24.1	49.9	81.4	69.3	42.9	108.8	23.9	14.6	118.0	45.1	33.8	90.1	67.1	550.8	47.6	44.9	58.6	30.7	93.2	0.0	80.4	166.7	57.3	36.7	38.1	38.6	53.5	34.6	41.9	107.7	20.2	0.0	49.5	146.5	42.8	99.8	924.3	65.3	55.2	99.6	0.0	66.9	35.1	35.0	0.0	0.0	85.1	37.2	34.3	76.5	87.3	47.4	90.2	85.2	43.0	32.9	49.1	95.5	370.7	78.0	60.7	163.2	104.5	50.7	75.0	64.2	149.6
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2404.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		270000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	401.9	154.7	103.7	356.0	103.2	437.3	355.4	106.3	115.0	266.6	94.9	337.4	314.3	220.5	94.9	494.0	231.9	282.6	351.1	101.1	152.7	307.9	254.4	687.7	321.1	141.7	117.6	170.9	284.7	81.0	100.0	378.2	122.9	208.5	307.9	46.1	388.7	205.2	83.4	418.2	356.3	254.4	125.2	479.7	698.8	127.0	125.9	309.6	210.2	139.6	386.4	436.1	350.0	114.9	1382.3	723.7	22.3	8.3	266.8	646.6	835.4	760.0	872.6	1635.2	799.8	786.6	1049.3	862.0	628.0	954.9	495.0	1054.3	378.1	1039.9	978.8	974.3	355.5	1140.7	651.8	50.0	322.7	808.2	1221.4	667.4	776.9	1030.4	504.3	1134.7	1029.0	260.3	494.8	578.9	586.1	563.0	378.1	601.2	619.3	947.6	1457.7	2.9	391.7	1275.3	376.6	527.7	340.7	325.6	900.7	1435.1	410.3	1190.6	756.5	814.2	1147.3	955.1	1134.4	876.9	2078.0	230.8	110.6	525.0	1238.3	541.3	603.8	1458.4	742.0	3160.6	558.9	449.7	499.9	866.5	620.0	544.6	1177.7	680.2	321.6	360.3	3746.8	817.6	356.9	1966.4	756.1	2257.9	103.7	103.2	106.3	115.0	101.1	152.7	141.7	117.6	122.9	125.2	125.9	114.9	617.1	179.5	130.5	0.3	507.8	549.1	330.6	454.3	307.9	31.6	257.0	201.8	12.8	121.5	221.4	183.9	18.8	497.4	567.6	371.0	74.3	1273.4	54.3	289.4	145.9	509.6	317.8	197.6	0.1	1206.9	2404.5	405.2	545.3	242.7	418.8	32.0	265.2	64.1	443.7	3.3	0.6	445.5	284.8	285.9	952.4	85.9	118.7	651.5	334.4	16.9	911.4	66.3	186.4	0.5	1.6	877.4	263.2	63.9	393.4	337.5	324.2	208.2	275.9	25.6	184.1	358.3	324.3	14.3	20.7	494.1	572.5	230.4	393.6	136.7	271.7	405.9
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998739-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7"	"Cancer enriched"	"Detected in many"	4	"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA		9000000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	0.3	33.5	291.3	1.5	313.2	0.0	0.1	250.3	442.4	0.0	172.3	11.4	0.6	0.0	0.0	0.2	0.0	0.2	0.6	318.0	310.2	4.5	0.3	0.5	0.2	300.5	235.8	0.3	5.6	0.0	100.9	0.0	292.8	0.5	2.3	74.3	0.2	0.2	0.2	0.6	2.4	1.1	212.3	0.1	3.3	0.3	254.2	1.3	0.4	0.0	0.2	0.2	1.1	309.3	0.0	0.0	104.1	0.2	0.0	0.0	0.1	2.6	1.9	0.1	0.1	0.4	0.2	0.0	3.8	0.0	0.1	0.7	0.1	7.2	1.4	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.0	0.1	0.0	4.0	0.0	9.0	15.1	2.8	0.0	41.6	0.0	55.5	94.5	0.0	0.1	0.0	2.1	0.1	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.3	313.2	250.3	442.4	318.0	310.2	300.5	235.8	292.8	212.3	254.2	309.3	0.1	0.0	0.0	16.6	0.0	0.8	1.2	1.0	0.0	104.3	0.2	0.3	0.7	0.0	1.8	5.5	8.4	0.0	0.1	0.0	0.0	0.1	2.6	0.2	0.0	1.1	5.3	0.0	78.1	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	297.8	49.3	0.0	30.5	0.0	0.0	0.9	0.0	0.4	0.0	15.0	0.0	16.3	0.0	32.2	18.8	2.3	0.0	0.0	0.0	1.1	0.0	31.9	12.8	50.7	0.0	0.4	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.9
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5"	"Low region specificity"	"Detected in all"							HPA007066	Approved					NA	NA		20000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	47.3	73.1	2.4	28.5	4.8	25.0	43.1	1.9	2.8	40.1	1.2	66.7	52.3	38.2	13.3	57.3	43.8	10.5	63.7	2.9	1.8	67.4	107.5	82.1	21.2	2.7	3.2	33.3	48.2	14.9	38.8	18.7	2.0	64.3	19.6	4.1	61.9	17.2	26.7	54.0	81.9	23.1	1.9	129.0	52.1	16.2	2.0	24.4	59.1	6.5	36.7	45.0	43.4	2.4	3.3	1.2	6.3	26.1	20.3	25.6	92.9	18.5	88.1	42.5	57.1	0.1	168.7	48.1	38.1	41.3	92.2	2.9	0.3	30.3	15.8	125.5	4.1	19.1	9.9	24.8	0.2	20.4	63.0	51.7	20.6	0.8	8.2	37.8	0.4	16.0	1.5	140.8	14.7	19.6	51.9	44.1	0.5	0.0	6.3	2.8	0.4	1.3	35.5	1.2	8.6	0.6	0.6	2.4	23.7	3.7	1.4	0.9	45.5	89.4	18.6	1.3	2.0	140.5	117.4	46.2	58.6	38.8	58.8	159.7	87.9	172.1	137.3	121.6	117.0	97.1	99.7	114.3	90.0	86.0	76.2	109.9	151.3	159.6	139.0	102.9	85.9	150.5	2.4	4.8	1.9	2.8	2.9	1.8	2.7	3.2	2.0	1.9	2.0	2.4	116.8	125.0	102.1	22.5	186.6	77.0	93.3	148.2	66.6	34.7	82.0	64.1	73.9	84.4	105.8	71.7	33.3	46.9	223.7	259.6	13.7	256.4	1.9	64.0	52.4	99.1	84.6	58.0	25.9	282.9	85.9	63.9	105.5	78.4	91.9	65.9	75.0	143.7	119.7	20.2	15.0	174.6	83.4	124.3	128.0	9.2	33.2	131.9	119.2	30.9	229.3	34.7	195.7	23.6	8.7	215.5	172.4	32.0	194.9	130.4	283.2	33.1	113.3	30.4	32.9	39.3	57.6	1.2	0.6	53.6	56.3	49.1	163.7	66.4	162.3	141.0
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11030528	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	NA		29000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	83.4	80.1	71.9	87.1	80.6	69.7	83.3	84.7	79.0	93.9	78.1	94.5	77.4	90.9	78.8	111.1	84.1	58.7	93.0	69.4	78.5	93.8	105.5	91.6	106.5	75.5	77.2	103.5	77.2	86.7	89.1	82.7	76.4	90.1	94.5	119.9	86.6	78.8	138.9	96.1	94.5	81.2	74.8	97.4	82.4	68.2	74.7	115.1	96.6	102.9	122.9	87.6	95.8	86.0	244.7	164.4	270.4	143.5	143.9	118.2	160.3	164.7	142.3	263.6	195.5	187.9	175.6	316.3	118.1	180.6	154.3	169.2	333.1	187.6	336.0	175.1	153.8	241.2	275.2	257.9	119.4	290.5	158.9	99.5	211.4	184.5	147.9	143.8	188.6	126.7	319.0	176.4	221.7	195.0	215.6	228.6	221.0	232.2	141.7	256.9	214.4	206.2	186.0	179.1	187.9	150.8	221.3	173.7	128.8	197.1	173.8	200.9	174.8	173.8	207.8	146.3	236.9	133.3	176.2	336.3	116.2	288.2	192.0	38.0	38.0	33.7	46.7	48.6	57.4	55.2	46.9	45.4	61.7	39.6	46.3	50.5	15.4	67.2	50.0	43.1	54.3	36.4	71.9	80.6	84.7	79.0	69.4	78.5	75.5	77.2	76.4	74.8	74.7	86.0	35.5	32.1	74.4	29.4	57.6	114.6	89.9	40.8	52.3	37.6	52.0	38.6	68.0	31.5	57.0	29.5	29.2	63.2	46.3	54.2	33.2	50.8	9.7	50.7	50.0	54.9	66.3	63.5	29.5	54.2	84.5	45.2	34.7	61.7	42.3	45.8	40.0	51.7	50.1	37.0	29.8	50.1	38.7	45.9	46.3	12.3	47.2	37.8	35.6	23.4	54.3	36.2	35.0	37.2	57.2	52.9	36.1	51.6	48.8	71.7	43.2	43.9	54.4	38.8	32.9	42.8	56.9	64.9	32.8	52.4	114.5	73.5	41.3	23.6	52.6	71.3
TARS1	TARS	ENSG00000113407	"Threonyl-tRNA synthetase 1"	P26639	5	33440696-33468091	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		580000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	29.0	32.2	13.7	33.8	16.2	45.0	26.8	20.0	20.1	24.0	17.1	42.6	30.7	24.7	35.8	40.9	17.4	19.9	38.7	13.8	17.9	32.4	68.6	24.1	29.9	22.4	18.5	17.9	68.1	33.8	9.9	37.1	18.3	27.6	42.8	40.7	36.8	26.4	38.4	19.1	29.8	37.2	18.4	21.7	40.0	18.7	18.3	31.7	37.6	28.4	40.1	42.9	10.8	22.6	253.0	136.1	132.7	189.5	80.2	129.9	230.1	237.5	172.9	152.5	163.7	176.6	128.7	96.0	84.8	176.5	271.8	151.1	261.1	207.1	267.4	158.9	140.5	151.1	332.9	108.5	256.7	225.6	141.0	133.7	287.7	217.5	273.9	102.4	144.3	191.8	236.3	204.6	191.5	105.7	166.3	104.7	159.2	181.5	168.4	137.1	237.9	123.4	170.8	119.8	81.0	102.7	245.6	175.8	195.5	103.8	85.9	236.3	123.0	132.8	211.9	102.5	196.3	135.4	258.4	132.6	156.2	302.6	148.3	34.2	22.0	22.6	27.4	24.5	27.6	28.7	25.2	26.6	32.6	23.9	21.5	27.5	2.6	46.2	18.3	18.3	24.2	20.6	13.7	16.2	20.0	20.1	13.8	17.9	22.4	18.5	18.3	18.4	18.3	22.6	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	0.0	0.0	0.0	0.0	36.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	42.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	52.1	2.6	0.0	0.0	0.0
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1272.2"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	58.9	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.4	1272.2	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.1	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26756223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Excitatory neurons: 106.6;Inhibitory neurons: 95.3;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (3.51e-1)"	3.4	5.8	5.2	2.5	4.5	1.6	4.3	5.3	5.1	7.4	10.7	4.4	1.8	7.6	7.0	2.9	7.7	7.5	5.7	4.2	6.2	17.3	2.9	4.3	2.2	7.1	6.2	8.8	3.0	14.6	5.0	3.8	7.0	5.2	3.0	9.2	3.2	6.3	3.1	2.2	1.7	8.7	4.8	2.8	3.1	4.9	5.7	17.4	7.8	5.0	2.6	4.8	3.0	6.0	2.4	1.9	8.5	5.3	11.5	18.5	2.4	11.1	8.2	4.9	4.8	4.1	5.8	5.6	9.5	15.0	15.2	1.0	4.8	5.6	4.7	1.7	2.2	1.4	6.6	1.2	6.3	3.2	1.4	9.3	4.5	9.4	5.7	19.7	6.7	7.2	5.3	0.0	77.1	0.1	6.3	3.5	3.9	3.2	9.2	4.7	8.4	0.6	18.9	2.5	8.4	3.2	5.3	1.2	5.5	6.9	2.1	1.2	6.5	6.2	1.7	4.7	2.8	1.2	3.1	2.6	22.1	1.7	6.4	1.1	0.5	1.8	4.2	0.6	5.1	1.6	3.2	4.7	0.9	2.0	2.4	2.9	0.0	4.5	0.6	1.7	1.7	1.3	5.2	4.5	5.3	5.1	4.2	6.2	7.1	6.2	7.0	4.8	5.7	6.0	6.0	3.2	4.1	66.9	8.2	3.6	5.3	7.6	7.4	7.4	5.7	5.3	6.4	1.5	2.5	20.2	14.6	4.0	18.1	1.0	5.9	4.8	11.1	15.7	18.9	6.8	9.5	2.1	106.6	3.1	2.2	9.3	6.1	9.0	8.9	9.3	7.1	1.9	1.6	5.0	95.3	2.1	10.2	2.4	2.7	3.1	9.0	2.4	10.6	42.2	0.8	7.4	13.4	102.5	72.4	2.6	0.4	9.1	5.5	1.9	0.6	19.2	17.4	19.3	0.0	9.5	11.1	25.6	8.9	3.1	4.5	1.9	14.4	13.1	1.6	2.3
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 103.8;Oligodendrocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	9.3	9.1	20.0	8.7	21.3	7.2	9.7	17.4	16.7	18.1	14.2	9.4	2.8	38.4	35.3	10.2	16.6	7.1	7.3	16.7	21.1	16.6	13.6	5.8	9.0	23.8	20.2	18.0	9.2	23.9	18.7	20.7	19.7	25.4	5.3	16.5	7.3	43.2	4.6	7.5	5.0	26.6	18.6	8.4	8.1	9.7	26.7	18.4	12.0	5.2	10.2	13.5	12.7	20.0	0.1	29.6	18.5	49.2	16.8	17.4	18.4	11.3	25.0	21.3	22.2	22.4	20.2	31.6	0.8	22.7	9.1	6.7	40.7	8.9	30.9	13.0	19.6	20.0	35.6	26.5	23.7	7.2	68.6	15.6	10.1	22.3	11.8	11.7	19.9	17.2	35.8	53.5	12.5	25.6	17.8	27.2	36.7	14.2	31.5	39.3	14.5	39.3	28.9	16.9	23.4	10.6	27.2	6.8	16.9	48.2	13.3	15.6	29.1	7.5	18.3	0.8	4.6	32.6	27.8	25.1	27.2	17.4	7.1	6.3	4.7	5.7	2.2	2.9	1.8	2.2	1.7	2.0	3.5	3.6	3.1	2.9	18.7	0.3	2.0	0.3	2.9	2.1	20.0	21.3	17.4	16.7	16.7	21.1	23.8	20.2	19.7	18.6	26.7	20.0	12.6	0.0	4.5	103.8	17.3	6.5	13.2	3.8	9.1	11.8	19.1	18.0	10.1	20.0	6.8	31.3	22.9	78.1	20.4	7.9	13.7	10.7	1.0	34.4	80.7	10.3	22.8	3.8	12.5	7.8	6.0	13.1	9.7	51.1	11.4	32.5	11.4	64.3	11.3	6.7	17.1	5.4	2.0	33.0	22.8	3.2	14.3	19.7	5.4	61.8	37.5	46.6	19.6	46.3	109.7	7.5	7.9	28.6	9.5	24.1	0.2	21.8	10.0	24.5	0.0	9.4	27.9	1.4	18.0	16.5	12.4	45.0	18.8	22.3	4.9	23.7
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"TBL1X receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	18.8	20.3	7.2	24.4	12.7	30.2	21.7	13.9	11.8	24.9	8.5	31.0	24.6	16.9	9.2	21.2	22.4	23.2	32.6	16.0	3.3	22.3	24.5	19.6	31.3	8.1	8.5	20.9	12.1	27.3	2.9	21.0	4.9	25.6	24.4	42.7	16.1	14.8	12.9	17.1	18.7	19.4	8.6	22.9	22.3	19.1	8.4	45.5	47.1	25.3	36.3	25.3	10.3	15.0	96.8	41.2	61.1	39.7	56.2	65.8	44.2	26.1	52.3	30.3	36.3	48.9	76.2	98.9	132.9	43.6	58.4	61.2	42.9	63.2	58.7	97.5	14.5	56.2	66.8	30.3	49.7	91.0	29.6	95.3	35.9	37.3	90.6	53.8	48.5	68.5	44.8	189.9	42.8	31.0	81.7	14.0	38.1	59.8	32.2	53.9	72.6	124.6	33.1	119.5	24.8	38.7	43.3	35.9	49.8	37.3	113.0	74.3	60.5	48.9	35.3	28.8	65.6	89.8	117.6	280.7	32.9	66.2	56.1	14.3	3.7	3.8	5.6	6.2	5.9	7.5	6.9	7.3	4.6	7.3	5.9	7.4	12.9	7.4	5.5	12.4	8.3	5.3	7.2	12.7	13.9	11.8	16.0	3.3	8.1	8.5	4.9	8.6	8.4	15.0	55.1	73.7	60.7	128.0	56.5	91.5	55.1	90.6	62.0	113.6	69.2	42.2	101.9	47.1	80.3	104.8	125.1	28.9	70.0	84.7	29.4	52.2	7.4	90.9	59.0	65.5	85.3	60.4	228.9	43.8	35.1	81.8	44.4	134.5	25.3	65.9	48.5	66.6	37.8	116.1	167.6	72.6	59.0	91.1	75.0	9.0	64.0	69.4	65.8	184.6	55.8	47.6	41.2	241.8	269.4	66.7	43.7	73.0	75.1	144.9	41.5	67.3	83.9	81.6	46.0	76.3	54.4	12.9	61.4	88.1	111.8	27.5	66.0	41.6	84.6	83.6
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box transcription factor 3"	O15119	12	114670255-114684175	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 178.4"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 613.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	13.3	178.4	5.1	2.5	4.7	0.0	34.1	3.9	5.7	37.5	2.9	7.4	37.6	32.8	44.6	2.8	24.0	4.5	13.2	3.8	14.9	12.9	31.3	32.8	1.4	4.6	4.4	44.2	2.9	1.0	12.9	41.3	4.8	80.4	3.7	1.8	18.9	53.2	10.4	14.9	30.3	10.0	3.8	7.0	6.0	1.3	6.6	1.3	50.0	16.5	1.7	53.9	34.2	3.7	2.4	18.2	0.0	0.0	26.1	35.6	40.1	103.0	97.3	39.0	38.3	16.3	4.4	0.0	1.6	18.0	2.4	4.7	8.4	3.6	47.7	0.0	12.3	0.0	4.8	48.1	8.4	0.0	0.0	16.0	2.4	13.1	26.8	0.0	0.5	0.0	3.8	0.0	3.4	1.6	0.0	0.5	0.2	53.0	5.4	0.0	0.0	2.6	0.0	129.3	6.6	19.4	14.6	6.6	3.6	44.6	5.1	0.2	0.0	11.9	7.7	6.8	33.9	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.7	3.9	5.7	3.8	14.9	4.6	4.4	4.8	3.8	6.6	3.7	48.9	0.0	1.9	0.3	1.8	9.8	85.2	5.8	7.4	14.3	110.3	80.5	12.5	0.0	1.1	35.0	4.2	60.7	0.7	12.0	0.0	0.6	1.5	3.3	144.7	38.6	4.9	0.0	0.0	0.0	7.0	41.3	5.1	3.8	0.0	3.9	1.1	40.2	6.1	1.7	0.0	23.9	4.1	0.9	4.6	2.8	5.3	2.9	3.6	14.0	0.0	1.9	0.0	0.0	0.0	0.3	22.4	6.0	0.0	72.4	37.9	0.1	0.4	2.0	39.5	27.2	58.2	0.1	3.8	3.2	9.8	613.9	2.0	112.0	12.1	69.1
TBX6		ENSG00000149922	"T-box transcription factor 6"	O95947	16	30085793-30091924	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4;Urothelial cells: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 4.1;RT4: 6.9;U-266/70: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.1	1.9	3.3	0.7	3.9	0.5	1.4	3.1	4.1	3.6	2.4	1.8	1.2	1.1	0.7	13.8	1.7	0.8	1.3	3.1	3.3	3.2	1.9	1.4	0.8	3.7	3.7	1.8	4.3	1.0	1.9	0.3	3.9	3.3	0.3	1.7	2.8	1.2	2.0	3.5	1.7	0.4	3.4	2.4	4.7	1.8	4.0	0.9	2.8	0.5	1.5	4.4	7.3	4.5	0.6	0.7	0.4	0.7	1.0	0.5	0.5	0.2	0.1	0.0	0.1	0.9	2.9	1.2	1.5	0.1	0.1	0.8	0.3	0.5	0.0	0.9	0.5	0.8	1.4	0.7	0.7	0.1	1.7	0.2	0.8	0.1	0.3	0.6	0.4	2.7	0.1	2.9	0.0	2.6	0.5	0.3	0.6	4.1	0.6	2.0	0.0	2.1	0.0	6.9	0.9	1.3	0.1	0.5	0.8	0.3	1.2	1.2	0.3	0.8	0.4	0.4	0.0	6.9	1.7	0.2	0.8	1.2	0.2	1.2	0.6	0.2	0.4	0.6	0.3	0.3	0.2	0.3	0.3	1.2	0.4	0.4	0.8	0.3	0.2	0.2	0.5	0.3	3.3	3.9	3.1	4.1	3.1	3.3	3.7	3.7	3.9	3.4	4.0	4.5	1.0	0.0	0.6	2.6	2.7	1.1	3.4	4.2	4.0	1.9	1.2	1.4	0.5	0.0	3.7	1.8	8.4	1.7	0.5	0.7	0.0	0.8	0.1	0.9	0.8	1.9	0.0	3.2	0.2	1.2	0.8	1.1	3.6	1.0	0.0	1.1	0.4	0.4	0.5	0.0	0.4	1.2	4.1	0.8	1.7	0.2	0.9	1.2	0.0	1.9	0.6	1.9	2.1	0.0	2.7	3.5	1.6	1.2	0.2	3.2	2.6	0.7	3.0	3.4	6.6	2.7	1.4	2.6	3.9	6.2	1.0	2.3	0.8	0.5	1.6	9.4
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1"	"Group enriched"	"Detected in all"	22	"dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA031257, HPA031258, HPA031259"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		890000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"		"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.2	10.8	5.3	28.1	5.1	24.8	8.2	5.4	5.9	5.4	5.8	10.1	10.3	3.2	2.0	5.4	4.9	21.2	3.3	4.5	6.8	5.8	12.8	23.9	12.4	10.0	6.6	2.9	3.6	2.9	2.3	14.2	8.8	6.4	13.0	1.6	9.0	4.0	1.0	1.3	11.9	12.6	8.9	57.8	11.2	1.4	9.7	15.1	1.8	3.3	8.3	13.9	2.1	14.7	0.2	5.4	0.3	0.1	1.2	3.9	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	12.1	0.0	0.3	0.0	0.0	0.0	0.0	9.4	0.7	17.8	0.0	0.0	1.6	6.2	15.3	2.1	0.0	0.0	0.9	1.1	2.3	0.1	0.6	2.2	0.6	0.2	2.4	76.7	0.2	18.0	23.7	2.6	0.0	1.2	21.0	0.0	0.2	1.1	0.2	0.0	0.8	0.0	0.0	14.4	2.0	0.6	0.2	1.4	1.0	4.6	0.9	0.3	0.4	60.8	1.7	324.3	322.4	333.6	7.3	466.0	11.9	8.3	13.5	3.7	129.0	4.5	2.3	1.3	271.1	11.9	423.1	22.6	13.9	216.7	5.3	5.1	5.4	5.9	4.5	6.8	10.0	6.6	8.8	8.9	9.7	14.7	3.9	3.2	10.8	8.1	9.9	0.4	1.2	0.5	2.8	1.0	3.0	3.0	1.1	5.7	1.7	1.8	6.2	0.6	16.4	0.8	9.8	5.2	0.4	1.0	0.6	5.0	1.8	12.8	1.2	9.5	0.5	2.9	7.1	3.8	71.0	0.5	16.8	8.6	88.8	3.3	1.8	1.9	12.2	193.6	19.5	0.7	0.3	132.9	3.6	191.1	63.7	4.9	26.8	3.0	5.9	4.4	7.9	0.0	16.4	5.8	0.2	6.3	1.0	4.1	19.7	1.3	1.7	0.5	0.7	26.2	0.6	0.5	13.4	0.3	2.7	1.2
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779746-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 103.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 84.6"	"Group enriched"	"Detected in many"	47	"NK-cells: 39.2;T-cells: 84.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	14.3	2.3	0.1	14.2	0.7	5.1	27.7	0.2	0.5	9.5	1.4	16.5	12.1	11.4	5.1	21.6	11.8	25.2	8.5	0.2	0.3	6.9	2.9	14.4	22.0	3.1	0.5	6.5	103.0	19.8	6.9	1.5	1.6	17.2	15.2	0.5	46.5	7.8	3.1	13.7	14.5	5.8	1.4	11.1	24.9	5.9	0.7	11.5	12.5	1.2	24.5	18.4	13.9	0.7	9.2	1.5	0.0	0.0	1.6	0.0	12.2	0.0	0.2	0.0	0.0	6.5	19.1	6.0	0.4	0.1	0.2	1.0	9.0	9.0	0.0	0.1	4.7	0.0	2.4	0.0	0.0	0.0	0.0	0.2	9.3	0.0	0.5	0.0	0.0	0.5	0.1	4.7	0.0	16.3	0.0	0.0	1.3	63.8	0.0	0.1	0.0	0.0	4.3	37.3	7.0	0.0	0.8	43.9	0.0	2.4	22.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	38.4	0.1	84.6	0.7	42.0	49.0	0.1	0.2	33.6	28.7	1.3	39.2	0.2	0.2	14.8	22.5	0.1	0.7	0.2	0.5	0.2	0.3	3.1	0.5	1.6	1.4	0.7	0.7	10.0	41.7	79.6	0.7	12.4	53.4	31.3	38.1	33.6	0.4	94.3	34.3	0.9	48.6	73.1	25.8	0.0	1.0	39.6	50.2	1.9	73.3	18.5	51.4	13.6	10.9	31.8	1.7	14.4	211.7	3.6	21.2	124.4	118.6	7.0	2.5	5.7	0.6	0.3	0.0	1.8	58.5	48.8	3.0	12.7	32.7	56.8	4.0	60.5	10.3	3.1	3.5	53.5	0.5	1.6	91.7	40.0	12.8	15.6	49.1	13.6	7.5	81.0	0.1	0.0	13.2	4.5	33.8	11.8	45.4	82.5	5.5	111.0	0.1	51.7	86.8
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204"	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	11.6	8.6	6.6	15.5	6.1	28.1	12.0	7.9	10.0	11.6	4.1	12.2	10.5	13.3	6.4	13.1	12.5	7.3	10.0	6.4	5.2	9.2	6.7	10.5	17.7	5.5	5.1	13.7	9.0	8.9	11.3	12.4	5.5	10.4	10.8	16.9	10.9	8.4	23.7	13.2	11.2	10.4	4.2	12.0	11.7	10.3	5.3	19.0	10.0	13.6	17.1	12.4	12.3	8.8	51.7	37.6	56.6	39.1	15.2	23.9	72.0	38.0	30.6	42.1	48.8	61.0	53.8	89.0	27.8	31.7	30.0	44.6	70.1	48.1	63.8	52.6	56.3	58.1	43.4	37.4	16.3	87.8	43.5	16.8	28.0	40.8	43.7	23.0	37.3	73.5	69.4	31.9	32.2	36.8	76.8	49.3	56.3	29.2	42.3	74.3	66.9	58.7	26.3	40.2	36.8	45.6	42.7	44.6	28.3	34.1	47.5	43.9	42.2	36.3	42.1	31.0	60.2	32.4	38.3	116.8	33.7	73.0	41.3	0.9	5.7	2.5	5.7	8.8	6.9	5.5	6.6	7.2	9.7	5.5	6.8	6.8	0.5	9.5	11.9	4.9	6.5	5.3	6.6	6.1	7.9	10.0	6.4	5.2	5.5	5.1	5.5	4.2	5.3	8.8	35.8	54.5	49.8	50.6	49.5	44.9	49.5	35.6	54.7	54.1	32.4	33.1	35.6	14.3	39.9	23.9	62.6	48.6	42.9	20.8	1.9	31.9	3.2	23.8	62.1	37.6	28.2	77.0	100.9	33.4	60.7	43.3	56.6	44.1	37.9	57.4	21.4	17.6	30.8	35.3	91.0	36.9	24.4	28.9	30.4	7.4	28.6	36.5	24.9	42.2	33.1	20.8	35.0	73.4	76.3	44.9	25.3	24.5	61.9	60.7	13.8	7.6	33.8	38.4	19.7	53.2	51.1	73.3	60.8	66.6	45.7	43.9	42.8	43.7	47.5	62.2
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0;Inhibitory neurons: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: AB_2675313"	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	7.1	6.5	4.2	1.7	3.1	1.6	7.5	0.0	2.9	10.2	0.0	9.1	1.6	9.0	0.2	16.3	6.9	1.0	4.9	3.7	2.4	7.6	7.4	7.1	1.6	0.9	1.0	7.6	8.2	1.2	7.4	1.2	1.1	6.9	1.3	0.9	9.9	1.0	5.7	14.3	10.0	1.4	0.0	7.3	8.0	15.3	1.8	2.3	9.6	1.3	1.6	7.8	11.0	2.1	6.6	2.3	3.2	2.1	1.0	2.1	5.5	4.2	2.8	2.1	3.5	5.0	2.5	10.9	3.6	1.1	3.1	5.4	3.9	3.3	1.2	8.5	3.9	3.4	2.2	1.6	1.5	6.0	4.7	1.2	2.9	3.0	3.0	0.9	1.0	3.1	4.1	3.9	1.6	3.0	9.4	1.8	3.4	2.2	3.1	4.7	2.0	5.7	0.5	5.2	6.2	2.0	2.7	2.0	2.7	2.0	1.2	4.8	3.9	3.8	8.9	3.9	1.9	7.0	6.2	4.5	2.3	4.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.1	0.0	2.9	3.7	2.4	0.9	1.0	1.1	0.0	1.8	2.1	10.0	0.0	9.6	23.5	9.1	22.6	11.3	19.4	12.0	25.1	11.5	6.9	7.3	17.2	10.1	9.2	18.8	6.3	11.0	16.6	0.0	10.8	127.0	14.2	9.9	9.3	16.8	9.9	54.0	7.5	5.5	8.1	10.7	22.2	1.3	10.0	8.9	12.6	6.2	10.1	63.5	13.8	12.2	12.4	13.3	36.2	12.5	9.4	7.2	22.5	12.0	5.6	6.2	29.7	55.0	13.3	13.5	6.4	8.7	20.9	13.0	6.0	13.4	12.6	6.6	5.8	8.5	19.1	13.4	19.5	22.9	4.5	13.0	4.3	17.9	14.6
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0"	"Low region specificity"	"Detected in many"							HPA028375	Approved					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	41.4	0.2	0.0	0.0	2.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	6.4	0.1	0.5	2.8	0.5	1.2	2.5	2.0	0.0	0.3	1.8	0.0	0.6	0.0	0.3	0.0	0.0	0.2	1.4	0.2	3.5	1.8	0.0	0.5	0.2	7.5	0.9	0.0	0.8	0.0	0.1	2.5	0.0	0.6	0.0	0.5	0.5	0.0	26.2	9.5	0.2	0.3	21.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.7	0.0	0.0	3.2	1.4	22.6	29.1	1.0	2.4	5.2	0.8	0.1	0.0	0.1
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866489	"Plasma proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"salivary gland: 776.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 52.0;Cholangiocytes: 62.9;Club cells: 94.9;Exocrine glandular cells: 372.3;Glandular and luminal cells: 84.7;Urothelial cells: 61.0"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	149	"basophil: 2374.2"	"Lineage enriched"	"Detected in many"	1592	"granulocytes: 2374.2"	"Cell line enriched"	"Detected in some"	21	"OE19: 159.0"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		4000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"				"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.1	0.2	0.0	0.7	0.0	190.7	5.4	0.0	0.2	31.7	0.0	0.2	9.6	3.1	0.0	23.0	1.4	173.8	0.1	0.0	0.0	0.1	0.4	1.4	0.3	0.0	0.0	0.0	5.3	108.5	0.2	0.5	0.0	1.2	0.8	0.0	776.3	0.0	0.1	0.9	1.0	0.0	0.0	4.5	76.3	0.3	0.0	1.3	0.0	0.0	0.9	15.5	10.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	2.2	0.0	0.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	159.0	7.5	0.0	0.2	0.0	1.5	0.0	0.0	0.0	7.3	0.0	1.6	0.0	0.0	3.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	2374.2	0.0	0.3	0.0	0.1	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.4	15.9	0.1	1.4	0.1	0.3	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	19.2	52.0	0.0	0.0	21.9	4.2	0.2	62.9	94.9	23.9	0.0	0.0	0.5	0.3	0.0	23.7	0.4	2.2	8.0	0.4	0.0	0.0	0.1	372.3	0.0	0.1	3.6	84.7	0.0	0.0	0.0	0.3	0.2	0.0	0.1	1.2	12.2	0.6	0.3	0.0	0.3	0.9	0.0	0.0	0.7	0.0	0.0	0.5	0.0	46.5	0.0	0.0	0.1	5.0	0.0	0.3	11.7	0.0	0.0	0.0	2.5	0.0	0.0	6.0	0.1	0.0	0.5	0.0	0.2	61.0
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357629-150400308	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	13.0	10.8	44.2	14.5	43.8	13.9	13.5	43.4	104.8	15.4	40.1	20.4	7.3	16.7	7.4	16.6	14.8	6.5	14.9	43.3	42.2	14.8	9.5	12.5	18.3	44.3	43.6	15.7	14.8	9.9	11.0	10.3	44.5	15.7	8.7	9.6	12.1	10.8	21.4	16.6	15.3	11.7	40.9	18.8	14.3	14.5	45.0	20.5	12.6	9.7	16.2	19.7	14.1	48.9	78.3	85.0	42.7	80.3	16.2	21.4	115.1	59.4	24.5	81.1	80.9	211.5	59.3	113.1	53.2	21.9	92.6	88.2	93.0	107.4	57.4	59.9	100.8	54.9	55.6	80.8	17.4	91.5	40.7	18.0	24.8	94.1	71.4	20.1	36.1	59.2	80.2	32.8	27.7	70.7	100.4	67.4	128.8	35.3	80.4	91.4	67.4	64.8	19.5	54.3	58.0	59.7	68.5	111.0	55.2	66.8	49.7	36.1	35.0	59.3	73.5	71.8	113.4	40.6	55.6	123.4	46.6	78.2	54.1	1.6	2.2	1.1	3.8	2.0	4.8	4.6	3.6	3.8	2.1	4.2	3.1	3.4	1.4	8.3	2.1	2.2	2.4	3.2	44.2	43.8	43.4	104.8	43.3	42.2	44.3	43.6	44.5	40.9	45.0	48.9	18.5	9.6	22.4	7.8	41.7	40.0	21.1	14.5	15.9	25.4	13.6	12.7	17.9	11.5	10.4	11.0	41.7	21.7	29.7	24.0	5.9	19.6	8.4	13.2	17.3	24.4	18.7	23.3	7.4	23.4	41.0	20.1	18.3	17.6	23.5	29.1	12.8	10.0	28.8	21.9	6.4	18.8	16.2	27.9	53.3	6.8	19.0	40.0	12.4	2.8	27.8	9.7	33.0	3.0	8.9	15.2	8.4	15.8	26.1	37.8	15.1	6.3	10.1	25.6	26.3	20.3	17.7	27.6	34.1	22.7	39.1	8.9	26.3	20.1	32.0	19.3
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789703	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 586.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavorable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	114.1	92.9	110.5	90.8	117.0	181.5	106.0	119.2	179.4	88.3	118.1	103.6	71.7	97.8	84.9	103.8	93.2	69.2	114.8	117.4	120.5	105.8	98.0	89.5	105.7	117.3	118.1	122.8	96.0	98.2	57.0	83.5	120.9	81.0	108.1	76.8	92.2	72.6	171.8	101.3	84.7	99.7	122.2	82.2	92.3	174.0	118.0	98.2	77.1	125.4	128.3	101.9	84.8	141.4	236.3	284.1	296.9	405.2	260.5	209.0	456.5	344.6	170.4	423.3	320.9	571.4	170.9	579.5	233.4	275.2	494.7	339.0	793.5	350.2	601.5	301.8	380.6	606.7	292.7	545.9	199.1	496.7	308.9	204.3	215.0	417.5	392.0	241.8	381.7	498.8	856.1	262.8	399.4	201.5	620.2	590.4	321.6	305.0	310.3	447.8	219.7	474.7	345.1	170.7	365.8	237.7	323.3	452.3	161.3	386.2	212.6	464.2	264.0	203.9	310.0	467.0	717.6	238.5	531.7	638.4	293.8	571.8	329.1	92.0	73.8	93.6	84.3	99.1	110.1	95.8	92.6	91.7	90.4	74.2	94.4	92.4	34.4	101.1	131.5	55.4	105.0	114.2	110.5	117.0	119.2	179.4	117.4	120.5	117.3	118.1	120.9	122.2	118.0	141.4	122.4	51.3	38.8	12.4	95.4	171.7	304.4	153.2	75.7	39.1	95.2	75.2	68.2	81.5	108.6	27.6	29.2	161.7	80.7	93.8	115.4	191.9	427.4	113.4	140.1	106.4	104.4	119.5	22.8	134.6	288.7	98.6	64.2	122.2	104.6	109.8	51.0	43.8	118.7	30.3	24.3	84.6	120.1	65.7	134.4	586.4	86.0	91.5	108.5	22.5	99.9	73.3	77.2	18.1	25.3	151.1	75.7	92.2	93.0	235.2	84.0	152.3	127.1	53.1	72.3	111.9	247.2	307.3	237.1	93.4	148.0	240.4	116.6	100.6	133.8	249.3
TDRD1	CT41.1	ENSG00000095627	"Tudor domain containing 1"	Q9BXT4	10	114179270-114232304	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 17.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.1;Late spermatids: 5.3;Spermatocytes: 25.6;Spermatogonia: 25.5"	"Cancer enriched"	"Detected in some"	5	"prostate cancer: 4.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 51.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037729	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA037729: AB_10670527"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.15e-2)"		"unprognostic (6.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.60e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.68e-1)"	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.2	2.0	0.2	0.0	0.2	0.3	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	17.5	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.3	0.3	0.2	0.1	0.3	0.4	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.9	3.5	2.8	0.0	0.0	0.0	0.3	2.7	0.3	0.0	0.2	7.1	0.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.0	0.0	0.3	5.3	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.7	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.5	0.5	25.6	25.5	0.0	0.0	0.1	0.1	0.7	0.1	0.0
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 224.8;Spermatocytes: 82.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.7	3.3	3.0	5.1	0.2	0.8	7.8	5.4	1.2	1.8	1.0	0.7	0.9	3.4	0.6	0.8	2.2	1.6	4.1	2.6	2.1	2.5	0.7	4.0	3.9	3.2	1.1	1.1	0.4	3.0	1.6	4.1	2.0	0.3	8.9	1.3	0.6	2.3	3.5	0.7	0.4	2.7	2.5	0.8	30.3	3.7	0.0	5.6	0.1	0.1	1.1	0.8	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.1	7.8	5.4	4.1	2.6	3.9	3.2	4.1	2.7	3.7	4.0	0.8	9.6	0.5	3.9	0.0	0.5	0.4	0.1	1.2	11.3	0.4	0.8	3.4	0.0	3.8	7.3	6.2	0.0	0.0	0.0	1.9	0.3	224.8	1.0	2.2	1.2	4.2	0.0	13.6	0.2	0.0	1.0	0.0	0.7	0.0	0.4	0.7	3.0	0.1	5.0	14.7	0.3	0.0	0.3	0.0	33.8	4.1	0.5	3.6	6.5	0.0	1.1	0.0	14.6	17.8	0.1	0.0	4.5	0.0	0.6	0.4	0.4	0.2	7.5	13.1	3.0	0.5	82.7	34.7	0.0	1.6	0.0	0.0	1.4	0.5	0.2
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.1;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Late spermatids: 60.4;Spermatocytes: 43.2;Spermatogonia: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.5	3.1	5.1	4.4	5.1	1.4	4.5	7.9	5.8	2.1	2.3	3.2	2.2	1.6	6.0	1.8	2.0	1.9	3.5	5.5	6.0	4.0	3.6	4.4	5.9	7.4	5.8	0.9	3.0	30.1	4.6	3.6	8.2	6.0	4.0	9.6	7.0	5.7	4.2	2.2	2.2	2.8	4.7	6.3	2.9	22.2	6.0	10.0	7.3	4.9	5.4	2.6	1.7	5.4	10.8	9.4	8.1	18.8	0.5	0.8	7.7	1.8	1.0	5.6	3.7	6.1	15.1	12.6	16.3	0.7	13.1	6.4	11.9	12.5	8.5	32.5	8.3	12.6	2.6	4.2	3.4	2.4	2.0	1.0	4.8	11.8	5.0	1.6	5.9	24.3	9.8	11.0	1.8	29.3	20.3	3.9	6.2	16.0	16.0	2.5	5.0	26.2	9.6	5.3	11.7	19.2	13.2	10.5	12.4	14.5	22.9	9.4	2.4	2.6	4.6	8.2	10.2	22.2	29.4	14.1	12.0	10.1	3.6	5.2	0.9	2.0	8.2	4.3	12.5	3.9	7.6	8.3	2.0	3.6	5.6	6.9	0.6	7.7	8.0	5.3	9.9	4.1	5.1	5.1	7.9	5.8	5.5	6.0	7.4	5.8	8.2	4.7	6.0	5.4	1.0	3.2	8.3	2.3	2.5	0.3	2.1	1.5	0.6	3.4	4.4	1.1	4.8	0.0	2.2	7.3	4.2	2.7	2.4	0.7	1.9	3.1	23.9	1.5	0.2	1.7	0.0	2.1	6.6	2.5	2.9	0.5	2.6	1.2	4.5	4.6	1.4	1.6	5.4	6.7	5.9	0.9	2.0	2.6	1.3	60.4	0.3	2.3	1.8	2.8	2.2	1.8	0.0	6.0	8.3	1.9	0.3	2.2	1.9	1.6	0.1	1.4	1.4	3.5	13.1	1.9	1.0	43.2	27.4	0.4	0.1	2.5	2.9	0.6	0.9	1.8
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269838	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 20.7;eosinophil: 13.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	0.9	1.7	0.1	2.1	0.2	6.1	1.4	0.1	0.4	1.2	1.0	1.3	1.6	1.1	4.2	3.4	1.9	1.1	1.3	0.0	0.4	1.1	2.5	2.0	3.1	1.1	0.3	0.4	0.8	1.2	0.6	1.1	1.1	0.5	1.3	1.8	2.3	1.0	0.6	3.6	1.5	0.8	0.3	1.7	1.1	1.2	0.7	2.0	1.3	0.5	3.3	1.0	1.6	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	2.2	1.3	2.7	0.0	2.2	1.9	2.0	0.0	0.1	0.6	1.1	0.0	1.8	0.1	0.8	13.5	1.0	0.1	0.0	2.2	20.3	0.0	0.3	1.7	0.0	1.4	0.0	0.6	7.5	0.5	4.1	1.0	1.3	4.9	0.4	1.4	0.8	3.1	2.7	0.0	3.4	0.9	0.0	0.2	0.6	0.3	0.5	1.1	0.7	4.2	0.0	0.0	0.0	2.8	0.0	20.3	15.4	2.6	0.0	3.0	0.1	20.7	0.6	13.3	0.1	0.7	0.3	1.0	0.2	0.5	1.5	0.7	0.5	0.5	0.5	3.6	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.0	0.4	1.1	0.3	1.1	0.3	0.7	0.2	0.6	6.4	6.8	0.7	6.8	2.5	1.7	0.2	2.8	0.9	1.7	1.1	1.8	7.2	2.6	0.0	0.0	1.5	3.3	2.1	0.0	1.7	6.4	13.9	1.5	1.2	3.0	12.6	6.7	1.1	0.1	0.8	0.0	25.1	19.6	0.7	0.0	2.9	4.9	0.0	1.6	1.4	4.1	4.6	1.8	2.6	0.0	5.9	1.8	10.3	1.7	6.6	0.0	0.5	0.2	1.0	0.6	0.4	15.4	1.3	3.0	2.0	0.2	3.1	6.6	1.8	0.8	0.7	1.4	9.8	3.0	0.8	3.4	0.3	2.1	1.6
TEF	KIAA1655	ENSG00000167074	"TEF transcription factor, PAR bZIP family member"	Q10587	22	41367333-41399326	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (6.75e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.12e-2)"	"unprognostic (7.17e-3)"	"prognostic favorable (3.47e-11)"	"unprognostic (7.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.55e-2)"	15.6	14.3	29.7	5.2	41.8	0.8	12.8	43.7	51.4	14.9	5.4	20.1	8.0	16.0	10.3	14.9	18.7	8.2	32.4	40.3	13.9	19.1	18.6	14.4	7.8	21.3	16.9	35.5	23.2	46.8	21.2	4.4	21.8	13.9	10.9	25.5	29.0	24.1	44.0	25.6	11.0	9.6	9.2	11.0	13.3	12.1	21.8	9.1	28.7	39.9	8.3	15.1	11.9	35.5	4.5	2.1	6.9	8.0	11.4	6.7	5.0	3.3	16.1	4.6	6.4	5.9	11.1	12.7	4.7	16.6	6.8	9.5	2.1	7.8	5.3	5.8	3.2	2.6	4.3	3.8	5.0	3.9	3.6	9.4	12.5	6.0	14.0	11.1	3.2	2.7	1.2	10.7	2.3	10.5	3.3	2.8	4.0	31.1	5.2	9.3	4.4	5.5	3.5	9.9	6.5	3.3	15.0	3.3	6.8	5.6	5.5	4.4	4.8	12.7	13.6	5.2	5.3	11.0	8.5	8.1	12.4	3.4	13.7	0.0	0.2	0.8	0.6	0.7	0.9	0.4	0.6	0.6	0.2	0.1	0.7	0.5	0.4	0.1	0.4	0.8	0.5	0.3	29.7	41.8	43.7	51.4	40.3	13.9	21.3	16.9	21.8	9.2	21.8	35.5	9.8	16.0	9.9	21.2	1.3	6.6	3.2	4.9	12.5	41.9	4.3	6.9	13.1	20.0	3.3	18.4	8.4	4.4	0.7	18.7	11.7	3.4	11.3	1.3	5.6	7.0	7.7	0.4	14.2	6.1	0.6	13.2	3.6	1.7	4.5	6.5	6.4	33.4	1.3	32.0	15.0	6.0	8.2	4.1	4.0	23.2	17.1	1.7	5.4	1.9	2.3	27.3	2.1	9.0	17.4	3.9	4.4	25.6	1.2	3.6	11.2	5.6	5.5	13.7	6.6	19.6	9.0	3.7	5.7	6.7	8.7	1.4	1.9	9.1	4.6	2.4
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TENT4B	"PAPD5, TRF4-2, TUT3"	ENSG00000121274	"Terminal nucleotidyltransferase 4B"	Q8NDF8	16	50152911-50235310	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042968, HPA048225"	Uncertain		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Nucleoli, Plasma membrane"	"HPA042968: AB_2678244, HPA048225: AB_2680319"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	6.1	6.4	2.4	1.7	2.3	7.1	4.6	3.9	2.6	7.3	3.0	6.9	4.6	6.9	2.3	5.4	6.5	2.0	3.7	2.7	3.0	4.2	8.9	5.0	2.3	2.2	2.4	6.8	4.3	3.9	4.8	2.8	2.2	5.3	1.9	1.4	4.7	1.7	5.4	5.5	5.9	2.5	2.2	4.6	5.5	5.7	3.1	1.7	4.7	2.1	1.9	7.2	6.4	2.7	5.5	1.9	0.6	3.3	3.8	2.0	4.3	3.9	2.3	3.5	1.6	3.4	2.3	6.5	5.6	2.7	1.4	3.6	3.9	2.0	3.1	3.8	4.5	3.6	1.6	5.4	3.8	2.4	4.9	1.9	2.6	2.3	3.3	2.3	1.8	2.1	4.2	1.5	4.1	1.5	3.5	4.6	4.2	1.5	4.5	4.9	4.8	6.9	1.7	0.5	4.0	2.2	4.9	2.7	2.3	1.5	1.5	0.9	3.0	2.1	4.1	4.0	1.9	4.9	3.7	6.9	1.7	2.7	2.7	0.0	0.4	0.0	0.4	0.2	0.1	0.3	0.2	0.5	0.2	0.2	0.3	0.5	0.7	0.2	0.2	0.4	0.1	0.1	2.4	2.3	3.9	2.6	2.7	3.0	2.2	2.4	2.2	2.2	3.1	2.7	17.9	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	17.8	16.3	0.0	0.0	0.0	14.7	0.0	18.1	82.8	0.0	3.9	10.9	0.0	44.3	24.4	6.1	0.0	0.0	0.0	14.9	11.5	6.7	0.0	31.5	0.0	13.5	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	22.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	18.3	14.9	17.3	0.0	0.0
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413501	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.9;Gastric mucus-secreting cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	9.4	7.8	3.4	12.1	4.1	5.1	8.7	3.2	4.0	7.8	6.0	17.4	28.0	6.9	7.3	6.8	7.2	10.7	6.8	3.3	4.3	6.5	6.5	11.0	15.0	6.0	5.3	6.2	6.2	13.7	5.7	6.6	5.1	7.9	17.9	5.0	8.3	6.3	10.3	7.9	15.5	9.7	3.8	14.8	9.6	2.3	5.8	10.2	8.1	5.1	15.1	7.5	7.8	5.2	9.2	4.2	4.1	4.5	26.1	9.9	7.3	6.8	6.0	4.0	5.1	8.7	10.2	8.1	4.2	17.0	7.3	9.3	3.5	13.6	6.8	7.8	3.5	9.5	9.4	5.7	7.5	8.0	16.1	14.1	11.8	6.5	5.2	17.1	15.2	6.7	3.1	5.8	14.0	5.4	4.7	5.8	1.8	28.4	3.6	12.2	10.2	2.8	13.2	13.8	1.2	1.9	5.4	12.8	4.2	11.8	6.5	4.9	20.1	15.5	10.6	4.9	1.9	12.9	6.9	5.1	3.7	6.9	5.5	3.6	2.3	0.0	1.0	2.8	1.0	1.7	0.5	1.0	0.8	2.4	0.5	0.6	4.5	0.5	2.9	5.4	0.6	0.3	3.4	4.1	3.2	4.0	3.3	4.3	6.0	5.3	5.1	3.8	5.8	5.2	3.7	9.6	14.1	13.1	8.4	2.8	4.8	3.1	2.8	0.3	3.2	2.8	3.2	8.6	5.6	1.8	2.1	2.0	14.3	23.9	1.9	4.8	0.2	2.9	4.2	5.8	4.2	2.1	1.9	5.1	2.5	3.4	25.5	4.2	10.8	2.6	8.2	4.9	6.4	0.0	2.1	12.8	0.0	10.4	4.6	1.3	5.0	10.2	5.4	16.9	12.9	2.6	7.2	4.5	3.9	6.0	12.8	3.8	8.4	5.1	21.8	3.8	12.2	2.6	0.0	5.1	6.1	0.0	0.6	2.4	1.4	1.9	5.0	2.2	8.3	4.9
TESK1		ENSG00000107140	"Testis associated actin remodelling kinase 1"	Q15569	9	35605262-35610041	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	40.2	44.7	24.4	11.2	22.0	6.1	33.5	17.9	25.9	22.6	14.8	29.9	13.3	25.7	11.1	12.8	18.7	13.0	19.2	22.0	21.3	18.0	13.8	19.9	11.9	20.6	24.2	15.9	16.0	16.8	26.6	9.1	21.8	22.4	8.5	6.7	17.4	19.8	69.2	19.1	18.9	17.1	18.2	16.2	22.2	57.0	28.1	10.4	19.0	27.6	8.5	27.9	16.0	20.4	17.0	16.0	10.7	16.9	42.5	17.5	12.1	19.7	17.3	17.8	11.3	9.3	4.8	30.9	10.3	19.7	47.1	5.8	6.8	14.1	3.4	20.0	9.2	4.6	14.1	8.4	24.4	4.0	14.6	17.2	21.8	13.9	19.0	18.9	12.6	15.3	5.3	11.3	18.0	19.1	7.9	18.4	6.2	16.1	18.6	12.9	6.6	7.3	13.1	8.0	8.8	10.3	11.2	13.0	8.1	7.3	15.9	5.7	11.1	39.2	16.2	27.9	12.0	6.0	10.2	11.2	28.2	4.6	9.1	0.0	0.6	0.1	1.1	0.1	1.0	0.3	0.4	1.8	0.8	0.2	0.5	0.5	0.0	0.9	0.3	0.8	0.1	0.7	24.4	22.0	17.9	25.9	22.0	21.3	20.6	24.2	21.8	18.2	28.1	20.4	13.4	6.4	7.7	9.1	8.9	14.4	6.3	5.9	4.6	10.9	13.9	11.0	1.9	7.2	4.2	7.3	8.4	3.8	20.0	19.9	1.9	6.6	35.1	5.6	9.2	9.7	9.5	1.7	6.5	10.4	8.6	9.0	18.8	11.2	1.3	10.1	10.8	8.4	13.9	13.5	8.5	14.8	0.0	7.8	22.4	34.9	12.2	19.3	14.2	2.8	6.3	12.6	20.6	4.5	6.8	10.2	11.0	14.3	10.7	19.2	13.4	7.8	4.2	15.3	6.6	10.1	10.9	14.8	10.0	4.7	13.9	3.3	11.8	5.4	7.3	9.7
TESK2		ENSG00000070759	"Testis associated actin remodelling kinase 2"	Q96S53	1	45343883-45491163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 222.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;RT4: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	3.8	2.1	7.1	2.8	10.6	10.2	6.6	10.3	8.3	6.4	4.8	5.3	8.6	3.2	3.7	7.1	3.0	2.6	2.4	7.3	8.0	2.5	6.9	3.9	3.9	10.8	10.1	9.8	3.6	3.4	2.4	3.5	10.3	15.5	7.0	2.8	8.4	2.6	8.3	12.7	10.8	2.9	8.5	5.3	4.5	9.6	9.9	4.2	3.4	4.7	5.2	4.7	7.4	15.1	1.9	0.0	0.9	0.1	3.5	1.8	14.6	0.7	4.9	2.1	3.6	4.3	1.7	6.2	0.6	1.8	5.4	2.3	3.9	3.1	1.6	4.4	4.9	4.2	2.0	3.2	1.9	1.4	11.1	1.9	3.2	2.4	3.4	3.2	1.7	8.1	0.8	12.4	1.4	0.7	3.6	2.9	3.8	1.8	1.8	5.2	0.1	1.5	1.9	14.7	0.4	1.6	3.8	7.3	14.1	8.6	11.3	1.8	0.0	0.2	2.1	1.3	1.3	8.0	5.0	1.2	1.1	0.0	1.0	12.8	4.6	13.3	2.7	3.4	1.9	8.0	2.5	1.8	2.4	6.6	4.1	2.3	19.0	1.5	8.0	1.3	1.9	3.4	7.1	10.6	10.3	8.3	7.3	8.0	10.8	10.1	10.3	8.5	9.9	15.1	3.9	0.0	2.8	54.2	10.7	7.8	7.1	2.8	14.2	2.4	11.9	9.4	1.3	4.3	3.4	0.0	14.6	8.3	4.2	13.9	0.0	1.3	23.7	4.6	1.8	3.2	4.2	5.0	10.2	2.7	2.8	3.7	7.7	8.9	7.0	2.4	2.2	6.3	6.8	0.0	6.7	6.9	4.1	5.5	4.4	7.8	2.8	6.0	3.6	15.9	4.6	1.1	4.1	18.6	222.9	1.1	7.3	1.9	9.8	10.6	14.9	1.2	2.0	3.1	6.6	2.6	6.1	22.0	13.6	12.6	8.5	14.8	4.7	1.8	4.9	8.0
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264, ER-phagy receptor"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 374.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	34.7	73.4	43.5	23.1	46.5	22.3	35.6	48.7	51.7	39.0	53.1	41.5	39.0	34.2	41.2	41.1	44.0	39.7	41.4	43.8	47.2	67.6	65.3	29.8	33.5	47.2	45.5	31.3	54.3	88.5	26.2	29.4	46.4	45.1	34.5	20.4	58.7	46.9	34.2	69.3	37.6	26.3	46.3	40.9	46.7	111.5	45.9	29.1	48.7	29.6	26.3	35.9	34.9	48.4	36.5	65.5	11.6	59.3	116.8	56.4	23.5	31.0	72.0	50.1	50.1	35.2	84.2	51.6	21.9	44.1	84.2	34.7	32.7	61.6	23.7	42.0	51.9	49.6	40.2	47.8	104.0	31.5	53.6	74.8	96.9	56.3	57.1	45.3	36.9	39.0	26.6	87.7	51.9	42.1	50.9	73.3	12.6	59.8	72.7	24.3	15.3	98.7	79.7	50.1	16.5	26.8	37.4	101.5	48.0	15.7	49.6	66.0	27.3	49.8	20.8	53.0	41.2	61.0	71.3	26.4	61.5	65.9	50.9	99.2	110.1	69.3	119.7	115.6	120.3	98.6	122.6	113.6	104.6	102.4	100.9	103.1	23.5	76.1	115.6	92.4	159.9	139.9	43.5	46.5	48.7	51.7	43.8	47.2	47.2	45.5	46.4	46.3	45.9	48.4	63.6	35.3	21.9	12.4	36.7	34.8	46.7	123.9	45.5	33.5	69.9	68.2	24.4	65.8	68.2	99.3	58.4	142.9	52.3	70.3	62.6	83.1	57.7	44.9	31.8	54.8	32.9	24.8	6.5	75.7	88.9	41.4	29.0	48.2	16.5	45.3	38.9	63.1	105.4	42.1	9.1	56.5	118.0	48.3	45.5	61.2	51.0	47.8	65.8	8.4	56.1	62.6	89.6	7.5	12.3	59.6	76.4	48.9	36.0	45.6	137.6	126.7	49.7	55.4	26.3	30.8	30.7	374.8	111.7	46.3	35.4	76.3	61.9	110.4	86.0	49.9
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7525.8;retina: 2433.0"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000	"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	80.9	1.2	186.3	1.0	412.5	2.4	13.3	591.8	274.2	2.0	58.9	2.3	0.9	1.7	1.4	11.0	1.4	1.9	12.1	173.7	287.7	3.4	7525.8	1.9	1.3	786.9	385.4	2.1	4.6	2.2	4.4	1.3	628.2	5.4	1.2	2433.0	55.8	1.8	2.1	4.2	1.6	1.5	484.9	2.9	1.9	14.3	398.1	1.2	2.2	2.7	3.0	1.2	2.8	862.1	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	186.3	412.5	591.8	274.2	173.7	287.7	786.9	385.4	628.2	484.9	398.1	862.1	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.3;retina: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.4	0.0	0.0	0.0	0.0	8.2	3.5	0.1	0.1	0.0	0.1	0.0	0.0	33.3	3.9	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	3.9	9.0	0.0	0.0	0.0	0.6	0.2	10.2	0.0	0.0	14.8	6.4	0.7	0.0	8.6	0.0	0.0	0.6	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.1	3.9	9.0	10.2	0.6	1.1	0.2	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366535	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"stomach 1: 7973.0"	"Group enriched"	"Detected in many"	9	"Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"MCF7: 13512.4;OE19: 5337.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		950000		"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	2.3	0.3	0.0	20.3	0.0	0.0	26.7	0.0	0.0	9.7	0.0	114.7	34.8	0.2	0.0	18.3	0.9	167.2	0.6	0.0	0.0	0.9	0.8	1.3	0.2	0.0	0.0	0.2	10.7	0.0	0.2	1.1	0.0	25.0	108.4	0.0	32.4	0.7	0.2	0.1	68.4	4.8	0.0	3.1	7973.0	0.1	0.0	0.2	5.3	0.0	0.2	30.6	2.2	0.0	0.0	42.7	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	16.2	5.7	0.0	1.1	0.0	1.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13512.4	4.6	0.5	5.5	5337.9	223.4	1.7	0.0	0.2	0.0	1.4	0.3	0.2	0.0	5.0	0.0	1.3	5.0	0.1	0.0	0.0	3.5	0.1	0.0	3.6	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	18.7	0.0	6.1	5.9	0.0	0.0	432.7	197.2	0.0	564.7	12.1	35.0	0.0	0.1	3.1	601.9	0.0	245.7	0.0	1.8	0.2	3.5	430.2	0.0	0.0	821.8	3.1	5.1	12908.9	2.9	13.4	0.0	0.0	1.6	0.2	0.0	0.0	1395.6	111.9	0.0	0.0	0.0	0.0	9.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14603.3	500.9	0.0	40.6	432.4	78.0	0.0	2.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	8.9	0.0	80.0	232.6
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	13.5	13.0	12.4	16.3	13.5	62.8	12.5	15.4	13.9	11.5	12.1	12.7	12.9	12.4	10.4	14.8	13.1	12.6	16.0	12.9	12.0	13.9	19.3	14.0	24.9	12.0	11.8	12.4	16.7	13.0	10.5	14.5	11.3	12.4	12.6	13.4	11.0	10.6	41.8	20.3	13.5	13.1	11.6	17.7	11.9	26.6	13.0	20.1	16.2	21.5	24.7	14.8	10.9	14.3	22.9	26.4	22.3	24.6	34.7	20.6	21.5	26.4	34.5	41.8	39.1	19.8	16.1	44.4	16.6	33.9	27.6	32.8	32.1	26.3	30.3	32.3	30.4	27.4	16.4	20.2	31.4	63.6	33.2	25.9	34.9	40.0	30.9	22.3	32.6	22.4	37.4	38.9	28.2	28.2	29.2	33.8	21.4	32.2	21.9	43.6	34.6	38.8	24.2	22.4	16.7	24.0	31.9	22.7	32.8	21.4	18.7	27.7	31.6	35.2	56.8	22.4	25.6	29.8	41.8	86.6	27.8	24.6	26.8	68.7	28.4	50.1	37.2	31.3	35.1	37.9	33.0	35.2	26.1	42.9	30.9	28.4	44.9	36.3	44.1	16.4	44.5	33.0	12.4	13.5	15.4	13.9	12.9	12.0	12.0	11.8	11.3	11.6	13.0	14.3	11.3	9.6	9.7	11.4	17.8	16.8	11.2	13.2	22.2	9.7	7.5	6.3	3.5	17.2	12.3	12.9	8.4	17.9	20.7	14.8	13.7	15.1	67.9	12.2	9.2	13.3	16.2	20.2	7.1	20.7	14.4	7.8	9.2	12.6	8.2	11.9	13.2	10.8	13.3	15.2	7.2	11.2	6.1	6.2	7.8	12.3	11.1	10.4	7.2	4.7	12.3	7.7	19.6	6.0	6.5	25.3	8.4	9.8	18.6	7.6	11.4	9.3	14.1	6.9	0.0	10.1	10.6	43.6	19.4	14.2	16.8	19.4	17.4	11.6	10.7	10.9
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 272.3;placenta: 191.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2284.2;Hepatic stellate cells: 872.4;Syncytiotrophoblasts: 879.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 22.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.3;neutrophil: 1.3;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 386.2;HUVEC TERT2: 742.5;LHCN-M2: 459.9;TIME: 451.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	NA	NA	58100000	87000000	"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	67.5	12.6	2.6	20.5	3.4	8.2	52.3	4.9	5.8	41.5	7.4	23.3	52.5	25.7	18.5	33.3	35.6	57.6	38.5	4.1	2.2	56.3	272.3	126.7	33.3	6.8	2.5	26.5	25.0	7.1	6.1	191.2	3.9	15.7	27.4	4.5	15.0	12.8	26.8	19.8	41.8	30.7	3.7	20.7	19.2	6.9	3.6	11.1	36.2	42.8	17.7	52.9	29.8	3.2	38.9	24.7	29.3	0.8	224.3	267.7	0.7	66.0	156.3	42.7	65.1	22.6	192.6	0.7	27.3	52.7	74.7	2.1	15.9	3.6	110.3	1.9	7.6	12.3	73.8	197.3	386.2	0.9	0.4	123.1	5.1	232.8	61.9	93.4	742.5	0.7	31.2	0.7	459.9	35.4	4.6	0.7	22.9	0.8	68.8	0.3	40.2	0.3	72.9	1.4	0.3	0.5	56.7	2.1	3.5	95.8	0.7	0.2	451.4	30.6	29.0	61.4	13.5	1.1	1.7	0.4	239.4	0.6	35.4	3.3	0.2	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.2	0.5	0.2	0.2	1.3	0.5	0.1	2.7	0.1	2.3	2.6	3.4	4.9	5.8	4.1	2.2	6.8	2.5	3.9	3.7	3.6	3.2	99.2	35.3	335.5	1.3	4.4	20.8	2.9	33.5	4.6	0.6	16.1	9.1	7.0	173.0	102.5	38.6	0.0	59.5	4.8	0.5	13.7	140.0	41.5	7.3	74.2	287.1	105.0	43.1	0.7	273.1	2284.2	283.0	12.2	5.3	13.9	1.5	872.4	382.1	50.2	1.7	0.2	11.3	158.7	63.7	41.3	15.2	171.8	21.9	26.6	13.1	33.7	33.1	1.0	0.0	0.1	157.6	34.1	70.0	9.5	8.0	36.6	109.4	45.2	1.1	216.9	141.2	127.8	2.7	0.5	10.2	18.5	879.2	8.1	30.6	18.5	16.7
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	685	"thyroid gland: 9329.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 5.5;Cardiomyocytes: 3.0;Early spermatids: 2.3;Late spermatids: 2.2;Microglial cells: 1.9;Proximal tubular cells: 4.0"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HSkMC: 2.4;Karpas-707: 5.6;PC-3: 2.8;U-266/70: 2.0;U-266/84: 1.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.1"	"Low region specificity"	"Detected in some"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	NA	NA		1600000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	1.6	3.2	3.0	0.5	0.4	7.8	1.4	0.2	1.9	1.2	1.5	1.8	0.0	1.8	1.0	2.0	0.4	8.6	13.6	1.7	0.2	2.9	3.6	4.2	12.0	0.4	0.5	1.2	8.0	2.7	1.2	0.2	0.5	3.6	0.1	0.1	3.9	1.8	2.8	6.3	1.7	0.1	0.2	1.9	2.2	2.9	0.5	0.4	9329.0	0.0	0.6	0.6	1.7	0.5	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	1.7	0.6	0.0	0.5	0.0	0.7	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.2	0.1	1.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.0	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.1	3.0	0.4	0.2	1.9	1.7	0.2	0.4	0.5	0.5	0.2	0.5	0.5	0.3	0.0	0.6	0.3	0.2	0.0	5.5	0.1	0.0	0.0	0.1	0.1	3.0	0.0	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.3	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.4	0.4	0.3	0.0	0.7	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	1.9	0.7	0.3	0.0	0.5	0.1	0.1	0.0	0.4	0.1	0.5	0.0	4.0	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.0	0.6	0.0	0.2	1.1	0.0	1.2
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447284-70554193	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3;Pancreatic endocrine cells: 74.5;Urothelial cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 11.3;eosinophil: 23.8;neutrophil: 23.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"A-431: 72.5;CAPAN-2: 82.5;HBEC3-KT: 72.3;OE19: 54.6;RPTEC TERT1: 72.6;U-87 MG: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.2	0.5	9.2	5.0	16.8	1.6	6.9	15.0	12.2	6.1	5.2	10.7	8.5	1.3	2.9	25.5	6.1	14.1	0.7	10.4	11.7	13.4	4.5	3.9	4.1	21.0	15.8	0.1	7.5	3.0	0.5	1.9	18.5	2.4	7.9	7.4	6.4	1.2	0.1	12.2	10.0	1.4	16.6	5.8	8.5	2.5	13.2	1.0	8.1	0.3	9.0	10.0	12.8	27.3	72.5	11.3	0.1	0.2	0.0	0.0	0.0	11.0	0.0	0.3	0.1	0.2	82.5	0.0	43.2	0.4	11.2	37.1	0.6	72.3	0.1	0.1	1.6	0.0	1.8	6.0	0.0	0.9	0.1	0.0	29.1	0.1	27.8	3.4	0.0	5.6	0.0	0.4	0.0	2.6	0.1	1.4	1.1	54.6	22.9	0.0	0.5	19.8	72.6	27.2	0.6	0.1	5.8	0.0	0.1	0.2	9.8	0.7	0.6	0.3	4.9	0.1	15.7	0.4	0.6	0.1	69.0	2.4	25.6	11.3	0.8	23.8	1.7	0.2	4.4	0.0	1.0	1.0	1.0	0.0	0.5	0.4	23.8	0.3	0.0	0.0	0.0	0.7	9.2	16.8	15.0	12.2	10.4	11.7	21.0	15.8	18.5	16.6	13.2	27.3	0.4	6.4	2.7	0.3	0.2	16.2	12.3	16.9	10.8	1.4	9.8	12.1	2.3	24.3	21.8	25.8	0.0	0.0	2.2	19.8	1.9	37.3	21.3	8.1	0.7	1.7	1.2	0.0	0.8	10.0	0.0	0.6	13.7	10.5	5.7	0.0	0.0	3.0	3.9	0.0	3.6	6.2	12.2	3.2	2.4	1.9	0.3	4.1	0.0	6.5	18.2	7.9	2.1	59.3	36.1	74.5	9.0	0.0	0.7	16.8	21.1	6.6	20.4	0.7	0.0	0.1	1.1	0.6	0.2	12.2	24.9	0.0	1.9	0.0	5.6	63.6
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028988-136063818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 457.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.8;Kupffer cells: 292.9;Langerhans cells: 251.2;Macrophages: 198.9;Pancreatic endocrine cells: 590.1;Smooth muscle cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 77.3"	"Group enriched"	"Detected in many"	32	"classical monocyte: 252.3;intermediate monocyte: 149.1;myeloid DC: 156.9;non-classical monocyte: 121.4;plasmacytoid DC: 324.5"	"Group enriched"	"Detected in all"	46	"dendritic cells: 324.5;monocytes: 252.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2857.3;GAMG: 2417.8;HSkMC: 2675.6;hTCEpi: 1915.6;LHCN-M2: 2269.4;U-2197: 1916.3;U-87 MG: 3667.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	133.2	55.3	9.5	164.0	10.4	25.9	112.2	10.0	25.5	51.8	51.9	92.8	48.2	59.7	41.6	28.7	59.7	146.1	95.5	10.4	11.5	124.0	132.1	89.7	66.2	15.8	11.9	25.4	22.4	18.4	77.6	457.6	15.7	69.5	84.4	2.8	68.3	58.9	34.8	314.1	65.3	291.0	12.2	121.1	67.4	7.6	77.3	57.7	40.4	41.7	44.4	138.9	39.0	14.0	102.2	405.6	0.8	3.8	1104.3	354.4	1.5	295.1	42.9	209.9	125.1	186.4	1276.3	0.1	181.6	2857.3	2417.8	498.0	1.0	981.4	208.0	2.3	0.1	0.1	451.6	501.3	718.9	0.7	3.9	2675.6	1915.6	77.9	93.1	827.5	188.1	0.2	0.2	3.8	2269.4	4.8	0.7	0.7	13.1	5.1	0.9	0.4	24.3	3.4	96.7	8.8	1.3	0.7	473.7	15.5	3.9	452.8	3.7	110.9	745.6	1419.3	59.8	1916.3	1139.6	0.3	0.7	1.9	3667.3	0.9	1077.5	1.6	252.3	1.0	0.9	149.1	1.0	1.0	1.0	2.0	156.9	0.4	0.3	1.0	5.3	6.2	121.4	324.5	0.5	108.5	9.5	10.4	10.0	25.5	10.4	11.5	15.8	11.9	15.7	12.2	77.3	14.0	12.4	3.2	21.4	0.0	6.3	119.4	4.8	141.8	4.6	0.4	1.9	5.5	8.9	4.3	21.8	1.8	0.0	9.9	146.5	1.3	0.0	67.5	2.4	2.3	57.9	16.4	3.5	8.8	0.4	112.6	8.5	113.5	0.5	1.7	5.1	0.0	21.0	25.7	251.8	1.7	0.0	7.8	6.1	292.9	251.2	1.9	10.2	198.9	49.8	4.7	151.1	0.3	6.2	0.0	0.0	590.1	0.0	2.2	1.9	1.0	0.1	2.7	8.5	0.2	26.3	156.8	326.1	0.2	0.9	1.9	55.7	19.4	8.5	10.8	0.9	2.5
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.9;Hepatic stellate cells: 322.7;Leydig cells: 146.3;Skeletal myocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 35.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 16.6;T-cells: 35.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 227.2;ASC TERT1: 108.4;RT4: 57.1;U-2197: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA		50000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favorable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (1.08e-2)"	66.3	35.2	6.9	9.2	6.8	5.0	62.1	7.6	8.0	56.6	20.4	28.8	8.2	33.9	24.2	28.5	36.6	20.0	16.2	7.6	6.7	28.2	16.6	27.3	7.2	6.0	10.1	81.5	12.3	5.9	7.1	58.5	7.8	16.4	12.5	1.5	35.0	32.7	12.8	25.0	19.7	27.4	7.9	40.0	18.1	11.0	8.0	7.7	13.2	29.4	4.2	47.3	28.6	7.8	9.9	9.4	14.1	2.4	227.2	108.4	44.6	7.1	35.3	8.1	9.9	4.4	1.4	0.1	1.7	13.0	6.4	1.4	3.6	1.0	6.2	34.1	7.6	0.0	11.1	41.2	5.0	0.3	0.1	26.3	4.7	17.8	4.0	1.3	4.2	0.0	23.6	0.7	2.4	0.2	0.1	0.1	5.9	4.6	3.2	0.5	4.8	2.1	3.2	57.1	0.7	0.0	3.4	0.2	20.4	5.8	1.2	3.7	12.7	13.5	3.5	78.0	1.7	34.8	3.3	0.0	2.8	1.9	1.7	1.2	0.0	0.0	35.2	0.2	19.4	0.0	8.7	19.2	0.0	0.0	2.7	12.7	0.6	16.6	1.4	1.2	4.5	8.1	6.9	6.8	7.6	8.0	7.6	6.7	6.0	10.1	7.8	7.9	8.0	7.8	77.6	9.6	9.7	58.8	3.1	37.6	10.0	2.3	44.3	0.3	38.2	60.1	20.7	30.0	4.2	31.3	2.1	27.5	66.7	0.5	3.9	2.0	54.3	11.2	32.8	90.5	24.0	10.7	7.7	5.1	12.0	143.9	5.1	8.1	2.5	20.5	322.7	21.0	11.8	0.0	34.0	1.9	8.2	23.2	29.4	29.8	146.3	5.2	35.6	82.4	0.7	1.2	62.8	7.5	0.9	3.3	0.4	74.4	21.3	8.5	1.4	20.9	8.3	0.2	13.1	187.2	36.5	0.8	2.2	17.2	34.1	58.0	36.9	92.2	3.7	8.0
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	7.5	5.9	3.9	12.4	4.0	7.6	10.2	3.6	3.8	10.5	8.6	8.6	4.8	22.0	4.4	5.7	24.2	8.6	6.3	3.7	3.9	9.2	9.3	8.6	16.9	5.7	4.6	13.7	15.1	13.2	3.0	11.6	4.6	9.0	5.5	5.2	10.2	7.8	2.1	5.8	8.3	18.6	4.8	14.6	7.0	11.4	4.9	17.8	8.5	3.7	18.7	9.5	6.6	4.5	16.1	4.2	45.0	52.3	6.2	5.6	16.1	8.9	10.3	21.3	15.5	22.9	20.5	42.5	23.2	9.2	9.7	16.4	36.1	23.6	20.8	20.0	13.2	53.5	10.6	30.5	9.6	23.6	12.7	9.1	15.0	4.8	16.4	19.1	20.9	20.6	26.1	27.3	10.4	22.8	38.8	43.6	37.1	23.0	11.1	33.2	52.7	24.0	13.8	10.7	13.5	40.0	3.1	23.3	23.1	34.8	28.7	51.2	15.6	3.7	13.7	0.3	17.2	29.6	11.9	40.3	0.3	27.2	16.6	16.0	5.0	1.6	4.0	4.3	4.4	7.2	3.6	4.1	6.7	4.9	6.0	5.1	2.0	3.8	3.0	6.7	3.8	3.8	3.9	4.0	3.6	3.8	3.7	3.9	5.7	4.6	4.6	4.8	4.9	4.5	11.5	9.6	8.8	0.0	41.7	44.6	31.4	10.5	50.7	0.2	25.5	16.6	17.3	14.3	9.4	7.3	2.1	6.6	26.5	1.3	7.9	19.7	2.8	11.4	13.4	17.9	6.6	13.5	0.0	7.7	1.7	12.9	8.6	13.7	16.5	35.7	10.8	5.8	10.4	0.0	0.0	3.7	10.2	10.0	25.8	3.2	6.2	13.2	14.2	0.0	12.7	7.4	3.1	0.0	0.0	15.9	4.8	7.5	35.3	27.5	0.3	7.0	5.3	2.0	6.6	10.0	13.9	3.0	19.8	11.6	25.4	9.0	27.0	11.0	4.2	16.4
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 713.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	25.7	1.3	0.6	0.9	0.8	0.7	2.2	3.7	2.0	78.7	0.8	1.4	0.8	1.0	1.6	713.5	4.4	0.6	5.1	0.5	0.6	2.5	1.7	5.3	1.5	1.5	0.9	3.0	3.2	0.2	3.3	1.2	1.4	4.1	0.9	1.7	89.7	4.4	1.1	73.2	1.9	0.5	0.4	2.6	1.8	2.9	0.9	1.3	2.7	0.3	40.4	1.3	144.2	0.9	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.7	2.0	0.5	0.6	1.5	0.9	1.4	0.4	0.9	0.9	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341079	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"esophagus: 1838.1"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	295	"neutrophil: 30.3"	"Lineage enriched"	"Detected in single"	303	"granulocytes: 30.3"	"Cell line enriched"	"Detected in single"	14	"EFO-21: 5.2"									HPA004728	Approved					NA	NA		14000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.6	0.3	0.2	0.2	0.0	1.4	3.9	0.0	0.1	54.3	0.0	0.3	0.0	0.2	0.8	1838.1	1.4	2.2	0.4	0.2	0.0	0.2	0.8	0.5	0.0	0.1	0.3	0.3	1.1	0.0	1.6	0.1	0.1	0.6	0.8	0.0	229.3	0.0	0.4	83.1	0.4	0.0	0.1	0.4	2.2	2.0	0.0	0.1	0.1	0.0	142.9	0.3	31.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.9	4.0	0.1	0.1	46.2	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.3	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.2	0.5	22.5	8.2	0.0	0.0	0.1	0.3	0.2
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	377	"prostate: 434.4"	"Cell type enriched"	"Detected in some"	20	"Prostatic glandular cells: 226.6"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	1.1	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	434.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	4.2	0.7	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	5.7	0.8	0.6	0.4	0.0	0.0	0.2	0.0	0.3	1.3	0.0	1.5	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	11.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.4	0.0	226.6	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.3	0.0	0.4	1.0	0.2	0.1	0.2	2.4
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276271-43302255	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 62.0;Late spermatids: 16.7"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"EFO-21: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 16: Immune cells - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"					"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76381132	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 241.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008758, HPA077077"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA008758: AB_1855714, HPA077077: "	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	25.7	21.9	13.8	20.1	14.2	33.4	29.7	13.6	16.3	21.4	13.2	24.1	19.9	24.2	21.1	11.2	19.0	16.7	17.2	14.4	13.8	19.6	19.5	21.8	33.0	13.1	14.2	20.3	41.6	14.2	9.5	26.2	13.1	17.1	25.7	37.2	15.6	19.0	31.7	14.5	20.0	22.0	13.9	26.0	21.5	18.1	14.2	30.6	22.1	32.9	28.7	20.4	15.0	13.6	37.7	29.3	54.6	31.1	36.4	51.5	33.4	38.0	38.9	46.4	40.8	58.9	38.9	100.8	57.1	36.2	40.7	36.5	67.4	44.6	73.9	78.3	21.5	72.2	20.2	27.4	40.2	92.3	34.9	37.1	57.8	41.3	76.9	28.1	40.7	70.5	85.3	55.3	42.0	40.4	81.4	51.9	22.7	98.5	31.8	60.3	124.7	105.0	27.1	38.8	53.1	35.6	36.7	40.1	20.5	36.5	40.6	35.8	36.7	55.4	91.7	114.2	33.9	49.9	56.6	241.7	13.3	50.8	30.6	0.7	1.5	1.7	4.5	1.6	5.2	3.3	4.7	5.0	2.1	3.6	3.4	4.4	0.5	5.6	1.5	0.9	4.7	1.7	13.8	14.2	13.6	16.3	14.4	13.8	13.1	14.2	13.1	13.9	14.2	13.6	42.4	25.6	25.3	0.0	13.6	0.0	0.0	0.0	0.0	0.0	29.6	24.0	0.0	0.0	6.2	11.0	0.0	14.2	31.6	0.0	13.7	10.9	0.0	13.6	34.7	9.8	0.0	0.0	0.0	26.4	21.5	11.3	0.0	19.3	7.6	24.5	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	8.3	0.0	0.0	0.0	0.0	14.1	0.0	0.0	7.6	0.0	0.0	16.3	5.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	16.3	13.4	34.4	0.0	0.0
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71664301-71680644	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 367.4;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	16.1	26.1	5.7	9.1	7.1	14.8	4.2	11.6	9.2	4.8	3.1	4.1	5.7	6.3	17.0	6.5	4.6	8.6	5.2	5.5	6.3	5.6	4.4	4.7	7.9	6.7	6.0	8.6	3.8	3.4	11.1	6.8	6.6	4.7	5.7	11.3	4.7	4.1	5.0	5.7	4.3	4.4	6.9	5.1	6.4	18.2	5.7	5.4	4.6	5.7	7.1	28.2	4.1	10.8	3.9	4.9	11.2	8.6	8.2	7.2	5.6	6.0	5.5	5.7	4.8	5.1	5.1	2.7	4.0	4.0	6.9	6.8	10.9	3.4	7.4	11.5	6.0	7.8	8.6	8.0	7.4	4.8	3.4	5.1	15.1	5.4	12.0	11.9	9.0	13.2	5.7	5.6	7.9	1.3	3.9	4.7	5.7	7.9	8.2	5.5	3.8	13.3	7.1	6.0	7.9	12.4	6.6	3.8	5.8	7.8	7.1	5.4	4.0	5.9	2.8	5.1	4.1	6.9	9.4	6.2	3.4	5.7	3.6	1.4	2.2	2.2	3.7	3.0	6.0	4.1	5.1	3.6	3.0	4.8	8.1	5.5	1.9	6.4	3.7	1.4	5.5	2.1	5.7	7.1	11.6	9.2	5.5	6.3	6.7	6.0	6.6	6.9	5.7	10.8	15.1	0.0	11.0	11.1	36.2	19.6	27.7	13.7	20.5	11.5	9.9	13.6	12.4	4.3	7.9	3.7	4.2	4.0	24.4	8.1	9.8	7.7	367.4	12.2	13.5	10.6	5.4	3.4	14.8	5.4	7.3	47.1	12.8	20.2	58.3	9.4	6.1	4.3	12.3	13.5	20.8	8.1	2.0	11.3	93.2	183.7	11.5	75.2	78.2	5.6	9.9	10.2	9.2	14.1	24.3	7.0	9.4	5.7	44.3	16.7	15.6	19.2	10.5	7.5	0.0	22.2	64.1	26.1	7.2	44.8	29.5	3.0	20.0	6.7	9.5	25.7
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		21000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	52.9	7.9	5.5	14.8	15.4	0.0	36.2	10.9	7.7	63.1	0.2	20.4	2.5	50.0	0.7	12.0	34.7	50.4	44.2	6.5	13.1	8.3	8.2	19.8	3.3	17.1	18.2	33.2	5.6	1.7	9.5	2.2	21.4	9.7	2.4	0.1	8.2	2.5	3.4	41.1	9.2	21.3	11.3	3.3	5.4	2.3	15.0	0.6	17.0	1.8	1.2	29.1	30.8	19.3	0.2	0.0	2.5	1.1	250.2	200.3	0.0	76.8	88.6	96.3	117.8	0.4	0.0	0.1	0.1	76.1	0.2	0.1	2.4	3.2	22.5	0.0	0.0	0.0	0.0	0.0	73.1	0.3	0.0	113.2	0.0	127.2	0.0	0.2	0.0	0.0	0.0	0.1	3.7	0.0	0.1	1.7	16.3	0.0	0.6	0.0	0.1	1.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.0	46.1	0.4	107.6	9.3	0.1	0.7	0.0	30.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	15.4	10.9	7.7	6.5	13.1	17.1	18.2	21.4	11.3	15.0	19.3	3.5	6.4	0.0	6.8	0.0	86.8	1.6	0.1	1.8	0.4	2.2	1.8	5.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	3.1	71.1	4.6	0.0	0.0	1.2	0.0	0.0	127.7	1.1	1.4	0.0	0.0	15.4	0.0	0.3	0.0	1.7	0.0	0.0	0.0	69.8	0.3	8.1	1.2	56.9	6.5	0.0	0.2	0.0	40.7	55.8	0.5	0.0	16.1	0.0	1.9	0.0	4.4	0.0	0.2	0.0	1.0	33.7	0.0	0.4	1.2	42.3	0.1	2.1	5.5	0.0	0.9
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	29	"Early spermatids: 297.1;Late spermatids: 1075.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9400000	"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	16.7	9.3	4.5	8.9	5.1	9.1	16.3	3.0	5.3	24.9	7.9	25.0	5.4	33.6	21.0	14.1	24.4	16.7	23.2	4.9	5.4	16.4	14.5	15.6	5.7	4.8	6.7	24.9	19.1	10.8	15.9	8.8	4.5	20.0	10.7	4.7	13.3	15.5	5.8	18.8	14.1	28.6	3.3	11.0	14.5	14.9	6.4	4.4	23.6	8.0	6.2	18.8	19.4	4.2	3.3	7.8	28.3	28.9	15.1	17.5	1.7	13.3	19.6	6.1	10.9	1.0	24.0	2.2	14.7	29.4	1.8	7.9	0.8	5.0	4.5	5.3	1.9	1.9	9.8	1.1	16.3	1.6	3.9	30.3	17.2	8.9	12.2	76.2	11.0	4.9	1.7	4.6	5.5	12.0	1.3	3.0	6.5	6.9	3.9	26.2	1.2	5.3	12.7	8.2	41.7	23.8	3.4	6.5	6.8	40.7	19.1	4.1	8.5	20.1	4.6	3.8	4.7	11.1	1.4	0.5	18.2	1.7	1.7	0.0	1.6	0.6	0.6	0.8	0.4	0.5	0.9	0.7	1.3	0.2	1.0	0.3	0.7	0.3	0.2	0.2	1.7	0.8	4.5	5.1	3.0	5.3	4.9	5.4	4.8	6.7	4.5	3.3	6.4	4.2	4.0	0.0	14.3	7.2	1.4	7.9	2.6	3.1	4.6	2.5	6.6	6.1	1.7	5.7	2.8	0.0	0.0	1.7	3.5	3.3	1.9	4.9	297.1	5.3	10.3	5.6	4.8	0.8	11.2	2.5	1.8	22.6	5.6	5.0	0.0	7.5	2.9	5.4	9.9	8.4	6.3	4.3	6.1	3.8	8.6	1075.2	23.3	3.7	10.6	0.0	1.9	1.5	1.0	0.0	3.2	3.7	2.9	10.1	1.4	2.3	2.7	3.8	2.6	3.7	0.0	11.8	8.1	20.8	4.8	3.7	5.3	1.4	2.2	2.4	3.4	2.2
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 216.7;heart muscle: 167.9;smooth muscle: 251.4;tongue: 214.6"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	216.7	1.2	15.4	5.2	19.6	10.6	26.8	13.8	13.0	2.1	5.0	58.1	2.2	26.8	1.6	6.0	2.5	10.4	167.9	12.2	24.5	0.7	0.3	1.3	1.1	22.3	25.3	4.1	22.8	35.7	14.3	0.2	19.9	9.0	8.7	7.5	46.5	5.7	77.2	2.9	3.3	251.4	21.7	0.3	8.6	8.7	28.0	3.6	27.0	214.6	4.0	3.5	5.8	20.0	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	19.6	13.8	13.0	12.2	24.5	22.3	25.3	19.9	21.7	28.0	20.0	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	6.0	5.2	8.7	8.1	9.7	7.5	5.8	10.0	12.2	5.5	9.8	6.6	6.3	4.7	4.5	6.5	4.1	4.6	4.6	8.8	8.8	7.5	9.9	4.6	12.3	9.4	9.0	4.7	3.9	6.7	3.7	6.4	9.9	5.1	5.5	5.8	6.9	4.1	6.2	6.3	5.9	5.7	8.8	6.3	5.3	16.8	9.5	12.8	4.7	6.2	11.6	9.5	3.8	10.7	27.0	15.8	32.4	26.1	20.8	15.4	40.2	15.4	14.5	29.8	31.1	30.8	16.1	37.2	11.9	20.0	46.0	17.1	43.0	24.4	36.9	12.3	19.1	22.2	18.4	21.0	16.0	50.5	20.2	10.6	14.4	33.3	21.8	13.6	33.3	34.5	52.3	17.4	27.3	20.5	38.1	29.6	31.5	34.2	21.1	53.3	30.3	33.4	17.2	26.1	21.2	16.6	39.0	19.9	25.3	36.7	14.0	37.1	16.6	26.6	29.9	21.8	48.3	15.9	26.4	54.7	22.2	36.0	22.8	13.4	7.3	6.4	9.8	10.7	14.8	13.3	11.7	12.4	11.9	11.5	13.5	13.4	0.7	11.2	9.4	7.2	12.8	6.6	8.7	9.7	10.0	12.2	8.8	8.8	9.4	9.0	9.9	8.8	9.5	10.7	20.4	19.2	11.7	48.3	21.0	12.9	15.6	16.8	23.9	30.8	13.1	14.1	9.6	2.8	17.9	11.0	20.9	24.7	23.2	6.0	15.6	16.5	67.1	15.0	23.6	16.7	9.5	21.0	45.3	8.2	16.7	19.9	9.2	21.9	27.3	32.4	8.2	10.3	16.1	28.6	51.6	8.7	10.2	6.9	11.1	11.6	19.3	15.0	3.6	32.8	14.3	12.9	10.3	41.7	74.6	12.7	7.0	17.0	15.6	16.7	9.2	10.2	10.5	27.6	6.6	21.6	22.9	73.4	30.5	13.8	9.1	18.7	22.3	17.7	13.4	12.9
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	22.8	26.1	26.2	22.7	28.2	25.1	26.3	29.0	43.8	28.6	33.3	28.5	23.0	27.1	38.1	26.3	26.6	19.6	21.0	25.9	28.1	22.5	26.0	27.3	32.7	27.9	26.8	32.1	27.8	23.9	21.8	23.4	28.8	26.8	22.8	34.9	22.4	19.2	23.5	29.6	28.1	22.6	26.3	30.8	24.1	15.1	28.0	38.2	26.0	17.7	27.4	24.6	25.8	30.5	59.6	48.6	61.1	66.1	44.0	42.0	32.8	39.6	38.9	42.8	56.9	34.3	59.4	60.5	44.3	43.6	41.2	44.1	74.6	29.6	72.3	58.1	67.5	84.8	69.1	46.8	40.8	99.5	58.0	83.5	36.1	49.1	56.2	37.3	40.2	90.6	129.3	53.5	43.9	62.6	86.0	96.3	34.0	79.7	47.5	86.3	38.2	50.0	67.6	66.4	46.9	41.5	111.0	30.2	39.3	48.6	30.3	60.0	41.8	38.4	19.8	55.2	67.8	37.1	58.0	51.7	34.3	86.8	43.2	9.8	8.3	9.2	11.1	10.9	12.9	10.7	12.1	12.1	7.9	11.5	13.1	12.6	4.7	11.0	12.2	13.3	10.2	7.9	26.2	28.2	29.0	43.8	25.9	28.1	27.9	26.8	28.8	26.3	28.0	30.5	65.8	137.8	151.4	68.2	81.2	83.4	67.7	69.3	80.8	67.5	45.3	45.3	53.6	20.0	89.0	64.4	158.4	42.3	69.5	65.9	11.7	55.0	5.7	54.9	102.4	68.4	67.5	88.5	64.8	50.9	36.4	68.2	46.9	70.8	80.4	90.4	59.6	37.9	38.9	53.8	72.7	55.9	46.8	44.6	58.1	9.0	93.2	61.9	30.2	75.9	82.4	41.2	69.0	96.5	119.9	47.3	36.3	91.4	66.4	76.2	55.1	28.9	77.5	108.9	124.9	81.0	98.1	69.0	35.8	55.7	77.0	43.6	76.2	84.2	57.9	73.8
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785503-2815807	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 136.6;Paneth cells: 160.6;Proximal enterocytes: 312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		2000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	13.4	19.6	31.8	11.8	31.6	19.6	15.3	29.8	48.4	15.3	25.4	21.3	22.6	18.7	6.3	31.0	17.6	3.3	38.0	33.2	28.7	22.7	73.0	13.7	11.6	33.7	31.7	18.8	17.5	6.0	32.0	7.8	30.7	37.6	7.0	9.3	15.7	5.2	40.6	20.0	21.5	6.1	26.9	23.0	16.1	70.2	28.6	13.8	17.9	11.0	8.3	18.7	15.9	30.4	91.4	66.3	25.1	54.6	12.8	12.5	89.9	55.4	20.4	53.8	43.4	78.4	28.3	81.3	26.4	21.7	37.7	72.4	37.8	45.6	22.5	0.3	79.7	28.9	75.9	94.4	13.7	56.3	43.1	13.9	16.0	44.8	20.0	15.5	31.0	54.0	68.2	38.7	23.1	70.5	63.1	105.0	74.7	27.2	90.2	51.7	33.8	77.5	22.8	51.9	68.5	54.6	48.5	42.9	27.6	13.1	41.8	53.8	35.5	41.2	35.5	88.6	95.4	67.1	60.7	55.7	46.0	93.3	50.1	9.3	2.5	1.2	3.7	2.9	3.0	3.8	2.7	5.2	3.6	5.3	3.4	3.0	1.0	3.0	6.0	7.0	7.6	2.5	31.8	31.6	29.8	48.4	33.2	28.7	33.7	31.7	30.7	26.9	28.6	30.4	5.1	3.2	10.6	15.0	12.0	6.8	10.3	15.6	11.4	20.3	12.6	10.8	9.0	5.7	9.7	11.0	35.5	27.6	8.7	136.6	9.8	18.7	17.6	11.1	8.3	7.4	40.8	13.7	12.1	15.1	55.9	11.1	9.2	10.1	5.7	23.1	7.1	85.9	23.0	6.7	10.5	59.9	6.1	9.8	6.0	23.4	11.5	9.1	3.6	3.7	8.3	13.5	4.1	4.0	7.1	21.3	160.6	6.0	17.2	16.6	312.2	10.8	9.7	32.4	13.1	10.6	15.0	55.6	19.2	13.4	5.8	33.8	8.0	15.9	48.2	8.4
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224432-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		59000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	41.9	40.6	24.0	45.9	24.7	44.6	43.7	28.5	26.3	36.6	31.2	40.2	33.9	39.5	34.9	40.6	39.3	29.6	47.2	24.3	26.2	32.3	45.8	37.4	57.1	25.6	24.6	45.3	35.6	52.0	30.0	40.1	26.7	50.4	38.7	40.9	38.8	31.3	115.3	38.2	35.1	42.1	24.1	48.0	37.8	34.3	25.0	63.1	46.0	64.0	60.8	37.1	36.2	28.1	100.7	63.9	110.1	94.9	88.0	69.7	90.9	104.6	107.4	107.2	109.8	74.7	91.5	187.5	38.5	113.8	73.8	89.1	125.2	106.9	131.3	97.4	70.1	157.7	94.3	85.6	94.6	157.2	102.5	105.7	65.7	107.1	86.7	75.2	118.4	107.5	127.8	93.5	77.6	57.8	180.4	92.7	130.5	64.2	50.4	163.6	133.4	99.4	77.0	125.4	69.6	83.9	117.5	77.0	92.7	108.7	73.1	69.3	122.4	89.2	100.4	82.5	111.6	56.7	80.7	162.4	82.2	109.2	92.7	85.8	36.9	64.7	51.5	43.9	46.0	53.6	43.9	46.5	42.4	61.0	46.4	43.1	80.8	51.2	48.6	46.7	40.7	47.3	24.0	24.7	28.5	26.3	24.3	26.2	25.6	24.6	26.7	24.1	25.0	28.1	101.0	115.4	101.7	32.3	136.1	56.7	94.5	126.9	78.0	98.0	76.4	65.5	113.7	75.8	106.2	47.8	31.3	150.7	151.9	64.3	97.8	155.7	9.7	92.1	114.7	96.2	72.4	114.9	65.6	104.1	147.2	98.3	58.6	106.0	92.9	120.5	80.7	78.8	101.6	87.5	63.2	70.1	89.5	77.1	71.7	12.0	80.2	89.9	72.9	53.4	155.5	129.4	196.7	47.7	53.4	111.5	61.9	83.5	119.7	125.2	51.6	76.0	87.6	93.2	92.1	114.6	116.5	145.9	118.4	89.6	68.5	144.1	129.0	141.0	87.1	86.4
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	90.6	16.4	97.9	78.6	114.8	0.2	25.6	12.9	286.8	78.9	0.0	35.4	10.2	58.6	27.8	29.4	23.1	101.0	12.9	135.4	73.3	142.2	7.4	21.6	40.4	83.6	37.0	9.2	14.8	39.4	18.1	62.0	60.8	15.5	41.8	25.3	8.5	47.0	3.4	13.9	14.5	304.7	35.4	21.9	17.4	11.4	43.6	73.2	37.9	8.3	35.6	216.7	21.7	108.7	0.7	3.9	108.5	0.1	461.3	331.5	0.3	738.4	832.5	263.6	289.3	0.2	0.2	0.4	0.1	1330.6	121.9	0.9	4.3	1.1	200.7	65.1	0.0	41.5	14.4	0.0	142.7	0.0	0.2	247.5	0.0	335.6	11.6	355.2	0.3	22.6	0.0	0.6	206.5	0.1	0.6	0.1	173.9	0.0	1.4	0.5	50.7	0.3	0.1	0.2	18.1	47.9	0.1	0.4	0.2	32.9	1.0	2.1	0.0	368.6	120.9	107.3	110.1	0.3	19.7	0.4	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.9	114.8	12.9	286.8	135.4	73.3	83.6	37.0	60.8	35.4	43.6	108.7	68.2	0.0	1.8	17.3	2.1	17.7	0.3	1.7	0.0	27.2	1.6	40.0	0.9	0.0	0.0	9.2	0.0	1.9	0.2	0.0	21.5	0.9	1.0	5.1	141.6	69.2	0.0	0.0	116.0	0.0	2.6	201.9	1.5	3.2	1.3	0.0	17.5	0.1	4.0	32.0	104.1	0.0	0.0	0.0	25.0	2.7	96.3	2.7	17.8	21.5	0.0	108.1	0.0	64.3	22.7	0.4	0.0	77.5	0.1	0.3	0.0	199.9	0.0	27.5	32.9	9.3	226.6	0.3	0.6	0.2	17.6	4.0	4.5	6.2	0.0	0.6
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300982-43323108	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 2.1;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"granulocytes: 2.1;NK-cells: 2.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		87000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	47.0	10.1	16.6	8.1	14.8	0.9	37.8	14.6	16.9	14.0	10.1	11.2	5.2	20.4	5.3	6.5	16.0	13.3	34.2	13.1	14.2	19.8	6.7	35.3	10.1	16.4	16.5	7.5	4.2	3.2	8.0	48.6	16.8	10.8	3.1	0.4	7.4	6.5	14.0	7.9	11.0	14.1	13.9	19.9	8.8	3.0	21.1	2.1	24.2	20.7	2.9	15.1	11.8	14.8	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	106.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	41.9	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.7	238.4	0.0	0.0	0.0	0.0	0.0	0.0	20.4	1.3	0.0	0.1	8.1	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	210.0	1.2	0.4	0.0	0.2	0.0	0.2	0.4	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	16.6	14.8	14.6	16.9	13.1	14.2	16.4	16.5	16.8	13.9	21.1	14.8	130.8	0.0	4.2	0.0	0.4	2.2	0.6	0.0	1.2	0.3	1.0	0.9	4.9	1.5	1.8	0.0	0.0	0.3	0.7	0.9	0.0	0.0	2.0	0.1	0.4	108.8	0.0	2.5	0.4	0.2	0.1	3.1	0.0	0.4	20.3	0.1	128.8	1.3	0.5	0.0	0.2	0.1	0.0	5.6	3.1	2.5	2.1	1.1	1.8	29.0	0.1	0.1	1.0	1.0	1.1	0.0	0.0	0.7	0.1	0.7	0.1	0.9	3.6	0.9	0.0	2.2	2.2	0.9	0.7	0.5	1.4	0.3	2.3	0.5	0.2	0.7
TIMD4	TIM4	ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919292-156963226	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 55.3;testis: 144.0"	"Group enriched"	"Detected in some"	23	"Early spermatids: 1336.2;Late spermatids: 1946.7"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.6;naive CD8 T-cell: 1.6;T-reg: 4.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.0"	"Group enriched"	"Detected in some"	18	"U-266/70: 96.7;U-266/84: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015625, CAB026027"	Approved		Approved	"Plasma membrane"		NA	NA		32000000	"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	14.9	0.4	0.4	6.9	0.3	16.1	0.4	0.3	1.4	0.1	1.8	1.1	0.4	0.0	1.3	0.1	0.1	1.3	0.7	0.5	0.4	3.4	16.3	1.6	55.3	0.5	0.4	0.0	0.2	0.1	0.0	5.0	0.5	0.3	0.8	0.0	0.2	0.0	0.1	0.3	1.7	1.0	0.3	8.0	0.2	144.0	0.5	22.4	1.1	0.0	17.4	4.8	0.1	0.5	0.1	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	96.7	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.3	2.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	4.0	0.7	0.4	0.3	0.3	1.4	0.5	0.4	0.5	0.4	0.5	0.3	0.5	0.5	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.4	5.9	0.1	1336.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.1	0.5	0.0	0.0	0.0	0.7	0.3	46.4	0.0	0.3	0.0	0.0	69.4	1.9	1946.7	14.9	1.9	0.0	2.8	0.0	0.0	1.0	0.0	0.3	0.0	0.0	10.9	6.5	0.0	0.0	0.8	0.0	0.0	13.1	0.0	0.1	16.6	8.1	0.0	0.0	0.3	1.7	0.1	0.1	0.0
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943667	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA		9100	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	15.2	25.1	16.1	11.2	15.2	8.4	13.0	15.9	22.8	20.2	16.3	27.6	16.9	18.3	7.0	20.9	13.9	6.8	52.3	15.8	15.4	20.0	34.6	10.7	11.1	15.4	15.2	16.2	17.6	13.5	14.4	8.3	15.6	17.5	8.2	4.2	14.0	11.6	62.1	15.7	14.3	10.2	16.6	19.4	20.8	11.0	17.6	7.7	13.8	49.2	8.1	20.1	15.3	16.2	64.5	37.2	24.4	52.0	28.6	28.6	33.3	34.9	26.6	43.8	39.6	82.5	18.1	98.5	45.5	27.5	37.3	46.6	75.7	38.4	21.7	45.5	98.7	53.6	31.4	70.1	72.4	66.3	21.9	31.6	60.1	37.0	53.5	19.4	30.4	53.3	97.2	55.7	20.7	58.5	59.2	53.7	61.3	61.8	116.8	60.4	35.6	68.8	24.9	42.0	46.2	28.3	39.0	50.5	112.8	19.3	29.7	64.4	19.6	30.1	40.2	69.7	72.5	70.4	84.8	99.5	24.2	92.7	48.6	14.3	12.9	4.1	11.3	14.1	10.4	8.6	11.0	10.9	16.4	7.9	9.9	10.6	1.1	10.3	8.7	12.5	9.8	9.5	16.1	15.2	15.9	22.8	15.8	15.4	15.4	15.2	15.6	16.6	17.6	16.2	20.0	35.3	16.4	13.7	31.8	27.9	33.7	41.9	14.2	53.0	43.8	37.6	36.1	32.9	21.5	29.5	41.7	38.5	25.6	48.4	66.5	47.8	11.7	24.8	42.1	22.2	40.1	28.2	13.5	42.9	43.2	25.4	19.4	31.6	33.0	26.4	20.3	62.2	34.9	52.2	13.9	45.5	26.4	21.7	11.1	13.7	36.7	17.2	21.4	1.9	22.9	23.5	44.3	11.1	10.9	42.1	29.0	29.3	25.8	31.8	45.9	75.1	12.4	63.6	32.9	25.0	33.7	38.7	33.9	18.7	19.9	32.6	20.2	29.5	64.6	30.9
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582408-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 2277.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 2325.3;Hepatic stellate cells: 2681.5;Langerhans cells: 2307.7;Leydig cells: 1776.0;Macrophages: 1705.0;Peritubular cells: 1561.7;Smooth muscle cells: 2043.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3225.4;ASC TERT1: 4323.2;fHDF/TERT166: 2762.5;HSkMC: 2960.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	127000000	520000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	1043.9	895.8	110.6	1713.4	110.5	122.2	253.0	114.1	329.6	630.5	160.0	228.0	68.3	342.1	237.4	130.8	570.2	1220.1	995.3	113.5	119.9	469.6	458.6	1221.2	150.4	132.9	125.2	820.8	170.1	224.1	510.7	589.3	130.1	749.1	204.0	25.9	518.6	412.7	61.8	132.4	180.0	741.1	118.9	239.9	208.9	267.7	286.5	80.3	340.0	78.9	119.7	2277.2	303.3	115.6	194.7	295.9	150.4	1850.9	3225.4	4323.2	36.4	2079.0	1728.4	632.5	514.0	118.9	360.1	1.8	269.6	2762.5	355.3	187.2	82.9	896.0	394.8	387.0	193.8	204.1	191.7	174.9	2097.2	136.6	2440.9	2960.8	227.7	1951.9	410.1	743.6	292.1	0.7	315.8	142.9	1088.6	343.1	2.5	518.0	166.8	229.8	647.9	2.5	318.3	173.8	1038.8	120.4	2.5	8.6	1243.6	8.2	276.9	277.6	15.3	257.6	284.8	943.7	1012.1	1108.3	206.3	58.8	135.0	7.4	2688.9	322.6	634.2	331.9	488.4	8.3	139.4	853.2	137.8	21.9	224.6	122.9	511.4	10.1	73.0	65.4	504.5	88.4	817.9	15.0	104.0	431.4	110.6	110.5	114.1	329.6	113.5	119.9	132.9	125.2	130.1	118.9	286.5	115.6	145.9	109.0	170.1	6.2	57.5	231.2	591.5	937.3	132.6	25.4	147.8	133.2	22.5	374.6	355.5	132.4	0.0	25.2	59.3	53.6	0.0	538.6	21.6	34.7	511.9	772.1	277.2	102.7	0.4	411.3	280.1	2325.3	53.5	66.7	491.4	163.7	2681.5	345.1	329.7	0.0	0.4	73.0	297.0	741.4	2307.7	86.9	1776.0	1705.0	512.3	6.5	289.0	141.7	73.2	8.5	0.6	802.1	42.4	1561.7	257.4	741.4	1.1	12.9	109.1	8.4	690.2	304.1	2043.5	52.8	10.6	25.8	174.7	45.0	126.5	231.9	50.5	513.7
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153068-12158912	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 177.7;breast: 119.6"	"Cell type enriched"	"Detected in many"	10	"Adipocytes: 363.9"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6"	"Region enhanced"	"Detected in all"		"cerebellum: 106.1"	"Region enriched"	"Detected in all"	9	"cerebellum: 47.7"						"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	177.7	8.3	7.7	3.9	8.4	0.6	119.6	49.6	7.2	9.3	3.9	12.1	1.4	8.1	1.0	2.9	6.8	4.4	31.0	6.8	8.8	2.8	1.1	6.6	0.6	13.7	8.6	3.8	4.0	1.4	12.3	9.9	11.7	5.5	4.3	1.0	8.9	2.3	16.7	7.7	11.0	4.4	11.3	3.4	9.2	0.7	7.1	2.0	23.1	30.1	0.1	9.8	8.7	11.6	0.7	24.2	0.7	0.0	212.9	53.0	26.4	0.8	8.9	1.0	1.3	0.5	0.1	0.0	2.2	0.9	0.8	0.9	0.0	0.8	0.4	1.0	0.0	0.0	12.7	0.9	33.2	0.0	0.1	91.9	2.2	5.8	0.2	1.6	0.0	0.0	0.5	17.3	0.2	0.6	0.0	0.0	50.7	0.0	6.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	5.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	53.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.4	49.6	7.2	6.8	8.8	13.7	8.6	11.7	11.3	7.1	11.6	363.9	0.0	0.0	0.0	0.4	0.1	1.3	0.3	0.6	0.4	12.4	2.8	7.0	0.0	0.2	0.0	0.0	0.4	1.4	1.3	0.0	0.6	1.6	0.2	2.1	33.6	6.6	5.3	0.1	2.6	2.7	15.7	0.0	0.0	0.0	0.2	22.5	0.0	3.4	0.0	0.2	2.8	0.0	1.2	0.3	7.5	12.2	0.8	3.6	0.0	0.0	0.7	0.0	9.0	0.1	4.6	4.8	2.6	0.0	4.2	2.7	0.5	5.5	0.0	32.9	3.1	29.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	2.0	2.2
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69274615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 237.5"	"Low region specificity"	"Detected in all"							"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	44.4	14.9	35.1	11.6	45.3	12.0	30.2	44.5	42.6	16.9	25.7	39.0	54.4	19.8	13.1	45.8	23.8	24.4	35.8	38.0	45.4	44.7	64.8	47.6	9.7	52.6	39.9	37.0	21.9	57.9	5.3	18.4	52.6	24.8	35.1	122.0	37.1	21.9	14.1	35.0	49.6	16.1	55.0	5.7	58.3	32.1	39.9	32.5	44.9	15.1	23.1	55.3	22.3	66.3	237.5	6.4	24.4	25.8	92.9	90.3	108.5	37.3	26.7	54.9	29.0	31.8	106.6	33.0	37.0	20.3	31.4	158.3	33.2	79.3	75.9	115.3	20.7	34.5	22.5	165.2	28.9	13.8	59.1	71.3	65.2	43.1	32.4	19.6	143.6	9.9	19.7	24.7	34.3	36.0	5.5	2.3	49.5	194.5	50.0	23.1	26.9	2.9	192.0	194.2	8.3	14.9	13.3	111.2	3.4	55.7	37.0	7.9	196.3	44.3	48.3	32.4	38.6	23.0	5.2	0.9	48.0	19.6	16.1	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.8	0.1	35.1	45.3	44.5	42.6	38.0	45.4	52.6	39.9	52.6	55.0	39.9	66.3	2.9	44.8	22.8	76.4	2.3	65.1	79.1	26.3	4.6	212.4	4.6	1.3	38.5	40.0	33.1	3.7	35.5	27.9	2.7	74.4	0.0	32.5	3.5	7.1	1.7	36.4	11.5	10.5	10.1	24.3	25.6	15.5	64.2	9.9	5.7	0.2	27.5	104.9	5.6	18.5	13.4	45.0	36.7	14.6	28.9	6.7	29.2	8.2	28.4	22.5	9.0	111.1	1.0	21.6	82.5	44.2	65.8	13.9	5.2	115.4	73.4	1.9	51.3	267.6	0.0	4.9	13.1	19.6	18.0	40.6	64.1	43.2	3.2	0.2	50.3	244.5
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174091-78187233	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 34.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"white matter: 3.6"	"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	3.7	2.7	2.5	20.4	3.4	77.9	5.9	3.6	3.4	5.9	1.3	24.4	18.0	3.0	0.2	27.2	4.9	3.4	2.8	2.7	2.4	11.0	9.2	9.1	34.8	3.4	3.3	1.3	5.6	0.6	0.6	14.8	3.3	3.4	15.7	0.1	6.3	1.5	5.5	14.2	18.3	10.1	2.6	12.4	17.9	3.1	3.8	25.1	2.0	1.6	30.6	5.5	9.0	4.4	443.9	357.7	68.2	92.5	7.6	28.0	47.3	207.6	113.2	323.1	442.3	324.2	178.7	144.1	72.9	131.7	133.9	204.2	63.4	187.1	158.0	51.2	230.4	252.5	119.9	213.3	2.2	107.1	162.9	13.8	7.1	166.1	22.5	22.3	137.9	49.4	156.7	311.9	130.8	352.0	56.0	68.6	36.7	259.1	240.9	152.6	276.4	324.1	90.6	138.5	33.6	94.2	162.0	481.2	59.7	59.4	303.9	156.1	57.8	302.3	305.7	219.9	292.1	132.5	71.4	181.9	149.0	71.9	142.1	0.0	1.1	0.0	1.8	2.1	0.7	5.8	7.9	4.0	3.4	1.7	0.4	2.2	1.8	10.8	1.7	1.1	34.0	5.5	2.5	3.4	3.6	3.4	2.7	2.4	3.4	3.3	3.3	2.6	3.8	4.4	1.6	0.0	2.7	0.0	17.1	28.4	13.3	17.8	2.2	0.0	10.6	9.4	0.9	2.8	8.3	12.9	0.0	92.8	3.6	35.0	7.9	7.7	3.0	9.2	3.3	10.6	5.4	108.6	0.3	11.2	210.4	15.7	19.4	7.0	0.0	15.9	7.5	10.5	65.2	0.0	0.2	32.7	8.2	15.5	19.1	6.8	0.6	10.9	3.6	0.0	5.7	0.0	3.1	0.0	1.0	9.6	7.5	0.7	53.6	4.9	3.1	17.5	5.8	0.0	0.0	1.7	20.1	3.8	16.8	24.7	11.2	51.0	8.7	1.7	60.8	24.0
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	"Tousled like kinase 2"	Q86UE8	17	62458658-62615481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.53e-3)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.32e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.88e-1)"	"unprognostic (7.30e-2)"	19.9	16.9	7.5	21.1	14.9	36.1	11.8	19.8	12.0	12.4	9.5	21.7	20.5	22.9	8.7	23.6	13.2	20.9	22.6	9.8	17.5	15.2	12.5	16.2	25.5	18.1	14.2	21.6	18.0	16.0	9.8	17.4	14.4	16.0	14.8	43.4	16.5	11.4	32.4	23.7	20.5	16.1	10.0	21.4	18.6	52.1	12.8	23.2	30.0	21.8	17.2	19.1	10.9	25.5	40.9	36.9	62.2	66.4	20.3	26.0	36.6	44.1	34.4	51.7	46.6	39.0	35.7	79.0	22.0	29.2	45.1	27.2	45.1	19.0	48.9	42.3	36.1	54.2	33.6	39.2	36.2	57.9	33.1	22.7	25.4	34.7	41.7	31.2	25.9	44.9	54.4	36.0	28.3	89.2	82.7	22.0	39.8	24.4	30.9	55.9	81.8	25.7	24.9	40.7	66.9	90.6	37.6	25.5	57.1	52.0	43.2	51.8	34.9	71.2	66.9	32.5	50.6	40.1	54.5	72.3	29.4	29.1	38.2	2.5	1.4	4.9	1.2	1.2	1.3	2.2	2.1	1.5	1.3	2.2	1.7	2.3	2.8	3.9	1.3	1.9	2.8	0.9	7.5	14.9	19.8	12.0	9.8	17.5	18.1	14.2	14.4	10.0	12.8	25.5	27.5	32.1	26.7	33.6	22.1	22.7	14.4	9.6	9.1	62.2	17.3	14.0	27.3	11.5	11.6	14.7	83.4	11.5	29.5	19.9	11.7	10.3	107.7	28.7	34.4	22.3	18.0	23.6	37.7	10.0	12.0	19.0	10.7	36.4	20.8	27.7	13.6	10.3	12.5	28.6	37.2	16.0	14.2	18.2	19.7	173.0	21.1	22.0	17.8	37.5	15.1	22.4	15.5	45.8	67.1	15.7	21.8	17.7	24.5	21.2	14.8	7.3	27.2	84.5	6.6	30.0	21.9	81.7	38.0	18.7	21.9	15.2	21.4	30.8	15.8	21.3
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732195	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		1300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	125.7	62.7	31.1	84.7	42.1	79.2	79.4	39.3	31.1	80.0	43.1	196.2	36.5	151.8	25.3	78.0	102.9	53.2	81.2	26.2	34.9	47.3	42.3	91.8	63.1	50.8	41.9	66.0	33.1	41.6	36.7	70.4	49.7	72.6	41.4	7.7	42.5	111.4	70.9	46.7	77.9	145.4	41.5	89.7	91.8	23.3	44.9	61.1	49.0	55.8	52.7	147.7	66.3	44.6	63.4	103.8	62.7	86.9	210.8	158.7	71.4	171.2	186.8	162.9	146.4	86.3	27.4	76.5	55.5	319.0	103.0	33.3	74.2	106.9	118.3	172.8	48.0	173.0	132.1	77.4	130.6	105.8	276.2	193.4	50.2	240.1	112.7	223.7	253.4	64.7	60.2	76.0	218.5	27.8	71.5	27.8	51.3	28.4	78.8	95.0	36.6	44.8	81.4	49.8	14.1	59.6	83.7	46.3	53.4	56.5	39.3	72.6	308.5	257.8	99.6	80.0	140.6	26.2	27.6	51.7	199.9	55.9	238.4	6.0	5.9	7.3	5.4	6.1	4.4	2.6	3.1	4.1	4.3	2.3	1.4	3.1	10.0	4.1	8.1	5.4	2.3	6.9	31.1	42.1	39.3	31.1	26.2	34.9	50.8	41.9	49.7	41.5	44.9	44.6	123.2	109.0	66.9	11.4	99.8	40.1	69.4	43.5	42.7	11.7	40.3	61.3	134.1	31.5	55.7	53.3	10.4	44.3	186.3	43.8	23.5	94.3	47.2	36.0	156.9	106.8	34.1	127.0	7.7	61.9	82.6	103.9	51.0	73.0	206.6	72.0	93.9	54.7	112.4	15.2	7.6	29.0	26.4	196.9	91.0	26.4	99.4	323.4	23.2	21.5	174.1	33.0	288.4	4.5	9.1	107.7	33.2	128.6	61.4	58.4	40.6	62.8	34.3	17.6	203.8	126.5	267.9	32.0	28.5	47.4	26.6	58.8	143.8	89.4	28.9	46.4
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 38.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 153.7;Inhibitory neurons: 127.2;Microglial cells: 139.6;Oligodendrocyte precursor cells: 108.6;Oligodendrocytes: 93.6;Skeletal myocytes: 135.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.3;hTERT-HME1: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		46000000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587"	"prognostic favorable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.81e-6)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	19.0	4.1	14.2	2.2	15.6	3.8	10.4	3.2	16.9	8.0	20.2	9.3	4.7	3.7	2.1	2.1	4.3	1.9	12.1	18.3	8.2	38.4	4.8	2.4	0.5	7.6	8.2	4.6	4.7	2.4	5.5	1.2	6.2	2.3	7.3	7.7	7.8	2.1	26.1	3.6	5.1	2.9	11.2	1.3	5.5	5.4	7.0	3.1	13.0	12.2	0.5	4.1	4.2	13.8	1.8	5.6	8.0	9.4	59.3	5.6	9.0	13.7	10.8	12.4	12.2	15.1	1.9	4.8	6.2	24.0	20.5	2.4	10.3	2.2	10.8	15.2	1.0	0.6	22.8	10.1	2.0	1.6	0.4	10.3	5.6	16.6	48.9	7.1	0.5	5.7	0.6	0.2	21.0	7.5	0.7	0.6	14.2	26.3	4.1	5.8	20.3	5.8	6.5	11.6	1.9	9.3	10.6	1.1	3.5	17.1	2.9	3.6	3.9	22.2	30.0	36.3	35.6	0.3	0.9	3.1	10.1	3.4	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	15.6	3.2	16.9	18.3	8.2	7.6	8.2	6.2	11.2	7.0	13.8	11.5	0.0	3.2	50.6	1.1	2.4	1.8	0.7	1.2	18.6	16.5	10.2	41.1	5.7	0.9	27.6	37.5	1.2	0.7	39.0	11.7	3.5	4.3	10.9	14.3	9.0	2.4	37.7	153.7	3.9	29.7	21.5	40.8	17.4	0.0	9.3	3.3	12.6	4.9	48.8	127.2	20.0	6.1	6.2	3.1	5.2	11.8	5.5	0.0	139.6	0.8	11.1	1.0	108.6	93.6	3.7	21.0	15.8	0.7	1.5	14.6	35.1	0.1	48.3	0.0	135.6	12.3	6.7	24.5	3.1	1.6	1.4	1.3	25.8	37.7	1.7
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Group enriched"	"Detected in some"	53	"Daudi: 68.6;REH: 22.9;U-698: 24.7"					"Low region specificity"	"Detected in many"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.9	0.3	1.0	15.8	0.9	1.4	0.8	1.0	1.2	0.2	0.5	1.4	1.2	0.4	0.4	0.5	0.5	1.3	0.1	0.9	1.2	0.2	0.4	0.8	42.3	1.9	1.5	0.0	0.1	0.1	0.2	0.2	2.0	1.0	1.9	0.1	1.4	0.4	0.2	0.5	10.0	0.3	2.0	24.3	2.9	0.1	1.4	5.1	0.4	0.1	47.9	2.7	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.4	0.0	0.1	0.0	24.7	0.0	0.1	0.0	0.3	0.4	0.9	0.0	2.8	0.0	39.0	0.0	0.0	6.4	24.0	0.1	0.1	1.3	0.1	3.6	7.2	0.0	1.8	1.0	0.9	1.0	1.2	0.9	1.2	1.9	1.5	2.0	2.0	1.4	2.2	0.2	0.0	1.1	0.0	57.2	0.4	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.2	2.7	0.3	0.0	0.0	0.9	0.0	0.2	1.3	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.0	1.9	0.8	0.0	0.0	4.5	0.0	16.9	1.0	0.2	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1803.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2394.6;Late spermatids: 2375.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017378: AB_2669604"	"prognostic unfavorable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favorable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	333.4	364.8	332.1	276.3	361.6	315.4	416.8	347.5	376.4	413.7	528.2	493.6	475.8	252.3	640.9	406.3	431.1	360.3	215.5	301.1	358.3	1144.5	1803.2	423.3	292.3	374.4	346.9	281.2	574.2	577.5	133.7	303.1	378.7	383.2	494.4	305.0	479.8	409.3	232.1	231.4	536.1	294.7	351.9	267.8	549.8	247.9	366.9	313.0	596.4	232.3	332.3	406.2	216.5	395.2	609.6	516.6	413.3	381.1	1169.3	645.1	513.6	450.2	854.0	572.0	519.7	837.6	1703.8	380.3	746.9	882.6	598.6	648.1	363.7	659.4	619.2	551.7	390.3	606.2	367.8	414.0	707.7	701.9	959.4	657.5	1511.3	640.9	925.8	809.3	481.6	461.0	556.2	1526.5	662.5	589.5	362.1	424.2	432.1	730.6	392.2	302.8	413.0	651.0	871.5	909.9	319.0	208.7	603.5	786.1	511.2	530.7	989.4	731.6	456.8	522.6	393.9	355.8	396.9	654.2	717.8	326.8	730.9	324.3	260.8	896.4	749.8	795.5	559.9	721.8	587.8	403.6	501.1	558.5	585.5	356.6	438.9	501.8	1242.0	463.8	769.5	587.0	544.8	1813.1	332.1	361.6	347.5	376.4	301.1	358.3	374.4	346.9	378.7	351.9	366.9	395.2	428.2	477.5	455.5	80.6	314.2	261.0	535.0	836.9	222.5	245.8	526.8	337.6	221.0	571.9	766.5	544.4	114.7	406.9	366.7	995.8	131.0	927.3	1504.8	340.5	240.0	321.9	294.9	232.7	43.9	816.9	913.0	336.0	325.7	501.9	257.7	194.5	358.7	2394.6	618.9	180.0	57.3	612.6	598.1	570.6	292.8	2375.1	288.6	458.2	247.3	58.1	540.3	467.7	285.3	94.5	115.5	846.7	651.3	287.3	589.8	550.0	1585.8	809.6	874.1	154.8	170.9	191.7	361.1	458.1	214.7	272.7	235.0	891.0	315.9	372.8	552.2	654.4
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584533-123598582	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	106.0	97.1	40.7	92.6	43.5	122.1	136.1	44.2	50.8	155.6	59.5	132.5	123.7	102.5	203.3	111.9	102.3	96.1	116.5	40.5	45.3	102.8	271.1	85.4	72.7	46.6	46.6	101.5	229.1	99.3	65.0	125.4	46.9	140.5	140.7	56.9	227.6	102.2	131.0	74.8	110.5	102.1	46.0	63.2	133.8	58.5	44.2	69.1	197.6	112.1	95.2	118.6	71.4	53.8	237.7	204.9	133.4	232.2	295.7	260.2	317.5	401.2	318.5	246.8	194.2	209.9	198.9	199.3	210.7	398.7	169.4	228.1	181.8	214.5	257.3	155.2	169.3	217.3	114.0	267.6	559.5	296.9	178.1	220.5	349.2	212.6	286.0	352.7	234.7	133.5	223.1	132.9	255.6	175.1	159.8	242.7	192.9	201.0	206.6	164.8	216.8	235.7	303.9	349.1	166.5	143.1	267.3	263.6	273.7	160.0	450.2	237.2	226.2	210.1	132.4	204.9	227.5	292.3	290.7	167.6	248.3	192.9	254.2	249.7	143.2	145.9	157.0	147.5	198.8	111.8	137.0	148.4	158.6	102.5	110.3	129.4	111.1	148.5	141.3	242.5	140.1	142.2	40.7	43.5	44.2	50.8	40.5	45.3	46.6	46.6	46.9	46.0	44.2	53.8	97.1	48.1	71.5	9.1	148.8	417.4	290.3	348.5	207.1	50.1	258.8	98.0	167.2	213.1	233.2	154.5	20.9	281.5	166.9	169.6	117.4	325.1	12.2	89.2	136.5	142.0	170.7	76.3	20.0	249.6	678.6	242.7	156.5	136.8	92.6	88.4	143.5	538.8	215.8	48.8	20.3	352.4	321.4	141.7	414.3	13.9	181.4	128.5	378.8	17.8	129.8	124.1	195.7	19.6	27.5	224.9	158.5	153.4	521.0	486.3	178.1	163.0	142.1	54.7	164.3	112.6	193.5	165.9	150.6	289.8	498.8	451.9	154.3	125.0	263.9	389.2
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354750-50359521	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	29.4	34.3	23.5	12.0	24.4	11.7	28.6	24.6	26.5	25.2	26.9	29.5	23.4	33.3	17.6	27.2	26.3	15.6	31.9	23.3	23.1	28.9	32.3	26.6	11.3	25.7	24.1	25.4	29.9	32.0	20.3	22.8	24.7	30.7	12.8	6.7	29.1	20.6	27.1	42.6	27.1	17.0	23.2	24.3	31.2	17.0	24.4	10.8	34.6	18.2	9.6	28.0	25.6	24.0	26.6	31.9	20.4	33.6	56.9	45.2	26.4	40.3	59.3	50.2	38.3	24.0	30.4	12.9	33.1	53.1	46.2	27.8	24.7	32.7	14.1	23.9	42.9	19.5	27.8	32.9	79.7	21.4	27.2	68.4	41.6	41.5	30.1	43.3	38.6	15.7	21.3	21.7	37.9	24.5	14.8	33.8	36.4	17.4	49.9	7.2	16.3	28.8	38.3	24.7	22.7	48.7	24.5	26.9	34.5	17.8	22.3	22.4	40.4	45.3	22.8	48.1	42.9	32.0	19.9	7.3	41.6	23.3	30.5	52.5	27.9	41.4	26.5	25.1	17.5	18.2	17.5	21.2	23.2	18.5	18.7	18.2	37.9	27.3	24.5	26.1	24.1	23.8	23.5	24.4	24.6	26.5	23.3	23.1	25.7	24.1	24.7	23.2	24.4	24.0	24.0	16.0	12.4	4.2	14.3	30.2	19.7	26.1	29.6	17.1	25.3	24.9	7.0	25.8	15.8	11.0	6.2	58.8	15.9	39.9	3.9	44.7	1.1	17.9	17.2	22.9	15.7	18.5	2.9	26.5	42.2	31.5	20.4	16.3	11.4	23.6	26.0	19.5	36.3	18.5	3.7	26.6	28.5	11.4	12.4	1.2	29.2	15.5	10.6	2.8	20.4	25.7	13.4	6.6	4.4	35.6	32.5	25.2	18.8	33.8	43.9	26.9	14.3	15.1	26.3	19.3	26.5	17.0	8.0	17.5	34.9	92.8	14.3	36.4	24.9	25.6
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 508.1;Late spermatids: 544.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	10.3	10.6	4.4	14.0	5.2	26.2	14.1	6.2	5.5	13.3	12.3	12.5	12.9	14.8	14.1	11.5	12.9	14.1	9.2	4.3	5.3	12.6	11.0	12.0	16.0	5.3	5.1	12.6	13.6	15.6	9.9	16.5	5.2	14.5	14.2	12.5	17.4	10.3	9.8	9.7	14.8	11.6	5.1	12.8	14.0	19.4	5.4	9.6	20.9	8.3	14.8	13.5	7.9	6.1	19.5	8.3	7.8	7.9	20.7	26.4	17.5	24.6	23.6	16.1	19.2	11.9	14.1	7.4	3.9	25.1	11.3	10.5	10.2	10.8	26.4	14.3	7.6	14.4	11.0	14.1	18.5	16.3	19.7	15.6	17.0	21.4	19.3	17.1	17.5	6.0	8.8	11.8	21.2	11.1	9.5	14.1	6.8	12.3	4.4	7.8	9.9	10.4	21.0	15.4	5.4	8.3	20.2	14.2	15.4	10.4	10.7	19.4	23.1	15.8	6.7	27.9	14.8	13.2	13.6	7.2	24.1	16.6	13.1	4.8	2.4	5.1	3.1	2.0	2.1	2.6	2.8	2.7	2.1	3.1	2.9	2.6	5.3	2.7	3.4	2.4	3.1	1.6	4.4	5.2	6.2	5.5	4.3	5.3	5.3	5.1	5.2	5.1	5.4	6.1	49.2	64.1	78.9	21.9	84.7	37.5	37.6	41.7	39.3	43.4	46.2	35.8	36.9	38.6	86.4	42.3	37.5	39.6	108.4	48.8	15.6	52.4	508.1	150.4	92.8	43.1	55.6	45.0	32.2	56.2	58.7	70.0	54.6	86.2	74.7	51.7	29.3	19.7	28.4	35.3	38.4	61.6	38.7	31.8	54.4	544.8	51.0	55.1	35.6	32.8	66.7	41.5	59.8	36.2	40.9	50.6	40.8	62.1	129.3	64.8	49.4	25.1	200.5	52.1	32.9	62.8	56.8	116.2	39.3	30.6	39.5	80.6	94.5	54.5	38.5	85.7
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		1200000	"Cluster 42: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	12.2	7.4	4.8	13.6	4.9	9.7	9.4	4.2	5.3	11.4	6.7	15.4	15.5	9.9	10.3	43.4	13.2	11.8	6.9	4.2	3.7	13.5	13.7	21.7	12.8	5.0	5.2	6.9	8.0	7.3	3.4	21.9	4.9	7.5	15.4	3.6	12.8	9.8	3.4	15.0	16.0	9.6	4.9	13.7	16.9	3.4	5.8	12.6	9.6	6.4	19.5	16.4	18.7	5.0	59.4	56.0	22.3	5.8	21.6	35.9	25.8	26.1	35.5	26.7	23.8	21.8	42.4	13.9	21.7	28.0	18.9	82.3	20.7	58.5	33.9	23.8	9.1	20.6	62.6	17.9	24.0	26.6	22.1	24.2	55.7	21.5	66.2	32.9	47.7	20.0	22.3	20.6	32.6	43.9	17.8	17.7	12.4	36.3	10.3	21.0	26.7	37.8	43.5	41.5	5.4	14.6	43.5	28.9	15.6	29.7	19.7	21.0	53.8	33.9	22.6	27.8	31.3	12.5	39.5	15.6	21.7	48.0	20.4	47.6	27.9	41.4	22.7	34.7	20.2	20.4	19.8	20.3	20.6	23.8	16.7	15.7	45.5	18.8	39.3	29.0	26.0	16.7	4.8	4.9	4.2	5.3	4.2	3.7	5.0	5.2	4.9	4.9	5.8	5.0	147.9	397.4	68.2	23.8	43.5	106.9	91.4	66.3	70.6	8.3	38.8	27.3	45.8	30.0	112.7	42.3	14.6	56.1	63.3	117.4	41.1	85.8	38.9	67.5	87.6	131.6	18.6	50.9	29.4	71.6	66.3	84.1	71.9	91.3	143.0	28.8	101.4	52.9	53.9	15.2	25.5	52.0	36.7	51.7	74.1	99.3	45.1	88.4	32.0	33.7	67.5	19.2	60.8	17.1	17.1	152.6	79.0	44.4	44.1	160.3	65.5	56.5	82.2	12.6	13.1	35.2	58.0	14.5	13.9	137.0	132.1	51.3	74.3	57.4	59.9	215.9
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TMPRSS13	"MSPL, MSPS, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900641-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.7;skin 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.9;Extravillous trophoblasts: 21.2;Glandular and luminal cells: 10.9;Ionocytes: 16.2;Syncytiotrophoblasts: 19.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.8;BEWO: 29.9;MCF7: 27.0;SK-BR-3: 42.8;T-47d: 43.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.3	0.4	0.2	0.7	0.2	0.6	7.1	0.0	0.7	6.7	0.0	0.4	0.3	0.6	0.6	15.7	0.3	0.4	0.1	0.9	0.0	2.6	0.2	3.9	1.2	0.0	0.0	0.1	2.5	0.0	0.3	2.9	0.0	1.4	0.4	0.0	11.0	0.1	0.2	41.0	0.8	0.2	0.0	1.5	0.2	0.4	0.0	0.9	6.6	0.0	4.8	0.5	9.3	0.1	13.8	0.1	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	10.2	0.1	0.7	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	27.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	1.4	0.0	4.0	0.4	0.1	0.0	42.8	0.6	1.7	43.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.2	0.2	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.6	0.0	0.2	1.7	4.6	1.7	1.2	0.0	7.4	4.6	1.4	7.2	5.3	0.0	0.0	15.9	0.2	0.3	0.0	8.3	0.3	2.4	1.3	0.2	0.0	0.0	0.2	1.2	21.2	0.3	0.5	10.9	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.5	16.2	1.2	1.9	0.8	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	5.7	3.9	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.2	5.2	8.0	19.4	0.4	0.5	0.8	9.0
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.7;intestine: 43.5;urinary bladder: 74.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"	"Immune cell enriched"	"Detected in single"	7	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.2	0.0	0.1	6.1	0.1	0.8	0.3	1.8	0.3	16.6	0.3	43.5	25.4	2.1	3.2	108.7	1.0	14.3	0.2	0.1	0.0	21.1	0.2	1.4	0.2	0.1	0.0	0.1	0.3	0.0	0.2	0.1	0.2	7.8	42.9	0.4	6.5	0.2	0.2	4.1	22.4	1.5	0.0	0.2	31.4	1.1	0.2	1.1	0.2	0.1	14.9	74.6	16.7	0.3	18.5	0.1	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	103.7	0.1	3.5	0.0	0.1	39.2	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	3.4	0.3	0.0	1.3	0.3	4.5	0.1	141.6	0.0	0.1	0.1	0.2	70.6	95.9	0.1	0.1	0.0	8.4	0.1	0.2	0.5	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.8	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.0	1.7	0.0	0.4	1.1	35.2	101.7	38.1	0.0	0.0	0.0	0.7	0.0	103.5	11.0	0.0	0.2	0.0	187.9	0.0	1.5	3.0	45.3	4.6	0.8	4.2	0.0	0.2	7.3	3.0	0.5	53.5	66.4	5.7	0.0	0.0	0.1	0.2	0.0	0.2	55.3	34.6	0.3	0.3	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	52.6	67.5	0.0	2.7	17.5	55.2	2.4	69.4	0.0	0.0	0.0	4.7	0.0	0.1	119.2	6.3	0.3	0.5	0.0	71.2	258.6
TMPRSS6	"FLJ30744, MT2"	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109713	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 128.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 61.0;Hepatocytes: 99.9;Late spermatids: 143.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 4.4;thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 5.0;SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.3"							NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.1	0.2	0.2	4.4	0.2	0.4	0.1	0.6	0.1	0.0	0.6	2.2	0.1	0.8	0.2	0.5	0.9	0.0	0.2	0.2	0.1	128.4	0.7	0.3	0.2	0.4	0.1	1.3	0.0	13.0	0.7	0.2	0.2	0.5	0.1	0.0	0.0	0.0	2.2	1.0	0.0	0.0	0.2	3.6	7.7	1.3	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.2	0.1	5.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.0	8.1	0.3	0.1	0.6	0.0	0.1	0.1	0.0	0.4	0.3	1.0	0.1	0.0	1.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.1	0.6	0.2	0.2	0.2	0.4	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.3	0.5	2.8	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.2	61.0	0.0	0.0	0.3	5.3	8.0	0.1	0.0	2.6	0.0	2.6	0.0	0.0	0.0	2.5	99.9	0.1	0.0	0.1	1.5	0.0	3.2	0.0	143.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.1	0.3	0.3	0.1	0.6	0.0
TMSB10	TB10	ENSG00000034510	"Thymosin beta 10"	P63313	2	84905656-84906671	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 16401.2;Pancreatic endocrine cells: 17155.8;Paneth cells: 14859.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"													NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (3.60e-1)"	"unprognostic (4.52e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.20e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (8.49e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (4.97e-5)"	"unprognostic (3.16e-2)"	2615.3	793.1	2689.6	2321.3	2793.9	2151.3	2237.7	2475.2	3465.2	1864.6	2537.0	3101.8	1043.8	1084.7	3568.4	2055.5	934.6	1678.7	1531.9	2920.3	2746.7	1511.5	753.6	2686.1	3289.8	2618.9	2602.9	3000.9	773.5	422.1	667.6	1867.9	2664.9	930.2	2727.6	164.6	1424.6	625.1	425.8	1055.5	2153.5	1746.1	2610.3	2314.6	1225.6	726.8	2697.0	3880.9	1050.7	1001.2	2614.6	2634.4	1379.7	2735.7	4179.1	4879.7	4367.9	2450.2	5716.2	11866.8	2267.0	6207.1	8860.4	6955.7	8321.0	3926.0	6366.0	2141.4	4396.8	12906.3	4202.7	1577.1	1269.9	14656.3	7495.5	7204.8	1203.6	969.6	3115.0	3298.9	3576.8	922.9	869.4	10328.2	7273.4	8459.2	4525.9	7545.5	10791.9	1117.3	371.3	3548.2	11749.0	3349.8	3276.5	3837.4	1546.6	11202.2	4994.4	2449.8	6704.6	1757.5	10528.0	804.1	2320.1	2096.0	4162.9	3586.1	5349.0	3999.0	1082.4	1596.4	10174.1	5455.4	3862.3	5018.4	6361.9	700.7	1262.7	1992.4	9124.5	3943.6	4390.2	10530.4	18217.1	11082.3	9181.1	15870.9	5713.8	16178.6	13824.2	9777.6	19825.0	16572.3	14273.3	12095.8	2524.9	7907.9	13950.4	11840.7	24168.9	49770.5	2689.6	2793.9	2475.2	3465.2	2920.3	2746.7	2618.9	2602.9	2664.9	2610.3	2697.0	2735.7	8162.0	1189.1	1204.5	38.5	3447.0	2152.8	1551.7	6421.9	1175.8	28.5	3535.0	3219.3	162.5	1265.3	2597.6	1923.8	14.6	4025.2	4651.7	3067.5	1013.5	7642.4	124.4	5122.3	2856.2	5762.7	2298.3	1028.8	73.5	7323.5	12194.2	3030.8	2692.7	6575.0	1398.4	7787.7	3750.9	382.6	6521.7	18.5	20.9	5508.5	2370.1	9660.7	10699.9	381.9	1523.5	7008.1	3317.3	122.7	16401.2	56.4	5596.3	24.1	36.4	17155.8	14859.3	1188.2	2808.9	2936.5	10487.4	2720.9	1187.9	103.8	1012.4	1252.2	3039.8	84.8	210.0	2596.4	1958.8	1560.0	4498.5	2022.2	6534.2	3048.3
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4 X-linked"	P62328	X	12975110-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 30742.3;Langerhans cells: 57681.0;monocytes: 48133.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033806	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	6173.6	4217.0	3255.7	5088.7	3773.0	8722.4	4452.0	3539.2	4521.9	3685.7	2999.1	4327.1	1776.8	3731.3	2877.9	2069.6	2709.3	4129.3	2652.4	3319.4	3573.5	3300.1	2360.4	6225.5	10448.1	4064.7	3620.0	2592.1	1852.6	483.2	1053.7	2450.2	4203.0	2335.6	3793.9	273.3	1886.8	2441.9	816.5	1962.4	3671.2	3340.7	4219.2	7935.5	4690.0	486.8	3591.8	6377.6	1648.7	1475.0	7233.8	5168.6	2907.2	4467.6	5980.6	4886.3	9387.7	14881.1	11264.5	12247.2	23.0	3083.9	8032.6	2344.3	4005.4	1016.1	4865.3	1417.1	2900.6	9443.7	4198.0	2564.2	1411.5	2072.7	3135.4	8343.4	80.9	1771.0	2621.8	12.9	2619.8	6994.8	14038.1	5755.3	2911.9	2781.9	2412.7	5704.5	14335.9	3714.1	230.0	22.0	8424.8	2121.5	8390.5	15083.5	3384.1	2853.1	3337.3	6352.0	3321.0	5858.5	14234.5	1720.4	994.2	422.9	4461.8	207.4	583.3	6898.2	5536.5	6961.4	11607.2	3383.5	1647.5	19441.4	3123.6	4432.5	3490.6	2774.8	5183.2	2860.5	2499.5	42940.3	34738.5	50992.6	21474.2	33907.1	18326.4	18757.1	23777.1	23343.2	31253.2	16919.4	19802.1	20330.2	35862.9	18444.5	37523.3	12797.6	34088.1	86809.5	3255.7	3773.0	3539.2	4521.9	3319.4	3573.5	4064.7	3620.0	4203.0	4219.2	3591.8	4467.6	6885.8	5253.2	4939.6	35.9	6293.8	8836.3	2708.7	10515.3	296.5	332.9	2318.3	1124.2	106.9	3484.4	8003.6	6882.2	22.9	283.0	9136.2	9016.2	2181.5	17304.6	142.1	2613.2	4698.0	9239.4	1765.0	1339.1	54.3	23029.4	511.7	4800.1	2728.9	5047.4	4380.4	4646.7	6638.0	1088.5	30742.3	62.2	81.0	4883.9	14806.8	20982.2	57681.0	343.6	3932.0	17648.1	6349.9	212.7	48133.8	86.7	20882.8	19.6	102.1	25113.5	5826.4	6035.9	2541.8	3272.5	6888.7	835.1	2596.4	99.4	5732.4	1018.2	5450.7	58.2	126.3	933.7	9528.5	454.8	12719.6	3874.8	3140.6	9064.0
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019575-115118257	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 376.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.3;Basal prostatic cells: 72.1;Basal respiratory cells: 150.6;Basal squamous epithelial cells: 126.3;Prostatic glandular cells: 69.2;Smooth muscle cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 798.5;hTEC/SVTERT24-B: 634.4;U-138 MG: 526.0;U-251 MG: 484.5;U-87 MG: 711.8;WM-115: 1253.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	840000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	61.0	4.7	16.4	170.4	28.5	0.9	41.2	14.0	9.8	43.6	3.0	174.3	16.7	106.8	12.2	23.9	25.5	14.1	32.6	15.6	34.3	82.0	7.7	54.2	39.8	20.3	43.8	5.3	4.8	2.3	7.2	4.0	28.0	39.1	28.3	4.8	19.8	33.3	6.2	25.9	56.5	376.2	15.0	40.8	62.4	4.8	65.4	17.1	13.3	3.2	22.6	96.7	15.9	20.5	25.1	6.0	6.9	1.3	37.5	10.1	0.1	205.7	798.5	425.4	203.6	5.3	55.3	0.0	32.8	291.7	6.9	89.9	0.0	12.0	241.3	0.4	2.2	0.0	4.8	0.0	0.7	0.4	3.9	6.2	1.7	634.4	289.9	42.9	0.1	0.0	0.0	5.2	11.4	0.0	0.1	0.3	65.2	0.9	85.3	0.2	451.9	0.1	373.3	0.1	0.6	5.9	91.4	0.2	19.3	140.9	1.0	1.4	0.1	526.0	88.4	94.2	484.5	14.3	0.4	0.4	711.8	0.6	1253.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.4	28.5	14.0	9.8	15.6	34.3	20.3	43.8	28.0	15.0	65.4	20.5	0.7	12.8	43.5	160.3	0.4	12.1	72.1	150.6	126.3	0.1	9.3	33.3	1.4	0.0	14.8	1.8	0.0	1.1	0.3	0.0	0.0	25.8	15.4	6.7	47.8	11.1	0.0	0.0	7.0	4.5	0.6	19.0	0.0	24.9	2.5	0.5	6.1	0.0	1.2	0.0	0.9	0.0	0.0	0.6	4.7	18.4	3.4	0.9	5.4	1.9	0.1	1.3	0.0	4.0	0.8	3.9	0.0	0.4	0.3	69.2	0.0	0.3	3.5	0.2	0.0	1.3	58.9	0.4	0.2	4.8	4.5	1.0	2.6	0.1	0.1	5.8
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 68.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6"	"Group enriched"	"Detected in some"	8	"HDLM-2: 103.7;NB-4: 214.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100		"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	1.4	0.5	0.0	3.3	0.0	12.7	0.5	0.0	0.1	0.1	0.0	0.9	0.0	1.5	0.0	0.7	0.3	0.6	2.6	0.1	0.0	1.2	0.6	3.6	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	1.5	2.4	0.2	0.1	6.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.8	0.0	0.0	0.0	0.0	103.7	0.0	19.4	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	10.1	0.0	23.2	39.5	36.6	7.2	17.2	13.9	7.6	7.0	5.0	5.2	20.8	2.0	68.0	4.3	13.6	14.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	3.0	0.0	90.7	8.4	1.2	12.1	4.6	0.2	17.4	20.4	2.0	2.8	4.0	0.0	2.1	0.9	60.8	0.5	0.0	7.4	0.1	15.5	5.9	10.7	0.0	0.0	0.0	3.3	1.7	2.0	1.5	30.5	12.6	0.0	1.8	0.1	36.5	0.0	0.0	0.4	10.2	14.1	72.7	0.0	0.3	108.3	5.4	1.9	3.4	0.1	2.1	0.0	0.1	14.3	0.0	0.0	10.4	1.7	0.0	0.1	3.0	0.2	0.0	0.6	4.0	0.0	0.0	1.3	4.1	1.1	100.0	0.0	0.4	0.3
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380046	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"urinary bladder: 196.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 443.9;Fibroblasts: 302.3;Langerhans cells: 137.4;Melanocytes: 74.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	22	"neutrophil: 183.0"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 183.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.5;HHSteC: 40.3;hTEC/SVTERT24-B: 54.9;SH-SY5Y: 21.6;U-2197: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Uncertain				"Secreted to blood"	NA	NA		100000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB032719: AB_2204650, HPA050884: AB_2681261"	"unprognostic (1.31e-1)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (9.16e-5)"	15.6	0.5	1.9	27.6	2.2	7.6	11.1	1.5	2.8	9.2	1.2	6.3	0.7	2.0	0.3	2.2	2.2	19.8	15.4	1.7	2.2	0.4	1.2	11.0	0.6	1.6	2.2	0.5	1.2	0.3	0.4	1.8	1.9	3.2	2.8	0.0	3.4	0.9	1.7	2.7	2.2	7.2	1.6	3.0	4.0	10.6	2.6	1.4	1.6	2.8	0.5	196.0	1.6	2.3	0.0	0.0	0.0	0.0	3.8	15.5	0.0	2.5	67.5	2.5	12.4	0.0	0.0	0.0	0.8	1.1	1.4	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.3	0.0	40.3	0.0	0.0	19.5	0.0	54.9	3.8	2.3	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.3	0.0	15.5	0.0	1.1	0.0	0.0	0.0	0.0	21.6	0.5	0.0	0.0	0.4	0.0	0.0	0.0	2.2	4.4	44.3	0.8	0.0	0.0	0.0	4.8	0.7	3.3	0.0	8.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	183.0	0.0	2.1	0.0	0.0	2.5	1.9	2.2	1.5	2.8	1.7	2.2	1.6	2.2	1.9	1.6	2.6	2.3	4.5	3.2	1.7	1.3	1.1	64.7	0.9	11.1	0.0	0.0	1.5	1.4	2.2	0.0	1.5	0.0	0.0	0.1	0.3	0.1	0.0	2.8	443.9	2.9	2.7	7.3	0.0	0.8	0.7	0.0	0.9	302.3	0.5	10.6	2.5	0.0	1.4	0.0	1.4	0.0	0.4	0.0	0.0	6.9	137.4	38.5	2.5	49.6	74.7	1.9	5.9	0.0	0.0	13.6	7.1	1.5	0.0	0.4	1.4	3.0	0.0	0.2	0.2	0.0	0.0	40.6	45.5	10.7	1.9	1.0	53.0	1.8	6.0	0.3	0.0	3.8
TNFRSF10B	"CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB"	ENSG00000120889	"TNF receptor superfamily member 10b"	O14763	8	23020133-23069031	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 81.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023625	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023625: AB_1847860"	"unprognostic (8.43e-3)"	"unprognostic (7.43e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.52e-2)"	20.7	21.8	4.4	17.1	4.0	13.9	16.8	3.7	4.2	10.7	19.5	14.7	22.0	11.1	6.8	10.4	13.5	23.9	14.0	4.8	3.9	15.1	34.7	22.9	14.9	4.7	4.8	17.8	21.9	19.6	6.5	13.6	4.4	12.2	21.7	1.1	13.2	10.7	10.6	6.9	25.0	16.2	4.8	17.4	14.1	5.1	5.9	8.3	16.8	4.8	16.7	31.1	9.5	4.7	39.0	98.4	144.6	46.5	71.7	93.7	143.0	91.2	123.5	50.7	77.6	40.9	39.1	23.1	59.1	52.4	88.4	37.2	39.3	179.7	90.4	22.9	31.2	0.0	43.6	85.4	238.0	9.6	37.5	136.1	164.6	110.5	121.1	131.9	160.4	27.5	16.1	0.2	104.5	12.3	0.8	14.3	37.0	52.6	34.6	21.0	53.5	14.8	100.2	62.7	0.2	24.2	46.4	14.0	51.1	101.6	23.1	9.9	145.3	71.8	36.4	23.2	66.6	27.4	4.7	10.8	74.6	17.8	106.6	3.8	17.8	0.6	1.9	12.6	3.0	4.0	2.4	2.0	15.8	1.9	4.7	1.9	3.6	1.2	17.5	0.0	1.6	7.8	4.4	4.0	3.7	4.2	4.8	3.9	4.7	4.8	4.4	4.8	5.9	4.7	41.8	12.8	35.6	8.1	17.6	31.6	35.0	55.9	34.7	0.8	31.7	26.7	3.7	12.8	36.4	12.9	0.0	4.2	10.4	28.4	3.9	29.1	1.3	42.2	16.8	39.4	0.0	4.0	3.3	26.5	8.8	18.8	60.6	81.9	9.5	17.1	18.9	27.1	9.8	0.0	1.1	20.8	14.2	21.3	69.6	2.3	7.2	33.1	19.6	38.4	15.5	2.6	1.0	15.1	0.6	50.7	22.6	6.8	5.1	37.7	36.4	9.2	18.7	0.3	0.0	15.4	14.3	0.3	2.1	25.3	18.2	4.2	14.3	21.0	26.0	53.1
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118951885	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 29.9;thyroid gland: 101.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 134.3;Collecting duct cells: 73.5;Ductal cells: 32.7;Proximal tubular cells: 117.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 22.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	40	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	40	"dendritic cells: 3.9"	"Group enriched"	"Detected in many"	4	"BJ: 546.7;BJ hTERT+: 2013.0"	"Low region specificity"	"Detected in all"							CAB034939	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (3.88e-4)"	3.3	3.3	2.6	5.3	3.1	0.0	2.6	2.6	4.1	1.1	3.5	2.5	1.4	10.2	0.5	0.4	1.4	5.8	9.4	2.5	2.7	29.9	14.2	9.4	7.0	5.0	3.0	0.3	1.8	0.5	1.8	4.9	3.3	1.6	3.5	0.3	1.4	1.0	0.4	0.5	2.2	2.6	3.1	2.6	1.2	0.1	3.0	1.3	101.8	0.8	2.9	10.7	0.3	3.8	0.0	0.9	8.6	0.0	27.5	5.3	0.0	546.7	2013.0	25.9	7.2	6.3	1.1	0.0	143.7	302.4	0.0	5.6	0.0	0.0	13.2	0.1	0.0	0.0	23.1	0.0	3.6	0.0	0.0	2.9	0.0	26.7	0.0	10.9	0.3	0.0	0.0	0.0	73.8	13.6	0.0	0.1	0.9	2.6	3.3	0.0	1.0	0.0	23.6	0.0	1.3	0.0	4.8	0.2	0.0	0.3	0.0	0.1	1.2	16.9	8.6	10.1	1.2	0.6	0.0	0.1	2.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.6	3.1	2.6	4.1	2.5	2.7	5.0	3.0	3.3	3.1	3.0	3.8	2.1	3.2	0.0	7.2	0.7	2.2	0.6	1.4	0.0	0.2	134.3	4.1	3.8	22.8	1.0	73.5	0.0	0.0	0.2	2.5	9.8	32.7	0.1	0.6	1.4	7.4	9.5	0.0	0.8	1.3	0.2	9.4	0.0	1.7	0.0	0.0	4.6	2.0	0.5	0.0	0.3	9.2	2.0	0.3	3.9	0.3	0.3	1.1	0.0	0.0	8.3	1.2	0.0	3.0	0.3	9.2	0.8	0.0	0.0	6.8	1.1	117.3	0.1	0.1	0.0	0.4	4.3	0.1	0.3	0.0	1.1	0.0	0.4	0.0	2.8	0.3
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 55.3;skin 1: 107.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.8	2.9	1.8	0.9	1.7	1.7	9.9	1.8	1.9	7.0	4.2	2.4	1.8	8.6	13.4	9.4	30.5	3.4	22.1	2.0	2.5	15.7	1.1	17.2	0.7	3.3	3.2	2.7	2.8	0.9	8.5	8.4	2.6	27.4	1.9	4.7	55.3	7.6	2.4	107.5	1.3	3.0	3.1	5.1	5.4	2.2	2.7	6.7	3.4	2.1	1.8	4.5	4.8	2.5	0.1	3.3	3.2	0.0	4.7	46.5	3.5	3.7	73.2	2.0	2.8	23.6	0.1	0.0	0.0	55.9	0.5	0.1	3.3	2.9	3.6	0.0	2.9	0.6	2.4	83.0	2.2	0.2	0.9	22.5	0.7	23.1	0.3	1.5	0.1	0.0	0.1	0.0	13.2	1.1	0.0	0.1	2.3	29.7	5.1	0.0	13.6	0.0	8.4	0.4	30.9	4.9	0.1	0.0	128.4	3.4	0.0	0.3	0.0	11.5	0.5	0.1	3.5	0.0	0.1	0.0	4.5	0.1	76.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	1.8	1.7	1.8	1.9	2.0	2.5	3.3	3.2	2.6	3.1	2.7	2.5	3.1	0.0	20.8	1.0	0.2	62.2	3.0	2.0	23.9	0.8	6.3	2.9	23.4	2.8	9.3	9.2	8.4	0.1	0.3	0.1	0.0	11.1	1.7	10.4	4.4	5.1	0.0	0.0	6.9	1.0	0.0	14.4	2.6	3.9	1.3	0.5	0.0	0.5	0.1	0.0	6.7	0.0	6.1	0.0	8.5	1.0	11.5	0.2	14.2	71.2	0.0	3.3	0.0	12.5	1.1	11.3	0.0	13.9	0.0	13.3	0.0	20.9	62.4	3.3	0.0	3.2	4.9	1.5	2.3	8.3	80.3	0.0	0.6	3.5	0.0	0.6
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 507.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	NA	NA	17700	570000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (2.19e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.14e-2)"	"prognostic favorable (8.22e-4)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.74e-1)"	166.5	133.3	33.7	76.7	34.4	42.4	120.0	35.3	38.6	105.0	47.8	114.1	101.5	111.8	23.0	105.6	106.7	88.8	80.6	32.4	40.3	94.5	176.5	130.7	38.1	45.7	40.4	90.6	57.3	53.7	57.3	82.4	39.6	86.9	56.4	3.5	76.0	46.3	91.0	103.7	109.5	97.5	40.4	111.3	84.4	22.6	39.7	39.2	97.4	63.1	36.1	113.2	113.2	37.4	40.2	296.4	40.9	60.2	277.7	282.0	75.7	82.2	143.0	108.2	93.9	34.7	153.6	3.7	28.9	179.3	85.6	107.1	12.9	96.4	74.1	0.8	25.3	20.3	79.2	82.2	245.5	104.4	66.9	291.8	94.4	90.2	131.4	250.4	134.1	42.0	33.7	29.8	126.3	57.1	34.0	100.0	102.1	146.1	87.6	27.9	66.6	32.4	83.7	70.7	0.1	2.1	117.8	60.9	62.5	103.6	16.4	111.4	146.0	84.6	71.7	64.7	78.4	0.1	10.6	12.8	100.5	95.9	107.0	17.1	165.8	93.5	62.2	130.4	60.0	0.5	25.1	51.0	123.7	0.4	22.3	34.0	507.2	9.7	111.5	31.6	26.2	117.3	33.7	34.4	35.3	38.6	32.4	40.3	45.7	40.4	39.6	40.4	39.7	37.4	102.0	51.3	37.1	15.3	4.8	123.0	115.8	127.3	81.4	0.4	50.1	35.9	9.3	67.2	70.8	27.6	0.0	62.0	35.5	204.0	15.6	98.7	1.2	25.5	66.5	111.8	33.6	30.1	4.6	119.4	120.2	109.3	43.8	42.3	7.6	27.6	159.2	145.0	176.4	0.0	1.3	56.8	32.6	146.7	113.4	5.4	102.2	102.4	71.2	32.8	127.1	15.9	104.0	11.1	0.9	116.6	239.4	65.8	4.2	141.2	227.5	96.9	30.8	0.7	124.9	64.1	89.4	1.3	1.1	57.0	134.7	148.6	31.2	21.5	57.4	140.1
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	8100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	45.6	5.4	3.9	68.4	3.8	52.1	34.7	4.8	17.9	14.3	5.6	12.8	16.8	11.6	0.4	5.5	14.6	15.6	10.9	3.7	9.0	7.5	15.7	32.0	32.1	18.3	7.2	6.3	5.9	2.3	4.5	35.8	10.6	6.4	10.8	0.8	6.5	2.6	10.7	7.8	23.9	16.8	9.0	53.3	16.4	2.2	8.9	12.7	7.6	6.3	21.3	28.9	8.8	14.1	0.0	0.3	4.1	0.0	9.6	13.5	8.9	1.1	2.0	4.0	4.3	1.8	34.0	0.2	0.6	3.9	5.6	0.0	0.8	0.0	2.2	14.5	0.0	0.0	0.2	0.0	25.2	0.3	3.8	14.8	0.0	13.0	0.0	7.2	19.6	0.2	45.7	6.4	1.5	0.0	0.0	8.1	0.2	4.9	1.4	1.2	0.4	25.9	0.0	0.8	0.0	0.1	0.6	0.4	1.4	6.4	0.0	51.8	7.8	5.3	0.2	27.0	0.0	1.9	0.0	0.0	30.8	37.0	1.4	0.6	127.1	18.2	48.4	260.5	26.5	13.5	34.4	40.5	71.7	8.4	9.8	15.5	138.0	13.4	387.1	15.1	70.9	150.4	3.9	3.8	4.8	17.9	3.7	9.0	18.3	7.2	10.6	9.0	8.9	14.1	99.4	9.6	15.9	0.7	42.8	16.8	3.9	1.0	1.2	0.2	3.2	4.1	3.6	5.7	6.5	3.7	0.0	0.9	268.7	12.8	0.0	0.5	0.6	1.7	5.1	46.0	0.0	7.4	0.2	0.6	6.3	13.2	12.8	4.9	2.5	1.4	31.1	17.0	72.6	0.0	0.2	3.0	0.0	200.5	288.0	1.2	2.1	230.2	16.0	30.9	175.3	0.3	109.2	0.0	0.1	0.7	4.2	0.4	72.5	8.0	25.8	0.4	1.5	1.2	32.9	6.8	9.8	0.0	0.9	0.7	10.5	30.1	138.4	1.9	4.8	8.8
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	5.3	0.0	0.1	3.1	2.3	0.6	3.5	0.0	0.6	0.2	0.1	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.9	0.0	0.2	0.3	0.0	0.9	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.2	0.2	0.1	0.0	0.3	0.1	0.9	0.9	0.7	0.5	0.1	1.4	2.5	1.4	0.7	1.0	0.1	1.2	1.1	0.9	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.3	0.0	0.6	0.0	0.2	0.2	0.1	0.2	0.1	0.7	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 141.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 438.1;intermediate monocyte: 420.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	35000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	27.7	31.6	39.5	37.7	43.7	48.4	29.5	39.7	47.3	33.5	66.7	45.9	74.7	13.3	19.2	12.5	31.8	54.1	18.0	35.3	37.6	55.6	16.2	100.7	33.1	44.8	43.3	24.8	41.1	18.0	19.7	14.7	41.1	22.6	41.9	13.0	141.9	32.1	5.3	10.5	39.5	24.8	40.0	30.6	54.0	4.6	44.8	14.1	27.0	10.1	24.5	26.0	15.5	38.8	20.8	8.3	2.8	5.5	3.2	1.7	3.4	3.7	2.7	1.5	1.3	4.6	12.8	9.1	43.6	3.8	5.2	13.1	0.1	3.6	1.6	16.2	7.0	5.9	18.2	9.7	6.7	5.1	5.9	3.6	3.6	1.0	5.7	8.8	4.7	6.5	4.6	3.5	1.3	3.1	2.3	16.6	2.7	20.3	6.0	16.5	3.4	39.9	110.6	13.5	5.1	4.9	7.2	18.8	2.5	4.1	25.2	12.4	2.4	4.8	5.8	2.1	8.1	0.8	2.8	2.4	1.9	44.1	9.5	75.2	438.1	158.9	0.9	420.9	0.8	13.7	0.5	0.7	283.5	25.0	2.4	1.5	56.9	7.9	265.4	130.8	0.9	257.1	39.5	43.7	39.7	47.3	35.3	37.6	44.8	43.3	41.1	40.0	44.8	38.8	0.2	6.4	10.4	0.0	2.1	0.0	0.2	0.2	8.0	0.1	0.4	0.1	0.0	0.0	2.0	1.8	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.2	0.1	0.0	1.2	5.9	0.0	0.2	0.0	2.9	11.2	0.4	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	19.5	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.7	0.3	1.5	0.2	0.0	0.1	0.2	0.0	0.0	2.6	0.0	0.0	0.8	0.1	0.6	0.2
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.5;Kupffer cells: 141.1;Langerhans cells: 246.7;Macrophages: 170.4;monocytes: 509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 505.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9"	"Cell line enriched"	"Detected in some"	7	"U-937: 167.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	790000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	8.2	5.3	2.8	25.9	2.6	20.1	4.7	2.7	4.1	2.2	5.8	5.5	10.7	1.4	1.5	4.8	2.4	12.4	3.8	2.7	3.1	1.5	5.3	10.9	20.9	6.3	3.0	1.1	1.5	0.7	1.0	9.0	4.2	1.7	8.4	0.4	3.3	1.2	1.4	1.9	6.4	5.0	4.6	15.9	5.0	1.2	3.5	5.3	3.0	1.6	17.7	11.1	2.1	5.2	0.1	0.4	0.1	0.1	0.7	0.8	0.2	0.3	0.8	0.6	2.1	0.1	1.7	0.3	0.2	0.2	0.3	0.1	0.0	0.1	0.1	11.6	0.0	0.9	0.4	0.0	0.4	10.2	0.3	2.0	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.6	1.2	0.0	0.1	5.3	0.1	1.1	0.0	0.0	0.2	0.0	0.6	0.3	1.3	0.3	0.0	0.0	0.4	0.2	0.1	22.3	0.2	0.3	0.0	0.0	0.4	10.0	0.3	0.1	10.3	167.0	1.7	12.6	350.9	100.1	5.4	272.3	31.5	4.4	21.5	4.4	206.4	7.1	9.9	3.4	505.4	5.0	234.1	77.8	19.4	165.8	2.8	2.6	2.7	4.1	2.7	3.1	6.3	3.0	4.2	4.6	3.5	5.2	3.1	16.0	12.9	6.2	7.0	7.1	0.7	1.3	1.2	0.9	2.4	3.2	0.6	10.0	4.2	5.5	0.0	0.5	40.6	0.6	1.9	2.3	1.2	0.4	0.7	3.6	1.2	14.5	18.1	32.5	1.1	29.6	3.1	0.5	5.1	0.9	3.9	2.8	87.5	0.0	11.2	0.9	0.0	141.1	246.7	0.6	5.3	170.4	8.8	15.0	509.4	0.2	5.2	55.3	5.1	1.7	0.5	1.9	1.5	2.7	2.2	1.3	2.0	0.3	6.6	1.4	4.1	0.1	0.7	0.5	4.7	1.1	10.5	1.2	1.8	3.1
TNFSF9	"4-1BB-L, 4-1BBL"	ENSG00000125657	"TNF superfamily member 9"	P41273	19	6531026-6535924	"Plasma proteins, Predicted intracellular proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 9.8;esophagus: 9.8;vagina: 9.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 85.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA059857			Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA059857: AB_2684144"	"unprognostic (2.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.88e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-3)"	1.8	0.6	3.5	1.0	3.0	3.7	0.8	3.7	7.6	9.8	2.3	1.2	0.3	0.3	0.3	9.8	1.1	1.0	0.6	3.9	3.3	0.9	0.4	4.9	1.1	3.6	2.9	0.5	0.3	0.5	0.3	0.9	3.4	0.3	1.8	0.3	1.5	0.1	0.7	1.4	1.2	0.4	3.1	2.2	0.6	3.3	3.1	0.5	0.4	0.3	0.7	0.7	9.5	6.3	10.7	13.4	0.2	4.8	2.5	6.0	0.4	1.5	4.8	3.6	17.1	0.3	18.0	11.3	6.8	3.0	0.0	19.2	5.4	2.3	0.9	0.0	2.6	1.8	18.4	4.4	0.4	0.3	85.8	1.0	10.1	20.1	5.5	2.6	0.6	1.6	10.9	0.2	1.3	1.5	0.9	1.8	1.8	0.7	9.5	1.2	0.0	2.8	22.9	0.4	0.0	0.0	29.8	1.7	5.0	0.6	1.2	16.4	6.2	0.0	9.6	26.0	0.0	26.9	10.2	20.9	10.2	5.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.5	3.0	3.7	7.6	3.9	3.3	3.6	2.9	3.4	3.1	3.1	6.3	11.3	0.0	4.5	0.0	57.5	2.7	0.3	4.3	6.2	0.2	4.0	3.8	8.1	0.0	1.6	0.0	0.0	0.1	51.6	4.3	0.0	0.3	0.1	5.7	3.9	6.8	14.2	0.0	2.2	0.2	0.0	12.6	23.0	9.2	8.9	0.6	1.8	0.0	4.5	0.0	2.5	3.4	2.0	1.9	15.9	0.0	0.0	22.5	3.6	0.0	1.6	0.8	0.0	1.5	2.9	0.8	4.9	0.0	17.2	0.9	0.2	0.1	0.9	0.2	0.0	2.5	7.5	0.1	0.4	12.7	1.3	0.1	31.5	0.9	5.7	0.3
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041954, HPA069561"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Vesicles	"HPA041954: AB_10794164, HPA069561: "	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	14.2	10.0	77.1	24.7	64.1	72.2	15.0	40.0	102.9	18.0	11.8	18.5	9.4	13.8	11.1	19.1	17.1	10.5	18.4	75.6	51.4	7.7	10.5	14.1	30.0	77.5	59.8	13.4	12.1	6.1	36.4	12.7	70.1	21.1	6.3	9.3	26.3	11.8	54.8	62.3	16.1	9.2	45.5	27.0	19.7	12.0	57.0	16.0	10.0	16.7	20.1	19.4	19.3	60.6	93.4	16.3	15.4	13.4	15.3	11.5	80.0	17.7	16.7	11.7	9.4	15.6	79.3	25.9	55.1	24.2	17.4	34.1	14.9	22.2	3.5	61.8	15.4	22.0	36.2	10.4	7.9	13.5	10.2	7.8	30.7	11.7	17.9	26.7	13.3	9.2	11.3	30.6	9.4	67.1	5.3	39.7	12.3	24.6	29.1	13.8	15.6	26.0	7.2	51.2	16.2	16.5	9.5	37.6	21.3	11.3	71.4	11.9	18.9	19.1	13.0	11.4	48.6	70.8	9.2	17.0	22.1	38.0	15.4	1.4	1.2	0.3	0.9	1.5	0.4	1.3	0.8	0.4	0.5	2.5	0.5	0.5	2.7	0.4	1.4	1.5	0.1	0.7	77.1	64.1	40.0	102.9	75.6	51.4	77.5	59.8	70.1	45.5	57.0	60.6	9.3	6.4	7.7	44.4	14.6	6.9	8.1	6.0	4.6	30.6	13.0	12.6	16.1	7.2	8.9	0.0	50.1	13.4	11.0	18.0	1.9	4.0	1.0	4.1	5.4	11.1	6.1	12.8	42.7	5.3	3.3	4.6	14.3	4.1	1.3	4.5	11.7	19.2	8.1	99.3	45.3	2.3	6.1	16.0	11.7	1.2	6.5	13.7	5.4	20.6	16.2	5.9	21.6	245.3	25.1	29.5	9.6	6.4	10.7	8.2	0.9	1.6	7.6	20.3	0.0	4.8	5.7	6.4	11.2	11.0	10.5	4.2	12.5	1.7	6.4	19.0
TNKS2	"ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798426-91865475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	18.4	19.3	14.7	21.2	16.1	38.5	22.2	18.0	17.0	21.1	25.0	14.8	14.9	22.5	19.8	22.8	17.8	20.8	11.1	14.3	14.9	17.4	21.2	19.7	28.1	14.6	15.1	30.3	22.0	21.8	14.4	31.2	15.8	19.6	17.1	31.2	18.5	16.6	55.6	27.3	15.3	20.7	16.0	30.0	19.8	11.8	17.4	37.7	29.6	40.5	29.4	24.1	17.1	19.7	29.1	24.3	48.9	41.7	33.8	30.6	54.5	30.6	55.5	36.5	44.5	21.7	23.2	27.2	14.3	40.0	24.6	30.6	31.0	23.6	51.3	27.7	29.9	22.6	22.9	24.3	32.9	44.0	32.3	31.4	30.6	37.0	65.3	54.8	34.8	24.1	16.9	29.4	38.5	15.6	38.1	29.9	24.6	13.2	16.1	35.2	30.5	20.9	25.0	30.9	12.8	22.9	30.8	13.4	38.7	39.2	32.5	30.3	37.8	19.6	16.5	26.1	29.5	36.7	32.1	34.8	25.9	32.4	17.9	0.2	0.7	1.2	0.9	0.6	0.8	1.0	0.9	0.8	1.0	1.0	0.7	0.6	0.7	1.0	0.6	1.5	0.5	0.4	14.7	16.1	18.0	17.0	14.3	14.9	14.6	15.1	15.8	16.0	17.4	19.7	39.1	41.7	22.3	63.3	51.6	74.6	32.5	23.8	56.9	41.7	38.8	24.0	23.2	8.6	31.0	44.1	47.9	45.2	48.7	19.2	7.9	16.0	4.7	41.1	29.3	37.1	33.0	27.5	77.5	24.5	55.1	30.9	50.4	52.1	2.5	34.8	35.7	35.9	26.1	42.1	78.5	19.3	26.4	55.3	49.4	8.1	31.1	48.4	33.8	67.5	46.5	24.9	37.0	66.9	68.0	29.0	12.3	35.3	45.7	44.7	16.1	16.6	47.4	34.8	46.0	40.5	28.0	19.1	21.7	75.9	109.1	101.0	49.1	30.5	14.9	61.7
TNN	TNW	ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067833-175148075	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 12.0;breast: 4.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.1;Fibroblasts: 7.5;Hepatic stellate cells: 2.5;Langerhans cells: 2.5;Smooth muscle cells: 10.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NB-4: 3.6;THP-1: 11.1;U-266/70: 2.7;U-937: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"	NA	NA		34000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	12.0	0.2	0.0	0.1	0.1	0.0	4.9	0.0	0.1	0.1	0.1	0.3	0.8	0.0	0.0	0.1	0.0	1.7	0.3	0.2	0.0	0.4	1.3	0.4	0.1	0.0	0.1	0.0	0.3	0.8	2.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	3.1	0.4	0.4	0.1	0.4	0.4	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	6.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.1	7.5	0.0	0.1	0.0	0.0	2.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	10.4	0.4	1.4	0.0	1.8	0.1	0.1	0.0	0.0	0.1
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Cluster 13: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	8.4	10.9	0.7	0.8	0.8	0.7	19.1	2.7	1.1	7.7	7.3	4.0	1.1	2.8	41.7	387.3	2.8	3.3	8734.3	1.2	0.7	19.2	4.0	78.5	3.9	0.8	0.9	2.4	6.8	1.6	17.6	5.2	1.0	170.1	4.1	0.4	120.8	2.2	21081.1	18.9	3.3	0.8	0.8	2.8	5.7	10.6	0.8	4.3	14.4	12403.9	1.6	5.3	5.4	0.7	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.7	0.8	2.7	1.1	1.2	0.7	0.8	0.9	1.0	0.8	0.8	0.7	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	622	"heart muscle: 10813.5"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.3	0.0	0.5	0.0	17.3	0.2	0.4	0.7	0.7	0.7	0.0	0.3	0.1	0.8	6.2	0.9	10813.5	0.6	0.2	1.0	1.1	7.3	1.6	0.5	2.8	1.4	2.3	0.2	0.6	1.0	1.3	2.4	0.0	0.2	1.3	0.0	6.5	1.2	0.6	0.0	0.6	0.4	0.7	3.7	0.3	0.1	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.4	0.6	0.2	0.5	2.8	1.3	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.5	23.0	10.6	28.8	14.6	31.7	25.0	14.0	10.0	20.2	23.0	24.5	20.5	24.0	33.8	23.1	20.6	27.7	20.8	10.5	17.1	30.5	28.4	17.3	29.9	18.2	13.4	22.4	31.5	39.8	15.6	36.8	16.5	23.4	29.9	65.0	20.9	28.1	25.0	11.6	20.9	28.2	15.1	20.6	30.7	37.3	13.1	35.6	36.8	27.0	32.3	33.3	14.0	21.5	94.8	123.7	154.5	104.8	133.3	144.5	110.4	112.3	145.6	112.2	113.6	111.4	87.1	117.5	78.5	173.0	140.4	71.6	126.3	108.8	160.8	66.6	71.9	76.2	144.8	55.9	103.9	78.4	55.1	110.8	80.2	151.0	184.8	78.2	248.6	52.9	113.4	54.8	298.1	50.3	87.2	37.3	99.3	39.8	90.9	83.1	150.5	74.1	73.4	109.5	87.5	73.6	160.6	60.3	135.8	99.8	71.2	61.9	225.1	79.5	113.8	116.8	136.7	53.2	95.8	155.8	69.9	91.3	154.4	8.2	8.2	6.9	11.9	11.0	16.5	10.3	10.9	9.3	10.3	10.8	11.6	11.9	8.4	14.1	14.0	5.0	8.3	10.5	10.6	14.6	14.0	10.0	10.5	17.1	18.2	13.4	16.5	15.1	13.1	21.5	42.3	12.8	25.0	45.7	49.0	59.1	40.9	29.7	60.3	105.0	38.7	24.0	53.8	30.0	28.7	27.6	98.0	81.9	44.9	39.8	17.6	39.0	105.4	38.6	46.1	64.8	53.2	27.1	142.2	41.5	50.0	52.8	53.0	46.7	22.1	62.8	50.7	38.1	42.7	89.2	77.8	46.3	28.5	40.0	42.2	60.9	46.6	42.1	24.9	50.6	47.4	143.1	26.8	79.9	84.7	58.9	24.9	60.2	42.9	57.0	33.9	36.1	27.6	187.9	26.3	72.5	48.8	58.5	76.3	42.0	53.3	131.3	36.9	40.2	37.2	60.2
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing adaptor 6A"	Q8NDV7	16	24610209-24827632	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.2	21.0	5.0	6.4	3.6	6.0	14.9	10.8	7.1	17.8	6.1	17.8	5.5	23.5	11.5	11.3	17.7	6.4	11.1	3.4	6.6	10.3	13.0	12.8	7.1	6.1	4.8	20.6	19.2	13.2	22.8	6.6	6.1	14.6	6.4	7.0	14.9	8.0	14.0	13.1	15.3	8.1	2.2	9.9	15.2	6.6	7.0	8.6	17.8	6.9	7.4	13.0	13.4	7.4	10.1	13.8	16.0	8.7	13.6	17.7	9.1	16.9	13.6	12.0	13.1	10.2	8.2	10.2	7.1	17.0	12.4	11.2	20.1	14.2	18.0	10.4	10.4	10.2	16.7	14.1	11.7	10.5	6.9	18.0	7.3	15.8	10.2	14.8	16.7	6.6	15.7	6.2	15.8	11.9	8.8	6.9	23.1	4.9	6.8	17.1	12.4	9.1	9.1	9.3	7.7	10.8	11.8	7.2	6.6	12.1	8.4	6.8	15.5	15.3	10.5	7.6	12.0	13.7	11.6	16.5	14.3	6.4	11.3	0.5	0.5	0.4	0.5	0.3	0.4	1.1	0.5	0.5	0.2	1.0	0.7	0.5	0.3	0.6	0.3	1.0	0.5	0.3	5.0	3.6	10.8	7.1	3.4	6.6	6.1	4.8	6.1	2.2	7.0	7.4	51.2	38.5	60.0	289.3	45.5	34.9	17.8	21.9	39.9	97.1	42.8	41.0	75.3	51.5	32.3	46.0	118.9	22.4	49.9	38.3	17.6	23.6	17.2	38.7	65.5	45.5	55.9	34.9	283.8	24.5	15.1	50.5	33.6	42.8	39.3	76.5	60.3	115.3	21.2	176.7	414.6	36.3	22.4	56.2	26.5	11.3	69.0	28.7	30.2	138.7	36.1	42.0	50.4	265.4	234.2	28.5	36.1	81.3	44.7	26.0	42.8	19.2	29.8	81.7	19.7	52.8	60.9	41.2	30.6	38.1	28.7	8.2	39.0	36.5	35.8	17.4
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218033982	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	248.2	60.3	51.6	42.9	98.0	42.3	100.9	71.7	45.5	99.5	45.1	373.4	23.4	253.7	44.3	117.8	136.2	80.4	170.4	34.0	53.4	74.6	39.6	117.2	11.5	82.3	79.2	110.4	55.2	33.2	15.4	54.5	106.4	126.1	41.7	7.7	52.9	225.0	171.6	47.8	78.9	178.0	72.2	70.1	115.2	23.5	80.9	21.5	65.8	207.2	7.5	228.4	82.6	82.9	0.3	0.4	8.9	0.1	135.1	74.1	0.8	22.9	7.8	1.3	0.9	10.0	0.1	0.0	13.1	66.6	1.5	1.7	1.4	1.3	0.7	9.4	0.8	19.8	5.7	2.6	9.8	0.1	2.3	35.2	0.0	24.4	0.2	43.6	32.2	0.1	0.6	2.6	18.8	4.4	0.1	1.4	0.9	0.2	0.4	75.4	16.8	1.0	4.8	0.2	2.1	10.1	3.9	9.7	2.0	6.1	3.1	8.5	63.2	16.6	29.5	17.5	4.9	1.1	0.1	0.1	9.8	2.7	1.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.8	51.6	98.0	71.7	45.5	34.0	53.4	82.3	79.2	106.4	72.2	80.9	82.9	93.3	173.1	85.9	29.7	1.1	16.2	48.6	29.5	42.1	4.8	7.2	21.2	339.0	38.6	27.5	14.7	0.0	8.7	0.5	0.1	7.9	36.1	2.2	3.0	29.5	76.6	0.0	143.1	3.9	19.1	1.5	52.4	1.1	3.8	30.4	8.8	71.7	38.5	13.0	42.1	5.3	0.0	6.1	15.3	19.3	11.9	169.6	16.7	10.6	32.8	1.3	14.1	0.0	15.6	52.0	17.0	0.0	504.0	0.4	12.1	0.0	26.1	22.3	1.3	368.1	29.7	183.5	1.1	1.9	5.7	11.8	1.9	4.1	20.7	0.2	17.3
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041153-32115334	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 274.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	68.0	274.8	2.0	0.9	3.1	3.4	40.0	4.4	1.8	45.1	3.5	35.9	3.0	66.7	3.2	18.1	37.4	4.7	73.8	0.7	0.8	13.0	17.6	51.1	0.8	1.5	1.1	67.0	3.7	0.4	6.8	3.8	1.5	15.6	1.7	0.3	19.5	1.0	14.2	27.4	29.0	3.1	2.2	30.7	18.8	11.4	3.0	0.7	27.7	7.2	0.4	34.5	35.2	0.4	0.1	0.3	0.3	0.2	12.4	20.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.2	0.0	0.1	0.0	0.0	0.1	1.3	1.1	0.2	0.6	0.0	2.8	0.0	0.3	0.2	0.2	0.5	0.0	0.5	0.0	0.5	0.7	0.4	0.0	0.2	0.0	0.1	0.3	0.0	3.5	0.3	0.1	0.2	0.0	0.1	0.1	0.2	1.3	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.4	15.8	0.0	0.4	0.4	0.2	8.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.1	4.4	1.8	0.7	0.8	1.5	1.1	1.5	2.2	3.0	0.4	54.7	3.2	2.4	2.6	0.5	32.9	0.2	0.3	0.6	1.3	1.3	1.8	2.5	4.3	0.2	0.0	0.0	0.5	1.0	0.0	0.0	0.2	3.0	1.3	39.7	38.8	0.0	25.0	7.1	0.0	2.6	318.4	6.1	1.1	0.0	94.8	12.8	0.9	0.7	0.0	4.2	0.1	0.0	0.6	39.1	2.8	27.1	4.7	32.0	17.8	0.0	1.2	0.0	1.0	1.2	0.0	0.1	4.5	2.5	0.5	0.0	0.3	0.9	0.6	0.0	21.7	20.8	4.1	2.1	1.6	26.6	1.0	4.8	5.6	0.2	0.4
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 498.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	Cytosol		NA	NA		140000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	26.8	35.4	58.2	12.4	73.5	13.6	25.8	27.5	80.9	35.9	17.6	26.3	25.5	23.5	11.5	93.4	22.4	18.4	31.3	85.0	39.4	43.1	113.3	26.6	14.2	39.9	39.1	24.6	58.2	18.9	54.2	12.1	39.8	31.4	8.2	11.4	31.6	20.5	76.2	75.9	23.4	11.1	32.9	28.8	31.9	73.4	42.7	13.2	24.7	22.7	14.2	33.5	48.8	56.5	31.4	32.6	16.3	18.6	34.0	21.2	14.2	27.2	24.5	31.3	27.7	35.4	19.5	14.6	25.6	25.3	47.9	27.7	14.7	33.4	8.5	30.1	30.1	11.9	6.9	54.2	48.4	22.8	29.0	32.1	38.5	18.6	17.9	17.1	19.7	21.7	19.9	38.5	26.1	26.3	29.1	27.9	20.0	33.9	42.1	21.8	16.6	14.6	20.9	41.3	43.5	25.5	24.4	29.4	30.7	8.3	23.3	25.7	36.0	33.8	14.4	14.4	16.0	38.8	37.8	18.3	53.2	14.9	27.0	45.4	126.6	139.6	33.4	114.0	27.8	38.8	35.3	31.5	99.9	50.0	27.4	26.1	179.1	44.5	108.8	52.4	48.8	77.3	58.2	73.5	27.5	80.9	85.0	39.4	39.9	39.1	39.8	32.9	42.7	56.5	19.5	9.6	19.3	15.0	27.8	66.9	43.9	71.7	23.3	42.6	30.3	24.6	22.8	58.6	30.9	23.9	8.4	49.2	28.0	50.8	70.5	66.3	173.6	11.7	14.8	24.9	51.6	45.0	35.1	69.2	41.1	27.6	19.4	15.8	38.1	20.7	37.9	112.2	92.1	74.0	17.0	30.8	48.8	38.4	33.1	498.2	21.8	48.3	71.2	16.9	50.6	38.1	19.6	10.6	15.0	76.3	53.7	30.9	33.4	55.7	66.6	110.1	15.4	20.6	6.6	18.5	24.5	100.7	39.6	76.3	98.9	104.4	22.0	27.4	29.3	74.0
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	27.1	25.5	15.3	38.9	17.6	49.1	34.7	25.2	16.5	36.2	12.0	30.1	28.8	42.9	25.5	34.1	29.7	26.2	38.5	15.3	16.0	32.1	27.7	28.0	50.4	13.5	16.2	40.6	28.8	53.2	11.7	34.4	15.1	38.7	33.3	112.3	27.1	34.2	29.9	32.4	28.6	34.2	16.4	36.4	32.1	19.5	14.6	82.5	45.8	36.7	46.6	43.7	18.5	25.3	57.6	58.6	125.9	155.3	41.1	51.7	50.1	54.4	69.6	49.4	53.9	30.1	44.6	176.9	37.1	79.2	30.5	47.7	105.6	60.5	82.5	85.5	56.7	268.5	71.2	50.6	28.9	212.8	137.4	37.1	29.7	55.3	48.2	49.8	81.7	118.6	92.0	84.3	64.4	64.0	138.5	52.5	95.9	38.5	44.1	569.9	71.0	82.6	43.9	199.5	63.2	109.7	81.1	57.4	49.9	72.2	59.7	187.1	78.7	68.3	52.6	55.2	58.9	129.6	78.6	185.1	44.9	155.6	46.5	3.2	1.4	2.8	3.0	1.7	3.3	2.0	2.9	3.1	2.2	2.5	3.3	3.0	1.0	3.9	2.6	2.8	2.3	1.1	15.3	17.6	25.2	16.5	15.3	16.0	13.5	16.2	15.1	16.4	14.6	25.3	36.4	64.1	62.7	65.3	47.3	39.1	47.9	30.9	31.3	62.4	44.4	31.9	121.5	34.3	36.1	25.8	56.3	47.8	65.8	29.9	13.7	34.3	3.6	48.0	58.8	36.6	59.3	65.6	77.8	33.4	24.5	40.2	28.5	45.1	34.1	71.4	25.0	35.1	26.2	60.6	89.8	32.3	20.3	40.7	50.1	6.0	39.1	45.3	23.2	43.1	49.8	51.3	68.0	76.4	113.0	35.5	22.2	33.4	46.0	56.2	20.6	25.6	39.2	95.7	32.9	56.5	51.0	94.9	44.0	57.9	37.6	46.7	53.7	48.4	39.2	64.3
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.6	12.0	5.5	10.1	6.9	16.2	11.2	7.5	8.3	17.9	12.2	13.7	11.1	13.5	7.1	14.8	13.5	7.4	11.8	6.0	5.7	13.9	17.0	13.7	12.7	5.9	5.0	20.3	12.7	7.4	12.9	8.4	6.1	16.7	9.9	6.9	13.9	6.8	10.4	14.7	17.7	9.7	4.0	25.0	13.5	11.1	6.3	13.6	14.3	5.7	13.4	11.4	15.5	8.1	22.1	21.1	40.9	16.8	14.8	12.3	25.7	14.2	17.6	32.1	28.3	22.2	9.3	29.9	10.5	14.9	13.4	39.6	18.6	25.2	25.9	15.3	45.4	23.5	31.4	24.1	20.1	32.3	14.9	6.1	37.5	26.8	12.7	18.6	27.1	17.2	112.5	15.7	15.2	22.3	20.6	25.0	17.0	15.8	19.9	31.6	27.1	4.6	15.8	28.9	26.7	19.3	17.4	15.4	13.7	16.4	11.9	20.7	19.9	13.2	27.6	13.0	17.6	23.2	20.8	28.2	10.2	19.4	14.0	1.9	4.3	1.8	5.5	4.4	3.8	4.5	3.6	3.9	4.7	4.9	3.3	3.5	1.5	4.3	2.6	5.4	4.2	3.7	5.5	6.9	7.5	8.3	6.0	5.7	5.9	5.0	6.1	4.0	6.3	8.1	7.2	0.0	2.6	12.1	7.2	1.8	2.6	6.2	2.8	4.6	3.7	3.9	0.2	8.6	5.0	3.7	10.4	5.2	7.2	7.0	1.9	4.8	1.3	5.3	6.7	5.7	4.8	2.1	8.9	4.3	3.6	4.3	12.2	5.0	1.3	15.0	7.9	7.1	4.0	1.7	7.7	5.3	4.1	3.4	3.8	1.8	10.5	5.1	5.4	6.5	4.3	3.1	5.2	4.5	9.2	6.4	4.6	7.5	6.1	3.4	4.5	2.8	8.2	6.1	6.6	4.9	9.6	6.6	4.9	3.6	1.6	4.0	5.9	7.6	5.8	2.9
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 265.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favorable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.7	14.6	17.3	14.1	17.6	21.4	16.3	17.9	20.1	18.0	14.8	18.5	12.6	15.4	15.1	21.1	14.7	12.2	21.9	17.5	17.7	15.0	15.7	15.9	15.1	17.1	18.7	15.9	15.8	20.4	13.6	15.5	17.5	14.7	15.2	16.1	14.8	17.4	55.5	21.5	14.8	19.7	16.8	13.7	16.9	14.3	18.3	26.1	17.1	25.8	21.3	17.4	16.0	19.5	27.1	27.4	22.7	21.5	32.1	30.6	30.3	25.3	49.6	52.7	50.3	27.0	31.6	16.2	17.5	41.5	42.0	31.5	37.4	38.8	66.8	28.6	15.1	18.1	17.7	37.8	41.5	33.6	28.7	40.0	39.8	41.7	39.4	35.9	38.0	30.1	22.6	27.4	37.9	22.8	33.4	19.3	12.8	39.5	43.2	29.7	23.7	18.6	24.5	33.4	20.9	21.5	25.0	26.3	21.3	29.8	24.8	12.6	25.0	27.2	24.9	24.1	22.5	35.1	41.7	36.9	12.8	16.4	28.7	40.9	27.4	40.0	23.1	29.2	25.0	24.0	20.5	22.2	26.0	24.9	21.3	24.4	48.6	29.2	27.5	33.7	31.7	28.9	17.3	17.6	17.9	20.1	17.5	17.7	17.1	18.7	17.5	16.8	18.3	19.5	60.0	67.3	64.0	0.0	43.3	87.3	63.9	81.3	58.1	75.0	50.4	42.0	51.8	42.9	64.4	46.0	29.2	73.5	69.3	51.0	62.6	47.3	76.1	42.6	46.9	53.4	68.9	48.8	0.0	51.4	64.1	48.4	40.8	50.4	61.4	41.4	37.9	43.1	43.8	42.1	0.0	45.4	52.9	41.3	61.6	36.5	48.7	46.1	39.2	0.0	55.3	40.4	46.4	0.0	0.0	51.4	51.9	44.0	44.4	59.0	91.4	64.0	57.4	54.5	32.9	54.1	58.6	131.9	66.8	50.5	88.8	265.8	62.0	55.5	43.8	70.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652516-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.7	0.7	0.5	0.5	0.8	4.2	0.5	1.4	8.0	0.2	0.0	0.1	0.1	3.7	6.7	0.0	0.1	0.8	0.7	0.1	0.2	0.9	1.0	2.4	2.9	0.1	0.8	0.1	0.3	0.0	1.4	2.6	0.1	0.2	2.9	0.3	0.2	6.6	0.2	0.0	1.4	0.7	0.3	0.7	0.7	1.6	0.2	0.0	1.4	0.1	2.9	1.0	2.6	0.1	0.3	7.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	4.0	2.6	2.0	0.0	0.9	4.3	2.7	0.9	0.0	0.8	8.7	0.2	3.9	2.6	0.0	0.0	2.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.8	1.9	15.0	2.0	0.5	0.0	0.1	0.0	11.6	0.1	0.3	3.8	18.0	8.4	0.4	0.0	0.8	0.0	10.9	9.2	0.0	2.9	7.5	0.0	5.8	3.3	0.7	18.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	4.2	0.5	0.8	0.7	2.4	2.9	1.4	1.4	0.7	1.0	0.0	0.0	1.5	0.0	1.2	3.1	3.8	13.0	16.5	0.5	0.2	2.5	1.5	0.0	7.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	21.8	31.0	0.3	0.3	2.4	3.2	0.1	0.2	0.4	0.4	0.0	0.7	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.5	2.0	0.0	1.3	15.7	0.6	0.1	1.8	0.0	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	6.8	0.2	0.0	0.1	35.8	0.1	0.0	0.0	2.6	0.1	0.4	1.6	2.3	0.3	0.4	0.1	0.3	0.2
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TPD52L2	"D54, hD54, TPD54"	ENSG00000101150	"TPD52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 187.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047489	Approved		Approved	Vesicles,Cytosol		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Vesicles	Cytosol	"HPA047489: AB_2680067"	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	85.1	84.6	75.8	52.8	76.8	98.9	68.9	76.0	88.1	74.1	74.0	79.7	38.3	72.6	31.4	109.6	68.0	42.6	85.7	76.8	81.6	66.2	51.4	60.8	43.2	80.8	77.4	60.7	45.5	38.3	58.9	65.9	79.5	66.3	35.2	24.6	50.3	60.9	70.2	70.8	52.6	72.1	78.0	71.4	54.5	40.2	83.5	35.7	49.8	53.4	41.7	83.6	71.5	81.4	175.2	87.9	54.5	66.9	122.4	193.8	80.4	196.7	173.0	343.1	145.0	326.9	194.9	70.0	211.3	200.0	204.2	168.4	111.5	269.0	198.7	39.5	46.4	66.9	112.6	199.6	129.9	85.0	66.3	140.3	296.6	138.5	221.3	121.6	160.1	74.0	140.4	101.0	137.0	96.3	83.5	109.4	78.7	172.6	308.1	114.0	59.5	113.3	135.8	76.0	82.3	92.2	230.9	177.5	165.3	80.3	120.6	171.5	170.1	273.4	79.1	160.9	145.4	63.2	108.6	85.0	256.8	79.0	86.6	66.9	73.0	47.1	29.4	55.1	36.8	33.5	32.3	34.2	47.6	31.4	32.4	29.8	137.3	47.5	48.1	24.0	38.8	74.6	75.8	76.8	76.0	88.1	76.8	81.6	80.8	77.4	79.5	78.0	83.5	81.4	37.5	16.0	23.4	36.2	26.6	44.1	28.3	58.8	33.0	18.9	28.0	31.1	45.4	20.0	31.3	22.0	6.2	77.2	28.6	27.8	39.2	50.5	7.8	21.7	38.4	36.7	18.6	26.9	19.6	32.1	104.0	37.7	23.9	31.9	38.7	25.8	28.9	14.5	187.3	8.4	21.7	27.2	20.3	47.4	33.0	12.1	42.0	52.3	28.4	7.5	50.6	32.5	27.8	13.6	32.3	74.8	25.1	65.1	29.4	51.7	37.5	36.6	26.5	19.7	46.0	18.9	65.6	13.9	25.6	37.2	42.3	108.8	25.0	42.3	27.9	44.4
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2470.8;tongue: 2005.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		170000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	340.4	588.6	446.2	269.7	480.2	334.8	274.5	476.5	541.9	314.1	446.9	425.6	421.0	240.5	220.2	764.4	248.2	216.8	819.8	481.0	462.0	609.0	536.1	308.6	253.9	459.2	460.4	269.9	238.1	496.4	236.8	287.2	467.2	272.1	435.3	625.0	377.6	273.3	2470.8	410.1	404.5	301.5	429.7	291.4	329.0	239.8	503.5	200.3	269.1	2005.8	410.4	363.8	440.6	454.4	1556.8	1350.5	706.1	1094.6	666.5	696.6	1236.3	1097.5	1184.9	1999.1	2407.5	1409.9	823.0	903.4	212.7	1069.7	1042.4	748.8	1671.0	1812.3	2189.4	1196.4	1265.1	1172.0	924.4	926.2	496.8	1351.5	924.0	764.0	739.7	1537.8	1305.0	2816.1	1233.3	451.0	615.0	336.5	1554.5	1130.0	709.6	1119.5	1741.0	1302.3	855.9	413.5	1156.1	930.7	1261.4	1061.1	497.2	830.0	953.3	977.8	542.7	1452.6	224.4	1003.2	778.2	1068.0	914.6	703.1	1631.7	653.4	285.7	1327.8	2153.1	821.2	784.9	1708.8	2304.1	2375.2	824.6	2402.3	845.7	863.3	820.0	808.0	2656.1	800.9	570.5	703.0	934.3	1387.7	2165.7	482.0	1106.3	4679.5	446.2	480.2	476.5	541.9	481.0	462.0	459.2	460.4	467.2	429.7	503.5	454.4	311.5	134.6	204.2	34.6	290.6	684.8	553.8	1756.4	414.9	284.6	294.3	303.3	552.5	391.7	673.0	389.9	110.5	1017.0	278.2	850.3	1508.5	1361.5	203.0	280.8	307.0	352.0	425.5	243.3	38.4	786.5	1824.0	386.5	408.3	343.9	362.8	364.8	276.6	547.3	937.3	297.8	33.7	567.2	1151.5	386.7	750.4	683.5	279.0	482.8	674.1	18.7	1129.8	739.6	312.0	17.1	26.7	1081.5	889.4	263.3	427.9	556.2	1595.9	1642.7	401.2	298.0	197.2	270.5	551.3	14.9	79.0	690.4	615.9	1530.4	352.9	869.2	827.0	652.5
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690056	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 39012.3;tongue: 16773.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	812	"plasmacytoid DC: 398.6"	"Lineage enriched"	"Detected in single"	920	"dendritic cells: 398.6"	"Cell line enhanced"	"Detected in many"		"BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1"									"HPA047089, HPA053624"	Approved					NA	NA		140000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	331.1	285.0	88.0	411.0	89.8	16.7	260.8	92.5	117.3	651.3	127.3	3498.4	217.7	1928.1	201.9	1018.0	849.7	442.4	788.5	84.8	81.1	144.0	41.0	283.1	62.2	86.1	79.2	388.4	73.7	24.1	82.6	142.3	80.5	1219.0	238.0	8.0	393.6	1988.7	39012.3	148.5	636.2	2340.8	78.6	140.1	1252.6	82.9	83.3	26.3	138.9	16773.7	21.2	1630.1	454.9	79.8	375.4	291.2	213.9	33.6	335.4	893.3	129.3	2309.6	934.4	983.0	667.9	12.2	24.2	0.4	213.0	1289.0	144.6	9.2	3.7	291.2	457.0	716.2	10.8	9.1	1054.1	11.8	540.2	2.3	102.7	1067.7	44.9	738.8	0.4	1399.1	235.7	25.3	5.6	0.8	1052.1	15.3	2.7	29.1	269.6	1.5	17.0	18.5	391.5	3.0	31.1	7.2	3.8	13.3	470.0	7.9	18.2	273.8	6.8	27.7	30.0	16.5	585.7	11.6	730.6	0.6	2.7	2.9	34.0	6.5	29.2	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.4	0.2	0.0	398.6	0.0	2.1	88.0	89.8	92.5	117.3	84.8	81.1	86.1	79.2	80.5	78.6	83.3	79.8	110.0	3.2	4.1	10.4	5.9	57.1	81.2	274.1	24.5	0.8	29.9	1066.2	619.5	4.3	42.1	7.3	0.0	12.1	116.7	1.4	0.0	21.4	4.3	20.3	488.3	80.3	2.4	4.0	2.5	5.7	104.8	332.6	99.4	18.7	2.5	142.0	181.3	1.4	32.4	1.7	4.6	1.9	48.8	3.1	77.9	32.4	283.0	24.2	67.6	9.4	6.5	11.7	1.0	3.0	0.4	8.4	0.1	2072.1	2.9	169.8	0.4	1.3	23.5	0.9	2222.0	594.8	2341.4	2.5	27.3	6.7	42.8	14.6	16.0	106.7	2.8	28.7
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	13	"skeletal muscle: 8905.8;tongue: 6106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	140.7	103.2	95.0	233.2	104.1	590.1	97.1	83.3	116.2	94.9	73.3	199.0	163.5	69.6	73.4	287.4	100.6	136.1	318.5	104.8	101.5	81.5	114.4	178.7	287.3	96.6	101.4	45.4	265.9	91.7	19.6	141.1	101.6	122.3	201.5	60.3	101.5	56.0	8905.8	103.0	167.8	111.6	94.6	208.9	152.8	64.8	93.8	203.0	88.8	6106.5	287.2	183.2	29.7	98.2	529.4	332.8	306.1	225.4	262.1	341.1	317.9	439.0	419.1	597.9	437.7	596.1	513.9	414.6	366.9	500.2	206.4	472.1	320.0	468.7	485.8	315.7	171.9	537.6	234.1	311.7	200.9	728.2	627.5	260.0	246.2	515.8	355.1	224.9	929.4	269.0	411.8	429.7	710.0	342.2	582.0	683.1	714.2	775.9	515.9	510.0	233.2	574.9	405.6	387.4	234.4	409.4	360.0	443.7	419.2	303.9	645.0	788.9	758.8	558.8	353.9	497.3	711.1	332.4	623.0	516.2	490.7	514.7	860.0	932.1	743.2	1729.3	547.2	945.6	480.1	395.2	464.0	504.4	792.6	324.5	347.2	442.6	824.3	386.4	1104.4	392.9	551.5	2029.4	95.0	104.1	83.3	116.2	104.8	101.5	96.6	101.4	101.6	94.6	93.8	98.2	346.0	621.8	343.2	17.6	318.6	149.5	227.6	169.5	127.5	84.2	135.4	88.4	85.0	125.8	275.6	97.5	31.3	127.3	475.7	494.5	105.7	292.1	72.3	353.7	191.1	395.7	141.0	189.8	65.7	347.0	331.0	170.4	245.6	474.2	531.3	119.5	200.3	110.6	559.1	304.5	50.5	291.2	93.6	355.6	504.7	182.3	46.6	648.3	152.9	31.9	704.0	54.5	466.5	12.5	30.6	530.4	363.9	29.7	218.2	204.8	220.1	179.8	230.8	62.8	19.7	155.1	128.5	38.6	67.6	223.6	143.3	101.9	422.6	119.2	302.1	324.6
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103002	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 2111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		370000000	"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	324.1	109.9	24.7	186.3	26.3	33.8	269.0	42.1	40.4	342.4	23.4	255.0	64.6	455.0	10.6	401.8	310.0	144.8	189.6	23.2	27.0	168.1	54.1	374.1	78.2	30.7	28.7	293.8	77.9	23.6	93.4	170.7	31.9	212.1	39.2	3.6	267.2	140.4	50.3	241.4	153.8	190.4	29.1	244.1	201.4	66.2	36.6	32.4	119.4	19.3	68.5	287.5	333.8	27.8	614.5	275.2	194.7	190.9	701.3	728.2	725.6	1082.9	470.3	356.4	357.7	325.5	473.5	31.1	724.2	492.9	383.9	331.6	72.9	386.7	141.6	503.8	138.8	305.4	270.2	232.3	357.0	52.3	728.3	715.2	94.0	327.6	331.1	353.2	427.2	115.7	46.2	217.9	360.8	290.2	152.4	233.0	227.1	461.2	380.4	201.4	413.2	143.4	87.3	387.9	75.3	315.3	670.4	155.5	298.8	90.6	5.3	60.8	1237.2	954.1	166.8	2111.0	875.3	82.4	167.3	142.5	651.4	144.5	337.0	130.8	81.4	5.9	96.0	93.9	71.4	59.6	69.0	84.3	96.6	53.0	18.6	47.2	82.1	75.2	50.4	76.8	151.0	158.4	24.7	26.3	42.1	40.4	23.2	27.0	30.7	28.7	31.9	29.1	36.6	27.8	389.4	400.6	156.6	9.4	148.6	431.1	1297.2	175.2	273.8	45.9	194.3	189.4	49.1	120.1	297.0	242.8	10.4	263.5	205.6	298.4	13.7	717.1	67.3	159.0	506.6	425.5	94.0	33.4	23.8	571.6	852.9	345.1	303.7	305.0	249.6	170.8	288.8	4.2	336.8	5.0	19.0	215.8	101.7	112.0	368.8	54.8	173.1	433.2	142.3	26.2	249.5	7.5	132.8	13.6	48.5	1017.2	258.8	547.2	310.9	900.2	61.2	29.0	133.1	11.7	335.2	170.0	516.6	29.5	10.1	328.2	343.8	568.9	192.0	222.3	162.7	1025.0
TPP1	"CLN2, LPIC, SCAR7, TPP-1"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612768-6619448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		9500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	74.7	145.9	71.0	74.6	81.0	111.7	44.3	80.3	81.4	53.8	120.1	59.1	59.9	74.0	43.1	39.5	47.1	65.1	56.3	70.6	78.4	71.6	92.7	81.5	77.7	85.2	82.6	49.7	36.2	54.2	63.6	94.2	81.0	38.9	59.7	48.5	42.5	57.5	31.4	39.5	73.3	92.0	74.7	135.0	48.4	20.0	83.3	47.4	45.7	39.0	60.9	68.4	42.8	90.4	26.1	48.1	25.9	50.5	309.9	160.1	21.8	50.9	220.7	36.9	62.0	20.1	122.5	37.4	32.6	136.6	220.2	85.8	48.3	68.7	57.9	37.3	27.6	32.2	23.8	54.9	210.9	45.8	182.6	231.8	104.5	45.9	102.6	240.4	158.8	32.9	59.8	124.6	110.4	30.2	16.6	52.4	18.0	61.5	57.1	36.1	21.6	77.0	62.8	38.2	4.5	20.4	52.6	44.6	91.0	76.5	30.8	79.7	188.0	119.7	33.1	101.1	19.8	92.3	95.3	14.0	139.8	101.7	64.5	67.0	167.1	38.2	39.9	171.2	30.0	35.1	31.4	41.0	185.9	37.0	20.1	27.2	27.5	29.1	125.1	93.1	60.3	138.8	71.0	81.0	80.3	81.4	70.6	78.4	85.2	82.6	81.0	74.7	83.3	90.4	32.0	25.6	37.3	31.6	53.0	23.7	28.4	29.8	13.1	24.8	21.1	23.9	41.8	50.1	26.8	16.5	12.5	35.4	71.0	55.2	5.9	42.2	11.8	13.3	30.2	40.7	16.7	37.5	12.5	13.4	45.3	40.3	16.3	24.8	62.2	25.6	75.7	81.0	261.6	15.2	12.4	31.3	26.4	376.5	126.5	11.2	27.1	219.8	90.7	15.9	156.0	37.9	49.4	8.0	21.9	17.4	44.1	26.4	26.4	23.5	99.7	51.6	14.5	23.8	6.6	19.0	20.3	0.8	1.1	27.6	20.0	88.0	42.2	24.6	32.5	26.5
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341284	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23236.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol		NA	NA		1500000	"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB008364: AB_591904, HPA039437: AB_2676508"	"prognostic favorable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.31e-5)"	"unprognostic (6.51e-2)"	5808.9	3790.0	1970.1	2971.0	2089.0	7021.6	4788.5	2017.1	2885.0	4815.0	2151.1	3979.7	3896.8	3466.6	5086.2	4739.6	3764.4	3768.2	4538.7	1920.3	2182.7	4819.1	6862.2	3615.7	5627.2	2141.5	2042.0	6982.0	10645.5	2467.5	2595.3	4390.6	2185.5	3646.9	3385.7	1026.8	8474.6	2254.8	23236.6	3472.5	3896.8	2786.2	2206.2	3281.4	3544.7	821.0	1977.3	3910.4	4425.0	13885.5	4621.3	4859.8	4376.0	2225.8	1905.1	1684.0	2793.7	1836.1	8042.9	11121.9	3311.0	3946.8	6100.9	2460.2	2560.6	3800.8	4814.7	4011.0	3236.5	4125.5	1627.8	3232.7	2281.2	5785.6	3386.6	1869.7	2010.7	3227.6	1369.1	4278.1	8106.1	4451.8	4843.1	9204.7	11563.7	1572.6	9416.5	7957.8	5168.0	3360.7	2443.5	1080.9	5091.4	3449.9	5437.0	10564.3	3194.8	6358.1	1773.3	3370.4	2645.5	3062.6	6392.2	3916.9	1185.4	3165.1	1308.7	4147.6	6396.8	2827.9	2383.4	12710.0	3402.5	1129.5	1605.0	1855.4	2470.9	2644.9	2873.7	3842.4	3013.5	3486.9	899.6	1195.3	1271.4	617.3	1006.6	978.8	1830.5	1337.9	1874.2	1366.7	1138.9	1036.9	1944.6	1636.5	546.5	1513.4	929.3	1454.0	1812.0	3204.4	1970.1	2089.0	2017.1	2885.0	1920.3	2182.7	2141.5	2042.0	2185.5	2206.2	1977.3	2225.8	4176.2	1593.0	3381.6	39.5	4868.3	3494.9	6406.7	2737.1	4501.1	371.9	5018.7	4187.9	2795.4	3154.1	2226.0	763.2	160.6	4470.7	5693.8	3799.1	3144.1	2527.2	1185.2	3111.2	5482.8	3928.3	2068.2	3074.8	44.9	5125.2	6375.7	3310.5	2398.6	5369.5	1842.3	4305.3	5062.0	4784.7	4614.9	213.7	39.1	5716.8	852.4	5939.9	3637.5	1381.9	6800.4	6005.9	1773.4	87.1	6495.9	2240.9	5186.5	25.1	50.5	5271.4	5556.8	3870.4	4453.2	6953.8	11028.2	9311.2	1156.1	656.2	2530.9	5300.1	3028.9	443.5	687.3	5411.6	3479.1	5749.6	5238.7	4437.6	5420.4	9158.8
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 107.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.6	0.9	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.9	0.4	0.5	0.5	0.4	0.6	0.5	0.4	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185913-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	19.8	20.7	7.1	27.7	6.9	60.9	18.5	10.1	10.6	23.0	5.9	24.1	18.3	16.8	3.8	40.4	18.8	11.0	21.8	7.0	6.2	26.8	40.8	26.0	32.8	8.5	6.7	18.8	72.7	7.6	21.9	8.4	6.6	29.1	6.3	3.2	29.0	9.6	29.3	23.6	30.7	5.3	6.7	36.9	27.5	20.8	7.2	16.6	24.8	5.0	15.7	22.6	27.0	6.8	62.8	40.9	14.5	24.7	7.8	9.0	35.9	21.4	14.0	17.6	14.9	26.2	29.6	38.3	20.5	10.1	13.7	38.6	18.8	38.1	3.5	27.1	87.1	22.5	71.2	46.0	30.5	45.4	42.7	14.6	22.9	12.9	17.7	10.3	17.9	37.3	27.8	61.7	7.6	70.5	32.5	51.2	21.3	21.3	38.0	87.6	19.7	83.0	13.4	61.5	16.8	28.0	18.4	66.2	31.3	6.1	28.0	47.0	19.4	14.6	36.2	19.2	24.4	73.9	14.1	46.7	18.0	31.5	23.5	16.9	30.5	51.4	21.2	26.5	20.3	13.6	19.1	19.5	32.5	6.7	12.6	15.3	40.6	32.1	16.7	68.7	29.5	22.4	7.1	6.9	10.1	10.6	7.0	6.2	8.5	6.7	6.6	6.7	7.2	6.8	22.2	9.6	19.3	12.1	80.3	42.1	57.4	48.9	33.6	32.6	38.8	30.1	12.0	17.2	31.8	33.1	18.8	25.5	151.7	66.2	27.4	52.3	20.7	17.1	25.1	27.2	18.0	17.4	11.6	62.9	54.5	27.2	77.5	32.4	27.3	31.6	12.8	24.0	46.4	43.7	12.9	55.3	46.8	46.9	59.4	8.8	32.3	69.6	42.7	9.4	111.4	22.5	117.4	14.1	15.3	80.6	67.7	32.4	133.1	125.9	55.0	28.9	19.7	32.8	19.7	20.5	23.7	49.9	31.5	34.3	45.6	30.6	84.3	31.2	71.0	92.5
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	8.3	7.9	14.9	13.8	16.9	16.1	9.1	20.0	18.8	10.6	13.2	11.1	9.9	8.3	4.1	15.3	8.3	6.0	11.0	15.6	14.3	10.3	15.1	9.6	20.2	17.9	15.7	7.3	8.0	4.8	10.1	8.3	18.2	12.5	5.5	4.2	11.5	8.3	8.5	12.1	12.0	6.2	14.9	16.8	9.6	17.8	15.7	17.8	14.1	5.1	14.7	11.0	11.5	18.1	25.4	76.3	20.2	18.0	5.6	8.8	39.5	20.5	11.1	29.2	19.8	47.5	44.5	31.2	25.8	12.8	39.3	65.0	27.9	33.3	11.8	47.9	22.8	23.6	76.2	30.0	8.3	23.5	23.4	6.6	9.9	23.7	13.4	10.9	13.9	28.5	40.5	34.5	13.2	36.6	38.3	33.6	33.1	57.4	33.9	35.8	31.1	42.7	18.0	19.6	32.9	15.4	25.6	58.9	23.7	22.5	42.4	27.2	15.7	37.8	24.2	24.6	34.8	14.3	25.2	31.2	13.3	19.2	28.5	2.0	4.8	9.1	12.3	5.8	17.8	15.2	13.4	15.6	6.5	12.3	10.7	13.2	4.2	14.0	12.0	14.8	24.0	8.3	14.9	16.9	20.0	18.8	15.6	14.3	17.9	15.7	18.2	14.9	15.7	18.1	7.9	0.0	6.4	7.5	12.5	11.9	14.1	18.1	4.0	6.9	8.3	7.0	7.5	12.8	8.7	5.5	0.0	19.4	7.4	23.3	3.9	19.2	3.2	4.4	4.3	11.0	11.4	9.0	5.6	12.8	28.9	6.9	9.7	6.1	10.2	11.8	4.2	4.1	13.3	18.5	4.5	16.1	6.1	2.2	8.7	4.1	3.4	6.2	14.2	2.8	32.7	4.5	11.3	2.5	5.7	20.8	6.2	7.9	11.3	20.0	15.6	6.3	5.6	9.8	19.7	4.1	7.4	17.5	23.8	5.3	12.8	17.8	13.9	6.5	15.4	10.0
TRAF4	"CART1, MLN62, RNF83"	ENSG00000076604	"TNF receptor associated factor 4"	Q9BUZ4	17	28744005-28750956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 54.0"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 54.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009055, HPA021904, HPA052377"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804"	"unprognostic (1.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.58e-3)"	10.7	19.4	16.1	11.2	17.8	31.2	19.3	15.6	19.1	10.9	18.4	28.4	47.1	9.1	4.1	28.6	14.4	20.3	5.2	15.5	15.5	45.0	60.1	22.7	18.8	18.6	17.7	12.2	32.1	4.0	14.5	16.4	17.0	31.4	22.2	3.6	46.8	6.9	1.8	15.4	38.7	5.1	15.6	19.0	35.9	15.1	16.3	13.6	29.1	0.8	20.1	36.7	11.8	23.9	41.2	62.7	85.3	41.6	12.0	13.9	131.2	27.3	22.8	28.2	37.2	50.2	50.0	62.5	38.8	29.9	19.0	61.0	39.1	61.5	11.6	20.3	58.5	22.5	111.7	58.3	45.9	10.9	25.0	26.5	59.2	33.2	39.7	25.5	22.2	29.1	60.1	5.4	26.1	67.3	34.6	22.7	65.9	80.2	14.4	52.1	38.8	30.6	80.8	115.7	53.2	61.3	42.0	181.7	84.3	73.4	69.5	17.2	15.0	17.8	37.4	20.3	39.2	8.2	21.3	80.1	14.0	17.8	81.9	5.7	0.5	1.9	1.0	1.1	2.6	9.7	1.8	1.9	2.9	9.3	1.3	1.3	0.2	1.8	0.9	54.0	1.0	1.8	16.1	17.8	15.6	19.1	15.5	15.5	18.6	17.7	17.0	15.6	16.3	23.9	9.3	22.4	28.3	28.4	59.2	137.5	185.0	58.2	122.3	3.4	134.8	100.1	0.4	44.3	66.7	20.2	6.2	107.9	88.3	121.3	43.0	78.5	53.4	102.8	22.8	20.7	84.1	4.8	0.9	109.2	136.8	20.4	83.1	133.7	7.0	10.1	8.9	38.1	13.9	8.4	1.6	81.6	61.1	2.2	71.9	12.1	3.7	16.0	39.2	3.7	7.3	23.0	5.2	37.7	19.8	128.0	125.7	1.5	36.6	219.0	155.7	33.8	68.7	2.3	0.0	9.8	34.9	5.8	22.6	57.7	78.6	124.4	31.5	14.5	93.5	346.4
TRAM1	"TRAM, TRAMP"	ENSG00000067167	"Translocation associated membrane protein 1"	Q15629	8	70573218-70608416	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023929	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA023929: AB_1858239"	"unprognostic (3.85e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (8.34e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.85e-2)"	93.2	82.8	26.6	95.9	28.9	102.3	115.8	27.6	42.1	139.2	47.7	85.4	91.7	93.4	148.5	65.2	78.5	117.7	59.8	24.8	31.1	120.7	190.2	146.3	103.5	32.5	27.9	73.4	175.5	117.3	38.8	146.8	32.4	87.2	79.7	33.3	193.9	86.0	26.7	49.2	93.6	96.7	29.1	90.0	94.7	61.0	29.1	98.6	170.7	54.9	114.3	120.2	47.7	34.5	171.1	172.5	73.6	45.2	352.6	367.8	105.2	302.9	301.7	231.7	279.1	109.9	275.8	169.1	58.5	259.6	91.3	219.3	67.6	262.1	221.8	112.2	76.1	118.5	54.6	125.7	515.4	91.3	66.3	441.5	249.6	114.2	410.8	238.5	196.7	85.0	77.8	430.3	288.6	47.2	210.4	65.7	48.3	132.3	81.0	100.9	55.3	113.8	610.5	160.4	53.4	54.2	195.0	389.0	180.5	103.1	144.1	102.0	195.3	141.0	117.5	162.4	102.0	338.7	140.1	85.5	160.3	92.9	105.0	150.1	97.3	64.9	120.8	107.7	153.5	107.9	132.1	137.6	114.3	87.9	119.6	125.2	28.2	130.7	113.7	190.4	146.8	232.7	26.6	28.9	27.6	42.1	24.8	31.1	32.5	27.9	32.4	29.1	29.1	34.5	138.3	275.7	132.0	19.6	166.4	85.5	85.2	214.0	69.4	23.7	114.2	62.4	43.0	131.5	209.3	178.4	14.6	154.3	200.5	69.3	68.4	174.5	142.8	77.9	140.7	134.3	44.2	59.7	27.4	247.7	236.7	177.0	70.8	186.6	72.4	59.0	137.8	202.9	182.7	23.5	26.1	95.5	156.6	134.9	251.0	222.2	127.4	123.7	202.7	29.0	132.1	65.6	128.8	34.2	40.3	290.5	51.0	94.4	670.6	199.6	78.0	147.0	110.2	32.9	124.9	76.4	99.5	134.8	56.8	72.3	88.5	194.3	154.2	78.2	65.5	130.6
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717553	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	46.4	50.6	32.5	32.7	35.6	35.6	45.7	28.9	37.6	54.0	22.7	50.0	39.7	42.5	18.5	72.2	59.0	33.3	88.1	34.5	34.2	59.9	121.5	33.3	47.6	33.1	32.2	58.8	76.2	39.9	35.3	33.3	33.5	41.6	36.9	22.3	46.1	26.5	193.9	67.7	36.7	30.3	26.8	39.9	49.5	40.1	36.7	27.5	33.3	138.9	36.4	48.9	50.4	32.5	113.4	277.6	56.7	150.2	61.1	62.1	167.6	67.6	60.7	152.2	95.3	347.9	156.5	361.1	123.7	65.1	41.1	207.3	223.0	167.7	67.1	139.3	241.8	105.9	225.1	246.0	105.3	192.0	69.4	74.2	114.6	121.1	188.2	55.0	106.1	122.5	338.4	120.8	50.5	367.8	138.6	141.5	106.0	133.8	140.1	314.1	118.9	500.6	112.8	83.0	268.4	102.2	70.0	254.5	135.8	46.5	184.5	137.2	60.2	63.7	112.9	112.5	99.5	135.5	161.1	289.2	39.7	152.1	88.8	0.1	24.0	0.8	24.7	38.9	47.3	42.1	36.0	31.5	54.9	30.7	42.1	35.9	2.6	31.9	29.8	8.4	33.4	33.0	32.5	35.6	28.9	37.6	34.5	34.2	33.1	32.2	33.5	26.8	36.7	32.5	20.4	22.4	17.5	16.3	21.3	25.4	44.3	63.2	38.1	29.3	32.4	36.8	2.1	45.8	39.8	31.3	10.4	112.6	5.9	28.7	88.0	67.7	24.1	30.6	21.1	21.3	35.5	42.1	31.6	53.8	56.2	23.7	36.2	28.1	16.5	41.5	12.8	48.8	46.1	47.1	31.1	37.5	59.0	14.5	14.8	13.0	16.4	14.7	12.4	12.2	26.3	20.2	12.3	11.6	16.2	31.9	14.5	21.4	37.9	45.9	14.1	140.9	30.1	22.2	19.7	29.9	29.4	37.2	70.9	70.7	28.1	67.2	15.1	58.9	74.9	42.8
TRAPPC10	"EHOC-1, TMEM1, TRS130"	ENSG00000160218	"Trafficking protein particle complex 10"	P48553	21	44012309-44106552	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.2;Oligodendrocytes: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"basophil: 9.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050423	Supported					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA050423: AB_2681123"	"unprognostic (1.82e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.76e-1)"	5.6	4.3	2.8	7.3	5.7	17.4	4.6	4.1	4.7	4.9	3.5	7.0	5.3	5.1	7.8	5.6	5.3	5.4	4.8	3.1	4.2	7.0	6.1	5.8	10.0	4.6	4.8	3.6	5.0	7.5	3.4	6.0	5.5	3.8	7.4	6.1	5.3	4.1	6.2	5.5	6.7	5.3	3.5	7.5	6.8	7.6	4.8	10.1	7.0	5.6	11.9	5.3	4.2	10.5	12.1	5.8	8.7	6.0	15.7	8.0	8.7	10.8	10.7	10.9	11.5	12.8	6.8	15.1	3.6	10.5	20.7	5.6	8.5	11.7	16.0	9.8	8.2	20.7	6.2	4.8	7.2	14.0	12.1	6.3	12.4	14.0	11.0	8.3	12.3	9.3	15.4	15.7	18.4	8.6	8.0	6.7	10.1	8.8	8.8	8.9	5.7	12.4	6.1	8.2	12.4	7.2	9.8	10.8	10.1	4.5	5.9	11.9	12.9	11.2	7.6	12.8	10.5	14.8	14.3	10.8	6.9	13.2	8.7	9.7	0.4	0.9	0.6	0.6	0.1	0.3	0.7	0.6	0.3	0.5	0.3	0.5	0.8	0.4	0.7	0.7	0.0	0.2	2.8	5.7	4.1	4.7	3.1	4.2	4.6	4.8	5.5	3.5	4.8	10.5	17.1	0.0	3.6	26.1	28.9	16.6	12.5	6.9	4.6	29.2	12.0	9.4	10.0	4.3	5.5	12.9	39.6	4.2	81.2	25.1	9.8	1.8	14.3	19.7	20.2	10.6	8.3	4.2	35.8	2.2	4.3	9.5	10.2	29.8	8.2	11.7	10.4	11.1	7.5	18.5	33.3	11.0	10.2	9.4	19.1	33.8	7.8	17.6	12.4	32.8	10.3	11.3	65.9	24.6	132.9	4.8	15.7	7.2	28.0	13.1	7.9	12.4	12.0	39.4	0.0	17.4	13.1	25.4	20.6	5.5	23.3	7.7	37.0	23.1	11.5	19.5
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018763-119025454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA039752: AB_2676664, HPA041371: AB_2677439"	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.8	37.8	14.6	4.3	14.8	8.2	20.2	15.3	18.6	17.9	15.5	22.9	8.4	17.9	11.8	21.3	18.0	5.2	27.2	14.4	16.7	36.8	26.1	19.5	8.1	15.6	15.0	15.5	25.5	13.5	29.2	5.6	15.0	20.8	6.1	9.2	18.9	12.3	38.3	19.6	23.6	4.0	15.3	22.1	22.6	31.5	14.7	16.9	17.6	18.2	6.1	19.3	16.0	16.2	15.5	14.1	16.9	20.2	25.2	19.3	8.7	59.6	44.3	45.6	40.0	35.1	6.4	18.6	40.3	27.2	23.6	14.5	32.0	25.9	32.9	31.5	15.3	28.5	14.2	40.0	33.4	25.3	14.8	25.1	29.2	40.1	30.1	23.5	42.3	20.7	34.7	7.3	28.8	38.6	30.0	24.9	13.7	30.0	44.4	26.3	13.1	25.9	34.7	20.2	7.4	16.2	10.5	13.1	15.4	19.8	58.5	21.5	24.9	10.5	18.8	13.1	19.7	9.2	18.9	45.9	11.8	20.1	18.5	68.3	37.0	77.0	50.8	45.8	53.5	59.1	59.6	59.8	37.2	55.5	54.7	59.6	32.6	54.6	58.3	52.4	96.4	61.2	14.6	14.8	15.3	18.6	14.4	16.7	15.6	15.0	15.0	15.3	14.7	16.2	50.3	38.5	34.4	7.5	38.8	51.4	59.1	166.1	37.5	60.1	38.4	38.7	30.8	41.5	83.4	71.7	14.6	90.7	61.1	30.4	140.8	107.6	41.9	46.0	39.1	47.7	67.6	45.3	9.0	76.2	56.5	45.1	15.3	33.2	62.1	335.0	46.1	21.8	80.4	38.7	11.7	33.5	152.5	27.3	30.7	16.4	44.4	33.1	30.2	10.3	76.3	88.5	41.2	10.1	15.0	103.4	44.3	60.9	26.9	51.1	83.0	206.1	89.0	61.2	46.0	21.6	82.2	78.2	67.0	28.7	59.0	87.3	52.7	49.1	36.8	52.4
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	7	"Macrophages: 75.6;monocytes: 28.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 92.4"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 92.4"	"Cell line enriched"	"Detected in single"	170	"HEL: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		43000000	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	0.9	1.0	1.7	2.7	2.1	8.7	0.5	2.2	4.5	0.3	1.3	0.3	0.0	0.1	0.4	0.1	0.4	0.9	0.3	1.9	2.5	0.2	0.3	2.1	5.4	3.3	2.4	0.1	0.4	0.2	0.4	0.5	2.8	0.2	0.9	0.2	0.4	0.3	0.1	0.3	0.4	0.2	2.5	7.3	0.2	0.1	3.6	4.1	0.3	0.5	4.8	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	1.7	2.8	0.2	1.8	0.4	0.2	0.1	0.0	0.7	0.3	0.5	0.0	10.7	0.0	0.3	0.9	0.0	110.6	1.7	2.1	2.2	4.5	1.9	2.5	3.3	2.4	2.8	2.5	3.6	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.0	75.6	0.0	6.5	28.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41189749-41201149	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.4;lymphoid tissue: 9.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 23.3;neutrophil: 33.3"	"Group enriched"	"Detected in many"	15	"B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		3400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.0	0.1	6.4	0.1	14.4	0.1	0.2	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.3	0.5	0.1	0.1	0.5	0.0	0.1	0.7	9.5	0.1	0.1	0.0	0.2	0.4	0.0	3.0	0.2	0.0	0.3	0.1	0.3	0.0	0.8	0.1	1.1	0.3	0.0	6.6	0.3	3.7	0.1	6.9	0.1	0.8	7.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.4	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	5.2	0.0	2.6	0.6	13.4	0.4	1.2	0.5	6.0	1.0	0.2	2.2	23.3	1.3	0.4	33.3	0.7	1.4	9.3	0.7	2.0	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.4	37.3	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	8.8	0.2	0.0	0.0	0.0
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406835	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	10.2	12.1	12.7	8.9	16.0	30.7	10.4	23.9	15.2	14.7	10.1	13.6	7.7	11.5	4.5	20.7	12.7	6.1	8.7	14.4	11.6	12.2	10.2	11.8	12.2	11.6	9.9	11.9	11.9	6.7	9.8	5.6	10.8	15.4	7.1	2.0	17.1	7.0	5.0	17.1	14.6	4.6	8.6	24.1	12.9	14.9	13.2	10.1	11.0	3.1	8.7	11.7	15.6	11.0	28.3	26.3	13.8	19.1	10.2	8.4	65.1	18.1	12.1	20.5	16.4	32.2	24.0	21.1	19.7	12.2	13.5	45.1	16.8	17.4	8.6	23.6	40.5	17.5	26.7	17.6	27.6	22.2	25.6	11.3	27.2	21.3	10.6	10.5	10.2	33.9	40.7	26.4	10.7	18.2	27.1	35.1	35.3	23.9	22.9	26.3	12.5	25.8	13.4	34.0	22.9	42.0	15.1	42.2	24.7	5.6	29.9	36.8	11.6	13.0	18.3	30.6	37.9	26.9	19.3	18.9	16.1	17.7	20.9	5.2	4.5	5.6	5.5	5.3	5.9	3.7	6.4	7.1	4.4	3.5	3.6	5.1	6.2	6.2	7.5	3.5	6.4	3.9	12.7	16.0	23.9	15.2	14.4	11.6	11.6	9.9	10.8	8.6	13.2	11.0	7.8	3.2	5.8	1.6	12.1	15.8	16.3	7.4	10.8	12.1	13.3	10.7	3.6	12.8	10.4	1.8	2.1	15.7	21.6	28.1	17.6	14.8	154.2	11.2	10.2	10.1	14.4	12.6	9.8	11.0	15.5	8.5	23.4	17.1	5.7	13.4	8.9	5.7	11.8	5.0	4.7	21.7	4.1	12.6	9.3	16.5	9.6	11.0	5.4	2.8	22.0	10.3	30.9	3.0	3.2	18.3	21.1	7.5	12.8	17.4	17.8	9.9	7.3	1.6	6.6	8.4	9.1	7.3	12.4	15.8	19.5	57.3	18.9	14.9	17.6	30.1
TRIM21	"RNF81, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004566, HPA005673"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favorable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.26e-6)"	"unprognostic (9.12e-3)"	14.1	13.0	6.1	21.6	6.0	27.7	11.9	5.9	8.0	11.9	7.2	17.1	20.3	12.5	13.0	12.0	14.6	12.9	13.1	5.5	6.8	16.3	17.6	23.5	23.8	8.2	6.3	20.6	11.7	6.8	7.1	14.4	7.0	11.3	18.4	2.4	19.5	12.9	5.5	11.4	19.2	17.9	7.8	32.5	15.5	3.5	7.8	21.8	10.0	8.2	23.2	16.7	10.9	7.2	13.5	15.5	7.7	7.3	15.5	23.1	10.7	16.8	31.7	64.6	71.4	7.2	37.6	20.5	7.5	25.0	66.5	18.4	13.6	25.7	20.1	34.5	14.6	31.6	8.5	6.5	34.3	37.3	29.6	22.7	14.9	13.0	9.2	23.3	40.3	17.3	10.1	21.6	21.9	11.9	19.8	26.5	6.6	14.9	8.0	13.8	10.0	10.9	25.6	12.0	0.1	3.3	13.8	14.9	19.1	12.0	5.3	24.5	36.7	15.6	12.3	8.3	6.1	11.4	9.5	13.0	14.0	29.2	11.5	105.2	132.4	311.9	89.3	139.6	78.6	50.2	76.6	81.1	109.5	57.9	67.6	71.7	354.0	78.0	130.9	36.7	100.1	175.2	6.1	6.0	5.9	8.0	5.5	6.8	8.2	6.3	7.0	7.8	7.8	7.2	8.9	9.6	6.3	0.0	6.4	2.0	6.1	7.5	11.4	0.4	2.7	3.2	2.3	12.8	9.8	5.5	0.0	6.8	11.0	12.8	7.9	11.3	0.1	3.7	4.5	7.8	2.4	8.2	0.2	8.5	9.6	5.7	10.2	5.7	12.6	8.1	9.7	8.7	9.6	1.7	0.1	7.3	0.0	11.9	2.2	1.3	4.4	9.6	1.8	1.9	20.7	2.6	22.6	1.0	0.1	9.7	4.7	7.2	4.0	4.3	10.0	4.9	7.9	0.0	13.1	4.7	5.3	0.3	0.8	4.7	1.7	9.0	10.5	4.5	6.0	3.8
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56836387-56914080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 23.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	16.3	20.7	9.8	19.8	10.4	47.7	13.1	9.5	23.2	14.5	11.1	19.7	19.4	12.1	8.5	20.4	18.2	9.7	11.1	9.0	11.3	11.9	29.8	25.0	17.3	10.3	9.9	14.3	16.7	13.0	10.3	9.5	10.3	9.3	17.3	11.8	15.3	7.4	12.6	29.2	20.2	12.4	11.4	41.6	17.0	9.1	12.1	18.5	10.8	7.6	19.7	12.1	14.6	9.0	77.2	37.4	9.0	30.7	66.6	55.8	0.1	29.6	59.6	69.4	59.3	36.7	41.1	74.6	59.8	28.6	75.4	44.5	44.5	39.9	38.5	64.1	35.0	48.1	29.0	41.0	57.0	58.2	33.2	25.1	65.7	36.2	76.4	32.9	46.7	50.2	12.0	43.8	35.8	51.3	65.6	41.9	5.8	63.3	71.5	46.3	30.2	47.4	40.5	59.7	17.5	16.3	23.3	37.1	69.7	5.8	50.3	46.8	31.3	32.2	23.1	50.1	31.2	24.7	51.1	12.1	31.2	39.4	13.0	4.8	3.0	1.2	1.0	2.5	1.3	2.2	0.9	1.0	3.1	1.7	0.7	1.0	23.5	1.1	1.8	2.2	2.0	1.1	9.8	10.4	9.5	23.2	9.0	11.3	10.3	9.9	10.3	11.4	12.1	9.0	27.3	35.3	19.8	7.5	12.7	18.5	8.5	10.5	13.1	9.9	12.6	11.9	7.5	20.0	16.6	9.2	29.2	5.4	15.1	54.8	0.0	19.1	3.5	44.9	20.0	32.7	18.6	11.1	4.1	21.6	10.7	16.0	32.6	72.5	3.8	23.0	32.2	30.9	14.8	3.3	8.2	28.7	6.1	27.5	24.6	2.1	9.6	29.3	14.2	8.4	28.3	5.7	11.3	12.1	0.3	32.2	54.2	9.4	17.7	21.6	20.0	8.0	18.5	22.2	6.6	13.1	9.2	0.4	0.3	24.5	30.5	15.9	11.5	45.3	25.7	25.4
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544064-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 2817.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	103.1	111.0	83.5	103.8	85.9	217.5	104.4	91.1	100.1	152.9	77.5	159.9	90.8	163.3	42.8	132.6	142.8	73.6	114.7	83.1	80.1	122.1	104.6	103.5	142.5	85.5	83.4	228.1	183.7	89.4	98.7	108.9	89.1	128.8	57.8	39.4	108.4	108.8	172.4	143.3	117.7	94.6	86.0	137.4	136.7	215.5	82.8	186.6	117.9	77.0	109.2	147.7	115.1	97.2	481.6	1080.4	491.9	365.1	218.9	186.5	616.5	321.5	291.1	311.4	237.0	732.8	375.0	562.5	196.1	270.7	492.8	317.7	590.5	480.5	163.6	281.3	2817.1	1012.8	407.6	537.7	254.4	640.9	577.5	252.4	248.2	385.9	274.9	220.1	301.3	597.7	507.1	259.4	284.8	705.0	756.5	640.8	372.8	443.6	637.5	761.9	340.9	550.2	260.8	730.6	517.1	403.4	343.9	359.3	170.7	131.9	273.2	493.1	272.4	643.1	273.2	148.6	562.5	397.7	665.7	604.7	293.0	432.9	418.6	1.9	9.7	8.2	12.8	11.1	17.2	15.9	18.0	17.4	13.7	19.1	22.8	20.5	4.3	24.9	7.9	21.2	12.4	10.1	83.5	85.9	91.1	100.1	83.1	80.1	85.5	83.4	89.1	86.0	82.8	97.2	60.8	12.8	18.6	18.3	51.0	64.2	60.2	34.7	47.3	61.8	86.6	87.5	9.5	51.5	29.0	33.1	27.1	61.2	72.4	88.3	23.5	44.8	96.9	70.7	53.3	49.7	64.6	46.7	10.3	56.3	61.6	48.3	65.7	80.2	21.6	136.3	35.7	31.9	46.9	55.5	12.6	79.4	14.2	36.5	70.7	110.6	65.9	48.3	28.4	6.5	32.8	49.8	19.6	10.6	18.2	56.3	50.0	41.3	43.5	52.1	47.3	36.3	28.7	34.1	59.2	69.3	61.6	158.7	83.1	58.0	60.7	56.1	54.5	80.9	94.1	45.6
TRIOBP	"DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara"	ENSG00000100106	"TRIO and F-actin binding protein"	Q9H2D6	22	37697048-37776556	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003747, HPA019769"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA003747: AB_1858328, HPA019769: AB_1858329"	"unprognostic (2.94e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.67e-2)"	56.3	46.5	15.4	27.3	16.6	25.7	50.8	14.7	14.9	73.1	22.1	70.6	23.9	71.8	12.8	78.5	66.1	27.8	74.6	12.8	13.2	37.2	21.6	51.6	17.4	20.0	17.2	55.7	32.7	31.1	16.9	44.2	16.5	45.3	17.0	4.8	44.3	33.3	24.3	32.0	38.0	31.0	16.6	53.1	53.6	26.1	16.9	16.7	48.2	14.3	12.5	66.5	65.7	17.3	65.9	53.1	33.2	26.4	73.1	118.1	47.5	113.0	111.9	57.7	42.1	11.8	44.8	24.5	30.4	69.6	31.6	52.7	9.2	63.7	18.1	39.6	29.1	6.8	41.6	22.4	75.5	32.1	28.9	47.1	29.8	52.0	24.5	125.3	71.9	20.6	6.4	34.6	45.5	39.3	14.4	23.1	20.2	65.4	63.2	25.1	23.9	17.2	41.0	52.8	16.2	25.4	50.9	46.5	59.7	32.8	25.4	23.0	151.9	87.2	38.6	60.6	27.0	30.4	9.1	15.4	82.7	13.0	104.3	7.7	7.6	12.2	1.8	7.5	0.6	1.3	1.5	1.8	4.1	2.4	1.2	1.8	18.2	1.9	12.5	1.9	2.5	2.0	15.4	16.6	14.7	14.9	12.8	13.2	20.0	17.2	16.5	16.6	16.9	17.3	102.0	19.2	29.7	17.9	10.7	6.2	48.3	18.3	18.8	22.8	40.1	45.1	65.2	62.9	23.3	58.8	2.1	105.7	14.7	63.8	15.6	42.7	30.3	32.6	107.0	91.6	22.9	28.2	4.7	51.6	34.2	65.5	58.1	34.2	6.3	128.1	124.6	17.1	42.7	16.8	4.6	52.1	6.1	56.0	7.5	10.6	113.1	31.2	14.2	27.2	32.0	29.6	8.2	7.5	14.0	62.8	46.9	92.2	9.5	41.9	24.8	15.8	23.9	7.3	52.6	17.7	31.8	49.8	23.4	57.2	6.1	116.0	12.7	22.5	40.6	57.9
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751530	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 362.8"	"Cell type enhanced"	"Detected in many"		"monocytes: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 26.4"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		24000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	110.7	60.3	15.5	25.5	15.6	8.6	92.3	15.3	17.8	123.9	18.6	112.1	30.5	66.5	17.5	253.3	80.1	27.6	125.7	14.6	16.7	81.7	27.0	115.4	14.5	17.5	16.5	99.4	44.7	18.6	22.4	48.6	16.0	80.4	19.9	16.9	85.4	45.0	362.8	57.8	56.0	26.4	15.8	40.0	58.6	29.9	17.5	9.6	75.5	177.3	21.9	86.7	147.4	14.8	83.5	49.7	17.1	25.8	64.7	67.9	61.1	52.5	60.0	58.8	51.1	67.8	46.7	1.8	69.2	44.6	47.6	60.2	38.8	76.5	34.7	52.5	15.5	27.0	48.4	52.3	53.4	1.4	8.3	79.0	50.9	52.5	39.8	77.2	61.2	3.7	40.2	22.1	43.7	28.3	7.5	18.7	36.3	51.9	41.7	12.2	35.1	24.5	50.0	40.9	0.1	19.6	69.1	30.7	20.0	39.4	32.2	14.7	120.5	39.3	70.4	103.8	56.4	23.1	13.4	8.4	63.6	7.9	26.2	0.0	0.8	0.0	0.6	0.1	0.9	1.5	0.3	1.1	5.2	1.7	0.3	0.2	0.1	2.5	0.1	26.4	0.0	0.5	15.5	15.6	15.3	17.8	14.6	16.7	17.5	16.5	16.0	15.8	17.5	14.8	43.0	28.9	19.8	6.5	5.6	85.4	104.9	76.9	43.9	14.7	28.3	16.6	8.7	20.0	66.9	16.5	37.5	9.9	16.5	39.1	5.9	45.0	16.4	30.3	32.1	43.1	7.7	4.4	0.1	38.0	37.9	66.3	10.7	55.7	29.7	8.8	38.9	3.7	9.6	0.0	0.2	16.3	24.4	6.7	90.4	13.6	55.9	19.6	37.4	3.7	196.9	12.5	0.0	5.5	0.4	91.5	24.7	36.1	9.0	116.6	25.8	23.8	24.8	18.5	32.9	26.4	46.4	5.7	6.9	51.3	83.3	14.2	7.4	24.5	25.9	120.7
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRIP12	"KIAA0045, TRIPC, ULF"	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763837-229923239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036835: AB_2675340, HPA045893: AB_2679486"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	48.2	32.3	20.2	47.1	26.7	53.9	33.6	20.2	31.4	34.8	15.7	40.8	25.6	30.8	33.4	47.6	28.1	33.9	41.5	16.0	25.4	41.3	42.8	33.3	48.2	20.7	20.8	32.7	29.3	45.0	24.8	44.6	22.1	39.9	33.9	34.8	30.2	33.0	81.7	29.3	27.6	38.2	17.9	41.1	39.1	127.7	21.5	60.3	44.5	59.0	56.3	46.3	26.5	30.0	97.1	100.7	96.2	79.0	94.9	106.2	88.3	144.5	103.0	106.9	118.7	80.5	75.3	37.8	96.2	135.6	129.5	76.3	140.5	105.9	159.3	132.4	52.9	264.1	84.4	78.3	76.4	195.8	163.2	88.1	80.3	174.9	108.5	74.9	145.1	88.2	188.2	38.2	122.5	72.5	105.3	68.5	77.0	50.3	47.7	94.8	189.8	33.6	75.7	156.4	94.4	67.5	1.6	51.9	97.7	85.1	48.2	118.3	188.8	133.9	94.7	84.9	115.5	66.4	79.3	119.0	103.8	77.0	116.6	34.0	14.2	23.6	12.9	16.2	13.1	9.6	12.0	12.7	13.4	8.9	9.5	9.7	36.0	13.9	18.7	12.6	19.5	9.8	20.2	26.7	20.2	31.4	16.0	25.4	20.7	20.8	22.1	17.9	21.5	30.0	78.3	89.8	51.2	85.8	43.4	31.0	32.8	36.3	25.6	31.2	41.2	29.8	91.0	34.3	52.8	31.3	52.1	27.0	60.8	57.3	15.6	37.5	119.5	63.5	65.2	59.3	18.6	40.2	147.6	45.1	25.1	43.7	56.6	73.5	39.2	53.1	50.0	54.3	35.1	42.1	130.3	32.5	30.5	89.6	32.2	102.1	34.8	70.8	26.6	122.7	63.9	25.8	56.7	127.2	251.3	57.8	35.0	45.5	52.1	44.7	25.7	34.5	73.1	32.1	19.7	57.5	45.0	137.2	59.3	43.1	36.2	42.4	47.0	60.2	31.9	54.5
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111875-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 131.7;Late spermatids: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 84.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	15.7	24.0	11.2	7.6	11.4	8.2	16.8	11.4	16.8	17.7	12.0	15.3	8.7	14.7	4.4	16.3	16.0	6.4	13.8	11.3	10.6	18.0	31.4	12.9	13.1	12.2	10.9	15.5	24.2	5.8	21.8	5.5	11.9	20.7	2.7	2.4	19.1	5.6	15.6	17.1	16.3	3.6	11.1	28.1	17.2	22.8	11.7	10.2	18.7	4.8	5.2	15.3	13.8	12.9	13.8	15.4	6.1	9.9	6.0	4.4	20.9	12.3	6.4	9.7	8.8	18.5	11.7	18.7	10.2	5.9	7.4	21.0	4.5	7.2	1.4	20.3	52.2	22.7	23.3	17.0	15.8	34.9	21.2	8.2	9.0	10.3	3.8	6.7	9.9	15.4	84.5	13.1	6.8	21.7	19.5	21.6	11.2	16.2	19.9	22.8	10.6	7.4	5.7	15.1	16.0	12.2	7.9	18.9	21.5	2.6	13.6	28.7	9.3	11.5	15.4	9.3	10.6	44.3	21.6	14.6	15.2	14.7	11.9	10.2	12.2	7.4	9.8	15.3	14.4	9.7	10.3	11.7	14.3	6.3	11.1	11.1	1.5	10.6	13.5	12.7	8.4	12.3	11.2	11.4	11.4	16.8	11.3	10.6	12.2	10.9	11.9	11.1	11.7	12.9	10.8	12.8	13.8	13.4	13.4	9.8	10.2	13.9	9.6	12.5	15.9	18.0	7.4	14.3	14.1	11.0	8.4	25.0	18.3	17.0	13.7	12.3	131.7	8.9	9.5	10.9	18.6	14.5	6.9	13.0	18.9	10.8	15.8	6.6	25.4	15.8	8.9	18.6	25.0	15.2	7.4	13.4	14.2	18.9	8.9	206.4	17.7	13.7	7.2	4.7	16.9	22.7	12.3	3.5	9.0	13.0	13.4	14.3	18.1	12.1	14.4	10.5	11.9	12.8	6.6	11.8	11.2	16.4	13.7	10.4	11.2	28.5	16.6	19.2	20.0	9.7
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 9.4;Excitatory neurons: 14.6;Granulosa cells: 12.3;Inhibitory neurons: 20.0;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 37.1;SH-SY5Y: 33.8;SuSa: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	3.9	3.0	13.9	1.3	10.6	1.0	3.7	0.8	23.7	9.5	0.9	3.2	0.9	13.4	6.6	1.6	5.3	4.2	2.4	9.3	17.2	3.9	16.8	2.1	1.6	6.2	5.1	17.5	7.1	5.3	24.4	4.3	6.9	5.5	2.1	6.2	1.5	5.2	31.1	1.2	1.6	8.6	3.4	1.0	2.0	2.6	12.6	4.7	10.1	1.0	1.6	2.5	5.5	13.3	0.0	0.3	37.1	0.1	7.1	9.8	0.0	2.1	13.1	2.0	0.7	0.0	0.0	0.0	5.3	13.8	3.1	0.2	0.3	0.6	1.0	0.1	23.3	18.0	0.0	1.5	2.7	0.0	0.1	22.8	0.0	12.0	0.0	11.8	0.9	9.1	0.0	0.2	14.0	0.0	0.3	0.1	19.6	0.1	0.0	11.3	16.4	0.1	3.5	0.3	25.3	33.8	0.0	0.5	3.1	74.2	0.0	2.2	0.0	15.7	15.9	0.2	2.2	5.8	0.9	0.0	2.3	0.0	13.8	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.2	0.1	0.9	0.0	0.1	13.9	10.6	0.8	23.7	9.3	17.2	6.2	5.1	6.9	3.4	12.6	13.3	0.4	0.0	0.0	9.4	0.3	0.4	1.4	0.8	5.2	4.2	0.5	1.9	1.8	0.0	1.9	3.7	0.0	0.8	0.2	0.0	0.0	1.7	0.4	0.3	7.9	1.9	0.0	0.0	14.6	0.2	0.6	7.0	0.5	0.5	1.3	12.3	0.4	0.0	0.5	8.4	20.0	0.0	0.0	0.0	0.4	0.6	5.9	0.2	0.0	1.0	0.1	2.2	0.0	17.1	9.4	0.2	0.0	3.8	0.1	0.4	0.0	0.4	0.0	0.9	0.0	1.5	3.3	1.2	1.9	0.1	0.1	0.7	0.7	2.9	0.0	0.3
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37632063-37869802	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 11.9;seminal vesicle: 9.0;smooth muscle: 12.6"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 133.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;BJ: 20.2;BJ hTERT+ SV40 Large T+: 9.1;fHDF/TERT166: 19.6;U-2197: 9.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.1"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	0.8	0.4	2.9	0.8	7.1	0.0	0.3	0.0	3.5	2.5	0.0	3.1	0.4	11.9	0.8	0.1	1.3	3.3	1.2	4.7	5.4	1.8	0.2	3.4	0.1	0.9	2.6	2.7	1.3	0.2	0.2	1.3	0.6	6.7	0.6	0.2	0.2	9.0	0.2	0.1	1.0	12.6	0.6	0.2	2.0	0.1	2.5	0.0	0.7	0.2	0.0	1.6	1.6	1.2	0.0	0.0	8.7	0.0	1.2	2.6	0.0	20.2	2.9	9.1	4.4	0.0	0.3	0.0	0.0	19.6	3.1	0.0	0.1	0.0	4.2	0.0	0.1	0.0	0.4	0.0	3.1	0.0	0.0	1.3	0.0	2.6	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.2	0.1	9.3	1.8	4.7	1.2	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	0.0	3.5	4.7	5.4	0.9	2.6	0.6	0.6	2.5	1.2	0.3	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.3	12.3	0.6	0.0	0.0	32.0	0.0	0.0	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	133.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	15.0	0.0	0.0	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.3;placenta: 20.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	4.3	0.5	1.2	0.7	1.5	0.2	3.3	0.6	1.3	3.4	5.8	2.8	1.2	4.8	1.6	5.7	5.4	2.3	0.5	1.5	1.9	1.4	0.1	13.3	1.1	1.8	3.4	1.2	0.7	0.9	0.2	20.8	1.2	2.2	1.6	0.3	0.9	5.4	0.4	1.9	1.2	4.0	1.6	2.2	1.6	0.6	2.0	0.2	9.4	1.0	0.8	1.8	2.0	1.2	0.0	4.9	0.2	0.0	8.8	2.1	0.0	3.2	4.9	0.7	0.1	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	1.2	1.5	0.6	1.3	1.5	1.9	1.8	3.4	1.2	1.6	2.0	1.2	3.4	0.0	2.6	2.0	0.0	2.3	1.9	0.0	0.0	1.4	0.4	2.9	0.7	0.0	10.5	3.7	0.0	1.3	0.0	0.1	0.0	0.0	1.0	3.0	4.0	1.6	0.0	0.0	19.3	0.2	0.0	3.1	0.0	8.0	0.0	0.1	0.0	0.0	0.3	0.0	47.2	0.0	0.0	0.0	5.3	0.5	6.2	1.8	1.8	12.2	0.1	0.0	0.0	2.0	0.3	0.0	5.1	0.7	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.3	20.2	0.1	0.7	0.1	3.4	0.4	0.1	2.1	0.0	1.5
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;intestine: 16.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.6	0.0	2.1	0.6	3.5	2.6	0.6	3.0	2.4	0.3	0.2	13.2	7.0	0.3	0.2	0.3	0.2	0.3	0.2	1.6	2.8	1.9	0.1	0.3	0.3	4.2	3.4	0.0	0.1	1.4	0.5	0.3	4.1	0.5	16.6	0.4	0.3	0.1	0.1	0.7	7.9	0.5	2.7	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.6	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.5	3.0	2.4	1.6	2.8	4.2	3.4	4.1	2.7	3.1	6.6	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	6.0	8.1	3.4	7.4	3.5	11.1	6.2	10.3	3.7	8.3	5.9	7.7	5.3	8.6	3.5	6.8	8.4	4.9	6.8	3.1	2.6	6.2	6.7	7.0	9.3	1.4	2.2	10.9	8.3	10.3	14.0	6.1	1.9	7.1	5.0	7.5	7.1	5.2	7.6	11.2	8.4	6.2	0.6	8.5	7.1	11.0	2.8	15.8	8.8	7.3	8.7	7.3	7.0	5.0	24.0	27.2	27.7	23.4	12.9	13.8	13.7	10.3	13.6	15.8	15.1	21.2	10.3	32.8	15.9	19.1	30.3	12.2	29.1	14.0	17.7	19.2	28.3	20.2	20.3	11.7	9.4	36.9	14.3	12.6	8.0	25.8	21.7	10.9	20.5	29.2	35.4	59.8	14.8	44.0	45.0	13.5	21.1	14.1	16.6	32.7	16.0	25.2	7.7	26.6	21.6	27.1	26.1	16.6	8.4	22.7	8.5	15.7	22.0	21.1	30.6	28.3	24.2	24.7	30.2	47.8	14.9	18.3	21.3	2.8	0.3	0.2	0.5	0.2	0.9	0.6	0.8	0.4	0.3	0.8	0.6	0.6	1.0	0.5	0.3	1.0	0.7	0.1	3.4	3.5	10.3	3.7	3.1	2.6	1.4	2.2	1.9	0.6	2.8	5.0	12.8	16.0	14.2	30.3	16.4	15.8	4.2	8.2	13.1	15.2	13.7	10.0	10.9	5.7	9.4	14.7	27.1	8.9	15.0	7.9	0.0	7.7	3.6	16.6	20.1	11.1	12.6	12.4	43.7	6.5	5.2	11.1	11.2	24.1	5.7	26.5	8.6	11.0	8.0	21.9	45.5	10.4	8.2	10.4	7.4	5.4	8.7	12.3	8.8	29.0	9.8	6.1	6.2	36.7	42.4	8.3	5.8	8.6	25.3	7.6	6.2	5.2	8.3	9.2	0.0	12.8	12.4	14.8	8.4	18.5	21.3	10.9	17.1	12.1	10.1	7.5
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	11.8	14.5	6.1	5.2	6.0	9.0	12.2	8.3	6.8	13.7	3.6	13.4	5.1	12.0	6.5	10.1	11.8	5.4	14.0	6.0	5.1	13.1	10.9	11.4	6.3	4.5	5.2	18.2	12.8	7.4	16.2	9.3	4.9	13.1	7.1	8.3	11.4	5.4	14.9	15.8	12.6	7.9	1.1	14.9	12.2	22.8	4.5	6.7	17.3	14.6	8.6	11.4	12.7	4.4	8.3	9.7	13.0	10.7	13.0	12.2	24.2	10.3	17.6	11.5	11.0	16.5	9.5	19.4	4.7	20.9	17.0	21.0	15.4	11.0	11.3	9.4	8.2	6.1	19.9	13.6	15.6	9.4	8.0	13.6	8.2	14.3	17.4	11.1	13.0	16.9	11.1	10.2	12.9	15.4	8.3	7.8	17.8	12.1	7.8	9.9	24.5	11.0	5.0	10.7	6.4	10.0	12.7	7.9	6.2	15.2	14.4	5.5	13.8	18.1	10.8	11.4	7.7	5.7	13.8	18.5	10.3	5.2	8.2	2.1	2.3	2.8	3.2	3.8	3.5	0.9	1.7	2.9	1.7	1.2	2.9	2.6	0.9	3.0	1.8	0.9	3.1	1.5	6.1	6.0	8.3	6.8	6.0	5.1	4.5	5.2	4.9	1.1	4.5	4.4	14.7	22.4	27.2	35.3	10.8	7.5	6.2	5.1	9.6	26.6	11.2	9.5	29.2	7.2	10.3	11.0	37.5	15.1	13.5	7.1	13.7	11.7	45.9	18.0	22.2	12.7	16.8	15.8	53.6	7.2	24.0	14.0	14.3	25.8	8.8	27.4	9.7	5.9	9.2	25.2	59.0	10.0	10.2	7.7	7.9	133.1	15.5	12.8	12.4	19.7	10.8	9.7	7.2	30.7	47.8	12.5	7.9	11.3	12.4	9.0	8.9	7.3	16.2	24.4	19.7	19.5	15.4	22.4	20.0	11.8	8.7	21.1	11.9	23.2	10.6	11.0
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047967-2089491	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	12.6	10.0	3.8	10.2	4.6	10.9	12.6	4.5	6.1	16.7	0.9	15.3	12.4	17.4	7.3	12.0	16.0	10.9	12.6	5.9	1.3	9.6	9.0	12.0	7.7	3.1	1.5	18.4	14.8	14.7	16.5	9.2	2.7	12.4	9.1	17.7	21.3	15.6	31.1	14.4	12.8	11.4	0.1	11.4	15.7	16.2	2.6	11.7	18.6	14.5	7.8	14.0	12.8	12.5	13.5	21.4	28.9	32.5	33.7	28.1	24.3	31.7	21.7	23.4	19.7	25.7	25.4	20.5	27.6	26.2	11.0	22.0	17.5	23.1	17.3	15.5	28.5	19.2	39.6	10.7	23.0	24.0	22.4	33.5	14.3	18.9	13.9	27.9	22.3	14.4	19.0	17.7	21.0	27.0	28.9	7.1	29.8	10.1	21.2	45.3	31.6	25.7	9.4	12.1	22.1	41.3	45.2	29.4	15.3	28.2	26.8	17.5	35.5	24.5	16.5	22.0	16.5	39.0	42.7	40.8	10.2	9.7	29.6	3.2	2.7	2.8	3.1	2.1	2.8	1.8	1.9	1.7	2.5	1.8	1.3	2.1	3.5	1.6	1.7	0.6	1.4	2.2	3.8	4.6	4.5	6.1	5.9	1.3	3.1	1.5	2.7	0.1	2.6	12.5	23.8	25.6	18.9	43.8	16.8	9.2	8.1	10.1	14.8	53.8	23.7	20.2	41.8	21.5	15.3	20.2	93.8	13.0	17.3	34.5	3.9	15.2	13.1	47.8	26.3	25.6	32.5	17.4	22.8	14.1	8.0	19.7	44.9	62.1	8.8	49.0	32.2	38.7	11.4	45.4	22.4	26.6	8.2	17.6	9.9	29.3	28.3	13.8	8.8	15.9	12.1	19.0	36.0	18.6	25.7	21.4	17.5	25.9	14.4	9.4	25.4	8.9	17.8	64.7	13.1	17.2	20.4	18.3	37.7	12.9	9.8	9.3	18.8	31.6	28.9	10.6
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18526951	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	40.4	55.6	41.1	32.2	42.2	60.8	56.6	43.1	50.8	44.8	45.7	49.5	42.8	40.2	56.3	56.7	49.3	36.5	68.2	42.1	44.5	70.1	62.3	43.9	42.9	42.4	42.3	44.6	45.4	61.5	36.5	61.4	42.4	43.1	59.0	43.6	46.4	41.1	77.1	47.2	43.4	42.9	43.9	34.0	45.4	55.5	41.8	45.9	52.4	83.0	57.4	46.9	42.2	46.5	51.3	79.1	73.7	51.1	82.2	85.4	63.7	77.1	103.0	92.2	90.3	54.3	27.5	65.5	49.2	86.4	103.7	77.0	74.0	70.3	102.0	95.4	87.7	41.1	38.6	79.7	106.3	64.6	69.8	75.0	139.9	48.6	131.6	102.2	76.8	68.4	66.9	55.2	112.7	85.7	45.7	66.8	45.1	115.6	81.5	37.0	72.5	54.7	63.6	68.8	52.2	88.6	75.7	61.6	101.1	77.1	59.7	64.8	43.1	63.0	38.0	126.4	59.4	37.2	76.0	56.9	64.5	34.2	80.5	187.8	69.8	155.7	50.4	81.6	52.4	78.5	48.0	54.0	66.1	69.2	51.5	54.9	123.6	57.9	114.3	54.5	84.4	91.1	41.1	42.2	43.1	50.8	42.1	44.5	42.4	42.3	42.4	43.9	41.8	46.5	63.0	64.1	57.5	22.9	44.4	42.6	81.5	159.2	26.7	41.0	39.2	42.2	68.0	42.9	90.4	44.1	25.0	191.9	34.2	85.5	125.2	112.4	48.0	58.4	36.0	54.4	61.6	74.5	29.1	101.3	107.7	48.6	32.6	48.9	44.9	46.2	47.2	36.0	79.6	37.0	28.4	65.0	156.6	45.2	33.6	21.2	56.2	51.6	56.9	26.2	82.3	86.1	54.6	32.2	32.8	132.7	76.2	43.2	47.0	103.0	72.2	126.8	113.4	43.3	46.0	44.7	81.2	177.6	153.7	32.8	48.4	296.1	38.1	91.5	47.8	97.4
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		280000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: AB_2684063"	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	16.2	16.9	20.9	13.5	21.9	47.8	25.4	22.7	28.4	17.4	18.9	23.3	16.9	15.8	17.9	16.6	14.2	13.2	19.5	21.0	23.6	24.4	22.9	14.3	19.1	21.3	22.4	16.7	18.4	21.7	13.1	10.8	22.3	14.5	18.8	16.6	14.9	17.2	31.6	19.3	14.6	14.2	21.4	14.7	15.0	26.2	22.0	24.1	17.2	31.0	18.2	15.6	12.8	23.8	56.2	24.8	38.4	34.1	35.0	27.8	21.1	45.6	43.2	50.3	48.4	71.1	32.3	81.7	51.9	45.4	30.1	27.0	55.0	46.6	69.8	43.2	44.3	48.0	33.0	68.3	40.0	69.3	32.5	24.2	51.3	56.3	38.7	23.0	43.2	40.0	72.9	39.4	47.4	30.5	38.2	77.5	46.6	32.8	47.2	67.6	43.1	59.3	63.7	36.0	48.9	30.6	31.4	46.6	61.2	29.2	29.3	54.1	30.8	36.2	56.4	22.9	45.1	33.8	97.0	85.4	40.3	46.8	45.6	27.6	29.8	28.6	22.5	27.9	26.9	27.4	23.4	19.8	27.4	21.0	26.5	22.9	9.3	26.9	24.3	20.1	25.6	28.8	20.9	21.9	22.7	28.4	21.0	23.6	21.3	22.4	22.3	21.4	22.0	23.8	34.7	32.1	24.4	15.0	37.5	39.1	34.4	49.1	23.3	32.1	38.2	27.6	34.7	42.9	36.9	42.3	22.9	34.9	34.3	22.3	43.0	64.4	80.0	24.9	29.7	42.7	19.9	34.7	19.8	60.0	33.3	32.5	15.8	23.9	40.0	36.0	58.5	44.4	35.2	16.8	19.8	27.7	57.0	35.6	34.9	19.8	36.4	29.8	67.6	15.0	45.4	88.7	44.3	29.1	33.5	45.4	22.2	31.2	25.4	34.7	24.4	58.7	33.0	29.5	26.3	39.9	81.8	152.8	96.6	36.7	43.9	28.5	36.8	38.5	37.9	28.8
TSPOAP1	"BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1"	ENSG00000005379	"TSPO associated protein 1"	O95153	17	58301228-58328795	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.0;Breast glandular cells: 7.1;Breast myoepithelial cells: 8.1;Collecting duct cells: 7.3;dendritic cells: 22.3;Endometrial ciliated cells: 9.3;Respiratory ciliated cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 127.5;HL-60: 52.6;NB-4: 52.6;REH: 99.9;THP-1: 33.0;U-266/70: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024662, HPA025244"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA024662: AB_2066340, HPA025244: AB_1845509"	"unprognostic (2.03e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.23e-4)"	"unprognostic (1.24e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.15e-7)"	"unprognostic (1.62e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-2)"	9.7	28.6	71.0	5.6	66.2	40.6	18.4	45.1	92.0	47.3	45.7	35.7	4.0	38.4	6.5	11.0	62.5	5.8	18.1	68.9	47.9	36.6	16.6	18.0	10.8	45.0	49.0	65.9	33.2	14.4	69.9	1.7	44.8	49.1	3.5	17.9	27.7	16.2	8.9	11.8	19.1	6.3	40.2	25.3	26.4	3.7	56.9	13.2	44.9	3.2	5.0	25.0	22.6	52.8	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.8	0.0	2.8	2.6	0.5	0.0	0.4	0.0	0.0	0.1	127.5	1.1	0.7	1.7	0.0	0.2	52.6	5.1	0.0	0.6	0.0	0.0	12.5	0.0	17.8	2.0	9.3	0.0	0.0	18.1	52.6	0.8	0.0	0.1	99.9	0.0	13.7	0.3	0.1	7.2	4.9	0.2	0.2	0.0	0.1	0.2	33.0	0.0	0.0	1.1	0.2	0.1	36.4	7.2	9.5	0.1	1.6	0.0	0.2	0.0	0.0	1.7	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.3	71.0	66.2	45.1	92.0	68.9	47.9	45.0	49.0	44.8	40.2	56.9	52.8	0.6	9.6	9.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.1	8.1	0.0	0.0	4.3	7.3	0.0	0.0	22.3	0.0	1.9	0.9	0.0	9.3	3.1	0.2	0.0	0.0	0.0	0.2	0.7	1.0	0.0	3.7	1.3	4.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.8	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	4.0	0.1	0.0	0.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	45.8	29.3	28.1	27.1	25.0	26.4	43.1	36.3	35.3	59.3	45.7	34.6	24.7	38.9	58.6	27.9	34.9	35.4	28.0	38.9	15.5	37.7	31.7	24.4	29.4	10.0	11.1	60.6	42.9	39.1	35.6	29.0	11.8	51.2	36.3	63.0	50.0	41.4	27.7	30.7	30.3	34.6	6.7	27.3	40.9	27.4	15.3	38.0	64.8	30.6	29.2	30.6	9.4	21.4	72.9	25.4	115.3	22.2	108.9	156.8	40.0	77.5	96.0	34.2	46.1	34.0	35.8	62.3	26.6	130.9	32.1	23.3	35.3	47.9	48.2	66.3	25.0	125.6	38.0	44.1	39.6	70.9	39.1	81.9	28.8	35.0	31.0	68.8	51.6	54.1	77.3	71.1	65.2	56.0	69.4	18.8	33.3	48.0	42.6	91.6	55.3	33.2	39.4	55.3	87.7	67.6	97.2	55.2	49.1	26.5	62.2	27.3	68.3	49.2	19.5	61.2	30.4	71.1	55.1	60.6	80.7	69.9	37.9	4.8	6.2	6.8	11.5	6.4	17.1	13.0	13.3	15.8	10.8	15.1	23.2	14.4	1.0	12.8	8.6	17.3	10.0	4.8	28.1	25.0	36.3	35.3	38.9	15.5	10.0	11.1	11.8	6.7	15.3	21.4	78.3	125.0	142.7	161.3	144.8	65.9	94.8	102.7	86.0	347.7	175.8	140.1	134.7	68.6	118.2	75.4	227.2	50.1	129.5	67.8	166.3	91.1	192.7	115.0	217.4	78.9	190.2	65.4	424.5	75.3	93.5	171.0	131.5	132.0	64.6	256.8	99.6	94.4	61.4	329.7	396.0	163.1	99.7	95.2	83.7	192.4	210.0	86.8	211.7	111.5	87.4	196.5	93.7	321.7	261.9	73.3	96.5	261.1	167.6	121.4	72.8	96.1	108.6	233.9	52.6	245.8	127.9	400.0	258.4	91.7	62.8	52.7	109.7	204.1	148.1	103.9
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060326-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005776, HPA070762"	Approved		Supported	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA005776: AB_1080416, HPA070762: AB_2686307"	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	3.8	4.7	2.6	6.4	3.9	5.4	4.2	2.8	3.7	3.3	3.6	5.0	4.3	3.0	1.7	5.2	2.6	2.8	3.1	2.4	2.8	2.6	1.4	2.6	7.3	5.4	3.5	2.7	3.5	3.9	2.3	2.7	3.6	2.5	5.4	2.5	3.3	2.5	4.7	4.9	4.0	4.0	3.0	4.3	3.9	4.2	3.8	8.9	3.6	2.3	7.9	3.3	3.6	4.7	27.7	10.0	19.8	28.0	7.7	6.7	24.6	14.5	6.7	20.8	18.3	14.1	4.8	33.4	21.8	9.6	23.2	28.1	35.2	18.7	32.0	25.9	24.8	28.5	19.5	18.2	5.5	42.1	31.5	7.7	7.0	15.4	28.4	5.2	14.4	26.0	22.3	29.6	15.9	42.4	28.1	26.0	30.9	26.3	20.0	40.0	72.7	14.6	12.7	12.4	16.8	7.0	21.7	21.4	8.4	14.9	11.7	17.0	14.6	13.1	27.6	31.0	31.8	13.5	12.5	40.6	8.8	31.2	53.7	0.9	2.3	1.5	1.2	2.8	1.2	1.5	1.4	2.0	2.6	1.5	1.4	1.7	0.4	2.6	1.6	1.4	2.7	1.0	2.6	3.9	2.8	3.7	2.4	2.8	5.4	3.5	3.6	3.0	3.8	4.7	4.4	6.4	6.4	6.8	13.4	13.3	17.1	8.5	12.0	5.7	7.6	6.3	7.3	5.7	7.3	12.9	8.4	9.7	8.9	10.6	5.9	6.6	6.9	8.9	15.6	6.9	4.9	30.3	8.1	8.0	7.6	11.0	8.6	12.3	9.5	24.7	5.7	3.0	11.4	11.8	4.7	8.3	0.0	8.6	12.1	7.0	6.5	14.5	7.2	10.3	22.1	3.3	14.4	2.5	13.5	9.3	5.1	4.1	16.0	22.7	6.2	3.8	5.1	7.2	0.0	18.4	8.5	9.2	12.4	19.4	14.3	3.8	12.3	12.2	13.5	17.9
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 167.2;skeletal muscle: 920.6;tongue: 369.5"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.6	0.4	2.7	0.5	2.4	4.3	0.5	2.8	4.9	0.3	0.0	0.4	0.4	0.4	0.2	2.7	0.3	0.7	167.2	1.9	3.4	0.2	0.3	1.2	1.4	11.2	4.4	0.7	1.7	0.0	0.8	0.5	6.6	2.7	0.0	1.9	7.0	0.0	920.6	0.8	0.6	0.0	3.2	0.7	0.4	1.6	4.8	0.7	0.6	369.5	0.4	0.2	0.3	5.3	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	2.7	2.4	2.8	4.9	1.9	3.4	11.2	4.4	6.6	3.2	4.8	5.3	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 165.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Hepatocytes: 72.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7"	"Low region specificity"	"Detected in all"													NA	NA		10000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	1.6	0.2	2.7	0.4	2.7	0.2	0.5	3.0	2.3	0.1	0.7	3.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	2.5	2.5	2.4	165.0	0.7	0.2	2.5	3.2	0.0	1.2	3.6	0.1	1.7	2.4	0.1	4.3	0.9	0.1	0.1	0.2	0.2	0.3	0.2	2.1	0.0	0.3	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.8	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	6.0	0.6	0.0	2.1	0.2	0.1	0.0	2.9	3.7	0.6	0.2	0.0	0.0	1.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	2.7	3.0	2.3	2.5	2.5	2.5	3.2	2.4	2.1	3.0	2.3	0.0	3.2	1.1	37.9	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	7.2	1.3	0.0	0.0	11.2	0.0	2.1	1.9	1.1	0.0	0.0	0.1	0.2	2.4	0.0	1.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	1.8	72.0	0.6	0.0	2.7	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	10.6	0.1	0.1	1.2	0.0	0.0	0.1	0.0	5.5	0.0	0.2	0.0	0.7	0.1	0.0	1.0	0.0	0.1	9.9	0.1	0.0	4.9	0.1
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475874-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 28.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 91.0;HSkMC: 78.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: AB_2685686"	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	8.2	4.4	5.4	5.7	5.5	9.0	5.2	4.7	5.4	6.1	7.1	3.6	3.5	5.0	4.7	5.5	4.9	4.0	2.8	6.3	7.3	4.1	28.7	3.3	8.4	5.2	6.3	4.1	6.4	7.2	7.0	2.8	8.1	4.6	4.0	2.9	5.0	4.3	2.7	12.5	4.0	5.4	3.2	4.6	4.0	3.0	5.2	6.2	7.6	1.7	7.9	5.0	5.3	4.3	21.1	10.8	8.2	14.6	91.0	35.3	8.2	22.4	31.1	21.3	18.1	40.1	12.5	13.1	18.8	20.9	38.8	20.4	10.5	35.2	22.9	13.6	4.8	6.2	11.6	11.8	25.2	9.3	14.1	78.5	22.6	20.9	35.0	10.1	7.3	11.0	8.0	13.4	17.2	24.2	9.1	5.9	9.8	11.4	18.0	2.8	8.8	7.1	8.3	15.0	18.2	8.6	31.1	13.5	14.0	10.1	14.8	6.0	7.5	47.2	18.8	14.2	19.5	19.8	14.5	14.0	22.8	6.6	14.1	0.6	1.1	1.8	4.0	2.2	4.4	3.6	3.6	4.2	1.1	3.8	3.0	4.7	2.6	5.7	2.3	2.0	3.8	2.3	5.4	5.5	4.7	5.4	6.3	7.3	5.2	6.3	8.1	3.2	5.2	4.3	3.9	9.6	11.4	6.2	15.7	6.4	17.2	9.5	1.8	24.4	8.0	5.8	5.3	18.6	10.3	22.0	25.0	7.4	19.8	8.7	1.9	10.2	4.9	8.4	30.5	7.5	9.5	38.9	8.3	9.4	8.6	13.8	2.6	9.3	9.5	8.3	8.2	60.7	4.9	18.5	9.1	5.3	2.0	17.6	6.5	10.3	18.6	6.9	3.6	2.8	8.4	11.5	30.9	8.5	7.1	13.3	9.3	11.3	8.6	14.3	11.0	4.7	8.4	20.3	6.6	16.3	10.1	9.6	11.4	6.1	20.0	10.9	17.9	12.3	9.5	10.9
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"choroid plexus: 142023.1"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 23659.3"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Group enriched"	"Detected in all"	7	"cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1381.8"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	99000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	4.2	0.6	148.5	0.5	56.7	9.6	0.4	621.7	83.7	2.0	142023.1	6.0	14.9	1.3	0.9	2.2	0.8	51.2	2.9	1730.9	37.3	18.4	21288.1	0.8	2.4	106.5	86.0	1.1	1785.1	186.8	6.0	2.7	27.1	1.6	4.5	80.1	1.8	0.4	1.1	15.6	6.8	0.3	12.3	3.8	49.8	2.3	688.2	1.1	1.3	0.0	0.1	2.3	0.6	133.9	1.6	0.4	0.6	0.5	0.8	0.1	1.0	0.8	0.3	0.0	0.0	160.1	0.0	2.9	39.6	0.5	0.6	0.4	0.0	0.3	0.0	5.9	0.8	5.2	1.8	249.0	0.4	11.2	1.0	0.1	0.1	0.1	0.0	0.7	0.0	0.3	2.8	0.4	0.0	0.5	0.4	0.7	0.6	4.5	0.3	0.3	7.4	0.2	0.3	1.6	0.9	1.1	5.8	0.0	0.2	1.7	0.6	0.2	1.7	2.4	57.0	0.5	4.3	1.0	2.6	17.6	0.7	4.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	148.5	56.7	621.7	83.7	1730.9	37.3	106.5	86.0	27.1	12.3	688.2	133.9	0.0	0.0	0.0	0.0	15.1	0.5	0.0	0.0	0.0	144.8	0.0	0.0	1.8	779.2	0.0	5.5	162.6	0.3	0.0	1.5	5.9	3.1	6.8	0.5	0.5	14.1	356.2	192.5	0.0	2.0	3.6	0.7	13.3	0.0	0.0	0.2	192.4	23659.3	2.4	26.9	0.1	19.6	0.0	313.7	0.0	8.7	0.3	1.2	0.0	0.0	0.0	24.9	0.0	0.0	0.0	130.5	5.2	0.0	0.0	0.2	1.3	26.9	0.0	56.0	0.0	0.0	0.3	3.3	1.1	0.0	0.1	4.0	10.9	0.0	1.7	0.0
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274600	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 479.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 98.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 4114.3"	"Low region specificity"	"Detected in all"							"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules		NA	Yes		160000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (8.48e-8)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	92.6	57.8	12.4	110.5	12.1	148.8	54.7	13.9	18.0	101.0	41.9	158.2	106.9	59.6	62.7	479.4	50.8	92.1	55.3	12.8	16.4	113.5	69.3	74.1	78.6	15.7	14.1	38.3	52.6	22.5	28.0	109.9	15.5	43.7	156.5	2.5	139.0	46.4	45.3	166.1	117.6	129.8	15.7	42.1	115.2	26.3	22.6	103.3	56.3	42.5	170.7	222.5	168.8	15.4	1295.3	987.5	211.7	363.9	220.5	368.4	816.3	1010.1	1126.1	1742.1	927.3	966.9	947.0	578.9	1053.2	1194.2	1047.3	580.5	1246.0	1412.1	1150.2	564.1	449.7	703.4	406.7	943.7	165.2	550.9	498.4	269.8	663.0	1485.6	619.9	550.6	1139.5	320.6	1026.8	308.3	1521.8	811.1	306.5	535.8	639.6	4114.3	1928.6	344.0	414.5	319.7	770.3	602.8	169.8	9.1	875.5	574.4	386.0	828.3	559.4	426.0	835.1	819.3	911.5	821.9	1717.4	101.6	306.5	565.2	431.6	536.1	725.9	98.8	14.6	29.9	12.3	17.3	19.7	10.5	13.1	11.7	27.0	7.4	7.0	7.9	12.2	13.6	13.1	21.6	17.6	20.8	12.4	12.1	13.9	18.0	12.8	16.4	15.7	14.1	15.5	15.7	22.6	15.4	94.3	118.6	136.1	2.6	54.9	194.5	354.2	317.7	306.7	1.3	61.3	75.8	0.9	45.8	150.9	58.8	0.0	291.9	50.1	432.7	70.5	285.8	7.9	107.7	65.8	83.0	77.5	155.5	2.1	559.2	1118.2	109.7	153.4	204.4	67.2	110.8	39.3	55.9	276.8	0.0	1.9	190.5	101.7	65.6	121.7	8.4	68.0	163.3	46.2	2.8	265.5	2.8	6.2	1.0	1.4	465.6	330.2	40.6	71.0	206.3	234.1	137.1	51.9	0.6	39.5	84.3	258.2	9.0	65.5	530.8	183.1	161.6	77.6	46.1	187.9	293.4
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219278170	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 360.2;tongue: 210.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 265.9;HBEC3-KT: 439.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		130000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	14.3	41.4	33.6	34.1	47.5	107.1	16.4	22.3	133.1	27.7	8.1	32.9	18.6	9.8	10.1	84.8	12.6	13.5	97.7	42.6	32.3	31.9	29.5	26.7	56.7	46.3	27.3	12.9	18.2	34.6	23.1	5.0	31.4	19.7	27.8	39.2	46.9	22.4	360.2	161.4	35.5	12.8	3.9	56.8	30.6	32.4	14.9	16.9	12.3	210.3	63.4	22.6	57.3	54.0	106.0	90.0	0.0	0.3	9.1	6.9	0.3	16.2	49.7	2.8	1.9	20.4	106.7	144.2	172.2	11.7	172.7	265.9	49.3	439.9	3.9	81.7	0.7	184.2	154.5	15.4	7.3	60.9	60.8	6.7	158.0	23.7	49.2	27.4	17.3	2.4	20.5	91.3	100.6	4.3	0.3	107.9	32.3	83.2	107.4	6.5	139.0	84.5	129.7	7.5	85.8	1.5	213.2	18.7	0.7	1.8	8.0	50.9	12.3	49.8	27.4	58.4	56.7	38.0	48.8	171.4	183.3	116.4	2.5	141.7	63.3	170.2	107.1	45.7	110.1	124.9	150.3	142.8	20.9	95.5	140.2	138.4	331.2	82.0	71.9	3.8	143.8	270.9	33.6	47.5	22.3	133.1	42.6	32.3	46.3	27.3	31.4	3.9	14.9	54.0	55.3	44.8	47.1	16.3	160.6	181.8	201.2	235.3	68.9	123.3	42.3	51.6	60.9	28.6	62.0	49.7	77.2	0.7	311.6	87.3	140.8	199.3	423.0	9.8	3.3	36.5	107.9	56.2	34.8	205.6	0.5	11.5	40.8	26.1	15.8	0.1	36.0	33.0	6.0	67.3	22.5	141.9	48.8	15.3	54.9	823.0	16.8	159.5	78.2	9.4	27.8	38.6	50.4	10.6	10.6	613.5	51.2	7.5	202.3	46.7	87.5	137.5	11.1	72.9	0.0	21.1	408.5	5.7	5.0	130.6	244.5	2.5	290.1	1.4	58.9	113.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 313.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8"					"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		89000000	"Cluster 24: B-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.7	24.8	99.4	12.1	93.3	3.4	2.1	100.5	127.6	3.3	0.0	18.4	3.7	9.7	0.2	3.6	2.3	8.8	5.5	88.6	313.3	13.3	0.9	4.1	7.1	208.8	132.7	3.9	3.2	0.4	55.1	1.8	266.2	3.0	2.6	24.8	10.6	0.4	0.6	5.2	8.0	12.7	74.2	1.3	7.2	38.0	183.4	1.0	2.5	0.3	5.2	7.3	5.3	82.5	30.1	421.3	152.6	173.9	17.9	170.8	6.8	181.0	31.0	105.8	48.2	57.2	53.5	89.6	93.6	136.8	74.3	112.1	148.9	26.7	26.3	22.7	15.5	0.7	32.5	383.7	6.0	0.0	67.6	98.4	7.9	161.9	14.0	136.8	88.4	5.9	9.2	2.5	122.3	288.6	1.2	31.5	274.3	11.2	237.3	0.1	54.1	9.5	131.8	8.1	424.9	433.8	251.2	4.4	137.1	27.5	15.0	1.9	110.9	142.8	156.9	197.3	185.3	1.4	19.6	35.2	150.2	11.5	260.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	99.4	93.3	100.5	127.6	88.6	313.3	208.8	132.7	266.2	74.2	183.4	82.5	0.4	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.4	1.8	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	28.7	8.2	0.5	2.6	3.8	4.9	0.0	37.9	21.4	0.7	6.1	27.0	0.7	0.0	0.0	0.0	0.0	0.2	5.0	45.1	0.1	0.0	0.0	0.0	16.8	0.3	0.2	0.0	9.4	0.0	0.3	0.0	16.1	9.2	49.2	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.1	0.2	0.4	3.0	0.0	1.0	0.1	0.0	0.2	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	134.5	112.6	162.0	97.2	163.4	423.9	94.4	149.4	182.7	88.1	482.7	198.3	142.0	107.7	209.1	343.3	507.2	106.0	435.8	174.0	185.2	122.5	140.1	130.5	95.5	184.1	233.6	72.9	123.8	87.8	118.0	86.3	213.9	120.2	111.9	261.8	177.9	121.5	202.5	240.0	166.4	119.8	162.9	85.6	161.4	765.7	192.6	162.9	115.7	96.6	119.7	188.3	139.4	133.9	706.2	1032.5	431.7	314.2	213.2	223.6	600.5	643.7	536.0	872.4	598.6	1101.0	840.2	429.0	480.2	631.2	848.2	1305.1	539.5	1039.2	330.2	307.9	458.5	311.2	789.6	877.8	134.5	370.0	331.5	145.0	291.5	667.5	183.1	215.7	631.7	300.6	443.0	239.7	731.2	1936.4	337.4	504.2	457.8	1234.8	1778.1	423.5	822.2	394.2	666.8	647.8	301.5	323.6	853.9	485.8	173.2	244.2	699.0	397.6	495.6	618.1	685.0	710.0	863.6	92.4	274.9	475.1	503.6	286.9	549.8	95.7	30.0	43.2	40.5	30.1	38.2	32.6	31.3	34.4	34.9	30.8	19.7	26.7	56.4	24.4	30.5	36.3	44.7	32.6	162.0	163.4	149.4	182.7	174.0	185.2	184.1	233.6	213.9	162.9	192.6	133.9	478.5	221.2	146.3	21.5	315.8	326.2	945.7	458.7	327.2	508.1	286.9	389.5	91.9	143.0	284.1	143.5	300.3	346.6	640.9	744.1	221.1	348.6	2190.0	1191.6	224.8	203.9	391.5	419.9	30.1	446.8	545.5	247.8	274.7	415.0	189.2	200.9	142.5	139.2	265.9	244.0	24.3	503.6	323.5	59.9	214.9	2907.1	254.2	299.3	138.7	22.5	224.0	299.3	49.4	15.6	19.7	477.4	697.2	153.1	264.0	475.1	540.7	345.5	1558.7	763.3	111.7	261.8	416.0	1717.5	740.9	419.1	297.6	321.1	362.9	89.8	487.3	592.7
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
TUBG1	"TUBG, TUBGCP1"	ENSG00000131462	"Tubulin gamma 1"	P23258	17	42609641-42615238	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 173.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 670.6;Erythroid cells: 286.9;Late spermatids: 560.5;Spermatocytes: 347.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004608	Enhanced					NA	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 34: Spermatids - Unknown function"			"CAB004608: AB_628417"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.08e-8)"	"unprognostic (2.62e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.48e-5)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.97e-2)"	23.0	30.4	17.7	20.4	18.4	51.7	19.0	17.8	25.4	17.6	21.1	24.0	16.6	20.7	13.4	35.6	16.3	10.1	43.6	18.5	19.8	24.8	27.1	19.1	18.0	20.3	18.0	12.5	48.7	29.9	20.2	21.0	20.0	19.7	14.9	10.5	19.1	18.3	60.7	29.0	18.1	27.2	15.9	19.3	29.8	173.8	21.4	27.6	14.8	36.3	20.6	21.7	19.9	19.7	117.8	288.8	112.1	124.0	70.5	47.8	97.7	133.4	87.2	205.6	158.8	177.4	76.9	80.2	92.8	105.9	178.5	171.9	124.2	178.0	149.7	225.9	142.6	64.1	168.5	299.3	34.6	73.8	87.6	38.1	54.0	251.1	75.8	50.6	131.9	119.0	119.7	77.2	155.9	326.7	176.3	66.2	59.3	176.7	139.1	81.8	164.2	130.5	91.7	136.6	158.9	74.5	78.0	76.9	63.6	113.9	233.6	70.2	88.5	197.9	131.0	169.2	207.0	111.2	169.0	126.2	108.6	70.6	144.2	1.7	13.1	3.1	10.6	25.1	11.6	14.9	9.8	11.4	15.7	15.0	10.4	10.5	0.4	12.7	27.4	44.1	13.5	10.4	17.7	18.4	17.8	25.4	18.5	19.8	20.3	18.0	20.0	15.9	21.4	19.7	14.9	16.0	4.2	3.9	12.8	17.6	16.3	49.4	12.0	14.1	14.6	16.5	18.8	14.3	24.1	7.3	4.2	45.8	7.0	10.2	39.2	35.2	670.6	15.1	13.7	20.1	9.6	286.9	7.2	54.4	78.6	15.7	15.8	10.7	2.5	16.9	15.7	15.9	40.2	20.2	6.4	13.7	38.7	6.3	10.8	560.5	22.7	9.7	17.8	8.4	26.4	17.7	10.3	4.0	3.8	42.3	6.2	21.8	41.5	15.2	15.1	76.6	18.1	10.9	59.2	7.1	43.5	347.8	128.0	27.3	28.6	20.1	8.5	15.0	14.0	15.6
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278635-133312337	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.0	22.2	14.4	20.9	15.4	35.0	13.4	13.5	19.3	15.7	18.2	18.2	22.1	16.0	10.5	17.3	30.3	14.9	20.4	14.8	14.1	19.3	16.4	17.3	20.9	17.1	15.2	26.8	28.3	26.0	3.5	15.8	17.5	17.8	13.3	11.8	28.2	17.1	33.2	22.5	22.1	14.9	13.0	21.9	20.4	21.7	15.0	20.7	19.0	24.4	14.4	15.9	5.8	14.5	64.2	84.2	30.7	35.6	28.3	29.8	42.9	47.5	66.5	50.0	49.5	97.0	45.9	42.1	27.7	48.6	21.6	47.2	35.8	32.3	22.8	50.5	75.7	24.6	46.7	52.3	35.5	63.4	57.0	31.3	29.9	46.5	58.0	55.3	33.3	29.9	36.4	45.6	41.2	79.9	41.4	56.3	30.4	37.2	64.6	32.7	32.9	19.5	32.7	40.8	20.6	43.0	33.0	40.1	36.1	17.9	23.6	38.3	45.6	30.9	27.6	38.0	47.9	43.7	25.9	53.8	102.3	27.3	19.8	6.4	22.5	15.9	15.3	23.2	14.8	11.4	13.3	14.6	27.6	12.3	14.0	15.4	13.8	27.7	25.8	11.7	18.3	19.0	14.4	15.4	13.5	19.3	14.8	14.1	17.1	15.2	17.5	13.0	15.0	14.5	29.1	48.1	38.5	18.9	36.7	13.9	27.4	30.2	23.3	45.7	25.9	25.3	33.9	22.8	38.8	40.5	31.3	41.4	40.1	34.8	23.5	34.5	25.9	78.0	41.6	26.4	29.3	28.0	17.5	37.1	32.9	35.9	38.7	37.1	39.9	49.5	28.9	27.5	44.4	38.7	15.9	36.2	8.2	42.7	25.5	28.6	33.8	51.6	14.2	15.9	75.0	39.3	62.8	9.5	20.1	37.3	33.5	35.3	37.2	28.6	37.3	53.4	112.2	74.8	32.9	39.9	32.1	74.3	65.3	29.0	13.8	42.5	35.7	50.4	36.0	30.3
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846348	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		610000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	69.7	114.6	69.6	67.1	74.2	75.1	65.8	78.9	78.1	59.4	93.3	101.5	104.4	64.9	34.7	105.2	73.6	46.6	177.8	68.1	75.3	107.3	145.1	58.3	69.2	73.1	77.4	61.4	114.2	117.1	55.4	47.6	74.1	57.7	86.1	35.8	88.9	59.7	224.4	76.0	83.9	53.6	72.9	66.2	106.1	73.3	77.0	59.9	62.7	221.5	79.3	67.1	62.9	74.3	176.2	323.1	102.4	216.2	144.9	131.4	208.7	125.8	144.4	194.9	183.0	351.3	189.4	390.5	228.5	126.4	112.4	337.6	244.2	242.9	116.2	155.4	370.8	151.7	254.8	433.6	171.7	273.8	134.8	169.9	188.1	211.9	208.7	126.8	235.2	213.0	339.0	150.3	144.4	355.0	262.3	266.3	231.8	213.9	196.9	361.8	187.3	569.6	169.3	168.4	178.8	219.6	110.0	388.5	180.2	84.6	231.5	217.6	150.1	115.9	136.4	146.7	196.6	229.8	253.6	172.2	148.6	336.8	157.1	94.6	155.8	72.3	103.1	153.6	115.3	100.6	97.2	108.7	199.3	98.8	91.7	95.3	32.4	97.2	119.2	123.1	140.1	185.6	69.6	74.2	78.9	78.1	68.1	75.3	73.1	77.4	74.1	72.9	77.0	74.3	108.2	70.5	76.7	29.4	144.6	168.1	262.5	322.0	158.2	102.4	165.1	139.2	134.4	190.1	182.6	176.6	87.6	333.1	113.2	260.0	334.6	230.2	381.8	116.1	92.5	111.3	148.5	148.1	17.5	289.8	299.2	111.2	153.4	79.6	105.9	170.6	108.5	247.1	253.8	74.0	19.9	230.5	217.7	167.5	146.4	669.0	109.3	128.6	138.7	14.0	167.5	140.6	88.6	28.6	30.3	199.7	215.3	111.7	264.9	245.3	330.7	451.9	237.3	116.3	85.5	105.5	129.1	205.7	177.4	230.1	156.0	287.0	120.2	288.2	418.7	277.6
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
TUSC3	"MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	23.3	68.8	18.7	8.4	18.4	0.1	28.3	22.3	17.1	25.0	46.6	14.5	9.3	31.9	100.8	11.8	57.6	16.7	34.9	17.1	48.2	25.2	6.9	18.4	6.8	8.9	11.6	73.6	35.0	54.0	69.6	80.5	8.9	46.4	15.5	40.9	12.1	29.7	4.5	8.2	8.2	32.5	7.7	5.3	10.8	23.2	21.0	7.5	9.5	5.7	5.6	34.0	13.0	8.0	52.1	38.4	104.3	96.7	125.2	126.7	0.2	74.9	168.8	85.2	139.3	0.1	0.1	0.7	24.5	105.9	92.4	39.3	37.5	76.1	116.0	0.1	49.8	0.0	30.1	6.0	51.9	0.2	5.6	111.8	22.8	121.0	43.1	113.7	6.9	15.9	70.9	15.6	123.2	41.2	20.6	0.4	49.2	0.0	33.5	24.8	88.7	0.3	108.3	127.1	40.7	74.6	0.0	40.6	56.5	76.2	49.8	0.2	29.0	71.9	71.3	31.3	36.5	0.0	10.0	0.4	1.2	0.0	102.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.4	22.3	17.1	17.1	48.2	8.9	11.6	8.9	7.7	21.0	8.0	88.6	0.0	10.3	13.4	0.6	9.9	61.1	123.5	63.7	50.4	40.0	52.1	47.5	18.6	47.0	79.1	8.4	472.9	0.9	2.1	17.6	179.0	11.5	100.8	48.6	36.2	95.7	0.0	141.0	12.2	321.8	53.4	7.7	35.0	1.3	39.3	7.5	0.0	41.8	32.0	155.3	26.3	95.6	0.0	6.3	7.6	34.8	1.5	24.9	24.4	1.6	35.9	0.0	61.3	3.9	23.8	4.1	23.0	2.6	63.8	0.0	23.7	172.4	28.1	39.5	2.0	49.7	60.9	47.4	26.2	4.1	783.8	1.6	46.6	7.8	51.4
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228612-52246788	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 183.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 205.0;monocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Uncertain	"Plasma membrane"		NA	NA		5900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA053874: AB_2682287"	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	50.3	32.0	16.6	28.1	16.4	28.3	39.0	12.9	26.5	35.7	13.2	32.4	21.8	35.4	0.6	44.5	27.9	17.2	94.8	17.3	15.4	31.2	29.3	34.9	33.3	15.5	13.7	29.5	17.3	6.8	18.3	15.8	16.0	29.1	4.8	0.9	36.7	18.7	183.4	32.4	33.6	14.1	15.4	54.8	24.5	14.2	14.7	21.3	23.8	4.3	15.1	36.2	36.4	18.0	24.9	59.8	10.7	28.6	29.1	47.5	35.7	56.0	55.9	49.1	43.4	32.3	51.6	89.9	36.5	27.1	39.2	37.5	11.9	60.0	4.2	52.4	34.0	89.6	38.0	78.9	49.1	54.3	139.6	46.4	28.8	50.4	12.8	21.9	82.9	50.1	21.0	36.0	20.7	21.7	65.0	117.1	30.4	15.2	171.9	27.0	22.0	92.0	22.3	38.4	13.6	59.7	19.7	74.7	109.2	4.2	19.3	40.5	105.9	55.1	68.4	50.4	47.4	37.4	35.9	45.6	125.9	143.8	73.7	97.5	167.8	143.4	107.7	169.1	95.0	109.1	112.4	114.6	159.7	83.1	86.5	108.9	242.0	93.7	181.6	150.6	141.9	149.6	16.6	16.4	12.9	26.5	17.3	15.4	15.5	13.7	16.0	15.4	14.7	18.0	44.3	6.4	7.8	2.0	50.7	17.2	29.5	59.2	12.5	14.0	29.9	28.2	28.8	27.1	23.7	12.9	0.0	42.4	77.0	64.4	37.2	86.8	3.1	34.2	27.5	35.9	22.1	17.7	7.5	100.8	84.3	34.0	18.8	86.3	40.6	28.4	31.1	13.3	205.0	6.7	4.2	20.2	30.5	108.8	56.7	2.7	35.1	111.8	33.8	3.7	202.4	14.9	97.9	3.5	3.5	103.2	55.7	33.8	25.2	20.3	65.5	25.4	12.2	5.1	52.6	16.1	38.6	1.7	25.1	27.2	15.3	22.6	64.4	53.7	23.9	31.3
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXNDC12	"AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19"	ENSG00000117862	"Thioredoxin domain containing 12"	O95881	1	52020131-52055191	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (6.54e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (4.44e-4)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.61e-4)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.40e-12)"	"unprognostic (2.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.17e-1)"	49.6	47.7	39.7	45.7	40.7	51.3	50.8	41.2	48.0	49.2	44.2	60.8	47.0	40.8	62.9	31.2	56.8	46.5	36.6	40.1	47.0	54.0	74.1	46.9	50.1	42.5	41.6	47.8	56.5	46.7	21.9	54.5	43.1	40.8	66.1	28.6	57.6	36.5	18.2	29.9	48.4	40.8	44.1	46.4	56.4	38.9	42.8	52.3	52.6	30.2	54.4	57.5	18.0	46.1	97.1	88.9	96.0	135.4	160.1	83.9	76.4	143.5	143.8	132.7	150.7	99.8	78.2	73.0	93.8	118.1	141.1	127.3	134.5	112.9	178.2	94.1	124.2	93.1	73.3	163.2	165.7	176.8	181.8	120.5	132.0	134.0	203.3	99.0	135.4	89.1	87.1	48.2	111.9	91.4	89.3	233.6	208.0	138.8	85.9	94.2	143.3	207.1	178.6	85.3	68.3	97.3	143.9	123.5	138.7	187.7	69.6	228.1	86.5	93.9	100.1	106.7	166.1	107.2	183.6	84.2	131.0	164.9	108.2	355.3	224.0	356.5	135.3	215.0	170.8	160.1	164.3	145.3	169.2	146.0	156.7	151.1	393.2	150.0	234.2	180.6	220.0	273.3	39.7	40.7	41.2	48.0	40.1	47.0	42.5	41.6	43.1	44.1	42.8	46.1	89.8	9.6	12.3	9.4	50.4	44.1	63.1	78.9	35.3	18.3	53.6	57.0	13.6	62.9	30.4	44.1	14.6	115.5	58.9	35.3	17.6	75.4	13.3	42.5	54.7	62.3	48.5	25.7	15.0	89.4	170.9	52.1	23.4	49.2	33.0	106.3	55.6	31.0	120.8	21.9	14.7	70.5	50.8	59.1	55.7	7.2	55.9	66.0	51.6	19.7	66.6	39.2	50.4	10.1	15.9	73.0	57.0	30.9	68.7	68.7	65.4	36.1	32.3	17.0	32.9	40.7	47.1	60.4	9.7	36.0	45.5	118.5	52.3	75.4	71.2	60.4
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910788	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	42	"Plasma cells: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 13.0;naive B-cell: 6.9;plasmacytoid DC: 26.7"	"Group enriched"	"Detected in many"	21	"B-cells: 13.0;dendritic cells: 26.7"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 2833.2;U-266/84: 6053.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	97.4	74.8	21.1	173.0	23.4	61.8	163.4	22.0	22.5	132.2	52.7	266.2	263.5	80.5	85.8	78.2	63.9	98.6	63.3	19.8	23.2	63.1	133.3	90.9	194.2	25.0	24.7	96.4	154.6	68.6	42.5	134.0	23.2	73.2	213.6	4.4	219.3	93.6	25.1	32.9	193.9	121.9	24.9	250.6	287.6	28.3	26.4	54.1	69.6	29.2	263.8	190.9	57.0	25.9	166.1	159.0	111.5	365.9	911.2	388.1	175.9	361.5	349.7	246.2	265.2	238.8	119.0	176.1	620.7	557.2	273.6	127.3	195.5	178.6	280.3	148.8	166.6	267.6	128.3	435.9	268.5	307.2	255.0	266.7	256.8	236.6	259.2	542.1	1334.0	109.7	170.5	1216.5	171.7	147.7	75.2	185.7	142.8	260.5	340.6	128.0	160.4	2833.2	201.1	149.6	168.7	90.5	462.4	280.2	209.4	514.9	143.5	133.9	369.7	280.5	194.2	243.0	386.5	1408.7	6053.9	305.0	144.7	191.7	392.2	0.0	0.4	0.0	0.9	0.7	0.7	13.0	0.2	0.7	1.0	6.9	0.2	0.4	0.0	0.0	0.1	26.7	0.9	0.5	21.1	23.4	22.0	22.5	19.8	23.2	25.0	24.7	23.2	24.9	26.4	25.9	1.3	0.0	4.8	0.0	14.6	0.9	0.2	0.4	3.4	0.0	1.8	1.3	0.2	0.0	2.0	0.0	0.0	0.9	5.6	1.2	0.0	9.0	0.1	1.1	6.9	3.2	4.9	11.2	0.0	10.7	1.9	4.1	6.1	2.3	1.3	0.6	3.9	4.9	1.5	0.0	0.0	15.9	0.0	0.8	0.7	0.0	0.0	1.3	3.6	0.0	1.8	0.1	0.0	0.0	0.0	9.5	1.5	0.4	677.7	0.4	3.2	0.5	1.7	0.5	6.6	0.5	4.2	0.1	0.1	3.9	0.1	1.2	2.0	0.2	5.8	0.2
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597209-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1100000	"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	38.3	55.9	45.4	38.6	47.5	83.0	49.1	49.1	63.6	42.5	40.1	41.7	42.1	38.3	66.9	54.2	35.2	40.0	80.0	50.0	50.9	51.7	80.7	30.6	41.2	47.7	47.2	47.1	62.2	51.4	38.2	48.1	49.5	40.5	43.4	77.9	48.5	39.3	149.0	36.5	40.6	43.4	46.2	32.2	46.7	41.9	47.5	48.0	197.9	146.8	49.9	51.8	35.1	54.0	77.7	74.8	99.2	102.8	83.2	121.6	70.2	90.2	91.8	113.4	95.4	67.0	74.2	83.4	78.1	98.4	82.3	93.7	94.4	81.3	116.9	85.7	43.1	114.9	58.3	127.1	98.3	168.9	71.7	92.9	82.4	107.4	97.4	118.8	93.0	62.9	85.5	136.0	116.0	74.4	98.1	109.8	71.9	53.5	79.6	78.2	66.8	145.9	133.0	118.6	81.6	74.5	51.3	70.9	88.1	78.3	77.5	89.1	74.3	118.7	62.9	41.9	89.5	130.8	151.1	130.5	77.2	127.0	89.1	98.5	63.1	48.3	26.9	55.8	37.2	38.9	33.0	35.8	54.8	35.4	32.0	32.9	48.3	43.3	54.9	47.0	42.9	61.5	45.4	47.5	49.1	63.6	50.0	50.9	47.7	47.2	49.5	46.2	47.5	54.0	89.7	57.7	45.9	25.5	80.0	134.3	123.1	177.1	75.7	82.7	89.3	110.4	110.1	67.2	108.3	29.5	139.7	242.3	82.7	72.2	109.5	150.5	246.9	88.0	90.0	84.2	75.9	153.8	43.8	128.3	130.9	86.1	52.0	90.3	53.2	167.5	52.8	78.0	150.1	57.2	43.6	111.6	77.3	97.3	97.0	294.1	77.6	90.5	65.8	15.9	121.8	86.0	78.2	26.2	55.6	139.5	83.7	83.8	88.9	121.2	110.0	144.7	75.1	97.1	65.7	73.0	167.1	204.1	108.0	93.9	126.0	358.6	72.4	171.0	109.7	123.1
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 459.7;Prostatic glandular cells: 557.4;Urothelial cells: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 1452.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		6100000	"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	47.1	148.1	22.5	40.6	21.1	64.7	28.0	20.9	22.6	28.0	37.3	50.9	58.4	47.9	21.0	30.7	39.0	55.9	65.8	21.1	29.8	37.9	46.5	63.0	34.4	55.2	26.7	34.1	19.0	33.8	21.2	39.1	33.3	41.0	45.6	20.1	20.8	60.6	67.8	12.4	39.4	51.6	22.9	27.8	52.1	37.8	24.6	42.8	30.4	64.0	34.1	141.6	30.1	25.7	228.4	1032.6	118.1	111.3	553.5	308.0	409.8	412.4	259.3	182.7	186.8	110.5	329.4	169.3	187.0	1452.6	682.1	77.7	235.7	158.6	214.1	82.7	101.8	143.1	765.8	468.0	885.7	226.3	149.9	176.9	159.8	403.7	128.1	557.1	634.0	227.9	200.5	77.5	276.8	109.1	233.4	102.7	114.4	453.0	1053.1	227.3	82.1	146.5	211.2	123.1	182.6	110.6	333.3	519.1	325.2	222.6	123.2	131.4	854.5	89.3	183.7	201.3	341.2	84.8	179.9	254.5	186.8	122.5	538.0	109.4	29.9	69.7	23.6	39.0	26.9	21.3	21.6	23.9	39.5	14.5	19.1	16.7	102.6	24.4	48.4	25.2	19.8	27.6	22.5	21.1	20.9	22.6	21.1	29.8	55.2	26.7	33.3	22.9	24.6	25.7	26.0	64.1	67.5	50.3	27.6	104.0	459.7	41.3	40.9	28.1	19.4	16.3	66.2	32.9	79.3	16.5	22.9	26.1	40.4	93.4	41.1	79.6	45.0	100.9	36.8	116.2	20.4	46.3	48.2	80.7	34.3	90.1	69.8	119.6	53.2	35.2	49.2	68.2	42.0	28.6	56.7	18.8	44.7	43.5	100.5	19.1	68.0	62.2	19.6	49.6	51.9	24.8	26.8	29.1	55.3	197.7	40.5	29.3	28.4	557.4	24.6	37.5	105.5	20.9	0.0	43.4	84.0	14.4	33.8	24.3	72.9	51.3	28.5	98.4	33.0	488.0
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		11000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	46.8	19.5	6.1	77.7	6.0	22.0	37.9	7.1	7.9	32.2	12.7	20.4	26.1	7.8	0.5	58.5	30.0	7.2	26.7	6.4	8.6	38.2	82.0	63.4	31.5	22.1	18.3	4.0	13.8	4.5	8.8	15.4	15.9	21.0	3.6	0.0	40.0	5.6	10.7	24.5	32.5	9.1	10.9	86.1	31.2	3.0	18.0	15.6	25.4	1.6	15.3	22.9	27.0	12.2	27.0	2.5	0.4	0.8	1.8	2.2	5.1	3.7	0.5	6.1	17.4	0.1	40.0	1.8	4.1	5.8	1.3	21.0	0.2	1.0	0.0	9.0	16.5	1.8	3.9	3.5	95.2	1.3	26.9	4.7	4.6	5.4	0.0	0.1	0.1	0.5	2.8	68.6	0.9	1.9	1.5	9.9	0.6	1.9	9.1	5.7	0.4	35.1	0.3	1.2	0.7	5.6	22.9	17.3	6.5	0.2	4.2	13.8	6.7	0.8	4.7	1.5	1.5	68.6	15.9	5.7	1.9	1.5	1.6	19.5	135.8	74.9	2.0	98.4	1.2	6.7	2.9	1.2	39.5	6.9	1.6	1.3	114.1	9.5	77.1	9.3	3.1	10.1	6.1	6.0	7.1	7.9	6.4	8.6	22.1	18.3	15.9	10.9	18.0	12.2	122.6	12.8	29.0	0.3	122.9	58.5	57.4	169.9	53.5	3.4	101.5	90.8	3.2	50.1	88.6	33.1	4.2	17.2	65.8	154.8	29.4	340.2	2.2	55.7	56.0	55.7	16.8	19.6	0.3	643.9	300.8	81.9	38.7	59.2	53.4	3.0	38.2	93.0	477.4	0.0	0.4	50.2	24.4	371.8	409.4	8.7	5.0	561.7	113.8	4.7	2174.6	2.9	71.1	0.5	0.2	364.0	86.4	1.9	102.1	109.8	214.5	105.1	78.0	6.6	26.3	93.3	62.4	1.5	8.0	71.7	56.7	33.5	62.5	3.7	51.1	76.0
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.5;lymphoid tissue: 113.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.7;T-cells: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002784, HPA074922"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	4.5	3.1	4.3	24.2	7.5	88.5	6.7	4.1	6.5	4.8	2.7	22.9	10.5	5.1	1.3	14.8	5.6	3.8	2.2	5.0	4.9	6.5	11.8	4.9	36.1	4.9	5.2	2.1	3.6	1.8	1.6	22.3	4.4	3.1	27.1	4.2	3.9	2.0	0.4	6.2	14.8	12.7	4.8	10.6	8.8	34.3	6.1	113.6	2.1	0.4	44.5	8.4	5.5	10.3	102.7	156.6	320.4	154.9	35.1	57.9	159.9	238.9	141.1	251.7	299.9	132.8	80.1	160.0	91.5	129.9	143.2	45.1	225.3	89.7	216.1	152.3	244.9	273.1	135.8	229.4	8.2	564.8	286.5	51.5	20.7	159.6	49.6	48.4	214.4	334.0	222.0	249.6	321.8	118.1	687.7	311.4	114.7	124.3	114.0	446.8	287.0	191.3	95.6	88.9	106.0	175.7	201.4	91.6	61.1	197.3	63.5	253.5	85.0	289.7	569.5	267.3	474.2	305.9	405.2	367.3	75.2	240.6	339.2	0.0	0.0	1.3	1.1	0.1	0.0	1.1	2.8	2.2	1.8	0.0	0.0	0.6	0.7	6.7	0.1	0.3	14.1	2.9	4.3	7.5	4.1	6.5	5.0	4.9	4.9	5.2	4.4	4.8	6.1	10.3	2.1	0.0	2.3	1.6	15.7	14.4	15.9	13.0	27.9	0.5	7.8	11.7	3.6	2.8	6.7	0.0	0.0	105.8	14.5	15.5	1.9	2.3	34.4	5.6	8.4	12.5	1.2	189.3	0.4	0.8	115.3	28.3	14.3	7.4	7.0	76.2	6.8	4.3	71.4	0.0	0.6	20.9	10.2	15.6	19.4	31.9	6.2	10.7	10.6	1.0	3.9	45.0	5.2	0.5	15.6	1.5	8.9	3.8	112.7	5.0	13.8	36.6	1.0	2.4	13.1	1.3	32.6	180.8	30.7	48.0	7.2	27.0	21.3	10.5	54.9	18.7
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583589	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;ovary: 49.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		17000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	21.5	3.5	18.2	1.4	30.3	0.8	5.2	17.7	27.1	2.1	0.0	2.3	1.6	4.6	3.5	13.1	11.5	2.5	2.2	27.7	10.7	11.3	0.8	3.3	1.3	20.9	22.6	49.7	9.8	0.9	0.9	5.7	18.6	2.6	0.9	2.6	1.9	6.1	0.9	13.8	2.4	4.4	14.4	5.5	3.2	18.8	15.7	0.4	1.1	1.8	3.7	2.1	4.1	32.0	10.3	6.7	20.7	22.7	18.9	12.8	69.2	14.6	9.3	14.2	13.1	37.7	3.4	0.4	18.3	11.9	19.9	23.7	23.3	3.6	6.5	5.8	15.5	3.2	20.2	18.1	13.3	5.2	0.4	4.1	7.3	10.9	3.6	5.8	10.6	9.8	19.1	4.3	7.9	9.8	2.4	1.0	47.7	16.0	6.7	31.9	18.6	3.8	1.2	19.7	24.6	7.0	13.7	21.6	16.3	29.8	17.8	6.0	8.4	28.0	12.2	21.0	22.5	1.7	3.5	3.1	17.2	33.8	17.2	1.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.5	0.3	0.1	0.3	0.1	0.1	18.2	30.3	17.7	27.1	27.7	10.7	20.9	22.6	18.6	14.4	15.7	32.0	3.4	3.2	1.1	17.6	0.9	6.8	8.5	0.4	0.6	2.7	2.2	2.2	2.9	2.8	0.7	3.7	6.2	2.9	1.1	1.3	0.0	3.9	3.6	1.1	13.0	5.4	1.8	0.0	42.4	3.6	10.2	10.5	8.6	1.9	0.0	7.6	9.7	0.4	1.2	0.0	4.6	0.9	0.0	1.9	1.3	5.1	44.4	0.9	8.8	1.0	0.1	8.3	1.0	29.1	46.8	4.6	0.1	47.0	0.3	6.4	1.2	1.2	0.5	4.0	0.0	3.9	4.3	4.0	6.5	4.2	10.9	18.9	0.7	5.8	2.3	5.7
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 678.4;U-251 MG: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	96.0	43.7	12.2	33.7	13.2	51.5	58.8	13.5	14.9	37.1	16.1	65.6	43.9	18.6	29.1	33.9	33.1	39.8	45.1	13.4	13.6	27.0	172.6	36.0	14.1	11.5	16.9	39.9	68.6	12.0	28.9	22.3	11.8	33.3	66.3	20.4	76.6	31.2	41.2	25.0	56.0	24.6	11.6	13.8	55.8	90.9	13.9	11.8	24.4	45.2	22.2	77.9	37.4	11.0	204.6	14.6	39.2	31.5	185.7	147.8	26.8	292.4	107.1	220.7	178.5	38.6	93.5	8.0	64.3	225.8	79.6	35.0	44.7	85.5	359.9	32.4	66.6	36.0	43.8	75.6	87.1	61.8	23.5	69.0	39.8	242.4	678.4	100.6	137.5	62.6	206.1	81.3	298.9	37.4	36.0	40.0	29.2	207.6	64.4	31.9	76.2	99.8	34.8	23.7	41.9	43.4	128.0	78.4	70.4	45.6	38.9	70.0	235.2	110.6	102.5	281.2	463.5	135.0	51.0	67.0	63.4	28.5	71.3	1.4	2.2	11.7	16.7	2.1	20.4	10.7	10.0	17.3	4.6	11.1	9.4	12.0	2.2	8.6	1.2	7.7	5.5	7.2	12.2	13.2	13.5	14.9	13.4	13.6	11.5	16.9	11.8	11.6	13.9	11.0	58.1	6.4	30.2	15.0	42.5	134.7	163.0	47.2	47.8	11.8	59.1	42.7	30.0	27.1	57.4	16.5	8.4	27.2	82.9	94.8	72.4	27.1	78.2	28.6	58.0	35.7	54.9	13.9	12.4	64.7	63.9	195.8	45.9	40.7	33.7	21.3	22.5	98.4	14.5	6.7	12.4	139.4	40.7	10.1	82.2	20.1	50.7	24.6	85.4	3.7	18.2	16.6	41.2	8.0	6.1	73.0	74.5	41.3	152.8	94.6	88.4	26.9	56.0	13.9	19.7	59.4	88.6	212.0	125.9	43.2	81.8	97.7	50.5	18.8	70.4	141.7
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm		NA	NA		14000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.21e-2)"	98.4	157.9	102.9	98.3	113.2	94.3	98.6	103.4	115.5	127.9	133.9	101.1	71.3	127.1	64.3	155.3	119.3	64.9	117.4	106.2	102.0	131.2	114.7	109.5	105.0	106.9	104.2	136.5	89.0	107.5	135.2	67.4	109.3	103.2	68.5	95.6	119.5	78.9	201.1	119.5	100.4	117.4	94.4	131.9	98.6	98.7	110.0	119.7	160.1	114.1	110.8	101.1	124.8	121.3	269.1	273.2	307.7	471.9	207.4	186.8	135.0	175.1	187.1	248.6	200.5	219.3	201.3	201.6	111.8	357.0	361.5	254.9	392.9	375.7	180.9	163.4	391.7	126.1	295.2	180.0	145.1	215.2	258.8	177.4	193.2	362.7	279.4	176.7	330.2	236.1	138.9	173.7	250.4	343.4	203.3	188.5	329.6	163.2	417.1	233.1	215.3	343.7	198.7	287.0	197.4	148.1	520.8	250.9	116.9	329.9	349.5	130.3	241.6	183.1	210.7	266.4	166.1	117.6	132.8	286.3	189.4	150.8	224.9	31.0	39.7	40.7	39.4	51.1	34.0	39.8	31.8	35.0	43.2	29.9	24.7	31.1	44.8	38.1	49.7	29.3	40.3	39.9	102.9	113.2	103.4	115.5	106.2	102.0	106.9	104.2	109.3	94.4	110.0	121.3	37.2	51.3	34.7	45.1	37.1	33.6	38.6	55.7	26.2	24.9	48.3	39.6	51.4	51.5	50.0	82.8	16.7	46.3	34.2	133.1	35.2	77.5	29.6	84.9	56.3	40.9	57.5	33.2	27.1	90.8	68.7	45.0	74.9	97.5	18.3	60.3	43.5	51.2	60.0	11.8	35.5	78.6	30.5	49.0	37.8	61.6	42.3	51.4	19.6	31.9	57.7	20.7	13.4	32.2	46.5	147.9	74.7	65.8	44.0	55.2	82.2	61.6	56.4	25.1	39.5	38.8	56.6	10.5	34.0	51.3	42.1	71.1	34.6	56.8	68.2	55.4
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805209-49813953	"Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		370000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	21.6	21.4	10.1	32.7	10.6	40.2	20.7	10.4	12.1	25.6	10.4	29.0	43.4	22.5	15.6	18.7	23.8	27.7	17.9	9.8	10.5	25.6	23.0	35.4	51.2	13.7	11.1	32.8	17.2	2.9	14.1	19.4	12.1	34.8	26.1	1.2	42.3	22.4	9.1	20.5	48.6	20.6	12.3	65.6	27.5	5.8	12.2	39.8	31.8	10.3	33.6	23.1	23.3	13.8	11.6	0.1	0.9	0.3	30.2	31.7	3.5	6.1	27.0	42.7	56.7	0.0	23.9	0.4	4.8	22.4	18.3	6.2	0.1	10.9	3.7	29.9	0.1	55.7	0.6	3.5	22.3	5.3	103.7	49.0	0.7	16.9	1.0	29.6	21.7	2.0	0.1	3.4	10.0	0.3	11.6	13.7	0.1	0.0	1.2	14.6	1.0	1.9	8.8	22.3	0.0	0.9	7.4	10.7	3.8	0.6	1.1	36.8	9.7	8.3	1.1	3.7	2.4	0.1	0.2	0.3	23.2	19.8	2.0	20.7	22.5	38.5	16.4	32.9	14.3	17.1	15.0	14.5	21.3	18.1	13.4	12.4	6.8	17.1	27.6	7.6	15.9	22.0	10.1	10.6	10.4	12.1	9.8	10.5	13.7	11.1	12.1	12.3	12.2	13.8	17.3	32.1	20.3	11.4	28.0	3.8	6.3	10.5	6.8	0.2	9.2	9.1	6.9	17.2	16.6	12.9	0.0	5.2	15.5	28.7	0.0	9.5	6.9	5.8	3.0	13.5	9.5	8.0	0.2	7.8	3.5	11.8	52.5	6.5	83.0	13.2	16.1	7.6	21.6	0.0	0.1	21.7	8.2	20.1	6.4	34.1	11.1	32.5	0.0	15.0	16.8	2.4	19.6	1.0	0.1	5.2	21.7	11.3	14.1	4.4	51.8	5.6	12.8	1.2	6.6	5.8	8.1	0.9	0.3	7.3	4.7	2.9	17.7	6.9	20.2	6.6
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628434	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	78.4	59.9	75.8	66.9	82.0	106.9	72.6	79.3	84.2	84.2	63.0	106.8	46.5	72.8	102.6	89.0	95.0	49.8	93.7	77.9	85.8	80.1	82.6	77.0	83.5	78.7	80.4	64.3	66.5	72.8	62.3	65.5	80.0	57.0	92.8	77.2	61.0	72.3	190.3	77.9	70.4	74.3	81.9	79.3	70.2	135.6	80.1	128.0	61.3	127.3	140.2	79.7	72.8	86.4	175.9	113.9	194.3	137.0	127.9	161.7	125.4	179.6	165.5	204.7	238.6	292.0	160.6	247.8	229.1	185.7	254.0	108.8	192.6	300.2	272.5	162.4	113.7	140.1	115.0	172.1	249.9	136.9	119.7	129.9	152.0	204.9	301.8	177.4	221.8	159.5	125.0	203.1	192.9	175.5	215.3	197.2	108.1	60.4	124.0	162.7	198.1	179.6	220.4	202.0	177.5	117.0	157.1	198.7	309.4	413.4	125.2	121.6	148.9	156.4	87.6	132.5	223.5	146.0	260.0	343.8	112.3	223.2	128.0	44.1	57.0	115.9	57.7	53.7	62.1	89.2	82.1	80.9	63.3	90.7	102.5	90.3	90.7	65.1	66.2	106.1	110.8	58.0	75.8	82.0	79.3	84.2	77.9	85.8	78.7	80.4	80.0	81.9	80.1	86.4	137.1	32.1	69.8	35.9	215.4	171.8	182.3	204.8	112.7	76.3	124.8	146.9	96.4	124.4	96.5	68.0	81.3	181.4	205.8	158.0	215.2	208.4	637.0	457.2	94.2	131.0	123.4	148.8	62.0	178.4	228.0	104.8	77.5	230.9	138.8	119.4	109.9	80.6	178.0	94.2	54.4	120.8	142.4	136.4	203.4	550.0	104.4	150.8	152.9	49.6	189.5	170.7	234.8	38.2	65.7	228.7	127.1	93.6	237.3	234.8	123.8	200.9	63.9	105.1	118.3	102.2	171.2	459.7	152.5	149.4	203.7	249.6	217.1	111.7	160.4	247.1
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 210.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 286.0;Late spermatids: 248.3;Suprabasal keratinocytes: 239.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Cytosol"		"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	21.0	19.1	15.8	25.4	21.4	31.5	20.1	21.0	24.3	25.2	11.6	39.7	22.5	22.7	14.7	52.2	16.3	16.0	37.9	16.1	18.7	27.0	30.3	15.6	38.8	21.5	19.2	15.6	18.4	21.5	9.7	18.9	21.7	22.6	24.2	17.5	21.0	20.8	210.2	28.0	23.6	27.2	20.3	20.7	21.8	23.2	21.0	24.9	16.1	84.1	46.4	24.5	32.1	26.5	54.5	57.8	52.7	38.9	42.2	44.3	74.9	51.7	41.4	48.2	42.1	40.0	27.0	84.5	52.8	51.2	39.4	57.2	66.3	48.1	77.2	44.8	53.9	31.7	28.6	45.9	41.3	46.5	57.4	38.0	70.3	45.8	66.1	33.8	65.6	55.8	56.5	88.9	40.1	24.3	59.4	42.5	58.2	40.1	29.6	76.1	27.9	78.1	56.4	35.1	22.7	42.3	48.9	41.8	41.6	77.4	41.1	29.9	49.6	48.1	36.8	57.0	58.7	34.3	43.8	118.9	36.9	42.8	37.7	13.3	15.8	39.0	22.2	16.8	29.9	34.1	28.3	29.1	20.2	24.4	28.3	28.9	28.1	32.5	18.6	14.8	28.9	21.8	15.8	21.4	21.0	24.3	16.1	18.7	21.5	19.2	21.7	20.3	21.0	26.5	28.3	22.4	14.4	31.3	70.6	286.0	36.5	47.8	111.5	18.8	47.0	31.0	67.6	27.1	32.2	25.8	6.2	47.0	47.8	41.4	82.2	30.9	139.5	36.7	25.7	35.5	38.4	26.5	47.9	26.7	59.6	31.1	32.6	39.9	21.0	13.9	31.1	62.3	48.1	15.2	46.3	38.3	44.7	36.5	81.1	248.3	19.6	35.7	67.6	30.9	43.1	28.7	36.0	36.2	84.4	43.0	30.4	21.1	154.3	65.7	40.4	75.6	35.4	17.1	6.6	25.9	43.5	70.8	50.8	85.3	239.7	66.8	58.2	13.8	30.1	54.0
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44801826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 211.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	26.7	20.9	21.1	13.4	22.8	25.9	17.5	21.9	24.7	13.5	20.0	22.2	13.3	20.2	8.4	16.1	16.3	12.1	34.7	21.3	21.8	24.4	27.6	16.9	16.2	22.4	22.3	13.7	26.7	20.5	8.2	14.2	22.6	14.8	14.1	20.7	12.6	21.3	61.3	15.3	16.6	20.4	22.1	19.7	21.6	12.2	22.0	22.9	16.9	51.8	14.9	21.2	12.5	24.2	51.9	11.5	34.9	44.3	46.2	20.6	31.3	37.0	27.5	29.5	31.7	40.5	6.7	66.4	33.4	35.8	38.6	20.5	49.4	43.5	27.2	61.9	51.1	107.3	7.0	33.6	35.5	79.2	19.4	33.3	50.0	39.5	39.5	14.7	47.0	71.3	99.8	47.9	43.0	24.6	89.2	13.3	86.7	35.4	44.2	73.2	31.1	61.2	41.4	28.3	39.3	72.5	49.6	18.2	52.3	30.5	17.6	68.5	37.3	31.1	21.2	28.5	58.5	73.8	144.7	64.1	29.3	96.1	36.3	3.2	16.1	8.5	20.8	16.8	22.8	16.0	19.0	21.5	17.3	16.2	20.1	21.3	4.9	20.8	20.1	24.6	21.1	17.4	21.1	22.8	21.9	24.7	21.3	21.8	22.4	22.3	22.6	22.1	22.0	24.2	54.6	57.7	115.4	70.8	48.3	47.7	38.4	32.0	39.3	58.8	37.3	34.0	70.6	28.6	48.4	53.3	66.7	40.7	53.3	29.8	25.4	32.9	63.4	36.8	68.5	54.1	30.0	37.4	56.3	40.7	26.3	41.3	26.0	49.7	43.6	66.6	37.1	69.7	35.3	32.0	57.5	31.2	26.4	42.2	37.4	211.1	41.3	42.9	28.4	32.8	43.2	39.5	49.4	73.9	56.7	43.2	21.5	50.4	53.6	55.6	27.4	36.7	43.0	102.2	26.3	59.3	42.8	42.9	49.4	44.9	56.0	35.8	49.4	75.6	46.0	40.9
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021, CAB079920"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		130000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	62.5	76.3	42.5	60.3	44.0	81.6	62.0	46.1	49.3	64.7	37.1	63.8	45.1	72.7	48.7	74.2	67.3	34.3	68.2	45.2	45.2	63.4	40.8	53.1	76.0	39.3	42.3	93.1	49.1	72.0	61.6	58.1	40.2	53.4	47.3	31.7	56.4	46.7	58.0	68.0	61.1	53.8	42.2	71.9	52.9	47.6	47.1	110.3	53.2	57.0	89.3	66.6	63.1	42.1	121.3	161.1	269.0	157.7	112.7	135.8	114.4	170.0	121.7	154.3	152.9	191.8	190.1	208.2	137.7	148.1	140.7	142.4	193.2	159.2	197.9	151.2	133.4	130.6	136.6	188.4	178.6	194.9	148.0	127.1	100.7	152.1	180.0	149.0	170.0	169.9	190.3	124.3	148.0	254.4	349.6	193.0	219.0	136.0	118.5	434.0	170.9	238.4	145.7	106.6	150.3	159.8	149.3	164.1	177.7	152.8	167.5	234.4	139.4	149.2	172.6	134.0	155.5	132.1	170.4	423.4	85.3	142.9	164.7	278.7	214.3	327.1	165.9	256.6	200.9	297.8	167.8	170.3	214.7	241.1	148.2	149.6	149.5	202.6	249.5	186.3	196.5	260.9	42.5	44.0	46.1	49.3	45.2	45.2	39.3	42.3	40.2	42.2	47.1	42.1	109.5	51.3	67.0	16.3	172.8	178.6	186.4	275.6	97.3	64.6	101.9	105.7	89.1	84.4	140.9	62.5	50.1	312.8	153.9	77.4	105.7	211.9	64.4	66.6	100.6	118.3	102.3	127.4	17.2	148.2	293.1	134.4	55.5	104.6	109.5	149.7	94.2	43.7	213.5	47.1	16.8	97.1	162.8	104.8	182.1	37.8	129.8	124.8	128.1	15.9	220.2	104.7	209.1	16.6	26.7	212.3	91.8	107.6	144.1	294.8	90.4	117.7	65.7	63.1	78.9	82.1	185.4	139.6	145.7	158.4	206.7	418.1	144.7	134.9	134.7	304.5
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 544.4"									"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		5800000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	41.5	46.0	63.7	37.1	64.8	54.4	33.9	65.0	72.0	35.5	54.4	45.5	39.6	35.0	41.0	49.1	38.5	34.0	51.5	65.4	65.3	40.1	40.9	33.9	48.8	67.8	64.7	33.9	30.3	43.2	31.2	42.7	66.8	39.1	45.6	28.1	33.9	36.8	63.5	36.2	40.7	48.6	62.3	37.6	37.5	28.5	66.7	51.9	36.4	53.1	52.5	46.8	32.3	65.5	121.9	68.9	98.3	77.4	105.1	93.1	56.6	100.0	113.6	125.8	118.7	79.0	57.0	114.2	49.0	133.5	94.7	101.4	132.1	108.6	124.3	114.4	142.9	132.1	63.3	94.8	70.0	190.9	91.0	82.7	93.1	91.2	65.7	90.6	143.4	69.4	544.4	59.3	137.9	89.6	100.0	137.6	72.8	134.8	71.6	80.5	147.6	31.2	118.8	96.2	88.0	65.4	79.9	99.1	95.6	89.4	61.7	104.0	103.8	88.6	113.5	75.5	103.6	57.3	99.7	103.7	120.0	87.5	86.0	84.4	87.8	105.7	84.9	102.2	79.7	77.3	79.9	91.6	109.2	73.6	69.0	82.9	73.2	81.2	89.0	106.3	106.1	141.1	63.7	64.8	65.0	72.0	65.4	65.3	67.8	64.7	66.8	62.3	66.7	65.5	102.6	109.0	83.9	26.1	110.7	125.5	171.6	318.5	51.2	54.5	76.9	72.8	64.9	101.5	180.3	71.7	16.7	312.1	159.0	215.1	197.6	288.2	79.9	133.1	104.6	125.9	126.0	173.0	25.6	385.0	406.5	102.6	60.1	124.9	129.3	79.3	109.6	159.8	298.5	69.0	24.3	153.1	193.3	126.9	159.7	61.1	87.3	140.9	126.3	19.7	257.9	98.4	200.8	22.6	30.4	432.1	222.1	103.8	98.4	186.7	213.5	257.2	173.9	45.5	105.2	81.0	205.4	202.8	121.2	87.6	129.7	372.1	130.1	133.7	154.0	208.4
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93441947	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 2532.0;Late spermatids: 8141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: AB_2679163"	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	52.4	48.6	46.4	62.1	49.9	69.9	41.6	40.3	51.6	35.8	26.8	55.9	42.5	44.0	38.3	60.4	37.3	33.5	57.6	50.8	53.2	54.4	45.5	38.2	80.0	45.2	43.9	31.3	30.6	40.4	32.6	49.5	52.2	46.0	44.0	50.3	36.0	34.5	83.0	41.3	42.3	42.7	44.3	42.9	41.0	186.9	44.3	79.4	29.0	70.3	73.8	76.4	38.6	44.4	190.3	133.2	221.1	142.6	82.9	81.4	154.5	259.4	135.6	201.0	167.3	239.8	80.0	380.2	57.3	151.1	133.8	147.7	245.2	188.7	189.7	323.3	128.4	258.0	66.6	214.2	106.4	311.9	165.1	86.3	75.2	120.8	148.9	143.1	157.3	146.9	292.8	58.0	210.9	155.3	310.4	286.2	288.9	165.9	189.4	237.3	179.9	186.6	170.1	280.9	214.9	195.6	136.1	158.5	130.0	118.7	207.5	188.0	165.8	135.7	114.6	124.1	189.9	99.5	289.4	324.0	53.5	162.5	170.2	133.7	89.5	101.3	99.3	123.3	116.8	174.0	124.8	124.1	119.6	144.7	109.3	104.9	27.7	106.0	141.7	89.6	198.6	202.5	46.4	49.9	40.3	51.6	50.8	53.2	45.2	43.9	52.2	44.3	44.3	44.4	87.5	38.5	45.8	24.8	151.4	322.2	231.3	219.1	92.2	72.1	84.3	60.5	74.6	60.1	112.2	90.1	27.1	236.0	104.3	76.3	191.7	141.4	2532.0	79.7	79.0	95.3	74.7	75.9	44.6	99.0	226.0	100.9	49.5	96.5	93.8	68.3	55.3	55.3	165.6	87.5	49.0	78.6	187.2	67.8	216.3	8141.3	93.8	97.0	147.7	33.7	152.9	111.9	79.3	38.7	42.1	135.5	83.8	86.1	113.3	218.2	61.2	171.3	88.9	57.6	46.0	101.9	146.2	338.4	227.6	142.2	322.5	284.7	128.2	86.4	94.9	260.3
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 99.9;Inhibitory neurons: 101.1;Oligodendrocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	13.5	22.2	13.0	12.9	18.4	20.1	13.4	19.6	16.7	15.8	9.3	24.3	16.2	19.4	12.6	22.8	14.6	12.3	23.2	13.6	13.9	13.6	13.9	11.2	12.4	19.1	15.1	23.3	26.9	21.1	15.2	20.0	20.7	14.1	13.4	19.3	15.0	12.8	41.8	25.3	15.9	17.4	10.4	12.2	20.4	9.5	16.6	17.1	21.0	27.5	14.2	17.3	16.7	28.7	37.9	24.5	28.8	31.6	37.5	49.0	22.5	24.4	31.1	24.0	24.3	26.6	43.2	32.4	29.2	43.6	18.6	27.5	37.2	28.2	28.1	33.8	20.8	35.1	41.5	30.2	27.4	36.6	23.9	40.4	24.7	32.1	26.8	43.9	35.0	23.3	61.7	42.4	22.0	19.6	24.1	16.7	38.2	24.2	19.9	23.6	28.1	34.8	23.0	17.0	35.0	26.7	38.8	26.8	49.5	30.4	21.1	26.0	30.4	21.1	32.0	26.5	20.2	18.8	27.7	37.1	30.9	41.4	28.4	3.4	4.9	2.4	3.0	3.7	5.1	3.6	5.0	5.0	4.1	3.2	4.5	3.6	5.5	1.8	2.8	1.8	6.4	3.6	13.0	18.4	19.6	16.7	13.6	13.9	19.1	15.1	20.7	10.4	16.6	28.7	13.5	22.4	24.0	65.6	17.7	17.6	14.6	13.0	21.6	14.7	18.6	13.2	42.2	15.7	12.9	9.2	25.0	33.1	12.3	12.0	9.8	12.8	3.0	22.4	23.3	15.4	16.3	33.4	99.9	14.8	13.5	18.5	14.8	24.6	6.3	27.9	17.2	16.4	16.5	16.8	101.1	16.2	16.2	22.1	10.9	4.8	11.1	16.1	5.4	46.9	22.9	10.5	19.6	82.4	185.2	19.5	19.5	8.6	24.3	19.3	25.5	10.3	12.9	33.5	19.7	15.2	16.4	8.5	15.0	35.8	22.4	20.5	18.3	21.1	18.6	18.5
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659968-83707958	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	50.1	49.8	43.0	43.6	46.4	84.9	42.3	42.2	46.7	40.7	30.6	44.2	39.3	43.1	38.8	50.8	36.9	37.0	63.0	50.1	50.2	55.2	74.0	39.0	51.1	46.7	47.2	36.1	50.5	72.2	28.6	50.4	50.7	45.4	41.3	55.8	34.5	46.8	125.8	42.4	39.6	47.1	43.6	37.7	42.4	42.0	46.3	69.4	45.3	72.9	65.1	53.3	35.2	57.0	154.5	137.8	101.9	77.9	83.4	89.3	164.0	140.8	125.4	147.7	111.3	56.8	105.5	153.9	86.6	120.0	137.0	172.0	141.8	101.7	152.7	79.7	66.0	95.1	97.9	90.3	111.7	116.6	98.3	74.7	127.1	124.1	172.4	92.8	112.8	72.6	102.7	105.7	124.6	91.0	160.8	66.6	132.6	147.5	126.3	117.6	113.7	80.4	98.7	65.0	90.4	101.2	130.9	131.7	102.0	100.2	64.6	84.2	111.8	92.2	84.9	154.2	143.6	146.1	222.0	74.7	139.4	85.1	114.1	34.9	21.2	22.6	19.8	31.4	19.3	19.0	16.9	18.2	24.2	19.6	16.9	18.5	22.7	31.8	30.7	10.5	24.2	20.5	43.0	46.4	42.2	46.7	50.1	50.2	46.7	47.2	50.7	43.6	46.3	57.0	39.5	35.3	42.2	29.4	53.9	103.2	66.2	43.0	42.7	58.4	41.2	28.3	76.7	31.5	46.8	22.0	20.9	59.9	38.9	49.9	19.6	55.1	37.9	47.7	50.9	42.8	51.4	51.8	61.9	53.5	86.9	42.2	32.1	74.9	50.1	33.6	25.7	73.4	52.1	75.7	58.7	41.5	42.7	51.2	87.5	18.3	24.5	52.4	42.7	41.2	46.5	31.0	39.1	33.2	67.9	70.4	36.5	27.8	56.2	68.8	48.9	39.6	33.4	34.1	39.5	33.4	42.9	74.1	50.5	45.2	92.5	164.3	47.7	28.9	41.1	84.0
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563627-56567868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.8	20.2	24.9	14.9	26.8	11.1	12.1	19.7	30.6	15.9	12.7	15.7	11.2	16.6	15.9	18.7	17.5	14.5	21.6	27.4	25.5	13.5	19.4	13.8	18.4	20.2	20.4	25.7	10.5	23.6	16.3	15.8	22.1	20.2	12.1	22.2	14.4	20.0	28.0	13.6	12.4	18.4	21.3	14.9	13.1	4.4	22.6	18.9	20.7	22.8	18.6	18.6	11.1	25.5	36.3	26.5	25.9	30.6	58.3	37.0	16.3	28.6	33.9	21.0	23.2	14.9	16.6	27.6	30.5	34.0	32.9	20.7	50.0	31.9	25.3	43.0	30.1	11.2	34.2	15.9	30.6	22.1	23.7	34.7	39.6	28.3	24.6	30.3	18.7	17.6	13.3	29.5	33.6	16.9	28.5	19.2	21.7	11.6	31.1	25.3	33.7	26.3	42.8	27.9	31.9	29.9	41.3	18.1	17.4	45.2	30.4	16.1	21.2	22.2	22.5	32.4	17.5	11.1	14.8	18.9	24.9	23.1	19.3	50.0	23.6	24.1	15.1	31.1	17.1	7.8	22.9	17.7	17.8	8.6	30.3	18.9	20.4	20.9	34.2	6.5	23.5	20.3	24.9	26.8	19.7	30.6	27.4	25.5	20.2	20.4	22.1	21.3	22.6	25.5	13.9	22.4	17.2	0.0	30.5	31.2	41.6	27.4	20.5	42.3	14.5	11.3	37.6	15.7	25.0	18.4	18.8	28.8	15.4	12.1	17.6	20.0	0.1	11.8	22.7	18.9	34.2	18.3	0.0	16.6	26.7	27.9	13.7	15.7	12.7	14.2	18.2	20.3	24.7	42.1	0.0	20.3	18.3	30.7	25.3	1.6	24.8	21.1	17.8	0.0	35.9	22.3	42.2	0.0	0.0	18.9	12.7	36.5	23.5	32.0	20.7	16.4	27.5	35.8	13.1	25.4	29.8	0.3	1.5	32.7	30.4	40.0	28.7	12.2	19.3	35.6
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3"	Q6ZT12	2	169827454-170084131	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.2;tongue: 87.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	14.2	12.4	4.4	7.7	5.8	7.4	9.2	5.9	8.5	10.9	2.8	8.8	8.1	10.1	6.9	12.8	8.4	9.3	29.4	8.0	3.3	15.2	21.0	8.8	7.2	2.4	2.7	10.2	11.9	21.5	2.1	8.7	3.3	13.1	8.5	21.2	11.5	10.3	71.2	9.2	7.5	11.1	3.2	8.8	9.3	9.7	3.4	9.5	17.9	87.1	7.3	11.0	2.3	8.4	14.8	12.4	12.9	17.1	25.0	19.7	10.8	26.1	15.0	14.7	11.8	19.1	9.1	16.7	22.2	20.5	12.0	19.0	15.5	13.2	18.2	17.4	13.4	61.1	12.6	20.3	12.4	20.4	18.9	11.9	12.1	19.3	12.9	11.7	14.8	8.3	32.4	17.6	25.6	14.0	13.3	10.0	10.1	14.9	10.2	12.6	21.1	17.8	10.5	20.5	25.1	13.7	18.4	16.7	10.6	10.2	10.9	11.4	18.9	22.1	9.0	17.5	16.7	14.2	11.9	15.1	18.2	11.8	12.5	0.0	0.6	0.5	0.9	0.6	1.3	0.6	0.5	0.8	0.9	0.3	0.9	1.2	0.6	0.8	0.5	0.7	1.0	0.4	4.4	5.8	5.9	8.5	8.0	3.3	2.4	2.7	3.3	3.2	3.4	8.4	19.0	44.8	26.9	162.6	16.3	25.9	12.4	14.8	20.5	46.3	15.8	8.9	109.7	17.2	20.0	12.9	81.3	19.7	22.9	17.1	3.9	8.7	7.6	16.8	21.9	26.4	16.7	24.4	305.1	11.0	8.4	22.2	23.4	22.0	16.5	22.7	30.4	39.0	10.2	63.9	302.0	11.3	22.4	20.9	18.7	10.2	25.7	18.7	16.0	110.5	18.7	61.7	14.4	232.2	288.0	10.7	15.0	19.2	21.3	20.9	15.3	10.0	13.4	51.5	26.3	29.0	21.8	12.4	8.6	22.9	29.0	23.0	18.1	17.3	13.2	17.2
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor"	P17480	17	44205033-44221626	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	34.8	36.5	36.2	44.8	33.7	54.9	35.4	38.2	37.1	50.6	30.1	49.4	33.6	50.8	27.5	41.8	41.9	32.5	38.8	35.5	32.7	38.1	36.1	32.3	67.6	34.0	34.5	41.6	41.4	38.2	33.8	29.2	32.2	41.6	28.2	23.1	37.7	40.8	63.7	47.4	42.5	36.3	31.6	49.8	34.7	20.8	34.9	73.6	46.4	36.6	51.7	45.1	41.8	35.0	69.1	104.3	77.3	93.2	49.6	56.5	72.3	70.6	46.7	70.1	52.0	50.7	54.8	250.0	69.3	65.3	51.9	63.6	99.1	59.2	57.9	145.3	109.5	100.5	73.8	83.7	32.5	192.1	85.7	56.9	52.2	44.6	65.6	67.2	58.9	108.8	117.4	75.9	58.9	113.7	188.3	75.0	73.7	46.6	81.6	184.0	104.3	112.0	40.4	54.5	119.5	90.3	70.4	62.2	54.2	47.9	89.9	120.8	75.5	109.9	133.1	65.1	95.0	66.6	61.7	151.1	64.8	86.0	100.1	9.6	5.7	6.1	15.5	6.3	16.7	11.7	10.8	16.2	6.7	14.1	12.2	13.1	9.7	15.7	11.6	12.7	10.0	11.3	36.2	33.7	38.2	37.1	35.5	32.7	34.0	34.5	32.2	31.6	34.9	35.0	41.4	41.7	42.1	14.7	57.5	20.5	19.6	17.9	57.5	88.8	31.0	29.6	44.5	35.8	32.2	38.6	79.2	30.9	60.3	41.7	35.2	27.2	2.3	39.3	57.7	42.7	47.3	61.2	8.5	40.8	40.7	38.9	23.9	48.1	31.7	43.1	32.5	26.5	25.9	26.9	8.2	32.5	12.2	18.4	13.3	3.6	36.7	27.4	23.2	8.4	38.1	33.9	54.6	3.5	10.6	28.1	30.7	50.8	42.2	17.4	26.7	25.4	26.5	57.6	52.6	48.5	45.9	5.3	44.0	52.1	24.3	32.7	53.1	40.2	32.8	11.8
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457794	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	99.7	188.7	60.5	35.0	60.9	85.8	89.4	53.3	91.6	94.9	64.0	93.6	49.2	94.5	21.1	89.7	89.1	33.7	116.1	72.3	53.1	118.4	122.2	72.0	35.2	64.0	64.8	115.2	100.3	64.7	146.1	34.8	64.1	93.8	14.1	23.8	86.1	50.7	216.6	113.8	67.7	23.2	52.9	77.8	88.5	174.8	55.1	26.9	111.8	84.3	18.1	91.8	85.3	57.5	71.7	49.4	23.3	50.6	57.7	70.6	35.1	71.3	84.3	50.9	54.1	30.8	58.8	31.8	63.5	70.8	26.3	40.8	18.2	54.8	18.6	56.3	39.4	26.4	53.5	41.4	94.5	33.6	51.1	65.2	70.4	40.1	38.7	62.3	62.9	42.7	55.6	83.6	38.3	45.4	67.2	56.8	37.6	27.4	42.9	30.4	33.3	76.0	48.3	43.9	67.1	97.3	40.1	40.9	116.7	10.8	48.5	54.4	76.8	67.4	51.4	145.0	47.7	186.6	80.7	33.2	128.7	62.5	61.4	6.4	6.6	10.4	3.8	8.0	6.2	5.3	4.5	5.2	6.7	6.0	5.3	4.2	6.7	2.7	4.9	10.2	5.5	4.9	60.5	60.9	53.3	91.6	72.3	53.1	64.0	64.8	64.1	52.9	55.1	57.5	26.7	41.7	30.1	13.7	25.1	37.2	44.9	26.7	15.9	37.2	36.3	25.1	47.2	64.3	21.2	44.1	27.1	54.5	31.9	105.0	80.3	58.1	297.0	29.1	35.6	30.5	46.8	172.0	14.4	65.0	43.1	39.0	28.5	32.2	34.3	50.0	47.5	61.6	54.8	13.5	11.9	66.2	20.3	52.8	35.9	1342.0	100.0	37.5	53.4	1.9	49.0	60.1	25.7	5.5	10.3	65.6	90.1	73.0	16.4	50.9	136.9	112.2	21.4	35.2	72.3	38.8	29.5	139.9	68.9	20.4	41.1	79.6	18.5	41.4	58.4	48.5
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		18000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	19.9	19.0	11.0	22.5	12.1	24.6	22.7	20.3	15.8	13.6	5.5	23.3	24.7	14.8	17.5	32.2	11.3	15.5	30.5	13.3	12.3	27.2	37.9	15.9	29.1	11.8	11.5	16.4	33.1	20.3	9.7	23.1	12.8	21.4	24.0	37.7	26.0	16.0	39.7	21.3	24.2	18.1	12.9	18.0	17.8	13.4	10.7	24.8	19.2	36.8	32.6	19.1	14.3	14.1	136.6	74.0	61.7	65.5	37.1	37.8	76.4	80.1	40.4	74.8	65.8	71.4	94.9	104.7	72.5	44.4	43.2	85.5	84.1	99.5	100.9	110.0	61.9	126.0	97.5	97.3	57.6	198.5	67.8	33.9	44.5	106.1	91.2	33.6	76.4	100.3	285.1	86.2	67.3	105.9	146.2	70.1	57.7	89.1	46.9	84.5	68.3	216.4	70.8	81.0	61.2	76.7	72.7	97.3	110.4	64.9	82.2	95.8	49.9	71.9	21.4	70.0	125.0	62.8	105.2	117.5	40.2	119.5	123.6	60.9	31.7	41.6	53.3	40.1	59.5	43.8	48.0	51.2	39.0	37.4	51.0	57.1	19.5	75.2	45.0	41.3	51.3	44.8	11.0	12.1	20.3	15.8	13.3	12.3	11.8	11.5	12.8	12.9	10.7	14.1	33.9	9.6	30.2	12.7	28.6	24.3	13.5	27.9	18.8	20.6	19.4	16.6	79.5	21.5	28.5	27.6	43.8	35.8	45.7	18.9	45.0	26.3	2.8	13.0	15.4	21.4	10.8	39.7	35.4	28.3	34.5	22.8	20.9	16.0	56.3	21.4	17.9	24.6	28.0	25.2	33.2	20.2	16.2	18.8	20.7	3.8	14.9	25.0	17.8	19.7	23.4	27.4	75.2	18.1	29.6	25.3	10.6	17.3	58.5	21.8	30.2	39.9	21.1	43.5	19.7	19.6	34.9	22.1	16.8	32.7	30.0	25.2	34.5	31.9	23.2	12.4
UFM1	"bA131P10.1, C13orf20"	ENSG00000120686	"Ubiquitin fold modifier 1"	P61960	13	38349849-38363619	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039758	Approved					NA	NA		240000	"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA039758: AB_10697555"	"unprognostic (8.08e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (9.67e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.90e-1)"	41.9	43.1	35.6	47.8	38.1	100.1	47.4	35.6	44.0	43.5	40.5	39.7	48.5	58.4	64.8	29.9	37.1	42.2	35.8	37.6	42.1	45.3	52.9	41.6	52.3	39.1	37.5	50.3	67.0	32.7	37.2	53.1	39.4	49.9	50.6	32.1	58.5	50.3	24.8	42.8	47.8	39.2	40.1	46.9	52.3	19.8	36.9	31.9	52.1	26.2	48.5	41.7	35.8	44.5	31.3	18.1	47.4	46.2	81.8	97.4	43.3	94.1	72.8	47.7	50.3	56.2	63.1	50.9	29.1	81.8	94.5	51.6	44.9	57.4	67.6	71.4	27.5	42.5	33.9	50.0	107.8	63.3	59.1	81.6	84.3	46.4	127.6	69.9	47.7	39.6	28.5	68.5	68.6	35.6	42.8	52.5	48.9	94.4	45.8	48.9	84.8	50.6	60.2	40.6	17.9	40.6	32.4	54.8	80.8	64.9	40.0	49.1	56.5	55.1	33.5	88.1	53.1	64.7	43.9	67.6	116.6	32.2	84.5	71.5	30.6	41.1	30.7	42.0	37.3	40.1	31.2	28.7	26.7	37.6	30.4	31.8	15.5	39.6	40.3	45.0	32.4	34.7	35.6	38.1	35.6	44.0	37.6	42.1	39.1	37.5	39.4	40.1	36.9	44.5	92.1	80.1	73.3	20.9	141.6	136.9	151.7	147.8	108.1	24.0	102.7	64.4	66.3	64.3	115.3	62.5	20.9	87.2	112.7	84.8	99.7	91.5	38.6	126.8	113.4	78.8	31.7	52.6	29.0	102.3	140.2	121.5	92.8	148.1	115.3	53.4	68.9	119.6	97.6	6.7	34.9	113.5	107.8	94.3	148.3	13.3	59.0	102.0	94.3	43.1	92.3	26.7	62.8	26.2	58.9	161.9	102.2	40.3	330.9	215.8	95.2	136.5	141.2	22.3	19.7	87.3	88.1	56.6	44.9	110.2	173.3	140.4	93.0	45.2	80.8	220.3
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		4000000	"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	8.1	8.5	4.2	13.7	4.6	21.8	7.6	4.8	6.5	9.1	5.0	12.4	9.0	7.3	19.9	8.0	6.5	6.5	8.0	4.3	4.6	8.2	14.9	8.4	12.3	4.7	4.4	5.1	14.8	8.7	6.5	8.7	5.0	8.7	10.0	9.7	8.6	6.2	13.2	8.8	10.2	6.2	4.0	9.4	10.7	6.4	4.8	11.7	10.4	13.0	12.6	7.5	6.6	5.6	34.8	11.8	22.0	47.6	28.0	22.3	34.3	39.4	16.7	12.7	11.3	26.0	24.9	49.4	15.4	28.3	11.3	25.3	16.8	16.8	25.5	31.5	8.2	43.4	14.9	82.3	28.0	58.6	25.9	16.3	13.0	25.4	23.0	25.0	29.8	19.8	28.4	25.6	26.9	24.4	23.5	33.5	39.5	24.0	12.4	19.2	21.3	20.9	23.8	25.2	11.7	17.4	27.3	36.0	24.4	22.5	14.4	40.2	43.1	34.6	24.4	20.1	28.4	27.3	40.4	22.3	29.3	31.4	32.6	3.8	2.5	2.5	2.3	2.5	2.3	1.6	1.9	2.1	1.9	3.3	1.6	2.3	3.7	1.9	2.5	3.1	1.6	1.4	4.2	4.6	4.8	6.5	4.3	4.6	4.7	4.4	5.0	4.0	4.8	5.6	14.6	35.3	24.7	24.8	14.3	8.2	6.4	11.1	5.7	19.8	11.2	7.1	16.7	12.8	20.7	3.7	22.9	10.5	22.1	21.5	1.9	14.0	9.2	18.4	27.7	16.5	22.8	31.5	40.6	19.5	20.1	16.6	21.9	22.2	11.4	20.8	17.9	39.7	16.6	20.2	37.6	21.9	8.2	25.4	16.4	2.3	14.9	20.0	14.2	32.8	26.0	7.5	15.5	31.2	46.5	19.4	10.4	13.5	31.5	13.3	25.3	8.4	12.7	20.2	6.6	18.5	13.3	10.0	8.5	9.4	10.7	10.8	18.9	16.0	22.8	10.1
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894622-131923150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 4.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA063990: AB_2685167"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	19.9	30.1	21.2	7.2	46.0	31.4	20.9	8.3	28.4	31.5	6.2	31.2	9.0	27.2	6.5	21.5	27.2	9.3	35.0	24.4	4.7	21.7	36.4	20.9	6.7	10.9	8.7	39.9	55.6	12.1	47.2	7.1	9.6	27.8	2.3	14.4	21.4	9.4	81.6	43.1	19.5	4.9	1.5	29.3	27.8	17.8	9.9	7.9	24.5	13.8	2.9	23.1	26.8	12.4	9.1	28.8	13.1	16.4	5.8	4.7	17.8	14.1	10.1	5.9	4.8	6.3	9.2	2.4	14.5	10.0	12.0	8.9	3.0	5.6	1.7	9.8	17.2	6.1	25.2	8.6	10.8	4.4	12.9	8.6	15.1	6.6	2.7	16.4	7.3	18.2	8.1	7.0	4.0	20.6	27.5	25.6	14.4	4.3	27.2	20.5	4.7	12.2	3.5	11.1	33.1	18.2	15.1	15.3	7.9	13.1	23.4	29.5	14.2	14.1	8.3	24.8	6.6	30.9	12.0	3.3	23.8	7.6	16.6	0.2	0.9	1.4	0.4	0.4	0.1	0.1	0.3	0.4	0.2	0.3	0.2	0.3	4.0	0.1	0.4	3.8	0.3	0.4	21.2	46.0	8.3	28.4	24.4	4.7	10.9	8.7	9.6	1.5	9.9	12.4	15.6	16.0	17.4	17.9	7.8	14.4	6.1	11.6	9.6	25.0	19.6	14.4	22.0	15.7	15.6	7.3	39.6	5.7	23.7	10.5	1.9	8.5	0.8	19.1	35.7	14.9	19.2	12.0	27.0	12.7	4.2	13.1	13.3	28.0	3.8	24.4	8.6	33.8	5.4	53.8	21.9	14.6	18.3	12.0	6.7	3.0	12.5	13.1	5.4	11.2	12.3	14.7	5.2	20.1	13.9	24.5	7.7	15.8	11.9	15.0	9.9	3.2	13.9	84.3	13.1	19.5	16.9	6.8	7.5	9.7	19.5	17.2	9.1	8.8	7.7	9.5
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333051-20356301	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	693	"kidney: 2277.8"	"Group enriched"	"Detected in some"	146	"Collecting duct cells: 248.3;Distal tubular cells: 950.9"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	NA	NA	55000000	66000000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2277.8	0.8	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	248.3	0.0	0.0	0.0	0.0	950.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844552	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.9;lymphoid tissue: 66.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.0"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		1500000	"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	7.7	7.3	5.6	23.5	6.8	58.9	7.8	5.8	7.3	18.6	5.0	10.7	8.0	8.6	2.0	23.6	13.8	6.5	14.3	5.0	5.6	6.6	12.6	38.1	25.9	7.9	6.5	19.3	8.8	0.5	11.6	9.0	7.5	8.1	4.5	5.5	7.7	5.1	8.5	6.0	18.5	4.9	6.2	66.2	13.8	6.1	8.2	20.7	5.9	1.5	17.6	10.7	19.6	8.7	44.0	18.7	0.4	0.3	0.5	1.0	47.6	0.1	0.0	0.0	0.1	41.4	97.0	3.4	46.4	0.0	7.5	15.4	0.0	2.2	0.0	0.4	0.5	245.7	136.3	24.2	3.9	94.1	245.9	0.6	2.0	0.5	2.1	2.3	17.9	42.5	87.1	1.1	0.0	71.2	100.9	50.8	0.9	69.9	1.7	32.8	1.0	1.5	1.6	17.7	0.3	66.7	19.2	189.7	0.9	0.5	47.1	56.5	48.1	0.8	65.9	0.5	0.5	1.3	5.9	4.0	0.6	31.3	0.2	59.1	16.0	31.2	19.3	16.9	17.4	6.7	11.4	13.6	12.3	3.6	8.8	11.9	40.1	14.7	25.6	7.2	10.8	18.1	5.6	6.8	5.8	7.3	5.0	5.6	7.9	6.5	7.5	6.2	8.2	8.7	3.8	44.8	8.3	6.8	16.6	1.1	1.7	1.0	0.6	12.0	4.9	2.4	68.3	7.2	4.4	3.7	20.9	4.7	27.0	40.9	0.0	7.2	5.3	1.3	3.3	6.6	6.0	14.9	1.2	6.0	11.6	2.2	2.0	2.3	45.0	9.9	7.9	1.2	58.5	5.0	1.5	3.6	2.0	21.6	8.2	0.5	2.8	22.2	1.8	5.6	22.5	4.5	61.8	3.0	7.9	47.3	30.7	1.5	27.4	1.6	5.5	0.7	1.6	16.2	0.0	4.5	2.6	1.2	1.4	1.5	1.4	25.9	30.9	2.0	6.3	2.3
UNC5B	"p53RDL1, UNC5H2"	ENSG00000107731	"Unc-5 netrin receptor B"	Q8IZJ1	10	71212570-71302864	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 112.7;Muller glia cells: 54.1;Oligodendrocytes: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.2;HHSteC: 146.3;hTCEpi: 132.1;SH-SY5Y: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076687	Approved					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA076687: "	"unprognostic (3.98e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (8.82e-3)"	"unprognostic (6.79e-3)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (7.70e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.25e-1)"	3.2	10.2	17.5	4.0	28.4	0.1	2.3	26.8	19.2	6.0	15.4	7.2	2.6	5.9	6.0	18.6	7.4	8.8	15.6	15.1	17.3	7.9	2.4	9.5	3.5	34.1	28.8	3.6	4.3	2.2	5.8	5.0	25.3	9.8	4.9	7.8	5.3	27.0	2.6	8.0	5.2	4.4	19.1	7.8	8.7	5.6	32.3	2.9	3.7	4.1	2.9	9.0	12.2	48.3	0.0	0.2	0.8	3.9	11.6	18.9	0.3	6.6	19.3	0.2	0.6	3.8	17.9	0.0	6.7	41.6	0.4	46.2	1.4	2.7	0.0	0.1	4.3	10.7	0.7	0.2	146.3	0.2	1.1	16.4	132.1	1.6	8.4	1.7	2.8	0.2	0.4	0.1	0.2	1.5	0.0	0.0	10.3	9.6	0.3	0.0	4.5	0.1	0.1	20.5	20.3	123.7	1.4	1.6	1.0	18.2	1.9	0.6	8.0	1.4	5.9	2.5	2.7	0.0	0.0	0.0	42.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	28.4	26.8	19.2	15.1	17.3	34.1	28.8	25.3	19.1	32.3	48.3	18.6	0.0	3.3	5.5	0.0	3.1	19.3	21.8	2.8	13.1	1.6	3.0	7.6	0.0	11.3	5.5	0.0	0.4	0.0	34.3	0.0	5.7	0.4	12.7	4.8	22.7	3.0	0.0	8.9	1.6	0.4	6.5	12.2	25.8	22.9	27.0	7.5	0.0	1.2	112.7	11.3	6.3	32.6	8.5	2.4	1.0	0.6	5.9	1.8	29.0	0.6	54.1	0.0	11.6	89.0	12.1	20.1	0.7	0.0	14.7	8.1	0.2	14.4	3.5	0.0	2.7	12.7	0.8	5.4	20.3	4.3	0.3	0.8	0.7	4.7	44.8
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 2078.8"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000		"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	1.9	9.0	8.9	1.0	17.2	0.0	1.3	7.0	17.4	1.8	0.0	2.9	1.4	2.4	1.7	0.6	1.9	2.0	3.1	6.6	15.4	1.1	1.0	2.5	0.5	18.1	8.7	2.8	0.3	0.1	1.2	1.8	21.4	3.3	3.4	6.4	6.3	3.9	0.1	0.2	1.9	2.0	8.0	4.2	2.1	2.6	16.4	1.9	11.9	0.4	0.3	2.6	1.6	40.5	0.0	0.5	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	4.2	0.0	0.2	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	0.0	0.2	4.8	0.3	12.3	0.0	0.1	1.2	0.0	7.9	0.0	0.0	0.0	0.1	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	17.2	7.0	17.4	6.6	15.4	18.1	8.7	21.4	8.0	16.4	40.5	0.7	0.0	0.0	105.4	0.0	0.1	0.1	0.1	0.0	1.9	0.7	1.5	1.7	0.0	0.2	1.8	0.0	0.5	0.0	2.6	0.0	0.0	0.7	0.5	3.4	0.7	1.2	0.0	326.1	0.0	0.1	4.6	0.0	1.2	0.0	20.2	0.4	0.0	1.8	0.0	448.3	0.5	0.0	0.8	0.0	0.8	21.1	0.4	1.8	57.1	0.0	1.3	0.0	308.1	2078.8	0.0	26.9	11.7	0.0	0.3	0.0	0.1	0.0	12.5	6.6	0.3	4.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235475-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.8;intestine: 6.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 638.7;Inhibitory neurons: 768.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4;renal cancer: 1.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.8;thalamus: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;HeLa: 2.9;NTERA-2: 8.6;SH-SY5Y: 2.9;SuSa: 2.8;U-251 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.0	1.7	1.7	0.0	2.4	0.0	0.0	0.0	3.1	2.3	0.0	0.3	6.0	1.7	0.0	0.0	0.1	0.0	0.0	2.4	19.8	2.1	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.1	3.3	0.0	0.0	4.8	0.5	4.9	0.0	0.2	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	7.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.5	0.2	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	0.0	3.1	2.4	19.8	0.4	1.6	0.0	0.0	7.0	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.1	0.1	0.0	0.0	638.7	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	40.4	768.3	0.7	0.0	0.0	0.0	4.4	0.0	0.0	0.0	42.2	0.0	1.8	0.0	43.2	10.2	0.0	0.0	0.0	0.0	1.8	2.0	0.6	0.0	2.6	0.0	0.0	0.7	0.7	1.2	0.1	0.1	0.0	0.0	0.0	2.6	0.0
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1 RNA helicase and ATPase"	Q92900	19	18831959-18868230	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		19000	"Cluster 48: NK-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favorable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.7	21.2	11.6	22.2	13.2	26.1	21.2	13.9	14.3	23.4	8.9	23.2	21.6	24.4	8.1	24.1	20.6	17.7	17.5	11.8	11.6	16.3	17.3	21.6	25.8	15.8	12.7	22.5	42.2	35.1	18.6	22.3	11.4	21.1	10.7	10.1	36.7	22.3	31.3	29.3	21.7	13.8	13.3	24.8	23.8	30.9	12.6	27.0	23.0	19.6	16.5	23.5	23.1	15.3	61.2	39.8	27.4	32.8	41.5	27.1	89.7	50.6	31.1	48.0	37.4	76.9	54.0	54.5	65.4	32.0	25.5	60.0	38.7	55.2	18.2	29.2	76.5	59.9	37.2	49.8	35.7	67.2	34.7	30.3	39.3	37.4	40.3	27.5	30.8	46.6	76.6	51.4	25.8	66.5	78.5	42.2	45.7	42.2	96.0	62.1	44.2	51.4	21.1	54.3	57.8	44.6	46.4	52.2	27.3	21.8	31.4	42.7	43.9	42.6	29.6	52.8	57.3	33.0	27.4	83.7	30.3	64.0	48.0	0.0	0.6	1.1	0.2	0.3	0.2	0.1	0.3	0.0	0.4	0.3	0.2	0.1	1.7	1.0	0.8	0.2	0.2	0.3	11.6	13.2	13.9	14.3	11.8	11.6	15.8	12.7	11.4	13.3	12.6	15.3	24.2	22.4	13.6	10.1	14.8	15.7	13.3	10.0	10.2	30.8	24.7	24.5	14.5	12.8	11.0	27.6	14.6	16.4	18.7	32.5	0.0	11.1	13.5	46.5	27.8	19.4	21.6	8.8	9.9	9.8	13.7	15.8	29.0	65.9	0.0	24.4	13.9	24.1	14.4	37.0	9.5	27.4	10.2	19.1	12.2	7.9	14.6	19.5	12.4	10.3	11.8	19.5	13.4	9.0	11.4	16.6	16.6	19.2	18.9	22.2	17.5	10.5	29.0	18.5	13.1	15.6	15.0	26.8	18.4	20.1	18.6	20.5	16.5	20.5	22.8	27.2
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2 regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067008			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Cytoplasmic bodies"	"HPA067008: AB_2685762"	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	12.8	8.1	12.4	14.1	13.7	21.0	12.7	15.8	15.1	12.0	12.5	16.2	10.0	14.9	10.7	10.9	11.0	8.9	10.6	12.5	13.6	10.9	16.7	10.4	18.9	11.8	12.2	16.2	13.7	14.8	7.9	14.1	11.6	13.5	12.9	14.8	11.1	12.2	22.0	12.9	11.4	12.1	11.9	14.8	11.3	19.5	12.7	21.5	12.8	21.4	17.7	13.4	11.8	13.2	35.9	22.3	18.8	23.5	14.0	17.9	21.2	27.5	12.7	19.2	23.0	21.2	28.6	51.4	9.1	23.0	15.8	29.4	27.2	24.9	27.4	32.5	15.7	61.6	18.2	19.4	15.8	28.1	39.8	13.5	19.0	24.3	16.4	18.2	23.8	27.1	37.1	25.7	22.2	17.7	34.8	16.4	18.0	27.1	11.8	30.4	22.5	25.3	18.2	14.2	12.1	13.0	21.6	23.1	23.8	18.7	27.9	37.1	25.5	15.0	31.4	31.1	21.1	23.4	19.8	41.4	24.0	26.9	12.1	13.7	4.2	10.2	4.3	4.2	4.2	10.7	4.9	4.5	3.0	10.6	5.4	4.5	29.5	5.4	2.9	11.5	3.8	1.8	12.4	13.7	15.8	15.1	12.5	13.6	11.8	12.2	11.6	11.9	12.7	13.2	74.8	25.6	34.6	32.0	133.3	71.9	35.0	46.9	64.3	66.3	53.8	38.6	69.6	52.9	39.4	49.7	102.2	47.0	79.6	97.7	39.2	47.7	70.1	99.3	86.2	62.6	66.3	108.4	36.1	44.8	51.7	48.2	58.1	88.7	58.9	71.8	64.2	89.5	41.1	52.2	31.6	90.2	48.8	71.4	125.3	116.9	86.3	56.0	53.4	31.9	89.0	45.5	98.9	37.2	45.4	53.7	78.9	59.0	121.2	38.7	70.6	34.1	41.5	97.2	98.6	54.3	60.1	182.9	149.8	47.3	81.8	56.5	73.6	35.9	65.5	36.3
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 64.6;Inhibitory neurons: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	19.4	30.0	22.0	13.8	24.3	4.6	16.5	21.9	27.7	20.1	20.9	26.0	18.9	18.6	22.9	18.8	20.6	12.6	55.3	22.4	23.0	28.6	27.1	15.8	17.9	24.1	23.5	19.8	15.9	37.2	23.9	14.9	26.6	19.7	25.8	29.5	18.7	18.4	106.8	16.3	19.3	18.5	19.9	19.7	23.0	17.6	22.9	21.2	22.3	105.7	21.9	20.1	18.0	22.8	20.2	28.6	33.5	32.2	34.1	38.4	4.8	38.5	43.3	70.7	48.1	97.7	39.4	66.6	68.5	26.1	60.7	53.5	60.0	70.0	52.6	19.0	24.2	89.2	41.3	80.3	22.7	54.2	25.6	37.6	72.3	37.9	48.8	51.2	24.6	53.5	39.9	23.9	50.0	26.8	58.6	29.2	25.4	42.0	61.5	31.4	50.0	37.9	67.6	26.2	46.4	28.7	32.9	148.9	34.0	28.1	23.9	34.6	23.5	46.2	28.8	25.9	34.6	30.1	37.2	26.5	79.7	31.1	36.8	28.6	10.2	14.2	14.8	14.3	18.3	12.3	13.7	14.7	16.0	15.7	16.7	14.7	0.3	22.3	10.2	14.4	14.2	12.6	22.0	24.3	21.9	27.7	22.4	23.0	24.1	23.5	26.6	19.9	22.9	22.8	7.0	0.0	7.8	51.6	7.0	6.4	9.3	18.1	6.8	20.7	7.8	5.8	44.0	10.0	11.8	16.5	8.4	22.9	5.3	13.9	60.7	18.2	15.1	10.5	8.5	10.5	12.0	5.2	64.6	13.1	15.7	9.2	7.7	6.9	8.2	17.5	6.1	14.2	11.6	18.5	68.9	9.1	18.3	6.6	3.9	8.6	10.5	5.8	14.2	33.7	13.2	16.7	10.3	44.2	50.3	19.1	6.6	12.0	5.0	8.4	10.9	19.4	14.8	22.8	6.6	9.6	11.9	24.6	18.2	6.2	5.3	17.4	6.2	19.7	13.2	9.6
URB1	"C21orf108, KIAA0539, NPA1"	ENSG00000142207	"URB1 ribosome biogenesis homolog"	O60287	21	32311018-32393012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018334	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli fibrillar center"		"HPA018334: AB_1856088"	"unprognostic (1.58e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.57e-1)"	"unprognostic (4.65e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.78e-2)"	5.3	7.5	4.7	4.0	4.5	3.2	4.9	3.8	5.0	6.5	14.4	4.7	2.3	11.2	4.2	6.9	8.0	2.5	6.3	5.9	4.6	3.4	5.2	3.7	4.1	6.9	5.4	7.6	5.9	5.6	4.5	3.4	6.8	9.9	2.8	2.1	7.2	8.0	8.8	7.1	3.4	5.5	4.5	3.5	4.3	6.6	5.1	3.8	4.1	4.3	3.9	8.7	6.6	6.1	12.7	16.0	7.0	14.6	14.1	11.2	11.3	12.9	6.4	9.6	7.4	22.3	7.1	12.7	7.0	12.7	10.5	7.8	19.9	30.5	9.9	9.9	12.1	43.6	14.7	11.8	10.2	24.5	9.3	18.2	10.4	21.9	23.6	7.1	10.4	14.6	39.7	12.1	14.2	12.8	15.9	8.7	23.4	15.1	14.7	18.7	16.4	15.3	6.5	12.0	15.8	14.1	15.1	12.5	14.0	5.2	11.0	9.3	12.1	23.6	14.1	9.8	14.6	17.0	17.7	20.0	10.7	22.0	12.2	0.9	0.3	0.0	0.4	0.3	0.8	0.6	0.5	0.5	0.3	0.5	0.6	0.6	0.3	0.8	0.1	0.3	0.5	0.3	4.7	4.5	3.8	5.0	5.9	4.6	6.9	5.4	6.8	4.5	5.1	6.1	8.1	3.2	10.5	14.7	8.5	9.7	14.5	11.3	25.6	7.2	9.6	8.6	9.4	2.8	17.2	1.8	4.2	5.9	5.9	2.4	0.0	4.8	9.4	35.0	38.0	7.6	7.8	8.0	27.6	6.0	3.9	8.7	7.7	22.1	0.0	45.4	4.6	8.5	4.0	15.2	29.0	4.7	6.1	2.7	3.1	6.0	5.6	3.4	5.4	15.0	3.0	3.9	3.1	26.2	27.5	4.5	4.3	7.5	4.2	20.9	0.8	2.4	18.6	5.6	6.6	18.1	8.8	12.8	15.4	16.2	11.4	4.2	5.5	13.2	7.1	14.6
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	336	"liver: 116.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 62.2"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000		"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	116.6	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	3.3	62.2	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	51.7	120.1	72.0	25.5	73.9	199.0	48.2	72.0	79.3	40.8	77.2	49.3	29.2	46.9	54.7	34.2	49.2	30.8	70.6	73.1	74.5	58.0	100.9	34.8	35.2	72.1	73.4	51.1	45.1	115.0	42.6	39.4	73.6	35.1	30.1	24.7	61.4	44.2	75.9	31.7	30.7	54.7	72.9	37.8	38.5	44.8	73.6	44.0	54.0	83.8	36.1	40.3	32.7	73.8	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	72.0	73.9	72.0	79.3	73.1	74.5	72.1	73.4	73.6	72.9	73.6	73.8	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.3	18.2	26.3	18.9	26.2	17.5	13.9	26.2	27.2	14.8	25.7	18.4	18.5	14.3	14.2	13.8	16.8	14.6	18.4	26.5	26.6	15.7	21.0	18.4	27.8	26.0	25.5	16.7	11.4	20.5	11.4	18.1	26.4	15.1	18.3	17.0	14.0	18.2	32.7	15.3	19.6	18.1	26.0	30.5	14.9	7.6	28.2	36.0	12.9	29.4	32.7	20.7	13.7	26.9	17.2	25.5	29.9	35.0	39.4	22.3	39.9	14.0	30.3	42.9	33.3	17.9	21.2	22.1	29.0	23.5	18.6	21.0	35.6	22.3	24.0	20.6	21.2	19.1	20.9	18.9	23.0	26.7	25.4	18.3	22.0	31.1	25.1	27.3	40.7	36.8	31.7	23.1	27.2	20.1	41.5	29.2	61.8	37.0	32.9	35.6	23.3	26.9	21.0	26.8	16.9	32.3	25.5	32.8	18.1	42.9	27.5	85.5	24.0	21.5	13.5	13.2	23.1	19.5	26.6	34.3	18.3	25.9	16.7	2.5	2.6	1.4	1.9	2.1	1.1	1.5	1.1	1.3	2.6	1.7	1.2	1.2	4.1	0.9	2.1	2.7	1.3	1.3	26.3	26.2	26.2	27.2	26.5	26.6	26.0	25.5	26.4	26.0	28.2	26.9	13.1	6.4	6.9	3.6	18.0	2.3	0.6	3.1	9.1	3.3	2.7	3.9	1.0	0.0	3.2	3.7	2.1	2.2	14.5	7.1	1.9	2.1	0.4	5.5	8.1	6.0	3.0	5.0	6.3	1.3	4.4	4.6	14.8	5.6	11.4	4.0	1.1	0.4	3.1	5.0	5.4	3.4	6.1	2.1	3.5	0.2	0.3	12.4	5.4	4.7	4.7	1.6	4.1	4.0	5.8	2.3	7.1	0.0	20.0	1.6	7.3	3.1	7.9	3.5	6.6	3.3	4.9	0.5	0.4	8.5	1.8	3.4	9.3	7.7	4.9	1.9
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	20.3	25.5	16.4	19.4	18.7	26.8	19.6	19.0	18.6	21.9	24.4	26.2	22.4	24.3	19.1	19.7	24.3	15.5	26.8	17.4	16.8	18.9	18.6	17.7	21.5	19.0	17.5	22.8	21.2	31.0	17.5	16.5	17.9	19.4	15.9	14.3	29.6	24.4	75.6	26.5	21.9	18.9	16.7	22.9	21.6	20.8	18.4	27.4	23.6	45.0	16.8	23.3	19.6	19.5	20.2	26.3	28.6	42.1	36.8	24.1	38.7	23.1	26.1	35.1	28.7	28.7	27.3	41.6	22.2	24.4	36.2	24.1	40.3	29.1	16.0	32.7	32.1	42.5	56.4	22.8	36.1	45.7	40.5	33.8	22.7	36.9	24.1	25.9	24.2	33.8	30.8	28.4	18.9	23.9	42.6	43.0	58.2	27.4	44.1	19.4	24.3	45.7	22.3	37.4	16.5	51.4	33.3	38.1	34.9	26.1	26.0	55.4	21.8	24.5	30.5	36.7	33.7	77.7	97.1	38.0	32.8	34.3	32.6	9.7	3.7	5.3	4.5	3.6	4.2	2.8	3.7	5.2	4.6	2.9	3.3	3.9	7.5	2.9	4.4	1.9	2.7	4.3	16.4	18.7	19.0	18.6	17.4	16.8	19.0	17.5	17.9	16.7	18.4	19.5	7.8	12.8	14.5	10.4	7.2	6.2	3.8	8.5	8.6	12.7	8.7	7.4	13.1	5.7	9.9	7.3	18.8	9.6	9.2	17.1	5.9	7.7	3.6	14.8	8.7	7.6	9.1	10.3	8.4	7.8	5.3	7.7	14.3	9.5	2.5	8.1	7.9	13.6	9.0	13.5	8.0	11.6	10.2	8.7	4.7	4.9	13.1	6.8	3.6	2.8	6.5	8.7	3.1	8.0	7.7	11.5	13.9	12.4	7.4	4.2	16.3	7.7	14.9	11.4	13.1	12.3	11.1	16.2	13.2	9.1	5.4	13.5	8.0	9.8	13.4	3.1
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	25.8	12.9	13.4	16.8	20.1	26.9	17.6	12.6	17.2	18.1	12.3	15.3	12.6	26.8	18.7	21.4	16.8	12.4	28.1	16.2	4.2	21.4	20.2	24.0	20.1	4.7	4.3	14.1	15.9	14.3	7.6	29.4	4.8	17.9	16.1	9.5	17.5	24.6	120.9	13.1	13.3	36.4	4.4	19.5	13.1	54.5	4.9	25.6	15.5	75.1	19.3	15.5	17.3	11.9	31.2	23.1	21.5	3.2	38.7	57.5	25.3	22.0	21.8	16.0	20.1	20.5	17.4	33.6	31.5	34.9	24.3	16.4	16.7	29.1	22.0	33.5	19.1	27.5	23.5	15.8	64.3	36.6	12.1	37.6	34.7	25.8	74.0	41.7	57.0	30.0	35.9	61.4	29.1	13.0	42.1	7.1	26.6	12.5	20.3	31.8	20.0	25.8	43.5	8.3	4.7	12.8	31.4	26.2	20.9	25.9	14.0	21.3	54.6	24.8	16.0	26.2	12.5	17.7	11.9	26.8	16.0	16.1	18.6	0.0	1.4	1.9	1.8	1.4	2.0	1.6	1.5	3.2	1.2	1.1	1.4	2.1	2.9	1.1	1.3	1.3	2.2	0.8	13.4	20.1	12.6	17.2	16.2	4.2	4.7	4.3	4.8	4.4	4.9	11.9	30.4	57.7	29.5	47.3	21.7	17.1	18.8	9.7	15.9	6.2	17.4	11.8	55.7	15.7	24.2	22.0	4.2	39.0	21.4	20.3	5.9	9.4	166.7	24.0	19.0	19.7	9.6	21.5	148.0	13.4	8.4	19.4	17.9	34.6	6.3	14.4	17.9	18.0	13.3	5.0	98.4	12.8	8.2	24.2	16.0	192.8	19.0	24.2	16.0	86.2	23.7	4.0	23.7	150.3	72.4	13.4	8.4	12.8	15.9	22.0	11.9	15.1	23.4	6.7	19.7	26.1	17.2	11.2	5.8	22.7	19.2	33.1	26.9	18.5	11.6	20.4
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.9"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 1.8;Early spermatids: 2.2;Spermatocytes: 5.1;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.0	0.9	0.0	0.5	1.8	0.0	2.1	0.6	0.0	1.0	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.5	1.0	1.0	0.1	0.1	0.2	0.4	1.9	0.9	0.3	1.3	0.0	0.0	0.2	0.8	0.1	0.1	0.6	0.7	0.0	0.3	1.4	0.0	0.0	0.8	0.2	0.4	4.9	0.8	0.0	0.3	0.0	0.1	0.3	0.0	2.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.6	0.5	0.2	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.2	0.0	1.3	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	1.1	0.3	0.1	0.6	0.1	0.2	0.9	0.5	2.1	0.6	1.0	1.0	1.9	0.9	0.8	0.8	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60177327-60422470	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 59.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 59.2;granulocytes: 29.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 171.4"					"Low region specificity"	"Detected in all"			HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	16.1	21.8	13.6	15.0	27.8	32.1	14.1	23.2	23.6	12.4	25.2	13.0	9.5	10.3	6.8	21.7	10.7	11.8	17.4	14.3	22.8	20.2	26.6	20.7	10.5	22.2	25.0	10.0	12.5	19.2	11.9	13.2	24.8	10.8	11.4	58.8	12.9	11.2	40.8	21.0	10.5	13.7	18.1	18.5	12.2	102.1	22.3	14.4	20.6	29.2	11.6	13.1	14.7	44.4	32.6	38.2	19.0	30.8	44.8	45.3	17.2	26.4	41.9	34.5	45.8	18.6	20.0	19.4	21.5	50.0	56.1	16.3	33.1	36.9	61.5	16.8	13.9	39.7	31.8	19.5	44.1	31.7	33.6	39.6	24.6	49.9	45.2	33.5	38.6	24.4	42.9	17.1	41.1	171.4	32.3	21.3	21.7	29.6	18.8	15.8	51.6	11.5	33.1	24.5	13.1	19.1	22.9	6.0	33.8	32.1	27.4	41.3	32.6	49.7	54.9	33.1	23.5	16.2	37.4	19.6	24.6	23.6	33.4	14.5	4.3	16.5	2.0	3.7	1.4	3.0	1.4	1.7	8.5	2.2	1.0	1.9	29.4	1.3	4.6	59.2	2.6	2.1	13.6	27.8	23.2	23.6	14.3	22.8	22.2	25.0	24.8	18.1	22.3	44.4	8.0	6.4	16.4	58.8	12.5	26.9	13.3	5.8	11.4	17.3	9.2	7.6	8.2	10.0	10.1	5.5	241.8	5.1	12.6	8.5	3.9	11.3	95.0	9.0	9.9	9.8	8.3	44.2	92.3	7.5	8.4	12.6	15.8	11.6	11.4	18.5	12.5	12.0	18.5	13.5	113.1	5.6	6.1	29.7	41.3	33.3	13.1	25.1	5.4	101.2	28.0	10.4	24.7	70.4	268.9	9.6	11.4	5.7	8.3	10.3	7.4	4.6	7.0	136.4	26.3	11.9	9.1	92.7	14.9	11.2	21.9	4.9	10.9	8.5	5.5	8.2
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	43.9	37.9	20.0	21.5	21.9	46.6	32.9	29.3	23.9	32.6	27.5	31.2	13.4	26.8	22.9	25.0	34.2	18.7	30.2	21.4	20.6	34.4	30.3	36.1	20.6	22.6	21.3	67.4	44.5	18.1	50.3	26.0	21.5	36.2	15.8	26.3	24.9	13.1	30.3	40.4	26.6	16.3	19.4	30.7	31.2	22.2	21.2	15.1	31.6	11.7	20.5	29.3	29.8	30.1	42.7	50.3	14.6	26.9	30.5	33.7	27.8	34.1	34.5	32.1	21.5	49.2	21.0	54.0	16.9	30.6	34.8	30.6	34.5	25.4	57.0	13.0	52.1	49.4	81.0	51.9	31.3	54.7	26.0	29.5	41.0	45.8	101.6	24.7	28.3	24.1	40.0	55.3	26.8	32.6	50.1	55.1	22.6	31.6	39.9	38.1	31.8	36.3	20.2	44.1	42.8	25.8	24.5	112.5	63.7	31.3	29.2	34.4	24.3	75.2	35.3	44.3	61.1	40.7	17.4	66.1	29.6	41.9	24.0	10.1	3.0	2.4	5.5	4.2	6.5	5.1	5.2	4.8	1.8	4.7	5.7	5.6	4.3	4.5	2.7	9.7	3.8	1.9	20.0	21.9	29.3	23.9	21.4	20.6	22.6	21.3	21.5	19.4	21.2	30.1	27.4	12.8	37.4	23.5	55.9	51.7	28.4	8.2	40.9	33.2	18.1	16.9	14.1	18.6	18.8	14.7	33.3	8.3	66.3	14.4	5.9	10.2	20.7	22.3	24.0	28.4	18.5	14.7	19.0	9.6	11.3	26.6	25.0	42.7	20.3	12.8	12.1	16.5	43.3	26.9	22.5	18.6	10.2	24.5	72.8	8.5	11.8	49.4	30.2	10.3	14.9	13.2	16.5	13.6	19.8	13.2	8.4	12.4	57.1	32.4	7.3	5.0	11.1	32.1	6.6	22.1	23.1	18.4	16.5	24.4	43.3	12.9	73.6	13.1	18.6	22.2
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568351	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.4;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	2.7	4.1	3.5	4.4	4.7	11.8	4.7	8.5	4.9	3.6	1.9	3.0	2.9	4.2	7.5	3.9	3.3	3.5	2.3	3.3	4.0	2.9	3.8	3.0	6.0	3.8	4.0	5.9	3.0	4.0	1.4	4.0	4.0	3.6	3.5	9.1	3.9	3.0	2.9	3.9	3.3	3.2	2.5	3.8	3.4	12.7	3.4	6.3	5.0	4.2	4.9	3.6	2.2	8.3	9.6	6.9	14.2	11.0	3.6	4.4	12.1	7.1	5.1	12.2	13.6	13.1	7.4	8.7	7.5	5.6	9.3	8.9	15.7	8.0	13.4	12.0	8.3	23.5	13.6	8.7	4.1	15.6	11.3	2.4	4.7	12.9	9.2	4.5	5.3	15.0	17.3	16.2	7.8	7.2	20.1	10.6	12.2	6.2	5.9	16.0	21.3	8.0	4.2	11.2	15.5	8.4	11.5	5.6	7.2	13.6	6.4	10.8	6.8	13.7	12.0	7.7	9.5	11.0	10.4	17.6	7.4	11.2	9.5	4.2	2.0	3.8	3.1	2.3	3.2	2.5	2.6	2.7	2.1	3.2	4.0	2.6	1.6	3.2	2.2	2.9	3.6	1.2	3.5	4.7	8.5	4.9	3.3	4.0	3.8	4.0	4.0	2.5	3.4	8.3	12.8	0.0	11.0	34.3	16.5	19.5	7.0	7.1	22.2	14.7	14.4	10.2	4.9	4.3	9.6	7.3	27.1	8.4	13.4	5.5	0.0	5.8	119.4	13.3	11.8	14.2	10.3	16.6	47.4	2.3	6.6	13.2	9.2	16.4	5.1	16.2	12.5	11.0	7.8	15.2	40.0	8.9	4.1	8.5	22.9	145.5	9.9	17.2	21.4	27.2	10.2	9.1	10.3	35.2	60.5	4.9	7.4	9.8	14.6	12.1	7.1	4.2	11.1	19.9	6.6	12.7	21.6	60.8	31.4	13.6	20.6	7.3	19.7	10.9	7.6	7.1
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Spermatocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006939, HPA064800"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA006939: , HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	3.8	3.0	3.1	3.2	3.0	13.4	3.9	5.8	4.4	4.3	2.4	4.5	4.5	4.9	3.6	3.7	4.3	3.4	3.2	3.0	3.0	3.9	4.0	4.1	3.8	2.8	3.1	4.9	3.8	4.7	3.8	3.3	2.7	3.8	3.4	5.8	3.5	3.1	4.3	5.4	4.3	4.1	2.9	4.4	3.6	15.2	3.2	5.7	4.0	3.4	3.2	4.0	3.8	3.2	10.2	7.4	13.1	12.9	7.4	5.5	9.0	5.4	6.9	6.2	6.1	5.3	5.2	12.0	3.4	6.7	9.2	9.3	11.1	5.9	6.7	2.9	8.6	5.6	6.1	5.5	6.3	13.0	6.1	6.4	6.8	6.7	8.5	5.7	7.7	10.0	21.7	7.9	4.1	9.1	7.9	14.6	14.8	5.2	5.6	14.9	10.2	8.2	5.9	5.3	10.0	17.7	6.9	14.0	4.3	12.0	6.5	6.6	6.5	5.5	20.5	7.0	6.5	7.0	6.3	10.3	4.6	7.8	11.0	0.6	0.3	0.9	0.5	0.6	0.7	0.4	0.6	0.3	0.3	0.2	0.4	1.0	0.3	0.5	0.3	0.6	0.5	0.2	3.1	3.0	5.8	4.4	3.0	3.0	2.8	3.1	2.7	2.9	3.2	3.2	13.7	12.8	7.0	19.6	16.1	40.5	18.2	5.2	26.7	18.7	17.4	10.8	10.5	8.6	6.8	1.8	22.9	8.3	16.4	20.7	0.0	10.4	89.1	27.1	15.3	14.4	10.7	10.8	26.1	10.4	8.4	13.4	15.3	25.6	9.5	13.4	12.8	9.8	8.2	21.9	26.2	18.1	8.2	9.1	19.9	42.5	14.3	12.4	10.6	18.7	7.7	10.1	12.3	18.6	26.2	12.0	7.7	12.8	21.7	22.3	12.4	5.7	10.6	18.7	13.1	16.2	14.9	72.4	37.0	23.1	41.5	26.8	19.2	6.4	14.4	15.3
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590960-52659301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 150.8;Early spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.4	8.6	30.4	3.3	31.2	2.9	6.4	27.4	31.5	7.6	22.4	3.9	4.4	6.5	5.4	11.5	7.0	5.3	28.6	30.8	33.3	9.9	2.9	3.9	3.7	27.9	33.9	11.0	5.2	10.4	4.6	5.3	26.7	6.9	4.0	11.5	8.3	6.7	14.5	7.5	4.2	5.0	30.4	3.3	6.0	12.3	32.5	3.4	9.3	12.5	5.5	6.0	7.4	26.8	8.1	5.7	18.0	13.3	19.1	23.8	19.8	13.0	10.5	9.5	7.9	11.5	6.2	5.4	14.9	13.0	13.4	4.7	31.6	15.1	17.2	4.7	11.1	8.4	5.3	12.8	19.1	11.2	9.4	20.4	13.9	9.7	9.1	18.4	14.2	7.4	8.3	7.4	20.3	7.4	4.8	5.9	13.3	9.0	6.8	12.0	13.1	1.1	20.3	14.8	10.8	12.9	6.4	21.5	12.9	17.1	7.9	8.2	13.3	9.2	20.1	10.9	19.9	7.5	3.7	4.2	14.2	6.7	11.6	0.7	0.4	0.1	0.7	0.4	0.5	0.4	1.2	0.6	0.9	0.4	0.2	0.2	0.1	0.4	0.3	1.4	0.4	0.3	30.4	31.2	27.4	31.5	30.8	33.3	27.9	33.9	26.7	30.4	32.5	26.8	10.0	6.4	7.2	24.2	6.4	5.4	11.2	15.2	26.2	150.8	13.7	11.7	44.9	14.3	16.4	14.7	4.2	12.1	10.7	5.2	21.5	10.8	229.8	18.4	34.9	12.5	4.2	6.7	32.6	12.0	12.5	17.8	17.3	15.6	0.0	22.9	13.6	6.8	5.8	35.3	24.3	5.9	10.2	8.4	4.6	34.1	28.9	7.9	8.8	21.5	12.9	30.0	5.2	30.2	12.6	12.5	9.9	36.1	9.5	21.1	3.9	17.1	23.8	8.7	6.6	16.2	15.9	3.2	14.4	25.9	8.2	7.7	8.0	18.3	7.1	17.7
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	25.8	47.5	18.7	26.6	24.5	43.5	26.4	31.0	26.4	26.9	21.6	24.4	21.7	25.3	20.4	23.0	22.3	18.9	21.6	19.3	20.4	18.2	23.8	23.1	35.1	20.1	20.4	31.1	24.6	25.2	26.9	27.3	21.7	23.5	26.0	57.0	31.2	18.6	23.1	29.5	28.7	22.9	18.5	36.0	32.5	20.6	20.8	26.9	28.6	19.5	34.5	23.1	24.6	36.0	43.9	20.5	47.0	34.0	40.1	49.0	46.4	54.0	36.5	35.3	46.6	19.1	43.2	49.1	35.6	48.8	27.5	39.2	59.0	43.4	53.6	48.3	42.1	104.3	75.7	34.5	35.5	53.0	53.7	39.8	36.6	36.1	39.7	48.1	106.1	36.2	83.8	133.2	44.0	21.9	44.2	68.5	29.7	44.5	36.8	61.3	47.2	57.3	40.7	36.2	57.1	35.6	50.4	45.7	122.7	62.3	23.4	63.0	76.1	37.7	30.9	46.7	31.8	105.6	81.7	48.1	36.3	64.5	56.6	82.1	19.5	35.0	12.2	9.4	13.9	28.6	17.8	17.9	21.1	29.8	20.5	13.1	16.8	12.2	10.9	15.3	21.4	12.6	18.7	24.5	31.0	26.4	19.3	20.4	20.1	20.4	21.7	18.5	20.8	36.0	37.9	54.5	42.1	32.0	55.4	22.2	25.1	30.3	33.0	86.5	22.2	24.5	65.3	21.5	24.4	20.2	62.6	61.4	48.3	17.8	25.4	28.5	71.4	33.3	48.5	32.5	21.7	88.1	66.4	20.0	56.3	42.0	33.1	41.4	49.9	200.4	27.5	22.1	29.2	50.5	74.2	31.3	32.6	22.6	28.1	47.7	34.8	34.4	58.7	52.5	55.9	30.7	36.0	54.3	112.3	23.8	16.4	51.6	150.1	20.7	24.1	20.2	27.3	69.2	32.9	51.7	39.8	52.7	47.4	35.1	25.7	32.6	41.8	54.8	31.6	21.6
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 48.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in all"		"REH: 46.7;U-698: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.9	2.8	4.3	2.6	3.2	5.3	2.6	6.0	3.8	3.4	0.4	2.6	1.7	2.9	1.6	1.9	2.6	1.6	2.0	3.3	3.7	2.0	1.6	2.7	2.6	2.7	3.9	3.1	2.0	1.5	2.7	1.4	2.5	2.3	1.5	9.3	2.0	1.6	2.9	3.0	1.7	1.6	0.7	2.5	1.8	4.8	4.1	6.7	7.0	1.0	2.5	2.5	2.6	3.8	6.0	1.8	23.6	11.6	2.8	3.0	9.7	2.3	2.2	3.4	4.3	7.5	1.4	24.5	2.5	2.9	4.9	2.6	14.7	2.2	5.1	6.1	11.0	8.8	10.3	2.7	2.0	6.9	5.2	3.1	1.7	5.0	3.1	3.1	2.2	24.9	18.7	6.4	2.6	3.5	26.7	10.5	6.5	6.4	2.2	46.7	11.3	5.4	1.4	4.1	15.8	6.5	3.1	1.1	1.3	5.5	3.5	6.1	6.1	8.1	8.0	2.6	3.1	12.2	11.4	63.9	1.0	6.9	1.5	5.1	0.4	0.6	0.3	0.4	0.2	0.6	0.2	0.3	0.1	0.4	0.4	0.3	1.0	0.4	0.5	0.3	0.2	0.2	4.3	3.2	6.0	3.8	3.3	3.7	2.7	3.9	2.5	0.7	4.1	3.8	2.4	0.0	9.7	20.2	2.0	5.0	3.0	3.9	1.2	27.5	3.6	3.3	4.6	4.3	6.5	5.5	43.8	2.9	4.5	1.4	1.9	1.9	6.5	4.1	5.0	2.8	0.0	8.2	42.8	2.0	1.6	4.3	3.1	4.6	1.3	4.8	1.4	2.1	2.0	15.2	48.6	1.9	4.1	3.1	4.6	7.2	3.7	3.1	3.6	14.0	5.0	2.8	2.1	56.3	31.8	2.6	1.9	6.0	3.0	4.5	2.1	1.1	7.1	10.9	6.6	6.2	3.4	13.3	14.3	2.7	6.3	5.7	2.4	5.1	2.2	4.6
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		4200	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	52.6	17.4	26.8	25.8	40.5	56.6	40.5	32.7	18.3	40.4	35.6	33.8	17.0	29.8	16.8	27.9	43.5	31.2	24.8	18.4	67.9	30.9	25.3	49.3	34.9	48.6	52.1	37.2	52.1	69.4	7.9	45.8	49.7	39.7	31.7	11.0	26.0	26.1	14.0	27.5	22.3	25.9	40.0	71.5	27.2	59.2	48.8	43.2	68.4	38.9	35.8	25.2	16.0	31.0	27.2	22.6	39.3	51.0	66.5	60.5	23.4	39.0	37.8	31.1	45.2	86.1	9.8	8.4	33.6	88.4	36.6	15.6	219.4	32.9	44.6	90.6	25.5	32.2	24.9	51.6	26.3	36.1	0.7	35.5	6.8	46.2	24.1	29.3	157.0	25.1	2.0	22.7	44.1	18.1	28.7	15.5	15.9	16.6	23.9	25.7	70.2	0.8	35.9	0.7	49.7	0.9	60.8	8.4	23.5	59.5	33.3	48.2	203.6	29.8	37.0	15.5	37.6	17.7	25.3	1.3	18.2	21.5	49.5	41.2	40.9	23.2	39.5	120.8	28.3	25.7	24.9	33.0	17.2	35.7	21.8	22.8	34.5	37.6	173.9	50.4	22.2	13.9	26.8	40.5	32.7	18.3	18.4	67.9	48.6	52.1	49.7	40.0	48.8	31.0	267.0	410.3	138.7	148.2	101.2	29.4	31.7	17.2	40.9	6.5	47.4	32.1	56.0	28.6	111.0	31.3	0.0	94.4	175.1	10.9	0.0	25.3	527.1	61.2	51.5	171.8	31.2	19.8	61.2	32.0	6.9	51.6	76.5	87.5	29.7	22.8	83.6	15.6	22.3	60.6	161.4	16.9	8.2	109.7	45.9	332.1	23.9	97.6	39.2	425.3	79.8	29.1	171.0	68.9	4.1	28.1	9.3	33.4	70.3	25.4	3.6	7.1	87.3	4.3	144.7	151.0	157.8	6.6	6.6	33.7	45.5	129.3	108.0	32.0	22.3	19.2
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651796-47659180	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Centriolar satellite"	"HPA050499: AB_2681146, HPA058400: AB_2683706"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	124.7	148.6	82.1	78.8	84.9	212.0	127.1	85.6	111.7	121.8	86.5	112.3	77.2	93.6	123.6	116.6	103.3	66.7	144.6	80.1	85.1	134.2	135.1	97.8	148.7	87.1	82.5	184.6	182.3	90.5	107.0	65.3	88.4	119.7	99.7	42.8	121.6	65.9	130.7	143.6	113.8	68.2	87.7	139.5	131.7	46.3	83.7	166.9	96.3	95.2	143.0	109.6	111.9	91.1	192.0	208.6	87.4	116.0	194.3	233.4	152.3	119.2	178.5	203.6	191.7	182.1	178.1	217.3	86.4	173.5	188.0	151.8	123.5	163.8	145.3	143.7	240.8	111.6	220.8	182.4	224.2	246.6	208.1	162.9	207.5	168.6	183.8	142.2	165.9	185.6	122.2	205.1	174.8	211.5	170.7	342.1	125.4	174.7	231.2	149.5	177.2	300.9	168.1	141.4	82.1	107.1	133.1	146.7	197.8	157.7	170.4	227.2	122.4	140.7	153.2	196.2	136.7	161.7	154.5	200.7	179.8	270.1	145.1	110.1	159.7	123.4	169.5	166.1	229.8	262.7	242.6	184.2	213.3	245.2	303.2	255.4	100.7	172.1	156.9	270.3	248.2	247.9	82.1	84.9	85.6	111.7	80.1	85.1	87.1	82.5	88.4	87.7	83.7	91.1	108.3	73.7	79.5	5.5	276.8	214.9	274.3	247.9	212.3	27.3	242.1	239.6	100.7	165.8	141.4	97.5	16.7	189.4	207.2	212.1	315.0	161.2	73.5	122.3	125.2	129.6	187.2	170.0	4.0	318.9	212.6	127.6	78.0	114.0	154.1	161.4	193.5	242.4	246.5	10.1	4.3	331.9	126.1	248.0	277.4	185.2	210.3	179.8	197.5	1.9	316.0	108.2	212.1	3.5	7.7	189.3	338.0	196.0	198.3	256.4	297.8	466.1	138.0	28.6	144.7	224.3	145.2	78.7	85.6	183.3	203.7	213.7	240.5	185.5	328.5	286.0
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914016-9960021	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		580000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	33.1	67.1	21.5	24.2	26.8	97.1	29.5	30.7	28.1	30.2	21.5	38.6	31.2	32.9	24.8	47.5	29.3	31.9	37.5	23.2	24.9	32.6	36.6	33.9	25.7	34.9	26.3	39.1	40.9	36.2	17.7	29.8	34.5	24.5	35.4	20.1	32.6	22.0	69.7	32.3	30.6	27.4	27.8	26.7	38.9	29.1	25.5	30.0	35.2	38.4	26.3	36.5	32.2	30.7	58.1	34.4	40.7	26.7	46.9	50.5	56.8	69.9	57.9	62.3	67.9	46.6	55.9	56.5	63.6	61.5	53.9	39.7	39.8	66.7	70.7	35.6	49.8	92.4	33.8	72.3	110.8	126.3	169.7	47.8	66.3	59.0	69.6	48.7	64.0	45.4	94.6	57.3	55.2	31.2	97.4	72.9	26.2	197.6	54.3	50.4	55.2	77.5	60.9	57.3	57.2	31.2	81.1	48.7	53.2	37.2	45.7	64.2	68.9	100.7	75.3	105.6	86.3	101.9	89.2	66.6	57.0	53.5	70.8	131.3	143.3	251.0	69.8	127.9	82.9	100.0	72.1	75.4	118.1	94.4	78.1	72.1	226.2	90.8	109.5	84.6	98.9	183.9	21.5	26.8	30.7	28.1	23.2	24.9	34.9	26.3	34.5	27.8	25.5	30.7	173.6	128.2	178.8	63.0	160.0	673.4	358.4	356.5	278.3	113.9	248.2	179.3	218.3	167.3	229.4	207.8	62.6	296.9	148.0	427.2	457.8	291.8	10.5	235.9	182.2	232.4	144.6	188.1	91.4	361.3	321.6	221.4	156.0	255.8	225.2	220.2	211.3	141.1	287.8	136.3	93.2	180.6	390.6	288.2	459.8	21.7	182.0	285.9	279.3	63.7	350.4	124.3	108.1	102.1	150.4	310.2	262.7	216.3	146.6	335.4	255.9	390.4	265.5	79.5	190.7	204.8	371.4	231.3	201.4	267.3	622.5	452.6	190.2	253.6	201.0	390.8
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383538	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 21.8;MCF7: 18.4;U-2197: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"	NA	Yes		2000000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: AB_2732418"	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	55.7	15.5	1.5	5.8	2.3	2.7	31.5	0.8	2.3	48.1	3.0	12.1	3.4	30.3	0.0	34.1	24.6	7.3	30.5	1.1	0.5	56.1	31.8	44.9	2.8	6.3	5.5	40.0	10.3	0.0	12.8	10.4	1.7	17.9	0.0	0.3	15.9	0.0	6.9	38.8	11.2	0.0	1.6	13.0	13.4	16.8	4.6	0.0	26.8	0.0	0.0	26.5	38.9	2.7	4.2	0.0	0.6	0.5	0.2	0.2	12.6	21.8	0.1	0.0	0.0	1.9	5.5	0.0	4.5	0.3	2.6	0.3	0.0	0.0	0.0	13.7	2.2	0.9	15.9	14.9	0.6	0.0	0.4	7.9	0.0	0.3	0.0	3.1	0.0	0.1	3.1	0.8	0.0	18.4	1.0	5.3	2.2	0.4	2.4	1.0	0.0	0.0	0.0	0.1	1.4	9.3	6.5	13.5	0.6	2.2	6.8	2.5	0.0	17.5	12.5	78.4	4.6	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	0.8	2.3	1.1	0.5	6.3	5.5	1.7	1.6	4.6	2.7	10.0	6.4	13.1	5.5	1.4	9.6	7.8	4.2	9.1	0.5	21.9	10.9	16.2	32.9	6.4	23.9	0.0	5.4	2.8	1.5	7.9	13.1	1.1	12.1	58.7	4.6	0.0	0.0	1.1	2.9	7.2	104.2	16.8	20.5	3.8	4.6	2.9	15.3	3.4	0.0	0.9	2.0	2.0	0.6	21.7	2.8	50.1	2.0	14.2	2.8	0.0	18.3	0.0	0.5	0.3	28.3	1.2	60.9	0.8	6.4	0.2	12.3	2.7	0.7	98.6	12.6	80.9	0.8	4.1	3.7	7.5	10.0	3.5	2.3	0.8	4.9
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VAT1	"FLJ20230, VATI"	ENSG00000108828	"Vesicle amine transport 1"	Q99536	17	43014607-43025123	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 133.2;Hofbauer cells: 146.4;Melanocytes: 122.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 295.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 104.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 104.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 680.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045170	Uncertain					NA	NA		2700000	"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA045170: AB_10964166"	"unprognostic (2.22e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-2)"	180.4	251.5	53.6	32.1	57.6	86.5	137.5	55.3	67.3	160.8	54.8	97.5	25.7	121.4	65.0	132.6	78.4	85.6	74.7	47.3	129.9	70.5	44.5	111.7	29.0	88.4	132.3	184.8	67.2	54.7	103.7	83.9	173.9	64.9	32.9	7.6	86.3	52.2	29.2	194.3	65.1	94.2	60.5	40.3	56.1	79.2	93.3	63.7	68.3	45.8	33.7	109.5	126.3	77.3	38.9	225.0	53.6	119.0	556.9	435.5	75.5	94.2	282.1	89.7	167.1	139.7	83.2	7.7	128.8	395.8	283.7	58.9	94.1	81.6	82.7	14.4	127.6	36.2	107.3	279.5	357.7	177.6	271.5	234.3	119.2	154.0	71.2	203.8	428.9	230.5	77.3	12.1	227.3	37.2	262.2	76.6	68.1	111.6	106.2	37.3	66.1	19.4	102.2	76.6	50.0	94.6	51.3	29.5	680.8	217.9	82.5	99.4	431.7	199.9	92.5	226.2	22.9	19.4	30.2	14.3	203.1	132.0	31.4	104.0	16.6	24.9	13.1	7.9	15.3	19.9	18.5	13.6	8.4	19.5	16.8	10.4	5.1	11.1	9.2	4.1	13.4	19.0	53.6	57.6	55.3	67.3	47.3	129.9	88.4	132.3	173.9	60.5	93.3	77.3	133.2	22.4	13.9	1.0	17.2	28.4	14.2	17.9	34.1	1.1	29.5	30.2	31.6	17.2	10.7	23.9	4.2	6.5	6.5	9.2	17.6	99.7	27.5	14.2	32.5	71.0	15.1	12.6	2.3	43.4	45.1	91.4	8.2	32.6	77.2	93.8	73.9	15.8	146.4	5.0	2.4	4.1	4.1	40.0	32.4	45.2	51.9	43.9	122.7	6.5	16.1	4.2	3.1	3.5	4.1	49.6	10.4	58.6	19.6	25.5	36.5	60.1	12.6	1.8	13.1	19.4	39.1	12.8	15.5	35.1	33.5	11.1	12.6	31.2	4.7	21.8
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772708-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 54.1;lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 30.7;dendritic cells: 31.3;granulocytes: 34.9;Hofbauer cells: 50.6;Kupffer cells: 29.4;Macrophages: 33.9;Microglial cells: 30.9;T-cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 100.7;Karpas-707: 114.7;MOLT-4: 115.8;REH: 76.1;THP-1: 88.9;U-266/84: 89.5;U-937: 95.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001864, HPA005925"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA001864: AB_1858722, HPA005925: "	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	6.6	3.8	3.3	36.3	3.3	54.1	2.7	3.6	4.6	2.6	4.5	6.5	5.8	1.8	1.4	3.7	2.4	6.3	1.9	3.3	4.4	2.1	5.0	11.5	46.4	6.2	4.9	1.1	1.3	4.2	1.6	8.7	5.6	2.8	7.1	0.2	6.1	2.3	1.0	1.7	14.1	5.3	5.0	44.9	5.5	1.8	5.7	45.7	2.0	2.1	39.1	13.0	1.7	7.6	1.6	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	12.7	51.0	16.5	0.0	0.0	0.2	0.0	0.0	0.0	22.0	1.8	61.8	0.0	0.0	0.0	60.7	100.7	0.0	0.0	0.0	0.0	0.0	0.0	63.9	2.3	114.7	0.0	9.6	115.8	36.6	0.0	0.0	0.0	76.1	0.0	41.0	2.2	0.0	0.0	0.0	0.0	18.3	0.1	0.0	8.0	88.9	0.2	0.0	1.6	0.1	0.1	69.9	89.5	57.9	0.1	95.3	0.0	1.6	18.3	20.0	22.0	30.3	15.7	14.3	16.1	19.3	16.6	13.6	17.2	15.6	40.6	19.2	39.8	14.4	14.5	18.2	3.3	3.3	3.6	4.6	3.3	4.4	6.2	4.9	5.6	5.0	5.7	7.6	0.5	3.2	3.0	0.0	30.7	1.3	0.8	3.7	0.0	0.5	0.4	0.4	1.1	0.0	6.9	0.0	0.0	0.8	31.3	1.5	0.0	4.2	5.4	5.3	0.3	1.5	1.2	9.9	1.9	0.4	0.7	1.2	1.1	1.1	34.9	0.0	1.8	0.3	50.6	0.0	1.5	1.0	8.2	29.4	19.6	2.2	0.0	33.9	1.8	30.9	18.8	0.0	22.6	0.5	1.2	9.9	6.1	0.0	21.6	0.3	0.0	0.2	11.9	0.0	0.0	0.3	1.2	1.7	1.4	0.3	0.9	1.4	26.5	0.3	2.4	0.6
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 48.3;Inhibitory neurons: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3"	"Group enriched"	"Detected in many"	22	"B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (3.97e-2)"	8.4	26.8	9.3	10.7	8.8	3.0	7.7	7.4	9.8	12.0	10.9	11.8	20.9	9.9	7.2	6.7	12.2	10.8	7.4	11.6	9.9	21.3	46.1	16.8	13.3	11.6	16.0	5.5	38.6	10.8	8.0	13.1	13.2	10.2	9.6	3.0	13.2	8.9	2.0	6.1	22.4	6.9	8.9	13.9	9.5	4.4	9.9	6.2	13.8	2.3	13.3	11.4	7.9	8.4	12.5	21.6	33.3	13.5	9.0	15.1	85.8	24.6	13.5	20.3	12.2	33.0	19.0	3.6	19.6	24.6	26.2	72.8	31.6	53.0	10.4	21.3	7.3	4.2	28.3	37.2	33.4	10.3	1.6	15.0	33.5	17.9	25.3	13.6	22.9	7.3	7.3	6.0	14.2	63.5	0.8	5.1	16.3	54.3	20.5	33.9	28.2	12.1	46.1	22.4	36.9	24.9	64.7	42.7	8.8	21.3	26.0	14.5	18.7	28.6	16.0	28.7	34.5	0.4	0.3	6.8	19.1	8.8	18.0	0.0	0.8	0.0	0.0	2.0	0.0	3.3	0.0	0.0	1.1	2.1	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.5	9.3	8.8	7.4	9.8	11.6	9.9	11.6	16.0	13.2	8.9	9.9	8.4	4.8	0.0	5.4	20.5	11.2	5.1	3.0	10.1	4.0	1.9	6.7	5.6	4.7	21.5	7.5	36.8	0.0	1.3	0.6	27.0	3.9	9.2	2.5	6.9	6.4	6.6	28.2	0.4	8.5	12.5	18.3	5.0	9.7	13.9	0.0	24.6	6.8	48.3	6.2	0.0	40.9	9.8	6.1	5.4	7.2	7.9	7.2	7.7	1.8	8.4	9.3	4.2	2.1	31.2	2.6	24.7	15.6	6.0	3.3	6.3	35.7	13.6	3.3	1.8	13.1	6.4	8.8	0.1	3.8	2.1	2.7	1.0	1.7	12.0	13.5	2.1
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900576-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;retina: 11.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.5;Cone photoreceptor cells: 16.7;Horizontal cells: 11.8;Muller glia cells: 7.6;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.7;MCF7: 5.6;RH-30: 4.6;SCLC-21H: 4.6;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.2"	HPA009708			Approved	"Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear speckles"		"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	1.5	0.4	1.8	0.1	1.0	0.0	1.1	5.4	1.6	0.9	0.6	0.6	0.0	1.0	0.0	0.4	0.7	0.0	0.6	1.9	2.6	0.4	0.0	0.5	0.0	0.9	1.0	0.7	1.2	0.2	0.9	0.2	1.0	0.7	0.0	11.1	0.8	0.0	0.5	1.2	0.3	0.3	0.7	0.0	0.2	0.2	1.6	0.0	0.2	0.1	0.0	0.5	0.4	1.0	1.5	3.6	0.8	4.7	1.2	0.7	2.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	1.8	0.0	0.1	0.0	3.0	0.0	0.0	2.1	0.6	0.0	0.0	1.2	0.0	0.2	0.0	1.3	0.4	0.2	0.0	0.0	1.8	5.6	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	1.5	1.2	4.6	5.6	3.7	0.0	2.1	0.1	2.1	0.2	0.9	2.2	0.5	1.1	0.9	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	5.4	1.6	1.9	2.6	0.9	1.0	1.0	0.7	1.6	1.0	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.5	1.4	1.4	0.1	0.0	0.1	0.0	16.7	0.1	0.1	0.2	1.9	1.2	0.1	0.0	0.1	1.5	0.0	0.0	0.6	0.6	0.4	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	11.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	4.2	7.6	0.0	2.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.8	0.8	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.1	0.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 389.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 142.6;Hepatic stellate cells: 94.9;Kupffer cells: 561.9;Proximal tubular cells: 188.4;Theca cells: 186.8"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 164.7;HSkMC: 111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		NA	NA	624000000	1300000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	29.1	43.2	4.0	34.7	3.5	8.3	15.0	5.0	4.5	6.7	6.0	15.0	15.4	9.4	2.4	7.7	9.8	29.5	9.4	2.8	7.6	64.3	43.7	18.1	96.3	6.5	6.2	39.5	13.3	18.4	7.0	43.2	7.0	9.7	23.5	1.5	8.7	5.5	3.1	3.6	14.4	11.0	6.0	389.3	14.4	5.4	11.2	24.6	7.3	6.3	75.9	72.7	5.5	5.9	0.0	0.0	0.8	0.3	0.6	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.1	25.7	0.0	0.0	0.0	0.0	164.7	0.2	0.0	111.0	0.0	29.3	0.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.5	5.0	4.5	2.8	7.6	6.5	6.2	7.0	6.0	11.2	5.9	9.6	0.0	5.6	0.0	1.7	9.9	0.5	0.4	0.0	0.1	0.9	0.6	1.9	0.0	0.2	3.7	0.0	1.3	1.1	0.0	9.8	142.6	0.3	0.7	14.0	40.3	0.0	2.7	0.0	3.2	1.2	60.1	0.0	0.8	1.3	7.5	94.9	3.2	3.6	0.0	0.0	0.0	0.0	561.9	15.9	0.0	17.1	7.9	1.8	6.5	0.0	4.0	0.0	0.0	0.1	2.3	1.1	7.5	0.9	1.3	0.0	188.4	1.5	0.0	0.0	5.5	19.2	0.1	2.3	0.4	7.4	2.7	10.0	186.8	0.1	0.4
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471618-83582303	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 975.7;Granulosa cells: 1131.8;Kupffer cells: 547.3;Macrophages: 605.6;monocytes: 948.1;Oligodendrocyte precursor cells: 1644.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 240.0;myeloid DC: 88.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 88.9;monocytes: 240.0"	"Cell line enhanced"	"Detected in many"		"AF22: 300.5;HSkMC: 199.5;hTERT-RPE1: 959.0;RPTEC TERT1: 381.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	42.0	23.9	18.6	74.9	20.8	32.6	15.6	24.2	23.0	29.4	5.2	11.3	3.8	17.8	1.8	3.8	8.6	30.5	45.0	25.7	27.8	6.5	2.7	34.4	2.3	36.1	19.3	2.1	3.1	2.4	2.1	73.5	31.3	6.8	10.7	0.2	7.6	4.2	3.9	11.2	5.7	48.0	28.9	13.9	7.7	4.8	44.9	2.7	6.6	6.8	1.9	48.3	7.2	42.7	0.2	5.6	300.5	0.1	119.8	81.5	0.1	2.3	6.2	2.1	1.5	3.1	0.2	0.0	45.2	111.5	3.9	0.0	0.4	0.4	1.7	0.1	9.8	2.1	0.0	2.3	5.5	0.1	0.0	199.5	0.1	127.6	1.2	959.0	0.1	0.0	0.0	0.1	64.6	0.0	0.5	0.0	51.1	0.0	10.3	0.0	63.0	0.1	381.0	0.0	3.6	15.5	0.0	0.0	0.2	33.2	0.2	0.5	116.5	90.6	0.5	168.3	179.0	0.0	0.1	0.2	41.8	0.1	16.4	8.3	240.0	0.5	0.5	31.3	0.3	0.2	0.1	0.1	88.9	0.1	0.1	0.0	3.9	0.5	3.5	1.7	0.0	94.0	18.6	20.8	24.2	23.0	25.7	27.8	36.1	19.3	31.3	28.9	44.9	42.7	23.4	19.2	19.8	128.9	5.5	38.6	10.6	14.9	1.2	0.0	1.8	1.9	8.2	44.3	17.5	25.8	0.0	5.9	7.4	0.0	0.0	1.9	3.0	64.4	975.7	29.9	0.0	5.2	1.5	0.7	7.0	348.1	3.6	241.3	12.6	1131.8	16.8	3.6	25.6	0.0	30.7	0.2	0.0	547.3	83.1	2.5	18.6	605.6	44.4	20.6	948.1	0.0	13.4	1644.7	1.5	32.3	1.1	117.8	2.5	2.5	0.0	1.8	16.2	0.0	0.0	11.0	80.6	0.9	1.2	1.1	28.7	11.5	12.7	1.6	0.3	0.9
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971871-134004975	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1045.7;tongue: 812.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005885, HPA030780, CAB072343"	Supported					NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (8.49e-4)"	"prognostic unfavorable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	96.3	129.8	104.8	96.2	113.5	53.9	106.2	112.8	137.4	62.8	149.0	154.1	265.7	54.4	196.9	172.3	61.5	90.3	403.5	116.7	122.3	200.9	206.2	79.3	89.6	113.4	105.1	60.8	99.7	181.8	63.4	104.5	118.3	82.4	166.4	316.0	132.9	72.5	1045.7	113.9	179.1	90.7	101.1	60.2	163.6	37.5	117.3	90.9	68.5	812.0	129.3	108.3	91.0	106.4	364.5	315.8	282.8	295.3	277.5	385.0	398.0	398.1	292.2	386.5	395.2	650.0	282.9	497.4	291.5	418.0	515.1	278.2	403.4	701.2	480.7	296.1	331.7	287.3	308.9	526.0	282.2	266.5	272.9	353.3	368.5	301.1	333.0	385.3	381.2	248.0	260.1	197.8	511.8	404.5	326.3	264.1	198.5	555.2	264.3	296.5	282.6	474.3	608.6	450.0	315.0	177.7	253.7	305.2	416.0	385.9	147.0	257.6	311.6	361.4	241.6	335.9	530.2	262.9	278.3	309.4	537.1	351.9	420.7	24.9	83.2	30.3	54.5	118.4	60.0	58.3	55.6	57.3	140.7	40.5	38.8	43.8	6.9	87.7	105.1	41.1	74.5	72.9	104.8	113.5	112.8	137.4	116.7	122.3	113.4	105.1	118.3	101.1	117.3	106.4	89.9	105.8	63.1	21.2	101.9	204.8	246.6	250.8	128.7	463.6	163.7	98.3	276.0	198.8	133.2	126.9	81.3	372.4	94.9	333.1	729.8	303.4	68.7	140.8	161.1	120.7	104.1	96.7	41.5	302.6	471.4	136.9	225.8	184.6	121.8	163.9	57.1	203.9	332.7	519.9	40.6	202.7	189.2	130.6	243.5	50.3	95.7	165.7	249.1	31.9	315.8	277.0	60.8	24.1	23.8	300.7	227.7	112.1	162.0	353.6	415.8	585.3	121.2	257.2	85.5	132.8	171.4	10.9	32.7	275.5	232.9	325.6	111.0	229.1	326.7	265.1
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405937	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 385.2;skeletal muscle: 914.4;tongue: 942.7"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 403.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	67.5	76.2	117.3	59.1	119.4	92.1	70.3	116.8	150.6	53.7	115.4	106.9	79.8	63.5	68.6	99.9	85.8	56.0	385.2	121.1	130.8	108.8	92.9	51.9	66.3	122.7	119.3	61.6	64.6	92.4	58.9	63.9	139.2	69.5	106.4	123.1	61.6	81.3	914.4	54.1	73.0	92.8	114.1	67.3	72.1	114.5	118.6	80.1	83.3	942.7	79.3	78.9	59.8	113.8	226.3	225.7	174.5	185.9	146.3	126.6	84.8	180.0	151.1	225.4	205.2	173.4	190.4	235.8	165.0	153.7	196.3	142.5	238.4	194.1	244.7	117.2	196.6	352.9	138.4	250.2	105.2	172.0	190.1	98.6	143.3	171.6	80.9	149.6	279.8	201.3	284.4	158.6	235.7	126.4	373.3	197.1	205.2	285.6	144.5	193.6	322.1	165.3	245.7	198.8	156.8	133.3	112.1	132.8	116.1	126.4	279.9	129.9	149.8	86.6	150.0	217.7	174.0	145.2	264.1	266.9	117.5	238.0	150.9	142.8	165.3	183.4	145.8	167.2	148.7	126.5	155.6	146.5	222.7	96.6	152.7	147.7	82.8	125.8	155.6	163.0	202.5	360.5	117.3	119.4	116.8	150.6	121.1	130.8	122.7	119.3	139.2	114.1	118.6	113.8	78.1	44.8	24.4	50.6	59.8	64.5	81.1	197.8	58.1	85.9	53.0	73.9	321.2	55.8	82.8	66.2	35.5	145.5	91.9	65.7	307.2	116.3	151.1	112.8	56.7	70.5	47.8	186.4	63.2	90.0	112.1	81.5	41.3	47.1	55.2	100.6	68.2	60.4	139.7	138.0	78.9	86.1	177.0	58.5	77.8	146.4	69.3	107.7	72.9	26.2	130.1	72.9	83.4	38.2	34.7	84.9	86.7	97.4	75.9	48.9	125.3	177.5	142.1	94.5	65.7	146.4	123.8	403.7	156.3	82.3	70.8	58.3	79.7	94.2	124.8	70.4
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 349.4;Muller glia cells: 265.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 79.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 398.9;U-87 MG: 628.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000	57000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	155.8	52.7	17.6	36.5	20.3	45.5	92.4	34.2	28.2	45.2	46.8	32.6	50.9	104.0	10.5	61.3	40.9	80.1	208.3	22.8	25.1	116.9	217.3	94.1	9.3	27.0	38.5	25.0	68.1	105.0	22.3	46.2	26.8	120.3	21.4	229.1	32.1	17.8	221.2	44.2	44.6	57.1	19.6	70.1	63.9	5.3	32.0	5.6	270.9	150.9	9.5	122.3	61.7	24.9	76.5	13.4	12.5	71.8	21.0	32.9	84.2	45.6	81.1	29.7	58.4	43.1	9.9	24.9	35.5	27.7	305.4	30.6	34.0	92.0	52.0	27.4	10.4	19.0	17.8	29.2	220.3	20.8	40.4	58.0	178.6	290.6	286.2	398.9	7.7	21.0	35.7	121.7	109.4	31.3	2.3	28.3	7.9	221.2	19.2	2.3	12.0	60.5	114.8	62.9	22.3	46.8	65.6	44.4	162.0	16.1	17.3	75.1	10.4	122.6	32.9	179.2	76.1	68.8	43.6	49.1	628.6	47.9	43.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	20.3	34.2	28.2	22.8	25.1	27.0	38.5	26.8	19.6	32.0	24.9	63.6	349.4	84.7	121.5	9.8	70.5	51.2	76.8	60.3	37.8	67.0	57.1	164.7	77.2	85.7	22.0	31.3	1.3	11.6	92.9	1.9	54.7	0.0	38.4	59.1	29.0	27.4	21.3	12.1	40.8	6.3	69.7	124.4	121.2	112.0	111.7	17.5	116.0	13.9	180.0	17.0	71.8	12.2	16.2	199.0	0.3	1.8	144.1	28.4	10.3	11.3	265.8	0.0	124.1	1.8	86.0	47.1	3.4	15.9	119.4	61.9	20.5	11.4	43.9	0.0	42.1	79.1	1.1	1.9	82.0	78.3	7.9	11.4	17.4	51.0	137.5
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345596-15384413	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 42.7"	"Cell type enriched"	"Detected in some"	12	"Fibroblasts: 39.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 2.8;EFO-21: 1.3;HSkMC: 2.8"	"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6"	"Not detected"	"Not detected"			HPA027342	Uncertain				"Secreted to blood"	NA	NA	592000	450000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	11.4	9.9	1.8	0.7	1.8	0.0	20.3	1.5	2.3	19.2	1.5	5.0	1.2	3.8	4.9	2.7	4.1	2.8	15.5	1.6	2.0	1.7	1.5	42.7	0.4	1.8	1.7	4.4	0.7	2.7	7.0	0.2	2.0	1.5	2.0	0.3	2.3	1.8	17.6	1.2	4.2	3.3	1.3	2.8	5.8	0.6	2.1	0.3	1.5	23.0	1.3	6.0	8.1	2.0	0.0	0.6	0.5	0.9	3.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.3	2.8	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.5	2.3	1.6	2.0	1.8	1.7	2.0	1.3	2.1	2.0	3.1	3.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 436.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.6	1.1	0.0	10.3	0.1	0.3	0.8	0.3	0.2	0.7	0.0	175.9	395.0	0.5	0.0	0.9	0.7	28.1	1.0	0.0	0.0	25.9	31.4	0.7	0.3	0.0	0.0	1.1	29.4	0.0	1.4	0.3	0.0	1.0	184.0	0.0	0.6	0.4	0.4	1.1	436.3	8.1	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.1	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 61.9;stomach 1: 97.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.0;OE19: 78.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	5.4	3.7	8.7	11.0	9.0	12.6	6.4	6.6	10.6	9.5	6.4	46.8	61.9	5.7	1.5	7.2	6.7	15.7	6.4	8.6	7.8	5.3	1.4	7.7	9.8	8.3	8.4	6.8	3.4	1.2	5.1	4.1	8.0	16.0	26.6	1.2	5.7	4.0	1.2	9.1	61.7	4.1	8.0	11.8	97.5	5.4	8.2	10.2	7.4	1.4	6.3	17.5	7.4	7.2	8.2	0.1	0.2	0.4	2.8	2.2	0.8	2.3	1.9	2.3	2.2	6.1	25.0	3.9	3.5	1.6	0.0	1.9	1.8	0.2	0.5	0.8	0.0	7.3	0.1	0.6	3.4	7.7	9.5	3.3	2.2	2.2	0.0	0.0	4.5	16.1	7.3	2.3	2.6	0.1	12.4	8.7	0.2	78.4	0.0	4.8	0.0	2.0	0.8	9.8	0.1	0.3	0.0	0.5	1.8	0.0	0.7	12.4	2.8	1.0	0.3	3.0	0.0	1.4	3.1	1.2	0.6	10.9	5.0	0.0	3.2	0.0	6.8	2.0	7.4	3.5	4.4	3.9	2.1	4.6	5.6	4.2	0.1	3.4	1.4	3.8	5.8	4.1	8.7	9.0	6.6	10.6	8.6	7.8	8.3	8.4	8.0	8.0	8.2	7.2	4.9	9.6	7.4	10.4	7.2	2.3	5.7	25.5	6.8	0.9	3.3	2.9	1.9	8.6	46.1	0.0	0.0	3.0	13.3	221.7	0.0	3.4	6.2	1.5	2.7	4.5	9.6	6.1	5.5	16.9	3.4	6.7	192.7	1.5	8.2	6.1	5.3	0.3	2.4	1.7	3.0	64.4	14.2	1.9	2.4	19.9	3.7	4.0	1.8	3.7	4.2	28.1	7.2	2.5	1.2	38.7	139.0	2.6	4.4	6.2	165.6	1.6	40.5	0.8	0.0	4.3	7.1	5.4	3.4	3.1	1.4	1.0	8.1	5.6	50.5	33.4
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 160.9;Excitatory neurons: 235.2;Inhibitory neurons: 253.2;Microglial cells: 204.2;Oligodendrocyte precursor cells: 217.1;Oligodendrocytes: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"		"HPA043865: AB_2678704"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	4.0	3.0	2.4	4.4	3.3	13.4	4.7	4.5	3.0	5.4	8.2	3.6	2.3	7.2	3.8	4.4	4.9	4.4	2.3	2.0	1.9	3.8	3.1	3.5	4.8	3.6	2.4	8.1	3.4	6.8	2.3	4.0	3.6	4.9	3.7	6.0	3.2	4.1	2.9	4.0	3.0	5.4	2.2	4.2	3.6	4.9	4.9	7.1	4.7	4.4	5.0	4.5	3.7	5.3	8.6	6.1	7.2	5.3	13.3	15.9	3.6	5.4	9.9	5.3	7.0	3.6	4.3	4.8	6.9	9.3	3.9	3.9	5.0	5.0	9.6	7.7	4.6	10.3	6.5	2.8	4.3	5.0	7.4	10.3	4.6	8.5	12.2	7.4	7.6	7.9	7.9	12.4	6.1	5.3	10.5	2.9	2.3	8.9	2.2	8.3	5.1	9.1	3.5	8.0	2.1	6.0	8.4	4.0	4.0	6.4	7.2	5.6	10.8	7.9	7.4	7.1	4.6	5.0	6.2	12.7	6.0	7.9	5.6	3.0	1.2	2.8	1.2	1.0	1.1	3.3	1.0	0.9	0.5	1.6	1.7	1.1	6.1	0.7	2.3	0.6	1.4	0.5	2.4	3.3	4.5	3.0	2.0	1.9	3.6	2.4	3.6	2.2	4.9	5.3	15.5	19.2	12.2	160.9	24.2	8.8	7.6	9.2	15.4	15.1	8.9	7.6	12.8	10.0	11.9	3.7	37.5	4.9	21.6	7.3	0.0	4.9	8.6	10.9	42.7	11.5	9.0	22.9	235.2	4.6	4.0	18.2	28.1	12.7	3.8	10.4	6.4	5.2	6.5	11.8	253.2	11.9	8.2	15.6	11.3	9.6	27.7	17.8	7.2	204.2	15.0	9.4	17.5	217.1	238.1	4.0	11.0	20.7	19.2	6.2	9.8	2.9	8.2	12.9	0.0	15.7	14.7	23.9	7.3	13.0	9.7	4.2	19.5	14.6	7.4	5.7
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 26.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 26.4;Hofbauer cells: 32.7;Pancreatic endocrine cells: 33.2;Proximal tubular cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	19.8	24.5	14.8	18.5	16.1	21.4	15.8	16.8	15.8	16.3	15.9	26.6	28.0	14.8	11.4	21.2	13.8	19.6	24.9	14.4	15.6	32.9	29.5	22.1	22.6	16.1	15.9	17.4	22.6	17.7	8.6	21.4	16.6	14.3	26.0	13.6	16.9	15.8	31.5	15.7	26.9	19.9	16.2	20.2	21.2	7.5	16.5	28.1	18.1	37.8	23.6	21.9	14.2	17.6	31.8	13.8	30.2	26.5	55.4	49.4	34.3	29.9	66.2	26.6	40.2	19.2	32.7	22.0	11.7	70.0	63.9	15.0	32.6	32.1	26.1	52.8	23.5	37.6	13.6	18.7	49.1	27.8	24.3	43.5	31.2	31.0	50.4	48.1	51.4	40.5	24.0	46.8	52.5	14.1	47.2	23.7	34.4	48.7	13.8	44.8	14.5	32.5	32.8	23.7	24.4	32.6	20.6	40.9	65.5	39.0	38.4	22.0	41.0	30.6	10.8	33.2	18.5	71.3	78.0	30.3	48.3	47.9	35.2	58.6	48.6	84.9	50.7	60.5	46.8	37.5	43.1	45.4	47.7	29.4	39.8	41.0	50.1	52.9	55.7	19.4	54.9	54.1	14.8	16.1	16.8	15.8	14.4	15.6	16.1	15.9	16.6	16.2	16.5	17.6	18.1	9.6	21.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	14.5	13.3	0.0	0.0	6.8	9.2	0.0	16.0	23.8	0.0	21.5	26.4	0.0	12.5	12.7	8.4	0.0	0.0	0.0	28.0	26.4	5.4	0.0	16.1	8.8	19.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	16.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.1	0.0	0.0	29.7	4.4	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	14.6	8.5	10.1	0.0	0.0
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29 retromer complex component"	Q9UBQ0	12	110491083-110502111	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	61.1	62.7	45.6	57.0	47.0	96.2	59.2	46.2	61.8	50.3	47.0	76.4	64.1	52.9	89.5	71.1	50.3	51.1	73.8	48.7	48.3	79.2	77.6	54.9	69.7	47.2	46.3	47.1	56.6	54.8	53.7	47.3	47.4	62.7	79.0	99.6	58.5	71.3	127.3	46.8	65.7	67.1	48.0	76.5	62.8	32.6	46.1	63.2	54.1	100.8	72.0	65.1	50.6	51.1	103.5	98.6	91.9	65.6	100.4	98.7	72.6	94.9	98.1	93.9	84.2	100.0	87.0	94.0	97.1	94.3	87.7	95.5	123.1	88.0	97.0	112.2	98.9	115.4	122.6	83.0	87.4	139.5	97.1	66.0	73.3	79.3	87.4	114.1	166.0	116.6	112.1	85.5	170.0	51.9	110.3	196.4	52.6	90.9	124.8	72.2	93.5	131.8	157.0	149.7	98.1	51.8	107.9	94.0	122.8	78.5	128.6	106.0	94.0	80.6	53.4	112.9	113.0	58.0	87.5	112.1	93.9	130.8	87.8	246.2	262.7	259.4	139.1	356.8	155.3	195.9	175.5	164.9	318.3	158.7	159.8	156.8	178.7	202.9	405.4	214.0	224.8	385.1	45.6	47.0	46.2	61.8	48.7	48.3	47.2	46.3	47.4	48.0	46.1	51.1	138.8	76.9	96.2	21.2	93.7	143.5	172.6	395.9	70.6	39.0	93.4	109.2	282.4	90.1	209.7	101.2	27.1	192.8	116.5	156.3	289.5	231.0	56.8	94.7	79.8	125.0	83.2	147.5	30.2	179.8	187.6	120.2	60.1	104.1	153.9	78.1	94.9	158.7	409.9	42.1	26.7	149.8	248.2	158.0	296.1	82.6	92.2	178.7	177.9	30.9	295.2	107.9	101.0	22.6	30.4	217.9	182.2	105.7	94.8	157.4	142.2	404.7	131.1	111.8	157.8	81.9	212.1	256.4	148.4	108.3	173.0	178.8	111.2	105.8	164.5	187.7
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35 retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes		NA	NA		500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Endosomes, Lysosomes"		"HPA040802: AB_2677142"	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	5.4	4.2	2.9	3.0	3.0	9.5	4.6	2.6	3.2	4.2	2.8	4.2	1.9	4.3	1.9	4.7	4.0	1.4	6.1	3.0	2.5	3.7	1.7	4.1	2.9	3.0	2.4	4.7	4.4	5.2	3.3	2.1	3.2	3.0	1.8	4.1	4.5	2.4	4.6	6.1	4.9	1.7	2.1	4.2	4.5	2.7	2.8	3.9	2.7	2.7	1.8	4.5	4.2	3.4	3.2	5.0	4.1	2.8	6.5	7.3	2.1	3.8	5.4	6.4	3.7	4.3	2.7	4.2	2.3	6.5	3.3	3.9	7.5	7.5	9.1	1.6	6.4	3.9	3.8	3.0	5.4	5.2	5.8	5.8	5.5	7.3	4.5	6.3	6.6	6.0	3.1	1.8	6.5	2.9	4.0	5.0	1.4	3.0	6.6	5.4	5.4	5.2	5.2	4.4	1.8	2.1	4.1	3.2	1.8	4.5	1.9	2.6	3.9	1.9	1.9	4.3	2.7	2.3	3.2	4.9	3.4	4.0	1.3	1.8	1.3	1.3	0.7	1.7	0.7	0.8	0.7	0.6	1.5	1.0	1.0	0.7	1.5	0.8	2.3	0.6	1.1	1.1	2.9	3.0	2.6	3.2	3.0	2.5	3.0	2.4	3.2	2.1	2.8	3.4	65.9	51.3	59.4	20.5	84.3	72.5	80.0	98.6	72.8	56.5	77.9	75.9	102.9	57.2	83.4	68.0	60.5	134.5	44.9	65.9	54.8	111.7	111.2	136.4	92.3	63.3	80.8	52.6	43.1	72.5	102.2	70.1	88.7	88.4	72.2	211.1	54.7	40.2	123.4	45.4	42.5	79.7	107.8	108.3	87.9	32.4	77.9	113.6	46.2	30.0	153.0	71.4	45.3	28.6	31.3	101.1	101.9	72.2	41.7	77.0	164.6	103.7	188.9	82.6	46.0	57.5	88.9	207.9	118.0	101.5	87.7	113.1	51.5	95.9	97.6	84.5
VPS39	"KIAA0770, VAM6"	ENSG00000166887	"VPS39 subunit of HOPS complex"	Q96JC1	15	42158701-42208307	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (4.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-2)"	"prognostic favorable (3.21e-7)"	"unprognostic (9.85e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.04e-2)"	24.2	24.9	16.0	18.5	17.0	23.8	19.0	13.7	19.8	23.5	12.4	22.1	18.5	23.8	24.7	20.4	25.3	20.6	28.3	17.8	17.5	22.3	13.0	24.5	23.0	15.8	16.7	21.1	26.5	43.7	19.8	22.0	16.6	24.1	19.8	21.3	22.0	26.1	36.5	29.4	21.4	27.3	15.9	22.9	20.9	20.9	19.0	31.6	26.6	34.7	26.2	20.4	17.5	15.6	15.6	21.6	30.7	35.0	55.2	52.9	19.5	27.3	49.1	32.5	34.1	18.5	13.2	13.9	27.0	50.1	34.0	36.0	24.1	27.4	29.8	43.6	13.7	33.7	34.6	17.4	38.1	30.8	25.0	46.6	38.8	30.5	31.4	38.0	34.3	38.2	25.2	37.4	36.4	13.9	23.7	17.2	19.1	34.9	18.4	17.9	28.6	22.0	23.7	36.0	27.2	39.7	22.5	21.5	14.4	31.5	34.5	39.7	37.6	28.0	11.8	33.9	20.3	31.7	45.3	20.2	34.2	27.6	23.2	38.5	14.7	18.2	14.9	16.4	15.1	15.2	13.3	16.1	15.6	11.9	13.4	12.7	16.6	20.8	15.6	6.7	13.1	18.5	16.0	17.0	13.7	19.8	17.8	17.5	15.8	16.7	16.6	15.9	19.0	15.6	14.4	22.4	43.2	27.1	15.7	3.6	3.3	5.6	10.8	11.7	14.0	13.2	57.0	15.7	11.4	9.2	14.6	10.3	12.6	17.5	1.9	7.3	11.4	16.0	16.8	14.4	9.6	16.6	31.2	8.0	7.8	13.7	24.5	15.7	9.5	15.3	9.7	11.8	12.2	11.8	32.2	11.9	10.2	16.9	4.4	21.6	12.2	14.7	3.6	30.9	16.0	13.5	8.2	29.1	34.4	10.2	11.4	13.9	28.7	5.8	14.7	6.2	13.3	11.6	0.0	8.9	10.7	5.2	4.5	12.6	7.0	13.4	13.7	10.5	10.0	4.5
VPS41	HVSP41	ENSG00000006715	"VPS41 subunit of HOPS complex"	P49754	7	38722974-38932394	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.2;Oligodendrocytes: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020080, HPA020299"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA020080: AB_1858768, HPA020299: AB_1858769"	"unprognostic (9.20e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.40e-8)"	"unprognostic (1.62e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	23.0	17.5	25.5	20.3	30.6	12.3	22.4	22.2	28.4	25.9	34.0	25.2	17.3	23.9	14.9	24.2	23.5	35.9	25.5	31.2	25.4	30.6	26.4	25.2	25.0	23.1	22.4	31.1	23.4	37.5	15.4	23.0	24.8	23.2	19.7	29.3	13.2	25.0	8.1	16.1	19.1	25.2	25.3	23.4	20.8	15.6	22.5	24.2	30.9	11.4	25.6	23.2	12.5	31.6	31.8	41.7	41.5	44.6	60.6	55.8	21.1	33.3	58.8	26.6	42.5	24.4	46.4	31.0	93.6	42.2	110.8	39.3	61.7	41.3	44.4	41.1	29.7	29.6	24.2	20.6	47.7	37.9	58.6	41.0	33.9	35.7	35.8	46.0	47.4	39.3	46.5	64.7	47.7	28.5	38.4	21.3	45.5	43.3	27.4	41.1	37.9	33.0	48.8	78.0	35.6	62.9	31.8	50.6	31.2	73.6	56.9	45.8	51.5	30.0	29.8	40.5	33.7	65.1	128.3	59.2	64.4	32.7	104.4	26.6	19.5	27.9	15.3	19.4	12.9	16.5	11.6	14.1	23.4	21.5	12.1	13.3	23.2	23.1	27.9	14.0	13.4	13.6	25.5	30.6	22.2	28.4	31.2	25.4	23.1	22.4	24.8	25.3	22.5	31.6	24.6	22.4	34.6	56.2	23.9	15.2	11.4	16.1	15.4	33.2	14.6	13.0	27.3	38.6	17.5	33.1	18.8	17.7	17.6	14.7	21.5	29.6	2.9	19.9	23.5	21.7	24.0	16.6	118.2	13.8	14.0	19.9	16.8	34.2	42.4	36.4	20.3	25.4	28.6	30.3	78.9	14.1	22.4	28.2	20.1	3.5	15.2	30.3	30.2	49.6	45.2	37.4	12.3	82.4	109.2	18.2	14.6	26.4	15.3	10.5	13.8	26.6	22.7	20.6	0.0	18.7	18.8	10.7	11.0	15.6	17.0	25.9	17.2	29.3	14.9	13.3
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.8;Late spermatids: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	19.1	26.8	32.3	12.0	34.6	6.6	17.8	40.2	43.0	20.1	27.7	22.0	12.6	18.7	22.5	16.7	16.1	13.7	38.6	34.0	33.2	21.1	12.5	15.4	13.5	30.6	31.4	14.0	11.1	26.4	19.1	17.3	31.5	18.8	17.2	29.2	14.3	20.1	19.3	16.5	15.3	25.2	31.5	16.2	17.4	11.0	32.9	17.0	19.8	16.6	15.3	18.5	15.9	32.8	31.5	24.3	40.9	27.0	37.1	29.4	19.0	44.7	23.7	45.3	37.4	17.7	26.1	19.3	26.5	37.0	19.9	26.0	42.4	27.0	49.0	38.7	31.1	24.6	33.5	16.8	24.7	17.6	30.2	25.8	24.8	43.5	22.8	29.7	37.1	38.6	34.4	28.3	40.0	53.5	34.7	17.5	28.4	28.7	38.4	23.7	41.9	27.4	31.2	30.0	28.5	59.7	34.9	29.8	46.9	46.2	48.9	45.6	32.6	20.8	25.1	18.7	31.3	21.3	49.4	18.9	30.9	24.4	30.2	23.6	26.6	4.7	16.0	28.0	15.0	15.6	13.6	15.1	25.9	12.8	13.2	13.9	2.5	14.1	19.9	14.6	16.8	18.4	32.3	34.6	40.2	43.0	34.0	33.2	30.6	31.4	31.5	31.5	32.9	32.8	9.4	12.8	14.0	85.8	11.9	7.4	8.2	12.7	13.1	20.9	11.0	10.2	44.0	8.6	11.0	16.5	18.8	20.9	12.5	8.3	7.9	12.3	202.8	9.7	14.2	10.4	7.8	4.6	79.4	7.2	9.5	14.7	12.8	10.1	6.3	24.6	12.1	7.2	19.0	30.3	90.2	8.1	14.2	18.0	8.6	267.9	21.5	13.6	10.6	45.9	19.7	17.9	6.2	92.5	59.5	11.4	11.6	14.7	8.4	6.4	13.6	9.2	11.5	23.8	32.9	7.3	17.1	18.1	15.1	11.6	7.7	14.8	11.2	21.2	9.7	7.9
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	24.2	18.3	10.5	25.5	13.1	52.6	28.8	13.2	17.8	26.8	9.3	42.3	35.1	22.7	19.5	75.4	18.6	23.7	16.2	10.3	14.6	23.8	28.4	23.8	31.2	13.5	15.9	19.3	17.3	27.8	11.5	28.7	14.0	23.4	37.0	7.0	24.7	19.5	11.0	32.3	36.4	21.0	12.6	28.8	32.5	12.1	12.5	31.4	28.5	13.0	39.1	30.2	31.1	15.6	57.1	21.9	22.4	24.5	33.5	47.1	38.9	48.6	45.5	36.4	39.2	15.7	39.4	54.1	31.2	35.7	30.9	119.6	26.8	53.1	47.5	40.6	22.3	27.6	27.8	23.7	48.6	94.5	56.8	43.1	80.3	32.3	56.2	36.5	33.9	31.0	14.3	49.4	52.1	20.2	59.9	29.2	23.2	22.7	32.3	48.8	47.2	52.4	45.6	66.2	38.2	33.6	36.9	35.4	55.3	28.3	34.2	50.5	52.8	55.4	27.3	21.6	32.7	163.6	86.5	69.3	31.9	44.0	42.3	163.6	54.6	125.0	52.2	56.5	49.0	64.8	54.3	54.2	46.2	73.4	48.2	51.1	185.9	68.4	76.5	45.6	66.7	56.6	10.5	13.1	13.2	17.8	10.3	14.6	13.5	15.9	14.0	12.6	12.5	15.6	52.0	115.4	57.4	21.5	62.4	68.8	47.2	66.5	44.9	37.0	54.4	46.0	39.5	47.1	72.4	33.1	22.9	70.0	92.2	142.0	45.0	48.0	113.3	92.2	74.0	44.6	45.5	27.8	27.3	42.1	56.7	51.0	47.4	145.5	59.3	37.7	36.8	55.8	46.4	43.7	29.6	76.8	67.1	58.8	33.0	15.5	49.0	58.0	32.0	18.7	53.4	39.2	76.2	18.6	49.5	91.3	120.7	36.5	42.1	43.1	61.8	57.9	85.1	31.5	59.2	45.6	54.7	30.1	29.4	87.5	83.4	140.4	67.4	56.5	72.6	79.5
VRK1		ENSG00000100749	"VRK serine/threonine kinase 1"	Q99986	14	96797304-96954846	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.4;testis: 37.1"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 198.9;Spermatogonia: 110.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	5.9	5.2	5.9	12.8	7.1	50.4	11.5	6.0	7.9	5.2	4.3	10.8	6.5	6.5	6.9	8.9	9.2	4.4	5.2	5.9	5.1	4.9	5.5	4.9	27.1	5.3	5.5	6.0	3.2	5.4	3.1	7.6	5.4	5.0	12.3	4.4	4.3	5.0	4.7	7.4	7.2	6.7	4.8	11.3	6.5	37.1	5.9	35.5	5.9	4.6	27.9	7.7	5.4	7.0	52.4	27.0	78.5	30.2	9.2	14.9	44.8	42.8	34.4	67.1	65.4	36.0	54.7	139.2	22.4	24.3	39.2	56.5	75.5	54.4	90.5	73.4	36.4	90.5	18.7	39.3	10.2	168.5	49.2	8.5	9.7	50.4	32.6	12.8	47.0	104.8	76.6	79.0	56.9	65.5	137.1	76.5	47.8	39.9	59.3	124.5	134.2	48.6	32.3	59.3	53.2	28.0	34.2	36.4	30.8	36.0	39.3	66.6	24.4	27.9	22.8	47.7	37.3	37.7	53.5	124.8	44.7	74.6	34.8	42.7	12.3	26.2	21.5	15.5	29.0	31.3	24.9	26.4	15.7	32.7	27.1	27.3	6.5	45.6	15.2	21.4	34.9	19.4	5.9	7.1	6.0	7.9	5.9	5.1	5.3	5.5	5.4	4.8	5.9	7.0	15.3	3.2	4.6	6.8	30.6	16.8	13.8	23.3	6.2	12.4	9.3	11.3	11.8	12.8	16.7	14.7	8.4	34.8	24.8	6.3	11.7	13.5	21.3	21.1	8.3	12.4	3.0	76.2	42.0	19.4	48.3	11.4	14.8	10.8	28.5	20.0	7.1	3.3	19.2	10.1	36.2	10.4	20.3	11.8	14.9	11.5	5.6	12.0	12.4	19.7	14.2	6.2	27.8	12.1	19.8	10.3	2.2	9.8	25.4	6.1	3.0	11.2	37.6	9.6	19.7	14.3	15.1	198.9	110.9	14.1	13.9	15.1	26.8	9.2	18.1	10.4
VRK3		ENSG00000105053	"VRK serine/threonine kinase 3"	Q8IV63	19	49976468-50025946	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 135.6"	"Group enriched"	"Detected in all"	7	"Early spermatids: 557.6;Late spermatids: 1646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA056489: AB_2683150"	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.66e-4)"	17.4	23.3	25.9	17.6	26.6	23.6	17.7	26.1	28.6	17.9	30.2	21.9	25.8	15.9	19.5	17.6	33.2	20.9	17.5	25.4	27.9	36.5	35.6	16.9	28.5	27.6	31.1	21.2	22.1	15.9	20.6	16.9	30.4	20.2	22.0	64.8	21.9	15.4	26.9	16.8	32.9	14.1	25.2	26.0	21.6	135.6	27.9	35.6	19.7	17.4	25.7	18.0	16.8	29.3	31.0	31.3	22.6	24.5	29.2	26.9	23.3	21.7	25.7	31.6	34.5	16.8	33.7	37.1	15.2	21.2	22.1	22.5	21.3	18.6	25.5	32.6	43.5	28.9	20.4	29.4	21.9	36.7	48.7	24.2	27.3	18.3	19.2	28.4	26.5	39.9	35.8	53.7	23.2	13.0	49.7	24.5	12.2	54.6	26.7	39.3	23.9	47.6	27.2	32.2	25.3	12.3	21.5	26.0	24.7	20.0	23.9	38.5	20.2	32.2	18.6	13.1	17.1	34.3	47.4	19.6	25.8	22.3	22.5	110.0	42.8	81.1	53.7	46.1	43.3	58.9	48.7	51.9	47.9	53.3	49.2	45.3	112.5	82.7	55.1	45.4	76.1	48.4	25.9	26.6	26.1	28.6	25.4	27.9	27.6	31.1	30.4	25.2	27.9	29.3	19.6	6.4	28.6	10.1	26.6	6.6	16.0	27.2	6.8	34.3	17.9	14.5	8.4	24.3	29.8	14.7	143.9	43.8	27.9	49.9	31.3	31.0	557.6	50.7	12.0	16.0	22.2	38.7	13.9	32.7	38.6	15.5	18.8	26.8	18.3	24.1	28.5	44.5	34.8	32.0	15.9	35.4	34.6	25.4	9.3	1646.8	22.1	22.9	14.2	6.5	40.6	33.2	41.2	10.1	15.3	34.2	67.9	25.9	18.6	20.6	87.5	91.4	71.8	116.0	13.1	12.0	15.2	142.8	52.6	10.5	10.9	57.3	28.0	24.9	36.0	30.1
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4"	"Cancer enriched"	"Detected in all"	5	"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	31	"dendritic cells: 17.8;monocytes: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		59000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	137.1	68.8	17.9	44.2	18.8	7.8	44.2	17.0	36.6	14.1	21.5	40.9	22.5	15.5	5.3	15.4	66.8	39.6	30.0	18.2	18.3	17.9	51.0	166.0	27.8	25.1	23.6	12.9	14.3	6.8	7.0	139.6	25.8	10.6	31.7	2.2	24.5	9.3	8.2	10.8	43.9	108.3	18.9	69.3	22.9	7.3	37.6	5.4	12.3	12.5	1.8	61.5	11.6	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	18.7	0.1	0.0	11.1	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.5	0.0	0.4	0.1	0.0	5.6	17.9	18.8	17.0	36.6	18.2	18.3	25.1	23.6	25.8	18.9	37.6	26.7	1.3	3.2	16.1	0.0	1.2	2.3	0.3	0.0	0.0	0.0	2.6	0.5	1.8	7.2	3.1	0.0	0.0	5.3	0.3	0.0	0.0	0.1	7.9	0.0	0.0	10.4	0.0	0.0	0.0	0.0	4.9	2.7	0.0	0.0	3.8	0.0	5.0	3.2	989.8	0.0	0.0	0.0	0.0	590.9	111.8	16.6	1.5	328.4	3.6	12.2	1.5	0.5	0.0	0.5	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	4.4	0.0	6.6	0.6	2.0	0.3	0.9	0.5	1.7	12.3	1.5	0.0	0.0	0.2
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.2;brain: 31.3;prostate: 9.7;retina: 14.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.0;Enteroendocrine cells: 7.3;Excitatory neurons: 12.5;Fibroblasts: 10.9;Inhibitory neurons: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6;glioma: 3.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 4.2;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		31000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.0	10.2	4.4	0.0	9.9	0.0	0.3	0.0	31.3	0.0	0.0	4.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	10.5	6.6	0.0	0.0	0.0	0.0	2.2	1.5	0.0	0.6	0.0	0.3	0.0	0.0	9.7	4.0	14.3	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	4.7	0.4	13.7	0.0	0.2	0.2	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.0	31.3	10.5	6.6	2.2	1.5	0.0	0.7	13.7	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	7.3	0.0	12.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	2.5	0.5	0.0	1.1	0.0	0.0	0.2	0.0	0.1	0.7	4.1	0.0	0.2	2.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6039.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 5507.4"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"CACO-2: 1748.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	6.2	98.9	2.4	2.5	2.7	0.3	0.9	5.4	3.7	1.0	0.4	0.9	4.6	1.4	0.9	0.5	2.2	61.2	53.1	2.5	2.8	3.6	6039.5	1.8	4.3	2.1	5.3	1.9	17.7	0.1	3.0	40.6	2.3	1.2	0.3	47.4	0.6	4.3	0.4	0.8	1.3	2.7	1.5	2.9	5.1	10.0	2.2	0.1	0.8	0.5	0.4	4.2	0.7	2.4	0.0	28.4	0.7	0.4	0.2	0.3	7.3	1.8	0.8	0.9	0.9	1748.9	0.1	1.2	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.2	0.2	1.2	1.1	86.7	2.5	6.1	0.5	0.4	0.0	0.6	0.0	3.9	0.1	0.0	1.6	0.3	0.2	0.7	0.2	0.0	0.8	0.4	0.1	0.4	3.5	0.1	0.3	0.0	1.0	1.4	115.6	8.0	0.2	4.3	0.3	0.0	1.0	0.4	0.3	0.1	0.2	1.0	0.5	1.4	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.4	2.7	5.4	3.7	2.5	2.8	2.1	5.3	2.3	1.5	2.2	2.4	0.1	0.0	1.1	2.0	21.5	0.0	0.0	0.0	0.0	13.0	0.1	0.1	18.1	1162.4	0.0	0.0	77.2	3.7	0.0	0.0	3.9	16.8	0.0	0.0	1.2	7.3	0.0	131.0	0.9	19.7	2.8	48.1	0.0	0.0	0.0	1.8	120.3	5507.4	4.7	38.7	1.0	0.1	0.0	160.3	0.3	0.2	0.0	0.3	0.0	0.0	20.1	6.9	0.0	1.0	0.5	23.5	1.2	1.5	0.0	0.0	0.1	9.5	0.0	38.3	0.0	0.4	1.5	4.2	0.6	0.0	0.0	9.6	9.0	0.7	0.0	0.0
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948877-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Adipocytes: 904.3;Endothelial cells: 737.5;Hepatic stellate cells: 424.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 76.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"HUVEC TERT2: 560.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	NA	NA	28300000000	5600000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	151.9	5.9	40.0	20.2	38.8	0.8	117.3	32.9	31.4	46.0	29.2	32.7	12.8	51.1	10.6	21.9	45.7	30.2	137.8	27.4	32.3	9.7	2.1	106.2	22.8	37.6	37.4	22.0	15.0	27.3	6.3	72.7	41.7	27.4	9.2	2.9	18.1	19.2	57.0	23.5	34.5	44.2	32.2	44.1	25.7	10.8	52.4	7.0	50.8	51.6	9.5	39.7	35.5	37.1	0.0	0.0	0.0	0.0	0.7	0.6	0.5	0.0	0.6	0.2	0.4	0.0	0.3	0.0	1.2	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	560.9	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.3	0.5	0.4	0.0	0.1	10.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	40.0	38.8	32.9	31.4	27.4	32.3	37.6	37.4	41.7	32.2	52.4	37.1	904.3	12.8	25.7	3.6	1.0	6.6	0.6	1.3	4.6	0.0	4.5	4.7	112.2	1.5	1.7	11.0	0.0	1.1	2.6	0.0	0.0	0.5	6.8	2.0	1.6	737.5	0.0	2.7	2.9	0.0	0.9	21.1	0.0	2.1	5.7	0.1	424.4	3.3	0.5	0.0	2.2	0.0	4.1	5.3	3.4	15.5	5.9	2.6	5.4	75.9	0.3	0.7	0.0	1.5	4.2	0.0	0.0	0.7	0.0	1.3	0.0	0.1	1.0	1.7	0.0	12.4	34.7	2.9	5.7	4.7	4.3	1.0	2.0	10.6	0.0	1.7
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322"	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	18.1	18.6	10.5	18.5	16.9	21.3	19.6	14.9	13.2	17.2	16.5	18.5	18.1	16.2	15.7	16.6	13.3	17.8	16.1	11.1	12.5	22.9	18.5	17.1	19.6	14.7	13.7	15.6	13.0	24.8	9.5	21.2	14.6	17.4	20.1	11.4	14.3	16.1	15.9	13.6	14.7	20.2	14.0	19.3	16.1	9.5	13.8	21.8	23.3	18.5	21.0	21.1	10.3	24.7	40.0	45.4	24.9	30.6	55.3	58.8	16.3	42.0	63.6	43.0	45.8	17.0	42.1	36.1	29.1	54.1	25.3	30.6	40.2	37.7	56.8	47.5	23.1	48.1	26.5	22.8	53.8	14.8	46.6	58.7	25.1	35.5	31.2	33.2	49.9	30.9	28.3	35.6	53.0	87.6	44.3	11.8	23.7	66.7	46.7	29.8	22.4	36.7	33.2	48.5	13.1	26.3	48.8	109.2	39.5	25.8	47.3	25.5	44.7	23.6	51.9	39.4	37.7	31.7	31.2	31.7	62.4	27.5	33.4	10.4	17.0	12.5	13.5	20.9	14.3	9.5	12.8	13.9	19.7	10.6	10.1	14.3	5.8	17.2	29.3	7.2	16.9	13.0	10.5	16.9	14.9	13.2	11.1	12.5	14.7	13.7	14.6	14.0	13.8	24.7	10.9	3.2	19.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	14.4	9.3	0.0	0.0	5.0	11.0	0.0	13.4	6.9	0.0	5.9	12.2	0.0	9.9	13.5	4.9	0.0	0.0	0.0	17.2	11.0	5.4	0.0	14.8	8.8	11.1	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.9	0.0	0.0	17.2	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	12.3	3.8	9.6	0.0	0.0
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"WASP like actin nucleation promoting factor"	O00401	7	123681943-123749003	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 282.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 138.3;U-2197: 128.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	20.4	24.7	19.2	12.8	22.2	5.6	21.7	13.5	42.4	29.1	13.6	42.4	37.2	27.1	18.3	29.5	18.7	28.4	18.2	43.0	20.4	44.1	46.8	19.9	7.8	18.0	19.1	35.1	29.5	40.0	13.0	34.6	17.4	25.3	37.9	24.9	22.3	24.0	24.7	18.0	41.5	23.6	13.5	17.0	30.1	22.5	20.9	10.3	35.2	28.7	11.0	38.7	22.5	18.4	34.4	24.8	26.7	23.0	41.2	42.4	34.7	23.3	38.7	16.9	21.7	20.5	42.2	3.5	18.1	35.3	36.0	25.1	50.1	25.7	25.9	6.0	19.9	3.0	19.6	22.2	44.7	4.6	2.9	34.2	47.0	25.0	42.2	37.9	29.5	3.6	15.5	6.6	40.6	20.7	6.0	6.1	50.1	36.5	22.4	3.6	21.6	7.7	35.6	138.3	32.9	48.1	32.1	95.0	63.0	41.4	18.6	4.5	33.8	44.9	12.6	128.1	23.2	7.2	2.7	7.5	38.8	3.8	36.7	2.4	1.7	0.8	1.7	1.7	1.4	2.0	1.1	1.0	1.5	1.3	1.4	1.5	0.7	2.5	3.0	1.9	0.6	0.6	19.2	22.2	13.5	42.4	43.0	20.4	18.0	19.1	17.4	13.5	20.9	18.4	71.2	86.6	61.1	36.9	11.5	60.4	48.9	44.4	46.1	32.9	67.6	57.1	69.8	52.9	53.7	53.3	20.9	41.6	12.6	200.2	52.8	52.6	26.2	58.0	53.1	43.9	67.9	5.9	55.9	54.1	52.4	62.6	50.0	68.8	3.8	35.0	56.4	61.9	12.7	26.9	51.2	105.1	40.7	13.8	25.1	9.3	48.1	15.6	30.2	34.7	14.0	60.9	6.2	42.7	48.7	70.6	113.4	64.7	14.0	104.4	108.0	96.0	49.5	32.4	19.7	54.1	75.3	17.2	21.3	54.9	68.3	81.3	13.1	76.0	74.8	282.3
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851305-120909524	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	15.2	12.3	5.9	16.9	5.7	6.6	15.3	6.7	5.1	15.4	10.8	15.2	14.2	15.3	10.8	14.8	17.7	15.0	7.8	6.0	7.1	24.4	20.2	15.2	18.6	10.1	6.5	16.0	13.6	38.6	5.3	16.8	10.9	15.6	16.6	15.1	14.4	14.2	3.5	9.7	14.9	16.9	10.3	18.5	16.1	11.5	6.6	17.9	22.5	6.5	20.2	15.7	8.6	14.7	28.5	25.1	24.8	43.4	35.4	42.2	18.0	26.0	52.4	28.3	34.9	14.7	29.1	19.9	13.1	37.5	22.5	26.5	29.1	35.8	35.4	26.5	24.2	20.8	19.9	15.3	33.6	29.6	23.6	36.7	28.5	26.2	42.2	51.7	53.1	14.0	16.9	23.3	30.1	12.1	18.7	12.9	12.8	24.8	16.1	7.7	43.3	17.4	33.7	21.8	12.2	21.8	22.6	24.9	68.8	43.3	18.4	18.7	40.0	18.6	11.6	2.8	25.1	12.9	8.6	24.3	26.4	24.8	9.9	27.4	8.5	3.8	4.5	11.2	3.6	8.5	3.0	4.1	9.7	4.6	3.1	3.3	0.6	5.9	25.3	2.3	4.3	5.2	5.9	5.7	6.7	5.1	6.0	7.1	10.1	6.5	10.9	10.3	6.6	14.7	23.7	6.4	16.4	77.7	42.3	12.0	13.5	15.5	10.8	42.8	16.6	13.6	8.3	27.1	20.1	25.8	98.0	19.3	30.5	24.3	11.7	18.3	3.8	31.7	33.1	24.4	27.1	16.6	57.0	10.5	12.1	21.8	29.6	32.7	9.5	34.2	33.9	33.9	32.2	25.2	54.2	24.5	12.2	43.2	16.5	4.4	43.5	34.9	3.6	30.9	42.4	21.0	20.6	112.1	84.7	25.3	23.4	38.7	25.6	17.9	34.8	19.9	30.1	85.3	19.7	28.9	17.9	25.8	16.3	15.6	14.2	15.2	18.9	41.7	20.6	19.3
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874261-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	2.6	3.6	2.1	2.7	2.3	3.6	3.6	2.3	3.2	2.5	1.4	3.0	4.1	3.2	3.2	3.2	3.1	2.3	4.0	2.2	2.9	5.2	4.2	1.7	3.3	2.5	2.1	3.2	2.2	3.5	1.9	2.7	2.7	2.2	4.0	2.6	1.9	2.3	4.8	3.6	2.9	3.4	1.5	2.1	2.3	3.5	2.8	3.2	3.2	6.0	3.7	4.1	2.3	2.5	5.3	5.8	6.4	12.5	12.3	10.4	11.4	7.6	6.6	10.1	9.8	14.8	7.5	10.2	7.2	6.6	8.5	6.6	18.2	13.3	16.0	4.6	11.1	17.0	9.0	17.7	8.0	22.1	9.9	9.5	9.4	12.0	23.6	6.4	10.8	10.2	26.7	5.9	11.3	6.5	14.8	13.3	14.9	7.3	14.3	11.1	9.7	16.1	11.2	6.5	11.4	9.8	6.5	8.2	9.8	11.0	4.7	14.1	8.3	8.3	6.9	7.4	8.4	8.0	12.8	16.3	8.7	15.3	8.8	1.3	1.6	0.6	1.4	1.7	2.0	1.9	1.3	1.4	2.1	1.9	1.7	1.7	0.6	1.3	1.7	2.4	1.6	1.1	2.1	2.3	2.3	3.2	2.2	2.9	2.5	2.1	2.7	1.5	2.8	2.5	10.1	9.6	16.9	12.1	13.6	20.5	21.4	24.4	13.1	10.2	8.4	9.1	27.9	7.2	19.1	5.5	2.1	25.3	7.9	7.8	15.6	18.0	14.3	14.7	25.3	12.6	5.4	22.1	19.2	10.6	34.9	16.5	9.7	13.3	15.2	15.8	8.2	15.0	18.0	15.2	20.3	10.6	24.4	7.2	6.0	8.9	17.1	9.2	1.8	12.2	13.7	6.4	5.2	10.6	9.9	14.2	6.6	15.4	9.3	17.3	13.9	38.1	15.7	8.3	13.1	20.1	41.9	43.0	32.3	18.2	17.3	21.5	10.7	21.0	19.2	17.0
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984332-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 162.0;Proximal tubular cells: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	14.8	21.7	12.3	12.0	12.6	11.3	15.3	12.7	18.3	14.0	11.5	16.4	11.6	14.8	3.3	26.0	13.9	4.9	20.6	12.6	11.6	25.1	31.7	12.7	8.8	13.6	12.1	13.7	18.3	8.3	18.9	10.2	13.1	16.4	4.2	7.1	16.0	9.3	23.7	21.5	14.6	4.1	11.8	18.2	15.8	17.7	13.0	8.4	15.6	8.8	6.7	15.2	15.6	13.4	58.3	55.2	16.7	28.2	15.7	14.4	68.0	25.6	14.3	30.5	22.6	62.8	19.6	68.9	29.8	37.2	3.6	46.6	45.4	53.3	11.8	36.1	75.3	33.3	34.1	79.8	36.7	71.7	30.1	18.5	28.1	18.2	42.5	15.5	28.3	32.7	74.9	25.7	11.4	62.3	53.2	102.9	96.1	39.7	35.8	99.1	39.8	107.0	19.4	35.8	63.7	60.4	24.3	20.0	26.5	11.5	47.5	42.6	28.8	34.3	41.7	67.8	40.7	83.0	74.9	33.7	29.6	44.3	37.0	11.5	77.5	18.9	53.4	84.8	52.8	56.6	53.7	58.0	117.8	69.7	53.2	48.4	3.6	57.1	70.8	74.6	65.2	66.7	12.3	12.6	12.7	18.3	12.6	11.6	13.6	12.1	13.1	11.8	13.0	13.4	20.8	9.6	13.0	10.4	19.5	19.4	28.4	57.9	25.0	28.6	23.1	22.6	13.6	15.7	31.1	31.3	22.9	90.3	14.5	22.4	70.5	73.2	35.6	18.0	17.4	24.6	32.3	20.8	9.8	54.4	162.0	22.3	23.0	18.9	16.5	47.7	23.6	43.0	46.0	26.9	7.9	33.0	44.7	19.2	17.2	38.2	15.5	19.2	16.0	5.6	47.7	32.2	23.7	1.5	6.0	47.8	23.9	16.1	30.0	27.9	28.8	207.8	27.2	24.8	13.1	16.2	31.7	36.5	30.6	29.8	20.3	60.1	18.7	43.7	48.3	24.2
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	9.1	6.3	2.2	8.4	2.8	2.9	9.3	2.8	2.6	7.3	7.4	5.9	5.4	6.7	4.2	6.6	7.4	3.1	4.4	2.6	3.1	5.9	11.2	4.5	7.1	2.2	2.7	7.6	5.1	9.2	3.0	6.2	2.2	5.8	7.7	4.3	4.4	4.9	10.3	5.0	4.9	8.0	2.3	6.2	6.6	11.7	2.7	8.5	6.0	7.4	11.8	9.4	4.3	2.7	35.6	22.2	21.7	33.5	23.0	18.8	24.9	24.1	15.9	27.8	24.3	23.8	11.6	42.4	32.4	18.2	17.7	23.1	55.0	28.4	44.4	34.3	28.1	39.7	22.7	19.0	19.1	74.8	20.0	18.5	19.8	35.4	53.3	16.3	27.2	29.1	49.7	20.2	24.2	20.4	35.9	15.5	78.7	30.7	34.7	33.9	75.5	32.5	13.8	23.4	33.4	30.1	27.8	33.6	39.6	29.6	13.5	29.9	24.0	20.9	33.1	38.4	54.9	29.3	36.8	64.5	30.5	47.2	55.0	0.1	6.8	0.6	9.3	7.1	12.0	9.3	8.4	11.0	13.5	8.6	12.9	11.9	0.6	9.6	8.1	7.4	12.4	7.4	2.2	2.8	2.8	2.6	2.6	3.1	2.2	2.7	2.2	2.3	2.7	2.7	11.4	9.6	14.3	5.9	13.1	20.9	21.9	13.1	15.4	11.3	11.2	9.7	14.9	8.6	23.4	7.3	6.2	10.7	8.6	4.6	9.8	12.8	33.2	11.7	20.4	13.2	3.6	10.7	12.4	13.8	9.9	14.9	8.2	7.5	16.4	11.9	8.9	27.4	7.9	15.2	12.5	6.4	14.2	7.3	5.7	43.6	12.5	7.1	10.6	5.6	8.2	7.4	10.3	13.0	7.5	12.3	4.1	11.7	10.9	31.4	3.0	7.4	17.6	7.3	13.1	23.0	13.8	52.3	50.8	21.7	22.4	5.1	10.6	31.1	9.8	15.4
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: AB_2679772"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	8.4	7.3	6.6	8.2	8.9	6.0	6.3	7.9	7.6	8.0	2.5	6.8	8.3	7.8	6.7	11.3	5.8	11.8	8.3	7.1	6.9	6.0	12.8	7.9	9.4	6.0	6.5	7.6	6.7	10.1	5.2	7.2	6.1	7.5	6.2	8.4	5.6	10.5	9.7	5.1	7.7	10.4	5.7	8.1	8.6	9.8	7.2	10.6	6.9	8.9	9.2	10.0	6.9	10.1	16.4	9.4	10.0	5.8	16.7	13.6	5.5	25.2	17.6	17.9	25.2	6.4	18.4	4.6	14.4	18.1	15.1	12.6	19.7	12.0	20.6	18.6	8.8	18.5	23.3	4.2	11.5	11.7	12.4	8.1	12.6	17.0	11.4	18.2	16.1	8.5	14.8	15.8	17.3	8.0	9.2	6.9	18.1	12.3	15.1	7.2	8.6	7.2	14.6	10.3	4.3	6.7	23.9	8.3	7.9	17.7	7.4	8.3	20.5	13.3	5.1	18.2	14.4	5.9	10.0	6.5	11.2	13.7	9.1	8.0	3.2	7.3	5.4	4.9	5.5	3.6	4.4	5.4	5.1	3.2	5.1	5.6	2.0	7.2	5.5	3.7	7.1	4.0	6.6	8.9	7.9	7.6	7.1	6.9	6.0	6.5	6.1	5.7	7.2	10.1	14.3	22.4	15.0	18.3	11.0	14.8	7.2	6.3	9.1	8.9	7.6	6.3	11.4	10.0	6.2	12.9	10.4	2.3	9.9	9.6	1.9	5.2	0.4	10.9	10.8	12.0	1.2	5.0	35.2	5.3	2.2	11.1	14.3	17.8	8.8	9.8	5.7	16.7	8.6	1.7	41.2	5.2	4.1	13.6	17.7	1.3	7.2	17.2	7.2	40.3	10.3	7.5	11.3	35.2	89.6	11.0	5.8	11.3	12.1	10.2	6.2	4.2	9.1	7.0	26.3	9.3	11.1	17.5	17.6	12.3	9.2	1.2	14.7	5.7	4.6	7.4
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289247	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043004, HPA055425"	Uncertain		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA043004: AB_10967417, HPA055425: "	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	19.4	19.0	2.2	14.1	2.4	12.6	18.9	1.8	3.8	21.2	2.5	16.4	13.5	23.6	13.6	19.1	17.4	3.2	12.8	2.7	2.7	15.6	17.1	14.7	10.6	2.2	2.4	17.3	19.2	3.0	19.7	5.5	2.6	16.8	11.2	3.0	18.7	2.7	26.1	23.9	15.6	9.6	2.2	20.4	16.7	14.8	2.5	6.3	16.4	12.6	18.8	19.6	17.8	3.5	0.9	21.1	15.3	61.2	11.4	1.6	56.2	42.3	4.9	0.2	7.0	27.8	15.5	49.4	35.5	22.5	60.2	23.4	3.9	31.0	19.3	31.6	32.2	65.6	20.3	54.0	10.4	56.6	74.2	12.5	5.2	18.4	9.5	15.6	0.0	26.6	37.5	13.8	6.8	23.3	32.1	46.8	45.1	8.5	18.3	47.1	28.1	40.3	9.3	20.7	30.9	40.3	20.4	44.4	46.9	18.3	17.2	37.8	30.9	37.9	42.8	31.6	64.3	56.5	104.3	83.5	16.4	55.9	35.3	12.1	17.3	6.2	24.9	28.7	21.4	16.1	18.2	22.4	27.9	18.9	17.0	21.7	1.2	28.1	33.9	13.7	18.6	20.1	2.2	2.4	1.8	3.8	2.7	2.7	2.2	2.4	2.6	2.2	2.5	3.5	21.0	0.0	11.7	2.9	30.4	43.7	30.8	40.7	28.5	14.4	23.8	20.2	7.2	17.2	25.7	23.9	6.2	44.0	33.9	20.4	11.7	43.5	65.0	19.0	30.9	22.9	13.8	13.7	11.1	43.0	48.7	27.7	20.4	24.3	21.6	35.1	14.6	26.4	28.9	13.5	6.5	21.5	22.4	19.0	24.1	23.3	25.7	22.0	17.8	5.6	29.0	17.9	36.0	2.5	2.8	33.1	15.6	23.0	25.0	38.0	18.2	37.8	14.7	10.1	13.1	35.7	28.3	42.3	37.2	23.6	42.6	38.2	26.1	46.8	31.9	30.0
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57029811	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA042074: AB_2677833, HPA051057: AB_2732563"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	5.9	7.6	13.2	5.9	14.2	7.2	4.9	7.0	19.8	4.8	3.1	5.4	4.1	4.8	5.3	4.4	4.2	5.3	5.9	16.2	11.1	5.3	7.4	5.0	7.4	14.6	8.8	4.2	4.2	9.2	8.4	4.7	14.7	7.5	4.9	18.8	4.2	5.7	8.2	4.3	4.3	5.6	7.8	6.2	4.9	4.6	9.6	10.3	9.1	9.6	5.8	5.0	4.5	16.0	4.7	7.7	8.7	4.9	13.5	7.8	2.2	9.2	7.8	7.4	8.8	3.1	2.9	13.0	3.6	8.3	6.3	4.9	8.8	7.2	9.2	15.1	5.4	12.3	5.8	2.8	8.1	18.7	15.0	6.7	5.9	9.9	6.6	6.1	9.3	6.1	6.0	17.5	9.3	4.6	13.0	5.5	3.7	2.4	5.1	5.8	6.7	6.3	5.7	8.4	11.3	5.6	6.5	3.1	4.3	7.4	4.9	5.2	8.3	10.5	5.3	3.2	5.0	17.4	14.2	13.9	8.6	9.3	7.2	4.0	3.0	5.5	3.6	4.4	4.5	2.4	4.0	3.7	3.6	2.2	4.2	3.8	2.6	4.6	5.5	1.7	5.2	2.0	13.2	14.2	7.0	19.8	16.2	11.1	14.6	8.8	14.7	7.8	9.6	16.0	8.7	3.2	4.8	99.6	7.5	2.9	1.9	2.3	2.8	24.5	3.4	2.4	12.5	5.7	6.8	0.0	31.3	2.0	7.7	5.8	3.9	3.2	21.0	4.4	6.0	6.6	8.4	8.2	268.8	3.6	1.2	6.3	7.7	3.9	10.8	9.0	9.3	8.9	5.8	26.9	223.0	2.7	0.0	16.2	2.8	7.0	5.6	11.3	0.0	111.5	8.8	7.1	10.3	146.3	244.7	2.6	2.6	8.2	10.1	2.6	4.5	3.2	5.7	26.3	6.6	10.7	5.8	2.0	1.7	5.8	2.4	0.7	9.9	9.3	4.1	1.6
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235798-159286703	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: AB_2683628"	"unprognostic (1.37e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	6.7	10.9	9.1	4.6	10.2	10.6	12.0	10.7	12.0	7.8	11.7	6.7	4.9	8.2	17.5	7.5	9.8	5.9	10.1	8.9	9.3	23.5	6.9	9.0	7.9	9.7	9.3	13.5	10.6	13.9	9.1	9.7	9.8	9.1	7.6	11.1	10.4	6.8	6.7	6.9	5.8	6.6	8.9	8.6	7.4	6.7	9.4	7.0	17.3	6.5	5.8	6.2	6.3	11.7	8.4	6.3	5.4	9.0	10.1	11.4	19.1	6.7	13.0	11.4	20.4	13.7	13.6	11.7	6.9	9.9	20.3	5.2	15.9	5.9	16.1	4.5	13.4	12.1	6.8	14.0	12.2	10.2	15.6	6.7	21.5	14.4	12.0	22.2	9.8	14.9	16.0	8.5	11.1	8.8	7.3	18.5	7.5	14.3	13.6	11.3	8.3	6.2	13.6	12.2	10.3	6.8	7.0	8.6	15.9	26.0	6.7	17.3	4.1	8.2	6.2	11.8	6.5	4.2	7.7	10.7	14.4	12.6	5.3	3.9	11.1	3.5	14.3	8.6	10.9	11.8	5.6	9.1	12.2	9.9	6.7	8.0	0.8	20.8	7.9	11.6	3.3	7.8	9.1	10.2	10.7	12.0	8.9	9.3	9.7	9.3	9.8	8.9	9.4	11.7	8.2	12.8	6.8	28.4	10.7	5.4	8.7	13.0	11.4	6.9	9.3	8.0	11.3	10.0	11.3	20.2	2.1	25.4	11.2	5.1	35.2	9.5	4.5	13.7	6.9	7.0	5.4	6.7	42.4	3.6	9.2	9.9	10.2	16.1	12.0	13.2	6.4	2.0	17.3	5.0	52.0	4.5	12.2	14.8	4.8	2.9	12.8	10.2	5.4	29.0	9.2	6.6	14.4	31.7	34.6	4.0	7.0	11.3	3.8	6.8	6.9	23.7	15.0	9.7	0.0	12.0	7.8	10.1	22.5	11.1	6.3	23.0	9.1	12.7	7.1	7.3
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234632-27308636	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	16.5	24.4	25.4	10.5	22.3	14.7	17.5	20.2	25.4	18.9	12.7	24.7	12.9	19.7	7.0	18.0	19.9	10.5	35.9	21.8	20.0	19.9	18.7	16.9	14.4	25.3	21.0	19.0	22.1	47.7	16.9	10.6	24.4	19.3	9.5	33.5	20.1	15.1	63.0	24.8	18.0	12.0	19.4	17.7	23.2	37.6	23.5	19.8	18.4	54.4	12.7	19.8	18.5	21.1	19.8	8.6	13.5	1.3	18.9	15.8	5.6	12.0	20.1	12.7	15.5	2.9	19.3	17.0	14.0	24.0	9.3	10.1	13.0	18.4	11.0	23.2	22.0	17.7	8.9	7.9	17.0	9.0	22.4	15.1	29.6	15.8	14.4	22.9	17.4	5.4	18.2	17.2	13.6	11.1	14.6	21.6	6.3	13.0	18.1	7.3	10.1	18.7	15.2	4.2	19.7	16.9	15.7	6.6	14.4	10.1	9.8	15.5	15.2	10.3	6.2	14.5	5.9	24.7	14.2	8.1	20.8	17.3	12.5	0.1	0.2	2.7	1.4	0.3	0.5	0.6	0.3	0.6	0.7	0.4	0.2	0.6	2.1	0.4	0.2	0.5	0.4	0.5	25.4	22.3	20.2	25.4	21.8	20.0	25.3	21.0	24.4	19.4	23.5	21.1	10.8	9.6	10.7	19.6	13.8	12.9	10.3	8.4	16.5	31.4	18.5	14.5	15.6	14.3	7.6	31.3	54.2	14.2	14.3	17.3	9.8	15.1	29.8	15.3	8.2	10.1	16.7	32.8	22.4	14.1	4.8	10.6	16.3	13.2	1.3	15.4	18.5	16.6	13.0	21.9	21.2	16.9	6.1	21.0	11.3	66.2	17.1	15.8	10.6	19.7	18.9	15.8	28.8	16.6	22.2	16.0	10.1	16.6	12.3	17.2	26.6	19.1	18.4	70.0	6.6	17.1	10.3	30.9	6.6	13.0	17.3	16.4	13.3	14.1	15.0	16.8
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573670-9593457	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	12.7	5.6	1.5	14.1	1.3	23.0	46.1	2.4	2.3	21.5	2.8	18.4	10.6	62.6	24.5	46.3	18.6	49.0	43.0	1.2	2.3	16.8	57.8	11.6	24.8	2.8	4.0	10.9	10.1	17.8	8.4	34.6	3.6	21.2	14.4	4.5	17.4	12.7	10.4	57.1	13.5	35.0	2.2	8.1	17.2	31.5	2.0	23.7	26.6	7.2	30.2	53.0	15.4	1.9	43.1	16.4	69.1	38.8	65.2	29.8	125.9	48.8	44.8	29.3	29.8	33.8	53.3	100.7	18.0	27.6	30.8	48.8	49.0	23.3	41.1	33.3	30.7	43.1	30.1	26.2	7.0	66.6	39.7	12.0	25.3	13.8	53.8	34.9	21.6	43.6	64.0	75.8	55.7	13.2	63.5	39.4	97.6	36.9	18.5	57.6	54.5	24.6	28.1	100.0	25.0	31.8	39.9	48.6	29.2	89.3	27.1	32.9	21.7	51.1	35.2	23.0	42.2	14.4	51.1	140.1	23.3	36.5	41.0	0.0	0.0	6.0	1.7	0.0	0.2	8.0	1.7	3.0	0.1	4.7	0.1	1.3	0.1	1.9	0.0	0.1	7.1	0.6	1.5	1.3	2.4	2.3	1.2	2.3	2.8	4.0	3.6	2.2	2.0	1.9	17.2	51.3	33.9	0.0	36.8	176.4	170.4	38.5	213.9	1.8	168.5	67.2	61.1	65.8	53.5	42.3	0.0	94.8	11.2	54.7	13.7	24.9	25.0	160.1	86.2	18.7	61.1	40.4	0.1	13.6	200.1	39.2	52.5	262.4	7.0	28.5	9.7	85.0	17.0	1.7	0.4	65.6	18.3	2.5	21.9	41.7	11.8	10.0	17.8	1.0	2.4	9.9	8.2	2.0	0.1	24.8	38.5	10.9	17.2	82.7	35.9	8.3	62.6	7.1	6.6	180.7	23.7	61.4	44.4	181.4	191.1	137.2	19.0	11.8	55.5	85.5
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 83.1;skeletal muscle: 62.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	2.0	3.0	14.9	3.3	14.8	0.0	4.9	4.6	39.1	4.7	0.3	36.0	17.9	5.8	4.2	5.7	15.4	1.3	83.1	18.3	7.7	0.8	1.3	0.9	0.5	13.8	6.0	1.1	42.8	2.3	29.6	3.0	8.8	16.7	11.9	28.8	47.3	12.3	62.3	15.8	21.5	4.5	1.9	2.7	14.7	6.6	14.2	7.1	1.8	31.0	1.0	5.5	3.4	10.5	7.4	6.6	4.6	13.2	0.0	0.0	8.8	0.0	0.0	0.1	0.0	2.7	0.2	18.8	2.4	0.0	1.3	0.3	10.4	0.0	0.0	0.0	12.1	0.0	5.8	31.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.2	0.0	0.0	9.8	0.2	0.2	11.5	7.2	0.4	0.0	0.0	15.3	0.0	1.1	37.6	14.8	2.4	10.2	0.9	1.3	1.3	2.2	0.1	0.0	4.8	0.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	14.8	4.6	39.1	18.3	7.7	13.8	6.0	8.8	1.9	14.2	10.5	0.3	0.0	0.0	76.4	0.3	1.3	8.5	3.1	0.0	62.0	19.4	18.7	58.1	31.5	14.1	0.0	160.6	15.5	0.2	34.3	0.0	17.1	1.2	7.7	9.2	1.3	32.4	0.0	128.5	9.1	6.7	2.7	3.6	15.8	0.0	8.6	0.4	0.2	3.4	1.7	98.8	77.3	6.1	1.3	2.2	2.6	0.9	0.1	1.8	29.0	0.6	60.3	0.0	9.0	3.2	3.2	57.0	6.0	0.2	11.1	47.7	1.1	6.6	106.8	13.1	3.5	5.0	0.7	7.7	1.1	5.5	15.6	0.4	0.1	59.0	8.9
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.4;salivary gland: 34.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Basal squamous epithelial cells: 34.7;Club cells: 31.3;Endometrial stromal cells: 101.6;Oligodendrocyte precursor cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 227.2;BJ hTERT+: 315.4;HeLa: 242.1;SiHa: 354.2;U-87 MG: 248.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.3	0.8	1.9	3.1	1.9	0.1	4.9	1.7	1.8	5.7	0.6	3.1	3.5	27.4	3.1	16.9	6.7	7.2	1.6	2.5	3.2	2.7	2.6	4.9	2.2	3.9	4.3	9.1	4.3	1.0	1.8	10.8	3.0	4.6	3.2	1.2	34.4	8.3	2.0	2.4	3.8	5.9	3.8	4.0	3.5	1.8	3.1	2.4	2.8	1.7	5.1	18.7	12.1	5.4	0.0	0.4	20.8	0.2	15.8	37.7	0.0	227.2	315.4	46.3	80.4	1.3	0.0	6.6	0.6	132.2	19.5	0.2	10.0	0.2	48.2	0.0	6.2	6.4	242.1	0.1	35.1	0.0	0.4	25.0	5.9	139.2	7.6	22.5	0.1	0.2	0.0	109.5	113.3	0.0	0.1	0.1	11.1	0.5	13.6	0.0	14.1	1.0	6.2	7.6	0.0	1.0	354.2	43.1	0.0	18.0	0.1	0.0	0.0	76.1	13.2	70.0	18.2	25.8	0.0	2.4	248.5	0.3	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	1.7	1.8	2.5	3.2	3.9	4.3	3.0	3.8	3.1	5.4	1.1	51.3	23.2	4.2	0.0	1.5	1.6	1.4	34.7	13.2	12.1	4.4	4.3	0.0	31.3	12.9	0.0	3.0	0.0	0.2	0.0	0.2	15.8	13.3	101.6	4.3	0.0	0.0	3.0	0.2	0.6	19.9	0.0	13.9	2.5	8.5	1.1	2.6	1.3	0.0	9.0	0.3	10.2	2.4	1.3	4.2	19.6	2.6	0.0	5.6	4.2	1.6	0.0	31.2	0.1	0.4	2.5	30.1	0.1	0.9	2.3	1.0	1.9	1.4	0.0	1.6	7.7	0.1	1.1	17.5	1.6	1.5	1.5	6.5	1.6	9.6
WNT7A	Wnt-7a	ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880071	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;gallbladder: 2.3;placenta: 2.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2;ovarian cancer: 11.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.0	0.0	3.6	0.1	3.1	0.1	0.0	1.0	3.7	0.2	0.3	0.0	0.0	1.1	0.2	0.4	0.1	2.3	0.0	2.4	2.1	0.2	0.0	2.0	0.2	5.1	1.9	0.0	0.1	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	3.4	1.3	0.0	1.3	2.5	0.0	0.0	0.0	0.1	0.3	0.1	2.8	8.6	0.0	0.8	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	7.6	0.0	56.0	0.0	0.1	11.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	1.7	100.3	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.6	3.1	1.0	3.7	2.4	2.1	5.1	1.9	2.5	3.4	2.5	2.8	0.0	12.8	0.0	8.5	0.0	5.9	2.8	2.6	0.0	0.0	0.0	0.0	0.7	8.6	1.4	0.0	0.0	68.7	0.0	0.0	0.0	13.8	17.3	14.5	0.4	0.6	0.0	0.0	4.0	9.1	147.5	0.4	0.0	17.9	0.0	0.0	0.0	0.0	7.4	0.0	2.4	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	1.0	0.0	0.0	0.0	4.5	0.3	98.8	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	6.0	2.3	0.0	1.3	185.7	1.5	0.0	0.0	6.0
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947932	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.7;skeletal muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 5.1;Ionocytes: 6.1;Respiratory ciliated cells: 12.5;Urothelial cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.2;PC-3: 10.8;RH-30: 16.4;SCLC-21H: 14.9;SiHa: 14.7;U-2197: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	3.3	1.4	0.4	1.1	0.6	0.1	3.0	0.6	0.8	4.1	7.7	18.7	1.3	5.3	0.4	5.8	5.5	2.1	10.1	0.7	0.9	0.9	0.2	3.9	0.3	1.2	0.9	9.8	2.8	1.2	2.8	2.1	2.1	2.5	1.1	0.0	2.4	1.0	26.3	1.1	6.0	4.3	0.5	1.0	5.9	1.5	0.7	1.1	2.0	2.8	0.3	4.9	3.4	0.5	1.0	3.3	0.4	0.1	0.4	0.7	8.1	1.1	0.9	0.1	0.0	0.0	8.8	0.0	4.7	1.5	3.3	16.2	0.4	0.8	0.0	1.6	0.6	0.0	6.0	0.2	0.4	0.0	0.5	0.1	4.0	0.1	0.1	0.3	1.0	0.0	0.0	0.1	1.8	2.2	0.0	0.0	1.0	0.0	10.8	0.2	16.4	1.7	4.6	1.1	14.9	0.0	14.7	6.6	0.0	5.2	8.4	1.8	0.6	2.1	1.3	10.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	0.8	0.7	0.9	1.2	0.9	2.1	0.5	0.7	0.5	0.3	3.2	0.6	0.3	0.0	0.9	1.3	3.6	0.0	0.0	3.1	1.3	1.4	0.0	4.3	1.8	0.0	0.3	0.2	0.8	0.0	0.7	0.1	2.1	2.1	0.4	3.0	0.0	0.7	1.3	0.2	5.1	1.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.9	6.1	0.0	0.4	0.1	4.4	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.9	1.1	0.0	4.5	0.1	1.8	0.1	0.1	12.5	0.0	0.0	1.3	1.1	0.0	1.8	3.9	0.3	0.0	0.2	0.1	0.1	5.3
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
WRNIP1	"bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP"	ENSG00000124535	"WRN helicase interacting protein 1"	Q96S55	6	2765393-2786952	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	23.7	31.1	45.6	22.6	47.0	49.0	28.8	47.8	46.8	29.2	46.2	29.7	23.6	26.7	37.1	48.3	35.6	24.6	39.5	47.8	46.7	35.7	33.0	30.3	34.7	44.4	44.8	30.1	43.9	46.4	43.1	43.3	43.5	28.5	29.1	45.8	46.1	26.8	44.0	37.2	27.4	23.8	43.6	28.7	29.1	31.5	47.4	43.9	39.0	76.3	34.7	32.1	31.7	45.1	86.8	42.7	42.5	70.1	44.1	37.7	56.5	38.9	54.2	69.8	69.2	67.8	39.4	77.4	103.1	50.4	75.6	65.9	70.2	78.1	67.8	77.9	77.5	80.9	50.3	107.4	50.1	51.4	53.8	38.7	62.7	64.4	69.5	48.5	89.8	71.8	62.8	27.2	51.6	84.5	76.7	92.7	36.5	59.3	52.5	60.3	62.2	78.4	75.3	52.5	127.8	36.5	45.9	46.1	93.7	66.7	59.4	57.1	49.4	52.1	39.4	45.8	95.8	34.8	65.3	59.8	20.4	55.0	72.1	9.4	1.6	2.3	4.0	1.8	1.2	2.3	2.7	2.8	1.3	1.3	3.1	3.0	0.7	2.6	0.9	2.6	4.2	1.4	45.6	47.0	47.8	46.8	47.8	46.7	44.4	44.8	43.5	43.6	47.4	45.1	16.4	19.2	14.6	14.0	12.4	32.5	13.4	20.1	23.9	24.8	22.3	19.4	23.7	24.3	12.3	11.0	8.4	30.4	11.8	29.6	3.9	14.5	45.0	21.9	19.7	20.9	39.7	26.1	23.5	13.5	25.6	15.1	11.7	17.5	9.5	12.7	28.2	25.0	12.4	8.4	20.8	21.2	24.4	16.2	17.9	13.4	22.4	12.4	21.4	23.4	15.0	20.0	10.3	26.2	23.0	18.0	16.3	22.2	10.2	18.5	14.8	13.7	24.1	17.4	6.6	19.9	17.8	22.1	23.9	32.4	32.1	25.4	12.5	20.5	25.0	16.3
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	41.9	22.1	14.1	45.9	35.7	48.7	35.7	22.9	26.9	47.0	5.2	40.7	28.6	49.4	24.6	27.7	45.9	39.6	32.5	14.1	35.9	29.0	15.6	58.3	34.5	38.7	22.7	47.7	29.6	19.0	23.8	75.0	40.6	27.6	30.9	76.0	27.4	32.1	23.0	23.2	33.7	44.8	17.0	69.9	32.7	21.6	33.2	24.8	28.8	16.1	35.2	32.8	39.1	80.0	30.8	21.3	65.3	37.5	40.3	49.7	69.7	26.6	37.9	20.6	39.6	32.0	12.2	30.6	29.6	36.6	26.2	28.4	40.0	19.6	30.9	85.3	33.1	48.7	41.9	32.7	75.7	34.1	69.2	60.2	26.3	30.1	18.4	31.5	83.1	31.7	49.8	28.6	36.9	19.4	44.4	38.4	19.4	17.1	17.3	35.5	35.9	18.5	31.1	24.6	20.9	28.8	27.8	27.3	36.7	77.8	22.1	44.5	46.5	25.3	19.2	34.8	26.4	12.8	34.9	31.2	23.9	26.8	23.4	75.0	41.1	71.5	21.6	70.3	26.1	22.1	18.1	24.2	65.5	25.3	17.0	19.7	37.1	21.4	82.5	21.5	30.2	26.4	14.1	35.7	22.9	26.9	14.1	35.9	38.7	22.7	40.6	17.0	33.2	80.0	300.4	221.2	476.1	189.7	245.4	249.2	185.6	138.4	253.8	91.9	186.7	147.7	67.5	144.4	194.2	239.1	348.2	360.7	183.2	222.7	27.4	124.9	153.0	201.2	187.6	254.9	194.4	148.1	229.5	65.1	217.2	284.6	190.6	301.5	163.5	436.3	316.6	43.3	228.2	82.4	267.8	191.5	162.8	412.6	288.9	26.6	141.4	358.9	197.5	206.1	153.2	170.5	112.3	349.3	658.2	76.7	185.4	122.6	144.9	196.3	178.7	30.7	137.5	381.4	124.9	243.8	221.9	119.6	104.8	202.2	280.3	714.5	183.9	98.5	133.6	148.9
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629545	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	29.4	23.6	17.7	15.1	19.9	44.5	30.6	19.6	24.8	37.0	16.9	28.3	17.5	33.8	6.9	25.4	32.0	11.8	24.3	17.8	17.9	27.7	27.8	27.2	20.7	19.9	18.0	45.8	35.9	13.4	27.1	15.4	20.2	32.7	5.4	9.0	31.1	17.5	35.6	39.0	27.6	9.3	18.6	34.5	30.9	37.7	18.3	21.1	34.7	13.3	10.6	29.1	29.6	25.5	39.8	35.7	21.2	27.9	21.9	16.3	41.2	22.8	26.5	39.6	40.0	46.4	25.4	26.7	44.1	21.3	28.9	34.2	30.2	33.2	10.0	47.1	39.0	35.5	30.2	41.3	28.3	47.5	30.8	28.8	27.0	28.0	20.2	21.3	24.2	56.4	32.4	69.0	12.4	44.0	44.9	73.8	48.3	24.8	69.6	49.3	26.8	47.0	15.8	30.7	30.2	34.4	25.9	25.1	23.2	13.8	32.0	41.6	24.1	18.1	29.5	41.3	39.0	117.7	75.0	39.0	31.0	40.1	27.4	8.8	10.0	9.3	11.8	10.2	11.3	10.1	11.0	9.1	8.0	12.2	13.1	10.0	6.4	8.3	13.9	6.9	14.2	12.1	17.7	19.9	19.6	24.8	17.8	17.9	19.9	18.0	20.2	18.6	18.3	25.5	18.3	0.0	1.8	3.9	22.9	19.6	16.2	28.1	14.2	14.1	89.4	54.4	1.4	25.8	20.1	47.8	12.5	46.0	24.8	28.3	35.2	19.8	39.9	24.7	13.3	16.4	18.6	14.1	2.3	34.4	26.4	16.7	33.6	32.3	19.7	27.7	17.5	46.4	19.8	3.3	2.5	21.2	24.4	19.2	11.0	19.1	28.3	18.3	26.6	3.7	26.5	13.9	23.7	1.0	3.7	15.1	12.4	21.8	19.4	12.2	28.9	159.5	13.4	14.2	39.5	15.9	21.6	36.1	57.3	14.6	17.8	65.9	20.6	17.8	23.9	14.3
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 42.2;intestine: 49.5;liver: 68.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		77000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.0	0.0	4.8	0.0	0.1	42.2	0.3	0.0	0.3	0.4	11.1	44.9	0.9	2.3	9.8	0.1	4.5	0.0	0.0	0.0	0.2	68.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.1	1.3	9.5	0.1	3.6	0.1	0.5	1.1	49.5	0.7	0.0	0.0	3.2	0.1	0.0	0.2	0.3	0.0	2.3	2.7	2.0	0.1	2.0	0.4	0.0	0.0	0.0	0.1	0.1	8.2	4.7	1.0	1.4	0.3	2.3	0.1	1.6	0.3	0.8	4.2	0.0	20.0	1.0	1.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	1.8	1.1	31.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.4	1.2	0.2	0.0	1.4	4.5	5.7	5.2	0.0	0.1	0.1	0.3	0.0	1.7	0.0	0.0	0.0	3.8	2.4	0.2	8.9	2.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.4	0.0	0.2	0.5	6.0	5.5	2.8	0.3	262.1	6.5	0.4	2.8	3.6	0.0	0.0	0.3	1.1	143.5	0.0	3.9	0.3	7.9	2.8	0.3	11.9	0.0	0.2	8.2	0.6	0.2	2.0	37.0	0.0	0.0	1.4	46.9	0.0	0.0	0.2	8.4	2.0	1.9	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	48.8	0.0	0.0	2.2	96.8	0.0	1.0	0.7	0.0	0.3	0.7	0.0	0.2	1.2	0.1	0.4	0.7	0.2	22.2	16.9
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913976	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"prognostic unfavorable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	9.2	7.7	6.5	9.2	7.5	8.3	9.7	6.8	7.0	9.6	12.9	12.4	10.1	8.4	10.0	11.5	7.4	8.6	7.8	5.8	8.2	11.8	12.1	8.5	10.4	7.6	8.1	7.5	8.3	18.4	6.3	8.6	7.3	8.5	10.1	21.4	8.6	7.4	10.3	8.8	10.1	7.4	8.5	10.4	10.2	4.2	8.1	8.9	14.9	11.9	8.6	9.6	6.1	10.3	15.8	13.2	10.2	8.8	11.8	15.0	13.3	16.9	12.4	8.9	7.7	5.9	17.9	14.7	24.3	14.4	17.1	5.6	15.3	10.5	16.3	15.5	8.3	9.9	11.1	9.2	14.9	18.1	19.7	10.4	16.0	14.9	19.0	10.2	12.7	10.8	15.9	16.4	17.6	16.5	10.2	8.8	8.4	15.6	10.3	10.8	11.9	15.6	13.4	22.6	6.8	10.0	22.9	13.0	13.5	9.0	8.0	8.7	15.7	0.5	6.0	27.0	18.9	13.8	14.9	15.8	18.3	12.7	11.5	9.3	1.8	2.6	3.3	1.5	3.0	3.1	2.4	3.6	1.0	4.0	2.7	1.9	5.6	2.4	2.9	2.9	1.8	1.5	6.5	7.5	6.8	7.0	5.8	8.2	7.6	8.1	7.3	8.5	8.1	10.3	50.0	80.1	91.6	26.4	42.1	26.6	36.3	35.0	28.5	72.1	29.7	19.9	44.5	44.3	55.2	53.3	95.9	17.9	41.7	122.9	27.4	36.0	2.7	38.4	44.9	55.0	47.4	23.5	30.0	54.0	30.0	38.4	39.8	50.4	60.7	30.9	64.2	85.8	29.0	75.7	34.9	62.2	26.4	43.6	33.0	4.1	42.6	44.2	8.8	29.0	45.8	45.8	55.6	32.6	41.9	65.4	53.5	51.6	39.5	53.0	59.2	59.8	50.6	133.7	65.7	43.6	34.9	15.2	21.0	30.8	35.5	38.0	40.8	30.0	48.0	68.1
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 202.3;skeletal muscle: 1034.1;tongue: 543.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	202.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.0	0.0	1034.1	1.2	0.1	0.0	0.0	0.5	0.1	3.0	0.0	0.1	0.3	543.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	22.9	17.2	14.3	16.4	17.3	10.2	22.9	15.6	14.6	27.2	15.2	20.1	19.0	24.9	17.6	16.1	25.3	16.6	13.1	12.9	17.3	24.8	24.2	20.7	24.5	16.8	17.4	34.6	21.6	24.0	25.8	15.6	17.4	22.9	15.6	15.2	18.5	23.6	21.3	31.9	24.0	17.5	15.2	24.2	17.4	12.4	16.0	21.2	26.7	9.8	21.7	22.9	20.3	18.3	14.3	33.8	36.7	22.6	51.0	35.8	124.8	33.6	88.7	29.9	22.3	11.8	14.7	46.6	14.5	37.5	14.7	15.6	23.6	49.3	23.6	21.5	24.7	24.9	35.7	21.7	45.0	16.8	42.2	50.1	56.4	39.7	77.4	34.2	34.5	19.0	31.2	22.5	32.5	27.2	17.9	16.3	23.5	20.4	21.2	19.3	17.9	33.7	36.2	36.9	8.8	29.9	36.1	27.2	23.5	54.6	29.9	13.8	57.1	11.2	32.1	18.4	15.4	54.5	46.4	25.4	26.5	19.4	41.6	41.4	20.2	26.8	23.2	16.6	22.7	27.1	26.7	23.5	17.9	25.0	28.3	20.8	73.1	24.3	23.3	17.4	24.7	16.9	14.3	17.3	15.6	14.6	12.9	17.3	16.8	17.4	17.4	15.2	16.0	18.3	26.0	60.9	63.2	16.6	39.9	13.8	20.4	25.5	59.2	35.6	19.0	25.9	11.8	31.5	47.7	16.5	39.6	42.5	38.9	13.4	35.2	19.3	2.3	32.2	44.8	29.9	16.3	20.8	18.0	19.2	20.3	29.2	15.3	25.5	47.4	25.0	22.9	40.5	18.2	26.9	22.0	13.9	20.3	23.9	14.9	2.7	30.7	19.6	8.8	15.0	40.1	24.9	54.6	17.1	27.5	19.5	15.0	28.2	29.1	18.9	32.7	66.1	55.0	51.0	26.3	43.3	27.7	28.7	54.9	21.4	11.1	32.0	42.3	26.3	18.1	10.5
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		940000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	79.6	74.0	52.8	102.4	58.4	112.0	114.6	56.0	69.9	96.4	38.1	91.0	82.2	103.3	85.3	96.8	95.8	83.2	77.1	58.1	56.4	100.2	140.6	76.6	127.8	52.4	50.7	104.0	71.7	118.4	61.4	87.1	54.4	84.7	106.6	102.0	71.6	91.3	103.1	91.6	82.3	100.1	59.1	83.9	77.0	69.5	51.0	176.8	129.2	92.7	140.9	131.7	72.7	65.6	234.4	194.9	427.0	230.5	185.5	210.9	256.6	269.9	279.2	307.1	328.5	421.0	225.7	225.6	214.8	239.1	269.2	203.5	425.2	329.5	469.7	215.0	291.0	488.5	282.9	398.0	229.2	437.1	230.0	193.5	172.1	361.2	156.6	218.4	368.0	272.1	314.4	199.7	405.9	225.9	496.7	221.7	498.0	236.0	170.6	429.8	376.7	186.5	331.9	262.6	372.6	314.6	217.8	159.9	201.1	428.5	196.7	325.8	264.2	287.3	241.5	190.6	312.3	240.0	311.4	493.6	223.4	339.5	290.0	253.2	172.7	175.0	153.6	177.1	165.3	121.2	148.1	157.0	168.0	121.6	147.6	149.1	192.7	172.9	217.4	102.1	167.5	330.4	52.8	58.4	56.0	69.9	58.1	56.4	52.4	50.7	54.4	59.1	51.0	65.6	129.0	105.8	126.3	65.6	131.0	113.7	174.0	242.4	90.5	136.7	93.6	87.1	163.0	105.8	190.0	101.2	45.9	210.5	141.6	79.8	97.8	304.3	103.0	147.4	175.4	142.4	133.3	159.4	73.9	235.8	238.8	134.1	74.5	159.1	146.7	140.2	82.8	222.5	157.3	89.2	82.4	90.7	173.0	100.5	85.3	30.0	101.5	130.7	69.4	108.7	310.9	142.0	138.0	93.0	111.4	247.9	70.3	129.4	132.5	137.4	82.8	139.9	160.1	114.0	111.7	142.9	161.3	252.2	179.2	114.7	120.3	165.5	149.7	165.3	112.0	161.2
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755897	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	6.1	6.0	4.1	6.5	3.8	7.8	6.6	4.3	4.5	5.9	3.9	5.8	4.8	5.8	5.0	7.1	5.2	4.4	6.2	3.9	3.3	4.8	6.0	4.3	8.1	3.7	3.0	6.1	5.8	6.5	3.7	7.8	4.3	4.6	6.4	4.6	8.1	4.5	7.3	5.4	5.2	5.3	3.1	6.1	5.8	4.6	3.2	7.9	4.6	8.5	8.3	7.4	5.1	4.3	19.8	23.3	13.3	15.8	14.3	16.6	42.0	14.8	15.0	17.9	17.4	58.8	24.6	35.4	23.6	15.0	25.8	24.9	26.7	38.9	20.0	15.5	41.8	23.6	16.4	33.0	20.6	25.3	13.2	15.6	24.4	16.9	30.5	23.0	28.5	18.4	33.7	15.9	19.1	16.1	18.9	30.4	73.5	13.0	28.2	21.0	28.4	21.1	22.9	27.8	20.5	10.0	22.7	19.5	14.7	51.5	36.5	22.7	19.5	16.9	17.7	27.8	25.3	9.4	10.7	37.0	15.7	18.6	14.3	10.2	6.1	3.7	8.4	8.0	8.8	7.3	8.8	8.7	8.5	9.6	9.0	10.5	1.0	11.9	9.6	8.2	8.4	5.1	4.1	3.8	4.3	4.5	3.9	3.3	3.7	3.0	4.3	3.1	3.2	4.3	14.5	6.4	4.4	25.5	16.1	10.1	20.1	27.0	14.2	16.8	11.4	8.4	7.7	1.5	15.1	11.0	20.9	34.7	15.9	5.4	7.9	19.9	6.5	19.7	17.7	10.2	7.2	21.2	22.2	16.5	36.9	12.5	6.6	24.6	7.0	18.9	6.8	5.6	20.1	15.2	31.2	7.3	16.2	9.3	6.0	4.6	10.5	10.4	5.4	18.7	16.0	12.3	16.5	26.7	44.1	14.2	7.6	8.6	9.3	13.9	7.9	11.5	9.0	19.9	13.1	10.5	19.1	6.3	12.8	12.9	8.4	17.9	13.9	24.3	12.8	12.6
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682418-42703805	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2038.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 8388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum, Vesicles, Plasma membrane"	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	532.0	254.5	141.7	422.4	155.4	863.9	401.1	153.3	157.7	331.8	154.4	600.2	364.9	406.2	211.3	365.0	337.0	209.8	789.7	140.6	159.4	318.9	309.9	396.3	407.9	175.1	160.2	311.7	266.7	133.8	122.2	242.2	178.8	307.8	378.1	391.8	270.5	219.5	2038.9	295.0	366.1	338.9	152.7	367.1	405.0	783.5	180.8	353.4	282.0	1133.9	382.2	501.5	332.3	173.5	1552.8	761.5	1020.4	1232.7	991.0	908.1	1200.2	971.5	768.9	1116.6	875.8	1034.6	1253.7	1630.6	1157.5	825.2	495.5	870.2	1162.6	1230.5	1103.9	1087.8	1278.0	1596.4	1491.9	1343.8	786.7	2214.4	1320.7	812.6	1092.3	1094.5	1365.7	630.0	950.3	1271.9	1823.0	720.6	1104.0	837.7	2816.5	2464.6	2902.1	755.0	1006.4	1789.6	1972.5	1938.2	1176.7	933.8	1731.6	1298.5	893.7	1294.0	2038.3	1096.8	443.2	5002.2	862.6	945.4	1748.6	1371.1	2209.3	1213.7	1670.6	2004.8	910.4	1750.3	1049.9	15.3	48.4	69.9	42.9	107.1	52.9	69.4	51.8	43.3	77.4	61.2	44.0	45.9	9.0	35.1	124.2	58.6	69.7	34.1	141.7	155.4	153.3	157.7	140.6	159.4	175.1	160.2	178.8	152.7	180.8	173.5	701.7	173.1	230.9	16.3	818.3	1397.7	1265.9	419.7	747.3	247.8	569.7	564.5	1072.3	441.8	355.5	325.5	150.1	753.9	678.4	620.6	1457.6	1013.6	8388.7	363.5	695.5	755.1	587.8	2244.2	16.2	886.6	1998.9	687.6	461.3	427.0	383.1	489.1	483.3	480.1	1708.7	121.1	27.1	930.2	354.0	1656.0	2342.9	3743.4	751.2	1307.6	905.4	19.7	1171.0	463.8	744.6	23.6	32.7	858.2	975.1	806.1	981.0	1935.1	993.3	1169.8	196.2	602.4	466.8	754.8	1083.7	3245.2	425.5	1113.5	1302.5	481.5	635.6	811.4	1257.7	1697.8
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 20.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	25.2	13.5	11.9	10.5	12.7	4.1	21.8	12.7	14.3	17.4	11.5	21.8	24.8	16.0	17.9	22.7	13.9	18.9	13.1	11.7	13.7	27.9	50.6	17.2	6.2	13.9	13.2	12.4	26.5	20.0	6.1	41.7	13.5	15.0	22.7	8.3	21.0	11.9	8.3	16.7	23.7	15.9	14.2	27.4	21.3	19.0	14.3	10.5	22.0	14.6	8.8	20.3	11.5	14.1	42.7	20.8	64.3	50.6	37.8	46.5	75.6	27.9	56.2	32.0	43.7	49.9	30.7	0.1	28.8	47.3	41.0	24.3	60.8	49.1	62.3	0.2	20.7	12.6	19.4	35.1	30.6	9.9	21.7	35.7	51.7	48.5	53.6	39.8	109.8	7.0	56.1	18.4	46.1	29.3	6.0	13.0	40.9	26.0	26.4	7.4	50.6	3.6	46.8	49.6	13.1	15.3	57.5	42.9	37.1	42.3	29.7	20.5	95.6	78.4	86.2	59.9	75.8	15.7	8.3	2.6	29.7	13.8	47.6	20.2	0.0	1.0	2.2	0.0	1.5	0.1	0.4	1.2	0.0	0.0	1.0	1.7	0.0	1.1	0.0	0.0	0.1	0.6	11.9	12.7	12.7	14.3	11.7	13.7	13.9	13.2	13.5	14.2	14.3	14.1	120.3	25.6	36.8	18.9	3.3	60.2	46.8	21.4	50.1	6.0	38.1	26.7	18.2	24.3	31.3	29.5	6.2	37.1	52.9	40.3	3.9	29.6	29.4	32.8	35.0	91.0	22.8	12.0	0.4	39.2	26.6	35.4	57.6	43.6	13.9	35.9	39.7	44.9	4.9	3.3	10.3	37.2	14.2	5.4	14.7	11.7	18.3	5.0	24.9	46.9	2.0	16.8	16.5	31.7	30.2	51.0	28.8	12.8	28.9	65.4	33.1	45.6	29.0	8.6	19.7	35.9	23.8	20.3	13.6	53.1	49.7	45.6	27.5	42.4	36.7	66.6
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763316-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA048070: AB_2680247, HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	13.3	13.0	12.5	10.4	12.8	17.6	13.8	18.1	15.6	18.0	2.8	12.9	7.0	16.1	12.9	12.7	15.9	8.5	11.4	10.9	16.4	10.6	8.5	11.2	13.1	9.5	10.0	22.1	13.1	12.1	15.6	11.2	9.3	14.0	9.2	17.6	15.0	10.3	15.0	15.3	13.4	9.4	4.8	13.4	11.9	18.5	12.3	14.9	16.8	7.4	11.9	14.0	15.0	12.8	28.3	28.9	31.8	7.1	25.2	20.8	18.0	18.3	18.7	18.9	18.9	25.8	19.6	40.9	13.4	20.8	13.7	26.1	28.6	19.6	30.2	24.6	17.3	29.4	19.8	20.0	12.2	22.3	21.9	19.0	13.5	20.9	16.5	23.3	25.3	22.9	24.1	18.9	23.5	29.9	26.4	24.4	20.0	19.2	26.1	40.5	31.8	14.3	16.5	37.2	24.2	23.8	29.4	20.2	8.3	21.8	22.9	17.4	37.0	22.6	28.3	15.6	23.9	23.3	24.8	43.6	19.3	17.3	17.2	0.3	1.4	1.5	1.5	1.6	1.7	1.9	1.3	1.3	1.1	1.9	1.8	1.8	1.0	2.3	1.5	3.4	1.1	1.4	12.5	12.8	18.1	15.6	10.9	16.4	9.5	10.0	9.3	4.8	12.3	12.8	26.8	25.6	34.3	54.2	32.7	19.9	11.2	13.3	27.9	42.0	27.7	25.3	45.9	14.3	25.0	9.2	41.7	19.7	32.4	15.7	1.9	15.7	35.4	26.8	36.0	29.7	20.4	23.5	86.7	15.5	13.5	24.4	23.0	28.6	17.7	54.1	21.8	16.8	19.1	52.2	84.3	18.9	12.2	22.6	12.3	17.7	33.8	19.5	5.4	51.5	28.6	24.6	32.0	68.9	76.5	18.0	13.3	48.5	30.3	18.9	14.0	14.7	33.0	30.8	19.7	35.5	24.8	62.8	49.0	29.2	23.3	15.7	29.3	32.5	21.6	13.2
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350090	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (7.29e-5)"	43.0	27.0	22.4	19.5	26.5	116.6	43.8	31.9	25.0	52.6	18.6	40.0	15.6	43.6	22.7	48.0	42.3	15.3	34.1	20.9	26.0	38.2	33.1	40.6	28.4	23.6	23.6	68.6	44.5	20.3	41.2	23.8	24.8	37.9	19.6	38.5	42.1	17.6	47.2	51.3	40.5	17.2	23.2	41.9	36.3	31.3	23.1	30.3	42.1	16.7	26.7	37.3	50.5	32.7	31.8	18.4	37.1	22.2	21.7	18.8	30.4	33.8	21.3	20.6	21.5	22.9	27.9	50.8	27.0	17.2	16.7	23.3	35.1	29.4	33.1	38.2	21.3	38.8	27.3	25.6	22.1	41.5	29.0	17.8	31.3	18.5	44.0	26.6	22.6	24.7	37.5	29.0	30.7	23.9	48.9	37.1	27.6	30.4	18.0	42.4	41.6	22.8	32.6	35.6	31.9	24.8	29.5	31.5	25.9	34.3	24.6	28.8	24.1	23.5	24.9	16.4	22.5	30.1	21.8	53.7	15.9	26.6	22.0	69.3	20.3	40.4	24.1	12.7	19.0	36.1	19.6	19.8	12.2	44.8	26.9	22.9	105.4	20.8	27.0	39.3	20.3	9.7	22.4	26.5	31.9	25.0	20.9	26.0	23.6	23.6	24.8	23.2	23.1	32.7	104.6	112.2	129.5	54.9	104.7	119.9	103.6	76.2	88.8	105.8	112.8	107.2	92.6	85.8	125.1	73.5	70.9	73.6	136.8	58.1	52.8	70.2	98.5	131.9	135.3	92.2	85.8	74.7	43.8	57.2	124.8	81.3	54.0	254.8	94.7	86.2	63.5	85.6	43.2	90.9	49.4	77.9	63.1	61.0	75.9	22.0	74.6	84.5	64.0	56.2	67.0	99.2	96.8	59.3	110.1	81.6	56.0	67.7	103.2	121.6	42.0	44.0	113.2	138.4	52.6	122.0	98.8	139.2	95.9	127.1	134.5	119.0	122.0	59.5	66.9	119.8
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	33.5	33.0	20.0	26.7	21.0	63.9	38.3	22.1	24.8	27.5	29.5	32.0	29.4	27.8	43.6	37.5	27.7	27.0	27.0	21.3	22.5	31.8	42.2	35.6	35.6	20.2	19.6	29.3	27.4	37.1	18.0	34.4	20.6	22.9	33.8	20.2	39.8	23.9	43.9	41.9	26.2	32.9	21.4	32.1	27.6	29.3	21.2	44.1	28.0	33.7	43.8	32.8	26.1	23.1	68.8	46.3	99.6	96.8	75.5	58.1	117.8	66.1	80.7	80.0	80.4	42.8	78.1	117.8	64.4	84.4	47.8	62.2	117.3	105.7	94.0	76.0	91.9	98.7	60.7	78.4	90.0	105.1	74.4	78.5	106.4	86.1	121.1	70.0	99.0	70.0	101.9	55.6	89.7	53.3	112.1	80.8	161.8	61.1	61.1	95.4	74.2	96.8	111.3	95.8	85.7	91.2	68.6	102.1	181.7	82.6	67.8	95.8	69.4	55.4	57.8	52.5	93.5	68.2	47.7	133.3	63.3	81.2	89.9	108.3	78.4	78.7	66.1	91.1	88.3	80.3	72.7	80.3	96.7	59.0	77.9	73.2	26.5	92.4	94.4	62.6	92.3	109.5	20.0	21.0	22.1	24.8	21.3	22.5	20.2	19.6	20.6	21.4	21.2	23.1	70.8	51.3	61.2	13.7	70.8	152.7	104.9	111.0	109.8	45.4	110.2	101.3	52.8	77.2	85.3	44.1	31.3	149.6	79.5	46.4	66.5	102.0	16.3	65.8	78.2	78.5	75.7	52.8	22.5	69.6	108.3	64.5	49.5	76.6	72.3	63.6	77.4	102.3	77.3	58.9	20.4	76.0	105.8	65.4	75.4	19.3	71.1	56.7	37.4	21.5	74.1	66.4	73.2	14.1	23.5	80.7	43.8	75.2	71.0	78.6	42.4	96.0	53.8	45.9	92.1	61.5	83.0	142.2	115.5	95.3	161.7	260.2	69.2	69.5	65.9	118.7
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885702-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212"	Enhanced		Supported	Cytosol		NA	NA		97000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (6.14e-4)"	"prognostic unfavorable (1.91e-6)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	133.1	120.6	214.6	140.0	225.1	111.1	106.8	156.3	275.9	103.7	155.9	160.8	128.4	102.0	83.5	148.3	97.6	97.6	105.0	232.0	221.6	155.6	96.7	126.4	174.3	187.5	175.4	81.2	58.1	123.1	48.3	123.2	187.7	99.9	173.5	114.9	83.8	133.4	85.7	129.9	135.3	142.6	174.1	162.3	123.5	56.8	201.5	139.1	118.1	78.6	210.3	153.5	91.6	195.0	306.5	227.8	179.5	173.2	291.0	255.5	238.9	270.8	263.2	327.7	284.6	479.6	336.9	324.2	272.6	361.9	355.5	315.5	256.1	506.0	388.0	124.1	153.1	242.4	180.8	285.8	192.6	396.8	223.6	201.4	370.4	257.2	328.4	223.6	333.5	196.0	265.6	152.6	340.9	363.2	312.1	325.3	169.7	348.9	341.6	240.3	259.5	251.1	352.3	336.6	189.8	202.6	459.9	485.7	331.1	207.7	354.6	376.3	381.2	504.6	259.7	288.8	281.2	100.4	196.9	292.5	369.9	260.8	263.5	105.5	95.2	90.5	71.3	130.8	74.0	71.2	89.3	87.7	102.8	66.5	70.6	86.2	93.4	72.4	155.4	65.9	113.8	71.9	214.6	225.1	156.3	275.9	232.0	221.6	187.5	175.4	187.7	174.1	201.5	195.0	421.4	253.2	289.0	35.6	292.8	276.7	256.0	270.8	195.2	239.9	229.6	199.3	197.1	200.1	236.5	248.3	50.1	358.6	317.2	532.6	230.9	476.1	17.7	183.0	274.2	351.5	298.1	183.4	93.8	489.8	627.7	246.4	192.7	278.5	227.9	262.8	300.9	155.9	410.3	292.7	64.1	388.4	160.7	394.5	329.9	24.2	188.9	418.7	222.3	51.5	543.5	229.0	295.5	25.6	63.0	654.9	429.9	210.3	301.8	419.0	328.9	364.5	206.4	131.5	230.1	173.3	337.8	51.1	171.3	333.3	325.3	531.3	369.3	394.2	382.4	440.5
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344275-1400222	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008445, CAB016200, CAB021109, CAB047350"	Approved		Supported	Cytosol		NA	NA		83000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	221.9	198.9	251.8	122.8	264.2	121.3	198.7	266.3	272.8	168.8	195.7	161.1	136.8	155.6	192.7	239.1	188.1	103.7	242.3	260.7	275.4	229.3	211.7	176.9	113.7	271.1	246.8	170.8	154.9	236.9	178.8	198.2	267.1	150.0	168.1	220.8	184.8	121.6	656.7	193.3	129.3	137.3	279.2	101.5	136.9	165.4	262.2	211.0	208.5	441.8	164.5	186.9	179.7	302.7	615.3	565.8	700.2	563.4	376.9	454.7	589.8	382.1	481.5	724.5	571.3	907.5	305.5	524.7	411.9	621.9	439.7	463.1	859.2	745.6	798.7	294.2	930.9	334.1	366.2	409.4	483.4	277.1	311.1	421.6	458.6	619.3	897.0	520.6	729.2	458.5	402.8	337.9	719.7	368.5	445.8	264.1	566.6	596.9	332.7	477.3	255.9	380.4	547.7	365.7	354.2	497.2	531.1	240.3	364.3	439.9	442.3	290.9	467.4	411.9	293.8	453.7	731.4	190.5	329.9	346.6	478.4	387.5	585.4	78.6	137.2	41.2	47.3	153.6	57.8	78.1	67.3	55.1	180.3	59.1	55.7	51.2	49.9	64.1	144.8	133.8	99.7	151.0	251.8	264.2	266.3	272.8	260.7	275.4	271.1	246.8	267.1	279.2	262.2	302.7	363.6	298.1	194.4	83.2	161.1	573.9	457.5	468.4	281.7	153.6	313.6	219.1	473.4	265.9	310.9	371.5	50.1	463.2	128.7	300.7	745.4	460.8	258.0	573.6	414.3	352.6	352.6	244.7	73.4	421.4	709.5	319.4	194.7	502.7	211.5	328.1	262.3	309.0	384.9	111.0	72.4	346.3	376.4	260.9	434.9	434.3	280.8	227.5	425.2	60.0	320.5	357.8	55.6	56.8	112.1	464.8	289.8	294.9	279.5	487.9	272.1	707.8	504.6	173.3	243.3	361.2	524.6	508.7	573.3	333.8	586.6	519.5	130.7	287.2	361.1	474.4
YWHAG	"14-3-3γ, 14-3-3GAMMA, PPP1R170"	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326799-76358991	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.4;skeletal muscle: 349.8"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 408.8;Suprabasal keratinocytes: 425.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013274, CAB018389, HPA026918"	Approved	Approved	Approved	Cytosol		NA	NA		66000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566"	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	188.1	99.2	165.6	60.6	185.3	27.3	61.0	80.2	337.4	41.1	8.5	48.4	47.8	50.9	20.8	64.5	37.9	54.5	111.4	206.5	206.1	50.8	72.4	47.1	43.2	204.5	120.7	40.7	59.7	50.1	32.6	55.4	192.9	46.1	44.0	87.2	39.9	40.0	349.8	43.7	41.6	66.4	81.5	44.2	38.2	28.9	135.1	40.2	29.7	238.4	48.6	78.8	46.3	199.1	189.0	231.9	200.5	256.7	200.5	114.9	90.5	213.3	105.0	129.6	139.5	147.0	196.7	263.5	71.7	190.8	215.2	171.6	254.3	235.8	180.5	179.9	110.9	250.2	150.0	164.5	182.6	309.0	234.0	127.1	221.0	151.5	310.8	137.3	208.9	140.2	349.9	289.0	195.8	177.6	222.3	227.1	223.0	150.7	160.4	256.3	203.0	291.7	204.5	126.3	107.0	297.1	236.7	299.2	156.0	256.9	208.5	184.2	222.6	250.7	145.7	225.4	290.1	95.1	191.6	399.5	225.5	285.3	273.8	1.5	2.3	0.5	0.8	2.0	1.4	1.3	1.0	1.1	2.4	0.7	0.7	0.9	0.5	0.5	1.8	2.6	0.9	0.9	165.6	185.3	80.2	337.4	206.5	206.1	204.5	120.7	192.9	81.5	135.1	199.1	73.7	32.1	26.4	23.2	51.8	408.8	128.3	87.9	126.9	102.9	107.0	70.1	234.0	40.0	55.1	38.6	12.5	36.5	39.3	49.9	37.2	52.4	91.2	96.0	82.9	92.0	85.4	72.8	99.9	38.2	84.1	97.4	61.2	127.9	67.3	38.7	50.0	93.1	83.5	124.5	78.5	35.7	44.7	90.3	229.0	25.2	46.3	87.8	94.3	40.3	64.2	27.1	20.6	23.1	57.1	71.1	29.9	43.2	56.6	129.8	34.1	61.3	47.2	35.3	32.9	92.5	91.5	13.4	19.0	160.1	425.4	67.2	41.5	46.4	45.1	177.1
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944522-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 501.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025918	Uncertain					NA	NA		42000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB025918: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	104.9	82.7	244.8	87.2	309.8	86.8	76.6	96.2	501.2	54.6	4.6	106.3	64.8	68.7	92.8	60.4	73.1	82.4	78.1	386.6	217.9	77.6	61.4	112.2	68.3	156.7	109.2	53.0	69.6	29.5	64.4	100.0	145.9	57.8	111.1	114.1	59.4	70.9	68.7	65.0	68.9	131.0	74.1	57.9	109.3	16.2	118.1	70.4	62.0	54.8	82.4	89.9	58.3	229.8	344.5	142.4	180.8	91.8	112.7	107.0	97.0	321.9	172.0	208.1	228.6	157.8	124.2	202.8	76.6	329.4	116.6	169.1	208.7	183.7	271.4	177.0	157.7	118.7	108.2	156.8	108.5	391.4	132.8	84.9	113.0	176.9	135.6	137.3	201.3	76.9	171.5	155.6	249.6	148.5	121.0	189.8	185.2	197.1	150.8	173.7	201.2	115.1	216.5	153.1	323.5	104.4	184.2	134.7	124.7	245.9	78.2	119.3	248.4	206.0	190.1	138.2	216.6	80.7	130.5	257.7	137.3	162.0	170.9	11.9	19.8	22.0	7.6	16.8	11.1	12.4	9.4	10.8	22.9	13.0	3.7	4.9	11.6	25.4	18.4	6.2	19.5	14.0	244.8	309.8	96.2	501.2	386.6	217.9	156.7	109.2	145.9	74.1	118.1	229.8	259.0	51.3	21.7	27.1	106.6	334.1	223.5	27.3	125.2	54.8	123.6	79.0	51.2	125.8	26.5	126.9	22.9	171.7	53.0	242.8	232.8	148.0	3.9	180.0	81.1	211.7	75.4	269.8	132.0	160.6	145.4	118.8	139.1	153.0	40.0	33.4	120.3	72.1	245.6	53.8	62.9	125.4	34.6	155.6	269.8	13.7	61.2	397.6	300.6	66.5	102.1	80.1	44.3	22.1	42.0	203.3	115.7	80.9	120.4	240.7	93.4	125.5	52.5	73.7	157.8	55.8	197.1	23.3	35.5	164.1	340.0	34.8	95.2	25.7	116.1	191.8
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583967-9630997	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007925, CAB010286"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		49000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Cytosol	Nucleoplasm	"CAB010286: AB_2218221, HPA007925: AB_1844340"	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	144.6	141.0	190.8	106.1	223.2	178.4	153.6	216.5	239.1	177.0	149.4	161.2	119.4	184.3	141.6	187.3	136.5	122.6	218.7	205.1	229.7	140.0	116.3	119.3	132.0	218.6	203.8	163.2	201.5	131.9	112.9	123.2	212.4	161.1	133.0	143.6	120.2	140.2	53.5	121.5	116.2	177.4	203.9	89.8	127.5	144.6	205.7	148.2	137.6	62.1	141.1	144.4	161.8	280.5	316.1	465.2	412.0	400.3	316.6	434.5	385.7	421.6	412.3	432.5	360.2	352.9	269.3	404.4	214.0	608.5	451.3	288.5	462.8	459.7	553.6	1003.0	374.8	378.8	268.9	379.9	241.1	369.1	219.7	295.8	264.5	473.6	305.9	394.9	493.5	285.6	378.5	236.8	539.3	219.3	658.2	374.4	700.7	351.9	527.5	473.0	533.3	497.4	478.8	276.9	390.1	659.9	384.1	392.2	317.3	343.8	244.4	187.0	453.9	539.6	380.7	473.4	654.4	239.3	351.4	526.6	461.8	378.9	458.8	99.5	102.7	120.5	207.8	137.8	255.6	151.9	192.8	223.5	144.2	147.8	103.6	170.1	31.1	252.0	137.0	73.1	208.4	344.1	190.8	223.2	216.5	239.1	205.1	229.7	218.6	203.8	212.4	203.9	205.7	280.5	186.6	51.3	67.3	26.1	144.0	316.7	366.5	339.0	143.4	201.4	198.4	153.7	82.6	90.1	143.4	136.1	27.1	261.6	189.9	209.9	416.7	371.5	281.9	132.9	175.8	191.0	187.1	179.2	57.3	283.7	615.3	242.0	115.2	131.6	125.0	152.5	84.9	97.9	215.3	572.0	45.1	129.2	270.6	111.9	228.3	360.5	174.0	132.3	295.3	30.0	195.0	229.2	155.5	39.7	186.6	261.2	150.9	250.5	187.9	323.7	135.9	278.8	111.7	105.8	197.2	191.5	312.7	432.2	205.8	252.1	355.3	238.6	217.7	252.9	186.5	457.3
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916523-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005065	Approved					NA	NA		320000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB005065: AB_2218378"	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	379.0	262.9	246.2	374.2	324.1	527.2	251.7	147.4	343.0	269.6	88.3	475.2	327.3	275.6	220.9	892.8	243.9	333.0	187.3	366.2	269.6	224.9	190.9	275.8	429.3	163.3	195.7	227.7	191.5	233.3	109.0	339.2	222.5	265.8	445.9	285.3	244.8	291.2	95.0	399.4	375.4	356.5	170.1	272.8	365.4	226.8	276.9	434.8	289.7	168.9	566.1	501.0	343.2	205.0	1902.4	879.2	1605.4	457.7	396.6	490.9	808.0	877.6	1099.2	1124.6	1098.2	602.4	1149.5	816.5	857.1	1349.3	937.2	785.0	1025.5	1213.5	1630.1	765.1	454.2	779.5	579.0	378.1	524.8	311.5	840.3	475.4	1524.0	936.7	1430.1	923.8	1008.7	584.9	887.8	758.9	920.2	660.6	1357.1	535.4	548.0	2269.0	1026.7	569.7	468.6	544.8	1023.1	963.5	889.7	642.7	669.5	609.8	1365.4	1094.7	896.0	374.6	879.0	554.6	834.3	693.7	798.3	503.6	625.3	994.6	925.8	595.2	2303.2	1340.5	427.5	705.8	559.0	589.1	559.3	484.8	463.3	537.3	497.3	395.9	348.3	441.8	616.5	503.7	726.9	313.4	663.9	1087.2	246.2	324.1	147.4	343.0	366.2	269.6	163.3	195.7	222.5	170.1	276.9	205.0	199.4	250.0	228.9	43.1	637.6	1007.0	438.4	309.3	507.6	120.4	285.9	209.9	87.0	188.8	321.3	263.0	89.6	243.4	491.2	552.7	121.3	405.2	1092.9	359.6	245.6	216.0	265.3	137.3	150.2	421.3	551.6	277.4	448.5	578.8	452.9	122.1	183.1	104.5	276.3	134.6	92.5	525.2	244.1	303.5	641.2	2118.0	125.6	456.9	391.3	56.2	334.9	110.9	407.8	51.3	91.5	771.0	452.7	147.1	457.2	427.2	310.6	160.4	292.0	96.3	131.5	229.4	290.4	170.2	92.6	908.0	1184.7	408.9	596.5	116.5	371.7	794.9
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282788	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	27.2	26.2	20.9	28.9	22.1	56.4	27.0	27.0	24.2	24.6	18.5	30.7	27.9	24.8	34.0	28.9	21.7	22.7	22.8	22.7	20.2	32.9	46.8	24.0	36.0	20.4	20.4	21.6	24.4	32.5	17.4	34.2	20.3	25.2	28.7	20.1	25.1	23.6	36.8	29.0	29.7	24.8	20.1	31.9	26.2	23.8	21.5	52.3	37.2	27.2	38.2	31.9	21.0	26.2	62.0	30.7	64.2	51.5	51.8	65.9	68.1	60.0	55.1	64.7	66.0	38.6	97.7	94.0	82.3	54.5	37.1	64.0	72.6	64.1	88.3	70.8	60.9	86.8	34.6	50.0	48.4	103.8	73.2	38.7	76.4	45.4	61.4	58.6	63.9	67.3	69.9	61.8	63.7	74.5	113.5	61.8	68.7	98.0	56.0	93.9	88.9	50.7	75.8	58.3	68.2	53.3	79.2	57.8	85.1	54.0	86.6	100.1	57.4	39.4	48.3	97.6	53.8	68.3	72.0	126.6	56.4	68.6	52.5	4.8	5.7	11.9	4.3	4.8	5.6	5.3	5.7	5.9	4.9	8.3	5.4	5.4	9.8	9.5	3.8	5.3	7.7	2.7	20.9	22.1	27.0	24.2	22.7	20.2	20.4	20.4	20.3	20.1	21.5	26.2	116.0	54.5	66.8	23.8	102.4	238.0	101.1	49.9	211.7	80.5	129.8	98.2	91.5	92.9	50.0	68.0	81.3	118.6	147.4	122.8	72.4	68.7	10.3	118.7	133.8	115.7	110.1	125.4	28.2	82.0	123.6	106.7	58.1	153.6	71.7	99.4	103.5	119.4	81.3	127.9	26.5	108.8	48.8	111.8	225.8	15.7	94.8	121.6	76.5	30.0	117.8	82.0	114.4	20.6	40.7	80.0	95.5	100.8	125.0	168.9	90.0	104.6	47.6	74.9	92.1	106.5	124.3	86.0	67.0	192.1	243.1	175.5	124.8	124.1	118.7	153.5
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 121.0;MOLT-4: 183.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	3.3	1.3	0.5	28.0	0.6	24.8	1.9	0.5	0.9	1.7	0.7	4.0	5.8	1.4	0.5	2.3	2.2	5.4	1.4	0.5	0.7	2.8	3.9	8.7	57.0	0.8	1.3	0.8	1.0	0.4	1.1	0.9	0.7	2.5	1.5	0.0	2.3	0.8	2.0	2.4	18.5	0.5	0.6	35.5	6.7	2.7	1.2	79.9	3.5	2.8	17.7	4.9	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	121.0	0.0	0.7	0.0	0.0	183.4	0.5	0.1	0.0	0.0	7.2	0.1	9.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	14.1	0.1	0.0	0.0	0.3	0.3	0.5	137.4	0.4	93.2	0.2	71.7	108.3	0.3	1.6	50.8	79.8	2.2	112.2	1.0	0.9	80.1	64.2	0.5	0.6	0.5	0.9	0.5	0.7	0.8	1.3	0.7	0.6	1.2	0.6	0.8	9.6	13.6	0.3	3.9	1.5	0.0	0.0	0.0	0.0	0.8	0.5	3.0	0.0	0.0	0.0	0.0	0.1	101.0	0.2	1.9	0.2	1.0	1.6	0.5	0.8	0.0	8.8	0.2	0.0	0.0	1.8	4.6	0.4	2.5	0.1	2.5	0.7	2.2	0.0	0.2	0.0	0.0	2.8	2.2	0.7	0.0	3.4	1.8	2.8	5.0	0.0	155.5	0.0	0.1	0.0	0.0	0.0	28.0	0.1	0.0	0.5	0.0	0.0	0.0	14.3	0.6	1.3	2.1	0.2	1.4	0.0	105.6	0.1	0.1	0.2
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Inhibitory neurons: 1.9;Late spermatids: 8.6;Oligodendrocyte precursor cells: 3.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"midbrain: 2.1"							NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.0	0.0	1.1	0.0	3.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853844-49890080	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA045341: AB_2679295"	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	3.6	2.6	2.3	5.3	2.1	11.0	3.4	5.6	2.3	3.1	1.3	5.7	5.3	3.5	2.7	6.5	3.3	3.5	3.3	2.2	1.6	3.7	4.7	4.2	6.6	2.2	1.9	3.6	5.3	3.0	3.3	3.9	2.1	3.4	4.8	4.7	3.8	2.1	4.5	5.0	5.3	3.2	1.2	5.1	4.5	3.8	2.2	10.9	3.3	3.2	5.5	4.0	3.5	4.0	14.9	13.1	24.5	19.5	7.4	8.1	15.2	8.6	7.1	9.3	8.6	13.5	6.5	29.3	5.9	9.2	9.7	16.7	17.4	11.1	9.9	11.6	21.2	16.8	13.2	12.8	10.7	36.0	23.2	7.6	16.5	10.2	15.4	9.3	12.6	28.0	18.2	13.7	11.1	11.9	30.0	17.1	13.4	12.9	9.1	35.5	22.1	17.8	9.9	14.9	12.9	25.7	8.5	24.9	17.3	15.2	11.8	20.3	14.7	12.7	19.9	7.5	12.3	13.5	9.0	26.5	7.7	15.9	15.2	0.4	0.4	0.7	0.8	0.6	1.6	0.6	0.8	0.9	1.0	0.4	1.0	0.8	0.2	2.9	0.6	1.0	0.6	0.6	2.3	2.1	5.6	2.3	2.2	1.6	2.2	1.9	2.1	1.2	2.2	4.0	4.9	0.0	6.5	11.4	7.2	5.1	5.1	5.0	4.0	7.9	6.3	6.1	7.2	7.2	8.6	5.5	14.6	3.6	23.5	8.7	3.9	9.2	4.8	10.0	10.1	6.6	12.6	12.8	14.7	7.1	6.4	5.1	7.7	10.1	0.0	10.1	5.3	6.9	6.8	13.5	14.7	9.5	4.1	12.6	5.2	4.6	3.1	7.3	0.0	16.9	8.5	2.5	16.5	12.1	16.6	13.3	8.5	4.1	12.5	9.2	3.8	2.9	6.2	9.9	6.6	5.8	7.1	4.8	6.4	6.7	3.8	3.3	17.2	7.4	11.0	6.8
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.2"	"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 60.4;U-266/84: 57.0"	"Low region specificity"	"Detected in all"							"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032"	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	8.9	35.6	3.2	6.0	3.6	41.2	8.1	4.6	5.6	7.9	2.2	5.7	4.0	13.7	7.1	6.5	6.6	11.9	4.6	3.9	7.2	6.5	11.2	6.9	5.1	5.3	7.2	8.5	9.4	14.0	4.8	6.9	5.0	7.8	4.9	14.2	4.1	4.2	2.5	8.8	4.7	8.5	2.2	6.5	6.5	12.2	5.3	6.4	9.5	3.1	5.4	9.6	5.1	5.4	12.8	10.0	9.6	10.9	13.3	10.2	9.3	11.6	16.6	10.9	16.5	12.0	6.2	22.5	5.1	11.6	19.6	9.5	14.1	8.2	17.6	11.9	13.9	2.6	10.3	7.3	10.2	8.9	5.2	5.9	17.2	15.2	19.9	4.8	6.2	12.2	15.1	38.0	7.8	18.6	24.0	4.3	9.5	9.3	12.3	10.1	10.7	26.4	4.8	10.1	13.6	7.9	16.1	23.8	11.2	4.8	8.5	4.2	7.0	16.0	8.9	11.3	11.5	60.4	57.0	20.9	21.0	14.5	10.6	0.1	2.4	1.2	1.6	2.8	1.9	2.6	1.8	1.3	2.4	1.9	2.6	1.9	2.3	0.5	3.2	2.1	1.3	1.2	3.2	3.6	4.6	5.6	3.9	7.2	5.3	7.2	5.0	2.2	5.3	5.4	19.0	6.4	41.1	8.1	24.7	60.0	32.9	6.2	26.2	14.5	15.6	15.9	4.9	12.8	12.4	7.3	2.1	6.7	20.8	7.1	11.7	5.4	14.0	20.8	34.8	19.6	4.2	2.1	13.8	5.0	5.5	31.9	10.2	27.1	16.5	6.7	9.3	20.4	6.1	32.0	15.5	10.2	10.2	6.3	24.8	5.3	4.1	14.5	35.6	5.6	7.2	10.1	5.2	4.5	8.1	3.9	6.0	10.5	20.3	24.7	5.4	4.8	13.5	13.6	6.6	36.1	21.0	21.5	14.1	19.3	63.2	9.7	20.8	7.3	5.6	20.9
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA054699: AB_2682579"	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	6.6	6.1	6.5	8.3	7.9	7.6	6.1	8.8	8.5	7.3	6.5	7.4	3.6	6.1	8.3	4.1	8.4	5.4	11.0	7.1	6.2	4.8	6.9	6.9	11.1	8.7	7.3	8.0	6.7	6.2	9.0	4.3	8.0	6.7	4.9	11.1	4.7	4.8	11.2	7.7	7.8	5.6	7.3	8.4	5.1	6.4	8.8	12.7	8.8	8.9	11.1	7.6	6.5	11.0	20.2	8.7	5.6	5.4	8.0	10.0	11.2	3.4	6.1	5.5	7.2	4.0	13.8	14.9	3.9	5.7	6.9	18.1	5.7	5.7	6.7	15.6	1.8	3.4	14.1	1.9	9.2	2.3	7.6	12.8	5.5	5.4	10.7	11.7	5.1	14.0	2.1	23.7	6.6	8.7	8.5	3.5	2.9	7.1	8.9	6.5	6.2	6.4	6.3	9.4	5.5	6.0	7.1	5.3	4.5	5.2	6.8	1.8	5.5	7.5	11.2	3.5	5.2	20.9	5.1	6.7	11.1	3.0	5.7	3.8	2.4	1.6	6.5	1.6	8.6	6.6	9.3	6.4	1.7	3.9	10.7	10.8	2.4	7.0	1.4	2.9	8.9	7.5	6.5	7.9	8.8	8.5	7.1	6.2	8.7	7.3	8.0	7.3	8.8	11.0	7.2	6.4	13.0	15.3	25.1	7.9	8.4	13.9	12.5	19.4	7.1	7.6	19.2	8.6	7.8	7.3	18.8	7.1	19.3	2.3	9.8	8.5	47.9	15.6	9.4	8.7	3.5	14.1	23.1	6.6	9.8	10.8	6.1	7.6	6.3	11.9	7.1	10.9	10.8	8.4	28.1	2.6	8.2	11.1	19.1	54.1	13.4	12.6	17.8	15.9	10.5	7.5	27.8	26.7	37.0	7.2	3.7	10.9	19.3	6.3	3.8	7.7	15.4	22.4	0.0	12.5	10.2	11.9	11.8	7.7	8.4	4.0	33.2	8.7	4.6	5.9
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22428838-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	9.1	15.2	6.7	10.9	8.1	8.9	8.1	7.6	7.0	9.7	10.0	10.0	7.8	9.7	7.1	6.4	10.0	8.5	7.5	6.8	7.2	7.4	6.3	8.6	14.2	8.1	8.4	10.7	12.3	8.8	10.6	5.9	7.8	10.1	8.3	12.5	8.2	7.0	10.4	8.3	14.5	7.0	9.9	17.4	9.9	7.3	7.7	9.9	9.5	7.8	15.0	9.6	6.7	9.9	8.6	10.0	15.7	16.6	11.1	9.7	15.2	7.1	8.2	11.4	12.6	8.9	10.8	10.3	8.9	8.6	8.9	10.6	15.6	7.7	13.5	13.3	13.1	22.1	20.0	10.3	9.6	12.4	20.5	7.9	11.1	14.5	10.9	8.5	9.6	13.7	23.5	0.1	9.0	6.4	8.4	16.1	9.7	7.0	8.0	14.7	11.9	11.5	5.4	9.2	12.7	10.8	14.4	10.4	6.1	10.1	19.1	10.2	12.0	13.3	11.2	14.6	7.3	6.5	9.7	9.8	8.0	15.1	9.6	1.0	0.5	0.3	1.0	1.2	1.3	0.8	0.8	0.8	0.8	1.1	0.8	1.0	0.1	2.9	0.5	0.5	1.4	0.4	6.7	8.1	7.6	7.0	6.8	7.2	8.1	8.4	7.8	9.9	7.7	9.9	7.6	12.8	16.7	12.1	12.2	5.7	3.1	4.2	8.0	15.0	7.0	5.0	11.8	8.6	11.7	1.8	31.3	4.6	11.0	3.6	1.9	5.2	4.6	8.9	10.8	8.0	16.2	3.4	15.0	7.4	4.5	7.0	6.6	6.0	16.4	21.1	4.2	3.4	4.8	11.8	20.1	5.1	8.2	5.7	5.7	6.7	5.9	8.1	14.2	25.3	4.1	5.6	13.4	18.6	24.1	6.4	8.2	6.8	12.4	4.8	4.7	2.6	8.8	22.7	13.1	11.9	9.6	7.2	8.2	6.9	4.1	2.9	13.3	13.5	5.8	3.5
ZC3HAV1	"ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043515-139132122	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		24000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	13.5	12.7	8.7	19.1	8.9	85.9	11.1	8.1	15.2	8.6	12.2	12.9	9.7	8.6	10.3	12.9	9.7	11.4	6.4	8.1	13.6	11.1	11.0	16.1	24.0	12.3	11.5	10.9	7.3	9.2	6.2	9.3	12.3	9.5	13.7	2.5	14.3	9.1	3.2	13.1	13.9	13.8	12.7	21.0	10.4	6.5	14.9	24.0	10.6	5.6	23.8	11.9	8.7	12.4	25.1	29.5	4.1	24.7	37.4	35.9	17.6	27.5	21.2	46.9	47.7	21.6	31.4	21.9	25.2	43.9	40.6	27.6	33.2	32.6	26.3	37.2	12.2	43.8	29.7	26.9	21.8	51.1	38.6	37.0	20.3	53.3	11.8	17.4	35.3	32.1	37.6	23.5	20.1	23.3	41.9	59.0	16.6	18.6	17.6	48.5	14.6	21.0	32.0	31.0	7.5	15.4	43.1	29.2	37.8	9.3	17.4	30.9	45.3	9.9	14.3	27.6	23.1	17.9	20.2	49.9	22.4	47.0	24.0	78.7	19.6	30.8	43.0	26.0	56.0	32.2	61.9	53.1	15.2	35.3	59.0	58.6	52.5	38.7	30.6	17.7	58.8	30.6	8.7	8.9	8.1	15.2	8.1	13.6	12.3	11.5	12.3	12.7	14.9	12.4	150.3	25.6	41.1	8.1	119.4	28.7	21.7	17.5	62.6	2.8	70.8	44.8	6.2	21.5	21.1	53.3	4.2	12.6	194.8	57.0	9.8	20.2	2.8	185.9	77.7	74.5	53.2	64.4	0.8	21.2	23.1	68.1	60.6	359.9	32.3	41.6	49.2	36.1	35.1	0.0	3.0	42.2	8.2	43.9	150.0	1.9	18.6	84.4	39.2	33.7	57.1	13.9	88.6	27.6	1.0	23.8	33.8	26.7	104.2	41.5	28.0	36.4	29.9	1.3	13.1	79.5	53.6	1.0	1.1	61.7	22.3	2.3	222.3	41.3	35.8	28.0
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type palmitoyltransferase 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.2;Inhibitory neurons: 17.7;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.2;K-562: 2.1;LHCN-M2: 2.2;MOLT-4: 2.4;NTERA-2: 2.0;RH-30: 3.1;RPTEC TERT1: 1.7;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003618, HPA064901"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686, HPA064901: "	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	0.8	1.5	1.7	0.3	1.7	0.1	1.6	1.8	1.5	1.6	1.3	1.0	0.2	1.9	1.0	0.8	1.2	0.8	1.7	1.5	2.5	1.5	0.2	1.2	0.3	2.2	2.2	2.5	1.1	1.1	1.1	0.0	2.0	1.1	0.5	1.9	4.5	1.1	0.3	0.7	0.3	1.5	1.8	0.8	0.4	0.6	3.0	0.8	2.0	0.5	0.2	0.7	0.8	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.1	0.0	2.2	0.0	2.4	0.0	2.0	0.0	0.0	0.0	3.1	0.0	1.7	0.0	0.8	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.7	1.8	1.5	1.5	2.5	2.2	2.2	2.0	1.8	3.0	2.0	2.9	6.4	3.1	8.5	0.1	4.0	1.6	0.0	3.4	4.2	2.0	1.5	9.5	1.5	1.3	5.5	4.2	0.0	0.3	0.0	0.0	0.7	0.0	0.2	2.9	3.5	1.8	0.4	18.2	0.7	0.0	3.5	0.0	0.3	1.3	2.5	2.2	0.1	0.1	0.0	17.7	0.0	0.0	0.0	4.4	0.2	0.9	0.1	0.0	5.6	0.0	2.2	1.0	17.1	9.1	0.2	0.0	3.8	0.0	0.7	0.0	1.0	0.0	2.3	6.6	5.4	2.5	0.2	0.7	2.2	3.7	0.0	0.5	2.3	0.0	0.6
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type palmitoyltransferase 5"	Q9C0B5	11	57667747-57701182	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	29.0	21.7	8.3	27.2	7.8	29.2	25.8	8.3	9.5	27.0	11.0	36.4	29.6	22.3	24.1	60.9	25.0	27.9	27.9	7.5	9.2	28.2	36.7	29.0	24.4	8.5	8.9	20.7	31.6	45.3	12.6	36.7	8.7	28.0	34.4	35.9	35.0	26.7	40.9	45.2	31.0	29.0	6.9	25.5	30.2	36.2	10.9	30.6	36.9	45.5	35.0	42.3	28.7	8.9	80.3	86.2	33.7	34.7	74.9	57.4	64.9	72.8	89.8	61.8	46.3	52.3	97.0	53.4	91.9	89.5	53.1	110.1	53.6	88.9	55.4	66.5	24.4	45.8	40.1	49.3	81.5	85.9	73.7	81.3	79.3	88.8	92.9	51.1	71.0	45.6	61.5	66.2	79.7	48.4	49.1	29.3	41.1	61.0	52.2	47.8	66.6	67.1	74.8	115.2	25.3	30.7	67.6	77.0	78.5	45.4	81.9	52.6	80.7	76.5	40.7	82.9	52.2	48.2	63.0	45.9	59.1	44.4	68.0	11.6	5.2	7.1	6.9	6.8	8.3	5.8	6.7	6.0	5.4	5.7	6.7	6.9	6.9	5.0	8.1	9.0	7.0	6.8	8.3	7.8	8.3	9.5	7.5	9.2	8.5	8.9	8.7	6.9	10.9	8.9	28.8	16.0	10.5	14.7	13.4	16.2	12.7	13.7	16.5	21.4	20.4	15.2	21.6	12.8	19.8	12.9	37.5	10.1	20.3	41.3	3.9	14.4	21.3	19.9	22.1	17.1	11.5	10.8	16.4	18.2	9.9	15.5	15.8	35.5	19.7	24.9	16.1	15.1	13.0	13.5	17.9	17.5	18.3	16.3	10.2	9.8	11.8	18.4	1.8	14.0	16.0	14.0	17.5	17.6	14.7	26.0	20.8	7.5	12.4	15.1	22.9	11.4	17.4	47.7	0.0	18.4	18.5	13.3	7.1	31.5	19.9	18.6	15.9	16.8	19.7	20.5
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520857-23556192	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;testis: 7.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Early spermatids: 38.9;Excitatory neurons: 31.0;Inhibitory neurons: 20.0;Late spermatids: 19.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 20.8;Spermatocytes: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.8;SuSa: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	0.5	0.7	1.8	0.5	6.3	0.1	0.4	11.9	5.3	0.4	0.0	0.7	0.1	0.7	0.4	0.2	2.2	0.4	0.3	3.2	0.0	1.3	0.2	0.5	0.3	1.5	0.1	0.5	0.4	1.7	3.4	0.2	0.2	0.6	0.2	3.1	0.4	1.2	0.7	0.5	0.3	0.6	0.0	0.2	0.4	7.3	0.9	0.2	0.7	0.5	0.2	0.3	0.2	2.3	0.1	3.1	2.4	4.8	1.6	0.2	0.1	0.7	0.2	0.3	1.2	0.3	0.2	0.2	0.3	0.0	0.3	0.1	1.2	0.1	0.5	2.2	0.8	2.5	0.0	0.6	0.2	0.4	1.7	0.3	0.1	0.5	0.1	1.3	0.3	2.1	0.4	0.4	0.1	0.8	0.3	0.3	2.9	0.3	0.7	1.4	0.0	0.0	1.3	1.2	2.7	1.7	0.4	0.6	0.1	3.6	1.0	0.6	0.1	0.0	1.2	0.7	0.3	0.3	1.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	6.3	11.9	5.3	3.2	0.0	1.5	0.1	0.2	0.0	0.9	2.3	0.5	0.0	1.1	22.5	0.7	0.1	0.6	1.1	0.0	9.0	2.2	2.3	2.5	0.0	2.4	1.8	0.0	0.3	0.1	0.6	1.9	2.8	38.9	12.2	0.6	1.1	6.7	0.0	31.0	2.4	0.0	1.4	2.0	2.5	0.0	3.2	0.7	0.2	1.0	8.4	20.0	0.7	2.0	1.0	1.9	19.1	0.6	0.8	0.0	4.7	1.0	2.7	0.0	27.2	20.8	1.2	1.2	0.4	0.1	1.4	0.4	1.4	9.8	3.8	0.0	2.5	1.3	16.5	1.2	0.7	0.0	0.3	0.4	0.2	0.6	0.3
ZFHX3	"ATBF1, C16orf47, FLJ26184, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 501.8"	"Cell type enhanced"	"Detected in all"		"Microglial cells: 285.8;Smooth muscle cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebral cortex: 501.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059353	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA059353: AB_2683987"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	6.0	4.3	5.9	1.9	5.8	0.9	3.6	2.8	501.8	5.2	7.1	6.0	1.5	4.7	4.0	2.0	3.6	4.2	3.5	68.3	12.1	3.2	3.1	4.3	1.2	72.3	13.7	2.8	4.0	9.7	3.9	6.2	49.5	6.9	2.6	4.5	4.0	6.4	9.9	2.6	2.6	4.1	11.3	3.1	3.6	1.8	12.5	1.3	7.4	10.7	0.7	6.8	3.5	56.5	5.0	9.2	14.7	12.3	5.3	6.7	15.1	3.9	4.3	2.5	2.8	10.6	2.9	2.3	5.5	7.5	3.4	3.5	9.4	4.7	3.4	9.3	2.3	0.4	13.1	15.1	4.9	1.6	3.5	2.5	2.8	7.3	6.5	2.3	4.7	1.0	1.1	0.6	6.3	10.9	0.5	3.1	2.4	2.7	1.5	7.0	4.0	0.8	4.0	8.8	10.9	3.9	6.9	2.1	4.8	6.7	3.0	0.7	10.3	6.0	7.0	6.5	4.9	4.7	1.7	1.6	2.9	1.4	4.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	5.9	5.8	2.8	501.8	68.3	12.1	72.3	13.7	49.5	11.3	12.5	56.5	13.6	70.5	26.7	109.7	8.6	17.0	55.6	13.1	37.0	122.0	24.5	20.6	23.7	47.1	34.8	47.8	22.9	47.4	5.2	11.0	5.9	23.0	2.6	94.6	33.1	40.3	26.9	7.4	22.0	23.4	19.4	68.8	25.5	154.6	21.0	20.7	44.6	37.5	67.0	23.5	8.7	23.2	22.4	84.2	142.6	2.8	10.5	72.9	21.4	285.8	40.8	13.9	3.1	83.9	18.5	20.7	22.4	19.9	2.2	77.5	6.9	7.4	29.3	34.1	124.9	153.7	177.3	3.7	16.8	29.5	17.2	62.1	7.7	12.4	31.0	43.8
ZFP36L1	"Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B"	ENSG00000185650	"ZFP36 ring finger protein like 1"	Q07352	14	68787660-68796253	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA transport, Transport"	"Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1973.2;Squamous epithelial cells: 2019.8;Suprabasal keratinocytes: 3223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 2901.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2901.2"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 462.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001301	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA001301: AB_1080644"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.68e-2)"	342.7	107.9	108.1	218.2	108.3	84.0	305.6	118.0	96.1	466.4	91.7	335.1	127.5	423.1	107.7	293.0	303.3	174.9	178.8	98.7	184.1	157.8	260.1	242.7	199.5	207.8	187.5	453.5	225.4	161.7	67.3	315.8	145.0	222.3	104.2	57.5	319.3	201.7	93.1	511.3	151.5	316.0	162.7	178.5	196.9	49.3	142.6	130.1	190.6	89.6	150.4	335.8	467.0	166.8	235.6	211.8	94.7	139.0	234.4	187.2	203.9	96.4	169.6	59.1	72.9	93.9	159.5	58.4	59.5	177.4	85.5	108.4	8.8	313.8	70.0	27.9	13.2	21.5	115.0	68.2	133.8	3.3	24.3	157.6	396.4	69.1	462.1	195.2	119.2	17.1	61.5	113.7	314.4	54.1	9.3	11.1	78.7	105.1	31.7	150.5	127.1	17.8	213.4	155.3	1.0	2.5	113.7	163.4	87.8	131.9	148.3	3.0	254.4	167.3	122.8	139.0	101.0	62.9	32.9	39.9	213.5	1.4	66.9	230.8	240.9	3.9	211.1	244.7	197.2	266.0	168.8	150.3	123.8	461.4	179.3	162.2	2901.2	154.3	176.1	16.2	174.5	257.5	108.1	108.3	118.0	96.1	98.7	184.1	207.8	187.5	145.0	162.7	142.6	166.8	830.2	477.5	415.6	172.7	513.8	1333.5	761.2	830.2	1973.2	4.6	750.7	504.4	84.2	420.4	523.9	364.1	0.0	442.1	276.5	164.4	84.1	575.8	97.0	434.6	479.6	571.0	20.4	87.7	1.5	573.1	476.6	894.3	218.6	656.2	200.8	21.1	292.7	595.6	548.3	0.0	0.7	225.3	215.7	613.9	1272.8	72.2	502.0	670.0	528.3	142.4	499.0	211.9	131.8	63.8	0.9	544.8	138.3	397.2	191.7	657.7	138.4	143.7	314.5	9.2	269.5	562.0	714.4	12.2	13.3	2019.8	3223.6	898.7	405.2	157.1	191.1	817.8
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	2.1	2.5	4.8	1.9	2.4	9.2	1.9	5.7	5.8	2.3	4.2	1.7	12.4	2.2	1.0	1.8	4.0	1.5	4.8	5.8	2.1	3.7	8.6	2.1	2.7	3.5	3.2	2.2	10.4	1.4	5.6	0.8	2.6	3.2	0.8	0.7	2.8	1.3	1.6	3.7	6.8	0.2	1.6	4.9	13.7	5.7	3.3	1.5	4.0	0.3	1.2	2.3	2.0	1.6	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	2.4	5.7	5.8	5.8	2.1	3.5	3.2	2.6	1.6	3.3	1.6	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZFYVE28	"KIAA1643, lst-2"	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418651	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.9;Inhibitory neurons: 93.2;NK-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.6;NB-4: 14.2;U-266/70: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	5.5	8.7	4.6	3.1	7.5	2.1	5.4	49.9	18.0	5.5	0.5	8.0	6.1	4.8	1.6	4.7	5.4	3.4	3.9	7.3	0.3	8.7	6.5	6.2	4.0	9.4	6.9	4.5	5.0	4.3	10.8	1.0	7.4	4.0	2.8	4.0	5.5	2.8	2.9	5.4	8.8	1.5	1.0	6.7	7.2	8.1	5.0	2.6	7.7	1.8	2.0	4.8	4.6	6.2	0.9	1.2	0.2	4.2	2.4	0.8	0.2	2.1	3.5	1.1	0.3	0.1	7.6	0.0	2.2	3.7	2.9	4.4	1.4	0.3	0.7	11.7	1.5	0.3	5.3	0.3	4.8	0.8	12.6	3.3	0.7	1.3	0.1	7.7	3.5	1.1	2.2	9.2	1.0	2.6	0.1	14.2	0.2	2.4	9.3	0.0	0.0	4.7	1.7	0.6	6.6	0.5	2.1	0.1	1.2	0.1	2.8	0.3	0.6	2.0	0.1	6.2	0.2	14.8	11.7	0.2	6.0	2.8	2.0	0.4	0.2	0.0	1.9	0.0	0.8	0.4	1.0	1.3	0.3	1.8	1.3	1.4	0.0	0.2	0.1	0.1	1.9	0.5	4.6	7.5	49.9	18.0	7.3	0.3	9.4	6.9	7.4	1.0	5.0	6.2	12.2	0.0	1.7	41.4	3.7	5.9	3.4	2.1	5.7	12.2	7.6	6.2	3.4	7.2	2.9	11.0	18.8	0.3	25.4	32.3	7.9	3.4	29.1	5.1	4.8	8.0	2.4	1.3	133.9	2.3	0.3	3.6	11.7	6.3	8.9	2.6	5.3	3.7	1.9	8.4	93.2	7.8	2.0	2.2	33.0	8.9	1.5	5.1	7.2	32.8	4.0	1.6	48.4	23.6	36.4	2.6	16.8	2.2	9.8	1.7	18.1	4.2	3.0	17.8	0.0	2.3	3.0	3.1	8.0	6.2	4.8	0.3	31.6	8.2	6.6	5.4
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	717	"salivary gland: 63926.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 194.0;Basal respiratory cells: 181.6;Breast glandular cells: 154.9;Club cells: 343.9;Intestinal goblet cells: 232.2;Prostatic glandular cells: 398.1;Urothelial cells: 357.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.3;intermediate monocyte: 11.4;non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 27.1;OE19: 57.5;SK-BR-3: 24.1;T-47d: 22.2"	"Not detected"	"Not detected"							"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		690000	"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	2.5	13.2	0.0	3.9	0.0	4.6	33.1	0.0	0.1	33.0	0.0	13.6	11.5	0.6	1.5	25.3	4.4	34.4	9.0	0.0	0.0	2.6	8.2	3.3	0.3	0.0	0.8	10.3	46.6	30.4	6.0	4.8	0.1	89.1	17.8	0.0	63926.2	7.1	6.1	47.7	9.6	0.4	0.0	4.2	33.2	4.4	0.0	0.2	2.9	0.1	5.9	11.2	16.3	0.0	0.0	1.1	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.3	0.0	0.2	2.1	0.0	4.4	0.0	0.0	0.0	9.0	2.8	2.4	1.6	0.0	0.0	0.1	0.2	0.0	1.2	0.1	0.0	0.0	0.2	3.6	0.2	27.1	0.0	0.4	0.1	57.5	5.0	0.0	0.0	8.6	0.2	6.3	0.0	0.0	0.1	24.1	0.0	0.1	22.2	0.0	3.1	0.1	0.5	1.9	0.1	0.0	0.5	0.3	0.3	6.5	0.3	1.7	6.3	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.4	1.2	7.4	0.0	0.5	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	9.1	194.0	181.6	0.0	0.0	154.9	82.5	0.0	70.1	343.9	1.8	0.0	0.1	2.0	107.1	0.0	5.9	7.7	3.5	1.6	2.8	58.2	0.4	0.0	28.1	3.2	1.8	21.9	13.0	5.7	1.7	0.7	0.1	14.6	0.0	0.0	232.2	140.4	4.6	0.5	5.7	0.0	4.4	83.6	0.0	5.6	0.0	0.0	0.0	0.0	46.4	65.3	0.0	0.0	398.1	12.5	0.0	74.7	0.0	0.0	0.0	19.2	1.4	0.6	9.5	24.0	0.3	2.5	21.3	76.7	357.4
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781655-122974510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 252.1;Microglial cells: 81.5;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 49.3;REH: 53.1;U-698: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.6	11.7	18.5	14.0	25.7	6.8	11.5	19.4	19.5	15.2	10.0	8.8	5.4	14.7	7.0	9.7	15.1	12.3	20.6	18.7	18.6	10.2	15.0	13.8	27.6	23.0	21.4	27.6	17.7	7.7	12.0	6.4	21.8	15.1	6.5	11.7	13.3	9.7	33.8	9.3	12.0	11.5	19.2	15.8	7.9	2.8	21.8	14.2	13.7	21.9	23.2	13.0	10.7	31.3	5.7	2.7	14.9	3.0	7.1	2.2	0.0	3.2	9.9	3.5	4.6	0.6	18.0	49.3	13.0	10.7	2.7	4.7	10.1	6.3	3.8	22.8	7.0	22.3	3.3	17.5	7.9	5.5	7.0	6.4	7.4	3.3	17.2	16.6	4.2	8.9	0.8	16.7	4.2	16.2	5.2	5.1	8.7	2.9	3.7	53.1	8.1	4.1	17.2	13.5	6.6	3.7	12.9	38.8	6.8	9.9	6.6	12.6	6.9	2.8	7.3	3.4	7.0	4.5	0.1	48.4	2.8	4.3	4.7	13.0	1.0	5.5	6.5	1.3	6.8	11.6	4.7	6.3	1.2	10.0	6.8	5.7	5.2	7.0	2.1	5.4	5.2	3.5	18.5	25.7	19.4	19.5	18.7	18.6	23.0	21.4	21.8	19.2	21.8	31.3	6.0	6.4	4.6	252.1	24.8	5.5	5.1	3.4	8.6	1.8	12.0	6.2	11.2	12.8	2.7	9.2	0.0	0.5	19.5	3.5	3.9	10.7	7.7	4.2	9.1	7.1	4.2	1.7	4.4	6.2	0.4	15.4	5.6	11.8	8.2	3.0	5.7	11.5	1.9	5.0	23.5	5.0	8.2	5.5	18.0	2.6	10.5	5.5	10.6	81.5	4.1	12.6	8.2	200.6	176.9	6.2	3.9	19.5	16.6	13.0	4.9	5.2	2.8	0.8	0.0	21.4	9.8	0.6	0.1	8.3	8.8	1.4	16.1	4.2	4.0	10.2
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 370.5;Early spermatids: 106.3;Excitatory neurons: 99.0;Inhibitory neurons: 96.5;Oligodendrocyte precursor cells: 139.7;Oligodendrocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA046498: AB_2679676"	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (7.52e-4)"	"prognostic unfavorable (1.84e-5)"	14.4	15.4	33.8	6.5	32.8	3.4	13.3	31.6	27.4	11.6	16.4	19.8	8.6	15.8	5.7	13.6	15.7	8.4	12.2	30.2	27.7	26.4	17.2	11.6	4.5	37.6	32.1	16.3	11.9	15.4	7.8	4.9	29.9	10.6	8.0	10.8	5.7	11.9	28.5	11.0	11.4	12.1	29.4	4.3	15.5	35.0	36.0	7.0	19.0	20.1	4.8	18.1	11.0	28.6	22.5	6.3	6.6	14.2	52.6	56.3	7.6	31.0	35.4	28.3	19.1	11.4	2.9	15.6	14.7	58.5	7.6	7.0	7.9	39.2	30.0	4.3	7.1	6.6	8.6	8.8	21.6	7.6	7.9	34.6	18.7	21.3	27.3	19.2	12.3	11.7	6.2	10.6	38.3	45.0	11.9	4.5	2.9	10.4	23.0	5.8	18.6	6.2	38.6	6.7	23.0	8.3	20.7	12.0	7.4	5.7	11.6	10.5	19.9	70.2	10.8	25.0	15.5	12.2	8.0	6.9	28.9	11.0	11.4	0.1	0.1	0.4	0.2	0.1	0.4	0.6	0.2	0.1	0.2	0.6	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.1	33.8	32.8	31.6	27.4	30.2	27.7	37.6	32.1	29.9	29.4	36.0	28.6	29.8	19.2	16.4	370.5	4.7	2.9	3.9	2.6	2.8	19.5	6.3	4.7	12.7	17.2	5.8	22.0	4.2	0.6	3.8	5.5	11.7	3.7	106.3	12.3	33.2	15.1	14.9	3.8	99.0	2.7	2.7	20.5	6.6	26.3	1.3	3.7	16.4	31.6	3.0	40.4	96.5	5.6	4.1	3.5	1.7	32.3	18.6	3.5	1.8	52.5	1.9	28.6	1.0	139.7	142.4	4.6	1.3	24.5	2.7	2.6	12.6	27.0	3.2	7.1	26.3	41.2	10.9	11.0	5.2	6.3	3.7	0.4	2.7	19.7	4.7	2.3
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981784-99986765	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"brain: 123.4;choroid plexus: 35.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 123.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 113.3"	HPA055031			Supported	"Nuclear bodies"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.0	0.2	17.0	0.0	19.0	0.0	0.0	123.4	16.2	0.0	35.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.0	10.4	0.1	0.0	0.0	0.0	20.9	14.8	0.0	0.0	0.0	1.2	0.0	22.5	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	4.9	86.2	5.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	5.8	0.0	7.3	0.0	4.6	0.1	3.9	0.0	0.0	43.5	66.1	6.4	4.0	4.4	0.0	0.0	4.3	0.0	6.2	0.0	3.9	0.4	0.0	2.2	6.5	0.0	0.0	2.9	0.4	34.3	80.5	0.0	2.0	19.8	3.3	0.1	0.4	2.2	179.7	0.0	2.8	0.5	0.0	3.3	4.2	33.5	0.0	20.2	0.0	3.6	5.8	0.6	0.0	0.0	4.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	19.0	123.4	16.2	16.0	10.4	20.9	14.8	22.5	8.8	27.1	11.3	0.2	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.7	0.0	0.0	1.8	6.2	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	10.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	1.5	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 38.8;Theca cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA003211: AB_1080661, HPA075255: AB_2732287"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	10.0	29.2	19.5	8.6	18.9	7.1	10.2	10.7	18.2	17.3	9.5	15.5	7.1	15.9	18.6	9.9	19.2	9.9	9.6	17.8	20.4	13.2	13.6	11.0	12.1	12.8	14.4	37.1	10.8	11.6	18.1	7.9	14.2	15.5	7.8	13.3	11.6	17.1	10.8	11.4	12.0	14.6	13.0	15.5	12.2	20.5	25.9	16.0	15.8	5.7	10.9	13.3	13.3	13.7	15.4	27.9	66.2	35.2	18.8	18.9	16.7	14.0	20.8	29.7	27.8	31.1	22.9	39.0	34.1	25.3	26.8	14.2	57.1	21.2	22.3	13.1	30.6	33.9	25.6	27.9	8.7	31.9	20.3	22.3	12.1	21.6	13.4	52.8	25.2	30.8	39.7	20.9	22.0	25.5	38.6	40.6	65.9	19.0	24.2	47.7	20.3	28.7	22.0	18.6	31.5	21.7	23.8	14.7	13.7	47.8	21.7	20.7	19.5	14.6	26.7	21.5	12.8	18.9	12.1	32.9	17.6	42.9	16.4	6.1	5.2	4.3	4.2	4.8	4.8	7.1	4.8	3.9	4.8	6.6	4.0	4.0	0.3	4.9	4.2	10.1	4.8	4.0	19.5	18.9	10.7	18.2	17.8	20.4	12.8	14.4	14.2	13.0	25.9	13.7	5.6	12.8	11.9	14.7	6.9	3.8	2.7	12.2	6.8	12.9	9.2	10.0	10.6	7.2	15.0	31.3	10.4	8.5	4.7	3.3	1.9	6.7	1.1	12.0	8.5	7.5	4.8	7.6	15.8	8.9	7.0	7.0	6.6	9.4	2.5	38.8	8.9	15.3	9.8	13.5	17.3	9.2	6.1	11.9	6.7	4.0	13.7	6.6	3.6	6.5	11.2	9.5	7.2	7.1	12.3	5.5	8.8	23.3	4.9	1.9	4.5	15.1	12.0	7.7	6.6	5.3	9.9	1.5	4.0	9.3	3.8	4.2	5.2	40.0	7.1	2.0
ZMYND10	"BLU, CILD22, DNAAF7"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50345732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 120.2;testis: 258.5"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"T-47d: 5.6;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.3	0.1	5.0	0.2	5.0	0.7	1.1	3.5	2.8	4.3	29.2	0.2	0.2	1.7	1.6	0.2	120.2	0.5	0.2	4.3	6.7	2.1	0.9	11.1	0.2	12.5	15.6	0.6	1.1	3.7	5.9	0.1	9.4	0.7	0.1	3.2	0.3	0.4	0.4	0.5	0.4	0.5	10.4	0.6	0.3	258.5	7.3	0.5	1.9	0.2	0.1	0.2	0.3	9.2	1.6	0.6	0.2	0.5	0.6	0.9	0.3	0.2	0.9	1.6	0.5	0.0	1.0	0.7	0.6	1.0	0.2	0.2	1.5	0.0	0.1	0.4	0.6	1.5	1.2	0.0	0.0	0.5	0.8	0.0	0.1	2.0	0.1	1.5	0.1	1.3	0.5	0.1	0.2	1.0	0.3	2.7	0.0	0.2	0.7	0.7	0.0	0.5	2.0	0.0	1.8	0.5	0.1	0.5	0.0	0.0	5.6	0.6	0.0	0.3	0.4	0.9	0.1	1.0	0.4	0.1	3.9	2.2	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	5.0	5.0	3.5	2.8	4.3	6.7	12.5	15.6	9.4	10.4	7.3	9.2	0.5	3.2	5.1	1.3	0.7	0.5	0.4	24.2	1.2	1.2	2.3	1.7	0.8	0.0	33.1	1.8	4.2	0.1	1.7	0.2	0.0	1.1	309.4	221.8	2.4	1.2	0.0	3.2	0.5	0.0	0.2	1.1	0.0	3.6	0.0	0.3	0.7	0.4	0.6	0.0	0.3	0.7	22.4	0.0	0.4	415.3	9.0	1.3	1.8	1.0	0.9	1.2	2.1	0.5	1.3	0.1	0.0	5.7	0.9	0.6	0.0	1.0	390.8	7.6	0.0	0.9	9.8	529.7	9.1	1.1	0.4	0.1	1.7	0.2	0.3	0.1
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	41.7	37.1	50.7	26.3	58.8	11.3	45.8	60.0	64.6	47.4	38.5	54.8	29.9	55.0	46.6	42.8	39.8	35.6	58.0	50.7	54.8	51.1	34.9	39.0	26.3	54.1	52.8	55.3	46.4	99.7	27.7	34.8	54.8	52.8	33.8	43.2	46.1	56.0	58.1	33.1	30.9	50.9	52.4	32.7	39.2	33.1	54.1	23.8	88.0	64.7	24.8	46.7	31.1	59.1	64.0	64.6	53.8	42.9	57.3	55.0	33.3	63.0	35.8	43.7	40.5	39.2	62.3	0.1	19.8	78.4	13.8	38.3	28.9	44.2	55.8	25.1	25.1	71.8	33.4	42.3	64.6	19.5	38.8	38.4	60.6	42.3	38.3	56.8	55.6	32.8	19.5	44.7	76.0	75.4	29.3	27.3	17.4	69.3	10.7	28.4	34.4	34.5	58.0	72.7	24.3	44.3	72.3	83.3	34.1	29.4	74.9	37.8	72.2	43.4	15.8	89.2	48.8	37.0	48.4	4.6	44.2	36.1	30.3	15.6	2.3	19.5	11.9	3.5	10.4	5.2	8.3	11.9	3.8	3.1	9.2	9.1	1.0	14.7	1.7	4.5	8.9	5.0	50.7	58.8	60.0	64.6	50.7	54.8	54.1	52.8	54.8	52.4	54.1	59.1	51.2	60.9	51.4	90.8	25.3	25.9	27.0	17.5	34.1	37.5	46.3	33.8	103.0	31.5	31.9	33.1	12.5	15.2	39.4	14.6	50.9	29.3	28.6	27.0	50.3	45.7	25.9	25.0	110.8	31.8	4.6	45.7	27.5	37.1	46.2	42.1	35.3	28.1	14.4	20.2	118.0	26.2	16.2	25.1	14.9	27.1	39.1	21.7	24.9	94.6	13.9	62.5	34.0	128.2	131.5	28.1	14.5	56.1	31.1	44.1	19.1	41.9	23.7	22.0	13.1	56.9	49.8	26.8	25.6	32.2	27.8	12.4	32.6	28.5	22.1	29.8
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4739833-4746119	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 28.3"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	1.8	1.3	1.6	2.4	1.6	1.0	1.7	1.6	2.5	0.9	1.7	0.8	4.0	0.6	0.5	0.9	1.1	2.8	0.6	1.6	1.8	1.9	3.1	4.6	1.7	2.4	2.0	0.7	1.2	5.5	1.4	1.2	2.0	1.7	0.7	0.3	3.1	0.8	0.4	1.4	3.0	0.7	2.0	5.5	1.9	28.3	2.4	0.8	1.1	0.1	0.4	1.8	0.7	2.6	2.1	0.3	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.5	1.1	0.9	1.9	0.0	0.0	0.0	0.2	1.6	0.4	0.1	0.0	0.2	0.7	0.0	0.2	0.5	0.3	0.0	0.6	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.6	0.6	0.9	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.6	1.6	1.6	2.5	1.6	1.8	2.4	2.0	2.0	2.0	2.4	2.6	0.8	0.0	2.0	1.3	0.6	0.9	8.0	1.8	0.6	0.3	4.4	3.7	0.7	2.8	3.1	1.8	0.0	0.1	0.2	3.3	0.0	1.6	191.4	2.8	0.3	1.4	1.2	0.0	0.0	3.9	0.0	0.7	4.6	2.7	0.0	0.3	3.9	0.6	5.2	0.0	0.1	2.9	0.0	11.9	7.3	30.9	0.6	12.9	1.8	1.9	21.9	2.0	0.0	1.0	0.5	3.5	1.4	2.2	0.1	6.7	3.8	0.8	3.7	0.3	0.0	0.2	1.0	24.3	2.0	0.5	0.9	0.0	0.2	0.3	1.3	8.5
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 392.5;tongue: 465.5"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.4	11.2	20.8	14.3	29.8	24.4	17.9	19.0	28.1	18.0	109.2	19.7	10.0	15.9	17.3	18.5	12.7	17.2	175.6	23.3	22.6	16.5	8.7	20.9	17.5	23.6	29.1	15.9	10.3	17.8	10.3	12.9	22.5	20.9	13.9	22.0	12.9	14.7	392.5	11.7	13.3	23.0	20.8	17.1	12.8	14.3	27.4	15.6	13.2	465.5	18.6	14.6	9.1	27.7	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	20.8	29.8	19.0	28.1	23.3	22.6	23.6	29.1	22.5	20.8	27.4	27.7	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225669-125375325	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	8.9	7.5	5.6	9.4	8.9	7.9	12.1	12.9	7.8	12.6	0.0	10.8	7.6	13.9	10.2	10.3	12.4	9.5	15.5	4.5	16.4	12.9	11.7	10.3	12.3	4.2	6.5	17.4	9.5	15.8	4.7	9.7	4.2	11.1	11.5	13.1	10.0	11.1	11.1	5.8	8.9	13.7	2.3	11.9	9.8	10.5	14.5	16.9	30.0	12.0	14.4	10.6	6.1	8.3	30.6	19.8	21.1	18.9	18.4	19.7	16.0	27.2	31.5	29.9	28.4	19.1	16.6	24.4	18.5	40.3	24.1	24.4	23.2	20.5	42.4	10.9	8.9	30.1	23.3	9.8	13.6	20.9	29.1	16.1	21.0	28.0	29.4	19.7	20.7	17.7	15.0	20.2	22.3	23.9	26.1	7.7	13.6	20.6	16.8	18.6	23.2	13.9	17.1	33.6	18.2	15.3	36.2	18.2	29.7	11.7	22.7	20.8	26.6	22.6	24.1	28.5	17.5	17.4	21.5	36.6	16.9	13.1	21.3	4.4	15.3	32.0	21.8	14.5	22.5	24.5	19.2	20.9	13.0	22.2	27.9	22.0	51.4	33.2	23.4	11.3	19.6	20.1	5.6	8.9	12.9	7.8	4.5	16.4	4.2	6.5	4.2	2.3	14.5	8.3	54.7	93.0	41.3	92.7	56.7	35.6	26.0	36.2	48.9	68.0	37.0	35.7	75.2	24.3	43.0	33.1	39.6	28.7	53.7	34.7	25.4	37.5	82.0	28.8	54.3	51.6	47.9	32.0	166.7	37.4	24.3	44.5	31.1	38.1	50.6	75.7	37.9	41.0	31.1	75.7	170.3	34.4	26.4	37.1	21.2	135.2	48.1	41.2	17.8	143.4	50.1	45.7	59.8	154.3	151.4	33.7	25.6	59.0	35.8	36.6	28.2	43.9	27.5	39.4	32.9	63.4	60.7	24.4	24.2	32.5	38.4	31.6	52.0	42.0	33.6	35.6
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	2.8	3.1	2.4	4.3	4.6	8.8	5.4	1.2	8.4	6.1	0.0	4.4	3.4	5.4	4.1	3.8	4.5	4.0	2.8	6.4	0.6	7.0	3.6	4.1	6.3	0.4	0.3	6.0	2.7	5.9	4.1	3.0	0.3	4.3	4.5	4.4	3.5	4.3	2.9	5.7	3.6	4.3	0.6	4.6	4.4	8.3	0.3	10.2	5.6	5.0	6.6	4.5	2.9	2.7	6.4	2.0	10.8	19.7	7.6	5.6	3.6	6.2	8.3	7.1	10.9	3.6	3.7	11.7	10.3	4.0	4.8	3.9	9.7	4.0	10.3	11.4	6.0	14.0	7.3	5.1	4.0	16.9	9.7	4.1	6.0	5.2	5.4	8.4	7.8	17.8	10.9	21.1	11.9	3.2	27.3	14.3	6.3	3.5	4.5	35.4	15.2	17.5	4.9	5.9	18.4	8.9	7.0	6.0	9.2	5.3	7.0	14.4	5.3	10.8	7.1	4.9	7.2	9.6	17.4	21.8	2.4	19.4	10.9	2.1	2.7	8.0	7.9	3.7	10.9	7.4	8.3	7.7	4.1	6.9	6.3	7.9	1.4	7.0	2.9	2.5	10.4	3.9	2.4	4.6	1.2	8.4	6.4	0.6	0.4	0.3	0.3	0.6	0.3	2.7	5.4	6.4	8.1	2.0	9.8	4.1	3.8	2.5	6.8	2.5	5.1	5.5	3.5	2.8	6.4	1.8	2.1	4.3	17.5	2.1	7.9	2.7	36.9	7.9	3.7	5.1	7.1	3.4	10.3	3.0	3.0	4.5	2.0	5.0	5.1	7.4	3.9	1.5	2.8	10.1	3.4	5.1	2.0	3.8	3.8	12.6	3.4	3.6	1.8	5.6	3.0	3.3	9.2	4.0	4.2	2.5	2.1	3.8	6.5	4.6	1.6	4.5	6.3	4.8	0.0	5.2	6.8	12.8	5.9	4.3	4.4	2.9	12.5	4.6	4.4	4.5
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 328.7;esophagus: 326.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 32.2;Pancreatic endocrine cells: 72.0;Squamous epithelial cells: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 51.8;monocytes: 27.4"	"Cell line enhanced"	"Detected in many"		"A-431: 124.4;EFO-21: 139.9;HBEC3-KT: 100.0;PC-3: 87.7;TIME: 236.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	5.2	11.6	4.0	5.6	4.2	8.7	12.2	4.8	3.7	69.5	10.9	4.5	1.8	21.8	328.7	326.7	16.4	6.7	1.8	3.2	3.9	11.0	2.1	12.1	4.5	3.5	3.8	6.1	4.3	3.7	8.4	24.9	3.5	24.5	4.2	3.4	44.8	144.1	2.9	53.7	2.6	10.3	4.2	4.5	7.4	3.4	4.3	3.6	21.3	2.9	41.0	11.6	117.5	3.9	124.4	25.9	2.4	1.6	3.0	4.0	5.5	6.0	0.4	14.8	2.2	0.9	36.7	1.6	139.9	9.0	1.4	17.3	3.7	100.0	60.1	1.5	2.4	7.9	9.8	4.1	7.0	0.5	0.6	2.9	70.2	1.6	57.0	14.6	76.5	1.6	0.5	1.1	0.4	29.1	0.5	0.7	1.9	31.4	87.7	0.5	0.4	0.9	7.7	11.5	1.0	8.2	0.2	22.7	3.6	23.3	23.3	2.7	236.2	0.8	50.5	3.0	4.5	1.2	1.0	1.1	1.6	8.9	1.7	51.8	27.4	11.4	1.0	24.4	0.6	0.7	0.7	1.2	7.4	0.6	1.1	0.7	18.5	0.5	21.1	4.9	1.0	20.7	4.0	4.2	4.8	3.7	3.2	3.9	3.5	3.8	3.5	4.2	4.3	3.9	1.1	12.8	2.6	1.3	0.7	9.2	6.2	5.7	4.6	0.5	5.7	7.6	0.9	1.5	9.4	9.2	2.1	3.8	1.7	1.0	0.0	8.6	0.6	14.1	4.2	1.1	0.0	0.0	1.0	3.0	5.0	2.2	2.6	32.2	1.3	3.9	1.4	0.1	9.4	0.0	1.7	2.5	2.0	11.3	4.0	0.3	1.2	9.5	3.6	0.0	14.4	4.0	0.0	1.0	1.4	72.0	0.3	1.2	0.1	7.6	0.3	1.2	6.9	0.3	0.0	0.5	1.9	4.2	5.8	69.7	21.2	0.7	0.8	0.4	2.4	21.3
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA054567: AB_2682527"	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	6.2	5.8	2.8	1.9	3.0	1.1	5.7	4.6	3.0	6.3	2.1	7.2	2.1	6.3	2.7	4.5	6.1	2.2	5.4	2.8	3.3	5.6	6.3	4.6	2.4	3.1	3.0	7.4	5.9	3.3	7.4	2.7	2.9	6.0	2.4	5.7	5.2	2.9	11.6	4.8	5.0	2.7	2.7	4.8	5.2	5.7	3.1	3.2	7.6	4.2	2.3	6.9	5.6	3.5	2.6	1.2	10.4	3.4	5.5	6.4	0.4	5.0	6.5	4.3	4.6	2.1	2.3	2.1	3.1	4.0	2.6	1.7	4.8	4.0	4.4	0.4	1.2	9.0	4.0	1.7	5.7	6.8	2.4	6.7	5.2	4.9	7.3	5.6	3.2	2.8	6.1	3.7	6.3	0.6	3.9	4.9	7.2	2.8	3.4	1.5	7.3	2.9	3.9	2.6	4.2	7.3	4.5	2.3	6.0	5.5	6.2	6.8	3.1	4.5	3.6	7.0	4.2	4.9	5.6	1.4	3.5	2.3	4.5	0.4	0.7	0.5	0.7	0.3	0.6	0.5	0.6	0.6	1.0	1.7	0.7	0.4	0.3	1.3	4.7	1.7	0.8	0.3	2.8	3.0	4.6	3.0	2.8	3.3	3.1	3.0	2.9	2.7	3.1	3.5	7.3	16.0	8.7	13.1	3.8	2.5	4.6	4.1	5.7	12.4	4.5	3.9	12.3	1.5	9.7	0.0	8.4	1.1	5.7	7.2	1.9	7.4	16.7	4.6	8.0	5.4	6.1	3.0	13.5	8.9	0.7	6.2	3.6	4.5	3.8	10.9	6.8	7.6	4.6	16.8	17.1	6.5	2.0	5.1	3.4	4.5	5.6	5.1	5.4	12.2	8.5	13.2	7.2	14.6	20.1	6.8	5.2	5.3	5.4	5.0	6.4	4.5	4.6	8.5	6.6	6.6	6.4	11.2	5.7	3.3	3.4	0.4	4.6	13.5	5.1	3.6
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.0	10.4	7.0	4.0	6.7	1.9	10.1	18.0	9.9	12.2	4.6	11.4	8.0	13.0	2.0	10.7	11.1	6.2	12.7	6.7	6.1	12.0	14.0	9.2	3.0	7.0	6.8	14.4	16.3	6.8	10.7	5.5	6.7	14.0	3.2	4.0	10.6	5.3	20.4	14.3	7.7	4.5	4.8	7.6	11.9	3.8	6.8	1.6	11.5	6.8	1.6	9.9	10.7	7.7	11.0	14.3	12.2	19.6	4.7	6.2	16.5	9.0	9.3	11.5	14.1	7.6	10.2	0.4	11.4	5.6	7.4	16.5	10.8	9.3	5.5	2.9	22.1	4.5	21.2	9.0	10.6	0.5	2.5	7.0	14.4	11.1	7.5	11.9	13.4	0.2	9.9	8.1	5.8	18.6	0.2	0.5	12.8	7.2	11.3	0.7	15.1	9.9	6.8	6.3	17.1	14.9	9.3	19.9	13.1	6.3	13.9	3.9	7.8	11.5	13.2	11.3	13.0	0.2	8.6	0.5	5.0	0.6	9.8	0.0	0.1	0.4	0.5	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.5	0.0	0.8	0.0	0.0	0.3	0.1	7.0	6.7	18.0	9.9	6.7	6.1	7.0	6.8	6.7	4.8	6.8	7.7	12.7	0.0	0.0	4.6	1.4	5.7	3.8	4.3	8.0	7.8	8.4	9.8	1.5	14.3	2.3	5.5	4.2	9.7	0.3	12.7	5.9	13.1	0.8	7.5	7.8	9.9	10.3	0.8	3.2	13.7	13.8	7.5	10.2	7.3	4.5	20.1	12.1	8.6	8.9	6.7	4.3	14.6	2.0	4.4	4.2	1.5	17.1	3.7	5.4	3.7	4.2	9.6	0.0	3.5	6.7	14.0	7.7	19.5	0.1	3.8	19.5	15.3	1.9	8.4	26.3	9.1	9.8	1.7	2.1	7.5	5.5	4.8	0.4	15.0	13.0	2.1
ZNF207	BuGZ	ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350132-32381885	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	71.8	65.5	36.8	74.0	40.2	239.5	67.8	50.3	45.3	72.0	44.4	68.7	55.1	70.6	72.0	111.1	62.3	58.5	60.5	38.6	37.7	63.2	63.4	72.3	101.0	39.3	37.2	71.7	55.3	72.0	61.3	78.7	40.7	57.2	81.3	61.9	71.6	56.4	84.5	76.3	63.6	77.8	40.7	69.3	63.6	66.3	39.4	103.8	63.0	62.1	128.6	93.2	78.2	48.0	169.9	203.5	215.8	122.4	113.0	121.3	172.6	165.5	231.9	230.1	205.3	195.2	157.3	231.5	124.8	204.6	178.5	170.6	282.1	200.6	258.1	120.0	188.9	237.9	183.8	202.9	118.2	305.0	209.4	141.3	118.3	162.0	89.6	129.4	215.9	115.5	245.9	173.2	223.9	154.6	245.2	142.5	187.1	160.8	114.8	217.5	193.5	217.0	191.5	324.9	150.6	167.7	155.8	113.2	148.1	183.9	204.8	178.7	154.1	129.4	153.4	132.5	227.8	146.7	235.6	369.5	110.6	141.9	204.9	110.5	75.7	78.1	67.6	84.8	70.2	59.7	61.7	62.7	99.8	44.7	50.8	59.1	38.6	83.9	92.5	47.1	86.9	90.6	36.8	40.2	50.3	45.3	38.6	37.7	39.3	37.2	40.7	40.7	39.4	48.0	119.3	80.1	114.7	135.8	131.1	149.4	195.5	120.8	149.1	134.2	108.8	64.1	32.9	65.8	146.1	64.4	225.2	123.3	191.1	118.2	54.8	94.9	62.0	101.9	116.9	110.1	115.9	125.1	171.2	105.7	175.5	101.3	124.9	144.2	75.3	152.8	85.3	58.4	98.7	101.0	163.0	95.2	93.6	98.8	130.2	26.1	107.2	133.1	55.2	123.7	175.8	55.0	168.9	215.7	257.4	146.5	91.2	97.8	144.9	160.3	101.7	57.7	115.0	141.0	124.9	146.3	145.6	136.3	113.5	175.9	148.5	178.7	143.8	90.0	109.9	250.3
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142804	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.7;Late spermatids: 58.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: AB_2683225"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	4.3	6.7	5.0	3.6	4.9	3.9	4.6	5.7	6.2	5.1	0.9	5.7	5.5	6.5	1.7	6.9	5.1	3.2	5.6	4.9	3.3	4.6	2.5	3.5	5.7	7.1	4.6	6.5	7.2	4.9	6.7	2.1	4.7	5.7	1.2	4.3	10.4	3.0	11.5	10.0	6.8	2.3	3.4	4.9	5.7	17.9	5.1	2.5	5.2	1.2	0.9	5.7	5.2	5.4	3.6	11.1	4.9	11.3	4.7	3.8	6.0	6.4	2.6	3.3	3.9	3.6	7.2	4.3	6.2	4.2	4.9	8.4	2.2	7.1	1.3	9.2	8.3	2.4	13.4	7.0	8.8	7.5	7.8	3.7	8.7	4.4	1.8	2.5	2.5	8.2	8.0	9.4	2.2	15.1	7.0	9.1	8.3	3.8	8.4	9.4	5.7	8.1	2.6	2.4	10.0	8.5	9.7	5.7	4.7	3.1	7.5	12.8	6.3	6.8	6.2	7.7	4.5	5.2	5.4	6.4	2.7	9.9	5.3	0.0	0.5	1.3	1.2	0.9	1.1	0.9	1.2	0.8	0.5	1.5	1.5	1.1	1.3	1.6	0.7	1.2	0.7	0.8	5.0	4.9	5.7	6.2	4.9	3.3	7.1	4.6	4.7	3.4	5.1	5.4	4.1	0.0	1.1	3.6	1.9	1.9	1.5	2.1	2.8	5.3	4.8	4.2	4.4	1.5	1.7	0.0	2.1	1.8	3.4	10.2	1.9	4.0	22.7	3.0	3.1	3.4	2.4	2.1	3.2	4.9	2.0	3.9	4.6	4.4	4.5	4.8	4.6	1.4	3.2	8.4	3.5	6.0	0.0	5.1	1.7	58.3	6.5	3.6	0.0	1.0	4.4	5.6	5.2	0.5	4.6	5.2	4.2	7.2	1.3	2.1	14.6	2.5	1.5	5.2	19.7	3.9	4.1	9.5	4.5	4.8	2.0	1.4	2.3	3.5	6.6	1.8
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	15.5	15.4	12.5	17.6	14.2	9.6	17.0	15.9	13.9	16.2	16.0	15.0	18.1	17.8	23.1	9.4	16.1	13.8	12.5	12.3	13.3	14.3	15.8	16.3	22.4	13.1	13.2	20.6	14.7	14.1	19.5	14.8	13.7	17.1	21.2	17.8	15.6	15.7	7.5	24.6	22.2	13.3	12.6	27.2	16.0	6.4	13.4	18.3	19.8	5.9	22.6	12.7	13.0	16.7	8.5	13.9	14.7	12.1	14.4	15.0	12.0	10.5	15.6	7.1	16.2	7.0	6.6	10.2	11.3	13.9	5.4	9.5	8.1	9.0	9.4	10.5	16.4	19.7	26.5	7.3	7.6	14.3	22.0	18.6	16.0	8.8	13.1	22.6	13.1	10.1	6.1	12.0	12.0	2.2	12.6	17.2	6.4	4.7	9.5	7.4	15.9	6.3	10.8	26.9	7.5	17.1	14.4	6.2	5.0	14.4	6.1	18.5	13.8	15.7	10.1	7.1	7.4	16.2	16.3	5.8	8.4	11.0	7.4	49.6	9.1	22.0	18.4	6.3	20.3	16.9	15.5	18.7	9.7	17.8	19.5	15.1	6.9	16.7	13.7	8.7	19.5	10.4	12.5	14.2	15.9	13.9	12.3	13.3	13.1	13.2	13.7	12.6	13.4	16.7	16.0	22.4	14.6	16.3	26.2	5.6	7.3	14.7	10.8	26.8	9.1	5.7	4.7	18.6	11.3	25.8	18.8	13.1	30.4	14.5	1.9	8.1	14.5	7.9	9.9	12.2	9.6	12.0	26.2	5.3	8.1	12.4	8.6	8.2	21.0	20.5	16.1	7.6	7.3	26.9	23.4	11.2	20.3	13.9	8.9	4.4	16.1	10.4	5.4	14.0	19.8	11.8	47.4	14.1	29.0	8.6	13.3	13.9	12.1	10.4	29.8	3.3	7.4	22.1	13.1	10.9	9.3	5.4	4.1	6.8	6.8	8.2	27.3	19.9	11.0	9.3
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.64e-4)"	6.3	6.9	9.5	5.9	10.3	5.0	8.3	14.0	10.7	7.8	8.8	6.9	5.4	8.0	7.6	6.6	8.0	5.9	5.7	9.2	10.5	6.9	7.4	6.1	10.3	9.7	10.1	11.0	6.6	10.4	8.0	7.7	9.9	8.5	5.8	8.7	5.6	6.9	6.4	6.5	5.8	6.8	9.6	9.5	8.6	7.4	10.1	17.2	8.3	6.4	11.2	7.1	6.5	13.2	9.6	13.4	15.8	19.7	12.6	10.9	7.4	9.2	13.1	8.7	17.0	6.6	7.3	16.8	13.9	8.6	10.4	5.5	18.2	9.7	11.7	21.9	22.8	29.3	14.7	8.2	9.0	25.8	12.4	9.9	10.6	8.6	16.0	14.5	13.1	19.2	2.9	0.4	9.4	5.1	24.3	6.8	25.3	9.8	7.0	14.4	15.9	14.4	9.0	17.2	26.7	27.3	20.6	9.2	7.2	15.2	7.7	13.7	11.3	9.6	15.8	7.4	11.8	37.6	54.5	36.1	6.3	10.6	13.1	17.3	4.8	9.9	10.8	3.5	11.8	12.0	10.2	10.6	5.9	12.2	13.3	11.2	4.2	11.9	3.5	6.2	13.5	5.7	9.5	10.3	14.0	10.7	9.2	10.5	9.7	10.1	9.9	9.6	10.1	13.2	8.0	0.0	1.5	13.7	8.1	3.1	3.8	4.8	3.4	6.0	5.4	4.6	7.0	1.5	6.4	5.5	2.1	5.6	6.3	3.3	3.9	4.2	22.6	4.0	4.6	8.4	2.4	7.8	10.5	4.0	4.5	4.4	3.6	3.7	1.3	8.7	8.9	3.9	4.4	8.4	10.3	4.7	2.0	5.7	3.7	30.0	5.6	3.9	1.8	9.4	5.2	6.3	11.3	17.1	16.8	6.1	3.3	5.7	4.0	6.0	4.2	3.3	4.1	5.4	6.6	5.9	5.5	4.4	8.7	3.3	3.8	2.2	6.9	8.6	3.3	2.9
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.1;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	1.8	1.2	3.0	1.1	3.5	0.4	1.9	3.4	4.3	2.7	3.1	2.7	1.0	2.4	2.4	1.6	2.3	1.3	2.0	3.1	3.5	2.3	2.1	1.5	1.9	3.6	3.1	3.4	2.8	1.9	1.6	1.5	3.5	2.1	1.3	2.3	1.9	1.3	2.0	1.4	1.8	1.9	3.1	1.9	2.2	2.6	3.5	1.6	2.4	1.8	1.4	1.8	1.8	4.2	5.8	4.3	6.9	7.0	2.4	1.0	3.7	2.8	1.4	2.7	3.7	6.7	1.4	11.5	3.4	1.0	4.0	3.9	4.9	2.8	1.6	4.6	7.4	2.0	10.0	6.0	3.5	0.0	3.4	1.9	3.0	2.9	2.5	1.9	2.0	13.7	10.0	4.1	3.3	2.8	10.1	4.0	13.5	4.9	4.6	8.5	4.4	7.8	2.2	0.8	7.2	4.7	5.4	2.1	4.6	5.2	1.1	2.8	3.2	2.7	4.6	2.1	5.5	5.5	9.3	3.0	6.9	0.3	4.6	1.3	1.9	1.9	4.2	2.0	5.2	12.5	4.7	5.8	3.9	11.4	7.0	6.5	0.1	5.7	1.2	7.4	4.3	3.5	3.0	3.5	3.4	4.3	3.1	3.5	3.6	3.1	3.5	3.1	3.5	4.2	4.2	0.0	2.6	2.0	5.2	4.2	2.9	4.0	5.7	5.7	3.8	6.6	5.6	0.0	3.9	5.5	0.0	3.9	3.5	3.1	3.9	7.0	8.6	5.5	6.8	5.2	1.2	2.1	3.4	4.0	5.0	3.4	1.5	2.2	0.0	4.0	3.6	3.9	6.1	0.0	3.3	2.4	0.0	3.8	1.3	6.9	3.7	2.9	0.0	3.7	1.8	4.2	0.0	3.0	8.1	3.7	7.6	5.3	1.4	4.1	2.6	3.2	6.5	3.9	0.0	4.4	4.4	18.1	21.7	3.3	4.7	2.1	3.2	3.4	3.8	1.8
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822557-76972901	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	2.5	2.2	3.2	2.2	5.3	4.9	2.4	9.2	4.4	3.0	0.0	2.8	1.9	3.2	2.8	2.5	2.9	2.0	2.3	3.4	4.3	2.0	2.1	2.1	2.6	2.3	3.5	4.3	2.8	3.1	3.6	2.2	2.6	2.6	1.5	2.4	2.7	2.3	2.5	4.1	2.5	2.1	1.4	2.3	2.8	6.8	3.5	4.1	2.6	3.1	2.4	2.6	2.9	5.7	2.5	2.4	4.7	3.4	3.7	3.4	1.9	1.8	2.6	2.9	2.4	2.3	2.3	3.6	0.9	2.5	3.2	4.6	3.0	2.8	2.5	3.8	3.1	3.4	3.9	2.8	2.1	5.7	3.7	3.4	3.1	2.8	4.4	3.4	3.0	5.5	3.3	2.9	3.1	2.2	6.9	3.2	2.5	0.6	2.6	4.3	4.9	2.4	2.4	3.8	2.6	2.8	3.6	2.2	2.5	2.2	2.5	3.9	3.2	5.3	2.0	1.3	2.9	2.0	3.0	4.4	3.6	3.0	3.9	0.7	2.0	3.9	3.1	1.9	3.0	5.9	2.3	2.1	1.4	4.4	2.6	2.7	2.1	1.9	1.8	2.8	2.7	0.9	3.2	5.3	9.2	4.4	3.4	4.3	2.3	3.5	2.6	1.4	3.5	5.7	9.3	9.6	7.9	39.5	11.9	7.1	8.5	5.4	10.8	15.3	8.0	7.6	9.5	12.8	6.7	7.3	10.4	8.4	12.9	5.6	1.9	5.4	6.9	10.8	12.6	9.3	6.0	12.8	37.7	3.9	7.2	8.8	9.2	10.5	1.3	15.8	10.0	6.8	6.0	25.2	25.3	5.0	6.1	7.2	7.2	6.0	10.5	8.7	7.2	16.9	8.4	9.7	9.2	41.7	39.7	4.7	3.1	7.2	9.1	6.8	5.9	3.0	10.9	15.9	6.6	14.2	10.4	26.7	26.2	8.8	8.4	6.0	12.4	7.8	5.7	6.3
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87265943	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	6.8	6.3	4.4	7.8	4.6	25.4	9.6	17.8	8.7	8.7	1.8	7.3	7.9	10.3	9.5	6.6	6.2	6.7	6.2	3.9	3.1	6.3	6.4	5.7	10.9	3.2	2.5	13.7	6.9	13.8	8.5	8.8	3.8	8.2	6.8	26.4	8.3	7.2	5.5	8.6	8.8	6.4	2.2	8.0	8.1	6.2	3.7	14.3	9.6	5.6	9.1	7.1	7.3	10.3	8.3	4.7	16.1	14.2	9.0	8.1	16.8	6.4	8.1	7.4	10.1	8.2	5.7	12.8	9.0	8.4	10.4	8.4	10.1	9.6	15.9	29.3	7.6	17.3	6.4	6.8	6.7	14.0	7.6	8.1	9.2	7.3	9.4	11.8	6.9	13.6	12.8	19.1	8.1	4.6	8.1	12.0	8.1	2.9	4.4	16.9	15.9	4.9	6.2	17.8	11.9	16.8	8.0	5.3	6.1	9.2	5.4	16.0	7.8	9.8	6.8	7.2	10.1	17.5	12.3	8.6	10.8	11.8	7.2	60.3	16.9	20.0	15.7	5.4	14.8	46.6	16.8	17.3	8.0	42.8	18.7	16.1	83.6	11.2	5.7	25.0	18.3	8.3	4.4	4.6	17.8	8.7	3.9	3.1	3.2	2.5	3.8	2.2	3.7	10.3	64.2	60.9	72.4	147.2	99.0	66.2	31.2	46.1	70.0	167.7	48.0	47.9	76.8	48.6	51.8	25.8	123.0	27.0	89.9	64.9	9.8	122.3	44.4	119.3	89.6	55.6	47.3	43.5	176.6	38.5	36.6	52.3	66.3	203.1	29.1	135.6	40.0	19.0	26.8	186.7	225.7	52.7	40.7	29.2	53.1	12.4	60.0	46.3	32.0	124.6	53.0	62.5	65.9	210.6	209.8	52.2	49.5	66.2	90.8	49.4	72.5	14.5	50.1	99.4	32.9	84.6	59.5	56.3	34.1	36.7	51.4	211.8	90.8	66.8	44.5	58.5
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 36.1"					"Low region specificity"	"Detected in all"			"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	3.6	1.0	2.3	2.6	3.2	2.7	4.5	3.8	2.8	6.5	2.3	3.6	2.7	7.4	2.3	5.1	4.4	3.3	3.2	2.3	2.9	7.4	1.2	2.4	3.0	3.0	3.1	10.2	5.5	0.8	2.4	1.5	3.1	5.4	2.7	9.1	2.8	2.3	0.9	4.4	3.8	4.0	2.6	3.9	4.7	6.4	2.9	2.8	6.9	1.5	2.9	4.5	4.9	3.5	2.1	4.7	28.2	0.0	2.4	5.8	0.0	7.1	5.6	6.1	8.7	2.4	3.5	0.0	6.1	5.9	18.3	4.2	0.0	16.2	9.5	0.0	9.3	0.0	36.1	3.9	5.0	0.2	0.1	8.9	5.0	12.7	14.7	8.6	10.4	0.1	0.0	15.1	6.1	0.0	0.0	1.5	27.2	0.0	0.0	0.0	4.1	8.5	4.4	5.3	15.9	26.2	16.7	14.3	9.8	17.1	9.4	0.0	4.6	8.1	3.4	5.9	12.9	0.5	0.2	0.0	0.8	0.1	17.1	0.0	0.1	0.3	0.1	0.4	0.0	0.2	0.2	0.0	0.3	1.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	2.3	3.2	3.8	2.8	2.3	2.9	3.0	3.1	3.1	2.6	2.9	3.5	2.0	0.0	0.5	0.3	1.8	1.5	3.1	2.3	7.4	4.0	2.3	1.7	0.6	1.5	2.7	7.3	0.0	0.7	1.9	0.3	1.9	2.5	3.2	1.8	5.3	2.3	3.0	4.0	0.8	1.6	2.2	3.8	13.3	1.9	0.0	11.5	1.8	0.2	0.5	0.0	1.9	1.4	2.0	1.0	1.2	0.9	2.5	0.8	0.0	5.6	1.5	3.3	3.1	5.5	6.7	1.8	0.1	1.2	0.3	2.0	0.6	1.8	0.8	4.3	6.6	4.1	2.8	7.2	3.7	5.9	2.3	0.8	1.2	2.7	1.8	3.0
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA043973: AB_10961277, HPA054680: AB_2682571"	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	6.3	3.8	4.5	3.7	5.0	6.3	5.2	5.9	5.4	6.8	3.5	6.1	1.9	6.4	4.6	2.3	6.7	2.9	3.5	4.5	4.3	3.2	2.2	4.2	3.5	4.8	4.7	7.3	4.3	3.1	3.0	3.4	5.1	4.3	2.5	5.6	3.0	3.6	7.8	3.6	3.7	5.2	4.6	6.8	3.6	3.8	4.9	3.5	3.3	4.1	3.0	5.7	4.7	6.6	1.2	0.8	4.6	6.1	6.6	6.2	1.8	2.7	4.0	2.5	3.6	0.1	0.9	1.8	3.3	3.5	0.6	1.0	1.2	0.9	3.6	4.9	1.3	8.5	1.9	1.8	5.5	3.2	4.6	5.4	3.2	2.1	6.6	3.3	3.6	2.2	1.5	3.9	3.2	0.5	1.7	8.1	1.7	2.8	1.5	3.1	2.6	1.9	2.4	1.4	2.5	5.1	2.6	0.3	4.9	1.8	1.1	5.5	5.8	4.1	1.9	6.9	3.0	1.7	0.9	1.7	4.3	5.8	5.0	8.6	3.4	5.3	3.5	4.5	4.6	2.3	3.0	2.9	4.3	2.2	3.5	3.3	6.4	13.8	4.6	2.7	3.2	2.2	4.5	5.0	5.9	5.4	4.5	4.3	4.8	4.7	5.1	4.6	4.9	6.6	8.8	6.4	8.7	9.1	6.6	3.1	5.4	1.6	6.2	12.7	4.5	5.6	3.7	0.0	2.7	3.7	4.2	3.0	4.7	2.2	1.9	2.7	5.8	2.3	9.0	7.5	2.4	3.4	12.6	3.0	3.0	9.1	3.1	3.1	16.5	12.0	5.0	2.2	5.1	8.4	15.7	1.0	4.1	9.1	6.0	3.7	9.9	8.0	1.8	11.2	9.5	5.5	12.3	13.6	22.9	2.3	2.1	9.1	4.1	4.1	2.0	2.1	3.5	17.4	13.1	10.8	9.8	11.9	7.3	2.6	2.7	1.4	5.5	4.3	2.3	3.5
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: AB_2683199"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	9.2	12.6	5.8	12.2	7.0	12.2	17.9	17.1	7.6	14.5	9.6	12.2	13.4	15.1	10.9	9.3	14.9	11.8	9.0	5.0	7.8	15.3	16.3	10.1	14.8	9.5	7.1	14.8	16.9	17.1	14.0	11.4	9.9	15.1	15.8	20.6	14.9	14.3	13.9	13.9	13.7	10.3	6.7	14.2	16.7	4.3	6.8	14.0	15.7	15.8	16.2	11.0	10.3	8.4	16.3	9.1	16.2	14.1	7.8	9.8	12.8	7.3	7.1	9.1	10.2	9.7	14.5	31.5	7.7	9.8	5.2	10.6	19.3	12.6	8.5	18.9	22.0	25.2	18.6	13.2	7.9	36.0	20.2	8.6	22.5	6.9	10.1	17.0	7.5	17.7	13.5	16.5	9.3	10.6	15.0	8.2	16.4	8.2	10.5	12.9	11.2	14.8	12.8	15.0	12.6	19.8	11.3	12.3	6.4	11.2	14.8	9.5	7.3	8.0	11.7	9.0	5.8	13.0	17.1	18.5	7.4	19.7	3.7	12.7	3.6	6.1	5.4	5.0	4.7	6.4	4.7	3.6	3.4	6.2	5.8	4.6	15.9	4.7	6.6	6.3	3.6	3.1	5.8	7.0	17.1	7.6	5.0	7.8	9.5	7.1	9.9	6.7	6.8	8.4	28.4	60.9	73.0	39.8	47.5	11.9	33.0	25.6	19.4	38.2	33.4	28.6	70.6	31.5	49.0	27.6	33.3	28.4	43.1	27.1	25.4	34.9	4.6	62.8	19.3	31.6	34.1	30.3	47.4	29.2	20.0	23.5	25.5	37.7	33.6	47.6	21.4	39.6	19.4	30.3	63.9	28.2	18.3	22.8	16.8	6.7	23.9	26.1	10.6	58.1	46.9	21.1	38.1	56.3	81.5	32.0	29.6	24.0	32.1	38.9	22.0	39.3	80.8	31.8	26.3	32.7	22.7	15.3	18.9	18.7	12.8	35.6	34.6	33.2	27.5	38.4
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.0;Inhibitory neurons: 14.2;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA030587: AB_10603246, HPA052438: AB_2681833"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	6.8	4.4	4.3	5.2	3.9	1.9	8.1	6.6	6.8	7.4	3.9	7.5	4.1	8.0	10.3	5.6	6.6	4.3	4.2	4.6	4.8	5.5	4.7	5.2	5.3	3.2	3.4	7.9	4.5	8.7	4.7	6.2	3.5	5.8	5.9	6.2	5.5	6.1	7.9	8.0	4.2	7.7	2.3	5.8	4.9	4.4	4.4	5.6	6.4	8.9	6.2	6.7	6.2	5.8	11.7	14.5	8.7	10.5	10.1	10.0	3.4	8.7	9.3	10.2	10.1	8.2	6.8	18.1	3.6	8.3	10.7	12.4	13.8	15.7	13.0	4.4	7.6	9.9	6.9	18.0	9.2	6.8	4.0	10.3	15.0	13.2	20.6	11.2	10.1	11.5	13.9	7.6	10.0	4.7	13.1	5.8	9.0	10.5	13.8	11.1	12.3	10.1	6.3	5.8	10.7	16.6	10.5	17.1	10.6	7.1	6.1	6.1	7.5	13.6	6.7	10.8	10.1	15.4	28.3	8.1	3.2	8.7	8.7	0.5	2.2	2.7	2.9	2.3	3.5	4.0	3.9	2.4	2.3	4.8	4.0	4.7	1.7	1.3	2.1	3.6	3.4	2.1	4.3	3.9	6.6	6.8	4.6	4.8	3.2	3.4	3.5	2.3	4.4	5.8	2.0	3.2	1.5	6.2	4.0	2.0	1.6	0.9	5.2	4.1	1.8	1.5	1.9	1.5	2.3	1.8	0.0	2.4	2.2	1.6	1.9	2.2	0.9	0.9	3.3	2.2	3.0	0.8	14.0	0.9	1.3	3.6	2.0	1.2	1.3	2.2	1.8	3.6	1.4	8.4	14.2	2.2	4.1	1.3	1.2	0.2	4.1	1.4	1.8	2.8	1.4	2.6	1.0	13.6	8.9	2.5	0.8	3.0	2.3	2.1	1.8	3.4	1.0	2.9	0.0	2.2	3.9	4.2	3.5	4.5	2.3	0.8	1.9	2.0	2.5	1.7
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431705-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	4.2	3.0	2.3	1.8	2.5	1.3	3.9	4.3	2.4	6.0	1.1	4.7	1.4	5.1	2.0	2.7	5.0	1.6	3.6	2.4	2.4	3.3	4.9	4.1	1.9	2.1	2.1	7.0	4.4	2.8	5.0	2.0	2.2	4.4	1.7	4.2	3.6	2.1	4.4	3.7	3.5	2.2	1.7	3.9	3.9	3.1	2.2	3.3	3.8	2.7	2.1	4.1	4.4	2.9	1.9	2.1	6.4	5.1	3.5	3.6	2.9	2.5	2.1	3.7	3.7	3.2	1.6	3.3	1.5	2.6	2.3	1.5	4.4	1.7	4.5	3.6	1.6	6.1	4.7	3.2	2.2	7.8	4.9	2.5	2.1	4.2	2.6	3.1	2.6	4.6	4.8	2.4	3.0	1.2	7.5	5.2	4.4	1.2	1.9	3.3	4.0	1.6	2.0	3.8	3.2	3.9	3.9	2.0	1.0	4.7	3.7	3.4	3.2	5.2	4.6	3.2	3.2	1.9	1.5	2.7	1.9	3.8	3.2	1.0	0.3	0.6	0.3	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.3	0.2	1.0	0.5	0.8	0.3	0.1	0.1	2.3	2.5	4.3	2.4	2.4	2.4	2.1	2.1	2.2	1.7	2.2	2.9	11.7	12.8	17.4	19.2	8.4	4.1	4.4	2.9	9.6	36.0	4.8	4.4	11.1	5.7	7.6	11.0	37.5	4.1	15.7	3.8	1.9	5.8	2.5	6.3	14.1	9.7	7.2	10.3	21.7	8.4	1.7	9.0	7.1	6.8	11.4	26.6	13.2	10.1	5.7	28.6	24.3	6.3	2.0	16.4	4.7	2.2	9.3	10.5	0.0	9.4	11.6	10.1	22.6	11.6	19.5	4.9	6.0	9.8	9.5	5.6	4.3	2.8	9.6	28.4	13.1	14.5	10.6	6.7	6.9	5.6	2.6	1.4	9.8	9.3	7.2	3.8
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912624-43935282	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA038611: AB_10669544, HPA075124: AB_2686735"	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	4.8	5.5	3.0	5.1	3.7	6.3	7.1	6.3	3.4	6.7	3.7	5.2	5.6	7.1	5.5	4.6	6.5	5.1	4.6	3.1	4.9	5.8	5.8	5.9	7.3	3.7	3.4	9.0	4.0	9.7	5.0	5.3	3.2	6.7	6.1	8.5	4.9	5.8	6.5	5.9	5.3	6.0	3.2	7.3	5.0	3.6	3.8	10.7	7.4	5.8	7.1	5.1	3.9	4.5	9.2	12.1	16.9	15.1	8.0	7.0	5.9	11.7	12.7	12.0	18.2	5.9	3.7	13.3	7.0	7.3	9.2	5.2	12.9	8.5	15.0	11.2	13.7	19.7	10.6	5.3	7.4	19.5	12.8	7.1	8.4	8.8	7.7	11.9	9.7	4.5	6.3	5.2	13.0	4.2	11.6	4.9	19.8	8.6	5.1	9.4	16.8	4.8	7.3	20.1	11.6	19.0	16.4	6.6	5.8	10.8	6.9	12.7	10.1	13.3	19.4	5.6	10.8	21.1	37.1	14.5	5.6	7.5	15.7	3.4	3.7	5.7	5.6	3.4	8.4	5.8	5.4	6.0	4.9	4.1	7.4	5.0	1.1	6.3	4.7	3.2	6.1	4.2	3.0	3.7	6.3	3.4	3.1	4.9	3.7	3.4	3.2	3.2	3.8	4.5	2.9	3.2	1.7	7.5	4.2	1.5	0.8	2.2	3.4	1.8	3.1	2.0	3.3	1.5	3.6	0.0	6.2	2.0	5.1	2.4	0.0	2.3	0.2	2.4	1.9	2.4	2.4	3.4	5.0	1.5	1.1	2.3	3.6	2.6	0.0	3.2	1.8	2.1	2.9	3.3	4.9	3.2	2.0	2.8	1.6	0.6	1.8	2.5	1.8	10.3	2.4	1.6	1.0	8.0	9.0	1.2	0.7	4.9	1.5	1.7	2.6	1.9	4.1	2.4	19.7	2.4	1.9	1.1	2.1	3.9	1.6	1.2	3.7	2.4	2.1	1.5
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863166-107013634	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.9;Oligodendrocyte precursor cells: 486.5;Oligodendrocytes: 152.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	3.4	8.4	10.6	1.9	16.6	0.1	3.8	13.9	14.2	8.0	6.2	4.9	1.0	4.2	1.8	7.8	5.2	2.9	5.8	8.6	16.4	3.9	1.6	3.0	0.8	14.7	16.0	7.4	1.1	6.1	4.1	3.1	17.6	6.8	3.8	8.2	7.7	4.1	13.2	6.7	2.2	6.7	10.0	2.9	1.7	5.9	16.0	2.0	7.2	5.8	1.3	3.9	6.2	15.9	4.8	12.6	22.5	14.0	6.9	4.9	3.2	3.2	4.0	2.8	3.0	14.8	5.7	0.1	8.3	2.9	13.8	7.6	14.9	12.4	3.5	0.1	2.1	0.0	5.3	0.1	2.6	3.4	0.4	4.6	6.0	6.8	18.0	7.4	1.3	6.0	0.0	6.7	7.3	8.2	2.7	0.1	16.0	0.0	10.0	0.0	15.4	0.3	7.8	4.4	10.6	12.3	6.3	0.1	4.7	13.7	11.2	0.1	1.3	3.8	13.2	8.1	9.8	0.0	0.1	0.1	5.8	0.3	13.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.6	16.6	13.9	14.2	8.6	16.4	14.7	16.0	17.6	10.0	16.0	15.9	25.6	22.4	29.1	114.9	0.9	33.6	10.8	10.6	44.9	60.7	21.6	18.7	27.7	25.8	10.3	7.3	31.3	14.4	0.2	14.7	5.9	7.9	63.1	7.6	25.5	23.3	16.8	2.1	18.4	2.6	7.3	14.1	4.1	10.1	17.1	18.7	40.4	0.0	1.8	18.5	91.6	15.5	12.2	0.8	4.2	16.8	14.6	1.3	12.4	15.9	2.0	19.8	0.0	486.5	152.2	7.7	5.3	27.1	0.0	15.1	6.3	17.4	15.2	39.4	26.3	21.5	22.1	1.3	24.7	24.0	11.5	3.1	1.1	22.0	17.5	6.6
ZNF479	KR19	ENSG00000185177	"Zinc finger protein 479"	Q96JC4	7	57119614-57139864	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 2.2"	"Group enriched"	"Detected in some"	9	"Early spermatids: 85.7;Late spermatids: 33.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"																		"unprognostic (1.54e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.5;Excitatory neurons: 118.2;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 86.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	1.1	6.0	23.0	0.7	23.3	3.6	2.7	42.0	20.6	2.4	0.7	1.6	0.9	5.0	8.3	0.9	3.0	2.2	2.1	20.6	39.4	2.2	0.8	1.6	1.5	3.4	14.6	5.6	1.8	3.9	5.9	0.5	10.3	3.6	0.8	11.7	1.5	3.8	1.4	1.7	1.2	2.3	5.5	2.3	1.4	5.2	32.2	1.0	6.0	0.7	1.1	1.3	1.7	14.8	0.2	2.0	2.1	3.4	0.5	0.5	0.6	0.4	1.0	2.0	1.7	0.2	0.9	0.3	0.3	0.8	1.5	0.7	1.1	0.9	1.2	0.1	1.3	1.0	3.2	2.3	0.6	0.4	0.2	0.8	0.5	1.1	0.5	1.7	1.8	1.4	0.8	0.5	0.5	2.2	0.1	0.4	9.7	1.3	0.7	0.2	2.9	0.3	1.1	0.8	4.8	2.2	1.0	0.5	0.4	2.1	1.2	0.3	0.5	0.6	1.0	1.1	1.5	0.4	1.3	0.2	0.8	0.3	0.3	3.1	0.4	0.3	2.7	0.2	1.6	0.8	1.7	1.3	0.1	1.2	3.3	3.6	1.5	1.1	0.4	0.5	1.1	0.8	23.0	23.3	42.0	20.6	20.6	39.4	3.4	14.6	10.3	5.5	32.2	14.8	1.6	0.0	6.3	33.0	1.4	0.8	6.3	1.5	2.2	46.5	2.0	7.6	4.0	1.5	4.0	7.3	20.9	1.1	3.0	0.2	5.9	1.0	20.3	2.6	1.9	2.0	3.0	0.0	118.2	2.0	0.5	6.1	1.5	3.5	0.0	4.9	1.4	2.1	0.3	35.3	122.4	0.1	0.0	0.9	1.9	8.6	4.7	0.6	1.8	13.1	0.4	19.1	5.2	54.3	86.8	1.0	1.1	10.1	0.2	4.2	0.8	0.2	1.6	26.8	6.6	5.5	3.5	11.0	4.1	0.6	1.4	0.7	2.6	6.3	0.2	3.7
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025824			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA025824: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	8.6	6.0	7.8	5.4	8.1	6.8	8.1	6.8	8.2	13.6	6.3	11.6	3.8	14.3	5.5	5.6	14.7	7.8	9.0	7.0	7.4	8.7	3.6	8.5	6.9	7.4	7.5	18.7	15.4	11.3	6.4	9.9	7.0	9.4	5.6	5.7	7.8	8.4	15.6	5.8	6.8	11.5	6.9	9.2	9.0	10.8	8.2	23.8	12.3	13.7	5.4	9.2	8.0	8.4	20.8	18.7	19.4	23.7	7.5	19.1	24.2	9.5	23.5	20.9	18.8	10.3	18.9	5.9	16.1	15.6	7.8	17.4	20.1	18.3	20.8	16.0	4.8	19.2	13.1	11.8	20.3	23.5	9.5	20.4	19.0	16.2	38.9	23.2	25.1	27.3	34.6	14.5	13.1	13.3	23.4	16.2	39.0	9.2	27.5	22.0	21.2	8.1	12.8	24.8	16.5	36.4	12.7	14.3	19.0	17.6	14.9	28.7	17.4	15.1	21.4	6.9	30.2	16.1	13.8	16.8	6.3	1.6	16.8	0.0	0.4	0.1	0.8	0.3	1.2	0.3	0.3	0.9	1.1	0.4	0.7	2.1	0.1	1.1	0.4	0.7	0.1	0.8	7.8	8.1	6.8	8.2	7.0	7.4	7.4	7.5	7.0	6.9	8.2	8.4	9.2	0.0	3.2	16.3	3.3	3.7	4.4	5.0	8.0	7.4	7.0	7.5	8.3	5.7	4.7	1.8	2.1	4.8	2.4	1.2	1.9	4.4	11.2	4.9	7.5	7.5	4.9	3.0	13.0	6.0	5.8	6.8	7.1	6.5	3.8	13.7	7.1	2.3	6.0	3.3	16.9	2.5	2.0	5.1	3.6	40.0	5.6	4.0	3.6	9.4	3.4	1.7	5.2	18.6	10.8	4.9	2.6	7.2	7.5	7.5	0.8	3.0	3.9	7.3	6.6	9.7	6.2	15.9	10.8	2.4	3.4	4.2	4.7	7.5	4.3	4.3
ZNF502	"FLJ12515, FLJ14855"	ENSG00000196653	"Zinc finger protein 502"	Q8TBZ5	3	44712643-44723831	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 16.2;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024761, HPA029557"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA024761: AB_10599830, HPA029557: AB_10601448"	"unprognostic (1.80e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (1.88e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.06e-4)"	3.0	3.1	1.5	0.9	1.8	0.8	3.5	2.7	1.7	4.2	1.2	3.9	0.8	4.6	1.3	2.6	4.1	0.9	2.8	1.6	1.8	4.2	2.1	1.9	1.2	1.6	1.7	5.3	4.0	1.3	4.2	1.8	1.5	4.9	1.5	5.2	3.2	2.2	3.2	3.6	2.6	1.9	1.5	3.4	3.1	5.0	1.8	1.4	3.8	2.3	1.1	3.9	3.4	1.5	0.0	0.7	1.9	0.0	2.1	3.0	0.0	1.6	0.4	1.9	1.1	0.1	0.9	0.0	0.5	1.5	2.0	1.0	0.0	2.4	1.6	0.0	0.9	0.0	0.0	0.0	2.3	0.0	0.9	2.4	0.9	2.2	0.0	0.5	1.4	0.0	0.0	0.0	1.9	0.0	0.0	0.5	3.1	0.5	0.0	0.0	1.2	0.0	2.2	2.4	2.0	2.5	0.9	1.6	0.0	2.2	0.0	0.0	1.8	0.0	1.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.4	0.6	0.3	1.0	0.8	1.0	0.8	0.5	1.2	1.5	1.2	0.0	1.2	0.3	0.3	0.2	0.3	1.5	1.8	2.7	1.7	1.6	1.8	1.6	1.7	1.5	1.5	1.8	1.5	4.0	6.4	5.1	3.3	3.9	1.7	3.3	3.2	4.0	12.0	2.4	3.6	4.5	2.8	4.4	3.7	14.6	2.5	3.3	1.4	0.0	3.2	3.1	1.0	3.4	5.4	4.9	1.7	3.0	3.0	1.3	3.2	1.5	1.5	2.5	5.6	4.2	1.6	1.1	10.1	5.9	1.6	4.1	0.8	0.7	2.9	4.7	1.0	0.0	3.7	2.1	11.5	2.1	3.0	2.6	2.7	1.1	6.8	0.5	3.4	2.0	1.6	3.1	16.2	0.0	4.6	2.8	14.1	17.8	2.6	2.6	1.5	1.9	4.3	3.0	1.9
ZNF507	"KIAA1084, Zfp507"	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: AB_2680864"	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	5.1	4.2	4.3	4.6	5.7	6.8	6.8	6.4	5.6	5.9	3.4	4.9	5.7	6.8	4.3	5.1	5.9	4.3	5.6	4.4	4.8	4.7	6.3	4.4	6.7	4.7	5.3	9.5	5.3	6.2	3.7	7.0	5.0	5.9	5.3	8.1	6.4	4.7	9.2	4.7	5.9	6.0	4.8	5.2	5.2	13.1	4.7	8.6	10.7	8.7	5.8	4.3	4.1	7.3	10.0	16.2	13.5	8.2	9.3	14.6	11.4	8.5	8.1	7.3	8.1	9.8	7.6	15.1	10.5	7.8	8.3	5.9	19.4	10.5	14.8	10.6	15.3	14.8	8.7	7.7	11.0	12.8	8.0	9.5	8.9	9.0	15.4	8.6	10.9	11.9	21.0	10.7	8.6	5.8	13.5	5.2	14.9	15.0	5.8	14.0	16.1	6.4	5.5	9.9	11.9	10.5	11.2	7.8	10.2	10.7	5.9	9.5	10.4	12.6	13.3	8.0	11.9	10.4	12.9	14.1	8.7	9.3	11.5	0.2	0.0	0.5	1.0	0.0	1.1	0.7	0.8	0.8	0.0	1.0	1.1	0.9	0.5	0.6	0.0	0.1	0.6	0.4	4.3	5.7	6.4	5.6	4.4	4.8	4.7	5.3	5.0	4.8	4.7	7.3	13.3	9.6	17.7	22.5	13.2	2.8	8.8	5.3	13.6	22.2	9.3	7.6	16.1	5.7	9.0	0.0	14.6	10.9	7.7	7.6	1.9	5.6	22.1	10.0	22.7	11.0	9.0	12.4	31.3	5.5	5.3	11.9	12.2	11.4	3.8	17.1	13.6	12.1	3.7	58.9	36.0	11.5	4.1	0.3	1.8	11.0	9.3	0.8	1.8	16.9	0.4	17.2	10.3	31.2	46.6	4.9	8.0	7.2	6.4	12.0	15.6	4.2	16.1	23.5	0.0	16.1	13.9	25.8	18.9	10.9	2.7	8.8	11.3	12.6	11.2	7.6
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956704-63969930	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.4;Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006688, HPA008731"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006688: AB_10963053, HPA008731: "	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	8.6	11.4	8.4	5.5	8.4	5.9	10.4	4.8	11.4	12.9	0.9	10.9	4.4	13.8	2.8	17.2	12.2	5.9	9.6	8.8	7.0	12.4	21.3	8.4	6.2	5.1	5.5	14.2	15.0	9.1	20.8	7.9	4.5	13.0	1.4	4.5	12.6	7.7	12.1	14.4	7.2	5.9	2.9	10.3	10.3	10.2	6.3	8.3	19.7	5.2	4.1	11.4	10.9	5.8	10.2	16.8	18.6	19.8	8.1	5.9	17.0	14.4	11.2	42.3	13.8	33.1	16.8	6.6	34.5	12.6	7.8	12.8	14.1	21.4	10.1	11.0	20.3	16.4	26.4	31.9	12.9	8.9	18.9	12.5	17.3	14.7	8.4	11.1	13.3	29.4	23.1	9.9	8.5	24.3	43.6	19.2	12.9	12.9	21.8	19.8	1.7	20.1	7.6	16.9	27.2	15.8	11.9	19.4	9.8	8.8	40.9	21.4	18.8	40.4	6.2	10.3	12.6	23.6	12.1	18.3	14.5	0.1	17.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.4	8.4	4.8	11.4	8.8	7.0	5.1	5.5	4.5	2.9	6.3	5.8	6.7	3.2	5.6	1.6	3.1	5.4	3.5	5.3	4.6	22.4	10.3	9.5	2.9	5.7	6.5	1.8	22.9	7.8	6.1	0.1	1.9	3.7	0.1	5.2	12.0	5.8	6.0	3.4	1.1	6.1	2.9	6.7	3.6	9.6	0.0	14.0	8.6	19.4	3.9	13.5	1.4	0.8	8.2	1.9	2.5	1.3	6.5	1.7	5.4	1.0	2.3	7.3	4.1	1.5	0.6	3.2	0.2	6.8	5.2	3.5	2.2	5.7	2.6	10.6	0.0	8.7	5.6	6.5	4.1	11.1	7.0	5.1	3.6	14.3	1.2	2.8
ZNF566	"FLJ14779, MGC12515"	ENSG00000186017	"Zinc finger protein 566"	Q969W8	19	36445119-36489902	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023456	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA023456: AB_2221143"	"unprognostic (1.68e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.89e-3)"	"unprognostic (5.71e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.19e-4)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.47e-3)"	4.1	5.0	5.0	3.6	5.0	3.2	4.2	7.9	6.6	4.5	4.5	4.7	3.2	4.6	4.4	2.8	5.0	2.9	4.7	4.5	5.0	3.9	5.7	3.7	4.2	4.6	4.7	6.3	3.9	4.7	5.0	2.6	4.9	4.0	2.6	5.5	3.0	3.1	4.7	3.8	4.0	4.1	4.5	4.4	3.7	2.4	5.1	3.4	4.7	6.0	4.3	4.2	3.6	5.9	3.7	9.1	10.3	11.5	7.6	7.6	7.1	7.3	6.2	9.0	9.5	3.8	1.5	7.3	7.7	4.6	4.0	2.6	9.5	2.5	10.1	11.7	7.1	7.3	6.2	3.2	5.4	7.9	8.5	6.6	3.8	4.8	7.3	4.2	3.5	7.5	10.8	0.1	6.3	6.0	10.3	3.8	12.5	6.7	4.0	6.7	8.2	4.9	2.7	7.3	9.7	14.4	8.9	4.9	7.0	4.9	4.4	10.7	3.7	7.8	10.8	3.2	7.0	2.8	8.4	10.0	0.3	5.0	10.5	6.5	1.1	1.6	3.9	1.2	6.5	6.5	5.0	4.9	2.3	5.3	6.0	6.1	1.0	4.0	1.3	1.6	5.6	2.5	5.0	5.0	7.9	6.6	4.5	5.0	4.6	4.7	4.9	4.5	5.1	5.9	7.6	9.6	7.7	14.0	9.3	3.3	4.2	4.4	7.4	22.3	4.5	3.0	10.2	4.3	7.4	5.5	35.5	6.7	8.4	1.6	11.7	4.5	4.1	4.2	8.1	8.1	3.0	8.0	24.0	2.5	3.2	10.5	3.1	4.0	2.5	10.6	10.0	4.3	4.4	32.0	26.9	4.5	6.1	3.2	3.9	0.6	8.4	3.5	10.6	11.2	2.5	8.6	8.2	14.1	20.7	2.3	4.7	14.7	5.2	5.1	2.8	6.8	4.0	22.2	19.7	12.2	9.6	11.4	5.7	5.7	3.3	1.9	9.3	9.6	4.9	2.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 48.9;Hepatocytes: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.30e-4)"	2.4	3.1	1.5	3.2	1.6	1.4	2.5	2.8	2.1	2.6	1.9	2.6	1.9	2.6	3.5	3.6	2.5	2.2	2.2	1.5	1.3	2.6	4.3	2.4	4.2	1.2	1.1	2.7	3.9	3.7	2.8	2.4	1.3	2.7	1.9	3.7	3.5	3.0	1.5	2.7	3.4	1.5	0.6	4.2	3.0	1.8	1.2	2.7	3.7	1.8	4.0	2.6	2.9	1.8	3.4	6.4	4.1	3.8	3.6	3.3	2.9	3.9	3.1	3.1	4.8	4.2	2.3	3.1	2.5	1.9	3.1	2.8	2.6	2.2	3.5	5.3	3.6	4.8	5.5	4.0	3.2	5.0	3.8	3.4	2.4	3.2	2.6	4.2	3.3	3.3	5.5	5.0	2.7	2.0	2.0	1.6	3.3	3.3	2.0	1.6	7.2	1.8	2.6	7.0	2.5	4.8	5.8	2.2	2.5	3.6	2.7	6.0	2.5	3.8	5.1	3.5	3.2	4.9	4.6	3.0	2.4	3.4	2.6	1.4	2.4	4.0	1.6	2.3	2.3	1.8	1.8	1.5	2.1	1.4	2.5	2.1	2.1	1.6	3.8	1.6	2.1	1.1	1.5	1.6	2.8	2.1	1.5	1.3	1.2	1.1	1.3	0.6	1.2	1.8	8.5	9.6	10.2	6.2	8.1	3.8	4.5	15.2	6.2	5.8	9.4	5.7	4.0	8.6	11.6	9.2	2.1	5.9	7.0	7.0	9.8	14.5	25.0	4.1	5.5	8.4	3.5	3.4	7.8	48.9	8.5	6.0	2.0	4.5	16.5	4.2	12.8	37.7	15.0	5.0	5.7	7.4	4.1	25.4	11.5	3.6	4.4	11.4	12.4	9.4	12.0	3.9	17.5	4.0	6.5	32.6	7.1	5.3	5.8	3.2	14.1	21.7	13.5	7.3	6.6	4.4	5.1	9.8	4.0	5.2	2.6	5.9	11.8	5.7	7.6	3.4
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 132.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria		No	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	17.1	9.4	9.7	14.3	10.7	28.7	12.4	9.1	9.8	10.1	12.1	11.2	11.0	11.3	9.0	8.1	10.7	14.1	13.2	8.9	9.4	11.8	9.6	18.8	14.2	14.0	11.0	9.9	9.2	13.0	8.5	12.3	10.8	9.7	10.5	8.7	10.3	9.6	15.5	11.8	12.4	13.6	13.3	19.1	11.4	13.4	11.9	13.1	13.8	14.5	13.4	16.5	9.0	11.3	16.3	24.9	5.8	8.2	31.4	24.5	9.8	21.6	50.9	132.7	54.9	28.4	13.2	13.5	27.3	43.5	37.6	30.7	10.8	29.3	45.1	12.8	3.6	16.0	18.1	12.5	27.2	13.0	18.7	26.3	26.9	29.7	22.0	24.3	20.3	8.0	12.4	16.2	33.6	6.8	14.2	8.7	5.6	14.0	20.7	8.9	19.6	3.8	21.8	22.1	5.9	4.3	31.6	61.1	22.4	7.1	15.7	10.8	50.9	64.8	18.3	23.8	21.1	10.7	4.0	7.2	26.0	8.7	14.6	19.3	12.3	20.1	13.5	15.2	12.0	9.4	13.6	13.1	9.1	7.1	12.9	10.0	51.9	9.9	27.1	5.2	11.0	11.5	9.7	10.7	9.1	9.8	8.9	9.4	14.0	11.0	10.8	13.3	11.9	11.3	36.5	41.7	27.2	10.4	25.8	27.8	21.2	14.4	19.4	15.7	13.7	11.2	14.4	10.0	24.8	20.2	10.4	6.1	18.7	28.0	0.0	23.9	37.4	15.9	17.9	38.1	13.1	10.7	12.5	22.7	7.0	28.0	28.5	18.6	27.3	8.1	29.3	13.4	15.1	11.8	11.7	14.2	16.2	26.4	38.0	21.1	22.7	34.2	19.6	15.0	30.2	29.5	17.5	7.1	9.9	32.3	21.8	27.1	9.3	32.8	18.7	6.7	42.8	15.1	0.0	27.8	29.9	42.0	16.3	16.2	21.7	11.4	31.4	10.2	10.4	35.7
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081289	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	41.0	39.4	29.7	45.3	31.1	60.0	52.6	36.9	47.0	45.0	36.8	40.8	35.5	70.7	67.6	29.3	45.4	29.6	42.7	30.7	29.1	35.3	30.2	40.4	62.5	32.0	27.7	56.7	33.8	33.2	64.5	36.3	31.6	44.2	42.9	62.1	39.5	38.0	58.9	43.4	37.9	50.1	29.3	42.6	35.6	50.4	30.3	47.6	48.5	38.9	49.3	37.9	35.2	38.8	86.8	31.1	122.3	73.0	46.5	79.8	71.0	103.2	55.6	89.2	113.2	58.7	55.5	177.6	89.0	64.2	82.7	53.5	111.1	63.9	133.4	127.5	79.9	154.5	127.3	50.0	70.8	171.5	62.7	61.7	80.3	86.1	73.5	98.1	76.3	90.3	165.1	93.6	69.6	29.3	145.0	58.4	128.7	52.9	59.6	159.8	92.3	108.4	60.5	72.6	93.8	58.3	88.7	58.8	91.4	63.7	74.7	76.8	102.5	65.9	62.1	51.9	103.8	75.7	100.6	193.8	96.4	160.3	94.6	99.1	33.4	32.1	44.5	32.3	51.2	68.8	47.5	44.0	26.8	63.1	61.2	48.7	30.7	48.2	33.8	73.4	49.6	31.2	29.7	31.1	36.9	47.0	30.7	29.1	32.0	27.7	31.6	29.3	30.3	38.8	86.9	99.3	154.5	83.6	109.8	50.6	94.4	66.1	59.7	166.5	61.4	66.5	99.9	50.1	68.4	49.7	129.3	55.1	136.9	85.8	49.0	60.2	190.3	79.9	123.5	63.5	73.0	87.1	135.3	68.2	50.4	92.6	62.7	85.7	87.4	132.8	50.7	41.8	45.4	213.7	114.7	64.5	54.9	34.5	39.7	46.2	185.4	55.7	48.0	73.1	74.8	116.6	139.0	90.5	131.9	69.2	76.5	115.5	127.5	54.8	41.2	41.1	76.5	202.2	118.3	88.1	99.2	218.7	113.0	55.3	46.5	63.5	89.6	96.4	55.1	68.5
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099295	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.0	0.0	0.3	0.0	0.6	0.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	56.8	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	5.8	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.9	0.7	0.3	0.9	0.4	0.2	0.5	0.1	0.5	1.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0
ZSWIM2	"MEX, MGC33890, ZZZ2"	ENSG00000163012	"Zinc finger SWIM-type containing 2"	Q8NEG5	2	186827475-186849208	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 9.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 61.1;Late spermatids: 18.6;Spermatocytes: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"								"unprognostic (2.00e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	61.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	18.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ZSWIM4	FLJ12221	ENSG00000132003	"Zinc finger SWIM-type containing 4"	Q9H7M6	19	13795460-13832230	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.6"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 34.2;Urothelial cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042084	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA042084: AB_10795392"	"unprognostic (3.29e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.25e-3)"	"unprognostic (6.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (3.47e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.63e-2)"	3.3	5.3	0.8	2.0	0.8	1.0	4.9	0.9	1.9	5.6	1.4	2.8	1.1	4.2	0.2	16.6	3.3	1.4	4.1	0.8	1.2	6.2	1.9	7.1	1.2	1.5	1.2	3.6	3.9	1.0	4.7	1.6	1.3	5.0	0.3	1.1	14.8	0.8	2.9	8.5	3.0	0.9	0.8	4.1	3.5	1.4	1.4	1.4	5.8	0.8	1.3	3.2	7.6	0.9	4.3	2.4	4.7	2.4	0.6	0.5	4.5	1.8	3.9	1.6	1.7	0.9	2.3	1.5	2.8	1.5	2.5	1.7	0.8	1.6	1.1	5.4	1.5	0.2	3.0	0.5	3.8	0.4	1.2	2.5	0.4	1.8	0.7	3.9	3.8	3.6	1.4	3.2	0.5	2.3	2.4	3.4	5.5	0.8	2.4	5.3	4.4	2.5	2.2	2.0	1.3	9.1	3.1	7.6	3.3	2.7	1.1	2.8	4.5	4.7	1.7	1.4	6.2	3.9	2.5	1.0	3.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.9	1.9	0.8	1.2	1.5	1.2	1.3	0.8	1.4	0.9	5.5	3.2	2.0	4.9	2.4	5.4	17.1	8.6	2.8	5.4	11.9	6.9	3.3	8.6	7.4	3.7	8.4	4.2	2.0	3.3	0.0	13.1	0.2	11.1	5.0	10.4	10.7	1.7	5.8	23.1	3.4	6.0	4.1	23.0	0.0	3.7	4.6	1.8	4.6	6.7	7.0	3.0	2.0	7.0	11.9	0.4	1.2	5.6	3.6	5.6	3.8	2.4	0.0	6.0	1.8	23.8	2.3	1.2	1.5	14.3	3.9	3.2	12.6	3.7	0.0	34.2	6.4	0.3	0.9	4.9	7.0	6.0	6.8	0.7	3.9	26.8
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773735	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	6.9	6.0	3.5	8.1	4.1	9.2	10.9	5.0	4.8	8.1	3.7	8.3	7.2	7.6	7.3	9.6	6.1	5.9	5.6	3.8	3.8	8.8	13.0	6.4	9.4	4.2	4.7	6.9	9.1	7.2	5.1	7.7	4.6	7.9	10.0	6.8	8.3	7.3	13.4	13.7	7.1	8.7	3.8	7.0	7.3	13.5	4.2	12.1	6.7	12.0	12.0	8.5	7.5	5.7	25.0	14.4	30.2	22.1	18.4	20.0	17.4	26.1	21.4	32.2	32.5	38.1	46.1	29.0	34.5	25.8	28.1	34.2	36.7	31.6	46.0	19.1	15.1	30.9	12.0	23.5	20.6	31.7	18.8	16.5	20.8	34.1	27.4	14.2	33.5	31.7	36.3	11.8	33.8	12.2	29.3	20.9	21.7	29.8	29.0	27.0	34.4	32.7	21.2	22.2	13.3	15.7	29.1	24.2	11.8	24.2	44.9	17.4	21.1	28.8	44.2	14.4	28.8	6.1	10.6	30.6	9.9	38.1	33.0	8.5	7.4	7.4	6.3	10.4	8.5	5.9	5.9	5.6	9.5	5.1	5.4	6.8	1.9	6.2	9.2	3.0	5.6	5.6	3.5	4.1	5.0	4.8	3.8	3.8	4.2	4.7	4.6	3.8	4.2	5.7	5.6	0.0	4.8	11.1	5.8	12.1	7.6	7.5	8.0	2.9	5.9	5.0	6.8	7.2	7.3	0.0	0.0	9.2	3.9	3.9	9.8	10.1	10.7	7.7	7.1	6.9	3.6	10.7	12.5	11.8	10.0	6.5	8.2	12.7	3.8	7.8	3.9	8.1	9.2	3.3	11.1	4.6	4.1	6.0	5.4	7.3	5.0	6.1	3.6	10.3	8.0	7.6	3.1	12.1	18.7	8.4	3.8	5.7	10.4	5.6	5.3	7.2	4.8	4.9	19.7	7.0	7.0	44.4	17.5	9.4	12.5	10.5	5.9	6.9	6.4	5.8
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4